id|nct_id|result_group_id|ctgov_group_code|title|period|description|count
854961|NCT03231371|2069870|P1|NOT COMPLETED|Overall Study||13
854962|NCT03231371|2069870|P1|COMPLETED|Overall Study||9
854963|NCT03231371|2069870|P1|Optional and Age Limited (12 Yrs+) MRI|Overall Study||9
854964|NCT03231371|2069870|P1|STARTED|Overall Study||22
854965|NCT03163134|2069877|P2|NOT COMPLETED|Overall Study||0
854966|NCT03163134|2069878|P1|NOT COMPLETED|Overall Study||0
854967|NCT03163134|2069877|P2|COMPLETED|Overall Study||85
854968|NCT03163134|2069878|P1|COMPLETED|Overall Study||85
854969|NCT03163134|2069877|P2|STARTED|Overall Study||85
854970|NCT03163134|2069878|P1|STARTED|Overall Study||85
854971|NCT03159143|2069886|P1|NOT COMPLETED|Overall Study||0
854972|NCT03159143|2069886|P1|COMPLETED|Overall Study||22
854973|NCT03159143|2069886|P1|STARTED|Overall Study||22
854974|NCT03157232|2069893|P1|NOT COMPLETED|Overall Study||0
854975|NCT03157232|2069893|P1|COMPLETED|Overall Study||18
854976|NCT03157232|2069893|P1|STARTED|Overall Study||18
854977|NCT03134326|2069897|P1|NOT COMPLETED|Overall Study||0
854978|NCT03134326|2069897|P1|COMPLETED|Overall Study||21
854979|NCT03134326|2069897|P1|STARTED|Overall Study||21
854980|NCT03134313|2069901|P1|NOT COMPLETED|Overall Study||0
854981|NCT03134313|2069901|P1|COMPLETED|Overall Study||25
854982|NCT03134313|2069901|P1|STARTED|Overall Study||25
854983|NCT03125031|2069905|P2|NOT COMPLETED|Overall Study||0
854984|NCT03125031|2069906|P1|NOT COMPLETED|Overall Study||0
854985|NCT03125031|2069905|P2|COMPLETED|Overall Study||44
854986|NCT03125031|2069906|P1|COMPLETED|Overall Study||44
854987|NCT03125031|2069905|P2|STARTED|Overall Study||44
854988|NCT03125031|2069906|P1|STARTED|Overall Study||44
854989|NCT03125018|2069911|P1|NOT COMPLETED|Overall Study||0
854990|NCT03125018|2069911|P1|COMPLETED|Overall Study||13
854991|NCT03125018|2069911|P1|STARTED|Overall Study||13
854992|NCT03125005|2069915|P1|NOT COMPLETED|Overall Study||0
854993|NCT03125005|2069915|P1|COMPLETED|Overall Study||51
854994|NCT03125005|2069915|P1|STARTED|Overall Study||51
854995|NCT03124979|2069919|P1|NOT COMPLETED|Overall Study||0
854996|NCT03124979|2069919|P1|COMPLETED|Overall Study||13
854997|NCT03124979|2069919|P1|STARTED|Overall Study||13
854998|NCT03124966|2069923|P1|NOT COMPLETED|Overall Study||0
854999|NCT03124966|2069923|P1|COMPLETED|Overall Study||118
855000|NCT03124966|2069923|P1|STARTED|Overall Study||118
855001|NCT03124927|2069927|P1|NOT COMPLETED|Overall Study||0
855002|NCT03124927|2069927|P1|COMPLETED|Overall Study||25
855003|NCT03124927|2069927|P1|STARTED|Overall Study||25
855004|NCT03124901|2069931|P1|NOT COMPLETED|Overall Study||0
855005|NCT03124901|2069931|P1|COMPLETED|Overall Study||147
855006|NCT03124901|2069931|P1|STARTED|Overall Study||147
855007|NCT03124836|2069935|P1|NOT COMPLETED|Overall Study||0
855008|NCT03124836|2069935|P1|COMPLETED|Overall Study||28
855009|NCT03124836|2069935|P1|STARTED|Overall Study||28
855010|NCT03124823|2069939|P1|NOT COMPLETED|Overall Study||0
855011|NCT03124823|2069939|P1|COMPLETED|Overall Study||11
855012|NCT03124823|2069939|P1|STARTED|Overall Study||11
855013|NCT03124797|2069943|P1|NOT COMPLETED|Overall Study||0
855014|NCT03124797|2069943|P1|COMPLETED|Overall Study||18
855015|NCT03124797|2069943|P1|STARTED|Overall Study||18
855016|NCT03124771|2069947|P1|NOT COMPLETED|Overall Study||0
855017|NCT03124771|2069947|P1|COMPLETED|Overall Study||132
855018|NCT03124771|2069947|P1|STARTED|Overall Study||132
855019|NCT03124758|2069951|P1|NOT COMPLETED|Overall Study||0
855020|NCT03124758|2069951|P1|COMPLETED|Overall Study||354
855021|NCT03124758|2069951|P1|STARTED|Overall Study||354
855022|NCT03124693|2069955|P1|NOT COMPLETED|Overall Study||0
855023|NCT03124693|2069955|P1|COMPLETED|Overall Study||90
855024|NCT03124693|2069955|P1|STARTED|Overall Study||90
855025|NCT03119831|2069962|P3|NOT COMPLETED|Overall Study||0
855026|NCT03119831|2069963|P2|NOT COMPLETED|Overall Study||0
855027|NCT03119831|2069964|P1|NOT COMPLETED|Overall Study||0
855028|NCT03119831|2069962|P3|COMPLETED|Overall Study||14
855029|NCT03119831|2069963|P2|COMPLETED|Overall Study||14
855030|NCT03119831|2069964|P1|COMPLETED|Overall Study||14
855031|NCT03119831|2069962|P3|STARTED|Overall Study||14
855032|NCT03119831|2069963|P2|STARTED|Overall Study||14
855033|NCT03119831|2069964|P1|STARTED|Overall Study||14
855034|NCT03115853|2069981|P1|NOT COMPLETED|Overall Study||0
855035|NCT03115853|2069981|P1|COMPLETED|Overall Study||31
855036|NCT03115853|2069981|P1|STARTED|Overall Study||31
855037|NCT03106870|2070001|P2|NOT COMPLETED|Overall Study||0
855038|NCT03106870|2070002|P1|NOT COMPLETED|Overall Study||0
855039|NCT03106870|2070001|P2|COMPLETED|Overall Study||31
855040|NCT03106870|2070002|P1|COMPLETED|Overall Study||31
855041|NCT03106870|2070001|P2|STARTED|Overall Study||31
855042|NCT03106870|2070002|P1|STARTED|Overall Study||31
855043|NCT03106337|2070012|P1|NOT COMPLETED|Overall Study||0
855044|NCT03106337|2070012|P1|COMPLETED|Overall Study||35
855045|NCT03106337|2070012|P1|STARTED|Overall Study||35
855046|NCT03091751|2070017|P1|NOT COMPLETED|Overall Study||0
855047|NCT03091751|2070017|P1|COMPLETED|Overall Study||22
855048|NCT03091751|2070017|P1|STARTED|Overall Study||22
855052|NCT03072719|2070038|P2|NOT COMPLETED|Overall Study||1
855053|NCT03072719|2070039|P1|NOT COMPLETED|Overall Study||1
855054|NCT03072719|2070038|P2|COMPLETED|Overall Study||59
855055|NCT03072719|2070039|P1|COMPLETED|Overall Study||59
855056|NCT03072719|2070038|P2|STARTED|Overall Study||60
855057|NCT03072719|2070039|P1|STARTED|Overall Study||60
855058|NCT03070730|2070052|P3|NOT COMPLETED|Overall Study||0
855059|NCT03070730|2070053|P2|NOT COMPLETED|Overall Study||0
855060|NCT03070730|2070054|P1|NOT COMPLETED|Overall Study||0
855061|NCT03070730|2070052|P3|COMPLETED|Overall Study||0
855062|NCT03070730|2070053|P2|COMPLETED|Overall Study||0
855063|NCT03070730|2070054|P1|COMPLETED|Overall Study||0
855064|NCT03070730|2070052|P3|STARTED|Overall Study||0
855065|NCT03070730|2070053|P2|STARTED|Overall Study||0
855066|NCT03070730|2070054|P1|STARTED|Overall Study||0
855067|NCT03065933|2070185|P1|NOT COMPLETED|Overall Study||5
855068|NCT03065933|2070185|P1|COMPLETED|Overall Study||0
855069|NCT03065933|2070185|P1|STARTED|Overall Study||5
855070|NCT03061513|2070191|P2|NOT COMPLETED|Overall Study||1
855071|NCT03061513|2070192|P1|NOT COMPLETED|Overall Study||0
855072|NCT03061513|2070191|P2|COMPLETED|Overall Study||4
855073|NCT03061513|2070192|P1|COMPLETED|Overall Study||6
855074|NCT03061513|2070191|P2|STARTED|Overall Study||5
855075|NCT03061513|2070192|P1|STARTED|Overall Study||6
855076|NCT03055221|2070200|P1|NOT COMPLETED|Overall Study||16
855077|NCT03055221|2070200|P1|COMPLETED|Overall Study||0
855078|NCT03055221|2070200|P1|STARTED|Overall Study||16
855085|NCT03048383|2070217|P3|NOT COMPLETED|Overall Study||12
855086|NCT03048383|2070218|P2|NOT COMPLETED|Overall Study||8
855087|NCT03048383|2070219|P1|NOT COMPLETED|Overall Study||13
855088|NCT03048383|2070217|P3|COMPLETED|Overall Study||10
855089|NCT03048383|2070218|P2|COMPLETED|Overall Study||13
855090|NCT03048383|2070219|P1|COMPLETED|Overall Study||15
855091|NCT03048383|2070217|P3|STARTED|Overall Study||22
855092|NCT03048383|2070218|P2|STARTED|Overall Study||21
855093|NCT03048383|2070219|P1|STARTED|Overall Study||28
855094|NCT03048006|2070230|P1|NOT COMPLETED|Overall Study||0
855095|NCT03048006|2070230|P1|COMPLETED|Overall Study||44456
855096|NCT03048006|2070230|P1|STARTED|Overall Study||44456
855097|NCT03047447|2070239|P3|NOT COMPLETED|Overall Study||0
855098|NCT03047447|2070240|P2|NOT COMPLETED|Overall Study||0
855099|NCT03047447|2070241|P1|NOT COMPLETED|Overall Study||0
855100|NCT03047447|2070239|P3|COMPLETED|Overall Study||10
855101|NCT03047447|2070240|P2|COMPLETED|Overall Study||10
855102|NCT03047447|2070241|P1|COMPLETED|Overall Study||10
855103|NCT03047447|2070239|P3|STARTED|Overall Study||10
855104|NCT03047447|2070240|P2|STARTED|Overall Study||10
855105|NCT03047447|2070241|P1|STARTED|Overall Study||10
855106|NCT03043534|2070263|P2|NOT COMPLETED|Overall Study||0
855107|NCT03043534|2070264|P1|NOT COMPLETED|Overall Study||0
855108|NCT03043534|2070263|P2|COMPLETED|Overall Study||14
855109|NCT03043534|2070264|P1|COMPLETED|Overall Study||15
855110|NCT03043534|2070263|P2|STARTED|Overall Study||14
855111|NCT03043534|2070264|P1|STARTED|Overall Study||15
855112|NCT03041298|2070272|P1|NOT COMPLETED|Overall Study||0
855113|NCT03041298|2070272|P1|COMPLETED|Overall Study||1537
855114|NCT03041298|2070272|P1|STARTED|Overall Study||1537
855115|NCT03039179|2070282|P2|NOT COMPLETED|Overall Study||0
855116|NCT03039179|2070283|P1|NOT COMPLETED|Overall Study||0
855117|NCT03039179|2070282|P2|COMPLETED|Overall Study||42
855118|NCT03039179|2070283|P1|COMPLETED|Overall Study||38
855119|NCT03039179|2070282|P2|STARTED|Overall Study||42
855120|NCT03039179|2070283|P1|STARTED|Overall Study||38
855121|NCT03037541|2070293|P2|NOT COMPLETED|Overall Study||0
855122|NCT03037541|2070294|P1|NOT COMPLETED|Overall Study||0
855123|NCT03037541|2070293|P2|COMPLETED|Overall Study||30
855124|NCT03037541|2070294|P1|COMPLETED|Overall Study||30
855125|NCT03037541|2070293|P2|STARTED|Overall Study||30
855126|NCT03037541|2070294|P1|STARTED|Overall Study||30
855127|NCT03035955|2070304|P2|NOT COMPLETED|Overall Study||1
855128|NCT03035955|2070305|P1|NOT COMPLETED|Overall Study||1
855129|NCT03035955|2070304|P2|COMPLETED|Overall Study||9
855130|NCT03035955|2070305|P1|COMPLETED|Overall Study||9
855131|NCT03035955|2070304|P2|STARTED|Overall Study||10
855132|NCT03035955|2070305|P1|STARTED|Overall Study||10
855133|NCT03028987|2070313|P2|NOT COMPLETED|Overall Study||0
855134|NCT03028987|2070314|P1|NOT COMPLETED|Overall Study||0
855135|NCT03028987|2070313|P2|COMPLETED|Overall Study||5
855136|NCT03028987|2070314|P1|COMPLETED|Overall Study||5
855137|NCT03028987|2070313|P2|STARTED|Overall Study||5
855138|NCT03028987|2070314|P1|STARTED|Overall Study||5
855139|NCT03026803|2070322|P1|NOT COMPLETED|Overall Study||0
855140|NCT03026803|2070322|P1|COMPLETED|Overall Study||4
855141|NCT03026803|2070322|P1|STARTED|Overall Study||4
855142|NCT03023709|2070328|P2|NOT COMPLETED|Overall Study||0
855143|NCT03023709|2070329|P1|NOT COMPLETED|Overall Study||0
855144|NCT03023709|2070328|P2|COMPLETED|Overall Study||0
855145|NCT03023709|2070329|P1|COMPLETED|Overall Study||3
855146|NCT03023709|2070328|P2|STARTED|Overall Study||0
855147|NCT03023709|2070329|P1|STARTED|Overall Study||3
855148|NCT03023683|2070339|P2|NOT COMPLETED|Overall Study||1
855149|NCT03023683|2070340|P1|NOT COMPLETED|Overall Study||0
855150|NCT03023683|2070339|P2|COMPLETED|Overall Study||17
855151|NCT03023683|2070340|P1|COMPLETED|Overall Study||0
855152|NCT03023683|2070339|P2|STARTED|Overall Study||18
855153|NCT03023683|2070340|P1|STARTED|Overall Study||0
855154|NCT03023553|2070350|P2|NOT COMPLETED|Overall Study||1
855155|NCT03023553|2070351|P1|NOT COMPLETED|Overall Study||0
855156|NCT03023553|2070350|P2|COMPLETED|Overall Study||8
855157|NCT03023553|2070351|P1|COMPLETED|Overall Study||4
855158|NCT03023553|2070350|P2|STARTED|Overall Study||9
855159|NCT03023553|2070351|P1|STARTED|Overall Study||4
855160|NCT03023488|2070359|P1|NOT COMPLETED|Overall Study||0
855161|NCT03023488|2070359|P1|COMPLETED|Overall Study||46
855162|NCT03023488|2070359|P1|STARTED|Overall Study||46
855163|NCT03023176|2070372|P1|NOT COMPLETED|Overall Study||0
855164|NCT03023176|2070372|P1|COMPLETED|Overall Study||20
855165|NCT03023176|2070372|P1|STARTED|Overall Study||20
855166|NCT03023137|2070379|P2|NOT COMPLETED|Overall Study||9
855167|NCT03023137|2070380|P1|NOT COMPLETED|Overall Study||4
855168|NCT03023137|2070379|P2|COMPLETED|Overall Study||162
855169|NCT03023137|2070380|P1|COMPLETED|Overall Study||174
855170|NCT03023137|2070379|P2|STARTED|Overall Study||171
855171|NCT03023137|2070380|P1|STARTED|Overall Study||178
855172|NCT03022435|2070411|P5|NOT COMPLETED|Overall Study||0
855173|NCT03022435|2070412|P4|NOT COMPLETED|Overall Study||0
855174|NCT03022435|2070413|P3|NOT COMPLETED|Overall Study||0
855175|NCT03022435|2070414|P2|NOT COMPLETED|Overall Study||0
855176|NCT03022435|2070415|P1|NOT COMPLETED|Overall Study||0
855177|NCT03022435|2070411|P5|COMPLETED|Overall Study||3
855178|NCT03022435|2070412|P4|COMPLETED|Overall Study||3
855179|NCT03022435|2070413|P3|COMPLETED|Overall Study||6
855180|NCT03022435|2070414|P2|COMPLETED|Overall Study||5
855181|NCT03022435|2070415|P1|COMPLETED|Overall Study||5
855182|NCT03022435|2070411|P5|STARTED|Overall Study||3
855183|NCT03022435|2070412|P4|STARTED|Overall Study||3
855184|NCT03022435|2070413|P3|STARTED|Overall Study||6
855185|NCT03022435|2070414|P2|STARTED|Overall Study||5
855186|NCT03022435|2070415|P1|STARTED|Overall Study||5
855187|NCT03022422|2070438|P6|NOT COMPLETED|Overall Study||0
855188|NCT03022422|2070439|P5|NOT COMPLETED|Overall Study||0
855189|NCT03022422|2070440|P4|NOT COMPLETED|Overall Study||0
855190|NCT03022422|2070441|P3|NOT COMPLETED|Overall Study||3
855191|NCT03022422|2070442|P2|NOT COMPLETED|Overall Study||0
855192|NCT03022422|2070443|P1|NOT COMPLETED|Overall Study||0
855193|NCT03022422|2070438|P6|COMPLETED|Overall Study||5
855194|NCT03022422|2070439|P5|COMPLETED|Overall Study||5
855195|NCT03022422|2070440|P4|COMPLETED|Overall Study||12
855196|NCT03022422|2070441|P3|COMPLETED|Overall Study||20
855197|NCT03022422|2070442|P2|COMPLETED|Overall Study||10
855198|NCT03022422|2070443|P1|COMPLETED|Overall Study||8
855199|NCT03022422|2070438|P6|STARTED|Overall Study||5
855200|NCT03022422|2070439|P5|STARTED|Overall Study||5
855201|NCT03022422|2070440|P4|STARTED|Overall Study||12
855202|NCT03022422|2070441|P3|STARTED|Overall Study||23
855203|NCT03022422|2070442|P2|STARTED|Overall Study||10
855204|NCT03022422|2070443|P1|STARTED|Overall Study||8
855205|NCT03022396|2070469|P6|NOT COMPLETED|Overall Study||0
855206|NCT03022396|2070470|P5|NOT COMPLETED|Overall Study||0
855207|NCT03022396|2070471|P4|NOT COMPLETED|Overall Study||0
855208|NCT03022396|2070472|P3|NOT COMPLETED|Overall Study||0
855209|NCT03022396|2070473|P2|NOT COMPLETED|Overall Study||0
855210|NCT03022396|2070474|P1|NOT COMPLETED|Overall Study||0
855211|NCT03022396|2070469|P6|COMPLETED|Overall Study||8
855212|NCT03022396|2070470|P5|COMPLETED|Overall Study||14
855213|NCT03022396|2070471|P4|COMPLETED|Overall Study||20
855214|NCT03022396|2070472|P3|COMPLETED|Overall Study||10
855215|NCT03022396|2070473|P2|COMPLETED|Overall Study||14
855216|NCT03022396|2070474|P1|COMPLETED|Overall Study||16
855217|NCT03022396|2070469|P6|STARTED|Overall Study||8
855218|NCT03022396|2070470|P5|STARTED|Overall Study||14
855219|NCT03022396|2070471|P4|STARTED|Overall Study||20
855220|NCT03022396|2070472|P3|STARTED|Overall Study||10
855221|NCT03022396|2070473|P2|STARTED|Overall Study||14
855222|NCT03022396|2070474|P1|STARTED|Overall Study||16
855223|NCT03020537|2070496|P2|NOT COMPLETED|Overall Study||0
855224|NCT03020537|2070497|P1|NOT COMPLETED|Overall Study||0
855225|NCT03020537|2070496|P2|COMPLETED|Overall Study||7
855226|NCT03020537|2070497|P1|COMPLETED|Overall Study||1
855227|NCT03020537|2070496|P2|STARTED|Overall Study||7
855228|NCT03020537|2070497|P1|STARTED|Overall Study||1
855229|NCT03020498|2070508|P3|NOT COMPLETED|Overall Study||0
855230|NCT03020498|2070509|P2|NOT COMPLETED|Overall Study||3
855231|NCT03020498|2070510|P1|NOT COMPLETED|Overall Study||0
855232|NCT03020498|2070508|P3|COMPLETED|Overall Study||36
855233|NCT03020498|2070509|P2|COMPLETED|Overall Study||38
855234|NCT03020498|2070510|P1|COMPLETED|Overall Study||14
855235|NCT03020498|2070508|P3|STARTED|Overall Study||36
855236|NCT03020498|2070509|P2|STARTED|Overall Study||41
855237|NCT03020498|2070510|P1|STARTED|Overall Study||14
855238|NCT03020472|2070521|P1|NOT COMPLETED|Overall Study||0
855239|NCT03020472|2070521|P1|COMPLETED|Overall Study||6
855240|NCT03020472|2070521|P1|STARTED|Overall Study||6
855241|NCT03019783|2070529|P2|NOT COMPLETED|Overall Study||0
855242|NCT03019783|2070530|P1|NOT COMPLETED|Overall Study||0
855243|NCT03019783|2070529|P2|COMPLETED|Overall Study||31
855244|NCT03019783|2070530|P1|COMPLETED|Overall Study||29
855245|NCT03019783|2070529|P2|STARTED|Overall Study||31
855246|NCT03019783|2070530|P1|STARTED|Overall Study||29
855247|NCT03002454|2070538|P1|NOT COMPLETED|Overall Study||0
855248|NCT03002454|2070538|P1|COMPLETED|Overall Study||4
855249|NCT03002454|2070538|P1|STARTED|Overall Study||4
855250|NCT03001674|2070545|P2|NOT COMPLETED|Overall Study||0
855251|NCT03001674|2070546|P1|NOT COMPLETED|Overall Study||0
855252|NCT03001674|2070545|P2|COMPLETED|Overall Study||5
855253|NCT03001674|2070546|P1|COMPLETED|Overall Study||10
855254|NCT03001674|2070545|P2|STARTED|Overall Study||5
855255|NCT03001674|2070546|P1|STARTED|Overall Study||10
855256|NCT03001258|2070555|P3|NOT COMPLETED|Overall Study||0
855257|NCT03001258|2070556|P2|NOT COMPLETED|Overall Study||0
855258|NCT03001258|2070557|P1|NOT COMPLETED|Overall Study||0
855259|NCT03001258|2070555|P3|COMPLETED|Overall Study||485
855260|NCT03001258|2070556|P2|COMPLETED|Overall Study||751
855261|NCT03001258|2070557|P1|COMPLETED|Overall Study||765
855262|NCT03001258|2070555|P3|STARTED|Overall Study||485
855263|NCT03001258|2070556|P2|STARTED|Overall Study||751
855264|NCT03001258|2070557|P1|STARTED|Overall Study||765
855265|NCT03000088|2070567|P2|NOT COMPLETED|Overall Study||0
855266|NCT03000088|2070568|P1|NOT COMPLETED|Overall Study||0
855267|NCT03000088|2070567|P2|COMPLETED|Overall Study||70
855268|NCT03000088|2070568|P1|COMPLETED|Overall Study||70
855269|NCT03000088|2070567|P2|STARTED|Overall Study||70
855270|NCT03000088|2070568|P1|STARTED|Overall Study||70
855271|NCT02997904|2070576|P2|NOT COMPLETED|Overall Study||0
855272|NCT02997904|2070577|P1|NOT COMPLETED|Overall Study||0
855273|NCT02997904|2070576|P2|COMPLETED|Overall Study||49
855274|NCT02997904|2070577|P1|COMPLETED|Overall Study||51
855275|NCT02997904|2070576|P2|STARTED|Overall Study||49
855276|NCT02997904|2070577|P1|STARTED|Overall Study||51
855277|NCT02990910|2070589|P2|NOT COMPLETED|Overall Study||10
855278|NCT02990910|2070590|P1|NOT COMPLETED|Overall Study||6
855279|NCT02990910|2070589|P2|COMPLETED|Overall Study||130
855280|NCT02990910|2070590|P1|COMPLETED|Overall Study||134
855281|NCT02990910|2070589|P2|STARTED|Overall Study||140
855282|NCT02990910|2070590|P1|STARTED|Overall Study||140
855283|NCT02988219|2070600|P2|NOT COMPLETED|Overall Study||3
855284|NCT02988219|2070601|P1|NOT COMPLETED|Overall Study||1
855285|NCT02988219|2070600|P2|COMPLETED|Overall Study||22
855286|NCT02988219|2070601|P1|COMPLETED|Overall Study||24
855287|NCT02988219|2070600|P2|STARTED|Overall Study||25
855288|NCT02988219|2070601|P1|STARTED|Overall Study||25
855289|NCT02987374|2070609|P1|NOT COMPLETED|Overall Study||0
855290|NCT02987374|2070609|P1|COMPLETED|Overall Study||10
855291|NCT02987374|2070609|P1|STARTED|Overall Study||10
855292|NCT02986282|2070614|P1|NOT COMPLETED|Overall Study||16
855293|NCT02986282|2070614|P1|COMPLETED|Overall Study||99
855294|NCT02986282|2070614|P1|STARTED|Overall Study||115
855295|NCT02977572|2070621|P2|NOT COMPLETED|Overall Study||2
855296|NCT02977572|2070622|P1|NOT COMPLETED|Overall Study||2
855297|NCT02977572|2070621|P2|COMPLETED|Overall Study||54
855298|NCT02977572|2070622|P1|COMPLETED|Overall Study||56
855299|NCT02977572|2070621|P2|STARTED|Overall Study||56
855300|NCT02977572|2070622|P1|STARTED|Overall Study||58
855301|NCT02974543|2070646|P2|NOT COMPLETED|Overall Study||0
855302|NCT02974543|2070647|P1|NOT COMPLETED|Overall Study||1
855303|NCT02974543|2070646|P2|COMPLETED|Overall Study||10
855304|NCT02974543|2070647|P1|COMPLETED|Overall Study||10
855305|NCT02974543|2070646|P2|Began Crossover Assignment|Overall Study||10
855306|NCT02974543|2070647|P1|Began Crossover Assignment|Overall Study||10
855307|NCT02974543|2070646|P2|Began Washout Period|Overall Study||10
855308|NCT02974543|2070647|P1|Began Washout Period|Overall Study||10
855309|NCT02974543|2070646|P2|STARTED|Overall Study||10
855310|NCT02974543|2070647|P1|STARTED|Overall Study||11
855311|NCT02971670|2070671|P4|NOT COMPLETED|Overall Study||2
855312|NCT02971670|2070672|P3|NOT COMPLETED|Overall Study||1
855313|NCT02971670|2070673|P2|NOT COMPLETED|Overall Study||1
855314|NCT02971670|2070674|P1|NOT COMPLETED|Overall Study||4
855315|NCT02971670|2070671|P4|COMPLETED|Overall Study||1
855316|NCT02971670|2070672|P3|COMPLETED|Overall Study||4
855317|NCT02971670|2070673|P2|COMPLETED|Overall Study||1
855318|NCT02971670|2070674|P1|COMPLETED|Overall Study||9
855319|NCT02971670|2070671|P4|STARTED|Overall Study||3
855320|NCT02971670|2070672|P3|STARTED|Overall Study||5
855321|NCT02971670|2070673|P2|STARTED|Overall Study||2
855322|NCT02971670|2070674|P1|STARTED|Overall Study||13
855323|NCT02964767|2070694|P2|NOT COMPLETED|Overall Study||0
855324|NCT02964767|2070695|P1|NOT COMPLETED|Overall Study||0
855325|NCT02964767|2070694|P2|COMPLETED|Overall Study||48
855326|NCT02964767|2070695|P1|COMPLETED|Overall Study||171
855327|NCT02964767|2070694|P2|STARTED|Overall Study||48
855328|NCT02964767|2070695|P1|STARTED|Overall Study||171
855329|NCT02961244|2070704|P2|NOT COMPLETED|Overall Study||9
855330|NCT02961244|2070705|P1|NOT COMPLETED|Overall Study||1
855331|NCT02961244|2070704|P2|COMPLETED|Overall Study||55
855332|NCT02961244|2070705|P1|COMPLETED|Overall Study||63
855333|NCT02961244|2070704|P2|Patients Excluded During Randomization|Overall Study||1
855334|NCT02961244|2070705|P1|Patients Excluded During Randomization|Overall Study||0
855335|NCT02961244|2070704|P2|STARTED|Overall Study||64
855336|NCT02961244|2070705|P1|STARTED|Overall Study||64
855337|NCT02959840|2070716|P3|NOT COMPLETED|Overall Study||0
855338|NCT02959840|2070717|P2|NOT COMPLETED|Overall Study||0
855339|NCT02959840|2070718|P1|NOT COMPLETED|Overall Study||0
855340|NCT02959840|2070716|P3|COMPLETED|Overall Study||60
855341|NCT02959840|2070717|P2|COMPLETED|Overall Study||60
855342|NCT02959840|2070718|P1|COMPLETED|Overall Study||60
855343|NCT02959840|2070716|P3|STARTED|Overall Study||60
855344|NCT02959840|2070717|P2|STARTED|Overall Study||60
855345|NCT02959840|2070718|P1|STARTED|Overall Study||60
855346|NCT02958995|2070761|P2|NOT COMPLETED|Overall Study||0
855347|NCT02958995|2070762|P1|NOT COMPLETED|Overall Study||0
855348|NCT02958995|2070761|P2|COMPLETED|Overall Study||107495
855349|NCT02958995|2070762|P1|COMPLETED|Overall Study||2630666
855350|NCT02958995|2070761|P2|STARTED|Overall Study||107495
855351|NCT02958995|2070762|P1|STARTED|Overall Study||2630666
855352|NCT02958956|2070772|P2|NOT COMPLETED|Overall Study||0
855353|NCT02958956|2070773|P1|NOT COMPLETED|Overall Study||0
855354|NCT02958956|2070772|P2|COMPLETED|Overall Study||198317
855355|NCT02958956|2070773|P1|COMPLETED|Overall Study||38190
855356|NCT02958956|2070772|P2|STARTED|Overall Study||198317
855357|NCT02958956|2070773|P1|STARTED|Overall Study||38190
855358|NCT02958345|2070788|P2|NOT COMPLETED|Overall Study||1
855359|NCT02958345|2070789|P1|NOT COMPLETED|Overall Study||1
855360|NCT02958345|2070788|P2|COMPLETED|Overall Study||13
855361|NCT02958345|2070789|P1|COMPLETED|Overall Study||13
855362|NCT02958345|2070788|P2|STARTED|Overall Study||14
855363|NCT02958345|2070789|P1|STARTED|Overall Study||14
855364|NCT02951767|2070797|P1|NOT COMPLETED|Overall Study||119
855365|NCT02951767|2070797|P1|COMPLETED|Overall Study||0
855366|NCT02951767|2070797|P1|STARTED|Overall Study||119
855367|NCT02949141|2070814|P1|NOT COMPLETED|Overall Study||0
855368|NCT02949141|2070814|P1|COMPLETED|Overall Study||62
855369|NCT02949141|2070814|P1|STARTED|Overall Study||62
855370|NCT02947984|2070823|P2|NOT COMPLETED|Overall Study||0
855371|NCT02947984|2070824|P1|NOT COMPLETED|Overall Study||0
855372|NCT02947984|2070823|P2|COMPLETED|Overall Study||22
855373|NCT02947984|2070824|P1|COMPLETED|Overall Study||22
855374|NCT02947984|2070823|P2|STARTED|Overall Study||22
855375|NCT02947984|2070824|P1|STARTED|Overall Study||22
855376|NCT02941640|2070840|P4|NOT COMPLETED|Overall Study||0
855377|NCT02941640|2070841|P3|NOT COMPLETED|Overall Study||0
855378|NCT02941640|2070842|P2|NOT COMPLETED|Overall Study||0
855379|NCT02941640|2070843|P1|NOT COMPLETED|Overall Study||0
855380|NCT02941640|2070840|P4|COMPLETED|Overall Study||30
855381|NCT02941640|2070841|P3|COMPLETED|Overall Study||30
855382|NCT02941640|2070842|P2|COMPLETED|Overall Study||30
855383|NCT02941640|2070843|P1|COMPLETED|Overall Study||30
855384|NCT02941640|2070840|P4|STARTED|Overall Study||30
855385|NCT02941640|2070841|P3|STARTED|Overall Study||30
855386|NCT02941640|2070842|P2|STARTED|Overall Study||30
855387|NCT02941640|2070843|P1|STARTED|Overall Study||30
855388|NCT02937506|2070875|P2|NOT COMPLETED|Overall Study||0
855389|NCT02937506|2070876|P1|NOT COMPLETED|Overall Study||0
855390|NCT02937506|2070875|P2|COMPLETED|Overall Study||300
855391|NCT02937506|2070876|P1|COMPLETED|Overall Study||300
855392|NCT02937506|2070875|P2|STARTED|Overall Study||300
855393|NCT02937506|2070876|P1|STARTED|Overall Study||300
855394|NCT02934347|2070884|P2|NOT COMPLETED|Overall Study||0
855395|NCT02934347|2070885|P1|NOT COMPLETED|Overall Study||0
855396|NCT02934347|2070884|P2|COMPLETED|Overall Study||407
855397|NCT02934347|2070885|P1|COMPLETED|Overall Study||374
855398|NCT02934347|2070884|P2|STARTED|Overall Study||407
855399|NCT02934347|2070885|P1|STARTED|Overall Study||374
855400|NCT02920749|2070901|P4|NOT COMPLETED|Overall Study||0
855401|NCT02920749|2070902|P3|NOT COMPLETED|Overall Study||0
855402|NCT02920749|2070903|P2|NOT COMPLETED|Overall Study||0
855403|NCT02920749|2070904|P1|NOT COMPLETED|Overall Study||0
855404|NCT02920749|2070901|P4|COMPLETED|Overall Study||30
855405|NCT02920749|2070902|P3|COMPLETED|Overall Study||30
855406|NCT02920749|2070903|P2|COMPLETED|Overall Study||30
855407|NCT02920749|2070904|P1|COMPLETED|Overall Study||30
855408|NCT02920749|2070901|P4|STARTED|Overall Study||30
855409|NCT02920749|2070902|P3|STARTED|Overall Study||30
855410|NCT02920749|2070903|P2|STARTED|Overall Study||30
855411|NCT02920749|2070904|P1|STARTED|Overall Study||30
855412|NCT02919657|2070918|P2|NOT COMPLETED|Overall Study||0
855413|NCT02919657|2070919|P1|NOT COMPLETED|Overall Study||0
855414|NCT02919657|2070918|P2|COMPLETED|Overall Study|completed with the same initial 10 participants|10
855415|NCT02919657|2070919|P1|COMPLETED|Overall Study|completed with the same initial 10 participants|10
855416|NCT02919657|2070918|P2|STARTED|Overall Study|10 Participants|10
855417|NCT02919657|2070919|P1|STARTED|Overall Study|10 Participants|10
855418|NCT02912650|2070929|P4|NOT COMPLETED|Overall Study||5
855419|NCT02912650|2070930|P3|NOT COMPLETED|Overall Study||2
855420|NCT02912650|2070931|P2|NOT COMPLETED|Overall Study||0
855421|NCT02912650|2070932|P1|NOT COMPLETED|Overall Study||1
855422|NCT02912650|2070929|P4|COMPLETED|Overall Study||160
855423|NCT02912650|2070930|P3|COMPLETED|Overall Study||173
855424|NCT02912650|2070931|P2|COMPLETED|Overall Study||172
855425|NCT02912650|2070932|P1|COMPLETED|Overall Study||55
855426|NCT02912650|2070929|P4|STARTED|Overall Study||165
855427|NCT02912650|2070930|P3|STARTED|Overall Study||175
855428|NCT02912650|2070931|P2|STARTED|Overall Study||172
855429|NCT02912650|2070932|P1|STARTED|Overall Study||56
855430|NCT02910362|2071016|P2|NOT COMPLETED|Overall Study||0
855431|NCT02910362|2071017|P1|NOT COMPLETED|Overall Study||0
855432|NCT02910362|2071016|P2|COMPLETED|Overall Study||7
855433|NCT02910362|2071017|P1|COMPLETED|Overall Study||8
855434|NCT02910362|2071016|P2|STARTED|Overall Study||7
855435|NCT02910362|2071017|P1|STARTED|Overall Study||8
855436|NCT02903238|2071023|P1|NOT COMPLETED|Overall Study||4
855437|NCT02903238|2071023|P1|COMPLETED|Overall Study||17
855438|NCT02903238|2071023|P1|STARTED|Overall Study||21
855439|NCT02895347|2071034|P2|NOT COMPLETED|Overall Study||1
855440|NCT02895347|2071035|P1|NOT COMPLETED|Overall Study||3
855441|NCT02895347|2071034|P2|COMPLETED|Overall Study||19
855442|NCT02895347|2071035|P1|COMPLETED|Overall Study||17
855443|NCT02895347|2071034|P2|STARTED|Overall Study||20
855444|NCT02895347|2071035|P1|STARTED|Overall Study||20
855445|NCT02891863|2071044|P1|NOT COMPLETED|Overall Study||0
855446|NCT02891863|2071044|P1|COMPLETED|Overall Study||9
855447|NCT02891863|2071044|P1|STARTED|Overall Study||9
855448|NCT02889289|2071049|P1|NOT COMPLETED|Overall Study||0
855449|NCT02889289|2071049|P1|COMPLETED|Overall Study||1
855450|NCT02889289|2071049|P1|STARTED|Overall Study||1
855451|NCT02886338|2071058|P1|NOT COMPLETED|Overall Study||1
855452|NCT02886338|2071058|P1|COMPLETED|Overall Study||9
855453|NCT02886338|2071058|P1|STARTED|Overall Study||10
855454|NCT02884427|2071065|P3|NOT COMPLETED|Overall Study||0
855455|NCT02884427|2071066|P2|NOT COMPLETED|Overall Study||0
855456|NCT02884427|2071067|P1|NOT COMPLETED|Overall Study||0
855457|NCT02884427|2071065|P3|COMPLETED|Overall Study||50
855458|NCT02884427|2071066|P2|COMPLETED|Overall Study||52
855459|NCT02884427|2071067|P1|COMPLETED|Overall Study||48
855460|NCT02884427|2071065|P3|STARTED|Overall Study||50
855461|NCT02884427|2071066|P2|STARTED|Overall Study||52
855462|NCT02884427|2071067|P1|STARTED|Overall Study||48
855463|NCT02882152|2071083|P2|NOT COMPLETED|Overall Study||0
855464|NCT02882152|2071084|P1|NOT COMPLETED|Overall Study||1
855465|NCT02882152|2071083|P2|COMPLETED|Overall Study||20
855466|NCT02882152|2071084|P1|COMPLETED|Overall Study||19
855467|NCT02882152|2071083|P2|STARTED|Overall Study||20
855468|NCT02882152|2071084|P1|STARTED|Overall Study||20
855469|NCT02881658|2071094|P2|NOT COMPLETED|Overall Study||5
855470|NCT02881658|2071095|P1|NOT COMPLETED|Overall Study||2
855471|NCT02881658|2071094|P2|COMPLETED|Overall Study||96
855472|NCT02881658|2071095|P1|COMPLETED|Overall Study||98
855473|NCT02881658|2071094|P2|STARTED|Overall Study||101
855474|NCT02881658|2071095|P1|STARTED|Overall Study||100
855475|NCT02873429|2071131|P2|NOT COMPLETED|16 Weeks||2
855476|NCT02873429|2071132|P1|NOT COMPLETED|16 Weeks||5
855477|NCT02873429|2071131|P2|COMPLETED|16 Weeks||96
855478|NCT02873429|2071132|P1|COMPLETED|16 Weeks||100
855479|NCT02873429|2071131|P2|STARTED|16 Weeks|1 Conv. participant Missed 6-8 week but was eligible for 16 week|98
855480|NCT02873429|2071132|P1|STARTED|16 Weeks|10 CAM participants Missed 6-8 week but are eligible for 16 week|105
855481|NCT02873429|2071131|P2|NOT COMPLETED|6-8 Weeks||1
855482|NCT02873429|2071132|P1|NOT COMPLETED|6-8 Weeks||10
855483|NCT02873429|2071131|P2|COMPLETED|6-8 Weeks||97
855484|NCT02873429|2071132|P1|COMPLETED|6-8 Weeks||95
855485|NCT02873429|2071131|P2|STARTED|6-8 Weeks|2 Con. participants not eligible to complete follow ups because they did not continue treatment.|98
855486|NCT02873429|2071132|P1|STARTED|6-8 Weeks|4 CAM participants not eligible to complete follow ups because they did not continue treatment.|105
855487|NCT02873429|2071131|P2|NOT COMPLETED|Baseline||0
855488|NCT02873429|2071132|P1|NOT COMPLETED|Baseline||0
855489|NCT02873429|2071131|P2|COMPLETED|Baseline||100
855490|NCT02873429|2071132|P1|COMPLETED|Baseline||109
855491|NCT02873429|2071131|P2|STARTED|Baseline||100
855492|NCT02873429|2071132|P1|STARTED|Baseline||109
855493|NCT02867150|2071142|P1|NOT COMPLETED|Overall Study||0
855494|NCT02867150|2071142|P1|COMPLETED|Overall Study||58
855495|NCT02867150|2071142|P1|STARTED|Overall Study||58
855496|NCT02863198|2071148|P2|NOT COMPLETED|Overall Study||0
855497|NCT02863198|2071149|P1|NOT COMPLETED|Overall Study||0
855498|NCT02863198|2071148|P2|COMPLETED|Overall Study||60
855499|NCT02863198|2071149|P1|COMPLETED|Overall Study||60
855500|NCT02863198|2071148|P2|STARTED|Overall Study||60
855501|NCT02863198|2071149|P1|STARTED|Overall Study||60
855502|NCT02862600|2071165|P1|NOT COMPLETED|Period 2--Perhexiline-high Target Range||7
855503|NCT02862600|2071165|P1|COMPLETED|Period 2--Perhexiline-high Target Range|Study terminated on April 26, 2017 due to lack of efficacy in first 15 subjects completing Period 2.|15
855504|NCT02862600|2071165|P1|STARTED|Period 2--Perhexiline-high Target Range|First subject completed Period 1 and moved into Period 2 perhexiline dosing on October 17, 2016|22
855505|NCT02862600|2071165|P1|NOT COMPLETED|Period 1--Perhexiline-low Target Range||13
855506|NCT02862600|2071165|P1|COMPLETED|Period 1--Perhexiline-low Target Range|Study terminated on April 26, 2017 due to lack of efficacy.|22
855507|NCT02862600|2071165|P1|STARTED|Period 1--Perhexiline-low Target Range|First subject underwent baseline functional assessment and perhexiline dosing on August 22, 2016|35
855508|NCT02862106|2071178|P2|NOT COMPLETED|Overall Study||6
855509|NCT02862106|2071179|P1|NOT COMPLETED|Overall Study||38
855510|NCT02862106|2071178|P2|COMPLETED|Overall Study||20
855511|NCT02862106|2071179|P1|COMPLETED|Overall Study||145
855512|NCT02862106|2071178|P2|STARTED|Overall Study||26
855513|NCT02862106|2071179|P1|STARTED|Overall Study||183
855514|NCT02856880|2071237|P1|NOT COMPLETED|Overall Study||1
855515|NCT02856880|2071237|P1|COMPLETED|Overall Study||44
855516|NCT02856880|2071237|P1|Received SLS Negative Control|Overall Study||44
855517|NCT02856880|2071237|P1|Received Non-SLS Negative Control|Overall Study||44
855518|NCT02856880|2071237|P1|Received Positive Control|Overall Study||45
855519|NCT02856880|2071237|P1|Received Test Zinc Non-IPMP|Overall Study||44
855520|NCT02856880|2071237|P1|Received Test Zinc-IPMP|Overall Study||44
855521|NCT02856880|2071237|P1|STARTED|Overall Study||45
855522|NCT02855411|2071261|P1|NOT COMPLETED|Overall Study||35
855523|NCT02855411|2071261|P1|COMPLETED|Overall Study||0
855524|NCT02855411|2071261|P1|Assigned to Study Treatment|Overall Study||0
855525|NCT02855411|2071261|P1|STARTED|Overall Study||35
855526|NCT02850159|2071283|P2|NOT COMPLETED|Overall Study||0
855527|NCT02850159|2071284|P1|NOT COMPLETED|Overall Study||0
855528|NCT02850159|2071283|P2|COMPLETED|Overall Study||16
855529|NCT02850159|2071284|P1|COMPLETED|Overall Study||16
855530|NCT02850159|2071283|P2|STARTED|Overall Study||16
855531|NCT02850159|2071284|P1|STARTED|Overall Study||16
855532|NCT02849678|2071292|P2|NOT COMPLETED|Overall Study||6
855533|NCT02849678|2071293|P1|NOT COMPLETED|Overall Study||6
855534|NCT02849678|2071292|P2|COMPLETED|Overall Study|Informed consent was obtained from 68 patients. Only 47 of these patients were randomized.|18
855535|NCT02849678|2071293|P1|COMPLETED|Overall Study|Informed consent was obtained from 68 patients. Only 47 of these patients were randomized.|17
855536|NCT02849678|2071292|P2|STARTED|Overall Study|Informed consent was obtained from 68 patients. Only 47 of these patients were randomized.|24
855537|NCT02849678|2071293|P1|STARTED|Overall Study|Informed consent was obtained from 68 patients. Only 47 of these patients were randomized.|23
855541|NCT02847169|2071311|P2|NOT COMPLETED|Second Intervention (1 Week)||0
855542|NCT02847169|2071312|P1|NOT COMPLETED|Second Intervention (1 Week)||0
855543|NCT02847169|2071311|P2|COMPLETED|Second Intervention (1 Week)||15
855544|NCT02847169|2071312|P1|COMPLETED|Second Intervention (1 Week)||15
855545|NCT02847169|2071311|P2|STARTED|Second Intervention (1 Week)||15
855546|NCT02847169|2071312|P1|STARTED|Second Intervention (1 Week)||15
855547|NCT02847169|2071311|P2|NOT COMPLETED|First Intervention (1 Week)||0
855548|NCT02847169|2071312|P1|NOT COMPLETED|First Intervention (1 Week)||0
855549|NCT02847169|2071311|P2|COMPLETED|First Intervention (1 Week)||15
855550|NCT02847169|2071312|P1|COMPLETED|First Intervention (1 Week)||15
855551|NCT02847169|2071311|P2|STARTED|First Intervention (1 Week)||15
855552|NCT02847169|2071312|P1|STARTED|First Intervention (1 Week)||15
855553|NCT02844998|2071349|P3|NOT COMPLETED|Overall Study||4
855554|NCT02844998|2071350|P2|NOT COMPLETED|Overall Study||4
855555|NCT02844998|2071351|P1|NOT COMPLETED|Overall Study||7
855556|NCT02844998|2071349|P3|COMPLETED|Overall Study||35
855557|NCT02844998|2071350|P2|COMPLETED|Overall Study||35
855558|NCT02844998|2071351|P1|COMPLETED|Overall Study||35
855559|NCT02844998|2071349|P3|STARTED|Overall Study||39
855560|NCT02844998|2071350|P2|STARTED|Overall Study||39
855561|NCT02844998|2071351|P1|STARTED|Overall Study||42
855562|NCT02840916|2071364|P2|NOT COMPLETED|Overall Study||3
855563|NCT02840916|2071365|P1|NOT COMPLETED|Overall Study||1
855564|NCT02840916|2071364|P2|COMPLETED|Overall Study||30
855565|NCT02840916|2071365|P1|COMPLETED|Overall Study||32
855566|NCT02840916|2071364|P2|STARTED|Overall Study||33
855567|NCT02840916|2071365|P1|STARTED|Overall Study||33
855568|NCT02839772|2071377|P2|NOT COMPLETED|Overall Study||0
855569|NCT02839772|2071378|P1|NOT COMPLETED|Overall Study||1
855570|NCT02839772|2071377|P2|COMPLETED|Overall Study||96
855571|NCT02839772|2071378|P1|COMPLETED|Overall Study|1 participant in Clinic B did not return for the 3 months post- intervention data collection.|96
855572|NCT02839772|2071377|P2|STARTED|Overall Study||96
855573|NCT02839772|2071378|P1|STARTED|Overall Study|Stratification was used. Clinic A enrolled 94 participants and Clinic B 99 participants|97
855574|NCT02834624|2071417|P2|NOT COMPLETED|Overall Study||0
855575|NCT02834624|2071418|P1|NOT COMPLETED|Overall Study||0
855576|NCT02834624|2071417|P2|COMPLETED|Overall Study||15
855577|NCT02834624|2071418|P1|COMPLETED|Overall Study||15
855578|NCT02834624|2071417|P2|STARTED|Overall Study||15
855579|NCT02834624|2071418|P1|STARTED|Overall Study||15
855580|NCT02832375|2071430|P2|NOT COMPLETED|Overall Study||0
855581|NCT02832375|2071431|P1|NOT COMPLETED|Overall Study||2
855582|NCT02832375|2071430|P2|COMPLETED|Overall Study||121
855583|NCT02832375|2071431|P1|COMPLETED|Overall Study||119
855584|NCT02832375|2071430|P2|STARTED|Overall Study||121
855585|NCT02832375|2071431|P1|STARTED|Overall Study||121
855586|NCT02829775|2071441|P1|NOT COMPLETED|Overall Study||5
855587|NCT02829775|2071441|P1|COMPLETED|Overall Study||4
855588|NCT02829775|2071441|P1|STARTED|Overall Study||9
855589|NCT02829463|2071448|P2|NOT COMPLETED|Overall Study||0
855590|NCT02829463|2071449|P1|NOT COMPLETED|Overall Study||0
855591|NCT02829463|2071448|P2|COMPLETED|Overall Study||62
855592|NCT02829463|2071449|P1|COMPLETED|Overall Study||59
855593|NCT02829463|2071448|P2|STARTED|Overall Study||62
855594|NCT02829463|2071449|P1|STARTED|Overall Study||59
855595|NCT02828137|2071458|P3|NOT COMPLETED|Overall Study||0
855596|NCT02828137|2071459|P2|NOT COMPLETED|Overall Study||0
855597|NCT02828137|2071460|P1|NOT COMPLETED|Overall Study||0
855598|NCT02828137|2071458|P3|COMPLETED|Overall Study||41
855599|NCT02828137|2071459|P2|COMPLETED|Overall Study||41
855600|NCT02828137|2071460|P1|COMPLETED|Overall Study||41
855601|NCT02828137|2071458|P3|STARTED|Overall Study||41
855602|NCT02828137|2071459|P2|STARTED|Overall Study||41
855603|NCT02828137|2071460|P1|STARTED|Overall Study||41
855604|NCT02826421|2071472|P4|NOT COMPLETED|Overall Study||2
855605|NCT02826421|2071473|P3|NOT COMPLETED|Overall Study||2
855606|NCT02826421|2071474|P2|NOT COMPLETED|Overall Study||3
855607|NCT02826421|2071475|P1|NOT COMPLETED|Overall Study||3
855608|NCT02826421|2071472|P4|COMPLETED|Overall Study||28
855609|NCT02826421|2071473|P3|COMPLETED|Overall Study||26
855610|NCT02826421|2071474|P2|COMPLETED|Overall Study||26
855611|NCT02826421|2071475|P1|COMPLETED|Overall Study||19
855612|NCT02826421|2071472|P4|Treated|Overall Study||28
855613|NCT02826421|2071473|P3|Treated|Overall Study||26
855614|NCT02826421|2071474|P2|Treated|Overall Study||26
855615|NCT02826421|2071475|P1|Treated|Overall Study||19
855616|NCT02826421|2071472|P4|STARTED|Overall Study||30
855617|NCT02826421|2071473|P3|STARTED|Overall Study||28
855618|NCT02826421|2071474|P2|STARTED|Overall Study||29
855619|NCT02826421|2071475|P1|STARTED|Overall Study||22
855620|NCT02823080|2071489|P2|NOT COMPLETED|Overall Study||0
855621|NCT02823080|2071490|P1|NOT COMPLETED|Overall Study||0
855622|NCT02823080|2071489|P2|COMPLETED|Overall Study||24
855623|NCT02823080|2071490|P1|COMPLETED|Overall Study||24
855624|NCT02823080|2071489|P2|STARTED|Overall Study||24
855625|NCT02823080|2071490|P1|STARTED|Overall Study||24
855626|NCT02822885|2071508|P1|NOT COMPLETED|Overall Study||0
855627|NCT02822885|2071508|P1|COMPLETED|Overall Study||70
855628|NCT02822885|2071508|P1|STARTED|Overall Study||70
855629|NCT02822287|2071516|P1|NOT COMPLETED|Overall Study||0
855630|NCT02822287|2071516|P1|COMPLETED|Overall Study||57
855631|NCT02822287|2071516|P1|STARTED|Overall Study||57
855632|NCT02821403|2071528|P2|NOT COMPLETED|"Third Intervention (1 Month)"||0
855633|NCT02821403|2071529|P1|NOT COMPLETED|"Third Intervention (1 Month)"||0
855634|NCT02821403|2071528|P2|COMPLETED|"Third Intervention (1 Month)"||40
855635|NCT02821403|2071529|P1|COMPLETED|"Third Intervention (1 Month)"||40
855636|NCT02821403|2071528|P2|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||14
855637|NCT02821403|2071529|P1|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||13
855638|NCT02821403|2071528|P2|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
855639|NCT02821403|2071529|P1|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
855640|NCT02821403|2071528|P2|Used Clear Lens|"Third Intervention (1 Month)"||13
855641|NCT02821403|2071529|P1|Used Clear Lens|"Third Intervention (1 Month)"||14
855642|NCT02821403|2071528|P2|STARTED|"Third Intervention (1 Month)"||40
855643|NCT02821403|2071529|P1|STARTED|"Third Intervention (1 Month)"||40
855644|NCT02821403|2071528|P2|NOT COMPLETED|"Second Intervention (1 Month)"||0
855645|NCT02821403|2071529|P1|NOT COMPLETED|"Second Intervention (1 Month)"||0
855646|NCT02821403|2071528|P2|COMPLETED|"Second Intervention (1 Month)"||40
855647|NCT02821403|2071529|P1|COMPLETED|"Second Intervention (1 Month)"||40
855648|NCT02821403|2071528|P2|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
855649|NCT02821403|2071529|P1|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
855650|NCT02821403|2071528|P2|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||13
855651|NCT02821403|2071529|P1|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||14
855652|NCT02821403|2071528|P2|Used Clear Lens|"Second Intervention (1 Month)"||14
855653|NCT02821403|2071529|P1|Used Clear Lens|"Second Intervention (1 Month)"||13
855654|NCT02821403|2071528|P2|STARTED|"Second Intervention (1 Month)"||40
855655|NCT02821403|2071529|P1|STARTED|"Second Intervention (1 Month)"||40
855656|NCT02821403|2071528|P2|NOT COMPLETED|"First Intervention (1 Month)"||0
855657|NCT02821403|2071529|P1|NOT COMPLETED|"First Intervention (1 Month)"||0
855658|NCT02821403|2071528|P2|COMPLETED|"First Intervention (1 Month)"||40
855659|NCT02821403|2071529|P1|COMPLETED|"First Intervention (1 Month)"||40
855660|NCT02821403|2071528|P2|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||13
855661|NCT02821403|2071529|P1|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||14
855662|NCT02821403|2071528|P2|Used Yellow Tinted Lens|"First Intervention (1 Month)"||14
855663|NCT02821403|2071529|P1|Used Yellow Tinted Lens|"First Intervention (1 Month)"||13
855664|NCT02821403|2071528|P2|Used Clear Lens|"First Intervention (1 Month)"||13
855665|NCT02821403|2071529|P1|Used Clear Lens|"First Intervention (1 Month)"||13
855666|NCT02821403|2071528|P2|STARTED|"First Intervention (1 Month)"||40
855667|NCT02821403|2071529|P1|STARTED|"First Intervention (1 Month)"||40
855668|NCT02818244|2071551|P4|NOT COMPLETED|Overall Study||0
855669|NCT02818244|2071552|P3|NOT COMPLETED|Overall Study||0
855670|NCT02818244|2071553|P2|NOT COMPLETED|Overall Study||0
855671|NCT02818244|2071554|P1|NOT COMPLETED|Overall Study||0
855672|NCT02818244|2071551|P4|COMPLETED|Overall Study||25
855673|NCT02818244|2071552|P3|COMPLETED|Overall Study||25
855674|NCT02818244|2071553|P2|COMPLETED|Overall Study||25
855675|NCT02818244|2071554|P1|COMPLETED|Overall Study||25
855676|NCT02818244|2071551|P4|STARTED|Overall Study||25
855677|NCT02818244|2071552|P3|STARTED|Overall Study||25
855678|NCT02818244|2071553|P2|STARTED|Overall Study||25
855679|NCT02818244|2071554|P1|STARTED|Overall Study||25
855680|NCT02817763|2071566|P2|NOT COMPLETED|Overall Study||0
855681|NCT02817763|2071567|P1|NOT COMPLETED|Overall Study||0
855682|NCT02817763|2071566|P2|COMPLETED|Overall Study||20
855683|NCT02817763|2071567|P1|COMPLETED|Overall Study||20
855684|NCT02817763|2071566|P2|STARTED|Overall Study||20
855685|NCT02817763|2071567|P1|STARTED|Overall Study||20
855686|NCT02815735|2071575|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
855687|NCT02815735|2071576|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
855688|NCT02815735|2071575|P2|COMPLETED|Second Intervention (4 Weeks)||37
855689|NCT02815735|2071576|P1|COMPLETED|Second Intervention (4 Weeks)||33
855690|NCT02815735|2071575|P2|STARTED|Second Intervention (4 Weeks)||37
855691|NCT02815735|2071576|P1|STARTED|Second Intervention (4 Weeks)||34
855692|NCT02815735|2071575|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
855693|NCT02815735|2071576|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
855694|NCT02815735|2071575|P2|COMPLETED|First Intervention (4 Weeks)||37
855695|NCT02815735|2071576|P1|COMPLETED|First Intervention (4 Weeks)||34
855696|NCT02815735|2071575|P2|STARTED|First Intervention (4 Weeks)||38
855697|NCT02815735|2071576|P1|STARTED|First Intervention (4 Weeks)||36
855698|NCT02814279|2071593|P2|NOT COMPLETED|Overall Study||0
855699|NCT02814279|2071594|P1|NOT COMPLETED|Overall Study||0
855700|NCT02814279|2071593|P2|COMPLETED|Overall Study||21
855701|NCT02814279|2071594|P1|COMPLETED|Overall Study||21
855702|NCT02814279|2071593|P2|STARTED|Overall Study||21
855703|NCT02814279|2071594|P1|STARTED|Overall Study||21
855704|NCT02814227|2071602|P1|NOT COMPLETED|Overall Study||0
855705|NCT02814227|2071602|P1|COMPLETED|Overall Study||52
855706|NCT02814227|2071602|P1|STARTED|Overall Study||52
855707|NCT02813070|2071612|P3|NOT COMPLETED|Overall Study||11
855708|NCT02813070|2071613|P2|NOT COMPLETED|Overall Study||3
855709|NCT02813070|2071614|P1|NOT COMPLETED|Overall Study||3
855710|NCT02813070|2071612|P3|COMPLETED|Overall Study||25
855711|NCT02813070|2071613|P2|COMPLETED|Overall Study||20
855712|NCT02813070|2071614|P1|COMPLETED|Overall Study||25
855713|NCT02813070|2071612|P3|Treated (Safety Population)|Overall Study||25
855714|NCT02813070|2071613|P2|Treated (Safety Population)|Overall Study||20
855715|NCT02813070|2071614|P1|Treated (Safety Population)|Overall Study||25
855716|NCT02813070|2071612|P3|STARTED|Overall Study||36
855717|NCT02813070|2071613|P2|STARTED|Overall Study||23
855718|NCT02813070|2071614|P1|STARTED|Overall Study||28
855719|NCT02809911|2071625|P2|NOT COMPLETED|Overall Study||0
855720|NCT02809911|2071626|P1|NOT COMPLETED|Overall Study||0
855721|NCT02809911|2071625|P2|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|19
855722|NCT02809911|2071626|P1|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|22
855723|NCT02809911|2071625|P2|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|19
855724|NCT02809911|2071626|P1|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|22
855725|NCT02809833|2071634|P1|NOT COMPLETED|Overall Study||300
855726|NCT02809833|2071634|P1|COMPLETED|Overall Study||550
855727|NCT02809833|2071634|P1|STARTED|Overall Study||850
855728|NCT02808130|2071714|P6|NOT COMPLETED|Overall Study||0
855729|NCT02808130|2071715|P5|NOT COMPLETED|Overall Study||0
855730|NCT02808130|2071716|P4|NOT COMPLETED|Overall Study||0
855731|NCT02808130|2071717|P3|NOT COMPLETED|Overall Study||0
855732|NCT02808130|2071718|P2|NOT COMPLETED|Overall Study||0
855733|NCT02808130|2071719|P1|NOT COMPLETED|Overall Study||0
855734|NCT02808130|2071714|P6|COMPLETED|Overall Study||15
855735|NCT02808130|2071715|P5|COMPLETED|Overall Study||15
855736|NCT02808130|2071716|P4|COMPLETED|Overall Study||15
855737|NCT02808130|2071717|P3|COMPLETED|Overall Study||15
855738|NCT02808130|2071718|P2|COMPLETED|Overall Study||15
855739|NCT02808130|2071719|P1|COMPLETED|Overall Study||15
855740|NCT02808130|2071714|P6|STARTED|Overall Study||15
855741|NCT02808130|2071715|P5|STARTED|Overall Study||15
855742|NCT02808130|2071716|P4|STARTED|Overall Study||15
855743|NCT02808130|2071717|P3|STARTED|Overall Study||15
855744|NCT02808130|2071718|P2|STARTED|Overall Study||15
855745|NCT02808130|2071719|P1|STARTED|Overall Study||15
855746|NCT02806544|2071745|P1|NOT COMPLETED|Overall Study||4
855747|NCT02806544|2071745|P1|COMPLETED|Overall Study||31
855748|NCT02806544|2071745|P1|STARTED|Overall Study||35
855749|NCT02806505|2071756|P2|NOT COMPLETED|Overall Study||11
855750|NCT02806505|2071757|P1|NOT COMPLETED|Overall Study||10
855751|NCT02806505|2071756|P2|COMPLETED|Overall Study||32
855752|NCT02806505|2071757|P1|COMPLETED|Overall Study||28
855753|NCT02806505|2071756|P2|STARTED|Overall Study||43
855754|NCT02806505|2071757|P1|STARTED|Overall Study||38
855755|NCT02805907|2071769|P2|NOT COMPLETED|Overall Study||3
855756|NCT02805907|2071770|P1|NOT COMPLETED|Overall Study||3
855757|NCT02805907|2071769|P2|COMPLETED|Overall Study||53
855758|NCT02805907|2071770|P1|COMPLETED|Overall Study||53
855759|NCT02805907|2071769|P2|STARTED|Overall Study||56
855760|NCT02805907|2071770|P1|STARTED|Overall Study||56
855761|NCT02802592|2071782|P1|NOT COMPLETED|Overall Study||4
855762|NCT02802592|2071782|P1|COMPLETED|Overall Study||0
855763|NCT02802592|2071782|P1|STARTED|Overall Study||4
855764|NCT02801396|2071791|P6|NOT COMPLETED|Period 3||0
855765|NCT02801396|2071792|P5|NOT COMPLETED|Period 3||0
855766|NCT02801396|2071793|P4|NOT COMPLETED|Period 3||0
855767|NCT02801396|2071794|P3|NOT COMPLETED|Period 3||0
855768|NCT02801396|2071795|P2|NOT COMPLETED|Period 3||0
855769|NCT02801396|2071796|P1|NOT COMPLETED|Period 3||0
855770|NCT02801396|2071791|P6|COMPLETED|Period 3||17
855771|NCT02801396|2071792|P5|COMPLETED|Period 3||16
855772|NCT02801396|2071793|P4|COMPLETED|Period 3||16
855773|NCT02801396|2071794|P3|COMPLETED|Period 3||17
855774|NCT02801396|2071795|P2|COMPLETED|Period 3||17
855775|NCT02801396|2071796|P1|COMPLETED|Period 3||17
855776|NCT02801396|2071791|P6|STARTED|Period 3||17
855777|NCT02801396|2071792|P5|STARTED|Period 3||16
855778|NCT02801396|2071793|P4|STARTED|Period 3||16
855779|NCT02801396|2071794|P3|STARTED|Period 3||17
855780|NCT02801396|2071795|P2|STARTED|Period 3||17
855781|NCT02801396|2071796|P1|STARTED|Period 3||17
855782|NCT02801396|2071791|P6|NOT COMPLETED|Period 2||0
855783|NCT02801396|2071792|P5|NOT COMPLETED|Period 2||0
855784|NCT02801396|2071793|P4|NOT COMPLETED|Period 2||0
855785|NCT02801396|2071794|P3|NOT COMPLETED|Period 2||0
855786|NCT02801396|2071795|P2|NOT COMPLETED|Period 2||0
855787|NCT02801396|2071796|P1|NOT COMPLETED|Period 2||0
855788|NCT02801396|2071791|P6|COMPLETED|Period 2||17
855789|NCT02801396|2071792|P5|COMPLETED|Period 2||16
855790|NCT02801396|2071793|P4|COMPLETED|Period 2||16
855791|NCT02801396|2071794|P3|COMPLETED|Period 2||17
855792|NCT02801396|2071795|P2|COMPLETED|Period 2||17
855793|NCT02801396|2071796|P1|COMPLETED|Period 2||17
855794|NCT02801396|2071791|P6|STARTED|Period 2||17
855795|NCT02801396|2071792|P5|STARTED|Period 2||16
855796|NCT02801396|2071793|P4|STARTED|Period 2||16
855797|NCT02801396|2071794|P3|STARTED|Period 2||17
855798|NCT02801396|2071795|P2|STARTED|Period 2||17
855799|NCT02801396|2071796|P1|STARTED|Period 2||17
855800|NCT02801396|2071791|P6|NOT COMPLETED|Period 1||0
855801|NCT02801396|2071792|P5|NOT COMPLETED|Period 1||1
855802|NCT02801396|2071793|P4|NOT COMPLETED|Period 1||0
855803|NCT02801396|2071794|P3|NOT COMPLETED|Period 1||0
855804|NCT02801396|2071795|P2|NOT COMPLETED|Period 1||0
855805|NCT02801396|2071796|P1|NOT COMPLETED|Period 1||0
855806|NCT02801396|2071791|P6|COMPLETED|Period 1||17
855807|NCT02801396|2071792|P5|COMPLETED|Period 1||16
855808|NCT02801396|2071793|P4|COMPLETED|Period 1||16
855809|NCT02801396|2071794|P3|COMPLETED|Period 1||17
855810|NCT02801396|2071795|P2|COMPLETED|Period 1||17
855811|NCT02801396|2071796|P1|COMPLETED|Period 1||17
855812|NCT02801396|2071791|P6|STARTED|Period 1||17
855813|NCT02801396|2071792|P5|STARTED|Period 1||17
855814|NCT02801396|2071793|P4|STARTED|Period 1||16
855815|NCT02801396|2071794|P3|STARTED|Period 1||17
855816|NCT02801396|2071795|P2|STARTED|Period 1||17
855817|NCT02801396|2071796|P1|STARTED|Period 1||17
855830|NCT02799082|2071824|P2|NOT COMPLETED|Overall Study||4
855831|NCT02799082|2071825|P1|NOT COMPLETED|Overall Study||4
855832|NCT02799082|2071824|P2|COMPLETED|Overall Study||77
855833|NCT02799082|2071825|P1|COMPLETED|Overall Study||37
855834|NCT02799082|2071824|P2|STARTED|Overall Study||81
855835|NCT02799082|2071825|P1|STARTED|Overall Study||41
855836|NCT02799069|2071862|P3|NOT COMPLETED|Overall Study||7
855837|NCT02799069|2071863|P2|NOT COMPLETED|Overall Study||7
855838|NCT02799069|2071864|P1|NOT COMPLETED|Overall Study||8
855839|NCT02799069|2071862|P3|COMPLETED|Overall Study||240
855840|NCT02799069|2071863|P2|COMPLETED|Overall Study||241
855841|NCT02799069|2071864|P1|COMPLETED|Overall Study||68
855842|NCT02799069|2071862|P3|ITT/Safety|Overall Study|1 subject received medication without Illumination and thus was excluded from ITT/safety population|246
855843|NCT02799069|2071863|P2|ITT/Safety|Overall Study||248
855844|NCT02799069|2071864|P1|ITT/Safety|Overall Study||76
855845|NCT02799069|2071862|P3|STARTED|Overall Study||247
855846|NCT02799069|2071863|P2|STARTED|Overall Study||248
855847|NCT02799069|2071864|P1|STARTED|Overall Study||76
855848|NCT02796092|2071976|P2|NOT COMPLETED|Overall Study||0
855849|NCT02796092|2071977|P1|NOT COMPLETED|Overall Study||0
855850|NCT02796092|2071976|P2|COMPLETED|Overall Study||50
855851|NCT02796092|2071977|P1|COMPLETED|Overall Study||50
855852|NCT02796092|2071976|P2|STARTED|Overall Study||50
855853|NCT02796092|2071977|P1|STARTED|Overall Study||50
855854|NCT02792049|2072011|P2|NOT COMPLETED|Overall Study||0
855855|NCT02792049|2072012|P1|NOT COMPLETED|Overall Study||0
855856|NCT02792049|2072011|P2|COMPLETED|Overall Study||35
855857|NCT02792049|2072012|P1|COMPLETED|Overall Study||35
855858|NCT02792049|2072011|P2|STARTED|Overall Study||35
855859|NCT02792049|2072012|P1|STARTED|Overall Study||35
855860|NCT02791659|2072028|P2|NOT COMPLETED|Overall Study||1
855861|NCT02791659|2072029|P1|NOT COMPLETED|Overall Study||0
855862|NCT02791659|2072028|P2|COMPLETED|Overall Study||27
855863|NCT02791659|2072029|P1|COMPLETED|Overall Study||27
855864|NCT02791659|2072028|P2|STARTED|Overall Study||28
855865|NCT02791659|2072029|P1|STARTED|Overall Study||27
855866|NCT02791269|2072037|P2|NOT COMPLETED|Overall Study||1
855867|NCT02791269|2072038|P1|NOT COMPLETED|Overall Study||0
855868|NCT02791269|2072037|P2|COMPLETED|Overall Study||19
855869|NCT02791269|2072038|P1|COMPLETED|Overall Study||4
855870|NCT02791269|2072037|P2|STARTED|Overall Study||20
855871|NCT02791269|2072038|P1|STARTED|Overall Study||4
855872|NCT02790281|2072052|P1|NOT COMPLETED|Overall Study||0
855873|NCT02790281|2072052|P1|COMPLETED|Overall Study||33
855874|NCT02790281|2072052|P1|STARTED|Overall Study||33
855875|NCT02788357|2072060|P2|NOT COMPLETED|Overall Study||0
855876|NCT02788357|2072061|P1|NOT COMPLETED|Overall Study||3
855877|NCT02788357|2072060|P2|COMPLETED|Overall Study||6
855878|NCT02788357|2072061|P1|COMPLETED|Overall Study||3
855879|NCT02788357|2072060|P2|STARTED|Overall Study||6
855880|NCT02788357|2072061|P1|STARTED|Overall Study||6
855881|NCT02788097|2072075|P2|NOT COMPLETED|Overall Study||0
855882|NCT02788097|2072076|P1|NOT COMPLETED|Overall Study||0
855883|NCT02788097|2072075|P2|COMPLETED|Overall Study||69
855884|NCT02788097|2072076|P1|COMPLETED|Overall Study||61
855885|NCT02788097|2072075|P2|STARTED|Overall Study||69
855886|NCT02788097|2072076|P1|STARTED|Overall Study||61
855890|NCT02786004|2072091|P2|NOT COMPLETED|Overall Study||14
855891|NCT02786004|2072092|P1|NOT COMPLETED|Overall Study||9
855892|NCT02786004|2072091|P2|COMPLETED|Overall Study||9
855893|NCT02786004|2072092|P1|COMPLETED|Overall Study||14
855894|NCT02786004|2072091|P2|STARTED|Overall Study||23
855895|NCT02786004|2072092|P1|STARTED|Overall Study||23
855896|NCT02784925|2072098|P1|NOT COMPLETED|Overall Study||0
855897|NCT02784925|2072098|P1|COMPLETED|Overall Study||30
855898|NCT02784925|2072098|P1|STARTED|Overall Study||30
855899|NCT02780622|2072102|P2|NOT COMPLETED|Treatment Period 2||0
855900|NCT02780622|2072103|P1|NOT COMPLETED|Treatment Period 2||0
855901|NCT02780622|2072102|P2|COMPLETED|Treatment Period 2||10
855902|NCT02780622|2072103|P1|COMPLETED|Treatment Period 2||10
855903|NCT02780622|2072102|P2|STARTED|Treatment Period 2||10
855904|NCT02780622|2072103|P1|STARTED|Treatment Period 2||10
855905|NCT02780622|2072102|P2|NOT COMPLETED|Treatment Period 1||0
855906|NCT02780622|2072103|P1|NOT COMPLETED|Treatment Period 1||0
855907|NCT02780622|2072102|P2|COMPLETED|Treatment Period 1||10
855908|NCT02780622|2072103|P1|COMPLETED|Treatment Period 1||10
855909|NCT02780622|2072102|P2|STARTED|Treatment Period 1||10
855910|NCT02780622|2072103|P1|STARTED|Treatment Period 1||10
855911|NCT02777268|2072141|P1|NOT COMPLETED|Overall Study||0
855912|NCT02777268|2072141|P1|COMPLETED|Overall Study||16
855913|NCT02777268|2072141|P1|STARTED|Overall Study||16
855914|NCT02777125|2072169|P2|NOT COMPLETED|Overall Study||47
855915|NCT02777125|2072170|P1|NOT COMPLETED|Overall Study||43
855916|NCT02777125|2072169|P2|COMPLETED|Overall Study||445
855917|NCT02777125|2072170|P1|COMPLETED|Overall Study||445
855918|NCT02777125|2072169|P2|STARTED|Overall Study||492
855919|NCT02777125|2072170|P1|STARTED|Overall Study||488
855920|NCT02774278|2072184|P1|NOT COMPLETED|Overall Study||264
855921|NCT02774278|2072184|P1|COMPLETED|Overall Study||0
855922|NCT02774278|2072184|P1|Safety Analysis Population (SAP)|Overall Study|SAP: all participants who received at least 1 dose of trial medication and had a safety follow-up.|261
855923|NCT02774278|2072184|P1|STARTED|Overall Study||264
855924|NCT02773758|2072194|P2|NOT COMPLETED|Overall Study||0
855925|NCT02773758|2072195|P1|NOT COMPLETED|Overall Study||0
855926|NCT02773758|2072194|P2|COMPLETED|Overall Study||70
855927|NCT02773758|2072195|P1|COMPLETED|Overall Study||71
855928|NCT02773758|2072194|P2|STARTED|Overall Study||70
855929|NCT02773758|2072195|P1|STARTED|Overall Study||71
855930|NCT02772666|2072205|P1|NOT COMPLETED|SFT Then O-Glass||0
855931|NCT02772666|2072205|P1|COMPLETED|SFT Then O-Glass||44
855932|NCT02772666|2072205|P1|STARTED|SFT Then O-Glass||44
855933|NCT02772666|2072205|P1|NOT COMPLETED|O-Glas Then SFT||0
855934|NCT02772666|2072205|P1|COMPLETED|O-Glas Then SFT||44
855935|NCT02772666|2072205|P1|STARTED|O-Glas Then SFT||44
855936|NCT02770625|2072210|P1|NOT COMPLETED|Overall Study||0
855937|NCT02770625|2072210|P1|COMPLETED|Overall Study||8
855938|NCT02770625|2072210|P1|STARTED|Overall Study||8
855939|NCT02767843|2072223|P1|NOT COMPLETED|Overall Study||0
855940|NCT02767843|2072223|P1|COMPLETED|Overall Study||4
855941|NCT02767843|2072223|P1|STARTED|Overall Study||4
855942|NCT02767765|2072229|P1|NOT COMPLETED|Overall Study||11
855943|NCT02767765|2072229|P1|COMPLETED|Overall Study||50
855944|NCT02767765|2072229|P1|STARTED|Overall Study||61
855945|NCT02766400|2072240|P2|NOT COMPLETED|Overall Study||2
855946|NCT02766400|2072241|P1|NOT COMPLETED|Overall Study||2
855947|NCT02766400|2072240|P2|COMPLETED|Overall Study||20
855948|NCT02766400|2072241|P1|COMPLETED|Overall Study||19
855949|NCT02766400|2072240|P2|STARTED|Overall Study||22
855950|NCT02766400|2072241|P1|STARTED|Overall Study||21
855951|NCT02766244|2072247|P1|NOT COMPLETED|Overall Study||0
855952|NCT02766244|2072247|P1|COMPLETED|Overall Study||3
855953|NCT02766244|2072247|P1|STARTED|Overall Study||3
855954|NCT02765269|2072258|P2|NOT COMPLETED|Overall Study||0
855955|NCT02765269|2072259|P1|NOT COMPLETED|Overall Study||0
855956|NCT02765269|2072258|P2|COMPLETED|Overall Study||21
855957|NCT02765269|2072259|P1|COMPLETED|Overall Study||25
855958|NCT02765269|2072258|P2|STARTED|Overall Study||21
855959|NCT02765269|2072259|P1|STARTED|Overall Study||25
855960|NCT02763189|2072273|P2|NOT COMPLETED|Overall Study||2
855961|NCT02763189|2072274|P1|NOT COMPLETED|Overall Study||0
855962|NCT02763189|2072273|P2|COMPLETED|Overall Study||2
855963|NCT02763189|2072274|P1|COMPLETED|Overall Study||4
855964|NCT02763189|2072273|P2|STARTED|Overall Study||4
855965|NCT02763189|2072274|P1|STARTED|Overall Study||4
855966|NCT02761733|2072286|P4|NOT COMPLETED|Overall Study||15
855967|NCT02761733|2072287|P3|NOT COMPLETED|Overall Study||27
855968|NCT02761733|2072288|P2|NOT COMPLETED|Overall Study||21
855969|NCT02761733|2072289|P1|NOT COMPLETED|Overall Study||30
855970|NCT02761733|2072286|P4|COMPLETED|Overall Study||45
855971|NCT02761733|2072287|P3|COMPLETED|Overall Study||33
855972|NCT02761733|2072288|P2|COMPLETED|Overall Study||39
855973|NCT02761733|2072289|P1|COMPLETED|Overall Study||30
855974|NCT02761733|2072286|P4|9/30/2015|Overall Study||50
855975|NCT02761733|2072287|P3|9/30/2015|Overall Study||33
855976|NCT02761733|2072288|P2|9/30/2015|Overall Study||44
855977|NCT02761733|2072289|P1|9/30/2015|Overall Study||40
855978|NCT02761733|2072286|P4|3/31/2015|Overall Study||50
855979|NCT02761733|2072287|P3|3/31/2015|Overall Study||43
855980|NCT02761733|2072288|P2|3/31/2015|Overall Study||47
855981|NCT02761733|2072289|P1|3/31/2015|Overall Study||48
855982|NCT02761733|2072286|P4|9/30/2014|Overall Study||55
855983|NCT02761733|2072287|P3|9/30/2014|Overall Study||48
855984|NCT02761733|2072288|P2|9/30/2014|Overall Study||56
855985|NCT02761733|2072289|P1|9/30/2014|Overall Study||53
855986|NCT02761733|2072286|P4|STARTED|Overall Study||60
855987|NCT02761733|2072287|P3|STARTED|Overall Study||60
855988|NCT02761733|2072288|P2|STARTED|Overall Study||60
855989|NCT02761733|2072289|P1|STARTED|Overall Study||60
855990|NCT02761629|2072321|P2|NOT COMPLETED|Overall Study||32
855991|NCT02761629|2072322|P1|NOT COMPLETED|Overall Study||27
855992|NCT02761629|2072321|P2|COMPLETED|Overall Study||58
855993|NCT02761629|2072322|P1|COMPLETED|Overall Study||63
855994|NCT02761629|2072321|P2|Treated|Overall Study||86
855995|NCT02761629|2072322|P1|Treated|Overall Study||82
855996|NCT02761629|2072321|P2|STARTED|Overall Study||90
855997|NCT02761629|2072322|P1|STARTED|Overall Study||90
855998|NCT02760810|2072342|P1|NOT COMPLETED|Overall Study||1
855999|NCT02760810|2072342|P1|COMPLETED|Overall Study||29
856000|NCT02760810|2072342|P1|STARTED|Overall Study||30
856001|NCT02760654|2072350|P2|NOT COMPLETED|Overall Study||6
856002|NCT02760654|2072351|P1|NOT COMPLETED|Overall Study||7
856003|NCT02760654|2072350|P2|COMPLETED|Overall Study||24
856004|NCT02760654|2072351|P1|COMPLETED|Overall Study||23
856005|NCT02760654|2072350|P2|STARTED|Overall Study||30
856006|NCT02760654|2072351|P1|STARTED|Overall Study||30
856007|NCT02759692|2072375|P2|NOT COMPLETED|Period 3||0
856008|NCT02759692|2072376|P1|NOT COMPLETED|Period 3||0
856009|NCT02759692|2072375|P2|COMPLETED|Period 3||139
856010|NCT02759692|2072376|P1|COMPLETED|Period 3||137
856011|NCT02759692|2072375|P2|STARTED|Period 3||139
856012|NCT02759692|2072376|P1|STARTED|Period 3||137
856013|NCT02759692|2072375|P2|NOT COMPLETED|Period 2||1
856014|NCT02759692|2072376|P1|NOT COMPLETED|Period 2||1
856015|NCT02759692|2072375|P2|COMPLETED|Period 2||139
856016|NCT02759692|2072376|P1|COMPLETED|Period 2||137
856017|NCT02759692|2072375|P2|STARTED|Period 2||140
856018|NCT02759692|2072376|P1|STARTED|Period 2||138
856019|NCT02759692|2072375|P2|NOT COMPLETED|Period 1||2
856020|NCT02759692|2072376|P1|NOT COMPLETED|Period 1||3
856021|NCT02759692|2072375|P2|COMPLETED|Period 1||140
856022|NCT02759692|2072376|P1|COMPLETED|Period 1||138
856023|NCT02759692|2072375|P2|STARTED|Period 1||142
856024|NCT02759692|2072376|P1|STARTED|Period 1||141
856025|NCT02759471|2072392|P1|NOT COMPLETED|Overall Study||2
856026|NCT02759471|2072392|P1|COMPLETED|Overall Study||52
856027|NCT02759471|2072392|P1|STARTED|Overall Study||54
856028|NCT02758210|2072402|P1|NOT COMPLETED|Overall Study||0
856029|NCT02758210|2072402|P1|COMPLETED|Overall Study||20
856030|NCT02758210|2072402|P1|STARTED|Overall Study||20
856031|NCT02756637|2072413|P2|NOT COMPLETED|Overall Study||54
856032|NCT02756637|2072414|P1|NOT COMPLETED|Overall Study||87
856033|NCT02756637|2072413|P2|COMPLETED|Overall Study||263
856034|NCT02756637|2072414|P1|COMPLETED|Overall Study||230
856035|NCT02756637|2072413|P2|Completed Curative Treatment|Overall Study||0
856036|NCT02756637|2072414|P1|Completed Curative Treatment|Overall Study||230
856037|NCT02756637|2072413|P2|Had NLR Value|Overall Study||263
856038|NCT02756637|2072414|P1|Had NLR Value|Overall Study||263
856039|NCT02756637|2072413|P2|Eligible for SWOG 8710|Overall Study||307
856040|NCT02756637|2072414|P1|Eligible for SWOG 8710|Overall Study||307
856041|NCT02756637|2072413|P2|STARTED|Overall Study||317
856042|NCT02756637|2072414|P1|STARTED|Overall Study||317
856043|NCT02756624|2072422|P2|NOT COMPLETED|Overall Study||7
856044|NCT02756624|2072423|P1|NOT COMPLETED|Overall Study||16
856045|NCT02756624|2072422|P2|COMPLETED|Overall Study||166
856046|NCT02756624|2072423|P1|COMPLETED|Overall Study||327
856047|NCT02756624|2072422|P2|STARTED|Overall Study||173
856048|NCT02756624|2072423|P1|STARTED|Overall Study||343
856049|NCT02756351|2072437|P2|NOT COMPLETED|Overall Study||0
856050|NCT02756351|2072438|P1|NOT COMPLETED|Overall Study||0
856051|NCT02756351|2072437|P2|COMPLETED|Overall Study||24
856052|NCT02756351|2072438|P1|COMPLETED|Overall Study||24
856053|NCT02756351|2072437|P2|STARTED|Overall Study||24
856054|NCT02756351|2072438|P1|STARTED|Overall Study||24
856055|NCT02755805|2072448|P2|NOT COMPLETED|Overall Study||4
856056|NCT02755805|2072449|P1|NOT COMPLETED|Overall Study||2
856057|NCT02755805|2072448|P2|COMPLETED|Overall Study||11
856058|NCT02755805|2072449|P1|COMPLETED|Overall Study||13
856059|NCT02755805|2072448|P2|STARTED|Overall Study||15
856060|NCT02755805|2072449|P1|STARTED|Overall Study||15
856061|NCT02755090|2072463|P2|NOT COMPLETED|Overall Study||0
856062|NCT02755090|2072464|P1|NOT COMPLETED|Overall Study||1
856063|NCT02755090|2072463|P2|COMPLETED|Overall Study||20
856064|NCT02755090|2072464|P1|COMPLETED|Overall Study||18
856065|NCT02755090|2072463|P2|STARTED|Overall Study||20
856066|NCT02755090|2072464|P1|STARTED|Overall Study||19
856067|NCT02753699|2072475|P3|NOT COMPLETED|Overall Study||23
856068|NCT02753699|2072476|P2|NOT COMPLETED|Overall Study||43
856069|NCT02753699|2072477|P1|NOT COMPLETED|Overall Study||14
856070|NCT02753699|2072475|P3|COMPLETED|Overall Study||139
856071|NCT02753699|2072476|P2|COMPLETED|Overall Study||354
856072|NCT02753699|2072477|P1|COMPLETED|Overall Study||150
856073|NCT02753699|2072475|P3|STARTED|Overall Study||162
856074|NCT02753699|2072476|P2|STARTED|Overall Study||397
856075|NCT02753699|2072477|P1|STARTED|Overall Study||164
856076|NCT02753413|2072493|P2|NOT COMPLETED|Overall Study||0
856077|NCT02753413|2072494|P1|NOT COMPLETED|Overall Study||0
856078|NCT02753413|2072493|P2|COMPLETED|Overall Study||51
856079|NCT02753413|2072494|P1|COMPLETED|Overall Study||49
856080|NCT02753413|2072493|P2|STARTED|Overall Study||51
856081|NCT02753413|2072494|P1|STARTED|Overall Study||49
856082|NCT02753075|2072529|P3|NOT COMPLETED|Overall Study||3
856083|NCT02753075|2072530|P2|NOT COMPLETED|Overall Study||3
856084|NCT02753075|2072531|P1|NOT COMPLETED|Overall Study||8
856085|NCT02753075|2072529|P3|COMPLETED|Overall Study||78
856086|NCT02753075|2072530|P2|COMPLETED|Overall Study||77
856087|NCT02753075|2072531|P1|COMPLETED|Overall Study||71
856088|NCT02753075|2072529|P3|STARTED|Overall Study||81
856089|NCT02753075|2072530|P2|STARTED|Overall Study||80
856090|NCT02753075|2072531|P1|STARTED|Overall Study||79
856091|NCT02752802|2072558|P2|NOT COMPLETED|Overall Study||0
856092|NCT02752802|2072559|P1|NOT COMPLETED|Overall Study||1
856093|NCT02752802|2072558|P2|COMPLETED|Overall Study||48
856094|NCT02752802|2072559|P1|COMPLETED|Overall Study||47
856095|NCT02752802|2072558|P2|STARTED|Overall Study||48
856096|NCT02752802|2072559|P1|STARTED|Overall Study||48
856097|NCT02751450|2072570|P2|NOT COMPLETED|Overall Study||0
856098|NCT02751450|2072571|P1|NOT COMPLETED|Overall Study||1
856099|NCT02751450|2072570|P2|COMPLETED|Overall Study||116
856100|NCT02751450|2072571|P1|COMPLETED|Overall Study||116
856101|NCT02751450|2072570|P2|STARTED|Overall Study||116
856102|NCT02751450|2072571|P1|STARTED|Overall Study||117
856109|NCT02750813|2072600|P2|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
856110|NCT02750813|2072601|P1|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
856111|NCT02750813|2072600|P2|COMPLETED|Period 2, Second 14 Days of Wear||120
856112|NCT02750813|2072601|P1|COMPLETED|Period 2, Second 14 Days of Wear||124
856113|NCT02750813|2072600|P2|STARTED|Period 2, Second 14 Days of Wear||120
856114|NCT02750813|2072601|P1|STARTED|Period 2, Second 14 Days of Wear||124
856115|NCT02750813|2072600|P2|NOT COMPLETED|Period 1, First 14 Days of Wear||1
856116|NCT02750813|2072601|P1|NOT COMPLETED|Period 1, First 14 Days of Wear||1
856117|NCT02750813|2072600|P2|COMPLETED|Period 1, First 14 Days of Wear||120
856118|NCT02750813|2072601|P1|COMPLETED|Period 1, First 14 Days of Wear||124
856119|NCT02750813|2072600|P2|STARTED|Period 1, First 14 Days of Wear||121
856120|NCT02750813|2072601|P1|STARTED|Period 1, First 14 Days of Wear||125
856121|NCT02750709|2072610|P6|NOT COMPLETED|Treatment Period 3||0
856122|NCT02750709|2072611|P5|NOT COMPLETED|Treatment Period 3||0
856123|NCT02750709|2072612|P4|NOT COMPLETED|Treatment Period 3||0
856124|NCT02750709|2072613|P3|NOT COMPLETED|Treatment Period 3||0
856125|NCT02750709|2072614|P2|NOT COMPLETED|Treatment Period 3||0
856126|NCT02750709|2072615|P1|NOT COMPLETED|Treatment Period 3||0
856127|NCT02750709|2072610|P6|COMPLETED|Treatment Period 3||3
856128|NCT02750709|2072611|P5|COMPLETED|Treatment Period 3||4
856129|NCT02750709|2072612|P4|COMPLETED|Treatment Period 3||4
856130|NCT02750709|2072613|P3|COMPLETED|Treatment Period 3||4
856131|NCT02750709|2072614|P2|COMPLETED|Treatment Period 3||4
856132|NCT02750709|2072615|P1|COMPLETED|Treatment Period 3||4
856133|NCT02750709|2072610|P6|STARTED|Treatment Period 3||3
856134|NCT02750709|2072611|P5|STARTED|Treatment Period 3||4
856135|NCT02750709|2072612|P4|STARTED|Treatment Period 3||4
856136|NCT02750709|2072613|P3|STARTED|Treatment Period 3||4
856137|NCT02750709|2072614|P2|STARTED|Treatment Period 3||4
856138|NCT02750709|2072615|P1|STARTED|Treatment Period 3||4
856139|NCT02750709|2072610|P6|NOT COMPLETED|Treatment Period 2||0
856140|NCT02750709|2072611|P5|NOT COMPLETED|Treatment Period 2||0
856141|NCT02750709|2072612|P4|NOT COMPLETED|Treatment Period 2||0
856142|NCT02750709|2072613|P3|NOT COMPLETED|Treatment Period 2||0
856143|NCT02750709|2072614|P2|NOT COMPLETED|Treatment Period 2||0
856144|NCT02750709|2072615|P1|NOT COMPLETED|Treatment Period 2||0
856145|NCT02750709|2072610|P6|COMPLETED|Treatment Period 2||3
856146|NCT02750709|2072611|P5|COMPLETED|Treatment Period 2||4
856147|NCT02750709|2072612|P4|COMPLETED|Treatment Period 2||4
856148|NCT02750709|2072613|P3|COMPLETED|Treatment Period 2||4
856149|NCT02750709|2072614|P2|COMPLETED|Treatment Period 2||4
856150|NCT02750709|2072615|P1|COMPLETED|Treatment Period 2||4
856151|NCT02750709|2072610|P6|STARTED|Treatment Period 2||3
856152|NCT02750709|2072611|P5|STARTED|Treatment Period 2||4
856153|NCT02750709|2072612|P4|STARTED|Treatment Period 2||4
856154|NCT02750709|2072613|P3|STARTED|Treatment Period 2||4
856155|NCT02750709|2072614|P2|STARTED|Treatment Period 2||4
856156|NCT02750709|2072615|P1|STARTED|Treatment Period 2||4
856157|NCT02750709|2072610|P6|NOT COMPLETED|Treatment Period 1||1
856158|NCT02750709|2072611|P5|NOT COMPLETED|Treatment Period 1||0
856159|NCT02750709|2072612|P4|NOT COMPLETED|Treatment Period 1||0
856160|NCT02750709|2072613|P3|NOT COMPLETED|Treatment Period 1||0
856161|NCT02750709|2072614|P2|NOT COMPLETED|Treatment Period 1||0
856162|NCT02750709|2072615|P1|NOT COMPLETED|Treatment Period 1||0
856163|NCT02750709|2072610|P6|COMPLETED|Treatment Period 1||3
856164|NCT02750709|2072611|P5|COMPLETED|Treatment Period 1||4
856165|NCT02750709|2072612|P4|COMPLETED|Treatment Period 1||4
856166|NCT02750709|2072613|P3|COMPLETED|Treatment Period 1||4
856167|NCT02750709|2072614|P2|COMPLETED|Treatment Period 1||4
856168|NCT02750709|2072615|P1|COMPLETED|Treatment Period 1||4
856169|NCT02750709|2072610|P6|STARTED|Treatment Period 1||4
856170|NCT02750709|2072611|P5|STARTED|Treatment Period 1||4
856171|NCT02750709|2072612|P4|STARTED|Treatment Period 1||4
856172|NCT02750709|2072613|P3|STARTED|Treatment Period 1||4
856173|NCT02750709|2072614|P2|STARTED|Treatment Period 1||4
856174|NCT02750709|2072615|P1|STARTED|Treatment Period 1||4
856175|NCT02750345|2072641|P6|NOT COMPLETED|Intervention 3||0
856176|NCT02750345|2072642|P5|NOT COMPLETED|Intervention 3||0
856177|NCT02750345|2072643|P4|NOT COMPLETED|Intervention 3||0
856178|NCT02750345|2072644|P3|NOT COMPLETED|Intervention 3||0
856179|NCT02750345|2072645|P2|NOT COMPLETED|Intervention 3||0
856180|NCT02750345|2072646|P1|NOT COMPLETED|Intervention 3||0
856181|NCT02750345|2072641|P6|COMPLETED|Intervention 3||4
856182|NCT02750345|2072642|P5|COMPLETED|Intervention 3||3
856183|NCT02750345|2072643|P4|COMPLETED|Intervention 3||4
856184|NCT02750345|2072644|P3|COMPLETED|Intervention 3||4
856185|NCT02750345|2072645|P2|COMPLETED|Intervention 3||4
856186|NCT02750345|2072646|P1|COMPLETED|Intervention 3||4
856187|NCT02750345|2072641|P6|STARTED|Intervention 3||4
856188|NCT02750345|2072642|P5|STARTED|Intervention 3||3
856189|NCT02750345|2072643|P4|STARTED|Intervention 3||4
856190|NCT02750345|2072644|P3|STARTED|Intervention 3||4
856191|NCT02750345|2072645|P2|STARTED|Intervention 3||4
856192|NCT02750345|2072646|P1|STARTED|Intervention 3||4
856193|NCT02750345|2072641|P6|NOT COMPLETED|Intervention 2||0
856194|NCT02750345|2072642|P5|NOT COMPLETED|Intervention 2||0
856195|NCT02750345|2072643|P4|NOT COMPLETED|Intervention 2||0
856196|NCT02750345|2072644|P3|NOT COMPLETED|Intervention 2||0
856197|NCT02750345|2072645|P2|NOT COMPLETED|Intervention 2||0
856198|NCT02750345|2072646|P1|NOT COMPLETED|Intervention 2||0
856199|NCT02750345|2072641|P6|COMPLETED|Intervention 2||4
856200|NCT02750345|2072642|P5|COMPLETED|Intervention 2||3
856201|NCT02750345|2072643|P4|COMPLETED|Intervention 2||4
856202|NCT02750345|2072644|P3|COMPLETED|Intervention 2||4
856203|NCT02750345|2072645|P2|COMPLETED|Intervention 2||4
856204|NCT02750345|2072646|P1|COMPLETED|Intervention 2||4
856205|NCT02750345|2072641|P6|STARTED|Intervention 2||4
856206|NCT02750345|2072642|P5|STARTED|Intervention 2||3
856207|NCT02750345|2072643|P4|STARTED|Intervention 2||4
856208|NCT02750345|2072644|P3|STARTED|Intervention 2||4
856209|NCT02750345|2072645|P2|STARTED|Intervention 2||4
856210|NCT02750345|2072646|P1|STARTED|Intervention 2||4
856211|NCT02750345|2072641|P6|NOT COMPLETED|Intervention 1||0
856212|NCT02750345|2072642|P5|NOT COMPLETED|Intervention 1||1
856213|NCT02750345|2072643|P4|NOT COMPLETED|Intervention 1||0
856214|NCT02750345|2072644|P3|NOT COMPLETED|Intervention 1||0
856215|NCT02750345|2072645|P2|NOT COMPLETED|Intervention 1||0
856216|NCT02750345|2072646|P1|NOT COMPLETED|Intervention 1||0
856217|NCT02750345|2072641|P6|COMPLETED|Intervention 1||4
856218|NCT02750345|2072642|P5|COMPLETED|Intervention 1||3
856219|NCT02750345|2072643|P4|COMPLETED|Intervention 1||4
856220|NCT02750345|2072644|P3|COMPLETED|Intervention 1||4
856221|NCT02750345|2072645|P2|COMPLETED|Intervention 1||4
856222|NCT02750345|2072646|P1|COMPLETED|Intervention 1||4
856223|NCT02750345|2072641|P6|STARTED|Intervention 1||4
856224|NCT02750345|2072642|P5|STARTED|Intervention 1||4
856225|NCT02750345|2072643|P4|STARTED|Intervention 1||4
856226|NCT02750345|2072644|P3|STARTED|Intervention 1||4
856227|NCT02750345|2072645|P2|STARTED|Intervention 1||4
856228|NCT02750345|2072646|P1|STARTED|Intervention 1||4
856229|NCT02750332|2072672|P2|NOT COMPLETED|Treatment Period 2||0
856230|NCT02750332|2072673|P1|NOT COMPLETED|Treatment Period 2||0
856231|NCT02750332|2072672|P2|COMPLETED|Treatment Period 2||9
856232|NCT02750332|2072673|P1|COMPLETED|Treatment Period 2||10
856233|NCT02750332|2072672|P2|STARTED|Treatment Period 2||9
856234|NCT02750332|2072673|P1|STARTED|Treatment Period 2||10
856235|NCT02750332|2072672|P2|NOT COMPLETED|Treatment Period 1||1
856236|NCT02750332|2072673|P1|NOT COMPLETED|Treatment Period 1||0
856237|NCT02750332|2072672|P2|COMPLETED|Treatment Period 1||9
856238|NCT02750332|2072673|P1|COMPLETED|Treatment Period 1||10
856239|NCT02750332|2072672|P2|STARTED|Treatment Period 1||10
856240|NCT02750332|2072673|P1|STARTED|Treatment Period 1||10
856241|NCT02750267|2072693|P2|NOT COMPLETED|Overall Study||0
856242|NCT02750267|2072694|P1|NOT COMPLETED|Overall Study||0
856243|NCT02750267|2072693|P2|COMPLETED|Overall Study||6
856244|NCT02750267|2072694|P1|COMPLETED|Overall Study||6
856245|NCT02750267|2072693|P2|STARTED|Overall Study||6
856246|NCT02750267|2072694|P1|STARTED|Overall Study||6
856247|NCT02748213|2072734|P2|NOT COMPLETED|Overall Study||112
856248|NCT02748213|2072735|P1|NOT COMPLETED|Overall Study||113
856249|NCT02748213|2072734|P2|COMPLETED|Overall Study||0
856250|NCT02748213|2072735|P1|COMPLETED|Overall Study|"*The reason Refused Treatment also includes those who did not cooperate or withdrew consent."|0
856251|NCT02748213|2072734|P2|Treated|Overall Study||110
856252|NCT02748213|2072735|P1|Treated|Overall Study||112
856253|NCT02748213|2072734|P2|STARTED|Overall Study||112
856254|NCT02748213|2072735|P1|STARTED|Overall Study||113
856255|NCT02746679|2072753|P2|NOT COMPLETED|Overall Study||6
856256|NCT02746679|2072754|P1|NOT COMPLETED|Overall Study||4
856257|NCT02746679|2072753|P2|COMPLETED|Overall Study||75
856258|NCT02746679|2072754|P1|COMPLETED|Overall Study||76
856259|NCT02746679|2072753|P2|STARTED|Overall Study||81
856260|NCT02746679|2072754|P1|STARTED|Overall Study||80
856261|NCT02746406|2072784|P1|NOT COMPLETED|Overall Study||0
856262|NCT02746406|2072784|P1|COMPLETED|Overall Study||5
856263|NCT02746406|2072784|P1|STARTED|Overall Study||5
856264|NCT02746107|2072788|P1|NOT COMPLETED|Overall Study||0
856265|NCT02746107|2072788|P1|COMPLETED|Overall Study||968
856266|NCT02746107|2072788|P1|CHA2DS2-VASC Score = 5|Overall Study||192
856267|NCT02746107|2072788|P1|CHA2DS2-VASC Score = 4|Overall Study||197
856268|NCT02746107|2072788|P1|CHA2DS2-VASC Score = 3|Overall Study||195
856269|NCT02746107|2072788|P1|CHA2DS2-VASC Score = 2|Overall Study||189
856270|NCT02746107|2072788|P1|CHA2DS2-VASC Score = 1|Overall Study||195
856271|NCT02746107|2072788|P1|Target=Physician|Overall Study||482
856272|NCT02746107|2072788|P1|Target=Patient|Overall Study||486
856273|NCT02746107|2072788|P1|5year Risk Estimate|Overall Study||485
856274|NCT02746107|2072788|P1|1year Risk Estimate|Overall Study||483
856275|NCT02746107|2072788|P1|1 Diagram DA|Overall Study||486
856276|NCT02746107|2072788|P1|2 Diagrams DA|Overall Study||482
856277|NCT02746107|2072788|P1|STARTED|Overall Study||968
856278|NCT02745626|2072806|P3|NOT COMPLETED|Overall Study||3
856279|NCT02745626|2072807|P2|NOT COMPLETED|Overall Study||6
856280|NCT02745626|2072808|P1|NOT COMPLETED|Overall Study||3
856281|NCT02745626|2072806|P3|COMPLETED|Overall Study||19
856282|NCT02745626|2072807|P2|COMPLETED|Overall Study||16
856283|NCT02745626|2072808|P1|COMPLETED|Overall Study||21
856284|NCT02745626|2072806|P3|STARTED|Overall Study||22
856285|NCT02745626|2072807|P2|STARTED|Overall Study||22
856286|NCT02745626|2072808|P1|STARTED|Overall Study||24
856287|NCT02743936|2072836|P2|NOT COMPLETED|Overall Study||0
856288|NCT02743936|2072837|P1|NOT COMPLETED|Overall Study||0
856289|NCT02743936|2072836|P2|COMPLETED|Overall Study||32
856290|NCT02743936|2072837|P1|COMPLETED|Overall Study||32
856291|NCT02743936|2072836|P2|STARTED|Overall Study||32
856292|NCT02743936|2072837|P1|STARTED|Overall Study||32
856293|NCT02743780|2072850|P5|NOT COMPLETED|Part 3 (7 Days)||0
856294|NCT02743780|2072851|P4|NOT COMPLETED|Part 3 (7 Days)||0
856295|NCT02743780|2072852|P3|NOT COMPLETED|Part 3 (7 Days)||1
856296|NCT02743780|2072853|P2|NOT COMPLETED|Part 3 (7 Days)||0
856297|NCT02743780|2072854|P1|NOT COMPLETED|Part 3 (7 Days)||0
856298|NCT02743780|2072850|P5|COMPLETED|Part 3 (7 Days)||25
856299|NCT02743780|2072851|P4|COMPLETED|Part 3 (7 Days)||0
856300|NCT02743780|2072852|P3|COMPLETED|Part 3 (7 Days)||24
856301|NCT02743780|2072853|P2|COMPLETED|Part 3 (7 Days)||0
856302|NCT02743780|2072854|P1|COMPLETED|Part 3 (7 Days)||0
856303|NCT02743780|2072850|P5|STARTED|Part 3 (7 Days)||25
856304|NCT02743780|2072851|P4|STARTED|Part 3 (7 Days)||0
856305|NCT02743780|2072852|P3|STARTED|Part 3 (7 Days)||25
856306|NCT02743780|2072853|P2|STARTED|Part 3 (7 Days)||0
856307|NCT02743780|2072854|P1|STARTED|Part 3 (7 Days)||0
856308|NCT02743780|2072850|P5|NOT COMPLETED|Part 2 (8 Days)||0
856309|NCT02743780|2072851|P4|NOT COMPLETED|Part 2 (8 Days)||0
856310|NCT02743780|2072852|P3|NOT COMPLETED|Part 2 (8 Days)||0
856311|NCT02743780|2072853|P2|NOT COMPLETED|Part 2 (8 Days)||0
856312|NCT02743780|2072854|P1|NOT COMPLETED|Part 2 (8 Days)||0
856313|NCT02743780|2072850|P5|COMPLETED|Part 2 (8 Days)||4
856314|NCT02743780|2072851|P4|COMPLETED|Part 2 (8 Days)||0
856315|NCT02743780|2072852|P3|COMPLETED|Part 2 (8 Days)||6
856316|NCT02743780|2072853|P2|COMPLETED|Part 2 (8 Days)||6
856317|NCT02743780|2072854|P1|COMPLETED|Part 2 (8 Days)||0
856318|NCT02743780|2072850|P5|STARTED|Part 2 (8 Days)||4
856319|NCT02743780|2072851|P4|STARTED|Part 2 (8 Days)||0
856320|NCT02743780|2072852|P3|STARTED|Part 2 (8 Days)||6
856321|NCT02743780|2072853|P2|STARTED|Part 2 (8 Days)||6
856322|NCT02743780|2072854|P1|STARTED|Part 2 (8 Days)||0
856323|NCT02743780|2072850|P5|NOT COMPLETED|Part 1 (3 Days)||0
856324|NCT02743780|2072851|P4|NOT COMPLETED|Part 1 (3 Days)||0
856325|NCT02743780|2072852|P3|NOT COMPLETED|Part 1 (3 Days)||0
856326|NCT02743780|2072853|P2|NOT COMPLETED|Part 1 (3 Days)||0
856327|NCT02743780|2072854|P1|NOT COMPLETED|Part 1 (3 Days)||0
856328|NCT02743780|2072850|P5|COMPLETED|Part 1 (3 Days)||8
856329|NCT02743780|2072851|P4|COMPLETED|Part 1 (3 Days)||6
856330|NCT02743780|2072852|P3|COMPLETED|Part 1 (3 Days)||6
856331|NCT02743780|2072853|P2|COMPLETED|Part 1 (3 Days)||6
856332|NCT02743780|2072854|P1|COMPLETED|Part 1 (3 Days)||6
856333|NCT02743780|2072850|P5|STARTED|Part 1 (3 Days)||8
856334|NCT02743780|2072851|P4|STARTED|Part 1 (3 Days)||6
856335|NCT02743780|2072852|P3|STARTED|Part 1 (3 Days)||6
856336|NCT02743780|2072853|P2|STARTED|Part 1 (3 Days)||6
856337|NCT02743780|2072854|P1|STARTED|Part 1 (3 Days)||6
856338|NCT02743702|2072901|P2|NOT COMPLETED|Overall Study||0
856339|NCT02743702|2072902|P1|NOT COMPLETED|Overall Study||0
856340|NCT02743702|2072901|P2|COMPLETED|Overall Study||10
856341|NCT02743702|2072902|P1|COMPLETED|Overall Study||11
856342|NCT02743702|2072901|P2|STARTED|Overall Study||10
856343|NCT02743702|2072902|P1|STARTED|Overall Study||11
856344|NCT02743117|2072910|P2|NOT COMPLETED|Overall Study||1
856345|NCT02743117|2072911|P1|NOT COMPLETED|Overall Study||1
856346|NCT02743117|2072910|P2|COMPLETED|Overall Study||240
856347|NCT02743117|2072911|P1|COMPLETED|Overall Study||59
856348|NCT02743117|2072910|P2|Treated|Overall Study||241
856349|NCT02743117|2072911|P1|Treated|Overall Study||59
856350|NCT02743117|2072910|P2|STARTED|Overall Study||241
856351|NCT02743117|2072911|P1|STARTED|Overall Study||60
856352|NCT02742987|2072927|P2|NOT COMPLETED|Overall Study||0
856353|NCT02742987|2072928|P1|NOT COMPLETED|Overall Study||0
856354|NCT02742987|2072927|P2|COMPLETED|Overall Study||21
856355|NCT02742987|2072928|P1|COMPLETED|Overall Study||21
856356|NCT02742987|2072927|P2|STARTED|Overall Study||21
856357|NCT02742987|2072928|P1|STARTED|Overall Study||21
856358|NCT02739698|2072936|P2|NOT COMPLETED|Overall Study||5
856359|NCT02739698|2072937|P1|NOT COMPLETED|Overall Study||6
856360|NCT02739698|2072936|P2|COMPLETED|Overall Study||16
856361|NCT02739698|2072937|P1|COMPLETED|Overall Study||16
856362|NCT02739698|2072936|P2|STARTED|Overall Study||21
856363|NCT02739698|2072937|P1|STARTED|Overall Study||22
856364|NCT02739594|2072945|P2|NOT COMPLETED|Overall Study||28
856365|NCT02739594|2072946|P1|NOT COMPLETED|Overall Study||25
856366|NCT02739594|2072945|P2|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|15
856367|NCT02739594|2072946|P1|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|21
856368|NCT02739594|2072945|P2|Completed at Week 96|Overall Study||10
856369|NCT02739594|2072946|P1|Completed at Week 96|Overall Study||10
856370|NCT02739594|2072945|P2|Completed at Week 44|Overall Study||5
856371|NCT02739594|2072946|P1|Completed at Week 44|Overall Study||11
856372|NCT02739594|2072945|P2|STARTED|Overall Study||43
856373|NCT02739594|2072946|P1|STARTED|Overall Study||46
856374|NCT02737852|2072976|P1|NOT COMPLETED|Overall Study||2
856375|NCT02737852|2072976|P1|COMPLETED|Overall Study||30
856376|NCT02737852|2072976|P1|STARTED|Overall Study||32
856377|NCT02737631|2072981|P1|NOT COMPLETED|Overall Study||0
856378|NCT02737631|2072981|P1|COMPLETED|Overall Study||222
856379|NCT02737631|2072981|P1|STARTED|Overall Study||222
856380|NCT02737618|2072986|P1|NOT COMPLETED|Overall Study||9
856381|NCT02737618|2072986|P1|COMPLETED|Overall Study||34
856382|NCT02737618|2072986|P1|STARTED|Overall Study||43
856383|NCT02737592|2072991|P1|NOT COMPLETED|Overall Study||1
856384|NCT02737592|2072991|P1|COMPLETED|Overall Study||33
856385|NCT02737592|2072991|P1|STARTED|Overall Study||34
856386|NCT02736721|2072996|P1|NOT COMPLETED|Overall Study||16
856387|NCT02736721|2072996|P1|COMPLETED|Overall Study||25
856388|NCT02736721|2072996|P1|STARTED|Overall Study||41
856389|NCT02735200|2073007|P2|NOT COMPLETED|Overall Study||5
856390|NCT02735200|2073008|P1|NOT COMPLETED|Overall Study||8
856391|NCT02735200|2073007|P2|COMPLETED|Overall Study||345
856392|NCT02735200|2073008|P1|COMPLETED|Overall Study||192
856393|NCT02735200|2073007|P2|STARTED|Overall Study||350
856394|NCT02735200|2073008|P1|STARTED|Overall Study||200
856395|NCT02734355|2073016|P2|NOT COMPLETED|Overall Study||0
856396|NCT02734355|2073017|P1|NOT COMPLETED|Overall Study||0
856397|NCT02734355|2073016|P2|COMPLETED|Overall Study||30
856398|NCT02734355|2073017|P1|COMPLETED|Overall Study||34
856399|NCT02734355|2073016|P2|STARTED|Overall Study||30
856400|NCT02734355|2073017|P1|STARTED|Overall Study||34
856401|NCT02734212|2073049|P2|NOT COMPLETED|Overall Study||10
856402|NCT02734212|2073050|P1|NOT COMPLETED|Overall Study||5
856403|NCT02734212|2073049|P2|COMPLETED|Overall Study||18
856404|NCT02734212|2073050|P1|COMPLETED|Overall Study||24
856405|NCT02734212|2073049|P2|STARTED|Overall Study||28
856406|NCT02734212|2073050|P1|STARTED|Overall Study||29
856407|NCT02734056|2073062|P2|NOT COMPLETED|Overall Study||1
856408|NCT02734056|2073063|P1|NOT COMPLETED|Overall Study||0
856409|NCT02734056|2073062|P2|COMPLETED|Overall Study||49
856410|NCT02734056|2073063|P1|COMPLETED|Overall Study||50
856411|NCT02734056|2073062|P2|STARTED|Overall Study||50
856412|NCT02734056|2073063|P1|STARTED|Overall Study||50
856413|NCT02732639|2073069|P1|NOT COMPLETED|Overall Study||1
856414|NCT02732639|2073069|P1|COMPLETED|Overall Study||30
856415|NCT02732639|2073069|P1|STARTED|Overall Study||31
856416|NCT02732561|2073082|P2|NOT COMPLETED|Overall Study||1
856417|NCT02732561|2073083|P1|NOT COMPLETED|Overall Study||2
856418|NCT02732561|2073082|P2|COMPLETED|Overall Study||4
856419|NCT02732561|2073083|P1|COMPLETED|Overall Study||3
856420|NCT02732561|2073082|P2|STARTED|Overall Study||5
856421|NCT02732561|2073083|P1|STARTED|Overall Study||5
856422|NCT02732327|2073093|P2|NOT COMPLETED|Overall Study||1
856423|NCT02732327|2073094|P1|NOT COMPLETED|Overall Study||0
856424|NCT02732327|2073093|P2|COMPLETED|Overall Study||1
856425|NCT02732327|2073094|P1|COMPLETED|Overall Study||0
856426|NCT02732327|2073093|P2|STARTED|Overall Study||2
856427|NCT02732327|2073094|P1|STARTED|Overall Study||0
856428|NCT02732210|2073102|P2|NOT COMPLETED|Overall Study||294
856429|NCT02732210|2073103|P1|NOT COMPLETED|Overall Study||85
856430|NCT02732210|2073102|P2|COMPLETED|Overall Study||338
856431|NCT02732210|2073103|P1|COMPLETED|Overall Study||218
856432|NCT02732210|2073102|P2|STARTED|Overall Study||632
856433|NCT02732210|2073103|P1|STARTED|Overall Study||303
856434|NCT02731833|2073121|P2|NOT COMPLETED|Overall Study||0
856435|NCT02731833|2073122|P1|NOT COMPLETED|Overall Study||0
856436|NCT02731833|2073121|P2|COMPLETED|Overall Study||111
856437|NCT02731833|2073122|P1|COMPLETED|Overall Study||111
856438|NCT02731833|2073121|P2|STARTED|Overall Study||111
856439|NCT02731833|2073122|P1|STARTED|Overall Study||111
856440|NCT02731313|2073134|P1|NOT COMPLETED|Overall Study||0
856441|NCT02731313|2073134|P1|COMPLETED|Overall Study||367
856442|NCT02731313|2073134|P1|STARTED|Overall Study||367
856443|NCT02731300|2073144|P2|NOT COMPLETED|Overall Study||0
856444|NCT02731300|2073145|P1|NOT COMPLETED|Overall Study||0
856445|NCT02731300|2073144|P2|COMPLETED|Overall Study||7
856446|NCT02731300|2073145|P1|COMPLETED|Overall Study||15
856447|NCT02731300|2073144|P2|STARTED|Overall Study||7
856448|NCT02731300|2073145|P1|STARTED|Overall Study||15
856449|NCT02731131|2073155|P2|NOT COMPLETED|Overall Study||2
856450|NCT02731131|2073156|P1|NOT COMPLETED|Overall Study||0
856451|NCT02731131|2073155|P2|COMPLETED|Overall Study||4
856452|NCT02731131|2073156|P1|COMPLETED|Overall Study||6
856453|NCT02731131|2073155|P2|STARTED|Overall Study||6
856454|NCT02731131|2073156|P1|STARTED|Overall Study||6
856464|NCT02730260|2073180|P2|NOT COMPLETED|Overall Study||75
856465|NCT02730260|2073181|P1|NOT COMPLETED|Overall Study||82
856466|NCT02730260|2073180|P2|COMPLETED|Overall Study||185
856467|NCT02730260|2073181|P1|COMPLETED|Overall Study||176
856468|NCT02730260|2073180|P2|STARTED|Overall Study||260
856469|NCT02730260|2073181|P1|STARTED|Overall Study||258
856470|NCT02726971|2073189|P2|NOT COMPLETED|Overall Study||9
856471|NCT02726971|2073190|P1|NOT COMPLETED|Overall Study||11
856472|NCT02726971|2073189|P2|COMPLETED|Overall Study||62
856473|NCT02726971|2073190|P1|COMPLETED|Overall Study||59
856474|NCT02726971|2073189|P2|STARTED|Overall Study||71
856475|NCT02726971|2073190|P1|STARTED|Overall Study||70
856476|NCT02726178|2073202|P2|NOT COMPLETED|Overall Study||0
856477|NCT02726178|2073203|P1|NOT COMPLETED|Overall Study||0
856478|NCT02726178|2073202|P2|COMPLETED|Overall Study||28
856479|NCT02726178|2073203|P1|COMPLETED|Overall Study||28
856480|NCT02726178|2073202|P2|STARTED|Overall Study||28
856481|NCT02726178|2073203|P1|STARTED|Overall Study||28
856482|NCT02726022|2073209|P1|NOT COMPLETED|Overall Study||36
856483|NCT02726022|2073209|P1|COMPLETED|Overall Study||78
856484|NCT02726022|2073209|P1|STARTED|Overall Study||114
856485|NCT02725788|2073220|P2|NOT COMPLETED|Overall Study||2
856486|NCT02725788|2073221|P1|NOT COMPLETED|Overall Study||1
856487|NCT02725788|2073220|P2|COMPLETED|Overall Study||122
856488|NCT02725788|2073221|P1|COMPLETED|Overall Study||122
856489|NCT02725788|2073220|P2|STARTED|Overall Study||124
856490|NCT02725788|2073221|P1|STARTED|Overall Study||123
856491|NCT02724449|2073227|P1|NOT COMPLETED|Overall Study||0
856492|NCT02724449|2073227|P1|COMPLETED|Overall Study||16
856493|NCT02724449|2073227|P1|STARTED|Overall Study||16
856494|NCT02723188|2073234|P3|NOT COMPLETED|Overall Study||0
856495|NCT02723188|2073235|P2|NOT COMPLETED|Overall Study||0
856496|NCT02723188|2073236|P1|NOT COMPLETED|Overall Study||1
856497|NCT02723188|2073234|P3|COMPLETED|Overall Study||15
856498|NCT02723188|2073235|P2|COMPLETED|Overall Study||15
856499|NCT02723188|2073236|P1|COMPLETED|Overall Study||14
856500|NCT02723188|2073234|P3|STARTED|Overall Study||15
856501|NCT02723188|2073235|P2|STARTED|Overall Study||15
856502|NCT02723188|2073236|P1|STARTED|Overall Study||15
856503|NCT02722564|2073247|P1|NOT COMPLETED|Overall Study||0
856504|NCT02722564|2073247|P1|COMPLETED|Overall Study||55
856505|NCT02722564|2073247|P1|STARTED|Overall Study||55
856506|NCT02721641|2073251|P1|NOT COMPLETED|Overall Study||0
856507|NCT02721641|2073251|P1|COMPLETED|Overall Study|In this continued access study, all participants were considered to have completed per protocol.|69
856508|NCT02721641|2073251|P1|STARTED|Overall Study||69
856509|NCT02721277|2073257|P1|NOT COMPLETED|Overall Study||0
856510|NCT02721277|2073257|P1|COMPLETED|Overall Study||2
856511|NCT02721277|2073257|P1|STARTED|Overall Study||2
856512|NCT02720952|2073286|P1|NOT COMPLETED|Overall Study||0
856513|NCT02720952|2073286|P1|COMPLETED|Overall Study||24
856514|NCT02720952|2073286|P1|STARTED|Overall Study||24
856515|NCT02717754|2073301|P6|NOT COMPLETED|Overall Study||20
856516|NCT02717754|2073302|P5|NOT COMPLETED|Overall Study||20
856517|NCT02717754|2073303|P4|NOT COMPLETED|Overall Study||10
856518|NCT02717754|2073304|P3|NOT COMPLETED|Overall Study||0
856519|NCT02717754|2073305|P2|NOT COMPLETED|Overall Study||0
856520|NCT02717754|2073306|P1|NOT COMPLETED|Overall Study||0
856521|NCT02717754|2073301|P6|COMPLETED|Overall Study||0
856522|NCT02717754|2073302|P5|COMPLETED|Overall Study||0
856523|NCT02717754|2073303|P4|COMPLETED|Overall Study||0
856524|NCT02717754|2073304|P3|COMPLETED|Overall Study||20
856525|NCT02717754|2073305|P2|COMPLETED|Overall Study||19
856526|NCT02717754|2073306|P1|COMPLETED|Overall Study||10
856527|NCT02717754|2073301|P6|STARTED|Overall Study||20
856528|NCT02717754|2073302|P5|STARTED|Overall Study||20
856529|NCT02717754|2073303|P4|STARTED|Overall Study||10
856530|NCT02717754|2073304|P3|STARTED|Overall Study||20
856531|NCT02717754|2073305|P2|STARTED|Overall Study||19
856532|NCT02717754|2073306|P1|STARTED|Overall Study||10
856533|NCT02716779|2073337|P3|NOT COMPLETED|Combination Therapy||1
856534|NCT02716779|2073338|P2|NOT COMPLETED|Combination Therapy||2
856535|NCT02716779|2073339|P1|NOT COMPLETED|Combination Therapy||0
856536|NCT02716779|2073337|P3|COMPLETED|Combination Therapy||25
856537|NCT02716779|2073338|P2|COMPLETED|Combination Therapy||23
856538|NCT02716779|2073339|P1|COMPLETED|Combination Therapy||14
856539|NCT02716779|2073337|P3|STARTED|Combination Therapy||26
856540|NCT02716779|2073338|P2|STARTED|Combination Therapy||25
856541|NCT02716779|2073339|P1|STARTED|Combination Therapy||14
856542|NCT02716779|2073337|P3|NOT COMPLETED|Monotherapy||1
856543|NCT02716779|2073338|P2|NOT COMPLETED|Monotherapy||1
856544|NCT02716779|2073339|P1|NOT COMPLETED|Monotherapy||0
856545|NCT02716779|2073337|P3|COMPLETED|Monotherapy||26
856546|NCT02716779|2073338|P2|COMPLETED|Monotherapy||25
856547|NCT02716779|2073339|P1|COMPLETED|Monotherapy||14
856548|NCT02716779|2073337|P3|STARTED|Monotherapy||27
856549|NCT02716779|2073338|P2|STARTED|Monotherapy||26
856550|NCT02716779|2073339|P1|STARTED|Monotherapy||14
856551|NCT02716298|2073383|P2|NOT COMPLETED|Second Intervention (1 Month)||0
856552|NCT02716298|2073384|P1|NOT COMPLETED|Second Intervention (1 Month)||0
856553|NCT02716298|2073383|P2|COMPLETED|Second Intervention (1 Month)||23
856554|NCT02716298|2073384|P1|COMPLETED|Second Intervention (1 Month)||24
856555|NCT02716298|2073383|P2|STARTED|Second Intervention (1 Month)||23
856556|NCT02716298|2073384|P1|STARTED|Second Intervention (1 Month)||24
856557|NCT02716298|2073383|P2|NOT COMPLETED|First Intervention (1 Month)||1
856558|NCT02716298|2073384|P1|NOT COMPLETED|First Intervention (1 Month)||1
856559|NCT02716298|2073383|P2|COMPLETED|First Intervention (1 Month)||23
856560|NCT02716298|2073384|P1|COMPLETED|First Intervention (1 Month)||24
856561|NCT02716298|2073383|P2|STARTED|First Intervention (1 Month)||24
856562|NCT02716298|2073384|P1|STARTED|First Intervention (1 Month)||25
856563|NCT02713594|2073401|P2|NOT COMPLETED|Overall Study||396
856564|NCT02713594|2073402|P1|NOT COMPLETED|Overall Study||390
856565|NCT02713594|2073401|P2|COMPLETED|Overall Study||552
856566|NCT02713594|2073402|P1|COMPLETED|Overall Study||562
856567|NCT02713594|2073401|P2|STARTED|Overall Study||948
856568|NCT02713594|2073402|P1|STARTED|Overall Study||952
856569|NCT02712333|2073414|P2|NOT COMPLETED|Second Period||0
856570|NCT02712333|2073415|P1|NOT COMPLETED|Second Period||0
856571|NCT02712333|2073414|P2|COMPLETED|Second Period||24
856572|NCT02712333|2073415|P1|COMPLETED|Second Period||31
856573|NCT02712333|2073414|P2|STARTED|Second Period||24
856574|NCT02712333|2073415|P1|STARTED|Second Period||31
856575|NCT02712333|2073414|P2|NOT COMPLETED|First Period||2
856576|NCT02712333|2073415|P1|NOT COMPLETED|First Period||3
856577|NCT02712333|2073414|P2|COMPLETED|First Period||24
856578|NCT02712333|2073415|P1|COMPLETED|First Period||31
856579|NCT02712333|2073414|P2|STARTED|First Period||26
856580|NCT02712333|2073415|P1|STARTED|First Period||34
856581|NCT02712099|2073435|P2|NOT COMPLETED|Overall Study||0
856582|NCT02712099|2073436|P1|NOT COMPLETED|Overall Study||0
856583|NCT02712099|2073435|P2|COMPLETED|Overall Study||20
856584|NCT02712099|2073436|P1|COMPLETED|Overall Study||30
856585|NCT02712099|2073435|P2|STARTED|Overall Study||20
856586|NCT02712099|2073436|P1|STARTED|Overall Study||30
856587|NCT02710630|2073457|P5|NOT COMPLETED|Period 6||0
856588|NCT02710630|2073458|P4|NOT COMPLETED|Period 6||0
856589|NCT02710630|2073459|P3|NOT COMPLETED|Period 6||0
856590|NCT02710630|2073460|P2|NOT COMPLETED|Period 6||0
856591|NCT02710630|2073461|P1|NOT COMPLETED|Period 6||0
856592|NCT02710630|2073457|P5|COMPLETED|Period 6||7
856593|NCT02710630|2073458|P4|COMPLETED|Period 6||7
856594|NCT02710630|2073459|P3|COMPLETED|Period 6||7
856595|NCT02710630|2073460|P2|COMPLETED|Period 6||7
856596|NCT02710630|2073461|P1|COMPLETED|Period 6||7
856597|NCT02710630|2073457|P5|STARTED|Period 6||7
856598|NCT02710630|2073458|P4|STARTED|Period 6||7
856599|NCT02710630|2073459|P3|STARTED|Period 6||7
856600|NCT02710630|2073460|P2|STARTED|Period 6||7
856601|NCT02710630|2073461|P1|STARTED|Period 6||7
856602|NCT02710630|2073457|P5|NOT COMPLETED|Period 5||0
856603|NCT02710630|2073458|P4|NOT COMPLETED|Period 5||0
856604|NCT02710630|2073459|P3|NOT COMPLETED|Period 5||0
856605|NCT02710630|2073460|P2|NOT COMPLETED|Period 5||0
856606|NCT02710630|2073461|P1|NOT COMPLETED|Period 5||0
856607|NCT02710630|2073457|P5|COMPLETED|Period 5||7
856608|NCT02710630|2073458|P4|COMPLETED|Period 5||7
856609|NCT02710630|2073459|P3|COMPLETED|Period 5||7
856610|NCT02710630|2073460|P2|COMPLETED|Period 5||7
856611|NCT02710630|2073461|P1|COMPLETED|Period 5||7
856612|NCT02710630|2073457|P5|STARTED|Period 5||7
856613|NCT02710630|2073458|P4|STARTED|Period 5||7
856614|NCT02710630|2073459|P3|STARTED|Period 5||7
856615|NCT02710630|2073460|P2|STARTED|Period 5||7
856616|NCT02710630|2073461|P1|STARTED|Period 5||7
856617|NCT02710630|2073457|P5|NOT COMPLETED|Period 4||0
856618|NCT02710630|2073458|P4|NOT COMPLETED|Period 4||0
856619|NCT02710630|2073459|P3|NOT COMPLETED|Period 4||0
856620|NCT02710630|2073460|P2|NOT COMPLETED|Period 4||0
856621|NCT02710630|2073461|P1|NOT COMPLETED|Period 4||0
856622|NCT02710630|2073457|P5|COMPLETED|Period 4||7
856623|NCT02710630|2073458|P4|COMPLETED|Period 4||7
856624|NCT02710630|2073459|P3|COMPLETED|Period 4||7
856625|NCT02710630|2073460|P2|COMPLETED|Period 4||7
856626|NCT02710630|2073461|P1|COMPLETED|Period 4||7
856627|NCT02710630|2073457|P5|STARTED|Period 4||7
856628|NCT02710630|2073458|P4|STARTED|Period 4||7
856629|NCT02710630|2073459|P3|STARTED|Period 4||7
856630|NCT02710630|2073460|P2|STARTED|Period 4||7
856631|NCT02710630|2073461|P1|STARTED|Period 4||7
856632|NCT02710630|2073457|P5|NOT COMPLETED|Period 3||0
856633|NCT02710630|2073458|P4|NOT COMPLETED|Period 3||0
856634|NCT02710630|2073459|P3|NOT COMPLETED|Period 3||0
856635|NCT02710630|2073460|P2|NOT COMPLETED|Period 3||0
856636|NCT02710630|2073461|P1|NOT COMPLETED|Period 3||0
856637|NCT02710630|2073457|P5|COMPLETED|Period 3||7
856638|NCT02710630|2073458|P4|COMPLETED|Period 3||7
856639|NCT02710630|2073459|P3|COMPLETED|Period 3||7
856640|NCT02710630|2073460|P2|COMPLETED|Period 3||7
856641|NCT02710630|2073461|P1|COMPLETED|Period 3||7
856642|NCT02710630|2073457|P5|STARTED|Period 3||7
856643|NCT02710630|2073458|P4|STARTED|Period 3||7
856644|NCT02710630|2073459|P3|STARTED|Period 3||7
856645|NCT02710630|2073460|P2|STARTED|Period 3||7
856646|NCT02710630|2073461|P1|STARTED|Period 3||7
856647|NCT02710630|2073457|P5|NOT COMPLETED|Period 2||0
856648|NCT02710630|2073458|P4|NOT COMPLETED|Period 2||0
856649|NCT02710630|2073459|P3|NOT COMPLETED|Period 2||0
856650|NCT02710630|2073460|P2|NOT COMPLETED|Period 2||0
856651|NCT02710630|2073461|P1|NOT COMPLETED|Period 2||0
856652|NCT02710630|2073457|P5|COMPLETED|Period 2||7
856653|NCT02710630|2073458|P4|COMPLETED|Period 2||7
856654|NCT02710630|2073459|P3|COMPLETED|Period 2||7
856655|NCT02710630|2073460|P2|COMPLETED|Period 2||7
856656|NCT02710630|2073461|P1|COMPLETED|Period 2||7
856657|NCT02710630|2073457|P5|Not Treated|Period 2||0
856658|NCT02710630|2073458|P4|Not Treated|Period 2||0
856659|NCT02710630|2073459|P3|Not Treated|Period 2||0
856660|NCT02710630|2073460|P2|Not Treated|Period 2||0
856661|NCT02710630|2073461|P1|Not Treated|Period 2||1
856662|NCT02710630|2073457|P5|STARTED|Period 2||7
856663|NCT02710630|2073458|P4|STARTED|Period 2||7
856664|NCT02710630|2073459|P3|STARTED|Period 2||7
856665|NCT02710630|2073460|P2|STARTED|Period 2||7
856666|NCT02710630|2073461|P1|STARTED|Period 2|1 subject not treated.|7
856667|NCT02710630|2073457|P5|NOT COMPLETED|Period 1||0
856668|NCT02710630|2073458|P4|NOT COMPLETED|Period 1||0
856669|NCT02710630|2073459|P3|NOT COMPLETED|Period 1||0
856670|NCT02710630|2073460|P2|NOT COMPLETED|Period 1||0
856671|NCT02710630|2073461|P1|NOT COMPLETED|Period 1||0
856672|NCT02710630|2073457|P5|COMPLETED|Period 1||7
856673|NCT02710630|2073458|P4|COMPLETED|Period 1||7
856674|NCT02710630|2073459|P3|COMPLETED|Period 1||7
856675|NCT02710630|2073460|P2|COMPLETED|Period 1||7
856676|NCT02710630|2073461|P1|COMPLETED|Period 1||7
856677|NCT02710630|2073457|P5|STARTED|Period 1||7
856678|NCT02710630|2073458|P4|STARTED|Period 1||7
856679|NCT02710630|2073459|P3|STARTED|Period 1||7
856680|NCT02710630|2073460|P2|STARTED|Period 1||7
856681|NCT02710630|2073461|P1|STARTED|Period 1||7
856682|NCT02710292|2073505|P2|NOT COMPLETED|Period 2, Second 10 Days of Wear||0
856683|NCT02710292|2073506|P1|NOT COMPLETED|Period 2, Second 10 Days of Wear||0
856684|NCT02710292|2073505|P2|COMPLETED|Period 2, Second 10 Days of Wear||49
856685|NCT02710292|2073506|P1|COMPLETED|Period 2, Second 10 Days of Wear||46
856686|NCT02710292|2073505|P2|STARTED|Period 2, Second 10 Days of Wear||49
856687|NCT02710292|2073506|P1|STARTED|Period 2, Second 10 Days of Wear||46
856688|NCT02710292|2073505|P2|NOT COMPLETED|Period 1, First 10 Days of Wear||3
856689|NCT02710292|2073506|P1|NOT COMPLETED|Period 1, First 10 Days of Wear||1
856690|NCT02710292|2073505|P2|COMPLETED|Period 1, First 10 Days of Wear||49
856691|NCT02710292|2073506|P1|COMPLETED|Period 1, First 10 Days of Wear||46
856692|NCT02710292|2073505|P2|STARTED|Period 1, First 10 Days of Wear||52
856693|NCT02710292|2073506|P1|STARTED|Period 1, First 10 Days of Wear||47
856694|NCT02709577|2073515|P4|NOT COMPLETED|Overall Study||0
856695|NCT02709577|2073516|P3|NOT COMPLETED|Overall Study||2
856696|NCT02709577|2073517|P2|NOT COMPLETED|Overall Study||5
856697|NCT02709577|2073518|P1|NOT COMPLETED|Overall Study||2
856698|NCT02709577|2073515|P4|COMPLETED|Overall Study||5
856699|NCT02709577|2073516|P3|COMPLETED|Overall Study||4
856700|NCT02709577|2073517|P2|COMPLETED|Overall Study||8
856701|NCT02709577|2073518|P1|COMPLETED|Overall Study||10
856702|NCT02709577|2073515|P4|STARTED|Overall Study||5
856703|NCT02709577|2073516|P3|STARTED|Overall Study||6
856704|NCT02709577|2073517|P2|STARTED|Overall Study||13
856705|NCT02709577|2073518|P1|STARTED|Overall Study||12
856706|NCT02709096|2073532|P2|NOT COMPLETED|Overall Study||1
856707|NCT02709096|2073533|P1|NOT COMPLETED|Overall Study||1
856708|NCT02709096|2073532|P2|COMPLETED|Overall Study||10
856709|NCT02709096|2073533|P1|COMPLETED|Overall Study||21
856710|NCT02709096|2073532|P2|STARTED|Overall Study||11
856711|NCT02709096|2073533|P1|STARTED|Overall Study||22
856712|NCT02708524|2073543|P4|NOT COMPLETED|Overall Study||0
856713|NCT02708524|2073544|P3|NOT COMPLETED|Overall Study||3
856714|NCT02708524|2073545|P2|NOT COMPLETED|Overall Study||6
856715|NCT02708524|2073546|P1|NOT COMPLETED|Overall Study||4
856716|NCT02708524|2073543|P4|COMPLETED|Overall Study||136
856717|NCT02708524|2073544|P3|COMPLETED|Overall Study||134
856718|NCT02708524|2073545|P2|COMPLETED|Overall Study||130
856719|NCT02708524|2073546|P1|COMPLETED|Overall Study||135
856720|NCT02708524|2073543|P4|STARTED|Overall Study||136
856721|NCT02708524|2073544|P3|STARTED|Overall Study||137
856722|NCT02708524|2073545|P2|STARTED|Overall Study||136
856723|NCT02708524|2073546|P1|STARTED|Overall Study||139
856724|NCT02708355|2073595|P3|NOT COMPLETED|Overall Study||0
856725|NCT02708355|2073596|P2|NOT COMPLETED|Overall Study||0
856726|NCT02708355|2073597|P1|NOT COMPLETED|Overall Study||1
856727|NCT02708355|2073595|P3|COMPLETED|Overall Study||12
856728|NCT02708355|2073596|P2|COMPLETED|Overall Study||22
856729|NCT02708355|2073597|P1|COMPLETED|Overall Study||20
856730|NCT02708355|2073595|P3|STARTED|Overall Study||12
856731|NCT02708355|2073596|P2|STARTED|Overall Study||22
856732|NCT02708355|2073597|P1|STARTED|Overall Study||21
856733|NCT02708277|2073610|P2|NOT COMPLETED|Overall Study||4
856734|NCT02708277|2073611|P1|NOT COMPLETED|Overall Study||7
856735|NCT02708277|2073610|P2|COMPLETED|Overall Study||39
856736|NCT02708277|2073611|P1|COMPLETED|Overall Study||43
856737|NCT02708277|2073610|P2|STARTED|Overall Study||43
856738|NCT02708277|2073611|P1|STARTED|Overall Study||50
856739|NCT02708238|2073626|P3|NOT COMPLETED|Overall Study||3
856740|NCT02708238|2073627|P2|NOT COMPLETED|Overall Study||1
856741|NCT02708238|2073628|P1|NOT COMPLETED|Overall Study||0
856742|NCT02708238|2073626|P3|COMPLETED|Overall Study||57
856743|NCT02708238|2073627|P2|COMPLETED|Overall Study||59
856744|NCT02708238|2073628|P1|COMPLETED|Overall Study||60
856745|NCT02708238|2073626|P3|STARTED|Overall Study||60
856746|NCT02708238|2073627|P2|STARTED|Overall Study||60
856747|NCT02708238|2073628|P1|STARTED|Overall Study||60
856748|NCT02708212|2073641|P2|NOT COMPLETED|Overall Study||0
856749|NCT02708212|2073642|P1|NOT COMPLETED|Overall Study||0
856750|NCT02708212|2073641|P2|COMPLETED|Overall Study||60
856751|NCT02708212|2073642|P1|COMPLETED|Overall Study||60
856752|NCT02708212|2073641|P2|STARTED|Overall Study||60
856753|NCT02708212|2073642|P1|STARTED|Overall Study||60
856754|NCT02707640|2073654|P2|NOT COMPLETED|Overall Study||7
856755|NCT02707640|2073655|P1|NOT COMPLETED|Overall Study||9
856756|NCT02707640|2073654|P2|COMPLETED|Overall Study||55
856757|NCT02707640|2073655|P1|COMPLETED|Overall Study||52
856758|NCT02707640|2073654|P2|STARTED|Overall Study||62
856759|NCT02707640|2073655|P1|STARTED|Overall Study||61
856760|NCT02707172|2073673|P1|NOT COMPLETED|2nd Set of Experiment||0
856761|NCT02707172|2073673|P1|COMPLETED|2nd Set of Experiment||28
856762|NCT02707172|2073673|P1|STARTED|2nd Set of Experiment||28
856763|NCT02707172|2073673|P1|NOT COMPLETED|Wash Out||0
856764|NCT02707172|2073673|P1|COMPLETED|Wash Out||28
856765|NCT02707172|2073673|P1|STARTED|Wash Out||28
856766|NCT02707172|2073673|P1|NOT COMPLETED|1st Set of Experiment||0
856767|NCT02707172|2073673|P1|COMPLETED|1st Set of Experiment||28
856768|NCT02707172|2073673|P1|STARTED|1st Set of Experiment||28
856778|NCT02705807|2073703|P1|NOT COMPLETED|Overall Study||0
856779|NCT02705807|2073703|P1|COMPLETED|Overall Study||10
856780|NCT02705807|2073703|P1|STARTED|Overall Study||10
856781|NCT02705716|2073735|P2|NOT COMPLETED|Overall Study||2
856782|NCT02705716|2073736|P1|NOT COMPLETED|Overall Study||4
856783|NCT02705716|2073735|P2|COMPLETED|Overall Study||68
856784|NCT02705716|2073736|P1|COMPLETED|Overall Study||68
856785|NCT02705716|2073735|P2|STARTED|Overall Study||70
856786|NCT02705716|2073736|P1|STARTED|Overall Study||72
856787|NCT02705365|2073748|P2|NOT COMPLETED|Overall Study||0
856788|NCT02705365|2073749|P1|NOT COMPLETED|Overall Study||0
856789|NCT02705365|2073748|P2|COMPLETED|Overall Study||800
856790|NCT02705365|2073749|P1|COMPLETED|Overall Study||400
856791|NCT02705365|2073748|P2|STARTED|Overall Study||800
856792|NCT02705365|2073749|P1|STARTED|Overall Study||400
856793|NCT02701556|2073759|P2|NOT COMPLETED|Overall Study||20
856794|NCT02701556|2073760|P1|NOT COMPLETED|Overall Study||23
856795|NCT02701556|2073759|P2|COMPLETED|Overall Study||178
856796|NCT02701556|2073760|P1|COMPLETED|Overall Study||175
856797|NCT02701556|2073759|P2|STARTED|Overall Study||198
856798|NCT02701556|2073760|P1|STARTED|Overall Study||198
856799|NCT02701387|2073766|P1|NOT COMPLETED|Overall Study||0
856800|NCT02701387|2073766|P1|COMPLETED|Overall Study||7
856801|NCT02701387|2073766|P1|STARTED|Overall Study||7
856802|NCT02701296|2073773|P2|NOT COMPLETED|Overall Study||2
856803|NCT02701296|2073774|P1|NOT COMPLETED|Overall Study||0
856804|NCT02701296|2073773|P2|COMPLETED|Overall Study|Data was incomplete for two participants their data was not included in the overall data analysis.|36
856805|NCT02701296|2073774|P1|COMPLETED|Overall Study||42
856806|NCT02701296|2073773|P2|STARTED|Overall Study||38
856807|NCT02701296|2073774|P1|STARTED|Overall Study||42
856808|NCT02701270|2073790|P4|NOT COMPLETED|Fourth Intervention at Visit 4||0
856809|NCT02701270|2073791|P3|NOT COMPLETED|Fourth Intervention at Visit 4||0
856810|NCT02701270|2073792|P2|NOT COMPLETED|Fourth Intervention at Visit 4||0
856811|NCT02701270|2073793|P1|NOT COMPLETED|Fourth Intervention at Visit 4||0
856812|NCT02701270|2073790|P4|COMPLETED|Fourth Intervention at Visit 4||3
856813|NCT02701270|2073791|P3|COMPLETED|Fourth Intervention at Visit 4||3
856814|NCT02701270|2073792|P2|COMPLETED|Fourth Intervention at Visit 4||3
856815|NCT02701270|2073793|P1|COMPLETED|Fourth Intervention at Visit 4||2
856816|NCT02701270|2073790|P4|STARTED|Fourth Intervention at Visit 4||3
856817|NCT02701270|2073791|P3|STARTED|Fourth Intervention at Visit 4||3
856818|NCT02701270|2073792|P2|STARTED|Fourth Intervention at Visit 4||3
856819|NCT02701270|2073793|P1|STARTED|Fourth Intervention at Visit 4||2
856820|NCT02701270|2073790|P4|NOT COMPLETED|Third Intervention at Visit 3||0
856821|NCT02701270|2073791|P3|NOT COMPLETED|Third Intervention at Visit 3||0
856822|NCT02701270|2073792|P2|NOT COMPLETED|Third Intervention at Visit 3||0
856823|NCT02701270|2073793|P1|NOT COMPLETED|Third Intervention at Visit 3||0
856824|NCT02701270|2073790|P4|COMPLETED|Third Intervention at Visit 3||3
856825|NCT02701270|2073791|P3|COMPLETED|Third Intervention at Visit 3||3
856826|NCT02701270|2073792|P2|COMPLETED|Third Intervention at Visit 3||3
856827|NCT02701270|2073793|P1|COMPLETED|Third Intervention at Visit 3||2
856828|NCT02701270|2073790|P4|STARTED|Third Intervention at Visit 3||3
856829|NCT02701270|2073791|P3|STARTED|Third Intervention at Visit 3||3
856830|NCT02701270|2073792|P2|STARTED|Third Intervention at Visit 3||3
856831|NCT02701270|2073793|P1|STARTED|Third Intervention at Visit 3||2
856832|NCT02701270|2073790|P4|NOT COMPLETED|Second Intervention at Visit 2||0
856833|NCT02701270|2073791|P3|NOT COMPLETED|Second Intervention at Visit 2||0
856834|NCT02701270|2073792|P2|NOT COMPLETED|Second Intervention at Visit 2||0
856835|NCT02701270|2073793|P1|NOT COMPLETED|Second Intervention at Visit 2||0
856836|NCT02701270|2073790|P4|COMPLETED|Second Intervention at Visit 2||3
856837|NCT02701270|2073791|P3|COMPLETED|Second Intervention at Visit 2||3
856838|NCT02701270|2073792|P2|COMPLETED|Second Intervention at Visit 2||3
856839|NCT02701270|2073793|P1|COMPLETED|Second Intervention at Visit 2||2
856840|NCT02701270|2073790|P4|STARTED|Second Intervention at Visit 2||3
856841|NCT02701270|2073791|P3|STARTED|Second Intervention at Visit 2||3
856842|NCT02701270|2073792|P2|STARTED|Second Intervention at Visit 2||3
856843|NCT02701270|2073793|P1|STARTED|Second Intervention at Visit 2||2
856844|NCT02701270|2073790|P4|NOT COMPLETED|First Intervention at Visit 1||0
856845|NCT02701270|2073791|P3|NOT COMPLETED|First Intervention at Visit 1||0
856846|NCT02701270|2073792|P2|NOT COMPLETED|First Intervention at Visit 1||0
856847|NCT02701270|2073793|P1|NOT COMPLETED|First Intervention at Visit 1||0
856848|NCT02701270|2073790|P4|COMPLETED|First Intervention at Visit 1||3
856849|NCT02701270|2073791|P3|COMPLETED|First Intervention at Visit 1||3
856850|NCT02701270|2073792|P2|COMPLETED|First Intervention at Visit 1||3
856851|NCT02701270|2073793|P1|COMPLETED|First Intervention at Visit 1||2
856852|NCT02701270|2073790|P4|STARTED|First Intervention at Visit 1||3
856853|NCT02701270|2073791|P3|STARTED|First Intervention at Visit 1||3
856854|NCT02701270|2073792|P2|STARTED|First Intervention at Visit 1||3
856855|NCT02701270|2073793|P1|STARTED|First Intervention at Visit 1||2
856856|NCT02699892|2073807|P1|NOT COMPLETED|Overall Study||36
856857|NCT02699892|2073807|P1|COMPLETED|Overall Study||94
856858|NCT02699892|2073807|P1|STARTED|Overall Study||130
856859|NCT02699684|2073812|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
856860|NCT02699684|2073813|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
856861|NCT02699684|2073812|P2|COMPLETED|Period 2, Second 30 Days of Wear||38
856862|NCT02699684|2073813|P1|COMPLETED|Period 2, Second 30 Days of Wear||36
856863|NCT02699684|2073812|P2|STARTED|Period 2, Second 30 Days of Wear||38
856864|NCT02699684|2073813|P1|STARTED|Period 2, Second 30 Days of Wear||37
856865|NCT02699684|2073812|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||0
856866|NCT02699684|2073813|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
856867|NCT02699684|2073812|P2|COMPLETED|Period 1, First 30 Days of Wear||38
856868|NCT02699684|2073813|P1|COMPLETED|Period 1, First 30 Days of Wear||37
856869|NCT02699684|2073812|P2|STARTED|Period 1, First 30 Days of Wear||38
856870|NCT02699684|2073813|P1|STARTED|Period 1, First 30 Days of Wear||37
856871|NCT02699593|2073823|P2|NOT COMPLETED|Period 2||2
856872|NCT02699593|2073824|P1|NOT COMPLETED|Period 2||2
856873|NCT02699593|2073823|P2|COMPLETED|Period 2||60
856874|NCT02699593|2073824|P1|COMPLETED|Period 2||65
856875|NCT02699593|2073823|P2|STARTED|Period 2||62
856876|NCT02699593|2073824|P1|STARTED|Period 2||67
856877|NCT02699593|2073823|P2|NOT COMPLETED|Period 1||7
856878|NCT02699593|2073824|P1|NOT COMPLETED|Period 1||5
856879|NCT02699593|2073823|P2|COMPLETED|Period 1||62
856880|NCT02699593|2073824|P1|COMPLETED|Period 1||67
856881|NCT02699593|2073823|P2|STARTED|Period 1||69
856882|NCT02699593|2073824|P1|STARTED|Period 1||72
856883|NCT02698566|2073832|P2|NOT COMPLETED|Overall Study||0
856884|NCT02698566|2073833|P1|NOT COMPLETED|Overall Study||0
856885|NCT02698566|2073832|P2|COMPLETED|Overall Study||3
856886|NCT02698566|2073833|P1|COMPLETED|Overall Study||35
856887|NCT02698566|2073832|P2|STARTED|Overall Study||3
856888|NCT02698566|2073833|P1|STARTED|Overall Study||35
856889|NCT02698423|2073841|P2|NOT COMPLETED|Overall Study||24
856890|NCT02698423|2073842|P1|NOT COMPLETED|Overall Study||19
856891|NCT02698423|2073841|P2|COMPLETED|Overall Study||307
856892|NCT02698423|2073842|P1|COMPLETED|Overall Study||317
856893|NCT02698423|2073841|P2|STARTED|Overall Study||331
856894|NCT02698423|2073842|P1|STARTED|Overall Study||336
856895|NCT02697890|2073850|P2|NOT COMPLETED|Overall Study||0
856896|NCT02697890|2073851|P1|NOT COMPLETED|Overall Study||0
856897|NCT02697890|2073850|P2|COMPLETED|Overall Study||14
856898|NCT02697890|2073851|P1|COMPLETED|Overall Study||14
856899|NCT02697890|2073850|P2|STARTED|Overall Study||14
856900|NCT02697890|2073851|P1|STARTED|Overall Study||14
856919|NCT02695446|2073878|P1|NOT COMPLETED|Overall Study||0
856920|NCT02695446|2073878|P1|COMPLETED|Overall Study||12
856921|NCT02695446|2073878|P1|STARTED|Overall Study||12
856922|NCT02695290|2073883|P1|NOT COMPLETED|Overall Study||0
856923|NCT02695290|2073883|P1|COMPLETED|Overall Study||1
856924|NCT02695290|2073883|P1|STARTED|Overall Study||1
856925|NCT02694718|2073889|P1|NOT COMPLETED|Overall Study||2
856926|NCT02694718|2073889|P1|COMPLETED|Overall Study||58
856927|NCT02694718|2073889|P1|STARTED|Overall Study||60
856928|NCT02694536|2073899|P1|NOT COMPLETED|Overall Study||80
856929|NCT02694536|2073899|P1|COMPLETED|Overall Study||0
856930|NCT02694536|2073899|P1|STARTED|Overall Study||80
856931|NCT02694315|2073908|P1|NOT COMPLETED|Overall Study||0
856932|NCT02694315|2073908|P1|COMPLETED|Overall Study||200
856933|NCT02694315|2073908|P1|STARTED|Overall Study||200
856934|NCT02694198|2073913|P1|NOT COMPLETED|Overall Study||0
856935|NCT02694198|2073913|P1|COMPLETED|Overall Study||135
856936|NCT02694198|2073913|P1|STARTED|Overall Study||135
856937|NCT02693704|2073922|P4|NOT COMPLETED|Overall Study||0
856938|NCT02693704|2073923|P3|NOT COMPLETED|Overall Study||0
856939|NCT02693704|2073924|P2|NOT COMPLETED|Overall Study||0
856940|NCT02693704|2073925|P1|NOT COMPLETED|Overall Study||0
856941|NCT02693704|2073922|P4|COMPLETED|Overall Study||10
856942|NCT02693704|2073923|P3|COMPLETED|Overall Study||10
856943|NCT02693704|2073924|P2|COMPLETED|Overall Study||10
856944|NCT02693704|2073925|P1|COMPLETED|Overall Study||10
856945|NCT02693704|2073922|P4|STARTED|Overall Study||10
856946|NCT02693704|2073923|P3|STARTED|Overall Study||10
856947|NCT02693704|2073924|P2|STARTED|Overall Study||10
856948|NCT02693704|2073925|P1|STARTED|Overall Study||10
856949|NCT02692859|2073945|P2|NOT COMPLETED|Overall Study||95
856950|NCT02692859|2073946|P1|NOT COMPLETED|Overall Study||84
856951|NCT02692859|2073945|P2|COMPLETED|Overall Study||901
856952|NCT02692859|2073946|P1|COMPLETED|Overall Study||912
856953|NCT02692859|2073945|P2|STARTED|Overall Study||996
856954|NCT02692859|2073946|P1|STARTED|Overall Study||996
856955|NCT02691507|2073954|P2|NOT COMPLETED|Overall Study||1
856956|NCT02691507|2073955|P1|NOT COMPLETED|Overall Study||0
856957|NCT02691507|2073954|P2|COMPLETED|Overall Study||12
856958|NCT02691507|2073955|P1|COMPLETED|Overall Study||40
856959|NCT02691507|2073954|P2|STARTED|Overall Study||13
856960|NCT02691507|2073955|P1|STARTED|Overall Study||40
856961|NCT02691416|2074087|P2|NOT COMPLETED|Overall Study||0
856962|NCT02691416|2074088|P1|NOT COMPLETED|Overall Study||0
856963|NCT02691416|2074087|P2|COMPLETED|Overall Study||30
856964|NCT02691416|2074088|P1|COMPLETED|Overall Study||30
856965|NCT02691416|2074087|P2|STARTED|Overall Study||30
856966|NCT02691416|2074088|P1|STARTED|Overall Study||30
856967|NCT02691143|2074110|P2|NOT COMPLETED|Overall Study||0
856968|NCT02691143|2074111|P1|NOT COMPLETED|Overall Study||0
856969|NCT02691143|2074110|P2|COMPLETED|Overall Study||23
856970|NCT02691143|2074111|P1|COMPLETED|Overall Study||27
856971|NCT02691143|2074110|P2|STARTED|Overall Study||23
856972|NCT02691143|2074111|P1|STARTED|Overall Study||27
856973|NCT02690727|2074119|P2|NOT COMPLETED|Overall Study||2
856974|NCT02690727|2074120|P1|NOT COMPLETED|Overall Study||2
856975|NCT02690727|2074119|P2|COMPLETED|Overall Study|2 subjects withdrawn from the study|7
856976|NCT02690727|2074120|P1|COMPLETED|Overall Study|2 subjects withdrawn from the study|7
856977|NCT02690727|2074119|P2|STARTED|Overall Study||9
856978|NCT02690727|2074120|P1|STARTED|Overall Study||9
856979|NCT02689804|2074130|P2|NOT COMPLETED|Overall Study||0
856980|NCT02689804|2074131|P1|NOT COMPLETED|Overall Study||2
856981|NCT02689804|2074130|P2|COMPLETED|Overall Study||16
856982|NCT02689804|2074131|P1|COMPLETED|Overall Study||16
856983|NCT02689804|2074130|P2|STARTED|Overall Study||16
856984|NCT02689804|2074131|P1|STARTED|Overall Study||18
856985|NCT02687217|2074159|P2|NOT COMPLETED|Overall Study||0
856986|NCT02687217|2074160|P1|NOT COMPLETED|Overall Study||0
856987|NCT02687217|2074159|P2|COMPLETED|Overall Study||30
856988|NCT02687217|2074160|P1|COMPLETED|Overall Study||30
856989|NCT02687217|2074159|P2|STARTED|Overall Study||30
856990|NCT02687217|2074160|P1|STARTED|Overall Study||30
856991|NCT02687126|2074170|P1|NOT COMPLETED|Data Analysis||0
856992|NCT02687126|2074170|P1|COMPLETED|Data Analysis||106
856993|NCT02687126|2074170|P1|STARTED|Data Analysis||106
856994|NCT02687126|2074170|P1|NOT COMPLETED|Data Collection||0
856995|NCT02687126|2074170|P1|COMPLETED|Data Collection||106
856996|NCT02687126|2074170|P1|STARTED|Data Collection||106
857003|NCT02684942|2074188|P6|NOT COMPLETED|Overall Study||0
857004|NCT02684942|2074189|P5|NOT COMPLETED|Overall Study||0
857005|NCT02684942|2074190|P4|NOT COMPLETED|Overall Study||0
857006|NCT02684942|2074191|P3|NOT COMPLETED|Overall Study||0
857007|NCT02684942|2074192|P2|NOT COMPLETED|Overall Study||0
857008|NCT02684942|2074193|P1|NOT COMPLETED|Overall Study||0
857009|NCT02684942|2074188|P6|COMPLETED|Overall Study||6
857010|NCT02684942|2074189|P5|COMPLETED|Overall Study||6
857011|NCT02684942|2074190|P4|COMPLETED|Overall Study||7
857012|NCT02684942|2074191|P3|COMPLETED|Overall Study||7
857013|NCT02684942|2074192|P2|COMPLETED|Overall Study||7
857014|NCT02684942|2074193|P1|COMPLETED|Overall Study||7
857015|NCT02684942|2074188|P6|STARTED|Overall Study||6
857016|NCT02684942|2074189|P5|STARTED|Overall Study||6
857017|NCT02684942|2074190|P4|STARTED|Overall Study||7
857018|NCT02684942|2074191|P3|STARTED|Overall Study||7
857019|NCT02684942|2074192|P2|STARTED|Overall Study||7
857020|NCT02684942|2074193|P1|STARTED|Overall Study||7
857021|NCT02684630|2074209|P2|NOT COMPLETED|Overall Study||3
857022|NCT02684630|2074210|P1|NOT COMPLETED|Overall Study||5
857023|NCT02684630|2074209|P2|COMPLETED|Overall Study||60
857024|NCT02684630|2074210|P1|COMPLETED|Overall Study||60
857025|NCT02684630|2074209|P2|STARTED|Overall Study||63
857026|NCT02684630|2074210|P1|STARTED|Overall Study||65
857027|NCT02684604|2074220|P2|NOT COMPLETED|Overall Study||0
857028|NCT02684604|2074221|P1|NOT COMPLETED|Overall Study||0
857029|NCT02684604|2074220|P2|COMPLETED|Overall Study||44
857030|NCT02684604|2074221|P1|COMPLETED|Overall Study||44
857031|NCT02684604|2074220|P2|STARTED|Overall Study||44
857032|NCT02684604|2074221|P1|STARTED|Overall Study||44
857033|NCT02684396|2074233|P6|NOT COMPLETED|Overall Study||0
857034|NCT02684396|2074234|P5|NOT COMPLETED|Overall Study||0
857035|NCT02684396|2074235|P4|NOT COMPLETED|Overall Study||0
857036|NCT02684396|2074236|P3|NOT COMPLETED|Overall Study||0
857037|NCT02684396|2074237|P2|NOT COMPLETED|Overall Study||0
857038|NCT02684396|2074238|P1|NOT COMPLETED|Overall Study||0
857039|NCT02684396|2074233|P6|COMPLETED|Overall Study||10
857040|NCT02684396|2074234|P5|COMPLETED|Overall Study||5
857041|NCT02684396|2074235|P4|COMPLETED|Overall Study||6
857042|NCT02684396|2074236|P3|COMPLETED|Overall Study||6
857043|NCT02684396|2074237|P2|COMPLETED|Overall Study||6
857044|NCT02684396|2074238|P1|COMPLETED|Overall Study||6
857045|NCT02684396|2074233|P6|STARTED|Overall Study||10
857046|NCT02684396|2074234|P5|STARTED|Overall Study||5
857047|NCT02684396|2074235|P4|STARTED|Overall Study||6
857048|NCT02684396|2074236|P3|STARTED|Overall Study||6
857049|NCT02684396|2074237|P2|STARTED|Overall Study||6
857050|NCT02684396|2074238|P1|STARTED|Overall Study||6
857051|NCT02683954|2074292|P2|NOT COMPLETED|Overall Study||0
857052|NCT02683954|2074293|P1|NOT COMPLETED|Overall Study||0
857053|NCT02683954|2074292|P2|COMPLETED|Overall Study||30
857054|NCT02683954|2074293|P1|COMPLETED|Overall Study||30
857055|NCT02683954|2074292|P2|STARTED|Overall Study||30
857056|NCT02683954|2074293|P1|STARTED|Overall Study||30
857057|NCT02682498|2074301|P2|NOT COMPLETED|Overall Study||0
857058|NCT02682498|2074302|P1|NOT COMPLETED|Overall Study||0
857059|NCT02682498|2074301|P2|COMPLETED|Overall Study||20
857060|NCT02682498|2074302|P1|COMPLETED|Overall Study||18
857061|NCT02682498|2074301|P2|STARTED|Overall Study||20
857062|NCT02682498|2074302|P1|STARTED|Overall Study||18
857063|NCT02681458|2074318|P2|NOT COMPLETED|Overall Study||656
857064|NCT02681458|2074319|P1|NOT COMPLETED|Overall Study||645
857065|NCT02681458|2074318|P2|COMPLETED|Overall Study||62
857066|NCT02681458|2074319|P1|COMPLETED|Overall Study||73
857067|NCT02681458|2074318|P2|STARTED|Overall Study||718
857068|NCT02681458|2074319|P1|STARTED|Overall Study||718
857069|NCT02679976|2074325|P1|NOT COMPLETED|Overall Study||0
857070|NCT02679976|2074325|P1|COMPLETED|Overall Study||30
857071|NCT02679976|2074325|P1|Myopes|Overall Study||14
857072|NCT02679976|2074325|P1|Hyperopes|Overall Study||16
857073|NCT02679976|2074325|P1|STARTED|Overall Study||30
857074|NCT02679469|2074334|P1|NOT COMPLETED|Overall Study||0
857075|NCT02679469|2074334|P1|COMPLETED|Overall Study||7
857076|NCT02679469|2074334|P1|STARTED|Overall Study||7
857077|NCT02678923|2074342|P2|NOT COMPLETED|Overall Study||5
857078|NCT02678923|2074343|P1|NOT COMPLETED|Overall Study||6
857079|NCT02678923|2074342|P2|COMPLETED|Overall Study||62
857080|NCT02678923|2074343|P1|COMPLETED|Overall Study||53
857081|NCT02678923|2074342|P2|mITT Population|Overall Study||61
857082|NCT02678923|2074343|P1|mITT Population|Overall Study||52
857083|NCT02678923|2074342|P2|Received at Least 1 Dose of Study Drug|Overall Study||64
857084|NCT02678923|2074343|P1|Received at Least 1 Dose of Study Drug|Overall Study||58
857085|NCT02678923|2074342|P2|STARTED|Overall Study||67
857086|NCT02678923|2074343|P1|STARTED|Overall Study||59
857087|NCT02678676|2074359|P2|NOT COMPLETED|Overall Study||872
857088|NCT02678676|2074360|P1|NOT COMPLETED|Overall Study||888
857089|NCT02678676|2074359|P2|COMPLETED|Overall Study||907
857090|NCT02678676|2074360|P1|COMPLETED|Overall Study||932
857091|NCT02678676|2074359|P2|STARTED|Overall Study||1779
857092|NCT02678676|2074360|P1|STARTED|Overall Study||1820
857093|NCT02678039|2074370|P2|NOT COMPLETED|Overall Study||0
857094|NCT02678039|2074371|P1|NOT COMPLETED|Overall Study||0
857095|NCT02678039|2074370|P2|COMPLETED|Overall Study||47
857096|NCT02678039|2074371|P1|COMPLETED|Overall Study||53
857097|NCT02678039|2074370|P2|STARTED|Overall Study||47
857098|NCT02678039|2074371|P1|STARTED|Overall Study||53
857099|NCT02677779|2074387|P2|NOT COMPLETED|Overall Study||0
857100|NCT02677779|2074388|P1|NOT COMPLETED|Overall Study||0
857101|NCT02677779|2074387|P2|COMPLETED|Overall Study||10
857102|NCT02677779|2074388|P1|COMPLETED|Overall Study||10
857103|NCT02677779|2074387|P2|STARTED|Overall Study||10
857104|NCT02677779|2074388|P1|STARTED|Overall Study||10
857105|NCT02677493|2074405|P3|NOT COMPLETED|Overall Study||3
857106|NCT02677493|2074406|P2|NOT COMPLETED|Overall Study||2
857107|NCT02677493|2074407|P1|NOT COMPLETED|Overall Study||11
857108|NCT02677493|2074405|P3|COMPLETED|Overall Study||296
857109|NCT02677493|2074406|P2|COMPLETED|Overall Study||296
857110|NCT02677493|2074407|P1|COMPLETED|Overall Study||1186
857111|NCT02677493|2074405|P3|STARTED|Overall Study||299
857112|NCT02677493|2074406|P2|STARTED|Overall Study||298
857113|NCT02677493|2074407|P1|STARTED|Overall Study||1197
857114|NCT02675907|2074420|P2|NOT COMPLETED|Study Overall||4
857115|NCT02675907|2074421|P1|NOT COMPLETED|Study Overall||3
857116|NCT02675907|2074420|P2|COMPLETED|Study Overall||97
857117|NCT02675907|2074421|P1|COMPLETED|Study Overall||97
857118|NCT02675907|2074420|P2|STARTED|Study Overall||101
857119|NCT02675907|2074421|P1|STARTED|Study Overall||100
857120|NCT02675907|2074420|P2|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5
857121|NCT02675907|2074421|P1|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5
857122|NCT02675907|2074420|P2|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||96
857123|NCT02675907|2074421|P1|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||95
857124|NCT02675907|2074420|P2|STARTED|Treatment Phase (48 Hours Post-Dose 1)||101
857125|NCT02675907|2074421|P1|STARTED|Treatment Phase (48 Hours Post-Dose 1)||100
857180|NCT02675543|2074466|P2|NOT COMPLETED|Overall Study||0
857181|NCT02675543|2074467|P1|NOT COMPLETED|Overall Study||0
857182|NCT02675543|2074466|P2|COMPLETED|Overall Study||20
857183|NCT02675543|2074467|P1|COMPLETED|Overall Study||15
857184|NCT02675543|2074466|P2|STARTED|Overall Study||20
857185|NCT02675543|2074467|P1|STARTED|Overall Study||15
857186|NCT02674334|2074475|P2|NOT COMPLETED|Overall Study||3
857187|NCT02674334|2074476|P1|NOT COMPLETED|Overall Study||7
857188|NCT02674334|2074475|P2|COMPLETED|Overall Study||40
857189|NCT02674334|2074476|P1|COMPLETED|Overall Study||40
857190|NCT02674334|2074475|P2|STARTED|Overall Study||43
857191|NCT02674334|2074476|P1|STARTED|Overall Study||47
857192|NCT02673944|2074484|P1|NOT COMPLETED|Overall Study||0
857193|NCT02673944|2074484|P1|COMPLETED|Overall Study||10
857194|NCT02673944|2074484|P1|STARTED|Overall Study||10
857195|NCT02672514|2074491|P2|NOT COMPLETED|Overall Study||0
857196|NCT02672514|2074492|P1|NOT COMPLETED|Overall Study||0
857197|NCT02672514|2074491|P2|COMPLETED|Overall Study||51
857198|NCT02672514|2074492|P1|COMPLETED|Overall Study||53
857199|NCT02672514|2074491|P2|STARTED|Overall Study||51
857200|NCT02672514|2074492|P1|STARTED|Overall Study||53
857201|NCT02670811|2074500|P2|NOT COMPLETED|Overall Study||0
857202|NCT02670811|2074501|P1|NOT COMPLETED|Overall Study||1
857203|NCT02670811|2074500|P2|COMPLETED|Overall Study||18
857204|NCT02670811|2074501|P1|COMPLETED|Overall Study||17
857205|NCT02670811|2074500|P2|STARTED|Overall Study||18
857206|NCT02670811|2074501|P1|STARTED|Overall Study||18
857207|NCT02670473|2074517|P1|NOT COMPLETED|Overall Study||1
857208|NCT02670473|2074517|P1|COMPLETED|Overall Study||34
857209|NCT02670473|2074517|P1|STARTED|Overall Study||35
857210|NCT02669095|2074572|P2|NOT COMPLETED|Overall Study||3
857211|NCT02669095|2074573|P1|NOT COMPLETED|Overall Study||1
857212|NCT02669095|2074572|P2|COMPLETED|Overall Study||72
857213|NCT02669095|2074573|P1|COMPLETED|Overall Study||74
857214|NCT02669095|2074572|P2|STARTED|Overall Study||75
857215|NCT02669095|2074573|P1|STARTED|Overall Study||75
857216|NCT02669043|2074581|P1|NOT COMPLETED|Overall Study||4
857217|NCT02669043|2074581|P1|COMPLETED|Overall Study||4
857218|NCT02669043|2074581|P1|STARTED|Overall Study||8
857222|NCT02667704|2074591|P1|NOT COMPLETED|Treatment Period 2||0
857223|NCT02667704|2074591|P1|COMPLETED|Treatment Period 2||13
857224|NCT02667704|2074591|P1|STARTED|Treatment Period 2||13
857225|NCT02667704|2074591|P1|NOT COMPLETED|Treatment Period 1||0
857226|NCT02667704|2074591|P1|COMPLETED|Treatment Period 1||13
857227|NCT02667704|2074591|P1|STARTED|Treatment Period 1||13
857228|NCT02666560|2074602|P2|NOT COMPLETED|Condition 2 (1 Day)||0
857229|NCT02666560|2074603|P1|NOT COMPLETED|Condition 2 (1 Day)||0
857230|NCT02666560|2074602|P2|COMPLETED|Condition 2 (1 Day)||11
857231|NCT02666560|2074603|P1|COMPLETED|Condition 2 (1 Day)||8
857232|NCT02666560|2074602|P2|STARTED|Condition 2 (1 Day)||11
857233|NCT02666560|2074603|P1|STARTED|Condition 2 (1 Day)||8
857234|NCT02666560|2074602|P2|NOT COMPLETED|Condition 1 (1 Day)||0
857235|NCT02666560|2074603|P1|NOT COMPLETED|Condition 1 (1 Day)||0
857236|NCT02666560|2074602|P2|COMPLETED|Condition 1 (1 Day)||11
857237|NCT02666560|2074603|P1|COMPLETED|Condition 1 (1 Day)||8
857238|NCT02666560|2074602|P2|STARTED|Condition 1 (1 Day)||11
857239|NCT02666560|2074603|P1|STARTED|Condition 1 (1 Day)||8
857240|NCT02666222|2074619|P1|NOT COMPLETED|Overall Study||2
857241|NCT02666222|2074619|P1|COMPLETED|Overall Study||49
857242|NCT02666222|2074619|P1|STARTED|Overall Study||51
857243|NCT02665260|2074631|P4|NOT COMPLETED|Overall Study||1
857244|NCT02665260|2074632|P3|NOT COMPLETED|Overall Study||4
857245|NCT02665260|2074633|P2|NOT COMPLETED|Overall Study||1
857246|NCT02665260|2074634|P1|NOT COMPLETED|Overall Study||2
857247|NCT02665260|2074631|P4|COMPLETED|Overall Study||21
857248|NCT02665260|2074632|P3|COMPLETED|Overall Study||21
857249|NCT02665260|2074633|P2|COMPLETED|Overall Study||22
857250|NCT02665260|2074634|P1|COMPLETED|Overall Study||22
857251|NCT02665260|2074631|P4|STARTED|Overall Study||22
857252|NCT02665260|2074632|P3|STARTED|Overall Study||25
857253|NCT02665260|2074633|P2|STARTED|Overall Study||23
857254|NCT02665260|2074634|P1|STARTED|Overall Study||24
857255|NCT02664987|2074648|P1|NOT COMPLETED|Overall Study||0
857256|NCT02664987|2074648|P1|COMPLETED|Overall Study||462
857257|NCT02664987|2074648|P1|STARTED|Overall Study||462
857258|NCT02664610|2074659|P2|NOT COMPLETED|Overall Study||7
857259|NCT02664610|2074660|P1|NOT COMPLETED|Overall Study||14
857260|NCT02664610|2074659|P2|COMPLETED|Overall Study||41
857261|NCT02664610|2074660|P1|COMPLETED|Overall Study||32
857262|NCT02664610|2074659|P2|STARTED|Overall Study||48
857263|NCT02664610|2074660|P1|STARTED|Overall Study||46
857264|NCT02664532|2074670|P2|NOT COMPLETED|Overall Study||0
857265|NCT02664532|2074671|P1|NOT COMPLETED|Overall Study||0
857266|NCT02664532|2074670|P2|COMPLETED|Overall Study||75
857267|NCT02664532|2074671|P1|COMPLETED|Overall Study||75
857268|NCT02664532|2074670|P2|STARTED|Overall Study||75
857269|NCT02664532|2074671|P1|STARTED|Overall Study||75
857270|NCT02664311|2074685|P2|NOT COMPLETED|Overall Study||0
857271|NCT02664311|2074686|P1|NOT COMPLETED|Overall Study||0
857272|NCT02664311|2074685|P2|COMPLETED|Overall Study||3
857273|NCT02664311|2074686|P1|COMPLETED|Overall Study||6
857274|NCT02664311|2074685|P2|STARTED|Overall Study||3
857275|NCT02664311|2074686|P1|STARTED|Overall Study||6
857276|NCT02663453|2074698|P2|NOT COMPLETED|Overall Study||4
857277|NCT02663453|2074699|P1|NOT COMPLETED|Overall Study||5
857278|NCT02663453|2074698|P2|COMPLETED|Overall Study||18
857279|NCT02663453|2074699|P1|COMPLETED|Overall Study||17
857280|NCT02663453|2074698|P2|STARTED|Overall Study||22
857281|NCT02663453|2074699|P1|STARTED|Overall Study||22
857282|NCT02663232|2074721|P1|NOT COMPLETED|Overall Study||0
857283|NCT02663232|2074721|P1|COMPLETED|Overall Study||264
857284|NCT02663232|2074721|P1|STARTED|Overall Study||264
857285|NCT02662608|2074742|P1|NOT COMPLETED|Overall Study||0
857286|NCT02662608|2074742|P1|COMPLETED|Overall Study||1
857287|NCT02662608|2074742|P1|STARTED|Overall Study||1
857288|NCT02662556|2074746|P1|NOT COMPLETED|Overall Study||8
857289|NCT02662556|2074746|P1|COMPLETED|Overall Study||132
857290|NCT02662556|2074746|P1|STARTED|Overall Study||140
857291|NCT02662387|2074755|P2|NOT COMPLETED|Overall Study||0
857292|NCT02662387|2074756|P1|NOT COMPLETED|Overall Study||0
857293|NCT02662387|2074755|P2|COMPLETED|Overall Study||28
857294|NCT02662387|2074756|P1|COMPLETED|Overall Study||27
857295|NCT02662387|2074755|P2|STARTED|Overall Study||28
857296|NCT02662387|2074756|P1|STARTED|Overall Study||27
857297|NCT02658461|2074767|P3|NOT COMPLETED|Overall Study||0
857298|NCT02658461|2074768|P2|NOT COMPLETED|Overall Study||0
857299|NCT02658461|2074769|P1|NOT COMPLETED|Overall Study||0
857300|NCT02658461|2074767|P3|COMPLETED|Overall Study||12
857301|NCT02658461|2074768|P2|COMPLETED|Overall Study||12
857302|NCT02658461|2074769|P1|COMPLETED|Overall Study||12
857303|NCT02658461|2074767|P3|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
857304|NCT02658461|2074768|P2|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
857305|NCT02658461|2074769|P1|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
857306|NCT02657629|2074797|P2|NOT COMPLETED|Overall Study||0
857307|NCT02657629|2074798|P1|NOT COMPLETED|Overall Study||2
857308|NCT02657629|2074797|P2|COMPLETED|Overall Study||14
857309|NCT02657629|2074798|P1|COMPLETED|Overall Study||12
857310|NCT02657629|2074797|P2|STARTED|Overall Study||14
857311|NCT02657629|2074798|P1|STARTED|Overall Study||14
857312|NCT02657538|2074804|P1|NOT COMPLETED|Overall Study||4
857313|NCT02657538|2074804|P1|COMPLETED|Overall Study||31
857314|NCT02657538|2074804|P1|Received Visual Caries Detection + Bite|Overall Study||35
857315|NCT02657538|2074804|P1|Received Near Infrared Transillumination|Overall Study||35
857316|NCT02657538|2074804|P1|STARTED|Overall Study||35
857317|NCT02656485|2074815|P4|NOT COMPLETED|Overall Study||2
857318|NCT02656485|2074816|P3|NOT COMPLETED|Overall Study||2
857319|NCT02656485|2074817|P2|NOT COMPLETED|Overall Study||3
857320|NCT02656485|2074818|P1|NOT COMPLETED|Overall Study||2
857321|NCT02656485|2074815|P4|COMPLETED|Overall Study||7
857322|NCT02656485|2074816|P3|COMPLETED|Overall Study||7
857323|NCT02656485|2074817|P2|COMPLETED|Overall Study||6
857324|NCT02656485|2074818|P1|COMPLETED|Overall Study||7
857325|NCT02656485|2074815|P4|STARTED|Overall Study||9
857326|NCT02656485|2074816|P3|STARTED|Overall Study||9
857327|NCT02656485|2074817|P2|STARTED|Overall Study||9
857328|NCT02656485|2074818|P1|STARTED|Overall Study||9
857329|NCT02656160|2074830|P2|NOT COMPLETED|Second Study Night||0
857330|NCT02656160|2074831|P1|NOT COMPLETED|Second Study Night||0
857331|NCT02656160|2074830|P2|COMPLETED|Second Study Night||6
857332|NCT02656160|2074831|P1|COMPLETED|Second Study Night||4
857333|NCT02656160|2074830|P2|STARTED|Second Study Night||6
857334|NCT02656160|2074831|P1|STARTED|Second Study Night|3 subjects did not return for the second study night|4
857335|NCT02656160|2074830|P2|NOT COMPLETED|First Study Night||0
857336|NCT02656160|2074831|P1|NOT COMPLETED|First Study Night||0
857337|NCT02656160|2074830|P2|COMPLETED|First Study Night||6
857338|NCT02656160|2074831|P1|COMPLETED|First Study Night||7
857339|NCT02656160|2074830|P2|STARTED|First Study Night||6
857340|NCT02656160|2074831|P1|STARTED|First Study Night||7
857341|NCT02653560|2074839|P4|NOT COMPLETED|Placebo Phase||0
857342|NCT02653560|2074840|P3|NOT COMPLETED|Placebo Phase||0
857343|NCT02653560|2074841|P2|NOT COMPLETED|Placebo Phase||0
857344|NCT02653560|2074842|P1|NOT COMPLETED|Placebo Phase||0
857345|NCT02653560|2074839|P4|COMPLETED|Placebo Phase||30
857346|NCT02653560|2074840|P3|COMPLETED|Placebo Phase||0
857347|NCT02653560|2074841|P2|COMPLETED|Placebo Phase||0
857348|NCT02653560|2074842|P1|COMPLETED|Placebo Phase||0
857349|NCT02653560|2074839|P4|STARTED|Placebo Phase||30
857350|NCT02653560|2074840|P3|STARTED|Placebo Phase||0
857351|NCT02653560|2074841|P2|STARTED|Placebo Phase||0
857352|NCT02653560|2074842|P1|STARTED|Placebo Phase||0
857353|NCT02653560|2074839|P4|NOT COMPLETED|KCl Phase||0
857354|NCT02653560|2074840|P3|NOT COMPLETED|KCl Phase||0
857355|NCT02653560|2074841|P2|NOT COMPLETED|KCl Phase||0
857356|NCT02653560|2074842|P1|NOT COMPLETED|KCl Phase||0
857357|NCT02653560|2074839|P4|COMPLETED|KCl Phase||0
857358|NCT02653560|2074840|P3|COMPLETED|KCl Phase||30
857359|NCT02653560|2074841|P2|COMPLETED|KCl Phase||0
857360|NCT02653560|2074842|P1|COMPLETED|KCl Phase||0
857361|NCT02653560|2074839|P4|STARTED|KCl Phase||0
857362|NCT02653560|2074840|P3|STARTED|KCl Phase||30
857363|NCT02653560|2074841|P2|STARTED|KCl Phase||0
857364|NCT02653560|2074842|P1|STARTED|KCl Phase||0
857365|NCT02653560|2074839|P4|NOT COMPLETED|K Citrate Phase||0
857366|NCT02653560|2074840|P3|NOT COMPLETED|K Citrate Phase||0
857367|NCT02653560|2074841|P2|NOT COMPLETED|K Citrate Phase||0
857368|NCT02653560|2074842|P1|NOT COMPLETED|K Citrate Phase||0
857369|NCT02653560|2074839|P4|COMPLETED|K Citrate Phase||0
857370|NCT02653560|2074840|P3|COMPLETED|K Citrate Phase||0
857371|NCT02653560|2074841|P2|COMPLETED|K Citrate Phase||30
857372|NCT02653560|2074842|P1|COMPLETED|K Citrate Phase||0
857373|NCT02653560|2074839|P4|STARTED|K Citrate Phase||0
857374|NCT02653560|2074840|P3|STARTED|K Citrate Phase||0
857375|NCT02653560|2074841|P2|STARTED|K Citrate Phase||30
857376|NCT02653560|2074842|P1|STARTED|K Citrate Phase||0
857377|NCT02653560|2074839|P4|NOT COMPLETED|KMgCit Phase||0
857378|NCT02653560|2074840|P3|NOT COMPLETED|KMgCit Phase||0
857379|NCT02653560|2074841|P2|NOT COMPLETED|KMgCit Phase||0
857380|NCT02653560|2074842|P1|NOT COMPLETED|KMgCit Phase||0
857381|NCT02653560|2074839|P4|COMPLETED|KMgCit Phase||0
857382|NCT02653560|2074840|P3|COMPLETED|KMgCit Phase||0
857383|NCT02653560|2074841|P2|COMPLETED|KMgCit Phase||0
857384|NCT02653560|2074842|P1|COMPLETED|KMgCit Phase||30
857385|NCT02653560|2074839|P4|STARTED|KMgCit Phase||0
857386|NCT02653560|2074840|P3|STARTED|KMgCit Phase||0
857387|NCT02653560|2074841|P2|STARTED|KMgCit Phase||0
857388|NCT02653560|2074842|P1|STARTED|KMgCit Phase||30
857389|NCT02653495|2074854|P2|NOT COMPLETED|Overall Study||0
857390|NCT02653495|2074855|P1|NOT COMPLETED|Overall Study||12
857391|NCT02653495|2074854|P2|COMPLETED|Overall Study||2
857392|NCT02653495|2074855|P1|COMPLETED|Overall Study||3
857393|NCT02653495|2074854|P2|STARTED|Overall Study||2
857394|NCT02653495|2074855|P1|STARTED|Overall Study||15
857395|NCT02652221|2074869|P1|NOT COMPLETED|Overall Study||0
857396|NCT02652221|2074869|P1|COMPLETED|Overall Study||55
857397|NCT02652221|2074869|P1|STARTED|Overall Study||55
857398|NCT02652208|2074878|P2|NOT COMPLETED|Overall Study||2
857399|NCT02652208|2074879|P1|NOT COMPLETED|Overall Study||4
857400|NCT02652208|2074878|P2|COMPLETED|Overall Study||15
857401|NCT02652208|2074879|P1|COMPLETED|Overall Study||13
857402|NCT02652208|2074878|P2|STARTED|Overall Study||17
857403|NCT02652208|2074879|P1|STARTED|Overall Study||17
857404|NCT02651922|2074889|P1|NOT COMPLETED|Overall Study||2
857405|NCT02651922|2074889|P1|COMPLETED|Overall Study||154
857406|NCT02651922|2074889|P1|STARTED|Overall Study||156
857407|NCT02651467|2074909|P3|NOT COMPLETED|Overall Study||4
857408|NCT02651467|2074910|P2|NOT COMPLETED|Overall Study||0
857409|NCT02651467|2074911|P1|NOT COMPLETED|Overall Study||1
857410|NCT02651467|2074909|P3|COMPLETED|Overall Study||69
857411|NCT02651467|2074910|P2|COMPLETED|Overall Study||74
857412|NCT02651467|2074911|P1|COMPLETED|Overall Study||73
857413|NCT02651467|2074909|P3|STARTED|Overall Study||73
857414|NCT02651467|2074910|P2|STARTED|Overall Study||74
857415|NCT02651467|2074911|P1|STARTED|Overall Study||74
857416|NCT02650440|2074932|P2|NOT COMPLETED|Overall Study||2
857417|NCT02650440|2074933|P1|NOT COMPLETED|Overall Study||0
857418|NCT02650440|2074932|P2|COMPLETED|Overall Study||8
857419|NCT02650440|2074933|P1|COMPLETED|Overall Study||10
857420|NCT02650440|2074932|P2|STARTED|Overall Study||10
857421|NCT02650440|2074933|P1|STARTED|Overall Study||10
857422|NCT02650219|2074951|P2|NOT COMPLETED|Overall Study||0
857423|NCT02650219|2074952|P1|NOT COMPLETED|Overall Study||0
857424|NCT02650219|2074951|P2|COMPLETED|Overall Study||20
857425|NCT02650219|2074952|P1|COMPLETED|Overall Study||40
857426|NCT02650219|2074951|P2|STARTED|Overall Study||20
857427|NCT02650219|2074952|P1|STARTED|Overall Study||40
857428|NCT02649634|2074964|P2|NOT COMPLETED|Overall Study||6
857429|NCT02649634|2074965|P1|NOT COMPLETED|Overall Study||3
857430|NCT02649634|2074964|P2|COMPLETED|Overall Study||60
857431|NCT02649634|2074965|P1|COMPLETED|Overall Study||66
857432|NCT02649634|2074964|P2|STARTED|Overall Study||66
857433|NCT02649634|2074965|P1|STARTED|Overall Study||69
857434|NCT02648438|2075024|P3|NOT COMPLETED|Overall Study||0
857435|NCT02648438|2075025|P2|NOT COMPLETED|Overall Study||3
857436|NCT02648438|2075026|P1|NOT COMPLETED|Overall Study||3
857437|NCT02648438|2075024|P3|COMPLETED|Overall Study||6
857438|NCT02648438|2075025|P2|COMPLETED|Overall Study||9
857439|NCT02648438|2075026|P1|COMPLETED|Overall Study||9
857440|NCT02648438|2075024|P3|STARTED|Overall Study||6
857441|NCT02648438|2075025|P2|STARTED|Overall Study||12
857442|NCT02648438|2075026|P1|STARTED|Overall Study||12
857443|NCT02648022|2075068|P2|NOT COMPLETED|Overall Study||0
857444|NCT02648022|2075069|P1|NOT COMPLETED|Overall Study||0
857445|NCT02648022|2075068|P2|COMPLETED|Overall Study||39
857446|NCT02648022|2075069|P1|COMPLETED|Overall Study||40
857447|NCT02648022|2075068|P2|STARTED|Overall Study||39
857448|NCT02648022|2075069|P1|STARTED|Overall Study||40
857449|NCT02646449|2075081|P2|NOT COMPLETED|Overall Study||0
857450|NCT02646449|2075082|P1|NOT COMPLETED|Overall Study||0
857451|NCT02646449|2075081|P2|COMPLETED|Overall Study||3
857452|NCT02646449|2075082|P1|COMPLETED|Overall Study||4
857453|NCT02646449|2075081|P2|STARTED|Overall Study||3
857454|NCT02646449|2075082|P1|STARTED|Overall Study||4
857455|NCT02645760|2075092|P2|NOT COMPLETED|Overall Study||0
857456|NCT02645760|2075093|P1|NOT COMPLETED|Overall Study||0
857457|NCT02645760|2075092|P2|COMPLETED|Overall Study||19
857458|NCT02645760|2075093|P1|COMPLETED|Overall Study||19
857459|NCT02645760|2075092|P2|STARTED|Overall Study||19
857460|NCT02645760|2075093|P1|STARTED|Overall Study||19
857461|NCT02644356|2075105|P1|NOT COMPLETED|Overall Study||2
857462|NCT02644356|2075105|P1|COMPLETED|Overall Study|49 of the 51 consented subjects completed pre-post knowledge testing (96%)|49
857463|NCT02644356|2075105|P1|STARTED|Overall Study||51
857464|NCT02643251|2075117|P2|NOT COMPLETED|Overall Study||2
857465|NCT02643251|2075118|P1|NOT COMPLETED|Overall Study||11
857466|NCT02643251|2075117|P2|COMPLETED|Overall Study||67
857467|NCT02643251|2075118|P1|COMPLETED|Overall Study||58
857468|NCT02643251|2075117|P2|STARTED|Overall Study||69
857469|NCT02643251|2075118|P1|STARTED|Overall Study||69
857470|NCT02645123|2075129|P3|NOT COMPLETED|Overall Study||0
857471|NCT02645123|2075130|P2|NOT COMPLETED|Overall Study||0
857472|NCT02645123|2075131|P1|NOT COMPLETED|Overall Study||0
857473|NCT02645123|2075129|P3|COMPLETED|Overall Study||25
857474|NCT02645123|2075130|P2|COMPLETED|Overall Study||25
857475|NCT02645123|2075131|P1|COMPLETED|Overall Study||25
857476|NCT02645123|2075129|P3|STARTED|Overall Study||25
857477|NCT02645123|2075130|P2|STARTED|Overall Study||25
857478|NCT02645123|2075131|P1|STARTED|Overall Study||25
857479|NCT02644109|2075150|P2|NOT COMPLETED|Overall Study||4
857480|NCT02644109|2075151|P1|NOT COMPLETED|Overall Study||0
857481|NCT02644109|2075150|P2|COMPLETED|Overall Study||24
857482|NCT02644109|2075151|P1|COMPLETED|Overall Study||24
857483|NCT02644109|2075150|P2|STARTED|Overall Study||28
857484|NCT02644109|2075151|P1|STARTED|Overall Study||24
857485|NCT02644096|2075159|P2|NOT COMPLETED|Overall Study||25
857486|NCT02644096|2075160|P1|NOT COMPLETED|Overall Study||28
857487|NCT02644096|2075159|P2|COMPLETED|Overall Study||57
857488|NCT02644096|2075160|P1|COMPLETED|Overall Study||65
857489|NCT02644096|2075159|P2|9 Month SF-36 Questionnaire|Overall Study||57
857490|NCT02644096|2075160|P1|9 Month SF-36 Questionnaire|Overall Study||65
857491|NCT02644096|2075159|P2|12 Week SF-36 Questionnaire|Overall Study||59
857492|NCT02644096|2075160|P1|12 Week SF-36 Questionnaire|Overall Study||68
857493|NCT02644096|2075159|P2|10 Week Interview|Overall Study||59
857494|NCT02644096|2075160|P1|10 Week Interview|Overall Study|Not done in control group|0
857495|NCT02644096|2075159|P2|2 Week Interview|Overall Study||68
857496|NCT02644096|2075160|P1|2 Week Interview|Overall Study|Not done in control group|0
857497|NCT02644096|2075159|P2|STARTED|Overall Study||82
857498|NCT02644096|2075160|P1|STARTED|Overall Study||93
857499|NCT02643615|2075168|P2|NOT COMPLETED|Overall Study||0
857500|NCT02643615|2075169|P1|NOT COMPLETED|Overall Study||0
857501|NCT02643615|2075168|P2|COMPLETED|Overall Study||11
857502|NCT02643615|2075169|P1|COMPLETED|Overall Study||9
857503|NCT02643615|2075168|P2|STARTED|Overall Study||11
857504|NCT02643615|2075169|P1|STARTED|Overall Study||9
857505|NCT02643225|2075183|P2|NOT COMPLETED|Overall Study||0
857506|NCT02643225|2075184|P1|NOT COMPLETED|Overall Study||0
857507|NCT02643225|2075183|P2|COMPLETED|Overall Study||40
857508|NCT02643225|2075184|P1|COMPLETED|Overall Study||40
857509|NCT02643225|2075183|P2|STARTED|Overall Study||40
857510|NCT02643225|2075184|P1|STARTED|Overall Study||40
857511|NCT02643199|2075196|P1|NOT COMPLETED|Overall Study||0
857512|NCT02643199|2075196|P1|COMPLETED|Overall Study||90
857513|NCT02643199|2075196|P1|STARTED|Overall Study||90
857514|NCT02643004|2075201|P2|NOT COMPLETED|Second Intervention (One Week)||0
857515|NCT02643004|2075202|P1|NOT COMPLETED|Second Intervention (One Week)||0
857516|NCT02643004|2075201|P2|COMPLETED|Second Intervention (One Week)||35
857517|NCT02643004|2075202|P1|COMPLETED|Second Intervention (One Week)||35
857518|NCT02643004|2075201|P2|STARTED|Second Intervention (One Week)||35
857519|NCT02643004|2075202|P1|STARTED|Second Intervention (One Week)||35
857520|NCT02643004|2075201|P2|NOT COMPLETED|First Intervention (One Week)||0
857521|NCT02643004|2075202|P1|NOT COMPLETED|First Intervention (One Week)||0
857522|NCT02643004|2075201|P2|COMPLETED|First Intervention (One Week)||35
857523|NCT02643004|2075202|P1|COMPLETED|First Intervention (One Week)||35
857524|NCT02643004|2075201|P2|STARTED|First Intervention (One Week)||35
857525|NCT02643004|2075202|P1|STARTED|First Intervention (One Week)||35
857526|NCT02642575|2075242|P1|NOT COMPLETED|Overall Study||0
857527|NCT02642575|2075242|P1|COMPLETED|Overall Study||67
857528|NCT02642575|2075242|P1|STARTED|Overall Study||67
857529|NCT02642536|2075250|P2|NOT COMPLETED|Overall Study||5
857530|NCT02642536|2075251|P1|NOT COMPLETED|Overall Study||2
857531|NCT02642536|2075250|P2|COMPLETED|Overall Study||18
857532|NCT02642536|2075251|P1|COMPLETED|Overall Study||19
857533|NCT02642536|2075250|P2|STARTED|Overall Study||23
857534|NCT02642536|2075251|P1|STARTED|Overall Study||21
857538|NCT02641912|2075285|P2|NOT COMPLETED|Overall Study||0
857539|NCT02641912|2075286|P1|NOT COMPLETED|Overall Study||0
857540|NCT02641912|2075285|P2|COMPLETED|Overall Study||47
857541|NCT02641912|2075286|P1|COMPLETED|Overall Study||53
857542|NCT02641912|2075285|P2|STARTED|Overall Study||47
857543|NCT02641912|2075286|P1|STARTED|Overall Study||53
857544|NCT02641379|2075365|P11|NOT COMPLETED|Overall Study||8
857545|NCT02641379|2075366|P10|NOT COMPLETED|Overall Study||9
857546|NCT02641379|2075367|P9|NOT COMPLETED|Overall Study||6
857547|NCT02641379|2075368|P8|NOT COMPLETED|Overall Study||19
857548|NCT02641379|2075369|P7|NOT COMPLETED|Overall Study||13
857549|NCT02641379|2075370|P6|NOT COMPLETED|Overall Study||16
857550|NCT02641379|2075371|P5|NOT COMPLETED|Overall Study||17
857551|NCT02641379|2075372|P4|NOT COMPLETED|Overall Study||17
857552|NCT02641379|2075373|P3|NOT COMPLETED|Overall Study||71
857553|NCT02641379|2075374|P2|NOT COMPLETED|Overall Study||51
857554|NCT02641379|2075375|P1|NOT COMPLETED|Overall Study||35
857555|NCT02641379|2075365|P11|COMPLETED|Overall Study||0
857556|NCT02641379|2075366|P10|COMPLETED|Overall Study||36
857557|NCT02641379|2075367|P9|COMPLETED|Overall Study||36
857558|NCT02641379|2075368|P8|COMPLETED|Overall Study||1
857559|NCT02641379|2075369|P7|COMPLETED|Overall Study||12
857560|NCT02641379|2075370|P6|COMPLETED|Overall Study||20
857561|NCT02641379|2075371|P5|COMPLETED|Overall Study||0
857562|NCT02641379|2075372|P4|COMPLETED|Overall Study||139
857563|NCT02641379|2075373|P3|COMPLETED|Overall Study||7
857564|NCT02641379|2075374|P2|COMPLETED|Overall Study||101
857565|NCT02641379|2075375|P1|COMPLETED|Overall Study||107
857566|NCT02641379|2075365|P11|STARTED|Overall Study||8
857567|NCT02641379|2075366|P10|STARTED|Overall Study||45
857568|NCT02641379|2075367|P9|STARTED|Overall Study||42
857569|NCT02641379|2075368|P8|STARTED|Overall Study||20
857570|NCT02641379|2075369|P7|STARTED|Overall Study||25
857571|NCT02641379|2075370|P6|STARTED|Overall Study||36
857572|NCT02641379|2075371|P5|STARTED|Overall Study||17
857573|NCT02641379|2075372|P4|STARTED|Overall Study||156
857574|NCT02641379|2075373|P3|STARTED|Overall Study||78
857575|NCT02641379|2075374|P2|STARTED|Overall Study||152
857576|NCT02641379|2075375|P1|STARTED|Overall Study||142
857577|NCT02641249|2075440|P1|NOT COMPLETED|Overall Study||4
857578|NCT02641249|2075440|P1|COMPLETED|Overall Study||15
857579|NCT02641249|2075440|P1|STARTED|Overall Study||19
857586|NCT02640157|2075465|P3|NOT COMPLETED|Overall Study||10
857587|NCT02640157|2075466|P2|NOT COMPLETED|Overall Study||5
857588|NCT02640157|2075467|P1|NOT COMPLETED|Overall Study||13
857589|NCT02640157|2075465|P3|COMPLETED|Overall Study||147
857590|NCT02640157|2075466|P2|COMPLETED|Overall Study||111
857591|NCT02640157|2075467|P1|COMPLETED|Overall Study||220
857592|NCT02640157|2075465|P3|Discontinued Study Drug|Overall Study||3
857593|NCT02640157|2075466|P2|Discontinued Study Drug|Overall Study||3
857594|NCT02640157|2075467|P1|Discontinued Study Drug|Overall Study||8
857595|NCT02640157|2075465|P3|Completed Study Drug|Overall Study||154
857596|NCT02640157|2075466|P2|Completed Study Drug|Overall Study||112
857597|NCT02640157|2075467|P1|Completed Study Drug|Overall Study||225
857598|NCT02640157|2075465|P3|Received Study Drug|Overall Study||157
857599|NCT02640157|2075466|P2|Received Study Drug|Overall Study|One participant in Arm B was randomized in error and never dispensed study drug.|115
857600|NCT02640157|2075467|P1|Received Study Drug|Overall Study||233
857601|NCT02640157|2075465|P3|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|157
857602|NCT02640157|2075466|P2|STARTED|Overall Study||116
857603|NCT02640157|2075467|P1|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|233
857604|NCT02639052|2075484|P1|NOT COMPLETED|Overall Study||1
857605|NCT02639052|2075484|P1|COMPLETED|Overall Study||34
857606|NCT02639052|2075484|P1|Visit 4 (3-month Follow-up)|Overall Study||34
857607|NCT02639052|2075484|P1|Visit 3 (1-month Follow-up)|Overall Study||35
857608|NCT02639052|2075484|P1|Visit 2 (1-week Follow-up)|Overall Study||35
857609|NCT02639052|2075484|P1|Visit 1 (Baseline)|Overall Study||35
857610|NCT02639052|2075484|P1|STARTED|Overall Study||35
857611|NCT02638493|2075501|P3|NOT COMPLETED|Overall Study||0
857612|NCT02638493|2075502|P2|NOT COMPLETED|Overall Study||0
857613|NCT02638493|2075503|P1|NOT COMPLETED|Overall Study||2
857614|NCT02638493|2075501|P3|COMPLETED|Overall Study||8
857615|NCT02638493|2075502|P2|COMPLETED|Overall Study||8
857616|NCT02638493|2075503|P1|COMPLETED|Overall Study||8
857617|NCT02638493|2075501|P3|STARTED|Overall Study||8
857618|NCT02638493|2075502|P2|STARTED|Overall Study||8
857619|NCT02638493|2075503|P1|STARTED|Overall Study|Two men were not able to provide semen samples, and thus were replaced|10
857620|NCT02638129|2075534|P2|NOT COMPLETED|Overall Study||30
857621|NCT02638129|2075535|P1|NOT COMPLETED|Overall Study||28
857622|NCT02638129|2075534|P2|COMPLETED|Overall Study||0
857623|NCT02638129|2075535|P1|COMPLETED|Overall Study||0
857624|NCT02638129|2075534|P2|STARTED|Overall Study||30
857625|NCT02638129|2075535|P1|STARTED|Overall Study||28
857626|NCT02638051|2075549|P2|NOT COMPLETED|Overall Study||0
857627|NCT02638051|2075550|P1|NOT COMPLETED|Overall Study||0
857628|NCT02638051|2075549|P2|COMPLETED|Overall Study||130
857629|NCT02638051|2075550|P1|COMPLETED|Overall Study||130
857630|NCT02638051|2075549|P2|STARTED|Overall Study||130
857631|NCT02638051|2075550|P1|STARTED|Overall Study||130
857632|NCT02637063|2075563|P3|NOT COMPLETED|Overall Study||6
857633|NCT02637063|2075564|P2|NOT COMPLETED|Overall Study||4
857634|NCT02637063|2075565|P1|NOT COMPLETED|Overall Study||5
857635|NCT02637063|2075563|P3|COMPLETED|Overall Study||62
857636|NCT02637063|2075564|P2|COMPLETED|Overall Study||64
857637|NCT02637063|2075565|P1|COMPLETED|Overall Study||62
857638|NCT02637063|2075563|P3|STARTED|Overall Study||68
857639|NCT02637063|2075564|P2|STARTED|Overall Study||68
857640|NCT02637063|2075565|P1|STARTED|Overall Study||67
857641|NCT02636907|2075591|P1|NOT COMPLETED|Overall Study||4
857642|NCT02636907|2075591|P1|COMPLETED|Overall Study|Completed autoinjector assessment period (Day 50).|73
857643|NCT02636907|2075591|P1|STARTED|Overall Study|Assigned to treatment.|77
857644|NCT02636595|2075598|P1|NOT COMPLETED|Overall Study||2
857645|NCT02636595|2075598|P1|COMPLETED|Overall Study||119
857646|NCT02636595|2075598|P1|STARTED|Overall Study||121
857647|NCT02635828|2075604|P1|NOT COMPLETED|Overall Study||14
857648|NCT02635828|2075604|P1|COMPLETED|Overall Study||40
857649|NCT02635828|2075604|P1|STARTED|Overall Study||54
857650|NCT02635425|2075611|P2|NOT COMPLETED|Overall Study||0
857651|NCT02635425|2075612|P1|NOT COMPLETED|Overall Study||0
857652|NCT02635425|2075611|P2|COMPLETED|Overall Study||15
857653|NCT02635425|2075612|P1|COMPLETED|Overall Study||15
857654|NCT02635425|2075611|P2|STARTED|Overall Study||15
857655|NCT02635425|2075612|P1|STARTED|Overall Study||15
857656|NCT02634788|2075622|P4|NOT COMPLETED|Overall Study||5
857657|NCT02634788|2075623|P3|NOT COMPLETED|Overall Study||5
857658|NCT02634788|2075624|P2|NOT COMPLETED|Overall Study||10
857659|NCT02634788|2075625|P1|NOT COMPLETED|Overall Study||4
857660|NCT02634788|2075622|P4|COMPLETED|Overall Study||77
857661|NCT02634788|2075623|P3|COMPLETED|Overall Study||75
857662|NCT02634788|2075624|P2|COMPLETED|Overall Study||71
857663|NCT02634788|2075625|P1|COMPLETED|Overall Study||75
857664|NCT02634788|2075622|P4|STARTED|Overall Study||82
857665|NCT02634788|2075623|P3|STARTED|Overall Study||80
857666|NCT02634788|2075624|P2|STARTED|Overall Study||81
857667|NCT02634788|2075625|P1|STARTED|Overall Study||79
857668|NCT02634073|2075691|P4|NOT COMPLETED|Overall Study||0
857669|NCT02634073|2075692|P3|NOT COMPLETED|Overall Study||0
857670|NCT02634073|2075693|P2|NOT COMPLETED|Overall Study||0
857671|NCT02634073|2075694|P1|NOT COMPLETED|Overall Study||0
857672|NCT02634073|2075691|P4|COMPLETED|Overall Study||4
857673|NCT02634073|2075692|P3|COMPLETED|Overall Study||4
857674|NCT02634073|2075693|P2|COMPLETED|Overall Study||4
857675|NCT02634073|2075694|P1|COMPLETED|Overall Study||4
857676|NCT02634073|2075691|P4|STARTED|Overall Study||4
857677|NCT02634073|2075692|P3|STARTED|Overall Study||4
857678|NCT02634073|2075693|P2|STARTED|Overall Study||4
857679|NCT02634073|2075694|P1|STARTED|Overall Study||4
857680|NCT02633787|2075780|P1|NOT COMPLETED|Overall Study||1
857681|NCT02633787|2075780|P1|COMPLETED|Overall Study||109
857682|NCT02633787|2075780|P1|STARTED|Overall Study||110
857683|NCT02633215|2075788|P2|NOT COMPLETED|Overall Study||3
857684|NCT02633215|2075789|P1|NOT COMPLETED|Overall Study||2
857685|NCT02633215|2075788|P2|COMPLETED|Overall Study||15
857686|NCT02633215|2075789|P1|COMPLETED|Overall Study||16
857687|NCT02633215|2075788|P2|STARTED|Overall Study||18
857688|NCT02633215|2075789|P1|STARTED|Overall Study||18
857689|NCT02632812|2075801|P2|NOT COMPLETED|Overall Study||0
857690|NCT02632812|2075802|P1|NOT COMPLETED|Overall Study||0
857691|NCT02632812|2075801|P2|COMPLETED|Overall Study||12
857692|NCT02632812|2075802|P1|COMPLETED|Overall Study||12
857693|NCT02632812|2075801|P2|STARTED|Overall Study||12
857694|NCT02632812|2075802|P1|STARTED|Overall Study||12
857695|NCT02630563|2075820|P1|NOT COMPLETED|Overall Study||1
857696|NCT02630563|2075820|P1|COMPLETED|Overall Study||8
857697|NCT02630563|2075820|P1|STARTED|Overall Study||9
857698|NCT02629354|2075831|P2|NOT COMPLETED|Follow-up||0
857699|NCT02629354|2075832|P1|NOT COMPLETED|Follow-up||0
857700|NCT02629354|2075831|P2|COMPLETED|Follow-up||18
857701|NCT02629354|2075832|P1|COMPLETED|Follow-up||18
857702|NCT02629354|2075831|P2|STARTED|Follow-up||18
857703|NCT02629354|2075832|P1|STARTED|Follow-up||18
857704|NCT02629354|2075831|P2|NOT COMPLETED|Period 2||0
857705|NCT02629354|2075832|P1|NOT COMPLETED|Period 2||0
857706|NCT02629354|2075831|P2|COMPLETED|Period 2||18
857707|NCT02629354|2075832|P1|COMPLETED|Period 2||18
857708|NCT02629354|2075831|P2|STARTED|Period 2||18
857709|NCT02629354|2075832|P1|STARTED|Period 2||18
857710|NCT02629354|2075831|P2|NOT COMPLETED|Washout Period||0
857711|NCT02629354|2075832|P1|NOT COMPLETED|Washout Period||0
857712|NCT02629354|2075831|P2|COMPLETED|Washout Period||18
857713|NCT02629354|2075832|P1|COMPLETED|Washout Period||18
857714|NCT02629354|2075831|P2|STARTED|Washout Period||18
857715|NCT02629354|2075832|P1|STARTED|Washout Period||18
857716|NCT02629354|2075831|P2|NOT COMPLETED|Period 1||0
857717|NCT02629354|2075832|P1|NOT COMPLETED|Period 1||0
857718|NCT02629354|2075831|P2|COMPLETED|Period 1||18
857719|NCT02629354|2075832|P1|COMPLETED|Period 1||18
857720|NCT02629354|2075831|P2|STARTED|Period 1||18
857721|NCT02629354|2075832|P1|STARTED|Period 1||18
857722|NCT02628938|2075857|P3|NOT COMPLETED|Overall Study||4
857723|NCT02628938|2075858|P2|NOT COMPLETED|Overall Study||2
857724|NCT02628938|2075859|P1|NOT COMPLETED|Overall Study||5
857725|NCT02628938|2075857|P3|COMPLETED|Overall Study||11
857726|NCT02628938|2075858|P2|COMPLETED|Overall Study||13
857727|NCT02628938|2075859|P1|COMPLETED|Overall Study||10
857728|NCT02628938|2075857|P3|STARTED|Overall Study||15
857729|NCT02628938|2075858|P2|STARTED|Overall Study||15
857730|NCT02628938|2075859|P1|STARTED|Overall Study||15
857731|NCT02628418|2075875|P2|NOT COMPLETED|Overall Study||2
857732|NCT02628418|2075876|P1|NOT COMPLETED|Overall Study||1
857733|NCT02628418|2075875|P2|COMPLETED|Overall Study||13
857734|NCT02628418|2075876|P1|COMPLETED|Overall Study||14
857735|NCT02628418|2075875|P2|STARTED|Overall Study||15
857736|NCT02628418|2075876|P1|STARTED|Overall Study||15
857737|NCT02628236|2075897|P1|NOT COMPLETED|Overall Study||0
857738|NCT02628236|2075897|P1|COMPLETED|Overall Study||14
857739|NCT02628236|2075897|P1|STARTED|Overall Study||14
857740|NCT02628106|2075934|P1|NOT COMPLETED|Overall Study||0
857741|NCT02628106|2075934|P1|COMPLETED|Overall Study||21
857742|NCT02628106|2075934|P1|STARTED|Overall Study||21
857743|NCT02627144|2075938|P1|NOT COMPLETED|Overall Study||365
857744|NCT02627144|2075938|P1|COMPLETED|Overall Study||0
857745|NCT02627144|2075938|P1|Treated|Overall Study||359
857746|NCT02627144|2075938|P1|STARTED|Overall Study||365
857747|NCT02627001|2075948|P2|NOT COMPLETED|Overall Study||0
857748|NCT02627001|2075949|P1|NOT COMPLETED|Overall Study||0
857749|NCT02627001|2075948|P2|COMPLETED|Overall Study||14
857750|NCT02627001|2075949|P1|COMPLETED|Overall Study||13
857751|NCT02627001|2075948|P2|STARTED|Overall Study||14
857752|NCT02627001|2075949|P1|STARTED|Overall Study||13
857753|NCT02625844|2075955|P1|NOT COMPLETED|Overall Study||0
857754|NCT02625844|2075955|P1|COMPLETED|Overall Study||110
857755|NCT02625844|2075955|P1|STARTED|Overall Study||110
857756|NCT02625298|2075961|P2|NOT COMPLETED|Overall Study||0
857757|NCT02625298|2075962|P1|NOT COMPLETED|Overall Study||1
857758|NCT02625298|2075961|P2|COMPLETED|Overall Study||13
857759|NCT02625298|2075962|P1|COMPLETED|Overall Study||10
857760|NCT02625298|2075961|P2|STARTED|Overall Study||13
857761|NCT02625298|2075962|P1|STARTED|Overall Study||11
857762|NCT02625233|2075972|P2|NOT COMPLETED|Overall Study||0
857763|NCT02625233|2075973|P1|NOT COMPLETED|Overall Study||2
857764|NCT02625233|2075972|P2|COMPLETED|Overall Study||56
857765|NCT02625233|2075973|P1|COMPLETED|Overall Study||47
857766|NCT02625233|2075972|P2|STARTED|Overall Study||56
857767|NCT02625233|2075973|P1|STARTED|Overall Study||49
857768|NCT02625220|2075981|P1|NOT COMPLETED|Overall Study||7
857769|NCT02625220|2075981|P1|COMPLETED|Overall Study||163
857770|NCT02625220|2075981|P1|STARTED|Overall Study||170
857771|NCT02625207|2075992|P4|NOT COMPLETED|Part 2 (11 Days)||0
857772|NCT02625207|2075993|P3|NOT COMPLETED|Part 2 (11 Days)||0
857773|NCT02625207|2075994|P2|NOT COMPLETED|Part 2 (11 Days)||0
857774|NCT02625207|2075995|P1|NOT COMPLETED|Part 2 (11 Days)||0
857775|NCT02625207|2075992|P4|COMPLETED|Part 2 (11 Days)||0
857776|NCT02625207|2075993|P3|COMPLETED|Part 2 (11 Days)||12
857777|NCT02625207|2075994|P2|COMPLETED|Part 2 (11 Days)||0
857778|NCT02625207|2075995|P1|COMPLETED|Part 2 (11 Days)||11
857779|NCT02625207|2075992|P4|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
857780|NCT02625207|2075993|P3|STARTED|Part 2 (11 Days)||12
857781|NCT02625207|2075994|P2|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
857782|NCT02625207|2075995|P1|STARTED|Part 2 (11 Days)||11
857783|NCT02625207|2075992|P4|NOT COMPLETED|Part 1 (6 Days)||0
857784|NCT02625207|2075993|P3|NOT COMPLETED|Part 1 (6 Days)||0
857785|NCT02625207|2075994|P2|NOT COMPLETED|Part 1 (6 Days)||0
857786|NCT02625207|2075995|P1|NOT COMPLETED|Part 1 (6 Days)||0
857787|NCT02625207|2075992|P4|COMPLETED|Part 1 (6 Days)||12
857788|NCT02625207|2075993|P3|COMPLETED|Part 1 (6 Days)||12
857789|NCT02625207|2075994|P2|COMPLETED|Part 1 (6 Days)||12
857790|NCT02625207|2075995|P1|COMPLETED|Part 1 (6 Days)||11
857791|NCT02625207|2075992|P4|STARTED|Part 1 (6 Days)||12
857792|NCT02625207|2075993|P3|STARTED|Part 1 (6 Days)||12
857793|NCT02625207|2075994|P2|STARTED|Part 1 (6 Days)||12
857794|NCT02625207|2075995|P1|STARTED|Part 1 (6 Days)||11
857795|NCT02624791|2076081|P6|NOT COMPLETED|Overall Study||0
857796|NCT02624791|2076082|P5|NOT COMPLETED|Overall Study||0
857797|NCT02624791|2076083|P4|NOT COMPLETED|Overall Study||0
857798|NCT02624791|2076084|P3|NOT COMPLETED|Overall Study||0
857799|NCT02624791|2076085|P2|NOT COMPLETED|Overall Study||0
857800|NCT02624791|2076086|P1|NOT COMPLETED|Overall Study||2
857801|NCT02624791|2076081|P6|COMPLETED|Overall Study||2
857802|NCT02624791|2076082|P5|COMPLETED|Overall Study||2
857803|NCT02624791|2076083|P4|COMPLETED|Overall Study||2
857804|NCT02624791|2076084|P3|COMPLETED|Overall Study||2
857805|NCT02624791|2076085|P2|COMPLETED|Overall Study||1
857806|NCT02624791|2076086|P1|COMPLETED|Overall Study||0
857807|NCT02624791|2076081|P6|STARTED|Overall Study||2
857808|NCT02624791|2076082|P5|STARTED|Overall Study||2
857809|NCT02624791|2076083|P4|STARTED|Overall Study||2
857810|NCT02624791|2076084|P3|STARTED|Overall Study||2
857811|NCT02624791|2076085|P2|STARTED|Overall Study||1
857812|NCT02624791|2076086|P1|STARTED|Overall Study||2
857813|NCT02622568|2076093|P2|NOT COMPLETED|Overall Study||5
857814|NCT02622568|2076094|P1|NOT COMPLETED|Overall Study||5
857815|NCT02622568|2076093|P2|COMPLETED|Overall Study||9
857816|NCT02622568|2076094|P1|COMPLETED|Overall Study||9
857817|NCT02622568|2076093|P2|STARTED|Overall Study||14
857818|NCT02622568|2076094|P1|STARTED|Overall Study||14
857819|NCT02621034|2076103|P3|NOT COMPLETED|Overall Study||5
857820|NCT02621034|2076104|P2|NOT COMPLETED|Overall Study||2
857821|NCT02621034|2076105|P1|NOT COMPLETED|Overall Study||3
857822|NCT02621034|2076103|P3|COMPLETED|Overall Study||50
857823|NCT02621034|2076104|P2|COMPLETED|Overall Study||50
857824|NCT02621034|2076105|P1|COMPLETED|Overall Study||50
857825|NCT02621034|2076103|P3|STARTED|Overall Study||55
857826|NCT02621034|2076104|P2|STARTED|Overall Study||52
857827|NCT02621034|2076105|P1|STARTED|Overall Study||53
857828|NCT02619812|2076122|P4|NOT COMPLETED|Overall Study||2
857829|NCT02619812|2076123|P3|NOT COMPLETED|Overall Study||1
857830|NCT02619812|2076124|P2|NOT COMPLETED|Overall Study||0
857831|NCT02619812|2076125|P1|NOT COMPLETED|Overall Study||0
857832|NCT02619812|2076122|P4|COMPLETED|Overall Study||0
857833|NCT02619812|2076123|P3|COMPLETED|Overall Study||0
857834|NCT02619812|2076124|P2|COMPLETED|Overall Study||0
857835|NCT02619812|2076125|P1|COMPLETED|Overall Study||0
857836|NCT02619812|2076122|P4|STARTED|Overall Study||2
857837|NCT02619812|2076123|P3|STARTED|Overall Study||1
857838|NCT02619812|2076124|P2|STARTED|Overall Study||0
857839|NCT02619812|2076125|P1|STARTED|Overall Study||0
857840|NCT02619799|2076141|P2|NOT COMPLETED|Overall Study||0
857841|NCT02619799|2076142|P1|NOT COMPLETED|Overall Study||0
857842|NCT02619799|2076141|P2|COMPLETED|Overall Study||25
857843|NCT02619799|2076142|P1|COMPLETED|Overall Study||25
857844|NCT02619799|2076141|P2|STARTED|Overall Study||25
857845|NCT02619799|2076142|P1|STARTED|Overall Study||25
857846|NCT02619591|2076160|P2|NOT COMPLETED|Overall Study||121
857847|NCT02619591|2076161|P1|NOT COMPLETED|Overall Study||139
857848|NCT02619591|2076160|P2|COMPLETED|Overall Study||0
857849|NCT02619591|2076161|P1|COMPLETED|Overall Study||0
857850|NCT02619591|2076160|P2|STARTED|Overall Study||121
857851|NCT02619591|2076161|P1|STARTED|Overall Study||139
857852|NCT02618772|2076169|P2|NOT COMPLETED|Overall Study||0
857853|NCT02618772|2076170|P1|NOT COMPLETED|Overall Study||1
857854|NCT02618772|2076169|P2|COMPLETED|Overall Study||40
857855|NCT02618772|2076170|P1|COMPLETED|Overall Study||38
857856|NCT02618772|2076169|P2|Withdrawal by Subject|Overall Study||0
857857|NCT02618772|2076170|P1|Withdrawal by Subject|Overall Study|The participant's family withdrew from the study after administration of the trial intervention.|1
857858|NCT02618772|2076169|P2|STARTED|Overall Study||40
857859|NCT02618772|2076170|P1|STARTED|Overall Study||39
857860|NCT02617888|2076205|P3|NOT COMPLETED|Overall Study||0
857861|NCT02617888|2076206|P2|NOT COMPLETED|Overall Study||7
857862|NCT02617888|2076207|P1|NOT COMPLETED|Overall Study||1
857863|NCT02617888|2076205|P3|COMPLETED|Overall Study||127
857864|NCT02617888|2076206|P2|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break samples.|44
857865|NCT02617888|2076207|P1|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break sample.|49
857866|NCT02617888|2076205|P3|STARTED|Overall Study||127
857867|NCT02617888|2076206|P2|STARTED|Overall Study||51
857868|NCT02617888|2076207|P1|STARTED|Overall Study||50
857869|NCT02617784|2076216|P2|NOT COMPLETED|Overall Study||0
857870|NCT02617784|2076217|P1|NOT COMPLETED|Overall Study||0
857871|NCT02617784|2076216|P2|COMPLETED|Overall Study||12
857872|NCT02617784|2076217|P1|COMPLETED|Overall Study||12
857873|NCT02617784|2076216|P2|Second Dose Assessment Period|Overall Study||12
857874|NCT02617784|2076217|P1|Second Dose Assessment Period|Overall Study||11
857875|NCT02617784|2076216|P2|First Dose Assessment Period|Overall Study||12
857876|NCT02617784|2076217|P1|First Dose Assessment Period|Overall Study||12
857877|NCT02617784|2076216|P2|STARTED|Overall Study||12
857878|NCT02617784|2076217|P1|STARTED|Overall Study|None were prematurely withdrawn; 1 switched to CAPD mid-study and was excluded from second analysis.|12
857879|NCT02616523|2076267|P3|NOT COMPLETED|Overall Study||0
857880|NCT02616523|2076268|P2|NOT COMPLETED|Overall Study||0
857881|NCT02616523|2076269|P1|NOT COMPLETED|Overall Study||1
857882|NCT02616523|2076267|P3|COMPLETED|Overall Study|April 2015|20
857883|NCT02616523|2076268|P2|COMPLETED|Overall Study|April 2015|20
857884|NCT02616523|2076269|P1|COMPLETED|Overall Study|April 2015|19
857885|NCT02616523|2076267|P3|STARTED|Overall Study|June 2014|20
857886|NCT02616523|2076268|P2|STARTED|Overall Study|June 2014|20
857887|NCT02616523|2076269|P1|STARTED|Overall Study|June 2014|20
857888|NCT02615717|2076285|P2|NOT COMPLETED|Overall Study||0
857889|NCT02615717|2076286|P1|NOT COMPLETED|Overall Study||0
857890|NCT02615717|2076285|P2|COMPLETED|Overall Study||3
857891|NCT02615717|2076286|P1|COMPLETED|Overall Study||3
857892|NCT02615717|2076285|P2|STARTED|Overall Study||3
857893|NCT02615717|2076286|P1|STARTED|Overall Study||3
857894|NCT02614924|2076300|P2|NOT COMPLETED|Overall Study||0
857895|NCT02614924|2076301|P1|NOT COMPLETED|Overall Study||0
857896|NCT02614924|2076300|P2|COMPLETED|Overall Study||20
857897|NCT02614924|2076301|P1|COMPLETED|Overall Study||20
857898|NCT02614924|2076300|P2|STARTED|Overall Study||20
857899|NCT02614924|2076301|P1|STARTED|Overall Study||20
857900|NCT02614586|2076309|P1|NOT COMPLETED|Overall Study||0
857901|NCT02614586|2076309|P1|COMPLETED|Overall Study||11
857902|NCT02614586|2076309|P1|STARTED|Overall Study||11
857903|NCT02614469|2076316|P2|NOT COMPLETED|Period 2||0
857904|NCT02614469|2076317|P1|NOT COMPLETED|Period 2||0
857905|NCT02614469|2076316|P2|COMPLETED|Period 2||9
857906|NCT02614469|2076317|P1|COMPLETED|Period 2||9
857907|NCT02614469|2076316|P2|STARTED|Period 2||9
857908|NCT02614469|2076317|P1|STARTED|Period 2||9
857909|NCT02614469|2076316|P2|NOT COMPLETED|Period 1||0
857910|NCT02614469|2076317|P1|NOT COMPLETED|Period 1||0
857911|NCT02614469|2076316|P2|COMPLETED|Period 1||9
857912|NCT02614469|2076317|P1|COMPLETED|Period 1||9
857913|NCT02614469|2076316|P2|STARTED|Period 1||9
857914|NCT02614469|2076317|P1|STARTED|Period 1||9
857915|NCT02614222|2076347|P2|NOT COMPLETED|Overall Study||0
857916|NCT02614222|2076348|P1|NOT COMPLETED|Overall Study||0
857917|NCT02614222|2076347|P2|COMPLETED|Overall Study||14
857918|NCT02614222|2076348|P1|COMPLETED|Overall Study||13
857919|NCT02614222|2076347|P2|STARTED|Overall Study||14
857920|NCT02614222|2076348|P1|STARTED|Overall Study||13
857921|NCT02613910|2076368|P1|NOT COMPLETED|Overall Study||1
857922|NCT02613910|2076368|P1|COMPLETED|Overall Study||0
857923|NCT02613910|2076368|P1|STARTED|Overall Study||1
857924|NCT02612077|2076417|P1|NOT COMPLETED|Overall Study||466
857925|NCT02612077|2076417|P1|COMPLETED|Overall Study||299
857926|NCT02612077|2076417|P1|Efficacy Analysis Set|Overall Study||737
857927|NCT02612077|2076417|P1|Safety Analysis Set|Overall Study||760
857928|NCT02612077|2076417|P1|Did Not Receive Study Product|Overall Study||5
857929|NCT02612077|2076417|P1|STARTED|Overall Study||765
857930|NCT02612064|2076429|P2|NOT COMPLETED|Overall Study||3
857931|NCT02612064|2076430|P1|NOT COMPLETED|Overall Study||1
857932|NCT02612064|2076429|P2|COMPLETED|Overall Study||112
857933|NCT02612064|2076430|P1|COMPLETED|Overall Study||114
857934|NCT02612064|2076429|P2|STARTED|Overall Study||115
857935|NCT02612064|2076430|P1|STARTED|Overall Study||115
857936|NCT02611765|2076442|P2|NOT COMPLETED|Overall Study||6
857937|NCT02611765|2076443|P1|NOT COMPLETED|Overall Study||2
857938|NCT02611765|2076442|P2|COMPLETED|Overall Study||29
857939|NCT02611765|2076443|P1|COMPLETED|Overall Study||27
857940|NCT02611765|2076442|P2|STARTED|Overall Study||35
857941|NCT02611765|2076443|P1|STARTED|Overall Study||29
857942|NCT02611154|2076449|P1|NOT COMPLETED|Overall Study||0
857943|NCT02611154|2076449|P1|COMPLETED|Overall Study||5
857944|NCT02611154|2076449|P1|STARTED|Overall Study||5
857951|NCT02609841|2076479|P1|NOT COMPLETED|Overall Study||28
857952|NCT02609841|2076479|P1|COMPLETED|Overall Study||212
857953|NCT02609841|2076479|P1|STARTED|Overall Study||240
857960|NCT02609178|2076522|P6|NOT COMPLETED|Third Crown||0
857961|NCT02609178|2076523|P5|NOT COMPLETED|Third Crown||0
857962|NCT02609178|2076524|P4|NOT COMPLETED|Third Crown||0
857963|NCT02609178|2076525|P3|NOT COMPLETED|Third Crown||0
857964|NCT02609178|2076526|P2|NOT COMPLETED|Third Crown||0
857965|NCT02609178|2076527|P1|NOT COMPLETED|Third Crown||0
857966|NCT02609178|2076522|P6|COMPLETED|Third Crown||2
857967|NCT02609178|2076523|P5|COMPLETED|Third Crown||0
857968|NCT02609178|2076524|P4|COMPLETED|Third Crown||2
857969|NCT02609178|2076525|P3|COMPLETED|Third Crown||5
857970|NCT02609178|2076526|P2|COMPLETED|Third Crown||1
857971|NCT02609178|2076527|P1|COMPLETED|Third Crown||0
857972|NCT02609178|2076522|P6|STARTED|Third Crown||2
857973|NCT02609178|2076523|P5|STARTED|Third Crown||0
857974|NCT02609178|2076524|P4|STARTED|Third Crown||2
857975|NCT02609178|2076525|P3|STARTED|Third Crown||5
857976|NCT02609178|2076526|P2|STARTED|Third Crown||1
857977|NCT02609178|2076527|P1|STARTED|Third Crown||0
857978|NCT02609178|2076522|P6|NOT COMPLETED|5-minute Washout Time||0
857979|NCT02609178|2076523|P5|NOT COMPLETED|5-minute Washout Time||0
857980|NCT02609178|2076524|P4|NOT COMPLETED|5-minute Washout Time||0
857981|NCT02609178|2076525|P3|NOT COMPLETED|5-minute Washout Time||0
857982|NCT02609178|2076526|P2|NOT COMPLETED|5-minute Washout Time||0
857983|NCT02609178|2076527|P1|NOT COMPLETED|5-minute Washout Time||0
857984|NCT02609178|2076522|P6|COMPLETED|5-minute Washout Time||2
857985|NCT02609178|2076523|P5|COMPLETED|5-minute Washout Time||0
857986|NCT02609178|2076524|P4|COMPLETED|5-minute Washout Time||2
857987|NCT02609178|2076525|P3|COMPLETED|5-minute Washout Time||5
857988|NCT02609178|2076526|P2|COMPLETED|5-minute Washout Time||1
857989|NCT02609178|2076527|P1|COMPLETED|5-minute Washout Time||0
857990|NCT02609178|2076522|P6|STARTED|5-minute Washout Time||2
857991|NCT02609178|2076523|P5|STARTED|5-minute Washout Time||0
857992|NCT02609178|2076524|P4|STARTED|5-minute Washout Time||2
857993|NCT02609178|2076525|P3|STARTED|5-minute Washout Time||5
857994|NCT02609178|2076526|P2|STARTED|5-minute Washout Time||1
857995|NCT02609178|2076527|P1|STARTED|5-minute Washout Time||0
857996|NCT02609178|2076522|P6|NOT COMPLETED|Second Crown||0
857997|NCT02609178|2076523|P5|NOT COMPLETED|Second Crown||0
857998|NCT02609178|2076524|P4|NOT COMPLETED|Second Crown||0
857999|NCT02609178|2076525|P3|NOT COMPLETED|Second Crown||0
858000|NCT02609178|2076526|P2|NOT COMPLETED|Second Crown||0
858001|NCT02609178|2076527|P1|NOT COMPLETED|Second Crown||0
858002|NCT02609178|2076522|P6|COMPLETED|Second Crown||2
858003|NCT02609178|2076523|P5|COMPLETED|Second Crown||0
858004|NCT02609178|2076524|P4|COMPLETED|Second Crown||2
858005|NCT02609178|2076525|P3|COMPLETED|Second Crown||5
858006|NCT02609178|2076526|P2|COMPLETED|Second Crown||1
858007|NCT02609178|2076527|P1|COMPLETED|Second Crown||0
858008|NCT02609178|2076522|P6|STARTED|Second Crown||2
858009|NCT02609178|2076523|P5|STARTED|Second Crown||0
858010|NCT02609178|2076524|P4|STARTED|Second Crown||2
858011|NCT02609178|2076525|P3|STARTED|Second Crown||5
858012|NCT02609178|2076526|P2|STARTED|Second Crown||1
858013|NCT02609178|2076527|P1|STARTED|Second Crown||0
858014|NCT02609178|2076522|P6|NOT COMPLETED|5-minute Washout Time||0
858015|NCT02609178|2076523|P5|NOT COMPLETED|5-minute Washout Time||0
858016|NCT02609178|2076524|P4|NOT COMPLETED|5-minute Washout Time||0
858017|NCT02609178|2076525|P3|NOT COMPLETED|5-minute Washout Time||0
858018|NCT02609178|2076526|P2|NOT COMPLETED|5-minute Washout Time||0
858019|NCT02609178|2076527|P1|NOT COMPLETED|5-minute Washout Time||0
858020|NCT02609178|2076522|P6|COMPLETED|5-minute Washout Time||2
858021|NCT02609178|2076523|P5|COMPLETED|5-minute Washout Time||0
858022|NCT02609178|2076524|P4|COMPLETED|5-minute Washout Time||2
858023|NCT02609178|2076525|P3|COMPLETED|5-minute Washout Time||5
858024|NCT02609178|2076526|P2|COMPLETED|5-minute Washout Time||1
858025|NCT02609178|2076527|P1|COMPLETED|5-minute Washout Time||0
858026|NCT02609178|2076522|P6|STARTED|5-minute Washout Time||2
858027|NCT02609178|2076523|P5|STARTED|5-minute Washout Time||0
858028|NCT02609178|2076524|P4|STARTED|5-minute Washout Time||2
858029|NCT02609178|2076525|P3|STARTED|5-minute Washout Time||5
858030|NCT02609178|2076526|P2|STARTED|5-minute Washout Time||1
858031|NCT02609178|2076527|P1|STARTED|5-minute Washout Time||0
858032|NCT02609178|2076522|P6|NOT COMPLETED|First Crown||0
858033|NCT02609178|2076523|P5|NOT COMPLETED|First Crown||0
858034|NCT02609178|2076524|P4|NOT COMPLETED|First Crown||1
858035|NCT02609178|2076525|P3|NOT COMPLETED|First Crown||1
858036|NCT02609178|2076526|P2|NOT COMPLETED|First Crown||0
858037|NCT02609178|2076527|P1|NOT COMPLETED|First Crown||0
858038|NCT02609178|2076522|P6|COMPLETED|First Crown||2
858039|NCT02609178|2076523|P5|COMPLETED|First Crown||0
858040|NCT02609178|2076524|P4|COMPLETED|First Crown||2
858041|NCT02609178|2076525|P3|COMPLETED|First Crown||5
858042|NCT02609178|2076526|P2|COMPLETED|First Crown||1
858043|NCT02609178|2076527|P1|COMPLETED|First Crown||0
858044|NCT02609178|2076522|P6|STARTED|First Crown||2
858045|NCT02609178|2076523|P5|STARTED|First Crown||0
858046|NCT02609178|2076524|P4|STARTED|First Crown||3
858047|NCT02609178|2076525|P3|STARTED|First Crown||6
858048|NCT02609178|2076526|P2|STARTED|First Crown||1
858049|NCT02609178|2076527|P1|STARTED|First Crown||0
858050|NCT02608489|2076544|P2|NOT COMPLETED|Overall Study||10
858051|NCT02608489|2076545|P1|NOT COMPLETED|Overall Study||13
858052|NCT02608489|2076544|P2|COMPLETED|Overall Study||33
858053|NCT02608489|2076545|P1|COMPLETED|Overall Study||30
858054|NCT02608489|2076544|P2|STARTED|Overall Study||43
858055|NCT02608489|2076545|P1|STARTED|Overall Study||43
858056|NCT02606838|2076565|P1|NOT COMPLETED|Overall Study||0
858057|NCT02606838|2076565|P1|COMPLETED|Overall Study||119
858058|NCT02606838|2076565|P1|STARTED|Overall Study||119
858059|NCT02606734|2076573|P1|NOT COMPLETED|Overall Study||0
858060|NCT02606734|2076573|P1|COMPLETED|Overall Study||44
858061|NCT02606734|2076573|P1|STARTED|Overall Study||44
858062|NCT02605928|2076577|P1|NOT COMPLETED|Overall Study||33
858063|NCT02605928|2076577|P1|COMPLETED|Overall Study||46
858064|NCT02605928|2076577|P1|Pivotal Phase, Statistical Phase|Overall Study||51
858065|NCT02605928|2076577|P1|STARTED|Overall Study||79
858066|NCT02604589|2076584|P3|NOT COMPLETED|Overall Study||1
858067|NCT02604589|2076585|P2|NOT COMPLETED|Overall Study||0
858068|NCT02604589|2076586|P1|NOT COMPLETED|Overall Study||0
858069|NCT02604589|2076584|P3|COMPLETED|Overall Study||1
858070|NCT02604589|2076585|P2|COMPLETED|Overall Study||5
858071|NCT02604589|2076586|P1|COMPLETED|Overall Study||3
858072|NCT02604589|2076584|P3|STARTED|Overall Study||2
858073|NCT02604589|2076585|P2|STARTED|Overall Study||5
858074|NCT02604589|2076586|P1|STARTED|Overall Study||3
858075|NCT02604550|2076614|P2|NOT COMPLETED|Overall Study||26
858076|NCT02604550|2076615|P1|NOT COMPLETED|Overall Study||25
858077|NCT02604550|2076614|P2|COMPLETED|Overall Study||33
858078|NCT02604550|2076615|P1|COMPLETED|Overall Study||31
858079|NCT02604550|2076614|P2|STARTED|Overall Study||59
858080|NCT02604550|2076615|P1|STARTED|Overall Study||56
858081|NCT02604407|2076642|P3|NOT COMPLETED|Overall Study||16
858082|NCT02604407|2076643|P2|NOT COMPLETED|Overall Study||12
858083|NCT02604407|2076644|P1|NOT COMPLETED|Overall Study||11
858084|NCT02604407|2076642|P3|COMPLETED|Overall Study||76
858085|NCT02604407|2076643|P2|COMPLETED|Overall Study||80
858086|NCT02604407|2076644|P1|COMPLETED|Overall Study||80
858087|NCT02604407|2076642|P3|TREATED|Overall Study||90
858088|NCT02604407|2076643|P2|TREATED|Overall Study||92
858089|NCT02604407|2076644|P1|TREATED|Overall Study||89
858090|NCT02604407|2076642|P3|STARTED|Overall Study||92
858091|NCT02604407|2076643|P2|STARTED|Overall Study||92
858092|NCT02604407|2076644|P1|STARTED|Overall Study||91
858093|NCT02604264|2076657|P2|NOT COMPLETED|Overall Study||242
858094|NCT02604264|2076658|P1|NOT COMPLETED|Overall Study||200
858095|NCT02604264|2076657|P2|COMPLETED|Overall Study||1225
858096|NCT02604264|2076658|P1|COMPLETED|Overall Study||1245
858097|NCT02604264|2076657|P2|STARTED|Overall Study||1467
858098|NCT02604264|2076658|P1|STARTED|Overall Study||1445
858099|NCT02604017|2076666|P2|NOT COMPLETED|Overall Study||8
858100|NCT02604017|2076667|P1|NOT COMPLETED|Overall Study||6
858101|NCT02604017|2076666|P2|COMPLETED|Overall Study||343
858102|NCT02604017|2076667|P1|COMPLETED|Overall Study||346
858103|NCT02604017|2076666|P2|STARTED|Overall Study||351
858104|NCT02604017|2076667|P1|STARTED|Overall Study||352
858105|NCT02603666|2076692|P1|NOT COMPLETED|Overall Study||0
858106|NCT02603666|2076692|P1|COMPLETED|Overall Study||130
858107|NCT02603666|2076692|P1|STARTED|Overall Study||130
858108|NCT02602223|2076696|P1|NOT COMPLETED|Overall Study||0
858109|NCT02602223|2076696|P1|COMPLETED|Overall Study||9
858110|NCT02602223|2076696|P1|STARTED|Overall Study||9
858114|NCT02598934|2076718|P2|NOT COMPLETED|Overall Study||22
858115|NCT02598934|2076719|P1|NOT COMPLETED|Overall Study||19
858116|NCT02598934|2076718|P2|COMPLETED|Overall Study||132
858117|NCT02598934|2076719|P1|COMPLETED|Overall Study||135
858118|NCT02598934|2076718|P2|STARTED|Overall Study||154
858119|NCT02598934|2076719|P1|STARTED|Overall Study||154
858120|NCT02598622|2076731|P2|NOT COMPLETED|Overall Study||0
858121|NCT02598622|2076732|P1|NOT COMPLETED|Overall Study||6
858122|NCT02598622|2076731|P2|COMPLETED|Overall Study||0
858123|NCT02598622|2076732|P1|COMPLETED|Overall Study||2
858124|NCT02598622|2076731|P2|STARTED|Overall Study|Study terminated prior to randomization phase. No enrollment in this arm.|0
858125|NCT02598622|2076732|P1|STARTED|Overall Study||8
858126|NCT02598128|2076738|P4|NOT COMPLETED|Period C: Days 12 to 20||0
858127|NCT02598128|2076739|P3|NOT COMPLETED|Period C: Days 12 to 20||0
858128|NCT02598128|2076740|P2|NOT COMPLETED|Period C: Days 12 to 20||0
858129|NCT02598128|2076741|P1|NOT COMPLETED|Period C: Days 12 to 20||0
858130|NCT02598128|2076738|P4|COMPLETED|Period C: Days 12 to 20||33
858131|NCT02598128|2076739|P3|COMPLETED|Period C: Days 12 to 20||0
858132|NCT02598128|2076740|P2|COMPLETED|Period C: Days 12 to 20||0
858133|NCT02598128|2076741|P1|COMPLETED|Period C: Days 12 to 20||0
858134|NCT02598128|2076738|P4|STARTED|Period C: Days 12 to 20||33
858135|NCT02598128|2076739|P3|STARTED|Period C: Days 12 to 20||0
858136|NCT02598128|2076740|P2|STARTED|Period C: Days 12 to 20||0
858137|NCT02598128|2076741|P1|STARTED|Period C: Days 12 to 20||0
858138|NCT02598128|2076738|P4|NOT COMPLETED|Period B: Days 1 to 11||0
858139|NCT02598128|2076739|P3|NOT COMPLETED|Period B: Days 1 to 11||0
858140|NCT02598128|2076740|P2|NOT COMPLETED|Period B: Days 1 to 11||0
858141|NCT02598128|2076741|P1|NOT COMPLETED|Period B: Days 1 to 11||0
858142|NCT02598128|2076738|P4|COMPLETED|Period B: Days 1 to 11||0
858143|NCT02598128|2076739|P3|COMPLETED|Period B: Days 1 to 11||16
858144|NCT02598128|2076740|P2|COMPLETED|Period B: Days 1 to 11||17
858145|NCT02598128|2076741|P1|COMPLETED|Period B: Days 1 to 11||0
858146|NCT02598128|2076738|P4|STARTED|Period B: Days 1 to 11||0
858147|NCT02598128|2076739|P3|STARTED|Period B: Days 1 to 11||16
858148|NCT02598128|2076740|P2|STARTED|Period B: Days 1 to 11||17
858149|NCT02598128|2076741|P1|STARTED|Period B: Days 1 to 11||0
858150|NCT02598128|2076738|P4|NOT COMPLETED|Period A: Days -7 to -1||0
858151|NCT02598128|2076739|P3|NOT COMPLETED|Period A: Days -7 to -1||0
858152|NCT02598128|2076740|P2|NOT COMPLETED|Period A: Days -7 to -1||0
858153|NCT02598128|2076741|P1|NOT COMPLETED|Period A: Days -7 to -1||1
858154|NCT02598128|2076738|P4|COMPLETED|Period A: Days -7 to -1||0
858155|NCT02598128|2076739|P3|COMPLETED|Period A: Days -7 to -1||0
858156|NCT02598128|2076740|P2|COMPLETED|Period A: Days -7 to -1||0
858157|NCT02598128|2076741|P1|COMPLETED|Period A: Days -7 to -1||33
858158|NCT02598128|2076738|P4|STARTED|Period A: Days -7 to -1||0
858159|NCT02598128|2076739|P3|STARTED|Period A: Days -7 to -1||0
858160|NCT02598128|2076740|P2|STARTED|Period A: Days -7 to -1||0
858161|NCT02598128|2076741|P1|STARTED|Period A: Days -7 to -1||34
858162|NCT02597907|2076755|P2|NOT COMPLETED|Overall Study||0
858163|NCT02597907|2076756|P1|NOT COMPLETED|Overall Study||0
858164|NCT02597907|2076755|P2|COMPLETED|Overall Study||44
858165|NCT02597907|2076756|P1|COMPLETED|Overall Study||44
858166|NCT02597907|2076755|P2|STARTED|Overall Study||44
858167|NCT02597907|2076756|P1|STARTED|Overall Study||44
858168|NCT02597855|2076764|P2|NOT COMPLETED|Overall Study||1
858169|NCT02597855|2076765|P1|NOT COMPLETED|Overall Study||2
858170|NCT02597855|2076764|P2|COMPLETED|Overall Study||13
858171|NCT02597855|2076765|P1|COMPLETED|Overall Study||16
858172|NCT02597855|2076764|P2|STARTED|Overall Study||14
858173|NCT02597855|2076765|P1|STARTED|Overall Study||18
858174|NCT02597582|2076775|P2|NOT COMPLETED|Overall Study||0
858175|NCT02597582|2076776|P1|NOT COMPLETED|Overall Study||0
858176|NCT02597582|2076775|P2|COMPLETED|Overall Study||20
858177|NCT02597582|2076776|P1|COMPLETED|Overall Study||21
858178|NCT02597582|2076775|P2|STARTED|Overall Study||20
858179|NCT02597582|2076776|P1|STARTED|Overall Study||21
858180|NCT02597543|2076794|P2|NOT COMPLETED|Overall Study||0
858181|NCT02597543|2076795|P1|NOT COMPLETED|Overall Study||0
858182|NCT02597543|2076794|P2|COMPLETED|Overall Study||8
858183|NCT02597543|2076795|P1|COMPLETED|Overall Study||6
858184|NCT02597543|2076794|P2|STARTED|Overall Study||8
858185|NCT02597543|2076795|P1|STARTED|Overall Study||6
858186|NCT02596958|2076811|P1|NOT COMPLETED|Overall Study||996
858187|NCT02596958|2076811|P1|COMPLETED|Overall Study||0
858188|NCT02596958|2076811|P1|STARTED|Overall Study||996
858189|NCT02596945|2076823|P1|NOT COMPLETED|Overall Study||56
858190|NCT02596945|2076823|P1|COMPLETED|Overall Study||167
858191|NCT02596945|2076823|P1|Treated|Overall Study||220
858192|NCT02596945|2076823|P1|STARTED|Overall Study||223
858193|NCT02596620|2076831|P2|NOT COMPLETED|Overall Study||1
858194|NCT02596620|2076832|P1|NOT COMPLETED|Overall Study||1
858195|NCT02596620|2076831|P2|COMPLETED|Overall Study|Completed on 30th September 2015|81
858196|NCT02596620|2076832|P1|COMPLETED|Overall Study|Completed on 30th September 2015|81
858197|NCT02596620|2076831|P2|STARTED|Overall Study|Started from 1st October 2013|82
858198|NCT02596620|2076832|P1|STARTED|Overall Study|Started from 1st October 2013|82
858199|NCT02596451|2076841|P3|NOT COMPLETED|Overall Study||14
858200|NCT02596451|2076842|P2|NOT COMPLETED|Overall Study||18
858201|NCT02596451|2076843|P1|NOT COMPLETED|Overall Study||4
858202|NCT02596451|2076841|P3|COMPLETED|Overall Study||373
858203|NCT02596451|2076842|P2|COMPLETED|Overall Study||374
858204|NCT02596451|2076843|P1|COMPLETED|Overall Study||381
858205|NCT02596451|2076841|P3|STARTED|Overall Study||387
858206|NCT02596451|2076842|P2|STARTED|Overall Study||392
858207|NCT02596451|2076843|P1|STARTED|Overall Study||385
858208|NCT02595502|2076850|P2|NOT COMPLETED|Period 3||2
858209|NCT02595502|2076851|P1|NOT COMPLETED|Period 3||1
858210|NCT02595502|2076850|P2|COMPLETED|Period 3||136
858211|NCT02595502|2076851|P1|COMPLETED|Period 3||140
858212|NCT02595502|2076850|P2|STARTED|Period 3||138
858213|NCT02595502|2076851|P1|STARTED|Period 3||141
858214|NCT02595502|2076850|P2|NOT COMPLETED|Period 2||2
858215|NCT02595502|2076851|P1|NOT COMPLETED|Period 2||1
858216|NCT02595502|2076850|P2|COMPLETED|Period 2||138
858217|NCT02595502|2076851|P1|COMPLETED|Period 2||141
858218|NCT02595502|2076850|P2|STARTED|Period 2||140
858219|NCT02595502|2076851|P1|STARTED|Period 2||142
858220|NCT02595502|2076850|P2|NOT COMPLETED|Period 1||2
858221|NCT02595502|2076851|P1|NOT COMPLETED|Period 1||1
858222|NCT02595502|2076850|P2|COMPLETED|Period 1||140
858223|NCT02595502|2076851|P1|COMPLETED|Period 1||142
858224|NCT02595502|2076850|P2|STARTED|Period 1||142
858225|NCT02595502|2076851|P1|STARTED|Period 1||143
858226|NCT02595450|2076857|P1|NOT COMPLETED|Overall Study||81
858227|NCT02595450|2076857|P1|COMPLETED|Overall Study||218
858228|NCT02595450|2076857|P1|Treated|Overall Study||291
858229|NCT02595450|2076857|P1|STARTED|Overall Study||299
858230|NCT02594826|2076865|P2|NOT COMPLETED|Overall Study||60
858231|NCT02594826|2076866|P1|NOT COMPLETED|Overall Study||57
858232|NCT02594826|2076865|P2|COMPLETED|Overall Study||298
858233|NCT02594826|2076866|P1|COMPLETED|Overall Study||290
858234|NCT02594826|2076865|P2|STARTED|Overall Study||358
858235|NCT02594826|2076866|P1|STARTED|Overall Study||347
858236|NCT02592655|2076874|P1|NOT COMPLETED|Fourth Tourniquet Right Thigh.||0
858237|NCT02592655|2076874|P1|COMPLETED|Fourth Tourniquet Right Thigh.||4
858238|NCT02592655|2076874|P1|Tourniquet Tape 5 cm Width|Fourth Tourniquet Right Thigh.||0
858239|NCT02592655|2076874|P1|Tourniquet Tape 10 cm Width|Fourth Tourniquet Right Thigh.||3
858240|NCT02592655|2076874|P1|Windlass Tourniquet|Fourth Tourniquet Right Thigh.||0
858241|NCT02592655|2076874|P1|ATS (Pneumatic)|Fourth Tourniquet Right Thigh.||1
858242|NCT02592655|2076874|P1|STARTED|Fourth Tourniquet Right Thigh.|Only the first 4 participants received all four interventions.|4
858243|NCT02592655|2076874|P1|NOT COMPLETED|Third Tourniquet, Left Thigh.||0
858244|NCT02592655|2076874|P1|COMPLETED|Third Tourniquet, Left Thigh.||19
858245|NCT02592655|2076874|P1|Tourniquet Tape 5 cm Width|Third Tourniquet, Left Thigh.||1
858246|NCT02592655|2076874|P1|Tourniquet Tape 10 cm Width|Third Tourniquet, Left Thigh.||6
858247|NCT02592655|2076874|P1|Windlass Tourniquet|Third Tourniquet, Left Thigh.||4
858248|NCT02592655|2076874|P1|ATS (Pneumatic)|Third Tourniquet, Left Thigh.||8
858249|NCT02592655|2076874|P1|STARTED|Third Tourniquet, Left Thigh.||19
858250|NCT02592655|2076874|P1|NOT COMPLETED|Second Tourniquet Right Thigh.||0
858251|NCT02592655|2076874|P1|COMPLETED|Second Tourniquet Right Thigh.||19
858252|NCT02592655|2076874|P1|Tourniquet Tape 5 cm Width|Second Tourniquet Right Thigh.||1
858253|NCT02592655|2076874|P1|Tourniquet Tape 10 cm Width|Second Tourniquet Right Thigh.||5
858254|NCT02592655|2076874|P1|Windlass Tourniquet|Second Tourniquet Right Thigh.||8
858255|NCT02592655|2076874|P1|ATS (Pneumatic)|Second Tourniquet Right Thigh.||5
858256|NCT02592655|2076874|P1|STARTED|Second Tourniquet Right Thigh.||19
858257|NCT02592655|2076874|P1|NOT COMPLETED|First Tourniquet, Left Thigh.||0
858258|NCT02592655|2076874|P1|COMPLETED|First Tourniquet, Left Thigh.||19
858259|NCT02592655|2076874|P1|Tourniquet Tape 5 cm Width|First Tourniquet, Left Thigh.||2
858260|NCT02592655|2076874|P1|Tourniquet Tape 10 cm Width|First Tourniquet, Left Thigh.||5
858261|NCT02592655|2076874|P1|Windlass Tourniquet|First Tourniquet, Left Thigh.||7
858262|NCT02592655|2076874|P1|ATS (Pneumatic)|First Tourniquet, Left Thigh.||5
858263|NCT02592655|2076874|P1|STARTED|First Tourniquet, Left Thigh.||19
858264|NCT02591537|2076891|P2|NOT COMPLETED|Overall Study||0
858265|NCT02591537|2076892|P1|NOT COMPLETED|Overall Study||0
858266|NCT02591537|2076891|P2|COMPLETED|Overall Study||8
858267|NCT02591537|2076892|P1|COMPLETED|Overall Study||8
858268|NCT02591537|2076891|P2|STARTED|Overall Study||8
858269|NCT02591537|2076892|P1|STARTED|Overall Study||8
858270|NCT02591238|2076916|P4|NOT COMPLETED|Overall Study||3
858271|NCT02591238|2076917|P3|NOT COMPLETED|Overall Study||0
858272|NCT02591238|2076918|P2|NOT COMPLETED|Overall Study||1
858273|NCT02591238|2076919|P1|NOT COMPLETED|Overall Study||1
858274|NCT02591238|2076916|P4|COMPLETED|Overall Study||15
858275|NCT02591238|2076917|P3|COMPLETED|Overall Study||17
858276|NCT02591238|2076918|P2|COMPLETED|Overall Study||16
858277|NCT02591238|2076919|P1|COMPLETED|Overall Study||15
858278|NCT02591238|2076916|P4|STARTED|Overall Study||18
858279|NCT02591238|2076917|P3|STARTED|Overall Study||17
858280|NCT02591238|2076918|P2|STARTED|Overall Study||17
858281|NCT02591238|2076919|P1|STARTED|Overall Study||16
858282|NCT02591056|2076949|P1|NOT COMPLETED|Overall Study||0
858283|NCT02591056|2076949|P1|COMPLETED|Overall Study||27
858284|NCT02591056|2076949|P1|STARTED|Overall Study||27
858285|NCT02590588|2076953|P1|NOT COMPLETED|Overall Study||1
858286|NCT02590588|2076953|P1|COMPLETED|Overall Study||0
858287|NCT02590588|2076953|P1|STARTED|Overall Study||1
858288|NCT02590562|2076961|P1|NOT COMPLETED|Overall Study||6
858289|NCT02590562|2076961|P1|COMPLETED|Overall Study||802
858290|NCT02590562|2076961|P1|STARTED|Overall Study||808
858291|NCT02588872|2077020|P2|NOT COMPLETED|Overall Study||0
858292|NCT02588872|2077021|P1|NOT COMPLETED|Overall Study||0
858293|NCT02588872|2077020|P2|COMPLETED|Overall Study||52
858294|NCT02588872|2077021|P1|COMPLETED|Overall Study||59
858295|NCT02588872|2077020|P2|STARTED|Overall Study||52
858296|NCT02588872|2077021|P1|STARTED|Overall Study||59
858297|NCT02588599|2077035|P1|NOT COMPLETED|Overall Study||0
858298|NCT02588599|2077035|P1|COMPLETED|Overall Study||54
858299|NCT02588599|2077035|P1|STARTED|Overall Study||54
858300|NCT02587819|2077040|P1|NOT COMPLETED|Overall Study||2
858301|NCT02587819|2077040|P1|COMPLETED|Overall Study||19
858302|NCT02587819|2077040|P1|Exposed|Overall Study||21
858303|NCT02587819|2077040|P1|STARTED|Overall Study||21
858304|NCT02587234|2077049|P2|NOT COMPLETED|Overall Study||3
858305|NCT02587234|2077050|P1|NOT COMPLETED|Overall Study||1
858306|NCT02587234|2077049|P2|COMPLETED|Overall Study||7
858307|NCT02587234|2077050|P1|COMPLETED|Overall Study||10
858308|NCT02587234|2077049|P2|STARTED|Overall Study||10
858309|NCT02587234|2077050|P1|STARTED|Overall Study||11
858310|NCT02587117|2077062|P2|NOT COMPLETED|Overall Study||0
858311|NCT02587117|2077063|P1|NOT COMPLETED|Overall Study||0
858312|NCT02587117|2077062|P2|COMPLETED|Overall Study||15
858313|NCT02587117|2077063|P1|COMPLETED|Overall Study||13
858314|NCT02587117|2077062|P2|STARTED|Overall Study||15
858315|NCT02587117|2077063|P1|STARTED|Overall Study||13
858319|NCT02586493|2077077|P1|NOT COMPLETED|Overall Study||12
858320|NCT02586493|2077077|P1|COMPLETED|Overall Study||266
858321|NCT02586493|2077077|P1|STARTED|Overall Study||278
858322|NCT02585999|2077083|P1|NOT COMPLETED|Overall Study||2
858415|NCT02578186|2077300|P2|NOT COMPLETED|Period 1 (First of Crossover)||5
858323|NCT02585999|2077083|P1|COMPLETED|Overall Study|28 participants enrolled; 2 withdrew prior to starting, leaving 26 to complete study activity.|26
858324|NCT02585999|2077083|P1|STARTED|Overall Study||28
858325|NCT02585895|2077090|P2|NOT COMPLETED|Post-primary Period||0
858326|NCT02585895|2077091|P1|NOT COMPLETED|Post-primary Period||0
858327|NCT02585895|2077090|P2|COMPLETED|Post-primary Period||19
858328|NCT02585895|2077091|P1|COMPLETED|Post-primary Period||20
858329|NCT02585895|2077090|P2|STARTED|Post-primary Period||19
858330|NCT02585895|2077091|P1|STARTED|Post-primary Period||20
858331|NCT02585895|2077090|P2|NOT COMPLETED|Primary Period||0
858332|NCT02585895|2077091|P1|NOT COMPLETED|Primary Period||0
858333|NCT02585895|2077090|P2|COMPLETED|Primary Period||19
858334|NCT02585895|2077091|P1|COMPLETED|Primary Period||20
858335|NCT02585895|2077090|P2|STARTED|Primary Period||19
858336|NCT02585895|2077091|P1|STARTED|Primary Period||20
858337|NCT02584686|2077108|P2|NOT COMPLETED|Overall Study||0
858338|NCT02584686|2077109|P1|NOT COMPLETED|Overall Study||0
858339|NCT02584686|2077108|P2|COMPLETED|Overall Study||12
858340|NCT02584686|2077109|P1|COMPLETED|Overall Study||12
858341|NCT02584686|2077108|P2|STARTED|Overall Study||12
858342|NCT02584686|2077109|P1|STARTED|Overall Study||12
858343|NCT02584673|2077137|P2|NOT COMPLETED|Overall Study||0
858344|NCT02584673|2077138|P1|NOT COMPLETED|Overall Study||0
858345|NCT02584673|2077137|P2|COMPLETED|Overall Study||15
858346|NCT02584673|2077138|P1|COMPLETED|Overall Study||15
858347|NCT02584673|2077137|P2|STARTED|Overall Study||15
858348|NCT02584673|2077138|P1|STARTED|Overall Study||15
858349|NCT02582983|2077150|P1|NOT COMPLETED|Overall Study||6
858350|NCT02582983|2077150|P1|COMPLETED|Overall Study||17
858351|NCT02582983|2077150|P1|STARTED|Overall Study||23
858352|NCT02582970|2077155|P1|NOT COMPLETED|Overall Study||0
858353|NCT02582970|2077155|P1|COMPLETED|Overall Study||40
858354|NCT02582970|2077155|P1|STARTED|Overall Study||40
858355|NCT02581475|2077167|P2|NOT COMPLETED|Overall Study||15
858356|NCT02581475|2077168|P1|NOT COMPLETED|Overall Study||11
858357|NCT02581475|2077167|P2|COMPLETED|Overall Study||178
858358|NCT02581475|2077168|P1|COMPLETED|Overall Study||182
858359|NCT02581475|2077167|P2|STARTED|Overall Study||193
858360|NCT02581475|2077168|P1|STARTED|Overall Study||193
858361|NCT02581410|2077182|P2|NOT COMPLETED|Overall Study||3
858362|NCT02581410|2077183|P1|NOT COMPLETED|Overall Study||2
858363|NCT02581410|2077182|P2|COMPLETED|Overall Study||212
858364|NCT02581410|2077183|P1|COMPLETED|Overall Study||213
858365|NCT02581410|2077182|P2|STARTED|Overall Study||215
858366|NCT02581410|2077183|P1|STARTED|Overall Study||215
858367|NCT02580799|2077203|P1|NOT COMPLETED|Overall Study||0
858368|NCT02580799|2077203|P1|COMPLETED|Overall Study||30
858369|NCT02580799|2077203|P1|STARTED|Overall Study||30
858370|NCT02580357|2077228|P3|NOT COMPLETED|Overall Study||0
858371|NCT02580357|2077229|P2|NOT COMPLETED|Overall Study||0
858372|NCT02580357|2077230|P1|NOT COMPLETED|Overall Study||3
858373|NCT02580357|2077228|P3|COMPLETED|Overall Study||18
858374|NCT02580357|2077229|P2|COMPLETED|Overall Study||18
858375|NCT02580357|2077230|P1|COMPLETED|Overall Study||15
858376|NCT02580357|2077228|P3|STARTED|Overall Study||18
858377|NCT02580357|2077229|P2|STARTED|Overall Study||18
858378|NCT02580357|2077230|P1|STARTED|Overall Study||18
858379|NCT02580318|2077241|P1|NOT COMPLETED|Overall Study||0
858380|NCT02580318|2077241|P1|COMPLETED|Overall Study||54
858381|NCT02580318|2077241|P1|Drinking Water (5 Minutes)|Overall Study||54
858382|NCT02580318|2077241|P1|Drinking Water (Immediate)|Overall Study||51
858383|NCT02580318|2077241|P1|Hyperventilation (10 Minutes)|Overall Study||54
858384|NCT02580318|2077241|P1|Hyperventilation (5 Minutes)|Overall Study||54
858385|NCT02580318|2077241|P1|Hyperventilation (Immediate)|Overall Study||54
858386|NCT02580318|2077241|P1|Poor Effort|Overall Study||53
858387|NCT02580318|2077241|P1|STARTED|Overall Study||54
858388|NCT02580240|2077247|P2|NOT COMPLETED|Overall Study||0
858389|NCT02580240|2077248|P1|NOT COMPLETED|Overall Study||2
858390|NCT02580240|2077247|P2|COMPLETED|Overall Study||58
858391|NCT02580240|2077248|P1|COMPLETED|Overall Study||60
858392|NCT02580240|2077247|P2|STARTED|Overall Study||58
858393|NCT02580240|2077248|P1|STARTED|Overall Study||62
858394|NCT02578992|2077258|P2|NOT COMPLETED|Overall Study||3
858395|NCT02578992|2077259|P1|NOT COMPLETED|Overall Study||3
858396|NCT02578992|2077258|P2|COMPLETED|Overall Study|October 2015|62
858397|NCT02578992|2077259|P1|COMPLETED|Overall Study|October 2015|62
858398|NCT02578992|2077258|P2|STARTED|Overall Study|November 2014|65
858399|NCT02578992|2077259|P1|STARTED|Overall Study|November 2014|65
858400|NCT02578316|2077271|P1|NOT COMPLETED|Extension Phase||6
858401|NCT02578316|2077271|P1|COMPLETED|Extension Phase||0
858402|NCT02578316|2077271|P1|STARTED|Extension Phase||6
858403|NCT02578316|2077271|P1|NOT COMPLETED|Study Phase||0
858404|NCT02578316|2077271|P1|COMPLETED|Study Phase||6
858405|NCT02578316|2077271|P1|STARTED|Study Phase||6
858406|NCT02578199|2077295|P1|NOT COMPLETED|Overall Study||4
858407|NCT02578199|2077295|P1|COMPLETED|Overall Study||27
858408|NCT02578199|2077295|P1|STARTED|Overall Study||31
858409|NCT02578186|2077300|P2|NOT COMPLETED|Period 2 (Second of Crossover)||0
858410|NCT02578186|2077301|P1|NOT COMPLETED|Period 2 (Second of Crossover)||0
858411|NCT02578186|2077300|P2|COMPLETED|Period 2 (Second of Crossover)||13
858412|NCT02578186|2077301|P1|COMPLETED|Period 2 (Second of Crossover)||12
858413|NCT02578186|2077300|P2|STARTED|Period 2 (Second of Crossover)||13
858414|NCT02578186|2077301|P1|STARTED|Period 2 (Second of Crossover)||12
858416|NCT02578186|2077301|P1|NOT COMPLETED|Period 1 (First of Crossover)||5
858417|NCT02578186|2077300|P2|COMPLETED|Period 1 (First of Crossover)||13
858418|NCT02578186|2077301|P1|COMPLETED|Period 1 (First of Crossover)||12
858419|NCT02578186|2077300|P2|STARTED|Period 1 (First of Crossover)||18
858420|NCT02578186|2077301|P1|STARTED|Period 1 (First of Crossover)||17
858421|NCT02577510|2077307|P2|NOT COMPLETED|Overall Study||0
858422|NCT02577510|2077308|P1|NOT COMPLETED|Overall Study||0
858423|NCT02577510|2077307|P2|COMPLETED|Overall Study||21
858424|NCT02577510|2077308|P1|COMPLETED|Overall Study||21
858425|NCT02577510|2077307|P2|STARTED|Overall Study||21
858426|NCT02577510|2077308|P1|STARTED|Overall Study||21
858427|NCT02577445|2077322|P2|NOT COMPLETED|Overall Study||17
858428|NCT02577445|2077323|P1|NOT COMPLETED|Overall Study||14
858429|NCT02577445|2077322|P2|COMPLETED|Overall Study|study terminated prematurely|0
858430|NCT02577445|2077323|P1|COMPLETED|Overall Study|study terminated prematurely|0
858431|NCT02577445|2077322|P2|STARTED|Overall Study||17
858432|NCT02577445|2077323|P1|STARTED|Overall Study||14
858433|NCT02577315|2077336|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
858434|NCT02577315|2077337|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
858435|NCT02577315|2077336|P2|COMPLETED|Treatment Period 2 (4 Days)||12
858436|NCT02577315|2077337|P1|COMPLETED|Treatment Period 2 (4 Days)||12
858437|NCT02577315|2077336|P2|STARTED|Treatment Period 2 (4 Days)||12
858438|NCT02577315|2077337|P1|STARTED|Treatment Period 2 (4 Days)||12
858439|NCT02577315|2077336|P2|NOT COMPLETED|Washout Period (5 Days)||0
858440|NCT02577315|2077337|P1|NOT COMPLETED|Washout Period (5 Days)||0
858441|NCT02577315|2077336|P2|COMPLETED|Washout Period (5 Days)||12
858442|NCT02577315|2077337|P1|COMPLETED|Washout Period (5 Days)||12
858443|NCT02577315|2077336|P2|STARTED|Washout Period (5 Days)||12
858444|NCT02577315|2077337|P1|STARTED|Washout Period (5 Days)||12
858445|NCT02577315|2077336|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||1
858446|NCT02577315|2077337|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
858447|NCT02577315|2077336|P2|COMPLETED|Treatment Period 1 (4 Days)||12
858448|NCT02577315|2077337|P1|COMPLETED|Treatment Period 1 (4 Days)||12
858449|NCT02577315|2077336|P2|STARTED|Treatment Period 1 (4 Days)||13
858450|NCT02577315|2077337|P1|STARTED|Treatment Period 1 (4 Days)||12
858451|NCT02576639|2077358|P5|NOT COMPLETED|Overall Study||4
858452|NCT02576639|2077359|P4|NOT COMPLETED|Overall Study||1
858453|NCT02576639|2077360|P3|NOT COMPLETED|Overall Study||2
858454|NCT02576639|2077361|P2|NOT COMPLETED|Overall Study||2
858455|NCT02576639|2077362|P1|NOT COMPLETED|Overall Study||2
858456|NCT02576639|2077358|P5|COMPLETED|Overall Study||20
858457|NCT02576639|2077359|P4|COMPLETED|Overall Study||25
858458|NCT02576639|2077360|P3|COMPLETED|Overall Study||23
858459|NCT02576639|2077361|P2|COMPLETED|Overall Study||23
858460|NCT02576639|2077362|P1|COMPLETED|Overall Study||22
858461|NCT02576639|2077358|P5|Safety Analysis Set|Overall Study||24
858462|NCT02576639|2077359|P4|Safety Analysis Set|Overall Study||26
858463|NCT02576639|2077360|P3|Safety Analysis Set|Overall Study||25
858464|NCT02576639|2077361|P2|Safety Analysis Set|Overall Study||25
858465|NCT02576639|2077362|P1|Safety Analysis Set|Overall Study||24
858466|NCT02576639|2077358|P5|Pharmacokinetic Analysis Set|Overall Study||24
858467|NCT02576639|2077359|P4|Pharmacokinetic Analysis Set|Overall Study||26
858468|NCT02576639|2077360|P3|Pharmacokinetic Analysis Set|Overall Study||25
858469|NCT02576639|2077361|P2|Pharmacokinetic Analysis Set|Overall Study||25
858470|NCT02576639|2077362|P1|Pharmacokinetic Analysis Set|Overall Study||0
858471|NCT02576639|2077358|P5|Pharmacodynamic Analysis Set|Overall Study||25
858472|NCT02576639|2077359|P4|Pharmacodynamic Analysis Set|Overall Study||25
858473|NCT02576639|2077360|P3|Pharmacodynamic Analysis Set|Overall Study||25
858474|NCT02576639|2077361|P2|Pharmacodynamic Analysis Set|Overall Study||24
858475|NCT02576639|2077362|P1|Pharmacodynamic Analysis Set|Overall Study||24
858476|NCT02576639|2077358|P5|STARTED|Overall Study||24
858477|NCT02576639|2077359|P4|STARTED|Overall Study||26
858478|NCT02576639|2077360|P3|STARTED|Overall Study||25
858479|NCT02576639|2077361|P2|STARTED|Overall Study||25
858480|NCT02576639|2077362|P1|STARTED|Overall Study||24
858481|NCT02576535|2077419|P1|NOT COMPLETED|Overall Study||2
858482|NCT02576535|2077419|P1|COMPLETED|Overall Study||16
858483|NCT02576535|2077419|P1|STARTED|Overall Study||18
858484|NCT02576249|2077430|P2|NOT COMPLETED|Overall Study||0
858485|NCT02576249|2077431|P1|NOT COMPLETED|Overall Study||0
858486|NCT02576249|2077430|P2|COMPLETED|Overall Study||14
858487|NCT02576249|2077431|P1|COMPLETED|Overall Study||15
858488|NCT02576249|2077430|P2|STARTED|Overall Study||14
858489|NCT02576249|2077431|P1|STARTED|Overall Study||15
858490|NCT02576145|2077443|P2|NOT COMPLETED|Overall Study||1
858491|NCT02576145|2077444|P1|NOT COMPLETED|Overall Study||3
858492|NCT02576145|2077443|P2|COMPLETED|Overall Study||4
858493|NCT02576145|2077444|P1|COMPLETED|Overall Study||3
858494|NCT02576145|2077443|P2|STARTED|Overall Study||5
858495|NCT02576145|2077444|P1|STARTED|Overall Study||6
858496|NCT02576041|2077480|P1|NOT COMPLETED|Bilastine (Active Treatement)||0
858497|NCT02576041|2077480|P1|COMPLETED|Bilastine (Active Treatement)||18
858498|NCT02576041|2077480|P1|STARTED|Bilastine (Active Treatement)||18
858499|NCT02576041|2077480|P1|NOT COMPLETED|Placebo (run-in)||0
858500|NCT02576041|2077480|P1|COMPLETED|Placebo (run-in)||18
858501|NCT02576041|2077480|P1|STARTED|Placebo (run-in)||18
858502|NCT02575911|2077486|P1|NOT COMPLETED|Overall Study||1
858503|NCT02575911|2077486|P1|COMPLETED|Overall Study||29
858504|NCT02575911|2077486|P1|STARTED|Overall Study||30
858505|NCT02574845|2077510|P6|NOT COMPLETED|Overall Study||1
858506|NCT02574845|2077511|P5|NOT COMPLETED|Overall Study||1
858507|NCT02574845|2077512|P4|NOT COMPLETED|Overall Study||0
858508|NCT02574845|2077513|P3|NOT COMPLETED|Overall Study||0
858509|NCT02574845|2077514|P2|NOT COMPLETED|Overall Study||1
858510|NCT02574845|2077515|P1|NOT COMPLETED|Overall Study||0
858511|NCT02574845|2077510|P6|COMPLETED|Overall Study||2
858512|NCT02574845|2077511|P5|COMPLETED|Overall Study||2
858513|NCT02574845|2077512|P4|COMPLETED|Overall Study||3
858514|NCT02574845|2077513|P3|COMPLETED|Overall Study||3
858515|NCT02574845|2077514|P2|COMPLETED|Overall Study||2
858516|NCT02574845|2077515|P1|COMPLETED|Overall Study||3
858517|NCT02574845|2077510|P6|Received R|Overall Study||3
858518|NCT02574845|2077511|P5|Received R|Overall Study||2
858519|NCT02574845|2077512|P4|Received R|Overall Study||3
858520|NCT02574845|2077513|P3|Received R|Overall Study||3
858521|NCT02574845|2077514|P2|Received R|Overall Study||2
858522|NCT02574845|2077515|P1|Received R|Overall Study||3
858523|NCT02574845|2077510|P6|Received T5|Overall Study||2
858524|NCT02574845|2077511|P5|Received T5|Overall Study||3
858525|NCT02574845|2077512|P4|Received T5|Overall Study||3
858526|NCT02574845|2077513|P3|Received T5|Overall Study||3
858527|NCT02574845|2077514|P2|Received T5|Overall Study||2
858528|NCT02574845|2077515|P1|Received T5|Overall Study||3
858529|NCT02574845|2077510|P6|Received T4|Overall Study||2
858530|NCT02574845|2077511|P5|Received T4|Overall Study||2
858531|NCT02574845|2077512|P4|Received T4|Overall Study||3
858532|NCT02574845|2077513|P3|Received T4|Overall Study||3
858533|NCT02574845|2077514|P2|Received T4|Overall Study||2
858534|NCT02574845|2077515|P1|Received T4|Overall Study||3
858535|NCT02574845|2077510|P6|Received T3|Overall Study||3
858536|NCT02574845|2077511|P5|Received T3|Overall Study||2
858537|NCT02574845|2077512|P4|Received T3|Overall Study||3
858538|NCT02574845|2077513|P3|Received T3|Overall Study||3
858539|NCT02574845|2077514|P2|Received T3|Overall Study||2
858540|NCT02574845|2077515|P1|Received T3|Overall Study|one subject missed treatment period 2|2
858541|NCT02574845|2077510|P6|Received T2|Overall Study||3
858542|NCT02574845|2077511|P5|Received T2|Overall Study||2
858543|NCT02574845|2077512|P4|Received T2|Overall Study||3
858544|NCT02574845|2077513|P3|Received T2|Overall Study||3
858545|NCT02574845|2077514|P2|Received T2|Overall Study||3
858546|NCT02574845|2077515|P1|Received T2|Overall Study||3
858547|NCT02574845|2077510|P6|Received T1|Overall Study|one subject missed treatment period 2|2
858548|NCT02574845|2077511|P5|Received T1|Overall Study||2
858549|NCT02574845|2077512|P4|Received T1|Overall Study||3
858550|NCT02574845|2077513|P3|Received T1|Overall Study||3
858551|NCT02574845|2077514|P2|Received T1|Overall Study||2
858552|NCT02574845|2077515|P1|Received T1|Overall Study||3
858553|NCT02574845|2077510|P6|STARTED|Overall Study||3
858554|NCT02574845|2077511|P5|STARTED|Overall Study||3
858555|NCT02574845|2077512|P4|STARTED|Overall Study||3
858556|NCT02574845|2077513|P3|STARTED|Overall Study||3
858557|NCT02574845|2077514|P2|STARTED|Overall Study||3
858558|NCT02574845|2077515|P1|STARTED|Overall Study||3
858559|NCT02574260|2077541|P1|NOT COMPLETED|Overall Study||1
858560|NCT02574260|2077541|P1|COMPLETED|Overall Study||2
858561|NCT02574260|2077541|P1|STARTED|Overall Study||3
858562|NCT02573870|2077549|P2|NOT COMPLETED|Overall Study||7
858563|NCT02573870|2077550|P1|NOT COMPLETED|Overall Study||0
858564|NCT02573870|2077549|P2|COMPLETED|Overall Study||35
858565|NCT02573870|2077550|P1|COMPLETED|Overall Study||20
858566|NCT02573870|2077549|P2|STARTED|Overall Study||42
858567|NCT02573870|2077550|P1|STARTED|Overall Study||20
858568|NCT02572752|2077559|P3|NOT COMPLETED|Period 3 Including Washout||0
858569|NCT02572752|2077560|P2|NOT COMPLETED|Period 3 Including Washout||0
858570|NCT02572752|2077561|P1|NOT COMPLETED|Period 3 Including Washout||0
858571|NCT02572752|2077559|P3|COMPLETED|Period 3 Including Washout||24
858572|NCT02572752|2077560|P2|COMPLETED|Period 3 Including Washout||23
858573|NCT02572752|2077561|P1|COMPLETED|Period 3 Including Washout||23
858574|NCT02572752|2077559|P3|STARTED|Period 3 Including Washout||24
858575|NCT02572752|2077560|P2|STARTED|Period 3 Including Washout||23
858576|NCT02572752|2077561|P1|STARTED|Period 3 Including Washout||23
858577|NCT02572752|2077559|P3|NOT COMPLETED|Period 2 Including Washout||0
858578|NCT02572752|2077560|P2|NOT COMPLETED|Period 2 Including Washout||0
858579|NCT02572752|2077561|P1|NOT COMPLETED|Period 2 Including Washout||0
858580|NCT02572752|2077559|P3|COMPLETED|Period 2 Including Washout||24
858581|NCT02572752|2077560|P2|COMPLETED|Period 2 Including Washout||23
858582|NCT02572752|2077561|P1|COMPLETED|Period 2 Including Washout||23
858583|NCT02572752|2077559|P3|STARTED|Period 2 Including Washout||24
858584|NCT02572752|2077560|P2|STARTED|Period 2 Including Washout||23
858585|NCT02572752|2077561|P1|STARTED|Period 2 Including Washout||23
858586|NCT02572752|2077559|P3|NOT COMPLETED|Period 1 Including Washout||0
858587|NCT02572752|2077560|P2|NOT COMPLETED|Period 1 Including Washout||0
858588|NCT02572752|2077561|P1|NOT COMPLETED|Period 1 Including Washout||0
858589|NCT02572752|2077559|P3|COMPLETED|Period 1 Including Washout||24
858590|NCT02572752|2077560|P2|COMPLETED|Period 1 Including Washout||23
858591|NCT02572752|2077561|P1|COMPLETED|Period 1 Including Washout||23
858592|NCT02572752|2077559|P3|STARTED|Period 1 Including Washout||24
858593|NCT02572752|2077560|P2|STARTED|Period 1 Including Washout||23
858594|NCT02572752|2077561|P1|STARTED|Period 1 Including Washout||23
858595|NCT02572609|2077576|P2|NOT COMPLETED|Period 2: Treatment Period 2||0
858596|NCT02572609|2077577|P1|NOT COMPLETED|Period 2: Treatment Period 2||0
858597|NCT02572609|2077576|P2|COMPLETED|Period 2: Treatment Period 2||18
858598|NCT02572609|2077577|P1|COMPLETED|Period 2: Treatment Period 2||18
858599|NCT02572609|2077576|P2|STARTED|Period 2: Treatment Period 2||18
858600|NCT02572609|2077577|P1|STARTED|Period 2: Treatment Period 2||18
858601|NCT02572609|2077576|P2|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
858602|NCT02572609|2077577|P1|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
858603|NCT02572609|2077576|P2|COMPLETED|Period 1: Treatment Period 1 + Washout||18
858604|NCT02572609|2077577|P1|COMPLETED|Period 1: Treatment Period 1 + Washout||18
858605|NCT02572609|2077576|P2|STARTED|Period 1: Treatment Period 1 + Washout||18
858606|NCT02572609|2077577|P1|STARTED|Period 1: Treatment Period 1 + Washout||18
858607|NCT02572427|2077587|P2|NOT COMPLETED|Overall Study||9
858608|NCT02572427|2077588|P1|NOT COMPLETED|Overall Study||6
858609|NCT02572427|2077587|P2|COMPLETED|Overall Study||36
858610|NCT02572427|2077588|P1|COMPLETED|Overall Study||31
858611|NCT02572427|2077587|P2|STARTED|Overall Study||45
858612|NCT02572427|2077588|P1|STARTED|Overall Study||37
858613|NCT02571634|2077596|P1|NOT COMPLETED|Overall Study||0
858614|NCT02571634|2077596|P1|COMPLETED|Overall Study|The final subject was enrolled on this date.|23
858615|NCT02571634|2077596|P1|STARTED|Overall Study|First subject wasn't enrolled until July related to receipt of medications from sponsor.|23
858616|NCT02571153|2077607|P3|NOT COMPLETED|Overall Study||2
858617|NCT02571153|2077608|P2|NOT COMPLETED|Overall Study||8
858618|NCT02571153|2077609|P1|NOT COMPLETED|Overall Study||6
858619|NCT02571153|2077607|P3|COMPLETED|Overall Study||43
858620|NCT02571153|2077608|P2|COMPLETED|Overall Study||37
858621|NCT02571153|2077609|P1|COMPLETED|Overall Study||39
858622|NCT02571153|2077607|P3|STARTED|Overall Study||45
858623|NCT02571153|2077608|P2|STARTED|Overall Study||45
858624|NCT02571153|2077609|P1|STARTED|Overall Study||45
858625|NCT02570425|2077637|P2|NOT COMPLETED|Visit 3||0
858626|NCT02570425|2077638|P1|NOT COMPLETED|Visit 3||0
858627|NCT02570425|2077637|P2|COMPLETED|Visit 3||231
858628|NCT02570425|2077638|P1|COMPLETED|Visit 3||229
858629|NCT02570425|2077637|P2|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|231
858630|NCT02570425|2077638|P1|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|229
858631|NCT02570425|2077637|P2|NOT COMPLETED|Visit 2||0
858632|NCT02570425|2077638|P1|NOT COMPLETED|Visit 2||0
858633|NCT02570425|2077637|P2|COMPLETED|Visit 2||247
858634|NCT02570425|2077638|P1|COMPLETED|Visit 2||251
858635|NCT02570425|2077637|P2|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|247
858636|NCT02570425|2077638|P1|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|251
858637|NCT02570425|2077637|P2|NOT COMPLETED|Visit 1||0
858638|NCT02570425|2077638|P1|NOT COMPLETED|Visit 1||0
858639|NCT02570425|2077637|P2|COMPLETED|Visit 1||242
858640|NCT02570425|2077638|P1|COMPLETED|Visit 1||274
858641|NCT02570425|2077637|P2|STARTED|Visit 1||242
858642|NCT02570425|2077638|P1|STARTED|Visit 1||274
858643|NCT02570295|2077687|P2|NOT COMPLETED|Overall Study||58
858644|NCT02570295|2077688|P1|NOT COMPLETED|Overall Study||11
858645|NCT02570295|2077687|P2|COMPLETED|Overall Study||289
858646|NCT02570295|2077688|P1|COMPLETED|Overall Study||364
858647|NCT02570295|2077687|P2|STARTED|Overall Study||347
858648|NCT02570295|2077688|P1|STARTED|Overall Study||375
858649|NCT02570165|2077717|P7|NOT COMPLETED|Overall Study||0
858650|NCT02570165|2077718|P6|NOT COMPLETED|Overall Study||2
858651|NCT02570165|2077719|P5|NOT COMPLETED|Overall Study||6
858652|NCT02570165|2077720|P4|NOT COMPLETED|Overall Study||5
858653|NCT02570165|2077721|P3|NOT COMPLETED|Overall Study||5
858654|NCT02570165|2077722|P2|NOT COMPLETED|Overall Study||3
858655|NCT02570165|2077723|P1|NOT COMPLETED|Overall Study||2
858656|NCT02570165|2077717|P7|COMPLETED|Overall Study||47
858657|NCT02570165|2077718|P6|COMPLETED|Overall Study||44
858658|NCT02570165|2077719|P5|COMPLETED|Overall Study||41
858659|NCT02570165|2077720|P4|COMPLETED|Overall Study||40
858660|NCT02570165|2077721|P3|COMPLETED|Overall Study||41
858661|NCT02570165|2077722|P2|COMPLETED|Overall Study||43
858662|NCT02570165|2077723|P1|COMPLETED|Overall Study||44
858663|NCT02570165|2077717|P7|STARTED|Overall Study||47
858664|NCT02570165|2077718|P6|STARTED|Overall Study||46
858665|NCT02570165|2077719|P5|STARTED|Overall Study||47
858666|NCT02570165|2077720|P4|STARTED|Overall Study||45
858667|NCT02570165|2077721|P3|STARTED|Overall Study||46
858668|NCT02570165|2077722|P2|STARTED|Overall Study||46
858669|NCT02570165|2077723|P1|STARTED|Overall Study||46
858670|NCT02570022|2077748|P2|NOT COMPLETED|Overall Study||0
858671|NCT02570022|2077749|P1|NOT COMPLETED|Overall Study||0
858672|NCT02570022|2077748|P2|COMPLETED|Overall Study||31
858673|NCT02570022|2077749|P1|COMPLETED|Overall Study||26
858674|NCT02570022|2077748|P2|STARTED|Overall Study||31
858675|NCT02570022|2077749|P1|STARTED|Overall Study||26
858676|NCT02569996|2077757|P1|NOT COMPLETED|Overall Study||55
858677|NCT02569996|2077757|P1|COMPLETED|Overall Study||69
858678|NCT02569996|2077757|P1|STARTED|Overall Study||124
858679|NCT02569658|2077769|P2|NOT COMPLETED|Overall Study||1
858680|NCT02569658|2077770|P1|NOT COMPLETED|Overall Study||1
858681|NCT02569658|2077769|P2|COMPLETED|Overall Study||56
858682|NCT02569658|2077770|P1|COMPLETED|Overall Study||52
858683|NCT02569658|2077769|P2|STARTED|Overall Study||57
858684|NCT02569658|2077770|P1|STARTED|Overall Study||53
858685|NCT02568852|2077788|P2|NOT COMPLETED|Overall Study||0
858686|NCT02568852|2077789|P1|NOT COMPLETED|Overall Study||0
858687|NCT02568852|2077788|P2|COMPLETED|Overall Study||25
858688|NCT02568852|2077789|P1|COMPLETED|Overall Study||25
858689|NCT02568852|2077788|P2|STARTED|Overall Study||25
858690|NCT02568852|2077789|P1|STARTED|Overall Study||25
858691|NCT02568384|2077825|P1|NOT COMPLETED|Overall Study||2
858692|NCT02568384|2077825|P1|COMPLETED|Overall Study||43
858693|NCT02568384|2077825|P1|STARTED|Overall Study||45
858694|NCT02568345|2077835|P1|NOT COMPLETED|Overall Study||0
858695|NCT02568345|2077835|P1|COMPLETED|Overall Study||31
858696|NCT02568345|2077835|P1|Treated at 2.6 mg/kg|Overall Study|Patients: 8th-10th|3
858697|NCT02568345|2077835|P1|Treated at 2.4 mg/kg|Overall Study|Patients: 1st-5th; 7th; 11th-15th; 21st-25th; 27th-31st|25
858698|NCT02568345|2077835|P1|Treated at 2.2 mg/kg|Overall Study|patients: 6th, 20th, 26th|3
858699|NCT02568345|2077835|P1|STARTED|Overall Study||31
858700|NCT02568254|2077839|P6|NOT COMPLETED|Period 3||0
858701|NCT02568254|2077840|P5|NOT COMPLETED|Period 3||1
858702|NCT02568254|2077841|P4|NOT COMPLETED|Period 3||0
858703|NCT02568254|2077842|P3|NOT COMPLETED|Period 3||0
858704|NCT02568254|2077843|P2|NOT COMPLETED|Period 3||0
858705|NCT02568254|2077844|P1|NOT COMPLETED|Period 3||0
858706|NCT02568254|2077839|P6|COMPLETED|Period 3||12
858707|NCT02568254|2077840|P5|COMPLETED|Period 3||11
858708|NCT02568254|2077841|P4|COMPLETED|Period 3||12
858709|NCT02568254|2077842|P3|COMPLETED|Period 3||12
858710|NCT02568254|2077843|P2|COMPLETED|Period 3||12
858711|NCT02568254|2077844|P1|COMPLETED|Period 3||13
858712|NCT02568254|2077839|P6|STARTED|Period 3||12
858713|NCT02568254|2077840|P5|STARTED|Period 3||12
858714|NCT02568254|2077841|P4|STARTED|Period 3||12
858715|NCT02568254|2077842|P3|STARTED|Period 3||12
858716|NCT02568254|2077843|P2|STARTED|Period 3||12
858717|NCT02568254|2077844|P1|STARTED|Period 3||13
858718|NCT02568254|2077839|P6|NOT COMPLETED|Period 2||0
858719|NCT02568254|2077840|P5|NOT COMPLETED|Period 2||0
858720|NCT02568254|2077841|P4|NOT COMPLETED|Period 2||0
858721|NCT02568254|2077842|P3|NOT COMPLETED|Period 2||1
858722|NCT02568254|2077843|P2|NOT COMPLETED|Period 2||0
858723|NCT02568254|2077844|P1|NOT COMPLETED|Period 2||0
858724|NCT02568254|2077839|P6|COMPLETED|Period 2||12
858725|NCT02568254|2077840|P5|COMPLETED|Period 2||12
858726|NCT02568254|2077841|P4|COMPLETED|Period 2||12
858727|NCT02568254|2077842|P3|COMPLETED|Period 2||12
858728|NCT02568254|2077843|P2|COMPLETED|Period 2||12
858729|NCT02568254|2077844|P1|COMPLETED|Period 2||13
858730|NCT02568254|2077839|P6|STARTED|Period 2||12
858731|NCT02568254|2077840|P5|STARTED|Period 2||12
858732|NCT02568254|2077841|P4|STARTED|Period 2||12
858733|NCT02568254|2077842|P3|STARTED|Period 2||13
858734|NCT02568254|2077843|P2|STARTED|Period 2||12
858735|NCT02568254|2077844|P1|STARTED|Period 2||13
858736|NCT02568254|2077839|P6|NOT COMPLETED|Period 1||0
858737|NCT02568254|2077840|P5|NOT COMPLETED|Period 1||0
858738|NCT02568254|2077841|P4|NOT COMPLETED|Period 1||0
858739|NCT02568254|2077842|P3|NOT COMPLETED|Period 1||0
858740|NCT02568254|2077843|P2|NOT COMPLETED|Period 1||0
858741|NCT02568254|2077844|P1|NOT COMPLETED|Period 1||0
858742|NCT02568254|2077839|P6|COMPLETED|Period 1||12
858743|NCT02568254|2077840|P5|COMPLETED|Period 1||12
858744|NCT02568254|2077841|P4|COMPLETED|Period 1||12
858745|NCT02568254|2077842|P3|COMPLETED|Period 1||13
858746|NCT02568254|2077843|P2|COMPLETED|Period 1||12
858747|NCT02568254|2077844|P1|COMPLETED|Period 1||13
858748|NCT02568254|2077839|P6|STARTED|Period 1||12
858749|NCT02568254|2077840|P5|STARTED|Period 1||12
858750|NCT02568254|2077841|P4|STARTED|Period 1||12
858751|NCT02568254|2077842|P3|STARTED|Period 1||13
858752|NCT02568254|2077843|P2|STARTED|Period 1||12
858753|NCT02568254|2077844|P1|STARTED|Period 1||13
858754|NCT02567188|2077852|P1|NOT COMPLETED|Overall Study||35
858755|NCT02567188|2077852|P1|COMPLETED|Overall Study||109
858756|NCT02567188|2077852|P1|STARTED|Overall Study||144
858757|NCT02565628|2077883|P2|NOT COMPLETED|Overall Study||0
858758|NCT02565628|2077884|P1|NOT COMPLETED|Overall Study||0
858759|NCT02565628|2077883|P2|COMPLETED|Overall Study||9
858760|NCT02565628|2077884|P1|COMPLETED|Overall Study||10
858761|NCT02565628|2077883|P2|Received Treatment|Overall Study||9
858762|NCT02565628|2077884|P1|Received Treatment|Overall Study||10
858763|NCT02565628|2077883|P2|STARTED|Overall Study||9
858764|NCT02565628|2077884|P1|STARTED|Overall Study||10
858765|NCT02565381|2077915|P3|NOT COMPLETED|Overall Study||1
858766|NCT02565381|2077916|P2|NOT COMPLETED|Overall Study||0
858767|NCT02565381|2077917|P1|NOT COMPLETED|Overall Study||1
858768|NCT02565381|2077915|P3|COMPLETED|Overall Study||24
858769|NCT02565381|2077916|P2|COMPLETED|Overall Study||25
858770|NCT02565381|2077917|P1|COMPLETED|Overall Study||24
858771|NCT02565381|2077915|P3|STARTED|Overall Study||25
858772|NCT02565381|2077916|P2|STARTED|Overall Study||25
858773|NCT02565381|2077917|P1|STARTED|Overall Study||25
858774|NCT02563834|2077957|P2|NOT COMPLETED|Insulin Infusion (*Day 2)||0
858775|NCT02563834|2077958|P1|NOT COMPLETED|Insulin Infusion (*Day 2)||0
858776|NCT02563834|2077957|P2|COMPLETED|Insulin Infusion (*Day 2)||8
858777|NCT02563834|2077958|P1|COMPLETED|Insulin Infusion (*Day 2)||10
858778|NCT02563834|2077957|P2|STARTED|Insulin Infusion (*Day 2)||8
858779|NCT02563834|2077958|P1|STARTED|Insulin Infusion (*Day 2)||10
858780|NCT02563834|2077957|P2|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
858781|NCT02563834|2077958|P1|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
858782|NCT02563834|2077957|P2|COMPLETED|Control (Saline) Infusion (*Day 1)||8
858783|NCT02563834|2077958|P1|COMPLETED|Control (Saline) Infusion (*Day 1)||10
858784|NCT02563834|2077957|P2|STARTED|Control (Saline) Infusion (*Day 1)||8
858785|NCT02563834|2077958|P1|STARTED|Control (Saline) Infusion (*Day 1)||10
858786|NCT02563093|2077978|P4|NOT COMPLETED|Overall Study||0
858787|NCT02563093|2077979|P3|NOT COMPLETED|Overall Study||0
858788|NCT02563093|2077980|P2|NOT COMPLETED|Overall Study||0
858789|NCT02563093|2077981|P1|NOT COMPLETED|Overall Study||0
858790|NCT02563093|2077978|P4|COMPLETED|Overall Study||51
858791|NCT02563093|2077979|P3|COMPLETED|Overall Study||53
858792|NCT02563093|2077980|P2|COMPLETED|Overall Study||52
858793|NCT02563093|2077981|P1|COMPLETED|Overall Study||52
858794|NCT02563093|2077978|P4|STARTED|Overall Study||51
858795|NCT02563093|2077979|P3|STARTED|Overall Study||53
858796|NCT02563093|2077980|P2|STARTED|Overall Study||52
858797|NCT02563093|2077981|P1|STARTED|Overall Study||52
858798|NCT02561572|2078009|P2|NOT COMPLETED|Overall Study||2
858799|NCT02561572|2078010|P1|NOT COMPLETED|Overall Study||2
858800|NCT02561572|2078009|P2|COMPLETED|Overall Study||62
858801|NCT02561572|2078010|P1|COMPLETED|Overall Study||62
858802|NCT02561572|2078009|P2|STARTED|Overall Study||64
858803|NCT02561572|2078010|P1|STARTED|Overall Study||64
858804|NCT02559622|2078030|P4|NOT COMPLETED|Overall Study||3
858805|NCT02559622|2078031|P3|NOT COMPLETED|Overall Study||2
858806|NCT02559622|2078032|P2|NOT COMPLETED|Overall Study||5
858807|NCT02559622|2078033|P1|NOT COMPLETED|Overall Study||1
858808|NCT02559622|2078030|P4|COMPLETED|Overall Study||20
858809|NCT02559622|2078031|P3|COMPLETED|Overall Study||24
858810|NCT02559622|2078032|P2|COMPLETED|Overall Study||49
858811|NCT02559622|2078033|P1|COMPLETED|Overall Study||47
858812|NCT02559622|2078030|P4|STARTED|Overall Study||23
858813|NCT02559622|2078031|P3|STARTED|Overall Study||26
858814|NCT02559622|2078032|P2|STARTED|Overall Study||54
858815|NCT02559622|2078033|P1|STARTED|Overall Study||48
858816|NCT02559414|2078115|P3|NOT COMPLETED|Overall Study||2
858817|NCT02559414|2078116|P2|NOT COMPLETED|Overall Study||2
858818|NCT02559414|2078117|P1|NOT COMPLETED|Overall Study||1
858819|NCT02559414|2078115|P3|COMPLETED|Overall Study||20
858820|NCT02559414|2078116|P2|COMPLETED|Overall Study||20
858821|NCT02559414|2078117|P1|COMPLETED|Overall Study||10
858822|NCT02559414|2078115|P3|STARTED|Overall Study||22
858823|NCT02559414|2078116|P2|STARTED|Overall Study||22
858824|NCT02559414|2078117|P1|STARTED|Overall Study||11
858825|NCT02557698|2078139|P2|NOT COMPLETED|Overall Study||0
858826|NCT02557698|2078140|P1|NOT COMPLETED|Overall Study||0
858827|NCT02557698|2078139|P2|COMPLETED|Overall Study||30
858828|NCT02557698|2078140|P1|COMPLETED|Overall Study||30
858829|NCT02557698|2078139|P2|STARTED|Overall Study||30
858830|NCT02557698|2078140|P1|STARTED|Overall Study||30
858831|NCT02557646|2078204|P1|NOT COMPLETED|Overall Study||276
858832|NCT02557646|2078204|P1|COMPLETED|Overall Study||417
858833|NCT02557646|2078204|P1|STARTED|Overall Study||693
858834|NCT02557555|2078222|P1|NOT COMPLETED|Overall Study||0
858835|NCT02557555|2078222|P1|COMPLETED|Overall Study||100
858836|NCT02557555|2078222|P1|STARTED|Overall Study||100
858837|NCT02556307|2078227|P1|NOT COMPLETED|Overall Study||53
858838|NCT02556307|2078227|P1|COMPLETED|Overall Study||217
858839|NCT02556307|2078227|P1|Treated|Overall Study||268
858840|NCT02556307|2078227|P1|STARTED|Overall Study||270
858841|NCT02555722|2078239|P2|NOT COMPLETED|Month 3||0
858842|NCT02555722|2078240|P1|NOT COMPLETED|Month 3||0
858843|NCT02555722|2078239|P2|COMPLETED|Month 3||29
858844|NCT02555722|2078240|P1|COMPLETED|Month 3||53
858845|NCT02555722|2078239|P2|STARTED|Month 3||29
858846|NCT02555722|2078240|P1|STARTED|Month 3||53
858847|NCT02555722|2078239|P2|NOT COMPLETED|Month 2||0
858848|NCT02555722|2078240|P1|NOT COMPLETED|Month 2||3
858849|NCT02555722|2078239|P2|COMPLETED|Month 2||29
858850|NCT02555722|2078240|P1|COMPLETED|Month 2||53
858851|NCT02555722|2078239|P2|STARTED|Month 2||29
858852|NCT02555722|2078240|P1|STARTED|Month 2||56
858853|NCT02555722|2078239|P2|NOT COMPLETED|Month 1||0
858854|NCT02555722|2078240|P1|NOT COMPLETED|Month 1||2
858855|NCT02555722|2078239|P2|COMPLETED|Month 1||29
858856|NCT02555722|2078240|P1|COMPLETED|Month 1||56
858857|NCT02555722|2078239|P2|STARTED|Month 1||29
858858|NCT02555722|2078240|P1|STARTED|Month 1||58
858859|NCT02555722|2078239|P2|NOT COMPLETED|Week 2||1
858860|NCT02555722|2078240|P1|NOT COMPLETED|Week 2||0
858861|NCT02555722|2078239|P2|COMPLETED|Week 2||29
858862|NCT02555722|2078240|P1|COMPLETED|Week 2||58
858863|NCT02555722|2078239|P2|STARTED|Week 2||30
858864|NCT02555722|2078240|P1|STARTED|Week 2||58
858865|NCT02555722|2078239|P2|NOT COMPLETED|Week 1||0
858866|NCT02555722|2078240|P1|NOT COMPLETED|Week 1||1
858867|NCT02555722|2078239|P2|COMPLETED|Week 1||30
858868|NCT02555722|2078240|P1|COMPLETED|Week 1||58
858869|NCT02555722|2078239|P2|STARTED|Week 1||30
858870|NCT02555722|2078240|P1|STARTED|Week 1||59
858871|NCT02555722|2078239|P2|NOT COMPLETED|Lens Dispensed||0
858872|NCT02555722|2078240|P1|NOT COMPLETED|Lens Dispensed||0
858873|NCT02555722|2078239|P2|COMPLETED|Lens Dispensed||30
858874|NCT02555722|2078240|P1|COMPLETED|Lens Dispensed||59
858875|NCT02555722|2078239|P2|STARTED|Lens Dispensed||30
858876|NCT02555722|2078240|P1|STARTED|Lens Dispensed||59
858877|NCT02555618|2078400|P2|NOT COMPLETED|Overall Study||0
858878|NCT02555618|2078401|P1|NOT COMPLETED|Overall Study||1
858879|NCT02555618|2078400|P2|COMPLETED|Overall Study||200
858880|NCT02555618|2078401|P1|COMPLETED|Overall Study||199
858881|NCT02555618|2078400|P2|STARTED|Overall Study||200
858882|NCT02555618|2078401|P1|STARTED|Overall Study||200
858883|NCT02555228|2078445|P2|NOT COMPLETED|Overall Study||0
858884|NCT02555228|2078446|P1|NOT COMPLETED|Overall Study||0
858885|NCT02555228|2078445|P2|COMPLETED|Overall Study|29th October 2015|27
858886|NCT02555228|2078446|P1|COMPLETED|Overall Study|19th November 2015|27
858887|NCT02555228|2078445|P2|STARTED|Overall Study|14th August 2015|27
858888|NCT02555228|2078446|P1|STARTED|Overall Study|20th August 2015|27
858889|NCT02554981|2078458|P1|NOT COMPLETED|Overall Study||5
858890|NCT02554981|2078458|P1|COMPLETED|Overall Study||46
858891|NCT02554981|2078458|P1|STARTED|Overall Study||51
858892|NCT02554877|2078486|P4|NOT COMPLETED|Overall Study||7
858893|NCT02554877|2078487|P3|NOT COMPLETED|Overall Study||6
858894|NCT02554877|2078488|P2|NOT COMPLETED|Overall Study||7
858895|NCT02554877|2078489|P1|NOT COMPLETED|Overall Study||12
858896|NCT02554877|2078486|P4|COMPLETED|Overall Study||45
858897|NCT02554877|2078487|P3|COMPLETED|Overall Study||46
858898|NCT02554877|2078488|P2|COMPLETED|Overall Study||44
858899|NCT02554877|2078489|P1|COMPLETED|Overall Study||39
858900|NCT02554877|2078486|P4|STARTED|Overall Study||52
858901|NCT02554877|2078487|P3|STARTED|Overall Study||52
858902|NCT02554877|2078488|P2|STARTED|Overall Study||51
858903|NCT02554877|2078489|P1|STARTED|Overall Study||51
858904|NCT02553629|2078553|P2|NOT COMPLETED|Overall Study||6
858905|NCT02553629|2078554|P1|NOT COMPLETED|Overall Study||3
858906|NCT02553629|2078553|P2|COMPLETED|Overall Study||50
858907|NCT02553629|2078554|P1|COMPLETED|Overall Study||50
858908|NCT02553629|2078553|P2|STARTED|Overall Study||56
858909|NCT02553629|2078554|P1|STARTED|Overall Study||53
858910|NCT02553512|2078568|P1|NOT COMPLETED|Overall Study||23
858911|NCT02553512|2078568|P1|COMPLETED|Overall Study||144
858912|NCT02553512|2078568|P1|STARTED|Overall Study||167
858913|NCT02553421|2078578|P2|NOT COMPLETED|Overall Study||1
858914|NCT02553421|2078579|P1|NOT COMPLETED|Overall Study||29
858915|NCT02553421|2078578|P2|COMPLETED|Overall Study||57
858916|NCT02553421|2078579|P1|COMPLETED|Overall Study||156
858917|NCT02553421|2078578|P2|STARTED|Overall Study||58
858918|NCT02553421|2078579|P1|STARTED|Overall Study||185
858919|NCT02552810|2078589|P2|NOT COMPLETED|Overall Study||0
858920|NCT02552810|2078590|P1|NOT COMPLETED|Overall Study||0
858921|NCT02552810|2078589|P2|COMPLETED|Overall Study||15
858922|NCT02552810|2078590|P1|COMPLETED|Overall Study||15
858923|NCT02552810|2078589|P2|STARTED|Overall Study||15
858924|NCT02552810|2078590|P1|STARTED|Overall Study||15
858925|NCT02552303|2078610|P4|NOT COMPLETED|Follow-Up||0
858926|NCT02552303|2078611|P3|NOT COMPLETED|Follow-Up||1
858927|NCT02552303|2078612|P2|NOT COMPLETED|Follow-Up||2
858928|NCT02552303|2078613|P1|NOT COMPLETED|Follow-Up||0
858929|NCT02552303|2078610|P4|COMPLETED|Follow-Up||10
858930|NCT02552303|2078611|P3|COMPLETED|Follow-Up||6
858931|NCT02552303|2078612|P2|COMPLETED|Follow-Up||6
858932|NCT02552303|2078613|P1|COMPLETED|Follow-Up||7
858933|NCT02552303|2078610|P4|STARTED|Follow-Up||10
858934|NCT02552303|2078611|P3|STARTED|Follow-Up||7
858935|NCT02552303|2078612|P2|STARTED|Follow-Up||8
858936|NCT02552303|2078613|P1|STARTED|Follow-Up||7
858937|NCT02552303|2078610|P4|NOT COMPLETED|Allocation||1
858938|NCT02552303|2078611|P3|NOT COMPLETED|Allocation||1
858939|NCT02552303|2078612|P2|NOT COMPLETED|Allocation||2
858940|NCT02552303|2078613|P1|NOT COMPLETED|Allocation||3
858941|NCT02552303|2078610|P4|COMPLETED|Allocation||10
858942|NCT02552303|2078611|P3|COMPLETED|Allocation||7
858943|NCT02552303|2078612|P2|COMPLETED|Allocation||8
858944|NCT02552303|2078613|P1|COMPLETED|Allocation||7
858945|NCT02552303|2078610|P4|STARTED|Allocation||11
858946|NCT02552303|2078611|P3|STARTED|Allocation||8
858947|NCT02552303|2078612|P2|STARTED|Allocation||10
858948|NCT02552303|2078613|P1|STARTED|Allocation||10
858949|NCT02551887|2078630|P3|NOT COMPLETED|Overall Study||0
858950|NCT02551887|2078631|P2|NOT COMPLETED|Overall Study||0
858951|NCT02551887|2078632|P1|NOT COMPLETED|Overall Study||0
858952|NCT02551887|2078630|P3|COMPLETED|Overall Study||222
858953|NCT02551887|2078631|P2|COMPLETED|Overall Study||124
858954|NCT02551887|2078632|P1|COMPLETED|Overall Study||301
858955|NCT02551887|2078630|P3|STARTED|Overall Study||222
858956|NCT02551887|2078631|P2|STARTED|Overall Study||124
858957|NCT02551887|2078632|P1|STARTED|Overall Study||301
858970|NCT02550288|2078657|P5|NOT COMPLETED|Overall Study||3
858971|NCT02550288|2078658|P4|NOT COMPLETED|Overall Study||3
858972|NCT02550288|2078659|P3|NOT COMPLETED|Overall Study||1
858973|NCT02550288|2078660|P2|NOT COMPLETED|Overall Study||3
858974|NCT02550288|2078661|P1|NOT COMPLETED|Overall Study||2
858975|NCT02550288|2078657|P5|COMPLETED|Overall Study||66
858976|NCT02550288|2078658|P4|COMPLETED|Overall Study||65
858977|NCT02550288|2078659|P3|COMPLETED|Overall Study||68
858978|NCT02550288|2078660|P2|COMPLETED|Overall Study||65
858979|NCT02550288|2078661|P1|COMPLETED|Overall Study||33
858980|NCT02550288|2078657|P5|STARTED|Overall Study||69
858981|NCT02550288|2078658|P4|STARTED|Overall Study||68
858982|NCT02550288|2078659|P3|STARTED|Overall Study||69
858983|NCT02550288|2078660|P2|STARTED|Overall Study||68
858984|NCT02550288|2078661|P1|STARTED|Overall Study||35
858985|NCT02550197|2078760|P2|NOT COMPLETED|Overall Study||0
858986|NCT02550197|2078761|P1|NOT COMPLETED|Overall Study||0
858987|NCT02550197|2078760|P2|COMPLETED|Overall Study||100
858988|NCT02550197|2078761|P1|COMPLETED|Overall Study||200
858989|NCT02550197|2078760|P2|STARTED|Overall Study||100
858990|NCT02550197|2078761|P1|STARTED|Overall Study||200
858991|NCT02550132|2078779|P1|NOT COMPLETED|Overall Study||0
858992|NCT02550132|2078779|P1|COMPLETED|Overall Study||25
858993|NCT02550132|2078779|P1|STARTED|Overall Study||25
858994|NCT02549027|2078810|P6|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
858995|NCT02549027|2078811|P5|NOT COMPLETED|Period 5 - MK-6096 or Placebo||2
858996|NCT02549027|2078812|P4|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
858997|NCT02549027|2078813|P3|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
858998|NCT02549027|2078814|P2|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
858999|NCT02549027|2078815|P1|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
859000|NCT02549027|2078810|P6|COMPLETED|Period 5 - MK-6096 or Placebo||1
859001|NCT02549027|2078811|P5|COMPLETED|Period 5 - MK-6096 or Placebo|The 2 participants who did not complete Period 5 did not receive study drug in Period 5|14
859002|NCT02549027|2078812|P4|COMPLETED|Period 5 - MK-6096 or Placebo||0
859003|NCT02549027|2078813|P3|COMPLETED|Period 5 - MK-6096 or Placebo||0
859004|NCT02549027|2078814|P2|COMPLETED|Period 5 - MK-6096 or Placebo||0
859005|NCT02549027|2078815|P1|COMPLETED|Period 5 - MK-6096 or Placebo||0
859006|NCT02549027|2078810|P6|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|1
859007|NCT02549027|2078811|P5|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|16
859008|NCT02549027|2078812|P4|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
859009|NCT02549027|2078813|P3|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
859010|NCT02549027|2078814|P2|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
859011|NCT02549027|2078815|P1|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg/Placebo (Period 5) arms|0
859012|NCT02549027|2078810|P6|NOT COMPLETED|Washout After Period 4||0
859013|NCT02549027|2078811|P5|NOT COMPLETED|Washout After Period 4||0
859014|NCT02549027|2078812|P4|NOT COMPLETED|Washout After Period 4||1
859015|NCT02549027|2078813|P3|NOT COMPLETED|Washout After Period 4||1
859016|NCT02549027|2078814|P2|NOT COMPLETED|Washout After Period 4||1
859017|NCT02549027|2078815|P1|NOT COMPLETED|Washout After Period 4||0
859018|NCT02549027|2078810|P6|COMPLETED|Washout After Period 4||0
859019|NCT02549027|2078811|P5|COMPLETED|Washout After Period 4||0
859020|NCT02549027|2078812|P4|COMPLETED|Washout After Period 4||4
859021|NCT02549027|2078813|P3|COMPLETED|Washout After Period 4||4
859022|NCT02549027|2078814|P2|COMPLETED|Washout After Period 4||4
859023|NCT02549027|2078815|P1|COMPLETED|Washout After Period 4||5
859024|NCT02549027|2078810|P6|STARTED|Washout After Period 4||0
859025|NCT02549027|2078811|P5|STARTED|Washout After Period 4||0
859026|NCT02549027|2078812|P4|STARTED|Washout After Period 4||5
859027|NCT02549027|2078813|P3|STARTED|Washout After Period 4||5
859028|NCT02549027|2078814|P2|STARTED|Washout After Period 4||5
859029|NCT02549027|2078815|P1|STARTED|Washout After Period 4||5
859030|NCT02549027|2078810|P6|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
859031|NCT02549027|2078811|P5|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
859032|NCT02549027|2078812|P4|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
859033|NCT02549027|2078813|P3|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
859034|NCT02549027|2078814|P2|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
859035|NCT02549027|2078815|P1|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
859036|NCT02549027|2078810|P6|COMPLETED|Period 4 - MK-1064 or Placebo||0
859037|NCT02549027|2078811|P5|COMPLETED|Period 4 - MK-1064 or Placebo||0
859038|NCT02549027|2078812|P4|COMPLETED|Period 4 - MK-1064 or Placebo||5
859039|NCT02549027|2078813|P3|COMPLETED|Period 4 - MK-1064 or Placebo||5
859040|NCT02549027|2078814|P2|COMPLETED|Period 4 - MK-1064 or Placebo||5
859041|NCT02549027|2078815|P1|COMPLETED|Period 4 - MK-1064 or Placebo||5
859042|NCT02549027|2078810|P6|STARTED|Period 4 - MK-1064 or Placebo||0
859043|NCT02549027|2078811|P5|STARTED|Period 4 - MK-1064 or Placebo||0
859044|NCT02549027|2078812|P4|STARTED|Period 4 - MK-1064 or Placebo||5
859045|NCT02549027|2078813|P3|STARTED|Period 4 - MK-1064 or Placebo||5
859046|NCT02549027|2078814|P2|STARTED|Period 4 - MK-1064 or Placebo||5
859047|NCT02549027|2078815|P1|STARTED|Period 4 - MK-1064 or Placebo||5
859048|NCT02549027|2078810|P6|NOT COMPLETED|Washout After Period 3||0
859049|NCT02549027|2078811|P5|NOT COMPLETED|Washout After Period 3||0
859050|NCT02549027|2078812|P4|NOT COMPLETED|Washout After Period 3||0
859051|NCT02549027|2078813|P3|NOT COMPLETED|Washout After Period 3||0
859052|NCT02549027|2078814|P2|NOT COMPLETED|Washout After Period 3||0
859053|NCT02549027|2078815|P1|NOT COMPLETED|Washout After Period 3||0
859054|NCT02549027|2078810|P6|COMPLETED|Washout After Period 3||0
859055|NCT02549027|2078811|P5|COMPLETED|Washout After Period 3||0
859056|NCT02549027|2078812|P4|COMPLETED|Washout After Period 3||5
859057|NCT02549027|2078813|P3|COMPLETED|Washout After Period 3||5
859058|NCT02549027|2078814|P2|COMPLETED|Washout After Period 3||5
859059|NCT02549027|2078815|P1|COMPLETED|Washout After Period 3||5
859060|NCT02549027|2078810|P6|STARTED|Washout After Period 3||0
859061|NCT02549027|2078811|P5|STARTED|Washout After Period 3||0
859062|NCT02549027|2078812|P4|STARTED|Washout After Period 3||5
859063|NCT02549027|2078813|P3|STARTED|Washout After Period 3||5
859064|NCT02549027|2078814|P2|STARTED|Washout After Period 3||5
859065|NCT02549027|2078815|P1|STARTED|Washout After Period 3||5
859066|NCT02549027|2078810|P6|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
859067|NCT02549027|2078811|P5|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
859068|NCT02549027|2078812|P4|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
859069|NCT02549027|2078813|P3|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
859070|NCT02549027|2078814|P2|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
859071|NCT02549027|2078815|P1|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
859072|NCT02549027|2078810|P6|COMPLETED|Period 3 - MK-1064 or Placebo||0
859073|NCT02549027|2078811|P5|COMPLETED|Period 3 - MK-1064 or Placebo||0
859074|NCT02549027|2078812|P4|COMPLETED|Period 3 - MK-1064 or Placebo||5
859075|NCT02549027|2078813|P3|COMPLETED|Period 3 - MK-1064 or Placebo||5
859076|NCT02549027|2078814|P2|COMPLETED|Period 3 - MK-1064 or Placebo||5
859077|NCT02549027|2078815|P1|COMPLETED|Period 3 - MK-1064 or Placebo||5
859078|NCT02549027|2078810|P6|STARTED|Period 3 - MK-1064 or Placebo||0
859079|NCT02549027|2078811|P5|STARTED|Period 3 - MK-1064 or Placebo||0
859080|NCT02549027|2078812|P4|STARTED|Period 3 - MK-1064 or Placebo||5
859081|NCT02549027|2078813|P3|STARTED|Period 3 - MK-1064 or Placebo||5
859082|NCT02549027|2078814|P2|STARTED|Period 3 - MK-1064 or Placebo||5
859083|NCT02549027|2078815|P1|STARTED|Period 3 - MK-1064 or Placebo||5
859084|NCT02549027|2078810|P6|NOT COMPLETED|Washout After Period 2||0
859085|NCT02549027|2078811|P5|NOT COMPLETED|Washout After Period 2||0
859086|NCT02549027|2078812|P4|NOT COMPLETED|Washout After Period 2||0
859087|NCT02549027|2078813|P3|NOT COMPLETED|Washout After Period 2||0
859088|NCT02549027|2078814|P2|NOT COMPLETED|Washout After Period 2||0
859089|NCT02549027|2078815|P1|NOT COMPLETED|Washout After Period 2||0
859090|NCT02549027|2078810|P6|COMPLETED|Washout After Period 2||0
859091|NCT02549027|2078811|P5|COMPLETED|Washout After Period 2||0
859092|NCT02549027|2078812|P4|COMPLETED|Washout After Period 2||5
859093|NCT02549027|2078813|P3|COMPLETED|Washout After Period 2||5
859094|NCT02549027|2078814|P2|COMPLETED|Washout After Period 2||5
859095|NCT02549027|2078815|P1|COMPLETED|Washout After Period 2||5
859096|NCT02549027|2078810|P6|STARTED|Washout After Period 2||0
859097|NCT02549027|2078811|P5|STARTED|Washout After Period 2||0
859098|NCT02549027|2078812|P4|STARTED|Washout After Period 2||5
859099|NCT02549027|2078813|P3|STARTED|Washout After Period 2||5
859100|NCT02549027|2078814|P2|STARTED|Washout After Period 2||5
859101|NCT02549027|2078815|P1|STARTED|Washout After Period 2||5
859102|NCT02549027|2078810|P6|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
859103|NCT02549027|2078811|P5|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
859104|NCT02549027|2078812|P4|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
859105|NCT02549027|2078813|P3|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
859106|NCT02549027|2078814|P2|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
859107|NCT02549027|2078815|P1|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
859108|NCT02549027|2078810|P6|COMPLETED|Period 2 - MK-1064 or Placebo||0
859109|NCT02549027|2078811|P5|COMPLETED|Period 2 - MK-1064 or Placebo||0
859110|NCT02549027|2078812|P4|COMPLETED|Period 2 - MK-1064 or Placebo||5
859111|NCT02549027|2078813|P3|COMPLETED|Period 2 - MK-1064 or Placebo||5
859112|NCT02549027|2078814|P2|COMPLETED|Period 2 - MK-1064 or Placebo||5
859113|NCT02549027|2078815|P1|COMPLETED|Period 2 - MK-1064 or Placebo||5
859114|NCT02549027|2078810|P6|STARTED|Period 2 - MK-1064 or Placebo||0
859115|NCT02549027|2078811|P5|STARTED|Period 2 - MK-1064 or Placebo||0
859116|NCT02549027|2078812|P4|STARTED|Period 2 - MK-1064 or Placebo||5
859117|NCT02549027|2078813|P3|STARTED|Period 2 - MK-1064 or Placebo||5
859118|NCT02549027|2078814|P2|STARTED|Period 2 - MK-1064 or Placebo||5
859119|NCT02549027|2078815|P1|STARTED|Period 2 - MK-1064 or Placebo||5
859120|NCT02549027|2078810|P6|NOT COMPLETED|Washout After Period 1||0
859121|NCT02549027|2078811|P5|NOT COMPLETED|Washout After Period 1||0
859122|NCT02549027|2078812|P4|NOT COMPLETED|Washout After Period 1||0
859123|NCT02549027|2078813|P3|NOT COMPLETED|Washout After Period 1||0
859124|NCT02549027|2078814|P2|NOT COMPLETED|Washout After Period 1||0
859125|NCT02549027|2078815|P1|NOT COMPLETED|Washout After Period 1||0
859126|NCT02549027|2078810|P6|COMPLETED|Washout After Period 1||0
859127|NCT02549027|2078811|P5|COMPLETED|Washout After Period 1||0
859128|NCT02549027|2078812|P4|COMPLETED|Washout After Period 1||5
859129|NCT02549027|2078813|P3|COMPLETED|Washout After Period 1||5
859130|NCT02549027|2078814|P2|COMPLETED|Washout After Period 1||5
859131|NCT02549027|2078815|P1|COMPLETED|Washout After Period 1||5
859132|NCT02549027|2078810|P6|STARTED|Washout After Period 1||0
859133|NCT02549027|2078811|P5|STARTED|Washout After Period 1||0
859134|NCT02549027|2078812|P4|STARTED|Washout After Period 1||5
859135|NCT02549027|2078813|P3|STARTED|Washout After Period 1||5
859136|NCT02549027|2078814|P2|STARTED|Washout After Period 1||5
859137|NCT02549027|2078815|P1|STARTED|Washout After Period 1||5
859138|NCT02549027|2078810|P6|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
859139|NCT02549027|2078811|P5|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
859140|NCT02549027|2078812|P4|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
859141|NCT02549027|2078813|P3|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
859142|NCT02549027|2078814|P2|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
859143|NCT02549027|2078815|P1|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
859144|NCT02549027|2078810|P6|COMPLETED|Period 1 - MK-1064 or Placebo||0
859145|NCT02549027|2078811|P5|COMPLETED|Period 1 - MK-1064 or Placebo||0
859146|NCT02549027|2078812|P4|COMPLETED|Period 1 - MK-1064 or Placebo||5
859147|NCT02549027|2078813|P3|COMPLETED|Period 1 - MK-1064 or Placebo||5
859148|NCT02549027|2078814|P2|COMPLETED|Period 1 - MK-1064 or Placebo||5
859149|NCT02549027|2078815|P1|COMPLETED|Period 1 - MK-1064 or Placebo||5
859150|NCT02549027|2078810|P6|STARTED|Period 1 - MK-1064 or Placebo||0
859151|NCT02549027|2078811|P5|STARTED|Period 1 - MK-1064 or Placebo||0
859152|NCT02549027|2078812|P4|STARTED|Period 1 - MK-1064 or Placebo||5
859153|NCT02549027|2078813|P3|STARTED|Period 1 - MK-1064 or Placebo||5
859154|NCT02549027|2078814|P2|STARTED|Period 1 - MK-1064 or Placebo||5
859155|NCT02549027|2078815|P1|STARTED|Period 1 - MK-1064 or Placebo||5
859156|NCT02549014|2078852|P2|NOT COMPLETED|Overall Study||0
859157|NCT02549014|2078853|P1|NOT COMPLETED|Overall Study||0
859158|NCT02549014|2078852|P2|COMPLETED|Overall Study||8
859159|NCT02549014|2078853|P1|COMPLETED|Overall Study||8
859160|NCT02549014|2078852|P2|STARTED|Overall Study||8
859161|NCT02549014|2078853|P1|STARTED|Overall Study||8
859162|NCT02548156|2078943|P6|NOT COMPLETED|Period 3||0
859163|NCT02548156|2078944|P5|NOT COMPLETED|Period 3||0
859164|NCT02548156|2078945|P4|NOT COMPLETED|Period 3||0
859165|NCT02548156|2078946|P3|NOT COMPLETED|Period 3||0
859166|NCT02548156|2078947|P2|NOT COMPLETED|Period 3||0
859167|NCT02548156|2078948|P1|NOT COMPLETED|Period 3||0
859168|NCT02548156|2078943|P6|COMPLETED|Period 3||5
859169|NCT02548156|2078944|P5|COMPLETED|Period 3||4
859170|NCT02548156|2078945|P4|COMPLETED|Period 3||5
859171|NCT02548156|2078946|P3|COMPLETED|Period 3||4
859172|NCT02548156|2078947|P2|COMPLETED|Period 3||5
859173|NCT02548156|2078948|P1|COMPLETED|Period 3||5
859174|NCT02548156|2078943|P6|STARTED|Period 3||5
859175|NCT02548156|2078944|P5|STARTED|Period 3||4
859176|NCT02548156|2078945|P4|STARTED|Period 3||5
859177|NCT02548156|2078946|P3|STARTED|Period 3||4
859178|NCT02548156|2078947|P2|STARTED|Period 3||5
859179|NCT02548156|2078948|P1|STARTED|Period 3||5
859180|NCT02548156|2078943|P6|NOT COMPLETED|Washout Period 2||0
859181|NCT02548156|2078944|P5|NOT COMPLETED|Washout Period 2||0
859182|NCT02548156|2078945|P4|NOT COMPLETED|Washout Period 2||0
859183|NCT02548156|2078946|P3|NOT COMPLETED|Washout Period 2||0
859184|NCT02548156|2078947|P2|NOT COMPLETED|Washout Period 2||0
859185|NCT02548156|2078948|P1|NOT COMPLETED|Washout Period 2||0
859186|NCT02548156|2078943|P6|COMPLETED|Washout Period 2||5
859187|NCT02548156|2078944|P5|COMPLETED|Washout Period 2||4
859188|NCT02548156|2078945|P4|COMPLETED|Washout Period 2||5
859189|NCT02548156|2078946|P3|COMPLETED|Washout Period 2||4
859190|NCT02548156|2078947|P2|COMPLETED|Washout Period 2||5
859191|NCT02548156|2078948|P1|COMPLETED|Washout Period 2||5
859192|NCT02548156|2078943|P6|STARTED|Washout Period 2||5
859193|NCT02548156|2078944|P5|STARTED|Washout Period 2||4
859194|NCT02548156|2078945|P4|STARTED|Washout Period 2||5
859195|NCT02548156|2078946|P3|STARTED|Washout Period 2||4
859196|NCT02548156|2078947|P2|STARTED|Washout Period 2||5
859197|NCT02548156|2078948|P1|STARTED|Washout Period 2||5
859198|NCT02548156|2078943|P6|NOT COMPLETED|Period 2||0
859199|NCT02548156|2078944|P5|NOT COMPLETED|Period 2||0
859200|NCT02548156|2078945|P4|NOT COMPLETED|Period 2||0
859201|NCT02548156|2078946|P3|NOT COMPLETED|Period 2||0
859202|NCT02548156|2078947|P2|NOT COMPLETED|Period 2||0
859203|NCT02548156|2078948|P1|NOT COMPLETED|Period 2||0
859204|NCT02548156|2078943|P6|COMPLETED|Period 2||5
859205|NCT02548156|2078944|P5|COMPLETED|Period 2||4
859206|NCT02548156|2078945|P4|COMPLETED|Period 2||5
859207|NCT02548156|2078946|P3|COMPLETED|Period 2||4
859208|NCT02548156|2078947|P2|COMPLETED|Period 2||5
859209|NCT02548156|2078948|P1|COMPLETED|Period 2||5
859210|NCT02548156|2078943|P6|STARTED|Period 2||5
859211|NCT02548156|2078944|P5|STARTED|Period 2||4
859212|NCT02548156|2078945|P4|STARTED|Period 2||5
859213|NCT02548156|2078946|P3|STARTED|Period 2||4
859214|NCT02548156|2078947|P2|STARTED|Period 2||5
859215|NCT02548156|2078948|P1|STARTED|Period 2||5
859216|NCT02548156|2078943|P6|NOT COMPLETED|Washout Period 1||0
859217|NCT02548156|2078944|P5|NOT COMPLETED|Washout Period 1||1
859218|NCT02548156|2078945|P4|NOT COMPLETED|Washout Period 1||0
859219|NCT02548156|2078946|P3|NOT COMPLETED|Washout Period 1||0
859220|NCT02548156|2078947|P2|NOT COMPLETED|Washout Period 1||0
859221|NCT02548156|2078948|P1|NOT COMPLETED|Washout Period 1||0
859222|NCT02548156|2078943|P6|COMPLETED|Washout Period 1||5
859223|NCT02548156|2078944|P5|COMPLETED|Washout Period 1||4
859224|NCT02548156|2078945|P4|COMPLETED|Washout Period 1||5
859225|NCT02548156|2078946|P3|COMPLETED|Washout Period 1||4
859226|NCT02548156|2078947|P2|COMPLETED|Washout Period 1||5
859227|NCT02548156|2078948|P1|COMPLETED|Washout Period 1||5
859228|NCT02548156|2078943|P6|STARTED|Washout Period 1||5
859229|NCT02548156|2078944|P5|STARTED|Washout Period 1||5
859230|NCT02548156|2078945|P4|STARTED|Washout Period 1||5
859231|NCT02548156|2078946|P3|STARTED|Washout Period 1||4
859232|NCT02548156|2078947|P2|STARTED|Washout Period 1||5
859233|NCT02548156|2078948|P1|STARTED|Washout Period 1||5
859234|NCT02548156|2078943|P6|NOT COMPLETED|Period 1||0
859235|NCT02548156|2078944|P5|NOT COMPLETED|Period 1||0
859236|NCT02548156|2078945|P4|NOT COMPLETED|Period 1||0
859237|NCT02548156|2078946|P3|NOT COMPLETED|Period 1||0
859238|NCT02548156|2078947|P2|NOT COMPLETED|Period 1||0
859239|NCT02548156|2078948|P1|NOT COMPLETED|Period 1||0
859240|NCT02548156|2078943|P6|COMPLETED|Period 1||5
859241|NCT02548156|2078944|P5|COMPLETED|Period 1||5
859242|NCT02548156|2078945|P4|COMPLETED|Period 1||5
859243|NCT02548156|2078946|P3|COMPLETED|Period 1||4
859244|NCT02548156|2078947|P2|COMPLETED|Period 1||5
859245|NCT02548156|2078948|P1|COMPLETED|Period 1||5
859246|NCT02548156|2078943|P6|STARTED|Period 1||5
859247|NCT02548156|2078944|P5|STARTED|Period 1||5
859248|NCT02548156|2078945|P4|STARTED|Period 1||5
859249|NCT02548156|2078946|P3|STARTED|Period 1||4
859250|NCT02548156|2078947|P2|STARTED|Period 1||5
859251|NCT02548156|2078948|P1|STARTED|Period 1||5
859252|NCT02547714|2078965|P1|NOT COMPLETED|Overall Study||0
859253|NCT02547714|2078965|P1|COMPLETED|Overall Study||34
859254|NCT02547714|2078965|P1|STARTED|Overall Study||34
859255|NCT02547454|2078975|P1|NOT COMPLETED|Overall Study||172
859256|NCT02547454|2078975|P1|COMPLETED|Overall Study||221
859257|NCT02547454|2078975|P1|STARTED|Overall Study||393
859258|NCT02547064|2079005|P2|NOT COMPLETED|Overall Study||2
859259|NCT02547064|2079006|P1|NOT COMPLETED|Overall Study||3
859260|NCT02547064|2079005|P2|COMPLETED|Overall Study||79
859261|NCT02547064|2079006|P1|COMPLETED|Overall Study||78
859262|NCT02547064|2079005|P2|STARTED|Overall Study||81
859263|NCT02547064|2079006|P1|STARTED|Overall Study||81
859264|NCT02545543|2079034|P2|NOT COMPLETED|Overall Study||34
859265|NCT02545543|2079035|P1|NOT COMPLETED|Overall Study||81
859266|NCT02545543|2079034|P2|COMPLETED|Overall Study||535
859267|NCT02545543|2079035|P1|COMPLETED|Overall Study||1628
859268|NCT02545543|2079034|P2|STARTED|Overall Study||569
859269|NCT02545543|2079035|P1|STARTED|Overall Study||1709
859270|NCT02545322|2079059|P1|NOT COMPLETED|Overall Study||3
859271|NCT02545322|2079059|P1|COMPLETED|Overall Study||15
859272|NCT02545322|2079059|P1|STARTED|Overall Study||18
859273|NCT02543918|2079066|P2|NOT COMPLETED|Overall Study||4
859274|NCT02543918|2079067|P1|NOT COMPLETED|Overall Study||3
859275|NCT02543918|2079066|P2|COMPLETED|Overall Study||39
859276|NCT02543918|2079067|P1|COMPLETED|Overall Study||38
859277|NCT02543918|2079066|P2|Received at Least 1 Dose of Study Drug|Overall Study||42
859278|NCT02543918|2079067|P1|Received at Least 1 Dose of Study Drug|Overall Study||41
859279|NCT02543918|2079066|P2|STARTED|Overall Study||43
859280|NCT02543918|2079067|P1|STARTED|Overall Study||41
859281|NCT02543437|2079073|P1|NOT COMPLETED|Overall Study||0
859282|NCT02543437|2079073|P1|COMPLETED|Overall Study||117
859283|NCT02543437|2079073|P1|STARTED|Overall Study||117
859284|NCT02542943|2079081|P3|NOT COMPLETED|Overall Study||0
859285|NCT02542943|2079082|P2|NOT COMPLETED|Overall Study||1
859286|NCT02542943|2079083|P1|NOT COMPLETED|Overall Study||1
859287|NCT02542943|2079081|P3|COMPLETED|Overall Study||81
859288|NCT02542943|2079082|P2|COMPLETED|Overall Study||79
859289|NCT02542943|2079083|P1|COMPLETED|Overall Study||78
859290|NCT02542943|2079081|P3|STARTED|Overall Study||81
859291|NCT02542943|2079082|P2|STARTED|Overall Study||80
859292|NCT02542943|2079083|P1|STARTED|Overall Study||79
859293|NCT02542761|2079108|P2|NOT COMPLETED|Second Intervention||0
859294|NCT02542761|2079109|P1|NOT COMPLETED|Second Intervention||0
859295|NCT02542761|2079108|P2|COMPLETED|Second Intervention||5
859296|NCT02542761|2079109|P1|COMPLETED|Second Intervention||5
859297|NCT02542761|2079108|P2|STARTED|Second Intervention||5
859298|NCT02542761|2079109|P1|STARTED|Second Intervention||5
859299|NCT02542761|2079108|P2|NOT COMPLETED|Acclimation Period 2||0
859300|NCT02542761|2079109|P1|NOT COMPLETED|Acclimation Period 2||0
859301|NCT02542761|2079108|P2|COMPLETED|Acclimation Period 2||5
859302|NCT02542761|2079109|P1|COMPLETED|Acclimation Period 2||5
859303|NCT02542761|2079108|P2|STARTED|Acclimation Period 2||5
859304|NCT02542761|2079109|P1|STARTED|Acclimation Period 2||5
859305|NCT02542761|2079108|P2|NOT COMPLETED|First Intervention||0
859306|NCT02542761|2079109|P1|NOT COMPLETED|First Intervention||0
859307|NCT02542761|2079108|P2|COMPLETED|First Intervention||5
859308|NCT02542761|2079109|P1|COMPLETED|First Intervention||5
859309|NCT02542761|2079108|P2|STARTED|First Intervention||5
859310|NCT02542761|2079109|P1|STARTED|First Intervention||5
859311|NCT02542761|2079108|P2|NOT COMPLETED|Acclimation Period 1||0
859312|NCT02542761|2079109|P1|NOT COMPLETED|Acclimation Period 1||0
859313|NCT02542761|2079108|P2|COMPLETED|Acclimation Period 1||5
859314|NCT02542761|2079109|P1|COMPLETED|Acclimation Period 1||5
859315|NCT02542761|2079108|P2|STARTED|Acclimation Period 1||5
859316|NCT02542761|2079109|P1|STARTED|Acclimation Period 1||5
859317|NCT02542280|2079127|P2|NOT COMPLETED|Overall Study||8
859318|NCT02542280|2079128|P1|NOT COMPLETED|Overall Study||12
859319|NCT02542280|2079127|P2|COMPLETED|Overall Study||167
859320|NCT02542280|2079128|P1|COMPLETED|Overall Study||162
859321|NCT02542280|2079127|P2|STARTED|Overall Study||175
859322|NCT02542280|2079128|P1|STARTED|Overall Study||174
859335|NCT02541864|2079239|P2|NOT COMPLETED|Overall Study||0
859336|NCT02541864|2079240|P1|NOT COMPLETED|Overall Study||0
859337|NCT02541864|2079239|P2|COMPLETED|Overall Study||166
859338|NCT02541864|2079240|P1|COMPLETED|Overall Study||164
859339|NCT02541864|2079239|P2|STARTED|Overall Study||166
859340|NCT02541864|2079240|P1|STARTED|Overall Study||164
859341|NCT02540850|2079249|P3|NOT COMPLETED|Overall Study||34
859342|NCT02540850|2079250|P2|NOT COMPLETED|Overall Study||66
859343|NCT02540850|2079251|P1|NOT COMPLETED|Overall Study||69
859344|NCT02540850|2079249|P3|COMPLETED|Overall Study||410
859345|NCT02540850|2079250|P2|COMPLETED|Overall Study||330
859346|NCT02540850|2079251|P1|COMPLETED|Overall Study||291
859347|NCT02540850|2079249|P3|STARTED|Overall Study||444
859348|NCT02540850|2079250|P2|STARTED|Overall Study||396
859349|NCT02540850|2079251|P1|STARTED|Overall Study||360
859350|NCT02540772|2079279|P2|NOT COMPLETED|Overall Study||0
859351|NCT02540772|2079280|P1|NOT COMPLETED|Overall Study||0
859352|NCT02540772|2079279|P2|COMPLETED|Overall Study||10
859353|NCT02540772|2079280|P1|COMPLETED|Overall Study||10
859354|NCT02540772|2079279|P2|STARTED|Overall Study||10
859355|NCT02540772|2079280|P1|STARTED|Overall Study||10
859356|NCT02540447|2079294|P2|NOT COMPLETED|Overall Study||0
859357|NCT02540447|2079295|P1|NOT COMPLETED|Overall Study||0
859358|NCT02540447|2079294|P2|COMPLETED|Overall Study||40
859359|NCT02540447|2079295|P1|COMPLETED|Overall Study||40
859360|NCT02540447|2079294|P2|STARTED|Overall Study||40
859361|NCT02540447|2079295|P1|STARTED|Overall Study||40
859362|NCT02540434|2079311|P2|NOT COMPLETED|Overall Study||0
859363|NCT02540434|2079312|P1|NOT COMPLETED|Overall Study||0
859364|NCT02540434|2079311|P2|COMPLETED|Overall Study||1
859365|NCT02540434|2079312|P1|COMPLETED|Overall Study||0
859366|NCT02540434|2079311|P2|STARTED|Overall Study||1
859367|NCT02540434|2079312|P1|STARTED|Overall Study||0
859374|NCT02540265|2079357|P3|NOT COMPLETED|Overall Study||1
859375|NCT02540265|2079358|P2|NOT COMPLETED|Overall Study||0
859376|NCT02540265|2079359|P1|NOT COMPLETED|Overall Study||0
859377|NCT02540265|2079357|P3|COMPLETED|Overall Study||18
859378|NCT02540265|2079358|P2|COMPLETED|Overall Study||20
859379|NCT02540265|2079359|P1|COMPLETED|Overall Study||20
859380|NCT02540265|2079357|P3|Treatment Completion|Overall Study||18
859381|NCT02540265|2079358|P2|Treatment Completion|Overall Study||19
859382|NCT02540265|2079359|P1|Treatment Completion|Overall Study||20
859383|NCT02540265|2079357|P3|STARTED|Overall Study||19
859384|NCT02540265|2079358|P2|STARTED|Overall Study||20
859385|NCT02540265|2079359|P1|STARTED|Overall Study||20
859386|NCT02540213|2079379|P1|NOT COMPLETED|Overall Study||39
859387|NCT02540213|2079379|P1|COMPLETED|Overall Study||201
859388|NCT02540213|2079379|P1|STARTED|Overall Study||240
859389|NCT02539992|2079403|P3|NOT COMPLETED|Overall Study||4
859390|NCT02539992|2079404|P2|NOT COMPLETED|Overall Study||4
859391|NCT02539992|2079405|P1|NOT COMPLETED|Overall Study||0
859392|NCT02539992|2079403|P3|COMPLETED|Overall Study||14
859393|NCT02539992|2079404|P2|COMPLETED|Overall Study||7
859394|NCT02539992|2079405|P1|COMPLETED|Overall Study||15
859395|NCT02539992|2079403|P3|STARTED|Overall Study||18
859396|NCT02539992|2079404|P2|STARTED|Overall Study||11
859397|NCT02539992|2079405|P1|STARTED|Overall Study||15
859398|NCT02539134|2079437|P6|NOT COMPLETED|Overall Study||0
859399|NCT02539134|2079438|P5|NOT COMPLETED|Overall Study||0
859400|NCT02539134|2079439|P4|NOT COMPLETED|Overall Study||0
859401|NCT02539134|2079440|P3|NOT COMPLETED|Overall Study||0
859402|NCT02539134|2079441|P2|NOT COMPLETED|Overall Study||0
859403|NCT02539134|2079442|P1|NOT COMPLETED|Overall Study||1
859404|NCT02539134|2079437|P6|COMPLETED|Overall Study||6
859405|NCT02539134|2079438|P5|COMPLETED|Overall Study||6
859406|NCT02539134|2079439|P4|COMPLETED|Overall Study||6
859407|NCT02539134|2079440|P3|COMPLETED|Overall Study||6
859408|NCT02539134|2079441|P2|COMPLETED|Overall Study||6
859409|NCT02539134|2079442|P1|COMPLETED|Overall Study||9
859410|NCT02539134|2079437|P6|STARTED|Overall Study||6
859411|NCT02539134|2079438|P5|STARTED|Overall Study||6
859412|NCT02539134|2079439|P4|STARTED|Overall Study||6
859413|NCT02539134|2079440|P3|STARTED|Overall Study||6
859414|NCT02539134|2079441|P2|STARTED|Overall Study||6
859415|NCT02539134|2079442|P1|STARTED|Overall Study||10
859416|NCT02539108|2079496|P2|NOT COMPLETED|Overall Study||0
859417|NCT02539108|2079497|P1|NOT COMPLETED|Overall Study||0
859418|NCT02539108|2079496|P2|COMPLETED|Overall Study||30
859419|NCT02539108|2079497|P1|COMPLETED|Overall Study||30
859420|NCT02539108|2079496|P2|STARTED|Overall Study||30
859421|NCT02539108|2079497|P1|STARTED|Overall Study||30
859422|NCT02537522|2079511|P4|NOT COMPLETED|Phase II - Period 2 Bilateral||0
859423|NCT02537522|2079512|P3|NOT COMPLETED|Phase II - Period 2 Bilateral||0
859424|NCT02537522|2079513|P2|NOT COMPLETED|Phase II - Period 2 Bilateral||0
859425|NCT02537522|2079514|P1|NOT COMPLETED|Phase II - Period 2 Bilateral||0
859426|NCT02537522|2079511|P4|COMPLETED|Phase II - Period 2 Bilateral||22
859427|NCT02537522|2079512|P3|COMPLETED|Phase II - Period 2 Bilateral||23
859428|NCT02537522|2079513|P2|COMPLETED|Phase II - Period 2 Bilateral||0
859429|NCT02537522|2079514|P1|COMPLETED|Phase II - Period 2 Bilateral||0
859430|NCT02537522|2079511|P4|STARTED|Phase II - Period 2 Bilateral||22
859431|NCT02537522|2079512|P3|STARTED|Phase II - Period 2 Bilateral||23
859432|NCT02537522|2079513|P2|STARTED|Phase II - Period 2 Bilateral||0
859433|NCT02537522|2079514|P1|STARTED|Phase II - Period 2 Bilateral||0
859434|NCT02537522|2079511|P4|NOT COMPLETED|Phase II - Period 1 Bilateral||1
859435|NCT02537522|2079512|P3|NOT COMPLETED|Phase II - Period 1 Bilateral||0
859436|NCT02537522|2079513|P2|NOT COMPLETED|Phase II - Period 1 Bilateral||0
859437|NCT02537522|2079514|P1|NOT COMPLETED|Phase II - Period 1 Bilateral||0
859438|NCT02537522|2079511|P4|COMPLETED|Phase II - Period 1 Bilateral||22
859439|NCT02537522|2079512|P3|COMPLETED|Phase II - Period 1 Bilateral||23
859440|NCT02537522|2079513|P2|COMPLETED|Phase II - Period 1 Bilateral||0
859441|NCT02537522|2079514|P1|COMPLETED|Phase II - Period 1 Bilateral||0
859442|NCT02537522|2079511|P4|STARTED|Phase II - Period 1 Bilateral||23
859443|NCT02537522|2079512|P3|STARTED|Phase II - Period 1 Bilateral||23
859444|NCT02537522|2079513|P2|STARTED|Phase II - Period 1 Bilateral||0
859445|NCT02537522|2079514|P1|STARTED|Phase II - Period 1 Bilateral||0
859446|NCT02537522|2079511|P4|NOT COMPLETED|Phase I - Contralateral||0
859447|NCT02537522|2079512|P3|NOT COMPLETED|Phase I - Contralateral||0
859448|NCT02537522|2079513|P2|NOT COMPLETED|Phase I - Contralateral||10
859449|NCT02537522|2079514|P1|NOT COMPLETED|Phase I - Contralateral||15
859450|NCT02537522|2079511|P4|COMPLETED|Phase I - Contralateral||0
859451|NCT02537522|2079512|P3|COMPLETED|Phase I - Contralateral||0
859452|NCT02537522|2079513|P2|COMPLETED|Phase I - Contralateral||27
859453|NCT02537522|2079514|P1|COMPLETED|Phase I - Contralateral||19
859454|NCT02537522|2079511|P4|STARTED|Phase I - Contralateral||0
859455|NCT02537522|2079512|P3|STARTED|Phase I - Contralateral||0
859456|NCT02537522|2079513|P2|STARTED|Phase I - Contralateral||37
859457|NCT02537522|2079514|P1|STARTED|Phase I - Contralateral||34
859458|NCT02538107|2079522|P1|NOT COMPLETED|Overall Study||110
859459|NCT02538107|2079522|P1|COMPLETED|Overall Study||180
859460|NCT02538107|2079522|P1|STARTED|Overall Study||290
859461|NCT02537730|2079542|P2|NOT COMPLETED|Second Intervention (7 Days)||0
859462|NCT02537730|2079543|P1|NOT COMPLETED|Second Intervention (7 Days)||0
859463|NCT02537730|2079542|P2|COMPLETED|Second Intervention (7 Days)||16
859464|NCT02537730|2079543|P1|COMPLETED|Second Intervention (7 Days)||17
859465|NCT02537730|2079542|P2|STARTED|Second Intervention (7 Days)||16
859466|NCT02537730|2079543|P1|STARTED|Second Intervention (7 Days)||17
859467|NCT02537730|2079542|P2|NOT COMPLETED|First Intervention (7 Days)||0
859468|NCT02537730|2079543|P1|NOT COMPLETED|First Intervention (7 Days)||0
859469|NCT02537730|2079542|P2|COMPLETED|First Intervention (7 Days)||16
859470|NCT02537730|2079543|P1|COMPLETED|First Intervention (7 Days)||17
859471|NCT02537730|2079542|P2|STARTED|First Intervention (7 Days)||16
859472|NCT02537730|2079543|P1|STARTED|First Intervention (7 Days)||17
859473|NCT02536781|2079557|P2|NOT COMPLETED|Overall Study||0
859474|NCT02536781|2079558|P1|NOT COMPLETED|Overall Study||2
859475|NCT02536781|2079557|P2|COMPLETED|Overall Study||34
859476|NCT02536781|2079558|P1|COMPLETED|Overall Study||34
859477|NCT02536781|2079557|P2|STARTED|Overall Study||34
859478|NCT02536781|2079558|P1|STARTED|Overall Study||36
859479|NCT02536664|2079568|P2|NOT COMPLETED|Overall Study||80
859480|NCT02536664|2079569|P1|NOT COMPLETED|Overall Study||107
859481|NCT02536664|2079568|P2|COMPLETED|Overall Study||97
859482|NCT02536664|2079569|P1|COMPLETED|Overall Study||205
859483|NCT02536664|2079568|P2|STARTED|Overall Study||177
859484|NCT02536664|2079569|P1|STARTED|Overall Study||312
859485|NCT02536313|2079589|P2|NOT COMPLETED|Overall Study||1
859486|NCT02536313|2079590|P1|NOT COMPLETED|Overall Study||0
859487|NCT02536313|2079589|P2|COMPLETED|Overall Study||24
859488|NCT02536313|2079590|P1|COMPLETED|Overall Study||24
859489|NCT02536313|2079589|P2|STARTED|Overall Study||25
859490|NCT02536313|2079590|P1|STARTED|Overall Study||24
859491|NCT02535741|2079606|P1|NOT COMPLETED|Overall Study||32
859492|NCT02535741|2079606|P1|COMPLETED|Overall Study|Completed cases at 2 years follow-up|136
859493|NCT02535741|2079606|P1|STARTED|Overall Study||168
859494|NCT02535026|2079610|P1|NOT COMPLETED|Overall Study||0
859495|NCT02535026|2079610|P1|COMPLETED|Overall Study||580
859496|NCT02535026|2079610|P1|STARTED|Overall Study||580
859497|NCT02534324|2079664|P2|NOT COMPLETED|Overall Study||8
859498|NCT02534324|2079665|P1|NOT COMPLETED|Overall Study||25
859499|NCT02534324|2079664|P2|COMPLETED|Overall Study||40
859500|NCT02534324|2079665|P1|COMPLETED|Overall Study||73
859501|NCT02534324|2079664|P2|STARTED|Overall Study||48
859502|NCT02534324|2079665|P1|STARTED|Overall Study||98
859503|NCT02534129|2079675|P2|NOT COMPLETED|Overall Study||0
859504|NCT02534129|2079676|P1|NOT COMPLETED|Overall Study||0
859505|NCT02534129|2079675|P2|COMPLETED|Overall Study||13
859506|NCT02534129|2079676|P1|COMPLETED|Overall Study||13
859507|NCT02534129|2079675|P2|STARTED|Overall Study||13
859508|NCT02534129|2079676|P1|STARTED|Overall Study||13
859509|NCT02533466|2079684|P2|NOT COMPLETED|Overall Study||0
859510|NCT02533466|2079685|P1|NOT COMPLETED|Overall Study||0
859511|NCT02533466|2079684|P2|COMPLETED|Overall Study||14
859512|NCT02533466|2079685|P1|COMPLETED|Overall Study||16
859513|NCT02533466|2079684|P2|STARTED|Overall Study||14
859514|NCT02533466|2079685|P1|STARTED|Overall Study||16
859515|NCT02533401|2079709|P1|NOT COMPLETED|Overall Study||11
859516|NCT02533401|2079709|P1|COMPLETED|Overall Study||23
859517|NCT02533401|2079709|P1|STARTED|Overall Study||34
859518|NCT02533258|2079717|P1|NOT COMPLETED|Overall Study||8
859519|NCT02533258|2079717|P1|COMPLETED|Overall Study||5
859520|NCT02533258|2079717|P1|STARTED|Overall Study||13
859521|NCT02532998|2079729|P1|NOT COMPLETED|Overall Study||0
859522|NCT02532998|2079729|P1|COMPLETED|Overall Study||23
859523|NCT02532998|2079729|P1|STARTED|Overall Study||23
859524|NCT02532374|2079811|P1|NOT COMPLETED|Overall Study||2
859525|NCT02532374|2079811|P1|COMPLETED|Overall Study||14
859526|NCT02532374|2079811|P1|STARTED|Overall Study||16
859527|NCT02531867|2079835|P1|NOT COMPLETED|Overall Study||0
859528|NCT02531867|2079835|P1|COMPLETED|Overall Study||13
859529|NCT02531867|2079835|P1|STARTED|Overall Study||13
859530|NCT02531646|2079842|P3|NOT COMPLETED|Overall Study||0
859531|NCT02531646|2079843|P2|NOT COMPLETED|Overall Study||1
859532|NCT02531646|2079844|P1|NOT COMPLETED|Overall Study||5
859533|NCT02531646|2079842|P3|COMPLETED|Overall Study||11
859534|NCT02531646|2079843|P2|COMPLETED|Overall Study||17
859535|NCT02531646|2079844|P1|COMPLETED|Overall Study||32
859536|NCT02531646|2079842|P3|STARTED|Overall Study||11
859537|NCT02531646|2079843|P2|STARTED|Overall Study||18
859538|NCT02531646|2079844|P1|STARTED|Overall Study||37
859539|NCT02531308|2079858|P1|NOT COMPLETED|Overall Study||3
859540|NCT02531308|2079858|P1|COMPLETED|Overall Study||2
859541|NCT02531308|2079858|P1|STARTED|Overall Study||5
859542|NCT02530671|2079864|P2|NOT COMPLETED|Overall Study||0
859543|NCT02530671|2079865|P1|NOT COMPLETED|Overall Study||3
859544|NCT02530671|2079864|P2|COMPLETED|Overall Study||55
859545|NCT02530671|2079865|P1|COMPLETED|Overall Study||52
859546|NCT02530671|2079864|P2|STARTED|Overall Study||55
859547|NCT02530671|2079865|P1|STARTED|Overall Study||55
859548|NCT02530450|2079883|P2|NOT COMPLETED|Overall Study||5
859549|NCT02530450|2079884|P1|NOT COMPLETED|Overall Study||6
859550|NCT02530450|2079883|P2|COMPLETED|Overall Study||9
859551|NCT02530450|2079884|P1|COMPLETED|Overall Study||10
859552|NCT02530450|2079883|P2|STARTED|Overall Study||14
859553|NCT02530450|2079884|P1|STARTED|Overall Study||16
859554|NCT02529995|2079892|P2|NOT COMPLETED|Part B||0
859555|NCT02529995|2079893|P1|NOT COMPLETED|Part B||0
859556|NCT02529995|2079892|P2|COMPLETED|Part B||0
859557|NCT02529995|2079893|P1|COMPLETED|Part B||0
859558|NCT02529995|2079892|P2|STARTED|Part B||0
859559|NCT02529995|2079893|P1|STARTED|Part B||0
859560|NCT02529995|2079892|P2|NOT COMPLETED|Part A||16
859561|NCT02529995|2079893|P1|NOT COMPLETED|Part A||15
859562|NCT02529995|2079892|P2|COMPLETED|Part A||0
859563|NCT02529995|2079893|P1|COMPLETED|Part A||0
859564|NCT02529995|2079892|P2|STARTED|Part A||16
859565|NCT02529995|2079893|P1|STARTED|Part A||15
859566|NCT02528721|2079929|P2|NOT COMPLETED|Overall Study||3
859567|NCT02528721|2079930|P1|NOT COMPLETED|Overall Study||7
859568|NCT02528721|2079929|P2|COMPLETED|Overall Study||76
859569|NCT02528721|2079930|P1|COMPLETED|Overall Study||196
859570|NCT02528721|2079929|P2|STARTED|Overall Study||79
859571|NCT02528721|2079930|P1|STARTED|Overall Study||203
859572|NCT02528331|2079940|P1|NOT COMPLETED|Overall Study||2
859573|NCT02528331|2079940|P1|COMPLETED|Overall Study||0
859574|NCT02528331|2079940|P1|STARTED|Overall Study||2
859575|NCT02528097|2079949|P2|NOT COMPLETED|Overall Study||0
859576|NCT02528097|2079950|P1|NOT COMPLETED|Overall Study||0
859577|NCT02528097|2079949|P2|COMPLETED|Overall Study||1
859578|NCT02528097|2079950|P1|COMPLETED|Overall Study||1
859579|NCT02528097|2079949|P2|STARTED|Overall Study||1
859580|NCT02528097|2079950|P1|STARTED|Overall Study||1
859581|NCT02527161|2079958|P1|NOT COMPLETED|Overall Study||62
859582|NCT02527161|2079958|P1|COMPLETED|Overall Study|Completed/Not completed counts are for knees at the 6 mo primary outcome interval.|96
859583|NCT02527161|2079958|P1|STARTED|Overall Study|All results are reported by knee throughout record. Participant=knee.|158
859584|NCT02527148|2079977|P2|NOT COMPLETED|Overall Study||0
859585|NCT02527148|2079978|P1|NOT COMPLETED|Overall Study||1
859586|NCT02527148|2079977|P2|COMPLETED|Overall Study||50
859587|NCT02527148|2079978|P1|COMPLETED|Overall Study||49
859588|NCT02527148|2079977|P2|STARTED|Overall Study||50
859589|NCT02527148|2079978|P1|STARTED|Overall Study||50
859590|NCT02526550|2079996|P1|NOT COMPLETED|Overall Study||1
859591|NCT02526550|2079996|P1|COMPLETED|Overall Study||49
859592|NCT02526550|2079996|P1|STARTED|Overall Study||50
859593|NCT02525536|2080005|P3|NOT COMPLETED|Overall Study||0
859594|NCT02525536|2080006|P2|NOT COMPLETED|Overall Study||0
859595|NCT02525536|2080007|P1|NOT COMPLETED|Overall Study||0
859596|NCT02525536|2080005|P3|COMPLETED|Overall Study||6
859597|NCT02525536|2080006|P2|COMPLETED|Overall Study||6
859598|NCT02525536|2080007|P1|COMPLETED|Overall Study||6
859599|NCT02525536|2080005|P3|STARTED|Overall Study||6
859600|NCT02525536|2080006|P2|STARTED|Overall Study||6
859601|NCT02525536|2080007|P1|STARTED|Overall Study||6
859602|NCT02524665|2080078|P1|NOT COMPLETED|Overall Study||1
859603|NCT02524665|2080078|P1|COMPLETED|Overall Study||19
859604|NCT02524665|2080078|P1|STARTED|Overall Study||20
859605|NCT02524561|2080096|P3|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
859606|NCT02524561|2080097|P2|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
859607|NCT02524561|2080098|P1|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
859608|NCT02524561|2080096|P3|COMPLETED|Final: Year 3 or 4 Post-randomization||187
859609|NCT02524561|2080097|P2|COMPLETED|Final: Year 3 or 4 Post-randomization||162
859610|NCT02524561|2080098|P1|COMPLETED|Final: Year 3 or 4 Post-randomization||168
859611|NCT02524561|2080096|P3|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||151
859612|NCT02524561|2080097|P2|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||139
859613|NCT02524561|2080098|P1|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||143
859614|NCT02524561|2080096|P3|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|187
859615|NCT02524561|2080097|P2|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|162
859616|NCT02524561|2080098|P1|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|168
859617|NCT02524561|2080096|P3|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
859618|NCT02524561|2080097|P2|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
859619|NCT02524561|2080098|P1|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
859620|NCT02524561|2080096|P3|COMPLETED|Year 1: Post Randomization Mammograms||187
859621|NCT02524561|2080097|P2|COMPLETED|Year 1: Post Randomization Mammograms||162
859622|NCT02524561|2080098|P1|COMPLETED|Year 1: Post Randomization Mammograms||168
859623|NCT02524561|2080096|P3|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|148
859624|NCT02524561|2080097|P2|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|123
859625|NCT02524561|2080098|P1|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post-randomization mammogram|136
859626|NCT02524561|2080096|P3|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|187
859627|NCT02524561|2080097|P2|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|162
859628|NCT02524561|2080098|P1|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|168
859629|NCT02524561|2080096|P3|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
859630|NCT02524561|2080097|P2|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
859631|NCT02524561|2080098|P1|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
859632|NCT02524561|2080096|P3|COMPLETED|Baseline: Pre-randomization Mammogram||187
859633|NCT02524561|2080097|P2|COMPLETED|Baseline: Pre-randomization Mammogram||162
859634|NCT02524561|2080098|P1|COMPLETED|Baseline: Pre-randomization Mammogram||168
859635|NCT02524561|2080096|P3|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||151
859636|NCT02524561|2080097|P2|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||133
859637|NCT02524561|2080098|P1|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||137
859638|NCT02524561|2080096|P3|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS.|187
859639|NCT02524561|2080097|P2|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|162
859640|NCT02524561|2080098|P1|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|168
859641|NCT02524418|2080115|P1|NOT COMPLETED|Overall Study||13
859642|NCT02524418|2080115|P1|COMPLETED|Overall Study||75
859643|NCT02524418|2080115|P1|STARTED|Overall Study||88
859644|NCT02524288|2080129|P1|NOT COMPLETED|Overall Study||1941
859645|NCT02524288|2080129|P1|COMPLETED|Overall Study||0
859646|NCT02524288|2080129|P1|Treated|Overall Study||1936
859647|NCT02524288|2080129|P1|STARTED|Overall Study||1941
859660|NCT02522624|2080154|P2|NOT COMPLETED|Overall Study||0
859661|NCT02522624|2080155|P1|NOT COMPLETED|Overall Study||1
859662|NCT02522624|2080154|P2|COMPLETED|Overall Study||163
859663|NCT02522624|2080155|P1|COMPLETED|Overall Study|Discontinued intervention due to technical failure (n=1)|164
859664|NCT02522624|2080154|P2|STARTED|Overall Study||163
859665|NCT02522624|2080155|P1|STARTED|Overall Study||165
859666|NCT02520414|2080171|P1|NOT COMPLETED|Overall Study||0
859667|NCT02520414|2080171|P1|COMPLETED|Overall Study||10
859668|NCT02520414|2080171|P1|STARTED|Overall Study||10
859669|NCT02519855|2080177|P2|NOT COMPLETED|Overall Study||4
859670|NCT02519855|2080178|P1|NOT COMPLETED|Overall Study||3
859671|NCT02519855|2080177|P2|COMPLETED|Overall Study||437
859672|NCT02519855|2080178|P1|COMPLETED|Overall Study||438
859673|NCT02519855|2080177|P2|Vaccinated at Week 4|Overall Study||424
859674|NCT02519855|2080178|P1|Vaccinated at Week 4|Overall Study||432
859675|NCT02519855|2080177|P2|Vaccinated on Day 1|Overall Study||441
859676|NCT02519855|2080178|P1|Vaccinated on Day 1|Overall Study||440
859677|NCT02519855|2080177|P2|STARTED|Overall Study|Participants are included as treated|441
859678|NCT02519855|2080178|P1|STARTED|Overall Study|Participants are included as treated|441
859679|NCT02519595|2080197|P3|NOT COMPLETED|Overall Study||16
859680|NCT02519595|2080198|P2|NOT COMPLETED|Overall Study||22
859681|NCT02519595|2080199|P1|NOT COMPLETED|Overall Study||8
859682|NCT02519595|2080197|P3|COMPLETED|Overall Study||40
859683|NCT02519595|2080198|P2|COMPLETED|Overall Study||35
859684|NCT02519595|2080199|P1|COMPLETED|Overall Study||50
859685|NCT02519595|2080197|P3|STARTED|Overall Study||56
859686|NCT02519595|2080198|P2|STARTED|Overall Study||57
859687|NCT02519595|2080199|P1|STARTED|Overall Study||58
859688|NCT02519387|2080222|P1|NOT COMPLETED|Overall Study||22
859689|NCT02519387|2080222|P1|COMPLETED|Overall Study||56
859690|NCT02519387|2080222|P1|STARTED|Overall Study||78
859691|NCT02518048|2080230|P1|NOT COMPLETED|Overall Study||1
859692|NCT02518048|2080230|P1|COMPLETED|Overall Study||34
859693|NCT02518048|2080230|P1|STARTED|Overall Study||35
859694|NCT02516306|2080243|P2|NOT COMPLETED|Period 2: Day 8 - 91||2
859695|NCT02516306|2080244|P1|NOT COMPLETED|Period 2: Day 8 - 91||1
859696|NCT02516306|2080243|P2|COMPLETED|Period 2: Day 8 - 91||23
859697|NCT02516306|2080244|P1|COMPLETED|Period 2: Day 8 - 91||49
859698|NCT02516306|2080243|P2|STARTED|Period 2: Day 8 - 91||25
859699|NCT02516306|2080244|P1|STARTED|Period 2: Day 8 - 91||50
859700|NCT02516306|2080243|P2|NOT COMPLETED|Period 1: Day 1 - 7||0
859701|NCT02516306|2080244|P1|NOT COMPLETED|Period 1: Day 1 - 7||0
859702|NCT02516306|2080243|P2|COMPLETED|Period 1: Day 1 - 7||25
859703|NCT02516306|2080244|P1|COMPLETED|Period 1: Day 1 - 7||50
859704|NCT02516306|2080243|P2|STARTED|Period 1: Day 1 - 7||25
859705|NCT02516306|2080244|P1|STARTED|Period 1: Day 1 - 7||50
859706|NCT02516163|2080250|P1|NOT COMPLETED|Overall Study||28
859707|NCT02516163|2080250|P1|COMPLETED|Overall Study||24
859708|NCT02516163|2080250|P1|STARTED|Overall Study||52
859709|NCT02516150|2080254|P1|NOT COMPLETED|Overall Study||0
859710|NCT02516150|2080254|P1|COMPLETED|Overall Study||15
859711|NCT02516150|2080254|P1|STARTED|Overall Study||15
859712|NCT02516098|2080264|P2|NOT COMPLETED|Washout After Period 2||0
859713|NCT02516098|2080265|P1|NOT COMPLETED|Washout After Period 2||0
859714|NCT02516098|2080264|P2|COMPLETED|Washout After Period 2||26
859715|NCT02516098|2080265|P1|COMPLETED|Washout After Period 2||27
859716|NCT02516098|2080264|P2|STARTED|Washout After Period 2||26
859717|NCT02516098|2080265|P1|STARTED|Washout After Period 2||27
859718|NCT02516098|2080264|P2|NOT COMPLETED|Period 2||1
859719|NCT02516098|2080265|P1|NOT COMPLETED|Period 2||0
859720|NCT02516098|2080264|P2|COMPLETED|Period 2||26
859721|NCT02516098|2080265|P1|COMPLETED|Period 2||27
859722|NCT02516098|2080264|P2|STARTED|Period 2||27
859723|NCT02516098|2080265|P1|STARTED|Period 2||27
859724|NCT02516098|2080264|P2|NOT COMPLETED|Washout After Period 1||1
859725|NCT02516098|2080265|P1|NOT COMPLETED|Washout After Period 1||0
859726|NCT02516098|2080264|P2|COMPLETED|Washout After Period 1||27
859727|NCT02516098|2080265|P1|COMPLETED|Washout After Period 1||27
859728|NCT02516098|2080264|P2|STARTED|Washout After Period 1||28
859729|NCT02516098|2080265|P1|STARTED|Washout After Period 1||27
859730|NCT02516098|2080264|P2|NOT COMPLETED|Period 1||0
859731|NCT02516098|2080265|P1|NOT COMPLETED|Period 1||1
859732|NCT02516098|2080264|P2|COMPLETED|Period 1||28
859733|NCT02516098|2080265|P1|COMPLETED|Period 1||27
859734|NCT02516098|2080264|P2|STARTED|Period 1||28
859735|NCT02516098|2080265|P1|STARTED|Period 1||28
859736|NCT02515994|2080279|P2|NOT COMPLETED|Overall Study||7
859737|NCT02515994|2080280|P1|NOT COMPLETED|Overall Study||10
859738|NCT02515994|2080279|P2|COMPLETED|Overall Study||105
859739|NCT02515994|2080280|P1|COMPLETED|Overall Study||99
859740|NCT02515994|2080279|P2|STARTED|Overall Study||112
859741|NCT02515994|2080280|P1|STARTED|Overall Study||109
859742|NCT02515279|2080292|P1|NOT COMPLETED|Overall Study||104
859743|NCT02515279|2080292|P1|COMPLETED|Overall Study||359
859744|NCT02515279|2080292|P1|STARTED|Overall Study||463
859745|NCT02515045|2080300|P3|NOT COMPLETED|Overall Study||4
859746|NCT02515045|2080301|P2|NOT COMPLETED|Overall Study||4
859747|NCT02515045|2080302|P1|NOT COMPLETED|Overall Study||0
859748|NCT02515045|2080300|P3|COMPLETED|Overall Study||55
859749|NCT02515045|2080301|P2|COMPLETED|Overall Study||26
859750|NCT02515045|2080302|P1|COMPLETED|Overall Study||29
859751|NCT02515045|2080300|P3|STARTED|Overall Study||59
859752|NCT02515045|2080301|P2|STARTED|Overall Study||30
859753|NCT02515045|2080302|P1|STARTED|Overall Study||29
859778|NCT02513095|2080360|P2|NOT COMPLETED|Overall Study||16
859779|NCT02513095|2080361|P1|NOT COMPLETED|Overall Study||14
859780|NCT02513095|2080360|P2|COMPLETED|Overall Study||1
859781|NCT02513095|2080361|P1|COMPLETED|Overall Study||3
859782|NCT02513095|2080360|P2|STARTED|Overall Study||17
859783|NCT02513095|2080361|P1|STARTED|Overall Study||17
859784|NCT02512900|2080369|P2|NOT COMPLETED|Overall Study||0
859785|NCT02512900|2080370|P1|NOT COMPLETED|Overall Study||0
859786|NCT02512900|2080369|P2|COMPLETED|Overall Study||10
859787|NCT02512900|2080370|P1|COMPLETED|Overall Study||11
859788|NCT02512900|2080369|P2|STARTED|Overall Study||10
859789|NCT02512900|2080370|P1|STARTED|Overall Study||11
859790|NCT02512783|2080403|P2|NOT COMPLETED|Overall Study||0
859791|NCT02512783|2080404|P1|NOT COMPLETED|Overall Study||0
859792|NCT02512783|2080403|P2|COMPLETED|Overall Study||75
859793|NCT02512783|2080404|P1|COMPLETED|Overall Study||96
859794|NCT02512783|2080403|P2|STARTED|Overall Study||75
859795|NCT02512783|2080404|P1|STARTED|Overall Study||96
859796|NCT02512679|2080412|P2|NOT COMPLETED|Overall Study||0
859797|NCT02512679|2080413|P1|NOT COMPLETED|Overall Study||0
859798|NCT02512679|2080412|P2|COMPLETED|Overall Study||0
859799|NCT02512679|2080413|P1|COMPLETED|Overall Study||20
859800|NCT02512679|2080412|P2|STARTED|Overall Study||0
859801|NCT02512679|2080413|P1|STARTED|Overall Study||20
859802|NCT02512393|2080423|P2|NOT COMPLETED|Overall Study||0
859803|NCT02512393|2080424|P1|NOT COMPLETED|Overall Study||1
859804|NCT02512393|2080423|P2|COMPLETED|Overall Study||20
859805|NCT02512393|2080424|P1|COMPLETED|Overall Study||20
859806|NCT02512393|2080423|P2|STARTED|Overall Study||20
859807|NCT02512393|2080424|P1|STARTED|Overall Study||21
859808|NCT02512224|2080506|P2|NOT COMPLETED|Overall Study||0
859809|NCT02512224|2080507|P1|NOT COMPLETED|Overall Study||0
859810|NCT02512224|2080506|P2|COMPLETED|Overall Study||2912
859811|NCT02512224|2080507|P1|COMPLETED|Overall Study||2912
859812|NCT02512224|2080506|P2|STARTED|Overall Study||2912
859813|NCT02512224|2080507|P1|STARTED|Overall Study||2912
859814|NCT02511782|2080526|P3|NOT COMPLETED|Overall Study||0
859815|NCT02511782|2080527|P2|NOT COMPLETED|Overall Study||0
859816|NCT02511782|2080528|P1|NOT COMPLETED|Overall Study||1
859817|NCT02511782|2080526|P3|COMPLETED|Overall Study||10
859818|NCT02511782|2080527|P2|COMPLETED|Overall Study||2
859819|NCT02511782|2080528|P1|COMPLETED|Overall Study||50
859820|NCT02511782|2080526|P3|STARTED|Overall Study||10
859821|NCT02511782|2080527|P2|STARTED|Overall Study||2
859822|NCT02511782|2080528|P1|STARTED|Overall Study||51
859823|NCT02510820|2080538|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
859824|NCT02510820|2080539|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
859825|NCT02510820|2080538|P2|COMPLETED|Second Intervention (4 Weeks)||26
859826|NCT02510820|2080539|P1|COMPLETED|Second Intervention (4 Weeks)||20
859827|NCT02510820|2080538|P2|STARTED|Second Intervention (4 Weeks)||26
859828|NCT02510820|2080539|P1|STARTED|Second Intervention (4 Weeks)||21
859829|NCT02510820|2080538|P2|NOT COMPLETED|Washout (1 Week)||0
859830|NCT02510820|2080539|P1|NOT COMPLETED|Washout (1 Week)||0
859831|NCT02510820|2080538|P2|COMPLETED|Washout (1 Week)||26
859832|NCT02510820|2080539|P1|COMPLETED|Washout (1 Week)||21
859833|NCT02510820|2080538|P2|STARTED|Washout (1 Week)||26
859834|NCT02510820|2080539|P1|STARTED|Washout (1 Week)||21
859835|NCT02510820|2080538|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
859836|NCT02510820|2080539|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
859837|NCT02510820|2080538|P2|COMPLETED|First Intervention (4 Weeks)||26
859838|NCT02510820|2080539|P1|COMPLETED|First Intervention (4 Weeks)||21
859839|NCT02510820|2080538|P2|STARTED|First Intervention (4 Weeks)||27
859840|NCT02510820|2080539|P1|STARTED|First Intervention (4 Weeks)||21
859841|NCT02508103|2080579|P2|NOT COMPLETED|Overall Study||0
859842|NCT02508103|2080580|P1|NOT COMPLETED|Overall Study||0
859843|NCT02508103|2080579|P2|COMPLETED|Overall Study||5
859844|NCT02508103|2080580|P1|COMPLETED|Overall Study||5
859845|NCT02508103|2080579|P2|STARTED|Overall Study||5
859846|NCT02508103|2080580|P1|STARTED|Overall Study||5
859847|NCT02507752|2080588|P1|NOT COMPLETED|Overall Study||17
859848|NCT02507752|2080588|P1|COMPLETED|Overall Study||55
859849|NCT02507752|2080588|P1|STARTED|Overall Study||72
859856|NCT02507375|2080632|P2|NOT COMPLETED|Overall Study||8
859857|NCT02507375|2080633|P1|NOT COMPLETED|Overall Study||4
859858|NCT02507375|2080632|P2|COMPLETED|Overall Study||1
859859|NCT02507375|2080633|P1|COMPLETED|Overall Study||2
859860|NCT02507375|2080632|P2|Extension Period|Overall Study||1
859861|NCT02507375|2080633|P1|Extension Period|Overall Study||2
859862|NCT02507375|2080632|P2|Cycle 6|Overall Study||1
859863|NCT02507375|2080633|P1|Cycle 6|Overall Study||3
859864|NCT02507375|2080632|P2|Cycle 5|Overall Study||1
859865|NCT02507375|2080633|P1|Cycle 5|Overall Study||3
859866|NCT02507375|2080632|P2|Cycle 4|Overall Study||2
859867|NCT02507375|2080633|P1|Cycle 4|Overall Study||4
859868|NCT02507375|2080632|P2|Cycle 3|Overall Study||5
859869|NCT02507375|2080633|P1|Cycle 3|Overall Study||4
859870|NCT02507375|2080632|P2|Cycle 2|Overall Study||5
859871|NCT02507375|2080633|P1|Cycle 2|Overall Study||5
859872|NCT02507375|2080632|P2|Received Pertuzumab|Overall Study||6
859873|NCT02507375|2080633|P1|Received Pertuzumab|Overall Study||6
859874|NCT02507375|2080632|P2|Cycle 1|Overall Study||9
859875|NCT02507375|2080633|P1|Cycle 1|Overall Study||6
859876|NCT02507375|2080632|P2|STARTED|Overall Study|Two patients in cohort 2 did not begin treatment in Cycle 1 so were not included in the analysis set|9
859877|NCT02507375|2080633|P1|STARTED|Overall Study||6
859878|NCT02506881|2080654|P4|NOT COMPLETED|Second Intervention (Day 1)||0
859879|NCT02506881|2080655|P3|NOT COMPLETED|Second Intervention (Day 1)||0
859880|NCT02506881|2080656|P2|NOT COMPLETED|Second Intervention (Day 1)||0
859881|NCT02506881|2080657|P1|NOT COMPLETED|Second Intervention (Day 1)||0
859882|NCT02506881|2080654|P4|COMPLETED|Second Intervention (Day 1)||12
859883|NCT02506881|2080655|P3|COMPLETED|Second Intervention (Day 1)||12
859884|NCT02506881|2080656|P2|COMPLETED|Second Intervention (Day 1)||12
859885|NCT02506881|2080657|P1|COMPLETED|Second Intervention (Day 1)||12
859886|NCT02506881|2080654|P4|STARTED|Second Intervention (Day 1)||12
859887|NCT02506881|2080655|P3|STARTED|Second Intervention (Day 1)||12
859888|NCT02506881|2080656|P2|STARTED|Second Intervention (Day 1)||12
859889|NCT02506881|2080657|P1|STARTED|Second Intervention (Day 1)||12
859890|NCT02506881|2080654|P4|NOT COMPLETED|Washout (at Least 25 Days)||0
859891|NCT02506881|2080655|P3|NOT COMPLETED|Washout (at Least 25 Days)||0
859892|NCT02506881|2080656|P2|NOT COMPLETED|Washout (at Least 25 Days)||0
859893|NCT02506881|2080657|P1|NOT COMPLETED|Washout (at Least 25 Days)||0
859894|NCT02506881|2080654|P4|COMPLETED|Washout (at Least 25 Days)||12
859895|NCT02506881|2080655|P3|COMPLETED|Washout (at Least 25 Days)||12
859896|NCT02506881|2080656|P2|COMPLETED|Washout (at Least 25 Days)||12
859897|NCT02506881|2080657|P1|COMPLETED|Washout (at Least 25 Days)||12
859898|NCT02506881|2080654|P4|STARTED|Washout (at Least 25 Days)||12
859899|NCT02506881|2080655|P3|STARTED|Washout (at Least 25 Days)||12
859900|NCT02506881|2080656|P2|STARTED|Washout (at Least 25 Days)||12
859901|NCT02506881|2080657|P1|STARTED|Washout (at Least 25 Days)||12
859902|NCT02506881|2080654|P4|NOT COMPLETED|First Intervention (Day 1)||12
859903|NCT02506881|2080655|P3|NOT COMPLETED|First Intervention (Day 1)||13
859904|NCT02506881|2080656|P2|NOT COMPLETED|First Intervention (Day 1)||0
859905|NCT02506881|2080657|P1|NOT COMPLETED|First Intervention (Day 1)||1
859906|NCT02506881|2080654|P4|COMPLETED|First Intervention (Day 1)||12
859907|NCT02506881|2080655|P3|COMPLETED|First Intervention (Day 1)||12
859908|NCT02506881|2080656|P2|COMPLETED|First Intervention (Day 1)||12
859909|NCT02506881|2080657|P1|COMPLETED|First Intervention (Day 1)||12
859910|NCT02506881|2080654|P4|STARTED|First Intervention (Day 1)||24
859911|NCT02506881|2080655|P3|STARTED|First Intervention (Day 1)||25
859912|NCT02506881|2080656|P2|STARTED|First Intervention (Day 1)||12
859913|NCT02506881|2080657|P1|STARTED|First Intervention (Day 1)||13
859914|NCT02506309|2080693|P2|NOT COMPLETED|Overall Study||1
859915|NCT02506309|2080694|P1|NOT COMPLETED|Overall Study||2
859916|NCT02506309|2080693|P2|COMPLETED|Overall Study||44
859917|NCT02506309|2080694|P1|COMPLETED|Overall Study||46
859918|NCT02506309|2080693|P2|STARTED|Overall Study||45
859919|NCT02506309|2080694|P1|STARTED|Overall Study||48
859920|NCT02506257|2080710|P4|NOT COMPLETED|Overall Study||0
859921|NCT02506257|2080711|P3|NOT COMPLETED|Overall Study||4
859922|NCT02506257|2080712|P2|NOT COMPLETED|Overall Study||2
859923|NCT02506257|2080713|P1|NOT COMPLETED|Overall Study||0
859924|NCT02506257|2080710|P4|COMPLETED|Overall Study||9
859925|NCT02506257|2080711|P3|COMPLETED|Overall Study||23
859926|NCT02506257|2080712|P2|COMPLETED|Overall Study||26
859927|NCT02506257|2080713|P1|COMPLETED|Overall Study||26
859928|NCT02506257|2080710|P4|STARTED|Overall Study||9
859929|NCT02506257|2080711|P3|STARTED|Overall Study||27
859930|NCT02506257|2080712|P2|STARTED|Overall Study||28
859931|NCT02506257|2080713|P1|STARTED|Overall Study||26
859932|NCT02504775|2080743|P2|NOT COMPLETED|Period 2||0
859933|NCT02504775|2080744|P1|NOT COMPLETED|Period 2||0
859934|NCT02504775|2080743|P2|COMPLETED|Period 2||14
859935|NCT02504775|2080744|P1|COMPLETED|Period 2||14
859936|NCT02504775|2080743|P2|STARTED|Period 2||14
859937|NCT02504775|2080744|P1|STARTED|Period 2||14
859938|NCT02504775|2080743|P2|NOT COMPLETED|Washout||0
859939|NCT02504775|2080744|P1|NOT COMPLETED|Washout||0
859940|NCT02504775|2080743|P2|COMPLETED|Washout||14
859941|NCT02504775|2080744|P1|COMPLETED|Washout||14
859942|NCT02504775|2080743|P2|STARTED|Washout||14
859943|NCT02504775|2080744|P1|STARTED|Washout||14
859944|NCT02504775|2080743|P2|NOT COMPLETED|Period 1||0
859945|NCT02504775|2080744|P1|NOT COMPLETED|Period 1||0
859946|NCT02504775|2080743|P2|COMPLETED|Period 1||14
859947|NCT02504775|2080744|P1|COMPLETED|Period 1||14
859948|NCT02504775|2080743|P2|STARTED|Period 1||14
859949|NCT02504775|2080744|P1|STARTED|Period 1||14
859950|NCT02504723|2080758|P2|NOT COMPLETED|Overall Study||0
859951|NCT02504723|2080759|P1|NOT COMPLETED|Overall Study||0
859952|NCT02504723|2080758|P2|COMPLETED|Overall Study||61
859953|NCT02504723|2080759|P1|COMPLETED|Overall Study||60
859954|NCT02504723|2080758|P2|STARTED|Overall Study||61
859955|NCT02504723|2080759|P1|STARTED|Overall Study||60
859956|NCT02504502|2080773|P2|NOT COMPLETED|Crossover to Enhanced Report||0
859957|NCT02504502|2080774|P1|NOT COMPLETED|Crossover to Enhanced Report||5
859958|NCT02504502|2080773|P2|COMPLETED|Crossover to Enhanced Report|the enhanced report arm was completed in first period and does not carry forward to period 2|0
859959|NCT02504502|2080774|P1|COMPLETED|Crossover to Enhanced Report||15
859960|NCT02504502|2080773|P2|STARTED|Crossover to Enhanced Report|The enhanced report arm was completed in first period and does not carry forward to period 2.|0
859961|NCT02504502|2080774|P1|STARTED|Crossover to Enhanced Report||20
859962|NCT02504502|2080773|P2|NOT COMPLETED|Routine Care vs. Enhanced Report||7
859963|NCT02504502|2080774|P1|NOT COMPLETED|Routine Care vs. Enhanced Report||4
859964|NCT02504502|2080773|P2|COMPLETED|Routine Care vs. Enhanced Report||21
859965|NCT02504502|2080774|P1|COMPLETED|Routine Care vs. Enhanced Report||20
859966|NCT02504502|2080773|P2|STARTED|Routine Care vs. Enhanced Report||28
859967|NCT02504502|2080774|P1|STARTED|Routine Care vs. Enhanced Report||24
859968|NCT02504320|2080784|P4|NOT COMPLETED|Treatment Period 4||0
859969|NCT02504320|2080785|P3|NOT COMPLETED|Treatment Period 4||0
859970|NCT02504320|2080786|P2|NOT COMPLETED|Treatment Period 4||0
859971|NCT02504320|2080787|P1|NOT COMPLETED|Treatment Period 4||0
859972|NCT02504320|2080784|P4|COMPLETED|Treatment Period 4||19
859973|NCT02504320|2080785|P3|COMPLETED|Treatment Period 4||18
859974|NCT02504320|2080786|P2|COMPLETED|Treatment Period 4||18
859975|NCT02504320|2080787|P1|COMPLETED|Treatment Period 4||19
859976|NCT02504320|2080784|P4|STARTED|Treatment Period 4||19
859977|NCT02504320|2080785|P3|STARTED|Treatment Period 4||18
859978|NCT02504320|2080786|P2|STARTED|Treatment Period 4||18
859979|NCT02504320|2080787|P1|STARTED|Treatment Period 4||19
859980|NCT02504320|2080784|P4|NOT COMPLETED|Treatment Period 3||1
859981|NCT02504320|2080785|P3|NOT COMPLETED|Treatment Period 3||1
859982|NCT02504320|2080786|P2|NOT COMPLETED|Treatment Period 3||0
859983|NCT02504320|2080787|P1|NOT COMPLETED|Treatment Period 3||0
859984|NCT02504320|2080784|P4|COMPLETED|Treatment Period 3||19
859985|NCT02504320|2080785|P3|COMPLETED|Treatment Period 3||18
859986|NCT02504320|2080786|P2|COMPLETED|Treatment Period 3||18
859987|NCT02504320|2080787|P1|COMPLETED|Treatment Period 3||19
859988|NCT02504320|2080784|P4|STARTED|Treatment Period 3||20
859989|NCT02504320|2080785|P3|STARTED|Treatment Period 3||19
859990|NCT02504320|2080786|P2|STARTED|Treatment Period 3||18
859991|NCT02504320|2080787|P1|STARTED|Treatment Period 3||19
859992|NCT02504320|2080784|P4|NOT COMPLETED|Treatment Period 2||0
859993|NCT02504320|2080785|P3|NOT COMPLETED|Treatment Period 2||0
859994|NCT02504320|2080786|P2|NOT COMPLETED|Treatment Period 2||1
859995|NCT02504320|2080787|P1|NOT COMPLETED|Treatment Period 2||0
859996|NCT02504320|2080784|P4|COMPLETED|Treatment Period 2||20
859997|NCT02504320|2080785|P3|COMPLETED|Treatment Period 2||19
859998|NCT02504320|2080786|P2|COMPLETED|Treatment Period 2||18
859999|NCT02504320|2080787|P1|COMPLETED|Treatment Period 2||19
860000|NCT02504320|2080784|P4|STARTED|Treatment Period 2||20
860001|NCT02504320|2080785|P3|STARTED|Treatment Period 2||19
860002|NCT02504320|2080786|P2|STARTED|Treatment Period 2||19
860003|NCT02504320|2080787|P1|STARTED|Treatment Period 2||19
860004|NCT02504320|2080784|P4|NOT COMPLETED|Treatment Period 1||0
860005|NCT02504320|2080785|P3|NOT COMPLETED|Treatment Period 1||1
860006|NCT02504320|2080786|P2|NOT COMPLETED|Treatment Period 1||0
860007|NCT02504320|2080787|P1|NOT COMPLETED|Treatment Period 1||0
860008|NCT02504320|2080784|P4|COMPLETED|Treatment Period 1||20
860009|NCT02504320|2080785|P3|COMPLETED|Treatment Period 1||19
860010|NCT02504320|2080786|P2|COMPLETED|Treatment Period 1||19
860011|NCT02504320|2080787|P1|COMPLETED|Treatment Period 1||19
860012|NCT02504320|2080784|P4|STARTED|Treatment Period 1||20
860013|NCT02504320|2080785|P3|STARTED|Treatment Period 1||20
860014|NCT02504320|2080786|P2|STARTED|Treatment Period 1||19
860015|NCT02504320|2080787|P1|STARTED|Treatment Period 1||19
860016|NCT02504073|2080805|P1|NOT COMPLETED|Overall Study||0
860017|NCT02504073|2080805|P1|COMPLETED|Overall Study||54
860018|NCT02504073|2080805|P1|STARTED|Overall Study||54
860019|NCT02503982|2080811|P1|NOT COMPLETED|Overall Study||0
860020|NCT02503982|2080811|P1|COMPLETED|Overall Study||13
860021|NCT02503982|2080811|P1|STARTED|Overall Study||13
860022|NCT02503865|2080818|P3|NOT COMPLETED|Overall Study||2
860023|NCT02503865|2080819|P2|NOT COMPLETED|Overall Study||47
860024|NCT02503865|2080820|P1|NOT COMPLETED|Overall Study||5
860025|NCT02503865|2080818|P3|COMPLETED|Overall Study||64
860026|NCT02503865|2080819|P2|COMPLETED|Overall Study||222
860027|NCT02503865|2080820|P1|COMPLETED|Overall Study||65
860028|NCT02503865|2080818|P3|STARTED|Overall Study||66
860029|NCT02503865|2080819|P2|STARTED|Overall Study||269
860030|NCT02503865|2080820|P1|STARTED|Overall Study||70
860031|NCT02503787|2080840|P1|NOT COMPLETED|Implant to 3 Month Endpoint||3
860032|NCT02503787|2080840|P1|COMPLETED|Implant to 3 Month Endpoint||29
860033|NCT02503787|2080840|P1|STARTED|Implant to 3 Month Endpoint||32
860034|NCT02503787|2080840|P1|NOT COMPLETED|Successful Trial (≥50% Pain Relief)||5
860035|NCT02503787|2080840|P1|COMPLETED|Successful Trial (≥50% Pain Relief)||32
860036|NCT02503787|2080840|P1|STARTED|Successful Trial (≥50% Pain Relief)||37
860037|NCT02503787|2080840|P1|NOT COMPLETED|Device Trial (HD Programming Trial)||7
860038|NCT02503787|2080840|P1|COMPLETED|Device Trial (HD Programming Trial)||37
860039|NCT02503787|2080840|P1|STARTED|Device Trial (HD Programming Trial)||44
860040|NCT02503787|2080840|P1|NOT COMPLETED|Enrollment||20
860041|NCT02503787|2080840|P1|COMPLETED|Enrollment||44
860042|NCT02503787|2080840|P1|STARTED|Enrollment||64
860043|NCT02503254|2080849|P2|NOT COMPLETED|Overall Study||0
860044|NCT02503254|2080850|P1|NOT COMPLETED|Overall Study||0
860045|NCT02503254|2080849|P2|COMPLETED|Overall Study||39
860046|NCT02503254|2080850|P1|COMPLETED|Overall Study||41
860047|NCT02503254|2080849|P2|STARTED|Overall Study||39
860048|NCT02503254|2080850|P1|STARTED|Overall Study||41
860049|NCT02503215|2080863|P1|NOT COMPLETED|Overall Study||3
860050|NCT02503215|2080863|P1|COMPLETED|Overall Study||14
860051|NCT02503215|2080863|P1|STARTED|Overall Study||17
860052|NCT02502734|2080869|P2|NOT COMPLETED|Double-blind Treatment Period 2||0
860053|NCT02502734|2080870|P1|NOT COMPLETED|Double-blind Treatment Period 2||0
860054|NCT02502734|2080869|P2|COMPLETED|Double-blind Treatment Period 2||30
860055|NCT02502734|2080870|P1|COMPLETED|Double-blind Treatment Period 2||28
860056|NCT02502734|2080869|P2|STARTED|Double-blind Treatment Period 2||30
860057|NCT02502734|2080870|P1|STARTED|Double-blind Treatment Period 2||28
860058|NCT02502734|2080869|P2|NOT COMPLETED|Washout Period||0
860059|NCT02502734|2080870|P1|NOT COMPLETED|Washout Period||1
860060|NCT02502734|2080869|P2|COMPLETED|Washout Period||30
860061|NCT02502734|2080870|P1|COMPLETED|Washout Period||28
860062|NCT02502734|2080869|P2|STARTED|Washout Period||30
860063|NCT02502734|2080870|P1|STARTED|Washout Period||29
860064|NCT02502734|2080869|P2|NOT COMPLETED|Double-blind Treatment Period 1||0
860065|NCT02502734|2080870|P1|NOT COMPLETED|Double-blind Treatment Period 1||1
860066|NCT02502734|2080869|P2|COMPLETED|Double-blind Treatment Period 1||30
860067|NCT02502734|2080870|P1|COMPLETED|Double-blind Treatment Period 1||29
860068|NCT02502734|2080869|P2|STARTED|Double-blind Treatment Period 1||30
860069|NCT02502734|2080870|P1|STARTED|Double-blind Treatment Period 1||30
860070|NCT02502487|2080881|P3|NOT COMPLETED|Overall Study||0
860071|NCT02502487|2080882|P2|NOT COMPLETED|Overall Study||0
860072|NCT02502487|2080883|P1|NOT COMPLETED|Overall Study||0
860073|NCT02502487|2080881|P3|COMPLETED|Overall Study||86
860074|NCT02502487|2080882|P2|COMPLETED|Overall Study||86
860075|NCT02502487|2080883|P1|COMPLETED|Overall Study||86
860076|NCT02502487|2080881|P3|STARTED|Overall Study||86
860077|NCT02502487|2080882|P2|STARTED|Overall Study||86
860078|NCT02502487|2080883|P1|STARTED|Overall Study||86
860079|NCT02501590|2080953|P2|NOT COMPLETED|Overall Study||0
860080|NCT02501590|2080954|P1|NOT COMPLETED|Overall Study||0
860081|NCT02501590|2080953|P2|COMPLETED|Overall Study||35
860082|NCT02501590|2080954|P1|COMPLETED|Overall Study||13
860083|NCT02501590|2080953|P2|STARTED|Overall Study||35
860084|NCT02501590|2080954|P1|STARTED|Overall Study||13
860085|NCT02500836|2080963|P3|NOT COMPLETED|Overall Study||1
860086|NCT02500836|2080964|P2|NOT COMPLETED|Overall Study||5
860087|NCT02500836|2080965|P1|NOT COMPLETED|Overall Study||3
860088|NCT02500836|2080963|P3|COMPLETED|Overall Study||127
860089|NCT02500836|2080964|P2|COMPLETED|Overall Study||254
860090|NCT02500836|2080965|P1|COMPLETED|Overall Study||256
860091|NCT02500836|2080963|P3|STARTED|Overall Study||128
860092|NCT02500836|2080964|P2|STARTED|Overall Study||259
860093|NCT02500836|2080965|P1|STARTED|Overall Study||259
860094|NCT02500758|2080976|P2|NOT COMPLETED|Second Intervention (2 Minutes)||2
860095|NCT02500758|2080977|P1|NOT COMPLETED|Second Intervention (2 Minutes)||3
860096|NCT02500758|2080976|P2|COMPLETED|Second Intervention (2 Minutes)||10
860097|NCT02500758|2080977|P1|COMPLETED|Second Intervention (2 Minutes)||10
860098|NCT02500758|2080976|P2|STARTED|Second Intervention (2 Minutes)||12
860099|NCT02500758|2080977|P1|STARTED|Second Intervention (2 Minutes)||13
860100|NCT02500758|2080976|P2|NOT COMPLETED|Washout (1 Week)||2
860101|NCT02500758|2080977|P1|NOT COMPLETED|Washout (1 Week)||2
860102|NCT02500758|2080976|P2|COMPLETED|Washout (1 Week)||12
860103|NCT02500758|2080977|P1|COMPLETED|Washout (1 Week)||13
860104|NCT02500758|2080976|P2|STARTED|Washout (1 Week)||14
860105|NCT02500758|2080977|P1|STARTED|Washout (1 Week)||15
860106|NCT02500758|2080976|P2|NOT COMPLETED|First Intervention (2 Minutes)||1
860107|NCT02500758|2080977|P1|NOT COMPLETED|First Intervention (2 Minutes)||0
860108|NCT02500758|2080976|P2|COMPLETED|First Intervention (2 Minutes)||14
860109|NCT02500758|2080977|P1|COMPLETED|First Intervention (2 Minutes)||15
860110|NCT02500758|2080976|P2|STARTED|First Intervention (2 Minutes)||15
860111|NCT02500758|2080977|P1|STARTED|First Intervention (2 Minutes)||15
860112|NCT02500537|2080987|P2|NOT COMPLETED|Overall Study||1
860113|NCT02500537|2080988|P1|NOT COMPLETED|Overall Study||3
860114|NCT02500537|2080987|P2|COMPLETED|Overall Study||39
860115|NCT02500537|2080988|P1|COMPLETED|Overall Study||57
860116|NCT02500537|2080987|P2|STARTED|Overall Study||40
860117|NCT02500537|2080988|P1|STARTED|Overall Study||60
860118|NCT02500368|2081006|P2|NOT COMPLETED|Second Intervention (1 Week)||0
860119|NCT02500368|2081007|P1|NOT COMPLETED|Second Intervention (1 Week)||0
860120|NCT02500368|2081006|P2|COMPLETED|Second Intervention (1 Week)||20
860121|NCT02500368|2081007|P1|COMPLETED|Second Intervention (1 Week)||20
860122|NCT02500368|2081006|P2|STARTED|Second Intervention (1 Week)||20
860123|NCT02500368|2081007|P1|STARTED|Second Intervention (1 Week)||20
860124|NCT02500368|2081006|P2|NOT COMPLETED|First Intervention (1 Week)||0
860125|NCT02500368|2081007|P1|NOT COMPLETED|First Intervention (1 Week)||0
860126|NCT02500368|2081006|P2|COMPLETED|First Intervention (1 Week)||20
860127|NCT02500368|2081007|P1|COMPLETED|First Intervention (1 Week)||20
860128|NCT02500368|2081006|P2|STARTED|First Intervention (1 Week)||20
860129|NCT02500368|2081007|P1|STARTED|First Intervention (1 Week)||20
860130|NCT02500056|2081057|P2|NOT COMPLETED|Overall Study||8
860131|NCT02500056|2081058|P1|NOT COMPLETED|Overall Study||7
860132|NCT02500056|2081057|P2|COMPLETED|Overall Study||65
860133|NCT02500056|2081058|P1|COMPLETED|Overall Study||63
860134|NCT02500056|2081057|P2|STARTED|Overall Study||73
860135|NCT02500056|2081058|P1|STARTED|Overall Study||70
860136|NCT02499692|2081068|P1|NOT COMPLETED|Overall Study||0
860137|NCT02499692|2081068|P1|COMPLETED|Overall Study||103
860138|NCT02499692|2081068|P1|STARTED|Overall Study||103
860139|NCT02499575|2081079|P2|NOT COMPLETED|Overall Study||1
860140|NCT02499575|2081080|P1|NOT COMPLETED|Overall Study||0
860141|NCT02499575|2081079|P2|COMPLETED|Overall Study||0
860142|NCT02499575|2081080|P1|COMPLETED|Overall Study||1
860143|NCT02499575|2081079|P2|STARTED|Overall Study||1
860144|NCT02499575|2081080|P1|STARTED|Overall Study||1
860145|NCT02498821|2081092|P2|NOT COMPLETED|Overall Study||5
860146|NCT02498821|2081093|P1|NOT COMPLETED|Overall Study||3
860147|NCT02498821|2081092|P2|COMPLETED|Overall Study||60
860148|NCT02498821|2081093|P1|COMPLETED|Overall Study||60
860149|NCT02498821|2081092|P2|STARTED|Overall Study||65
860150|NCT02498821|2081093|P1|STARTED|Overall Study||63
860151|NCT02498678|2081122|P2|NOT COMPLETED|Overall Study||2
860152|NCT02498678|2081123|P1|NOT COMPLETED|Overall Study||0
860153|NCT02498678|2081122|P2|COMPLETED|Overall Study||23
860154|NCT02498678|2081123|P1|COMPLETED|Overall Study||25
860155|NCT02498678|2081122|P2|STARTED|Overall Study||25
860156|NCT02498678|2081123|P1|STARTED|Overall Study||25
860157|NCT02498522|2081139|P2|NOT COMPLETED|Overall Study||2
860158|NCT02498522|2081140|P1|NOT COMPLETED|Overall Study||2
860159|NCT02498522|2081139|P2|COMPLETED|Overall Study||83
860160|NCT02498522|2081140|P1|COMPLETED|Overall Study||83
860161|NCT02498522|2081139|P2|STARTED|Overall Study||85
860162|NCT02498522|2081140|P1|STARTED|Overall Study||85
860163|NCT02497235|2081151|P5|NOT COMPLETED|Overall Study||0
860164|NCT02497235|2081152|P4|NOT COMPLETED|Overall Study||0
860165|NCT02497235|2081153|P3|NOT COMPLETED|Overall Study||0
860166|NCT02497235|2081154|P2|NOT COMPLETED|Overall Study||0
860167|NCT02497235|2081155|P1|NOT COMPLETED|Overall Study||0
860168|NCT02497235|2081151|P5|COMPLETED|Overall Study||3
860169|NCT02497235|2081152|P4|COMPLETED|Overall Study||2
860170|NCT02497235|2081153|P3|COMPLETED|Overall Study||2
860171|NCT02497235|2081154|P2|COMPLETED|Overall Study||2
860172|NCT02497235|2081155|P1|COMPLETED|Overall Study||2
860173|NCT02497235|2081151|P5|STARTED|Overall Study||3
860174|NCT02497235|2081152|P4|STARTED|Overall Study||2
860175|NCT02497235|2081153|P3|STARTED|Overall Study||2
860176|NCT02497235|2081154|P2|STARTED|Overall Study||2
860177|NCT02497235|2081155|P1|STARTED|Overall Study||2
860178|NCT02496533|2081187|P2|NOT COMPLETED|Overall Study||6
860179|NCT02496533|2081188|P1|NOT COMPLETED|Overall Study||3
860180|NCT02496533|2081187|P2|COMPLETED|Overall Study||106
860181|NCT02496533|2081188|P1|COMPLETED|Overall Study||102
860182|NCT02496533|2081187|P2|STARTED|Overall Study||112
860183|NCT02496533|2081188|P1|STARTED|Overall Study||105
860184|NCT02496221|2081200|P2|NOT COMPLETED|Treatment Period 2 - 4 Days||1
860185|NCT02496221|2081201|P1|NOT COMPLETED|Treatment Period 2 - 4 Days||2
860186|NCT02496221|2081200|P2|COMPLETED|Treatment Period 2 - 4 Days||9
860187|NCT02496221|2081201|P1|COMPLETED|Treatment Period 2 - 4 Days||8
860188|NCT02496221|2081200|P2|STARTED|Treatment Period 2 - 4 Days||10
860189|NCT02496221|2081201|P1|STARTED|Treatment Period 2 - 4 Days||10
860190|NCT02496221|2081200|P2|NOT COMPLETED|Treatment Period 1 - 4 Days||0
860191|NCT02496221|2081201|P1|NOT COMPLETED|Treatment Period 1 - 4 Days||0
860192|NCT02496221|2081200|P2|COMPLETED|Treatment Period 1 - 4 Days||10
860193|NCT02496221|2081201|P1|COMPLETED|Treatment Period 1 - 4 Days||10
860194|NCT02496221|2081200|P2|STARTED|Treatment Period 1 - 4 Days||10
860195|NCT02496221|2081201|P1|STARTED|Treatment Period 1 - 4 Days||10
860196|NCT02496039|2081235|P1|NOT COMPLETED|Overall Study||4
860197|NCT02496039|2081235|P1|COMPLETED|Overall Study||1
860198|NCT02496039|2081235|P1|STARTED|Overall Study||5
860199|NCT02496000|2081250|P3|NOT COMPLETED|Overall Study||2
860200|NCT02496000|2081251|P2|NOT COMPLETED|Overall Study||5
860201|NCT02496000|2081252|P1|NOT COMPLETED|Overall Study||2
860202|NCT02496000|2081250|P3|COMPLETED|Overall Study||61
860203|NCT02496000|2081251|P2|COMPLETED|Overall Study||56
860204|NCT02496000|2081252|P1|COMPLETED|Overall Study||62
860205|NCT02496000|2081250|P3|STARTED|Overall Study||63
860206|NCT02496000|2081251|P2|STARTED|Overall Study||61
860207|NCT02496000|2081252|P1|STARTED|Overall Study||64
860208|NCT02495948|2081261|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
860209|NCT02495948|2081262|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
860210|NCT02495948|2081261|P2|COMPLETED|Period 2, Second 30 Days of Wear||82
860211|NCT02495948|2081262|P1|COMPLETED|Period 2, Second 30 Days of Wear||82
860212|NCT02495948|2081261|P2|STARTED|Period 2, Second 30 Days of Wear||83
860213|NCT02495948|2081262|P1|STARTED|Period 2, Second 30 Days of Wear||83
860214|NCT02495948|2081261|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||1
860215|NCT02495948|2081262|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
860216|NCT02495948|2081261|P2|COMPLETED|Period 1, First 30 Days of Wear||83
860217|NCT02495948|2081262|P1|COMPLETED|Period 1, First 30 Days of Wear||83
860218|NCT02495948|2081261|P2|STARTED|Period 1, First 30 Days of Wear||84
860219|NCT02495948|2081262|P1|STARTED|Period 1, First 30 Days of Wear||83
860220|NCT02495831|2081269|P2|NOT COMPLETED|Second Intervention||0
860221|NCT02495831|2081270|P1|NOT COMPLETED|Second Intervention||0
860222|NCT02495831|2081269|P2|COMPLETED|Second Intervention||10
860223|NCT02495831|2081270|P1|COMPLETED|Second Intervention||12
860224|NCT02495831|2081269|P2|STARTED|Second Intervention||10
860225|NCT02495831|2081270|P1|STARTED|Second Intervention|One participant withdrew at the end of period 1|12
860226|NCT02495831|2081269|P2|NOT COMPLETED|First Intervention||0
860227|NCT02495831|2081270|P1|NOT COMPLETED|First Intervention||0
860228|NCT02495831|2081269|P2|COMPLETED|First Intervention||10
860229|NCT02495831|2081270|P1|COMPLETED|First Intervention||13
860230|NCT02495831|2081269|P2|STARTED|First Intervention||10
860231|NCT02495831|2081270|P1|STARTED|First Intervention||13
860232|NCT02495623|2081287|P3|NOT COMPLETED|Overall Study||8
860233|NCT02495623|2081288|P2|NOT COMPLETED|Overall Study||9
860234|NCT02495623|2081289|P1|NOT COMPLETED|Overall Study||5
860235|NCT02495623|2081287|P3|COMPLETED|Overall Study||20
860236|NCT02495623|2081288|P2|COMPLETED|Overall Study||17
860237|NCT02495623|2081289|P1|COMPLETED|Overall Study||20
860238|NCT02495623|2081287|P3|Dosed|Overall Study||22
860239|NCT02495623|2081288|P2|Dosed|Overall Study||19
860240|NCT02495623|2081289|P1|Dosed|Overall Study||22
860241|NCT02495623|2081287|P3|STARTED|Overall Study||28
860242|NCT02495623|2081288|P2|STARTED|Overall Study||26
860243|NCT02495623|2081289|P1|STARTED|Overall Study||25
860244|NCT02494596|2081297|P3|NOT COMPLETED|Overall Study||1
860245|NCT02494596|2081298|P2|NOT COMPLETED|Overall Study||5
860246|NCT02494596|2081299|P1|NOT COMPLETED|Overall Study||3
860247|NCT02494596|2081297|P3|COMPLETED|Overall Study||6
860248|NCT02494596|2081298|P2|COMPLETED|Overall Study||2
860249|NCT02494596|2081299|P1|COMPLETED|Overall Study||2
860250|NCT02494596|2081297|P3|STARTED|Overall Study||7
860251|NCT02494596|2081298|P2|STARTED|Overall Study||7
860252|NCT02494596|2081299|P1|STARTED|Overall Study||5
860253|NCT02494440|2081324|P1|NOT COMPLETED|Overall Study||0
860254|NCT02494440|2081324|P1|COMPLETED|Overall Study||90
860255|NCT02494440|2081324|P1|STARTED|Overall Study||90
860256|NCT02494323|2081330|P1|NOT COMPLETED|Overall Study||0
860257|NCT02494323|2081330|P1|COMPLETED|Overall Study||70
860258|NCT02494323|2081330|P1|STARTED|Overall Study||70
860268|NCT02493127|2081350|P2|NOT COMPLETED|Overall Study||1
860269|NCT02493127|2081351|P1|NOT COMPLETED|Overall Study||1
860270|NCT02493127|2081350|P2|COMPLETED|Overall Study||60
860271|NCT02493127|2081351|P1|COMPLETED|Overall Study||60
860272|NCT02493127|2081350|P2|STARTED|Overall Study||61
860273|NCT02493127|2081351|P1|STARTED|Overall Study||61
860274|NCT02493088|2081363|P1|NOT COMPLETED|Overall Study||0
860275|NCT02493088|2081363|P1|COMPLETED|Overall Study||11
860276|NCT02493088|2081363|P1|STARTED|Overall Study||11
860277|NCT02493036|2081372|P3|NOT COMPLETED|Overall Study||2
860278|NCT02493036|2081373|P2|NOT COMPLETED|Overall Study||2
860279|NCT02493036|2081374|P1|NOT COMPLETED|Overall Study||1
860280|NCT02493036|2081372|P3|COMPLETED|Overall Study||15
860281|NCT02493036|2081373|P2|COMPLETED|Overall Study||18
860282|NCT02493036|2081374|P1|COMPLETED|Overall Study||16
860283|NCT02493036|2081372|P3|STARTED|Overall Study||17
860284|NCT02493036|2081373|P2|STARTED|Overall Study||20
860285|NCT02493036|2081374|P1|STARTED|Overall Study||17
860286|NCT02492984|2081384|P2|NOT COMPLETED|Overall Study||0
860287|NCT02492984|2081385|P1|NOT COMPLETED|Overall Study||3
860288|NCT02492984|2081384|P2|COMPLETED|Overall Study||14
860289|NCT02492984|2081385|P1|COMPLETED|Overall Study||70
860290|NCT02492984|2081384|P2|STARTED|Overall Study||14
860291|NCT02492984|2081385|P1|STARTED|Overall Study||73
860292|NCT02492841|2081408|P3|NOT COMPLETED|Overall Study||35
860293|NCT02492841|2081409|P2|NOT COMPLETED|Overall Study||31
860294|NCT02492841|2081410|P1|NOT COMPLETED|Overall Study||34
860295|NCT02492841|2081408|P3|COMPLETED|Overall Study||25
860296|NCT02492841|2081409|P2|COMPLETED|Overall Study||22
860297|NCT02492841|2081410|P1|COMPLETED|Overall Study||22
860298|NCT02492841|2081408|P3|STARTED|Overall Study||60
860299|NCT02492841|2081409|P2|STARTED|Overall Study||53
860300|NCT02492841|2081410|P1|STARTED|Overall Study||56
860301|NCT02492451|2081424|P3|NOT COMPLETED|Overall Study||0
860302|NCT02492451|2081425|P2|NOT COMPLETED|Overall Study||0
860303|NCT02492451|2081426|P1|NOT COMPLETED|Overall Study||0
860304|NCT02492451|2081424|P3|COMPLETED|Overall Study||39
860305|NCT02492451|2081425|P2|COMPLETED|Overall Study||39
860306|NCT02492451|2081426|P1|COMPLETED|Overall Study||40
860307|NCT02492451|2081424|P3|STARTED|Overall Study||39
860308|NCT02492451|2081425|P2|STARTED|Overall Study||39
860309|NCT02492451|2081426|P1|STARTED|Overall Study||40
860310|NCT02492165|2081438|P4|NOT COMPLETED|Overall Study||0
860311|NCT02492165|2081439|P3|NOT COMPLETED|Overall Study||0
860312|NCT02492165|2081440|P2|NOT COMPLETED|Overall Study||1
860313|NCT02492165|2081441|P1|NOT COMPLETED|Overall Study||0
860314|NCT02492165|2081438|P4|COMPLETED|Overall Study||30
860315|NCT02492165|2081439|P3|COMPLETED|Overall Study||60
860316|NCT02492165|2081440|P2|COMPLETED|Overall Study||59
860317|NCT02492165|2081441|P1|COMPLETED|Overall Study||100
860318|NCT02492165|2081438|P4|STARTED|Overall Study||30
860319|NCT02492165|2081439|P3|STARTED|Overall Study||60
860320|NCT02492165|2081440|P2|STARTED|Overall Study||60
860321|NCT02492165|2081441|P1|STARTED|Overall Study||100
860322|NCT02491944|2081463|P1|NOT COMPLETED|Overall Study||0
860323|NCT02491944|2081463|P1|COMPLETED|Overall Study||10
860324|NCT02491944|2081463|P1|STARTED|Overall Study||10
860325|NCT02491892|2081485|P2|NOT COMPLETED|Overall Study||38
860326|NCT02491892|2081486|P1|NOT COMPLETED|Overall Study||41
860327|NCT02491892|2081485|P2|COMPLETED|Overall Study||0
860328|NCT02491892|2081486|P1|COMPLETED|Overall Study||0
860329|NCT02491892|2081485|P2|Treated|Overall Study|One participant was randomized but died before receiving study medication.|37
860330|NCT02491892|2081486|P1|Treated|Overall Study||41
860331|NCT02491892|2081485|P2|STARTED|Overall Study||38
860332|NCT02491892|2081486|P1|STARTED|Overall Study||41
860333|NCT02490670|2081532|P2|NOT COMPLETED|Period 2 (19 Days)||0
860334|NCT02490670|2081533|P1|NOT COMPLETED|Period 2 (19 Days)||0
860335|NCT02490670|2081532|P2|COMPLETED|Period 2 (19 Days)||14
860336|NCT02490670|2081533|P1|COMPLETED|Period 2 (19 Days)||14
860337|NCT02490670|2081532|P2|STARTED|Period 2 (19 Days)||14
860338|NCT02490670|2081533|P1|STARTED|Period 2 (19 Days)||14
860339|NCT02490670|2081532|P2|NOT COMPLETED|Washout Period (7 Days)||0
860340|NCT02490670|2081533|P1|NOT COMPLETED|Washout Period (7 Days)||0
860341|NCT02490670|2081532|P2|COMPLETED|Washout Period (7 Days)||14
860342|NCT02490670|2081533|P1|COMPLETED|Washout Period (7 Days)||14
860343|NCT02490670|2081532|P2|STARTED|Washout Period (7 Days)||14
860344|NCT02490670|2081533|P1|STARTED|Washout Period (7 Days)||14
860345|NCT02490670|2081532|P2|NOT COMPLETED|Period 1 (19 Days)||0
860346|NCT02490670|2081533|P1|NOT COMPLETED|Period 1 (19 Days)||0
860347|NCT02490670|2081532|P2|COMPLETED|Period 1 (19 Days)||14
860348|NCT02490670|2081533|P1|COMPLETED|Period 1 (19 Days)||14
860349|NCT02490670|2081532|P2|STARTED|Period 1 (19 Days)||14
860350|NCT02490670|2081533|P1|STARTED|Period 1 (19 Days)||14
860351|NCT02490475|2081545|P4|NOT COMPLETED|Period 2: Extension Phase||1
860352|NCT02490475|2081546|P3|NOT COMPLETED|Period 2: Extension Phase||3
860353|NCT02490475|2081547|P2|NOT COMPLETED|Period 2: Extension Phase||0
860354|NCT02490475|2081548|P1|NOT COMPLETED|Period 2: Extension Phase||1
860355|NCT02490475|2081545|P4|COMPLETED|Period 2: Extension Phase||0
860356|NCT02490475|2081546|P3|COMPLETED|Period 2: Extension Phase||0
860357|NCT02490475|2081547|P2|COMPLETED|Period 2: Extension Phase||0
860358|NCT02490475|2081548|P1|COMPLETED|Period 2: Extension Phase||0
860359|NCT02490475|2081545|P4|STARTED|Period 2: Extension Phase||1
860360|NCT02490475|2081546|P3|STARTED|Period 2: Extension Phase||3
860361|NCT02490475|2081547|P2|STARTED|Period 2: Extension Phase||0
860362|NCT02490475|2081548|P1|STARTED|Period 2: Extension Phase||1
860363|NCT02490475|2081545|P4|NOT COMPLETED|Period 1: First 6 Cycles||5
860364|NCT02490475|2081546|P3|NOT COMPLETED|Period 1: First 6 Cycles||6
860365|NCT02490475|2081547|P2|NOT COMPLETED|Period 1: First 6 Cycles||2
860366|NCT02490475|2081548|P1|NOT COMPLETED|Period 1: First 6 Cycles||6
860367|NCT02490475|2081545|P4|COMPLETED|Period 1: First 6 Cycles||0
860368|NCT02490475|2081546|P3|COMPLETED|Period 1: First 6 Cycles||0
860369|NCT02490475|2081547|P2|COMPLETED|Period 1: First 6 Cycles||0
860370|NCT02490475|2081548|P1|COMPLETED|Period 1: First 6 Cycles||0
860371|NCT02490475|2081545|P4|STARTED|Period 1: First 6 Cycles||5
860372|NCT02490475|2081546|P3|STARTED|Period 1: First 6 Cycles||6
860373|NCT02490475|2081547|P2|STARTED|Period 1: First 6 Cycles||2
860374|NCT02490475|2081548|P1|STARTED|Period 1: First 6 Cycles||6
860375|NCT02490293|2081626|P2|NOT COMPLETED|Overall Study||3
860376|NCT02490293|2081627|P1|NOT COMPLETED|Overall Study||2
860377|NCT02490293|2081626|P2|COMPLETED|Overall Study||99
860378|NCT02490293|2081627|P1|COMPLETED|Overall Study||94
860379|NCT02490293|2081626|P2|STARTED|Overall Study||102
860380|NCT02490293|2081627|P1|STARTED|Overall Study||96
860381|NCT02489799|2081637|P2|NOT COMPLETED|Overall Study||9
860382|NCT02489799|2081638|P1|NOT COMPLETED|Overall Study||9
860383|NCT02489799|2081637|P2|COMPLETED|Overall Study||38
860384|NCT02489799|2081638|P1|COMPLETED|Overall Study||36
860385|NCT02489799|2081637|P2|Postsurgical One Week Visit (V3)|Overall Study||39
860386|NCT02489799|2081638|P1|Postsurgical One Week Visit (V3)|Overall Study||40
860387|NCT02489799|2081637|P2|Presurgical Consent Visit (V2)|Overall Study||39
860388|NCT02489799|2081638|P1|Presurgical Consent Visit (V2)|Overall Study||40
860389|NCT02489799|2081637|P2|STARTED|Overall Study||47
860390|NCT02489799|2081638|P1|STARTED|Overall Study||45
860391|NCT02488980|2081665|P3|NOT COMPLETED|Overall Study||2
860392|NCT02488980|2081666|P2|NOT COMPLETED|Overall Study||2
860393|NCT02488980|2081667|P1|NOT COMPLETED|Overall Study||2
860394|NCT02488980|2081665|P3|COMPLETED|Overall Study||99
860395|NCT02488980|2081666|P2|COMPLETED|Overall Study||99
860396|NCT02488980|2081667|P1|COMPLETED|Overall Study||102
860397|NCT02488980|2081665|P3|STARTED|Overall Study||101
860398|NCT02488980|2081666|P2|STARTED|Overall Study||101
860399|NCT02488980|2081667|P1|STARTED|Overall Study||104
860400|NCT02488317|2081686|P2|NOT COMPLETED|Overall Study||47
860401|NCT02488317|2081687|P1|NOT COMPLETED|Overall Study||54
860402|NCT02488317|2081686|P2|COMPLETED|Overall Study||70
860403|NCT02488317|2081687|P1|COMPLETED|Overall Study||63
860404|NCT02488317|2081686|P2|STARTED|Overall Study||117
860405|NCT02488317|2081687|P1|STARTED|Overall Study||117
860406|NCT02488070|2081701|P1|NOT COMPLETED|Overall Study||0
860407|NCT02488070|2081701|P1|COMPLETED|Overall Study||10
860408|NCT02488070|2081701|P1|STARTED|Overall Study||10
860409|NCT02488018|2081709|P1|NOT COMPLETED|Overall Study||0
860410|NCT02488018|2081709|P1|COMPLETED|Overall Study||10
860411|NCT02488018|2081709|P1|STARTED|Overall Study||10
860418|NCT02486952|2081744|P1|NOT COMPLETED|Overall Study||50
860419|NCT02486952|2081744|P1|COMPLETED|Overall Study||104
860420|NCT02486952|2081744|P1|Started Induction Therapy|Overall Study||151
860421|NCT02486952|2081744|P1|STARTED|Overall Study||154
860422|NCT02485483|2081751|P2|NOT COMPLETED|Overall Study||0
860423|NCT02485483|2081752|P1|NOT COMPLETED|Overall Study||54
860424|NCT02485483|2081751|P2|COMPLETED|Overall Study||1015
860425|NCT02485483|2081752|P1|COMPLETED|Overall Study||223
860426|NCT02485483|2081751|P2|STARTED|Overall Study||1015
860427|NCT02485483|2081752|P1|STARTED|Overall Study||277
860428|NCT02485353|2081767|P1|NOT COMPLETED|Overall Study||2
860429|NCT02485353|2081767|P1|COMPLETED|Overall Study||0
860430|NCT02485353|2081767|P1|STARTED|Overall Study||2
860431|NCT02485158|2081772|P1|NOT COMPLETED|Overall Study||4
860432|NCT02485158|2081772|P1|COMPLETED|Overall Study||24
860433|NCT02485158|2081772|P1|STARTED|Overall Study||28
860434|NCT02484911|2081861|P2|NOT COMPLETED|Overall Study||2
860435|NCT02484911|2081862|P1|NOT COMPLETED|Overall Study||4
860436|NCT02484911|2081861|P2|COMPLETED|Overall Study||58
860437|NCT02484911|2081862|P1|COMPLETED|Overall Study||56
860438|NCT02484911|2081861|P2|STARTED|Overall Study||60
860439|NCT02484911|2081862|P1|STARTED|Overall Study||60
860440|NCT02484898|2081890|P1|NOT COMPLETED|Overall Study||18
860441|NCT02484898|2081890|P1|COMPLETED|Overall Study||182
860442|NCT02484898|2081890|P1|STARTED|Overall Study||200
860443|NCT02484729|2081904|P10|NOT COMPLETED|Overall Study||1
860444|NCT02484729|2081905|P9|NOT COMPLETED|Overall Study||0
860445|NCT02484729|2081906|P8|NOT COMPLETED|Overall Study||0
860446|NCT02484729|2081907|P7|NOT COMPLETED|Overall Study||0
860447|NCT02484729|2081908|P6|NOT COMPLETED|Overall Study||0
860448|NCT02484729|2081909|P5|NOT COMPLETED|Overall Study||0
860449|NCT02484729|2081910|P4|NOT COMPLETED|Overall Study||0
860450|NCT02484729|2081911|P3|NOT COMPLETED|Overall Study||0
860451|NCT02484729|2081912|P2|NOT COMPLETED|Overall Study||0
860452|NCT02484729|2081913|P1|NOT COMPLETED|Overall Study||0
860453|NCT02484729|2081904|P10|COMPLETED|Overall Study||7
860454|NCT02484729|2081905|P9|COMPLETED|Overall Study||6
860455|NCT02484729|2081906|P8|COMPLETED|Overall Study||6
860456|NCT02484729|2081907|P7|COMPLETED|Overall Study||5
860457|NCT02484729|2081908|P6|COMPLETED|Overall Study||6
860458|NCT02484729|2081909|P5|COMPLETED|Overall Study||5
860459|NCT02484729|2081910|P4|COMPLETED|Overall Study||6
860460|NCT02484729|2081911|P3|COMPLETED|Overall Study||6
860461|NCT02484729|2081912|P2|COMPLETED|Overall Study||6
860462|NCT02484729|2081913|P1|COMPLETED|Overall Study||16
860463|NCT02484729|2081904|P10|STARTED|Overall Study||8
860464|NCT02484729|2081905|P9|STARTED|Overall Study||6
860465|NCT02484729|2081906|P8|STARTED|Overall Study||6
860466|NCT02484729|2081907|P7|STARTED|Overall Study||5
860467|NCT02484729|2081908|P6|STARTED|Overall Study||6
860468|NCT02484729|2081909|P5|STARTED|Overall Study||5
860469|NCT02484729|2081910|P4|STARTED|Overall Study||6
860470|NCT02484729|2081911|P3|STARTED|Overall Study||6
860471|NCT02484729|2081912|P2|STARTED|Overall Study||6
860472|NCT02484729|2081913|P1|STARTED|Overall Study||16
860473|NCT02483975|2082111|P2|NOT COMPLETED|Overall Study||2
860474|NCT02483975|2082112|P1|NOT COMPLETED|Overall Study||2
860475|NCT02483975|2082111|P2|COMPLETED|Overall Study|Subject reported as not completed due to AE was discontinued due to exacerbation, was not an AE/SAE|53
860476|NCT02483975|2082112|P1|COMPLETED|Overall Study||54
860477|NCT02483975|2082111|P2|STARTED|Overall Study||55
860478|NCT02483975|2082112|P1|STARTED|Overall Study||56
860479|NCT02483611|2082129|P3|NOT COMPLETED|Overall Study||1
860480|NCT02483611|2082130|P2|NOT COMPLETED|Overall Study||0
860481|NCT02483611|2082131|P1|NOT COMPLETED|Overall Study||0
860482|NCT02483611|2082129|P3|COMPLETED|Overall Study|One patient required decurarization|15
860483|NCT02483611|2082130|P2|COMPLETED|Overall Study||16
860484|NCT02483611|2082131|P1|COMPLETED|Overall Study||16
860485|NCT02483611|2082129|P3|STARTED|Overall Study||16
860486|NCT02483611|2082130|P2|STARTED|Overall Study||16
860487|NCT02483611|2082131|P1|STARTED|Overall Study||16
860488|NCT02482428|2082231|P5|NOT COMPLETED|Overall Study||7
860489|NCT02482428|2082232|P4|NOT COMPLETED|Overall Study||2
860490|NCT02482428|2082233|P3|NOT COMPLETED|Overall Study||1
860491|NCT02482428|2082234|P2|NOT COMPLETED|Overall Study||12
860492|NCT02482428|2082235|P1|NOT COMPLETED|Overall Study||9
860493|NCT02482428|2082231|P5|COMPLETED|Overall Study||15
860494|NCT02482428|2082232|P4|COMPLETED|Overall Study||8
860495|NCT02482428|2082233|P3|COMPLETED|Overall Study||9
860496|NCT02482428|2082234|P2|COMPLETED|Overall Study||10
860497|NCT02482428|2082235|P1|COMPLETED|Overall Study||15
860498|NCT02482428|2082231|P5|STARTED|Overall Study||22
860499|NCT02482428|2082232|P4|STARTED|Overall Study||10
860500|NCT02482428|2082233|P3|STARTED|Overall Study||10
860501|NCT02482428|2082234|P2|STARTED|Overall Study||22
860502|NCT02482428|2082235|P1|STARTED|Overall Study||24
860503|NCT02482129|2082257|P2|NOT COMPLETED|Overall Study||2
860504|NCT02482129|2082258|P1|NOT COMPLETED|Overall Study||6
860505|NCT02482129|2082257|P2|COMPLETED|Overall Study||9
860506|NCT02482129|2082258|P1|COMPLETED|Overall Study||26
860507|NCT02482129|2082257|P2|Treated, as Randomized|Overall Study||9
860508|NCT02482129|2082258|P1|Treated, as Randomized|Overall Study||30
860509|NCT02482129|2082257|P2|STARTED|Overall Study||11
860510|NCT02482129|2082258|P1|STARTED|Overall Study||32
860511|NCT02481934|2082285|P1|NOT COMPLETED|Overall Study||2
860512|NCT02481934|2082285|P1|COMPLETED|Overall Study||3
860513|NCT02481934|2082285|P1|STARTED|Overall Study||5
860514|NCT02481219|2082292|P2|NOT COMPLETED|Overall Study||1
860515|NCT02481219|2082293|P1|NOT COMPLETED|Overall Study||2
860516|NCT02481219|2082292|P2|COMPLETED|Overall Study||61
860517|NCT02481219|2082293|P1|COMPLETED|Overall Study||58
860518|NCT02481219|2082292|P2|STARTED|Overall Study||62
860519|NCT02481219|2082293|P1|STARTED|Overall Study||60
860520|NCT02480712|2082309|P1|NOT COMPLETED|Overall Study||11
860521|NCT02480712|2082309|P1|COMPLETED|Overall Study||96
860522|NCT02480712|2082309|P1|STARTED|Overall Study||107
860523|NCT02480582|2082326|P6|NOT COMPLETED|Overall Study||0
860524|NCT02480582|2082327|P5|NOT COMPLETED|Overall Study||0
860525|NCT02480582|2082328|P4|NOT COMPLETED|Overall Study||0
860526|NCT02480582|2082329|P3|NOT COMPLETED|Overall Study||0
860527|NCT02480582|2082330|P2|NOT COMPLETED|Overall Study||0
860528|NCT02480582|2082331|P1|NOT COMPLETED|Overall Study||0
860529|NCT02480582|2082326|P6|COMPLETED|Overall Study||7
860530|NCT02480582|2082327|P5|COMPLETED|Overall Study||7
860531|NCT02480582|2082328|P4|COMPLETED|Overall Study||7
860532|NCT02480582|2082329|P3|COMPLETED|Overall Study||7
860533|NCT02480582|2082330|P2|COMPLETED|Overall Study||7
860534|NCT02480582|2082331|P1|COMPLETED|Overall Study||7
860535|NCT02480582|2082326|P6|STARTED|Overall Study||7
860536|NCT02480582|2082327|P5|STARTED|Overall Study||7
860537|NCT02480582|2082328|P4|STARTED|Overall Study||7
860538|NCT02480582|2082329|P3|STARTED|Overall Study||7
860539|NCT02480582|2082330|P2|STARTED|Overall Study||7
860540|NCT02480582|2082331|P1|STARTED|Overall Study||7
860541|NCT02480439|2082354|P3|NOT COMPLETED|Treatment Period 3||0
860542|NCT02480439|2082355|P2|NOT COMPLETED|Treatment Period 3||0
860543|NCT02480439|2082356|P1|NOT COMPLETED|Treatment Period 3||0
860544|NCT02480439|2082354|P3|COMPLETED|Treatment Period 3||7
860545|NCT02480439|2082355|P2|COMPLETED|Treatment Period 3||7
860546|NCT02480439|2082356|P1|COMPLETED|Treatment Period 3||8
860547|NCT02480439|2082354|P3|STARTED|Treatment Period 3|1 Participant was withdrawn due to an Adverse Event after completing Period 2.|7
860548|NCT02480439|2082355|P2|STARTED|Treatment Period 3||7
860549|NCT02480439|2082356|P1|STARTED|Treatment Period 3||8
860550|NCT02480439|2082354|P3|NOT COMPLETED|Treatment Period 2||0
860551|NCT02480439|2082355|P2|NOT COMPLETED|Treatment Period 2||0
860552|NCT02480439|2082356|P1|NOT COMPLETED|Treatment Period 2||0
860553|NCT02480439|2082354|P3|COMPLETED|Treatment Period 2||8
860554|NCT02480439|2082355|P2|COMPLETED|Treatment Period 2||7
860555|NCT02480439|2082356|P1|COMPLETED|Treatment Period 2||8
860556|NCT02480439|2082354|P3|STARTED|Treatment Period 2||8
860557|NCT02480439|2082355|P2|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|7
860558|NCT02480439|2082356|P1|STARTED|Treatment Period 2||8
860559|NCT02480439|2082354|P3|NOT COMPLETED|Treatment Period 1||0
860560|NCT02480439|2082355|P2|NOT COMPLETED|Treatment Period 1||0
860561|NCT02480439|2082356|P1|NOT COMPLETED|Treatment Period 1||0
860562|NCT02480439|2082354|P3|COMPLETED|Treatment Period 1||8
860563|NCT02480439|2082355|P2|COMPLETED|Treatment Period 1||8
860564|NCT02480439|2082356|P1|COMPLETED|Treatment Period 1||8
860565|NCT02480439|2082354|P3|STARTED|Treatment Period 1||8
860566|NCT02480439|2082355|P2|STARTED|Treatment Period 1||8
860567|NCT02480439|2082356|P1|STARTED|Treatment Period 1||8
860568|NCT02480166|2082382|P3|NOT COMPLETED|Overall Study||0
860569|NCT02480166|2082383|P2|NOT COMPLETED|Overall Study||0
860570|NCT02480166|2082384|P1|NOT COMPLETED|Overall Study||0
860571|NCT02480166|2082382|P3|COMPLETED|Overall Study||4
860572|NCT02480166|2082383|P2|COMPLETED|Overall Study||36
860573|NCT02480166|2082384|P1|COMPLETED|Overall Study||20
860574|NCT02480166|2082382|P3|STARTED|Overall Study||4
860575|NCT02480166|2082383|P2|STARTED|Overall Study||36
860576|NCT02480166|2082384|P1|STARTED|Overall Study||20
860585|NCT02480010|2082406|P2|NOT COMPLETED|Overall Study||33
860586|NCT02480010|2082407|P1|NOT COMPLETED|Overall Study||35
860587|NCT02480010|2082406|P2|COMPLETED|Overall Study||0
860588|NCT02480010|2082407|P1|COMPLETED|Overall Study||0
860589|NCT02480010|2082406|P2|STARTED|Overall Study||33
860590|NCT02480010|2082407|P1|STARTED|Overall Study||35
860591|NCT02479763|2082453|P2|NOT COMPLETED|Overall Study||3
860592|NCT02479763|2082454|P1|NOT COMPLETED|Overall Study||3
860593|NCT02479763|2082453|P2|COMPLETED|Overall Study||50
860594|NCT02479763|2082454|P1|COMPLETED|Overall Study||50
860595|NCT02479763|2082453|P2|STARTED|Overall Study||53
860596|NCT02479763|2082454|P1|STARTED|Overall Study||53
860597|NCT02479412|2082469|P9|NOT COMPLETED|Overall Study||1
860598|NCT02479412|2082470|P8|NOT COMPLETED|Overall Study||1
860599|NCT02479412|2082471|P7|NOT COMPLETED|Overall Study||0
860600|NCT02479412|2082472|P6|NOT COMPLETED|Overall Study||0
860601|NCT02479412|2082473|P5|NOT COMPLETED|Overall Study||1
860602|NCT02479412|2082474|P4|NOT COMPLETED|Overall Study||1
860603|NCT02479412|2082475|P3|NOT COMPLETED|Overall Study||2
860604|NCT02479412|2082476|P2|NOT COMPLETED|Overall Study||0
860605|NCT02479412|2082477|P1|NOT COMPLETED|Overall Study||0
860606|NCT02479412|2082469|P9|COMPLETED|Overall Study||6
860607|NCT02479412|2082470|P8|COMPLETED|Overall Study||4
860608|NCT02479412|2082471|P7|COMPLETED|Overall Study||6
860609|NCT02479412|2082472|P6|COMPLETED|Overall Study||5
860610|NCT02479412|2082473|P5|COMPLETED|Overall Study||5
860611|NCT02479412|2082474|P4|COMPLETED|Overall Study||6
860612|NCT02479412|2082475|P3|COMPLETED|Overall Study||4
860613|NCT02479412|2082476|P2|COMPLETED|Overall Study||6
860614|NCT02479412|2082477|P1|COMPLETED|Overall Study||6
860615|NCT02479412|2082469|P9|STARTED|Overall Study||7
860616|NCT02479412|2082470|P8|STARTED|Overall Study||5
860617|NCT02479412|2082471|P7|STARTED|Overall Study||6
860618|NCT02479412|2082472|P6|STARTED|Overall Study||5
860619|NCT02479412|2082473|P5|STARTED|Overall Study||6
860620|NCT02479412|2082474|P4|STARTED|Overall Study||7
860621|NCT02479412|2082475|P3|STARTED|Overall Study||6
860622|NCT02479412|2082476|P2|STARTED|Overall Study||6
860623|NCT02479412|2082477|P1|STARTED|Overall Study||6
860624|NCT02479139|2082554|P6|NOT COMPLETED|Overall Study||6
860625|NCT02479139|2082555|P5|NOT COMPLETED|Overall Study||5
860626|NCT02479139|2082556|P4|NOT COMPLETED|Overall Study||7
860627|NCT02479139|2082557|P3|NOT COMPLETED|Overall Study||7
860628|NCT02479139|2082558|P2|NOT COMPLETED|Overall Study||10
860629|NCT02479139|2082559|P1|NOT COMPLETED|Overall Study||8
860630|NCT02479139|2082554|P6|COMPLETED|Overall Study||19
860631|NCT02479139|2082555|P5|COMPLETED|Overall Study||17
860632|NCT02479139|2082556|P4|COMPLETED|Overall Study||14
860633|NCT02479139|2082557|P3|COMPLETED|Overall Study||21
860634|NCT02479139|2082558|P2|COMPLETED|Overall Study||12
860635|NCT02479139|2082559|P1|COMPLETED|Overall Study||19
860636|NCT02479139|2082554|P6|STARTED|Overall Study||25
860637|NCT02479139|2082555|P5|STARTED|Overall Study||22
860638|NCT02479139|2082556|P4|STARTED|Overall Study||21
860639|NCT02479139|2082557|P3|STARTED|Overall Study||28
860640|NCT02479139|2082558|P2|STARTED|Overall Study||22
860641|NCT02479139|2082559|P1|STARTED|Overall Study||27
860642|NCT02478671|2082585|P1|NOT COMPLETED|Overall Study||0
860643|NCT02478671|2082585|P1|COMPLETED|Overall Study||4
860644|NCT02478671|2082585|P1|STARTED|Overall Study||4
860651|NCT02478372|2082601|P2|NOT COMPLETED|Overall Study||14
860652|NCT02478372|2082602|P1|NOT COMPLETED|Overall Study||13
860653|NCT02478372|2082601|P2|COMPLETED|Overall Study||107
860654|NCT02478372|2082602|P1|COMPLETED|Overall Study||108
860655|NCT02478372|2082601|P2|Reviewed at One Year|Overall Study|Routine folow up at one year - four patients did not attend, two patients died|107
860656|NCT02478372|2082602|P1|Reviewed at One Year|Overall Study|Routine follow up at one year|108
860657|NCT02478372|2082601|P2|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks|113
860658|NCT02478372|2082602|P1|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks - one patient refused to attend|108
860659|NCT02478372|2082601|P2|Recieved Allocation Intervention|Overall Study||113
860660|NCT02478372|2082602|P1|Recieved Allocation Intervention|Overall Study||109
860661|NCT02478372|2082601|P2|STARTED|Overall Study||121
860662|NCT02478372|2082602|P1|STARTED|Overall Study||121
860663|NCT02477709|2082624|P1|NOT COMPLETED|Overall Study||0
860664|NCT02477709|2082624|P1|COMPLETED|Overall Study||6
860665|NCT02477709|2082624|P1|STARTED|Overall Study||6
860666|NCT02477605|2082630|P2|NOT COMPLETED|Overall Study||4
860667|NCT02477605|2082631|P1|NOT COMPLETED|Overall Study||1
860668|NCT02477605|2082630|P2|COMPLETED|Overall Study||64
860669|NCT02477605|2082631|P1|COMPLETED|Overall Study||67
860670|NCT02477605|2082630|P2|Randomized and Treated|Overall Study||68
860671|NCT02477605|2082631|P1|Randomized and Treated|Overall Study||67
860672|NCT02477605|2082630|P2|STARTED|Overall Study||68
860673|NCT02477605|2082631|P1|STARTED|Overall Study||68
860674|NCT02477527|2082645|P1|NOT COMPLETED|Overall Study||6
860675|NCT02477527|2082645|P1|COMPLETED|Overall Study||21
860676|NCT02477527|2082645|P1|STARTED|Overall Study||27
860677|NCT02477020|2082655|P2|NOT COMPLETED|Overall Study||28
860678|NCT02477020|2082656|P1|NOT COMPLETED|Overall Study||30
860679|NCT02477020|2082655|P2|COMPLETED|Overall Study|Completed = participants who completed study treatment.|55
860680|NCT02477020|2082656|P1|COMPLETED|Overall Study|Completed = participants who completed study treatment.|51
860681|NCT02477020|2082655|P2|STARTED|Overall Study||83
860682|NCT02477020|2082656|P1|STARTED|Overall Study||81
860683|NCT02476617|2082684|P1|NOT COMPLETED|Overall Study||2
860684|NCT02476617|2082684|P1|COMPLETED|Overall Study||23
860685|NCT02476617|2082684|P1|STARTED|Overall Study||25
860686|NCT02476422|2082690|P2|NOT COMPLETED|Overall Study||1
860687|NCT02476422|2082691|P1|NOT COMPLETED|Overall Study||0
860688|NCT02476422|2082690|P2|COMPLETED|Overall Study||161
860689|NCT02476422|2082691|P1|COMPLETED|Overall Study||166
860690|NCT02476422|2082690|P2|STARTED|Overall Study||162
860691|NCT02476422|2082691|P1|STARTED|Overall Study|"started = Randomized Set/Full analysis set/Safety set"|166
860692|NCT02475980|2082721|P1|NOT COMPLETED|Overall Study||5
860693|NCT02475980|2082721|P1|COMPLETED|Overall Study||8
860694|NCT02475980|2082721|P1|STARTED|Overall Study||13
860695|NCT02475564|2082732|P2|NOT COMPLETED|Overall Study||1
860696|NCT02475564|2082733|P1|NOT COMPLETED|Overall Study||4
860697|NCT02475564|2082732|P2|COMPLETED|Overall Study||21
860698|NCT02475564|2082733|P1|COMPLETED|Overall Study||18
860699|NCT02475564|2082732|P2|STARTED|Overall Study||22
860700|NCT02475564|2082733|P1|STARTED|Overall Study||22
860707|NCT02475278|2082756|P1|NOT COMPLETED|Overall Study||2
860708|NCT02475278|2082756|P1|COMPLETED|Overall Study||48
860709|NCT02475278|2082756|P1|STARTED|Overall Study||50
860710|NCT02475031|2082769|P2|NOT COMPLETED|Overall Study||0
860711|NCT02475031|2082770|P1|NOT COMPLETED|Overall Study||0
860712|NCT02475031|2082769|P2|COMPLETED|Overall Study||35
860713|NCT02475031|2082770|P1|COMPLETED|Overall Study||35
860714|NCT02475031|2082769|P2|STARTED|Overall Study||35
860715|NCT02475031|2082770|P1|STARTED|Overall Study||35
860716|NCT02474498|2082787|P3|NOT COMPLETED|Overall Study||0
860717|NCT02474498|2082788|P2|NOT COMPLETED|Overall Study||0
860718|NCT02474498|2082789|P1|NOT COMPLETED|Overall Study||0
860719|NCT02474498|2082787|P3|COMPLETED|Overall Study||14
860720|NCT02474498|2082788|P2|COMPLETED|Overall Study||14
860721|NCT02474498|2082789|P1|COMPLETED|Overall Study||13
860722|NCT02474498|2082787|P3|STARTED|Overall Study||14
860723|NCT02474498|2082788|P2|STARTED|Overall Study||14
860724|NCT02474498|2082789|P1|STARTED|Overall Study||13
860725|NCT02473991|2082806|P1|NOT COMPLETED|Overall Study||0
860726|NCT02473991|2082806|P1|COMPLETED|Overall Study||395
860727|NCT02473991|2082806|P1|STARTED|Overall Study||395
860728|NCT02473523|2082812|P1|NOT COMPLETED|Overall Study||2
860729|NCT02473523|2082812|P1|COMPLETED|Overall Study||0
860730|NCT02473523|2082812|P1|STARTED|Overall Study||2
860731|NCT02473510|2082833|P2|NOT COMPLETED|Overall Study||2
860732|NCT02473510|2082834|P1|NOT COMPLETED|Overall Study||1
860733|NCT02473510|2082833|P2|COMPLETED|Overall Study||238
860734|NCT02473510|2082834|P1|COMPLETED|Overall Study||59
860735|NCT02473510|2082833|P2|STARTED|Overall Study||240
860736|NCT02473510|2082834|P1|STARTED|Overall Study||60
860737|NCT02473367|2082848|P1|NOT COMPLETED|Period 4||1
860738|NCT02473367|2082848|P1|COMPLETED|Period 4||18
860739|NCT02473367|2082848|P1|STARTED|Period 4||19
860740|NCT02473367|2082848|P1|NOT COMPLETED|Wait 3||0
860741|NCT02473367|2082848|P1|COMPLETED|Wait 3||19
860742|NCT02473367|2082848|P1|STARTED|Wait 3||19
860743|NCT02473367|2082848|P1|NOT COMPLETED|Period 3||0
860744|NCT02473367|2082848|P1|COMPLETED|Period 3||19
860745|NCT02473367|2082848|P1|STARTED|Period 3||19
860746|NCT02473367|2082848|P1|NOT COMPLETED|Wait 2||0
860747|NCT02473367|2082848|P1|COMPLETED|Wait 2||19
860748|NCT02473367|2082848|P1|STARTED|Wait 2||19
860749|NCT02473367|2082848|P1|NOT COMPLETED|Period 2||0
860750|NCT02473367|2082848|P1|COMPLETED|Period 2||19
860751|NCT02473367|2082848|P1|STARTED|Period 2||19
860752|NCT02473367|2082848|P1|NOT COMPLETED|Wait 1||1
860753|NCT02473367|2082848|P1|COMPLETED|Wait 1||19
860754|NCT02473367|2082848|P1|STARTED|Wait 1||20
860755|NCT02473367|2082848|P1|NOT COMPLETED|Period 1||0
860756|NCT02473367|2082848|P1|COMPLETED|Period 1||20
860757|NCT02473367|2082848|P1|STARTED|Period 1||20
860758|NCT02472886|2082869|P3|NOT COMPLETED|Overall Study||1
860759|NCT02472886|2082870|P2|NOT COMPLETED|Overall Study||2
860760|NCT02472886|2082871|P1|NOT COMPLETED|Overall Study||0
860761|NCT02472886|2082869|P3|COMPLETED|Overall Study||26
860762|NCT02472886|2082870|P2|COMPLETED|Overall Study||57
860763|NCT02472886|2082871|P1|COMPLETED|Overall Study||67
860764|NCT02472886|2082869|P3|STARTED|Overall Study||27
860765|NCT02472886|2082870|P2|STARTED|Overall Study||59
860766|NCT02472886|2082871|P1|STARTED|Overall Study||67
860767|NCT02472847|2082899|P2|NOT COMPLETED|Overall Study||5
860768|NCT02472847|2082900|P1|NOT COMPLETED|Overall Study||1
860769|NCT02472847|2082899|P2|COMPLETED|Overall Study||21
860770|NCT02472847|2082900|P1|COMPLETED|Overall Study||23
860771|NCT02472847|2082899|P2|STARTED|Overall Study||26
860772|NCT02472847|2082900|P1|STARTED|Overall Study||24
860773|NCT02472756|2082906|P1|NOT COMPLETED|Maintenance (Approximately 2 Years)||10
860774|NCT02472756|2082906|P1|COMPLETED|Maintenance (Approximately 2 Years)||10
860775|NCT02472756|2082906|P1|STARTED|Maintenance (Approximately 2 Years)|Out of 39 participants who completed induction period, 19 did not continue in maintenance period.|20
860776|NCT02472756|2082906|P1|NOT COMPLETED|Induction (Approximately 6 Months)||2
860777|NCT02472756|2082906|P1|COMPLETED|Induction (Approximately 6 Months)||39
860778|NCT02472756|2082906|P1|Treated|Induction (Approximately 6 Months)||40
860779|NCT02472756|2082906|P1|STARTED|Induction (Approximately 6 Months)||41
860780|NCT02472639|2082914|P2|NOT COMPLETED|Overall Study||3
860781|NCT02472639|2082915|P1|NOT COMPLETED|Overall Study||4
860782|NCT02472639|2082914|P2|COMPLETED|Overall Study||0
860783|NCT02472639|2082915|P1|COMPLETED|Overall Study||0
860784|NCT02472639|2082914|P2|STARTED|Overall Study||3
860785|NCT02472639|2082915|P1|STARTED|Overall Study||4
860786|NCT02472522|2082931|P2|NOT COMPLETED|Overall Study||0
860787|NCT02472522|2082932|P1|NOT COMPLETED|Overall Study||0
860788|NCT02472522|2082931|P2|COMPLETED|Overall Study||50
860789|NCT02472522|2082932|P1|COMPLETED|Overall Study||50
860790|NCT02472522|2082931|P2|STARTED|Overall Study||50
860791|NCT02472522|2082932|P1|STARTED|Overall Study||50
860792|NCT02472366|2082964|P2|NOT COMPLETED|Overall Study||0
860793|NCT02472366|2082965|P1|NOT COMPLETED|Overall Study||1
860794|NCT02472366|2082964|P2|COMPLETED|Overall Study||10
860795|NCT02472366|2082965|P1|COMPLETED|Overall Study||5
860796|NCT02472366|2082964|P2|STARTED|Overall Study||10
860797|NCT02472366|2082965|P1|STARTED|Overall Study|6 subjects receiving ILUVIEN, 7 eyes receiving ILUVIEN|6
860798|NCT02471755|2082981|P2|NOT COMPLETED|Overall Study||1
860799|NCT02471755|2082982|P1|NOT COMPLETED|Overall Study||1
860800|NCT02471755|2082981|P2|COMPLETED|Overall Study||44
860801|NCT02471755|2082982|P1|COMPLETED|Overall Study||44
860802|NCT02471755|2082981|P2|STARTED|Overall Study||45
860803|NCT02471755|2082982|P1|STARTED|Overall Study||45
860804|NCT02471612|2082998|P1|NOT COMPLETED|Overall Study||2
860805|NCT02471612|2082998|P1|COMPLETED|Overall Study||157
860806|NCT02471612|2082998|P1|STARTED|Overall Study||159
860807|NCT02470949|2083015|P2|NOT COMPLETED|Second Intervention||0
860808|NCT02470949|2083016|P1|NOT COMPLETED|Second Intervention||0
860809|NCT02470949|2083015|P2|COMPLETED|Second Intervention||2
860810|NCT02470949|2083016|P1|COMPLETED|Second Intervention||4
860811|NCT02470949|2083015|P2|STARTED|Second Intervention||2
860812|NCT02470949|2083016|P1|STARTED|Second Intervention||4
860813|NCT02470949|2083015|P2|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
860814|NCT02470949|2083016|P1|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
860815|NCT02470949|2083015|P2|COMPLETED|Washout Period for a Minimum of 4 Weeks||5
860816|NCT02470949|2083016|P1|COMPLETED|Washout Period for a Minimum of 4 Weeks||4
860817|NCT02470949|2083015|P2|STARTED|Washout Period for a Minimum of 4 Weeks||5
860818|NCT02470949|2083016|P1|STARTED|Washout Period for a Minimum of 4 Weeks||4
860819|NCT02470949|2083015|P2|NOT COMPLETED|First Intervention||0
860820|NCT02470949|2083016|P1|NOT COMPLETED|First Intervention||0
860821|NCT02470949|2083015|P2|COMPLETED|First Intervention||5
860822|NCT02470949|2083016|P1|COMPLETED|First Intervention||4
860823|NCT02470949|2083015|P2|STARTED|First Intervention||5
860824|NCT02470949|2083016|P1|STARTED|First Intervention||4
860825|NCT02470494|2083026|P1|NOT COMPLETED|Overall Study||5
860826|NCT02470494|2083026|P1|COMPLETED|Overall Study||41
860827|NCT02470494|2083026|P1|STARTED|Overall Study||46
860828|NCT02470429|2083036|P2|NOT COMPLETED|Overall Study||0
860829|NCT02470429|2083037|P1|NOT COMPLETED|Overall Study||2
860830|NCT02470429|2083036|P2|COMPLETED|Overall Study||49
860831|NCT02470429|2083037|P1|COMPLETED|Overall Study||48
860832|NCT02470429|2083036|P2|STARTED|Overall Study||49
860833|NCT02470429|2083037|P1|STARTED|Overall Study||50
860834|NCT02470403|2083055|P5|NOT COMPLETED|Overall Study||0
860835|NCT02470403|2083056|P4|NOT COMPLETED|Overall Study||4
860836|NCT02470403|2083057|P3|NOT COMPLETED|Overall Study||0
860837|NCT02470403|2083058|P2|NOT COMPLETED|Overall Study||1
860838|NCT02470403|2083059|P1|NOT COMPLETED|Overall Study||2
860839|NCT02470403|2083055|P5|COMPLETED|Overall Study||10
860840|NCT02470403|2083056|P4|COMPLETED|Overall Study||39
860841|NCT02470403|2083057|P3|COMPLETED|Overall Study||40
860842|NCT02470403|2083058|P2|COMPLETED|Overall Study||43
860843|NCT02470403|2083059|P1|COMPLETED|Overall Study||42
860844|NCT02470403|2083055|P5|Normoglycemic|Overall Study||5
860845|NCT02470403|2083056|P4|Normoglycemic|Overall Study||23
860846|NCT02470403|2083057|P3|Normoglycemic|Overall Study||20
860847|NCT02470403|2083058|P2|Normoglycemic|Overall Study||20
860848|NCT02470403|2083059|P1|Normoglycemic|Overall Study||20
860849|NCT02470403|2083055|P5|Dysglycemic|Overall Study||5
860850|NCT02470403|2083056|P4|Dysglycemic|Overall Study||20
860851|NCT02470403|2083057|P3|Dysglycemic|Overall Study||20
860852|NCT02470403|2083058|P2|Dysglycemic|Overall Study||24
860853|NCT02470403|2083059|P1|Dysglycemic|Overall Study||24
860854|NCT02470403|2083055|P5|STARTED|Overall Study||10
860855|NCT02470403|2083056|P4|STARTED|Overall Study||43
860856|NCT02470403|2083057|P3|STARTED|Overall Study||40
860857|NCT02470403|2083058|P2|STARTED|Overall Study||44
860858|NCT02470403|2083059|P1|STARTED|Overall Study||44
860859|NCT02469961|2083099|P2|NOT COMPLETED|Overall Study||1
860860|NCT02469961|2083100|P1|NOT COMPLETED|Overall Study||4
860861|NCT02469961|2083099|P2|COMPLETED|Overall Study||24
860862|NCT02469961|2083100|P1|COMPLETED|Overall Study||21
860863|NCT02469961|2083099|P2|STARTED|Overall Study||25
860864|NCT02469961|2083100|P1|STARTED|Overall Study||25
860865|NCT02469597|2083114|P2|NOT COMPLETED|Overall Study||0
860866|NCT02469597|2083115|P1|NOT COMPLETED|Overall Study||0
860867|NCT02469597|2083114|P2|COMPLETED|Overall Study||24
860868|NCT02469597|2083115|P1|COMPLETED|Overall Study||22
860869|NCT02469597|2083114|P2|STARTED|Overall Study||24
860870|NCT02469597|2083115|P1|STARTED|Overall Study||22
860871|NCT02469298|2083135|P4|NOT COMPLETED|Overall Study||2
860872|NCT02469298|2083136|P3|NOT COMPLETED|Overall Study||2
860873|NCT02469298|2083137|P2|NOT COMPLETED|Overall Study||1
860874|NCT02469298|2083138|P1|NOT COMPLETED|Overall Study||1
860875|NCT02469298|2083135|P4|COMPLETED|Overall Study||5
860876|NCT02469298|2083136|P3|COMPLETED|Overall Study||14
860877|NCT02469298|2083137|P2|COMPLETED|Overall Study||6
860878|NCT02469298|2083138|P1|COMPLETED|Overall Study||14
860879|NCT02469298|2083135|P4|STARTED|Overall Study||7
860880|NCT02469298|2083136|P3|STARTED|Overall Study||16
860881|NCT02469298|2083137|P2|STARTED|Overall Study||7
860882|NCT02469298|2083138|P1|STARTED|Overall Study||15
860883|NCT02469116|2083276|P1|NOT COMPLETED|Overall Study||0
860884|NCT02469116|2083276|P1|COMPLETED|Overall Study||18
860885|NCT02469116|2083276|P1|STARTED|Overall Study||18
860886|NCT02468414|2083288|P2|NOT COMPLETED|Overall Study||0
860887|NCT02468414|2083289|P1|NOT COMPLETED|Overall Study||3
860888|NCT02468414|2083288|P2|COMPLETED|Overall Study||0
860889|NCT02468414|2083289|P1|COMPLETED|Overall Study||0
860890|NCT02468414|2083288|P2|Safety Follow-up|Overall Study||0
860891|NCT02468414|2083289|P1|Safety Follow-up|Overall Study||0
860892|NCT02468414|2083288|P2|Implantation|Overall Study||0
860893|NCT02468414|2083289|P1|Implantation|Overall Study||1
860894|NCT02468414|2083288|P2|Harvesting|Overall Study||0
860895|NCT02468414|2083289|P1|Harvesting|Overall Study||1
860896|NCT02468414|2083288|P2|Successfully Screened|Overall Study||0
860897|NCT02468414|2083289|P1|Successfully Screened|Overall Study||2
860898|NCT02468414|2083288|P2|STARTED|Overall Study||0
860899|NCT02468414|2083289|P1|STARTED|Overall Study||3
860900|NCT02468154|2083297|P2|NOT COMPLETED|Overall Study||0
860901|NCT02468154|2083298|P1|NOT COMPLETED|Overall Study||0
860902|NCT02468154|2083297|P2|COMPLETED|Overall Study||28
860903|NCT02468154|2083298|P1|COMPLETED|Overall Study||29
860904|NCT02468154|2083297|P2|STARTED|Overall Study||28
860905|NCT02468154|2083298|P1|STARTED|Overall Study||29
860906|NCT02467777|2083312|P2|NOT COMPLETED|Overall Study||0
860907|NCT02467777|2083313|P1|NOT COMPLETED|Overall Study||0
860908|NCT02467777|2083312|P2|COMPLETED|Overall Study||27
860909|NCT02467777|2083313|P1|COMPLETED|Overall Study||23
860910|NCT02467777|2083312|P2|STARTED|Overall Study||27
860911|NCT02467777|2083313|P1|STARTED|Overall Study||23
860912|NCT02467491|2083319|P1|NOT COMPLETED|Overall Study||0
860913|NCT02467491|2083319|P1|COMPLETED|Overall Study||12
860914|NCT02467491|2083319|P1|STARTED|Overall Study||12
860915|NCT02467075|2083330|P2|NOT COMPLETED|30 Day Follow-up||0
860916|NCT02467075|2083331|P1|NOT COMPLETED|30 Day Follow-up||0
860917|NCT02467075|2083330|P2|COMPLETED|30 Day Follow-up||1
860918|NCT02467075|2083331|P1|COMPLETED|30 Day Follow-up||0
860919|NCT02467075|2083330|P2|STARTED|30 Day Follow-up||1
860920|NCT02467075|2083331|P1|STARTED|30 Day Follow-up||0
860921|NCT02467075|2083330|P2|NOT COMPLETED|72 Hour Follow-up||0
860922|NCT02467075|2083331|P1|NOT COMPLETED|72 Hour Follow-up||0
860923|NCT02467075|2083330|P2|COMPLETED|72 Hour Follow-up||1
860924|NCT02467075|2083331|P1|COMPLETED|72 Hour Follow-up||0
860925|NCT02467075|2083330|P2|STARTED|72 Hour Follow-up||1
860926|NCT02467075|2083331|P1|STARTED|72 Hour Follow-up||0
860927|NCT02467075|2083330|P2|NOT COMPLETED|48 Hour Follow-up||0
860928|NCT02467075|2083331|P1|NOT COMPLETED|48 Hour Follow-up||0
860929|NCT02467075|2083330|P2|COMPLETED|48 Hour Follow-up||1
860930|NCT02467075|2083331|P1|COMPLETED|48 Hour Follow-up||0
860931|NCT02467075|2083330|P2|STARTED|48 Hour Follow-up||1
860932|NCT02467075|2083331|P1|STARTED|48 Hour Follow-up||0
860933|NCT02467075|2083330|P2|NOT COMPLETED|Initial CT Scan||0
860934|NCT02467075|2083331|P1|NOT COMPLETED|Initial CT Scan||0
860935|NCT02467075|2083330|P2|COMPLETED|Initial CT Scan||1
860936|NCT02467075|2083331|P1|COMPLETED|Initial CT Scan||0
860937|NCT02467075|2083330|P2|STARTED|Initial CT Scan||1
860938|NCT02467075|2083331|P1|STARTED|Initial CT Scan||0
860939|NCT02466425|2083349|P2|NOT COMPLETED|Overall Study||16
860940|NCT02466425|2083350|P1|NOT COMPLETED|Overall Study||14
860941|NCT02466425|2083349|P2|COMPLETED|Overall Study||116
860942|NCT02466425|2083350|P1|COMPLETED|Overall Study||118
860943|NCT02466425|2083349|P2|Treated|Overall Study||132
860944|NCT02466425|2083350|P1|Treated|Overall Study||131
860945|NCT02466425|2083349|P2|STARTED|Overall Study||132
860946|NCT02466425|2083350|P1|STARTED|Overall Study||132
860947|NCT02466412|2083360|P2|NOT COMPLETED|Second Intervention (Day 3)||0
860948|NCT02466412|2083361|P1|NOT COMPLETED|Second Intervention (Day 3)||0
860949|NCT02466412|2083360|P2|COMPLETED|Second Intervention (Day 3)||24
860950|NCT02466412|2083361|P1|COMPLETED|Second Intervention (Day 3)||24
860951|NCT02466412|2083360|P2|STARTED|Second Intervention (Day 3)||24
860952|NCT02466412|2083361|P1|STARTED|Second Intervention (Day 3)||24
860953|NCT02466412|2083360|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
860954|NCT02466412|2083361|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
860955|NCT02466412|2083360|P2|COMPLETED|Washout Period of 1 Day (Day 2)||24
860956|NCT02466412|2083361|P1|COMPLETED|Washout Period of 1 Day (Day 2)||24
860957|NCT02466412|2083360|P2|STARTED|Washout Period of 1 Day (Day 2)||24
860958|NCT02466412|2083361|P1|STARTED|Washout Period of 1 Day (Day 2)||24
860959|NCT02466412|2083360|P2|NOT COMPLETED|First Intervention (Day 1)||0
860960|NCT02466412|2083361|P1|NOT COMPLETED|First Intervention (Day 1)||0
860961|NCT02466412|2083360|P2|COMPLETED|First Intervention (Day 1)||24
860962|NCT02466412|2083361|P1|COMPLETED|First Intervention (Day 1)||24
860963|NCT02466412|2083360|P2|STARTED|First Intervention (Day 1)||24
860964|NCT02466412|2083361|P1|STARTED|First Intervention (Day 1)||24
860965|NCT02466412|2083360|P2|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
860966|NCT02466412|2083361|P1|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
860967|NCT02466412|2083360|P2|COMPLETED|Washout Period of 1 Day (Day -1)||24
860968|NCT02466412|2083361|P1|COMPLETED|Washout Period of 1 Day (Day -1)||24
860969|NCT02466412|2083360|P2|STARTED|Washout Period of 1 Day (Day -1)||24
860970|NCT02466412|2083361|P1|STARTED|Washout Period of 1 Day (Day -1)||24
860971|NCT02465866|2083370|P4|NOT COMPLETED|Period 4: Washout (14 Days)||0
860972|NCT02465866|2083371|P3|NOT COMPLETED|Period 4: Washout (14 Days)||0
860973|NCT02465866|2083372|P2|NOT COMPLETED|Period 4: Washout (14 Days)||0
860974|NCT02465866|2083373|P1|NOT COMPLETED|Period 4: Washout (14 Days)||0
860975|NCT02465866|2083370|P4|COMPLETED|Period 4: Washout (14 Days)||5
860976|NCT02465866|2083371|P3|COMPLETED|Period 4: Washout (14 Days)||5
860977|NCT02465866|2083372|P2|COMPLETED|Period 4: Washout (14 Days)||4
860978|NCT02465866|2083373|P1|COMPLETED|Period 4: Washout (14 Days)||5
860979|NCT02465866|2083370|P4|STARTED|Period 4: Washout (14 Days)||5
860980|NCT02465866|2083371|P3|STARTED|Period 4: Washout (14 Days)||5
860981|NCT02465866|2083372|P2|STARTED|Period 4: Washout (14 Days)||4
860982|NCT02465866|2083373|P1|STARTED|Period 4: Washout (14 Days)||5
860983|NCT02465866|2083370|P4|NOT COMPLETED|Period 4||0
860984|NCT02465866|2083371|P3|NOT COMPLETED|Period 4||0
860985|NCT02465866|2083372|P2|NOT COMPLETED|Period 4||0
860986|NCT02465866|2083373|P1|NOT COMPLETED|Period 4||0
860987|NCT02465866|2083370|P4|COMPLETED|Period 4||5
860988|NCT02465866|2083371|P3|COMPLETED|Period 4||5
860989|NCT02465866|2083372|P2|COMPLETED|Period 4||4
860990|NCT02465866|2083373|P1|COMPLETED|Period 4||5
860991|NCT02465866|2083370|P4|STARTED|Period 4||5
860992|NCT02465866|2083371|P3|STARTED|Period 4||5
860993|NCT02465866|2083372|P2|STARTED|Period 4||4
860994|NCT02465866|2083373|P1|STARTED|Period 4||5
860995|NCT02465866|2083370|P4|NOT COMPLETED|Period 3: Washout (14 Days)||0
860996|NCT02465866|2083371|P3|NOT COMPLETED|Period 3: Washout (14 Days)||0
860997|NCT02465866|2083372|P2|NOT COMPLETED|Period 3: Washout (14 Days)||0
860998|NCT02465866|2083373|P1|NOT COMPLETED|Period 3: Washout (14 Days)||0
860999|NCT02465866|2083370|P4|COMPLETED|Period 3: Washout (14 Days)||5
861000|NCT02465866|2083371|P3|COMPLETED|Period 3: Washout (14 Days)||5
861001|NCT02465866|2083372|P2|COMPLETED|Period 3: Washout (14 Days)||4
861002|NCT02465866|2083373|P1|COMPLETED|Period 3: Washout (14 Days)||5
861003|NCT02465866|2083370|P4|STARTED|Period 3: Washout (14 Days)||5
861004|NCT02465866|2083371|P3|STARTED|Period 3: Washout (14 Days)||5
861005|NCT02465866|2083372|P2|STARTED|Period 3: Washout (14 Days)||4
861006|NCT02465866|2083373|P1|STARTED|Period 3: Washout (14 Days)||5
861007|NCT02465866|2083370|P4|NOT COMPLETED|Period 3||0
861008|NCT02465866|2083371|P3|NOT COMPLETED|Period 3||0
861009|NCT02465866|2083372|P2|NOT COMPLETED|Period 3||1
861010|NCT02465866|2083373|P1|NOT COMPLETED|Period 3||0
861011|NCT02465866|2083370|P4|COMPLETED|Period 3||5
861012|NCT02465866|2083371|P3|COMPLETED|Period 3||5
861013|NCT02465866|2083372|P2|COMPLETED|Period 3||4
861014|NCT02465866|2083373|P1|COMPLETED|Period 3||5
861015|NCT02465866|2083370|P4|STARTED|Period 3||5
861016|NCT02465866|2083371|P3|STARTED|Period 3||5
861017|NCT02465866|2083372|P2|STARTED|Period 3||5
861018|NCT02465866|2083373|P1|STARTED|Period 3||5
861019|NCT02465866|2083370|P4|NOT COMPLETED|Period 2: Washout (14 Days)||0
861020|NCT02465866|2083371|P3|NOT COMPLETED|Period 2: Washout (14 Days)||0
861021|NCT02465866|2083372|P2|NOT COMPLETED|Period 2: Washout (14 Days)||0
861022|NCT02465866|2083373|P1|NOT COMPLETED|Period 2: Washout (14 Days)||0
861023|NCT02465866|2083370|P4|COMPLETED|Period 2: Washout (14 Days)||5
861024|NCT02465866|2083371|P3|COMPLETED|Period 2: Washout (14 Days)||5
861025|NCT02465866|2083372|P2|COMPLETED|Period 2: Washout (14 Days)||5
861026|NCT02465866|2083373|P1|COMPLETED|Period 2: Washout (14 Days)||5
861027|NCT02465866|2083370|P4|STARTED|Period 2: Washout (14 Days)||5
861028|NCT02465866|2083371|P3|STARTED|Period 2: Washout (14 Days)||5
861029|NCT02465866|2083372|P2|STARTED|Period 2: Washout (14 Days)||5
861030|NCT02465866|2083373|P1|STARTED|Period 2: Washout (14 Days)||5
861031|NCT02465866|2083370|P4|NOT COMPLETED|Period 2||0
861032|NCT02465866|2083371|P3|NOT COMPLETED|Period 2||0
861033|NCT02465866|2083372|P2|NOT COMPLETED|Period 2||0
861034|NCT02465866|2083373|P1|NOT COMPLETED|Period 2||0
861035|NCT02465866|2083370|P4|COMPLETED|Period 2||5
861036|NCT02465866|2083371|P3|COMPLETED|Period 2||5
861037|NCT02465866|2083372|P2|COMPLETED|Period 2||5
861038|NCT02465866|2083373|P1|COMPLETED|Period 2||5
861039|NCT02465866|2083370|P4|STARTED|Period 2||5
861040|NCT02465866|2083371|P3|STARTED|Period 2||5
861041|NCT02465866|2083372|P2|STARTED|Period 2||5
861042|NCT02465866|2083373|P1|STARTED|Period 2||5
861043|NCT02465866|2083370|P4|NOT COMPLETED|Period 1: Washout (14 Days)||0
861044|NCT02465866|2083371|P3|NOT COMPLETED|Period 1: Washout (14 Days)||0
861045|NCT02465866|2083372|P2|NOT COMPLETED|Period 1: Washout (14 Days)||0
861046|NCT02465866|2083373|P1|NOT COMPLETED|Period 1: Washout (14 Days)||0
861047|NCT02465866|2083370|P4|COMPLETED|Period 1: Washout (14 Days)||5
861048|NCT02465866|2083371|P3|COMPLETED|Period 1: Washout (14 Days)||5
861049|NCT02465866|2083372|P2|COMPLETED|Period 1: Washout (14 Days)||5
861050|NCT02465866|2083373|P1|COMPLETED|Period 1: Washout (14 Days)||5
861051|NCT02465866|2083370|P4|STARTED|Period 1: Washout (14 Days)||5
861052|NCT02465866|2083371|P3|STARTED|Period 1: Washout (14 Days)||5
861053|NCT02465866|2083372|P2|STARTED|Period 1: Washout (14 Days)||5
861054|NCT02465866|2083373|P1|STARTED|Period 1: Washout (14 Days)||5
861055|NCT02465866|2083370|P4|NOT COMPLETED|Period 1||0
861056|NCT02465866|2083371|P3|NOT COMPLETED|Period 1||0
861057|NCT02465866|2083372|P2|NOT COMPLETED|Period 1||0
861058|NCT02465866|2083373|P1|NOT COMPLETED|Period 1||0
861059|NCT02465866|2083370|P4|COMPLETED|Period 1||5
861060|NCT02465866|2083371|P3|COMPLETED|Period 1||5
861061|NCT02465866|2083372|P2|COMPLETED|Period 1||5
861062|NCT02465866|2083373|P1|COMPLETED|Period 1||5
861063|NCT02465866|2083370|P4|STARTED|Period 1||5
861064|NCT02465866|2083371|P3|STARTED|Period 1||5
861065|NCT02465866|2083372|P2|STARTED|Period 1||5
861066|NCT02465866|2083373|P1|STARTED|Period 1||5
861067|NCT02465632|2083446|P3|NOT COMPLETED|Overall Study||17
861068|NCT02465632|2083447|P2|NOT COMPLETED|Overall Study||23
861069|NCT02465632|2083448|P1|NOT COMPLETED|Overall Study||31
861070|NCT02465632|2083446|P3|COMPLETED|Overall Study||203
861071|NCT02465632|2083447|P2|COMPLETED|Overall Study||417
861072|NCT02465632|2083448|P1|COMPLETED|Overall Study||409
861073|NCT02465632|2083446|P3|STARTED|Overall Study||220
861074|NCT02465632|2083447|P2|STARTED|Overall Study||440
861075|NCT02465632|2083448|P1|STARTED|Overall Study||440
861076|NCT02465489|2083459|P1|NOT COMPLETED|Overall Study||5
861077|NCT02465489|2083459|P1|COMPLETED|Overall Study||15
861078|NCT02465489|2083459|P1|STARTED|Overall Study||20
861079|NCT02465073|2083489|P3|NOT COMPLETED|Overall Study||1
861080|NCT02465073|2083490|P2|NOT COMPLETED|Overall Study||1
861081|NCT02465073|2083491|P1|NOT COMPLETED|Overall Study||2
861082|NCT02465073|2083489|P3|COMPLETED|Overall Study||15
861083|NCT02465073|2083490|P2|COMPLETED|Overall Study||15
861084|NCT02465073|2083491|P1|COMPLETED|Overall Study||15
861085|NCT02465073|2083489|P3|STARTED|Overall Study||16
861086|NCT02465073|2083490|P2|STARTED|Overall Study||16
861087|NCT02465073|2083491|P1|STARTED|Overall Study||17
861088|NCT02463409|2083499|P1|NOT COMPLETED|Overall Study||2
861089|NCT02463409|2083499|P1|COMPLETED|Overall Study||4
861090|NCT02463409|2083499|P1|STARTED|Overall Study||6
861091|NCT02463331|2083507|P2|NOT COMPLETED|Overall Study||6
861092|NCT02463331|2083508|P1|NOT COMPLETED|Overall Study||16
861093|NCT02463331|2083507|P2|COMPLETED|Overall Study||25
861094|NCT02463331|2083508|P1|COMPLETED|Overall Study||10
861095|NCT02463331|2083507|P2|STARTED|Overall Study||31
861096|NCT02463331|2083508|P1|STARTED|Overall Study||26
861097|NCT02463227|2083516|P1|NOT COMPLETED|Overall Study||0
861098|NCT02463227|2083516|P1|COMPLETED|Overall Study||14
861099|NCT02463227|2083516|P1|STARTED|Overall Study||14
861100|NCT02463097|2083524|P1|NOT COMPLETED|Overall Study||1
861101|NCT02463097|2083524|P1|COMPLETED|Overall Study||123
861102|NCT02463097|2083524|P1|STARTED|Overall Study||124
861103|NCT02462473|2083530|P1|NOT COMPLETED|Overall Study||4
861104|NCT02462473|2083530|P1|COMPLETED|Overall Study||5
861105|NCT02462473|2083530|P1|STARTED|Overall Study||9
861106|NCT02462291|2083543|P2|NOT COMPLETED|Overall Study||6
861107|NCT02462291|2083544|P1|NOT COMPLETED|Overall Study||5
861108|NCT02462291|2083543|P2|COMPLETED|Overall Study||75
861109|NCT02462291|2083544|P1|COMPLETED|Overall Study||77
861110|NCT02462291|2083543|P2|STARTED|Overall Study||81
861111|NCT02462291|2083544|P1|STARTED|Overall Study||82
861112|NCT02461992|2083582|P1|NOT COMPLETED|Overall Study||0
861113|NCT02461992|2083582|P1|COMPLETED|Overall Study||13
861114|NCT02461992|2083582|P1|STARTED|Overall Study||13
861115|NCT02461693|2083601|P2|NOT COMPLETED|Overall Study||0
861116|NCT02461693|2083602|P1|NOT COMPLETED|Overall Study||0
861117|NCT02461693|2083601|P2|COMPLETED|Overall Study||102
861118|NCT02461693|2083602|P1|COMPLETED|Overall Study||103
861119|NCT02461693|2083601|P2|STARTED|Overall Study||102
861120|NCT02461693|2083602|P1|STARTED|Overall Study||103
861121|NCT02461290|2083614|P1|NOT COMPLETED|Overall Study||10
861122|NCT02461290|2083614|P1|COMPLETED|Overall Study||89
861123|NCT02461290|2083614|P1|STARTED|Overall Study||99
861124|NCT02460822|2083621|P1|NOT COMPLETED|Overall Study||1
861125|NCT02460822|2083621|P1|COMPLETED|Overall Study||15
861126|NCT02460822|2083621|P1|STARTED|Overall Study||16
861127|NCT02460458|2083630|P1|NOT COMPLETED|Prospective Phase||0
861128|NCT02460458|2083630|P1|COMPLETED|Prospective Phase|Information not yet available.|0
861129|NCT02460458|2083630|P1|STARTED|Prospective Phase|Information not yet available.|0
861130|NCT02460458|2083630|P1|NOT COMPLETED|Confirmatory Phase||266
861131|NCT02460458|2083630|P1|COMPLETED|Confirmatory Phase|Information not yet available.|0
861132|NCT02460458|2083630|P1|STARTED|Confirmatory Phase||266
861133|NCT02460458|2083630|P1|NOT COMPLETED|Retrospective Phase||0
861134|NCT02460458|2083630|P1|COMPLETED|Retrospective Phase||266
861135|NCT02460458|2083630|P1|STARTED|Retrospective Phase||266
861136|NCT02458768|2083638|P2|NOT COMPLETED|Overall Study||5
861137|NCT02458768|2083639|P1|NOT COMPLETED|Overall Study||7
861138|NCT02458768|2083638|P2|COMPLETED|Overall Study||50
861139|NCT02458768|2083639|P1|COMPLETED|Overall Study||50
861140|NCT02458768|2083638|P2|STARTED|Overall Study||55
861141|NCT02458768|2083639|P1|STARTED|Overall Study||57
861142|NCT02458365|2083647|P2|NOT COMPLETED|Overall Study||294
861143|NCT02458365|2083648|P1|NOT COMPLETED|Overall Study||277
861144|NCT02458365|2083647|P2|COMPLETED|Overall Study||1607
861145|NCT02458365|2083648|P1|COMPLETED|Overall Study||1723
861146|NCT02458365|2083647|P2|STARTED|Overall Study||1901
861147|NCT02458365|2083648|P1|STARTED|Overall Study||2000
861148|NCT02457728|2083668|P1|NOT COMPLETED|Overall Study||0
861149|NCT02457728|2083668|P1|COMPLETED|Overall Study||34
861150|NCT02457728|2083668|P1|STARTED|Overall Study||34
861151|NCT02457611|2083672|P1|NOT COMPLETED|Overall Study||3
861152|NCT02457611|2083672|P1|COMPLETED|Overall Study||23
861153|NCT02457611|2083672|P1|STARTED|Overall Study||26
861154|NCT02457247|2083688|P4|NOT COMPLETED|Period 2||0
861155|NCT02457247|2083689|P3|NOT COMPLETED|Period 2||0
861156|NCT02457247|2083690|P2|NOT COMPLETED|Period 2||3
861157|NCT02457247|2083691|P1|NOT COMPLETED|Period 2||2
861158|NCT02457247|2083688|P4|COMPLETED|Period 2||70
861159|NCT02457247|2083689|P3|COMPLETED|Period 2||68
861160|NCT02457247|2083690|P2|COMPLETED|Period 2||65
861161|NCT02457247|2083691|P1|COMPLETED|Period 2||64
861162|NCT02457247|2083688|P4|STARTED|Period 2||70
861163|NCT02457247|2083689|P3|STARTED|Period 2||68
861164|NCT02457247|2083690|P2|STARTED|Period 2||68
861165|NCT02457247|2083691|P1|STARTED|Period 2||66
861166|NCT02457247|2083688|P4|NOT COMPLETED|Period 1||0
861167|NCT02457247|2083689|P3|NOT COMPLETED|Period 1||0
861168|NCT02457247|2083690|P2|NOT COMPLETED|Period 1||2
861169|NCT02457247|2083691|P1|NOT COMPLETED|Period 1||2
861170|NCT02457247|2083688|P4|COMPLETED|Period 1||70
861171|NCT02457247|2083689|P3|COMPLETED|Period 1||68
861172|NCT02457247|2083690|P2|COMPLETED|Period 1||68
861173|NCT02457247|2083691|P1|COMPLETED|Period 1||66
861174|NCT02457247|2083688|P4|STARTED|Period 1||70
861175|NCT02457247|2083689|P3|STARTED|Period 1||68
861176|NCT02457247|2083690|P2|STARTED|Period 1||70
861177|NCT02457247|2083691|P1|STARTED|Period 1||68
861178|NCT02455050|2083715|P4|NOT COMPLETED|Treatment Period 2||1
861179|NCT02455050|2083716|P3|NOT COMPLETED|Treatment Period 2||2
861180|NCT02455050|2083717|P2|NOT COMPLETED|Treatment Period 2||0
861181|NCT02455050|2083718|P1|NOT COMPLETED|Treatment Period 2||1
861182|NCT02455050|2083715|P4|COMPLETED|Treatment Period 2||17
861183|NCT02455050|2083716|P3|COMPLETED|Treatment Period 2||17
861184|NCT02455050|2083717|P2|COMPLETED|Treatment Period 2||18
861185|NCT02455050|2083718|P1|COMPLETED|Treatment Period 2||18
861186|NCT02455050|2083715|P4|STARTED|Treatment Period 2||18
861187|NCT02455050|2083716|P3|STARTED|Treatment Period 2||19
861188|NCT02455050|2083717|P2|STARTED|Treatment Period 2||18
861189|NCT02455050|2083718|P1|STARTED|Treatment Period 2||19
861190|NCT02455050|2083715|P4|NOT COMPLETED|Treatment Period 1||2
861191|NCT02455050|2083716|P3|NOT COMPLETED|Treatment Period 1||1
861192|NCT02455050|2083717|P2|NOT COMPLETED|Treatment Period 1||1
861193|NCT02455050|2083718|P1|NOT COMPLETED|Treatment Period 1||1
861194|NCT02455050|2083715|P4|COMPLETED|Treatment Period 1||18
861195|NCT02455050|2083716|P3|COMPLETED|Treatment Period 1||19
861196|NCT02455050|2083717|P2|COMPLETED|Treatment Period 1||18
861197|NCT02455050|2083718|P1|COMPLETED|Treatment Period 1||19
861198|NCT02455050|2083715|P4|STARTED|Treatment Period 1||20
861199|NCT02455050|2083716|P3|STARTED|Treatment Period 1||20
861200|NCT02455050|2083717|P2|STARTED|Treatment Period 1||19
861201|NCT02455050|2083718|P1|STARTED|Treatment Period 1||20
861202|NCT02454959|2083782|P1|NOT COMPLETED|Overall Study||9
861203|NCT02454959|2083782|P1|COMPLETED|Overall Study||70
861204|NCT02454959|2083782|P1|GFF MDI (PT003) Without Aerochamber|Overall Study||77
861205|NCT02454959|2083782|P1|GFF MDI (PT003) With Aerochamber|Overall Study||73
861206|NCT02454959|2083782|P1|STARTED|Overall Study||79
861213|NCT02454296|2083823|P2|NOT COMPLETED|Overall Study||0
861214|NCT02454296|2083824|P1|NOT COMPLETED|Overall Study||0
861215|NCT02454296|2083823|P2|COMPLETED|Overall Study||21
861216|NCT02454296|2083824|P1|COMPLETED|Overall Study||20
861217|NCT02454296|2083823|P2|STARTED|Overall Study||21
861218|NCT02454296|2083824|P1|STARTED|Overall Study||20
861219|NCT02454283|2083836|P2|NOT COMPLETED|Overall Study||0
861220|NCT02454283|2083837|P1|NOT COMPLETED|Overall Study||0
861221|NCT02454283|2083836|P2|COMPLETED|Overall Study||15
861222|NCT02454283|2083837|P1|COMPLETED|Overall Study||26
861223|NCT02454283|2083836|P2|STARTED|Overall Study||15
861224|NCT02454283|2083837|P1|STARTED|Overall Study||26
861225|NCT02454127|2083849|P4|NOT COMPLETED|Overall Study||20
861226|NCT02454127|2083850|P3|NOT COMPLETED|Overall Study||14
861227|NCT02454127|2083851|P2|NOT COMPLETED|Overall Study||14
861228|NCT02454127|2083852|P1|NOT COMPLETED|Overall Study||19
861229|NCT02454127|2083849|P4|COMPLETED|Overall Study||20
861230|NCT02454127|2083850|P3|COMPLETED|Overall Study||26
861231|NCT02454127|2083851|P2|COMPLETED|Overall Study||26
861232|NCT02454127|2083852|P1|COMPLETED|Overall Study||21
861233|NCT02454127|2083849|P4|STARTED|Overall Study||40
861234|NCT02454127|2083850|P3|STARTED|Overall Study||40
861235|NCT02454127|2083851|P2|STARTED|Overall Study||40
861236|NCT02454127|2083852|P1|STARTED|Overall Study||40
861237|NCT02454101|2083892|P2|NOT COMPLETED|Overall Study||7
861238|NCT02454101|2083893|P1|NOT COMPLETED|Overall Study||5
861239|NCT02454101|2083892|P2|COMPLETED|Overall Study||143
861240|NCT02454101|2083893|P1|COMPLETED|Overall Study||145
861241|NCT02454101|2083892|P2|STARTED|Overall Study||150
861242|NCT02454101|2083893|P1|STARTED|Overall Study||150
861243|NCT02453581|2083915|P3|NOT COMPLETED|Overall Study||0
861244|NCT02453581|2083916|P2|NOT COMPLETED|Overall Study||0
861245|NCT02453581|2083917|P1|NOT COMPLETED|Overall Study||0
861246|NCT02453581|2083915|P3|COMPLETED|Overall Study||8
861247|NCT02453581|2083916|P2|COMPLETED|Overall Study||8
861248|NCT02453581|2083917|P1|COMPLETED|Overall Study||8
861249|NCT02453581|2083915|P3|STARTED|Overall Study||8
861250|NCT02453581|2083916|P2|STARTED|Overall Study||8
861251|NCT02453581|2083917|P1|STARTED|Overall Study||8
861252|NCT02452944|2083939|P2|NOT COMPLETED|Overall Study||0
861253|NCT02452944|2083940|P1|NOT COMPLETED|Overall Study||0
861254|NCT02452944|2083939|P2|COMPLETED|Overall Study||31
861255|NCT02452944|2083940|P1|COMPLETED|Overall Study||31
861256|NCT02452944|2083939|P2|STARTED|Overall Study||31
861257|NCT02452944|2083940|P1|STARTED|Overall Study||31
861258|NCT02451150|2083950|P2|NOT COMPLETED|Overall Study||0
861259|NCT02451150|2083951|P1|NOT COMPLETED|Overall Study||0
861260|NCT02451150|2083950|P2|COMPLETED|Overall Study||3
861261|NCT02451150|2083951|P1|COMPLETED|Overall Study||3
861262|NCT02451150|2083950|P2|STARTED|Overall Study||3
861263|NCT02451150|2083951|P1|STARTED|Overall Study||3
861264|NCT02450799|2084004|P3|NOT COMPLETED|Overall Study||0
861265|NCT02450799|2084005|P2|NOT COMPLETED|Overall Study||0
861266|NCT02450799|2084006|P1|NOT COMPLETED|Overall Study||0
861267|NCT02450799|2084004|P3|COMPLETED|Overall Study||30
861268|NCT02450799|2084005|P2|COMPLETED|Overall Study||37
861269|NCT02450799|2084006|P1|COMPLETED|Overall Study||31
861270|NCT02450799|2084004|P3|STARTED|Overall Study||30
861271|NCT02450799|2084005|P2|STARTED|Overall Study||37
861272|NCT02450799|2084006|P1|STARTED|Overall Study||31
861273|NCT02450747|2084017|P1|NOT COMPLETED|Overall Study||0
861274|NCT02450747|2084017|P1|COMPLETED|Overall Study||39
861275|NCT02450747|2084017|P1|STARTED|Overall Study||39
861282|NCT02449902|2084043|P2|NOT COMPLETED|Overall Study||2
861283|NCT02449902|2084044|P1|NOT COMPLETED|Overall Study||0
861284|NCT02449902|2084043|P2|COMPLETED|Overall Study||24
861285|NCT02449902|2084044|P1|COMPLETED|Overall Study||24
861286|NCT02449902|2084043|P2|STARTED|Overall Study||26
861287|NCT02449902|2084044|P1|STARTED|Overall Study||24
861288|NCT02449798|2084068|P1|NOT COMPLETED|Overall Study||0
861289|NCT02449798|2084068|P1|COMPLETED|Overall Study||120
861290|NCT02449798|2084068|P1|STARTED|Overall Study||120
861291|NCT02449356|2084082|P2|NOT COMPLETED|Overall Study||0
861292|NCT02449356|2084083|P1|NOT COMPLETED|Overall Study||0
861293|NCT02449356|2084082|P2|COMPLETED|Overall Study||30
861294|NCT02449356|2084083|P1|COMPLETED|Overall Study||30
861295|NCT02449356|2084082|P2|STARTED|Overall Study||30
861296|NCT02449356|2084083|P1|STARTED|Overall Study||30
861297|NCT02449044|2084099|P1|NOT COMPLETED|Overall Study||64
861298|NCT02449044|2084099|P1|COMPLETED|Overall Study|Participants who completed Weeks 58, 106 and 216 visit.|47
861299|NCT02449044|2084099|P1|STARTED|Overall Study||111
861300|NCT02448914|2084118|P2|NOT COMPLETED|Second Intervention (1 Day)||0
861301|NCT02448914|2084119|P1|NOT COMPLETED|Second Intervention (1 Day)||0
861302|NCT02448914|2084118|P2|COMPLETED|Second Intervention (1 Day)||5
861303|NCT02448914|2084119|P1|COMPLETED|Second Intervention (1 Day)||6
861304|NCT02448914|2084118|P2|STARTED|Second Intervention (1 Day)||5
861305|NCT02448914|2084119|P1|STARTED|Second Intervention (1 Day)||6
861306|NCT02448914|2084118|P2|NOT COMPLETED|First Intervention (1 Day)||0
861307|NCT02448914|2084119|P1|NOT COMPLETED|First Intervention (1 Day)||0
861308|NCT02448914|2084118|P2|COMPLETED|First Intervention (1 Day)||5
861309|NCT02448914|2084119|P1|COMPLETED|First Intervention (1 Day)||6
861310|NCT02448914|2084118|P2|STARTED|First Intervention (1 Day)||5
861311|NCT02448914|2084119|P1|STARTED|First Intervention (1 Day)||6
861312|NCT02448862|2084137|P2|NOT COMPLETED|Overall Study||0
861313|NCT02448862|2084138|P1|NOT COMPLETED|Overall Study||0
861314|NCT02448862|2084137|P2|COMPLETED|Overall Study||6050
861315|NCT02448862|2084138|P1|COMPLETED|Overall Study||4525
861316|NCT02448862|2084137|P2|STARTED|Overall Study||6050
861317|NCT02448862|2084138|P1|STARTED|Overall Study||4525
861318|NCT02448563|2084156|P2|NOT COMPLETED|Overall Study||11
861319|NCT02448563|2084157|P1|NOT COMPLETED|Overall Study||16
861320|NCT02448563|2084156|P2|COMPLETED|Overall Study||19
861321|NCT02448563|2084157|P1|COMPLETED|Overall Study||16
861322|NCT02448563|2084156|P2|STARTED|Overall Study|Randomized after completing Visit 2|30
861323|NCT02448563|2084157|P1|STARTED|Overall Study|Randomized after completing Visit 2|32
861324|NCT02447458|2084182|P6|NOT COMPLETED|Overall Study||0
861325|NCT02447458|2084183|P5|NOT COMPLETED|Overall Study||0
861326|NCT02447458|2084184|P4|NOT COMPLETED|Overall Study||0
861327|NCT02447458|2084185|P3|NOT COMPLETED|Overall Study||1
861328|NCT02447458|2084186|P2|NOT COMPLETED|Overall Study||0
861329|NCT02447458|2084187|P1|NOT COMPLETED|Overall Study||0
861330|NCT02447458|2084182|P6|COMPLETED|Overall Study||10
861331|NCT02447458|2084183|P5|COMPLETED|Overall Study||6
861332|NCT02447458|2084184|P4|COMPLETED|Overall Study||6
861333|NCT02447458|2084185|P3|COMPLETED|Overall Study||5
861334|NCT02447458|2084186|P2|COMPLETED|Overall Study||6
861335|NCT02447458|2084187|P1|COMPLETED|Overall Study||5
861336|NCT02447458|2084182|P6|STARTED|Overall Study||10
861337|NCT02447458|2084183|P5|STARTED|Overall Study||6
861338|NCT02447458|2084184|P4|STARTED|Overall Study||6
861339|NCT02447458|2084185|P3|STARTED|Overall Study||6
861340|NCT02447458|2084186|P2|STARTED|Overall Study||6
861341|NCT02447458|2084187|P1|STARTED|Overall Study||5
861342|NCT02447432|2084285|P2|NOT COMPLETED|Epoch 002||0
861343|NCT02447432|2084286|P1|NOT COMPLETED|Epoch 002||0
861344|NCT02447432|2084285|P2|COMPLETED|Epoch 002||145
861345|NCT02447432|2084286|P1|COMPLETED|Epoch 002||152
861346|NCT02447432|2084285|P2|STARTED|Epoch 002||145
861347|NCT02447432|2084286|P1|STARTED|Epoch 002||152
861348|NCT02447432|2084285|P2|NOT COMPLETED|Epoch 001||13
861349|NCT02447432|2084286|P1|NOT COMPLETED|Epoch 001||5
861350|NCT02447432|2084285|P2|COMPLETED|Epoch 001||147
861351|NCT02447432|2084286|P1|COMPLETED|Epoch 001||155
861352|NCT02447432|2084285|P2|STARTED|Epoch 001||160
861353|NCT02447432|2084286|P1|STARTED|Epoch 001||160
861354|NCT02447133|2084318|P1|NOT COMPLETED|Overall Study||0
861355|NCT02447133|2084318|P1|COMPLETED|Overall Study||12
861356|NCT02447133|2084318|P1|STARTED|Overall Study||12
861357|NCT02447029|2084326|P2|NOT COMPLETED|Overall Study||2
861358|NCT02447029|2084327|P1|NOT COMPLETED|Overall Study||3
861359|NCT02447029|2084326|P2|COMPLETED|Overall Study||68
861360|NCT02447029|2084327|P1|COMPLETED|Overall Study||69
861361|NCT02447029|2084326|P2|Treated|Overall Study||68
861362|NCT02447029|2084327|P1|Treated|Overall Study||69
861363|NCT02447029|2084326|P2|STARTED|Overall Study||70
861364|NCT02447029|2084327|P1|STARTED|Overall Study||72
861365|NCT02446990|2084347|P2|NOT COMPLETED|Overall Study||658
861366|NCT02446990|2084348|P1|NOT COMPLETED|Overall Study||720
861367|NCT02446990|2084347|P2|COMPLETED|Overall Study||8894
861368|NCT02446990|2084348|P1|COMPLETED|Overall Study||8830
861369|NCT02446990|2084347|P2|STARTED|Overall Study||9552
861370|NCT02446990|2084348|P1|STARTED|Overall Study||9550
861371|NCT02446717|2084385|P5|NOT COMPLETED|Overall Study||1
861372|NCT02446717|2084386|P4|NOT COMPLETED|Overall Study||1
861373|NCT02446717|2084387|P3|NOT COMPLETED|Overall Study||2
861374|NCT02446717|2084388|P2|NOT COMPLETED|Overall Study||1
861375|NCT02446717|2084389|P1|NOT COMPLETED|Overall Study||0
861376|NCT02446717|2084385|P5|COMPLETED|Overall Study||46
861377|NCT02446717|2084386|P4|COMPLETED|Overall Study||43
861378|NCT02446717|2084387|P3|COMPLETED|Overall Study||20
861379|NCT02446717|2084388|P2|COMPLETED|Overall Study||21
861380|NCT02446717|2084389|P1|COMPLETED|Overall Study||6
861381|NCT02446717|2084385|P5|STARTED|Overall Study||47
861382|NCT02446717|2084386|P4|STARTED|Overall Study||44
861383|NCT02446717|2084387|P3|STARTED|Overall Study||22
861384|NCT02446717|2084388|P2|STARTED|Overall Study||22
861385|NCT02446717|2084389|P1|STARTED|Overall Study||6
861386|NCT02446613|2084418|P2|NOT COMPLETED|Overall Study||0
861387|NCT02446613|2084419|P1|NOT COMPLETED|Overall Study||0
861388|NCT02446613|2084418|P2|COMPLETED|Overall Study||10
861389|NCT02446613|2084419|P1|COMPLETED|Overall Study||6
861390|NCT02446613|2084418|P2|STARTED|Overall Study||10
861391|NCT02446613|2084419|P1|STARTED|Overall Study||6
861392|NCT02446496|2084441|P1|NOT COMPLETED|Overall Study||0
861393|NCT02446496|2084441|P1|COMPLETED|Overall Study||24
861394|NCT02446496|2084441|P1|STARTED|Overall Study||24
861395|NCT02446483|2084453|P2|NOT COMPLETED|Period 3: Intervention Period 2||0
861396|NCT02446483|2084454|P1|NOT COMPLETED|Period 3: Intervention Period 2||0
861397|NCT02446483|2084453|P2|COMPLETED|Period 3: Intervention Period 2||30
861398|NCT02446483|2084454|P1|COMPLETED|Period 3: Intervention Period 2||30
861399|NCT02446483|2084453|P2|STARTED|Period 3: Intervention Period 2||30
861400|NCT02446483|2084454|P1|STARTED|Period 3: Intervention Period 2||30
861401|NCT02446483|2084453|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
861402|NCT02446483|2084454|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
861403|NCT02446483|2084453|P2|COMPLETED|Period 2: Washout Period (7 Days)||30
861404|NCT02446483|2084454|P1|COMPLETED|Period 2: Washout Period (7 Days)||30
861405|NCT02446483|2084453|P2|STARTED|Period 2: Washout Period (7 Days)||30
861406|NCT02446483|2084454|P1|STARTED|Period 2: Washout Period (7 Days)||30
861407|NCT02446483|2084453|P2|NOT COMPLETED|Period 1: Intervention Period 1||0
861408|NCT02446483|2084454|P1|NOT COMPLETED|Period 1: Intervention Period 1||0
861409|NCT02446483|2084453|P2|COMPLETED|Period 1: Intervention Period 1||30
861410|NCT02446483|2084454|P1|COMPLETED|Period 1: Intervention Period 1||30
861411|NCT02446483|2084453|P2|STARTED|Period 1: Intervention Period 1||30
861412|NCT02446483|2084454|P1|STARTED|Period 1: Intervention Period 1||30
861413|NCT02446171|2084470|P4|NOT COMPLETED|Overall Study||0
861414|NCT02446171|2084471|P3|NOT COMPLETED|Overall Study||2
861415|NCT02446171|2084472|P2|NOT COMPLETED|Overall Study||0
861416|NCT02446171|2084473|P1|NOT COMPLETED|Overall Study||0
861417|NCT02446171|2084470|P4|COMPLETED|Overall Study||11
861418|NCT02446171|2084471|P3|COMPLETED|Overall Study||9
861419|NCT02446171|2084472|P2|COMPLETED|Overall Study||11
861420|NCT02446171|2084473|P1|COMPLETED|Overall Study||11
861421|NCT02446171|2084470|P4|STARTED|Overall Study||11
861422|NCT02446171|2084471|P3|STARTED|Overall Study||11
861423|NCT02446171|2084472|P2|STARTED|Overall Study||11
861424|NCT02446171|2084473|P1|STARTED|Overall Study||11
861425|NCT02446015|2084544|P2|NOT COMPLETED|Overall Study||1
861426|NCT02446015|2084545|P1|NOT COMPLETED|Overall Study||1
861427|NCT02446015|2084544|P2|COMPLETED|Overall Study||62
861428|NCT02446015|2084545|P1|COMPLETED|Overall Study||33
861429|NCT02446015|2084544|P2|STARTED|Overall Study||63
861430|NCT02446015|2084545|P1|STARTED|Overall Study||34
861431|NCT02445755|2084556|P1|NOT COMPLETED|Overall Study||13
861432|NCT02445755|2084556|P1|COMPLETED|Overall Study||100
861433|NCT02445755|2084556|P1|STARTED|Overall Study|Neonates will be tested with 3 transcutaneous (TcB) devices +/-30 minutes of routine bilirubin labs|113
861434|NCT02445573|2084565|P2|NOT COMPLETED|Overall Study||2
861435|NCT02445573|2084566|P1|NOT COMPLETED|Overall Study||1
861436|NCT02445573|2084565|P2|COMPLETED|Overall Study||38
861437|NCT02445573|2084566|P1|COMPLETED|Overall Study||39
861438|NCT02445573|2084565|P2|STARTED|Overall Study||40
861439|NCT02445573|2084566|P1|STARTED|Overall Study||40
861440|NCT02445287|2084582|P2|NOT COMPLETED|Overall Study||0
861441|NCT02445287|2084583|P1|NOT COMPLETED|Overall Study||0
861442|NCT02445287|2084582|P2|COMPLETED|Overall Study||13
861443|NCT02445287|2084583|P1|COMPLETED|Overall Study||35
861444|NCT02445287|2084582|P2|STARTED|Overall Study||13
861445|NCT02445287|2084583|P1|STARTED|Overall Study||35
861446|NCT02445196|2084598|P2|NOT COMPLETED|Overall Study||6
861447|NCT02445196|2084599|P1|NOT COMPLETED|Overall Study||11
861448|NCT02445196|2084598|P2|COMPLETED|Overall Study||52
861449|NCT02445196|2084599|P1|COMPLETED|Overall Study||51
861450|NCT02445196|2084598|P2|STARTED|Overall Study||58
861451|NCT02445196|2084599|P1|STARTED|Overall Study||62
861452|NCT02444715|2084614|P2|NOT COMPLETED|Overall Study||16
861453|NCT02444715|2084615|P1|NOT COMPLETED|Overall Study||10
861454|NCT02444715|2084614|P2|COMPLETED|Overall Study||32
861455|NCT02444715|2084615|P1|COMPLETED|Overall Study||36
861456|NCT02444715|2084614|P2|STARTED|Overall Study||48
861457|NCT02444715|2084615|P1|STARTED|Overall Study||46
861458|NCT02444533|2084646|P2|NOT COMPLETED|Overall Study||4
861459|NCT02444533|2084647|P1|NOT COMPLETED|Overall Study||2
861460|NCT02444533|2084646|P2|COMPLETED|Overall Study||18
861461|NCT02444533|2084647|P1|COMPLETED|Overall Study||15
861462|NCT02444533|2084646|P2|STARTED|Overall Study||22
861463|NCT02444533|2084647|P1|STARTED|Overall Study||17
861464|NCT02444182|2084663|P2|NOT COMPLETED|Overall Study||5
861465|NCT02444182|2084664|P1|NOT COMPLETED|Overall Study||2
861466|NCT02444182|2084663|P2|COMPLETED|Overall Study||49
861467|NCT02444182|2084664|P1|COMPLETED|Overall Study||52
861468|NCT02444182|2084663|P2|STARTED|Overall Study||54
861469|NCT02444182|2084664|P1|STARTED|Overall Study||54
861470|NCT02443792|2084674|P2|NOT COMPLETED|Overall Study||2
861471|NCT02443792|2084675|P1|NOT COMPLETED|Overall Study||7
861472|NCT02443792|2084674|P2|COMPLETED|Overall Study||23
861473|NCT02443792|2084675|P1|COMPLETED|Overall Study||43
861474|NCT02443792|2084674|P2|STARTED|Overall Study||25
861475|NCT02443792|2084675|P1|STARTED|Overall Study||50
861476|NCT02442804|2084691|P2|NOT COMPLETED|Overall Study||1
861477|NCT02442804|2084692|P1|NOT COMPLETED|Overall Study||1
861478|NCT02442804|2084691|P2|COMPLETED|Overall Study||7
861479|NCT02442804|2084692|P1|COMPLETED|Overall Study||7
861480|NCT02442804|2084691|P2|STARTED|Overall Study||8
861481|NCT02442804|2084692|P1|STARTED|Overall Study||8
861482|NCT02442700|2084722|P2|NOT COMPLETED|Later 12 Weeks||0
861483|NCT02442700|2084723|P1|NOT COMPLETED|Later 12 Weeks||0
861484|NCT02442700|2084722|P2|COMPLETED|Later 12 Weeks||12
861485|NCT02442700|2084723|P1|COMPLETED|Later 12 Weeks||12
861486|NCT02442700|2084722|P2|STARTED|Later 12 Weeks||12
861487|NCT02442700|2084723|P1|STARTED|Later 12 Weeks||12
861488|NCT02442700|2084722|P2|NOT COMPLETED|First 12 Weeks||0
861489|NCT02442700|2084723|P1|NOT COMPLETED|First 12 Weeks||0
861490|NCT02442700|2084722|P2|COMPLETED|First 12 Weeks||12
861491|NCT02442700|2084723|P1|COMPLETED|First 12 Weeks||12
861492|NCT02442700|2084722|P2|STARTED|First 12 Weeks||12
861493|NCT02442700|2084723|P1|STARTED|First 12 Weeks||12
861494|NCT02442349|2084731|P1|NOT COMPLETED|Overall Study||171
861495|NCT02442349|2084731|P1|COMPLETED|Overall Study||0
861496|NCT02442349|2084731|P1|STARTED|Overall Study||171
861497|NCT02442310|2084736|P1|NOT COMPLETED|Overall Study||3
861498|NCT02442310|2084736|P1|COMPLETED|Overall Study||17
861499|NCT02442310|2084736|P1|STARTED|Overall Study||20
861503|NCT02442271|2084765|P1|NOT COMPLETED|Overall Study||4
861504|NCT02442271|2084765|P1|COMPLETED|Overall Study||218
861505|NCT02442271|2084765|P1|STARTED|Overall Study||222
861506|NCT02441218|2084791|P2|NOT COMPLETED|Overall Study||612
861507|NCT02441218|2084792|P1|NOT COMPLETED|Overall Study||578
861508|NCT02441218|2084791|P2|COMPLETED|Overall Study||2652
861509|NCT02441218|2084792|P1|COMPLETED|Overall Study||2663
861510|NCT02441218|2084791|P2|STARTED|Overall Study||3264
861511|NCT02441218|2084792|P1|STARTED|Overall Study||3241
861512|NCT02441179|2084818|P2|NOT COMPLETED|Overall Study||1
861513|NCT02441179|2084819|P1|NOT COMPLETED|Overall Study||1
861514|NCT02441179|2084818|P2|COMPLETED|Overall Study||16
861515|NCT02441179|2084819|P1|COMPLETED|Overall Study||17
861516|NCT02441179|2084818|P2|STARTED|Overall Study||17
861517|NCT02441179|2084819|P1|STARTED|Overall Study||18
861518|NCT02441114|2084837|P1|NOT COMPLETED|Period3||0
861519|NCT02441114|2084837|P1|COMPLETED|Period3||6
861520|NCT02441114|2084837|P1|STARTED|Period3||6
861521|NCT02441114|2084837|P1|NOT COMPLETED|Washout2||4
861522|NCT02441114|2084837|P1|COMPLETED|Washout2||6
861523|NCT02441114|2084837|P1|STARTED|Washout2||10
861524|NCT02441114|2084837|P1|NOT COMPLETED|Period2||0
861525|NCT02441114|2084837|P1|COMPLETED|Period2||10
861526|NCT02441114|2084837|P1|STARTED|Period2||10
861527|NCT02441114|2084837|P1|NOT COMPLETED|Washout1||0
861528|NCT02441114|2084837|P1|COMPLETED|Washout1||10
861529|NCT02441114|2084837|P1|STARTED|Washout1||10
861530|NCT02441114|2084837|P1|NOT COMPLETED|Period1||0
861531|NCT02441114|2084837|P1|COMPLETED|Period1||10
861532|NCT02441114|2084837|P1|STARTED|Period1||10
861533|NCT02440659|2084845|P2|NOT COMPLETED|Overall Study||335
861534|NCT02440659|2084846|P1|NOT COMPLETED|Overall Study||651
861535|NCT02440659|2084845|P2|COMPLETED|Overall Study||614
861536|NCT02440659|2084846|P1|COMPLETED|Overall Study||1346
861537|NCT02440659|2084845|P2|STARTED|Overall Study||949
861538|NCT02440659|2084846|P1|STARTED|Overall Study||1997
861539|NCT02440633|2084852|P1|NOT COMPLETED|Overall Study||0
861540|NCT02440633|2084852|P1|COMPLETED|Overall Study||8
861541|NCT02440633|2084852|P1|STARTED|Overall Study||8
861542|NCT02440308|2084861|P1|NOT COMPLETED|Overall Study||0
861543|NCT02440308|2084861|P1|COMPLETED|Overall Study||10
861544|NCT02440308|2084861|P1|STARTED|Overall Study||10
861545|NCT02439879|2084868|P2|NOT COMPLETED|Overall Study||0
861546|NCT02439879|2084869|P1|NOT COMPLETED|Overall Study||0
861547|NCT02439879|2084868|P2|COMPLETED|Overall Study||17
861548|NCT02439879|2084869|P1|COMPLETED|Overall Study||16
861549|NCT02439879|2084868|P2|STARTED|Overall Study||17
861550|NCT02439879|2084869|P1|STARTED|Overall Study||16
861551|NCT02439164|2084877|P2|NOT COMPLETED|Overall Study||0
861552|NCT02439164|2084878|P1|NOT COMPLETED|Overall Study||0
861553|NCT02439164|2084877|P2|COMPLETED|Overall Study||18
861554|NCT02439164|2084878|P1|COMPLETED|Overall Study||18
861555|NCT02439164|2084877|P2|STARTED|Overall Study||18
861556|NCT02439164|2084878|P1|STARTED|Overall Study||18
861557|NCT02439138|2084891|P1|NOT COMPLETED|Overall Study||3
861558|NCT02439138|2084891|P1|COMPLETED|Overall Study||2
861559|NCT02439138|2084891|P1|STARTED|Overall Study||5
861560|NCT02438540|2084904|P2|NOT COMPLETED|Overall Study||0
861561|NCT02438540|2084905|P1|NOT COMPLETED|Overall Study||0
861562|NCT02438540|2084904|P2|COMPLETED|Overall Study||20
861563|NCT02438540|2084905|P1|COMPLETED|Overall Study||19
861564|NCT02438540|2084904|P2|STARTED|Overall Study||20
861565|NCT02438540|2084905|P1|STARTED|Overall Study||19
861566|NCT02438137|2084947|P2|NOT COMPLETED|Overall Study||6
861567|NCT02438137|2084948|P1|NOT COMPLETED|Overall Study||8
861568|NCT02438137|2084947|P2|COMPLETED|Overall Study||15
861569|NCT02438137|2084948|P1|COMPLETED|Overall Study||36
861570|NCT02438137|2084947|P2|STARTED|Overall Study||21
861571|NCT02438137|2084948|P1|STARTED|Overall Study||44
861572|NCT02437903|2084956|P1|NOT COMPLETED|Overall Study||5
861573|NCT02437903|2084956|P1|COMPLETED|Overall Study||25
861574|NCT02437903|2084956|P1|STARTED|Overall Study||30
861575|NCT02437513|2084964|P1|NOT COMPLETED|Overall Study||2
861576|NCT02437513|2084964|P1|COMPLETED|Overall Study||0
861577|NCT02437513|2084964|P1|STARTED|Overall Study||2
861578|NCT02437409|2084972|P1|NOT COMPLETED|Overall Study||15
861579|NCT02437409|2084972|P1|COMPLETED|Overall Study|In total 100 patients fulfilled the in-and exclusion criteria,15 patients were excluded/discontinued|100
861580|NCT02437409|2084972|P1|STARTED|Overall Study|Eventually 100 evaluable patients, attrition rate of 15%|115
861581|NCT02437344|2084981|P1|NOT COMPLETED|Overall Study||1
861582|NCT02437344|2084981|P1|COMPLETED|Overall Study||15
861583|NCT02437344|2084981|P1|STARTED|Overall Study||16
861584|NCT02437305|2084987|P2|NOT COMPLETED|Overall Study||12
861585|NCT02437305|2084988|P1|NOT COMPLETED|Overall Study||18
861586|NCT02437305|2084987|P2|COMPLETED|Overall Study||38
861587|NCT02437305|2084988|P1|COMPLETED|Overall Study||32
861588|NCT02437305|2084987|P2|STARTED|Overall Study||50
861589|NCT02437305|2084988|P1|STARTED|Overall Study||50
861590|NCT02437253|2084998|P2|NOT COMPLETED|Overall Study||0
861591|NCT02437253|2084999|P1|NOT COMPLETED|Overall Study||0
861592|NCT02437253|2084998|P2|COMPLETED|Overall Study||1
861593|NCT02437253|2084999|P1|COMPLETED|Overall Study||1
861594|NCT02437253|2084998|P2|STARTED|Overall Study||1
861595|NCT02437253|2084999|P1|STARTED|Overall Study||1
861596|NCT02436811|2085016|P3|NOT COMPLETED|Overall Study||7
861597|NCT02436811|2085017|P2|NOT COMPLETED|Overall Study||9
861598|NCT02436811|2085018|P1|NOT COMPLETED|Overall Study||2
861599|NCT02436811|2085016|P3|COMPLETED|Overall Study||53
861600|NCT02436811|2085017|P2|COMPLETED|Overall Study||51
861601|NCT02436811|2085018|P1|COMPLETED|Overall Study||58
861602|NCT02436811|2085016|P3|STARTED|Overall Study||60
861603|NCT02436811|2085017|P2|STARTED|Overall Study||60
861604|NCT02436811|2085018|P1|STARTED|Overall Study||60
861605|NCT02436577|2085032|P6|NOT COMPLETED|Overall Study||0
861606|NCT02436577|2085033|P5|NOT COMPLETED|Overall Study||0
861607|NCT02436577|2085034|P4|NOT COMPLETED|Overall Study||0
861608|NCT02436577|2085035|P3|NOT COMPLETED|Overall Study||0
861609|NCT02436577|2085036|P2|NOT COMPLETED|Overall Study||1
861610|NCT02436577|2085037|P1|NOT COMPLETED|Overall Study||0
861611|NCT02436577|2085032|P6|COMPLETED|Overall Study||7
861612|NCT02436577|2085033|P5|COMPLETED|Overall Study||7
861613|NCT02436577|2085034|P4|COMPLETED|Overall Study||7
861614|NCT02436577|2085035|P3|COMPLETED|Overall Study||7
861615|NCT02436577|2085036|P2|COMPLETED|Overall Study||6
861616|NCT02436577|2085037|P1|COMPLETED|Overall Study||7
861617|NCT02436577|2085032|P6|STARTED|Overall Study||7
861618|NCT02436577|2085033|P5|STARTED|Overall Study||7
861619|NCT02436577|2085034|P4|STARTED|Overall Study||7
861620|NCT02436577|2085035|P3|STARTED|Overall Study||7
861621|NCT02436577|2085036|P2|STARTED|Overall Study||7
861622|NCT02436577|2085037|P1|STARTED|Overall Study||7
861623|NCT02436330|2085092|P2|NOT COMPLETED|Cohort 6||1
861624|NCT02436330|2085093|P1|NOT COMPLETED|Cohort 6||3
861625|NCT02436330|2085092|P2|COMPLETED|Cohort 6||4
861626|NCT02436330|2085093|P1|COMPLETED|Cohort 6||1
861627|NCT02436330|2085092|P2|STARTED|Cohort 6||5
861628|NCT02436330|2085093|P1|STARTED|Cohort 6||4
861629|NCT02436330|2085092|P2|NOT COMPLETED|Cohort 5||4
861630|NCT02436330|2085093|P1|NOT COMPLETED|Cohort 5||6
861631|NCT02436330|2085092|P2|COMPLETED|Cohort 5||1
861632|NCT02436330|2085093|P1|COMPLETED|Cohort 5||4
861633|NCT02436330|2085092|P2|STARTED|Cohort 5||5
861634|NCT02436330|2085093|P1|STARTED|Cohort 5||10
861635|NCT02436330|2085092|P2|NOT COMPLETED|Cohort 4||0
861636|NCT02436330|2085093|P1|NOT COMPLETED|Cohort 4||2
861637|NCT02436330|2085092|P2|COMPLETED|Cohort 4||0
861638|NCT02436330|2085093|P1|COMPLETED|Cohort 4||4
861639|NCT02436330|2085092|P2|STARTED|Cohort 4|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
861640|NCT02436330|2085093|P1|STARTED|Cohort 4||6
861641|NCT02436330|2085092|P2|NOT COMPLETED|Cohort 3||0
861642|NCT02436330|2085093|P1|NOT COMPLETED|Cohort 3||5
861643|NCT02436330|2085092|P2|COMPLETED|Cohort 3||0
861644|NCT02436330|2085093|P1|COMPLETED|Cohort 3||7
861645|NCT02436330|2085092|P2|STARTED|Cohort 3|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
861646|NCT02436330|2085093|P1|STARTED|Cohort 3||12
861647|NCT02436330|2085092|P2|NOT COMPLETED|Cohort 2||3
861648|NCT02436330|2085093|P1|NOT COMPLETED|Cohort 2||4
861649|NCT02436330|2085092|P2|COMPLETED|Cohort 2||7
861650|NCT02436330|2085093|P1|COMPLETED|Cohort 2||10
861651|NCT02436330|2085092|P2|STARTED|Cohort 2||10
861652|NCT02436330|2085093|P1|STARTED|Cohort 2||14
861653|NCT02436330|2085092|P2|NOT COMPLETED|Cohort 1||3
861654|NCT02436330|2085093|P1|NOT COMPLETED|Cohort 1||5
861655|NCT02436330|2085092|P2|COMPLETED|Cohort 1||1
861656|NCT02436330|2085093|P1|COMPLETED|Cohort 1||9
861657|NCT02436330|2085092|P2|STARTED|Cohort 1||4
861658|NCT02436330|2085093|P1|STARTED|Cohort 1||14
861659|NCT02436304|2085138|P3|NOT COMPLETED|Overall Study||1
861660|NCT02436304|2085139|P2|NOT COMPLETED|Overall Study||2
861661|NCT02436304|2085140|P1|NOT COMPLETED|Overall Study||0
861662|NCT02436304|2085138|P3|COMPLETED|Overall Study||100
861663|NCT02436304|2085139|P2|COMPLETED|Overall Study||100
861664|NCT02436304|2085140|P1|COMPLETED|Overall Study||153
861665|NCT02436304|2085138|P3|STARTED|Overall Study||101
861666|NCT02436304|2085139|P2|STARTED|Overall Study||102
861667|NCT02436304|2085140|P1|STARTED|Overall Study||153
861668|NCT02436031|2085155|P2|NOT COMPLETED|Second Study Night||0
861669|NCT02436031|2085156|P1|NOT COMPLETED|Second Study Night||0
861670|NCT02436031|2085155|P2|COMPLETED|Second Study Night||8
861671|NCT02436031|2085156|P1|COMPLETED|Second Study Night||7
861672|NCT02436031|2085155|P2|STARTED|Second Study Night||8
861673|NCT02436031|2085156|P1|STARTED|Second Study Night|1 participant did not tolerate the study setup so did not participate in the second study night|7
861674|NCT02436031|2085155|P2|NOT COMPLETED|First Study Night||0
861675|NCT02436031|2085156|P1|NOT COMPLETED|First Study Night||0
861676|NCT02436031|2085155|P2|COMPLETED|First Study Night||8
861677|NCT02436031|2085156|P1|COMPLETED|First Study Night||8
861678|NCT02436031|2085155|P2|STARTED|First Study Night||8
861679|NCT02436031|2085156|P1|STARTED|First Study Night||8
861680|NCT02435966|2085169|P3|NOT COMPLETED|Overall Study||0
861681|NCT02435966|2085170|P2|NOT COMPLETED|Overall Study||1
861682|NCT02435966|2085171|P1|NOT COMPLETED|Overall Study||0
861683|NCT02435966|2085169|P3|COMPLETED|Overall Study||30
861684|NCT02435966|2085170|P2|COMPLETED|Overall Study||53
861685|NCT02435966|2085171|P1|COMPLETED|Overall Study||47
861686|NCT02435966|2085169|P3|Follow-up|Overall Study||30
861687|NCT02435966|2085170|P2|Follow-up|Overall Study||53
861688|NCT02435966|2085171|P1|Follow-up|Overall Study||47
861689|NCT02435966|2085169|P3|Second Intervention|Overall Study||30
861690|NCT02435966|2085170|P2|Second Intervention|Overall Study||53
861691|NCT02435966|2085171|P1|Second Intervention|Overall Study||47
861692|NCT02435966|2085169|P3|First Intervention|Overall Study||30
861693|NCT02435966|2085170|P2|First Intervention|Overall Study||54
861694|NCT02435966|2085171|P1|First Intervention|Overall Study||47
861695|NCT02435966|2085169|P3|STARTED|Overall Study||30
861696|NCT02435966|2085170|P2|STARTED|Overall Study||54
861697|NCT02435966|2085171|P1|STARTED|Overall Study||47
861698|NCT02435836|2085179|P1|NOT COMPLETED|Overall Study||631
861699|NCT02435836|2085179|P1|COMPLETED|Overall Study||0
861700|NCT02435836|2085179|P1|STARTED|Overall Study||631
861701|NCT02434939|2085197|P2|NOT COMPLETED|Overall Study||49
861702|NCT02434939|2085198|P1|NOT COMPLETED|Overall Study||37
861703|NCT02434939|2085197|P2|COMPLETED|Overall Study||71
861704|NCT02434939|2085198|P1|COMPLETED|Overall Study||83
861705|NCT02434939|2085197|P2|STARTED|Overall Study||120
861706|NCT02434939|2085198|P1|STARTED|Overall Study||120
861707|NCT02434523|2085212|P2|NOT COMPLETED|Overall Study||6
861708|NCT02434523|2085213|P1|NOT COMPLETED|Overall Study||5
861709|NCT02434523|2085212|P2|COMPLETED|Overall Study||9
861710|NCT02434523|2085213|P1|COMPLETED|Overall Study||10
861711|NCT02434523|2085212|P2|STARTED|Overall Study||15
861712|NCT02434523|2085213|P1|STARTED|Overall Study||15
861716|NCT02433834|2085237|P1|NOT COMPLETED|Overall Study||37
861717|NCT02433834|2085237|P1|COMPLETED|Overall Study|Subject PT001101-040014 did not complete Period 4 but completed the study. CSR states 210 completed.|211
861718|NCT02433834|2085237|P1|SAL 50 µg|Overall Study||167
861719|NCT02433834|2085237|P1|Placebo MDI|Overall Study||174
861720|NCT02433834|2085237|P1|GP MDI 1.9 µg|Overall Study||107
861721|NCT02433834|2085237|P1|GP MDI 3.6 µg|Overall Study||118
861722|NCT02433834|2085237|P1|GP MDI 7.2 µg|Overall Study||228
861723|NCT02433834|2085237|P1|GP MDI 14.4 µg|Overall Study||230
861724|NCT02433834|2085237|P1|GP MDI 28.8 µg|Overall Study||112
861725|NCT02433834|2085237|P1|STARTED|Overall Study||248
861726|NCT02433366|2085297|P2|NOT COMPLETED|Overall Study||0
861727|NCT02433366|2085298|P1|NOT COMPLETED|Overall Study||0
861728|NCT02433366|2085297|P2|COMPLETED|Overall Study||802
861729|NCT02433366|2085298|P1|COMPLETED|Overall Study||411
861730|NCT02433366|2085297|P2|STARTED|Overall Study||802
861731|NCT02433366|2085298|P1|STARTED|Overall Study||411
861732|NCT02433340|2085310|P4|NOT COMPLETED|Overall Study||2
861733|NCT02433340|2085311|P3|NOT COMPLETED|Overall Study||2
861734|NCT02433340|2085312|P2|NOT COMPLETED|Overall Study||2
861735|NCT02433340|2085313|P1|NOT COMPLETED|Overall Study||2
861736|NCT02433340|2085310|P4|COMPLETED|Overall Study||38
861737|NCT02433340|2085311|P3|COMPLETED|Overall Study||37
861738|NCT02433340|2085312|P2|COMPLETED|Overall Study||35
861739|NCT02433340|2085313|P1|COMPLETED|Overall Study||40
861740|NCT02433340|2085310|P4|STARTED|Overall Study||40
861741|NCT02433340|2085311|P3|STARTED|Overall Study||39
861742|NCT02433340|2085312|P2|STARTED|Overall Study||37
861743|NCT02433340|2085313|P1|STARTED|Overall Study||42
861744|NCT02432105|2086208|P3|NOT COMPLETED|Overall Study||3
861745|NCT02432105|2086209|P2|NOT COMPLETED|Overall Study||2
861746|NCT02432105|2086210|P1|NOT COMPLETED|Overall Study||2
861747|NCT02432105|2086208|P3|COMPLETED|Overall Study||108
861748|NCT02432105|2086209|P2|COMPLETED|Overall Study||108
861749|NCT02432105|2086210|P1|COMPLETED|Overall Study||162
861750|NCT02432105|2086208|P3|STARTED|Overall Study||111
861751|NCT02432105|2086209|P2|STARTED|Overall Study||110
861752|NCT02432105|2086210|P1|STARTED|Overall Study||164
861753|NCT02432040|2086227|P2|NOT COMPLETED|Overall Study||6
861754|NCT02432040|2086228|P1|NOT COMPLETED|Overall Study||8
861755|NCT02432040|2086227|P2|COMPLETED|Overall Study||8
861756|NCT02432040|2086228|P1|COMPLETED|Overall Study||6
861757|NCT02432040|2086227|P2|STARTED|Overall Study||14
861758|NCT02432040|2086228|P1|STARTED|Overall Study||14
861759|NCT02431754|2086250|P2|NOT COMPLETED|Period 2 (8 Weeks)||4
861760|NCT02431754|2086251|P1|NOT COMPLETED|Period 2 (8 Weeks)||1
861761|NCT02431754|2086250|P2|COMPLETED|Period 2 (8 Weeks)||78
861762|NCT02431754|2086251|P1|COMPLETED|Period 2 (8 Weeks)||74
861763|NCT02431754|2086250|P2|STARTED|Period 2 (8 Weeks)||82
861764|NCT02431754|2086251|P1|STARTED|Period 2 (8 Weeks)||75
861765|NCT02431754|2086250|P2|NOT COMPLETED|Wash-out Period (4 Weeks)||0
861766|NCT02431754|2086251|P1|NOT COMPLETED|Wash-out Period (4 Weeks)||4
861767|NCT02431754|2086250|P2|COMPLETED|Wash-out Period (4 Weeks)||82
861768|NCT02431754|2086251|P1|COMPLETED|Wash-out Period (4 Weeks)||75
861769|NCT02431754|2086250|P2|STARTED|Wash-out Period (4 Weeks)||82
861770|NCT02431754|2086251|P1|STARTED|Wash-out Period (4 Weeks)||79
861771|NCT02431754|2086250|P2|NOT COMPLETED|Period 1 (8 Weeks)||4
861772|NCT02431754|2086251|P1|NOT COMPLETED|Period 1 (8 Weeks)||6
861773|NCT02431754|2086250|P2|COMPLETED|Period 1 (8 Weeks)||82
861774|NCT02431754|2086251|P1|COMPLETED|Period 1 (8 Weeks)||79
861775|NCT02431754|2086250|P2|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||86
861776|NCT02431754|2086251|P1|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||85
861777|NCT02431754|2086250|P2|STARTED|Period 1 (8 Weeks)||86
861778|NCT02431754|2086251|P1|STARTED|Period 1 (8 Weeks)||85
861779|NCT02431741|2086269|P1|NOT COMPLETED|Overall Study||0
861780|NCT02431741|2086269|P1|COMPLETED|Overall Study||14
861781|NCT02431741|2086269|P1|STARTED|Overall Study||14
861782|NCT02431598|2086273|P6|NOT COMPLETED|Overall Study||0
861783|NCT02431598|2086274|P5|NOT COMPLETED|Overall Study||0
861784|NCT02431598|2086275|P4|NOT COMPLETED|Overall Study||0
861785|NCT02431598|2086276|P3|NOT COMPLETED|Overall Study||0
861786|NCT02431598|2086277|P2|NOT COMPLETED|Overall Study||0
861787|NCT02431598|2086278|P1|NOT COMPLETED|Overall Study||0
861788|NCT02431598|2086273|P6|COMPLETED|Overall Study||6
861789|NCT02431598|2086274|P5|COMPLETED|Overall Study||7
861790|NCT02431598|2086275|P4|COMPLETED|Overall Study||7
861791|NCT02431598|2086276|P3|COMPLETED|Overall Study||9
861792|NCT02431598|2086277|P2|COMPLETED|Overall Study||9
861793|NCT02431598|2086278|P1|COMPLETED|Overall Study||6
861794|NCT02431598|2086273|P6|STARTED|Overall Study||6
861795|NCT02431598|2086274|P5|STARTED|Overall Study||7
861796|NCT02431598|2086275|P4|STARTED|Overall Study||7
861797|NCT02431598|2086276|P3|STARTED|Overall Study||9
861798|NCT02431598|2086277|P2|STARTED|Overall Study||9
861799|NCT02431598|2086278|P1|STARTED|Overall Study||6
861800|NCT02431455|2086304|P2|NOT COMPLETED|Overall Study||0
861801|NCT02431455|2086305|P1|NOT COMPLETED|Overall Study||0
861802|NCT02431455|2086304|P2|COMPLETED|Overall Study||112
861803|NCT02431455|2086305|P1|COMPLETED|Overall Study||112
861804|NCT02431455|2086304|P2|STARTED|Overall Study||112
861805|NCT02431455|2086305|P1|STARTED|Overall Study||112
861806|NCT02431299|2086319|P2|NOT COMPLETED|Overall Study||1
861807|NCT02431299|2086320|P1|NOT COMPLETED|Overall Study||53
861808|NCT02431299|2086319|P2|COMPLETED|Overall Study||62
861809|NCT02431299|2086320|P1|COMPLETED|Overall Study||183
861810|NCT02431299|2086319|P2|STARTED|Overall Study||63
861811|NCT02431299|2086320|P1|STARTED|Overall Study||236
861812|NCT02430870|2086341|P8|NOT COMPLETED|Part 2||1
861813|NCT02430870|2086342|P7|NOT COMPLETED|Part 2||1
861814|NCT02430870|2086343|P6|NOT COMPLETED|Part 2||0
861815|NCT02430870|2086344|P5|NOT COMPLETED|Part 2||0
861816|NCT02430870|2086345|P4|NOT COMPLETED|Part 2||0
861817|NCT02430870|2086346|P3|NOT COMPLETED|Part 2||0
861818|NCT02430870|2086347|P2|NOT COMPLETED|Part 2||0
861819|NCT02430870|2086348|P1|NOT COMPLETED|Part 2||0
861820|NCT02430870|2086341|P8|COMPLETED|Part 2||7
861821|NCT02430870|2086342|P7|COMPLETED|Part 2||5
861822|NCT02430870|2086343|P6|COMPLETED|Part 2||6
861823|NCT02430870|2086344|P5|COMPLETED|Part 2||6
861824|NCT02430870|2086345|P4|COMPLETED|Part 2||6
861825|NCT02430870|2086346|P3|COMPLETED|Part 2||0
861826|NCT02430870|2086347|P2|COMPLETED|Part 2||0
861827|NCT02430870|2086348|P1|COMPLETED|Part 2||0
861828|NCT02430870|2086341|P8|STARTED|Part 2||8
861829|NCT02430870|2086342|P7|STARTED|Part 2||6
861830|NCT02430870|2086343|P6|STARTED|Part 2||6
861831|NCT02430870|2086344|P5|STARTED|Part 2||6
861832|NCT02430870|2086345|P4|STARTED|Part 2||6
861833|NCT02430870|2086346|P3|STARTED|Part 2||0
861834|NCT02430870|2086347|P2|STARTED|Part 2||0
861835|NCT02430870|2086348|P1|STARTED|Part 2||0
861836|NCT02430870|2086341|P8|NOT COMPLETED|Part 1||0
861837|NCT02430870|2086342|P7|NOT COMPLETED|Part 1||0
861838|NCT02430870|2086343|P6|NOT COMPLETED|Part 1||0
861839|NCT02430870|2086344|P5|NOT COMPLETED|Part 1||0
861840|NCT02430870|2086345|P4|NOT COMPLETED|Part 1||0
861841|NCT02430870|2086346|P3|NOT COMPLETED|Part 1||0
861842|NCT02430870|2086347|P2|NOT COMPLETED|Part 1||0
861843|NCT02430870|2086348|P1|NOT COMPLETED|Part 1||0
861844|NCT02430870|2086341|P8|COMPLETED|Part 1||0
861845|NCT02430870|2086342|P7|COMPLETED|Part 1||0
861846|NCT02430870|2086343|P6|COMPLETED|Part 1||0
861847|NCT02430870|2086344|P5|COMPLETED|Part 1||0
861848|NCT02430870|2086345|P4|COMPLETED|Part 1||0
861849|NCT02430870|2086346|P3|COMPLETED|Part 1||4
861850|NCT02430870|2086347|P2|COMPLETED|Part 1||6
861851|NCT02430870|2086348|P1|COMPLETED|Part 1||6
861852|NCT02430870|2086341|P8|STARTED|Part 1||0
861853|NCT02430870|2086342|P7|STARTED|Part 1||0
861854|NCT02430870|2086343|P6|STARTED|Part 1||0
861855|NCT02430870|2086344|P5|STARTED|Part 1||0
861856|NCT02430870|2086345|P4|STARTED|Part 1||0
861857|NCT02430870|2086346|P3|STARTED|Part 1||4
861858|NCT02430870|2086347|P2|STARTED|Part 1||6
861859|NCT02430870|2086348|P1|STARTED|Part 1||6
861860|NCT02430532|2086422|P2|NOT COMPLETED|Overall Study||28
861861|NCT02430532|2086423|P1|NOT COMPLETED|Overall Study||30
861862|NCT02430532|2086422|P2|COMPLETED|Overall Study||0
861863|NCT02430532|2086423|P1|COMPLETED|Overall Study||0
861864|NCT02430532|2086422|P2|STARTED|Overall Study||28
861865|NCT02430532|2086423|P1|STARTED|Overall Study||30
861866|NCT02430389|2086439|P2|NOT COMPLETED|Overall Study||0
861867|NCT02430389|2086440|P1|NOT COMPLETED|Overall Study||0
861868|NCT02430389|2086439|P2|COMPLETED|Overall Study||10
861869|NCT02430389|2086440|P1|COMPLETED|Overall Study||10
861870|NCT02430389|2086439|P2|STARTED|Overall Study||10
861871|NCT02430389|2086440|P1|STARTED|Overall Study||10
861872|NCT02430090|2086451|P3|NOT COMPLETED|Overall Study||0
861873|NCT02430090|2086452|P2|NOT COMPLETED|Overall Study||0
861874|NCT02430090|2086453|P1|NOT COMPLETED|Overall Study||0
861875|NCT02430090|2086451|P3|COMPLETED|Overall Study||15
861876|NCT02430090|2086452|P2|COMPLETED|Overall Study||15
861877|NCT02430090|2086453|P1|COMPLETED|Overall Study||15
861878|NCT02430090|2086451|P3|STARTED|Overall Study||15
861879|NCT02430090|2086452|P2|STARTED|Overall Study||15
861880|NCT02430090|2086453|P1|STARTED|Overall Study||15
861881|NCT02429258|2086463|P2|NOT COMPLETED|Overall Study||1
861882|NCT02429258|2086464|P1|NOT COMPLETED|Overall Study||2
861883|NCT02429258|2086463|P2|COMPLETED|Overall Study||49
861884|NCT02429258|2086464|P1|COMPLETED|Overall Study||48
861885|NCT02429258|2086463|P2|STARTED|Overall Study||50
861886|NCT02429258|2086464|P1|STARTED|Overall Study||50
861887|NCT02428478|2086490|P2|NOT COMPLETED|Second Study Night||0
861888|NCT02428478|2086491|P1|NOT COMPLETED|Second Study Night||0
861889|NCT02428478|2086490|P2|COMPLETED|Second Study Night||6
861890|NCT02428478|2086491|P1|COMPLETED|Second Study Night||8
861891|NCT02428478|2086490|P2|STARTED|Second Study Night|2 participants did not return for the second study night|6
861892|NCT02428478|2086491|P1|STARTED|Second Study Night|1 participant did not return for the second study night|8
861893|NCT02428478|2086490|P2|NOT COMPLETED|First Study Night||0
861894|NCT02428478|2086491|P1|NOT COMPLETED|First Study Night||0
861895|NCT02428478|2086490|P2|COMPLETED|First Study Night||8
861896|NCT02428478|2086491|P1|COMPLETED|First Study Night||9
861897|NCT02428478|2086490|P2|STARTED|First Study Night||8
861898|NCT02428478|2086491|P1|STARTED|First Study Night||9
861899|NCT02428413|2086501|P2|NOT COMPLETED|Overall Study||9
861900|NCT02428413|2086502|P1|NOT COMPLETED|Overall Study||8
861901|NCT02428413|2086501|P2|COMPLETED|Overall Study||52
861902|NCT02428413|2086502|P1|COMPLETED|Overall Study||56
861903|NCT02428413|2086501|P2|STARTED|Overall Study||61
861904|NCT02428413|2086502|P1|STARTED|Overall Study||64
861905|NCT02428231|2086516|P2|NOT COMPLETED|Overall Study||17
861906|NCT02428231|2086517|P1|NOT COMPLETED|Overall Study||13
861907|NCT02428231|2086516|P2|COMPLETED|Overall Study||15
861908|NCT02428231|2086517|P1|COMPLETED|Overall Study||17
861909|NCT02428231|2086516|P2|STARTED|Overall Study||32
861910|NCT02428231|2086517|P1|STARTED|Overall Study||30
861911|NCT02427984|2086534|P3|NOT COMPLETED|Overall Study||18
861912|NCT02427984|2086535|P2|NOT COMPLETED|Overall Study||5
861913|NCT02427984|2086536|P1|NOT COMPLETED|Overall Study||13
861914|NCT02427984|2086534|P3|COMPLETED|Overall Study||32
861915|NCT02427984|2086535|P2|COMPLETED|Overall Study||40
861916|NCT02427984|2086536|P1|COMPLETED|Overall Study||40
861917|NCT02427984|2086534|P3|STARTED|Overall Study||50
861918|NCT02427984|2086535|P2|STARTED|Overall Study||45
861919|NCT02427984|2086536|P1|STARTED|Overall Study||53
861920|NCT02427750|2086552|P2|NOT COMPLETED|Overall Study||0
861921|NCT02427750|2086553|P1|NOT COMPLETED|Overall Study||0
861922|NCT02427750|2086552|P2|COMPLETED|Overall Study||63
861923|NCT02427750|2086553|P1|COMPLETED|Overall Study||63
861924|NCT02427750|2086552|P2|STARTED|Overall Study||63
861925|NCT02427750|2086553|P1|STARTED|Overall Study||63
861926|NCT02427477|2086578|P2|NOT COMPLETED|Period 3||0
861927|NCT02427477|2086579|P1|NOT COMPLETED|Period 3||0
861928|NCT02427477|2086578|P2|COMPLETED|Period 3||60
861929|NCT02427477|2086579|P1|COMPLETED|Period 3||59
861930|NCT02427477|2086578|P2|STARTED|Period 3||60
861931|NCT02427477|2086579|P1|STARTED|Period 3||59
861932|NCT02427477|2086578|P2|NOT COMPLETED|Period 2||0
861933|NCT02427477|2086579|P1|NOT COMPLETED|Period 2||0
861934|NCT02427477|2086578|P2|COMPLETED|Period 2||60
861935|NCT02427477|2086579|P1|COMPLETED|Period 2||59
861936|NCT02427477|2086578|P2|STARTED|Period 2||60
861937|NCT02427477|2086579|P1|STARTED|Period 2||59
861938|NCT02427477|2086578|P2|NOT COMPLETED|Period 1||0
861939|NCT02427477|2086579|P1|NOT COMPLETED|Period 1||1
861940|NCT02427477|2086578|P2|COMPLETED|Period 1||60
861941|NCT02427477|2086579|P1|COMPLETED|Period 1||59
861942|NCT02427477|2086578|P2|STARTED|Period 1||60
861943|NCT02427477|2086579|P1|STARTED|Period 1||60
861944|NCT02427399|2086592|P5|NOT COMPLETED|Overall Study||15
861945|NCT02427399|2086593|P4|NOT COMPLETED|Overall Study||18
861946|NCT02427399|2086594|P3|NOT COMPLETED|Overall Study||12
861947|NCT02427399|2086595|P2|NOT COMPLETED|Overall Study||16
861948|NCT02427399|2086596|P1|NOT COMPLETED|Overall Study||14
861949|NCT02427399|2086592|P5|COMPLETED|Overall Study||205
861950|NCT02427399|2086593|P4|COMPLETED|Overall Study||202
861951|NCT02427399|2086594|P3|COMPLETED|Overall Study||208
861952|NCT02427399|2086595|P2|COMPLETED|Overall Study||204
861953|NCT02427399|2086596|P1|COMPLETED|Overall Study||206
861954|NCT02427399|2086592|P5|STARTED|Overall Study||220
861955|NCT02427399|2086593|P4|STARTED|Overall Study||220
861956|NCT02427399|2086594|P3|STARTED|Overall Study||220
861957|NCT02427399|2086595|P2|STARTED|Overall Study||220
861958|NCT02427399|2086596|P1|STARTED|Overall Study||220
861959|NCT02425956|2086618|P1|NOT COMPLETED|Overall Study||0
861960|NCT02425956|2086618|P1|COMPLETED|Overall Study||21
861961|NCT02425956|2086618|P1|STARTED|Overall Study||21
861962|NCT02425826|2086625|P2|NOT COMPLETED|Overall Study||27
861963|NCT02425826|2086626|P1|NOT COMPLETED|Overall Study||9
861964|NCT02425826|2086625|P2|COMPLETED|Overall Study|Completed = participants who completed Week 16|121
861965|NCT02425826|2086626|P1|COMPLETED|Overall Study||64
861966|NCT02425826|2086625|P2|Received Treatment|Overall Study|Received treatment includes participants who received at least one dose of study drug.|147
861967|NCT02425826|2086626|P1|Received Treatment|Overall Study|Received treatment includes participants who received at least one dose of study drug.|73
861968|NCT02425826|2086625|P2|STARTED|Overall Study||148
861969|NCT02425826|2086626|P1|STARTED|Overall Study||73
861970|NCT02424591|2086655|P2|NOT COMPLETED|Overall Study||3
861971|NCT02424591|2086656|P1|NOT COMPLETED|Overall Study||2
861972|NCT02424591|2086655|P2|COMPLETED|Overall Study||20
861973|NCT02424591|2086656|P1|COMPLETED|Overall Study||20
861974|NCT02424591|2086655|P2|STARTED|Overall Study||23
861975|NCT02424591|2086656|P1|STARTED|Overall Study||22
861976|NCT02424578|2086668|P2|NOT COMPLETED|Overall Study||1
861977|NCT02424578|2086669|P1|NOT COMPLETED|Overall Study||0
861978|NCT02424578|2086668|P2|COMPLETED|Overall Study||14
861979|NCT02424578|2086669|P1|COMPLETED|Overall Study||15
861980|NCT02424578|2086668|P2|STARTED|Overall Study||15
861981|NCT02424578|2086669|P1|STARTED|Overall Study||15
861982|NCT02424565|2086675|P2|NOT COMPLETED|Period 2 (D3)||0
861983|NCT02424565|2086676|P1|NOT COMPLETED|Period 2 (D3)||0
861984|NCT02424565|2086675|P2|COMPLETED|Period 2 (D3)||6
861985|NCT02424565|2086676|P1|COMPLETED|Period 2 (D3)||8
861986|NCT02424565|2086675|P2|STARTED|Period 2 (D3)||6
861987|NCT02424565|2086676|P1|STARTED|Period 2 (D3)||8
861988|NCT02424565|2086675|P2|NOT COMPLETED|Washout Period||0
861989|NCT02424565|2086676|P1|NOT COMPLETED|Washout Period||0
861990|NCT02424565|2086675|P2|COMPLETED|Washout Period||6
861991|NCT02424565|2086676|P1|COMPLETED|Washout Period||8
861992|NCT02424565|2086675|P2|STARTED|Washout Period||6
861993|NCT02424565|2086676|P1|STARTED|Washout Period||8
861994|NCT02424565|2086675|P2|NOT COMPLETED|Period 1 (D0)||1
861995|NCT02424565|2086676|P1|NOT COMPLETED|Period 1 (D0)||0
861996|NCT02424565|2086675|P2|COMPLETED|Period 1 (D0)||6
861997|NCT02424565|2086676|P1|COMPLETED|Period 1 (D0)||8
861998|NCT02424565|2086675|P2|STARTED|Period 1 (D0)||7
861999|NCT02424565|2086676|P1|STARTED|Period 1 (D0)||8
862000|NCT02424149|2086684|P2|NOT COMPLETED|Overall Study||1
862001|NCT02424149|2086685|P1|NOT COMPLETED|Overall Study||2
862002|NCT02424149|2086684|P2|COMPLETED|Overall Study||52
862003|NCT02424149|2086685|P1|COMPLETED|Overall Study||52
862004|NCT02424149|2086684|P2|STARTED|Overall Study||53
862005|NCT02424149|2086685|P1|STARTED|Overall Study||54
862006|NCT02423993|2086703|P4|NOT COMPLETED|Overall Study||0
862007|NCT02423993|2086704|P3|NOT COMPLETED|Overall Study||0
862008|NCT02423993|2086705|P2|NOT COMPLETED|Overall Study||0
862009|NCT02423993|2086706|P1|NOT COMPLETED|Overall Study||0
862010|NCT02423993|2086703|P4|COMPLETED|Overall Study||19
862011|NCT02423993|2086704|P3|COMPLETED|Overall Study||23
862012|NCT02423993|2086705|P2|COMPLETED|Overall Study||16
862013|NCT02423993|2086706|P1|COMPLETED|Overall Study||19
862014|NCT02423993|2086703|P4|STARTED|Overall Study||19
862015|NCT02423993|2086704|P3|STARTED|Overall Study||23
862016|NCT02423993|2086705|P2|STARTED|Overall Study||16
862017|NCT02423993|2086706|P1|STARTED|Overall Study||19
862018|NCT02423980|2086736|P1|NOT COMPLETED|Overall Study||0
862019|NCT02423980|2086736|P1|COMPLETED|Overall Study||7
862020|NCT02423980|2086736|P1|STARTED|Overall Study||7
862021|NCT02423798|2086746|P1|NOT COMPLETED|Overall Study||3
862022|NCT02423798|2086746|P1|COMPLETED|Overall Study||21
862023|NCT02423798|2086746|P1|STARTED|Overall Study||24
862024|NCT02423577|2086754|P2|NOT COMPLETED|Overall Study||0
862025|NCT02423577|2086755|P1|NOT COMPLETED|Overall Study||0
862026|NCT02423577|2086754|P2|COMPLETED|Overall Study||26
862027|NCT02423577|2086755|P1|COMPLETED|Overall Study||53
862028|NCT02423577|2086754|P2|STARTED|Overall Study||26
862029|NCT02423577|2086755|P1|STARTED|Overall Study||53
862030|NCT02423447|2086761|P2|NOT COMPLETED|Overall Study||0
862031|NCT02423447|2086762|P1|NOT COMPLETED|Overall Study||0
862032|NCT02423447|2086761|P2|COMPLETED|Overall Study||12
862033|NCT02423447|2086762|P1|COMPLETED|Overall Study||13
862034|NCT02423447|2086761|P2|STARTED|Overall Study||12
862035|NCT02423447|2086762|P1|STARTED|Overall Study||13
862036|NCT02423408|2086778|P2|NOT COMPLETED|Overall Study||2
862037|NCT02423408|2086779|P1|NOT COMPLETED|Overall Study||1
862038|NCT02423408|2086778|P2|COMPLETED|Overall Study||80
862039|NCT02423408|2086779|P1|COMPLETED|Overall Study||82
862040|NCT02423408|2086778|P2|STARTED|Overall Study||82
862041|NCT02423408|2086779|P1|STARTED|Overall Study||83
862042|NCT02423317|2086793|P2|NOT COMPLETED|Overall Study||0
862043|NCT02423317|2086794|P1|NOT COMPLETED|Overall Study||0
862044|NCT02423317|2086793|P2|COMPLETED|Overall Study||30
862045|NCT02423317|2086794|P1|COMPLETED|Overall Study||30
862046|NCT02423317|2086793|P2|STARTED|Overall Study||30
862047|NCT02423317|2086794|P1|STARTED|Overall Study||30
862048|NCT02423291|2086812|P1|NOT COMPLETED|Overall Study||15
862049|NCT02423291|2086812|P1|COMPLETED|Overall Study|Patients that have completed therapy|0
862050|NCT02423291|2086812|P1|STARTED|Overall Study|Patients enrolled|15
862051|NCT02421211|2086818|P2|NOT COMPLETED|Overall Study||0
862052|NCT02421211|2086819|P1|NOT COMPLETED|Overall Study||0
862053|NCT02421211|2086818|P2|COMPLETED|Overall Study||20
862054|NCT02421211|2086819|P1|COMPLETED|Overall Study||20
862055|NCT02421211|2086818|P2|STARTED|Overall Study||20
862056|NCT02421211|2086819|P1|STARTED|Overall Study||20
862057|NCT02421120|2086863|P1|NOT COMPLETED|Overall Study||1
862058|NCT02421120|2086863|P1|COMPLETED|Overall Study||20
862059|NCT02421120|2086863|P1|STARTED|Overall Study||21
862060|NCT02420951|2086873|P2|NOT COMPLETED|Overall Study||0
862061|NCT02420951|2086874|P1|NOT COMPLETED|Overall Study||0
862062|NCT02420951|2086873|P2|COMPLETED|Overall Study||25
862063|NCT02420951|2086874|P1|COMPLETED|Overall Study||25
862064|NCT02420951|2086873|P2|STARTED|Overall Study||25
862065|NCT02420951|2086874|P1|STARTED|Overall Study||25
862066|NCT02420093|2086886|P2|NOT COMPLETED|Overall Study||1
862067|NCT02420093|2086887|P1|NOT COMPLETED|Overall Study||1
862068|NCT02420093|2086886|P2|COMPLETED|Overall Study||7
862069|NCT02420093|2086887|P1|COMPLETED|Overall Study||8
862070|NCT02420093|2086886|P2|STARTED|Overall Study||8
862071|NCT02420093|2086887|P1|STARTED|Overall Study||9
862072|NCT02420041|2086903|P2|NOT COMPLETED|Overall Study||0
862073|NCT02420041|2086904|P1|NOT COMPLETED|Overall Study||0
862074|NCT02420041|2086903|P2|COMPLETED|Overall Study||14
862075|NCT02420041|2086904|P1|COMPLETED|Overall Study||14
862076|NCT02420041|2086903|P2|STARTED|Overall Study||14
862077|NCT02420041|2086904|P1|STARTED|Overall Study||14
862081|NCT02419313|2086940|P2|NOT COMPLETED|Second Intervention||0
862082|NCT02419313|2086941|P1|NOT COMPLETED|Second Intervention||1
862083|NCT02419313|2086940|P2|COMPLETED|Second Intervention||15
862084|NCT02419313|2086941|P1|COMPLETED|Second Intervention||15
862085|NCT02419313|2086940|P2|STARTED|Second Intervention||15
862086|NCT02419313|2086941|P1|STARTED|Second Intervention||16
862087|NCT02419313|2086940|P2|NOT COMPLETED|First Intervention||0
862088|NCT02419313|2086941|P1|NOT COMPLETED|First Intervention||2
862089|NCT02419313|2086940|P2|COMPLETED|First Intervention||15
862090|NCT02419313|2086941|P1|COMPLETED|First Intervention||16
862091|NCT02419313|2086940|P2|STARTED|First Intervention||15
862092|NCT02419313|2086941|P1|STARTED|First Intervention||18
862093|NCT02419001|2086953|P2|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
862094|NCT02419001|2086954|P1|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
862095|NCT02419001|2086953|P2|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
862096|NCT02419001|2086954|P1|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
862097|NCT02419001|2086953|P2|STARTED|Period 2- Ceftriaxone With SYN-004||5
862098|NCT02419001|2086954|P1|STARTED|Period 2- Ceftriaxone With SYN-004||5
862099|NCT02419001|2086953|P2|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||0
862100|NCT02419001|2086954|P1|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||1
862101|NCT02419001|2086953|P2|COMPLETED|Period 1- Ceftriaxone Without SYN-004||5
862102|NCT02419001|2086954|P1|COMPLETED|Period 1- Ceftriaxone Without SYN-004|The Adverse Event (AE) was with ceftriaxone, not with Investigational Product (IP)|5
862103|NCT02419001|2086953|P2|STARTED|Period 1- Ceftriaxone Without SYN-004||5
862104|NCT02419001|2086954|P1|STARTED|Period 1- Ceftriaxone Without SYN-004||6
862105|NCT02418676|2086967|P3|NOT COMPLETED|Overall Study||0
862106|NCT02418676|2086968|P2|NOT COMPLETED|Overall Study||0
862107|NCT02418676|2086969|P1|NOT COMPLETED|Overall Study||0
862108|NCT02418676|2086967|P3|COMPLETED|Overall Study||5
862109|NCT02418676|2086968|P2|COMPLETED|Overall Study||5
862110|NCT02418676|2086969|P1|COMPLETED|Overall Study||5
862111|NCT02418676|2086967|P3|STARTED|Overall Study||5
862112|NCT02418676|2086968|P2|STARTED|Overall Study||5
862113|NCT02418676|2086969|P1|STARTED|Overall Study||5
862114|NCT02418468|2086982|P2|NOT COMPLETED|Overall Study||1
862115|NCT02418468|2086983|P1|NOT COMPLETED|Overall Study||2
862116|NCT02418468|2086982|P2|COMPLETED|Overall Study||10
862117|NCT02418468|2086983|P1|COMPLETED|Overall Study||11
862118|NCT02418468|2086982|P2|STARTED|Overall Study||11
862119|NCT02418468|2086983|P1|STARTED|Overall Study||13
862120|NCT02418234|2086989|P1|NOT COMPLETED|Overall Study||0
862121|NCT02418234|2086989|P1|COMPLETED|Overall Study||314
862122|NCT02418234|2086989|P1|STARTED|Overall Study||314
862123|NCT02418026|2087002|P2|NOT COMPLETED|Overall Study||0
862124|NCT02418026|2087003|P1|NOT COMPLETED|Overall Study||0
862125|NCT02418026|2087002|P2|COMPLETED|Overall Study||35
862126|NCT02418026|2087003|P1|COMPLETED|Overall Study||44
862127|NCT02418026|2087002|P2|STARTED|Overall Study||35
862128|NCT02418026|2087003|P1|STARTED|Overall Study||44
862129|NCT02417961|2087033|P1|NOT COMPLETED|Overall Study||4
862130|NCT02417961|2087033|P1|COMPLETED|Overall Study||112
862131|NCT02417961|2087033|P1|STARTED|Overall Study||116
862132|NCT02417753|2087043|P1|NOT COMPLETED|Overall Study||1
862133|NCT02417753|2087043|P1|COMPLETED|Overall Study||0
862134|NCT02417753|2087043|P1|STARTED|Overall Study||1
862135|NCT02417532|2087053|P1|NOT COMPLETED|Overall Study||4
862136|NCT02417532|2087053|P1|COMPLETED|Overall Study||52
862137|NCT02417532|2087053|P1|STARTED|Overall Study||56
862138|NCT02417376|2087066|P2|NOT COMPLETED|Overall Study||10
862139|NCT02417376|2087067|P1|NOT COMPLETED|Overall Study||5
862140|NCT02417376|2087066|P2|COMPLETED|Overall Study||25
862141|NCT02417376|2087067|P1|COMPLETED|Overall Study||30
862142|NCT02417376|2087066|P2|STARTED|Overall Study||35
862143|NCT02417376|2087067|P1|STARTED|Overall Study||35
862144|NCT02417129|2087111|P2|NOT COMPLETED|Overall Study||0
862145|NCT02417129|2087112|P1|NOT COMPLETED|Overall Study||0
862146|NCT02417129|2087111|P2|COMPLETED|Overall Study||0
862147|NCT02417129|2087112|P1|COMPLETED|Overall Study||2
862148|NCT02417129|2087111|P2|STARTED|Overall Study||0
862149|NCT02417129|2087112|P1|STARTED|Overall Study||2
862150|NCT02416973|2087125|P3|NOT COMPLETED|Overall Study||1
862151|NCT02416973|2087126|P2|NOT COMPLETED|Overall Study||3
862152|NCT02416973|2087127|P1|NOT COMPLETED|Overall Study||1
862153|NCT02416973|2087125|P3|COMPLETED|Overall Study||13
862154|NCT02416973|2087126|P2|COMPLETED|Overall Study||10
862155|NCT02416973|2087127|P1|COMPLETED|Overall Study||13
862156|NCT02416973|2087125|P3|STARTED|Overall Study||14
862157|NCT02416973|2087126|P2|STARTED|Overall Study||13
862158|NCT02416973|2087127|P1|STARTED|Overall Study||14
862159|NCT02416180|2087135|P1|NOT COMPLETED|Overall Study||1
862160|NCT02416180|2087135|P1|COMPLETED|Overall Study||110
862161|NCT02416180|2087135|P1|STARTED|Overall Study||111
862162|NCT02415959|2087147|P5|NOT COMPLETED|Overall Study||0
862163|NCT02415959|2087148|P4|NOT COMPLETED|Overall Study||1
862164|NCT02415959|2087149|P3|NOT COMPLETED|Overall Study||0
862165|NCT02415959|2087150|P2|NOT COMPLETED|Overall Study||1
862166|NCT02415959|2087151|P1|NOT COMPLETED|Overall Study||0
862167|NCT02415959|2087147|P5|COMPLETED|Overall Study||14
862168|NCT02415959|2087148|P4|COMPLETED|Overall Study||13
862169|NCT02415959|2087149|P3|COMPLETED|Overall Study||14
862170|NCT02415959|2087150|P2|COMPLETED|Overall Study||13
862171|NCT02415959|2087151|P1|COMPLETED|Overall Study||14
862172|NCT02415959|2087147|P5|STARTED|Overall Study||14
862173|NCT02415959|2087148|P4|STARTED|Overall Study||14
862174|NCT02415959|2087149|P3|STARTED|Overall Study||14
862175|NCT02415959|2087150|P2|STARTED|Overall Study||14
862176|NCT02415959|2087151|P1|STARTED|Overall Study||14
862177|NCT02415439|2087196|P13|NOT COMPLETED|Overall Study||0
862178|NCT02415439|2087197|P12|NOT COMPLETED|Overall Study||0
862179|NCT02415439|2087198|P11|NOT COMPLETED|Overall Study||0
862180|NCT02415439|2087199|P10|NOT COMPLETED|Overall Study||0
862181|NCT02415439|2087200|P9|NOT COMPLETED|Overall Study||1
862182|NCT02415439|2087201|P8|NOT COMPLETED|Overall Study||0
862183|NCT02415439|2087202|P7|NOT COMPLETED|Overall Study||0
862184|NCT02415439|2087203|P6|NOT COMPLETED|Overall Study||0
862185|NCT02415439|2087204|P5|NOT COMPLETED|Overall Study||0
862186|NCT02415439|2087205|P4|NOT COMPLETED|Overall Study||0
862187|NCT02415439|2087206|P3|NOT COMPLETED|Overall Study||0
862188|NCT02415439|2087207|P2|NOT COMPLETED|Overall Study||0
862189|NCT02415439|2087208|P1|NOT COMPLETED|Overall Study||0
862190|NCT02415439|2087196|P13|COMPLETED|Overall Study||8
862191|NCT02415439|2087197|P12|COMPLETED|Overall Study||6
862192|NCT02415439|2087198|P11|COMPLETED|Overall Study||6
862193|NCT02415439|2087199|P10|COMPLETED|Overall Study||6
862194|NCT02415439|2087200|P9|COMPLETED|Overall Study||5
862195|NCT02415439|2087201|P8|COMPLETED|Overall Study||12
862196|NCT02415439|2087202|P7|COMPLETED|Overall Study||6
862197|NCT02415439|2087203|P6|COMPLETED|Overall Study||6
862198|NCT02415439|2087204|P5|COMPLETED|Overall Study||6
862199|NCT02415439|2087205|P4|COMPLETED|Overall Study||6
862200|NCT02415439|2087206|P3|COMPLETED|Overall Study||6
862201|NCT02415439|2087207|P2|COMPLETED|Overall Study||6
862202|NCT02415439|2087208|P1|COMPLETED|Overall Study||6
862203|NCT02415439|2087196|P13|STARTED|Overall Study||8
862204|NCT02415439|2087197|P12|STARTED|Overall Study||6
862205|NCT02415439|2087198|P11|STARTED|Overall Study||6
862206|NCT02415439|2087199|P10|STARTED|Overall Study||6
862207|NCT02415439|2087200|P9|STARTED|Overall Study||6
862208|NCT02415439|2087201|P8|STARTED|Overall Study||12
862209|NCT02415439|2087202|P7|STARTED|Overall Study||6
862210|NCT02415439|2087203|P6|STARTED|Overall Study||6
862211|NCT02415439|2087204|P5|STARTED|Overall Study||6
862212|NCT02415439|2087205|P4|STARTED|Overall Study||6
862213|NCT02415439|2087206|P3|STARTED|Overall Study||6
862214|NCT02415439|2087207|P2|STARTED|Overall Study||6
862215|NCT02415439|2087208|P1|STARTED|Overall Study||6
862216|NCT02414828|2087266|P4|NOT COMPLETED|Overall Study||2
862217|NCT02414828|2087267|P3|NOT COMPLETED|Overall Study||1
862218|NCT02414828|2087268|P2|NOT COMPLETED|Overall Study||1
862219|NCT02414828|2087269|P1|NOT COMPLETED|Overall Study||0
862220|NCT02414828|2087266|P4|COMPLETED|Overall Study||29
862221|NCT02414828|2087267|P3|COMPLETED|Overall Study||19
862222|NCT02414828|2087268|P2|COMPLETED|Overall Study||9
862223|NCT02414828|2087269|P1|COMPLETED|Overall Study||11
862224|NCT02414828|2087266|P4|STARTED|Overall Study||31
862225|NCT02414828|2087267|P3|STARTED|Overall Study||20
862226|NCT02414828|2087268|P2|STARTED|Overall Study||10
862227|NCT02414828|2087269|P1|STARTED|Overall Study||11
862228|NCT02414152|2087307|P1|NOT COMPLETED|Overall Study||2
862229|NCT02414152|2087307|P1|COMPLETED|Overall Study|Both subjects completed 56 days of anakinra but did not complete all visits in observational period|0
862230|NCT02414152|2087307|P1|STARTED|Overall Study||2
862231|NCT02413879|2087311|P1|NOT COMPLETED|Overall Study||0
862232|NCT02413879|2087311|P1|COMPLETED|Overall Study||86
862233|NCT02413879|2087311|P1|STARTED|Overall Study||86
862234|NCT02413593|2087317|P1|NOT COMPLETED|Overall Study||4
862235|NCT02413593|2087317|P1|COMPLETED|Overall Study||107
862236|NCT02413593|2087317|P1|STARTED|Overall Study||111
862237|NCT02413333|2087330|P2|NOT COMPLETED|Period 2||0
862238|NCT02413333|2087331|P1|NOT COMPLETED|Period 2||1
862239|NCT02413333|2087330|P2|COMPLETED|Period 2||65
862240|NCT02413333|2087331|P1|COMPLETED|Period 2||64
862241|NCT02413333|2087330|P2|STARTED|Period 2||65
862242|NCT02413333|2087331|P1|STARTED|Period 2||65
862243|NCT02413333|2087330|P2|NOT COMPLETED|Period 1||1
862244|NCT02413333|2087331|P1|NOT COMPLETED|Period 1||1
862245|NCT02413333|2087330|P2|COMPLETED|Period 1||65
862246|NCT02413333|2087331|P1|COMPLETED|Period 1||65
862247|NCT02413333|2087330|P2|Randomized and Treated|Period 1||66
862248|NCT02413333|2087331|P1|Randomized and Treated|Period 1||66
862249|NCT02413333|2087330|P2|STARTED|Period 1||66
862250|NCT02413333|2087331|P1|STARTED|Period 1||66
862251|NCT02413294|2087339|P1|NOT COMPLETED|Overall Study||1
862252|NCT02413294|2087339|P1|COMPLETED|Overall Study||11
862253|NCT02413294|2087339|P1|STARTED|Overall Study||12
862254|NCT02413203|2087359|P2|NOT COMPLETED|Overall Study||0
862255|NCT02413203|2087360|P1|NOT COMPLETED|Overall Study||0
862256|NCT02413203|2087359|P2|COMPLETED|Overall Study||10
862257|NCT02413203|2087360|P1|COMPLETED|Overall Study||10
862258|NCT02413203|2087359|P2|STARTED|Overall Study||10
862259|NCT02413203|2087360|P1|STARTED|Overall Study||10
862260|NCT02413034|2087382|P2|NOT COMPLETED|Overall Study||0
862261|NCT02413034|2087383|P1|NOT COMPLETED|Overall Study||0
862262|NCT02413034|2087382|P2|COMPLETED|Overall Study||14
862263|NCT02413034|2087383|P1|COMPLETED|Overall Study||14
862264|NCT02413034|2087382|P2|STARTED|Overall Study||14
862265|NCT02413034|2087383|P1|STARTED|Overall Study||14
862266|NCT02412657|2087394|P3|NOT COMPLETED|Overall Study||3
862267|NCT02412657|2087395|P2|NOT COMPLETED|Overall Study||2
862268|NCT02412657|2087396|P1|NOT COMPLETED|Overall Study||1
862269|NCT02412657|2087394|P3|COMPLETED|Overall Study||22
862270|NCT02412657|2087395|P2|COMPLETED|Overall Study||23
862271|NCT02412657|2087396|P1|COMPLETED|Overall Study||24
862272|NCT02412657|2087394|P3|STARTED|Overall Study||25
862273|NCT02412657|2087395|P2|STARTED|Overall Study||25
862274|NCT02412657|2087396|P1|STARTED|Overall Study||25
862275|NCT02411929|2087404|P1|NOT COMPLETED|Period 2||0
862276|NCT02411929|2087404|P1|COMPLETED|Period 2||8
862277|NCT02411929|2087404|P1|STARTED|Period 2||8
862278|NCT02411929|2087404|P1|NOT COMPLETED|Washout Period||0
862279|NCT02411929|2087404|P1|COMPLETED|Washout Period||8
862280|NCT02411929|2087404|P1|STARTED|Washout Period||8
862281|NCT02411929|2087404|P1|NOT COMPLETED|Period 1||0
862282|NCT02411929|2087404|P1|COMPLETED|Period 1||8
862283|NCT02411929|2087404|P1|STARTED|Period 1||8
862284|NCT02411747|2087436|P2|NOT COMPLETED|Overall Study||4
862285|NCT02411747|2087437|P1|NOT COMPLETED|Overall Study||3
862286|NCT02411747|2087436|P2|COMPLETED|Overall Study||12
862287|NCT02411747|2087437|P1|COMPLETED|Overall Study||13
862288|NCT02411747|2087436|P2|Simulation Training Completed|Overall Study||16
862289|NCT02411747|2087437|P1|Simulation Training Completed|Overall Study||16
862290|NCT02411747|2087436|P2|STARTED|Overall Study||16
862291|NCT02411747|2087437|P1|STARTED|Overall Study||16
862292|NCT02411539|2087445|P2|NOT COMPLETED|Overall Study||1
862293|NCT02411539|2087446|P1|NOT COMPLETED|Overall Study||2
862294|NCT02411539|2087445|P2|COMPLETED|Overall Study||19
862295|NCT02411539|2087446|P1|COMPLETED|Overall Study||18
862296|NCT02411539|2087445|P2|STARTED|Overall Study||20
862297|NCT02411539|2087446|P1|STARTED|Overall Study||20
862298|NCT02411292|2087515|P1|NOT COMPLETED|Overall Study||21
862299|NCT02411292|2087515|P1|COMPLETED|Overall Study||89
862300|NCT02411292|2087515|P1|STARTED|Overall Study||110
862301|NCT02411201|2087521|P1|NOT COMPLETED|Overall Study||6
862302|NCT02411201|2087521|P1|COMPLETED|Overall Study||45
862303|NCT02411201|2087521|P1|STARTED|Overall Study||51
862304|NCT02410824|2087532|P2|NOT COMPLETED|Second Intervention (One Week)||0
862305|NCT02410824|2087533|P1|NOT COMPLETED|Second Intervention (One Week)||0
862306|NCT02410824|2087532|P2|COMPLETED|Second Intervention (One Week)||22
862307|NCT02410824|2087533|P1|COMPLETED|Second Intervention (One Week)||22
862308|NCT02410824|2087532|P2|STARTED|Second Intervention (One Week)||22
862309|NCT02410824|2087533|P1|STARTED|Second Intervention (One Week)||22
862310|NCT02410824|2087532|P2|NOT COMPLETED|First Intervention (One Week)||1
862311|NCT02410824|2087533|P1|NOT COMPLETED|First Intervention (One Week)||0
862312|NCT02410824|2087532|P2|COMPLETED|First Intervention (One Week)||22
862313|NCT02410824|2087533|P1|COMPLETED|First Intervention (One Week)||22
862314|NCT02410824|2087532|P2|STARTED|First Intervention (One Week)||23
862315|NCT02410824|2087533|P1|STARTED|First Intervention (One Week)||22
862316|NCT02410291|2087567|P2|NOT COMPLETED|Overall Study||0
862317|NCT02410291|2087568|P1|NOT COMPLETED|Overall Study||0
862318|NCT02410291|2087567|P2|COMPLETED|Overall Study||29
862319|NCT02410291|2087568|P1|COMPLETED|Overall Study||29
862320|NCT02410291|2087567|P2|STARTED|Overall Study||29
862321|NCT02410291|2087568|P1|STARTED|Overall Study||29
862334|NCT02406937|2087604|P3|NOT COMPLETED|Overall Study||2
862335|NCT02406937|2087605|P2|NOT COMPLETED|Overall Study||1
862336|NCT02406937|2087606|P1|NOT COMPLETED|Overall Study||1
862337|NCT02406937|2087604|P3|COMPLETED|Overall Study||58
862338|NCT02406937|2087605|P2|COMPLETED|Overall Study||59
862339|NCT02406937|2087606|P1|COMPLETED|Overall Study||59
862340|NCT02406937|2087604|P3|STARTED|Overall Study||60
862341|NCT02406937|2087605|P2|STARTED|Overall Study||60
862342|NCT02406937|2087606|P1|STARTED|Overall Study||60
862343|NCT02406586|2087665|P3|NOT COMPLETED|Overall Study||2
862344|NCT02406586|2087666|P2|NOT COMPLETED|Overall Study||4
862345|NCT02406586|2087667|P1|NOT COMPLETED|Overall Study||1
862346|NCT02406586|2087665|P3|COMPLETED|Overall Study||10
862347|NCT02406586|2087666|P2|COMPLETED|Overall Study||8
862348|NCT02406586|2087667|P1|COMPLETED|Overall Study||11
862349|NCT02406586|2087665|P3|STARTED|Overall Study||12
862350|NCT02406586|2087666|P2|STARTED|Overall Study||12
862351|NCT02406586|2087667|P1|STARTED|Overall Study||12
862352|NCT02406495|2087720|P1|NOT COMPLETED|Overall Study||0
862353|NCT02406495|2087720|P1|COMPLETED|Overall Study||40
862354|NCT02406495|2087720|P1|STARTED|Overall Study||40
862355|NCT02405429|2087759|P1|NOT COMPLETED|Overall Study||0
862356|NCT02405429|2087759|P1|COMPLETED|Overall Study||49
862357|NCT02405429|2087759|P1|STARTED|Overall Study||49
862358|NCT02405390|2087769|P2|NOT COMPLETED|Overall Study||0
862359|NCT02405390|2087770|P1|NOT COMPLETED|Overall Study||0
862360|NCT02405390|2087769|P2|COMPLETED|Overall Study||46
862361|NCT02405390|2087770|P1|COMPLETED|Overall Study||46
862362|NCT02405390|2087769|P2|STARTED|Overall Study||46
862363|NCT02405390|2087770|P1|STARTED|Overall Study||46
862364|NCT02404649|2087780|P2|NOT COMPLETED|Overall Study||2
862365|NCT02404649|2087781|P1|NOT COMPLETED|Overall Study||1
862366|NCT02404649|2087780|P2|COMPLETED|Overall Study||14
862367|NCT02404649|2087781|P1|COMPLETED|Overall Study||16
862368|NCT02404649|2087780|P2|STARTED|Overall Study||16
862369|NCT02404649|2087781|P1|STARTED|Overall Study||17
862370|NCT02404545|2087789|P2|NOT COMPLETED|Overall Study||6
862371|NCT02404545|2087790|P1|NOT COMPLETED|Overall Study||6
862372|NCT02404545|2087789|P2|COMPLETED|Overall Study||0
862373|NCT02404545|2087790|P1|COMPLETED|Overall Study||0
862374|NCT02404545|2087789|P2|STARTED|Overall Study||6
862375|NCT02404545|2087790|P1|STARTED|Overall Study||6
862376|NCT02404493|2087799|P2|NOT COMPLETED|Overall Study||1
862377|NCT02404493|2087800|P1|NOT COMPLETED|Overall Study||1
862378|NCT02404493|2087799|P2|COMPLETED|Overall Study||5
862379|NCT02404493|2087800|P1|COMPLETED|Overall Study||16
862380|NCT02404493|2087799|P2|STARTED|Overall Study||6
862381|NCT02404493|2087800|P1|STARTED|Overall Study||17
862382|NCT02403830|2088040|P2|NOT COMPLETED|Visit 2||0
862383|NCT02403830|2088041|P1|NOT COMPLETED|Visit 2||0
862384|NCT02403830|2088040|P2|COMPLETED|Visit 2||15
862385|NCT02403830|2088041|P1|COMPLETED|Visit 2||14
862386|NCT02403830|2088040|P2|STARTED|Visit 2||15
862387|NCT02403830|2088041|P1|STARTED|Visit 2|One subject completed visit 1 and then withdrew from the study for an adverse event (nausea).|14
862388|NCT02403830|2088040|P2|NOT COMPLETED|Visit 1||0
862389|NCT02403830|2088041|P1|NOT COMPLETED|Visit 1||0
862390|NCT02403830|2088040|P2|COMPLETED|Visit 1||15
862391|NCT02403830|2088041|P1|COMPLETED|Visit 1||15
862392|NCT02403830|2088040|P2|STARTED|Visit 1||15
862393|NCT02403830|2088041|P1|STARTED|Visit 1||15
862394|NCT02403206|2088053|P2|NOT COMPLETED|Overall Study||10
862395|NCT02403206|2088054|P1|NOT COMPLETED|Overall Study||11
862396|NCT02403206|2088053|P2|COMPLETED|Overall Study||186
862397|NCT02403206|2088054|P1|COMPLETED|Overall Study||183
862398|NCT02403206|2088053|P2|Randomized and Treated|Overall Study||190
862399|NCT02403206|2088054|P1|Randomized and Treated|Overall Study||188
862400|NCT02403206|2088053|P2|Treated Prior to Randomization|Overall Study||1
862401|NCT02403206|2088054|P1|Treated Prior to Randomization|Overall Study||0
862402|NCT02403206|2088053|P2|STARTED|Overall Study||196
862403|NCT02403206|2088054|P1|STARTED|Overall Study||194
862404|NCT02403180|2088065|P2|NOT COMPLETED|Period 2 (5 Days)||1
862405|NCT02403180|2088066|P1|NOT COMPLETED|Period 2 (5 Days)||0
862406|NCT02403180|2088065|P2|COMPLETED|Period 2 (5 Days)||32
862407|NCT02403180|2088066|P1|COMPLETED|Period 2 (5 Days)||36
862408|NCT02403180|2088065|P2|STARTED|Period 2 (5 Days)||33
862409|NCT02403180|2088066|P1|STARTED|Period 2 (5 Days)||36
862410|NCT02403180|2088065|P2|NOT COMPLETED|Period 1 (5 Days)||0
862411|NCT02403180|2088066|P1|NOT COMPLETED|Period 1 (5 Days)||0
862412|NCT02403180|2088065|P2|COMPLETED|Period 1 (5 Days)||33
862413|NCT02403180|2088066|P1|COMPLETED|Period 1 (5 Days)||36
862414|NCT02403180|2088065|P2|Randomized|Period 1 (5 Days)||33
862415|NCT02403180|2088066|P1|Randomized|Period 1 (5 Days)||36
862416|NCT02403180|2088065|P2|STARTED|Period 1 (5 Days)||33
862417|NCT02403180|2088066|P1|STARTED|Period 1 (5 Days)||36
862418|NCT02403180|2088065|P2|NOT COMPLETED|Pre-Treatment Period||1
862419|NCT02403180|2088066|P1|NOT COMPLETED|Pre-Treatment Period||0
862420|NCT02403180|2088065|P2|COMPLETED|Pre-Treatment Period||33
862421|NCT02403180|2088066|P1|COMPLETED|Pre-Treatment Period||36
862422|NCT02403180|2088065|P2|STARTED|Pre-Treatment Period||34
862423|NCT02403180|2088066|P1|STARTED|Pre-Treatment Period||36
862424|NCT02402933|2088074|P1|NOT COMPLETED|Overall Study||14
862425|NCT02402933|2088074|P1|COMPLETED|Overall Study||12
862426|NCT02402933|2088074|P1|Received at Least One Dose of Study Drug|Overall Study||22
862427|NCT02402933|2088074|P1|STARTED|Overall Study||26
862428|NCT02402764|2088081|P1|NOT COMPLETED|Overall Study||0
862429|NCT02402764|2088081|P1|COMPLETED|Overall Study||10
862430|NCT02402764|2088081|P1|STARTED|Overall Study||10
862431|NCT02402322|2088092|P3|NOT COMPLETED|Follow-up||24
862432|NCT02402322|2088093|P2|NOT COMPLETED|Follow-up||3
862433|NCT02402322|2088094|P1|NOT COMPLETED|Follow-up||6
862434|NCT02402322|2088092|P3|COMPLETED|Follow-up||0
862435|NCT02402322|2088093|P2|COMPLETED|Follow-up||21
862436|NCT02402322|2088094|P1|COMPLETED|Follow-up||18
862437|NCT02402322|2088092|P3|STARTED|Follow-up|These individuals were not evaluated at this follow-up as they started an alternative treatment.|24
862438|NCT02402322|2088093|P2|STARTED|Follow-up||24
862439|NCT02402322|2088094|P1|STARTED|Follow-up||24
862440|NCT02402322|2088092|P3|NOT COMPLETED|Pretreatment||1
862441|NCT02402322|2088093|P2|NOT COMPLETED|Pretreatment||1
862442|NCT02402322|2088094|P1|NOT COMPLETED|Pretreatment||3
862443|NCT02402322|2088092|P3|COMPLETED|Pretreatment||24
862444|NCT02402322|2088093|P2|COMPLETED|Pretreatment||24
862445|NCT02402322|2088094|P1|COMPLETED|Pretreatment||24
862446|NCT02402322|2088092|P3|Posttreatment Measures|Pretreatment||24
862447|NCT02402322|2088093|P2|Posttreatment Measures|Pretreatment||24
862448|NCT02402322|2088094|P1|Posttreatment Measures|Pretreatment||24
862449|NCT02402322|2088092|P3|STARTED|Pretreatment||25
862450|NCT02402322|2088093|P2|STARTED|Pretreatment||25
862451|NCT02402322|2088094|P1|STARTED|Pretreatment||27
862452|NCT02402296|2088128|P2|NOT COMPLETED|Overall Study||0
862453|NCT02402296|2088129|P1|NOT COMPLETED|Overall Study||0
862454|NCT02402296|2088128|P2|COMPLETED|Overall Study||15
862455|NCT02402296|2088129|P1|COMPLETED|Overall Study||15
862456|NCT02402296|2088128|P2|STARTED|Overall Study||15
862457|NCT02402296|2088129|P1|STARTED|Overall Study||15
862458|NCT02402127|2088147|P6|NOT COMPLETED|Third Wear Period (1 Day)||0
862459|NCT02402127|2088148|P5|NOT COMPLETED|Third Wear Period (1 Day)||0
862460|NCT02402127|2088149|P4|NOT COMPLETED|Third Wear Period (1 Day)||0
862461|NCT02402127|2088150|P3|NOT COMPLETED|Third Wear Period (1 Day)||0
862462|NCT02402127|2088151|P2|NOT COMPLETED|Third Wear Period (1 Day)||0
862463|NCT02402127|2088152|P1|NOT COMPLETED|Third Wear Period (1 Day)||0
862464|NCT02402127|2088147|P6|COMPLETED|Third Wear Period (1 Day)||4
862465|NCT02402127|2088148|P5|COMPLETED|Third Wear Period (1 Day)||4
862466|NCT02402127|2088149|P4|COMPLETED|Third Wear Period (1 Day)||4
862467|NCT02402127|2088150|P3|COMPLETED|Third Wear Period (1 Day)||4
862468|NCT02402127|2088151|P2|COMPLETED|Third Wear Period (1 Day)||4
862469|NCT02402127|2088152|P1|COMPLETED|Third Wear Period (1 Day)||4
862470|NCT02402127|2088147|P6|STARTED|Third Wear Period (1 Day)||4
862471|NCT02402127|2088148|P5|STARTED|Third Wear Period (1 Day)||4
862472|NCT02402127|2088149|P4|STARTED|Third Wear Period (1 Day)||4
862473|NCT02402127|2088150|P3|STARTED|Third Wear Period (1 Day)||4
862474|NCT02402127|2088151|P2|STARTED|Third Wear Period (1 Day)||4
862475|NCT02402127|2088152|P1|STARTED|Third Wear Period (1 Day)||4
862476|NCT02402127|2088147|P6|NOT COMPLETED|Second Wear Period (1 Day)||0
862477|NCT02402127|2088148|P5|NOT COMPLETED|Second Wear Period (1 Day)||0
862478|NCT02402127|2088149|P4|NOT COMPLETED|Second Wear Period (1 Day)||0
862479|NCT02402127|2088150|P3|NOT COMPLETED|Second Wear Period (1 Day)||0
862480|NCT02402127|2088151|P2|NOT COMPLETED|Second Wear Period (1 Day)||0
862481|NCT02402127|2088152|P1|NOT COMPLETED|Second Wear Period (1 Day)||0
862482|NCT02402127|2088147|P6|COMPLETED|Second Wear Period (1 Day)||4
862483|NCT02402127|2088148|P5|COMPLETED|Second Wear Period (1 Day)||4
862484|NCT02402127|2088149|P4|COMPLETED|Second Wear Period (1 Day)||4
862485|NCT02402127|2088150|P3|COMPLETED|Second Wear Period (1 Day)||4
862486|NCT02402127|2088151|P2|COMPLETED|Second Wear Period (1 Day)||4
862487|NCT02402127|2088152|P1|COMPLETED|Second Wear Period (1 Day)||4
862488|NCT02402127|2088147|P6|STARTED|Second Wear Period (1 Day)||4
862489|NCT02402127|2088148|P5|STARTED|Second Wear Period (1 Day)||4
862490|NCT02402127|2088149|P4|STARTED|Second Wear Period (1 Day)||4
862491|NCT02402127|2088150|P3|STARTED|Second Wear Period (1 Day)||4
862492|NCT02402127|2088151|P2|STARTED|Second Wear Period (1 Day)||4
862493|NCT02402127|2088152|P1|STARTED|Second Wear Period (1 Day)||4
862494|NCT02402127|2088147|P6|NOT COMPLETED|First Wear Period (1 Day)||0
862495|NCT02402127|2088148|P5|NOT COMPLETED|First Wear Period (1 Day)||0
862496|NCT02402127|2088149|P4|NOT COMPLETED|First Wear Period (1 Day)||0
862497|NCT02402127|2088150|P3|NOT COMPLETED|First Wear Period (1 Day)||0
862498|NCT02402127|2088151|P2|NOT COMPLETED|First Wear Period (1 Day)||0
862499|NCT02402127|2088152|P1|NOT COMPLETED|First Wear Period (1 Day)||0
862500|NCT02402127|2088147|P6|COMPLETED|First Wear Period (1 Day)||4
862501|NCT02402127|2088148|P5|COMPLETED|First Wear Period (1 Day)||4
862502|NCT02402127|2088149|P4|COMPLETED|First Wear Period (1 Day)||4
862503|NCT02402127|2088150|P3|COMPLETED|First Wear Period (1 Day)||4
862504|NCT02402127|2088151|P2|COMPLETED|First Wear Period (1 Day)||4
862505|NCT02402127|2088152|P1|COMPLETED|First Wear Period (1 Day)||4
862506|NCT02402127|2088147|P6|Randomized and Treated|First Wear Period (1 Day)||4
862507|NCT02402127|2088148|P5|Randomized and Treated|First Wear Period (1 Day)||4
862508|NCT02402127|2088149|P4|Randomized and Treated|First Wear Period (1 Day)||4
862509|NCT02402127|2088150|P3|Randomized and Treated|First Wear Period (1 Day)||4
862510|NCT02402127|2088151|P2|Randomized and Treated|First Wear Period (1 Day)||4
862511|NCT02402127|2088152|P1|Randomized and Treated|First Wear Period (1 Day)||4
862512|NCT02402127|2088147|P6|STARTED|First Wear Period (1 Day)||4
862513|NCT02402127|2088148|P5|STARTED|First Wear Period (1 Day)||4
862514|NCT02402127|2088149|P4|STARTED|First Wear Period (1 Day)||4
862515|NCT02402127|2088150|P3|STARTED|First Wear Period (1 Day)||4
862516|NCT02402127|2088151|P2|STARTED|First Wear Period (1 Day)||4
862517|NCT02402127|2088152|P1|STARTED|First Wear Period (1 Day)||4
862518|NCT02401867|2088163|P1|NOT COMPLETED|Analysis||9
862519|NCT02401867|2088163|P1|COMPLETED|Analysis|Comparative analysis of vaginal HPV DNA results and cervical HPV DNA results|131
862520|NCT02401867|2088163|P1|STARTED|Analysis||140
862521|NCT02401867|2088163|P1|NOT COMPLETED|Specimen Collection||10
862522|NCT02401867|2088163|P1|COMPLETED|Specimen Collection|Completed both vaginal self-swab and provider-collected cervical swab|140
862523|NCT02401867|2088163|P1|STARTED|Specimen Collection||150
862524|NCT02401867|2088163|P1|NOT COMPLETED|Enrolled||0
862525|NCT02401867|2088163|P1|COMPLETED|Enrolled||150
862526|NCT02401867|2088163|P1|STARTED|Enrolled||150
862527|NCT02401555|2088171|P3|NOT COMPLETED|Overall Study||0
862528|NCT02401555|2088172|P2|NOT COMPLETED|Overall Study||0
862529|NCT02401555|2088173|P1|NOT COMPLETED|Overall Study||0
862530|NCT02401555|2088171|P3|COMPLETED|Overall Study||120
862531|NCT02401555|2088172|P2|COMPLETED|Overall Study||212
862532|NCT02401555|2088173|P1|COMPLETED|Overall Study||87
862533|NCT02401555|2088171|P3|STARTED|Overall Study||120
862534|NCT02401555|2088172|P2|STARTED|Overall Study||212
862535|NCT02401555|2088173|P1|STARTED|Overall Study||87
862536|NCT02401529|2088183|P2|NOT COMPLETED|Overall Study||7
862537|NCT02401529|2088184|P1|NOT COMPLETED|Overall Study||9
862538|NCT02401529|2088183|P2|COMPLETED|Overall Study||50
862539|NCT02401529|2088184|P1|COMPLETED|Overall Study||50
862540|NCT02401529|2088183|P2|STARTED|Overall Study||57
862541|NCT02401529|2088184|P1|STARTED|Overall Study||59
862542|NCT02401464|2088212|P4|NOT COMPLETED|Intervention Period 2 (6 Days)||0
862543|NCT02401464|2088213|P3|NOT COMPLETED|Intervention Period 2 (6 Days)||0
862544|NCT02401464|2088214|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
862545|NCT02401464|2088215|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
862546|NCT02401464|2088212|P4|COMPLETED|Intervention Period 2 (6 Days)||13
862547|NCT02401464|2088213|P3|COMPLETED|Intervention Period 2 (6 Days)||13
862548|NCT02401464|2088214|P2|COMPLETED|Intervention Period 2 (6 Days)||13
862549|NCT02401464|2088215|P1|COMPLETED|Intervention Period 2 (6 Days)||13
862550|NCT02401464|2088212|P4|STARTED|Intervention Period 2 (6 Days)||13
862551|NCT02401464|2088213|P3|STARTED|Intervention Period 2 (6 Days)||13
862552|NCT02401464|2088214|P2|STARTED|Intervention Period 2 (6 Days)||13
862553|NCT02401464|2088215|P1|STARTED|Intervention Period 2 (6 Days)||13
862554|NCT02401464|2088212|P4|NOT COMPLETED|Washout Period (At Least 6 Days)||0
862555|NCT02401464|2088213|P3|NOT COMPLETED|Washout Period (At Least 6 Days)||0
862556|NCT02401464|2088214|P2|NOT COMPLETED|Washout Period (At Least 6 Days)||0
862557|NCT02401464|2088215|P1|NOT COMPLETED|Washout Period (At Least 6 Days)||0
862558|NCT02401464|2088212|P4|COMPLETED|Washout Period (At Least 6 Days)||13
862559|NCT02401464|2088213|P3|COMPLETED|Washout Period (At Least 6 Days)||13
862560|NCT02401464|2088214|P2|COMPLETED|Washout Period (At Least 6 Days)||13
862561|NCT02401464|2088215|P1|COMPLETED|Washout Period (At Least 6 Days)||13
862562|NCT02401464|2088212|P4|STARTED|Washout Period (At Least 6 Days)||13
862563|NCT02401464|2088213|P3|STARTED|Washout Period (At Least 6 Days)||13
862564|NCT02401464|2088214|P2|STARTED|Washout Period (At Least 6 Days)||13
862565|NCT02401464|2088215|P1|STARTED|Washout Period (At Least 6 Days)||13
862566|NCT02401464|2088212|P4|NOT COMPLETED|Intervention Period 1 (6 Days)||0
862567|NCT02401464|2088213|P3|NOT COMPLETED|Intervention Period 1 (6 Days)||0
862568|NCT02401464|2088214|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
862569|NCT02401464|2088215|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
862570|NCT02401464|2088212|P4|COMPLETED|Intervention Period 1 (6 Days)||13
862571|NCT02401464|2088213|P3|COMPLETED|Intervention Period 1 (6 Days)||13
862572|NCT02401464|2088214|P2|COMPLETED|Intervention Period 1 (6 Days)||13
862573|NCT02401464|2088215|P1|COMPLETED|Intervention Period 1 (6 Days)||13
862574|NCT02401464|2088212|P4|STARTED|Intervention Period 1 (6 Days)||13
862575|NCT02401464|2088213|P3|STARTED|Intervention Period 1 (6 Days)||13
862576|NCT02401464|2088214|P2|STARTED|Intervention Period 1 (6 Days)||13
862577|NCT02401464|2088215|P1|STARTED|Intervention Period 1 (6 Days)||13
862578|NCT02400996|2088249|P1|NOT COMPLETED|Overall Study||0
862579|NCT02400996|2088249|P1|COMPLETED|Overall Study||40
862580|NCT02400996|2088249|P1|STARTED|Overall Study||40
862581|NCT02400710|2088255|P2|NOT COMPLETED|Overall Study||0
862582|NCT02400710|2088256|P1|NOT COMPLETED|Overall Study||0
862583|NCT02400710|2088255|P2|COMPLETED|Overall Study||10
862584|NCT02400710|2088256|P1|COMPLETED|Overall Study||10
862585|NCT02400710|2088255|P2|STARTED|Overall Study||10
862586|NCT02400710|2088256|P1|STARTED|Overall Study||10
862587|NCT02400346|2088264|P1|NOT COMPLETED|Overall Study||44
862588|NCT02400346|2088264|P1|COMPLETED|Overall Study||88
862589|NCT02400346|2088264|P1|STARTED|Overall Study||132
862590|NCT02400333|2088272|P4|NOT COMPLETED|Overall Study||2
862591|NCT02400333|2088273|P3|NOT COMPLETED|Overall Study||2
862592|NCT02400333|2088274|P2|NOT COMPLETED|Overall Study||1
862593|NCT02400333|2088275|P1|NOT COMPLETED|Overall Study||1
862594|NCT02400333|2088272|P4|COMPLETED|Overall Study||7
862595|NCT02400333|2088273|P3|COMPLETED|Overall Study||7
862596|NCT02400333|2088274|P2|COMPLETED|Overall Study||8
862597|NCT02400333|2088275|P1|COMPLETED|Overall Study||8
862598|NCT02400333|2088272|P4|STARTED|Overall Study||9
862599|NCT02400333|2088273|P3|STARTED|Overall Study||9
862600|NCT02400333|2088274|P2|STARTED|Overall Study||9
862601|NCT02400333|2088275|P1|STARTED|Overall Study||9
862602|NCT02399345|2088333|P1|NOT COMPLETED|Overall Study||0
862603|NCT02399345|2088333|P1|COMPLETED|Overall Study||10
862604|NCT02399345|2088333|P1|STARTED|Overall Study||10
862605|NCT02399163|2088339|P1|NOT COMPLETED|Overall Study||9
862606|NCT02399163|2088339|P1|COMPLETED|Overall Study||53
862607|NCT02399163|2088339|P1|STARTED|Overall Study||62
862608|NCT02399111|2088367|P4|NOT COMPLETED|Overall Study||0
862609|NCT02399111|2088368|P3|NOT COMPLETED|Overall Study||0
862610|NCT02399111|2088369|P2|NOT COMPLETED|Overall Study||0
862611|NCT02399111|2088370|P1|NOT COMPLETED|Overall Study||0
862612|NCT02399111|2088367|P4|COMPLETED|Overall Study||0
862613|NCT02399111|2088368|P3|COMPLETED|Overall Study||4
862614|NCT02399111|2088369|P2|COMPLETED|Overall Study||1
862615|NCT02399111|2088370|P1|COMPLETED|Overall Study||4
862616|NCT02399111|2088367|P4|STARTED|Overall Study||0
862617|NCT02399111|2088368|P3|STARTED|Overall Study||4
862618|NCT02399111|2088369|P2|STARTED|Overall Study||1
862619|NCT02399111|2088370|P1|STARTED|Overall Study||4
862620|NCT02397915|2088384|P4|NOT COMPLETED|Period 2||0
862621|NCT02397915|2088385|P3|NOT COMPLETED|Period 2||0
862622|NCT02397915|2088386|P2|NOT COMPLETED|Period 2||0
862623|NCT02397915|2088387|P1|NOT COMPLETED|Period 2||0
862624|NCT02397915|2088384|P4|COMPLETED|Period 2||149
862625|NCT02397915|2088385|P3|COMPLETED|Period 2||149
862626|NCT02397915|2088386|P2|COMPLETED|Period 2||0
862627|NCT02397915|2088387|P1|COMPLETED|Period 2||0
862628|NCT02397915|2088384|P4|STARTED|Period 2||149
862629|NCT02397915|2088385|P3|STARTED|Period 2||149
862630|NCT02397915|2088386|P2|STARTED|Period 2||0
862631|NCT02397915|2088387|P1|STARTED|Period 2||0
862632|NCT02397915|2088384|P4|NOT COMPLETED|Period 1||0
862633|NCT02397915|2088385|P3|NOT COMPLETED|Period 1||0
862634|NCT02397915|2088386|P2|NOT COMPLETED|Period 1||1
862635|NCT02397915|2088387|P1|NOT COMPLETED|Period 1||1
862636|NCT02397915|2088384|P4|COMPLETED|Period 1||0
862637|NCT02397915|2088385|P3|COMPLETED|Period 1||0
862638|NCT02397915|2088386|P2|COMPLETED|Period 1||149
862639|NCT02397915|2088387|P1|COMPLETED|Period 1||149
862640|NCT02397915|2088384|P4|STARTED|Period 1||0
862641|NCT02397915|2088385|P3|STARTED|Period 1||0
862642|NCT02397915|2088386|P2|STARTED|Period 1||150
862643|NCT02397915|2088387|P1|STARTED|Period 1||150
862644|NCT02397655|2088437|P1|NOT COMPLETED|Overall Study||1301
862645|NCT02397655|2088437|P1|COMPLETED|Overall Study||10711
862646|NCT02397655|2088437|P1|STARTED|Overall Study||12012
862647|NCT02397564|2088441|P1|NOT COMPLETED|Overall Study||4
862648|NCT02397564|2088441|P1|COMPLETED|Overall Study||16
862649|NCT02397564|2088441|P1|STARTED|Overall Study||20
862650|NCT02396537|2088448|P2|NOT COMPLETED|Overall Study||1
862651|NCT02396537|2088449|P1|NOT COMPLETED|Overall Study||0
862652|NCT02396537|2088448|P2|COMPLETED|Overall Study||36
862653|NCT02396537|2088449|P1|COMPLETED|Overall Study||40
862654|NCT02396537|2088448|P2|STARTED|Overall Study||37
862655|NCT02396537|2088449|P1|STARTED|Overall Study||40
862656|NCT02396316|2088457|P2|NOT COMPLETED|Overall Study||5
862657|NCT02396316|2088458|P1|NOT COMPLETED|Overall Study||7
862658|NCT02396316|2088457|P2|COMPLETED|Overall Study||22
862659|NCT02396316|2088458|P1|COMPLETED|Overall Study||20
862660|NCT02396316|2088457|P2|Received Active Injection at Week 9|Overall Study||1
862661|NCT02396316|2088458|P1|Received Active Injection at Week 9|Overall Study||2
862662|NCT02396316|2088457|P2|Received Active Injection at Week 5|Overall Study||4
862663|NCT02396316|2088458|P1|Received Active Injection at Week 5|Overall Study||4
862664|NCT02396316|2088457|P2|Received AFL Injection at Week 1|Overall Study||22
862665|NCT02396316|2088458|P1|Received AFL Injection at Week 1|Overall Study||0
862666|NCT02396316|2088457|P2|Received Sham Injection at Week 1|Overall Study||0
862667|NCT02396316|2088458|P1|Received Sham Injection at Week 1|Overall Study||10
862668|NCT02396316|2088457|P2|Treated|Overall Study||27
862669|NCT02396316|2088458|P1|Treated|Overall Study||27
862670|NCT02396316|2088457|P2|STARTED|Overall Study||27
862671|NCT02396316|2088458|P1|STARTED|Overall Study||27
862672|NCT02396160|2088470|P2|NOT COMPLETED|Overall Study||2
862673|NCT02396160|2088471|P1|NOT COMPLETED|Overall Study||6
862674|NCT02396160|2088470|P2|COMPLETED|Overall Study||73
862675|NCT02396160|2088471|P1|COMPLETED|Overall Study||69
862676|NCT02396160|2088470|P2|STARTED|Overall Study||75
862677|NCT02396160|2088471|P1|STARTED|Overall Study||75
862678|NCT02396147|2088487|P2|NOT COMPLETED|Period 3||0
862679|NCT02396147|2088488|P1|NOT COMPLETED|Period 3||0
862680|NCT02396147|2088487|P2|COMPLETED|Period 3||27
862681|NCT02396147|2088488|P1|COMPLETED|Period 3||27
862682|NCT02396147|2088487|P2|STARTED|Period 3||27
862683|NCT02396147|2088488|P1|STARTED|Period 3||27
862684|NCT02396147|2088487|P2|NOT COMPLETED|Period 2||0
862685|NCT02396147|2088488|P1|NOT COMPLETED|Period 2||0
862686|NCT02396147|2088487|P2|COMPLETED|Period 2||27
862687|NCT02396147|2088488|P1|COMPLETED|Period 2||27
862688|NCT02396147|2088487|P2|STARTED|Period 2||27
862689|NCT02396147|2088488|P1|STARTED|Period 2||27
862690|NCT02396147|2088487|P2|NOT COMPLETED|Period 1||0
862691|NCT02396147|2088488|P1|NOT COMPLETED|Period 1||0
862692|NCT02396147|2088487|P2|COMPLETED|Period 1||27
862693|NCT02396147|2088488|P1|COMPLETED|Period 1||27
862694|NCT02396147|2088487|P2|STARTED|Period 1||27
862695|NCT02396147|2088488|P1|STARTED|Period 1||27
862700|NCT02395536|2088565|P2|NOT COMPLETED|Overall Study||30
862701|NCT02395536|2088566|P1|NOT COMPLETED|Overall Study||20
862702|NCT02395536|2088565|P2|COMPLETED|Overall Study||227
862703|NCT02395536|2088566|P1|COMPLETED|Overall Study||244
862704|NCT02395536|2088565|P2|REVEAL LINQ Insertion|Overall Study||231
862705|NCT02395536|2088566|P1|REVEAL LINQ Insertion|Overall Study||251
862706|NCT02395536|2088565|P2|STARTED|Overall Study||257
862707|NCT02395536|2088566|P1|STARTED|Overall Study||264
862708|NCT02395302|2088572|P1|NOT COMPLETED|Overall Study||14
862709|NCT02395302|2088572|P1|COMPLETED|Overall Study||14
862710|NCT02395302|2088572|P1|STARTED|Overall Study||28
862711|NCT02395055|2088578|P2|NOT COMPLETED|Overall Study||3
862712|NCT02395055|2088579|P1|NOT COMPLETED|Overall Study||7
862713|NCT02395055|2088578|P2|COMPLETED|Overall Study||44
862714|NCT02395055|2088579|P1|COMPLETED|Overall Study||40
862715|NCT02395055|2088578|P2|STARTED|Overall Study||47
862716|NCT02395055|2088579|P1|STARTED|Overall Study||47
862717|NCT02394925|2088589|P1|NOT COMPLETED|Overall Study||29
862718|NCT02394925|2088589|P1|COMPLETED|Overall Study||79
862719|NCT02394925|2088589|P1|STARTED|Overall Study||108
862720|NCT02394808|2088593|P2|NOT COMPLETED|Period 2||0
862721|NCT02394808|2088594|P1|NOT COMPLETED|Period 2||1
862722|NCT02394808|2088593|P2|COMPLETED|Period 2||28
862723|NCT02394808|2088594|P1|COMPLETED|Period 2||24
862724|NCT02394808|2088593|P2|STARTED|Period 2||28
862725|NCT02394808|2088594|P1|STARTED|Period 2||25
862726|NCT02394808|2088593|P2|NOT COMPLETED|Period 1||1
862727|NCT02394808|2088594|P1|NOT COMPLETED|Period 1||0
862728|NCT02394808|2088593|P2|COMPLETED|Period 1||28
862729|NCT02394808|2088594|P1|COMPLETED|Period 1||25
862730|NCT02394808|2088593|P2|STARTED|Period 1||29
862731|NCT02394808|2088594|P1|STARTED|Period 1||25
862732|NCT02394756|2088602|P6|NOT COMPLETED|Period 3||0
862733|NCT02394756|2088603|P5|NOT COMPLETED|Period 3||0
862734|NCT02394756|2088604|P4|NOT COMPLETED|Period 3||0
862735|NCT02394756|2088605|P3|NOT COMPLETED|Period 3||0
862736|NCT02394756|2088606|P2|NOT COMPLETED|Period 3||0
862737|NCT02394756|2088607|P1|NOT COMPLETED|Period 3||0
862738|NCT02394756|2088602|P6|COMPLETED|Period 3||6
862739|NCT02394756|2088603|P5|COMPLETED|Period 3||6
862740|NCT02394756|2088604|P4|COMPLETED|Period 3||6
862741|NCT02394756|2088605|P3|COMPLETED|Period 3||6
862742|NCT02394756|2088606|P2|COMPLETED|Period 3||6
862743|NCT02394756|2088607|P1|COMPLETED|Period 3||7
862744|NCT02394756|2088602|P6|STARTED|Period 3||6
862745|NCT02394756|2088603|P5|STARTED|Period 3||6
862746|NCT02394756|2088604|P4|STARTED|Period 3||6
862747|NCT02394756|2088605|P3|STARTED|Period 3||6
862748|NCT02394756|2088606|P2|STARTED|Period 3||6
862749|NCT02394756|2088607|P1|STARTED|Period 3||7
862750|NCT02394756|2088602|P6|NOT COMPLETED|Period 2||0
862751|NCT02394756|2088603|P5|NOT COMPLETED|Period 2||1
862752|NCT02394756|2088604|P4|NOT COMPLETED|Period 2||0
862753|NCT02394756|2088605|P3|NOT COMPLETED|Period 2||0
862754|NCT02394756|2088606|P2|NOT COMPLETED|Period 2||0
862755|NCT02394756|2088607|P1|NOT COMPLETED|Period 2||0
862756|NCT02394756|2088602|P6|COMPLETED|Period 2||6
862757|NCT02394756|2088603|P5|COMPLETED|Period 2||6
862758|NCT02394756|2088604|P4|COMPLETED|Period 2||6
862759|NCT02394756|2088605|P3|COMPLETED|Period 2||6
862760|NCT02394756|2088606|P2|COMPLETED|Period 2||6
862761|NCT02394756|2088607|P1|COMPLETED|Period 2||7
862762|NCT02394756|2088602|P6|STARTED|Period 2||6
862763|NCT02394756|2088603|P5|STARTED|Period 2||7
862764|NCT02394756|2088604|P4|STARTED|Period 2||6
862765|NCT02394756|2088605|P3|STARTED|Period 2||6
862766|NCT02394756|2088606|P2|STARTED|Period 2||6
862767|NCT02394756|2088607|P1|STARTED|Period 2||7
862768|NCT02394756|2088602|P6|NOT COMPLETED|Period 1||1
862769|NCT02394756|2088603|P5|NOT COMPLETED|Period 1||0
862770|NCT02394756|2088604|P4|NOT COMPLETED|Period 1||1
862771|NCT02394756|2088605|P3|NOT COMPLETED|Period 1||1
862772|NCT02394756|2088606|P2|NOT COMPLETED|Period 1||1
862773|NCT02394756|2088607|P1|NOT COMPLETED|Period 1||0
862774|NCT02394756|2088602|P6|COMPLETED|Period 1||6
862775|NCT02394756|2088603|P5|COMPLETED|Period 1||7
862776|NCT02394756|2088604|P4|COMPLETED|Period 1||6
862777|NCT02394756|2088605|P3|COMPLETED|Period 1||6
862778|NCT02394756|2088606|P2|COMPLETED|Period 1||6
862779|NCT02394756|2088607|P1|COMPLETED|Period 1||7
862780|NCT02394756|2088602|P6|STARTED|Period 1||7
862781|NCT02394756|2088603|P5|STARTED|Period 1||7
862782|NCT02394756|2088604|P4|STARTED|Period 1||7
862783|NCT02394756|2088605|P3|STARTED|Period 1||7
862784|NCT02394756|2088606|P2|STARTED|Period 1||7
862785|NCT02394756|2088607|P1|STARTED|Period 1||7
862786|NCT02394665|2088621|P3|NOT COMPLETED|Overall Study||0
862787|NCT02394665|2088622|P2|NOT COMPLETED|Overall Study||0
862788|NCT02394665|2088623|P1|NOT COMPLETED|Overall Study||1
862789|NCT02394665|2088621|P3|COMPLETED|Overall Study||0
862790|NCT02394665|2088622|P2|COMPLETED|Overall Study||0
862791|NCT02394665|2088623|P1|COMPLETED|Overall Study||0
862792|NCT02394665|2088621|P3|STARTED|Overall Study||0
862793|NCT02394665|2088622|P2|STARTED|Overall Study||0
862794|NCT02394665|2088623|P1|STARTED|Overall Study||1
862795|NCT02394457|2088645|P2|NOT COMPLETED|Overall Study||0
862796|NCT02394457|2088646|P1|NOT COMPLETED|Overall Study||0
862797|NCT02394457|2088645|P2|COMPLETED|Overall Study||13
862798|NCT02394457|2088646|P1|COMPLETED|Overall Study||15
862799|NCT02394457|2088645|P2|STARTED|Overall Study||13
862800|NCT02394457|2088646|P1|STARTED|Overall Study||15
862801|NCT02393950|2088664|P2|NOT COMPLETED|Overall Study||1
862802|NCT02393950|2088665|P1|NOT COMPLETED|Overall Study||1
862803|NCT02393950|2088664|P2|COMPLETED|Overall Study||8
862804|NCT02393950|2088665|P1|COMPLETED|Overall Study||8
862805|NCT02393950|2088664|P2|Period 4|Overall Study|6 subjects ODM-106 Capsule A 100 mg (10 x 10mg) and 2 subjects on placebo|8
862806|NCT02393950|2088665|P1|Period 4|Overall Study|6 subjects ODM-106 Capsule B 50 mg and 2 subjects on placebo|8
862807|NCT02393950|2088664|P2|Period 3|Overall Study|6 subjects ODM-106 Capsule B 200 mg (20 x 10mg) and 2 subjects on placebo|8
862808|NCT02393950|2088665|P1|Period 3|Overall Study|6 subjects ODM-106 Capsule B 25 mg and 2 subjects on placebo|8
862809|NCT02393950|2088664|P2|Period 2|Overall Study|6 subjects ODM-106 Capsule B 100 mg (10 x 10mg) and 2 subjects on placebo|8
862810|NCT02393950|2088665|P1|Period 2|Overall Study|6 subjects ODM-106 Capsule B 10 mg and 2 subjects on placebo|8
862811|NCT02393950|2088664|P2|Period 1|Overall Study|6 subjects ODM-106 Capsule B 100 mg (1 x 100mg) and 2 subjects on placebo|8
862812|NCT02393950|2088665|P1|Period 1|Overall Study|6 subjects ODM-106 Capsule B 2 mg and 2 subjects on placebo|8
862813|NCT02393950|2088664|P2|STARTED|Overall Study||9
862814|NCT02393950|2088665|P1|STARTED|Overall Study||9
862815|NCT02393677|2088732|P2|NOT COMPLETED|Overall Study||0
862816|NCT02393677|2088733|P1|NOT COMPLETED|Overall Study||0
862817|NCT02393677|2088732|P2|COMPLETED|Overall Study||40
862818|NCT02393677|2088733|P1|COMPLETED|Overall Study||40
862819|NCT02393677|2088732|P2|STARTED|Overall Study||40
862820|NCT02393677|2088733|P1|STARTED|Overall Study||40
862821|NCT02393547|2088739|P1|NOT COMPLETED|Overall Study||6
862822|NCT02393547|2088739|P1|COMPLETED|Overall Study||14
862823|NCT02393547|2088739|P1|STARTED|Overall Study||20
862824|NCT02392767|2088748|P2|NOT COMPLETED|Overall Study||0
862825|NCT02392767|2088749|P1|NOT COMPLETED|Overall Study||0
862826|NCT02392767|2088748|P2|COMPLETED|Overall Study||13
862827|NCT02392767|2088749|P1|COMPLETED|Overall Study||12
862828|NCT02392767|2088748|P2|STARTED|Overall Study||13
862829|NCT02392767|2088749|P1|STARTED|Overall Study||12
862830|NCT02392247|2088765|P1|NOT COMPLETED|Overall Study||2
862831|NCT02392247|2088765|P1|COMPLETED|Overall Study||50
862832|NCT02392247|2088765|P1|STARTED|Overall Study||52
862833|NCT02392208|2088770|P1|NOT COMPLETED|Telavancin After Hemodialysis||0
862834|NCT02392208|2088770|P1|COMPLETED|Telavancin After Hemodialysis||8
862835|NCT02392208|2088770|P1|STARTED|Telavancin After Hemodialysis||8
862836|NCT02392208|2088770|P1|NOT COMPLETED|Telavancin Before Hemodialysis||0
862837|NCT02392208|2088770|P1|COMPLETED|Telavancin Before Hemodialysis||8
862838|NCT02392208|2088770|P1|STARTED|Telavancin Before Hemodialysis||8
862839|NCT02391714|2088782|P2|NOT COMPLETED|Overall Study||0
862840|NCT02391714|2088783|P1|NOT COMPLETED|Overall Study||0
862841|NCT02391714|2088782|P2|COMPLETED|Overall Study||40
862842|NCT02391714|2088783|P1|COMPLETED|Overall Study||40
862843|NCT02391714|2088782|P2|STARTED|Overall Study||40
862844|NCT02391714|2088783|P1|STARTED|Overall Study||40
862845|NCT02391311|2088795|P2|NOT COMPLETED|Overall Study||2
862846|NCT02391311|2088796|P1|NOT COMPLETED|Overall Study||3
862847|NCT02391311|2088795|P2|COMPLETED|Overall Study||19
862848|NCT02391311|2088796|P1|COMPLETED|Overall Study||18
862849|NCT02391311|2088795|P2|STARTED|Overall Study||21
862850|NCT02391311|2088796|P1|STARTED|Overall Study||21
862851|NCT02391038|2088804|P3|NOT COMPLETED|Overall Study||6
862852|NCT02391038|2088805|P2|NOT COMPLETED|Overall Study||3
862853|NCT02391038|2088806|P1|NOT COMPLETED|Overall Study||3
862854|NCT02391038|2088804|P3|COMPLETED|Overall Study||0
862855|NCT02391038|2088805|P2|COMPLETED|Overall Study||0
862856|NCT02391038|2088806|P1|COMPLETED|Overall Study||0
862857|NCT02391038|2088804|P3|STARTED|Overall Study||6
862858|NCT02391038|2088805|P2|STARTED|Overall Study||3
862859|NCT02391038|2088806|P1|STARTED|Overall Study||3
862860|NCT02390167|2088920|P1|NOT COMPLETED|Overall Study||1
862861|NCT02390167|2088920|P1|COMPLETED|Overall Study||375
862862|NCT02390167|2088920|P1|Without Diabetes|Overall Study||43
862863|NCT02390167|2088920|P1|With Diabetes|Overall Study||333
862864|NCT02390167|2088920|P1|STARTED|Overall Study||376
862865|NCT02389881|2088946|P7|NOT COMPLETED|Overall Study||0
862866|NCT02389881|2088947|P6|NOT COMPLETED|Overall Study||0
862867|NCT02389881|2088948|P5|NOT COMPLETED|Overall Study||0
862868|NCT02389881|2088949|P4|NOT COMPLETED|Overall Study||0
862869|NCT02389881|2088950|P3|NOT COMPLETED|Overall Study||0
862870|NCT02389881|2088951|P2|NOT COMPLETED|Overall Study||0
862871|NCT02389881|2088952|P1|NOT COMPLETED|Overall Study||0
862872|NCT02389881|2088946|P7|COMPLETED|Overall Study||2
862873|NCT02389881|2088947|P6|COMPLETED|Overall Study||8
862874|NCT02389881|2088948|P5|COMPLETED|Overall Study||6
862875|NCT02389881|2088949|P4|COMPLETED|Overall Study||6
862876|NCT02389881|2088950|P3|COMPLETED|Overall Study||6
862877|NCT02389881|2088951|P2|COMPLETED|Overall Study||6
862878|NCT02389881|2088952|P1|COMPLETED|Overall Study||6
862879|NCT02389881|2088946|P7|STARTED|Overall Study||2
862880|NCT02389881|2088947|P6|STARTED|Overall Study||8
862881|NCT02389881|2088948|P5|STARTED|Overall Study||6
862882|NCT02389881|2088949|P4|STARTED|Overall Study||6
862883|NCT02389881|2088950|P3|STARTED|Overall Study||6
862884|NCT02389881|2088951|P2|STARTED|Overall Study||6
862885|NCT02389881|2088952|P1|STARTED|Overall Study||6
862886|NCT02389452|2089001|P1|NOT COMPLETED|Overall Study||25
862887|NCT02389452|2089001|P1|COMPLETED|Overall Study||369
862888|NCT02389452|2089001|P1|Participants Received Repeat Injection|Overall Study|Repeat injection based on physician's assessment of efficacy and safety at Week 26, 39 or 52.|11
862889|NCT02389452|2089001|P1|STARTED|Overall Study||394
862890|NCT02389374|2089022|P3|NOT COMPLETED|Overall Study||1
862891|NCT02389374|2089023|P2|NOT COMPLETED|Overall Study||28
862892|NCT02389374|2089024|P1|NOT COMPLETED|Overall Study||9
862893|NCT02389374|2089022|P3|COMPLETED|Overall Study||10
862894|NCT02389374|2089023|P2|COMPLETED|Overall Study||87
862895|NCT02389374|2089024|P1|COMPLETED|Overall Study||46
862896|NCT02389374|2089022|P3|STARTED|Overall Study||11
862897|NCT02389374|2089023|P2|STARTED|Overall Study||115
862898|NCT02389374|2089024|P1|STARTED|Overall Study||55
862899|NCT02389361|2089056|P2|NOT COMPLETED|Overall Study||0
862900|NCT02389361|2089057|P1|NOT COMPLETED|Overall Study||0
862901|NCT02389361|2089056|P2|COMPLETED|Overall Study||27
862902|NCT02389361|2089057|P1|COMPLETED|Overall Study||24
862903|NCT02389361|2089056|P2|STARTED|Overall Study||27
862904|NCT02389361|2089057|P1|STARTED|Overall Study||24
862905|NCT02389088|2089063|P1|NOT COMPLETED|Phase II - All Study Participants||0
862906|NCT02389088|2089063|P1|COMPLETED|Phase II - All Study Participants||9
862907|NCT02389088|2089063|P1|STARTED|Phase II - All Study Participants||9
862908|NCT02389088|2089063|P1|NOT COMPLETED|Overall Study - Phase I||0
862909|NCT02389088|2089063|P1|COMPLETED|Overall Study - Phase I||9
862910|NCT02389088|2089063|P1|STARTED|Overall Study - Phase I||9
862911|NCT02388815|2089107|P1|NOT COMPLETED|Overall Study||4
862912|NCT02388815|2089107|P1|COMPLETED|Overall Study||85
862913|NCT02388815|2089107|P1|STARTED|Overall Study||89
862914|NCT02388763|2089111|P2|NOT COMPLETED|Period 2, 10 Days of Wear||0
862915|NCT02388763|2089112|P1|NOT COMPLETED|Period 2, 10 Days of Wear||0
862916|NCT02388763|2089111|P2|COMPLETED|Period 2, 10 Days of Wear||30
862917|NCT02388763|2089112|P1|COMPLETED|Period 2, 10 Days of Wear||30
862918|NCT02388763|2089111|P2|STARTED|Period 2, 10 Days of Wear||30
862919|NCT02388763|2089112|P1|STARTED|Period 2, 10 Days of Wear||30
862920|NCT02388763|2089111|P2|NOT COMPLETED|Period 1, 10 Days of Wear||1
862921|NCT02388763|2089112|P1|NOT COMPLETED|Period 1, 10 Days of Wear||1
862922|NCT02388763|2089111|P2|COMPLETED|Period 1, 10 Days of Wear||30
862923|NCT02388763|2089112|P1|COMPLETED|Period 1, 10 Days of Wear||30
862924|NCT02388763|2089111|P2|STARTED|Period 1, 10 Days of Wear||31
862925|NCT02388763|2089112|P1|STARTED|Period 1, 10 Days of Wear||31
862926|NCT02388763|2089111|P2|NOT COMPLETED|Habitual, 10 Days of Wear||1
862927|NCT02388763|2089112|P1|NOT COMPLETED|Habitual, 10 Days of Wear||1
862928|NCT02388763|2089111|P2|COMPLETED|Habitual, 10 Days of Wear||31
862929|NCT02388763|2089112|P1|COMPLETED|Habitual, 10 Days of Wear||31
862930|NCT02388763|2089111|P2|STARTED|Habitual, 10 Days of Wear||32
862931|NCT02388763|2089112|P1|STARTED|Habitual, 10 Days of Wear||32
862932|NCT02387268|2089123|P1|NOT COMPLETED|Overall Study||1
862933|NCT02387268|2089123|P1|COMPLETED|Overall Study||9
862934|NCT02387268|2089123|P1|STARTED|Overall Study||10
862935|NCT02388347|2089133|P5|NOT COMPLETED|Overall Study||0
862936|NCT02388347|2089134|P4|NOT COMPLETED|Overall Study||0
862937|NCT02388347|2089135|P3|NOT COMPLETED|Overall Study||1
862938|NCT02388347|2089136|P2|NOT COMPLETED|Overall Study||0
862939|NCT02388347|2089137|P1|NOT COMPLETED|Overall Study||0
862940|NCT02388347|2089133|P5|COMPLETED|Overall Study||6
862941|NCT02388347|2089134|P4|COMPLETED|Overall Study||6
862942|NCT02388347|2089135|P3|COMPLETED|Overall Study||5
862943|NCT02388347|2089136|P2|COMPLETED|Overall Study||6
862944|NCT02388347|2089137|P1|COMPLETED|Overall Study||8
862945|NCT02388347|2089133|P5|STARTED|Overall Study||6
862946|NCT02388347|2089134|P4|STARTED|Overall Study||6
862947|NCT02388347|2089135|P3|STARTED|Overall Study||6
862948|NCT02388347|2089136|P2|STARTED|Overall Study||6
862949|NCT02388347|2089137|P1|STARTED|Overall Study||8
862950|NCT02388295|2089205|P3|NOT COMPLETED|Treatment Weeks 3 to 12||0
862951|NCT02388295|2089206|P2|NOT COMPLETED|Treatment Weeks 3 to 12||1
862952|NCT02388295|2089207|P1|NOT COMPLETED|Treatment Weeks 3 to 12||1
862953|NCT02388295|2089205|P3|COMPLETED|Treatment Weeks 3 to 12||17
862954|NCT02388295|2089206|P2|COMPLETED|Treatment Weeks 3 to 12||13
862955|NCT02388295|2089207|P1|COMPLETED|Treatment Weeks 3 to 12||15
862956|NCT02388295|2089205|P3|STARTED|Treatment Weeks 3 to 12||17
862957|NCT02388295|2089206|P2|STARTED|Treatment Weeks 3 to 12||14
862958|NCT02388295|2089207|P1|STARTED|Treatment Weeks 3 to 12||16
862959|NCT02388295|2089205|P3|NOT COMPLETED|Dose Escalation Week 2||1
862960|NCT02388295|2089206|P2|NOT COMPLETED|Dose Escalation Week 2||2
862961|NCT02388295|2089207|P1|NOT COMPLETED|Dose Escalation Week 2||1
862962|NCT02388295|2089205|P3|COMPLETED|Dose Escalation Week 2||17
862963|NCT02388295|2089206|P2|COMPLETED|Dose Escalation Week 2||14
862964|NCT02388295|2089207|P1|COMPLETED|Dose Escalation Week 2||16
862965|NCT02388295|2089205|P3|STARTED|Dose Escalation Week 2||18
862966|NCT02388295|2089206|P2|STARTED|Dose Escalation Week 2||16
862967|NCT02388295|2089207|P1|STARTED|Dose Escalation Week 2||17
862968|NCT02388295|2089205|P3|NOT COMPLETED|Dose Escalation Week 1||2
862969|NCT02388295|2089206|P2|NOT COMPLETED|Dose Escalation Week 1||3
862970|NCT02388295|2089207|P1|NOT COMPLETED|Dose Escalation Week 1||2
862971|NCT02388295|2089205|P3|COMPLETED|Dose Escalation Week 1||18
862972|NCT02388295|2089206|P2|COMPLETED|Dose Escalation Week 1||16
862973|NCT02388295|2089207|P1|COMPLETED|Dose Escalation Week 1||17
862974|NCT02388295|2089205|P3|STARTED|Dose Escalation Week 1|Number randomized to treatment|20
862975|NCT02388295|2089206|P2|STARTED|Dose Escalation Week 1|Number randomized to treatment|19
862976|NCT02388295|2089207|P1|STARTED|Dose Escalation Week 1|Number randomized to treatment|19
862977|NCT02388191|2089223|P2|NOT COMPLETED|Overall Study||0
862978|NCT02388191|2089224|P1|NOT COMPLETED|Overall Study||1
862979|NCT02388191|2089223|P2|COMPLETED|Overall Study||60
862980|NCT02388191|2089224|P1|COMPLETED|Overall Study||58
862981|NCT02388191|2089223|P2|STARTED|Overall Study||60
862982|NCT02388191|2089224|P1|STARTED|Overall Study||59
862983|NCT02388074|2089238|P1|NOT COMPLETED|Overall Study||3
862984|NCT02388074|2089238|P1|COMPLETED|Overall Study||22
862985|NCT02388074|2089238|P1|STARTED|Overall Study||25
862989|NCT02387983|2089253|P1|NOT COMPLETED|Overall Study||7
862990|NCT02387983|2089253|P1|COMPLETED|Overall Study||58
862991|NCT02387983|2089253|P1|STARTED|Overall Study||65
862992|NCT02387801|2089267|P2|NOT COMPLETED|Post-Treatment Follow-up||0
862993|NCT02387801|2089268|P1|NOT COMPLETED|Post-Treatment Follow-up||0
862994|NCT02387801|2089267|P2|COMPLETED|Post-Treatment Follow-up||12
862995|NCT02387801|2089268|P1|COMPLETED|Post-Treatment Follow-up||0
862996|NCT02387801|2089267|P2|STARTED|Post-Treatment Follow-up||12
862997|NCT02387801|2089268|P1|STARTED|Post-Treatment Follow-up||0
862998|NCT02387801|2089267|P2|NOT COMPLETED|Maintenance Dosing Period||0
862999|NCT02387801|2089268|P1|NOT COMPLETED|Maintenance Dosing Period||0
863000|NCT02387801|2089267|P2|COMPLETED|Maintenance Dosing Period||12
863001|NCT02387801|2089268|P1|COMPLETED|Maintenance Dosing Period||0
863002|NCT02387801|2089267|P2|STARTED|Maintenance Dosing Period||12
863003|NCT02387801|2089268|P1|STARTED|Maintenance Dosing Period|All participants from Induction Dosing Period went to ixe Q4W arm during Maintenance Dosing Period.|0
863004|NCT02387801|2089267|P2|NOT COMPLETED|Induction Dosing Period||0
863005|NCT02387801|2089268|P1|NOT COMPLETED|Induction Dosing Period||0
863006|NCT02387801|2089267|P2|COMPLETED|Induction Dosing Period||6
863007|NCT02387801|2089268|P1|COMPLETED|Induction Dosing Period||6
863008|NCT02387801|2089267|P2|STARTED|Induction Dosing Period||6
863009|NCT02387801|2089268|P1|STARTED|Induction Dosing Period||6
863010|NCT02387710|2089286|P2|NOT COMPLETED|Second Study Night||0
863011|NCT02387710|2089287|P1|NOT COMPLETED|Second Study Night||0
863012|NCT02387710|2089286|P2|COMPLETED|Second Study Night||7
863013|NCT02387710|2089287|P1|COMPLETED|Second Study Night||9
863014|NCT02387710|2089286|P2|STARTED|Second Study Night|2 patients did not come back for excessive sleep disruption due to the equipment|7
863015|NCT02387710|2089287|P1|STARTED|Second Study Night||9
863016|NCT02387710|2089286|P2|NOT COMPLETED|First Study Night||0
863017|NCT02387710|2089287|P1|NOT COMPLETED|First Study Night||0
863018|NCT02387710|2089286|P2|COMPLETED|First Study Night||9
863019|NCT02387710|2089287|P1|COMPLETED|First Study Night||9
863020|NCT02387710|2089286|P2|STARTED|First Study Night||9
863021|NCT02387710|2089287|P1|STARTED|First Study Night||9
863022|NCT02387580|2089303|P6|NOT COMPLETED|Overall Study||0
863023|NCT02387580|2089304|P5|NOT COMPLETED|Overall Study||0
863024|NCT02387580|2089305|P4|NOT COMPLETED|Overall Study||1
863025|NCT02387580|2089306|P3|NOT COMPLETED|Overall Study||0
863026|NCT02387580|2089307|P2|NOT COMPLETED|Overall Study||0
863027|NCT02387580|2089308|P1|NOT COMPLETED|Overall Study||0
863028|NCT02387580|2089303|P6|COMPLETED|Overall Study||8
863029|NCT02387580|2089304|P5|COMPLETED|Overall Study||8
863030|NCT02387580|2089305|P4|COMPLETED|Overall Study||7
863031|NCT02387580|2089306|P3|COMPLETED|Overall Study||8
863032|NCT02387580|2089307|P2|COMPLETED|Overall Study||8
863033|NCT02387580|2089308|P1|COMPLETED|Overall Study||8
863034|NCT02387580|2089303|P6|STARTED|Overall Study||8
863035|NCT02387580|2089304|P5|STARTED|Overall Study||8
863036|NCT02387580|2089305|P4|STARTED|Overall Study||8
863037|NCT02387580|2089306|P3|STARTED|Overall Study||8
863038|NCT02387580|2089307|P2|STARTED|Overall Study||8
863039|NCT02387580|2089308|P1|STARTED|Overall Study||8
863040|NCT02387554|2089344|P4|NOT COMPLETED|Overall Study||2
863041|NCT02387554|2089345|P3|NOT COMPLETED|Overall Study||2
863042|NCT02387554|2089346|P2|NOT COMPLETED|Overall Study||0
863043|NCT02387554|2089347|P1|NOT COMPLETED|Overall Study||3
863044|NCT02387554|2089344|P4|COMPLETED|Overall Study||6
863045|NCT02387554|2089345|P3|COMPLETED|Overall Study||6
863046|NCT02387554|2089346|P2|COMPLETED|Overall Study||7
863047|NCT02387554|2089347|P1|COMPLETED|Overall Study||7
863048|NCT02387554|2089344|P4|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
863049|NCT02387554|2089345|P3|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
863050|NCT02387554|2089346|P2|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|7
863051|NCT02387554|2089347|P1|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|10
863052|NCT02387502|2089360|P3|NOT COMPLETED|Overall Study||0
863053|NCT02387502|2089361|P2|NOT COMPLETED|Overall Study||0
863054|NCT02387502|2089362|P1|NOT COMPLETED|Overall Study||0
863055|NCT02387502|2089360|P3|COMPLETED|Overall Study||40
863056|NCT02387502|2089361|P2|COMPLETED|Overall Study||40
863057|NCT02387502|2089362|P1|COMPLETED|Overall Study||40
863058|NCT02387502|2089360|P3|STARTED|Overall Study||40
863059|NCT02387502|2089361|P2|STARTED|Overall Study||40
863060|NCT02387502|2089362|P1|STARTED|Overall Study||40
863061|NCT02384538|2089372|P2|NOT COMPLETED|Overall Study||15
863062|NCT02384538|2089373|P1|NOT COMPLETED|Overall Study||6
863063|NCT02384538|2089372|P2|COMPLETED|Overall Study||49
863064|NCT02384538|2089373|P1|COMPLETED|Overall Study||61
863065|NCT02384538|2089372|P2|STARTED|Overall Study||64
863066|NCT02384538|2089373|P1|STARTED|Overall Study||67
863067|NCT02384070|2089394|P3|NOT COMPLETED|Overall Study||0
863068|NCT02384070|2089395|P2|NOT COMPLETED|Overall Study||0
863069|NCT02384070|2089396|P1|NOT COMPLETED|Overall Study||0
863070|NCT02384070|2089394|P3|COMPLETED|Overall Study||100
863071|NCT02384070|2089395|P2|COMPLETED|Overall Study||100
863072|NCT02384070|2089396|P1|COMPLETED|Overall Study||100
863073|NCT02384070|2089394|P3|STARTED|Overall Study||100
863074|NCT02384070|2089395|P2|STARTED|Overall Study||100
863075|NCT02384070|2089396|P1|STARTED|Overall Study||100
863076|NCT02383862|2089412|P2|NOT COMPLETED|3 Month Follow up||21
863077|NCT02383862|2089413|P1|NOT COMPLETED|3 Month Follow up||23
863078|NCT02383862|2089412|P2|COMPLETED|3 Month Follow up||128
863079|NCT02383862|2089413|P1|COMPLETED|3 Month Follow up||128
863080|NCT02383862|2089412|P2|STARTED|3 Month Follow up||149
863081|NCT02383862|2089413|P1|STARTED|3 Month Follow up||151
863082|NCT02383862|2089412|P2|NOT COMPLETED|Baseline||0
863083|NCT02383862|2089413|P1|NOT COMPLETED|Baseline||0
863084|NCT02383862|2089412|P2|COMPLETED|Baseline||149
863085|NCT02383862|2089413|P1|COMPLETED|Baseline||151
863086|NCT02383862|2089412|P2|STARTED|Baseline||149
863087|NCT02383862|2089413|P1|STARTED|Baseline||151
863088|NCT02383719|2089444|P1|NOT COMPLETED|Overall Study||0
863089|NCT02383719|2089444|P1|COMPLETED|Overall Study||18
863090|NCT02383719|2089444|P1|STARTED|Overall Study||18
863091|NCT02383420|2089451|P3|NOT COMPLETED|Overall Study||0
863092|NCT02383420|2089452|P2|NOT COMPLETED|Overall Study||0
863093|NCT02383420|2089453|P1|NOT COMPLETED|Overall Study||2
863094|NCT02383420|2089451|P3|COMPLETED|Overall Study||3
863095|NCT02383420|2089452|P2|COMPLETED|Overall Study||10
863096|NCT02383420|2089453|P1|COMPLETED|Overall Study||8
863097|NCT02383420|2089451|P3|STARTED|Overall Study||3
863098|NCT02383420|2089452|P2|STARTED|Overall Study||10
863099|NCT02383420|2089453|P1|STARTED|Overall Study||10
863100|NCT02382913|2089471|P10|NOT COMPLETED|Overall Study||0
863101|NCT02382913|2089472|P9|NOT COMPLETED|Overall Study||0
863102|NCT02382913|2089473|P8|NOT COMPLETED|Overall Study||0
863103|NCT02382913|2089474|P7|NOT COMPLETED|Overall Study||0
863104|NCT02382913|2089475|P6|NOT COMPLETED|Overall Study||0
863105|NCT02382913|2089476|P5|NOT COMPLETED|Overall Study||0
863106|NCT02382913|2089477|P4|NOT COMPLETED|Overall Study||0
863107|NCT02382913|2089478|P3|NOT COMPLETED|Overall Study||0
863108|NCT02382913|2089479|P2|NOT COMPLETED|Overall Study||0
863109|NCT02382913|2089480|P1|NOT COMPLETED|Overall Study||0
863110|NCT02382913|2089471|P10|COMPLETED|Overall Study||33
863111|NCT02382913|2089472|P9|COMPLETED|Overall Study||30
863112|NCT02382913|2089473|P8|COMPLETED|Overall Study||30
863113|NCT02382913|2089474|P7|COMPLETED|Overall Study||37
863114|NCT02382913|2089475|P6|COMPLETED|Overall Study||30
863115|NCT02382913|2089476|P5|COMPLETED|Overall Study||33
863116|NCT02382913|2089477|P4|COMPLETED|Overall Study||27
863117|NCT02382913|2089478|P3|COMPLETED|Overall Study||32
863118|NCT02382913|2089479|P2|COMPLETED|Overall Study||36
863119|NCT02382913|2089480|P1|COMPLETED|Overall Study||27
863120|NCT02382913|2089471|P10|STARTED|Overall Study||33
863121|NCT02382913|2089472|P9|STARTED|Overall Study||30
863122|NCT02382913|2089473|P8|STARTED|Overall Study||30
863123|NCT02382913|2089474|P7|STARTED|Overall Study||37
863124|NCT02382913|2089475|P6|STARTED|Overall Study||30
863125|NCT02382913|2089476|P5|STARTED|Overall Study||33
863126|NCT02382913|2089477|P4|STARTED|Overall Study||27
863127|NCT02382913|2089478|P3|STARTED|Overall Study||32
863128|NCT02382913|2089479|P2|STARTED|Overall Study||36
863129|NCT02382913|2089480|P1|STARTED|Overall Study||27
863130|NCT02382640|2089520|P4|NOT COMPLETED|Intervention Period 4 (3 Days)||0
863131|NCT02382640|2089521|P3|NOT COMPLETED|Intervention Period 4 (3 Days)||0
863132|NCT02382640|2089522|P2|NOT COMPLETED|Intervention Period 4 (3 Days)||0
863133|NCT02382640|2089523|P1|NOT COMPLETED|Intervention Period 4 (3 Days)||1
863134|NCT02382640|2089520|P4|COMPLETED|Intervention Period 4 (3 Days)||9
863135|NCT02382640|2089521|P3|COMPLETED|Intervention Period 4 (3 Days)||9
863136|NCT02382640|2089522|P2|COMPLETED|Intervention Period 4 (3 Days)||9
863137|NCT02382640|2089523|P1|COMPLETED|Intervention Period 4 (3 Days)||8
863138|NCT02382640|2089520|P4|STARTED|Intervention Period 4 (3 Days)||9
863139|NCT02382640|2089521|P3|STARTED|Intervention Period 4 (3 Days)||9
863140|NCT02382640|2089522|P2|STARTED|Intervention Period 4 (3 Days)||9
863141|NCT02382640|2089523|P1|STARTED|Intervention Period 4 (3 Days)||9
863142|NCT02382640|2089520|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
863143|NCT02382640|2089521|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
863144|NCT02382640|2089522|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
863145|NCT02382640|2089523|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
863146|NCT02382640|2089520|P4|COMPLETED|Washout Period 3 (7 Days)||9
863147|NCT02382640|2089521|P3|COMPLETED|Washout Period 3 (7 Days)||9
863148|NCT02382640|2089522|P2|COMPLETED|Washout Period 3 (7 Days)||9
863149|NCT02382640|2089523|P1|COMPLETED|Washout Period 3 (7 Days)||9
863150|NCT02382640|2089520|P4|STARTED|Washout Period 3 (7 Days)||9
863151|NCT02382640|2089521|P3|STARTED|Washout Period 3 (7 Days)||9
863152|NCT02382640|2089522|P2|STARTED|Washout Period 3 (7 Days)||9
863153|NCT02382640|2089523|P1|STARTED|Washout Period 3 (7 Days)||9
863154|NCT02382640|2089520|P4|NOT COMPLETED|Intervention Period 3 (3 Days)||0
863155|NCT02382640|2089521|P3|NOT COMPLETED|Intervention Period 3 (3 Days)||0
863156|NCT02382640|2089522|P2|NOT COMPLETED|Intervention Period 3 (3 Days)||0
863157|NCT02382640|2089523|P1|NOT COMPLETED|Intervention Period 3 (3 Days)||0
863158|NCT02382640|2089520|P4|COMPLETED|Intervention Period 3 (3 Days)||9
863159|NCT02382640|2089521|P3|COMPLETED|Intervention Period 3 (3 Days)||9
863160|NCT02382640|2089522|P2|COMPLETED|Intervention Period 3 (3 Days)||9
863161|NCT02382640|2089523|P1|COMPLETED|Intervention Period 3 (3 Days)||9
863162|NCT02382640|2089520|P4|STARTED|Intervention Period 3 (3 Days)||9
863163|NCT02382640|2089521|P3|STARTED|Intervention Period 3 (3 Days)||9
863164|NCT02382640|2089522|P2|STARTED|Intervention Period 3 (3 Days)||9
863165|NCT02382640|2089523|P1|STARTED|Intervention Period 3 (3 Days)||9
863166|NCT02382640|2089520|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
863167|NCT02382640|2089521|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
863168|NCT02382640|2089522|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
863169|NCT02382640|2089523|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
863170|NCT02382640|2089520|P4|COMPLETED|Washout Period 2 (7 Days)||9
863171|NCT02382640|2089521|P3|COMPLETED|Washout Period 2 (7 Days)||9
863172|NCT02382640|2089522|P2|COMPLETED|Washout Period 2 (7 Days)||9
863173|NCT02382640|2089523|P1|COMPLETED|Washout Period 2 (7 Days)||9
863174|NCT02382640|2089520|P4|STARTED|Washout Period 2 (7 Days)||9
863175|NCT02382640|2089521|P3|STARTED|Washout Period 2 (7 Days)||9
863176|NCT02382640|2089522|P2|STARTED|Washout Period 2 (7 Days)||9
863177|NCT02382640|2089523|P1|STARTED|Washout Period 2 (7 Days)||9
863178|NCT02382640|2089520|P4|NOT COMPLETED|Intervention Period 2 (3 Days)||0
863179|NCT02382640|2089521|P3|NOT COMPLETED|Intervention Period 2 (3 Days)||0
863180|NCT02382640|2089522|P2|NOT COMPLETED|Intervention Period 2 (3 Days)||0
863181|NCT02382640|2089523|P1|NOT COMPLETED|Intervention Period 2 (3 Days)||0
863182|NCT02382640|2089520|P4|COMPLETED|Intervention Period 2 (3 Days)||9
863183|NCT02382640|2089521|P3|COMPLETED|Intervention Period 2 (3 Days)||9
863184|NCT02382640|2089522|P2|COMPLETED|Intervention Period 2 (3 Days)||9
863185|NCT02382640|2089523|P1|COMPLETED|Intervention Period 2 (3 Days)||9
863186|NCT02382640|2089520|P4|STARTED|Intervention Period 2 (3 Days)||9
863187|NCT02382640|2089521|P3|STARTED|Intervention Period 2 (3 Days)||9
863188|NCT02382640|2089522|P2|STARTED|Intervention Period 2 (3 Days)||9
863189|NCT02382640|2089523|P1|STARTED|Intervention Period 2 (3 Days)||9
863190|NCT02382640|2089520|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
863191|NCT02382640|2089521|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
863192|NCT02382640|2089522|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
863193|NCT02382640|2089523|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
863194|NCT02382640|2089520|P4|COMPLETED|Washout Period 1 (7 Days)||9
863195|NCT02382640|2089521|P3|COMPLETED|Washout Period 1 (7 Days)||9
863196|NCT02382640|2089522|P2|COMPLETED|Washout Period 1 (7 Days)||9
863197|NCT02382640|2089523|P1|COMPLETED|Washout Period 1 (7 Days)||9
863198|NCT02382640|2089520|P4|STARTED|Washout Period 1 (7 Days)||9
863199|NCT02382640|2089521|P3|STARTED|Washout Period 1 (7 Days)||9
863200|NCT02382640|2089522|P2|STARTED|Washout Period 1 (7 Days)||9
863201|NCT02382640|2089523|P1|STARTED|Washout Period 1 (7 Days)||9
863202|NCT02382640|2089520|P4|NOT COMPLETED|Intervention Period 1 (3 Days)||0
863203|NCT02382640|2089521|P3|NOT COMPLETED|Intervention Period 1 (3 Days)||0
863204|NCT02382640|2089522|P2|NOT COMPLETED|Intervention Period 1 (3 Days)||0
863205|NCT02382640|2089523|P1|NOT COMPLETED|Intervention Period 1 (3 Days)||0
863206|NCT02382640|2089520|P4|COMPLETED|Intervention Period 1 (3 Days)||9
863207|NCT02382640|2089521|P3|COMPLETED|Intervention Period 1 (3 Days)||9
863208|NCT02382640|2089522|P2|COMPLETED|Intervention Period 1 (3 Days)||9
863209|NCT02382640|2089523|P1|COMPLETED|Intervention Period 1 (3 Days)||9
863210|NCT02382640|2089520|P4|STARTED|Intervention Period 1 (3 Days)||9
863211|NCT02382640|2089521|P3|STARTED|Intervention Period 1 (3 Days)||9
863212|NCT02382640|2089522|P2|STARTED|Intervention Period 1 (3 Days)||9
863213|NCT02382640|2089523|P1|STARTED|Intervention Period 1 (3 Days)||9
863214|NCT02382133|2089561|P1|NOT COMPLETED|Overall Study||33
863215|NCT02382133|2089561|P1|COMPLETED|Overall Study||10
863216|NCT02382133|2089561|P1|STARTED|Overall Study||43
863217|NCT02381678|2089566|P3|NOT COMPLETED|Overall Study||0
863218|NCT02381678|2089567|P2|NOT COMPLETED|Overall Study||0
863219|NCT02381678|2089568|P1|NOT COMPLETED|Overall Study||0
863220|NCT02381678|2089566|P3|COMPLETED|Overall Study||32
863221|NCT02381678|2089567|P2|COMPLETED|Overall Study||139
863222|NCT02381678|2089568|P1|COMPLETED|Overall Study||54
863223|NCT02381678|2089566|P3|STARTED|Overall Study||32
863224|NCT02381678|2089567|P2|STARTED|Overall Study||139
863225|NCT02381678|2089568|P1|STARTED|Overall Study||54
863226|NCT02381418|2089574|P1|NOT COMPLETED|Overall Study||0
863227|NCT02381418|2089574|P1|COMPLETED|Overall Study||120
863228|NCT02381418|2089574|P1|STARTED|Overall Study||120
863229|NCT02381288|2089584|P4|NOT COMPLETED|Overall Study||0
863230|NCT02381288|2089585|P3|NOT COMPLETED|Overall Study||0
863231|NCT02381288|2089586|P2|NOT COMPLETED|Overall Study||0
863232|NCT02381288|2089587|P1|NOT COMPLETED|Overall Study||0
863233|NCT02381288|2089584|P4|COMPLETED|Overall Study||5
863234|NCT02381288|2089585|P3|COMPLETED|Overall Study||5
863235|NCT02381288|2089586|P2|COMPLETED|Overall Study||2
863236|NCT02381288|2089587|P1|COMPLETED|Overall Study||5
863237|NCT02381288|2089584|P4|STARTED|Overall Study||5
863238|NCT02381288|2089585|P3|STARTED|Overall Study||5
863239|NCT02381288|2089586|P2|STARTED|Overall Study||2
863240|NCT02381288|2089587|P1|STARTED|Overall Study||5
863241|NCT02380742|2089616|P2|NOT COMPLETED|Overall Study||0
863242|NCT02380742|2089617|P1|NOT COMPLETED|Overall Study||1
863243|NCT02380742|2089616|P2|COMPLETED|Overall Study||26
863244|NCT02380742|2089617|P1|COMPLETED|Overall Study||27
863245|NCT02380742|2089616|P2|STARTED|Overall Study||26
863246|NCT02380742|2089617|P1|STARTED|Overall Study||28
863247|NCT02380287|2089637|P8|NOT COMPLETED|Overall Study||0
863248|NCT02380287|2089638|P7|NOT COMPLETED|Overall Study||0
863249|NCT02380287|2089639|P6|NOT COMPLETED|Overall Study||0
863250|NCT02380287|2089640|P5|NOT COMPLETED|Overall Study||0
863251|NCT02380287|2089641|P4|NOT COMPLETED|Overall Study||0
863252|NCT02380287|2089642|P3|NOT COMPLETED|Overall Study||1
863253|NCT02380287|2089643|P2|NOT COMPLETED|Overall Study||0
863254|NCT02380287|2089644|P1|NOT COMPLETED|Overall Study||0
863255|NCT02380287|2089637|P8|COMPLETED|Overall Study||3
863256|NCT02380287|2089638|P7|COMPLETED|Overall Study||3
863257|NCT02380287|2089639|P6|COMPLETED|Overall Study||3
863258|NCT02380287|2089640|P5|COMPLETED|Overall Study||3
863259|NCT02380287|2089641|P4|COMPLETED|Overall Study||3
863260|NCT02380287|2089642|P3|COMPLETED|Overall Study||2
863261|NCT02380287|2089643|P2|COMPLETED|Overall Study||3
863262|NCT02380287|2089644|P1|COMPLETED|Overall Study||1
863263|NCT02380287|2089637|P8|STARTED|Overall Study||3
863264|NCT02380287|2089638|P7|STARTED|Overall Study||3
863265|NCT02380287|2089639|P6|STARTED|Overall Study||3
863266|NCT02380287|2089640|P5|STARTED|Overall Study||3
863267|NCT02380287|2089641|P4|STARTED|Overall Study||3
863268|NCT02380287|2089642|P3|STARTED|Overall Study||3
863269|NCT02380287|2089643|P2|STARTED|Overall Study||3
863270|NCT02380287|2089644|P1|STARTED|Overall Study||1
863271|NCT02380261|2089655|P1|NOT COMPLETED|Overall Study||0
863272|NCT02380261|2089655|P1|COMPLETED|Overall Study||35
863273|NCT02380261|2089655|P1|STARTED|Overall Study||35
863274|NCT02380248|2089660|P1|NOT COMPLETED|Overall Study||14
863275|NCT02380248|2089660|P1|COMPLETED|Overall Study||186
863276|NCT02380248|2089660|P1|STARTED|Overall Study||200
863277|NCT02379637|2089667|P2|NOT COMPLETED|Overall Study||1
863278|NCT02379637|2089668|P1|NOT COMPLETED|Overall Study||2
863279|NCT02379637|2089667|P2|COMPLETED|Overall Study||34
863280|NCT02379637|2089668|P1|COMPLETED|Overall Study||33
863281|NCT02379637|2089667|P2|STARTED|Overall Study||35
863282|NCT02379637|2089668|P1|STARTED|Overall Study||35
863283|NCT02378961|2089680|P4|NOT COMPLETED|Overall Study||1
863284|NCT02378961|2089681|P3|NOT COMPLETED|Overall Study||1
863285|NCT02378961|2089682|P2|NOT COMPLETED|Overall Study||2
863286|NCT02378961|2089683|P1|NOT COMPLETED|Overall Study||4
863287|NCT02378961|2089680|P4|COMPLETED|Overall Study||28
863288|NCT02378961|2089681|P3|COMPLETED|Overall Study||35
863289|NCT02378961|2089682|P2|COMPLETED|Overall Study||28
863290|NCT02378961|2089683|P1|COMPLETED|Overall Study||29
863291|NCT02378961|2089680|P4|STARTED|Overall Study||29
863292|NCT02378961|2089681|P3|STARTED|Overall Study||36
863293|NCT02378961|2089682|P2|STARTED|Overall Study||30
863294|NCT02378961|2089683|P1|STARTED|Overall Study||33
863295|NCT02378506|2089713|P1|NOT COMPLETED|Overall Study||25
863296|NCT02378506|2089713|P1|COMPLETED|Overall Study||163
863297|NCT02378506|2089713|P1|Treated|Overall Study||187
863298|NCT02378506|2089713|P1|STARTED|Overall Study||188
863299|NCT02376998|2089730|P1|NOT COMPLETED|Overall Study||9
863300|NCT02376998|2089730|P1|COMPLETED|Overall Study||11
863301|NCT02376998|2089730|P1|STARTED|Overall Study||20
863302|NCT02376530|2089738|P4|NOT COMPLETED|Overall Study||0
863303|NCT02376530|2089739|P3|NOT COMPLETED|Overall Study||0
863304|NCT02376530|2089740|P2|NOT COMPLETED|Overall Study||0
863305|NCT02376530|2089741|P1|NOT COMPLETED|Overall Study||0
863306|NCT02376530|2089738|P4|COMPLETED|Overall Study||197
863307|NCT02376530|2089739|P3|COMPLETED|Overall Study||197
863308|NCT02376530|2089740|P2|COMPLETED|Overall Study||198
863309|NCT02376530|2089741|P1|COMPLETED|Overall Study||196
863310|NCT02376530|2089738|P4|STARTED|Overall Study||197
863311|NCT02376530|2089739|P3|STARTED|Overall Study||197
863312|NCT02376530|2089740|P2|STARTED|Overall Study||198
863313|NCT02376530|2089741|P1|STARTED|Overall Study||196
863314|NCT02375724|2089753|P2|NOT COMPLETED|Overall Study||6
863315|NCT02375724|2089754|P1|NOT COMPLETED|Overall Study||6
863316|NCT02375724|2089753|P2|COMPLETED|Overall Study||128
863317|NCT02375724|2089754|P1|COMPLETED|Overall Study||129
863318|NCT02375724|2089753|P2|STARTED|Overall Study||134
863319|NCT02375724|2089754|P1|STARTED|Overall Study||135
863320|NCT02375373|2089764|P1|NOT COMPLETED|Overall Study||11
863321|NCT02375373|2089764|P1|COMPLETED|Overall Study||1
863322|NCT02375373|2089764|P1|STARTED|Overall Study||12
863323|NCT02375347|2089768|P1|NOT COMPLETED|Overall Study||1
863324|NCT02375347|2089768|P1|COMPLETED|Overall Study||12
863325|NCT02375347|2089768|P1|STARTED|Overall Study||13
863332|NCT02374398|2089789|P4|NOT COMPLETED|Overall Study||0
863333|NCT02374398|2089790|P3|NOT COMPLETED|Overall Study||3
863334|NCT02374398|2089791|P2|NOT COMPLETED|Overall Study||1
863335|NCT02374398|2089792|P1|NOT COMPLETED|Overall Study||2
863336|NCT02374398|2089789|P4|COMPLETED|Overall Study||32
863337|NCT02374398|2089790|P3|COMPLETED|Overall Study||29
863338|NCT02374398|2089791|P2|COMPLETED|Overall Study||31
863339|NCT02374398|2089792|P1|COMPLETED|Overall Study||29
863340|NCT02374398|2089789|P4|STARTED|Overall Study||32
863341|NCT02374398|2089790|P3|STARTED|Overall Study||32
863342|NCT02374398|2089791|P2|STARTED|Overall Study||32
863343|NCT02374398|2089792|P1|STARTED|Overall Study||31
863344|NCT02374346|2089818|P1|NOT COMPLETED|Overall Study||48
863345|NCT02374346|2089818|P1|COMPLETED|Overall Study||446
863346|NCT02374346|2089818|P1|STARTED|Overall Study||494
863347|NCT02374164|2089827|P3|NOT COMPLETED|Treatment Period 3||0
863348|NCT02374164|2089828|P2|NOT COMPLETED|Treatment Period 3||0
863349|NCT02374164|2089829|P1|NOT COMPLETED|Treatment Period 3||0
863350|NCT02374164|2089827|P3|COMPLETED|Treatment Period 3||12
863351|NCT02374164|2089828|P2|COMPLETED|Treatment Period 3||11
863352|NCT02374164|2089829|P1|COMPLETED|Treatment Period 3||12
863353|NCT02374164|2089827|P3|STARTED|Treatment Period 3||12
863354|NCT02374164|2089828|P2|STARTED|Treatment Period 3|One participant was Lost-to-Follow-Up prior to treatment A.|11
863355|NCT02374164|2089829|P1|STARTED|Treatment Period 3||12
863356|NCT02374164|2089827|P3|NOT COMPLETED|Treatment Period 2||0
863357|NCT02374164|2089828|P2|NOT COMPLETED|Treatment Period 2||0
863358|NCT02374164|2089829|P1|NOT COMPLETED|Treatment Period 2||0
863359|NCT02374164|2089827|P3|COMPLETED|Treatment Period 2||12
863360|NCT02374164|2089828|P2|COMPLETED|Treatment Period 2||12
863361|NCT02374164|2089829|P1|COMPLETED|Treatment Period 2||12
863362|NCT02374164|2089827|P3|STARTED|Treatment Period 2||12
863363|NCT02374164|2089828|P2|STARTED|Treatment Period 2||12
863364|NCT02374164|2089829|P1|STARTED|Treatment Period 2||12
863365|NCT02374164|2089827|P3|NOT COMPLETED|Treatment Period 1||0
863366|NCT02374164|2089828|P2|NOT COMPLETED|Treatment Period 1||0
863367|NCT02374164|2089829|P1|NOT COMPLETED|Treatment Period 1||0
863368|NCT02374164|2089827|P3|COMPLETED|Treatment Period 1||12
863369|NCT02374164|2089828|P2|COMPLETED|Treatment Period 1||12
863370|NCT02374164|2089829|P1|COMPLETED|Treatment Period 1||12
863371|NCT02374164|2089827|P3|STARTED|Treatment Period 1||12
863372|NCT02374164|2089828|P2|STARTED|Treatment Period 1||12
863373|NCT02374164|2089829|P1|STARTED|Treatment Period 1||12
863374|NCT02372344|2089846|P3|NOT COMPLETED|Period 3 (Visit 4)||0
863375|NCT02372344|2089847|P2|NOT COMPLETED|Period 3 (Visit 4)||0
863376|NCT02372344|2089848|P1|NOT COMPLETED|Period 3 (Visit 4)||0
863377|NCT02372344|2089846|P3|COMPLETED|Period 3 (Visit 4)||14
863378|NCT02372344|2089847|P2|COMPLETED|Period 3 (Visit 4)||14
863379|NCT02372344|2089848|P1|COMPLETED|Period 3 (Visit 4)||14
863380|NCT02372344|2089846|P3|STARTED|Period 3 (Visit 4)||14
863381|NCT02372344|2089847|P2|STARTED|Period 3 (Visit 4)||14
863382|NCT02372344|2089848|P1|STARTED|Period 3 (Visit 4)||14
863383|NCT02372344|2089846|P3|NOT COMPLETED|Period 2 (Visit 3)||0
863384|NCT02372344|2089847|P2|NOT COMPLETED|Period 2 (Visit 3)||0
863385|NCT02372344|2089848|P1|NOT COMPLETED|Period 2 (Visit 3)||0
863386|NCT02372344|2089846|P3|COMPLETED|Period 2 (Visit 3)||14
863387|NCT02372344|2089847|P2|COMPLETED|Period 2 (Visit 3)||14
863388|NCT02372344|2089848|P1|COMPLETED|Period 2 (Visit 3)||14
863389|NCT02372344|2089846|P3|STARTED|Period 2 (Visit 3)||14
863390|NCT02372344|2089847|P2|STARTED|Period 2 (Visit 3)||14
863391|NCT02372344|2089848|P1|STARTED|Period 2 (Visit 3)||14
863392|NCT02372344|2089846|P3|NOT COMPLETED|Period 1 (Visit 2)||0
863393|NCT02372344|2089847|P2|NOT COMPLETED|Period 1 (Visit 2)||0
863394|NCT02372344|2089848|P1|NOT COMPLETED|Period 1 (Visit 2)||0
863395|NCT02372344|2089846|P3|COMPLETED|Period 1 (Visit 2)||14
863396|NCT02372344|2089847|P2|COMPLETED|Period 1 (Visit 2)||14
863397|NCT02372344|2089848|P1|COMPLETED|Period 1 (Visit 2)||14
863398|NCT02372344|2089846|P3|STARTED|Period 1 (Visit 2)||14
863399|NCT02372344|2089847|P2|STARTED|Period 1 (Visit 2)||14
863400|NCT02372344|2089848|P1|STARTED|Period 1 (Visit 2)||14
863401|NCT02372097|2089864|P2|NOT COMPLETED|Second Intervention Period (8 Days)||0
863402|NCT02372097|2089865|P1|NOT COMPLETED|Second Intervention Period (8 Days)||0
863403|NCT02372097|2089864|P2|COMPLETED|Second Intervention Period (8 Days)||12
863404|NCT02372097|2089865|P1|COMPLETED|Second Intervention Period (8 Days)||12
863405|NCT02372097|2089864|P2|STARTED|Second Intervention Period (8 Days)||12
863406|NCT02372097|2089865|P1|STARTED|Second Intervention Period (8 Days)||12
863407|NCT02372097|2089864|P2|NOT COMPLETED|Wash Out Period (13 Days)||0
863408|NCT02372097|2089865|P1|NOT COMPLETED|Wash Out Period (13 Days)||0
863409|NCT02372097|2089864|P2|COMPLETED|Wash Out Period (13 Days)||12
863410|NCT02372097|2089865|P1|COMPLETED|Wash Out Period (13 Days)||12
863411|NCT02372097|2089864|P2|STARTED|Wash Out Period (13 Days)||12
863412|NCT02372097|2089865|P1|STARTED|Wash Out Period (13 Days)||12
863413|NCT02372097|2089864|P2|NOT COMPLETED|First Intervention Period (8 Days)||0
863414|NCT02372097|2089865|P1|NOT COMPLETED|First Intervention Period (8 Days)||0
863415|NCT02372097|2089864|P2|COMPLETED|First Intervention Period (8 Days)||12
863416|NCT02372097|2089865|P1|COMPLETED|First Intervention Period (8 Days)||12
863417|NCT02372097|2089864|P2|STARTED|First Intervention Period (8 Days)||12
863418|NCT02372097|2089865|P1|STARTED|First Intervention Period (8 Days)||12
863419|NCT02372071|2089891|P1|NOT COMPLETED|Overall Study||18
863420|NCT02372071|2089891|P1|COMPLETED|Overall Study||93
863421|NCT02372071|2089891|P1|STARTED|Overall Study||111
863422|NCT02372058|2089896|P1|NOT COMPLETED|Overall Study||3
863423|NCT02372058|2089896|P1|COMPLETED|Overall Study||100
863424|NCT02372058|2089896|P1|STARTED|Overall Study||103
863425|NCT02371876|2089902|P1|NOT COMPLETED|Overall Study||0
863426|NCT02371876|2089902|P1|COMPLETED|Overall Study||134
863427|NCT02371876|2089902|P1|STARTED|Overall Study||134
863428|NCT02371850|2089912|P1|NOT COMPLETED|Overall Study||0
863429|NCT02371850|2089912|P1|COMPLETED|Overall Study||10
863430|NCT02371850|2089912|P1|STARTED|Overall Study||10
863431|NCT02371759|2089925|P8|NOT COMPLETED|Overall Study||4
863432|NCT02371759|2089926|P7|NOT COMPLETED|Overall Study||0
863433|NCT02371759|2089927|P6|NOT COMPLETED|Overall Study||1
863434|NCT02371759|2089928|P5|NOT COMPLETED|Overall Study||3
863435|NCT02371759|2089929|P4|NOT COMPLETED|Overall Study||0
863436|NCT02371759|2089930|P3|NOT COMPLETED|Overall Study||1
863437|NCT02371759|2089931|P2|NOT COMPLETED|Overall Study||1
863438|NCT02371759|2089932|P1|NOT COMPLETED|Overall Study||3
863439|NCT02371759|2089925|P8|COMPLETED|Overall Study||24
863440|NCT02371759|2089926|P7|COMPLETED|Overall Study||25
863441|NCT02371759|2089927|P6|COMPLETED|Overall Study||25
863442|NCT02371759|2089928|P5|COMPLETED|Overall Study||24
863443|NCT02371759|2089929|P4|COMPLETED|Overall Study||31
863444|NCT02371759|2089930|P3|COMPLETED|Overall Study||32
863445|NCT02371759|2089931|P2|COMPLETED|Overall Study||30
863446|NCT02371759|2089932|P1|COMPLETED|Overall Study||29
863447|NCT02371759|2089925|P8|STARTED|Overall Study||28
863448|NCT02371759|2089926|P7|STARTED|Overall Study||25
863449|NCT02371759|2089927|P6|STARTED|Overall Study||26
863450|NCT02371759|2089928|P5|STARTED|Overall Study||27
863451|NCT02371759|2089929|P4|STARTED|Overall Study||31
863452|NCT02371759|2089930|P3|STARTED|Overall Study||33
863453|NCT02371759|2089931|P2|STARTED|Overall Study||31
863454|NCT02371759|2089932|P1|STARTED|Overall Study||32
863455|NCT02370914|2090142|P1|NOT COMPLETED|Overall Study||2
863456|NCT02370914|2090142|P1|COMPLETED|Overall Study||82
863457|NCT02370914|2090142|P1|STARTED|Overall Study||84
863458|NCT02370667|2090149|P3|NOT COMPLETED|Overall Study||0
863459|NCT02370667|2090150|P2|NOT COMPLETED|Overall Study||1
863460|NCT02370667|2090151|P1|NOT COMPLETED|Overall Study||0
863461|NCT02370667|2090149|P3|COMPLETED|Overall Study||10
863462|NCT02370667|2090150|P2|COMPLETED|Overall Study||10
863463|NCT02370667|2090151|P1|COMPLETED|Overall Study||10
863464|NCT02370667|2090149|P3|STARTED|Overall Study||10
863465|NCT02370667|2090150|P2|STARTED|Overall Study||11
863466|NCT02370667|2090151|P1|STARTED|Overall Study||10
863467|NCT02370615|2090215|P2|NOT COMPLETED|Overall Study||0
863468|NCT02370615|2090216|P1|NOT COMPLETED|Overall Study||1
863469|NCT02370615|2090215|P2|COMPLETED|Overall Study||18
863470|NCT02370615|2090216|P1|COMPLETED|Overall Study||15
863471|NCT02370615|2090215|P2|STARTED|Overall Study||18
863472|NCT02370615|2090216|P1|STARTED|Overall Study||16
863473|NCT02370602|2090259|P6|NOT COMPLETED|Overall Study||0
863474|NCT02370602|2090260|P5|NOT COMPLETED|Overall Study||0
863475|NCT02370602|2090261|P4|NOT COMPLETED|Overall Study||0
863476|NCT02370602|2090262|P3|NOT COMPLETED|Overall Study||0
863477|NCT02370602|2090263|P2|NOT COMPLETED|Overall Study||0
863478|NCT02370602|2090264|P1|NOT COMPLETED|Overall Study||1
863479|NCT02370602|2090259|P6|COMPLETED|Overall Study||2
863480|NCT02370602|2090260|P5|COMPLETED|Overall Study||3
863481|NCT02370602|2090261|P4|COMPLETED|Overall Study||3
863482|NCT02370602|2090262|P3|COMPLETED|Overall Study||2
863483|NCT02370602|2090263|P2|COMPLETED|Overall Study||2
863484|NCT02370602|2090264|P1|COMPLETED|Overall Study||0
863485|NCT02370602|2090259|P6|STARTED|Overall Study||2
863486|NCT02370602|2090260|P5|STARTED|Overall Study||3
863487|NCT02370602|2090261|P4|STARTED|Overall Study||3
863488|NCT02370602|2090262|P3|STARTED|Overall Study||2
863489|NCT02370602|2090263|P2|STARTED|Overall Study||2
863490|NCT02370602|2090264|P1|STARTED|Overall Study||1
863491|NCT02370537|2090358|P3|NOT COMPLETED|Part B||259
863492|NCT02370537|2090359|P2|NOT COMPLETED|Part B||3
863493|NCT02370537|2090360|P1|NOT COMPLETED|Part B||1
863494|NCT02370537|2090358|P3|COMPLETED|Part B||23
863495|NCT02370537|2090359|P2|COMPLETED|Part B||12
863496|NCT02370537|2090360|P1|COMPLETED|Part B||15
863497|NCT02370537|2090358|P3|Period 2 Sequence BA|Part B||12
863498|NCT02370537|2090359|P2|Period 2 Sequence BA|Part B||7
863499|NCT02370537|2090360|P1|Period 2 Sequence BA|Part B||7
863500|NCT02370537|2090358|P3|Period 2 Sequence AB|Part B||11
863501|NCT02370537|2090359|P2|Period 2 Sequence AB|Part B||5
863502|NCT02370537|2090360|P1|Period 2 Sequence AB|Part B||8
863503|NCT02370537|2090358|P3|Period 1 Sequence BA|Part B||12
863504|NCT02370537|2090359|P2|Period 1 Sequence BA|Part B||7
863505|NCT02370537|2090360|P1|Period 1 Sequence BA|Part B||7
863506|NCT02370537|2090358|P3|Period 1 Sequence AB|Part B||11
863507|NCT02370537|2090359|P2|Period 1 Sequence AB|Part B||6
863508|NCT02370537|2090360|P1|Period 1 Sequence AB|Part B||8
863509|NCT02370537|2090358|P3|Eligible for Randomisation|Part B||23
863510|NCT02370537|2090359|P2|Eligible for Randomisation|Part B||13
863511|NCT02370537|2090360|P1|Eligible for Randomisation|Part B||15
863512|NCT02370537|2090358|P3|STARTED|Part B||282
863513|NCT02370537|2090359|P2|STARTED|Part B||15
863514|NCT02370537|2090360|P1|STARTED|Part B||16
863515|NCT02370537|2090358|P3|NOT COMPLETED|Part A (Open-label Recruitment)||1
863516|NCT02370537|2090359|P2|NOT COMPLETED|Part A (Open-label Recruitment)||1
863517|NCT02370537|2090360|P1|NOT COMPLETED|Part A (Open-label Recruitment)||0
863518|NCT02370537|2090358|P3|COMPLETED|Part A (Open-label Recruitment)||282
863519|NCT02370537|2090359|P2|COMPLETED|Part A (Open-label Recruitment)||15
863520|NCT02370537|2090360|P1|COMPLETED|Part A (Open-label Recruitment)||16
863521|NCT02370537|2090358|P3|STARTED|Part A (Open-label Recruitment)||283
863522|NCT02370537|2090359|P2|STARTED|Part A (Open-label Recruitment)||16
863523|NCT02370537|2090360|P1|STARTED|Part A (Open-label Recruitment)||16
863524|NCT02370407|2090409|P2|NOT COMPLETED|Overall Study||0
863525|NCT02370407|2090410|P1|NOT COMPLETED|Overall Study||0
863526|NCT02370407|2090409|P2|COMPLETED|Overall Study||20
863527|NCT02370407|2090410|P1|COMPLETED|Overall Study||20
863528|NCT02370407|2090409|P2|STARTED|Overall Study||20
863529|NCT02370407|2090410|P1|STARTED|Overall Study||20
863530|NCT02370121|2090434|P2|NOT COMPLETED|Overall Study||1
863531|NCT02370121|2090435|P1|NOT COMPLETED|Overall Study||1
863532|NCT02370121|2090434|P2|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
863533|NCT02370121|2090435|P1|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
863534|NCT02370121|2090434|P2|STARTED|Overall Study||12
863535|NCT02370121|2090435|P1|STARTED|Overall Study||12
863536|NCT02369796|2090478|P5|NOT COMPLETED|Overall Study||0
863537|NCT02369796|2090479|P4|NOT COMPLETED|Overall Study||0
863538|NCT02369796|2090480|P3|NOT COMPLETED|Overall Study||0
863539|NCT02369796|2090481|P2|NOT COMPLETED|Overall Study||0
863540|NCT02369796|2090482|P1|NOT COMPLETED|Overall Study||0
863541|NCT02369796|2090478|P5|COMPLETED|Overall Study||3
863542|NCT02369796|2090479|P4|COMPLETED|Overall Study||3
863543|NCT02369796|2090480|P3|COMPLETED|Overall Study||3
863544|NCT02369796|2090481|P2|COMPLETED|Overall Study||3
863545|NCT02369796|2090482|P1|COMPLETED|Overall Study||3
863546|NCT02369796|2090478|P5|STARTED|Overall Study||3
863547|NCT02369796|2090479|P4|STARTED|Overall Study||3
863548|NCT02369796|2090480|P3|STARTED|Overall Study||3
863549|NCT02369796|2090481|P2|STARTED|Overall Study||3
863550|NCT02369796|2090482|P1|STARTED|Overall Study||3
863551|NCT02369510|2090524|P3|NOT COMPLETED|Overall Study||6
863552|NCT02369510|2090525|P2|NOT COMPLETED|Overall Study||3
863553|NCT02369510|2090526|P1|NOT COMPLETED|Overall Study||2
863554|NCT02369510|2090524|P3|COMPLETED|Overall Study||17
863555|NCT02369510|2090525|P2|COMPLETED|Overall Study||19
863556|NCT02369510|2090526|P1|COMPLETED|Overall Study||21
863557|NCT02369510|2090524|P3|STARTED|Overall Study||23
863558|NCT02369510|2090525|P2|STARTED|Overall Study||22
863559|NCT02369510|2090526|P1|STARTED|Overall Study||23
863566|NCT02368457|2090614|P2|NOT COMPLETED|Overall Study||0
863567|NCT02368457|2090615|P1|NOT COMPLETED|Overall Study||0
863568|NCT02368457|2090614|P2|COMPLETED|Overall Study||12
863569|NCT02368457|2090615|P1|COMPLETED|Overall Study||12
863570|NCT02368457|2090614|P2|STARTED|Overall Study||12
863571|NCT02368457|2090615|P1|STARTED|Overall Study||12
863572|NCT02368314|2090625|P2|NOT COMPLETED|Overall Study||3
863573|NCT02368314|2090626|P1|NOT COMPLETED|Overall Study||3
863574|NCT02368314|2090625|P2|COMPLETED|Overall Study||57
863575|NCT02368314|2090626|P1|COMPLETED|Overall Study||61
863576|NCT02368314|2090625|P2|STARTED|Overall Study||60
863577|NCT02368314|2090626|P1|STARTED|Overall Study||64
863578|NCT02368093|2090638|P2|NOT COMPLETED|Overall Study||0
863579|NCT02368093|2090639|P1|NOT COMPLETED|Overall Study||0
863580|NCT02368093|2090638|P2|COMPLETED|Overall Study||24
863581|NCT02368093|2090639|P1|COMPLETED|Overall Study||24
863582|NCT02368093|2090638|P2|STARTED|Overall Study||24
863583|NCT02368093|2090639|P1|STARTED|Overall Study||24
863584|NCT02367885|2090648|P3|NOT COMPLETED|Overall Study||0
863585|NCT02367885|2090649|P2|NOT COMPLETED|Overall Study||0
863586|NCT02367885|2090650|P1|NOT COMPLETED|Overall Study||2
863587|NCT02367885|2090648|P3|COMPLETED|Overall Study||33
863588|NCT02367885|2090649|P2|COMPLETED|Overall Study||33
863589|NCT02367885|2090650|P1|COMPLETED|Overall Study||31
863590|NCT02367885|2090648|P3|STARTED|Overall Study||33
863591|NCT02367885|2090649|P2|STARTED|Overall Study||33
863592|NCT02367885|2090650|P1|STARTED|Overall Study||33
863593|NCT02367872|2090723|P8|NOT COMPLETED|Overall Study||0
863594|NCT02367872|2090724|P7|NOT COMPLETED|Overall Study||0
863595|NCT02367872|2090725|P6|NOT COMPLETED|Overall Study||0
863596|NCT02367872|2090726|P5|NOT COMPLETED|Overall Study||0
863597|NCT02367872|2090727|P4|NOT COMPLETED|Overall Study||0
863598|NCT02367872|2090728|P3|NOT COMPLETED|Overall Study||0
863599|NCT02367872|2090729|P2|NOT COMPLETED|Overall Study||0
863600|NCT02367872|2090730|P1|NOT COMPLETED|Overall Study||0
863601|NCT02367872|2090723|P8|COMPLETED|Overall Study||6
863602|NCT02367872|2090724|P7|COMPLETED|Overall Study||6
863603|NCT02367872|2090725|P6|COMPLETED|Overall Study||6
863604|NCT02367872|2090726|P5|COMPLETED|Overall Study||6
863605|NCT02367872|2090727|P4|COMPLETED|Overall Study||6
863606|NCT02367872|2090728|P3|COMPLETED|Overall Study||6
863607|NCT02367872|2090729|P2|COMPLETED|Overall Study||6
863608|NCT02367872|2090730|P1|COMPLETED|Overall Study||6
863609|NCT02367872|2090723|P8|STARTED|Overall Study||6
863610|NCT02367872|2090724|P7|STARTED|Overall Study||6
863611|NCT02367872|2090725|P6|STARTED|Overall Study||6
863612|NCT02367872|2090726|P5|STARTED|Overall Study||6
863613|NCT02367872|2090727|P4|STARTED|Overall Study||6
863614|NCT02367872|2090728|P3|STARTED|Overall Study||6
863615|NCT02367872|2090729|P2|STARTED|Overall Study||6
863616|NCT02367872|2090730|P1|STARTED|Overall Study||6
863617|NCT02367391|2090885|P2|NOT COMPLETED|Overall Study||0
863618|NCT02367391|2090886|P1|NOT COMPLETED|Overall Study||2
863619|NCT02367391|2090885|P2|COMPLETED|Overall Study||76
863620|NCT02367391|2090886|P1|COMPLETED|Overall Study||74
863621|NCT02367391|2090885|P2|STARTED|Overall Study||76
863622|NCT02367391|2090886|P1|STARTED|Overall Study||76
863623|NCT02367170|2090906|P2|NOT COMPLETED|Overall Study||0
863624|NCT02367170|2090907|P1|NOT COMPLETED|Overall Study||0
863625|NCT02367170|2090906|P2|COMPLETED|Overall Study||0
863626|NCT02367170|2090907|P1|COMPLETED|Overall Study||1
863627|NCT02367170|2090906|P2|STARTED|Overall Study||0
863628|NCT02367170|2090907|P1|STARTED|Overall Study||1
863629|NCT02367066|2090919|P2|NOT COMPLETED|Overall Study||0
863630|NCT02367066|2090920|P1|NOT COMPLETED|Overall Study||0
863631|NCT02367066|2090919|P2|COMPLETED|Overall Study||10
863632|NCT02367066|2090920|P1|COMPLETED|Overall Study||10
863633|NCT02367066|2090919|P2|STARTED|Overall Study||10
863634|NCT02367066|2090920|P1|STARTED|Overall Study||10
863635|NCT02366936|2090978|P1|NOT COMPLETED|Overall Study||8
863636|NCT02366936|2090978|P1|COMPLETED|Overall Study||24
863637|NCT02366936|2090978|P1|STARTED|Overall Study||32
863638|NCT02366923|2090983|P1|NOT COMPLETED|Overall Study||6
863639|NCT02366923|2090983|P1|COMPLETED|Overall Study||22
863640|NCT02366923|2090983|P1|STARTED|Overall Study||28
863641|NCT02366910|2090996|P1|NOT COMPLETED|Overall Study||5
863642|NCT02366910|2090996|P1|COMPLETED|Overall Study||21
863643|NCT02366910|2090996|P1|STARTED|Overall Study||26
863644|NCT02366767|2091010|P2|NOT COMPLETED|Overall Study||0
863645|NCT02366767|2091011|P1|NOT COMPLETED|Overall Study||1
863646|NCT02366767|2091010|P2|COMPLETED|Overall Study||10
863647|NCT02366767|2091011|P1|COMPLETED|Overall Study||10
863648|NCT02366767|2091010|P2|STARTED|Overall Study||10
863649|NCT02366767|2091011|P1|STARTED|Overall Study||11
863650|NCT02366689|2091024|P3|NOT COMPLETED|Overall Study||2
863651|NCT02366689|2091025|P2|NOT COMPLETED|Overall Study||3
863652|NCT02366689|2091026|P1|NOT COMPLETED|Overall Study||4
863653|NCT02366689|2091024|P3|COMPLETED|Overall Study||59
863654|NCT02366689|2091025|P2|COMPLETED|Overall Study||55
863655|NCT02366689|2091026|P1|COMPLETED|Overall Study||56
863656|NCT02366689|2091024|P3|STARTED|Overall Study||61
863657|NCT02366689|2091025|P2|STARTED|Overall Study||58
863658|NCT02366689|2091026|P1|STARTED|Overall Study||60
863659|NCT02366637|2091049|P2|NOT COMPLETED|Second Intervention Period||1
863660|NCT02366637|2091050|P1|NOT COMPLETED|Second Intervention Period||1
863661|NCT02366637|2091049|P2|COMPLETED|Second Intervention Period||0
863662|NCT02366637|2091050|P1|COMPLETED|Second Intervention Period||0
863663|NCT02366637|2091049|P2|STARTED|Second Intervention Period||1
863664|NCT02366637|2091050|P1|STARTED|Second Intervention Period||1
863665|NCT02366637|2091049|P2|NOT COMPLETED|Washout Period 28 to 49 Days||0
863666|NCT02366637|2091050|P1|NOT COMPLETED|Washout Period 28 to 49 Days||0
863667|NCT02366637|2091049|P2|COMPLETED|Washout Period 28 to 49 Days||1
863668|NCT02366637|2091050|P1|COMPLETED|Washout Period 28 to 49 Days||1
863669|NCT02366637|2091049|P2|STARTED|Washout Period 28 to 49 Days||1
863670|NCT02366637|2091050|P1|STARTED|Washout Period 28 to 49 Days||1
863671|NCT02366637|2091049|P2|NOT COMPLETED|First Intervention Period||5
863672|NCT02366637|2091050|P1|NOT COMPLETED|First Intervention Period||6
863673|NCT02366637|2091049|P2|COMPLETED|First Intervention Period||1
863674|NCT02366637|2091050|P1|COMPLETED|First Intervention Period||1
863675|NCT02366637|2091049|P2|STARTED|First Intervention Period||6
863676|NCT02366637|2091050|P1|STARTED|First Intervention Period||7
863677|NCT02366338|2091077|P3|NOT COMPLETED|Overall Study||0
863678|NCT02366338|2091078|P2|NOT COMPLETED|Overall Study||0
863679|NCT02366338|2091079|P1|NOT COMPLETED|Overall Study||0
863680|NCT02366338|2091077|P3|COMPLETED|Overall Study||36
863681|NCT02366338|2091078|P2|COMPLETED|Overall Study||39
863682|NCT02366338|2091079|P1|COMPLETED|Overall Study||73
863683|NCT02366338|2091077|P3|STARTED|Overall Study||36
863684|NCT02366338|2091078|P2|STARTED|Overall Study||39
863685|NCT02366338|2091079|P1|STARTED|Overall Study||73
863686|NCT02365688|2091087|P1|NOT COMPLETED|Overall Study||0
863687|NCT02365688|2091087|P1|COMPLETED|Overall Study|All subjects consented to an change in standard infusion volume pre-incision|18
863688|NCT02365688|2091087|P1|STARTED|Overall Study|All subjects received a bolus of 500cc before first incision|18
863689|NCT02365298|2091091|P2|NOT COMPLETED|Period 2||2
863690|NCT02365298|2091092|P1|NOT COMPLETED|Period 2||2
863691|NCT02365298|2091091|P2|COMPLETED|Period 2||12
863692|NCT02365298|2091092|P1|COMPLETED|Period 2||12
863693|NCT02365298|2091091|P2|STARTED|Period 2||14
863694|NCT02365298|2091092|P1|STARTED|Period 2||14
863695|NCT02365298|2091091|P2|NOT COMPLETED|Period 1||0
863696|NCT02365298|2091092|P1|NOT COMPLETED|Period 1||0
863697|NCT02365298|2091091|P2|COMPLETED|Period 1||14
863698|NCT02365298|2091092|P1|COMPLETED|Period 1||14
863699|NCT02365298|2091091|P2|STARTED|Period 1||14
863700|NCT02365298|2091092|P1|STARTED|Period 1||14
863701|NCT02364778|2091110|P1|NOT COMPLETED|Overall Study||0
863702|NCT02364778|2091110|P1|COMPLETED|Overall Study||30
863703|NCT02364778|2091110|P1|STARTED|Overall Study||30
863704|NCT02364700|2091122|P1|NOT COMPLETED|Overall Study||0
863705|NCT02364700|2091122|P1|COMPLETED|Overall Study||12
863706|NCT02364700|2091122|P1|STARTED|Overall Study||12
863707|NCT02364180|2091131|P1|NOT COMPLETED|Overall Study||1
863708|NCT02364180|2091131|P1|COMPLETED|Overall Study||10
863709|NCT02364180|2091131|P1|STARTED|Overall Study||11
863710|NCT02363907|2091135|P1|NOT COMPLETED|Overall Study||0
863711|NCT02363907|2091135|P1|COMPLETED|Overall Study||30
863712|NCT02363907|2091135|P1|STARTED|Overall Study||30
863713|NCT02363478|2091139|P1|NOT COMPLETED|Overall Study||8
863714|NCT02363478|2091139|P1|COMPLETED|Overall Study||22
863715|NCT02363478|2091139|P1|STARTED|Overall Study||30
863716|NCT02363270|2091148|P2|NOT COMPLETED|Overall Study||0
863717|NCT02363270|2091149|P1|NOT COMPLETED|Overall Study||0
863718|NCT02363270|2091148|P2|COMPLETED|Overall Study||24
863719|NCT02363270|2091149|P1|COMPLETED|Overall Study||24
863720|NCT02363270|2091148|P2|STARTED|Overall Study||24
863721|NCT02363270|2091149|P1|STARTED|Overall Study||24
863722|NCT02362412|2091155|P2|NOT COMPLETED|Treatment Period III||1
863723|NCT02362412|2091156|P1|NOT COMPLETED|Treatment Period III||0
863724|NCT02362412|2091155|P2|COMPLETED|Treatment Period III||10
863725|NCT02362412|2091156|P1|COMPLETED|Treatment Period III||9
863726|NCT02362412|2091155|P2|TREATED|Treatment Period III||11
863727|NCT02362412|2091156|P1|TREATED|Treatment Period III||9
863728|NCT02362412|2091155|P2|STARTED|Treatment Period III||11
863729|NCT02362412|2091156|P1|STARTED|Treatment Period III||9
863730|NCT02362412|2091155|P2|NOT COMPLETED|Treatment Period II||0
863731|NCT02362412|2091156|P1|NOT COMPLETED|Treatment Period II||0
863732|NCT02362412|2091155|P2|COMPLETED|Treatment Period II||11
863733|NCT02362412|2091156|P1|COMPLETED|Treatment Period II||9
863734|NCT02362412|2091155|P2|TREATED|Treatment Period II||11
863735|NCT02362412|2091156|P1|TREATED|Treatment Period II||9
863736|NCT02362412|2091155|P2|STARTED|Treatment Period II||11
863737|NCT02362412|2091156|P1|STARTED|Treatment Period II||9
863738|NCT02362373|2091182|P1|NOT COMPLETED|Overall Study||0
863739|NCT02362373|2091182|P1|COMPLETED|Overall Study||20
863740|NCT02362373|2091182|P1|STARTED|Overall Study||20
863741|NCT02362360|2091190|P2|NOT COMPLETED|Period 2||0
863742|NCT02362360|2091191|P1|NOT COMPLETED|Period 2||0
863743|NCT02362360|2091190|P2|COMPLETED|Period 2||25
863744|NCT02362360|2091191|P1|COMPLETED|Period 2||23
863745|NCT02362360|2091190|P2|STARTED|Period 2||25
863746|NCT02362360|2091191|P1|STARTED|Period 2||23
863747|NCT02362360|2091190|P2|NOT COMPLETED|Period 1||1
863748|NCT02362360|2091191|P1|NOT COMPLETED|Period 1||3
863749|NCT02362360|2091190|P2|COMPLETED|Period 1||25
863750|NCT02362360|2091191|P1|COMPLETED|Period 1||23
863751|NCT02362360|2091190|P2|STARTED|Period 1||26
863752|NCT02362360|2091191|P1|STARTED|Period 1||26
863753|NCT02362321|2091199|P2|NOT COMPLETED|Overall Study||0
863754|NCT02362321|2091200|P1|NOT COMPLETED|Overall Study||4
863755|NCT02362321|2091199|P2|COMPLETED|Overall Study||10
863756|NCT02362321|2091200|P1|COMPLETED|Overall Study||6
863757|NCT02362321|2091199|P2|STARTED|Overall Study||10
863758|NCT02362321|2091200|P1|STARTED|Overall Study||10
863759|NCT02361736|2091208|P2|NOT COMPLETED|Overall Study||1
863760|NCT02361736|2091209|P1|NOT COMPLETED|Overall Study||1
863761|NCT02361736|2091208|P2|COMPLETED|Overall Study||59
863762|NCT02361736|2091209|P1|COMPLETED|Overall Study||59
863763|NCT02361736|2091208|P2|STARTED|Overall Study||60
863764|NCT02361736|2091209|P1|STARTED|Overall Study||60
863765|NCT02361580|2091229|P2|NOT COMPLETED|Overall Study||3
863766|NCT02361580|2091230|P1|NOT COMPLETED|Overall Study||6
863767|NCT02361580|2091229|P2|COMPLETED|Overall Study||0
863768|NCT02361580|2091230|P1|COMPLETED|Overall Study||0
863769|NCT02361580|2091229|P2|STARTED|Overall Study||3
863770|NCT02361580|2091230|P1|STARTED|Overall Study||6
863771|NCT02360995|2091243|P3|NOT COMPLETED|Overall Study||2
863772|NCT02360995|2091244|P2|NOT COMPLETED|Overall Study||1
863773|NCT02360995|2091245|P1|NOT COMPLETED|Overall Study||2
863774|NCT02360995|2091243|P3|COMPLETED|Overall Study||41
863775|NCT02360995|2091244|P2|COMPLETED|Overall Study||42
863776|NCT02360995|2091245|P1|COMPLETED|Overall Study||41
863777|NCT02360995|2091243|P3|STARTED|Overall Study||43
863778|NCT02360995|2091244|P2|STARTED|Overall Study||43
863779|NCT02360995|2091245|P1|STARTED|Overall Study||43
863780|NCT02360475|2091272|P4|NOT COMPLETED|Overall Study||5
863781|NCT02360475|2091273|P3|NOT COMPLETED|Overall Study||8
863782|NCT02360475|2091274|P2|NOT COMPLETED|Overall Study||13
863783|NCT02360475|2091275|P1|NOT COMPLETED|Overall Study||4
863784|NCT02360475|2091272|P4|COMPLETED|Overall Study||120
863785|NCT02360475|2091273|P3|COMPLETED|Overall Study||117
863786|NCT02360475|2091274|P2|COMPLETED|Overall Study||111
863787|NCT02360475|2091275|P1|COMPLETED|Overall Study||122
863788|NCT02360475|2091272|P4|STARTED|Overall Study||125
863789|NCT02360475|2091273|P3|STARTED|Overall Study||125
863790|NCT02360475|2091274|P2|STARTED|Overall Study||124
863791|NCT02360475|2091275|P1|STARTED|Overall Study||126
863792|NCT02360124|2091336|P3|NOT COMPLETED|Overall Study||26
863793|NCT02360124|2091337|P2|NOT COMPLETED|Overall Study||12
863794|NCT02360124|2091338|P1|NOT COMPLETED|Overall Study||28
863795|NCT02360124|2091336|P3|COMPLETED|Overall Study||82
863796|NCT02360124|2091337|P2|COMPLETED|Overall Study||95
863797|NCT02360124|2091338|P1|COMPLETED|Overall Study||80
863798|NCT02360124|2091336|P3|STARTED|Overall Study||108
863799|NCT02360124|2091337|P2|STARTED|Overall Study||107
863800|NCT02360124|2091338|P1|STARTED|Overall Study||108
863801|NCT02360059|2091351|P2|NOT COMPLETED|Overall Study||0
863802|NCT02360059|2091352|P1|NOT COMPLETED|Overall Study||0
863803|NCT02360059|2091351|P2|COMPLETED|Overall Study||0
863804|NCT02360059|2091352|P1|COMPLETED|Overall Study||1
863805|NCT02360059|2091351|P2|STARTED|Overall Study||0
863806|NCT02360059|2091352|P1|STARTED|Overall Study||1
863807|NCT02359955|2091360|P2|NOT COMPLETED|Overall Study||0
863808|NCT02359955|2091361|P1|NOT COMPLETED|Overall Study||0
863809|NCT02359955|2091360|P2|COMPLETED|Overall Study||10
863810|NCT02359955|2091361|P1|COMPLETED|Overall Study||10
863811|NCT02359955|2091360|P2|STARTED|Overall Study||10
863812|NCT02359955|2091361|P1|STARTED|Overall Study||10
863813|NCT02359903|2091379|P2|NOT COMPLETED|Overall Study||2
863814|NCT02359903|2091380|P1|NOT COMPLETED|Overall Study||0
863815|NCT02359903|2091379|P2|COMPLETED|Overall Study||43
863816|NCT02359903|2091380|P1|COMPLETED|Overall Study||45
863817|NCT02359903|2091379|P2|STARTED|Overall Study||45
863818|NCT02359903|2091380|P1|STARTED|Overall Study||45
863819|NCT02359877|2091392|P4|NOT COMPLETED|Overall Study||3
863820|NCT02359877|2091393|P3|NOT COMPLETED|Overall Study||0
863821|NCT02359877|2091394|P2|NOT COMPLETED|Overall Study||0
863822|NCT02359877|2091395|P1|NOT COMPLETED|Overall Study||1
863823|NCT02359877|2091392|P4|COMPLETED|Overall Study||11
863824|NCT02359877|2091393|P3|COMPLETED|Overall Study||6
863825|NCT02359877|2091394|P2|COMPLETED|Overall Study||6
863826|NCT02359877|2091395|P1|COMPLETED|Overall Study||33
863827|NCT02359877|2091392|P4|STARTED|Overall Study||14
863828|NCT02359877|2091393|P3|STARTED|Overall Study||6
863829|NCT02359877|2091394|P2|STARTED|Overall Study||6
863830|NCT02359877|2091395|P1|STARTED|Overall Study||34
863831|NCT02359435|2091447|P2|NOT COMPLETED|Overall Study||4
863832|NCT02359435|2091448|P1|NOT COMPLETED|Overall Study||4
863833|NCT02359435|2091447|P2|COMPLETED|Overall Study||216
863834|NCT02359435|2091448|P1|COMPLETED|Overall Study||216
863835|NCT02359435|2091447|P2|STARTED|Overall Study||220
863836|NCT02359435|2091448|P1|STARTED|Overall Study||220
863837|NCT02359045|2091456|P2|NOT COMPLETED|Overall Study||3
863838|NCT02359045|2091457|P1|NOT COMPLETED|Overall Study||4
863839|NCT02359045|2091456|P2|COMPLETED|Overall Study||39
863840|NCT02359045|2091457|P1|COMPLETED|Overall Study||36
863841|NCT02359045|2091456|P2|STARTED|Overall Study||42
863842|NCT02359045|2091457|P1|STARTED|Overall Study||40
863843|NCT02358876|2091690|P1|NOT COMPLETED|Overall Study||2
863844|NCT02358876|2091690|P1|COMPLETED|Overall Study|All 32 participants completed the in-clinic portion and 30 out of the 32 completed the home portion.|30
863845|NCT02358876|2091690|P1|STARTED|Overall Study||32
863846|NCT02358668|2091697|P3|NOT COMPLETED|Overall Study||0
863847|NCT02358668|2091698|P2|NOT COMPLETED|Overall Study||1
863848|NCT02358668|2091699|P1|NOT COMPLETED|Overall Study||2
863849|NCT02358668|2091697|P3|COMPLETED|Overall Study||12
863850|NCT02358668|2091698|P2|COMPLETED|Overall Study||23
863851|NCT02358668|2091699|P1|COMPLETED|Overall Study||22
863852|NCT02358668|2091697|P3|STARTED|Overall Study||12
863853|NCT02358668|2091698|P2|STARTED|Overall Study||24
863854|NCT02358668|2091699|P1|STARTED|Overall Study||24
863855|NCT02358044|2091841|P2|NOT COMPLETED|Overall Study||7
863856|NCT02358044|2091842|P1|NOT COMPLETED|Overall Study||2
863857|NCT02358044|2091841|P2|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|121
863858|NCT02358044|2091842|P1|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|127
863859|NCT02358044|2091841|P2|Treated|Overall Study||126
863860|NCT02358044|2091842|P1|Treated|Overall Study||129
863861|NCT02358044|2091841|P2|STARTED|Overall Study||128
863862|NCT02358044|2091842|P1|STARTED|Overall Study||129
863863|NCT02357940|2091860|P2|NOT COMPLETED|Overall Study||2
863864|NCT02357940|2091861|P1|NOT COMPLETED|Overall Study||0
863865|NCT02357940|2091860|P2|COMPLETED|Overall Study||30
863866|NCT02357940|2091861|P1|COMPLETED|Overall Study||9
863867|NCT02357940|2091860|P2|STARTED|Overall Study||32
863868|NCT02357940|2091861|P1|STARTED|Overall Study||9
863869|NCT02357485|2091985|P1|NOT COMPLETED|Overall Study||0
863870|NCT02357485|2091985|P1|COMPLETED|Overall Study||6
863871|NCT02357485|2091985|P1|STARTED|Overall Study|6 subjects, 8 knees ( 2 bilateral & 4 unilateral)|6
863872|NCT02357342|2091995|P2|NOT COMPLETED|Extension Study||0
863873|NCT02357342|2091996|P1|NOT COMPLETED|Extension Study||0
863874|NCT02357342|2091995|P2|COMPLETED|Extension Study||9
863875|NCT02357342|2091996|P1|COMPLETED|Extension Study||4
863876|NCT02357342|2091995|P2|STARTED|Extension Study||9
863877|NCT02357342|2091996|P1|STARTED|Extension Study||4
863878|NCT02357342|2091995|P2|NOT COMPLETED|First 6 Months||0
863879|NCT02357342|2091996|P1|NOT COMPLETED|First 6 Months||2
863880|NCT02357342|2091995|P2|COMPLETED|First 6 Months||20
863881|NCT02357342|2091996|P1|COMPLETED|First 6 Months|2 patients died. Neither deaths were study drug related.|18
863882|NCT02357342|2091995|P2|STARTED|First 6 Months||20
863883|NCT02357342|2091996|P1|STARTED|First 6 Months||20
863884|NCT02357264|2092008|P2|NOT COMPLETED|Overall Study||0
863885|NCT02357264|2092009|P1|NOT COMPLETED|Overall Study||0
863886|NCT02357264|2092008|P2|COMPLETED|Overall Study||130
863887|NCT02357264|2092009|P1|COMPLETED|Overall Study||56
863888|NCT02357264|2092008|P2|STARTED|Overall Study||130
863889|NCT02357264|2092009|P1|STARTED|Overall Study||56
863890|NCT02356900|2092017|P2|NOT COMPLETED|Overall Study||0
863891|NCT02356900|2092018|P1|NOT COMPLETED|Overall Study||0
863892|NCT02356900|2092017|P2|COMPLETED|Overall Study||10
863893|NCT02356900|2092018|P1|COMPLETED|Overall Study||11
863894|NCT02356900|2092017|P2|STARTED|Overall Study||10
863895|NCT02356900|2092018|P1|STARTED|Overall Study||11
863896|NCT02356588|2092038|P2|NOT COMPLETED|Overall Study||13
863897|NCT02356588|2092039|P1|NOT COMPLETED|Overall Study||5
863898|NCT02356588|2092038|P2|COMPLETED|Overall Study||41
863899|NCT02356588|2092039|P1|COMPLETED|Overall Study||102
863900|NCT02356588|2092038|P2|STARTED|Overall Study||54
863901|NCT02356588|2092039|P1|STARTED|Overall Study||107
863902|NCT02355977|2092074|P3|NOT COMPLETED|Overall Study||0
863903|NCT02355977|2092075|P2|NOT COMPLETED|Overall Study||0
863904|NCT02355977|2092076|P1|NOT COMPLETED|Overall Study||0
863905|NCT02355977|2092074|P3|COMPLETED|Overall Study||23
863906|NCT02355977|2092075|P2|COMPLETED|Overall Study||26
863907|NCT02355977|2092076|P1|COMPLETED|Overall Study||21
863908|NCT02355977|2092074|P3|STARTED|Overall Study||23
863909|NCT02355977|2092075|P2|STARTED|Overall Study||26
863910|NCT02355977|2092076|P1|STARTED|Overall Study||21
863911|NCT02355275|2092090|P1|NOT COMPLETED|Overall Study||8
863912|NCT02355275|2092090|P1|COMPLETED|Overall Study||14
863913|NCT02355275|2092090|P1|STARTED|Overall Study||22
863914|NCT02355158|2092095|P1|NOT COMPLETED|Overall Study||150
863915|NCT02355158|2092095|P1|COMPLETED|Overall Study||47
863916|NCT02355158|2092095|P1|STARTED|Overall Study||197
863917|NCT02354924|2092101|P2|NOT COMPLETED|Overall Study||0
863918|NCT02354924|2092102|P1|NOT COMPLETED|Overall Study||0
863919|NCT02354924|2092101|P2|COMPLETED|Overall Study||20
863920|NCT02354924|2092102|P1|COMPLETED|Overall Study||40
863921|NCT02354924|2092101|P2|STARTED|Overall Study||20
863922|NCT02354924|2092102|P1|STARTED|Overall Study||40
863923|NCT02354833|2092114|P2|NOT COMPLETED|Overall Study||0
863924|NCT02354833|2092115|P1|NOT COMPLETED|Overall Study||0
863925|NCT02354833|2092114|P2|COMPLETED|Overall Study||43
863926|NCT02354833|2092115|P1|COMPLETED|Overall Study||38
863927|NCT02354833|2092114|P2|STARTED|Overall Study||43
863928|NCT02354833|2092115|P1|STARTED|Overall Study||38
863929|NCT02354599|2092133|P6|NOT COMPLETED|Overall Study||1
863930|NCT02354599|2092134|P5|NOT COMPLETED|Overall Study||0
863931|NCT02354599|2092135|P4|NOT COMPLETED|Overall Study||0
863932|NCT02354599|2092136|P3|NOT COMPLETED|Overall Study||0
863933|NCT02354599|2092137|P2|NOT COMPLETED|Overall Study||1
863934|NCT02354599|2092138|P1|NOT COMPLETED|Overall Study||1
863935|NCT02354599|2092133|P6|COMPLETED|Overall Study||5
863936|NCT02354599|2092134|P5|COMPLETED|Overall Study||2
863937|NCT02354599|2092135|P4|COMPLETED|Overall Study||6
863938|NCT02354599|2092136|P3|COMPLETED|Overall Study||6
863939|NCT02354599|2092137|P2|COMPLETED|Overall Study||5
863940|NCT02354599|2092138|P1|COMPLETED|Overall Study||5
863941|NCT02354599|2092133|P6|STARTED|Overall Study||6
863942|NCT02354599|2092134|P5|STARTED|Overall Study||2
863943|NCT02354599|2092135|P4|STARTED|Overall Study||6
863944|NCT02354599|2092136|P3|STARTED|Overall Study||6
863945|NCT02354599|2092137|P2|STARTED|Overall Study||6
863946|NCT02354599|2092138|P1|STARTED|Overall Study||6
863947|NCT02353871|2092210|P2|NOT COMPLETED|Overall Study||9
863948|NCT02353871|2092211|P1|NOT COMPLETED|Overall Study||3
863949|NCT02353871|2092210|P2|COMPLETED|Overall Study||51
863950|NCT02353871|2092211|P1|COMPLETED|Overall Study||122
863951|NCT02353871|2092210|P2|STARTED|Overall Study|Randomised. Included a subject who was randomised by mistake (excluded from mITT population).|60
863952|NCT02353871|2092211|P1|STARTED|Overall Study|Randomised.|125
863953|NCT02353754|2092233|P2|NOT COMPLETED|Overall Study||0
863954|NCT02353754|2092234|P1|NOT COMPLETED|Overall Study||2
863955|NCT02353754|2092233|P2|COMPLETED|Overall Study||0
863956|NCT02353754|2092234|P1|COMPLETED|Overall Study||10
863957|NCT02353754|2092233|P2|STARTED|Overall Study||0
863958|NCT02353754|2092234|P1|STARTED|Overall Study||12
863959|NCT02353572|2092244|P1|NOT COMPLETED|Overall Study||3
863960|NCT02353572|2092244|P1|COMPLETED|Overall Study||0
863961|NCT02353572|2092244|P1|STARTED|Overall Study||3
863962|NCT02353468|2092248|P1|NOT COMPLETED|Overall Study||3
863963|NCT02353468|2092248|P1|COMPLETED|Overall Study||0
863964|NCT02353468|2092248|P1|STARTED|Overall Study||3
863965|NCT02353442|2092254|P2|NOT COMPLETED|Overall Study||4
863966|NCT02353442|2092255|P1|NOT COMPLETED|Overall Study||3
863967|NCT02353442|2092254|P2|COMPLETED|Overall Study||27
863968|NCT02353442|2092255|P1|COMPLETED|Overall Study||25
863969|NCT02353442|2092254|P2|STARTED|Overall Study||31
863970|NCT02353442|2092255|P1|STARTED|Overall Study||28
863971|NCT02352779|2092272|P3|NOT COMPLETED|Overall Study||2
863972|NCT02352779|2092273|P2|NOT COMPLETED|Overall Study||1
863973|NCT02352779|2092274|P1|NOT COMPLETED|Overall Study||8
863974|NCT02352779|2092272|P3|COMPLETED|Overall Study||33
863975|NCT02352779|2092273|P2|COMPLETED|Overall Study||35
863976|NCT02352779|2092274|P1|COMPLETED|Overall Study||29
863977|NCT02352779|2092272|P3|STARTED|Overall Study||35
863978|NCT02352779|2092273|P2|STARTED|Overall Study||36
863979|NCT02352779|2092274|P1|STARTED|Overall Study||37
863980|NCT02352298|2092282|P1|NOT COMPLETED|Overall Study||0
863981|NCT02352298|2092282|P1|COMPLETED|Overall Study||52
863982|NCT02352298|2092282|P1|STARTED|Overall Study||52
863983|NCT02351960|2092289|P2|NOT COMPLETED|Overall Study||12
863984|NCT02351960|2092290|P1|NOT COMPLETED|Overall Study||11
863985|NCT02351960|2092289|P2|COMPLETED|Overall Study||76
863986|NCT02351960|2092290|P1|COMPLETED|Overall Study||197
863987|NCT02351960|2092289|P2|STARTED|Overall Study||88
863988|NCT02351960|2092290|P1|STARTED|Overall Study||208
863989|NCT02351934|2092311|P2|NOT COMPLETED|Follow-Up||10
863990|NCT02351934|2092312|P1|NOT COMPLETED|Follow-Up||7
863991|NCT02351934|2092311|P2|COMPLETED|Follow-Up||51
863992|NCT02351934|2092312|P1|COMPLETED|Follow-Up||44
863993|NCT02351934|2092311|P2|STARTED|Follow-Up||61
863994|NCT02351934|2092312|P1|STARTED|Follow-Up||51
863995|NCT02351934|2092311|P2|NOT COMPLETED|Allocation||0
863996|NCT02351934|2092312|P1|NOT COMPLETED|Allocation||11
863997|NCT02351934|2092311|P2|COMPLETED|Allocation||61
863998|NCT02351934|2092312|P1|COMPLETED|Allocation||51
863999|NCT02351934|2092311|P2|Received Allocation|Allocation||61
864000|NCT02351934|2092312|P1|Received Allocation|Allocation||51
864001|NCT02351934|2092311|P2|STARTED|Allocation||61
864002|NCT02351934|2092312|P1|STARTED|Allocation||62
864003|NCT02351817|2092328|P2|NOT COMPLETED|Period 2||2
864004|NCT02351817|2092329|P1|NOT COMPLETED|Period 2||1
864005|NCT02351817|2092328|P2|COMPLETED|Period 2||3
864006|NCT02351817|2092329|P1|COMPLETED|Period 2||4
864007|NCT02351817|2092328|P2|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
864008|NCT02351817|2092329|P1|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
864009|NCT02351817|2092328|P2|NOT COMPLETED|Period 1||3
864010|NCT02351817|2092329|P1|NOT COMPLETED|Period 1||1
864011|NCT02351817|2092328|P2|COMPLETED|Period 1||2
864012|NCT02351817|2092329|P1|COMPLETED|Period 1||4
864013|NCT02351817|2092328|P2|STARTED|Period 1||5
864014|NCT02351817|2092329|P1|STARTED|Period 1||5
864015|NCT02351817|2092328|P2|NOT COMPLETED|Baseline Period||0
864016|NCT02351817|2092329|P1|NOT COMPLETED|Baseline Period||0
864017|NCT02351817|2092328|P2|COMPLETED|Baseline Period||5
864018|NCT02351817|2092329|P1|COMPLETED|Baseline Period||5
864019|NCT02351817|2092328|P2|STARTED|Baseline Period||5
864020|NCT02351817|2092329|P1|STARTED|Baseline Period||5
864021|NCT02351505|2092336|P1|NOT COMPLETED|Overall Study||0
864022|NCT02351505|2092336|P1|COMPLETED|Overall Study||1
864023|NCT02351505|2092336|P1|STARTED|Overall Study||1
864024|NCT02350881|2092347|P1|NOT COMPLETED|Overall Study||0
864025|NCT02350881|2092347|P1|COMPLETED|Overall Study|64 patients were completed (6 bilateral)|64
864026|NCT02350881|2092347|P1|STARTED|Overall Study|64 patients were included (6 bilateral)|64
864027|NCT02350569|2092375|P1|NOT COMPLETED|Retreatment (LDV/SOF 12 Weeks)||0
864028|NCT02350569|2092375|P1|COMPLETED|Retreatment (LDV/SOF 12 Weeks)||1
864029|NCT02350569|2092375|P1|STARTED|Retreatment (LDV/SOF 12 Weeks)|1 completed treatment (Main Study), experienced virologic failure, and entered Retreatment Phase|1
864030|NCT02350569|2092375|P1|NOT COMPLETED|Main Study (LDV/SOF 4 Weeks)||0
864031|NCT02350569|2092375|P1|COMPLETED|Main Study (LDV/SOF 4 Weeks)|1 participant discontinued treatment, but completed follow-up visits and study.|16
864032|NCT02350569|2092375|P1|STARTED|Main Study (LDV/SOF 4 Weeks)||16
864033|NCT02349711|2092387|P2|NOT COMPLETED|Overall Study||2
864034|NCT02349711|2092388|P1|NOT COMPLETED|Overall Study||3
864035|NCT02349711|2092387|P2|COMPLETED|Overall Study||84
864036|NCT02349711|2092388|P1|COMPLETED|Overall Study||84
864037|NCT02349711|2092387|P2|STARTED|Overall Study||86
864038|NCT02349711|2092388|P1|STARTED|Overall Study||87
864039|NCT02349685|2092403|P3|NOT COMPLETED|Overall Study||4
864040|NCT02349685|2092404|P2|NOT COMPLETED|Overall Study||2
864041|NCT02349685|2092405|P1|NOT COMPLETED|Overall Study||5
864042|NCT02349685|2092403|P3|COMPLETED|Overall Study||37
864043|NCT02349685|2092404|P2|COMPLETED|Overall Study||87
864044|NCT02349685|2092405|P1|COMPLETED|Overall Study||84
864045|NCT02349685|2092403|P3|STARTED|Overall Study||41
864046|NCT02349685|2092404|P2|STARTED|Overall Study||89
864047|NCT02349685|2092405|P1|STARTED|Overall Study||89
864048|NCT02349542|2092416|P1|NOT COMPLETED|Overall Study||5
864049|NCT02349542|2092416|P1|COMPLETED|Overall Study||15
864050|NCT02349542|2092416|P1|STARTED|Overall Study||20
864051|NCT02349451|2092425|P4|NOT COMPLETED|Overall Study||1
864052|NCT02349451|2092426|P3|NOT COMPLETED|Overall Study||2
864053|NCT02349451|2092427|P2|NOT COMPLETED|Overall Study||1
864054|NCT02349451|2092428|P1|NOT COMPLETED|Overall Study||0
864055|NCT02349451|2092425|P4|COMPLETED|Overall Study||72
864056|NCT02349451|2092426|P3|COMPLETED|Overall Study||69
864057|NCT02349451|2092427|P2|COMPLETED|Overall Study||71
864058|NCT02349451|2092428|P1|COMPLETED|Overall Study||24
864059|NCT02349451|2092425|P4|STARTED|Overall Study||73
864060|NCT02349451|2092426|P3|STARTED|Overall Study||71
864061|NCT02349451|2092427|P2|STARTED|Overall Study||72
864062|NCT02349451|2092428|P1|STARTED|Overall Study||24
864063|NCT02349438|2092464|P2|NOT COMPLETED|Period 2||0
864064|NCT02349438|2092465|P1|NOT COMPLETED|Period 2||0
864065|NCT02349438|2092464|P2|COMPLETED|Period 2||10
864066|NCT02349438|2092465|P1|COMPLETED|Period 2||11
864067|NCT02349438|2092464|P2|STARTED|Period 2||10
864068|NCT02349438|2092465|P1|STARTED|Period 2||11
864069|NCT02349438|2092464|P2|NOT COMPLETED|Period 1||0
864070|NCT02349438|2092465|P1|NOT COMPLETED|Period 1||0
864071|NCT02349438|2092464|P2|COMPLETED|Period 1||10
864072|NCT02349438|2092465|P1|COMPLETED|Period 1||11
864073|NCT02349438|2092464|P2|STARTED|Period 1||10
864074|NCT02349438|2092465|P1|STARTED|Period 1||11
864075|NCT02349048|2092477|P2|NOT COMPLETED|Overall Study||0
864076|NCT02349048|2092478|P1|NOT COMPLETED|Overall Study||5
864077|NCT02349048|2092477|P2|COMPLETED|Overall Study||9
864078|NCT02349048|2092478|P1|COMPLETED|Overall Study||54
864079|NCT02349048|2092477|P2|STARTED|Overall Study||9
864080|NCT02349048|2092478|P1|STARTED|Overall Study||59
864081|NCT02348658|2092498|P2|NOT COMPLETED|Period 2 (7 Days)||0
864082|NCT02348658|2092499|P1|NOT COMPLETED|Period 2 (7 Days)||0
864083|NCT02348658|2092498|P2|COMPLETED|Period 2 (7 Days)||6
864084|NCT02348658|2092499|P1|COMPLETED|Period 2 (7 Days)||6
864085|NCT02348658|2092498|P2|STARTED|Period 2 (7 Days)||6
864086|NCT02348658|2092499|P1|STARTED|Period 2 (7 Days)||6
864087|NCT02348658|2092498|P2|NOT COMPLETED|Washout Period (22 Days)||0
864088|NCT02348658|2092499|P1|NOT COMPLETED|Washout Period (22 Days)||0
864089|NCT02348658|2092498|P2|COMPLETED|Washout Period (22 Days)||6
864090|NCT02348658|2092499|P1|COMPLETED|Washout Period (22 Days)||6
864091|NCT02348658|2092498|P2|STARTED|Washout Period (22 Days)||6
864092|NCT02348658|2092499|P1|STARTED|Washout Period (22 Days)||6
864093|NCT02348658|2092498|P2|NOT COMPLETED|Period 1 (7 Days)||0
864094|NCT02348658|2092499|P1|NOT COMPLETED|Period 1 (7 Days)||0
864095|NCT02348658|2092498|P2|COMPLETED|Period 1 (7 Days)||6
864096|NCT02348658|2092499|P1|COMPLETED|Period 1 (7 Days)||6
864097|NCT02348658|2092498|P2|STARTED|Period 1 (7 Days)||6
864098|NCT02348658|2092499|P1|STARTED|Period 1 (7 Days)||6
864099|NCT02347488|2092533|P1|NOT COMPLETED|Overall Study||0
864100|NCT02347488|2092533|P1|COMPLETED|Overall Study||30
864101|NCT02347488|2092533|P1|STARTED|Overall Study||30
864102|NCT02347176|2092547|P4|NOT COMPLETED|Overall Study||4
864103|NCT02347176|2092548|P3|NOT COMPLETED|Overall Study||8
864104|NCT02347176|2092549|P2|NOT COMPLETED|Overall Study||10
864105|NCT02347176|2092550|P1|NOT COMPLETED|Overall Study||12
864106|NCT02347176|2092547|P4|COMPLETED|Overall Study||48
864107|NCT02347176|2092548|P3|COMPLETED|Overall Study||43
864108|NCT02347176|2092549|P2|COMPLETED|Overall Study||40
864109|NCT02347176|2092550|P1|COMPLETED|Overall Study||39
864110|NCT02347176|2092547|P4|STARTED|Overall Study||52
864111|NCT02347176|2092548|P3|STARTED|Overall Study||51
864112|NCT02347176|2092549|P2|STARTED|Overall Study||50
864113|NCT02347176|2092550|P1|STARTED|Overall Study||51
864114|NCT02347085|2092596|P1|NOT COMPLETED|Overall Study||10
864115|NCT02347085|2092596|P1|COMPLETED|Overall Study||33
864116|NCT02347085|2092596|P1|Placebo MDI|Overall Study||40
864117|NCT02347085|2092596|P1|GFF MDI 14.4/9.6 µg|Overall Study||40
864118|NCT02347085|2092596|P1|STARTED|Overall Study||43
864119|NCT02347072|2092618|P1|NOT COMPLETED|Overall Study||18
864120|NCT02347072|2092618|P1|COMPLETED|Overall Study||62
864121|NCT02347072|2092618|P1|Spiriva Respimat 5 µg|Overall Study||73
864122|NCT02347072|2092618|P1|Placebo MDI|Overall Study||72
864123|NCT02347072|2092618|P1|GFF MDI 14.4/9.6 µg|Overall Study||75
864124|NCT02347072|2092618|P1|STARTED|Overall Study||80
864125|NCT02346877|2092652|P2|NOT COMPLETED|Overall Study||0
864126|NCT02346877|2092653|P1|NOT COMPLETED|Overall Study||19
864127|NCT02346877|2092652|P2|COMPLETED|Overall Study||0
864128|NCT02346877|2092653|P1|COMPLETED|Overall Study||0
864129|NCT02346877|2092652|P2|STARTED|Overall Study||0
864130|NCT02346877|2092653|P1|STARTED|Overall Study||19
864131|NCT02346721|2092663|P1|NOT COMPLETED|Overall Study||4
864132|NCT02346721|2092663|P1|COMPLETED|Overall Study||107
864133|NCT02346721|2092663|P1|STARTED|Overall Study||111
864134|NCT02345720|2092672|P1|NOT COMPLETED|Overall Study||0
864135|NCT02345720|2092672|P1|COMPLETED|Overall Study||20
864136|NCT02345720|2092672|P1|STARTED|Overall Study||20
864137|NCT02345031|2092680|P2|NOT COMPLETED|Overall Study||1
864138|NCT02345031|2092681|P1|NOT COMPLETED|Overall Study||1
864139|NCT02345031|2092680|P2|COMPLETED|Overall Study||39
864140|NCT02345031|2092681|P1|COMPLETED|Overall Study||37
864141|NCT02345031|2092680|P2|STARTED|Overall Study||40
864142|NCT02345031|2092681|P1|STARTED|Overall Study||38
864143|NCT02344745|2092695|P2|NOT COMPLETED|Overall Study||0
864144|NCT02344745|2092696|P1|NOT COMPLETED|Overall Study||2
864145|NCT02344745|2092695|P2|COMPLETED|Overall Study||40
864146|NCT02344745|2092696|P1|COMPLETED|Overall Study||38
864147|NCT02344745|2092695|P2|STARTED|Overall Study||40
864148|NCT02344745|2092696|P1|STARTED|Overall Study||40
864149|NCT02344407|2092711|P3|NOT COMPLETED|Overall Study||6
864150|NCT02344407|2092712|P2|NOT COMPLETED|Overall Study||9
864151|NCT02344407|2092713|P1|NOT COMPLETED|Overall Study||8
864152|NCT02344407|2092711|P3|COMPLETED|Overall Study||494
864153|NCT02344407|2092712|P2|COMPLETED|Overall Study||491
864154|NCT02344407|2092713|P1|COMPLETED|Overall Study||492
864155|NCT02344407|2092711|P3|STARTED|Overall Study||500
864156|NCT02344407|2092712|P2|STARTED|Overall Study||500
864157|NCT02344407|2092713|P1|STARTED|Overall Study||500
864158|NCT02344342|2092728|P4|NOT COMPLETED|Overall Study||10
864159|NCT02344342|2092729|P3|NOT COMPLETED|Overall Study||14
864160|NCT02344342|2092730|P2|NOT COMPLETED|Overall Study||9
864161|NCT02344342|2092731|P1|NOT COMPLETED|Overall Study||11
864162|NCT02344342|2092728|P4|COMPLETED|Overall Study||3
864163|NCT02344342|2092729|P3|COMPLETED|Overall Study||0
864164|NCT02344342|2092730|P2|COMPLETED|Overall Study||2
864165|NCT02344342|2092731|P1|COMPLETED|Overall Study||2
864166|NCT02344342|2092728|P4|STARTED|Overall Study||13
864167|NCT02344342|2092729|P3|STARTED|Overall Study||14
864168|NCT02344342|2092730|P2|STARTED|Overall Study||11
864169|NCT02344342|2092731|P1|STARTED|Overall Study||13
864170|NCT02343380|2092755|P2|NOT COMPLETED|Overall Study||0
864171|NCT02343380|2092756|P1|NOT COMPLETED|Overall Study||0
864172|NCT02343380|2092755|P2|COMPLETED|Overall Study|Morning test (second week)|10
864173|NCT02343380|2092756|P1|COMPLETED|Overall Study|Evening test (second week)|10
864174|NCT02343380|2092755|P2|STARTED|Overall Study|Evening test (first week)|10
864175|NCT02343380|2092756|P1|STARTED|Overall Study|Morning test (first week)|10
864176|NCT02343159|2092769|P3|NOT COMPLETED|Overall Study||30
864177|NCT02343159|2092770|P2|NOT COMPLETED|Overall Study||26
864178|NCT02343159|2092771|P1|NOT COMPLETED|Overall Study||26
864179|NCT02343159|2092769|P3|COMPLETED|Overall Study||0
864180|NCT02343159|2092770|P2|COMPLETED|Overall Study||1
864181|NCT02343159|2092771|P1|COMPLETED|Overall Study||1
864182|NCT02343159|2092769|P3|STARTED|Overall Study||30
864183|NCT02343159|2092770|P2|STARTED|Overall Study||27
864184|NCT02343159|2092771|P1|STARTED|Overall Study||27
864185|NCT02343081|2092798|P2|NOT COMPLETED|Second Intervention (Day 4)||0
864186|NCT02343081|2092799|P1|NOT COMPLETED|Second Intervention (Day 4)||0
864187|NCT02343081|2092798|P2|COMPLETED|Second Intervention (Day 4)||8
864188|NCT02343081|2092799|P1|COMPLETED|Second Intervention (Day 4)||8
864189|NCT02343081|2092798|P2|Received Intervention|Second Intervention (Day 4)||8
864190|NCT02343081|2092799|P1|Received Intervention|Second Intervention (Day 4)||8
864191|NCT02343081|2092798|P2|STARTED|Second Intervention (Day 4)||8
864192|NCT02343081|2092799|P1|STARTED|Second Intervention (Day 4)||8
864193|NCT02343081|2092798|P2|NOT COMPLETED|Washout (10 Hours)||0
864194|NCT02343081|2092799|P1|NOT COMPLETED|Washout (10 Hours)||0
864195|NCT02343081|2092798|P2|COMPLETED|Washout (10 Hours)||8
864196|NCT02343081|2092799|P1|COMPLETED|Washout (10 Hours)||8
864197|NCT02343081|2092798|P2|STARTED|Washout (10 Hours)||8
864198|NCT02343081|2092799|P1|STARTED|Washout (10 Hours)||8
864199|NCT02343081|2092798|P2|NOT COMPLETED|First Intervention (Day 3)||0
864200|NCT02343081|2092799|P1|NOT COMPLETED|First Intervention (Day 3)||0
864201|NCT02343081|2092798|P2|COMPLETED|First Intervention (Day 3)||8
864202|NCT02343081|2092799|P1|COMPLETED|First Intervention (Day 3)||8
864203|NCT02343081|2092798|P2|Received Intervention|First Intervention (Day 3)||8
864204|NCT02343081|2092799|P1|Received Intervention|First Intervention (Day 3)||8
864205|NCT02343081|2092798|P2|STARTED|First Intervention (Day 3)||8
864206|NCT02343081|2092799|P1|STARTED|First Intervention (Day 3)||8
864213|NCT02342704|2092834|P2|NOT COMPLETED|Overall Study||51
864214|NCT02342704|2092835|P1|NOT COMPLETED|Overall Study||53
864215|NCT02342704|2092834|P2|COMPLETED|Overall Study||3
864216|NCT02342704|2092835|P1|COMPLETED|Overall Study||1
864217|NCT02342704|2092834|P2|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
864218|NCT02342704|2092835|P1|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
864219|NCT02342561|2092861|P1|NOT COMPLETED|Overall Study||0
864220|NCT02342561|2092861|P1|COMPLETED|Overall Study||20
864221|NCT02342561|2092861|P1|STARTED|Overall Study||20
864222|NCT02342535|2092869|P1|NOT COMPLETED|Overall Study||0
864223|NCT02342535|2092869|P1|COMPLETED|Overall Study|30 women in aerobic class and 38 kids in kids exercise class|68
864224|NCT02342535|2092869|P1|STARTED|Overall Study|30 women who participated in the aerobic exercise class and 38 children.|68
864225|NCT02342418|2092875|P2|NOT COMPLETED|Overall Study||1
864226|NCT02342418|2092876|P1|NOT COMPLETED|Overall Study||0
864227|NCT02342418|2092875|P2|COMPLETED|Overall Study||9
864228|NCT02342418|2092876|P1|COMPLETED|Overall Study||9
864229|NCT02342418|2092875|P2|STARTED|Overall Study||10
864230|NCT02342418|2092876|P1|STARTED|Overall Study||9
864231|NCT02342288|2092886|P2|NOT COMPLETED|Overall Study||6
864232|NCT02342288|2092887|P1|NOT COMPLETED|Overall Study||5
864233|NCT02342288|2092886|P2|COMPLETED|Overall Study||27
864234|NCT02342288|2092887|P1|COMPLETED|Overall Study||25
864235|NCT02342288|2092886|P2|STARTED|Overall Study|various issues listed below caused removal of subjects|33
864236|NCT02342288|2092887|P1|STARTED|Overall Study|16 patients were not randomized to either arm.|30
864237|NCT02342223|2092893|P1|NOT COMPLETED|Overall Study||1
864238|NCT02342223|2092893|P1|COMPLETED|Overall Study||19
864239|NCT02342223|2092893|P1|STARTED|Overall Study||20
864240|NCT02342197|2092904|P2|NOT COMPLETED|Overall Study||2
864241|NCT02342197|2092905|P1|NOT COMPLETED|Overall Study||3
864242|NCT02342197|2092904|P2|COMPLETED|Overall Study||28
864243|NCT02342197|2092905|P1|COMPLETED|Overall Study||27
864244|NCT02342197|2092904|P2|STARTED|Overall Study||30
864245|NCT02342197|2092905|P1|STARTED|Overall Study||30
864246|NCT02341859|2092911|P2|NOT COMPLETED|Second Intervention (1 Day)||0
864247|NCT02341859|2092912|P1|NOT COMPLETED|Second Intervention (1 Day)||0
864248|NCT02341859|2092911|P2|COMPLETED|Second Intervention (1 Day)||9
864249|NCT02341859|2092912|P1|COMPLETED|Second Intervention (1 Day)||10
864250|NCT02341859|2092911|P2|STARTED|Second Intervention (1 Day)||9
864251|NCT02341859|2092912|P1|STARTED|Second Intervention (1 Day)||10
864252|NCT02341859|2092911|P2|NOT COMPLETED|First Intervention (1 Day)||0
864253|NCT02341859|2092912|P1|NOT COMPLETED|First Intervention (1 Day)||0
864254|NCT02341859|2092911|P2|COMPLETED|First Intervention (1 Day)||9
864255|NCT02341859|2092912|P1|COMPLETED|First Intervention (1 Day)||10
864256|NCT02341859|2092911|P2|STARTED|First Intervention (1 Day)||9
864257|NCT02341859|2092912|P1|STARTED|First Intervention (1 Day)||10
864258|NCT02341482|2093065|P1|NOT COMPLETED|Overall Study||1
864259|NCT02341482|2093065|P1|COMPLETED|Overall Study||12
864260|NCT02341482|2093065|P1|STARTED|Overall Study||13
864261|NCT02341144|2093093|P2|NOT COMPLETED|Overall Study||1
864262|NCT02341144|2093094|P1|NOT COMPLETED|Overall Study||2
864263|NCT02341144|2093093|P2|COMPLETED|Overall Study||30
864264|NCT02341144|2093094|P1|COMPLETED|Overall Study||28
864265|NCT02341144|2093093|P2|STARTED|Overall Study||31
864266|NCT02341144|2093094|P1|STARTED|Overall Study||30
864267|NCT02340338|2093115|P7|NOT COMPLETED|Overall Study||0
864268|NCT02340338|2093116|P6|NOT COMPLETED|Overall Study||0
864269|NCT02340338|2093117|P5|NOT COMPLETED|Overall Study||0
864270|NCT02340338|2093118|P4|NOT COMPLETED|Overall Study||0
864271|NCT02340338|2093119|P3|NOT COMPLETED|Overall Study||0
864272|NCT02340338|2093120|P2|NOT COMPLETED|Overall Study||0
864273|NCT02340338|2093121|P1|NOT COMPLETED|Overall Study||0
864274|NCT02340338|2093115|P7|COMPLETED|Overall Study||12
864275|NCT02340338|2093116|P6|COMPLETED|Overall Study|1 withdrew voluntarily after the first immunization; safety and serum assessment completed.|9
864276|NCT02340338|2093117|P5|COMPLETED|Overall Study||9
864277|NCT02340338|2093118|P4|COMPLETED|Overall Study||9
864278|NCT02340338|2093119|P3|COMPLETED|Overall Study||3
864279|NCT02340338|2093120|P2|COMPLETED|Overall Study||2
864280|NCT02340338|2093121|P1|COMPLETED|Overall Study||2
864281|NCT02340338|2093115|P7|STARTED|Overall Study|Placebos were randomly assigned to dose groups 1-6, included in the 46 participants.|12
864282|NCT02340338|2093116|P6|STARTED|Overall Study|9 vaccine + 3 placebo|9
864283|NCT02340338|2093117|P5|STARTED|Overall Study|9 vaccine + 3 placebo|9
864284|NCT02340338|2093118|P4|STARTED|Overall Study|9 vaccine + 3 placebo|9
864285|NCT02340338|2093119|P3|STARTED|Overall Study|3 vaccine + 1 placebo|3
864286|NCT02340338|2093120|P2|STARTED|Overall Study|2 vaccine + 1 placebo|2
864287|NCT02340338|2093121|P1|STARTED|Overall Study|2 vaccine + 1 placebo|2
864288|NCT02340104|2093144|P1|NOT COMPLETED|Overall Study||0
864289|NCT02340104|2093144|P1|COMPLETED|Overall Study||8
864290|NCT02340104|2093144|P1|STARTED|Overall Study||8
864291|NCT02340000|2093151|P2|NOT COMPLETED|Time Period 2||15
864292|NCT02340000|2093152|P1|NOT COMPLETED|Time Period 2||19
864293|NCT02340000|2093151|P2|COMPLETED|Time Period 2||52
864294|NCT02340000|2093152|P1|COMPLETED|Time Period 2||50
864295|NCT02340000|2093151|P2|STARTED|Time Period 2||67
864296|NCT02340000|2093152|P1|STARTED|Time Period 2||69
864297|NCT02340000|2093151|P2|NOT COMPLETED|Time Period 1||15
864298|NCT02340000|2093152|P1|NOT COMPLETED|Time Period 1||12
864299|NCT02340000|2093151|P2|COMPLETED|Time Period 1||74
864300|NCT02340000|2093152|P1|COMPLETED|Time Period 1||78
864301|NCT02340000|2093151|P2|STARTED|Time Period 1||89
864302|NCT02340000|2093152|P1|STARTED|Time Period 1||90
864303|NCT02339831|2093181|P2|NOT COMPLETED|Overall Study||7
864304|NCT02339831|2093182|P1|NOT COMPLETED|Overall Study||20
864305|NCT02339831|2093181|P2|COMPLETED|Overall Study||45
864306|NCT02339831|2093182|P1|COMPLETED|Overall Study||38
864307|NCT02339831|2093181|P2|Lost to Follow Up|Overall Study||7
864308|NCT02339831|2093182|P1|Lost to Follow Up|Overall Study||20
864309|NCT02339831|2093181|P2|STARTED|Overall Study||52
864310|NCT02339831|2093182|P1|STARTED|Overall Study||58
864311|NCT02339584|2093206|P2|NOT COMPLETED|Overall Study||15
864312|NCT02339584|2093207|P1|NOT COMPLETED|Overall Study||15
864313|NCT02339584|2093206|P2|COMPLETED|Overall Study||176
864314|NCT02339584|2093207|P1|COMPLETED|Overall Study||173
864315|NCT02339584|2093206|P2|STARTED|Overall Study||191
864316|NCT02339584|2093207|P1|STARTED|Overall Study||188
864317|NCT02339246|2093215|P3|NOT COMPLETED|Third Period (7 Days)||0
864318|NCT02339246|2093216|P2|NOT COMPLETED|Third Period (7 Days)||0
864319|NCT02339246|2093217|P1|NOT COMPLETED|Third Period (7 Days)||0
864320|NCT02339246|2093215|P3|COMPLETED|Third Period (7 Days)||0
864321|NCT02339246|2093216|P2|COMPLETED|Third Period (7 Days)||16
864322|NCT02339246|2093217|P1|COMPLETED|Third Period (7 Days)||15
864323|NCT02339246|2093215|P3|STARTED|Third Period (7 Days)||0
864324|NCT02339246|2093216|P2|STARTED|Third Period (7 Days)||16
864325|NCT02339246|2093217|P1|STARTED|Third Period (7 Days)||15
864326|NCT02339246|2093215|P3|NOT COMPLETED|Second Intervention (7 Days)||0
864327|NCT02339246|2093216|P2|NOT COMPLETED|Second Intervention (7 Days)||0
864328|NCT02339246|2093217|P1|NOT COMPLETED|Second Intervention (7 Days)||0
864329|NCT02339246|2093215|P3|COMPLETED|Second Intervention (7 Days)||0
864330|NCT02339246|2093216|P2|COMPLETED|Second Intervention (7 Days)||15
864331|NCT02339246|2093217|P1|COMPLETED|Second Intervention (7 Days)||16
864332|NCT02339246|2093215|P3|STARTED|Second Intervention (7 Days)||0
864333|NCT02339246|2093216|P2|STARTED|Second Intervention (7 Days)||15
864334|NCT02339246|2093217|P1|STARTED|Second Intervention (7 Days)||16
864335|NCT02339246|2093215|P3|NOT COMPLETED|First Intervention (7 Days)||0
864336|NCT02339246|2093216|P2|NOT COMPLETED|First Intervention (7 Days)||0
864337|NCT02339246|2093217|P1|NOT COMPLETED|First Intervention (7 Days)||0
864338|NCT02339246|2093215|P3|COMPLETED|First Intervention (7 Days)||31
864339|NCT02339246|2093216|P2|COMPLETED|First Intervention (7 Days)||0
864340|NCT02339246|2093217|P1|COMPLETED|First Intervention (7 Days)||0
864341|NCT02339246|2093215|P3|STARTED|First Intervention (7 Days)||31
864342|NCT02339246|2093216|P2|STARTED|First Intervention (7 Days)||0
864343|NCT02339246|2093217|P1|STARTED|First Intervention (7 Days)||0
864344|NCT02339038|2093231|P1|NOT COMPLETED|Overall Study||600
864345|NCT02339038|2093231|P1|COMPLETED|Overall Study||0
864346|NCT02339038|2093231|P1|STARTED|Overall Study||600
864347|NCT02338713|2093235|P1|NOT COMPLETED|Overall Study||0
864348|NCT02338713|2093235|P1|COMPLETED|Overall Study||27
864349|NCT02338713|2093235|P1|STARTED|Overall Study||27
864350|NCT02338336|2093259|P4|NOT COMPLETED|Overall Study||0
864351|NCT02338336|2093260|P3|NOT COMPLETED|Overall Study||0
864352|NCT02338336|2093261|P2|NOT COMPLETED|Overall Study||0
864353|NCT02338336|2093262|P1|NOT COMPLETED|Overall Study||2
864354|NCT02338336|2093259|P4|COMPLETED|Overall Study||4
864355|NCT02338336|2093260|P3|COMPLETED|Overall Study||7
864356|NCT02338336|2093261|P2|COMPLETED|Overall Study||17
864357|NCT02338336|2093262|P1|COMPLETED|Overall Study||24
864358|NCT02338336|2093259|P4|STARTED|Overall Study||4
864359|NCT02338336|2093260|P3|STARTED|Overall Study||7
864360|NCT02338336|2093261|P2|STARTED|Overall Study||17
864361|NCT02338336|2093262|P1|STARTED|Overall Study||26
864362|NCT02338076|2093270|P1|NOT COMPLETED|Overall Study||0
864363|NCT02338076|2093270|P1|COMPLETED|Overall Study||20
864364|NCT02338076|2093270|P1|STARTED|Overall Study||20
864365|NCT02337959|2093288|P3|NOT COMPLETED|Overall Study||0
864366|NCT02337959|2093289|P2|NOT COMPLETED|Overall Study||3
864367|NCT02337959|2093290|P1|NOT COMPLETED|Overall Study||0
864368|NCT02337959|2093288|P3|COMPLETED|Overall Study||7
864369|NCT02337959|2093289|P2|COMPLETED|Overall Study||7
864370|NCT02337959|2093290|P1|COMPLETED|Overall Study||10
864371|NCT02337959|2093288|P3|STARTED|Overall Study||7
864372|NCT02337959|2093289|P2|STARTED|Overall Study||10
864373|NCT02337959|2093290|P1|STARTED|Overall Study||10
864374|NCT02337062|2093300|P2|NOT COMPLETED|Overall Study||19
864375|NCT02337062|2093301|P1|NOT COMPLETED|Overall Study||17
864376|NCT02337062|2093300|P2|COMPLETED|Overall Study||556
864377|NCT02337062|2093301|P1|COMPLETED|Overall Study||555
864378|NCT02337062|2093300|P2|STARTED|Overall Study||575
864379|NCT02337062|2093301|P1|STARTED|Overall Study||572
864380|NCT02336958|2093309|P2|NOT COMPLETED|Overall Study||0
864381|NCT02336958|2093310|P1|NOT COMPLETED|Overall Study||0
864382|NCT02336958|2093309|P2|COMPLETED|Overall Study||20
864383|NCT02336958|2093310|P1|COMPLETED|Overall Study||20
864384|NCT02336958|2093309|P2|STARTED|Overall Study||20
864385|NCT02336958|2093310|P1|STARTED|Overall Study||20
864386|NCT02336763|2093318|P1|NOT COMPLETED|Overall Study||0
864387|NCT02336763|2093318|P1|COMPLETED|Overall Study||2
864388|NCT02336763|2093318|P1|STARTED|Overall Study||2
864389|NCT02336607|2093332|P4|NOT COMPLETED|Overall Study||87
864390|NCT02336607|2093333|P3|NOT COMPLETED|Overall Study||6
864391|NCT02336607|2093334|P2|NOT COMPLETED|Overall Study||10
864392|NCT02336607|2093335|P1|NOT COMPLETED|Overall Study||4
864393|NCT02336607|2093332|P4|COMPLETED|Overall Study||180
864394|NCT02336607|2093333|P3|COMPLETED|Overall Study||86
864395|NCT02336607|2093334|P2|COMPLETED|Overall Study||75
864396|NCT02336607|2093335|P1|COMPLETED|Overall Study||81
864397|NCT02336607|2093332|P4|Patients Included in Safety Population|Overall Study||260
864398|NCT02336607|2093333|P3|Patients Included in Safety Population|Overall Study||92
864399|NCT02336607|2093334|P2|Patients Included in Safety Population|Overall Study||85
864400|NCT02336607|2093335|P1|Patients Included in Safety Population|Overall Study||85
864401|NCT02336607|2093332|P4|Patients Included in PP Population|Overall Study||162
864402|NCT02336607|2093333|P3|Patients Included in PP Population|Overall Study||75
864403|NCT02336607|2093334|P2|Patients Included in PP Population|Overall Study||75
864404|NCT02336607|2093335|P1|Patients Included in PP Population|Overall Study||78
864405|NCT02336607|2093332|P4|Patients Included in ITT Population|Overall Study||222
864406|NCT02336607|2093333|P3|Patients Included in ITT Population|Overall Study||91
864407|NCT02336607|2093334|P2|Patients Included in ITT Population|Overall Study||84
864408|NCT02336607|2093335|P1|Patients Included in ITT Population|Overall Study||84
864409|NCT02336607|2093332|P4|STARTED|Overall Study||267
864410|NCT02336607|2093333|P3|STARTED|Overall Study||92
864411|NCT02336607|2093334|P2|STARTED|Overall Study||85
864412|NCT02336607|2093335|P1|STARTED|Overall Study||85
864413|NCT02336438|2093389|P1|NOT COMPLETED|Overall Study||1
864414|NCT02336438|2093389|P1|COMPLETED|Overall Study||10
864415|NCT02336438|2093389|P1|STARTED|Overall Study||11
864416|NCT02336425|2093402|P4|NOT COMPLETED|Overall Study||3
864417|NCT02336425|2093403|P3|NOT COMPLETED|Overall Study||3
864418|NCT02336425|2093404|P2|NOT COMPLETED|Overall Study||2
864419|NCT02336425|2093405|P1|NOT COMPLETED|Overall Study||2
864420|NCT02336425|2093402|P4|COMPLETED|Overall Study||0
864421|NCT02336425|2093403|P3|COMPLETED|Overall Study||0
864422|NCT02336425|2093404|P2|COMPLETED|Overall Study||0
864423|NCT02336425|2093405|P1|COMPLETED|Overall Study||0
864424|NCT02336425|2093402|P4|STARTED|Overall Study||3
864425|NCT02336425|2093403|P3|STARTED|Overall Study||3
864426|NCT02336425|2093404|P2|STARTED|Overall Study||2
864427|NCT02336425|2093405|P1|STARTED|Overall Study||2
864428|NCT02336178|2093455|P1|NOT COMPLETED|Overall Study||4
864429|NCT02336178|2093455|P1|COMPLETED|Overall Study||66
864430|NCT02336178|2093455|P1|STARTED|Overall Study||70
864431|NCT02335710|2093543|P2|NOT COMPLETED|Overall Study||0
864432|NCT02335710|2093544|P1|NOT COMPLETED|Overall Study||0
864433|NCT02335710|2093543|P2|COMPLETED|Overall Study||10
864434|NCT02335710|2093544|P1|COMPLETED|Overall Study||40
864435|NCT02335710|2093543|P2|STARTED|Overall Study||10
864436|NCT02335710|2093544|P1|STARTED|Overall Study||40
864437|NCT02335502|2093564|P1|NOT COMPLETED|Overall Study||17
864438|NCT02335502|2093564|P1|COMPLETED|Overall Study||49
864439|NCT02335502|2093564|P1|Receiving Permanent System|Overall Study||56
864440|NCT02335502|2093564|P1|Received Trial System|Overall Study||65
864441|NCT02335502|2093564|P1|STARTED|Overall Study||66
864442|NCT02335489|2093569|P1|NOT COMPLETED|Overall Study||10
864443|NCT02335489|2093569|P1|COMPLETED|Overall Study||0
864444|NCT02335489|2093569|P1|Receiving Permanent System|Overall Study||8
864445|NCT02335489|2093569|P1|Received Trial System|Overall Study||9
864446|NCT02335489|2093569|P1|STARTED|Overall Study||10
864447|NCT02334982|2093580|P7|NOT COMPLETED|Overall Study||0
864448|NCT02334982|2093581|P6|NOT COMPLETED|Overall Study||0
864449|NCT02334982|2093582|P5|NOT COMPLETED|Overall Study||0
864450|NCT02334982|2093583|P4|NOT COMPLETED|Overall Study||0
864451|NCT02334982|2093584|P3|NOT COMPLETED|Overall Study||0
864452|NCT02334982|2093585|P2|NOT COMPLETED|Overall Study||0
864453|NCT02334982|2093586|P1|NOT COMPLETED|Overall Study||0
864454|NCT02334982|2093580|P7|COMPLETED|Overall Study||12
864455|NCT02334982|2093581|P6|COMPLETED|Overall Study||6
864456|NCT02334982|2093582|P5|COMPLETED|Overall Study||6
864457|NCT02334982|2093583|P4|COMPLETED|Overall Study||6
864458|NCT02334982|2093584|P3|COMPLETED|Overall Study||6
864459|NCT02334982|2093585|P2|COMPLETED|Overall Study||5
864460|NCT02334982|2093586|P1|COMPLETED|Overall Study||6
864461|NCT02334982|2093580|P7|STARTED|Overall Study||12
864462|NCT02334982|2093581|P6|STARTED|Overall Study||6
864463|NCT02334982|2093582|P5|STARTED|Overall Study||6
864464|NCT02334982|2093583|P4|STARTED|Overall Study||6
864465|NCT02334982|2093584|P3|STARTED|Overall Study||6
864466|NCT02334982|2093585|P2|STARTED|Overall Study||5
864467|NCT02334982|2093586|P1|STARTED|Overall Study||6
864468|NCT02334813|2093692|P2|NOT COMPLETED|Overall Study||1
864469|NCT02334813|2093693|P1|NOT COMPLETED|Overall Study||3
864470|NCT02334813|2093692|P2|COMPLETED|Overall Study||13
864471|NCT02334813|2093693|P1|COMPLETED|Overall Study||9
864472|NCT02334813|2093692|P2|STARTED|Overall Study||14
864473|NCT02334813|2093693|P1|STARTED|Overall Study||12
864474|NCT02334787|2093703|P4|NOT COMPLETED|Overall Study||0
864475|NCT02334787|2093704|P3|NOT COMPLETED|Overall Study||0
864476|NCT02334787|2093705|P2|NOT COMPLETED|Overall Study||0
864477|NCT02334787|2093706|P1|NOT COMPLETED|Overall Study||0
864478|NCT02334787|2093703|P4|COMPLETED|Overall Study||8
864479|NCT02334787|2093704|P3|COMPLETED|Overall Study||8
864480|NCT02334787|2093705|P2|COMPLETED|Overall Study||8
864481|NCT02334787|2093706|P1|COMPLETED|Overall Study||8
864482|NCT02334787|2093703|P4|STARTED|Overall Study||8
864483|NCT02334787|2093704|P3|STARTED|Overall Study||8
864484|NCT02334787|2093705|P2|STARTED|Overall Study||8
864485|NCT02334787|2093706|P1|STARTED|Overall Study||8
864486|NCT02334267|2093730|P2|NOT COMPLETED|Overall Study||0
864487|NCT02334267|2093731|P1|NOT COMPLETED|Overall Study||1
864488|NCT02334267|2093730|P2|COMPLETED|Overall Study||5
864489|NCT02334267|2093731|P1|COMPLETED|Overall Study||5
864490|NCT02334267|2093730|P2|STARTED|Overall Study||5
864491|NCT02334267|2093731|P1|STARTED|Overall Study||6
864492|NCT02332902|2093743|P1|NOT COMPLETED|Overall Study||7
864493|NCT02332902|2093743|P1|COMPLETED|Overall Study||17
864494|NCT02332902|2093743|P1|STARTED|Overall Study||24
864495|NCT02332798|2093751|P3|NOT COMPLETED|Overall Study||1
864496|NCT02332798|2093752|P2|NOT COMPLETED|Overall Study||2
864497|NCT02332798|2093753|P1|NOT COMPLETED|Overall Study||1
864498|NCT02332798|2093751|P3|COMPLETED|Overall Study||11
864499|NCT02332798|2093752|P2|COMPLETED|Overall Study||12
864500|NCT02332798|2093753|P1|COMPLETED|Overall Study||12
864501|NCT02332798|2093751|P3|STARTED|Overall Study||12
864502|NCT02332798|2093752|P2|STARTED|Overall Study||14
864503|NCT02332798|2093753|P1|STARTED|Overall Study||13
864504|NCT02332590|2093805|P2|NOT COMPLETED|Overall Study||19
864505|NCT02332590|2093806|P1|NOT COMPLETED|Overall Study||29
864506|NCT02332590|2093805|P2|COMPLETED|Overall Study|All 165 participants entered open-label treatment period.|165
864507|NCT02332590|2093806|P1|COMPLETED|Overall Study|155 participants entered open-label treatment period and 1 did not enroll.|156
864508|NCT02332590|2093805|P2|Treated|Overall Study||184
864509|NCT02332590|2093806|P1|Treated|Overall Study||184
864510|NCT02332590|2093805|P2|STARTED|Overall Study||184
864511|NCT02332590|2093806|P1|STARTED|Overall Study||185
864512|NCT02331940|2093870|P2|NOT COMPLETED|Overall Study||5
864513|NCT02331940|2093871|P1|NOT COMPLETED|Overall Study||7
864514|NCT02331940|2093870|P2|COMPLETED|Overall Study||95
864515|NCT02331940|2093871|P1|COMPLETED|Overall Study||93
864516|NCT02331940|2093870|P2|STARTED|Overall Study||100
864517|NCT02331940|2093871|P1|STARTED|Overall Study||100
864518|NCT02331589|2093885|P2|NOT COMPLETED|Overall Study||5
864519|NCT02331589|2093886|P1|NOT COMPLETED|Overall Study||5
864520|NCT02331589|2093885|P2|COMPLETED|Overall Study||31
864521|NCT02331589|2093886|P1|COMPLETED|Overall Study||34
864522|NCT02331589|2093885|P2|STARTED|Overall Study||36
864523|NCT02331589|2093886|P1|STARTED|Overall Study||39
864524|NCT02331446|2093902|P4|NOT COMPLETED|Overall Study||3
864525|NCT02331446|2093903|P3|NOT COMPLETED|Overall Study||3
864526|NCT02331446|2093904|P2|NOT COMPLETED|Overall Study||5
864527|NCT02331446|2093905|P1|NOT COMPLETED|Overall Study||4
864528|NCT02331446|2093902|P4|COMPLETED|Overall Study||8
864529|NCT02331446|2093903|P3|COMPLETED|Overall Study||8
864530|NCT02331446|2093904|P2|COMPLETED|Overall Study||6
864531|NCT02331446|2093905|P1|COMPLETED|Overall Study||5
864532|NCT02331446|2093902|P4|STARTED|Overall Study||11
864533|NCT02331446|2093903|P3|STARTED|Overall Study||11
864534|NCT02331446|2093904|P2|STARTED|Overall Study||11
864535|NCT02331446|2093905|P1|STARTED|Overall Study||9
864536|NCT02331108|2093981|P6|NOT COMPLETED|Overall Study||2
864537|NCT02331108|2093982|P5|NOT COMPLETED|Overall Study||2
864538|NCT02331108|2093983|P4|NOT COMPLETED|Overall Study||1
864539|NCT02331108|2093984|P3|NOT COMPLETED|Overall Study||1
864540|NCT02331108|2093985|P2|NOT COMPLETED|Overall Study||2
864541|NCT02331108|2093986|P1|NOT COMPLETED|Overall Study||1
864542|NCT02331108|2093981|P6|COMPLETED|Overall Study||50
864543|NCT02331108|2093982|P5|COMPLETED|Overall Study||50
864544|NCT02331108|2093983|P4|COMPLETED|Overall Study||50
864545|NCT02331108|2093984|P3|COMPLETED|Overall Study||50
864546|NCT02331108|2093985|P2|COMPLETED|Overall Study||50
864547|NCT02331108|2093986|P1|COMPLETED|Overall Study||50
864548|NCT02331108|2093981|P6|STARTED|Overall Study||52
864549|NCT02331108|2093982|P5|STARTED|Overall Study||52
864550|NCT02331108|2093983|P4|STARTED|Overall Study||51
864551|NCT02331108|2093984|P3|STARTED|Overall Study||51
864552|NCT02331108|2093985|P2|STARTED|Overall Study||52
864553|NCT02331108|2093986|P1|STARTED|Overall Study||51
864554|NCT02330588|2094013|P5|NOT COMPLETED|Overall Study||19
864555|NCT02330588|2094014|P4|NOT COMPLETED|Overall Study||22
864556|NCT02330588|2094015|P3|NOT COMPLETED|Overall Study||15
864557|NCT02330588|2094016|P2|NOT COMPLETED|Overall Study||18
864558|NCT02330588|2094017|P1|NOT COMPLETED|Overall Study||16
864559|NCT02330588|2094013|P5|COMPLETED|Overall Study||28
864560|NCT02330588|2094014|P4|COMPLETED|Overall Study||24
864561|NCT02330588|2094015|P3|COMPLETED|Overall Study||31
864562|NCT02330588|2094016|P2|COMPLETED|Overall Study||25
864563|NCT02330588|2094017|P1|COMPLETED|Overall Study||28
864564|NCT02330588|2094013|P5|STARTED|Overall Study||47
864565|NCT02330588|2094014|P4|STARTED|Overall Study||46
864566|NCT02330588|2094015|P3|STARTED|Overall Study||46
864567|NCT02330588|2094016|P2|STARTED|Overall Study||43
864568|NCT02330588|2094017|P1|STARTED|Overall Study||44
864569|NCT02330523|2094044|P2|NOT COMPLETED|Overall Study||0
864570|NCT02330523|2094045|P1|NOT COMPLETED|Overall Study||0
864571|NCT02330523|2094044|P2|COMPLETED|Overall Study||19
864572|NCT02330523|2094045|P1|COMPLETED|Overall Study||21
864573|NCT02330523|2094044|P2|STARTED|Overall Study||19
864574|NCT02330523|2094045|P1|STARTED|Overall Study||21
864575|NCT02330276|2094058|P3|NOT COMPLETED|Overall Study||0
864576|NCT02330276|2094059|P2|NOT COMPLETED|Overall Study||0
864577|NCT02330276|2094060|P1|NOT COMPLETED|Overall Study||0
864578|NCT02330276|2094058|P3|COMPLETED|Overall Study||4
864579|NCT02330276|2094059|P2|COMPLETED|Overall Study||4
864580|NCT02330276|2094060|P1|COMPLETED|Overall Study||4
864581|NCT02330276|2094058|P3|STARTED|Overall Study||4
864582|NCT02330276|2094059|P2|STARTED|Overall Study||4
864583|NCT02330276|2094060|P1|STARTED|Overall Study||4
864584|NCT02330172|2094082|P2|NOT COMPLETED|Overall Study||1
864585|NCT02330172|2094083|P1|NOT COMPLETED|Overall Study||3
864586|NCT02330172|2094082|P2|COMPLETED|Overall Study||21
864587|NCT02330172|2094083|P1|COMPLETED|Overall Study||19
864588|NCT02330172|2094082|P2|STARTED|Overall Study||22
864589|NCT02330172|2094083|P1|STARTED|Overall Study||22
864590|NCT02329964|2094093|P2|NOT COMPLETED|Overall Study||0
864591|NCT02329964|2094094|P1|NOT COMPLETED|Overall Study||0
864592|NCT02329964|2094093|P2|COMPLETED|Overall Study||40
864593|NCT02329964|2094094|P1|COMPLETED|Overall Study||40
864594|NCT02329964|2094093|P2|STARTED|Overall Study||40
864595|NCT02329964|2094094|P1|STARTED|Overall Study||40
864596|NCT02329730|2094120|P12|NOT COMPLETED|Overall Study||0
864597|NCT02329730|2094121|P11|NOT COMPLETED|Overall Study||0
864598|NCT02329730|2094122|P10|NOT COMPLETED|Overall Study||1
864599|NCT02329730|2094123|P9|NOT COMPLETED|Overall Study||1
864600|NCT02329730|2094124|P8|NOT COMPLETED|Overall Study||1
864601|NCT02329730|2094125|P7|NOT COMPLETED|Overall Study||1
864602|NCT02329730|2094126|P6|NOT COMPLETED|Overall Study||2
864603|NCT02329730|2094127|P5|NOT COMPLETED|Overall Study||3
864604|NCT02329730|2094128|P4|NOT COMPLETED|Overall Study||0
864605|NCT02329730|2094129|P3|NOT COMPLETED|Overall Study||0
864606|NCT02329730|2094130|P2|NOT COMPLETED|Overall Study||0
864607|NCT02329730|2094131|P1|NOT COMPLETED|Overall Study||0
864608|NCT02329730|2094120|P12|COMPLETED|Overall Study||8
864609|NCT02329730|2094121|P11|COMPLETED|Overall Study||8
864610|NCT02329730|2094122|P10|COMPLETED|Overall Study||7
864611|NCT02329730|2094123|P9|COMPLETED|Overall Study||7
864612|NCT02329730|2094124|P8|COMPLETED|Overall Study||13
864613|NCT02329730|2094125|P7|COMPLETED|Overall Study||13
864614|NCT02329730|2094126|P6|COMPLETED|Overall Study||12
864615|NCT02329730|2094127|P5|COMPLETED|Overall Study||11
864616|NCT02329730|2094128|P4|COMPLETED|Overall Study||14
864617|NCT02329730|2094129|P3|COMPLETED|Overall Study||14
864618|NCT02329730|2094130|P2|COMPLETED|Overall Study||14
864619|NCT02329730|2094131|P1|COMPLETED|Overall Study||14
864620|NCT02329730|2094120|P12|STARTED|Overall Study||8
864621|NCT02329730|2094121|P11|STARTED|Overall Study||8
864622|NCT02329730|2094122|P10|STARTED|Overall Study||8
864623|NCT02329730|2094123|P9|STARTED|Overall Study||8
864624|NCT02329730|2094124|P8|STARTED|Overall Study||14
864625|NCT02329730|2094125|P7|STARTED|Overall Study||14
864626|NCT02329730|2094126|P6|STARTED|Overall Study||14
864627|NCT02329730|2094127|P5|STARTED|Overall Study||14
864628|NCT02329730|2094128|P4|STARTED|Overall Study||14
864629|NCT02329730|2094129|P3|STARTED|Overall Study||14
864630|NCT02329730|2094130|P2|STARTED|Overall Study||14
864631|NCT02329730|2094131|P1|STARTED|Overall Study||14
864632|NCT02329600|2094208|P3|NOT COMPLETED|Overall Study||0
864633|NCT02329600|2094209|P2|NOT COMPLETED|Overall Study||0
864634|NCT02329600|2094210|P1|NOT COMPLETED|Overall Study||0
864635|NCT02329600|2094208|P3|COMPLETED|Overall Study||15
864636|NCT02329600|2094209|P2|COMPLETED|Overall Study||15
864637|NCT02329600|2094210|P1|COMPLETED|Overall Study||10
864638|NCT02329600|2094208|P3|STARTED|Overall Study||15
864639|NCT02329600|2094209|P2|STARTED|Overall Study||15
864640|NCT02329600|2094210|P1|STARTED|Overall Study||10
864641|NCT02329431|2094223|P2|NOT COMPLETED|Overall Study||13
864642|NCT02329431|2094224|P1|NOT COMPLETED|Overall Study||20
864643|NCT02329431|2094223|P2|COMPLETED|Overall Study||76
864644|NCT02329431|2094224|P1|COMPLETED|Overall Study||72
864645|NCT02329431|2094223|P2|Baseline Interview|Overall Study||85
864646|NCT02329431|2094224|P1|Baseline Interview|Overall Study||87
864647|NCT02329431|2094223|P2|STARTED|Overall Study||89
864648|NCT02329431|2094224|P1|STARTED|Overall Study||92
864649|NCT02329223|2094243|P3|NOT COMPLETED|Overall Study||6
864650|NCT02329223|2094244|P2|NOT COMPLETED|Overall Study||3
864651|NCT02329223|2094245|P1|NOT COMPLETED|Overall Study||1
864652|NCT02329223|2094243|P3|COMPLETED|Overall Study||68
864653|NCT02329223|2094244|P2|COMPLETED|Overall Study||68
864654|NCT02329223|2094245|P1|COMPLETED|Overall Study||72
864655|NCT02329223|2094243|P3|Safety Set|Overall Study||74
864656|NCT02329223|2094244|P2|Safety Set|Overall Study||71
864657|NCT02329223|2094245|P1|Safety Set|Overall Study||73
864658|NCT02329223|2094243|P3|Full Analysis Set|Overall Study||74
864659|NCT02329223|2094244|P2|Full Analysis Set|Overall Study||70
864660|NCT02329223|2094245|P1|Full Analysis Set|Overall Study||73
864661|NCT02329223|2094243|P3|STARTED|Overall Study||74
864662|NCT02329223|2094244|P2|STARTED|Overall Study||71
864663|NCT02329223|2094245|P1|STARTED|Overall Study||73
864664|NCT02329015|2094278|P2|NOT COMPLETED|Overall Study||0
864665|NCT02329015|2094279|P1|NOT COMPLETED|Overall Study||0
864666|NCT02329015|2094278|P2|COMPLETED|Overall Study||64
864667|NCT02329015|2094279|P1|COMPLETED|Overall Study||48
864668|NCT02329015|2094278|P2|STARTED|Overall Study||64
864669|NCT02329015|2094279|P1|STARTED|Overall Study||48
864670|NCT02328937|2094295|P6|NOT COMPLETED|Period 3||0
864671|NCT02328937|2094296|P5|NOT COMPLETED|Period 3||0
864672|NCT02328937|2094297|P4|NOT COMPLETED|Period 3||0
864673|NCT02328937|2094298|P3|NOT COMPLETED|Period 3||0
864674|NCT02328937|2094299|P2|NOT COMPLETED|Period 3||0
864675|NCT02328937|2094300|P1|NOT COMPLETED|Period 3||0
864676|NCT02328937|2094295|P6|COMPLETED|Period 3||6
864677|NCT02328937|2094296|P5|COMPLETED|Period 3||6
864678|NCT02328937|2094297|P4|COMPLETED|Period 3||5
864679|NCT02328937|2094298|P3|COMPLETED|Period 3||6
864680|NCT02328937|2094299|P2|COMPLETED|Period 3||6
864681|NCT02328937|2094300|P1|COMPLETED|Period 3||7
864682|NCT02328937|2094295|P6|STARTED|Period 3||6
864683|NCT02328937|2094296|P5|STARTED|Period 3||6
864684|NCT02328937|2094297|P4|STARTED|Period 3||5
864685|NCT02328937|2094298|P3|STARTED|Period 3||6
864686|NCT02328937|2094299|P2|STARTED|Period 3||6
864687|NCT02328937|2094300|P1|STARTED|Period 3||7
864688|NCT02328937|2094295|P6|NOT COMPLETED|Period 2||0
864689|NCT02328937|2094296|P5|NOT COMPLETED|Period 2||0
864690|NCT02328937|2094297|P4|NOT COMPLETED|Period 2||0
864691|NCT02328937|2094298|P3|NOT COMPLETED|Period 2||1
864692|NCT02328937|2094299|P2|NOT COMPLETED|Period 2||0
864693|NCT02328937|2094300|P1|NOT COMPLETED|Period 2||0
864694|NCT02328937|2094295|P6|COMPLETED|Period 2||6
864695|NCT02328937|2094296|P5|COMPLETED|Period 2||6
864696|NCT02328937|2094297|P4|COMPLETED|Period 2||5
864697|NCT02328937|2094298|P3|COMPLETED|Period 2||6
864698|NCT02328937|2094299|P2|COMPLETED|Period 2||6
864699|NCT02328937|2094300|P1|COMPLETED|Period 2||7
864700|NCT02328937|2094295|P6|STARTED|Period 2||6
864701|NCT02328937|2094296|P5|STARTED|Period 2||6
864702|NCT02328937|2094297|P4|STARTED|Period 2||5
864703|NCT02328937|2094298|P3|STARTED|Period 2||7
864704|NCT02328937|2094299|P2|STARTED|Period 2||6
864705|NCT02328937|2094300|P1|STARTED|Period 2||7
864706|NCT02328937|2094295|P6|NOT COMPLETED|Period 1||0
864707|NCT02328937|2094296|P5|NOT COMPLETED|Period 1||0
864708|NCT02328937|2094297|P4|NOT COMPLETED|Period 1||1
864709|NCT02328937|2094298|P3|NOT COMPLETED|Period 1||0
864710|NCT02328937|2094299|P2|NOT COMPLETED|Period 1||0
864711|NCT02328937|2094300|P1|NOT COMPLETED|Period 1||0
864712|NCT02328937|2094295|P6|COMPLETED|Period 1||6
864713|NCT02328937|2094296|P5|COMPLETED|Period 1||6
864714|NCT02328937|2094297|P4|COMPLETED|Period 1||5
864715|NCT02328937|2094298|P3|COMPLETED|Period 1||7
864716|NCT02328937|2094299|P2|COMPLETED|Period 1||6
864717|NCT02328937|2094300|P1|COMPLETED|Period 1||7
864718|NCT02328937|2094295|P6|STARTED|Period 1||6
864719|NCT02328937|2094296|P5|STARTED|Period 1||6
864720|NCT02328937|2094297|P4|STARTED|Period 1||6
864721|NCT02328937|2094298|P3|STARTED|Period 1||7
864722|NCT02328937|2094299|P2|STARTED|Period 1||6
864723|NCT02328937|2094300|P1|STARTED|Period 1||7
864724|NCT02328404|2094313|P2|NOT COMPLETED|Overall Study||1
864725|NCT02328404|2094314|P1|NOT COMPLETED|Overall Study||1
864726|NCT02328404|2094313|P2|COMPLETED|Overall Study||29
864727|NCT02328404|2094314|P1|COMPLETED|Overall Study||29
864728|NCT02328404|2094313|P2|STARTED|Overall Study||30
864729|NCT02328404|2094314|P1|STARTED|Overall Study||30
864730|NCT02327429|2094348|P1|NOT COMPLETED|Overall Study||2
864731|NCT02327429|2094348|P1|COMPLETED|Overall Study||17
864732|NCT02327429|2094348|P1|STARTED|Overall Study||19
864733|NCT02327117|2094370|P2|NOT COMPLETED|Overall Study||0
864734|NCT02327117|2094371|P1|NOT COMPLETED|Overall Study||0
864735|NCT02327117|2094370|P2|COMPLETED|Overall Study||45
864736|NCT02327117|2094371|P1|COMPLETED|Overall Study||45
864737|NCT02327117|2094370|P2|STARTED|Overall Study||45
864738|NCT02327117|2094371|P1|STARTED|Overall Study||45
864739|NCT02326844|2094377|P1|NOT COMPLETED|Overall Study||0
864740|NCT02326844|2094377|P1|COMPLETED|Overall Study||3
864741|NCT02326844|2094377|P1|STARTED|Overall Study||3
864742|NCT02326649|2094384|P1|NOT COMPLETED|Overall Study||12
864743|NCT02326649|2094384|P1|COMPLETED|Overall Study||21
864744|NCT02326649|2094384|P1|STARTED|Overall Study||33
864745|NCT02325856|2094390|P2|NOT COMPLETED|Overall Study||27
864746|NCT02325856|2094391|P1|NOT COMPLETED|Overall Study||20
864747|NCT02325856|2094390|P2|COMPLETED|Overall Study||123
864748|NCT02325856|2094391|P1|COMPLETED|Overall Study||128
864749|NCT02325856|2094390|P2|STARTED|Overall Study||150
864750|NCT02325856|2094391|P1|STARTED|Overall Study||148
864751|NCT02325713|2094415|P16|NOT COMPLETED|Intervention Period 4 (2 Days)||0
864752|NCT02325713|2094416|P15|NOT COMPLETED|Intervention Period 4 (2 Days)||0
864753|NCT02325713|2094417|P14|NOT COMPLETED|Intervention Period 4 (2 Days)||0
864754|NCT02325713|2094418|P13|NOT COMPLETED|Intervention Period 4 (2 Days)||0
864755|NCT02325713|2094419|P12|NOT COMPLETED|Intervention Period 4 (2 Days)||0
864756|NCT02325713|2094420|P11|NOT COMPLETED|Intervention Period 4 (2 Days)||0
864757|NCT02325713|2094421|P10|NOT COMPLETED|Intervention Period 4 (2 Days)||0
864758|NCT02325713|2094422|P9|NOT COMPLETED|Intervention Period 4 (2 Days)||0
864759|NCT02325713|2094423|P8|NOT COMPLETED|Intervention Period 4 (2 Days)||0
864760|NCT02325713|2094424|P7|NOT COMPLETED|Intervention Period 4 (2 Days)||0
864761|NCT02325713|2094425|P6|NOT COMPLETED|Intervention Period 4 (2 Days)||0
864762|NCT02325713|2094426|P5|NOT COMPLETED|Intervention Period 4 (2 Days)||0
864763|NCT02325713|2094427|P4|NOT COMPLETED|Intervention Period 4 (2 Days)||0
864764|NCT02325713|2094428|P3|NOT COMPLETED|Intervention Period 4 (2 Days)||0
864765|NCT02325713|2094429|P2|NOT COMPLETED|Intervention Period 4 (2 Days)||0
864766|NCT02325713|2094430|P1|NOT COMPLETED|Intervention Period 4 (2 Days)||0
864767|NCT02325713|2094415|P16|COMPLETED|Intervention Period 4 (2 Days)||2
864768|NCT02325713|2094416|P15|COMPLETED|Intervention Period 4 (2 Days)||2
864769|NCT02325713|2094417|P14|COMPLETED|Intervention Period 4 (2 Days)||2
864770|NCT02325713|2094418|P13|COMPLETED|Intervention Period 4 (2 Days)||2
864771|NCT02325713|2094419|P12|COMPLETED|Intervention Period 4 (2 Days)||2
864772|NCT02325713|2094420|P11|COMPLETED|Intervention Period 4 (2 Days)||1
864773|NCT02325713|2094421|P10|COMPLETED|Intervention Period 4 (2 Days)||1
864774|NCT02325713|2094422|P9|COMPLETED|Intervention Period 4 (2 Days)||2
864775|NCT02325713|2094423|P8|COMPLETED|Intervention Period 4 (2 Days)||2
864776|NCT02325713|2094424|P7|COMPLETED|Intervention Period 4 (2 Days)||2
864777|NCT02325713|2094425|P6|COMPLETED|Intervention Period 4 (2 Days)||2
864778|NCT02325713|2094426|P5|COMPLETED|Intervention Period 4 (2 Days)||2
864779|NCT02325713|2094427|P4|COMPLETED|Intervention Period 4 (2 Days)||2
864780|NCT02325713|2094428|P3|COMPLETED|Intervention Period 4 (2 Days)||2
864781|NCT02325713|2094429|P2|COMPLETED|Intervention Period 4 (2 Days)||2
864782|NCT02325713|2094430|P1|COMPLETED|Intervention Period 4 (2 Days)||1
864783|NCT02325713|2094415|P16|STARTED|Intervention Period 4 (2 Days)||2
864784|NCT02325713|2094416|P15|STARTED|Intervention Period 4 (2 Days)||2
864785|NCT02325713|2094417|P14|STARTED|Intervention Period 4 (2 Days)||2
864786|NCT02325713|2094418|P13|STARTED|Intervention Period 4 (2 Days)||2
864787|NCT02325713|2094419|P12|STARTED|Intervention Period 4 (2 Days)||2
864788|NCT02325713|2094420|P11|STARTED|Intervention Period 4 (2 Days)||1
864789|NCT02325713|2094421|P10|STARTED|Intervention Period 4 (2 Days)||1
864790|NCT02325713|2094422|P9|STARTED|Intervention Period 4 (2 Days)||2
864791|NCT02325713|2094423|P8|STARTED|Intervention Period 4 (2 Days)||2
864792|NCT02325713|2094424|P7|STARTED|Intervention Period 4 (2 Days)||2
864793|NCT02325713|2094425|P6|STARTED|Intervention Period 4 (2 Days)||2
864794|NCT02325713|2094426|P5|STARTED|Intervention Period 4 (2 Days)||2
864795|NCT02325713|2094427|P4|STARTED|Intervention Period 4 (2 Days)||2
864796|NCT02325713|2094428|P3|STARTED|Intervention Period 4 (2 Days)||2
864797|NCT02325713|2094429|P2|STARTED|Intervention Period 4 (2 Days)||2
864798|NCT02325713|2094430|P1|STARTED|Intervention Period 4 (2 Days)||1
864799|NCT02325713|2094415|P16|NOT COMPLETED|Intervention Period 3 (2 Days)||0
864800|NCT02325713|2094416|P15|NOT COMPLETED|Intervention Period 3 (2 Days)||0
864801|NCT02325713|2094417|P14|NOT COMPLETED|Intervention Period 3 (2 Days)||0
864802|NCT02325713|2094418|P13|NOT COMPLETED|Intervention Period 3 (2 Days)||0
864803|NCT02325713|2094419|P12|NOT COMPLETED|Intervention Period 3 (2 Days)||0
864804|NCT02325713|2094420|P11|NOT COMPLETED|Intervention Period 3 (2 Days)||0
864805|NCT02325713|2094421|P10|NOT COMPLETED|Intervention Period 3 (2 Days)||1
864806|NCT02325713|2094422|P9|NOT COMPLETED|Intervention Period 3 (2 Days)||0
864807|NCT02325713|2094423|P8|NOT COMPLETED|Intervention Period 3 (2 Days)||0
864808|NCT02325713|2094424|P7|NOT COMPLETED|Intervention Period 3 (2 Days)||0
864809|NCT02325713|2094425|P6|NOT COMPLETED|Intervention Period 3 (2 Days)||0
864810|NCT02325713|2094426|P5|NOT COMPLETED|Intervention Period 3 (2 Days)||0
864811|NCT02325713|2094427|P4|NOT COMPLETED|Intervention Period 3 (2 Days)||0
864812|NCT02325713|2094428|P3|NOT COMPLETED|Intervention Period 3 (2 Days)||0
864813|NCT02325713|2094429|P2|NOT COMPLETED|Intervention Period 3 (2 Days)||0
864814|NCT02325713|2094430|P1|NOT COMPLETED|Intervention Period 3 (2 Days)||0
864815|NCT02325713|2094415|P16|COMPLETED|Intervention Period 3 (2 Days)||2
864816|NCT02325713|2094416|P15|COMPLETED|Intervention Period 3 (2 Days)||2
864817|NCT02325713|2094417|P14|COMPLETED|Intervention Period 3 (2 Days)||2
864818|NCT02325713|2094418|P13|COMPLETED|Intervention Period 3 (2 Days)||2
864819|NCT02325713|2094419|P12|COMPLETED|Intervention Period 3 (2 Days)||2
864820|NCT02325713|2094420|P11|COMPLETED|Intervention Period 3 (2 Days)||1
864821|NCT02325713|2094421|P10|COMPLETED|Intervention Period 3 (2 Days)||1
864822|NCT02325713|2094422|P9|COMPLETED|Intervention Period 3 (2 Days)||2
864823|NCT02325713|2094423|P8|COMPLETED|Intervention Period 3 (2 Days)||2
864824|NCT02325713|2094424|P7|COMPLETED|Intervention Period 3 (2 Days)||2
864825|NCT02325713|2094425|P6|COMPLETED|Intervention Period 3 (2 Days)||2
864826|NCT02325713|2094426|P5|COMPLETED|Intervention Period 3 (2 Days)||2
864827|NCT02325713|2094427|P4|COMPLETED|Intervention Period 3 (2 Days)||2
864828|NCT02325713|2094428|P3|COMPLETED|Intervention Period 3 (2 Days)||2
864829|NCT02325713|2094429|P2|COMPLETED|Intervention Period 3 (2 Days)||2
864830|NCT02325713|2094430|P1|COMPLETED|Intervention Period 3 (2 Days)||1
864831|NCT02325713|2094415|P16|STARTED|Intervention Period 3 (2 Days)||2
864832|NCT02325713|2094416|P15|STARTED|Intervention Period 3 (2 Days)||2
864833|NCT02325713|2094417|P14|STARTED|Intervention Period 3 (2 Days)||2
864834|NCT02325713|2094418|P13|STARTED|Intervention Period 3 (2 Days)||2
864835|NCT02325713|2094419|P12|STARTED|Intervention Period 3 (2 Days)||2
864836|NCT02325713|2094420|P11|STARTED|Intervention Period 3 (2 Days)||1
864837|NCT02325713|2094421|P10|STARTED|Intervention Period 3 (2 Days)||2
864838|NCT02325713|2094422|P9|STARTED|Intervention Period 3 (2 Days)||2
864839|NCT02325713|2094423|P8|STARTED|Intervention Period 3 (2 Days)||2
864840|NCT02325713|2094424|P7|STARTED|Intervention Period 3 (2 Days)||2
864841|NCT02325713|2094425|P6|STARTED|Intervention Period 3 (2 Days)||2
864842|NCT02325713|2094426|P5|STARTED|Intervention Period 3 (2 Days)||2
864843|NCT02325713|2094427|P4|STARTED|Intervention Period 3 (2 Days)||2
864844|NCT02325713|2094428|P3|STARTED|Intervention Period 3 (2 Days)||2
864845|NCT02325713|2094429|P2|STARTED|Intervention Period 3 (2 Days)||2
864846|NCT02325713|2094430|P1|STARTED|Intervention Period 3 (2 Days)||1
864847|NCT02325713|2094415|P16|NOT COMPLETED|Intervention Period 2 (2 Days)||0
864848|NCT02325713|2094416|P15|NOT COMPLETED|Intervention Period 2 (2 Days)||0
864849|NCT02325713|2094417|P14|NOT COMPLETED|Intervention Period 2 (2 Days)||0
864850|NCT02325713|2094418|P13|NOT COMPLETED|Intervention Period 2 (2 Days)||0
864851|NCT02325713|2094419|P12|NOT COMPLETED|Intervention Period 2 (2 Days)||0
864852|NCT02325713|2094420|P11|NOT COMPLETED|Intervention Period 2 (2 Days)||0
864853|NCT02325713|2094421|P10|NOT COMPLETED|Intervention Period 2 (2 Days)||0
864854|NCT02325713|2094422|P9|NOT COMPLETED|Intervention Period 2 (2 Days)||0
864855|NCT02325713|2094423|P8|NOT COMPLETED|Intervention Period 2 (2 Days)||0
864856|NCT02325713|2094424|P7|NOT COMPLETED|Intervention Period 2 (2 Days)||0
864857|NCT02325713|2094425|P6|NOT COMPLETED|Intervention Period 2 (2 Days)||0
864858|NCT02325713|2094426|P5|NOT COMPLETED|Intervention Period 2 (2 Days)||0
864859|NCT02325713|2094427|P4|NOT COMPLETED|Intervention Period 2 (2 Days)||0
864860|NCT02325713|2094428|P3|NOT COMPLETED|Intervention Period 2 (2 Days)||0
864861|NCT02325713|2094429|P2|NOT COMPLETED|Intervention Period 2 (2 Days)||0
864862|NCT02325713|2094430|P1|NOT COMPLETED|Intervention Period 2 (2 Days)||1
864863|NCT02325713|2094415|P16|COMPLETED|Intervention Period 2 (2 Days)||2
864864|NCT02325713|2094416|P15|COMPLETED|Intervention Period 2 (2 Days)||2
864865|NCT02325713|2094417|P14|COMPLETED|Intervention Period 2 (2 Days)||2
864866|NCT02325713|2094418|P13|COMPLETED|Intervention Period 2 (2 Days)||2
864867|NCT02325713|2094419|P12|COMPLETED|Intervention Period 2 (2 Days)||2
864868|NCT02325713|2094420|P11|COMPLETED|Intervention Period 2 (2 Days)||1
864869|NCT02325713|2094421|P10|COMPLETED|Intervention Period 2 (2 Days)||2
864870|NCT02325713|2094422|P9|COMPLETED|Intervention Period 2 (2 Days)||2
864871|NCT02325713|2094423|P8|COMPLETED|Intervention Period 2 (2 Days)||2
864872|NCT02325713|2094424|P7|COMPLETED|Intervention Period 2 (2 Days)||2
864873|NCT02325713|2094425|P6|COMPLETED|Intervention Period 2 (2 Days)||2
864874|NCT02325713|2094426|P5|COMPLETED|Intervention Period 2 (2 Days)||2
864875|NCT02325713|2094427|P4|COMPLETED|Intervention Period 2 (2 Days)||2
864876|NCT02325713|2094428|P3|COMPLETED|Intervention Period 2 (2 Days)||2
864877|NCT02325713|2094429|P2|COMPLETED|Intervention Period 2 (2 Days)||2
864878|NCT02325713|2094430|P1|COMPLETED|Intervention Period 2 (2 Days)||1
864879|NCT02325713|2094415|P16|STARTED|Intervention Period 2 (2 Days)||2
864880|NCT02325713|2094416|P15|STARTED|Intervention Period 2 (2 Days)||2
864881|NCT02325713|2094417|P14|STARTED|Intervention Period 2 (2 Days)||2
864882|NCT02325713|2094418|P13|STARTED|Intervention Period 2 (2 Days)||2
864883|NCT02325713|2094419|P12|STARTED|Intervention Period 2 (2 Days)||2
864884|NCT02325713|2094420|P11|STARTED|Intervention Period 2 (2 Days)||1
864885|NCT02325713|2094421|P10|STARTED|Intervention Period 2 (2 Days)||2
864886|NCT02325713|2094422|P9|STARTED|Intervention Period 2 (2 Days)||2
864887|NCT02325713|2094423|P8|STARTED|Intervention Period 2 (2 Days)||2
864888|NCT02325713|2094424|P7|STARTED|Intervention Period 2 (2 Days)||2
864889|NCT02325713|2094425|P6|STARTED|Intervention Period 2 (2 Days)||2
864890|NCT02325713|2094426|P5|STARTED|Intervention Period 2 (2 Days)||2
864891|NCT02325713|2094427|P4|STARTED|Intervention Period 2 (2 Days)||2
864892|NCT02325713|2094428|P3|STARTED|Intervention Period 2 (2 Days)||2
864893|NCT02325713|2094429|P2|STARTED|Intervention Period 2 (2 Days)||2
864894|NCT02325713|2094430|P1|STARTED|Intervention Period 2 (2 Days)||2
864895|NCT02325713|2094415|P16|NOT COMPLETED|Intervention Period 1 (2 Days)||0
864896|NCT02325713|2094416|P15|NOT COMPLETED|Intervention Period 1 (2 Days)||0
864897|NCT02325713|2094417|P14|NOT COMPLETED|Intervention Period 1 (2 Days)||0
864898|NCT02325713|2094418|P13|NOT COMPLETED|Intervention Period 1 (2 Days)||0
864899|NCT02325713|2094419|P12|NOT COMPLETED|Intervention Period 1 (2 Days)||0
864900|NCT02325713|2094420|P11|NOT COMPLETED|Intervention Period 1 (2 Days)||1
864901|NCT02325713|2094421|P10|NOT COMPLETED|Intervention Period 1 (2 Days)||0
864902|NCT02325713|2094422|P9|NOT COMPLETED|Intervention Period 1 (2 Days)||0
864903|NCT02325713|2094423|P8|NOT COMPLETED|Intervention Period 1 (2 Days)||0
864904|NCT02325713|2094424|P7|NOT COMPLETED|Intervention Period 1 (2 Days)||0
864905|NCT02325713|2094425|P6|NOT COMPLETED|Intervention Period 1 (2 Days)||0
864906|NCT02325713|2094426|P5|NOT COMPLETED|Intervention Period 1 (2 Days)||0
864907|NCT02325713|2094427|P4|NOT COMPLETED|Intervention Period 1 (2 Days)||0
864908|NCT02325713|2094428|P3|NOT COMPLETED|Intervention Period 1 (2 Days)||0
864909|NCT02325713|2094429|P2|NOT COMPLETED|Intervention Period 1 (2 Days)||0
864910|NCT02325713|2094430|P1|NOT COMPLETED|Intervention Period 1 (2 Days)||0
864911|NCT02325713|2094415|P16|COMPLETED|Intervention Period 1 (2 Days)||2
864912|NCT02325713|2094416|P15|COMPLETED|Intervention Period 1 (2 Days)||2
864913|NCT02325713|2094417|P14|COMPLETED|Intervention Period 1 (2 Days)||2
864914|NCT02325713|2094418|P13|COMPLETED|Intervention Period 1 (2 Days)||2
864915|NCT02325713|2094419|P12|COMPLETED|Intervention Period 1 (2 Days)||2
864916|NCT02325713|2094420|P11|COMPLETED|Intervention Period 1 (2 Days)||1
864917|NCT02325713|2094421|P10|COMPLETED|Intervention Period 1 (2 Days)||2
864918|NCT02325713|2094422|P9|COMPLETED|Intervention Period 1 (2 Days)||2
864919|NCT02325713|2094423|P8|COMPLETED|Intervention Period 1 (2 Days)||2
864920|NCT02325713|2094424|P7|COMPLETED|Intervention Period 1 (2 Days)||2
864921|NCT02325713|2094425|P6|COMPLETED|Intervention Period 1 (2 Days)||2
864922|NCT02325713|2094426|P5|COMPLETED|Intervention Period 1 (2 Days)||2
864923|NCT02325713|2094427|P4|COMPLETED|Intervention Period 1 (2 Days)||2
864924|NCT02325713|2094428|P3|COMPLETED|Intervention Period 1 (2 Days)||2
864925|NCT02325713|2094429|P2|COMPLETED|Intervention Period 1 (2 Days)||2
864926|NCT02325713|2094430|P1|COMPLETED|Intervention Period 1 (2 Days)||2
864927|NCT02325713|2094415|P16|STARTED|Intervention Period 1 (2 Days)||2
864928|NCT02325713|2094416|P15|STARTED|Intervention Period 1 (2 Days)||2
864929|NCT02325713|2094417|P14|STARTED|Intervention Period 1 (2 Days)||2
864930|NCT02325713|2094418|P13|STARTED|Intervention Period 1 (2 Days)||2
864931|NCT02325713|2094419|P12|STARTED|Intervention Period 1 (2 Days)||2
864932|NCT02325713|2094420|P11|STARTED|Intervention Period 1 (2 Days)||2
864933|NCT02325713|2094421|P10|STARTED|Intervention Period 1 (2 Days)||2
864934|NCT02325713|2094422|P9|STARTED|Intervention Period 1 (2 Days)||2
864935|NCT02325713|2094423|P8|STARTED|Intervention Period 1 (2 Days)||2
864936|NCT02325713|2094424|P7|STARTED|Intervention Period 1 (2 Days)||2
864937|NCT02325713|2094425|P6|STARTED|Intervention Period 1 (2 Days)||2
864938|NCT02325713|2094426|P5|STARTED|Intervention Period 1 (2 Days)||2
864939|NCT02325713|2094427|P4|STARTED|Intervention Period 1 (2 Days)||2
864940|NCT02325713|2094428|P3|STARTED|Intervention Period 1 (2 Days)||2
864941|NCT02325713|2094429|P2|STARTED|Intervention Period 1 (2 Days)||2
864942|NCT02325713|2094430|P1|STARTED|Intervention Period 1 (2 Days)||2
864943|NCT02325518|2094525|P2|NOT COMPLETED|Overall Study||3
864944|NCT02325518|2094526|P1|NOT COMPLETED|Overall Study||4
864945|NCT02325518|2094525|P2|COMPLETED|Overall Study||100
864946|NCT02325518|2094526|P1|COMPLETED|Overall Study||94
864947|NCT02325518|2094525|P2|Per Protocol Set (PPS)|Overall Study||97
864948|NCT02325518|2094526|P1|Per Protocol Set (PPS)|Overall Study||92
864949|NCT02325518|2094525|P2|Full Analysis Set (FAS)|Overall Study||101
864950|NCT02325518|2094526|P1|Full Analysis Set (FAS)|Overall Study||98
864951|NCT02325518|2094525|P2|Safety Set|Overall Study||103
864952|NCT02325518|2094526|P1|Safety Set|Overall Study||98
864953|NCT02325518|2094525|P2|STARTED|Overall Study||103
864954|NCT02325518|2094526|P1|STARTED|Overall Study||98
864955|NCT02324673|2094538|P3|NOT COMPLETED|Overall Study||0
864956|NCT02324673|2094539|P2|NOT COMPLETED|Overall Study||0
864957|NCT02324673|2094540|P1|NOT COMPLETED|Overall Study||0
864958|NCT02324673|2094538|P3|COMPLETED|Overall Study||21
864959|NCT02324673|2094539|P2|COMPLETED|Overall Study||20
864960|NCT02324673|2094540|P1|COMPLETED|Overall Study||20
864961|NCT02324673|2094538|P3|STARTED|Overall Study||21
864962|NCT02324673|2094539|P2|STARTED|Overall Study||20
864963|NCT02324673|2094540|P1|STARTED|Overall Study||20
864964|NCT02324660|2094641|P1|NOT COMPLETED|Overall Study||32
864965|NCT02324660|2094641|P1|COMPLETED|Overall Study||137
864966|NCT02324660|2094641|P1|STARTED|Overall Study||169
864967|NCT02322892|2094648|P2|NOT COMPLETED|Overall Study||3
864968|NCT02322892|2094649|P1|NOT COMPLETED|Overall Study||2
864969|NCT02322892|2094648|P2|COMPLETED|Overall Study|Received thiamine|31
864970|NCT02322892|2094649|P1|COMPLETED|Overall Study|Received placebo|33
864971|NCT02322892|2094648|P2|STARTED|Overall Study|Number randomized|34
864972|NCT02322892|2094649|P1|STARTED|Overall Study|Number randomized|35
864973|NCT02322879|2094665|P2|NOT COMPLETED|Second Intervention||0
864974|NCT02322879|2094666|P1|NOT COMPLETED|Second Intervention||0
864975|NCT02322879|2094665|P2|COMPLETED|Second Intervention||10
864976|NCT02322879|2094666|P1|COMPLETED|Second Intervention||10
864977|NCT02322879|2094665|P2|STARTED|Second Intervention||10
864978|NCT02322879|2094666|P1|STARTED|Second Intervention||10
864979|NCT02322879|2094665|P2|NOT COMPLETED|Washout||0
864980|NCT02322879|2094666|P1|NOT COMPLETED|Washout||0
864981|NCT02322879|2094665|P2|COMPLETED|Washout||10
864982|NCT02322879|2094666|P1|COMPLETED|Washout||10
864983|NCT02322879|2094665|P2|STARTED|Washout||10
864984|NCT02322879|2094666|P1|STARTED|Washout||10
864985|NCT02322879|2094665|P2|NOT COMPLETED|First Intervention||0
864986|NCT02322879|2094666|P1|NOT COMPLETED|First Intervention||1
864987|NCT02322879|2094665|P2|COMPLETED|First Intervention||10
864988|NCT02322879|2094666|P1|COMPLETED|First Intervention||10
864989|NCT02322879|2094665|P2|STARTED|First Intervention||10
864990|NCT02322879|2094666|P1|STARTED|First Intervention||11
864991|NCT02322788|2094672|P4|NOT COMPLETED|Visit 6||0
864992|NCT02322788|2094673|P3|NOT COMPLETED|Visit 6||0
864993|NCT02322788|2094674|P2|NOT COMPLETED|Visit 6||0
864994|NCT02322788|2094675|P1|NOT COMPLETED|Visit 6||0
864995|NCT02322788|2094672|P4|COMPLETED|Visit 6||15
864996|NCT02322788|2094673|P3|COMPLETED|Visit 6||15
864997|NCT02322788|2094674|P2|COMPLETED|Visit 6||16
864998|NCT02322788|2094675|P1|COMPLETED|Visit 6||14
864999|NCT02322788|2094672|P4|STARTED|Visit 6||15
865000|NCT02322788|2094673|P3|STARTED|Visit 6||15
865001|NCT02322788|2094674|P2|STARTED|Visit 6||16
865002|NCT02322788|2094675|P1|STARTED|Visit 6||14
865003|NCT02322788|2094672|P4|NOT COMPLETED|Visit 5||0
865004|NCT02322788|2094673|P3|NOT COMPLETED|Visit 5||0
865005|NCT02322788|2094674|P2|NOT COMPLETED|Visit 5||0
865006|NCT02322788|2094675|P1|NOT COMPLETED|Visit 5||0
865007|NCT02322788|2094672|P4|COMPLETED|Visit 5||14
865008|NCT02322788|2094673|P3|COMPLETED|Visit 5||15
865009|NCT02322788|2094674|P2|COMPLETED|Visit 5||15
865010|NCT02322788|2094675|P1|COMPLETED|Visit 5||16
865011|NCT02322788|2094672|P4|STARTED|Visit 5||14
865012|NCT02322788|2094673|P3|STARTED|Visit 5||15
865013|NCT02322788|2094674|P2|STARTED|Visit 5||15
865014|NCT02322788|2094675|P1|STARTED|Visit 5||16
865015|NCT02322788|2094672|P4|NOT COMPLETED|Visit 4||0
865016|NCT02322788|2094673|P3|NOT COMPLETED|Visit 4||0
865017|NCT02322788|2094674|P2|NOT COMPLETED|Visit 4||0
865018|NCT02322788|2094675|P1|NOT COMPLETED|Visit 4||0
865019|NCT02322788|2094672|P4|COMPLETED|Visit 4||15
865020|NCT02322788|2094673|P3|COMPLETED|Visit 4||16
865021|NCT02322788|2094674|P2|COMPLETED|Visit 4||14
865022|NCT02322788|2094675|P1|COMPLETED|Visit 4||15
865023|NCT02322788|2094672|P4|STARTED|Visit 4||15
865024|NCT02322788|2094673|P3|STARTED|Visit 4||16
865025|NCT02322788|2094674|P2|STARTED|Visit 4||14
865026|NCT02322788|2094675|P1|STARTED|Visit 4||15
865027|NCT02322788|2094672|P4|NOT COMPLETED|Visit 3||0
865028|NCT02322788|2094673|P3|NOT COMPLETED|Visit 3||0
865029|NCT02322788|2094674|P2|NOT COMPLETED|Visit 3||0
865030|NCT02322788|2094675|P1|NOT COMPLETED|Visit 3||0
865031|NCT02322788|2094672|P4|COMPLETED|Visit 3||16
865032|NCT02322788|2094673|P3|COMPLETED|Visit 3||14
865033|NCT02322788|2094674|P2|COMPLETED|Visit 3||15
865034|NCT02322788|2094675|P1|COMPLETED|Visit 3||15
865035|NCT02322788|2094672|P4|STARTED|Visit 3||16
865036|NCT02322788|2094673|P3|STARTED|Visit 3||14
865037|NCT02322788|2094674|P2|STARTED|Visit 3||15
865038|NCT02322788|2094675|P1|STARTED|Visit 3||15
865039|NCT02322775|2094687|P2|NOT COMPLETED|Overall Study||6
865040|NCT02322775|2094688|P1|NOT COMPLETED|Overall Study||5
865041|NCT02322775|2094687|P2|COMPLETED|Overall Study||99
865042|NCT02322775|2094688|P1|COMPLETED|Overall Study||101
865043|NCT02322775|2094687|P2|STARTED|Overall Study||105
865044|NCT02322775|2094688|P1|STARTED|Overall Study||106
865045|NCT02322749|2094714|P6|NOT COMPLETED|Period 3||0
865046|NCT02322749|2094715|P5|NOT COMPLETED|Period 3||0
865047|NCT02322749|2094716|P4|NOT COMPLETED|Period 3||0
865048|NCT02322749|2094717|P3|NOT COMPLETED|Period 3||1
865049|NCT02322749|2094718|P2|NOT COMPLETED|Period 3||0
865050|NCT02322749|2094719|P1|NOT COMPLETED|Period 3||0
865051|NCT02322749|2094714|P6|COMPLETED|Period 3||8
865052|NCT02322749|2094715|P5|COMPLETED|Period 3||8
865053|NCT02322749|2094716|P4|COMPLETED|Period 3||6
865054|NCT02322749|2094717|P3|COMPLETED|Period 3||7
865055|NCT02322749|2094718|P2|COMPLETED|Period 3||8
865056|NCT02322749|2094719|P1|COMPLETED|Period 3||8
865057|NCT02322749|2094714|P6|STARTED|Period 3||8
865058|NCT02322749|2094715|P5|STARTED|Period 3||8
865059|NCT02322749|2094716|P4|STARTED|Period 3||6
865060|NCT02322749|2094717|P3|STARTED|Period 3||8
865061|NCT02322749|2094718|P2|STARTED|Period 3||8
865062|NCT02322749|2094719|P1|STARTED|Period 3||8
865063|NCT02322749|2094714|P6|NOT COMPLETED|Period 2||0
865064|NCT02322749|2094715|P5|NOT COMPLETED|Period 2||0
865065|NCT02322749|2094716|P4|NOT COMPLETED|Period 2||2
865066|NCT02322749|2094717|P3|NOT COMPLETED|Period 2||0
865067|NCT02322749|2094718|P2|NOT COMPLETED|Period 2||0
865068|NCT02322749|2094719|P1|NOT COMPLETED|Period 2||0
865069|NCT02322749|2094714|P6|COMPLETED|Period 2||8
865070|NCT02322749|2094715|P5|COMPLETED|Period 2||8
865071|NCT02322749|2094716|P4|COMPLETED|Period 2||6
865072|NCT02322749|2094717|P3|COMPLETED|Period 2||8
865073|NCT02322749|2094718|P2|COMPLETED|Period 2||8
865074|NCT02322749|2094719|P1|COMPLETED|Period 2||8
865075|NCT02322749|2094714|P6|STARTED|Period 2||8
865076|NCT02322749|2094715|P5|STARTED|Period 2||8
865077|NCT02322749|2094716|P4|STARTED|Period 2||8
865078|NCT02322749|2094717|P3|STARTED|Period 2||8
865079|NCT02322749|2094718|P2|STARTED|Period 2||8
865080|NCT02322749|2094719|P1|STARTED|Period 2||8
865081|NCT02322749|2094714|P6|NOT COMPLETED|Period 1||0
865082|NCT02322749|2094715|P5|NOT COMPLETED|Period 1||0
865083|NCT02322749|2094716|P4|NOT COMPLETED|Period 1||0
865084|NCT02322749|2094717|P3|NOT COMPLETED|Period 1||0
865085|NCT02322749|2094718|P2|NOT COMPLETED|Period 1||0
865086|NCT02322749|2094719|P1|NOT COMPLETED|Period 1||0
865087|NCT02322749|2094714|P6|COMPLETED|Period 1||8
865088|NCT02322749|2094715|P5|COMPLETED|Period 1||8
865089|NCT02322749|2094716|P4|COMPLETED|Period 1||8
865090|NCT02322749|2094717|P3|COMPLETED|Period 1||8
865091|NCT02322749|2094718|P2|COMPLETED|Period 1||8
865092|NCT02322749|2094719|P1|COMPLETED|Period 1||8
865093|NCT02322749|2094714|P6|STARTED|Period 1||8
865094|NCT02322749|2094715|P5|STARTED|Period 1||8
865095|NCT02322749|2094716|P4|STARTED|Period 1||8
865096|NCT02322749|2094717|P3|STARTED|Period 1||8
865097|NCT02322749|2094718|P2|STARTED|Period 1||8
865098|NCT02322749|2094719|P1|STARTED|Period 1||8
865099|NCT02322528|2094742|P1|NOT COMPLETED|Overall Study||0
865100|NCT02322528|2094742|P1|COMPLETED|Overall Study||10
865101|NCT02322528|2094742|P1|STARTED|Overall Study||10
865102|NCT02322216|2094749|P2|NOT COMPLETED|Overall Study||4
865103|NCT02322216|2094750|P1|NOT COMPLETED|Overall Study||2
865104|NCT02322216|2094749|P2|COMPLETED|Overall Study||123
865105|NCT02322216|2094750|P1|COMPLETED|Overall Study||124
865106|NCT02322216|2094749|P2|Per Protocol Set (PPS)|Overall Study||122
865107|NCT02322216|2094750|P1|Per Protocol Set (PPS)|Overall Study||123
865108|NCT02322216|2094749|P2|Treated (Safety Set)|Overall Study||126
865109|NCT02322216|2094750|P1|Treated (Safety Set)|Overall Study||126
865110|NCT02322216|2094749|P2|STARTED|Overall Study||127
865111|NCT02322216|2094750|P1|STARTED|Overall Study||126
865112|NCT02321527|2094757|P1|NOT COMPLETED|Overall Study||1
865113|NCT02321527|2094757|P1|COMPLETED|Overall Study||20
865114|NCT02321527|2094757|P1|STARTED|Overall Study||21
865115|NCT02321436|2094763|P2|NOT COMPLETED|Overall Study||1
865116|NCT02321436|2094764|P1|NOT COMPLETED|Overall Study||1
865117|NCT02321436|2094763|P2|COMPLETED|Overall Study||13
865118|NCT02321436|2094764|P1|COMPLETED|Overall Study||27
865119|NCT02321436|2094763|P2|STARTED|Overall Study||14
865120|NCT02321436|2094764|P1|STARTED|Overall Study||28
865121|NCT02320838|2094780|P5|NOT COMPLETED|Third Intervention (1 Day)||0
865122|NCT02320838|2094781|P4|NOT COMPLETED|Third Intervention (1 Day)||0
865123|NCT02320838|2094782|P3|NOT COMPLETED|Third Intervention (1 Day)||0
865124|NCT02320838|2094783|P2|NOT COMPLETED|Third Intervention (1 Day)||0
865125|NCT02320838|2094784|P1|NOT COMPLETED|Third Intervention (1 Day)||0
865126|NCT02320838|2094780|P5|COMPLETED|Third Intervention (1 Day)||7
865127|NCT02320838|2094781|P4|COMPLETED|Third Intervention (1 Day)||7
865128|NCT02320838|2094782|P3|COMPLETED|Third Intervention (1 Day)||8
865129|NCT02320838|2094783|P2|COMPLETED|Third Intervention (1 Day)||8
865130|NCT02320838|2094784|P1|COMPLETED|Third Intervention (1 Day)||8
865131|NCT02320838|2094780|P5|STARTED|Third Intervention (1 Day)||7
865132|NCT02320838|2094781|P4|STARTED|Third Intervention (1 Day)||7
865133|NCT02320838|2094782|P3|STARTED|Third Intervention (1 Day)||8
865134|NCT02320838|2094783|P2|STARTED|Third Intervention (1 Day)||8
865135|NCT02320838|2094784|P1|STARTED|Third Intervention (1 Day)||8
865136|NCT02320838|2094780|P5|NOT COMPLETED|Washout (1 Day)||0
865137|NCT02320838|2094781|P4|NOT COMPLETED|Washout (1 Day)||0
865138|NCT02320838|2094782|P3|NOT COMPLETED|Washout (1 Day)||0
865139|NCT02320838|2094783|P2|NOT COMPLETED|Washout (1 Day)||0
865140|NCT02320838|2094784|P1|NOT COMPLETED|Washout (1 Day)||0
865141|NCT02320838|2094780|P5|COMPLETED|Washout (1 Day)||7
865142|NCT02320838|2094781|P4|COMPLETED|Washout (1 Day)||7
865143|NCT02320838|2094782|P3|COMPLETED|Washout (1 Day)||8
865144|NCT02320838|2094783|P2|COMPLETED|Washout (1 Day)||8
865145|NCT02320838|2094784|P1|COMPLETED|Washout (1 Day)||8
865146|NCT02320838|2094780|P5|STARTED|Washout (1 Day)||7
865147|NCT02320838|2094781|P4|STARTED|Washout (1 Day)||7
865148|NCT02320838|2094782|P3|STARTED|Washout (1 Day)||8
865149|NCT02320838|2094783|P2|STARTED|Washout (1 Day)||8
865150|NCT02320838|2094784|P1|STARTED|Washout (1 Day)||8
865151|NCT02320838|2094780|P5|NOT COMPLETED|Second Intervention (1 Day)||0
865152|NCT02320838|2094781|P4|NOT COMPLETED|Second Intervention (1 Day)||0
865153|NCT02320838|2094782|P3|NOT COMPLETED|Second Intervention (1 Day)||0
865154|NCT02320838|2094783|P2|NOT COMPLETED|Second Intervention (1 Day)||0
865155|NCT02320838|2094784|P1|NOT COMPLETED|Second Intervention (1 Day)||0
865156|NCT02320838|2094780|P5|COMPLETED|Second Intervention (1 Day)||7
865157|NCT02320838|2094781|P4|COMPLETED|Second Intervention (1 Day)||7
865158|NCT02320838|2094782|P3|COMPLETED|Second Intervention (1 Day)||8
865159|NCT02320838|2094783|P2|COMPLETED|Second Intervention (1 Day)||8
865160|NCT02320838|2094784|P1|COMPLETED|Second Intervention (1 Day)||8
865161|NCT02320838|2094780|P5|STARTED|Second Intervention (1 Day)||7
865162|NCT02320838|2094781|P4|STARTED|Second Intervention (1 Day)||7
865163|NCT02320838|2094782|P3|STARTED|Second Intervention (1 Day)||8
865164|NCT02320838|2094783|P2|STARTED|Second Intervention (1 Day)||8
865165|NCT02320838|2094784|P1|STARTED|Second Intervention (1 Day)||8
865166|NCT02320838|2094780|P5|NOT COMPLETED|Washout (1 Day)||0
865167|NCT02320838|2094781|P4|NOT COMPLETED|Washout (1 Day)||0
865168|NCT02320838|2094782|P3|NOT COMPLETED|Washout (1 Day)||0
865169|NCT02320838|2094783|P2|NOT COMPLETED|Washout (1 Day)||0
865170|NCT02320838|2094784|P1|NOT COMPLETED|Washout (1 Day)||0
865171|NCT02320838|2094780|P5|COMPLETED|Washout (1 Day)||7
865172|NCT02320838|2094781|P4|COMPLETED|Washout (1 Day)||7
865173|NCT02320838|2094782|P3|COMPLETED|Washout (1 Day)||8
865174|NCT02320838|2094783|P2|COMPLETED|Washout (1 Day)||8
865175|NCT02320838|2094784|P1|COMPLETED|Washout (1 Day)||8
865176|NCT02320838|2094780|P5|STARTED|Washout (1 Day)||7
865177|NCT02320838|2094781|P4|STARTED|Washout (1 Day)||7
865178|NCT02320838|2094782|P3|STARTED|Washout (1 Day)||8
865179|NCT02320838|2094783|P2|STARTED|Washout (1 Day)||8
865180|NCT02320838|2094784|P1|STARTED|Washout (1 Day)||8
865181|NCT02320838|2094780|P5|NOT COMPLETED|First Intervention (1 Day)||0
865182|NCT02320838|2094781|P4|NOT COMPLETED|First Intervention (1 Day)||0
865183|NCT02320838|2094782|P3|NOT COMPLETED|First Intervention (1 Day)||0
865184|NCT02320838|2094783|P2|NOT COMPLETED|First Intervention (1 Day)||0
865185|NCT02320838|2094784|P1|NOT COMPLETED|First Intervention (1 Day)||0
865186|NCT02320838|2094780|P5|COMPLETED|First Intervention (1 Day)||7
865187|NCT02320838|2094781|P4|COMPLETED|First Intervention (1 Day)||7
865188|NCT02320838|2094782|P3|COMPLETED|First Intervention (1 Day)||8
865189|NCT02320838|2094783|P2|COMPLETED|First Intervention (1 Day)||8
865190|NCT02320838|2094784|P1|COMPLETED|First Intervention (1 Day)||8
865191|NCT02320838|2094780|P5|STARTED|First Intervention (1 Day)||7
865192|NCT02320838|2094781|P4|STARTED|First Intervention (1 Day)||7
865193|NCT02320838|2094782|P3|STARTED|First Intervention (1 Day)||8
865194|NCT02320838|2094783|P2|STARTED|First Intervention (1 Day)||8
865195|NCT02320838|2094784|P1|STARTED|First Intervention (1 Day)||8
865196|NCT02320721|2094851|P2|NOT COMPLETED|Overall Study||34
865197|NCT02320721|2094852|P1|NOT COMPLETED|Overall Study||27
865198|NCT02320721|2094851|P2|COMPLETED|Overall Study||472
865199|NCT02320721|2094852|P1|COMPLETED|Overall Study||481
865200|NCT02320721|2094851|P2|Treated (Safety Population)|Overall Study||505
865201|NCT02320721|2094852|P1|Treated (Safety Population)|Overall Study||508
865202|NCT02320721|2094851|P2|STARTED|Overall Study||506
865203|NCT02320721|2094852|P1|STARTED|Overall Study||508
865204|NCT02320695|2094880|P1|NOT COMPLETED|Overall Study||0
865205|NCT02320695|2094880|P1|COMPLETED|Overall Study||60
865206|NCT02320695|2094880|P1|Pain Relief Ointment|Overall Study||60
865207|NCT02320695|2094880|P1|Original Ointment|Overall Study||60
865208|NCT02320695|2094880|P1|Antibiotic/Pain Relieving Ointment|Overall Study||60
865209|NCT02320695|2094880|P1|Pain Relieving Cream|Overall Study||59
865210|NCT02320695|2094880|P1|Alcohol|Overall Study||60
865211|NCT02320695|2094880|P1|Saline|Overall Study||60
865212|NCT02320695|2094880|P1|STARTED|Overall Study||60
865213|NCT02320396|2094909|P2|NOT COMPLETED|Overall Study||4
865214|NCT02320396|2094910|P1|NOT COMPLETED|Overall Study||4
865215|NCT02320396|2094909|P2|COMPLETED|Overall Study||221
865216|NCT02320396|2094910|P1|COMPLETED|Overall Study||220
865217|NCT02320396|2094909|P2|Treated (Full Analysis Set)|Overall Study||225
865218|NCT02320396|2094910|P1|Treated (Full Analysis Set)|Overall Study||223
865219|NCT02320396|2094909|P2|STARTED|Overall Study||225
865220|NCT02320396|2094910|P1|STARTED|Overall Study||224
865221|NCT02320227|2094940|P1|NOT COMPLETED|Overall Study||0
865222|NCT02320227|2094940|P1|COMPLETED|Overall Study||30
865223|NCT02320227|2094940|P1|STARTED|Overall Study||30
865224|NCT02320214|2094945|P1|NOT COMPLETED|Overall Study||0
865225|NCT02320214|2094945|P1|COMPLETED|Overall Study||30
865226|NCT02320214|2094945|P1|STARTED|Overall Study||30
865227|NCT02319824|2094950|P1|NOT COMPLETED|Overall Study||0
865228|NCT02319824|2094950|P1|COMPLETED|Overall Study||2
865229|NCT02319824|2094950|P1|STARTED|Overall Study||2
865230|NCT02319668|2094958|P2|NOT COMPLETED|Overall Study||2
865231|NCT02319668|2094959|P1|NOT COMPLETED|Overall Study||0
865232|NCT02319668|2094958|P2|COMPLETED|Overall Study||17
865233|NCT02319668|2094959|P1|COMPLETED|Overall Study||19
865234|NCT02319668|2094958|P2|STARTED|Overall Study||19
865235|NCT02319668|2094959|P1|STARTED|Overall Study||19
865236|NCT02319525|2094973|P2|NOT COMPLETED|Overall Study||1
865237|NCT02319525|2094974|P1|NOT COMPLETED|Overall Study||2
865238|NCT02319525|2094973|P2|COMPLETED|Overall Study||147
865239|NCT02319525|2094974|P1|COMPLETED|Overall Study||151
865240|NCT02319525|2094973|P2|Primary Research Completion|Overall Study||147
865241|NCT02319525|2094974|P1|Primary Research Completion|Overall Study||151
865242|NCT02319525|2094973|P2|STARTED|Overall Study||148
865243|NCT02319525|2094974|P1|STARTED|Overall Study||153
865244|NCT02319486|2094992|P1|NOT COMPLETED|Overall Study||0
865245|NCT02319486|2094992|P1|COMPLETED|Overall Study||26
865246|NCT02319486|2094992|P1|STARTED|Overall Study||26
865247|NCT02319317|2095000|P2|NOT COMPLETED|Overall Study||0
865248|NCT02319317|2095001|P1|NOT COMPLETED|Overall Study||0
865249|NCT02319317|2095000|P2|COMPLETED|Overall Study||29
865250|NCT02319317|2095001|P1|COMPLETED|Overall Study||31
865251|NCT02319317|2095000|P2|STARTED|Overall Study||29
865252|NCT02319317|2095001|P1|STARTED|Overall Study||31
865253|NCT02319148|2095010|P4|NOT COMPLETED|Second Intervention Period||2
865254|NCT02319148|2095011|P3|NOT COMPLETED|Second Intervention Period||1
865255|NCT02319148|2095012|P2|NOT COMPLETED|Second Intervention Period||1
865256|NCT02319148|2095013|P1|NOT COMPLETED|Second Intervention Period||0
865257|NCT02319148|2095010|P4|COMPLETED|Second Intervention Period||6
865258|NCT02319148|2095011|P3|COMPLETED|Second Intervention Period||6
865259|NCT02319148|2095012|P2|COMPLETED|Second Intervention Period||6
865260|NCT02319148|2095013|P1|COMPLETED|Second Intervention Period||0
865261|NCT02319148|2095010|P4|STARTED|Second Intervention Period||8
865262|NCT02319148|2095011|P3|STARTED|Second Intervention Period||7
865263|NCT02319148|2095012|P2|STARTED|Second Intervention Period||7
865264|NCT02319148|2095013|P1|STARTED|Second Intervention Period||0
865265|NCT02319148|2095010|P4|NOT COMPLETED|Washout Period 4 Days||0
865266|NCT02319148|2095011|P3|NOT COMPLETED|Washout Period 4 Days||0
865267|NCT02319148|2095012|P2|NOT COMPLETED|Washout Period 4 Days||0
865268|NCT02319148|2095013|P1|NOT COMPLETED|Washout Period 4 Days||0
865269|NCT02319148|2095010|P4|COMPLETED|Washout Period 4 Days||0
865270|NCT02319148|2095011|P3|COMPLETED|Washout Period 4 Days||0
865271|NCT02319148|2095012|P2|COMPLETED|Washout Period 4 Days||0
865272|NCT02319148|2095013|P1|COMPLETED|Washout Period 4 Days||22
865273|NCT02319148|2095010|P4|STARTED|Washout Period 4 Days||0
865274|NCT02319148|2095011|P3|STARTED|Washout Period 4 Days||0
865275|NCT02319148|2095012|P2|STARTED|Washout Period 4 Days||0
865276|NCT02319148|2095013|P1|STARTED|Washout Period 4 Days||22
865277|NCT02319148|2095010|P4|NOT COMPLETED|First Intervention Period||0
865278|NCT02319148|2095011|P3|NOT COMPLETED|First Intervention Period||0
865279|NCT02319148|2095012|P2|NOT COMPLETED|First Intervention Period||0
865280|NCT02319148|2095013|P1|NOT COMPLETED|First Intervention Period||0
865281|NCT02319148|2095010|P4|COMPLETED|First Intervention Period||0
865282|NCT02319148|2095011|P3|COMPLETED|First Intervention Period||0
865283|NCT02319148|2095012|P2|COMPLETED|First Intervention Period||0
865284|NCT02319148|2095013|P1|COMPLETED|First Intervention Period||22
865285|NCT02319148|2095010|P4|STARTED|First Intervention Period||0
865286|NCT02319148|2095011|P3|STARTED|First Intervention Period||0
865287|NCT02319148|2095012|P2|STARTED|First Intervention Period||0
865288|NCT02319148|2095013|P1|STARTED|First Intervention Period||22
865289|NCT02319031|2095075|P2|NOT COMPLETED|Follow-Up Period||0
865290|NCT02319031|2095076|P1|NOT COMPLETED|Follow-Up Period||0
865291|NCT02319031|2095075|P2|COMPLETED|Follow-Up Period||26
865292|NCT02319031|2095076|P1|COMPLETED|Follow-Up Period||23
865293|NCT02319031|2095075|P2|STARTED|Follow-Up Period||26
865294|NCT02319031|2095076|P1|STARTED|Follow-Up Period||23
865295|NCT02319031|2095075|P2|NOT COMPLETED|Treatment Period||0
865296|NCT02319031|2095076|P1|NOT COMPLETED|Treatment Period||1
865297|NCT02319031|2095075|P2|COMPLETED|Treatment Period||26
865298|NCT02319031|2095076|P1|COMPLETED|Treatment Period||23
865299|NCT02319031|2095075|P2|STARTED|Treatment Period||26
865300|NCT02319031|2095076|P1|STARTED|Treatment Period||24
865301|NCT02318940|2095088|P2|NOT COMPLETED|Overall Study||0
865302|NCT02318940|2095089|P1|NOT COMPLETED|Overall Study||1
865303|NCT02318940|2095088|P2|COMPLETED|Overall Study||50
865304|NCT02318940|2095089|P1|COMPLETED|Overall Study||49
865305|NCT02318940|2095088|P2|STARTED|Overall Study||50
865306|NCT02318940|2095089|P1|STARTED|Overall Study|in the last patient we lost the record.|50
865307|NCT02318693|2095103|P2|NOT COMPLETED|Overall Study||1
865308|NCT02318693|2095104|P1|NOT COMPLETED|Overall Study||0
865309|NCT02318693|2095103|P2|COMPLETED|Overall Study||26
865310|NCT02318693|2095104|P1|COMPLETED|Overall Study||26
865311|NCT02318693|2095103|P2|Treated|Overall Study|1 randomized participant did not receive treatment.|26
865312|NCT02318693|2095104|P1|Treated|Overall Study||26
865313|NCT02318693|2095103|P2|STARTED|Overall Study||27
865314|NCT02318693|2095104|P1|STARTED|Overall Study||26
865315|NCT02318303|2095125|P7|NOT COMPLETED|Overall Study||2
865316|NCT02318303|2095126|P6|NOT COMPLETED|Overall Study||6
865317|NCT02318303|2095127|P5|NOT COMPLETED|Overall Study||5
865318|NCT02318303|2095128|P4|NOT COMPLETED|Overall Study||3
865319|NCT02318303|2095129|P3|NOT COMPLETED|Overall Study||3
865320|NCT02318303|2095130|P2|NOT COMPLETED|Overall Study||3
865321|NCT02318303|2095131|P1|NOT COMPLETED|Overall Study||4
865322|NCT02318303|2095125|P7|COMPLETED|Overall Study||158
865323|NCT02318303|2095126|P6|COMPLETED|Overall Study||153
865324|NCT02318303|2095127|P5|COMPLETED|Overall Study||152
865325|NCT02318303|2095128|P4|COMPLETED|Overall Study||155
865326|NCT02318303|2095129|P3|COMPLETED|Overall Study||157
865327|NCT02318303|2095130|P2|COMPLETED|Overall Study||155
865328|NCT02318303|2095131|P1|COMPLETED|Overall Study||155
865329|NCT02318303|2095125|P7|STARTED|Overall Study||160
865330|NCT02318303|2095126|P6|STARTED|Overall Study||159
865331|NCT02318303|2095127|P5|STARTED|Overall Study||157
865332|NCT02318303|2095128|P4|STARTED|Overall Study||158
865333|NCT02318303|2095129|P3|STARTED|Overall Study||160
865334|NCT02318303|2095130|P2|STARTED|Overall Study||158
865335|NCT02318303|2095131|P1|STARTED|Overall Study||159
865336|NCT02317809|2095147|P2|NOT COMPLETED|Second Intervention Period (8 Days)||0
865337|NCT02317809|2095148|P1|NOT COMPLETED|Second Intervention Period (8 Days)||0
865338|NCT02317809|2095147|P2|COMPLETED|Second Intervention Period (8 Days)||17
865339|NCT02317809|2095148|P1|COMPLETED|Second Intervention Period (8 Days)||14
865340|NCT02317809|2095147|P2|STARTED|Second Intervention Period (8 Days)||17
865341|NCT02317809|2095148|P1|STARTED|Second Intervention Period (8 Days)||14
865342|NCT02317809|2095147|P2|NOT COMPLETED|First Intervention Period (8 Days)||0
865343|NCT02317809|2095148|P1|NOT COMPLETED|First Intervention Period (8 Days)||3
865344|NCT02317809|2095147|P2|COMPLETED|First Intervention Period (8 Days)||17
865345|NCT02317809|2095148|P1|COMPLETED|First Intervention Period (8 Days)||14
865346|NCT02317809|2095147|P2|STARTED|First Intervention Period (8 Days)||17
865347|NCT02317809|2095148|P1|STARTED|First Intervention Period (8 Days)||17
865348|NCT02317510|2095192|P2|NOT COMPLETED|Overall Study||1
865349|NCT02317510|2095193|P1|NOT COMPLETED|Overall Study||0
865350|NCT02317510|2095192|P2|COMPLETED|Overall Study||24
865351|NCT02317510|2095193|P1|COMPLETED|Overall Study||25
865352|NCT02317510|2095192|P2|STARTED|Overall Study||25
865353|NCT02317510|2095193|P1|STARTED|Overall Study||25
865366|NCT02316769|2095249|P2|NOT COMPLETED|Overall Study||0
865367|NCT02316769|2095250|P1|NOT COMPLETED|Overall Study||2
865368|NCT02316769|2095249|P2|COMPLETED|Overall Study||33
865369|NCT02316769|2095250|P1|COMPLETED|Overall Study||31
865370|NCT02316769|2095249|P2|STARTED|Overall Study||33
865371|NCT02316769|2095250|P1|STARTED|Overall Study||33
865372|NCT02316678|2095260|P2|NOT COMPLETED|Overall Study||0
865373|NCT02316678|2095261|P1|NOT COMPLETED|Overall Study||0
865374|NCT02316678|2095260|P2|COMPLETED|Overall Study||7694
865375|NCT02316678|2095261|P1|COMPLETED|Overall Study||1879
865376|NCT02316678|2095260|P2|STARTED|Overall Study||7694
865377|NCT02316678|2095261|P1|STARTED|Overall Study||1879
865378|NCT02316613|2095267|P1|NOT COMPLETED|Overall Study||104
865379|NCT02316613|2095267|P1|COMPLETED|Overall Study||156
865380|NCT02316613|2095267|P1|Overall Population|Overall Study||241
865381|NCT02316613|2095267|P1|Safety Population|Overall Study||255
865382|NCT02316613|2095267|P1|STARTED|Overall Study||260
865383|NCT02316470|2095308|P4|NOT COMPLETED|Overall Study||2
865384|NCT02316470|2095309|P3|NOT COMPLETED|Overall Study||5
865385|NCT02316470|2095310|P2|NOT COMPLETED|Overall Study||6
865386|NCT02316470|2095311|P1|NOT COMPLETED|Overall Study||5
865387|NCT02316470|2095308|P4|COMPLETED|Overall Study||46
865388|NCT02316470|2095309|P3|COMPLETED|Overall Study||147
865389|NCT02316470|2095310|P2|COMPLETED|Overall Study||146
865390|NCT02316470|2095311|P1|COMPLETED|Overall Study||143
865391|NCT02316470|2095308|P4|STARTED|Overall Study||48
865392|NCT02316470|2095309|P3|STARTED|Overall Study||152
865393|NCT02316470|2095310|P2|STARTED|Overall Study||152
865394|NCT02316470|2095311|P1|STARTED|Overall Study||148
865395|NCT02316366|2095407|P2|NOT COMPLETED|Overall Study||0
865396|NCT02316366|2095408|P1|NOT COMPLETED|Overall Study||0
865397|NCT02316366|2095407|P2|COMPLETED|Overall Study||40
865398|NCT02316366|2095408|P1|COMPLETED|Overall Study||40
865399|NCT02316366|2095407|P2|STARTED|Overall Study||40
865400|NCT02316366|2095408|P1|STARTED|Overall Study||40
865401|NCT02315989|2095418|P1|NOT COMPLETED|Overall Study||0
865402|NCT02315989|2095418|P1|COMPLETED|Overall Study||6
865403|NCT02315989|2095418|P1|STARTED|Overall Study||6
865404|NCT02315352|2095428|P8|NOT COMPLETED|Fifth Intervention (Day 2)||0
865405|NCT02315352|2095429|P7|NOT COMPLETED|Fifth Intervention (Day 2)||0
865406|NCT02315352|2095430|P6|NOT COMPLETED|Fifth Intervention (Day 2)||0
865407|NCT02315352|2095431|P5|NOT COMPLETED|Fifth Intervention (Day 2)||0
865408|NCT02315352|2095432|P4|NOT COMPLETED|Fifth Intervention (Day 2)||0
865409|NCT02315352|2095433|P3|NOT COMPLETED|Fifth Intervention (Day 2)||0
865410|NCT02315352|2095434|P2|NOT COMPLETED|Fifth Intervention (Day 2)||0
865411|NCT02315352|2095435|P1|NOT COMPLETED|Fifth Intervention (Day 2)||0
865412|NCT02315352|2095428|P8|COMPLETED|Fifth Intervention (Day 2)||8
865413|NCT02315352|2095429|P7|COMPLETED|Fifth Intervention (Day 2)||9
865414|NCT02315352|2095430|P6|COMPLETED|Fifth Intervention (Day 2)||7
865415|NCT02315352|2095431|P5|COMPLETED|Fifth Intervention (Day 2)||8
865416|NCT02315352|2095432|P4|COMPLETED|Fifth Intervention (Day 2)||8
865417|NCT02315352|2095433|P3|COMPLETED|Fifth Intervention (Day 2)||7
865418|NCT02315352|2095434|P2|COMPLETED|Fifth Intervention (Day 2)||0
865419|NCT02315352|2095435|P1|COMPLETED|Fifth Intervention (Day 2)||0
865420|NCT02315352|2095428|P8|STARTED|Fifth Intervention (Day 2)||8
865421|NCT02315352|2095429|P7|STARTED|Fifth Intervention (Day 2)||9
865422|NCT02315352|2095430|P6|STARTED|Fifth Intervention (Day 2)||7
865423|NCT02315352|2095431|P5|STARTED|Fifth Intervention (Day 2)||8
865424|NCT02315352|2095432|P4|STARTED|Fifth Intervention (Day 2)||8
865425|NCT02315352|2095433|P3|STARTED|Fifth Intervention (Day 2)||7
865426|NCT02315352|2095434|P2|STARTED|Fifth Intervention (Day 2)||0
865427|NCT02315352|2095435|P1|STARTED|Fifth Intervention (Day 2)||0
865428|NCT02315352|2095428|P8|NOT COMPLETED|Fourth Intervention (Day 2)||0
865429|NCT02315352|2095429|P7|NOT COMPLETED|Fourth Intervention (Day 2)||0
865430|NCT02315352|2095430|P6|NOT COMPLETED|Fourth Intervention (Day 2)||0
865431|NCT02315352|2095431|P5|NOT COMPLETED|Fourth Intervention (Day 2)||0
865432|NCT02315352|2095432|P4|NOT COMPLETED|Fourth Intervention (Day 2)||0
865433|NCT02315352|2095433|P3|NOT COMPLETED|Fourth Intervention (Day 2)||0
865434|NCT02315352|2095434|P2|NOT COMPLETED|Fourth Intervention (Day 2)||0
865435|NCT02315352|2095435|P1|NOT COMPLETED|Fourth Intervention (Day 2)||0
865436|NCT02315352|2095428|P8|COMPLETED|Fourth Intervention (Day 2)||8
865437|NCT02315352|2095429|P7|COMPLETED|Fourth Intervention (Day 2)||9
865438|NCT02315352|2095430|P6|COMPLETED|Fourth Intervention (Day 2)||7
865439|NCT02315352|2095431|P5|COMPLETED|Fourth Intervention (Day 2)||8
865440|NCT02315352|2095432|P4|COMPLETED|Fourth Intervention (Day 2)||8
865441|NCT02315352|2095433|P3|COMPLETED|Fourth Intervention (Day 2)||7
865442|NCT02315352|2095434|P2|COMPLETED|Fourth Intervention (Day 2)||0
865443|NCT02315352|2095435|P1|COMPLETED|Fourth Intervention (Day 2)||0
865444|NCT02315352|2095428|P8|STARTED|Fourth Intervention (Day 2)||8
865445|NCT02315352|2095429|P7|STARTED|Fourth Intervention (Day 2)||9
865446|NCT02315352|2095430|P6|STARTED|Fourth Intervention (Day 2)||7
865447|NCT02315352|2095431|P5|STARTED|Fourth Intervention (Day 2)||8
865448|NCT02315352|2095432|P4|STARTED|Fourth Intervention (Day 2)||8
865449|NCT02315352|2095433|P3|STARTED|Fourth Intervention (Day 2)||7
865450|NCT02315352|2095434|P2|STARTED|Fourth Intervention (Day 2)||0
865451|NCT02315352|2095435|P1|STARTED|Fourth Intervention (Day 2)||0
865452|NCT02315352|2095428|P8|NOT COMPLETED|Third Intervention (Day 2)||0
865453|NCT02315352|2095429|P7|NOT COMPLETED|Third Intervention (Day 2)||0
865454|NCT02315352|2095430|P6|NOT COMPLETED|Third Intervention (Day 2)||0
865455|NCT02315352|2095431|P5|NOT COMPLETED|Third Intervention (Day 2)||0
865456|NCT02315352|2095432|P4|NOT COMPLETED|Third Intervention (Day 2)||0
865457|NCT02315352|2095433|P3|NOT COMPLETED|Third Intervention (Day 2)||0
865458|NCT02315352|2095434|P2|NOT COMPLETED|Third Intervention (Day 2)||0
865459|NCT02315352|2095435|P1|NOT COMPLETED|Third Intervention (Day 2)||0
865460|NCT02315352|2095428|P8|COMPLETED|Third Intervention (Day 2)||8
865461|NCT02315352|2095429|P7|COMPLETED|Third Intervention (Day 2)||9
865462|NCT02315352|2095430|P6|COMPLETED|Third Intervention (Day 2)||7
865463|NCT02315352|2095431|P5|COMPLETED|Third Intervention (Day 2)||8
865464|NCT02315352|2095432|P4|COMPLETED|Third Intervention (Day 2)||8
865465|NCT02315352|2095433|P3|COMPLETED|Third Intervention (Day 2)||7
865466|NCT02315352|2095434|P2|COMPLETED|Third Intervention (Day 2)||0
865467|NCT02315352|2095435|P1|COMPLETED|Third Intervention (Day 2)||0
865468|NCT02315352|2095428|P8|STARTED|Third Intervention (Day 2)||8
865469|NCT02315352|2095429|P7|STARTED|Third Intervention (Day 2)||9
865470|NCT02315352|2095430|P6|STARTED|Third Intervention (Day 2)||7
865471|NCT02315352|2095431|P5|STARTED|Third Intervention (Day 2)||8
865472|NCT02315352|2095432|P4|STARTED|Third Intervention (Day 2)||8
865473|NCT02315352|2095433|P3|STARTED|Third Intervention (Day 2)||7
865474|NCT02315352|2095434|P2|STARTED|Third Intervention (Day 2)||0
865475|NCT02315352|2095435|P1|STARTED|Third Intervention (Day 2)||0
865476|NCT02315352|2095428|P8|NOT COMPLETED|Second Intervention (Day 1)||0
865477|NCT02315352|2095429|P7|NOT COMPLETED|Second Intervention (Day 1)||0
865478|NCT02315352|2095430|P6|NOT COMPLETED|Second Intervention (Day 1)||0
865479|NCT02315352|2095431|P5|NOT COMPLETED|Second Intervention (Day 1)||0
865480|NCT02315352|2095432|P4|NOT COMPLETED|Second Intervention (Day 1)||0
865481|NCT02315352|2095433|P3|NOT COMPLETED|Second Intervention (Day 1)||0
865482|NCT02315352|2095434|P2|NOT COMPLETED|Second Intervention (Day 1)||0
865483|NCT02315352|2095435|P1|NOT COMPLETED|Second Intervention (Day 1)||0
865484|NCT02315352|2095428|P8|COMPLETED|Second Intervention (Day 1)||0
865485|NCT02315352|2095429|P7|COMPLETED|Second Intervention (Day 1)||0
865486|NCT02315352|2095430|P6|COMPLETED|Second Intervention (Day 1)||0
865487|NCT02315352|2095431|P5|COMPLETED|Second Intervention (Day 1)||0
865488|NCT02315352|2095432|P4|COMPLETED|Second Intervention (Day 1)||0
865489|NCT02315352|2095433|P3|COMPLETED|Second Intervention (Day 1)||0
865490|NCT02315352|2095434|P2|COMPLETED|Second Intervention (Day 1)||24
865491|NCT02315352|2095435|P1|COMPLETED|Second Intervention (Day 1)|Out of 24 subjects completing this period, 1 discontinued before assignment to any sequence on Day 2|24
865492|NCT02315352|2095428|P8|STARTED|Second Intervention (Day 1)||0
865493|NCT02315352|2095429|P7|STARTED|Second Intervention (Day 1)||0
865494|NCT02315352|2095430|P6|STARTED|Second Intervention (Day 1)||0
865495|NCT02315352|2095431|P5|STARTED|Second Intervention (Day 1)||0
865496|NCT02315352|2095432|P4|STARTED|Second Intervention (Day 1)||0
865497|NCT02315352|2095433|P3|STARTED|Second Intervention (Day 1)||0
865498|NCT02315352|2095434|P2|STARTED|Second Intervention (Day 1)||24
865499|NCT02315352|2095435|P1|STARTED|Second Intervention (Day 1)||24
865500|NCT02315352|2095428|P8|NOT COMPLETED|First Intervention (Day 1)||0
865501|NCT02315352|2095429|P7|NOT COMPLETED|First Intervention (Day 1)||0
865502|NCT02315352|2095430|P6|NOT COMPLETED|First Intervention (Day 1)||0
865503|NCT02315352|2095431|P5|NOT COMPLETED|First Intervention (Day 1)||0
865504|NCT02315352|2095432|P4|NOT COMPLETED|First Intervention (Day 1)||0
865505|NCT02315352|2095433|P3|NOT COMPLETED|First Intervention (Day 1)||0
865506|NCT02315352|2095434|P2|NOT COMPLETED|First Intervention (Day 1)||0
865507|NCT02315352|2095435|P1|NOT COMPLETED|First Intervention (Day 1)||0
865508|NCT02315352|2095428|P8|COMPLETED|First Intervention (Day 1)||0
865509|NCT02315352|2095429|P7|COMPLETED|First Intervention (Day 1)||0
865510|NCT02315352|2095430|P6|COMPLETED|First Intervention (Day 1)||0
865511|NCT02315352|2095431|P5|COMPLETED|First Intervention (Day 1)||0
865512|NCT02315352|2095432|P4|COMPLETED|First Intervention (Day 1)||0
865513|NCT02315352|2095433|P3|COMPLETED|First Intervention (Day 1)||0
865514|NCT02315352|2095434|P2|COMPLETED|First Intervention (Day 1)||24
865515|NCT02315352|2095435|P1|COMPLETED|First Intervention (Day 1)||24
865516|NCT02315352|2095428|P8|STARTED|First Intervention (Day 1)||0
865517|NCT02315352|2095429|P7|STARTED|First Intervention (Day 1)||0
865518|NCT02315352|2095430|P6|STARTED|First Intervention (Day 1)||0
865519|NCT02315352|2095431|P5|STARTED|First Intervention (Day 1)||0
865520|NCT02315352|2095432|P4|STARTED|First Intervention (Day 1)||0
865521|NCT02315352|2095433|P3|STARTED|First Intervention (Day 1)||0
865522|NCT02315352|2095434|P2|STARTED|First Intervention (Day 1)||24
865523|NCT02315352|2095435|P1|STARTED|First Intervention (Day 1)||24
865524|NCT02314689|2095462|P1|NOT COMPLETED|Overall Study||0
865525|NCT02314689|2095462|P1|COMPLETED|Overall Study|Target citrulline level reached with first 4 subjects enrolled at initial IV citrulline of 20 mg/kg|4
865526|NCT02314689|2095462|P1|STARTED|Overall Study||4
865527|NCT02314637|2095468|P2|NOT COMPLETED|Overall Study||14
865528|NCT02314637|2095469|P1|NOT COMPLETED|Overall Study||16
865529|NCT02314637|2095468|P2|COMPLETED|Overall Study||75
865530|NCT02314637|2095469|P1|COMPLETED|Overall Study||135
865531|NCT02314637|2095468|P2|STARTED|Overall Study||89
865532|NCT02314637|2095469|P1|STARTED|Overall Study||151
865533|NCT02314546|2095482|P3|NOT COMPLETED|Overall Study||0
865534|NCT02314546|2095483|P2|NOT COMPLETED|Overall Study||0
865535|NCT02314546|2095484|P1|NOT COMPLETED|Overall Study||0
865536|NCT02314546|2095482|P3|COMPLETED|Overall Study||5
865537|NCT02314546|2095483|P2|COMPLETED|Overall Study||5
865538|NCT02314546|2095484|P1|COMPLETED|Overall Study||5
865539|NCT02314546|2095482|P3|STARTED|Overall Study||5
865540|NCT02314546|2095483|P2|STARTED|Overall Study||5
865541|NCT02314546|2095484|P1|STARTED|Overall Study||5
865542|NCT02314520|2095512|P2|NOT COMPLETED|Overall Study||0
865543|NCT02314520|2095513|P1|NOT COMPLETED|Overall Study||0
865544|NCT02314520|2095512|P2|COMPLETED|Overall Study||80
865545|NCT02314520|2095513|P1|COMPLETED|Overall Study||72
865546|NCT02314520|2095512|P2|STARTED|Overall Study||80
865547|NCT02314520|2095513|P1|STARTED|Overall Study||72
865548|NCT02314260|2095525|P1|NOT COMPLETED|Overall Study||0
865549|NCT02314260|2095525|P1|COMPLETED|Overall Study||80
865550|NCT02314260|2095525|P1|STARTED|Overall Study||80
865551|NCT02314104|2095535|P3|NOT COMPLETED|Overall Study||18
865552|NCT02314104|2095536|P2|NOT COMPLETED|Overall Study||20
865553|NCT02314104|2095537|P1|NOT COMPLETED|Overall Study||14
865554|NCT02314104|2095535|P3|COMPLETED|Overall Study||53
865555|NCT02314104|2095536|P2|COMPLETED|Overall Study||58
865556|NCT02314104|2095537|P1|COMPLETED|Overall Study||57
865557|NCT02314104|2095535|P3|STARTED|Overall Study||71
865558|NCT02314104|2095536|P2|STARTED|Overall Study||78
865559|NCT02314104|2095537|P1|STARTED|Overall Study||71
865560|NCT02313766|2095560|P3|NOT COMPLETED|Overall Study||0
865561|NCT02313766|2095561|P2|NOT COMPLETED|Overall Study||3
865562|NCT02313766|2095562|P1|NOT COMPLETED|Overall Study||1
865563|NCT02313766|2095560|P3|COMPLETED|Overall Study||50
865564|NCT02313766|2095561|P2|COMPLETED|Overall Study||47
865565|NCT02313766|2095562|P1|COMPLETED|Overall Study||49
865566|NCT02313766|2095560|P3|STARTED|Overall Study||50
865567|NCT02313766|2095561|P2|STARTED|Overall Study||50
865568|NCT02313766|2095562|P1|STARTED|Overall Study||50
865569|NCT02313558|2095578|P2|NOT COMPLETED|Overall Study||4
865570|NCT02313558|2095579|P1|NOT COMPLETED|Overall Study||6
865571|NCT02313558|2095578|P2|COMPLETED|Overall Study||46
865572|NCT02313558|2095579|P1|COMPLETED|Overall Study||44
865573|NCT02313558|2095578|P2|STARTED|Overall Study||50
865574|NCT02313558|2095579|P1|STARTED|Overall Study||50
865575|NCT02313233|2095593|P2|NOT COMPLETED|Overall Study||3
865576|NCT02313233|2095594|P1|NOT COMPLETED|Overall Study||2
865577|NCT02313233|2095593|P2|COMPLETED|Overall Study||18
865578|NCT02313233|2095594|P1|COMPLETED|Overall Study||18
865579|NCT02313233|2095593|P2|STARTED|Overall Study||21
865580|NCT02313233|2095594|P1|STARTED|Overall Study||20
865581|NCT02313155|2095616|P2|NOT COMPLETED|Overall Study||1
865582|NCT02313155|2095617|P1|NOT COMPLETED|Overall Study||0
865583|NCT02313155|2095616|P2|COMPLETED|Overall Study||54
865584|NCT02313155|2095617|P1|COMPLETED|Overall Study||55
865585|NCT02313155|2095616|P2|STARTED|Overall Study||55
865586|NCT02313155|2095617|P1|STARTED|Overall Study||55
865587|NCT02312739|2095667|P2|NOT COMPLETED|Overall Study||2
865588|NCT02312739|2095668|P1|NOT COMPLETED|Overall Study||6
865589|NCT02312739|2095667|P2|COMPLETED|Overall Study||34
865590|NCT02312739|2095668|P1|COMPLETED|Overall Study||30
865591|NCT02312739|2095667|P2|Withdrawn Prior to Procedure|Overall Study||2
865592|NCT02312739|2095668|P1|Withdrawn Prior to Procedure|Overall Study||6
865593|NCT02312739|2095667|P2|STARTED|Overall Study||36
865594|NCT02312739|2095668|P1|STARTED|Overall Study||36
865595|NCT02312726|2095682|P3|NOT COMPLETED|Overall Study||67
865596|NCT02312726|2095683|P2|NOT COMPLETED|Overall Study||0
865597|NCT02312726|2095684|P1|NOT COMPLETED|Overall Study||0
865598|NCT02312726|2095682|P3|COMPLETED|Overall Study||0
865599|NCT02312726|2095683|P2|COMPLETED|Overall Study||30
865600|NCT02312726|2095684|P1|COMPLETED|Overall Study||38
865601|NCT02312726|2095682|P3|STARTED|Overall Study||67
865602|NCT02312726|2095683|P2|STARTED|Overall Study||30
865603|NCT02312726|2095684|P1|STARTED|Overall Study||38
865604|NCT02312154|2095696|P1|NOT COMPLETED|Overall Study||1
865605|NCT02312154|2095696|P1|COMPLETED|Overall Study||24
865606|NCT02312154|2095696|P1|STARTED|Overall Study||25
865607|NCT02311972|2095713|P2|NOT COMPLETED|Overall Study||0
865608|NCT02311972|2095714|P1|NOT COMPLETED|Overall Study||0
865609|NCT02311972|2095713|P2|COMPLETED|Overall Study||8
865610|NCT02311972|2095714|P1|COMPLETED|Overall Study||12
865611|NCT02311972|2095713|P2|STARTED|Overall Study||8
865612|NCT02311972|2095714|P1|STARTED|Overall Study||12
865613|NCT02311907|2095733|P2|NOT COMPLETED|Overall Study||0
865614|NCT02311907|2095734|P1|NOT COMPLETED|Overall Study||0
865615|NCT02311907|2095733|P2|COMPLETED|Overall Study||91
865616|NCT02311907|2095734|P1|COMPLETED|Overall Study||94
865617|NCT02311907|2095733|P2|STARTED|Overall Study||91
865618|NCT02311907|2095734|P1|STARTED|Overall Study||94
865619|NCT02311881|2095759|P3|NOT COMPLETED|Overall Study||41
865620|NCT02311881|2095760|P2|NOT COMPLETED|Overall Study||43
865621|NCT02311881|2095761|P1|NOT COMPLETED|Overall Study||35
865622|NCT02311881|2095759|P3|COMPLETED|Overall Study||196
865623|NCT02311881|2095760|P2|COMPLETED|Overall Study||193
865624|NCT02311881|2095761|P1|COMPLETED|Overall Study||200
865625|NCT02311881|2095759|P3|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|237
865626|NCT02311881|2095760|P2|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|236
865627|NCT02311881|2095761|P1|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|234
865628|NCT02311881|2095759|P3|STARTED|Overall Study|Started refers to all randomized participants.|237
865629|NCT02311881|2095760|P2|STARTED|Overall Study|Started refers to all randomized participants.|236
865630|NCT02311881|2095761|P1|STARTED|Overall Study|Started refers to all randomized participants.|235
865631|NCT02311309|2095799|P3|NOT COMPLETED|Overall Study||0
865632|NCT02311309|2095800|P2|NOT COMPLETED|Overall Study||0
865633|NCT02311309|2095801|P1|NOT COMPLETED|Overall Study||0
865634|NCT02311309|2095799|P3|COMPLETED|Overall Study||863
865635|NCT02311309|2095800|P2|COMPLETED|Overall Study||35
865636|NCT02311309|2095801|P1|COMPLETED|Overall Study||541
865637|NCT02311309|2095799|P3|STARTED|Overall Study||863
865638|NCT02311309|2095800|P2|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|35
865639|NCT02311309|2095801|P1|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|541
865640|NCT02310776|2095812|P1|NOT COMPLETED|Overall Study||0
865641|NCT02310776|2095812|P1|COMPLETED|Overall Study||501
865642|NCT02310776|2095812|P1|STARTED|Overall Study||501
865643|NCT02310750|2095827|P16|NOT COMPLETED|HP MAD and Fasted/Fed||0
865644|NCT02310750|2095828|P15|NOT COMPLETED|HP MAD and Fasted/Fed||0
865645|NCT02310750|2095829|P14|NOT COMPLETED|HP MAD and Fasted/Fed||0
865646|NCT02310750|2095830|P13|NOT COMPLETED|HP MAD and Fasted/Fed||0
865647|NCT02310750|2095831|P12|NOT COMPLETED|HP MAD and Fasted/Fed||0
865648|NCT02310750|2095832|P11|NOT COMPLETED|HP MAD and Fasted/Fed||0
865649|NCT02310750|2095833|P10|NOT COMPLETED|HP MAD and Fasted/Fed||0
865650|NCT02310750|2095834|P9|NOT COMPLETED|HP MAD and Fasted/Fed||0
865651|NCT02310750|2095835|P8|NOT COMPLETED|HP MAD and Fasted/Fed||0
865652|NCT02310750|2095836|P7|NOT COMPLETED|HP MAD and Fasted/Fed||0
865653|NCT02310750|2095837|P6|NOT COMPLETED|HP MAD and Fasted/Fed||0
865654|NCT02310750|2095838|P5|NOT COMPLETED|HP MAD and Fasted/Fed||1
865655|NCT02310750|2095839|P4|NOT COMPLETED|HP MAD and Fasted/Fed||0
865656|NCT02310750|2095840|P3|NOT COMPLETED|HP MAD and Fasted/Fed||0
865657|NCT02310750|2095841|P2|NOT COMPLETED|HP MAD and Fasted/Fed||0
865658|NCT02310750|2095842|P1|NOT COMPLETED|HP MAD and Fasted/Fed||0
865659|NCT02310750|2095827|P16|COMPLETED|HP MAD and Fasted/Fed||2
865660|NCT02310750|2095828|P15|COMPLETED|HP MAD and Fasted/Fed||2
865661|NCT02310750|2095829|P14|COMPLETED|HP MAD and Fasted/Fed||2
865662|NCT02310750|2095830|P13|COMPLETED|HP MAD and Fasted/Fed||2
865663|NCT02310750|2095831|P12|COMPLETED|HP MAD and Fasted/Fed||2
865664|NCT02310750|2095832|P11|COMPLETED|HP MAD and Fasted/Fed||2
865665|NCT02310750|2095833|P10|COMPLETED|HP MAD and Fasted/Fed||0
865666|NCT02310750|2095834|P9|COMPLETED|HP MAD and Fasted/Fed||0
865667|NCT02310750|2095835|P8|COMPLETED|HP MAD and Fasted/Fed||0
865668|NCT02310750|2095836|P7|COMPLETED|HP MAD and Fasted/Fed||2
865669|NCT02310750|2095837|P6|COMPLETED|HP MAD and Fasted/Fed||0
865670|NCT02310750|2095838|P5|COMPLETED|HP MAD and Fasted/Fed||4
865671|NCT02310750|2095839|P4|COMPLETED|HP MAD and Fasted/Fed||0
865672|NCT02310750|2095840|P3|COMPLETED|HP MAD and Fasted/Fed||0
865673|NCT02310750|2095841|P2|COMPLETED|HP MAD and Fasted/Fed||0
865674|NCT02310750|2095842|P1|COMPLETED|HP MAD and Fasted/Fed||0
865675|NCT02310750|2095827|P16|STARTED|HP MAD and Fasted/Fed||2
865676|NCT02310750|2095828|P15|STARTED|HP MAD and Fasted/Fed||2
865677|NCT02310750|2095829|P14|STARTED|HP MAD and Fasted/Fed||2
865678|NCT02310750|2095830|P13|STARTED|HP MAD and Fasted/Fed||2
865679|NCT02310750|2095831|P12|STARTED|HP MAD and Fasted/Fed||2
865680|NCT02310750|2095832|P11|STARTED|HP MAD and Fasted/Fed||2
865681|NCT02310750|2095833|P10|STARTED|HP MAD and Fasted/Fed||0
865682|NCT02310750|2095834|P9|STARTED|HP MAD and Fasted/Fed||0
865683|NCT02310750|2095835|P8|STARTED|HP MAD and Fasted/Fed||0
865684|NCT02310750|2095836|P7|STARTED|HP MAD and Fasted/Fed||2
865685|NCT02310750|2095837|P6|STARTED|HP MAD and Fasted/Fed||0
865686|NCT02310750|2095838|P5|STARTED|HP MAD and Fasted/Fed||5
865687|NCT02310750|2095839|P4|STARTED|HP MAD and Fasted/Fed||0
865688|NCT02310750|2095840|P3|STARTED|HP MAD and Fasted/Fed||0
865689|NCT02310750|2095841|P2|STARTED|HP MAD and Fasted/Fed||0
865690|NCT02310750|2095842|P1|STARTED|HP MAD and Fasted/Fed||0
865691|NCT02310750|2095827|P16|NOT COMPLETED|HP Washout 2||0
865692|NCT02310750|2095828|P15|NOT COMPLETED|HP Washout 2||0
865693|NCT02310750|2095829|P14|NOT COMPLETED|HP Washout 2||0
865694|NCT02310750|2095830|P13|NOT COMPLETED|HP Washout 2||0
865695|NCT02310750|2095831|P12|NOT COMPLETED|HP Washout 2||0
865696|NCT02310750|2095832|P11|NOT COMPLETED|HP Washout 2||0
865697|NCT02310750|2095833|P10|NOT COMPLETED|HP Washout 2||0
865698|NCT02310750|2095834|P9|NOT COMPLETED|HP Washout 2||0
865699|NCT02310750|2095835|P8|NOT COMPLETED|HP Washout 2||0
865700|NCT02310750|2095836|P7|NOT COMPLETED|HP Washout 2||7
865701|NCT02310750|2095837|P6|NOT COMPLETED|HP Washout 2||0
865702|NCT02310750|2095838|P5|NOT COMPLETED|HP Washout 2||1
865703|NCT02310750|2095839|P4|NOT COMPLETED|HP Washout 2||0
865704|NCT02310750|2095840|P3|NOT COMPLETED|HP Washout 2||0
865705|NCT02310750|2095841|P2|NOT COMPLETED|HP Washout 2||0
865706|NCT02310750|2095842|P1|NOT COMPLETED|HP Washout 2||0
865707|NCT02310750|2095827|P16|COMPLETED|HP Washout 2||2
865708|NCT02310750|2095828|P15|COMPLETED|HP Washout 2||2
865709|NCT02310750|2095829|P14|COMPLETED|HP Washout 2||2
865710|NCT02310750|2095830|P13|COMPLETED|HP Washout 2||2
865711|NCT02310750|2095831|P12|COMPLETED|HP Washout 2||2
865712|NCT02310750|2095832|P11|COMPLETED|HP Washout 2||2
865713|NCT02310750|2095833|P10|COMPLETED|HP Washout 2||0
865714|NCT02310750|2095834|P9|COMPLETED|HP Washout 2||0
865715|NCT02310750|2095835|P8|COMPLETED|HP Washout 2||0
865716|NCT02310750|2095836|P7|COMPLETED|HP Washout 2||2
865717|NCT02310750|2095837|P6|COMPLETED|HP Washout 2||0
865718|NCT02310750|2095838|P5|COMPLETED|HP Washout 2||5
865719|NCT02310750|2095839|P4|COMPLETED|HP Washout 2||0
865720|NCT02310750|2095840|P3|COMPLETED|HP Washout 2||0
865721|NCT02310750|2095841|P2|COMPLETED|HP Washout 2||0
865722|NCT02310750|2095842|P1|COMPLETED|HP Washout 2||0
865723|NCT02310750|2095827|P16|STARTED|HP Washout 2||2
865724|NCT02310750|2095828|P15|STARTED|HP Washout 2||2
865725|NCT02310750|2095829|P14|STARTED|HP Washout 2||2
865726|NCT02310750|2095830|P13|STARTED|HP Washout 2||2
865727|NCT02310750|2095831|P12|STARTED|HP Washout 2||2
865728|NCT02310750|2095832|P11|STARTED|HP Washout 2||2
865729|NCT02310750|2095833|P10|STARTED|HP Washout 2||0
865730|NCT02310750|2095834|P9|STARTED|HP Washout 2||0
865731|NCT02310750|2095835|P8|STARTED|HP Washout 2||0
865732|NCT02310750|2095836|P7|STARTED|HP Washout 2||9
865733|NCT02310750|2095837|P6|STARTED|HP Washout 2||0
865734|NCT02310750|2095838|P5|STARTED|HP Washout 2||6
865735|NCT02310750|2095839|P4|STARTED|HP Washout 2||0
865736|NCT02310750|2095840|P3|STARTED|HP Washout 2||0
865737|NCT02310750|2095841|P2|STARTED|HP Washout 2||0
865738|NCT02310750|2095842|P1|STARTED|HP Washout 2||0
865739|NCT02310750|2095827|P16|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
865740|NCT02310750|2095828|P15|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
865741|NCT02310750|2095829|P14|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
865742|NCT02310750|2095830|P13|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
865743|NCT02310750|2095831|P12|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
865744|NCT02310750|2095832|P11|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
865745|NCT02310750|2095833|P10|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
865746|NCT02310750|2095834|P9|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||8
865747|NCT02310750|2095835|P8|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
865748|NCT02310750|2095836|P7|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
865749|NCT02310750|2095837|P6|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
865750|NCT02310750|2095838|P5|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
865751|NCT02310750|2095839|P4|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||1
865752|NCT02310750|2095840|P3|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
865753|NCT02310750|2095841|P2|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
865754|NCT02310750|2095842|P1|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
865755|NCT02310750|2095827|P16|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
865756|NCT02310750|2095828|P15|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
865757|NCT02310750|2095829|P14|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
865758|NCT02310750|2095830|P13|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
865759|NCT02310750|2095831|P12|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
865760|NCT02310750|2095832|P11|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
865761|NCT02310750|2095833|P10|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
865762|NCT02310750|2095834|P9|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
865763|NCT02310750|2095835|P8|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
865764|NCT02310750|2095836|P7|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
865765|NCT02310750|2095837|P6|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
865766|NCT02310750|2095838|P5|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
865767|NCT02310750|2095839|P4|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
865768|NCT02310750|2095840|P3|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
865769|NCT02310750|2095841|P2|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
865770|NCT02310750|2095842|P1|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
865771|NCT02310750|2095827|P16|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
865772|NCT02310750|2095828|P15|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
865773|NCT02310750|2095829|P14|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
865774|NCT02310750|2095830|P13|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
865775|NCT02310750|2095831|P12|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
865776|NCT02310750|2095832|P11|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
865777|NCT02310750|2095833|P10|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
865778|NCT02310750|2095834|P9|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||14
865779|NCT02310750|2095835|P8|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
865780|NCT02310750|2095836|P7|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
865781|NCT02310750|2095837|P6|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
865782|NCT02310750|2095838|P5|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
865783|NCT02310750|2095839|P4|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
865784|NCT02310750|2095840|P3|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
865785|NCT02310750|2095841|P2|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
865786|NCT02310750|2095842|P1|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
865787|NCT02310750|2095827|P16|NOT COMPLETED|HP Washout 1||0
865788|NCT02310750|2095828|P15|NOT COMPLETED|HP Washout 1||0
865789|NCT02310750|2095829|P14|NOT COMPLETED|HP Washout 1||0
865790|NCT02310750|2095830|P13|NOT COMPLETED|HP Washout 1||0
865791|NCT02310750|2095831|P12|NOT COMPLETED|HP Washout 1||0
865792|NCT02310750|2095832|P11|NOT COMPLETED|HP Washout 1||0
865793|NCT02310750|2095833|P10|NOT COMPLETED|HP Washout 1||0
865794|NCT02310750|2095834|P9|NOT COMPLETED|HP Washout 1||0
865795|NCT02310750|2095835|P8|NOT COMPLETED|HP Washout 1||0
865796|NCT02310750|2095836|P7|NOT COMPLETED|HP Washout 1||3
865797|NCT02310750|2095837|P6|NOT COMPLETED|HP Washout 1||2
865798|NCT02310750|2095838|P5|NOT COMPLETED|HP Washout 1||2
865799|NCT02310750|2095839|P4|NOT COMPLETED|HP Washout 1||1
865800|NCT02310750|2095840|P3|NOT COMPLETED|HP Washout 1||1
865801|NCT02310750|2095841|P2|NOT COMPLETED|HP Washout 1||0
865802|NCT02310750|2095842|P1|NOT COMPLETED|HP Washout 1||0
865803|NCT02310750|2095827|P16|COMPLETED|HP Washout 1||2
865804|NCT02310750|2095828|P15|COMPLETED|HP Washout 1||2
865805|NCT02310750|2095829|P14|COMPLETED|HP Washout 1||2
865806|NCT02310750|2095830|P13|COMPLETED|HP Washout 1||2
865807|NCT02310750|2095831|P12|COMPLETED|HP Washout 1||2
865808|NCT02310750|2095832|P11|COMPLETED|HP Washout 1||2
865809|NCT02310750|2095833|P10|COMPLETED|HP Washout 1||0
865810|NCT02310750|2095834|P9|COMPLETED|HP Washout 1||0
865811|NCT02310750|2095835|P8|COMPLETED|HP Washout 1||0
865812|NCT02310750|2095836|P7|COMPLETED|HP Washout 1||9
865813|NCT02310750|2095837|P6|COMPLETED|HP Washout 1||6
865814|NCT02310750|2095838|P5|COMPLETED|HP Washout 1||6
865815|NCT02310750|2095839|P4|COMPLETED|HP Washout 1||4
865816|NCT02310750|2095840|P3|COMPLETED|HP Washout 1||5
865817|NCT02310750|2095841|P2|COMPLETED|HP Washout 1||0
865818|NCT02310750|2095842|P1|COMPLETED|HP Washout 1||0
865819|NCT02310750|2095827|P16|STARTED|HP Washout 1||2
865820|NCT02310750|2095828|P15|STARTED|HP Washout 1||2
865821|NCT02310750|2095829|P14|STARTED|HP Washout 1||2
865822|NCT02310750|2095830|P13|STARTED|HP Washout 1||2
865823|NCT02310750|2095831|P12|STARTED|HP Washout 1||2
865824|NCT02310750|2095832|P11|STARTED|HP Washout 1||2
865825|NCT02310750|2095833|P10|STARTED|HP Washout 1||0
865826|NCT02310750|2095834|P9|STARTED|HP Washout 1||0
865827|NCT02310750|2095835|P8|STARTED|HP Washout 1||0
865828|NCT02310750|2095836|P7|STARTED|HP Washout 1||12
865829|NCT02310750|2095837|P6|STARTED|HP Washout 1||8
865830|NCT02310750|2095838|P5|STARTED|HP Washout 1||8
865831|NCT02310750|2095839|P4|STARTED|HP Washout 1||5
865832|NCT02310750|2095840|P3|STARTED|HP Washout 1||6
865833|NCT02310750|2095841|P2|STARTED|HP Washout 1||0
865834|NCT02310750|2095842|P1|STARTED|HP Washout 1||0
865835|NCT02310750|2095827|P16|NOT COMPLETED|HP Period 1||0
865836|NCT02310750|2095828|P15|NOT COMPLETED|HP Period 1||0
865837|NCT02310750|2095829|P14|NOT COMPLETED|HP Period 1||0
865838|NCT02310750|2095830|P13|NOT COMPLETED|HP Period 1||0
865839|NCT02310750|2095831|P12|NOT COMPLETED|HP Period 1||0
865840|NCT02310750|2095832|P11|NOT COMPLETED|HP Period 1||0
865841|NCT02310750|2095833|P10|NOT COMPLETED|HP Period 1||0
865842|NCT02310750|2095834|P9|NOT COMPLETED|HP Period 1||0
865843|NCT02310750|2095835|P8|NOT COMPLETED|HP Period 1||0
865844|NCT02310750|2095836|P7|NOT COMPLETED|HP Period 1||1
865845|NCT02310750|2095837|P6|NOT COMPLETED|HP Period 1||0
865846|NCT02310750|2095838|P5|NOT COMPLETED|HP Period 1||0
865847|NCT02310750|2095839|P4|NOT COMPLETED|HP Period 1||1
865848|NCT02310750|2095840|P3|NOT COMPLETED|HP Period 1||0
865849|NCT02310750|2095841|P2|NOT COMPLETED|HP Period 1||0
865850|NCT02310750|2095842|P1|NOT COMPLETED|HP Period 1||1
865851|NCT02310750|2095827|P16|COMPLETED|HP Period 1||2
865852|NCT02310750|2095828|P15|COMPLETED|HP Period 1||2
865853|NCT02310750|2095829|P14|COMPLETED|HP Period 1||2
865854|NCT02310750|2095830|P13|COMPLETED|HP Period 1||2
865855|NCT02310750|2095831|P12|COMPLETED|HP Period 1||2
865856|NCT02310750|2095832|P11|COMPLETED|HP Period 1||2
865857|NCT02310750|2095833|P10|COMPLETED|HP Period 1||0
865858|NCT02310750|2095834|P9|COMPLETED|HP Period 1||0
865859|NCT02310750|2095835|P8|COMPLETED|HP Period 1||0
865860|NCT02310750|2095836|P7|COMPLETED|HP Period 1||12
865861|NCT02310750|2095837|P6|COMPLETED|HP Period 1||8
865862|NCT02310750|2095838|P5|COMPLETED|HP Period 1||8
865863|NCT02310750|2095839|P4|COMPLETED|HP Period 1||5
865864|NCT02310750|2095840|P3|COMPLETED|HP Period 1||6
865865|NCT02310750|2095841|P2|COMPLETED|HP Period 1||6
865866|NCT02310750|2095842|P1|COMPLETED|HP Period 1||6
865867|NCT02310750|2095827|P16|STARTED|HP Period 1||2
865868|NCT02310750|2095828|P15|STARTED|HP Period 1||2
865869|NCT02310750|2095829|P14|STARTED|HP Period 1||2
865870|NCT02310750|2095830|P13|STARTED|HP Period 1||2
865871|NCT02310750|2095831|P12|STARTED|HP Period 1||2
865872|NCT02310750|2095832|P11|STARTED|HP Period 1||2
865873|NCT02310750|2095833|P10|STARTED|HP Period 1||0
865874|NCT02310750|2095834|P9|STARTED|HP Period 1||0
865875|NCT02310750|2095835|P8|STARTED|HP Period 1||0
865876|NCT02310750|2095836|P7|STARTED|HP Period 1||13
865877|NCT02310750|2095837|P6|STARTED|HP Period 1||8
865878|NCT02310750|2095838|P5|STARTED|HP Period 1||8
865879|NCT02310750|2095839|P4|STARTED|HP Period 1||6
865880|NCT02310750|2095840|P3|STARTED|HP Period 1||6
865881|NCT02310750|2095841|P2|STARTED|HP Period 1||6
865882|NCT02310750|2095842|P1|STARTED|HP Period 1||7
865883|NCT02310646|2096283|P2|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
865884|NCT02310646|2096284|P1|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
865885|NCT02310646|2096283|P2|COMPLETED|Second Intervention (Day 8 - Day 14)||104
865886|NCT02310646|2096284|P1|COMPLETED|Second Intervention (Day 8 - Day 14)||107
865887|NCT02310646|2096283|P2|STARTED|Second Intervention (Day 8 - Day 14)||104
865888|NCT02310646|2096284|P1|STARTED|Second Intervention (Day 8 - Day 14)||107
865889|NCT02310646|2096283|P2|NOT COMPLETED|First Intervention (Day 1 - Day 7)||0
865890|NCT02310646|2096284|P1|NOT COMPLETED|First Intervention (Day 1 - Day 7)||2
865891|NCT02310646|2096283|P2|COMPLETED|First Intervention (Day 1 - Day 7)||104
865892|NCT02310646|2096284|P1|COMPLETED|First Intervention (Day 1 - Day 7)||107
865893|NCT02310646|2096283|P2|STARTED|First Intervention (Day 1 - Day 7)||104
865894|NCT02310646|2096284|P1|STARTED|First Intervention (Day 1 - Day 7)||109
865895|NCT02310581|2096312|P4|NOT COMPLETED|Overall Study||1
865896|NCT02310581|2096313|P3|NOT COMPLETED|Overall Study||1
865897|NCT02310581|2096314|P2|NOT COMPLETED|Overall Study||2
865898|NCT02310581|2096315|P1|NOT COMPLETED|Overall Study||3
865899|NCT02310581|2096312|P4|COMPLETED|Overall Study||9
865900|NCT02310581|2096313|P3|COMPLETED|Overall Study||9
865901|NCT02310581|2096314|P2|COMPLETED|Overall Study||9
865902|NCT02310581|2096315|P1|COMPLETED|Overall Study||6
865903|NCT02310581|2096312|P4|STARTED|Overall Study||10
865904|NCT02310581|2096313|P3|STARTED|Overall Study||10
865905|NCT02310581|2096314|P2|STARTED|Overall Study||11
865906|NCT02310581|2096315|P1|STARTED|Overall Study||9
865907|NCT02310568|2096354|P5|NOT COMPLETED|Stage 2 (4 Weeks)||1
865908|NCT02310568|2096355|P4|NOT COMPLETED|Stage 2 (4 Weeks)||5
865909|NCT02310568|2096356|P3|NOT COMPLETED|Stage 2 (4 Weeks)||1
865910|NCT02310568|2096357|P2|NOT COMPLETED|Stage 2 (4 Weeks)||1
865911|NCT02310568|2096358|P1|NOT COMPLETED|Stage 2 (4 Weeks)||1
865912|NCT02310568|2096354|P5|COMPLETED|Stage 2 (4 Weeks)||19
865913|NCT02310568|2096355|P4|COMPLETED|Stage 2 (4 Weeks)||17
865914|NCT02310568|2096356|P3|COMPLETED|Stage 2 (4 Weeks)||13
865915|NCT02310568|2096357|P2|COMPLETED|Stage 2 (4 Weeks)||12
865916|NCT02310568|2096358|P1|COMPLETED|Stage 2 (4 Weeks)||11
865917|NCT02310568|2096354|P5|STARTED|Stage 2 (4 Weeks)||20
865918|NCT02310568|2096355|P4|STARTED|Stage 2 (4 Weeks)||22
865919|NCT02310568|2096356|P3|STARTED|Stage 2 (4 Weeks)||14
865920|NCT02310568|2096357|P2|STARTED|Stage 2 (4 Weeks)||13
865921|NCT02310568|2096358|P1|STARTED|Stage 2 (4 Weeks)||12
865922|NCT02310568|2096354|P5|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
865923|NCT02310568|2096355|P4|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
865924|NCT02310568|2096356|P3|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
865925|NCT02310568|2096357|P2|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
865926|NCT02310568|2096358|P1|NOT COMPLETED|Stage 1 ( 4 Weeks)||3
865927|NCT02310568|2096354|P5|COMPLETED|Stage 1 ( 4 Weeks)||20
865928|NCT02310568|2096355|P4|COMPLETED|Stage 1 ( 4 Weeks)||22
865929|NCT02310568|2096356|P3|COMPLETED|Stage 1 ( 4 Weeks)||14
865930|NCT02310568|2096357|P2|COMPLETED|Stage 1 ( 4 Weeks)||13
865931|NCT02310568|2096358|P1|COMPLETED|Stage 1 ( 4 Weeks)||12
865932|NCT02310568|2096354|P5|STARTED|Stage 1 ( 4 Weeks)||21
865933|NCT02310568|2096355|P4|STARTED|Stage 1 ( 4 Weeks)||24
865934|NCT02310568|2096356|P3|STARTED|Stage 1 ( 4 Weeks)||15
865935|NCT02310568|2096357|P2|STARTED|Stage 1 ( 4 Weeks)||15
865936|NCT02310568|2096358|P1|STARTED|Stage 1 ( 4 Weeks)||15
865937|NCT02310126|2096438|P2|NOT COMPLETED|Period 2 (15 Minutes)||0
865938|NCT02310126|2096439|P1|NOT COMPLETED|Period 2 (15 Minutes)||0
865939|NCT02310126|2096438|P2|COMPLETED|Period 2 (15 Minutes)||95
865940|NCT02310126|2096439|P1|COMPLETED|Period 2 (15 Minutes)||94
865941|NCT02310126|2096438|P2|Myopes|Period 2 (15 Minutes)||63
865942|NCT02310126|2096439|P1|Myopes|Period 2 (15 Minutes)||56
865943|NCT02310126|2096438|P2|Hyperopes|Period 2 (15 Minutes)||32
865944|NCT02310126|2096439|P1|Hyperopes|Period 2 (15 Minutes)||38
865945|NCT02310126|2096438|P2|STARTED|Period 2 (15 Minutes)||95
865946|NCT02310126|2096439|P1|STARTED|Period 2 (15 Minutes)||94
865947|NCT02310126|2096438|P2|NOT COMPLETED|Period 1 (15 Minutes)||2
865948|NCT02310126|2096439|P1|NOT COMPLETED|Period 1 (15 Minutes)||0
865949|NCT02310126|2096438|P2|COMPLETED|Period 1 (15 Minutes)||95
865950|NCT02310126|2096439|P1|COMPLETED|Period 1 (15 Minutes)||94
865951|NCT02310126|2096438|P2|Myopes|Period 1 (15 Minutes)||64
865952|NCT02310126|2096439|P1|Myopes|Period 1 (15 Minutes)||56
865953|NCT02310126|2096438|P2|Hyperopes|Period 1 (15 Minutes)||33
865954|NCT02310126|2096439|P1|Hyperopes|Period 1 (15 Minutes)||38
865955|NCT02310126|2096438|P2|STARTED|Period 1 (15 Minutes)||97
865956|NCT02310126|2096439|P1|STARTED|Period 1 (15 Minutes)||94
865957|NCT02309723|2096448|P3|NOT COMPLETED|Overall Study||24
865958|NCT02309723|2096449|P2|NOT COMPLETED|Overall Study||23
865959|NCT02309723|2096450|P1|NOT COMPLETED|Overall Study||24
865960|NCT02309723|2096448|P3|COMPLETED|Overall Study||105
865961|NCT02309723|2096449|P2|COMPLETED|Overall Study||105
865962|NCT02309723|2096450|P1|COMPLETED|Overall Study||105
865963|NCT02309723|2096448|P3|STARTED|Overall Study||129
865964|NCT02309723|2096449|P2|STARTED|Overall Study||128
865965|NCT02309723|2096450|P1|STARTED|Overall Study||129
865966|NCT02309294|2096464|P1|NOT COMPLETED|Overall Study||2
865967|NCT02309294|2096464|P1|COMPLETED|Overall Study||41
865968|NCT02309294|2096464|P1|STARTED|Overall Study||43
865969|NCT02309112|2096471|P3|NOT COMPLETED|Overall Study||1
865970|NCT02309112|2096472|P2|NOT COMPLETED|Overall Study||1
865971|NCT02309112|2096473|P1|NOT COMPLETED|Overall Study||1
865972|NCT02309112|2096471|P3|COMPLETED|Overall Study||4
865973|NCT02309112|2096472|P2|COMPLETED|Overall Study||4
865974|NCT02309112|2096473|P1|COMPLETED|Overall Study||4
865975|NCT02309112|2096471|P3|Completed Yoga Intervention|Overall Study||4
865976|NCT02309112|2096472|P2|Completed Yoga Intervention|Overall Study||5
865977|NCT02309112|2096473|P1|Completed Yoga Intervention|Overall Study||4
865978|NCT02309112|2096471|P3|STARTED|Overall Study||5
865979|NCT02309112|2096472|P2|STARTED|Overall Study||5
865980|NCT02309112|2096473|P1|STARTED|Overall Study||5
865981|NCT02308787|2096494|P1|NOT COMPLETED|Overall Study||0
865982|NCT02308787|2096494|P1|COMPLETED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
865983|NCT02308787|2096494|P1|STARTED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
865984|NCT02308748|2096509|P10|NOT COMPLETED|Period 5||0
865985|NCT02308748|2096510|P9|NOT COMPLETED|Period 5||1
865986|NCT02308748|2096511|P8|NOT COMPLETED|Period 5||0
865987|NCT02308748|2096512|P7|NOT COMPLETED|Period 5||0
865988|NCT02308748|2096513|P6|NOT COMPLETED|Period 5||0
865989|NCT02308748|2096514|P5|NOT COMPLETED|Period 5||0
865990|NCT02308748|2096515|P4|NOT COMPLETED|Period 5||0
865991|NCT02308748|2096516|P3|NOT COMPLETED|Period 5||0
865992|NCT02308748|2096517|P2|NOT COMPLETED|Period 5||0
865993|NCT02308748|2096518|P1|NOT COMPLETED|Period 5||1
865994|NCT02308748|2096509|P10|COMPLETED|Period 5||2
865995|NCT02308748|2096510|P9|COMPLETED|Period 5||1
865996|NCT02308748|2096511|P8|COMPLETED|Period 5||1
865997|NCT02308748|2096512|P7|COMPLETED|Period 5||2
865998|NCT02308748|2096513|P6|COMPLETED|Period 5||3
865999|NCT02308748|2096514|P5|COMPLETED|Period 5||2
866000|NCT02308748|2096515|P4|COMPLETED|Period 5||2
866001|NCT02308748|2096516|P3|COMPLETED|Period 5||1
866002|NCT02308748|2096517|P2|COMPLETED|Period 5||2
866003|NCT02308748|2096518|P1|COMPLETED|Period 5||1
866004|NCT02308748|2096509|P10|STARTED|Period 5||2
866005|NCT02308748|2096510|P9|STARTED|Period 5||2
866006|NCT02308748|2096511|P8|STARTED|Period 5||1
866007|NCT02308748|2096512|P7|STARTED|Period 5||2
866008|NCT02308748|2096513|P6|STARTED|Period 5||3
866009|NCT02308748|2096514|P5|STARTED|Period 5||2
866010|NCT02308748|2096515|P4|STARTED|Period 5||2
866011|NCT02308748|2096516|P3|STARTED|Period 5||1
866012|NCT02308748|2096517|P2|STARTED|Period 5||2
866013|NCT02308748|2096518|P1|STARTED|Period 5||2
866014|NCT02308748|2096509|P10|NOT COMPLETED|Period 4||0
866015|NCT02308748|2096510|P9|NOT COMPLETED|Period 4||0
866016|NCT02308748|2096511|P8|NOT COMPLETED|Period 4||0
866017|NCT02308748|2096512|P7|NOT COMPLETED|Period 4||0
866018|NCT02308748|2096513|P6|NOT COMPLETED|Period 4||0
866019|NCT02308748|2096514|P5|NOT COMPLETED|Period 4||0
866020|NCT02308748|2096515|P4|NOT COMPLETED|Period 4||0
866021|NCT02308748|2096516|P3|NOT COMPLETED|Period 4||0
866022|NCT02308748|2096517|P2|NOT COMPLETED|Period 4||0
866023|NCT02308748|2096518|P1|NOT COMPLETED|Period 4||0
866024|NCT02308748|2096509|P10|COMPLETED|Period 4||2
866025|NCT02308748|2096510|P9|COMPLETED|Period 4||2
866026|NCT02308748|2096511|P8|COMPLETED|Period 4||1
866027|NCT02308748|2096512|P7|COMPLETED|Period 4||2
866028|NCT02308748|2096513|P6|COMPLETED|Period 4||3
866029|NCT02308748|2096514|P5|COMPLETED|Period 4||2
866030|NCT02308748|2096515|P4|COMPLETED|Period 4||2
866031|NCT02308748|2096516|P3|COMPLETED|Period 4||1
866032|NCT02308748|2096517|P2|COMPLETED|Period 4||2
866033|NCT02308748|2096518|P1|COMPLETED|Period 4||2
866034|NCT02308748|2096509|P10|STARTED|Period 4||2
866035|NCT02308748|2096510|P9|STARTED|Period 4||2
866036|NCT02308748|2096511|P8|STARTED|Period 4||1
866037|NCT02308748|2096512|P7|STARTED|Period 4||2
866038|NCT02308748|2096513|P6|STARTED|Period 4||3
866039|NCT02308748|2096514|P5|STARTED|Period 4||2
866040|NCT02308748|2096515|P4|STARTED|Period 4||2
866041|NCT02308748|2096516|P3|STARTED|Period 4||1
866042|NCT02308748|2096517|P2|STARTED|Period 4||2
866043|NCT02308748|2096518|P1|STARTED|Period 4||2
866044|NCT02308748|2096509|P10|NOT COMPLETED|Period 3||1
866045|NCT02308748|2096510|P9|NOT COMPLETED|Period 3||0
866046|NCT02308748|2096511|P8|NOT COMPLETED|Period 3||0
866047|NCT02308748|2096512|P7|NOT COMPLETED|Period 3||0
866048|NCT02308748|2096513|P6|NOT COMPLETED|Period 3||0
866049|NCT02308748|2096514|P5|NOT COMPLETED|Period 3||0
866050|NCT02308748|2096515|P4|NOT COMPLETED|Period 3||0
866051|NCT02308748|2096516|P3|NOT COMPLETED|Period 3||0
866052|NCT02308748|2096517|P2|NOT COMPLETED|Period 3||0
866053|NCT02308748|2096518|P1|NOT COMPLETED|Period 3||0
866054|NCT02308748|2096509|P10|COMPLETED|Period 3||2
866055|NCT02308748|2096510|P9|COMPLETED|Period 3||2
866056|NCT02308748|2096511|P8|COMPLETED|Period 3||1
866057|NCT02308748|2096512|P7|COMPLETED|Period 3||2
866058|NCT02308748|2096513|P6|COMPLETED|Period 3||3
866059|NCT02308748|2096514|P5|COMPLETED|Period 3||2
866060|NCT02308748|2096515|P4|COMPLETED|Period 3||2
866061|NCT02308748|2096516|P3|COMPLETED|Period 3||1
866062|NCT02308748|2096517|P2|COMPLETED|Period 3||2
866063|NCT02308748|2096518|P1|COMPLETED|Period 3||2
866064|NCT02308748|2096509|P10|STARTED|Period 3||3
866065|NCT02308748|2096510|P9|STARTED|Period 3||2
866066|NCT02308748|2096511|P8|STARTED|Period 3||1
866067|NCT02308748|2096512|P7|STARTED|Period 3||2
866068|NCT02308748|2096513|P6|STARTED|Period 3||3
866069|NCT02308748|2096514|P5|STARTED|Period 3||2
866070|NCT02308748|2096515|P4|STARTED|Period 3||2
866071|NCT02308748|2096516|P3|STARTED|Period 3||1
866072|NCT02308748|2096517|P2|STARTED|Period 3||2
866073|NCT02308748|2096518|P1|STARTED|Period 3||2
866074|NCT02308748|2096509|P10|NOT COMPLETED|Period 2||0
866075|NCT02308748|2096510|P9|NOT COMPLETED|Period 2||0
866076|NCT02308748|2096511|P8|NOT COMPLETED|Period 2||1
866077|NCT02308748|2096512|P7|NOT COMPLETED|Period 2||0
866078|NCT02308748|2096513|P6|NOT COMPLETED|Period 2||0
866079|NCT02308748|2096514|P5|NOT COMPLETED|Period 2||0
866080|NCT02308748|2096515|P4|NOT COMPLETED|Period 2||0
866081|NCT02308748|2096516|P3|NOT COMPLETED|Period 2||0
866082|NCT02308748|2096517|P2|NOT COMPLETED|Period 2||0
866083|NCT02308748|2096518|P1|NOT COMPLETED|Period 2||0
866084|NCT02308748|2096509|P10|COMPLETED|Period 2||3
866085|NCT02308748|2096510|P9|COMPLETED|Period 2||2
866086|NCT02308748|2096511|P8|COMPLETED|Period 2||1
866087|NCT02308748|2096512|P7|COMPLETED|Period 2||2
866088|NCT02308748|2096513|P6|COMPLETED|Period 2||3
866089|NCT02308748|2096514|P5|COMPLETED|Period 2||2
866090|NCT02308748|2096515|P4|COMPLETED|Period 2||2
866091|NCT02308748|2096516|P3|COMPLETED|Period 2||1
866092|NCT02308748|2096517|P2|COMPLETED|Period 2||2
866093|NCT02308748|2096518|P1|COMPLETED|Period 2||2
866094|NCT02308748|2096509|P10|STARTED|Period 2||3
866095|NCT02308748|2096510|P9|STARTED|Period 2||2
866096|NCT02308748|2096511|P8|STARTED|Period 2||2
866097|NCT02308748|2096512|P7|STARTED|Period 2||2
866098|NCT02308748|2096513|P6|STARTED|Period 2||3
866099|NCT02308748|2096514|P5|STARTED|Period 2||2
866100|NCT02308748|2096515|P4|STARTED|Period 2||2
866101|NCT02308748|2096516|P3|STARTED|Period 2||1
866102|NCT02308748|2096517|P2|STARTED|Period 2||2
866103|NCT02308748|2096518|P1|STARTED|Period 2||2
866104|NCT02308748|2096509|P10|NOT COMPLETED|Period 1||0
866105|NCT02308748|2096510|P9|NOT COMPLETED|Period 1||0
866106|NCT02308748|2096511|P8|NOT COMPLETED|Period 1||0
866107|NCT02308748|2096512|P7|NOT COMPLETED|Period 1||0
866108|NCT02308748|2096513|P6|NOT COMPLETED|Period 1||0
866109|NCT02308748|2096514|P5|NOT COMPLETED|Period 1||0
866110|NCT02308748|2096515|P4|NOT COMPLETED|Period 1||0
866111|NCT02308748|2096516|P3|NOT COMPLETED|Period 1||1
866112|NCT02308748|2096517|P2|NOT COMPLETED|Period 1||0
866113|NCT02308748|2096518|P1|NOT COMPLETED|Period 1||0
866114|NCT02308748|2096509|P10|COMPLETED|Period 1||3
866115|NCT02308748|2096510|P9|COMPLETED|Period 1||2
866116|NCT02308748|2096511|P8|COMPLETED|Period 1||2
866117|NCT02308748|2096512|P7|COMPLETED|Period 1||2
866118|NCT02308748|2096513|P6|COMPLETED|Period 1||3
866119|NCT02308748|2096514|P5|COMPLETED|Period 1||2
866120|NCT02308748|2096515|P4|COMPLETED|Period 1||2
866121|NCT02308748|2096516|P3|COMPLETED|Period 1|One subject withdraw consent before starting Period 2|1
866122|NCT02308748|2096517|P2|COMPLETED|Period 1||2
866123|NCT02308748|2096518|P1|COMPLETED|Period 1||2
866124|NCT02308748|2096509|P10|STARTED|Period 1||3
866125|NCT02308748|2096510|P9|STARTED|Period 1||2
866126|NCT02308748|2096511|P8|STARTED|Period 1||2
866127|NCT02308748|2096512|P7|STARTED|Period 1||2
866128|NCT02308748|2096513|P6|STARTED|Period 1||3
866129|NCT02308748|2096514|P5|STARTED|Period 1||2
866130|NCT02308748|2096515|P4|STARTED|Period 1||2
866131|NCT02308748|2096516|P3|STARTED|Period 1||2
866132|NCT02308748|2096517|P2|STARTED|Period 1||2
866133|NCT02308748|2096518|P1|STARTED|Period 1||2
866134|NCT02308371|2096532|P2|NOT COMPLETED|Overall Study||0
866135|NCT02308371|2096533|P1|NOT COMPLETED|Overall Study||0
866136|NCT02308371|2096532|P2|COMPLETED|Overall Study|Consider eligible for retrospective enrollment if admitted up until 10/15/2012|50
866137|NCT02308371|2096533|P1|COMPLETED|Overall Study|Ended enrollment and recruitment 3/1/2016|50
866138|NCT02308371|2096532|P2|STARTED|Overall Study|Consider eligible for retrospective enrollment if admitted after 4/1/2012|50
866139|NCT02308371|2096533|P1|STARTED|Overall Study|Started enrollment and recruitment 11/26/2014|50
866140|NCT02308124|2096550|P3|NOT COMPLETED|Overall Study||8
866141|NCT02308124|2096551|P2|NOT COMPLETED|Overall Study||8
866142|NCT02308124|2096552|P1|NOT COMPLETED|Overall Study||6
866143|NCT02308124|2096550|P3|COMPLETED|Overall Study||21
866144|NCT02308124|2096551|P2|COMPLETED|Overall Study||21
866145|NCT02308124|2096552|P1|COMPLETED|Overall Study||23
866146|NCT02308124|2096550|P3|STARTED|Overall Study||29
866147|NCT02308124|2096551|P2|STARTED|Overall Study||29
866148|NCT02308124|2096552|P1|STARTED|Overall Study||29
866149|NCT02307838|2096575|P3|NOT COMPLETED|Overall Study||0
866150|NCT02307838|2096576|P2|NOT COMPLETED|Overall Study||0
866151|NCT02307838|2096577|P1|NOT COMPLETED|Overall Study||0
866152|NCT02307838|2096575|P3|COMPLETED|Overall Study||55
866153|NCT02307838|2096576|P2|COMPLETED|Overall Study||64
866154|NCT02307838|2096577|P1|COMPLETED|Overall Study||56
866155|NCT02307838|2096575|P3|STARTED|Overall Study||55
866156|NCT02307838|2096576|P2|STARTED|Overall Study||64
866157|NCT02307838|2096577|P1|STARTED|Overall Study||56
866158|NCT02307552|2096620|P1|NOT COMPLETED|Overall Study||0
866159|NCT02307552|2096620|P1|COMPLETED|Overall Study||1
866160|NCT02307552|2096620|P1|STARTED|Overall Study||1
866161|NCT02307526|2096624|P1|NOT COMPLETED|Day 2 - 60 mg of Pyridostigmine||0
866162|NCT02307526|2096624|P1|COMPLETED|Day 2 - 60 mg of Pyridostigmine||10
866163|NCT02307526|2096624|P1|STARTED|Day 2 - 60 mg of Pyridostigmine||10
866164|NCT02307526|2096624|P1|NOT COMPLETED|Day 1 - No Drug||0
866165|NCT02307526|2096624|P1|COMPLETED|Day 1 - No Drug||10
866166|NCT02307526|2096624|P1|STARTED|Day 1 - No Drug||10
866167|NCT02307318|2096634|P1|NOT COMPLETED|Overall Study||0
866168|NCT02307318|2096634|P1|COMPLETED|Overall Study||51
866169|NCT02307318|2096634|P1|STARTED|Overall Study||51
866170|NCT02307266|2096644|P3|NOT COMPLETED|Overall Study||6
866171|NCT02307266|2096645|P2|NOT COMPLETED|Overall Study||1
866172|NCT02307266|2096646|P1|NOT COMPLETED|Overall Study||8
866173|NCT02307266|2096644|P3|COMPLETED|Overall Study||25
866174|NCT02307266|2096645|P2|COMPLETED|Overall Study||32
866175|NCT02307266|2096646|P1|COMPLETED|Overall Study||25
866176|NCT02307266|2096644|P3|STARTED|Overall Study||31
866177|NCT02307266|2096645|P2|STARTED|Overall Study||33
866178|NCT02307266|2096646|P1|STARTED|Overall Study||33
866179|NCT02307188|2096654|P1|NOT COMPLETED|Overall Study||4
866180|NCT02307188|2096654|P1|COMPLETED|Overall Study|Four of 5 patients did not meet required criteria to complete the study after they were enrolled.|1
866181|NCT02307188|2096654|P1|STARTED|Overall Study||5
866182|NCT02307123|2096658|P1|NOT COMPLETED|Overall Study||0
866183|NCT02307123|2096658|P1|COMPLETED|Overall Study||483
866184|NCT02307123|2096658|P1|STARTED|Overall Study||483
866185|NCT02306928|2096663|P1|NOT COMPLETED|Overall Study||0
866186|NCT02306928|2096663|P1|COMPLETED|Overall Study||15
866187|NCT02306928|2096663|P1|STARTED|Overall Study||15
866188|NCT02306759|2096673|P2|NOT COMPLETED|Overall Study||0
866189|NCT02306759|2096674|P1|NOT COMPLETED|Overall Study||0
866190|NCT02306759|2096673|P2|COMPLETED|Overall Study||30
866191|NCT02306759|2096674|P1|COMPLETED|Overall Study||30
866192|NCT02306759|2096673|P2|STARTED|Overall Study||30
866193|NCT02306759|2096674|P1|STARTED|Overall Study||30
866194|NCT02305446|2096688|P1|NOT COMPLETED|Overall Study||1
866195|NCT02305446|2096688|P1|COMPLETED|Overall Study||54
866196|NCT02305446|2096688|P1|STARTED|Overall Study||55
866197|NCT02305329|2096697|P4|NOT COMPLETED|Overall Study||0
866198|NCT02305329|2096698|P3|NOT COMPLETED|Overall Study||0
866199|NCT02305329|2096699|P2|NOT COMPLETED|Overall Study||1
866200|NCT02305329|2096700|P1|NOT COMPLETED|Overall Study||0
866201|NCT02305329|2096697|P4|COMPLETED|Overall Study||14
866202|NCT02305329|2096698|P3|COMPLETED|Overall Study||14
866203|NCT02305329|2096699|P2|COMPLETED|Overall Study||13
866204|NCT02305329|2096700|P1|COMPLETED|Overall Study||14
866205|NCT02305329|2096697|P4|Period 2|Overall Study||14
866206|NCT02305329|2096698|P3|Period 2|Overall Study||14
866207|NCT02305329|2096699|P2|Period 2|Overall Study||13
866208|NCT02305329|2096700|P1|Period 2|Overall Study||14
866209|NCT02305329|2096697|P4|Period 1|Overall Study||14
866210|NCT02305329|2096698|P3|Period 1|Overall Study||14
866211|NCT02305329|2096699|P2|Period 1|Overall Study||14
866212|NCT02305329|2096700|P1|Period 1|Overall Study||14
866213|NCT02305329|2096697|P4|STARTED|Overall Study||14
866214|NCT02305329|2096698|P3|STARTED|Overall Study||14
866215|NCT02305329|2096699|P2|STARTED|Overall Study||14
866216|NCT02305329|2096700|P1|STARTED|Overall Study||14
866217|NCT02305316|2096724|P2|NOT COMPLETED|Overall Study||0
866218|NCT02305316|2096725|P1|NOT COMPLETED|Overall Study||0
866219|NCT02305316|2096724|P2|COMPLETED|Overall Study||14
866220|NCT02305316|2096725|P1|COMPLETED|Overall Study||14
866221|NCT02305316|2096724|P2|STARTED|Overall Study||14
866222|NCT02305316|2096725|P1|STARTED|Overall Study||14
866223|NCT02305277|2096743|P6|NOT COMPLETED|Overall Study||0
866224|NCT02305277|2096744|P5|NOT COMPLETED|Overall Study||1
866225|NCT02305277|2096745|P4|NOT COMPLETED|Overall Study||0
866226|NCT02305277|2096746|P3|NOT COMPLETED|Overall Study||0
866227|NCT02305277|2096747|P2|NOT COMPLETED|Overall Study||0
866228|NCT02305277|2096748|P1|NOT COMPLETED|Overall Study||1
866229|NCT02305277|2096743|P6|COMPLETED|Overall Study||14
866230|NCT02305277|2096744|P5|COMPLETED|Overall Study||13
866231|NCT02305277|2096745|P4|COMPLETED|Overall Study||14
866232|NCT02305277|2096746|P3|COMPLETED|Overall Study||14
866233|NCT02305277|2096747|P2|COMPLETED|Overall Study||14
866234|NCT02305277|2096748|P1|COMPLETED|Overall Study||14
866235|NCT02305277|2096743|P6|Received TBM|Overall Study||14
866236|NCT02305277|2096744|P5|Received TBM|Overall Study||14
866237|NCT02305277|2096745|P4|Received TBM|Overall Study||14
866238|NCT02305277|2096746|P3|Received TBM|Overall Study||14
866239|NCT02305277|2096747|P2|Received TBM|Overall Study||14
866240|NCT02305277|2096748|P1|Received TBM|Overall Study||15
866241|NCT02305277|2096743|P6|Received CM|Overall Study||14
866242|NCT02305277|2096744|P5|Received CM|Overall Study||14
866243|NCT02305277|2096745|P4|Received CM|Overall Study||14
866244|NCT02305277|2096746|P3|Received CM|Overall Study||14
866245|NCT02305277|2096747|P2|Received CM|Overall Study||14
866246|NCT02305277|2096748|P1|Received CM|Overall Study||15
866247|NCT02305277|2096743|P6|STARTED|Overall Study||14
866248|NCT02305277|2096744|P5|STARTED|Overall Study||14
866249|NCT02305277|2096745|P4|STARTED|Overall Study||14
866250|NCT02305277|2096746|P3|STARTED|Overall Study||14
866251|NCT02305277|2096747|P2|STARTED|Overall Study||14
866252|NCT02305277|2096748|P1|STARTED|Overall Study||15
866253|NCT02305017|2096776|P2|NOT COMPLETED|Overall Study||0
866254|NCT02305017|2096777|P1|NOT COMPLETED|Overall Study||0
866255|NCT02305017|2096776|P2|COMPLETED|Overall Study||14
866256|NCT02305017|2096777|P1|COMPLETED|Overall Study||14
866257|NCT02305017|2096776|P2|STARTED|Overall Study||14
866258|NCT02305017|2096777|P1|STARTED|Overall Study||14
866259|NCT02304926|2096791|P2|NOT COMPLETED|Overall Study||1
866260|NCT02304926|2096792|P1|NOT COMPLETED|Overall Study||2
866261|NCT02304926|2096791|P2|COMPLETED|Overall Study||19
866262|NCT02304926|2096792|P1|COMPLETED|Overall Study||20
866263|NCT02304926|2096791|P2|STARTED|Overall Study||20
866264|NCT02304926|2096792|P1|STARTED|Overall Study||22
866265|NCT02304432|2096836|P4|NOT COMPLETED|Second Open Label DCS||0
866266|NCT02304432|2096837|P3|NOT COMPLETED|Second Open Label DCS||0
866267|NCT02304432|2096838|P2|NOT COMPLETED|Second Open Label DCS||0
866268|NCT02304432|2096839|P1|NOT COMPLETED|Second Open Label DCS||0
866269|NCT02304432|2096836|P4|COMPLETED|Second Open Label DCS||2
866270|NCT02304432|2096837|P3|COMPLETED|Second Open Label DCS||0
866271|NCT02304432|2096838|P2|COMPLETED|Second Open Label DCS||0
866272|NCT02304432|2096839|P1|COMPLETED|Second Open Label DCS||0
866273|NCT02304432|2096836|P4|STARTED|Second Open Label DCS||2
866274|NCT02304432|2096837|P3|STARTED|Second Open Label DCS||0
866275|NCT02304432|2096838|P2|STARTED|Second Open Label DCS||0
866276|NCT02304432|2096839|P1|STARTED|Second Open Label DCS||0
866277|NCT02304432|2096836|P4|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
866278|NCT02304432|2096837|P3|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
866279|NCT02304432|2096838|P2|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
866280|NCT02304432|2096839|P1|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
866281|NCT02304432|2096836|P4|COMPLETED|Double-Blind DCS Placebo Crossover||0
866282|NCT02304432|2096837|P3|COMPLETED|Double-Blind DCS Placebo Crossover||1
866283|NCT02304432|2096838|P2|COMPLETED|Double-Blind DCS Placebo Crossover||1
866284|NCT02304432|2096839|P1|COMPLETED|Double-Blind DCS Placebo Crossover||0
866285|NCT02304432|2096836|P4|STARTED|Double-Blind DCS Placebo Crossover||0
866286|NCT02304432|2096837|P3|STARTED|Double-Blind DCS Placebo Crossover||1
866287|NCT02304432|2096838|P2|STARTED|Double-Blind DCS Placebo Crossover||1
866288|NCT02304432|2096839|P1|STARTED|Double-Blind DCS Placebo Crossover||0
866289|NCT02304432|2096836|P4|NOT COMPLETED|Open Label DCS||0
866290|NCT02304432|2096837|P3|NOT COMPLETED|Open Label DCS||0
866291|NCT02304432|2096838|P2|NOT COMPLETED|Open Label DCS||0
866292|NCT02304432|2096839|P1|NOT COMPLETED|Open Label DCS||0
866293|NCT02304432|2096836|P4|COMPLETED|Open Label DCS||0
866294|NCT02304432|2096837|P3|COMPLETED|Open Label DCS||0
866295|NCT02304432|2096838|P2|COMPLETED|Open Label DCS||0
866296|NCT02304432|2096839|P1|COMPLETED|Open Label DCS||2
866297|NCT02304432|2096836|P4|STARTED|Open Label DCS||0
866298|NCT02304432|2096837|P3|STARTED|Open Label DCS||0
866299|NCT02304432|2096838|P2|STARTED|Open Label DCS||0
866300|NCT02304432|2096839|P1|STARTED|Open Label DCS||2
866301|NCT02303743|2096873|P2|NOT COMPLETED|Overall Study||0
866302|NCT02303743|2096874|P1|NOT COMPLETED|Overall Study||0
866303|NCT02303743|2096873|P2|COMPLETED|Overall Study||152
866304|NCT02303743|2096874|P1|COMPLETED|Overall Study||108
866305|NCT02303743|2096873|P2|STARTED|Overall Study||152
866306|NCT02303743|2096874|P1|STARTED|Overall Study||108
866307|NCT02303704|2096884|P2|NOT COMPLETED|Overall Study||9
866308|NCT02303704|2096885|P1|NOT COMPLETED|Overall Study||5
866309|NCT02303704|2096884|P2|COMPLETED|Overall Study||219
866310|NCT02303704|2096885|P1|COMPLETED|Overall Study||215
866311|NCT02303704|2096884|P2|STARTED|Overall Study||228
866312|NCT02303704|2096885|P1|STARTED|Overall Study||220
866313|NCT02302365|2096901|P1|NOT COMPLETED|Overall Study||2
866314|NCT02302365|2096901|P1|COMPLETED|Overall Study|The Per-protocol Analysis Set comprised 54 procedures performed in 41 subjects|41
866315|NCT02302365|2096901|P1|STARTED|Overall Study|Data were collected from 58 WBCD procedures performed in 43 subjects - Full and Safety Analysis Sets|43
866325|NCT02301936|2096950|P2|NOT COMPLETED|Overall Study||0
866326|NCT02301936|2096951|P1|NOT COMPLETED|Overall Study||1
866327|NCT02301936|2096950|P2|COMPLETED|Overall Study||1
866328|NCT02301936|2096951|P1|COMPLETED|Overall Study||8
866329|NCT02301936|2096950|P2|STARTED|Overall Study||1
866330|NCT02301936|2096951|P1|STARTED|Overall Study||9
866331|NCT02301429|2096973|P1|NOT COMPLETED|Overall Study||3
866332|NCT02301429|2096973|P1|COMPLETED|Overall Study||13
866333|NCT02301429|2096973|P1|STARTED|Overall Study||16
866334|NCT02301377|2096979|P2|NOT COMPLETED|Overall Study||0
866335|NCT02301377|2096980|P1|NOT COMPLETED|Overall Study||0
866336|NCT02301377|2096979|P2|COMPLETED|Overall Study||2
866337|NCT02301377|2096980|P1|COMPLETED|Overall Study||3
866338|NCT02301377|2096979|P2|STARTED|Overall Study||2
866339|NCT02301377|2096980|P1|STARTED|Overall Study||3
866340|NCT02301169|2096992|P2|NOT COMPLETED|Overall Study||0
866341|NCT02301169|2096993|P1|NOT COMPLETED|Overall Study||1
866342|NCT02301169|2096992|P2|COMPLETED|Overall Study||21
866343|NCT02301169|2096993|P1|COMPLETED|Overall Study||20
866344|NCT02301169|2096992|P2|STARTED|Overall Study||21
866345|NCT02301169|2096993|P1|STARTED|Overall Study||21
866346|NCT02300311|2097009|P2|NOT COMPLETED|Overall Study||0
866347|NCT02300311|2097010|P1|NOT COMPLETED|Overall Study||19
866348|NCT02300311|2097009|P2|COMPLETED|Overall Study||69
866349|NCT02300311|2097010|P1|COMPLETED|Overall Study||50
866350|NCT02300311|2097009|P2|STARTED|Overall Study||69
866351|NCT02300311|2097010|P1|STARTED|Overall Study||69
866352|NCT02300129|2097022|P4|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
866353|NCT02300129|2097023|P3|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
866354|NCT02300129|2097024|P2|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
866355|NCT02300129|2097025|P1|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
866356|NCT02300129|2097022|P4|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
866357|NCT02300129|2097023|P3|COMPLETED|Period 2 Treatment 2 (2 Weeks)||7
866358|NCT02300129|2097024|P2|COMPLETED|Period 2 Treatment 2 (2 Weeks)||4
866359|NCT02300129|2097025|P1|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
866360|NCT02300129|2097022|P4|STARTED|Period 2 Treatment 2 (2 Weeks)||10
866361|NCT02300129|2097023|P3|STARTED|Period 2 Treatment 2 (2 Weeks)||7
866362|NCT02300129|2097024|P2|STARTED|Period 2 Treatment 2 (2 Weeks)||4
866363|NCT02300129|2097025|P1|STARTED|Period 2 Treatment 2 (2 Weeks)||10
866364|NCT02300129|2097022|P4|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
866365|NCT02300129|2097023|P3|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
866366|NCT02300129|2097024|P2|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
866367|NCT02300129|2097025|P1|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
866368|NCT02300129|2097022|P4|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
866369|NCT02300129|2097023|P3|COMPLETED|Period 2 Treatment 1 (2 Weeks)||7
866370|NCT02300129|2097024|P2|COMPLETED|Period 2 Treatment 1 (2 Weeks)||4
866371|NCT02300129|2097025|P1|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
866372|NCT02300129|2097022|P4|STARTED|Period 2 Treatment 1 (2 Weeks)|Withdrawal consent of 1 subject between the Period 1 and Period 2|11
866373|NCT02300129|2097023|P3|STARTED|Period 2 Treatment 1 (2 Weeks)||7
866374|NCT02300129|2097024|P2|STARTED|Period 2 Treatment 1 (2 Weeks)||4
866375|NCT02300129|2097025|P1|STARTED|Period 2 Treatment 1 (2 Weeks)||11
866376|NCT02300129|2097022|P4|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
866377|NCT02300129|2097023|P3|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
866378|NCT02300129|2097024|P2|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
866379|NCT02300129|2097025|P1|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
866380|NCT02300129|2097022|P4|COMPLETED|Period 1 Session 3 (Day 5)||11
866381|NCT02300129|2097023|P3|COMPLETED|Period 1 Session 3 (Day 5)||7
866382|NCT02300129|2097024|P2|COMPLETED|Period 1 Session 3 (Day 5)||4
866383|NCT02300129|2097025|P1|COMPLETED|Period 1 Session 3 (Day 5)||11
866384|NCT02300129|2097022|P4|STARTED|Period 1 Session 3 (Day 5)||11
866385|NCT02300129|2097023|P3|STARTED|Period 1 Session 3 (Day 5)||7
866386|NCT02300129|2097024|P2|STARTED|Period 1 Session 3 (Day 5)||4
866387|NCT02300129|2097025|P1|STARTED|Period 1 Session 3 (Day 5)||11
866388|NCT02300129|2097022|P4|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
866389|NCT02300129|2097023|P3|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
866390|NCT02300129|2097024|P2|NOT COMPLETED|Period 1 Session 2 (Day 3)||1
866391|NCT02300129|2097025|P1|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
866392|NCT02300129|2097022|P4|COMPLETED|Period 1 Session 2 (Day 3)||11
866393|NCT02300129|2097023|P3|COMPLETED|Period 1 Session 2 (Day 3)||7
866394|NCT02300129|2097024|P2|COMPLETED|Period 1 Session 2 (Day 3)||4
866395|NCT02300129|2097025|P1|COMPLETED|Period 1 Session 2 (Day 3)||11
866396|NCT02300129|2097022|P4|STARTED|Period 1 Session 2 (Day 3)||11
866397|NCT02300129|2097023|P3|STARTED|Period 1 Session 2 (Day 3)||7
866398|NCT02300129|2097024|P2|STARTED|Period 1 Session 2 (Day 3)|Withdrawal consent of 1 subject between Day 1 and Day 3|5
866399|NCT02300129|2097025|P1|STARTED|Period 1 Session 2 (Day 3)||11
866400|NCT02300129|2097022|P4|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
866401|NCT02300129|2097023|P3|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
866402|NCT02300129|2097024|P2|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
866403|NCT02300129|2097025|P1|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
866404|NCT02300129|2097022|P4|COMPLETED|Period 1 Session 1 (Day 1)||11
866405|NCT02300129|2097023|P3|COMPLETED|Period 1 Session 1 (Day 1)||7
866406|NCT02300129|2097024|P2|COMPLETED|Period 1 Session 1 (Day 1)||5
866407|NCT02300129|2097025|P1|COMPLETED|Period 1 Session 1 (Day 1)||11
866408|NCT02300129|2097022|P4|STARTED|Period 1 Session 1 (Day 1)||11
866409|NCT02300129|2097023|P3|STARTED|Period 1 Session 1 (Day 1)||7
866410|NCT02300129|2097024|P2|STARTED|Period 1 Session 1 (Day 1)||5
866411|NCT02300129|2097025|P1|STARTED|Period 1 Session 1 (Day 1)||11
866412|NCT02300103|2097035|P1|NOT COMPLETED|Overall Study||6
866413|NCT02300103|2097035|P1|COMPLETED|Overall Study||63
866414|NCT02300103|2097035|P1|STARTED|Overall Study||69
866415|NCT02300025|2097048|P4|NOT COMPLETED|Overall Study||0
866416|NCT02300025|2097049|P3|NOT COMPLETED|Overall Study||0
866417|NCT02300025|2097050|P2|NOT COMPLETED|Overall Study||0
866418|NCT02300025|2097051|P1|NOT COMPLETED|Overall Study||0
866419|NCT02300025|2097048|P4|COMPLETED|Overall Study||6
866420|NCT02300025|2097049|P3|COMPLETED|Overall Study||6
866421|NCT02300025|2097050|P2|COMPLETED|Overall Study||6
866422|NCT02300025|2097051|P1|COMPLETED|Overall Study||10
866423|NCT02300025|2097048|P4|STARTED|Overall Study||6
866424|NCT02300025|2097049|P3|STARTED|Overall Study||6
866425|NCT02300025|2097050|P2|STARTED|Overall Study||6
866426|NCT02300025|2097051|P1|STARTED|Overall Study||10
866427|NCT02299869|2097097|P4|NOT COMPLETED|Overall Study||0
866428|NCT02299869|2097098|P3|NOT COMPLETED|Overall Study||0
866429|NCT02299869|2097099|P2|NOT COMPLETED|Overall Study||0
866430|NCT02299869|2097100|P1|NOT COMPLETED|Overall Study||0
866431|NCT02299869|2097097|P4|COMPLETED|Overall Study||10
866432|NCT02299869|2097098|P3|COMPLETED|Overall Study||10
866433|NCT02299869|2097099|P2|COMPLETED|Overall Study||10
866434|NCT02299869|2097100|P1|COMPLETED|Overall Study||10
866435|NCT02299869|2097097|P4|STARTED|Overall Study||10
866436|NCT02299869|2097098|P3|STARTED|Overall Study||10
866437|NCT02299869|2097099|P2|STARTED|Overall Study||10
866438|NCT02299869|2097100|P1|STARTED|Overall Study||10
866439|NCT02299791|2097125|P2|NOT COMPLETED|Overall Study||0
866440|NCT02299791|2097126|P1|NOT COMPLETED|Overall Study||0
866441|NCT02299791|2097125|P2|COMPLETED|Overall Study||2803
866442|NCT02299791|2097126|P1|COMPLETED|Overall Study||2053
866443|NCT02299791|2097125|P2|STARTED|Overall Study||2803
866444|NCT02299791|2097126|P1|STARTED|Overall Study||2053
866445|NCT02299635|2097132|P1|NOT COMPLETED|Overall Study||19
866446|NCT02299635|2097132|P1|COMPLETED|Overall Study||0
866447|NCT02299635|2097132|P1|STARTED|Overall Study||19
866448|NCT02299427|2097153|P2|NOT COMPLETED|Overall Study||3
866449|NCT02299427|2097154|P1|NOT COMPLETED|Overall Study||23
866450|NCT02299427|2097153|P2|COMPLETED|Overall Study||31
866451|NCT02299427|2097154|P1|COMPLETED|Overall Study||12
866452|NCT02299427|2097153|P2|STARTED|Overall Study||34
866453|NCT02299427|2097154|P1|STARTED|Overall Study||35
866454|NCT02299349|2097164|P2|NOT COMPLETED|Overall Study||0
866455|NCT02299349|2097165|P1|NOT COMPLETED|Overall Study||0
866456|NCT02299349|2097164|P2|COMPLETED|Overall Study||35
866457|NCT02299349|2097165|P1|COMPLETED|Overall Study||35
866458|NCT02299349|2097164|P2|STARTED|Overall Study||35
866459|NCT02299349|2097165|P1|STARTED|Overall Study||35
866460|NCT02299258|2097175|P2|NOT COMPLETED|Overall Study||1
866461|NCT02299258|2097176|P1|NOT COMPLETED|Overall Study||1
866462|NCT02299258|2097175|P2|COMPLETED|Overall Study||30
866463|NCT02299258|2097176|P1|COMPLETED|Overall Study||31
866464|NCT02299258|2097175|P2|STARTED|Overall Study||31
866465|NCT02299258|2097176|P1|STARTED|Overall Study||32
866466|NCT02299076|2097186|P2|NOT COMPLETED|Overall Study||14
866467|NCT02299076|2097187|P1|NOT COMPLETED|Overall Study||20
866468|NCT02299076|2097186|P2|COMPLETED|Overall Study||212
866469|NCT02299076|2097187|P1|COMPLETED|Overall Study||210
866470|NCT02299076|2097186|P2|STARTED|Overall Study||226
866471|NCT02299076|2097187|P1|STARTED|Overall Study||230
866472|NCT02298868|2097195|P1|NOT COMPLETED|Overall Study||3
866473|NCT02298868|2097195|P1|COMPLETED|Overall Study||7
866474|NCT02298868|2097195|P1|STARTED|Overall Study||10
866475|NCT02298842|2097209|P2|NOT COMPLETED|Second Platelet Donation (Day 6-8)||6
866476|NCT02298842|2097210|P1|NOT COMPLETED|Second Platelet Donation (Day 6-8)||8
866477|NCT02298842|2097209|P2|COMPLETED|Second Platelet Donation (Day 6-8)||30
866478|NCT02298842|2097210|P1|COMPLETED|Second Platelet Donation (Day 6-8)||30
866479|NCT02298842|2097209|P2|STARTED|Second Platelet Donation (Day 6-8)||36
866480|NCT02298842|2097210|P1|STARTED|Second Platelet Donation (Day 6-8)||38
866481|NCT02298842|2097209|P2|NOT COMPLETED|First Platelet Donation (Day 0)||5
866482|NCT02298842|2097210|P1|NOT COMPLETED|First Platelet Donation (Day 0)||6
866483|NCT02298842|2097209|P2|COMPLETED|First Platelet Donation (Day 0)||36
866484|NCT02298842|2097210|P1|COMPLETED|First Platelet Donation (Day 0)||38
866485|NCT02298842|2097209|P2|STARTED|First Platelet Donation (Day 0)||41
866486|NCT02298842|2097210|P1|STARTED|First Platelet Donation (Day 0)||44
866487|NCT02298361|2097237|P3|NOT COMPLETED|Overall Study||0
866488|NCT02298361|2097238|P2|NOT COMPLETED|Overall Study||0
866489|NCT02298361|2097239|P1|NOT COMPLETED|Overall Study||0
866490|NCT02298361|2097237|P3|COMPLETED|Overall Study||12227
866491|NCT02298361|2097238|P2|COMPLETED|Overall Study||12784
866492|NCT02298361|2097239|P1|COMPLETED|Overall Study||2240
866493|NCT02298361|2097237|P3|STARTED|Overall Study||12227
866494|NCT02298361|2097238|P2|STARTED|Overall Study||12784
866495|NCT02298361|2097239|P1|STARTED|Overall Study||2240
866496|NCT02298192|2097255|P2|NOT COMPLETED|Overall Study||6
866497|NCT02298192|2097256|P1|NOT COMPLETED|Overall Study||19
866498|NCT02298192|2097255|P2|COMPLETED|Overall Study||204
866499|NCT02298192|2097256|P1|COMPLETED|Overall Study||191
866500|NCT02298192|2097255|P2|STARTED|Overall Study||210
866501|NCT02298192|2097256|P1|STARTED|Overall Study||210
866502|NCT02297841|2097268|P1|NOT COMPLETED|Overall Study||8
866503|NCT02297841|2097268|P1|COMPLETED|Overall Study||201
866504|NCT02297841|2097268|P1|Challenge Phase|Overall Study||201
866505|NCT02297841|2097268|P1|Induction Phase|Overall Study||209
866506|NCT02297841|2097268|P1|STARTED|Overall Study||209
866507|NCT02297308|2097272|P1|NOT COMPLETED|Overall Study||0
866508|NCT02297308|2097272|P1|COMPLETED|Overall Study||90
866509|NCT02297308|2097272|P1|STARTED|Overall Study||90
866510|NCT02296931|2097279|P2|NOT COMPLETED|Overall Study||2
866511|NCT02296931|2097280|P1|NOT COMPLETED|Overall Study||0
866512|NCT02296931|2097279|P2|COMPLETED|Overall Study||22
866513|NCT02296931|2097280|P1|COMPLETED|Overall Study||10
866514|NCT02296931|2097279|P2|STARTED|Overall Study||24
866515|NCT02296931|2097280|P1|STARTED|Overall Study||10
866516|NCT02295774|2097286|P1|NOT COMPLETED|Overall Study||3
866517|NCT02295774|2097286|P1|COMPLETED|Overall Study||10
866518|NCT02295774|2097286|P1|STARTED|Overall Study||13
866519|NCT02295644|2097294|P4|NOT COMPLETED|Overall Study||0
866520|NCT02295644|2097295|P3|NOT COMPLETED|Overall Study||0
866521|NCT02295644|2097296|P2|NOT COMPLETED|Overall Study||0
866522|NCT02295644|2097297|P1|NOT COMPLETED|Overall Study||0
866523|NCT02295644|2097294|P4|COMPLETED|Overall Study||7
866524|NCT02295644|2097295|P3|COMPLETED|Overall Study||7
866525|NCT02295644|2097296|P2|COMPLETED|Overall Study||7
866526|NCT02295644|2097297|P1|COMPLETED|Overall Study||7
866527|NCT02295644|2097294|P4|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
866528|NCT02295644|2097295|P3|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
866529|NCT02295644|2097296|P2|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
866530|NCT02295644|2097297|P1|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
866531|NCT02295020|2097317|P2|NOT COMPLETED|Overall Study||3
866532|NCT02295020|2097318|P1|NOT COMPLETED|Overall Study||3
866533|NCT02295020|2097317|P2|COMPLETED|Overall Study||17
866534|NCT02295020|2097318|P1|COMPLETED|Overall Study||17
866535|NCT02295020|2097317|P2|STARTED|Overall Study||20
866536|NCT02295020|2097318|P1|STARTED|Overall Study||20
866537|NCT02294773|2097350|P2|NOT COMPLETED|Overall Study||2
866538|NCT02294773|2097351|P1|NOT COMPLETED|Overall Study||0
866539|NCT02294773|2097350|P2|COMPLETED|Overall Study||4
866540|NCT02294773|2097351|P1|COMPLETED|Overall Study||7
866541|NCT02294773|2097350|P2|STARTED|Overall Study||6
866542|NCT02294773|2097351|P1|STARTED|Overall Study||7
866543|NCT02294734|2097367|P2|NOT COMPLETED|Overall Study||8
866544|NCT02294734|2097368|P1|NOT COMPLETED|Overall Study||14
866545|NCT02294734|2097367|P2|COMPLETED|Overall Study||55
866546|NCT02294734|2097368|P1|COMPLETED|Overall Study||49
866547|NCT02294734|2097367|P2|STARTED|Overall Study||63
866548|NCT02294734|2097368|P1|STARTED|Overall Study||63
866549|NCT02294682|2097420|P2|NOT COMPLETED|Overall Study||0
866550|NCT02294682|2097421|P1|NOT COMPLETED|Overall Study||1
866551|NCT02294682|2097420|P2|COMPLETED|Overall Study||53
866552|NCT02294682|2097421|P1|COMPLETED|Overall Study||52
866553|NCT02294682|2097420|P2|STARTED|Overall Study||53
866554|NCT02294682|2097421|P1|STARTED|Overall Study||53
866555|NCT02294604|2097464|P3|NOT COMPLETED|Overall Study||0
866556|NCT02294604|2097465|P2|NOT COMPLETED|Overall Study||3
866557|NCT02294604|2097466|P1|NOT COMPLETED|Overall Study||1
866558|NCT02294604|2097464|P3|COMPLETED|Overall Study||80
866559|NCT02294604|2097465|P2|COMPLETED|Overall Study||77
866560|NCT02294604|2097466|P1|COMPLETED|Overall Study||79
866561|NCT02294604|2097464|P3|STARTED|Overall Study||80
866562|NCT02294604|2097465|P2|STARTED|Overall Study||80
866563|NCT02294604|2097466|P1|STARTED|Overall Study||80
866572|NCT02294019|2097538|P1|NOT COMPLETED|Overall Study||103
866573|NCT02294019|2097538|P1|COMPLETED|Overall Study||635
866574|NCT02294019|2097538|P1|STARTED|Overall Study||738
866575|NCT02293538|2097545|P2|NOT COMPLETED|Overall Study||2
866576|NCT02293538|2097546|P1|NOT COMPLETED|Overall Study||1
866577|NCT02293538|2097545|P2|COMPLETED|Overall Study||69
866578|NCT02293538|2097546|P1|COMPLETED|Overall Study||72
866579|NCT02293538|2097545|P2|STARTED|Overall Study||71
866580|NCT02293538|2097546|P1|STARTED|Overall Study||73
866581|NCT02292849|2097562|P3|NOT COMPLETED|Overall Study||2
866582|NCT02292849|2097563|P2|NOT COMPLETED|Overall Study||2
866583|NCT02292849|2097564|P1|NOT COMPLETED|Overall Study||4
866584|NCT02292849|2097562|P3|COMPLETED|Overall Study||8
866585|NCT02292849|2097563|P2|COMPLETED|Overall Study||6
866586|NCT02292849|2097564|P1|COMPLETED|Overall Study||7
866587|NCT02292849|2097562|P3|STARTED|Overall Study||10
866588|NCT02292849|2097563|P2|STARTED|Overall Study||8
866589|NCT02292849|2097564|P1|STARTED|Overall Study||11
866590|NCT02292433|2097575|P3|NOT COMPLETED|Third Intervention Period (7 Days)||0
866591|NCT02292433|2097576|P2|NOT COMPLETED|Third Intervention Period (7 Days)||0
866592|NCT02292433|2097577|P1|NOT COMPLETED|Third Intervention Period (7 Days)||0
866593|NCT02292433|2097575|P3|COMPLETED|Third Intervention Period (7 Days)||4
866594|NCT02292433|2097576|P2|COMPLETED|Third Intervention Period (7 Days)||4
866595|NCT02292433|2097577|P1|COMPLETED|Third Intervention Period (7 Days)||4
866596|NCT02292433|2097575|P3|STARTED|Third Intervention Period (7 Days)||4
866597|NCT02292433|2097576|P2|STARTED|Third Intervention Period (7 Days)||4
866598|NCT02292433|2097577|P1|STARTED|Third Intervention Period (7 Days)||4
866599|NCT02292433|2097575|P3|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
866600|NCT02292433|2097576|P2|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
866601|NCT02292433|2097577|P1|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
866602|NCT02292433|2097575|P3|COMPLETED|Second Washout Period (7 to 14 Days)||4
866603|NCT02292433|2097576|P2|COMPLETED|Second Washout Period (7 to 14 Days)||4
866604|NCT02292433|2097577|P1|COMPLETED|Second Washout Period (7 to 14 Days)||4
866605|NCT02292433|2097575|P3|STARTED|Second Washout Period (7 to 14 Days)||4
866606|NCT02292433|2097576|P2|STARTED|Second Washout Period (7 to 14 Days)||4
866607|NCT02292433|2097577|P1|STARTED|Second Washout Period (7 to 14 Days)||4
866608|NCT02292433|2097575|P3|NOT COMPLETED|Second Intervention Period (7 Days)||0
866609|NCT02292433|2097576|P2|NOT COMPLETED|Second Intervention Period (7 Days)||0
866610|NCT02292433|2097577|P1|NOT COMPLETED|Second Intervention Period (7 Days)||0
866611|NCT02292433|2097575|P3|COMPLETED|Second Intervention Period (7 Days)||4
866612|NCT02292433|2097576|P2|COMPLETED|Second Intervention Period (7 Days)||4
866613|NCT02292433|2097577|P1|COMPLETED|Second Intervention Period (7 Days)||4
866614|NCT02292433|2097575|P3|STARTED|Second Intervention Period (7 Days)||4
866615|NCT02292433|2097576|P2|STARTED|Second Intervention Period (7 Days)||4
866616|NCT02292433|2097577|P1|STARTED|Second Intervention Period (7 Days)||4
866617|NCT02292433|2097575|P3|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
866618|NCT02292433|2097576|P2|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
866619|NCT02292433|2097577|P1|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
866620|NCT02292433|2097575|P3|COMPLETED|First Washout Period (7 to 14 Days)||4
866621|NCT02292433|2097576|P2|COMPLETED|First Washout Period (7 to 14 Days)||4
866622|NCT02292433|2097577|P1|COMPLETED|First Washout Period (7 to 14 Days)||4
866623|NCT02292433|2097575|P3|STARTED|First Washout Period (7 to 14 Days)||4
866624|NCT02292433|2097576|P2|STARTED|First Washout Period (7 to 14 Days)||4
866625|NCT02292433|2097577|P1|STARTED|First Washout Period (7 to 14 Days)||4
866626|NCT02292433|2097575|P3|NOT COMPLETED|First Intervention Period (7 Days)||0
866627|NCT02292433|2097576|P2|NOT COMPLETED|First Intervention Period (7 Days)||0
866628|NCT02292433|2097577|P1|NOT COMPLETED|First Intervention Period (7 Days)||0
866629|NCT02292433|2097575|P3|COMPLETED|First Intervention Period (7 Days)||4
866630|NCT02292433|2097576|P2|COMPLETED|First Intervention Period (7 Days)||4
866631|NCT02292433|2097577|P1|COMPLETED|First Intervention Period (7 Days)||4
866632|NCT02292433|2097575|P3|STARTED|First Intervention Period (7 Days)||4
866633|NCT02292433|2097576|P2|STARTED|First Intervention Period (7 Days)||4
866634|NCT02292433|2097577|P1|STARTED|First Intervention Period (7 Days)||4
866635|NCT02292212|2097648|P1|NOT COMPLETED|Post-ViE Phase||0
866636|NCT02292212|2097648|P1|COMPLETED|Post-ViE Phase||14
866637|NCT02292212|2097648|P1|STARTED|Post-ViE Phase||14
866638|NCT02292212|2097648|P1|NOT COMPLETED|ViE Phase||3
866639|NCT02292212|2097648|P1|COMPLETED|ViE Phase||14
866640|NCT02292212|2097648|P1|STARTED|ViE Phase||17
866641|NCT02292212|2097648|P1|NOT COMPLETED|Pre-ViE Phase||0
866642|NCT02292212|2097648|P1|COMPLETED|Pre-ViE Phase||17
866643|NCT02292212|2097648|P1|STARTED|Pre-ViE Phase||17
866644|NCT02291718|2097683|P3|NOT COMPLETED|Overall Study||0
866645|NCT02291718|2097684|P2|NOT COMPLETED|Overall Study||0
866646|NCT02291718|2097685|P1|NOT COMPLETED|Overall Study||0
866647|NCT02291718|2097683|P3|COMPLETED|Overall Study||50
866648|NCT02291718|2097684|P2|COMPLETED|Overall Study||50
866649|NCT02291718|2097685|P1|COMPLETED|Overall Study||50
866650|NCT02291718|2097683|P3|STARTED|Overall Study||50
866651|NCT02291718|2097684|P2|STARTED|Overall Study||50
866652|NCT02291718|2097685|P1|STARTED|Overall Study||50
866653|NCT02291679|2097705|P3|NOT COMPLETED|Overall Study||59
866654|NCT02291679|2097706|P2|NOT COMPLETED|Overall Study||42
866655|NCT02291679|2097707|P1|NOT COMPLETED|Overall Study||44
866656|NCT02291679|2097705|P3|COMPLETED|Overall Study||352
866657|NCT02291679|2097706|P2|COMPLETED|Overall Study||369
866658|NCT02291679|2097707|P1|COMPLETED|Overall Study||357
866659|NCT02291679|2097705|P3|STARTED|Overall Study||411
866660|NCT02291679|2097706|P2|STARTED|Overall Study||411
866661|NCT02291679|2097707|P1|STARTED|Overall Study||401
866662|NCT02291510|2097740|P4|NOT COMPLETED|Overall Study||1
866663|NCT02291510|2097741|P3|NOT COMPLETED|Overall Study||0
866664|NCT02291510|2097742|P2|NOT COMPLETED|Overall Study||0
866665|NCT02291510|2097743|P1|NOT COMPLETED|Overall Study||0
866666|NCT02291510|2097740|P4|COMPLETED|Overall Study||4
866667|NCT02291510|2097741|P3|COMPLETED|Overall Study||5
866668|NCT02291510|2097742|P2|COMPLETED|Overall Study||5
866669|NCT02291510|2097743|P1|COMPLETED|Overall Study||5
866670|NCT02291510|2097740|P4|Completed Treatment D|Overall Study||5
866671|NCT02291510|2097741|P3|Completed Treatment D|Overall Study||5
866672|NCT02291510|2097742|P2|Completed Treatment D|Overall Study||5
866673|NCT02291510|2097743|P1|Completed Treatment D|Overall Study||5
866674|NCT02291510|2097740|P4|Completed Treatment C|Overall Study||4
866675|NCT02291510|2097741|P3|Completed Treatment C|Overall Study||5
866676|NCT02291510|2097742|P2|Completed Treatment C|Overall Study||5
866677|NCT02291510|2097743|P1|Completed Treatment C|Overall Study||5
866678|NCT02291510|2097740|P4|Completed Treatment B|Overall Study||4
866679|NCT02291510|2097741|P3|Completed Treatment B|Overall Study||5
866680|NCT02291510|2097742|P2|Completed Treatment B|Overall Study||5
866681|NCT02291510|2097743|P1|Completed Treatment B|Overall Study||5
866682|NCT02291510|2097740|P4|Completed Treatment A|Overall Study||5
866683|NCT02291510|2097741|P3|Completed Treatment A|Overall Study||5
866684|NCT02291510|2097742|P2|Completed Treatment A|Overall Study||5
866685|NCT02291510|2097743|P1|Completed Treatment A|Overall Study||5
866686|NCT02291510|2097740|P4|STARTED|Overall Study||5
866687|NCT02291510|2097741|P3|STARTED|Overall Study||5
866688|NCT02291510|2097742|P2|STARTED|Overall Study||5
866689|NCT02291510|2097743|P1|STARTED|Overall Study||5
866690|NCT02291419|2097759|P2|NOT COMPLETED|Overall Study||5
866691|NCT02291419|2097760|P1|NOT COMPLETED|Overall Study||1
866692|NCT02291419|2097759|P2|COMPLETED|Overall Study||0
866693|NCT02291419|2097760|P1|COMPLETED|Overall Study||0
866694|NCT02291419|2097759|P2|STARTED|Overall Study||5
866695|NCT02291419|2097760|P1|STARTED|Overall Study||1
866696|NCT02290821|2097778|P2|NOT COMPLETED|Overall Study||3
866697|NCT02290821|2097779|P1|NOT COMPLETED|Overall Study||6
866698|NCT02290821|2097778|P2|COMPLETED|Overall Study||103
866699|NCT02290821|2097779|P1|COMPLETED|Overall Study||103
866700|NCT02290821|2097778|P2|STARTED|Overall Study||106
866701|NCT02290821|2097779|P1|STARTED|Overall Study||109
866702|NCT02290509|2097787|P2|NOT COMPLETED|Overall Study||14
866703|NCT02290509|2097788|P1|NOT COMPLETED|Overall Study||49
866704|NCT02290509|2097787|P2|COMPLETED|Overall Study||325
866705|NCT02290509|2097788|P1|COMPLETED|Overall Study||962
866706|NCT02290509|2097787|P2|STARTED|Overall Study||339
866707|NCT02290509|2097788|P1|STARTED|Overall Study||1011
866708|NCT02289989|2097802|P2|NOT COMPLETED|Overall Study||0
866709|NCT02289989|2097803|P1|NOT COMPLETED|Overall Study||0
866710|NCT02289989|2097802|P2|COMPLETED|Overall Study||1
866711|NCT02289989|2097803|P1|COMPLETED|Overall Study||0
866712|NCT02289989|2097802|P2|STARTED|Overall Study||1
866713|NCT02289989|2097803|P1|STARTED|Overall Study||0
866714|NCT02289963|2097821|P2|NOT COMPLETED|Overall Study||10
866715|NCT02289963|2097822|P1|NOT COMPLETED|Overall Study||5
866716|NCT02289963|2097821|P2|COMPLETED|Overall Study||87
866717|NCT02289963|2097822|P1|COMPLETED|Overall Study||97
866718|NCT02289963|2097821|P2|Treated|Overall Study||97
866719|NCT02289963|2097822|P1|Treated|Overall Study||102
866720|NCT02289963|2097821|P2|STARTED|Overall Study|Randomized|97
866721|NCT02289963|2097822|P1|STARTED|Overall Study|Randomized|102
866722|NCT02289755|2097870|P1|NOT COMPLETED|Follow up Period [4 Days]||0
866723|NCT02289755|2097870|P1|COMPLETED|Follow up Period [4 Days]||16
866724|NCT02289755|2097870|P1|STARTED|Follow up Period [4 Days]||16
866725|NCT02289755|2097870|P1|NOT COMPLETED|ALLN-177 Treatment Period [4 Days]||0
866726|NCT02289755|2097870|P1|COMPLETED|ALLN-177 Treatment Period [4 Days]||16
866727|NCT02289755|2097870|P1|STARTED|ALLN-177 Treatment Period [4 Days]||16
866728|NCT02289755|2097870|P1|NOT COMPLETED|Baseline Period [No Treatment, 3 Days]||0
866729|NCT02289755|2097870|P1|COMPLETED|Baseline Period [No Treatment, 3 Days]||16
866730|NCT02289755|2097870|P1|STARTED|Baseline Period [No Treatment, 3 Days]||16
866731|NCT02289742|2097877|P4|NOT COMPLETED|Third Wear Period||1
866732|NCT02289742|2097878|P3|NOT COMPLETED|Third Wear Period||0
866733|NCT02289742|2097879|P2|NOT COMPLETED|Third Wear Period||1
866734|NCT02289742|2097880|P1|NOT COMPLETED|Third Wear Period||0
866735|NCT02289742|2097877|P4|COMPLETED|Third Wear Period||8
866736|NCT02289742|2097878|P3|COMPLETED|Third Wear Period||11
866737|NCT02289742|2097879|P2|COMPLETED|Third Wear Period||10
866738|NCT02289742|2097880|P1|COMPLETED|Third Wear Period||11
866739|NCT02289742|2097877|P4|STARTED|Third Wear Period||9
866740|NCT02289742|2097878|P3|STARTED|Third Wear Period||11
866741|NCT02289742|2097879|P2|STARTED|Third Wear Period||11
866742|NCT02289742|2097880|P1|STARTED|Third Wear Period||11
866743|NCT02289742|2097877|P4|NOT COMPLETED|Second Wear Period||0
866744|NCT02289742|2097878|P3|NOT COMPLETED|Second Wear Period||0
866745|NCT02289742|2097879|P2|NOT COMPLETED|Second Wear Period||0
866746|NCT02289742|2097880|P1|NOT COMPLETED|Second Wear Period||0
866747|NCT02289742|2097877|P4|COMPLETED|Second Wear Period||9
866748|NCT02289742|2097878|P3|COMPLETED|Second Wear Period||11
866749|NCT02289742|2097879|P2|COMPLETED|Second Wear Period||11
866750|NCT02289742|2097880|P1|COMPLETED|Second Wear Period||11
866751|NCT02289742|2097877|P4|STARTED|Second Wear Period||9
866752|NCT02289742|2097878|P3|STARTED|Second Wear Period||11
866753|NCT02289742|2097879|P2|STARTED|Second Wear Period||11
866754|NCT02289742|2097880|P1|STARTED|Second Wear Period||11
866755|NCT02289742|2097877|P4|NOT COMPLETED|First Wear Period||1
866756|NCT02289742|2097878|P3|NOT COMPLETED|First Wear Period||1
866757|NCT02289742|2097879|P2|NOT COMPLETED|First Wear Period||1
866758|NCT02289742|2097880|P1|NOT COMPLETED|First Wear Period||0
866759|NCT02289742|2097877|P4|COMPLETED|First Wear Period||9
866760|NCT02289742|2097878|P3|COMPLETED|First Wear Period||11
866761|NCT02289742|2097879|P2|COMPLETED|First Wear Period||11
866762|NCT02289742|2097880|P1|COMPLETED|First Wear Period||11
866763|NCT02289742|2097877|P4|Treated|First Wear Period||9
866764|NCT02289742|2097878|P3|Treated|First Wear Period||12
866765|NCT02289742|2097879|P2|Treated|First Wear Period||11
866766|NCT02289742|2097880|P1|Treated|First Wear Period||11
866767|NCT02289742|2097877|P4|STARTED|First Wear Period||10
866768|NCT02289742|2097878|P3|STARTED|First Wear Period||12
866769|NCT02289742|2097879|P2|STARTED|First Wear Period||12
866770|NCT02289742|2097880|P1|STARTED|First Wear Period||11
866771|NCT02289469|2097899|P2|NOT COMPLETED|Overall Study||0
866772|NCT02289469|2097900|P1|NOT COMPLETED|Overall Study||6
866773|NCT02289469|2097899|P2|COMPLETED|Overall Study||244
866774|NCT02289469|2097900|P1|COMPLETED|Overall Study||244
866775|NCT02289469|2097899|P2|STARTED|Overall Study||244
866776|NCT02289469|2097900|P1|STARTED|Overall Study||250
866777|NCT02289105|2097910|P2|NOT COMPLETED|Overall Study||0
866778|NCT02289105|2097911|P1|NOT COMPLETED|Overall Study||0
866779|NCT02289105|2097910|P2|COMPLETED|Overall Study||637
866780|NCT02289105|2097911|P1|COMPLETED|Overall Study||642
866781|NCT02289105|2097910|P2|STARTED|Overall Study||637
866782|NCT02289105|2097911|P1|STARTED|Overall Study||642
866783|NCT02289079|2097923|P2|NOT COMPLETED|Overall Study||1
866784|NCT02289079|2097924|P1|NOT COMPLETED|Overall Study||2
866785|NCT02289079|2097923|P2|COMPLETED|Overall Study||29
866786|NCT02289079|2097924|P1|COMPLETED|Overall Study||28
866787|NCT02289079|2097923|P2|STARTED|Overall Study||30
866788|NCT02289079|2097924|P1|STARTED|Overall Study||30
866789|NCT02288364|2097938|P2|NOT COMPLETED|Overall Study||0
866790|NCT02288364|2097939|P1|NOT COMPLETED|Overall Study||0
866791|NCT02288364|2097938|P2|COMPLETED|Overall Study||44
866792|NCT02288364|2097939|P1|COMPLETED|Overall Study||42
866793|NCT02288364|2097938|P2|STARTED|Overall Study||44
866794|NCT02288364|2097939|P1|STARTED|Overall Study||42
866795|NCT02288312|2097966|P3|NOT COMPLETED|Overall Study||0
866796|NCT02288312|2097967|P2|NOT COMPLETED|Overall Study||0
866797|NCT02288312|2097968|P1|NOT COMPLETED|Overall Study||1
866798|NCT02288312|2097966|P3|COMPLETED|Overall Study||6
866799|NCT02288312|2097967|P2|COMPLETED|Overall Study||6
866800|NCT02288312|2097968|P1|COMPLETED|Overall Study||5
866801|NCT02288312|2097966|P3|STARTED|Overall Study||6
866802|NCT02288312|2097967|P2|STARTED|Overall Study||6
866803|NCT02288312|2097968|P1|STARTED|Overall Study||6
866804|NCT02288273|2097987|P2|NOT COMPLETED|Overall Study||8
866805|NCT02288273|2097988|P1|NOT COMPLETED|Overall Study||8
866806|NCT02288273|2097987|P2|COMPLETED|Overall Study||48
866807|NCT02288273|2097988|P1|COMPLETED|Overall Study||53
866808|NCT02288273|2097987|P2|STARTED|Overall Study||56
866809|NCT02288273|2097988|P1|STARTED|Overall Study||61
866810|NCT02288091|2098006|P1|NOT COMPLETED|Overall Study||8
866811|NCT02288091|2098006|P1|COMPLETED|Overall Study||24
866812|NCT02288091|2098006|P1|Randomized/Treated|Overall Study||25
866813|NCT02288091|2098006|P1|STARTED|Overall Study||32
866814|NCT02287779|2098022|P8|NOT COMPLETED|Overall Study||0
866815|NCT02287779|2098023|P7|NOT COMPLETED|Overall Study||0
866816|NCT02287779|2098024|P6|NOT COMPLETED|Overall Study||0
866817|NCT02287779|2098025|P5|NOT COMPLETED|Overall Study||0
866818|NCT02287779|2098026|P4|NOT COMPLETED|Overall Study||0
866819|NCT02287779|2098027|P3|NOT COMPLETED|Overall Study||0
866820|NCT02287779|2098028|P2|NOT COMPLETED|Overall Study||0
866821|NCT02287779|2098029|P1|NOT COMPLETED|Overall Study||0
866822|NCT02287779|2098022|P8|COMPLETED|Overall Study||9
866823|NCT02287779|2098023|P7|COMPLETED|Overall Study||9
866824|NCT02287779|2098024|P6|COMPLETED|Overall Study||9
866825|NCT02287779|2098025|P5|COMPLETED|Overall Study||9
866826|NCT02287779|2098026|P4|COMPLETED|Overall Study||9
866827|NCT02287779|2098027|P3|COMPLETED|Overall Study||9
866828|NCT02287779|2098028|P2|COMPLETED|Overall Study||9
866829|NCT02287779|2098029|P1|COMPLETED|Overall Study||21
866830|NCT02287779|2098022|P8|STARTED|Overall Study||9
866831|NCT02287779|2098023|P7|STARTED|Overall Study||9
866832|NCT02287779|2098024|P6|STARTED|Overall Study||9
866833|NCT02287779|2098025|P5|STARTED|Overall Study||9
866834|NCT02287779|2098026|P4|STARTED|Overall Study||9
866835|NCT02287779|2098027|P3|STARTED|Overall Study||9
866836|NCT02287779|2098028|P2|STARTED|Overall Study||9
866837|NCT02287779|2098029|P1|STARTED|Overall Study||21
866838|NCT02287623|2098169|P2|NOT COMPLETED|Overall Study||1
866839|NCT02287623|2098170|P1|NOT COMPLETED|Overall Study||0
866840|NCT02287623|2098169|P2|COMPLETED|Overall Study||29
866841|NCT02287623|2098170|P1|COMPLETED|Overall Study||30
866842|NCT02287623|2098169|P2|STARTED|Overall Study||30
866843|NCT02287623|2098170|P1|STARTED|Overall Study||30
866844|NCT02287610|2098186|P1|NOT COMPLETED|Overall Study||16
866845|NCT02287610|2098186|P1|COMPLETED|Overall Study||48
866846|NCT02287610|2098186|P1|Per Protocol Follow-Up|Overall Study||56
866847|NCT02287610|2098186|P1|STARTED|Overall Study||64
866848|NCT02287415|2098219|P1|NOT COMPLETED|Overall Study||0
866849|NCT02287415|2098219|P1|COMPLETED|Overall Study||13
866850|NCT02287415|2098219|P1|STARTED|Overall Study||13
866851|NCT02287402|2098225|P1|NOT COMPLETED|Follow-up||3
866852|NCT02287402|2098225|P1|COMPLETED|Follow-up||103
866853|NCT02287402|2098225|P1|STARTED|Follow-up|64 participants who completed the Treatment Period did not continue to Follow-up.|106
866854|NCT02287402|2098225|P1|NOT COMPLETED|Treatment Period||27
866855|NCT02287402|2098225|P1|COMPLETED|Treatment Period||170
866856|NCT02287402|2098225|P1|STARTED|Treatment Period||197
866857|NCT02287376|2098240|P1|NOT COMPLETED|Overall Study||0
866858|NCT02287376|2098240|P1|COMPLETED|Overall Study||25
866859|NCT02287376|2098240|P1|STARTED|Overall Study||25
866860|NCT02287350|2098283|P1|NOT COMPLETED|Overall Study||3
866861|NCT02287350|2098283|P1|COMPLETED|Overall Study||48
866862|NCT02287350|2098283|P1|STARTED|Overall Study||51
866863|NCT02286518|2098342|P14|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
866864|NCT02286518|2098343|P13|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
866865|NCT02286518|2098344|P12|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
866866|NCT02286518|2098345|P11|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
866867|NCT02286518|2098346|P10|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
866868|NCT02286518|2098347|P9|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
866869|NCT02286518|2098348|P8|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
866870|NCT02286518|2098349|P7|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
866871|NCT02286518|2098350|P6|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
866872|NCT02286518|2098351|P5|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
866873|NCT02286518|2098352|P4|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
866874|NCT02286518|2098353|P3|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
866875|NCT02286518|2098354|P2|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
866876|NCT02286518|2098355|P1|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
866877|NCT02286518|2098342|P14|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
866878|NCT02286518|2098343|P13|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
866879|NCT02286518|2098344|P12|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
866880|NCT02286518|2098345|P11|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
866881|NCT02286518|2098346|P10|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
866882|NCT02286518|2098347|P9|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
866883|NCT02286518|2098348|P8|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
866884|NCT02286518|2098349|P7|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
866885|NCT02286518|2098350|P6|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
866886|NCT02286518|2098351|P5|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
866887|NCT02286518|2098352|P4|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
866888|NCT02286518|2098353|P3|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
866889|NCT02286518|2098354|P2|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
866890|NCT02286518|2098355|P1|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
866891|NCT02286518|2098342|P14|STARTED|Crossover Treatment (Part 2: 3 Days)||0
866892|NCT02286518|2098343|P13|STARTED|Crossover Treatment (Part 2: 3 Days)||0
866893|NCT02286518|2098344|P12|STARTED|Crossover Treatment (Part 2: 3 Days)||0
866894|NCT02286518|2098345|P11|STARTED|Crossover Treatment (Part 2: 3 Days)||0
866895|NCT02286518|2098346|P10|STARTED|Crossover Treatment (Part 2: 3 Days)||0
866896|NCT02286518|2098347|P9|STARTED|Crossover Treatment (Part 2: 3 Days)||6
866897|NCT02286518|2098348|P8|STARTED|Crossover Treatment (Part 2: 3 Days)||6
866898|NCT02286518|2098349|P7|STARTED|Crossover Treatment (Part 2: 3 Days)||0
866899|NCT02286518|2098350|P6|STARTED|Crossover Treatment (Part 2: 3 Days)||0
866900|NCT02286518|2098351|P5|STARTED|Crossover Treatment (Part 2: 3 Days)||0
866901|NCT02286518|2098352|P4|STARTED|Crossover Treatment (Part 2: 3 Days)||0
866902|NCT02286518|2098353|P3|STARTED|Crossover Treatment (Part 2: 3 Days)||0
866903|NCT02286518|2098354|P2|STARTED|Crossover Treatment (Part 2: 3 Days)||0
866904|NCT02286518|2098355|P1|STARTED|Crossover Treatment (Part 2: 3 Days)||0
866905|NCT02286518|2098342|P14|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
866906|NCT02286518|2098343|P13|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
866907|NCT02286518|2098344|P12|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
866908|NCT02286518|2098345|P11|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
866909|NCT02286518|2098346|P10|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
866910|NCT02286518|2098347|P9|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
866911|NCT02286518|2098348|P8|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
866912|NCT02286518|2098349|P7|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
866913|NCT02286518|2098350|P6|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
866914|NCT02286518|2098351|P5|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
866915|NCT02286518|2098352|P4|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
866916|NCT02286518|2098353|P3|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
866917|NCT02286518|2098354|P2|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
866918|NCT02286518|2098355|P1|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
866919|NCT02286518|2098342|P14|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
866920|NCT02286518|2098343|P13|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
866921|NCT02286518|2098344|P12|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
866922|NCT02286518|2098345|P11|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
866923|NCT02286518|2098346|P10|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
866924|NCT02286518|2098347|P9|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
866925|NCT02286518|2098348|P8|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
866926|NCT02286518|2098349|P7|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
866927|NCT02286518|2098350|P6|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
866928|NCT02286518|2098351|P5|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
866929|NCT02286518|2098352|P4|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
866930|NCT02286518|2098353|P3|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
866931|NCT02286518|2098354|P2|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
866932|NCT02286518|2098355|P1|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
866933|NCT02286518|2098342|P14|STARTED|Washout Crossover Period(Part 2:14 Days)||0
866934|NCT02286518|2098343|P13|STARTED|Washout Crossover Period(Part 2:14 Days)||0
866935|NCT02286518|2098344|P12|STARTED|Washout Crossover Period(Part 2:14 Days)||0
866936|NCT02286518|2098345|P11|STARTED|Washout Crossover Period(Part 2:14 Days)||0
866937|NCT02286518|2098346|P10|STARTED|Washout Crossover Period(Part 2:14 Days)||0
866938|NCT02286518|2098347|P9|STARTED|Washout Crossover Period(Part 2:14 Days)||6
866939|NCT02286518|2098348|P8|STARTED|Washout Crossover Period(Part 2:14 Days)||6
866940|NCT02286518|2098349|P7|STARTED|Washout Crossover Period(Part 2:14 Days)||0
866941|NCT02286518|2098350|P6|STARTED|Washout Crossover Period(Part 2:14 Days)||0
866942|NCT02286518|2098351|P5|STARTED|Washout Crossover Period(Part 2:14 Days)||0
866943|NCT02286518|2098352|P4|STARTED|Washout Crossover Period(Part 2:14 Days)||0
866944|NCT02286518|2098353|P3|STARTED|Washout Crossover Period(Part 2:14 Days)||0
866945|NCT02286518|2098354|P2|STARTED|Washout Crossover Period(Part 2:14 Days)||0
866946|NCT02286518|2098355|P1|STARTED|Washout Crossover Period(Part 2:14 Days)||0
866947|NCT02286518|2098342|P14|NOT COMPLETED|All Parts (16 Days)||0
866948|NCT02286518|2098343|P13|NOT COMPLETED|All Parts (16 Days)||0
866949|NCT02286518|2098344|P12|NOT COMPLETED|All Parts (16 Days)||0
866950|NCT02286518|2098345|P11|NOT COMPLETED|All Parts (16 Days)||0
866951|NCT02286518|2098346|P10|NOT COMPLETED|All Parts (16 Days)||0
866952|NCT02286518|2098347|P9|NOT COMPLETED|All Parts (16 Days)||0
866953|NCT02286518|2098348|P8|NOT COMPLETED|All Parts (16 Days)||0
866954|NCT02286518|2098349|P7|NOT COMPLETED|All Parts (16 Days)||0
866955|NCT02286518|2098350|P6|NOT COMPLETED|All Parts (16 Days)||0
866956|NCT02286518|2098351|P5|NOT COMPLETED|All Parts (16 Days)||0
866957|NCT02286518|2098352|P4|NOT COMPLETED|All Parts (16 Days)||0
866958|NCT02286518|2098353|P3|NOT COMPLETED|All Parts (16 Days)||0
866959|NCT02286518|2098354|P2|NOT COMPLETED|All Parts (16 Days)||0
866960|NCT02286518|2098355|P1|NOT COMPLETED|All Parts (16 Days)||0
866961|NCT02286518|2098342|P14|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
866962|NCT02286518|2098343|P13|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
866963|NCT02286518|2098344|P12|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
866964|NCT02286518|2098345|P11|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
866965|NCT02286518|2098346|P10|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|4
866966|NCT02286518|2098347|P9|COMPLETED|All Parts (16 Days)|Only participants of Part 2 would continue in next period.|6
866967|NCT02286518|2098348|P8|COMPLETED|All Parts (16 Days)|Only participants of Part 2 continued in next period.|6
866968|NCT02286518|2098349|P7|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
866969|NCT02286518|2098350|P6|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
866970|NCT02286518|2098351|P5|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
866971|NCT02286518|2098352|P4|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
866972|NCT02286518|2098353|P3|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
866973|NCT02286518|2098354|P2|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
866974|NCT02286518|2098355|P1|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
866975|NCT02286518|2098342|P14|STARTED|All Parts (16 Days)||6
866976|NCT02286518|2098343|P13|STARTED|All Parts (16 Days)||6
866977|NCT02286518|2098344|P12|STARTED|All Parts (16 Days)||6
866978|NCT02286518|2098345|P11|STARTED|All Parts (16 Days)||6
866979|NCT02286518|2098346|P10|STARTED|All Parts (16 Days)||4
866980|NCT02286518|2098347|P9|STARTED|All Parts (16 Days)||6
866981|NCT02286518|2098348|P8|STARTED|All Parts (16 Days)||6
866982|NCT02286518|2098349|P7|STARTED|All Parts (16 Days)||6
866983|NCT02286518|2098350|P6|STARTED|All Parts (16 Days)||6
866984|NCT02286518|2098351|P5|STARTED|All Parts (16 Days)||6
866985|NCT02286518|2098352|P4|STARTED|All Parts (16 Days)||6
866986|NCT02286518|2098353|P3|STARTED|All Parts (16 Days)||6
866987|NCT02286518|2098354|P2|STARTED|All Parts (16 Days)||6
866988|NCT02286518|2098355|P1|STARTED|All Parts (16 Days)||6
866989|NCT02286193|2098495|P1|NOT COMPLETED|Overall Study||204
866990|NCT02286193|2098495|P1|COMPLETED|Overall Study||418
866991|NCT02286193|2098495|P1|STARTED|Overall Study||622
866992|NCT02286102|2098502|P2|NOT COMPLETED|Overall Study||1
866993|NCT02286102|2098503|P1|NOT COMPLETED|Overall Study||1
866994|NCT02286102|2098502|P2|COMPLETED|Overall Study||33
866995|NCT02286102|2098503|P1|COMPLETED|Overall Study||35
866996|NCT02286102|2098502|P2|STARTED|Overall Study||34
866997|NCT02286102|2098503|P1|STARTED|Overall Study||36
867004|NCT02285270|2098540|P1|NOT COMPLETED|Overall Study||5
867005|NCT02285270|2098540|P1|COMPLETED|Overall Study||5
867006|NCT02285270|2098540|P1|STARTED|Overall Study||10
867007|NCT02284880|2098548|P4|NOT COMPLETED|Overall Study||0
867008|NCT02284880|2098549|P3|NOT COMPLETED|Overall Study||2
867009|NCT02284880|2098550|P2|NOT COMPLETED|Overall Study||0
867010|NCT02284880|2098551|P1|NOT COMPLETED|Overall Study||0
867011|NCT02284880|2098548|P4|COMPLETED|Overall Study||10
867012|NCT02284880|2098549|P3|COMPLETED|Overall Study||8
867013|NCT02284880|2098550|P2|COMPLETED|Overall Study||9
867014|NCT02284880|2098551|P1|COMPLETED|Overall Study||11
867015|NCT02284880|2098548|P4|Second Period (4 Days)|Overall Study||10
867016|NCT02284880|2098549|P3|Second Period (4 Days)|Overall Study||8
867017|NCT02284880|2098550|P2|Second Period (4 Days)|Overall Study||9
867018|NCT02284880|2098551|P1|Second Period (4 Days)|Overall Study||11
867019|NCT02284880|2098548|P4|Wash-out Period (7 Days)|Overall Study||10
867020|NCT02284880|2098549|P3|Wash-out Period (7 Days)|Overall Study||10
867021|NCT02284880|2098550|P2|Wash-out Period (7 Days)|Overall Study||9
867022|NCT02284880|2098551|P1|Wash-out Period (7 Days)|Overall Study||11
867023|NCT02284880|2098548|P4|First Period (4 Days)|Overall Study||10
867024|NCT02284880|2098549|P3|First Period (4 Days)|Overall Study||10
867025|NCT02284880|2098550|P2|First Period (4 Days)|Overall Study||9
867026|NCT02284880|2098551|P1|First Period (4 Days)|Overall Study||11
867027|NCT02284880|2098548|P4|STARTED|Overall Study||10
867028|NCT02284880|2098549|P3|STARTED|Overall Study||10
867029|NCT02284880|2098550|P2|STARTED|Overall Study||9
867030|NCT02284880|2098551|P1|STARTED|Overall Study||11
867031|NCT02284867|2098567|P2|NOT COMPLETED|Overall Study||0
867032|NCT02284867|2098568|P1|NOT COMPLETED|Overall Study||0
867033|NCT02284867|2098567|P2|COMPLETED|Overall Study||30
867034|NCT02284867|2098568|P1|COMPLETED|Overall Study||30
867035|NCT02284867|2098567|P2|STARTED|Overall Study||30
867036|NCT02284867|2098568|P1|STARTED|Overall Study||30
867037|NCT02284854|2098578|P2|NOT COMPLETED|Overall Study||0
867038|NCT02284854|2098579|P1|NOT COMPLETED|Overall Study||5
867039|NCT02284854|2098578|P2|COMPLETED|Overall Study||20
867040|NCT02284854|2098579|P1|COMPLETED|Overall Study||18
867041|NCT02284854|2098578|P2|STARTED|Overall Study||20
867042|NCT02284854|2098579|P1|STARTED|Overall Study||23
867043|NCT02284828|2098596|P1|NOT COMPLETED|Overall Study||4
867044|NCT02284828|2098596|P1|COMPLETED|Overall Study||22
867045|NCT02284828|2098596|P1|STARTED|Overall Study||26
867046|NCT02284555|2098608|P1|NOT COMPLETED|Overall Study||0
867047|NCT02284555|2098608|P1|COMPLETED|Overall Study||12
867048|NCT02284555|2098608|P1|STARTED|Overall Study||12
867049|NCT02284516|2098615|P2|NOT COMPLETED|Overall Study||36
867050|NCT02284516|2098616|P1|NOT COMPLETED|Overall Study||38
867051|NCT02284516|2098615|P2|COMPLETED|Overall Study||319
867052|NCT02284516|2098616|P1|COMPLETED|Overall Study||318
867053|NCT02284516|2098615|P2|Safety Population|Overall Study|Two placebo participants were included in Lifitegrast arm for safety analysis set (N=357).|357
867054|NCT02284516|2098616|P1|Safety Population|Overall Study|Two placebo participants were considered for Lifitegrast arm; Placebo safety analysis set (N= 354).|354
867055|NCT02284516|2098615|P2|STARTED|Overall Study||355
867056|NCT02284516|2098616|P1|STARTED|Overall Study||356
867057|NCT02284386|2098624|P1|NOT COMPLETED|Overall Study||0
867058|NCT02284386|2098624|P1|COMPLETED|Overall Study||15
867059|NCT02284386|2098624|P1|STARTED|Overall Study||15
867060|NCT02284347|2098633|P1|NOT COMPLETED|Overall Study||3
867061|NCT02284347|2098633|P1|COMPLETED|Overall Study||48
867062|NCT02284347|2098633|P1|STARTED|Overall Study||51
867063|NCT02284243|2098641|P2|NOT COMPLETED|Overall Study||3
867064|NCT02284243|2098642|P1|NOT COMPLETED|Overall Study||4
867065|NCT02284243|2098641|P2|COMPLETED|Overall Study||81
867066|NCT02284243|2098642|P1|COMPLETED|Overall Study||80
867067|NCT02284243|2098641|P2|STARTED|Overall Study||84
867068|NCT02284243|2098642|P1|STARTED|Overall Study||84
867069|NCT02284165|2098663|P3|NOT COMPLETED|Overall Study||0
867070|NCT02284165|2098664|P2|NOT COMPLETED|Overall Study||0
867071|NCT02284165|2098665|P1|NOT COMPLETED|Overall Study||0
867072|NCT02284165|2098663|P3|COMPLETED|Overall Study||70996
867073|NCT02284165|2098664|P2|COMPLETED|Overall Study||40272
867074|NCT02284165|2098665|P1|COMPLETED|Overall Study||36448
867075|NCT02284165|2098663|P3|STARTED|Overall Study||70996
867076|NCT02284165|2098664|P2|STARTED|Overall Study||40272
867077|NCT02284165|2098665|P1|STARTED|Overall Study||36448
867078|NCT02283840|2098684|P3|NOT COMPLETED|Overall Study||0
867079|NCT02283840|2098685|P2|NOT COMPLETED|Overall Study||1
867080|NCT02283840|2098686|P1|NOT COMPLETED|Overall Study||0
867081|NCT02283840|2098684|P3|COMPLETED|Overall Study||20
867082|NCT02283840|2098685|P2|COMPLETED|Overall Study||19
867083|NCT02283840|2098686|P1|COMPLETED|Overall Study||20
867084|NCT02283840|2098684|P3|STARTED|Overall Study||20
867085|NCT02283840|2098685|P2|STARTED|Overall Study||20
867086|NCT02283840|2098686|P1|STARTED|Overall Study||20
867087|NCT02283827|2098705|P2|NOT COMPLETED|Overall Study||3
867088|NCT02283827|2098706|P1|NOT COMPLETED|Overall Study||1
867089|NCT02283827|2098705|P2|COMPLETED|Overall Study||13
867090|NCT02283827|2098706|P1|COMPLETED|Overall Study||15
867091|NCT02283827|2098705|P2|STARTED|Overall Study||16
867092|NCT02283827|2098706|P1|STARTED|Overall Study||16
867093|NCT02283814|2098723|P2|NOT COMPLETED|Overall Study||2
867094|NCT02283814|2098724|P1|NOT COMPLETED|Overall Study||3
867095|NCT02283814|2098723|P2|COMPLETED|Overall Study||14
867096|NCT02283814|2098724|P1|COMPLETED|Overall Study||13
867097|NCT02283814|2098723|P2|STARTED|Overall Study||16
867098|NCT02283814|2098724|P1|STARTED|Overall Study||16
867099|NCT02283788|2098738|P4|NOT COMPLETED|Overall Study||2
867100|NCT02283788|2098739|P3|NOT COMPLETED|Overall Study||5
867101|NCT02283788|2098740|P2|NOT COMPLETED|Overall Study||4
867102|NCT02283788|2098741|P1|NOT COMPLETED|Overall Study||1
867103|NCT02283788|2098738|P4|COMPLETED|Overall Study||14
867104|NCT02283788|2098739|P3|COMPLETED|Overall Study||12
867105|NCT02283788|2098740|P2|COMPLETED|Overall Study||13
867106|NCT02283788|2098741|P1|COMPLETED|Overall Study||16
867107|NCT02283788|2098738|P4|STARTED|Overall Study||16
867108|NCT02283788|2098739|P3|STARTED|Overall Study||17
867109|NCT02283788|2098740|P2|STARTED|Overall Study||17
867110|NCT02283788|2098741|P1|STARTED|Overall Study||17
867114|NCT02282982|2098812|P1|NOT COMPLETED|Overall Study||206
867115|NCT02282982|2098812|P1|COMPLETED|Overall Study||153
867116|NCT02282982|2098812|P1|Attended Follow-up Visit|Overall Study||349
867117|NCT02282982|2098812|P1|Attended Visit 5|Overall Study||83
867118|NCT02282982|2098812|P1|Attended Visit 4|Overall Study||194
867119|NCT02282982|2098812|P1|Attended Visit 3|Overall Study||298
867120|NCT02282982|2098812|P1|Attended Visit 2|Overall Study||341
867121|NCT02282982|2098812|P1|Attended Visit 1|Overall Study||359
867122|NCT02282982|2098812|P1|STARTED|Overall Study||359
867123|NCT02282813|2098830|P3|NOT COMPLETED|Overall Study||3
867124|NCT02282813|2098831|P2|NOT COMPLETED|Overall Study||23
867125|NCT02282813|2098832|P1|NOT COMPLETED|Overall Study||12
867126|NCT02282813|2098830|P3|COMPLETED|Overall Study||39
867127|NCT02282813|2098831|P2|COMPLETED|Overall Study||130
867128|NCT02282813|2098832|P1|COMPLETED|Overall Study||91
867129|NCT02282813|2098830|P3|STARTED|Overall Study|Randomization to take adjunctive treatment in addition to CTAP101 capsules began after week 12.|42
867130|NCT02282813|2098831|P2|STARTED|Overall Study|ITT Population - not randomized or randomized to CTAP101 monotherapy|153
867131|NCT02282813|2098832|P1|STARTED|Overall Study|ITT Population|103
867132|NCT02282631|2098851|P2|NOT COMPLETED|Overall Study||0
867133|NCT02282631|2098852|P1|NOT COMPLETED|Overall Study||2
867134|NCT02282631|2098851|P2|COMPLETED|Overall Study||15
867135|NCT02282631|2098852|P1|COMPLETED|Overall Study||12
867136|NCT02282631|2098851|P2|STARTED|Overall Study||15
867137|NCT02282631|2098852|P1|STARTED|Overall Study|The two dropouts happened on the 2nd and 3rd weeks post-baseline, respectively|14
867138|NCT02282605|2098893|P3|NOT COMPLETED|Overall Study||0
867139|NCT02282605|2098894|P2|NOT COMPLETED|Overall Study||0
867140|NCT02282605|2098895|P1|NOT COMPLETED|Overall Study||3
867141|NCT02282605|2098893|P3|COMPLETED|Overall Study||24
867142|NCT02282605|2098894|P2|COMPLETED|Overall Study||12
867143|NCT02282605|2098895|P1|COMPLETED|Overall Study||24
867144|NCT02282605|2098893|P3|STARTED|Overall Study||24
867145|NCT02282605|2098894|P2|STARTED|Overall Study||12
867146|NCT02282605|2098895|P1|STARTED|Overall Study||27
867147|NCT02282527|2098917|P2|NOT COMPLETED|Overall Study||1
867148|NCT02282527|2098918|P1|NOT COMPLETED|Overall Study||1
867149|NCT02282527|2098917|P2|COMPLETED|Overall Study||15
867150|NCT02282527|2098918|P1|COMPLETED|Overall Study||15
867151|NCT02282527|2098917|P2|STARTED|Overall Study||16
867152|NCT02282527|2098918|P1|STARTED|Overall Study||16
867153|NCT02281591|2098932|P4|NOT COMPLETED|Overall Study||0
867154|NCT02281591|2098933|P3|NOT COMPLETED|Overall Study||0
867155|NCT02281591|2098934|P2|NOT COMPLETED|Overall Study||0
867156|NCT02281591|2098935|P1|NOT COMPLETED|Overall Study||0
867157|NCT02281591|2098932|P4|COMPLETED|Overall Study||8
867158|NCT02281591|2098933|P3|COMPLETED|Overall Study||8
867159|NCT02281591|2098934|P2|COMPLETED|Overall Study||8
867160|NCT02281591|2098935|P1|COMPLETED|Overall Study||8
867161|NCT02281591|2098932|P4|STARTED|Overall Study||8
867162|NCT02281591|2098933|P3|STARTED|Overall Study||8
867163|NCT02281591|2098934|P2|STARTED|Overall Study||8
867164|NCT02281591|2098935|P1|STARTED|Overall Study||8
867165|NCT02281526|2098959|P2|NOT COMPLETED|Overall Study||0
867166|NCT02281526|2098960|P1|NOT COMPLETED|Overall Study||1
867167|NCT02281526|2098959|P2|COMPLETED|Overall Study||8
867168|NCT02281526|2098960|P1|COMPLETED|Overall Study||8
867169|NCT02281526|2098959|P2|STARTED|Overall Study||8
867170|NCT02281526|2098960|P1|STARTED|Overall Study||9
867171|NCT02281448|2098970|P2|NOT COMPLETED|Overall Study||1
867172|NCT02281448|2098971|P1|NOT COMPLETED|Overall Study||2
867173|NCT02281448|2098970|P2|COMPLETED|Overall Study||9
867174|NCT02281448|2098971|P1|COMPLETED|Overall Study||8
867175|NCT02281448|2098970|P2|STARTED|Overall Study||10
867176|NCT02281448|2098971|P1|STARTED|Overall Study||10
867177|NCT02281422|2098984|P5|NOT COMPLETED|Overall Study||0
867178|NCT02281422|2098985|P4|NOT COMPLETED|Overall Study||0
867179|NCT02281422|2098986|P3|NOT COMPLETED|Overall Study||0
867180|NCT02281422|2098987|P2|NOT COMPLETED|Overall Study||0
867181|NCT02281422|2098988|P1|NOT COMPLETED|Overall Study||0
867182|NCT02281422|2098984|P5|COMPLETED|Overall Study||8
867183|NCT02281422|2098985|P4|COMPLETED|Overall Study||8
867184|NCT02281422|2098986|P3|COMPLETED|Overall Study||8
867185|NCT02281422|2098987|P2|COMPLETED|Overall Study||8
867186|NCT02281422|2098988|P1|COMPLETED|Overall Study||8
867187|NCT02281422|2098984|P5|STARTED|Overall Study||8
867188|NCT02281422|2098985|P4|STARTED|Overall Study||8
867189|NCT02281422|2098986|P3|STARTED|Overall Study||8
867190|NCT02281422|2098987|P2|STARTED|Overall Study||8
867191|NCT02281422|2098988|P1|STARTED|Overall Study||8
867192|NCT02281318|2099012|P2|NOT COMPLETED|Overall Study||5
867193|NCT02281318|2099013|P1|NOT COMPLETED|Overall Study||14
867194|NCT02281318|2099012|P2|COMPLETED|Overall Study||269
867195|NCT02281318|2099013|P1|COMPLETED|Overall Study||263
867196|NCT02281318|2099012|P2|STARTED|Overall Study||274
867197|NCT02281318|2099013|P1|STARTED|Overall Study||277
867198|NCT02281136|2099025|P1|NOT COMPLETED|Overall Study||0
867199|NCT02281136|2099025|P1|COMPLETED|Overall Study||29
867200|NCT02281136|2099025|P1|STARTED|Overall Study||29
867201|NCT02280811|2099062|P5|NOT COMPLETED|Retreated at the MTD||0
867202|NCT02280811|2099063|P4|NOT COMPLETED|Retreated at the MTD||0
867203|NCT02280811|2099064|P3|NOT COMPLETED|Retreated at the MTD||0
867204|NCT02280811|2099065|P2|NOT COMPLETED|Retreated at the MTD||0
867205|NCT02280811|2099066|P1|NOT COMPLETED|Retreated at the MTD||0
867206|NCT02280811|2099062|P5|COMPLETED|Retreated at the MTD||1
867207|NCT02280811|2099063|P4|COMPLETED|Retreated at the MTD||0
867208|NCT02280811|2099064|P3|COMPLETED|Retreated at the MTD||0
867209|NCT02280811|2099065|P2|COMPLETED|Retreated at the MTD||0
867210|NCT02280811|2099066|P1|COMPLETED|Retreated at the MTD||0
867211|NCT02280811|2099062|P5|STARTED|Retreated at the MTD|Patient originally started in Grp1(HPV-16 E6mTCR PBL 1x10^9+HD IL-2) and was retreated at the MTD.|1
867212|NCT02280811|2099063|P4|STARTED|Retreated at the MTD||0
867213|NCT02280811|2099064|P3|STARTED|Retreated at the MTD||0
867214|NCT02280811|2099065|P2|STARTED|Retreated at the MTD||0
867215|NCT02280811|2099066|P1|STARTED|Retreated at the MTD||0
867216|NCT02280811|2099062|P5|NOT COMPLETED|Drug Administration||0
867217|NCT02280811|2099063|P4|NOT COMPLETED|Drug Administration||0
867218|NCT02280811|2099064|P3|NOT COMPLETED|Drug Administration||0
867219|NCT02280811|2099065|P2|NOT COMPLETED|Drug Administration||0
867220|NCT02280811|2099066|P1|NOT COMPLETED|Drug Administration||0
867221|NCT02280811|2099062|P5|COMPLETED|Drug Administration||2
867222|NCT02280811|2099063|P4|COMPLETED|Drug Administration||6
867223|NCT02280811|2099064|P3|COMPLETED|Drug Administration||1
867224|NCT02280811|2099065|P2|COMPLETED|Drug Administration||2
867225|NCT02280811|2099066|P1|COMPLETED|Drug Administration||1
867226|NCT02280811|2099062|P5|STARTED|Drug Administration||2
867227|NCT02280811|2099063|P4|STARTED|Drug Administration||6
867228|NCT02280811|2099064|P3|STARTED|Drug Administration||1
867229|NCT02280811|2099065|P2|STARTED|Drug Administration||2
867230|NCT02280811|2099066|P1|STARTED|Drug Administration||1
867231|NCT02280655|2099107|P2|NOT COMPLETED|Overall Study||0
867232|NCT02280655|2099108|P1|NOT COMPLETED|Overall Study||0
867233|NCT02280655|2099107|P2|COMPLETED|Overall Study||18
867234|NCT02280655|2099108|P1|COMPLETED|Overall Study||25
867235|NCT02280655|2099107|P2|STARTED|Overall Study||18
867236|NCT02280655|2099108|P1|STARTED|Overall Study||25
867237|NCT02280499|2099116|P1|NOT COMPLETED|Overall Study||61
867238|NCT02280499|2099116|P1|COMPLETED|Overall Study||26
867239|NCT02280499|2099116|P1|STARTED|Overall Study||87
867240|NCT02280473|2099124|P2|NOT COMPLETED|Overall Study||3
867241|NCT02280473|2099125|P1|NOT COMPLETED|Overall Study||1
867242|NCT02280473|2099124|P2|COMPLETED|Overall Study||91
867243|NCT02280473|2099125|P1|COMPLETED|Overall Study||93
867244|NCT02280473|2099124|P2|STARTED|Overall Study||94
867245|NCT02280473|2099125|P1|STARTED|Overall Study||94
867246|NCT02280187|2099139|P1|NOT COMPLETED|Overall Study||218
867247|NCT02280187|2099139|P1|COMPLETED|Overall Study||182
867248|NCT02280187|2099139|P1|STARTED|Overall Study||400
867249|NCT02280122|2099157|P3|NOT COMPLETED|Overall Study||0
867250|NCT02280122|2099158|P2|NOT COMPLETED|Overall Study||0
867251|NCT02280122|2099159|P1|NOT COMPLETED|Overall Study||0
867252|NCT02280122|2099157|P3|COMPLETED|Overall Study||30
867253|NCT02280122|2099158|P2|COMPLETED|Overall Study||15
867254|NCT02280122|2099159|P1|COMPLETED|Overall Study||15
867255|NCT02280122|2099157|P3|STARTED|Overall Study||30
867256|NCT02280122|2099158|P2|STARTED|Overall Study||15
867257|NCT02280122|2099159|P1|STARTED|Overall Study||15
867258|NCT02279667|2099168|P3|NOT COMPLETED|Overall Study||0
867259|NCT02279667|2099169|P2|NOT COMPLETED|Overall Study||0
867260|NCT02279667|2099170|P1|NOT COMPLETED|Overall Study||0
867261|NCT02279667|2099168|P3|COMPLETED|Overall Study||6
867262|NCT02279667|2099169|P2|COMPLETED|Overall Study||6
867263|NCT02279667|2099170|P1|COMPLETED|Overall Study||6
867264|NCT02279667|2099168|P3|STARTED|Overall Study||6
867265|NCT02279667|2099169|P2|STARTED|Overall Study||6
867266|NCT02279667|2099170|P1|STARTED|Overall Study||6
867267|NCT02279420|2099188|P1|NOT COMPLETED|Overall Study||23
867268|NCT02279420|2099188|P1|COMPLETED|Overall Study||50
867269|NCT02279420|2099188|P1|STARTED|Overall Study||73
867270|NCT02279407|2099196|P4|NOT COMPLETED|Overall Study||1
867271|NCT02279407|2099197|P3|NOT COMPLETED|Overall Study||5
867272|NCT02279407|2099198|P2|NOT COMPLETED|Overall Study||1
867273|NCT02279407|2099199|P1|NOT COMPLETED|Overall Study||2
867274|NCT02279407|2099196|P4|COMPLETED|Overall Study||20
867275|NCT02279407|2099197|P3|COMPLETED|Overall Study||15
867276|NCT02279407|2099198|P2|COMPLETED|Overall Study||20
867277|NCT02279407|2099199|P1|COMPLETED|Overall Study||20
867278|NCT02279407|2099196|P4|STARTED|Overall Study||21
867279|NCT02279407|2099197|P3|STARTED|Overall Study||20
867280|NCT02279407|2099198|P2|STARTED|Overall Study||21
867281|NCT02279407|2099199|P1|STARTED|Overall Study||22
867285|NCT02278783|2099214|P1|NOT COMPLETED|Overall Study||0
867286|NCT02278783|2099214|P1|COMPLETED|Overall Study||1
867287|NCT02278783|2099214|P1|STARTED|Overall Study||1
867288|NCT02278640|2099221|P1|NOT COMPLETED|Overall Study||0
867289|NCT02278640|2099221|P1|COMPLETED|Overall Study||40
867290|NCT02278640|2099221|P1|STARTED|Overall Study||40
867291|NCT02278614|2099230|P2|NOT COMPLETED|Overall Study||5
867292|NCT02278614|2099231|P1|NOT COMPLETED|Overall Study||5
867293|NCT02278614|2099230|P2|COMPLETED|Overall Study||110
867294|NCT02278614|2099231|P1|COMPLETED|Overall Study||122
867295|NCT02278614|2099230|P2|STARTED|Overall Study||115
867296|NCT02278614|2099231|P1|STARTED|Overall Study||127
867297|NCT02278484|2099237|P1|NOT COMPLETED|Overall Study||0
867298|NCT02278484|2099237|P1|COMPLETED|Overall Study||50
867299|NCT02278484|2099237|P1|STARTED|Overall Study||50
867300|NCT02278146|2099246|P2|NOT COMPLETED|Overall Study||2
867301|NCT02278146|2099247|P1|NOT COMPLETED|Overall Study||0
867302|NCT02278146|2099246|P2|COMPLETED|Overall Study||8
867303|NCT02278146|2099247|P1|COMPLETED|Overall Study||6
867304|NCT02278146|2099246|P2|STARTED|Overall Study||10
867305|NCT02278146|2099247|P1|STARTED|Overall Study||6
867306|NCT02277691|2099257|P1|NOT COMPLETED|Overall Study||46
867307|NCT02277691|2099257|P1|COMPLETED|Overall Study||295
867308|NCT02277691|2099257|P1|STARTED|Overall Study||341
867309|NCT02277626|2099267|P2|NOT COMPLETED|Overall Study||0
867310|NCT02277626|2099268|P1|NOT COMPLETED|Overall Study||0
867311|NCT02277626|2099267|P2|COMPLETED|Overall Study||9
867312|NCT02277626|2099268|P1|COMPLETED|Overall Study||6
867313|NCT02277626|2099267|P2|STARTED|Overall Study||9
867314|NCT02277626|2099268|P1|STARTED|Overall Study||6
867315|NCT02277249|2099284|P2|NOT COMPLETED|Overall Study||0
867316|NCT02277249|2099285|P1|NOT COMPLETED|Overall Study||0
867317|NCT02277249|2099284|P2|COMPLETED|Overall Study||30
867318|NCT02277249|2099285|P1|COMPLETED|Overall Study||30
867319|NCT02277249|2099284|P2|STARTED|Overall Study||30
867320|NCT02277249|2099285|P1|STARTED|Overall Study||30
867321|NCT02277119|2099294|P3|NOT COMPLETED|Overall Study||8
867322|NCT02277119|2099295|P2|NOT COMPLETED|Overall Study||4
867323|NCT02277119|2099296|P1|NOT COMPLETED|Overall Study||3
867324|NCT02277119|2099294|P3|COMPLETED|Overall Study||19
867325|NCT02277119|2099295|P2|COMPLETED|Overall Study||20
867326|NCT02277119|2099296|P1|COMPLETED|Overall Study||55
867327|NCT02277119|2099294|P3|STARTED|Overall Study||27
867328|NCT02277119|2099295|P2|STARTED|Overall Study||24
867329|NCT02277119|2099296|P1|STARTED|Overall Study||58
867330|NCT02277093|2099313|P1|NOT COMPLETED|Overall Study||0
867331|NCT02277093|2099313|P1|COMPLETED|Overall Study||11
867332|NCT02277093|2099313|P1|STARTED|Overall Study||11
867333|NCT02276560|2099324|P3|NOT COMPLETED|Overall Study||0
867334|NCT02276560|2099325|P2|NOT COMPLETED|Overall Study||0
867335|NCT02276560|2099326|P1|NOT COMPLETED|Overall Study||1
867336|NCT02276560|2099324|P3|COMPLETED|Overall Study||0
867337|NCT02276560|2099325|P2|COMPLETED|Overall Study||0
867338|NCT02276560|2099326|P1|COMPLETED|Overall Study||0
867339|NCT02276560|2099324|P3|STARTED|Overall Study||0
867340|NCT02276560|2099325|P2|STARTED|Overall Study||0
867341|NCT02276560|2099326|P1|STARTED|Overall Study||1
867342|NCT02276274|2099336|P2|NOT COMPLETED|Second Intervention Period||0
867343|NCT02276274|2099337|P1|NOT COMPLETED|Second Intervention Period||0
867344|NCT02276274|2099336|P2|COMPLETED|Second Intervention Period||6
867345|NCT02276274|2099337|P1|COMPLETED|Second Intervention Period||6
867346|NCT02276274|2099336|P2|STARTED|Second Intervention Period||6
867347|NCT02276274|2099337|P1|STARTED|Second Intervention Period||6
867348|NCT02276274|2099336|P2|NOT COMPLETED|Washout Period (at Least 15 Days)||0
867349|NCT02276274|2099337|P1|NOT COMPLETED|Washout Period (at Least 15 Days)||0
867350|NCT02276274|2099336|P2|COMPLETED|Washout Period (at Least 15 Days)||6
867351|NCT02276274|2099337|P1|COMPLETED|Washout Period (at Least 15 Days)||6
867352|NCT02276274|2099336|P2|STARTED|Washout Period (at Least 15 Days)||6
867353|NCT02276274|2099337|P1|STARTED|Washout Period (at Least 15 Days)||6
867354|NCT02276274|2099336|P2|NOT COMPLETED|First Intervention Period||0
867355|NCT02276274|2099337|P1|NOT COMPLETED|First Intervention Period||0
867356|NCT02276274|2099336|P2|COMPLETED|First Intervention Period||6
867357|NCT02276274|2099337|P1|COMPLETED|First Intervention Period||6
867358|NCT02276274|2099336|P2|STARTED|First Intervention Period||6
867359|NCT02276274|2099337|P1|STARTED|First Intervention Period||6
867360|NCT02275767|2099448|P3|NOT COMPLETED|Overall Study||3
867361|NCT02275767|2099449|P2|NOT COMPLETED|Overall Study||4
867362|NCT02275767|2099450|P1|NOT COMPLETED|Overall Study||2
867363|NCT02275767|2099448|P3|COMPLETED|Overall Study||19
867364|NCT02275767|2099449|P2|COMPLETED|Overall Study||18
867365|NCT02275767|2099450|P1|COMPLETED|Overall Study||20
867366|NCT02275767|2099448|P3|STARTED|Overall Study||22
867367|NCT02275767|2099449|P2|STARTED|Overall Study||22
867368|NCT02275767|2099450|P1|STARTED|Overall Study||22
867369|NCT02275611|2099465|P4|NOT COMPLETED|Outpatient Drinking||0
867370|NCT02275611|2099466|P3|NOT COMPLETED|Outpatient Drinking||0
867371|NCT02275611|2099467|P2|NOT COMPLETED|Outpatient Drinking||0
867372|NCT02275611|2099468|P1|NOT COMPLETED|Outpatient Drinking||0
867373|NCT02275611|2099465|P4|COMPLETED|Outpatient Drinking||3
867374|NCT02275611|2099466|P3|COMPLETED|Outpatient Drinking||6
867375|NCT02275611|2099467|P2|COMPLETED|Outpatient Drinking||0
867376|NCT02275611|2099468|P1|COMPLETED|Outpatient Drinking||0
867377|NCT02275611|2099465|P4|STARTED|Outpatient Drinking||3
867378|NCT02275611|2099466|P3|STARTED|Outpatient Drinking||6
867379|NCT02275611|2099467|P2|STARTED|Outpatient Drinking||0
867380|NCT02275611|2099468|P1|STARTED|Outpatient Drinking||0
867381|NCT02275611|2099465|P4|NOT COMPLETED|Inpatient Withdrawal||0
867382|NCT02275611|2099466|P3|NOT COMPLETED|Inpatient Withdrawal||0
867383|NCT02275611|2099467|P2|NOT COMPLETED|Inpatient Withdrawal||0
867384|NCT02275611|2099468|P1|NOT COMPLETED|Inpatient Withdrawal||1
867385|NCT02275611|2099465|P4|COMPLETED|Inpatient Withdrawal||0
867386|NCT02275611|2099466|P3|COMPLETED|Inpatient Withdrawal||0
867387|NCT02275611|2099467|P2|COMPLETED|Inpatient Withdrawal||4
867388|NCT02275611|2099468|P1|COMPLETED|Inpatient Withdrawal||4
867389|NCT02275611|2099465|P4|STARTED|Inpatient Withdrawal||0
867390|NCT02275611|2099466|P3|STARTED|Inpatient Withdrawal||0
867391|NCT02275611|2099467|P2|STARTED|Inpatient Withdrawal||4
867392|NCT02275611|2099468|P1|STARTED|Inpatient Withdrawal||5
867393|NCT02275546|2099480|P2|NOT COMPLETED|Treatment Period 2||2
867394|NCT02275546|2099481|P1|NOT COMPLETED|Treatment Period 2||2
867395|NCT02275546|2099480|P2|COMPLETED|Treatment Period 2||81
867396|NCT02275546|2099481|P1|COMPLETED|Treatment Period 2||79
867397|NCT02275546|2099480|P2|STARTED|Treatment Period 2||83
867398|NCT02275546|2099481|P1|STARTED|Treatment Period 2||81
867399|NCT02275546|2099480|P2|NOT COMPLETED|Treatment Period 1||0
867400|NCT02275546|2099481|P1|NOT COMPLETED|Treatment Period 1||0
867401|NCT02275546|2099480|P2|COMPLETED|Treatment Period 1||83
867402|NCT02275546|2099481|P1|COMPLETED|Treatment Period 1||81
867403|NCT02275546|2099480|P2|STARTED|Treatment Period 1||83
867404|NCT02275546|2099481|P1|STARTED|Treatment Period 1||81
867405|NCT02275481|2099491|P2|NOT COMPLETED|Overall Study||3
867406|NCT02275481|2099492|P1|NOT COMPLETED|Overall Study||9
867407|NCT02275481|2099491|P2|COMPLETED|Overall Study||31
867408|NCT02275481|2099492|P1|COMPLETED|Overall Study||23
867409|NCT02275481|2099491|P2|STARTED|Overall Study||34
867410|NCT02275481|2099492|P1|STARTED|Overall Study||32
867411|NCT02275364|2099498|P2|NOT COMPLETED|Period 4||0
867412|NCT02275364|2099499|P1|NOT COMPLETED|Period 4||0
867413|NCT02275364|2099498|P2|COMPLETED|Period 4||14
867414|NCT02275364|2099499|P1|COMPLETED|Period 4||12
867415|NCT02275364|2099498|P2|STARTED|Period 4||14
867416|NCT02275364|2099499|P1|STARTED|Period 4||12
867417|NCT02275364|2099498|P2|NOT COMPLETED|Period 3||0
867418|NCT02275364|2099499|P1|NOT COMPLETED|Period 3||0
867419|NCT02275364|2099498|P2|COMPLETED|Period 3||14
867420|NCT02275364|2099499|P1|COMPLETED|Period 3||12
867421|NCT02275364|2099498|P2|STARTED|Period 3||14
867422|NCT02275364|2099499|P1|STARTED|Period 3||12
867423|NCT02275364|2099498|P2|NOT COMPLETED|Washout Period 2||0
867424|NCT02275364|2099499|P1|NOT COMPLETED|Washout Period 2||0
867425|NCT02275364|2099498|P2|COMPLETED|Washout Period 2||14
867426|NCT02275364|2099499|P1|COMPLETED|Washout Period 2||12
867427|NCT02275364|2099498|P2|STARTED|Washout Period 2||14
867428|NCT02275364|2099499|P1|STARTED|Washout Period 2||12
867429|NCT02275364|2099498|P2|NOT COMPLETED|Period 2||0
867430|NCT02275364|2099499|P1|NOT COMPLETED|Period 2||0
867431|NCT02275364|2099498|P2|COMPLETED|Period 2||14
867432|NCT02275364|2099499|P1|COMPLETED|Period 2||12
867433|NCT02275364|2099498|P2|STARTED|Period 2||14
867434|NCT02275364|2099499|P1|STARTED|Period 2||12
867435|NCT02275364|2099498|P2|NOT COMPLETED|Washout Period 1||0
867436|NCT02275364|2099499|P1|NOT COMPLETED|Washout Period 1||0
867437|NCT02275364|2099498|P2|COMPLETED|Washout Period 1||14
867438|NCT02275364|2099499|P1|COMPLETED|Washout Period 1||12
867439|NCT02275364|2099498|P2|STARTED|Washout Period 1||14
867440|NCT02275364|2099499|P1|STARTED|Washout Period 1||12
867441|NCT02275364|2099498|P2|NOT COMPLETED|Period 1||0
867442|NCT02275364|2099499|P1|NOT COMPLETED|Period 1||2
867443|NCT02275364|2099498|P2|COMPLETED|Period 1||14
867444|NCT02275364|2099499|P1|COMPLETED|Period 1||12
867445|NCT02275364|2099498|P2|STARTED|Period 1||14
867446|NCT02275364|2099499|P1|STARTED|Period 1||14
867447|NCT02275156|2099531|P3|NOT COMPLETED|Overall Study||0
867448|NCT02275156|2099532|P2|NOT COMPLETED|Overall Study||0
867449|NCT02275156|2099533|P1|NOT COMPLETED|Overall Study||0
867450|NCT02275156|2099531|P3|COMPLETED|Overall Study||6
867451|NCT02275156|2099532|P2|COMPLETED|Overall Study||6
867452|NCT02275156|2099533|P1|COMPLETED|Overall Study||6
867453|NCT02275156|2099531|P3|STARTED|Overall Study||6
867454|NCT02275156|2099532|P2|STARTED|Overall Study||6
867455|NCT02275156|2099533|P1|STARTED|Overall Study||6
867573|NCT02272725|2099819|P2|COMPLETED|Overall Study||42
867492|NCT02274948|2099577|P2|NOT COMPLETED|Overall Study||91
867493|NCT02274948|2099578|P1|NOT COMPLETED|Overall Study||98
867494|NCT02274948|2099577|P2|COMPLETED|Overall Study||82
867495|NCT02274948|2099578|P1|COMPLETED|Overall Study||68
867496|NCT02274948|2099577|P2|STARTED|Overall Study||173
867497|NCT02274948|2099578|P1|STARTED|Overall Study||166
867498|NCT02274792|2099592|P1|NOT COMPLETED|Overall Study||25
867499|NCT02274792|2099592|P1|COMPLETED|Overall Study||107
867500|NCT02274792|2099592|P1|Received Treatment|Overall Study||131
867501|NCT02274792|2099592|P1|STARTED|Overall Study||132
867502|NCT02274688|2099602|P2|NOT COMPLETED|Overall Study||13
867503|NCT02274688|2099603|P1|NOT COMPLETED|Overall Study||14
867504|NCT02274688|2099602|P2|COMPLETED|Overall Study||72
867505|NCT02274688|2099603|P1|COMPLETED|Overall Study||72
867506|NCT02274688|2099602|P2|STARTED|Overall Study||85
867507|NCT02274688|2099603|P1|STARTED|Overall Study||86
867508|NCT02274675|2099625|P1|NOT COMPLETED|Overall Study||0
867509|NCT02274675|2099625|P1|COMPLETED|Overall Study||7
867510|NCT02274675|2099625|P1|STARTED|Overall Study||7
867511|NCT02274558|2099638|P3|NOT COMPLETED|Overall Study||9
867512|NCT02274558|2099639|P2|NOT COMPLETED|Overall Study||13
867513|NCT02274558|2099640|P1|NOT COMPLETED|Overall Study||7
867514|NCT02274558|2099638|P3|COMPLETED|Overall Study||71
867515|NCT02274558|2099639|P2|COMPLETED|Overall Study||63
867516|NCT02274558|2099640|P1|COMPLETED|Overall Study||71
867517|NCT02274558|2099638|P3|Included in the Safety Analysis Set|Overall Study||79
867518|NCT02274558|2099639|P2|Included in the Safety Analysis Set|Overall Study||72
867519|NCT02274558|2099640|P1|Included in the Safety Analysis Set|Overall Study||76
867520|NCT02274558|2099638|P3|STARTED|Overall Study||80
867521|NCT02274558|2099639|P2|STARTED|Overall Study||76
867522|NCT02274558|2099640|P1|STARTED|Overall Study||78
867523|NCT02273908|2099656|P2|NOT COMPLETED|Overall Study||5
867524|NCT02273908|2099657|P1|NOT COMPLETED|Overall Study||33
867525|NCT02273908|2099656|P2|COMPLETED|Overall Study||169
867526|NCT02273908|2099657|P1|COMPLETED|Overall Study||124
867527|NCT02273908|2099656|P2|STARTED|Overall Study||174
867528|NCT02273908|2099657|P1|STARTED|Overall Study||157
867529|NCT02273752|2099679|P1|NOT COMPLETED|Overall Study||2
867530|NCT02273752|2099679|P1|COMPLETED|Overall Study||0
867531|NCT02273752|2099679|P1|STARTED|Overall Study||2
867532|NCT02273323|2099690|P2|NOT COMPLETED|Overall Study||0
867533|NCT02273323|2099691|P1|NOT COMPLETED|Overall Study||0
867534|NCT02273323|2099690|P2|COMPLETED|Overall Study||15
867535|NCT02273323|2099691|P1|COMPLETED|Overall Study||15
867536|NCT02273323|2099690|P2|STARTED|Overall Study||15
867537|NCT02273323|2099691|P1|STARTED|Overall Study||15
867538|NCT02273310|2099709|P2|NOT COMPLETED|Overall Study||3
867539|NCT02273310|2099710|P1|NOT COMPLETED|Overall Study||18
867540|NCT02273310|2099709|P2|COMPLETED|Overall Study||38
867541|NCT02273310|2099710|P1|COMPLETED|Overall Study||24
867542|NCT02273310|2099709|P2|STARTED|Overall Study||41
867543|NCT02273310|2099710|P1|STARTED|Overall Study||42
867544|NCT02273167|2099724|P3|NOT COMPLETED|Overall Study||21
867545|NCT02273167|2099725|P2|NOT COMPLETED|Overall Study||23
867546|NCT02273167|2099726|P1|NOT COMPLETED|Overall Study||24
867547|NCT02273167|2099724|P3|COMPLETED|Overall Study||262
867548|NCT02273167|2099725|P2|COMPLETED|Overall Study||260
867549|NCT02273167|2099726|P1|COMPLETED|Overall Study||259
867550|NCT02273167|2099724|P3|STARTED|Overall Study||283
867551|NCT02273167|2099725|P2|STARTED|Overall Study||283
867552|NCT02273167|2099726|P1|STARTED|Overall Study||283
867553|NCT02273141|2099751|P2|NOT COMPLETED|Overall Study||25
867554|NCT02273141|2099752|P1|NOT COMPLETED|Overall Study||17
867555|NCT02273141|2099751|P2|COMPLETED|Overall Study||233
867556|NCT02273141|2099752|P1|COMPLETED|Overall Study||240
867557|NCT02273141|2099751|P2|STARTED|Overall Study||258
867558|NCT02273141|2099752|P1|STARTED|Overall Study||257
867559|NCT02273115|2099772|P4|NOT COMPLETED|Overall Study||1
867560|NCT02273115|2099773|P3|NOT COMPLETED|Overall Study||0
867561|NCT02273115|2099774|P2|NOT COMPLETED|Overall Study||0
867562|NCT02273115|2099775|P1|NOT COMPLETED|Overall Study||0
867563|NCT02273115|2099772|P4|COMPLETED|Overall Study||71
867564|NCT02273115|2099773|P3|COMPLETED|Overall Study||67
867565|NCT02273115|2099774|P2|COMPLETED|Overall Study||90
867566|NCT02273115|2099775|P1|COMPLETED|Overall Study||94
867567|NCT02273115|2099772|P4|STARTED|Overall Study||72
867568|NCT02273115|2099773|P3|STARTED|Overall Study||67
867569|NCT02273115|2099774|P2|STARTED|Overall Study||90
867570|NCT02273115|2099775|P1|STARTED|Overall Study||94
867571|NCT02272725|2099819|P2|NOT COMPLETED|Overall Study||0
867572|NCT02272725|2099820|P1|NOT COMPLETED|Overall Study||2
867574|NCT02272725|2099820|P1|COMPLETED|Overall Study||47
867575|NCT02272725|2099819|P2|STARTED|Overall Study||42
867576|NCT02272725|2099820|P1|STARTED|Overall Study||49
867577|NCT02271854|2099830|P1|NOT COMPLETED|Overall Study||4
867578|NCT02271854|2099830|P1|COMPLETED|Overall Study||98
867579|NCT02271854|2099830|P1|STARTED|Overall Study||102
867580|NCT02271698|2099841|P4|NOT COMPLETED|Overall Study||0
867581|NCT02271698|2099842|P3|NOT COMPLETED|Overall Study||0
867582|NCT02271698|2099843|P2|NOT COMPLETED|Overall Study||0
867583|NCT02271698|2099844|P1|NOT COMPLETED|Overall Study||0
867584|NCT02271698|2099841|P4|COMPLETED|Overall Study||11
867585|NCT02271698|2099842|P3|COMPLETED|Overall Study||10
867586|NCT02271698|2099843|P2|COMPLETED|Overall Study||10
867587|NCT02271698|2099844|P1|COMPLETED|Overall Study||11
867588|NCT02271698|2099841|P4|STARTED|Overall Study||11
867589|NCT02271698|2099842|P3|STARTED|Overall Study||10
867590|NCT02271698|2099843|P2|STARTED|Overall Study||10
867591|NCT02271698|2099844|P1|STARTED|Overall Study||11
867592|NCT02271529|2099858|P1|NOT COMPLETED|Overall Study||1
867593|NCT02271529|2099858|P1|COMPLETED|Overall Study||39
867594|NCT02271529|2099858|P1|STARTED|Overall Study||40
867595|NCT02271477|2099864|P2|NOT COMPLETED|Overall Study||0
867596|NCT02271477|2099865|P1|NOT COMPLETED|Overall Study||0
867597|NCT02271477|2099864|P2|COMPLETED|Overall Study||80
867598|NCT02271477|2099865|P1|COMPLETED|Overall Study||80
867599|NCT02271477|2099864|P2|STARTED|Overall Study||80
867600|NCT02271477|2099865|P1|STARTED|Overall Study||80
867601|NCT02270944|2099879|P2|NOT COMPLETED|Overall Study||5
867602|NCT02270944|2099880|P1|NOT COMPLETED|Overall Study||11
867603|NCT02270944|2099879|P2|COMPLETED|Overall Study||516
867604|NCT02270944|2099880|P1|COMPLETED|Overall Study||518
867605|NCT02270944|2099879|P2|STARTED|Overall Study||521
867606|NCT02270944|2099880|P1|STARTED|Overall Study||529
867607|NCT02270684|2099896|P2|NOT COMPLETED|Overall Study||3
867608|NCT02270684|2099897|P1|NOT COMPLETED|Overall Study||1
867609|NCT02270684|2099896|P2|COMPLETED|Overall Study||0
867610|NCT02270684|2099897|P1|COMPLETED|Overall Study||0
867611|NCT02270684|2099896|P2|STARTED|Overall Study||3
867612|NCT02270684|2099897|P1|STARTED|Overall Study||1
867613|NCT02270515|2099903|P1|NOT COMPLETED|Intervention Period 3: 12-18 Months||24
867614|NCT02270515|2099903|P1|COMPLETED|Intervention Period 3: 12-18 Months||103
867615|NCT02270515|2099903|P1|STARTED|Intervention Period 3: 12-18 Months||127
867616|NCT02270515|2099903|P1|NOT COMPLETED|Intervention Period 2: 6-12 Months||32
867617|NCT02270515|2099903|P1|COMPLETED|Intervention Period 2: 6-12 Months||127
867618|NCT02270515|2099903|P1|STARTED|Intervention Period 2: 6-12 Months||159
867619|NCT02270515|2099903|P1|NOT COMPLETED|Intervention Period 1: 0-6 Months||16
867620|NCT02270515|2099903|P1|COMPLETED|Intervention Period 1: 0-6 Months||159
867621|NCT02270515|2099903|P1|STARTED|Intervention Period 1: 0-6 Months||175
867622|NCT02269709|2099918|P1|NOT COMPLETED|Six Month Follow-up||12
867623|NCT02269709|2099918|P1|COMPLETED|Six Month Follow-up||5
867624|NCT02269709|2099918|P1|STARTED|Six Month Follow-up||17
867625|NCT02269709|2099918|P1|NOT COMPLETED|Prior to Hospital Discharge||0
867626|NCT02269709|2099918|P1|COMPLETED|Prior to Hospital Discharge||17
867627|NCT02269709|2099918|P1|STARTED|Prior to Hospital Discharge||17
867628|NCT02269709|2099918|P1|NOT COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||1
867629|NCT02269709|2099918|P1|COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||17
867630|NCT02269709|2099918|P1|STARTED|Follow-up #1 (24-72 Hours Post-surgery)||18
867631|NCT02269709|2099918|P1|NOT COMPLETED|Time of Enrollment||3
867632|NCT02269709|2099918|P1|COMPLETED|Time of Enrollment||18
867633|NCT02269709|2099918|P1|STARTED|Time of Enrollment||21
867634|NCT02269657|2099923|P1|NOT COMPLETED|Overall Study||3
867635|NCT02269657|2099923|P1|COMPLETED|Overall Study||37
867636|NCT02269657|2099923|P1|STARTED|Overall Study||40
867637|NCT02269488|2099937|P1|NOT COMPLETED|Overall Study||0
867638|NCT02269488|2099937|P1|COMPLETED|Overall Study||100
867639|NCT02269488|2099937|P1|STARTED|Overall Study||100
867640|NCT02269475|2099943|P2|NOT COMPLETED|Overall Study||1
867641|NCT02269475|2099944|P1|NOT COMPLETED|Overall Study||3
867642|NCT02269475|2099943|P2|COMPLETED|Overall Study||432
867643|NCT02269475|2099944|P1|COMPLETED|Overall Study||865
867644|NCT02269475|2099943|P2|Per Protocol Population|Overall Study||430
867645|NCT02269475|2099944|P1|Per Protocol Population|Overall Study||849
867646|NCT02269475|2099943|P2|Received IP (Safety Population)|Overall Study||433
867647|NCT02269475|2099944|P1|Received IP (Safety Population)|Overall Study||868
867648|NCT02269475|2099943|P2|STARTED|Overall Study||433
867649|NCT02269475|2099944|P1|STARTED|Overall Study||868
867650|NCT02269098|2099957|P2|NOT COMPLETED|Overall Study||9
867651|NCT02269098|2099958|P1|NOT COMPLETED|Overall Study||14
867652|NCT02269098|2099957|P2|COMPLETED|Overall Study||41
867653|NCT02269098|2099958|P1|COMPLETED|Overall Study||37
867654|NCT02269098|2099957|P2|STARTED|Overall Study||50
867655|NCT02269098|2099958|P1|STARTED|Overall Study||51
867656|NCT02268877|2099974|P2|NOT COMPLETED|Overall Study||5
867657|NCT02268877|2099975|P1|NOT COMPLETED|Overall Study||4
867658|NCT02268877|2099974|P2|COMPLETED|Overall Study|106 patients received the intervention.|106
867659|NCT02268877|2099975|P1|COMPLETED|Overall Study||118
867660|NCT02268877|2099974|P2|STARTED|Overall Study|111 patients were randomized to this arm.|111
867661|NCT02268877|2099975|P1|STARTED|Overall Study||122
867662|NCT02268864|2099986|P3|NOT COMPLETED|Overall Study||0
867663|NCT02268864|2099987|P2|NOT COMPLETED|Overall Study||1
867664|NCT02268864|2099988|P1|NOT COMPLETED|Overall Study||2
867665|NCT02268864|2099986|P3|COMPLETED|Overall Study||64
867666|NCT02268864|2099987|P2|COMPLETED|Overall Study||24
867667|NCT02268864|2099988|P1|COMPLETED|Overall Study||15
867668|NCT02268864|2099986|P3|STARTED|Overall Study||64
867669|NCT02268864|2099987|P2|STARTED|Overall Study||25
867670|NCT02268864|2099988|P1|STARTED|Overall Study||17
867671|NCT02268396|2100010|P1|NOT COMPLETED|Overall Study||12
867672|NCT02268396|2100010|P1|COMPLETED|Overall Study||126
867673|NCT02268396|2100010|P1|STARTED|Overall Study||138
867674|NCT02268058|2100023|P4|NOT COMPLETED|Overall Study||0
867675|NCT02268058|2100024|P3|NOT COMPLETED|Overall Study||0
867676|NCT02268058|2100025|P2|NOT COMPLETED|Overall Study||0
867677|NCT02268058|2100026|P1|NOT COMPLETED|Overall Study||1
867678|NCT02268058|2100023|P4|COMPLETED|Overall Study||20
867679|NCT02268058|2100024|P3|COMPLETED|Overall Study||20
867680|NCT02268058|2100025|P2|COMPLETED|Overall Study||20
867681|NCT02268058|2100026|P1|COMPLETED|Overall Study||19
867682|NCT02268058|2100023|P4|STARTED|Overall Study||20
867683|NCT02268058|2100024|P3|STARTED|Overall Study||20
867684|NCT02268058|2100025|P2|STARTED|Overall Study||20
867685|NCT02268058|2100026|P1|STARTED|Overall Study||20
867686|NCT02267837|2100050|P2|NOT COMPLETED|Overall Study||0
867687|NCT02267837|2100051|P1|NOT COMPLETED|Overall Study||0
867688|NCT02267837|2100050|P2|COMPLETED|Overall Study||9
867689|NCT02267837|2100051|P1|COMPLETED|Overall Study||11
867690|NCT02267837|2100050|P2|STARTED|Overall Study||9
867691|NCT02267837|2100051|P1|STARTED|Overall Study||11
867692|NCT02267824|2100059|P2|NOT COMPLETED|Overall Study||1
867693|NCT02267824|2100060|P1|NOT COMPLETED|Overall Study||10
867694|NCT02267824|2100059|P2|COMPLETED|Overall Study||17
867695|NCT02267824|2100060|P1|COMPLETED|Overall Study||73
867696|NCT02267824|2100059|P2|STARTED|Overall Study||18
867697|NCT02267824|2100060|P1|STARTED|Overall Study||83
867698|NCT02267629|2100066|P1|NOT COMPLETED|Overall Study||0
867699|NCT02267629|2100066|P1|COMPLETED|Overall Study||7
867700|NCT02267629|2100066|P1|STARTED|Overall Study||7
867701|NCT02267447|2100073|P2|NOT COMPLETED|Overall Study||0
867702|NCT02267447|2100074|P1|NOT COMPLETED|Overall Study||0
867703|NCT02267447|2100073|P2|COMPLETED|Overall Study||26968
867704|NCT02267447|2100074|P1|COMPLETED|Overall Study||77251
867705|NCT02267447|2100073|P2|STARTED|Overall Study||26968
867706|NCT02267447|2100074|P1|STARTED|Overall Study||77251
867707|NCT02266810|2100084|P2|NOT COMPLETED|Overall Study||1
867708|NCT02266810|2100085|P1|NOT COMPLETED|Overall Study||1
867709|NCT02266810|2100084|P2|COMPLETED|Overall Study|sinus sides|79
867710|NCT02266810|2100085|P1|COMPLETED|Overall Study|sinus sides|79
867711|NCT02266810|2100084|P2|STARTED|Overall Study|sinus sides|80
867712|NCT02266810|2100085|P1|STARTED|Overall Study|sinus sides|80
867713|NCT02266797|2100111|P2|NOT COMPLETED|Overall Study||1
867714|NCT02266797|2100112|P1|NOT COMPLETED|Overall Study||0
867715|NCT02266797|2100111|P2|COMPLETED|Overall Study||2
867716|NCT02266797|2100112|P1|COMPLETED|Overall Study||1
867717|NCT02266797|2100111|P2|STARTED|Overall Study||3
867718|NCT02266797|2100112|P1|STARTED|Overall Study||1
867719|NCT02266472|2100130|P2|NOT COMPLETED|Period 2+ Washout||0
867720|NCT02266472|2100131|P1|NOT COMPLETED|Period 2+ Washout||0
867721|NCT02266472|2100130|P2|COMPLETED|Period 2+ Washout||15
867722|NCT02266472|2100131|P1|COMPLETED|Period 2+ Washout||15
867723|NCT02266472|2100130|P2|STARTED|Period 2+ Washout||15
867724|NCT02266472|2100131|P1|STARTED|Period 2+ Washout||15
867725|NCT02266472|2100130|P2|NOT COMPLETED|Period 1+ Washout||0
867726|NCT02266472|2100131|P1|NOT COMPLETED|Period 1+ Washout||0
867727|NCT02266472|2100130|P2|COMPLETED|Period 1+ Washout||15
867728|NCT02266472|2100131|P1|COMPLETED|Period 1+ Washout||15
867729|NCT02266472|2100130|P2|STARTED|Period 1+ Washout||15
867730|NCT02266472|2100131|P1|STARTED|Period 1+ Washout||15
867731|NCT02266381|2100150|P3|NOT COMPLETED|Overall Study||4
867732|NCT02266381|2100151|P2|NOT COMPLETED|Overall Study||5
867733|NCT02266381|2100152|P1|NOT COMPLETED|Overall Study||3
867734|NCT02266381|2100150|P3|COMPLETED|Overall Study||146
867735|NCT02266381|2100151|P2|COMPLETED|Overall Study||145
867736|NCT02266381|2100152|P1|COMPLETED|Overall Study||147
867737|NCT02266381|2100150|P3|STARTED|Overall Study||150
867738|NCT02266381|2100151|P2|STARTED|Overall Study||150
867739|NCT02266381|2100152|P1|STARTED|Overall Study||150
867740|NCT02266277|2100175|P6|NOT COMPLETED|Overall Study||0
867741|NCT02266277|2100176|P5|NOT COMPLETED|Overall Study||0
867742|NCT02266277|2100177|P4|NOT COMPLETED|Overall Study||0
867743|NCT02266277|2100178|P3|NOT COMPLETED|Overall Study||0
867744|NCT02266277|2100179|P2|NOT COMPLETED|Overall Study||0
867745|NCT02266277|2100180|P1|NOT COMPLETED|Overall Study||0
867746|NCT02266277|2100175|P6|COMPLETED|Overall Study||5000
867747|NCT02266277|2100176|P5|COMPLETED|Overall Study||5000
867748|NCT02266277|2100177|P4|COMPLETED|Overall Study||5000
867749|NCT02266277|2100178|P3|COMPLETED|Overall Study||5000
867750|NCT02266277|2100179|P2|COMPLETED|Overall Study||5000
867751|NCT02266277|2100180|P1|COMPLETED|Overall Study||5000
867752|NCT02266277|2100175|P6|STARTED|Overall Study||5000
867753|NCT02266277|2100176|P5|STARTED|Overall Study||5000
867754|NCT02266277|2100177|P4|STARTED|Overall Study||5000
867755|NCT02266277|2100178|P3|STARTED|Overall Study||5000
867756|NCT02266277|2100179|P2|STARTED|Overall Study||5000
867757|NCT02266277|2100180|P1|STARTED|Overall Study||5000
867758|NCT02265848|2100204|P2|NOT COMPLETED|Overall Study||0
867759|NCT02265848|2100205|P1|NOT COMPLETED|Overall Study||0
867849|NCT02263911|2100291|P3|NOT COMPLETED|Period 3 Washout||0
867760|NCT02265848|2100204|P2|COMPLETED|Overall Study|Last subject for this study completed the visit on December 24, 2014|11
867761|NCT02265848|2100205|P1|COMPLETED|Overall Study||11
867762|NCT02265848|2100204|P2|STARTED|Overall Study||11
867763|NCT02265848|2100205|P1|STARTED|Overall Study|First subject for this study was randomized on October 1st 2014|11
867764|NCT02265783|2100217|P1|NOT COMPLETED|Overall Study||0
867765|NCT02265783|2100217|P1|COMPLETED|Overall Study|All subjects completed, one excluded from the analysis due to an issue with the data collection|20
867766|NCT02265783|2100217|P1|STARTED|Overall Study||20
867767|NCT02265237|2100225|P4|NOT COMPLETED|As Treated (Overall Study)||1
867768|NCT02265237|2100226|P3|NOT COMPLETED|As Treated (Overall Study)||10
867769|NCT02265237|2100227|P2|NOT COMPLETED|As Treated (Overall Study)||3
867770|NCT02265237|2100228|P1|NOT COMPLETED|As Treated (Overall Study)||5
867771|NCT02265237|2100225|P4|COMPLETED|As Treated (Overall Study)||2
867772|NCT02265237|2100226|P3|COMPLETED|As Treated (Overall Study)||51
867773|NCT02265237|2100227|P2|COMPLETED|As Treated (Overall Study)||57
867774|NCT02265237|2100228|P1|COMPLETED|As Treated (Overall Study)||55
867775|NCT02265237|2100225|P4|STARTED|As Treated (Overall Study)||3
867776|NCT02265237|2100226|P3|STARTED|As Treated (Overall Study)||61
867777|NCT02265237|2100227|P2|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
867778|NCT02265237|2100228|P1|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
867779|NCT02265237|2100225|P4|NOT COMPLETED|As Enrolled (Overall Study)||1
867780|NCT02265237|2100226|P3|NOT COMPLETED|As Enrolled (Overall Study)||10
867781|NCT02265237|2100227|P2|NOT COMPLETED|As Enrolled (Overall Study)||3
867782|NCT02265237|2100228|P1|NOT COMPLETED|As Enrolled (Overall Study)||5
867783|NCT02265237|2100225|P4|COMPLETED|As Enrolled (Overall Study)||2
867784|NCT02265237|2100226|P3|COMPLETED|As Enrolled (Overall Study)||51
867785|NCT02265237|2100227|P2|COMPLETED|As Enrolled (Overall Study)||58
867786|NCT02265237|2100228|P1|COMPLETED|As Enrolled (Overall Study)||54
867787|NCT02265237|2100225|P4|STARTED|As Enrolled (Overall Study)||3
867788|NCT02265237|2100226|P3|STARTED|As Enrolled (Overall Study)||61
867789|NCT02265237|2100227|P2|STARTED|As Enrolled (Overall Study)||61
867790|NCT02265237|2100228|P1|STARTED|As Enrolled (Overall Study)||59
867791|NCT02264977|2100247|P1|NOT COMPLETED|Overall Study||7
867792|NCT02264977|2100247|P1|COMPLETED|Overall Study||2
867793|NCT02264977|2100247|P1|STARTED|Overall Study||9
867794|NCT02264821|2100258|P3|NOT COMPLETED|Overall Study||6
867795|NCT02264821|2100259|P2|NOT COMPLETED|Overall Study||3
867796|NCT02264821|2100260|P1|NOT COMPLETED|Overall Study||1
867797|NCT02264821|2100258|P3|COMPLETED|Overall Study||58
867798|NCT02264821|2100259|P2|COMPLETED|Overall Study||61
867799|NCT02264821|2100260|P1|COMPLETED|Overall Study||63
867800|NCT02264821|2100258|P3|STARTED|Overall Study|Double Blind|64
867801|NCT02264821|2100259|P2|STARTED|Overall Study|Double Blind|64
867802|NCT02264821|2100260|P1|STARTED|Overall Study|Double Blind|64
867803|NCT02264249|2100274|P3|NOT COMPLETED|Overall Study||0
867804|NCT02264249|2100275|P2|NOT COMPLETED|Overall Study||0
867805|NCT02264249|2100276|P1|NOT COMPLETED|Overall Study||0
867806|NCT02264249|2100274|P3|COMPLETED|Overall Study||241
867807|NCT02264249|2100275|P2|COMPLETED|Overall Study||187
867808|NCT02264249|2100276|P1|COMPLETED|Overall Study||21
867809|NCT02264249|2100274|P3|STARTED|Overall Study||241
867810|NCT02264249|2100275|P2|STARTED|Overall Study||187
867811|NCT02264249|2100276|P1|STARTED|Overall Study||21
867812|NCT02263911|2100290|P4|NOT COMPLETED|Period 5||0
867813|NCT02263911|2100291|P3|NOT COMPLETED|Period 5||0
867814|NCT02263911|2100292|P2|NOT COMPLETED|Period 5||0
867815|NCT02263911|2100293|P1|NOT COMPLETED|Period 5||0
867816|NCT02263911|2100290|P4|COMPLETED|Period 5||4
867817|NCT02263911|2100291|P3|COMPLETED|Period 5||4
867818|NCT02263911|2100292|P2|COMPLETED|Period 5||4
867819|NCT02263911|2100293|P1|COMPLETED|Period 5||4
867820|NCT02263911|2100290|P4|STARTED|Period 5||4
867821|NCT02263911|2100291|P3|STARTED|Period 5||4
867822|NCT02263911|2100292|P2|STARTED|Period 5||4
867823|NCT02263911|2100293|P1|STARTED|Period 5||4
867824|NCT02263911|2100290|P4|NOT COMPLETED|Period 4 Washout||0
867825|NCT02263911|2100291|P3|NOT COMPLETED|Period 4 Washout||0
867826|NCT02263911|2100292|P2|NOT COMPLETED|Period 4 Washout||0
867827|NCT02263911|2100293|P1|NOT COMPLETED|Period 4 Washout||0
867828|NCT02263911|2100290|P4|COMPLETED|Period 4 Washout||4
867829|NCT02263911|2100291|P3|COMPLETED|Period 4 Washout||4
867830|NCT02263911|2100292|P2|COMPLETED|Period 4 Washout||4
867831|NCT02263911|2100293|P1|COMPLETED|Period 4 Washout||4
867832|NCT02263911|2100290|P4|STARTED|Period 4 Washout||4
867833|NCT02263911|2100291|P3|STARTED|Period 4 Washout||4
867834|NCT02263911|2100292|P2|STARTED|Period 4 Washout||4
867835|NCT02263911|2100293|P1|STARTED|Period 4 Washout||4
867836|NCT02263911|2100290|P4|NOT COMPLETED|Period 4||0
867837|NCT02263911|2100291|P3|NOT COMPLETED|Period 4||0
867838|NCT02263911|2100292|P2|NOT COMPLETED|Period 4||0
867839|NCT02263911|2100293|P1|NOT COMPLETED|Period 4||0
867840|NCT02263911|2100290|P4|COMPLETED|Period 4||4
867841|NCT02263911|2100291|P3|COMPLETED|Period 4||4
867842|NCT02263911|2100292|P2|COMPLETED|Period 4||4
867843|NCT02263911|2100293|P1|COMPLETED|Period 4||4
867844|NCT02263911|2100290|P4|STARTED|Period 4||4
867845|NCT02263911|2100291|P3|STARTED|Period 4||4
867846|NCT02263911|2100292|P2|STARTED|Period 4||4
867847|NCT02263911|2100293|P1|STARTED|Period 4||4
867848|NCT02263911|2100290|P4|NOT COMPLETED|Period 3 Washout||0
867850|NCT02263911|2100292|P2|NOT COMPLETED|Period 3 Washout||0
867851|NCT02263911|2100293|P1|NOT COMPLETED|Period 3 Washout||0
867852|NCT02263911|2100290|P4|COMPLETED|Period 3 Washout||4
867853|NCT02263911|2100291|P3|COMPLETED|Period 3 Washout||4
867854|NCT02263911|2100292|P2|COMPLETED|Period 3 Washout||4
867855|NCT02263911|2100293|P1|COMPLETED|Period 3 Washout||4
867856|NCT02263911|2100290|P4|STARTED|Period 3 Washout||4
867857|NCT02263911|2100291|P3|STARTED|Period 3 Washout||4
867858|NCT02263911|2100292|P2|STARTED|Period 3 Washout||4
867859|NCT02263911|2100293|P1|STARTED|Period 3 Washout||4
867860|NCT02263911|2100290|P4|NOT COMPLETED|Period 3||0
867861|NCT02263911|2100291|P3|NOT COMPLETED|Period 3||0
867862|NCT02263911|2100292|P2|NOT COMPLETED|Period 3||0
867863|NCT02263911|2100293|P1|NOT COMPLETED|Period 3||0
867864|NCT02263911|2100290|P4|COMPLETED|Period 3||4
867865|NCT02263911|2100291|P3|COMPLETED|Period 3||4
867866|NCT02263911|2100292|P2|COMPLETED|Period 3||4
867867|NCT02263911|2100293|P1|COMPLETED|Period 3||4
867868|NCT02263911|2100290|P4|STARTED|Period 3||4
867869|NCT02263911|2100291|P3|STARTED|Period 3||4
867870|NCT02263911|2100292|P2|STARTED|Period 3||4
867871|NCT02263911|2100293|P1|STARTED|Period 3||4
867872|NCT02263911|2100290|P4|NOT COMPLETED|Period 2 Washout||0
867873|NCT02263911|2100291|P3|NOT COMPLETED|Period 2 Washout||0
867874|NCT02263911|2100292|P2|NOT COMPLETED|Period 2 Washout||0
867875|NCT02263911|2100293|P1|NOT COMPLETED|Period 2 Washout||0
867876|NCT02263911|2100290|P4|COMPLETED|Period 2 Washout||4
867877|NCT02263911|2100291|P3|COMPLETED|Period 2 Washout||4
867878|NCT02263911|2100292|P2|COMPLETED|Period 2 Washout||4
867879|NCT02263911|2100293|P1|COMPLETED|Period 2 Washout||4
867880|NCT02263911|2100290|P4|STARTED|Period 2 Washout||4
867881|NCT02263911|2100291|P3|STARTED|Period 2 Washout||4
867882|NCT02263911|2100292|P2|STARTED|Period 2 Washout||4
867883|NCT02263911|2100293|P1|STARTED|Period 2 Washout||4
867884|NCT02263911|2100290|P4|NOT COMPLETED|Period 2||0
867885|NCT02263911|2100291|P3|NOT COMPLETED|Period 2||0
867886|NCT02263911|2100292|P2|NOT COMPLETED|Period 2||0
867887|NCT02263911|2100293|P1|NOT COMPLETED|Period 2||0
867888|NCT02263911|2100290|P4|COMPLETED|Period 2||4
867889|NCT02263911|2100291|P3|COMPLETED|Period 2||4
867890|NCT02263911|2100292|P2|COMPLETED|Period 2||4
867891|NCT02263911|2100293|P1|COMPLETED|Period 2||4
867892|NCT02263911|2100290|P4|STARTED|Period 2||4
867893|NCT02263911|2100291|P3|STARTED|Period 2||4
867894|NCT02263911|2100292|P2|STARTED|Period 2||4
867895|NCT02263911|2100293|P1|STARTED|Period 2||4
867896|NCT02263911|2100290|P4|NOT COMPLETED|Period 1 Washout||0
867897|NCT02263911|2100291|P3|NOT COMPLETED|Period 1 Washout||0
867898|NCT02263911|2100292|P2|NOT COMPLETED|Period 1 Washout||0
867899|NCT02263911|2100293|P1|NOT COMPLETED|Period 1 Washout||0
867900|NCT02263911|2100290|P4|COMPLETED|Period 1 Washout||4
867901|NCT02263911|2100291|P3|COMPLETED|Period 1 Washout||4
867902|NCT02263911|2100292|P2|COMPLETED|Period 1 Washout||4
867903|NCT02263911|2100293|P1|COMPLETED|Period 1 Washout||4
867904|NCT02263911|2100290|P4|STARTED|Period 1 Washout||4
867905|NCT02263911|2100291|P3|STARTED|Period 1 Washout||4
867906|NCT02263911|2100292|P2|STARTED|Period 1 Washout||4
867907|NCT02263911|2100293|P1|STARTED|Period 1 Washout||4
867908|NCT02263911|2100290|P4|NOT COMPLETED|Period 1||0
867909|NCT02263911|2100291|P3|NOT COMPLETED|Period 1||0
867910|NCT02263911|2100292|P2|NOT COMPLETED|Period 1||0
867911|NCT02263911|2100293|P1|NOT COMPLETED|Period 1||0
867912|NCT02263911|2100290|P4|COMPLETED|Period 1||4
867913|NCT02263911|2100291|P3|COMPLETED|Period 1||4
867914|NCT02263911|2100292|P2|COMPLETED|Period 1||4
867915|NCT02263911|2100293|P1|COMPLETED|Period 1||4
867916|NCT02263911|2100290|P4|STARTED|Period 1||4
867917|NCT02263911|2100291|P3|STARTED|Period 1||4
867918|NCT02263911|2100292|P2|STARTED|Period 1||4
867919|NCT02263911|2100293|P1|STARTED|Period 1||4
867920|NCT02263833|2100315|P1|NOT COMPLETED|Overall Study||0
867921|NCT02263833|2100315|P1|COMPLETED|Overall Study||742
867922|NCT02263833|2100315|P1|STARTED|Overall Study||742
867923|NCT02263131|2100322|P2|NOT COMPLETED|Overall Study||1
867924|NCT02263131|2100323|P1|NOT COMPLETED|Overall Study||10
867925|NCT02263131|2100322|P2|COMPLETED|Overall Study||68
867926|NCT02263131|2100323|P1|COMPLETED|Overall Study||337
867927|NCT02263131|2100322|P2|STARTED|Overall Study||69
867928|NCT02263131|2100323|P1|STARTED|Overall Study||347
867929|NCT02263118|2100335|P4|NOT COMPLETED|Overall Study||2
867930|NCT02263118|2100336|P3|NOT COMPLETED|Overall Study||8
867931|NCT02263118|2100337|P2|NOT COMPLETED|Overall Study||8
867932|NCT02263118|2100338|P1|NOT COMPLETED|Overall Study||4
867933|NCT02263118|2100335|P4|COMPLETED|Overall Study||12
867934|NCT02263118|2100336|P3|COMPLETED|Overall Study||22
867935|NCT02263118|2100337|P2|COMPLETED|Overall Study||24
867936|NCT02263118|2100338|P1|COMPLETED|Overall Study||20
867937|NCT02263118|2100335|P4|STARTED|Overall Study||14
867938|NCT02263118|2100336|P3|STARTED|Overall Study||30
867939|NCT02263118|2100337|P2|STARTED|Overall Study||32
867940|NCT02263118|2100338|P1|STARTED|Overall Study||24
867941|NCT02262754|2100363|P3|NOT COMPLETED|Overall Study||9
867942|NCT02262754|2100364|P2|NOT COMPLETED|Overall Study||9
867943|NCT02262754|2100365|P1|NOT COMPLETED|Overall Study||16
867944|NCT02262754|2100363|P3|COMPLETED|Overall Study||65
867945|NCT02262754|2100364|P2|COMPLETED|Overall Study||65
867946|NCT02262754|2100365|P1|COMPLETED|Overall Study||58
867947|NCT02262754|2100363|P3|STARTED|Overall Study||74
867948|NCT02262754|2100364|P2|STARTED|Overall Study||74
867949|NCT02262754|2100365|P1|STARTED|Overall Study||74
867950|NCT02262728|2100440|P2|NOT COMPLETED|Overall Study||0
867951|NCT02262728|2100441|P1|NOT COMPLETED|Overall Study||0
867952|NCT02262728|2100440|P2|COMPLETED|Overall Study||21
867953|NCT02262728|2100441|P1|COMPLETED|Overall Study||19
867954|NCT02262728|2100440|P2|STARTED|Overall Study||21
867955|NCT02262728|2100441|P1|STARTED|Overall Study||19
867956|NCT02262078|2100471|P2|NOT COMPLETED|Overall Study||0
867957|NCT02262078|2100472|P1|NOT COMPLETED|Overall Study||0
867958|NCT02262078|2100471|P2|COMPLETED|Overall Study||13
867959|NCT02262078|2100472|P1|COMPLETED|Overall Study||13
867960|NCT02262078|2100471|P2|STARTED|Overall Study||13
867961|NCT02262078|2100472|P1|STARTED|Overall Study||13
867962|NCT02262039|2100480|P2|NOT COMPLETED|Overall Study||0
867963|NCT02262039|2100481|P1|NOT COMPLETED|Overall Study||0
867964|NCT02262039|2100480|P2|COMPLETED|Overall Study||27
867965|NCT02262039|2100481|P1|COMPLETED|Overall Study||14
867966|NCT02262039|2100480|P2|STARTED|Overall Study||27
867967|NCT02262039|2100481|P1|STARTED|Overall Study||14
867968|NCT02261948|2100501|P2|NOT COMPLETED|Overall Study||0
867969|NCT02261948|2100502|P1|NOT COMPLETED|Overall Study||0
867970|NCT02261948|2100501|P2|COMPLETED|Overall Study||19
867971|NCT02261948|2100502|P1|COMPLETED|Overall Study||23
867972|NCT02261948|2100501|P2|STARTED|Overall Study||19
867973|NCT02261948|2100502|P1|STARTED|Overall Study||23
867974|NCT02261818|2100512|P1|NOT COMPLETED|Overall Study||3
867975|NCT02261818|2100512|P1|COMPLETED|Overall Study||27
867976|NCT02261818|2100512|P1|STARTED|Overall Study||30
867977|NCT02261493|2100519|P3|NOT COMPLETED|Overall Study||26
867978|NCT02261493|2100520|P2|NOT COMPLETED|Overall Study||47
867979|NCT02261493|2100521|P1|NOT COMPLETED|Overall Study||30
867980|NCT02261493|2100519|P3|COMPLETED|Overall Study||287
867981|NCT02261493|2100520|P2|COMPLETED|Overall Study||271
867982|NCT02261493|2100521|P1|COMPLETED|Overall Study||126
867983|NCT02261493|2100519|P3|STARTED|Overall Study||313
867984|NCT02261493|2100520|P2|STARTED|Overall Study||318
867985|NCT02261493|2100521|P1|STARTED|Overall Study||156
867986|NCT02261467|2100549|P2|NOT COMPLETED|Overall Study||37
867987|NCT02261467|2100550|P1|NOT COMPLETED|Overall Study||21
867988|NCT02261467|2100549|P2|COMPLETED|Overall Study||253
867989|NCT02261467|2100550|P1|COMPLETED|Overall Study||80
867990|NCT02261467|2100549|P2|STARTED|Overall Study||290
867991|NCT02261467|2100550|P1|STARTED|Overall Study||101
867992|NCT02261428|2100570|P2|NOT COMPLETED|Overall Study||0
867993|NCT02261428|2100571|P1|NOT COMPLETED|Overall Study||0
867994|NCT02261428|2100570|P2|COMPLETED|Overall Study||10
867995|NCT02261428|2100571|P1|COMPLETED|Overall Study||10
867996|NCT02261428|2100570|P2|STARTED|Overall Study|Washout (30 minutes)|10
867997|NCT02261428|2100571|P1|STARTED|Overall Study|Washout (30 minutes)|10
867998|NCT02260882|2100591|P2|NOT COMPLETED|Overall Study||1
867999|NCT02260882|2100592|P1|NOT COMPLETED|Overall Study||0
868000|NCT02260882|2100591|P2|COMPLETED|Overall Study||81
868001|NCT02260882|2100592|P1|COMPLETED|Overall Study||161
868002|NCT02260882|2100591|P2|STARTED|Overall Study||82
868003|NCT02260882|2100592|P1|STARTED|Overall Study||161
868010|NCT02260492|2100656|P3|NOT COMPLETED|Overall Study||5
868011|NCT02260492|2100657|P2|NOT COMPLETED|Overall Study||13
868012|NCT02260492|2100658|P1|NOT COMPLETED|Overall Study||23
868013|NCT02260492|2100656|P3|COMPLETED|Overall Study||37
868014|NCT02260492|2100657|P2|COMPLETED|Overall Study||406
868015|NCT02260492|2100658|P1|COMPLETED|Overall Study||395
868016|NCT02260492|2100656|P3|Completed Day 1|Overall Study||42
868017|NCT02260492|2100657|P2|Completed Day 1|Overall Study||419
868018|NCT02260492|2100658|P1|Completed Day 1|Overall Study||418
868019|NCT02260492|2100656|P3|STARTED|Overall Study||42
868020|NCT02260492|2100657|P2|STARTED|Overall Study||419
868021|NCT02260492|2100658|P1|STARTED|Overall Study||418
868022|NCT02260440|2100672|P1|NOT COMPLETED|Overall Study||0
868023|NCT02260440|2100672|P1|COMPLETED|Overall Study||31
868024|NCT02260440|2100672|P1|STARTED|Overall Study||31
868025|NCT02260401|2100680|P2|NOT COMPLETED|Overall Study||12
868026|NCT02260401|2100681|P1|NOT COMPLETED|Overall Study||5
868027|NCT02260401|2100680|P2|COMPLETED|Overall Study||73
868028|NCT02260401|2100681|P1|COMPLETED|Overall Study||75
868029|NCT02260401|2100680|P2|STARTED|Overall Study||85
868030|NCT02260401|2100681|P1|STARTED|Overall Study||80
868031|NCT02259608|2100687|P1|NOT COMPLETED|Overall Study||0
868032|NCT02259608|2100687|P1|COMPLETED|Overall Study||15
868033|NCT02259608|2100687|P1|STARTED|Overall Study||15
868034|NCT02259400|2100694|P2|NOT COMPLETED|Overall Study||2
868035|NCT02259400|2100695|P1|NOT COMPLETED|Overall Study||0
868036|NCT02259400|2100694|P2|COMPLETED|Overall Study||60
868037|NCT02259400|2100695|P1|COMPLETED|Overall Study||62
868038|NCT02259400|2100694|P2|STARTED|Overall Study||62
868039|NCT02259400|2100695|P1|STARTED|Overall Study||62
868040|NCT02259348|2100727|P1|NOT COMPLETED|Overall Study||10
868041|NCT02259348|2100727|P1|COMPLETED|Overall Study||2
868042|NCT02259348|2100727|P1|One Year Post-transplant|Overall Study||2
868043|NCT02259348|2100727|P1|STARTED|Overall Study||12
868044|NCT02258529|2100739|P1|NOT COMPLETED|Overall Study||10
868045|NCT02258529|2100739|P1|COMPLETED|Overall Study||0
868046|NCT02258529|2100739|P1|STARTED|Overall Study||10
868047|NCT02258477|2100751|P4|NOT COMPLETED|Fourth Intervention (1 Week)||0
868048|NCT02258477|2100752|P3|NOT COMPLETED|Fourth Intervention (1 Week)||0
868049|NCT02258477|2100753|P2|NOT COMPLETED|Fourth Intervention (1 Week)||0
868050|NCT02258477|2100754|P1|NOT COMPLETED|Fourth Intervention (1 Week)||0
868051|NCT02258477|2100751|P4|COMPLETED|Fourth Intervention (1 Week)||8
868052|NCT02258477|2100752|P3|COMPLETED|Fourth Intervention (1 Week)||8
868053|NCT02258477|2100753|P2|COMPLETED|Fourth Intervention (1 Week)||8
868054|NCT02258477|2100754|P1|COMPLETED|Fourth Intervention (1 Week)||9
868055|NCT02258477|2100751|P4|STARTED|Fourth Intervention (1 Week)||8
868056|NCT02258477|2100752|P3|STARTED|Fourth Intervention (1 Week)||8
868057|NCT02258477|2100753|P2|STARTED|Fourth Intervention (1 Week)||8
868058|NCT02258477|2100754|P1|STARTED|Fourth Intervention (1 Week)||9
868059|NCT02258477|2100751|P4|NOT COMPLETED|Third Intervention (1 Week)||0
868060|NCT02258477|2100752|P3|NOT COMPLETED|Third Intervention (1 Week)||0
868061|NCT02258477|2100753|P2|NOT COMPLETED|Third Intervention (1 Week)||0
868062|NCT02258477|2100754|P1|NOT COMPLETED|Third Intervention (1 Week)||0
868063|NCT02258477|2100751|P4|COMPLETED|Third Intervention (1 Week)||8
868064|NCT02258477|2100752|P3|COMPLETED|Third Intervention (1 Week)||8
868065|NCT02258477|2100753|P2|COMPLETED|Third Intervention (1 Week)||8
868066|NCT02258477|2100754|P1|COMPLETED|Third Intervention (1 Week)||9
868067|NCT02258477|2100751|P4|STARTED|Third Intervention (1 Week)||8
868068|NCT02258477|2100752|P3|STARTED|Third Intervention (1 Week)||8
868069|NCT02258477|2100753|P2|STARTED|Third Intervention (1 Week)||8
868070|NCT02258477|2100754|P1|STARTED|Third Intervention (1 Week)||9
868071|NCT02258477|2100751|P4|NOT COMPLETED|Second Intervention (1 Week)||1
868072|NCT02258477|2100752|P3|NOT COMPLETED|Second Intervention (1 Week)||1
868073|NCT02258477|2100753|P2|NOT COMPLETED|Second Intervention (1 Week)||0
868074|NCT02258477|2100754|P1|NOT COMPLETED|Second Intervention (1 Week)||0
868075|NCT02258477|2100751|P4|COMPLETED|Second Intervention (1 Week)||8
868076|NCT02258477|2100752|P3|COMPLETED|Second Intervention (1 Week)||8
868077|NCT02258477|2100753|P2|COMPLETED|Second Intervention (1 Week)||8
868078|NCT02258477|2100754|P1|COMPLETED|Second Intervention (1 Week)||9
868079|NCT02258477|2100751|P4|STARTED|Second Intervention (1 Week)||9
868080|NCT02258477|2100752|P3|STARTED|Second Intervention (1 Week)||9
868081|NCT02258477|2100753|P2|STARTED|Second Intervention (1 Week)||8
868082|NCT02258477|2100754|P1|STARTED|Second Intervention (1 Week)||9
868083|NCT02258477|2100751|P4|NOT COMPLETED|First Intervention (1 Week)||0
868084|NCT02258477|2100752|P3|NOT COMPLETED|First Intervention (1 Week)||0
868085|NCT02258477|2100753|P2|NOT COMPLETED|First Intervention (1 Week)||1
868086|NCT02258477|2100754|P1|NOT COMPLETED|First Intervention (1 Week)||1
868087|NCT02258477|2100751|P4|COMPLETED|First Intervention (1 Week)||9
868088|NCT02258477|2100752|P3|COMPLETED|First Intervention (1 Week)||9
868089|NCT02258477|2100753|P2|COMPLETED|First Intervention (1 Week)||8
868090|NCT02258477|2100754|P1|COMPLETED|First Intervention (1 Week)||9
868091|NCT02258477|2100751|P4|STARTED|First Intervention (1 Week)||9
868092|NCT02258477|2100752|P3|STARTED|First Intervention (1 Week)||9
868093|NCT02258477|2100753|P2|STARTED|First Intervention (1 Week)||9
868094|NCT02258477|2100754|P1|STARTED|First Intervention (1 Week)||10
868095|NCT02258412|2100772|P3|NOT COMPLETED|Overall Study||0
868096|NCT02258412|2100773|P2|NOT COMPLETED|Overall Study||0
868097|NCT02258412|2100774|P1|NOT COMPLETED|Overall Study||0
868098|NCT02258412|2100772|P3|COMPLETED|Overall Study||61
868099|NCT02258412|2100773|P2|COMPLETED|Overall Study||25
868100|NCT02258412|2100774|P1|COMPLETED|Overall Study||26
868101|NCT02258412|2100772|P3|STARTED|Overall Study||61
868102|NCT02258412|2100773|P2|STARTED|Overall Study||25
868103|NCT02258412|2100774|P1|STARTED|Overall Study||26
868104|NCT02258334|2100785|P4|NOT COMPLETED|Overall Study||0
868105|NCT02258334|2100786|P3|NOT COMPLETED|Overall Study||0
868106|NCT02258334|2100787|P2|NOT COMPLETED|Overall Study||0
868107|NCT02258334|2100788|P1|NOT COMPLETED|Overall Study||1
868108|NCT02258334|2100785|P4|COMPLETED|Overall Study||52
868109|NCT02258334|2100786|P3|COMPLETED|Overall Study||52
868110|NCT02258334|2100787|P2|COMPLETED|Overall Study||54
868111|NCT02258334|2100788|P1|COMPLETED|Overall Study||49
868112|NCT02258334|2100785|P4|STARTED|Overall Study||52
868113|NCT02258334|2100786|P3|STARTED|Overall Study||52
868114|NCT02258334|2100787|P2|STARTED|Overall Study||54
868115|NCT02258334|2100788|P1|STARTED|Overall Study||50
868116|NCT02257918|2100817|P3|NOT COMPLETED|Overall Study||2
868117|NCT02257918|2100818|P2|NOT COMPLETED|Overall Study||1
868118|NCT02257918|2100819|P1|NOT COMPLETED|Overall Study||4
868119|NCT02257918|2100817|P3|COMPLETED|Overall Study||39
868120|NCT02257918|2100818|P2|COMPLETED|Overall Study||66
868121|NCT02257918|2100819|P1|COMPLETED|Overall Study||68
868122|NCT02257918|2100817|P3|Test of Cure Visit|Overall Study||40
868123|NCT02257918|2100818|P2|Test of Cure Visit|Overall Study||67
868124|NCT02257918|2100819|P1|Test of Cure Visit|Overall Study||72
868125|NCT02257918|2100817|P3|STARTED|Overall Study||41
868126|NCT02257918|2100818|P2|STARTED|Overall Study||67
868127|NCT02257918|2100819|P1|STARTED|Overall Study||72
868128|NCT02257684|2100869|P1|NOT COMPLETED|Overall Study||4
868129|NCT02257684|2100869|P1|COMPLETED|Overall Study||0
868130|NCT02257684|2100869|P1|STARTED|Overall Study||4
868131|NCT02257385|2100879|P2|NOT COMPLETED|Overall Study||22
868132|NCT02257385|2100880|P1|NOT COMPLETED|Overall Study||22
868133|NCT02257385|2100879|P2|COMPLETED|Overall Study||457
868134|NCT02257385|2100880|P1|COMPLETED|Overall Study||460
868135|NCT02257385|2100879|P2|STARTED|Overall Study||479
868136|NCT02257385|2100880|P1|STARTED|Overall Study||482
868137|NCT02257372|2100890|P2|NOT COMPLETED|Overall Study||10
868138|NCT02257372|2100891|P1|NOT COMPLETED|Overall Study||7
868139|NCT02257372|2100890|P2|COMPLETED|Overall Study||109
868140|NCT02257372|2100891|P1|COMPLETED|Overall Study||110
868141|NCT02257372|2100890|P2|STARTED|Overall Study||119
868142|NCT02257372|2100891|P1|STARTED|Overall Study||117
868143|NCT02256982|2100901|P2|NOT COMPLETED|Overall Study||1
868144|NCT02256982|2100902|P1|NOT COMPLETED|Overall Study||0
868145|NCT02256982|2100901|P2|COMPLETED|Overall Study||1
868146|NCT02256982|2100902|P1|COMPLETED|Overall Study||1
868147|NCT02256982|2100901|P2|STARTED|Overall Study||2
868148|NCT02256982|2100902|P1|STARTED|Overall Study||1
868149|NCT02256969|2100911|P3|NOT COMPLETED|Overall Study||1
868150|NCT02256969|2100912|P2|NOT COMPLETED|Overall Study||1
868151|NCT02256969|2100913|P1|NOT COMPLETED|Overall Study||2
868152|NCT02256969|2100911|P3|COMPLETED|Overall Study||14
868153|NCT02256969|2100912|P2|COMPLETED|Overall Study||14
868154|NCT02256969|2100913|P1|COMPLETED|Overall Study||13
868155|NCT02256969|2100911|P3|STARTED|Overall Study||15
868156|NCT02256969|2100912|P2|STARTED|Overall Study||15
868157|NCT02256969|2100913|P1|STARTED|Overall Study||15
868158|NCT02256891|2100932|P2|NOT COMPLETED|Overall Study||13
868159|NCT02256891|2100933|P1|NOT COMPLETED|Overall Study||12
868160|NCT02256891|2100932|P2|COMPLETED|Overall Study||29
868161|NCT02256891|2100933|P1|COMPLETED|Overall Study||43
868162|NCT02256891|2100932|P2|STARTED|Overall Study||42
868163|NCT02256891|2100933|P1|STARTED|Overall Study||55
868164|NCT02256553|2100957|P1|NOT COMPLETED|Period III||3
868165|NCT02256553|2100957|P1|COMPLETED|Period III||91
868166|NCT02256553|2100957|P1|STARTED|Period III||94
868167|NCT02256553|2100957|P1|NOT COMPLETED|Period II||2
868168|NCT02256553|2100957|P1|COMPLETED|Period II||94
868169|NCT02256553|2100957|P1|STARTED|Period II||96
868170|NCT02256553|2100957|P1|NOT COMPLETED|Period I||6
868171|NCT02256553|2100957|P1|COMPLETED|Period I||96
868172|NCT02256553|2100957|P1|STARTED|Period I||102
868173|NCT02256488|2100970|P4|NOT COMPLETED|Overall Study||6
868174|NCT02256488|2100971|P3|NOT COMPLETED|Overall Study||10
868175|NCT02256488|2100972|P2|NOT COMPLETED|Overall Study||6
868176|NCT02256488|2100973|P1|NOT COMPLETED|Overall Study||8
868177|NCT02256488|2100970|P4|COMPLETED|Overall Study||384
868178|NCT02256488|2100971|P3|COMPLETED|Overall Study||382
868179|NCT02256488|2100972|P2|COMPLETED|Overall Study||386
868180|NCT02256488|2100973|P1|COMPLETED|Overall Study||379
868181|NCT02256488|2100970|P4|STARTED|Overall Study||390
868182|NCT02256488|2100971|P3|STARTED|Overall Study||392
868183|NCT02256488|2100972|P2|STARTED|Overall Study||392
868184|NCT02256488|2100973|P1|STARTED|Overall Study||387
868193|NCT02256358|2101028|P2|NOT COMPLETED|Overall Study||1
868194|NCT02256358|2101029|P1|NOT COMPLETED|Overall Study||0
868195|NCT02256358|2101028|P2|COMPLETED|Overall Study||33
868196|NCT02256358|2101029|P1|COMPLETED|Overall Study||34
868197|NCT02256358|2101028|P2|STARTED|Overall Study||34
868198|NCT02256358|2101029|P1|STARTED|Overall Study||34
868199|NCT02256345|2101037|P2|NOT COMPLETED|Overall Study||0
868200|NCT02256345|2101038|P1|NOT COMPLETED|Overall Study||0
868201|NCT02256345|2101037|P2|COMPLETED|Overall Study||3
868202|NCT02256345|2101038|P1|COMPLETED|Overall Study||9
868203|NCT02256345|2101037|P2|STARTED|Overall Study||3
868204|NCT02256345|2101038|P1|STARTED|Overall Study||9
868205|NCT02256072|2101052|P2|NOT COMPLETED|Overall Study||29
868206|NCT02256072|2101053|P1|NOT COMPLETED|Overall Study||42
868207|NCT02256072|2101052|P2|COMPLETED|Overall Study||162
868208|NCT02256072|2101053|P1|COMPLETED|Overall Study|Completed the 3-month follow-up|152
868209|NCT02256072|2101052|P2|Completed 1 Month Follow-Up|Overall Study||179
868210|NCT02256072|2101053|P1|Completed 1 Month Follow-Up|Overall Study|Completed the 1-month follow-up|167
868211|NCT02256072|2101052|P2|STARTED|Overall Study||191
868212|NCT02256072|2101053|P1|STARTED|Overall Study||194
868213|NCT02255565|2101070|P3|NOT COMPLETED|Overall Study||0
868214|NCT02255565|2101071|P2|NOT COMPLETED|Overall Study||1
868215|NCT02255565|2101072|P1|NOT COMPLETED|Overall Study||0
868216|NCT02255565|2101070|P3|COMPLETED|Overall Study||9
868217|NCT02255565|2101071|P2|COMPLETED|Overall Study||8
868218|NCT02255565|2101072|P1|COMPLETED|Overall Study||9
868219|NCT02255565|2101070|P3|STARTED|Overall Study||9
868220|NCT02255565|2101071|P2|STARTED|Overall Study||9
868221|NCT02255565|2101072|P1|STARTED|Overall Study||9
868222|NCT02255279|2101133|P2|NOT COMPLETED|Overall Study||9
868223|NCT02255279|2101134|P1|NOT COMPLETED|Overall Study||5
868224|NCT02255279|2101133|P2|COMPLETED|Overall Study||134
868225|NCT02255279|2101134|P1|COMPLETED|Overall Study||139
868226|NCT02255279|2101133|P2|STARTED|Overall Study||143
868227|NCT02255279|2101134|P1|STARTED|Overall Study||144
868228|NCT02255149|2101160|P1|NOT COMPLETED|Overall Study||5
868229|NCT02255149|2101160|P1|COMPLETED|Overall Study||5
868230|NCT02255149|2101160|P1|STARTED|Overall Study||10
868235|NCT02254772|2101185|P1|NOT COMPLETED|Overall Study||2
868236|NCT02254772|2101185|P1|COMPLETED|Overall Study||7
868237|NCT02254772|2101185|P1|STARTED|Overall Study||9
868238|NCT02254551|2101191|P1|NOT COMPLETED|Maintenance||0
868239|NCT02254551|2101191|P1|COMPLETED|Maintenance||0
868240|NCT02254551|2101191|P1|STARTED|Maintenance||0
868241|NCT02254551|2101191|P1|NOT COMPLETED|Expansion||0
868242|NCT02254551|2101191|P1|COMPLETED|Expansion||0
868243|NCT02254551|2101191|P1|STARTED|Expansion||0
868244|NCT02254551|2101191|P1|NOT COMPLETED|Dose Escalation||3
868245|NCT02254551|2101191|P1|COMPLETED|Dose Escalation|Due to toxicity and lack of efficacy, no other dose levels were examined.|4
868246|NCT02254551|2101191|P1|Cohort 3: LDE225 800mg|Dose Escalation||0
868247|NCT02254551|2101191|P1|Cohort 2: LDE225 600mg|Dose Escalation||0
868248|NCT02254551|2101191|P1|Cohort 1: LDE225 400mg|Dose Escalation|1 patient was found to be refractory to bortezomib and deemed ineligible.|7
868249|NCT02254551|2101191|P1|STARTED|Dose Escalation||7
868250|NCT02254486|2101201|P2|NOT COMPLETED|Overall Study||55
868251|NCT02254486|2101202|P1|NOT COMPLETED|Overall Study||50
868252|NCT02254486|2101201|P2|COMPLETED|Overall Study||255
868253|NCT02254486|2101202|P1|COMPLETED|Overall Study||261
868254|NCT02254486|2101201|P2|STARTED|Overall Study||310
868255|NCT02254486|2101202|P1|STARTED|Overall Study||311
868256|NCT02254460|2101218|P2|NOT COMPLETED|Overall Study||0
868257|NCT02254460|2101219|P1|NOT COMPLETED|Overall Study||1
868258|NCT02254460|2101218|P2|COMPLETED|Overall Study||12
868259|NCT02254460|2101219|P1|COMPLETED|Overall Study||12
868260|NCT02254460|2101218|P2|STARTED|Overall Study||12
868261|NCT02254460|2101219|P1|STARTED|Overall Study||13
868262|NCT02254252|2101227|P2|NOT COMPLETED|Overall Study||2
868263|NCT02254252|2101228|P1|NOT COMPLETED|Overall Study||3
868264|NCT02254252|2101227|P2|COMPLETED|Overall Study||25
868265|NCT02254252|2101228|P1|COMPLETED|Overall Study||24
868266|NCT02254252|2101227|P2|STARTED|Overall Study||27
868267|NCT02254252|2101228|P1|STARTED|Overall Study||27
868268|NCT02253654|2101240|P2|NOT COMPLETED|Overall Study||18
868269|NCT02253654|2101241|P1|NOT COMPLETED|Overall Study||23
868270|NCT02253654|2101240|P2|COMPLETED|Overall Study||90
868271|NCT02253654|2101241|P1|COMPLETED|Overall Study||85
868272|NCT02253654|2101240|P2|Received Treatment|Overall Study||107
868273|NCT02253654|2101241|P1|Received Treatment|Overall Study||104
868274|NCT02253654|2101240|P2|STARTED|Overall Study||108
868275|NCT02253654|2101241|P1|STARTED|Overall Study||108
868276|NCT02253173|2101265|P4|NOT COMPLETED|Overall Study||14
868277|NCT02253173|2101266|P3|NOT COMPLETED|Overall Study||13
868278|NCT02253173|2101267|P2|NOT COMPLETED|Overall Study||17
868279|NCT02253173|2101268|P1|NOT COMPLETED|Overall Study||16
868280|NCT02253173|2101265|P4|COMPLETED|Overall Study||178
868281|NCT02253173|2101266|P3|COMPLETED|Overall Study||177
868282|NCT02253173|2101267|P2|COMPLETED|Overall Study||174
868283|NCT02253173|2101268|P1|COMPLETED|Overall Study||175
868284|NCT02253173|2101265|P4|STARTED|Overall Study||192
868285|NCT02253173|2101266|P3|STARTED|Overall Study||190
868286|NCT02253173|2101267|P2|STARTED|Overall Study||191
868287|NCT02253173|2101268|P1|STARTED|Overall Study||191
868288|NCT02253160|2101465|P3|NOT COMPLETED|Overall Study||0
868289|NCT02253160|2101466|P2|NOT COMPLETED|Overall Study||0
868290|NCT02253160|2101467|P1|NOT COMPLETED|Overall Study||0
868291|NCT02253160|2101465|P3|COMPLETED|Overall Study||10
868292|NCT02253160|2101466|P2|COMPLETED|Overall Study||12
868293|NCT02253160|2101467|P1|COMPLETED|Overall Study||1
868294|NCT02253160|2101465|P3|STARTED|Overall Study||10
868295|NCT02253160|2101466|P2|STARTED|Overall Study||12
868296|NCT02253160|2101467|P1|STARTED|Overall Study||1
868297|NCT02252016|2101505|P2|NOT COMPLETED|Overall Study||3
868298|NCT02252016|2101506|P1|NOT COMPLETED|Overall Study||3
868299|NCT02252016|2101505|P2|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|49
868300|NCT02252016|2101506|P1|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|104
868301|NCT02252016|2101505|P2|STARTED|Overall Study||52
868302|NCT02252016|2101506|P1|STARTED|Overall Study||107
868303|NCT02252965|2101520|P2|NOT COMPLETED|Overall Study||43
868304|NCT02252965|2101521|P1|NOT COMPLETED|Overall Study||40
868305|NCT02252965|2101520|P2|COMPLETED|Overall Study||222
868306|NCT02252965|2101521|P1|COMPLETED|Overall Study||227
868307|NCT02252965|2101520|P2|Safety Population|Overall Study||264
868308|NCT02252965|2101521|P1|Safety Population|Overall Study|Out of 261, 12 subjects intolerant to the Metformin IR switched to Metformin XR group.|261
868309|NCT02252965|2101520|P2|STARTED|Overall Study||265
868310|NCT02252965|2101521|P1|STARTED|Overall Study||267
868311|NCT02252744|2101548|P1|NOT COMPLETED|Overall Study||0
868312|NCT02252744|2101548|P1|COMPLETED|Overall Study||286
868313|NCT02252744|2101548|P1|STARTED|Overall Study||286
868314|NCT02252718|2101552|P1|NOT COMPLETED|Overall Study||0
868315|NCT02252718|2101552|P1|COMPLETED|Overall Study||100
868316|NCT02252718|2101552|P1|STARTED|Overall Study||100
868317|NCT02252445|2101558|P2|NOT COMPLETED|Overall Study||0
868318|NCT02252445|2101559|P1|NOT COMPLETED|Overall Study||0
868319|NCT02252445|2101558|P2|COMPLETED|Overall Study||41
868320|NCT02252445|2101559|P1|COMPLETED|Overall Study||41
868321|NCT02252445|2101558|P2|STARTED|Overall Study||41
868322|NCT02252445|2101559|P1|STARTED|Overall Study||41
868323|NCT02252354|2101585|P2|NOT COMPLETED|Overall Study||0
868324|NCT02252354|2101586|P1|NOT COMPLETED|Overall Study||0
868325|NCT02252354|2101585|P2|COMPLETED|Overall Study||6
868326|NCT02252354|2101586|P1|COMPLETED|Overall Study||6
868327|NCT02252354|2101585|P2|STARTED|Overall Study||6
868328|NCT02252354|2101586|P1|STARTED|Overall Study||6
868329|NCT02252133|2101631|P2|NOT COMPLETED|Period 2||0
868330|NCT02252133|2101632|P1|NOT COMPLETED|Period 2||0
868331|NCT02252133|2101631|P2|COMPLETED|Period 2||24
868332|NCT02252133|2101632|P1|COMPLETED|Period 2||23
868333|NCT02252133|2101631|P2|STARTED|Period 2||24
868334|NCT02252133|2101632|P1|STARTED|Period 2||23
868335|NCT02252133|2101631|P2|NOT COMPLETED|Period 1||0
868336|NCT02252133|2101632|P1|NOT COMPLETED|Period 1||0
868337|NCT02252133|2101631|P2|COMPLETED|Period 1||24
868338|NCT02252133|2101632|P1|COMPLETED|Period 1||23
868339|NCT02252133|2101631|P2|STARTED|Period 1||24
868340|NCT02252133|2101632|P1|STARTED|Period 1||23
868341|NCT02251912|2101640|P2|NOT COMPLETED|Overall Study||5
868342|NCT02251912|2101641|P1|NOT COMPLETED|Overall Study||2
868343|NCT02251912|2101640|P2|COMPLETED|Overall Study||5
868344|NCT02251912|2101641|P1|COMPLETED|Overall Study||10
868345|NCT02251912|2101640|P2|STARTED|Overall Study||10
868346|NCT02251912|2101641|P1|STARTED|Overall Study||12
868347|NCT02251886|2101655|P4|NOT COMPLETED|Overall Study||0
868348|NCT02251886|2101656|P3|NOT COMPLETED|Overall Study||0
868349|NCT02251886|2101657|P2|NOT COMPLETED|Overall Study||0
868350|NCT02251886|2101658|P1|NOT COMPLETED|Overall Study||0
868351|NCT02251886|2101655|P4|COMPLETED|Overall Study||54
868352|NCT02251886|2101656|P3|COMPLETED|Overall Study||44
868353|NCT02251886|2101657|P2|COMPLETED|Overall Study||54
868354|NCT02251886|2101658|P1|COMPLETED|Overall Study||48
868355|NCT02251886|2101655|P4|STARTED|Overall Study||54
868356|NCT02251886|2101656|P3|STARTED|Overall Study||44
868357|NCT02251886|2101657|P2|STARTED|Overall Study||54
868358|NCT02251886|2101658|P1|STARTED|Overall Study||48
868359|NCT02251652|2101668|P1|NOT COMPLETED|Overall Study||1
868360|NCT02251652|2101668|P1|COMPLETED|Overall Study||16
868361|NCT02251652|2101668|P1|STARTED|Overall Study||17
868362|NCT02251613|2101678|P1|NOT COMPLETED|Overall Study||0
868363|NCT02251613|2101678|P1|COMPLETED|Overall Study||50
868364|NCT02251613|2101678|P1|STARTED|Overall Study||50
868365|NCT02251561|2101686|P1|NOT COMPLETED|Overall Study||0
868366|NCT02251561|2101686|P1|COMPLETED|Overall Study||28
868367|NCT02251561|2101686|P1|STARTED|Overall Study||28
868368|NCT02250807|2101694|P1|NOT COMPLETED|Overall Study||0
868369|NCT02250807|2101694|P1|COMPLETED|Overall Study||40
868370|NCT02250807|2101694|P1|STARTED|Overall Study||40
868371|NCT02250703|2101706|P2|NOT COMPLETED|Overall Study||1
868372|NCT02250703|2101707|P1|NOT COMPLETED|Overall Study||1
868373|NCT02250703|2101706|P2|COMPLETED|Overall Study||36
868374|NCT02250703|2101707|P1|COMPLETED|Overall Study||37
868375|NCT02250703|2101706|P2|STARTED|Overall Study||37
868376|NCT02250703|2101707|P1|STARTED|Overall Study||38
868377|NCT02250274|2101721|P2|NOT COMPLETED|Overall Study||6
868378|NCT02250274|2101722|P1|NOT COMPLETED|Overall Study||7
868379|NCT02250274|2101721|P2|COMPLETED|Overall Study||40
868380|NCT02250274|2101722|P1|COMPLETED|Overall Study||78
868381|NCT02250274|2101721|P2|STARTED|Overall Study||46
868382|NCT02250274|2101722|P1|STARTED|Overall Study||85
868383|NCT02249728|2101732|P1|NOT COMPLETED|Part Two (up to 6 Days)||0
868384|NCT02249728|2101732|P1|COMPLETED|Part Two (up to 6 Days)||6
868385|NCT02249728|2101732|P1|STARTED|Part Two (up to 6 Days)||6
868386|NCT02249728|2101732|P1|NOT COMPLETED|Part One (4 Days)||0
868387|NCT02249728|2101732|P1|COMPLETED|Part One (4 Days)||6
868388|NCT02249728|2101732|P1|STARTED|Part One (4 Days)||6
868389|NCT02249104|2101742|P1|NOT COMPLETED|Overall Study||3
868390|NCT02249104|2101742|P1|COMPLETED|Overall Study||25
868391|NCT02249104|2101742|P1|STARTED|Overall Study||28
868392|NCT02249052|2101751|P1|NOT COMPLETED|Overall Study||0
868393|NCT02249052|2101751|P1|COMPLETED|Overall Study||19
868394|NCT02249052|2101751|P1|STARTED|Overall Study||19
868395|NCT02248818|2101775|P9|NOT COMPLETED|Randomised Study||0
868396|NCT02248818|2101776|P8|NOT COMPLETED|Randomised Study||0
868397|NCT02248818|2101777|P7|NOT COMPLETED|Randomised Study||0
868398|NCT02248818|2101778|P6|NOT COMPLETED|Randomised Study||8
868399|NCT02248818|2101779|P5|NOT COMPLETED|Randomised Study||0
868400|NCT02248818|2101780|P4|NOT COMPLETED|Randomised Study||0
868401|NCT02248818|2101781|P3|NOT COMPLETED|Randomised Study||0
868402|NCT02248818|2101782|P2|NOT COMPLETED|Randomised Study||0
868403|NCT02248818|2101783|P1|NOT COMPLETED|Randomised Study||0
868404|NCT02248818|2101775|P9|COMPLETED|Randomised Study||0
868405|NCT02248818|2101776|P8|COMPLETED|Randomised Study||4
868406|NCT02248818|2101777|P7|COMPLETED|Randomised Study||6
868407|NCT02248818|2101778|P6|COMPLETED|Randomised Study||0
868408|NCT02248818|2101779|P5|COMPLETED|Randomised Study||6
868409|NCT02248818|2101780|P4|COMPLETED|Randomised Study||6
868410|NCT02248818|2101781|P3|COMPLETED|Randomised Study||6
868411|NCT02248818|2101782|P2|COMPLETED|Randomised Study||6
868412|NCT02248818|2101783|P1|COMPLETED|Randomised Study||6
868413|NCT02248818|2101775|P9|STARTED|Randomised Study||0
868414|NCT02248818|2101776|P8|STARTED|Randomised Study||4
868415|NCT02248818|2101777|P7|STARTED|Randomised Study||6
868416|NCT02248818|2101778|P6|STARTED|Randomised Study||8
868417|NCT02248818|2101779|P5|STARTED|Randomised Study||6
868418|NCT02248818|2101780|P4|STARTED|Randomised Study||6
868419|NCT02248818|2101781|P3|STARTED|Randomised Study||6
868420|NCT02248818|2101782|P2|STARTED|Randomised Study||6
868421|NCT02248818|2101783|P1|STARTED|Randomised Study||6
868422|NCT02248818|2101775|P9|NOT COMPLETED|Screening||107
868423|NCT02248818|2101776|P8|NOT COMPLETED|Screening||0
868424|NCT02248818|2101777|P7|NOT COMPLETED|Screening||0
868425|NCT02248818|2101778|P6|NOT COMPLETED|Screening||0
868426|NCT02248818|2101779|P5|NOT COMPLETED|Screening||0
868427|NCT02248818|2101780|P4|NOT COMPLETED|Screening||0
868428|NCT02248818|2101781|P3|NOT COMPLETED|Screening||0
868429|NCT02248818|2101782|P2|NOT COMPLETED|Screening||0
868430|NCT02248818|2101783|P1|NOT COMPLETED|Screening||0
868431|NCT02248818|2101775|P9|COMPLETED|Screening||48
868432|NCT02248818|2101776|P8|COMPLETED|Screening||0
868433|NCT02248818|2101777|P7|COMPLETED|Screening||0
868434|NCT02248818|2101778|P6|COMPLETED|Screening||0
868435|NCT02248818|2101779|P5|COMPLETED|Screening||0
868436|NCT02248818|2101780|P4|COMPLETED|Screening||0
868437|NCT02248818|2101781|P3|COMPLETED|Screening||0
868438|NCT02248818|2101782|P2|COMPLETED|Screening||0
868439|NCT02248818|2101783|P1|COMPLETED|Screening||0
868440|NCT02248818|2101775|P9|STARTED|Screening||155
868441|NCT02248818|2101776|P8|STARTED|Screening||0
868442|NCT02248818|2101777|P7|STARTED|Screening||0
868443|NCT02248818|2101778|P6|STARTED|Screening||0
868444|NCT02248818|2101779|P5|STARTED|Screening||0
868445|NCT02248818|2101780|P4|STARTED|Screening||0
868446|NCT02248818|2101781|P3|STARTED|Screening||0
868447|NCT02248818|2101782|P2|STARTED|Screening||0
868448|NCT02248818|2101783|P1|STARTED|Screening||0
868449|NCT02248766|2101921|P1|NOT COMPLETED|Overall Study||0
868450|NCT02248766|2101921|P1|COMPLETED|Overall Study||30
868451|NCT02248766|2101921|P1|STARTED|Overall Study||30
868452|NCT02248727|2101933|P1|NOT COMPLETED|Overall Study||0
868453|NCT02248727|2101933|P1|COMPLETED|Overall Study||30
868454|NCT02248727|2101933|P1|STARTED|Overall Study||30
868455|NCT02248675|2101946|P2|NOT COMPLETED|Overall Study||1
868456|NCT02248675|2101947|P1|NOT COMPLETED|Overall Study||3
868457|NCT02248675|2101946|P2|COMPLETED|Overall Study||27
868458|NCT02248675|2101947|P1|COMPLETED|Overall Study||23
868459|NCT02248675|2101946|P2|STARTED|Overall Study||28
868460|NCT02248675|2101947|P1|STARTED|Overall Study||26
868461|NCT02248558|2101961|P2|NOT COMPLETED|Overall Study||45
868462|NCT02248558|2101962|P1|NOT COMPLETED|Overall Study||52
868463|NCT02248558|2101961|P2|COMPLETED|Overall Study||307
868464|NCT02248558|2101962|P1|COMPLETED|Overall Study||317
868465|NCT02248558|2101961|P2|STARTED|Overall Study||352
868466|NCT02248558|2101962|P1|STARTED|Overall Study||369
868467|NCT02248480|2101974|P2|NOT COMPLETED|Overall Study||14
868468|NCT02248480|2101975|P1|NOT COMPLETED|Overall Study||17
868469|NCT02248480|2101974|P2|COMPLETED|Overall Study||162
868470|NCT02248480|2101975|P1|COMPLETED|Overall Study||161
868471|NCT02248480|2101974|P2|Efficacy Population|Overall Study||176
868472|NCT02248480|2101975|P1|Efficacy Population|Overall Study||177
868473|NCT02248480|2101974|P2|STARTED|Overall Study||176
868474|NCT02248480|2101975|P1|STARTED|Overall Study||178
868475|NCT02248246|2102013|P1|NOT COMPLETED|Overall Study||0
868476|NCT02248246|2102013|P1|COMPLETED|Overall Study||40
868477|NCT02248246|2102013|P1|STARTED|Overall Study||40
868478|NCT02248103|2102020|P2|NOT COMPLETED|Overall Study||0
868479|NCT02248103|2102021|P1|NOT COMPLETED|Overall Study||0
868480|NCT02248103|2102020|P2|COMPLETED|Overall Study||10
868481|NCT02248103|2102021|P1|COMPLETED|Overall Study||10
868482|NCT02248103|2102020|P2|STARTED|Overall Study||10
868483|NCT02248103|2102021|P1|STARTED|Overall Study||10
868484|NCT02247960|2102033|P2|NOT COMPLETED|Catheter Removed||10
868485|NCT02247960|2102034|P1|NOT COMPLETED|Catheter Removed||7
868486|NCT02247960|2102033|P2|COMPLETED|Catheter Removed||74
868487|NCT02247960|2102034|P1|COMPLETED|Catheter Removed||76
868488|NCT02247960|2102033|P2|STARTED|Catheter Removed||84
868489|NCT02247960|2102034|P1|STARTED|Catheter Removed||83
868490|NCT02247960|2102033|P2|NOT COMPLETED|Patient Consent and Randomization||6
868491|NCT02247960|2102034|P1|NOT COMPLETED|Patient Consent and Randomization||2
868492|NCT02247960|2102033|P2|COMPLETED|Patient Consent and Randomization||84
868493|NCT02247960|2102034|P1|COMPLETED|Patient Consent and Randomization||83
868494|NCT02247960|2102033|P2|STARTED|Patient Consent and Randomization||90
868495|NCT02247960|2102034|P1|STARTED|Patient Consent and Randomization||85
868496|NCT02247765|2102044|P1|NOT COMPLETED|Overall Study||0
868497|NCT02247765|2102044|P1|COMPLETED|Overall Study||18
868498|NCT02247765|2102044|P1|STARTED|Overall Study||18
868499|NCT02247401|2102052|P3|NOT COMPLETED|Overall Study||2
868500|NCT02247401|2102053|P2|NOT COMPLETED|Overall Study||2
868501|NCT02247401|2102054|P1|NOT COMPLETED|Overall Study||6
868502|NCT02247401|2102052|P3|COMPLETED|Overall Study||27
868503|NCT02247401|2102053|P2|COMPLETED|Overall Study||29
868504|NCT02247401|2102054|P1|COMPLETED|Overall Study||94
868505|NCT02247401|2102052|P3|STARTED|Overall Study||29
868506|NCT02247401|2102053|P2|STARTED|Overall Study||31
868507|NCT02247401|2102054|P1|STARTED|Overall Study||100
868508|NCT02247011|2102073|P1|NOT COMPLETED|Overall Study||125
868509|NCT02247011|2102073|P1|COMPLETED|Overall Study||975
868510|NCT02247011|2102073|P1|STARTED|Overall Study||1100
868511|NCT02246673|2102095|P5|NOT COMPLETED|Overall Study||1
868512|NCT02246673|2102096|P4|NOT COMPLETED|Overall Study||2
868513|NCT02246673|2102097|P3|NOT COMPLETED|Overall Study||0
868514|NCT02246673|2102098|P2|NOT COMPLETED|Overall Study||0
868515|NCT02246673|2102099|P1|NOT COMPLETED|Overall Study||1
868516|NCT02246673|2102095|P5|COMPLETED|Overall Study||11
868517|NCT02246673|2102096|P4|COMPLETED|Overall Study||12
868518|NCT02246673|2102097|P3|COMPLETED|Overall Study||12
868519|NCT02246673|2102098|P2|COMPLETED|Overall Study||12
868520|NCT02246673|2102099|P1|COMPLETED|Overall Study||13
868521|NCT02246673|2102095|P5|STARTED|Overall Study||12
868522|NCT02246673|2102096|P4|STARTED|Overall Study||14
868523|NCT02246673|2102097|P3|STARTED|Overall Study||12
868524|NCT02246673|2102098|P2|STARTED|Overall Study||12
868525|NCT02246673|2102099|P1|STARTED|Overall Study||14
868526|NCT02246582|2102204|P2|NOT COMPLETED|Overall Study||4
868527|NCT02246582|2102205|P1|NOT COMPLETED|Overall Study||3
868528|NCT02246582|2102204|P2|COMPLETED|Overall Study||41
868529|NCT02246582|2102205|P1|COMPLETED|Overall Study||41
868530|NCT02246582|2102204|P2|STARTED|Overall Study||45
868531|NCT02246582|2102205|P1|STARTED|Overall Study||44
868532|NCT02246166|2102213|P2|NOT COMPLETED|Overall Study||0
868533|NCT02246166|2102214|P1|NOT COMPLETED|Overall Study||1
868534|NCT02246166|2102213|P2|COMPLETED|Overall Study||27
868535|NCT02246166|2102214|P1|COMPLETED|Overall Study||25
868536|NCT02246166|2102213|P2|STARTED|Overall Study||27
868537|NCT02246166|2102214|P1|STARTED|Overall Study||26
868538|NCT02246114|2102250|P2|NOT COMPLETED|Overall Study||0
868539|NCT02246114|2102251|P1|NOT COMPLETED|Overall Study||1
868540|NCT02246114|2102250|P2|COMPLETED|Overall Study||0
868541|NCT02246114|2102251|P1|COMPLETED|Overall Study||0
868542|NCT02246114|2102250|P2|STARTED|Overall Study||0
868543|NCT02246114|2102251|P1|STARTED|Overall Study||1
868544|NCT02246062|2102261|P4|NOT COMPLETED|Overall Study||0
868545|NCT02246062|2102262|P3|NOT COMPLETED|Overall Study||0
868546|NCT02246062|2102263|P2|NOT COMPLETED|Overall Study||0
868547|NCT02246062|2102264|P1|NOT COMPLETED|Overall Study||0
868548|NCT02246062|2102261|P4|COMPLETED|Overall Study||21
868549|NCT02246062|2102262|P3|COMPLETED|Overall Study||21
868550|NCT02246062|2102263|P2|COMPLETED|Overall Study||21
868551|NCT02246062|2102264|P1|COMPLETED|Overall Study||21
868552|NCT02246062|2102261|P4|STARTED|Overall Study||21
868553|NCT02246062|2102262|P3|STARTED|Overall Study||21
868554|NCT02246062|2102263|P2|STARTED|Overall Study||21
868555|NCT02246062|2102264|P1|STARTED|Overall Study||21
868556|NCT02245412|2102285|P3|NOT COMPLETED|Overall Study||0
868557|NCT02245412|2102286|P2|NOT COMPLETED|Overall Study||3
868558|NCT02245412|2102287|P1|NOT COMPLETED|Overall Study||5
868559|NCT02245412|2102285|P3|COMPLETED|Overall Study||2
868560|NCT02245412|2102286|P2|COMPLETED|Overall Study||3
868561|NCT02245412|2102287|P1|COMPLETED|Overall Study||12
868562|NCT02245412|2102285|P3|STARTED|Overall Study||2
868563|NCT02245412|2102286|P2|STARTED|Overall Study||6
868564|NCT02245412|2102287|P1|STARTED|Overall Study||17
868565|NCT02245360|2102297|P2|NOT COMPLETED|Overall Study||2
868566|NCT02245360|2102298|P1|NOT COMPLETED|Overall Study||5
868567|NCT02245360|2102297|P2|COMPLETED|Overall Study||52
868568|NCT02245360|2102298|P1|COMPLETED|Overall Study||48
868569|NCT02245360|2102297|P2|STARTED|Overall Study||54
868570|NCT02245360|2102298|P1|STARTED|Overall Study||53
868571|NCT02244840|2102306|P1|NOT COMPLETED|Overall Study||0
868572|NCT02244840|2102306|P1|COMPLETED|Overall Study||40
868573|NCT02244840|2102306|P1|STARTED|Overall Study||40
868574|NCT02244619|2102312|P2|NOT COMPLETED|Overall Study||21
868575|NCT02244619|2102313|P1|NOT COMPLETED|Overall Study||8
868576|NCT02244619|2102312|P2|COMPLETED|Overall Study||245
868577|NCT02244619|2102313|P1|COMPLETED|Overall Study||241
868578|NCT02244619|2102312|P2|STARTED|Overall Study||266
868579|NCT02244619|2102313|P1|STARTED|Overall Study||249
868580|NCT02244580|2102331|P1|NOT COMPLETED|Overall Study||241
868581|NCT02244580|2102331|P1|COMPLETED|Overall Study|An RT-qPCR assay was performed from breast cancer tissues of 769 out of the 1010 patients.|769
868582|NCT02244580|2102331|P1|STARTED|Overall Study||1010
868583|NCT02243943|2102341|P2|NOT COMPLETED|Overall Study||0
868584|NCT02243943|2102342|P1|NOT COMPLETED|Overall Study||0
868585|NCT02243943|2102341|P2|COMPLETED|Overall Study||50
868586|NCT02243943|2102342|P1|COMPLETED|Overall Study||50
868587|NCT02243943|2102341|P2|STARTED|Overall Study||50
868588|NCT02243943|2102342|P1|STARTED|Overall Study||50
868589|NCT02243293|2102369|P22|NOT COMPLETED|Overall Study||3
868590|NCT02243293|2102370|P21|NOT COMPLETED|Overall Study||2
868591|NCT02243293|2102371|P20|NOT COMPLETED|Overall Study||1
868592|NCT02243293|2102372|P19|NOT COMPLETED|Overall Study||0
868593|NCT02243293|2102373|P18|NOT COMPLETED|Overall Study||1
868594|NCT02243293|2102374|P17|NOT COMPLETED|Overall Study||3
868595|NCT02243293|2102375|P16|NOT COMPLETED|Overall Study||1
868596|NCT02243293|2102376|P15|NOT COMPLETED|Overall Study||1
868597|NCT02243293|2102377|P14|NOT COMPLETED|Overall Study||0
868598|NCT02243293|2102378|P13|NOT COMPLETED|Overall Study||0
868599|NCT02243293|2102379|P12|NOT COMPLETED|Overall Study||3
868600|NCT02243293|2102380|P11|NOT COMPLETED|Overall Study||0
868601|NCT02243293|2102381|P10|NOT COMPLETED|Overall Study||2
868602|NCT02243293|2102382|P9|NOT COMPLETED|Overall Study||0
868603|NCT02243293|2102383|P8|NOT COMPLETED|Overall Study||0
868604|NCT02243293|2102384|P7|NOT COMPLETED|Overall Study||3
868605|NCT02243293|2102385|P6|NOT COMPLETED|Overall Study||0
868606|NCT02243293|2102386|P5|NOT COMPLETED|Overall Study||1
868607|NCT02243293|2102387|P4|NOT COMPLETED|Overall Study||1
868608|NCT02243293|2102388|P3|NOT COMPLETED|Overall Study||1
868609|NCT02243293|2102389|P2|NOT COMPLETED|Overall Study||1
868610|NCT02243293|2102390|P1|NOT COMPLETED|Overall Study||2
868611|NCT02243293|2102369|P22|COMPLETED|Overall Study||55
868612|NCT02243293|2102370|P21|COMPLETED|Overall Study||143
868613|NCT02243293|2102371|P20|COMPLETED|Overall Study||47
868614|NCT02243293|2102372|P19|COMPLETED|Overall Study||22
868615|NCT02243293|2102373|P18|COMPLETED|Overall Study||21
868616|NCT02243293|2102374|P17|COMPLETED|Overall Study||37
868617|NCT02243293|2102375|P16|COMPLETED|Overall Study||26
868618|NCT02243293|2102376|P15|COMPLETED|Overall Study||27
868619|NCT02243293|2102377|P14|COMPLETED|Overall Study||0
868620|NCT02243293|2102378|P13|COMPLETED|Overall Study||0
868621|NCT02243293|2102379|P12|COMPLETED|Overall Study||50
868622|NCT02243293|2102380|P11|COMPLETED|Overall Study||0
868623|NCT02243293|2102381|P10|COMPLETED|Overall Study||53
868624|NCT02243293|2102382|P9|COMPLETED|Overall Study||0
868625|NCT02243293|2102383|P8|COMPLETED|Overall Study||0
868626|NCT02243293|2102384|P7|COMPLETED|Overall Study||27
868627|NCT02243293|2102385|P6|COMPLETED|Overall Study||31
868628|NCT02243293|2102386|P5|COMPLETED|Overall Study||30
868629|NCT02243293|2102387|P4|COMPLETED|Overall Study||29
868630|NCT02243293|2102388|P3|COMPLETED|Overall Study||24
868631|NCT02243293|2102389|P2|COMPLETED|Overall Study||23
868632|NCT02243293|2102390|P1|COMPLETED|Overall Study||23
868633|NCT02243293|2102369|P22|STARTED|Overall Study||58
868634|NCT02243293|2102370|P21|STARTED|Overall Study||145
868635|NCT02243293|2102371|P20|STARTED|Overall Study||48
868636|NCT02243293|2102372|P19|STARTED|Overall Study||22
868637|NCT02243293|2102373|P18|STARTED|Overall Study||22
868638|NCT02243293|2102374|P17|STARTED|Overall Study||40
868639|NCT02243293|2102375|P16|STARTED|Overall Study||27
868640|NCT02243293|2102376|P15|STARTED|Overall Study||28
868641|NCT02243293|2102377|P14|STARTED|Overall Study||0
868642|NCT02243293|2102378|P13|STARTED|Overall Study||0
868643|NCT02243293|2102379|P12|STARTED|Overall Study||53
868644|NCT02243293|2102380|P11|STARTED|Overall Study||0
868645|NCT02243293|2102381|P10|STARTED|Overall Study||55
868646|NCT02243293|2102382|P9|STARTED|Overall Study||0
868647|NCT02243293|2102383|P8|STARTED|Overall Study||0
868648|NCT02243293|2102384|P7|STARTED|Overall Study||30
868649|NCT02243293|2102385|P6|STARTED|Overall Study||31
868650|NCT02243293|2102386|P5|STARTED|Overall Study||31
868651|NCT02243293|2102387|P4|STARTED|Overall Study||30
868652|NCT02243293|2102388|P3|STARTED|Overall Study||25
868653|NCT02243293|2102389|P2|STARTED|Overall Study||24
868654|NCT02243293|2102390|P1|STARTED|Overall Study||25
868655|NCT02243280|2102489|P11|NOT COMPLETED|Treated||3
868656|NCT02243280|2102490|P10|NOT COMPLETED|Treated||0
868657|NCT02243280|2102491|P9|NOT COMPLETED|Treated||1
868658|NCT02243280|2102492|P8|NOT COMPLETED|Treated||0
868659|NCT02243280|2102493|P7|NOT COMPLETED|Treated||0
868660|NCT02243280|2102494|P6|NOT COMPLETED|Treated||0
868661|NCT02243280|2102495|P5|NOT COMPLETED|Treated||0
868662|NCT02243280|2102496|P4|NOT COMPLETED|Treated||0
868663|NCT02243280|2102497|P3|NOT COMPLETED|Treated||0
868664|NCT02243280|2102498|P2|NOT COMPLETED|Treated||0
868665|NCT02243280|2102499|P1|NOT COMPLETED|Treated||1
868666|NCT02243280|2102489|P11|COMPLETED|Treated||31
868667|NCT02243280|2102490|P10|COMPLETED|Treated||0
868668|NCT02243280|2102491|P9|COMPLETED|Treated||31
868669|NCT02243280|2102492|P8|COMPLETED|Treated||0
868670|NCT02243280|2102493|P7|COMPLETED|Treated||0
868671|NCT02243280|2102494|P6|COMPLETED|Treated||27
868672|NCT02243280|2102495|P5|COMPLETED|Treated||0
868673|NCT02243280|2102496|P4|COMPLETED|Treated||0
868674|NCT02243280|2102497|P3|COMPLETED|Treated||0
868675|NCT02243280|2102498|P2|COMPLETED|Treated||39
868676|NCT02243280|2102499|P1|COMPLETED|Treated||41
868677|NCT02243280|2102489|P11|Completed Treatment|Treated||33
868678|NCT02243280|2102490|P10|Completed Treatment|Treated||0
868679|NCT02243280|2102491|P9|Completed Treatment|Treated||32
868680|NCT02243280|2102492|P8|Completed Treatment|Treated||0
868681|NCT02243280|2102493|P7|Completed Treatment|Treated||0
868682|NCT02243280|2102494|P6|Completed Treatment|Treated||27
868683|NCT02243280|2102495|P5|Completed Treatment|Treated||0
868684|NCT02243280|2102496|P4|Completed Treatment|Treated||0
868685|NCT02243280|2102497|P3|Completed Treatment|Treated||0
868686|NCT02243280|2102498|P2|Completed Treatment|Treated||38
868687|NCT02243280|2102499|P1|Completed Treatment|Treated||42
868688|NCT02243280|2102489|P11|STARTED|Treated||34
868689|NCT02243280|2102490|P10|STARTED|Treated||0
868690|NCT02243280|2102491|P9|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|32
868691|NCT02243280|2102492|P8|STARTED|Treated||0
868692|NCT02243280|2102493|P7|STARTED|Treated||0
868693|NCT02243280|2102494|P6|STARTED|Treated||27
868694|NCT02243280|2102495|P5|STARTED|Treated||0
868695|NCT02243280|2102496|P4|STARTED|Treated||0
868696|NCT02243280|2102497|P3|STARTED|Treated||0
868697|NCT02243280|2102498|P2|STARTED|Treated||39
868698|NCT02243280|2102499|P1|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|42
868699|NCT02243280|2102489|P11|NOT COMPLETED|Enrolled||0
868700|NCT02243280|2102490|P10|NOT COMPLETED|Enrolled||0
868701|NCT02243280|2102491|P9|NOT COMPLETED|Enrolled||0
868702|NCT02243280|2102492|P8|NOT COMPLETED|Enrolled||0
868703|NCT02243280|2102493|P7|NOT COMPLETED|Enrolled||0
868704|NCT02243280|2102494|P6|NOT COMPLETED|Enrolled||0
868705|NCT02243280|2102495|P5|NOT COMPLETED|Enrolled||0
868706|NCT02243280|2102496|P4|NOT COMPLETED|Enrolled||0
868707|NCT02243280|2102497|P3|NOT COMPLETED|Enrolled||0
868708|NCT02243280|2102498|P2|NOT COMPLETED|Enrolled||0
868709|NCT02243280|2102499|P1|NOT COMPLETED|Enrolled||0
868710|NCT02243280|2102489|P11|COMPLETED|Enrolled||34
868711|NCT02243280|2102490|P10|COMPLETED|Enrolled||0
868712|NCT02243280|2102491|P9|COMPLETED|Enrolled||34
868713|NCT02243280|2102492|P8|COMPLETED|Enrolled||0
868714|NCT02243280|2102493|P7|COMPLETED|Enrolled||0
868715|NCT02243280|2102494|P6|COMPLETED|Enrolled||27
868716|NCT02243280|2102495|P5|COMPLETED|Enrolled||0
868717|NCT02243280|2102496|P4|COMPLETED|Enrolled||0
868718|NCT02243280|2102497|P3|COMPLETED|Enrolled||0
868719|NCT02243280|2102498|P2|COMPLETED|Enrolled||39
868720|NCT02243280|2102499|P1|COMPLETED|Enrolled||40
868721|NCT02243280|2102489|P11|STARTED|Enrolled||34
868722|NCT02243280|2102490|P10|STARTED|Enrolled||0
868723|NCT02243280|2102491|P9|STARTED|Enrolled||34
868724|NCT02243280|2102492|P8|STARTED|Enrolled||0
868725|NCT02243280|2102493|P7|STARTED|Enrolled||0
868726|NCT02243280|2102494|P6|STARTED|Enrolled||27
868727|NCT02243280|2102495|P5|STARTED|Enrolled||0
868728|NCT02243280|2102496|P4|STARTED|Enrolled||0
868729|NCT02243280|2102497|P3|STARTED|Enrolled||0
868730|NCT02243280|2102498|P2|STARTED|Enrolled||39
868731|NCT02243280|2102499|P1|STARTED|Enrolled||40
868732|NCT02243202|2102554|P4|NOT COMPLETED|Overall Study||23
868733|NCT02243202|2102555|P3|NOT COMPLETED|Overall Study||31
868734|NCT02243202|2102556|P2|NOT COMPLETED|Overall Study||25
868735|NCT02243202|2102557|P1|NOT COMPLETED|Overall Study||25
868736|NCT02243202|2102554|P4|COMPLETED|Overall Study||61
868737|NCT02243202|2102555|P3|COMPLETED|Overall Study||53
868738|NCT02243202|2102556|P2|COMPLETED|Overall Study||60
868739|NCT02243202|2102557|P1|COMPLETED|Overall Study||57
868740|NCT02243202|2102554|P4|Treated|Overall Study||83
868741|NCT02243202|2102555|P3|Treated|Overall Study||84
868742|NCT02243202|2102556|P2|Treated|Overall Study||85
868743|NCT02243202|2102557|P1|Treated|Overall Study||82
868744|NCT02243202|2102554|P4|STARTED|Overall Study||84
868745|NCT02243202|2102555|P3|STARTED|Overall Study||84
868746|NCT02243202|2102556|P2|STARTED|Overall Study||85
868747|NCT02243202|2102557|P1|STARTED|Overall Study||82
868748|NCT02243176|2102593|P2|NOT COMPLETED|Overall Study||15
868749|NCT02243176|2102594|P1|NOT COMPLETED|Overall Study||14
868750|NCT02243176|2102593|P2|COMPLETED|Overall Study||229
868751|NCT02243176|2102594|P1|COMPLETED|Overall Study||230
868752|NCT02243176|2102593|P2|STARTED|Overall Study||244
868753|NCT02243176|2102594|P1|STARTED|Overall Study|3 of the randomized subjects withdrew before taking any medication|244
868754|NCT02243046|2102619|P3|NOT COMPLETED|Overall Study||4
868755|NCT02243046|2102620|P2|NOT COMPLETED|Overall Study||1
868756|NCT02243046|2102621|P1|NOT COMPLETED|Overall Study||1
868757|NCT02243046|2102619|P3|COMPLETED|Overall Study||49
868758|NCT02243046|2102620|P2|COMPLETED|Overall Study||53
868759|NCT02243046|2102621|P1|COMPLETED|Overall Study||54
868760|NCT02243046|2102619|P3|6 Month|Overall Study|2 subjects didn't return for 6 month clinic visit|49
868761|NCT02243046|2102620|P2|6 Month|Overall Study||53
868762|NCT02243046|2102621|P1|6 Month|Overall Study||54
868763|NCT02243046|2102619|P3|3 Month|Overall Study|2 subjects didn't return for 3 month clinic visit|51
868764|NCT02243046|2102620|P2|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|53
868765|NCT02243046|2102621|P1|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|54
868766|NCT02243046|2102619|P3|STARTED|Overall Study||53
868767|NCT02243046|2102620|P2|STARTED|Overall Study||54
868768|NCT02243046|2102621|P1|STARTED|Overall Study||55
868769|NCT02243007|2102646|P2|NOT COMPLETED|Overall Study||0
868770|NCT02243007|2102647|P1|NOT COMPLETED|Overall Study||0
868771|NCT02243007|2102646|P2|COMPLETED|Overall Study||3
868772|NCT02243007|2102647|P1|COMPLETED|Overall Study||4
868773|NCT02243007|2102646|P2|STARTED|Overall Study||3
868774|NCT02243007|2102647|P1|STARTED|Overall Study||4
868775|NCT02242994|2102669|P1|NOT COMPLETED|Overall Study||0
868776|NCT02242994|2102669|P1|COMPLETED|Overall Study||5
868777|NCT02242994|2102669|P1|STARTED|Overall Study||5
868778|NCT02242643|2102676|P2|NOT COMPLETED|Overall Study||78
868779|NCT02242643|2102677|P1|NOT COMPLETED|Overall Study||75
868780|NCT02242643|2102676|P2|COMPLETED|Overall Study||1139
868781|NCT02242643|2102677|P1|COMPLETED|Overall Study||1132
868782|NCT02242643|2102676|P2|STARTED|Overall Study||1217
868783|NCT02242643|2102677|P1|STARTED|Overall Study||1207
868784|NCT02242630|2102713|P4|NOT COMPLETED|Overall Study||0
868785|NCT02242630|2102714|P3|NOT COMPLETED|Overall Study||0
868786|NCT02242630|2102715|P2|NOT COMPLETED|Overall Study||0
868787|NCT02242630|2102716|P1|NOT COMPLETED|Overall Study||0
868788|NCT02242630|2102713|P4|COMPLETED|Overall Study||16
868789|NCT02242630|2102714|P3|COMPLETED|Overall Study||15
868790|NCT02242630|2102715|P2|COMPLETED|Overall Study||15
868791|NCT02242630|2102716|P1|COMPLETED|Overall Study||15
868792|NCT02242630|2102713|P4|STARTED|Overall Study||16
868793|NCT02242630|2102714|P3|STARTED|Overall Study||15
868794|NCT02242630|2102715|P2|STARTED|Overall Study||15
868795|NCT02242630|2102716|P1|STARTED|Overall Study||15
868796|NCT02242305|2102732|P2|NOT COMPLETED|Overall Study||10
868797|NCT02242305|2102733|P1|NOT COMPLETED|Overall Study||6
868798|NCT02242305|2102732|P2|COMPLETED|Overall Study||141
868799|NCT02242305|2102733|P1|COMPLETED|Overall Study||145
868800|NCT02242305|2102732|P2|STARTED|Overall Study||151
868801|NCT02242305|2102733|P1|STARTED|Overall Study||151
868802|NCT02242019|2102751|P1|NOT COMPLETED|Overall Study||0
868803|NCT02242019|2102751|P1|COMPLETED|Overall Study||109
868804|NCT02242019|2102751|P1|STARTED|Overall Study||109
868805|NCT02241889|2102757|P6|NOT COMPLETED|Overall Study||1
868806|NCT02241889|2102758|P5|NOT COMPLETED|Overall Study||0
868807|NCT02241889|2102759|P4|NOT COMPLETED|Overall Study||0
868808|NCT02241889|2102760|P3|NOT COMPLETED|Overall Study||1
868809|NCT02241889|2102761|P2|NOT COMPLETED|Overall Study||0
868810|NCT02241889|2102762|P1|NOT COMPLETED|Overall Study||0
868811|NCT02241889|2102757|P6|COMPLETED|Overall Study||3
868812|NCT02241889|2102758|P5|COMPLETED|Overall Study||5
868813|NCT02241889|2102759|P4|COMPLETED|Overall Study||3
868814|NCT02241889|2102760|P3|COMPLETED|Overall Study||2
868815|NCT02241889|2102761|P2|COMPLETED|Overall Study||4
868816|NCT02241889|2102762|P1|COMPLETED|Overall Study||4
868817|NCT02241889|2102757|P6|STARTED|Overall Study||4
868818|NCT02241889|2102758|P5|STARTED|Overall Study||5
868819|NCT02241889|2102759|P4|STARTED|Overall Study||3
868820|NCT02241889|2102760|P3|STARTED|Overall Study||3
868821|NCT02241889|2102761|P2|STARTED|Overall Study||4
868822|NCT02241889|2102762|P1|STARTED|Overall Study||4
868823|NCT02241785|2102797|P1|NOT COMPLETED|Overall Study||47
868824|NCT02241785|2102797|P1|COMPLETED|Overall Study||0
868825|NCT02241785|2102797|P1|STARTED|Overall Study||47
868826|NCT02241486|2102805|P1|NOT COMPLETED|Overall Study||0
868827|NCT02241486|2102805|P1|COMPLETED|Overall Study||2
868828|NCT02241486|2102805|P1|STARTED|Overall Study||2
868829|NCT02241187|2102809|P1|NOT COMPLETED|Overall Study||2
868830|NCT02241187|2102809|P1|COMPLETED|Overall Study||0
868831|NCT02241187|2102809|P1|STARTED|Overall Study||2
868832|NCT02240628|2102816|P2|NOT COMPLETED|Overall Study||5
868833|NCT02240628|2102817|P1|NOT COMPLETED|Overall Study||6
868834|NCT02240628|2102816|P2|COMPLETED|Overall Study||33
868835|NCT02240628|2102817|P1|COMPLETED|Overall Study||32
868836|NCT02240628|2102816|P2|STARTED|Overall Study||38
868837|NCT02240628|2102817|P1|STARTED|Overall Study||38
868838|NCT02240589|2102827|P2|NOT COMPLETED|Overall Study||2
868839|NCT02240589|2102828|P1|NOT COMPLETED|Overall Study||2
868840|NCT02240589|2102827|P2|COMPLETED|Overall Study||4
868841|NCT02240589|2102828|P1|COMPLETED|Overall Study||3
868842|NCT02240589|2102827|P2|STARTED|Overall Study||6
868843|NCT02240589|2102828|P1|STARTED|Overall Study||5
868844|NCT02240368|2102851|P3|NOT COMPLETED|Overall Study||1
868845|NCT02240368|2102852|P2|NOT COMPLETED|Overall Study||0
868846|NCT02240368|2102853|P1|NOT COMPLETED|Overall Study||1
868847|NCT02240368|2102851|P3|COMPLETED|Overall Study||18
868848|NCT02240368|2102852|P2|COMPLETED|Overall Study||22
868849|NCT02240368|2102853|P1|COMPLETED|Overall Study||8
868850|NCT02240368|2102851|P3|STARTED|Overall Study||19
868851|NCT02240368|2102852|P2|STARTED|Overall Study||22
868852|NCT02240368|2102853|P1|STARTED|Overall Study||9
868853|NCT02240329|2102870|P1|NOT COMPLETED|Overall Study||0
868854|NCT02240329|2102870|P1|COMPLETED|Overall Study||4
868855|NCT02240329|2102870|P1|Determination of Urge to Cough|Overall Study||4
868856|NCT02240329|2102870|P1|STARTED|Overall Study||4
868857|NCT02239978|2102877|P2|NOT COMPLETED|Overall Study||0
868858|NCT02239978|2102878|P1|NOT COMPLETED|Overall Study||2
868859|NCT02239978|2102877|P2|COMPLETED|Overall Study||12
868860|NCT02239978|2102878|P1|COMPLETED|Overall Study||28
868861|NCT02239978|2102877|P2|STARTED|Overall Study||12
868862|NCT02239978|2102878|P1|STARTED|Overall Study||30
868863|NCT02239926|2102895|P2|NOT COMPLETED|Overall Study||1
868864|NCT02239926|2102896|P1|NOT COMPLETED|Overall Study||0
868865|NCT02239926|2102895|P2|COMPLETED|Overall Study||1
868866|NCT02239926|2102896|P1|COMPLETED|Overall Study||0
868867|NCT02239926|2102895|P2|STARTED|Overall Study||2
868868|NCT02239926|2102896|P1|STARTED|Overall Study||0
868869|NCT02239744|2102906|P2|NOT COMPLETED|Period 2||0
868870|NCT02239744|2102907|P1|NOT COMPLETED|Period 2||0
868871|NCT02239744|2102906|P2|COMPLETED|Period 2||18
868872|NCT02239744|2102907|P1|COMPLETED|Period 2||17
868873|NCT02239744|2102906|P2|STARTED|Period 2||18
868874|NCT02239744|2102907|P1|STARTED|Period 2||17
868875|NCT02239744|2102906|P2|NOT COMPLETED|Period 1||0
868876|NCT02239744|2102907|P1|NOT COMPLETED|Period 1||0
868877|NCT02239744|2102906|P2|COMPLETED|Period 1||18
868878|NCT02239744|2102907|P1|COMPLETED|Period 1||17
868879|NCT02239744|2102906|P2|STARTED|Period 1||18
868880|NCT02239744|2102907|P1|STARTED|Period 1||17
868881|NCT02239692|2102921|P2|NOT COMPLETED|Overall Study||13
868882|NCT02239692|2102922|P1|NOT COMPLETED|Overall Study||6
868883|NCT02239692|2102921|P2|COMPLETED|Overall Study||118
868884|NCT02239692|2102922|P1|COMPLETED|Overall Study||67
868885|NCT02239692|2102921|P2|Safety Analysis Set|Overall Study||125
868886|NCT02239692|2102922|P1|Safety Analysis Set|Overall Study||70
868887|NCT02239692|2102921|P2|Per-protocol Analysis Set|Overall Study||120
868888|NCT02239692|2102922|P1|Per-protocol Analysis Set|Overall Study||66
868889|NCT02239692|2102921|P2|Intention-to-treat Analysis Set|Overall Study||131
868890|NCT02239692|2102922|P1|Intention-to-treat Analysis Set|Overall Study||73
868891|NCT02239692|2102921|P2|STARTED|Overall Study||131
868892|NCT02239692|2102922|P1|STARTED|Overall Study||73
868893|NCT02239679|2102941|P3|NOT COMPLETED|Overall Study||1
868894|NCT02239679|2102942|P2|NOT COMPLETED|Overall Study||3
868895|NCT02239679|2102943|P1|NOT COMPLETED|Overall Study||3
868896|NCT02239679|2102941|P3|COMPLETED|Overall Study||53
868897|NCT02239679|2102942|P2|COMPLETED|Overall Study||56
868898|NCT02239679|2102943|P1|COMPLETED|Overall Study||50
868899|NCT02239679|2102941|P3|STARTED|Overall Study||54
868900|NCT02239679|2102942|P2|STARTED|Overall Study||59
868901|NCT02239679|2102943|P1|STARTED|Overall Study||53
868902|NCT02239289|2103155|P1|NOT COMPLETED|Overall Study||0
868903|NCT02239289|2103155|P1|COMPLETED|Overall Study||21
868904|NCT02239289|2103155|P1|STARTED|Overall Study||21
868905|NCT02238782|2103174|P1|NOT COMPLETED|Overall Study||0
868906|NCT02238782|2103174|P1|COMPLETED|Overall Study||12
868907|NCT02238782|2103174|P1|Subjects Treated|Overall Study||12
868908|NCT02238782|2103174|P1|STARTED|Overall Study||12
868909|NCT02238379|2103180|P2|NOT COMPLETED|Overall Study||0
868910|NCT02238379|2103181|P1|NOT COMPLETED|Overall Study||1
868911|NCT02238379|2103180|P2|COMPLETED|Overall Study||14
868912|NCT02238379|2103181|P1|COMPLETED|Overall Study||11
868913|NCT02238379|2103180|P2|STARTED|Overall Study||14
868914|NCT02238379|2103181|P1|STARTED|Overall Study||12
868915|NCT02238080|2103207|P1|NOT COMPLETED|Overall Study||25
868916|NCT02238080|2103207|P1|COMPLETED|Overall Study||172
868917|NCT02238080|2103207|P1|STARTED|Overall Study||197
868918|NCT02238067|2103221|P1|NOT COMPLETED|Overall Study||45
868919|NCT02238067|2103221|P1|COMPLETED|Overall Study||151
868920|NCT02238067|2103221|P1|STARTED|Overall Study||196
868921|NCT02238028|2103244|P2|NOT COMPLETED|Overall Study||2
868922|NCT02238028|2103245|P1|NOT COMPLETED|Overall Study||2
868923|NCT02238028|2103244|P2|COMPLETED|Overall Study||12
868924|NCT02238028|2103245|P1|COMPLETED|Overall Study||12
868925|NCT02238028|2103244|P2|STARTED|Overall Study||14
868926|NCT02238028|2103245|P1|STARTED|Overall Study||14
868927|NCT02237118|2103266|P2|NOT COMPLETED|Overall Study||1
868928|NCT02237118|2103267|P1|NOT COMPLETED|Overall Study||1
868929|NCT02237118|2103266|P2|COMPLETED|Overall Study||62
868930|NCT02237118|2103267|P1|COMPLETED|Overall Study||59
868931|NCT02237118|2103266|P2|STARTED|Overall Study||63
868932|NCT02237118|2103267|P1|STARTED|Overall Study||60
868933|NCT02237092|2103281|P1|NOT COMPLETED|Overall Study||0
868934|NCT02237092|2103281|P1|COMPLETED|Overall Study||196
868935|NCT02237092|2103281|P1|STARTED|Overall Study||196
868936|NCT02236767|2103298|P1|NOT COMPLETED|Overall Study||0
868937|NCT02236767|2103298|P1|COMPLETED|Overall Study||1
868938|NCT02236767|2103298|P1|STARTED|Overall Study||1
868945|NCT02236598|2103313|P2|NOT COMPLETED|Overall Study||2
868946|NCT02236598|2103314|P1|NOT COMPLETED|Overall Study||0
868947|NCT02236598|2103313|P2|COMPLETED|Overall Study||12
868948|NCT02236598|2103314|P1|COMPLETED|Overall Study||15
868949|NCT02236598|2103313|P2|STARTED|Overall Study||14
868950|NCT02236598|2103314|P1|STARTED|Overall Study||15
868951|NCT02236546|2103326|P1|NOT COMPLETED|Overall Study||0
868952|NCT02236546|2103326|P1|COMPLETED|Overall Study||3
868953|NCT02236546|2103326|P1|STARTED|Overall Study||3
868954|NCT02236130|2103335|P2|NOT COMPLETED|Overall Study||12
868955|NCT02236130|2103336|P1|NOT COMPLETED|Overall Study||7
868956|NCT02236130|2103335|P2|COMPLETED|Overall Study||15
868957|NCT02236130|2103336|P1|COMPLETED|Overall Study||15
868958|NCT02236130|2103335|P2|STARTED|Overall Study||27
868959|NCT02236130|2103336|P1|STARTED|Overall Study||22
868960|NCT02235831|2103344|P6|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
868961|NCT02235831|2103345|P5|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
868962|NCT02235831|2103346|P4|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
868963|NCT02235831|2103347|P3|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
868964|NCT02235831|2103348|P2|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
868965|NCT02235831|2103349|P1|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
868966|NCT02235831|2103344|P6|COMPLETED|Period 3, Third 5 Days of Wear||4
868967|NCT02235831|2103345|P5|COMPLETED|Period 3, Third 5 Days of Wear||4
868968|NCT02235831|2103346|P4|COMPLETED|Period 3, Third 5 Days of Wear||4
868969|NCT02235831|2103347|P3|COMPLETED|Period 3, Third 5 Days of Wear||4
868970|NCT02235831|2103348|P2|COMPLETED|Period 3, Third 5 Days of Wear||4
868971|NCT02235831|2103349|P1|COMPLETED|Period 3, Third 5 Days of Wear||4
868972|NCT02235831|2103344|P6|STARTED|Period 3, Third 5 Days of Wear||4
868973|NCT02235831|2103345|P5|STARTED|Period 3, Third 5 Days of Wear||4
868974|NCT02235831|2103346|P4|STARTED|Period 3, Third 5 Days of Wear||4
868975|NCT02235831|2103347|P3|STARTED|Period 3, Third 5 Days of Wear||4
868976|NCT02235831|2103348|P2|STARTED|Period 3, Third 5 Days of Wear||4
868977|NCT02235831|2103349|P1|STARTED|Period 3, Third 5 Days of Wear||4
868978|NCT02235831|2103344|P6|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
868979|NCT02235831|2103345|P5|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
868980|NCT02235831|2103346|P4|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
868981|NCT02235831|2103347|P3|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
868982|NCT02235831|2103348|P2|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
868983|NCT02235831|2103349|P1|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
868984|NCT02235831|2103344|P6|COMPLETED|Period 2, Second 5 Days of Wear||4
868985|NCT02235831|2103345|P5|COMPLETED|Period 2, Second 5 Days of Wear||4
868986|NCT02235831|2103346|P4|COMPLETED|Period 2, Second 5 Days of Wear||4
868987|NCT02235831|2103347|P3|COMPLETED|Period 2, Second 5 Days of Wear||4
868988|NCT02235831|2103348|P2|COMPLETED|Period 2, Second 5 Days of Wear||4
868989|NCT02235831|2103349|P1|COMPLETED|Period 2, Second 5 Days of Wear||4
868990|NCT02235831|2103344|P6|STARTED|Period 2, Second 5 Days of Wear||4
868991|NCT02235831|2103345|P5|STARTED|Period 2, Second 5 Days of Wear||4
868992|NCT02235831|2103346|P4|STARTED|Period 2, Second 5 Days of Wear||4
868993|NCT02235831|2103347|P3|STARTED|Period 2, Second 5 Days of Wear||4
868994|NCT02235831|2103348|P2|STARTED|Period 2, Second 5 Days of Wear||4
868995|NCT02235831|2103349|P1|STARTED|Period 2, Second 5 Days of Wear||4
868996|NCT02235831|2103344|P6|NOT COMPLETED|Period 1, First 5 Days of Wear||0
868997|NCT02235831|2103345|P5|NOT COMPLETED|Period 1, First 5 Days of Wear||0
868998|NCT02235831|2103346|P4|NOT COMPLETED|Period 1, First 5 Days of Wear||0
868999|NCT02235831|2103347|P3|NOT COMPLETED|Period 1, First 5 Days of Wear||0
869000|NCT02235831|2103348|P2|NOT COMPLETED|Period 1, First 5 Days of Wear||0
869001|NCT02235831|2103349|P1|NOT COMPLETED|Period 1, First 5 Days of Wear||0
869002|NCT02235831|2103344|P6|COMPLETED|Period 1, First 5 Days of Wear||4
869003|NCT02235831|2103345|P5|COMPLETED|Period 1, First 5 Days of Wear||4
869004|NCT02235831|2103346|P4|COMPLETED|Period 1, First 5 Days of Wear||4
869005|NCT02235831|2103347|P3|COMPLETED|Period 1, First 5 Days of Wear||4
869006|NCT02235831|2103348|P2|COMPLETED|Period 1, First 5 Days of Wear||4
869007|NCT02235831|2103349|P1|COMPLETED|Period 1, First 5 Days of Wear||4
869008|NCT02235831|2103344|P6|STARTED|Period 1, First 5 Days of Wear||4
869009|NCT02235831|2103345|P5|STARTED|Period 1, First 5 Days of Wear||4
869010|NCT02235831|2103346|P4|STARTED|Period 1, First 5 Days of Wear||4
869011|NCT02235831|2103347|P3|STARTED|Period 1, First 5 Days of Wear||4
869012|NCT02235831|2103348|P2|STARTED|Period 1, First 5 Days of Wear||4
869013|NCT02235831|2103349|P1|STARTED|Period 1, First 5 Days of Wear||4
869014|NCT02235493|2103356|P1|NOT COMPLETED|Overall Study||0
869015|NCT02235493|2103356|P1|COMPLETED|Overall Study||6
869016|NCT02235493|2103356|P1|STARTED|Overall Study||6
869017|NCT02235454|2103361|P1|NOT COMPLETED|Overall Study||2
869018|NCT02235454|2103361|P1|COMPLETED|Overall Study||55
869019|NCT02235454|2103361|P1|STARTED|Overall Study||57
869020|NCT02235311|2103367|P2|NOT COMPLETED|Overall Study||2
869021|NCT02235311|2103368|P1|NOT COMPLETED|Overall Study||0
869022|NCT02235311|2103367|P2|COMPLETED|Overall Study||0
869023|NCT02235311|2103368|P1|COMPLETED|Overall Study||1
869024|NCT02235311|2103367|P2|STARTED|Overall Study||2
869025|NCT02235311|2103368|P1|STARTED|Overall Study||1
869026|NCT02235285|2103380|P1|NOT COMPLETED|Overall Study||13
869027|NCT02235285|2103380|P1|COMPLETED|Overall Study||149
869028|NCT02235285|2103380|P1|STARTED|Overall Study||162
869029|NCT02235077|2103386|P2|NOT COMPLETED|Overall Study||19
869030|NCT02235077|2103387|P1|NOT COMPLETED|Overall Study||18
869031|NCT02235077|2103386|P2|COMPLETED|Overall Study||159
869032|NCT02235077|2103387|P1|COMPLETED|Overall Study||164
869033|NCT02235077|2103386|P2|STARTED|Overall Study||178
869034|NCT02235077|2103387|P1|STARTED|Overall Study||182
869035|NCT02235064|2103415|P2|NOT COMPLETED|Overall Study||0
869036|NCT02235064|2103416|P1|NOT COMPLETED|Overall Study||0
869037|NCT02235064|2103415|P2|COMPLETED|Overall Study||1
869038|NCT02235064|2103416|P1|COMPLETED|Overall Study||1
869039|NCT02235064|2103415|P2|STARTED|Overall Study||1
869040|NCT02235064|2103416|P1|STARTED|Overall Study||1
869041|NCT02234479|2103444|P2|NOT COMPLETED|Overall Study||3
869042|NCT02234479|2103445|P1|NOT COMPLETED|Overall Study||1
869043|NCT02234479|2103444|P2|COMPLETED|Overall Study||15
869044|NCT02234479|2103445|P1|COMPLETED|Overall Study||15
869045|NCT02234479|2103444|P2|STARTED|Overall Study||18
869046|NCT02234479|2103445|P1|STARTED|Overall Study||16
869047|NCT02234427|2103451|P1|NOT COMPLETED|Overall Study||1
869048|NCT02234427|2103451|P1|COMPLETED|Overall Study|One individual withdrew after first visit|33
869049|NCT02234427|2103451|P1|STARTED|Overall Study||34
869050|NCT02234362|2103455|P1|NOT COMPLETED|Overall Study||26
869051|NCT02234362|2103455|P1|COMPLETED|Overall Study||21
869052|NCT02234362|2103455|P1|Received at Least One Dose of Medication|Overall Study||27
869053|NCT02234362|2103455|P1|STARTED|Overall Study||47
869054|NCT02234011|2103472|P1|NOT COMPLETED|Overall Study||0
869055|NCT02234011|2103472|P1|COMPLETED|Overall Study||0
869056|NCT02234011|2103472|P1|STARTED|Overall Study||0
869057|NCT02233998|2103479|P3|NOT COMPLETED|Overall Study||0
869058|NCT02233998|2103480|P2|NOT COMPLETED|Overall Study||0
869059|NCT02233998|2103481|P1|NOT COMPLETED|Overall Study||0
869060|NCT02233998|2103479|P3|COMPLETED|Overall Study||53
869061|NCT02233998|2103480|P2|COMPLETED|Overall Study||52
869062|NCT02233998|2103481|P1|COMPLETED|Overall Study||53
869063|NCT02233998|2103479|P3|STARTED|Overall Study||53
869064|NCT02233998|2103480|P2|STARTED|Overall Study||52
869065|NCT02233998|2103481|P1|STARTED|Overall Study||53
869066|NCT02233985|2103515|P2|NOT COMPLETED|Overall Study||0
869067|NCT02233985|2103516|P1|NOT COMPLETED|Overall Study||0
869068|NCT02233985|2103515|P2|COMPLETED|Overall Study||31
869069|NCT02233985|2103516|P1|COMPLETED|Overall Study||33
869070|NCT02233985|2103515|P2|STARTED|Overall Study||31
869071|NCT02233985|2103516|P1|STARTED|Overall Study||33
869072|NCT02233842|2103524|P1|NOT COMPLETED|Questionnaire 3 Version 2||0
869073|NCT02233842|2103524|P1|COMPLETED|Questionnaire 3 Version 2||5
869074|NCT02233842|2103524|P1|STARTED|Questionnaire 3 Version 2||5
869075|NCT02233842|2103524|P1|NOT COMPLETED|Questionnaire 3 Version 1||0
869076|NCT02233842|2103524|P1|COMPLETED|Questionnaire 3 Version 1||5
869077|NCT02233842|2103524|P1|STARTED|Questionnaire 3 Version 1||5
869078|NCT02233842|2103524|P1|NOT COMPLETED|Questionnaire 2 Version 2||0
869079|NCT02233842|2103524|P1|COMPLETED|Questionnaire 2 Version 2||5
869080|NCT02233842|2103524|P1|STARTED|Questionnaire 2 Version 2||5
869081|NCT02233842|2103524|P1|NOT COMPLETED|Questionnaire 2 Version 1||0
869082|NCT02233842|2103524|P1|COMPLETED|Questionnaire 2 Version 1||5
869083|NCT02233842|2103524|P1|STARTED|Questionnaire 2 Version 1||5
869084|NCT02233842|2103524|P1|NOT COMPLETED|Questionnaire 1 Version 2||0
869085|NCT02233842|2103524|P1|COMPLETED|Questionnaire 1 Version 2||5
869086|NCT02233842|2103524|P1|STARTED|Questionnaire 1 Version 2||5
869087|NCT02233842|2103524|P1|NOT COMPLETED|Questionnaire 1 Version 1||0
869088|NCT02233842|2103524|P1|COMPLETED|Questionnaire 1 Version 1||5
869089|NCT02233842|2103524|P1|STARTED|Questionnaire 1 Version 1||5
869090|NCT02233803|2103531|P2|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
869091|NCT02233803|2103532|P1|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
869092|NCT02233803|2103531|P2|COMPLETED|Treatment Period 2 (4-Wks)||91
869093|NCT02233803|2103532|P1|COMPLETED|Treatment Period 2 (4-Wks)||93
869094|NCT02233803|2103531|P2|STARTED|Treatment Period 2 (4-Wks)||93
869095|NCT02233803|2103532|P1|STARTED|Treatment Period 2 (4-Wks)||95
869096|NCT02233803|2103531|P2|NOT COMPLETED|Washout Period (4-Wks)||2
869097|NCT02233803|2103532|P1|NOT COMPLETED|Washout Period (4-Wks)||2
869098|NCT02233803|2103531|P2|COMPLETED|Washout Period (4-Wks)||93
869099|NCT02233803|2103532|P1|COMPLETED|Washout Period (4-Wks)||95
869100|NCT02233803|2103531|P2|STARTED|Washout Period (4-Wks)||95
869101|NCT02233803|2103532|P1|STARTED|Washout Period (4-Wks)||97
869102|NCT02233803|2103531|P2|NOT COMPLETED|Treatment Period 1 (4-Wks)||4
869103|NCT02233803|2103532|P1|NOT COMPLETED|Treatment Period 1 (4-Wks)||3
869104|NCT02233803|2103531|P2|COMPLETED|Treatment Period 1 (4-Wks)||95
869105|NCT02233803|2103532|P1|COMPLETED|Treatment Period 1 (4-Wks)||97
869106|NCT02233803|2103531|P2|STARTED|Treatment Period 1 (4-Wks)||99
869107|NCT02233803|2103532|P1|STARTED|Treatment Period 1 (4-Wks)||100
869108|NCT02233647|2103542|P1|NOT COMPLETED|Overall Study||1
869109|NCT02233647|2103542|P1|COMPLETED|Overall Study||10
869110|NCT02233647|2103542|P1|80 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
869111|NCT02233647|2103542|P1|40 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
869112|NCT02233647|2103542|P1|20 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
869113|NCT02233647|2103542|P1|10 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
869114|NCT02233647|2103542|P1|0 mg Cocaine With 210 mg Phendimetrazine|Overall Study||10
869115|NCT02233647|2103542|P1|80 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
869116|NCT02233647|2103542|P1|40 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
869117|NCT02233647|2103542|P1|20 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
869118|NCT02233647|2103542|P1|10 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
869119|NCT02233647|2103542|P1|0 mg Cocaine With 140 mg Phendimetrazine|Overall Study||10
869120|NCT02233647|2103542|P1|80 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
869121|NCT02233647|2103542|P1|40 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
869122|NCT02233647|2103542|P1|20 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
869123|NCT02233647|2103542|P1|10 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
869124|NCT02233647|2103542|P1|0 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
869125|NCT02233647|2103542|P1|80 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
869126|NCT02233647|2103542|P1|40 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
869127|NCT02233647|2103542|P1|20 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
869128|NCT02233647|2103542|P1|10 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
869129|NCT02233647|2103542|P1|0 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
869130|NCT02233647|2103542|P1|STARTED|Overall Study||11
869131|NCT02233309|2103571|P1|NOT COMPLETED|Overall Study||5
869132|NCT02233309|2103571|P1|COMPLETED|Overall Study||31
869133|NCT02233309|2103571|P1|STARTED|Overall Study||36
869134|NCT02233296|2103577|P2|NOT COMPLETED|Overall Study||0
869135|NCT02233296|2103578|P1|NOT COMPLETED|Overall Study||0
869136|NCT02233296|2103577|P2|COMPLETED|Overall Study||14
869137|NCT02233296|2103578|P1|COMPLETED|Overall Study||16
869138|NCT02233296|2103577|P2|STARTED|Overall Study||14
869139|NCT02233296|2103578|P1|STARTED|Overall Study||16
869140|NCT02233101|2103596|P2|NOT COMPLETED|Overall Study||1
869141|NCT02233101|2103597|P1|NOT COMPLETED|Overall Study||12
869142|NCT02233101|2103596|P2|COMPLETED|Overall Study||80
869143|NCT02233101|2103597|P1|COMPLETED|Overall Study||74
869144|NCT02233101|2103596|P2|STARTED|Overall Study||81
869145|NCT02233101|2103597|P1|STARTED|Overall Study||86
869146|NCT02232880|2103605|P1|NOT COMPLETED|Overall Study||1
869147|NCT02232880|2103605|P1|COMPLETED|Overall Study||0
869148|NCT02232880|2103605|P1|STARTED|Overall Study||1
869149|NCT02232698|2103614|P2|NOT COMPLETED|Overall Study||20
869150|NCT02232698|2103615|P1|NOT COMPLETED|Overall Study||10
869151|NCT02232698|2103614|P2|COMPLETED|Overall Study||101
869152|NCT02232698|2103615|P1|COMPLETED|Overall Study||110
869153|NCT02232698|2103614|P2|STARTED|Overall Study||121
869154|NCT02232698|2103615|P1|STARTED|Overall Study||120
869155|NCT02232126|2103638|P2|NOT COMPLETED|Overall Study||0
869156|NCT02232126|2103639|P1|NOT COMPLETED|Overall Study||0
869157|NCT02232126|2103638|P2|COMPLETED|Overall Study||90
869158|NCT02232126|2103639|P1|COMPLETED|Overall Study||91
869159|NCT02232126|2103638|P2|STARTED|Overall Study||90
869160|NCT02232126|2103639|P1|STARTED|Overall Study||91
869161|NCT02231918|2103650|P3|NOT COMPLETED|Overall Study||1
869162|NCT02231918|2103651|P2|NOT COMPLETED|Overall Study||1
869163|NCT02231918|2103652|P1|NOT COMPLETED|Overall Study||0
869164|NCT02231918|2103650|P3|COMPLETED|Overall Study||1
869165|NCT02231918|2103651|P2|COMPLETED|Overall Study||14
869166|NCT02231918|2103652|P1|COMPLETED|Overall Study||9
869167|NCT02231918|2103650|P3|STARTED|Overall Study||2
869168|NCT02231918|2103651|P2|STARTED|Overall Study||15
869169|NCT02231918|2103652|P1|STARTED|Overall Study||9
869170|NCT02231177|2103714|P6|NOT COMPLETED|Treatment Period 3 (21 Days)||0
869171|NCT02231177|2103715|P5|NOT COMPLETED|Treatment Period 3 (21 Days)||0
869172|NCT02231177|2103716|P4|NOT COMPLETED|Treatment Period 3 (21 Days)||0
869173|NCT02231177|2103717|P3|NOT COMPLETED|Treatment Period 3 (21 Days)||0
869174|NCT02231177|2103718|P2|NOT COMPLETED|Treatment Period 3 (21 Days)||0
869175|NCT02231177|2103719|P1|NOT COMPLETED|Treatment Period 3 (21 Days)||0
869176|NCT02231177|2103714|P6|COMPLETED|Treatment Period 3 (21 Days)||9
869177|NCT02231177|2103715|P5|COMPLETED|Treatment Period 3 (21 Days)||8
869178|NCT02231177|2103716|P4|COMPLETED|Treatment Period 3 (21 Days)||7
869179|NCT02231177|2103717|P3|COMPLETED|Treatment Period 3 (21 Days)||8
869180|NCT02231177|2103718|P2|COMPLETED|Treatment Period 3 (21 Days)||7
869181|NCT02231177|2103719|P1|COMPLETED|Treatment Period 3 (21 Days)||8
869182|NCT02231177|2103714|P6|STARTED|Treatment Period 3 (21 Days)||9
869183|NCT02231177|2103715|P5|STARTED|Treatment Period 3 (21 Days)||8
869184|NCT02231177|2103716|P4|STARTED|Treatment Period 3 (21 Days)||7
869185|NCT02231177|2103717|P3|STARTED|Treatment Period 3 (21 Days)||8
869186|NCT02231177|2103718|P2|STARTED|Treatment Period 3 (21 Days)||7
869187|NCT02231177|2103719|P1|STARTED|Treatment Period 3 (21 Days)||8
869188|NCT02231177|2103714|P6|NOT COMPLETED|Treatment Period 2 (21 Days)||0
869189|NCT02231177|2103715|P5|NOT COMPLETED|Treatment Period 2 (21 Days)||0
869190|NCT02231177|2103716|P4|NOT COMPLETED|Treatment Period 2 (21 Days)||0
869191|NCT02231177|2103717|P3|NOT COMPLETED|Treatment Period 2 (21 Days)||0
869192|NCT02231177|2103718|P2|NOT COMPLETED|Treatment Period 2 (21 Days)||0
869193|NCT02231177|2103719|P1|NOT COMPLETED|Treatment Period 2 (21 Days)||0
869194|NCT02231177|2103714|P6|COMPLETED|Treatment Period 2 (21 Days)||9
869195|NCT02231177|2103715|P5|COMPLETED|Treatment Period 2 (21 Days)||8
869196|NCT02231177|2103716|P4|COMPLETED|Treatment Period 2 (21 Days)||7
869197|NCT02231177|2103717|P3|COMPLETED|Treatment Period 2 (21 Days)||8
869198|NCT02231177|2103718|P2|COMPLETED|Treatment Period 2 (21 Days)||7
869199|NCT02231177|2103719|P1|COMPLETED|Treatment Period 2 (21 Days)||8
869200|NCT02231177|2103714|P6|STARTED|Treatment Period 2 (21 Days)||9
869201|NCT02231177|2103715|P5|STARTED|Treatment Period 2 (21 Days)||8
869202|NCT02231177|2103716|P4|STARTED|Treatment Period 2 (21 Days)||7
869203|NCT02231177|2103717|P3|STARTED|Treatment Period 2 (21 Days)||8
869204|NCT02231177|2103718|P2|STARTED|Treatment Period 2 (21 Days)||7
869205|NCT02231177|2103719|P1|STARTED|Treatment Period 2 (21 Days)||8
869206|NCT02231177|2103714|P6|NOT COMPLETED|Treatment Period 1 (21 Days)||0
869207|NCT02231177|2103715|P5|NOT COMPLETED|Treatment Period 1 (21 Days)||0
869208|NCT02231177|2103716|P4|NOT COMPLETED|Treatment Period 1 (21 Days)||0
869209|NCT02231177|2103717|P3|NOT COMPLETED|Treatment Period 1 (21 Days)||0
869210|NCT02231177|2103718|P2|NOT COMPLETED|Treatment Period 1 (21 Days)||0
869211|NCT02231177|2103719|P1|NOT COMPLETED|Treatment Period 1 (21 Days)||0
869212|NCT02231177|2103714|P6|COMPLETED|Treatment Period 1 (21 Days)||9
869213|NCT02231177|2103715|P5|COMPLETED|Treatment Period 1 (21 Days)||8
869214|NCT02231177|2103716|P4|COMPLETED|Treatment Period 1 (21 Days)||7
869215|NCT02231177|2103717|P3|COMPLETED|Treatment Period 1 (21 Days)||8
869216|NCT02231177|2103718|P2|COMPLETED|Treatment Period 1 (21 Days)||7
869217|NCT02231177|2103719|P1|COMPLETED|Treatment Period 1 (21 Days)||8
869218|NCT02231177|2103714|P6|STARTED|Treatment Period 1 (21 Days)||9
869219|NCT02231177|2103715|P5|STARTED|Treatment Period 1 (21 Days)||8
869220|NCT02231177|2103716|P4|STARTED|Treatment Period 1 (21 Days)||7
869221|NCT02231177|2103717|P3|STARTED|Treatment Period 1 (21 Days)||8
869222|NCT02231177|2103718|P2|STARTED|Treatment Period 1 (21 Days)||7
869223|NCT02231177|2103719|P1|STARTED|Treatment Period 1 (21 Days)||8
869224|NCT02231164|2103775|P2|NOT COMPLETED|Overall Study||6
869225|NCT02231164|2103776|P1|NOT COMPLETED|Overall Study||6
869226|NCT02231164|2103775|P2|COMPLETED|Overall Study||0
869227|NCT02231164|2103776|P1|COMPLETED|Overall Study||0
869228|NCT02231164|2103775|P2|STARTED|Overall Study||6
869229|NCT02231164|2103776|P1|STARTED|Overall Study||6
869230|NCT02230995|2103784|P2|NOT COMPLETED|Period 2 + Washout||0
869231|NCT02230995|2103785|P1|NOT COMPLETED|Period 2 + Washout||0
869232|NCT02230995|2103784|P2|COMPLETED|Period 2 + Washout||15
869233|NCT02230995|2103785|P1|COMPLETED|Period 2 + Washout||15
869234|NCT02230995|2103784|P2|STARTED|Period 2 + Washout||15
869235|NCT02230995|2103785|P1|STARTED|Period 2 + Washout||15
869236|NCT02230995|2103784|P2|NOT COMPLETED|Period 1 + Washout||0
869237|NCT02230995|2103785|P1|NOT COMPLETED|Period 1 + Washout||0
869238|NCT02230995|2103784|P2|COMPLETED|Period 1 + Washout||15
869239|NCT02230995|2103785|P1|COMPLETED|Period 1 + Washout||15
869240|NCT02230995|2103784|P2|STARTED|Period 1 + Washout||15
869241|NCT02230995|2103785|P1|STARTED|Period 1 + Washout||15
869242|NCT02230956|2103804|P3|NOT COMPLETED|Overall Study||7
869243|NCT02230956|2103805|P2|NOT COMPLETED|Overall Study||6
869244|NCT02230956|2103806|P1|NOT COMPLETED|Overall Study||5
869245|NCT02230956|2103804|P3|COMPLETED|Overall Study||82
869246|NCT02230956|2103805|P2|COMPLETED|Overall Study||37
869247|NCT02230956|2103806|P1|COMPLETED|Overall Study||39
869248|NCT02230956|2103804|P3|STARTED|Overall Study||89
869249|NCT02230956|2103805|P2|STARTED|Overall Study||43
869250|NCT02230956|2103806|P1|STARTED|Overall Study||44
869251|NCT02230904|2103828|P2|NOT COMPLETED|Overall Study||1
869252|NCT02230904|2103829|P1|NOT COMPLETED|Overall Study||0
869253|NCT02230904|2103828|P2|COMPLETED|Overall Study||27
869254|NCT02230904|2103829|P1|COMPLETED|Overall Study||29
869255|NCT02230904|2103828|P2|STARTED|Overall Study||28
869256|NCT02230904|2103829|P1|STARTED|Overall Study||29
869257|NCT02230761|2103851|P2|NOT COMPLETED|Overall Study||1
869258|NCT02230761|2103852|P1|NOT COMPLETED|Overall Study||0
869259|NCT02230761|2103851|P2|COMPLETED|Overall Study||29
869260|NCT02230761|2103852|P1|COMPLETED|Overall Study||60
869261|NCT02230761|2103851|P2|STARTED|Overall Study||30
869262|NCT02230761|2103852|P1|STARTED|Overall Study||60
869263|NCT02230683|2103862|P1|NOT COMPLETED|Overall Study||1
869264|NCT02230683|2103862|P1|COMPLETED|Overall Study||22
869265|NCT02230683|2103862|P1|STARTED|Overall Study||23
869266|NCT02230670|2103879|P2|NOT COMPLETED|Overall Study||8
869267|NCT02230670|2103880|P1|NOT COMPLETED|Overall Study||4
869268|NCT02230670|2103879|P2|COMPLETED|Overall Study||34
869269|NCT02230670|2103880|P1|COMPLETED|Overall Study||40
869270|NCT02230670|2103879|P2|STARTED|Overall Study|One subject randomized to placebo withdrew from the study before receiving any study treatment.|42
869271|NCT02230670|2103880|P1|STARTED|Overall Study||44
869272|NCT02230540|2103890|P2|NOT COMPLETED|Overall Study||0
869273|NCT02230540|2103891|P1|NOT COMPLETED|Overall Study||0
869274|NCT02230540|2103890|P2|COMPLETED|Overall Study||0
869275|NCT02230540|2103891|P1|COMPLETED|Overall Study||8
869276|NCT02230540|2103890|P2|STARTED|Overall Study|The study was terminated before initiation of sequence B. Sequence B was therefore not initiated.|0
869277|NCT02230540|2103891|P1|STARTED|Overall Study||8
869278|NCT02230085|2103895|P1|NOT COMPLETED|Overall Study||4
869279|NCT02230085|2103895|P1|COMPLETED|Overall Study||106
869280|NCT02230085|2103895|P1|STARTED|Overall Study||110
869281|NCT02229864|2103899|P1|NOT COMPLETED|2 - Year Visit||1
869282|NCT02229864|2103899|P1|COMPLETED|2 - Year Visit||11
869283|NCT02229864|2103899|P1|STARTED|2 - Year Visit||12
869284|NCT02229864|2103899|P1|NOT COMPLETED|1 - Year Visit||0
869285|NCT02229864|2103899|P1|COMPLETED|1 - Year Visit||12
869286|NCT02229864|2103899|P1|STARTED|1 - Year Visit||12
869287|NCT02229864|2103899|P1|NOT COMPLETED|6 - Month Visit||0
869288|NCT02229864|2103899|P1|COMPLETED|6 - Month Visit||12
869289|NCT02229864|2103899|P1|STARTED|6 - Month Visit||12
869290|NCT02229864|2103899|P1|NOT COMPLETED|1 - Month Visit||0
869291|NCT02229864|2103899|P1|COMPLETED|1 - Month Visit||12
869292|NCT02229864|2103899|P1|STARTED|1 - Month Visit||12
869293|NCT02229539|2103948|P3|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||10
869294|NCT02229539|2103949|P2|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||7
869295|NCT02229539|2103950|P1|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||9
869296|NCT02229539|2103948|P3|COMPLETED|Cycle 2 (Optional Continuation Phase)||22
869297|NCT02229539|2103949|P2|COMPLETED|Cycle 2 (Optional Continuation Phase)||29
869298|NCT02229539|2103950|P1|COMPLETED|Cycle 2 (Optional Continuation Phase)||26
869299|NCT02229539|2103948|P3|STARTED|Cycle 2 (Optional Continuation Phase)||32
869300|NCT02229539|2103949|P2|STARTED|Cycle 2 (Optional Continuation Phase)||36
869301|NCT02229539|2103950|P1|STARTED|Cycle 2 (Optional Continuation Phase)||35
869302|NCT02229539|2103948|P3|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
869303|NCT02229539|2103949|P2|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||5
869304|NCT02229539|2103950|P1|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
869305|NCT02229539|2103948|P3|COMPLETED|Cycle 1 (Treatment Per Protocol)||72
869306|NCT02229539|2103949|P2|COMPLETED|Cycle 1 (Treatment Per Protocol)||71
869307|NCT02229539|2103950|P1|COMPLETED|Cycle 1 (Treatment Per Protocol)||74
869308|NCT02229539|2103948|P3|STARTED|Cycle 1 (Treatment Per Protocol)||75
869309|NCT02229539|2103949|P2|STARTED|Cycle 1 (Treatment Per Protocol)||76
869310|NCT02229539|2103950|P1|STARTED|Cycle 1 (Treatment Per Protocol)||77
869311|NCT02229513|2103960|P2|NOT COMPLETED|Overall Study||0
869312|NCT02229513|2103961|P1|NOT COMPLETED|Overall Study||0
869313|NCT02229513|2103960|P2|COMPLETED|Overall Study||100
869314|NCT02229513|2103961|P1|COMPLETED|Overall Study||100
869315|NCT02229513|2103960|P2|STARTED|Overall Study||100
869316|NCT02229513|2103961|P1|STARTED|Overall Study||100
869323|NCT02229461|2104011|P6|NOT COMPLETED|Overall Study||0
869324|NCT02229461|2104012|P5|NOT COMPLETED|Overall Study||0
869325|NCT02229461|2104013|P4|NOT COMPLETED|Overall Study||0
869326|NCT02229461|2104014|P3|NOT COMPLETED|Overall Study||0
869327|NCT02229461|2104015|P2|NOT COMPLETED|Overall Study||0
869328|NCT02229461|2104016|P1|NOT COMPLETED|Overall Study||0
869329|NCT02229461|2104011|P6|COMPLETED|Overall Study||17
869330|NCT02229461|2104012|P5|COMPLETED|Overall Study||17
869331|NCT02229461|2104013|P4|COMPLETED|Overall Study||17
869332|NCT02229461|2104014|P3|COMPLETED|Overall Study||17
869333|NCT02229461|2104015|P2|COMPLETED|Overall Study||17
869334|NCT02229461|2104016|P1|COMPLETED|Overall Study||17
869335|NCT02229461|2104011|P6|STARTED|Overall Study|Randomized and received treatment|17
869336|NCT02229461|2104012|P5|STARTED|Overall Study|Randomized and received treatment|17
869337|NCT02229461|2104013|P4|STARTED|Overall Study|Randomized and received treatment|17
869338|NCT02229461|2104014|P3|STARTED|Overall Study|Randomized and received treatment|17
869339|NCT02229461|2104015|P2|STARTED|Overall Study|Randomized and received treatment|17
869340|NCT02229461|2104016|P1|STARTED|Overall Study|Randomized and received treatment|17
869361|NCT02229318|2104104|P1|NOT COMPLETED|Overall Study||0
869362|NCT02229318|2104104|P1|COMPLETED|Overall Study|September 15th 2014 11 completed|11
869363|NCT02229318|2104104|P1|STARTED|Overall Study|September 6th 2014 11 enrolled|11
869364|NCT02229214|2104111|P2|NOT COMPLETED|Overall Study||0
869365|NCT02229214|2104112|P1|NOT COMPLETED|Overall Study||6
869366|NCT02229214|2104111|P2|COMPLETED|Overall Study||10
869367|NCT02229214|2104112|P1|COMPLETED|Overall Study||35
869368|NCT02229214|2104111|P2|STARTED|Overall Study||10
869369|NCT02229214|2104112|P1|STARTED|Overall Study||41
869370|NCT02228980|2104136|P4|NOT COMPLETED|Overall Study||3
869371|NCT02228980|2104137|P3|NOT COMPLETED|Overall Study||2
869372|NCT02228980|2104138|P2|NOT COMPLETED|Overall Study||3
869373|NCT02228980|2104139|P1|NOT COMPLETED|Overall Study||24
869374|NCT02228980|2104136|P4|COMPLETED|Overall Study||148
869375|NCT02228980|2104137|P3|COMPLETED|Overall Study||149
869376|NCT02228980|2104138|P2|COMPLETED|Overall Study||147
869377|NCT02228980|2104139|P1|COMPLETED|Overall Study||126
869378|NCT02228980|2104136|P4|STARTED|Overall Study||151
869379|NCT02228980|2104137|P3|STARTED|Overall Study||151
869380|NCT02228980|2104138|P2|STARTED|Overall Study||150
869381|NCT02228980|2104139|P1|STARTED|Overall Study||150
869382|NCT02228720|2104161|P1|NOT COMPLETED|Open Label - Day 90||0
869383|NCT02228720|2104161|P1|COMPLETED|Open Label - Day 90||14
869384|NCT02228720|2104161|P1|STARTED|Open Label - Day 90||14
869385|NCT02228720|2104161|P1|NOT COMPLETED|Open Label - Day 30||1
869386|NCT02228720|2104161|P1|COMPLETED|Open Label - Day 30||14
869387|NCT02228720|2104161|P1|STARTED|Open Label - Day 30||15
869388|NCT02228720|2104161|P1|NOT COMPLETED|Open Label - Baseline||0
869389|NCT02228720|2104161|P1|COMPLETED|Open Label - Baseline||15
869390|NCT02228720|2104161|P1|STARTED|Open Label - Baseline||15
869391|NCT02228395|2104169|P3|NOT COMPLETED|Third Intervention Period||0
869392|NCT02228395|2104170|P2|NOT COMPLETED|Third Intervention Period||0
869393|NCT02228395|2104171|P1|NOT COMPLETED|Third Intervention Period||0
869394|NCT02228395|2104169|P3|COMPLETED|Third Intervention Period||3
869395|NCT02228395|2104170|P2|COMPLETED|Third Intervention Period||3
869396|NCT02228395|2104171|P1|COMPLETED|Third Intervention Period||3
869397|NCT02228395|2104169|P3|STARTED|Third Intervention Period||3
869398|NCT02228395|2104170|P2|STARTED|Third Intervention Period||3
869399|NCT02228395|2104171|P1|STARTED|Third Intervention Period||3
869400|NCT02228395|2104169|P3|NOT COMPLETED|Washout Period (at Least 10 Days)||0
869401|NCT02228395|2104170|P2|NOT COMPLETED|Washout Period (at Least 10 Days)||0
869402|NCT02228395|2104171|P1|NOT COMPLETED|Washout Period (at Least 10 Days)||0
869403|NCT02228395|2104169|P3|COMPLETED|Washout Period (at Least 10 Days)||3
869404|NCT02228395|2104170|P2|COMPLETED|Washout Period (at Least 10 Days)||3
869405|NCT02228395|2104171|P1|COMPLETED|Washout Period (at Least 10 Days)||3
869406|NCT02228395|2104169|P3|STARTED|Washout Period (at Least 10 Days)||3
869407|NCT02228395|2104170|P2|STARTED|Washout Period (at Least 10 Days)||3
869408|NCT02228395|2104171|P1|STARTED|Washout Period (at Least 10 Days)||3
869409|NCT02228395|2104169|P3|NOT COMPLETED|Second Intervention Period||0
869410|NCT02228395|2104170|P2|NOT COMPLETED|Second Intervention Period||0
869411|NCT02228395|2104171|P1|NOT COMPLETED|Second Intervention Period||0
869412|NCT02228395|2104169|P3|COMPLETED|Second Intervention Period||3
869413|NCT02228395|2104170|P2|COMPLETED|Second Intervention Period||3
869414|NCT02228395|2104171|P1|COMPLETED|Second Intervention Period||3
869415|NCT02228395|2104169|P3|STARTED|Second Intervention Period||3
869416|NCT02228395|2104170|P2|STARTED|Second Intervention Period||3
869417|NCT02228395|2104171|P1|STARTED|Second Intervention Period||3
869418|NCT02228395|2104169|P3|NOT COMPLETED|Washout Period (at Least 10 Days)||0
869419|NCT02228395|2104170|P2|NOT COMPLETED|Washout Period (at Least 10 Days)||0
869420|NCT02228395|2104171|P1|NOT COMPLETED|Washout Period (at Least 10 Days)||0
869421|NCT02228395|2104169|P3|COMPLETED|Washout Period (at Least 10 Days)||3
869422|NCT02228395|2104170|P2|COMPLETED|Washout Period (at Least 10 Days)||3
869423|NCT02228395|2104171|P1|COMPLETED|Washout Period (at Least 10 Days)||3
869424|NCT02228395|2104169|P3|STARTED|Washout Period (at Least 10 Days)||3
869425|NCT02228395|2104170|P2|STARTED|Washout Period (at Least 10 Days)||3
869426|NCT02228395|2104171|P1|STARTED|Washout Period (at Least 10 Days)||3
869427|NCT02228395|2104169|P3|NOT COMPLETED|First Intervention Period||1
869428|NCT02228395|2104170|P2|NOT COMPLETED|First Intervention Period||1
869429|NCT02228395|2104171|P1|NOT COMPLETED|First Intervention Period||1
869430|NCT02228395|2104169|P3|COMPLETED|First Intervention Period||2
869431|NCT02228395|2104170|P2|COMPLETED|First Intervention Period||2
869432|NCT02228395|2104171|P1|COMPLETED|First Intervention Period||2
869433|NCT02228395|2104169|P3|STARTED|First Intervention Period||3
869434|NCT02228395|2104170|P2|STARTED|First Intervention Period||3
869435|NCT02228395|2104171|P1|STARTED|First Intervention Period||3
869436|NCT02227810|2104237|P2|NOT COMPLETED|Overall Study||5
869437|NCT02227810|2104238|P1|NOT COMPLETED|Overall Study||2
869438|NCT02227810|2104237|P2|COMPLETED|Overall Study||29
869439|NCT02227810|2104238|P1|COMPLETED|Overall Study||17
869440|NCT02227810|2104237|P2|STARTED|Overall Study||34
869441|NCT02227810|2104238|P1|STARTED|Overall Study||19
869442|NCT02227485|2104252|P2|NOT COMPLETED|Second Follow-up||2
869443|NCT02227485|2104253|P1|NOT COMPLETED|Second Follow-up||2
869444|NCT02227485|2104252|P2|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|36
869445|NCT02227485|2104253|P1|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|34
869446|NCT02227485|2104252|P2|STARTED|Second Follow-up||38
869447|NCT02227485|2104253|P1|STARTED|Second Follow-up||36
869448|NCT02227485|2104252|P2|NOT COMPLETED|First Follow-up||2
869449|NCT02227485|2104253|P1|NOT COMPLETED|First Follow-up||4
869450|NCT02227485|2104252|P2|COMPLETED|First Follow-up|After 2 weeks, 2 patients had withdrew the study.|38
869451|NCT02227485|2104253|P1|COMPLETED|First Follow-up|At the first follow-up we lost 4 patients.|36
869452|NCT02227485|2104252|P2|STARTED|First Follow-up||40
869453|NCT02227485|2104253|P1|STARTED|First Follow-up||40
869454|NCT02227368|2104271|P2|NOT COMPLETED|Overall Study||4
869455|NCT02227368|2104272|P1|NOT COMPLETED|Overall Study||2
869456|NCT02227368|2104271|P2|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|20
869457|NCT02227368|2104272|P1|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|14
869458|NCT02227368|2104271|P2|Sujects Who Completed Treatment|Overall Study||17
869459|NCT02227368|2104272|P1|Sujects Who Completed Treatment|Overall Study||10
869460|NCT02227368|2104271|P2|Sujects Who Received Treatment|Overall Study||24
869461|NCT02227368|2104272|P1|Sujects Who Received Treatment|Overall Study||16
869462|NCT02227368|2104271|P2|STARTED|Overall Study||24
869463|NCT02227368|2104272|P1|STARTED|Overall Study||16
869464|NCT02227121|2104280|P1|NOT COMPLETED|Overall Study||0
869465|NCT02227121|2104280|P1|COMPLETED|Overall Study||16
869466|NCT02227121|2104280|P1|STARTED|Overall Study||16
869467|NCT02227108|2104284|P1|NOT COMPLETED|Overall Study||31
869468|NCT02227108|2104284|P1|COMPLETED|Overall Study||1
869469|NCT02227108|2104284|P1|Treated|Overall Study||30
869470|NCT02227108|2104284|P1|STARTED|Overall Study||32
869471|NCT02226562|2104313|P2|NOT COMPLETED|Overall Study||1
869472|NCT02226562|2104314|P1|NOT COMPLETED|Overall Study||0
869473|NCT02226562|2104313|P2|COMPLETED|Overall Study|Lost to follow up|95
869474|NCT02226562|2104314|P1|COMPLETED|Overall Study||95
869475|NCT02226562|2104313|P2|STARTED|Overall Study||96
869476|NCT02226562|2104314|P1|STARTED|Overall Study||95
869477|NCT02226549|2104332|P2|NOT COMPLETED|Overall Study||1
869478|NCT02226549|2104333|P1|NOT COMPLETED|Overall Study||1
869479|NCT02226549|2104332|P2|COMPLETED|Overall Study||23
869480|NCT02226549|2104333|P1|COMPLETED|Overall Study||22
869481|NCT02226549|2104332|P2|STARTED|Overall Study||24
869482|NCT02226549|2104333|P1|STARTED|Overall Study||23
869483|NCT02226198|2104343|P3|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
869484|NCT02226198|2104344|P2|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
869485|NCT02226198|2104345|P1|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
869486|NCT02226198|2104343|P3|COMPLETED|Maintenance Phase (12 Weeks)||0
869487|NCT02226198|2104344|P2|COMPLETED|Maintenance Phase (12 Weeks)||0
869488|NCT02226198|2104345|P1|COMPLETED|Maintenance Phase (12 Weeks)||13
869489|NCT02226198|2104343|P3|STARTED|Maintenance Phase (12 Weeks)||0
869490|NCT02226198|2104344|P2|STARTED|Maintenance Phase (12 Weeks)||0
869491|NCT02226198|2104345|P1|STARTED|Maintenance Phase (12 Weeks)||13
869492|NCT02226198|2104343|P3|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
869493|NCT02226198|2104344|P2|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
869494|NCT02226198|2104345|P1|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
869495|NCT02226198|2104343|P3|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||7
869496|NCT02226198|2104344|P2|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||6
869497|NCT02226198|2104345|P1|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
869498|NCT02226198|2104343|P3|STARTED|Cross-Over: Second Interv. (6 Weeks)||7
869499|NCT02226198|2104344|P2|STARTED|Cross-Over: Second Interv. (6 Weeks)||6
869500|NCT02226198|2104345|P1|STARTED|Cross-Over: Second Interv. (6 Weeks)||0
869501|NCT02226198|2104343|P3|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
869502|NCT02226198|2104344|P2|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||1
869503|NCT02226198|2104345|P1|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
869504|NCT02226198|2104343|P3|COMPLETED|Cross-Over: First Intervention (6 Weeks)||7
869505|NCT02226198|2104344|P2|COMPLETED|Cross-Over: First Intervention (6 Weeks)||6
869506|NCT02226198|2104345|P1|COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
869507|NCT02226198|2104343|P3|STARTED|Cross-Over: First Intervention (6 Weeks)||7
869508|NCT02226198|2104344|P2|STARTED|Cross-Over: First Intervention (6 Weeks)||7
869509|NCT02226198|2104345|P1|STARTED|Cross-Over: First Intervention (6 Weeks)||0
869510|NCT02226198|2104343|P3|NOT COMPLETED|Lead-in Phase||0
869511|NCT02226198|2104344|P2|NOT COMPLETED|Lead-in Phase||0
869512|NCT02226198|2104345|P1|NOT COMPLETED|Lead-in Phase||1
869513|NCT02226198|2104343|P3|COMPLETED|Lead-in Phase||0
869514|NCT02226198|2104344|P2|COMPLETED|Lead-in Phase||0
869515|NCT02226198|2104345|P1|COMPLETED|Lead-in Phase||10
869516|NCT02226198|2104343|P3|STARTED|Lead-in Phase||0
869517|NCT02226198|2104344|P2|STARTED|Lead-in Phase||0
869518|NCT02226198|2104345|P1|STARTED|Lead-in Phase||11
869519|NCT02226003|2104421|P3|NOT COMPLETED|Overall Study||6
869520|NCT02226003|2104422|P2|NOT COMPLETED|Overall Study||1
869521|NCT02226003|2104423|P1|NOT COMPLETED|Overall Study||2
869522|NCT02226003|2104421|P3|COMPLETED|Overall Study||91
869523|NCT02226003|2104422|P2|COMPLETED|Overall Study||95
869524|NCT02226003|2104423|P1|COMPLETED|Overall Study||96
869525|NCT02226003|2104421|P3|STARTED|Overall Study||97
869526|NCT02226003|2104422|P2|STARTED|Overall Study||96
869527|NCT02226003|2104423|P1|STARTED|Overall Study||98
869528|NCT02225860|2104457|P2|NOT COMPLETED|Overall Study||0
869529|NCT02225860|2104458|P1|NOT COMPLETED|Overall Study||1
869530|NCT02225860|2104457|P2|COMPLETED|Overall Study||17
869531|NCT02225860|2104458|P1|COMPLETED|Overall Study||16
869532|NCT02225860|2104457|P2|STARTED|Overall Study||17
869533|NCT02225860|2104458|P1|STARTED|Overall Study||17
869534|NCT02224820|2104468|P1|NOT COMPLETED|Overall Study||0
869535|NCT02224820|2104468|P1|COMPLETED|Overall Study|One patient did not receive full dose|8
869536|NCT02224820|2104468|P1|STARTED|Overall Study||8
869537|NCT02224664|2104476|P5|NOT COMPLETED|Dose Escalation Period (21 Days)||11
869538|NCT02224664|2104477|P4|NOT COMPLETED|Dose Escalation Period (21 Days)||3
869539|NCT02224664|2104478|P3|NOT COMPLETED|Dose Escalation Period (21 Days)||2
869540|NCT02224664|2104479|P2|NOT COMPLETED|Dose Escalation Period (21 Days)||0
869541|NCT02224664|2104480|P1|NOT COMPLETED|Dose Escalation Period (21 Days)||0
869542|NCT02224664|2104476|P5|COMPLETED|Dose Escalation Period (21 Days)||8
869543|NCT02224664|2104477|P4|COMPLETED|Dose Escalation Period (21 Days)||3
869544|NCT02224664|2104478|P3|COMPLETED|Dose Escalation Period (21 Days)||9
869545|NCT02224664|2104479|P2|COMPLETED|Dose Escalation Period (21 Days)||9
869546|NCT02224664|2104480|P1|COMPLETED|Dose Escalation Period (21 Days)||0
869547|NCT02224664|2104476|P5|STARTED|Dose Escalation Period (21 Days)||19
869548|NCT02224664|2104477|P4|STARTED|Dose Escalation Period (21 Days)||6
869549|NCT02224664|2104478|P3|STARTED|Dose Escalation Period (21 Days)||11
869550|NCT02224664|2104479|P2|STARTED|Dose Escalation Period (21 Days)||9
869551|NCT02224664|2104480|P1|STARTED|Dose Escalation Period (21 Days)||0
869552|NCT02224664|2104476|P5|NOT COMPLETED|Lead-in Period (3 Days)||0
869553|NCT02224664|2104477|P4|NOT COMPLETED|Lead-in Period (3 Days)||0
869554|NCT02224664|2104478|P3|NOT COMPLETED|Lead-in Period (3 Days)||0
869555|NCT02224664|2104479|P2|NOT COMPLETED|Lead-in Period (3 Days)||0
869556|NCT02224664|2104480|P1|NOT COMPLETED|Lead-in Period (3 Days)||5
869557|NCT02224664|2104476|P5|COMPLETED|Lead-in Period (3 Days)||0
869558|NCT02224664|2104477|P4|COMPLETED|Lead-in Period (3 Days)||0
869559|NCT02224664|2104478|P3|COMPLETED|Lead-in Period (3 Days)||0
869560|NCT02224664|2104479|P2|COMPLETED|Lead-in Period (3 Days)||0
869561|NCT02224664|2104480|P1|COMPLETED|Lead-in Period (3 Days)||45
869562|NCT02224664|2104476|P5|STARTED|Lead-in Period (3 Days)||0
869563|NCT02224664|2104477|P4|STARTED|Lead-in Period (3 Days)||0
869564|NCT02224664|2104478|P3|STARTED|Lead-in Period (3 Days)||0
869565|NCT02224664|2104479|P2|STARTED|Lead-in Period (3 Days)||0
869566|NCT02224664|2104480|P1|STARTED|Lead-in Period (3 Days)||50
869567|NCT02224625|2104560|P1|NOT COMPLETED|Sensitization||55
869568|NCT02224625|2104560|P1|COMPLETED|Sensitization||194
869569|NCT02224625|2104560|P1|STARTED|Sensitization|Subjects from Irritation study also participated in Sensitization Study|249
869570|NCT02224625|2104560|P1|NOT COMPLETED|Irritation||6
869571|NCT02224625|2104560|P1|COMPLETED|Irritation||33
869572|NCT02224625|2104560|P1|STARTED|Irritation||39
869573|NCT02224508|2104574|P2|NOT COMPLETED|Overall Study||0
869574|NCT02224508|2104575|P1|NOT COMPLETED|Overall Study||0
869575|NCT02224508|2104574|P2|COMPLETED|Overall Study||653
869576|NCT02224508|2104575|P1|COMPLETED|Overall Study||935
869577|NCT02224508|2104574|P2|STARTED|Overall Study|Number of patients surveyed in the control segment of the health plan (contracted care).|653
869578|NCT02224508|2104575|P1|STARTED|Overall Study|Number of patients surveyed in intervention segment of the health plan (group practice).|935
869579|NCT02224404|2104585|P1|NOT COMPLETED|Overall Study||0
869580|NCT02224404|2104585|P1|COMPLETED|Overall Study||21
869581|NCT02224404|2104585|P1|STARTED|Overall Study||21
869582|NCT02224053|2104590|P1|NOT COMPLETED|AZD9291 Alone||0
869583|NCT02224053|2104590|P1|COMPLETED|AZD9291 Alone||47
869584|NCT02224053|2104590|P1|STARTED|AZD9291 Alone||47
869585|NCT02224053|2104590|P1|NOT COMPLETED|AZD9291 and Omeprazole Co-administration||21
869586|NCT02224053|2104590|P1|COMPLETED|AZD9291 and Omeprazole Co-administration||47
869587|NCT02224053|2104590|P1|STARTED|AZD9291 and Omeprazole Co-administration||68
869588|NCT02223871|2104622|P1|NOT COMPLETED|Overall Study||0
869589|NCT02223871|2104622|P1|COMPLETED|Overall Study||8
869590|NCT02223871|2104622|P1|STARTED|Overall Study||8
869591|NCT02223754|2104636|P2|NOT COMPLETED|Period 2||3
869592|NCT02223754|2104637|P1|NOT COMPLETED|Period 2||3
869593|NCT02223754|2104636|P2|COMPLETED|Period 2||141
869594|NCT02223754|2104637|P1|COMPLETED|Period 2||156
869595|NCT02223754|2104636|P2|STARTED|Period 2||144
869596|NCT02223754|2104637|P1|STARTED|Period 2||159
869597|NCT02223754|2104636|P2|NOT COMPLETED|Period 1||15
869598|NCT02223754|2104637|P1|NOT COMPLETED|Period 1||4
869599|NCT02223754|2104636|P2|COMPLETED|Period 1||144
869600|NCT02223754|2104637|P1|COMPLETED|Period 1||159
869601|NCT02223754|2104636|P2|STARTED|Period 1||159
869602|NCT02223754|2104637|P1|STARTED|Period 1||163
869603|NCT02223715|2104657|P1|NOT COMPLETED|Overall Study||104
869604|NCT02223715|2104657|P1|COMPLETED|Overall Study||496
869605|NCT02223715|2104657|P1|STARTED|Overall Study||600
869606|NCT02223650|2104666|P2|NOT COMPLETED|Overall Study||0
869607|NCT02223650|2104667|P1|NOT COMPLETED|Overall Study||0
869608|NCT02223650|2104666|P2|COMPLETED|Overall Study||31
869609|NCT02223650|2104667|P1|COMPLETED|Overall Study||27
869610|NCT02223650|2104666|P2|STARTED|Overall Study||31
869611|NCT02223650|2104667|P1|STARTED|Overall Study||27
869612|NCT02223429|2104701|P4|NOT COMPLETED|Overall Study||0
869613|NCT02223429|2104702|P3|NOT COMPLETED|Overall Study||0
869614|NCT02223429|2104703|P2|NOT COMPLETED|Overall Study||0
869615|NCT02223429|2104704|P1|NOT COMPLETED|Overall Study||1
869616|NCT02223429|2104701|P4|COMPLETED|Overall Study||8
869617|NCT02223429|2104702|P3|COMPLETED|Overall Study||8
869618|NCT02223429|2104703|P2|COMPLETED|Overall Study||8
869619|NCT02223429|2104704|P1|COMPLETED|Overall Study||7
869620|NCT02223429|2104701|P4|STARTED|Overall Study||8
869621|NCT02223429|2104702|P3|STARTED|Overall Study||8
869622|NCT02223429|2104703|P2|STARTED|Overall Study||8
869623|NCT02223429|2104704|P1|STARTED|Overall Study||8
869624|NCT02223364|2104735|P3|NOT COMPLETED|Overall Study||3
869625|NCT02223364|2104736|P2|NOT COMPLETED|Overall Study||0
869626|NCT02223364|2104737|P1|NOT COMPLETED|Overall Study||5
869627|NCT02223364|2104735|P3|COMPLETED|Overall Study||52
869628|NCT02223364|2104736|P2|COMPLETED|Overall Study||55
869629|NCT02223364|2104737|P1|COMPLETED|Overall Study||50
869630|NCT02223364|2104735|P3|STARTED|Overall Study||55
869631|NCT02223364|2104736|P2|STARTED|Overall Study||55
869632|NCT02223364|2104737|P1|STARTED|Overall Study||55
869633|NCT02223260|2104787|P1|NOT COMPLETED|Overall Study||0
869634|NCT02223260|2104787|P1|COMPLETED|Overall Study||8
869635|NCT02223260|2104787|P1|STARTED|Overall Study||8
869636|NCT02223065|2104805|P2|NOT COMPLETED|Overall Study||0
869637|NCT02223065|2104806|P1|NOT COMPLETED|Overall Study||0
869638|NCT02223065|2104805|P2|COMPLETED|Overall Study||18
869639|NCT02223065|2104806|P1|COMPLETED|Overall Study||18
869640|NCT02223065|2104805|P2|STARTED|Overall Study||18
869641|NCT02223065|2104806|P1|STARTED|Overall Study||18
869642|NCT02222870|2104824|P2|NOT COMPLETED|Overall Study||0
869643|NCT02222870|2104825|P1|NOT COMPLETED|Overall Study||0
869644|NCT02222870|2104824|P2|COMPLETED|Overall Study||30
869645|NCT02222870|2104825|P1|COMPLETED|Overall Study||30
869646|NCT02222870|2104824|P2|STARTED|Overall Study||30
869647|NCT02222870|2104825|P1|STARTED|Overall Study||30
869648|NCT02222818|2104841|P2|NOT COMPLETED|Period 2||0
869649|NCT02222818|2104842|P1|NOT COMPLETED|Period 2||0
869650|NCT02222818|2104841|P2|COMPLETED|Period 2|End of CAFR evaluation period|30
869651|NCT02222818|2104842|P1|COMPLETED|Period 2|End of CAFRPlus evaluation period|33
869652|NCT02222818|2104841|P2|STARTED|Period 2|Start of CAFR evaluation period|30
869653|NCT02222818|2104842|P1|STARTED|Period 2|Start of CAFRPlus evaluation period|33
869654|NCT02222818|2104841|P2|NOT COMPLETED|Period 1||3
869655|NCT02222818|2104842|P1|NOT COMPLETED|Period 1||0
869656|NCT02222818|2104841|P2|COMPLETED|Period 1|End of CAFRPlus evaluation period|30
869657|NCT02222818|2104842|P1|COMPLETED|Period 1|End of CAFR evaluation period|33
869658|NCT02222818|2104841|P2|STARTED|Period 1|Start of CAFRPlus evaluation period|33
869659|NCT02222818|2104842|P1|STARTED|Period 1|Start of CAFR evaluation period|33
869660|NCT02222558|2104849|P6|NOT COMPLETED|Period 3||1
869661|NCT02222558|2104850|P5|NOT COMPLETED|Period 3||0
869662|NCT02222558|2104851|P4|NOT COMPLETED|Period 3||0
869663|NCT02222558|2104852|P3|NOT COMPLETED|Period 3||0
869664|NCT02222558|2104853|P2|NOT COMPLETED|Period 3||0
869665|NCT02222558|2104854|P1|NOT COMPLETED|Period 3||0
869666|NCT02222558|2104849|P6|COMPLETED|Period 3||7
869667|NCT02222558|2104850|P5|COMPLETED|Period 3||8
869668|NCT02222558|2104851|P4|COMPLETED|Period 3||1
869669|NCT02222558|2104852|P3|COMPLETED|Period 3||4
869670|NCT02222558|2104853|P2|COMPLETED|Period 3||0
869671|NCT02222558|2104854|P1|COMPLETED|Period 3||0
869672|NCT02222558|2104849|P6|STARTED|Period 3||8
869673|NCT02222558|2104850|P5|STARTED|Period 3||8
869674|NCT02222558|2104851|P4|STARTED|Period 3||1
869675|NCT02222558|2104852|P3|STARTED|Period 3||4
869676|NCT02222558|2104853|P2|STARTED|Period 3||0
869677|NCT02222558|2104854|P1|STARTED|Period 3||0
869678|NCT02222558|2104849|P6|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
869679|NCT02222558|2104850|P5|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
869680|NCT02222558|2104851|P4|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
869681|NCT02222558|2104852|P3|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
869682|NCT02222558|2104853|P2|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
869683|NCT02222558|2104854|P1|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
869684|NCT02222558|2104849|P6|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
869685|NCT02222558|2104850|P5|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
869686|NCT02222558|2104851|P4|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
869687|NCT02222558|2104852|P3|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
869688|NCT02222558|2104853|P2|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||21
869689|NCT02222558|2104854|P1|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
869690|NCT02222558|2104849|P6|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
869691|NCT02222558|2104850|P5|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
869692|NCT02222558|2104851|P4|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
869693|NCT02222558|2104852|P3|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
869694|NCT02222558|2104853|P2|STARTED|Period 2: Two Times Daily Dosing 90 mg||21
869695|NCT02222558|2104854|P1|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
869696|NCT02222558|2104849|P6|NOT COMPLETED|Period 1: Single Dose||0
869697|NCT02222558|2104850|P5|NOT COMPLETED|Period 1: Single Dose||0
869698|NCT02222558|2104851|P4|NOT COMPLETED|Period 1: Single Dose||0
869699|NCT02222558|2104852|P3|NOT COMPLETED|Period 1: Single Dose||0
869700|NCT02222558|2104853|P2|NOT COMPLETED|Period 1: Single Dose||0
869701|NCT02222558|2104854|P1|NOT COMPLETED|Period 1: Single Dose||4
869702|NCT02222558|2104849|P6|COMPLETED|Period 1: Single Dose||0
869703|NCT02222558|2104850|P5|COMPLETED|Period 1: Single Dose||0
869704|NCT02222558|2104851|P4|COMPLETED|Period 1: Single Dose||0
869705|NCT02222558|2104852|P3|COMPLETED|Period 1: Single Dose||0
869706|NCT02222558|2104853|P2|COMPLETED|Period 1: Single Dose||0
869707|NCT02222558|2104854|P1|COMPLETED|Period 1: Single Dose||21
869708|NCT02222558|2104849|P6|STARTED|Period 1: Single Dose||0
869709|NCT02222558|2104850|P5|STARTED|Period 1: Single Dose||0
869710|NCT02222558|2104851|P4|STARTED|Period 1: Single Dose||0
869711|NCT02222558|2104852|P3|STARTED|Period 1: Single Dose||0
869712|NCT02222558|2104853|P2|STARTED|Period 1: Single Dose||0
869713|NCT02222558|2104854|P1|STARTED|Period 1: Single Dose||25
869714|NCT02222493|2104870|P2|NOT COMPLETED|Overall Study||40
869715|NCT02222493|2104871|P1|NOT COMPLETED|Overall Study||44
869716|NCT02222493|2104870|P2|COMPLETED|Overall Study||286
869717|NCT02222493|2104871|P1|COMPLETED|Overall Study||280
869718|NCT02222493|2104870|P2|Received Treatment|Overall Study||326
869719|NCT02222493|2104871|P1|Received Treatment|Overall Study||323
869720|NCT02222493|2104870|P2|STARTED|Overall Study||326
869721|NCT02222493|2104871|P1|STARTED|Overall Study||324
869722|NCT02222246|2104879|P2|NOT COMPLETED|Overall Study||27
869723|NCT02222246|2104880|P1|NOT COMPLETED|Overall Study||27
869724|NCT02222246|2104879|P2|COMPLETED|Overall Study||26
869725|NCT02222246|2104880|P1|COMPLETED|Overall Study||26
869726|NCT02222246|2104879|P2|STARTED|Overall Study||53
869727|NCT02222246|2104880|P1|STARTED|Overall Study||53
869728|NCT02222207|2104908|P1|NOT COMPLETED|Overall Study||4
869729|NCT02222207|2104908|P1|COMPLETED|Overall Study||48
869730|NCT02222207|2104908|P1|Treated and Valid for Full Analysis Set|Overall Study||51
869731|NCT02222207|2104908|P1|STARTED|Overall Study||52
869732|NCT02222181|2104915|P1|NOT COMPLETED|Overall Study||108
869733|NCT02222181|2104915|P1|COMPLETED|Overall Study||55
869734|NCT02222181|2104915|P1|STARTED|Overall Study||163
869735|NCT02222129|2104927|P2|NOT COMPLETED|Overall Study||0
869736|NCT02222129|2104928|P1|NOT COMPLETED|Overall Study||0
869737|NCT02222129|2104927|P2|COMPLETED|Overall Study||106
869738|NCT02222129|2104928|P1|COMPLETED|Overall Study||100
869739|NCT02222129|2104927|P2|STARTED|Overall Study||106
869740|NCT02222129|2104928|P1|STARTED|Overall Study||100
869741|NCT02221947|2104936|P2|NOT COMPLETED|Overall Study||0
869742|NCT02221947|2104937|P1|NOT COMPLETED|Overall Study||0
869743|NCT02221947|2104936|P2|COMPLETED|Overall Study||3
869744|NCT02221947|2104937|P1|COMPLETED|Overall Study||6
869745|NCT02221947|2104936|P2|STARTED|Overall Study||3
869746|NCT02221947|2104937|P1|STARTED|Overall Study||6
869747|NCT02221648|2104945|P2|NOT COMPLETED|Overall Study||3
869748|NCT02221648|2104946|P1|NOT COMPLETED|Overall Study||3
869749|NCT02221648|2104945|P2|COMPLETED|Overall Study||18
869750|NCT02221648|2104946|P1|COMPLETED|Overall Study||19
869751|NCT02221648|2104945|P2|STARTED|Overall Study||21
869752|NCT02221648|2104946|P1|STARTED|Overall Study||22
869753|NCT02221557|2104956|P1|NOT COMPLETED|Overall Study||3
869754|NCT02221557|2104956|P1|COMPLETED|Overall Study||5
869755|NCT02221557|2104956|P1|STARTED|Overall Study||8
869756|NCT02220998|2104962|P2|NOT COMPLETED|Overall Study||11
869757|NCT02220998|2104963|P1|NOT COMPLETED|Overall Study||7
869758|NCT02220998|2104962|P2|COMPLETED|Overall Study||123
869759|NCT02220998|2104963|P1|COMPLETED|Overall Study||128
869760|NCT02220998|2104962|P2|STARTED|Overall Study||134
869761|NCT02220998|2104963|P1|STARTED|Overall Study||135
869762|NCT02220920|2104981|P2|NOT COMPLETED|Overall Study||3
869763|NCT02220920|2104982|P1|NOT COMPLETED|Overall Study||3
869764|NCT02220920|2104981|P2|COMPLETED|Overall Study||67
869765|NCT02220920|2104982|P1|COMPLETED|Overall Study||73
869766|NCT02220920|2104981|P2|STARTED|Overall Study||70
869767|NCT02220920|2104982|P1|STARTED|Overall Study||76
869768|NCT02220764|2104998|P2|NOT COMPLETED|Overall Study||1
869769|NCT02220764|2104999|P1|NOT COMPLETED|Overall Study||4
869770|NCT02220764|2104998|P2|COMPLETED|Overall Study||7
869771|NCT02220764|2104999|P1|COMPLETED|Overall Study||20
869772|NCT02220764|2104998|P2|STARTED|Overall Study||8
869773|NCT02220764|2104999|P1|STARTED|Overall Study||24
869774|NCT02220205|2105011|P2|NOT COMPLETED|Overall Study||0
869775|NCT02220205|2105012|P1|NOT COMPLETED|Overall Study||1
869776|NCT02220205|2105011|P2|COMPLETED|Overall Study||30
869777|NCT02220205|2105012|P1|COMPLETED|Overall Study||29
869778|NCT02220205|2105011|P2|STARTED|Overall Study||30
869779|NCT02220205|2105012|P1|STARTED|Overall Study||30
869780|NCT02219997|2105022|P3|NOT COMPLETED|Second Filter||0
869781|NCT02219997|2105023|P2|NOT COMPLETED|Second Filter||0
869782|NCT02219997|2105024|P1|NOT COMPLETED|Second Filter||0
869783|NCT02219997|2105022|P3|COMPLETED|Second Filter||18
869784|NCT02219997|2105023|P2|COMPLETED|Second Filter||17
869785|NCT02219997|2105024|P1|COMPLETED|Second Filter||0
869786|NCT02219997|2105022|P3|STARTED|Second Filter||18
869787|NCT02219997|2105023|P2|STARTED|Second Filter||17
869788|NCT02219997|2105024|P1|STARTED|Second Filter||0
869789|NCT02219997|2105022|P3|NOT COMPLETED|First Filter||0
869790|NCT02219997|2105023|P2|NOT COMPLETED|First Filter||0
869791|NCT02219997|2105024|P1|NOT COMPLETED|First Filter||0
869792|NCT02219997|2105022|P3|COMPLETED|First Filter||18
869793|NCT02219997|2105023|P2|COMPLETED|First Filter||17
869794|NCT02219997|2105024|P1|COMPLETED|First Filter||33
869795|NCT02219997|2105022|P3|STARTED|First Filter||18
869796|NCT02219997|2105023|P2|STARTED|First Filter||17
869797|NCT02219997|2105024|P1|STARTED|First Filter||33
869798|NCT02219932|2105037|P2|NOT COMPLETED|Overall Study||51
869799|NCT02219932|2105038|P1|NOT COMPLETED|Overall Study||65
869800|NCT02219932|2105037|P2|COMPLETED|Overall Study||266
869801|NCT02219932|2105038|P1|COMPLETED|Overall Study||254
869802|NCT02219932|2105037|P2|Randomized, Not Treated|Overall Study||1
869803|NCT02219932|2105038|P1|Randomized, Not Treated|Overall Study||0
869804|NCT02219932|2105037|P2|STARTED|Overall Study||317
869805|NCT02219932|2105038|P1|STARTED|Overall Study||319
869806|NCT02219685|2105054|P2|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
869807|NCT02219685|2105055|P1|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
869808|NCT02219685|2105054|P2|COMPLETED|Open-Label (After Posttreatment Week 4)||14
869809|NCT02219685|2105055|P1|COMPLETED|Open-Label (After Posttreatment Week 4)||0
869810|NCT02219685|2105054|P2|STARTED|Open-Label (After Posttreatment Week 4)||14
869811|NCT02219685|2105055|P1|STARTED|Open-Label (After Posttreatment Week 4)|Only participants from the Placebo arm were eligible to enroll in the Open-Label Phase.|0
869812|NCT02219685|2105054|P2|NOT COMPLETED|Blinded Treatment Phase||0
869813|NCT02219685|2105055|P1|NOT COMPLETED|Blinded Treatment Phase||2
869814|NCT02219685|2105054|P2|COMPLETED|Blinded Treatment Phase||14
869815|NCT02219685|2105055|P1|COMPLETED|Blinded Treatment Phase||24
869816|NCT02219685|2105054|P2|STARTED|Blinded Treatment Phase||14
869817|NCT02219685|2105055|P1|STARTED|Blinded Treatment Phase||26
869818|NCT02219516|2105103|P4|NOT COMPLETED|Overall Study||0
869819|NCT02219516|2105104|P3|NOT COMPLETED|Overall Study||0
869820|NCT02219516|2105105|P2|NOT COMPLETED|Overall Study||0
869821|NCT02219516|2105106|P1|NOT COMPLETED|Overall Study||0
869822|NCT02219516|2105103|P4|COMPLETED|Overall Study||8
869823|NCT02219516|2105104|P3|COMPLETED|Overall Study||7
869824|NCT02219516|2105105|P2|COMPLETED|Overall Study||8
869825|NCT02219516|2105106|P1|COMPLETED|Overall Study||8
869826|NCT02219516|2105103|P4|STARTED|Overall Study||8
869827|NCT02219516|2105104|P3|STARTED|Overall Study||7
869828|NCT02219516|2105105|P2|STARTED|Overall Study||8
869829|NCT02219516|2105106|P1|STARTED|Overall Study||8
869830|NCT02219503|2105152|P1|NOT COMPLETED|Overall Study||0
869831|NCT02219503|2105152|P1|COMPLETED|Overall Study||60
869832|NCT02219503|2105152|P1|STARTED|Overall Study||60
869833|NCT02219477|2105161|P3|NOT COMPLETED|Overall Study||1
869834|NCT02219477|2105162|P2|NOT COMPLETED|Overall Study||2
869835|NCT02219477|2105163|P1|NOT COMPLETED|Overall Study||0
869836|NCT02219477|2105161|P3|COMPLETED|Overall Study||2
869837|NCT02219477|2105162|P2|COMPLETED|Overall Study||22
869838|NCT02219477|2105163|P1|COMPLETED|Overall Study||9
869839|NCT02219477|2105161|P3|STARTED|Overall Study||3
869840|NCT02219477|2105162|P2|STARTED|Overall Study||24
869841|NCT02219477|2105163|P1|STARTED|Overall Study||9
869842|NCT02219464|2105191|P2|NOT COMPLETED|Overall Study||0
869843|NCT02219464|2105192|P1|NOT COMPLETED|Overall Study||3
869844|NCT02219464|2105191|P2|COMPLETED|Overall Study||30
869845|NCT02219464|2105192|P1|COMPLETED|Overall Study||27
869846|NCT02219464|2105191|P2|STARTED|Overall Study||30
869847|NCT02219464|2105192|P1|STARTED|Overall Study||30
869848|NCT02219282|2105202|P2|NOT COMPLETED|Overall Study||1
869849|NCT02219282|2105203|P1|NOT COMPLETED|Overall Study||1
869850|NCT02219282|2105202|P2|COMPLETED|Overall Study||32
869851|NCT02219282|2105203|P1|COMPLETED|Overall Study||32
869852|NCT02219282|2105202|P2|STARTED|Overall Study||33
869853|NCT02219282|2105203|P1|STARTED|Overall Study||33
869854|NCT02219256|2105229|P12|NOT COMPLETED|Overall Study||0
869855|NCT02219256|2105230|P11|NOT COMPLETED|Overall Study||0
869856|NCT02219256|2105231|P10|NOT COMPLETED|Overall Study||0
869857|NCT02219256|2105232|P9|NOT COMPLETED|Overall Study||0
869858|NCT02219256|2105233|P8|NOT COMPLETED|Overall Study||0
869859|NCT02219256|2105234|P7|NOT COMPLETED|Overall Study||0
869860|NCT02219256|2105235|P6|NOT COMPLETED|Overall Study||0
869861|NCT02219256|2105236|P5|NOT COMPLETED|Overall Study||0
869862|NCT02219256|2105237|P4|NOT COMPLETED|Overall Study||0
869863|NCT02219256|2105238|P3|NOT COMPLETED|Overall Study||0
869864|NCT02219256|2105239|P2|NOT COMPLETED|Overall Study||0
869865|NCT02219256|2105240|P1|NOT COMPLETED|Overall Study||0
869866|NCT02219256|2105229|P12|COMPLETED|Overall Study||6
869867|NCT02219256|2105230|P11|COMPLETED|Overall Study||6
869868|NCT02219256|2105231|P10|COMPLETED|Overall Study||6
869869|NCT02219256|2105232|P9|COMPLETED|Overall Study||6
869870|NCT02219256|2105233|P8|COMPLETED|Overall Study||8
869871|NCT02219256|2105234|P7|COMPLETED|Overall Study||6
869872|NCT02219256|2105235|P6|COMPLETED|Overall Study||6
869873|NCT02219256|2105236|P5|COMPLETED|Overall Study||6
869874|NCT02219256|2105237|P4|COMPLETED|Overall Study||4
869875|NCT02219256|2105238|P3|COMPLETED|Overall Study||4
869876|NCT02219256|2105239|P2|COMPLETED|Overall Study||4
869877|NCT02219256|2105240|P1|COMPLETED|Overall Study||12
869878|NCT02219256|2105229|P12|STARTED|Overall Study||6
869879|NCT02219256|2105230|P11|STARTED|Overall Study||6
869880|NCT02219256|2105231|P10|STARTED|Overall Study||6
869881|NCT02219256|2105232|P9|STARTED|Overall Study||6
869882|NCT02219256|2105233|P8|STARTED|Overall Study||8
869883|NCT02219256|2105234|P7|STARTED|Overall Study||6
869884|NCT02219256|2105235|P6|STARTED|Overall Study||6
869885|NCT02219256|2105236|P5|STARTED|Overall Study||6
869886|NCT02219256|2105237|P4|STARTED|Overall Study||4
869887|NCT02219256|2105238|P3|STARTED|Overall Study||4
869888|NCT02219256|2105239|P2|STARTED|Overall Study||4
869889|NCT02219256|2105240|P1|STARTED|Overall Study||12
869896|NCT02217280|2105391|P1|NOT COMPLETED|Overall Study||4
869897|NCT02217280|2105391|P1|COMPLETED|Overall Study||16
869898|NCT02217280|2105391|P1|STARTED|Overall Study||20
869899|NCT02218307|2105398|P2|NOT COMPLETED|Overall Study||1
869900|NCT02218307|2105399|P1|NOT COMPLETED|Overall Study||9
869901|NCT02218307|2105398|P2|COMPLETED|Overall Study||33
869902|NCT02218307|2105399|P1|COMPLETED|Overall Study||25
869903|NCT02218307|2105398|P2|STARTED|Overall Study||34
869904|NCT02218307|2105399|P1|STARTED|Overall Study||34
869905|NCT02218268|2105407|P2|NOT COMPLETED|Final Phase (2 Hours)||0
869906|NCT02218268|2105408|P1|NOT COMPLETED|Final Phase (2 Hours)||0
869907|NCT02218268|2105407|P2|COMPLETED|Final Phase (2 Hours)||21
869908|NCT02218268|2105408|P1|COMPLETED|Final Phase (2 Hours)||19
869909|NCT02218268|2105407|P2|STARTED|Final Phase (2 Hours)||21
869910|NCT02218268|2105408|P1|STARTED|Final Phase (2 Hours)||19
869911|NCT02218268|2105407|P2|NOT COMPLETED|24 Hour Washout||9
869912|NCT02218268|2105408|P1|NOT COMPLETED|24 Hour Washout||11
869913|NCT02218268|2105407|P2|COMPLETED|24 Hour Washout||21
869914|NCT02218268|2105408|P1|COMPLETED|24 Hour Washout||19
869915|NCT02218268|2105407|P2|STARTED|24 Hour Washout||30
869916|NCT02218268|2105408|P1|STARTED|24 Hour Washout||30
869917|NCT02218268|2105407|P2|NOT COMPLETED|First Phase (2 Hours)||0
869918|NCT02218268|2105408|P1|NOT COMPLETED|First Phase (2 Hours)||0
869919|NCT02218268|2105407|P2|COMPLETED|First Phase (2 Hours)||30
869920|NCT02218268|2105408|P1|COMPLETED|First Phase (2 Hours)||30
869921|NCT02218268|2105407|P2|STARTED|First Phase (2 Hours)||30
869922|NCT02218268|2105408|P1|STARTED|First Phase (2 Hours)||30
869923|NCT02218216|2105416|P3|NOT COMPLETED|Overall Study||0
869924|NCT02218216|2105417|P2|NOT COMPLETED|Overall Study||0
869925|NCT02218216|2105418|P1|NOT COMPLETED|Overall Study||6
869926|NCT02218216|2105416|P3|COMPLETED|Overall Study||3
869927|NCT02218216|2105417|P2|COMPLETED|Overall Study||2
869928|NCT02218216|2105418|P1|COMPLETED|Overall Study||8
869929|NCT02218216|2105416|P3|STARTED|Overall Study||3
869930|NCT02218216|2105417|P2|STARTED|Overall Study||2
869931|NCT02218216|2105418|P1|STARTED|Overall Study||14
869932|NCT02217982|2105428|P2|NOT COMPLETED|Overall Study||1
869933|NCT02217982|2105429|P1|NOT COMPLETED|Overall Study||1
869934|NCT02217982|2105428|P2|COMPLETED|Overall Study||3
869935|NCT02217982|2105429|P1|COMPLETED|Overall Study|Trial closed before patient finished|0
869936|NCT02217982|2105428|P2|STARTED|Overall Study||4
869937|NCT02217982|2105429|P1|STARTED|Overall Study||1
869938|NCT02217878|2105439|P2|NOT COMPLETED|Overall Study||2
869939|NCT02217878|2105440|P1|NOT COMPLETED|Overall Study||2
869940|NCT02217878|2105439|P2|COMPLETED|Overall Study||35
869941|NCT02217878|2105440|P1|COMPLETED|Overall Study||35
869942|NCT02217878|2105439|P2|STARTED|Overall Study||37
869943|NCT02217878|2105440|P1|STARTED|Overall Study||37
869944|NCT02216695|2105520|P1|NOT COMPLETED|Overall Study||0
869945|NCT02216695|2105520|P1|COMPLETED|Overall Study|This is a database study and hence, 64882 patients were finally included|64882
869946|NCT02216695|2105520|P1|STARTED|Overall Study||64882
869947|NCT02216591|2105531|P2|NOT COMPLETED|Overall Study||1
869948|NCT02216591|2105532|P1|NOT COMPLETED|Overall Study||0
869949|NCT02216591|2105531|P2|COMPLETED|Overall Study||9
869950|NCT02216591|2105532|P1|COMPLETED|Overall Study||11
869951|NCT02216591|2105531|P2|STARTED|Overall Study||10
869952|NCT02216591|2105532|P1|STARTED|Overall Study||11
869953|NCT02216422|2105542|P1|NOT COMPLETED|Overall Study||0
869954|NCT02216422|2105542|P1|COMPLETED|Overall Study||36
869955|NCT02216422|2105542|P1|STARTED|Overall Study||36
869956|NCT02216357|2105550|P2|NOT COMPLETED|Overall Study||1
869957|NCT02216357|2105551|P1|NOT COMPLETED|Overall Study||2
869958|NCT02216357|2105550|P2|COMPLETED|Overall Study||4
869959|NCT02216357|2105551|P1|COMPLETED|Overall Study||12
869960|NCT02216357|2105550|P2|STARTED|Overall Study||5
869961|NCT02216357|2105551|P1|STARTED|Overall Study||14
869962|NCT02216097|2105577|P2|NOT COMPLETED|Overall Study||0
869963|NCT02216097|2105578|P1|NOT COMPLETED|Overall Study||0
869964|NCT02216097|2105577|P2|COMPLETED|Overall Study||6
869965|NCT02216097|2105578|P1|COMPLETED|Overall Study||8
869966|NCT02216097|2105577|P2|STARTED|Overall Study||6
869967|NCT02216097|2105578|P1|STARTED|Overall Study||8
869968|NCT02215954|2105603|P3|NOT COMPLETED|Overall Study||6
869969|NCT02215954|2105604|P2|NOT COMPLETED|Overall Study||1
869970|NCT02215954|2105605|P1|NOT COMPLETED|Overall Study||1
869971|NCT02215954|2105603|P3|COMPLETED|Overall Study||205
869972|NCT02215954|2105604|P2|COMPLETED|Overall Study||211
869973|NCT02215954|2105605|P1|COMPLETED|Overall Study||213
869974|NCT02215954|2105603|P3|Safety Analysis Set|Overall Study||208
869975|NCT02215954|2105604|P2|Safety Analysis Set|Overall Study||211
869976|NCT02215954|2105605|P1|Safety Analysis Set|Overall Study||213
869977|NCT02215954|2105603|P3|Per Protocol (PP) Analysis Set|Overall Study||205
869978|NCT02215954|2105604|P2|Per Protocol (PP) Analysis Set|Overall Study||208
869979|NCT02215954|2105605|P1|Per Protocol (PP) Analysis Set|Overall Study||212
869980|NCT02215954|2105603|P3|Intention-To-Treat (ITT) Analysis Set|Overall Study||211
869981|NCT02215954|2105604|P2|Intention-To-Treat (ITT) Analysis Set|Overall Study||212
869982|NCT02215954|2105605|P1|Intention-To-Treat (ITT) Analysis Set|Overall Study||214
869983|NCT02215954|2105603|P3|STARTED|Overall Study||211
869984|NCT02215954|2105604|P2|STARTED|Overall Study||212
869985|NCT02215954|2105605|P1|STARTED|Overall Study||214
869986|NCT02215252|2105628|P3|NOT COMPLETED|Overall Study||4
869987|NCT02215252|2105629|P2|NOT COMPLETED|Overall Study||8
869988|NCT02215252|2105630|P1|NOT COMPLETED|Overall Study||2
869989|NCT02215252|2105628|P3|COMPLETED|Overall Study||41
869990|NCT02215252|2105629|P2|COMPLETED|Overall Study||38
869991|NCT02215252|2105630|P1|COMPLETED|Overall Study||42
869992|NCT02215252|2105628|P3|STARTED|Overall Study||45
869993|NCT02215252|2105629|P2|STARTED|Overall Study||46
869994|NCT02215252|2105630|P1|STARTED|Overall Study||44
869995|NCT02214615|2105689|P2|NOT COMPLETED|Second Intervention||0
869996|NCT02214615|2105690|P1|NOT COMPLETED|Second Intervention||0
869997|NCT02214615|2105689|P2|COMPLETED|Second Intervention||1
869998|NCT02214615|2105690|P1|COMPLETED|Second Intervention||1
869999|NCT02214615|2105689|P2|STARTED|Second Intervention||1
870000|NCT02214615|2105690|P1|STARTED|Second Intervention||1
870001|NCT02214615|2105689|P2|NOT COMPLETED|Washout||0
870002|NCT02214615|2105690|P1|NOT COMPLETED|Washout||0
870003|NCT02214615|2105689|P2|COMPLETED|Washout||1
870004|NCT02214615|2105690|P1|COMPLETED|Washout||1
870005|NCT02214615|2105689|P2|STARTED|Washout||1
870006|NCT02214615|2105690|P1|STARTED|Washout||1
870007|NCT02214615|2105689|P2|NOT COMPLETED|First Intervention||0
870008|NCT02214615|2105690|P1|NOT COMPLETED|First Intervention||0
870009|NCT02214615|2105689|P2|COMPLETED|First Intervention||1
870010|NCT02214615|2105690|P1|COMPLETED|First Intervention||1
870011|NCT02214615|2105689|P2|STARTED|First Intervention||1
870012|NCT02214615|2105690|P1|STARTED|First Intervention||1
870013|NCT02214238|2105700|P2|NOT COMPLETED|Overall Study||6
870014|NCT02214238|2105701|P1|NOT COMPLETED|Overall Study||6
870015|NCT02214238|2105700|P2|COMPLETED|Overall Study||17
870016|NCT02214238|2105701|P1|COMPLETED|Overall Study||20
870017|NCT02214238|2105700|P2|STARTED|Overall Study||23
870018|NCT02214238|2105701|P1|STARTED|Overall Study||26
870019|NCT02214225|2105714|P3|NOT COMPLETED|Overall Study||22
870020|NCT02214225|2105715|P2|NOT COMPLETED|Overall Study||19
870021|NCT02214225|2105716|P1|NOT COMPLETED|Overall Study||55
870022|NCT02214225|2105714|P3|COMPLETED|Overall Study||850
870023|NCT02214225|2105715|P2|COMPLETED|Overall Study||852
870024|NCT02214225|2105716|P1|COMPLETED|Overall Study||1686
870025|NCT02214225|2105714|P3|STARTED|Overall Study||872
870026|NCT02214225|2105715|P2|STARTED|Overall Study||871
870027|NCT02214225|2105716|P1|STARTED|Overall Study||1741
870028|NCT02214186|2105775|P2|NOT COMPLETED|Overall Study||2
870029|NCT02214186|2105776|P1|NOT COMPLETED|Overall Study||2
870030|NCT02214186|2105775|P2|COMPLETED|Overall Study||21
870031|NCT02214186|2105776|P1|COMPLETED|Overall Study||21
870032|NCT02214186|2105775|P2|STARTED|Overall Study||23
870033|NCT02214186|2105776|P1|STARTED|Overall Study||23
870034|NCT02213900|2105800|P2|NOT COMPLETED|Overall Study||0
870035|NCT02213900|2105801|P1|NOT COMPLETED|Overall Study||0
870036|NCT02213900|2105800|P2|COMPLETED|Overall Study||67
870037|NCT02213900|2105801|P1|COMPLETED|Overall Study||68
870038|NCT02213900|2105800|P2|STARTED|Overall Study||67
870039|NCT02213900|2105801|P1|STARTED|Overall Study||68
870040|NCT02213666|2105813|P1|NOT COMPLETED|Overall Study||1
870041|NCT02213666|2105813|P1|COMPLETED|Overall Study||71
870042|NCT02213666|2105813|P1|STARTED|Overall Study||72
870043|NCT02213510|2105819|P2|NOT COMPLETED|Overall Study||1
870044|NCT02213510|2105820|P1|NOT COMPLETED|Overall Study||1
870045|NCT02213510|2105819|P2|COMPLETED|Overall Study||18
870046|NCT02213510|2105820|P1|COMPLETED|Overall Study||20
870047|NCT02213510|2105819|P2|STARTED|Overall Study||19
870048|NCT02213510|2105820|P1|STARTED|Overall Study||21
870049|NCT02213250|2105846|P2|NOT COMPLETED|Overall Study||0
870050|NCT02213250|2105847|P1|NOT COMPLETED|Overall Study||0
870051|NCT02213250|2105846|P2|COMPLETED|Overall Study||8
870052|NCT02213250|2105847|P1|COMPLETED|Overall Study||4
870053|NCT02213250|2105846|P2|STARTED|Overall Study||8
870054|NCT02213250|2105847|P1|STARTED|Overall Study||4
870055|NCT02213198|2105878|P2|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||7
870056|NCT02213198|2105879|P1|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||23
870057|NCT02213198|2105878|P2|COMPLETED|Follow up 2 6 Months Post TCC Treatment||60
870058|NCT02213198|2105879|P1|COMPLETED|Follow up 2 6 Months Post TCC Treatment||102
870059|NCT02213198|2105878|P2|STARTED|Follow up 2 6 Months Post TCC Treatment||67
870060|NCT02213198|2105879|P1|STARTED|Follow up 2 6 Months Post TCC Treatment||125
870061|NCT02213198|2105878|P2|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||41
870062|NCT02213198|2105879|P1|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||93
870063|NCT02213198|2105878|P2|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||67
870064|NCT02213198|2105879|P1|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||125
870065|NCT02213198|2105878|P2|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||108
870066|NCT02213198|2105879|P1|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||218
870067|NCT02213198|2105878|P2|NOT COMPLETED|Baseline||51
870068|NCT02213198|2105879|P1|NOT COMPLETED|Baseline||88
870069|NCT02213198|2105878|P2|COMPLETED|Baseline||108
870070|NCT02213198|2105879|P1|COMPLETED|Baseline||218
870071|NCT02213198|2105878|P2|STARTED|Baseline||159
870072|NCT02213198|2105879|P1|STARTED|Baseline||306
870073|NCT02213055|2105889|P2|NOT COMPLETED|Overall Study||0
870074|NCT02213055|2105890|P1|NOT COMPLETED|Overall Study||39
870075|NCT02213055|2105889|P2|COMPLETED|Overall Study||0
870076|NCT02213055|2105890|P1|COMPLETED|Overall Study||58
870077|NCT02213055|2105889|P2|STARTED|Overall Study||0
870078|NCT02213055|2105890|P1|STARTED|Overall Study||97
870079|NCT02212977|2105898|P2|NOT COMPLETED|Overall Study||6
870080|NCT02212977|2105899|P1|NOT COMPLETED|Overall Study||5
870081|NCT02212977|2105898|P2|COMPLETED|Overall Study||48
870082|NCT02212977|2105899|P1|COMPLETED|Overall Study||50
870083|NCT02212977|2105898|P2|STARTED|Overall Study||54
870084|NCT02212977|2105899|P1|STARTED|Overall Study||55
870085|NCT02212834|2105915|P2|NOT COMPLETED|Overall Study||0
870086|NCT02212834|2105916|P1|NOT COMPLETED|Overall Study||0
870087|NCT02212834|2105915|P2|COMPLETED|Overall Study||2506
870088|NCT02212834|2105916|P1|COMPLETED|Overall Study||33938
870089|NCT02212834|2105915|P2|STARTED|Overall Study||2506
870090|NCT02212834|2105916|P1|STARTED|Overall Study||33938
870091|NCT02212457|2105928|P6|NOT COMPLETED|Overall Study||13
870092|NCT02212457|2105929|P5|NOT COMPLETED|Overall Study||15
870093|NCT02212457|2105930|P4|NOT COMPLETED|Overall Study||11
870094|NCT02212457|2105931|P3|NOT COMPLETED|Overall Study||16
870095|NCT02212457|2105932|P2|NOT COMPLETED|Overall Study||21
870096|NCT02212457|2105933|P1|NOT COMPLETED|Overall Study||19
870097|NCT02212457|2105928|P6|COMPLETED|Overall Study||147
870098|NCT02212457|2105929|P5|COMPLETED|Overall Study||137
870099|NCT02212457|2105930|P4|COMPLETED|Overall Study||123
870100|NCT02212457|2105931|P3|COMPLETED|Overall Study||141
870101|NCT02212457|2105932|P2|COMPLETED|Overall Study||211
870102|NCT02212457|2105933|P1|COMPLETED|Overall Study||209
870103|NCT02212457|2105928|P6|STARTED|Overall Study||160
870104|NCT02212457|2105929|P5|STARTED|Overall Study||152
870105|NCT02212457|2105930|P4|STARTED|Overall Study||134
870106|NCT02212457|2105931|P3|STARTED|Overall Study||157
870107|NCT02212457|2105932|P2|STARTED|Overall Study||232
870108|NCT02212457|2105933|P1|STARTED|Overall Study||228
870109|NCT02212301|2105971|P2|NOT COMPLETED|Period 2||0
870110|NCT02212301|2105972|P1|NOT COMPLETED|Period 2||0
870111|NCT02212301|2105971|P2|COMPLETED|Period 2||21
870112|NCT02212301|2105972|P1|COMPLETED|Period 2||21
870113|NCT02212301|2105971|P2|STARTED|Period 2||21
870114|NCT02212301|2105972|P1|STARTED|Period 2||21
870115|NCT02212301|2105971|P2|NOT COMPLETED|Period 1||1
870116|NCT02212301|2105972|P1|NOT COMPLETED|Period 1||0
870117|NCT02212301|2105971|P2|COMPLETED|Period 1||21
870118|NCT02212301|2105972|P1|COMPLETED|Period 1||21
870119|NCT02212301|2105971|P2|STARTED|Period 1||22
870120|NCT02212301|2105972|P1|STARTED|Period 1||21
870121|NCT02212197|2105983|P3|NOT COMPLETED|Overall Study||0
870122|NCT02212197|2105984|P2|NOT COMPLETED|Overall Study||0
870123|NCT02212197|2105985|P1|NOT COMPLETED|Overall Study||1
870124|NCT02212197|2105983|P3|COMPLETED|Overall Study||17
870125|NCT02212197|2105984|P2|COMPLETED|Overall Study||15
870126|NCT02212197|2105985|P1|COMPLETED|Overall Study||18
870127|NCT02212197|2105983|P3|STARTED|Overall Study||17
870128|NCT02212197|2105984|P2|STARTED|Overall Study||15
870129|NCT02212197|2105985|P1|STARTED|Overall Study||19
870130|NCT02212106|2106010|P2|NOT COMPLETED|Overall Study||4
870131|NCT02212106|2106011|P1|NOT COMPLETED|Overall Study||10
870132|NCT02212106|2106010|P2|COMPLETED|Overall Study||96
870133|NCT02212106|2106011|P1|COMPLETED|Overall Study||292
870134|NCT02212106|2106010|P2|STARTED|Overall Study||100
870135|NCT02212106|2106011|P1|STARTED|Overall Study||302
870136|NCT02212028|2106029|P2|NOT COMPLETED|Overall Study||0
870137|NCT02212028|2106030|P1|NOT COMPLETED|Overall Study||0
870138|NCT02212028|2106029|P2|COMPLETED|Overall Study||26
870139|NCT02212028|2106030|P1|COMPLETED|Overall Study||26
870140|NCT02212028|2106029|P2|STARTED|Overall Study||26
870141|NCT02212028|2106030|P1|STARTED|Overall Study||26
870142|NCT02210208|2106038|P1|NOT COMPLETED|Overall Study||5
870143|NCT02210208|2106038|P1|COMPLETED|Overall Study||23
870144|NCT02210208|2106038|P1|STARTED|Overall Study||28
870145|NCT02210195|2106044|P2|NOT COMPLETED|Overall Study||0
870146|NCT02210195|2106045|P1|NOT COMPLETED|Overall Study||4
870147|NCT02210195|2106044|P2|COMPLETED|Overall Study||10
870148|NCT02210195|2106045|P1|COMPLETED|Overall Study||6
870149|NCT02210195|2106044|P2|STARTED|Overall Study||10
870150|NCT02210195|2106045|P1|STARTED|Overall Study||10
870157|NCT02210052|2106128|P1|NOT COMPLETED|Overall Study||0
870158|NCT02210052|2106128|P1|COMPLETED|Overall Study||6
870159|NCT02210052|2106128|P1|STARTED|Overall Study||6
870160|NCT02209766|2106136|P5|NOT COMPLETED|Overall Study||0
870161|NCT02209766|2106137|P4|NOT COMPLETED|Overall Study||1
870162|NCT02209766|2106138|P3|NOT COMPLETED|Overall Study||0
870163|NCT02209766|2106139|P2|NOT COMPLETED|Overall Study||0
870164|NCT02209766|2106140|P1|NOT COMPLETED|Overall Study||0
870165|NCT02209766|2106136|P5|COMPLETED|Overall Study||6
870166|NCT02209766|2106137|P4|COMPLETED|Overall Study||2
870167|NCT02209766|2106138|P3|COMPLETED|Overall Study||6
870168|NCT02209766|2106139|P2|COMPLETED|Overall Study||3
870169|NCT02209766|2106140|P1|COMPLETED|Overall Study||6
870170|NCT02209766|2106136|P5|STARTED|Overall Study||6
870171|NCT02209766|2106137|P4|STARTED|Overall Study||3
870172|NCT02209766|2106138|P3|STARTED|Overall Study||6
870173|NCT02209766|2106139|P2|STARTED|Overall Study||3
870174|NCT02209766|2106140|P1|STARTED|Overall Study||6
870175|NCT02209506|2106191|P5|NOT COMPLETED|Overall Study||1
870176|NCT02209506|2106192|P4|NOT COMPLETED|Overall Study||0
870177|NCT02209506|2106193|P3|NOT COMPLETED|Overall Study||0
870178|NCT02209506|2106194|P2|NOT COMPLETED|Overall Study||0
870179|NCT02209506|2106195|P1|NOT COMPLETED|Overall Study||0
870180|NCT02209506|2106191|P5|COMPLETED|Overall Study||5
870181|NCT02209506|2106192|P4|COMPLETED|Overall Study||2
870182|NCT02209506|2106193|P3|COMPLETED|Overall Study||6
870183|NCT02209506|2106194|P2|COMPLETED|Overall Study||6
870184|NCT02209506|2106195|P1|COMPLETED|Overall Study||3
870185|NCT02209506|2106191|P5|STARTED|Overall Study||6
870186|NCT02209506|2106192|P4|STARTED|Overall Study||2
870187|NCT02209506|2106193|P3|STARTED|Overall Study||6
870188|NCT02209506|2106194|P2|STARTED|Overall Study||6
870189|NCT02209506|2106195|P1|STARTED|Overall Study||3
870190|NCT02209454|2106270|P2|NOT COMPLETED|Second Period||0
870191|NCT02209454|2106271|P1|NOT COMPLETED|Second Period||1
870192|NCT02209454|2106270|P2|COMPLETED|Second Period||13
870193|NCT02209454|2106271|P1|COMPLETED|Second Period||12
870194|NCT02209454|2106270|P2|STARTED|Second Period||13
870195|NCT02209454|2106271|P1|STARTED|Second Period||13
870196|NCT02209454|2106270|P2|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
870197|NCT02209454|2106271|P1|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
870198|NCT02209454|2106270|P2|COMPLETED|Washout Period a Minimum of a 7 Day||13
870199|NCT02209454|2106271|P1|COMPLETED|Washout Period a Minimum of a 7 Day||13
870200|NCT02209454|2106270|P2|STARTED|Washout Period a Minimum of a 7 Day||13
870201|NCT02209454|2106271|P1|STARTED|Washout Period a Minimum of a 7 Day||13
870202|NCT02209454|2106270|P2|NOT COMPLETED|First Period||0
870203|NCT02209454|2106271|P1|NOT COMPLETED|First Period||0
870204|NCT02209454|2106270|P2|COMPLETED|First Period||13
870205|NCT02209454|2106271|P1|COMPLETED|First Period||13
870206|NCT02209454|2106270|P2|STARTED|First Period||13
870207|NCT02209454|2106271|P1|STARTED|First Period||13
870208|NCT02209181|2106289|P4|NOT COMPLETED|Overall Study||0
870209|NCT02209181|2106290|P3|NOT COMPLETED|Overall Study||1
870210|NCT02209181|2106291|P2|NOT COMPLETED|Overall Study||1
870211|NCT02209181|2106292|P1|NOT COMPLETED|Overall Study||1
870212|NCT02209181|2106289|P4|COMPLETED|Overall Study||66
870213|NCT02209181|2106290|P3|COMPLETED|Overall Study||68
870214|NCT02209181|2106291|P2|COMPLETED|Overall Study||66
870215|NCT02209181|2106292|P1|COMPLETED|Overall Study||66
870216|NCT02209181|2106289|P4|STARTED|Overall Study||66
870217|NCT02209181|2106290|P3|STARTED|Overall Study||69
870218|NCT02209181|2106291|P2|STARTED|Overall Study||67
870219|NCT02209181|2106292|P1|STARTED|Overall Study||67
870220|NCT02209064|2106454|P1|NOT COMPLETED|Overall Study||0
870221|NCT02209064|2106454|P1|COMPLETED|Overall Study||25
870222|NCT02209064|2106454|P1|STARTED|Overall Study||25
870223|NCT02208310|2106463|P2|NOT COMPLETED|Overall Study||5
870224|NCT02208310|2106464|P1|NOT COMPLETED|Overall Study||6
870225|NCT02208310|2106463|P2|COMPLETED|Overall Study||0
870226|NCT02208310|2106464|P1|COMPLETED|Overall Study||0
870227|NCT02208310|2106463|P2|Day 180|Overall Study||1
870228|NCT02208310|2106464|P1|Day 180|Overall Study||0
870229|NCT02208310|2106463|P2|STARTED|Overall Study||5
870230|NCT02208310|2106464|P1|STARTED|Overall Study||6
870231|NCT02207907|2106496|P2|NOT COMPLETED|Overall Study||8
870232|NCT02207907|2106497|P1|NOT COMPLETED|Overall Study||11
870233|NCT02207907|2106496|P2|COMPLETED|Overall Study||115
870234|NCT02207907|2106497|P1|COMPLETED|Overall Study||113
870235|NCT02207907|2106496|P2|STARTED|Overall Study||123
870236|NCT02207907|2106497|P1|STARTED|Overall Study||124
870237|NCT02207829|2106515|P2|NOT COMPLETED|Overall Study||34
870238|NCT02207829|2106516|P1|NOT COMPLETED|Overall Study||42
870239|NCT02207829|2106515|P2|COMPLETED|Overall Study||474
870240|NCT02207829|2106516|P1|COMPLETED|Overall Study||467
870241|NCT02207829|2106515|P2|STARTED|Overall Study||508
870242|NCT02207829|2106516|P1|STARTED|Overall Study||509
870243|NCT02207608|2106524|P2|NOT COMPLETED|Overall Study||0
870244|NCT02207608|2106525|P1|NOT COMPLETED|Overall Study||1
870245|NCT02207608|2106524|P2|COMPLETED|Overall Study||15
870246|NCT02207608|2106525|P1|COMPLETED|Overall Study||14
870247|NCT02207608|2106524|P2|STARTED|Overall Study||15
870248|NCT02207608|2106525|P1|STARTED|Overall Study||15
870249|NCT02207478|2106533|P2|NOT COMPLETED|Overall Study||0
870250|NCT02207478|2106534|P1|NOT COMPLETED|Overall Study||0
870251|NCT02207478|2106533|P2|COMPLETED|Overall Study||46
870252|NCT02207478|2106534|P1|COMPLETED|Overall Study||40
870253|NCT02207478|2106533|P2|STARTED|Overall Study||46
870254|NCT02207478|2106534|P1|STARTED|Overall Study||40
870255|NCT02207413|2106548|P6|NOT COMPLETED|Overall Study||13
870256|NCT02207413|2106549|P5|NOT COMPLETED|Overall Study||7
870257|NCT02207413|2106550|P4|NOT COMPLETED|Overall Study||1
870258|NCT02207413|2106551|P3|NOT COMPLETED|Overall Study||0
870259|NCT02207413|2106552|P2|NOT COMPLETED|Overall Study||0
870260|NCT02207413|2106553|P1|NOT COMPLETED|Overall Study||1
870261|NCT02207413|2106548|P6|COMPLETED|Overall Study|Primed subjects: 41; Unprimed subjects: 420|461
870262|NCT02207413|2106549|P5|COMPLETED|Overall Study|Primed subjects: 40; Unprimed subjects: 419|459
870263|NCT02207413|2106550|P4|COMPLETED|Overall Study|Primed subjects: 312; Unprimed subjects: 98|410
870264|NCT02207413|2106551|P3|COMPLETED|Overall Study|Primed subjects: 309; Unprimed subjects: 101|410
870265|NCT02207413|2106552|P2|COMPLETED|Overall Study||60
870266|NCT02207413|2106553|P1|COMPLETED|Overall Study||59
870267|NCT02207413|2106548|P6|STARTED|Overall Study||474
870268|NCT02207413|2106549|P5|STARTED|Overall Study||466
870269|NCT02207413|2106550|P4|STARTED|Overall Study||411
870270|NCT02207413|2106551|P3|STARTED|Overall Study||410
870271|NCT02207413|2106552|P2|STARTED|Overall Study||60
870272|NCT02207413|2106553|P1|STARTED|Overall Study||60
870273|NCT02207400|2106649|P2|NOT COMPLETED|Overall Study||14
870274|NCT02207400|2106650|P1|NOT COMPLETED|Overall Study||16
870275|NCT02207400|2106649|P2|COMPLETED|Overall Study||109
870276|NCT02207400|2106650|P1|COMPLETED|Overall Study||107
870277|NCT02207400|2106649|P2|STARTED|Overall Study||123
870278|NCT02207400|2106650|P1|STARTED|Overall Study||123
870279|NCT02206776|2106670|P2|NOT COMPLETED|Overall Study||0
870280|NCT02206776|2106671|P1|NOT COMPLETED|Overall Study||0
870281|NCT02206776|2106670|P2|COMPLETED|Overall Study||1
870282|NCT02206776|2106671|P1|COMPLETED|Overall Study||1
870283|NCT02206776|2106670|P2|STARTED|Overall Study||1
870284|NCT02206776|2106671|P1|STARTED|Overall Study||1
870285|NCT02206607|2106677|P5|NOT COMPLETED|Fourth Intervention Period||0
870286|NCT02206607|2106678|P4|NOT COMPLETED|Fourth Intervention Period||0
870287|NCT02206607|2106679|P3|NOT COMPLETED|Fourth Intervention Period||0
870288|NCT02206607|2106680|P2|NOT COMPLETED|Fourth Intervention Period||0
870289|NCT02206607|2106681|P1|NOT COMPLETED|Fourth Intervention Period||0
870290|NCT02206607|2106677|P5|COMPLETED|Fourth Intervention Period||10
870291|NCT02206607|2106678|P4|COMPLETED|Fourth Intervention Period||10
870292|NCT02206607|2106679|P3|COMPLETED|Fourth Intervention Period||9
870293|NCT02206607|2106680|P2|COMPLETED|Fourth Intervention Period||9
870294|NCT02206607|2106681|P1|COMPLETED|Fourth Intervention Period||0
870295|NCT02206607|2106677|P5|STARTED|Fourth Intervention Period||10
870296|NCT02206607|2106678|P4|STARTED|Fourth Intervention Period||10
870297|NCT02206607|2106679|P3|STARTED|Fourth Intervention Period||9
870298|NCT02206607|2106680|P2|STARTED|Fourth Intervention Period||9
870299|NCT02206607|2106681|P1|STARTED|Fourth Intervention Period||0
870300|NCT02206607|2106677|P5|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
870301|NCT02206607|2106678|P4|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
870302|NCT02206607|2106679|P3|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
870303|NCT02206607|2106680|P2|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
870304|NCT02206607|2106681|P1|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
870305|NCT02206607|2106677|P5|COMPLETED|Third Washout Period 5 to 10 Days||10
870306|NCT02206607|2106678|P4|COMPLETED|Third Washout Period 5 to 10 Days||10
870307|NCT02206607|2106679|P3|COMPLETED|Third Washout Period 5 to 10 Days||9
870308|NCT02206607|2106680|P2|COMPLETED|Third Washout Period 5 to 10 Days||9
870309|NCT02206607|2106681|P1|COMPLETED|Third Washout Period 5 to 10 Days||0
870310|NCT02206607|2106677|P5|STARTED|Third Washout Period 5 to 10 Days||10
870311|NCT02206607|2106678|P4|STARTED|Third Washout Period 5 to 10 Days||10
870312|NCT02206607|2106679|P3|STARTED|Third Washout Period 5 to 10 Days||9
870313|NCT02206607|2106680|P2|STARTED|Third Washout Period 5 to 10 Days||9
870314|NCT02206607|2106681|P1|STARTED|Third Washout Period 5 to 10 Days||0
870315|NCT02206607|2106677|P5|NOT COMPLETED|Third Intervention Period||0
870316|NCT02206607|2106678|P4|NOT COMPLETED|Third Intervention Period||0
870317|NCT02206607|2106679|P3|NOT COMPLETED|Third Intervention Period||0
870318|NCT02206607|2106680|P2|NOT COMPLETED|Third Intervention Period||0
870319|NCT02206607|2106681|P1|NOT COMPLETED|Third Intervention Period||0
870320|NCT02206607|2106677|P5|COMPLETED|Third Intervention Period||10
870321|NCT02206607|2106678|P4|COMPLETED|Third Intervention Period||10
870322|NCT02206607|2106679|P3|COMPLETED|Third Intervention Period||9
870323|NCT02206607|2106680|P2|COMPLETED|Third Intervention Period||9
870324|NCT02206607|2106681|P1|COMPLETED|Third Intervention Period||0
870325|NCT02206607|2106677|P5|STARTED|Third Intervention Period||10
870326|NCT02206607|2106678|P4|STARTED|Third Intervention Period||10
870327|NCT02206607|2106679|P3|STARTED|Third Intervention Period||9
870328|NCT02206607|2106680|P2|STARTED|Third Intervention Period||9
870329|NCT02206607|2106681|P1|STARTED|Third Intervention Period||0
870330|NCT02206607|2106677|P5|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
870331|NCT02206607|2106678|P4|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
870332|NCT02206607|2106679|P3|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
870333|NCT02206607|2106680|P2|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
870334|NCT02206607|2106681|P1|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
870335|NCT02206607|2106677|P5|COMPLETED|Second Washout Period 5 to 10 Days||10
870336|NCT02206607|2106678|P4|COMPLETED|Second Washout Period 5 to 10 Days||10
870337|NCT02206607|2106679|P3|COMPLETED|Second Washout Period 5 to 10 Days||9
870338|NCT02206607|2106680|P2|COMPLETED|Second Washout Period 5 to 10 Days||9
870339|NCT02206607|2106681|P1|COMPLETED|Second Washout Period 5 to 10 Days||0
870340|NCT02206607|2106677|P5|STARTED|Second Washout Period 5 to 10 Days||10
870341|NCT02206607|2106678|P4|STARTED|Second Washout Period 5 to 10 Days||10
870342|NCT02206607|2106679|P3|STARTED|Second Washout Period 5 to 10 Days||9
870343|NCT02206607|2106680|P2|STARTED|Second Washout Period 5 to 10 Days||9
870344|NCT02206607|2106681|P1|STARTED|Second Washout Period 5 to 10 Days||0
870345|NCT02206607|2106677|P5|NOT COMPLETED|Second Intervention Period||0
870346|NCT02206607|2106678|P4|NOT COMPLETED|Second Intervention Period||1
870347|NCT02206607|2106679|P3|NOT COMPLETED|Second Intervention Period||0
870348|NCT02206607|2106680|P2|NOT COMPLETED|Second Intervention Period||0
870349|NCT02206607|2106681|P1|NOT COMPLETED|Second Intervention Period||0
870350|NCT02206607|2106677|P5|COMPLETED|Second Intervention Period||10
870351|NCT02206607|2106678|P4|COMPLETED|Second Intervention Period||10
870352|NCT02206607|2106679|P3|COMPLETED|Second Intervention Period||9
870353|NCT02206607|2106680|P2|COMPLETED|Second Intervention Period||9
870354|NCT02206607|2106681|P1|COMPLETED|Second Intervention Period||0
870355|NCT02206607|2106677|P5|STARTED|Second Intervention Period||10
870356|NCT02206607|2106678|P4|STARTED|Second Intervention Period||11
870357|NCT02206607|2106679|P3|STARTED|Second Intervention Period||9
870358|NCT02206607|2106680|P2|STARTED|Second Intervention Period||9
870359|NCT02206607|2106681|P1|STARTED|Second Intervention Period||0
870360|NCT02206607|2106677|P5|NOT COMPLETED|First Washout Period 5 to 10 Days||0
870361|NCT02206607|2106678|P4|NOT COMPLETED|First Washout Period 5 to 10 Days||0
870362|NCT02206607|2106679|P3|NOT COMPLETED|First Washout Period 5 to 10 Days||0
870363|NCT02206607|2106680|P2|NOT COMPLETED|First Washout Period 5 to 10 Days||0
870364|NCT02206607|2106681|P1|NOT COMPLETED|First Washout Period 5 to 10 Days||0
870365|NCT02206607|2106677|P5|COMPLETED|First Washout Period 5 to 10 Days||10
870366|NCT02206607|2106678|P4|COMPLETED|First Washout Period 5 to 10 Days||11
870367|NCT02206607|2106679|P3|COMPLETED|First Washout Period 5 to 10 Days||9
870368|NCT02206607|2106680|P2|COMPLETED|First Washout Period 5 to 10 Days||9
870369|NCT02206607|2106681|P1|COMPLETED|First Washout Period 5 to 10 Days||0
870370|NCT02206607|2106677|P5|STARTED|First Washout Period 5 to 10 Days||10
870371|NCT02206607|2106678|P4|STARTED|First Washout Period 5 to 10 Days||11
870372|NCT02206607|2106679|P3|STARTED|First Washout Period 5 to 10 Days||9
870373|NCT02206607|2106680|P2|STARTED|First Washout Period 5 to 10 Days||9
870374|NCT02206607|2106681|P1|STARTED|First Washout Period 5 to 10 Days||0
870375|NCT02206607|2106677|P5|NOT COMPLETED|First Intervention Period||0
870376|NCT02206607|2106678|P4|NOT COMPLETED|First Intervention Period||0
870377|NCT02206607|2106679|P3|NOT COMPLETED|First Intervention Period||0
870378|NCT02206607|2106680|P2|NOT COMPLETED|First Intervention Period||0
870379|NCT02206607|2106681|P1|NOT COMPLETED|First Intervention Period||0
870380|NCT02206607|2106677|P5|COMPLETED|First Intervention Period||10
870381|NCT02206607|2106678|P4|COMPLETED|First Intervention Period||11
870382|NCT02206607|2106679|P3|COMPLETED|First Intervention Period||9
870383|NCT02206607|2106680|P2|COMPLETED|First Intervention Period||9
870384|NCT02206607|2106681|P1|COMPLETED|First Intervention Period||0
870385|NCT02206607|2106677|P5|STARTED|First Intervention Period||10
870386|NCT02206607|2106678|P4|STARTED|First Intervention Period||11
870387|NCT02206607|2106679|P3|STARTED|First Intervention Period||9
870388|NCT02206607|2106680|P2|STARTED|First Intervention Period||9
870389|NCT02206607|2106681|P1|STARTED|First Intervention Period||0
870390|NCT02206607|2106677|P5|NOT COMPLETED|Open-Label Run-In||0
870391|NCT02206607|2106678|P4|NOT COMPLETED|Open-Label Run-In||0
870392|NCT02206607|2106679|P3|NOT COMPLETED|Open-Label Run-In||0
870393|NCT02206607|2106680|P2|NOT COMPLETED|Open-Label Run-In||0
870394|NCT02206607|2106681|P1|NOT COMPLETED|Open-Label Run-In||3
870395|NCT02206607|2106677|P5|COMPLETED|Open-Label Run-In||0
870396|NCT02206607|2106678|P4|COMPLETED|Open-Label Run-In||0
870397|NCT02206607|2106679|P3|COMPLETED|Open-Label Run-In||0
870398|NCT02206607|2106680|P2|COMPLETED|Open-Label Run-In||0
870399|NCT02206607|2106681|P1|COMPLETED|Open-Label Run-In||39
870400|NCT02206607|2106677|P5|STARTED|Open-Label Run-In||0
870401|NCT02206607|2106678|P4|STARTED|Open-Label Run-In||0
870402|NCT02206607|2106679|P3|STARTED|Open-Label Run-In||0
870403|NCT02206607|2106680|P2|STARTED|Open-Label Run-In||0
870404|NCT02206607|2106681|P1|STARTED|Open-Label Run-In||42
870405|NCT02205814|2106737|P4|NOT COMPLETED|Overall Study||4
870406|NCT02205814|2106738|P3|NOT COMPLETED|Overall Study||5
870407|NCT02205814|2106739|P2|NOT COMPLETED|Overall Study||1
870408|NCT02205814|2106740|P1|NOT COMPLETED|Overall Study||2
870409|NCT02205814|2106737|P4|COMPLETED|Overall Study||104
870410|NCT02205814|2106738|P3|COMPLETED|Overall Study||103
870411|NCT02205814|2106739|P2|COMPLETED|Overall Study||109
870412|NCT02205814|2106740|P1|COMPLETED|Overall Study||108
870413|NCT02205814|2106737|P4|STARTED|Overall Study||108
870414|NCT02205814|2106738|P3|STARTED|Overall Study||108
870415|NCT02205814|2106739|P2|STARTED|Overall Study||110
870416|NCT02205814|2106740|P1|STARTED|Overall Study||110
870417|NCT02205476|2106764|P2|NOT COMPLETED|Overall Study||3
870418|NCT02205476|2106765|P1|NOT COMPLETED|Overall Study||7
870419|NCT02205476|2106764|P2|COMPLETED|Overall Study||0
870420|NCT02205476|2106765|P1|COMPLETED|Overall Study||0
870421|NCT02205476|2106764|P2|STARTED|Overall Study||3
870422|NCT02205476|2106765|P1|STARTED|Overall Study||7
870423|NCT02205333|2106804|P9|NOT COMPLETED|Overall Study||0
870424|NCT02205333|2106805|P8|NOT COMPLETED|Overall Study||2
870425|NCT02205333|2106806|P7|NOT COMPLETED|Overall Study||5
870426|NCT02205333|2106807|P6|NOT COMPLETED|Overall Study||3
870427|NCT02205333|2106808|P5|NOT COMPLETED|Overall Study||5
870428|NCT02205333|2106809|P4|NOT COMPLETED|Overall Study||7
870429|NCT02205333|2106810|P3|NOT COMPLETED|Overall Study||2
870430|NCT02205333|2106811|P2|NOT COMPLETED|Overall Study||6
870431|NCT02205333|2106812|P1|NOT COMPLETED|Overall Study||6
870432|NCT02205333|2106804|P9|COMPLETED|Overall Study||1
870433|NCT02205333|2106805|P8|COMPLETED|Overall Study||1
870434|NCT02205333|2106806|P7|COMPLETED|Overall Study||2
870435|NCT02205333|2106807|P6|COMPLETED|Overall Study||4
870436|NCT02205333|2106808|P5|COMPLETED|Overall Study||1
870437|NCT02205333|2106809|P4|COMPLETED|Overall Study||0
870438|NCT02205333|2106810|P3|COMPLETED|Overall Study||1
870439|NCT02205333|2106811|P2|COMPLETED|Overall Study||0
870440|NCT02205333|2106812|P1|COMPLETED|Overall Study||2
870441|NCT02205333|2106804|P9|STARTED|Overall Study||1
870442|NCT02205333|2106805|P8|STARTED|Overall Study||3
870443|NCT02205333|2106806|P7|STARTED|Overall Study||7
870444|NCT02205333|2106807|P6|STARTED|Overall Study||7
870445|NCT02205333|2106808|P5|STARTED|Overall Study||6
870446|NCT02205333|2106809|P4|STARTED|Overall Study||7
870447|NCT02205333|2106810|P3|STARTED|Overall Study||3
870448|NCT02205333|2106811|P2|STARTED|Overall Study||6
870449|NCT02205333|2106812|P1|STARTED|Overall Study||8
870450|NCT02204748|2106985|P1|NOT COMPLETED|Overall Study||0
870451|NCT02204748|2106985|P1|COMPLETED|Overall Study||5
870452|NCT02204748|2106985|P1|STARTED|Overall Study||5
870453|NCT02204657|2106999|P2|NOT COMPLETED|Overall Study||0
870454|NCT02204657|2107000|P1|NOT COMPLETED|Overall Study||7
870455|NCT02204657|2106999|P2|COMPLETED|Overall Study||25
870456|NCT02204657|2107000|P1|COMPLETED|Overall Study||25
870457|NCT02204657|2106999|P2|STARTED|Overall Study||25
870458|NCT02204657|2107000|P1|STARTED|Overall Study||32
870459|NCT02204579|2107008|P1|NOT COMPLETED|Overall Study||2
870460|NCT02204579|2107008|P1|COMPLETED|Overall Study||5
870461|NCT02204579|2107008|P1|Treated|Overall Study||5
870462|NCT02204579|2107008|P1|Participants Started in Post-Amendment|Overall Study|Two participants from pre-amendment were re-enrolled with different identification numbers.|5
870463|NCT02204579|2107008|P1|Participants Started in Pre-Amendment|Overall Study|Two participants completed treatment in pre-amendment and were re-enrolled in post-amendment.|2
870464|NCT02204579|2107008|P1|STARTED|Overall Study||7
870465|NCT02204449|2107062|P2|NOT COMPLETED|Overall Study||11
870466|NCT02204449|2107063|P1|NOT COMPLETED|Overall Study||7
870467|NCT02204449|2107062|P2|COMPLETED|Overall Study||37
870468|NCT02204449|2107063|P1|COMPLETED|Overall Study||39
870469|NCT02204449|2107062|P2|STARTED|Overall Study||48
870470|NCT02204449|2107063|P1|STARTED|Overall Study||46
870471|NCT02204410|2107073|P1|NOT COMPLETED|Overall Study||11
870472|NCT02204410|2107073|P1|COMPLETED|Overall Study||10
870473|NCT02204410|2107073|P1|STARTED|Overall Study||21
870474|NCT02204371|2107078|P1|NOT COMPLETED|Overall Study||1
870475|NCT02204371|2107078|P1|COMPLETED|Overall Study||6
870476|NCT02204371|2107078|P1|STARTED|Overall Study||7
870477|NCT02204319|2107101|P1|NOT COMPLETED|Overall Study||3
870478|NCT02204319|2107101|P1|COMPLETED|Overall Study|3 did not complete study.|7
870479|NCT02204319|2107101|P1|STARTED|Overall Study||10
870480|NCT02204007|2107109|P2|NOT COMPLETED|Overall Study||1
870481|NCT02204007|2107110|P1|NOT COMPLETED|Overall Study||1
870482|NCT02204007|2107109|P2|COMPLETED|Overall Study||17
870483|NCT02204007|2107110|P1|COMPLETED|Overall Study||17
870484|NCT02204007|2107109|P2|STARTED|Overall Study||18
870485|NCT02204007|2107110|P1|STARTED|Overall Study||18
870486|NCT02203916|2107121|P3|NOT COMPLETED|Overall Study||11
870487|NCT02203916|2107122|P2|NOT COMPLETED|Overall Study||10
870488|NCT02203916|2107123|P1|NOT COMPLETED|Overall Study||8
870489|NCT02203916|2107121|P3|COMPLETED|Overall Study||120
870490|NCT02203916|2107122|P2|COMPLETED|Overall Study||122
870491|NCT02203916|2107123|P1|COMPLETED|Overall Study||57
870492|NCT02203916|2107121|P3|Safety Analysis Set (SAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the SAS.|130
870493|NCT02203916|2107122|P2|Safety Analysis Set (SAS)|Overall Study||132
870494|NCT02203916|2107123|P1|Safety Analysis Set (SAS)|Overall Study||65
870495|NCT02203916|2107121|P3|Full Analysis Set (FAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the FAS.|130
870496|NCT02203916|2107122|P2|Full Analysis Set (FAS)|Overall Study||132
870497|NCT02203916|2107123|P1|Full Analysis Set (FAS)|Overall Study||65
870498|NCT02203916|2107121|P3|STARTED|Overall Study|1 participant was randomized twice and counted only once.|131
870499|NCT02203916|2107122|P2|STARTED|Overall Study||132
870500|NCT02203916|2107123|P1|STARTED|Overall Study||65
870501|NCT02203786|2107147|P4|NOT COMPLETED|Overall Study||0
870502|NCT02203786|2107148|P3|NOT COMPLETED|Overall Study||2
870503|NCT02203786|2107149|P2|NOT COMPLETED|Overall Study||0
870504|NCT02203786|2107150|P1|NOT COMPLETED|Overall Study||0
870505|NCT02203786|2107147|P4|COMPLETED|Overall Study||15
870506|NCT02203786|2107148|P3|COMPLETED|Overall Study||15
870507|NCT02203786|2107149|P2|COMPLETED|Overall Study||15
870508|NCT02203786|2107150|P1|COMPLETED|Overall Study||15
870509|NCT02203786|2107147|P4|STARTED|Overall Study||15
870510|NCT02203786|2107148|P3|STARTED|Overall Study||17
870511|NCT02203786|2107149|P2|STARTED|Overall Study||15
870512|NCT02203786|2107150|P1|STARTED|Overall Study||15
870513|NCT02203747|2107182|P2|NOT COMPLETED|Overall Study||0
870514|NCT02203747|2107183|P1|NOT COMPLETED|Overall Study||0
870515|NCT02203747|2107182|P2|COMPLETED|Overall Study||34
870516|NCT02203747|2107183|P1|COMPLETED|Overall Study||45
870517|NCT02203747|2107182|P2|STARTED|Overall Study||34
870518|NCT02203747|2107183|P1|STARTED|Overall Study||45
870519|NCT02203721|2107193|P2|NOT COMPLETED|Overall Study||3
870520|NCT02203721|2107194|P1|NOT COMPLETED|Overall Study||1
870521|NCT02203721|2107193|P2|COMPLETED|Overall Study||148
870522|NCT02203721|2107194|P1|COMPLETED|Overall Study||147
870523|NCT02203721|2107193|P2|STARTED|Overall Study||151
870524|NCT02203721|2107194|P1|STARTED|Overall Study||148
870525|NCT02203578|2107202|P1|NOT COMPLETED|Overall Study||0
870526|NCT02203578|2107202|P1|COMPLETED|Overall Study||1
870527|NCT02203578|2107202|P1|STARTED|Overall Study||1
870528|NCT02203565|2107214|P1|NOT COMPLETED|Overall Study||1
870529|NCT02203565|2107214|P1|COMPLETED|Overall Study||19
870530|NCT02203565|2107214|P1|STARTED|Overall Study||20
870531|NCT02203162|2107218|P1|NOT COMPLETED|Overall Study||0
870532|NCT02203162|2107218|P1|COMPLETED|Overall Study||30
870533|NCT02203162|2107218|P1|STARTED|Overall Study||30
870534|NCT02203149|2107227|P5|NOT COMPLETED|Part 2||1
870535|NCT02203149|2107228|P4|NOT COMPLETED|Part 2||3
870536|NCT02203149|2107229|P3|NOT COMPLETED|Part 2||1
870537|NCT02203149|2107230|P2|NOT COMPLETED|Part 2||0
870538|NCT02203149|2107231|P1|NOT COMPLETED|Part 2||0
870539|NCT02203149|2107227|P5|COMPLETED|Part 2||34
870540|NCT02203149|2107228|P4|COMPLETED|Part 2||71
870541|NCT02203149|2107229|P3|COMPLETED|Part 2||226
870542|NCT02203149|2107230|P2|COMPLETED|Part 2||0
870543|NCT02203149|2107231|P1|COMPLETED|Part 2||0
870544|NCT02203149|2107227|P5|Started Deferred Active Treatment|Part 2||0
870545|NCT02203149|2107228|P4|Started Deferred Active Treatment|Part 2|1 participant in Deferred Treatment Arm receiving Placebo did not receive Deferred Active Treatment.|73
870546|NCT02203149|2107229|P3|Started Deferred Active Treatment|Part 2||0
870547|NCT02203149|2107230|P2|Started Deferred Active Treatment|Part 2||0
870548|NCT02203149|2107231|P1|Started Deferred Active Treatment|Part 2||0
870549|NCT02203149|2107227|P5|STARTED|Part 2||35
870550|NCT02203149|2107228|P4|STARTED|Part 2||74
870551|NCT02203149|2107229|P3|STARTED|Part 2||227
870552|NCT02203149|2107230|P2|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
870553|NCT02203149|2107231|P1|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
870554|NCT02203149|2107227|P5|NOT COMPLETED|Part 1||0
870555|NCT02203149|2107228|P4|NOT COMPLETED|Part 1||0
870556|NCT02203149|2107229|P3|NOT COMPLETED|Part 1||0
870557|NCT02203149|2107230|P2|NOT COMPLETED|Part 1||1
870558|NCT02203149|2107231|P1|NOT COMPLETED|Part 1||0
870559|NCT02203149|2107227|P5|COMPLETED|Part 1||0
870560|NCT02203149|2107228|P4|COMPLETED|Part 1||0
870561|NCT02203149|2107229|P3|COMPLETED|Part 1||0
870562|NCT02203149|2107230|P2|COMPLETED|Part 1||31
870563|NCT02203149|2107231|P1|COMPLETED|Part 1||31
870564|NCT02203149|2107227|P5|STARTED|Part 1||0
870565|NCT02203149|2107228|P4|STARTED|Part 1||0
870566|NCT02203149|2107229|P3|STARTED|Part 1||0
870567|NCT02203149|2107230|P2|STARTED|Part 1||32
870568|NCT02203149|2107231|P1|STARTED|Part 1||31
870569|NCT02203032|2107264|P4|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||46
870570|NCT02203032|2107265|P3|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||26
870571|NCT02203032|2107266|P2|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||15
870572|NCT02203032|2107267|P1|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||0
870573|NCT02203032|2107264|P4|COMPLETED|Blinded Phase (Week 16 to Week 44)||539
870574|NCT02203032|2107265|P3|COMPLETED|Blinded Phase (Week 16 to Week 44)||107
870575|NCT02203032|2107266|P2|COMPLETED|Blinded Phase (Week 16 to Week 44)||120
870576|NCT02203032|2107267|P1|COMPLETED|Blinded Phase (Week 16 to Week 44)||0
870577|NCT02203032|2107264|P4|STARTED|Blinded Phase (Week 16 to Week 44)||585
870578|NCT02203032|2107265|P3|STARTED|Blinded Phase (Week 16 to Week 44)||133
870579|NCT02203032|2107266|P2|STARTED|Blinded Phase (Week 16 to Week 44)||135
870580|NCT02203032|2107267|P1|STARTED|Blinded Phase (Week 16 to Week 44)||0
870581|NCT02203032|2107264|P4|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
870582|NCT02203032|2107265|P3|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
870583|NCT02203032|2107266|P2|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
870584|NCT02203032|2107267|P1|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||19
870585|NCT02203032|2107264|P4|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
870586|NCT02203032|2107265|P3|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
870587|NCT02203032|2107266|P2|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
870588|NCT02203032|2107267|P1|COMPLETED|Open Label Run-in (Week 0 to Week 16)||853
870589|NCT02203032|2107264|P4|Treated|Open Label Run-in (Week 0 to Week 16)||0
870590|NCT02203032|2107265|P3|Treated|Open Label Run-in (Week 0 to Week 16)||0
870591|NCT02203032|2107266|P2|Treated|Open Label Run-in (Week 0 to Week 16)||0
870592|NCT02203032|2107267|P1|Treated|Open Label Run-in (Week 0 to Week 16)||871
870593|NCT02203032|2107264|P4|STARTED|Open Label Run-in (Week 0 to Week 16)||0
870594|NCT02203032|2107265|P3|STARTED|Open Label Run-in (Week 0 to Week 16)||0
870595|NCT02203032|2107266|P2|STARTED|Open Label Run-in (Week 0 to Week 16)||0
870596|NCT02203032|2107267|P1|STARTED|Open Label Run-in (Week 0 to Week 16)||872
870597|NCT02202785|2107284|P3|NOT COMPLETED|Overall Study||17
870598|NCT02202785|2107285|P2|NOT COMPLETED|Overall Study||15
870599|NCT02202785|2107286|P1|NOT COMPLETED|Overall Study||11
870600|NCT02202785|2107284|P3|COMPLETED|Overall Study||0
870601|NCT02202785|2107285|P2|COMPLETED|Overall Study||0
870602|NCT02202785|2107286|P1|COMPLETED|Overall Study||0
870603|NCT02202785|2107284|P3|STARTED|Overall Study||17
870604|NCT02202785|2107285|P2|STARTED|Overall Study||15
870605|NCT02202785|2107286|P1|STARTED|Overall Study||11
870606|NCT02202759|2107323|P3|NOT COMPLETED|Overall Study||14
870607|NCT02202759|2107324|P2|NOT COMPLETED|Overall Study||15
870608|NCT02202759|2107325|P1|NOT COMPLETED|Overall Study||9
870609|NCT02202759|2107323|P3|COMPLETED|Overall Study||0
870610|NCT02202759|2107324|P2|COMPLETED|Overall Study||0
870611|NCT02202759|2107325|P1|COMPLETED|Overall Study||0
870612|NCT02202759|2107323|P3|STARTED|Overall Study||14
870613|NCT02202759|2107324|P2|STARTED|Overall Study||15
870614|NCT02202759|2107325|P1|STARTED|Overall Study||9
870615|NCT02202538|2107359|P1|NOT COMPLETED|Overall Study||8
870616|NCT02202538|2107359|P1|COMPLETED|Overall Study||45
870617|NCT02202538|2107359|P1|Screen Failure|Overall Study||2
870618|NCT02202538|2107359|P1|STARTED|Overall Study||53
870619|NCT02202252|2107372|P2|NOT COMPLETED|Overall Study||0
870620|NCT02202252|2107373|P1|NOT COMPLETED|Overall Study||0
870621|NCT02202252|2107372|P2|COMPLETED|Overall Study||30
870622|NCT02202252|2107373|P1|COMPLETED|Overall Study||30
870623|NCT02202252|2107372|P2|STARTED|Overall Study||30
870624|NCT02202252|2107373|P1|STARTED|Overall Study||30
870625|NCT02202135|2107383|P1|NOT COMPLETED|Overall Study||0
870626|NCT02202135|2107383|P1|COMPLETED|Overall Study||4
870627|NCT02202135|2107383|P1|STARTED|Overall Study||4
870628|NCT02201953|2107389|P2|NOT COMPLETED|Overall Study||56
870629|NCT02201953|2107390|P1|NOT COMPLETED|Overall Study||20
870630|NCT02201953|2107389|P2|COMPLETED|Overall Study||224
870631|NCT02201953|2107390|P1|COMPLETED|Overall Study||258
870632|NCT02201953|2107389|P2|STARTED|Overall Study||280
870633|NCT02201953|2107390|P1|STARTED|Overall Study||278
870634|NCT02201940|2107408|P2|NOT COMPLETED|Overall Study||116
870635|NCT02201940|2107409|P1|NOT COMPLETED|Overall Study||12
870636|NCT02201940|2107408|P2|COMPLETED|Overall Study||0
870637|NCT02201940|2107409|P1|COMPLETED|Overall Study||613
870638|NCT02201940|2107408|P2|STARTED|Overall Study||116
870639|NCT02201940|2107409|P1|STARTED|Overall Study||625
870640|NCT02201901|2107428|P3|NOT COMPLETED|Overall Study||13
870641|NCT02201901|2107429|P2|NOT COMPLETED|Overall Study||9
870642|NCT02201901|2107430|P1|NOT COMPLETED|Overall Study||15
870643|NCT02201901|2107428|P3|COMPLETED|Overall Study||77
870644|NCT02201901|2107429|P2|COMPLETED|Overall Study||79
870645|NCT02201901|2107430|P1|COMPLETED|Overall Study||75
870646|NCT02201901|2107428|P3|STARTED|Overall Study||90
870647|NCT02201901|2107429|P2|STARTED|Overall Study||88
870648|NCT02201901|2107430|P1|STARTED|Overall Study||90
870649|NCT02201784|2107461|P2|NOT COMPLETED|Overall Study||0
870650|NCT02201784|2107462|P1|NOT COMPLETED|Overall Study||2
870651|NCT02201784|2107461|P2|COMPLETED|Overall Study||30
870652|NCT02201784|2107462|P1|COMPLETED|Overall Study||28
870653|NCT02201784|2107461|P2|STARTED|Overall Study||30
870654|NCT02201784|2107462|P1|STARTED|Overall Study||30
870655|NCT02201524|2107480|P4|NOT COMPLETED|Overall Study||4
870656|NCT02201524|2107481|P3|NOT COMPLETED|Overall Study||4
870657|NCT02201524|2107482|P2|NOT COMPLETED|Overall Study||3
870658|NCT02201524|2107483|P1|NOT COMPLETED|Overall Study||2
870659|NCT02201524|2107480|P4|COMPLETED|Overall Study||10
870660|NCT02201524|2107481|P3|COMPLETED|Overall Study||12
870661|NCT02201524|2107482|P2|COMPLETED|Overall Study||12
870662|NCT02201524|2107483|P1|COMPLETED|Overall Study||12
870663|NCT02201524|2107480|P4|STARTED|Overall Study||14
870664|NCT02201524|2107481|P3|STARTED|Overall Study||16
870665|NCT02201524|2107482|P2|STARTED|Overall Study||15
870666|NCT02201524|2107483|P1|STARTED|Overall Study||14
870667|NCT02201446|2107567|P2|NOT COMPLETED|Overall Study||0
870668|NCT02201446|2107568|P1|NOT COMPLETED|Overall Study||0
870669|NCT02201446|2107567|P2|COMPLETED|Overall Study||58
870670|NCT02201446|2107568|P1|COMPLETED|Overall Study||81
870671|NCT02201446|2107567|P2|STARTED|Overall Study||58
870672|NCT02201446|2107568|P1|STARTED|Overall Study||81
870673|NCT02201420|2107596|P1|NOT COMPLETED|Overall Study||0
870674|NCT02201420|2107596|P1|COMPLETED|Overall Study||5
870675|NCT02201420|2107596|P1|STARTED|Overall Study||5
870676|NCT02201056|2107608|P7|NOT COMPLETED|Overall Study||0
870677|NCT02201056|2107609|P6|NOT COMPLETED|Overall Study||0
870678|NCT02201056|2107610|P5|NOT COMPLETED|Overall Study||0
870679|NCT02201056|2107611|P4|NOT COMPLETED|Overall Study||0
870680|NCT02201056|2107612|P3|NOT COMPLETED|Overall Study||0
870681|NCT02201056|2107613|P2|NOT COMPLETED|Overall Study||0
870682|NCT02201056|2107614|P1|NOT COMPLETED|Overall Study||0
870683|NCT02201056|2107608|P7|COMPLETED|Overall Study||6
870684|NCT02201056|2107609|P6|COMPLETED|Overall Study||6
870685|NCT02201056|2107610|P5|COMPLETED|Overall Study||6
870686|NCT02201056|2107611|P4|COMPLETED|Overall Study||6
870687|NCT02201056|2107612|P3|COMPLETED|Overall Study||6
870688|NCT02201056|2107613|P2|COMPLETED|Overall Study||6
870689|NCT02201056|2107614|P1|COMPLETED|Overall Study||12
870690|NCT02201056|2107608|P7|STARTED|Overall Study||6
870691|NCT02201056|2107609|P6|STARTED|Overall Study||6
870692|NCT02201056|2107610|P5|STARTED|Overall Study||6
870693|NCT02201056|2107611|P4|STARTED|Overall Study||6
870694|NCT02201056|2107612|P3|STARTED|Overall Study||6
870695|NCT02201056|2107613|P2|STARTED|Overall Study||6
870696|NCT02201056|2107614|P1|STARTED|Overall Study||12
870697|NCT02200536|2107672|P3|NOT COMPLETED|Overall Study||0
870698|NCT02200536|2107673|P2|NOT COMPLETED|Overall Study||0
870699|NCT02200536|2107674|P1|NOT COMPLETED|Overall Study||0
870700|NCT02200536|2107672|P3|COMPLETED|Overall Study||30
870701|NCT02200536|2107673|P2|COMPLETED|Overall Study||30
870702|NCT02200536|2107674|P1|COMPLETED|Overall Study||32
870703|NCT02200536|2107672|P3|STARTED|Overall Study||30
870704|NCT02200536|2107673|P2|STARTED|Overall Study||30
870705|NCT02200536|2107674|P1|STARTED|Overall Study||32
870706|NCT02200458|2107685|P1|NOT COMPLETED|Overall Study||0
870707|NCT02200458|2107685|P1|COMPLETED|Overall Study||62
870708|NCT02200458|2107685|P1|STARTED|Overall Study||62
870709|NCT02200328|2107691|P2|NOT COMPLETED|Overall Study||33
870710|NCT02200328|2107692|P1|NOT COMPLETED|Overall Study||43
870711|NCT02200328|2107691|P2|COMPLETED|Overall Study||0
870712|NCT02200328|2107692|P1|COMPLETED|Overall Study||0
870713|NCT02200328|2107691|P2|STARTED|Overall Study||33
870714|NCT02200328|2107692|P1|STARTED|Overall Study||43
870715|NCT02199717|2107700|P1|NOT COMPLETED|Overall Study||0
870716|NCT02199717|2107700|P1|COMPLETED|Overall Study||66
870717|NCT02199717|2107700|P1|STARTED|Overall Study||66
870718|NCT02199574|2107707|P1|NOT COMPLETED|Overall Study||0
870719|NCT02199574|2107707|P1|COMPLETED|Overall Study||12
870720|NCT02199574|2107707|P1|STARTED|Overall Study||12
870721|NCT02199509|2107716|P2|NOT COMPLETED|Overall Study||1
870722|NCT02199509|2107717|P1|NOT COMPLETED|Overall Study||1
870723|NCT02199509|2107716|P2|COMPLETED|Overall Study||3
870724|NCT02199509|2107717|P1|COMPLETED|Overall Study||2
870725|NCT02199509|2107716|P2|STARTED|Overall Study||4
870726|NCT02199509|2107717|P1|STARTED|Overall Study||3
870727|NCT02198963|2107729|P1|NOT COMPLETED|Overall Study||7
870728|NCT02198963|2107729|P1|COMPLETED|Overall Study||36
870729|NCT02198963|2107729|P1|STARTED|Overall Study||43
870730|NCT02198833|2107740|P2|NOT COMPLETED|Overall Study||0
870731|NCT02198833|2107741|P1|NOT COMPLETED|Overall Study||0
870732|NCT02198833|2107740|P2|COMPLETED|Overall Study||1
870733|NCT02198833|2107741|P1|COMPLETED|Overall Study||1
870734|NCT02198833|2107740|P2|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed.|1
870735|NCT02198833|2107741|P1|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed|1
870736|NCT02198430|2107755|P2|NOT COMPLETED|Overall Study||0
870737|NCT02198430|2107756|P1|NOT COMPLETED|Overall Study||0
870738|NCT02198430|2107755|P2|COMPLETED|Overall Study||51
870739|NCT02198430|2107756|P1|COMPLETED|Overall Study||53
870740|NCT02198430|2107755|P2|STARTED|Overall Study||51
870741|NCT02198430|2107756|P1|STARTED|Overall Study||53
870742|NCT02198235|2107771|P3|NOT COMPLETED|Overall Study||2
870743|NCT02198235|2107772|P2|NOT COMPLETED|Overall Study||2
870744|NCT02198235|2107773|P1|NOT COMPLETED|Overall Study||3
870745|NCT02198235|2107771|P3|COMPLETED|Overall Study||28
870746|NCT02198235|2107772|P2|COMPLETED|Overall Study||28
870747|NCT02198235|2107773|P1|COMPLETED|Overall Study||27
870748|NCT02198235|2107771|P3|STARTED|Overall Study||30
870749|NCT02198235|2107772|P2|STARTED|Overall Study||30
870750|NCT02198235|2107773|P1|STARTED|Overall Study||30
870751|NCT02198040|2107793|P3|NOT COMPLETED|Overall Study||1
870752|NCT02198040|2107794|P2|NOT COMPLETED|Overall Study||1
870753|NCT02198040|2107795|P1|NOT COMPLETED|Overall Study||0
870754|NCT02198040|2107793|P3|COMPLETED|Overall Study||8
870755|NCT02198040|2107794|P2|COMPLETED|Overall Study||8
870756|NCT02198040|2107795|P1|COMPLETED|Overall Study||9
870757|NCT02198040|2107793|P3|STARTED|Overall Study||9
870758|NCT02198040|2107794|P2|STARTED|Overall Study||9
870759|NCT02198040|2107795|P1|STARTED|Overall Study||9
870760|NCT02197806|2107825|P4|NOT COMPLETED|Overall Study||1
870761|NCT02197806|2107826|P3|NOT COMPLETED|Overall Study||0
870762|NCT02197806|2107827|P2|NOT COMPLETED|Overall Study||1
870763|NCT02197806|2107828|P1|NOT COMPLETED|Overall Study||0
870764|NCT02197806|2107825|P4|COMPLETED|Overall Study||16
870765|NCT02197806|2107826|P3|COMPLETED|Overall Study||16
870766|NCT02197806|2107827|P2|COMPLETED|Overall Study||16
870767|NCT02197806|2107828|P1|COMPLETED|Overall Study||15
870768|NCT02197806|2107825|P4|STARTED|Overall Study||17
870769|NCT02197806|2107826|P3|STARTED|Overall Study||16
870770|NCT02197806|2107827|P2|STARTED|Overall Study||17
870771|NCT02197806|2107828|P1|STARTED|Overall Study||15
870772|NCT02197455|2107838|P1|NOT COMPLETED|Overall Study||0
870773|NCT02197455|2107838|P1|COMPLETED|Overall Study||30
870774|NCT02197455|2107838|P1|STARTED|Overall Study||30
870775|NCT02197273|2107845|P2|NOT COMPLETED|Overall Study||0
870776|NCT02197273|2107846|P1|NOT COMPLETED|Overall Study||0
870777|NCT02197273|2107845|P2|COMPLETED|Overall Study||104
870778|NCT02197273|2107846|P1|COMPLETED|Overall Study||107
870779|NCT02197273|2107845|P2|STARTED|Overall Study||104
870780|NCT02197273|2107846|P1|STARTED|Overall Study||107
870790|NCT02197234|2107899|P1|NOT COMPLETED|Part B: Day 33 to End Part B (AZD9291)||30
870791|NCT02197234|2107899|P1|COMPLETED|Part B: Day 33 to End Part B (AZD9291)||20
870792|NCT02197234|2107899|P1|STARTED|Part B: Day 33 to End Part B (AZD9291)|49 completed Part A + 1 entered Part B without completing Part A (due to AE) = 50 started Part B|50
870793|NCT02197234|2107899|P1|NOT COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||0
870794|NCT02197234|2107899|P1|COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
870795|NCT02197234|2107899|P1|STARTED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
870796|NCT02197234|2107899|P1|NOT COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||3
870797|NCT02197234|2107899|P1|COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||49
870798|NCT02197234|2107899|P1|STARTED|Part A: Day 3-30 (AZD9291 Alone)||52
870799|NCT02197234|2107899|P1|NOT COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||0
870800|NCT02197234|2107899|P1|COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||52
870801|NCT02197234|2107899|P1|STARTED|Part A: Day 1-2 (Simvastatin Alone)||52
870802|NCT02197065|2107920|P2|NOT COMPLETED|Overall Study||0
870803|NCT02197065|2107921|P1|NOT COMPLETED|Overall Study||0
870804|NCT02197065|2107920|P2|COMPLETED|Overall Study||10
870805|NCT02197065|2107921|P1|COMPLETED|Overall Study||10
870806|NCT02197065|2107920|P2|STARTED|Overall Study||10
870807|NCT02197065|2107921|P1|STARTED|Overall Study||10
870808|NCT02196766|2107930|P2|NOT COMPLETED|Second Intervention (7 Days)||0
870809|NCT02196766|2107931|P1|NOT COMPLETED|Second Intervention (7 Days)||0
870810|NCT02196766|2107930|P2|COMPLETED|Second Intervention (7 Days)||15
870811|NCT02196766|2107931|P1|COMPLETED|Second Intervention (7 Days)||15
870812|NCT02196766|2107930|P2|STARTED|Second Intervention (7 Days)||15
870813|NCT02196766|2107931|P1|STARTED|Second Intervention (7 Days)||15
870814|NCT02196766|2107930|P2|NOT COMPLETED|First Intervention (7 Days)||0
870815|NCT02196766|2107931|P1|NOT COMPLETED|First Intervention (7 Days)||0
870816|NCT02196766|2107930|P2|COMPLETED|First Intervention (7 Days)||15
870817|NCT02196766|2107931|P1|COMPLETED|First Intervention (7 Days)||15
870818|NCT02196766|2107930|P2|STARTED|First Intervention (7 Days)||15
870819|NCT02196766|2107931|P1|STARTED|First Intervention (7 Days)||15
870820|NCT02196714|2107947|P4|NOT COMPLETED|Overall Study||0
870821|NCT02196714|2107948|P3|NOT COMPLETED|Overall Study||1
870822|NCT02196714|2107949|P2|NOT COMPLETED|Overall Study||0
870823|NCT02196714|2107950|P1|NOT COMPLETED|Overall Study||0
870824|NCT02196714|2107947|P4|COMPLETED|Overall Study||24
870825|NCT02196714|2107948|P3|COMPLETED|Overall Study||23
870826|NCT02196714|2107949|P2|COMPLETED|Overall Study||23
870827|NCT02196714|2107950|P1|COMPLETED|Overall Study||24
870828|NCT02196714|2107947|P4|STARTED|Overall Study||24
870829|NCT02196714|2107948|P3|STARTED|Overall Study||24
870830|NCT02196714|2107949|P2|STARTED|Overall Study||23
870831|NCT02196714|2107950|P1|STARTED|Overall Study||24
870832|NCT02196675|2108073|P3|NOT COMPLETED|Overall Study||1
870833|NCT02196675|2108074|P2|NOT COMPLETED|Overall Study||2
870834|NCT02196675|2108075|P1|NOT COMPLETED|Overall Study||2
870835|NCT02196675|2108073|P3|COMPLETED|Overall Study||7
870836|NCT02196675|2108074|P2|COMPLETED|Overall Study||68
870837|NCT02196675|2108075|P1|COMPLETED|Overall Study||25
870838|NCT02196675|2108073|P3|STARTED|Overall Study||8
870839|NCT02196675|2108074|P2|STARTED|Overall Study||70
870840|NCT02196675|2108075|P1|STARTED|Overall Study||27
870841|NCT02196259|2108098|P3|NOT COMPLETED|Overall Study||1
870842|NCT02196259|2108099|P2|NOT COMPLETED|Overall Study||3
870843|NCT02196259|2108100|P1|NOT COMPLETED|Overall Study||0
870844|NCT02196259|2108098|P3|COMPLETED|Overall Study||2
870845|NCT02196259|2108099|P2|COMPLETED|Overall Study||4
870846|NCT02196259|2108100|P1|COMPLETED|Overall Study||3
870847|NCT02196259|2108098|P3|STARTED|Overall Study||3
870848|NCT02196259|2108099|P2|STARTED|Overall Study||7
870849|NCT02196259|2108100|P1|STARTED|Overall Study||3
870850|NCT02196168|2108109|P2|NOT COMPLETED|Overall Study||0
870851|NCT02196168|2108110|P1|NOT COMPLETED|Overall Study||0
870852|NCT02196168|2108109|P2|COMPLETED|Overall Study||0
870853|NCT02196168|2108110|P1|COMPLETED|Overall Study||6
870854|NCT02196168|2108109|P2|STARTED|Overall Study||0
870855|NCT02196168|2108110|P1|STARTED|Overall Study||6
870856|NCT02196077|2108128|P1|NOT COMPLETED|Overall Study||47
870857|NCT02196077|2108128|P1|COMPLETED|Overall Study||133
870858|NCT02196077|2108128|P1|FF MDI 9.6 μg|Overall Study||157
870859|NCT02196077|2108128|P1|BD MDI 320 μg|Overall Study||108
870860|NCT02196077|2108128|P1|BFF MDI 80/9.6 μg|Overall Study||103
870861|NCT02196077|2108128|P1|BFF MDI 160/9.6 μg|Overall Study||106
870862|NCT02196077|2108128|P1|BFF MDI 320/9.6 μg|Overall Study||155
870863|NCT02196077|2108128|P1|STARTED|Overall Study||180
870864|NCT02195986|2108178|P3|NOT COMPLETED|Overall Study||2
870865|NCT02195986|2108179|P2|NOT COMPLETED|Overall Study||5
870866|NCT02195986|2108180|P1|NOT COMPLETED|Overall Study||3
870867|NCT02195986|2108178|P3|COMPLETED|Overall Study||71
870868|NCT02195986|2108179|P2|COMPLETED|Overall Study||142
870869|NCT02195986|2108180|P1|COMPLETED|Overall Study||143
870870|NCT02195986|2108178|P3|STARTED|Overall Study||73
870871|NCT02195986|2108179|P2|STARTED|Overall Study||147
870872|NCT02195986|2108180|P1|STARTED|Overall Study||146
870873|NCT02195713|2108197|P2|NOT COMPLETED|Overall Study||0
870874|NCT02195713|2108198|P1|NOT COMPLETED|Overall Study||0
870875|NCT02195713|2108197|P2|COMPLETED|Overall Study||10
870876|NCT02195713|2108198|P1|COMPLETED|Overall Study||10
870877|NCT02195713|2108197|P2|STARTED|Overall Study||10
870878|NCT02195713|2108198|P1|STARTED|Overall Study||10
870879|NCT02195687|2108206|P2|NOT COMPLETED|Overall Study||2
870880|NCT02195687|2108207|P1|NOT COMPLETED|Overall Study||5
870881|NCT02195687|2108206|P2|COMPLETED|Overall Study||99
870882|NCT02195687|2108207|P1|COMPLETED|Overall Study||311
870883|NCT02195687|2108206|P2|STARTED|Overall Study||101
870884|NCT02195687|2108207|P1|STARTED|Overall Study||316
870885|NCT02195583|2108223|P1|NOT COMPLETED|Overall Study||9
870886|NCT02195583|2108223|P1|COMPLETED|Overall Study||53
870887|NCT02195583|2108223|P1|Sodium Fluoride (1426 Ppm) + Zinc Base B|Overall Study|Discontinuations: 1 withdrawal of consent in Period 2;1 adverse event each in Period 3 and Period 4|60
870888|NCT02195583|2108223|P1|Sodium Fluoride (1426 Ppm)|Overall Study|Discontinuation:1 lost to follow up, 1 withdrawal of consent in Period 2, 1 other reason in Period 5|59
870889|NCT02195583|2108223|P1|Sodium Fluoride (250 Ppm)|Overall Study||55
870890|NCT02195583|2108223|P1|Sodium Fluoride (1426 Ppm) + Zinc Base A|Overall Study|Discontinuations: 1 withdrawal of consent in Period 3 and 1 withdrawal of consent in Period 4|58
870891|NCT02195583|2108223|P1|Sodium Fluoride (0 Ppm)|Overall Study||59
870892|NCT02195583|2108223|P1|Sodium Fluoride (1150 Ppm)|Overall Study|Discontinuations: 1 due to other reason in Period 5|57
870893|NCT02195583|2108223|P1|STARTED|Overall Study||62
870894|NCT02195414|2108255|P1|NOT COMPLETED|Overall Study||0
870895|NCT02195414|2108255|P1|COMPLETED|Overall Study||31
870896|NCT02195414|2108255|P1|Primary Endpoint|Overall Study||31
870897|NCT02195414|2108255|P1|STARTED|Overall Study||31
870898|NCT02194621|2108265|P3|NOT COMPLETED|Overall Study||9
870899|NCT02194621|2108266|P2|NOT COMPLETED|Overall Study||6
870900|NCT02194621|2108267|P1|NOT COMPLETED|Overall Study||6
870901|NCT02194621|2108265|P3|COMPLETED|Overall Study||34
870902|NCT02194621|2108266|P2|COMPLETED|Overall Study||36
870903|NCT02194621|2108267|P1|COMPLETED|Overall Study||37
870904|NCT02194621|2108265|P3|STARTED|Overall Study||43
870905|NCT02194621|2108266|P2|STARTED|Overall Study||42
870906|NCT02194621|2108267|P1|STARTED|Overall Study||43
870907|NCT02194088|2108286|P2|NOT COMPLETED|Overall Study||0
870908|NCT02194088|2108287|P1|NOT COMPLETED|Overall Study||0
870909|NCT02194088|2108286|P2|COMPLETED|Overall Study||25
870910|NCT02194088|2108287|P1|COMPLETED|Overall Study||75
870911|NCT02194088|2108286|P2|STARTED|Overall Study||25
870912|NCT02194088|2108287|P1|STARTED|Overall Study||75
870913|NCT02194062|2108300|P3|NOT COMPLETED|Overall Study||5
870914|NCT02194062|2108301|P2|NOT COMPLETED|Overall Study||2
870915|NCT02194062|2108302|P1|NOT COMPLETED|Overall Study||2
870916|NCT02194062|2108300|P3|COMPLETED|Overall Study||7
870917|NCT02194062|2108301|P2|COMPLETED|Overall Study||8
870918|NCT02194062|2108302|P1|COMPLETED|Overall Study||8
870919|NCT02194062|2108300|P3|STARTED|Overall Study||12
870920|NCT02194062|2108301|P2|STARTED|Overall Study||10
870921|NCT02194062|2108302|P1|STARTED|Overall Study||10
870922|NCT02193828|2108317|P4|NOT COMPLETED|Overall Study||1
870923|NCT02193828|2108318|P3|NOT COMPLETED|Overall Study||1
870924|NCT02193828|2108319|P2|NOT COMPLETED|Overall Study||0
870925|NCT02193828|2108320|P1|NOT COMPLETED|Overall Study||0
870926|NCT02193828|2108317|P4|COMPLETED|Overall Study||16
870927|NCT02193828|2108318|P3|COMPLETED|Overall Study||22
870928|NCT02193828|2108319|P2|COMPLETED|Overall Study||18
870929|NCT02193828|2108320|P1|COMPLETED|Overall Study||18
870930|NCT02193828|2108317|P4|STARTED|Overall Study||17
870931|NCT02193828|2108318|P3|STARTED|Overall Study||23
870932|NCT02193828|2108319|P2|STARTED|Overall Study||18
870933|NCT02193828|2108320|P1|STARTED|Overall Study||18
870934|NCT02193815|2108358|P1|NOT COMPLETED|Overall Study||0
870935|NCT02193815|2108358|P1|COMPLETED|Overall Study||15
870936|NCT02193815|2108358|P1|STARTED|Overall Study||15
870937|NCT02193178|2108393|P1|NOT COMPLETED|Overall Study||2
870938|NCT02193178|2108393|P1|COMPLETED|Overall Study||13
870939|NCT02193178|2108393|P1|STARTED|Overall Study||15
870940|NCT02193165|2108443|P3|NOT COMPLETED|6 Week Product Use||0
870941|NCT02193165|2108444|P2|NOT COMPLETED|6 Week Product Use||1
870942|NCT02193165|2108445|P1|NOT COMPLETED|6 Week Product Use||0
870943|NCT02193165|2108443|P3|COMPLETED|6 Week Product Use||39
870944|NCT02193165|2108444|P2|COMPLETED|6 Week Product Use|1 subject failed to keep appointment time and didn't return to clinical site.|38
870945|NCT02193165|2108445|P1|COMPLETED|6 Week Product Use||39
870946|NCT02193165|2108443|P3|STARTED|6 Week Product Use||39
870947|NCT02193165|2108444|P2|STARTED|6 Week Product Use||39
870948|NCT02193165|2108445|P1|STARTED|6 Week Product Use||39
870949|NCT02193165|2108443|P3|NOT COMPLETED|4 Week Product Use||1
870950|NCT02193165|2108444|P2|NOT COMPLETED|4 Week Product Use||1
870951|NCT02193165|2108445|P1|NOT COMPLETED|4 Week Product Use||1
870952|NCT02193165|2108443|P3|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
870953|NCT02193165|2108444|P2|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
870954|NCT02193165|2108445|P1|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
870955|NCT02193165|2108443|P3|STARTED|4 Week Product Use||40
870956|NCT02193165|2108444|P2|STARTED|4 Week Product Use||40
870957|NCT02193165|2108445|P1|STARTED|4 Week Product Use||40
870958|NCT02193087|2108472|P4|NOT COMPLETED|Overall Study||79
870959|NCT02193087|2108473|P3|NOT COMPLETED|Overall Study||7
870960|NCT02193087|2108474|P2|NOT COMPLETED|Overall Study||14
870961|NCT02193087|2108475|P1|NOT COMPLETED|Overall Study||37
870962|NCT02193087|2108472|P4|COMPLETED|Overall Study||524
870963|NCT02193087|2108473|P3|COMPLETED|Overall Study||93
870964|NCT02193087|2108474|P2|COMPLETED|Overall Study||86
870965|NCT02193087|2108475|P1|COMPLETED|Overall Study||162
870966|NCT02193087|2108472|P4|Received Vaccination|Overall Study||602
870967|NCT02193087|2108473|P3|Received Vaccination|Overall Study||100
870968|NCT02193087|2108474|P2|Received Vaccination|Overall Study||97
870969|NCT02193087|2108475|P1|Received Vaccination|Overall Study||197
870970|NCT02193087|2108472|P4|STARTED|Overall Study||603
870971|NCT02193087|2108473|P3|STARTED|Overall Study||100
870972|NCT02193087|2108474|P2|STARTED|Overall Study||100
870973|NCT02193087|2108475|P1|STARTED|Overall Study||199
870974|NCT02193074|2108520|P2|NOT COMPLETED|Overall Study||15
870975|NCT02193074|2108521|P1|NOT COMPLETED|Overall Study||17
870976|NCT02193074|2108520|P2|COMPLETED|Overall Study||65
870977|NCT02193074|2108521|P1|COMPLETED|Overall Study||24
870978|NCT02193074|2108520|P2|Completed Due to Early Study Termination|Overall Study||39
870979|NCT02193074|2108521|P1|Completed Due to Early Study Termination|Overall Study||13
870980|NCT02193074|2108520|P2|Completed During Follow-Up Period|Overall Study||26
870981|NCT02193074|2108521|P1|Completed During Follow-Up Period|Overall Study||11
870982|NCT02193074|2108520|P2|STARTED|Overall Study|Randomized and received double-blind treatment.|80
870983|NCT02193074|2108521|P1|STARTED|Overall Study|Randomized and received double-blind treatment.|41
870984|NCT02192879|2108556|P3|NOT COMPLETED|Overall Study||0
870985|NCT02192879|2108557|P2|NOT COMPLETED|Overall Study||0
870986|NCT02192879|2108558|P1|NOT COMPLETED|Overall Study||0
870987|NCT02192879|2108556|P3|COMPLETED|Overall Study||3
870988|NCT02192879|2108557|P2|COMPLETED|Overall Study||4
870989|NCT02192879|2108558|P1|COMPLETED|Overall Study||3
870990|NCT02192879|2108556|P3|STARTED|Overall Study||3
870991|NCT02192879|2108557|P2|STARTED|Overall Study||4
870992|NCT02192879|2108558|P1|STARTED|Overall Study||3
870993|NCT02192814|2108584|P1|NOT COMPLETED|Overall Study||0
870994|NCT02192814|2108584|P1|COMPLETED|Overall Study||9
870995|NCT02192814|2108584|P1|STARTED|Overall Study||9
870996|NCT02192684|2108597|P2|NOT COMPLETED|Overall Study||0
870997|NCT02192684|2108598|P1|NOT COMPLETED|Overall Study||0
870998|NCT02192684|2108597|P2|COMPLETED|Overall Study||15
870999|NCT02192684|2108598|P1|COMPLETED|Overall Study||30
871000|NCT02192684|2108597|P2|STARTED|Overall Study||15
871001|NCT02192684|2108598|P1|STARTED|Overall Study||30
871002|NCT02192606|2108606|P2|NOT COMPLETED|Overall Study||4
871003|NCT02192606|2108607|P1|NOT COMPLETED|Overall Study||2
871004|NCT02192606|2108606|P2|COMPLETED|Overall Study||24
871005|NCT02192606|2108607|P1|COMPLETED|Overall Study||27
871006|NCT02192606|2108606|P2|STARTED|Overall Study||28
871007|NCT02192606|2108607|P1|STARTED|Overall Study||29
871008|NCT02192164|2108615|P1|NOT COMPLETED|Overall Study||14
871009|NCT02192164|2108615|P1|COMPLETED|Overall Study||112
871010|NCT02192164|2108615|P1|Etanercept Treated Population|Overall Study||112
871011|NCT02192164|2108615|P1|STARTED|Overall Study||126
871012|NCT02191865|2108634|P3|NOT COMPLETED|Overall Study||0
871013|NCT02191865|2108635|P2|NOT COMPLETED|Overall Study||0
871014|NCT02191865|2108636|P1|NOT COMPLETED|Overall Study||0
871015|NCT02191865|2108634|P3|COMPLETED|Overall Study||17
871016|NCT02191865|2108635|P2|COMPLETED|Overall Study||8
871017|NCT02191865|2108636|P1|COMPLETED|Overall Study||8
871018|NCT02191865|2108634|P3|STARTED|Overall Study||17
871019|NCT02191865|2108635|P2|STARTED|Overall Study||8
871020|NCT02191865|2108636|P1|STARTED|Overall Study||8
871021|NCT02191046|2108658|P2|NOT COMPLETED|Overall Study||1
871022|NCT02191046|2108659|P1|NOT COMPLETED|Overall Study||5
871023|NCT02191046|2108658|P2|COMPLETED|Overall Study|exclude 1 patient because low compliance|38
871024|NCT02191046|2108659|P1|COMPLETED|Overall Study|exclude 5 patients because low compliance|36
871025|NCT02191046|2108658|P2|STARTED|Overall Study||39
871026|NCT02191046|2108659|P1|STARTED|Overall Study||41
871027|NCT02191033|2108667|P2|NOT COMPLETED|Overall Study||1
871028|NCT02191033|2108668|P1|NOT COMPLETED|Overall Study||2
871029|NCT02191033|2108667|P2|COMPLETED|Overall Study||19
871030|NCT02191033|2108668|P1|COMPLETED|Overall Study||18
871031|NCT02191033|2108667|P2|STARTED|Overall Study||20
871032|NCT02191033|2108668|P1|STARTED|Overall Study||20
871033|NCT02190604|2108697|P19|NOT COMPLETED|Part 3 (Patients)||0
871034|NCT02190604|2108698|P18|NOT COMPLETED|Part 3 (Patients)||0
871035|NCT02190604|2108699|P17|NOT COMPLETED|Part 3 (Patients)||0
871036|NCT02190604|2108700|P16|NOT COMPLETED|Part 3 (Patients)||0
871037|NCT02190604|2108701|P15|NOT COMPLETED|Part 3 (Patients)||0
871038|NCT02190604|2108702|P14|NOT COMPLETED|Part 3 (Patients)||0
871039|NCT02190604|2108703|P13|NOT COMPLETED|Part 3 (Patients)||0
871040|NCT02190604|2108704|P12|NOT COMPLETED|Part 3 (Patients)||0
871041|NCT02190604|2108705|P11|NOT COMPLETED|Part 3 (Patients)||0
871042|NCT02190604|2108706|P10|NOT COMPLETED|Part 3 (Patients)||0
871043|NCT02190604|2108707|P9|NOT COMPLETED|Part 3 (Patients)||0
871044|NCT02190604|2108708|P8|NOT COMPLETED|Part 3 (Patients)||0
871045|NCT02190604|2108709|P7|NOT COMPLETED|Part 3 (Patients)||0
871046|NCT02190604|2108710|P6|NOT COMPLETED|Part 3 (Patients)||0
871047|NCT02190604|2108711|P5|NOT COMPLETED|Part 3 (Patients)||0
871048|NCT02190604|2108712|P4|NOT COMPLETED|Part 3 (Patients)||0
871049|NCT02190604|2108713|P3|NOT COMPLETED|Part 3 (Patients)||0
871050|NCT02190604|2108714|P2|NOT COMPLETED|Part 3 (Patients)||0
871051|NCT02190604|2108715|P1|NOT COMPLETED|Part 3 (Patients)||0
871052|NCT02190604|2108697|P19|COMPLETED|Part 3 (Patients)||12
871053|NCT02190604|2108698|P18|COMPLETED|Part 3 (Patients)||19
871054|NCT02190604|2108699|P17|COMPLETED|Part 3 (Patients)||12
871055|NCT02190604|2108700|P16|COMPLETED|Part 3 (Patients)||6
871056|NCT02190604|2108701|P15|COMPLETED|Part 3 (Patients)||0
871057|NCT02190604|2108702|P14|COMPLETED|Part 3 (Patients)||0
871058|NCT02190604|2108703|P13|COMPLETED|Part 3 (Patients)||0
871059|NCT02190604|2108704|P12|COMPLETED|Part 3 (Patients)||0
871060|NCT02190604|2108705|P11|COMPLETED|Part 3 (Patients)||0
871061|NCT02190604|2108706|P10|COMPLETED|Part 3 (Patients)||0
871062|NCT02190604|2108707|P9|COMPLETED|Part 3 (Patients)||0
871063|NCT02190604|2108708|P8|COMPLETED|Part 3 (Patients)||0
871064|NCT02190604|2108709|P7|COMPLETED|Part 3 (Patients)||0
871065|NCT02190604|2108710|P6|COMPLETED|Part 3 (Patients)||0
871066|NCT02190604|2108711|P5|COMPLETED|Part 3 (Patients)||0
871067|NCT02190604|2108712|P4|COMPLETED|Part 3 (Patients)||0
871068|NCT02190604|2108713|P3|COMPLETED|Part 3 (Patients)||0
871069|NCT02190604|2108714|P2|COMPLETED|Part 3 (Patients)||0
871070|NCT02190604|2108715|P1|COMPLETED|Part 3 (Patients)||0
871071|NCT02190604|2108697|P19|STARTED|Part 3 (Patients)||12
871072|NCT02190604|2108698|P18|STARTED|Part 3 (Patients)||19
871073|NCT02190604|2108699|P17|STARTED|Part 3 (Patients)||12
871074|NCT02190604|2108700|P16|STARTED|Part 3 (Patients)||6
871075|NCT02190604|2108701|P15|STARTED|Part 3 (Patients)||0
871076|NCT02190604|2108702|P14|STARTED|Part 3 (Patients)||0
871077|NCT02190604|2108703|P13|STARTED|Part 3 (Patients)||0
871078|NCT02190604|2108704|P12|STARTED|Part 3 (Patients)||0
871079|NCT02190604|2108705|P11|STARTED|Part 3 (Patients)||0
871080|NCT02190604|2108706|P10|STARTED|Part 3 (Patients)||0
871081|NCT02190604|2108707|P9|STARTED|Part 3 (Patients)||0
871082|NCT02190604|2108708|P8|STARTED|Part 3 (Patients)||0
871083|NCT02190604|2108709|P7|STARTED|Part 3 (Patients)||0
871084|NCT02190604|2108710|P6|STARTED|Part 3 (Patients)||0
871085|NCT02190604|2108711|P5|STARTED|Part 3 (Patients)||0
871086|NCT02190604|2108712|P4|STARTED|Part 3 (Patients)||0
871087|NCT02190604|2108713|P3|STARTED|Part 3 (Patients)||0
871088|NCT02190604|2108714|P2|STARTED|Part 3 (Patients)||0
871089|NCT02190604|2108715|P1|STARTED|Part 3 (Patients)||0
871090|NCT02190604|2108697|P19|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
871091|NCT02190604|2108698|P18|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
871092|NCT02190604|2108699|P17|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
871093|NCT02190604|2108700|P16|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
871094|NCT02190604|2108701|P15|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||2
871095|NCT02190604|2108702|P14|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||1
871096|NCT02190604|2108703|P13|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
871097|NCT02190604|2108704|P12|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
871098|NCT02190604|2108705|P11|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
871099|NCT02190604|2108706|P10|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
871100|NCT02190604|2108707|P9|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
871101|NCT02190604|2108708|P8|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
871102|NCT02190604|2108709|P7|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
871103|NCT02190604|2108710|P6|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
871104|NCT02190604|2108711|P5|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
871105|NCT02190604|2108712|P4|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
871106|NCT02190604|2108713|P3|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
871107|NCT02190604|2108714|P2|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
871108|NCT02190604|2108715|P1|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
871109|NCT02190604|2108697|P19|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
871110|NCT02190604|2108698|P18|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
871111|NCT02190604|2108699|P17|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
871112|NCT02190604|2108700|P16|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
871113|NCT02190604|2108701|P15|COMPLETED|Part 1 and 2 (Healthy Volunteers)||8
871114|NCT02190604|2108702|P14|COMPLETED|Part 1 and 2 (Healthy Volunteers)||5
871115|NCT02190604|2108703|P13|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
871116|NCT02190604|2108704|P12|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
871117|NCT02190604|2108705|P11|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
871118|NCT02190604|2108706|P10|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
871119|NCT02190604|2108707|P9|COMPLETED|Part 1 and 2 (Healthy Volunteers)||16
871120|NCT02190604|2108708|P8|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
871121|NCT02190604|2108709|P7|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
871122|NCT02190604|2108710|P6|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
871123|NCT02190604|2108711|P5|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
871124|NCT02190604|2108712|P4|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
871125|NCT02190604|2108713|P3|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
871126|NCT02190604|2108714|P2|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
871127|NCT02190604|2108715|P1|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
871128|NCT02190604|2108697|P19|STARTED|Part 1 and 2 (Healthy Volunteers)||0
871129|NCT02190604|2108698|P18|STARTED|Part 1 and 2 (Healthy Volunteers)||0
871130|NCT02190604|2108699|P17|STARTED|Part 1 and 2 (Healthy Volunteers)||0
871131|NCT02190604|2108700|P16|STARTED|Part 1 and 2 (Healthy Volunteers)||0
871132|NCT02190604|2108701|P15|STARTED|Part 1 and 2 (Healthy Volunteers)||10
871133|NCT02190604|2108702|P14|STARTED|Part 1 and 2 (Healthy Volunteers)||6
871134|NCT02190604|2108703|P13|STARTED|Part 1 and 2 (Healthy Volunteers)||6
871135|NCT02190604|2108704|P12|STARTED|Part 1 and 2 (Healthy Volunteers)||6
871136|NCT02190604|2108705|P11|STARTED|Part 1 and 2 (Healthy Volunteers)||6
871137|NCT02190604|2108706|P10|STARTED|Part 1 and 2 (Healthy Volunteers)||6
871138|NCT02190604|2108707|P9|STARTED|Part 1 and 2 (Healthy Volunteers)||16
871139|NCT02190604|2108708|P8|STARTED|Part 1 and 2 (Healthy Volunteers)||6
871140|NCT02190604|2108709|P7|STARTED|Part 1 and 2 (Healthy Volunteers)||6
871141|NCT02190604|2108710|P6|STARTED|Part 1 and 2 (Healthy Volunteers)||6
871142|NCT02190604|2108711|P5|STARTED|Part 1 and 2 (Healthy Volunteers)||6
871143|NCT02190604|2108712|P4|STARTED|Part 1 and 2 (Healthy Volunteers)||6
871144|NCT02190604|2108713|P3|STARTED|Part 1 and 2 (Healthy Volunteers)||6
871145|NCT02190604|2108714|P2|STARTED|Part 1 and 2 (Healthy Volunteers)||6
871146|NCT02190604|2108715|P1|STARTED|Part 1 and 2 (Healthy Volunteers)||6
871147|NCT02190591|2108906|P2|NOT COMPLETED|Overall Study||11
871148|NCT02190591|2108907|P1|NOT COMPLETED|Overall Study||2
871149|NCT02190591|2108906|P2|COMPLETED|Overall Study||91
871150|NCT02190591|2108907|P1|COMPLETED|Overall Study||100
871151|NCT02190591|2108906|P2|STARTED|Overall Study||102
871152|NCT02190591|2108907|P1|STARTED|Overall Study||102
871153|NCT02190435|2108919|P2|NOT COMPLETED|Overall Study||0
871154|NCT02190435|2108920|P1|NOT COMPLETED|Overall Study||15
871155|NCT02190435|2108919|P2|COMPLETED|Overall Study||24
871156|NCT02190435|2108920|P1|COMPLETED|Overall Study||26
871157|NCT02190435|2108919|P2|STARTED|Overall Study||24
871158|NCT02190435|2108920|P1|STARTED|Overall Study||41
871159|NCT02189954|2108930|P2|NOT COMPLETED|Overall Study||0
871160|NCT02189954|2108931|P1|NOT COMPLETED|Overall Study||0
871161|NCT02189954|2108930|P2|COMPLETED|Overall Study||45
871162|NCT02189954|2108931|P1|COMPLETED|Overall Study||45
871163|NCT02189954|2108930|P2|STARTED|Overall Study||45
871164|NCT02189954|2108931|P1|STARTED|Overall Study||45
871165|NCT02189941|2108939|P3|NOT COMPLETED|Overall Study||1
871166|NCT02189941|2108940|P2|NOT COMPLETED|Overall Study||0
871167|NCT02189941|2108941|P1|NOT COMPLETED|Overall Study||0
871168|NCT02189941|2108939|P3|COMPLETED|Overall Study||2
871169|NCT02189941|2108940|P2|COMPLETED|Overall Study||4
871170|NCT02189941|2108941|P1|COMPLETED|Overall Study||4
871171|NCT02189941|2108939|P3|STARTED|Overall Study||3
871172|NCT02189941|2108940|P2|STARTED|Overall Study||4
871173|NCT02189941|2108941|P1|STARTED|Overall Study||4
871174|NCT02189915|2108964|P1|NOT COMPLETED|Overall Study||3
871175|NCT02189915|2108964|P1|COMPLETED|Overall Study||11
871176|NCT02189915|2108964|P1|STARTED|Overall Study||14
871177|NCT02189863|2108969|P2|NOT COMPLETED|Second 2 Weeks||0
871178|NCT02189863|2108970|P1|NOT COMPLETED|Second 2 Weeks||0
871179|NCT02189863|2108969|P2|COMPLETED|Second 2 Weeks||13
871180|NCT02189863|2108970|P1|COMPLETED|Second 2 Weeks||8
871181|NCT02189863|2108969|P2|STARTED|Second 2 Weeks||13
871182|NCT02189863|2108970|P1|STARTED|Second 2 Weeks||8
871183|NCT02189863|2108969|P2|NOT COMPLETED|First 2 Weeks||2
871184|NCT02189863|2108970|P1|NOT COMPLETED|First 2 Weeks||4
871185|NCT02189863|2108969|P2|COMPLETED|First 2 Weeks||13
871186|NCT02189863|2108970|P1|COMPLETED|First 2 Weeks||8
871187|NCT02189863|2108969|P2|STARTED|First 2 Weeks||15
871188|NCT02189863|2108970|P1|STARTED|First 2 Weeks||12
871205|NCT02189759|2109018|P4|NOT COMPLETED|Overall Study||5
871206|NCT02189759|2109019|P3|NOT COMPLETED|Overall Study||2
871207|NCT02189759|2109020|P2|NOT COMPLETED|Overall Study||0
871208|NCT02189759|2109021|P1|NOT COMPLETED|Overall Study||0
871209|NCT02189759|2109018|P4|COMPLETED|Overall Study||84
871210|NCT02189759|2109019|P3|COMPLETED|Overall Study||81
871211|NCT02189759|2109020|P2|COMPLETED|Overall Study||101
871212|NCT02189759|2109021|P1|COMPLETED|Overall Study||102
871213|NCT02189759|2109018|P4|STARTED|Overall Study||89
871214|NCT02189759|2109019|P3|STARTED|Overall Study||83
871215|NCT02189759|2109020|P2|STARTED|Overall Study||101
871216|NCT02189759|2109021|P1|STARTED|Overall Study||102
871217|NCT02189317|2109041|P2|NOT COMPLETED|Overall Study||0
871218|NCT02189317|2109042|P1|NOT COMPLETED|Overall Study||0
871219|NCT02189317|2109041|P2|COMPLETED|Overall Study||16
871220|NCT02189317|2109042|P1|COMPLETED|Overall Study||16
871221|NCT02189317|2109041|P2|STARTED|Overall Study||16
871222|NCT02189317|2109042|P1|STARTED|Overall Study||16
871223|NCT02189252|2109056|P4|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
871224|NCT02189252|2109057|P3|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
871225|NCT02189252|2109058|P2|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
871226|NCT02189252|2109059|P1|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
871227|NCT02189252|2109056|P4|COMPLETED|Period 2 (Visit6b, Week 12)||4
871228|NCT02189252|2109057|P3|COMPLETED|Period 2 (Visit6b, Week 12)||3
871229|NCT02189252|2109058|P2|COMPLETED|Period 2 (Visit6b, Week 12)||2
871230|NCT02189252|2109059|P1|COMPLETED|Period 2 (Visit6b, Week 12)||4
871231|NCT02189252|2109056|P4|STARTED|Period 2 (Visit6b, Week 12)||4
871232|NCT02189252|2109057|P3|STARTED|Period 2 (Visit6b, Week 12)||3
871233|NCT02189252|2109058|P2|STARTED|Period 2 (Visit6b, Week 12)||2
871234|NCT02189252|2109059|P1|STARTED|Period 2 (Visit6b, Week 12)||4
871235|NCT02189252|2109056|P4|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
871236|NCT02189252|2109057|P3|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
871237|NCT02189252|2109058|P2|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||2
871238|NCT02189252|2109059|P1|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
871239|NCT02189252|2109056|P4|COMPLETED|Period 1 (Visit 4b, Week 4)||4
871240|NCT02189252|2109057|P3|COMPLETED|Period 1 (Visit 4b, Week 4)||3
871241|NCT02189252|2109058|P2|COMPLETED|Period 1 (Visit 4b, Week 4)||2
871242|NCT02189252|2109059|P1|COMPLETED|Period 1 (Visit 4b, Week 4)||4
871243|NCT02189252|2109056|P4|STARTED|Period 1 (Visit 4b, Week 4)||4
871244|NCT02189252|2109057|P3|STARTED|Period 1 (Visit 4b, Week 4)||3
871245|NCT02189252|2109058|P2|STARTED|Period 1 (Visit 4b, Week 4)||4
871246|NCT02189252|2109059|P1|STARTED|Period 1 (Visit 4b, Week 4)||4
871247|NCT02189161|2109091|P1|NOT COMPLETED|Overall Study||0
871248|NCT02189161|2109091|P1|COMPLETED|Overall Study||10
871249|NCT02189161|2109091|P1|STARTED|Overall Study||10
871250|NCT02189122|2109099|P2|NOT COMPLETED|Overall Study||0
871251|NCT02189122|2109100|P1|NOT COMPLETED|Overall Study||0
871252|NCT02189122|2109099|P2|COMPLETED|Overall Study||18
871253|NCT02189122|2109100|P1|COMPLETED|Overall Study||18
871254|NCT02189122|2109099|P2|STARTED|Overall Study||18
871255|NCT02189122|2109100|P1|STARTED|Overall Study||18
871256|NCT02188849|2109118|P2|NOT COMPLETED|Overall Study||8
871257|NCT02188849|2109119|P1|NOT COMPLETED|Overall Study||3
871258|NCT02188849|2109118|P2|COMPLETED|Overall Study||17
871259|NCT02188849|2109119|P1|COMPLETED|Overall Study||22
871260|NCT02188849|2109118|P2|STARTED|Overall Study||25
871261|NCT02188849|2109119|P1|STARTED|Overall Study||25
871262|NCT02188784|2109133|P2|NOT COMPLETED|Overall Study||13
871263|NCT02188784|2109134|P1|NOT COMPLETED|Overall Study||9
871264|NCT02188784|2109133|P2|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|101
871265|NCT02188784|2109134|P1|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|102
871266|NCT02188784|2109133|P2|STARTED|Overall Study||114
871267|NCT02188784|2109134|P1|STARTED|Overall Study||111
871268|NCT02188589|2109150|P1|NOT COMPLETED|Overall Study||0
871269|NCT02188589|2109150|P1|COMPLETED|Overall Study||30
871270|NCT02188589|2109150|P1|STARTED|Overall Study||30
871271|NCT02187809|2109155|P1|NOT COMPLETED|Overall Study||3
871272|NCT02187809|2109155|P1|COMPLETED|Overall Study||0
871273|NCT02187809|2109155|P1|Treated|Overall Study||1
871274|NCT02187809|2109155|P1|STARTED|Overall Study||3
871275|NCT02187744|2109167|P2|NOT COMPLETED|Treatment||5
871276|NCT02187744|2109168|P1|NOT COMPLETED|Treatment||4
871277|NCT02187744|2109167|P2|COMPLETED|Treatment||107
871278|NCT02187744|2109168|P1|COMPLETED|Treatment||109
871279|NCT02187744|2109167|P2|STARTED|Treatment||112
871280|NCT02187744|2109168|P1|STARTED|Treatment||113
871281|NCT02187744|2109167|P2|NOT COMPLETED|Study||6
871282|NCT02187744|2109168|P1|NOT COMPLETED|Study||4
871283|NCT02187744|2109167|P2|COMPLETED|Study||106
871284|NCT02187744|2109168|P1|COMPLETED|Study||109
871285|NCT02187744|2109167|P2|STARTED|Study|Received treatment|112
871286|NCT02187744|2109168|P1|STARTED|Study|Received treatment|113
871287|NCT02187029|2109188|P4|NOT COMPLETED|Overall Study||3
871288|NCT02187029|2109189|P3|NOT COMPLETED|Overall Study||11
871289|NCT02187029|2109190|P2|NOT COMPLETED|Overall Study||1
871290|NCT02187029|2109191|P1|NOT COMPLETED|Overall Study||1
871291|NCT02187029|2109188|P4|COMPLETED|Overall Study||6
871292|NCT02187029|2109189|P3|COMPLETED|Overall Study||0
871293|NCT02187029|2109190|P2|COMPLETED|Overall Study||2
871294|NCT02187029|2109191|P1|COMPLETED|Overall Study||6
871295|NCT02187029|2109188|P4|STARTED|Overall Study||9
871296|NCT02187029|2109189|P3|STARTED|Overall Study||11
871297|NCT02187029|2109190|P2|STARTED|Overall Study||3
871298|NCT02187029|2109191|P1|STARTED|Overall Study||7
871299|NCT02187016|2109267|P4|NOT COMPLETED|Overall Study||0
871300|NCT02187016|2109268|P3|NOT COMPLETED|Overall Study||1
871301|NCT02187016|2109269|P2|NOT COMPLETED|Overall Study||2
871302|NCT02187016|2109270|P1|NOT COMPLETED|Overall Study||1
871303|NCT02187016|2109267|P4|COMPLETED|Overall Study||51
871304|NCT02187016|2109268|P3|COMPLETED|Overall Study||78
871305|NCT02187016|2109269|P2|COMPLETED|Overall Study||78
871306|NCT02187016|2109270|P1|COMPLETED|Overall Study||79
871307|NCT02187016|2109267|P4|STARTED|Overall Study||51
871308|NCT02187016|2109268|P3|STARTED|Overall Study||79
871309|NCT02187016|2109269|P2|STARTED|Overall Study||80
871310|NCT02187016|2109270|P1|STARTED|Overall Study||80
871311|NCT02186808|2109300|P1|NOT COMPLETED|Overall Study||13
871312|NCT02186808|2109300|P1|COMPLETED|Overall Study||67
871313|NCT02186808|2109300|P1|STARTED|Overall Study||80
871314|NCT02186665|2109307|P2|NOT COMPLETED|Overall Study||1
871315|NCT02186665|2109308|P1|NOT COMPLETED|Overall Study||0
871316|NCT02186665|2109307|P2|COMPLETED|Overall Study||10
871317|NCT02186665|2109308|P1|COMPLETED|Overall Study||8
871318|NCT02186665|2109307|P2|STARTED|Overall Study||11
871319|NCT02186665|2109308|P1|STARTED|Overall Study||8
871320|NCT02186587|2109316|P2|NOT COMPLETED|Overall Study||0
871321|NCT02186587|2109317|P1|NOT COMPLETED|Overall Study||5
871322|NCT02186587|2109316|P2|COMPLETED|Overall Study||0
871323|NCT02186587|2109317|P1|COMPLETED|Overall Study||23
871324|NCT02186587|2109316|P2|STARTED|Overall Study||0
871325|NCT02186587|2109317|P1|STARTED|Overall Study||28
871326|NCT02186223|2109322|P1|NOT COMPLETED|Overall Study||21
871327|NCT02186223|2109322|P1|COMPLETED|Overall Study||151
871328|NCT02186223|2109322|P1|Device Placed|Overall Study||163
871329|NCT02186223|2109322|P1|STARTED|Overall Study||172
871330|NCT02185729|2109331|P1|NOT COMPLETED|24 Hours Into Dextrose Infusion||0
871331|NCT02185729|2109331|P1|COMPLETED|24 Hours Into Dextrose Infusion||12
871332|NCT02185729|2109331|P1|STARTED|24 Hours Into Dextrose Infusion||12
871333|NCT02185729|2109331|P1|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
871334|NCT02185729|2109331|P1|COMPLETED|4 Hours Into Dextrose Infusion||12
871335|NCT02185729|2109331|P1|STARTED|4 Hours Into Dextrose Infusion||12
871336|NCT02185729|2109331|P1|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
871337|NCT02185729|2109331|P1|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
871338|NCT02185729|2109331|P1|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
871339|NCT02185729|2109331|P1|NOT COMPLETED|24 Hours Into ClinOleic Infusion||0
871340|NCT02185729|2109331|P1|COMPLETED|24 Hours Into ClinOleic Infusion||12
871341|NCT02185729|2109331|P1|STARTED|24 Hours Into ClinOleic Infusion||12
871342|NCT02185729|2109331|P1|NOT COMPLETED|4 Hours Into ClinOleic Infusion||0
871343|NCT02185729|2109331|P1|COMPLETED|4 Hours Into ClinOleic Infusion||12
871344|NCT02185729|2109331|P1|STARTED|4 Hours Into ClinOleic Infusion||12
871345|NCT02185729|2109331|P1|NOT COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||0
871346|NCT02185729|2109331|P1|COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||12
871347|NCT02185729|2109331|P1|STARTED|0 Hour (Baseline) of ClinOleic Infusion||12
871348|NCT02185729|2109331|P1|NOT COMPLETED|24 Hours Into Intralipid Infusion||0
871349|NCT02185729|2109331|P1|COMPLETED|24 Hours Into Intralipid Infusion||12
871350|NCT02185729|2109331|P1|STARTED|24 Hours Into Intralipid Infusion||12
871351|NCT02185729|2109331|P1|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
871352|NCT02185729|2109331|P1|COMPLETED|4 Hours Into Intralipid Infusion||12
871353|NCT02185729|2109331|P1|STARTED|4 Hours Into Intralipid Infusion||12
871354|NCT02185729|2109331|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
871355|NCT02185729|2109331|P1|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
871356|NCT02185729|2109331|P1|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
871357|NCT02185729|2109331|P1|NOT COMPLETED|24 Hours Into Saline Infusion||0
871358|NCT02185729|2109331|P1|COMPLETED|24 Hours Into Saline Infusion||12
871359|NCT02185729|2109331|P1|STARTED|24 Hours Into Saline Infusion||12
871360|NCT02185729|2109331|P1|NOT COMPLETED|4 Hours Into Saline Infusion||0
871361|NCT02185729|2109331|P1|COMPLETED|4 Hours Into Saline Infusion||12
871362|NCT02185729|2109331|P1|STARTED|4 Hours Into Saline Infusion||12
871363|NCT02185729|2109331|P1|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
871364|NCT02185729|2109331|P1|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
871365|NCT02185729|2109331|P1|STARTED|0 Hour (Baseline) of Saline Infusion||12
871366|NCT02185534|2109352|P6|NOT COMPLETED|Third Period||0
871367|NCT02185534|2109353|P5|NOT COMPLETED|Third Period||0
871368|NCT02185534|2109354|P4|NOT COMPLETED|Third Period||0
871369|NCT02185534|2109355|P3|NOT COMPLETED|Third Period||0
871370|NCT02185534|2109356|P2|NOT COMPLETED|Third Period||0
871371|NCT02185534|2109357|P1|NOT COMPLETED|Third Period||0
871372|NCT02185534|2109352|P6|COMPLETED|Third Period||13
871373|NCT02185534|2109353|P5|COMPLETED|Third Period||13
871374|NCT02185534|2109354|P4|COMPLETED|Third Period||13
871375|NCT02185534|2109355|P3|COMPLETED|Third Period||14
871376|NCT02185534|2109356|P2|COMPLETED|Third Period||14
871377|NCT02185534|2109357|P1|COMPLETED|Third Period||13
871378|NCT02185534|2109352|P6|STARTED|Third Period||13
871379|NCT02185534|2109353|P5|STARTED|Third Period||13
871380|NCT02185534|2109354|P4|STARTED|Third Period||13
871381|NCT02185534|2109355|P3|STARTED|Third Period||14
871382|NCT02185534|2109356|P2|STARTED|Third Period||14
871383|NCT02185534|2109357|P1|STARTED|Third Period||13
871384|NCT02185534|2109352|P6|NOT COMPLETED|Second Washout Period||0
871385|NCT02185534|2109353|P5|NOT COMPLETED|Second Washout Period||0
871386|NCT02185534|2109354|P4|NOT COMPLETED|Second Washout Period||0
871387|NCT02185534|2109355|P3|NOT COMPLETED|Second Washout Period||0
871388|NCT02185534|2109356|P2|NOT COMPLETED|Second Washout Period||0
871389|NCT02185534|2109357|P1|NOT COMPLETED|Second Washout Period||0
871390|NCT02185534|2109352|P6|COMPLETED|Second Washout Period||13
871391|NCT02185534|2109353|P5|COMPLETED|Second Washout Period||13
871392|NCT02185534|2109354|P4|COMPLETED|Second Washout Period||13
871393|NCT02185534|2109355|P3|COMPLETED|Second Washout Period||14
871394|NCT02185534|2109356|P2|COMPLETED|Second Washout Period||14
871395|NCT02185534|2109357|P1|COMPLETED|Second Washout Period||13
871396|NCT02185534|2109352|P6|STARTED|Second Washout Period||13
871397|NCT02185534|2109353|P5|STARTED|Second Washout Period||13
871398|NCT02185534|2109354|P4|STARTED|Second Washout Period||13
871399|NCT02185534|2109355|P3|STARTED|Second Washout Period||14
871400|NCT02185534|2109356|P2|STARTED|Second Washout Period||14
871401|NCT02185534|2109357|P1|STARTED|Second Washout Period||13
871402|NCT02185534|2109352|P6|NOT COMPLETED|Second Period||0
871403|NCT02185534|2109353|P5|NOT COMPLETED|Second Period||0
871404|NCT02185534|2109354|P4|NOT COMPLETED|Second Period||0
871405|NCT02185534|2109355|P3|NOT COMPLETED|Second Period||0
871406|NCT02185534|2109356|P2|NOT COMPLETED|Second Period||0
871407|NCT02185534|2109357|P1|NOT COMPLETED|Second Period||0
871408|NCT02185534|2109352|P6|COMPLETED|Second Period||13
871409|NCT02185534|2109353|P5|COMPLETED|Second Period||13
871410|NCT02185534|2109354|P4|COMPLETED|Second Period||13
871411|NCT02185534|2109355|P3|COMPLETED|Second Period||14
871412|NCT02185534|2109356|P2|COMPLETED|Second Period||14
871413|NCT02185534|2109357|P1|COMPLETED|Second Period||13
871414|NCT02185534|2109352|P6|STARTED|Second Period||13
871415|NCT02185534|2109353|P5|STARTED|Second Period||13
871416|NCT02185534|2109354|P4|STARTED|Second Period||13
871417|NCT02185534|2109355|P3|STARTED|Second Period||14
871418|NCT02185534|2109356|P2|STARTED|Second Period||14
871419|NCT02185534|2109357|P1|STARTED|Second Period||13
871420|NCT02185534|2109352|P6|NOT COMPLETED|First Washout Period||1
871421|NCT02185534|2109353|P5|NOT COMPLETED|First Washout Period||1
871422|NCT02185534|2109354|P4|NOT COMPLETED|First Washout Period||0
871423|NCT02185534|2109355|P3|NOT COMPLETED|First Washout Period||0
871424|NCT02185534|2109356|P2|NOT COMPLETED|First Washout Period||0
871425|NCT02185534|2109357|P1|NOT COMPLETED|First Washout Period||1
871426|NCT02185534|2109352|P6|COMPLETED|First Washout Period||13
871427|NCT02185534|2109353|P5|COMPLETED|First Washout Period||13
871428|NCT02185534|2109354|P4|COMPLETED|First Washout Period||13
871429|NCT02185534|2109355|P3|COMPLETED|First Washout Period||14
871430|NCT02185534|2109356|P2|COMPLETED|First Washout Period||14
871431|NCT02185534|2109357|P1|COMPLETED|First Washout Period||13
871432|NCT02185534|2109352|P6|STARTED|First Washout Period||14
871433|NCT02185534|2109353|P5|STARTED|First Washout Period||14
871434|NCT02185534|2109354|P4|STARTED|First Washout Period||13
871435|NCT02185534|2109355|P3|STARTED|First Washout Period||14
871436|NCT02185534|2109356|P2|STARTED|First Washout Period||14
871437|NCT02185534|2109357|P1|STARTED|First Washout Period||14
871438|NCT02185534|2109352|P6|NOT COMPLETED|First Period||0
871439|NCT02185534|2109353|P5|NOT COMPLETED|First Period||0
871440|NCT02185534|2109354|P4|NOT COMPLETED|First Period||1
871441|NCT02185534|2109355|P3|NOT COMPLETED|First Period||0
871442|NCT02185534|2109356|P2|NOT COMPLETED|First Period||0
871443|NCT02185534|2109357|P1|NOT COMPLETED|First Period||0
871444|NCT02185534|2109352|P6|COMPLETED|First Period||14
871445|NCT02185534|2109353|P5|COMPLETED|First Period||14
871446|NCT02185534|2109354|P4|COMPLETED|First Period||13
871447|NCT02185534|2109355|P3|COMPLETED|First Period||14
871448|NCT02185534|2109356|P2|COMPLETED|First Period||14
871449|NCT02185534|2109357|P1|COMPLETED|First Period||14
871450|NCT02185534|2109352|P6|STARTED|First Period||14
871451|NCT02185534|2109353|P5|STARTED|First Period||14
871452|NCT02185534|2109354|P4|STARTED|First Period||14
871453|NCT02185534|2109355|P3|STARTED|First Period||14
871454|NCT02185534|2109356|P2|STARTED|First Period||14
871455|NCT02185534|2109357|P1|STARTED|First Period||14
871456|NCT02185339|2109374|P2|NOT COMPLETED|Overall Study||1
871457|NCT02185339|2109375|P1|NOT COMPLETED|Overall Study||0
871458|NCT02185339|2109374|P2|COMPLETED|Overall Study||30
871459|NCT02185339|2109375|P1|COMPLETED|Overall Study||30
871460|NCT02185339|2109374|P2|STARTED|Overall Study||31
871461|NCT02185339|2109375|P1|STARTED|Overall Study||30
871462|NCT02185183|2109397|P1|NOT COMPLETED|Overall Study||0
871463|NCT02185183|2109397|P1|COMPLETED|Overall Study||14
871464|NCT02185183|2109397|P1|STARTED|Overall Study||14
871465|NCT02185131|2109403|P2|NOT COMPLETED|Overall Study||1
871466|NCT02185131|2109404|P1|NOT COMPLETED|Overall Study||1
871467|NCT02185131|2109403|P2|COMPLETED|Overall Study||8
871468|NCT02185131|2109404|P1|COMPLETED|Overall Study||6
871469|NCT02185131|2109403|P2|STARTED|Overall Study||9
871470|NCT02185131|2109404|P1|STARTED|Overall Study||7
871471|NCT02185105|2109412|P1|NOT COMPLETED|Overall Study||0
871472|NCT02185105|2109412|P1|COMPLETED|Overall Study||30
871473|NCT02185105|2109412|P1|STARTED|Overall Study||30
871474|NCT02184624|2109460|P5|NOT COMPLETED|Overall Study||0
871475|NCT02184624|2109461|P4|NOT COMPLETED|Overall Study||0
871476|NCT02184624|2109462|P3|NOT COMPLETED|Overall Study||0
871477|NCT02184624|2109463|P2|NOT COMPLETED|Overall Study||0
871478|NCT02184624|2109464|P1|NOT COMPLETED|Overall Study||0
871479|NCT02184624|2109460|P5|COMPLETED|Overall Study||98
871480|NCT02184624|2109461|P4|COMPLETED|Overall Study||118
871481|NCT02184624|2109462|P3|COMPLETED|Overall Study||100
871482|NCT02184624|2109463|P2|COMPLETED|Overall Study||80
871483|NCT02184624|2109464|P1|COMPLETED|Overall Study||171
871484|NCT02184624|2109460|P5|STARTED|Overall Study||98
871485|NCT02184624|2109461|P4|STARTED|Overall Study||118
871486|NCT02184624|2109462|P3|STARTED|Overall Study||100
871487|NCT02184624|2109463|P2|STARTED|Overall Study||80
871488|NCT02184624|2109464|P1|STARTED|Overall Study||171
871489|NCT02184494|2109509|P3|NOT COMPLETED|Overall Study||0
871490|NCT02184494|2109510|P2|NOT COMPLETED|Overall Study||2
871491|NCT02184494|2109511|P1|NOT COMPLETED|Overall Study||1
871492|NCT02184494|2109509|P3|COMPLETED|Overall Study||8
871493|NCT02184494|2109510|P2|COMPLETED|Overall Study||11
871494|NCT02184494|2109511|P1|COMPLETED|Overall Study||12
871495|NCT02184494|2109509|P3|STARTED|Overall Study||8
871496|NCT02184494|2109510|P2|STARTED|Overall Study||13
871497|NCT02184494|2109511|P1|STARTED|Overall Study||13
871498|NCT02183675|2109537|P6|NOT COMPLETED|Treatment Period 3 (10 Days)||0
871499|NCT02183675|2109538|P5|NOT COMPLETED|Treatment Period 3 (10 Days)||0
871500|NCT02183675|2109539|P4|NOT COMPLETED|Treatment Period 3 (10 Days)||0
871501|NCT02183675|2109540|P3|NOT COMPLETED|Treatment Period 3 (10 Days)||0
871502|NCT02183675|2109541|P2|NOT COMPLETED|Treatment Period 3 (10 Days)||0
871503|NCT02183675|2109542|P1|NOT COMPLETED|Treatment Period 3 (10 Days)||0
871504|NCT02183675|2109537|P6|COMPLETED|Treatment Period 3 (10 Days)||4
871505|NCT02183675|2109538|P5|COMPLETED|Treatment Period 3 (10 Days)||6
871506|NCT02183675|2109539|P4|COMPLETED|Treatment Period 3 (10 Days)||6
871507|NCT02183675|2109540|P3|COMPLETED|Treatment Period 3 (10 Days)||6
871508|NCT02183675|2109541|P2|COMPLETED|Treatment Period 3 (10 Days)||6
871509|NCT02183675|2109542|P1|COMPLETED|Treatment Period 3 (10 Days)||6
871510|NCT02183675|2109537|P6|STARTED|Treatment Period 3 (10 Days)||4
871511|NCT02183675|2109538|P5|STARTED|Treatment Period 3 (10 Days)||6
871512|NCT02183675|2109539|P4|STARTED|Treatment Period 3 (10 Days)||6
871513|NCT02183675|2109540|P3|STARTED|Treatment Period 3 (10 Days)||6
871514|NCT02183675|2109541|P2|STARTED|Treatment Period 3 (10 Days)||6
871515|NCT02183675|2109542|P1|STARTED|Treatment Period 3 (10 Days)||6
871516|NCT02183675|2109537|P6|NOT COMPLETED|Treatment Period 2 (10 Days)||2
871517|NCT02183675|2109538|P5|NOT COMPLETED|Treatment Period 2 (10 Days)||0
871518|NCT02183675|2109539|P4|NOT COMPLETED|Treatment Period 2 (10 Days)||0
871519|NCT02183675|2109540|P3|NOT COMPLETED|Treatment Period 2 (10 Days)||0
871520|NCT02183675|2109541|P2|NOT COMPLETED|Treatment Period 2 (10 Days)||0
871521|NCT02183675|2109542|P1|NOT COMPLETED|Treatment Period 2 (10 Days)||0
871522|NCT02183675|2109537|P6|COMPLETED|Treatment Period 2 (10 Days)|Patients withdrew after completion of treatment period 2 but before beginning of treatment period 3|4
871523|NCT02183675|2109538|P5|COMPLETED|Treatment Period 2 (10 Days)||6
871524|NCT02183675|2109539|P4|COMPLETED|Treatment Period 2 (10 Days)||6
871525|NCT02183675|2109540|P3|COMPLETED|Treatment Period 2 (10 Days)||6
871526|NCT02183675|2109541|P2|COMPLETED|Treatment Period 2 (10 Days)||6
871527|NCT02183675|2109542|P1|COMPLETED|Treatment Period 2 (10 Days)||6
871528|NCT02183675|2109537|P6|STARTED|Treatment Period 2 (10 Days)||6
871529|NCT02183675|2109538|P5|STARTED|Treatment Period 2 (10 Days)||6
871530|NCT02183675|2109539|P4|STARTED|Treatment Period 2 (10 Days)||6
871531|NCT02183675|2109540|P3|STARTED|Treatment Period 2 (10 Days)||6
871532|NCT02183675|2109541|P2|STARTED|Treatment Period 2 (10 Days)||6
871533|NCT02183675|2109542|P1|STARTED|Treatment Period 2 (10 Days)||6
871534|NCT02183675|2109537|P6|NOT COMPLETED|Treatment Period 1 (10 Days)||0
871535|NCT02183675|2109538|P5|NOT COMPLETED|Treatment Period 1 (10 Days)||0
871536|NCT02183675|2109539|P4|NOT COMPLETED|Treatment Period 1 (10 Days)||0
871537|NCT02183675|2109540|P3|NOT COMPLETED|Treatment Period 1 (10 Days)||0
871538|NCT02183675|2109541|P2|NOT COMPLETED|Treatment Period 1 (10 Days)||0
871539|NCT02183675|2109542|P1|NOT COMPLETED|Treatment Period 1 (10 Days)||0
871540|NCT02183675|2109537|P6|COMPLETED|Treatment Period 1 (10 Days)||6
871541|NCT02183675|2109538|P5|COMPLETED|Treatment Period 1 (10 Days)||6
871542|NCT02183675|2109539|P4|COMPLETED|Treatment Period 1 (10 Days)||6
871543|NCT02183675|2109540|P3|COMPLETED|Treatment Period 1 (10 Days)||6
871544|NCT02183675|2109541|P2|COMPLETED|Treatment Period 1 (10 Days)||6
871545|NCT02183675|2109542|P1|COMPLETED|Treatment Period 1 (10 Days)||6
871546|NCT02183675|2109537|P6|STARTED|Treatment Period 1 (10 Days)||6
871547|NCT02183675|2109538|P5|STARTED|Treatment Period 1 (10 Days)||6
871548|NCT02183675|2109539|P4|STARTED|Treatment Period 1 (10 Days)||6
871549|NCT02183675|2109540|P3|STARTED|Treatment Period 1 (10 Days)||6
871550|NCT02183675|2109541|P2|STARTED|Treatment Period 1 (10 Days)||6
871551|NCT02183675|2109542|P1|STARTED|Treatment Period 1 (10 Days)||6
871552|NCT02183519|2109566|P2|NOT COMPLETED|Overall Study||3
871553|NCT02183519|2109567|P1|NOT COMPLETED|Overall Study||3
871554|NCT02183519|2109566|P2|COMPLETED|Overall Study||13
871555|NCT02183519|2109567|P1|COMPLETED|Overall Study||25
871556|NCT02183519|2109566|P2|STARTED|Overall Study||16
871557|NCT02183519|2109567|P1|STARTED|Overall Study||28
871558|NCT02182895|2109575|P2|NOT COMPLETED|Overall Study||4
871559|NCT02182895|2109576|P1|NOT COMPLETED|Overall Study||2
871560|NCT02182895|2109575|P2|COMPLETED|Overall Study||33
871561|NCT02182895|2109576|P1|COMPLETED|Overall Study||33
871562|NCT02182895|2109575|P2|STARTED|Overall Study||37
871563|NCT02182895|2109576|P1|STARTED|Overall Study||35
871564|NCT02181790|2109598|P2|NOT COMPLETED|Overall Study||0
871565|NCT02181790|2109599|P1|NOT COMPLETED|Overall Study||2
871566|NCT02181790|2109598|P2|COMPLETED|Overall Study||0
871567|NCT02181790|2109599|P1|COMPLETED|Overall Study||0
871568|NCT02181790|2109598|P2|STARTED|Overall Study||0
871569|NCT02181790|2109599|P1|STARTED|Overall Study||2
871570|NCT02181530|2109607|P1|NOT COMPLETED|Overall Study||0
871571|NCT02181530|2109607|P1|COMPLETED|Overall Study||43
871572|NCT02181530|2109607|P1|STARTED|Overall Study||43
871573|NCT02181517|2109620|P3|NOT COMPLETED|Overall Study||0
871574|NCT02181517|2109621|P2|NOT COMPLETED|Overall Study||0
871575|NCT02181517|2109622|P1|NOT COMPLETED|Overall Study||0
871576|NCT02181517|2109620|P3|COMPLETED|Overall Study||5
871577|NCT02181517|2109621|P2|COMPLETED|Overall Study||10
871578|NCT02181517|2109622|P1|COMPLETED|Overall Study||10
871579|NCT02181517|2109620|P3|STARTED|Overall Study||5
871580|NCT02181517|2109621|P2|STARTED|Overall Study||10
871581|NCT02181517|2109622|P1|STARTED|Overall Study||10
871582|NCT02181504|2109645|P3|NOT COMPLETED|Overall Study||1
871583|NCT02181504|2109646|P2|NOT COMPLETED|Overall Study||1
871584|NCT02181504|2109647|P1|NOT COMPLETED|Overall Study||1
871585|NCT02181504|2109645|P3|COMPLETED|Overall Study||4
871586|NCT02181504|2109646|P2|COMPLETED|Overall Study||9
871587|NCT02181504|2109647|P1|COMPLETED|Overall Study||9
871588|NCT02181504|2109645|P3|STARTED|Overall Study||5
871589|NCT02181504|2109646|P2|STARTED|Overall Study||10
871590|NCT02181504|2109647|P1|STARTED|Overall Study||10
871591|NCT02181387|2109669|P2|NOT COMPLETED|Overall Study||4
871592|NCT02181387|2109670|P1|NOT COMPLETED|Overall Study||2
871593|NCT02181387|2109669|P2|COMPLETED|Overall Study||15
871594|NCT02181387|2109670|P1|COMPLETED|Overall Study||12
871595|NCT02181387|2109669|P2|STARTED|Overall Study||19
871596|NCT02181387|2109670|P1|STARTED|Overall Study||14
871597|NCT02181140|2109676|P1|NOT COMPLETED|Overall Study||0
871598|NCT02181140|2109676|P1|COMPLETED|Overall Study||56
871599|NCT02181140|2109676|P1|STARTED|Overall Study||56
871600|NCT02181127|2109682|P1|NOT COMPLETED|Overall Study||0
871601|NCT02181127|2109682|P1|COMPLETED|Overall Study||22
871602|NCT02181127|2109682|P1|STARTED|Overall Study||22
871603|NCT02180893|2109689|P2|NOT COMPLETED|Overall Study||7
871604|NCT02180893|2109690|P1|NOT COMPLETED|Overall Study||3
871605|NCT02180893|2109689|P2|COMPLETED|Overall Study||23
871606|NCT02180893|2109690|P1|COMPLETED|Overall Study||27
871607|NCT02180893|2109689|P2|STARTED|Overall Study||30
871608|NCT02180893|2109690|P1|STARTED|Overall Study||30
871609|NCT02180828|2109704|P2|NOT COMPLETED|Overall Study||7
871610|NCT02180828|2109705|P1|NOT COMPLETED|Overall Study||5
871611|NCT02180828|2109704|P2|COMPLETED|Overall Study||113
871612|NCT02180828|2109705|P1|COMPLETED|Overall Study||115
871613|NCT02180828|2109704|P2|STARTED|Overall Study||120
871614|NCT02180828|2109705|P1|STARTED|Overall Study||120
871615|NCT02180646|2109729|P2|NOT COMPLETED|Second Intervention (7 Days)||0
871616|NCT02180646|2109730|P1|NOT COMPLETED|Second Intervention (7 Days)||0
871617|NCT02180646|2109729|P2|COMPLETED|Second Intervention (7 Days)||6
871618|NCT02180646|2109730|P1|COMPLETED|Second Intervention (7 Days)||6
871619|NCT02180646|2109729|P2|STARTED|Second Intervention (7 Days)||6
871620|NCT02180646|2109730|P1|STARTED|Second Intervention (7 Days)||6
871621|NCT02180646|2109729|P2|NOT COMPLETED|Washout (7 Days)||0
871622|NCT02180646|2109730|P1|NOT COMPLETED|Washout (7 Days)||0
871623|NCT02180646|2109729|P2|COMPLETED|Washout (7 Days)||6
871624|NCT02180646|2109730|P1|COMPLETED|Washout (7 Days)||6
871625|NCT02180646|2109729|P2|STARTED|Washout (7 Days)||6
871626|NCT02180646|2109730|P1|STARTED|Washout (7 Days)||6
871627|NCT02180646|2109729|P2|NOT COMPLETED|First Intervention (7 Days)||0
871628|NCT02180646|2109730|P1|NOT COMPLETED|First Intervention (7 Days)||0
871629|NCT02180646|2109729|P2|COMPLETED|First Intervention (7 Days)||6
871630|NCT02180646|2109730|P1|COMPLETED|First Intervention (7 Days)||6
871631|NCT02180646|2109729|P2|STARTED|First Intervention (7 Days)||6
871632|NCT02180646|2109730|P1|STARTED|First Intervention (7 Days)||6
871633|NCT02180230|2109740|P1|NOT COMPLETED|Overall Study||7
871634|NCT02180230|2109740|P1|COMPLETED|Overall Study||31
871635|NCT02180230|2109740|P1|STARTED|Overall Study||38
871636|NCT02180061|2109747|P2|NOT COMPLETED|Overall Study||8
871637|NCT02180061|2109748|P1|NOT COMPLETED|Overall Study||34
871638|NCT02180061|2109747|P2|COMPLETED|Overall Study||0
871639|NCT02180061|2109748|P1|COMPLETED|Overall Study||0
871640|NCT02180061|2109747|P2|STARTED|Overall Study||8
871641|NCT02180061|2109748|P1|STARTED|Overall Study||34
871648|NCT02179424|2109781|P4|NOT COMPLETED|Overall Study||0
871649|NCT02179424|2109782|P3|NOT COMPLETED|Overall Study||0
871650|NCT02179424|2109783|P2|NOT COMPLETED|Overall Study||0
871651|NCT02179424|2109784|P1|NOT COMPLETED|Overall Study||0
871652|NCT02179424|2109781|P4|COMPLETED|Overall Study||39
871653|NCT02179424|2109782|P3|COMPLETED|Overall Study||516
871654|NCT02179424|2109783|P2|COMPLETED|Overall Study||11
871655|NCT02179424|2109784|P1|COMPLETED|Overall Study||76
871656|NCT02179424|2109781|P4|STARTED|Overall Study||39
871657|NCT02179424|2109782|P3|STARTED|Overall Study||516
871658|NCT02179424|2109783|P2|STARTED|Overall Study||11
871659|NCT02179424|2109784|P1|STARTED|Overall Study||76
871660|NCT02179398|2109801|P2|NOT COMPLETED|Overall Study||4
871661|NCT02179398|2109802|P1|NOT COMPLETED|Overall Study||3
871662|NCT02179398|2109801|P2|COMPLETED|Overall Study||140
871663|NCT02179398|2109802|P1|COMPLETED|Overall Study||131
871664|NCT02179398|2109801|P2|STARTED|Overall Study||144
871665|NCT02179398|2109802|P1|STARTED|Overall Study||134
871666|NCT02178995|2109822|P9|NOT COMPLETED|Open Label||0
871667|NCT02178995|2109823|P8|NOT COMPLETED|Open Label||0
871668|NCT02178995|2109824|P7|NOT COMPLETED|Open Label||0
871669|NCT02178995|2109825|P6|NOT COMPLETED|Open Label||0
871670|NCT02178995|2109826|P5|NOT COMPLETED|Open Label||0
871671|NCT02178995|2109827|P4|NOT COMPLETED|Open Label||0
871672|NCT02178995|2109828|P3|NOT COMPLETED|Open Label||0
871673|NCT02178995|2109829|P2|NOT COMPLETED|Open Label||0
871674|NCT02178995|2109830|P1|NOT COMPLETED|Open Label||2
871675|NCT02178995|2109822|P9|COMPLETED|Open Label||0
871676|NCT02178995|2109823|P8|COMPLETED|Open Label||0
871677|NCT02178995|2109824|P7|COMPLETED|Open Label||0
871678|NCT02178995|2109825|P6|COMPLETED|Open Label||0
871679|NCT02178995|2109826|P5|COMPLETED|Open Label||0
871680|NCT02178995|2109827|P4|COMPLETED|Open Label||0
871681|NCT02178995|2109828|P3|COMPLETED|Open Label||0
871682|NCT02178995|2109829|P2|COMPLETED|Open Label||14
871683|NCT02178995|2109830|P1|COMPLETED|Open Label||28
871684|NCT02178995|2109822|P9|STARTED|Open Label||0
871685|NCT02178995|2109823|P8|STARTED|Open Label||0
871686|NCT02178995|2109824|P7|STARTED|Open Label||0
871687|NCT02178995|2109825|P6|STARTED|Open Label||0
871688|NCT02178995|2109826|P5|STARTED|Open Label||0
871689|NCT02178995|2109827|P4|STARTED|Open Label||0
871690|NCT02178995|2109828|P3|STARTED|Open Label||0
871691|NCT02178995|2109829|P2|STARTED|Open Label|One was lost to follow-up after completion of visit 4.|14
871692|NCT02178995|2109830|P1|STARTED|Open Label|2 declined to join open-label. 1 withdrew from double-blind but rejoined open-label due to benefit.|30
871693|NCT02178995|2109822|P9|NOT COMPLETED|Double Blind||1
871694|NCT02178995|2109823|P8|NOT COMPLETED|Double Blind||2
871695|NCT02178995|2109824|P7|NOT COMPLETED|Double Blind||0
871696|NCT02178995|2109825|P6|NOT COMPLETED|Double Blind||1
871697|NCT02178995|2109826|P5|NOT COMPLETED|Double Blind||0
871698|NCT02178995|2109827|P4|NOT COMPLETED|Double Blind||0
871699|NCT02178995|2109828|P3|NOT COMPLETED|Double Blind||0
871700|NCT02178995|2109829|P2|NOT COMPLETED|Double Blind||1
871701|NCT02178995|2109830|P1|NOT COMPLETED|Double Blind||0
871702|NCT02178995|2109822|P9|COMPLETED|Double Blind||0
871703|NCT02178995|2109823|P8|COMPLETED|Double Blind||4
871704|NCT02178995|2109824|P7|COMPLETED|Double Blind||5
871705|NCT02178995|2109825|P6|COMPLETED|Double Blind||5
871706|NCT02178995|2109826|P5|COMPLETED|Double Blind||6
871707|NCT02178995|2109827|P4|COMPLETED|Double Blind||6
871708|NCT02178995|2109828|P3|COMPLETED|Double Blind||5
871709|NCT02178995|2109829|P2|COMPLETED|Double Blind||15
871710|NCT02178995|2109830|P1|COMPLETED|Double Blind||0
871711|NCT02178995|2109822|P9|STARTED|Double Blind||1
871712|NCT02178995|2109823|P8|STARTED|Double Blind||6
871713|NCT02178995|2109824|P7|STARTED|Double Blind||5
871714|NCT02178995|2109825|P6|STARTED|Double Blind||6
871715|NCT02178995|2109826|P5|STARTED|Double Blind||6
871716|NCT02178995|2109827|P4|STARTED|Double Blind||6
871717|NCT02178995|2109828|P3|STARTED|Double Blind||5
871718|NCT02178995|2109829|P2|STARTED|Double Blind||16
871719|NCT02178995|2109830|P1|STARTED|Double Blind||0
871720|NCT02178787|2109903|P2|NOT COMPLETED|Overall Study||9
871721|NCT02178787|2109904|P1|NOT COMPLETED|Overall Study||5
871722|NCT02178787|2109903|P2|COMPLETED|Overall Study||30
871723|NCT02178787|2109904|P1|COMPLETED|Overall Study||30
871724|NCT02178787|2109903|P2|STARTED|Overall Study||39
871725|NCT02178787|2109904|P1|STARTED|Overall Study||35
871726|NCT02178540|2109912|P1|NOT COMPLETED|Overall Study||0
871727|NCT02178540|2109912|P1|COMPLETED|Overall Study||45
871728|NCT02178540|2109912|P1|STARTED|Overall Study||45
871729|NCT02178059|2109919|P2|NOT COMPLETED|Second Intervention||0
871730|NCT02178059|2109920|P1|NOT COMPLETED|Second Intervention||0
871731|NCT02178059|2109919|P2|COMPLETED|Second Intervention||17
871732|NCT02178059|2109920|P1|COMPLETED|Second Intervention||16
871733|NCT02178059|2109919|P2|STARTED|Second Intervention||17
871734|NCT02178059|2109920|P1|STARTED|Second Intervention||16
871735|NCT02178059|2109919|P2|NOT COMPLETED|Washout||0
871736|NCT02178059|2109920|P1|NOT COMPLETED|Washout||1
871737|NCT02178059|2109919|P2|COMPLETED|Washout||17
871738|NCT02178059|2109920|P1|COMPLETED|Washout||16
871739|NCT02178059|2109919|P2|STARTED|Washout||17
871740|NCT02178059|2109920|P1|STARTED|Washout||17
871741|NCT02178059|2109919|P2|NOT COMPLETED|First Intervention||0
871742|NCT02178059|2109920|P1|NOT COMPLETED|First Intervention||0
871743|NCT02178059|2109919|P2|COMPLETED|First Intervention||17
871744|NCT02178059|2109920|P1|COMPLETED|First Intervention||17
871745|NCT02178059|2109919|P2|STARTED|First Intervention||17
871746|NCT02178059|2109920|P1|STARTED|First Intervention||17
871747|NCT02177266|2109938|P2|NOT COMPLETED|Overall Study||1
871748|NCT02177266|2109939|P1|NOT COMPLETED|Overall Study||1
871749|NCT02177266|2109938|P2|COMPLETED|Overall Study||0
871750|NCT02177266|2109939|P1|COMPLETED|Overall Study||0
871751|NCT02177266|2109938|P2|STARTED|Overall Study||1
871752|NCT02177266|2109939|P1|STARTED|Overall Study||1
871753|NCT02177201|2109951|P2|NOT COMPLETED|Overall Study||3
871754|NCT02177201|2109952|P1|NOT COMPLETED|Overall Study||3
871755|NCT02177201|2109951|P2|COMPLETED|Overall Study||77
871756|NCT02177201|2109952|P1|COMPLETED|Overall Study||77
871757|NCT02177201|2109951|P2|STARTED|Overall Study||80
871758|NCT02177201|2109952|P1|STARTED|Overall Study||80
871759|NCT02177032|2109962|P4|NOT COMPLETED|Overall Study||0
871760|NCT02177032|2109963|P3|NOT COMPLETED|Overall Study||3
871761|NCT02177032|2109964|P2|NOT COMPLETED|Overall Study||2
871762|NCT02177032|2109965|P1|NOT COMPLETED|Overall Study||5
871763|NCT02177032|2109962|P4|COMPLETED|Overall Study||88
871764|NCT02177032|2109963|P3|COMPLETED|Overall Study||351
871765|NCT02177032|2109964|P2|COMPLETED|Overall Study||86
871766|NCT02177032|2109965|P1|COMPLETED|Overall Study||350
871767|NCT02177032|2109962|P4|STARTED|Overall Study||88
871768|NCT02177032|2109963|P3|STARTED|Overall Study||354
871769|NCT02177032|2109964|P2|STARTED|Overall Study||88
871770|NCT02177032|2109965|P1|STARTED|Overall Study||355
871771|NCT02176655|2109999|P1|NOT COMPLETED|Overall Study||6
871772|NCT02176655|2109999|P1|COMPLETED|Overall Study||25
871773|NCT02176655|2109999|P1|STARTED|Overall Study||31
871774|NCT02176525|2110028|P8|NOT COMPLETED|Overall Study||0
871775|NCT02176525|2110029|P7|NOT COMPLETED|Overall Study||1
871776|NCT02176525|2110030|P6|NOT COMPLETED|Overall Study||1
871777|NCT02176525|2110031|P5|NOT COMPLETED|Overall Study||1
871778|NCT02176525|2110032|P4|NOT COMPLETED|Overall Study||1
871779|NCT02176525|2110033|P3|NOT COMPLETED|Overall Study||0
871780|NCT02176525|2110034|P2|NOT COMPLETED|Overall Study||0
871781|NCT02176525|2110035|P1|NOT COMPLETED|Overall Study||1
871782|NCT02176525|2110028|P8|COMPLETED|Overall Study||10
871783|NCT02176525|2110029|P7|COMPLETED|Overall Study||8
871784|NCT02176525|2110030|P6|COMPLETED|Overall Study||5
871785|NCT02176525|2110031|P5|COMPLETED|Overall Study||7
871786|NCT02176525|2110032|P4|COMPLETED|Overall Study||8
871787|NCT02176525|2110033|P3|COMPLETED|Overall Study||9
871788|NCT02176525|2110034|P2|COMPLETED|Overall Study||9
871789|NCT02176525|2110035|P1|COMPLETED|Overall Study||14
871790|NCT02176525|2110028|P8|STARTED|Overall Study||10
871791|NCT02176525|2110029|P7|STARTED|Overall Study||9
871792|NCT02176525|2110030|P6|STARTED|Overall Study|6 subjects randomized, 5 subjects treated with at least one dose, 1 subject was not treated|6
871793|NCT02176525|2110031|P5|STARTED|Overall Study||8
871794|NCT02176525|2110032|P4|STARTED|Overall Study||9
871795|NCT02176525|2110033|P3|STARTED|Overall Study||9
871796|NCT02176525|2110034|P2|STARTED|Overall Study||9
871797|NCT02176525|2110035|P1|STARTED|Overall Study|15 subjects randomized, 14 subjects treated with at least one dose, 1 subject was not treated|15
871798|NCT02176421|2110212|P1|NOT COMPLETED|Overall Study||5
871799|NCT02176421|2110212|P1|COMPLETED|Overall Study||75
871800|NCT02176421|2110212|P1|STARTED|Overall Study||80
871801|NCT02176356|2110221|P1|NOT COMPLETED|Overall Study||23
871802|NCT02176356|2110221|P1|COMPLETED|Overall Study||93
871803|NCT02176356|2110221|P1|Eligible and Received Treatment|Overall Study||100
871804|NCT02176356|2110221|P1|STARTED|Overall Study||116
871805|NCT02176343|2110238|P1|NOT COMPLETED|Overall Study||0
871806|NCT02176343|2110238|P1|COMPLETED|Overall Study||31
871807|NCT02176343|2110238|P1|STARTED|Overall Study||31
871808|NCT02175771|2110257|P9|NOT COMPLETED|Treatment Period||6
871809|NCT02175771|2110258|P8|NOT COMPLETED|Treatment Period||17
871810|NCT02175771|2110259|P7|NOT COMPLETED|Treatment Period||5
871811|NCT02175771|2110260|P6|NOT COMPLETED|Treatment Period||10
871812|NCT02175771|2110261|P5|NOT COMPLETED|Treatment Period||5
871813|NCT02175771|2110262|P4|NOT COMPLETED|Treatment Period||13
871814|NCT02175771|2110263|P3|NOT COMPLETED|Treatment Period||7
871815|NCT02175771|2110264|P2|NOT COMPLETED|Treatment Period||16
871816|NCT02175771|2110265|P1|NOT COMPLETED|Treatment Period||0
871817|NCT02175771|2110257|P9|COMPLETED|Treatment Period||38
871818|NCT02175771|2110258|P8|COMPLETED|Treatment Period||116
871819|NCT02175771|2110259|P7|COMPLETED|Treatment Period||36
871820|NCT02175771|2110260|P6|COMPLETED|Treatment Period||110
871821|NCT02175771|2110261|P5|COMPLETED|Treatment Period||36
871822|NCT02175771|2110262|P4|COMPLETED|Treatment Period||113
871823|NCT02175771|2110263|P3|COMPLETED|Treatment Period||35
871824|NCT02175771|2110264|P2|COMPLETED|Treatment Period||111
871825|NCT02175771|2110265|P1|COMPLETED|Treatment Period||0
871826|NCT02175771|2110257|P9|STARTED|Treatment Period||44
871827|NCT02175771|2110258|P8|STARTED|Treatment Period||133
871828|NCT02175771|2110259|P7|STARTED|Treatment Period||41
871829|NCT02175771|2110260|P6|STARTED|Treatment Period||120
871830|NCT02175771|2110261|P5|STARTED|Treatment Period||41
871831|NCT02175771|2110262|P4|STARTED|Treatment Period||126
871832|NCT02175771|2110263|P3|STARTED|Treatment Period||42
871833|NCT02175771|2110264|P2|STARTED|Treatment Period||127
871834|NCT02175771|2110265|P1|STARTED|Treatment Period||0
871835|NCT02175771|2110257|P9|NOT COMPLETED|Run-In Period (Pre-assignment)||0
871836|NCT02175771|2110258|P8|NOT COMPLETED|Run-In Period (Pre-assignment)||0
871837|NCT02175771|2110259|P7|NOT COMPLETED|Run-In Period (Pre-assignment)||0
871838|NCT02175771|2110260|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
871839|NCT02175771|2110261|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
871840|NCT02175771|2110262|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
871841|NCT02175771|2110263|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
871842|NCT02175771|2110264|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
871843|NCT02175771|2110265|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||84
871844|NCT02175771|2110257|P9|COMPLETED|Run-In Period (Pre-assignment)||0
871845|NCT02175771|2110258|P8|COMPLETED|Run-In Period (Pre-assignment)||0
871846|NCT02175771|2110259|P7|COMPLETED|Run-In Period (Pre-assignment)||0
871847|NCT02175771|2110260|P6|COMPLETED|Run-In Period (Pre-assignment)||0
871848|NCT02175771|2110261|P5|COMPLETED|Run-In Period (Pre-assignment)||0
871849|NCT02175771|2110262|P4|COMPLETED|Run-In Period (Pre-assignment)||0
871850|NCT02175771|2110263|P3|COMPLETED|Run-In Period (Pre-assignment)||0
871851|NCT02175771|2110264|P2|COMPLETED|Run-In Period (Pre-assignment)||0
871852|NCT02175771|2110265|P1|COMPLETED|Run-In Period (Pre-assignment)||674
871853|NCT02175771|2110257|P9|STARTED|Run-In Period (Pre-assignment)||0
871854|NCT02175771|2110258|P8|STARTED|Run-In Period (Pre-assignment)||0
871855|NCT02175771|2110259|P7|STARTED|Run-In Period (Pre-assignment)||0
871856|NCT02175771|2110260|P6|STARTED|Run-In Period (Pre-assignment)||0
871857|NCT02175771|2110261|P5|STARTED|Run-In Period (Pre-assignment)||0
871858|NCT02175771|2110262|P4|STARTED|Run-In Period (Pre-assignment)||0
871859|NCT02175771|2110263|P3|STARTED|Run-In Period (Pre-assignment)||0
871860|NCT02175771|2110264|P2|STARTED|Run-In Period (Pre-assignment)||0
871861|NCT02175771|2110265|P1|STARTED|Run-In Period (Pre-assignment)|Enrolled; two participants were enrolled but had no enrollment date in their records.|758
871862|NCT02175745|2110323|P1|NOT COMPLETED|Overall Study||1
871863|NCT02175745|2110323|P1|COMPLETED|Overall Study||1
871864|NCT02175745|2110323|P1|STARTED|Overall Study||2
871865|NCT02175212|2110330|P2|NOT COMPLETED|Overall Study||147
871866|NCT02175212|2110331|P1|NOT COMPLETED|Overall Study||163
871867|NCT02175212|2110330|P2|COMPLETED|Overall Study||31
871868|NCT02175212|2110331|P1|COMPLETED|Overall Study||14
871869|NCT02175212|2110330|P2|STARTED|Overall Study||178
871870|NCT02175212|2110331|P1|STARTED|Overall Study||177
871871|NCT02175199|2110347|P2|NOT COMPLETED|Overall Study||5
871872|NCT02175199|2110348|P1|NOT COMPLETED|Overall Study||3
871873|NCT02175199|2110347|P2|COMPLETED|Overall Study||71
871874|NCT02175199|2110348|P1|COMPLETED|Overall Study||71
871875|NCT02175199|2110347|P2|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|74
871876|NCT02175199|2110348|P1|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|72
871877|NCT02175199|2110347|P2|STARTED|Overall Study||76
871878|NCT02175199|2110348|P1|STARTED|Overall Study||74
871879|NCT02175121|2110362|P5|NOT COMPLETED|Overall Study||1
871880|NCT02175121|2110363|P4|NOT COMPLETED|Overall Study||1
871881|NCT02175121|2110364|P3|NOT COMPLETED|Overall Study||2
871882|NCT02175121|2110365|P2|NOT COMPLETED|Overall Study||1
871883|NCT02175121|2110366|P1|NOT COMPLETED|Overall Study||1
871884|NCT02175121|2110362|P5|COMPLETED|Overall Study||33
871885|NCT02175121|2110363|P4|COMPLETED|Overall Study||34
871886|NCT02175121|2110364|P3|COMPLETED|Overall Study||32
871887|NCT02175121|2110365|P2|COMPLETED|Overall Study||34
871888|NCT02175121|2110366|P1|COMPLETED|Overall Study||33
871889|NCT02175121|2110362|P5|STARTED|Overall Study||34
871890|NCT02175121|2110363|P4|STARTED|Overall Study||35
871891|NCT02175121|2110364|P3|STARTED|Overall Study||34
871892|NCT02175121|2110365|P2|STARTED|Overall Study||35
871893|NCT02175121|2110366|P1|STARTED|Overall Study||34
871894|NCT02173769|2110493|P1|NOT COMPLETED|Overall Study||4
871895|NCT02173769|2110493|P1|COMPLETED|Overall Study||1854
871896|NCT02173769|2110493|P1|STARTED|Overall Study||1858
871897|NCT02173535|2110524|P20|NOT COMPLETED|Period 5||0
871898|NCT02173535|2110525|P19|NOT COMPLETED|Period 5||0
871899|NCT02173535|2110526|P18|NOT COMPLETED|Period 5||0
871900|NCT02173535|2110527|P17|NOT COMPLETED|Period 5||0
871901|NCT02173535|2110528|P16|NOT COMPLETED|Period 5||0
871902|NCT02173535|2110529|P15|NOT COMPLETED|Period 5||0
871903|NCT02173535|2110530|P14|NOT COMPLETED|Period 5||0
871904|NCT02173535|2110531|P13|NOT COMPLETED|Period 5||0
871905|NCT02173535|2110532|P12|NOT COMPLETED|Period 5||0
871906|NCT02173535|2110533|P11|NOT COMPLETED|Period 5||0
871907|NCT02173535|2110534|P10|NOT COMPLETED|Period 5||0
871908|NCT02173535|2110535|P9|NOT COMPLETED|Period 5||0
871909|NCT02173535|2110536|P8|NOT COMPLETED|Period 5||0
871910|NCT02173535|2110537|P7|NOT COMPLETED|Period 5||0
871911|NCT02173535|2110538|P6|NOT COMPLETED|Period 5||0
871912|NCT02173535|2110539|P5|NOT COMPLETED|Period 5||0
871913|NCT02173535|2110540|P4|NOT COMPLETED|Period 5||0
871914|NCT02173535|2110541|P3|NOT COMPLETED|Period 5||0
871915|NCT02173535|2110542|P2|NOT COMPLETED|Period 5||0
871916|NCT02173535|2110543|P1|NOT COMPLETED|Period 5||0
871917|NCT02173535|2110524|P20|COMPLETED|Period 5||12
871918|NCT02173535|2110525|P19|COMPLETED|Period 5||12
871919|NCT02173535|2110526|P18|COMPLETED|Period 5||12
871920|NCT02173535|2110527|P17|COMPLETED|Period 5||12
871921|NCT02173535|2110528|P16|COMPLETED|Period 5||12
871922|NCT02173535|2110529|P15|COMPLETED|Period 5||12
871923|NCT02173535|2110530|P14|COMPLETED|Period 5||12
871924|NCT02173535|2110531|P13|COMPLETED|Period 5||12
871925|NCT02173535|2110532|P12|COMPLETED|Period 5||12
871926|NCT02173535|2110533|P11|COMPLETED|Period 5||12
871927|NCT02173535|2110534|P10|COMPLETED|Period 5||12
871928|NCT02173535|2110535|P9|COMPLETED|Period 5||12
871929|NCT02173535|2110536|P8|COMPLETED|Period 5||12
871930|NCT02173535|2110537|P7|COMPLETED|Period 5||12
871931|NCT02173535|2110538|P6|COMPLETED|Period 5||12
871932|NCT02173535|2110539|P5|COMPLETED|Period 5||12
871933|NCT02173535|2110540|P4|COMPLETED|Period 5||12
871934|NCT02173535|2110541|P3|COMPLETED|Period 5||12
871935|NCT02173535|2110542|P2|COMPLETED|Period 5||12
871936|NCT02173535|2110543|P1|COMPLETED|Period 5||12
871937|NCT02173535|2110524|P20|STARTED|Period 5||12
871938|NCT02173535|2110525|P19|STARTED|Period 5||12
871939|NCT02173535|2110526|P18|STARTED|Period 5||12
871940|NCT02173535|2110527|P17|STARTED|Period 5||12
871941|NCT02173535|2110528|P16|STARTED|Period 5||12
871942|NCT02173535|2110529|P15|STARTED|Period 5||12
871943|NCT02173535|2110530|P14|STARTED|Period 5||12
871944|NCT02173535|2110531|P13|STARTED|Period 5||12
871945|NCT02173535|2110532|P12|STARTED|Period 5||12
871946|NCT02173535|2110533|P11|STARTED|Period 5||12
871947|NCT02173535|2110534|P10|STARTED|Period 5||12
871948|NCT02173535|2110535|P9|STARTED|Period 5||12
871949|NCT02173535|2110536|P8|STARTED|Period 5||12
871950|NCT02173535|2110537|P7|STARTED|Period 5||12
871951|NCT02173535|2110538|P6|STARTED|Period 5||12
871952|NCT02173535|2110539|P5|STARTED|Period 5||12
871953|NCT02173535|2110540|P4|STARTED|Period 5||12
871954|NCT02173535|2110541|P3|STARTED|Period 5||12
871955|NCT02173535|2110542|P2|STARTED|Period 5||12
871956|NCT02173535|2110543|P1|STARTED|Period 5||12
871957|NCT02173535|2110524|P20|NOT COMPLETED|Period 4||0
871958|NCT02173535|2110525|P19|NOT COMPLETED|Period 4||0
871959|NCT02173535|2110526|P18|NOT COMPLETED|Period 4||0
871960|NCT02173535|2110527|P17|NOT COMPLETED|Period 4||0
871961|NCT02173535|2110528|P16|NOT COMPLETED|Period 4||0
871962|NCT02173535|2110529|P15|NOT COMPLETED|Period 4||0
871963|NCT02173535|2110530|P14|NOT COMPLETED|Period 4||0
871964|NCT02173535|2110531|P13|NOT COMPLETED|Period 4||0
871965|NCT02173535|2110532|P12|NOT COMPLETED|Period 4||0
871966|NCT02173535|2110533|P11|NOT COMPLETED|Period 4||0
871967|NCT02173535|2110534|P10|NOT COMPLETED|Period 4||0
871968|NCT02173535|2110535|P9|NOT COMPLETED|Period 4||0
871969|NCT02173535|2110536|P8|NOT COMPLETED|Period 4||0
871970|NCT02173535|2110537|P7|NOT COMPLETED|Period 4||0
871971|NCT02173535|2110538|P6|NOT COMPLETED|Period 4||0
871972|NCT02173535|2110539|P5|NOT COMPLETED|Period 4||0
871973|NCT02173535|2110540|P4|NOT COMPLETED|Period 4||0
871974|NCT02173535|2110541|P3|NOT COMPLETED|Period 4||0
871975|NCT02173535|2110542|P2|NOT COMPLETED|Period 4||0
871976|NCT02173535|2110543|P1|NOT COMPLETED|Period 4||0
871977|NCT02173535|2110524|P20|COMPLETED|Period 4||12
871978|NCT02173535|2110525|P19|COMPLETED|Period 4||12
871979|NCT02173535|2110526|P18|COMPLETED|Period 4||12
871980|NCT02173535|2110527|P17|COMPLETED|Period 4||12
871981|NCT02173535|2110528|P16|COMPLETED|Period 4||12
871982|NCT02173535|2110529|P15|COMPLETED|Period 4||12
871983|NCT02173535|2110530|P14|COMPLETED|Period 4||12
871984|NCT02173535|2110531|P13|COMPLETED|Period 4||12
871985|NCT02173535|2110532|P12|COMPLETED|Period 4||12
871986|NCT02173535|2110533|P11|COMPLETED|Period 4||12
871987|NCT02173535|2110534|P10|COMPLETED|Period 4||12
871988|NCT02173535|2110535|P9|COMPLETED|Period 4||12
871989|NCT02173535|2110536|P8|COMPLETED|Period 4||12
871990|NCT02173535|2110537|P7|COMPLETED|Period 4||12
871991|NCT02173535|2110538|P6|COMPLETED|Period 4||12
871992|NCT02173535|2110539|P5|COMPLETED|Period 4||12
871993|NCT02173535|2110540|P4|COMPLETED|Period 4||12
871994|NCT02173535|2110541|P3|COMPLETED|Period 4||12
871995|NCT02173535|2110542|P2|COMPLETED|Period 4||12
871996|NCT02173535|2110543|P1|COMPLETED|Period 4||12
871997|NCT02173535|2110524|P20|STARTED|Period 4||12
871998|NCT02173535|2110525|P19|STARTED|Period 4||12
871999|NCT02173535|2110526|P18|STARTED|Period 4||12
872000|NCT02173535|2110527|P17|STARTED|Period 4||12
872001|NCT02173535|2110528|P16|STARTED|Period 4||12
872002|NCT02173535|2110529|P15|STARTED|Period 4||12
872003|NCT02173535|2110530|P14|STARTED|Period 4||12
872004|NCT02173535|2110531|P13|STARTED|Period 4||12
872005|NCT02173535|2110532|P12|STARTED|Period 4||12
872006|NCT02173535|2110533|P11|STARTED|Period 4||12
872007|NCT02173535|2110534|P10|STARTED|Period 4||12
872008|NCT02173535|2110535|P9|STARTED|Period 4||12
872009|NCT02173535|2110536|P8|STARTED|Period 4||12
872010|NCT02173535|2110537|P7|STARTED|Period 4||12
872011|NCT02173535|2110538|P6|STARTED|Period 4||12
872012|NCT02173535|2110539|P5|STARTED|Period 4||12
872013|NCT02173535|2110540|P4|STARTED|Period 4||12
872014|NCT02173535|2110541|P3|STARTED|Period 4||12
872015|NCT02173535|2110542|P2|STARTED|Period 4||12
872016|NCT02173535|2110543|P1|STARTED|Period 4||12
872017|NCT02173535|2110524|P20|NOT COMPLETED|Period 3||0
872018|NCT02173535|2110525|P19|NOT COMPLETED|Period 3||0
872019|NCT02173535|2110526|P18|NOT COMPLETED|Period 3||0
872020|NCT02173535|2110527|P17|NOT COMPLETED|Period 3||0
872021|NCT02173535|2110528|P16|NOT COMPLETED|Period 3||0
872022|NCT02173535|2110529|P15|NOT COMPLETED|Period 3||0
872023|NCT02173535|2110530|P14|NOT COMPLETED|Period 3||0
872024|NCT02173535|2110531|P13|NOT COMPLETED|Period 3||0
872025|NCT02173535|2110532|P12|NOT COMPLETED|Period 3||0
872026|NCT02173535|2110533|P11|NOT COMPLETED|Period 3||0
872027|NCT02173535|2110534|P10|NOT COMPLETED|Period 3||0
872028|NCT02173535|2110535|P9|NOT COMPLETED|Period 3||0
872029|NCT02173535|2110536|P8|NOT COMPLETED|Period 3||0
872030|NCT02173535|2110537|P7|NOT COMPLETED|Period 3||0
872031|NCT02173535|2110538|P6|NOT COMPLETED|Period 3||0
872032|NCT02173535|2110539|P5|NOT COMPLETED|Period 3||0
872033|NCT02173535|2110540|P4|NOT COMPLETED|Period 3||0
872034|NCT02173535|2110541|P3|NOT COMPLETED|Period 3||0
872035|NCT02173535|2110542|P2|NOT COMPLETED|Period 3||0
872036|NCT02173535|2110543|P1|NOT COMPLETED|Period 3||0
872037|NCT02173535|2110524|P20|COMPLETED|Period 3||12
872038|NCT02173535|2110525|P19|COMPLETED|Period 3||12
872039|NCT02173535|2110526|P18|COMPLETED|Period 3||12
872040|NCT02173535|2110527|P17|COMPLETED|Period 3||12
872041|NCT02173535|2110528|P16|COMPLETED|Period 3||12
872042|NCT02173535|2110529|P15|COMPLETED|Period 3||12
872043|NCT02173535|2110530|P14|COMPLETED|Period 3||12
872044|NCT02173535|2110531|P13|COMPLETED|Period 3||12
872045|NCT02173535|2110532|P12|COMPLETED|Period 3||12
872046|NCT02173535|2110533|P11|COMPLETED|Period 3||12
872047|NCT02173535|2110534|P10|COMPLETED|Period 3||12
872048|NCT02173535|2110535|P9|COMPLETED|Period 3||12
872049|NCT02173535|2110536|P8|COMPLETED|Period 3||12
872050|NCT02173535|2110537|P7|COMPLETED|Period 3||12
872051|NCT02173535|2110538|P6|COMPLETED|Period 3||12
872052|NCT02173535|2110539|P5|COMPLETED|Period 3||12
872053|NCT02173535|2110540|P4|COMPLETED|Period 3||12
872054|NCT02173535|2110541|P3|COMPLETED|Period 3||12
872055|NCT02173535|2110542|P2|COMPLETED|Period 3||12
872056|NCT02173535|2110543|P1|COMPLETED|Period 3||12
872057|NCT02173535|2110524|P20|STARTED|Period 3||12
872058|NCT02173535|2110525|P19|STARTED|Period 3||12
872059|NCT02173535|2110526|P18|STARTED|Period 3||12
872060|NCT02173535|2110527|P17|STARTED|Period 3||12
872061|NCT02173535|2110528|P16|STARTED|Period 3||12
872062|NCT02173535|2110529|P15|STARTED|Period 3||12
872063|NCT02173535|2110530|P14|STARTED|Period 3||12
872064|NCT02173535|2110531|P13|STARTED|Period 3||12
872065|NCT02173535|2110532|P12|STARTED|Period 3||12
872066|NCT02173535|2110533|P11|STARTED|Period 3||12
872067|NCT02173535|2110534|P10|STARTED|Period 3||12
872068|NCT02173535|2110535|P9|STARTED|Period 3||12
872069|NCT02173535|2110536|P8|STARTED|Period 3||12
872070|NCT02173535|2110537|P7|STARTED|Period 3||12
872071|NCT02173535|2110538|P6|STARTED|Period 3||12
872072|NCT02173535|2110539|P5|STARTED|Period 3||12
872073|NCT02173535|2110540|P4|STARTED|Period 3||12
872074|NCT02173535|2110541|P3|STARTED|Period 3||12
872075|NCT02173535|2110542|P2|STARTED|Period 3||12
872076|NCT02173535|2110543|P1|STARTED|Period 3||12
872077|NCT02173535|2110524|P20|NOT COMPLETED|Period 2||0
872078|NCT02173535|2110525|P19|NOT COMPLETED|Period 2||0
872079|NCT02173535|2110526|P18|NOT COMPLETED|Period 2||0
872080|NCT02173535|2110527|P17|NOT COMPLETED|Period 2||0
872081|NCT02173535|2110528|P16|NOT COMPLETED|Period 2||0
872082|NCT02173535|2110529|P15|NOT COMPLETED|Period 2||0
872083|NCT02173535|2110530|P14|NOT COMPLETED|Period 2||0
872084|NCT02173535|2110531|P13|NOT COMPLETED|Period 2||0
872085|NCT02173535|2110532|P12|NOT COMPLETED|Period 2||0
872086|NCT02173535|2110533|P11|NOT COMPLETED|Period 2||0
872087|NCT02173535|2110534|P10|NOT COMPLETED|Period 2||0
872088|NCT02173535|2110535|P9|NOT COMPLETED|Period 2||0
872089|NCT02173535|2110536|P8|NOT COMPLETED|Period 2||0
872090|NCT02173535|2110537|P7|NOT COMPLETED|Period 2||0
872091|NCT02173535|2110538|P6|NOT COMPLETED|Period 2||0
872092|NCT02173535|2110539|P5|NOT COMPLETED|Period 2||0
872093|NCT02173535|2110540|P4|NOT COMPLETED|Period 2||0
872094|NCT02173535|2110541|P3|NOT COMPLETED|Period 2||0
872095|NCT02173535|2110542|P2|NOT COMPLETED|Period 2||0
872096|NCT02173535|2110543|P1|NOT COMPLETED|Period 2||0
872097|NCT02173535|2110524|P20|COMPLETED|Period 2||12
872098|NCT02173535|2110525|P19|COMPLETED|Period 2||12
872099|NCT02173535|2110526|P18|COMPLETED|Period 2||12
872100|NCT02173535|2110527|P17|COMPLETED|Period 2||12
872101|NCT02173535|2110528|P16|COMPLETED|Period 2||12
872102|NCT02173535|2110529|P15|COMPLETED|Period 2||12
872103|NCT02173535|2110530|P14|COMPLETED|Period 2||12
872104|NCT02173535|2110531|P13|COMPLETED|Period 2||12
872105|NCT02173535|2110532|P12|COMPLETED|Period 2||12
872106|NCT02173535|2110533|P11|COMPLETED|Period 2||12
872107|NCT02173535|2110534|P10|COMPLETED|Period 2||12
872108|NCT02173535|2110535|P9|COMPLETED|Period 2||12
872109|NCT02173535|2110536|P8|COMPLETED|Period 2||12
872110|NCT02173535|2110537|P7|COMPLETED|Period 2||12
872111|NCT02173535|2110538|P6|COMPLETED|Period 2||12
872112|NCT02173535|2110539|P5|COMPLETED|Period 2||12
872113|NCT02173535|2110540|P4|COMPLETED|Period 2||12
872114|NCT02173535|2110541|P3|COMPLETED|Period 2||12
872115|NCT02173535|2110542|P2|COMPLETED|Period 2||12
872116|NCT02173535|2110543|P1|COMPLETED|Period 2||12
872117|NCT02173535|2110524|P20|STARTED|Period 2||12
872118|NCT02173535|2110525|P19|STARTED|Period 2||12
872119|NCT02173535|2110526|P18|STARTED|Period 2||12
872120|NCT02173535|2110527|P17|STARTED|Period 2||12
872121|NCT02173535|2110528|P16|STARTED|Period 2||12
872122|NCT02173535|2110529|P15|STARTED|Period 2||12
872123|NCT02173535|2110530|P14|STARTED|Period 2||12
872124|NCT02173535|2110531|P13|STARTED|Period 2||12
872125|NCT02173535|2110532|P12|STARTED|Period 2||12
872126|NCT02173535|2110533|P11|STARTED|Period 2||12
872127|NCT02173535|2110534|P10|STARTED|Period 2||12
872128|NCT02173535|2110535|P9|STARTED|Period 2||12
872129|NCT02173535|2110536|P8|STARTED|Period 2||12
872130|NCT02173535|2110537|P7|STARTED|Period 2||12
872131|NCT02173535|2110538|P6|STARTED|Period 2||12
872132|NCT02173535|2110539|P5|STARTED|Period 2||12
872133|NCT02173535|2110540|P4|STARTED|Period 2||12
872134|NCT02173535|2110541|P3|STARTED|Period 2||12
872135|NCT02173535|2110542|P2|STARTED|Period 2||12
872136|NCT02173535|2110543|P1|STARTED|Period 2||12
872137|NCT02173535|2110524|P20|NOT COMPLETED|Period 1||0
872138|NCT02173535|2110525|P19|NOT COMPLETED|Period 1||0
872139|NCT02173535|2110526|P18|NOT COMPLETED|Period 1||0
872140|NCT02173535|2110527|P17|NOT COMPLETED|Period 1||0
872141|NCT02173535|2110528|P16|NOT COMPLETED|Period 1||0
872142|NCT02173535|2110529|P15|NOT COMPLETED|Period 1||0
872143|NCT02173535|2110530|P14|NOT COMPLETED|Period 1||0
872144|NCT02173535|2110531|P13|NOT COMPLETED|Period 1||0
872145|NCT02173535|2110532|P12|NOT COMPLETED|Period 1||0
872146|NCT02173535|2110533|P11|NOT COMPLETED|Period 1||0
872147|NCT02173535|2110534|P10|NOT COMPLETED|Period 1||0
872148|NCT02173535|2110535|P9|NOT COMPLETED|Period 1||0
872149|NCT02173535|2110536|P8|NOT COMPLETED|Period 1||0
872150|NCT02173535|2110537|P7|NOT COMPLETED|Period 1||0
872151|NCT02173535|2110538|P6|NOT COMPLETED|Period 1||0
872152|NCT02173535|2110539|P5|NOT COMPLETED|Period 1||0
872153|NCT02173535|2110540|P4|NOT COMPLETED|Period 1||0
872154|NCT02173535|2110541|P3|NOT COMPLETED|Period 1||0
872155|NCT02173535|2110542|P2|NOT COMPLETED|Period 1||0
872156|NCT02173535|2110543|P1|NOT COMPLETED|Period 1||0
872157|NCT02173535|2110524|P20|COMPLETED|Period 1||12
872158|NCT02173535|2110525|P19|COMPLETED|Period 1||12
872159|NCT02173535|2110526|P18|COMPLETED|Period 1||12
872160|NCT02173535|2110527|P17|COMPLETED|Period 1||12
872161|NCT02173535|2110528|P16|COMPLETED|Period 1||12
872162|NCT02173535|2110529|P15|COMPLETED|Period 1||12
872163|NCT02173535|2110530|P14|COMPLETED|Period 1||12
872164|NCT02173535|2110531|P13|COMPLETED|Period 1||12
872165|NCT02173535|2110532|P12|COMPLETED|Period 1||12
872166|NCT02173535|2110533|P11|COMPLETED|Period 1||12
872167|NCT02173535|2110534|P10|COMPLETED|Period 1||12
872168|NCT02173535|2110535|P9|COMPLETED|Period 1||12
872169|NCT02173535|2110536|P8|COMPLETED|Period 1||12
872170|NCT02173535|2110537|P7|COMPLETED|Period 1||12
872171|NCT02173535|2110538|P6|COMPLETED|Period 1||12
872172|NCT02173535|2110539|P5|COMPLETED|Period 1||12
872173|NCT02173535|2110540|P4|COMPLETED|Period 1||12
872174|NCT02173535|2110541|P3|COMPLETED|Period 1||12
872175|NCT02173535|2110542|P2|COMPLETED|Period 1||12
872176|NCT02173535|2110543|P1|COMPLETED|Period 1||12
872177|NCT02173535|2110524|P20|STARTED|Period 1||12
872178|NCT02173535|2110525|P19|STARTED|Period 1||12
872179|NCT02173535|2110526|P18|STARTED|Period 1||12
872180|NCT02173535|2110527|P17|STARTED|Period 1||12
872181|NCT02173535|2110528|P16|STARTED|Period 1||12
872182|NCT02173535|2110529|P15|STARTED|Period 1||12
872183|NCT02173535|2110530|P14|STARTED|Period 1||12
872184|NCT02173535|2110531|P13|STARTED|Period 1||12
872185|NCT02173535|2110532|P12|STARTED|Period 1||12
872186|NCT02173535|2110533|P11|STARTED|Period 1||12
872187|NCT02173535|2110534|P10|STARTED|Period 1||12
872188|NCT02173535|2110535|P9|STARTED|Period 1||12
872189|NCT02173535|2110536|P8|STARTED|Period 1||12
872190|NCT02173535|2110537|P7|STARTED|Period 1||12
872191|NCT02173535|2110538|P6|STARTED|Period 1||12
872192|NCT02173535|2110539|P5|STARTED|Period 1||12
872193|NCT02173535|2110540|P4|STARTED|Period 1||12
872194|NCT02173535|2110541|P3|STARTED|Period 1||12
872195|NCT02173535|2110542|P2|STARTED|Period 1||12
872196|NCT02173535|2110543|P1|STARTED|Period 1||12
872197|NCT02173392|2110582|P2|NOT COMPLETED|Overall Study||4
872198|NCT02173392|2110583|P1|NOT COMPLETED|Overall Study||14
872199|NCT02173392|2110582|P2|COMPLETED|Overall Study||68
872200|NCT02173392|2110583|P1|COMPLETED|Overall Study||59
872201|NCT02173392|2110582|P2|STARTED|Overall Study||72
872202|NCT02173392|2110583|P1|STARTED|Overall Study||73
872203|NCT02173054|2110596|P3|NOT COMPLETED|Overall Study||1
872204|NCT02173054|2110597|P2|NOT COMPLETED|Overall Study||0
872205|NCT02173054|2110598|P1|NOT COMPLETED|Overall Study||1
872206|NCT02173054|2110596|P3|COMPLETED|Overall Study||39
872207|NCT02173054|2110597|P2|COMPLETED|Overall Study||40
872208|NCT02173054|2110598|P1|COMPLETED|Overall Study||39
872209|NCT02173054|2110596|P3|STARTED|Overall Study||40
872210|NCT02173054|2110597|P2|STARTED|Overall Study||40
872211|NCT02173054|2110598|P1|STARTED|Overall Study||40
872212|NCT02172755|2110620|P2|NOT COMPLETED|Overall Study||4
872213|NCT02172755|2110621|P1|NOT COMPLETED|Overall Study||2
872214|NCT02172755|2110620|P2|COMPLETED|Overall Study||12
872215|NCT02172755|2110621|P1|COMPLETED|Overall Study||12
872216|NCT02172755|2110620|P2|STARTED|Overall Study||16
872217|NCT02172755|2110621|P1|STARTED|Overall Study||14
872218|NCT02172742|2110633|P2|NOT COMPLETED|Overall Study||0
872219|NCT02172742|2110634|P1|NOT COMPLETED|Overall Study||1
872220|NCT02172742|2110633|P2|COMPLETED|Overall Study||6
872221|NCT02172742|2110634|P1|COMPLETED|Overall Study||6
872222|NCT02172742|2110633|P2|STARTED|Overall Study||6
872223|NCT02172742|2110634|P1|STARTED|Overall Study||7
872224|NCT02172625|2110643|P2|NOT COMPLETED|Overall Study||3
872225|NCT02172625|2110644|P1|NOT COMPLETED|Overall Study||0
872226|NCT02172625|2110643|P2|COMPLETED|Overall Study||16
872227|NCT02172625|2110644|P1|COMPLETED|Overall Study||19
872228|NCT02172625|2110643|P2|STARTED|Overall Study||19
872229|NCT02172625|2110644|P1|STARTED|Overall Study||19
872230|NCT02172040|2110666|P4|NOT COMPLETED|Overall Study||1
872231|NCT02172040|2110667|P3|NOT COMPLETED|Overall Study||2
872232|NCT02172040|2110668|P2|NOT COMPLETED|Overall Study||3
872233|NCT02172040|2110669|P1|NOT COMPLETED|Overall Study||0
872234|NCT02172040|2110666|P4|COMPLETED|Overall Study||26
872235|NCT02172040|2110667|P3|COMPLETED|Overall Study||29
872236|NCT02172040|2110668|P2|COMPLETED|Overall Study||42
872237|NCT02172040|2110669|P1|COMPLETED|Overall Study||49
872238|NCT02172040|2110666|P4|STARTED|Overall Study||27
872239|NCT02172040|2110667|P3|STARTED|Overall Study||31
872240|NCT02172040|2110668|P2|STARTED|Overall Study||45
872241|NCT02172040|2110669|P1|STARTED|Overall Study||49
872242|NCT02171611|2110715|P6|NOT COMPLETED|Overall Study||0
872243|NCT02171611|2110716|P5|NOT COMPLETED|Overall Study||0
872244|NCT02171611|2110717|P4|NOT COMPLETED|Overall Study||0
872245|NCT02171611|2110718|P3|NOT COMPLETED|Overall Study||0
872246|NCT02171611|2110719|P2|NOT COMPLETED|Overall Study||0
872247|NCT02171611|2110720|P1|NOT COMPLETED|Overall Study||0
872248|NCT02171611|2110715|P6|COMPLETED|Overall Study||5
872249|NCT02171611|2110716|P5|COMPLETED|Overall Study||5
872250|NCT02171611|2110717|P4|COMPLETED|Overall Study||5
872251|NCT02171611|2110718|P3|COMPLETED|Overall Study||5
872252|NCT02171611|2110719|P2|COMPLETED|Overall Study||5
872253|NCT02171611|2110720|P1|COMPLETED|Overall Study||5
872254|NCT02171611|2110715|P6|STARTED|Overall Study||5
872255|NCT02171611|2110716|P5|STARTED|Overall Study||5
872256|NCT02171611|2110717|P4|STARTED|Overall Study||5
872257|NCT02171611|2110718|P3|STARTED|Overall Study||5
872258|NCT02171611|2110719|P2|STARTED|Overall Study||5
872259|NCT02171611|2110720|P1|STARTED|Overall Study||5
872260|NCT02171247|2110790|P2|NOT COMPLETED|Overall Study||0
872261|NCT02171247|2110791|P1|NOT COMPLETED|Overall Study||0
872262|NCT02171247|2110790|P2|COMPLETED|Overall Study||17
872263|NCT02171247|2110791|P1|COMPLETED|Overall Study||16
872264|NCT02171247|2110790|P2|STARTED|Overall Study||17
872265|NCT02171247|2110791|P1|STARTED|Overall Study||16
872266|NCT02171234|2110808|P5|NOT COMPLETED|Overall Study||0
872267|NCT02171234|2110809|P4|NOT COMPLETED|Overall Study||0
872268|NCT02171234|2110810|P3|NOT COMPLETED|Overall Study||0
872269|NCT02171234|2110811|P2|NOT COMPLETED|Overall Study||0
872270|NCT02171234|2110812|P1|NOT COMPLETED|Overall Study||0
872271|NCT02171234|2110808|P5|COMPLETED|Overall Study||6
872272|NCT02171234|2110809|P4|COMPLETED|Overall Study||6
872273|NCT02171234|2110810|P3|COMPLETED|Overall Study||6
872274|NCT02171234|2110811|P2|COMPLETED|Overall Study||6
872275|NCT02171234|2110812|P1|COMPLETED|Overall Study||8
872276|NCT02171234|2110808|P5|STARTED|Overall Study||6
872277|NCT02171234|2110809|P4|STARTED|Overall Study||6
872278|NCT02171234|2110810|P3|STARTED|Overall Study||6
872279|NCT02171234|2110811|P2|STARTED|Overall Study||6
872280|NCT02171234|2110812|P1|STARTED|Overall Study||8
872281|NCT02171195|2110841|P9|NOT COMPLETED|Overall Study||0
872282|NCT02171195|2110842|P8|NOT COMPLETED|Overall Study||0
872283|NCT02171195|2110843|P7|NOT COMPLETED|Overall Study||0
872284|NCT02171195|2110844|P6|NOT COMPLETED|Overall Study||0
872285|NCT02171195|2110845|P5|NOT COMPLETED|Overall Study||0
872286|NCT02171195|2110846|P4|NOT COMPLETED|Overall Study||0
872287|NCT02171195|2110847|P3|NOT COMPLETED|Overall Study||0
872288|NCT02171195|2110848|P2|NOT COMPLETED|Overall Study||0
872289|NCT02171195|2110849|P1|NOT COMPLETED|Overall Study||0
872290|NCT02171195|2110841|P9|COMPLETED|Overall Study||6
872291|NCT02171195|2110842|P8|COMPLETED|Overall Study||6
872292|NCT02171195|2110843|P7|COMPLETED|Overall Study||6
872293|NCT02171195|2110844|P6|COMPLETED|Overall Study||6
872294|NCT02171195|2110845|P5|COMPLETED|Overall Study||6
872295|NCT02171195|2110846|P4|COMPLETED|Overall Study||6
872296|NCT02171195|2110847|P3|COMPLETED|Overall Study||6
872297|NCT02171195|2110848|P2|COMPLETED|Overall Study||6
872298|NCT02171195|2110849|P1|COMPLETED|Overall Study||16
872299|NCT02171195|2110841|P9|STARTED|Overall Study||6
872300|NCT02171195|2110842|P8|STARTED|Overall Study||6
872301|NCT02171195|2110843|P7|STARTED|Overall Study||6
872302|NCT02171195|2110844|P6|STARTED|Overall Study||6
872303|NCT02171195|2110845|P5|STARTED|Overall Study||6
872304|NCT02171195|2110846|P4|STARTED|Overall Study||6
872305|NCT02171195|2110847|P3|STARTED|Overall Study||6
872306|NCT02171195|2110848|P2|STARTED|Overall Study||6
872307|NCT02171195|2110849|P1|STARTED|Overall Study||16
872308|NCT02170779|2110871|P2|NOT COMPLETED|Overall Study||1
872309|NCT02170779|2110872|P1|NOT COMPLETED|Overall Study||1
872310|NCT02170779|2110871|P2|COMPLETED|Overall Study||19
872311|NCT02170779|2110872|P1|COMPLETED|Overall Study||19
872312|NCT02170779|2110871|P2|STARTED|Overall Study||20
872313|NCT02170779|2110872|P1|STARTED|Overall Study||20
872314|NCT02170688|2110899|P5|NOT COMPLETED|Overall Study||0
872315|NCT02170688|2110900|P4|NOT COMPLETED|Overall Study||2
872316|NCT02170688|2110901|P3|NOT COMPLETED|Overall Study||4
872317|NCT02170688|2110902|P2|NOT COMPLETED|Overall Study||3
872318|NCT02170688|2110903|P1|NOT COMPLETED|Overall Study||4
872319|NCT02170688|2110899|P5|COMPLETED|Overall Study||25
872320|NCT02170688|2110900|P4|COMPLETED|Overall Study||25
872321|NCT02170688|2110901|P3|COMPLETED|Overall Study||25
872322|NCT02170688|2110902|P2|COMPLETED|Overall Study||26
872323|NCT02170688|2110903|P1|COMPLETED|Overall Study||25
872324|NCT02170688|2110899|P5|STARTED|Overall Study||25
872325|NCT02170688|2110900|P4|STARTED|Overall Study||27
872326|NCT02170688|2110901|P3|STARTED|Overall Study||29
872327|NCT02170688|2110902|P2|STARTED|Overall Study||29
872328|NCT02170688|2110903|P1|STARTED|Overall Study||29
872329|NCT02170662|2110922|P2|NOT COMPLETED|Overall Study||0
872330|NCT02170662|2110923|P1|NOT COMPLETED|Overall Study||0
872331|NCT02170662|2110922|P2|COMPLETED|Overall Study||6
872332|NCT02170662|2110923|P1|COMPLETED|Overall Study||3
872333|NCT02170662|2110922|P2|STARTED|Overall Study||6
872334|NCT02170662|2110923|P1|STARTED|Overall Study||3
872335|NCT02170649|2110935|P1|NOT COMPLETED|Fed Period||0
872336|NCT02170649|2110935|P1|COMPLETED|Fed Period||12
872337|NCT02170649|2110935|P1|STARTED|Fed Period||12
872338|NCT02170649|2110935|P1|NOT COMPLETED|Fasting Period||0
872339|NCT02170649|2110935|P1|COMPLETED|Fasting Period||12
872340|NCT02170649|2110935|P1|STARTED|Fasting Period||12
872341|NCT02170532|2110942|P1|NOT COMPLETED|Overall Study||0
872342|NCT02170532|2110942|P1|COMPLETED|Overall Study||10
872343|NCT02170532|2110942|P1|STARTED|Overall Study||10
872344|NCT02170519|2110972|P2|NOT COMPLETED|Overall Study||0
872345|NCT02170519|2110973|P1|NOT COMPLETED|Overall Study||0
872346|NCT02170519|2110972|P2|COMPLETED|Overall Study||5
872347|NCT02170519|2110973|P1|COMPLETED|Overall Study||22
872348|NCT02170519|2110972|P2|STARTED|Overall Study||5
872349|NCT02170519|2110973|P1|STARTED|Overall Study||22
872350|NCT02170376|2110994|P5|NOT COMPLETED|Overall Study||0
872351|NCT02170376|2110995|P4|NOT COMPLETED|Overall Study||0
872352|NCT02170376|2110996|P3|NOT COMPLETED|Overall Study||0
872353|NCT02170376|2110997|P2|NOT COMPLETED|Overall Study||1
872354|NCT02170376|2110998|P1|NOT COMPLETED|Overall Study||0
872355|NCT02170376|2110994|P5|COMPLETED|Overall Study||16
872356|NCT02170376|2110995|P4|COMPLETED|Overall Study||16
872357|NCT02170376|2110996|P3|COMPLETED|Overall Study||16
872358|NCT02170376|2110997|P2|COMPLETED|Overall Study||15
872359|NCT02170376|2110998|P1|COMPLETED|Overall Study||16
872360|NCT02170376|2110994|P5|Pharmacokinetic Population|Overall Study||16
872361|NCT02170376|2110995|P4|Pharmacokinetic Population|Overall Study||16
872362|NCT02170376|2110996|P3|Pharmacokinetic Population|Overall Study||16
872363|NCT02170376|2110997|P2|Pharmacokinetic Population|Overall Study||15
872364|NCT02170376|2110998|P1|Pharmacokinetic Population|Overall Study||16
872365|NCT02170376|2110994|P5|STARTED|Overall Study||16
872366|NCT02170376|2110995|P4|STARTED|Overall Study||16
872367|NCT02170376|2110996|P3|STARTED|Overall Study||16
872368|NCT02170376|2110997|P2|STARTED|Overall Study||16
872369|NCT02170376|2110998|P1|STARTED|Overall Study||16
872370|NCT02170220|2111037|P2|NOT COMPLETED|Overall Study||0
872371|NCT02170220|2111038|P1|NOT COMPLETED|Overall Study||0
872372|NCT02170220|2111037|P2|COMPLETED|Overall Study||6
872373|NCT02170220|2111038|P1|COMPLETED|Overall Study||6
872374|NCT02170220|2111037|P2|STARTED|Overall Study||6
872375|NCT02170220|2111038|P1|STARTED|Overall Study||6
872376|NCT02170207|2111064|P1|NOT COMPLETED|Overall Study||5
872377|NCT02170207|2111064|P1|COMPLETED|Overall Study||58
872378|NCT02170207|2111064|P1|STARTED|Overall Study||63
872379|NCT02170077|2111075|P3|NOT COMPLETED|Overall Study||12
872380|NCT02170077|2111076|P2|NOT COMPLETED|Overall Study||13
872381|NCT02170077|2111077|P1|NOT COMPLETED|Overall Study||9
872382|NCT02170077|2111075|P3|COMPLETED|Overall Study||35
872383|NCT02170077|2111076|P2|COMPLETED|Overall Study||34
872384|NCT02170077|2111077|P1|COMPLETED|Overall Study||41
872385|NCT02170077|2111075|P3|Intent to Treat (ITT) Population|Overall Study||47
872386|NCT02170077|2111076|P2|Intent to Treat (ITT) Population|Overall Study||46
872387|NCT02170077|2111077|P1|Intent to Treat (ITT) Population|Overall Study||50
872388|NCT02170077|2111075|P3|STARTED|Overall Study||47
872389|NCT02170077|2111076|P2|STARTED|Overall Study||47
872390|NCT02170077|2111077|P1|STARTED|Overall Study||50
872391|NCT02170064|2111088|P3|NOT COMPLETED|Overall Study||1
872392|NCT02170064|2111089|P2|NOT COMPLETED|Overall Study||2
872393|NCT02170064|2111090|P1|NOT COMPLETED|Overall Study||6
872394|NCT02170064|2111088|P3|COMPLETED|Overall Study||10
872395|NCT02170064|2111089|P2|COMPLETED|Overall Study||7
872396|NCT02170064|2111090|P1|COMPLETED|Overall Study||9
872397|NCT02170064|2111088|P3|Efficacy Population (EP)|Overall Study||10
872398|NCT02170064|2111089|P2|Efficacy Population (EP)|Overall Study||8
872399|NCT02170064|2111090|P1|Efficacy Population (EP)|Overall Study||11
872400|NCT02170064|2111088|P3|Pharmacokinetic Population (PKP)|Overall Study||10
872401|NCT02170064|2111089|P2|Pharmacokinetic Population (PKP)|Overall Study||8
872402|NCT02170064|2111090|P1|Pharmacokinetic Population (PKP)|Overall Study||11
872403|NCT02170064|2111088|P3|Safety Population (SP)|Overall Study||11
872404|NCT02170064|2111089|P2|Safety Population (SP)|Overall Study||8
872405|NCT02170064|2111090|P1|Safety Population (SP)|Overall Study||12
872406|NCT02170064|2111088|P3|STARTED|Overall Study||11
872407|NCT02170064|2111089|P2|STARTED|Overall Study||9
872408|NCT02170064|2111090|P1|STARTED|Overall Study||15
872409|NCT02169895|2111108|P4|NOT COMPLETED|Overall Study||2
872410|NCT02169895|2111109|P3|NOT COMPLETED|Overall Study||0
872411|NCT02169895|2111110|P2|NOT COMPLETED|Overall Study||0
872412|NCT02169895|2111111|P1|NOT COMPLETED|Overall Study||0
872413|NCT02169895|2111108|P4|COMPLETED|Overall Study||2
872414|NCT02169895|2111109|P3|COMPLETED|Overall Study||4
872415|NCT02169895|2111110|P2|COMPLETED|Overall Study||4
872416|NCT02169895|2111111|P1|COMPLETED|Overall Study||4
872417|NCT02169895|2111108|P4|Placebo|Overall Study||4
872418|NCT02169895|2111109|P3|Placebo|Overall Study||4
872419|NCT02169895|2111110|P2|Placebo|Overall Study||4
872420|NCT02169895|2111111|P1|Placebo|Overall Study||4
872421|NCT02169895|2111108|P4|100 mg BIA 9-1067|Overall Study||2
872422|NCT02169895|2111109|P3|100 mg BIA 9-1067|Overall Study||4
872423|NCT02169895|2111110|P2|100 mg BIA 9-1067|Overall Study||4
872424|NCT02169895|2111111|P1|100 mg BIA 9-1067|Overall Study||4
872425|NCT02169895|2111108|P4|50 mg BIA 9-1067|Overall Study||4
872426|NCT02169895|2111109|P3|50 mg BIA 9-1067|Overall Study||4
872427|NCT02169895|2111110|P2|50 mg BIA 9-1067|Overall Study||4
872428|NCT02169895|2111111|P1|50 mg BIA 9-1067|Overall Study||4
872429|NCT02169895|2111108|P4|25 mg BIA 9-1067|Overall Study||4
872430|NCT02169895|2111109|P3|25 mg BIA 9-1067|Overall Study||4
872431|NCT02169895|2111110|P2|25 mg BIA 9-1067|Overall Study||4
872432|NCT02169895|2111111|P1|25 mg BIA 9-1067|Overall Study||4
872433|NCT02169895|2111108|P4|STARTED|Overall Study||4
872434|NCT02169895|2111109|P3|STARTED|Overall Study||4
872435|NCT02169895|2111110|P2|STARTED|Overall Study||4
872436|NCT02169895|2111111|P1|STARTED|Overall Study||4
872437|NCT02169479|2111133|P4|NOT COMPLETED|Overall Study||0
872438|NCT02169479|2111134|P3|NOT COMPLETED|Overall Study||0
872439|NCT02169479|2111135|P2|NOT COMPLETED|Overall Study||1
872440|NCT02169479|2111136|P1|NOT COMPLETED|Overall Study||1
872441|NCT02169479|2111133|P4|COMPLETED|Overall Study||4
872442|NCT02169479|2111134|P3|COMPLETED|Overall Study||4
872443|NCT02169479|2111135|P2|COMPLETED|Overall Study||3
872444|NCT02169479|2111136|P1|COMPLETED|Overall Study||3
872445|NCT02169479|2111133|P4|Placebo|Overall Study||4
872446|NCT02169479|2111134|P3|Placebo|Overall Study||4
872447|NCT02169479|2111135|P2|Placebo|Overall Study||3
872448|NCT02169479|2111136|P1|Placebo|Overall Study||3
872449|NCT02169479|2111133|P4|100 mg BIA 9-1067|Overall Study||4
872450|NCT02169479|2111134|P3|100 mg BIA 9-1067|Overall Study||4
872451|NCT02169479|2111135|P2|100 mg BIA 9-1067|Overall Study||4
872452|NCT02169479|2111136|P1|100 mg BIA 9-1067|Overall Study||3
872453|NCT02169479|2111133|P4|50 mg BIA 9-1067|Overall Study||4
872454|NCT02169479|2111134|P3|50 mg BIA 9-1067|Overall Study||4
872455|NCT02169479|2111135|P2|50 mg BIA 9-1067|Overall Study||4
872456|NCT02169479|2111136|P1|50 mg BIA 9-1067|Overall Study||4
872457|NCT02169479|2111133|P4|25 mg BIA 9-1067|Overall Study||4
872458|NCT02169479|2111134|P3|25 mg BIA 9-1067|Overall Study||4
872459|NCT02169479|2111135|P2|25 mg BIA 9-1067|Overall Study||3
872460|NCT02169479|2111136|P1|25 mg BIA 9-1067|Overall Study||4
872461|NCT02169479|2111133|P4|STARTED|Overall Study||4
872462|NCT02169479|2111134|P3|STARTED|Overall Study||4
872463|NCT02169479|2111135|P2|STARTED|Overall Study||4
872464|NCT02169479|2111136|P1|STARTED|Overall Study||4
872465|NCT02169466|2111158|P4|NOT COMPLETED|Overall Study||0
872466|NCT02169466|2111159|P3|NOT COMPLETED|Overall Study||0
872467|NCT02169466|2111160|P2|NOT COMPLETED|Overall Study||1
872468|NCT02169466|2111161|P1|NOT COMPLETED|Overall Study||1
872469|NCT02169466|2111158|P4|COMPLETED|Overall Study||5
872470|NCT02169466|2111159|P3|COMPLETED|Overall Study||5
872471|NCT02169466|2111160|P2|COMPLETED|Overall Study||5
872472|NCT02169466|2111161|P1|COMPLETED|Overall Study||5
872473|NCT02169466|2111158|P4|Placebo|Overall Study||5
872474|NCT02169466|2111159|P3|Placebo|Overall Study||5
872475|NCT02169466|2111160|P2|Placebo|Overall Study||6
872476|NCT02169466|2111161|P1|Placebo|Overall Study||5
872477|NCT02169466|2111158|P4|100 mg BIA 9-1067|Overall Study||5
872478|NCT02169466|2111159|P3|100 mg BIA 9-1067|Overall Study||5
872479|NCT02169466|2111160|P2|100 mg BIA 9-1067|Overall Study||6
872480|NCT02169466|2111161|P1|100 mg BIA 9-1067|Overall Study||6
872481|NCT02169466|2111158|P4|50 mg BIA 9-1067|Overall Study||5
872482|NCT02169466|2111159|P3|50 mg BIA 9-1067|Overall Study||5
872483|NCT02169466|2111160|P2|50 mg BIA 9-1067|Overall Study||6
872484|NCT02169466|2111161|P1|50 mg BIA 9-1067|Overall Study||6
872485|NCT02169466|2111158|P4|25 mg BIA 9-1067|Overall Study||5
872486|NCT02169466|2111159|P3|25 mg BIA 9-1067|Overall Study||5
872487|NCT02169466|2111160|P2|25 mg BIA 9-1067|Overall Study||5
872488|NCT02169466|2111161|P1|25 mg BIA 9-1067|Overall Study||6
872489|NCT02169466|2111158|P4|STARTED|Overall Study||5
872490|NCT02169466|2111159|P3|STARTED|Overall Study||5
872491|NCT02169466|2111160|P2|STARTED|Overall Study||6
872492|NCT02169466|2111161|P1|STARTED|Overall Study||6
872493|NCT02169453|2111187|P4|NOT COMPLETED|Overall Study||0
872494|NCT02169453|2111188|P3|NOT COMPLETED|Overall Study||1
872495|NCT02169453|2111189|P2|NOT COMPLETED|Overall Study||0
872496|NCT02169453|2111190|P1|NOT COMPLETED|Overall Study||0
872497|NCT02169453|2111187|P4|COMPLETED|Overall Study||3
872498|NCT02169453|2111188|P3|COMPLETED|Overall Study||2
872499|NCT02169453|2111189|P2|COMPLETED|Overall Study||3
872500|NCT02169453|2111190|P1|COMPLETED|Overall Study||3
872501|NCT02169453|2111187|P4|Placebo|Overall Study||3
872502|NCT02169453|2111188|P3|Placebo|Overall Study||3
872503|NCT02169453|2111189|P2|Placebo|Overall Study||3
872504|NCT02169453|2111190|P1|Placebo|Overall Study||3
872505|NCT02169453|2111187|P4|100 mg BIA 9-1067|Overall Study||3
872506|NCT02169453|2111188|P3|100 mg BIA 9-1067|Overall Study||3
872507|NCT02169453|2111189|P2|100 mg BIA 9-1067|Overall Study||3
872508|NCT02169453|2111190|P1|100 mg BIA 9-1067|Overall Study||3
872509|NCT02169453|2111187|P4|50 mg BIA 9-1067|Overall Study||3
872510|NCT02169453|2111188|P3|50 mg BIA 9-1067|Overall Study||2
872511|NCT02169453|2111189|P2|50 mg BIA 9-1067|Overall Study||3
872512|NCT02169453|2111190|P1|50 mg BIA 9-1067|Overall Study||3
872513|NCT02169453|2111187|P4|25 mg BIA 9-1067|Overall Study||3
872514|NCT02169453|2111188|P3|25 mg BIA 9-1067|Overall Study||3
872515|NCT02169453|2111189|P2|25 mg BIA 9-1067|Overall Study||3
872516|NCT02169453|2111190|P1|25 mg BIA 9-1067|Overall Study||3
872517|NCT02169453|2111187|P4|STARTED|Overall Study||3
872518|NCT02169453|2111188|P3|STARTED|Overall Study||3
872519|NCT02169453|2111189|P2|STARTED|Overall Study||3
872520|NCT02169453|2111190|P1|STARTED|Overall Study||3
872521|NCT02169440|2111222|P2|NOT COMPLETED|Overall Study||0
872522|NCT02169440|2111223|P1|NOT COMPLETED|Overall Study||0
872523|NCT02169440|2111222|P2|COMPLETED|Overall Study||10
872524|NCT02169440|2111223|P1|COMPLETED|Overall Study||10
872525|NCT02169440|2111222|P2|STARTED|Overall Study||10
872526|NCT02169440|2111223|P1|STARTED|Overall Study||10
872527|NCT02169427|2111236|P1|NOT COMPLETED|Overall Study||0
872528|NCT02169427|2111236|P1|COMPLETED|Overall Study||6
872529|NCT02169427|2111236|P1|STARTED|Overall Study||6
872530|NCT02169414|2111246|P4|NOT COMPLETED|Overall Study||0
872531|NCT02169414|2111247|P3|NOT COMPLETED|Overall Study||0
872532|NCT02169414|2111248|P2|NOT COMPLETED|Overall Study||1
872533|NCT02169414|2111249|P1|NOT COMPLETED|Overall Study||1
872534|NCT02169414|2111246|P4|COMPLETED|Overall Study||18
872535|NCT02169414|2111247|P3|COMPLETED|Overall Study||18
872536|NCT02169414|2111248|P2|COMPLETED|Overall Study||18
872537|NCT02169414|2111249|P1|COMPLETED|Overall Study||18
872538|NCT02169414|2111246|P4|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
872539|NCT02169414|2111247|P3|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
872540|NCT02169414|2111248|P2|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
872541|NCT02169414|2111249|P1|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
872542|NCT02169414|2111246|P4|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
872543|NCT02169414|2111247|P3|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
872544|NCT02169414|2111248|P2|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||19
872545|NCT02169414|2111249|P1|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
872546|NCT02169414|2111246|P4|STARTED|Overall Study||18
872547|NCT02169414|2111247|P3|STARTED|Overall Study||18
872548|NCT02169414|2111248|P2|STARTED|Overall Study||19
872549|NCT02169414|2111249|P1|STARTED|Overall Study||19
872550|NCT02169336|2111290|P3|NOT COMPLETED|Overall Study||3
872551|NCT02169336|2111291|P2|NOT COMPLETED|Overall Study||4
872552|NCT02169336|2111292|P1|NOT COMPLETED|Overall Study||4
872553|NCT02169336|2111290|P3|COMPLETED|Overall Study||29
872554|NCT02169336|2111291|P2|COMPLETED|Overall Study||28
872555|NCT02169336|2111292|P1|COMPLETED|Overall Study||27
872556|NCT02169336|2111290|P3|STARTED|Overall Study||32
872557|NCT02169336|2111291|P2|STARTED|Overall Study||32
872558|NCT02169336|2111292|P1|STARTED|Overall Study||31
872559|NCT02169115|2111303|P3|NOT COMPLETED|Overall Study||0
872560|NCT02169115|2111304|P2|NOT COMPLETED|Overall Study||0
872561|NCT02169115|2111305|P1|NOT COMPLETED|Overall Study||0
872562|NCT02169115|2111303|P3|COMPLETED|Overall Study||21
872563|NCT02169115|2111304|P2|COMPLETED|Overall Study||21
872564|NCT02169115|2111305|P1|COMPLETED|Overall Study||19
872565|NCT02169115|2111303|P3|STARTED|Overall Study||21
872566|NCT02169115|2111304|P2|STARTED|Overall Study||21
872567|NCT02169115|2111305|P1|STARTED|Overall Study||19
872568|NCT02168491|2111313|P1|NOT COMPLETED|Overall Study||1
872569|NCT02168491|2111313|P1|COMPLETED|Overall Study||8
872570|NCT02168491|2111313|P1|STARTED|Overall Study||9
872571|NCT02168478|2111319|P1|NOT COMPLETED|Overall Study||4
872572|NCT02168478|2111319|P1|COMPLETED|Overall Study||202
872573|NCT02168478|2111319|P1|STARTED|Overall Study||206
872574|NCT02168439|2111325|P2|NOT COMPLETED|Overall Study||2
872575|NCT02168439|2111326|P1|NOT COMPLETED|Overall Study||0
872576|NCT02168439|2111325|P2|COMPLETED|Overall Study||18
872577|NCT02168439|2111326|P1|COMPLETED|Overall Study||20
872578|NCT02168439|2111325|P2|STARTED|Overall Study||20
872579|NCT02168439|2111326|P1|STARTED|Overall Study||20
872580|NCT02168387|2111344|P2|NOT COMPLETED|Overall Study||3
872581|NCT02168387|2111345|P1|NOT COMPLETED|Overall Study||7
872582|NCT02168387|2111344|P2|COMPLETED|Overall Study||16
872583|NCT02168387|2111345|P1|COMPLETED|Overall Study||13
872584|NCT02168387|2111344|P2|STARTED|Overall Study||19
872585|NCT02168387|2111345|P1|STARTED|Overall Study||20
872586|NCT02168361|2111357|P2|NOT COMPLETED|Overall Study||10
872587|NCT02168361|2111358|P1|NOT COMPLETED|Overall Study||5
872588|NCT02168361|2111357|P2|COMPLETED|Overall Study||21
872589|NCT02168361|2111358|P1|COMPLETED|Overall Study||57
872590|NCT02168361|2111357|P2|STARTED|Overall Study||31
872591|NCT02168361|2111358|P1|STARTED|Overall Study||62
872592|NCT02167893|2111366|P1|NOT COMPLETED|Overall Study||163
872593|NCT02167893|2111366|P1|COMPLETED|Overall Study||11125
872594|NCT02167893|2111366|P1|STARTED|Overall Study||11288
872595|NCT02167867|2111377|P2|NOT COMPLETED|Overall Study||0
872596|NCT02167867|2111378|P1|NOT COMPLETED|Overall Study||0
872597|NCT02167867|2111377|P2|COMPLETED|Overall Study||22
872598|NCT02167867|2111378|P1|COMPLETED|Overall Study||22
872599|NCT02167867|2111377|P2|STARTED|Overall Study||22
872600|NCT02167867|2111378|P1|STARTED|Overall Study||22
872601|NCT02167815|2111386|P2|NOT COMPLETED|Overall Study||0
872602|NCT02167815|2111387|P1|NOT COMPLETED|Overall Study||0
872603|NCT02167815|2111386|P2|COMPLETED|Overall Study||21
872604|NCT02167815|2111387|P1|COMPLETED|Overall Study||9
872605|NCT02167815|2111386|P2|STARTED|Overall Study||21
872606|NCT02167815|2111387|P1|STARTED|Overall Study||9
872607|NCT02167139|2111400|P4|NOT COMPLETED|Transition-extension||5
872608|NCT02167139|2111401|P3|NOT COMPLETED|Transition-extension||8
872609|NCT02167139|2111402|P2|NOT COMPLETED|Transition-extension||0
872610|NCT02167139|2111403|P1|NOT COMPLETED|Transition-extension||6
872611|NCT02167139|2111400|P4|COMPLETED|Transition-extension||124
872612|NCT02167139|2111401|P3|COMPLETED|Transition-extension||117
872613|NCT02167139|2111402|P2|COMPLETED|Transition-extension||0
872614|NCT02167139|2111403|P1|COMPLETED|Transition-extension||248
872615|NCT02167139|2111400|P4|STARTED|Transition-extension||129
872616|NCT02167139|2111401|P3|STARTED|Transition-extension||125
872617|NCT02167139|2111402|P2|STARTED|Transition-extension||0
872618|NCT02167139|2111403|P1|STARTED|Transition-extension||254
872619|NCT02167139|2111400|P4|NOT COMPLETED|Randomised, Double-blind||0
872620|NCT02167139|2111401|P3|NOT COMPLETED|Randomised, Double-blind||0
872621|NCT02167139|2111402|P2|NOT COMPLETED|Randomised, Double-blind||19
872622|NCT02167139|2111403|P1|NOT COMPLETED|Randomised, Double-blind||17
872623|NCT02167139|2111400|P4|COMPLETED|Randomised, Double-blind||0
872624|NCT02167139|2111401|P3|COMPLETED|Randomised, Double-blind||0
872625|NCT02167139|2111402|P2|COMPLETED|Randomised, Double-blind||254
872626|NCT02167139|2111403|P1|COMPLETED|Randomised, Double-blind||254
872627|NCT02167139|2111400|P4|STARTED|Randomised, Double-blind||0
872628|NCT02167139|2111401|P3|STARTED|Randomised, Double-blind||0
872629|NCT02167139|2111402|P2|STARTED|Randomised, Double-blind||273
872630|NCT02167139|2111403|P1|STARTED|Randomised, Double-blind||271
872631|NCT02166697|2111417|P1|NOT COMPLETED|Overall Study||347
872632|NCT02166697|2111417|P1|COMPLETED|Overall Study||13804
872633|NCT02166697|2111417|P1|STARTED|Overall Study||14151
872634|NCT02165826|2111429|P3|NOT COMPLETED|Down-Titration Period||7
872635|NCT02165826|2111430|P2|NOT COMPLETED|Down-Titration Period||11
872636|NCT02165826|2111431|P1|NOT COMPLETED|Down-Titration Period||7
872637|NCT02165826|2111429|P3|COMPLETED|Down-Titration Period||31
872638|NCT02165826|2111430|P2|COMPLETED|Down-Titration Period||28
872639|NCT02165826|2111431|P1|COMPLETED|Down-Titration Period||20
872640|NCT02165826|2111429|P3|Safety Analysis Set: Received Study Drug|Down-Titration Period||38
872641|NCT02165826|2111430|P2|Safety Analysis Set: Received Study Drug|Down-Titration Period||39
872642|NCT02165826|2111431|P1|Safety Analysis Set: Received Study Drug|Down-Titration Period||27
872643|NCT02165826|2111429|P3|STARTED|Down-Titration Period||38
872644|NCT02165826|2111430|P2|STARTED|Down-Titration Period||39
872645|NCT02165826|2111431|P1|STARTED|Down-Titration Period||27
872646|NCT02165826|2111429|P3|NOT COMPLETED|Main Treatment Period||109
872647|NCT02165826|2111430|P2|NOT COMPLETED|Main Treatment Period||90
872648|NCT02165826|2111431|P1|NOT COMPLETED|Main Treatment Period||81
872649|NCT02165826|2111429|P3|COMPLETED|Main Treatment Period||334
872650|NCT02165826|2111430|P2|COMPLETED|Main Treatment Period||349
872651|NCT02165826|2111431|P1|COMPLETED|Main Treatment Period||360
872652|NCT02165826|2111429|P3|Safety Analysis Set: Received Study Drug|Main Treatment Period||443
872653|NCT02165826|2111430|P2|Safety Analysis Set: Received Study Drug|Main Treatment Period||437
872654|NCT02165826|2111431|P1|Safety Analysis Set: Received Study Drug|Main Treatment Period||441
872655|NCT02165826|2111429|P3|STARTED|Main Treatment Period||443
872656|NCT02165826|2111430|P2|STARTED|Main Treatment Period||439
872657|NCT02165826|2111431|P1|STARTED|Main Treatment Period||441
872658|NCT02165462|2111488|P1|NOT COMPLETED|Overall Study||0
872659|NCT02165462|2111488|P1|COMPLETED|Overall Study||17
872660|NCT02165462|2111488|P1|STARTED|Overall Study||17
872661|NCT02165111|2111507|P2|NOT COMPLETED|Overall Study||0
872662|NCT02165111|2111508|P1|NOT COMPLETED|Overall Study||0
872663|NCT02165111|2111507|P2|COMPLETED|Overall Study||40
872664|NCT02165111|2111508|P1|COMPLETED|Overall Study||40
872665|NCT02165111|2111507|P2|STARTED|Overall Study||40
872666|NCT02165111|2111508|P1|STARTED|Overall Study||40
872667|NCT02165072|2111524|P1|NOT COMPLETED|Overall Study||0
872668|NCT02165072|2111524|P1|COMPLETED|Overall Study||30
872669|NCT02165072|2111524|P1|STARTED|Overall Study||30
872745|NCT02164396|2111638|P3|NOT COMPLETED|Overall Study||0
872746|NCT02164396|2111639|P2|NOT COMPLETED|Overall Study||0
872747|NCT02164396|2111640|P1|NOT COMPLETED|Overall Study||0
872748|NCT02164396|2111638|P3|COMPLETED|Overall Study||10
872749|NCT02164396|2111639|P2|COMPLETED|Overall Study||10
872750|NCT02164396|2111640|P1|COMPLETED|Overall Study||10
872751|NCT02164396|2111638|P3|STARTED|Overall Study||10
872752|NCT02164396|2111639|P2|STARTED|Overall Study||10
872753|NCT02164396|2111640|P1|STARTED|Overall Study||10
872766|NCT02163915|2111678|P5|NOT COMPLETED|Overall Study||4
872767|NCT02163915|2111679|P4|NOT COMPLETED|Overall Study||3
872768|NCT02163915|2111680|P3|NOT COMPLETED|Overall Study||2
872769|NCT02163915|2111681|P2|NOT COMPLETED|Overall Study||0
872770|NCT02163915|2111682|P1|NOT COMPLETED|Overall Study||3
872771|NCT02163915|2111678|P5|COMPLETED|Overall Study||6
872772|NCT02163915|2111679|P4|COMPLETED|Overall Study||6
872773|NCT02163915|2111680|P3|COMPLETED|Overall Study||8
872774|NCT02163915|2111681|P2|COMPLETED|Overall Study||8
872775|NCT02163915|2111682|P1|COMPLETED|Overall Study||7
872776|NCT02163915|2111678|P5|STARTED|Overall Study||10
872777|NCT02163915|2111679|P4|STARTED|Overall Study||9
872778|NCT02163915|2111680|P3|STARTED|Overall Study||10
872779|NCT02163915|2111681|P2|STARTED|Overall Study||8
872780|NCT02163915|2111682|P1|STARTED|Overall Study||10
872781|NCT02163733|2111737|P3|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||24
872782|NCT02163733|2111738|P2|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
872783|NCT02163733|2111739|P1|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
872784|NCT02163733|2111737|P3|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||14
872785|NCT02163733|2111738|P2|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
872786|NCT02163733|2111739|P1|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
872787|NCT02163733|2111737|P3|STARTED|Part B: Day 15 to End Part B (AZD9291)|No patients completed previous period as relates to Part A and arm is applicable only for Part B.|38
872788|NCT02163733|2111738|P2|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
872789|NCT02163733|2111739|P1|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
872790|NCT02163733|2111737|P3|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
872791|NCT02163733|2111738|P2|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
872792|NCT02163733|2111739|P1|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
872793|NCT02163733|2111737|P3|COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
872794|NCT02163733|2111738|P2|COMPLETED|Part A: Day 10-15 (2nd Intervention)||20
872795|NCT02163733|2111739|P1|COMPLETED|Part A: Day 10-15 (2nd Intervention)||18
872796|NCT02163733|2111737|P3|STARTED|Part A: Day 10-15 (2nd Intervention)||0
872797|NCT02163733|2111738|P2|STARTED|Part A: Day 10-15 (2nd Intervention)||20
872798|NCT02163733|2111739|P1|STARTED|Part A: Day 10-15 (2nd Intervention)||18
872799|NCT02163733|2111737|P3|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
872800|NCT02163733|2111738|P2|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
872801|NCT02163733|2111739|P1|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
872802|NCT02163733|2111737|P3|COMPLETED|Part A: Day 1-9 (1st Intervention)||0
872803|NCT02163733|2111738|P2|COMPLETED|Part A: Day 1-9 (1st Intervention)||20
872804|NCT02163733|2111739|P1|COMPLETED|Part A: Day 1-9 (1st Intervention)||18
872805|NCT02163733|2111737|P3|STARTED|Part A: Day 1-9 (1st Intervention)||0
872806|NCT02163733|2111738|P2|STARTED|Part A: Day 1-9 (1st Intervention)||20
872807|NCT02163733|2111739|P1|STARTED|Part A: Day 1-9 (1st Intervention)||18
872808|NCT02163421|2111778|P4|NOT COMPLETED|Overall Study||0
872809|NCT02163421|2111779|P3|NOT COMPLETED|Overall Study||0
872810|NCT02163421|2111780|P2|NOT COMPLETED|Overall Study||0
872811|NCT02163421|2111781|P1|NOT COMPLETED|Overall Study||0
872812|NCT02163421|2111778|P4|COMPLETED|Overall Study||12
872813|NCT02163421|2111779|P3|COMPLETED|Overall Study||12
872814|NCT02163421|2111780|P2|COMPLETED|Overall Study||12
872815|NCT02163421|2111781|P1|COMPLETED|Overall Study||12
872816|NCT02163421|2111778|P4|STARTED|Overall Study||12
872817|NCT02163421|2111779|P3|STARTED|Overall Study||12
872818|NCT02163421|2111780|P2|STARTED|Overall Study||12
872819|NCT02163421|2111781|P1|STARTED|Overall Study||12
872820|NCT02163395|2111788|P1|NOT COMPLETED|Overall Study||5
872821|NCT02163395|2111788|P1|COMPLETED|Overall Study||39
872822|NCT02163395|2111788|P1|STARTED|Overall Study||44
872829|NCT02162862|2111807|P3|NOT COMPLETED|Overall Study||4
872830|NCT02162862|2111808|P2|NOT COMPLETED|Overall Study||11
872831|NCT02162862|2111809|P1|NOT COMPLETED|Overall Study||0
872832|NCT02162862|2111807|P3|COMPLETED|Overall Study||29
872833|NCT02162862|2111808|P2|COMPLETED|Overall Study||24
872834|NCT02162862|2111809|P1|COMPLETED|Overall Study||31
872835|NCT02162862|2111807|P3|STARTED|Overall Study||33
872836|NCT02162862|2111808|P2|STARTED|Overall Study||35
872837|NCT02162862|2111809|P1|STARTED|Overall Study||31
872838|NCT02162758|2111822|P2|NOT COMPLETED|Overall Study||1
872839|NCT02162758|2111823|P1|NOT COMPLETED|Overall Study||0
872840|NCT02162758|2111822|P2|COMPLETED|Overall Study||2
872841|NCT02162758|2111823|P1|COMPLETED|Overall Study||3
872842|NCT02162758|2111822|P2|STARTED|Overall Study||3
872843|NCT02162758|2111823|P1|STARTED|Overall Study||3
872844|NCT02162680|2111838|P3|NOT COMPLETED|Overall Study||0
872845|NCT02162680|2111839|P2|NOT COMPLETED|Overall Study||0
872846|NCT02162680|2111840|P1|NOT COMPLETED|Overall Study||0
872847|NCT02162680|2111838|P3|COMPLETED|Overall Study||32
872848|NCT02162680|2111839|P2|COMPLETED|Overall Study||33
872849|NCT02162680|2111840|P1|COMPLETED|Overall Study||33
872850|NCT02162680|2111838|P3|STARTED|Overall Study||32
872851|NCT02162680|2111839|P2|STARTED|Overall Study||33
872852|NCT02162680|2111840|P1|STARTED|Overall Study||33
872853|NCT02161549|2111850|P2|NOT COMPLETED|Overall Study||2
872854|NCT02161549|2111851|P1|NOT COMPLETED|Overall Study||6
872855|NCT02161549|2111850|P2|COMPLETED|Overall Study||29
872856|NCT02161549|2111851|P1|COMPLETED|Overall Study||34
872857|NCT02161549|2111850|P2|STARTED|Overall Study||31
872858|NCT02161549|2111851|P1|STARTED|Overall Study||40
872859|NCT02161146|2111862|P5|NOT COMPLETED|Overall Study||1
872860|NCT02161146|2111863|P4|NOT COMPLETED|Overall Study||3
872861|NCT02161146|2111864|P3|NOT COMPLETED|Overall Study||0
872862|NCT02161146|2111865|P2|NOT COMPLETED|Overall Study||4
872863|NCT02161146|2111866|P1|NOT COMPLETED|Overall Study||1
872864|NCT02161146|2111862|P5|COMPLETED|Overall Study||48
872865|NCT02161146|2111863|P4|COMPLETED|Overall Study||45
872866|NCT02161146|2111864|P3|COMPLETED|Overall Study||49
872867|NCT02161146|2111865|P2|COMPLETED|Overall Study||43
872868|NCT02161146|2111866|P1|COMPLETED|Overall Study||46
872869|NCT02161146|2111862|P5|STARTED|Overall Study||49
872870|NCT02161146|2111863|P4|STARTED|Overall Study||48
872871|NCT02161146|2111864|P3|STARTED|Overall Study||49
872872|NCT02161146|2111865|P2|STARTED|Overall Study||47
872873|NCT02161146|2111866|P1|STARTED|Overall Study||47
872874|NCT02161016|2111879|P1|NOT COMPLETED|Overall Study||1
872875|NCT02161016|2111879|P1|COMPLETED|Overall Study||0
872876|NCT02161016|2111879|P1|STARTED|Overall Study||1
872877|NCT02160990|2111889|P2|NOT COMPLETED|Overall Study||0
872878|NCT02160990|2111890|P1|NOT COMPLETED|Overall Study||0
872879|NCT02160990|2111889|P2|COMPLETED|Overall Study||10
872880|NCT02160990|2111890|P1|COMPLETED|Overall Study||10
872881|NCT02160990|2111889|P2|STARTED|Overall Study||10
872882|NCT02160990|2111890|P1|STARTED|Overall Study||10
872883|NCT02160977|2111910|P2|NOT COMPLETED|Six Months After Surgery||1
872884|NCT02160977|2111911|P1|NOT COMPLETED|Six Months After Surgery||2
872885|NCT02160977|2111910|P2|COMPLETED|Six Months After Surgery||42
872886|NCT02160977|2111911|P1|COMPLETED|Six Months After Surgery||42
872887|NCT02160977|2111910|P2|STARTED|Six Months After Surgery||43
872888|NCT02160977|2111911|P1|STARTED|Six Months After Surgery||44
872889|NCT02160977|2111910|P2|NOT COMPLETED|Three Months After Surgery||2
872890|NCT02160977|2111911|P1|NOT COMPLETED|Three Months After Surgery||0
872891|NCT02160977|2111910|P2|COMPLETED|Three Months After Surgery||43
872892|NCT02160977|2111911|P1|COMPLETED|Three Months After Surgery||44
872893|NCT02160977|2111910|P2|STARTED|Three Months After Surgery||45
872894|NCT02160977|2111911|P1|STARTED|Three Months After Surgery||44
872895|NCT02160977|2111910|P2|NOT COMPLETED|Six Weeks After Surgery||0
872896|NCT02160977|2111911|P1|NOT COMPLETED|Six Weeks After Surgery||1
872897|NCT02160977|2111910|P2|COMPLETED|Six Weeks After Surgery||45
872898|NCT02160977|2111911|P1|COMPLETED|Six Weeks After Surgery||44
872899|NCT02160977|2111910|P2|STARTED|Six Weeks After Surgery||45
872900|NCT02160977|2111911|P1|STARTED|Six Weeks After Surgery||45
872901|NCT02160977|2111910|P2|NOT COMPLETED|One Week After Surgery||0
872902|NCT02160977|2111911|P1|NOT COMPLETED|One Week After Surgery||0
872903|NCT02160977|2111910|P2|COMPLETED|One Week After Surgery||45
872904|NCT02160977|2111911|P1|COMPLETED|One Week After Surgery||45
872905|NCT02160977|2111910|P2|STARTED|One Week After Surgery||45
872906|NCT02160977|2111911|P1|STARTED|One Week After Surgery||45
872907|NCT02160873|2111923|P2|NOT COMPLETED|Overall Study||0
872908|NCT02160873|2111924|P1|NOT COMPLETED|Overall Study||0
872909|NCT02160873|2111923|P2|COMPLETED|Overall Study||6
872910|NCT02160873|2111924|P1|COMPLETED|Overall Study||6
872911|NCT02160873|2111923|P2|STARTED|Overall Study||6
872912|NCT02160873|2111924|P1|STARTED|Overall Study||6
872913|NCT02160314|2111938|P2|NOT COMPLETED|Overall Study||13
872914|NCT02160314|2111939|P1|NOT COMPLETED|Overall Study||1
872915|NCT02160314|2111938|P2|COMPLETED|Overall Study||59
872916|NCT02160314|2111939|P1|COMPLETED|Overall Study||72
872917|NCT02160314|2111938|P2|STARTED|Overall Study||72
872918|NCT02160314|2111939|P1|STARTED|Overall Study||73
872919|NCT02159950|2111947|P2|NOT COMPLETED|Overall Study||2
872920|NCT02159950|2111948|P1|NOT COMPLETED|Overall Study||0
872921|NCT02159950|2111947|P2|COMPLETED|Overall Study||0
872922|NCT02159950|2111948|P1|COMPLETED|Overall Study||0
872923|NCT02159950|2111947|P2|STARTED|Overall Study||2
872924|NCT02159950|2111948|P1|STARTED|Overall Study||0
872925|NCT02159859|2111980|P1|NOT COMPLETED|Overall Study||0
872926|NCT02159859|2111980|P1|COMPLETED|Overall Study||7
872927|NCT02159859|2111980|P1|STARTED|Overall Study||7
872928|NCT02159768|2111993|P1|NOT COMPLETED|Overall Study||0
872929|NCT02159768|2111993|P1|COMPLETED|Overall Study|Completed 27 July 2015|30
872930|NCT02159768|2111993|P1|STARTED|Overall Study|Started 16 July 2014|30
872931|NCT02159547|2112000|P2|NOT COMPLETED|Overall Study||0
872932|NCT02159547|2112001|P1|NOT COMPLETED|Overall Study||0
872933|NCT02159547|2112000|P2|COMPLETED|Overall Study||112
872934|NCT02159547|2112001|P1|COMPLETED|Overall Study||112
872935|NCT02159547|2112000|P2|STARTED|Overall Study||112
872936|NCT02159547|2112001|P1|STARTED|Overall Study||112
872937|NCT02159482|2112009|P1|NOT COMPLETED|Overall Study||5
872938|NCT02159482|2112009|P1|COMPLETED|Overall Study||6
872939|NCT02159482|2112009|P1|STARTED|Overall Study||11
872940|NCT02159365|2112014|P1|NOT COMPLETED|Overall Study||22
872941|NCT02159365|2112014|P1|COMPLETED|Overall Study|Completed = Still on Treatment|48
872942|NCT02159365|2112014|P1|STARTED|Overall Study||70
872943|NCT02159352|2112020|P2|NOT COMPLETED|Overall Study||2
872944|NCT02159352|2112021|P1|NOT COMPLETED|Overall Study||3
872945|NCT02159352|2112020|P2|COMPLETED|Overall Study||12
872946|NCT02159352|2112021|P1|COMPLETED|Overall Study||11
872947|NCT02159352|2112020|P2|Phase 2 (Day 5-14)|Overall Study||12
872948|NCT02159352|2112021|P1|Phase 2 (Day 5-14)|Overall Study||11
872949|NCT02159352|2112020|P2|Phase 1 (Day 1- 4)|Overall Study||14
872950|NCT02159352|2112021|P1|Phase 1 (Day 1- 4)|Overall Study||14
872951|NCT02159352|2112020|P2|STARTED|Overall Study||14
872952|NCT02159352|2112021|P1|STARTED|Overall Study||14
872953|NCT02159118|2112073|P2|NOT COMPLETED|Overall Study||0
872954|NCT02159118|2112074|P1|NOT COMPLETED|Overall Study||0
872955|NCT02159118|2112073|P2|COMPLETED|Overall Study||22
872956|NCT02159118|2112074|P1|COMPLETED|Overall Study||22
872957|NCT02159118|2112073|P2|STARTED|Overall Study||22
872958|NCT02159118|2112074|P1|STARTED|Overall Study||22
872959|NCT02159040|2112096|P1|NOT COMPLETED|Overall Study||1
872960|NCT02159040|2112096|P1|COMPLETED|Overall Study||0
872961|NCT02159040|2112096|P1|STARTED|Overall Study||1
872962|NCT02158728|2112109|P1|NOT COMPLETED|Overall Study||27
872963|NCT02158728|2112109|P1|COMPLETED|Overall Study||53
872964|NCT02158728|2112109|P1|STARTED|Overall Study||80
872965|NCT02158572|2112113|P1|NOT COMPLETED|Overall Study||1043
872966|NCT02158572|2112113|P1|COMPLETED|Overall Study||989
872967|NCT02158572|2112113|P1|STARTED|Overall Study||2032
872968|NCT02158442|2112126|P2|NOT COMPLETED|Overall Study||0
872969|NCT02158442|2112127|P1|NOT COMPLETED|Overall Study||2
872970|NCT02158442|2112126|P2|COMPLETED|Overall Study||7
872971|NCT02158442|2112127|P1|COMPLETED|Overall Study||6
872972|NCT02158442|2112126|P2|STARTED|Overall Study||7
872973|NCT02158442|2112127|P1|STARTED|Overall Study||8
872974|NCT02158273|2112135|P2|NOT COMPLETED|Overall Study||3
872975|NCT02158273|2112136|P1|NOT COMPLETED|Overall Study||3
872976|NCT02158273|2112135|P2|COMPLETED|Overall Study||22
872977|NCT02158273|2112136|P1|COMPLETED|Overall Study||22
872978|NCT02158273|2112135|P2|STARTED|Overall Study||25
872979|NCT02158273|2112136|P1|STARTED|Overall Study||25
872980|NCT02158247|2112146|P1|NOT COMPLETED|Overall Study||5
872981|NCT02158247|2112146|P1|COMPLETED|Overall Study||176
872982|NCT02158247|2112146|P1|STARTED|Overall Study||181
872983|NCT02158039|2112162|P1|NOT COMPLETED|Overall Study||10
872984|NCT02158039|2112162|P1|COMPLETED|Overall Study||23
872985|NCT02158039|2112162|P1|STARTED|Overall Study||33
872986|NCT02157948|2112169|P2|NOT COMPLETED|Overall Study||9
872987|NCT02157948|2112170|P1|NOT COMPLETED|Overall Study||9
872988|NCT02157948|2112169|P2|COMPLETED|Overall Study||188
872989|NCT02157948|2112170|P1|COMPLETED|Overall Study||188
872990|NCT02157948|2112169|P2|Received Treatment|Overall Study||196
872991|NCT02157948|2112170|P1|Received Treatment|Overall Study||196
872992|NCT02157948|2112169|P2|STARTED|Overall Study||197
872993|NCT02157948|2112170|P1|STARTED|Overall Study||197
872994|NCT02157935|2112182|P2|NOT COMPLETED|Overall Study||65
872995|NCT02157935|2112183|P1|NOT COMPLETED|Overall Study||39
872996|NCT02157935|2112182|P2|COMPLETED|Overall Study||548
872997|NCT02157935|2112183|P1|COMPLETED|Overall Study||567
872998|NCT02157935|2112182|P2|STARTED|Overall Study||613
872999|NCT02157935|2112183|P1|STARTED|Overall Study||606
873000|NCT02157909|2112201|P2|NOT COMPLETED|Overall Study||0
873001|NCT02157909|2112202|P1|NOT COMPLETED|Overall Study||0
873002|NCT02157909|2112201|P2|COMPLETED|Overall Study||66
873003|NCT02157909|2112202|P1|COMPLETED|Overall Study||66
873004|NCT02157909|2112201|P2|STARTED|Overall Study||66
873005|NCT02157909|2112202|P1|STARTED|Overall Study||66
873006|NCT02157883|2112209|P1|NOT COMPLETED|Part B: Day 19 to End Part B (AZD9291)||22
873007|NCT02157883|2112209|P1|COMPLETED|Part B: Day 19 to End Part B (AZD9291)||16
873008|NCT02157883|2112209|P1|STARTED|Part B: Day 19 to End Part B (AZD9291)||38
873009|NCT02157883|2112209|P1|NOT COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||1
873010|NCT02157883|2112209|P1|COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||38
873011|NCT02157883|2112209|P1|STARTED|Part A: Day 6-18 (AZD9291+Itraconozole)||39
873012|NCT02157883|2112209|P1|NOT COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||0
873013|NCT02157883|2112209|P1|COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||39
873014|NCT02157883|2112209|P1|STARTED|Part A: Day 1-5 (AZD9291 Alone)||39
873015|NCT02157623|2112240|P2|NOT COMPLETED|Overall Study||3
873016|NCT02157623|2112241|P1|NOT COMPLETED|Overall Study||4
873017|NCT02157623|2112240|P2|COMPLETED|Overall Study||0
873018|NCT02157623|2112241|P1|COMPLETED|Overall Study||0
873019|NCT02157623|2112240|P2|STARTED|Overall Study||3
873020|NCT02157623|2112241|P1|STARTED|Overall Study||4
873021|NCT02157376|2112249|P2|NOT COMPLETED|Overall Study||18
873022|NCT02157376|2112250|P1|NOT COMPLETED|Overall Study||22
873023|NCT02157376|2112249|P2|COMPLETED|Overall Study||138
873024|NCT02157376|2112250|P1|COMPLETED|Overall Study||133
873025|NCT02157376|2112249|P2|STARTED|Overall Study||156
873026|NCT02157376|2112250|P1|STARTED|Overall Study||155
873027|NCT02157298|2112260|P2|NOT COMPLETED|Overall Study||2
873028|NCT02157298|2112261|P1|NOT COMPLETED|Overall Study||4
873029|NCT02157298|2112260|P2|COMPLETED|Overall Study||58
873030|NCT02157298|2112261|P1|COMPLETED|Overall Study||119
873031|NCT02157298|2112260|P2|STARTED|Overall Study||60
873032|NCT02157298|2112261|P1|STARTED|Overall Study||123
873033|NCT02157116|2112275|P1|NOT COMPLETED|Overall Study||9
873034|NCT02157116|2112275|P1|COMPLETED|Overall Study||4
873035|NCT02157116|2112275|P1|STARTED|Overall Study|signed consent form|13
873036|NCT02156466|2112289|P5|NOT COMPLETED|Overall Study||0
873037|NCT02156466|2112290|P4|NOT COMPLETED|Overall Study||2
873038|NCT02156466|2112291|P3|NOT COMPLETED|Overall Study||1
873039|NCT02156466|2112292|P2|NOT COMPLETED|Overall Study||0
873040|NCT02156466|2112293|P1|NOT COMPLETED|Overall Study||0
873041|NCT02156466|2112289|P5|COMPLETED|Overall Study||8
873042|NCT02156466|2112290|P4|COMPLETED|Overall Study||7
873043|NCT02156466|2112291|P3|COMPLETED|Overall Study||7
873044|NCT02156466|2112292|P2|COMPLETED|Overall Study||8
873045|NCT02156466|2112293|P1|COMPLETED|Overall Study||8
873046|NCT02156466|2112289|P5|STARTED|Overall Study||8
873047|NCT02156466|2112290|P4|STARTED|Overall Study||9
873048|NCT02156466|2112291|P3|STARTED|Overall Study||8
873049|NCT02156466|2112292|P2|STARTED|Overall Study||8
873050|NCT02156466|2112293|P1|STARTED|Overall Study||8
873051|NCT02156271|2112474|P2|NOT COMPLETED|Overall Study||3
873052|NCT02156271|2112475|P1|NOT COMPLETED|Overall Study||4
873053|NCT02156271|2112474|P2|COMPLETED|Overall Study||10
873054|NCT02156271|2112475|P1|COMPLETED|Overall Study||22
873055|NCT02156271|2112474|P2|STARTED|Overall Study||13
873056|NCT02156271|2112475|P1|STARTED|Overall Study||26
873057|NCT02156167|2112507|P1|NOT COMPLETED|Overall Study||0
873058|NCT02156167|2112507|P1|COMPLETED|Overall Study||15
873059|NCT02156167|2112507|P1|STARTED|Overall Study||15
873060|NCT02155985|2112514|P3|NOT COMPLETED|Overall Study||1
873061|NCT02155985|2112515|P2|NOT COMPLETED|Overall Study||0
873062|NCT02155985|2112516|P1|NOT COMPLETED|Overall Study||1
873063|NCT02155985|2112514|P3|COMPLETED|Overall Study||39
873064|NCT02155985|2112515|P2|COMPLETED|Overall Study||41
873065|NCT02155985|2112516|P1|COMPLETED|Overall Study||39
873066|NCT02155985|2112514|P3|STARTED|Overall Study||40
873067|NCT02155985|2112515|P2|STARTED|Overall Study||41
873068|NCT02155985|2112516|P1|STARTED|Overall Study||40
873069|NCT02155881|2112583|P2|NOT COMPLETED|Overall Study||4
873070|NCT02155881|2112584|P1|NOT COMPLETED|Overall Study||2
873071|NCT02155881|2112583|P2|COMPLETED|Overall Study||36
873072|NCT02155881|2112584|P1|COMPLETED|Overall Study||38
873073|NCT02155881|2112583|P2|STARTED|Overall Study||40
873074|NCT02155881|2112584|P1|STARTED|Overall Study||40
873075|NCT02155543|2112611|P7|NOT COMPLETED|Overall Study||0
873076|NCT02155543|2112612|P6|NOT COMPLETED|Overall Study||0
873077|NCT02155543|2112613|P5|NOT COMPLETED|Overall Study||0
873078|NCT02155543|2112614|P4|NOT COMPLETED|Overall Study||0
873079|NCT02155543|2112615|P3|NOT COMPLETED|Overall Study||0
873080|NCT02155543|2112616|P2|NOT COMPLETED|Overall Study||0
873081|NCT02155543|2112617|P1|NOT COMPLETED|Overall Study||0
873082|NCT02155543|2112611|P7|COMPLETED|Overall Study||9
873083|NCT02155543|2112612|P6|COMPLETED|Overall Study||3
873084|NCT02155543|2112613|P5|COMPLETED|Overall Study||3
873085|NCT02155543|2112614|P4|COMPLETED|Overall Study||9
873086|NCT02155543|2112615|P3|COMPLETED|Overall Study||9
873087|NCT02155543|2112616|P2|COMPLETED|Overall Study||9
873088|NCT02155543|2112617|P1|COMPLETED|Overall Study||9
873089|NCT02155543|2112611|P7|STARTED|Overall Study||9
873090|NCT02155543|2112612|P6|STARTED|Overall Study||3
873091|NCT02155543|2112613|P5|STARTED|Overall Study||3
873092|NCT02155543|2112614|P4|STARTED|Overall Study||9
873093|NCT02155543|2112615|P3|STARTED|Overall Study||9
873094|NCT02155543|2112616|P2|STARTED|Overall Study||9
873095|NCT02155543|2112617|P1|STARTED|Overall Study||9
873096|NCT02155335|2112630|P2|NOT COMPLETED|Period 2||0
873097|NCT02155335|2112631|P1|NOT COMPLETED|Period 2||0
873098|NCT02155335|2112630|P2|COMPLETED|Period 2||49
873099|NCT02155335|2112631|P1|COMPLETED|Period 2||50
873100|NCT02155335|2112630|P2|STARTED|Period 2||49
873101|NCT02155335|2112631|P1|STARTED|Period 2||50
873102|NCT02155335|2112630|P2|NOT COMPLETED|Period 1||1
873103|NCT02155335|2112631|P1|NOT COMPLETED|Period 1||0
873104|NCT02155335|2112630|P2|COMPLETED|Period 1||49
873105|NCT02155335|2112631|P1|COMPLETED|Period 1||50
873106|NCT02155335|2112630|P2|Treated|Period 1||49
873107|NCT02155335|2112631|P1|Treated|Period 1||50
873108|NCT02155335|2112630|P2|STARTED|Period 1||50
873109|NCT02155335|2112631|P1|STARTED|Period 1||50
873110|NCT02155322|2112636|P1|NOT COMPLETED|Overall Study||14
873111|NCT02155322|2112636|P1|COMPLETED|Overall Study||19
873112|NCT02155322|2112636|P1|Treated|Overall Study|32 of 33 participants treated. 1 participant not treated at the discretion of the investigator.|32
873113|NCT02155322|2112636|P1|STARTED|Overall Study||33
873114|NCT02155283|2112641|P1|NOT COMPLETED|Overall Study||7
873115|NCT02155283|2112641|P1|COMPLETED|Overall Study||9
873116|NCT02155283|2112641|P1|STARTED|Overall Study||16
873117|NCT02155010|2112648|P2|NOT COMPLETED|Overall Study||6
873118|NCT02155010|2112649|P1|NOT COMPLETED|Overall Study||6
873119|NCT02155010|2112648|P2|COMPLETED|Overall Study||31
873120|NCT02155010|2112649|P1|COMPLETED|Overall Study||31
873121|NCT02155010|2112648|P2|STARTED|Overall Study||37
873122|NCT02155010|2112649|P1|STARTED|Overall Study||37
873123|NCT02154906|2112659|P2|NOT COMPLETED|Overall Study||3
873124|NCT02154906|2112660|P1|NOT COMPLETED|Overall Study||2
873125|NCT02154906|2112659|P2|COMPLETED|Overall Study||17
873126|NCT02154906|2112660|P1|COMPLETED|Overall Study||19
873127|NCT02154906|2112659|P2|STARTED|Overall Study||20
873128|NCT02154906|2112660|P1|STARTED|Overall Study||21
873129|NCT02154425|2112668|P1|NOT COMPLETED|Sampling Period||0
873130|NCT02154425|2112668|P1|COMPLETED|Sampling Period||17
873131|NCT02154425|2112668|P1|STARTED|Sampling Period||17
873132|NCT02154425|2112668|P1|NOT COMPLETED|Screening Period||1
873133|NCT02154425|2112668|P1|COMPLETED|Screening Period||17
873134|NCT02154425|2112668|P1|STARTED|Screening Period||18
873135|NCT02154386|2112700|P2|NOT COMPLETED|Overall Study||2
873136|NCT02154386|2112701|P1|NOT COMPLETED|Overall Study||1
873137|NCT02154386|2112700|P2|COMPLETED|Overall Study||21
873138|NCT02154386|2112701|P1|COMPLETED|Overall Study||22
873139|NCT02154386|2112700|P2|STARTED|Overall Study||23
873140|NCT02154386|2112701|P1|STARTED|Overall Study||23
873141|NCT02154243|2112714|P3|NOT COMPLETED|Overall Study||0
873142|NCT02154243|2112715|P2|NOT COMPLETED|Overall Study||0
873143|NCT02154243|2112716|P1|NOT COMPLETED|Overall Study||0
873144|NCT02154243|2112714|P3|COMPLETED|Overall Study||4
873145|NCT02154243|2112715|P2|COMPLETED|Overall Study||4
873146|NCT02154243|2112716|P1|COMPLETED|Overall Study||5
873147|NCT02154243|2112714|P3|STARTED|Overall Study||4
873148|NCT02154243|2112715|P2|STARTED|Overall Study||4
873149|NCT02154243|2112716|P1|STARTED|Overall Study||5
873150|NCT02154139|2112727|P1|NOT COMPLETED|Overall Study||7
873151|NCT02154139|2112727|P1|COMPLETED|Overall Study||644
873152|NCT02154139|2112727|P1|STARTED|Overall Study||651
873153|NCT02154087|2112735|P1|NOT COMPLETED|Overall Study||1
873154|NCT02154087|2112735|P1|COMPLETED|Overall Study||0
873155|NCT02154087|2112735|P1|STARTED|Overall Study||1
873156|NCT02154048|2112742|P3|NOT COMPLETED|Overall Study||0
873157|NCT02154048|2112743|P2|NOT COMPLETED|Overall Study||0
873158|NCT02154048|2112744|P1|NOT COMPLETED|Overall Study||0
873159|NCT02154048|2112742|P3|COMPLETED|Overall Study||1
873160|NCT02154048|2112743|P2|COMPLETED|Overall Study||2
873161|NCT02154048|2112744|P1|COMPLETED|Overall Study||2
873162|NCT02154048|2112742|P3|STARTED|Overall Study||1
873163|NCT02154048|2112743|P2|STARTED|Overall Study||2
873164|NCT02154048|2112744|P1|STARTED|Overall Study||2
873165|NCT02153827|2112754|P2|NOT COMPLETED|Overall Study||9
873166|NCT02153827|2112755|P1|NOT COMPLETED|Overall Study||3
873167|NCT02153827|2112754|P2|COMPLETED|Overall Study||14
873168|NCT02153827|2112755|P1|COMPLETED|Overall Study||22
873169|NCT02153827|2112754|P2|STARTED|Overall Study||23
873170|NCT02153827|2112755|P1|STARTED|Overall Study||25
873171|NCT02153788|2112771|P2|NOT COMPLETED|Overall Study||1
873172|NCT02153788|2112772|P1|NOT COMPLETED|Overall Study||2
873173|NCT02153788|2112771|P2|COMPLETED|Overall Study||18
873174|NCT02153788|2112772|P1|COMPLETED|Overall Study||23
873175|NCT02153788|2112771|P2|STARTED|Overall Study||19
873176|NCT02153788|2112772|P1|STARTED|Overall Study||25
873177|NCT02153736|2112792|P2|NOT COMPLETED|Overall Study||2
873178|NCT02153736|2112793|P1|NOT COMPLETED|Overall Study||2
873179|NCT02153736|2112792|P2|COMPLETED|Overall Study||5
873180|NCT02153736|2112793|P1|COMPLETED|Overall Study||5
873181|NCT02153736|2112792|P2|STARTED|Overall Study||7
873182|NCT02153736|2112793|P1|STARTED|Overall Study||7
873183|NCT02153489|2112809|P2|NOT COMPLETED|Period 2||0
873184|NCT02153489|2112810|P1|NOT COMPLETED|Period 2||0
873185|NCT02153489|2112809|P2|COMPLETED|Period 2||15
873186|NCT02153489|2112810|P1|COMPLETED|Period 2||15
873187|NCT02153489|2112809|P2|STARTED|Period 2||15
873188|NCT02153489|2112810|P1|STARTED|Period 2||15
873189|NCT02153489|2112809|P2|NOT COMPLETED|Period 1||0
873190|NCT02153489|2112810|P1|NOT COMPLETED|Period 1||0
873191|NCT02153489|2112809|P2|COMPLETED|Period 1||15
873192|NCT02153489|2112810|P1|COMPLETED|Period 1||15
873193|NCT02153489|2112809|P2|STARTED|Period 1||15
873194|NCT02153489|2112810|P1|STARTED|Period 1||15
873195|NCT02153398|2112853|P5|NOT COMPLETED|Overall Study||0
873196|NCT02153398|2112854|P4|NOT COMPLETED|Overall Study||1
873197|NCT02153398|2112855|P3|NOT COMPLETED|Overall Study||1
873198|NCT02153398|2112856|P2|NOT COMPLETED|Overall Study||0
873199|NCT02153398|2112857|P1|NOT COMPLETED|Overall Study||1
873200|NCT02153398|2112853|P5|COMPLETED|Overall Study||10
873201|NCT02153398|2112854|P4|COMPLETED|Overall Study||9
873202|NCT02153398|2112855|P3|COMPLETED|Overall Study||9
873203|NCT02153398|2112856|P2|COMPLETED|Overall Study||10
873204|NCT02153398|2112857|P1|COMPLETED|Overall Study||9
873205|NCT02153398|2112853|P5|STARTED|Overall Study||10
873206|NCT02153398|2112854|P4|STARTED|Overall Study||10
873207|NCT02153398|2112855|P3|STARTED|Overall Study||10
873208|NCT02153398|2112856|P2|STARTED|Overall Study||10
873209|NCT02153398|2112857|P1|STARTED|Overall Study||10
873210|NCT02153346|2112979|P1|NOT COMPLETED|Overall Study||11
873211|NCT02153346|2112979|P1|COMPLETED|Overall Study||90
873212|NCT02153346|2112979|P1|STARTED|Overall Study||101
873213|NCT02153099|2112993|P7|NOT COMPLETED|Overall Study||0
873214|NCT02153099|2112994|P6|NOT COMPLETED|Overall Study||0
873215|NCT02153099|2112995|P5|NOT COMPLETED|Overall Study||0
873216|NCT02153099|2112996|P4|NOT COMPLETED|Overall Study||0
873217|NCT02153099|2112997|P3|NOT COMPLETED|Overall Study||0
873218|NCT02153099|2112998|P2|NOT COMPLETED|Overall Study||0
873219|NCT02153099|2112999|P1|NOT COMPLETED|Overall Study||0
873220|NCT02153099|2112993|P7|COMPLETED|Overall Study||12
873221|NCT02153099|2112994|P6|COMPLETED|Overall Study||6
873222|NCT02153099|2112995|P5|COMPLETED|Overall Study||6
873223|NCT02153099|2112996|P4|COMPLETED|Overall Study||6
873224|NCT02153099|2112997|P3|COMPLETED|Overall Study||6
873225|NCT02153099|2112998|P2|COMPLETED|Overall Study||6
873226|NCT02153099|2112999|P1|COMPLETED|Overall Study||6
873227|NCT02153099|2112993|P7|STARTED|Overall Study||12
873228|NCT02153099|2112994|P6|STARTED|Overall Study||6
873229|NCT02153099|2112995|P5|STARTED|Overall Study||6
873230|NCT02153099|2112996|P4|STARTED|Overall Study||6
873231|NCT02153099|2112997|P3|STARTED|Overall Study||6
873232|NCT02153099|2112998|P2|STARTED|Overall Study||6
873233|NCT02153099|2112999|P1|STARTED|Overall Study||6
873234|NCT02153086|2113053|P1|NOT COMPLETED|Overall Study||4
873235|NCT02153086|2113053|P1|COMPLETED|Overall Study||232
873236|NCT02153086|2113053|P1|STARTED|Overall Study||236
873237|NCT02152605|2113069|P2|NOT COMPLETED|Overall Study||18
873238|NCT02152605|2113070|P1|NOT COMPLETED|Overall Study||19
873239|NCT02152605|2113069|P2|COMPLETED|Overall Study||230
873240|NCT02152605|2113070|P1|COMPLETED|Overall Study||229
873241|NCT02152605|2113069|P2|STARTED|Overall Study||248
873242|NCT02152605|2113070|P1|STARTED|Overall Study||248
873243|NCT02152566|2113080|P1|NOT COMPLETED|Overall Study||3
873244|NCT02152566|2113080|P1|COMPLETED|Overall Study||3
873245|NCT02152566|2113080|P1|STARTED|Overall Study||6
873246|NCT02152371|2113086|P2|NOT COMPLETED|Overall Study||16
873247|NCT02152371|2113087|P1|NOT COMPLETED|Overall Study||12
873248|NCT02152371|2113086|P2|COMPLETED|Overall Study||134
873249|NCT02152371|2113087|P1|COMPLETED|Overall Study||138
873250|NCT02152371|2113086|P2|Received at Least 1 Dose of Study Drug.|Overall Study||150
873251|NCT02152371|2113087|P1|Received at Least 1 Dose of Study Drug.|Overall Study||150
873252|NCT02152371|2113086|P2|STARTED|Overall Study||150
873253|NCT02152371|2113087|P1|STARTED|Overall Study||150
873254|NCT02152007|2113123|P1|NOT COMPLETED|Overall Study||1
873255|NCT02152007|2113123|P1|COMPLETED|Overall Study||14
873256|NCT02152007|2113123|P1|STARTED|Overall Study||15
873257|NCT02151994|2113132|P13|NOT COMPLETED|Food Effect (FE): Fed||0
873258|NCT02151994|2113133|P12|NOT COMPLETED|Food Effect (FE): Fed||0
873259|NCT02151994|2113134|P11|NOT COMPLETED|Food Effect (FE): Fed||0
873260|NCT02151994|2113135|P10|NOT COMPLETED|Food Effect (FE): Fed||0
873261|NCT02151994|2113136|P9|NOT COMPLETED|Food Effect (FE): Fed||0
873262|NCT02151994|2113137|P8|NOT COMPLETED|Food Effect (FE): Fed||0
873263|NCT02151994|2113138|P7|NOT COMPLETED|Food Effect (FE): Fed||0
873264|NCT02151994|2113139|P6|NOT COMPLETED|Food Effect (FE): Fed||0
873265|NCT02151994|2113140|P5|NOT COMPLETED|Food Effect (FE): Fed||0
873266|NCT02151994|2113141|P4|NOT COMPLETED|Food Effect (FE): Fed||0
873267|NCT02151994|2113142|P3|NOT COMPLETED|Food Effect (FE): Fed||0
873268|NCT02151994|2113143|P2|NOT COMPLETED|Food Effect (FE): Fed||0
873269|NCT02151994|2113144|P1|NOT COMPLETED|Food Effect (FE): Fed||0
873270|NCT02151994|2113132|P13|COMPLETED|Food Effect (FE): Fed||12
873271|NCT02151994|2113133|P12|COMPLETED|Food Effect (FE): Fed||0
873272|NCT02151994|2113134|P11|COMPLETED|Food Effect (FE): Fed||0
873273|NCT02151994|2113135|P10|COMPLETED|Food Effect (FE): Fed||0
873274|NCT02151994|2113136|P9|COMPLETED|Food Effect (FE): Fed||0
873275|NCT02151994|2113137|P8|COMPLETED|Food Effect (FE): Fed||0
873276|NCT02151994|2113138|P7|COMPLETED|Food Effect (FE): Fed||0
873277|NCT02151994|2113139|P6|COMPLETED|Food Effect (FE): Fed||0
873278|NCT02151994|2113140|P5|COMPLETED|Food Effect (FE): Fed||0
873279|NCT02151994|2113141|P4|COMPLETED|Food Effect (FE): Fed||0
873280|NCT02151994|2113142|P3|COMPLETED|Food Effect (FE): Fed||0
873281|NCT02151994|2113143|P2|COMPLETED|Food Effect (FE): Fed||0
873282|NCT02151994|2113144|P1|COMPLETED|Food Effect (FE): Fed||0
873283|NCT02151994|2113132|P13|STARTED|Food Effect (FE): Fed||12
873284|NCT02151994|2113133|P12|STARTED|Food Effect (FE): Fed||0
873285|NCT02151994|2113134|P11|STARTED|Food Effect (FE): Fed||0
873286|NCT02151994|2113135|P10|STARTED|Food Effect (FE): Fed||0
873287|NCT02151994|2113136|P9|STARTED|Food Effect (FE): Fed||0
873288|NCT02151994|2113137|P8|STARTED|Food Effect (FE): Fed||0
873289|NCT02151994|2113138|P7|STARTED|Food Effect (FE): Fed||0
873290|NCT02151994|2113139|P6|STARTED|Food Effect (FE): Fed||0
873291|NCT02151994|2113140|P5|STARTED|Food Effect (FE): Fed||0
873292|NCT02151994|2113141|P4|STARTED|Food Effect (FE): Fed||0
873293|NCT02151994|2113142|P3|STARTED|Food Effect (FE): Fed||0
873294|NCT02151994|2113143|P2|STARTED|Food Effect (FE): Fed||0
873295|NCT02151994|2113144|P1|STARTED|Food Effect (FE): Fed||0
873296|NCT02151994|2113132|P13|NOT COMPLETED|Food Effect (FE): Fasted||0
873297|NCT02151994|2113133|P12|NOT COMPLETED|Food Effect (FE): Fasted||0
873298|NCT02151994|2113134|P11|NOT COMPLETED|Food Effect (FE): Fasted||0
873299|NCT02151994|2113135|P10|NOT COMPLETED|Food Effect (FE): Fasted||0
873300|NCT02151994|2113136|P9|NOT COMPLETED|Food Effect (FE): Fasted||0
873301|NCT02151994|2113137|P8|NOT COMPLETED|Food Effect (FE): Fasted||0
873302|NCT02151994|2113138|P7|NOT COMPLETED|Food Effect (FE): Fasted||0
873303|NCT02151994|2113139|P6|NOT COMPLETED|Food Effect (FE): Fasted||0
873304|NCT02151994|2113140|P5|NOT COMPLETED|Food Effect (FE): Fasted||0
873305|NCT02151994|2113141|P4|NOT COMPLETED|Food Effect (FE): Fasted||0
873306|NCT02151994|2113142|P3|NOT COMPLETED|Food Effect (FE): Fasted||0
873307|NCT02151994|2113143|P2|NOT COMPLETED|Food Effect (FE): Fasted||0
873308|NCT02151994|2113144|P1|NOT COMPLETED|Food Effect (FE): Fasted||0
873309|NCT02151994|2113132|P13|COMPLETED|Food Effect (FE): Fasted||0
873310|NCT02151994|2113133|P12|COMPLETED|Food Effect (FE): Fasted||12
873311|NCT02151994|2113134|P11|COMPLETED|Food Effect (FE): Fasted||0
873312|NCT02151994|2113135|P10|COMPLETED|Food Effect (FE): Fasted||0
873313|NCT02151994|2113136|P9|COMPLETED|Food Effect (FE): Fasted||0
873314|NCT02151994|2113137|P8|COMPLETED|Food Effect (FE): Fasted||0
873315|NCT02151994|2113138|P7|COMPLETED|Food Effect (FE): Fasted||0
873316|NCT02151994|2113139|P6|COMPLETED|Food Effect (FE): Fasted||0
873317|NCT02151994|2113140|P5|COMPLETED|Food Effect (FE): Fasted||0
873318|NCT02151994|2113141|P4|COMPLETED|Food Effect (FE): Fasted||0
873319|NCT02151994|2113142|P3|COMPLETED|Food Effect (FE): Fasted||0
873320|NCT02151994|2113143|P2|COMPLETED|Food Effect (FE): Fasted||0
873321|NCT02151994|2113144|P1|COMPLETED|Food Effect (FE): Fasted||0
873322|NCT02151994|2113132|P13|STARTED|Food Effect (FE): Fasted||0
873323|NCT02151994|2113133|P12|STARTED|Food Effect (FE): Fasted||12
873324|NCT02151994|2113134|P11|STARTED|Food Effect (FE): Fasted||0
873325|NCT02151994|2113135|P10|STARTED|Food Effect (FE): Fasted||0
873326|NCT02151994|2113136|P9|STARTED|Food Effect (FE): Fasted||0
873327|NCT02151994|2113137|P8|STARTED|Food Effect (FE): Fasted||0
873328|NCT02151994|2113138|P7|STARTED|Food Effect (FE): Fasted||0
873329|NCT02151994|2113139|P6|STARTED|Food Effect (FE): Fasted||0
873330|NCT02151994|2113140|P5|STARTED|Food Effect (FE): Fasted||0
873331|NCT02151994|2113141|P4|STARTED|Food Effect (FE): Fasted||0
873332|NCT02151994|2113142|P3|STARTED|Food Effect (FE): Fasted||0
873333|NCT02151994|2113143|P2|STARTED|Food Effect (FE): Fasted||0
873334|NCT02151994|2113144|P1|STARTED|Food Effect (FE): Fasted||0
873335|NCT02151994|2113132|P13|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
873336|NCT02151994|2113133|P12|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
873337|NCT02151994|2113134|P11|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
873338|NCT02151994|2113135|P10|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
873339|NCT02151994|2113136|P9|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
873340|NCT02151994|2113137|P8|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
873341|NCT02151994|2113138|P7|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
873342|NCT02151994|2113139|P6|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
873343|NCT02151994|2113140|P5|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
873344|NCT02151994|2113141|P4|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
873345|NCT02151994|2113142|P3|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
873346|NCT02151994|2113143|P2|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
873347|NCT02151994|2113144|P1|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
873348|NCT02151994|2113132|P13|COMPLETED|Multiple Ascending Dose (MAD)||0
873349|NCT02151994|2113133|P12|COMPLETED|Multiple Ascending Dose (MAD)||0
873350|NCT02151994|2113134|P11|COMPLETED|Multiple Ascending Dose (MAD)||0
873351|NCT02151994|2113135|P10|COMPLETED|Multiple Ascending Dose (MAD)||0
873352|NCT02151994|2113136|P9|COMPLETED|Multiple Ascending Dose (MAD)||6
873353|NCT02151994|2113137|P8|COMPLETED|Multiple Ascending Dose (MAD)||0
873354|NCT02151994|2113138|P7|COMPLETED|Multiple Ascending Dose (MAD)||6
873355|NCT02151994|2113139|P6|COMPLETED|Multiple Ascending Dose (MAD)||6
873356|NCT02151994|2113140|P5|COMPLETED|Multiple Ascending Dose (MAD)||6
873357|NCT02151994|2113141|P4|COMPLETED|Multiple Ascending Dose (MAD)||6
873358|NCT02151994|2113142|P3|COMPLETED|Multiple Ascending Dose (MAD)||0
873359|NCT02151994|2113143|P2|COMPLETED|Multiple Ascending Dose (MAD)||0
873360|NCT02151994|2113144|P1|COMPLETED|Multiple Ascending Dose (MAD)||10
873361|NCT02151994|2113132|P13|STARTED|Multiple Ascending Dose (MAD)||0
873362|NCT02151994|2113133|P12|STARTED|Multiple Ascending Dose (MAD)||0
873363|NCT02151994|2113134|P11|STARTED|Multiple Ascending Dose (MAD)||0
873364|NCT02151994|2113135|P10|STARTED|Multiple Ascending Dose (MAD)||0
873365|NCT02151994|2113136|P9|STARTED|Multiple Ascending Dose (MAD)||6
873366|NCT02151994|2113137|P8|STARTED|Multiple Ascending Dose (MAD)||0
873367|NCT02151994|2113138|P7|STARTED|Multiple Ascending Dose (MAD)||6
873368|NCT02151994|2113139|P6|STARTED|Multiple Ascending Dose (MAD)||6
873369|NCT02151994|2113140|P5|STARTED|Multiple Ascending Dose (MAD)||6
873370|NCT02151994|2113141|P4|STARTED|Multiple Ascending Dose (MAD)||6
873371|NCT02151994|2113142|P3|STARTED|Multiple Ascending Dose (MAD)||0
873372|NCT02151994|2113143|P2|STARTED|Multiple Ascending Dose (MAD)||0
873373|NCT02151994|2113144|P1|STARTED|Multiple Ascending Dose (MAD)||10
873374|NCT02151994|2113132|P13|NOT COMPLETED|Single Ascending Dose (SAD)||0
873375|NCT02151994|2113133|P12|NOT COMPLETED|Single Ascending Dose (SAD)||0
873376|NCT02151994|2113134|P11|NOT COMPLETED|Single Ascending Dose (SAD)||0
873377|NCT02151994|2113135|P10|NOT COMPLETED|Single Ascending Dose (SAD)||0
873378|NCT02151994|2113136|P9|NOT COMPLETED|Single Ascending Dose (SAD)||0
873379|NCT02151994|2113137|P8|NOT COMPLETED|Single Ascending Dose (SAD)||0
873380|NCT02151994|2113138|P7|NOT COMPLETED|Single Ascending Dose (SAD)||0
873381|NCT02151994|2113139|P6|NOT COMPLETED|Single Ascending Dose (SAD)||0
873382|NCT02151994|2113140|P5|NOT COMPLETED|Single Ascending Dose (SAD)||0
873383|NCT02151994|2113141|P4|NOT COMPLETED|Single Ascending Dose (SAD)||0
873384|NCT02151994|2113142|P3|NOT COMPLETED|Single Ascending Dose (SAD)||0
873385|NCT02151994|2113143|P2|NOT COMPLETED|Single Ascending Dose (SAD)||0
873386|NCT02151994|2113144|P1|NOT COMPLETED|Single Ascending Dose (SAD)||0
873387|NCT02151994|2113132|P13|COMPLETED|Single Ascending Dose (SAD)||0
873388|NCT02151994|2113133|P12|COMPLETED|Single Ascending Dose (SAD)||0
873389|NCT02151994|2113134|P11|COMPLETED|Single Ascending Dose (SAD)||6
873390|NCT02151994|2113135|P10|COMPLETED|Single Ascending Dose (SAD)||6
873391|NCT02151994|2113136|P9|COMPLETED|Single Ascending Dose (SAD)||0
873392|NCT02151994|2113137|P8|COMPLETED|Single Ascending Dose (SAD)||6
873393|NCT02151994|2113138|P7|COMPLETED|Single Ascending Dose (SAD)||6
873394|NCT02151994|2113139|P6|COMPLETED|Single Ascending Dose (SAD)||6
873395|NCT02151994|2113140|P5|COMPLETED|Single Ascending Dose (SAD)||6
873396|NCT02151994|2113141|P4|COMPLETED|Single Ascending Dose (SAD)||6
873397|NCT02151994|2113142|P3|COMPLETED|Single Ascending Dose (SAD)||6
873398|NCT02151994|2113143|P2|COMPLETED|Single Ascending Dose (SAD)||6
873399|NCT02151994|2113144|P1|COMPLETED|Single Ascending Dose (SAD)||18
873400|NCT02151994|2113132|P13|STARTED|Single Ascending Dose (SAD)||0
873401|NCT02151994|2113133|P12|STARTED|Single Ascending Dose (SAD)||0
873402|NCT02151994|2113134|P11|STARTED|Single Ascending Dose (SAD)||6
873403|NCT02151994|2113135|P10|STARTED|Single Ascending Dose (SAD)||6
873404|NCT02151994|2113136|P9|STARTED|Single Ascending Dose (SAD)||0
873405|NCT02151994|2113137|P8|STARTED|Single Ascending Dose (SAD)||6
873406|NCT02151994|2113138|P7|STARTED|Single Ascending Dose (SAD)||6
873407|NCT02151994|2113139|P6|STARTED|Single Ascending Dose (SAD)||6
873408|NCT02151994|2113140|P5|STARTED|Single Ascending Dose (SAD)||6
873409|NCT02151994|2113141|P4|STARTED|Single Ascending Dose (SAD)||6
873410|NCT02151994|2113142|P3|STARTED|Single Ascending Dose (SAD)||6
873411|NCT02151994|2113143|P2|STARTED|Single Ascending Dose (SAD)||6
873412|NCT02151994|2113144|P1|STARTED|Single Ascending Dose (SAD)||18
873413|NCT02151981|2113184|P2|NOT COMPLETED|Overall Study||140
873414|NCT02151981|2113185|P1|NOT COMPLETED|Overall Study||279
873415|NCT02151981|2113184|P2|COMPLETED|Overall Study||0
873416|NCT02151981|2113185|P1|COMPLETED|Overall Study||0
873417|NCT02151981|2113184|P2|Crossed Over AZD9291|Overall Study|Patients randomised to chemotherapy were allowed to crossover to AZD9291 after progression|82
873418|NCT02151981|2113185|P1|Crossed Over AZD9291|Overall Study||0
873419|NCT02151981|2113184|P2|Did Not Receive Treatment|Overall Study||4
873420|NCT02151981|2113185|P1|Did Not Receive Treatment|Overall Study||0
873421|NCT02151981|2113184|P2|Received Randomised Treatment Only|Overall Study||54
873422|NCT02151981|2113185|P1|Received Randomised Treatment Only|Overall Study||279
873423|NCT02151981|2113184|P2|STARTED|Overall Study||140
873424|NCT02151981|2113185|P1|STARTED|Overall Study||279
873425|NCT02151786|2113201|P1|NOT COMPLETED|Overall Study||36
873426|NCT02151786|2113201|P1|COMPLETED|Overall Study||1084
873427|NCT02151786|2113201|P1|STARTED|Overall Study||1120
873428|NCT02151773|2113212|P1|NOT COMPLETED|Overall Study||64
873429|NCT02151773|2113212|P1|COMPLETED|Overall Study||3429
873430|NCT02151773|2113212|P1|STARTED|Overall Study||3493
873431|NCT02151253|2113217|P2|NOT COMPLETED|Overall Study||0
873432|NCT02151253|2113218|P1|NOT COMPLETED|Overall Study||0
873433|NCT02151253|2113217|P2|COMPLETED|Overall Study||15
873434|NCT02151253|2113218|P1|COMPLETED|Overall Study||13
873435|NCT02151253|2113217|P2|STARTED|Overall Study||15
873436|NCT02151253|2113218|P1|STARTED|Overall Study||13
873437|NCT02151058|2113235|P3|NOT COMPLETED|Overall Study||5
873438|NCT02151058|2113236|P2|NOT COMPLETED|Overall Study||1
873439|NCT02151058|2113237|P1|NOT COMPLETED|Overall Study||2
873440|NCT02151058|2113235|P3|COMPLETED|Overall Study||86
873441|NCT02151058|2113236|P2|COMPLETED|Overall Study||90
873442|NCT02151058|2113237|P1|COMPLETED|Overall Study||43
873443|NCT02151058|2113235|P3|STARTED|Overall Study||91
873444|NCT02151058|2113236|P2|STARTED|Overall Study||91
873445|NCT02151058|2113237|P1|STARTED|Overall Study||45
873446|NCT02150954|2113271|P2|NOT COMPLETED|Overall Study||0
873447|NCT02150954|2113272|P1|NOT COMPLETED|Overall Study||1
873448|NCT02150954|2113271|P2|COMPLETED|Overall Study||59
873449|NCT02150954|2113272|P1|COMPLETED|Overall Study||57
873450|NCT02150954|2113271|P2|STARTED|Overall Study||59
873451|NCT02150954|2113272|P1|STARTED|Overall Study||58
873452|NCT02150499|2113296|P2|NOT COMPLETED|Overall Study||0
873453|NCT02150499|2113297|P1|NOT COMPLETED|Overall Study||0
873454|NCT02150499|2113296|P2|COMPLETED|Overall Study||9
873455|NCT02150499|2113297|P1|COMPLETED|Overall Study||9
873456|NCT02150499|2113296|P2|STARTED|Overall Study||9
873457|NCT02150499|2113297|P1|STARTED|Overall Study||9
873458|NCT02150460|2113319|P2|NOT COMPLETED|Overall Study||0
873459|NCT02150460|2113320|P1|NOT COMPLETED|Overall Study||0
873460|NCT02150460|2113319|P2|COMPLETED|Overall Study||50
873461|NCT02150460|2113320|P1|COMPLETED|Overall Study||50
873462|NCT02150460|2113319|P2|STARTED|Overall Study||50
873463|NCT02150460|2113320|P1|STARTED|Overall Study||50
873464|NCT02150213|2113344|P1|NOT COMPLETED|Overall Study||2
873465|NCT02150213|2113344|P1|COMPLETED|Overall Study||57
873466|NCT02150213|2113344|P1|STARTED|Overall Study||59
873467|NCT02150109|2113349|P1|NOT COMPLETED|Overall Study||0
873468|NCT02150109|2113349|P1|COMPLETED|Overall Study||372
873469|NCT02150109|2113349|P1|STARTED|Overall Study||372
873470|NCT02150044|2113361|P1|NOT COMPLETED|Overall Study||0
873471|NCT02150044|2113361|P1|COMPLETED|Overall Study||29
873472|NCT02150044|2113361|P1|Study Cohort|Overall Study||13
873473|NCT02150044|2113361|P1|Lead-In Subjects|Overall Study||16
873474|NCT02150044|2113361|P1|STARTED|Overall Study||29
873475|NCT02149875|2113370|P3|NOT COMPLETED|Overall Study||9
873476|NCT02149875|2113371|P2|NOT COMPLETED|Overall Study||8
873477|NCT02149875|2113372|P1|NOT COMPLETED|Overall Study||7
873478|NCT02149875|2113370|P3|COMPLETED|Overall Study||20
873479|NCT02149875|2113371|P2|COMPLETED|Overall Study||20
873480|NCT02149875|2113372|P1|COMPLETED|Overall Study||20
873481|NCT02149875|2113370|P3|STARTED|Overall Study||29
873482|NCT02149875|2113371|P2|STARTED|Overall Study||28
873483|NCT02149875|2113372|P1|STARTED|Overall Study||27
873484|NCT02149342|2113383|P1|NOT COMPLETED|Overall Study||0
873485|NCT02149342|2113383|P1|COMPLETED|Overall Study|14 patients|14
873486|NCT02149342|2113383|P1|STARTED|Overall Study|14 patients|14
873487|NCT02149303|2113395|P1|NOT COMPLETED|Overall Study||0
873488|NCT02149303|2113395|P1|COMPLETED|Overall Study||191
873489|NCT02149303|2113395|P1|STARTED|Overall Study||191
873493|NCT02149108|2113416|P2|NOT COMPLETED|Overall Study||383
873494|NCT02149108|2113417|P1|NOT COMPLETED|Overall Study||380
873495|NCT02149108|2113416|P2|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|3
873496|NCT02149108|2113417|P1|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|2
873497|NCT02149108|2113416|P2|STARTED|Overall Study|Randomised patients.|386
873498|NCT02149108|2113417|P1|STARTED|Overall Study|Randomised patients.|382
873499|NCT02148809|2113429|P1|NOT COMPLETED|Overall Study||0
873500|NCT02148809|2113429|P1|COMPLETED|Overall Study||14
873501|NCT02148809|2113429|P1|STARTED|Overall Study||14
873502|NCT02148718|2113434|P1|NOT COMPLETED|Overall Study||18
873503|NCT02148718|2113434|P1|COMPLETED|Overall Study||62
873504|NCT02148718|2113434|P1|STARTED|Overall Study||80
873505|NCT02148523|2113441|P3|NOT COMPLETED|Overall Study||0
873506|NCT02148523|2113442|P2|NOT COMPLETED|Overall Study||0
873507|NCT02148523|2113443|P1|NOT COMPLETED|Overall Study||0
873508|NCT02148523|2113441|P3|COMPLETED|Overall Study||67
873509|NCT02148523|2113442|P2|COMPLETED|Overall Study||67
873510|NCT02148523|2113443|P1|COMPLETED|Overall Study||67
873511|NCT02148523|2113441|P3|STARTED|Overall Study||67
873512|NCT02148523|2113442|P2|STARTED|Overall Study||67
873513|NCT02148523|2113443|P1|STARTED|Overall Study||67
873514|NCT02148445|2113456|P2|NOT COMPLETED|Overall Study||3
873515|NCT02148445|2113457|P1|NOT COMPLETED|Overall Study||1
873516|NCT02148445|2113456|P2|COMPLETED|Overall Study||197
873517|NCT02148445|2113457|P1|COMPLETED|Overall Study||197
873518|NCT02148445|2113456|P2|STARTED|Overall Study||200
873519|NCT02148445|2113457|P1|STARTED|Overall Study||198
873520|NCT02148107|2113496|P3|NOT COMPLETED|Overall Study||0
873521|NCT02148107|2113497|P2|NOT COMPLETED|Overall Study||0
873522|NCT02148107|2113498|P1|NOT COMPLETED|Overall Study||0
873523|NCT02148107|2113496|P3|COMPLETED|Overall Study||3
873524|NCT02148107|2113497|P2|COMPLETED|Overall Study||7
873525|NCT02148107|2113498|P1|COMPLETED|Overall Study||8
873526|NCT02148107|2113496|P3|STARTED|Overall Study||3
873527|NCT02148107|2113497|P2|STARTED|Overall Study||7
873528|NCT02148107|2113498|P1|STARTED|Overall Study||8
873529|NCT02147691|2113516|P2|NOT COMPLETED|Overall Study||1
873530|NCT02147691|2113517|P1|NOT COMPLETED|Overall Study||4
873531|NCT02147691|2113516|P2|COMPLETED|Overall Study||11
873532|NCT02147691|2113517|P1|COMPLETED|Overall Study||6
873533|NCT02147691|2113516|P2|STARTED|Overall Study||12
873534|NCT02147691|2113517|P1|STARTED|Overall Study||10
873535|NCT02147561|2113561|P1|NOT COMPLETED|Overall Study||4
873536|NCT02147561|2113561|P1|COMPLETED|Overall Study||276
873537|NCT02147561|2113561|P1|STARTED|Overall Study||280
873538|NCT02147522|2113569|P2|NOT COMPLETED|Overall Study||48
873539|NCT02147522|2113570|P1|NOT COMPLETED|Overall Study||56
873540|NCT02147522|2113569|P2|COMPLETED|Overall Study||122
873541|NCT02147522|2113570|P1|COMPLETED|Overall Study||122
873542|NCT02147522|2113569|P2|STARTED|Overall Study||170
873543|NCT02147522|2113570|P1|STARTED|Overall Study||178
873544|NCT02147288|2113582|P10|NOT COMPLETED|Overall Study||0
873545|NCT02147288|2113583|P9|NOT COMPLETED|Overall Study||0
873546|NCT02147288|2113584|P8|NOT COMPLETED|Overall Study||0
873547|NCT02147288|2113585|P7|NOT COMPLETED|Overall Study||0
873548|NCT02147288|2113586|P6|NOT COMPLETED|Overall Study||0
873549|NCT02147288|2113587|P5|NOT COMPLETED|Overall Study||0
873550|NCT02147288|2113588|P4|NOT COMPLETED|Overall Study||0
873551|NCT02147288|2113589|P3|NOT COMPLETED|Overall Study||0
873552|NCT02147288|2113590|P2|NOT COMPLETED|Overall Study||2
873553|NCT02147288|2113591|P1|NOT COMPLETED|Overall Study||1
873554|NCT02147288|2113582|P10|COMPLETED|Overall Study||0
873555|NCT02147288|2113583|P9|COMPLETED|Overall Study||0
873556|NCT02147288|2113584|P8|COMPLETED|Overall Study||0
873557|NCT02147288|2113585|P7|COMPLETED|Overall Study||0
873558|NCT02147288|2113586|P6|COMPLETED|Overall Study||0
873559|NCT02147288|2113587|P5|COMPLETED|Overall Study||0
873560|NCT02147288|2113588|P4|COMPLETED|Overall Study||0
873561|NCT02147288|2113589|P3|COMPLETED|Overall Study||0
873562|NCT02147288|2113590|P2|COMPLETED|Overall Study||22
873563|NCT02147288|2113591|P1|COMPLETED|Overall Study||21
873564|NCT02147288|2113582|P10|STARTED|Overall Study||0
873565|NCT02147288|2113583|P9|STARTED|Overall Study||0
873566|NCT02147288|2113584|P8|STARTED|Overall Study||0
873567|NCT02147288|2113585|P7|STARTED|Overall Study||0
873568|NCT02147288|2113586|P6|STARTED|Overall Study||0
873569|NCT02147288|2113587|P5|STARTED|Overall Study||0
873570|NCT02147288|2113588|P4|STARTED|Overall Study||0
873571|NCT02147288|2113589|P3|STARTED|Overall Study||0
873572|NCT02147288|2113590|P2|STARTED|Overall Study||24
873573|NCT02147288|2113591|P1|STARTED|Overall Study||22
873574|NCT02147093|2113599|P2|NOT COMPLETED|Period 2||0
873575|NCT02147093|2113600|P1|NOT COMPLETED|Period 2||2
873576|NCT02147093|2113599|P2|COMPLETED|Period 2||19
873577|NCT02147093|2113600|P1|COMPLETED|Period 2||18
873578|NCT02147093|2113599|P2|STARTED|Period 2||19
873579|NCT02147093|2113600|P1|STARTED|Period 2||20
873580|NCT02147093|2113599|P2|NOT COMPLETED|Period 1||1
873581|NCT02147093|2113600|P1|NOT COMPLETED|Period 1||0
873582|NCT02147093|2113599|P2|COMPLETED|Period 1||19
873583|NCT02147093|2113600|P1|COMPLETED|Period 1||20
873584|NCT02147093|2113599|P2|STARTED|Period 1||20
873585|NCT02147093|2113600|P1|STARTED|Period 1||20
873586|NCT02146599|2113608|P1|NOT COMPLETED|Overall Study||5
873587|NCT02146599|2113608|P1|COMPLETED|Overall Study||296
873588|NCT02146599|2113608|P1|STARTED|Overall Study||301
873589|NCT02146482|2113614|P2|NOT COMPLETED|Overall Study||0
873590|NCT02146482|2113615|P1|NOT COMPLETED|Overall Study||0
873591|NCT02146482|2113614|P2|COMPLETED|Overall Study||25
873592|NCT02146482|2113615|P1|COMPLETED|Overall Study||21
873593|NCT02146482|2113614|P2|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|25
873594|NCT02146482|2113615|P1|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|21
873595|NCT02146352|2113621|P1|NOT COMPLETED|Overall Study||2
873596|NCT02146352|2113621|P1|COMPLETED|Overall Study||28
873597|NCT02146352|2113621|P1|7 Days Post-stent Removal|Overall Study||28
873598|NCT02146352|2113621|P1|30 or 60 Days Post-procedure|Overall Study||30
873599|NCT02146352|2113621|P1|STARTED|Overall Study||30
873600|NCT02146326|2113639|P4|NOT COMPLETED|Overall Study||48
873601|NCT02146326|2113640|P3|NOT COMPLETED|Overall Study||43
873602|NCT02146326|2113641|P2|NOT COMPLETED|Overall Study||37
873603|NCT02146326|2113642|P1|NOT COMPLETED|Overall Study||28
873604|NCT02146326|2113639|P4|COMPLETED|Overall Study||210
873605|NCT02146326|2113640|P3|COMPLETED|Overall Study||168
873606|NCT02146326|2113641|P2|COMPLETED|Overall Study||66
873607|NCT02146326|2113642|P1|COMPLETED|Overall Study||61
873608|NCT02146326|2113639|P4|12 Months|Overall Study||210
873609|NCT02146326|2113640|P3|12 Months|Overall Study||168
873610|NCT02146326|2113641|P2|12 Months|Overall Study||66
873611|NCT02146326|2113642|P1|12 Months|Overall Study||61
873612|NCT02146326|2113639|P4|6 Months|Overall Study||235
873613|NCT02146326|2113640|P3|6 Months|Overall Study||186
873614|NCT02146326|2113641|P2|6 Months|Overall Study||71
873615|NCT02146326|2113642|P1|6 Months|Overall Study||71
873616|NCT02146326|2113639|P4|3 Months|Overall Study||0
873617|NCT02146326|2113640|P3|3 Months|Overall Study||0
873618|NCT02146326|2113641|P2|3 Months|Overall Study||83
873619|NCT02146326|2113642|P1|3 Months|Overall Study||71
873620|NCT02146326|2113639|P4|Baseline|Overall Study||258
873621|NCT02146326|2113640|P3|Baseline|Overall Study||211
873622|NCT02146326|2113641|P2|Baseline|Overall Study||103
873623|NCT02146326|2113642|P1|Baseline|Overall Study||89
873624|NCT02146326|2113639|P4|STARTED|Overall Study||258
873625|NCT02146326|2113640|P3|STARTED|Overall Study||211
873626|NCT02146326|2113641|P2|STARTED|Overall Study||103
873627|NCT02146326|2113642|P1|STARTED|Overall Study||89
873628|NCT02146248|2113804|P1|NOT COMPLETED|Overall Study||2
873629|NCT02146248|2113804|P1|COMPLETED|Overall Study||9
873630|NCT02146248|2113804|P1|HSG 5|Overall Study||1
873631|NCT02146248|2113804|P1|HSG 4|Overall Study||7
873632|NCT02146248|2113804|P1|HSG 3|Overall Study||9
873633|NCT02146248|2113804|P1|HSG 2|Overall Study||10
873634|NCT02146248|2113804|P1|HSG 1|Overall Study||10
873635|NCT02146248|2113804|P1|Uterine Sounding|Overall Study|one subject dropped out after uterine sound before HSG #1|11
873636|NCT02146248|2113804|P1|Enrolled|Overall Study||11
873637|NCT02146248|2113804|P1|STARTED|Overall Study||11
873638|NCT02146105|2113812|P1|NOT COMPLETED|Overall Study||6
873639|NCT02146105|2113812|P1|COMPLETED|Overall Study||39
873640|NCT02146105|2113812|P1|STARTED|Overall Study||45
873641|NCT02146001|2113818|P2|NOT COMPLETED|Overall Study||0
873642|NCT02146001|2113819|P1|NOT COMPLETED|Overall Study||0
873643|NCT02146001|2113818|P2|COMPLETED|Overall Study||19
873644|NCT02146001|2113819|P1|COMPLETED|Overall Study||19
873645|NCT02146001|2113818|P2|STARTED|Overall Study||19
873646|NCT02146001|2113819|P1|STARTED|Overall Study||19
873647|NCT02145754|2113829|P1|NOT COMPLETED|Overall Study||0
873648|NCT02145754|2113829|P1|COMPLETED|Overall Study||235
873649|NCT02145754|2113829|P1|STARTED|Overall Study||235
873650|NCT02145676|2113836|P3|NOT COMPLETED|Overall Study||0
873651|NCT02145676|2113837|P2|NOT COMPLETED|Overall Study||0
873652|NCT02145676|2113838|P1|NOT COMPLETED|Overall Study||0
873653|NCT02145676|2113836|P3|COMPLETED|Overall Study||18
873654|NCT02145676|2113837|P2|COMPLETED|Overall Study||18
873655|NCT02145676|2113838|P1|COMPLETED|Overall Study||17
873656|NCT02145676|2113836|P3|STARTED|Overall Study||18
873657|NCT02145676|2113837|P2|STARTED|Overall Study||18
873658|NCT02145676|2113838|P1|STARTED|Overall Study||17
873659|NCT02145468|2113863|P2|NOT COMPLETED|Overall Study||8
873660|NCT02145468|2113864|P1|NOT COMPLETED|Overall Study||5
873661|NCT02145468|2113863|P2|COMPLETED|Overall Study||1723
873662|NCT02145468|2113864|P1|COMPLETED|Overall Study||1753
873663|NCT02145468|2113863|P2|STARTED|Overall Study||1731
873664|NCT02145468|2113864|P1|STARTED|Overall Study||1758
873665|NCT02145299|2113922|P2|NOT COMPLETED|Overall Study||0
873666|NCT02145299|2113923|P1|NOT COMPLETED|Overall Study||0
873667|NCT02145299|2113922|P2|COMPLETED|Overall Study||2
873668|NCT02145299|2113923|P1|COMPLETED|Overall Study||6
873669|NCT02145299|2113922|P2|STARTED|Overall Study||2
873670|NCT02145299|2113923|P1|STARTED|Overall Study||6
873671|NCT02145156|2113952|P3|NOT COMPLETED|Overall Study||41
873672|NCT02145156|2113953|P2|NOT COMPLETED|Overall Study||52
873673|NCT02145156|2113954|P1|NOT COMPLETED|Overall Study||60
873674|NCT02145156|2113952|P3|COMPLETED|Overall Study||398
873675|NCT02145156|2113953|P2|COMPLETED|Overall Study||373
873676|NCT02145156|2113954|P1|COMPLETED|Overall Study||370
873677|NCT02145156|2113952|P3|STARTED|Overall Study||439
873678|NCT02145156|2113953|P2|STARTED|Overall Study||425
873679|NCT02145156|2113954|P1|STARTED|Overall Study||430
873680|NCT02144337|2113997|P2|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||0
873681|NCT02144337|2113998|P1|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||3
873682|NCT02144337|2113997|P2|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
873683|NCT02144337|2113998|P1|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
873684|NCT02144337|2113997|P2|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|5
873685|NCT02144337|2113998|P1|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|8
873686|NCT02144337|2113997|P2|NOT COMPLETED|T2 Follow-up (Post-intervention)||1
873687|NCT02144337|2113998|P1|NOT COMPLETED|T2 Follow-up (Post-intervention)||4
873688|NCT02144337|2113997|P2|COMPLETED|T2 Follow-up (Post-intervention)||4
873689|NCT02144337|2113998|P1|COMPLETED|T2 Follow-up (Post-intervention)||4
873690|NCT02144337|2113997|P2|STARTED|T2 Follow-up (Post-intervention)||5
873691|NCT02144337|2113998|P1|STARTED|T2 Follow-up (Post-intervention)||8
873692|NCT02144337|2113997|P2|NOT COMPLETED|Baseline 0 Months||0
873693|NCT02144337|2113998|P1|NOT COMPLETED|Baseline 0 Months||0
873694|NCT02144337|2113997|P2|COMPLETED|Baseline 0 Months||5
873695|NCT02144337|2113998|P1|COMPLETED|Baseline 0 Months||8
873696|NCT02144337|2113997|P2|STARTED|Baseline 0 Months||5
873697|NCT02144337|2113998|P1|STARTED|Baseline 0 Months||8
873698|NCT02144259|2114011|P3|NOT COMPLETED|Overall Study||18
873699|NCT02144259|2114012|P2|NOT COMPLETED|Overall Study||5
873700|NCT02144259|2114013|P1|NOT COMPLETED|Overall Study||10
873701|NCT02144259|2114011|P3|COMPLETED|Overall Study||16
873702|NCT02144259|2114012|P2|COMPLETED|Overall Study||28
873703|NCT02144259|2114013|P1|COMPLETED|Overall Study||23
873704|NCT02144259|2114011|P3|STARTED|Overall Study||34
873705|NCT02144259|2114012|P2|STARTED|Overall Study||33
873706|NCT02144259|2114013|P1|STARTED|Overall Study||33
873707|NCT02144220|2114027|P1|NOT COMPLETED|Overall Study||19
873708|NCT02144220|2114027|P1|COMPLETED|Overall Study||258
873709|NCT02144220|2114027|P1|STARTED|Overall Study||277
873710|NCT02144012|2114037|P2|NOT COMPLETED|Overall Study||15
873711|NCT02144012|2114038|P1|NOT COMPLETED|Overall Study||34
873712|NCT02144012|2114037|P2|COMPLETED|Overall Study||0
873713|NCT02144012|2114038|P1|COMPLETED|Overall Study||0
873714|NCT02144012|2114037|P2|STARTED|Overall Study||15
873715|NCT02144012|2114038|P1|STARTED|Overall Study||34
873716|NCT02143947|2114075|P2|NOT COMPLETED|Overall Study||2
873717|NCT02143947|2114076|P1|NOT COMPLETED|Overall Study||4
873718|NCT02143947|2114075|P2|COMPLETED|Overall Study||42
873719|NCT02143947|2114076|P1|COMPLETED|Overall Study||32
873720|NCT02143947|2114075|P2|STARTED|Overall Study||44
873721|NCT02143947|2114076|P1|STARTED|Overall Study||36
873722|NCT02143583|2114091|P3|NOT COMPLETED|Overall Study||2
873723|NCT02143583|2114092|P2|NOT COMPLETED|Overall Study||0
873724|NCT02143583|2114093|P1|NOT COMPLETED|Overall Study||1
873725|NCT02143583|2114091|P3|COMPLETED|Overall Study||66
873726|NCT02143583|2114092|P2|COMPLETED|Overall Study||66
873727|NCT02143583|2114093|P1|COMPLETED|Overall Study||61
873728|NCT02143583|2114091|P3|STARTED|Overall Study||68
873729|NCT02143583|2114092|P2|STARTED|Overall Study||66
873730|NCT02143583|2114093|P1|STARTED|Overall Study||62
873731|NCT02143141|2114106|P2|NOT COMPLETED|Overall Study||0
873732|NCT02143141|2114107|P1|NOT COMPLETED|Overall Study||1
873733|NCT02143141|2114106|P2|COMPLETED|Overall Study||6
873734|NCT02143141|2114107|P1|COMPLETED|Overall Study||6
873735|NCT02143141|2114106|P2|STARTED|Overall Study||6
873736|NCT02143141|2114107|P1|STARTED|Overall Study||7
873737|NCT02142738|2114119|P2|NOT COMPLETED|Overall Study||151
873738|NCT02142738|2114120|P1|NOT COMPLETED|Overall Study||154
873739|NCT02142738|2114119|P2|COMPLETED|Overall Study||0
873740|NCT02142738|2114120|P1|COMPLETED|Overall Study||0
873741|NCT02142738|2114119|P2|Treated|Overall Study||150
873742|NCT02142738|2114120|P1|Treated|Overall Study||154
873743|NCT02142738|2114119|P2|STARTED|Overall Study||151
873744|NCT02142738|2114120|P1|STARTED|Overall Study||154
873745|NCT02142712|2114133|P4|NOT COMPLETED|Overall Study||0
873746|NCT02142712|2114134|P3|NOT COMPLETED|Overall Study||1
873747|NCT02142712|2114135|P2|NOT COMPLETED|Overall Study||1
873748|NCT02142712|2114136|P1|NOT COMPLETED|Overall Study||1
873749|NCT02142712|2114133|P4|COMPLETED|Overall Study||0
873750|NCT02142712|2114134|P3|COMPLETED|Overall Study||0
873751|NCT02142712|2114135|P2|COMPLETED|Overall Study||0
873752|NCT02142712|2114136|P1|COMPLETED|Overall Study||0
873753|NCT02142712|2114133|P4|STARTED|Overall Study||0
873754|NCT02142712|2114134|P3|STARTED|Overall Study||1
873755|NCT02142712|2114135|P2|STARTED|Overall Study||1
873756|NCT02142712|2114136|P1|STARTED|Overall Study||1
873757|NCT02142504|2114159|P3|NOT COMPLETED|Overall Study||43
873758|NCT02142504|2114160|P2|NOT COMPLETED|Overall Study||42
873759|NCT02142504|2114161|P1|NOT COMPLETED|Overall Study||31
873760|NCT02142504|2114159|P3|COMPLETED|Overall Study||111
873761|NCT02142504|2114160|P2|COMPLETED|Overall Study||105
873762|NCT02142504|2114161|P1|COMPLETED|Overall Study||122
873763|NCT02142504|2114159|P3|Received Booster (Second Vaccination)|Overall Study||116
873764|NCT02142504|2114160|P2|Received Booster (Second Vaccination)|Overall Study||109
873765|NCT02142504|2114161|P1|Received Booster (Second Vaccination)|Overall Study||126
873766|NCT02142504|2114159|P3|Randomized and Received Treatment|Overall Study||154
873767|NCT02142504|2114160|P2|Randomized and Received Treatment|Overall Study||145
873768|NCT02142504|2114161|P1|Randomized and Received Treatment|Overall Study||153
873769|NCT02142504|2114159|P3|STARTED|Overall Study||154
873770|NCT02142504|2114160|P2|STARTED|Overall Study||147
873771|NCT02142504|2114161|P1|STARTED|Overall Study||153
873772|NCT02142361|2114247|P3|NOT COMPLETED|Overall Study||0
873773|NCT02142361|2114248|P2|NOT COMPLETED|Overall Study||0
873774|NCT02142361|2114249|P1|NOT COMPLETED|Overall Study||0
873775|NCT02142361|2114247|P3|COMPLETED|Overall Study||20
873776|NCT02142361|2114248|P2|COMPLETED|Overall Study||20
873777|NCT02142361|2114249|P1|COMPLETED|Overall Study||20
873778|NCT02142361|2114247|P3|STARTED|Overall Study||20
873779|NCT02142361|2114248|P2|STARTED|Overall Study||20
873780|NCT02142361|2114249|P1|STARTED|Overall Study||20
873781|NCT02142153|2114358|P10|NOT COMPLETED|Overall Study||0
873782|NCT02142153|2114359|P9|NOT COMPLETED|Overall Study||0
873783|NCT02142153|2114360|P8|NOT COMPLETED|Overall Study||0
873784|NCT02142153|2114361|P7|NOT COMPLETED|Overall Study||0
873785|NCT02142153|2114362|P6|NOT COMPLETED|Overall Study||0
873786|NCT02142153|2114363|P5|NOT COMPLETED|Overall Study||0
873787|NCT02142153|2114364|P4|NOT COMPLETED|Overall Study||0
873788|NCT02142153|2114365|P3|NOT COMPLETED|Overall Study||0
873789|NCT02142153|2114366|P2|NOT COMPLETED|Overall Study||0
873790|NCT02142153|2114367|P1|NOT COMPLETED|Overall Study||0
873791|NCT02142153|2114358|P10|COMPLETED|Overall Study||2
873792|NCT02142153|2114359|P9|COMPLETED|Overall Study||6
873793|NCT02142153|2114360|P8|COMPLETED|Overall Study||2
873794|NCT02142153|2114361|P7|COMPLETED|Overall Study||6
873795|NCT02142153|2114362|P6|COMPLETED|Overall Study||2
873796|NCT02142153|2114363|P5|COMPLETED|Overall Study||6
873797|NCT02142153|2114364|P4|COMPLETED|Overall Study||2
873798|NCT02142153|2114365|P3|COMPLETED|Overall Study||6
873799|NCT02142153|2114366|P2|COMPLETED|Overall Study||2
873800|NCT02142153|2114367|P1|COMPLETED|Overall Study||6
873801|NCT02142153|2114358|P10|STARTED|Overall Study||2
873802|NCT02142153|2114359|P9|STARTED|Overall Study||6
873803|NCT02142153|2114360|P8|STARTED|Overall Study||2
873804|NCT02142153|2114361|P7|STARTED|Overall Study||6
873805|NCT02142153|2114362|P6|STARTED|Overall Study||2
873806|NCT02142153|2114363|P5|STARTED|Overall Study||6
873807|NCT02142153|2114364|P4|STARTED|Overall Study||2
873808|NCT02142153|2114365|P3|STARTED|Overall Study||6
873809|NCT02142153|2114366|P2|STARTED|Overall Study||2
873810|NCT02142153|2114367|P1|STARTED|Overall Study||6
873811|NCT02141997|2114403|P4|NOT COMPLETED|Overall Study||1
873812|NCT02141997|2114404|P3|NOT COMPLETED|Overall Study||3
873813|NCT02141997|2114405|P2|NOT COMPLETED|Overall Study||6
873814|NCT02141997|2114406|P1|NOT COMPLETED|Overall Study||3
873815|NCT02141997|2114403|P4|COMPLETED|Overall Study||54
873816|NCT02141997|2114404|P3|COMPLETED|Overall Study||53
873817|NCT02141997|2114405|P2|COMPLETED|Overall Study||49
873818|NCT02141997|2114406|P1|COMPLETED|Overall Study||53
873819|NCT02141997|2114403|P4|STARTED|Overall Study||55
873820|NCT02141997|2114404|P3|STARTED|Overall Study||56
873821|NCT02141997|2114405|P2|STARTED|Overall Study||55
873822|NCT02141997|2114406|P1|STARTED|Overall Study||56
873823|NCT02141984|2114444|P1|NOT COMPLETED|Overall Study||2
873824|NCT02141984|2114444|P1|COMPLETED|Overall Study||26
873825|NCT02141984|2114444|P1|STARTED|Overall Study||28
873826|NCT02141867|2114451|P1|NOT COMPLETED|Overall Study||94
873827|NCT02141867|2114451|P1|COMPLETED|Overall Study||3927
873828|NCT02141867|2114451|P1|STARTED|Overall Study||4021
873829|NCT02141854|2114463|P6|NOT COMPLETED|Treatment Period||38
873830|NCT02141854|2114464|P5|NOT COMPLETED|Treatment Period||10
873831|NCT02141854|2114465|P4|NOT COMPLETED|Treatment Period||11
873832|NCT02141854|2114466|P3|NOT COMPLETED|Treatment Period||9
873833|NCT02141854|2114467|P2|NOT COMPLETED|Treatment Period||10
873834|NCT02141854|2114468|P1|NOT COMPLETED|Treatment Period||0
873835|NCT02141854|2114463|P6|COMPLETED|Treatment Period||107
873836|NCT02141854|2114464|P5|COMPLETED|Treatment Period||136
873837|NCT02141854|2114465|P4|COMPLETED|Treatment Period||135
873838|NCT02141854|2114466|P3|COMPLETED|Treatment Period||136
873839|NCT02141854|2114467|P2|COMPLETED|Treatment Period||136
873840|NCT02141854|2114468|P1|COMPLETED|Treatment Period||0
873841|NCT02141854|2114463|P6|Full Analysis Set|Treatment Period||143
873842|NCT02141854|2114464|P5|Full Analysis Set|Treatment Period||145
873843|NCT02141854|2114465|P4|Full Analysis Set|Treatment Period||146
873844|NCT02141854|2114466|P3|Full Analysis Set|Treatment Period||141
873845|NCT02141854|2114467|P2|Full Analysis Set|Treatment Period||145
873846|NCT02141854|2114468|P1|Full Analysis Set|Treatment Period||0
873847|NCT02141854|2114463|P6|Safety Population|Treatment Period||144
873848|NCT02141854|2114464|P5|Safety Population|Treatment Period||145
873849|NCT02141854|2114465|P4|Safety Population|Treatment Period||146
873850|NCT02141854|2114466|P3|Safety Population|Treatment Period||143
873851|NCT02141854|2114467|P2|Safety Population|Treatment Period||145
873852|NCT02141854|2114468|P1|Safety Population|Treatment Period||0
873853|NCT02141854|2114463|P6|Intent to Treat Population|Treatment Period||145
873854|NCT02141854|2114464|P5|Intent to Treat Population|Treatment Period||146
873855|NCT02141854|2114465|P4|Intent to Treat Population|Treatment Period||146
873856|NCT02141854|2114466|P3|Intent to Treat Population|Treatment Period||145
873857|NCT02141854|2114467|P2|Intent to Treat Population|Treatment Period||146
873858|NCT02141854|2114468|P1|Intent to Treat Population|Treatment Period||0
873859|NCT02141854|2114463|P6|STARTED|Treatment Period||145
873860|NCT02141854|2114464|P5|STARTED|Treatment Period||146
873861|NCT02141854|2114465|P4|STARTED|Treatment Period||146
873862|NCT02141854|2114466|P3|STARTED|Treatment Period||145
873863|NCT02141854|2114467|P2|STARTED|Treatment Period||146
873864|NCT02141854|2114468|P1|STARTED|Treatment Period||0
873865|NCT02141854|2114463|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
873866|NCT02141854|2114464|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
873867|NCT02141854|2114465|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
873868|NCT02141854|2114466|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
873869|NCT02141854|2114467|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
873870|NCT02141854|2114468|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||154
873871|NCT02141854|2114463|P6|COMPLETED|Run-In Period (Pre-assignment)||0
873872|NCT02141854|2114464|P5|COMPLETED|Run-In Period (Pre-assignment)||0
873873|NCT02141854|2114465|P4|COMPLETED|Run-In Period (Pre-assignment)||0
873874|NCT02141854|2114466|P3|COMPLETED|Run-In Period (Pre-assignment)||0
873875|NCT02141854|2114467|P2|COMPLETED|Run-In Period (Pre-assignment)||0
873876|NCT02141854|2114468|P1|COMPLETED|Run-In Period (Pre-assignment)||728
873877|NCT02141854|2114463|P6|STARTED|Run-In Period (Pre-assignment)||0
873878|NCT02141854|2114464|P5|STARTED|Run-In Period (Pre-assignment)||0
873879|NCT02141854|2114465|P4|STARTED|Run-In Period (Pre-assignment)||0
873880|NCT02141854|2114466|P3|STARTED|Run-In Period (Pre-assignment)||0
873881|NCT02141854|2114467|P2|STARTED|Run-In Period (Pre-assignment)||0
873882|NCT02141854|2114468|P1|STARTED|Run-In Period (Pre-assignment)||882
873883|NCT02141633|2114522|P2|NOT COMPLETED|Overall Study||0
873884|NCT02141633|2114523|P1|NOT COMPLETED|Overall Study||1
873885|NCT02141633|2114522|P2|COMPLETED|Overall Study||15
873886|NCT02141633|2114523|P1|COMPLETED|Overall Study||15
873887|NCT02141633|2114522|P2|STARTED|Overall Study||15
873888|NCT02141633|2114523|P1|STARTED|Overall Study||16
873889|NCT02141620|2114531|P2|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
873890|NCT02141620|2114532|P1|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
873891|NCT02141620|2114531|P2|COMPLETED|Treatment Condition 2 (7 Days)||7
873892|NCT02141620|2114532|P1|COMPLETED|Treatment Condition 2 (7 Days)||7
873893|NCT02141620|2114531|P2|STARTED|Treatment Condition 2 (7 Days)||7
873894|NCT02141620|2114532|P1|STARTED|Treatment Condition 2 (7 Days)||7
873895|NCT02141620|2114531|P2|NOT COMPLETED|Treatment Condition 1 (7 Days)||0
873896|NCT02141620|2114532|P1|NOT COMPLETED|Treatment Condition 1 (7 Days)||1
873897|NCT02141620|2114531|P2|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to placebo for Condition 2.|7
873898|NCT02141620|2114532|P1|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to n-acetylcysteine for Condition 2.|7
873899|NCT02141620|2114531|P2|STARTED|Treatment Condition 1 (7 Days)||7
873900|NCT02141620|2114532|P1|STARTED|Treatment Condition 1 (7 Days)||8
873901|NCT02141581|2114593|P3|NOT COMPLETED|Overall Study||0
873902|NCT02141581|2114594|P2|NOT COMPLETED|Overall Study||0
873903|NCT02141581|2114595|P1|NOT COMPLETED|Overall Study||0
873904|NCT02141581|2114593|P3|COMPLETED|Overall Study||25
873905|NCT02141581|2114594|P2|COMPLETED|Overall Study||19
873906|NCT02141581|2114595|P1|COMPLETED|Overall Study||42
873907|NCT02141581|2114593|P3|STARTED|Overall Study||25
873908|NCT02141581|2114594|P2|STARTED|Overall Study||19
873909|NCT02141581|2114595|P1|STARTED|Overall Study||42
873910|NCT02141516|2114609|P3|NOT COMPLETED|Overall Study||0
873911|NCT02141516|2114610|P2|NOT COMPLETED|Overall Study||5
873912|NCT02141516|2114611|P1|NOT COMPLETED|Overall Study||0
873913|NCT02141516|2114609|P3|COMPLETED|Overall Study||87
873914|NCT02141516|2114610|P2|COMPLETED|Overall Study||107
873915|NCT02141516|2114611|P1|COMPLETED|Overall Study||40
873916|NCT02141516|2114609|P3|STARTED|Overall Study||87
873917|NCT02141516|2114610|P2|STARTED|Overall Study||112
873918|NCT02141516|2114611|P1|STARTED|Overall Study||40
873919|NCT02141360|2114661|P3|NOT COMPLETED|Overall Study||0
873920|NCT02141360|2114662|P2|NOT COMPLETED|Overall Study||0
873921|NCT02141360|2114663|P1|NOT COMPLETED|Overall Study||7
873922|NCT02141360|2114661|P3|COMPLETED|Overall Study||6
873923|NCT02141360|2114662|P2|COMPLETED|Overall Study||6
873924|NCT02141360|2114663|P1|COMPLETED|Overall Study||4
873925|NCT02141360|2114661|P3|STARTED|Overall Study||6
873926|NCT02141360|2114662|P2|STARTED|Overall Study||6
873927|NCT02141360|2114663|P1|STARTED|Overall Study||11
873928|NCT02141217|2114673|P2|NOT COMPLETED|Overall Study||8
873929|NCT02141217|2114674|P1|NOT COMPLETED|Overall Study||11
873930|NCT02141217|2114673|P2|COMPLETED|Overall Study||229
873931|NCT02141217|2114674|P1|COMPLETED|Overall Study||223
873932|NCT02141217|2114673|P2|ITT Population-Actual Treatment Received|Overall Study||235
873933|NCT02141217|2114674|P1|ITT Population-Actual Treatment Received|Overall Study||236
873934|NCT02141217|2114673|P2|ITT Population-Randomized Treatment Arm|Overall Study||237
873935|NCT02141217|2114674|P1|ITT Population-Randomized Treatment Arm|Overall Study||234
873936|NCT02141217|2114673|P2|STARTED|Overall Study||237
873937|NCT02141217|2114674|P1|STARTED|Overall Study||234
873938|NCT02140957|2114694|P2|NOT COMPLETED|Overall Study||23
873939|NCT02140957|2114695|P1|NOT COMPLETED|Overall Study||27
873940|NCT02140957|2114694|P2|COMPLETED|Overall Study||99
873941|NCT02140957|2114695|P1|COMPLETED|Overall Study||102
873942|NCT02140957|2114694|P2|STARTED|Overall Study||122
873943|NCT02140957|2114695|P1|STARTED|Overall Study||129
873944|NCT02140788|2114705|P4|NOT COMPLETED|Overall Study||0
873945|NCT02140788|2114706|P3|NOT COMPLETED|Overall Study||0
873946|NCT02140788|2114707|P2|NOT COMPLETED|Overall Study||0
873947|NCT02140788|2114708|P1|NOT COMPLETED|Overall Study||0
873948|NCT02140788|2114705|P4|COMPLETED|Overall Study||0
873949|NCT02140788|2114706|P3|COMPLETED|Overall Study||0
873950|NCT02140788|2114707|P2|COMPLETED|Overall Study||0
873951|NCT02140788|2114708|P1|COMPLETED|Overall Study||0
873952|NCT02140788|2114705|P4|STARTED|Overall Study||0
873953|NCT02140788|2114706|P3|STARTED|Overall Study||0
873954|NCT02140788|2114707|P2|STARTED|Overall Study||0
873955|NCT02140788|2114708|P1|STARTED|Overall Study||0
873956|NCT02140645|2114740|P6|NOT COMPLETED|Overall Study||70896
873957|NCT02140645|2114741|P5|NOT COMPLETED|Overall Study||3286
873958|NCT02140645|2114742|P4|NOT COMPLETED|Overall Study||13833
873959|NCT02140645|2114743|P3|NOT COMPLETED|Overall Study||4236
873960|NCT02140645|2114744|P2|NOT COMPLETED|Overall Study||61654
873961|NCT02140645|2114745|P1|NOT COMPLETED|Overall Study||5489
873962|NCT02140645|2114740|P6|COMPLETED|Overall Study||3050
873963|NCT02140645|2114741|P5|COMPLETED|Overall Study||150
873964|NCT02140645|2114742|P4|COMPLETED|Overall Study||530
873965|NCT02140645|2114743|P3|COMPLETED|Overall Study||205
873966|NCT02140645|2114744|P2|COMPLETED|Overall Study||3041
873967|NCT02140645|2114745|P1|COMPLETED|Overall Study||243
873968|NCT02140645|2114740|P6|STARTED|Overall Study||73946
873969|NCT02140645|2114741|P5|STARTED|Overall Study||3436
873970|NCT02140645|2114742|P4|STARTED|Overall Study||14363
873971|NCT02140645|2114743|P3|STARTED|Overall Study||4441
873972|NCT02140645|2114744|P2|STARTED|Overall Study||64695
873973|NCT02140645|2114745|P1|STARTED|Overall Study||5732
873974|NCT02140593|2114834|P2|NOT COMPLETED|Overall Study||0
873975|NCT02140593|2114835|P1|NOT COMPLETED|Overall Study||0
873976|NCT02140593|2114834|P2|COMPLETED|Overall Study||65
873977|NCT02140593|2114835|P1|COMPLETED|Overall Study||63
873978|NCT02140593|2114834|P2|STARTED|Overall Study||65
873979|NCT02140593|2114835|P1|STARTED|Overall Study||63
873980|NCT02140372|2114843|P1|NOT COMPLETED|Overall Study||0
873981|NCT02140372|2114843|P1|COMPLETED|Overall Study||10
873982|NCT02140372|2114843|P1|STARTED|Overall Study||10
873983|NCT02140164|2114854|P1|NOT COMPLETED|Overall Study||2
873984|NCT02140164|2114854|P1|COMPLETED|Overall Study||5
873985|NCT02140164|2114854|P1|STARTED|Overall Study||7
873986|NCT02140060|2114871|P6|NOT COMPLETED|Overall Study||1
873987|NCT02140060|2114872|P5|NOT COMPLETED|Overall Study||1
873988|NCT02140060|2114873|P4|NOT COMPLETED|Overall Study||2
873989|NCT02140060|2114874|P3|NOT COMPLETED|Overall Study||0
873990|NCT02140060|2114875|P2|NOT COMPLETED|Overall Study||0
873991|NCT02140060|2114876|P1|NOT COMPLETED|Overall Study||0
873992|NCT02140060|2114871|P6|COMPLETED|Overall Study||43
873993|NCT02140060|2114872|P5|COMPLETED|Overall Study||44
873994|NCT02140060|2114873|P4|COMPLETED|Overall Study||43
873995|NCT02140060|2114874|P3|COMPLETED|Overall Study||44
873996|NCT02140060|2114875|P2|COMPLETED|Overall Study||44
873997|NCT02140060|2114876|P1|COMPLETED|Overall Study||44
873998|NCT02140060|2114871|P6|STARTED|Overall Study||44
873999|NCT02140060|2114872|P5|STARTED|Overall Study||45
874000|NCT02140060|2114873|P4|STARTED|Overall Study||45
874001|NCT02140060|2114874|P3|STARTED|Overall Study||44
874002|NCT02140060|2114875|P2|STARTED|Overall Study||44
874003|NCT02140060|2114876|P1|STARTED|Overall Study||44
874004|NCT02139982|2114901|P10|NOT COMPLETED|Overall Study||0
874005|NCT02139982|2114902|P9|NOT COMPLETED|Overall Study||0
874006|NCT02139982|2114903|P8|NOT COMPLETED|Overall Study||0
874007|NCT02139982|2114904|P7|NOT COMPLETED|Overall Study||0
874008|NCT02139982|2114905|P6|NOT COMPLETED|Overall Study||0
874009|NCT02139982|2114906|P5|NOT COMPLETED|Overall Study||0
874010|NCT02139982|2114907|P4|NOT COMPLETED|Overall Study||1
874011|NCT02139982|2114908|P3|NOT COMPLETED|Overall Study||0
874012|NCT02139982|2114909|P2|NOT COMPLETED|Overall Study||1
874013|NCT02139982|2114910|P1|NOT COMPLETED|Overall Study||0
874014|NCT02139982|2114901|P10|COMPLETED|Overall Study||13
874015|NCT02139982|2114902|P9|COMPLETED|Overall Study||13
874016|NCT02139982|2114903|P8|COMPLETED|Overall Study||13
874017|NCT02139982|2114904|P7|COMPLETED|Overall Study||13
874018|NCT02139982|2114905|P6|COMPLETED|Overall Study||13
874019|NCT02139982|2114906|P5|COMPLETED|Overall Study||13
874020|NCT02139982|2114907|P4|COMPLETED|Overall Study||7
874021|NCT02139982|2114908|P3|COMPLETED|Overall Study||8
874022|NCT02139982|2114909|P2|COMPLETED|Overall Study||7
874023|NCT02139982|2114910|P1|COMPLETED|Overall Study||8
874024|NCT02139982|2114901|P10|STARTED|Overall Study||13
874025|NCT02139982|2114902|P9|STARTED|Overall Study||13
874026|NCT02139982|2114903|P8|STARTED|Overall Study||13
874027|NCT02139982|2114904|P7|STARTED|Overall Study||13
874028|NCT02139982|2114905|P6|STARTED|Overall Study||13
874029|NCT02139982|2114906|P5|STARTED|Overall Study||13
874030|NCT02139982|2114907|P4|STARTED|Overall Study||8
874031|NCT02139982|2114908|P3|STARTED|Overall Study||8
874032|NCT02139982|2114909|P2|STARTED|Overall Study||8
874033|NCT02139982|2114910|P1|STARTED|Overall Study||8
874034|NCT02139943|2114955|P3|NOT COMPLETED|Overall Study||7
874035|NCT02139943|2114956|P2|NOT COMPLETED|Overall Study||6
874036|NCT02139943|2114957|P1|NOT COMPLETED|Overall Study||10
874037|NCT02139943|2114955|P3|COMPLETED|Overall Study||110
874038|NCT02139943|2114956|P2|COMPLETED|Overall Study||111
874039|NCT02139943|2114957|P1|COMPLETED|Overall Study||107
874040|NCT02139943|2114955|P3|STARTED|Overall Study||117
874041|NCT02139943|2114956|P2|STARTED|Overall Study||117
874042|NCT02139943|2114957|P1|STARTED|Overall Study||117
874043|NCT02139878|2114968|P2|NOT COMPLETED|Second Intervention (7 Days)||0
874044|NCT02139878|2114969|P1|NOT COMPLETED|Second Intervention (7 Days)||0
874045|NCT02139878|2114968|P2|COMPLETED|Second Intervention (7 Days)||10
874046|NCT02139878|2114969|P1|COMPLETED|Second Intervention (7 Days)||9
874047|NCT02139878|2114968|P2|STARTED|Second Intervention (7 Days)||10
874048|NCT02139878|2114969|P1|STARTED|Second Intervention (7 Days)||9
874049|NCT02139878|2114968|P2|NOT COMPLETED|Washout Period (8 Days)||0
874050|NCT02139878|2114969|P1|NOT COMPLETED|Washout Period (8 Days)||0
874051|NCT02139878|2114968|P2|COMPLETED|Washout Period (8 Days)||10
874052|NCT02139878|2114969|P1|COMPLETED|Washout Period (8 Days)||9
874053|NCT02139878|2114968|P2|STARTED|Washout Period (8 Days)||10
874054|NCT02139878|2114969|P1|STARTED|Washout Period (8 Days)||9
874055|NCT02139878|2114968|P2|NOT COMPLETED|First Intervention (7 Days)||0
874056|NCT02139878|2114969|P1|NOT COMPLETED|First Intervention (7 Days)||1
874057|NCT02139878|2114968|P2|COMPLETED|First Intervention (7 Days)||10
874058|NCT02139878|2114969|P1|COMPLETED|First Intervention (7 Days)||9
874059|NCT02139878|2114968|P2|STARTED|First Intervention (7 Days)||10
874060|NCT02139878|2114969|P1|STARTED|First Intervention (7 Days)||10
874061|NCT02139644|2114982|P6|NOT COMPLETED|Treatment Period||17
874062|NCT02139644|2114983|P5|NOT COMPLETED|Treatment Period||8
874063|NCT02139644|2114984|P4|NOT COMPLETED|Treatment Period||9
874064|NCT02139644|2114985|P3|NOT COMPLETED|Treatment Period||8
874065|NCT02139644|2114986|P2|NOT COMPLETED|Treatment Period||3
874066|NCT02139644|2114987|P1|NOT COMPLETED|Treatment Period||0
874067|NCT02139644|2114982|P6|COMPLETED|Treatment Period||113
874068|NCT02139644|2114983|P5|COMPLETED|Treatment Period||121
874069|NCT02139644|2114984|P4|COMPLETED|Treatment Period||121
874070|NCT02139644|2114985|P3|COMPLETED|Treatment Period||121
874071|NCT02139644|2114986|P2|COMPLETED|Treatment Period||126
874072|NCT02139644|2114987|P1|COMPLETED|Treatment Period||0
874073|NCT02139644|2114982|P6|STARTED|Treatment Period|Randomized|130
874074|NCT02139644|2114983|P5|STARTED|Treatment Period|Randomized|129
874075|NCT02139644|2114984|P4|STARTED|Treatment Period|Randomized|130
874076|NCT02139644|2114985|P3|STARTED|Treatment Period|Randomized|129
874077|NCT02139644|2114986|P2|STARTED|Treatment Period|Randomized|129
874078|NCT02139644|2114987|P1|STARTED|Treatment Period||0
874079|NCT02139644|2114982|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
874080|NCT02139644|2114983|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
874081|NCT02139644|2114984|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
874082|NCT02139644|2114985|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
874083|NCT02139644|2114986|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
874084|NCT02139644|2114987|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||140
874085|NCT02139644|2114982|P6|COMPLETED|Run-In Period (Pre-assignment)||0
874086|NCT02139644|2114983|P5|COMPLETED|Run-In Period (Pre-assignment)||0
874087|NCT02139644|2114984|P4|COMPLETED|Run-In Period (Pre-assignment)||0
874088|NCT02139644|2114985|P3|COMPLETED|Run-In Period (Pre-assignment)||0
874089|NCT02139644|2114986|P2|COMPLETED|Run-In Period (Pre-assignment)||0
874090|NCT02139644|2114987|P1|COMPLETED|Run-In Period (Pre-assignment)||647
874091|NCT02139644|2114982|P6|STARTED|Run-In Period (Pre-assignment)||0
874092|NCT02139644|2114983|P5|STARTED|Run-In Period (Pre-assignment)||0
874093|NCT02139644|2114984|P4|STARTED|Run-In Period (Pre-assignment)||0
874094|NCT02139644|2114985|P3|STARTED|Run-In Period (Pre-assignment)||0
874095|NCT02139644|2114986|P2|STARTED|Run-In Period (Pre-assignment)||0
874096|NCT02139644|2114987|P1|STARTED|Run-In Period (Pre-assignment)|Enrolled|787
874097|NCT02139228|2115041|P2|NOT COMPLETED|Overall Study||0
874098|NCT02139228|2115042|P1|NOT COMPLETED|Overall Study||0
874099|NCT02139228|2115041|P2|COMPLETED|Overall Study||211
874100|NCT02139228|2115042|P1|COMPLETED|Overall Study||215
874101|NCT02139228|2115041|P2|STARTED|Overall Study||211
874102|NCT02139228|2115042|P1|STARTED|Overall Study||215
874103|NCT02139176|2115052|P2|NOT COMPLETED|Overall Study||0
874104|NCT02139176|2115053|P1|NOT COMPLETED|Overall Study||0
874105|NCT02139176|2115052|P2|COMPLETED|Overall Study||100
874106|NCT02139176|2115053|P1|COMPLETED|Overall Study||100
874107|NCT02139176|2115052|P2|STARTED|Overall Study||100
874108|NCT02139176|2115053|P1|STARTED|Overall Study||100
874109|NCT02139137|2115065|P2|NOT COMPLETED|Overall Study||10
874110|NCT02139137|2115066|P1|NOT COMPLETED|Overall Study||7
874111|NCT02139137|2115065|P2|COMPLETED|Overall Study||10
874112|NCT02139137|2115066|P1|COMPLETED|Overall Study||15
874113|NCT02139137|2115065|P2|STARTED|Overall Study||20
874114|NCT02139137|2115066|P1|STARTED|Overall Study||22
874115|NCT02139046|2115085|P5|NOT COMPLETED|Overall Study||57
874116|NCT02139046|2115086|P4|NOT COMPLETED|Overall Study||68
874117|NCT02139046|2115087|P3|NOT COMPLETED|Overall Study||59
874118|NCT02139046|2115088|P2|NOT COMPLETED|Overall Study||54
874119|NCT02139046|2115089|P1|NOT COMPLETED|Overall Study||62
874120|NCT02139046|2115085|P5|COMPLETED|Overall Study||301
874121|NCT02139046|2115086|P4|COMPLETED|Overall Study||290
874122|NCT02139046|2115087|P3|COMPLETED|Overall Study||298
874123|NCT02139046|2115088|P2|COMPLETED|Overall Study||305
874124|NCT02139046|2115089|P1|COMPLETED|Overall Study|Completed=Completed Study Drug|296
874125|NCT02139046|2115085|P5|Full Analysis Set|Overall Study||357
874126|NCT02139046|2115086|P4|Full Analysis Set|Overall Study||357
874127|NCT02139046|2115087|P3|Full Analysis Set|Overall Study||355
874128|NCT02139046|2115088|P2|Full Analysis Set|Overall Study||357
874129|NCT02139046|2115089|P1|Full Analysis Set|Overall Study||357
874130|NCT02139046|2115085|P5|Safety Analysis Set|Overall Study||357
874131|NCT02139046|2115086|P4|Safety Analysis Set|Overall Study||357
874132|NCT02139046|2115087|P3|Safety Analysis Set|Overall Study||355
874133|NCT02139046|2115088|P2|Safety Analysis Set|Overall Study||358
874134|NCT02139046|2115089|P1|Safety Analysis Set|Overall Study||356
874135|NCT02139046|2115085|P5|STARTED|Overall Study||358
874136|NCT02139046|2115086|P4|STARTED|Overall Study||358
874137|NCT02139046|2115087|P3|STARTED|Overall Study||357
874138|NCT02139046|2115088|P2|STARTED|Overall Study||359
874139|NCT02139046|2115089|P1|STARTED|Overall Study||358
874140|NCT02139007|2115113|P2|NOT COMPLETED|Patient Participant Recruitment||1
874141|NCT02139007|2115114|P1|NOT COMPLETED|Patient Participant Recruitment||2
874142|NCT02139007|2115113|P2|COMPLETED|Patient Participant Recruitment||13
874143|NCT02139007|2115114|P1|COMPLETED|Patient Participant Recruitment||11
874144|NCT02139007|2115113|P2|STARTED|Patient Participant Recruitment||14
874145|NCT02139007|2115114|P1|STARTED|Patient Participant Recruitment||13
874146|NCT02139007|2115113|P2|NOT COMPLETED|Study Site Recruitment||4
874147|NCT02139007|2115114|P1|NOT COMPLETED|Study Site Recruitment||3
874148|NCT02139007|2115113|P2|COMPLETED|Study Site Recruitment||1
874149|NCT02139007|2115114|P1|COMPLETED|Study Site Recruitment||1
874150|NCT02139007|2115113|P2|STARTED|Study Site Recruitment||5
874151|NCT02139007|2115114|P1|STARTED|Study Site Recruitment||4
874152|NCT02138838|2115129|P2|NOT COMPLETED|Overall Study||11
874153|NCT02138838|2115130|P1|NOT COMPLETED|Overall Study||8
874154|NCT02138838|2115129|P2|COMPLETED|Overall Study||16
874155|NCT02138838|2115130|P1|COMPLETED|Overall Study||20
874156|NCT02138838|2115129|P2|Received Study Drug|Overall Study||25
874157|NCT02138838|2115130|P1|Received Study Drug|Overall Study||28
874158|NCT02138838|2115129|P2|STARTED|Overall Study||27
874159|NCT02138838|2115130|P1|STARTED|Overall Study||28
874160|NCT02138825|2115148|P2|NOT COMPLETED|Long-term Extension||0
874161|NCT02138825|2115149|P1|NOT COMPLETED|Long-term Extension||0
874162|NCT02138825|2115148|P2|COMPLETED|Long-term Extension||38
874163|NCT02138825|2115149|P1|COMPLETED|Long-term Extension||32
874164|NCT02138825|2115148|P2|STARTED|Long-term Extension||38
874165|NCT02138825|2115149|P1|STARTED|Long-term Extension||32
874166|NCT02138825|2115148|P2|NOT COMPLETED|Main Study Treatment||35
874167|NCT02138825|2115149|P1|NOT COMPLETED|Main Study Treatment||40
874168|NCT02138825|2115148|P2|COMPLETED|Main Study Treatment||39
874169|NCT02138825|2115149|P1|COMPLETED|Main Study Treatment||33
874170|NCT02138825|2115148|P2|STARTED|Main Study Treatment|safety population|74
874171|NCT02138825|2115149|P1|STARTED|Main Study Treatment|safety population|73
874172|NCT02138747|2115161|P4|NOT COMPLETED|Treatment Period 2||3
874173|NCT02138747|2115162|P3|NOT COMPLETED|Treatment Period 2||2
874174|NCT02138747|2115163|P2|NOT COMPLETED|Treatment Period 2||7
874175|NCT02138747|2115164|P1|NOT COMPLETED|Treatment Period 2||17
874176|NCT02138747|2115161|P4|COMPLETED|Treatment Period 2||24
874177|NCT02138747|2115162|P3|COMPLETED|Treatment Period 2||24
874178|NCT02138747|2115163|P2|COMPLETED|Treatment Period 2||125
874179|NCT02138747|2115164|P1|COMPLETED|Treatment Period 2||121
874180|NCT02138747|2115161|P4|STARTED|Treatment Period 2|One participant completed treatment in period 1.|27
874181|NCT02138747|2115162|P3|STARTED|Treatment Period 2|One participant completed treatment in period 1.|26
874182|NCT02138747|2115163|P2|STARTED|Treatment Period 2||132
874183|NCT02138747|2115164|P1|STARTED|Treatment Period 2|Two participants who discontinued treatment in period 1 entered period 2.|138
874184|NCT02138747|2115161|P4|NOT COMPLETED|Treatment Period 1||4
874185|NCT02138747|2115162|P3|NOT COMPLETED|Treatment Period 1||4
874186|NCT02138747|2115163|P2|NOT COMPLETED|Treatment Period 1||25
874187|NCT02138747|2115164|P1|NOT COMPLETED|Treatment Period 1||20
874188|NCT02138747|2115161|P4|COMPLETED|Treatment Period 1||28
874189|NCT02138747|2115162|P3|COMPLETED|Treatment Period 1||27
874190|NCT02138747|2115163|P2|COMPLETED|Treatment Period 1||132
874191|NCT02138747|2115164|P1|COMPLETED|Treatment Period 1||136
874192|NCT02138747|2115161|P4|STARTED|Treatment Period 1||32
874193|NCT02138747|2115162|P3|STARTED|Treatment Period 1||31
874194|NCT02138747|2115163|P2|STARTED|Treatment Period 1||157
874195|NCT02138747|2115164|P1|STARTED|Treatment Period 1||156
874196|NCT02138461|2115198|P2|NOT COMPLETED|Overall Study||0
874197|NCT02138461|2115199|P1|NOT COMPLETED|Overall Study||0
874198|NCT02138461|2115198|P2|COMPLETED|Overall Study||110
874199|NCT02138461|2115199|P1|COMPLETED|Overall Study||101
874200|NCT02138461|2115198|P2|STARTED|Overall Study||110
874201|NCT02138461|2115199|P1|STARTED|Overall Study||101
874202|NCT02138097|2115223|P2|NOT COMPLETED|Overall Study||0
874203|NCT02138097|2115224|P1|NOT COMPLETED|Overall Study||0
874204|NCT02138097|2115223|P2|COMPLETED|Overall Study||459722
874205|NCT02138097|2115224|P1|COMPLETED|Overall Study||155345
874206|NCT02138097|2115223|P2|STARTED|Overall Study||459722
874207|NCT02138097|2115224|P1|STARTED|Overall Study||155345
874208|NCT02138006|2115416|P2|NOT COMPLETED|Overall Study||0
874209|NCT02138006|2115417|P1|NOT COMPLETED|Overall Study||0
874210|NCT02138006|2115416|P2|COMPLETED|Overall Study||54
874211|NCT02138006|2115417|P1|COMPLETED|Overall Study||48
874212|NCT02138006|2115416|P2|STARTED|Overall Study||54
874213|NCT02138006|2115417|P1|STARTED|Overall Study||48
874214|NCT02137785|2115427|P2|NOT COMPLETED|Overall Study||4
874215|NCT02137785|2115428|P1|NOT COMPLETED|Overall Study||3
874216|NCT02137785|2115427|P2|COMPLETED|Overall Study||130
874217|NCT02137785|2115428|P1|COMPLETED|Overall Study||132
874218|NCT02137785|2115427|P2|STARTED|Overall Study||134
874219|NCT02137785|2115428|P1|STARTED|Overall Study||135
874220|NCT02137603|2115536|P2|NOT COMPLETED|Overall Study||0
874221|NCT02137603|2115537|P1|NOT COMPLETED|Overall Study||2
874222|NCT02137603|2115536|P2|COMPLETED|Overall Study||18
874223|NCT02137603|2115537|P1|COMPLETED|Overall Study||16
874224|NCT02137603|2115536|P2|STARTED|Overall Study||18
874225|NCT02137603|2115537|P1|STARTED|Overall Study||18
874226|NCT02137512|2115545|P1|NOT COMPLETED|Overall Study||0
874227|NCT02137512|2115545|P1|COMPLETED|Overall Study||30
874228|NCT02137512|2115545|P1|STARTED|Overall Study||30
874229|NCT02137447|2115561|P1|NOT COMPLETED|Overall Study||0
874230|NCT02137447|2115561|P1|COMPLETED|Overall Study||10
874231|NCT02137447|2115561|P1|STARTED|Overall Study||10
874232|NCT02137382|2115566|P2|NOT COMPLETED|Cross-over Period 2||0
874233|NCT02137382|2115567|P1|NOT COMPLETED|Cross-over Period 2||0
874234|NCT02137382|2115566|P2|COMPLETED|Cross-over Period 2||21
874235|NCT02137382|2115567|P1|COMPLETED|Cross-over Period 2||18
874236|NCT02137382|2115566|P2|STARTED|Cross-over Period 2||21
874237|NCT02137382|2115567|P1|STARTED|Cross-over Period 2||18
874238|NCT02137382|2115566|P2|NOT COMPLETED|Wash Out||0
874239|NCT02137382|2115567|P1|NOT COMPLETED|Wash Out||0
874240|NCT02137382|2115566|P2|COMPLETED|Wash Out||21
874241|NCT02137382|2115567|P1|COMPLETED|Wash Out||18
874242|NCT02137382|2115566|P2|STARTED|Wash Out||21
874243|NCT02137382|2115567|P1|STARTED|Wash Out||18
874244|NCT02137382|2115566|P2|NOT COMPLETED|Cross-over Period 1||0
874245|NCT02137382|2115567|P1|NOT COMPLETED|Cross-over Period 1||2
874246|NCT02137382|2115566|P2|COMPLETED|Cross-over Period 1||21
874247|NCT02137382|2115567|P1|COMPLETED|Cross-over Period 1||18
874248|NCT02137382|2115566|P2|STARTED|Cross-over Period 1||21
874249|NCT02137382|2115567|P1|STARTED|Cross-over Period 1||20
874250|NCT02136498|2115587|P2|NOT COMPLETED|Overall Study||0
874251|NCT02136498|2115588|P1|NOT COMPLETED|Overall Study||0
874252|NCT02136498|2115587|P2|COMPLETED|Overall Study||33
874253|NCT02136498|2115588|P1|COMPLETED|Overall Study||33
874254|NCT02136498|2115587|P2|STARTED|Overall Study||33
874255|NCT02136498|2115588|P1|STARTED|Overall Study||33
874256|NCT02136238|2115598|P3|NOT COMPLETED|Overall Study||0
874257|NCT02136238|2115599|P2|NOT COMPLETED|Overall Study||0
874258|NCT02136238|2115600|P1|NOT COMPLETED|Overall Study||0
874259|NCT02136238|2115598|P3|COMPLETED|Overall Study||10
874260|NCT02136238|2115599|P2|COMPLETED|Overall Study||4
874261|NCT02136238|2115600|P1|COMPLETED|Overall Study||4
874262|NCT02136238|2115598|P3|STARTED|Overall Study||10
874263|NCT02136238|2115599|P2|STARTED|Overall Study||4
874264|NCT02136238|2115600|P1|STARTED|Overall Study||4
874265|NCT02136134|2115613|P2|NOT COMPLETED|Overall Study||251
874266|NCT02136134|2115614|P1|NOT COMPLETED|Overall Study||247
874267|NCT02136134|2115613|P2|COMPLETED|Overall Study||0
874268|NCT02136134|2115614|P1|COMPLETED|Overall Study||0
874269|NCT02136134|2115613|P2|Treated|Overall Study||243
874270|NCT02136134|2115614|P1|Treated|Overall Study||237
874271|NCT02136134|2115613|P2|STARTED|Overall Study||251
874272|NCT02136134|2115614|P1|STARTED|Overall Study||247
874276|NCT02135900|2115643|P1|NOT COMPLETED|Overall Study||0
874277|NCT02135900|2115643|P1|COMPLETED|Overall Study||32
874278|NCT02135900|2115643|P1|STARTED|Overall Study|32 subjects started the study. 50 subjects were screened.|32
874279|NCT02135445|2115652|P2|NOT COMPLETED|Overall Study||0
874280|NCT02135445|2115653|P1|NOT COMPLETED|Overall Study||2
874281|NCT02135445|2115652|P2|COMPLETED|Overall Study||38
874282|NCT02135445|2115653|P1|COMPLETED|Overall Study||63
874283|NCT02135445|2115652|P2|STARTED|Overall Study||38
874284|NCT02135445|2115653|P1|STARTED|Overall Study||65
874285|NCT02135432|2115704|P2|NOT COMPLETED|Overall Study||0
874286|NCT02135432|2115705|P1|NOT COMPLETED|Overall Study||0
874287|NCT02135432|2115704|P2|COMPLETED|Overall Study||4
874288|NCT02135432|2115705|P1|COMPLETED|Overall Study||8
874289|NCT02135432|2115704|P2|STARTED|Overall Study||4
874290|NCT02135432|2115705|P1|STARTED|Overall Study||8
874291|NCT02135016|2115720|P3|NOT COMPLETED|Overall Study||0
874292|NCT02135016|2115721|P2|NOT COMPLETED|Overall Study||0
874293|NCT02135016|2115722|P1|NOT COMPLETED|Overall Study||0
874294|NCT02135016|2115720|P3|COMPLETED|Overall Study||15
874295|NCT02135016|2115721|P2|COMPLETED|Overall Study||15
874296|NCT02135016|2115722|P1|COMPLETED|Overall Study||15
874297|NCT02135016|2115720|P3|STARTED|Overall Study||15
874298|NCT02135016|2115721|P2|STARTED|Overall Study||15
874299|NCT02135016|2115722|P1|STARTED|Overall Study||15
874300|NCT02134977|2115742|P1|NOT COMPLETED|Overall Study||102
874301|NCT02134977|2115742|P1|COMPLETED|Overall Study||2714
874302|NCT02134977|2115742|P1|STARTED|Overall Study||2816
874303|NCT02134717|2115763|P1|NOT COMPLETED|Overall Study||0
874304|NCT02134717|2115763|P1|COMPLETED|Overall Study||3
874305|NCT02134717|2115763|P1|STARTED|Overall Study||3
874306|NCT02134587|2115767|P1|NOT COMPLETED|Overall Study||30
874307|NCT02134587|2115767|P1|COMPLETED|Overall Study||173
874308|NCT02134587|2115767|P1|STARTED|Overall Study||203
874309|NCT02134184|2115779|P3|NOT COMPLETED|Overall Study||0
874310|NCT02134184|2115780|P2|NOT COMPLETED|Overall Study||0
874311|NCT02134184|2115781|P1|NOT COMPLETED|Overall Study||0
874312|NCT02134184|2115779|P3|COMPLETED|Overall Study||8
874313|NCT02134184|2115780|P2|COMPLETED|Overall Study||37
874314|NCT02134184|2115781|P1|COMPLETED|Overall Study||33
874315|NCT02134184|2115779|P3|STARTED|Overall Study||8
874316|NCT02134184|2115780|P2|STARTED|Overall Study||37
874317|NCT02134184|2115781|P1|STARTED|Overall Study||33
874318|NCT02134119|2115794|P2|NOT COMPLETED|Overall Study||0
874319|NCT02134119|2115795|P1|NOT COMPLETED|Overall Study||0
874320|NCT02134119|2115794|P2|COMPLETED|Overall Study||15
874321|NCT02134119|2115795|P1|COMPLETED|Overall Study||30
874322|NCT02134119|2115794|P2|STARTED|Overall Study||15
874323|NCT02134119|2115795|P1|STARTED|Overall Study||30
874324|NCT02133781|2115836|P3|NOT COMPLETED|Overall Study||0
874325|NCT02133781|2115837|P2|NOT COMPLETED|Overall Study||0
874326|NCT02133781|2115838|P1|NOT COMPLETED|Overall Study||0
874327|NCT02133781|2115836|P3|COMPLETED|Overall Study||21
874328|NCT02133781|2115837|P2|COMPLETED|Overall Study||24
874329|NCT02133781|2115838|P1|COMPLETED|Overall Study||6
874330|NCT02133781|2115836|P3|STARTED|Overall Study||21
874331|NCT02133781|2115837|P2|STARTED|Overall Study||24
874332|NCT02133781|2115838|P1|STARTED|Overall Study||6
874333|NCT02133664|2115851|P2|NOT COMPLETED|Overall Study||7
874334|NCT02133664|2115852|P1|NOT COMPLETED|Overall Study||5
874335|NCT02133664|2115851|P2|COMPLETED|Overall Study||21
874336|NCT02133664|2115852|P1|COMPLETED|Overall Study||21
874337|NCT02133664|2115851|P2|STARTED|Overall Study||28
874338|NCT02133664|2115852|P1|STARTED|Overall Study||26
874339|NCT02133534|2115864|P1|NOT COMPLETED|Overall Study||0
874340|NCT02133534|2115864|P1|COMPLETED|Overall Study||1
874341|NCT02133534|2115864|P1|STARTED|Overall Study||1
874342|NCT02133352|2115868|P1|NOT COMPLETED|Longer Term Extension||6
874343|NCT02133352|2115868|P1|COMPLETED|Longer Term Extension||4
874344|NCT02133352|2115868|P1|STARTED|Longer Term Extension||10
874345|NCT02133352|2115868|P1|NOT COMPLETED|Main Study (180 Day)||0
874346|NCT02133352|2115868|P1|COMPLETED|Main Study (180 Day)||10
874347|NCT02133352|2115868|P1|STARTED|Main Study (180 Day)||10
874348|NCT02133235|2115879|P2|NOT COMPLETED|Overall Study||0
874349|NCT02133235|2115880|P1|NOT COMPLETED|Overall Study||0
874350|NCT02133235|2115879|P2|COMPLETED|Overall Study||57
874351|NCT02133235|2115880|P1|COMPLETED|Overall Study||55
874352|NCT02133235|2115879|P2|STARTED|Overall Study||57
874353|NCT02133235|2115880|P1|STARTED|Overall Study||55
874354|NCT02133131|2115899|P7|NOT COMPLETED|Overall Study||12
874355|NCT02133131|2115900|P6|NOT COMPLETED|Overall Study||14
874356|NCT02133131|2115901|P5|NOT COMPLETED|Overall Study||15
874357|NCT02133131|2115902|P4|NOT COMPLETED|Overall Study||6
874358|NCT02133131|2115903|P3|NOT COMPLETED|Overall Study||1
874359|NCT02133131|2115904|P2|NOT COMPLETED|Overall Study||5
874360|NCT02133131|2115905|P1|NOT COMPLETED|Overall Study||5
874361|NCT02133131|2115899|P7|COMPLETED|Overall Study||0
874362|NCT02133131|2115900|P6|COMPLETED|Overall Study||0
874363|NCT02133131|2115901|P5|COMPLETED|Overall Study||0
874364|NCT02133131|2115902|P4|COMPLETED|Overall Study||15
874365|NCT02133131|2115903|P3|COMPLETED|Overall Study||19
874366|NCT02133131|2115904|P2|COMPLETED|Overall Study||25
874367|NCT02133131|2115905|P1|COMPLETED|Overall Study||26
874368|NCT02133131|2115899|P7|STARTED|Overall Study||12
874369|NCT02133131|2115900|P6|STARTED|Overall Study||14
874370|NCT02133131|2115901|P5|STARTED|Overall Study||15
874371|NCT02133131|2115902|P4|STARTED|Overall Study||21
874372|NCT02133131|2115903|P3|STARTED|Overall Study||20
874373|NCT02133131|2115904|P2|STARTED|Overall Study||30
874374|NCT02133131|2115905|P1|STARTED|Overall Study||31
874375|NCT02133066|2115944|P2|NOT COMPLETED|Overall Study||0
874376|NCT02133066|2115945|P1|NOT COMPLETED|Overall Study||0
874377|NCT02133066|2115944|P2|COMPLETED|Overall Study||64
874378|NCT02133066|2115945|P1|COMPLETED|Overall Study||64
874379|NCT02133066|2115944|P2|STARTED|Overall Study||64
874380|NCT02133066|2115945|P1|STARTED|Overall Study||64
874381|NCT02132949|2115959|P2|NOT COMPLETED|Adjuvant Treatment Period||167
874382|NCT02132949|2115960|P1|NOT COMPLETED|Adjuvant Treatment Period||149
874383|NCT02132949|2115959|P2|COMPLETED|Adjuvant Treatment Period||23
874384|NCT02132949|2115960|P1|COMPLETED|Adjuvant Treatment Period||29
874385|NCT02132949|2115959|P2|STARTED|Adjuvant Treatment Period|Includes a participant who did not complete neoadjuvant treatment but started adjuvant treatment.|190
874386|NCT02132949|2115960|P1|STARTED|Adjuvant Treatment Period|At clinical cutoff (03 March 2016), some participants had not yet received adjuvant treatment.|178
874387|NCT02132949|2115959|P2|NOT COMPLETED|Neoadjuvant Treatment Period||12
874388|NCT02132949|2115960|P1|NOT COMPLETED|Neoadjuvant Treatment Period||17
874389|NCT02132949|2115959|P2|COMPLETED|Neoadjuvant Treatment Period||189
874390|NCT02132949|2115960|P1|COMPLETED|Neoadjuvant Treatment Period||182
874391|NCT02132949|2115959|P2|No Treatment|Neoadjuvant Treatment Period||3
874392|NCT02132949|2115960|P1|No Treatment|Neoadjuvant Treatment Period||1
874393|NCT02132949|2115959|P2|STARTED|Neoadjuvant Treatment Period||201
874394|NCT02132949|2115960|P1|STARTED|Neoadjuvant Treatment Period|A participant enrolled in Cohort B received Cohort A treatment, hence counted under Cohort A.|199
874395|NCT02132936|2115992|P4|NOT COMPLETED|Overall Study||14
874396|NCT02132936|2115993|P3|NOT COMPLETED|Overall Study||14
874397|NCT02132936|2115994|P2|NOT COMPLETED|Overall Study||9
874398|NCT02132936|2115995|P1|NOT COMPLETED|Overall Study||10
874399|NCT02132936|2115992|P4|COMPLETED|Overall Study||29
874400|NCT02132936|2115993|P3|COMPLETED|Overall Study||174
874401|NCT02132936|2115994|P2|COMPLETED|Overall Study||38
874402|NCT02132936|2115995|P1|COMPLETED|Overall Study||175
874403|NCT02132936|2115992|P4|STARTED|Overall Study||43
874404|NCT02132936|2115993|P3|STARTED|Overall Study||188
874405|NCT02132936|2115994|P2|STARTED|Overall Study||47
874406|NCT02132936|2115995|P1|STARTED|Overall Study||185
874407|NCT02132832|2116013|P2|NOT COMPLETED|Overall Study||7
874408|NCT02132832|2116014|P1|NOT COMPLETED|Overall Study||3
874409|NCT02132832|2116013|P2|COMPLETED|Overall Study||16
874410|NCT02132832|2116014|P1|COMPLETED|Overall Study||16
874411|NCT02132832|2116013|P2|STARTED|Overall Study||23
874412|NCT02132832|2116014|P1|STARTED|Overall Study||19
874413|NCT02132767|2116044|P2|NOT COMPLETED|Overall Study||15
874414|NCT02132767|2116045|P1|NOT COMPLETED|Overall Study||17
874415|NCT02132767|2116044|P2|COMPLETED|Overall Study||246
874416|NCT02132767|2116045|P1|COMPLETED|Overall Study||245
874417|NCT02132767|2116044|P2|STARTED|Overall Study||261
874418|NCT02132767|2116045|P1|STARTED|Overall Study||262
874419|NCT02132611|2116065|P1|NOT COMPLETED|Overall Study||2
874420|NCT02132611|2116065|P1|COMPLETED|Overall Study||98
874421|NCT02132611|2116065|P1|STARTED|Overall Study||100
874422|NCT02132572|2116070|P1|NOT COMPLETED|Overall Study||0
874423|NCT02132572|2116070|P1|COMPLETED|Overall Study||201
874424|NCT02132572|2116070|P1|STARTED|Overall Study||201
874425|NCT02132169|2116076|P2|NOT COMPLETED|Overall Study||9
874426|NCT02132169|2116077|P1|NOT COMPLETED|Overall Study||15
874427|NCT02132169|2116076|P2|COMPLETED|Overall Study||162
874428|NCT02132169|2116077|P1|COMPLETED|Overall Study||326
874429|NCT02132169|2116076|P2|STARTED|Overall Study||171
874430|NCT02132169|2116077|P1|STARTED|Overall Study||341
874431|NCT02132117|2116091|P2|NOT COMPLETED|Overall Study||5
874432|NCT02132117|2116092|P1|NOT COMPLETED|Overall Study||11
874433|NCT02132117|2116091|P2|COMPLETED|Overall Study||216
874434|NCT02132117|2116092|P1|COMPLETED|Overall Study||213
874435|NCT02132117|2116091|P2|STARTED|Overall Study||221
874436|NCT02132117|2116092|P1|STARTED|Overall Study||224
874437|NCT02131636|2116110|P2|NOT COMPLETED|Overall Study||5
874438|NCT02131636|2116111|P1|NOT COMPLETED|Overall Study||12
874439|NCT02131636|2116110|P2|COMPLETED|Overall Study||213
874440|NCT02131636|2116111|P1|COMPLETED|Overall Study||210
874441|NCT02131636|2116110|P2|STARTED|Overall Study||218
874442|NCT02131636|2116111|P1|STARTED|Overall Study||222
874443|NCT02131532|2116127|P1|NOT COMPLETED|Overall Study||4
874444|NCT02131532|2116127|P1|COMPLETED|Overall Study||8
874445|NCT02131532|2116127|P1|STARTED|Overall Study||12
874446|NCT02131402|2116146|P1|NOT COMPLETED|Overall Study||0
874447|NCT02131402|2116146|P1|COMPLETED|Overall Study||60
874448|NCT02131402|2116146|P1|STARTED|Overall Study||60
874449|NCT02131311|2116217|P1|NOT COMPLETED|Overall Study||4
874450|NCT02131311|2116217|P1|COMPLETED|Overall Study||86
874451|NCT02131311|2116217|P1|STARTED|Overall Study||90
874452|NCT02131272|2116229|P2|NOT COMPLETED|Overall Study||2
874453|NCT02131272|2116230|P1|NOT COMPLETED|Overall Study||1
874454|NCT02131272|2116229|P2|COMPLETED|Overall Study||20
874455|NCT02131272|2116230|P1|COMPLETED|Overall Study||19
874456|NCT02131272|2116229|P2|STARTED|Overall Study||22
874457|NCT02131272|2116230|P1|STARTED|Overall Study||20
874458|NCT02131233|2116250|P2|NOT COMPLETED|Overall Study||27
874459|NCT02131233|2116251|P1|NOT COMPLETED|Overall Study||43
874460|NCT02131233|2116250|P2|COMPLETED|Overall Study|Completed to Week 48|242
874461|NCT02131233|2116251|P1|COMPLETED|Overall Study|Completed to Week 48|490
874462|NCT02131233|2116250|P2|Treated|Overall Study||266
874463|NCT02131233|2116251|P1|Treated|Overall Study||531
874464|NCT02131233|2116250|P2|STARTED|Overall Study|Enrolled participants|269
874465|NCT02131233|2116251|P1|STARTED|Overall Study|Enrolled participants|533
874466|NCT02131064|2116271|P2|NOT COMPLETED|Overall Study||223
874467|NCT02131064|2116272|P1|NOT COMPLETED|Overall Study||221
874468|NCT02131064|2116271|P2|COMPLETED|Overall Study||0
874469|NCT02131064|2116272|P1|COMPLETED|Overall Study||0
874470|NCT02131064|2116271|P2|STARTED|Overall Study||223
874471|NCT02131064|2116272|P1|STARTED|Overall Study||221
874472|NCT02130999|2116304|P2|NOT COMPLETED|Overall Study||0
874473|NCT02130999|2116305|P1|NOT COMPLETED|Overall Study||0
874474|NCT02130999|2116304|P2|COMPLETED|Overall Study||8
874475|NCT02130999|2116305|P1|COMPLETED|Overall Study||6
874476|NCT02130999|2116304|P2|STARTED|Overall Study||8
874477|NCT02130999|2116305|P1|STARTED|Overall Study||6
874478|NCT02130635|2116340|P9|NOT COMPLETED|Part B-Dose-Response Relationship||0
874479|NCT02130635|2116341|P8|NOT COMPLETED|Part B-Dose-Response Relationship||0
874480|NCT02130635|2116342|P7|NOT COMPLETED|Part B-Dose-Response Relationship||0
874481|NCT02130635|2116343|P6|NOT COMPLETED|Part B-Dose-Response Relationship||0
874482|NCT02130635|2116344|P5|NOT COMPLETED|Part B-Dose-Response Relationship||0
874483|NCT02130635|2116345|P4|NOT COMPLETED|Part B-Dose-Response Relationship||0
874484|NCT02130635|2116346|P3|NOT COMPLETED|Part B-Dose-Response Relationship||0
874485|NCT02130635|2116347|P2|NOT COMPLETED|Part B-Dose-Response Relationship||0
874486|NCT02130635|2116348|P1|NOT COMPLETED|Part B-Dose-Response Relationship||0
874487|NCT02130635|2116340|P9|COMPLETED|Part B-Dose-Response Relationship||5
874488|NCT02130635|2116341|P8|COMPLETED|Part B-Dose-Response Relationship||5
874489|NCT02130635|2116342|P7|COMPLETED|Part B-Dose-Response Relationship||6
874490|NCT02130635|2116343|P6|COMPLETED|Part B-Dose-Response Relationship||5
874491|NCT02130635|2116344|P5|COMPLETED|Part B-Dose-Response Relationship||5
874492|NCT02130635|2116345|P4|COMPLETED|Part B-Dose-Response Relationship||5
874493|NCT02130635|2116346|P3|COMPLETED|Part B-Dose-Response Relationship||5
874494|NCT02130635|2116347|P2|COMPLETED|Part B-Dose-Response Relationship||0
874495|NCT02130635|2116348|P1|COMPLETED|Part B-Dose-Response Relationship||0
874496|NCT02130635|2116340|P9|STARTED|Part B-Dose-Response Relationship||5
874497|NCT02130635|2116341|P8|STARTED|Part B-Dose-Response Relationship||5
874498|NCT02130635|2116342|P7|STARTED|Part B-Dose-Response Relationship||6
874499|NCT02130635|2116343|P6|STARTED|Part B-Dose-Response Relationship||5
874500|NCT02130635|2116344|P5|STARTED|Part B-Dose-Response Relationship||5
874501|NCT02130635|2116345|P4|STARTED|Part B-Dose-Response Relationship||5
874502|NCT02130635|2116346|P3|STARTED|Part B-Dose-Response Relationship||5
874503|NCT02130635|2116347|P2|STARTED|Part B-Dose-Response Relationship||0
874504|NCT02130635|2116348|P1|STARTED|Part B-Dose-Response Relationship||0
874505|NCT02130635|2116340|P9|NOT COMPLETED|Part A-Safety and Tolerability||0
874506|NCT02130635|2116341|P8|NOT COMPLETED|Part A-Safety and Tolerability||0
874507|NCT02130635|2116342|P7|NOT COMPLETED|Part A-Safety and Tolerability||0
874508|NCT02130635|2116343|P6|NOT COMPLETED|Part A-Safety and Tolerability||0
874509|NCT02130635|2116344|P5|NOT COMPLETED|Part A-Safety and Tolerability||0
874510|NCT02130635|2116345|P4|NOT COMPLETED|Part A-Safety and Tolerability||0
874511|NCT02130635|2116346|P3|NOT COMPLETED|Part A-Safety and Tolerability||0
874512|NCT02130635|2116347|P2|NOT COMPLETED|Part A-Safety and Tolerability||0
874513|NCT02130635|2116348|P1|NOT COMPLETED|Part A-Safety and Tolerability||0
874514|NCT02130635|2116340|P9|COMPLETED|Part A-Safety and Tolerability||0
874515|NCT02130635|2116341|P8|COMPLETED|Part A-Safety and Tolerability||0
874516|NCT02130635|2116342|P7|COMPLETED|Part A-Safety and Tolerability||0
874517|NCT02130635|2116343|P6|COMPLETED|Part A-Safety and Tolerability||0
874518|NCT02130635|2116344|P5|COMPLETED|Part A-Safety and Tolerability||0
874519|NCT02130635|2116345|P4|COMPLETED|Part A-Safety and Tolerability||0
874520|NCT02130635|2116346|P3|COMPLETED|Part A-Safety and Tolerability||0
874521|NCT02130635|2116347|P2|COMPLETED|Part A-Safety and Tolerability||21
874522|NCT02130635|2116348|P1|COMPLETED|Part A-Safety and Tolerability||7
874523|NCT02130635|2116340|P9|STARTED|Part A-Safety and Tolerability||0
874524|NCT02130635|2116341|P8|STARTED|Part A-Safety and Tolerability||0
874525|NCT02130635|2116342|P7|STARTED|Part A-Safety and Tolerability||0
874526|NCT02130635|2116343|P6|STARTED|Part A-Safety and Tolerability||0
874527|NCT02130635|2116344|P5|STARTED|Part A-Safety and Tolerability||0
874528|NCT02130635|2116345|P4|STARTED|Part A-Safety and Tolerability||0
874529|NCT02130635|2116346|P3|STARTED|Part A-Safety and Tolerability||0
874530|NCT02130635|2116347|P2|STARTED|Part A-Safety and Tolerability||21
874531|NCT02130635|2116348|P1|STARTED|Part A-Safety and Tolerability||7
874532|NCT02130284|2116520|P1|NOT COMPLETED|Overall Study||9
874533|NCT02130284|2116520|P1|COMPLETED|Overall Study||71
874534|NCT02130284|2116520|P1|STARTED|Overall Study||80
874535|NCT02130193|2116533|P3|NOT COMPLETED|Part B: 52-week Double-blind Period||8
874536|NCT02130193|2116534|P2|NOT COMPLETED|Part B: 52-week Double-blind Period||10
874537|NCT02130193|2116535|P1|NOT COMPLETED|Part B: 52-week Double-blind Period||0
874538|NCT02130193|2116533|P3|COMPLETED|Part B: 52-week Double-blind Period||37
874539|NCT02130193|2116534|P2|COMPLETED|Part B: 52-week Double-blind Period||38
874540|NCT02130193|2116535|P1|COMPLETED|Part B: 52-week Double-blind Period||0
874541|NCT02130193|2116533|P3|STARTED|Part B: 52-week Double-blind Period||45
874542|NCT02130193|2116534|P2|STARTED|Part B: 52-week Double-blind Period||48
874543|NCT02130193|2116535|P1|STARTED|Part B: 52-week Double-blind Period||0
874544|NCT02130193|2116533|P3|NOT COMPLETED|Part A: 4-week Open-label Period||0
874545|NCT02130193|2116534|P2|NOT COMPLETED|Part A: 4-week Open-label Period||0
874546|NCT02130193|2116535|P1|NOT COMPLETED|Part A: 4-week Open-label Period||0
874547|NCT02130193|2116533|P3|COMPLETED|Part A: 4-week Open-label Period||0
874548|NCT02130193|2116534|P2|COMPLETED|Part A: 4-week Open-label Period||0
874549|NCT02130193|2116535|P1|COMPLETED|Part A: 4-week Open-label Period||9
874550|NCT02130193|2116533|P3|STARTED|Part A: 4-week Open-label Period||0
874551|NCT02130193|2116534|P2|STARTED|Part A: 4-week Open-label Period||0
874552|NCT02130193|2116535|P1|STARTED|Part A: 4-week Open-label Period||9
874553|NCT02129777|2116604|P7|NOT COMPLETED|Open-Label Period||48
874554|NCT02129777|2116605|P6|NOT COMPLETED|Open-Label Period||12
874555|NCT02129777|2116606|P5|NOT COMPLETED|Open-Label Period||0
874556|NCT02129777|2116607|P4|NOT COMPLETED|Open-Label Period||0
874557|NCT02129777|2116608|P3|NOT COMPLETED|Open-Label Period||0
874558|NCT02129777|2116609|P2|NOT COMPLETED|Open-Label Period||0
874559|NCT02129777|2116610|P1|NOT COMPLETED|Open-Label Period||0
874560|NCT02129777|2116604|P7|COMPLETED|Open-Label Period||0
874561|NCT02129777|2116605|P6|COMPLETED|Open-Label Period||0
874562|NCT02129777|2116606|P5|COMPLETED|Open-Label Period||0
874563|NCT02129777|2116607|P4|COMPLETED|Open-Label Period||0
874564|NCT02129777|2116608|P3|COMPLETED|Open-Label Period||0
874565|NCT02129777|2116609|P2|COMPLETED|Open-Label Period||0
874566|NCT02129777|2116610|P1|COMPLETED|Open-Label Period||0
874567|NCT02129777|2116604|P7|STARTED|Open-Label Period||48
874568|NCT02129777|2116605|P6|STARTED|Open-Label Period||12
874569|NCT02129777|2116606|P5|STARTED|Open-Label Period||0
874570|NCT02129777|2116607|P4|STARTED|Open-Label Period||0
874571|NCT02129777|2116608|P3|STARTED|Open-Label Period||0
874572|NCT02129777|2116609|P2|STARTED|Open-Label Period||0
874573|NCT02129777|2116610|P1|STARTED|Open-Label Period||0
874574|NCT02129777|2116604|P7|NOT COMPLETED|Double-Blind Period||0
874575|NCT02129777|2116605|P6|NOT COMPLETED|Double-Blind Period||0
874576|NCT02129777|2116606|P5|NOT COMPLETED|Double-Blind Period||7
874577|NCT02129777|2116607|P4|NOT COMPLETED|Double-Blind Period||7
874578|NCT02129777|2116608|P3|NOT COMPLETED|Double-Blind Period||4
874579|NCT02129777|2116609|P2|NOT COMPLETED|Double-Blind Period||8
874580|NCT02129777|2116610|P1|NOT COMPLETED|Double-Blind Period||7
874581|NCT02129777|2116604|P7|COMPLETED|Double-Blind Period||0
874582|NCT02129777|2116605|P6|COMPLETED|Double-Blind Period||0
874583|NCT02129777|2116606|P5|COMPLETED|Double-Blind Period||18
874584|NCT02129777|2116607|P4|COMPLETED|Double-Blind Period||18
874585|NCT02129777|2116608|P3|COMPLETED|Double-Blind Period||20
874586|NCT02129777|2116609|P2|COMPLETED|Double-Blind Period||16
874587|NCT02129777|2116610|P1|COMPLETED|Double-Blind Period||17
874588|NCT02129777|2116604|P7|STARTED|Double-Blind Period||0
874589|NCT02129777|2116605|P6|STARTED|Double-Blind Period||0
874590|NCT02129777|2116606|P5|STARTED|Double-Blind Period||25
874591|NCT02129777|2116607|P4|STARTED|Double-Blind Period||25
874592|NCT02129777|2116608|P3|STARTED|Double-Blind Period||24
874593|NCT02129777|2116609|P2|STARTED|Double-Blind Period||24
874594|NCT02129777|2116610|P1|STARTED|Double-Blind Period||24
874595|NCT02129725|2116716|P2|NOT COMPLETED|Overall Study||3
874596|NCT02129725|2116717|P1|NOT COMPLETED|Overall Study||2
874597|NCT02129725|2116716|P2|COMPLETED|Overall Study||4
874598|NCT02129725|2116717|P1|COMPLETED|Overall Study||6
874599|NCT02129725|2116716|P2|STARTED|Overall Study||7
874600|NCT02129725|2116717|P1|STARTED|Overall Study||8
874601|NCT02129608|2116726|P3|NOT COMPLETED|Overall Study||3
874602|NCT02129608|2116727|P2|NOT COMPLETED|Overall Study||1
874603|NCT02129608|2116728|P1|NOT COMPLETED|Overall Study||0
874604|NCT02129608|2116726|P3|COMPLETED|Overall Study||12
874605|NCT02129608|2116727|P2|COMPLETED|Overall Study||13
874606|NCT02129608|2116728|P1|COMPLETED|Overall Study||15
874607|NCT02129608|2116726|P3|End of Treatment|Overall Study||12
874608|NCT02129608|2116727|P2|End of Treatment|Overall Study||13
874609|NCT02129608|2116728|P1|End of Treatment|Overall Study||15
874610|NCT02129608|2116726|P3|STARTED|Overall Study||15
874611|NCT02129608|2116727|P2|STARTED|Overall Study||14
874612|NCT02129608|2116728|P1|STARTED|Overall Study||15
874613|NCT02129192|2116741|P2|NOT COMPLETED|Period 5||0
874614|NCT02129192|2116742|P1|NOT COMPLETED|Period 5||0
874615|NCT02129192|2116741|P2|COMPLETED|Period 5||0
874616|NCT02129192|2116742|P1|COMPLETED|Period 5||36
874617|NCT02129192|2116741|P2|STARTED|Period 5|This sequence consists of only 4 periods.|0
874618|NCT02129192|2116742|P1|STARTED|Period 5||36
874619|NCT02129192|2116741|P2|NOT COMPLETED|Period 4 Including Washout Period||0
874620|NCT02129192|2116742|P1|NOT COMPLETED|Period 4 Including Washout Period||0
874621|NCT02129192|2116741|P2|COMPLETED|Period 4 Including Washout Period||35
874622|NCT02129192|2116742|P1|COMPLETED|Period 4 Including Washout Period||36
874623|NCT02129192|2116741|P2|STARTED|Period 4 Including Washout Period||35
874624|NCT02129192|2116742|P1|STARTED|Period 4 Including Washout Period||36
874625|NCT02129192|2116741|P2|NOT COMPLETED|Period 3 Including Washout Period||0
874626|NCT02129192|2116742|P1|NOT COMPLETED|Period 3 Including Washout Period||0
874627|NCT02129192|2116741|P2|COMPLETED|Period 3 Including Washout Period||35
874628|NCT02129192|2116742|P1|COMPLETED|Period 3 Including Washout Period||36
874629|NCT02129192|2116741|P2|STARTED|Period 3 Including Washout Period||35
874630|NCT02129192|2116742|P1|STARTED|Period 3 Including Washout Period||36
874631|NCT02129192|2116741|P2|NOT COMPLETED|Period 2 Including Washout Period||0
874632|NCT02129192|2116742|P1|NOT COMPLETED|Period 2 Including Washout Period||0
874633|NCT02129192|2116741|P2|COMPLETED|Period 2 Including Washout Period||35
874634|NCT02129192|2116742|P1|COMPLETED|Period 2 Including Washout Period||36
874635|NCT02129192|2116741|P2|STARTED|Period 2 Including Washout Period||35
874636|NCT02129192|2116742|P1|STARTED|Period 2 Including Washout Period||36
874637|NCT02129192|2116741|P2|NOT COMPLETED|Period 1 Including Washout Period||1
874638|NCT02129192|2116742|P1|NOT COMPLETED|Period 1 Including Washout Period||0
874639|NCT02129192|2116741|P2|COMPLETED|Period 1 Including Washout Period|Withdrawal by one subject in washout period|35
874640|NCT02129192|2116742|P1|COMPLETED|Period 1 Including Washout Period||36
874641|NCT02129192|2116741|P2|STARTED|Period 1 Including Washout Period||36
874642|NCT02129192|2116742|P1|STARTED|Period 1 Including Washout Period||36
874643|NCT02129062|2116759|P1|NOT COMPLETED|Overall Study||3
874644|NCT02129062|2116759|P1|COMPLETED|Overall Study||0
874645|NCT02129062|2116759|P1|STARTED|Overall Study||3
874646|NCT02128919|2116766|P2|NOT COMPLETED|Overall Study||1
874647|NCT02128919|2116767|P1|NOT COMPLETED|Overall Study||3
874648|NCT02128919|2116766|P2|COMPLETED|Overall Study||15
874649|NCT02128919|2116767|P1|COMPLETED|Overall Study||14
874650|NCT02128919|2116766|P2|STARTED|Overall Study||16
874651|NCT02128919|2116767|P1|STARTED|Overall Study||17
874652|NCT02128867|2116780|P3|NOT COMPLETED|Overall Study||4
874653|NCT02128867|2116781|P2|NOT COMPLETED|Overall Study||2
874654|NCT02128867|2116782|P1|NOT COMPLETED|Overall Study||3
874655|NCT02128867|2116780|P3|COMPLETED|Overall Study||50
874656|NCT02128867|2116781|P2|COMPLETED|Overall Study||50
874657|NCT02128867|2116782|P1|COMPLETED|Overall Study||50
874658|NCT02128867|2116780|P3|STARTED|Overall Study||54
874659|NCT02128867|2116781|P2|STARTED|Overall Study||52
874660|NCT02128867|2116782|P1|STARTED|Overall Study||53
874661|NCT02128542|2116792|P2|NOT COMPLETED|Overall Study||0
874662|NCT02128542|2116793|P1|NOT COMPLETED|Overall Study||4
874663|NCT02128542|2116792|P2|COMPLETED|Overall Study||19
874664|NCT02128542|2116793|P1|COMPLETED|Overall Study||43
874665|NCT02128542|2116792|P2|STARTED|Overall Study||19
874666|NCT02128542|2116793|P1|STARTED|Overall Study||47
874667|NCT02128490|2116811|P5|NOT COMPLETED|Overall Study||7
874668|NCT02128490|2116812|P4|NOT COMPLETED|Overall Study||6
874669|NCT02128490|2116813|P3|NOT COMPLETED|Overall Study||5
874670|NCT02128490|2116814|P2|NOT COMPLETED|Overall Study||6
874671|NCT02128490|2116815|P1|NOT COMPLETED|Overall Study||5
874672|NCT02128490|2116811|P5|COMPLETED|Overall Study||31
874673|NCT02128490|2116812|P4|COMPLETED|Overall Study||31
874674|NCT02128490|2116813|P3|COMPLETED|Overall Study||34
874675|NCT02128490|2116814|P2|COMPLETED|Overall Study||31
874676|NCT02128490|2116815|P1|COMPLETED|Overall Study||33
874677|NCT02128490|2116811|P5|STARTED|Overall Study||38
874678|NCT02128490|2116812|P4|STARTED|Overall Study||37
874679|NCT02128490|2116813|P3|STARTED|Overall Study||39
874680|NCT02128490|2116814|P2|STARTED|Overall Study||37
874681|NCT02128490|2116815|P1|STARTED|Overall Study||38
874682|NCT02128269|2116837|P1|NOT COMPLETED|Follow-up||0
874683|NCT02128269|2116837|P1|COMPLETED|Follow-up||9
874684|NCT02128269|2116837|P1|STARTED|Follow-up|All enrolled patients were followed for 12 weeks after their last infusion of ALXN1007.|9
874685|NCT02128269|2116837|P1|NOT COMPLETED|Treatment Period||2
874686|NCT02128269|2116837|P1|COMPLETED|Treatment Period||7
874687|NCT02128269|2116837|P1|STARTED|Treatment Period||9
874688|NCT02127892|2116845|P4|NOT COMPLETED|Overall Study||0
874689|NCT02127892|2116846|P3|NOT COMPLETED|Overall Study||0
874690|NCT02127892|2116847|P2|NOT COMPLETED|Overall Study||1
874691|NCT02127892|2116848|P1|NOT COMPLETED|Overall Study||1
874692|NCT02127892|2116845|P4|COMPLETED|Overall Study||0
874693|NCT02127892|2116846|P3|COMPLETED|Overall Study||0
874694|NCT02127892|2116847|P2|COMPLETED|Overall Study||1
874695|NCT02127892|2116848|P1|COMPLETED|Overall Study||6
874696|NCT02127892|2116845|P4|STARTED|Overall Study||0
874697|NCT02127892|2116846|P3|STARTED|Overall Study||0
874698|NCT02127892|2116847|P2|STARTED|Overall Study||2
874699|NCT02127892|2116848|P1|STARTED|Overall Study||7
874700|NCT02127567|2116874|P1|NOT COMPLETED|Overall Study||0
874701|NCT02127567|2116874|P1|COMPLETED|Overall Study||41
874702|NCT02127567|2116874|P1|STARTED|Overall Study|41 participants completed 123 domains, 3 domains were completed with the tool per participant|41
874703|NCT02127372|2116896|P2|NOT COMPLETED|Overall Study||0
874704|NCT02127372|2116897|P1|NOT COMPLETED|Overall Study||1
874705|NCT02127372|2116896|P2|COMPLETED|Overall Study||28
874706|NCT02127372|2116897|P1|COMPLETED|Overall Study|Completed at least one cycle and were available for dose limiting toxicity (DLT) evaluation.|14
874707|NCT02127372|2116896|P2|Started Study Treatment|Overall Study||28
874708|NCT02127372|2116897|P1|Started Study Treatment|Overall Study||15
874709|NCT02127372|2116896|P2|STARTED|Overall Study|Signed Consent|28
874710|NCT02127372|2116897|P1|STARTED|Overall Study|Signed Consent|15
874711|NCT02127307|2116907|P1|NOT COMPLETED|Overall Study||308
874712|NCT02127307|2116907|P1|COMPLETED|Overall Study||656
874713|NCT02127307|2116907|P1|STARTED|Overall Study||964
874714|NCT02126839|2116913|P2|NOT COMPLETED|Overall Study||14
874715|NCT02126839|2116914|P1|NOT COMPLETED|Overall Study||10
874716|NCT02126839|2116913|P2|COMPLETED|Overall Study||80
874717|NCT02126839|2116914|P1|COMPLETED|Overall Study||82
874718|NCT02126839|2116913|P2|Full Analysis Set|Overall Study||92
874719|NCT02126839|2116914|P1|Full Analysis Set|Overall Study||92
874720|NCT02126839|2116913|P2|Safety Population|Overall Study||93
874721|NCT02126839|2116914|P1|Safety Population|Overall Study||92
874722|NCT02126839|2116913|P2|STARTED|Overall Study||94
874723|NCT02126839|2116914|P1|STARTED|Overall Study||92
874724|NCT02126748|2116927|P3|NOT COMPLETED|Overall Study||5
874725|NCT02126748|2116928|P2|NOT COMPLETED|Overall Study||3
874726|NCT02126748|2116929|P1|NOT COMPLETED|Overall Study||2
874727|NCT02126748|2116927|P3|COMPLETED|Overall Study||31
874728|NCT02126748|2116928|P2|COMPLETED|Overall Study||31
874729|NCT02126748|2116929|P1|COMPLETED|Overall Study||31
874730|NCT02126748|2116927|P3|STARTED|Overall Study||36
874731|NCT02126748|2116928|P2|STARTED|Overall Study||34
874732|NCT02126748|2116929|P1|STARTED|Overall Study||33
874733|NCT02126670|2116941|P4|NOT COMPLETED|Overall Study||1
874734|NCT02126670|2116942|P3|NOT COMPLETED|Overall Study||0
874735|NCT02126670|2116943|P2|NOT COMPLETED|Overall Study||0
874736|NCT02126670|2116944|P1|NOT COMPLETED|Overall Study||1
874737|NCT02126670|2116941|P4|COMPLETED|Overall Study||24
874738|NCT02126670|2116942|P3|COMPLETED|Overall Study||25
874739|NCT02126670|2116943|P2|COMPLETED|Overall Study||24
874740|NCT02126670|2116944|P1|COMPLETED|Overall Study||25
874741|NCT02126670|2116941|P4|STARTED|Overall Study||25
874742|NCT02126670|2116942|P3|STARTED|Overall Study||25
874743|NCT02126670|2116943|P2|STARTED|Overall Study||24
874744|NCT02126670|2116944|P1|STARTED|Overall Study||26
874745|NCT02126319|2116960|P2|NOT COMPLETED|Overall Study||24
874746|NCT02126319|2116961|P1|NOT COMPLETED|Overall Study||21
874747|NCT02126319|2116960|P2|COMPLETED|Overall Study||43
874748|NCT02126319|2116961|P1|COMPLETED|Overall Study||40
874749|NCT02126319|2116960|P2|STARTED|Overall Study||67
874750|NCT02126319|2116961|P1|STARTED|Overall Study||61
874751|NCT02126306|2116987|P2|NOT COMPLETED|Overall Study||0
874752|NCT02126306|2116988|P1|NOT COMPLETED|Overall Study||0
874753|NCT02126306|2116987|P2|COMPLETED|Overall Study||13
874754|NCT02126306|2116988|P1|COMPLETED|Overall Study||10
874755|NCT02126306|2116987|P2|STARTED|Overall Study||13
874756|NCT02126306|2116988|P1|STARTED|Overall Study||10
874757|NCT02125877|2116996|P2|NOT COMPLETED|Overall Study||10
874758|NCT02125877|2116997|P1|NOT COMPLETED|Overall Study||13
874759|NCT02125877|2116996|P2|COMPLETED|Overall Study||77
874760|NCT02125877|2116997|P1|COMPLETED|Overall Study||73
874761|NCT02125877|2116996|P2|Safety Set|Overall Study||87
874762|NCT02125877|2116997|P1|Safety Set|Overall Study||86
874763|NCT02125877|2116996|P2|Pharmacokinetic Subset A|Overall Study||15
874764|NCT02125877|2116997|P1|Pharmacokinetic Subset A|Overall Study||16
874765|NCT02125877|2116996|P2|Pharmacokinetic Analysis Set|Overall Study||83
874766|NCT02125877|2116997|P1|Pharmacokinetic Analysis Set|Overall Study||83
874767|NCT02125877|2116996|P2|STARTED|Overall Study||87
874768|NCT02125877|2116997|P1|STARTED|Overall Study||86
874769|NCT02125838|2117027|P2|NOT COMPLETED|Overall Study||4
874770|NCT02125838|2117028|P1|NOT COMPLETED|Overall Study||4
874771|NCT02125838|2117027|P2|COMPLETED|Overall Study|Analysed (n=50 )|50
874772|NCT02125838|2117028|P1|COMPLETED|Overall Study|Analysed (n=50 )|50
874773|NCT02125838|2117027|P2|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions) (n= 2) NBA used (n= 2)|54
874774|NCT02125838|2117028|P1|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions)(n= 2) NBA used (n= 2)|54
874775|NCT02125734|2117046|P2|NOT COMPLETED|Period 2||1
874776|NCT02125734|2117047|P1|NOT COMPLETED|Period 2||0
874777|NCT02125734|2117046|P2|COMPLETED|Period 2||47
874778|NCT02125734|2117047|P1|COMPLETED|Period 2||40
874779|NCT02125734|2117046|P2|STARTED|Period 2||48
874780|NCT02125734|2117047|P1|STARTED|Period 2||40
874781|NCT02125734|2117046|P2|NOT COMPLETED|Period 1||0
874782|NCT02125734|2117047|P1|NOT COMPLETED|Period 1||0
874783|NCT02125734|2117046|P2|COMPLETED|Period 1||48
874784|NCT02125734|2117047|P1|COMPLETED|Period 1||40
874785|NCT02125734|2117046|P2|STARTED|Period 1||48
874786|NCT02125734|2117047|P1|STARTED|Period 1||40
874787|NCT02125604|2117057|P1|NOT COMPLETED|Overall Study||31
874788|NCT02125604|2117057|P1|COMPLETED|Overall Study||180
874789|NCT02125604|2117057|P1|STARTED|Overall Study|enrolled and received at least 1 dose of study drug|211
874790|NCT02125292|2117071|P6|NOT COMPLETED|Third Intervention (1 Hour)||0
874791|NCT02125292|2117072|P5|NOT COMPLETED|Third Intervention (1 Hour)||0
874792|NCT02125292|2117073|P4|NOT COMPLETED|Third Intervention (1 Hour)||0
874793|NCT02125292|2117074|P3|NOT COMPLETED|Third Intervention (1 Hour)||0
874794|NCT02125292|2117075|P2|NOT COMPLETED|Third Intervention (1 Hour)||0
874795|NCT02125292|2117076|P1|NOT COMPLETED|Third Intervention (1 Hour)||0
874796|NCT02125292|2117071|P6|COMPLETED|Third Intervention (1 Hour)||3
874797|NCT02125292|2117072|P5|COMPLETED|Third Intervention (1 Hour)||3
874798|NCT02125292|2117073|P4|COMPLETED|Third Intervention (1 Hour)||3
874799|NCT02125292|2117074|P3|COMPLETED|Third Intervention (1 Hour)||3
874800|NCT02125292|2117075|P2|COMPLETED|Third Intervention (1 Hour)||3
874801|NCT02125292|2117076|P1|COMPLETED|Third Intervention (1 Hour)||3
874802|NCT02125292|2117071|P6|STARTED|Third Intervention (1 Hour)||3
874803|NCT02125292|2117072|P5|STARTED|Third Intervention (1 Hour)||3
874804|NCT02125292|2117073|P4|STARTED|Third Intervention (1 Hour)||3
874805|NCT02125292|2117074|P3|STARTED|Third Intervention (1 Hour)||3
874806|NCT02125292|2117075|P2|STARTED|Third Intervention (1 Hour)||3
874807|NCT02125292|2117076|P1|STARTED|Third Intervention (1 Hour)||3
874808|NCT02125292|2117071|P6|NOT COMPLETED|Washout (2 Hours)||0
874809|NCT02125292|2117072|P5|NOT COMPLETED|Washout (2 Hours)||0
874810|NCT02125292|2117073|P4|NOT COMPLETED|Washout (2 Hours)||0
874811|NCT02125292|2117074|P3|NOT COMPLETED|Washout (2 Hours)||0
874812|NCT02125292|2117075|P2|NOT COMPLETED|Washout (2 Hours)||0
874813|NCT02125292|2117076|P1|NOT COMPLETED|Washout (2 Hours)||0
874814|NCT02125292|2117071|P6|COMPLETED|Washout (2 Hours)||3
874815|NCT02125292|2117072|P5|COMPLETED|Washout (2 Hours)||3
874816|NCT02125292|2117073|P4|COMPLETED|Washout (2 Hours)||3
874817|NCT02125292|2117074|P3|COMPLETED|Washout (2 Hours)||3
874818|NCT02125292|2117075|P2|COMPLETED|Washout (2 Hours)||3
874819|NCT02125292|2117076|P1|COMPLETED|Washout (2 Hours)||3
874820|NCT02125292|2117071|P6|STARTED|Washout (2 Hours)||3
874821|NCT02125292|2117072|P5|STARTED|Washout (2 Hours)||3
874822|NCT02125292|2117073|P4|STARTED|Washout (2 Hours)||3
874823|NCT02125292|2117074|P3|STARTED|Washout (2 Hours)||3
874824|NCT02125292|2117075|P2|STARTED|Washout (2 Hours)||3
874825|NCT02125292|2117076|P1|STARTED|Washout (2 Hours)||3
874826|NCT02125292|2117071|P6|NOT COMPLETED|Second Intervention (1 Hour)||0
874827|NCT02125292|2117072|P5|NOT COMPLETED|Second Intervention (1 Hour)||0
874828|NCT02125292|2117073|P4|NOT COMPLETED|Second Intervention (1 Hour)||0
874829|NCT02125292|2117074|P3|NOT COMPLETED|Second Intervention (1 Hour)||0
874830|NCT02125292|2117075|P2|NOT COMPLETED|Second Intervention (1 Hour)||0
874831|NCT02125292|2117076|P1|NOT COMPLETED|Second Intervention (1 Hour)||0
874832|NCT02125292|2117071|P6|COMPLETED|Second Intervention (1 Hour)||3
874833|NCT02125292|2117072|P5|COMPLETED|Second Intervention (1 Hour)||3
874834|NCT02125292|2117073|P4|COMPLETED|Second Intervention (1 Hour)||3
874835|NCT02125292|2117074|P3|COMPLETED|Second Intervention (1 Hour)||3
874836|NCT02125292|2117075|P2|COMPLETED|Second Intervention (1 Hour)||3
874837|NCT02125292|2117076|P1|COMPLETED|Second Intervention (1 Hour)||3
874838|NCT02125292|2117071|P6|STARTED|Second Intervention (1 Hour)||3
874839|NCT02125292|2117072|P5|STARTED|Second Intervention (1 Hour)||3
874840|NCT02125292|2117073|P4|STARTED|Second Intervention (1 Hour)||3
874841|NCT02125292|2117074|P3|STARTED|Second Intervention (1 Hour)||3
874842|NCT02125292|2117075|P2|STARTED|Second Intervention (1 Hour)||3
874843|NCT02125292|2117076|P1|STARTED|Second Intervention (1 Hour)||3
874844|NCT02125292|2117071|P6|NOT COMPLETED|Washout (2 Hours)||0
874845|NCT02125292|2117072|P5|NOT COMPLETED|Washout (2 Hours)||0
874846|NCT02125292|2117073|P4|NOT COMPLETED|Washout (2 Hours)||0
874847|NCT02125292|2117074|P3|NOT COMPLETED|Washout (2 Hours)||0
874848|NCT02125292|2117075|P2|NOT COMPLETED|Washout (2 Hours)||0
874849|NCT02125292|2117076|P1|NOT COMPLETED|Washout (2 Hours)||0
874850|NCT02125292|2117071|P6|COMPLETED|Washout (2 Hours)||3
874851|NCT02125292|2117072|P5|COMPLETED|Washout (2 Hours)||3
874852|NCT02125292|2117073|P4|COMPLETED|Washout (2 Hours)||3
874853|NCT02125292|2117074|P3|COMPLETED|Washout (2 Hours)||3
874854|NCT02125292|2117075|P2|COMPLETED|Washout (2 Hours)||3
874855|NCT02125292|2117076|P1|COMPLETED|Washout (2 Hours)||3
874856|NCT02125292|2117071|P6|STARTED|Washout (2 Hours)||3
874857|NCT02125292|2117072|P5|STARTED|Washout (2 Hours)||3
874858|NCT02125292|2117073|P4|STARTED|Washout (2 Hours)||3
874859|NCT02125292|2117074|P3|STARTED|Washout (2 Hours)||3
874860|NCT02125292|2117075|P2|STARTED|Washout (2 Hours)||3
874861|NCT02125292|2117076|P1|STARTED|Washout (2 Hours)||3
874862|NCT02125292|2117071|P6|NOT COMPLETED|First Intervention (1 Hour)||0
874863|NCT02125292|2117072|P5|NOT COMPLETED|First Intervention (1 Hour)||0
874864|NCT02125292|2117073|P4|NOT COMPLETED|First Intervention (1 Hour)||0
874865|NCT02125292|2117074|P3|NOT COMPLETED|First Intervention (1 Hour)||0
874866|NCT02125292|2117075|P2|NOT COMPLETED|First Intervention (1 Hour)||0
874867|NCT02125292|2117076|P1|NOT COMPLETED|First Intervention (1 Hour)||0
874868|NCT02125292|2117071|P6|COMPLETED|First Intervention (1 Hour)||3
874869|NCT02125292|2117072|P5|COMPLETED|First Intervention (1 Hour)||3
874870|NCT02125292|2117073|P4|COMPLETED|First Intervention (1 Hour)||3
874871|NCT02125292|2117074|P3|COMPLETED|First Intervention (1 Hour)||3
874872|NCT02125292|2117075|P2|COMPLETED|First Intervention (1 Hour)||3
874873|NCT02125292|2117076|P1|COMPLETED|First Intervention (1 Hour)||3
874874|NCT02125292|2117071|P6|STARTED|First Intervention (1 Hour)||3
874875|NCT02125292|2117072|P5|STARTED|First Intervention (1 Hour)||3
874876|NCT02125292|2117073|P4|STARTED|First Intervention (1 Hour)||3
874877|NCT02125292|2117074|P3|STARTED|First Intervention (1 Hour)||3
874878|NCT02125292|2117075|P2|STARTED|First Intervention (1 Hour)||3
874879|NCT02125292|2117076|P1|STARTED|First Intervention (1 Hour)||3
874880|NCT02124863|2117097|P1|NOT COMPLETED|Overall Study||17
874881|NCT02124863|2117097|P1|COMPLETED|Overall Study||50
874882|NCT02124863|2117097|P1|STARTED|Overall Study||67
874883|NCT02124798|2117103|P1|NOT COMPLETED|Overall Study||4
874884|NCT02124798|2117103|P1|COMPLETED|Overall Study||91
874885|NCT02124798|2117103|P1|STARTED|Overall Study||95
874886|NCT02124603|2117109|P1|NOT COMPLETED|Overall Study||0
874887|NCT02124603|2117109|P1|COMPLETED|Overall Study||120
874888|NCT02124603|2117109|P1|STARTED|Overall Study||120
874889|NCT02124460|2117117|P2|NOT COMPLETED|Overall Study||24
874890|NCT02124460|2117118|P1|NOT COMPLETED|Overall Study||33
874891|NCT02124460|2117117|P2|COMPLETED|Overall Study||336
874892|NCT02124460|2117118|P1|COMPLETED|Overall Study||328
874893|NCT02124460|2117117|P2|STARTED|Overall Study||360
874894|NCT02124460|2117118|P1|STARTED|Overall Study||361
874895|NCT02124304|2117150|P2|NOT COMPLETED|Overall Study||0
874896|NCT02124304|2117151|P1|NOT COMPLETED|Overall Study||0
874897|NCT02124304|2117150|P2|COMPLETED|Overall Study||15
874898|NCT02124304|2117151|P1|COMPLETED|Overall Study||15
874899|NCT02124304|2117150|P2|STARTED|Overall Study||15
874900|NCT02124304|2117151|P1|STARTED|Overall Study||15
874901|NCT02124161|2117161|P2|NOT COMPLETED|Overall Study||15
874902|NCT02124161|2117162|P1|NOT COMPLETED|Overall Study||16
874903|NCT02124161|2117161|P2|COMPLETED|Overall Study||426
874904|NCT02124161|2117162|P1|COMPLETED|Overall Study||425
874905|NCT02124161|2117161|P2|Vaccination 2|Overall Study||432
874906|NCT02124161|2117162|P1|Vaccination 2|Overall Study||431
874907|NCT02124161|2117161|P2|Vaccination 1|Overall Study||437
874908|NCT02124161|2117162|P1|Vaccination 1|Overall Study||439
874909|NCT02124161|2117161|P2|STARTED|Overall Study||441
874910|NCT02124161|2117162|P1|STARTED|Overall Study||441
874911|NCT02124122|2117194|P2|NOT COMPLETED|Overall Study||0
874912|NCT02124122|2117195|P1|NOT COMPLETED|Overall Study||0
874913|NCT02124122|2117194|P2|COMPLETED|Overall Study||19
874914|NCT02124122|2117195|P1|COMPLETED|Overall Study||41
874915|NCT02124122|2117194|P2|STARTED|Overall Study||19
874916|NCT02124122|2117195|P1|STARTED|Overall Study||41
874917|NCT02124044|2117205|P2|NOT COMPLETED|Overall Study||1
874918|NCT02124044|2117206|P1|NOT COMPLETED|Overall Study||0
874919|NCT02124044|2117205|P2|COMPLETED|Overall Study||9
874920|NCT02124044|2117206|P1|COMPLETED|Overall Study||20
874921|NCT02124044|2117205|P2|STARTED|Overall Study||10
874922|NCT02124044|2117206|P1|STARTED|Overall Study||20
874923|NCT02123745|2117212|P1|NOT COMPLETED|Overall Study||0
874924|NCT02123745|2117212|P1|COMPLETED|Overall Study||71
874925|NCT02123745|2117212|P1|STARTED|Overall Study||71
874926|NCT02123472|2117220|P2|NOT COMPLETED|Period 2 (7 Days)||1
874927|NCT02123472|2117221|P1|NOT COMPLETED|Period 2 (7 Days)||0
874928|NCT02123472|2117220|P2|COMPLETED|Period 2 (7 Days)||13
874929|NCT02123472|2117221|P1|COMPLETED|Period 2 (7 Days)||14
874930|NCT02123472|2117220|P2|STARTED|Period 2 (7 Days)||14
874931|NCT02123472|2117221|P1|STARTED|Period 2 (7 Days)||14
874932|NCT02123472|2117220|P2|NOT COMPLETED|Washout Period (1 Day)||0
874933|NCT02123472|2117221|P1|NOT COMPLETED|Washout Period (1 Day)||0
874934|NCT02123472|2117220|P2|COMPLETED|Washout Period (1 Day)||14
874935|NCT02123472|2117221|P1|COMPLETED|Washout Period (1 Day)||14
874936|NCT02123472|2117220|P2|STARTED|Washout Period (1 Day)||14
874937|NCT02123472|2117221|P1|STARTED|Washout Period (1 Day)||14
874938|NCT02123472|2117220|P2|NOT COMPLETED|Period 1 (7 Days)||0
874939|NCT02123472|2117221|P1|NOT COMPLETED|Period 1 (7 Days)||0
874940|NCT02123472|2117220|P2|COMPLETED|Period 1 (7 Days)||14
874941|NCT02123472|2117221|P1|COMPLETED|Period 1 (7 Days)||14
874942|NCT02123472|2117220|P2|STARTED|Period 1 (7 Days)||14
874943|NCT02123472|2117221|P1|STARTED|Period 1 (7 Days)||14
874944|NCT02123459|2117231|P2|NOT COMPLETED|Period 2 (7 Days)||0
874945|NCT02123459|2117232|P1|NOT COMPLETED|Period 2 (7 Days)||0
874946|NCT02123459|2117231|P2|COMPLETED|Period 2 (7 Days)||14
874947|NCT02123459|2117232|P1|COMPLETED|Period 2 (7 Days)||13
874948|NCT02123459|2117231|P2|STARTED|Period 2 (7 Days)||14
874949|NCT02123459|2117232|P1|STARTED|Period 2 (7 Days)||13
874950|NCT02123459|2117231|P2|NOT COMPLETED|Washout Period (1 Day)||0
874951|NCT02123459|2117232|P1|NOT COMPLETED|Washout Period (1 Day)||1
874952|NCT02123459|2117231|P2|COMPLETED|Washout Period (1 Day)||14
874953|NCT02123459|2117232|P1|COMPLETED|Washout Period (1 Day)||13
874954|NCT02123459|2117231|P2|STARTED|Washout Period (1 Day)||14
874955|NCT02123459|2117232|P1|STARTED|Washout Period (1 Day)||14
874956|NCT02123459|2117231|P2|NOT COMPLETED|Period 1 (7 Days)||0
874957|NCT02123459|2117232|P1|NOT COMPLETED|Period 1 (7 Days)||0
874958|NCT02123459|2117231|P2|COMPLETED|Period 1 (7 Days)||14
874959|NCT02123459|2117232|P1|COMPLETED|Period 1 (7 Days)||14
874960|NCT02123459|2117231|P2|STARTED|Period 1 (7 Days)||14
874961|NCT02123459|2117232|P1|STARTED|Period 1 (7 Days)||14
874962|NCT02123446|2117242|P2|NOT COMPLETED|Period 2 (7 Days)||0
874963|NCT02123446|2117243|P1|NOT COMPLETED|Period 2 (7 Days)||0
874964|NCT02123446|2117242|P2|COMPLETED|Period 2 (7 Days)||14
874965|NCT02123446|2117243|P1|COMPLETED|Period 2 (7 Days)||13
874966|NCT02123446|2117242|P2|STARTED|Period 2 (7 Days)||14
874967|NCT02123446|2117243|P1|STARTED|Period 2 (7 Days)||13
874968|NCT02123446|2117242|P2|NOT COMPLETED|Washout Period (1 Day)||0
874969|NCT02123446|2117243|P1|NOT COMPLETED|Washout Period (1 Day)||1
874970|NCT02123446|2117242|P2|COMPLETED|Washout Period (1 Day)||14
874971|NCT02123446|2117243|P1|COMPLETED|Washout Period (1 Day)||13
874972|NCT02123446|2117242|P2|STARTED|Washout Period (1 Day)||14
874973|NCT02123446|2117243|P1|STARTED|Washout Period (1 Day)||14
874974|NCT02123446|2117242|P2|NOT COMPLETED|Period 1 (7 Days)||0
874975|NCT02123446|2117243|P1|NOT COMPLETED|Period 1 (7 Days)||0
874976|NCT02123446|2117242|P2|COMPLETED|Period 1 (7 Days)||14
874977|NCT02123446|2117243|P1|COMPLETED|Period 1 (7 Days)||14
874978|NCT02123446|2117242|P2|STARTED|Period 1 (7 Days)||14
874979|NCT02123446|2117243|P1|STARTED|Period 1 (7 Days)||14
874980|NCT02123017|2117256|P3|NOT COMPLETED|Overall Study||0
874981|NCT02123017|2117257|P2|NOT COMPLETED|Overall Study||0
874982|NCT02123017|2117258|P1|NOT COMPLETED|Overall Study||0
874983|NCT02123017|2117256|P3|COMPLETED|Overall Study||12
874984|NCT02123017|2117257|P2|COMPLETED|Overall Study||12
874985|NCT02123017|2117258|P1|COMPLETED|Overall Study||8
874986|NCT02123017|2117256|P3|STARTED|Overall Study||12
874987|NCT02123017|2117257|P2|STARTED|Overall Study||12
874988|NCT02123017|2117258|P1|STARTED|Overall Study||8
874989|NCT02122549|2117275|P1|NOT COMPLETED|Overall Study||0
874990|NCT02122549|2117275|P1|COMPLETED|Overall Study||59
874991|NCT02122549|2117275|P1|STARTED|Overall Study||59
874992|NCT02122445|2117279|P1|NOT COMPLETED|Overall Study||0
874993|NCT02122445|2117279|P1|COMPLETED|Overall Study||20
874994|NCT02122445|2117279|P1|STARTED|Overall Study||20
874995|NCT02122406|2117284|P1|NOT COMPLETED|Overall Study||0
874996|NCT02122406|2117284|P1|COMPLETED|Overall Study||200
874997|NCT02122406|2117284|P1|STARTED|Overall Study||200
874998|NCT02121860|2117292|P4|NOT COMPLETED|Overall Study||0
874999|NCT02121860|2117293|P3|NOT COMPLETED|Overall Study||0
875000|NCT02121860|2117294|P2|NOT COMPLETED|Overall Study||0
875001|NCT02121860|2117295|P1|NOT COMPLETED|Overall Study||0
875002|NCT02121860|2117292|P4|COMPLETED|Overall Study||8
875003|NCT02121860|2117293|P3|COMPLETED|Overall Study||8
875004|NCT02121860|2117294|P2|COMPLETED|Overall Study||12
875005|NCT02121860|2117295|P1|COMPLETED|Overall Study||8
875006|NCT02121860|2117292|P4|STARTED|Overall Study||8
875007|NCT02121860|2117293|P3|STARTED|Overall Study||8
875008|NCT02121860|2117294|P2|STARTED|Overall Study||12
875009|NCT02121860|2117295|P1|STARTED|Overall Study||8
875010|NCT02121847|2117314|P1|NOT COMPLETED|Overall Study||3
875011|NCT02121847|2117314|P1|COMPLETED|Overall Study||37
875012|NCT02121847|2117314|P1|STARTED|Overall Study||40
875013|NCT02121795|2117335|P2|NOT COMPLETED|Overall Study||334
875014|NCT02121795|2117336|P1|NOT COMPLETED|Overall Study||334
875015|NCT02121795|2117335|P2|COMPLETED|Overall Study||0
875016|NCT02121795|2117336|P1|COMPLETED|Overall Study||0
875017|NCT02121795|2117335|P2|STARTED|Overall Study||334
875018|NCT02121795|2117336|P1|STARTED|Overall Study||334
875019|NCT02121535|2117352|P2|NOT COMPLETED|Period 4 (8 Trial Days)||0
875020|NCT02121535|2117353|P1|NOT COMPLETED|Period 4 (8 Trial Days)||0
875021|NCT02121535|2117352|P2|COMPLETED|Period 4 (8 Trial Days)||35
875022|NCT02121535|2117353|P1|COMPLETED|Period 4 (8 Trial Days)||35
875023|NCT02121535|2117352|P2|STARTED|Period 4 (8 Trial Days)||35
875024|NCT02121535|2117353|P1|STARTED|Period 4 (8 Trial Days)||35
875025|NCT02121535|2117352|P2|NOT COMPLETED|Period 3 (8 Trial Days)||0
875026|NCT02121535|2117353|P1|NOT COMPLETED|Period 3 (8 Trial Days)||1
875027|NCT02121535|2117352|P2|COMPLETED|Period 3 (8 Trial Days)||35
875028|NCT02121535|2117353|P1|COMPLETED|Period 3 (8 Trial Days)|1 subject withdrew consent during the washout period between Period 3 and 4.|35
875029|NCT02121535|2117352|P2|STARTED|Period 3 (8 Trial Days)||35
875030|NCT02121535|2117353|P1|STARTED|Period 3 (8 Trial Days)||36
875031|NCT02121535|2117352|P2|NOT COMPLETED|Period 2 (8 Trial Days)||0
875032|NCT02121535|2117353|P1|NOT COMPLETED|Period 2 (8 Trial Days)||0
875033|NCT02121535|2117352|P2|COMPLETED|Period 2 (8 Trial Days)||35
875034|NCT02121535|2117353|P1|COMPLETED|Period 2 (8 Trial Days)||36
875035|NCT02121535|2117352|P2|STARTED|Period 2 (8 Trial Days)||35
875036|NCT02121535|2117353|P1|STARTED|Period 2 (8 Trial Days)||36
875037|NCT02121535|2117352|P2|NOT COMPLETED|Period 1 (8 Trial Days)||1
875038|NCT02121535|2117353|P1|NOT COMPLETED|Period 1 (8 Trial Days)||0
875039|NCT02121535|2117352|P2|COMPLETED|Period 1 (8 Trial Days)|1 subject withdrew his consent during the washout period between Period 1 and 2.|35
875040|NCT02121535|2117353|P1|COMPLETED|Period 1 (8 Trial Days)||36
875041|NCT02121535|2117352|P2|STARTED|Period 1 (8 Trial Days)||36
875042|NCT02121535|2117353|P1|STARTED|Period 1 (8 Trial Days)||36
875043|NCT02121522|2117376|P1|NOT COMPLETED|Overall Study||1
875044|NCT02121522|2117376|P1|COMPLETED|Overall Study||13
875045|NCT02121522|2117376|P1|STARTED|Overall Study||14
875046|NCT02121509|2117383|P4|NOT COMPLETED|Treatment Period-2 (4 Days)||0
875047|NCT02121509|2117384|P3|NOT COMPLETED|Treatment Period-2 (4 Days)||0
875048|NCT02121509|2117385|P2|NOT COMPLETED|Treatment Period-2 (4 Days)||0
875049|NCT02121509|2117386|P1|NOT COMPLETED|Treatment Period-2 (4 Days)||0
875050|NCT02121509|2117383|P4|COMPLETED|Treatment Period-2 (4 Days)||8
875051|NCT02121509|2117384|P3|COMPLETED|Treatment Period-2 (4 Days)||8
875052|NCT02121509|2117385|P2|COMPLETED|Treatment Period-2 (4 Days)||24
875053|NCT02121509|2117386|P1|COMPLETED|Treatment Period-2 (4 Days)||28
875054|NCT02121509|2117383|P4|STARTED|Treatment Period-2 (4 Days)||8
875055|NCT02121509|2117384|P3|STARTED|Treatment Period-2 (4 Days)||8
875056|NCT02121509|2117385|P2|STARTED|Treatment Period-2 (4 Days)||24
875057|NCT02121509|2117386|P1|STARTED|Treatment Period-2 (4 Days)||28
875058|NCT02121509|2117383|P4|NOT COMPLETED|Washout Period (35 Days)||0
875059|NCT02121509|2117384|P3|NOT COMPLETED|Washout Period (35 Days)||0
875060|NCT02121509|2117385|P2|NOT COMPLETED|Washout Period (35 Days)||4
875061|NCT02121509|2117386|P1|NOT COMPLETED|Washout Period (35 Days)||2
875062|NCT02121509|2117383|P4|COMPLETED|Washout Period (35 Days)||8
875063|NCT02121509|2117384|P3|COMPLETED|Washout Period (35 Days)||8
875064|NCT02121509|2117385|P2|COMPLETED|Washout Period (35 Days)||24
875065|NCT02121509|2117386|P1|COMPLETED|Washout Period (35 Days)||28
875066|NCT02121509|2117383|P4|STARTED|Washout Period (35 Days)||8
875067|NCT02121509|2117384|P3|STARTED|Washout Period (35 Days)||8
875068|NCT02121509|2117385|P2|STARTED|Washout Period (35 Days)||28
875069|NCT02121509|2117386|P1|STARTED|Washout Period (35 Days)||30
875070|NCT02121509|2117383|P4|NOT COMPLETED|Treatment Period-1 (4 Days)||0
875071|NCT02121509|2117384|P3|NOT COMPLETED|Treatment Period-1 (4 Days)||0
875072|NCT02121509|2117385|P2|NOT COMPLETED|Treatment Period-1 (4 Days)||0
875073|NCT02121509|2117386|P1|NOT COMPLETED|Treatment Period-1 (4 Days)||0
875074|NCT02121509|2117383|P4|COMPLETED|Treatment Period-1 (4 Days)||8
875075|NCT02121509|2117384|P3|COMPLETED|Treatment Period-1 (4 Days)||8
875076|NCT02121509|2117385|P2|COMPLETED|Treatment Period-1 (4 Days)||28
875077|NCT02121509|2117386|P1|COMPLETED|Treatment Period-1 (4 Days)||30
875078|NCT02121509|2117383|P4|STARTED|Treatment Period-1 (4 Days)||8
875079|NCT02121509|2117384|P3|STARTED|Treatment Period-1 (4 Days)||8
875080|NCT02121509|2117385|P2|STARTED|Treatment Period-1 (4 Days)||28
875081|NCT02121509|2117386|P1|STARTED|Treatment Period-1 (4 Days)||30
875082|NCT02121483|2117419|P3|NOT COMPLETED|Overall Study||0
875083|NCT02121483|2117420|P2|NOT COMPLETED|Overall Study||0
875084|NCT02121483|2117421|P1|NOT COMPLETED|Overall Study||0
875085|NCT02121483|2117419|P3|COMPLETED|Overall Study||10
875086|NCT02121483|2117420|P2|COMPLETED|Overall Study||8
875087|NCT02121483|2117421|P1|COMPLETED|Overall Study||9
875088|NCT02121483|2117419|P3|STARTED|Overall Study||10
875089|NCT02121483|2117420|P2|STARTED|Overall Study||8
875090|NCT02121483|2117421|P1|STARTED|Overall Study||9
875091|NCT02121210|2117452|P2|NOT COMPLETED|Overall Study||9
875092|NCT02121210|2117453|P1|NOT COMPLETED|Overall Study||7
875093|NCT02121210|2117452|P2|COMPLETED|Overall Study||58
875094|NCT02121210|2117453|P1|COMPLETED|Overall Study||58
875095|NCT02121210|2117452|P2|STARTED|Overall Study||67
875096|NCT02121210|2117453|P1|STARTED|Overall Study||65
875097|NCT02121067|2117461|P1|NOT COMPLETED|Overall Study||0
875098|NCT02121067|2117461|P1|COMPLETED|Overall Study||50
875099|NCT02121067|2117461|P1|STARTED|Overall Study||50
875100|NCT02121041|2117469|P2|NOT COMPLETED|Overall Study||6
875101|NCT02121041|2117470|P1|NOT COMPLETED|Overall Study||1
875102|NCT02121041|2117469|P2|COMPLETED|Overall Study||8
875103|NCT02121041|2117470|P1|COMPLETED|Overall Study||13
875104|NCT02121041|2117469|P2|STARTED|Overall Study||14
875105|NCT02121041|2117470|P1|STARTED|Overall Study||14
875106|NCT02120833|2117478|P2|NOT COMPLETED|Overall Study||1
875107|NCT02120833|2117479|P1|NOT COMPLETED|Overall Study||4
875108|NCT02120833|2117478|P2|COMPLETED|Overall Study||11
875109|NCT02120833|2117479|P1|COMPLETED|Overall Study||35
875110|NCT02120833|2117478|P2|STARTED|Overall Study||12
875111|NCT02120833|2117479|P1|STARTED|Overall Study||39
875112|NCT02120664|2117638|P5|NOT COMPLETED|Overall Study||0
875113|NCT02120664|2117639|P4|NOT COMPLETED|Overall Study||1
875114|NCT02120664|2117640|P3|NOT COMPLETED|Overall Study||0
875115|NCT02120664|2117641|P2|NOT COMPLETED|Overall Study||0
875116|NCT02120664|2117642|P1|NOT COMPLETED|Overall Study||0
875117|NCT02120664|2117638|P5|COMPLETED|Overall Study||10
875118|NCT02120664|2117639|P4|COMPLETED|Overall Study||3
875119|NCT02120664|2117640|P3|COMPLETED|Overall Study||7
875120|NCT02120664|2117641|P2|COMPLETED|Overall Study||4
875121|NCT02120664|2117642|P1|COMPLETED|Overall Study||10
875122|NCT02120664|2117638|P5|STARTED|Overall Study||10
875123|NCT02120664|2117639|P4|STARTED|Overall Study||4
875124|NCT02120664|2117640|P3|STARTED|Overall Study||7
875125|NCT02120664|2117641|P2|STARTED|Overall Study||4
875126|NCT02120664|2117642|P1|STARTED|Overall Study||10
875127|NCT02120625|2117660|P1|NOT COMPLETED|Overall Study||2
875128|NCT02120625|2117660|P1|COMPLETED|Overall Study||6
875129|NCT02120625|2117660|P1|STARTED|Overall Study||8
875130|NCT02120443|2117667|P1|NOT COMPLETED|Overall Study||0
875131|NCT02120443|2117667|P1|COMPLETED|Overall Study||43
875132|NCT02120443|2117667|P1|STARTED|Overall Study||43
875133|NCT02120417|2117675|P2|NOT COMPLETED|Overall Study||68
875134|NCT02120417|2117676|P1|NOT COMPLETED|Overall Study||60
875135|NCT02120417|2117675|P2|COMPLETED|Overall Study||5
875136|NCT02120417|2117676|P1|COMPLETED|Overall Study||16
875137|NCT02120417|2117675|P2|STARTED|Overall Study||73
875138|NCT02120417|2117676|P1|STARTED|Overall Study||76
875139|NCT02120300|2117698|P4|NOT COMPLETED|Overall Study||1
875140|NCT02120300|2117699|P3|NOT COMPLETED|Overall Study||0
875141|NCT02120300|2117700|P2|NOT COMPLETED|Overall Study||0
875142|NCT02120300|2117701|P1|NOT COMPLETED|Overall Study||3
875143|NCT02120300|2117698|P4|COMPLETED|Overall Study||5
875144|NCT02120300|2117699|P3|COMPLETED|Overall Study||10
875145|NCT02120300|2117700|P2|COMPLETED|Overall Study||5
875146|NCT02120300|2117701|P1|COMPLETED|Overall Study||98
875147|NCT02120300|2117698|P4|STARTED|Overall Study||6
875148|NCT02120300|2117699|P3|STARTED|Overall Study||10
875149|NCT02120300|2117700|P2|STARTED|Overall Study||5
875150|NCT02120300|2117701|P1|STARTED|Overall Study||101
875151|NCT02120027|2117739|P2|NOT COMPLETED|Overall Study||119
875152|NCT02120027|2117740|P1|NOT COMPLETED|Overall Study||116
875153|NCT02120027|2117739|P2|COMPLETED|Overall Study||160
875154|NCT02120027|2117740|P1|COMPLETED|Overall Study||161
875155|NCT02120027|2117739|P2|STARTED|Overall Study||279
875156|NCT02120027|2117740|P1|STARTED|Overall Study||277
875157|NCT02120001|2117756|P2|NOT COMPLETED|Overall Study||0
875158|NCT02120001|2117757|P1|NOT COMPLETED|Overall Study||0
875159|NCT02120001|2117756|P2|COMPLETED|Overall Study||19
875160|NCT02120001|2117757|P1|COMPLETED|Overall Study||17
875161|NCT02120001|2117756|P2|STARTED|Overall Study||19
875162|NCT02120001|2117757|P1|STARTED|Overall Study||17
875163|NCT02119676|2117769|P4|NOT COMPLETED|Overall Study||101
875164|NCT02119676|2117770|P3|NOT COMPLETED|Overall Study||97
875165|NCT02119676|2117771|P2|NOT COMPLETED|Overall Study||86
875166|NCT02119676|2117772|P1|NOT COMPLETED|Overall Study||83
875167|NCT02119676|2117769|P4|COMPLETED|Overall Study||10
875168|NCT02119676|2117770|P3|COMPLETED|Overall Study||13
875169|NCT02119676|2117771|P2|COMPLETED|Overall Study||2
875170|NCT02119676|2117772|P1|COMPLETED|Overall Study||4
875171|NCT02119676|2117769|P4|Treated Patients|Overall Study||106
875172|NCT02119676|2117770|P3|Treated Patients|Overall Study||106
875173|NCT02119676|2117771|P2|Treated Patients|Overall Study||86
875174|NCT02119676|2117772|P1|Treated Patients|Overall Study||85
875175|NCT02119676|2117769|P4|STARTED|Overall Study||111
875176|NCT02119676|2117770|P3|STARTED|Overall Study||110
875177|NCT02119676|2117771|P2|STARTED|Overall Study||88
875178|NCT02119676|2117772|P1|STARTED|Overall Study||87
875179|NCT02119663|2117804|P2|NOT COMPLETED|Overall Study||41
875180|NCT02119663|2117805|P1|NOT COMPLETED|Overall Study||40
875181|NCT02119663|2117804|P2|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|2
875182|NCT02119663|2117805|P1|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|3
875183|NCT02119663|2117804|P2|STARTED|Overall Study||43
875184|NCT02119663|2117805|P1|STARTED|Overall Study||43
875191|NCT02119325|2117838|P2|NOT COMPLETED|Period 2||0
875192|NCT02119325|2117839|P1|NOT COMPLETED|Period 2||0
875193|NCT02119325|2117838|P2|COMPLETED|Period 2||47
875194|NCT02119325|2117839|P1|COMPLETED|Period 2||48
875195|NCT02119325|2117838|P2|STARTED|Period 2||47
875196|NCT02119325|2117839|P1|STARTED|Period 2||48
875197|NCT02119325|2117838|P2|NOT COMPLETED|Washout Period 1||1
875198|NCT02119325|2117839|P1|NOT COMPLETED|Washout Period 1||0
875199|NCT02119325|2117838|P2|COMPLETED|Washout Period 1||47
875200|NCT02119325|2117839|P1|COMPLETED|Washout Period 1||48
875201|NCT02119325|2117838|P2|STARTED|Washout Period 1||48
875202|NCT02119325|2117839|P1|STARTED|Washout Period 1||48
875203|NCT02119325|2117838|P2|NOT COMPLETED|Period 1||0
875204|NCT02119325|2117839|P1|NOT COMPLETED|Period 1||0
875205|NCT02119325|2117838|P2|COMPLETED|Period 1||48
875206|NCT02119325|2117839|P1|COMPLETED|Period 1||48
875207|NCT02119325|2117838|P2|STARTED|Period 1||48
875208|NCT02119325|2117839|P1|STARTED|Period 1||48
875209|NCT02119299|2117883|P1|NOT COMPLETED|Overall Study||9
875210|NCT02119299|2117883|P1|COMPLETED|Overall Study||67
875211|NCT02119299|2117883|P1|STARTED|Overall Study||76
875212|NCT02119286|2117897|P3|NOT COMPLETED|Overall Study||7
875213|NCT02119286|2117898|P2|NOT COMPLETED|Overall Study||11
875214|NCT02119286|2117899|P1|NOT COMPLETED|Overall Study||26
875215|NCT02119286|2117897|P3|COMPLETED|Overall Study||200
875216|NCT02119286|2117898|P2|COMPLETED|Overall Study||195
875217|NCT02119286|2117899|P1|COMPLETED|Overall Study||180
875218|NCT02119286|2117897|P3|STARTED|Overall Study||207
875219|NCT02119286|2117898|P2|STARTED|Overall Study||206
875220|NCT02119286|2117899|P1|STARTED|Overall Study||206
875221|NCT02119104|2117910|P1|NOT COMPLETED|Overall Study||16
875222|NCT02119104|2117910|P1|COMPLETED|Overall Study||1071
875223|NCT02119104|2117910|P1|STARTED|Overall Study||1087
875224|NCT02118961|2117916|P2|NOT COMPLETED|Overall Study||0
875225|NCT02118961|2117917|P1|NOT COMPLETED|Overall Study||1
875226|NCT02118961|2117916|P2|COMPLETED|Overall Study||222
875227|NCT02118961|2117917|P1|COMPLETED|Overall Study||223
875228|NCT02118961|2117916|P2|STARTED|Overall Study||222
875229|NCT02118961|2117917|P1|STARTED|Overall Study||224
875230|NCT02118896|2117945|P10|NOT COMPLETED|Overall Study||2
875231|NCT02118896|2117946|P9|NOT COMPLETED|Overall Study||4
875232|NCT02118896|2117947|P8|NOT COMPLETED|Overall Study||2
875233|NCT02118896|2117948|P7|NOT COMPLETED|Overall Study||2
875234|NCT02118896|2117949|P6|NOT COMPLETED|Overall Study||28
875235|NCT02118896|2117950|P5|NOT COMPLETED|Overall Study||17
875236|NCT02118896|2117951|P4|NOT COMPLETED|Overall Study||24
875237|NCT02118896|2117952|P3|NOT COMPLETED|Overall Study||14
875238|NCT02118896|2117953|P2|NOT COMPLETED|Overall Study||15
875239|NCT02118896|2117954|P1|NOT COMPLETED|Overall Study||17
875240|NCT02118896|2117945|P10|COMPLETED|Overall Study||7
875241|NCT02118896|2117946|P9|COMPLETED|Overall Study||84
875242|NCT02118896|2117947|P8|COMPLETED|Overall Study||105
875243|NCT02118896|2117948|P7|COMPLETED|Overall Study||83
875244|NCT02118896|2117949|P6|COMPLETED|Overall Study||163
875245|NCT02118896|2117950|P5|COMPLETED|Overall Study||113
875246|NCT02118896|2117951|P4|COMPLETED|Overall Study||55
875247|NCT02118896|2117952|P3|COMPLETED|Overall Study||53
875248|NCT02118896|2117953|P2|COMPLETED|Overall Study||32
875249|NCT02118896|2117954|P1|COMPLETED|Overall Study||30
875250|NCT02118896|2117945|P10|STARTED|Overall Study||9
875251|NCT02118896|2117946|P9|STARTED|Overall Study||88
875252|NCT02118896|2117947|P8|STARTED|Overall Study||107
875253|NCT02118896|2117948|P7|STARTED|Overall Study||85
875254|NCT02118896|2117949|P6|STARTED|Overall Study||191
875255|NCT02118896|2117950|P5|STARTED|Overall Study||130
875256|NCT02118896|2117951|P4|STARTED|Overall Study||79
875257|NCT02118896|2117952|P3|STARTED|Overall Study||67
875258|NCT02118896|2117953|P2|STARTED|Overall Study||47
875259|NCT02118896|2117954|P1|STARTED|Overall Study||47
875260|NCT02118831|2118029|P3|NOT COMPLETED|Overall Study||0
875261|NCT02118831|2118030|P2|NOT COMPLETED|Overall Study||0
875262|NCT02118831|2118031|P1|NOT COMPLETED|Overall Study||0
875263|NCT02118831|2118029|P3|COMPLETED|Overall Study||20
875264|NCT02118831|2118030|P2|COMPLETED|Overall Study||15
875265|NCT02118831|2118031|P1|COMPLETED|Overall Study||21
875266|NCT02118831|2118029|P3|STARTED|Overall Study||20
875267|NCT02118831|2118030|P2|STARTED|Overall Study||15
875268|NCT02118831|2118031|P1|STARTED|Overall Study||21
875269|NCT02118792|2118044|P2|NOT COMPLETED|Overall Study||37
875270|NCT02118792|2118045|P1|NOT COMPLETED|Overall Study||31
875271|NCT02118792|2118044|P2|COMPLETED|Overall Study||213
875272|NCT02118792|2118045|P1|COMPLETED|Overall Study||483
875273|NCT02118792|2118044|P2|Treated|Overall Study||250
875274|NCT02118792|2118045|P1|Treated|Overall Study||513
875275|NCT02118792|2118044|P2|STARTED|Overall Study||250
875276|NCT02118792|2118045|P1|STARTED|Overall Study||514
875277|NCT02118766|2118087|P2|NOT COMPLETED|Overall Study||31
875278|NCT02118766|2118088|P1|NOT COMPLETED|Overall Study||30
875279|NCT02118766|2118087|P2|COMPLETED|Overall Study||225
875280|NCT02118766|2118088|P1|COMPLETED|Overall Study||477
875281|NCT02118766|2118087|P2|Treated|Overall Study||256
875282|NCT02118766|2118088|P1|Treated|Overall Study||503
875283|NCT02118766|2118087|P2|STARTED|Overall Study||256
875284|NCT02118766|2118088|P1|STARTED|Overall Study||507
875285|NCT02118597|2118110|P1|NOT COMPLETED|Overall Study||16
875286|NCT02118597|2118110|P1|COMPLETED|Overall Study||3
875287|NCT02118597|2118110|P1|STARTED|Overall Study||19
875288|NCT02118441|2118126|P2|NOT COMPLETED|Overall Study||1
875289|NCT02118441|2118127|P1|NOT COMPLETED|Overall Study||3
875290|NCT02118441|2118126|P2|COMPLETED|Overall Study||63
875291|NCT02118441|2118127|P1|COMPLETED|Overall Study||62
875292|NCT02118441|2118126|P2|STARTED|Overall Study||64
875293|NCT02118441|2118127|P1|STARTED|Overall Study||65
875294|NCT02117687|2118141|P2|NOT COMPLETED|Overall Study||4
875295|NCT02117687|2118142|P1|NOT COMPLETED|Overall Study||1
875296|NCT02117687|2118141|P2|COMPLETED|Overall Study||36
875297|NCT02117687|2118142|P1|COMPLETED|Overall Study||39
875298|NCT02117687|2118141|P2|STARTED|Overall Study||40
875299|NCT02117687|2118142|P1|STARTED|Overall Study||40
875300|NCT02117570|2118177|P3|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||6
875301|NCT02117570|2118178|P2|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||3
875302|NCT02117570|2118179|P1|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||1
875303|NCT02117570|2118177|P3|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||54
875304|NCT02117570|2118178|P2|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||59
875305|NCT02117570|2118179|P1|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||20
875306|NCT02117570|2118177|P3|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
875307|NCT02117570|2118178|P2|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
875308|NCT02117570|2118179|P1|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||4
875309|NCT02117570|2118177|P3|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||50
875310|NCT02117570|2118178|P2|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||53
875311|NCT02117570|2118179|P1|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||17
875312|NCT02117570|2118177|P3|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||60
875313|NCT02117570|2118178|P2|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||61
875314|NCT02117570|2118179|P1|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||21
875315|NCT02117570|2118177|P3|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|60
875316|NCT02117570|2118178|P2|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|62
875317|NCT02117570|2118179|P1|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|21
875318|NCT02117570|2118177|P3|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
875319|NCT02117570|2118178|P2|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||3
875320|NCT02117570|2118179|P1|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
875321|NCT02117570|2118177|P3|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||17
875322|NCT02117570|2118178|P2|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||15
875323|NCT02117570|2118179|P1|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||5
875324|NCT02117570|2118177|P3|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||18
875325|NCT02117570|2118178|P2|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||17
875326|NCT02117570|2118179|P1|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||6
875327|NCT02117570|2118177|P3|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
875328|NCT02117570|2118178|P2|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
875329|NCT02117570|2118179|P1|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||6
875330|NCT02117570|2118177|P3|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
875331|NCT02117570|2118178|P2|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
875332|NCT02117570|2118179|P1|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||6
875333|NCT02117570|2118177|P3|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
875334|NCT02117570|2118178|P2|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
875335|NCT02117570|2118179|P1|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|6
875336|NCT02117544|2118229|P2|NOT COMPLETED|Period 2||0
875337|NCT02117544|2118230|P1|NOT COMPLETED|Period 2||0
875338|NCT02117544|2118229|P2|COMPLETED|Period 2||55
875339|NCT02117544|2118230|P1|COMPLETED|Period 2||52
875340|NCT02117544|2118229|P2|STARTED|Period 2||55
875341|NCT02117544|2118230|P1|STARTED|Period 2||52
875342|NCT02117544|2118229|P2|NOT COMPLETED|Period 1||0
875343|NCT02117544|2118230|P1|NOT COMPLETED|Period 1||2
875344|NCT02117544|2118229|P2|COMPLETED|Period 1||55
875345|NCT02117544|2118230|P1|COMPLETED|Period 1||52
875346|NCT02117544|2118229|P2|Treated|Period 1||55
875347|NCT02117544|2118230|P1|Treated|Period 1||52
875348|NCT02117544|2118229|P2|STARTED|Period 1||55
875349|NCT02117544|2118230|P1|STARTED|Period 1||54
875350|NCT02117479|2118245|P2|NOT COMPLETED|Overall Study||156
875351|NCT02117479|2118246|P1|NOT COMPLETED|Overall Study||156
875352|NCT02117479|2118245|P2|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|4
875353|NCT02117479|2118246|P1|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|5
875354|NCT02117479|2118245|P2|STARTED|Overall Study||160
875355|NCT02117479|2118246|P1|STARTED|Overall Study||161
875356|NCT02117414|2118264|P2|NOT COMPLETED|Overall Study||6
875357|NCT02117414|2118265|P1|NOT COMPLETED|Overall Study||15
875358|NCT02117414|2118264|P2|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the Control group.|82
875359|NCT02117414|2118265|P1|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the MRI group.|160
875360|NCT02117414|2118264|P2|STARTED|Overall Study|Subjects randomized to the Control group.|88
875361|NCT02117414|2118265|P1|STARTED|Overall Study|Subjects randomized to the MRI group.|175
875362|NCT02117310|2118283|P1|NOT COMPLETED|Overall Study||0
875363|NCT02117310|2118283|P1|COMPLETED|Overall Study||5
875364|NCT02117310|2118283|P1|STARTED|Overall Study||5
875365|NCT02117193|2118287|P1|NOT COMPLETED|Overall Study||0
875366|NCT02117193|2118287|P1|COMPLETED|Overall Study||10
875367|NCT02117193|2118287|P1|Placebo Intake + Sleep Deprivation|Overall Study||10
875368|NCT02117193|2118287|P1|Alcohol Intake + Sleep Deprivation|Overall Study||10
875369|NCT02117193|2118287|P1|Placebo Intake + Normal Sleep|Overall Study||10
875370|NCT02117193|2118287|P1|Alcohol Intake + Normal Sleep|Overall Study||10
875371|NCT02117193|2118287|P1|STARTED|Overall Study||10
875372|NCT02117050|2118309|P1|NOT COMPLETED|Overall Study||1
875373|NCT02117050|2118309|P1|COMPLETED|Overall Study||0
875374|NCT02117050|2118309|P1|STARTED|Overall Study||1
875375|NCT02116582|2118321|P1|NOT COMPLETED|Overall Study||185
875376|NCT02116582|2118321|P1|COMPLETED|Overall Study|Completed indicates participants were still on study drug at the time of the data cut-off.|30
875377|NCT02116582|2118321|P1|Treated|Overall Study||214
875378|NCT02116582|2118321|P1|STARTED|Overall Study||215
875379|NCT02116530|2118331|P2|NOT COMPLETED|Overall Study||4
875380|NCT02116530|2118332|P1|NOT COMPLETED|Overall Study||9
875381|NCT02116530|2118331|P2|COMPLETED|Overall Study||184
875382|NCT02116530|2118332|P1|COMPLETED|Overall Study||183
875383|NCT02116530|2118331|P2|STARTED|Overall Study||188
875384|NCT02116530|2118332|P1|STARTED|Overall Study||192
875385|NCT02116322|2118346|P1|NOT COMPLETED|Overall Study||0
875386|NCT02116322|2118346|P1|COMPLETED|Overall Study||1
875387|NCT02116322|2118346|P1|STARTED|Overall Study||1
875388|NCT02115984|2118353|P2|NOT COMPLETED|Overall Study||7
875389|NCT02115984|2118354|P1|NOT COMPLETED|Overall Study||6
875390|NCT02115984|2118353|P2|COMPLETED|Overall Study||16
875391|NCT02115984|2118354|P1|COMPLETED|Overall Study||51
875392|NCT02115984|2118353|P2|STARTED|Overall Study||23
875393|NCT02115984|2118354|P1|STARTED|Overall Study||57
875394|NCT02115815|2118367|P7|NOT COMPLETED|Overall Study||0
875395|NCT02115815|2118368|P6|NOT COMPLETED|Overall Study||2
875396|NCT02115815|2118369|P5|NOT COMPLETED|Overall Study||0
875397|NCT02115815|2118370|P4|NOT COMPLETED|Overall Study||0
875398|NCT02115815|2118371|P3|NOT COMPLETED|Overall Study||0
875399|NCT02115815|2118372|P2|NOT COMPLETED|Overall Study||0
875400|NCT02115815|2118373|P1|NOT COMPLETED|Overall Study||2
875401|NCT02115815|2118367|P7|COMPLETED|Overall Study||20
875402|NCT02115815|2118368|P6|COMPLETED|Overall Study||20
875403|NCT02115815|2118369|P5|COMPLETED|Overall Study||20
875404|NCT02115815|2118370|P4|COMPLETED|Overall Study||20
875405|NCT02115815|2118371|P3|COMPLETED|Overall Study||20
875406|NCT02115815|2118372|P2|COMPLETED|Overall Study||20
875407|NCT02115815|2118373|P1|COMPLETED|Overall Study||22
875408|NCT02115815|2118367|P7|STARTED|Overall Study||20
875409|NCT02115815|2118368|P6|STARTED|Overall Study||22
875410|NCT02115815|2118369|P5|STARTED|Overall Study||20
875411|NCT02115815|2118370|P4|STARTED|Overall Study||20
875412|NCT02115815|2118371|P3|STARTED|Overall Study||20
875413|NCT02115815|2118372|P2|STARTED|Overall Study||20
875414|NCT02115815|2118373|P1|STARTED|Overall Study||24
875415|NCT02115581|2118468|P2|NOT COMPLETED|Overall Study||0
875416|NCT02115581|2118469|P1|NOT COMPLETED|Overall Study||0
875417|NCT02115581|2118468|P2|COMPLETED|Overall Study||21
875418|NCT02115581|2118469|P1|COMPLETED|Overall Study||17
875419|NCT02115581|2118468|P2|STARTED|Overall Study||21
875420|NCT02115581|2118469|P1|STARTED|Overall Study||17
875421|NCT02115321|2118481|P2|NOT COMPLETED|Overall Study||0
875422|NCT02115321|2118482|P1|NOT COMPLETED|Overall Study||1
875423|NCT02115321|2118481|P2|COMPLETED|Overall Study||10
875424|NCT02115321|2118482|P1|COMPLETED|Overall Study||29
875425|NCT02115321|2118481|P2|STARTED|Overall Study||10
875426|NCT02115321|2118482|P1|STARTED|Overall Study||30
875427|NCT02115269|2118502|P1|NOT COMPLETED|Overall Study||57
875428|NCT02115269|2118502|P1|COMPLETED|Overall Study||702
875429|NCT02115269|2118502|P1|STARTED|Overall Study||759
875430|NCT02115256|2118522|P2|NOT COMPLETED|Overall Study||1
875431|NCT02115256|2118523|P1|NOT COMPLETED|Overall Study||0
875432|NCT02115256|2118522|P2|COMPLETED|Overall Study||2
875433|NCT02115256|2118523|P1|COMPLETED|Overall Study||3
875434|NCT02115256|2118522|P2|STARTED|Overall Study||3
875435|NCT02115256|2118523|P1|STARTED|Overall Study||3
875436|NCT02114931|2118537|P2|NOT COMPLETED|Overall Study||30
875437|NCT02114931|2118538|P1|NOT COMPLETED|Overall Study||25
875438|NCT02114931|2118537|P2|COMPLETED|Overall Study||207
875439|NCT02114931|2118538|P1|COMPLETED|Overall Study||205
875440|NCT02114931|2118537|P2|Received Treatment|Overall Study||237
875441|NCT02114931|2118538|P1|Received Treatment|Overall Study|One participant was enrolled in error and did not receive treatment in the extension study|229
875442|NCT02114931|2118537|P2|STARTED|Overall Study||237
875443|NCT02114931|2118538|P1|STARTED|Overall Study||230
875444|NCT02114892|2118554|P2|NOT COMPLETED|Overall Study||2
875445|NCT02114892|2118555|P1|NOT COMPLETED|Overall Study||1
875446|NCT02114892|2118554|P2|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawl|10
875447|NCT02114892|2118555|P1|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
875448|NCT02114892|2118554|P2|STARTED|Overall Study||12
875449|NCT02114892|2118555|P1|STARTED|Overall Study||12
875450|NCT02114268|2118595|P6|NOT COMPLETED|Overall Study||3
875451|NCT02114268|2118596|P5|NOT COMPLETED|Overall Study||0
875452|NCT02114268|2118597|P4|NOT COMPLETED|Overall Study||0
875453|NCT02114268|2118598|P3|NOT COMPLETED|Overall Study||1
875454|NCT02114268|2118599|P2|NOT COMPLETED|Overall Study||1
875455|NCT02114268|2118600|P1|NOT COMPLETED|Overall Study||6
875456|NCT02114268|2118595|P6|COMPLETED|Overall Study||75
875457|NCT02114268|2118596|P5|COMPLETED|Overall Study||6
875458|NCT02114268|2118597|P4|COMPLETED|Overall Study||6
875459|NCT02114268|2118598|P3|COMPLETED|Overall Study||5
875460|NCT02114268|2118599|P2|COMPLETED|Overall Study||5
875461|NCT02114268|2118600|P1|COMPLETED|Overall Study||28
875462|NCT02114268|2118595|P6|STARTED|Overall Study||78
875463|NCT02114268|2118596|P5|STARTED|Overall Study||6
875464|NCT02114268|2118597|P4|STARTED|Overall Study||6
875465|NCT02114268|2118598|P3|STARTED|Overall Study||6
875466|NCT02114268|2118599|P2|STARTED|Overall Study||6
875467|NCT02114268|2118600|P1|STARTED|Overall Study||34
875468|NCT02114216|2118653|P3|NOT COMPLETED|Overall Study||0
875469|NCT02114216|2118654|P2|NOT COMPLETED|Overall Study||0
875470|NCT02114216|2118655|P1|NOT COMPLETED|Overall Study||0
875471|NCT02114216|2118653|P3|COMPLETED|Overall Study||14
875472|NCT02114216|2118654|P2|COMPLETED|Overall Study||45
875473|NCT02114216|2118655|P1|COMPLETED|Overall Study||16
875474|NCT02114216|2118653|P3|STARTED|Overall Study||14
875475|NCT02114216|2118654|P2|STARTED|Overall Study||45
875476|NCT02114216|2118655|P1|STARTED|Overall Study||16
875477|NCT02114177|2118668|P2|NOT COMPLETED|Overall Study||4
875478|NCT02114177|2118669|P1|NOT COMPLETED|Overall Study||9
875479|NCT02114177|2118668|P2|COMPLETED|Overall Study||151
875480|NCT02114177|2118669|P1|COMPLETED|Overall Study||146
875481|NCT02114177|2118668|P2|STARTED|Overall Study||155
875482|NCT02114177|2118669|P1|STARTED|Overall Study||155
875483|NCT02114151|2118693|P1|NOT COMPLETED|Overall Study||7
875484|NCT02114151|2118693|P1|COMPLETED|Overall Study||96
875485|NCT02114151|2118693|P1|STARTED|Overall Study||103
875486|NCT02113579|2118710|P2|NOT COMPLETED|Overall Study||4
875487|NCT02113579|2118711|P1|NOT COMPLETED|Overall Study||10
875488|NCT02113579|2118710|P2|COMPLETED|Overall Study||185
875489|NCT02113579|2118711|P1|COMPLETED|Overall Study||176
875490|NCT02113579|2118710|P2|STARTED|Overall Study||189
875491|NCT02113579|2118711|P1|STARTED|Overall Study||186
875492|NCT02113449|2118735|P1|NOT COMPLETED|Overall Study||4
875493|NCT02113449|2118735|P1|COMPLETED|Overall Study||143
875494|NCT02113449|2118735|P1|STARTED|Overall Study||147
875495|NCT02113436|2118751|P4|NOT COMPLETED|Period 2: 16 Weeks||11
875496|NCT02113436|2118752|P3|NOT COMPLETED|Period 2: 16 Weeks||9
875497|NCT02113436|2118753|P2|NOT COMPLETED|Period 2: 16 Weeks||0
875498|NCT02113436|2118754|P1|NOT COMPLETED|Period 2: 16 Weeks||0
875499|NCT02113436|2118751|P4|COMPLETED|Period 2: 16 Weeks||136
875500|NCT02113436|2118752|P3|COMPLETED|Period 2: 16 Weeks||132
875501|NCT02113436|2118753|P2|COMPLETED|Period 2: 16 Weeks||0
875502|NCT02113436|2118754|P1|COMPLETED|Period 2: 16 Weeks||0
875503|NCT02113436|2118751|P4|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn’t transfer to TP2.|147
875504|NCT02113436|2118752|P3|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn’t transfer to TP2.|141
875505|NCT02113436|2118753|P2|STARTED|Period 2: 16 Weeks||0
875506|NCT02113436|2118754|P1|STARTED|Period 2: 16 Weeks||0
875507|NCT02113436|2118751|P4|NOT COMPLETED|Period 1: 8 Weeks||0
875508|NCT02113436|2118752|P3|NOT COMPLETED|Period 1: 8 Weeks||0
875509|NCT02113436|2118753|P2|NOT COMPLETED|Period 1: 8 Weeks||2
875510|NCT02113436|2118754|P1|NOT COMPLETED|Period 1: 8 Weeks||8
875511|NCT02113436|2118751|P4|COMPLETED|Period 1: 8 Weeks||0
875512|NCT02113436|2118752|P3|COMPLETED|Period 1: 8 Weeks||0
875513|NCT02113436|2118753|P2|COMPLETED|Period 1: 8 Weeks||148
875514|NCT02113436|2118754|P1|COMPLETED|Period 1: 8 Weeks||142
875515|NCT02113436|2118751|P4|STARTED|Period 1: 8 Weeks||0
875516|NCT02113436|2118752|P3|STARTED|Period 1: 8 Weeks||0
875517|NCT02113436|2118753|P2|STARTED|Period 1: 8 Weeks||150
875518|NCT02113436|2118754|P1|STARTED|Period 1: 8 Weeks||150
875519|NCT02113124|2118777|P2|NOT COMPLETED|Overall Study||1
875520|NCT02113124|2118778|P1|NOT COMPLETED|Overall Study||1
875521|NCT02113124|2118777|P2|COMPLETED|Overall Study||24
875522|NCT02113124|2118778|P1|COMPLETED|Overall Study||17
875523|NCT02113124|2118777|P2|STARTED|Overall Study||25
875524|NCT02113124|2118778|P1|STARTED|Overall Study||18
875525|NCT02113007|2118784|P1|NOT COMPLETED|Overall Study||2
875526|NCT02113007|2118784|P1|COMPLETED|Overall Study||0
875527|NCT02113007|2118784|P1|STARTED|Overall Study||2
875528|NCT02112448|2118792|P2|NOT COMPLETED|Overall Study||10
875529|NCT02112448|2118793|P1|NOT COMPLETED|Overall Study||8
875530|NCT02112448|2118792|P2|COMPLETED|Overall Study||30
875531|NCT02112448|2118793|P1|COMPLETED|Overall Study||30
875532|NCT02112448|2118792|P2|STARTED|Overall Study||40
875533|NCT02112448|2118793|P1|STARTED|Overall Study||38
875534|NCT02112370|2118803|P2|NOT COMPLETED|Overall Study||0
875535|NCT02112370|2118804|P1|NOT COMPLETED|Overall Study||0
875536|NCT02112370|2118803|P2|COMPLETED|Overall Study||74
875537|NCT02112370|2118804|P1|COMPLETED|Overall Study||74
875538|NCT02112370|2118803|P2|STARTED|Overall Study||74
875539|NCT02112370|2118804|P1|STARTED|Overall Study||74
875540|NCT02111863|2118824|P1|NOT COMPLETED|Overall Study||0
875541|NCT02111863|2118824|P1|COMPLETED|Overall Study||6
875542|NCT02111863|2118824|P1|STARTED|Overall Study||6
875543|NCT02111603|2118830|P1|NOT COMPLETED|Overall Study||1
875544|NCT02111603|2118830|P1|COMPLETED|Overall Study||12
875545|NCT02111603|2118830|P1|STARTED|Overall Study||13
875546|NCT02111369|2118839|P1|NOT COMPLETED|Overall Study||3
875547|NCT02111369|2118839|P1|COMPLETED|Overall Study||15
875548|NCT02111369|2118839|P1|STARTED|Overall Study||18
875549|NCT02111252|2118847|P1|NOT COMPLETED|Overall Study||0
875550|NCT02111252|2118847|P1|COMPLETED|Overall Study||55
875551|NCT02111252|2118847|P1|STARTED|Overall Study||55
875552|NCT02111083|2118863|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
875553|NCT02111083|2118864|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
875554|NCT02111083|2118863|P2|COMPLETED|Fourth Intervention (1 Day)||18
875555|NCT02111083|2118864|P1|COMPLETED|Fourth Intervention (1 Day)||18
875556|NCT02111083|2118863|P2|STARTED|Fourth Intervention (1 Day)||18
875557|NCT02111083|2118864|P1|STARTED|Fourth Intervention (1 Day)||18
875558|NCT02111083|2118863|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
875559|NCT02111083|2118864|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
875560|NCT02111083|2118863|P2|COMPLETED|Interval Between Dosing (7-8 Days)||18
875561|NCT02111083|2118864|P1|COMPLETED|Interval Between Dosing (7-8 Days)||18
875562|NCT02111083|2118863|P2|STARTED|Interval Between Dosing (7-8 Days)||19
875563|NCT02111083|2118864|P1|STARTED|Interval Between Dosing (7-8 Days)||19
875564|NCT02111083|2118863|P2|NOT COMPLETED|Third Intervention (1 Day)||0
875565|NCT02111083|2118864|P1|NOT COMPLETED|Third Intervention (1 Day)||0
875566|NCT02111083|2118863|P2|COMPLETED|Third Intervention (1 Day)||19
875567|NCT02111083|2118864|P1|COMPLETED|Third Intervention (1 Day)||19
875568|NCT02111083|2118863|P2|STARTED|Third Intervention (1 Day)||19
875569|NCT02111083|2118864|P1|STARTED|Third Intervention (1 Day)||19
875570|NCT02111083|2118863|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
875571|NCT02111083|2118864|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
875572|NCT02111083|2118863|P2|COMPLETED|Interval Between Dosing (7-8 Days)||19
875573|NCT02111083|2118864|P1|COMPLETED|Interval Between Dosing (7-8 Days)||19
875574|NCT02111083|2118863|P2|STARTED|Interval Between Dosing (7-8 Days)||19
875575|NCT02111083|2118864|P1|STARTED|Interval Between Dosing (7-8 Days)||19
875576|NCT02111083|2118863|P2|NOT COMPLETED|Second Intervention (1 Day)||0
875577|NCT02111083|2118864|P1|NOT COMPLETED|Second Intervention (1 Day)||0
875578|NCT02111083|2118863|P2|COMPLETED|Second Intervention (1 Day)||19
875579|NCT02111083|2118864|P1|COMPLETED|Second Intervention (1 Day)||19
875580|NCT02111083|2118863|P2|STARTED|Second Intervention (1 Day)||19
875581|NCT02111083|2118864|P1|STARTED|Second Intervention (1 Day)||19
875582|NCT02111083|2118863|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
875583|NCT02111083|2118864|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
875584|NCT02111083|2118863|P2|COMPLETED|Interval Between Dosing (7-8 Days)||19
875585|NCT02111083|2118864|P1|COMPLETED|Interval Between Dosing (7-8 Days)||19
875586|NCT02111083|2118863|P2|STARTED|Interval Between Dosing (7-8 Days)||19
875587|NCT02111083|2118864|P1|STARTED|Interval Between Dosing (7-8 Days)||19
875588|NCT02111083|2118863|P2|NOT COMPLETED|First Intervention (1 Day)||0
875589|NCT02111083|2118864|P1|NOT COMPLETED|First Intervention (1 Day)||0
875590|NCT02111083|2118863|P2|COMPLETED|First Intervention (1 Day)||19
875591|NCT02111083|2118864|P1|COMPLETED|First Intervention (1 Day)||19
875592|NCT02111083|2118863|P2|STARTED|First Intervention (1 Day)||19
875593|NCT02111083|2118864|P1|STARTED|First Intervention (1 Day)||19
875594|NCT02110381|2118884|P2|NOT COMPLETED|Dual Modality||1
875595|NCT02110381|2118885|P1|NOT COMPLETED|Dual Modality||2
875596|NCT02110381|2118884|P2|COMPLETED|Dual Modality||7
875597|NCT02110381|2118885|P1|COMPLETED|Dual Modality||5
875598|NCT02110381|2118884|P2|Began Active Treatment|Dual Modality||7
875599|NCT02110381|2118885|P1|Began Active Treatment|Dual Modality||7
875600|NCT02110381|2118884|P2|STARTED|Dual Modality||8
875601|NCT02110381|2118885|P1|STARTED|Dual Modality||7
875602|NCT02110381|2118884|P2|NOT COMPLETED|Single Modality||1
875603|NCT02110381|2118885|P1|NOT COMPLETED|Single Modality||2
875604|NCT02110381|2118884|P2|COMPLETED|Single Modality||8
875605|NCT02110381|2118885|P1|COMPLETED|Single Modality||7
875606|NCT02110381|2118884|P2|STARTED|Single Modality||9
875607|NCT02110381|2118885|P1|STARTED|Single Modality||9
875608|NCT02110238|2118898|P2|NOT COMPLETED|14 Week Blinded Extension Phase||12
875609|NCT02110238|2118899|P1|NOT COMPLETED|14 Week Blinded Extension Phase||12
875610|NCT02110238|2118898|P2|COMPLETED|14 Week Blinded Extension Phase||188
875611|NCT02110238|2118899|P1|COMPLETED|14 Week Blinded Extension Phase||190
875612|NCT02110238|2118898|P2|STARTED|14 Week Blinded Extension Phase||200
875613|NCT02110238|2118899|P1|STARTED|14 Week Blinded Extension Phase||202
875614|NCT02110238|2118898|P2|NOT COMPLETED|12 Week Pivotal Phase||9
875615|NCT02110238|2118899|P1|NOT COMPLETED|12 Week Pivotal Phase||10
875616|NCT02110238|2118898|P2|COMPLETED|12 Week Pivotal Phase||200
875617|NCT02110238|2118899|P1|COMPLETED|12 Week Pivotal Phase||202
875618|NCT02110238|2118898|P2|STARTED|12 Week Pivotal Phase||209
875619|NCT02110238|2118899|P1|STARTED|12 Week Pivotal Phase|One subject was randomized but not treated. As a result there were 211 safety subjects|212
875620|NCT02110147|2118905|P1|NOT COMPLETED|Overall Study||0
875621|NCT02110147|2118905|P1|COMPLETED|Overall Study||4
875622|NCT02110147|2118905|P1|STARTED|Overall Study||4
875623|NCT02109731|2118911|P1|NOT COMPLETED|Overall Study||0
875624|NCT02109731|2118911|P1|COMPLETED|Overall Study||15
875625|NCT02109731|2118911|P1|STARTED|Overall Study||15
875626|NCT02109640|2118917|P2|NOT COMPLETED|Overall Study||0
875627|NCT02109640|2118918|P1|NOT COMPLETED|Overall Study||0
875628|NCT02109640|2118917|P2|COMPLETED|Overall Study||23
875629|NCT02109640|2118918|P1|COMPLETED|Overall Study||27
875630|NCT02109640|2118917|P2|STARTED|Overall Study||23
875631|NCT02109640|2118918|P1|STARTED|Overall Study||27
875632|NCT02109497|2118928|P1|NOT COMPLETED|Overall Study||1
875633|NCT02109497|2118928|P1|COMPLETED|Overall Study|One participant completed the safety assessments but did not complete all doses of the study drugs.|17
875634|NCT02109497|2118928|P1|STARTED|Overall Study||18
875635|NCT02109458|2118933|P1|NOT COMPLETED|Overall Study||0
875636|NCT02109458|2118933|P1|COMPLETED|Overall Study||24
875637|NCT02109458|2118933|P1|STARTED|Overall Study||24
875638|NCT02109445|2118940|P1|NOT COMPLETED|Overall Study||3
875639|NCT02109445|2118940|P1|COMPLETED|Overall Study||0
875640|NCT02109445|2118940|P1|STARTED|Overall Study||3
875641|NCT02109172|2118973|P6|NOT COMPLETED|Overall Study||1
875642|NCT02109172|2118974|P5|NOT COMPLETED|Overall Study||1
875643|NCT02109172|2118975|P4|NOT COMPLETED|Overall Study||1
875644|NCT02109172|2118976|P3|NOT COMPLETED|Overall Study||1
875645|NCT02109172|2118977|P2|NOT COMPLETED|Overall Study||0
875646|NCT02109172|2118978|P1|NOT COMPLETED|Overall Study||1
875647|NCT02109172|2118973|P6|COMPLETED|Overall Study||10
875648|NCT02109172|2118974|P5|COMPLETED|Overall Study||9
875649|NCT02109172|2118975|P4|COMPLETED|Overall Study||10
875650|NCT02109172|2118976|P3|COMPLETED|Overall Study||9
875651|NCT02109172|2118977|P2|COMPLETED|Overall Study||11
875652|NCT02109172|2118978|P1|COMPLETED|Overall Study||10
875653|NCT02109172|2118973|P6|STARTED|Overall Study||11
875654|NCT02109172|2118974|P5|STARTED|Overall Study||10
875655|NCT02109172|2118975|P4|STARTED|Overall Study||11
875656|NCT02109172|2118976|P3|STARTED|Overall Study||10
875657|NCT02109172|2118977|P2|STARTED|Overall Study||11
875658|NCT02109172|2118978|P1|STARTED|Overall Study||11
875659|NCT02109159|2118988|P2|NOT COMPLETED|Overall Study||0
875660|NCT02109159|2118989|P1|NOT COMPLETED|Overall Study||0
875661|NCT02109159|2118988|P2|COMPLETED|Overall Study||4175
875662|NCT02109159|2118989|P1|COMPLETED|Overall Study||4178
875663|NCT02109159|2118988|P2|STARTED|Overall Study||4175
875664|NCT02109159|2118989|P1|STARTED|Overall Study||4178
875665|NCT02109133|2118999|P2|NOT COMPLETED|Overall Study||0
875666|NCT02109133|2119000|P1|NOT COMPLETED|Overall Study||1
875667|NCT02109133|2118999|P2|COMPLETED|Overall Study||34
875668|NCT02109133|2119000|P1|COMPLETED|Overall Study||32
875669|NCT02109133|2118999|P2|STARTED|Overall Study||34
875670|NCT02109133|2119000|P1|STARTED|Overall Study||33
875671|NCT02109107|2119012|P1|NOT COMPLETED|Overall Study||2
875672|NCT02109107|2119012|P1|COMPLETED|Overall Study||52
875673|NCT02109107|2119012|P1|STARTED|Overall Study||54
875680|NCT02108691|2119036|P2|NOT COMPLETED|Overall Study||9
875681|NCT02108691|2119037|P1|NOT COMPLETED|Overall Study||8
875682|NCT02108691|2119036|P2|COMPLETED|Overall Study||31
875683|NCT02108691|2119037|P1|COMPLETED|Overall Study||32
875684|NCT02108691|2119036|P2|STARTED|Overall Study||40
875685|NCT02108691|2119037|P1|STARTED|Overall Study||40
875686|NCT02108652|2119055|P1|NOT COMPLETED|Overall Study||310
875687|NCT02108652|2119055|P1|COMPLETED|Overall Study||0
875688|NCT02108652|2119055|P1|STARTED|Overall Study||310
875689|NCT02108288|2119079|P3|NOT COMPLETED|Overall Study||0
875690|NCT02108288|2119080|P2|NOT COMPLETED|Overall Study||0
875691|NCT02108288|2119081|P1|NOT COMPLETED|Overall Study||0
875692|NCT02108288|2119079|P3|COMPLETED|Overall Study||10
875693|NCT02108288|2119080|P2|COMPLETED|Overall Study||10
875694|NCT02108288|2119081|P1|COMPLETED|Overall Study||10
875695|NCT02108288|2119079|P3|STARTED|Overall Study||10
875696|NCT02108288|2119080|P2|STARTED|Overall Study||10
875697|NCT02108288|2119081|P1|STARTED|Overall Study||10
875698|NCT02108223|2119097|P3|NOT COMPLETED|Overall Study||0
875699|NCT02108223|2119098|P2|NOT COMPLETED|Overall Study||0
875700|NCT02108223|2119099|P1|NOT COMPLETED|Overall Study||0
875701|NCT02108223|2119097|P3|COMPLETED|Overall Study||35
875702|NCT02108223|2119098|P2|COMPLETED|Overall Study||50
875703|NCT02108223|2119099|P1|COMPLETED|Overall Study||52
875704|NCT02108223|2119097|P3|STARTED|Overall Study||35
875705|NCT02108223|2119098|P2|STARTED|Overall Study||50
875706|NCT02108223|2119099|P1|STARTED|Overall Study||52
875707|NCT02108171|2119121|P2|NOT COMPLETED|Overall Study||0
875708|NCT02108171|2119122|P1|NOT COMPLETED|Overall Study||0
875709|NCT02108171|2119121|P2|COMPLETED|Overall Study||41
875710|NCT02108171|2119122|P1|COMPLETED|Overall Study||40
875711|NCT02108171|2119121|P2|STARTED|Overall Study||41
875712|NCT02108171|2119122|P1|STARTED|Overall Study||40
875713|NCT02107898|2119224|P2|NOT COMPLETED|Overall Study||12
875714|NCT02107898|2119225|P1|NOT COMPLETED|Overall Study||6
875715|NCT02107898|2119224|P2|COMPLETED|Overall Study||132
875716|NCT02107898|2119225|P1|COMPLETED|Overall Study||66
875717|NCT02107898|2119224|P2|Treated|Overall Study||143
875718|NCT02107898|2119225|P1|Treated|Overall Study||72
875719|NCT02107898|2119224|P2|STARTED|Overall Study|Randomized|144
875720|NCT02107898|2119225|P1|STARTED|Overall Study|Randomized|72
875721|NCT02107599|2119277|P1|NOT COMPLETED|Overall Study||0
875722|NCT02107599|2119277|P1|COMPLETED|Overall Study||96
875723|NCT02107599|2119277|P1|STARTED|Overall Study||96
875724|NCT02107482|2119284|P1|NOT COMPLETED|Overall Study||4
875725|NCT02107482|2119284|P1|COMPLETED|Overall Study||17
875726|NCT02107482|2119284|P1|STARTED|Overall Study|21 participants enrolled. Total of 21 participants recvd both active and sham|21
875727|NCT02107339|2119292|P2|NOT COMPLETED|Overall Study||4
875728|NCT02107339|2119293|P1|NOT COMPLETED|Overall Study||1
875729|NCT02107339|2119292|P2|COMPLETED|Overall Study||53
875730|NCT02107339|2119293|P1|COMPLETED|Overall Study||62
875731|NCT02107339|2119292|P2|STARTED|Overall Study||57
875732|NCT02107339|2119293|P1|STARTED|Overall Study||63
875733|NCT02107313|2119321|P2|NOT COMPLETED|Overall Study||1
875734|NCT02107313|2119322|P1|NOT COMPLETED|Overall Study||0
875735|NCT02107313|2119321|P2|COMPLETED|Overall Study||8
875736|NCT02107313|2119322|P1|COMPLETED|Overall Study||9
875737|NCT02107313|2119321|P2|STARTED|Overall Study|One participant from the study did not cross over and participate in the FED cohort|9
875738|NCT02107313|2119322|P1|STARTED|Overall Study||9
875739|NCT02107274|2119332|P2|NOT COMPLETED|Control Phase||2
875740|NCT02107274|2119333|P1|NOT COMPLETED|Control Phase||3
875741|NCT02107274|2119332|P2|COMPLETED|Control Phase||35
875742|NCT02107274|2119333|P1|COMPLETED|Control Phase||33
875743|NCT02107274|2119332|P2|STARTED|Control Phase||37
875744|NCT02107274|2119333|P1|STARTED|Control Phase||36
875745|NCT02107274|2119332|P2|NOT COMPLETED|Treatment vs. Placebo||2
875746|NCT02107274|2119333|P1|NOT COMPLETED|Treatment vs. Placebo||3
875747|NCT02107274|2119332|P2|COMPLETED|Treatment vs. Placebo||37
875748|NCT02107274|2119333|P1|COMPLETED|Treatment vs. Placebo||36
875749|NCT02107274|2119332|P2|STARTED|Treatment vs. Placebo||39
875750|NCT02107274|2119333|P1|STARTED|Treatment vs. Placebo||39
875751|NCT02107196|2119347|P2|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||5
875752|NCT02107196|2119348|P1|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||23
875753|NCT02107196|2119347|P2|COMPLETED|4-week Randomized Withdrawal (RW) Period||109
875754|NCT02107196|2119348|P1|COMPLETED|4-week Randomized Withdrawal (RW) Period||315
875755|NCT02107196|2119347|P2|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|90
875756|NCT02107196|2119348|P1|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|272
875757|NCT02107196|2119347|P2|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of placebo during RW period|114
875758|NCT02107196|2119348|P1|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of ibodutant during RW period|338
875759|NCT02107196|2119347|P2|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|114
875760|NCT02107196|2119348|P1|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|338
875761|NCT02107196|2119347|P2|NOT COMPLETED|12-week Treatment Period||39
875762|NCT02107196|2119348|P1|NOT COMPLETED|12-week Treatment Period||44
875763|NCT02107196|2119347|P2|COMPLETED|12-week Treatment Period||225
875764|NCT02107196|2119348|P1|COMPLETED|12-week Treatment Period||227
875765|NCT02107196|2119347|P2|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|216
875766|NCT02107196|2119348|P1|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|221
875767|NCT02107196|2119347|P2|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|264
875768|NCT02107196|2119348|P1|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|271
875769|NCT02107196|2119347|P2|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|264
875770|NCT02107196|2119348|P1|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|271
875771|NCT02107014|2119361|P1|NOT COMPLETED|Overall Study||1
875772|NCT02107014|2119361|P1|COMPLETED|Overall Study||8
875773|NCT02107014|2119361|P1|STARTED|Overall Study||9
875774|NCT02106962|2119431|P2|NOT COMPLETED|Overall Study||0
875775|NCT02106962|2119432|P1|NOT COMPLETED|Overall Study||0
875776|NCT02106962|2119431|P2|COMPLETED|Overall Study||9
875777|NCT02106962|2119432|P1|COMPLETED|Overall Study||8
875778|NCT02106962|2119431|P2|STARTED|Overall Study||9
875779|NCT02106962|2119432|P1|STARTED|Overall Study||8
875780|NCT02106923|2119443|P6|NOT COMPLETED|Overall Study||1
875781|NCT02106923|2119444|P5|NOT COMPLETED|Overall Study||0
875782|NCT02106923|2119445|P4|NOT COMPLETED|Overall Study||0
875783|NCT02106923|2119446|P3|NOT COMPLETED|Overall Study||0
875784|NCT02106923|2119447|P2|NOT COMPLETED|Overall Study||0
875785|NCT02106923|2119448|P1|NOT COMPLETED|Overall Study||0
875786|NCT02106923|2119443|P6|COMPLETED|Overall Study||11
875787|NCT02106923|2119444|P5|COMPLETED|Overall Study||12
875788|NCT02106923|2119445|P4|COMPLETED|Overall Study||12
875789|NCT02106923|2119446|P3|COMPLETED|Overall Study||12
875790|NCT02106923|2119447|P2|COMPLETED|Overall Study||12
875791|NCT02106923|2119448|P1|COMPLETED|Overall Study||12
875792|NCT02106923|2119443|P6|STARTED|Overall Study||12
875793|NCT02106923|2119444|P5|STARTED|Overall Study||12
875794|NCT02106923|2119445|P4|STARTED|Overall Study||12
875795|NCT02106923|2119446|P3|STARTED|Overall Study||12
875796|NCT02106923|2119447|P2|STARTED|Overall Study||12
875797|NCT02106923|2119448|P1|STARTED|Overall Study||12
875798|NCT02106832|2119496|P4|NOT COMPLETED|Overall Study||15
875799|NCT02106832|2119497|P3|NOT COMPLETED|Overall Study||16
875800|NCT02106832|2119498|P2|NOT COMPLETED|Overall Study||25
875801|NCT02106832|2119499|P1|NOT COMPLETED|Overall Study||23
875802|NCT02106832|2119496|P4|COMPLETED|Overall Study||73
875803|NCT02106832|2119497|P3|COMPLETED|Overall Study||70
875804|NCT02106832|2119498|P2|COMPLETED|Overall Study||151
875805|NCT02106832|2119499|P1|COMPLETED|Overall Study||148
875806|NCT02106832|2119496|P4|Participants Received Treatment|Overall Study||88
875807|NCT02106832|2119497|P3|Participants Received Treatment|Overall Study||86
875808|NCT02106832|2119498|P2|Participants Received Treatment|Overall Study||174
875809|NCT02106832|2119499|P1|Participants Received Treatment|Overall Study||171
875810|NCT02106832|2119496|P4|STARTED|Overall Study||88
875811|NCT02106832|2119497|P3|STARTED|Overall Study||86
875812|NCT02106832|2119498|P2|STARTED|Overall Study||176
875813|NCT02106832|2119499|P1|STARTED|Overall Study||171
875814|NCT02106728|2119534|P2|NOT COMPLETED|Overall Study||0
875815|NCT02106728|2119535|P1|NOT COMPLETED|Overall Study||0
875816|NCT02106728|2119534|P2|COMPLETED|Overall Study||47
875817|NCT02106728|2119535|P1|COMPLETED|Overall Study||70
875818|NCT02106728|2119534|P2|STARTED|Overall Study||47
875819|NCT02106728|2119535|P1|STARTED|Overall Study||70
875820|NCT02106494|2119551|P2|NOT COMPLETED|Overall Study||25
875821|NCT02106494|2119552|P1|NOT COMPLETED|Overall Study||26
875822|NCT02106494|2119551|P2|COMPLETED|Overall Study||446
875823|NCT02106494|2119552|P1|COMPLETED|Overall Study||445
875824|NCT02106494|2119551|P2|Efficacy Population|Overall Study||452
875825|NCT02106494|2119552|P1|Efficacy Population|Overall Study||450
875826|NCT02106494|2119551|P2|Safety Population|Overall Study||459
875827|NCT02106494|2119552|P1|Safety Population|Overall Study||456
875828|NCT02106494|2119551|P2|STARTED|Overall Study||471
875829|NCT02106494|2119552|P1|STARTED|Overall Study||471
875830|NCT02106403|2119566|P6|NOT COMPLETED|Follow-Up Visit 3||1
875831|NCT02106403|2119567|P5|NOT COMPLETED|Follow-Up Visit 3||0
875832|NCT02106403|2119568|P4|NOT COMPLETED|Follow-Up Visit 3||0
875833|NCT02106403|2119569|P3|NOT COMPLETED|Follow-Up Visit 3||0
875834|NCT02106403|2119570|P2|NOT COMPLETED|Follow-Up Visit 3||0
875835|NCT02106403|2119571|P1|NOT COMPLETED|Follow-Up Visit 3||0
875836|NCT02106403|2119566|P6|COMPLETED|Follow-Up Visit 3||8
875837|NCT02106403|2119567|P5|COMPLETED|Follow-Up Visit 3||8
875838|NCT02106403|2119568|P4|COMPLETED|Follow-Up Visit 3||8
875839|NCT02106403|2119569|P3|COMPLETED|Follow-Up Visit 3||9
875840|NCT02106403|2119570|P2|COMPLETED|Follow-Up Visit 3||8
875841|NCT02106403|2119571|P1|COMPLETED|Follow-Up Visit 3||8
875842|NCT02106403|2119566|P6|STARTED|Follow-Up Visit 3||9
875843|NCT02106403|2119567|P5|STARTED|Follow-Up Visit 3||8
875844|NCT02106403|2119568|P4|STARTED|Follow-Up Visit 3||8
875845|NCT02106403|2119569|P3|STARTED|Follow-Up Visit 3||9
875846|NCT02106403|2119570|P2|STARTED|Follow-Up Visit 3||8
875847|NCT02106403|2119571|P1|STARTED|Follow-Up Visit 3||8
875848|NCT02106403|2119566|P6|NOT COMPLETED|Follow-Up Visit 2||0
875849|NCT02106403|2119567|P5|NOT COMPLETED|Follow-Up Visit 2||0
875850|NCT02106403|2119568|P4|NOT COMPLETED|Follow-Up Visit 2||0
875851|NCT02106403|2119569|P3|NOT COMPLETED|Follow-Up Visit 2||0
875852|NCT02106403|2119570|P2|NOT COMPLETED|Follow-Up Visit 2||0
875853|NCT02106403|2119571|P1|NOT COMPLETED|Follow-Up Visit 2||0
875854|NCT02106403|2119566|P6|COMPLETED|Follow-Up Visit 2||9
875855|NCT02106403|2119567|P5|COMPLETED|Follow-Up Visit 2||8
875856|NCT02106403|2119568|P4|COMPLETED|Follow-Up Visit 2||8
875857|NCT02106403|2119569|P3|COMPLETED|Follow-Up Visit 2||9
875858|NCT02106403|2119570|P2|COMPLETED|Follow-Up Visit 2||8
875859|NCT02106403|2119571|P1|COMPLETED|Follow-Up Visit 2||8
875860|NCT02106403|2119566|P6|STARTED|Follow-Up Visit 2||9
875861|NCT02106403|2119567|P5|STARTED|Follow-Up Visit 2||8
875862|NCT02106403|2119568|P4|STARTED|Follow-Up Visit 2||8
875863|NCT02106403|2119569|P3|STARTED|Follow-Up Visit 2||9
875864|NCT02106403|2119570|P2|STARTED|Follow-Up Visit 2||8
875865|NCT02106403|2119571|P1|STARTED|Follow-Up Visit 2||8
875866|NCT02106403|2119566|P6|NOT COMPLETED|Visit 1, Treatment Period 3||0
875867|NCT02106403|2119567|P5|NOT COMPLETED|Visit 1, Treatment Period 3||0
875868|NCT02106403|2119568|P4|NOT COMPLETED|Visit 1, Treatment Period 3||0
875869|NCT02106403|2119569|P3|NOT COMPLETED|Visit 1, Treatment Period 3||0
875870|NCT02106403|2119570|P2|NOT COMPLETED|Visit 1, Treatment Period 3||0
875871|NCT02106403|2119571|P1|NOT COMPLETED|Visit 1, Treatment Period 3||0
875872|NCT02106403|2119566|P6|COMPLETED|Visit 1, Treatment Period 3||9
875873|NCT02106403|2119567|P5|COMPLETED|Visit 1, Treatment Period 3||8
875874|NCT02106403|2119568|P4|COMPLETED|Visit 1, Treatment Period 3||8
875875|NCT02106403|2119569|P3|COMPLETED|Visit 1, Treatment Period 3||9
875876|NCT02106403|2119570|P2|COMPLETED|Visit 1, Treatment Period 3||8
875877|NCT02106403|2119571|P1|COMPLETED|Visit 1, Treatment Period 3||8
875878|NCT02106403|2119566|P6|STARTED|Visit 1, Treatment Period 3||9
875879|NCT02106403|2119567|P5|STARTED|Visit 1, Treatment Period 3||8
875880|NCT02106403|2119568|P4|STARTED|Visit 1, Treatment Period 3||8
875881|NCT02106403|2119569|P3|STARTED|Visit 1, Treatment Period 3||9
875882|NCT02106403|2119570|P2|STARTED|Visit 1, Treatment Period 3||8
875883|NCT02106403|2119571|P1|STARTED|Visit 1, Treatment Period 3||8
875884|NCT02106403|2119566|P6|NOT COMPLETED|Visit 1, Treatment Period 2||0
875885|NCT02106403|2119567|P5|NOT COMPLETED|Visit 1, Treatment Period 2||0
875886|NCT02106403|2119568|P4|NOT COMPLETED|Visit 1, Treatment Period 2||0
875887|NCT02106403|2119569|P3|NOT COMPLETED|Visit 1, Treatment Period 2||0
875888|NCT02106403|2119570|P2|NOT COMPLETED|Visit 1, Treatment Period 2||0
875889|NCT02106403|2119571|P1|NOT COMPLETED|Visit 1, Treatment Period 2||0
875890|NCT02106403|2119566|P6|COMPLETED|Visit 1, Treatment Period 2||9
875891|NCT02106403|2119567|P5|COMPLETED|Visit 1, Treatment Period 2||8
875892|NCT02106403|2119568|P4|COMPLETED|Visit 1, Treatment Period 2||8
875893|NCT02106403|2119569|P3|COMPLETED|Visit 1, Treatment Period 2||9
875894|NCT02106403|2119570|P2|COMPLETED|Visit 1, Treatment Period 2||8
875895|NCT02106403|2119571|P1|COMPLETED|Visit 1, Treatment Period 2||8
875896|NCT02106403|2119566|P6|STARTED|Visit 1, Treatment Period 2||9
875897|NCT02106403|2119567|P5|STARTED|Visit 1, Treatment Period 2||8
875898|NCT02106403|2119568|P4|STARTED|Visit 1, Treatment Period 2||8
875899|NCT02106403|2119569|P3|STARTED|Visit 1, Treatment Period 2||9
875900|NCT02106403|2119570|P2|STARTED|Visit 1, Treatment Period 2||8
875901|NCT02106403|2119571|P1|STARTED|Visit 1, Treatment Period 2||8
875902|NCT02106403|2119566|P6|NOT COMPLETED|Visit 1, Treatment Period 1||0
875903|NCT02106403|2119567|P5|NOT COMPLETED|Visit 1, Treatment Period 1||0
875904|NCT02106403|2119568|P4|NOT COMPLETED|Visit 1, Treatment Period 1||0
875905|NCT02106403|2119569|P3|NOT COMPLETED|Visit 1, Treatment Period 1||0
875906|NCT02106403|2119570|P2|NOT COMPLETED|Visit 1, Treatment Period 1||0
875907|NCT02106403|2119571|P1|NOT COMPLETED|Visit 1, Treatment Period 1||0
875908|NCT02106403|2119566|P6|COMPLETED|Visit 1, Treatment Period 1||9
875909|NCT02106403|2119567|P5|COMPLETED|Visit 1, Treatment Period 1||8
875910|NCT02106403|2119568|P4|COMPLETED|Visit 1, Treatment Period 1||8
875911|NCT02106403|2119569|P3|COMPLETED|Visit 1, Treatment Period 1||9
875912|NCT02106403|2119570|P2|COMPLETED|Visit 1, Treatment Period 1||8
875913|NCT02106403|2119571|P1|COMPLETED|Visit 1, Treatment Period 1||8
875914|NCT02106403|2119566|P6|STARTED|Visit 1, Treatment Period 1||9
875915|NCT02106403|2119567|P5|STARTED|Visit 1, Treatment Period 1||8
875916|NCT02106403|2119568|P4|STARTED|Visit 1, Treatment Period 1||8
875917|NCT02106403|2119569|P3|STARTED|Visit 1, Treatment Period 1||9
875918|NCT02106403|2119570|P2|STARTED|Visit 1, Treatment Period 1||8
875919|NCT02106403|2119571|P1|STARTED|Visit 1, Treatment Period 1||8
875920|NCT02106156|2119594|P3|NOT COMPLETED|Overall Study||0
875921|NCT02106156|2119595|P2|NOT COMPLETED|Overall Study||40
875922|NCT02106156|2119596|P1|NOT COMPLETED|Overall Study||2549
875923|NCT02106156|2119594|P3|COMPLETED|Overall Study||518
875924|NCT02106156|2119595|P2|COMPLETED|Overall Study||50
875925|NCT02106156|2119596|P1|COMPLETED|Overall Study||7071
875926|NCT02106156|2119594|P3|STARTED|Overall Study||518
875927|NCT02106156|2119595|P2|STARTED|Overall Study||90
875928|NCT02106156|2119596|P1|STARTED|Overall Study||9620
875929|NCT02105987|2119620|P6|NOT COMPLETED|Continuation Phase||0
875930|NCT02105987|2119621|P5|NOT COMPLETED|Continuation Phase||1
875931|NCT02105987|2119622|P4|NOT COMPLETED|Continuation Phase||0
875932|NCT02105987|2119623|P3|NOT COMPLETED|Continuation Phase||0
875933|NCT02105987|2119624|P2|NOT COMPLETED|Continuation Phase||0
875934|NCT02105987|2119625|P1|NOT COMPLETED|Continuation Phase||0
875935|NCT02105987|2119620|P6|COMPLETED|Continuation Phase||23
875936|NCT02105987|2119621|P5|COMPLETED|Continuation Phase||13
875937|NCT02105987|2119622|P4|COMPLETED|Continuation Phase||0
875938|NCT02105987|2119623|P3|COMPLETED|Continuation Phase||0
875939|NCT02105987|2119624|P2|COMPLETED|Continuation Phase||0
875940|NCT02105987|2119625|P1|COMPLETED|Continuation Phase||0
875941|NCT02105987|2119620|P6|STARTED|Continuation Phase||23
875942|NCT02105987|2119621|P5|STARTED|Continuation Phase||14
875943|NCT02105987|2119622|P4|STARTED|Continuation Phase||0
875944|NCT02105987|2119623|P3|STARTED|Continuation Phase||0
875945|NCT02105987|2119624|P2|STARTED|Continuation Phase||0
875946|NCT02105987|2119625|P1|STARTED|Continuation Phase||0
875947|NCT02105987|2119620|P6|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
875948|NCT02105987|2119621|P5|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
875949|NCT02105987|2119622|P4|NOT COMPLETED|Late Switch Phase (24 Weeks)||14
875950|NCT02105987|2119623|P3|NOT COMPLETED|Late Switch Phase (24 Weeks)||45
875951|NCT02105987|2119624|P2|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
875952|NCT02105987|2119625|P1|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
875953|NCT02105987|2119620|P6|COMPLETED|Late Switch Phase (24 Weeks)||0
875954|NCT02105987|2119621|P5|COMPLETED|Late Switch Phase (24 Weeks)||0
875955|NCT02105987|2119622|P4|COMPLETED|Late Switch Phase (24 Weeks)||230
875956|NCT02105987|2119623|P3|COMPLETED|Late Switch Phase (24 Weeks)||230
875957|NCT02105987|2119624|P2|COMPLETED|Late Switch Phase (24 Weeks)||0
875958|NCT02105987|2119625|P1|COMPLETED|Late Switch Phase (24 Weeks)||0
875959|NCT02105987|2119620|P6|STARTED|Late Switch Phase (24 Weeks)||0
875960|NCT02105987|2119621|P5|STARTED|Late Switch Phase (24 Weeks)||0
875961|NCT02105987|2119622|P4|STARTED|Late Switch Phase (24 Weeks)||244
875962|NCT02105987|2119623|P3|STARTED|Late Switch Phase (24 Weeks)||275
875963|NCT02105987|2119624|P2|STARTED|Late Switch Phase (24 Weeks)||0
875964|NCT02105987|2119625|P1|STARTED|Late Switch Phase (24 Weeks)||0
875965|NCT02105987|2119620|P6|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
875966|NCT02105987|2119621|P5|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
875967|NCT02105987|2119622|P4|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
875968|NCT02105987|2119623|P3|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
875969|NCT02105987|2119624|P2|NOT COMPLETED|Early Switch Phase (24 Weeks)||34
875970|NCT02105987|2119625|P1|NOT COMPLETED|Early Switch Phase (24 Weeks)||36
875971|NCT02105987|2119620|P6|COMPLETED|Early Switch Phase (24 Weeks)||0
875972|NCT02105987|2119621|P5|COMPLETED|Early Switch Phase (24 Weeks)||0
875973|NCT02105987|2119622|P4|COMPLETED|Early Switch Phase (24 Weeks)||0
875974|NCT02105987|2119623|P3|COMPLETED|Early Switch Phase (24 Weeks)||0
875975|NCT02105987|2119624|P2|COMPLETED|Early Switch Phase (24 Weeks)||244
875976|NCT02105987|2119625|P1|COMPLETED|Early Switch Phase (24 Weeks)||239
875977|NCT02105987|2119620|P6|STARTED|Early Switch Phase (24 Weeks)||0
875978|NCT02105987|2119621|P5|STARTED|Early Switch Phase (24 Weeks)||0
875979|NCT02105987|2119622|P4|STARTED|Early Switch Phase (24 Weeks)||0
875980|NCT02105987|2119623|P3|STARTED|Early Switch Phase (24 Weeks)||0
875981|NCT02105987|2119624|P2|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|278
875982|NCT02105987|2119625|P1|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|275
875983|NCT02105974|2119679|P3|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||58
875984|NCT02105974|2119680|P2|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||42
875985|NCT02105974|2119681|P1|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||0
875986|NCT02105974|2119679|P3|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|756
875987|NCT02105974|2119680|P2|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|764
875988|NCT02105974|2119681|P1|COMPLETED|12 Week (Wk) Treatment Period (TP)||0
875989|NCT02105974|2119679|P3|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|754
875990|NCT02105974|2119680|P2|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|764
875991|NCT02105974|2119681|P1|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)||0
875992|NCT02105974|2119679|P3|STARTED|12 Week (Wk) Treatment Period (TP)||814
875993|NCT02105974|2119680|P2|STARTED|12 Week (Wk) Treatment Period (TP)||806
875994|NCT02105974|2119681|P1|STARTED|12 Week (Wk) Treatment Period (TP)||0
875995|NCT02105974|2119679|P3|NOT COMPLETED|2 Week Run-in Period||0
875996|NCT02105974|2119680|P2|NOT COMPLETED|2 Week Run-in Period||0
875997|NCT02105974|2119681|P1|NOT COMPLETED|2 Week Run-in Period||801
875998|NCT02105974|2119679|P3|COMPLETED|2 Week Run-in Period||0
875999|NCT02105974|2119680|P2|COMPLETED|2 Week Run-in Period||0
876000|NCT02105974|2119681|P1|COMPLETED|2 Week Run-in Period||1622
876001|NCT02105974|2119679|P3|STARTED|2 Week Run-in Period||0
876002|NCT02105974|2119680|P2|STARTED|2 Week Run-in Period||0
876003|NCT02105974|2119681|P1|STARTED|2 Week Run-in Period||2423
876004|NCT02105740|2119693|P2|NOT COMPLETED|Overall Study||1
876005|NCT02105740|2119694|P1|NOT COMPLETED|Overall Study||0
876006|NCT02105740|2119693|P2|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|11
876007|NCT02105740|2119694|P1|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|12
876008|NCT02105740|2119693|P2|Second|Overall Study|Application of EVA and HADS scales. One accompanying lost|11
876009|NCT02105740|2119694|P1|Second|Overall Study|Intervention with hypnosis and application of EVA scales and HADS (n = 12)|12
876010|NCT02105740|2119693|P2|STARTED|Overall Study|Application of EVA and HADS scales|12
876011|NCT02105740|2119694|P1|STARTED|Overall Study|Application of EVA and HADS scales and after that application of hypnosis intervention|12
876012|NCT02105701|2119706|P4|NOT COMPLETED|Overall Study||2
876013|NCT02105701|2119707|P3|NOT COMPLETED|Overall Study||3
876014|NCT02105701|2119708|P2|NOT COMPLETED|Overall Study||1
876015|NCT02105701|2119709|P1|NOT COMPLETED|Overall Study||4
876016|NCT02105701|2119706|P4|COMPLETED|Overall Study||104
876017|NCT02105701|2119707|P3|COMPLETED|Overall Study||102
876018|NCT02105701|2119708|P2|COMPLETED|Overall Study||103
876019|NCT02105701|2119709|P1|COMPLETED|Overall Study||101
876020|NCT02105701|2119706|P4|STARTED|Overall Study||106
876021|NCT02105701|2119707|P3|STARTED|Overall Study||105
876022|NCT02105701|2119708|P2|STARTED|Overall Study||104
876023|NCT02105701|2119709|P1|STARTED|Overall Study||105
876034|NCT02105662|2119744|P1|NOT COMPLETED|Overall Study||6
876035|NCT02105662|2119744|P1|COMPLETED|Overall Study||212
876036|NCT02105662|2119744|P1|STARTED|Overall Study||218
876037|NCT02105636|2119753|P2|NOT COMPLETED|Overall Study||108
876038|NCT02105636|2119754|P1|NOT COMPLETED|Overall Study||195
876039|NCT02105636|2119753|P2|COMPLETED|Overall Study|Completed=Still on Treatment|3
876040|NCT02105636|2119754|P1|COMPLETED|Overall Study|Completed=Still on Treatment|41
876041|NCT02105636|2119753|P2|STARTED|Overall Study||111
876042|NCT02105636|2119754|P1|STARTED|Overall Study||236
876043|NCT02105467|2119766|P2|NOT COMPLETED|Period 3||1
876044|NCT02105467|2119767|P1|NOT COMPLETED|Period 3||0
876045|NCT02105467|2119766|P2|COMPLETED|Period 3||102
876046|NCT02105467|2119767|P1|COMPLETED|Period 3||0
876047|NCT02105467|2119766|P2|STARTED|Period 3|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|103
876048|NCT02105467|2119767|P1|STARTED|Period 3|The Immediate Treatment Group completed the study with Period 2|0
876049|NCT02105467|2119766|P2|NOT COMPLETED|Period 2||2
876050|NCT02105467|2119767|P1|NOT COMPLETED|Period 2||2
876051|NCT02105467|2119766|P2|COMPLETED|Period 2||102
876052|NCT02105467|2119767|P1|COMPLETED|Period 2||312
876053|NCT02105467|2119766|P2|STARTED|Period 2|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|104
876054|NCT02105467|2119767|P1|STARTED|Period 2||314
876055|NCT02105467|2119766|P2|NOT COMPLETED|Period 1||0
876056|NCT02105467|2119767|P1|NOT COMPLETED|Period 1||2
876057|NCT02105467|2119766|P2|COMPLETED|Period 1||105
876058|NCT02105467|2119767|P1|COMPLETED|Period 1||314
876059|NCT02105467|2119766|P2|STARTED|Period 1||105
876060|NCT02105467|2119767|P1|STARTED|Period 1||316
876061|NCT02105454|2119779|P1|NOT COMPLETED|Overall Study||1
876062|NCT02105454|2119779|P1|COMPLETED|Overall Study||78
876063|NCT02105454|2119779|P1|STARTED|Overall Study||79
876064|NCT02105285|2119789|P3|NOT COMPLETED|Overall Study||0
876065|NCT02105285|2119790|P2|NOT COMPLETED|Overall Study||2
876066|NCT02105285|2119791|P1|NOT COMPLETED|Overall Study||2
876067|NCT02105285|2119789|P3|COMPLETED|Overall Study||37
876068|NCT02105285|2119790|P2|COMPLETED|Overall Study||76
876069|NCT02105285|2119791|P1|COMPLETED|Overall Study||76
876070|NCT02105285|2119789|P3|STARTED|Overall Study||37
876071|NCT02105285|2119790|P2|STARTED|Overall Study||78
876072|NCT02105285|2119791|P1|STARTED|Overall Study||78
876073|NCT02105272|2119810|P2|NOT COMPLETED|Overall Study||3
876074|NCT02105272|2119811|P1|NOT COMPLETED|Overall Study||5
876075|NCT02105272|2119810|P2|COMPLETED|Overall Study||116
876076|NCT02105272|2119811|P1|COMPLETED|Overall Study||113
876077|NCT02105272|2119810|P2|STARTED|Overall Study||119
876078|NCT02105272|2119811|P1|STARTED|Overall Study||118
876079|NCT02105012|2119827|P1|NOT COMPLETED|Overall Study||33
876080|NCT02105012|2119827|P1|COMPLETED|Overall Study||114
876081|NCT02105012|2119827|P1|Placebo MDI|Overall Study||127
876082|NCT02105012|2119827|P1|BD MDI 40 µg|Overall Study||63
876083|NCT02105012|2119827|P1|BD MDI 80 µg|Overall Study||64
876084|NCT02105012|2119827|P1|BD MDI 160 µg|Overall Study||132
876085|NCT02105012|2119827|P1|BD MDI 320 µg|Overall Study||124
876086|NCT02105012|2119827|P1|STARTED|Overall Study||147
876087|NCT02104947|2119861|P2|NOT COMPLETED|Overall Study||56
876088|NCT02104947|2119862|P1|NOT COMPLETED|Overall Study||79
876089|NCT02104947|2119861|P2|COMPLETED|Overall Study||146
876090|NCT02104947|2119862|P1|COMPLETED|Overall Study||222
876091|NCT02104947|2119861|P2|STARTED|Overall Study||202
876092|NCT02104947|2119862|P1|STARTED|Overall Study||301
876093|NCT02104895|2119880|P2|NOT COMPLETED|Overall Study||14
876094|NCT02104895|2119881|P1|NOT COMPLETED|Overall Study||0
876095|NCT02104895|2119880|P2|COMPLETED|Overall Study||246
876096|NCT02104895|2119881|P1|COMPLETED|Overall Study||260
876097|NCT02104895|2119880|P2|STARTED|Overall Study||260
876098|NCT02104895|2119881|P1|STARTED|Overall Study||260
876099|NCT02104830|2119894|P3|NOT COMPLETED|Overall Study||7
876100|NCT02104830|2119895|P2|NOT COMPLETED|Overall Study||7
876101|NCT02104830|2119896|P1|NOT COMPLETED|Overall Study||4
876102|NCT02104830|2119894|P3|COMPLETED|Overall Study||36
876103|NCT02104830|2119895|P2|COMPLETED|Overall Study||36
876104|NCT02104830|2119896|P1|COMPLETED|Overall Study||38
876105|NCT02104830|2119894|P3|STARTED|Overall Study||43
876106|NCT02104830|2119895|P2|STARTED|Overall Study||43
876107|NCT02104830|2119896|P1|STARTED|Overall Study||42
876108|NCT02104804|2119921|P2|NOT COMPLETED|Overall Study||19
876109|NCT02104804|2119922|P1|NOT COMPLETED|Overall Study||16
876110|NCT02104804|2119921|P2|COMPLETED|Overall Study|Of the 19 who did not complete, 1 did not take study medication after randomization.|213
876111|NCT02104804|2119922|P1|COMPLETED|Overall Study|Number of patients who completed 24 weeks of treatment|218
876112|NCT02104804|2119921|P2|STARTED|Overall Study|Number of patients who were randomized|232
876113|NCT02104804|2119922|P1|STARTED|Overall Study|Number of patients who were randomized|234
876114|NCT02104219|2119938|P1|NOT COMPLETED|Overall Study||0
876115|NCT02104219|2119938|P1|COMPLETED|Overall Study||32
876116|NCT02104219|2119938|P1|STARTED|Overall Study||32
876117|NCT02103855|2119945|P1|NOT COMPLETED|Overall Study||2
876118|NCT02103855|2119945|P1|COMPLETED|Overall Study||4
876119|NCT02103855|2119945|P1|STARTED|Overall Study||6
876120|NCT02103439|2119955|P2|NOT COMPLETED|Overall Study||3
876121|NCT02103439|2119956|P1|NOT COMPLETED|Overall Study||3
876122|NCT02103439|2119955|P2|COMPLETED|Overall Study||67
876123|NCT02103439|2119956|P1|COMPLETED|Overall Study||67
876124|NCT02103439|2119955|P2|STARTED|Overall Study||70
876125|NCT02103439|2119956|P1|STARTED|Overall Study||70
876126|NCT02103309|2119976|P2|NOT COMPLETED|Overall Study||0
876127|NCT02103309|2119977|P1|NOT COMPLETED|Overall Study||0
876128|NCT02103309|2119976|P2|COMPLETED|Overall Study||22
876129|NCT02103309|2119977|P1|COMPLETED|Overall Study||20
876130|NCT02103309|2119976|P2|STARTED|Overall Study||22
876131|NCT02103309|2119977|P1|STARTED|Overall Study||20
876132|NCT02103114|2119991|P2|NOT COMPLETED|Overall Study||1
876133|NCT02103114|2119992|P1|NOT COMPLETED|Overall Study||0
876134|NCT02103114|2119991|P2|COMPLETED|Overall Study||19
876135|NCT02103114|2119992|P1|COMPLETED|Overall Study||20
876136|NCT02103114|2119991|P2|STARTED|Overall Study||20
876137|NCT02103114|2119992|P1|STARTED|Overall Study||20
876138|NCT02103062|2120048|P2|NOT COMPLETED|Overall Study||23
876139|NCT02103062|2120049|P1|NOT COMPLETED|Overall Study||18
876140|NCT02103062|2120048|P2|COMPLETED|Overall Study||0
876141|NCT02103062|2120049|P1|COMPLETED|Overall Study||0
876142|NCT02103062|2120048|P2|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|20
876143|NCT02103062|2120049|P1|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|17
876144|NCT02103062|2120048|P2|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|23
876145|NCT02103062|2120049|P1|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|18
876146|NCT02103062|2120048|P2|STARTED|Overall Study||23
876147|NCT02103062|2120049|P1|STARTED|Overall Study||18
876148|NCT02102932|2120075|P8|NOT COMPLETED|Overall Study||0
876149|NCT02102932|2120076|P7|NOT COMPLETED|Overall Study||0
876150|NCT02102932|2120077|P6|NOT COMPLETED|Overall Study||0
876151|NCT02102932|2120078|P5|NOT COMPLETED|Overall Study||0
876152|NCT02102932|2120079|P4|NOT COMPLETED|Overall Study||0
876153|NCT02102932|2120080|P3|NOT COMPLETED|Overall Study||0
876154|NCT02102932|2120081|P2|NOT COMPLETED|Overall Study||0
876155|NCT02102932|2120082|P1|NOT COMPLETED|Overall Study||0
876156|NCT02102932|2120075|P8|COMPLETED|Overall Study||12
876157|NCT02102932|2120076|P7|COMPLETED|Overall Study||12
876158|NCT02102932|2120077|P6|COMPLETED|Overall Study||12
876159|NCT02102932|2120078|P5|COMPLETED|Overall Study||12
876160|NCT02102932|2120079|P4|COMPLETED|Overall Study||12
876161|NCT02102932|2120080|P3|COMPLETED|Overall Study||12
876162|NCT02102932|2120081|P2|COMPLETED|Overall Study||12
876163|NCT02102932|2120082|P1|COMPLETED|Overall Study||12
876164|NCT02102932|2120075|P8|STARTED|Overall Study||12
876165|NCT02102932|2120076|P7|STARTED|Overall Study||12
876166|NCT02102932|2120077|P6|STARTED|Overall Study||12
876167|NCT02102932|2120078|P5|STARTED|Overall Study||12
876168|NCT02102932|2120079|P4|STARTED|Overall Study||12
876169|NCT02102932|2120080|P3|STARTED|Overall Study||12
876170|NCT02102932|2120081|P2|STARTED|Overall Study||12
876171|NCT02102932|2120082|P1|STARTED|Overall Study||12
876190|NCT02102399|2120157|P2|NOT COMPLETED|Overall Study||4
876191|NCT02102399|2120158|P1|NOT COMPLETED|Overall Study||6
876192|NCT02102399|2120157|P2|COMPLETED|Overall Study||17
876193|NCT02102399|2120158|P1|COMPLETED|Overall Study||14
876194|NCT02102399|2120157|P2|STARTED|Overall Study||21
876195|NCT02102399|2120158|P1|STARTED|Overall Study||20
876196|NCT02101359|2120208|P2|NOT COMPLETED|Overall Study||19
876197|NCT02101359|2120209|P1|NOT COMPLETED|Overall Study||29
876198|NCT02101359|2120208|P2|COMPLETED|Overall Study||277
876199|NCT02101359|2120209|P1|COMPLETED|Overall Study||266
876200|NCT02101359|2120208|P2|STARTED|Overall Study||296
876201|NCT02101359|2120209|P1|STARTED|Overall Study||295
876202|NCT02101294|2120215|P1|NOT COMPLETED|Overall Study||11
876203|NCT02101294|2120215|P1|COMPLETED|Overall Study||20
876204|NCT02101294|2120215|P1|STARTED|Overall Study||31
876205|NCT02101190|2120224|P2|NOT COMPLETED|Overall Study||0
876206|NCT02101190|2120225|P1|NOT COMPLETED|Overall Study||0
876207|NCT02101190|2120224|P2|COMPLETED|Overall Study||8
876208|NCT02101190|2120225|P1|COMPLETED|Overall Study||8
876209|NCT02101190|2120224|P2|STARTED|Overall Study||8
876210|NCT02101190|2120225|P1|STARTED|Overall Study||8
876211|NCT02101112|2120235|P6|NOT COMPLETED|Overall Study||0
876212|NCT02101112|2120236|P5|NOT COMPLETED|Overall Study||1
876213|NCT02101112|2120237|P4|NOT COMPLETED|Overall Study||0
876214|NCT02101112|2120238|P3|NOT COMPLETED|Overall Study||1
876215|NCT02101112|2120239|P2|NOT COMPLETED|Overall Study||0
876216|NCT02101112|2120240|P1|NOT COMPLETED|Overall Study||0
876217|NCT02101112|2120235|P6|COMPLETED|Overall Study||5
876218|NCT02101112|2120236|P5|COMPLETED|Overall Study||5
876219|NCT02101112|2120237|P4|COMPLETED|Overall Study||5
876220|NCT02101112|2120238|P3|COMPLETED|Overall Study||5
876221|NCT02101112|2120239|P2|COMPLETED|Overall Study||5
876222|NCT02101112|2120240|P1|COMPLETED|Overall Study||6
876223|NCT02101112|2120235|P6|STARTED|Overall Study||5
876224|NCT02101112|2120236|P5|STARTED|Overall Study||6
876225|NCT02101112|2120237|P4|STARTED|Overall Study||5
876226|NCT02101112|2120238|P3|STARTED|Overall Study||6
876227|NCT02101112|2120239|P2|STARTED|Overall Study||5
876228|NCT02101112|2120240|P1|STARTED|Overall Study||6
876229|NCT02101008|2120265|P1|NOT COMPLETED|Overall Study||0
876230|NCT02101008|2120265|P1|COMPLETED|Overall Study||12
876231|NCT02101008|2120265|P1|STARTED|Overall Study||12
876232|NCT02100839|2120272|P2|NOT COMPLETED|Multiple Ascending Dose||0
876233|NCT02100839|2120273|P1|NOT COMPLETED|Multiple Ascending Dose||4
876234|NCT02100839|2120272|P2|COMPLETED|Multiple Ascending Dose||3
876235|NCT02100839|2120273|P1|COMPLETED|Multiple Ascending Dose||9
876236|NCT02100839|2120272|P2|STARTED|Multiple Ascending Dose||3
876237|NCT02100839|2120273|P1|STARTED|Multiple Ascending Dose||13
876238|NCT02100839|2120272|P2|NOT COMPLETED|Single Ascending Dose||0
876239|NCT02100839|2120273|P1|NOT COMPLETED|Single Ascending Dose||0
876240|NCT02100839|2120272|P2|COMPLETED|Single Ascending Dose||12
876241|NCT02100839|2120273|P1|COMPLETED|Single Ascending Dose||24
876242|NCT02100839|2120272|P2|STARTED|Single Ascending Dose||12
876243|NCT02100839|2120273|P1|STARTED|Single Ascending Dose||24
876244|NCT02100826|2120285|P2|NOT COMPLETED|Period 2 (7 Days)||0
876245|NCT02100826|2120286|P1|NOT COMPLETED|Period 2 (7 Days)||0
876246|NCT02100826|2120285|P2|COMPLETED|Period 2 (7 Days)||14
876247|NCT02100826|2120286|P1|COMPLETED|Period 2 (7 Days)||14
876248|NCT02100826|2120285|P2|STARTED|Period 2 (7 Days)||14
876249|NCT02100826|2120286|P1|STARTED|Period 2 (7 Days)||14
876250|NCT02100826|2120285|P2|NOT COMPLETED|Washout Period (1 Day)||0
876251|NCT02100826|2120286|P1|NOT COMPLETED|Washout Period (1 Day)||0
876252|NCT02100826|2120285|P2|COMPLETED|Washout Period (1 Day)||14
876253|NCT02100826|2120286|P1|COMPLETED|Washout Period (1 Day)||14
876254|NCT02100826|2120285|P2|STARTED|Washout Period (1 Day)||14
876255|NCT02100826|2120286|P1|STARTED|Washout Period (1 Day)||14
876256|NCT02100826|2120285|P2|NOT COMPLETED|Period 1 (7 Days)||0
876257|NCT02100826|2120286|P1|NOT COMPLETED|Period 1 (7 Days)||0
876258|NCT02100826|2120285|P2|COMPLETED|Period 1 (7 Days)||14
876259|NCT02100826|2120286|P1|COMPLETED|Period 1 (7 Days)||14
876260|NCT02100826|2120285|P2|STARTED|Period 1 (7 Days)||14
876261|NCT02100826|2120286|P1|STARTED|Period 1 (7 Days)||14
876262|NCT02100644|2120296|P3|NOT COMPLETED|LTG and VPA Maintenance Phase||0
876263|NCT02100644|2120297|P2|NOT COMPLETED|LTG and VPA Maintenance Phase||0
876264|NCT02100644|2120298|P1|NOT COMPLETED|LTG and VPA Maintenance Phase||0
876265|NCT02100644|2120296|P3|COMPLETED|LTG and VPA Maintenance Phase||20
876266|NCT02100644|2120297|P2|COMPLETED|LTG and VPA Maintenance Phase||0
876267|NCT02100644|2120298|P1|COMPLETED|LTG and VPA Maintenance Phase||0
876268|NCT02100644|2120296|P3|STARTED|LTG and VPA Maintenance Phase||20
876269|NCT02100644|2120297|P2|STARTED|LTG and VPA Maintenance Phase||0
876270|NCT02100644|2120298|P1|STARTED|LTG and VPA Maintenance Phase||0
876271|NCT02100644|2120296|P3|NOT COMPLETED|VPA Reduction Phase||0
876272|NCT02100644|2120297|P2|NOT COMPLETED|VPA Reduction Phase||0
876273|NCT02100644|2120298|P1|NOT COMPLETED|VPA Reduction Phase||0
876274|NCT02100644|2120296|P3|COMPLETED|VPA Reduction Phase||0
876275|NCT02100644|2120297|P2|COMPLETED|VPA Reduction Phase||20
876276|NCT02100644|2120298|P1|COMPLETED|VPA Reduction Phase||0
876277|NCT02100644|2120296|P3|STARTED|VPA Reduction Phase||0
876278|NCT02100644|2120297|P2|STARTED|VPA Reduction Phase||20
876279|NCT02100644|2120298|P1|STARTED|VPA Reduction Phase||0
876280|NCT02100644|2120296|P3|NOT COMPLETED|LTG Escalation Phase||0
876281|NCT02100644|2120297|P2|NOT COMPLETED|LTG Escalation Phase||0
876282|NCT02100644|2120298|P1|NOT COMPLETED|LTG Escalation Phase||13
876283|NCT02100644|2120296|P3|COMPLETED|LTG Escalation Phase||0
876284|NCT02100644|2120297|P2|COMPLETED|LTG Escalation Phase||0
876285|NCT02100644|2120298|P1|COMPLETED|LTG Escalation Phase||20
876286|NCT02100644|2120296|P3|STARTED|LTG Escalation Phase||0
876287|NCT02100644|2120297|P2|STARTED|LTG Escalation Phase||0
876288|NCT02100644|2120298|P1|STARTED|LTG Escalation Phase||33
876289|NCT02100579|2120310|P2|NOT COMPLETED|Overall Study||0
876290|NCT02100579|2120311|P1|NOT COMPLETED|Overall Study||0
876291|NCT02100579|2120310|P2|COMPLETED|Overall Study||20
876292|NCT02100579|2120311|P1|COMPLETED|Overall Study||20
876293|NCT02100579|2120310|P2|STARTED|Overall Study||20
876294|NCT02100579|2120311|P1|STARTED|Overall Study||20
876295|NCT02100514|2120323|P2|NOT COMPLETED|Overall Study||74
876296|NCT02100514|2120324|P1|NOT COMPLETED|Overall Study||29
876297|NCT02100514|2120323|P2|COMPLETED|Overall Study||425
876298|NCT02100514|2120324|P1|COMPLETED|Overall Study||218
876299|NCT02100514|2120323|P2|STARTED|Overall Study||499
876300|NCT02100514|2120324|P1|STARTED|Overall Study||247
876301|NCT02100475|2120384|P2|NOT COMPLETED|Overall Study||2
876302|NCT02100475|2120385|P1|NOT COMPLETED|Overall Study||2
876303|NCT02100475|2120384|P2|COMPLETED|Overall Study||13
876304|NCT02100475|2120385|P1|COMPLETED|Overall Study||14
876305|NCT02100475|2120384|P2|STARTED|Overall Study||15
876306|NCT02100475|2120385|P1|STARTED|Overall Study||16
876307|NCT02100410|2120395|P6|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
876308|NCT02100410|2120396|P5|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
876309|NCT02100410|2120397|P4|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
876310|NCT02100410|2120398|P3|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
876311|NCT02100410|2120399|P2|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
876312|NCT02100410|2120400|P1|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
876313|NCT02100410|2120395|P6|COMPLETED|Exposure Pair 3, 30 Minutes||9
876314|NCT02100410|2120396|P5|COMPLETED|Exposure Pair 3, 30 Minutes||8
876315|NCT02100410|2120397|P4|COMPLETED|Exposure Pair 3, 30 Minutes||8
876316|NCT02100410|2120398|P3|COMPLETED|Exposure Pair 3, 30 Minutes||8
876317|NCT02100410|2120399|P2|COMPLETED|Exposure Pair 3, 30 Minutes||8
876318|NCT02100410|2120400|P1|COMPLETED|Exposure Pair 3, 30 Minutes||8
876319|NCT02100410|2120395|P6|STARTED|Exposure Pair 3, 30 Minutes||9
876320|NCT02100410|2120396|P5|STARTED|Exposure Pair 3, 30 Minutes||8
876321|NCT02100410|2120397|P4|STARTED|Exposure Pair 3, 30 Minutes||8
876322|NCT02100410|2120398|P3|STARTED|Exposure Pair 3, 30 Minutes||8
876323|NCT02100410|2120399|P2|STARTED|Exposure Pair 3, 30 Minutes||8
876324|NCT02100410|2120400|P1|STARTED|Exposure Pair 3, 30 Minutes||8
876325|NCT02100410|2120395|P6|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
876326|NCT02100410|2120396|P5|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
876327|NCT02100410|2120397|P4|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
876328|NCT02100410|2120398|P3|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
876329|NCT02100410|2120399|P2|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
876330|NCT02100410|2120400|P1|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
876331|NCT02100410|2120395|P6|COMPLETED|Exposure Pair 2, 30 Minutes||9
876332|NCT02100410|2120396|P5|COMPLETED|Exposure Pair 2, 30 Minutes||8
876333|NCT02100410|2120397|P4|COMPLETED|Exposure Pair 2, 30 Minutes||8
876334|NCT02100410|2120398|P3|COMPLETED|Exposure Pair 2, 30 Minutes||8
876335|NCT02100410|2120399|P2|COMPLETED|Exposure Pair 2, 30 Minutes||8
876336|NCT02100410|2120400|P1|COMPLETED|Exposure Pair 2, 30 Minutes||8
876337|NCT02100410|2120395|P6|STARTED|Exposure Pair 2, 30 Minutes||9
876338|NCT02100410|2120396|P5|STARTED|Exposure Pair 2, 30 Minutes||8
876339|NCT02100410|2120397|P4|STARTED|Exposure Pair 2, 30 Minutes||8
876340|NCT02100410|2120398|P3|STARTED|Exposure Pair 2, 30 Minutes||8
876341|NCT02100410|2120399|P2|STARTED|Exposure Pair 2, 30 Minutes||8
876342|NCT02100410|2120400|P1|STARTED|Exposure Pair 2, 30 Minutes||8
876343|NCT02100410|2120395|P6|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
876344|NCT02100410|2120396|P5|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
876345|NCT02100410|2120397|P4|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
876346|NCT02100410|2120398|P3|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
876347|NCT02100410|2120399|P2|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
876348|NCT02100410|2120400|P1|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
876349|NCT02100410|2120395|P6|COMPLETED|Exposure Pair 1, 30 Minutes||9
876350|NCT02100410|2120396|P5|COMPLETED|Exposure Pair 1, 30 Minutes||8
876351|NCT02100410|2120397|P4|COMPLETED|Exposure Pair 1, 30 Minutes||8
876352|NCT02100410|2120398|P3|COMPLETED|Exposure Pair 1, 30 Minutes||8
876353|NCT02100410|2120399|P2|COMPLETED|Exposure Pair 1, 30 Minutes||8
876354|NCT02100410|2120400|P1|COMPLETED|Exposure Pair 1, 30 Minutes||8
876355|NCT02100410|2120395|P6|STARTED|Exposure Pair 1, 30 Minutes||9
876356|NCT02100410|2120396|P5|STARTED|Exposure Pair 1, 30 Minutes||8
876357|NCT02100410|2120397|P4|STARTED|Exposure Pair 1, 30 Minutes||8
876358|NCT02100410|2120398|P3|STARTED|Exposure Pair 1, 30 Minutes||8
876359|NCT02100410|2120399|P2|STARTED|Exposure Pair 1, 30 Minutes||8
876360|NCT02100410|2120400|P1|STARTED|Exposure Pair 1, 30 Minutes||8
876361|NCT02100189|2120416|P1|NOT COMPLETED|Overall Study||0
876362|NCT02100189|2120416|P1|COMPLETED|Overall Study||50
876363|NCT02100189|2120416|P1|STARTED|Overall Study||50
876364|NCT02100007|2120423|P1|NOT COMPLETED|Overall Study||0
876365|NCT02100007|2120423|P1|COMPLETED|Overall Study||46
876366|NCT02100007|2120423|P1|STARTED|Overall Study||46
876367|NCT02099838|2120436|P2|NOT COMPLETED|Overall Study||2
876368|NCT02099838|2120437|P1|NOT COMPLETED|Overall Study||4
876369|NCT02099838|2120436|P2|COMPLETED|Overall Study||49
876370|NCT02099838|2120437|P1|COMPLETED|Overall Study||43
876371|NCT02099838|2120436|P2|STARTED|Overall Study||51
876372|NCT02099838|2120437|P1|STARTED|Overall Study||47
876373|NCT02099708|2120467|P1|NOT COMPLETED|Overall Study||200
876374|NCT02099708|2120467|P1|COMPLETED|Overall Study||3302
876375|NCT02099708|2120467|P1|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3302
876376|NCT02099708|2120467|P1|STARTED|Overall Study|Number of cases.|3502
876377|NCT02099682|2120478|P1|NOT COMPLETED|Overall Study||111
876378|NCT02099682|2120478|P1|COMPLETED|Overall Study||3255
876379|NCT02099682|2120478|P1|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3255
876380|NCT02099682|2120478|P1|STARTED|Overall Study|Number of cases.|3366
876381|NCT02099461|2120492|P3|NOT COMPLETED|Overall Study||0
876382|NCT02099461|2120493|P2|NOT COMPLETED|Overall Study||0
876383|NCT02099461|2120494|P1|NOT COMPLETED|Overall Study||0
876384|NCT02099461|2120492|P3|COMPLETED|Overall Study||28
876385|NCT02099461|2120493|P2|COMPLETED|Overall Study||27
876386|NCT02099461|2120494|P1|COMPLETED|Overall Study||27
876387|NCT02099461|2120492|P3|STARTED|Overall Study||28
876388|NCT02099461|2120493|P2|STARTED|Overall Study||27
876389|NCT02099461|2120494|P1|STARTED|Overall Study||27
876390|NCT02099344|2120504|P2|NOT COMPLETED|Overall Study||0
876391|NCT02099344|2120505|P1|NOT COMPLETED|Overall Study||1
876392|NCT02099344|2120504|P2|COMPLETED|Overall Study||0
876393|NCT02099344|2120505|P1|COMPLETED|Overall Study||0
876394|NCT02099344|2120504|P2|STARTED|Overall Study||0
876395|NCT02099344|2120505|P1|STARTED|Overall Study||1
876396|NCT02099318|2120513|P2|NOT COMPLETED|Overall Study||0
876397|NCT02099318|2120514|P1|NOT COMPLETED|Overall Study||0
876398|NCT02099318|2120513|P2|COMPLETED|Overall Study||20
876399|NCT02099318|2120514|P1|COMPLETED|Overall Study||20
876400|NCT02099318|2120513|P2|STARTED|Overall Study||20
876401|NCT02099318|2120514|P1|STARTED|Overall Study||20
876402|NCT02099266|2120528|P1|NOT COMPLETED|Overall Study||0
876403|NCT02099266|2120528|P1|COMPLETED|Overall Study||15
876404|NCT02099266|2120528|P1|STARTED|Overall Study||15
876405|NCT02099084|2120535|P2|NOT COMPLETED|Second Intervention||0
876406|NCT02099084|2120536|P1|NOT COMPLETED|Second Intervention||0
876407|NCT02099084|2120535|P2|COMPLETED|Second Intervention||4
876408|NCT02099084|2120536|P1|COMPLETED|Second Intervention||4
876409|NCT02099084|2120535|P2|STARTED|Second Intervention||4
876410|NCT02099084|2120536|P1|STARTED|Second Intervention||4
876411|NCT02099084|2120535|P2|NOT COMPLETED|Washout Period of 14 Days||0
876412|NCT02099084|2120536|P1|NOT COMPLETED|Washout Period of 14 Days||0
876413|NCT02099084|2120535|P2|COMPLETED|Washout Period of 14 Days||4
876414|NCT02099084|2120536|P1|COMPLETED|Washout Period of 14 Days||4
876415|NCT02099084|2120535|P2|STARTED|Washout Period of 14 Days||4
876416|NCT02099084|2120536|P1|STARTED|Washout Period of 14 Days||4
876417|NCT02099084|2120535|P2|NOT COMPLETED|First Intervention||0
876418|NCT02099084|2120536|P1|NOT COMPLETED|First Intervention||0
876419|NCT02099084|2120535|P2|COMPLETED|First Intervention||4
876420|NCT02099084|2120536|P1|COMPLETED|First Intervention||4
876421|NCT02099084|2120535|P2|STARTED|First Intervention||4
876422|NCT02099084|2120536|P1|STARTED|First Intervention||4
876423|NCT02099006|2120554|P1|NOT COMPLETED|Overall Study||1
876424|NCT02099006|2120554|P1|COMPLETED|Overall Study||8
876425|NCT02099006|2120554|P1|Received Gabapentin|Overall Study||8
876426|NCT02099006|2120554|P1|Received Ketamine|Overall Study||6
876427|NCT02099006|2120554|P1|Received Loperamide|Overall Study||7
876428|NCT02099006|2120554|P1|Received Ketoprofen|Overall Study||3
876429|NCT02099006|2120554|P1|Received Amitriptyline/ Baclofen|Overall Study||7
876430|NCT02099006|2120554|P1|Received Placebo|Overall Study||9
876431|NCT02099006|2120554|P1|STARTED|Overall Study||9
876432|NCT02098746|2120562|P1|NOT COMPLETED|Overall Study||5
876433|NCT02098746|2120562|P1|COMPLETED|Overall Study||289
876434|NCT02098746|2120562|P1|STARTED|Overall Study||294
876435|NCT02098733|2120570|P1|NOT COMPLETED|Overall Study||10
876436|NCT02098733|2120570|P1|COMPLETED|Overall Study||1158
876437|NCT02098733|2120570|P1|STARTED|Overall Study||1168
876438|NCT02098395|2120584|P4|NOT COMPLETED|Overall Study||27
876439|NCT02098395|2120585|P3|NOT COMPLETED|Overall Study||42
876440|NCT02098395|2120586|P2|NOT COMPLETED|Overall Study||32
876441|NCT02098395|2120587|P1|NOT COMPLETED|Overall Study||26
876442|NCT02098395|2120584|P4|COMPLETED|Overall Study||180
876443|NCT02098395|2120585|P3|COMPLETED|Overall Study||165
876444|NCT02098395|2120586|P2|COMPLETED|Overall Study||177
876445|NCT02098395|2120587|P1|COMPLETED|Overall Study||186
876446|NCT02098395|2120584|P4|Exposed|Overall Study||206
876447|NCT02098395|2120585|P3|Exposed|Overall Study||206
876448|NCT02098395|2120586|P2|Exposed|Overall Study||209
876449|NCT02098395|2120587|P1|Exposed|Overall Study||211
876450|NCT02098395|2120584|P4|STARTED|Overall Study||207
876451|NCT02098395|2120585|P3|STARTED|Overall Study||207
876452|NCT02098395|2120586|P2|STARTED|Overall Study||209
876453|NCT02098395|2120587|P1|STARTED|Overall Study||212
876454|NCT02098304|2120605|P1|NOT COMPLETED|Overall Study||0
876455|NCT02098304|2120605|P1|COMPLETED|Overall Study||42
876456|NCT02098304|2120605|P1|STARTED|Overall Study||42
876457|NCT02098109|2120614|P2|NOT COMPLETED|Overall Study||0
876458|NCT02098109|2120615|P1|NOT COMPLETED|Overall Study||3
876459|NCT02098109|2120614|P2|COMPLETED|Overall Study||51
876460|NCT02098109|2120615|P1|COMPLETED|Overall Study||46
876461|NCT02098109|2120614|P2|STARTED|Overall Study||51
876462|NCT02098109|2120615|P1|STARTED|Overall Study||49
876463|NCT02097992|2120641|P4|NOT COMPLETED|Overall Study||0
876464|NCT02097992|2120642|P3|NOT COMPLETED|Overall Study||0
876465|NCT02097992|2120643|P2|NOT COMPLETED|Overall Study||0
876466|NCT02097992|2120644|P1|NOT COMPLETED|Overall Study||0
876467|NCT02097992|2120641|P4|COMPLETED|Overall Study||2
876468|NCT02097992|2120642|P3|COMPLETED|Overall Study||4
876469|NCT02097992|2120643|P2|COMPLETED|Overall Study||3
876470|NCT02097992|2120644|P1|COMPLETED|Overall Study||2
876471|NCT02097992|2120641|P4|STARTED|Overall Study||2
876472|NCT02097992|2120642|P3|STARTED|Overall Study||4
876473|NCT02097992|2120643|P2|STARTED|Overall Study||3
876474|NCT02097992|2120644|P1|STARTED|Overall Study||2
876475|NCT02097849|2120652|P2|NOT COMPLETED|Overall Study||0
876476|NCT02097849|2120653|P1|NOT COMPLETED|Overall Study||0
876477|NCT02097849|2120652|P2|COMPLETED|Overall Study||38
876478|NCT02097849|2120653|P1|COMPLETED|Overall Study||33
876479|NCT02097849|2120652|P2|STARTED|Overall Study||38
876480|NCT02097849|2120653|P1|STARTED|Overall Study||33
876481|NCT02097823|2120691|P2|NOT COMPLETED|Overall Study||1
876482|NCT02097823|2120692|P1|NOT COMPLETED|Overall Study||1
876483|NCT02097823|2120691|P2|COMPLETED|Overall Study||3
876484|NCT02097823|2120692|P1|COMPLETED|Overall Study||10
876485|NCT02097823|2120691|P2|STARTED|Overall Study||4
876486|NCT02097823|2120692|P1|STARTED|Overall Study||11
876487|NCT02097745|2120707|P1|NOT COMPLETED|Overall Study||178
876488|NCT02097745|2120707|P1|COMPLETED|Overall Study||157
876489|NCT02097745|2120707|P1|STARTED|Overall Study|Six participants did not receive any treatment and were not included in any analyses.|335
876490|NCT02097719|2120731|P2|NOT COMPLETED|Overall Study||1
876491|NCT02097719|2120732|P1|NOT COMPLETED|Overall Study||3
876492|NCT02097719|2120731|P2|COMPLETED|Overall Study||50
876493|NCT02097719|2120732|P1|COMPLETED|Overall Study||46
876494|NCT02097719|2120731|P2|STARTED|Overall Study||51
876495|NCT02097719|2120732|P1|STARTED|Overall Study||49
876496|NCT02097537|2120738|P1|NOT COMPLETED|Overall Study||0
876497|NCT02097537|2120738|P1|COMPLETED|Overall Study||10
876498|NCT02097537|2120738|P1|Follow-Up|Overall Study||10
876499|NCT02097537|2120738|P1|Enrollment|Overall Study|Inhalation of Methacholine Chloride|10
876500|NCT02097537|2120738|P1|STARTED|Overall Study||10
876501|NCT02097290|2120744|P1|NOT COMPLETED|Overall Study||17
876502|NCT02097290|2120744|P1|COMPLETED|Overall Study|Active subjects at the end of 3 month follow up visit for primary end point data collection|193
876503|NCT02097290|2120744|P1|STARTED|Overall Study||210
876504|NCT02097238|2120754|P1|NOT COMPLETED|Overall Study||19
876505|NCT02097238|2120754|P1|COMPLETED|Overall Study||0
876506|NCT02097238|2120754|P1|STARTED|Overall Study||19
876507|NCT02097108|2120760|P1|NOT COMPLETED|Overall Study||2
876508|NCT02097108|2120760|P1|COMPLETED|Overall Study||9
876509|NCT02097108|2120760|P1|STARTED|Overall Study||11
876510|NCT02097056|2120767|P1|NOT COMPLETED|Overall Study||58
876511|NCT02097056|2120767|P1|COMPLETED|Overall Study||113
876512|NCT02097056|2120767|P1|ParticipantsTreated|Overall Study||170
876513|NCT02097056|2120767|P1|STARTED|Overall Study||171
876514|NCT02097030|2120775|P2|NOT COMPLETED|Second Intervention (3 Days)||0
876515|NCT02097030|2120776|P1|NOT COMPLETED|Second Intervention (3 Days)||0
876516|NCT02097030|2120775|P2|COMPLETED|Second Intervention (3 Days)||16
876517|NCT02097030|2120776|P1|COMPLETED|Second Intervention (3 Days)||14
876518|NCT02097030|2120775|P2|STARTED|Second Intervention (3 Days)||16
876519|NCT02097030|2120776|P1|STARTED|Second Intervention (3 Days)||14
876520|NCT02097030|2120775|P2|NOT COMPLETED|First Intervention (3 Days)||1
876521|NCT02097030|2120776|P1|NOT COMPLETED|First Intervention (3 Days)||1
876522|NCT02097030|2120775|P2|COMPLETED|First Intervention (3 Days)||16
876523|NCT02097030|2120776|P1|COMPLETED|First Intervention (3 Days)||14
876524|NCT02097030|2120775|P2|STARTED|First Intervention (3 Days)||17
876525|NCT02097030|2120776|P1|STARTED|First Intervention (3 Days)||15
876526|NCT02096900|2120839|P2|NOT COMPLETED|Overall Study||2
876527|NCT02096900|2120840|P1|NOT COMPLETED|Overall Study||4
876528|NCT02096900|2120839|P2|COMPLETED|Overall Study||42
876529|NCT02096900|2120840|P1|COMPLETED|Overall Study||38
876530|NCT02096900|2120839|P2|STARTED|Overall Study|Allocated to Zolpidem|44
876531|NCT02096900|2120840|P1|STARTED|Overall Study|Allocated to Midazolam|42
876532|NCT02096835|2120857|P3|NOT COMPLETED|Overall Study||1
876533|NCT02096835|2120858|P2|NOT COMPLETED|Overall Study||0
876534|NCT02096835|2120859|P1|NOT COMPLETED|Overall Study||3
876535|NCT02096835|2120857|P3|COMPLETED|Overall Study||50
876536|NCT02096835|2120858|P2|COMPLETED|Overall Study||53
876537|NCT02096835|2120859|P1|COMPLETED|Overall Study||50
876538|NCT02096835|2120857|P3|STARTED|Overall Study||51
876539|NCT02096835|2120858|P2|STARTED|Overall Study||53
876540|NCT02096835|2120859|P1|STARTED|Overall Study||53
876541|NCT02096744|2120876|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||1
876542|NCT02096744|2120877|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
876543|NCT02096744|2120876|P2|COMPLETED|Treatment Period 3 (7 Days)||27
876544|NCT02096744|2120877|P1|COMPLETED|Treatment Period 3 (7 Days)||28
876545|NCT02096744|2120876|P2|STARTED|Treatment Period 3 (7 Days)||28
876546|NCT02096744|2120877|P1|STARTED|Treatment Period 3 (7 Days)||28
876547|NCT02096744|2120876|P2|NOT COMPLETED|Washout Period 2 (3 Days)||0
876548|NCT02096744|2120877|P1|NOT COMPLETED|Washout Period 2 (3 Days)||0
876549|NCT02096744|2120876|P2|COMPLETED|Washout Period 2 (3 Days)||28
876550|NCT02096744|2120877|P1|COMPLETED|Washout Period 2 (3 Days)||28
876551|NCT02096744|2120876|P2|STARTED|Washout Period 2 (3 Days)||28
876552|NCT02096744|2120877|P1|STARTED|Washout Period 2 (3 Days)||28
876553|NCT02096744|2120876|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||0
876554|NCT02096744|2120877|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
876555|NCT02096744|2120876|P2|COMPLETED|Treatment Period 2 (7 Days)||28
876556|NCT02096744|2120877|P1|COMPLETED|Treatment Period 2 (7 Days)||28
876557|NCT02096744|2120876|P2|STARTED|Treatment Period 2 (7 Days)||28
876558|NCT02096744|2120877|P1|STARTED|Treatment Period 2 (7 Days)||28
876559|NCT02096744|2120876|P2|NOT COMPLETED|Washout Period 1(7 Days)||0
876560|NCT02096744|2120877|P1|NOT COMPLETED|Washout Period 1(7 Days)||0
876561|NCT02096744|2120876|P2|COMPLETED|Washout Period 1(7 Days)||28
876562|NCT02096744|2120877|P1|COMPLETED|Washout Period 1(7 Days)||28
876563|NCT02096744|2120876|P2|STARTED|Washout Period 1(7 Days)||28
876564|NCT02096744|2120877|P1|STARTED|Washout Period 1(7 Days)||28
876565|NCT02096744|2120876|P2|NOT COMPLETED|Treatment Period 1(7 Days)||1
876566|NCT02096744|2120877|P1|NOT COMPLETED|Treatment Period 1(7 Days)||1
876567|NCT02096744|2120876|P2|COMPLETED|Treatment Period 1(7 Days)||28
876568|NCT02096744|2120877|P1|COMPLETED|Treatment Period 1(7 Days)||28
876569|NCT02096744|2120876|P2|STARTED|Treatment Period 1(7 Days)||29
876570|NCT02096744|2120877|P1|STARTED|Treatment Period 1(7 Days)||29
876571|NCT02096731|2120892|P2|NOT COMPLETED|Overall Study||0
876572|NCT02096731|2120893|P1|NOT COMPLETED|Overall Study||0
876573|NCT02096731|2120892|P2|COMPLETED|Overall Study||88955
876574|NCT02096731|2120893|P1|COMPLETED|Overall Study||26442
876575|NCT02096731|2120892|P2|STARTED|Overall Study||88955
876576|NCT02096731|2120893|P1|STARTED|Overall Study||26442
876577|NCT02096718|2120910|P3|NOT COMPLETED|Overall Study||0
876578|NCT02096718|2120911|P2|NOT COMPLETED|Overall Study||0
876579|NCT02096718|2120912|P1|NOT COMPLETED|Overall Study||0
876580|NCT02096718|2120910|P3|COMPLETED|Overall Study||14
876581|NCT02096718|2120911|P2|COMPLETED|Overall Study||8
876582|NCT02096718|2120912|P1|COMPLETED|Overall Study||8
876583|NCT02096718|2120910|P3|STARTED|Overall Study||14
876584|NCT02096718|2120911|P2|STARTED|Overall Study||8
876585|NCT02096718|2120912|P1|STARTED|Overall Study||8
876586|NCT02096705|2120931|P2|NOT COMPLETED|Follow-up||4
876587|NCT02096705|2120932|P1|NOT COMPLETED|Follow-up||4
876588|NCT02096705|2120931|P2|COMPLETED|Follow-up||135
876589|NCT02096705|2120932|P1|COMPLETED|Follow-up||125
876590|NCT02096705|2120931|P2|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|139
876591|NCT02096705|2120932|P1|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|129
876592|NCT02096705|2120931|P2|NOT COMPLETED|Treatment||5
876593|NCT02096705|2120932|P1|NOT COMPLETED|Treatment||9
876594|NCT02096705|2120931|P2|COMPLETED|Treatment||134
876595|NCT02096705|2120932|P1|COMPLETED|Treatment||124
876596|NCT02096705|2120931|P2|STARTED|Treatment||139
876597|NCT02096705|2120932|P1|STARTED|Treatment||133
876598|NCT02096692|2120944|P1|NOT COMPLETED|Overall Study||4
876599|NCT02096692|2120944|P1|COMPLETED|Overall Study||150
876600|NCT02096692|2120944|P1|STARTED|Overall Study||154
876601|NCT02096679|2120950|P1|NOT COMPLETED|Overall Study||0
876602|NCT02096679|2120950|P1|COMPLETED|Overall Study||8
876603|NCT02096679|2120950|P1|STARTED|Overall Study||8
876604|NCT02096575|2120975|P3|NOT COMPLETED|Overall Study||5
876605|NCT02096575|2120976|P2|NOT COMPLETED|Overall Study||0
876606|NCT02096575|2120977|P1|NOT COMPLETED|Overall Study||0
876607|NCT02096575|2120975|P3|COMPLETED|Overall Study||0
876608|NCT02096575|2120976|P2|COMPLETED|Overall Study||67
876609|NCT02096575|2120977|P1|COMPLETED|Overall Study||68
876610|NCT02096575|2120975|P3|STARTED|Overall Study||5
876611|NCT02096575|2120976|P2|STARTED|Overall Study||67
876612|NCT02096575|2120977|P1|STARTED|Overall Study||68
876613|NCT02096458|2120991|P1|NOT COMPLETED|Overall Study||0
876614|NCT02096458|2120991|P1|COMPLETED|Overall Study||8
876615|NCT02096458|2120991|P1|STARTED|Overall Study||8
876622|NCT02096042|2121030|P3|NOT COMPLETED|Overall Study||0
876623|NCT02096042|2121031|P2|NOT COMPLETED|Overall Study||0
876624|NCT02096042|2121032|P1|NOT COMPLETED|Overall Study||1
876625|NCT02096042|2121030|P3|COMPLETED|Overall Study||0
876626|NCT02096042|2121031|P2|COMPLETED|Overall Study||0
876627|NCT02096042|2121032|P1|COMPLETED|Overall Study||0
876628|NCT02096042|2121030|P3|STARTED|Overall Study||0
876629|NCT02096042|2121031|P2|STARTED|Overall Study||0
876630|NCT02096042|2121032|P1|STARTED|Overall Study||1
876631|NCT02095873|2121041|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
876632|NCT02095873|2121042|P1|NOT COMPLETED|Second Intervention (8 Weeks)||2
876633|NCT02095873|2121041|P2|COMPLETED|Second Intervention (8 Weeks)||16
876634|NCT02095873|2121042|P1|COMPLETED|Second Intervention (8 Weeks)||13
876635|NCT02095873|2121041|P2|STARTED|Second Intervention (8 Weeks)||16
876636|NCT02095873|2121042|P1|STARTED|Second Intervention (8 Weeks)||15
876637|NCT02095873|2121041|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
876638|NCT02095873|2121042|P1|NOT COMPLETED|First Intervention (8 Weeks)||1
876639|NCT02095873|2121041|P2|COMPLETED|First Intervention (8 Weeks)||16
876640|NCT02095873|2121042|P1|COMPLETED|First Intervention (8 Weeks)||15
876641|NCT02095873|2121041|P2|STARTED|First Intervention (8 Weeks)||16
876642|NCT02095873|2121042|P1|STARTED|First Intervention (8 Weeks)||16
876643|NCT02095691|2121054|P1|NOT COMPLETED|Overall Study||1
876644|NCT02095691|2121054|P1|COMPLETED|Overall Study|Subjects with follow up available at 12 months.|18
876645|NCT02095691|2121054|P1|STARTED|Overall Study|Subjects who were consented and treated with study ablation catheter.|19
876646|NCT02095561|2121073|P2|NOT COMPLETED|Overall Study||0
876647|NCT02095561|2121074|P1|NOT COMPLETED|Overall Study||0
876648|NCT02095561|2121073|P2|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|2964
876649|NCT02095561|2121074|P1|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|3049
876650|NCT02095561|2121073|P2|HPV Tested at Health Centers|Overall Study||599
876651|NCT02095561|2121074|P1|HPV Tested at Health Centers|Overall Study||99
876652|NCT02095561|2121073|P2|HPV Self-tested Women|Overall Study|HPV self-testing only applies to the HPV self-testing arm|0
876653|NCT02095561|2121074|P1|HPV Self-tested Women|Overall Study||2519
876654|NCT02095561|2121073|P2|Self-testing Acceptability|Overall Study|Acceptablity only applies to the group of women being offered self-testing.|0
876655|NCT02095561|2121074|P1|Self-testing Acceptability|Overall Study||2616
876656|NCT02095561|2121073|P2|STARTED|Overall Study||2964
876657|NCT02095561|2121074|P1|STARTED|Overall Study||3049
876658|NCT02095535|2121086|P1|NOT COMPLETED|Analysis||0
876659|NCT02095535|2121086|P1|COMPLETED|Analysis||18
876660|NCT02095535|2121086|P1|STARTED|Analysis||18
876661|NCT02095535|2121086|P1|NOT COMPLETED|Recruitment||2
876662|NCT02095535|2121086|P1|COMPLETED|Recruitment||18
876663|NCT02095535|2121086|P1|STARTED|Recruitment||20
876664|NCT02095223|2121092|P2|NOT COMPLETED|Overall Study||0
876665|NCT02095223|2121093|P1|NOT COMPLETED|Overall Study||1
876666|NCT02095223|2121092|P2|COMPLETED|Overall Study||2
876667|NCT02095223|2121093|P1|COMPLETED|Overall Study|1 participant dropped out of this study due to the time commitment associated with participation.|1
876668|NCT02095223|2121092|P2|STARTED|Overall Study||2
876669|NCT02095223|2121093|P1|STARTED|Overall Study||2
876670|NCT02095197|2121103|P2|NOT COMPLETED|Overall Study||3
876671|NCT02095197|2121104|P1|NOT COMPLETED|Overall Study||0
876672|NCT02095197|2121103|P2|COMPLETED|Overall Study||36
876673|NCT02095197|2121104|P1|COMPLETED|Overall Study||40
876674|NCT02095197|2121103|P2|STARTED|Overall Study||39
876675|NCT02095197|2121104|P1|STARTED|Overall Study||40
876676|NCT02095158|2121116|P1|NOT COMPLETED|Overall Study||75
876677|NCT02095158|2121116|P1|COMPLETED|Overall Study||365
876678|NCT02095158|2121116|P1|STARTED|Overall Study||440
876679|NCT02094937|2121121|P4|NOT COMPLETED|12 Weeks in Period 2||12
876680|NCT02094937|2121122|P3|NOT COMPLETED|12 Weeks in Period 2||12
876681|NCT02094937|2121123|P2|NOT COMPLETED|12 Weeks in Period 2||11
876682|NCT02094937|2121124|P1|NOT COMPLETED|12 Weeks in Period 2||0
876683|NCT02094937|2121121|P4|COMPLETED|12 Weeks in Period 2||112
876684|NCT02094937|2121122|P3|COMPLETED|12 Weeks in Period 2||112
876685|NCT02094937|2121123|P2|COMPLETED|12 Weeks in Period 2||112
876686|NCT02094937|2121124|P1|COMPLETED|12 Weeks in Period 2||0
876687|NCT02094937|2121121|P4|STARTED|12 Weeks in Period 2||124
876688|NCT02094937|2121122|P3|STARTED|12 Weeks in Period 2||124
876689|NCT02094937|2121123|P2|STARTED|12 Weeks in Period 2||123
876690|NCT02094937|2121124|P1|STARTED|12 Weeks in Period 2||0
876691|NCT02094937|2121121|P4|NOT COMPLETED|8 Weeks in Period 1||0
876692|NCT02094937|2121122|P3|NOT COMPLETED|8 Weeks in Period 1||0
876693|NCT02094937|2121123|P2|NOT COMPLETED|8 Weeks in Period 1||0
876694|NCT02094937|2121124|P1|NOT COMPLETED|8 Weeks in Period 1||60
876695|NCT02094937|2121121|P4|COMPLETED|8 Weeks in Period 1||0
876696|NCT02094937|2121122|P3|COMPLETED|8 Weeks in Period 1||0
876697|NCT02094937|2121123|P2|COMPLETED|8 Weeks in Period 1||0
876698|NCT02094937|2121124|P1|COMPLETED|8 Weeks in Period 1||370
876699|NCT02094937|2121121|P4|STARTED|8 Weeks in Period 1||0
876700|NCT02094937|2121122|P3|STARTED|8 Weeks in Period 1||0
876701|NCT02094937|2121123|P2|STARTED|8 Weeks in Period 1||0
876702|NCT02094937|2121124|P1|STARTED|8 Weeks in Period 1||430
876703|NCT02094898|2121154|P1|NOT COMPLETED|Overall Study||5
876704|NCT02094898|2121154|P1|COMPLETED|Overall Study||7
876705|NCT02094898|2121154|P1|STARTED|Overall Study||12
876706|NCT02094885|2121201|P2|NOT COMPLETED|Overall Study||5
876707|NCT02094885|2121202|P1|NOT COMPLETED|Overall Study||2
876708|NCT02094885|2121201|P2|COMPLETED|Overall Study||122
876709|NCT02094885|2121202|P1|COMPLETED|Overall Study||123
876710|NCT02094885|2121201|P2|STARTED|Overall Study||127
876711|NCT02094885|2121202|P1|STARTED|Overall Study||125
876712|NCT02094677|2121216|P2|NOT COMPLETED|Overall Study||1
876713|NCT02094677|2121217|P1|NOT COMPLETED|Overall Study||3
876714|NCT02094677|2121216|P2|COMPLETED|Overall Study||30
876715|NCT02094677|2121217|P1|COMPLETED|Overall Study||40
876716|NCT02094677|2121216|P2|STARTED|Overall Study||31
876717|NCT02094677|2121217|P1|STARTED|Overall Study||43
876718|NCT02094612|2121281|P2|NOT COMPLETED|Overall Study||70
876719|NCT02094612|2121282|P1|NOT COMPLETED|Overall Study||79
876720|NCT02094612|2121281|P2|COMPLETED|Overall Study||25
876721|NCT02094612|2121282|P1|COMPLETED|Overall Study||33
876722|NCT02094612|2121281|P2|6 Month Follow up|Overall Study||25
876723|NCT02094612|2121282|P1|6 Month Follow up|Overall Study||33
876724|NCT02094612|2121281|P2|3 Month Follow up|Overall Study||43
876725|NCT02094612|2121282|P1|3 Month Follow up|Overall Study||50
876726|NCT02094612|2121281|P2|1 Month Follow up|Overall Study||50
876727|NCT02094612|2121282|P1|1 Month Follow up|Overall Study||67
876728|NCT02094612|2121281|P2|STARTED|Overall Study||95
876729|NCT02094612|2121282|P1|STARTED|Overall Study||112
876730|NCT02094573|2121302|P2|NOT COMPLETED|Overall Study||110
876731|NCT02094573|2121303|P1|NOT COMPLETED|Overall Study||112
876732|NCT02094573|2121302|P2|COMPLETED|Overall Study||0
876733|NCT02094573|2121303|P1|COMPLETED|Overall Study||0
876734|NCT02094573|2121302|P2|Treated|Overall Study||110
876735|NCT02094573|2121303|P1|Treated|Overall Study||109
876736|NCT02094573|2121302|P2|STARTED|Overall Study||110
876737|NCT02094573|2121303|P1|STARTED|Overall Study||112
876738|NCT02094534|2121337|P2|NOT COMPLETED|Overall Study||0
876739|NCT02094534|2121338|P1|NOT COMPLETED|Overall Study||0
876740|NCT02094534|2121337|P2|COMPLETED|Overall Study||10
876741|NCT02094534|2121338|P1|COMPLETED|Overall Study||15
876742|NCT02094534|2121337|P2|STARTED|Overall Study||10
876743|NCT02094534|2121338|P1|STARTED|Overall Study||15
876744|NCT02094443|2121348|P2|NOT COMPLETED|Overall Study||17
876745|NCT02094443|2121349|P1|NOT COMPLETED|Overall Study||15
876746|NCT02094443|2121348|P2|COMPLETED|Overall Study||9
876747|NCT02094443|2121349|P1|COMPLETED|Overall Study||11
876748|NCT02094443|2121348|P2|Completed at Week 24|Overall Study||8
876749|NCT02094443|2121349|P1|Completed at Week 24|Overall Study||11
876750|NCT02094443|2121348|P2|Completed at Week 12|Overall Study||1
876751|NCT02094443|2121349|P1|Completed at Week 12|Overall Study||0
876752|NCT02094443|2121348|P2|STARTED|Overall Study||26
876753|NCT02094443|2121349|P1|STARTED|Overall Study||26
876754|NCT02094352|2121369|P2|NOT COMPLETED|Overall Study||0
876755|NCT02094352|2121370|P1|NOT COMPLETED|Overall Study||0
876756|NCT02094352|2121369|P2|COMPLETED|Overall Study||1
876757|NCT02094352|2121370|P1|COMPLETED|Overall Study||2
876758|NCT02094352|2121369|P2|STARTED|Overall Study||1
876759|NCT02094352|2121370|P1|STARTED|Overall Study||2
876760|NCT02094326|2121376|P1|NOT COMPLETED|Overall Study||0
876761|NCT02094326|2121376|P1|COMPLETED|Overall Study||301
876762|NCT02094326|2121376|P1|STARTED|Overall Study||301
876763|NCT02094300|2121385|P1|NOT COMPLETED|Overall Study||20
876764|NCT02094300|2121385|P1|COMPLETED|Overall Study||6
876765|NCT02094300|2121385|P1|30 Days|Overall Study||24
876766|NCT02094300|2121385|P1|STARTED|Overall Study||26
876767|NCT02094261|2121389|P1|NOT COMPLETED|Overall Study||210
876768|NCT02094261|2121389|P1|COMPLETED|Overall Study||0
876769|NCT02094261|2121389|P1|STARTED|Overall Study||210
876770|NCT02093962|2121398|P2|NOT COMPLETED|Overall Study||131
876771|NCT02093962|2121399|P1|NOT COMPLETED|Overall Study||134
876772|NCT02093962|2121398|P2|COMPLETED|Overall Study||0
876773|NCT02093962|2121399|P1|COMPLETED|Overall Study||0
876774|NCT02093962|2121398|P2|Received Treatment|Overall Study||130
876775|NCT02093962|2121399|P1|Received Treatment|Overall Study||130
876776|NCT02093962|2121398|P2|STARTED|Overall Study||131
876777|NCT02093962|2121399|P1|STARTED|Overall Study||134
876778|NCT02093949|2121407|P2|NOT COMPLETED|Overall Study||0
876779|NCT02093949|2121408|P1|NOT COMPLETED|Overall Study||0
876780|NCT02093949|2121407|P2|COMPLETED|Overall Study||47
876781|NCT02093949|2121408|P1|COMPLETED|Overall Study||105
876782|NCT02093949|2121407|P2|STARTED|Overall Study||47
876783|NCT02093949|2121408|P1|STARTED|Overall Study||105
876784|NCT02093923|2121431|P5|NOT COMPLETED|Overall Study||0
876785|NCT02093923|2121432|P4|NOT COMPLETED|Overall Study||2
876786|NCT02093923|2121433|P3|NOT COMPLETED|Overall Study||0
876787|NCT02093923|2121434|P2|NOT COMPLETED|Overall Study||0
876788|NCT02093923|2121435|P1|NOT COMPLETED|Overall Study||0
876789|NCT02093923|2121431|P5|COMPLETED|Overall Study||13
876790|NCT02093923|2121432|P4|COMPLETED|Overall Study||10
876791|NCT02093923|2121433|P3|COMPLETED|Overall Study||5
876792|NCT02093923|2121434|P2|COMPLETED|Overall Study||4
876793|NCT02093923|2121435|P1|COMPLETED|Overall Study||4
876794|NCT02093923|2121431|P5|Treated - 2 Doses:|Overall Study||13
876795|NCT02093923|2121432|P4|Treated - 2 Doses:|Overall Study||10
876796|NCT02093923|2121433|P3|Treated - 2 Doses:|Overall Study||5
876797|NCT02093923|2121434|P2|Treated - 2 Doses:|Overall Study||4
876798|NCT02093923|2121435|P1|Treated - 2 Doses:|Overall Study||4
876799|NCT02093923|2121431|P5|Treated - 1 Dose Only:|Overall Study||0
876800|NCT02093923|2121432|P4|Treated - 1 Dose Only:|Overall Study||1
876801|NCT02093923|2121433|P3|Treated - 1 Dose Only:|Overall Study||0
876802|NCT02093923|2121434|P2|Treated - 1 Dose Only:|Overall Study||0
876803|NCT02093923|2121435|P1|Treated - 1 Dose Only:|Overall Study||0
876804|NCT02093923|2121431|P5|Total Treated|Overall Study||13
876805|NCT02093923|2121432|P4|Total Treated|Overall Study||11
876806|NCT02093923|2121433|P3|Total Treated|Overall Study||5
876807|NCT02093923|2121434|P2|Total Treated|Overall Study||4
876808|NCT02093923|2121435|P1|Total Treated|Overall Study||4
876809|NCT02093923|2121431|P5|STARTED|Overall Study||13
876810|NCT02093923|2121432|P4|STARTED|Overall Study||12
876811|NCT02093923|2121433|P3|STARTED|Overall Study||5
876812|NCT02093923|2121434|P2|STARTED|Overall Study||4
876813|NCT02093923|2121435|P1|STARTED|Overall Study||4
876814|NCT02093897|2121490|P1|NOT COMPLETED|Overall Study||19
876815|NCT02093897|2121490|P1|COMPLETED|Overall Study||65
876816|NCT02093897|2121490|P1|STARTED|Overall Study||84
876817|NCT02093819|2121518|P8|NOT COMPLETED|Overall Study||0
876818|NCT02093819|2121519|P7|NOT COMPLETED|Overall Study||0
876819|NCT02093819|2121520|P6|NOT COMPLETED|Overall Study||0
876820|NCT02093819|2121521|P5|NOT COMPLETED|Overall Study||0
876821|NCT02093819|2121522|P4|NOT COMPLETED|Overall Study||0
876822|NCT02093819|2121523|P3|NOT COMPLETED|Overall Study||0
876823|NCT02093819|2121524|P2|NOT COMPLETED|Overall Study||0
876824|NCT02093819|2121525|P1|NOT COMPLETED|Overall Study||0
876825|NCT02093819|2121518|P8|COMPLETED|Overall Study||6
876826|NCT02093819|2121519|P7|COMPLETED|Overall Study||5
876827|NCT02093819|2121520|P6|COMPLETED|Overall Study||6
876828|NCT02093819|2121521|P5|COMPLETED|Overall Study||6
876829|NCT02093819|2121522|P4|COMPLETED|Overall Study||6
876830|NCT02093819|2121523|P3|COMPLETED|Overall Study||10
876831|NCT02093819|2121524|P2|COMPLETED|Overall Study||6
876832|NCT02093819|2121525|P1|COMPLETED|Overall Study||15
876833|NCT02093819|2121518|P8|STARTED|Overall Study||6
876834|NCT02093819|2121519|P7|STARTED|Overall Study||5
876835|NCT02093819|2121520|P6|STARTED|Overall Study||6
876836|NCT02093819|2121521|P5|STARTED|Overall Study||6
876837|NCT02093819|2121522|P4|STARTED|Overall Study||6
876838|NCT02093819|2121523|P3|STARTED|Overall Study||10
876839|NCT02093819|2121524|P2|STARTED|Overall Study||6
876840|NCT02093819|2121525|P1|STARTED|Overall Study||15
876841|NCT02093702|2121561|P2|NOT COMPLETED|Overall Study||0
876842|NCT02093702|2121562|P1|NOT COMPLETED|Overall Study||0
876843|NCT02093702|2121561|P2|COMPLETED|Overall Study||3
876844|NCT02093702|2121562|P1|COMPLETED|Overall Study||2
876845|NCT02093702|2121561|P2|STARTED|Overall Study||3
876846|NCT02093702|2121562|P1|STARTED|Overall Study||2
876847|NCT02093520|2121592|P2|NOT COMPLETED|Overall Study||22
876848|NCT02093520|2121593|P1|NOT COMPLETED|Overall Study||6
876849|NCT02093520|2121592|P2|COMPLETED|Overall Study||131
876850|NCT02093520|2121593|P1|COMPLETED|Overall Study||143
876851|NCT02093520|2121592|P2|STARTED|Overall Study||153
876852|NCT02093520|2121593|P1|STARTED|Overall Study||149
876853|NCT02093390|2121605|P2|NOT COMPLETED|Overall Study||1
876854|NCT02093390|2121606|P1|NOT COMPLETED|Overall Study||0
876855|NCT02093390|2121605|P2|COMPLETED|Overall Study||19
876856|NCT02093390|2121606|P1|COMPLETED|Overall Study||20
876857|NCT02093390|2121605|P2|STARTED|Overall Study||20
876858|NCT02093390|2121606|P1|STARTED|Overall Study||20
876859|NCT02093351|2121645|P3|NOT COMPLETED|Overall Study||3
876860|NCT02093351|2121646|P2|NOT COMPLETED|Overall Study||2
876861|NCT02093351|2121647|P1|NOT COMPLETED|Overall Study||2
876862|NCT02093351|2121645|P3|COMPLETED|Overall Study||23
876863|NCT02093351|2121646|P2|COMPLETED|Overall Study||21
876864|NCT02093351|2121647|P1|COMPLETED|Overall Study||28
876865|NCT02093351|2121645|P3|Completing Treatment Period 3|Overall Study||23
876866|NCT02093351|2121646|P2|Completing Treatment Period 3|Overall Study||21
876867|NCT02093351|2121647|P1|Completing Treatment Period 3|Overall Study||28
876868|NCT02093351|2121645|P3|Completing Treatment Period 2|Overall Study||23
876869|NCT02093351|2121646|P2|Completing Treatment Period 2|Overall Study||21
876870|NCT02093351|2121647|P1|Completing Treatment Period 2|Overall Study||29
876871|NCT02093351|2121645|P3|Completing Treatment Period 1|Overall Study||23
876872|NCT02093351|2121646|P2|Completing Treatment Period 1|Overall Study||22
876873|NCT02093351|2121647|P1|Completing Treatment Period 1|Overall Study||29
876874|NCT02093351|2121645|P3|STARTED|Overall Study||26
876875|NCT02093351|2121646|P2|STARTED|Overall Study||23
876876|NCT02093351|2121647|P1|STARTED|Overall Study||30
876877|NCT02093234|2121679|P3|NOT COMPLETED|Overall Study||4
876878|NCT02093234|2121680|P2|NOT COMPLETED|Overall Study||4
876879|NCT02093234|2121681|P1|NOT COMPLETED|Overall Study||3
876880|NCT02093234|2121679|P3|COMPLETED|Overall Study||50
876881|NCT02093234|2121680|P2|COMPLETED|Overall Study||52
876882|NCT02093234|2121681|P1|COMPLETED|Overall Study||53
876883|NCT02093234|2121679|P3|STARTED|Overall Study||54
876884|NCT02093234|2121680|P2|STARTED|Overall Study||56
876885|NCT02093234|2121681|P1|STARTED|Overall Study||56
876886|NCT02093026|2121698|P1|NOT COMPLETED|Overall Study||193
876887|NCT02093026|2121698|P1|COMPLETED|Overall Study|At predefined end-of-treatment date, 272 ongoing participants were designated as completed study.|272
876888|NCT02093026|2121698|P1|STARTED|Overall Study||465
876889|NCT02092961|2121720|P3|NOT COMPLETED|Overall Study||16
876890|NCT02092961|2121721|P2|NOT COMPLETED|Overall Study||14
876891|NCT02092961|2121722|P1|NOT COMPLETED|Overall Study||21
876892|NCT02092961|2121720|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|13
876893|NCT02092961|2121721|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|14
876894|NCT02092961|2121722|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|12
876895|NCT02092961|2121720|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
876896|NCT02092961|2121721|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/study stopped|5
876897|NCT02092961|2121722|P1|Randomised But Did Not Receive Treatment|Overall Study|Study stopped|1
876898|NCT02092961|2121720|P3|STARTED|Overall Study|Patients who received treatment|29
876899|NCT02092961|2121721|P2|STARTED|Overall Study|Patients who received treatment|28
876900|NCT02092961|2121722|P1|STARTED|Overall Study|Patients who received treatment|33
876901|NCT02092857|2121746|P3|NOT COMPLETED|Overall Study||13
876902|NCT02092857|2121747|P2|NOT COMPLETED|Overall Study||12
876903|NCT02092857|2121748|P1|NOT COMPLETED|Overall Study||10
876904|NCT02092857|2121746|P3|COMPLETED|Overall Study||16
876905|NCT02092857|2121747|P2|COMPLETED|Overall Study||18
876906|NCT02092857|2121748|P1|COMPLETED|Overall Study||20
876907|NCT02092857|2121746|P3|STARTED|Overall Study||29
876908|NCT02092857|2121747|P2|STARTED|Overall Study||30
876909|NCT02092857|2121748|P1|STARTED|Overall Study||30
876910|NCT02092662|2121758|P2|NOT COMPLETED|Overall Study||0
876911|NCT02092662|2121759|P1|NOT COMPLETED|Overall Study||13
876912|NCT02092662|2121758|P2|COMPLETED|Overall Study||19
876913|NCT02092662|2121759|P1|COMPLETED|Overall Study||25
876914|NCT02092662|2121758|P2|Recruited|Overall Study||19
876915|NCT02092662|2121759|P1|Recruited|Overall Study||38
876916|NCT02092662|2121758|P2|STARTED|Overall Study||19
876917|NCT02092662|2121759|P1|STARTED|Overall Study||38
876918|NCT02092649|2121768|P2|NOT COMPLETED|Overall Study||0
876919|NCT02092649|2121769|P1|NOT COMPLETED|Overall Study||0
876920|NCT02092649|2121768|P2|COMPLETED|Overall Study|13 participants finished study|13
876921|NCT02092649|2121769|P1|COMPLETED|Overall Study|13 participants finished study|13
876922|NCT02092649|2121768|P2|STARTED|Overall Study|13 participants recruited|13
876923|NCT02092649|2121769|P1|STARTED|Overall Study|13 participants recruited|13
876924|NCT02092610|2121787|P2|NOT COMPLETED|Overall Study||12
876925|NCT02092610|2121788|P1|NOT COMPLETED|Overall Study||8
876926|NCT02092610|2121787|P2|COMPLETED|Overall Study||40
876927|NCT02092610|2121788|P1|COMPLETED|Overall Study||17
876928|NCT02092610|2121787|P2|STARTED|Overall Study||52
876929|NCT02092610|2121788|P1|STARTED|Overall Study||25
876930|NCT02092441|2121802|P2|NOT COMPLETED|Overall Study||0
876931|NCT02092441|2121803|P1|NOT COMPLETED|Overall Study||0
876932|NCT02092441|2121802|P2|COMPLETED|Overall Study||43
876933|NCT02092441|2121803|P1|COMPLETED|Overall Study||37
876934|NCT02092441|2121802|P2|STARTED|Overall Study||43
876935|NCT02092441|2121803|P1|STARTED|Overall Study||37
876936|NCT02092415|2121813|P1|NOT COMPLETED|Overall Study||0
876937|NCT02092415|2121813|P1|COMPLETED|Overall Study||10
876938|NCT02092415|2121813|P1|STARTED|Overall Study||10
876939|NCT02092389|2121818|P1|NOT COMPLETED|Overall Study||6
876940|NCT02092389|2121818|P1|COMPLETED|Overall Study||4
876941|NCT02092389|2121818|P1|STARTED|Overall Study||10
876942|NCT02092350|2121830|P2|NOT COMPLETED|Overall Study||12
876943|NCT02092350|2121831|P1|NOT COMPLETED|Overall Study||10
876944|NCT02092350|2121830|P2|COMPLETED|Overall Study||102
876945|NCT02092350|2121831|P1|COMPLETED|Overall Study||113
876946|NCT02092350|2121830|P2|STARTED|Overall Study||114
876947|NCT02092350|2121831|P1|STARTED|Overall Study||123
876948|NCT02092311|2121848|P2|NOT COMPLETED|Overall Study||0
876949|NCT02092311|2121849|P1|NOT COMPLETED|Overall Study||0
876950|NCT02092311|2121848|P2|COMPLETED|Overall Study||285
876951|NCT02092311|2121849|P1|COMPLETED|Overall Study||285
876952|NCT02092311|2121848|P2|STARTED|Overall Study||285
876953|NCT02092311|2121849|P1|STARTED|Overall Study||285
876954|NCT02092168|2121861|P2|NOT COMPLETED|Overall Study||0
876955|NCT02092168|2121862|P1|NOT COMPLETED|Overall Study||0
876956|NCT02092168|2121861|P2|COMPLETED|Overall Study||12
876957|NCT02092168|2121862|P1|COMPLETED|Overall Study||12
876958|NCT02092168|2121861|P2|STARTED|Overall Study||12
876959|NCT02092168|2121862|P1|STARTED|Overall Study||12
876960|NCT02092116|2121874|P2|NOT COMPLETED|Overall Study||4
876961|NCT02092116|2121875|P1|NOT COMPLETED|Overall Study||0
876962|NCT02092116|2121874|P2|COMPLETED|Overall Study||16
876963|NCT02092116|2121875|P1|COMPLETED|Overall Study||6
876964|NCT02092116|2121874|P2|STARTED|Overall Study||20
876965|NCT02092116|2121875|P1|STARTED|Overall Study||6
876966|NCT02091986|2121887|P3|NOT COMPLETED|Overall Study||8
876967|NCT02091986|2121888|P2|NOT COMPLETED|Overall Study||11
876968|NCT02091986|2121889|P1|NOT COMPLETED|Overall Study||7
876969|NCT02091986|2121887|P3|COMPLETED|Overall Study||84
876970|NCT02091986|2121888|P2|COMPLETED|Overall Study||84
876971|NCT02091986|2121889|P1|COMPLETED|Overall Study||85
876972|NCT02091986|2121887|P3|STARTED|Overall Study||92
876973|NCT02091986|2121888|P2|STARTED|Overall Study||95
876974|NCT02091986|2121889|P1|STARTED|Overall Study||92
876981|NCT02091856|2121954|P3|NOT COMPLETED|Follow-up Assessment||0
876982|NCT02091856|2121955|P2|NOT COMPLETED|Follow-up Assessment||3
876983|NCT02091856|2121956|P1|NOT COMPLETED|Follow-up Assessment||5
876984|NCT02091856|2121954|P3|COMPLETED|Follow-up Assessment||0
876985|NCT02091856|2121955|P2|COMPLETED|Follow-up Assessment||9
876986|NCT02091856|2121956|P1|COMPLETED|Follow-up Assessment||10
876987|NCT02091856|2121954|P3|STARTED|Follow-up Assessment|WLCG participants were lost at follow-up.|0
876988|NCT02091856|2121955|P2|STARTED|Follow-up Assessment|Only a subset of R-CBT participants responded to our request to complete the follow-up assessment.|12
876989|NCT02091856|2121956|P1|STARTED|Follow-up Assessment|Only a subset of C-CBT participants responded to our request to complete the follow-up assessment.|15
876990|NCT02091856|2121954|P3|NOT COMPLETED|Active Intervention Interval||7
876991|NCT02091856|2121955|P2|NOT COMPLETED|Active Intervention Interval||7
876992|NCT02091856|2121956|P1|NOT COMPLETED|Active Intervention Interval||19
876993|NCT02091856|2121954|P3|COMPLETED|Active Intervention Interval||19
876994|NCT02091856|2121955|P2|COMPLETED|Active Intervention Interval||12
876995|NCT02091856|2121956|P1|COMPLETED|Active Intervention Interval||15
876996|NCT02091856|2121954|P3|STARTED|Active Intervention Interval||26
876997|NCT02091856|2121955|P2|STARTED|Active Intervention Interval||19
876998|NCT02091856|2121956|P1|STARTED|Active Intervention Interval||34
876999|NCT02091778|2121976|P1|NOT COMPLETED|Overall Study||1
877000|NCT02091778|2121976|P1|COMPLETED|Overall Study||20
877001|NCT02091778|2121976|P1|STARTED|Overall Study||21
877002|NCT02091752|2121980|P1|NOT COMPLETED|Overall Study||3
877003|NCT02091752|2121980|P1|COMPLETED|Overall Study||0
877004|NCT02091752|2121980|P1|STARTED|Overall Study||3
877005|NCT02091726|2121991|P1|NOT COMPLETED|Overall Study||6
877006|NCT02091726|2121991|P1|COMPLETED|Overall Study||104
877007|NCT02091726|2121991|P1|4 Week Followup|Overall Study||104
877008|NCT02091726|2121991|P1|1 Week Followup|Overall Study||110
877009|NCT02091726|2121991|P1|STARTED|Overall Study||110
877010|NCT02091466|2122001|P2|NOT COMPLETED|Overall Study||0
877011|NCT02091466|2122002|P1|NOT COMPLETED|Overall Study||0
877012|NCT02091466|2122001|P2|COMPLETED|Overall Study||20
877013|NCT02091466|2122002|P1|COMPLETED|Overall Study||20
877014|NCT02091466|2122001|P2|STARTED|Overall Study||20
877015|NCT02091466|2122002|P1|STARTED|Overall Study||20
877016|NCT02091414|2122008|P1|NOT COMPLETED|Overall Study||4
877017|NCT02091414|2122008|P1|COMPLETED|Overall Study||32
877018|NCT02091414|2122008|P1|STARTED|Overall Study||36
877019|NCT02090855|2122020|P1|NOT COMPLETED|Overall Study||2
877020|NCT02090855|2122020|P1|COMPLETED|Overall Study||106
877021|NCT02090855|2122020|P1|STARTED|Overall Study||108
877022|NCT02090777|2122027|P1|NOT COMPLETED|Overall Study||0
877023|NCT02090777|2122027|P1|COMPLETED|Overall Study||4
877024|NCT02090777|2122027|P1|STARTED|Overall Study||4
877025|NCT02090764|2122033|P2|NOT COMPLETED|Overall Study||20
877026|NCT02090764|2122034|P1|NOT COMPLETED|Overall Study||6
877027|NCT02090764|2122033|P2|COMPLETED|Overall Study||186
877028|NCT02090764|2122034|P1|COMPLETED|Overall Study||200
877029|NCT02090764|2122033|P2|STARTED|Overall Study||206
877030|NCT02090764|2122034|P1|STARTED|Overall Study||206
877031|NCT02090413|2122043|P3|NOT COMPLETED|Overall Study||23
877032|NCT02090413|2122044|P2|NOT COMPLETED|Overall Study||20
877033|NCT02090413|2122045|P1|NOT COMPLETED|Overall Study||19
877034|NCT02090413|2122043|P3|COMPLETED|Overall Study||57
877035|NCT02090413|2122044|P2|COMPLETED|Overall Study||60
877036|NCT02090413|2122045|P1|COMPLETED|Overall Study||62
877037|NCT02090413|2122043|P3|STARTED|Overall Study||80
877038|NCT02090413|2122044|P2|STARTED|Overall Study||80
877039|NCT02090413|2122045|P1|STARTED|Overall Study||81
877040|NCT02090088|2122119|P1|NOT COMPLETED|Overall Study||0
877041|NCT02090088|2122119|P1|COMPLETED|Overall Study||4
877042|NCT02090088|2122119|P1|Gave Birth|Overall Study||4
877043|NCT02090088|2122119|P1|STARTED|Overall Study||4
877044|NCT02089737|2122131|P1|NOT COMPLETED|Overall Study||6
877045|NCT02089737|2122131|P1|COMPLETED|Overall Study||3085
877046|NCT02089737|2122131|P1|STARTED|Overall Study||3091
877047|NCT02089347|2122140|P2|NOT COMPLETED|Overall Study||0
877048|NCT02089347|2122141|P1|NOT COMPLETED|Overall Study||1
877049|NCT02089347|2122140|P2|COMPLETED|Overall Study||178
877050|NCT02089347|2122141|P1|COMPLETED|Overall Study||355
877051|NCT02089347|2122140|P2|STARTED|Overall Study||178
877052|NCT02089347|2122141|P1|STARTED|Overall Study||356
877053|NCT02089191|2122163|P2|NOT COMPLETED|Period 2, Second 12 Hours||0
877054|NCT02089191|2122164|P1|NOT COMPLETED|Period 2, Second 12 Hours||0
877055|NCT02089191|2122163|P2|COMPLETED|Period 2, Second 12 Hours||15
877056|NCT02089191|2122164|P1|COMPLETED|Period 2, Second 12 Hours||15
877057|NCT02089191|2122163|P2|STARTED|Period 2, Second 12 Hours||15
877058|NCT02089191|2122164|P1|STARTED|Period 2, Second 12 Hours|One participant discontinued between Period 1 and Period 2 due to availability|15
877059|NCT02089191|2122163|P2|NOT COMPLETED|Period 1, First 12 Hours||0
877060|NCT02089191|2122164|P1|NOT COMPLETED|Period 1, First 12 Hours||0
877061|NCT02089191|2122163|P2|COMPLETED|Period 1, First 12 Hours||15
877062|NCT02089191|2122164|P1|COMPLETED|Period 1, First 12 Hours||16
877063|NCT02089191|2122163|P2|STARTED|Period 1, First 12 Hours||15
877064|NCT02089191|2122164|P1|STARTED|Period 1, First 12 Hours||16
877065|NCT02089113|2122174|P2|NOT COMPLETED|Overall Study||0
877066|NCT02089113|2122175|P1|NOT COMPLETED|Overall Study||1
877067|NCT02089113|2122174|P2|COMPLETED|Overall Study||80
877068|NCT02089113|2122175|P1|COMPLETED|Overall Study||160
877069|NCT02089113|2122174|P2|STARTED|Overall Study||80
877070|NCT02089113|2122175|P1|STARTED|Overall Study||161
877071|NCT02088957|2122181|P2|NOT COMPLETED|Overall Study||0
877072|NCT02088957|2122182|P1|NOT COMPLETED|Overall Study||1
877073|NCT02088957|2122181|P2|COMPLETED|Overall Study||0
877074|NCT02088957|2122182|P1|COMPLETED|Overall Study||0
877075|NCT02088957|2122181|P2|STARTED|Overall Study||0
877076|NCT02088957|2122182|P1|STARTED|Overall Study||1
877077|NCT02088177|2122198|P1|NOT COMPLETED|Overall Study||3
877078|NCT02088177|2122198|P1|COMPLETED|Overall Study||9
877079|NCT02088177|2122198|P1|STARTED|Overall Study||12
877080|NCT02087995|2122203|P1|NOT COMPLETED|Overall Study||0
877081|NCT02087995|2122203|P1|COMPLETED|Overall Study||51
877082|NCT02087995|2122203|P1|STARTED|Overall Study||51
877083|NCT02087943|2122210|P5|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
877084|NCT02087943|2122211|P4|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
877085|NCT02087943|2122212|P3|NOT COMPLETED|Observational Follow-up Phase Week 24-30||3
877086|NCT02087943|2122213|P2|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
877087|NCT02087943|2122214|P1|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
877088|NCT02087943|2122210|P5|COMPLETED|Observational Follow-up Phase Week 24-30||22
877089|NCT02087943|2122211|P4|COMPLETED|Observational Follow-up Phase Week 24-30||23
877090|NCT02087943|2122212|P3|COMPLETED|Observational Follow-up Phase Week 24-30||45
877091|NCT02087943|2122213|P2|COMPLETED|Observational Follow-up Phase Week 24-30||46
877092|NCT02087943|2122214|P1|COMPLETED|Observational Follow-up Phase Week 24-30||0
877093|NCT02087943|2122210|P5|STARTED|Observational Follow-up Phase Week 24-30||23
877094|NCT02087943|2122211|P4|STARTED|Observational Follow-up Phase Week 24-30||24
877095|NCT02087943|2122212|P3|STARTED|Observational Follow-up Phase Week 24-30||48
877096|NCT02087943|2122213|P2|STARTED|Observational Follow-up Phase Week 24-30||46
877097|NCT02087943|2122214|P1|STARTED|Observational Follow-up Phase Week 24-30||0
877098|NCT02087943|2122210|P5|NOT COMPLETED|Active Treatment Phase Week 12-24||2
877099|NCT02087943|2122211|P4|NOT COMPLETED|Active Treatment Phase Week 12-24||2
877100|NCT02087943|2122212|P3|NOT COMPLETED|Active Treatment Phase Week 12-24||5
877101|NCT02087943|2122213|P2|NOT COMPLETED|Active Treatment Phase Week 12-24||4
877102|NCT02087943|2122214|P1|NOT COMPLETED|Active Treatment Phase Week 12-24||0
877103|NCT02087943|2122210|P5|COMPLETED|Active Treatment Phase Week 12-24||21
877104|NCT02087943|2122211|P4|COMPLETED|Active Treatment Phase Week 12-24||22
877105|NCT02087943|2122212|P3|COMPLETED|Active Treatment Phase Week 12-24||44
877106|NCT02087943|2122213|P2|COMPLETED|Active Treatment Phase Week 12-24||42
877107|NCT02087943|2122214|P1|COMPLETED|Active Treatment Phase Week 12-24||0
877108|NCT02087943|2122210|P5|STARTED|Active Treatment Phase Week 12-24||23
877109|NCT02087943|2122211|P4|STARTED|Active Treatment Phase Week 12-24||24
877110|NCT02087943|2122212|P3|STARTED|Active Treatment Phase Week 12-24||49
877111|NCT02087943|2122213|P2|STARTED|Active Treatment Phase Week 12-24||46
877112|NCT02087943|2122214|P1|STARTED|Active Treatment Phase Week 12-24||0
877113|NCT02087943|2122210|P5|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
877114|NCT02087943|2122211|P4|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
877115|NCT02087943|2122212|P3|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||13
877116|NCT02087943|2122213|P2|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||12
877117|NCT02087943|2122214|P1|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||14
877118|NCT02087943|2122210|P5|COMPLETED|Placebo-Controlled Phase Week 0-12||0
877119|NCT02087943|2122211|P4|COMPLETED|Placebo-Controlled Phase Week 0-12||0
877120|NCT02087943|2122212|P3|COMPLETED|Placebo-Controlled Phase Week 0-12|1 participant who completed week 12 did not enter the active treatment phase.|50
877121|NCT02087943|2122213|P2|COMPLETED|Placebo-Controlled Phase Week 0-12||46
877122|NCT02087943|2122214|P1|COMPLETED|Placebo-Controlled Phase Week 0-12|3 participants who completed week 12 did not enter the active treatment phase.|50
877123|NCT02087943|2122210|P5|Safety Population|Placebo-Controlled Phase Week 0-12||0
877124|NCT02087943|2122211|P4|Safety Population|Placebo-Controlled Phase Week 0-12||0
877125|NCT02087943|2122212|P3|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|63
877126|NCT02087943|2122213|P2|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|58
877220|NCT02084082|2122474|P2|COMPLETED|Treatment Period 2 (4 Days)||26
877127|NCT02087943|2122214|P1|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|64
877128|NCT02087943|2122210|P5|STARTED|Placebo-Controlled Phase Week 0-12||0
877129|NCT02087943|2122211|P4|STARTED|Placebo-Controlled Phase Week 0-12||0
877130|NCT02087943|2122212|P3|STARTED|Placebo-Controlled Phase Week 0-12||63
877131|NCT02087943|2122213|P2|STARTED|Placebo-Controlled Phase Week 0-12||58
877132|NCT02087943|2122214|P1|STARTED|Placebo-Controlled Phase Week 0-12||64
877133|NCT02087774|2122240|P2|NOT COMPLETED|Overall Study||20
877134|NCT02087774|2122241|P1|NOT COMPLETED|Overall Study||8
877135|NCT02087774|2122240|P2|COMPLETED|Overall Study||130
877136|NCT02087774|2122241|P1|COMPLETED|Overall Study||142
877137|NCT02087774|2122240|P2|STARTED|Overall Study||150
877138|NCT02087774|2122241|P1|STARTED|Overall Study||150
877139|NCT02087748|2122249|P1|NOT COMPLETED|Overall Study||0
877140|NCT02087748|2122249|P1|COMPLETED|Overall Study||24
877141|NCT02087748|2122249|P1|STARTED|Overall Study||24
877142|NCT02087670|2122261|P2|NOT COMPLETED|Overall Study||2
877143|NCT02087670|2122262|P1|NOT COMPLETED|Overall Study||3
877144|NCT02087670|2122261|P2|COMPLETED|Overall Study||20
877145|NCT02087670|2122262|P1|COMPLETED|Overall Study||17
877146|NCT02087670|2122261|P2|STARTED|Overall Study||22
877147|NCT02087670|2122262|P1|STARTED|Overall Study||20
877148|NCT02087241|2122274|P4|NOT COMPLETED|Overall Study||7
877149|NCT02087241|2122275|P3|NOT COMPLETED|Overall Study||1
877150|NCT02087241|2122276|P2|NOT COMPLETED|Overall Study||3
877151|NCT02087241|2122277|P1|NOT COMPLETED|Overall Study||3
877152|NCT02087241|2122274|P4|COMPLETED|Overall Study||0
877153|NCT02087241|2122275|P3|COMPLETED|Overall Study||0
877154|NCT02087241|2122276|P2|COMPLETED|Overall Study||0
877155|NCT02087241|2122277|P1|COMPLETED|Overall Study||0
877156|NCT02087241|2122274|P4|STARTED|Overall Study||7
877157|NCT02087241|2122275|P3|STARTED|Overall Study||1
877158|NCT02087241|2122276|P2|STARTED|Overall Study||3
877159|NCT02087241|2122277|P1|STARTED|Overall Study||3
877160|NCT02087176|2122303|P1|NOT COMPLETED|Overall Study||32
877161|NCT02087176|2122303|P1|COMPLETED|Overall Study|The sponsor terminated the study early.|0
877162|NCT02087176|2122303|P1|STARTED|Overall Study||32
877163|NCT02087059|2122308|P1|NOT COMPLETED|Overall Study||7
877164|NCT02087059|2122308|P1|COMPLETED|Overall Study||44
877165|NCT02087059|2122308|P1|STARTED|Overall Study||51
877166|NCT02086786|2122318|P2|NOT COMPLETED|Overall Study||16
877167|NCT02086786|2122319|P1|NOT COMPLETED|Overall Study||18
877168|NCT02086786|2122318|P2|COMPLETED|Overall Study||19
877169|NCT02086786|2122319|P1|COMPLETED|Overall Study||17
877170|NCT02086786|2122318|P2|STARTED|Overall Study||35
877171|NCT02086786|2122319|P1|STARTED|Overall Study||35
877172|NCT02086708|2122343|P1|NOT COMPLETED|Overall Study||0
877173|NCT02086708|2122343|P1|COMPLETED|Overall Study||24
877174|NCT02086708|2122343|P1|STARTED|Overall Study||24
877175|NCT02086591|2122355|P1|NOT COMPLETED|Overall Study||5
877176|NCT02086591|2122355|P1|COMPLETED|Overall Study||2
877177|NCT02086591|2122355|P1|STARTED|Overall Study||7
877178|NCT02085785|2122363|P2|NOT COMPLETED|Overall Study||2
877179|NCT02085785|2122364|P1|NOT COMPLETED|Overall Study||2
877180|NCT02085785|2122363|P2|COMPLETED|Overall Study||6
877181|NCT02085785|2122364|P1|COMPLETED|Overall Study||5
877182|NCT02085785|2122363|P2|STARTED|Overall Study||8
877183|NCT02085785|2122364|P1|STARTED|Overall Study||7
877184|NCT02085720|2122376|P1|NOT COMPLETED|Overall Study||0
877185|NCT02085720|2122376|P1|COMPLETED|Overall Study||819
877186|NCT02085720|2122376|P1|STARTED|Overall Study||819
877187|NCT02085161|2122388|P4|NOT COMPLETED|Overall Study||10
877188|NCT02085161|2122389|P3|NOT COMPLETED|Overall Study||5
877189|NCT02085161|2122390|P2|NOT COMPLETED|Overall Study||10
877190|NCT02085161|2122391|P1|NOT COMPLETED|Overall Study||12
877191|NCT02085161|2122388|P4|COMPLETED|Overall Study||66
877192|NCT02085161|2122389|P3|COMPLETED|Overall Study||71
877193|NCT02085161|2122390|P2|COMPLETED|Overall Study||66
877194|NCT02085161|2122391|P1|COMPLETED|Overall Study||64
877195|NCT02085161|2122388|P4|STARTED|Overall Study||76
877196|NCT02085161|2122389|P3|STARTED|Overall Study||76
877197|NCT02085161|2122390|P2|STARTED|Overall Study||76
877198|NCT02085161|2122391|P1|STARTED|Overall Study||76
877199|NCT02084797|2122430|P1|NOT COMPLETED|Overall Study||0
877200|NCT02084797|2122430|P1|COMPLETED|Overall Study||10
877201|NCT02084797|2122430|P1|STARTED|Overall Study||10
877202|NCT02084706|2122439|P2|NOT COMPLETED|Overall Study||0
877203|NCT02084706|2122440|P1|NOT COMPLETED|Overall Study||0
877204|NCT02084706|2122439|P2|COMPLETED|Overall Study||31
877205|NCT02084706|2122440|P1|COMPLETED|Overall Study||29
877206|NCT02084706|2122439|P2|STARTED|Overall Study||31
877207|NCT02084706|2122440|P1|STARTED|Overall Study||29
877208|NCT02084628|2122446|P1|NOT COMPLETED|Overall Study||0
877209|NCT02084628|2122446|P1|COMPLETED|Overall Study||1
877210|NCT02084628|2122446|P1|STARTED|Overall Study||1
877211|NCT02084238|2122459|P1|NOT COMPLETED|Overall Study||2
877212|NCT02084238|2122459|P1|COMPLETED|Overall Study||38
877213|NCT02084238|2122459|P1|STARTED|Overall Study||40
877214|NCT02084082|2122472|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
877215|NCT02084082|2122473|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
877216|NCT02084082|2122474|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
877217|NCT02084082|2122475|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
877218|NCT02084082|2122472|P4|COMPLETED|Treatment Period 2 (4 Days)||6
877219|NCT02084082|2122473|P3|COMPLETED|Treatment Period 2 (4 Days)||7
877221|NCT02084082|2122475|P1|COMPLETED|Treatment Period 2 (4 Days)||26
877222|NCT02084082|2122472|P4|STARTED|Treatment Period 2 (4 Days)||6
877223|NCT02084082|2122473|P3|STARTED|Treatment Period 2 (4 Days)||7
877224|NCT02084082|2122474|P2|STARTED|Treatment Period 2 (4 Days)||26
877225|NCT02084082|2122475|P1|STARTED|Treatment Period 2 (4 Days)||26
877226|NCT02084082|2122472|P4|NOT COMPLETED|Washout Period 1 (35 Days)||2
877227|NCT02084082|2122473|P3|NOT COMPLETED|Washout Period 1 (35 Days)||1
877228|NCT02084082|2122474|P2|NOT COMPLETED|Washout Period 1 (35 Days)||0
877229|NCT02084082|2122475|P1|NOT COMPLETED|Washout Period 1 (35 Days)||0
877230|NCT02084082|2122472|P4|COMPLETED|Washout Period 1 (35 Days)||6
877231|NCT02084082|2122473|P3|COMPLETED|Washout Period 1 (35 Days)||7
877232|NCT02084082|2122474|P2|COMPLETED|Washout Period 1 (35 Days)||26
877233|NCT02084082|2122475|P1|COMPLETED|Washout Period 1 (35 Days)||26
877234|NCT02084082|2122472|P4|STARTED|Washout Period 1 (35 Days)||8
877235|NCT02084082|2122473|P3|STARTED|Washout Period 1 (35 Days)||8
877236|NCT02084082|2122474|P2|STARTED|Washout Period 1 (35 Days)||26
877237|NCT02084082|2122475|P1|STARTED|Washout Period 1 (35 Days)||26
877238|NCT02084082|2122472|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
877239|NCT02084082|2122473|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
877240|NCT02084082|2122474|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
877241|NCT02084082|2122475|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
877242|NCT02084082|2122472|P4|COMPLETED|Treatment Period 1 (4 Days)||8
877243|NCT02084082|2122473|P3|COMPLETED|Treatment Period 1 (4 Days)||8
877244|NCT02084082|2122474|P2|COMPLETED|Treatment Period 1 (4 Days)||26
877245|NCT02084082|2122475|P1|COMPLETED|Treatment Period 1 (4 Days)||26
877246|NCT02084082|2122472|P4|STARTED|Treatment Period 1 (4 Days)||8
877247|NCT02084082|2122473|P3|STARTED|Treatment Period 1 (4 Days)||8
877248|NCT02084082|2122474|P2|STARTED|Treatment Period 1 (4 Days)||26
877249|NCT02084082|2122475|P1|STARTED|Treatment Period 1 (4 Days)||26
877250|NCT02084069|2122507|P2|NOT COMPLETED|Overall Study||0
877251|NCT02084069|2122508|P1|NOT COMPLETED|Overall Study||0
877252|NCT02084069|2122507|P2|COMPLETED|Overall Study||29
877253|NCT02084069|2122508|P1|COMPLETED|Overall Study||29
877254|NCT02084069|2122507|P2|STARTED|Overall Study||29
877255|NCT02084069|2122508|P1|STARTED|Overall Study||29
877256|NCT02084056|2122516|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
877257|NCT02084056|2122517|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
877258|NCT02084056|2122518|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
877259|NCT02084056|2122519|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
877260|NCT02084056|2122516|P4|COMPLETED|Treatment Period 2 (4 Days)||8
877261|NCT02084056|2122517|P3|COMPLETED|Treatment Period 2 (4 Days)||8
877262|NCT02084056|2122518|P2|COMPLETED|Treatment Period 2 (4 Days)||30
877263|NCT02084056|2122519|P1|COMPLETED|Treatment Period 2 (4 Days)||26
877264|NCT02084056|2122516|P4|STARTED|Treatment Period 2 (4 Days)||8
877265|NCT02084056|2122517|P3|STARTED|Treatment Period 2 (4 Days)||8
877266|NCT02084056|2122518|P2|STARTED|Treatment Period 2 (4 Days)||30
877267|NCT02084056|2122519|P1|STARTED|Treatment Period 2 (4 Days)||26
877268|NCT02084056|2122516|P4|NOT COMPLETED|Washout Period 1 (35 Days)||0
877269|NCT02084056|2122517|P3|NOT COMPLETED|Washout Period 1 (35 Days)||0
877270|NCT02084056|2122518|P2|NOT COMPLETED|Washout Period 1 (35 Days)||0
877271|NCT02084056|2122519|P1|NOT COMPLETED|Washout Period 1 (35 Days)||1
877272|NCT02084056|2122516|P4|COMPLETED|Washout Period 1 (35 Days)||8
877273|NCT02084056|2122517|P3|COMPLETED|Washout Period 1 (35 Days)||8
877274|NCT02084056|2122518|P2|COMPLETED|Washout Period 1 (35 Days)||30
877275|NCT02084056|2122519|P1|COMPLETED|Washout Period 1 (35 Days)||26
877276|NCT02084056|2122516|P4|STARTED|Washout Period 1 (35 Days)||8
877277|NCT02084056|2122517|P3|STARTED|Washout Period 1 (35 Days)||8
877278|NCT02084056|2122518|P2|STARTED|Washout Period 1 (35 Days)||30
877279|NCT02084056|2122519|P1|STARTED|Washout Period 1 (35 Days)||27
877280|NCT02084056|2122516|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
877281|NCT02084056|2122517|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
877282|NCT02084056|2122518|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
877283|NCT02084056|2122519|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||1
877284|NCT02084056|2122516|P4|COMPLETED|Treatment Period 1 (4 Days)||8
877285|NCT02084056|2122517|P3|COMPLETED|Treatment Period 1 (4 Days)||8
877286|NCT02084056|2122518|P2|COMPLETED|Treatment Period 1 (4 Days)||30
877287|NCT02084056|2122519|P1|COMPLETED|Treatment Period 1 (4 Days)||27
877288|NCT02084056|2122516|P4|STARTED|Treatment Period 1 (4 Days)||8
877289|NCT02084056|2122517|P3|STARTED|Treatment Period 1 (4 Days)||8
877290|NCT02084056|2122518|P2|STARTED|Treatment Period 1 (4 Days)||30
877291|NCT02084056|2122519|P1|STARTED|Treatment Period 1 (4 Days)||28
877292|NCT02083965|2122551|P2|NOT COMPLETED|Treatment Period||0
877293|NCT02083965|2122552|P1|NOT COMPLETED|Treatment Period||1
877294|NCT02083965|2122551|P2|COMPLETED|Treatment Period||8
877295|NCT02083965|2122552|P1|COMPLETED|Treatment Period||9
877296|NCT02083965|2122551|P2|STARTED|Treatment Period|1 participant completed PK period 1 and 2, then chose to withdraw and did not enter treatment period|8
877297|NCT02083965|2122552|P1|STARTED|Treatment Period||10
877298|NCT02083965|2122551|P2|NOT COMPLETED|PK Period 2||0
877299|NCT02083965|2122552|P1|NOT COMPLETED|PK Period 2||0
877300|NCT02083965|2122551|P2|COMPLETED|PK Period 2||9
877301|NCT02083965|2122552|P1|COMPLETED|PK Period 2||10
877302|NCT02083965|2122551|P2|STARTED|PK Period 2||9
877303|NCT02083965|2122552|P1|STARTED|PK Period 2||10
877304|NCT02083965|2122551|P2|NOT COMPLETED|Washout Period||0
877305|NCT02083965|2122552|P1|NOT COMPLETED|Washout Period||0
877306|NCT02083965|2122551|P2|COMPLETED|Washout Period||9
877307|NCT02083965|2122552|P1|COMPLETED|Washout Period||10
877308|NCT02083965|2122551|P2|STARTED|Washout Period||9
877309|NCT02083965|2122552|P1|STARTED|Washout Period||10
877310|NCT02083965|2122551|P2|NOT COMPLETED|PK Period 1||0
877311|NCT02083965|2122552|P1|NOT COMPLETED|PK Period 1||0
877312|NCT02083965|2122551|P2|COMPLETED|PK Period 1||9
877313|NCT02083965|2122552|P1|COMPLETED|PK Period 1||10
877314|NCT02083965|2122551|P2|STARTED|PK Period 1||9
877315|NCT02083965|2122552|P1|STARTED|PK Period 1||10
877316|NCT02083679|2122612|P4|NOT COMPLETED|Overall Study||0
877317|NCT02083679|2122613|P3|NOT COMPLETED|Overall Study||0
877318|NCT02083679|2122614|P2|NOT COMPLETED|Overall Study||0
877319|NCT02083679|2122615|P1|NOT COMPLETED|Overall Study||0
877320|NCT02083679|2122612|P4|COMPLETED|Overall Study||3
877321|NCT02083679|2122613|P3|COMPLETED|Overall Study||3
877322|NCT02083679|2122614|P2|COMPLETED|Overall Study||6
877323|NCT02083679|2122615|P1|COMPLETED|Overall Study||3
877324|NCT02083679|2122612|P4|STARTED|Overall Study||3
877325|NCT02083679|2122613|P3|STARTED|Overall Study||3
877326|NCT02083679|2122614|P2|STARTED|Overall Study||6
877327|NCT02083679|2122615|P1|STARTED|Overall Study||3
877328|NCT02083406|2122632|P3|NOT COMPLETED|Overall Study||0
877329|NCT02083406|2122633|P2|NOT COMPLETED|Overall Study||0
877330|NCT02083406|2122634|P1|NOT COMPLETED|Overall Study||0
877331|NCT02083406|2122632|P3|COMPLETED|Overall Study||7
877332|NCT02083406|2122633|P2|COMPLETED|Overall Study||8
877333|NCT02083406|2122634|P1|COMPLETED|Overall Study||7
877334|NCT02083406|2122632|P3|STARTED|Overall Study||7
877335|NCT02083406|2122633|P2|STARTED|Overall Study||8
877336|NCT02083406|2122634|P1|STARTED|Overall Study||7
877337|NCT02083380|2122654|P3|NOT COMPLETED|Overall Study||84
877338|NCT02083380|2122655|P2|NOT COMPLETED|Overall Study||95
877339|NCT02083380|2122656|P1|NOT COMPLETED|Overall Study||91
877340|NCT02083380|2122654|P3|COMPLETED|Overall Study||65
877341|NCT02083380|2122655|P2|COMPLETED|Overall Study||56
877342|NCT02083380|2122656|P1|COMPLETED|Overall Study||57
877343|NCT02083380|2122654|P3|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|149
877344|NCT02083380|2122655|P2|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|151
877345|NCT02083380|2122656|P1|STARTED|Overall Study|5 subjects excluded from safety / ITT population - no drug administered|148
877346|NCT02083263|2122751|P2|NOT COMPLETED|Overall Study||0
877347|NCT02083263|2122752|P1|NOT COMPLETED|Overall Study||0
877348|NCT02083263|2122751|P2|COMPLETED|Overall Study||16
877349|NCT02083263|2122752|P1|COMPLETED|Overall Study||16
877350|NCT02083263|2122751|P2|STARTED|Overall Study||16
877351|NCT02083263|2122752|P1|STARTED|Overall Study||16
877352|NCT02083107|2122761|P3|NOT COMPLETED|Overall Study||0
877353|NCT02083107|2122762|P2|NOT COMPLETED|Overall Study||0
877354|NCT02083107|2122763|P1|NOT COMPLETED|Overall Study||0
877355|NCT02083107|2122761|P3|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
877356|NCT02083107|2122762|P2|COMPLETED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
877357|NCT02083107|2122763|P1|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
877358|NCT02083107|2122761|P3|STARTED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
877359|NCT02083107|2122762|P2|STARTED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
877360|NCT02083107|2122763|P1|STARTED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
877361|NCT02082912|2122800|P2|NOT COMPLETED|Overall Study||1
877362|NCT02082912|2122801|P1|NOT COMPLETED|Overall Study||0
877363|NCT02082912|2122800|P2|COMPLETED|Overall Study||6
877364|NCT02082912|2122801|P1|COMPLETED|Overall Study||7
877365|NCT02082912|2122800|P2|STARTED|Overall Study||7
877366|NCT02082912|2122801|P1|STARTED|Overall Study||7
877367|NCT02082769|2122810|P3|NOT COMPLETED|Overall Study||36
877368|NCT02082769|2122811|P2|NOT COMPLETED|Overall Study||27
877369|NCT02082769|2122812|P1|NOT COMPLETED|Overall Study||24
877370|NCT02082769|2122810|P3|COMPLETED|Overall Study||132
877371|NCT02082769|2122811|P2|COMPLETED|Overall Study||141
877372|NCT02082769|2122812|P1|COMPLETED|Overall Study||144
877373|NCT02082769|2122810|P3|STARTED|Overall Study||168
877374|NCT02082769|2122811|P2|STARTED|Overall Study||168
877375|NCT02082769|2122812|P1|STARTED|Overall Study||168
877376|NCT02082392|2122828|P2|NOT COMPLETED|Overall Study||0
877377|NCT02082392|2122829|P1|NOT COMPLETED|Overall Study||0
877378|NCT02082392|2122828|P2|COMPLETED|Overall Study||1
877379|NCT02082392|2122829|P1|COMPLETED|Overall Study||2
877380|NCT02082392|2122828|P2|STARTED|Overall Study||1
877381|NCT02082392|2122829|P1|STARTED|Overall Study||2
877382|NCT02082288|2122861|P1|NOT COMPLETED|Overall Study||0
877383|NCT02082288|2122861|P1|COMPLETED|Overall Study||243
877384|NCT02082288|2122861|P1|STARTED|Overall Study||243
877385|NCT02082262|2122865|P1|NOT COMPLETED|Overall Study||51
877386|NCT02082262|2122865|P1|COMPLETED|Overall Study||89
877387|NCT02082262|2122865|P1|STARTED|Overall Study||140
877388|NCT02082184|2122871|P2|NOT COMPLETED|Overall Study||13
877389|NCT02082184|2122872|P1|NOT COMPLETED|Overall Study||10
877390|NCT02082184|2122871|P2|COMPLETED|Overall Study||62
877391|NCT02082184|2122872|P1|COMPLETED|Overall Study||139
877392|NCT02082184|2122871|P2|STARTED|Overall Study||75
877393|NCT02082184|2122872|P1|STARTED|Overall Study||149
877394|NCT02082158|2122897|P6|NOT COMPLETED|Overall Study||7
877395|NCT02082158|2122898|P5|NOT COMPLETED|Overall Study||4
877396|NCT02082158|2122899|P4|NOT COMPLETED|Overall Study||4
877397|NCT02082158|2122900|P3|NOT COMPLETED|Overall Study||14
877398|NCT02082158|2122901|P2|NOT COMPLETED|Overall Study||8
877399|NCT02082158|2122902|P1|NOT COMPLETED|Overall Study||8
877400|NCT02082158|2122897|P6|COMPLETED|Overall Study||56
877401|NCT02082158|2122898|P5|COMPLETED|Overall Study||64
877402|NCT02082158|2122899|P4|COMPLETED|Overall Study|Includes completion with respirator from secondary randomization after fit-test failure of 1st model|68
877403|NCT02082158|2122900|P3|COMPLETED|Overall Study||38
877404|NCT02082158|2122901|P2|COMPLETED|Overall Study||53
877405|NCT02082158|2122902|P1|COMPLETED|Overall Study||58
877406|NCT02082158|2122897|P6|STARTED|Overall Study||63
877407|NCT02082158|2122898|P5|STARTED|Overall Study||68
877408|NCT02082158|2122899|P4|STARTED|Overall Study||72
877409|NCT02082158|2122900|P3|STARTED|Overall Study||52
877410|NCT02082158|2122901|P2|STARTED|Overall Study||61
877411|NCT02082158|2122902|P1|STARTED|Overall Study||66
877412|NCT02081859|2122924|P2|NOT COMPLETED|Overall Study||31
877413|NCT02081859|2122925|P1|NOT COMPLETED|Overall Study||34
877414|NCT02081859|2122924|P2|COMPLETED|Overall Study||119
877415|NCT02081859|2122925|P1|COMPLETED|Overall Study||116
877416|NCT02081859|2122924|P2|STARTED|Overall Study||150
877417|NCT02081859|2122925|P1|STARTED|Overall Study||150
877418|NCT02081677|2122937|P4|NOT COMPLETED|Overall Study||0
877419|NCT02081677|2122938|P3|NOT COMPLETED|Overall Study||2
877420|NCT02081677|2122939|P2|NOT COMPLETED|Overall Study||1
877421|NCT02081677|2122940|P1|NOT COMPLETED|Overall Study||1
877422|NCT02081677|2122937|P4|COMPLETED|Overall Study||19
877423|NCT02081677|2122938|P3|COMPLETED|Overall Study||17
877424|NCT02081677|2122939|P2|COMPLETED|Overall Study||18
877425|NCT02081677|2122940|P1|COMPLETED|Overall Study||18
877426|NCT02081677|2122937|P4|STARTED|Overall Study||19
877427|NCT02081677|2122938|P3|STARTED|Overall Study||19
877428|NCT02081677|2122939|P2|STARTED|Overall Study||19
877429|NCT02081677|2122940|P1|STARTED|Overall Study||19
877430|NCT02081599|2123032|P2|NOT COMPLETED|Period 2：Open-label Period||4
877431|NCT02081599|2123033|P1|NOT COMPLETED|Period 2：Open-label Period||6
877432|NCT02081599|2123032|P2|COMPLETED|Period 2：Open-label Period||71
877433|NCT02081599|2123033|P1|COMPLETED|Period 2：Open-label Period||57
877434|NCT02081599|2123032|P2|STARTED|Period 2：Open-label Period||75
877435|NCT02081599|2123033|P1|STARTED|Period 2：Open-label Period||63
877436|NCT02081599|2123032|P2|NOT COMPLETED|Period 1：Double-blind Period||2
877437|NCT02081599|2123033|P1|NOT COMPLETED|Period 1：Double-blind Period||8
877438|NCT02081599|2123032|P2|COMPLETED|Period 1：Double-blind Period||75
877439|NCT02081599|2123033|P1|COMPLETED|Period 1：Double-blind Period||63
877440|NCT02081599|2123032|P2|STARTED|Period 1：Double-blind Period||77
877441|NCT02081599|2123033|P1|STARTED|Period 1：Double-blind Period||71
877442|NCT02081586|2123051|P4|NOT COMPLETED|Overall Study||1
877443|NCT02081586|2123052|P3|NOT COMPLETED|Overall Study||1
877444|NCT02081586|2123053|P2|NOT COMPLETED|Overall Study||1
877445|NCT02081586|2123054|P1|NOT COMPLETED|Overall Study||0
877446|NCT02081586|2123051|P4|COMPLETED|Overall Study||2
877447|NCT02081586|2123052|P3|COMPLETED|Overall Study||3
877448|NCT02081586|2123053|P2|COMPLETED|Overall Study||2
877449|NCT02081586|2123054|P1|COMPLETED|Overall Study||3
877450|NCT02081586|2123051|P4|STARTED|Overall Study||3
877451|NCT02081586|2123052|P3|STARTED|Overall Study||4
877452|NCT02081586|2123053|P2|STARTED|Overall Study||3
877453|NCT02081586|2123054|P1|STARTED|Overall Study||3
877454|NCT02081443|2123083|P2|NOT COMPLETED|Overall Study||0
877455|NCT02081443|2123084|P1|NOT COMPLETED|Overall Study||0
877456|NCT02081443|2123083|P2|COMPLETED|Overall Study||30
877457|NCT02081443|2123084|P1|COMPLETED|Overall Study||30
877458|NCT02081443|2123083|P2|STARTED|Overall Study||30
877459|NCT02081443|2123084|P1|STARTED|Overall Study||30
877460|NCT02081365|2123096|P2|NOT COMPLETED|Overall Study||23
877461|NCT02081365|2123097|P1|NOT COMPLETED|Overall Study||30
877462|NCT02081365|2123096|P2|COMPLETED|Overall Study||54
877463|NCT02081365|2123097|P1|COMPLETED|Overall Study||44
877464|NCT02081365|2123096|P2|Received Allocated Intervention|Overall Study||59
877465|NCT02081365|2123097|P1|Received Allocated Intervention|Overall Study||46
877466|NCT02081365|2123096|P2|STARTED|Overall Study||77
877467|NCT02081365|2123097|P1|STARTED|Overall Study||74
877468|NCT02081183|2123111|P2|NOT COMPLETED|Overall Study||4
877469|NCT02081183|2123112|P1|NOT COMPLETED|Overall Study||4
877470|NCT02081183|2123111|P2|COMPLETED|Overall Study||2
877471|NCT02081183|2123112|P1|COMPLETED|Overall Study||1
877472|NCT02081183|2123111|P2|STARTED|Overall Study||6
877473|NCT02081183|2123112|P1|STARTED|Overall Study||5
877474|NCT02081079|2123128|P2|NOT COMPLETED|Overall Study||2
877475|NCT02081079|2123129|P1|NOT COMPLETED|Overall Study||4
877476|NCT02081079|2123128|P2|COMPLETED|Overall Study||39
877477|NCT02081079|2123129|P1|COMPLETED|Overall Study||40
877478|NCT02081079|2123128|P2|STARTED|Overall Study||41
877479|NCT02081079|2123129|P1|STARTED|Overall Study||44
877480|NCT02081014|2123151|P6|NOT COMPLETED|Overall Study||0
877481|NCT02081014|2123152|P5|NOT COMPLETED|Overall Study||0
877482|NCT02081014|2123153|P4|NOT COMPLETED|Overall Study||0
877483|NCT02081014|2123154|P3|NOT COMPLETED|Overall Study||0
877484|NCT02081014|2123155|P2|NOT COMPLETED|Overall Study||0
877485|NCT02081014|2123156|P1|NOT COMPLETED|Overall Study||0
877486|NCT02081014|2123151|P6|COMPLETED|Overall Study||2
877487|NCT02081014|2123152|P5|COMPLETED|Overall Study||2
877488|NCT02081014|2123153|P4|COMPLETED|Overall Study||2
877489|NCT02081014|2123154|P3|COMPLETED|Overall Study||2
877490|NCT02081014|2123155|P2|COMPLETED|Overall Study||2
877491|NCT02081014|2123156|P1|COMPLETED|Overall Study||2
877492|NCT02081014|2123151|P6|STARTED|Overall Study||2
877493|NCT02081014|2123152|P5|STARTED|Overall Study||2
877494|NCT02081014|2123153|P4|STARTED|Overall Study||2
877495|NCT02081014|2123154|P3|STARTED|Overall Study||2
877496|NCT02081014|2123155|P2|STARTED|Overall Study||2
877497|NCT02081014|2123156|P1|STARTED|Overall Study||2
877498|NCT02081001|2123202|P12|NOT COMPLETED|Overall Study||0
877499|NCT02081001|2123203|P11|NOT COMPLETED|Overall Study||0
877500|NCT02081001|2123204|P10|NOT COMPLETED|Overall Study||0
877501|NCT02081001|2123205|P9|NOT COMPLETED|Overall Study||0
877502|NCT02081001|2123206|P8|NOT COMPLETED|Overall Study||0
877503|NCT02081001|2123207|P7|NOT COMPLETED|Overall Study||0
877504|NCT02081001|2123208|P6|NOT COMPLETED|Overall Study||0
877505|NCT02081001|2123209|P5|NOT COMPLETED|Overall Study||1
877506|NCT02081001|2123210|P4|NOT COMPLETED|Overall Study||0
877507|NCT02081001|2123211|P3|NOT COMPLETED|Overall Study||0
877508|NCT02081001|2123212|P2|NOT COMPLETED|Overall Study||0
877509|NCT02081001|2123213|P1|NOT COMPLETED|Overall Study||0
877510|NCT02081001|2123202|P12|COMPLETED|Overall Study||1
877511|NCT02081001|2123203|P11|COMPLETED|Overall Study||2
877512|NCT02081001|2123204|P10|COMPLETED|Overall Study||1
877513|NCT02081001|2123205|P9|COMPLETED|Overall Study||2
877514|NCT02081001|2123206|P8|COMPLETED|Overall Study||1
877515|NCT02081001|2123207|P7|COMPLETED|Overall Study||2
877516|NCT02081001|2123208|P6|COMPLETED|Overall Study||1
877517|NCT02081001|2123209|P5|COMPLETED|Overall Study||2
877518|NCT02081001|2123210|P4|COMPLETED|Overall Study||1
877519|NCT02081001|2123211|P3|COMPLETED|Overall Study||2
877520|NCT02081001|2123212|P2|COMPLETED|Overall Study||1
877521|NCT02081001|2123213|P1|COMPLETED|Overall Study||2
877522|NCT02081001|2123202|P12|STARTED|Overall Study||1
877523|NCT02081001|2123203|P11|STARTED|Overall Study||2
877524|NCT02081001|2123204|P10|STARTED|Overall Study||1
877525|NCT02081001|2123205|P9|STARTED|Overall Study||2
877526|NCT02081001|2123206|P8|STARTED|Overall Study||1
877527|NCT02081001|2123207|P7|STARTED|Overall Study||2
877528|NCT02081001|2123208|P6|STARTED|Overall Study||1
877529|NCT02081001|2123209|P5|STARTED|Overall Study||3
877530|NCT02081001|2123210|P4|STARTED|Overall Study||1
877531|NCT02081001|2123211|P3|STARTED|Overall Study||2
877532|NCT02081001|2123212|P2|STARTED|Overall Study||1
877533|NCT02081001|2123213|P1|STARTED|Overall Study||2
877534|NCT02080780|2123277|P1|NOT COMPLETED|Overall Study||0
877535|NCT02080780|2123277|P1|COMPLETED|Overall Study||24
877536|NCT02080780|2123277|P1|STARTED|Overall Study||24
877537|NCT02080546|2123286|P2|NOT COMPLETED|Overall Study||11
877538|NCT02080546|2123287|P1|NOT COMPLETED|Overall Study||8
877539|NCT02080546|2123286|P2|COMPLETED|Overall Study||52
877540|NCT02080546|2123287|P1|COMPLETED|Overall Study||49
877541|NCT02080546|2123286|P2|STARTED|Overall Study||63
877542|NCT02080546|2123287|P1|STARTED|Overall Study||57
877543|NCT02080507|2123297|P2|NOT COMPLETED|Overall Study||0
877544|NCT02080507|2123298|P1|NOT COMPLETED|Overall Study||0
877545|NCT02080507|2123297|P2|COMPLETED|Overall Study||7
877546|NCT02080507|2123298|P1|COMPLETED|Overall Study||5
877547|NCT02080507|2123297|P2|STARTED|Overall Study||7
877548|NCT02080507|2123298|P1|STARTED|Overall Study||5
877549|NCT02080481|2123308|P2|NOT COMPLETED|Overall Study||0
877550|NCT02080481|2123309|P1|NOT COMPLETED|Overall Study||1
877551|NCT02080481|2123308|P2|COMPLETED|Overall Study||67
877552|NCT02080481|2123309|P1|COMPLETED|Overall Study||67
877553|NCT02080481|2123308|P2|STARTED|Overall Study||67
877554|NCT02080481|2123309|P1|STARTED|Overall Study||68
877555|NCT02080312|2123321|P1|NOT COMPLETED|Overall Study||0
877556|NCT02080312|2123321|P1|COMPLETED|Overall Study||6
877557|NCT02080312|2123321|P1|STARTED|Overall Study||6
877558|NCT02080091|2123327|P1|NOT COMPLETED|Overall Study||25
877559|NCT02080091|2123327|P1|COMPLETED|Overall Study||0
877560|NCT02080091|2123327|P1|STARTED|Overall Study||25
877561|NCT02079844|2123336|P3|NOT COMPLETED|Treatment Period 3||0
877562|NCT02079844|2123337|P2|NOT COMPLETED|Treatment Period 3||0
877563|NCT02079844|2123338|P1|NOT COMPLETED|Treatment Period 3||0
877564|NCT02079844|2123336|P3|COMPLETED|Treatment Period 3||5
877565|NCT02079844|2123337|P2|COMPLETED|Treatment Period 3||5
877566|NCT02079844|2123338|P1|COMPLETED|Treatment Period 3||5
877567|NCT02079844|2123336|P3|STARTED|Treatment Period 3||5
877568|NCT02079844|2123337|P2|STARTED|Treatment Period 3|1 Participant Voluntarily Withdrew after completing Period 2.|5
877569|NCT02079844|2123338|P1|STARTED|Treatment Period 3||5
877570|NCT02079844|2123336|P3|NOT COMPLETED|Treatment Period 2||0
877571|NCT02079844|2123337|P2|NOT COMPLETED|Treatment Period 2||1
877572|NCT02079844|2123338|P1|NOT COMPLETED|Treatment Period 2||0
877573|NCT02079844|2123336|P3|COMPLETED|Treatment Period 2||5
877574|NCT02079844|2123337|P2|COMPLETED|Treatment Period 2||6
877575|NCT02079844|2123338|P1|COMPLETED|Treatment Period 2||5
877576|NCT02079844|2123336|P3|STARTED|Treatment Period 2||5
877577|NCT02079844|2123337|P2|STARTED|Treatment Period 2||7
877578|NCT02079844|2123338|P1|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|5
877579|NCT02079844|2123336|P3|NOT COMPLETED|Treatment Period 1||2
877580|NCT02079844|2123337|P2|NOT COMPLETED|Treatment Period 1||0
877581|NCT02079844|2123338|P1|NOT COMPLETED|Treatment Period 1||0
877582|NCT02079844|2123336|P3|COMPLETED|Treatment Period 1||5
877583|NCT02079844|2123337|P2|COMPLETED|Treatment Period 1||7
877584|NCT02079844|2123338|P1|COMPLETED|Treatment Period 1||6
877585|NCT02079844|2123336|P3|STARTED|Treatment Period 1||7
877586|NCT02079844|2123337|P2|STARTED|Treatment Period 1||7
877587|NCT02079844|2123338|P1|STARTED|Treatment Period 1||6
877588|NCT02079805|2123396|P2|NOT COMPLETED|Overall Study||2
877589|NCT02079805|2123397|P1|NOT COMPLETED|Overall Study||0
877590|NCT02079805|2123396|P2|COMPLETED|Overall Study||15
877591|NCT02079805|2123397|P1|COMPLETED|Overall Study||16
877592|NCT02079805|2123396|P2|STARTED|Overall Study||17
877593|NCT02079805|2123397|P1|STARTED|Overall Study||16
877594|NCT02079649|2123419|P4|NOT COMPLETED|Overall Study||2
877595|NCT02079649|2123420|P3|NOT COMPLETED|Overall Study||1
877596|NCT02079649|2123421|P2|NOT COMPLETED|Overall Study||0
877597|NCT02079649|2123422|P1|NOT COMPLETED|Overall Study||1
877598|NCT02079649|2123419|P4|COMPLETED|Overall Study||38
877599|NCT02079649|2123420|P3|COMPLETED|Overall Study||40
877600|NCT02079649|2123421|P2|COMPLETED|Overall Study||41
877601|NCT02079649|2123422|P1|COMPLETED|Overall Study||41
877602|NCT02079649|2123419|P4|Treated|Overall Study||40
877603|NCT02079649|2123420|P3|Treated|Overall Study||40
877604|NCT02079649|2123421|P2|Treated|Overall Study||41
877605|NCT02079649|2123422|P1|Treated|Overall Study||41
877606|NCT02079649|2123419|P4|STARTED|Overall Study||40
877607|NCT02079649|2123420|P3|STARTED|Overall Study||41
877608|NCT02079649|2123421|P2|STARTED|Overall Study||41
877609|NCT02079649|2123422|P1|STARTED|Overall Study||42
877610|NCT02079610|2123439|P2|NOT COMPLETED|Overall Study||1
877611|NCT02079610|2123440|P1|NOT COMPLETED|Overall Study||1
877612|NCT02079610|2123439|P2|COMPLETED|Overall Study||16
877613|NCT02079610|2123440|P1|COMPLETED|Overall Study||18
877614|NCT02079610|2123439|P2|STARTED|Overall Study||17
877615|NCT02079610|2123440|P1|STARTED|Overall Study||19
877616|NCT02079532|2123450|P1|NOT COMPLETED|Overall Study||29
877617|NCT02079532|2123450|P1|COMPLETED|Overall Study||273
877618|NCT02079532|2123450|P1|STARTED|Overall Study||302
877619|NCT02079519|2123472|P1|NOT COMPLETED|Overall Study||10
877620|NCT02079519|2123472|P1|COMPLETED|Overall Study||0
877621|NCT02079519|2123472|P1|STARTED|Overall Study||10
877622|NCT02079311|2123478|P2|NOT COMPLETED|Overall Study||1
877623|NCT02079311|2123479|P1|NOT COMPLETED|Overall Study||0
877624|NCT02079311|2123478|P2|COMPLETED|Overall Study||26
877625|NCT02079311|2123479|P1|COMPLETED|Overall Study||28
877626|NCT02079311|2123478|P2|STARTED|Overall Study||27
877627|NCT02079311|2123479|P1|STARTED|Overall Study||28
877628|NCT02078492|2123488|P3|NOT COMPLETED|Overall Study||0
877629|NCT02078492|2123489|P2|NOT COMPLETED|Overall Study||0
877630|NCT02078492|2123490|P1|NOT COMPLETED|Overall Study||0
877631|NCT02078492|2123488|P3|COMPLETED|Overall Study||80
877632|NCT02078492|2123489|P2|COMPLETED|Overall Study||80
877633|NCT02078492|2123490|P1|COMPLETED|Overall Study||80
877634|NCT02078492|2123488|P3|STARTED|Overall Study||80
877635|NCT02078492|2123489|P2|STARTED|Overall Study||80
877636|NCT02078492|2123490|P1|STARTED|Overall Study||80
877637|NCT02078193|2123507|P1|NOT COMPLETED|Overall Study||0
877638|NCT02078193|2123507|P1|COMPLETED|Overall Study||3
877639|NCT02078193|2123507|P1|STARTED|Overall Study||3
877640|NCT02078180|2123513|P1|NOT COMPLETED|Overall Study||5
877641|NCT02078180|2123513|P1|COMPLETED|Overall Study||29
877642|NCT02078180|2123513|P1|XL 300|Overall Study||32
877643|NCT02078180|2123513|P1|XL 150|Overall Study||31
877644|NCT02078180|2123513|P1|SR150|Overall Study||32
877645|NCT02078180|2123513|P1|SR100|Overall Study||31
877646|NCT02078180|2123513|P1|IR100|Overall Study||31
877647|NCT02078180|2123513|P1|IR75|Overall Study||30
877648|NCT02078180|2123513|P1|STARTED|Overall Study||34
877649|NCT02077374|2123530|P2|NOT COMPLETED|Overall Study||2
877650|NCT02077374|2123531|P1|NOT COMPLETED|Overall Study||0
877651|NCT02077374|2123530|P2|COMPLETED|Overall Study||17
877652|NCT02077374|2123531|P1|COMPLETED|Overall Study||19
877653|NCT02077374|2123530|P2|STARTED|Overall Study||19
877654|NCT02077374|2123531|P1|STARTED|Overall Study||19
877655|NCT02076919|2123559|P4|NOT COMPLETED|Overall Study||0
877656|NCT02076919|2123560|P3|NOT COMPLETED|Overall Study||0
877657|NCT02076919|2123561|P2|NOT COMPLETED|Overall Study||0
877658|NCT02076919|2123562|P1|NOT COMPLETED|Overall Study||0
877659|NCT02076919|2123559|P4|COMPLETED|Overall Study||12
877660|NCT02076919|2123560|P3|COMPLETED|Overall Study||36
877661|NCT02076919|2123561|P2|COMPLETED|Overall Study||8
877662|NCT02076919|2123562|P1|COMPLETED|Overall Study||24
877663|NCT02076919|2123559|P4|STARTED|Overall Study||12
877664|NCT02076919|2123560|P3|STARTED|Overall Study||36
877665|NCT02076919|2123561|P2|STARTED|Overall Study||8
877666|NCT02076919|2123562|P1|STARTED|Overall Study||24
877667|NCT02076334|2123664|P4|NOT COMPLETED|Overall Study||1
877668|NCT02076334|2123665|P3|NOT COMPLETED|Overall Study||1
877669|NCT02076334|2123666|P2|NOT COMPLETED|Overall Study||1
877670|NCT02076334|2123667|P1|NOT COMPLETED|Overall Study||1
877671|NCT02076334|2123664|P4|COMPLETED|Overall Study||20
877672|NCT02076334|2123665|P3|COMPLETED|Overall Study||20
877673|NCT02076334|2123666|P2|COMPLETED|Overall Study||20
877674|NCT02076334|2123667|P1|COMPLETED|Overall Study||20
877675|NCT02076334|2123664|P4|STARTED|Overall Study||21
877676|NCT02076334|2123665|P3|STARTED|Overall Study||21
877677|NCT02076334|2123666|P2|STARTED|Overall Study||21
877678|NCT02076334|2123667|P1|STARTED|Overall Study||21
877679|NCT02076009|2123683|P2|NOT COMPLETED|Overall Study||286
877680|NCT02076009|2123684|P1|NOT COMPLETED|Overall Study||283
877681|NCT02076009|2123683|P2|COMPLETED|Overall Study||0
877682|NCT02076009|2123684|P1|COMPLETED|Overall Study||0
877683|NCT02076009|2123683|P2|Treated|Overall Study||283
877684|NCT02076009|2123684|P1|Treated|Overall Study||281
877685|NCT02076009|2123683|P2|STARTED|Overall Study||286
877686|NCT02076009|2123684|P1|STARTED|Overall Study||283
877687|NCT02075632|2123706|P2|NOT COMPLETED|Overall Study||5
877688|NCT02075632|2123707|P1|NOT COMPLETED|Overall Study||1
877689|NCT02075632|2123706|P2|COMPLETED|Overall Study||143
877690|NCT02075632|2123707|P1|COMPLETED|Overall Study||161
877691|NCT02075632|2123706|P2|STARTED|Overall Study||148
877692|NCT02075632|2123707|P1|STARTED|Overall Study||162
877693|NCT02075515|2123720|P3|NOT COMPLETED|Overall Study||8
877694|NCT02075515|2123721|P2|NOT COMPLETED|Overall Study||5
877695|NCT02075515|2123722|P1|NOT COMPLETED|Overall Study||4
877696|NCT02075515|2123720|P3|COMPLETED|Overall Study||208
877697|NCT02075515|2123721|P2|COMPLETED|Overall Study||212
877698|NCT02075515|2123722|P1|COMPLETED|Overall Study||214
877699|NCT02075515|2123720|P3|STARTED|Overall Study||216
877700|NCT02075515|2123721|P2|STARTED|Overall Study||217
877701|NCT02075515|2123722|P1|STARTED|Overall Study||218
877702|NCT02075463|2123757|P1|NOT COMPLETED|Overall Study||8
877703|NCT02075463|2123757|P1|COMPLETED|Overall Study||7
877704|NCT02075463|2123757|P1|STARTED|Overall Study||15
877705|NCT02075411|2123786|P4|NOT COMPLETED|Overall Study||0
877706|NCT02075411|2123787|P3|NOT COMPLETED|Overall Study||0
877707|NCT02075411|2123788|P2|NOT COMPLETED|Overall Study||0
877708|NCT02075411|2123789|P1|NOT COMPLETED|Overall Study||0
877709|NCT02075411|2123786|P4|COMPLETED|Overall Study||1
877710|NCT02075411|2123787|P3|COMPLETED|Overall Study||0
877711|NCT02075411|2123788|P2|COMPLETED|Overall Study||0
877712|NCT02075411|2123789|P1|COMPLETED|Overall Study||0
877713|NCT02075411|2123786|P4|STARTED|Overall Study||1
877714|NCT02075411|2123787|P3|STARTED|Overall Study||0
877715|NCT02075411|2123788|P2|STARTED|Overall Study||0
877716|NCT02075411|2123789|P1|STARTED|Overall Study||0
877717|NCT02075125|2123809|P2|NOT COMPLETED|Overall Study||1
877718|NCT02075125|2123810|P1|NOT COMPLETED|Overall Study||0
877719|NCT02075125|2123809|P2|COMPLETED|Overall Study|One patient switched to clopidogrel treatment after 18 days of ticagrelor treatment.|19
877720|NCT02075125|2123810|P1|COMPLETED|Overall Study||19
877721|NCT02075125|2123809|P2|STARTED|Overall Study||20
877722|NCT02075125|2123810|P1|STARTED|Overall Study||19
877723|NCT02075073|2123831|P3|NOT COMPLETED|Overall Study||0
877724|NCT02075073|2123832|P2|NOT COMPLETED|Overall Study||1
877725|NCT02075073|2123833|P1|NOT COMPLETED|Overall Study||0
877726|NCT02075073|2123831|P3|COMPLETED|Overall Study||36
877727|NCT02075073|2123832|P2|COMPLETED|Overall Study||36
877728|NCT02075073|2123833|P1|COMPLETED|Overall Study||36
877729|NCT02075073|2123831|P3|STARTED|Overall Study||36
877730|NCT02075073|2123832|P2|STARTED|Overall Study||37
877731|NCT02075073|2123833|P1|STARTED|Overall Study||36
877732|NCT02075021|2123850|P1|NOT COMPLETED|Overall Study||0
877733|NCT02075021|2123850|P1|COMPLETED|Overall Study||3
877734|NCT02075021|2123850|P1|STARTED|Overall Study||3
877735|NCT02075008|2123855|P1|NOT COMPLETED|Overall Study||176
877736|NCT02075008|2123855|P1|COMPLETED|Overall Study||94
877737|NCT02075008|2123855|P1|STARTED|Overall Study||270
877738|NCT02074995|2123859|P3|NOT COMPLETED|Overall Study||0
877739|NCT02074995|2123860|P2|NOT COMPLETED|Overall Study||0
877740|NCT02074995|2123861|P1|NOT COMPLETED|Overall Study||0
877741|NCT02074995|2123859|P3|COMPLETED|Overall Study||0
877742|NCT02074995|2123860|P2|COMPLETED|Overall Study||0
877743|NCT02074995|2123861|P1|COMPLETED|Overall Study||1
877744|NCT02074995|2123859|P3|STARTED|Overall Study||0
877745|NCT02074995|2123860|P2|STARTED|Overall Study||0
877746|NCT02074995|2123861|P1|STARTED|Overall Study||1
877747|NCT02074982|2123878|P2|NOT COMPLETED|Overall Study||54
877748|NCT02074982|2123879|P1|NOT COMPLETED|Overall Study||51
877749|NCT02074982|2123878|P2|COMPLETED|Overall Study||285
877750|NCT02074982|2123879|P1|COMPLETED|Overall Study||286
877751|NCT02074982|2123878|P2|Safety Set (SF)|Overall Study||336
877752|NCT02074982|2123879|P1|Safety Set (SF)|Overall Study||335
877753|NCT02074982|2123878|P2|Full Analysis Set (FAS)|Overall Study||339
877754|NCT02074982|2123879|P1|Full Analysis Set (FAS)|Overall Study||336
877755|NCT02074982|2123878|P2|STARTED|Overall Study||339
877756|NCT02074982|2123879|P1|STARTED|Overall Study||337
877757|NCT02074709|2123891|P2|NOT COMPLETED|Overall Study||1
877758|NCT02074709|2123892|P1|NOT COMPLETED|Overall Study||1
877759|NCT02074709|2123891|P2|COMPLETED|Overall Study||29
877760|NCT02074709|2123892|P1|COMPLETED|Overall Study||29
877761|NCT02074709|2123891|P2|STARTED|Overall Study||30
877762|NCT02074709|2123892|P1|STARTED|Overall Study||30
877763|NCT02074553|2123900|P8|NOT COMPLETED|Intervention Period 4||0
877764|NCT02074553|2123901|P7|NOT COMPLETED|Intervention Period 4||0
877765|NCT02074553|2123902|P6|NOT COMPLETED|Intervention Period 4||0
877766|NCT02074553|2123903|P5|NOT COMPLETED|Intervention Period 4||0
877767|NCT02074553|2123904|P4|NOT COMPLETED|Intervention Period 4||0
877768|NCT02074553|2123905|P3|NOT COMPLETED|Intervention Period 4||0
877769|NCT02074553|2123906|P2|NOT COMPLETED|Intervention Period 4||0
877770|NCT02074553|2123907|P1|NOT COMPLETED|Intervention Period 4||0
877771|NCT02074553|2123900|P8|COMPLETED|Intervention Period 4||11
877772|NCT02074553|2123901|P7|COMPLETED|Intervention Period 4||11
877773|NCT02074553|2123902|P6|COMPLETED|Intervention Period 4||10
877774|NCT02074553|2123903|P5|COMPLETED|Intervention Period 4||12
877775|NCT02074553|2123904|P4|COMPLETED|Intervention Period 4||11
877776|NCT02074553|2123905|P3|COMPLETED|Intervention Period 4||11
877777|NCT02074553|2123906|P2|COMPLETED|Intervention Period 4||12
877778|NCT02074553|2123907|P1|COMPLETED|Intervention Period 4||11
877779|NCT02074553|2123900|P8|STARTED|Intervention Period 4||11
877780|NCT02074553|2123901|P7|STARTED|Intervention Period 4||11
877781|NCT02074553|2123902|P6|STARTED|Intervention Period 4||10
877782|NCT02074553|2123903|P5|STARTED|Intervention Period 4||12
877783|NCT02074553|2123904|P4|STARTED|Intervention Period 4||11
877784|NCT02074553|2123905|P3|STARTED|Intervention Period 4||11
877785|NCT02074553|2123906|P2|STARTED|Intervention Period 4||12
877786|NCT02074553|2123907|P1|STARTED|Intervention Period 4||11
877787|NCT02074553|2123900|P8|NOT COMPLETED|Washout Period 3||1
877788|NCT02074553|2123901|P7|NOT COMPLETED|Washout Period 3||0
877789|NCT02074553|2123902|P6|NOT COMPLETED|Washout Period 3||0
877790|NCT02074553|2123903|P5|NOT COMPLETED|Washout Period 3||0
877791|NCT02074553|2123904|P4|NOT COMPLETED|Washout Period 3||0
877792|NCT02074553|2123905|P3|NOT COMPLETED|Washout Period 3||0
877793|NCT02074553|2123906|P2|NOT COMPLETED|Washout Period 3||0
877794|NCT02074553|2123907|P1|NOT COMPLETED|Washout Period 3||0
877795|NCT02074553|2123900|P8|COMPLETED|Washout Period 3||11
877796|NCT02074553|2123901|P7|COMPLETED|Washout Period 3||11
877797|NCT02074553|2123902|P6|COMPLETED|Washout Period 3||10
877798|NCT02074553|2123903|P5|COMPLETED|Washout Period 3||12
877799|NCT02074553|2123904|P4|COMPLETED|Washout Period 3||11
877800|NCT02074553|2123905|P3|COMPLETED|Washout Period 3||11
877801|NCT02074553|2123906|P2|COMPLETED|Washout Period 3||12
877802|NCT02074553|2123907|P1|COMPLETED|Washout Period 3||11
877803|NCT02074553|2123900|P8|STARTED|Washout Period 3||12
877804|NCT02074553|2123901|P7|STARTED|Washout Period 3||11
877805|NCT02074553|2123902|P6|STARTED|Washout Period 3||10
877806|NCT02074553|2123903|P5|STARTED|Washout Period 3||12
877807|NCT02074553|2123904|P4|STARTED|Washout Period 3||11
877808|NCT02074553|2123905|P3|STARTED|Washout Period 3||11
877809|NCT02074553|2123906|P2|STARTED|Washout Period 3||12
877810|NCT02074553|2123907|P1|STARTED|Washout Period 3||11
877811|NCT02074553|2123900|P8|NOT COMPLETED|Intervention Period 3||0
877812|NCT02074553|2123901|P7|NOT COMPLETED|Intervention Period 3||0
877813|NCT02074553|2123902|P6|NOT COMPLETED|Intervention Period 3||0
877814|NCT02074553|2123903|P5|NOT COMPLETED|Intervention Period 3||0
877815|NCT02074553|2123904|P4|NOT COMPLETED|Intervention Period 3||0
877816|NCT02074553|2123905|P3|NOT COMPLETED|Intervention Period 3||0
877817|NCT02074553|2123906|P2|NOT COMPLETED|Intervention Period 3||0
877818|NCT02074553|2123907|P1|NOT COMPLETED|Intervention Period 3||0
877819|NCT02074553|2123900|P8|COMPLETED|Intervention Period 3||12
877820|NCT02074553|2123901|P7|COMPLETED|Intervention Period 3||11
877821|NCT02074553|2123902|P6|COMPLETED|Intervention Period 3||10
877822|NCT02074553|2123903|P5|COMPLETED|Intervention Period 3||12
877823|NCT02074553|2123904|P4|COMPLETED|Intervention Period 3||11
877824|NCT02074553|2123905|P3|COMPLETED|Intervention Period 3||11
877825|NCT02074553|2123906|P2|COMPLETED|Intervention Period 3||12
877826|NCT02074553|2123907|P1|COMPLETED|Intervention Period 3||11
877827|NCT02074553|2123900|P8|STARTED|Intervention Period 3||12
877828|NCT02074553|2123901|P7|STARTED|Intervention Period 3||11
877829|NCT02074553|2123902|P6|STARTED|Intervention Period 3||10
877830|NCT02074553|2123903|P5|STARTED|Intervention Period 3||12
877831|NCT02074553|2123904|P4|STARTED|Intervention Period 3||11
877832|NCT02074553|2123905|P3|STARTED|Intervention Period 3||11
877833|NCT02074553|2123906|P2|STARTED|Intervention Period 3||12
877834|NCT02074553|2123907|P1|STARTED|Intervention Period 3||11
877835|NCT02074553|2123900|P8|NOT COMPLETED|Washout Period 2||0
877836|NCT02074553|2123901|P7|NOT COMPLETED|Washout Period 2||1
877837|NCT02074553|2123902|P6|NOT COMPLETED|Washout Period 2||1
877838|NCT02074553|2123903|P5|NOT COMPLETED|Washout Period 2||0
877839|NCT02074553|2123904|P4|NOT COMPLETED|Washout Period 2||0
877840|NCT02074553|2123905|P3|NOT COMPLETED|Washout Period 2||1
877841|NCT02074553|2123906|P2|NOT COMPLETED|Washout Period 2||0
877842|NCT02074553|2123907|P1|NOT COMPLETED|Washout Period 2||0
877843|NCT02074553|2123900|P8|COMPLETED|Washout Period 2||12
877844|NCT02074553|2123901|P7|COMPLETED|Washout Period 2||11
877845|NCT02074553|2123902|P6|COMPLETED|Washout Period 2||10
877846|NCT02074553|2123903|P5|COMPLETED|Washout Period 2||12
877847|NCT02074553|2123904|P4|COMPLETED|Washout Period 2||11
877848|NCT02074553|2123905|P3|COMPLETED|Washout Period 2||11
877849|NCT02074553|2123906|P2|COMPLETED|Washout Period 2||12
877850|NCT02074553|2123907|P1|COMPLETED|Washout Period 2||11
877851|NCT02074553|2123900|P8|STARTED|Washout Period 2||12
877852|NCT02074553|2123901|P7|STARTED|Washout Period 2||12
877853|NCT02074553|2123902|P6|STARTED|Washout Period 2||11
877854|NCT02074553|2123903|P5|STARTED|Washout Period 2||12
877855|NCT02074553|2123904|P4|STARTED|Washout Period 2||11
877856|NCT02074553|2123905|P3|STARTED|Washout Period 2||12
877857|NCT02074553|2123906|P2|STARTED|Washout Period 2||12
877858|NCT02074553|2123907|P1|STARTED|Washout Period 2||11
877859|NCT02074553|2123900|P8|NOT COMPLETED|Intervention Period 2||0
877860|NCT02074553|2123901|P7|NOT COMPLETED|Intervention Period 2||0
877861|NCT02074553|2123902|P6|NOT COMPLETED|Intervention Period 2||0
877862|NCT02074553|2123903|P5|NOT COMPLETED|Intervention Period 2||0
877863|NCT02074553|2123904|P4|NOT COMPLETED|Intervention Period 2||0
877864|NCT02074553|2123905|P3|NOT COMPLETED|Intervention Period 2||0
877865|NCT02074553|2123906|P2|NOT COMPLETED|Intervention Period 2||0
877866|NCT02074553|2123907|P1|NOT COMPLETED|Intervention Period 2||0
877867|NCT02074553|2123900|P8|COMPLETED|Intervention Period 2||12
877868|NCT02074553|2123901|P7|COMPLETED|Intervention Period 2||12
877869|NCT02074553|2123902|P6|COMPLETED|Intervention Period 2||11
877870|NCT02074553|2123903|P5|COMPLETED|Intervention Period 2||12
877871|NCT02074553|2123904|P4|COMPLETED|Intervention Period 2||11
877872|NCT02074553|2123905|P3|COMPLETED|Intervention Period 2||12
877873|NCT02074553|2123906|P2|COMPLETED|Intervention Period 2||12
877874|NCT02074553|2123907|P1|COMPLETED|Intervention Period 2||11
877875|NCT02074553|2123900|P8|STARTED|Intervention Period 2||12
877876|NCT02074553|2123901|P7|STARTED|Intervention Period 2||12
877877|NCT02074553|2123902|P6|STARTED|Intervention Period 2||11
877878|NCT02074553|2123903|P5|STARTED|Intervention Period 2||12
877879|NCT02074553|2123904|P4|STARTED|Intervention Period 2||11
877880|NCT02074553|2123905|P3|STARTED|Intervention Period 2||12
877881|NCT02074553|2123906|P2|STARTED|Intervention Period 2||12
877882|NCT02074553|2123907|P1|STARTED|Intervention Period 2||11
877883|NCT02074553|2123900|P8|NOT COMPLETED|Washout Period 1||0
877884|NCT02074553|2123901|P7|NOT COMPLETED|Washout Period 1||0
877885|NCT02074553|2123902|P6|NOT COMPLETED|Washout Period 1||1
877886|NCT02074553|2123903|P5|NOT COMPLETED|Washout Period 1||0
877887|NCT02074553|2123904|P4|NOT COMPLETED|Washout Period 1||1
877888|NCT02074553|2123905|P3|NOT COMPLETED|Washout Period 1||0
877889|NCT02074553|2123906|P2|NOT COMPLETED|Washout Period 1||0
877890|NCT02074553|2123907|P1|NOT COMPLETED|Washout Period 1||1
877891|NCT02074553|2123900|P8|COMPLETED|Washout Period 1||12
877892|NCT02074553|2123901|P7|COMPLETED|Washout Period 1||12
877893|NCT02074553|2123902|P6|COMPLETED|Washout Period 1||11
877894|NCT02074553|2123903|P5|COMPLETED|Washout Period 1||12
877895|NCT02074553|2123904|P4|COMPLETED|Washout Period 1||11
877896|NCT02074553|2123905|P3|COMPLETED|Washout Period 1||12
877897|NCT02074553|2123906|P2|COMPLETED|Washout Period 1||12
877898|NCT02074553|2123907|P1|COMPLETED|Washout Period 1||11
877899|NCT02074553|2123900|P8|STARTED|Washout Period 1||12
877900|NCT02074553|2123901|P7|STARTED|Washout Period 1||12
877901|NCT02074553|2123902|P6|STARTED|Washout Period 1||12
877902|NCT02074553|2123903|P5|STARTED|Washout Period 1||12
877903|NCT02074553|2123904|P4|STARTED|Washout Period 1||12
877904|NCT02074553|2123905|P3|STARTED|Washout Period 1||12
877905|NCT02074553|2123906|P2|STARTED|Washout Period 1||12
877906|NCT02074553|2123907|P1|STARTED|Washout Period 1||12
877907|NCT02074553|2123900|P8|NOT COMPLETED|Intervention Period 1||0
877908|NCT02074553|2123901|P7|NOT COMPLETED|Intervention Period 1||0
877909|NCT02074553|2123902|P6|NOT COMPLETED|Intervention Period 1||0
877910|NCT02074553|2123903|P5|NOT COMPLETED|Intervention Period 1||0
877911|NCT02074553|2123904|P4|NOT COMPLETED|Intervention Period 1||1
877912|NCT02074553|2123905|P3|NOT COMPLETED|Intervention Period 1||0
877913|NCT02074553|2123906|P2|NOT COMPLETED|Intervention Period 1||0
877914|NCT02074553|2123907|P1|NOT COMPLETED|Intervention Period 1||0
877915|NCT02074553|2123900|P8|COMPLETED|Intervention Period 1||12
877916|NCT02074553|2123901|P7|COMPLETED|Intervention Period 1||12
877917|NCT02074553|2123902|P6|COMPLETED|Intervention Period 1||12
877918|NCT02074553|2123903|P5|COMPLETED|Intervention Period 1||12
877919|NCT02074553|2123904|P4|COMPLETED|Intervention Period 1||12
877920|NCT02074553|2123905|P3|COMPLETED|Intervention Period 1||12
877921|NCT02074553|2123906|P2|COMPLETED|Intervention Period 1||12
877922|NCT02074553|2123907|P1|COMPLETED|Intervention Period 1||12
877923|NCT02074553|2123900|P8|STARTED|Intervention Period 1||12
877924|NCT02074553|2123901|P7|STARTED|Intervention Period 1||12
877925|NCT02074553|2123902|P6|STARTED|Intervention Period 1||12
877926|NCT02074553|2123903|P5|STARTED|Intervention Period 1||12
877927|NCT02074553|2123904|P4|STARTED|Intervention Period 1||13
877928|NCT02074553|2123905|P3|STARTED|Intervention Period 1||12
877929|NCT02074553|2123906|P2|STARTED|Intervention Period 1||12
877930|NCT02074553|2123907|P1|STARTED|Intervention Period 1||12
877931|NCT02074514|2124089|P2|NOT COMPLETED|Overall Study||4
877932|NCT02074514|2124090|P1|NOT COMPLETED|Overall Study||3
877933|NCT02074514|2124089|P2|COMPLETED|Overall Study||54
877934|NCT02074514|2124090|P1|COMPLETED|Overall Study||56
877935|NCT02074514|2124089|P2|STARTED|Overall Study||58
877936|NCT02074514|2124090|P1|STARTED|Overall Study||59
877937|NCT02074384|2124111|P3|NOT COMPLETED|Overall Study||0
877938|NCT02074384|2124112|P2|NOT COMPLETED|Overall Study||0
877939|NCT02074384|2124113|P1|NOT COMPLETED|Overall Study||0
877940|NCT02074384|2124111|P3|COMPLETED|Overall Study||17
877941|NCT02074384|2124112|P2|COMPLETED|Overall Study||70
877942|NCT02074384|2124113|P1|COMPLETED|Overall Study||74
877943|NCT02074384|2124111|P3|STARTED|Overall Study||17
877944|NCT02074384|2124112|P2|STARTED|Overall Study||70
877945|NCT02074384|2124113|P1|STARTED|Overall Study||74
877946|NCT02074358|2124121|P6|NOT COMPLETED|Overall Study||0
877947|NCT02074358|2124122|P5|NOT COMPLETED|Overall Study||0
877948|NCT02074358|2124123|P4|NOT COMPLETED|Overall Study||0
877949|NCT02074358|2124124|P3|NOT COMPLETED|Overall Study||0
877950|NCT02074358|2124125|P2|NOT COMPLETED|Overall Study||0
877951|NCT02074358|2124126|P1|NOT COMPLETED|Overall Study||0
877952|NCT02074358|2124121|P6|COMPLETED|Overall Study||2
877953|NCT02074358|2124122|P5|COMPLETED|Overall Study||3
877954|NCT02074358|2124123|P4|COMPLETED|Overall Study||2
877955|NCT02074358|2124124|P3|COMPLETED|Overall Study||2
877956|NCT02074358|2124125|P2|COMPLETED|Overall Study||3
877957|NCT02074358|2124126|P1|COMPLETED|Overall Study||3
877958|NCT02074358|2124121|P6|STARTED|Overall Study||2
877959|NCT02074358|2124122|P5|STARTED|Overall Study||3
877960|NCT02074358|2124123|P4|STARTED|Overall Study||2
877961|NCT02074358|2124124|P3|STARTED|Overall Study||2
877962|NCT02074358|2124125|P2|STARTED|Overall Study||3
877963|NCT02074358|2124126|P1|STARTED|Overall Study||3
877964|NCT02074345|2124215|P1|NOT COMPLETED|Overall Study||0
877965|NCT02074345|2124215|P1|COMPLETED|Overall Study||31
877966|NCT02074345|2124215|P1|STARTED|Overall Study||31
877967|NCT02074059|2124231|P6|NOT COMPLETED|Overall Study||1
877968|NCT02074059|2124232|P5|NOT COMPLETED|Overall Study||1
877969|NCT02074059|2124233|P4|NOT COMPLETED|Overall Study||0
877970|NCT02074059|2124234|P3|NOT COMPLETED|Overall Study||0
877971|NCT02074059|2124235|P2|NOT COMPLETED|Overall Study||0
877972|NCT02074059|2124236|P1|NOT COMPLETED|Overall Study||0
877973|NCT02074059|2124231|P6|COMPLETED|Overall Study||39
877974|NCT02074059|2124232|P5|COMPLETED|Overall Study||7
877975|NCT02074059|2124233|P4|COMPLETED|Overall Study||8
877976|NCT02074059|2124234|P3|COMPLETED|Overall Study||8
877977|NCT02074059|2124235|P2|COMPLETED|Overall Study||8
877978|NCT02074059|2124236|P1|COMPLETED|Overall Study||8
877979|NCT02074059|2124231|P6|STARTED|Overall Study||40
877980|NCT02074059|2124232|P5|STARTED|Overall Study||8
877981|NCT02074059|2124233|P4|STARTED|Overall Study||8
877982|NCT02074059|2124234|P3|STARTED|Overall Study||8
877983|NCT02074059|2124235|P2|STARTED|Overall Study||8
877984|NCT02074059|2124236|P1|STARTED|Overall Study||8
877985|NCT02073747|2124276|P2|NOT COMPLETED|Overall Study||1
877986|NCT02073747|2124277|P1|NOT COMPLETED|Overall Study||1
877987|NCT02073747|2124276|P2|COMPLETED|Overall Study||14
877988|NCT02073747|2124277|P1|COMPLETED|Overall Study||14
877989|NCT02073747|2124276|P2|STARTED|Overall Study||15
877990|NCT02073747|2124277|P1|STARTED|Overall Study||15
877991|NCT02073656|2124283|P1|NOT COMPLETED|Retreatment Substudy||0
877992|NCT02073656|2124283|P1|COMPLETED|Retreatment Substudy||9
877993|NCT02073656|2124283|P1|STARTED|Retreatment Substudy|Only participants experiencing virologic relapse in the Primary Study were eligible for retreatment.|9
877994|NCT02073656|2124283|P1|NOT COMPLETED|Primary Study||8
877995|NCT02073656|2124283|P1|COMPLETED|Primary Study||327
877996|NCT02073656|2124283|P1|STARTED|Primary Study||335
877997|NCT02073461|2124302|P3|NOT COMPLETED|Overall Study||1
877998|NCT02073461|2124303|P2|NOT COMPLETED|Overall Study||1
877999|NCT02073461|2124304|P1|NOT COMPLETED|Overall Study||4
878000|NCT02073461|2124302|P3|COMPLETED|Overall Study||78
878001|NCT02073461|2124303|P2|COMPLETED|Overall Study||77
878002|NCT02073461|2124304|P1|COMPLETED|Overall Study||75
878003|NCT02073461|2124302|P3|STARTED|Overall Study||79
878004|NCT02073461|2124303|P2|STARTED|Overall Study||78
878005|NCT02073461|2124304|P1|STARTED|Overall Study||79
878006|NCT02073448|2124333|P3|NOT COMPLETED|Overall Study||5
878007|NCT02073448|2124334|P2|NOT COMPLETED|Overall Study||12
878008|NCT02073448|2124335|P1|NOT COMPLETED|Overall Study||2
878009|NCT02073448|2124333|P3|COMPLETED|Overall Study||99
878010|NCT02073448|2124334|P2|COMPLETED|Overall Study||200
878011|NCT02073448|2124335|P1|COMPLETED|Overall Study||99
878012|NCT02073448|2124333|P3|STARTED|Overall Study||104
878013|NCT02073448|2124334|P2|STARTED|Overall Study||212
878014|NCT02073448|2124335|P1|STARTED|Overall Study||101
878015|NCT02072980|2124361|P2|NOT COMPLETED|Period 2, Second Wear||1
878016|NCT02072980|2124362|P1|NOT COMPLETED|Period 2, Second Wear||0
878017|NCT02072980|2124361|P2|COMPLETED|Period 2, Second Wear||7
878018|NCT02072980|2124362|P1|COMPLETED|Period 2, Second Wear||7
878019|NCT02072980|2124361|P2|STARTED|Period 2, Second Wear||8
878020|NCT02072980|2124362|P1|STARTED|Period 2, Second Wear||7
878021|NCT02072980|2124361|P2|NOT COMPLETED|Period 1, First Wear||0
878022|NCT02072980|2124362|P1|NOT COMPLETED|Period 1, First Wear||0
878023|NCT02072980|2124361|P2|COMPLETED|Period 1, First Wear||8
878024|NCT02072980|2124362|P1|COMPLETED|Period 1, First Wear||7
878025|NCT02072980|2124361|P2|STARTED|Period 1, First Wear||8
878026|NCT02072980|2124362|P1|STARTED|Period 1, First Wear||7
878027|NCT02072421|2124368|P1|NOT COMPLETED|Overall Study||390
878028|NCT02072421|2124368|P1|COMPLETED|Overall Study||2489
878029|NCT02072421|2124368|P1|STARTED|Overall Study||2879
878030|NCT02072200|2124376|P1|NOT COMPLETED|Overall Study||2
878031|NCT02072200|2124376|P1|COMPLETED|Overall Study||145
878032|NCT02072200|2124376|P1|STARTED|Overall Study||147
878033|NCT02072096|2124384|P2|NOT COMPLETED|Overall Study||78
878034|NCT02072096|2124385|P1|NOT COMPLETED|Overall Study||85
878035|NCT02072096|2124384|P2|COMPLETED|Overall Study||15
878036|NCT02072096|2124385|P1|COMPLETED|Overall Study||14
878037|NCT02072096|2124384|P2|Received at Least One Dose of Study Drug|Overall Study||93
878038|NCT02072096|2124385|P1|Received at Least One Dose of Study Drug|Overall Study||98
878039|NCT02072096|2124384|P2|STARTED|Overall Study||93
878040|NCT02072096|2124385|P1|STARTED|Overall Study||99
878041|NCT02071849|2124407|P1|NOT COMPLETED|2-year Extended Follow-up||1
878042|NCT02071849|2124407|P1|COMPLETED|2-year Extended Follow-up||14
878043|NCT02071849|2124407|P1|STARTED|2-year Extended Follow-up||15
878044|NCT02071849|2124407|P1|NOT COMPLETED|6-month Primary Endpoint||5
878045|NCT02071849|2124407|P1|COMPLETED|6-month Primary Endpoint||15
878046|NCT02071849|2124407|P1|STARTED|6-month Primary Endpoint||20
878047|NCT02071823|2124441|P2|NOT COMPLETED|Overall Study||0
878048|NCT02071823|2124442|P1|NOT COMPLETED|Overall Study||1
878049|NCT02071823|2124441|P2|COMPLETED|Overall Study||6
878050|NCT02071823|2124442|P1|COMPLETED|Overall Study||5
878051|NCT02071823|2124441|P2|STARTED|Overall Study||6
878052|NCT02071823|2124442|P1|STARTED|Overall Study||6
878053|NCT02071810|2124457|P5|NOT COMPLETED|Overall Study||1
878054|NCT02071810|2124458|P4|NOT COMPLETED|Overall Study||1
878055|NCT02071810|2124459|P3|NOT COMPLETED|Overall Study||0
878056|NCT02071810|2124460|P2|NOT COMPLETED|Overall Study||0
878057|NCT02071810|2124461|P1|NOT COMPLETED|Overall Study||0
878058|NCT02071810|2124457|P5|COMPLETED|Overall Study||8
878059|NCT02071810|2124458|P4|COMPLETED|Overall Study||6
878060|NCT02071810|2124459|P3|COMPLETED|Overall Study||6
878061|NCT02071810|2124460|P2|COMPLETED|Overall Study||6
878062|NCT02071810|2124461|P1|COMPLETED|Overall Study||6
878063|NCT02071810|2124457|P5|STARTED|Overall Study||9
878064|NCT02071810|2124458|P4|STARTED|Overall Study||7
878065|NCT02071810|2124459|P3|STARTED|Overall Study||6
878066|NCT02071810|2124460|P2|STARTED|Overall Study||6
878067|NCT02071810|2124461|P1|STARTED|Overall Study||6
878068|NCT02071771|2124473|P2|NOT COMPLETED|Period 2: Second 10 Days||0
878069|NCT02071771|2124474|P1|NOT COMPLETED|Period 2: Second 10 Days||0
878070|NCT02071771|2124473|P2|COMPLETED|Period 2: Second 10 Days||38
878071|NCT02071771|2124474|P1|COMPLETED|Period 2: Second 10 Days||39
878072|NCT02071771|2124473|P2|STARTED|Period 2: Second 10 Days|One participant completed Period 1 but did not start Period 2 due to unacceptable fit with DACP T.|38
878073|NCT02071771|2124474|P1|STARTED|Period 2: Second 10 Days||39
878074|NCT02071771|2124473|P2|NOT COMPLETED|Period 1: First 10 Days||0
878075|NCT02071771|2124474|P1|NOT COMPLETED|Period 1: First 10 Days||2
878076|NCT02071771|2124473|P2|COMPLETED|Period 1: First 10 Days||39
878077|NCT02071771|2124474|P1|COMPLETED|Period 1: First 10 Days||39
878078|NCT02071771|2124473|P2|Dispensed|Period 1: First 10 Days||39
878079|NCT02071771|2124474|P1|Dispensed|Period 1: First 10 Days||39
878080|NCT02071771|2124473|P2|STARTED|Period 1: First 10 Days||39
878081|NCT02071771|2124474|P1|STARTED|Period 1: First 10 Days||41
878082|NCT02071108|2124482|P1|NOT COMPLETED|Overall Study||0
878083|NCT02071108|2124482|P1|COMPLETED|Overall Study||35
878084|NCT02071108|2124482|P1|STARTED|Overall Study||35
878085|NCT02071082|2124503|P2|NOT COMPLETED|Overall Study||75
878086|NCT02071082|2124504|P1|NOT COMPLETED|Overall Study||4
878087|NCT02071082|2124503|P2|COMPLETED|Overall Study||0
878088|NCT02071082|2124504|P1|COMPLETED|Overall Study||0
878089|NCT02071082|2124503|P2|STARTED|Overall Study||75
878090|NCT02071082|2124504|P1|STARTED|Overall Study||4
878091|NCT02070965|2124535|P3|NOT COMPLETED|Overall Study||1
878092|NCT02070965|2124536|P2|NOT COMPLETED|Overall Study||2
878093|NCT02070965|2124537|P1|NOT COMPLETED|Overall Study||2
878094|NCT02070965|2124535|P3|COMPLETED|Overall Study||24
878095|NCT02070965|2124536|P2|COMPLETED|Overall Study||21
878096|NCT02070965|2124537|P1|COMPLETED|Overall Study||25
878097|NCT02070965|2124535|P3|STARTED|Overall Study||25
878098|NCT02070965|2124536|P2|STARTED|Overall Study||23
878099|NCT02070965|2124537|P1|STARTED|Overall Study||27
878100|NCT02070692|2124547|P2|NOT COMPLETED|Overall Study||12
878101|NCT02070692|2124548|P1|NOT COMPLETED|Overall Study||10
878102|NCT02070692|2124547|P2|COMPLETED|Overall Study||16
878103|NCT02070692|2124548|P1|COMPLETED|Overall Study||18
878104|NCT02070692|2124547|P2|STARTED|Overall Study||28
878105|NCT02070692|2124548|P1|STARTED|Overall Study||28
878106|NCT02070640|2124564|P2|NOT COMPLETED|Overall Study||0
878107|NCT02070640|2124565|P1|NOT COMPLETED|Overall Study||11
878108|NCT02070640|2124564|P2|COMPLETED|Overall Study||6
878109|NCT02070640|2124565|P1|COMPLETED|Overall Study||82
878110|NCT02070640|2124564|P2|STARTED|Overall Study||6
878111|NCT02070640|2124565|P1|STARTED|Overall Study||93
878112|NCT02070588|2124578|P3|NOT COMPLETED|Overall Study||0
878113|NCT02070588|2124579|P2|NOT COMPLETED|Overall Study||1
878114|NCT02070588|2124580|P1|NOT COMPLETED|Overall Study||39
878115|NCT02070588|2124578|P3|COMPLETED|Overall Study||0
878116|NCT02070588|2124579|P2|COMPLETED|Overall Study||25
878117|NCT02070588|2124580|P1|COMPLETED|Overall Study||47
878118|NCT02070588|2124578|P3|STARTED|Overall Study||0
878119|NCT02070588|2124579|P2|STARTED|Overall Study||26
878120|NCT02070588|2124580|P1|STARTED|Overall Study||86
878121|NCT02070380|2124598|P4|NOT COMPLETED|Second Injection||5
878122|NCT02070380|2124599|P3|NOT COMPLETED|Second Injection||1
878123|NCT02070380|2124600|P2|NOT COMPLETED|Second Injection||2
878124|NCT02070380|2124601|P1|NOT COMPLETED|Second Injection||0
878125|NCT02070380|2124598|P4|COMPLETED|Second Injection||46
878126|NCT02070380|2124599|P3|COMPLETED|Second Injection||50
878127|NCT02070380|2124600|P2|COMPLETED|Second Injection||32
878128|NCT02070380|2124601|P1|COMPLETED|Second Injection||31
878129|NCT02070380|2124598|P4|STARTED|Second Injection||51
878130|NCT02070380|2124599|P3|STARTED|Second Injection||51
878131|NCT02070380|2124600|P2|STARTED|Second Injection||34
878132|NCT02070380|2124601|P1|STARTED|Second Injection||31
878133|NCT02070380|2124598|P4|NOT COMPLETED|Washout (no Second Injection/MRI)||3
878134|NCT02070380|2124599|P3|NOT COMPLETED|Washout (no Second Injection/MRI)||2
878135|NCT02070380|2124600|P2|NOT COMPLETED|Washout (no Second Injection/MRI)||5
878136|NCT02070380|2124601|P1|NOT COMPLETED|Washout (no Second Injection/MRI)||0
878137|NCT02070380|2124598|P4|COMPLETED|Washout (no Second Injection/MRI)||51
878138|NCT02070380|2124599|P3|COMPLETED|Washout (no Second Injection/MRI)||51
878139|NCT02070380|2124600|P2|COMPLETED|Washout (no Second Injection/MRI)||34
878140|NCT02070380|2124601|P1|COMPLETED|Washout (no Second Injection/MRI)||31
878141|NCT02070380|2124598|P4|STARTED|Washout (no Second Injection/MRI)||54
878142|NCT02070380|2124599|P3|STARTED|Washout (no Second Injection/MRI)||53
878143|NCT02070380|2124600|P2|STARTED|Washout (no Second Injection/MRI)||39
878144|NCT02070380|2124601|P1|STARTED|Washout (no Second Injection/MRI)||31
878145|NCT02070380|2124598|P4|NOT COMPLETED|First Injection||0
878146|NCT02070380|2124599|P3|NOT COMPLETED|First Injection||0
878147|NCT02070380|2124600|P2|NOT COMPLETED|First Injection||0
878148|NCT02070380|2124601|P1|NOT COMPLETED|First Injection||0
878149|NCT02070380|2124598|P4|COMPLETED|First Injection||54
878150|NCT02070380|2124599|P3|COMPLETED|First Injection||53
878151|NCT02070380|2124600|P2|COMPLETED|First Injection||39
878152|NCT02070380|2124601|P1|COMPLETED|First Injection||31
878153|NCT02070380|2124598|P4|STARTED|First Injection||54
878154|NCT02070380|2124599|P3|STARTED|First Injection||53
878155|NCT02070380|2124600|P2|STARTED|First Injection||39
878156|NCT02070380|2124601|P1|STARTED|First Injection||31
878157|NCT02070302|2124651|P2|NOT COMPLETED|Overall Study||0
878158|NCT02070302|2124652|P1|NOT COMPLETED|Overall Study||0
878159|NCT02070302|2124651|P2|COMPLETED|Overall Study||5
878160|NCT02070302|2124652|P1|COMPLETED|Overall Study||5
878161|NCT02070302|2124651|P2|STARTED|Overall Study||5
878162|NCT02070302|2124652|P1|STARTED|Overall Study||5
878163|NCT02070237|2124670|P2|NOT COMPLETED|Overall Study||3
878164|NCT02070237|2124671|P1|NOT COMPLETED|Overall Study||3
878165|NCT02070237|2124670|P2|COMPLETED|Overall Study||42
878166|NCT02070237|2124671|P1|COMPLETED|Overall Study||42
878167|NCT02070237|2124670|P2|STARTED|Overall Study||45
878168|NCT02070237|2124671|P1|STARTED|Overall Study||45
878169|NCT02069093|2124679|P1|NOT COMPLETED|Overall Study||30
878170|NCT02069093|2124679|P1|COMPLETED|Overall Study||56
878171|NCT02069093|2124679|P1|Pharmacokinetic Analysis Set|Overall Study||50
878172|NCT02069093|2124679|P1|STARTED|Overall Study||86
878173|NCT02068443|2124691|P3|NOT COMPLETED|Overall Study||3
878174|NCT02068443|2124692|P2|NOT COMPLETED|Overall Study||6
878175|NCT02068443|2124693|P1|NOT COMPLETED|Overall Study||7
878176|NCT02068443|2124691|P3|COMPLETED|Overall Study||148
878177|NCT02068443|2124692|P2|COMPLETED|Overall Study||146
878178|NCT02068443|2124693|P1|COMPLETED|Overall Study||64
878179|NCT02068443|2124691|P3|STARTED|Overall Study||151
878180|NCT02068443|2124692|P2|STARTED|Overall Study||152
878181|NCT02068443|2124693|P1|STARTED|Overall Study||71
878182|NCT02068222|2124728|P1|NOT COMPLETED|Overall Study||1
878183|NCT02068222|2124728|P1|COMPLETED|Overall Study||9
878184|NCT02068222|2124728|P1|STARTED|Overall Study||10
878188|NCT02068027|2124742|P2|NOT COMPLETED|Overall Study||16
878189|NCT02068027|2124743|P1|NOT COMPLETED|Overall Study||13
878190|NCT02068027|2124742|P2|COMPLETED|Overall Study||114
878191|NCT02068027|2124743|P1|COMPLETED|Overall Study||117
878192|NCT02068027|2124742|P2|STARTED|Overall Study||130
878193|NCT02068027|2124743|P1|STARTED|Overall Study||130
878194|NCT02067728|2124753|P2|NOT COMPLETED|6 Month Measurements||97
878195|NCT02067728|2124754|P1|NOT COMPLETED|6 Month Measurements||114
878196|NCT02067728|2124753|P2|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|113
878197|NCT02067728|2124754|P1|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|106
878198|NCT02067728|2124753|P2|STARTED|6 Month Measurements||210
878199|NCT02067728|2124754|P1|STARTED|6 Month Measurements||220
878200|NCT02067728|2124753|P2|NOT COMPLETED|6 Month Follow up Survey||60
878201|NCT02067728|2124754|P1|NOT COMPLETED|6 Month Follow up Survey||48
878202|NCT02067728|2124753|P2|COMPLETED|6 Month Follow up Survey|150 parent/guardians completed surveys at this time point, along with 69 teens.|150
878203|NCT02067728|2124754|P1|COMPLETED|6 Month Follow up Survey|172 parent/guardians completed surveys at this time point, along with 71 teens.|172
878204|NCT02067728|2124753|P2|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|210
878205|NCT02067728|2124754|P1|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|220
878206|NCT02067728|2124753|P2|NOT COMPLETED|Baseline - 1 Month Follow up Survey||28
878207|NCT02067728|2124754|P1|NOT COMPLETED|Baseline - 1 Month Follow up Survey||7
878208|NCT02067728|2124753|P2|COMPLETED|Baseline - 1 Month Follow up Survey|182 parent/guardians completed the surveys, along with 75 teens.|182
878209|NCT02067728|2124754|P1|COMPLETED|Baseline - 1 Month Follow up Survey|213 parents/guardians completed the surveys, along with 82 teens.|213
878210|NCT02067728|2124753|P2|STARTED|Baseline - 1 Month Follow up Survey||210
878211|NCT02067728|2124754|P1|STARTED|Baseline - 1 Month Follow up Survey||220
878212|NCT02067585|2124785|P3|NOT COMPLETED|Overall Study||0
878213|NCT02067585|2124786|P2|NOT COMPLETED|Overall Study||0
878214|NCT02067585|2124787|P1|NOT COMPLETED|Overall Study||0
878215|NCT02067585|2124785|P3|COMPLETED|Overall Study||16
878216|NCT02067585|2124786|P2|COMPLETED|Overall Study||16
878217|NCT02067585|2124787|P1|COMPLETED|Overall Study||16
878218|NCT02067585|2124785|P3|STARTED|Overall Study||16
878219|NCT02067585|2124786|P2|STARTED|Overall Study||16
878220|NCT02067585|2124787|P1|STARTED|Overall Study||16
878221|NCT02067533|2124824|P2|NOT COMPLETED|Overall Study||2
878222|NCT02067533|2124825|P1|NOT COMPLETED|Overall Study||4
878223|NCT02067533|2124824|P2|COMPLETED|Overall Study||44
878224|NCT02067533|2124825|P1|COMPLETED|Overall Study||41
878225|NCT02067533|2124824|P2|STARTED|Overall Study||46
878226|NCT02067533|2124825|P1|STARTED|Overall Study||45
878227|NCT02067273|2124833|P2|NOT COMPLETED|Overall Study||3
878228|NCT02067273|2124834|P1|NOT COMPLETED|Overall Study||0
878229|NCT02067273|2124833|P2|COMPLETED|Overall Study||12
878230|NCT02067273|2124834|P1|COMPLETED|Overall Study||5
878231|NCT02067273|2124833|P2|STARTED|Overall Study||15
878232|NCT02067273|2124834|P1|STARTED|Overall Study||5
878233|NCT02066922|2124840|P1|NOT COMPLETED|Overall Study||1
878234|NCT02066922|2124840|P1|COMPLETED|Overall Study||14
878235|NCT02066922|2124840|P1|STARTED|Overall Study||15
878236|NCT02066896|2124850|P2|NOT COMPLETED|Overall Study||0
878237|NCT02066896|2124851|P1|NOT COMPLETED|Overall Study||0
878238|NCT02066896|2124850|P2|COMPLETED|Overall Study||33
878239|NCT02066896|2124851|P1|COMPLETED|Overall Study||33
878240|NCT02066896|2124850|P2|STARTED|Overall Study||33
878241|NCT02066896|2124851|P1|STARTED|Overall Study||33
878242|NCT02066857|2124863|P2|NOT COMPLETED|Overall Study||1
878243|NCT02066857|2124864|P1|NOT COMPLETED|Overall Study||1
878244|NCT02066857|2124863|P2|COMPLETED|Overall Study||3
878245|NCT02066857|2124864|P1|COMPLETED|Overall Study||0
878246|NCT02066857|2124863|P2|STARTED|Overall Study||4
878247|NCT02066857|2124864|P1|STARTED|Overall Study||1
878248|NCT02066740|2124878|P1|NOT COMPLETED|Overall Study||2
878249|NCT02066740|2124878|P1|COMPLETED|Overall Study||32
878250|NCT02066740|2124878|P1|STARTED|Overall Study||34
878251|NCT02066727|2124885|P2|NOT COMPLETED|Overall Study||0
878252|NCT02066727|2124886|P1|NOT COMPLETED|Overall Study||0
878253|NCT02066727|2124885|P2|COMPLETED|Overall Study||30
878254|NCT02066727|2124886|P1|COMPLETED|Overall Study||30
878255|NCT02066727|2124885|P2|STARTED|Overall Study||30
878256|NCT02066727|2124886|P1|STARTED|Overall Study||30
878257|NCT02066402|2124894|P2|NOT COMPLETED|Overall Study||23
878258|NCT02066402|2124895|P1|NOT COMPLETED|Overall Study||26
878259|NCT02066402|2124894|P2|COMPLETED|Overall Study||275
878260|NCT02066402|2124895|P1|COMPLETED|Overall Study||274
878261|NCT02066402|2124894|P2|Completed Study Treatment Period|Overall Study||256
878262|NCT02066402|2124895|P1|Completed Study Treatment Period|Overall Study||261
878263|NCT02066402|2124894|P2|Participants Received Treatment|Overall Study||297
878264|NCT02066402|2124895|P1|Participants Received Treatment|Overall Study||292
878265|NCT02066402|2124894|P2|STARTED|Overall Study||298
878266|NCT02066402|2124895|P1|STARTED|Overall Study||300
878267|NCT02066233|2124923|P2|NOT COMPLETED|Standard Endoscopy (Day 2)||0
878268|NCT02066233|2124924|P1|NOT COMPLETED|Standard Endoscopy (Day 2)||0
878269|NCT02066233|2124923|P2|COMPLETED|Standard Endoscopy (Day 2)||44
878270|NCT02066233|2124924|P1|COMPLETED|Standard Endoscopy (Day 2)||44
878271|NCT02066233|2124923|P2|STARTED|Standard Endoscopy (Day 2)||44
878272|NCT02066233|2124924|P1|STARTED|Standard Endoscopy (Day 2)||44
878273|NCT02066233|2124923|P2|NOT COMPLETED|EG Scan II (Day 1)||6
878274|NCT02066233|2124924|P1|NOT COMPLETED|EG Scan II (Day 1)||6
878275|NCT02066233|2124923|P2|COMPLETED|EG Scan II (Day 1)||44
878276|NCT02066233|2124924|P1|COMPLETED|EG Scan II (Day 1)||44
878277|NCT02066233|2124923|P2|STARTED|EG Scan II (Day 1)||50
878278|NCT02066233|2124924|P1|STARTED|EG Scan II (Day 1)||50
878279|NCT02066051|2124932|P1|NOT COMPLETED|Overall Study||1
878280|NCT02066051|2124932|P1|COMPLETED|Overall Study||7
878281|NCT02066051|2124932|P1|STARTED|Overall Study||8
878282|NCT02065453|2124939|P2|NOT COMPLETED|Overall Study||4
878283|NCT02065453|2124940|P1|NOT COMPLETED|Overall Study||3
878284|NCT02065453|2124939|P2|COMPLETED|Overall Study||21
878285|NCT02065453|2124940|P1|COMPLETED|Overall Study||24
878286|NCT02065453|2124939|P2|STARTED|Overall Study||25
878287|NCT02065453|2124940|P1|STARTED|Overall Study||27
878288|NCT02064985|2124948|P3|NOT COMPLETED|Overall Study||0
878289|NCT02064985|2124949|P2|NOT COMPLETED|Overall Study||0
878290|NCT02064985|2124950|P1|NOT COMPLETED|Overall Study||0
878291|NCT02064985|2124948|P3|COMPLETED|Overall Study||12
878292|NCT02064985|2124949|P2|COMPLETED|Overall Study||12
878293|NCT02064985|2124950|P1|COMPLETED|Overall Study||12
878294|NCT02064985|2124948|P3|STARTED|Overall Study||12
878295|NCT02064985|2124949|P2|STARTED|Overall Study||12
878296|NCT02064985|2124950|P1|STARTED|Overall Study||12
878297|NCT02064920|2125113|P2|NOT COMPLETED|Overall Study||9
878298|NCT02064920|2125114|P1|NOT COMPLETED|Overall Study||1
878299|NCT02064920|2125113|P2|COMPLETED|Overall Study||21
878300|NCT02064920|2125114|P1|COMPLETED|Overall Study||5
878301|NCT02064920|2125113|P2|Treated|Overall Study|Two participants discontinued from study prior to treatment|28
878302|NCT02064920|2125114|P1|Treated|Overall Study||6
878303|NCT02064920|2125113|P2|STARTED|Overall Study||30
878304|NCT02064920|2125114|P1|STARTED|Overall Study||6
878305|NCT02064907|2125124|P2|NOT COMPLETED|Period 2||0
878306|NCT02064907|2125125|P1|NOT COMPLETED|Period 2||0
878307|NCT02064907|2125124|P2|COMPLETED|Period 2||26
878308|NCT02064907|2125125|P1|COMPLETED|Period 2||26
878309|NCT02064907|2125124|P2|STARTED|Period 2||26
878310|NCT02064907|2125125|P1|STARTED|Period 2||26
878311|NCT02064907|2125124|P2|NOT COMPLETED|Period 1||0
878312|NCT02064907|2125125|P1|NOT COMPLETED|Period 1||0
878313|NCT02064907|2125124|P2|COMPLETED|Period 1||26
878314|NCT02064907|2125125|P1|COMPLETED|Period 1||26
878315|NCT02064907|2125124|P2|STARTED|Period 1||26
878316|NCT02064907|2125125|P1|STARTED|Period 1||26
878317|NCT02064894|2125144|P3|NOT COMPLETED|Overall Study||115
878318|NCT02064894|2125145|P2|NOT COMPLETED|Overall Study||102
878319|NCT02064894|2125146|P1|NOT COMPLETED|Overall Study||43
878320|NCT02064894|2125144|P3|COMPLETED|Overall Study||86
878321|NCT02064894|2125145|P2|COMPLETED|Overall Study||99
878322|NCT02064894|2125146|P1|COMPLETED|Overall Study||56
878323|NCT02064894|2125144|P3|Avalaible at T-90|Overall Study||129
878324|NCT02064894|2125145|P2|Avalaible at T-90|Overall Study||134
878325|NCT02064894|2125146|P1|Avalaible at T-90|Overall Study||74
878326|NCT02064894|2125144|P3|Available at T-60|Overall Study||177
878327|NCT02064894|2125145|P2|Available at T-60|Overall Study||188
878328|NCT02064894|2125146|P1|Available at T-60|Overall Study||91
878329|NCT02064894|2125144|P3|STARTED|Overall Study|"Received allocated intervention (n=199)
Did not receive allocated intervention (n=2)"|201
878330|NCT02064894|2125145|P2|STARTED|Overall Study|"Received allocated intervention (n=198)
Did not receive allocated intervention (n=3)"|201
878331|NCT02064894|2125146|P1|STARTED|Overall Study|"Received allocated intervention (n=98)
Did not receive intervention (n=1)"|99
878332|NCT02064231|2125157|P4|NOT COMPLETED|Third Test Period (Own Product)||0
878333|NCT02064231|2125158|P3|NOT COMPLETED|Third Test Period (Own Product)||0
878334|NCT02064231|2125159|P2|NOT COMPLETED|Third Test Period (Own Product)||0
878335|NCT02064231|2125160|P1|NOT COMPLETED|Third Test Period (Own Product)||0
878336|NCT02064231|2125157|P4|COMPLETED|Third Test Period (Own Product)||1
878337|NCT02064231|2125158|P3|COMPLETED|Third Test Period (Own Product)||0
878338|NCT02064231|2125159|P2|COMPLETED|Third Test Period (Own Product)||8
878339|NCT02064231|2125160|P1|COMPLETED|Third Test Period (Own Product)||8
878340|NCT02064231|2125157|P4|STARTED|Third Test Period (Own Product)||1
878341|NCT02064231|2125158|P3|STARTED|Third Test Period (Own Product)||0
878342|NCT02064231|2125159|P2|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test C proceeded to test Own product afterwards|8
878343|NCT02064231|2125160|P1|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test A proceeded to test Own product afterwards.|8
878344|NCT02064231|2125157|P4|NOT COMPLETED|Second Test Period (Test B or Test D)||0
878345|NCT02064231|2125158|P3|NOT COMPLETED|Second Test Period (Test B or Test D)||0
878346|NCT02064231|2125159|P2|NOT COMPLETED|Second Test Period (Test B or Test D)||1
878347|NCT02064231|2125160|P1|NOT COMPLETED|Second Test Period (Test B or Test D)||1
878348|NCT02064231|2125157|P4|COMPLETED|Second Test Period (Test B or Test D)||1
878349|NCT02064231|2125158|P3|COMPLETED|Second Test Period (Test B or Test D)||0
878350|NCT02064231|2125159|P2|COMPLETED|Second Test Period (Test B or Test D)||7
878351|NCT02064231|2125160|P1|COMPLETED|Second Test Period (Test B or Test D)||6
878352|NCT02064231|2125157|P4|STARTED|Second Test Period (Test B or Test D)||1
878353|NCT02064231|2125158|P3|STARTED|Second Test Period (Test B or Test D)||0
878354|NCT02064231|2125159|P2|STARTED|Second Test Period (Test B or Test D)||8
878355|NCT02064231|2125160|P1|STARTED|Second Test Period (Test B or Test D)||7
878356|NCT02064231|2125157|P4|NOT COMPLETED|First Test Period (Test A or Test C)||0
878357|NCT02064231|2125158|P3|NOT COMPLETED|First Test Period (Test A or Test C)||1
878358|NCT02064231|2125159|P2|NOT COMPLETED|First Test Period (Test A or Test C)||4
878359|NCT02064231|2125160|P1|NOT COMPLETED|First Test Period (Test A or Test C)||7
878360|NCT02064231|2125157|P4|COMPLETED|First Test Period (Test A or Test C)||1
878361|NCT02064231|2125158|P3|COMPLETED|First Test Period (Test A or Test C)||0
878362|NCT02064231|2125159|P2|COMPLETED|First Test Period (Test A or Test C)||8
878363|NCT02064231|2125160|P1|COMPLETED|First Test Period (Test A or Test C)||7
878364|NCT02064231|2125157|P4|STARTED|First Test Period (Test A or Test C)||1
878365|NCT02064231|2125158|P3|STARTED|First Test Period (Test A or Test C)||1
878366|NCT02064231|2125159|P2|STARTED|First Test Period (Test A or Test C)||12
878367|NCT02064231|2125160|P1|STARTED|First Test Period (Test A or Test C)||14
878368|NCT02064205|2125172|P1|NOT COMPLETED|Overall Study||1
878369|NCT02064205|2125172|P1|COMPLETED|Overall Study||31
878370|NCT02064205|2125172|P1|Condition D|Overall Study||32
878371|NCT02064205|2125172|P1|Condition C|Overall Study||31
878372|NCT02064205|2125172|P1|Condition B|Overall Study||32
878373|NCT02064205|2125172|P1|Condition A|Overall Study||32
878374|NCT02064205|2125172|P1|STARTED|Overall Study||32
878375|NCT02063880|2125190|P2|NOT COMPLETED|Overall Study||27
878376|NCT02063880|2125191|P1|NOT COMPLETED|Overall Study||28
878377|NCT02063880|2125190|P2|COMPLETED|Overall Study||66
878378|NCT02063880|2125191|P1|COMPLETED|Overall Study||62
878379|NCT02063880|2125190|P2|STARTED|Overall Study||93
878380|NCT02063880|2125191|P1|STARTED|Overall Study||90
878381|NCT02063854|2125208|P7|NOT COMPLETED|Overall Study||6
878382|NCT02063854|2125209|P6|NOT COMPLETED|Overall Study||31
878383|NCT02063854|2125210|P5|NOT COMPLETED|Overall Study||11
878384|NCT02063854|2125211|P4|NOT COMPLETED|Overall Study||10
878385|NCT02063854|2125212|P3|NOT COMPLETED|Overall Study||30
878386|NCT02063854|2125213|P2|NOT COMPLETED|Overall Study||12
878387|NCT02063854|2125214|P1|NOT COMPLETED|Overall Study||21
878388|NCT02063854|2125208|P7|COMPLETED|Overall Study||60
878389|NCT02063854|2125209|P6|COMPLETED|Overall Study||170
878390|NCT02063854|2125210|P5|COMPLETED|Overall Study||54
878391|NCT02063854|2125211|P4|COMPLETED|Overall Study||58
878392|NCT02063854|2125212|P3|COMPLETED|Overall Study||176
878393|NCT02063854|2125213|P2|COMPLETED|Overall Study||54
878394|NCT02063854|2125214|P1|COMPLETED|Overall Study||178
878395|NCT02063854|2125208|P7|Full Analysis Set: Received Study Drug|Overall Study||66
878396|NCT02063854|2125209|P6|Full Analysis Set: Received Study Drug|Overall Study||200
878397|NCT02063854|2125210|P5|Full Analysis Set: Received Study Drug|Overall Study||65
878398|NCT02063854|2125211|P4|Full Analysis Set: Received Study Drug|Overall Study||68
878399|NCT02063854|2125212|P3|Full Analysis Set: Received Study Drug|Overall Study||206
878400|NCT02063854|2125213|P2|Full Analysis Set: Received Study Drug|Overall Study||66
878401|NCT02063854|2125214|P1|Full Analysis Set: Received Study Drug|Overall Study||199
878402|NCT02063854|2125208|P7|STARTED|Overall Study||66
878403|NCT02063854|2125209|P6|STARTED|Overall Study||201
878404|NCT02063854|2125210|P5|STARTED|Overall Study||65
878405|NCT02063854|2125211|P4|STARTED|Overall Study||68
878406|NCT02063854|2125212|P3|STARTED|Overall Study||206
878407|NCT02063854|2125213|P2|STARTED|Overall Study||66
878408|NCT02063854|2125214|P1|STARTED|Overall Study||199
878409|NCT02063737|2125298|P2|NOT COMPLETED|Overall Study||4
878410|NCT02063737|2125299|P1|NOT COMPLETED|Overall Study||11
878411|NCT02063737|2125298|P2|COMPLETED|Overall Study||44
878412|NCT02063737|2125299|P1|COMPLETED|Overall Study||41
878413|NCT02063737|2125298|P2|STARTED|Overall Study||48
878414|NCT02063737|2125299|P1|STARTED|Overall Study||52
878415|NCT02063659|2125334|P3|NOT COMPLETED|Overall Study||3
878416|NCT02063659|2125335|P2|NOT COMPLETED|Overall Study||3
878417|NCT02063659|2125336|P1|NOT COMPLETED|Overall Study||2
878418|NCT02063659|2125334|P3|COMPLETED|Overall Study||22
878419|NCT02063659|2125335|P2|COMPLETED|Overall Study||22
878420|NCT02063659|2125336|P1|COMPLETED|Overall Study||24
878421|NCT02063659|2125334|P3|STARTED|Overall Study||25
878422|NCT02063659|2125335|P2|STARTED|Overall Study||25
878423|NCT02063659|2125336|P1|STARTED|Overall Study||26
878424|NCT02063516|2125364|P2|NOT COMPLETED|Overall Study||0
878425|NCT02063516|2125365|P1|NOT COMPLETED|Overall Study||0
878426|NCT02063516|2125364|P2|COMPLETED|Overall Study||40
878427|NCT02063516|2125365|P1|COMPLETED|Overall Study||40
878428|NCT02063516|2125364|P2|STARTED|Overall Study||40
878429|NCT02063516|2125365|P1|STARTED|Overall Study||40
878430|NCT02063230|2125379|P4|NOT COMPLETED|Overall Study||0
878431|NCT02063230|2125380|P3|NOT COMPLETED|Overall Study||0
878432|NCT02063230|2125381|P2|NOT COMPLETED|Overall Study||0
878433|NCT02063230|2125382|P1|NOT COMPLETED|Overall Study||0
878434|NCT02063230|2125379|P4|COMPLETED|Overall Study||8
878435|NCT02063230|2125380|P3|COMPLETED|Overall Study||8
878436|NCT02063230|2125381|P2|COMPLETED|Overall Study||8
878437|NCT02063230|2125382|P1|COMPLETED|Overall Study||8
878438|NCT02063230|2125379|P4|Received Treatment|Overall Study||8
878439|NCT02063230|2125380|P3|Received Treatment|Overall Study||8
878440|NCT02063230|2125381|P2|Received Treatment|Overall Study||8
878441|NCT02063230|2125382|P1|Received Treatment|Overall Study||8
878442|NCT02063230|2125379|P4|STARTED|Overall Study||8
878443|NCT02063230|2125380|P3|STARTED|Overall Study||8
878444|NCT02063230|2125381|P2|STARTED|Overall Study||8
878445|NCT02063230|2125382|P1|STARTED|Overall Study||8
878446|NCT02063035|2125414|P2|NOT COMPLETED|Overall Study||0
878447|NCT02063035|2125415|P1|NOT COMPLETED|Overall Study||0
878448|NCT02063035|2125414|P2|COMPLETED|Overall Study||17
878449|NCT02063035|2125415|P1|COMPLETED|Overall Study||12
878450|NCT02063035|2125414|P2|STARTED|Overall Study||17
878451|NCT02063035|2125415|P1|STARTED|Overall Study||12
878452|NCT02062905|2125429|P2|NOT COMPLETED|Overall Study||2
878453|NCT02062905|2125430|P1|NOT COMPLETED|Overall Study||7
878454|NCT02062905|2125429|P2|COMPLETED|Overall Study||31
878455|NCT02062905|2125430|P1|COMPLETED|Overall Study||28
878456|NCT02062905|2125429|P2|STARTED|Overall Study||33
878457|NCT02062905|2125430|P1|STARTED|Overall Study||35
878458|NCT02062879|2125440|P2|NOT COMPLETED|Overall Study||1
878459|NCT02062879|2125441|P1|NOT COMPLETED|Overall Study||4
878460|NCT02062879|2125440|P2|COMPLETED|Overall Study||9
878461|NCT02062879|2125441|P1|COMPLETED|Overall Study||6
878462|NCT02062879|2125440|P2|STARTED|Overall Study||10
878463|NCT02062879|2125441|P1|STARTED|Overall Study||10
878464|NCT02062801|2125453|P2|NOT COMPLETED|Overall Study||4
878465|NCT02062801|2125454|P1|NOT COMPLETED|Overall Study||2
878466|NCT02062801|2125453|P2|COMPLETED|Overall Study||297
878467|NCT02062801|2125454|P1|COMPLETED|Overall Study||299
878468|NCT02062801|2125453|P2|STARTED|Overall Study||301
878469|NCT02062801|2125454|P1|STARTED|Overall Study||301
878470|NCT02062710|2125464|P6|NOT COMPLETED|Overall Study||0
878471|NCT02062710|2125465|P5|NOT COMPLETED|Overall Study||0
878472|NCT02062710|2125466|P4|NOT COMPLETED|Overall Study||0
878473|NCT02062710|2125467|P3|NOT COMPLETED|Overall Study||0
878474|NCT02062710|2125468|P2|NOT COMPLETED|Overall Study||0
878475|NCT02062710|2125469|P1|NOT COMPLETED|Overall Study||0
878476|NCT02062710|2125464|P6|COMPLETED|Overall Study||4
878477|NCT02062710|2125465|P5|COMPLETED|Overall Study||3
878478|NCT02062710|2125466|P4|COMPLETED|Overall Study||3
878479|NCT02062710|2125467|P3|COMPLETED|Overall Study||5
878480|NCT02062710|2125468|P2|COMPLETED|Overall Study||4
878481|NCT02062710|2125469|P1|COMPLETED|Overall Study||3
878482|NCT02062710|2125464|P6|STARTED|Overall Study|4 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
878483|NCT02062710|2125465|P5|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this aprticular sequence|3
878484|NCT02062710|2125466|P4|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
878485|NCT02062710|2125467|P3|STARTED|Overall Study|5 of total of 22 subjects randomized to receive the 3 study drugs in this particular sequence|5
878486|NCT02062710|2125468|P2|STARTED|Overall Study|4 of the total 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
878577|NCT02061592|2125689|P1|STARTED|Period 1||66
878487|NCT02062710|2125469|P1|STARTED|Overall Study|3 of total 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
878488|NCT02062658|2125477|P1|NOT COMPLETED|Overall Study||2
878489|NCT02062658|2125477|P1|COMPLETED|Overall Study||8
878490|NCT02062658|2125477|P1|STARTED|Overall Study||10
878491|NCT02062645|2125481|P1|NOT COMPLETED|Overall Study||15
878492|NCT02062645|2125481|P1|COMPLETED|Overall Study||100
878493|NCT02062645|2125481|P1|STARTED|Overall Study||115
878494|NCT02062580|2125491|P2|NOT COMPLETED|Overall Study||13
878495|NCT02062580|2125492|P1|NOT COMPLETED|Overall Study||12
878496|NCT02062580|2125491|P2|COMPLETED|Overall Study||65
878497|NCT02062580|2125492|P1|COMPLETED|Overall Study||59
878498|NCT02062580|2125491|P2|STARTED|Overall Study||78
878499|NCT02062580|2125492|P1|STARTED|Overall Study||71
878500|NCT02062502|2125502|P2|NOT COMPLETED|Overall Study||35
878501|NCT02062502|2125503|P1|NOT COMPLETED|Overall Study||43
878502|NCT02062502|2125502|P2|COMPLETED|Overall Study||270
878503|NCT02062502|2125503|P1|COMPLETED|Overall Study||263
878504|NCT02062502|2125502|P2|Vaccinated Dose 1|Overall Study||305
878505|NCT02062502|2125503|P1|Vaccinated Dose 1|Overall Study||306
878506|NCT02062502|2125502|P2|STARTED|Overall Study||305
878507|NCT02062502|2125503|P1|STARTED|Overall Study||306
878508|NCT02062450|2125523|P1|NOT COMPLETED|Overall Study||124
878509|NCT02062450|2125523|P1|COMPLETED|Overall Study||255
878510|NCT02062450|2125523|P1|Per Protocol Cohort|Overall Study|255 patients attended their 2-year follow-up visit.|255
878511|NCT02062450|2125523|P1|STARTED|Overall Study|379 patients were successfully reached by phone and convoked for the 2-year follow-up visit.|379
878512|NCT02062437|2125537|P1|NOT COMPLETED|Overall Study||52
878513|NCT02062437|2125537|P1|COMPLETED|Overall Study|80 patients were effectively enrolled, when coming back for their 2-year follow-up visit.|80
878514|NCT02062437|2125537|P1|STARTED|Overall Study|132 patients who undergone THR (July-Oct 2010), complying with in/exclusion criteria were identified|132
878515|NCT02062385|2125550|P4|NOT COMPLETED|Overall Study||9
878516|NCT02062385|2125551|P3|NOT COMPLETED|Overall Study||12
878517|NCT02062385|2125552|P2|NOT COMPLETED|Overall Study||65
878518|NCT02062385|2125553|P1|NOT COMPLETED|Overall Study||78
878519|NCT02062385|2125550|P4|COMPLETED|Overall Study||391
878520|NCT02062385|2125551|P3|COMPLETED|Overall Study||388
878521|NCT02062385|2125552|P2|COMPLETED|Overall Study||1555
878522|NCT02062385|2125553|P1|COMPLETED|Overall Study||1542
878523|NCT02062385|2125550|P4|Received Vaccination 3|Overall Study||392
878524|NCT02062385|2125551|P3|Received Vaccination 3|Overall Study||389
878525|NCT02062385|2125552|P2|Received Vaccination 3|Overall Study||1554
878526|NCT02062385|2125553|P1|Received Vaccination 3|Overall Study||1543
878527|NCT02062385|2125550|P4|Received Vaccination 2|Overall Study||393
878528|NCT02062385|2125551|P3|Received Vaccination 2|Overall Study||392
878529|NCT02062385|2125552|P2|Received Vaccination 2|Overall Study||1566
878530|NCT02062385|2125553|P1|Received Vaccination 2|Overall Study||1554
878531|NCT02062385|2125550|P4|Received Vaccination 1|Overall Study||400
878532|NCT02062385|2125551|P3|Received Vaccination 1|Overall Study||400
878533|NCT02062385|2125552|P2|Received Vaccination 1|Overall Study||1619
878534|NCT02062385|2125553|P1|Received Vaccination 1|Overall Study||1618
878535|NCT02062385|2125550|P4|STARTED|Overall Study||400
878536|NCT02062385|2125551|P3|STARTED|Overall Study||400
878537|NCT02062385|2125552|P2|STARTED|Overall Study||1620
878538|NCT02062385|2125553|P1|STARTED|Overall Study||1620
878539|NCT02062359|2125573|P1|NOT COMPLETED|Overall Study||0
878540|NCT02062359|2125573|P1|COMPLETED|Overall Study||2
878541|NCT02062359|2125573|P1|STARTED|Overall Study||2
878542|NCT02062294|2125579|P1|NOT COMPLETED|Overall Study||0
878543|NCT02062294|2125579|P1|COMPLETED|Overall Study||14
878544|NCT02062294|2125579|P1|STARTED|Overall Study||14
878545|NCT02062177|2125586|P2|NOT COMPLETED|Overall Study||0
878546|NCT02062177|2125587|P1|NOT COMPLETED|Overall Study||0
878547|NCT02062177|2125586|P2|COMPLETED|Overall Study||70
878548|NCT02062177|2125587|P1|COMPLETED|Overall Study||70
878549|NCT02062177|2125586|P2|STARTED|Overall Study||70
878550|NCT02062177|2125587|P1|STARTED|Overall Study||70
878551|NCT02061748|2125599|P2|NOT COMPLETED|Overall Study||0
878552|NCT02061748|2125600|P1|NOT COMPLETED|Overall Study||0
878553|NCT02061748|2125599|P2|COMPLETED|Overall Study||30853
878554|NCT02061748|2125600|P1|COMPLETED|Overall Study||7646
878555|NCT02061748|2125599|P2|STARTED|Overall Study||30853
878556|NCT02061748|2125600|P1|STARTED|Overall Study||7646
878557|NCT02061696|2125674|P2|NOT COMPLETED|Overall Study||0
878558|NCT02061696|2125675|P1|NOT COMPLETED|Overall Study||0
878559|NCT02061696|2125674|P2|COMPLETED|Overall Study||22
878560|NCT02061696|2125675|P1|COMPLETED|Overall Study||17
878561|NCT02061696|2125674|P2|STARTED|Overall Study||22
878562|NCT02061696|2125675|P1|STARTED|Overall Study||17
878563|NCT02061683|2125681|P1|NOT COMPLETED|Overall Study||60
878564|NCT02061683|2125681|P1|COMPLETED|Overall Study||203
878565|NCT02061683|2125681|P1|STARTED|Overall Study||263
878566|NCT02061592|2125688|P2|NOT COMPLETED|Period 2||1
878567|NCT02061592|2125689|P1|NOT COMPLETED|Period 2||0
878568|NCT02061592|2125688|P2|COMPLETED|Period 2||61
878569|NCT02061592|2125689|P1|COMPLETED|Period 2||64
878570|NCT02061592|2125688|P2|STARTED|Period 2||62
878571|NCT02061592|2125689|P1|STARTED|Period 2||64
878572|NCT02061592|2125688|P2|NOT COMPLETED|Period 1||0
878573|NCT02061592|2125689|P1|NOT COMPLETED|Period 1||2
878574|NCT02061592|2125688|P2|COMPLETED|Period 1||62
878575|NCT02061592|2125689|P1|COMPLETED|Period 1||64
878576|NCT02061592|2125688|P2|STARTED|Period 1||62
878578|NCT02061540|2125701|P1|NOT COMPLETED|Overall Study||4
878579|NCT02061540|2125701|P1|COMPLETED|Overall Study||23
878580|NCT02061540|2125701|P1|Down-Titrated on LUM001 During the Study|Overall Study||5
878581|NCT02061540|2125701|P1|STARTED|Overall Study||27
878582|NCT02061358|2125723|P9|NOT COMPLETED|Overall Study||0
878583|NCT02061358|2125724|P8|NOT COMPLETED|Overall Study||0
878584|NCT02061358|2125725|P7|NOT COMPLETED|Overall Study||0
878585|NCT02061358|2125726|P6|NOT COMPLETED|Overall Study||0
878586|NCT02061358|2125727|P5|NOT COMPLETED|Overall Study||0
878587|NCT02061358|2125728|P4|NOT COMPLETED|Overall Study||0
878588|NCT02061358|2125729|P3|NOT COMPLETED|Overall Study||0
878589|NCT02061358|2125730|P2|NOT COMPLETED|Overall Study||0
878590|NCT02061358|2125731|P1|NOT COMPLETED|Overall Study||0
878591|NCT02061358|2125723|P9|COMPLETED|Overall Study||16
878592|NCT02061358|2125724|P8|COMPLETED|Overall Study||6
878593|NCT02061358|2125725|P7|COMPLETED|Overall Study||6
878594|NCT02061358|2125726|P6|COMPLETED|Overall Study||6
878595|NCT02061358|2125727|P5|COMPLETED|Overall Study||6
878596|NCT02061358|2125728|P4|COMPLETED|Overall Study||6
878597|NCT02061358|2125729|P3|COMPLETED|Overall Study||6
878598|NCT02061358|2125730|P2|COMPLETED|Overall Study||6
878599|NCT02061358|2125731|P1|COMPLETED|Overall Study||6
878600|NCT02061358|2125723|P9|STARTED|Overall Study||16
878601|NCT02061358|2125724|P8|STARTED|Overall Study||6
878602|NCT02061358|2125725|P7|STARTED|Overall Study||6
878603|NCT02061358|2125726|P6|STARTED|Overall Study||6
878604|NCT02061358|2125727|P5|STARTED|Overall Study||6
878605|NCT02061358|2125728|P4|STARTED|Overall Study||6
878606|NCT02061358|2125729|P3|STARTED|Overall Study||6
878607|NCT02061358|2125730|P2|STARTED|Overall Study||6
878608|NCT02061358|2125731|P1|STARTED|Overall Study||6
878609|NCT02060838|2125869|P2|NOT COMPLETED|Overall Study||0
878610|NCT02060838|2125870|P1|NOT COMPLETED|Overall Study||0
878611|NCT02060838|2125869|P2|COMPLETED|Overall Study||22
878612|NCT02060838|2125870|P1|COMPLETED|Overall Study||28
878613|NCT02060838|2125869|P2|STARTED|Overall Study||22
878614|NCT02060838|2125870|P1|STARTED|Overall Study||28
878615|NCT02060539|2125878|P1|NOT COMPLETED|Overall Study||0
878616|NCT02060539|2125878|P1|COMPLETED|Overall Study||19
878617|NCT02060539|2125878|P1|STARTED|Overall Study||19
878618|NCT02060526|2125926|P3|NOT COMPLETED|Overall Study||0
878619|NCT02060526|2125927|P2|NOT COMPLETED|Overall Study||0
878620|NCT02060526|2125928|P1|NOT COMPLETED|Overall Study||0
878621|NCT02060526|2125926|P3|COMPLETED|Overall Study||7
878622|NCT02060526|2125927|P2|COMPLETED|Overall Study||7
878623|NCT02060526|2125928|P1|COMPLETED|Overall Study||7
878624|NCT02060526|2125926|P3|STARTED|Overall Study||7
878625|NCT02060526|2125927|P2|STARTED|Overall Study||7
878626|NCT02060526|2125928|P1|STARTED|Overall Study||7
878627|NCT02059993|2125966|P2|NOT COMPLETED|Overall Study||4
878628|NCT02059993|2125967|P1|NOT COMPLETED|Overall Study||2
878629|NCT02059993|2125966|P2|COMPLETED|Overall Study||37
878630|NCT02059993|2125967|P1|COMPLETED|Overall Study||40
878631|NCT02059993|2125966|P2|STARTED|Overall Study||41
878632|NCT02059993|2125967|P1|STARTED|Overall Study||42
878633|NCT02059928|2125973|P1|NOT COMPLETED|Overall Study||0
878634|NCT02059928|2125973|P1|COMPLETED|Overall Study||20
878635|NCT02059928|2125973|P1|STARTED|Overall Study||20
878636|NCT02059902|2125979|P2|NOT COMPLETED|Overall Study||4
878637|NCT02059902|2125980|P1|NOT COMPLETED|Overall Study||4
878638|NCT02059902|2125979|P2|COMPLETED|Overall Study||14
878639|NCT02059902|2125980|P1|COMPLETED|Overall Study||14
878640|NCT02059902|2125979|P2|STARTED|Overall Study||18
878641|NCT02059902|2125980|P1|STARTED|Overall Study||18
878642|NCT02059642|2125988|P2|NOT COMPLETED|Overall Study||24
878643|NCT02059642|2125989|P1|NOT COMPLETED|Overall Study||27
878644|NCT02059642|2125988|P2|COMPLETED|Overall Study||128
878645|NCT02059642|2125989|P1|COMPLETED|Overall Study||121
878646|NCT02059642|2125988|P2|STARTED|Overall Study||152
878647|NCT02059642|2125989|P1|STARTED|Overall Study||148
878648|NCT02059291|2126003|P6|NOT COMPLETED|Overall Study||2
878649|NCT02059291|2126004|P5|NOT COMPLETED|Overall Study||0
878650|NCT02059291|2126005|P4|NOT COMPLETED|Overall Study||2
878651|NCT02059291|2126006|P3|NOT COMPLETED|Overall Study||1
878652|NCT02059291|2126007|P2|NOT COMPLETED|Overall Study||1
878653|NCT02059291|2126008|P1|NOT COMPLETED|Overall Study||0
878654|NCT02059291|2126003|P6|COMPLETED|Overall Study||22
878655|NCT02059291|2126004|P5|COMPLETED|Overall Study||22
878656|NCT02059291|2126005|P4|COMPLETED|Overall Study||33
878657|NCT02059291|2126006|P3|COMPLETED|Overall Study||36
878658|NCT02059291|2126007|P2|COMPLETED|Overall Study||31
878659|NCT02059291|2126008|P1|COMPLETED|Overall Study||31
878660|NCT02059291|2126003|P6|STARTED|Overall Study||24
878661|NCT02059291|2126004|P5|STARTED|Overall Study||22
878662|NCT02059291|2126005|P4|STARTED|Overall Study||35
878663|NCT02059291|2126006|P3|STARTED|Overall Study||37
878664|NCT02059291|2126007|P2|STARTED|Overall Study||32
878665|NCT02059291|2126008|P1|STARTED|Overall Study||31
878666|NCT02059187|2126024|P2|NOT COMPLETED|Overall Study||22
878667|NCT02059187|2126025|P1|NOT COMPLETED|Overall Study||25
878668|NCT02059187|2126024|P2|COMPLETED|Overall Study||244
878669|NCT02059187|2126025|P1|COMPLETED|Overall Study||240
878670|NCT02059187|2126024|P2|STARTED|Overall Study||266
878671|NCT02059187|2126025|P1|STARTED|Overall Study||265
878672|NCT02059174|2126051|P2|NOT COMPLETED|Period 4||0
878673|NCT02059174|2126052|P1|NOT COMPLETED|Period 4||0
878674|NCT02059174|2126051|P2|COMPLETED|Period 4||35
878675|NCT02059174|2126052|P1|COMPLETED|Period 4||35
878676|NCT02059174|2126051|P2|STARTED|Period 4||35
878677|NCT02059174|2126052|P1|STARTED|Period 4||35
878678|NCT02059174|2126051|P2|NOT COMPLETED|Period 3||0
878679|NCT02059174|2126052|P1|NOT COMPLETED|Period 3||1
878680|NCT02059174|2126051|P2|COMPLETED|Period 3||35
878681|NCT02059174|2126052|P1|COMPLETED|Period 3||35
878682|NCT02059174|2126051|P2|STARTED|Period 3||35
878683|NCT02059174|2126052|P1|STARTED|Period 3||36
878684|NCT02059174|2126051|P2|NOT COMPLETED|Period 2||2
878685|NCT02059174|2126052|P1|NOT COMPLETED|Period 2||1
878686|NCT02059174|2126051|P2|COMPLETED|Period 2||35
878687|NCT02059174|2126052|P1|COMPLETED|Period 2||36
878688|NCT02059174|2126051|P2|STARTED|Period 2||37
878689|NCT02059174|2126052|P1|STARTED|Period 2||37
878690|NCT02059174|2126051|P2|NOT COMPLETED|Period 1||2
878691|NCT02059174|2126052|P1|NOT COMPLETED|Period 1||0
878692|NCT02059174|2126051|P2|COMPLETED|Period 1||37
878693|NCT02059174|2126052|P1|COMPLETED|Period 1||37
878694|NCT02059174|2126051|P2|STARTED|Period 1||39
878695|NCT02059174|2126052|P1|STARTED|Period 1||37
878696|NCT02059161|2126076|P2|NOT COMPLETED|Overall Study||41
878697|NCT02059161|2126077|P1|NOT COMPLETED|Overall Study||49
878698|NCT02059161|2126076|P2|COMPLETED|Overall Study||222
878699|NCT02059161|2126077|P1|COMPLETED|Overall Study||196
878700|NCT02059161|2126076|P2|Treated|Overall Study||258
878701|NCT02059161|2126077|P1|Treated|Overall Study||241
878702|NCT02059161|2126076|P2|STARTED|Overall Study||263
878703|NCT02059161|2126077|P1|STARTED|Overall Study||245
878704|NCT02059135|2126139|P2|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
878705|NCT02059135|2126140|P1|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
878706|NCT02059135|2126139|P2|COMPLETED|Neonatal Follow-up (Safety Population)||50
878707|NCT02059135|2126140|P1|COMPLETED|Neonatal Follow-up (Safety Population)||56
878708|NCT02059135|2126139|P2|STARTED|Neonatal Follow-up (Safety Population)||54
878709|NCT02059135|2126140|P1|STARTED|Neonatal Follow-up (Safety Population)||60
878710|NCT02059135|2126139|P2|NOT COMPLETED|Maternal Follow-up (ITT Population)||7
878711|NCT02059135|2126140|P1|NOT COMPLETED|Maternal Follow-up (ITT Population)||3
878712|NCT02059135|2126139|P2|COMPLETED|Maternal Follow-up (ITT Population)||51
878713|NCT02059135|2126140|P1|COMPLETED|Maternal Follow-up (ITT Population)||59
878714|NCT02059135|2126139|P2|STARTED|Maternal Follow-up (ITT Population)||58
878715|NCT02059135|2126140|P1|STARTED|Maternal Follow-up (ITT Population)||62
878716|NCT02059070|2126154|P2|NOT COMPLETED|Overall Study||4
878717|NCT02059070|2126155|P1|NOT COMPLETED|Overall Study||5
878718|NCT02059070|2126154|P2|COMPLETED|Overall Study||16
878719|NCT02059070|2126155|P1|COMPLETED|Overall Study||14
878720|NCT02059070|2126154|P2|STARTED|Overall Study||20
878721|NCT02059070|2126155|P1|STARTED|Overall Study||19
878722|NCT02058992|2126167|P1|NOT COMPLETED|Overall Study||116
878723|NCT02058992|2126167|P1|COMPLETED|Overall Study||3223
878724|NCT02058992|2126167|P1|STARTED|Overall Study||3339
878725|NCT02058628|2126178|P2|NOT COMPLETED|Overall Study||8
878726|NCT02058628|2126179|P1|NOT COMPLETED|Overall Study||7
878727|NCT02058628|2126178|P2|COMPLETED|Overall Study||102
878728|NCT02058628|2126179|P1|COMPLETED|Overall Study||104
878729|NCT02058628|2126178|P2|STARTED|Overall Study||110
878730|NCT02058628|2126179|P1|STARTED|Overall Study||111
878731|NCT02058563|2126211|P2|NOT COMPLETED|Overall Study||24
878732|NCT02058563|2126212|P1|NOT COMPLETED|Overall Study||28
878733|NCT02058563|2126211|P2|COMPLETED|Overall Study||433
878734|NCT02058563|2126212|P1|COMPLETED|Overall Study||426
878735|NCT02058563|2126211|P2|STARTED|Overall Study||457
878736|NCT02058563|2126212|P1|STARTED|Overall Study||454
878737|NCT02058537|2126248|P1|NOT COMPLETED|Overall Study||1
878738|NCT02058537|2126248|P1|COMPLETED|Overall Study||2
878739|NCT02058537|2126248|P1|STARTED|Overall Study||3
878740|NCT02058498|2126254|P1|NOT COMPLETED|Overall Study||4
878741|NCT02058498|2126254|P1|COMPLETED|Overall Study||8
878742|NCT02058498|2126254|P1|6 Weeks|Overall Study||8
878743|NCT02058498|2126254|P1|STARTED|Overall Study||12
878744|NCT02058290|2126262|P2|NOT COMPLETED|Overall Study||9
878745|NCT02058290|2126263|P1|NOT COMPLETED|Overall Study||11
878746|NCT02058290|2126262|P2|COMPLETED|Overall Study||36
878747|NCT02058290|2126263|P1|COMPLETED|Overall Study||66
878748|NCT02058290|2126262|P2|STARTED|Overall Study||45
878749|NCT02058290|2126263|P1|STARTED|Overall Study||77
878750|NCT02058160|2126279|P2|NOT COMPLETED|Overall Study||14
878751|NCT02058160|2126280|P1|NOT COMPLETED|Overall Study||31
878752|NCT02058160|2126279|P2|COMPLETED|Overall Study||355
878753|NCT02058160|2126280|P1|COMPLETED|Overall Study||336
878754|NCT02058160|2126279|P2|Treated|Overall Study||365
878755|NCT02058160|2126280|P1|Treated|Overall Study||365
878756|NCT02058160|2126279|P2|STARTED|Overall Study||369
878757|NCT02058160|2126280|P1|STARTED|Overall Study||367
878758|NCT02058147|2126317|P3|NOT COMPLETED|Overall Study||29
878759|NCT02058147|2126318|P2|NOT COMPLETED|Overall Study||27
878760|NCT02058147|2126319|P1|NOT COMPLETED|Overall Study||29
878761|NCT02058147|2126317|P3|COMPLETED|Overall Study||205
878762|NCT02058147|2126318|P2|COMPLETED|Overall Study||440
878763|NCT02058147|2126319|P1|COMPLETED|Overall Study||440
878764|NCT02058147|2126317|P3|Treated|Overall Study||233
878765|NCT02058147|2126318|P2|Treated|Overall Study||467
878766|NCT02058147|2126319|P1|Treated|Overall Study||469
878767|NCT02058147|2126317|P3|STARTED|Overall Study||234
878768|NCT02058147|2126318|P2|STARTED|Overall Study||467
878769|NCT02058147|2126319|P1|STARTED|Overall Study||469
878770|NCT02058069|2126368|P1|NOT COMPLETED|Overall Study||11
878771|NCT02058069|2126368|P1|COMPLETED|Overall Study||89
878772|NCT02058069|2126368|P1|STARTED|Overall Study||100
878773|NCT02057835|2126387|P10|NOT COMPLETED|Overall Study||0
878774|NCT02057835|2126388|P9|NOT COMPLETED|Overall Study||0
878775|NCT02057835|2126389|P8|NOT COMPLETED|Overall Study||0
878776|NCT02057835|2126390|P7|NOT COMPLETED|Overall Study||0
878777|NCT02057835|2126391|P6|NOT COMPLETED|Overall Study||0
878778|NCT02057835|2126392|P5|NOT COMPLETED|Overall Study||0
878779|NCT02057835|2126393|P4|NOT COMPLETED|Overall Study||0
878780|NCT02057835|2126394|P3|NOT COMPLETED|Overall Study||0
878781|NCT02057835|2126395|P2|NOT COMPLETED|Overall Study||2
878782|NCT02057835|2126396|P1|NOT COMPLETED|Overall Study||0
878783|NCT02057835|2126387|P10|COMPLETED|Overall Study||6
878784|NCT02057835|2126388|P9|COMPLETED|Overall Study||6
878785|NCT02057835|2126389|P8|COMPLETED|Overall Study||6
878786|NCT02057835|2126390|P7|COMPLETED|Overall Study||6
878787|NCT02057835|2126391|P6|COMPLETED|Overall Study||8
878788|NCT02057835|2126392|P5|COMPLETED|Overall Study||6
878789|NCT02057835|2126393|P4|COMPLETED|Overall Study||6
878790|NCT02057835|2126394|P3|COMPLETED|Overall Study||6
878791|NCT02057835|2126395|P2|COMPLETED|Overall Study||4
878792|NCT02057835|2126396|P1|COMPLETED|Overall Study||8
878793|NCT02057835|2126387|P10|STARTED|Overall Study||6
878794|NCT02057835|2126388|P9|STARTED|Overall Study||6
878795|NCT02057835|2126389|P8|STARTED|Overall Study||6
878796|NCT02057835|2126390|P7|STARTED|Overall Study||6
878797|NCT02057835|2126391|P6|STARTED|Overall Study||8
878798|NCT02057835|2126392|P5|STARTED|Overall Study||6
878799|NCT02057835|2126393|P4|STARTED|Overall Study||6
878800|NCT02057835|2126394|P3|STARTED|Overall Study||6
878801|NCT02057835|2126395|P2|STARTED|Overall Study||6
878802|NCT02057835|2126396|P1|STARTED|Overall Study||8
878803|NCT02057549|2126475|P2|NOT COMPLETED|Overall Study||0
878804|NCT02057549|2126476|P1|NOT COMPLETED|Overall Study||3
878805|NCT02057549|2126475|P2|COMPLETED|Overall Study||18
878806|NCT02057549|2126476|P1|COMPLETED|Overall Study||15
878807|NCT02057549|2126475|P2|STARTED|Overall Study||18
878808|NCT02057549|2126476|P1|STARTED|Overall Study||18
878809|NCT02057406|2126499|P3|NOT COMPLETED|Overall Study||4
878810|NCT02057406|2126500|P2|NOT COMPLETED|Overall Study||3
878811|NCT02057406|2126501|P1|NOT COMPLETED|Overall Study||1
878812|NCT02057406|2126499|P3|COMPLETED|Overall Study||32
878813|NCT02057406|2126500|P2|COMPLETED|Overall Study||33
878814|NCT02057406|2126501|P1|COMPLETED|Overall Study||35
878815|NCT02057406|2126499|P3|STARTED|Overall Study||36
878816|NCT02057406|2126500|P2|STARTED|Overall Study||36
878817|NCT02057406|2126501|P1|STARTED|Overall Study||36
878818|NCT02057393|2126512|P1|NOT COMPLETED|Overall Study||2
878819|NCT02057393|2126512|P1|COMPLETED|Overall Study||87
878820|NCT02057393|2126512|P1|STARTED|Overall Study||89
878821|NCT02057276|2126518|P2|NOT COMPLETED|Overall Study||0
878822|NCT02057276|2126519|P1|NOT COMPLETED|Overall Study||0
878823|NCT02057276|2126518|P2|COMPLETED|Overall Study||0
878824|NCT02057276|2126519|P1|COMPLETED|Overall Study||0
878825|NCT02057276|2126518|P2|STARTED|Overall Study||0
878826|NCT02057276|2126519|P1|STARTED|Overall Study||0
878827|NCT02057250|2126533|P5|NOT COMPLETED|Extension Phase||36
878828|NCT02057250|2126534|P4|NOT COMPLETED|Extension Phase||0
878829|NCT02057250|2126535|P3|NOT COMPLETED|Extension Phase||0
878830|NCT02057250|2126536|P2|NOT COMPLETED|Extension Phase||0
878831|NCT02057250|2126537|P1|NOT COMPLETED|Extension Phase||0
878832|NCT02057250|2126533|P5|COMPLETED|Extension Phase||156
878833|NCT02057250|2126534|P4|COMPLETED|Extension Phase||0
878834|NCT02057250|2126535|P3|COMPLETED|Extension Phase||0
878835|NCT02057250|2126536|P2|COMPLETED|Extension Phase||0
878836|NCT02057250|2126537|P1|COMPLETED|Extension Phase||0
878837|NCT02057250|2126533|P5|Treated|Extension Phase||188
878838|NCT02057250|2126534|P4|Treated|Extension Phase||0
878839|NCT02057250|2126535|P3|Treated|Extension Phase||0
878840|NCT02057250|2126536|P2|Treated|Extension Phase||0
878841|NCT02057250|2126537|P1|Treated|Extension Phase||0
878842|NCT02057250|2126533|P5|STARTED|Extension Phase|9 participants who completed AID Assessment phase did not enter extension phase.|192
878843|NCT02057250|2126534|P4|STARTED|Extension Phase||0
878844|NCT02057250|2126535|P3|STARTED|Extension Phase||0
878845|NCT02057250|2126536|P2|STARTED|Extension Phase||0
878846|NCT02057250|2126537|P1|STARTED|Extension Phase||0
878847|NCT02057250|2126533|P5|NOT COMPLETED|AID Assessment Phase||0
878848|NCT02057250|2126534|P4|NOT COMPLETED|AID Assessment Phase||2
878849|NCT02057250|2126535|P3|NOT COMPLETED|AID Assessment Phase||7
878850|NCT02057250|2126536|P2|NOT COMPLETED|AID Assessment Phase||3
878851|NCT02057250|2126537|P1|NOT COMPLETED|AID Assessment Phase||4
878852|NCT02057250|2126533|P5|COMPLETED|AID Assessment Phase||0
878853|NCT02057250|2126534|P4|COMPLETED|AID Assessment Phase||54
878854|NCT02057250|2126535|P3|COMPLETED|AID Assessment Phase||45
878855|NCT02057250|2126536|P2|COMPLETED|AID Assessment Phase||50
878856|NCT02057250|2126537|P1|COMPLETED|AID Assessment Phase||52
878857|NCT02057250|2126533|P5|STARTED|AID Assessment Phase||0
878858|NCT02057250|2126534|P4|STARTED|AID Assessment Phase||56
878859|NCT02057250|2126535|P3|STARTED|AID Assessment Phase||52
878860|NCT02057250|2126536|P2|STARTED|AID Assessment Phase||53
878861|NCT02057250|2126537|P1|STARTED|AID Assessment Phase||56
878862|NCT02057237|2126550|P1|NOT COMPLETED|Overall Study||0
878863|NCT02057237|2126550|P1|COMPLETED|Overall Study||1
878864|NCT02057237|2126550|P1|STARTED|Overall Study||1
878865|NCT02056834|2126555|P1|NOT COMPLETED|Overall Study||7
878866|NCT02056834|2126555|P1|COMPLETED|Overall Study||29
878867|NCT02056834|2126555|P1|6 Months|Overall Study||31
878868|NCT02056834|2126555|P1|6 Weeks|Overall Study||34
878869|NCT02056834|2126555|P1|STARTED|Overall Study||36
878870|NCT02056392|2126580|P6|NOT COMPLETED|Overall Study||0
878871|NCT02056392|2126581|P5|NOT COMPLETED|Overall Study||1
878872|NCT02056392|2126582|P4|NOT COMPLETED|Overall Study||0
878873|NCT02056392|2126583|P3|NOT COMPLETED|Overall Study||3
878874|NCT02056392|2126584|P2|NOT COMPLETED|Overall Study||1
878875|NCT02056392|2126585|P1|NOT COMPLETED|Overall Study||2
878876|NCT02056392|2126580|P6|COMPLETED|Overall Study||9
878877|NCT02056392|2126581|P5|COMPLETED|Overall Study||7
878878|NCT02056392|2126582|P4|COMPLETED|Overall Study||9
878879|NCT02056392|2126583|P3|COMPLETED|Overall Study||6
878880|NCT02056392|2126584|P2|COMPLETED|Overall Study||8
878881|NCT02056392|2126585|P1|COMPLETED|Overall Study||8
878882|NCT02056392|2126580|P6|STARTED|Overall Study||9
878883|NCT02056392|2126581|P5|STARTED|Overall Study||8
878884|NCT02056392|2126582|P4|STARTED|Overall Study||9
878885|NCT02056392|2126583|P3|STARTED|Overall Study||9
878886|NCT02056392|2126584|P2|STARTED|Overall Study||9
878887|NCT02056392|2126585|P1|STARTED|Overall Study||10
878888|NCT02055430|2126622|P2|NOT COMPLETED|Overall Study||0
878889|NCT02055430|2126623|P1|NOT COMPLETED|Overall Study||0
878890|NCT02055430|2126622|P2|COMPLETED|Overall Study||45
878891|NCT02055430|2126623|P1|COMPLETED|Overall Study||45
878892|NCT02055430|2126622|P2|STARTED|Overall Study||45
878893|NCT02055430|2126623|P1|STARTED|Overall Study||45
878894|NCT02055404|2126629|P1|NOT COMPLETED|Overall Study||0
878895|NCT02055404|2126629|P1|COMPLETED|Overall Study||3
878896|NCT02055404|2126629|P1|STARTED|Overall Study||3
878897|NCT02055352|2126644|P2|NOT COMPLETED|Overall Study||17
878898|NCT02055352|2126645|P1|NOT COMPLETED|Overall Study||6
878899|NCT02055352|2126644|P2|COMPLETED|Overall Study||96
878900|NCT02055352|2126645|P1|COMPLETED|Overall Study||103
878901|NCT02055352|2126644|P2|Per-Protocol Set (PPS)|Overall Study||111
878902|NCT02055352|2126645|P1|Per-Protocol Set (PPS)|Overall Study||108
878903|NCT02055352|2126644|P2|STARTED|Overall Study||113
878904|NCT02055352|2126645|P1|STARTED|Overall Study||109
878905|NCT02054910|2126661|P2|NOT COMPLETED|Overall Study||1
878906|NCT02054910|2126662|P1|NOT COMPLETED|Overall Study||4
878907|NCT02054910|2126661|P2|COMPLETED|Overall Study||0
878908|NCT02054910|2126662|P1|COMPLETED|Overall Study||0
878909|NCT02054910|2126661|P2|STARTED|Overall Study||1
878910|NCT02054910|2126662|P1|STARTED|Overall Study||4
878911|NCT02054754|2126680|P6|NOT COMPLETED|Overall Study||0
878912|NCT02054754|2126681|P5|NOT COMPLETED|Overall Study||0
878913|NCT02054754|2126682|P4|NOT COMPLETED|Overall Study||0
878914|NCT02054754|2126683|P3|NOT COMPLETED|Overall Study||0
878915|NCT02054754|2126684|P2|NOT COMPLETED|Overall Study||0
878916|NCT02054754|2126685|P1|NOT COMPLETED|Overall Study||0
878917|NCT02054754|2126680|P6|COMPLETED|Overall Study||10
878918|NCT02054754|2126681|P5|COMPLETED|Overall Study||6
878919|NCT02054754|2126682|P4|COMPLETED|Overall Study||6
878920|NCT02054754|2126683|P3|COMPLETED|Overall Study||6
878921|NCT02054754|2126684|P2|COMPLETED|Overall Study||6
878922|NCT02054754|2126685|P1|COMPLETED|Overall Study||6
878923|NCT02054754|2126680|P6|STARTED|Overall Study||10
878924|NCT02054754|2126681|P5|STARTED|Overall Study||6
878925|NCT02054754|2126682|P4|STARTED|Overall Study||6
878926|NCT02054754|2126683|P3|STARTED|Overall Study||6
878927|NCT02054754|2126684|P2|STARTED|Overall Study||6
878928|NCT02054754|2126685|P1|STARTED|Overall Study||6
878929|NCT02054715|2126702|P2|NOT COMPLETED|Follow-up 2||19
878930|NCT02054715|2126703|P1|NOT COMPLETED|Follow-up 2||19
878931|NCT02054715|2126702|P2|COMPLETED|Follow-up 2||173
878932|NCT02054715|2126703|P1|COMPLETED|Follow-up 2||192
878933|NCT02054715|2126702|P2|STARTED|Follow-up 2||192
878934|NCT02054715|2126703|P1|STARTED|Follow-up 2||211
878935|NCT02054715|2126702|P2|NOT COMPLETED|Baseline/Follow-up 1||7
878936|NCT02054715|2126703|P1|NOT COMPLETED|Baseline/Follow-up 1||8
878937|NCT02054715|2126702|P2|COMPLETED|Baseline/Follow-up 1||192
878938|NCT02054715|2126703|P1|COMPLETED|Baseline/Follow-up 1||211
878939|NCT02054715|2126702|P2|STARTED|Baseline/Follow-up 1||199
878940|NCT02054715|2126703|P1|STARTED|Baseline/Follow-up 1||219
878941|NCT02054702|2126717|P2|NOT COMPLETED|Overall Study||12
878942|NCT02054702|2126718|P1|NOT COMPLETED|Overall Study||24
878943|NCT02054702|2126717|P2|COMPLETED|Overall Study||21
878944|NCT02054702|2126718|P1|COMPLETED|Overall Study||40
878945|NCT02054702|2126717|P2|STARTED|Overall Study||33
878946|NCT02054702|2126718|P1|STARTED|Overall Study||64
878947|NCT02054572|2126746|P1|NOT COMPLETED|Overall Study||0
878948|NCT02054572|2126746|P1|COMPLETED|Overall Study||6
878949|NCT02054572|2126746|P1|STARTED|Overall Study||6
878950|NCT02054481|2126773|P4|NOT COMPLETED|Overall Study||1
878951|NCT02054481|2126774|P3|NOT COMPLETED|Overall Study||2
878952|NCT02054481|2126775|P2|NOT COMPLETED|Overall Study||2
878953|NCT02054481|2126776|P1|NOT COMPLETED|Overall Study||4
878954|NCT02054481|2126773|P4|COMPLETED|Overall Study||39
878955|NCT02054481|2126774|P3|COMPLETED|Overall Study||40
878956|NCT02054481|2126775|P2|COMPLETED|Overall Study||39
878957|NCT02054481|2126776|P1|COMPLETED|Overall Study||39
878958|NCT02054481|2126773|P4|STARTED|Overall Study||40
878959|NCT02054481|2126774|P3|STARTED|Overall Study||42
878960|NCT02054481|2126775|P2|STARTED|Overall Study||41
878961|NCT02054481|2126776|P1|STARTED|Overall Study||43
878962|NCT02054325|2126824|P2|NOT COMPLETED|Overall Study||5
878963|NCT02054325|2126825|P1|NOT COMPLETED|Overall Study||8
878964|NCT02054325|2126824|P2|COMPLETED|Overall Study||50
878965|NCT02054325|2126825|P1|COMPLETED|Overall Study||43
878966|NCT02054325|2126824|P2|STARTED|Overall Study||55
878967|NCT02054325|2126825|P1|STARTED|Overall Study||51
878968|NCT02053610|2126835|P2|NOT COMPLETED|Overall Study||174
878969|NCT02053610|2126836|P1|NOT COMPLETED|Overall Study||235
878970|NCT02053610|2126835|P2|COMPLETED|Overall Study|Completed=Completed Treatment|159
878971|NCT02053610|2126836|P1|COMPLETED|Overall Study|Completed=Completed Treatment|95
878972|NCT02053610|2126835|P2|Received Study Drug|Overall Study||331
878973|NCT02053610|2126836|P1|Received Study Drug|Overall Study||326
878974|NCT02053610|2126835|P2|STARTED|Overall Study||333
878975|NCT02053610|2126836|P1|STARTED|Overall Study||330
878976|NCT02053493|2126868|P2|NOT COMPLETED|Overall Study||1
878977|NCT02053493|2126869|P1|NOT COMPLETED|Overall Study||1
878978|NCT02053493|2126868|P2|COMPLETED|Overall Study||58
878979|NCT02053493|2126869|P1|COMPLETED|Overall Study||50
878980|NCT02053493|2126868|P2|STARTED|Overall Study||59
878981|NCT02053493|2126869|P1|STARTED|Overall Study||51
878982|NCT02052895|2126910|P3|NOT COMPLETED|Overall Study||0
878983|NCT02052895|2126911|P2|NOT COMPLETED|Overall Study||0
878984|NCT02052895|2126912|P1|NOT COMPLETED|Overall Study||0
878985|NCT02052895|2126910|P3|COMPLETED|Overall Study||15
878986|NCT02052895|2126911|P2|COMPLETED|Overall Study||15
878987|NCT02052895|2126912|P1|COMPLETED|Overall Study||196
878988|NCT02052895|2126910|P3|STARTED|Overall Study||15
878989|NCT02052895|2126911|P2|STARTED|Overall Study||15
878990|NCT02052895|2126912|P1|STARTED|Overall Study||196
878991|NCT02052752|2126922|P3|NOT COMPLETED|Overall Study||0
878992|NCT02052752|2126923|P2|NOT COMPLETED|Overall Study||0
878993|NCT02052752|2126924|P1|NOT COMPLETED|Overall Study||0
878994|NCT02052752|2126922|P3|COMPLETED|Overall Study||30
878995|NCT02052752|2126923|P2|COMPLETED|Overall Study||30
878996|NCT02052752|2126924|P1|COMPLETED|Overall Study||30
878997|NCT02052752|2126922|P3|STARTED|Overall Study||30
878998|NCT02052752|2126923|P2|STARTED|Overall Study||30
878999|NCT02052752|2126924|P1|STARTED|Overall Study||30
879000|NCT02052661|2126947|P1|NOT COMPLETED|Overall Study||0
879001|NCT02052661|2126947|P1|COMPLETED|Overall Study||300
879002|NCT02052661|2126947|P1|STARTED|Overall Study||300
879003|NCT02052635|2126961|P2|NOT COMPLETED|Overall Study||0
879004|NCT02052635|2126962|P1|NOT COMPLETED|Overall Study||0
879005|NCT02052635|2126961|P2|COMPLETED|Overall Study||6
879006|NCT02052635|2126962|P1|COMPLETED|Overall Study||7
879007|NCT02052635|2126961|P2|STARTED|Overall Study||6
879008|NCT02052635|2126962|P1|STARTED|Overall Study||7
879009|NCT02052544|2126970|P1|NOT COMPLETED|Overall Study||0
879010|NCT02052544|2126970|P1|COMPLETED|Overall Study|Last Subject Out|123
879011|NCT02052544|2126970|P1|STARTED|Overall Study|First Subject In|123
879012|NCT02052466|2126975|P1|NOT COMPLETED|Overall Study||2
879013|NCT02052466|2126975|P1|COMPLETED|Overall Study||30
879014|NCT02052466|2126975|P1|STARTED|Overall Study||32
879015|NCT02052414|2126990|P1|NOT COMPLETED|Overall Study||17
879016|NCT02052414|2126990|P1|COMPLETED|Overall Study||17
879017|NCT02052414|2126990|P1|STARTED|Overall Study||34
879018|NCT02052011|2127000|P2|NOT COMPLETED|Overall Study||2
879019|NCT02052011|2127001|P1|NOT COMPLETED|Overall Study||4
879020|NCT02052011|2127000|P2|COMPLETED|Overall Study||8
879021|NCT02052011|2127001|P1|COMPLETED|Overall Study||17
879022|NCT02052011|2127000|P2|STARTED|Overall Study||10
879023|NCT02052011|2127001|P1|STARTED|Overall Study||21
879024|NCT02051816|2127011|P4|NOT COMPLETED|Overall Study||0
879025|NCT02051816|2127012|P3|NOT COMPLETED|Overall Study||0
879026|NCT02051816|2127013|P2|NOT COMPLETED|Overall Study||0
879027|NCT02051816|2127014|P1|NOT COMPLETED|Overall Study||0
879028|NCT02051816|2127011|P4|COMPLETED|Overall Study||36
879029|NCT02051816|2127012|P3|COMPLETED|Overall Study||37
879030|NCT02051816|2127013|P2|COMPLETED|Overall Study||40
879031|NCT02051816|2127014|P1|COMPLETED|Overall Study||37
879032|NCT02051816|2127011|P4|STARTED|Overall Study||36
879033|NCT02051816|2127012|P3|STARTED|Overall Study||37
879034|NCT02051816|2127013|P2|STARTED|Overall Study||40
879035|NCT02051816|2127014|P1|STARTED|Overall Study||37
879036|NCT02051790|2127052|P1|NOT COMPLETED|Overall Study||0
879037|NCT02051790|2127052|P1|COMPLETED|Overall Study||241
879038|NCT02051790|2127052|P1|STARTED|Overall Study||241
879039|NCT02051595|2127056|P1|NOT COMPLETED|Overall Study||0
879040|NCT02051595|2127056|P1|COMPLETED|Overall Study||25
879041|NCT02051595|2127056|P1|STARTED|Overall Study||25
879042|NCT02051426|2127062|P2|NOT COMPLETED|Second Intervention||0
879043|NCT02051426|2127063|P1|NOT COMPLETED|Second Intervention||0
879044|NCT02051426|2127062|P2|COMPLETED|Second Intervention||19
879045|NCT02051426|2127063|P1|COMPLETED|Second Intervention||16
879046|NCT02051426|2127062|P2|STARTED|Second Intervention||19
879047|NCT02051426|2127063|P1|STARTED|Second Intervention||16
879048|NCT02051426|2127062|P2|NOT COMPLETED|Washout Period of 1 Month||0
879049|NCT02051426|2127063|P1|NOT COMPLETED|Washout Period of 1 Month||0
879050|NCT02051426|2127062|P2|COMPLETED|Washout Period of 1 Month||19
879051|NCT02051426|2127063|P1|COMPLETED|Washout Period of 1 Month||16
879052|NCT02051426|2127062|P2|STARTED|Washout Period of 1 Month||19
879053|NCT02051426|2127063|P1|STARTED|Washout Period of 1 Month||16
879054|NCT02051426|2127062|P2|NOT COMPLETED|First Intervention||0
879055|NCT02051426|2127063|P1|NOT COMPLETED|First Intervention||0
879056|NCT02051426|2127062|P2|COMPLETED|First Intervention||19
879057|NCT02051426|2127063|P1|COMPLETED|First Intervention||16
879058|NCT02051426|2127062|P2|STARTED|First Intervention||19
879059|NCT02051426|2127063|P1|STARTED|First Intervention||16
879060|NCT02051335|2127077|P4|NOT COMPLETED|Period 4||0
879061|NCT02051335|2127078|P3|NOT COMPLETED|Period 4||0
879062|NCT02051335|2127079|P2|NOT COMPLETED|Period 4||0
879063|NCT02051335|2127080|P1|NOT COMPLETED|Period 4||0
879064|NCT02051335|2127077|P4|COMPLETED|Period 4||4
879065|NCT02051335|2127078|P3|COMPLETED|Period 4||5
879066|NCT02051335|2127079|P2|COMPLETED|Period 4||7
879067|NCT02051335|2127080|P1|COMPLETED|Period 4||7
879068|NCT02051335|2127077|P4|STARTED|Period 4||4
879069|NCT02051335|2127078|P3|STARTED|Period 4||5
879070|NCT02051335|2127079|P2|STARTED|Period 4||7
879071|NCT02051335|2127080|P1|STARTED|Period 4||7
879072|NCT02051335|2127077|P4|NOT COMPLETED|Period 3||0
879073|NCT02051335|2127078|P3|NOT COMPLETED|Period 3||0
879074|NCT02051335|2127079|P2|NOT COMPLETED|Period 3||0
879075|NCT02051335|2127080|P1|NOT COMPLETED|Period 3||0
879076|NCT02051335|2127077|P4|COMPLETED|Period 3||4
879077|NCT02051335|2127078|P3|COMPLETED|Period 3||5
879078|NCT02051335|2127079|P2|COMPLETED|Period 3||7
879079|NCT02051335|2127080|P1|COMPLETED|Period 3||7
879080|NCT02051335|2127077|P4|STARTED|Period 3||4
879081|NCT02051335|2127078|P3|STARTED|Period 3|2 Participants received treatment in Period 2 but discontinued prior to Period 3.|5
879082|NCT02051335|2127079|P2|STARTED|Period 3||7
879083|NCT02051335|2127080|P1|STARTED|Period 3||7
879084|NCT02051335|2127077|P4|NOT COMPLETED|Period 2||0
879085|NCT02051335|2127078|P3|NOT COMPLETED|Period 2||0
879086|NCT02051335|2127079|P2|NOT COMPLETED|Period 2||0
879087|NCT02051335|2127080|P1|NOT COMPLETED|Period 2||0
879088|NCT02051335|2127077|P4|COMPLETED|Period 2||4
879089|NCT02051335|2127078|P3|COMPLETED|Period 2||7
879090|NCT02051335|2127079|P2|COMPLETED|Period 2||7
879091|NCT02051335|2127080|P1|COMPLETED|Period 2||7
879092|NCT02051335|2127077|P4|STARTED|Period 2|2 Participants received treatment in Period 1 but discontinued prior to Period 2.|4
879093|NCT02051335|2127078|P3|STARTED|Period 2||7
879094|NCT02051335|2127079|P2|STARTED|Period 2||7
879095|NCT02051335|2127080|P1|STARTED|Period 2||7
879096|NCT02051335|2127077|P4|NOT COMPLETED|Period 1||0
879097|NCT02051335|2127078|P3|NOT COMPLETED|Period 1||0
879098|NCT02051335|2127079|P2|NOT COMPLETED|Period 1||0
879099|NCT02051335|2127080|P1|NOT COMPLETED|Period 1||0
879100|NCT02051335|2127077|P4|COMPLETED|Period 1||6
879101|NCT02051335|2127078|P3|COMPLETED|Period 1||7
879102|NCT02051335|2127079|P2|COMPLETED|Period 1||7
879103|NCT02051335|2127080|P1|COMPLETED|Period 1||7
879104|NCT02051335|2127077|P4|STARTED|Period 1||6
879105|NCT02051335|2127078|P3|STARTED|Period 1||7
879106|NCT02051335|2127079|P2|STARTED|Period 1||7
879107|NCT02051335|2127080|P1|STARTED|Period 1||7
879108|NCT02050334|2127132|P2|NOT COMPLETED|Overall Study||0
879109|NCT02050334|2127133|P1|NOT COMPLETED|Overall Study||0
879110|NCT02050334|2127132|P2|COMPLETED|Overall Study||9
879111|NCT02050334|2127133|P1|COMPLETED|Overall Study||9
879112|NCT02050334|2127132|P2|STARTED|Overall Study||9
879113|NCT02050334|2127133|P1|STARTED|Overall Study||9
879114|NCT02050321|2127141|P1|NOT COMPLETED|Overall Study||2
879115|NCT02050321|2127141|P1|COMPLETED|Overall Study||0
879116|NCT02050321|2127141|P1|STARTED|Overall Study||2
879117|NCT02050048|2127147|P2|NOT COMPLETED|Overall Study||2
879118|NCT02050048|2127148|P1|NOT COMPLETED|Overall Study||5
879119|NCT02050048|2127147|P2|COMPLETED|Overall Study||10
879120|NCT02050048|2127148|P1|COMPLETED|Overall Study||9
879121|NCT02050048|2127147|P2|STARTED|Overall Study||12
879122|NCT02050048|2127148|P1|STARTED|Overall Study||14
879123|NCT02049931|2127157|P3|NOT COMPLETED|Overall Study||3
879124|NCT02049931|2127158|P2|NOT COMPLETED|Overall Study||5
879125|NCT02049931|2127159|P1|NOT COMPLETED|Overall Study||3
879126|NCT02049931|2127157|P3|COMPLETED|Overall Study||17
879127|NCT02049931|2127158|P2|COMPLETED|Overall Study||15
879128|NCT02049931|2127159|P1|COMPLETED|Overall Study||17
879129|NCT02049931|2127157|P3|STARTED|Overall Study||20
879130|NCT02049931|2127158|P2|STARTED|Overall Study||20
879131|NCT02049931|2127159|P1|STARTED|Overall Study||20
879132|NCT02049450|2127167|P1|NOT COMPLETED|Overall Study||4
879133|NCT02049450|2127167|P1|COMPLETED|Overall Study|Completed = Completed Core phase of study|26
879134|NCT02049450|2127167|P1|Entered Extension Phase|Overall Study|Of 26 who completed Core phase 18 moved into Ext. phase; All 18 eventually discontinued Ext. phase|18
879135|NCT02049450|2127167|P1|Discontinued Treatment Prior to Week 30|Overall Study||4
879136|NCT02049450|2127167|P1|STARTED|Overall Study||30
879137|NCT02049151|2127183|P2|NOT COMPLETED|Overall Study||0
879138|NCT02049151|2127184|P1|NOT COMPLETED|Overall Study||0
879139|NCT02049151|2127183|P2|COMPLETED|Overall Study||17
879140|NCT02049151|2127184|P1|COMPLETED|Overall Study||15
879141|NCT02049151|2127183|P2|STARTED|Overall Study|1 subject did not receive treatment|17
879142|NCT02049151|2127184|P1|STARTED|Overall Study|2 subjects did not receive treatment|15
879143|NCT02048904|2127198|P1|NOT COMPLETED|Overall Study||77
879144|NCT02048904|2127198|P1|COMPLETED|Overall Study||65
879145|NCT02048904|2127198|P1|STARTED|Overall Study||142
879146|NCT02048891|2127204|P2|NOT COMPLETED|Overall Study||0
879147|NCT02048891|2127205|P1|NOT COMPLETED|Overall Study||0
879148|NCT02048891|2127204|P2|COMPLETED|Overall Study||1
879149|NCT02048891|2127205|P1|COMPLETED|Overall Study||2
879150|NCT02048891|2127204|P2|STARTED|Overall Study||1
879151|NCT02048891|2127205|P1|STARTED|Overall Study||2
879152|NCT02048072|2127211|P1|NOT COMPLETED|Overall Study||4
879153|NCT02048072|2127211|P1|COMPLETED|Overall Study||29
879154|NCT02048072|2127211|P1|STARTED|Overall Study||33
879155|NCT02047747|2127215|P1|NOT COMPLETED|Overall Study||3
879156|NCT02047747|2127215|P1|COMPLETED|Overall Study||1
879157|NCT02047747|2127215|P1|STARTED|Overall Study||4
879158|NCT02047227|2127222|P2|NOT COMPLETED|Overall Study||130
879159|NCT02047227|2127223|P1|NOT COMPLETED|Overall Study||144
879160|NCT02047227|2127222|P2|COMPLETED|Overall Study||347
879161|NCT02047227|2127223|P1|COMPLETED|Overall Study||318
879162|NCT02047227|2127222|P2|Completed Ovarian Stimulation Phase|Overall Study||440
879163|NCT02047227|2127223|P1|Completed Ovarian Stimulation Phase|Overall Study||424
879164|NCT02047227|2127222|P2|STARTED|Overall Study||477
879165|NCT02047227|2127223|P1|STARTED|Overall Study||462
879166|NCT02046993|2127241|P2|NOT COMPLETED|Overall Study||11
879167|NCT02046993|2127242|P1|NOT COMPLETED|Overall Study||3
879168|NCT02046993|2127241|P2|COMPLETED|Overall Study||94
879169|NCT02046993|2127242|P1|COMPLETED|Overall Study||102
879170|NCT02046993|2127241|P2|6th Month|Overall Study||94
879171|NCT02046993|2127242|P1|6th Month|Overall Study||102
879172|NCT02046993|2127241|P2|3rd Month|Overall Study||97
879173|NCT02046993|2127242|P1|3rd Month|Overall Study||104
879174|NCT02046993|2127241|P2|STARTED|Overall Study||105
879175|NCT02046993|2127242|P1|STARTED|Overall Study||105
879176|NCT02046980|2127261|P3|NOT COMPLETED|Overall Study||1
879177|NCT02046980|2127262|P2|NOT COMPLETED|Overall Study||5
879178|NCT02046980|2127263|P1|NOT COMPLETED|Overall Study||2
879179|NCT02046980|2127261|P3|COMPLETED|Overall Study||72
879180|NCT02046980|2127262|P2|COMPLETED|Overall Study||67
879181|NCT02046980|2127263|P1|COMPLETED|Overall Study||70
879182|NCT02046980|2127261|P3|STARTED|Overall Study||73
879183|NCT02046980|2127262|P2|STARTED|Overall Study||72
879184|NCT02046980|2127263|P1|STARTED|Overall Study||72
879185|NCT02046863|2127271|P1|NOT COMPLETED|Overall Study||0
879186|NCT02046863|2127271|P1|COMPLETED|Overall Study||7
879187|NCT02046863|2127271|P1|STARTED|Overall Study||7
879188|NCT02046772|2127277|P2|NOT COMPLETED|Overall Study||0
879189|NCT02046772|2127278|P1|NOT COMPLETED|Overall Study||0
879190|NCT02046772|2127277|P2|COMPLETED|Overall Study||33
879191|NCT02046772|2127278|P1|COMPLETED|Overall Study||30
879192|NCT02046772|2127277|P2|STARTED|Overall Study||33
879193|NCT02046772|2127278|P1|STARTED|Overall Study||30
879194|NCT02046265|2127296|P4|NOT COMPLETED|Overall Study||2
879195|NCT02046265|2127297|P3|NOT COMPLETED|Overall Study||2
879196|NCT02046265|2127298|P2|NOT COMPLETED|Overall Study||2
879197|NCT02046265|2127299|P1|NOT COMPLETED|Overall Study||1
879198|NCT02046265|2127296|P4|COMPLETED|Overall Study||12
879199|NCT02046265|2127297|P3|COMPLETED|Overall Study||10
879200|NCT02046265|2127298|P2|COMPLETED|Overall Study||15
879201|NCT02046265|2127299|P1|COMPLETED|Overall Study||16
879202|NCT02046265|2127296|P4|STARTED|Overall Study||14
879203|NCT02046265|2127297|P3|STARTED|Overall Study||12
879204|NCT02046265|2127298|P2|STARTED|Overall Study||17
879205|NCT02046265|2127299|P1|STARTED|Overall Study||17
879206|NCT02046226|2127309|P1|NOT COMPLETED|Overall Study||7
879207|NCT02046226|2127309|P1|COMPLETED|Overall Study||0
879208|NCT02046226|2127309|P1|STARTED|Overall Study||7
879209|NCT02046200|2127316|P2|NOT COMPLETED|Second Intervention (1 Day)||0
879210|NCT02046200|2127317|P1|NOT COMPLETED|Second Intervention (1 Day)||0
879211|NCT02046200|2127316|P2|COMPLETED|Second Intervention (1 Day)||6
879212|NCT02046200|2127317|P1|COMPLETED|Second Intervention (1 Day)||5
879213|NCT02046200|2127316|P2|STARTED|Second Intervention (1 Day)||6
879214|NCT02046200|2127317|P1|STARTED|Second Intervention (1 Day)||5
879215|NCT02046200|2127316|P2|NOT COMPLETED|First Intervention (1 Day)||0
879216|NCT02046200|2127317|P1|NOT COMPLETED|First Intervention (1 Day)||0
879217|NCT02046200|2127316|P2|COMPLETED|First Intervention (1 Day)||6
879218|NCT02046200|2127317|P1|COMPLETED|First Intervention (1 Day)||5
879219|NCT02046200|2127316|P2|STARTED|First Intervention (1 Day)||6
879220|NCT02046200|2127317|P1|STARTED|First Intervention (1 Day)||5
879227|NCT02045836|2127404|P2|NOT COMPLETED|Overall Study||14
879228|NCT02045836|2127405|P1|NOT COMPLETED|Overall Study||9
879229|NCT02045836|2127404|P2|COMPLETED|Overall Study||419
879230|NCT02045836|2127405|P1|COMPLETED|Overall Study||423
879231|NCT02045836|2127404|P2|STARTED|Overall Study||433
879232|NCT02045836|2127405|P1|STARTED|Overall Study||432
879233|NCT02045797|2127435|P3|NOT COMPLETED|Overall Study||1
879234|NCT02045797|2127436|P2|NOT COMPLETED|Overall Study||7
879235|NCT02045797|2127437|P1|NOT COMPLETED|Overall Study||7
879236|NCT02045797|2127435|P3|COMPLETED|Overall Study||24
879237|NCT02045797|2127436|P2|COMPLETED|Overall Study||32
879238|NCT02045797|2127437|P1|COMPLETED|Overall Study||51
879239|NCT02045797|2127435|P3|STARTED|Overall Study||25
879240|NCT02045797|2127436|P2|STARTED|Overall Study||39
879241|NCT02045797|2127437|P1|STARTED|Overall Study||58
879242|NCT02045732|2127582|P2|NOT COMPLETED|Overall Study||1
879243|NCT02045732|2127583|P1|NOT COMPLETED|Overall Study||1
879244|NCT02045732|2127582|P2|COMPLETED|Overall Study||2
879245|NCT02045732|2127583|P1|COMPLETED|Overall Study||0
879246|NCT02045732|2127582|P2|STARTED|Overall Study||3
879247|NCT02045732|2127583|P1|STARTED|Overall Study||1
879248|NCT02045511|2127603|P2|NOT COMPLETED|Overall Study||0
879249|NCT02045511|2127604|P1|NOT COMPLETED|Overall Study||0
879250|NCT02045511|2127603|P2|COMPLETED|Overall Study||7
879251|NCT02045511|2127604|P1|COMPLETED|Overall Study||8
879252|NCT02045511|2127603|P2|STARTED|Overall Study||7
879253|NCT02045511|2127604|P1|STARTED|Overall Study||8
879254|NCT02045264|2127620|P1|NOT COMPLETED|Overall Study||0
879255|NCT02045264|2127620|P1|COMPLETED|Overall Study||12
879256|NCT02045264|2127620|P1|STARTED|Overall Study||12
879257|NCT02045238|2127637|P2|NOT COMPLETED|Overall Study||1
879258|NCT02045238|2127638|P1|NOT COMPLETED|Overall Study||7
879259|NCT02045238|2127637|P2|COMPLETED|Overall Study||14
879260|NCT02045238|2127638|P1|COMPLETED|Overall Study||9
879261|NCT02045238|2127637|P2|STARTED|Overall Study||15
879262|NCT02045238|2127638|P1|STARTED|Overall Study||16
879263|NCT02044991|2127648|P2|NOT COMPLETED|Overall Study||0
879264|NCT02044991|2127649|P1|NOT COMPLETED|Overall Study||0
879265|NCT02044991|2127648|P2|COMPLETED|Overall Study||0
879266|NCT02044991|2127649|P1|COMPLETED|Overall Study||2
879267|NCT02044991|2127648|P2|STARTED|Overall Study||0
879268|NCT02044991|2127649|P1|STARTED|Overall Study||2
879269|NCT02044848|2127661|P2|NOT COMPLETED|Overall Study||3
879270|NCT02044848|2127662|P1|NOT COMPLETED|Overall Study||2
879271|NCT02044848|2127661|P2|COMPLETED|Overall Study||0
879272|NCT02044848|2127662|P1|COMPLETED|Overall Study||0
879273|NCT02044848|2127661|P2|STARTED|Overall Study||3
879274|NCT02044848|2127662|P1|STARTED|Overall Study||2
879275|NCT02044822|2127668|P1|NOT COMPLETED|Overall Study||93
879276|NCT02044822|2127668|P1|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|9
879277|NCT02044822|2127668|P1|STARTED|Overall Study||102
879278|NCT02044458|2127680|P2|NOT COMPLETED|Overall Study||8
879279|NCT02044458|2127681|P1|NOT COMPLETED|Overall Study||3
879280|NCT02044458|2127680|P2|COMPLETED|Overall Study||61
879281|NCT02044458|2127681|P1|COMPLETED|Overall Study||62
879282|NCT02044458|2127680|P2|STARTED|Overall Study||69
879283|NCT02044458|2127681|P1|STARTED|Overall Study||65
879284|NCT02044393|2127693|P2|NOT COMPLETED|Period 2||0
879285|NCT02044393|2127694|P1|NOT COMPLETED|Period 2||0
879286|NCT02044393|2127693|P2|COMPLETED|Period 2||10
879287|NCT02044393|2127694|P1|COMPLETED|Period 2||10
879288|NCT02044393|2127693|P2|STARTED|Period 2||10
879289|NCT02044393|2127694|P1|STARTED|Period 2||10
879290|NCT02044393|2127693|P2|NOT COMPLETED|Period 1||0
879291|NCT02044393|2127694|P1|NOT COMPLETED|Period 1||0
879292|NCT02044393|2127693|P2|COMPLETED|Period 1||10
879293|NCT02044393|2127694|P1|COMPLETED|Period 1||10
879294|NCT02044393|2127693|P2|STARTED|Period 1||10
879295|NCT02044393|2127694|P1|STARTED|Period 1||10
879296|NCT02044380|2127707|P1|NOT COMPLETED|Overall Study||0
879297|NCT02044380|2127707|P1|COMPLETED|Overall Study||14
879298|NCT02044380|2127707|P1|STARTED|Overall Study|Started are the treated patients|14
879299|NCT02044367|2127711|P6|NOT COMPLETED|Overall Study||0
879300|NCT02044367|2127712|P5|NOT COMPLETED|Overall Study||0
879301|NCT02044367|2127713|P4|NOT COMPLETED|Overall Study||0
879302|NCT02044367|2127714|P3|NOT COMPLETED|Overall Study||0
879303|NCT02044367|2127715|P2|NOT COMPLETED|Overall Study||0
879304|NCT02044367|2127716|P1|NOT COMPLETED|Overall Study||0
879305|NCT02044367|2127711|P6|COMPLETED|Overall Study||9
879306|NCT02044367|2127712|P5|COMPLETED|Overall Study||9
879307|NCT02044367|2127713|P4|COMPLETED|Overall Study||9
879308|NCT02044367|2127714|P3|COMPLETED|Overall Study||9
879309|NCT02044367|2127715|P2|COMPLETED|Overall Study||9
879310|NCT02044367|2127716|P1|COMPLETED|Overall Study||9
879311|NCT02044367|2127711|P6|STARTED|Overall Study||9
879312|NCT02044367|2127712|P5|STARTED|Overall Study||9
879313|NCT02044367|2127713|P4|STARTED|Overall Study||9
879314|NCT02044367|2127714|P3|STARTED|Overall Study||9
879315|NCT02044367|2127715|P2|STARTED|Overall Study||9
879316|NCT02044367|2127716|P1|STARTED|Overall Study||9
879317|NCT02044302|2127739|P2|NOT COMPLETED|Overall Study||0
879318|NCT02044302|2127740|P1|NOT COMPLETED|Overall Study||2
879319|NCT02044302|2127739|P2|COMPLETED|Overall Study||0
879320|NCT02044302|2127740|P1|COMPLETED|Overall Study||0
879321|NCT02044302|2127739|P2|STARTED|Overall Study||0
879322|NCT02044302|2127740|P1|STARTED|Overall Study||2
879323|NCT02043808|2127748|P2|NOT COMPLETED|Overall Study||0
879324|NCT02043808|2127749|P1|NOT COMPLETED|Overall Study||0
879325|NCT02043808|2127748|P2|COMPLETED|Overall Study||12793
879326|NCT02043808|2127749|P1|COMPLETED|Overall Study||12793
879327|NCT02043808|2127748|P2|STARTED|Overall Study||12793
879328|NCT02043808|2127749|P1|STARTED|Overall Study||12793
879329|NCT02043782|2127787|P6|NOT COMPLETED|Period 3||0
879330|NCT02043782|2127788|P5|NOT COMPLETED|Period 3||0
879331|NCT02043782|2127789|P4|NOT COMPLETED|Period 3||0
879332|NCT02043782|2127790|P3|NOT COMPLETED|Period 3||0
879333|NCT02043782|2127791|P2|NOT COMPLETED|Period 3||0
879334|NCT02043782|2127792|P1|NOT COMPLETED|Period 3||0
879335|NCT02043782|2127787|P6|COMPLETED|Period 3||6
879336|NCT02043782|2127788|P5|COMPLETED|Period 3||6
879337|NCT02043782|2127789|P4|COMPLETED|Period 3||6
879338|NCT02043782|2127790|P3|COMPLETED|Period 3||6
879339|NCT02043782|2127791|P2|COMPLETED|Period 3||6
879340|NCT02043782|2127792|P1|COMPLETED|Period 3||7
879341|NCT02043782|2127787|P6|STARTED|Period 3||6
879342|NCT02043782|2127788|P5|STARTED|Period 3||6
879343|NCT02043782|2127789|P4|STARTED|Period 3||6
879344|NCT02043782|2127790|P3|STARTED|Period 3||6
879345|NCT02043782|2127791|P2|STARTED|Period 3||6
879346|NCT02043782|2127792|P1|STARTED|Period 3||7
879347|NCT02043782|2127787|P6|NOT COMPLETED|Period 2||0
879348|NCT02043782|2127788|P5|NOT COMPLETED|Period 2||0
879349|NCT02043782|2127789|P4|NOT COMPLETED|Period 2||0
879350|NCT02043782|2127790|P3|NOT COMPLETED|Period 2||0
879351|NCT02043782|2127791|P2|NOT COMPLETED|Period 2||0
879352|NCT02043782|2127792|P1|NOT COMPLETED|Period 2||0
879353|NCT02043782|2127787|P6|COMPLETED|Period 2||6
879354|NCT02043782|2127788|P5|COMPLETED|Period 2||6
879355|NCT02043782|2127789|P4|COMPLETED|Period 2||6
879356|NCT02043782|2127790|P3|COMPLETED|Period 2||6
879357|NCT02043782|2127791|P2|COMPLETED|Period 2||6
879358|NCT02043782|2127792|P1|COMPLETED|Period 2||7
879359|NCT02043782|2127787|P6|STARTED|Period 2||6
879360|NCT02043782|2127788|P5|STARTED|Period 2||6
879361|NCT02043782|2127789|P4|STARTED|Period 2||6
879362|NCT02043782|2127790|P3|STARTED|Period 2||6
879363|NCT02043782|2127791|P2|STARTED|Period 2||6
879364|NCT02043782|2127792|P1|STARTED|Period 2||7
879365|NCT02043782|2127787|P6|NOT COMPLETED|Period 1||0
879366|NCT02043782|2127788|P5|NOT COMPLETED|Period 1||0
879367|NCT02043782|2127789|P4|NOT COMPLETED|Period 1||0
879368|NCT02043782|2127790|P3|NOT COMPLETED|Period 1||1
879369|NCT02043782|2127791|P2|NOT COMPLETED|Period 1||0
879370|NCT02043782|2127792|P1|NOT COMPLETED|Period 1||0
879371|NCT02043782|2127787|P6|COMPLETED|Period 1||6
879372|NCT02043782|2127788|P5|COMPLETED|Period 1||6
879373|NCT02043782|2127789|P4|COMPLETED|Period 1||6
879374|NCT02043782|2127790|P3|COMPLETED|Period 1|One subject discontinued due to an adverse event while testing own product|6
879375|NCT02043782|2127791|P2|COMPLETED|Period 1||6
879376|NCT02043782|2127792|P1|COMPLETED|Period 1||7
879377|NCT02043782|2127787|P6|STARTED|Period 1||6
879378|NCT02043782|2127788|P5|STARTED|Period 1||6
879379|NCT02043782|2127789|P4|STARTED|Period 1||6
879380|NCT02043782|2127790|P3|STARTED|Period 1||7
879381|NCT02043782|2127791|P2|STARTED|Period 1||6
879382|NCT02043782|2127792|P1|STARTED|Period 1||7
879383|NCT02043379|2127802|P2|NOT COMPLETED|Overall Study||0
879384|NCT02043379|2127803|P1|NOT COMPLETED|Overall Study||0
879385|NCT02043379|2127802|P2|COMPLETED|Overall Study||20
879386|NCT02043379|2127803|P1|COMPLETED|Overall Study||30
879387|NCT02043379|2127802|P2|STARTED|Overall Study||20
879388|NCT02043379|2127803|P1|STARTED|Overall Study||30
879389|NCT02043366|2127865|P6|NOT COMPLETED|Overall Study||2
879390|NCT02043366|2127866|P5|NOT COMPLETED|Overall Study||2
879391|NCT02043366|2127867|P4|NOT COMPLETED|Overall Study||2
879392|NCT02043366|2127868|P3|NOT COMPLETED|Overall Study||2
879393|NCT02043366|2127869|P2|NOT COMPLETED|Overall Study||2
879394|NCT02043366|2127870|P1|NOT COMPLETED|Overall Study||2
879395|NCT02043366|2127865|P6|COMPLETED|Overall Study||28
879396|NCT02043366|2127866|P5|COMPLETED|Overall Study||28
879397|NCT02043366|2127867|P4|COMPLETED|Overall Study||28
879398|NCT02043366|2127868|P3|COMPLETED|Overall Study||28
879399|NCT02043366|2127869|P2|COMPLETED|Overall Study||28
879400|NCT02043366|2127870|P1|COMPLETED|Overall Study||28
879401|NCT02043366|2127865|P6|STARTED|Overall Study||30
879402|NCT02043366|2127866|P5|STARTED|Overall Study||30
879403|NCT02043366|2127867|P4|STARTED|Overall Study||30
879404|NCT02043366|2127868|P3|STARTED|Overall Study||30
879405|NCT02043366|2127869|P2|STARTED|Overall Study||30
879406|NCT02043366|2127870|P1|STARTED|Overall Study||30
879407|NCT02043145|2127893|P3|NOT COMPLETED|Overall Study||0
879408|NCT02043145|2127894|P2|NOT COMPLETED|Overall Study||0
879409|NCT02043145|2127895|P1|NOT COMPLETED|Overall Study||0
879410|NCT02043145|2127893|P3|COMPLETED|Overall Study||425
879411|NCT02043145|2127894|P2|COMPLETED|Overall Study||247
879412|NCT02043145|2127895|P1|COMPLETED|Overall Study||55
879413|NCT02043145|2127893|P3|STARTED|Overall Study||425
879414|NCT02043145|2127894|P2|STARTED|Overall Study||247
879415|NCT02043145|2127895|P1|STARTED|Overall Study||55
879416|NCT02043132|2127908|P2|NOT COMPLETED|Overall Study||9
879417|NCT02043132|2127909|P1|NOT COMPLETED|Overall Study||5
879418|NCT02043132|2127908|P2|COMPLETED|Overall Study||49
879419|NCT02043132|2127909|P1|COMPLETED|Overall Study||53
879420|NCT02043132|2127908|P2|STARTED|Overall Study||58
879421|NCT02043132|2127909|P1|STARTED|Overall Study||58
879422|NCT02042924|2127929|P1|NOT COMPLETED|Overall Study||1
879423|NCT02042924|2127929|P1|COMPLETED|Overall Study||1
879424|NCT02042924|2127929|P1|STARTED|Overall Study||2
879425|NCT02042911|2127935|P1|NOT COMPLETED|Overall Study||1
879426|NCT02042911|2127935|P1|COMPLETED|Overall Study||9
879427|NCT02042911|2127935|P1|STARTED|Overall Study||10
879428|NCT02042872|2127949|P2|NOT COMPLETED|Overall Study||5
879429|NCT02042872|2127950|P1|NOT COMPLETED|Overall Study||0
879430|NCT02042872|2127949|P2|COMPLETED|Overall Study||8
879431|NCT02042872|2127950|P1|COMPLETED|Overall Study||8
879432|NCT02042872|2127949|P2|STARTED|Overall Study||13
879433|NCT02042872|2127950|P1|STARTED|Overall Study||8
879434|NCT02042534|2127960|P2|NOT COMPLETED|Overall Study||0
879435|NCT02042534|2127961|P1|NOT COMPLETED|Overall Study||0
879436|NCT02042534|2127960|P2|COMPLETED|Overall Study||94
879437|NCT02042534|2127961|P1|COMPLETED|Overall Study||101
879438|NCT02042534|2127960|P2|STARTED|Overall Study||94
879439|NCT02042534|2127961|P1|STARTED|Overall Study||101
879440|NCT02042443|2127977|P2|NOT COMPLETED|Overall Study||26
879441|NCT02042443|2127978|P1|NOT COMPLETED|Overall Study||27
879442|NCT02042443|2127977|P2|COMPLETED|Overall Study||0
879443|NCT02042443|2127978|P1|COMPLETED|Overall Study||0
879444|NCT02042443|2127977|P2|Eligible and Analyzable|Overall Study||20
879445|NCT02042443|2127978|P1|Eligible and Analyzable|Overall Study||24
879446|NCT02042443|2127977|P2|STARTED|Overall Study||26
879447|NCT02042443|2127978|P1|STARTED|Overall Study||27
879448|NCT02042404|2127990|P2|NOT COMPLETED|Overall Study||0
879449|NCT02042404|2127991|P1|NOT COMPLETED|Overall Study||5
879450|NCT02042404|2127990|P2|COMPLETED|Overall Study||5
879451|NCT02042404|2127991|P1|COMPLETED|Overall Study|39 subjects completed 30 days evaluation. 38 subjects completed 120 days evaluation.|38
879452|NCT02042404|2127990|P2|STARTED|Overall Study||5
879453|NCT02042404|2127991|P1|STARTED|Overall Study|Enrollment was stopped after 43 were enrolled, had approval to enroll 45 primary cohort subjects|43
879454|NCT02042274|2128002|P1|NOT COMPLETED|Overall Study||0
879455|NCT02042274|2128002|P1|COMPLETED|Overall Study||12
879456|NCT02042274|2128002|P1|STARTED|Overall Study||12
879457|NCT02042131|2128010|P3|NOT COMPLETED|Overall Study||0
879458|NCT02042131|2128011|P2|NOT COMPLETED|Overall Study||0
879459|NCT02042131|2128012|P1|NOT COMPLETED|Overall Study||0
879460|NCT02042131|2128010|P3|COMPLETED|Overall Study||33
879461|NCT02042131|2128011|P2|COMPLETED|Overall Study||32
879462|NCT02042131|2128012|P1|COMPLETED|Overall Study||32
879463|NCT02042131|2128010|P3|STARTED|Overall Study||33
879464|NCT02042131|2128011|P2|STARTED|Overall Study||32
879465|NCT02042131|2128012|P1|STARTED|Overall Study||32
879466|NCT02041533|2128031|P2|NOT COMPLETED|Overall Study||258
879467|NCT02041533|2128032|P1|NOT COMPLETED|Overall Study||228
879468|NCT02041533|2128031|P2|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|12
879469|NCT02041533|2128032|P1|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|43
879470|NCT02041533|2128031|P2|Began Treatment|Overall Study||263
879471|NCT02041533|2128032|P1|Began Treatment|Overall Study||267
879472|NCT02041533|2128031|P2|STARTED|Overall Study||270
879473|NCT02041533|2128032|P1|STARTED|Overall Study||271
879474|NCT02041520|2128054|P2|NOT COMPLETED|Overall Study||7
879475|NCT02041520|2128055|P1|NOT COMPLETED|Overall Study||6
879476|NCT02041520|2128054|P2|COMPLETED|Overall Study||28
879477|NCT02041520|2128055|P1|COMPLETED|Overall Study||29
879478|NCT02041520|2128054|P2|STARTED|Overall Study|35 patients randomly assigned to placebo|35
879479|NCT02041520|2128055|P1|STARTED|Overall Study|35 patients randomly assigned to omega 3 fatty acids|35
879480|NCT02041377|2128075|P1|NOT COMPLETED|Overall Study||0
879481|NCT02041377|2128075|P1|COMPLETED|Overall Study||134
879482|NCT02041377|2128075|P1|STARTED|Overall Study||134
879483|NCT02041325|2128085|P2|NOT COMPLETED|Overall Study||3
879484|NCT02041325|2128086|P1|NOT COMPLETED|Overall Study||3
879485|NCT02041325|2128085|P2|COMPLETED|Overall Study||13
879486|NCT02041325|2128086|P1|COMPLETED|Overall Study||19
879487|NCT02041325|2128085|P2|STARTED|Overall Study||16
879488|NCT02041325|2128086|P1|STARTED|Overall Study||22
879489|NCT02041286|2128098|P1|NOT COMPLETED|Overall Study||1
879490|NCT02041286|2128098|P1|COMPLETED|Overall Study|One subject discontinued from testing after low BG fingerstick result (hypoglycemia AE).|135
879491|NCT02041286|2128098|P1|STARTED|Overall Study||136
879492|NCT02041221|2128112|P6|NOT COMPLETED|Part 2||0
879493|NCT02041221|2128113|P5|NOT COMPLETED|Part 2||0
879494|NCT02041221|2128114|P4|NOT COMPLETED|Part 2||0
879495|NCT02041221|2128115|P3|NOT COMPLETED|Part 2||1
879496|NCT02041221|2128116|P2|NOT COMPLETED|Part 2||0
879497|NCT02041221|2128117|P1|NOT COMPLETED|Part 2||0
879498|NCT02041221|2128112|P6|COMPLETED|Part 2||6
879499|NCT02041221|2128113|P5|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
879500|NCT02041221|2128114|P4|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
879501|NCT02041221|2128115|P3|COMPLETED|Part 2||5
879502|NCT02041221|2128116|P2|COMPLETED|Part 2||6
879503|NCT02041221|2128117|P1|COMPLETED|Part 2||6
879504|NCT02041221|2128112|P6|STARTED|Part 2||6
879505|NCT02041221|2128113|P5|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
879506|NCT02041221|2128114|P4|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually.|0
879507|NCT02041221|2128115|P3|STARTED|Part 2||6
879508|NCT02041221|2128116|P2|STARTED|Part 2||6
879509|NCT02041221|2128117|P1|STARTED|Part 2||6
879510|NCT02041221|2128112|P6|NOT COMPLETED|Part 1||0
879511|NCT02041221|2128113|P5|NOT COMPLETED|Part 1||0
879512|NCT02041221|2128114|P4|NOT COMPLETED|Part 1||0
879513|NCT02041221|2128115|P3|NOT COMPLETED|Part 1||0
879514|NCT02041221|2128116|P2|NOT COMPLETED|Part 1||0
879515|NCT02041221|2128117|P1|NOT COMPLETED|Part 1||0
879516|NCT02041221|2128112|P6|COMPLETED|Part 1||10
879517|NCT02041221|2128113|P5|COMPLETED|Part 1||6
879518|NCT02041221|2128114|P4|COMPLETED|Part 1||6
879519|NCT02041221|2128115|P3|COMPLETED|Part 1||6
879520|NCT02041221|2128116|P2|COMPLETED|Part 1||6
879521|NCT02041221|2128117|P1|COMPLETED|Part 1||6
879522|NCT02041221|2128112|P6|STARTED|Part 1||10
879523|NCT02041221|2128113|P5|STARTED|Part 1||6
879524|NCT02041221|2128114|P4|STARTED|Part 1||6
879525|NCT02041221|2128115|P3|STARTED|Part 1||6
879526|NCT02041221|2128116|P2|STARTED|Part 1||6
879527|NCT02041221|2128117|P1|STARTED|Part 1||6
879528|NCT02040792|2128136|P5|NOT COMPLETED|Overall Study||7
879529|NCT02040792|2128137|P4|NOT COMPLETED|Overall Study||7
879530|NCT02040792|2128138|P3|NOT COMPLETED|Overall Study||3
879531|NCT02040792|2128139|P2|NOT COMPLETED|Overall Study||3
879532|NCT02040792|2128140|P1|NOT COMPLETED|Overall Study||6
879533|NCT02040792|2128136|P5|COMPLETED|Overall Study||67
879534|NCT02040792|2128137|P4|COMPLETED|Overall Study||64
879535|NCT02040792|2128138|P3|COMPLETED|Overall Study||68
879536|NCT02040792|2128139|P2|COMPLETED|Overall Study||65
879537|NCT02040792|2128140|P1|COMPLETED|Overall Study||64
879538|NCT02040792|2128136|P5|STARTED|Overall Study||74
879539|NCT02040792|2128137|P4|STARTED|Overall Study||71
879540|NCT02040792|2128138|P3|STARTED|Overall Study||71
879541|NCT02040792|2128139|P2|STARTED|Overall Study||68
879542|NCT02040792|2128140|P1|STARTED|Overall Study||70
879543|NCT02040623|2128155|P3|NOT COMPLETED|Overall Study||2
879544|NCT02040623|2128156|P2|NOT COMPLETED|Overall Study||6
879545|NCT02040623|2128157|P1|NOT COMPLETED|Overall Study||4
879546|NCT02040623|2128155|P3|COMPLETED|Overall Study||10
879547|NCT02040623|2128156|P2|COMPLETED|Overall Study||6
879548|NCT02040623|2128157|P1|COMPLETED|Overall Study||7
879549|NCT02040623|2128155|P3|STARTED|Overall Study||12
879550|NCT02040623|2128156|P2|STARTED|Overall Study||12
879551|NCT02040623|2128157|P1|STARTED|Overall Study||11
879552|NCT02040532|2128165|P1|NOT COMPLETED|Overall Study||12
879553|NCT02040532|2128165|P1|COMPLETED|Overall Study||20
879554|NCT02040532|2128165|P1|Received at Least One Dose of Medication|Overall Study||26
879555|NCT02040532|2128165|P1|STARTED|Overall Study||32
879556|NCT02040428|2128178|P2|NOT COMPLETED|Overall Study||4
879557|NCT02040428|2128179|P1|NOT COMPLETED|Overall Study||5
879558|NCT02040428|2128178|P2|COMPLETED|Overall Study||77
879559|NCT02040428|2128179|P1|COMPLETED|Overall Study||70
879560|NCT02040428|2128178|P2|Intent to Treat (Randomized Subjects)|Overall Study||80
879561|NCT02040428|2128179|P1|Intent to Treat (Randomized Subjects)|Overall Study||76
879562|NCT02040428|2128178|P2|STARTED|Overall Study||81
879563|NCT02040428|2128179|P1|STARTED|Overall Study||75
879564|NCT02040116|2128191|P1|NOT COMPLETED|Overall Study||0
879565|NCT02040116|2128191|P1|COMPLETED|Overall Study||19
879566|NCT02040116|2128191|P1|STARTED|Overall Study||19
879567|NCT02040077|2128202|P3|NOT COMPLETED|Overall Study||0
879568|NCT02040077|2128203|P2|NOT COMPLETED|Overall Study||0
879569|NCT02040077|2128204|P1|NOT COMPLETED|Overall Study||0
879570|NCT02040077|2128202|P3|COMPLETED|Overall Study||25
879571|NCT02040077|2128203|P2|COMPLETED|Overall Study||24
879572|NCT02040077|2128204|P1|COMPLETED|Overall Study||27
879573|NCT02040077|2128202|P3|STARTED|Overall Study||25
879574|NCT02040077|2128203|P2|STARTED|Overall Study||24
879575|NCT02040077|2128204|P1|STARTED|Overall Study||27
879576|NCT02039817|2128217|P2|NOT COMPLETED|Overall Study||0
879577|NCT02039817|2128218|P1|NOT COMPLETED|Overall Study||0
879578|NCT02039817|2128217|P2|COMPLETED|Overall Study||8
879579|NCT02039817|2128218|P1|COMPLETED|Overall Study||8
879580|NCT02039817|2128217|P2|STARTED|Overall Study||8
879581|NCT02039817|2128218|P1|STARTED|Overall Study||8
879582|NCT02039778|2128227|P1|NOT COMPLETED|Overall Study||4
879583|NCT02039778|2128227|P1|COMPLETED|Overall Study||0
879584|NCT02039778|2128227|P1|STARTED|Overall Study||4
879585|NCT02039687|2128239|P4|NOT COMPLETED|Overall Study||0
879586|NCT02039687|2128240|P3|NOT COMPLETED|Overall Study||3
879587|NCT02039687|2128241|P2|NOT COMPLETED|Overall Study||1
879588|NCT02039687|2128242|P1|NOT COMPLETED|Overall Study||0
879589|NCT02039687|2128239|P4|COMPLETED|Overall Study||16
879590|NCT02039687|2128240|P3|COMPLETED|Overall Study||13
879591|NCT02039687|2128241|P2|COMPLETED|Overall Study||15
879592|NCT02039687|2128242|P1|COMPLETED|Overall Study||16
879593|NCT02039687|2128239|P4|STARTED|Overall Study||16
879594|NCT02039687|2128240|P3|STARTED|Overall Study||16
879595|NCT02039687|2128241|P2|STARTED|Overall Study||16
879596|NCT02039687|2128242|P1|STARTED|Overall Study||16
879597|NCT02039427|2128272|P4|NOT COMPLETED|Overall Study||5
879598|NCT02039427|2128273|P3|NOT COMPLETED|Overall Study||3
879599|NCT02039427|2128274|P2|NOT COMPLETED|Overall Study||1
879600|NCT02039427|2128275|P1|NOT COMPLETED|Overall Study||3
879601|NCT02039427|2128272|P4|COMPLETED|Overall Study||43
879602|NCT02039427|2128273|P3|COMPLETED|Overall Study||45
879603|NCT02039427|2128274|P2|COMPLETED|Overall Study||47
879604|NCT02039427|2128275|P1|COMPLETED|Overall Study||45
879605|NCT02039427|2128272|P4|STARTED|Overall Study||48
879606|NCT02039427|2128273|P3|STARTED|Overall Study||48
879607|NCT02039427|2128274|P2|STARTED|Overall Study||48
879608|NCT02039427|2128275|P1|STARTED|Overall Study||48
879609|NCT02039414|2128295|P2|NOT COMPLETED|Overall Study||2
879610|NCT02039414|2128296|P1|NOT COMPLETED|Overall Study||6
879611|NCT02039414|2128295|P2|COMPLETED|Overall Study||16
879612|NCT02039414|2128296|P1|COMPLETED|Overall Study||16
879613|NCT02039414|2128295|P2|STARTED|Overall Study||18
879614|NCT02039414|2128296|P1|STARTED|Overall Study||22
879615|NCT02039115|2128310|P2|NOT COMPLETED|Overall Study||0
879616|NCT02039115|2128311|P1|NOT COMPLETED|Overall Study||0
879617|NCT02039115|2128310|P2|COMPLETED|Overall Study||0
879618|NCT02039115|2128311|P1|COMPLETED|Overall Study||1
879619|NCT02039115|2128310|P2|STARTED|Overall Study||0
879620|NCT02039115|2128311|P1|STARTED|Overall Study||1
879621|NCT02038959|2128319|P2|NOT COMPLETED|Overall Study||8
879622|NCT02038959|2128320|P1|NOT COMPLETED|Overall Study||6
879623|NCT02038959|2128319|P2|COMPLETED|Overall Study||89
879624|NCT02038959|2128320|P1|COMPLETED|Overall Study||92
879625|NCT02038959|2128319|P2|STARTED|Overall Study||97
879626|NCT02038959|2128320|P1|STARTED|Overall Study||98
879627|NCT02038933|2128348|P1|NOT COMPLETED|Follow-up||19
879628|NCT02038933|2128348|P1|COMPLETED|Follow-up|Includes subjects still on-treatment and subjects off-treatment continuing in the Follow-up period.|102
879629|NCT02038933|2128348|P1|STARTED|Follow-up||121
879630|NCT02038933|2128348|P1|NOT COMPLETED|Treatment||114
879631|NCT02038933|2128348|P1|COMPLETED|Treatment|Subjects continuing in the treatment period|7
879632|NCT02038933|2128348|P1|STARTED|Treatment||121
879633|NCT02038907|2128381|P14|NOT COMPLETED|Overall Study||0
879634|NCT02038907|2128382|P13|NOT COMPLETED|Overall Study||0
879635|NCT02038907|2128383|P12|NOT COMPLETED|Overall Study||0
879636|NCT02038907|2128384|P11|NOT COMPLETED|Overall Study||2
879637|NCT02038907|2128385|P10|NOT COMPLETED|Overall Study||0
879638|NCT02038907|2128386|P9|NOT COMPLETED|Overall Study||0
879639|NCT02038907|2128387|P8|NOT COMPLETED|Overall Study||0
879640|NCT02038907|2128388|P7|NOT COMPLETED|Overall Study||0
879641|NCT02038907|2128389|P6|NOT COMPLETED|Overall Study||0
879642|NCT02038907|2128390|P5|NOT COMPLETED|Overall Study||0
879643|NCT02038907|2128391|P4|NOT COMPLETED|Overall Study||0
879644|NCT02038907|2128392|P3|NOT COMPLETED|Overall Study||0
879645|NCT02038907|2128393|P2|NOT COMPLETED|Overall Study||0
879646|NCT02038907|2128394|P1|NOT COMPLETED|Overall Study||0
879647|NCT02038907|2128381|P14|COMPLETED|Overall Study||31
879648|NCT02038907|2128382|P13|COMPLETED|Overall Study||29
879649|NCT02038907|2128383|P12|COMPLETED|Overall Study||28
879650|NCT02038907|2128384|P11|COMPLETED|Overall Study||27
879651|NCT02038907|2128385|P10|COMPLETED|Overall Study||30
879652|NCT02038907|2128386|P9|COMPLETED|Overall Study||29
879653|NCT02038907|2128387|P8|COMPLETED|Overall Study||32
879654|NCT02038907|2128388|P7|COMPLETED|Overall Study||30
879655|NCT02038907|2128389|P6|COMPLETED|Overall Study||31
879656|NCT02038907|2128390|P5|COMPLETED|Overall Study||30
879657|NCT02038907|2128391|P4|COMPLETED|Overall Study||31
879658|NCT02038907|2128392|P3|COMPLETED|Overall Study||30
879659|NCT02038907|2128393|P2|COMPLETED|Overall Study||30
879660|NCT02038907|2128394|P1|COMPLETED|Overall Study||30
879661|NCT02038907|2128381|P14|STARTED|Overall Study||31
879662|NCT02038907|2128382|P13|STARTED|Overall Study||29
879663|NCT02038907|2128383|P12|STARTED|Overall Study||28
879664|NCT02038907|2128384|P11|STARTED|Overall Study||29
879665|NCT02038907|2128385|P10|STARTED|Overall Study||30
879666|NCT02038907|2128386|P9|STARTED|Overall Study||29
879667|NCT02038907|2128387|P8|STARTED|Overall Study||32
879668|NCT02038907|2128388|P7|STARTED|Overall Study||30
879669|NCT02038907|2128389|P6|STARTED|Overall Study||31
879670|NCT02038907|2128390|P5|STARTED|Overall Study||30
879671|NCT02038907|2128391|P4|STARTED|Overall Study||31
879672|NCT02038907|2128392|P3|STARTED|Overall Study||30
879673|NCT02038907|2128393|P2|STARTED|Overall Study||30
879674|NCT02038907|2128394|P1|STARTED|Overall Study||30
879675|NCT02038790|2128922|P2|NOT COMPLETED|Day 1 - Second Treatment||0
879676|NCT02038790|2128923|P1|NOT COMPLETED|Day 1 - Second Treatment||0
879677|NCT02038790|2128922|P2|COMPLETED|Day 1 - Second Treatment||16
879678|NCT02038790|2128923|P1|COMPLETED|Day 1 - Second Treatment||15
879679|NCT02038790|2128922|P2|STARTED|Day 1 - Second Treatment||16
879680|NCT02038790|2128923|P1|STARTED|Day 1 - Second Treatment||15
879681|NCT02038790|2128922|P2|NOT COMPLETED|Day 0 - First Treatment||1
879682|NCT02038790|2128923|P1|NOT COMPLETED|Day 0 - First Treatment||1
879683|NCT02038790|2128922|P2|COMPLETED|Day 0 - First Treatment||16
879684|NCT02038790|2128923|P1|COMPLETED|Day 0 - First Treatment||15
879685|NCT02038790|2128922|P2|STARTED|Day 0 - First Treatment||17
879686|NCT02038790|2128923|P1|STARTED|Day 0 - First Treatment||16
879687|NCT02038543|2128958|P4|NOT COMPLETED|Overall Study||2
879688|NCT02038543|2128959|P3|NOT COMPLETED|Overall Study||0
879689|NCT02038543|2128960|P2|NOT COMPLETED|Overall Study||0
879690|NCT02038543|2128961|P1|NOT COMPLETED|Overall Study||0
879691|NCT02038543|2128958|P4|COMPLETED|Overall Study||1
879692|NCT02038543|2128959|P3|COMPLETED|Overall Study||8
879693|NCT02038543|2128960|P2|COMPLETED|Overall Study||4
879694|NCT02038543|2128961|P1|COMPLETED|Overall Study||7
879695|NCT02038543|2128958|P4|STARTED|Overall Study||3
879696|NCT02038543|2128959|P3|STARTED|Overall Study||8
879697|NCT02038543|2128960|P2|STARTED|Overall Study||4
879698|NCT02038543|2128961|P1|STARTED|Overall Study||7
879699|NCT02038075|2128977|P2|NOT COMPLETED|Overall Study||0
879700|NCT02038075|2128978|P1|NOT COMPLETED|Overall Study||3
879701|NCT02038075|2128977|P2|COMPLETED|Overall Study||76
879702|NCT02038075|2128978|P1|COMPLETED|Overall Study||73
879703|NCT02038075|2128977|P2|STARTED|Overall Study||76
879704|NCT02038075|2128978|P1|STARTED|Overall Study||76
879705|NCT02037776|2128986|P2|NOT COMPLETED|Overall Study||4
879706|NCT02037776|2128987|P1|NOT COMPLETED|Overall Study||5
879707|NCT02037776|2128986|P2|COMPLETED|Overall Study||60
879708|NCT02037776|2128987|P1|COMPLETED|Overall Study||56
879709|NCT02037776|2128986|P2|STARTED|Overall Study||64
879710|NCT02037776|2128987|P1|STARTED|Overall Study||61
879714|NCT02037477|2129011|P4|NOT COMPLETED|Treatment Period 2||0
879715|NCT02037477|2129012|P3|NOT COMPLETED|Treatment Period 2||0
879716|NCT02037477|2129013|P2|NOT COMPLETED|Treatment Period 2||0
879717|NCT02037477|2129014|P1|NOT COMPLETED|Treatment Period 2||0
879718|NCT02037477|2129011|P4|COMPLETED|Treatment Period 2||5
879719|NCT02037477|2129012|P3|COMPLETED|Treatment Period 2||4
879720|NCT02037477|2129013|P2|COMPLETED|Treatment Period 2||5
879721|NCT02037477|2129014|P1|COMPLETED|Treatment Period 2||5
879722|NCT02037477|2129011|P4|STARTED|Treatment Period 2||5
879723|NCT02037477|2129012|P3|STARTED|Treatment Period 2||4
879724|NCT02037477|2129013|P2|STARTED|Treatment Period 2||5
879725|NCT02037477|2129014|P1|STARTED|Treatment Period 2||5
879726|NCT02037477|2129011|P4|NOT COMPLETED|Treatment Period 1||0
879727|NCT02037477|2129012|P3|NOT COMPLETED|Treatment Period 1||1
879728|NCT02037477|2129013|P2|NOT COMPLETED|Treatment Period 1||0
879729|NCT02037477|2129014|P1|NOT COMPLETED|Treatment Period 1||0
879730|NCT02037477|2129011|P4|COMPLETED|Treatment Period 1||5
879731|NCT02037477|2129012|P3|COMPLETED|Treatment Period 1||4
879732|NCT02037477|2129013|P2|COMPLETED|Treatment Period 1||5
879733|NCT02037477|2129014|P1|COMPLETED|Treatment Period 1||5
879734|NCT02037477|2129011|P4|STARTED|Treatment Period 1||5
879735|NCT02037477|2129012|P3|STARTED|Treatment Period 1||5
879736|NCT02037477|2129013|P2|STARTED|Treatment Period 1||5
879737|NCT02037477|2129014|P1|STARTED|Treatment Period 1||5
879738|NCT02037425|2129040|P1|NOT COMPLETED|Overall Study||26
879739|NCT02037425|2129040|P1|COMPLETED|Overall Study||18
879740|NCT02037425|2129040|P1|Randomized to Treatment|Overall Study||32
879741|NCT02037425|2129040|P1|STARTED|Overall Study||44
879742|NCT02037347|2129082|P1|NOT COMPLETED|Overall Study||0
879743|NCT02037347|2129082|P1|COMPLETED|Overall Study||1
879744|NCT02037347|2129082|P1|STARTED|Overall Study||1
879745|NCT02036840|2129088|P1|NOT COMPLETED|Overall Study||0
879746|NCT02036840|2129088|P1|COMPLETED|Overall Study||513
879747|NCT02036840|2129088|P1|STARTED|Overall Study||513
879748|NCT02036775|2129092|P6|NOT COMPLETED|Treatment Period 3 (6 Days)||0
879749|NCT02036775|2129093|P5|NOT COMPLETED|Treatment Period 3 (6 Days)||0
879750|NCT02036775|2129094|P4|NOT COMPLETED|Treatment Period 3 (6 Days)||0
879751|NCT02036775|2129095|P3|NOT COMPLETED|Treatment Period 3 (6 Days)||0
879752|NCT02036775|2129096|P2|NOT COMPLETED|Treatment Period 3 (6 Days)||0
879753|NCT02036775|2129097|P1|NOT COMPLETED|Treatment Period 3 (6 Days)||0
879754|NCT02036775|2129092|P6|COMPLETED|Treatment Period 3 (6 Days)||3
879755|NCT02036775|2129093|P5|COMPLETED|Treatment Period 3 (6 Days)||4
879756|NCT02036775|2129094|P4|COMPLETED|Treatment Period 3 (6 Days)||4
879757|NCT02036775|2129095|P3|COMPLETED|Treatment Period 3 (6 Days)||4
879758|NCT02036775|2129096|P2|COMPLETED|Treatment Period 3 (6 Days)||4
879759|NCT02036775|2129097|P1|COMPLETED|Treatment Period 3 (6 Days)||4
879760|NCT02036775|2129092|P6|STARTED|Treatment Period 3 (6 Days)||3
879761|NCT02036775|2129093|P5|STARTED|Treatment Period 3 (6 Days)||4
879762|NCT02036775|2129094|P4|STARTED|Treatment Period 3 (6 Days)||4
879763|NCT02036775|2129095|P3|STARTED|Treatment Period 3 (6 Days)||4
879764|NCT02036775|2129096|P2|STARTED|Treatment Period 3 (6 Days)||4
879765|NCT02036775|2129097|P1|STARTED|Treatment Period 3 (6 Days)||4
879766|NCT02036775|2129092|P6|NOT COMPLETED|Treatment Period 2 (6 Days)||1
879767|NCT02036775|2129093|P5|NOT COMPLETED|Treatment Period 2 (6 Days)||0
879768|NCT02036775|2129094|P4|NOT COMPLETED|Treatment Period 2 (6 Days)||0
879769|NCT02036775|2129095|P3|NOT COMPLETED|Treatment Period 2 (6 Days)||0
879770|NCT02036775|2129096|P2|NOT COMPLETED|Treatment Period 2 (6 Days)||0
879771|NCT02036775|2129097|P1|NOT COMPLETED|Treatment Period 2 (6 Days)||0
879772|NCT02036775|2129092|P6|COMPLETED|Treatment Period 2 (6 Days)||3
879773|NCT02036775|2129093|P5|COMPLETED|Treatment Period 2 (6 Days)||4
879774|NCT02036775|2129094|P4|COMPLETED|Treatment Period 2 (6 Days)||4
879775|NCT02036775|2129095|P3|COMPLETED|Treatment Period 2 (6 Days)||4
879776|NCT02036775|2129096|P2|COMPLETED|Treatment Period 2 (6 Days)||4
879777|NCT02036775|2129097|P1|COMPLETED|Treatment Period 2 (6 Days)||4
879778|NCT02036775|2129092|P6|STARTED|Treatment Period 2 (6 Days)||4
879779|NCT02036775|2129093|P5|STARTED|Treatment Period 2 (6 Days)||4
879780|NCT02036775|2129094|P4|STARTED|Treatment Period 2 (6 Days)||4
879781|NCT02036775|2129095|P3|STARTED|Treatment Period 2 (6 Days)||4
879782|NCT02036775|2129096|P2|STARTED|Treatment Period 2 (6 Days)||4
879783|NCT02036775|2129097|P1|STARTED|Treatment Period 2 (6 Days)||4
879784|NCT02036775|2129092|P6|NOT COMPLETED|Treatment Period 1 (6 Days)||0
879785|NCT02036775|2129093|P5|NOT COMPLETED|Treatment Period 1 (6 Days)||0
879786|NCT02036775|2129094|P4|NOT COMPLETED|Treatment Period 1 (6 Days)||0
879787|NCT02036775|2129095|P3|NOT COMPLETED|Treatment Period 1 (6 Days)||0
879788|NCT02036775|2129096|P2|NOT COMPLETED|Treatment Period 1 (6 Days)||0
879789|NCT02036775|2129097|P1|NOT COMPLETED|Treatment Period 1 (6 Days)||0
879790|NCT02036775|2129092|P6|COMPLETED|Treatment Period 1 (6 Days)||4
879791|NCT02036775|2129093|P5|COMPLETED|Treatment Period 1 (6 Days)||4
879792|NCT02036775|2129094|P4|COMPLETED|Treatment Period 1 (6 Days)||4
879793|NCT02036775|2129095|P3|COMPLETED|Treatment Period 1 (6 Days)||4
879794|NCT02036775|2129096|P2|COMPLETED|Treatment Period 1 (6 Days)||4
879795|NCT02036775|2129097|P1|COMPLETED|Treatment Period 1 (6 Days)||4
879796|NCT02036775|2129092|P6|STARTED|Treatment Period 1 (6 Days)||4
879797|NCT02036775|2129093|P5|STARTED|Treatment Period 1 (6 Days)||4
879798|NCT02036775|2129094|P4|STARTED|Treatment Period 1 (6 Days)||4
879799|NCT02036775|2129095|P3|STARTED|Treatment Period 1 (6 Days)||4
879800|NCT02036775|2129096|P2|STARTED|Treatment Period 1 (6 Days)||4
879801|NCT02036775|2129097|P1|STARTED|Treatment Period 1 (6 Days)||4
879802|NCT02036580|2129138|P3|NOT COMPLETED|Overall Study||0
879803|NCT02036580|2129139|P2|NOT COMPLETED|Overall Study||1
879804|NCT02036580|2129140|P1|NOT COMPLETED|Overall Study||1
879805|NCT02036580|2129138|P3|COMPLETED|Overall Study||4
879806|NCT02036580|2129139|P2|COMPLETED|Overall Study||7
879807|NCT02036580|2129140|P1|COMPLETED|Overall Study||7
879808|NCT02036580|2129138|P3|STARTED|Overall Study||4
879809|NCT02036580|2129139|P2|STARTED|Overall Study||8
879810|NCT02036580|2129140|P1|STARTED|Overall Study||8
879811|NCT02036541|2129153|P1|NOT COMPLETED|Overall Study||16
879812|NCT02036541|2129153|P1|COMPLETED|Overall Study||49
879813|NCT02036541|2129153|P1|Completed Endpoint Visit|Overall Study||54
879814|NCT02036541|2129153|P1|STARTED|Overall Study||65
879815|NCT02036515|2129161|P3|NOT COMPLETED|Overall Study||14
879816|NCT02036515|2129162|P2|NOT COMPLETED|Overall Study||12
879817|NCT02036515|2129163|P1|NOT COMPLETED|Overall Study||5
879818|NCT02036515|2129161|P3|COMPLETED|Overall Study||139
879819|NCT02036515|2129162|P2|COMPLETED|Overall Study||143
879820|NCT02036515|2129163|P1|COMPLETED|Overall Study||151
879821|NCT02036515|2129161|P3|Treated|Overall Study||153
879822|NCT02036515|2129162|P2|Treated|Overall Study||153
879823|NCT02036515|2129163|P1|Treated|Overall Study||156
879824|NCT02036515|2129161|P3|STARTED|Overall Study||153
879825|NCT02036515|2129162|P2|STARTED|Overall Study||155
879826|NCT02036515|2129163|P1|STARTED|Overall Study||156
879827|NCT02036424|2129242|P2|NOT COMPLETED|Overall Study||0
879828|NCT02036424|2129243|P1|NOT COMPLETED|Overall Study||0
879829|NCT02036424|2129242|P2|COMPLETED|Overall Study|27 study eyes, not number of subjects|27
879830|NCT02036424|2129243|P1|COMPLETED|Overall Study|23 study eyes, not number of subjects|23
879831|NCT02036424|2129242|P2|STARTED|Overall Study|27 study eyes, not number of subjects|27
879832|NCT02036424|2129243|P1|STARTED|Overall Study|23 study eyes, not number of subjects|23
879833|NCT02036320|2129251|P2|NOT COMPLETED|Period 2||0
879834|NCT02036320|2129252|P1|NOT COMPLETED|Period 2||0
879835|NCT02036320|2129251|P2|COMPLETED|Period 2||95
879836|NCT02036320|2129252|P1|COMPLETED|Period 2||95
879837|NCT02036320|2129251|P2|STARTED|Period 2||95
879838|NCT02036320|2129252|P1|STARTED|Period 2||95
879839|NCT02036320|2129251|P2|NOT COMPLETED|Period 1||0
879840|NCT02036320|2129252|P1|NOT COMPLETED|Period 1||0
879841|NCT02036320|2129251|P2|COMPLETED|Period 1||95
879842|NCT02036320|2129252|P1|COMPLETED|Period 1||95
879843|NCT02036320|2129251|P2|STARTED|Period 1||95
879844|NCT02036320|2129252|P1|STARTED|Period 1||95
879845|NCT02035748|2129262|P1|NOT COMPLETED|Overall Study||20
879846|NCT02035748|2129262|P1|COMPLETED|Overall Study||448
879847|NCT02035748|2129262|P1|STARTED|Overall Study||468
879860|NCT02035475|2129321|P1|NOT COMPLETED|Overall Study||6
879861|NCT02035475|2129321|P1|COMPLETED|Overall Study|Six subjects did not complete the study due to withdrawal of consent.|114
879862|NCT02035475|2129321|P1|STARTED|Overall Study|120 subjects were consented for participation in the study.|120
879863|NCT02035345|2129327|P1|NOT COMPLETED|Overall Study||0
879864|NCT02035345|2129327|P1|COMPLETED|Overall Study||15
879865|NCT02035345|2129327|P1|STARTED|Overall Study||15
879866|NCT02035332|2129332|P1|NOT COMPLETED|Overall Study||1
879867|NCT02035332|2129332|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|20
879868|NCT02035332|2129332|P1|Treated|Overall Study|Treatment Completed|20
879869|NCT02035332|2129332|P1|STARTED|Overall Study|Treatment Attempted|21
879870|NCT02034877|2129340|P2|NOT COMPLETED|Overall Study||6
879871|NCT02034877|2129341|P1|NOT COMPLETED|Overall Study||0
879872|NCT02034877|2129340|P2|COMPLETED|Overall Study||993
879873|NCT02034877|2129341|P1|COMPLETED|Overall Study||200
879874|NCT02034877|2129340|P2|STARTED|Overall Study||999
879875|NCT02034877|2129341|P1|STARTED|Overall Study||200
879876|NCT02034708|2129359|P2|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
879877|NCT02034708|2129360|P1|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
879878|NCT02034708|2129359|P2|COMPLETED|Second Contrast Agent Injection (1 Day)||120
879879|NCT02034708|2129360|P1|COMPLETED|Second Contrast Agent Injection (1 Day)||129
879880|NCT02034708|2129359|P2|STARTED|Second Contrast Agent Injection (1 Day)||120
879881|NCT02034708|2129360|P1|STARTED|Second Contrast Agent Injection (1 Day)||129
879882|NCT02034708|2129359|P2|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||10
879883|NCT02034708|2129360|P1|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||9
879884|NCT02034708|2129359|P2|COMPLETED|Wash-out (From 2 Days up to 14 Days)||120
879885|NCT02034708|2129360|P1|COMPLETED|Wash-out (From 2 Days up to 14 Days)||129
879886|NCT02034708|2129359|P2|STARTED|Wash-out (From 2 Days up to 14 Days)||130
879887|NCT02034708|2129360|P1|STARTED|Wash-out (From 2 Days up to 14 Days)||138
879888|NCT02034708|2129359|P2|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
879889|NCT02034708|2129360|P1|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
879890|NCT02034708|2129359|P2|COMPLETED|First Contrast Agent Injection (1 Day)||130
879891|NCT02034708|2129360|P1|COMPLETED|First Contrast Agent Injection (1 Day)||138
879892|NCT02034708|2129359|P2|STARTED|First Contrast Agent Injection (1 Day)||130
879893|NCT02034708|2129360|P1|STARTED|First Contrast Agent Injection (1 Day)||138
879894|NCT02034591|2129371|P6|NOT COMPLETED|Overall Study||0
879895|NCT02034591|2129372|P5|NOT COMPLETED|Overall Study||1
879896|NCT02034591|2129373|P4|NOT COMPLETED|Overall Study||0
879897|NCT02034591|2129374|P3|NOT COMPLETED|Overall Study||0
879898|NCT02034591|2129375|P2|NOT COMPLETED|Overall Study||0
879899|NCT02034591|2129376|P1|NOT COMPLETED|Overall Study||0
879900|NCT02034591|2129371|P6|COMPLETED|Overall Study||3
879901|NCT02034591|2129372|P5|COMPLETED|Overall Study||3
879902|NCT02034591|2129373|P4|COMPLETED|Overall Study||3
879903|NCT02034591|2129374|P3|COMPLETED|Overall Study||4
879904|NCT02034591|2129375|P2|COMPLETED|Overall Study||3
879905|NCT02034591|2129376|P1|COMPLETED|Overall Study||4
879906|NCT02034591|2129371|P6|STARTED|Overall Study||3
879907|NCT02034591|2129372|P5|STARTED|Overall Study||4
879908|NCT02034591|2129373|P4|STARTED|Overall Study||3
879909|NCT02034591|2129374|P3|STARTED|Overall Study||4
879910|NCT02034591|2129375|P2|STARTED|Overall Study||3
879911|NCT02034591|2129376|P1|STARTED|Overall Study||4
879912|NCT02034578|2129399|P6|NOT COMPLETED|Overall Study||0
879913|NCT02034578|2129400|P5|NOT COMPLETED|Overall Study||0
879914|NCT02034578|2129401|P4|NOT COMPLETED|Overall Study||0
879915|NCT02034578|2129402|P3|NOT COMPLETED|Overall Study||0
879916|NCT02034578|2129403|P2|NOT COMPLETED|Overall Study||0
879917|NCT02034578|2129404|P1|NOT COMPLETED|Overall Study||0
879918|NCT02034578|2129399|P6|COMPLETED|Overall Study||3
879919|NCT02034578|2129400|P5|COMPLETED|Overall Study||4
879920|NCT02034578|2129401|P4|COMPLETED|Overall Study||3
879921|NCT02034578|2129402|P3|COMPLETED|Overall Study||4
879922|NCT02034578|2129403|P2|COMPLETED|Overall Study||3
879923|NCT02034578|2129404|P1|COMPLETED|Overall Study||4
879924|NCT02034578|2129399|P6|STARTED|Overall Study||3
879925|NCT02034578|2129400|P5|STARTED|Overall Study||4
879926|NCT02034578|2129401|P4|STARTED|Overall Study||3
879927|NCT02034578|2129402|P3|STARTED|Overall Study||4
879928|NCT02034578|2129403|P2|STARTED|Overall Study||3
879929|NCT02034578|2129404|P1|STARTED|Overall Study||4
879930|NCT02034565|2129431|P2|NOT COMPLETED|Overall Study||0
879931|NCT02034565|2129432|P1|NOT COMPLETED|Overall Study||1
879932|NCT02034565|2129431|P2|COMPLETED|Overall Study||7
879933|NCT02034565|2129432|P1|COMPLETED|Overall Study||6
879934|NCT02034565|2129431|P2|STARTED|Overall Study||7
879935|NCT02034565|2129432|P1|STARTED|Overall Study||7
879936|NCT02034552|2129449|P3|NOT COMPLETED|Overall Study||15
879937|NCT02034552|2129450|P2|NOT COMPLETED|Overall Study||17
879938|NCT02034552|2129451|P1|NOT COMPLETED|Overall Study||6
879939|NCT02034552|2129449|P3|COMPLETED|Overall Study||7
879940|NCT02034552|2129450|P2|COMPLETED|Overall Study||7
879941|NCT02034552|2129451|P1|COMPLETED|Overall Study||16
879942|NCT02034552|2129449|P3|Received Treatment|Overall Study||22
879943|NCT02034552|2129450|P2|Received Treatment|Overall Study||22
879944|NCT02034552|2129451|P1|Received Treatment|Overall Study||19
879945|NCT02034552|2129449|P3|STARTED|Overall Study||22
879946|NCT02034552|2129450|P2|STARTED|Overall Study||24
879947|NCT02034552|2129451|P1|STARTED|Overall Study||22
879948|NCT02034513|2129476|P2|NOT COMPLETED|Overall Study||57
879949|NCT02034513|2129477|P1|NOT COMPLETED|Overall Study||49
879950|NCT02034513|2129476|P2|COMPLETED|Overall Study||195
879951|NCT02034513|2129477|P1|COMPLETED|Overall Study||200
879952|NCT02034513|2129476|P2|Exposed|Overall Study||251
879953|NCT02034513|2129477|P1|Exposed|Overall Study||249
879954|NCT02034513|2129476|P2|STARTED|Overall Study||252
879955|NCT02034513|2129477|P1|STARTED|Overall Study||249
879956|NCT02034162|2129495|P3|NOT COMPLETED|Open-label||0
879957|NCT02034162|2129496|P2|NOT COMPLETED|Open-label||0
879958|NCT02034162|2129497|P1|NOT COMPLETED|Open-label||0
879959|NCT02034162|2129495|P3|COMPLETED|Open-label||278
879960|NCT02034162|2129496|P2|COMPLETED|Open-label||0
879961|NCT02034162|2129497|P1|COMPLETED|Open-label||0
879962|NCT02034162|2129495|P3|STARTED|Open-label||278
879963|NCT02034162|2129496|P2|STARTED|Open-label||0
879964|NCT02034162|2129497|P1|STARTED|Open-label||0
879965|NCT02034162|2129495|P3|NOT COMPLETED|Double-blind||0
879966|NCT02034162|2129496|P2|NOT COMPLETED|Double-blind||8
879967|NCT02034162|2129497|P1|NOT COMPLETED|Double-blind||9
879968|NCT02034162|2129495|P3|COMPLETED|Double-blind||0
879969|NCT02034162|2129496|P2|COMPLETED|Double-blind||141
879970|NCT02034162|2129497|P1|COMPLETED|Double-blind||137
879971|NCT02034162|2129495|P3|STARTED|Double-blind||0
879972|NCT02034162|2129496|P2|STARTED|Double-blind||149
879973|NCT02034162|2129497|P1|STARTED|Double-blind||146
879974|NCT02033317|2129525|P1|NOT COMPLETED|Overall Study||0
879975|NCT02033317|2129525|P1|COMPLETED|Overall Study||6
879976|NCT02033317|2129525|P1|STARTED|Overall Study||6
879977|NCT02033213|2129532|P2|NOT COMPLETED|Overall Study||0
879978|NCT02033213|2129533|P1|NOT COMPLETED|Overall Study||0
879979|NCT02033213|2129532|P2|COMPLETED|Overall Study||8
879980|NCT02033213|2129533|P1|COMPLETED|Overall Study||8
879981|NCT02033213|2129532|P2|STARTED|Overall Study||8
879982|NCT02033213|2129533|P1|STARTED|Overall Study||8
879983|NCT02033200|2129551|P2|NOT COMPLETED|Overall Study||0
879984|NCT02033200|2129552|P1|NOT COMPLETED|Overall Study||0
879985|NCT02033200|2129551|P2|COMPLETED|Overall Study||40
879986|NCT02033200|2129552|P1|COMPLETED|Overall Study||40
879987|NCT02033200|2129551|P2|STARTED|Overall Study||40
879988|NCT02033200|2129552|P1|STARTED|Overall Study||40
879989|NCT02033174|2129572|P2|NOT COMPLETED|Second Intervention||0
879990|NCT02033174|2129573|P1|NOT COMPLETED|Second Intervention||0
879991|NCT02033174|2129572|P2|COMPLETED|Second Intervention||8
879992|NCT02033174|2129573|P1|COMPLETED|Second Intervention||8
879993|NCT02033174|2129572|P2|STARTED|Second Intervention||8
879994|NCT02033174|2129573|P1|STARTED|Second Intervention||8
879995|NCT02033174|2129572|P2|NOT COMPLETED|Washout (1 Week)||0
879996|NCT02033174|2129573|P1|NOT COMPLETED|Washout (1 Week)||0
879997|NCT02033174|2129572|P2|COMPLETED|Washout (1 Week)||8
879998|NCT02033174|2129573|P1|COMPLETED|Washout (1 Week)||8
879999|NCT02033174|2129572|P2|STARTED|Washout (1 Week)||8
880000|NCT02033174|2129573|P1|STARTED|Washout (1 Week)||8
880001|NCT02033174|2129572|P2|NOT COMPLETED|First Intervention||0
880002|NCT02033174|2129573|P1|NOT COMPLETED|First Intervention||0
880003|NCT02033174|2129572|P2|COMPLETED|First Intervention||8
880004|NCT02033174|2129573|P1|COMPLETED|First Intervention||8
880005|NCT02033174|2129572|P2|STARTED|First Intervention||8
880006|NCT02033174|2129573|P1|STARTED|First Intervention||8
880007|NCT02032901|2129581|P2|NOT COMPLETED|Follow-Up Period (24 Weeks)||1
880008|NCT02032901|2129582|P1|NOT COMPLETED|Follow-Up Period (24 Weeks)||0
880009|NCT02032901|2129581|P2|COMPLETED|Follow-Up Period (24 Weeks)||50
880010|NCT02032901|2129582|P1|COMPLETED|Follow-Up Period (24 Weeks)||101
880011|NCT02032901|2129581|P2|STARTED|Follow-Up Period (24 Weeks)||51
880012|NCT02032901|2129582|P1|STARTED|Follow-Up Period (24 Weeks)|Participant could enter follow up period even if the treatment period was not completed.|101
880013|NCT02032901|2129581|P2|NOT COMPLETED|Treatment Period (12 Weeks)||0
880014|NCT02032901|2129582|P1|NOT COMPLETED|Treatment Period (12 Weeks)||1
880015|NCT02032901|2129581|P2|COMPLETED|Treatment Period (12 Weeks)||51
880016|NCT02032901|2129582|P1|COMPLETED|Treatment Period (12 Weeks)||100
880017|NCT02032901|2129581|P2|STARTED|Treatment Period (12 Weeks)||51
880018|NCT02032901|2129582|P1|STARTED|Treatment Period (12 Weeks)||101
880019|NCT02032888|2129606|P3|NOT COMPLETED|Follow-up Period||0
880020|NCT02032888|2129607|P2|NOT COMPLETED|Follow-up Period||2
880021|NCT02032888|2129608|P1|NOT COMPLETED|Follow-up Period||3
880022|NCT02032888|2129606|P3|COMPLETED|Follow-up Period||52
880023|NCT02032888|2129607|P2|COMPLETED|Follow-up Period||47
880024|NCT02032888|2129608|P1|COMPLETED|Follow-up Period||97
880025|NCT02032888|2129606|P3|STARTED|Follow-up Period||52
880026|NCT02032888|2129607|P2|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|49
880027|NCT02032888|2129608|P1|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|100
880028|NCT02032888|2129606|P3|NOT COMPLETED|Treatment Period||0
880029|NCT02032888|2129607|P2|NOT COMPLETED|Treatment Period||2
880030|NCT02032888|2129608|P1|NOT COMPLETED|Treatment Period||2
880031|NCT02032888|2129606|P3|COMPLETED|Treatment Period||52
880032|NCT02032888|2129607|P2|COMPLETED|Treatment Period||48
880033|NCT02032888|2129608|P1|COMPLETED|Treatment Period||99
880034|NCT02032888|2129606|P3|STARTED|Treatment Period||52
880035|NCT02032888|2129607|P2|STARTED|Treatment Period||50
880036|NCT02032888|2129608|P1|STARTED|Treatment Period||101
880037|NCT02032875|2129639|P2|NOT COMPLETED|Follow-up Period||11
880038|NCT02032875|2129640|P1|NOT COMPLETED|Follow-up Period||3
880039|NCT02032875|2129639|P2|COMPLETED|Follow-up Period||46
880040|NCT02032875|2129640|P1|COMPLETED|Follow-up Period||50
880041|NCT02032875|2129639|P2|STARTED|Follow-up Period|Of 60 participants in treatment period, 57 continued in follow-up, 3 entered treatment extension.|57
880042|NCT02032875|2129640|P1|STARTED|Follow-up Period|Out of 53 participants who entered the treatment period, all 53 continued in the follow-up period.|53
880043|NCT02032875|2129639|P2|NOT COMPLETED|Treatment Period||4
880044|NCT02032875|2129640|P1|NOT COMPLETED|Treatment Period||1
880045|NCT02032875|2129639|P2|COMPLETED|Treatment Period||56
880046|NCT02032875|2129640|P1|COMPLETED|Treatment Period||52
880047|NCT02032875|2129639|P2|STARTED|Treatment Period||60
880048|NCT02032875|2129640|P1|STARTED|Treatment Period||53
880049|NCT02032758|2129660|P2|NOT COMPLETED|Overall Study||0
880050|NCT02032758|2129661|P1|NOT COMPLETED|Overall Study||0
880051|NCT02032758|2129660|P2|COMPLETED|Overall Study||11
880052|NCT02032758|2129661|P1|COMPLETED|Overall Study||27
880053|NCT02032758|2129660|P2|STARTED|Overall Study||11
880054|NCT02032758|2129661|P1|STARTED|Overall Study||27
880055|NCT02032706|2129669|P1|NOT COMPLETED|Overall Study||6
880056|NCT02032706|2129669|P1|COMPLETED|Overall Study||30
880057|NCT02032706|2129669|P1|STARTED|Overall Study||36
880058|NCT02032641|2129682|P1|NOT COMPLETED|Overall Study||1
880059|NCT02032641|2129682|P1|COMPLETED|Overall Study|16 brows completed study (half underwent treatment, half were control)|8
880060|NCT02032641|2129682|P1|STARTED|Overall Study|18 Brows enrolled for evaluation|9
880061|NCT02032420|2129694|P2|NOT COMPLETED|Overall Study||0
880062|NCT02032420|2129695|P1|NOT COMPLETED|Overall Study||0
880063|NCT02032420|2129694|P2|COMPLETED|Overall Study||17
880064|NCT02032420|2129695|P1|COMPLETED|Overall Study||18
880065|NCT02032420|2129694|P2|STARTED|Overall Study||17
880066|NCT02032420|2129695|P1|STARTED|Overall Study||18
880067|NCT02032407|2129707|P1|NOT COMPLETED|Overall Study||5
880068|NCT02032407|2129707|P1|COMPLETED|Overall Study||63
880069|NCT02032407|2129707|P1|STARTED|Overall Study||68
880070|NCT02032238|2129720|P2|NOT COMPLETED|Overall Study||0
880071|NCT02032238|2129721|P1|NOT COMPLETED|Overall Study||2
880072|NCT02032238|2129720|P2|COMPLETED|Overall Study||0
880073|NCT02032238|2129721|P1|COMPLETED|Overall Study||10
880074|NCT02032238|2129720|P2|STARTED|Overall Study|Study Terminated due to slow enrollment, no subjects enrolled in this study arm|0
880075|NCT02032238|2129721|P1|STARTED|Overall Study||12
880076|NCT02032212|2129731|P4|NOT COMPLETED|Overall Study||0
880077|NCT02032212|2129732|P3|NOT COMPLETED|Overall Study||0
880078|NCT02032212|2129733|P2|NOT COMPLETED|Overall Study||0
880079|NCT02032212|2129734|P1|NOT COMPLETED|Overall Study||0
880080|NCT02032212|2129731|P4|COMPLETED|Overall Study||3
880081|NCT02032212|2129732|P3|COMPLETED|Overall Study||3
880082|NCT02032212|2129733|P2|COMPLETED|Overall Study||3
880083|NCT02032212|2129734|P1|COMPLETED|Overall Study||3
880084|NCT02032212|2129731|P4|STARTED|Overall Study||3
880085|NCT02032212|2129732|P3|STARTED|Overall Study||3
880086|NCT02032212|2129733|P2|STARTED|Overall Study||3
880087|NCT02032212|2129734|P1|STARTED|Overall Study||3
880088|NCT02031679|2129762|P2|NOT COMPLETED|Overall Study||2
880089|NCT02031679|2129763|P1|NOT COMPLETED|Overall Study||0
880090|NCT02031679|2129762|P2|COMPLETED|Overall Study||12
880091|NCT02031679|2129763|P1|COMPLETED|Overall Study||14
880092|NCT02031679|2129762|P2|STARTED|Overall Study||14
880093|NCT02031679|2129763|P1|STARTED|Overall Study||14
880094|NCT02031471|2129773|P1|NOT COMPLETED|Long Term Extension (LTE) Period||2
880095|NCT02031471|2129773|P1|COMPLETED|Long Term Extension (LTE) Period||37
880096|NCT02031471|2129773|P1|STARTED|Long Term Extension (LTE) Period|Only participants who achieved at least a moderate EULAR response at Week 24 entered the LTE Period.|39
880097|NCT02031471|2129773|P1|NOT COMPLETED|24 Week Treatment Period||11
880098|NCT02031471|2129773|P1|COMPLETED|24 Week Treatment Period||46
880099|NCT02031471|2129773|P1|STARTED|24 Week Treatment Period||57
880100|NCT02031458|2129806|P3|NOT COMPLETED|Overall Study||253
880101|NCT02031458|2129807|P2|NOT COMPLETED|Overall Study||267
880102|NCT02031458|2129808|P1|NOT COMPLETED|Overall Study||139
880103|NCT02031458|2129806|P3|COMPLETED|Overall Study||0
880104|NCT02031458|2129807|P2|COMPLETED|Overall Study||0
880105|NCT02031458|2129808|P1|COMPLETED|Overall Study||0
880106|NCT02031458|2129806|P3|STARTED|Overall Study||253
880107|NCT02031458|2129807|P2|STARTED|Overall Study||267
880108|NCT02031458|2129808|P1|STARTED|Overall Study||139
880109|NCT02030600|2129904|P2|NOT COMPLETED|Treatment Period 2||18
880110|NCT02030600|2129905|P1|NOT COMPLETED|Treatment Period 2||25
880111|NCT02030600|2129904|P2|COMPLETED|Treatment Period 2||297
880112|NCT02030600|2129905|P1|COMPLETED|Treatment Period 2||283
880113|NCT02030600|2129904|P2|STARTED|Treatment Period 2||315
880114|NCT02030600|2129905|P1|STARTED|Treatment Period 2||308
880115|NCT02030600|2129904|P2|NOT COMPLETED|Treatment Period 1||45
880116|NCT02030600|2129905|P1|NOT COMPLETED|Treatment Period 1||53
880117|NCT02030600|2129904|P2|COMPLETED|Treatment Period 1||315
880118|NCT02030600|2129905|P1|COMPLETED|Treatment Period 1||308
880119|NCT02030600|2129904|P2|Exposed|Treatment Period 1||357
880120|NCT02030600|2129905|P1|Exposed|Treatment Period 1||356
880121|NCT02030600|2129904|P2|STARTED|Treatment Period 1||360
880122|NCT02030600|2129905|P1|STARTED|Treatment Period 1||361
880123|NCT02030574|2129921|P1|NOT COMPLETED|Overall Study||0
880124|NCT02030574|2129921|P1|COMPLETED|Overall Study||2
880125|NCT02030574|2129921|P1|STARTED|Overall Study||2
880126|NCT02030535|2129926|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
880127|NCT02030535|2129926|P1|COMPLETED|Treatment Period 3 (1 Day)||52
880128|NCT02030535|2129926|P1|STARTED|Treatment Period 3 (1 Day)||52
880129|NCT02030535|2129926|P1|NOT COMPLETED|Washout Period 2 (21 Days)||0
880130|NCT02030535|2129926|P1|COMPLETED|Washout Period 2 (21 Days)||52
880131|NCT02030535|2129926|P1|STARTED|Washout Period 2 (21 Days)||52
880132|NCT02030535|2129926|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
880133|NCT02030535|2129926|P1|COMPLETED|Treatment Period 2 (1 Day)||52
880134|NCT02030535|2129926|P1|STARTED|Treatment Period 2 (1 Day)||52
880135|NCT02030535|2129926|P1|NOT COMPLETED|Washout Period 1 (21 Days)||1
880136|NCT02030535|2129926|P1|COMPLETED|Washout Period 1 (21 Days)||52
880137|NCT02030535|2129926|P1|STARTED|Washout Period 1 (21 Days)||53
880138|NCT02030535|2129926|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
880139|NCT02030535|2129926|P1|COMPLETED|Treatment Period 1 (1 Day)||53
880140|NCT02030535|2129926|P1|STARTED|Treatment Period 1 (1 Day)||53
880141|NCT02030405|2129994|P1|NOT COMPLETED|Overall Study||2
880142|NCT02030405|2129994|P1|COMPLETED|Overall Study||2
880143|NCT02030405|2129994|P1|STARTED|Overall Study||4
880144|NCT02030041|2130002|P3|NOT COMPLETED|Overall Study||1
880145|NCT02030041|2130003|P2|NOT COMPLETED|Overall Study||2
880146|NCT02030041|2130004|P1|NOT COMPLETED|Overall Study||2
880147|NCT02030041|2130002|P3|COMPLETED|Overall Study||10
880148|NCT02030041|2130003|P2|COMPLETED|Overall Study||9
880149|NCT02030041|2130004|P1|COMPLETED|Overall Study||9
880150|NCT02030041|2130002|P3|STARTED|Overall Study||11
880151|NCT02030041|2130003|P2|STARTED|Overall Study||11
880152|NCT02030041|2130004|P1|STARTED|Overall Study||11
880153|NCT02029989|2130017|P2|NOT COMPLETED|Overall Study||11
880154|NCT02029989|2130018|P1|NOT COMPLETED|Overall Study||16
880155|NCT02029989|2130017|P2|COMPLETED|Overall Study||49
880156|NCT02029989|2130018|P1|COMPLETED|Overall Study||45
880157|NCT02029989|2130017|P2|STARTED|Overall Study||60
880158|NCT02029989|2130018|P1|STARTED|Overall Study|A subject was given the same ID# as withdrawn subject (ID # counted twice) causing N=61 discrepancy.|61
880159|NCT02029911|2130024|P1|NOT COMPLETED|Overall Study||0
880160|NCT02029911|2130024|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|60
880161|NCT02029911|2130024|P1|Treated|Overall Study|Treatment Completed|60
880162|NCT02029911|2130024|P1|STARTED|Overall Study|Treatment Attempted|60
880163|NCT02029846|2130032|P2|NOT COMPLETED|Overall Study||0
880164|NCT02029846|2130033|P1|NOT COMPLETED|Overall Study||0
880165|NCT02029846|2130032|P2|COMPLETED|Overall Study||0
880166|NCT02029846|2130033|P1|COMPLETED|Overall Study||0
880167|NCT02029846|2130032|P2|STARTED|Overall Study||0
880168|NCT02029846|2130033|P1|STARTED|Overall Study||0
880169|NCT02029755|2130046|P3|NOT COMPLETED|Overall Study||0
880170|NCT02029755|2130047|P2|NOT COMPLETED|Overall Study||0
880171|NCT02029755|2130048|P1|NOT COMPLETED|Overall Study||0
880172|NCT02029755|2130046|P3|COMPLETED|Overall Study||36
880173|NCT02029755|2130047|P2|COMPLETED|Overall Study||36
880174|NCT02029755|2130048|P1|COMPLETED|Overall Study||36
880175|NCT02029755|2130046|P3|STARTED|Overall Study||36
880176|NCT02029755|2130047|P2|STARTED|Overall Study||36
880177|NCT02029755|2130048|P1|STARTED|Overall Study||36
880178|NCT02029703|2130061|P2|NOT COMPLETED|Overall Study||0
880179|NCT02029703|2130062|P1|NOT COMPLETED|Overall Study||0
880180|NCT02029703|2130061|P2|COMPLETED|Overall Study||22
880181|NCT02029703|2130062|P1|COMPLETED|Overall Study||20
880182|NCT02029703|2130061|P2|STARTED|Overall Study||22
880183|NCT02029703|2130062|P1|STARTED|Overall Study||20
880184|NCT02029521|2130070|P2|NOT COMPLETED|Overall Study||1
880185|NCT02029521|2130071|P1|NOT COMPLETED|Overall Study||2
880186|NCT02029521|2130070|P2|COMPLETED|Overall Study||22
880187|NCT02029521|2130071|P1|COMPLETED|Overall Study||22
880188|NCT02029521|2130070|P2|STARTED|Overall Study||23
880189|NCT02029521|2130071|P1|STARTED|Overall Study||24
880190|NCT02029495|2130156|P3|NOT COMPLETED|Overall Study||2
880191|NCT02029495|2130157|P2|NOT COMPLETED|Overall Study||0
880192|NCT02029495|2130158|P1|NOT COMPLETED|Overall Study||1
880193|NCT02029495|2130156|P3|COMPLETED|Overall Study||159
880194|NCT02029495|2130157|P2|COMPLETED|Overall Study||158
880195|NCT02029495|2130158|P1|COMPLETED|Overall Study||158
880196|NCT02029495|2130156|P3|STARTED|Overall Study||161
880197|NCT02029495|2130157|P2|STARTED|Overall Study||158
880198|NCT02029495|2130158|P1|STARTED|Overall Study||159
880199|NCT02029417|2130169|P1|NOT COMPLETED|Overall Study||2
880200|NCT02029417|2130169|P1|COMPLETED|Overall Study||0
880201|NCT02029417|2130169|P1|STARTED|Overall Study||2
880202|NCT02029196|2130176|P2|NOT COMPLETED|Overall Study||1
880203|NCT02029196|2130177|P1|NOT COMPLETED|Overall Study||20
880204|NCT02029196|2130176|P2|COMPLETED|Overall Study||101
880205|NCT02029196|2130177|P1|COMPLETED|Overall Study||286
880206|NCT02029196|2130176|P2|STARTED|Overall Study||102
880207|NCT02029196|2130177|P1|STARTED|Overall Study||306
880208|NCT02028780|2130197|P12|NOT COMPLETED|Follow up Phase||0
880209|NCT02028780|2130198|P11|NOT COMPLETED|Follow up Phase||0
880210|NCT02028780|2130199|P10|NOT COMPLETED|Follow up Phase||0
880211|NCT02028780|2130200|P9|NOT COMPLETED|Follow up Phase||0
880212|NCT02028780|2130201|P8|NOT COMPLETED|Follow up Phase||0
880213|NCT02028780|2130202|P7|NOT COMPLETED|Follow up Phase||0
880214|NCT02028780|2130203|P6|NOT COMPLETED|Follow up Phase||0
880215|NCT02028780|2130204|P5|NOT COMPLETED|Follow up Phase||0
880216|NCT02028780|2130205|P4|NOT COMPLETED|Follow up Phase||0
880217|NCT02028780|2130206|P3|NOT COMPLETED|Follow up Phase||0
880218|NCT02028780|2130207|P2|NOT COMPLETED|Follow up Phase||0
880219|NCT02028780|2130208|P1|NOT COMPLETED|Follow up Phase||0
880220|NCT02028780|2130197|P12|COMPLETED|Follow up Phase||9
880221|NCT02028780|2130198|P11|COMPLETED|Follow up Phase||9
880222|NCT02028780|2130199|P10|COMPLETED|Follow up Phase||9
880223|NCT02028780|2130200|P9|COMPLETED|Follow up Phase||9
880224|NCT02028780|2130201|P8|COMPLETED|Follow up Phase||3
880225|NCT02028780|2130202|P7|COMPLETED|Follow up Phase||9
880226|NCT02028780|2130203|P6|COMPLETED|Follow up Phase||6
880227|NCT02028780|2130204|P5|COMPLETED|Follow up Phase||6
880228|NCT02028780|2130205|P4|COMPLETED|Follow up Phase||6
880229|NCT02028780|2130206|P3|COMPLETED|Follow up Phase||6
880230|NCT02028780|2130207|P2|COMPLETED|Follow up Phase||2
880231|NCT02028780|2130208|P1|COMPLETED|Follow up Phase||6
880232|NCT02028780|2130197|P12|STARTED|Follow up Phase||9
880233|NCT02028780|2130198|P11|STARTED|Follow up Phase||9
880234|NCT02028780|2130199|P10|STARTED|Follow up Phase||9
880235|NCT02028780|2130200|P9|STARTED|Follow up Phase||9
880236|NCT02028780|2130201|P8|STARTED|Follow up Phase||3
880237|NCT02028780|2130202|P7|STARTED|Follow up Phase||9
880238|NCT02028780|2130203|P6|STARTED|Follow up Phase||6
880239|NCT02028780|2130204|P5|STARTED|Follow up Phase||6
880240|NCT02028780|2130205|P4|STARTED|Follow up Phase||6
880241|NCT02028780|2130206|P3|STARTED|Follow up Phase||6
880242|NCT02028780|2130207|P2|STARTED|Follow up Phase||2
880243|NCT02028780|2130208|P1|STARTED|Follow up Phase||6
880244|NCT02028780|2130197|P12|NOT COMPLETED|Observation Phase||0
880245|NCT02028780|2130198|P11|NOT COMPLETED|Observation Phase||0
880246|NCT02028780|2130199|P10|NOT COMPLETED|Observation Phase||0
880247|NCT02028780|2130200|P9|NOT COMPLETED|Observation Phase||0
880248|NCT02028780|2130201|P8|NOT COMPLETED|Observation Phase||0
880249|NCT02028780|2130202|P7|NOT COMPLETED|Observation Phase||0
880250|NCT02028780|2130203|P6|NOT COMPLETED|Observation Phase||0
880251|NCT02028780|2130204|P5|NOT COMPLETED|Observation Phase||0
880252|NCT02028780|2130205|P4|NOT COMPLETED|Observation Phase||0
880253|NCT02028780|2130206|P3|NOT COMPLETED|Observation Phase||0
880254|NCT02028780|2130207|P2|NOT COMPLETED|Observation Phase||0
880255|NCT02028780|2130208|P1|NOT COMPLETED|Observation Phase||0
880256|NCT02028780|2130197|P12|COMPLETED|Observation Phase||9
880257|NCT02028780|2130198|P11|COMPLETED|Observation Phase||9
880258|NCT02028780|2130199|P10|COMPLETED|Observation Phase||9
880259|NCT02028780|2130200|P9|COMPLETED|Observation Phase||9
880260|NCT02028780|2130201|P8|COMPLETED|Observation Phase||3
880261|NCT02028780|2130202|P7|COMPLETED|Observation Phase||9
880262|NCT02028780|2130203|P6|COMPLETED|Observation Phase||6
880263|NCT02028780|2130204|P5|COMPLETED|Observation Phase||6
880264|NCT02028780|2130205|P4|COMPLETED|Observation Phase||6
880265|NCT02028780|2130206|P3|COMPLETED|Observation Phase||6
880266|NCT02028780|2130207|P2|COMPLETED|Observation Phase||2
880267|NCT02028780|2130208|P1|COMPLETED|Observation Phase||6
880268|NCT02028780|2130197|P12|STARTED|Observation Phase||9
880269|NCT02028780|2130198|P11|STARTED|Observation Phase||9
880270|NCT02028780|2130199|P10|STARTED|Observation Phase||9
880271|NCT02028780|2130200|P9|STARTED|Observation Phase||9
880272|NCT02028780|2130201|P8|STARTED|Observation Phase||3
880273|NCT02028780|2130202|P7|STARTED|Observation Phase||9
880274|NCT02028780|2130203|P6|STARTED|Observation Phase||6
880275|NCT02028780|2130204|P5|STARTED|Observation Phase||6
880276|NCT02028780|2130205|P4|STARTED|Observation Phase||6
880277|NCT02028780|2130206|P3|STARTED|Observation Phase||6
880278|NCT02028780|2130207|P2|STARTED|Observation Phase||2
880279|NCT02028780|2130208|P1|STARTED|Observation Phase||6
880280|NCT02028767|2130273|P2|NOT COMPLETED|Treatment Period 2||0
880281|NCT02028767|2130274|P1|NOT COMPLETED|Treatment Period 2||2
880282|NCT02028767|2130273|P2|COMPLETED|Treatment Period 2||16
880283|NCT02028767|2130274|P1|COMPLETED|Treatment Period 2||14
880284|NCT02028767|2130273|P2|STARTED|Treatment Period 2||16
880285|NCT02028767|2130274|P1|STARTED|Treatment Period 2||16
880286|NCT02028767|2130273|P2|NOT COMPLETED|Treatment Period 1||0
880287|NCT02028767|2130274|P1|NOT COMPLETED|Treatment Period 1||0
880288|NCT02028767|2130273|P2|COMPLETED|Treatment Period 1||16
880289|NCT02028767|2130274|P1|COMPLETED|Treatment Period 1||16
880290|NCT02028767|2130273|P2|STARTED|Treatment Period 1||16
880291|NCT02028767|2130274|P1|STARTED|Treatment Period 1||16
880292|NCT02028754|2130286|P2|NOT COMPLETED|Overall Study||8
880293|NCT02028754|2130287|P1|NOT COMPLETED|Overall Study||7
880294|NCT02028754|2130286|P2|COMPLETED|Overall Study||82
880295|NCT02028754|2130287|P1|COMPLETED|Overall Study||83
880296|NCT02028754|2130286|P2|STARTED|Overall Study||90
880297|NCT02028754|2130287|P1|STARTED|Overall Study||90
880298|NCT02028676|2130314|P9|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
880299|NCT02028676|2130315|P8|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
880300|NCT02028676|2130316|P7|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
880301|NCT02028676|2130317|P6|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
880302|NCT02028676|2130318|P5|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
880303|NCT02028676|2130319|P4|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
880304|NCT02028676|2130320|P3|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
880305|NCT02028676|2130321|P2|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
880306|NCT02028676|2130322|P1|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
880307|NCT02028676|2130314|P9|COMPLETED|Subsequent Cotrimoxazole Randomization||382
880308|NCT02028676|2130315|P8|COMPLETED|Subsequent Cotrimoxazole Randomization||376
880309|NCT02028676|2130316|P7|COMPLETED|Subsequent Cotrimoxazole Randomization||0
880310|NCT02028676|2130317|P6|COMPLETED|Subsequent Cotrimoxazole Randomization||0
880311|NCT02028676|2130318|P5|COMPLETED|Subsequent Cotrimoxazole Randomization||0
880312|NCT02028676|2130319|P4|COMPLETED|Subsequent Cotrimoxazole Randomization||0
880313|NCT02028676|2130320|P3|COMPLETED|Subsequent Cotrimoxazole Randomization||0
880314|NCT02028676|2130321|P2|COMPLETED|Subsequent Cotrimoxazole Randomization||0
880315|NCT02028676|2130322|P1|COMPLETED|Subsequent Cotrimoxazole Randomization||0
880316|NCT02028676|2130314|P9|STARTED|Subsequent Cotrimoxazole Randomization||382
880317|NCT02028676|2130315|P8|STARTED|Subsequent Cotrimoxazole Randomization||376
880318|NCT02028676|2130316|P7|STARTED|Subsequent Cotrimoxazole Randomization||0
880319|NCT02028676|2130317|P6|STARTED|Subsequent Cotrimoxazole Randomization||0
880320|NCT02028676|2130318|P5|STARTED|Subsequent Cotrimoxazole Randomization||0
880321|NCT02028676|2130319|P4|STARTED|Subsequent Cotrimoxazole Randomization||0
880322|NCT02028676|2130320|P3|STARTED|Subsequent Cotrimoxazole Randomization||0
880323|NCT02028676|2130321|P2|STARTED|Subsequent Cotrimoxazole Randomization||0
880324|NCT02028676|2130322|P1|STARTED|Subsequent Cotrimoxazole Randomization||0
880325|NCT02028676|2130314|P9|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
880326|NCT02028676|2130315|P8|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
880327|NCT02028676|2130316|P7|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
880328|NCT02028676|2130317|P6|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
880329|NCT02028676|2130318|P5|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
880330|NCT02028676|2130319|P4|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
880331|NCT02028676|2130320|P3|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
880332|NCT02028676|2130321|P2|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
880333|NCT02028676|2130322|P1|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
880334|NCT02028676|2130314|P9|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
880335|NCT02028676|2130315|P8|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
880336|NCT02028676|2130316|P7|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||333
880408|NCT02028325|2130495|P1|STARTED|Overall Study||136
880337|NCT02028676|2130317|P6|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||336
880338|NCT02028676|2130318|P5|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
880339|NCT02028676|2130319|P4|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
880340|NCT02028676|2130320|P3|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
880341|NCT02028676|2130321|P2|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
880342|NCT02028676|2130322|P1|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
880343|NCT02028676|2130314|P9|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
880344|NCT02028676|2130315|P8|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
880345|NCT02028676|2130316|P7|STARTED|Subsequent Once vs Twice Daily ABC+3TC||333
880346|NCT02028676|2130317|P6|STARTED|Subsequent Once vs Twice Daily ABC+3TC||336
880347|NCT02028676|2130318|P5|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
880348|NCT02028676|2130319|P4|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
880349|NCT02028676|2130320|P3|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
880350|NCT02028676|2130321|P2|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
880351|NCT02028676|2130322|P1|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
880352|NCT02028676|2130314|P9|NOT COMPLETED|Initial Enrolment: Induction ART||0
880353|NCT02028676|2130315|P8|NOT COMPLETED|Initial Enrolment: Induction ART||0
880354|NCT02028676|2130316|P7|NOT COMPLETED|Initial Enrolment: Induction ART||0
880355|NCT02028676|2130317|P6|NOT COMPLETED|Initial Enrolment: Induction ART||0
880356|NCT02028676|2130318|P5|NOT COMPLETED|Initial Enrolment: Induction ART||0
880357|NCT02028676|2130319|P4|NOT COMPLETED|Initial Enrolment: Induction ART||0
880358|NCT02028676|2130320|P3|NOT COMPLETED|Initial Enrolment: Induction ART||0
880359|NCT02028676|2130321|P2|NOT COMPLETED|Initial Enrolment: Induction ART||0
880360|NCT02028676|2130322|P1|NOT COMPLETED|Initial Enrolment: Induction ART||0
880361|NCT02028676|2130314|P9|COMPLETED|Initial Enrolment: Induction ART||0
880362|NCT02028676|2130315|P8|COMPLETED|Initial Enrolment: Induction ART||0
880363|NCT02028676|2130316|P7|COMPLETED|Initial Enrolment: Induction ART||0
880364|NCT02028676|2130317|P6|COMPLETED|Initial Enrolment: Induction ART||0
880365|NCT02028676|2130318|P5|COMPLETED|Initial Enrolment: Induction ART||405
880366|NCT02028676|2130319|P4|COMPLETED|Initial Enrolment: Induction ART||404
880367|NCT02028676|2130320|P3|COMPLETED|Initial Enrolment: Induction ART||397
880368|NCT02028676|2130321|P2|COMPLETED|Initial Enrolment: Induction ART||0
880369|NCT02028676|2130322|P1|COMPLETED|Initial Enrolment: Induction ART||0
880370|NCT02028676|2130314|P9|STARTED|Initial Enrolment: Induction ART||0
880371|NCT02028676|2130315|P8|STARTED|Initial Enrolment: Induction ART||0
880372|NCT02028676|2130316|P7|STARTED|Initial Enrolment: Induction ART||0
880373|NCT02028676|2130317|P6|STARTED|Initial Enrolment: Induction ART||0
880374|NCT02028676|2130318|P5|STARTED|Initial Enrolment: Induction ART||405
880375|NCT02028676|2130319|P4|STARTED|Initial Enrolment: Induction ART||404
880376|NCT02028676|2130320|P3|STARTED|Initial Enrolment: Induction ART||397
880377|NCT02028676|2130321|P2|STARTED|Initial Enrolment: Induction ART||0
880378|NCT02028676|2130322|P1|STARTED|Initial Enrolment: Induction ART||0
880379|NCT02028676|2130314|P9|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
880380|NCT02028676|2130315|P8|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
880381|NCT02028676|2130316|P7|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
880382|NCT02028676|2130317|P6|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
880383|NCT02028676|2130318|P5|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
880384|NCT02028676|2130319|P4|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
880385|NCT02028676|2130320|P3|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
880386|NCT02028676|2130321|P2|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
880387|NCT02028676|2130322|P1|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
880388|NCT02028676|2130314|P9|COMPLETED|Initial Enrolment: CDM vs LCM||0
880389|NCT02028676|2130315|P8|COMPLETED|Initial Enrolment: CDM vs LCM||0
880390|NCT02028676|2130316|P7|COMPLETED|Initial Enrolment: CDM vs LCM||0
880391|NCT02028676|2130317|P6|COMPLETED|Initial Enrolment: CDM vs LCM||0
880392|NCT02028676|2130318|P5|COMPLETED|Initial Enrolment: CDM vs LCM||0
880393|NCT02028676|2130319|P4|COMPLETED|Initial Enrolment: CDM vs LCM||0
880394|NCT02028676|2130320|P3|COMPLETED|Initial Enrolment: CDM vs LCM||0
880395|NCT02028676|2130321|P2|COMPLETED|Initial Enrolment: CDM vs LCM||600
880396|NCT02028676|2130322|P1|COMPLETED|Initial Enrolment: CDM vs LCM||606
880397|NCT02028676|2130314|P9|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
880398|NCT02028676|2130315|P8|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
880399|NCT02028676|2130316|P7|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
880400|NCT02028676|2130317|P6|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
880401|NCT02028676|2130318|P5|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
880402|NCT02028676|2130319|P4|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
880403|NCT02028676|2130320|P3|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
880404|NCT02028676|2130321|P2|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|600
880405|NCT02028676|2130322|P1|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|606
880406|NCT02028325|2130495|P1|NOT COMPLETED|Overall Study||10
880407|NCT02028325|2130495|P1|COMPLETED|Overall Study||126
880409|NCT02028169|2130499|P1|NOT COMPLETED|Overall Study||28
880410|NCT02028169|2130499|P1|COMPLETED|Overall Study||92
880411|NCT02028169|2130499|P1|STARTED|Overall Study||120
880412|NCT02028065|2130525|P3|NOT COMPLETED|Treatment Through Study Completion||14
880413|NCT02028065|2130526|P2|NOT COMPLETED|Treatment Through Study Completion||15
880414|NCT02028065|2130527|P1|NOT COMPLETED|Treatment Through Study Completion||12
880415|NCT02028065|2130525|P3|COMPLETED|Treatment Through Study Completion||134
880416|NCT02028065|2130526|P2|COMPLETED|Treatment Through Study Completion||136
880417|NCT02028065|2130527|P1|COMPLETED|Treatment Through Study Completion||64
880418|NCT02028065|2130525|P3|Received Third Dose|Treatment Through Study Completion||134
880419|NCT02028065|2130526|P2|Received Third Dose|Treatment Through Study Completion||136
880420|NCT02028065|2130527|P1|Received Third Dose|Treatment Through Study Completion||64
880421|NCT02028065|2130525|P3|Received Second Dose|Treatment Through Study Completion||138
880422|NCT02028065|2130526|P2|Received Second Dose|Treatment Through Study Completion||140
880423|NCT02028065|2130527|P1|Received Second Dose|Treatment Through Study Completion||69
880424|NCT02028065|2130525|P3|Received First Dose|Treatment Through Study Completion||148
880425|NCT02028065|2130526|P2|Received First Dose|Treatment Through Study Completion||151
880426|NCT02028065|2130527|P1|Received First Dose|Treatment Through Study Completion||76
880427|NCT02028065|2130525|P3|STARTED|Treatment Through Study Completion|Does not include the 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|148
880428|NCT02028065|2130526|P2|STARTED|Treatment Through Study Completion||151
880429|NCT02028065|2130527|P1|STARTED|Treatment Through Study Completion|Includes 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|76
880430|NCT02028065|2130525|P3|NOT COMPLETED|Randomization Through Start Treatment||3
880431|NCT02028065|2130526|P2|NOT COMPLETED|Randomization Through Start Treatment||3
880432|NCT02028065|2130527|P1|NOT COMPLETED|Randomization Through Start Treatment||1
880433|NCT02028065|2130525|P3|COMPLETED|Randomization Through Start Treatment||149
880434|NCT02028065|2130526|P2|COMPLETED|Randomization Through Start Treatment||151
880435|NCT02028065|2130527|P1|COMPLETED|Randomization Through Start Treatment||75
880436|NCT02028065|2130525|P3|STARTED|Randomization Through Start Treatment|Randomized|152
880437|NCT02028065|2130526|P2|STARTED|Randomization Through Start Treatment|Randomized|154
880438|NCT02028065|2130527|P1|STARTED|Randomization Through Start Treatment|Randomized|76
880439|NCT02027883|2130540|P2|NOT COMPLETED|Overall Study||0
880440|NCT02027883|2130541|P1|NOT COMPLETED|Overall Study||0
880441|NCT02027883|2130540|P2|COMPLETED|Overall Study||50
880442|NCT02027883|2130541|P1|COMPLETED|Overall Study||50
880443|NCT02027883|2130540|P2|STARTED|Overall Study||50
880444|NCT02027883|2130541|P1|STARTED|Overall Study||50
880445|NCT02027844|2130554|P3|NOT COMPLETED|Overall Study||2
880446|NCT02027844|2130555|P2|NOT COMPLETED|Overall Study||6
880447|NCT02027844|2130556|P1|NOT COMPLETED|Overall Study||5
880448|NCT02027844|2130554|P3|COMPLETED|Overall Study||37
880449|NCT02027844|2130555|P2|COMPLETED|Overall Study||33
880450|NCT02027844|2130556|P1|COMPLETED|Overall Study||34
880451|NCT02027844|2130554|P3|STARTED|Overall Study||39
880452|NCT02027844|2130555|P2|STARTED|Overall Study||39
880453|NCT02027844|2130556|P1|STARTED|Overall Study||39
880454|NCT02027402|2130575|P2|NOT COMPLETED|Overall Study||1
880455|NCT02027402|2130576|P1|NOT COMPLETED|Overall Study||4
880456|NCT02027402|2130575|P2|COMPLETED|Overall Study||99
880457|NCT02027402|2130576|P1|COMPLETED|Overall Study||94
880458|NCT02027402|2130575|P2|STARTED|Overall Study||100
880459|NCT02027402|2130576|P1|STARTED|Overall Study||98
880460|NCT02027311|2130590|P2|NOT COMPLETED|Overall Study||2
880461|NCT02027311|2130591|P1|NOT COMPLETED|Overall Study||3
880462|NCT02027311|2130590|P2|COMPLETED|Overall Study|1 cases was dropped due to tachycardia and 1 were desaturation.|33
880463|NCT02027311|2130591|P1|COMPLETED|Overall Study|1 case was dropped due to hypotension and 2 were desaturation.|30
880464|NCT02027311|2130590|P2|STARTED|Overall Study||35
880465|NCT02027311|2130591|P1|STARTED|Overall Study||33
880466|NCT02027272|2130601|P2|NOT COMPLETED|Overall Study||1
880467|NCT02027272|2130602|P1|NOT COMPLETED|Overall Study||0
880468|NCT02027272|2130601|P2|COMPLETED|Overall Study||0
880469|NCT02027272|2130602|P1|COMPLETED|Overall Study||0
880470|NCT02027272|2130601|P2|STARTED|Overall Study||1
880471|NCT02027272|2130602|P1|STARTED|Overall Study||0
880472|NCT02026453|2130611|P3|NOT COMPLETED|Overall Study||13
880473|NCT02026453|2130612|P2|NOT COMPLETED|Overall Study||9
880474|NCT02026453|2130613|P1|NOT COMPLETED|Overall Study||6
880475|NCT02026453|2130611|P3|COMPLETED|Overall Study||89
880476|NCT02026453|2130612|P2|COMPLETED|Overall Study||94
880477|NCT02026453|2130613|P1|COMPLETED|Overall Study||95
880478|NCT02026453|2130611|P3|STARTED|Overall Study||102
880479|NCT02026453|2130612|P2|STARTED|Overall Study||103
880480|NCT02026453|2130613|P1|STARTED|Overall Study||101
880481|NCT02026258|2130626|P2|NOT COMPLETED|Recieved Allocated Intervention||2
880482|NCT02026258|2130627|P1|NOT COMPLETED|Recieved Allocated Intervention||1
880483|NCT02026258|2130626|P2|COMPLETED|Recieved Allocated Intervention||17
880484|NCT02026258|2130627|P1|COMPLETED|Recieved Allocated Intervention||15
880485|NCT02026258|2130626|P2|STARTED|Recieved Allocated Intervention||19
880486|NCT02026258|2130627|P1|STARTED|Recieved Allocated Intervention||16
880487|NCT02026258|2130626|P2|NOT COMPLETED|Randomized||2
880488|NCT02026258|2130627|P1|NOT COMPLETED|Randomized||4
880489|NCT02026258|2130626|P2|COMPLETED|Randomized||19
880490|NCT02026258|2130627|P1|COMPLETED|Randomized||16
880491|NCT02026258|2130626|P2|STARTED|Randomized||21
880492|NCT02026258|2130627|P1|STARTED|Randomized||20
880493|NCT02026206|2130641|P2|NOT COMPLETED|Overall Study||8
880494|NCT02026206|2130642|P1|NOT COMPLETED|Overall Study||4
880495|NCT02026206|2130641|P2|COMPLETED|Overall Study||36
880496|NCT02026206|2130642|P1|COMPLETED|Overall Study||40
880497|NCT02026206|2130641|P2|STARTED|Overall Study||44
880498|NCT02026206|2130642|P1|STARTED|Overall Study||44
880499|NCT02026193|2130652|P2|NOT COMPLETED|Overall Study||0
880500|NCT02026193|2130653|P1|NOT COMPLETED|Overall Study||0
880501|NCT02026193|2130652|P2|COMPLETED|Overall Study||8
880502|NCT02026193|2130653|P1|COMPLETED|Overall Study||3
880503|NCT02026193|2130652|P2|STARTED|Overall Study||8
880504|NCT02026193|2130653|P1|STARTED|Overall Study||3
880505|NCT02026141|2130661|P2|NOT COMPLETED|Overall Study||1
880506|NCT02026141|2130662|P1|NOT COMPLETED|Overall Study||0
880507|NCT02026141|2130661|P2|COMPLETED|Overall Study||19
880508|NCT02026141|2130662|P1|COMPLETED|Overall Study||20
880509|NCT02026141|2130661|P2|STARTED|Overall Study||20
880510|NCT02026141|2130662|P1|STARTED|Overall Study||20
880511|NCT02025907|2130670|P2|NOT COMPLETED|Overall Study||12
880512|NCT02025907|2130671|P1|NOT COMPLETED|Overall Study||27
880513|NCT02025907|2130670|P2|COMPLETED|Overall Study||96
880514|NCT02025907|2130671|P1|COMPLETED|Overall Study||81
880515|NCT02025907|2130670|P2|STARTED|Overall Study|Participant flow is presented for safety population.|108
880516|NCT02025907|2130671|P1|STARTED|Overall Study|Participant flow is presented for safety population.|108
880517|NCT02025829|2130687|P2|NOT COMPLETED|Overall Study||0
880518|NCT02025829|2130688|P1|NOT COMPLETED|Overall Study||0
880519|NCT02025829|2130687|P2|COMPLETED|Overall Study||11
880520|NCT02025829|2130688|P1|COMPLETED|Overall Study||3
880521|NCT02025829|2130687|P2|STARTED|Overall Study||11
880522|NCT02025829|2130688|P1|STARTED|Overall Study||3
880523|NCT02025647|2130697|P1|NOT COMPLETED|Overall Study||0
880524|NCT02025647|2130697|P1|COMPLETED|Overall Study||139
880525|NCT02025647|2130697|P1|Session 3 (Rating Module: 30-45 Days)|Overall Study|"27 did not generate IRS
36 lost to follow up"|76
880526|NCT02025647|2130697|P1|Session 2 (Narrative Module: 24-48 Hrs)|Overall Study|"19 lost to follow up or technology issues
3 administered wrong session"|117
880527|NCT02025647|2130697|P1|Immediate Retest (Rating Module: 5 Min)|Overall Study|"27 did not generate IRS
15 technology issues or administered wrong session"|97
880528|NCT02025647|2130697|P1|Session 1 (Narrative Module)|Overall Study||139
880529|NCT02025647|2130697|P1|STARTED|Overall Study||139
880530|NCT02025075|2130728|P2|NOT COMPLETED|Overall Study||2
880531|NCT02025075|2130729|P1|NOT COMPLETED|Overall Study||0
880532|NCT02025075|2130728|P2|COMPLETED|Overall Study||19
880533|NCT02025075|2130729|P1|COMPLETED|Overall Study||16
880534|NCT02025075|2130728|P2|STARTED|Overall Study||21
880535|NCT02025075|2130729|P1|STARTED|Overall Study||16
880536|NCT02024971|2130753|P1|NOT COMPLETED|Overall Study||36
880537|NCT02024971|2130753|P1|COMPLETED|Overall Study|Including 162 patients with missing efficacy data at two or more time points.|1067
880538|NCT02024971|2130753|P1|Safety Analysis Set|Overall Study|All participants with available data who were enrolled prior to Day 15 of the start of treatment.|1067
880539|NCT02024971|2130753|P1|STARTED|Overall Study||1103
880540|NCT02024932|2130766|P6|NOT COMPLETED|Overall Study||0
880541|NCT02024932|2130767|P5|NOT COMPLETED|Overall Study||2
880542|NCT02024932|2130768|P4|NOT COMPLETED|Overall Study||2
880543|NCT02024932|2130769|P3|NOT COMPLETED|Overall Study||0
880544|NCT02024932|2130770|P2|NOT COMPLETED|Overall Study||3
880545|NCT02024932|2130771|P1|NOT COMPLETED|Overall Study||2
880546|NCT02024932|2130766|P6|COMPLETED|Overall Study||9
880547|NCT02024932|2130767|P5|COMPLETED|Overall Study||16
880548|NCT02024932|2130768|P4|COMPLETED|Overall Study||0
880549|NCT02024932|2130769|P3|COMPLETED|Overall Study||2
880550|NCT02024932|2130770|P2|COMPLETED|Overall Study||1
880551|NCT02024932|2130771|P1|COMPLETED|Overall Study||0
880552|NCT02024932|2130766|P6|Pharmacodynamic (PD) Analysis Set|Overall Study||9
880553|NCT02024932|2130767|P5|Pharmacodynamic (PD) Analysis Set|Overall Study||18
880554|NCT02024932|2130768|P4|Pharmacodynamic (PD) Analysis Set|Overall Study||2
880555|NCT02024932|2130769|P3|Pharmacodynamic (PD) Analysis Set|Overall Study||2
880556|NCT02024932|2130770|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||4
880557|NCT02024932|2130771|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||2
880558|NCT02024932|2130766|P6|Pharmacokinetic (PK) Analysis Set|Overall Study||0
880559|NCT02024932|2130767|P5|Pharmacokinetic (PK) Analysis Set|Overall Study||18
880560|NCT02024932|2130768|P4|Pharmacokinetic (PK) Analysis Set|Overall Study||2
880561|NCT02024932|2130769|P3|Pharmacokinetic (PK) Analysis Set|Overall Study||0
880562|NCT02024932|2130770|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||4
880563|NCT02024932|2130771|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||2
880564|NCT02024932|2130766|P6|Safety Analysis Set|Overall Study||9
880565|NCT02024932|2130767|P5|Safety Analysis Set|Overall Study||18
880566|NCT02024932|2130768|P4|Safety Analysis Set|Overall Study||2
880567|NCT02024932|2130769|P3|Safety Analysis Set|Overall Study||2
880568|NCT02024932|2130770|P2|Safety Analysis Set|Overall Study||4
880569|NCT02024932|2130771|P1|Safety Analysis Set|Overall Study||2
880570|NCT02024932|2130766|P6|STARTED|Overall Study||9
880571|NCT02024932|2130767|P5|STARTED|Overall Study||18
880572|NCT02024932|2130768|P4|STARTED|Overall Study||2
880573|NCT02024932|2130769|P3|STARTED|Overall Study||2
880574|NCT02024932|2130770|P2|STARTED|Overall Study||4
880575|NCT02024932|2130771|P1|STARTED|Overall Study||2
880576|NCT02024867|2130830|P2|NOT COMPLETED|Overall Study||7
880577|NCT02024867|2130831|P1|NOT COMPLETED|Overall Study||9
880578|NCT02024867|2130830|P2|COMPLETED|Overall Study||124
880579|NCT02024867|2130831|P1|COMPLETED|Overall Study||125
880580|NCT02024867|2130830|P2|STARTED|Overall Study||131
880581|NCT02024867|2130831|P1|STARTED|Overall Study||134
880582|NCT02024724|2130849|P2|NOT COMPLETED|Overall Study||0
880583|NCT02024724|2130850|P1|NOT COMPLETED|Overall Study||1
880584|NCT02024724|2130849|P2|COMPLETED|Overall Study||30
880585|NCT02024724|2130850|P1|COMPLETED|Overall Study||29
880586|NCT02024724|2130849|P2|STARTED|Overall Study||30
880587|NCT02024724|2130850|P1|STARTED|Overall Study||30
880588|NCT02024698|2130856|P2|NOT COMPLETED|Second Intervention (7 Days)||0
880589|NCT02024698|2130857|P1|NOT COMPLETED|Second Intervention (7 Days)||0
880590|NCT02024698|2130856|P2|COMPLETED|Second Intervention (7 Days)||26
880591|NCT02024698|2130857|P1|COMPLETED|Second Intervention (7 Days)||16
880592|NCT02024698|2130856|P2|Received Etafilcon A Twice|Second Intervention (7 Days)||0
880593|NCT02024698|2130857|P1|Received Etafilcon A Twice|Second Intervention (7 Days)||1
880594|NCT02024698|2130856|P2|STARTED|Second Intervention (7 Days)||26
880595|NCT02024698|2130857|P1|STARTED|Second Intervention (7 Days)||16
880596|NCT02024698|2130856|P2|NOT COMPLETED|First Intervention (7 Days)||1
880597|NCT02024698|2130857|P1|NOT COMPLETED|First Intervention (7 Days)||0
880598|NCT02024698|2130856|P2|COMPLETED|First Intervention (7 Days)||26
880599|NCT02024698|2130857|P1|COMPLETED|First Intervention (7 Days)||16
880600|NCT02024698|2130856|P2|STARTED|First Intervention (7 Days)||27
880601|NCT02024698|2130857|P1|STARTED|First Intervention (7 Days)||16
880602|NCT02024386|2130886|P3|NOT COMPLETED|Overall Study||0
880603|NCT02024386|2130887|P2|NOT COMPLETED|Overall Study||0
880604|NCT02024386|2130888|P1|NOT COMPLETED|Overall Study||0
880605|NCT02024386|2130886|P3|COMPLETED|Overall Study||5
880606|NCT02024386|2130887|P2|COMPLETED|Overall Study||11
880607|NCT02024386|2130888|P1|COMPLETED|Overall Study||6
880608|NCT02024386|2130886|P3|STARTED|Overall Study||5
880609|NCT02024386|2130887|P2|STARTED|Overall Study||11
880610|NCT02024386|2130888|P1|STARTED|Overall Study||6
880611|NCT02024165|2130911|P1|NOT COMPLETED|Overall Study||0
880612|NCT02024165|2130911|P1|COMPLETED|Overall Study||71
880613|NCT02024165|2130911|P1|STARTED|Overall Study||71
880620|NCT02023918|2130927|P1|NOT COMPLETED|Overall Study||0
880621|NCT02023918|2130927|P1|COMPLETED|Overall Study||6
880622|NCT02023918|2130927|P1|STARTED|Overall Study||6
880623|NCT02023879|2130935|P3|NOT COMPLETED|Overall Study||9
880624|NCT02023879|2130936|P2|NOT COMPLETED|Overall Study||9
880625|NCT02023879|2130937|P1|NOT COMPLETED|Overall Study||4
880626|NCT02023879|2130935|P3|COMPLETED|Overall Study|48 participants entered open-label extension treatment period.|50
880627|NCT02023879|2130936|P2|COMPLETED|Overall Study|106 participants entered open-label extension treatment period.|107
880628|NCT02023879|2130937|P1|COMPLETED|Overall Study|51 participants entered open-label extension treatment period.|54
880629|NCT02023879|2130935|P3|Treated|Overall Study||58
880630|NCT02023879|2130936|P2|Treated|Overall Study||115
880631|NCT02023879|2130937|P1|Treated|Overall Study||58
880632|NCT02023879|2130935|P3|STARTED|Overall Study||59
880633|NCT02023879|2130936|P2|STARTED|Overall Study||116
880634|NCT02023879|2130937|P1|STARTED|Overall Study||58
880635|NCT02023801|2131020|P1|NOT COMPLETED|Overall Study||0
880636|NCT02023801|2131020|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|24
880637|NCT02023801|2131020|P1|Treated|Overall Study|Treatment Completed|24
880638|NCT02023801|2131020|P1|STARTED|Overall Study|Treatment Attempted|24
880639|NCT02023515|2131028|P2|NOT COMPLETED|Overall Study||3
880640|NCT02023515|2131029|P1|NOT COMPLETED|Overall Study||1
880641|NCT02023515|2131028|P2|COMPLETED|Overall Study||22
880642|NCT02023515|2131029|P1|COMPLETED|Overall Study||23
880643|NCT02023515|2131028|P2|STARTED|Overall Study||25
880644|NCT02023515|2131029|P1|STARTED|Overall Study||24
880645|NCT02023268|2131039|P2|NOT COMPLETED|Overall Study||4
880646|NCT02023268|2131040|P1|NOT COMPLETED|Overall Study||0
880647|NCT02023268|2131039|P2|COMPLETED|Overall Study||49
880648|NCT02023268|2131040|P1|COMPLETED|Overall Study||52
880649|NCT02023268|2131039|P2|STARTED|Overall Study||53
880650|NCT02023268|2131040|P1|STARTED|Overall Study||52
880651|NCT02023125|2131048|P3|NOT COMPLETED|Period 2||0
880652|NCT02023125|2131049|P2|NOT COMPLETED|Period 2||0
880653|NCT02023125|2131050|P1|NOT COMPLETED|Period 2||0
880654|NCT02023125|2131048|P3|COMPLETED|Period 2||24
880655|NCT02023125|2131049|P2|COMPLETED|Period 2||9
880656|NCT02023125|2131050|P1|COMPLETED|Period 2||9
880657|NCT02023125|2131048|P3|STARTED|Period 2||24
880658|NCT02023125|2131049|P2|STARTED|Period 2||9
880659|NCT02023125|2131050|P1|STARTED|Period 2||9
880660|NCT02023125|2131048|P3|NOT COMPLETED|Washout Period||0
880661|NCT02023125|2131049|P2|NOT COMPLETED|Washout Period||0
880662|NCT02023125|2131050|P1|NOT COMPLETED|Washout Period||0
880663|NCT02023125|2131048|P3|COMPLETED|Washout Period||24
880664|NCT02023125|2131049|P2|COMPLETED|Washout Period||9
880665|NCT02023125|2131050|P1|COMPLETED|Washout Period||9
880666|NCT02023125|2131048|P3|STARTED|Washout Period||24
880667|NCT02023125|2131049|P2|STARTED|Washout Period||9
880668|NCT02023125|2131050|P1|STARTED|Washout Period||9
880669|NCT02023125|2131048|P3|NOT COMPLETED|Period 1||0
880670|NCT02023125|2131049|P2|NOT COMPLETED|Period 1||0
880671|NCT02023125|2131050|P1|NOT COMPLETED|Period 1||0
880672|NCT02023125|2131048|P3|COMPLETED|Period 1||24
880673|NCT02023125|2131049|P2|COMPLETED|Period 1||9
880674|NCT02023125|2131050|P1|COMPLETED|Period 1||9
880675|NCT02023125|2131048|P3|STARTED|Period 1||24
880676|NCT02023125|2131049|P2|STARTED|Period 1||9
880677|NCT02023125|2131050|P1|STARTED|Period 1||9
880678|NCT02023112|2131111|P2|NOT COMPLETED|Overall Study||1
880679|NCT02023112|2131112|P1|NOT COMPLETED|Overall Study||2
880680|NCT02023112|2131111|P2|COMPLETED|Overall Study||85
880681|NCT02023112|2131112|P1|COMPLETED|Overall Study||83
880682|NCT02023112|2131111|P2|STARTED|Overall Study||86
880683|NCT02023112|2131112|P1|STARTED|Overall Study||85
880684|NCT02023099|2131133|P3|NOT COMPLETED|Overall Study||3
880685|NCT02023099|2131134|P2|NOT COMPLETED|Overall Study||0
880686|NCT02023099|2131135|P1|NOT COMPLETED|Overall Study||3
880687|NCT02023099|2131133|P3|COMPLETED|Overall Study||39
880688|NCT02023099|2131134|P2|COMPLETED|Overall Study||106
880689|NCT02023099|2131135|P1|COMPLETED|Overall Study||212
880690|NCT02023099|2131133|P3|STARTED|Overall Study||42
880691|NCT02023099|2131134|P2|STARTED|Overall Study||106
880692|NCT02023099|2131135|P1|STARTED|Overall Study||215
880693|NCT02022748|2131153|P3|NOT COMPLETED|Overall Study||0
880694|NCT02022748|2131154|P2|NOT COMPLETED|Overall Study||2
880695|NCT02022748|2131155|P1|NOT COMPLETED|Overall Study||1
880696|NCT02022748|2131153|P3|COMPLETED|Overall Study||13
880697|NCT02022748|2131154|P2|COMPLETED|Overall Study||4
880698|NCT02022748|2131155|P1|COMPLETED|Overall Study||7
880699|NCT02022748|2131153|P3|Subjects Who Completed Treatment|Overall Study||13
880700|NCT02022748|2131154|P2|Subjects Who Completed Treatment|Overall Study||4
880701|NCT02022748|2131155|P1|Subjects Who Completed Treatment|Overall Study||7
880702|NCT02022748|2131153|P3|Subject Who Started Treatment|Overall Study||13
880703|NCT02022748|2131154|P2|Subject Who Started Treatment|Overall Study||6
880704|NCT02022748|2131155|P1|Subject Who Started Treatment|Overall Study||8
880705|NCT02022748|2131153|P3|STARTED|Overall Study||13
880706|NCT02022748|2131154|P2|STARTED|Overall Study||6
880707|NCT02022748|2131155|P1|STARTED|Overall Study||8
880708|NCT02022670|2131181|P3|NOT COMPLETED|Overall Study||1
880709|NCT02022670|2131182|P2|NOT COMPLETED|Overall Study||0
880710|NCT02022670|2131183|P1|NOT COMPLETED|Overall Study||1
880711|NCT02022670|2131181|P3|COMPLETED|Overall Study||11
880712|NCT02022670|2131182|P2|COMPLETED|Overall Study||10
880713|NCT02022670|2131183|P1|COMPLETED|Overall Study||10
880714|NCT02022670|2131181|P3|STARTED|Overall Study||12
880715|NCT02022670|2131182|P2|STARTED|Overall Study||10
880716|NCT02022670|2131183|P1|STARTED|Overall Study||11
880717|NCT02022085|2131197|P1|NOT COMPLETED|Overall Study||1
880718|NCT02022085|2131197|P1|COMPLETED|Overall Study||53
880719|NCT02022085|2131197|P1|STARTED|Overall Study||54
880720|NCT02022020|2131218|P1|NOT COMPLETED|Overall Study||0
880721|NCT02022020|2131218|P1|COMPLETED|Overall Study||220
880722|NCT02022020|2131218|P1|STARTED|Overall Study||220
880723|NCT02022007|2131227|P3|NOT COMPLETED|Overall Study||2
880724|NCT02022007|2131228|P2|NOT COMPLETED|Overall Study||1
880725|NCT02022007|2131229|P1|NOT COMPLETED|Overall Study||1
880726|NCT02022007|2131227|P3|COMPLETED|Overall Study||11
880727|NCT02022007|2131228|P2|COMPLETED|Overall Study||11
880728|NCT02022007|2131229|P1|COMPLETED|Overall Study||12
880729|NCT02022007|2131227|P3|STARTED|Overall Study||13
880730|NCT02022007|2131228|P2|STARTED|Overall Study||12
880731|NCT02022007|2131229|P1|STARTED|Overall Study||13
880732|NCT02021812|2131270|P1|NOT COMPLETED|Overall Study||26
880733|NCT02021812|2131270|P1|COMPLETED|Overall Study||5
880734|NCT02021812|2131270|P1|STARTED|Overall Study||31
880735|NCT02021461|2131278|P1|NOT COMPLETED|Overall Study||0
880736|NCT02021461|2131278|P1|COMPLETED|Overall Study||38
880737|NCT02021461|2131278|P1|STARTED|Overall Study||38
880738|NCT02021331|2131286|P2|NOT COMPLETED|Overall Study||2
880739|NCT02021331|2131287|P1|NOT COMPLETED|Overall Study||0
880740|NCT02021331|2131286|P2|COMPLETED|Overall Study||1
880741|NCT02021331|2131287|P1|COMPLETED|Overall Study||2
880742|NCT02021331|2131286|P2|STARTED|Overall Study||3
880743|NCT02021331|2131287|P1|STARTED|Overall Study||2
880744|NCT02021071|2131299|P2|NOT COMPLETED|Overall Study||0
880745|NCT02021071|2131300|P1|NOT COMPLETED|Overall Study||0
880746|NCT02021071|2131299|P2|COMPLETED|Overall Study||12
880747|NCT02021071|2131300|P1|COMPLETED|Overall Study||12
880748|NCT02021071|2131299|P2|STARTED|Overall Study||12
880749|NCT02021071|2131300|P1|STARTED|Overall Study||12
880750|NCT02020941|2131307|P1|NOT COMPLETED|Overall Study||8
880751|NCT02020941|2131307|P1|COMPLETED|Overall Study||2
880752|NCT02020941|2131307|P1|STARTED|Overall Study||10
880753|NCT02020863|2131316|P1|NOT COMPLETED|Overall Study||5
880754|NCT02020863|2131316|P1|COMPLETED|Overall Study||35
880755|NCT02020863|2131316|P1|STARTED|Overall Study||40
880756|NCT02020577|2131322|P2|NOT COMPLETED|Overall Study||55
880757|NCT02020577|2131323|P1|NOT COMPLETED|Overall Study||3
880758|NCT02020577|2131322|P2|COMPLETED|Overall Study||0
880759|NCT02020577|2131323|P1|COMPLETED|Overall Study||0
880760|NCT02020577|2131322|P2|STARTED|Overall Study||55
880761|NCT02020577|2131323|P1|STARTED|Overall Study||3
880762|NCT02020512|2131350|P1|NOT COMPLETED|Overall Study||8
880763|NCT02020512|2131350|P1|COMPLETED|Overall Study||79
880764|NCT02020512|2131350|P1|STARTED|Overall Study||87
880765|NCT02020369|2131356|P2|NOT COMPLETED|Overall Study||2
880766|NCT02020369|2131357|P1|NOT COMPLETED|Overall Study||3
880767|NCT02020369|2131356|P2|COMPLETED|Overall Study||11
880768|NCT02020369|2131357|P1|COMPLETED|Overall Study||11
880769|NCT02020369|2131356|P2|STARTED|Overall Study||13
880770|NCT02020369|2131357|P1|STARTED|Overall Study||14
880771|NCT02020304|2131373|P2|NOT COMPLETED|Overall Study||2
880772|NCT02020304|2131374|P1|NOT COMPLETED|Overall Study||3
880773|NCT02020304|2131373|P2|COMPLETED|Overall Study||26
880774|NCT02020304|2131374|P1|COMPLETED|Overall Study||27
880775|NCT02020304|2131373|P2|STARTED|Overall Study||28
880776|NCT02020304|2131374|P1|STARTED|Overall Study||30
880777|NCT02020135|2131390|P1|NOT COMPLETED|Overall Study||9
880778|NCT02020135|2131390|P1|COMPLETED|Overall Study||0
880779|NCT02020135|2131390|P1|STARTED|Overall Study||9
880780|NCT02020031|2131402|P2|NOT COMPLETED|Overall Study||1
880781|NCT02020031|2131403|P1|NOT COMPLETED|Overall Study||1
880782|NCT02020031|2131402|P2|COMPLETED|Overall Study||10
880783|NCT02020031|2131403|P1|COMPLETED|Overall Study||10
880784|NCT02020031|2131402|P2|STARTED|Overall Study||11
880785|NCT02020031|2131403|P1|STARTED|Overall Study||11
880786|NCT02019563|2131413|P2|NOT COMPLETED|Overall Study||0
880787|NCT02019563|2131414|P1|NOT COMPLETED|Overall Study||0
880788|NCT02019563|2131413|P2|COMPLETED|Overall Study|72 incisors were treated in the RCT group|30
880789|NCT02019563|2131414|P1|COMPLETED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
880790|NCT02019563|2131413|P2|STARTED|Overall Study|72 incisors were treated in the RCT group|30
880791|NCT02019563|2131414|P1|STARTED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
880792|NCT02019550|2131430|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
880793|NCT02019550|2131431|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
880794|NCT02019550|2131430|P2|COMPLETED|Treatment Period 2 (4 Weeks)||50
880795|NCT02019550|2131431|P1|COMPLETED|Treatment Period 2 (4 Weeks)||46
880796|NCT02019550|2131430|P2|STARTED|Treatment Period 2 (4 Weeks)||50
880797|NCT02019550|2131431|P1|STARTED|Treatment Period 2 (4 Weeks)||46
880798|NCT02019550|2131430|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
880799|NCT02019550|2131431|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
880800|NCT02019550|2131430|P2|COMPLETED|Treatment Period 1 (4 Weeks)||50
880801|NCT02019550|2131431|P1|COMPLETED|Treatment Period 1 (4 Weeks)||46
880802|NCT02019550|2131430|P2|STARTED|Treatment Period 1 (4 Weeks)||51
880803|NCT02019550|2131431|P1|STARTED|Treatment Period 1 (4 Weeks)||46
880813|NCT02018809|2131499|P4|NOT COMPLETED|Overall Study||0
880814|NCT02018809|2131500|P3|NOT COMPLETED|Overall Study||0
880815|NCT02018809|2131501|P2|NOT COMPLETED|Overall Study||0
880816|NCT02018809|2131502|P1|NOT COMPLETED|Overall Study||0
880817|NCT02018809|2131499|P4|COMPLETED|Overall Study||50
880818|NCT02018809|2131500|P3|COMPLETED|Overall Study||50
880819|NCT02018809|2131501|P2|COMPLETED|Overall Study||50
880820|NCT02018809|2131502|P1|COMPLETED|Overall Study||50
880821|NCT02018809|2131499|P4|STARTED|Overall Study||50
880822|NCT02018809|2131500|P3|STARTED|Overall Study||50
880823|NCT02018809|2131501|P2|STARTED|Overall Study||50
880824|NCT02018809|2131502|P1|STARTED|Overall Study||50
880825|NCT02017574|2131518|P2|NOT COMPLETED|Overall Study||0
880826|NCT02017574|2131519|P1|NOT COMPLETED|Overall Study||0
880827|NCT02017574|2131518|P2|COMPLETED|Overall Study||12
880828|NCT02017574|2131519|P1|COMPLETED|Overall Study||12
880829|NCT02017574|2131518|P2|STARTED|Overall Study||12
880830|NCT02017574|2131519|P1|STARTED|Overall Study||12
880831|NCT02017093|2131529|P2|NOT COMPLETED|Overall Study||0
880832|NCT02017093|2131530|P1|NOT COMPLETED|Overall Study||0
880833|NCT02017093|2131529|P2|COMPLETED|Overall Study||3
880834|NCT02017093|2131530|P1|COMPLETED|Overall Study||4
880835|NCT02017093|2131529|P2|STARTED|Overall Study||3
880836|NCT02017093|2131530|P1|STARTED|Overall Study||4
880837|NCT02017015|2131538|P1|NOT COMPLETED|Overall Study||69
880838|NCT02017015|2131538|P1|COMPLETED|Overall Study|Completed = Participants remaining on treatment at the time of the data cut-off of 01 Jun 2015|14
880839|NCT02017015|2131538|P1|Safety Population|Overall Study||83
880840|NCT02017015|2131538|P1|STARTED|Overall Study||83
880841|NCT02016963|2131545|P1|NOT COMPLETED|Overall Study||0
880842|NCT02016963|2131545|P1|COMPLETED|Overall Study||20
880843|NCT02016963|2131545|P1|STARTED|Overall Study||20
880844|NCT02016690|2131561|P1|NOT COMPLETED|Overall Study||24
880845|NCT02016690|2131561|P1|COMPLETED|Overall Study|(Effectiveness analysis set)|288
880846|NCT02016690|2131561|P1|Safety Analysis Set (SAS)|Overall Study||304
880847|NCT02016690|2131561|P1|Treated|Overall Study||312
880848|NCT02016690|2131561|P1|STARTED|Overall Study||312
880849|NCT02016625|2131574|P2|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||0
880850|NCT02016625|2131575|P1|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||3
880851|NCT02016625|2131574|P2|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
880852|NCT02016625|2131575|P1|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||13
880853|NCT02016625|2131574|P2|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
880854|NCT02016625|2131575|P1|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||16
880855|NCT02016625|2131574|P2|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||1
880856|NCT02016625|2131575|P1|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||0
880857|NCT02016625|2131574|P2|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||15
880858|NCT02016625|2131575|P1|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||16
880859|NCT02016625|2131574|P2|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
880860|NCT02016625|2131575|P1|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
880861|NCT02016482|2131609|P2|NOT COMPLETED|Period B||7
880862|NCT02016482|2131610|P1|NOT COMPLETED|Period B||13
880863|NCT02016482|2131609|P2|COMPLETED|Period B||87
880864|NCT02016482|2131610|P1|COMPLETED|Period B||81
880865|NCT02016482|2131609|P2|STARTED|Period B||94
880866|NCT02016482|2131610|P1|STARTED|Period B||94
880867|NCT02016482|2131609|P2|NOT COMPLETED|Period A||15
880868|NCT02016482|2131610|P1|NOT COMPLETED|Period A||14
880869|NCT02016482|2131609|P2|COMPLETED|Period A|8 participants early escaped to the end of Period A and 86 continued to the end of Period A.|94
880870|NCT02016482|2131610|P1|COMPLETED|Period A|56 participants early escaped to the end of Period A and 38 continued to the end of Period A.|94
880871|NCT02016482|2131609|P2|STARTED|Period A||109
880872|NCT02016482|2131610|P1|STARTED|Period A||108
880873|NCT02016170|2131701|P3|NOT COMPLETED|Overall Study||0
880874|NCT02016170|2131702|P2|NOT COMPLETED|Overall Study||1
880875|NCT02016170|2131703|P1|NOT COMPLETED|Overall Study||2
880876|NCT02016170|2131701|P3|COMPLETED|Overall Study||27
880877|NCT02016170|2131702|P2|COMPLETED|Overall Study||27
880878|NCT02016170|2131703|P1|COMPLETED|Overall Study||25
880879|NCT02016170|2131701|P3|STARTED|Overall Study||27
880880|NCT02016170|2131702|P2|STARTED|Overall Study||28
880881|NCT02016170|2131703|P1|STARTED|Overall Study||27
880882|NCT02016105|2131714|P6|NOT COMPLETED|EXTENSION PERIOD||6
880883|NCT02016105|2131715|P5|NOT COMPLETED|EXTENSION PERIOD||6
880884|NCT02016105|2131716|P4|NOT COMPLETED|EXTENSION PERIOD||5
880885|NCT02016105|2131717|P3|NOT COMPLETED|EXTENSION PERIOD||5
880886|NCT02016105|2131718|P2|NOT COMPLETED|EXTENSION PERIOD||0
880887|NCT02016105|2131719|P1|NOT COMPLETED|EXTENSION PERIOD||0
880888|NCT02016105|2131714|P6|COMPLETED|EXTENSION PERIOD||100
880889|NCT02016105|2131715|P5|COMPLETED|EXTENSION PERIOD||50
880890|NCT02016105|2131716|P4|COMPLETED|EXTENSION PERIOD||104
880891|NCT02016105|2131717|P3|COMPLETED|EXTENSION PERIOD||47
880892|NCT02016105|2131718|P2|COMPLETED|EXTENSION PERIOD||0
880893|NCT02016105|2131719|P1|COMPLETED|EXTENSION PERIOD||0
880894|NCT02016105|2131714|P6|STARTED|EXTENSION PERIOD|6 patients did not proceed from Treatment Period 2 into Extension Period|106
880895|NCT02016105|2131715|P5|STARTED|EXTENSION PERIOD|3 patients did not proceed from Treatment Period 2 into Extension Period|56
880896|NCT02016105|2131716|P4|STARTED|EXTENSION PERIOD|7 patients did not proceed from Treatment Period 2 into Extension Period|109
880897|NCT02016105|2131717|P3|STARTED|EXTENSION PERIOD|5 patients did not proceed from Treatment Period 2 into Extension Period|52
880898|NCT02016105|2131718|P2|STARTED|EXTENSION PERIOD||0
880899|NCT02016105|2131719|P1|STARTED|EXTENSION PERIOD||0
880900|NCT02016105|2131714|P6|NOT COMPLETED|TREATMENT PERIOD 2||14
880901|NCT02016105|2131715|P5|NOT COMPLETED|TREATMENT PERIOD 2||4
880902|NCT02016105|2131716|P4|NOT COMPLETED|TREATMENT PERIOD 2||11
880903|NCT02016105|2131717|P3|NOT COMPLETED|TREATMENT PERIOD 2||6
880904|NCT02016105|2131718|P2|NOT COMPLETED|TREATMENT PERIOD 2||0
880905|NCT02016105|2131719|P1|NOT COMPLETED|TREATMENT PERIOD 2||0
880906|NCT02016105|2131714|P6|COMPLETED|TREATMENT PERIOD 2||112
880907|NCT02016105|2131715|P5|COMPLETED|TREATMENT PERIOD 2||59
880908|NCT02016105|2131716|P4|COMPLETED|TREATMENT PERIOD 2||116
880909|NCT02016105|2131717|P3|COMPLETED|TREATMENT PERIOD 2||57
880910|NCT02016105|2131718|P2|COMPLETED|TREATMENT PERIOD 2||0
880911|NCT02016105|2131719|P1|COMPLETED|TREATMENT PERIOD 2||0
880912|NCT02016105|2131714|P6|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|126
880913|NCT02016105|2131715|P5|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|63
880914|NCT02016105|2131716|P4|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|127
880915|NCT02016105|2131717|P3|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|63
880916|NCT02016105|2131718|P2|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
880917|NCT02016105|2131719|P1|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
880918|NCT02016105|2131714|P6|NOT COMPLETED|TREATMENT PERIOD 1||0
880919|NCT02016105|2131715|P5|NOT COMPLETED|TREATMENT PERIOD 1||0
880920|NCT02016105|2131716|P4|NOT COMPLETED|TREATMENT PERIOD 1||0
880921|NCT02016105|2131717|P3|NOT COMPLETED|TREATMENT PERIOD 1||0
880922|NCT02016105|2131718|P2|NOT COMPLETED|TREATMENT PERIOD 1||33
880923|NCT02016105|2131719|P1|NOT COMPLETED|TREATMENT PERIOD 1||30
880924|NCT02016105|2131714|P6|COMPLETED|TREATMENT PERIOD 1||0
880925|NCT02016105|2131715|P5|COMPLETED|TREATMENT PERIOD 1||0
880926|NCT02016105|2131716|P4|COMPLETED|TREATMENT PERIOD 1||0
880927|NCT02016105|2131717|P3|COMPLETED|TREATMENT PERIOD 1||0
880928|NCT02016105|2131718|P2|COMPLETED|TREATMENT PERIOD 1|11 patients did not proceed into Treatment Period 2|201
880929|NCT02016105|2131719|P1|COMPLETED|TREATMENT PERIOD 1|12 patients did not proceed into Treatment Period 2|201
880930|NCT02016105|2131714|P6|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
880931|NCT02016105|2131715|P5|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
880932|NCT02016105|2131716|P4|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
880933|NCT02016105|2131717|P3|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
880934|NCT02016105|2131718|P2|STARTED|TREATMENT PERIOD 1||234
880935|NCT02016105|2131719|P1|STARTED|TREATMENT PERIOD 1||231
880936|NCT02015910|2131769|P2|NOT COMPLETED|Overall Study||0
880937|NCT02015910|2131770|P1|NOT COMPLETED|Overall Study||0
880938|NCT02015910|2131769|P2|COMPLETED|Overall Study||1
880939|NCT02015910|2131770|P1|COMPLETED|Overall Study||0
880940|NCT02015910|2131769|P2|STARTED|Overall Study||1
880941|NCT02015910|2131770|P1|STARTED|Overall Study||0
880942|NCT02015793|2131778|P2|NOT COMPLETED|Overall Study||4
880943|NCT02015793|2131779|P1|NOT COMPLETED|Overall Study||4
880944|NCT02015793|2131778|P2|COMPLETED|Overall Study||11
880945|NCT02015793|2131779|P1|COMPLETED|Overall Study||11
880946|NCT02015793|2131778|P2|Entered Open-label Extension Period|Overall Study||14
880947|NCT02015793|2131779|P1|Entered Open-label Extension Period|Overall Study||13
880948|NCT02015793|2131778|P2|Completed Double-Blind Period|Overall Study||14
880949|NCT02015793|2131779|P1|Completed Double-Blind Period|Overall Study||14
880950|NCT02015793|2131778|P2|STARTED|Overall Study||15
880951|NCT02015793|2131779|P1|STARTED|Overall Study||15
880952|NCT02015676|2131812|P3|NOT COMPLETED|Overall Study||3
880953|NCT02015676|2131813|P2|NOT COMPLETED|Overall Study||34
880954|NCT02015676|2131814|P1|NOT COMPLETED|Overall Study||9
880955|NCT02015676|2131812|P3|COMPLETED|Overall Study||3
880956|NCT02015676|2131813|P2|COMPLETED|Overall Study||14
880957|NCT02015676|2131814|P1|COMPLETED|Overall Study||6
880958|NCT02015676|2131812|P3|STARTED|Overall Study||6
880959|NCT02015676|2131813|P2|STARTED|Overall Study||48
880960|NCT02015676|2131814|P1|STARTED|Overall Study||15
880961|NCT02015663|2131830|P2|NOT COMPLETED|Overall Study||12
880962|NCT02015663|2131831|P1|NOT COMPLETED|Overall Study||15
880963|NCT02015663|2131830|P2|COMPLETED|Overall Study||4
880964|NCT02015663|2131831|P1|COMPLETED|Overall Study||1
880965|NCT02015663|2131830|P2|STARTED|Overall Study||16
880966|NCT02015663|2131831|P1|STARTED|Overall Study||16
880967|NCT02015546|2131863|P3|NOT COMPLETED|Overall Study||4
880968|NCT02015546|2131864|P2|NOT COMPLETED|Overall Study||2
880969|NCT02015546|2131865|P1|NOT COMPLETED|Overall Study||3
880970|NCT02015546|2131863|P3|COMPLETED|Overall Study||22
880971|NCT02015546|2131864|P2|COMPLETED|Overall Study||19
880972|NCT02015546|2131865|P1|COMPLETED|Overall Study||20
880973|NCT02015546|2131863|P3|STARTED|Overall Study||26
880974|NCT02015546|2131864|P2|STARTED|Overall Study||21
880975|NCT02015546|2131865|P1|STARTED|Overall Study||23
880979|NCT02015234|2131906|P2|NOT COMPLETED|Overall Study||25
880980|NCT02015234|2131907|P1|NOT COMPLETED|Overall Study||36
880981|NCT02015234|2131906|P2|COMPLETED|Overall Study||54
880982|NCT02015234|2131907|P1|COMPLETED|Overall Study||43
880983|NCT02015234|2131906|P2|STARTED|Overall Study||79
880984|NCT02015234|2131907|P1|STARTED|Overall Study||79
880985|NCT02015221|2131921|P2|NOT COMPLETED|Overall Study||6
880986|NCT02015221|2131922|P1|NOT COMPLETED|Overall Study||9
880987|NCT02015221|2131921|P2|COMPLETED|Overall Study||34
880988|NCT02015221|2131922|P1|COMPLETED|Overall Study||32
880989|NCT02015221|2131921|P2|STARTED|Overall Study||40
880990|NCT02015221|2131922|P1|STARTED|Overall Study||41
880991|NCT02015195|2131935|P7|NOT COMPLETED|Overall Study||0
880992|NCT02015195|2131936|P6|NOT COMPLETED|Overall Study||0
880993|NCT02015195|2131937|P5|NOT COMPLETED|Overall Study||0
880994|NCT02015195|2131938|P4|NOT COMPLETED|Overall Study||1
880995|NCT02015195|2131939|P3|NOT COMPLETED|Overall Study||0
880996|NCT02015195|2131940|P2|NOT COMPLETED|Overall Study||0
880997|NCT02015195|2131941|P1|NOT COMPLETED|Overall Study||0
880998|NCT02015195|2131935|P7|COMPLETED|Overall Study||16
880999|NCT02015195|2131936|P6|COMPLETED|Overall Study||16
881000|NCT02015195|2131937|P5|COMPLETED|Overall Study||16
881001|NCT02015195|2131938|P4|COMPLETED|Overall Study||0
881002|NCT02015195|2131939|P3|COMPLETED|Overall Study||16
881003|NCT02015195|2131940|P2|COMPLETED|Overall Study||16
881004|NCT02015195|2131941|P1|COMPLETED|Overall Study||16
881005|NCT02015195|2131935|P7|STARTED|Overall Study||16
881006|NCT02015195|2131936|P6|STARTED|Overall Study||16
881007|NCT02015195|2131937|P5|STARTED|Overall Study||16
881008|NCT02015195|2131938|P4|STARTED|Overall Study||1
881009|NCT02015195|2131939|P3|STARTED|Overall Study||16
881010|NCT02015195|2131940|P2|STARTED|Overall Study||16
881011|NCT02015195|2131941|P1|STARTED|Overall Study||16
881012|NCT02014584|2131964|P6|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
881013|NCT02014584|2131965|P5|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||1
881014|NCT02014584|2131966|P4|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
881015|NCT02014584|2131967|P3|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
881016|NCT02014584|2131968|P2|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
881017|NCT02014584|2131969|P1|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
881018|NCT02014584|2131964|P6|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
881019|NCT02014584|2131965|P5|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
881020|NCT02014584|2131966|P4|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
881021|NCT02014584|2131967|P3|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
881022|NCT02014584|2131968|P2|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
881023|NCT02014584|2131969|P1|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
881024|NCT02014584|2131964|P6|STARTED|Target Follow-up (F/U) Period (24 Weeks)||2
881025|NCT02014584|2131965|P5|STARTED|Target Follow-up (F/U) Period (24 Weeks)||3
881026|NCT02014584|2131966|P4|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
881027|NCT02014584|2131967|P3|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
881028|NCT02014584|2131968|P2|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
881029|NCT02014584|2131969|P1|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
881030|NCT02014584|2131964|P6|NOT COMPLETED|Open-Label Period (24 Weeks)||0
881031|NCT02014584|2131965|P5|NOT COMPLETED|Open-Label Period (24 Weeks)||0
881032|NCT02014584|2131966|P4|NOT COMPLETED|Open-Label Period (24 Weeks)||1
881033|NCT02014584|2131967|P3|NOT COMPLETED|Open-Label Period (24 Weeks)||5
881034|NCT02014584|2131968|P2|NOT COMPLETED|Open-Label Period (24 Weeks)||0
881035|NCT02014584|2131969|P1|NOT COMPLETED|Open-Label Period (24 Weeks)||0
881036|NCT02014584|2131964|P6|COMPLETED|Open-Label Period (24 Weeks)||0
881037|NCT02014584|2131965|P5|COMPLETED|Open-Label Period (24 Weeks)||0
881038|NCT02014584|2131966|P4|COMPLETED|Open-Label Period (24 Weeks)||47
881039|NCT02014584|2131967|P3|COMPLETED|Open-Label Period (24 Weeks)||44
881040|NCT02014584|2131968|P2|COMPLETED|Open-Label Period (24 Weeks)||0
881041|NCT02014584|2131969|P1|COMPLETED|Open-Label Period (24 Weeks)||0
881042|NCT02014584|2131964|P6|STARTED|Open-Label Period (24 Weeks)||0
881043|NCT02014584|2131965|P5|STARTED|Open-Label Period (24 Weeks)||0
881044|NCT02014584|2131966|P4|STARTED|Open-Label Period (24 Weeks)||48
881045|NCT02014584|2131967|P3|STARTED|Open-Label Period (24 Weeks)||49
881046|NCT02014584|2131968|P2|STARTED|Open-Label Period (24 Weeks)||0
881047|NCT02014584|2131969|P1|STARTED|Open-Label Period (24 Weeks)||0
881048|NCT02014584|2131964|P6|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
881049|NCT02014584|2131965|P5|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
881050|NCT02014584|2131966|P4|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
881051|NCT02014584|2131967|P3|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
881052|NCT02014584|2131968|P2|NOT COMPLETED|Double-Blind Period (24 Weeks)||6
881053|NCT02014584|2131969|P1|NOT COMPLETED|Double-Blind Period (24 Weeks)||2
881054|NCT02014584|2131964|P6|COMPLETED|Double-Blind Period (24 Weeks)||0
881055|NCT02014584|2131965|P5|COMPLETED|Double-Blind Period (24 Weeks)||0
881056|NCT02014584|2131966|P4|COMPLETED|Double-Blind Period (24 Weeks)||0
881057|NCT02014584|2131967|P3|COMPLETED|Double-Blind Period (24 Weeks)||0
881058|NCT02014584|2131968|P2|COMPLETED|Double-Blind Period (24 Weeks)||52
881059|NCT02014584|2131969|P1|COMPLETED|Double-Blind Period (24 Weeks)||57
881060|NCT02014584|2131964|P6|STARTED|Double-Blind Period (24 Weeks)||0
881061|NCT02014584|2131965|P5|STARTED|Double-Blind Period (24 Weeks)||0
881062|NCT02014584|2131966|P4|STARTED|Double-Blind Period (24 Weeks)||0
881063|NCT02014584|2131967|P3|STARTED|Double-Blind Period (24 Weeks)||0
881064|NCT02014584|2131968|P2|STARTED|Double-Blind Period (24 Weeks)||58
881065|NCT02014584|2131969|P1|STARTED|Double-Blind Period (24 Weeks)||59
881066|NCT02014480|2132086|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||2
881067|NCT02014480|2132087|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
881068|NCT02014480|2132088|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
881069|NCT02014480|2132089|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
881070|NCT02014480|2132090|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||1
881071|NCT02014480|2132091|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
881072|NCT02014480|2132086|P6|COMPLETED|Treatment Period 3 (14 Days)||32
881073|NCT02014480|2132087|P5|COMPLETED|Treatment Period 3 (14 Days)||34
881074|NCT02014480|2132088|P4|COMPLETED|Treatment Period 3 (14 Days)||31
881075|NCT02014480|2132089|P3|COMPLETED|Treatment Period 3 (14 Days)||29
881076|NCT02014480|2132090|P2|COMPLETED|Treatment Period 3 (14 Days)||32
881077|NCT02014480|2132091|P1|COMPLETED|Treatment Period 3 (14 Days)||34
881078|NCT02014480|2132086|P6|STARTED|Treatment Period 3 (14 Days)||34
881079|NCT02014480|2132087|P5|STARTED|Treatment Period 3 (14 Days)||34
881080|NCT02014480|2132088|P4|STARTED|Treatment Period 3 (14 Days)||31
881081|NCT02014480|2132089|P3|STARTED|Treatment Period 3 (14 Days)||30
881082|NCT02014480|2132090|P2|STARTED|Treatment Period 3 (14 Days)||33
881083|NCT02014480|2132091|P1|STARTED|Treatment Period 3 (14 Days)||34
881084|NCT02014480|2132086|P6|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
881085|NCT02014480|2132087|P5|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
881086|NCT02014480|2132088|P4|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
881087|NCT02014480|2132089|P3|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
881088|NCT02014480|2132090|P2|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
881089|NCT02014480|2132091|P1|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
881090|NCT02014480|2132086|P6|COMPLETED|Washout Period 2 (10 to 14 Days)||34
881091|NCT02014480|2132087|P5|COMPLETED|Washout Period 2 (10 to 14 Days)||34
881092|NCT02014480|2132088|P4|COMPLETED|Washout Period 2 (10 to 14 Days)||31
881093|NCT02014480|2132089|P3|COMPLETED|Washout Period 2 (10 to 14 Days)||30
881094|NCT02014480|2132090|P2|COMPLETED|Washout Period 2 (10 to 14 Days)||33
881095|NCT02014480|2132091|P1|COMPLETED|Washout Period 2 (10 to 14 Days)||34
881096|NCT02014480|2132086|P6|STARTED|Washout Period 2 (10 to 14 Days)||34
881097|NCT02014480|2132087|P5|STARTED|Washout Period 2 (10 to 14 Days)||34
881098|NCT02014480|2132088|P4|STARTED|Washout Period 2 (10 to 14 Days)||31
881099|NCT02014480|2132089|P3|STARTED|Washout Period 2 (10 to 14 Days)||30
881100|NCT02014480|2132090|P2|STARTED|Washout Period 2 (10 to 14 Days)||33
881101|NCT02014480|2132091|P1|STARTED|Washout Period 2 (10 to 14 Days)||34
881102|NCT02014480|2132086|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
881103|NCT02014480|2132087|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
881104|NCT02014480|2132088|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
881105|NCT02014480|2132089|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||2
881106|NCT02014480|2132090|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
881107|NCT02014480|2132091|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||1
881108|NCT02014480|2132086|P6|COMPLETED|Treatment Period 2 (14 Days)||34
881109|NCT02014480|2132087|P5|COMPLETED|Treatment Period 2 (14 Days)||34
881110|NCT02014480|2132088|P4|COMPLETED|Treatment Period 2 (14 Days)||31
881111|NCT02014480|2132089|P3|COMPLETED|Treatment Period 2 (14 Days)||30
881112|NCT02014480|2132090|P2|COMPLETED|Treatment Period 2 (14 Days)||33
881113|NCT02014480|2132091|P1|COMPLETED|Treatment Period 2 (14 Days)||34
881114|NCT02014480|2132086|P6|STARTED|Treatment Period 2 (14 Days)||34
881115|NCT02014480|2132087|P5|STARTED|Treatment Period 2 (14 Days)||34
881116|NCT02014480|2132088|P4|STARTED|Treatment Period 2 (14 Days)||32
881117|NCT02014480|2132089|P3|STARTED|Treatment Period 2 (14 Days)||32
881118|NCT02014480|2132090|P2|STARTED|Treatment Period 2 (14 Days)||34
881119|NCT02014480|2132091|P1|STARTED|Treatment Period 2 (14 Days)||35
881120|NCT02014480|2132086|P6|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
881121|NCT02014480|2132087|P5|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
881122|NCT02014480|2132088|P4|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
881123|NCT02014480|2132089|P3|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
881124|NCT02014480|2132090|P2|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
881125|NCT02014480|2132091|P1|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
881126|NCT02014480|2132086|P6|COMPLETED|Washout Period 1 (10 to 14 Days)||34
881127|NCT02014480|2132087|P5|COMPLETED|Washout Period 1 (10 to 14 Days)||34
881128|NCT02014480|2132088|P4|COMPLETED|Washout Period 1 (10 to 14 Days)||32
881129|NCT02014480|2132089|P3|COMPLETED|Washout Period 1 (10 to 14 Days)||32
881130|NCT02014480|2132090|P2|COMPLETED|Washout Period 1 (10 to 14 Days)||34
881131|NCT02014480|2132091|P1|COMPLETED|Washout Period 1 (10 to 14 Days)||35
881132|NCT02014480|2132086|P6|STARTED|Washout Period 1 (10 to 14 Days)||34
881133|NCT02014480|2132087|P5|STARTED|Washout Period 1 (10 to 14 Days)||34
881134|NCT02014480|2132088|P4|STARTED|Washout Period 1 (10 to 14 Days)||32
881135|NCT02014480|2132089|P3|STARTED|Washout Period 1 (10 to 14 Days)||33
881136|NCT02014480|2132090|P2|STARTED|Washout Period 1 (10 to 14 Days)||34
881137|NCT02014480|2132091|P1|STARTED|Washout Period 1 (10 to 14 Days)||35
881138|NCT02014480|2132086|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||0
881139|NCT02014480|2132087|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||1
881140|NCT02014480|2132088|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||2
881141|NCT02014480|2132089|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||1
881142|NCT02014480|2132090|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
881143|NCT02014480|2132091|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||0
881144|NCT02014480|2132086|P6|COMPLETED|Treatment Period 1 (14 Days)||34
881145|NCT02014480|2132087|P5|COMPLETED|Treatment Period 1 (14 Days)||34
881146|NCT02014480|2132088|P4|COMPLETED|Treatment Period 1 (14 Days)||32
881147|NCT02014480|2132089|P3|COMPLETED|Treatment Period 1 (14 Days)||33
881148|NCT02014480|2132090|P2|COMPLETED|Treatment Period 1 (14 Days)||34
881149|NCT02014480|2132091|P1|COMPLETED|Treatment Period 1 (14 Days)||35
881150|NCT02014480|2132086|P6|STARTED|Treatment Period 1 (14 Days)|One participant randomized to Sequence 6 actually received UMEC in Treatment Periods 2 and 3.|34
881151|NCT02014480|2132087|P5|STARTED|Treatment Period 1 (14 Days)||35
881152|NCT02014480|2132088|P4|STARTED|Treatment Period 1 (14 Days)||34
881153|NCT02014480|2132089|P3|STARTED|Treatment Period 1 (14 Days)||34
881154|NCT02014480|2132090|P2|STARTED|Treatment Period 1 (14 Days)||35
881155|NCT02014480|2132091|P1|STARTED|Treatment Period 1 (14 Days)||35
881156|NCT02014467|2132110|P2|NOT COMPLETED|Overall Study||7
881157|NCT02014467|2132111|P1|NOT COMPLETED|Overall Study||25
881158|NCT02014467|2132110|P2|COMPLETED|Overall Study||112
881159|NCT02014467|2132111|P1|COMPLETED|Overall Study||340
881160|NCT02014467|2132110|P2|STARTED|Overall Study||119
881161|NCT02014467|2132111|P1|STARTED|Overall Study||365
881162|NCT02014441|2132171|P1|NOT COMPLETED|Overall Study||30
881163|NCT02014441|2132171|P1|COMPLETED|Overall Study||31
881164|NCT02014441|2132171|P1|Received Treatment|Overall Study||60
881165|NCT02014441|2132171|P1|STARTED|Overall Study||61
881166|NCT02014402|2132267|P4|NOT COMPLETED|Overall Study||3
881167|NCT02014402|2132268|P3|NOT COMPLETED|Overall Study||3
881168|NCT02014402|2132269|P2|NOT COMPLETED|Overall Study||3
881169|NCT02014402|2132270|P1|NOT COMPLETED|Overall Study||2
881170|NCT02014402|2132267|P4|COMPLETED|Overall Study||82
881171|NCT02014402|2132268|P3|COMPLETED|Overall Study||32
881172|NCT02014402|2132269|P2|COMPLETED|Overall Study||27
881173|NCT02014402|2132270|P1|COMPLETED|Overall Study||29
881174|NCT02014402|2132267|P4|Bovine Thrombin|Overall Study||28
881175|NCT02014402|2132268|P3|Bovine Thrombin|Overall Study||12
881176|NCT02014402|2132269|P2|Bovine Thrombin|Overall Study||10
881177|NCT02014402|2132270|P1|Bovine Thrombin|Overall Study||11
881178|NCT02014402|2132267|P4|Human Thrombin|Overall Study||57
881179|NCT02014402|2132268|P3|Human Thrombin|Overall Study||23
881180|NCT02014402|2132269|P2|Human Thrombin|Overall Study||20
881181|NCT02014402|2132270|P1|Human Thrombin|Overall Study||20
881182|NCT02014402|2132267|P4|STARTED|Overall Study||85
881183|NCT02014402|2132268|P3|STARTED|Overall Study||35
881184|NCT02014402|2132269|P2|STARTED|Overall Study||30
881185|NCT02014402|2132270|P1|STARTED|Overall Study||31
881186|NCT02014363|2132300|P3|NOT COMPLETED|Overall Study||24
881187|NCT02014363|2132301|P2|NOT COMPLETED|Overall Study||19
881188|NCT02014363|2132302|P1|NOT COMPLETED|Overall Study||17
881189|NCT02014363|2132300|P3|COMPLETED|Overall Study||31
881190|NCT02014363|2132301|P2|COMPLETED|Overall Study||35
881191|NCT02014363|2132302|P1|COMPLETED|Overall Study||38
881192|NCT02014363|2132300|P3|STARTED|Overall Study||55
881193|NCT02014363|2132301|P2|STARTED|Overall Study||54
881194|NCT02014363|2132302|P1|STARTED|Overall Study||55
881195|NCT02014272|2132310|P2|NOT COMPLETED|Intervention Period 2||0
881196|NCT02014272|2132311|P1|NOT COMPLETED|Intervention Period 2||0
881197|NCT02014272|2132310|P2|COMPLETED|Intervention Period 2||13
881198|NCT02014272|2132311|P1|COMPLETED|Intervention Period 2||13
881199|NCT02014272|2132310|P2|STARTED|Intervention Period 2||13
881200|NCT02014272|2132311|P1|STARTED|Intervention Period 2||13
881201|NCT02014272|2132310|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
881202|NCT02014272|2132311|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
881203|NCT02014272|2132310|P2|COMPLETED|Washout Period 1 (7 Days)||13
881204|NCT02014272|2132311|P1|COMPLETED|Washout Period 1 (7 Days)||13
881205|NCT02014272|2132310|P2|STARTED|Washout Period 1 (7 Days)||13
881206|NCT02014272|2132311|P1|STARTED|Washout Period 1 (7 Days)||13
881207|NCT02014272|2132310|P2|NOT COMPLETED|Intervention Period 1||1
881208|NCT02014272|2132311|P1|NOT COMPLETED|Intervention Period 1||1
881209|NCT02014272|2132310|P2|COMPLETED|Intervention Period 1||13
881210|NCT02014272|2132311|P1|COMPLETED|Intervention Period 1||13
881211|NCT02014272|2132310|P2|STARTED|Intervention Period 1||14
881212|NCT02014272|2132311|P1|STARTED|Intervention Period 1||14
881213|NCT02014051|2132329|P2|NOT COMPLETED|Overall Study||1
881214|NCT02014051|2132330|P1|NOT COMPLETED|Overall Study||1
881215|NCT02014051|2132329|P2|COMPLETED|Overall Study||5
881216|NCT02014051|2132330|P1|COMPLETED|Overall Study||2
881217|NCT02014051|2132329|P2|STARTED|Overall Study||6
881218|NCT02014051|2132330|P1|STARTED|Overall Study||3
881219|NCT02013830|2132343|P1|NOT COMPLETED|Overall Study||30
881220|NCT02013830|2132343|P1|COMPLETED|Overall Study||15
881221|NCT02013830|2132343|P1|STARTED|Overall Study||45
881222|NCT02013817|2132354|P1|NOT COMPLETED|Overall Study||27
881223|NCT02013817|2132354|P1|COMPLETED|Overall Study||16
881224|NCT02013817|2132354|P1|STARTED|Overall Study||43
881225|NCT02013765|2132363|P1|NOT COMPLETED|Overall Study||1
881226|NCT02013765|2132363|P1|COMPLETED|Overall Study||4
881227|NCT02013765|2132363|P1|STARTED|Overall Study||5
881228|NCT02013687|2132377|P4|NOT COMPLETED|Overall Study||2
881229|NCT02013687|2132378|P3|NOT COMPLETED|Overall Study||2
881230|NCT02013687|2132379|P2|NOT COMPLETED|Overall Study||0
881231|NCT02013687|2132380|P1|NOT COMPLETED|Overall Study||0
881232|NCT02013687|2132377|P4|COMPLETED|Overall Study||14
881233|NCT02013687|2132378|P3|COMPLETED|Overall Study||14
881234|NCT02013687|2132379|P2|COMPLETED|Overall Study||6
881235|NCT02013687|2132380|P1|COMPLETED|Overall Study||6
881236|NCT02013687|2132377|P4|STARTED|Overall Study||16
881237|NCT02013687|2132378|P3|STARTED|Overall Study||16
881238|NCT02013687|2132379|P2|STARTED|Overall Study||6
881239|NCT02013687|2132380|P1|STARTED|Overall Study||6
881240|NCT02013622|2132410|P1|NOT COMPLETED|Overall Study||24
881241|NCT02013622|2132410|P1|COMPLETED|Overall Study||25
881242|NCT02013622|2132410|P1|STARTED|Overall Study||49
881243|NCT02013609|2132430|P1|NOT COMPLETED|Overall Study||18
881244|NCT02013609|2132430|P1|COMPLETED|Overall Study||29
881245|NCT02013609|2132430|P1|STARTED|Overall Study|One participant out of 48 participants enrolled had discontinued before receiving study medication.|47
881246|NCT02013544|2132455|P2|NOT COMPLETED|Overall Study||20
881247|NCT02013544|2132456|P1|NOT COMPLETED|Overall Study||11
881248|NCT02013544|2132455|P2|COMPLETED|Overall Study||356
881249|NCT02013544|2132456|P1|COMPLETED|Overall Study||171
881250|NCT02013544|2132455|P2|ITT Population|Overall Study||325
881251|NCT02013544|2132456|P1|ITT Population|Overall Study||157
881252|NCT02013544|2132455|P2|Safety Population|Overall Study||374
881253|NCT02013544|2132456|P1|Safety Population|Overall Study||180
881254|NCT02013544|2132455|P2|STARTED|Overall Study||376
881255|NCT02013544|2132456|P1|STARTED|Overall Study||182
881256|NCT02013531|2132478|P1|NOT COMPLETED|Overall Study||5
881257|NCT02013531|2132478|P1|COMPLETED|Overall Study||32
881258|NCT02013531|2132478|P1|STARTED|Overall Study||37
881259|NCT02013388|2132508|P8|NOT COMPLETED|Overall Study||0
881260|NCT02013388|2132509|P7|NOT COMPLETED|Overall Study||0
881261|NCT02013388|2132510|P6|NOT COMPLETED|Overall Study||0
881262|NCT02013388|2132511|P5|NOT COMPLETED|Overall Study||1
881263|NCT02013388|2132512|P4|NOT COMPLETED|Overall Study||0
881264|NCT02013388|2132513|P3|NOT COMPLETED|Overall Study||0
881265|NCT02013388|2132514|P2|NOT COMPLETED|Overall Study||0
881266|NCT02013388|2132515|P1|NOT COMPLETED|Overall Study||1
881267|NCT02013388|2132508|P8|COMPLETED|Overall Study||4
881268|NCT02013388|2132509|P7|COMPLETED|Overall Study||6
881269|NCT02013388|2132510|P6|COMPLETED|Overall Study||6
881270|NCT02013388|2132511|P5|COMPLETED|Overall Study||5
881271|NCT02013388|2132512|P4|COMPLETED|Overall Study||6
881272|NCT02013388|2132513|P3|COMPLETED|Overall Study||6
881273|NCT02013388|2132514|P2|COMPLETED|Overall Study||6
881274|NCT02013388|2132515|P1|COMPLETED|Overall Study||8
881275|NCT02013388|2132508|P8|STARTED|Overall Study||4
881276|NCT02013388|2132509|P7|STARTED|Overall Study||6
881277|NCT02013388|2132510|P6|STARTED|Overall Study||6
881278|NCT02013388|2132511|P5|STARTED|Overall Study||6
881279|NCT02013388|2132512|P4|STARTED|Overall Study||6
881280|NCT02013388|2132513|P3|STARTED|Overall Study||6
881281|NCT02013388|2132514|P2|STARTED|Overall Study||6
881282|NCT02013388|2132515|P1|STARTED|Overall Study||9
881283|NCT02013245|2132553|P4|NOT COMPLETED|Overall Study||0
881284|NCT02013245|2132554|P3|NOT COMPLETED|Overall Study||0
881285|NCT02013245|2132555|P2|NOT COMPLETED|Overall Study||1
881286|NCT02013245|2132556|P1|NOT COMPLETED|Overall Study||0
881287|NCT02013245|2132553|P4|COMPLETED|Overall Study||9
881288|NCT02013245|2132554|P3|COMPLETED|Overall Study||9
881289|NCT02013245|2132555|P2|COMPLETED|Overall Study||8
881290|NCT02013245|2132556|P1|COMPLETED|Overall Study||9
881291|NCT02013245|2132553|P4|STARTED|Overall Study||9
881292|NCT02013245|2132554|P3|STARTED|Overall Study||9
881293|NCT02013245|2132555|P2|STARTED|Overall Study||9
881294|NCT02013245|2132556|P1|STARTED|Overall Study||9
881295|NCT02013206|2132572|P2|NOT COMPLETED|Overall Study||22
881296|NCT02013206|2132573|P1|NOT COMPLETED|Overall Study||27
881297|NCT02013206|2132572|P2|COMPLETED|Overall Study||1
881298|NCT02013206|2132573|P1|COMPLETED|Overall Study|3 Patients were on-going at clinical cut-off. Not Completed=patients who discontinued treatment.|2
881299|NCT02013206|2132572|P2|Received Study Drug|Overall Study||23
881300|NCT02013206|2132573|P1|Received Study Drug|Overall Study||26
881301|NCT02013206|2132572|P2|STARTED|Overall Study||23
881302|NCT02013206|2132573|P1|STARTED|Overall Study||29
881303|NCT02013167|2132595|P2|NOT COMPLETED|Overall Study||178
881304|NCT02013167|2132596|P1|NOT COMPLETED|Overall Study||101
881305|NCT02013167|2132595|P2|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off; 22 were receiving treatment|93
881306|NCT02013167|2132596|P1|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off|33
881307|NCT02013167|2132595|P2|Received Treatment|Overall Study||267
881308|NCT02013167|2132596|P1|Received Treatment|Overall Study||109
881309|NCT02013167|2132595|P2|STARTED|Overall Study||271
881310|NCT02013167|2132596|P1|STARTED|Overall Study||134
881311|NCT02013050|2132627|P4|NOT COMPLETED|Overall Study||4
881312|NCT02013050|2132628|P3|NOT COMPLETED|Overall Study||0
881313|NCT02013050|2132629|P2|NOT COMPLETED|Overall Study||5
881314|NCT02013050|2132630|P1|NOT COMPLETED|Overall Study||4
881315|NCT02013050|2132627|P4|COMPLETED|Overall Study||19
881316|NCT02013050|2132628|P3|COMPLETED|Overall Study||3
881317|NCT02013050|2132629|P2|COMPLETED|Overall Study||36
881318|NCT02013050|2132630|P1|COMPLETED|Overall Study||38
881319|NCT02013050|2132627|P4|STARTED|Overall Study||23
881320|NCT02013050|2132628|P3|STARTED|Overall Study||3
881321|NCT02013050|2132629|P2|STARTED|Overall Study||41
881322|NCT02013050|2132630|P1|STARTED|Overall Study||42
881323|NCT02012686|2132674|P2|NOT COMPLETED|Overall Study||2
881324|NCT02012686|2132675|P1|NOT COMPLETED|Overall Study||0
881325|NCT02012686|2132674|P2|COMPLETED|Overall Study||48
881326|NCT02012686|2132675|P1|COMPLETED|Overall Study||50
881327|NCT02012686|2132674|P2|STARTED|Overall Study||50
881328|NCT02012686|2132675|P1|STARTED|Overall Study||50
881329|NCT02012582|2132691|P4|NOT COMPLETED|Overall Study||1
881330|NCT02012582|2132692|P3|NOT COMPLETED|Overall Study||0
881331|NCT02012582|2132693|P2|NOT COMPLETED|Overall Study||0
881332|NCT02012582|2132694|P1|NOT COMPLETED|Overall Study||0
881333|NCT02012582|2132691|P4|COMPLETED|Overall Study||7
881334|NCT02012582|2132692|P3|COMPLETED|Overall Study||8
881335|NCT02012582|2132693|P2|COMPLETED|Overall Study||8
881336|NCT02012582|2132694|P1|COMPLETED|Overall Study||8
881337|NCT02012582|2132691|P4|STARTED|Overall Study||8
881338|NCT02012582|2132692|P3|STARTED|Overall Study||8
881339|NCT02012582|2132693|P2|STARTED|Overall Study||8
881340|NCT02012582|2132694|P1|STARTED|Overall Study||8
881341|NCT02012452|2132722|P2|NOT COMPLETED|Overall Study||1
881342|NCT02012452|2132723|P1|NOT COMPLETED|Overall Study||6
881343|NCT02012452|2132722|P2|COMPLETED|Overall Study||1
881344|NCT02012452|2132723|P1|COMPLETED|Overall Study||1
881345|NCT02012452|2132722|P2|STARTED|Overall Study||2
881346|NCT02012452|2132723|P1|STARTED|Overall Study||7
881347|NCT02012218|2132736|P5|NOT COMPLETED|Overall Study||1
881348|NCT02012218|2132737|P4|NOT COMPLETED|Overall Study||2
881349|NCT02012218|2132738|P3|NOT COMPLETED|Overall Study||2
881350|NCT02012218|2132739|P2|NOT COMPLETED|Overall Study||1
881351|NCT02012218|2132740|P1|NOT COMPLETED|Overall Study||4
881352|NCT02012218|2132736|P5|COMPLETED|Overall Study||5
881353|NCT02012218|2132737|P4|COMPLETED|Overall Study||17
881354|NCT02012218|2132738|P3|COMPLETED|Overall Study||11
881355|NCT02012218|2132739|P2|COMPLETED|Overall Study||10
881356|NCT02012218|2132740|P1|COMPLETED|Overall Study||8
881357|NCT02012218|2132736|P5|STARTED|Overall Study||6
881358|NCT02012218|2132737|P4|STARTED|Overall Study||19
881359|NCT02012218|2132738|P3|STARTED|Overall Study||13
881360|NCT02012218|2132739|P2|STARTED|Overall Study||11
881361|NCT02012218|2132740|P1|STARTED|Overall Study||12
881362|NCT02011893|2132752|P3|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||1
881363|NCT02011893|2132753|P2|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
881364|NCT02011893|2132754|P1|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
881365|NCT02011893|2132752|P3|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||51
881366|NCT02011893|2132753|P2|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||45
881367|NCT02011893|2132754|P1|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
881368|NCT02011893|2132752|P3|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
881369|NCT02011893|2132753|P2|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||45
881370|NCT02011893|2132754|P1|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
881371|NCT02011893|2132752|P3|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
881372|NCT02011893|2132753|P2|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||44
881373|NCT02011893|2132754|P1|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
881374|NCT02011893|2132752|P3|STARTED|Period 2 (12 Weeks to 24 Weeks)||52
881375|NCT02011893|2132753|P2|STARTED|Period 2 (12 Weeks to 24 Weeks)||45
881376|NCT02011893|2132754|P1|STARTED|Period 2 (12 Weeks to 24 Weeks)||0
881377|NCT02011893|2132752|P3|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||3
881378|NCT02011893|2132753|P2|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
881379|NCT02011893|2132754|P1|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
881380|NCT02011893|2132752|P3|COMPLETED|Period 1 (Randomization to 12 Weeks)||52
881381|NCT02011893|2132753|P2|COMPLETED|Period 1 (Randomization to 12 Weeks)||45
881382|NCT02011893|2132754|P1|COMPLETED|Period 1 (Randomization to 12 Weeks)||0
881383|NCT02011893|2132752|P3|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
881384|NCT02011893|2132753|P2|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
881385|NCT02011893|2132754|P1|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
881386|NCT02011893|2132752|P3|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
881387|NCT02011893|2132753|P2|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
881388|NCT02011893|2132754|P1|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
881389|NCT02011893|2132752|P3|STARTED|Period 1 (Randomization to 12 Weeks)||55
881390|NCT02011893|2132753|P2|STARTED|Period 1 (Randomization to 12 Weeks)||45
881391|NCT02011893|2132754|P1|STARTED|Period 1 (Randomization to 12 Weeks)||0
881392|NCT02011893|2132752|P3|NOT COMPLETED|Enrollment to Randomization||0
881393|NCT02011893|2132753|P2|NOT COMPLETED|Enrollment to Randomization||0
881394|NCT02011893|2132754|P1|NOT COMPLETED|Enrollment to Randomization||73
881395|NCT02011893|2132752|P3|COMPLETED|Enrollment to Randomization||0
881396|NCT02011893|2132753|P2|COMPLETED|Enrollment to Randomization||0
881397|NCT02011893|2132754|P1|COMPLETED|Enrollment to Randomization||100
881398|NCT02011893|2132752|P3|Randomization|Enrollment to Randomization||0
881399|NCT02011893|2132753|P2|Randomization|Enrollment to Randomization||0
881400|NCT02011893|2132754|P1|Randomization|Enrollment to Randomization||100
881401|NCT02011893|2132752|P3|Permanent Stimulation Implant|Enrollment to Randomization||0
881402|NCT02011893|2132753|P2|Permanent Stimulation Implant|Enrollment to Randomization||0
881403|NCT02011893|2132754|P1|Permanent Stimulation Implant|Enrollment to Randomization||101
881404|NCT02011893|2132752|P3|Trial Stimulation Implant|Enrollment to Randomization||0
881405|NCT02011893|2132753|P2|Trial Stimulation Implant|Enrollment to Randomization||0
881406|NCT02011893|2132754|P1|Trial Stimulation Implant|Enrollment to Randomization||121
881407|NCT02011893|2132752|P3|Baseline|Enrollment to Randomization||0
881408|NCT02011893|2132753|P2|Baseline|Enrollment to Randomization||0
881409|NCT02011893|2132754|P1|Baseline|Enrollment to Randomization||141
881410|NCT02011893|2132752|P3|STARTED|Enrollment to Randomization||0
881411|NCT02011893|2132753|P2|STARTED|Enrollment to Randomization||0
881412|NCT02011893|2132754|P1|STARTED|Enrollment to Randomization||173
881413|NCT02011516|2132767|P2|NOT COMPLETED|Overall Study||2
881414|NCT02011516|2132768|P1|NOT COMPLETED|Overall Study||4
881415|NCT02011516|2132767|P2|COMPLETED|Overall Study||6
881416|NCT02011516|2132768|P1|COMPLETED|Overall Study||4
881417|NCT02011516|2132767|P2|STARTED|Overall Study||8
881418|NCT02011516|2132768|P1|STARTED|Overall Study||8
881419|NCT02011490|2132777|P6|NOT COMPLETED|Part 2||0
881420|NCT02011490|2132778|P5|NOT COMPLETED|Part 2||0
881421|NCT02011490|2132779|P4|NOT COMPLETED|Part 2||0
881422|NCT02011490|2132780|P3|NOT COMPLETED|Part 2||0
881423|NCT02011490|2132781|P2|NOT COMPLETED|Part 2||0
881424|NCT02011490|2132782|P1|NOT COMPLETED|Part 2||0
881425|NCT02011490|2132777|P6|COMPLETED|Part 2||6
881426|NCT02011490|2132778|P5|COMPLETED|Part 2||6
881427|NCT02011490|2132779|P4|COMPLETED|Part 2||6
881428|NCT02011490|2132780|P3|COMPLETED|Part 2||0
881429|NCT02011490|2132781|P2|COMPLETED|Part 2||0
881430|NCT02011490|2132782|P1|COMPLETED|Part 2||0
881431|NCT02011490|2132777|P6|STARTED|Part 2|2 had also participated in Part 1 (both in healthy group)|6
881432|NCT02011490|2132778|P5|STARTED|Part 2|3 had also participated in Part 1 (2 in moderate, 1 in severe groups)|6
881433|NCT02011490|2132779|P4|STARTED|Part 2|4 had also participated in Part 1 (all in severe group)|6
881434|NCT02011490|2132780|P3|STARTED|Part 2||0
881435|NCT02011490|2132781|P2|STARTED|Part 2||0
881436|NCT02011490|2132782|P1|STARTED|Part 2||0
881437|NCT02011490|2132777|P6|NOT COMPLETED|Part 1||0
881438|NCT02011490|2132778|P5|NOT COMPLETED|Part 1||0
881439|NCT02011490|2132779|P4|NOT COMPLETED|Part 1||0
881440|NCT02011490|2132780|P3|NOT COMPLETED|Part 1||0
881441|NCT02011490|2132781|P2|NOT COMPLETED|Part 1||0
881442|NCT02011490|2132782|P1|NOT COMPLETED|Part 1||0
881443|NCT02011490|2132777|P6|COMPLETED|Part 1||0
881444|NCT02011490|2132778|P5|COMPLETED|Part 1||0
881445|NCT02011490|2132779|P4|COMPLETED|Part 1||0
881446|NCT02011490|2132780|P3|COMPLETED|Part 1||8
881447|NCT02011490|2132781|P2|COMPLETED|Part 1||8
881448|NCT02011490|2132782|P1|COMPLETED|Part 1||8
881449|NCT02011490|2132777|P6|STARTED|Part 1||0
881450|NCT02011490|2132778|P5|STARTED|Part 1||0
881451|NCT02011490|2132779|P4|STARTED|Part 1||0
881452|NCT02011490|2132780|P3|STARTED|Part 1||8
881453|NCT02011490|2132781|P2|STARTED|Part 1||8
881454|NCT02011490|2132782|P1|STARTED|Part 1||8
881455|NCT02011464|2132870|P2|NOT COMPLETED|Overall Study||0
881456|NCT02011464|2132871|P1|NOT COMPLETED|Overall Study||0
881457|NCT02011464|2132870|P2|COMPLETED|Overall Study||10
881458|NCT02011464|2132871|P1|COMPLETED|Overall Study||10
881459|NCT02011464|2132870|P2|STARTED|Overall Study||10
881460|NCT02011464|2132871|P1|STARTED|Overall Study||10
881461|NCT02011113|2132891|P1|NOT COMPLETED|Overall Study||36
881462|NCT02011113|2132891|P1|COMPLETED|Overall Study|Completed = participants with progressive disease were considered as completed.|0
881463|NCT02011113|2132891|P1|STARTED|Overall Study||36
881464|NCT02010996|2132907|P2|NOT COMPLETED|Overall Study||0
881465|NCT02010996|2132908|P1|NOT COMPLETED|Overall Study||0
881466|NCT02010996|2132907|P2|COMPLETED|Overall Study||36
881467|NCT02010996|2132908|P1|COMPLETED|Overall Study||36
881468|NCT02010996|2132907|P2|STARTED|Overall Study||36
881469|NCT02010996|2132908|P1|STARTED|Overall Study||36
881470|NCT02010684|2132920|P2|NOT COMPLETED|Overall Study||23
881471|NCT02010684|2132921|P1|NOT COMPLETED|Overall Study||12
881472|NCT02010684|2132920|P2|COMPLETED|Overall Study||59
881473|NCT02010684|2132921|P1|COMPLETED|Overall Study||27
881474|NCT02010684|2132920|P2|STARTED|Overall Study||82
881475|NCT02010684|2132921|P1|STARTED|Overall Study||39
881476|NCT02010632|2132939|P2|NOT COMPLETED|Second Intervention (7 Days)||0
881477|NCT02010632|2132940|P1|NOT COMPLETED|Second Intervention (7 Days)||1
881478|NCT02010632|2132939|P2|COMPLETED|Second Intervention (7 Days)||16
881479|NCT02010632|2132940|P1|COMPLETED|Second Intervention (7 Days)||15
881480|NCT02010632|2132939|P2|STARTED|Second Intervention (7 Days)||16
881481|NCT02010632|2132940|P1|STARTED|Second Intervention (7 Days)||16
881482|NCT02010632|2132939|P2|NOT COMPLETED|Wash Out Period (14 Days)||0
881483|NCT02010632|2132940|P1|NOT COMPLETED|Wash Out Period (14 Days)||0
881484|NCT02010632|2132939|P2|COMPLETED|Wash Out Period (14 Days)||16
881485|NCT02010632|2132940|P1|COMPLETED|Wash Out Period (14 Days)||16
881486|NCT02010632|2132939|P2|STARTED|Wash Out Period (14 Days)||16
881487|NCT02010632|2132940|P1|STARTED|Wash Out Period (14 Days)||16
881488|NCT02010632|2132939|P2|NOT COMPLETED|First Intervention (7 Days)||0
881489|NCT02010632|2132940|P1|NOT COMPLETED|First Intervention (7 Days)||0
881490|NCT02010632|2132939|P2|COMPLETED|First Intervention (7 Days)||16
881491|NCT02010632|2132940|P1|COMPLETED|First Intervention (7 Days)||16
881492|NCT02010632|2132939|P2|STARTED|First Intervention (7 Days)||16
881493|NCT02010632|2132940|P1|STARTED|First Intervention (7 Days)||16
881494|NCT02010255|2132960|P14|NOT COMPLETED|Overall Study||1
881495|NCT02010255|2132961|P13|NOT COMPLETED|Overall Study||0
881496|NCT02010255|2132962|P12|NOT COMPLETED|Overall Study||1
881497|NCT02010255|2132963|P11|NOT COMPLETED|Overall Study||2
881498|NCT02010255|2132964|P10|NOT COMPLETED|Overall Study||0
881499|NCT02010255|2132965|P9|NOT COMPLETED|Overall Study||1
881500|NCT02010255|2132966|P8|NOT COMPLETED|Overall Study||1
881501|NCT02010255|2132967|P7|NOT COMPLETED|Overall Study||1
881502|NCT02010255|2132968|P6|NOT COMPLETED|Overall Study||0
881503|NCT02010255|2132969|P5|NOT COMPLETED|Overall Study||4
881504|NCT02010255|2132970|P4|NOT COMPLETED|Overall Study||6
881505|NCT02010255|2132971|P3|NOT COMPLETED|Overall Study||7
881506|NCT02010255|2132972|P2|NOT COMPLETED|Overall Study||2
881507|NCT02010255|2132973|P1|NOT COMPLETED|Overall Study||6
881508|NCT02010255|2132960|P14|COMPLETED|Overall Study||2
881509|NCT02010255|2132961|P13|COMPLETED|Overall Study||3
881510|NCT02010255|2132962|P12|COMPLETED|Overall Study||4
881511|NCT02010255|2132963|P11|COMPLETED|Overall Study||1
881512|NCT02010255|2132964|P10|COMPLETED|Overall Study||23
881513|NCT02010255|2132965|P9|COMPLETED|Overall Study||21
881514|NCT02010255|2132966|P8|COMPLETED|Overall Study||32
881515|NCT02010255|2132967|P7|COMPLETED|Overall Study||33
881516|NCT02010255|2132968|P6|COMPLETED|Overall Study||49
881517|NCT02010255|2132969|P5|COMPLETED|Overall Study||48
881518|NCT02010255|2132970|P4|COMPLETED|Overall Study||20
881519|NCT02010255|2132971|P3|COMPLETED|Overall Study||18
881520|NCT02010255|2132972|P2|COMPLETED|Overall Study||26
881521|NCT02010255|2132973|P1|COMPLETED|Overall Study||22
881522|NCT02010255|2132960|P14|STARTED|Overall Study||3
881523|NCT02010255|2132961|P13|STARTED|Overall Study||3
881524|NCT02010255|2132962|P12|STARTED|Overall Study||5
881525|NCT02010255|2132963|P11|STARTED|Overall Study||3
881526|NCT02010255|2132964|P10|STARTED|Overall Study||23
881527|NCT02010255|2132965|P9|STARTED|Overall Study||22
881528|NCT02010255|2132966|P8|STARTED|Overall Study||33
881529|NCT02010255|2132967|P7|STARTED|Overall Study||34
881530|NCT02010255|2132968|P6|STARTED|Overall Study||49
881531|NCT02010255|2132969|P5|STARTED|Overall Study||52
881532|NCT02010255|2132970|P4|STARTED|Overall Study||26
881533|NCT02010255|2132971|P3|STARTED|Overall Study||25
881534|NCT02010255|2132972|P2|STARTED|Overall Study||28
881535|NCT02010255|2132973|P1|STARTED|Overall Study||28
881536|NCT02010216|2133297|P1|NOT COMPLETED|Overall Study||0
881537|NCT02010216|2133297|P1|COMPLETED|Overall Study||23
881538|NCT02010216|2133297|P1|STARTED|Overall Study||23
881539|NCT02009982|2133305|P2|NOT COMPLETED|Overall Study||0
881540|NCT02009982|2133306|P1|NOT COMPLETED|Overall Study||0
881541|NCT02009982|2133305|P2|COMPLETED|Overall Study||2
881542|NCT02009982|2133306|P1|COMPLETED|Overall Study||1
881543|NCT02009982|2133305|P2|STARTED|Overall Study||2
881544|NCT02009982|2133306|P1|STARTED|Overall Study||1
881545|NCT02009878|2133317|P3|NOT COMPLETED|Overall Study||0
881546|NCT02009878|2133318|P2|NOT COMPLETED|Overall Study||1
881547|NCT02009878|2133319|P1|NOT COMPLETED|Overall Study||0
881548|NCT02009878|2133317|P3|COMPLETED|Overall Study||9
881549|NCT02009878|2133318|P2|COMPLETED|Overall Study||10
881550|NCT02009878|2133319|P1|COMPLETED|Overall Study||10
881551|NCT02009878|2133317|P3|STARTED|Overall Study||9
881552|NCT02009878|2133318|P2|STARTED|Overall Study||11
881553|NCT02009878|2133319|P1|STARTED|Overall Study||10
881554|NCT02009865|2133353|P2|NOT COMPLETED|Overall Study||5
881555|NCT02009865|2133354|P1|NOT COMPLETED|Overall Study||1
881556|NCT02009865|2133353|P2|COMPLETED|Overall Study||76
881557|NCT02009865|2133354|P1|COMPLETED|Overall Study||80
881558|NCT02009865|2133353|P2|STARTED|Overall Study||81
881559|NCT02009865|2133354|P1|STARTED|Overall Study||81
881560|NCT02009722|2133370|P2|NOT COMPLETED|Overall Study||3
881561|NCT02009722|2133371|P1|NOT COMPLETED|Overall Study||1
881562|NCT02009722|2133370|P2|COMPLETED|Overall Study||40
881563|NCT02009722|2133371|P1|COMPLETED|Overall Study||40
881564|NCT02009722|2133370|P2|Received Intervention|Overall Study||42
881565|NCT02009722|2133371|P1|Received Intervention|Overall Study||41
881566|NCT02009722|2133370|P2|STARTED|Overall Study||43
881567|NCT02009722|2133371|P1|STARTED|Overall Study||41
881568|NCT02009696|2133395|P1|NOT COMPLETED|Overall Study||2
881569|NCT02009696|2133395|P1|COMPLETED|Overall Study||219
881570|NCT02009696|2133395|P1|STARTED|Overall Study||221
881571|NCT02009163|2133403|P3|NOT COMPLETED|Randomized-withdrawal Period||35
881572|NCT02009163|2133404|P2|NOT COMPLETED|Randomized-withdrawal Period||88
881573|NCT02009163|2133405|P1|NOT COMPLETED|Randomized-withdrawal Period||0
881574|NCT02009163|2133403|P3|COMPLETED|Randomized-withdrawal Period||102
881575|NCT02009163|2133404|P2|COMPLETED|Randomized-withdrawal Period||50
881576|NCT02009163|2133405|P1|COMPLETED|Randomized-withdrawal Period||0
881577|NCT02009163|2133403|P3|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|137
881578|NCT02009163|2133404|P2|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|138
881579|NCT02009163|2133405|P1|STARTED|Randomized-withdrawal Period|The open-label treatment group is not an arm of the randomized-withdrawal period.|0
881580|NCT02009163|2133403|P3|NOT COMPLETED|Open-label Period (Non-randomized)||0
881581|NCT02009163|2133404|P2|NOT COMPLETED|Open-label Period (Non-randomized)||0
881582|NCT02009163|2133405|P1|NOT COMPLETED|Open-label Period (Non-randomized)||143
881583|NCT02009163|2133403|P3|COMPLETED|Open-label Period (Non-randomized)||0
881584|NCT02009163|2133404|P2|COMPLETED|Open-label Period (Non-randomized)||0
881585|NCT02009163|2133405|P1|COMPLETED|Open-label Period (Non-randomized)||275
881586|NCT02009163|2133403|P3|STARTED|Open-label Period (Non-randomized)||0
881587|NCT02009163|2133404|P2|STARTED|Open-label Period (Non-randomized)||0
881588|NCT02009163|2133405|P1|STARTED|Open-label Period (Non-randomized)||418
881589|NCT02008942|2133438|P2|NOT COMPLETED|Second Intervention||0
881590|NCT02008942|2133439|P1|NOT COMPLETED|Second Intervention||1
881591|NCT02008942|2133438|P2|COMPLETED|Second Intervention||30
881592|NCT02008942|2133439|P1|COMPLETED|Second Intervention||25
881593|NCT02008942|2133438|P2|STARTED|Second Intervention||30
881594|NCT02008942|2133439|P1|STARTED|Second Intervention||26
881595|NCT02008942|2133438|P2|NOT COMPLETED|First Intervention||0
881596|NCT02008942|2133439|P1|NOT COMPLETED|First Intervention||0
881597|NCT02008942|2133438|P2|COMPLETED|First Intervention||30
881598|NCT02008942|2133439|P1|COMPLETED|First Intervention||27
881599|NCT02008942|2133438|P2|STARTED|First Intervention||30
881600|NCT02008942|2133439|P1|STARTED|First Intervention||27
881601|NCT02008682|2133447|P2|NOT COMPLETED|Overall Study||14
881602|NCT02008682|2133448|P1|NOT COMPLETED|Overall Study||27
881603|NCT02008682|2133447|P2|COMPLETED|Overall Study|Completed without discontinuation of trial product|170
881604|NCT02008682|2133448|P1|COMPLETED|Overall Study|Completed without discontinuation of trial product|157
881605|NCT02008682|2133447|P2|Exposed|Overall Study||184
881606|NCT02008682|2133448|P1|Exposed|Overall Study|1 subject withdrawn before exposure to trial product|183
881607|NCT02008682|2133447|P2|STARTED|Overall Study||184
881608|NCT02008682|2133448|P1|STARTED|Overall Study||184
881609|NCT02008617|2133466|P2|NOT COMPLETED|Overall Study||0
881610|NCT02008617|2133467|P1|NOT COMPLETED|Overall Study||0
881611|NCT02008617|2133466|P2|COMPLETED|Overall Study||10
881612|NCT02008617|2133467|P1|COMPLETED|Overall Study||8
881613|NCT02008617|2133466|P2|STARTED|Overall Study||10
881614|NCT02008617|2133467|P1|STARTED|Overall Study||8
881615|NCT02008526|2133482|P3|NOT COMPLETED|Overall Study||9
881616|NCT02008526|2133483|P2|NOT COMPLETED|Overall Study||14
881617|NCT02008526|2133484|P1|NOT COMPLETED|Overall Study||8
881618|NCT02008526|2133482|P3|COMPLETED|Overall Study||84
881619|NCT02008526|2133483|P2|COMPLETED|Overall Study||85
881620|NCT02008526|2133484|P1|COMPLETED|Overall Study||86
881621|NCT02008526|2133482|P3|STARTED|Overall Study||93
881622|NCT02008526|2133483|P2|STARTED|Overall Study||99
881623|NCT02008526|2133484|P1|STARTED|Overall Study||94
881624|NCT02008227|2133497|P2|NOT COMPLETED|Overall Study||613
881625|NCT02008227|2133498|P1|NOT COMPLETED|Overall Study||612
881626|NCT02008227|2133497|P2|COMPLETED|Overall Study||0
881627|NCT02008227|2133498|P1|COMPLETED|Overall Study||0
881628|NCT02008227|2133497|P2|Treated|Overall Study||608
881629|NCT02008227|2133498|P1|Treated|Overall Study||579
881630|NCT02008227|2133497|P2|STARTED|Overall Study||613
881631|NCT02008227|2133498|P1|STARTED|Overall Study||612
881632|NCT02007954|2133559|P1|NOT COMPLETED|Overall Study||7
881633|NCT02007954|2133559|P1|COMPLETED|Overall Study||17
881991|NCT02000921|2134507|P3|COMPLETED|Overall Study||46
881634|NCT02007954|2133559|P1|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to first imaging follow-up due to unrelated serious adverse event and death|23
881635|NCT02007954|2133559|P1|Completed First TACE|Overall Study||24
881636|NCT02007954|2133559|P1|STARTED|Overall Study|A total of 32 participants were consented, with 8 patients screened out prior to treatment.|24
881637|NCT02007863|2133572|P1|NOT COMPLETED|Overall Study||0
881638|NCT02007863|2133572|P1|COMPLETED|Overall Study||2
881639|NCT02007863|2133572|P1|STARTED|Overall Study||2
881640|NCT02007577|2133578|P2|NOT COMPLETED|Overall Study||1
881641|NCT02007577|2133579|P1|NOT COMPLETED|Overall Study||1
881642|NCT02007577|2133578|P2|COMPLETED|Overall Study||13
881643|NCT02007577|2133579|P1|COMPLETED|Overall Study||26
881644|NCT02007577|2133578|P2|STARTED|Overall Study||14
881645|NCT02007577|2133579|P1|STARTED|Overall Study||27
881646|NCT02007434|2133595|P8|NOT COMPLETED|Overall Study||0
881647|NCT02007434|2133596|P7|NOT COMPLETED|Overall Study||0
881648|NCT02007434|2133597|P6|NOT COMPLETED|Overall Study||0
881649|NCT02007434|2133598|P5|NOT COMPLETED|Overall Study||0
881650|NCT02007434|2133599|P4|NOT COMPLETED|Overall Study||0
881651|NCT02007434|2133600|P3|NOT COMPLETED|Overall Study||1
881652|NCT02007434|2133601|P2|NOT COMPLETED|Overall Study||1
881653|NCT02007434|2133602|P1|NOT COMPLETED|Overall Study||1
881654|NCT02007434|2133595|P8|COMPLETED|Overall Study||4
881655|NCT02007434|2133596|P7|COMPLETED|Overall Study||18
881656|NCT02007434|2133597|P6|COMPLETED|Overall Study||4
881657|NCT02007434|2133598|P5|COMPLETED|Overall Study||16
881658|NCT02007434|2133599|P4|COMPLETED|Overall Study||4
881659|NCT02007434|2133600|P3|COMPLETED|Overall Study||16
881660|NCT02007434|2133601|P2|COMPLETED|Overall Study||3
881661|NCT02007434|2133602|P1|COMPLETED|Overall Study||16
881662|NCT02007434|2133595|P8|Received Treatment|Overall Study||4
881663|NCT02007434|2133596|P7|Received Treatment|Overall Study||18
881664|NCT02007434|2133597|P6|Received Treatment|Overall Study||4
881665|NCT02007434|2133598|P5|Received Treatment|Overall Study||16
881666|NCT02007434|2133599|P4|Received Treatment|Overall Study||4
881667|NCT02007434|2133600|P3|Received Treatment|Overall Study||17
881668|NCT02007434|2133601|P2|Received Treatment|Overall Study||3
881669|NCT02007434|2133602|P1|Received Treatment|Overall Study||17
881670|NCT02007434|2133595|P8|STARTED|Overall Study||4
881671|NCT02007434|2133596|P7|STARTED|Overall Study||18
881672|NCT02007434|2133597|P6|STARTED|Overall Study||4
881673|NCT02007434|2133598|P5|STARTED|Overall Study||16
881674|NCT02007434|2133599|P4|STARTED|Overall Study||4
881675|NCT02007434|2133600|P3|STARTED|Overall Study||17
881676|NCT02007434|2133601|P2|STARTED|Overall Study||4
881677|NCT02007434|2133602|P1|STARTED|Overall Study||17
881678|NCT02007369|2133703|P3|NOT COMPLETED|Overall Study||0
881679|NCT02007369|2133704|P2|NOT COMPLETED|Overall Study||0
881680|NCT02007369|2133705|P1|NOT COMPLETED|Overall Study||0
881681|NCT02007369|2133703|P3|COMPLETED|Overall Study||54
881682|NCT02007369|2133704|P2|COMPLETED|Overall Study||40
881683|NCT02007369|2133705|P1|COMPLETED|Overall Study||42
881684|NCT02007369|2133703|P3|STARTED|Overall Study||54
881685|NCT02007369|2133704|P2|STARTED|Overall Study||40
881686|NCT02007369|2133705|P1|STARTED|Overall Study||42
881687|NCT02007278|2133724|P2|NOT COMPLETED|Overall Study||3
881688|NCT02007278|2133725|P1|NOT COMPLETED|Overall Study||2
881689|NCT02007278|2133724|P2|COMPLETED|Overall Study||17
881690|NCT02007278|2133725|P1|COMPLETED|Overall Study||18
881691|NCT02007278|2133724|P2|STARTED|Overall Study||20
881692|NCT02007278|2133725|P1|STARTED|Overall Study||20
881693|NCT02007252|2133747|P2|NOT COMPLETED|Overall Study||11
881694|NCT02007252|2133748|P1|NOT COMPLETED|Overall Study||11
881695|NCT02007252|2133747|P2|COMPLETED|Overall Study||22
881696|NCT02007252|2133748|P1|COMPLETED|Overall Study||20
881697|NCT02007252|2133747|P2|Pharmacodynamic Analysis Set|Overall Study||33
881698|NCT02007252|2133748|P1|Pharmacodynamic Analysis Set|Overall Study||31
881699|NCT02007252|2133747|P2|Safety Analysis Set|Overall Study||33
881700|NCT02007252|2133748|P1|Safety Analysis Set|Overall Study||31
881701|NCT02007252|2133747|P2|STARTED|Overall Study||33
881702|NCT02007252|2133748|P1|STARTED|Overall Study||31
881703|NCT02007200|2133754|P1|NOT COMPLETED|Overall Study||0
881704|NCT02007200|2133754|P1|COMPLETED|Overall Study||55
881705|NCT02007200|2133754|P1|STARTED|Overall Study||55
881706|NCT02007070|2133761|P1|NOT COMPLETED|Overall Study||38
881707|NCT02007070|2133761|P1|COMPLETED|Overall Study||0
881708|NCT02007070|2133761|P1|STARTED|Overall Study||38
881709|NCT02006836|2133773|P3|NOT COMPLETED|Self-control Period: Month 7-month 12||0
881710|NCT02006836|2133774|P2|NOT COMPLETED|Self-control Period: Month 7-month 12||0
881711|NCT02006836|2133775|P1|NOT COMPLETED|Self-control Period: Month 7-month 12||0
881712|NCT02006836|2133773|P3|COMPLETED|Self-control Period: Month 7-month 12||19
881713|NCT02006836|2133774|P2|COMPLETED|Self-control Period: Month 7-month 12||0
881714|NCT02006836|2133775|P1|COMPLETED|Self-control Period: Month 7-month 12||0
881715|NCT02006836|2133773|P3|STARTED|Self-control Period: Month 7-month 12||19
881716|NCT02006836|2133774|P2|STARTED|Self-control Period: Month 7-month 12||0
881717|NCT02006836|2133775|P1|STARTED|Self-control Period: Month 7-month 12||0
881718|NCT02006836|2133773|P3|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
881719|NCT02006836|2133774|P2|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
881720|NCT02006836|2133775|P1|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
881721|NCT02006836|2133773|P3|COMPLETED|Case-control Period: Month 1- Month 6||0
881722|NCT02006836|2133774|P2|COMPLETED|Case-control Period: Month 1- Month 6||20
881723|NCT02006836|2133775|P1|COMPLETED|Case-control Period: Month 1- Month 6||20
881724|NCT02006836|2133773|P3|STARTED|Case-control Period: Month 1- Month 6||0
881725|NCT02006836|2133774|P2|STARTED|Case-control Period: Month 1- Month 6||20
881726|NCT02006836|2133775|P1|STARTED|Case-control Period: Month 1- Month 6||20
881727|NCT02006732|2133795|P4|NOT COMPLETED|Overall Study||4
881728|NCT02006732|2133796|P3|NOT COMPLETED|Overall Study||9
881729|NCT02006732|2133797|P2|NOT COMPLETED|Overall Study||12
881730|NCT02006732|2133798|P1|NOT COMPLETED|Overall Study||20
881731|NCT02006732|2133795|P4|COMPLETED|Overall Study||198
881732|NCT02006732|2133796|P3|COMPLETED|Overall Study||193
881733|NCT02006732|2133797|P2|COMPLETED|Overall Study||191
881734|NCT02006732|2133798|P1|COMPLETED|Overall Study||182
881735|NCT02006732|2133795|P4|STARTED|Overall Study||202
881736|NCT02006732|2133796|P3|STARTED|Overall Study||202
881737|NCT02006732|2133797|P2|STARTED|Overall Study||203
881738|NCT02006732|2133798|P1|STARTED|Overall Study||202
881739|NCT02006719|2133838|P2|NOT COMPLETED|Overall Study||5
881740|NCT02006719|2133839|P1|NOT COMPLETED|Overall Study||18
881741|NCT02006719|2133838|P2|COMPLETED|Overall Study||80
881742|NCT02006719|2133839|P1|COMPLETED|Overall Study||219
881743|NCT02006719|2133838|P2|STARTED|Overall Study||85
881744|NCT02006719|2133839|P1|STARTED|Overall Study||237
881745|NCT02006706|2133869|P1|NOT COMPLETED|Overall Study||1
881746|NCT02006706|2133869|P1|COMPLETED|Overall Study||14
881747|NCT02006706|2133869|P1|STARTED|Overall Study||15
881748|NCT02006667|2133874|P1|NOT COMPLETED|Overall Study||6
881749|NCT02006667|2133874|P1|COMPLETED|Overall Study||7
881750|NCT02006667|2133874|P1|STARTED|Overall Study||13
881751|NCT02006407|2133884|P1|NOT COMPLETED|Overall Study||0
881752|NCT02006407|2133884|P1|COMPLETED|Overall Study||5
881753|NCT02006407|2133884|P1|STARTED|Overall Study||5
881754|NCT02006342|2133892|P2|NOT COMPLETED|Overall Study||0
881755|NCT02006342|2133893|P1|NOT COMPLETED|Overall Study||1
881756|NCT02006342|2133892|P2|COMPLETED|Overall Study||20
881757|NCT02006342|2133893|P1|COMPLETED|Overall Study||19
881758|NCT02006342|2133892|P2|STARTED|Overall Study||20
881759|NCT02006342|2133893|P1|STARTED|Overall Study||20
881760|NCT02006108|2133907|P1|NOT COMPLETED|Overall Study||2
881761|NCT02006108|2133907|P1|COMPLETED|Overall Study||19
881762|NCT02006108|2133907|P1|MR Imaging|Overall Study||19
881763|NCT02006108|2133907|P1|STARTED|Overall Study||21
881764|NCT02005692|2133912|P1|NOT COMPLETED|Overall Study||7
881765|NCT02005692|2133912|P1|COMPLETED|Overall Study||63
881766|NCT02005692|2133912|P1|STARTED|Overall Study||70
881767|NCT02005601|2133919|P2|NOT COMPLETED|Overall Study||0
881768|NCT02005601|2133920|P1|NOT COMPLETED|Overall Study||0
881769|NCT02005601|2133919|P2|COMPLETED|Overall Study||53
881770|NCT02005601|2133920|P1|COMPLETED|Overall Study||53
881771|NCT02005601|2133919|P2|STARTED|Overall Study||53
881772|NCT02005601|2133920|P1|STARTED|Overall Study||53
881773|NCT02005562|2133932|P2|NOT COMPLETED|Overall Study||15
881774|NCT02005562|2133933|P1|NOT COMPLETED|Overall Study||12
881775|NCT02005562|2133932|P2|COMPLETED|Overall Study||110
881776|NCT02005562|2133933|P1|COMPLETED|Overall Study||115
881777|NCT02005562|2133932|P2|Transplanted|Overall Study||121
881778|NCT02005562|2133933|P1|Transplanted|Overall Study||126
881779|NCT02005562|2133932|P2|STARTED|Overall Study||125
881780|NCT02005562|2133933|P1|STARTED|Overall Study||127
881781|NCT02005549|2133961|P1|NOT COMPLETED|Overall Study||0
881782|NCT02005549|2133961|P1|COMPLETED|Overall Study||18
881783|NCT02005549|2133961|P1|STARTED|Overall Study||18
881784|NCT02005536|2133967|P1|NOT COMPLETED|Overall Study||0
881785|NCT02005536|2133967|P1|COMPLETED|Overall Study||60
881786|NCT02005536|2133967|P1|STARTED|Overall Study||60
881787|NCT02005484|2133975|P1|NOT COMPLETED|Overall Study||4
881788|NCT02005484|2133975|P1|COMPLETED|Overall Study||2
881789|NCT02005484|2133975|P1|STARTED|Overall Study||6
881790|NCT02005393|2133985|P1|NOT COMPLETED|Overall Study||0
881791|NCT02005393|2133985|P1|COMPLETED|Overall Study||20
881792|NCT02005393|2133985|P1|STARTED|Overall Study||20
881793|NCT02005211|2133996|P7|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
881794|NCT02005211|2133997|P6|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
881795|NCT02005211|2133998|P5|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||1
881796|NCT02005211|2133999|P4|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
881797|NCT02005211|2134000|P3|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
881798|NCT02005211|2134001|P2|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
881799|NCT02005211|2134002|P1|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
881800|NCT02005211|2133996|P7|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
881801|NCT02005211|2133997|P6|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
881802|NCT02005211|2133998|P5|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||5
881803|NCT02005211|2133999|P4|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
881804|NCT02005211|2134000|P3|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
881805|NCT02005211|2134001|P2|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
881806|NCT02005211|2134002|P1|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
881807|NCT02005211|2133996|P7|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
881808|NCT02005211|2133997|P6|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
881809|NCT02005211|2133998|P5|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
881810|NCT02005211|2133999|P4|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
881811|NCT02005211|2134000|P3|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
881812|NCT02005211|2134001|P2|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
881813|NCT02005211|2134002|P1|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
881814|NCT02005211|2133996|P7|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
881815|NCT02005211|2133997|P6|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
881816|NCT02005211|2133998|P5|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
881817|NCT02005211|2133999|P4|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
881818|NCT02005211|2134000|P3|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
881819|NCT02005211|2134001|P2|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
881820|NCT02005211|2134002|P1|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
881821|NCT02005211|2133996|P7|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
881822|NCT02005211|2133997|P6|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
881823|NCT02005211|2133998|P5|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
881824|NCT02005211|2133999|P4|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
881825|NCT02005211|2134000|P3|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
881826|NCT02005211|2134001|P2|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
881827|NCT02005211|2134002|P1|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
881828|NCT02005211|2133996|P7|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
881829|NCT02005211|2133997|P6|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
881830|NCT02005211|2133998|P5|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
881831|NCT02005211|2133999|P4|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
881832|NCT02005211|2134000|P3|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
881833|NCT02005211|2134001|P2|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
881834|NCT02005211|2134002|P1|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
881835|NCT02005029|2134037|P2|NOT COMPLETED|Second Intervention (1 Day)||0
881836|NCT02005029|2134038|P1|NOT COMPLETED|Second Intervention (1 Day)||0
881837|NCT02005029|2134037|P2|COMPLETED|Second Intervention (1 Day)||5
881838|NCT02005029|2134038|P1|COMPLETED|Second Intervention (1 Day)||4
881839|NCT02005029|2134037|P2|STARTED|Second Intervention (1 Day)||5
881840|NCT02005029|2134038|P1|STARTED|Second Intervention (1 Day)||4
881841|NCT02005029|2134037|P2|NOT COMPLETED|Washout (2 Weeks)||0
881842|NCT02005029|2134038|P1|NOT COMPLETED|Washout (2 Weeks)||0
881843|NCT02005029|2134037|P2|COMPLETED|Washout (2 Weeks)||5
881844|NCT02005029|2134038|P1|COMPLETED|Washout (2 Weeks)||4
881845|NCT02005029|2134037|P2|STARTED|Washout (2 Weeks)||5
881846|NCT02005029|2134038|P1|STARTED|Washout (2 Weeks)||4
881847|NCT02005029|2134037|P2|NOT COMPLETED|First Intervention (1 Day)||0
881848|NCT02005029|2134038|P1|NOT COMPLETED|First Intervention (1 Day)||1
881849|NCT02005029|2134037|P2|COMPLETED|First Intervention (1 Day)||5
881850|NCT02005029|2134038|P1|COMPLETED|First Intervention (1 Day)||4
881851|NCT02005029|2134037|P2|STARTED|First Intervention (1 Day)||5
881852|NCT02005029|2134038|P1|STARTED|First Intervention (1 Day)||5
881853|NCT02004990|2134064|P1|NOT COMPLETED|Overall Study||0
881854|NCT02004990|2134064|P1|COMPLETED|Overall Study||12
881855|NCT02004990|2134064|P1|STARTED|Overall Study||12
881856|NCT02004886|2134073|P4|NOT COMPLETED|Overall Study||0
881857|NCT02004886|2134074|P3|NOT COMPLETED|Overall Study||0
881858|NCT02004886|2134075|P2|NOT COMPLETED|Overall Study||1
881859|NCT02004886|2134076|P1|NOT COMPLETED|Overall Study||1
881860|NCT02004886|2134073|P4|COMPLETED|Overall Study||19
881861|NCT02004886|2134074|P3|COMPLETED|Overall Study||18
881862|NCT02004886|2134075|P2|COMPLETED|Overall Study||17
881863|NCT02004886|2134076|P1|COMPLETED|Overall Study||18
881864|NCT02004886|2134073|P4|STARTED|Overall Study||19
881865|NCT02004886|2134074|P3|STARTED|Overall Study||18
881866|NCT02004886|2134075|P2|STARTED|Overall Study||18
881867|NCT02004886|2134076|P1|STARTED|Overall Study||19
881868|NCT02004873|2134126|P1|NOT COMPLETED|Overall Study||424
881869|NCT02004873|2134126|P1|COMPLETED|Overall Study|6-Month Follow-up|301
881870|NCT02004873|2134126|P1|Micra Implant Success|Overall Study||719
881871|NCT02004873|2134126|P1|STARTED|Overall Study|Micra Implant Attempt|725
881872|NCT02004847|2134135|P2|NOT COMPLETED|Overall Study||1
881873|NCT02004847|2134136|P1|NOT COMPLETED|Overall Study||1
881874|NCT02004847|2134135|P2|COMPLETED|Overall Study||22
881875|NCT02004847|2134136|P1|COMPLETED|Overall Study||23
881876|NCT02004847|2134135|P2|STARTED|Overall Study||23
881877|NCT02004847|2134136|P1|STARTED|Overall Study||24
881887|NCT02004158|2134229|P1|NOT COMPLETED|Overall Study||3
881888|NCT02004158|2134229|P1|COMPLETED|Overall Study||20
881889|NCT02004158|2134229|P1|STARTED|Overall Study||23
881890|NCT02004132|2134237|P1|NOT COMPLETED|Overall Study||0
881891|NCT02004132|2134237|P1|COMPLETED|Overall Study||12
881892|NCT02004132|2134237|P1|Received Study Drug|Overall Study||12
881893|NCT02004132|2134237|P1|STARTED|Overall Study||12
881894|NCT02004093|2134245|P2|NOT COMPLETED|Overall Study||73
881895|NCT02004093|2134246|P1|NOT COMPLETED|Overall Study||74
881896|NCT02004093|2134245|P2|COMPLETED|Overall Study||1
881897|NCT02004093|2134246|P1|COMPLETED|Overall Study||1
881898|NCT02004093|2134245|P2|STARTED|Overall Study||74
881899|NCT02004093|2134246|P1|STARTED|Overall Study|Includes 1 participant who was randomized to chemotherapy group but received pertuzumab+chemotherapy|75
881900|NCT02003963|2134278|P2|NOT COMPLETED|Overall Study||1
881901|NCT02003963|2134279|P1|NOT COMPLETED|Overall Study||2
881902|NCT02003963|2134278|P2|COMPLETED|Overall Study|1 participant was removed from analysis for completing final visit outside of visit window.|18
881903|NCT02003963|2134279|P1|COMPLETED|Overall Study|2 participants dropped out: 1 due to lack of interest and 1 due to a mental health hospitalization.|20
881904|NCT02003963|2134278|P2|STARTED|Overall Study||19
881905|NCT02003963|2134279|P1|STARTED|Overall Study||22
881906|NCT02003638|2134297|P2|NOT COMPLETED|Overall Study||0
881907|NCT02003638|2134298|P1|NOT COMPLETED|Overall Study||1
881908|NCT02003638|2134297|P2|COMPLETED|Overall Study||3
881909|NCT02003638|2134298|P1|COMPLETED|Overall Study|1 withdrew after developing bacterial pharyngitis. Not considered treatment-emergent.|5
881910|NCT02003638|2134297|P2|STARTED|Overall Study||3
881911|NCT02003638|2134298|P1|STARTED|Overall Study||6
881912|NCT02003534|2134304|P1|NOT COMPLETED|Overall Study||47
881913|NCT02003534|2134304|P1|COMPLETED|Overall Study||329
881914|NCT02003534|2134304|P1|STARTED|Overall Study||376
881915|NCT02003404|2134308|P1|NOT COMPLETED|Overall Study||0
881916|NCT02003404|2134308|P1|COMPLETED|Overall Study||17
881917|NCT02003404|2134308|P1|STARTED|Overall Study||17
881918|NCT02003391|2134316|P2|NOT COMPLETED|Overall Study||2
881919|NCT02003391|2134317|P1|NOT COMPLETED|Overall Study||3
881920|NCT02003391|2134316|P2|COMPLETED|Overall Study||73
881921|NCT02003391|2134317|P1|COMPLETED|Overall Study||78
881922|NCT02003391|2134316|P2|Intent to Treat Population|Overall Study||73
881923|NCT02003391|2134317|P1|Intent to Treat Population|Overall Study||78
881924|NCT02003391|2134316|P2|Safety Population|Overall Study||75
881925|NCT02003391|2134317|P1|Safety Population|Overall Study||81
881926|NCT02003391|2134316|P2|STARTED|Overall Study||75
881927|NCT02003391|2134317|P1|STARTED|Overall Study||81
881928|NCT02003352|2134327|P1|NOT COMPLETED|Overall Study||0
881929|NCT02003352|2134327|P1|COMPLETED|Overall Study||98
881930|NCT02003352|2134327|P1|STARTED|Overall Study||98
881931|NCT02003014|2134331|P1|NOT COMPLETED|Overall Study||19
881932|NCT02003014|2134331|P1|COMPLETED|Overall Study||880
881933|NCT02003014|2134331|P1|STARTED|Overall Study||899
881934|NCT02002936|2134341|P1|NOT COMPLETED|Overall Study||0
881935|NCT02002936|2134341|P1|COMPLETED|Overall Study||1
881936|NCT02002936|2134341|P1|STARTED|Overall Study||1
881937|NCT02002871|2134350|P1|NOT COMPLETED|Overall Study||1
881938|NCT02002871|2134350|P1|COMPLETED|Overall Study||20
881939|NCT02002871|2134350|P1|STARTED|Overall Study||21
881940|NCT02002702|2134379|P3|NOT COMPLETED|Overall Study||0
881941|NCT02002702|2134380|P2|NOT COMPLETED|Overall Study||0
881942|NCT02002702|2134381|P1|NOT COMPLETED|Overall Study||0
881943|NCT02002702|2134379|P3|COMPLETED|Overall Study||15
881944|NCT02002702|2134380|P2|COMPLETED|Overall Study||15
881945|NCT02002702|2134381|P1|COMPLETED|Overall Study||16
881946|NCT02002702|2134379|P3|STARTED|Overall Study||15
881947|NCT02002702|2134380|P2|STARTED|Overall Study||15
881948|NCT02002702|2134381|P1|STARTED|Overall Study||16
881949|NCT02002689|2134413|P1|NOT COMPLETED|Overall Study||10
881950|NCT02002689|2134413|P1|COMPLETED|Overall Study||0
881951|NCT02002689|2134413|P1|STARTED|Overall Study||10
881952|NCT02002650|2134421|P2|NOT COMPLETED|Overall Study||0
881953|NCT02002650|2134422|P1|NOT COMPLETED|Overall Study||0
881954|NCT02002650|2134421|P2|COMPLETED|Overall Study||1303
881955|NCT02002650|2134422|P1|COMPLETED|Overall Study||1297
881956|NCT02002650|2134421|P2|STARTED|Overall Study||1303
881957|NCT02002650|2134422|P1|STARTED|Overall Study||1297
881958|NCT02002221|2134432|P2|NOT COMPLETED|Overall Study||3
881959|NCT02002221|2134433|P1|NOT COMPLETED|Overall Study||2
881960|NCT02002221|2134432|P2|COMPLETED|Overall Study||75
881961|NCT02002221|2134433|P1|COMPLETED|Overall Study||76
881962|NCT02002221|2134432|P2|STARTED|Overall Study||78
881963|NCT02002221|2134433|P1|STARTED|Overall Study||78
881964|NCT02002208|2134449|P2|NOT COMPLETED|Overall Study||40
881965|NCT02002208|2134450|P1|NOT COMPLETED|Overall Study||37
881966|NCT02002208|2134449|P2|COMPLETED|Overall Study||30
881967|NCT02002208|2134450|P1|COMPLETED|Overall Study||32
881968|NCT02002208|2134449|P2|STARTED|Overall Study||70
881969|NCT02002208|2134450|P1|STARTED|Overall Study||69
881970|NCT02001181|2134460|P2|NOT COMPLETED|Overall Study||3
881971|NCT02001181|2134461|P1|NOT COMPLETED|Overall Study||1
881972|NCT02001181|2134460|P2|COMPLETED|Overall Study||31
881973|NCT02001181|2134461|P1|COMPLETED|Overall Study||34
881974|NCT02001181|2134460|P2|STARTED|Overall Study||34
881975|NCT02001181|2134461|P1|STARTED|Overall Study||35
881976|NCT02000973|2134479|P4|NOT COMPLETED|Overall Study||0
881977|NCT02000973|2134480|P3|NOT COMPLETED|Overall Study||0
881978|NCT02000973|2134481|P2|NOT COMPLETED|Overall Study||0
881979|NCT02000973|2134482|P1|NOT COMPLETED|Overall Study||0
881980|NCT02000973|2134479|P4|COMPLETED|Overall Study||20
881981|NCT02000973|2134480|P3|COMPLETED|Overall Study||20
881982|NCT02000973|2134481|P2|COMPLETED|Overall Study||20
881983|NCT02000973|2134482|P1|COMPLETED|Overall Study||20
881984|NCT02000973|2134479|P4|STARTED|Overall Study||20
881985|NCT02000973|2134480|P3|STARTED|Overall Study||20
881986|NCT02000973|2134481|P2|STARTED|Overall Study||20
881987|NCT02000973|2134482|P1|STARTED|Overall Study||20
881988|NCT02000921|2134507|P3|NOT COMPLETED|Overall Study||10
881989|NCT02000921|2134508|P2|NOT COMPLETED|Overall Study||16
881990|NCT02000921|2134509|P1|NOT COMPLETED|Overall Study||5
881992|NCT02000921|2134508|P2|COMPLETED|Overall Study||37
881993|NCT02000921|2134509|P1|COMPLETED|Overall Study||22
881994|NCT02000921|2134507|P3|STARTED|Overall Study||56
881995|NCT02000921|2134508|P2|STARTED|Overall Study||53
881996|NCT02000921|2134509|P1|STARTED|Overall Study||27
881997|NCT02000752|2134528|P2|NOT COMPLETED|Overall Study||13
881998|NCT02000752|2134529|P1|NOT COMPLETED|Overall Study||31
881999|NCT02000752|2134528|P2|COMPLETED|Overall Study||47
882000|NCT02000752|2134529|P1|COMPLETED|Overall Study||29
882001|NCT02000752|2134528|P2|STARTED|Overall Study||60
882002|NCT02000752|2134529|P1|STARTED|Overall Study||60
882003|NCT02000531|2134543|P2|NOT COMPLETED|Overall Study||8
882004|NCT02000531|2134544|P1|NOT COMPLETED|Overall Study||4
882005|NCT02000531|2134543|P2|COMPLETED|Overall Study||16
882006|NCT02000531|2134544|P1|COMPLETED|Overall Study||17
882007|NCT02000531|2134543|P2|Safety Population|Overall Study||24
882008|NCT02000531|2134544|P1|Safety Population|Overall Study||21
882009|NCT02000531|2134543|P2|STARTED|Overall Study||24
882010|NCT02000531|2134544|P1|STARTED|Overall Study||21
882011|NCT02000440|2134552|P1|NOT COMPLETED|Overall Study||4
882012|NCT02000440|2134552|P1|COMPLETED|Overall Study||13
882013|NCT02000440|2134552|P1|STARTED|Overall Study||17
882014|NCT02000427|2134572|P1|NOT COMPLETED|Overall Study||22
882015|NCT02000427|2134572|P1|COMPLETED|Overall Study|Indicates participants ongoing in study as of the data cut-off date of 20 May 2015.|23
882016|NCT02000427|2134572|P1|STARTED|Overall Study||45
882017|NCT02000154|2134587|P1|NOT COMPLETED|Overall Study||0
882018|NCT02000154|2134587|P1|COMPLETED|Overall Study||1
882019|NCT02000154|2134587|P1|STARTED|Overall Study||1
882020|NCT01999894|2134595|P1|NOT COMPLETED|Overall Study||36
882021|NCT01999894|2134595|P1|COMPLETED|Overall Study||66
882022|NCT01999894|2134595|P1|STARTED|Overall Study||102
882023|NCT01999400|2134600|P6|NOT COMPLETED|Fourth Intervention (1 Day)||0
882024|NCT01999400|2134601|P5|NOT COMPLETED|Fourth Intervention (1 Day)||0
882025|NCT01999400|2134602|P4|NOT COMPLETED|Fourth Intervention (1 Day)||0
882026|NCT01999400|2134603|P3|NOT COMPLETED|Fourth Intervention (1 Day)||0
882027|NCT01999400|2134604|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
882028|NCT01999400|2134605|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
882029|NCT01999400|2134600|P6|COMPLETED|Fourth Intervention (1 Day)||0
882030|NCT01999400|2134601|P5|COMPLETED|Fourth Intervention (1 Day)||0
882031|NCT01999400|2134602|P4|COMPLETED|Fourth Intervention (1 Day)||0
882032|NCT01999400|2134603|P3|COMPLETED|Fourth Intervention (1 Day)||1
882033|NCT01999400|2134604|P2|COMPLETED|Fourth Intervention (1 Day)||0
882034|NCT01999400|2134605|P1|COMPLETED|Fourth Intervention (1 Day)||1
882035|NCT01999400|2134600|P6|STARTED|Fourth Intervention (1 Day)||0
882036|NCT01999400|2134601|P5|STARTED|Fourth Intervention (1 Day)||0
882037|NCT01999400|2134602|P4|STARTED|Fourth Intervention (1 Day)||0
882038|NCT01999400|2134603|P3|STARTED|Fourth Intervention (1 Day)||1
882039|NCT01999400|2134604|P2|STARTED|Fourth Intervention (1 Day)||0
882040|NCT01999400|2134605|P1|STARTED|Fourth Intervention (1 Day)||1
882041|NCT01999400|2134600|P6|NOT COMPLETED|Washout (10 Days)||0
882042|NCT01999400|2134601|P5|NOT COMPLETED|Washout (10 Days)||0
882043|NCT01999400|2134602|P4|NOT COMPLETED|Washout (10 Days)||0
882044|NCT01999400|2134603|P3|NOT COMPLETED|Washout (10 Days)||0
882045|NCT01999400|2134604|P2|NOT COMPLETED|Washout (10 Days)||0
882046|NCT01999400|2134605|P1|NOT COMPLETED|Washout (10 Days)||0
882047|NCT01999400|2134600|P6|COMPLETED|Washout (10 Days)||0
882048|NCT01999400|2134601|P5|COMPLETED|Washout (10 Days)||0
882049|NCT01999400|2134602|P4|COMPLETED|Washout (10 Days)||0
882050|NCT01999400|2134603|P3|COMPLETED|Washout (10 Days)||1
882051|NCT01999400|2134604|P2|COMPLETED|Washout (10 Days)||0
882052|NCT01999400|2134605|P1|COMPLETED|Washout (10 Days)||1
882053|NCT01999400|2134600|P6|STARTED|Washout (10 Days)||0
882054|NCT01999400|2134601|P5|STARTED|Washout (10 Days)||0
882055|NCT01999400|2134602|P4|STARTED|Washout (10 Days)||0
882056|NCT01999400|2134603|P3|STARTED|Washout (10 Days)||1
882057|NCT01999400|2134604|P2|STARTED|Washout (10 Days)||0
882058|NCT01999400|2134605|P1|STARTED|Washout (10 Days)||1
882059|NCT01999400|2134600|P6|NOT COMPLETED|Third Intervention (1 Day)||1
882060|NCT01999400|2134601|P5|NOT COMPLETED|Third Intervention (1 Day)||0
882061|NCT01999400|2134602|P4|NOT COMPLETED|Third Intervention (1 Day)||0
882062|NCT01999400|2134603|P3|NOT COMPLETED|Third Intervention (1 Day)||0
882063|NCT01999400|2134604|P2|NOT COMPLETED|Third Intervention (1 Day)||0
882064|NCT01999400|2134605|P1|NOT COMPLETED|Third Intervention (1 Day)||0
882065|NCT01999400|2134600|P6|COMPLETED|Third Intervention (1 Day)||0
882066|NCT01999400|2134601|P5|COMPLETED|Third Intervention (1 Day)||1
882067|NCT01999400|2134602|P4|COMPLETED|Third Intervention (1 Day)||1
882068|NCT01999400|2134603|P3|COMPLETED|Third Intervention (1 Day)||1
882069|NCT01999400|2134604|P2|COMPLETED|Third Intervention (1 Day)||0
882070|NCT01999400|2134605|P1|COMPLETED|Third Intervention (1 Day)||2
882071|NCT01999400|2134600|P6|STARTED|Third Intervention (1 Day)||1
882072|NCT01999400|2134601|P5|STARTED|Third Intervention (1 Day)||1
882073|NCT01999400|2134602|P4|STARTED|Third Intervention (1 Day)||1
882074|NCT01999400|2134603|P3|STARTED|Third Intervention (1 Day)||1
882075|NCT01999400|2134604|P2|STARTED|Third Intervention (1 Day)||0
882076|NCT01999400|2134605|P1|STARTED|Third Intervention (1 Day)||2
882077|NCT01999400|2134600|P6|NOT COMPLETED|Washout (10 Days)||0
882078|NCT01999400|2134601|P5|NOT COMPLETED|Washout (10 Days)||0
882079|NCT01999400|2134602|P4|NOT COMPLETED|Washout (10 Days)||0
882080|NCT01999400|2134603|P3|NOT COMPLETED|Washout (10 Days)||0
882081|NCT01999400|2134604|P2|NOT COMPLETED|Washout (10 Days)||0
882082|NCT01999400|2134605|P1|NOT COMPLETED|Washout (10 Days)||0
882083|NCT01999400|2134600|P6|COMPLETED|Washout (10 Days)||1
882084|NCT01999400|2134601|P5|COMPLETED|Washout (10 Days)||1
882085|NCT01999400|2134602|P4|COMPLETED|Washout (10 Days)||1
882086|NCT01999400|2134603|P3|COMPLETED|Washout (10 Days)||1
882087|NCT01999400|2134604|P2|COMPLETED|Washout (10 Days)||0
882088|NCT01999400|2134605|P1|COMPLETED|Washout (10 Days)||2
882089|NCT01999400|2134600|P6|STARTED|Washout (10 Days)||1
882090|NCT01999400|2134601|P5|STARTED|Washout (10 Days)||1
882091|NCT01999400|2134602|P4|STARTED|Washout (10 Days)||1
882092|NCT01999400|2134603|P3|STARTED|Washout (10 Days)||1
882093|NCT01999400|2134604|P2|STARTED|Washout (10 Days)||0
882094|NCT01999400|2134605|P1|STARTED|Washout (10 Days)||2
882095|NCT01999400|2134600|P6|NOT COMPLETED|Second Intervention (1 Day)||0
882096|NCT01999400|2134601|P5|NOT COMPLETED|Second Intervention (1 Day)||0
882097|NCT01999400|2134602|P4|NOT COMPLETED|Second Intervention (1 Day)||0
882098|NCT01999400|2134603|P3|NOT COMPLETED|Second Intervention (1 Day)||0
882099|NCT01999400|2134604|P2|NOT COMPLETED|Second Intervention (1 Day)||0
882100|NCT01999400|2134605|P1|NOT COMPLETED|Second Intervention (1 Day)||0
882101|NCT01999400|2134600|P6|COMPLETED|Second Intervention (1 Day)||3
882102|NCT01999400|2134601|P5|COMPLETED|Second Intervention (1 Day)||3
882103|NCT01999400|2134602|P4|COMPLETED|Second Intervention (1 Day)||2
882104|NCT01999400|2134603|P3|COMPLETED|Second Intervention (1 Day)||3
882105|NCT01999400|2134604|P2|COMPLETED|Second Intervention (1 Day)||4
882106|NCT01999400|2134605|P1|COMPLETED|Second Intervention (1 Day)||5
882107|NCT01999400|2134600|P6|STARTED|Second Intervention (1 Day)||3
882108|NCT01999400|2134601|P5|STARTED|Second Intervention (1 Day)||3
882109|NCT01999400|2134602|P4|STARTED|Second Intervention (1 Day)||2
882110|NCT01999400|2134603|P3|STARTED|Second Intervention (1 Day)||3
882111|NCT01999400|2134604|P2|STARTED|Second Intervention (1 Day)||4
882112|NCT01999400|2134605|P1|STARTED|Second Intervention (1 Day)||5
882113|NCT01999400|2134600|P6|NOT COMPLETED|Washout (10 Days)||0
882114|NCT01999400|2134601|P5|NOT COMPLETED|Washout (10 Days)||0
882115|NCT01999400|2134602|P4|NOT COMPLETED|Washout (10 Days)||0
882116|NCT01999400|2134603|P3|NOT COMPLETED|Washout (10 Days)||0
882117|NCT01999400|2134604|P2|NOT COMPLETED|Washout (10 Days)||0
882118|NCT01999400|2134605|P1|NOT COMPLETED|Washout (10 Days)||0
882119|NCT01999400|2134600|P6|COMPLETED|Washout (10 Days)||3
882120|NCT01999400|2134601|P5|COMPLETED|Washout (10 Days)||3
882121|NCT01999400|2134602|P4|COMPLETED|Washout (10 Days)||2
882122|NCT01999400|2134603|P3|COMPLETED|Washout (10 Days)||3
882123|NCT01999400|2134604|P2|COMPLETED|Washout (10 Days)||4
882124|NCT01999400|2134605|P1|COMPLETED|Washout (10 Days)||5
882125|NCT01999400|2134600|P6|STARTED|Washout (10 Days)||3
882126|NCT01999400|2134601|P5|STARTED|Washout (10 Days)||3
882127|NCT01999400|2134602|P4|STARTED|Washout (10 Days)||2
882128|NCT01999400|2134603|P3|STARTED|Washout (10 Days)||3
882129|NCT01999400|2134604|P2|STARTED|Washout (10 Days)||4
882130|NCT01999400|2134605|P1|STARTED|Washout (10 Days)||5
882131|NCT01999400|2134600|P6|NOT COMPLETED|First Intervention (1 Day)||1
882132|NCT01999400|2134601|P5|NOT COMPLETED|First Intervention (1 Day)||0
882133|NCT01999400|2134602|P4|NOT COMPLETED|First Intervention (1 Day)||3
882134|NCT01999400|2134603|P3|NOT COMPLETED|First Intervention (1 Day)||2
882135|NCT01999400|2134604|P2|NOT COMPLETED|First Intervention (1 Day)||2
882136|NCT01999400|2134605|P1|NOT COMPLETED|First Intervention (1 Day)||2
882137|NCT01999400|2134600|P6|COMPLETED|First Intervention (1 Day)||3
882138|NCT01999400|2134601|P5|COMPLETED|First Intervention (1 Day)||4
882139|NCT01999400|2134602|P4|COMPLETED|First Intervention (1 Day)||2
882140|NCT01999400|2134603|P3|COMPLETED|First Intervention (1 Day)||3
882141|NCT01999400|2134604|P2|COMPLETED|First Intervention (1 Day)||4
882142|NCT01999400|2134605|P1|COMPLETED|First Intervention (1 Day)||4
882143|NCT01999400|2134600|P6|STARTED|First Intervention (1 Day)||4
882144|NCT01999400|2134601|P5|STARTED|First Intervention (1 Day)||4
882145|NCT01999400|2134602|P4|STARTED|First Intervention (1 Day)||5
882146|NCT01999400|2134603|P3|STARTED|First Intervention (1 Day)||5
882147|NCT01999400|2134604|P2|STARTED|First Intervention (1 Day)||6
882148|NCT01999400|2134605|P1|STARTED|First Intervention (1 Day)||6
882149|NCT01999348|2134625|P1|NOT COMPLETED|Overall Study||120
882150|NCT01999348|2134625|P1|COMPLETED|Overall Study||1433
882151|NCT01999348|2134625|P1|STARTED|Overall Study||1553
882152|NCT01999231|2134639|P4|NOT COMPLETED|Overall Study||0
882153|NCT01999231|2134640|P3|NOT COMPLETED|Overall Study||0
882154|NCT01999231|2134641|P2|NOT COMPLETED|Overall Study||0
882155|NCT01999231|2134642|P1|NOT COMPLETED|Overall Study||0
882156|NCT01999231|2134639|P4|COMPLETED|Overall Study||6
882157|NCT01999231|2134640|P3|COMPLETED|Overall Study||6
882158|NCT01999231|2134641|P2|COMPLETED|Overall Study||6
882159|NCT01999231|2134642|P1|COMPLETED|Overall Study||6
882160|NCT01999231|2134639|P4|STARTED|Overall Study||6
882161|NCT01999231|2134640|P3|STARTED|Overall Study||6
882162|NCT01999231|2134641|P2|STARTED|Overall Study||6
882163|NCT01999231|2134642|P1|STARTED|Overall Study||6
882164|NCT01999192|2134676|P4|NOT COMPLETED|Extension Phase||0
882165|NCT01999192|2134677|P3|NOT COMPLETED|Extension Phase||24
882166|NCT01999192|2134678|P2|NOT COMPLETED|Extension Phase||18
882167|NCT01999192|2134679|P1|NOT COMPLETED|Extension Phase||13
882168|NCT01999192|2134676|P4|COMPLETED|Extension Phase||0
882169|NCT01999192|2134677|P3|COMPLETED|Extension Phase||44
882170|NCT01999192|2134678|P2|COMPLETED|Extension Phase||38
882171|NCT01999192|2134679|P1|COMPLETED|Extension Phase||41
882172|NCT01999192|2134676|P4|STARTED|Extension Phase|No Placebo arm for Extension Phase, all patients terminated or were switched to tregalizumab Groups.|0
882173|NCT01999192|2134677|P3|STARTED|Extension Phase|Some patients terminated after Main Phase 2.|68
882174|NCT01999192|2134678|P2|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|56
882175|NCT01999192|2134679|P1|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|54
882176|NCT01999192|2134676|P4|NOT COMPLETED|Main Phase II||1
882177|NCT01999192|2134677|P3|NOT COMPLETED|Main Phase II||22
882178|NCT01999192|2134678|P2|NOT COMPLETED|Main Phase II||9
882179|NCT01999192|2134679|P1|NOT COMPLETED|Main Phase II||9
882180|NCT01999192|2134676|P4|COMPLETED|Main Phase II||43
882181|NCT01999192|2134677|P3|COMPLETED|Main Phase II||76
882182|NCT01999192|2134678|P2|COMPLETED|Main Phase II||66
882183|NCT01999192|2134679|P1|COMPLETED|Main Phase II||55
882184|NCT01999192|2134676|P4|STARTED|Main Phase II|non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched|44
882185|NCT01999192|2134677|P3|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|98
882186|NCT01999192|2134678|P2|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|75
882187|NCT01999192|2134679|P1|STARTED|Main Phase II|Non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched.|64
882188|NCT01999192|2134676|P4|NOT COMPLETED|Main Phase I||8
882189|NCT01999192|2134677|P3|NOT COMPLETED|Main Phase I||8
882190|NCT01999192|2134678|P2|NOT COMPLETED|Main Phase I||10
882191|NCT01999192|2134679|P1|NOT COMPLETED|Main Phase I||11
882192|NCT01999192|2134676|P4|COMPLETED|Main Phase I||72
882193|NCT01999192|2134677|P3|COMPLETED|Main Phase I||70
882194|NCT01999192|2134678|P2|COMPLETED|Main Phase I||70
882195|NCT01999192|2134679|P1|COMPLETED|Main Phase I||72
882196|NCT01999192|2134676|P4|STARTED|Main Phase I||80
882197|NCT01999192|2134677|P3|STARTED|Main Phase I||78
882198|NCT01999192|2134678|P2|STARTED|Main Phase I||80
882199|NCT01999192|2134679|P1|STARTED|Main Phase I||83
882200|NCT01998919|2134691|P2|NOT COMPLETED|Overall Study||35
882201|NCT01998919|2134692|P1|NOT COMPLETED|Overall Study||42
882202|NCT01998919|2134691|P2|COMPLETED|Overall Study||39
882203|NCT01998919|2134692|P1|COMPLETED|Overall Study||37
882204|NCT01998919|2134691|P2|Randomized|Overall Study|One participant withdrew consent prior to 1st dose and was excluded from safety analysis population.|76
882205|NCT01998919|2134692|P1|Randomized|Overall Study|1 participant randomized to erlotinib didn't receive study drug; analyzed in placebo for safety|78
882206|NCT01998919|2134691|P2|STARTED|Overall Study||74
882207|NCT01998919|2134692|P1|STARTED|Overall Study||79
882208|NCT01998906|2134713|P3|NOT COMPLETED|Overall Study||98
882209|NCT01998906|2134714|P2|NOT COMPLETED|Overall Study||114
882210|NCT01998906|2134715|P1|NOT COMPLETED|Overall Study||114
882211|NCT01998906|2134713|P3|COMPLETED|Overall Study||1
882212|NCT01998906|2134714|P2|COMPLETED|Overall Study||2
882213|NCT01998906|2134715|P1|COMPLETED|Overall Study||1
882214|NCT01998906|2134713|P3|STARTED|Overall Study||99
882215|NCT01998906|2134714|P2|STARTED|Overall Study||116
882216|NCT01998906|2134715|P1|STARTED|Overall Study||115
882217|NCT01998893|2134759|P1|NOT COMPLETED|Overall Study||17
882218|NCT01998893|2134759|P1|COMPLETED|Overall Study||21
882219|NCT01998893|2134759|P1|2nd Treatment Cycle Completed Until PD|Overall Study||3
882220|NCT01998893|2134759|P1|2nd Treatment Cycle Started|Overall Study||5
882221|NCT01998893|2134759|P1|1st Treatment Cycle Completed Until PD|Overall Study|Progressive disease (PD)|30
882222|NCT01998893|2134759|P1|STARTED|Overall Study||38
882223|NCT01998880|2134771|P2|NOT COMPLETED|Overall Study||40
882224|NCT01998880|2134772|P1|NOT COMPLETED|Overall Study||29
882225|NCT01998880|2134771|P2|COMPLETED|Overall Study||78
882226|NCT01998880|2134772|P1|COMPLETED|Overall Study|Completed=Completed treatment.|204
882227|NCT01998880|2134771|P2|Received Study Drug|Overall Study||116
882228|NCT01998880|2134772|P1|Received Study Drug|Overall Study||230
882229|NCT01998880|2134771|P2|STARTED|Overall Study||118
882230|NCT01998880|2134772|P1|STARTED|Overall Study||233
882231|NCT01998737|2134790|P2|NOT COMPLETED|Overall Study||0
882232|NCT01998737|2134791|P1|NOT COMPLETED|Overall Study||23
882233|NCT01998737|2134790|P2|COMPLETED|Overall Study||100
882234|NCT01998737|2134791|P1|COMPLETED|Overall Study||888
882235|NCT01998737|2134790|P2|STARTED|Overall Study||100
882236|NCT01998737|2134791|P1|STARTED|Overall Study||911
882237|NCT01998581|2134803|P2|NOT COMPLETED|Overall Study||12
882238|NCT01998581|2134804|P1|NOT COMPLETED|Overall Study||46
882239|NCT01998581|2134803|P2|COMPLETED|Overall Study||44
882240|NCT01998581|2134804|P1|COMPLETED|Overall Study||123
882241|NCT01998581|2134803|P2|STARTED|Overall Study||56
882242|NCT01998581|2134804|P1|STARTED|Overall Study||169
882243|NCT01998477|2134816|P2|NOT COMPLETED|Overall Study||5
882244|NCT01998477|2134817|P1|NOT COMPLETED|Overall Study||10
882245|NCT01998477|2134816|P2|COMPLETED|Overall Study||143
882246|NCT01998477|2134817|P1|COMPLETED|Overall Study||272
882247|NCT01998477|2134816|P2|STARTED|Overall Study||148
882248|NCT01998477|2134817|P1|STARTED|Overall Study||282
882249|NCT01998438|2134851|P3|NOT COMPLETED|Overall Study||0
882250|NCT01998438|2134852|P2|NOT COMPLETED|Overall Study||0
882251|NCT01998438|2134853|P1|NOT COMPLETED|Overall Study||0
882252|NCT01998438|2134851|P3|COMPLETED|Overall Study||318
882253|NCT01998438|2134852|P2|COMPLETED|Overall Study||318
882254|NCT01998438|2134853|P1|COMPLETED|Overall Study||319
882255|NCT01998438|2134851|P3|STARTED|Overall Study||318
882256|NCT01998438|2134852|P2|STARTED|Overall Study||318
882257|NCT01998438|2134853|P1|STARTED|Overall Study||319
882258|NCT01998399|2134863|P2|NOT COMPLETED|Overall Study||9
882259|NCT01998399|2134864|P1|NOT COMPLETED|Overall Study||8
882260|NCT01998399|2134863|P2|COMPLETED|Overall Study||4
882261|NCT01998399|2134864|P1|COMPLETED|Overall Study||4
882262|NCT01998399|2134863|P2|STARTED|Overall Study||13
882263|NCT01998399|2134864|P1|STARTED|Overall Study||12
882264|NCT01998360|2134872|P2|NOT COMPLETED|Overall Study||0
882265|NCT01998360|2134873|P1|NOT COMPLETED|Overall Study||0
882266|NCT01998360|2134872|P2|COMPLETED|Overall Study||50
882267|NCT01998360|2134873|P1|COMPLETED|Overall Study||50
882268|NCT01998360|2134872|P2|STARTED|Overall Study||50
882269|NCT01998360|2134873|P1|STARTED|Overall Study||50
882270|NCT01998269|2134887|P1|NOT COMPLETED|Overall Study||0
882271|NCT01998269|2134887|P1|COMPLETED|Overall Study||193
882272|NCT01998269|2134887|P1|STARTED|Overall Study||193
882273|NCT01997905|2134891|P1|NOT COMPLETED|Overall Study||3
882274|NCT01997905|2134891|P1|COMPLETED|Overall Study||10
882275|NCT01997905|2134891|P1|Baseline Completed|Overall Study||11
882276|NCT01997905|2134891|P1|STARTED|Overall Study||13
882277|NCT01997892|2134900|P1|NOT COMPLETED|Overall Study||68
882278|NCT01997892|2134900|P1|COMPLETED|Overall Study||959
882279|NCT01997892|2134900|P1|Received Darbepoetin Alfa|Overall Study||987
882280|NCT01997892|2134900|P1|STARTED|Overall Study||1027
882281|NCT01997723|2134912|P1|NOT COMPLETED|Overall Study||0
882282|NCT01997723|2134912|P1|COMPLETED|Overall Study||75
882283|NCT01997723|2134912|P1|STARTED|Overall Study||75
882284|NCT01997567|2134920|P2|NOT COMPLETED|Overall Study||0
882285|NCT01997567|2134921|P1|NOT COMPLETED|Overall Study||0
882286|NCT01997567|2134920|P2|COMPLETED|Overall Study||0
882287|NCT01997567|2134921|P1|COMPLETED|Overall Study||0
882288|NCT01997567|2134920|P2|STARTED|Overall Study||0
882289|NCT01997567|2134921|P1|STARTED|Overall Study||0
882290|NCT01997437|2134927|P1|NOT COMPLETED|Overall Study||0
882291|NCT01997437|2134927|P1|COMPLETED|Overall Study||6
882292|NCT01997437|2134927|P1|STARTED|Overall Study||6
882293|NCT01997411|2134939|P8|NOT COMPLETED|Overall Study||0
882294|NCT01997411|2134940|P7|NOT COMPLETED|Overall Study||0
882295|NCT01997411|2134941|P6|NOT COMPLETED|Overall Study||1
882296|NCT01997411|2134942|P5|NOT COMPLETED|Overall Study||0
882297|NCT01997411|2134943|P4|NOT COMPLETED|Overall Study||0
882298|NCT01997411|2134944|P3|NOT COMPLETED|Overall Study||0
882299|NCT01997411|2134945|P2|NOT COMPLETED|Overall Study||0
882300|NCT01997411|2134946|P1|NOT COMPLETED|Overall Study||0
882301|NCT01997411|2134939|P8|COMPLETED|Overall Study||6
882302|NCT01997411|2134940|P7|COMPLETED|Overall Study||6
882303|NCT01997411|2134941|P6|COMPLETED|Overall Study||5
882304|NCT01997411|2134942|P5|COMPLETED|Overall Study||6
882305|NCT01997411|2134943|P4|COMPLETED|Overall Study||6
882306|NCT01997411|2134944|P3|COMPLETED|Overall Study||6
882307|NCT01997411|2134945|P2|COMPLETED|Overall Study||6
882308|NCT01997411|2134946|P1|COMPLETED|Overall Study||6
882309|NCT01997411|2134939|P8|STARTED|Overall Study||6
882310|NCT01997411|2134940|P7|STARTED|Overall Study||6
882311|NCT01997411|2134941|P6|STARTED|Overall Study||6
882312|NCT01997411|2134942|P5|STARTED|Overall Study||6
882313|NCT01997411|2134943|P4|STARTED|Overall Study||6
882314|NCT01997411|2134944|P3|STARTED|Overall Study||6
882315|NCT01997411|2134945|P2|STARTED|Overall Study||6
882316|NCT01997411|2134946|P1|STARTED|Overall Study||6
882317|NCT01997398|2135036|P1|NOT COMPLETED|Overall Study||1
882318|NCT01997398|2135036|P1|COMPLETED|Overall Study|One patient took PD meds 3 hours prior to 6 mo. UPDRS testing and was excluded from the analysis.|34
882319|NCT01997398|2135036|P1|STARTED|Overall Study||35
882320|NCT01997216|2135045|P2|NOT COMPLETED|Second 9 Hours||0
882321|NCT01997216|2135046|P1|NOT COMPLETED|Second 9 Hours||0
882322|NCT01997216|2135045|P2|COMPLETED|Second 9 Hours||21
882323|NCT01997216|2135046|P1|COMPLETED|Second 9 Hours||19
882324|NCT01997216|2135045|P2|STARTED|Second 9 Hours||21
882325|NCT01997216|2135046|P1|STARTED|Second 9 Hours|One participant was not exposed to Pair 1 due to product unavailability, but was exposed to Pair 2.|19
882326|NCT01997216|2135045|P2|NOT COMPLETED|First 9 Hours||0
882327|NCT01997216|2135046|P1|NOT COMPLETED|First 9 Hours||0
882328|NCT01997216|2135045|P2|COMPLETED|First 9 Hours||21
882329|NCT01997216|2135046|P1|COMPLETED|First 9 Hours||18
882330|NCT01997216|2135045|P2|STARTED|First 9 Hours||21
882331|NCT01997216|2135046|P1|STARTED|First 9 Hours||18
882332|NCT01996904|2135058|P2|NOT COMPLETED|Overall Study||27
882333|NCT01996904|2135059|P1|NOT COMPLETED|Overall Study||38
882334|NCT01996904|2135058|P2|COMPLETED|Overall Study||90
882335|NCT01996904|2135059|P1|COMPLETED|Overall Study||101
882336|NCT01996904|2135058|P2|STARTED|Overall Study||117
882337|NCT01996904|2135059|P1|STARTED|Overall Study||139
882338|NCT01996813|2135065|P1|NOT COMPLETED|Overall Study||0
882339|NCT01996813|2135065|P1|COMPLETED|Overall Study||23
882340|NCT01996813|2135065|P1|STARTED|Overall Study||23
882341|NCT01996748|2135072|P2|NOT COMPLETED|Overall Study||6
882342|NCT01996748|2135073|P1|NOT COMPLETED|Overall Study||8
882343|NCT01996748|2135072|P2|COMPLETED|Overall Study||63
882344|NCT01996748|2135073|P1|COMPLETED|Overall Study||58
882345|NCT01996748|2135072|P2|STARTED|Overall Study||69
882346|NCT01996748|2135073|P1|STARTED|Overall Study||66
882347|NCT01996709|2135087|P2|NOT COMPLETED|Overall Study||1
882348|NCT01996709|2135088|P1|NOT COMPLETED|Overall Study||5
882349|NCT01996709|2135087|P2|COMPLETED|Overall Study||67
882350|NCT01996709|2135088|P1|COMPLETED|Overall Study||61
882351|NCT01996709|2135087|P2|STARTED|Overall Study||68
882352|NCT01996709|2135088|P1|STARTED|Overall Study||66
882353|NCT01996657|2135105|P3|NOT COMPLETED|Overall Study||14
882354|NCT01996657|2135106|P2|NOT COMPLETED|Overall Study||11
882355|NCT01996657|2135107|P1|NOT COMPLETED|Overall Study||13
882356|NCT01996657|2135105|P3|COMPLETED|Overall Study||234
882357|NCT01996657|2135106|P2|COMPLETED|Overall Study||239
882358|NCT01996657|2135107|P1|COMPLETED|Overall Study||237
882359|NCT01996657|2135105|P3|STARTED|Overall Study||248
882360|NCT01996657|2135106|P2|STARTED|Overall Study||250
882361|NCT01996657|2135107|P1|STARTED|Overall Study||250
882362|NCT01996410|2135129|P8|NOT COMPLETED|Overall Study||0
882363|NCT01996410|2135130|P7|NOT COMPLETED|Overall Study||0
882364|NCT01996410|2135131|P6|NOT COMPLETED|Overall Study||0
882365|NCT01996410|2135132|P5|NOT COMPLETED|Overall Study||0
882366|NCT01996410|2135133|P4|NOT COMPLETED|Overall Study||0
882367|NCT01996410|2135134|P3|NOT COMPLETED|Overall Study||0
882368|NCT01996410|2135135|P2|NOT COMPLETED|Overall Study||0
882369|NCT01996410|2135136|P1|NOT COMPLETED|Overall Study||0
882370|NCT01996410|2135129|P8|COMPLETED|Overall Study||0
882371|NCT01996410|2135130|P7|COMPLETED|Overall Study||0
882372|NCT01996410|2135131|P6|COMPLETED|Overall Study||2
882373|NCT01996410|2135132|P5|COMPLETED|Overall Study||2
882374|NCT01996410|2135133|P4|COMPLETED|Overall Study||0
882375|NCT01996410|2135134|P3|COMPLETED|Overall Study||0
882376|NCT01996410|2135135|P2|COMPLETED|Overall Study||3
882377|NCT01996410|2135136|P1|COMPLETED|Overall Study||3
882378|NCT01996410|2135129|P8|STARTED|Overall Study||0
882379|NCT01996410|2135130|P7|STARTED|Overall Study||0
882380|NCT01996410|2135131|P6|STARTED|Overall Study||2
882381|NCT01996410|2135132|P5|STARTED|Overall Study||2
882382|NCT01996410|2135133|P4|STARTED|Overall Study||0
882383|NCT01996410|2135134|P3|STARTED|Overall Study||0
882384|NCT01996410|2135135|P2|STARTED|Overall Study||3
882385|NCT01996410|2135136|P1|STARTED|Overall Study||3
882386|NCT01996332|2135148|P1|NOT COMPLETED|Overall Study||1805
882387|NCT01996332|2135148|P1|COMPLETED|Overall Study||0
882388|NCT01996332|2135148|P1|STARTED|Overall Study||1805
882389|NCT01996319|2135156|P2|NOT COMPLETED|Overall Study||3
882390|NCT01996319|2135157|P1|NOT COMPLETED|Overall Study||8
882391|NCT01996319|2135156|P2|COMPLETED|Overall Study||95
882392|NCT01996319|2135157|P1|COMPLETED|Overall Study||88
882393|NCT01996319|2135156|P2|STARTED|Overall Study||98
882394|NCT01996319|2135157|P1|STARTED|Overall Study||96
882395|NCT01995461|2135177|P1|NOT COMPLETED|Overall Study||5
882396|NCT01995461|2135177|P1|COMPLETED|Overall Study||21
882397|NCT01995461|2135177|P1|STARTED|Overall Study||26
882398|NCT01995357|2135183|P6|NOT COMPLETED|Period 5||0
882399|NCT01995357|2135184|P5|NOT COMPLETED|Period 5||0
882400|NCT01995357|2135185|P4|NOT COMPLETED|Period 5||0
882401|NCT01995357|2135186|P3|NOT COMPLETED|Period 5||1
882402|NCT01995357|2135187|P2|NOT COMPLETED|Period 5||0
882403|NCT01995357|2135188|P1|NOT COMPLETED|Period 5||2
882404|NCT01995357|2135183|P6|COMPLETED|Period 5||4
882405|NCT01995357|2135184|P5|COMPLETED|Period 5||4
882406|NCT01995357|2135185|P4|COMPLETED|Period 5||3
882407|NCT01995357|2135186|P3|COMPLETED|Period 5||3
882408|NCT01995357|2135187|P2|COMPLETED|Period 5||3
882409|NCT01995357|2135188|P1|COMPLETED|Period 5||2
882410|NCT01995357|2135183|P6|STARTED|Period 5||4
882411|NCT01995357|2135184|P5|STARTED|Period 5|1 subject terminated due to an adverse event. Subject counted as completed as some B products tested|4
882412|NCT01995357|2135185|P4|STARTED|Period 5||3
882413|NCT01995357|2135186|P3|STARTED|Period 5||4
882414|NCT01995357|2135187|P2|STARTED|Period 5||3
882415|NCT01995357|2135188|P1|STARTED|Period 5|The two discontinued subjects tested zero planned B products in period 5.|4
882416|NCT01995357|2135183|P6|NOT COMPLETED|Period 4||0
882417|NCT01995357|2135184|P5|NOT COMPLETED|Period 4||0
882418|NCT01995357|2135185|P4|NOT COMPLETED|Period 4||0
882419|NCT01995357|2135186|P3|NOT COMPLETED|Period 4||0
882420|NCT01995357|2135187|P2|NOT COMPLETED|Period 4||0
882421|NCT01995357|2135188|P1|NOT COMPLETED|Period 4||0
882422|NCT01995357|2135183|P6|COMPLETED|Period 4||4
882423|NCT01995357|2135184|P5|COMPLETED|Period 4||4
882424|NCT01995357|2135185|P4|COMPLETED|Period 4||3
882425|NCT01995357|2135186|P3|COMPLETED|Period 4||4
882426|NCT01995357|2135187|P2|COMPLETED|Period 4||3
882427|NCT01995357|2135188|P1|COMPLETED|Period 4||4
882428|NCT01995357|2135183|P6|STARTED|Period 4||4
882429|NCT01995357|2135184|P5|STARTED|Period 4||4
882430|NCT01995357|2135185|P4|STARTED|Period 4||3
882431|NCT01995357|2135186|P3|STARTED|Period 4|The subject who did not complete period 5, erroneously used product A when B should have been used.|4
882432|NCT01995357|2135187|P2|STARTED|Period 4||3
882433|NCT01995357|2135188|P1|STARTED|Period 4||4
882434|NCT01995357|2135183|P6|NOT COMPLETED|Period 3||0
882435|NCT01995357|2135184|P5|NOT COMPLETED|Period 3||0
882436|NCT01995357|2135185|P4|NOT COMPLETED|Period 3||0
882437|NCT01995357|2135186|P3|NOT COMPLETED|Period 3||0
882438|NCT01995357|2135187|P2|NOT COMPLETED|Period 3||0
882439|NCT01995357|2135188|P1|NOT COMPLETED|Period 3||0
882440|NCT01995357|2135183|P6|COMPLETED|Period 3||4
882441|NCT01995357|2135184|P5|COMPLETED|Period 3||4
882442|NCT01995357|2135185|P4|COMPLETED|Period 3||3
882443|NCT01995357|2135186|P3|COMPLETED|Period 3||4
882444|NCT01995357|2135187|P2|COMPLETED|Period 3||3
882445|NCT01995357|2135188|P1|COMPLETED|Period 3||4
882446|NCT01995357|2135183|P6|STARTED|Period 3||4
882447|NCT01995357|2135184|P5|STARTED|Period 3||4
882448|NCT01995357|2135185|P4|STARTED|Period 3||3
882449|NCT01995357|2135186|P3|STARTED|Period 3||4
882450|NCT01995357|2135187|P2|STARTED|Period 3||3
882451|NCT01995357|2135188|P1|STARTED|Period 3||4
882452|NCT01995357|2135183|P6|NOT COMPLETED|Period 2||0
882453|NCT01995357|2135184|P5|NOT COMPLETED|Period 2||0
882454|NCT01995357|2135185|P4|NOT COMPLETED|Period 2||0
882455|NCT01995357|2135186|P3|NOT COMPLETED|Period 2||0
882456|NCT01995357|2135187|P2|NOT COMPLETED|Period 2||0
882457|NCT01995357|2135188|P1|NOT COMPLETED|Period 2||0
882458|NCT01995357|2135183|P6|COMPLETED|Period 2||4
882459|NCT01995357|2135184|P5|COMPLETED|Period 2||4
882460|NCT01995357|2135185|P4|COMPLETED|Period 2||3
882461|NCT01995357|2135186|P3|COMPLETED|Period 2||4
882462|NCT01995357|2135187|P2|COMPLETED|Period 2||3
882463|NCT01995357|2135188|P1|COMPLETED|Period 2||4
882464|NCT01995357|2135183|P6|STARTED|Period 2||4
882465|NCT01995357|2135184|P5|STARTED|Period 2||4
882466|NCT01995357|2135185|P4|STARTED|Period 2||3
882467|NCT01995357|2135186|P3|STARTED|Period 2||4
882468|NCT01995357|2135187|P2|STARTED|Period 2||3
882469|NCT01995357|2135188|P1|STARTED|Period 2||4
882470|NCT01995357|2135183|P6|NOT COMPLETED|Period 1||0
882471|NCT01995357|2135184|P5|NOT COMPLETED|Period 1||0
882472|NCT01995357|2135185|P4|NOT COMPLETED|Period 1||0
882473|NCT01995357|2135186|P3|NOT COMPLETED|Period 1||0
882474|NCT01995357|2135187|P2|NOT COMPLETED|Period 1||0
882475|NCT01995357|2135188|P1|NOT COMPLETED|Period 1||0
882476|NCT01995357|2135183|P6|COMPLETED|Period 1||4
882477|NCT01995357|2135184|P5|COMPLETED|Period 1||4
882478|NCT01995357|2135185|P4|COMPLETED|Period 1||3
882479|NCT01995357|2135186|P3|COMPLETED|Period 1||4
882480|NCT01995357|2135187|P2|COMPLETED|Period 1||3
882481|NCT01995357|2135188|P1|COMPLETED|Period 1||4
882482|NCT01995357|2135183|P6|STARTED|Period 1||4
882483|NCT01995357|2135184|P5|STARTED|Period 1||4
882484|NCT01995357|2135185|P4|STARTED|Period 1||3
882485|NCT01995357|2135186|P3|STARTED|Period 1||4
882486|NCT01995357|2135187|P2|STARTED|Period 1||3
882487|NCT01995357|2135188|P1|STARTED|Period 1||4
882488|NCT01995136|2135204|P1|NOT COMPLETED|Overall Study||1
882489|NCT01995136|2135204|P1|COMPLETED|Overall Study||31
882490|NCT01995136|2135204|P1|STARTED|Overall Study||32
882491|NCT01995045|2135210|P2|NOT COMPLETED|Overall Study||0
882492|NCT01995045|2135211|P1|NOT COMPLETED|Overall Study||0
882493|NCT01995045|2135210|P2|COMPLETED|Overall Study||28
882494|NCT01995045|2135211|P1|COMPLETED|Overall Study||29
882495|NCT01995045|2135210|P2|STARTED|Overall Study||28
882496|NCT01995045|2135211|P1|STARTED|Overall Study||29
882497|NCT01994902|2135223|P2|NOT COMPLETED|Test Period 2||6
882498|NCT01994902|2135224|P1|NOT COMPLETED|Test Period 2||0
882499|NCT01994902|2135223|P2|COMPLETED|Test Period 2||55
882500|NCT01994902|2135224|P1|COMPLETED|Test Period 2||57
882501|NCT01994902|2135223|P2|STARTED|Test Period 2||61
882502|NCT01994902|2135224|P1|STARTED|Test Period 2||57
882503|NCT01994902|2135223|P2|NOT COMPLETED|Test Period 1||3
882504|NCT01994902|2135224|P1|NOT COMPLETED|Test Period 1||6
882505|NCT01994902|2135223|P2|COMPLETED|Test Period 1|The subject testing Coloplast test product discontinued due to device deficiency with adverse event|61
882506|NCT01994902|2135224|P1|COMPLETED|Test Period 1||57
882507|NCT01994902|2135223|P2|STARTED|Test Period 1|Randomisation mistake:a subject randomised to SenSura Convex Light but tested Coloplast test product|64
882508|NCT01994902|2135224|P1|STARTED|Test Period 1||63
882509|NCT01994876|2135230|P2|NOT COMPLETED|Test Period 2||1
882510|NCT01994876|2135231|P1|NOT COMPLETED|Test Period 2||1
882511|NCT01994876|2135230|P2|COMPLETED|Test Period 2||6
882512|NCT01994876|2135231|P1|COMPLETED|Test Period 2||8
882513|NCT01994876|2135230|P2|STARTED|Test Period 2||7
882514|NCT01994876|2135231|P1|STARTED|Test Period 2||9
882515|NCT01994876|2135230|P2|NOT COMPLETED|Test Period 1||2
882516|NCT01994876|2135231|P1|NOT COMPLETED|Test Period 1||0
882517|NCT01994876|2135230|P2|COMPLETED|Test Period 1||7
882518|NCT01994876|2135231|P1|COMPLETED|Test Period 1||9
882519|NCT01994876|2135230|P2|STARTED|Test Period 1||9
882520|NCT01994876|2135231|P1|STARTED|Test Period 1||9
882521|NCT01994876|2135230|P2|NOT COMPLETED|Baseline - Own Product||0
882522|NCT01994876|2135231|P1|NOT COMPLETED|Baseline - Own Product||0
882523|NCT01994876|2135230|P2|COMPLETED|Baseline - Own Product||9
882524|NCT01994876|2135231|P1|COMPLETED|Baseline - Own Product||9
882525|NCT01994876|2135230|P2|STARTED|Baseline - Own Product||9
882526|NCT01994876|2135231|P1|STARTED|Baseline - Own Product||9
882527|NCT01994863|2135239|P2|NOT COMPLETED|Period 2||4
882528|NCT01994863|2135240|P1|NOT COMPLETED|Period 2||1
882529|NCT01994863|2135239|P2|COMPLETED|Period 2||5
882530|NCT01994863|2135240|P1|COMPLETED|Period 2||7
882531|NCT01994863|2135239|P2|STARTED|Period 2||9
882532|NCT01994863|2135240|P1|STARTED|Period 2||8
882533|NCT01994863|2135239|P2|NOT COMPLETED|Period 1||3
882534|NCT01994863|2135240|P1|NOT COMPLETED|Period 1||7
882535|NCT01994863|2135239|P2|COMPLETED|Period 1||9
882536|NCT01994863|2135240|P1|COMPLETED|Period 1||4
882537|NCT01994863|2135239|P2|STARTED|Period 1||12
882538|NCT01994863|2135240|P1|STARTED|Period 1||11
882539|NCT01994785|2135250|P4|NOT COMPLETED|Overall Study||3
882540|NCT01994785|2135251|P3|NOT COMPLETED|Overall Study||0
882541|NCT01994785|2135252|P2|NOT COMPLETED|Overall Study||1
882542|NCT01994785|2135253|P1|NOT COMPLETED|Overall Study||8
882543|NCT01994785|2135250|P4|COMPLETED|Overall Study||114
882544|NCT01994785|2135251|P3|COMPLETED|Overall Study||117
882545|NCT01994785|2135252|P2|COMPLETED|Overall Study||108
882546|NCT01994785|2135253|P1|COMPLETED|Overall Study||101
882547|NCT01994785|2135250|P4|STARTED|Overall Study||117
882548|NCT01994785|2135251|P3|STARTED|Overall Study||117
882549|NCT01994785|2135252|P2|STARTED|Overall Study||109
882550|NCT01994785|2135253|P1|STARTED|Overall Study||109
882551|NCT01994746|2135263|P2|NOT COMPLETED|Second Visit||0
882552|NCT01994746|2135264|P1|NOT COMPLETED|Second Visit||0
882553|NCT01994746|2135263|P2|COMPLETED|Second Visit||38
882554|NCT01994746|2135264|P1|COMPLETED|Second Visit|Safety population|38
882555|NCT01994746|2135263|P2|Efficacy|Second Visit||38
882556|NCT01994746|2135264|P1|Efficacy|Second Visit|Those who completed both visits were included in the efficacy population.|37
882557|NCT01994746|2135263|P2|STARTED|Second Visit||38
882558|NCT01994746|2135264|P1|STARTED|Second Visit|One participant requested to withdraw after completing the first dosing visit.|38
882559|NCT01994746|2135263|P2|NOT COMPLETED|First Visit||0
882560|NCT01994746|2135264|P1|NOT COMPLETED|First Visit||0
882561|NCT01994746|2135263|P2|COMPLETED|First Visit||38
882562|NCT01994746|2135264|P1|COMPLETED|First Visit|Safety population|39
882563|NCT01994746|2135263|P2|Efficacy|First Visit||38
882564|NCT01994746|2135264|P1|Efficacy|First Visit|Those who completed both visits were included in the efficacy population.|37
882565|NCT01994746|2135263|P2|STARTED|First Visit||38
882566|NCT01994746|2135264|P1|STARTED|First Visit||39
882567|NCT01994720|2135272|P2|NOT COMPLETED|Overall Study||56
882568|NCT01994720|2135273|P1|NOT COMPLETED|Overall Study||46
882569|NCT01994720|2135272|P2|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6554
882570|NCT01994720|2135273|P1|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6543
882571|NCT01994720|2135272|P2|STARTED|Overall Study||6610
882572|NCT01994720|2135273|P1|STARTED|Overall Study||6589
882579|NCT01994486|2135340|P1|NOT COMPLETED|Overall Study||0
882580|NCT01994486|2135340|P1|COMPLETED|Overall Study||20
882581|NCT01994486|2135340|P1|STARTED|Overall Study||20
882582|NCT01994291|2135352|P3|NOT COMPLETED|Overall Study||9
882583|NCT01994291|2135353|P2|NOT COMPLETED|Overall Study||7
882584|NCT01994291|2135354|P1|NOT COMPLETED|Overall Study||15
882585|NCT01994291|2135352|P3|COMPLETED|Overall Study||47
882586|NCT01994291|2135353|P2|COMPLETED|Overall Study||36
882587|NCT01994291|2135354|P1|COMPLETED|Overall Study||84
882588|NCT01994291|2135352|P3|Received Treatment|Overall Study||56
882589|NCT01994291|2135353|P2|Received Treatment|Overall Study||43
882590|NCT01994291|2135354|P1|Received Treatment|Overall Study||99
882591|NCT01994291|2135352|P3|STARTED|Overall Study||56
882592|NCT01994291|2135353|P2|STARTED|Overall Study||43
882593|NCT01994291|2135354|P1|STARTED|Overall Study||99
882594|NCT01993940|2135410|P2|NOT COMPLETED|Overall Study||44
882595|NCT01993940|2135411|P1|NOT COMPLETED|Overall Study||40
882596|NCT01993940|2135410|P2|COMPLETED|Overall Study||232
882597|NCT01993940|2135411|P1|COMPLETED|Overall Study||237
882598|NCT01993940|2135410|P2|Received Treatment|Overall Study||276
882599|NCT01993940|2135411|P1|Received Treatment|Overall Study||272
882600|NCT01993940|2135410|P2|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|276
882601|NCT01993940|2135411|P1|STARTED|Overall Study|Includes one participant who enrolled at two different sites|277
882602|NCT01993888|2135427|P2|NOT COMPLETED|Overall Study||3
882603|NCT01993888|2135428|P1|NOT COMPLETED|Overall Study||2
882604|NCT01993888|2135427|P2|COMPLETED|Overall Study||49
882605|NCT01993888|2135428|P1|COMPLETED|Overall Study||48
882606|NCT01993888|2135427|P2|STARTED|Overall Study||52
882607|NCT01993888|2135428|P1|STARTED|Overall Study||50
882608|NCT01993823|2135446|P2|NOT COMPLETED|Overall Study||16
882609|NCT01993823|2135447|P1|NOT COMPLETED|Overall Study||7
882610|NCT01993823|2135446|P2|COMPLETED|Overall Study||79
882611|NCT01993823|2135447|P1|COMPLETED|Overall Study||88
882612|NCT01993823|2135446|P2|STARTED|Overall Study||95
882613|NCT01993823|2135447|P1|STARTED|Overall Study||95
882614|NCT01993238|2135455|P1|NOT COMPLETED|Overall Study||0
882615|NCT01993238|2135455|P1|COMPLETED|Overall Study||11
882616|NCT01993238|2135455|P1|STARTED|Overall Study||11
882617|NCT01993030|2135462|P2|NOT COMPLETED|Overall Study||4
882618|NCT01993030|2135463|P1|NOT COMPLETED|Overall Study||0
882619|NCT01993030|2135462|P2|COMPLETED|Overall Study||31
882620|NCT01993030|2135463|P1|COMPLETED|Overall Study||36
882621|NCT01993030|2135462|P2|STARTED|Overall Study||35
882622|NCT01993030|2135463|P1|STARTED|Overall Study||36
882623|NCT01992874|2135477|P3|NOT COMPLETED|Part B||0
882624|NCT01992874|2135478|P2|NOT COMPLETED|Part B||0
882625|NCT01992874|2135479|P1|NOT COMPLETED|Part B||0
882626|NCT01992874|2135477|P3|COMPLETED|Part B||38
882627|NCT01992874|2135478|P2|COMPLETED|Part B||0
882628|NCT01992874|2135479|P1|COMPLETED|Part B||0
882629|NCT01992874|2135477|P3|STARTED|Part B||38
882630|NCT01992874|2135478|P2|STARTED|Part B||0
882631|NCT01992874|2135479|P1|STARTED|Part B||0
882632|NCT01992874|2135477|P3|NOT COMPLETED|Part A||0
882633|NCT01992874|2135478|P2|NOT COMPLETED|Part A||0
882634|NCT01992874|2135479|P1|NOT COMPLETED|Part A||0
882635|NCT01992874|2135477|P3|COMPLETED|Part A||0
882636|NCT01992874|2135478|P2|COMPLETED|Part A||17
882637|NCT01992874|2135479|P1|COMPLETED|Part A||21
882638|NCT01992874|2135477|P3|STARTED|Part A||0
882639|NCT01992874|2135478|P2|STARTED|Part A||17
882640|NCT01992874|2135479|P1|STARTED|Part A||21
882641|NCT01992536|2135517|P10|NOT COMPLETED|Overall Study||1
882642|NCT01992536|2135518|P9|NOT COMPLETED|Overall Study||1
882643|NCT01992536|2135519|P8|NOT COMPLETED|Overall Study||0
882644|NCT01992536|2135520|P7|NOT COMPLETED|Overall Study||7
882645|NCT01992536|2135521|P6|NOT COMPLETED|Overall Study||1
882646|NCT01992536|2135522|P5|NOT COMPLETED|Overall Study||0
882647|NCT01992536|2135523|P4|NOT COMPLETED|Overall Study||2
882648|NCT01992536|2135524|P3|NOT COMPLETED|Overall Study||1
882649|NCT01992536|2135525|P2|NOT COMPLETED|Overall Study||3
882650|NCT01992536|2135526|P1|NOT COMPLETED|Overall Study||4
882651|NCT01992536|2135517|P10|COMPLETED|Overall Study||18
882652|NCT01992536|2135518|P9|COMPLETED|Overall Study||18
882653|NCT01992536|2135519|P8|COMPLETED|Overall Study||21
882654|NCT01992536|2135520|P7|COMPLETED|Overall Study||0
882655|NCT01992536|2135521|P6|COMPLETED|Overall Study||20
882656|NCT01992536|2135522|P5|COMPLETED|Overall Study||11
882657|NCT01992536|2135523|P4|COMPLETED|Overall Study||22
882658|NCT01992536|2135524|P3|COMPLETED|Overall Study||16
882659|NCT01992536|2135525|P2|COMPLETED|Overall Study||22
882660|NCT01992536|2135526|P1|COMPLETED|Overall Study||22
882661|NCT01992536|2135517|P10|STARTED|Overall Study||19
882662|NCT01992536|2135518|P9|STARTED|Overall Study||19
882663|NCT01992536|2135519|P8|STARTED|Overall Study||21
882664|NCT01992536|2135520|P7|STARTED|Overall Study||7
882665|NCT01992536|2135521|P6|STARTED|Overall Study||21
882666|NCT01992536|2135522|P5|STARTED|Overall Study||11
882667|NCT01992536|2135523|P4|STARTED|Overall Study||24
882668|NCT01992536|2135524|P3|STARTED|Overall Study||17
882669|NCT01992536|2135525|P2|STARTED|Overall Study||25
882670|NCT01992536|2135526|P1|STARTED|Overall Study||26
882671|NCT01992523|2135743|P2|NOT COMPLETED|Overall Study||0
882672|NCT01992523|2135744|P1|NOT COMPLETED|Overall Study||0
882673|NCT01992523|2135743|P2|COMPLETED|Overall Study||41
882674|NCT01992523|2135744|P1|COMPLETED|Overall Study||41
882675|NCT01992523|2135743|P2|STARTED|Overall Study||41
882676|NCT01992523|2135744|P1|STARTED|Overall Study||41
882677|NCT01992185|2135758|P2|NOT COMPLETED|Overall Study||0
882678|NCT01992185|2135759|P1|NOT COMPLETED|Overall Study||0
882679|NCT01992185|2135758|P2|COMPLETED|Overall Study||8
882680|NCT01992185|2135759|P1|COMPLETED|Overall Study||7
882681|NCT01992185|2135758|P2|STARTED|Overall Study||8
882682|NCT01992185|2135759|P1|STARTED|Overall Study||7
882683|NCT01992172|2135767|P2|NOT COMPLETED|Overall Study||0
882684|NCT01992172|2135768|P1|NOT COMPLETED|Overall Study||0
882685|NCT01992172|2135767|P2|COMPLETED|Overall Study||0
882686|NCT01992172|2135768|P1|COMPLETED|Overall Study||7
882687|NCT01992172|2135767|P2|STARTED|Overall Study||0
882688|NCT01992172|2135768|P1|STARTED|Overall Study||7
882689|NCT01992107|2135777|P3|NOT COMPLETED|Overall Study||36
882690|NCT01992107|2135778|P2|NOT COMPLETED|Overall Study||33
882691|NCT01992107|2135779|P1|NOT COMPLETED|Overall Study||68
882692|NCT01992107|2135777|P3|COMPLETED|Overall Study||545
882693|NCT01992107|2135778|P2|COMPLETED|Overall Study||560
882694|NCT01992107|2135779|P1|COMPLETED|Overall Study||1091
882695|NCT01992107|2135777|P3|STARTED|Overall Study||581
882696|NCT01992107|2135778|P2|STARTED|Overall Study||593
882697|NCT01992107|2135779|P1|STARTED|Overall Study||1159
882698|NCT01992094|2135835|P3|NOT COMPLETED|Overall Study||21
882699|NCT01992094|2135836|P2|NOT COMPLETED|Overall Study||24
882700|NCT01992094|2135837|P1|NOT COMPLETED|Overall Study||50
882701|NCT01992094|2135835|P3|COMPLETED|Overall Study||648
882702|NCT01992094|2135836|P2|COMPLETED|Overall Study||652
882703|NCT01992094|2135837|P1|COMPLETED|Overall Study||1285
882704|NCT01992094|2135835|P3|STARTED|Overall Study||669
882705|NCT01992094|2135836|P2|STARTED|Overall Study||676
882706|NCT01992094|2135837|P1|STARTED|Overall Study||1335
882707|NCT01991990|2135895|P2|NOT COMPLETED|Overall Study||0
882708|NCT01991990|2135896|P1|NOT COMPLETED|Overall Study||0
882709|NCT01991990|2135895|P2|COMPLETED|Overall Study||12
882710|NCT01991990|2135896|P1|COMPLETED|Overall Study||6
882711|NCT01991990|2135895|P2|STARTED|Overall Study||12
882712|NCT01991990|2135896|P1|STARTED|Overall Study||6
882713|NCT01991548|2135936|P1|NOT COMPLETED|Overall Study||1
882714|NCT01991548|2135936|P1|COMPLETED|Overall Study||39
882715|NCT01991548|2135936|P1|STARTED|Overall Study||40
882716|NCT01991314|2135942|P2|NOT COMPLETED|Overall Study||11
882717|NCT01991314|2135943|P1|NOT COMPLETED|Overall Study||11
882718|NCT01991314|2135942|P2|COMPLETED|Overall Study||32
882719|NCT01991314|2135943|P1|COMPLETED|Overall Study||34
882720|NCT01991314|2135942|P2|STARTED|Overall Study||43
882721|NCT01991314|2135943|P1|STARTED|Overall Study||45
882722|NCT01990898|2135961|P1|NOT COMPLETED|Overall Study||4
882723|NCT01990898|2135961|P1|COMPLETED|Overall Study||22
882724|NCT01990898|2135961|P1|3 Months|Overall Study||22
882725|NCT01990898|2135961|P1|STARTED|Overall Study||26
882726|NCT01990859|2135965|P1|NOT COMPLETED|90 Day Follow Up for All Participants||0
882727|NCT01990859|2135965|P1|COMPLETED|90 Day Follow Up for All Participants||20
882728|NCT01990859|2135965|P1|STARTED|90 Day Follow Up for All Participants|All entered into 90 day follow-up whether treatment and/or post dose follow up was completed or not.|20
882729|NCT01990859|2135965|P1|NOT COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||17
882730|NCT01990859|2135965|P1|COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||3
882731|NCT01990859|2135965|P1|STARTED|Week 12 to Week 24 Post Dosing Follow Up|All were entered into follow-up whether dosing was completed or not.|20
882732|NCT01990859|2135965|P1|NOT COMPLETED|Treatment (4 Doses Over 12 Weeks)||5
882733|NCT01990859|2135965|P1|COMPLETED|Treatment (4 Doses Over 12 Weeks)||15
882734|NCT01990859|2135965|P1|STARTED|Treatment (4 Doses Over 12 Weeks)||20
882735|NCT01990794|2135976|P1|NOT COMPLETED|Overall Study||3
882736|NCT01990794|2135976|P1|COMPLETED|Overall Study||10
882737|NCT01990794|2135976|P1|One Month Into Study|Overall Study||10
882738|NCT01990794|2135976|P1|STARTED|Overall Study||13
882739|NCT01990703|2136090|P2|NOT COMPLETED|Overall Study||45
882740|NCT01990703|2136091|P1|NOT COMPLETED|Overall Study||39
882741|NCT01990703|2136090|P2|COMPLETED|Overall Study||93
882742|NCT01990703|2136091|P1|COMPLETED|Overall Study||108
882743|NCT01990703|2136090|P2|STARTED|Overall Study||138
882744|NCT01990703|2136091|P1|STARTED|Overall Study||147
882745|NCT01990677|2136101|P2|NOT COMPLETED|Overall Study||1
882746|NCT01990677|2136102|P1|NOT COMPLETED|Overall Study||2
882747|NCT01990677|2136101|P2|COMPLETED|Overall Study||5
882748|NCT01990677|2136102|P1|COMPLETED|Overall Study||10
882749|NCT01990677|2136101|P2|STARTED|Overall Study||6
882750|NCT01990677|2136102|P1|STARTED|Overall Study||12
882751|NCT01990664|2136114|P2|NOT COMPLETED|Overall Study||11
882752|NCT01990664|2136115|P1|NOT COMPLETED|Overall Study||7
882753|NCT01990664|2136114|P2|COMPLETED|Overall Study||79
882754|NCT01990664|2136115|P1|COMPLETED|Overall Study||95
882755|NCT01990664|2136114|P2|STARTED|Overall Study||90
882756|NCT01990664|2136115|P1|STARTED|Overall Study||102
882757|NCT01990534|2136121|P1|NOT COMPLETED|Overall Study||60
882758|NCT01990534|2136121|P1|COMPLETED|Overall Study||0
882759|NCT01990534|2136121|P1|Ongoing|Overall Study||36
882760|NCT01990534|2136121|P1|STARTED|Overall Study||60
882761|NCT01990339|2136137|P1|NOT COMPLETED|Overall Study||2312
882762|NCT01990339|2136137|P1|COMPLETED|Overall Study||12653
882763|NCT01990339|2136137|P1|STARTED|Overall Study||14965
882764|NCT01990261|2136142|P1|NOT COMPLETED|Overall Study||25
882765|NCT01990261|2136142|P1|COMPLETED|Overall Study||8
882766|NCT01990261|2136142|P1|Treated|Overall Study||29
882767|NCT01990261|2136142|P1|STARTED|Overall Study||33
882768|NCT01989689|2136154|P2|NOT COMPLETED|Treatment Period ( 3 Months)||0
882769|NCT01989689|2136155|P1|NOT COMPLETED|Treatment Period ( 3 Months)||0
882770|NCT01989689|2136154|P2|COMPLETED|Treatment Period ( 3 Months)||10
882771|NCT01989689|2136155|P1|COMPLETED|Treatment Period ( 3 Months)||11
882772|NCT01989689|2136154|P2|STARTED|Treatment Period ( 3 Months)||10
882773|NCT01989689|2136155|P1|STARTED|Treatment Period ( 3 Months)||11
882774|NCT01989689|2136154|P2|NOT COMPLETED|Treatment Period 1 ( 3 Months)||3
882775|NCT01989689|2136155|P1|NOT COMPLETED|Treatment Period 1 ( 3 Months)||0
882776|NCT01989689|2136154|P2|COMPLETED|Treatment Period 1 ( 3 Months)||10
882777|NCT01989689|2136155|P1|COMPLETED|Treatment Period 1 ( 3 Months)||11
882778|NCT01989689|2136154|P2|STARTED|Treatment Period 1 ( 3 Months)||13
882779|NCT01989689|2136155|P1|STARTED|Treatment Period 1 ( 3 Months)||11
882780|NCT01989689|2136154|P2|NOT COMPLETED|Baseline||0
882781|NCT01989689|2136155|P1|NOT COMPLETED|Baseline||0
882782|NCT01989689|2136154|P2|COMPLETED|Baseline||13
882783|NCT01989689|2136155|P1|COMPLETED|Baseline||11
882784|NCT01989689|2136154|P2|STARTED|Baseline||13
882785|NCT01989689|2136155|P1|STARTED|Baseline||11
882786|NCT01989572|2136171|P6|NOT COMPLETED|Overall Study||110
882787|NCT01989572|2136172|P5|NOT COMPLETED|Overall Study||98
882788|NCT01989572|2136173|P4|NOT COMPLETED|Overall Study||51
882789|NCT01989572|2136174|P3|NOT COMPLETED|Overall Study||62
882790|NCT01989572|2136175|P2|NOT COMPLETED|Overall Study||58
882791|NCT01989572|2136176|P1|NOT COMPLETED|Overall Study||55
882792|NCT01989572|2136171|P6|COMPLETED|Overall Study||79
882793|NCT01989572|2136172|P5|COMPLETED|Overall Study||92
882794|NCT01989572|2136173|P4|COMPLETED|Overall Study||56
882795|NCT01989572|2136174|P3|COMPLETED|Overall Study||47
882796|NCT01989572|2136175|P2|COMPLETED|Overall Study||53
882797|NCT01989572|2136176|P1|COMPLETED|Overall Study||54
882798|NCT01989572|2136171|P6|Treated|Overall Study||171
882799|NCT01989572|2136172|P5|Treated|Overall Study||186
882800|NCT01989572|2136173|P4|Treated|Overall Study||104
882801|NCT01989572|2136174|P3|Treated|Overall Study||107
882802|NCT01989572|2136175|P2|Treated|Overall Study||110
882803|NCT01989572|2136176|P1|Treated|Overall Study||104
882804|NCT01989572|2136171|P6|STARTED|Overall Study||189
882805|NCT01989572|2136172|P5|STARTED|Overall Study||190
882806|NCT01989572|2136173|P4|STARTED|Overall Study||107
882807|NCT01989572|2136174|P3|STARTED|Overall Study||109
882808|NCT01989572|2136175|P2|STARTED|Overall Study||111
882809|NCT01989572|2136176|P1|STARTED|Overall Study||109
882810|NCT01989455|2136209|P5|NOT COMPLETED|Overall Study||1
882811|NCT01989455|2136210|P4|NOT COMPLETED|Overall Study||0
882812|NCT01989455|2136211|P3|NOT COMPLETED|Overall Study||1
882813|NCT01989455|2136212|P2|NOT COMPLETED|Overall Study||2
882814|NCT01989455|2136213|P1|NOT COMPLETED|Overall Study||0
882815|NCT01989455|2136209|P5|COMPLETED|Overall Study||7
882816|NCT01989455|2136210|P4|COMPLETED|Overall Study||14
882817|NCT01989455|2136211|P3|COMPLETED|Overall Study||13
882818|NCT01989455|2136212|P2|COMPLETED|Overall Study||12
882819|NCT01989455|2136213|P1|COMPLETED|Overall Study||14
882820|NCT01989455|2136209|P5|STARTED|Overall Study||8
882821|NCT01989455|2136210|P4|STARTED|Overall Study||14
882822|NCT01989455|2136211|P3|STARTED|Overall Study||14
882823|NCT01989455|2136212|P2|STARTED|Overall Study||14
882824|NCT01989455|2136213|P1|STARTED|Overall Study||14
882825|NCT01989195|2136247|P1|NOT COMPLETED|Overall Study||0
882826|NCT01989195|2136247|P1|COMPLETED|Overall Study||6
882827|NCT01989195|2136247|P1|STARTED|Overall Study||6
882828|NCT01989169|2136257|P2|NOT COMPLETED|Period 2||1
882829|NCT01989169|2136258|P1|NOT COMPLETED|Period 2||0
882830|NCT01989169|2136257|P2|COMPLETED|Period 2||14
882831|NCT01989169|2136258|P1|COMPLETED|Period 2||15
882832|NCT01989169|2136257|P2|STARTED|Period 2||15
882833|NCT01989169|2136258|P1|STARTED|Period 2||15
882834|NCT01989169|2136257|P2|NOT COMPLETED|Period 1||0
882835|NCT01989169|2136258|P1|NOT COMPLETED|Period 1||0
882836|NCT01989169|2136257|P2|COMPLETED|Period 1||15
882837|NCT01989169|2136258|P1|COMPLETED|Period 1||15
882838|NCT01989169|2136257|P2|STARTED|Period 1||15
882839|NCT01989169|2136258|P1|STARTED|Period 1||15
882858|NCT01989130|2136295|P2|NOT COMPLETED|Overall Study||0
882859|NCT01989130|2136296|P1|NOT COMPLETED|Overall Study||0
882860|NCT01989130|2136295|P2|COMPLETED|Overall Study||27
882861|NCT01989130|2136296|P1|COMPLETED|Overall Study||43
882862|NCT01989130|2136295|P2|STARTED|Overall Study||27
882863|NCT01989130|2136296|P1|STARTED|Overall Study||43
882864|NCT01988857|2136308|P1|NOT COMPLETED|Overall Study||0
882865|NCT01988857|2136308|P1|COMPLETED|Overall Study||300
882866|NCT01988857|2136308|P1|STARTED|Overall Study||300
882867|NCT01988662|2136317|P2|NOT COMPLETED|Overall Study||2
882868|NCT01988662|2136318|P1|NOT COMPLETED|Overall Study||4
882869|NCT01988662|2136317|P2|COMPLETED|Overall Study||99
882870|NCT01988662|2136318|P1|COMPLETED|Overall Study||100
882871|NCT01988662|2136317|P2|STARTED|Overall Study||101
882872|NCT01988662|2136318|P1|STARTED|Overall Study||104
882873|NCT01988415|2136335|P1|NOT COMPLETED|Overall Study||0
882874|NCT01988415|2136335|P1|COMPLETED|Overall Study||26
882875|NCT01988415|2136335|P1|STARTED|Overall Study|52 eyes of 26 subjects (paired-eyes: commercial and investigational software)|26
882876|NCT01988402|2136345|P2|NOT COMPLETED|Overall Study||2
882877|NCT01988402|2136346|P1|NOT COMPLETED|Overall Study||2
882878|NCT01988402|2136345|P2|COMPLETED|Overall Study||17
882879|NCT01988402|2136346|P1|COMPLETED|Overall Study||14
882880|NCT01988402|2136345|P2|STARTED|Overall Study||19
882881|NCT01988402|2136346|P1|STARTED|Overall Study||16
882882|NCT01988129|2136356|P2|NOT COMPLETED|Overall Study||0
882883|NCT01988129|2136357|P1|NOT COMPLETED|Overall Study||0
882884|NCT01988129|2136356|P2|COMPLETED|Overall Study||588
882885|NCT01988129|2136357|P1|COMPLETED|Overall Study||601
882886|NCT01988129|2136356|P2|Completed 1-year Follow-up Survey|Overall Study||4
882887|NCT01988129|2136357|P1|Completed 1-year Follow-up Survey|Overall Study||100
882888|NCT01988129|2136356|P2|Screened for Sleep Disorders|Overall Study||15
882889|NCT01988129|2136357|P1|Screened for Sleep Disorders|Overall Study||416
882890|NCT01988129|2136356|P2|Attended Education Session|Overall Study||18
882891|NCT01988129|2136357|P1|Attended Education Session|Overall Study||542
882892|NCT01988129|2136356|P2|STARTED|Overall Study|Control participant data obtained from department. Individuals were not enrolled.|588
882893|NCT01988129|2136357|P1|STARTED|Overall Study|Intervention participant data obtained from department. Individuals not enrolled for primary aim.|601
882894|NCT01988012|2136384|P1|NOT COMPLETED|Overall Study||15
882895|NCT01988012|2136384|P1|COMPLETED|Overall Study||85
882896|NCT01988012|2136384|P1|STARTED|Overall Study||100
882897|NCT01987986|2136410|P4|NOT COMPLETED|Overall Study||0
882898|NCT01987986|2136411|P3|NOT COMPLETED|Overall Study||2
882899|NCT01987986|2136412|P2|NOT COMPLETED|Overall Study||0
882900|NCT01987986|2136413|P1|NOT COMPLETED|Overall Study||2
882901|NCT01987986|2136410|P4|COMPLETED|Overall Study||24
882902|NCT01987986|2136411|P3|COMPLETED|Overall Study||38
882903|NCT01987986|2136412|P2|COMPLETED|Overall Study||43
882904|NCT01987986|2136413|P1|COMPLETED|Overall Study||41
882905|NCT01987986|2136410|P4|STARTED|Overall Study||24
882906|NCT01987986|2136411|P3|STARTED|Overall Study||40
882907|NCT01987986|2136412|P2|STARTED|Overall Study||43
882908|NCT01987986|2136413|P1|STARTED|Overall Study||43
882909|NCT01987960|2136453|P4|NOT COMPLETED|Period 3||71
882910|NCT01987960|2136454|P3|NOT COMPLETED|Period 3||0
882911|NCT01987960|2136455|P2|NOT COMPLETED|Period 3||0
882912|NCT01987960|2136456|P1|NOT COMPLETED|Period 3||0
882913|NCT01987960|2136453|P4|COMPLETED|Period 3||119
882914|NCT01987960|2136454|P3|COMPLETED|Period 3||0
882915|NCT01987960|2136455|P2|COMPLETED|Period 3||0
882916|NCT01987960|2136456|P1|COMPLETED|Period 3||0
882917|NCT01987960|2136453|P4|STARTED|Period 3||190
882918|NCT01987960|2136454|P3|STARTED|Period 3||0
882919|NCT01987960|2136455|P2|STARTED|Period 3||0
882920|NCT01987960|2136456|P1|STARTED|Period 3||0
882921|NCT01987960|2136453|P4|NOT COMPLETED|Period 2||0
882922|NCT01987960|2136454|P3|NOT COMPLETED|Period 2||9
882923|NCT01987960|2136455|P2|NOT COMPLETED|Period 2||5
882924|NCT01987960|2136456|P1|NOT COMPLETED|Period 2||0
882925|NCT01987960|2136453|P4|COMPLETED|Period 2||0
882926|NCT01987960|2136454|P3|COMPLETED|Period 2||14
882927|NCT01987960|2136455|P2|COMPLETED|Period 2||12
882928|NCT01987960|2136456|P1|COMPLETED|Period 2||0
882929|NCT01987960|2136453|P4|STARTED|Period 2||0
882930|NCT01987960|2136454|P3|STARTED|Period 2||23
882931|NCT01987960|2136455|P2|STARTED|Period 2||17
882932|NCT01987960|2136456|P1|STARTED|Period 2||0
882933|NCT01987960|2136453|P4|NOT COMPLETED|Period 1||0
882934|NCT01987960|2136454|P3|NOT COMPLETED|Period 1||0
882935|NCT01987960|2136455|P2|NOT COMPLETED|Period 1||0
882936|NCT01987960|2136456|P1|NOT COMPLETED|Period 1||186
882937|NCT01987960|2136453|P4|COMPLETED|Period 1||0
882938|NCT01987960|2136454|P3|COMPLETED|Period 1||0
882939|NCT01987960|2136455|P2|COMPLETED|Period 1||0
882940|NCT01987960|2136456|P1|COMPLETED|Period 1||231
882941|NCT01987960|2136453|P4|STARTED|Period 1||0
882942|NCT01987960|2136454|P3|STARTED|Period 1||0
882943|NCT01987960|2136455|P2|STARTED|Period 1||0
882944|NCT01987960|2136456|P1|STARTED|Period 1||417
882972|NCT01987765|2136551|P1|NOT COMPLETED|Overall Study||102
882973|NCT01987765|2136551|P1|COMPLETED|Overall Study||745
882974|NCT01987765|2136551|P1|STARTED|Overall Study||847
882975|NCT01987752|2136556|P1|NOT COMPLETED|Overall Study||0
882976|NCT01987752|2136556|P1|COMPLETED|Overall Study||732
882977|NCT01987752|2136556|P1|STARTED|Overall Study||732
882978|NCT01987583|2136563|P2|NOT COMPLETED|Overall Study||2
882979|NCT01987583|2136564|P1|NOT COMPLETED|Overall Study||3
882980|NCT01987583|2136563|P2|COMPLETED|Overall Study||38
882981|NCT01987583|2136564|P1|COMPLETED|Overall Study||37
882982|NCT01987583|2136563|P2|STARTED|Overall Study||40
882983|NCT01987583|2136564|P1|STARTED|Overall Study||40
882984|NCT01987557|2136575|P3|NOT COMPLETED|Overall Study||3
882985|NCT01987557|2136576|P2|NOT COMPLETED|Overall Study||3
882986|NCT01987557|2136577|P1|NOT COMPLETED|Overall Study||3
882987|NCT01987557|2136575|P3|COMPLETED|Overall Study||13
882988|NCT01987557|2136576|P2|COMPLETED|Overall Study||13
882989|NCT01987557|2136577|P1|COMPLETED|Overall Study||13
882990|NCT01987557|2136575|P3|STARTED|Overall Study||16
882991|NCT01987557|2136576|P2|STARTED|Overall Study||16
882992|NCT01987557|2136577|P1|STARTED|Overall Study||16
882993|NCT01987479|2136585|P1|NOT COMPLETED|Overall Study||17
882994|NCT01987479|2136585|P1|COMPLETED|Overall Study||133
882995|NCT01987479|2136585|P1|STARTED|Overall Study||150
882996|NCT01987453|2136613|P3|NOT COMPLETED|Overall Study||1
882997|NCT01987453|2136614|P2|NOT COMPLETED|Overall Study||12
882998|NCT01987453|2136615|P1|NOT COMPLETED|Overall Study||1
882999|NCT01987453|2136613|P3|COMPLETED|Overall Study||7
883000|NCT01987453|2136614|P2|COMPLETED|Overall Study||29
883001|NCT01987453|2136615|P1|COMPLETED|Overall Study||50
883002|NCT01987453|2136613|P3|STARTED|Overall Study||8
883003|NCT01987453|2136614|P2|STARTED|Overall Study||41
883004|NCT01987453|2136615|P1|STARTED|Overall Study||51
883005|NCT01987349|2136646|P8|NOT COMPLETED|Overall Study||1
883006|NCT01987349|2136647|P7|NOT COMPLETED|Overall Study||0
883007|NCT01987349|2136648|P6|NOT COMPLETED|Overall Study||0
883008|NCT01987349|2136649|P5|NOT COMPLETED|Overall Study||0
883009|NCT01987349|2136650|P4|NOT COMPLETED|Overall Study||0
883010|NCT01987349|2136651|P3|NOT COMPLETED|Overall Study||0
883011|NCT01987349|2136652|P2|NOT COMPLETED|Overall Study||0
883012|NCT01987349|2136653|P1|NOT COMPLETED|Overall Study||0
883013|NCT01987349|2136646|P8|COMPLETED|Overall Study||24
883014|NCT01987349|2136647|P7|COMPLETED|Overall Study||10
883015|NCT01987349|2136648|P6|COMPLETED|Overall Study||6
883016|NCT01987349|2136649|P5|COMPLETED|Overall Study||6
883017|NCT01987349|2136650|P4|COMPLETED|Overall Study||6
883018|NCT01987349|2136651|P3|COMPLETED|Overall Study||8
883019|NCT01987349|2136652|P2|COMPLETED|Overall Study||6
883020|NCT01987349|2136653|P1|COMPLETED|Overall Study||6
883021|NCT01987349|2136646|P8|STARTED|Overall Study||25
883022|NCT01987349|2136647|P7|STARTED|Overall Study||10
883023|NCT01987349|2136648|P6|STARTED|Overall Study||6
883024|NCT01987349|2136649|P5|STARTED|Overall Study||6
883025|NCT01987349|2136650|P4|STARTED|Overall Study||6
883026|NCT01987349|2136651|P3|STARTED|Overall Study||8
883027|NCT01987349|2136652|P2|STARTED|Overall Study||6
883028|NCT01987349|2136653|P1|STARTED|Overall Study||6
883029|NCT01987232|2136684|P5|NOT COMPLETED|Overall Study||0
883030|NCT01987232|2136685|P4|NOT COMPLETED|Overall Study||1
883031|NCT01987232|2136686|P3|NOT COMPLETED|Overall Study||0
883032|NCT01987232|2136687|P2|NOT COMPLETED|Overall Study||0
883033|NCT01987232|2136688|P1|NOT COMPLETED|Overall Study||0
883034|NCT01987232|2136684|P5|COMPLETED|Overall Study||6
883035|NCT01987232|2136685|P4|COMPLETED|Overall Study||14
883036|NCT01987232|2136686|P3|COMPLETED|Overall Study||3
883037|NCT01987232|2136687|P2|COMPLETED|Overall Study||3
883038|NCT01987232|2136688|P1|COMPLETED|Overall Study||5
883039|NCT01987232|2136684|P5|STARTED|Overall Study||6
883040|NCT01987232|2136685|P4|STARTED|Overall Study||15
883041|NCT01987232|2136686|P3|STARTED|Overall Study||3
883042|NCT01987232|2136687|P2|STARTED|Overall Study||3
883043|NCT01987232|2136688|P1|STARTED|Overall Study||5
883044|NCT01987219|2136753|P6|NOT COMPLETED|Overall Study||0
883045|NCT01987219|2136754|P5|NOT COMPLETED|Overall Study||0
883046|NCT01987219|2136755|P4|NOT COMPLETED|Overall Study||0
883047|NCT01987219|2136756|P3|NOT COMPLETED|Overall Study||1
883048|NCT01987219|2136757|P2|NOT COMPLETED|Overall Study||0
883049|NCT01987219|2136758|P1|NOT COMPLETED|Overall Study||0
883050|NCT01987219|2136753|P6|COMPLETED|Overall Study||1
883051|NCT01987219|2136754|P5|COMPLETED|Overall Study||1
883052|NCT01987219|2136755|P4|COMPLETED|Overall Study||2
883053|NCT01987219|2136756|P3|COMPLETED|Overall Study||6
883054|NCT01987219|2136757|P2|COMPLETED|Overall Study||2
883055|NCT01987219|2136758|P1|COMPLETED|Overall Study||2
883056|NCT01987219|2136753|P6|STARTED|Overall Study||1
883057|NCT01987219|2136754|P5|STARTED|Overall Study||1
883058|NCT01987219|2136755|P4|STARTED|Overall Study||2
883059|NCT01987219|2136756|P3|STARTED|Overall Study||7
883060|NCT01987219|2136757|P2|STARTED|Overall Study||2
883061|NCT01987219|2136758|P1|STARTED|Overall Study||2
883062|NCT01986985|2136775|P1|NOT COMPLETED|Overall Study||7
883063|NCT01986985|2136775|P1|COMPLETED|Overall Study||51
883064|NCT01986985|2136775|P1|STARTED|Overall Study||58
883065|NCT01986946|2136781|P2|NOT COMPLETED|Overall Study||0
883066|NCT01986946|2136782|P1|NOT COMPLETED|Overall Study||0
883067|NCT01986946|2136781|P2|COMPLETED|Overall Study||9
883068|NCT01986946|2136782|P1|COMPLETED|Overall Study||5
883069|NCT01986946|2136781|P2|STARTED|Overall Study||9
883070|NCT01986946|2136782|P1|STARTED|Overall Study||5
883071|NCT01986855|2136815|P3|NOT COMPLETED|Overall Study||11
883072|NCT01986855|2136816|P2|NOT COMPLETED|Overall Study||14
883073|NCT01986855|2136817|P1|NOT COMPLETED|Overall Study||13
883074|NCT01986855|2136815|P3|COMPLETED|Overall Study||143
883075|NCT01986855|2136816|P2|COMPLETED|Overall Study||142
883076|NCT01986855|2136817|P1|COMPLETED|Overall Study||145
883077|NCT01986855|2136815|P3|Treated|Overall Study||154
883078|NCT01986855|2136816|P2|Treated|Overall Study||155
883079|NCT01986855|2136817|P1|Treated|Overall Study||158
883080|NCT01986855|2136815|P3|STARTED|Overall Study||154
883081|NCT01986855|2136816|P2|STARTED|Overall Study||156
883082|NCT01986855|2136817|P1|STARTED|Overall Study||158
883083|NCT01986790|2136849|P3|NOT COMPLETED|Overall Study||0
883084|NCT01986790|2136850|P2|NOT COMPLETED|Overall Study||0
883085|NCT01986790|2136851|P1|NOT COMPLETED|Overall Study||0
883086|NCT01986790|2136849|P3|COMPLETED|Overall Study||98
883087|NCT01986790|2136850|P2|COMPLETED|Overall Study||154
883088|NCT01986790|2136851|P1|COMPLETED|Overall Study||91
883089|NCT01986790|2136849|P3|STARTED|Overall Study||98
883090|NCT01986790|2136850|P2|STARTED|Overall Study||154
883091|NCT01986790|2136851|P1|STARTED|Overall Study||91
883092|NCT01986751|2136867|P2|NOT COMPLETED|Overall Study||2
883093|NCT01986751|2136868|P1|NOT COMPLETED|Overall Study||10
883094|NCT01986751|2136867|P2|COMPLETED|Overall Study||2
883095|NCT01986751|2136868|P1|COMPLETED|Overall Study||0
883096|NCT01986751|2136867|P2|STARTED|Overall Study||4
883097|NCT01986751|2136868|P1|STARTED|Overall Study||10
883098|NCT01986361|2136890|P2|NOT COMPLETED|Overall Study||0
883099|NCT01986361|2136891|P1|NOT COMPLETED|Overall Study||0
883100|NCT01986361|2136890|P2|COMPLETED|Overall Study||21
883101|NCT01986361|2136891|P1|COMPLETED|Overall Study||101
883102|NCT01986361|2136890|P2|STARTED|Overall Study||21
883103|NCT01986361|2136891|P1|STARTED|Overall Study||101
883104|NCT01986231|2136913|P1|NOT COMPLETED|Overall Study||1
883105|NCT01986231|2136913|P1|COMPLETED|Overall Study||11
883106|NCT01986231|2136913|P1|STARTED|Overall Study||12
883107|NCT01986062|2136920|P2|NOT COMPLETED|Overall Study||1
883108|NCT01986062|2136921|P1|NOT COMPLETED|Overall Study||1
883109|NCT01986062|2136920|P2|COMPLETED|Overall Study||49
883110|NCT01986062|2136921|P1|COMPLETED|Overall Study||46
883111|NCT01986062|2136920|P2|STARTED|Overall Study||50
883112|NCT01986062|2136921|P1|STARTED|Overall Study||47
883113|NCT01985685|2136939|P2|NOT COMPLETED|Overall Study||0
883114|NCT01985685|2136940|P1|NOT COMPLETED|Overall Study||0
883115|NCT01985685|2136939|P2|COMPLETED|Overall Study||29
883116|NCT01985685|2136940|P1|COMPLETED|Overall Study||27
883117|NCT01985685|2136939|P2|STARTED|Overall Study||29
883118|NCT01985685|2136940|P1|STARTED|Overall Study||27
883119|NCT01985581|2136952|P2|NOT COMPLETED|Second Intervention||4
883120|NCT01985581|2136953|P1|NOT COMPLETED|Second Intervention||2
883121|NCT01985581|2136952|P2|COMPLETED|Second Intervention||19
883122|NCT01985581|2136953|P1|COMPLETED|Second Intervention||20
883123|NCT01985581|2136952|P2|STARTED|Second Intervention||23
883124|NCT01985581|2136953|P1|STARTED|Second Intervention||22
883125|NCT01985581|2136952|P2|NOT COMPLETED|First Intervention||2
883126|NCT01985581|2136953|P1|NOT COMPLETED|First Intervention||3
883127|NCT01985581|2136952|P2|COMPLETED|First Intervention||23
883128|NCT01985581|2136953|P1|COMPLETED|First Intervention||22
883129|NCT01985581|2136952|P2|STARTED|First Intervention||25
883130|NCT01985581|2136953|P1|STARTED|First Intervention||25
883131|NCT01985425|2136973|P2|NOT COMPLETED|Overall Study||0
883132|NCT01985425|2136974|P1|NOT COMPLETED|Overall Study||0
883133|NCT01985425|2136973|P2|COMPLETED|Overall Study||51
883134|NCT01985425|2136974|P1|COMPLETED|Overall Study||49
883135|NCT01985425|2136973|P2|STARTED|Overall Study||51
883136|NCT01985425|2136974|P1|STARTED|Overall Study||49
883137|NCT01985321|2136994|P2|NOT COMPLETED|Overall Study||5
883138|NCT01985321|2136995|P1|NOT COMPLETED|Overall Study||11
883139|NCT01985321|2136994|P2|COMPLETED|Overall Study||78
883140|NCT01985321|2136995|P1|COMPLETED|Overall Study||79
883141|NCT01985321|2136994|P2|STARTED|Overall Study|This is treatment eligible subjects only|83
883142|NCT01985321|2136995|P1|STARTED|Overall Study|This is Treatment Eligible Subjects only|90
883143|NCT01985126|2137005|P2|NOT COMPLETED|Overall Study||106
883144|NCT01985126|2137006|P1|NOT COMPLETED|Overall Study||18
883145|NCT01985126|2137005|P2|COMPLETED|Overall Study||0
883146|NCT01985126|2137006|P1|COMPLETED|Overall Study||0
883147|NCT01985126|2137005|P2|STARTED|Overall Study||106
883148|NCT01985126|2137006|P1|STARTED|Overall Study||18
883149|NCT01984697|2137029|P5|NOT COMPLETED|Overall Study||314
883150|NCT01984697|2137030|P4|NOT COMPLETED|Overall Study||301
883151|NCT01984697|2137031|P3|NOT COMPLETED|Overall Study||301
883152|NCT01984697|2137032|P2|NOT COMPLETED|Overall Study||301
883153|NCT01984697|2137033|P1|NOT COMPLETED|Overall Study||301
883154|NCT01984697|2137029|P5|COMPLETED|Overall Study|Follow-up continues for participants not discontinued|0
883155|NCT01984697|2137030|P4|COMPLETED|Overall Study|Follow-up continues for participants not discontinued|0
883156|NCT01984697|2137031|P3|COMPLETED|Overall Study|Follow-up continues for participants not discontinued|0
883157|NCT01984697|2137032|P2|COMPLETED|Overall Study|Follow-up continues for participants not discontinued|0
883158|NCT01984697|2137033|P1|COMPLETED|Overall Study|Follow-up continues for participants not discontinued|0
883159|NCT01984697|2137029|P5|Vaccination 3|Overall Study||311
883160|NCT01984697|2137030|P4|Vaccination 3|Overall Study||293
883161|NCT01984697|2137031|P3|Vaccination 3|Overall Study||0
883162|NCT01984697|2137032|P2|Vaccination 3|Overall Study||0
883163|NCT01984697|2137033|P1|Vaccination 3|Overall Study||0
883164|NCT01984697|2137029|P5|Vaccination 2|Overall Study||313
883165|NCT01984697|2137030|P4|Vaccination 2|Overall Study||298
883166|NCT01984697|2137031|P3|Vaccination 2|Overall Study||291
883167|NCT01984697|2137032|P2|Vaccination 2|Overall Study||296
883168|NCT01984697|2137033|P1|Vaccination 2|Overall Study||293
883169|NCT01984697|2137029|P5|Vaccination 1|Overall Study||314
883170|NCT01984697|2137030|P4|Vaccination 1|Overall Study||300
883171|NCT01984697|2137031|P3|Vaccination 1|Overall Study||300
883172|NCT01984697|2137032|P2|Vaccination 1|Overall Study||301
883173|NCT01984697|2137033|P1|Vaccination 1|Overall Study||301
883174|NCT01984697|2137029|P5|STARTED|Overall Study||314
883175|NCT01984697|2137030|P4|STARTED|Overall Study||301
883176|NCT01984697|2137031|P3|STARTED|Overall Study||301
883177|NCT01984697|2137032|P2|STARTED|Overall Study||301
883178|NCT01984697|2137033|P1|STARTED|Overall Study||301
883179|NCT01984684|2137132|P2|NOT COMPLETED|Overall Study||59
883180|NCT01984684|2137133|P1|NOT COMPLETED|Overall Study||57
883181|NCT01984684|2137132|P2|COMPLETED|Overall Study||368
883182|NCT01984684|2137133|P1|COMPLETED|Overall Study||366
883183|NCT01984684|2137132|P2|STARTED|Overall Study||427
883184|NCT01984684|2137133|P1|STARTED|Overall Study||423
883185|NCT01984515|2137143|P1|NOT COMPLETED|Overall Study||19
883186|NCT01984515|2137143|P1|COMPLETED|Overall Study||40
883187|NCT01984515|2137143|P1|Received CBT Session|Overall Study||40
883188|NCT01984515|2137143|P1|STARTED|Overall Study||59
883189|NCT01984294|2137152|P3|NOT COMPLETED|Overall Study||7
883190|NCT01984294|2137153|P2|NOT COMPLETED|Overall Study||3
883191|NCT01984294|2137154|P1|NOT COMPLETED|Overall Study||4
883192|NCT01984294|2137152|P3|COMPLETED|Overall Study||27
883193|NCT01984294|2137153|P2|COMPLETED|Overall Study||29
883194|NCT01984294|2137154|P1|COMPLETED|Overall Study||31
883195|NCT01984294|2137152|P3|STARTED|Overall Study||34
883196|NCT01984294|2137153|P2|STARTED|Overall Study||32
883197|NCT01984294|2137154|P1|STARTED|Overall Study||35
883198|NCT01984229|2137176|P2|NOT COMPLETED|Safety Follow-up Period||1
883199|NCT01984229|2137177|P1|NOT COMPLETED|Safety Follow-up Period||2
883200|NCT01984229|2137176|P2|COMPLETED|Safety Follow-up Period||16
883201|NCT01984229|2137177|P1|COMPLETED|Safety Follow-up Period||4
883202|NCT01984229|2137176|P2|STARTED|Safety Follow-up Period||17
883203|NCT01984229|2137177|P1|STARTED|Safety Follow-up Period||6
883204|NCT01984229|2137176|P2|NOT COMPLETED|Period 3||0
883205|NCT01984229|2137177|P1|NOT COMPLETED|Period 3||0
883206|NCT01984229|2137176|P2|COMPLETED|Period 3||17
883207|NCT01984229|2137177|P1|COMPLETED|Period 3||6
883208|NCT01984229|2137176|P2|STARTED|Period 3||17
883209|NCT01984229|2137177|P1|STARTED|Period 3||6
883210|NCT01984229|2137176|P2|NOT COMPLETED|Period 2||0
883211|NCT01984229|2137177|P1|NOT COMPLETED|Period 2||0
883212|NCT01984229|2137176|P2|COMPLETED|Period 2||17
883213|NCT01984229|2137177|P1|COMPLETED|Period 2||6
883214|NCT01984229|2137176|P2|STARTED|Period 2||17
883215|NCT01984229|2137177|P1|STARTED|Period 2||6
883216|NCT01984229|2137176|P2|NOT COMPLETED|Period 1||0
883217|NCT01984229|2137177|P1|NOT COMPLETED|Period 1||0
883218|NCT01984229|2137176|P2|COMPLETED|Period 1||17
883219|NCT01984229|2137177|P1|COMPLETED|Period 1||6
883220|NCT01984229|2137176|P2|STARTED|Period 1||17
883221|NCT01984229|2137177|P1|STARTED|Period 1||6
883222|NCT01983878|2137227|P1|NOT COMPLETED|Overall Study||0
883223|NCT01983878|2137227|P1|COMPLETED|Overall Study||36
883224|NCT01983878|2137227|P1|Received At Least One Dose of Study Drug|Overall Study||36
883225|NCT01983878|2137227|P1|STARTED|Overall Study||36
883226|NCT01983839|2137238|P1|NOT COMPLETED|Overall Study||0
883227|NCT01983839|2137238|P1|COMPLETED|Overall Study||18
883228|NCT01983839|2137238|P1|STARTED|Overall Study||18
883229|NCT01983787|2137243|P1|NOT COMPLETED|Overall Study||0
883230|NCT01983787|2137243|P1|COMPLETED|Overall Study||10
883231|NCT01983787|2137243|P1|STARTED|Overall Study||10
883232|NCT01983566|2137270|P4|NOT COMPLETED|Test Period 4||0
883233|NCT01983566|2137271|P3|NOT COMPLETED|Test Period 4||0
883234|NCT01983566|2137272|P2|NOT COMPLETED|Test Period 4||0
883235|NCT01983566|2137273|P1|NOT COMPLETED|Test Period 4||0
883236|NCT01983566|2137270|P4|COMPLETED|Test Period 4||0
883237|NCT01983566|2137271|P3|COMPLETED|Test Period 4||0
883238|NCT01983566|2137272|P2|COMPLETED|Test Period 4||0
883239|NCT01983566|2137273|P1|COMPLETED|Test Period 4||0
883240|NCT01983566|2137270|P4|STARTED|Test Period 4||0
883241|NCT01983566|2137271|P3|STARTED|Test Period 4||0
883242|NCT01983566|2137272|P2|STARTED|Test Period 4||0
883243|NCT01983566|2137273|P1|STARTED|Test Period 4||0
883244|NCT01983566|2137270|P4|NOT COMPLETED|Wash-Out 3||0
883245|NCT01983566|2137271|P3|NOT COMPLETED|Wash-Out 3||0
883246|NCT01983566|2137272|P2|NOT COMPLETED|Wash-Out 3||0
883247|NCT01983566|2137273|P1|NOT COMPLETED|Wash-Out 3||0
883248|NCT01983566|2137270|P4|COMPLETED|Wash-Out 3||0
883249|NCT01983566|2137271|P3|COMPLETED|Wash-Out 3||0
883250|NCT01983566|2137272|P2|COMPLETED|Wash-Out 3||0
883251|NCT01983566|2137273|P1|COMPLETED|Wash-Out 3||0
883252|NCT01983566|2137270|P4|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
883253|NCT01983566|2137271|P3|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
883254|NCT01983566|2137272|P2|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
883255|NCT01983566|2137273|P1|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
883256|NCT01983566|2137270|P4|NOT COMPLETED|Test Period 3||0
883257|NCT01983566|2137271|P3|NOT COMPLETED|Test Period 3||0
883258|NCT01983566|2137272|P2|NOT COMPLETED|Test Period 3||0
883259|NCT01983566|2137273|P1|NOT COMPLETED|Test Period 3||0
883260|NCT01983566|2137270|P4|COMPLETED|Test Period 3||4
883261|NCT01983566|2137271|P3|COMPLETED|Test Period 3||2
883262|NCT01983566|2137272|P2|COMPLETED|Test Period 3||3
883263|NCT01983566|2137273|P1|COMPLETED|Test Period 3||2
883264|NCT01983566|2137270|P4|STARTED|Test Period 3||4
883265|NCT01983566|2137271|P3|STARTED|Test Period 3||2
883266|NCT01983566|2137272|P2|STARTED|Test Period 3||3
883267|NCT01983566|2137273|P1|STARTED|Test Period 3||2
883268|NCT01983566|2137270|P4|NOT COMPLETED|Wash-Out 2||0
883269|NCT01983566|2137271|P3|NOT COMPLETED|Wash-Out 2||0
883270|NCT01983566|2137272|P2|NOT COMPLETED|Wash-Out 2||0
883271|NCT01983566|2137273|P1|NOT COMPLETED|Wash-Out 2||0
883272|NCT01983566|2137270|P4|COMPLETED|Wash-Out 2||4
883273|NCT01983566|2137271|P3|COMPLETED|Wash-Out 2||2
883274|NCT01983566|2137272|P2|COMPLETED|Wash-Out 2||3
883275|NCT01983566|2137273|P1|COMPLETED|Wash-Out 2||2
883276|NCT01983566|2137270|P4|STARTED|Wash-Out 2||4
883277|NCT01983566|2137271|P3|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
883278|NCT01983566|2137272|P2|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|3
883279|NCT01983566|2137273|P1|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
883280|NCT01983566|2137270|P4|NOT COMPLETED|Test Period 2||0
883281|NCT01983566|2137271|P3|NOT COMPLETED|Test Period 2||0
883282|NCT01983566|2137272|P2|NOT COMPLETED|Test Period 2||0
883283|NCT01983566|2137273|P1|NOT COMPLETED|Test Period 2||0
883284|NCT01983566|2137270|P4|COMPLETED|Test Period 2||4
883285|NCT01983566|2137271|P3|COMPLETED|Test Period 2||4
883286|NCT01983566|2137272|P2|COMPLETED|Test Period 2||4
883287|NCT01983566|2137273|P1|COMPLETED|Test Period 2||4
883288|NCT01983566|2137270|P4|STARTED|Test Period 2||4
883289|NCT01983566|2137271|P3|STARTED|Test Period 2||4
883290|NCT01983566|2137272|P2|STARTED|Test Period 2||4
883291|NCT01983566|2137273|P1|STARTED|Test Period 2||4
883292|NCT01983566|2137270|P4|NOT COMPLETED|Wash-Out 1||0
883293|NCT01983566|2137271|P3|NOT COMPLETED|Wash-Out 1||0
883294|NCT01983566|2137272|P2|NOT COMPLETED|Wash-Out 1||0
883295|NCT01983566|2137273|P1|NOT COMPLETED|Wash-Out 1||0
883296|NCT01983566|2137270|P4|COMPLETED|Wash-Out 1||4
883297|NCT01983566|2137271|P3|COMPLETED|Wash-Out 1||4
883298|NCT01983566|2137272|P2|COMPLETED|Wash-Out 1||4
883299|NCT01983566|2137273|P1|COMPLETED|Wash-Out 1||4
883300|NCT01983566|2137270|P4|STARTED|Wash-Out 1||4
883301|NCT01983566|2137271|P3|STARTED|Wash-Out 1||4
883302|NCT01983566|2137272|P2|STARTED|Wash-Out 1||4
883303|NCT01983566|2137273|P1|STARTED|Wash-Out 1||4
883304|NCT01983566|2137270|P4|NOT COMPLETED|Test Period 1||0
883305|NCT01983566|2137271|P3|NOT COMPLETED|Test Period 1||0
883306|NCT01983566|2137272|P2|NOT COMPLETED|Test Period 1||0
883307|NCT01983566|2137273|P1|NOT COMPLETED|Test Period 1||0
883308|NCT01983566|2137270|P4|COMPLETED|Test Period 1||4
883309|NCT01983566|2137271|P3|COMPLETED|Test Period 1||4
883310|NCT01983566|2137272|P2|COMPLETED|Test Period 1||4
883311|NCT01983566|2137273|P1|COMPLETED|Test Period 1||4
883312|NCT01983566|2137270|P4|STARTED|Test Period 1||4
883313|NCT01983566|2137271|P3|STARTED|Test Period 1||4
883314|NCT01983566|2137272|P2|STARTED|Test Period 1||4
883315|NCT01983566|2137273|P1|STARTED|Test Period 1||4
883316|NCT01983254|2137294|P2|NOT COMPLETED|Overall Study||30
883317|NCT01983254|2137295|P1|NOT COMPLETED|Overall Study||34
883318|NCT01983254|2137294|P2|COMPLETED|Overall Study|69 patients, 37 caregivers|106
883319|NCT01983254|2137295|P1|COMPLETED|Overall Study|62 patients, 29 caregivers|91
883320|NCT01983254|2137294|P2|Interview 3|Overall Study|69 patients, 37 caregivers|106
883321|NCT01983254|2137295|P1|Interview 3|Overall Study|62 patients, 29 caregivers|91
883322|NCT01983254|2137294|P2|Interview 2|Overall Study|71 patients, 39 caregivers|110
883323|NCT01983254|2137295|P1|Interview 2|Overall Study|65 patients, 30 caregivers|95
883324|NCT01983254|2137294|P2|Interview 1|Overall Study|89 patients, 47 caregivers|136
883325|NCT01983254|2137295|P1|Interview 1|Overall Study|86 patients, 39 caregivers|125
883326|NCT01983254|2137294|P2|STARTED|Overall Study|89 patients, 47 caregivers|136
883327|NCT01983254|2137295|P1|STARTED|Overall Study|86 patients, 39 caregivers|125
883328|NCT01983111|2137307|P2|NOT COMPLETED|Overall Study||7
883329|NCT01983111|2137308|P1|NOT COMPLETED|Overall Study||12
883330|NCT01983111|2137307|P2|COMPLETED|Overall Study||59
883331|NCT01983111|2137308|P1|COMPLETED|Overall Study||58
883332|NCT01983111|2137307|P2|STARTED|Overall Study||66
883333|NCT01983111|2137308|P1|STARTED|Overall Study||70
883334|NCT01983020|2137328|P4|NOT COMPLETED|Overall Study||0
883335|NCT01983020|2137329|P3|NOT COMPLETED|Overall Study||0
883336|NCT01983020|2137330|P2|NOT COMPLETED|Overall Study||0
883337|NCT01983020|2137331|P1|NOT COMPLETED|Overall Study||0
883338|NCT01983020|2137328|P4|COMPLETED|Overall Study||11
883339|NCT01983020|2137329|P3|COMPLETED|Overall Study||12
883340|NCT01983020|2137330|P2|COMPLETED|Overall Study||11
883341|NCT01983020|2137331|P1|COMPLETED|Overall Study||12
883342|NCT01983020|2137328|P4|STARTED|Overall Study||11
883343|NCT01983020|2137329|P3|STARTED|Overall Study||12
883344|NCT01983020|2137330|P2|STARTED|Overall Study||11
883345|NCT01983020|2137331|P1|STARTED|Overall Study||12
883346|NCT01982812|2137343|P2|NOT COMPLETED|Overall Study||10
883347|NCT01982812|2137344|P1|NOT COMPLETED|Overall Study||1
883348|NCT01982812|2137343|P2|COMPLETED|Overall Study||11
883349|NCT01982812|2137344|P1|COMPLETED|Overall Study||22
883350|NCT01982812|2137343|P2|STARTED|Overall Study||21
883351|NCT01982812|2137344|P1|STARTED|Overall Study||23
883352|NCT01982695|2137358|P2|NOT COMPLETED|Overall Study||1
883353|NCT01982695|2137359|P1|NOT COMPLETED|Overall Study||0
883354|NCT01982695|2137358|P2|COMPLETED|Overall Study||10
883355|NCT01982695|2137359|P1|COMPLETED|Overall Study||12
883356|NCT01982695|2137358|P2|STARTED|Overall Study||11
883357|NCT01982695|2137359|P1|STARTED|Overall Study||12
883358|NCT01982539|2137365|P1|NOT COMPLETED|Overall Study||0
883359|NCT01982539|2137365|P1|COMPLETED|Overall Study||25
883360|NCT01982539|2137365|P1|STARTED|Overall Study||25
883361|NCT01982435|2137371|P2|NOT COMPLETED|Overall Study||0
883362|NCT01982435|2137372|P1|NOT COMPLETED|Overall Study||1
883363|NCT01982435|2137371|P2|COMPLETED|Overall Study||12
883364|NCT01982435|2137372|P1|COMPLETED|Overall Study||14
883365|NCT01982435|2137371|P2|STARTED|Overall Study||12
883366|NCT01982435|2137372|P1|STARTED|Overall Study||15
883367|NCT01982292|2137402|P2|NOT COMPLETED|Overall Study||1
883368|NCT01982292|2137403|P1|NOT COMPLETED|Overall Study||12
883369|NCT01982292|2137402|P2|COMPLETED|Overall Study||107
883370|NCT01982292|2137403|P1|COMPLETED|Overall Study||203
883371|NCT01982292|2137402|P2|Safety Set|Overall Study||108
883372|NCT01982292|2137403|P1|Safety Set|Overall Study||212
883373|NCT01982292|2137402|P2|Full Analaysis Set (FAS)|Overall Study||108
883374|NCT01982292|2137403|P1|Full Analaysis Set (FAS)|Overall Study|FAS excludes mis-randomized patients|213
883375|NCT01982292|2137402|P2|STARTED|Overall Study||108
883376|NCT01982292|2137403|P1|STARTED|Overall Study|"Started indicates Randomized set"|215
883377|NCT01982253|2137424|P3|NOT COMPLETED|Overall Study||4
883378|NCT01982253|2137425|P2|NOT COMPLETED|Overall Study||4
883379|NCT01982253|2137426|P1|NOT COMPLETED|Overall Study||2
883380|NCT01982253|2137424|P3|COMPLETED|Overall Study||0
883381|NCT01982253|2137425|P2|COMPLETED|Overall Study||0
883382|NCT01982253|2137426|P1|COMPLETED|Overall Study||0
883383|NCT01982253|2137424|P3|STARTED|Overall Study||4
883384|NCT01982253|2137425|P2|STARTED|Overall Study||4
883385|NCT01982253|2137426|P1|STARTED|Overall Study||2
883386|NCT01981967|2137439|P2|NOT COMPLETED|Overall Study||0
883387|NCT01981967|2137440|P1|NOT COMPLETED|Overall Study||0
883388|NCT01981967|2137439|P2|COMPLETED|Overall Study||3149
883389|NCT01981967|2137440|P1|COMPLETED|Overall Study||6851
883390|NCT01981967|2137439|P2|STARTED|Overall Study||3149
883391|NCT01981967|2137440|P1|STARTED|Overall Study||6851
883392|NCT01981863|2137452|P2|NOT COMPLETED|Overall Study||0
883393|NCT01981863|2137453|P1|NOT COMPLETED|Overall Study||0
883394|NCT01981863|2137452|P2|COMPLETED|Overall Study||20
883395|NCT01981863|2137453|P1|COMPLETED|Overall Study||20
883396|NCT01981863|2137452|P2|STARTED|Overall Study||20
883397|NCT01981863|2137453|P1|STARTED|Overall Study||20
883398|NCT01981616|2137465|P2|NOT COMPLETED|Overall Study||1
883399|NCT01981616|2137466|P1|NOT COMPLETED|Overall Study||1
883400|NCT01981616|2137465|P2|COMPLETED|Overall Study||62
883401|NCT01981616|2137466|P1|COMPLETED|Overall Study||63
883402|NCT01981616|2137465|P2|STARTED|Overall Study||63
883403|NCT01981616|2137466|P1|STARTED|Overall Study||64
883404|NCT01981473|2137481|P3|NOT COMPLETED|Overall Study||8
883405|NCT01981473|2137482|P2|NOT COMPLETED|Overall Study||0
883406|NCT01981473|2137483|P1|NOT COMPLETED|Overall Study||2
883407|NCT01981473|2137481|P3|COMPLETED|Overall Study||196
883408|NCT01981473|2137482|P2|COMPLETED|Overall Study||199
883409|NCT01981473|2137483|P1|COMPLETED|Overall Study||200
883410|NCT01981473|2137481|P3|STARTED|Overall Study||204
883411|NCT01981473|2137482|P2|STARTED|Overall Study||199
883412|NCT01981473|2137483|P1|STARTED|Overall Study||202
883413|NCT01981356|2137524|P2|NOT COMPLETED|Overall Study||2
883414|NCT01981356|2137525|P1|NOT COMPLETED|Overall Study||7
883415|NCT01981356|2137524|P2|COMPLETED|Overall Study||4
883416|NCT01981356|2137525|P1|COMPLETED|Overall Study||5
883417|NCT01981356|2137524|P2|STARTED|Overall Study||6
883418|NCT01981356|2137525|P1|STARTED|Overall Study||12
883425|NCT01980992|2137561|P2|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||1
883426|NCT01980992|2137562|P1|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||3
883427|NCT01980992|2137561|P2|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
883428|NCT01980992|2137562|P1|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
883429|NCT01980992|2137561|P2|STARTED|52 Weeks Open Label Active Wheat OIT||19
883430|NCT01980992|2137562|P1|STARTED|52 Weeks Open Label Active Wheat OIT||21
883431|NCT01980992|2137561|P2|NOT COMPLETED|52 Weeks Blinded Study Treatment||4
883432|NCT01980992|2137562|P1|NOT COMPLETED|52 Weeks Blinded Study Treatment||2
883433|NCT01980992|2137561|P2|COMPLETED|52 Weeks Blinded Study Treatment||19
883434|NCT01980992|2137562|P1|COMPLETED|52 Weeks Blinded Study Treatment||21
883435|NCT01980992|2137561|P2|STARTED|52 Weeks Blinded Study Treatment||23
883436|NCT01980992|2137562|P1|STARTED|52 Weeks Blinded Study Treatment||23
883437|NCT01980940|2137576|P8|NOT COMPLETED|Overall Study||0
883438|NCT01980940|2137577|P7|NOT COMPLETED|Overall Study||0
883439|NCT01980940|2137578|P6|NOT COMPLETED|Overall Study||2
883440|NCT01980940|2137579|P5|NOT COMPLETED|Overall Study||0
883441|NCT01980940|2137580|P4|NOT COMPLETED|Overall Study||0
883442|NCT01980940|2137581|P3|NOT COMPLETED|Overall Study||0
883443|NCT01980940|2137582|P2|NOT COMPLETED|Overall Study||0
883444|NCT01980940|2137583|P1|NOT COMPLETED|Overall Study||0
883445|NCT01980940|2137576|P8|COMPLETED|Overall Study||24
883446|NCT01980940|2137577|P7|COMPLETED|Overall Study||24
883447|NCT01980940|2137578|P6|COMPLETED|Overall Study||0
883448|NCT01980940|2137579|P5|COMPLETED|Overall Study||2
883449|NCT01980940|2137580|P4|COMPLETED|Overall Study||3
883450|NCT01980940|2137581|P3|COMPLETED|Overall Study||5
883451|NCT01980940|2137582|P2|COMPLETED|Overall Study||5
883452|NCT01980940|2137583|P1|COMPLETED|Overall Study||5
883453|NCT01980940|2137576|P8|Treated|Overall Study||24
883454|NCT01980940|2137577|P7|Treated|Overall Study||24
883455|NCT01980940|2137578|P6|Treated|Overall Study||2
883456|NCT01980940|2137579|P5|Treated|Overall Study||2
883457|NCT01980940|2137580|P4|Treated|Overall Study||3
883458|NCT01980940|2137581|P3|Treated|Overall Study||5
883459|NCT01980940|2137582|P2|Treated|Overall Study||5
883460|NCT01980940|2137583|P1|Treated|Overall Study||5
883461|NCT01980940|2137576|P8|STARTED|Overall Study||24
883462|NCT01980940|2137577|P7|STARTED|Overall Study||24
883463|NCT01980940|2137578|P6|STARTED|Overall Study||2
883464|NCT01980940|2137579|P5|STARTED|Overall Study||2
883465|NCT01980940|2137580|P4|STARTED|Overall Study||3
883466|NCT01980940|2137581|P3|STARTED|Overall Study||5
883467|NCT01980940|2137582|P2|STARTED|Overall Study||5
883468|NCT01980940|2137583|P1|STARTED|Overall Study||5
883469|NCT01980875|2137638|P3|NOT COMPLETED|Overall Study||24
883470|NCT01980875|2137639|P2|NOT COMPLETED|Overall Study||25
883471|NCT01980875|2137640|P1|NOT COMPLETED|Overall Study||8
883472|NCT01980875|2137638|P3|COMPLETED|Overall Study||0
883473|NCT01980875|2137639|P2|COMPLETED|Overall Study||0
883474|NCT01980875|2137640|P1|COMPLETED|Overall Study||0
883475|NCT01980875|2137638|P3|STARTED|Overall Study||24
883476|NCT01980875|2137639|P2|STARTED|Overall Study||25
883477|NCT01980875|2137640|P1|STARTED|Overall Study||8
883478|NCT01980628|2137663|P1|NOT COMPLETED|Overall Study||39
883479|NCT01980628|2137663|P1|COMPLETED|Overall Study|Participants who remain on treatment at Primary Completion.|24
883480|NCT01980628|2137663|P1|STARTED|Overall Study|Total number of patients enrolled to the study and received study treatment|63
883481|NCT01980589|2137671|P3|NOT COMPLETED|Overall Study||0
883482|NCT01980589|2137672|P2|NOT COMPLETED|Overall Study||0
883483|NCT01980589|2137673|P1|NOT COMPLETED|Overall Study||0
883484|NCT01980589|2137671|P3|COMPLETED|Overall Study||16
883485|NCT01980589|2137672|P2|COMPLETED|Overall Study||3
883486|NCT01980589|2137673|P1|COMPLETED|Overall Study||3
883487|NCT01980589|2137671|P3|STARTED|Overall Study||16
883488|NCT01980589|2137672|P2|STARTED|Overall Study||3
883489|NCT01980589|2137673|P1|STARTED|Overall Study||3
883490|NCT01980524|2137690|P2|NOT COMPLETED|Study Day 2||0
883491|NCT01980524|2137691|P1|NOT COMPLETED|Study Day 2||0
883492|NCT01980524|2137690|P2|COMPLETED|Study Day 2||4
883493|NCT01980524|2137691|P1|COMPLETED|Study Day 2||4
883494|NCT01980524|2137690|P2|STARTED|Study Day 2||4
883495|NCT01980524|2137691|P1|STARTED|Study Day 2||4
883496|NCT01980524|2137690|P2|NOT COMPLETED|Washout (at Least 2 Weeks)||0
883497|NCT01980524|2137691|P1|NOT COMPLETED|Washout (at Least 2 Weeks)||0
883498|NCT01980524|2137690|P2|COMPLETED|Washout (at Least 2 Weeks)||4
883499|NCT01980524|2137691|P1|COMPLETED|Washout (at Least 2 Weeks)||4
883500|NCT01980524|2137690|P2|STARTED|Washout (at Least 2 Weeks)||4
883501|NCT01980524|2137691|P1|STARTED|Washout (at Least 2 Weeks)||4
883502|NCT01980524|2137690|P2|NOT COMPLETED|Study Day 1||0
883503|NCT01980524|2137691|P1|NOT COMPLETED|Study Day 1||0
883504|NCT01980524|2137690|P2|COMPLETED|Study Day 1||4
883505|NCT01980524|2137691|P1|COMPLETED|Study Day 1||4
883506|NCT01980524|2137690|P2|STARTED|Study Day 1||4
883507|NCT01980524|2137691|P1|STARTED|Study Day 1||4
883508|NCT01980095|2137703|P2|NOT COMPLETED|Overall Study||11
883509|NCT01980095|2137704|P1|NOT COMPLETED|Overall Study||14
883510|NCT01980095|2137703|P2|COMPLETED|Overall Study||30
883511|NCT01980095|2137704|P1|COMPLETED|Overall Study||63
883512|NCT01980095|2137703|P2|Treated|Overall Study||41
883513|NCT01980095|2137704|P1|Treated|Overall Study|Of 78 patients randomized, 1 patient erroneously randomized and not treated|77
883514|NCT01980095|2137703|P2|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|41
883515|NCT01980095|2137704|P1|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|77
883516|NCT01979185|2137714|P2|NOT COMPLETED|Period 2||1
883517|NCT01979185|2137715|P1|NOT COMPLETED|Period 2||0
883518|NCT01979185|2137714|P2|COMPLETED|Period 2|1 subject discontinued due to a positive drug test prior to receiving Simvastatin alone in Period 2.|14
883519|NCT01979185|2137715|P1|COMPLETED|Period 2||15
883520|NCT01979185|2137714|P2|STARTED|Period 2||15
883521|NCT01979185|2137715|P1|STARTED|Period 2||15
883522|NCT01979185|2137714|P2|NOT COMPLETED|Period 1||0
883523|NCT01979185|2137715|P1|NOT COMPLETED|Period 1||0
883524|NCT01979185|2137714|P2|COMPLETED|Period 1||15
883525|NCT01979185|2137715|P1|COMPLETED|Period 1||15
883526|NCT01979185|2137714|P2|STARTED|Period 1||15
883527|NCT01979185|2137715|P1|STARTED|Period 1||15
883528|NCT01979133|2137725|P1|NOT COMPLETED|Overall Study||3
883529|NCT01979133|2137725|P1|COMPLETED|Overall Study||7
883530|NCT01979133|2137725|P1|STARTED|Overall Study||10
883531|NCT01979029|2137744|P2|NOT COMPLETED|Overall Study||0
883532|NCT01979029|2137745|P1|NOT COMPLETED|Overall Study||0
883533|NCT01979029|2137744|P2|COMPLETED|Overall Study||28
883534|NCT01979029|2137745|P1|COMPLETED|Overall Study||29
883535|NCT01979029|2137744|P2|STARTED|Overall Study||28
883536|NCT01979029|2137745|P1|STARTED|Overall Study||29
883537|NCT01978743|2137755|P1|NOT COMPLETED|Overall Study||0
883538|NCT01978743|2137755|P1|COMPLETED|Overall Study||10
883539|NCT01978743|2137755|P1|STARTED|Overall Study||10
883540|NCT01978600|2137769|P2|NOT COMPLETED|Overall Study||0
883541|NCT01978600|2137770|P1|NOT COMPLETED|Overall Study||0
883542|NCT01978600|2137769|P2|COMPLETED|Overall Study||42
883543|NCT01978600|2137770|P1|COMPLETED|Overall Study||44
883544|NCT01978600|2137769|P2|STARTED|Overall Study||42
883545|NCT01978600|2137770|P1|STARTED|Overall Study||44
883546|NCT01978145|2137780|P2|NOT COMPLETED|Treatment Period 2||14
883547|NCT01978145|2137781|P1|NOT COMPLETED|Treatment Period 2||19
883548|NCT01978145|2137780|P2|COMPLETED|Treatment Period 2||179
883549|NCT01978145|2137781|P1|COMPLETED|Treatment Period 2||185
883550|NCT01978145|2137780|P2|STARTED|Treatment Period 2||193
883551|NCT01978145|2137781|P1|STARTED|Treatment Period 2||204
883552|NCT01978145|2137780|P2|NOT COMPLETED|Washout Period 1||3
883553|NCT01978145|2137781|P1|NOT COMPLETED|Washout Period 1||1
883554|NCT01978145|2137780|P2|COMPLETED|Washout Period 1||193
883555|NCT01978145|2137781|P1|COMPLETED|Washout Period 1||204
883556|NCT01978145|2137780|P2|STARTED|Washout Period 1||196
883557|NCT01978145|2137781|P1|STARTED|Washout Period 1||205
883558|NCT01978145|2137780|P2|NOT COMPLETED|Treatment Period 1||16
883559|NCT01978145|2137781|P1|NOT COMPLETED|Treatment Period 1||9
883560|NCT01978145|2137780|P2|COMPLETED|Treatment Period 1||196
883561|NCT01978145|2137781|P1|COMPLETED|Treatment Period 1||205
883562|NCT01978145|2137780|P2|STARTED|Treatment Period 1||212
883563|NCT01978145|2137781|P1|STARTED|Treatment Period 1||214
883564|NCT01978119|2137797|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||2
883565|NCT01978119|2137798|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||0
883566|NCT01978119|2137797|P2|COMPLETED|Treatment Period 2 (12 Weeks)||40
883567|NCT01978119|2137798|P1|COMPLETED|Treatment Period 2 (12 Weeks)||38
883568|NCT01978119|2137797|P2|STARTED|Treatment Period 2 (12 Weeks)||42
883569|NCT01978119|2137798|P1|STARTED|Treatment Period 2 (12 Weeks)||38
883570|NCT01978119|2137797|P2|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
883571|NCT01978119|2137798|P1|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
883572|NCT01978119|2137797|P2|COMPLETED|Washout Period 1 (3 Weeks)||42
883573|NCT01978119|2137798|P1|COMPLETED|Washout Period 1 (3 Weeks)||38
883574|NCT01978119|2137797|P2|STARTED|Washout Period 1 (3 Weeks)||42
883575|NCT01978119|2137798|P1|STARTED|Washout Period 1 (3 Weeks)||38
883576|NCT01978119|2137797|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||0
883577|NCT01978119|2137798|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
883578|NCT01978119|2137797|P2|COMPLETED|Treatment Period 1 (12 Weeks)||42
883579|NCT01978119|2137798|P1|COMPLETED|Treatment Period 1 (12 Weeks)||38
883580|NCT01978119|2137797|P2|STARTED|Treatment Period 1 (12 Weeks)||42
883581|NCT01978119|2137798|P1|STARTED|Treatment Period 1 (12 Weeks)||40
883582|NCT01977820|2137824|P2|NOT COMPLETED|Overall Study||1
883583|NCT01977820|2137825|P1|NOT COMPLETED|Overall Study||1
883584|NCT01977820|2137824|P2|COMPLETED|Overall Study||0
883585|NCT01977820|2137825|P1|COMPLETED|Overall Study||0
883586|NCT01977820|2137824|P2|STARTED|Overall Study||1
883587|NCT01977820|2137825|P1|STARTED|Overall Study||1
883588|NCT01977794|2137833|P2|NOT COMPLETED|Overall Study||6
883589|NCT01977794|2137834|P1|NOT COMPLETED|Overall Study||8
883590|NCT01977794|2137833|P2|COMPLETED|Overall Study||94
883591|NCT01977794|2137834|P1|COMPLETED|Overall Study||92
883592|NCT01977794|2137833|P2|STARTED|Overall Study||100
883593|NCT01977794|2137834|P1|STARTED|Overall Study||100
883594|NCT01977781|2137850|P2|NOT COMPLETED|Overall Study||1
883595|NCT01977781|2137851|P1|NOT COMPLETED|Overall Study||6
883596|NCT01977781|2137850|P2|COMPLETED|Overall Study||15
883597|NCT01977781|2137851|P1|COMPLETED|Overall Study||18
883598|NCT01977781|2137850|P2|STARTED|Overall Study||16
883599|NCT01977781|2137851|P1|STARTED|Overall Study||24
883600|NCT01977729|2137869|P1|NOT COMPLETED|Overall Study||1
883601|NCT01977729|2137869|P1|COMPLETED|Overall Study||0
883602|NCT01977729|2137869|P1|STARTED|Overall Study||1
883603|NCT01977690|2137881|P2|NOT COMPLETED|Overall Study||4
883604|NCT01977690|2137882|P1|NOT COMPLETED|Overall Study||0
883605|NCT01977690|2137881|P2|COMPLETED|Overall Study||11
883606|NCT01977690|2137882|P1|COMPLETED|Overall Study||15
883607|NCT01977690|2137881|P2|STARTED|Overall Study||15
883608|NCT01977690|2137882|P1|STARTED|Overall Study||15
883609|NCT01977625|2137888|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
883610|NCT01977625|2137889|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
883611|NCT01977625|2137888|P2|COMPLETED|Second Intervention (4 Weeks)||7
883612|NCT01977625|2137889|P1|COMPLETED|Second Intervention (4 Weeks)||7
883613|NCT01977625|2137888|P2|STARTED|Second Intervention (4 Weeks)||7
883614|NCT01977625|2137889|P1|STARTED|Second Intervention (4 Weeks)||8
883615|NCT01977625|2137888|P2|NOT COMPLETED|Washout (2 Weeks)||0
883616|NCT01977625|2137889|P1|NOT COMPLETED|Washout (2 Weeks)||0
883617|NCT01977625|2137888|P2|COMPLETED|Washout (2 Weeks)||7
883618|NCT01977625|2137889|P1|COMPLETED|Washout (2 Weeks)||8
883619|NCT01977625|2137888|P2|STARTED|Washout (2 Weeks)||7
883620|NCT01977625|2137889|P1|STARTED|Washout (2 Weeks)||8
883621|NCT01977625|2137888|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
883622|NCT01977625|2137889|P1|NOT COMPLETED|First Intervention (4 Weeks)||3
883623|NCT01977625|2137888|P2|COMPLETED|First Intervention (4 Weeks)||7
883624|NCT01977625|2137889|P1|COMPLETED|First Intervention (4 Weeks)||8
883625|NCT01977625|2137888|P2|STARTED|First Intervention (4 Weeks)||7
883626|NCT01977625|2137889|P1|STARTED|First Intervention (4 Weeks)||11
883627|NCT01977612|2137899|P2|NOT COMPLETED|Overall Study||1
883628|NCT01977612|2137900|P1|NOT COMPLETED|Overall Study||1
883629|NCT01977612|2137899|P2|COMPLETED|Overall Study||79
883630|NCT01977612|2137900|P1|COMPLETED|Overall Study||84
883631|NCT01977612|2137899|P2|STARTED|Overall Study||80
883632|NCT01977612|2137900|P1|STARTED|Overall Study||85
883633|NCT01977573|2137922|P4|NOT COMPLETED|Overall Study||3
883634|NCT01977573|2137923|P3|NOT COMPLETED|Overall Study||4
883635|NCT01977573|2137924|P2|NOT COMPLETED|Overall Study||3
883636|NCT01977573|2137925|P1|NOT COMPLETED|Overall Study||20
883637|NCT01977573|2137922|P4|COMPLETED|Overall Study||33
883638|NCT01977573|2137923|P3|COMPLETED|Overall Study||32
883639|NCT01977573|2137924|P2|COMPLETED|Overall Study||41
883640|NCT01977573|2137925|P1|COMPLETED|Overall Study||116
883641|NCT01977573|2137922|P4|STARTED|Overall Study||36
883642|NCT01977573|2137923|P3|STARTED|Overall Study||36
883643|NCT01977573|2137924|P2|STARTED|Overall Study||44
883644|NCT01977573|2137925|P1|STARTED|Overall Study||136
883645|NCT01977482|2138039|P6|NOT COMPLETED|Overall Study||5
883646|NCT01977482|2138040|P5|NOT COMPLETED|Overall Study||3
883647|NCT01977482|2138041|P4|NOT COMPLETED|Overall Study||4
883648|NCT01977482|2138042|P3|NOT COMPLETED|Overall Study||5
883649|NCT01977482|2138043|P2|NOT COMPLETED|Overall Study||9
883650|NCT01977482|2138044|P1|NOT COMPLETED|Overall Study||3
883651|NCT01977482|2138039|P6|COMPLETED|Overall Study||14
883652|NCT01977482|2138040|P5|COMPLETED|Overall Study||37
883653|NCT01977482|2138041|P4|COMPLETED|Overall Study||35
883654|NCT01977482|2138042|P3|COMPLETED|Overall Study||35
883655|NCT01977482|2138043|P2|COMPLETED|Overall Study||30
883656|NCT01977482|2138044|P1|COMPLETED|Overall Study||36
883657|NCT01977482|2138039|P6|STARTED|Overall Study||19
883658|NCT01977482|2138040|P5|STARTED|Overall Study||40
883659|NCT01977482|2138041|P4|STARTED|Overall Study||39
883660|NCT01977482|2138042|P3|STARTED|Overall Study||40
883661|NCT01977482|2138043|P2|STARTED|Overall Study||39
883662|NCT01977482|2138044|P1|STARTED|Overall Study||39
883663|NCT01977456|2138159|P1|NOT COMPLETED|Overall Study||5
883664|NCT01977456|2138159|P1|COMPLETED|Overall Study||22
883665|NCT01977456|2138159|P1|STARTED|Overall Study||27
883666|NCT01976988|2138168|P2|NOT COMPLETED|Overall Study||18
883667|NCT01976988|2138169|P1|NOT COMPLETED|Overall Study||16
883668|NCT01976988|2138168|P2|COMPLETED|Overall Study||184
883669|NCT01976988|2138169|P1|COMPLETED|Overall Study||192
883670|NCT01976988|2138168|P2|STARTED|Overall Study||202
883671|NCT01976988|2138169|P1|STARTED|Overall Study||208
883672|NCT01976871|2138185|P1|NOT COMPLETED|Overall Study||1
883673|NCT01976871|2138185|P1|COMPLETED|Overall Study||20
883674|NCT01976871|2138185|P1|STARTED|Overall Study||21
883675|NCT01976845|2138197|P3|NOT COMPLETED|Overall Study||3
883676|NCT01976845|2138198|P2|NOT COMPLETED|Overall Study||8
883677|NCT01976845|2138199|P1|NOT COMPLETED|Overall Study||8
883678|NCT01976845|2138197|P3|COMPLETED|Overall Study||40
883679|NCT01976845|2138198|P2|COMPLETED|Overall Study||40
883680|NCT01976845|2138199|P1|COMPLETED|Overall Study||40
883681|NCT01976845|2138197|P3|STARTED|Overall Study||43
883682|NCT01976845|2138198|P2|STARTED|Overall Study||48
883683|NCT01976845|2138199|P1|STARTED|Overall Study||48
883684|NCT01976819|2138213|P1|NOT COMPLETED|Overall Study||5
883685|NCT01976819|2138213|P1|COMPLETED|Overall Study||11
883686|NCT01976819|2138213|P1|STARTED|Overall Study||16
883687|NCT01976806|2138224|P2|NOT COMPLETED|Overall Study||6
883688|NCT01976806|2138225|P1|NOT COMPLETED|Overall Study||3
883689|NCT01976806|2138224|P2|COMPLETED|Overall Study||22
883690|NCT01976806|2138225|P1|COMPLETED|Overall Study||24
883691|NCT01976806|2138224|P2|STARTED|Overall Study||28
883692|NCT01976806|2138225|P1|STARTED|Overall Study||27
883693|NCT01976663|2138231|P1|NOT COMPLETED|Overall Study||42
883694|NCT01976663|2138231|P1|COMPLETED|Overall Study||84
883695|NCT01976663|2138231|P1|STARTED|Overall Study||126
883696|NCT01976650|2138245|P1|NOT COMPLETED|Overall Study||6
883697|NCT01976650|2138245|P1|COMPLETED|Overall Study||718
883698|NCT01976650|2138245|P1|STARTED|Overall Study||724
883699|NCT01976624|2138250|P1|NOT COMPLETED|Overall Study||14
883700|NCT01976624|2138250|P1|COMPLETED|Overall Study||742
883701|NCT01976624|2138250|P1|STARTED|Overall Study||756
883702|NCT01976572|2138255|P3|NOT COMPLETED|Overall Study||0
883703|NCT01976572|2138256|P2|NOT COMPLETED|Overall Study||0
883704|NCT01976572|2138257|P1|NOT COMPLETED|Overall Study||0
883705|NCT01976572|2138255|P3|COMPLETED|Overall Study||6
883706|NCT01976572|2138256|P2|COMPLETED|Overall Study||6
883707|NCT01976572|2138257|P1|COMPLETED|Overall Study||6
883708|NCT01976572|2138255|P3|STARTED|Overall Study||6
883709|NCT01976572|2138256|P2|STARTED|Overall Study||6
883710|NCT01976572|2138257|P1|STARTED|Overall Study||6
883711|NCT01976507|2138278|P1|NOT COMPLETED|Overall Study||7
883712|NCT01976507|2138278|P1|COMPLETED|Overall Study||94
883713|NCT01976507|2138278|P1|Received Initial Dose of Dabigatran|Overall Study||100
883714|NCT01976507|2138278|P1|STARTED|Overall Study||101
883715|NCT01976442|2138287|P2|NOT COMPLETED|Overall Study||0
883716|NCT01976442|2138288|P1|NOT COMPLETED|Overall Study||0
883717|NCT01976442|2138287|P2|COMPLETED|Overall Study||31
883718|NCT01976442|2138288|P1|COMPLETED|Overall Study||69
883719|NCT01976442|2138287|P2|STARTED|Overall Study||31
883720|NCT01976442|2138288|P1|STARTED|Overall Study||69
883721|NCT01976338|2138302|P2|NOT COMPLETED|Overall Study||4
883722|NCT01976338|2138303|P1|NOT COMPLETED|Overall Study||13
883723|NCT01976338|2138302|P2|COMPLETED|Overall Study|12 months|89
883724|NCT01976338|2138303|P1|COMPLETED|Overall Study|12 months|177
883725|NCT01976338|2138302|P2|Discontinued Study Prior to 6 Months|Overall Study||2
883726|NCT01976338|2138303|P1|Discontinued Study Prior to 6 Months|Overall Study||5
883727|NCT01976338|2138302|P2|Completed 6 Months|Overall Study||91
883728|NCT01976338|2138303|P1|Completed 6 Months|Overall Study||185
883729|NCT01976338|2138302|P2|STARTED|Overall Study||93
883730|NCT01976338|2138303|P1|STARTED|Overall Study||190
883731|NCT01976312|2138330|P2|NOT COMPLETED|Overall Study||9
883732|NCT01976312|2138331|P1|NOT COMPLETED|Overall Study||17
883733|NCT01976312|2138330|P2|COMPLETED|Overall Study|Completed study at 12 months|53
883734|NCT01976312|2138331|P1|COMPLETED|Overall Study|Completed study at 12 months|173
883735|NCT01976312|2138330|P2|Discontinued Study Prior to 3 Months|Overall Study||2
883736|NCT01976312|2138331|P1|Discontinued Study Prior to 3 Months|Overall Study||4
883737|NCT01976312|2138330|P2|Completed 3 Months|Overall Study||60
883738|NCT01976312|2138331|P1|Completed 3 Months|Overall Study||186
883739|NCT01976312|2138330|P2|STARTED|Overall Study||62
883740|NCT01976312|2138331|P1|STARTED|Overall Study||190
883741|NCT01976299|2138352|P2|NOT COMPLETED|Overall Study||6
883742|NCT01976299|2138353|P1|NOT COMPLETED|Overall Study||23
883743|NCT01976299|2138352|P2|COMPLETED|Overall Study|2 subjects did not proceed onto procedure in this arm.|280
883744|NCT01976299|2138353|P1|COMPLETED|Overall Study|9 subjects did not proceed onto procedure in this arm.|269
883745|NCT01976299|2138352|P2|Completed Procedure|Overall Study||284
883746|NCT01976299|2138353|P1|Completed Procedure|Overall Study||283
883747|NCT01976299|2138352|P2|STARTED|Overall Study||286
883748|NCT01976299|2138353|P1|STARTED|Overall Study||292
883749|NCT01976273|2138369|P2|NOT COMPLETED|Overall Study||1
883750|NCT01976273|2138370|P1|NOT COMPLETED|Overall Study||1
883751|NCT01976273|2138369|P2|COMPLETED|Overall Study||9
883752|NCT01976273|2138370|P1|COMPLETED|Overall Study||9
883753|NCT01976273|2138369|P2|STARTED|Overall Study||10
883754|NCT01976273|2138370|P1|STARTED|Overall Study||10
883755|NCT01975974|2138376|P1|NOT COMPLETED|Overall Study||0
883756|NCT01975974|2138376|P1|COMPLETED|Overall Study||100
883757|NCT01975974|2138376|P1|STARTED|Overall Study||100
883758|NCT01975948|2138384|P4|NOT COMPLETED|Overall Study||6
883759|NCT01975948|2138385|P3|NOT COMPLETED|Overall Study||7
883760|NCT01975948|2138386|P2|NOT COMPLETED|Overall Study||21
883761|NCT01975948|2138387|P1|NOT COMPLETED|Overall Study||17
883762|NCT01975948|2138384|P4|COMPLETED|Overall Study||51
883763|NCT01975948|2138385|P3|COMPLETED|Overall Study||65
883764|NCT01975948|2138386|P2|COMPLETED|Overall Study||34
883765|NCT01975948|2138387|P1|COMPLETED|Overall Study||39
883766|NCT01975948|2138384|P4|STARTED|Overall Study||57
883767|NCT01975948|2138385|P3|STARTED|Overall Study||72
883768|NCT01975948|2138386|P2|STARTED|Overall Study||55
883769|NCT01975948|2138387|P1|STARTED|Overall Study||56
883770|NCT01975935|2138413|P2|NOT COMPLETED|Overall Study||1
883771|NCT01975935|2138414|P1|NOT COMPLETED|Overall Study||3
883772|NCT01975935|2138413|P2|COMPLETED|Overall Study||20
883773|NCT01975935|2138414|P1|COMPLETED|Overall Study||18
883774|NCT01975935|2138413|P2|STARTED|Overall Study||21
883775|NCT01975935|2138414|P1|STARTED|Overall Study||21
883776|NCT01975909|2138426|P2|NOT COMPLETED|Overall Study||0
883777|NCT01975909|2138427|P1|NOT COMPLETED|Overall Study||0
883778|NCT01975909|2138426|P2|COMPLETED|Overall Study||10
883779|NCT01975909|2138427|P1|COMPLETED|Overall Study||10
883780|NCT01975909|2138426|P2|STARTED|Overall Study||10
883781|NCT01975909|2138427|P1|STARTED|Overall Study||10
883782|NCT01975675|2138447|P4|NOT COMPLETED|Overall Study||0
883783|NCT01975675|2138448|P3|NOT COMPLETED|Overall Study||0
883784|NCT01975675|2138449|P2|NOT COMPLETED|Overall Study||1
883785|NCT01975675|2138450|P1|NOT COMPLETED|Overall Study||0
883786|NCT01975675|2138447|P4|COMPLETED|Overall Study||87
883787|NCT01975675|2138448|P3|COMPLETED|Overall Study||88
883788|NCT01975675|2138449|P2|COMPLETED|Overall Study||82
883789|NCT01975675|2138450|P1|COMPLETED|Overall Study||83
883790|NCT01975675|2138447|P4|STARTED|Overall Study||87
883791|NCT01975675|2138448|P3|STARTED|Overall Study||88
883792|NCT01975675|2138449|P2|STARTED|Overall Study||83
883793|NCT01975675|2138450|P1|STARTED|Overall Study||83
883794|NCT01975467|2138472|P2|NOT COMPLETED|Overall Study||0
883795|NCT01975467|2138473|P1|NOT COMPLETED|Overall Study||0
883796|NCT01975467|2138472|P2|COMPLETED|Overall Study||0
883797|NCT01975467|2138473|P1|COMPLETED|Overall Study||0
883798|NCT01975467|2138472|P2|STARTED|Overall Study|Study terminated before enrollment|0
883799|NCT01975467|2138473|P1|STARTED|Overall Study|Study terminated before enrollment|0
883800|NCT01975285|2138483|P2|NOT COMPLETED|Overall Study||2
883801|NCT01975285|2138484|P1|NOT COMPLETED|Overall Study||2
883802|NCT01975285|2138483|P2|COMPLETED|Overall Study||28
883803|NCT01975285|2138484|P1|COMPLETED|Overall Study||28
883804|NCT01975285|2138483|P2|STARTED|Overall Study||30
883805|NCT01975285|2138484|P1|STARTED|Overall Study||30
883806|NCT01975246|2138500|P2|NOT COMPLETED|Overall Study||2
883807|NCT01975246|2138501|P1|NOT COMPLETED|Overall Study||4
883808|NCT01975246|2138500|P2|COMPLETED|Overall Study||158
883809|NCT01975246|2138501|P1|COMPLETED|Overall Study||145
883810|NCT01975246|2138500|P2|STARTED|Overall Study||160
883811|NCT01975246|2138501|P1|STARTED|Overall Study||149
883812|NCT01975220|2138514|P6|NOT COMPLETED|Test Period 2||0
883813|NCT01975220|2138515|P5|NOT COMPLETED|Test Period 2||0
883814|NCT01975220|2138516|P4|NOT COMPLETED|Test Period 2||0
883815|NCT01975220|2138517|P3|NOT COMPLETED|Test Period 2||0
883816|NCT01975220|2138518|P2|NOT COMPLETED|Test Period 2||0
883817|NCT01975220|2138519|P1|NOT COMPLETED|Test Period 2||0
883818|NCT01975220|2138514|P6|COMPLETED|Test Period 2||12
883819|NCT01975220|2138515|P5|COMPLETED|Test Period 2||12
883820|NCT01975220|2138516|P4|COMPLETED|Test Period 2||12
883821|NCT01975220|2138517|P3|COMPLETED|Test Period 2||12
883822|NCT01975220|2138518|P2|COMPLETED|Test Period 2||11
883823|NCT01975220|2138519|P1|COMPLETED|Test Period 2||12
883824|NCT01975220|2138514|P6|STARTED|Test Period 2||12
883825|NCT01975220|2138515|P5|STARTED|Test Period 2||12
883826|NCT01975220|2138516|P4|STARTED|Test Period 2||12
883827|NCT01975220|2138517|P3|STARTED|Test Period 2||12
883828|NCT01975220|2138518|P2|STARTED|Test Period 2||11
883829|NCT01975220|2138519|P1|STARTED|Test Period 2||12
883830|NCT01975220|2138514|P6|NOT COMPLETED|Test Period 1||0
883831|NCT01975220|2138515|P5|NOT COMPLETED|Test Period 1||0
883832|NCT01975220|2138516|P4|NOT COMPLETED|Test Period 1||0
883833|NCT01975220|2138517|P3|NOT COMPLETED|Test Period 1||0
883834|NCT01975220|2138518|P2|NOT COMPLETED|Test Period 1||1
883835|NCT01975220|2138519|P1|NOT COMPLETED|Test Period 1||0
883836|NCT01975220|2138514|P6|COMPLETED|Test Period 1||12
883837|NCT01975220|2138515|P5|COMPLETED|Test Period 1||12
883838|NCT01975220|2138516|P4|COMPLETED|Test Period 1||12
883839|NCT01975220|2138517|P3|COMPLETED|Test Period 1||12
883840|NCT01975220|2138518|P2|COMPLETED|Test Period 1||11
883841|NCT01975220|2138519|P1|COMPLETED|Test Period 1||12
883842|NCT01975220|2138514|P6|STARTED|Test Period 1||12
883843|NCT01975220|2138515|P5|STARTED|Test Period 1||12
883844|NCT01975220|2138516|P4|STARTED|Test Period 1||12
883845|NCT01975220|2138517|P3|STARTED|Test Period 1||12
883846|NCT01975220|2138518|P2|STARTED|Test Period 1||12
883847|NCT01975220|2138519|P1|STARTED|Test Period 1||12
883848|NCT01974895|2138565|P2|NOT COMPLETED|Overall Study||15
883849|NCT01974895|2138566|P1|NOT COMPLETED|Overall Study||15
883850|NCT01974895|2138565|P2|COMPLETED|Overall Study||141
883851|NCT01974895|2138566|P1|COMPLETED|Overall Study||143
883852|NCT01974895|2138565|P2|STARTED|Overall Study||156
883853|NCT01974895|2138566|P1|STARTED|Overall Study||158
883854|NCT01974817|2138596|P1|NOT COMPLETED|Overall Study||8
883855|NCT01974817|2138596|P1|COMPLETED|Overall Study||17
883856|NCT01974817|2138596|P1|STARTED|Overall Study||25
883857|NCT01974752|2138602|P2|NOT COMPLETED|Overall Study||15
883858|NCT01974752|2138603|P1|NOT COMPLETED|Overall Study||37
883859|NCT01974752|2138602|P2|COMPLETED|Overall Study||17
883860|NCT01974752|2138603|P1|COMPLETED|Overall Study||60
883861|NCT01974752|2138602|P2|STARTED|Overall Study||32
883862|NCT01974752|2138603|P1|STARTED|Overall Study||97
883863|NCT01974700|2138617|P2|NOT COMPLETED|Overall Study||0
883864|NCT01974700|2138618|P1|NOT COMPLETED|Overall Study||0
883865|NCT01974700|2138617|P2|COMPLETED|Overall Study||3
883866|NCT01974700|2138618|P1|COMPLETED|Overall Study||5
883867|NCT01974700|2138617|P2|STARTED|Overall Study||3
883868|NCT01974700|2138618|P1|STARTED|Overall Study||5
883869|NCT01974323|2138630|P2|NOT COMPLETED|Overall Study||93
883870|NCT01974323|2138631|P1|NOT COMPLETED|Overall Study||92
883871|NCT01974323|2138630|P2|COMPLETED|Overall Study||1027
883872|NCT01974323|2138631|P1|COMPLETED|Overall Study||1026
883873|NCT01974323|2138630|P2|STARTED|Overall Study||1120
883874|NCT01974323|2138631|P1|STARTED|Overall Study||1118
883875|NCT01974245|2138655|P2|NOT COMPLETED|Overall Study||8
883876|NCT01974245|2138656|P1|NOT COMPLETED|Overall Study||9
883877|NCT01974245|2138655|P2|COMPLETED|Overall Study||20
883878|NCT01974245|2138656|P1|COMPLETED|Overall Study||18
883879|NCT01974245|2138655|P2|STARTED|Overall Study||28
883880|NCT01974245|2138656|P1|STARTED|Overall Study||27
883881|NCT01974141|2138664|P2|NOT COMPLETED|Overall Study||82
883882|NCT01974141|2138665|P1|NOT COMPLETED|Overall Study||96
883883|NCT01974141|2138664|P2|COMPLETED|Overall Study||976
883884|NCT01974141|2138665|P1|COMPLETED|Overall Study||948
883885|NCT01974141|2138664|P2|STARTED|Overall Study||1058
883886|NCT01974141|2138665|P1|STARTED|Overall Study||1044
883887|NCT01973777|2138687|P1|NOT COMPLETED|Overall Study||7
883888|NCT01973777|2138687|P1|COMPLETED|Overall Study||44
883889|NCT01973777|2138687|P1|One Year Follow-up|Overall Study||44
883890|NCT01973777|2138687|P1|STARTED|Overall Study|January 2014|51
883891|NCT01973608|2138697|P4|NOT COMPLETED|Overall Study||0
883892|NCT01973608|2138698|P3|NOT COMPLETED|Overall Study||0
883893|NCT01973608|2138699|P2|NOT COMPLETED|Overall Study||0
883894|NCT01973608|2138700|P1|NOT COMPLETED|Overall Study||0
883895|NCT01973608|2138697|P4|COMPLETED|Overall Study||2
883896|NCT01973608|2138698|P3|COMPLETED|Overall Study||6
883897|NCT01973608|2138699|P2|COMPLETED|Overall Study||2
883898|NCT01973608|2138700|P1|COMPLETED|Overall Study||2
883899|NCT01973608|2138697|P4|STARTED|Overall Study||2
883900|NCT01973608|2138698|P3|STARTED|Overall Study||6
883901|NCT01973608|2138699|P2|STARTED|Overall Study||2
883902|NCT01973608|2138700|P1|STARTED|Overall Study||2
883903|NCT01973595|2138722|P4|NOT COMPLETED|Intervention Phase 2||0
883904|NCT01973595|2138723|P3|NOT COMPLETED|Intervention Phase 2||0
883905|NCT01973595|2138724|P2|NOT COMPLETED|Intervention Phase 2||0
883906|NCT01973595|2138725|P1|NOT COMPLETED|Intervention Phase 2||0
883907|NCT01973595|2138722|P4|COMPLETED|Intervention Phase 2||14
883908|NCT01973595|2138723|P3|COMPLETED|Intervention Phase 2||14
883909|NCT01973595|2138724|P2|COMPLETED|Intervention Phase 2||14
883910|NCT01973595|2138725|P1|COMPLETED|Intervention Phase 2||14
883911|NCT01973595|2138722|P4|STARTED|Intervention Phase 2||14
883912|NCT01973595|2138723|P3|STARTED|Intervention Phase 2||14
883913|NCT01973595|2138724|P2|STARTED|Intervention Phase 2||14
883914|NCT01973595|2138725|P1|STARTED|Intervention Phase 2||14
883915|NCT01973595|2138722|P4|NOT COMPLETED|Washout||0
883916|NCT01973595|2138723|P3|NOT COMPLETED|Washout||1
883917|NCT01973595|2138724|P2|NOT COMPLETED|Washout||0
883918|NCT01973595|2138725|P1|NOT COMPLETED|Washout||1
883919|NCT01973595|2138722|P4|COMPLETED|Washout||14
883920|NCT01973595|2138723|P3|COMPLETED|Washout||14
883921|NCT01973595|2138724|P2|COMPLETED|Washout||14
883922|NCT01973595|2138725|P1|COMPLETED|Washout||14
883923|NCT01973595|2138722|P4|STARTED|Washout||14
883924|NCT01973595|2138723|P3|STARTED|Washout||15
883925|NCT01973595|2138724|P2|STARTED|Washout||14
883926|NCT01973595|2138725|P1|STARTED|Washout||15
883927|NCT01973595|2138722|P4|NOT COMPLETED|Intervention Phase 1||0
883928|NCT01973595|2138723|P3|NOT COMPLETED|Intervention Phase 1||0
883929|NCT01973595|2138724|P2|NOT COMPLETED|Intervention Phase 1||0
883930|NCT01973595|2138725|P1|NOT COMPLETED|Intervention Phase 1||0
883931|NCT01973595|2138722|P4|COMPLETED|Intervention Phase 1||14
883932|NCT01973595|2138723|P3|COMPLETED|Intervention Phase 1||15
883933|NCT01973595|2138724|P2|COMPLETED|Intervention Phase 1||14
883934|NCT01973595|2138725|P1|COMPLETED|Intervention Phase 1||15
883935|NCT01973595|2138722|P4|STARTED|Intervention Phase 1||14
883936|NCT01973595|2138723|P3|STARTED|Intervention Phase 1||15
883937|NCT01973595|2138724|P2|STARTED|Intervention Phase 1||14
883938|NCT01973595|2138725|P1|STARTED|Intervention Phase 1||15
883939|NCT01973491|2138739|P1|NOT COMPLETED|Treatment Period (16 Weeks)||1
883940|NCT01973491|2138739|P1|COMPLETED|Treatment Period (16 Weeks)||18
883941|NCT01973491|2138739|P1|STARTED|Treatment Period (16 Weeks)||19
883942|NCT01973491|2138739|P1|NOT COMPLETED|Titration Period(4 Weeks)||0
883943|NCT01973491|2138739|P1|COMPLETED|Titration Period(4 Weeks)||19
883944|NCT01973491|2138739|P1|STARTED|Titration Period(4 Weeks)||19
883945|NCT01973491|2138739|P1|NOT COMPLETED|Baseline Control Period (8 Weeks)||18
883946|NCT01973491|2138739|P1|COMPLETED|Baseline Control Period (8 Weeks)||19
883947|NCT01973491|2138739|P1|STARTED|Baseline Control Period (8 Weeks)||37
883948|NCT01973439|2138755|P1|NOT COMPLETED|Overall Study||5
883949|NCT01973439|2138755|P1|COMPLETED|Overall Study||18
883950|NCT01973439|2138755|P1|One Evaluable PK Day Only|Overall Study|5 children had only one evaluable PK day.|5
883951|NCT01973439|2138755|P1|Two Evaluable PK Days|Overall Study|18 Children had two evaluable PK days|18
883952|NCT01973439|2138755|P1|STARTED|Overall Study||23
883953|NCT01973413|2138764|P2|NOT COMPLETED|Overall Study||0
883954|NCT01973413|2138765|P1|NOT COMPLETED|Overall Study||1
883955|NCT01973413|2138764|P2|COMPLETED|Overall Study||20
883956|NCT01973413|2138765|P1|COMPLETED|Overall Study||11
883957|NCT01973413|2138764|P2|STARTED|Overall Study||20
883958|NCT01973413|2138765|P1|STARTED|Overall Study||12
883959|NCT01973387|2138777|P2|NOT COMPLETED|Overall Study||18
883960|NCT01973387|2138778|P1|NOT COMPLETED|Overall Study||106
883961|NCT01973387|2138777|P2|COMPLETED|Overall Study||36
883962|NCT01973387|2138778|P1|COMPLETED|Overall Study||0
883963|NCT01973387|2138777|P2|Treated|Overall Study||52
883964|NCT01973387|2138778|P1|Treated|Overall Study||104
883965|NCT01973387|2138777|P2|STARTED|Overall Study||54
883966|NCT01973387|2138778|P1|STARTED|Overall Study||106
883967|NCT01973348|2138792|P4|NOT COMPLETED|Overall Study||0
883968|NCT01973348|2138793|P3|NOT COMPLETED|Overall Study||0
883969|NCT01973348|2138794|P2|NOT COMPLETED|Overall Study||3
883970|NCT01973348|2138795|P1|NOT COMPLETED|Overall Study||8
883971|NCT01973348|2138792|P4|COMPLETED|Overall Study||0
883972|NCT01973348|2138793|P3|COMPLETED|Overall Study||0
883973|NCT01973348|2138794|P2|COMPLETED|Overall Study||15
883974|NCT01973348|2138795|P1|COMPLETED|Overall Study||19
883975|NCT01973348|2138792|P4|STARTED|Overall Study||0
883976|NCT01973348|2138793|P3|STARTED|Overall Study||0
883977|NCT01973348|2138794|P2|STARTED|Overall Study||18
883978|NCT01973348|2138795|P1|STARTED|Overall Study||27
883979|NCT01973231|2138815|P2|NOT COMPLETED|Overall Study||12
883980|NCT01973231|2138816|P1|NOT COMPLETED|Overall Study||11
883981|NCT01973231|2138815|P2|COMPLETED|Overall Study||190
883982|NCT01973231|2138816|P1|COMPLETED|Overall Study||191
883983|NCT01973231|2138815|P2|STARTED|Overall Study||202
883984|NCT01973231|2138816|P1|STARTED|Overall Study||202
883985|NCT01973218|2138836|P2|NOT COMPLETED|Overall Study||0
883986|NCT01973218|2138837|P1|NOT COMPLETED|Overall Study||2
883987|NCT01973218|2138836|P2|COMPLETED|Overall Study||88
883988|NCT01973218|2138837|P1|COMPLETED|Overall Study||174
883989|NCT01973218|2138836|P2|STARTED|Overall Study||88
883990|NCT01973218|2138837|P1|STARTED|Overall Study||176
883991|NCT01973205|2138860|P2|NOT COMPLETED|Overall Study||22
883992|NCT01973205|2138861|P1|NOT COMPLETED|Overall Study||30
883993|NCT01973205|2138860|P2|COMPLETED|Overall Study||425
883994|NCT01973205|2138861|P1|COMPLETED|Overall Study||423
883995|NCT01973205|2138860|P2|STARTED|Overall Study||447
883996|NCT01973205|2138861|P1|STARTED|Overall Study||453
883997|NCT01972776|2138879|P6|NOT COMPLETED|Part 2||7
883998|NCT01972776|2138880|P5|NOT COMPLETED|Part 2||13
883999|NCT01972776|2138881|P4|NOT COMPLETED|Part 2||0
884000|NCT01972776|2138882|P3|NOT COMPLETED|Part 2||0
884001|NCT01972776|2138883|P2|NOT COMPLETED|Part 2||0
884002|NCT01972776|2138884|P1|NOT COMPLETED|Part 2||0
884003|NCT01972776|2138879|P6|COMPLETED|Part 2||0
884004|NCT01972776|2138880|P5|COMPLETED|Part 2||1
884005|NCT01972776|2138881|P4|COMPLETED|Part 2||0
884006|NCT01972776|2138882|P3|COMPLETED|Part 2||0
884007|NCT01972776|2138883|P2|COMPLETED|Part 2||0
884008|NCT01972776|2138884|P1|COMPLETED|Part 2||0
884009|NCT01972776|2138879|P6|STARTED|Part 2||7
884010|NCT01972776|2138880|P5|STARTED|Part 2||14
884011|NCT01972776|2138881|P4|STARTED|Part 2||0
884012|NCT01972776|2138882|P3|STARTED|Part 2||0
884013|NCT01972776|2138883|P2|STARTED|Part 2||0
884014|NCT01972776|2138884|P1|STARTED|Part 2||0
884015|NCT01972776|2138879|P6|NOT COMPLETED|Part 1||0
884016|NCT01972776|2138880|P5|NOT COMPLETED|Part 1||0
884017|NCT01972776|2138881|P4|NOT COMPLETED|Part 1||1
884018|NCT01972776|2138882|P3|NOT COMPLETED|Part 1||2
884019|NCT01972776|2138883|P2|NOT COMPLETED|Part 1||0
884020|NCT01972776|2138884|P1|NOT COMPLETED|Part 1||0
884021|NCT01972776|2138879|P6|COMPLETED|Part 1||0
884022|NCT01972776|2138880|P5|COMPLETED|Part 1||0
884023|NCT01972776|2138881|P4|COMPLETED|Part 1||6
884024|NCT01972776|2138882|P3|COMPLETED|Part 1||6
884025|NCT01972776|2138883|P2|COMPLETED|Part 1||6
884026|NCT01972776|2138884|P1|COMPLETED|Part 1||6
884027|NCT01972776|2138879|P6|STARTED|Part 1||0
884028|NCT01972776|2138880|P5|STARTED|Part 1||0
884029|NCT01972776|2138881|P4|STARTED|Part 1||7
884030|NCT01972776|2138882|P3|STARTED|Part 1||8
884031|NCT01972776|2138883|P2|STARTED|Part 1||6
884032|NCT01972776|2138884|P1|STARTED|Part 1||6
884033|NCT01972659|2138954|P2|NOT COMPLETED|Overall Study||3
884034|NCT01972659|2138955|P1|NOT COMPLETED|Overall Study||4
884035|NCT01972659|2138954|P2|COMPLETED|Overall Study||37
884036|NCT01972659|2138955|P1|COMPLETED|Overall Study||36
884037|NCT01972659|2138954|P2|STARTED|Overall Study||40
884038|NCT01972659|2138955|P1|STARTED|Overall Study||40
884039|NCT01972516|2138963|P2|NOT COMPLETED|Overall Study||0
884040|NCT01972516|2138964|P1|NOT COMPLETED|Overall Study||0
884041|NCT01972516|2138963|P2|COMPLETED|Overall Study||1
884042|NCT01972516|2138964|P1|COMPLETED|Overall Study||3
884043|NCT01972516|2138963|P2|STARTED|Overall Study||1
884044|NCT01972516|2138964|P1|STARTED|Overall Study||3
884045|NCT01972438|2138980|P2|NOT COMPLETED|Post Month 12 Study Period||4
884046|NCT01972438|2138981|P1|NOT COMPLETED|Post Month 12 Study Period||3
884047|NCT01972438|2138980|P2|COMPLETED|Post Month 12 Study Period||0
884048|NCT01972438|2138981|P1|COMPLETED|Post Month 12 Study Period||0
884049|NCT01972438|2138980|P2|STARTED|Post Month 12 Study Period||4
884050|NCT01972438|2138981|P1|STARTED|Post Month 12 Study Period||3
884051|NCT01972438|2138980|P2|NOT COMPLETED|Months 6-12 Study Period||2
884052|NCT01972438|2138981|P1|NOT COMPLETED|Months 6-12 Study Period||3
884053|NCT01972438|2138980|P2|COMPLETED|Months 6-12 Study Period||4
884054|NCT01972438|2138981|P1|COMPLETED|Months 6-12 Study Period||3
884055|NCT01972438|2138980|P2|STARTED|Months 6-12 Study Period||6
884056|NCT01972438|2138981|P1|STARTED|Months 6-12 Study Period||6
884057|NCT01972438|2138980|P2|NOT COMPLETED|Months 3-6 Crossover Period||1
884058|NCT01972438|2138981|P1|NOT COMPLETED|Months 3-6 Crossover Period||0
884059|NCT01972438|2138980|P2|COMPLETED|Months 3-6 Crossover Period||6
884060|NCT01972438|2138981|P1|COMPLETED|Months 3-6 Crossover Period||6
884061|NCT01972438|2138980|P2|STARTED|Months 3-6 Crossover Period|Two participants who missed Month 3 visit completed this pd but one who completed Month 3 didn't|7
884062|NCT01972438|2138981|P1|STARTED|Months 3-6 Crossover Period||6
884063|NCT01972438|2138980|P2|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
884064|NCT01972438|2138981|P1|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
884065|NCT01972438|2138980|P2|COMPLETED|Baseline-Month 3 Crossover Period||6
884066|NCT01972438|2138981|P1|COMPLETED|Baseline-Month 3 Crossover Period||6
884067|NCT01972438|2138980|P2|STARTED|Baseline-Month 3 Crossover Period|One participant never started IP, as unable to donate blood for preparation of ASEDs|9
884068|NCT01972438|2138981|P1|STARTED|Baseline-Month 3 Crossover Period|Two participants never started IP: one died and one did not meet the inclusion criteria|9
884069|NCT01972152|2139033|P6|NOT COMPLETED|Third Treatment Visit||0
884070|NCT01972152|2139034|P5|NOT COMPLETED|Third Treatment Visit||0
884071|NCT01972152|2139035|P4|NOT COMPLETED|Third Treatment Visit||0
884072|NCT01972152|2139036|P3|NOT COMPLETED|Third Treatment Visit||0
884073|NCT01972152|2139037|P2|NOT COMPLETED|Third Treatment Visit||0
884074|NCT01972152|2139038|P1|NOT COMPLETED|Third Treatment Visit||0
884075|NCT01972152|2139033|P6|COMPLETED|Third Treatment Visit||5
884076|NCT01972152|2139034|P5|COMPLETED|Third Treatment Visit||5
884077|NCT01972152|2139035|P4|COMPLETED|Third Treatment Visit||5
884078|NCT01972152|2139036|P3|COMPLETED|Third Treatment Visit||5
884079|NCT01972152|2139037|P2|COMPLETED|Third Treatment Visit||3
884080|NCT01972152|2139038|P1|COMPLETED|Third Treatment Visit||5
884081|NCT01972152|2139033|P6|STARTED|Third Treatment Visit||5
884082|NCT01972152|2139034|P5|STARTED|Third Treatment Visit||5
884083|NCT01972152|2139035|P4|STARTED|Third Treatment Visit||5
884084|NCT01972152|2139036|P3|STARTED|Third Treatment Visit||5
884085|NCT01972152|2139037|P2|STARTED|Third Treatment Visit||3
884086|NCT01972152|2139038|P1|STARTED|Third Treatment Visit||5
884087|NCT01972152|2139033|P6|NOT COMPLETED|Second Treatment Visit||0
884088|NCT01972152|2139034|P5|NOT COMPLETED|Second Treatment Visit||0
884089|NCT01972152|2139035|P4|NOT COMPLETED|Second Treatment Visit||0
884090|NCT01972152|2139036|P3|NOT COMPLETED|Second Treatment Visit||0
884091|NCT01972152|2139037|P2|NOT COMPLETED|Second Treatment Visit||1
884092|NCT01972152|2139038|P1|NOT COMPLETED|Second Treatment Visit||0
884093|NCT01972152|2139033|P6|COMPLETED|Second Treatment Visit||5
884094|NCT01972152|2139034|P5|COMPLETED|Second Treatment Visit||5
884095|NCT01972152|2139035|P4|COMPLETED|Second Treatment Visit||5
884096|NCT01972152|2139036|P3|COMPLETED|Second Treatment Visit||5
884097|NCT01972152|2139037|P2|COMPLETED|Second Treatment Visit||3
884098|NCT01972152|2139038|P1|COMPLETED|Second Treatment Visit||5
884099|NCT01972152|2139033|P6|STARTED|Second Treatment Visit||5
884100|NCT01972152|2139034|P5|STARTED|Second Treatment Visit||5
884101|NCT01972152|2139035|P4|STARTED|Second Treatment Visit||5
884102|NCT01972152|2139036|P3|STARTED|Second Treatment Visit||5
884103|NCT01972152|2139037|P2|STARTED|Second Treatment Visit||4
884104|NCT01972152|2139038|P1|STARTED|Second Treatment Visit||5
884105|NCT01972152|2139033|P6|NOT COMPLETED|First Treatment Visit||0
884106|NCT01972152|2139034|P5|NOT COMPLETED|First Treatment Visit||0
884107|NCT01972152|2139035|P4|NOT COMPLETED|First Treatment Visit||0
884108|NCT01972152|2139036|P3|NOT COMPLETED|First Treatment Visit||0
884109|NCT01972152|2139037|P2|NOT COMPLETED|First Treatment Visit||1
884110|NCT01972152|2139038|P1|NOT COMPLETED|First Treatment Visit||0
884111|NCT01972152|2139033|P6|COMPLETED|First Treatment Visit||5
884112|NCT01972152|2139034|P5|COMPLETED|First Treatment Visit||5
884113|NCT01972152|2139035|P4|COMPLETED|First Treatment Visit||5
884114|NCT01972152|2139036|P3|COMPLETED|First Treatment Visit||5
884115|NCT01972152|2139037|P2|COMPLETED|First Treatment Visit||4
884116|NCT01972152|2139038|P1|COMPLETED|First Treatment Visit||5
884117|NCT01972152|2139033|P6|STARTED|First Treatment Visit||5
884118|NCT01972152|2139034|P5|STARTED|First Treatment Visit||5
884119|NCT01972152|2139035|P4|STARTED|First Treatment Visit||5
884120|NCT01972152|2139036|P3|STARTED|First Treatment Visit||5
884121|NCT01972152|2139037|P2|STARTED|First Treatment Visit||5
884122|NCT01972152|2139038|P1|STARTED|First Treatment Visit||5
884123|NCT01971723|2139075|P2|NOT COMPLETED|Overall Study||3
884124|NCT01971723|2139076|P1|NOT COMPLETED|Overall Study||2
884125|NCT01971723|2139075|P2|COMPLETED|Overall Study||13
884126|NCT01971723|2139076|P1|COMPLETED|Overall Study||14
884127|NCT01971723|2139075|P2|STARTED|Overall Study||16
884128|NCT01971723|2139076|P1|STARTED|Overall Study||16
884129|NCT01971554|2139110|P4|NOT COMPLETED|Overall Study||0
884130|NCT01971554|2139111|P3|NOT COMPLETED|Overall Study||0
884131|NCT01971554|2139112|P2|NOT COMPLETED|Overall Study||0
884132|NCT01971554|2139113|P1|NOT COMPLETED|Overall Study||1
884133|NCT01971554|2139110|P4|COMPLETED|Overall Study||18
884134|NCT01971554|2139111|P3|COMPLETED|Overall Study||18
884135|NCT01971554|2139112|P2|COMPLETED|Overall Study||18
884136|NCT01971554|2139113|P1|COMPLETED|Overall Study||8
884137|NCT01971554|2139110|P4|STARTED|Overall Study||18
884138|NCT01971554|2139111|P3|STARTED|Overall Study||18
884139|NCT01971554|2139112|P2|STARTED|Overall Study||18
884140|NCT01971554|2139113|P1|STARTED|Overall Study||9
884141|NCT01971385|2139150|P3|NOT COMPLETED|Overall Study||4
884142|NCT01971385|2139151|P2|NOT COMPLETED|Overall Study||5
884143|NCT01971385|2139152|P1|NOT COMPLETED|Overall Study||3
884144|NCT01971385|2139150|P3|COMPLETED|Overall Study||15
884145|NCT01971385|2139151|P2|COMPLETED|Overall Study||13
884146|NCT01971385|2139152|P1|COMPLETED|Overall Study||14
884147|NCT01971385|2139150|P3|STARTED|Overall Study||19
884148|NCT01971385|2139151|P2|STARTED|Overall Study||18
884149|NCT01971385|2139152|P1|STARTED|Overall Study||17
884150|NCT01971255|2139161|P2|NOT COMPLETED|Overall Study||2
884151|NCT01971255|2139162|P1|NOT COMPLETED|Overall Study||1
884152|NCT01971255|2139161|P2|COMPLETED|Overall Study||40
884153|NCT01971255|2139162|P1|COMPLETED|Overall Study||31
884154|NCT01971255|2139161|P2|STARTED|Overall Study||42
884155|NCT01971255|2139162|P1|STARTED|Overall Study||32
884156|NCT01971086|2139178|P1|NOT COMPLETED|Overall Study||0
884157|NCT01971086|2139178|P1|COMPLETED|Overall Study||300
884158|NCT01971086|2139178|P1|STARTED|Overall Study||300
884159|NCT01970995|2139193|P3|NOT COMPLETED|End of Study (Population at Day 90)||1
884160|NCT01970995|2139194|P2|NOT COMPLETED|End of Study (Population at Day 90)||0
884161|NCT01970995|2139195|P1|NOT COMPLETED|End of Study (Population at Day 90)||1
884162|NCT01970995|2139193|P3|COMPLETED|End of Study (Population at Day 90)||38
884163|NCT01970995|2139194|P2|COMPLETED|End of Study (Population at Day 90)||41
884164|NCT01970995|2139195|P1|COMPLETED|End of Study (Population at Day 90)||76
884165|NCT01970995|2139193|P3|STARTED|End of Study (Population at Day 90)||39
884166|NCT01970995|2139194|P2|STARTED|End of Study (Population at Day 90)||41
884167|NCT01970995|2139195|P1|STARTED|End of Study (Population at Day 90)||77
884168|NCT01970995|2139193|P3|NOT COMPLETED|Confinement Period (Population at Day 5)||1
884169|NCT01970995|2139194|P2|NOT COMPLETED|Confinement Period (Population at Day 5)||1
884170|NCT01970995|2139195|P1|NOT COMPLETED|Confinement Period (Population at Day 5)||1
884171|NCT01970995|2139193|P3|COMPLETED|Confinement Period (Population at Day 5)||39
884172|NCT01970995|2139194|P2|COMPLETED|Confinement Period (Population at Day 5)||41
884173|NCT01970995|2139195|P1|COMPLETED|Confinement Period (Population at Day 5)||77
884174|NCT01970995|2139193|P3|STARTED|Confinement Period (Population at Day 5)||40
884175|NCT01970995|2139194|P2|STARTED|Confinement Period (Population at Day 5)||42
884176|NCT01970995|2139195|P1|STARTED|Confinement Period (Population at Day 5)||78
884177|NCT01970982|2139218|P3|NOT COMPLETED|Overall Study||2
884178|NCT01970982|2139219|P2|NOT COMPLETED|Overall Study||0
884179|NCT01970982|2139220|P1|NOT COMPLETED|Overall Study||0
884180|NCT01970982|2139218|P3|COMPLETED|Overall Study||38
884181|NCT01970982|2139219|P2|COMPLETED|Overall Study||40
884182|NCT01970982|2139220|P1|COMPLETED|Overall Study||80
884183|NCT01970982|2139218|P3|STARTED|Overall Study||40
884184|NCT01970982|2139219|P2|STARTED|Overall Study||40
884185|NCT01970982|2139220|P1|STARTED|Overall Study||80
884186|NCT01970878|2139242|P4|NOT COMPLETED|Overall Study||24
884187|NCT01970878|2139243|P3|NOT COMPLETED|Overall Study||26
884188|NCT01970878|2139244|P2|NOT COMPLETED|Overall Study||27
884189|NCT01970878|2139245|P1|NOT COMPLETED|Overall Study||37
884190|NCT01970878|2139242|P4|COMPLETED|Overall Study||147
884191|NCT01970878|2139243|P3|COMPLETED|Overall Study||187
884192|NCT01970878|2139244|P2|COMPLETED|Overall Study||191
884193|NCT01970878|2139245|P1|COMPLETED|Overall Study||253
884194|NCT01970878|2139242|P4|STARTED|Overall Study||171
884195|NCT01970878|2139243|P3|STARTED|Overall Study||213
884196|NCT01970878|2139244|P2|STARTED|Overall Study|218 subjects were reported in the CSR, 1 had no completion status|218
884197|NCT01970878|2139245|P1|STARTED|Overall Study||290
884198|NCT01970787|2139271|P1|NOT COMPLETED|Overall Study||1
884199|NCT01970787|2139271|P1|COMPLETED|Overall Study||21
884200|NCT01970787|2139271|P1|STARTED|Overall Study||22
884201|NCT01970488|2139281|P5|NOT COMPLETED|Part 2: Post Week 16||8
884202|NCT01970488|2139282|P4|NOT COMPLETED|Part 2: Post Week 16||8
884203|NCT01970488|2139283|P3|NOT COMPLETED|Part 2: Post Week 16||17
884204|NCT01970488|2139284|P2|NOT COMPLETED|Part 2: Post Week 16||0
884205|NCT01970488|2139285|P1|NOT COMPLETED|Part 2: Post Week 16||0
884206|NCT01970488|2139281|P5|COMPLETED|Part 2: Post Week 16||69
884207|NCT01970488|2139282|P4|COMPLETED|Part 2: Post Week 16||71
884208|NCT01970488|2139283|P3|COMPLETED|Part 2: Post Week 16||135
884209|NCT01970488|2139284|P2|COMPLETED|Part 2: Post Week 16||0
884210|NCT01970488|2139285|P1|COMPLETED|Part 2: Post Week 16||0
884211|NCT01970488|2139281|P5|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|77
884212|NCT01970488|2139282|P4|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|79
884213|NCT01970488|2139283|P3|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|152
884214|NCT01970488|2139284|P2|STARTED|Part 2: Post Week 16||0
884215|NCT01970488|2139285|P1|STARTED|Part 2: Post Week 16||0
884216|NCT01970488|2139281|P5|NOT COMPLETED|Part 1: Through Week 16||0
884217|NCT01970488|2139282|P4|NOT COMPLETED|Part 1: Through Week 16||0
884218|NCT01970488|2139283|P3|NOT COMPLETED|Part 1: Through Week 16||0
884219|NCT01970488|2139284|P2|NOT COMPLETED|Part 1: Through Week 16||13
884220|NCT01970488|2139285|P1|NOT COMPLETED|Part 1: Through Week 16||11
884221|NCT01970488|2139281|P5|COMPLETED|Part 1: Through Week 16||0
884222|NCT01970488|2139282|P4|COMPLETED|Part 1: Through Week 16||0
884223|NCT01970488|2139283|P3|COMPLETED|Part 1: Through Week 16||0
884224|NCT01970488|2139284|P2|COMPLETED|Part 1: Through Week 16||162
884225|NCT01970488|2139285|P1|COMPLETED|Part 1: Through Week 16||164
884226|NCT01970488|2139281|P5|Received Treatment|Part 1: Through Week 16||0
884227|NCT01970488|2139282|P4|Received Treatment|Part 1: Through Week 16||0
884228|NCT01970488|2139283|P3|Received Treatment|Part 1: Through Week 16||0
884229|NCT01970488|2139284|P2|Received Treatment|Part 1: Through Week 16||173
884230|NCT01970488|2139285|P1|Received Treatment|Part 1: Through Week 16||174
884231|NCT01970488|2139281|P5|STARTED|Part 1: Through Week 16||0
884232|NCT01970488|2139282|P4|STARTED|Part 1: Through Week 16||0
884233|NCT01970488|2139283|P3|STARTED|Part 1: Through Week 16||0
884234|NCT01970488|2139284|P2|STARTED|Part 1: Through Week 16||175
884235|NCT01970488|2139285|P1|STARTED|Part 1: Through Week 16||175
884236|NCT01970475|2139352|P2|NOT COMPLETED|Overall Study||11
884237|NCT01970475|2139353|P1|NOT COMPLETED|Overall Study||21
884238|NCT01970475|2139352|P2|COMPLETED|Overall Study||251
884239|NCT01970475|2139353|P1|COMPLETED|Overall Study||243
884240|NCT01970475|2139352|P2|STARTED|Overall Study||262
884241|NCT01970475|2139353|P1|STARTED|Overall Study||264
884242|NCT01970397|2139373|P2|NOT COMPLETED|Overall Study||5
884243|NCT01970397|2139374|P1|NOT COMPLETED|Overall Study||2
884244|NCT01970397|2139373|P2|COMPLETED|Overall Study||64
884245|NCT01970397|2139374|P1|COMPLETED|Overall Study||67
884246|NCT01970397|2139373|P2|STARTED|Overall Study||69
884247|NCT01970397|2139374|P1|STARTED|Overall Study||69
884248|NCT01969799|2139386|P2|NOT COMPLETED|Overall Study||14
884249|NCT01969799|2139387|P1|NOT COMPLETED|Overall Study||17
884250|NCT01969799|2139386|P2|COMPLETED|Overall Study||58
884251|NCT01969799|2139387|P1|COMPLETED|Overall Study||54
884252|NCT01969799|2139386|P2|STARTED|Overall Study||72
884253|NCT01969799|2139387|P1|STARTED|Overall Study||71
884254|NCT01969747|2139411|P4|NOT COMPLETED|Overall Study||0
884255|NCT01969747|2139412|P3|NOT COMPLETED|Overall Study||0
884256|NCT01969747|2139413|P2|NOT COMPLETED|Overall Study||0
884257|NCT01969747|2139414|P1|NOT COMPLETED|Overall Study||0
884258|NCT01969747|2139411|P4|COMPLETED|Overall Study||18
884259|NCT01969747|2139412|P3|COMPLETED|Overall Study||19
884260|NCT01969747|2139413|P2|COMPLETED|Overall Study||19
884261|NCT01969747|2139414|P1|COMPLETED|Overall Study||19
884262|NCT01969747|2139411|P4|STARTED|Overall Study||18
884263|NCT01969747|2139412|P3|STARTED|Overall Study||19
884264|NCT01969747|2139413|P2|STARTED|Overall Study||19
884265|NCT01969747|2139414|P1|STARTED|Overall Study||19
884266|NCT01969721|2139424|P4|NOT COMPLETED|Overall Study||6
884267|NCT01969721|2139425|P3|NOT COMPLETED|Overall Study||5
884268|NCT01969721|2139426|P2|NOT COMPLETED|Overall Study||12
884269|NCT01969721|2139427|P1|NOT COMPLETED|Overall Study||4
884270|NCT01969721|2139424|P4|COMPLETED|Overall Study||46
884271|NCT01969721|2139425|P3|COMPLETED|Overall Study||45
884272|NCT01969721|2139426|P2|COMPLETED|Overall Study||57
884273|NCT01969721|2139427|P1|COMPLETED|Overall Study||54
884274|NCT01969721|2139424|P4|STARTED|Overall Study||52
884275|NCT01969721|2139425|P3|STARTED|Overall Study||50
884276|NCT01969721|2139426|P2|STARTED|Overall Study||69
884277|NCT01969721|2139427|P1|STARTED|Overall Study||58
884278|NCT01969565|2139453|P1|NOT COMPLETED|Overall Study||1
884279|NCT01969565|2139453|P1|COMPLETED|Overall Study||0
884280|NCT01969565|2139453|P1|STARTED|Overall Study||1
884281|NCT01969539|2139457|P1|NOT COMPLETED|Overall Study||0
884282|NCT01969539|2139457|P1|COMPLETED|Overall Study||11
884283|NCT01969539|2139457|P1|STARTED|Overall Study||11
884284|NCT01969435|2139463|P1|NOT COMPLETED|Overall Study||0
884285|NCT01969435|2139463|P1|COMPLETED|Overall Study||50
884286|NCT01969435|2139463|P1|STARTED|Overall Study||50
884287|NCT01969162|2139476|P1|NOT COMPLETED|Overall Study||0
884288|NCT01969162|2139476|P1|COMPLETED|Overall Study||35
884289|NCT01969162|2139476|P1|STARTED|Overall Study||35
884290|NCT01969084|2139482|P2|NOT COMPLETED|Overall Study||1
884291|NCT01969084|2139483|P1|NOT COMPLETED|Overall Study||0
884292|NCT01969084|2139482|P2|COMPLETED|Overall Study|One subject withdrew due to unrelated serious adverse event|21
884293|NCT01969084|2139483|P1|COMPLETED|Overall Study||19
884294|NCT01969084|2139482|P2|STARTED|Overall Study||22
884295|NCT01969084|2139483|P1|STARTED|Overall Study||19
884296|NCT01969058|2139499|P2|NOT COMPLETED|Overall Study||0
884297|NCT01969058|2139500|P1|NOT COMPLETED|Overall Study||3
884298|NCT01969058|2139499|P2|COMPLETED|Overall Study||26
884299|NCT01969058|2139500|P1|COMPLETED|Overall Study||47
884300|NCT01969058|2139499|P2|STARTED|Overall Study||26
884301|NCT01969058|2139500|P1|STARTED|Overall Study||50
884302|NCT01968980|2139532|P2|NOT COMPLETED|Overall Study||14
884303|NCT01968980|2139533|P1|NOT COMPLETED|Overall Study||16
884304|NCT01968980|2139532|P2|COMPLETED|Overall Study||171
884305|NCT01968980|2139533|P1|COMPLETED|Overall Study||169
884306|NCT01968980|2139532|P2|STARTED|Overall Study||185
884307|NCT01968980|2139533|P1|STARTED|Overall Study||185
884308|NCT01968967|2139595|P2|NOT COMPLETED|Overall Study||134
884309|NCT01968967|2139596|P1|NOT COMPLETED|Overall Study||146
884310|NCT01968967|2139595|P2|COMPLETED|Overall Study||934
884311|NCT01968967|2139596|P1|COMPLETED|Overall Study||925
884312|NCT01968967|2139595|P2|Treated|Overall Study||1063
884313|NCT01968967|2139596|P1|Treated|Overall Study||1065
884314|NCT01968967|2139595|P2|STARTED|Overall Study||1068
884315|NCT01968967|2139596|P1|STARTED|Overall Study||1071
884316|NCT01968954|2139657|P2|NOT COMPLETED|Overall Study||43
884317|NCT01968954|2139658|P1|NOT COMPLETED|Overall Study||40
884318|NCT01968954|2139657|P2|COMPLETED|Overall Study||314
884319|NCT01968954|2139658|P1|COMPLETED|Overall Study||314
884320|NCT01968954|2139657|P2|Treated|Overall Study||356
884321|NCT01968954|2139658|P1|Treated|Overall Study||353
884322|NCT01968954|2139657|P2|STARTED|Overall Study||357
884323|NCT01968954|2139658|P1|STARTED|Overall Study||354
884324|NCT01968811|2139722|P1|NOT COMPLETED|Overall Study||5
884325|NCT01968811|2139722|P1|COMPLETED|Overall Study||5
884326|NCT01968811|2139722|P1|STARTED|Overall Study||10
884327|NCT01968694|2139729|P2|NOT COMPLETED|Visit 2 (1 Day)||0
884328|NCT01968694|2139730|P1|NOT COMPLETED|Visit 2 (1 Day)||0
884329|NCT01968694|2139729|P2|COMPLETED|Visit 2 (1 Day)||8
884330|NCT01968694|2139730|P1|COMPLETED|Visit 2 (1 Day)||10
884331|NCT01968694|2139729|P2|STARTED|Visit 2 (1 Day)||8
884332|NCT01968694|2139730|P1|STARTED|Visit 2 (1 Day)||10
884333|NCT01968694|2139729|P2|NOT COMPLETED|Washout (1 Month)||1
884334|NCT01968694|2139730|P1|NOT COMPLETED|Washout (1 Month)||0
884335|NCT01968694|2139729|P2|COMPLETED|Washout (1 Month)||8
884336|NCT01968694|2139730|P1|COMPLETED|Washout (1 Month)||10
884337|NCT01968694|2139729|P2|STARTED|Washout (1 Month)||9
884338|NCT01968694|2139730|P1|STARTED|Washout (1 Month)||10
884339|NCT01968694|2139729|P2|NOT COMPLETED|Visit 1 (1 Day)||0
884340|NCT01968694|2139730|P1|NOT COMPLETED|Visit 1 (1 Day)||0
884341|NCT01968694|2139729|P2|COMPLETED|Visit 1 (1 Day)||9
884342|NCT01968694|2139730|P1|COMPLETED|Visit 1 (1 Day)||10
884343|NCT01968694|2139729|P2|STARTED|Visit 1 (1 Day)||9
884344|NCT01968694|2139730|P1|STARTED|Visit 1 (1 Day)||10
884345|NCT01968551|2139747|P3|NOT COMPLETED|Extension Phase||4
884346|NCT01968551|2139748|P2|NOT COMPLETED|Extension Phase||1
884347|NCT01968551|2139749|P1|NOT COMPLETED|Extension Phase||1
884348|NCT01968551|2139747|P3|COMPLETED|Extension Phase||30
884349|NCT01968551|2139748|P2|COMPLETED|Extension Phase||86
884350|NCT01968551|2139749|P1|COMPLETED|Extension Phase||19
884351|NCT01968551|2139747|P3|STARTED|Extension Phase|7 participant completed the Open-Label Phase, but did not enter in the Extension Phase|34
884352|NCT01968551|2139748|P2|STARTED|Extension Phase||87
884353|NCT01968551|2139749|P1|STARTED|Extension Phase||20
884354|NCT01968551|2139747|P3|NOT COMPLETED|Open Label Phase (48 Weeks)||5
884355|NCT01968551|2139748|P2|NOT COMPLETED|Open Label Phase (48 Weeks)||3
884356|NCT01968551|2139749|P1|NOT COMPLETED|Open Label Phase (48 Weeks)||2
884357|NCT01968551|2139747|P3|COMPLETED|Open Label Phase (48 Weeks)||41
884358|NCT01968551|2139748|P2|COMPLETED|Open Label Phase (48 Weeks)||87
884359|NCT01968551|2139749|P1|COMPLETED|Open Label Phase (48 Weeks)||20
884360|NCT01968551|2139747|P3|STARTED|Open Label Phase (48 Weeks)||46
884361|NCT01968551|2139748|P2|STARTED|Open Label Phase (48 Weeks)||90
884362|NCT01968551|2139749|P1|STARTED|Open Label Phase (48 Weeks)||22
884363|NCT01968434|2139765|P2|NOT COMPLETED|Overall Study||6
884364|NCT01968434|2139766|P1|NOT COMPLETED|Overall Study||3
884365|NCT01968434|2139765|P2|COMPLETED|Overall Study||66
884366|NCT01968434|2139766|P1|COMPLETED|Overall Study||75
884367|NCT01968434|2139765|P2|STARTED|Overall Study||72
884368|NCT01968434|2139766|P1|STARTED|Overall Study||78
884369|NCT01968226|2139776|P1|NOT COMPLETED|Overall Study||2
884370|NCT01968226|2139776|P1|COMPLETED|Overall Study||1
884371|NCT01968226|2139776|P1|STARTED|Overall Study||3
884372|NCT01968135|2139782|P2|NOT COMPLETED|Overall Study||0
884373|NCT01968135|2139783|P1|NOT COMPLETED|Overall Study||0
884374|NCT01968135|2139782|P2|COMPLETED|Overall Study||16
884375|NCT01968135|2139783|P1|COMPLETED|Overall Study||16
884376|NCT01968135|2139782|P2|STARTED|Overall Study||16
884377|NCT01968135|2139783|P1|STARTED|Overall Study||16
884378|NCT01968057|2139795|P1|NOT COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||0
884379|NCT01968057|2139795|P1|COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||18
884380|NCT01968057|2139795|P1|Received Baricitinib + Ciclosporin|Period 2 (At Dosing Day 4 to Day 7)||18
884381|NCT01968057|2139795|P1|STARTED|Period 2 (At Dosing Day 4 to Day 7)||18
884382|NCT01968057|2139795|P1|NOT COMPLETED|Period 1 (Day 1 to Predosing Day 4)||0
884383|NCT01968057|2139795|P1|COMPLETED|Period 1 (Day 1 to Predosing Day 4)||18
884384|NCT01968057|2139795|P1|Received Baricitinib|Period 1 (Day 1 to Predosing Day 4)||18
884385|NCT01968057|2139795|P1|STARTED|Period 1 (Day 1 to Predosing Day 4)||18
884386|NCT01967940|2139808|P3|NOT COMPLETED|Part 2||14
884387|NCT01967940|2139809|P2|NOT COMPLETED|Part 2||16
884388|NCT01967940|2139810|P1|NOT COMPLETED|Part 2||8
884389|NCT01967940|2139808|P3|COMPLETED|Part 2||0
884390|NCT01967940|2139809|P2|COMPLETED|Part 2||0
884391|NCT01967940|2139810|P1|COMPLETED|Part 2||0
884392|NCT01967940|2139808|P3|STARTED|Part 2|1 participant completed Part 1, but did not enter Part 2 of the study|14
884393|NCT01967940|2139809|P2|STARTED|Part 2|12 participants completed Part 1, but did not enter Part 2 of the study|16
884394|NCT01967940|2139810|P1|STARTED|Part 2|4 participants completed Part 1, but did not enter Part 2 of the study|8
884395|NCT01967940|2139808|P3|NOT COMPLETED|Part 1||0
884396|NCT01967940|2139809|P2|NOT COMPLETED|Part 1||0
884397|NCT01967940|2139810|P1|NOT COMPLETED|Part 1||0
884398|NCT01967940|2139808|P3|COMPLETED|Part 1||15
884399|NCT01967940|2139809|P2|COMPLETED|Part 1||28
884400|NCT01967940|2139810|P1|COMPLETED|Part 1||12
884401|NCT01967940|2139808|P3|STARTED|Part 1||15
884402|NCT01967940|2139809|P2|STARTED|Part 1||28
884403|NCT01967940|2139810|P1|STARTED|Part 1||12
884404|NCT01967836|2139821|P1|NOT COMPLETED|Overall Study||9
884405|NCT01967836|2139821|P1|COMPLETED|Overall Study||11
884406|NCT01967836|2139821|P1|STARTED|Overall Study||20
884407|NCT01967784|2139827|P1|NOT COMPLETED|Overall Study||0
884408|NCT01967784|2139827|P1|COMPLETED|Overall Study||100
884409|NCT01967784|2139827|P1|STARTED|Overall Study||100
884410|NCT01967732|2139837|P4|NOT COMPLETED|Second Intervention (Day 3)||0
884411|NCT01967732|2139838|P3|NOT COMPLETED|Second Intervention (Day 3)||0
884412|NCT01967732|2139839|P2|NOT COMPLETED|Second Intervention (Day 3)||0
884413|NCT01967732|2139840|P1|NOT COMPLETED|Second Intervention (Day 3)||0
884414|NCT01967732|2139837|P4|COMPLETED|Second Intervention (Day 3)||9
884415|NCT01967732|2139838|P3|COMPLETED|Second Intervention (Day 3)||9
884416|NCT01967732|2139839|P2|COMPLETED|Second Intervention (Day 3)||20
884417|NCT01967732|2139840|P1|COMPLETED|Second Intervention (Day 3)||22
884418|NCT01967732|2139837|P4|STARTED|Second Intervention (Day 3)||9
884419|NCT01967732|2139838|P3|STARTED|Second Intervention (Day 3)||9
884420|NCT01967732|2139839|P2|STARTED|Second Intervention (Day 3)||20
884421|NCT01967732|2139840|P1|STARTED|Second Intervention (Day 3)||22
884422|NCT01967732|2139837|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
884423|NCT01967732|2139838|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
884424|NCT01967732|2139839|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
884425|NCT01967732|2139840|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
884426|NCT01967732|2139837|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
884427|NCT01967732|2139838|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
884428|NCT01967732|2139839|P2|COMPLETED|Washout Period of 1 Day (Day 2)||20
884429|NCT01967732|2139840|P1|COMPLETED|Washout Period of 1 Day (Day 2)||22
884430|NCT01967732|2139837|P4|STARTED|Washout Period of 1 Day (Day 2)||9
884431|NCT01967732|2139838|P3|STARTED|Washout Period of 1 Day (Day 2)||9
884432|NCT01967732|2139839|P2|STARTED|Washout Period of 1 Day (Day 2)||20
884433|NCT01967732|2139840|P1|STARTED|Washout Period of 1 Day (Day 2)||22
884434|NCT01967732|2139837|P4|NOT COMPLETED|First Intervention (Day 1)||0
884435|NCT01967732|2139838|P3|NOT COMPLETED|First Intervention (Day 1)||0
884436|NCT01967732|2139839|P2|NOT COMPLETED|First Intervention (Day 1)||1
884437|NCT01967732|2139840|P1|NOT COMPLETED|First Intervention (Day 1)||0
884438|NCT01967732|2139837|P4|COMPLETED|First Intervention (Day 1)||9
884439|NCT01967732|2139838|P3|COMPLETED|First Intervention (Day 1)||9
884440|NCT01967732|2139839|P2|COMPLETED|First Intervention (Day 1)|Subject discontinued from the study prior to product use|20
884441|NCT01967732|2139840|P1|COMPLETED|First Intervention (Day 1)||22
884442|NCT01967732|2139837|P4|STARTED|First Intervention (Day 1)||9
884443|NCT01967732|2139838|P3|STARTED|First Intervention (Day 1)||9
884444|NCT01967732|2139839|P2|STARTED|First Intervention (Day 1)||21
884445|NCT01967732|2139840|P1|STARTED|First Intervention (Day 1)||22
884446|NCT01967732|2139837|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
884447|NCT01967732|2139838|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
884448|NCT01967732|2139839|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||1
884449|NCT01967732|2139840|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
884450|NCT01967732|2139837|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
884451|NCT01967732|2139838|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
884452|NCT01967732|2139839|P2|COMPLETED|Washout Period of 1 Day (Day 0)||21
884453|NCT01967732|2139840|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
884454|NCT01967732|2139837|P4|STARTED|Washout Period of 1 Day (Day 0)||9
884455|NCT01967732|2139838|P3|STARTED|Washout Period of 1 Day (Day 0)||9
884456|NCT01967732|2139839|P2|STARTED|Washout Period of 1 Day (Day 0)||22
884457|NCT01967732|2139840|P1|STARTED|Washout Period of 1 Day (Day 0)||22
884458|NCT01967719|2139854|P4|NOT COMPLETED|Second Intervention (Day 3)||0
884459|NCT01967719|2139855|P3|NOT COMPLETED|Second Intervention (Day 3)||0
884460|NCT01967719|2139856|P2|NOT COMPLETED|Second Intervention (Day 3)||1
884461|NCT01967719|2139857|P1|NOT COMPLETED|Second Intervention (Day 3)||0
884462|NCT01967719|2139854|P4|COMPLETED|Second Intervention (Day 3)||8
884463|NCT01967719|2139855|P3|COMPLETED|Second Intervention (Day 3)||9
884464|NCT01967719|2139856|P2|COMPLETED|Second Intervention (Day 3)||20
884465|NCT01967719|2139857|P1|COMPLETED|Second Intervention (Day 3)||22
884466|NCT01967719|2139854|P4|STARTED|Second Intervention (Day 3)||8
884467|NCT01967719|2139855|P3|STARTED|Second Intervention (Day 3)||9
884468|NCT01967719|2139856|P2|STARTED|Second Intervention (Day 3)||21
884469|NCT01967719|2139857|P1|STARTED|Second Intervention (Day 3)||22
884470|NCT01967719|2139854|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
884471|NCT01967719|2139855|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
884472|NCT01967719|2139856|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
884473|NCT01967719|2139857|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
884474|NCT01967719|2139854|P4|COMPLETED|Washout Period of 1 Day (Day 2)||8
884475|NCT01967719|2139855|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
884476|NCT01967719|2139856|P2|COMPLETED|Washout Period of 1 Day (Day 2)||21
884477|NCT01967719|2139857|P1|COMPLETED|Washout Period of 1 Day (Day 2)||22
884478|NCT01967719|2139854|P4|STARTED|Washout Period of 1 Day (Day 2)||8
884479|NCT01967719|2139855|P3|STARTED|Washout Period of 1 Day (Day 2)||9
884480|NCT01967719|2139856|P2|STARTED|Washout Period of 1 Day (Day 2)||21
884481|NCT01967719|2139857|P1|STARTED|Washout Period of 1 Day (Day 2)||22
884482|NCT01967719|2139854|P4|NOT COMPLETED|First Intervention (Day 1)||1
884483|NCT01967719|2139855|P3|NOT COMPLETED|First Intervention (Day 1)||0
884484|NCT01967719|2139856|P2|NOT COMPLETED|First Intervention (Day 1)||1
884485|NCT01967719|2139857|P1|NOT COMPLETED|First Intervention (Day 1)||0
884486|NCT01967719|2139854|P4|COMPLETED|First Intervention (Day 1)||8
884487|NCT01967719|2139855|P3|COMPLETED|First Intervention (Day 1)||9
884488|NCT01967719|2139856|P2|COMPLETED|First Intervention (Day 1)||21
884489|NCT01967719|2139857|P1|COMPLETED|First Intervention (Day 1)||22
884490|NCT01967719|2139854|P4|STARTED|First Intervention (Day 1)||9
884491|NCT01967719|2139855|P3|STARTED|First Intervention (Day 1)||9
884492|NCT01967719|2139856|P2|STARTED|First Intervention (Day 1)||22
884493|NCT01967719|2139857|P1|STARTED|First Intervention (Day 1)||22
884494|NCT01967719|2139854|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
884495|NCT01967719|2139855|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
884496|NCT01967719|2139856|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
884497|NCT01967719|2139857|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
884498|NCT01967719|2139854|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
884499|NCT01967719|2139855|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
884500|NCT01967719|2139856|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
884501|NCT01967719|2139857|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
884502|NCT01967719|2139854|P4|STARTED|Washout Period of 1 Day (Day 0)||9
884503|NCT01967719|2139855|P3|STARTED|Washout Period of 1 Day (Day 0)||9
884504|NCT01967719|2139856|P2|STARTED|Washout Period of 1 Day (Day 0)||22
884505|NCT01967719|2139857|P1|STARTED|Washout Period of 1 Day (Day 0)||22
884506|NCT01967706|2139872|P4|NOT COMPLETED|Second Intervention (Day 3)||0
884507|NCT01967706|2139873|P3|NOT COMPLETED|Second Intervention (Day 3)||0
884508|NCT01967706|2139874|P2|NOT COMPLETED|Second Intervention (Day 3)||0
884509|NCT01967706|2139875|P1|NOT COMPLETED|Second Intervention (Day 3)||0
884510|NCT01967706|2139872|P4|COMPLETED|Second Intervention (Day 3)||9
884511|NCT01967706|2139873|P3|COMPLETED|Second Intervention (Day 3)||9
884512|NCT01967706|2139874|P2|COMPLETED|Second Intervention (Day 3)||22
884513|NCT01967706|2139875|P1|COMPLETED|Second Intervention (Day 3)||21
884514|NCT01967706|2139872|P4|STARTED|Second Intervention (Day 3)||9
884515|NCT01967706|2139873|P3|STARTED|Second Intervention (Day 3)||9
884516|NCT01967706|2139874|P2|STARTED|Second Intervention (Day 3)||22
884517|NCT01967706|2139875|P1|STARTED|Second Intervention (Day 3)||21
884518|NCT01967706|2139872|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
884519|NCT01967706|2139873|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
884520|NCT01967706|2139874|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
884521|NCT01967706|2139875|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
884522|NCT01967706|2139872|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
884523|NCT01967706|2139873|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
884524|NCT01967706|2139874|P2|COMPLETED|Washout Period of 1 Day (Day 2)||22
884525|NCT01967706|2139875|P1|COMPLETED|Washout Period of 1 Day (Day 2)||21
884526|NCT01967706|2139872|P4|STARTED|Washout Period of 1 Day (Day 2)||9
884527|NCT01967706|2139873|P3|STARTED|Washout Period of 1 Day (Day 2)||9
884528|NCT01967706|2139874|P2|STARTED|Washout Period of 1 Day (Day 2)||22
884529|NCT01967706|2139875|P1|STARTED|Washout Period of 1 Day (Day 2)||21
884530|NCT01967706|2139872|P4|NOT COMPLETED|First Intervention (Day 1)||0
884531|NCT01967706|2139873|P3|NOT COMPLETED|First Intervention (Day 1)||0
884532|NCT01967706|2139874|P2|NOT COMPLETED|First Intervention (Day 1)||0
884533|NCT01967706|2139875|P1|NOT COMPLETED|First Intervention (Day 1)||1
884534|NCT01967706|2139872|P4|COMPLETED|First Intervention (Day 1)||9
884535|NCT01967706|2139873|P3|COMPLETED|First Intervention (Day 1)||9
884536|NCT01967706|2139874|P2|COMPLETED|First Intervention (Day 1)||22
884537|NCT01967706|2139875|P1|COMPLETED|First Intervention (Day 1)||21
884538|NCT01967706|2139872|P4|STARTED|First Intervention (Day 1)||9
884539|NCT01967706|2139873|P3|STARTED|First Intervention (Day 1)||9
884540|NCT01967706|2139874|P2|STARTED|First Intervention (Day 1)||22
884541|NCT01967706|2139875|P1|STARTED|First Intervention (Day 1)||22
884542|NCT01967706|2139872|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
884543|NCT01967706|2139873|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
884544|NCT01967706|2139874|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
884545|NCT01967706|2139875|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
884546|NCT01967706|2139872|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
884547|NCT01967706|2139873|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
884548|NCT01967706|2139874|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
884549|NCT01967706|2139875|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
884550|NCT01967706|2139872|P4|STARTED|Washout Period of 1 Day (Day 0)||9
884551|NCT01967706|2139873|P3|STARTED|Washout Period of 1 Day (Day 0)||9
884552|NCT01967706|2139874|P2|STARTED|Washout Period of 1 Day (Day 0)||22
884553|NCT01967706|2139875|P1|STARTED|Washout Period of 1 Day (Day 0)||22
884554|NCT01967550|2139890|P2|NOT COMPLETED|Overall Study||2
884555|NCT01967550|2139891|P1|NOT COMPLETED|Overall Study||5
884556|NCT01967550|2139890|P2|COMPLETED|Overall Study||149
884557|NCT01967550|2139891|P1|COMPLETED|Overall Study||148
884558|NCT01967550|2139890|P2|STARTED|Overall Study||151
884559|NCT01967550|2139891|P1|STARTED|Overall Study||153
884560|NCT01967342|2139900|P3|NOT COMPLETED|Overall Study||29
884561|NCT01967342|2139901|P2|NOT COMPLETED|Overall Study||25
884562|NCT01967342|2139902|P1|NOT COMPLETED|Overall Study||27
884563|NCT01967342|2139900|P3|COMPLETED|Overall Study||68
884564|NCT01967342|2139901|P2|COMPLETED|Overall Study||70
884565|NCT01967342|2139902|P1|COMPLETED|Overall Study||71
884566|NCT01967342|2139900|P3|10-week Follow-up|Overall Study||80
884567|NCT01967342|2139901|P2|10-week Follow-up|Overall Study||83
884568|NCT01967342|2139902|P1|10-week Follow-up|Overall Study||78
884569|NCT01967342|2139900|P3|5-week Follow-up|Overall Study||76
884570|NCT01967342|2139901|P2|5-week Follow-up|Overall Study||78
884571|NCT01967342|2139902|P1|5-week Follow-up|Overall Study||83
884572|NCT01967342|2139900|P3|STARTED|Overall Study||97
884573|NCT01967342|2139901|P2|STARTED|Overall Study||95
884574|NCT01967342|2139902|P1|STARTED|Overall Study||98
884575|NCT01967277|2139921|P2|NOT COMPLETED|Overall Study||3
884576|NCT01967277|2139922|P1|NOT COMPLETED|Overall Study||1
884577|NCT01967277|2139921|P2|COMPLETED|Overall Study||19
884578|NCT01967277|2139922|P1|COMPLETED|Overall Study||21
884579|NCT01967277|2139921|P2|STARTED|Overall Study||22
884580|NCT01967277|2139922|P1|STARTED|Overall Study||22
884581|NCT01967147|2139932|P2|NOT COMPLETED|Overall Study||20
884582|NCT01967147|2139933|P1|NOT COMPLETED|Overall Study||13
884583|NCT01967147|2139932|P2|COMPLETED|Overall Study||82
884584|NCT01967147|2139933|P1|COMPLETED|Overall Study||99
884585|NCT01967147|2139932|P2|STARTED|Overall Study||102
884586|NCT01967147|2139933|P1|STARTED|Overall Study||112
884587|NCT01967121|2139951|P3|NOT COMPLETED|Overall Study||0
884588|NCT01967121|2139952|P2|NOT COMPLETED|Overall Study||0
884589|NCT01967121|2139953|P1|NOT COMPLETED|Overall Study||0
884590|NCT01967121|2139951|P3|COMPLETED|Overall Study||25
884591|NCT01967121|2139952|P2|COMPLETED|Overall Study||25
884592|NCT01967121|2139953|P1|COMPLETED|Overall Study||25
884593|NCT01967121|2139951|P3|STARTED|Overall Study||25
884594|NCT01967121|2139952|P2|STARTED|Overall Study||25
884595|NCT01967121|2139953|P1|STARTED|Overall Study||25
884596|NCT01967069|2139963|P2|NOT COMPLETED|Overall Study||8
884597|NCT01967069|2139964|P1|NOT COMPLETED|Overall Study||8
884598|NCT01967069|2139963|P2|COMPLETED|Overall Study||87
884599|NCT01967069|2139964|P1|COMPLETED|Overall Study||174
884600|NCT01967069|2139963|P2|STARTED|Overall Study||95
884601|NCT01967069|2139964|P1|STARTED|Overall Study||182
884602|NCT01966926|2139972|P2|NOT COMPLETED|Overall Study||0
884603|NCT01966926|2139973|P1|NOT COMPLETED|Overall Study||0
884604|NCT01966926|2139972|P2|COMPLETED|Overall Study||15
884605|NCT01966926|2139973|P1|COMPLETED|Overall Study||15
884606|NCT01966926|2139972|P2|STARTED|Overall Study||15
884607|NCT01966926|2139973|P1|STARTED|Overall Study||15
884608|NCT01966770|2139989|P1|NOT COMPLETED|Overall Study||0
884609|NCT01966770|2139989|P1|COMPLETED|Overall Study||20
884610|NCT01966770|2139989|P1|STARTED|Overall Study||20
884611|NCT01966718|2140098|P1|NOT COMPLETED|Overall Study||0
884612|NCT01966718|2140098|P1|COMPLETED|Overall Study||8
884613|NCT01966718|2140098|P1|STARTED|Overall Study||8
884614|NCT01966432|2140109|P3|NOT COMPLETED|Overall Study||26
884615|NCT01966432|2140110|P2|NOT COMPLETED|Overall Study||13
884616|NCT01966432|2140111|P1|NOT COMPLETED|Overall Study||5
884617|NCT01966432|2140109|P3|COMPLETED|Overall Study||28
884618|NCT01966432|2140110|P2|COMPLETED|Overall Study||21
884619|NCT01966432|2140111|P1|COMPLETED|Overall Study||5
884620|NCT01966432|2140109|P3|STARTED|Overall Study||54
884621|NCT01966432|2140110|P2|STARTED|Overall Study||34
884622|NCT01966432|2140111|P1|STARTED|Overall Study||10
884623|NCT01966380|2140131|P2|NOT COMPLETED|Overall Study||1
884624|NCT01966380|2140132|P1|NOT COMPLETED|Overall Study||0
884625|NCT01966380|2140131|P2|COMPLETED|Overall Study||2
884626|NCT01966380|2140132|P1|COMPLETED|Overall Study||3
884627|NCT01966380|2140131|P2|STARTED|Overall Study||3
884628|NCT01966380|2140132|P1|STARTED|Overall Study||3
884629|NCT01966354|2140141|P3|NOT COMPLETED|Overall Study||0
884630|NCT01966354|2140142|P2|NOT COMPLETED|Overall Study||0
884631|NCT01966354|2140143|P1|NOT COMPLETED|Overall Study||0
884632|NCT01966354|2140141|P3|COMPLETED|Overall Study||72
884633|NCT01966354|2140142|P2|COMPLETED|Overall Study||73
884634|NCT01966354|2140143|P1|COMPLETED|Overall Study||75
884635|NCT01966354|2140141|P3|STARTED|Overall Study||72
884636|NCT01966354|2140142|P2|STARTED|Overall Study||73
884637|NCT01966354|2140143|P1|STARTED|Overall Study||75
884638|NCT01966159|2140168|P2|NOT COMPLETED|Overall Study||0
884639|NCT01966159|2140169|P1|NOT COMPLETED|Overall Study||0
884640|NCT01966159|2140168|P2|COMPLETED|Overall Study||207
884641|NCT01966159|2140169|P1|COMPLETED|Overall Study||205
884642|NCT01966159|2140168|P2|STARTED|Overall Study||207
884643|NCT01966159|2140169|P1|STARTED|Overall Study||205
884644|NCT01966120|2140181|P2|NOT COMPLETED|Overall Study||6
884645|NCT01966120|2140182|P1|NOT COMPLETED|Overall Study||1
884646|NCT01966120|2140181|P2|COMPLETED|Overall Study||26
884647|NCT01966120|2140182|P1|COMPLETED|Overall Study||54
884648|NCT01966120|2140181|P2|STARTED|Overall Study||32
884649|NCT01966120|2140182|P1|STARTED|Overall Study||55
884650|NCT01966068|2140206|P1|NOT COMPLETED|Overall Study||138
884651|NCT01966068|2140206|P1|COMPLETED|Overall Study||156
884652|NCT01966068|2140206|P1|Use the MyAsthma Portal More Than Once|Overall Study||156
884653|NCT01966068|2140206|P1|Used the MyAsthma Portal at Least Once|Overall Study||237
884654|NCT01966068|2140206|P1|STARTED|Overall Study||294
884655|NCT01966042|2140211|P1|NOT COMPLETED|Overall Study||2
884656|NCT01966042|2140211|P1|COMPLETED|Overall Study||11
884657|NCT01966042|2140211|P1|STARTED|Overall Study||13
884658|NCT01965938|2140220|P2|NOT COMPLETED|Overall Study||0
884659|NCT01965938|2140221|P1|NOT COMPLETED|Overall Study||1
884660|NCT01965938|2140220|P2|COMPLETED|Overall Study||20
884661|NCT01965938|2140221|P1|COMPLETED|Overall Study||20
884662|NCT01965938|2140220|P2|STARTED|Overall Study||20
884663|NCT01965938|2140221|P1|STARTED|Overall Study||21
884664|NCT01965899|2140241|P1|NOT COMPLETED|Overall Study||6
884665|NCT01965899|2140241|P1|COMPLETED|Overall Study||145
884666|NCT01965899|2140241|P1|STARTED|Overall Study||151
884667|NCT01965834|2140252|P1|NOT COMPLETED|Overall Study||4
884668|NCT01965834|2140252|P1|COMPLETED|Overall Study||2
884669|NCT01965834|2140252|P1|STARTED|Overall Study||6
884670|NCT01965756|2140260|P2|NOT COMPLETED|Overall Study||0
884671|NCT01965756|2140261|P1|NOT COMPLETED|Overall Study||0
884672|NCT01965756|2140260|P2|COMPLETED|Overall Study||10
884673|NCT01965756|2140261|P1|COMPLETED|Overall Study||10
884674|NCT01965756|2140260|P2|STARTED|Overall Study||10
884675|NCT01965756|2140261|P1|STARTED|Overall Study||10
884676|NCT01965665|2140275|P1|NOT COMPLETED|Overall Study||1
884677|NCT01965665|2140275|P1|COMPLETED|Overall Study||19
884678|NCT01965665|2140275|P1|STARTED|Overall Study||20
884679|NCT01965652|2140283|P2|NOT COMPLETED|Overall Study||210
884680|NCT01965652|2140284|P1|NOT COMPLETED|Overall Study||210
884681|NCT01965652|2140283|P2|COMPLETED|Overall Study||413
884682|NCT01965652|2140284|P1|COMPLETED|Overall Study||413
884683|NCT01965652|2140283|P2|Received Treatment|Overall Study||623
884684|NCT01965652|2140284|P1|Received Treatment|Overall Study||622
884685|NCT01965652|2140283|P2|STARTED|Overall Study|Includes three participants who each enrolled at two different sites|623
884686|NCT01965652|2140284|P1|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|623
884687|NCT01965600|2140314|P4|NOT COMPLETED|Second Intervention||2
884688|NCT01965600|2140315|P3|NOT COMPLETED|Second Intervention||2
884689|NCT01965600|2140316|P2|NOT COMPLETED|Second Intervention||0
884690|NCT01965600|2140317|P1|NOT COMPLETED|Second Intervention||0
884691|NCT01965600|2140314|P4|COMPLETED|Second Intervention||0
884692|NCT01965600|2140315|P3|COMPLETED|Second Intervention||1
884693|NCT01965600|2140316|P2|COMPLETED|Second Intervention||4
884694|NCT01965600|2140317|P1|COMPLETED|Second Intervention||4
884695|NCT01965600|2140314|P4|STARTED|Second Intervention||2
884696|NCT01965600|2140315|P3|STARTED|Second Intervention||3
884697|NCT01965600|2140316|P2|STARTED|Second Intervention||4
884698|NCT01965600|2140317|P1|STARTED|Second Intervention||4
884699|NCT01965600|2140314|P4|NOT COMPLETED|Washout Period of Approximately 15 Days||2
884700|NCT01965600|2140315|P3|NOT COMPLETED|Washout Period of Approximately 15 Days||2
884701|NCT01965600|2140316|P2|NOT COMPLETED|Washout Period of Approximately 15 Days||4
884702|NCT01965600|2140317|P1|NOT COMPLETED|Washout Period of Approximately 15 Days||2
884703|NCT01965600|2140314|P4|COMPLETED|Washout Period of Approximately 15 Days||2
884704|NCT01965600|2140315|P3|COMPLETED|Washout Period of Approximately 15 Days||3
884705|NCT01965600|2140316|P2|COMPLETED|Washout Period of Approximately 15 Days||4
884706|NCT01965600|2140317|P1|COMPLETED|Washout Period of Approximately 15 Days||4
884707|NCT01965600|2140314|P4|STARTED|Washout Period of Approximately 15 Days||4
884708|NCT01965600|2140315|P3|STARTED|Washout Period of Approximately 15 Days||5
884709|NCT01965600|2140316|P2|STARTED|Washout Period of Approximately 15 Days||8
884710|NCT01965600|2140317|P1|STARTED|Washout Period of Approximately 15 Days||6
884711|NCT01965600|2140314|P4|NOT COMPLETED|First Intervention||0
884712|NCT01965600|2140315|P3|NOT COMPLETED|First Intervention||0
884713|NCT01965600|2140316|P2|NOT COMPLETED|First Intervention||0
884714|NCT01965600|2140317|P1|NOT COMPLETED|First Intervention||0
884715|NCT01965600|2140314|P4|COMPLETED|First Intervention||4
884716|NCT01965600|2140315|P3|COMPLETED|First Intervention||5
884717|NCT01965600|2140316|P2|COMPLETED|First Intervention||8
884718|NCT01965600|2140317|P1|COMPLETED|First Intervention||6
884719|NCT01965600|2140314|P4|Received at Least One Dose of Drug|First Intervention||4
884720|NCT01965600|2140315|P3|Received at Least One Dose of Drug|First Intervention||5
884721|NCT01965600|2140316|P2|Received at Least One Dose of Drug|First Intervention||8
884722|NCT01965600|2140317|P1|Received at Least One Dose of Drug|First Intervention||6
884723|NCT01965600|2140314|P4|STARTED|First Intervention||4
884724|NCT01965600|2140315|P3|STARTED|First Intervention||5
884725|NCT01965600|2140316|P2|STARTED|First Intervention||8
884726|NCT01965600|2140317|P1|STARTED|First Intervention||6
884727|NCT01965561|2140361|P1|NOT COMPLETED|Overall Study||0
884728|NCT01965561|2140361|P1|COMPLETED|Overall Study||10
884729|NCT01965561|2140361|P1|STARTED|Overall Study||10
884730|NCT01965535|2140374|P2|NOT COMPLETED|Overall Study||1
884731|NCT01965535|2140375|P1|NOT COMPLETED|Overall Study||2
884732|NCT01965535|2140374|P2|COMPLETED|Overall Study||76
884733|NCT01965535|2140375|P1|COMPLETED|Overall Study||76
884734|NCT01965535|2140374|P2|STARTED|Overall Study||77
884735|NCT01965535|2140375|P1|STARTED|Overall Study||78
884736|NCT01965431|2140389|P6|NOT COMPLETED|Overall Study||6
884737|NCT01965431|2140390|P5|NOT COMPLETED|Overall Study||6
884738|NCT01965431|2140391|P4|NOT COMPLETED|Overall Study||6
884739|NCT01965431|2140392|P3|NOT COMPLETED|Overall Study||6
884740|NCT01965431|2140393|P2|NOT COMPLETED|Overall Study||6
884741|NCT01965431|2140394|P1|NOT COMPLETED|Overall Study||6
884742|NCT01965431|2140389|P6|COMPLETED|Overall Study||2
884743|NCT01965431|2140390|P5|COMPLETED|Overall Study||2
884744|NCT01965431|2140391|P4|COMPLETED|Overall Study||2
884745|NCT01965431|2140392|P3|COMPLETED|Overall Study||2
884746|NCT01965431|2140393|P2|COMPLETED|Overall Study||2
884747|NCT01965431|2140394|P1|COMPLETED|Overall Study||2
884748|NCT01965431|2140389|P6|STARTED|Overall Study||8
884749|NCT01965431|2140390|P5|STARTED|Overall Study||8
884750|NCT01965431|2140391|P4|STARTED|Overall Study||8
884751|NCT01965431|2140392|P3|STARTED|Overall Study||8
884752|NCT01965431|2140393|P2|STARTED|Overall Study||8
884753|NCT01965431|2140394|P1|STARTED|Overall Study|Started are actually Treated subjects|8
884754|NCT01965327|2140407|P1|NOT COMPLETED|Overall Study||2
884755|NCT01965327|2140407|P1|COMPLETED|Overall Study|Prior to completion, 2 subjects were withdrawn by the PI for failure to adhere to study protocol.|10
884756|NCT01965327|2140407|P1|STARTED|Overall Study||12
884757|NCT01965288|2140414|P2|NOT COMPLETED|Overall Study||0
884758|NCT01965288|2140415|P1|NOT COMPLETED|Overall Study||0
884759|NCT01965288|2140414|P2|COMPLETED|Overall Study||30
884760|NCT01965288|2140415|P1|COMPLETED|Overall Study||30
884761|NCT01965288|2140414|P2|STARTED|Overall Study||30
884762|NCT01965288|2140415|P1|STARTED|Overall Study||30
884763|NCT01965262|2140621|P2|NOT COMPLETED|Second Intervention (7 Days)||10
884764|NCT01965262|2140622|P1|NOT COMPLETED|Second Intervention (7 Days)||1
884765|NCT01965262|2140621|P2|COMPLETED|Second Intervention (7 Days)||5
884766|NCT01965262|2140622|P1|COMPLETED|Second Intervention (7 Days)||14
884767|NCT01965262|2140621|P2|STARTED|Second Intervention (7 Days)||15
884768|NCT01965262|2140622|P1|STARTED|Second Intervention (7 Days)||15
884769|NCT01965262|2140621|P2|NOT COMPLETED|First Intervention (7 Days)||0
884770|NCT01965262|2140622|P1|NOT COMPLETED|First Intervention (7 Days)||0
884771|NCT01965262|2140621|P2|COMPLETED|First Intervention (7 Days)||15
884772|NCT01965262|2140622|P1|COMPLETED|First Intervention (7 Days)||15
884773|NCT01965262|2140621|P2|STARTED|First Intervention (7 Days)||15
884774|NCT01965262|2140622|P1|STARTED|First Intervention (7 Days)||15
884775|NCT01965158|2140686|P2|NOT COMPLETED|Overall Study||35
884776|NCT01965158|2140687|P1|NOT COMPLETED|Overall Study||41
884777|NCT01965158|2140686|P2|COMPLETED|Overall Study||238
884778|NCT01965158|2140687|P1|COMPLETED|Overall Study||233
884779|NCT01965158|2140686|P2|Received Treatment|Overall Study||273
884780|NCT01965158|2140687|P1|Received Treatment|Overall Study||272
884781|NCT01965158|2140686|P2|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|273
884782|NCT01965158|2140687|P1|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|274
884783|NCT01965067|2140703|P2|NOT COMPLETED|Overall Study||0
884784|NCT01965067|2140704|P1|NOT COMPLETED|Overall Study||0
884785|NCT01965067|2140703|P2|COMPLETED|Overall Study||30
884786|NCT01965067|2140704|P1|COMPLETED|Overall Study||30
884787|NCT01965067|2140703|P2|STARTED|Overall Study||30
884788|NCT01965067|2140704|P1|STARTED|Overall Study||30
884789|NCT01964976|2140722|P1|NOT COMPLETED|Overall Study||31
884790|NCT01964976|2140722|P1|COMPLETED|Overall Study||1065
884791|NCT01964976|2140722|P1|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1096
884792|NCT01964950|2140736|P1|NOT COMPLETED|Overall Study||25
884793|NCT01964950|2140736|P1|COMPLETED|Overall Study||1076
884794|NCT01964950|2140736|P1|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1101
884795|NCT01964898|2140750|P2|NOT COMPLETED|Overall Study||7
884796|NCT01964898|2140751|P1|NOT COMPLETED|Overall Study||7
884797|NCT01964898|2140750|P2|COMPLETED|Overall Study||26
884798|NCT01964898|2140751|P1|COMPLETED|Overall Study||24
884799|NCT01964898|2140750|P2|12 Week Assessment|Overall Study||30
884800|NCT01964898|2140751|P1|12 Week Assessment|Overall Study||25
884801|NCT01964898|2140750|P2|STARTED|Overall Study||33
884802|NCT01964898|2140751|P1|STARTED|Overall Study||31
884803|NCT01964716|2140773|P2|NOT COMPLETED|Overall Study||6
884804|NCT01964716|2140774|P1|NOT COMPLETED|Overall Study||5
884805|NCT01964716|2140773|P2|COMPLETED|Overall Study||244
884806|NCT01964716|2140774|P1|COMPLETED|Overall Study||245
884807|NCT01964716|2140773|P2|Vaccinated Dose 3|Overall Study||244
884808|NCT01964716|2140774|P1|Vaccinated Dose 3|Overall Study||247
884809|NCT01964716|2140773|P2|Vaccinated Dose 2|Overall Study||248
884810|NCT01964716|2140774|P1|Vaccinated Dose 2|Overall Study||249
884811|NCT01964716|2140773|P2|Vaccinated Dose 1|Overall Study||250
884812|NCT01964716|2140774|P1|Vaccinated Dose 1|Overall Study||250
884813|NCT01964716|2140773|P2|STARTED|Overall Study||250
884814|NCT01964716|2140774|P1|STARTED|Overall Study||250
884815|NCT01964547|2140812|P2|NOT COMPLETED|Overall Study||11
884816|NCT01964547|2140813|P1|NOT COMPLETED|Overall Study||12
884817|NCT01964547|2140812|P2|COMPLETED|Overall Study||48
884818|NCT01964547|2140813|P1|COMPLETED|Overall Study||50
884819|NCT01964547|2140812|P2|STARTED|Overall Study||59
884820|NCT01964547|2140813|P1|STARTED|Overall Study||62
884821|NCT01964352|2140841|P4|NOT COMPLETED|Overall Study||8
884822|NCT01964352|2140842|P3|NOT COMPLETED|Overall Study||6
884823|NCT01964352|2140843|P2|NOT COMPLETED|Overall Study||11
884824|NCT01964352|2140844|P1|NOT COMPLETED|Overall Study||26
884825|NCT01964352|2140841|P4|COMPLETED|Overall Study||195
884826|NCT01964352|2140842|P3|COMPLETED|Overall Study||196
884827|NCT01964352|2140843|P2|COMPLETED|Overall Study||192
884828|NCT01964352|2140844|P1|COMPLETED|Overall Study||178
884829|NCT01964352|2140841|P4|STARTED|Overall Study||203
884830|NCT01964352|2140842|P3|STARTED|Overall Study||202
884831|NCT01964352|2140843|P2|STARTED|Overall Study||203
884832|NCT01964352|2140844|P1|STARTED|Overall Study||204
884833|NCT01964326|2140874|P1|NOT COMPLETED|Overall Study||297
884834|NCT01964326|2140874|P1|COMPLETED|Overall Study||1014
884835|NCT01964326|2140874|P1|STARTED|Overall Study||1311
884836|NCT01964222|2140883|P2|NOT COMPLETED|Overall Study||11
884837|NCT01964222|2140884|P1|NOT COMPLETED|Overall Study||15
884838|NCT01964222|2140883|P2|COMPLETED|Overall Study||89
884839|NCT01964222|2140884|P1|COMPLETED|Overall Study||86
884840|NCT01964222|2140883|P2|STARTED|Overall Study||100
884841|NCT01964222|2140884|P1|STARTED|Overall Study||101
884842|NCT01963845|2140900|P2|NOT COMPLETED|Overall Study||0
884843|NCT01963845|2140901|P1|NOT COMPLETED|Overall Study||0
884844|NCT01963845|2140900|P2|COMPLETED|Overall Study||25
884845|NCT01963845|2140901|P1|COMPLETED|Overall Study||25
884846|NCT01963845|2140900|P2|STARTED|Overall Study||25
884847|NCT01963845|2140901|P1|STARTED|Overall Study||25
884848|NCT01963767|2140917|P2|NOT COMPLETED|Overall Study||2
884849|NCT01963767|2140918|P1|NOT COMPLETED|Overall Study||6
884850|NCT01963767|2140917|P2|COMPLETED|Overall Study||53
884851|NCT01963767|2140918|P1|COMPLETED|Overall Study||52
884852|NCT01963767|2140917|P2|STARTED|Overall Study||55
884853|NCT01963767|2140918|P1|STARTED|Overall Study||58
884854|NCT01963676|2140928|P2|NOT COMPLETED|Overall Study||0
884855|NCT01963676|2140929|P1|NOT COMPLETED|Overall Study||1
884856|NCT01963676|2140928|P2|COMPLETED|Overall Study||13
884857|NCT01963676|2140929|P1|COMPLETED|Overall Study||13
884858|NCT01963676|2140928|P2|STARTED|Overall Study||13
884859|NCT01963676|2140929|P1|STARTED|Overall Study||14
884860|NCT01963611|2140942|P5|NOT COMPLETED|Overall Study||51
884861|NCT01963611|2140943|P4|NOT COMPLETED|Overall Study||52
884862|NCT01963611|2140944|P3|NOT COMPLETED|Overall Study||52
884863|NCT01963611|2140945|P2|NOT COMPLETED|Overall Study||49
884864|NCT01963611|2140946|P1|NOT COMPLETED|Overall Study||51
884865|NCT01963611|2140942|P5|COMPLETED|Overall Study||0
884866|NCT01963611|2140943|P4|COMPLETED|Overall Study||0
884867|NCT01963611|2140944|P3|COMPLETED|Overall Study||0
884868|NCT01963611|2140945|P2|COMPLETED|Overall Study||0
884869|NCT01963611|2140946|P1|COMPLETED|Overall Study||0
884870|NCT01963611|2140942|P5|Safety Analysis Set|Overall Study||50
884871|NCT01963611|2140943|P4|Safety Analysis Set|Overall Study||52
884872|NCT01963611|2140944|P3|Safety Analysis Set|Overall Study||52
884873|NCT01963611|2140945|P2|Safety Analysis Set|Overall Study||49
884874|NCT01963611|2140946|P1|Safety Analysis Set|Overall Study||51
884875|NCT01963611|2140942|P5|STARTED|Overall Study||51
884876|NCT01963611|2140943|P4|STARTED|Overall Study||52
884877|NCT01963611|2140944|P3|STARTED|Overall Study||52
884878|NCT01963611|2140945|P2|STARTED|Overall Study||49
884879|NCT01963611|2140946|P1|STARTED|Overall Study||51
884880|NCT01963403|2141005|P2|NOT COMPLETED|Overall Study||4
884881|NCT01963403|2141006|P1|NOT COMPLETED|Overall Study||2
884882|NCT01963403|2141005|P2|COMPLETED|Overall Study|Follow-up over three months|9
884883|NCT01963403|2141006|P1|COMPLETED|Overall Study|Follow-up over three months|11
884884|NCT01963403|2141005|P2|STARTED|Overall Study||13
884885|NCT01963403|2141006|P1|STARTED|Overall Study||13
884886|NCT01963260|2141028|P10|NOT COMPLETED|Overall Study||0
884887|NCT01963260|2141029|P9|NOT COMPLETED|Overall Study||0
884888|NCT01963260|2141030|P8|NOT COMPLETED|Overall Study||0
884889|NCT01963260|2141031|P7|NOT COMPLETED|Overall Study||0
884890|NCT01963260|2141032|P6|NOT COMPLETED|Overall Study||0
884891|NCT01963260|2141033|P5|NOT COMPLETED|Overall Study||2
884892|NCT01963260|2141034|P4|NOT COMPLETED|Overall Study||1
884893|NCT01963260|2141035|P3|NOT COMPLETED|Overall Study||0
884894|NCT01963260|2141036|P2|NOT COMPLETED|Overall Study||0
884895|NCT01963260|2141037|P1|NOT COMPLETED|Overall Study||2
884896|NCT01963260|2141028|P10|COMPLETED|Overall Study||4
884897|NCT01963260|2141029|P9|COMPLETED|Overall Study||1
884898|NCT01963260|2141030|P8|COMPLETED|Overall Study||2
884899|NCT01963260|2141031|P7|COMPLETED|Overall Study||3
884900|NCT01963260|2141032|P6|COMPLETED|Overall Study||10
884901|NCT01963260|2141033|P5|COMPLETED|Overall Study||4
884902|NCT01963260|2141034|P4|COMPLETED|Overall Study||5
884903|NCT01963260|2141035|P3|COMPLETED|Overall Study||6
884904|NCT01963260|2141036|P2|COMPLETED|Overall Study||6
884905|NCT01963260|2141037|P1|COMPLETED|Overall Study||4
884906|NCT01963260|2141028|P10|Treated|Overall Study||4
884907|NCT01963260|2141029|P9|Treated|Overall Study||1
884908|NCT01963260|2141030|P8|Treated|Overall Study||2
884909|NCT01963260|2141031|P7|Treated|Overall Study||3
884910|NCT01963260|2141032|P6|Treated|Overall Study||10
884911|NCT01963260|2141033|P5|Treated|Overall Study||6
884912|NCT01963260|2141034|P4|Treated|Overall Study||6
884913|NCT01963260|2141035|P3|Treated|Overall Study||6
884914|NCT01963260|2141036|P2|Treated|Overall Study||6
884915|NCT01963260|2141037|P1|Treated|Overall Study||6
884916|NCT01963260|2141028|P10|STARTED|Overall Study||4
884917|NCT01963260|2141029|P9|STARTED|Overall Study||1
884918|NCT01963260|2141030|P8|STARTED|Overall Study||2
884919|NCT01963260|2141031|P7|STARTED|Overall Study||3
884920|NCT01963260|2141032|P6|STARTED|Overall Study||10
884921|NCT01963260|2141033|P5|STARTED|Overall Study||6
884922|NCT01963260|2141034|P4|STARTED|Overall Study||6
884923|NCT01963260|2141035|P3|STARTED|Overall Study||6
884924|NCT01963260|2141036|P2|STARTED|Overall Study||6
884925|NCT01963260|2141037|P1|STARTED|Overall Study||6
884926|NCT01963143|2141092|P3|NOT COMPLETED|Overall Study||1
884927|NCT01963143|2141093|P2|NOT COMPLETED|Overall Study||1
884928|NCT01963143|2141094|P1|NOT COMPLETED|Overall Study||0
884929|NCT01963143|2141092|P3|COMPLETED|Overall Study||14
884930|NCT01963143|2141093|P2|COMPLETED|Overall Study||18
884931|NCT01963143|2141094|P1|COMPLETED|Overall Study||14
884932|NCT01963143|2141092|P3|STARTED|Overall Study||15
884933|NCT01963143|2141093|P2|STARTED|Overall Study||19
884934|NCT01963143|2141094|P1|STARTED|Overall Study||14
884935|NCT01963091|2141106|P2|NOT COMPLETED|Overall Study||0
884936|NCT01963091|2141107|P1|NOT COMPLETED|Overall Study||0
884937|NCT01963091|2141106|P2|COMPLETED|Overall Study||16
884938|NCT01963091|2141107|P1|COMPLETED|Overall Study||17
884939|NCT01963091|2141106|P2|STARTED|Overall Study||16
884940|NCT01963091|2141107|P1|STARTED|Overall Study||17
884941|NCT01962974|2141117|P1|NOT COMPLETED|Overall Study||7
884942|NCT01962974|2141117|P1|COMPLETED|Overall Study||0
884943|NCT01962974|2141117|P1|STARTED|Overall Study||7
884944|NCT01962961|2141126|P3|NOT COMPLETED|Overall Study||1
884945|NCT01962961|2141127|P2|NOT COMPLETED|Overall Study||1
884946|NCT01962961|2141128|P1|NOT COMPLETED|Overall Study||0
884947|NCT01962961|2141126|P3|COMPLETED|Overall Study||6
884948|NCT01962961|2141127|P2|COMPLETED|Overall Study||7
884949|NCT01962961|2141128|P1|COMPLETED|Overall Study||9
884950|NCT01962961|2141126|P3|STARTED|Overall Study||7
884951|NCT01962961|2141127|P2|STARTED|Overall Study||8
884952|NCT01962961|2141128|P1|STARTED|Overall Study||9
884953|NCT01962922|2141144|P2|NOT COMPLETED|Extendion Portion (up to Month 6)||3
884954|NCT01962922|2141145|P1|NOT COMPLETED|Extendion Portion (up to Month 6)||5
884955|NCT01962922|2141144|P2|COMPLETED|Extendion Portion (up to Month 6)||20
884956|NCT01962922|2141145|P1|COMPLETED|Extendion Portion (up to Month 6)||18
884957|NCT01962922|2141144|P2|STARTED|Extendion Portion (up to Month 6)||23
884958|NCT01962922|2141145|P1|STARTED|Extendion Portion (up to Month 6)||23
884959|NCT01962922|2141144|P2|NOT COMPLETED|PK Portion Day 21||0
884960|NCT01962922|2141145|P1|NOT COMPLETED|PK Portion Day 21||0
884961|NCT01962922|2141144|P2|COMPLETED|PK Portion Day 21||23
884962|NCT01962922|2141145|P1|COMPLETED|PK Portion Day 21||23
884963|NCT01962922|2141144|P2|STARTED|PK Portion Day 21||23
884964|NCT01962922|2141145|P1|STARTED|PK Portion Day 21||23
884965|NCT01962922|2141144|P2|NOT COMPLETED|PK Portion Day 14||0
884966|NCT01962922|2141145|P1|NOT COMPLETED|PK Portion Day 14||0
884967|NCT01962922|2141144|P2|COMPLETED|PK Portion Day 14||23
884968|NCT01962922|2141145|P1|COMPLETED|PK Portion Day 14||23
884969|NCT01962922|2141144|P2|STARTED|PK Portion Day 14||23
884970|NCT01962922|2141145|P1|STARTED|PK Portion Day 14||23
884971|NCT01962922|2141144|P2|NOT COMPLETED|PK Portion Day 7||0
884972|NCT01962922|2141145|P1|NOT COMPLETED|PK Portion Day 7||4
884973|NCT01962922|2141144|P2|COMPLETED|PK Portion Day 7||23
884974|NCT01962922|2141145|P1|COMPLETED|PK Portion Day 7||23
884975|NCT01962922|2141144|P2|STARTED|PK Portion Day 7||23
884976|NCT01962922|2141145|P1|STARTED|PK Portion Day 7||27
884977|NCT01962675|2141169|P2|NOT COMPLETED|Overall Study||0
884978|NCT01962675|2141170|P1|NOT COMPLETED|Overall Study||0
884979|NCT01962675|2141169|P2|COMPLETED|Overall Study||7
884980|NCT01962675|2141170|P1|COMPLETED|Overall Study||7
884981|NCT01962675|2141169|P2|STARTED|Overall Study||7
884982|NCT01962675|2141170|P1|STARTED|Overall Study||7
884983|NCT01962493|2141184|P2|NOT COMPLETED|Overall Study||5
884984|NCT01962493|2141185|P1|NOT COMPLETED|Overall Study||5
884985|NCT01962493|2141184|P2|COMPLETED|Overall Study||77
884986|NCT01962493|2141185|P1|COMPLETED|Overall Study||73
884987|NCT01962493|2141184|P2|STARTED|Overall Study||82
884988|NCT01962493|2141185|P1|STARTED|Overall Study||78
884989|NCT01962441|2141208|P3|NOT COMPLETED|Retreatment Substudy||0
884990|NCT01962441|2141209|P2|NOT COMPLETED|Retreatment Substudy||0
884991|NCT01962441|2141210|P1|NOT COMPLETED|Retreatment Substudy||2
884992|NCT01962441|2141208|P3|COMPLETED|Retreatment Substudy||0
884993|NCT01962441|2141209|P2|COMPLETED|Retreatment Substudy||10
884994|NCT01962441|2141210|P1|COMPLETED|Retreatment Substudy||18
884995|NCT01962441|2141208|P3|STARTED|Retreatment Substudy|Participants in the SOF+RBV+Peg-IFN group were not eligible to enroll in the Retreatment Substudy.|0
884996|NCT01962441|2141209|P2|STARTED|Retreatment Substudy|10 participants who experienced virologic failure enrolled into the Retreatment Substudy.|10
884997|NCT01962441|2141210|P1|STARTED|Retreatment Substudy|20 participants who experienced virologic failure enrolled into the Retreatment Substudy.|20
884998|NCT01962441|2141208|P3|NOT COMPLETED|Randomized Period||11
884999|NCT01962441|2141209|P2|NOT COMPLETED|Randomized Period||11
885000|NCT01962441|2141210|P1|NOT COMPLETED|Randomized Period||10
885001|NCT01962441|2141208|P3|COMPLETED|Randomized Period||189
885002|NCT01962441|2141209|P2|COMPLETED|Randomized Period||190
885003|NCT01962441|2141210|P1|COMPLETED|Randomized Period||190
885004|NCT01962441|2141208|P3|STARTED|Randomized Period||200
885005|NCT01962441|2141209|P2|STARTED|Randomized Period||201
885006|NCT01962441|2141210|P1|STARTED|Randomized Period||200
885007|NCT01962428|2141242|P2|NOT COMPLETED|Overall Study||6
885008|NCT01962428|2141243|P1|NOT COMPLETED|Overall Study||10
885009|NCT01962428|2141242|P2|COMPLETED|Overall Study||133
885010|NCT01962428|2141243|P1|COMPLETED|Overall Study||129
885011|NCT01962428|2141242|P2|STARTED|Overall Study||139
885012|NCT01962428|2141243|P1|STARTED|Overall Study||139
885013|NCT01961544|2141249|P1|NOT COMPLETED|Overall Study||13
885014|NCT01961544|2141249|P1|COMPLETED|Overall Study||88
885015|NCT01961544|2141249|P1|STARTED|Overall Study||101
885016|NCT01961349|2141257|P3|NOT COMPLETED|Overall Study||2
885017|NCT01961349|2141258|P2|NOT COMPLETED|Overall Study||6
885018|NCT01961349|2141259|P1|NOT COMPLETED|Overall Study||3
885019|NCT01961349|2141257|P3|COMPLETED|Overall Study||109
885020|NCT01961349|2141258|P2|COMPLETED|Overall Study||101
885021|NCT01961349|2141259|P1|COMPLETED|Overall Study||51
885022|NCT01961349|2141257|P3|STARTED|Overall Study||111
885023|NCT01961349|2141258|P2|STARTED|Overall Study||107
885024|NCT01961349|2141259|P1|STARTED|Overall Study||54
885025|NCT01961271|2141270|P1|NOT COMPLETED|Overall Study||50
885026|NCT01961271|2141270|P1|COMPLETED|Overall Study||64
885027|NCT01961271|2141270|P1|STARTED|Overall Study||114
885028|NCT01960907|2141281|P2|NOT COMPLETED|Overall Study||45
885029|NCT01960907|2141282|P1|NOT COMPLETED|Overall Study||36
885030|NCT01960907|2141281|P2|COMPLETED|Overall Study||109
885031|NCT01960907|2141282|P1|COMPLETED|Overall Study||122
885032|NCT01960907|2141281|P2|STARTED|Overall Study||154
885033|NCT01960907|2141282|P1|STARTED|Overall Study||158
885034|NCT01960842|2141292|P1|NOT COMPLETED|Overall Study||3
885035|NCT01960842|2141292|P1|COMPLETED|Overall Study||28
885036|NCT01960842|2141292|P1|STARTED|Overall Study||31
885037|NCT01960816|2141315|P1|NOT COMPLETED|Overall Study||1
885038|NCT01960816|2141315|P1|COMPLETED|Overall Study||32
885039|NCT01960816|2141315|P1|STARTED|Overall Study||33
885040|NCT01960725|2141323|P2|NOT COMPLETED|Overall Study||5
885041|NCT01960725|2141324|P1|NOT COMPLETED|Overall Study||6
885042|NCT01960725|2141323|P2|COMPLETED|Overall Study||28
885043|NCT01960725|2141324|P1|COMPLETED|Overall Study||27
885044|NCT01960725|2141323|P2|Received Third Vaccine|Overall Study||32
885045|NCT01960725|2141324|P1|Received Third Vaccine|Overall Study||32
885046|NCT01960725|2141323|P2|Recieved Second Vaccine|Overall Study||33
885047|NCT01960725|2141324|P1|Recieved Second Vaccine|Overall Study||33
885048|NCT01960725|2141323|P2|Received First Vaccine|Overall Study||33
885049|NCT01960725|2141324|P1|Received First Vaccine|Overall Study||33
885050|NCT01960725|2141323|P2|STARTED|Overall Study||33
885051|NCT01960725|2141324|P1|STARTED|Overall Study||33
885052|NCT01960530|2141346|P1|NOT COMPLETED|Overall Study||0
885053|NCT01960530|2141346|P1|COMPLETED|Overall Study||14
885054|NCT01960530|2141346|P1|STARTED|Overall Study||14
885055|NCT01960400|2141381|P2|NOT COMPLETED|Overall Study||0
885056|NCT01960400|2141382|P1|NOT COMPLETED|Overall Study||0
885057|NCT01960400|2141381|P2|COMPLETED|Overall Study||11
885058|NCT01960400|2141382|P1|COMPLETED|Overall Study||11
885059|NCT01960400|2141381|P2|STARTED|Overall Study||11
885060|NCT01960400|2141382|P1|STARTED|Overall Study||11
885061|NCT01960387|2141394|P1|NOT COMPLETED|Overall Study||0
885062|NCT01960387|2141394|P1|COMPLETED|Overall Study||2
885063|NCT01960387|2141394|P1|STARTED|Overall Study||2
885064|NCT01960296|2141403|P2|NOT COMPLETED|Overall Study||3
885065|NCT01960296|2141404|P1|NOT COMPLETED|Overall Study||2
885066|NCT01960296|2141403|P2|COMPLETED|Overall Study||22
885067|NCT01960296|2141404|P1|COMPLETED|Overall Study||21
885068|NCT01960296|2141403|P2|STARTED|Overall Study||25
885069|NCT01960296|2141404|P1|STARTED|Overall Study||23
885070|NCT01960140|2141424|P1|NOT COMPLETED|Period 2 (Days 3-18)||2
885071|NCT01960140|2141424|P1|COMPLETED|Period 2 (Days 3-18)||38
885072|NCT01960140|2141424|P1|Received Simvastatin|Period 2 (Days 3-18)||38
885073|NCT01960140|2141424|P1|Received At Least 1 Dose of Baricitinib|Period 2 (Days 3-18)||40
885074|NCT01960140|2141424|P1|STARTED|Period 2 (Days 3-18)||40
885075|NCT01960140|2141424|P1|NOT COMPLETED|Period 1 (Days 1-2)||0
885076|NCT01960140|2141424|P1|COMPLETED|Period 1 (Days 1-2)||40
885077|NCT01960140|2141424|P1|Received Simvastatin|Period 1 (Days 1-2)||40
885078|NCT01960140|2141424|P1|STARTED|Period 1 (Days 1-2)||40
885079|NCT01960114|2141435|P2|NOT COMPLETED|Overall Study||1
885080|NCT01960114|2141436|P1|NOT COMPLETED|Overall Study||1
885081|NCT01960114|2141435|P2|COMPLETED|Overall Study||268
885082|NCT01960114|2141436|P1|COMPLETED|Overall Study||133
885083|NCT01960114|2141435|P2|STARTED|Overall Study||269
885084|NCT01960114|2141436|P1|STARTED|Overall Study||134
885085|NCT01959945|2141454|P4|NOT COMPLETED|Overall Study||16
885086|NCT01959945|2141455|P3|NOT COMPLETED|Overall Study||19
885087|NCT01959945|2141456|P2|NOT COMPLETED|Overall Study||3
885088|NCT01959945|2141457|P1|NOT COMPLETED|Overall Study||4
885089|NCT01959945|2141454|P4|COMPLETED|Overall Study||15
885090|NCT01959945|2141455|P3|COMPLETED|Overall Study||9
885091|NCT01959945|2141456|P2|COMPLETED|Overall Study||75
885092|NCT01959945|2141457|P1|COMPLETED|Overall Study||76
885093|NCT01959945|2141454|P4|STARTED|Overall Study||31
885094|NCT01959945|2141455|P3|STARTED|Overall Study||28
885095|NCT01959945|2141456|P2|STARTED|Overall Study||78
885096|NCT01959945|2141457|P1|STARTED|Overall Study||80
885097|NCT01959932|2141482|P3|NOT COMPLETED|Overall Study||0
885098|NCT01959932|2141483|P2|NOT COMPLETED|Overall Study||0
885099|NCT01959932|2141484|P1|NOT COMPLETED|Overall Study||1
885100|NCT01959932|2141482|P3|COMPLETED|Overall Study||39
885101|NCT01959932|2141483|P2|COMPLETED|Overall Study||41
885102|NCT01959932|2141484|P1|COMPLETED|Overall Study||79
885103|NCT01959932|2141482|P3|STARTED|Overall Study||39
885104|NCT01959932|2141483|P2|STARTED|Overall Study||41
885105|NCT01959932|2141484|P1|STARTED|Overall Study||80
885106|NCT01959880|2141506|P4|NOT COMPLETED|Overall Study||181
885107|NCT01959880|2141507|P3|NOT COMPLETED|Overall Study||208
885108|NCT01959880|2141508|P2|NOT COMPLETED|Overall Study||369
885109|NCT01959880|2141509|P1|NOT COMPLETED|Overall Study||1132
885110|NCT01959880|2141506|P4|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
885111|NCT01959880|2141507|P3|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|1
885112|NCT01959880|2141508|P2|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
885113|NCT01959880|2141509|P1|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
885114|NCT01959880|2141506|P4|STARTED|Overall Study||181
885115|NCT01959880|2141507|P3|STARTED|Overall Study||209
885116|NCT01959880|2141508|P2|STARTED|Overall Study||369
885117|NCT01959880|2141509|P1|STARTED|Overall Study||1132
885118|NCT01959685|2141531|P1|NOT COMPLETED|Overall Study||0
885119|NCT01959685|2141531|P1|COMPLETED|Overall Study||9
885120|NCT01959685|2141531|P1|STARTED|Overall Study||9
885121|NCT01959607|2141538|P4|NOT COMPLETED|Second Intervention (Day 3)||0
885122|NCT01959607|2141539|P3|NOT COMPLETED|Second Intervention (Day 3)||0
885123|NCT01959607|2141540|P2|NOT COMPLETED|Second Intervention (Day 3)||0
885124|NCT01959607|2141541|P1|NOT COMPLETED|Second Intervention (Day 3)||0
885125|NCT01959607|2141538|P4|COMPLETED|Second Intervention (Day 3)||9
885126|NCT01959607|2141539|P3|COMPLETED|Second Intervention (Day 3)||9
885127|NCT01959607|2141540|P2|COMPLETED|Second Intervention (Day 3)||21
885128|NCT01959607|2141541|P1|COMPLETED|Second Intervention (Day 3)||21
885129|NCT01959607|2141538|P4|STARTED|Second Intervention (Day 3)||9
885130|NCT01959607|2141539|P3|STARTED|Second Intervention (Day 3)||9
885131|NCT01959607|2141540|P2|STARTED|Second Intervention (Day 3)||21
885132|NCT01959607|2141541|P1|STARTED|Second Intervention (Day 3)||21
885133|NCT01959607|2141538|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
885134|NCT01959607|2141539|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
885135|NCT01959607|2141540|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
885136|NCT01959607|2141541|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
885137|NCT01959607|2141538|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
885138|NCT01959607|2141539|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
885139|NCT01959607|2141540|P2|COMPLETED|Washout Period of 1 Day (Day 2)||21
885140|NCT01959607|2141541|P1|COMPLETED|Washout Period of 1 Day (Day 2)||21
885141|NCT01959607|2141538|P4|STARTED|Washout Period of 1 Day (Day 2)||9
885142|NCT01959607|2141539|P3|STARTED|Washout Period of 1 Day (Day 2)||9
885143|NCT01959607|2141540|P2|STARTED|Washout Period of 1 Day (Day 2)||21
885144|NCT01959607|2141541|P1|STARTED|Washout Period of 1 Day (Day 2)||21
885145|NCT01959607|2141538|P4|NOT COMPLETED|First Intervention (Day 1)||0
885146|NCT01959607|2141539|P3|NOT COMPLETED|First Intervention (Day 1)||0
885147|NCT01959607|2141540|P2|NOT COMPLETED|First Intervention (Day 1)||1
885148|NCT01959607|2141541|P1|NOT COMPLETED|First Intervention (Day 1)||1
885149|NCT01959607|2141538|P4|COMPLETED|First Intervention (Day 1)||9
885150|NCT01959607|2141539|P3|COMPLETED|First Intervention (Day 1)||9
885151|NCT01959607|2141540|P2|COMPLETED|First Intervention (Day 1)||21
885152|NCT01959607|2141541|P1|COMPLETED|First Intervention (Day 1)||21
885153|NCT01959607|2141538|P4|STARTED|First Intervention (Day 1)||9
885154|NCT01959607|2141539|P3|STARTED|First Intervention (Day 1)||9
885155|NCT01959607|2141540|P2|STARTED|First Intervention (Day 1)||22
885156|NCT01959607|2141541|P1|STARTED|First Intervention (Day 1)||22
885157|NCT01959607|2141538|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
885158|NCT01959607|2141539|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
885159|NCT01959607|2141540|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
885160|NCT01959607|2141541|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
885161|NCT01959607|2141538|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
885162|NCT01959607|2141539|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
885163|NCT01959607|2141540|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
885164|NCT01959607|2141541|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
885165|NCT01959607|2141538|P4|STARTED|Washout Period of 1 Day (Day 0)||9
885166|NCT01959607|2141539|P3|STARTED|Washout Period of 1 Day (Day 0)||9
885167|NCT01959607|2141540|P2|STARTED|Washout Period of 1 Day (Day 0)||22
885168|NCT01959607|2141541|P1|STARTED|Washout Period of 1 Day (Day 0)||22
885169|NCT01959581|2141554|P1|NOT COMPLETED|Overall Study||5
885170|NCT01959581|2141554|P1|COMPLETED|Overall Study||25
885171|NCT01959581|2141554|P1|STARTED|Overall Study||30
885172|NCT01959516|2141558|P2|NOT COMPLETED|Epoch 2||1
885173|NCT01959516|2141559|P1|NOT COMPLETED|Epoch 2||2
885174|NCT01959516|2141558|P2|COMPLETED|Epoch 2||62
885175|NCT01959516|2141559|P1|COMPLETED|Epoch 2||61
885176|NCT01959516|2141558|P2|STARTED|Epoch 2||63
885177|NCT01959516|2141559|P1|STARTED|Epoch 2||63
885178|NCT01959516|2141558|P2|NOT COMPLETED|Epoch 1||5
885179|NCT01959516|2141559|P1|NOT COMPLETED|Epoch 1||10
885180|NCT01959516|2141558|P2|COMPLETED|Epoch 1||58
885181|NCT01959516|2141559|P1|COMPLETED|Epoch 1||53
885182|NCT01959516|2141558|P2|ITT Population|Epoch 1||62
885183|NCT01959516|2141559|P1|ITT Population|Epoch 1||62
885184|NCT01959516|2141558|P2|Safety Population|Epoch 1||62
885185|NCT01959516|2141559|P1|Safety Population|Epoch 1||62
885186|NCT01959516|2141558|P2|STARTED|Epoch 1||63
885187|NCT01959516|2141559|P1|STARTED|Epoch 1||63
885188|NCT01959503|2141569|P2|NOT COMPLETED|Overall Study||2
885189|NCT01959503|2141570|P1|NOT COMPLETED|Overall Study||3
885190|NCT01959503|2141569|P2|COMPLETED|Overall Study||49
885191|NCT01959503|2141570|P1|COMPLETED|Overall Study||104
885192|NCT01959503|2141569|P2|STARTED|Overall Study||51
885193|NCT01959503|2141570|P1|STARTED|Overall Study||107
885194|NCT01959412|2141590|P6|NOT COMPLETED|Overall Study||0
885195|NCT01959412|2141591|P5|NOT COMPLETED|Overall Study||3
885196|NCT01959412|2141592|P4|NOT COMPLETED|Overall Study||2
885197|NCT01959412|2141593|P3|NOT COMPLETED|Overall Study||0
885198|NCT01959412|2141594|P2|NOT COMPLETED|Overall Study||1
885199|NCT01959412|2141595|P1|NOT COMPLETED|Overall Study||1
885200|NCT01959412|2141590|P6|COMPLETED|Overall Study||15
885201|NCT01959412|2141591|P5|COMPLETED|Overall Study||13
885202|NCT01959412|2141592|P4|COMPLETED|Overall Study||13
885203|NCT01959412|2141593|P3|COMPLETED|Overall Study||15
885204|NCT01959412|2141594|P2|COMPLETED|Overall Study||14
885205|NCT01959412|2141595|P1|COMPLETED|Overall Study||14
885206|NCT01959412|2141590|P6|STARTED|Overall Study||15
885207|NCT01959412|2141591|P5|STARTED|Overall Study||16
885208|NCT01959412|2141592|P4|STARTED|Overall Study||15
885209|NCT01959412|2141593|P3|STARTED|Overall Study||15
885210|NCT01959412|2141594|P2|STARTED|Overall Study||15
885211|NCT01959412|2141595|P1|STARTED|Overall Study||15
885212|NCT01959035|2141633|P1|NOT COMPLETED|Overall Study||11
885213|NCT01959035|2141633|P1|COMPLETED|Overall Study||77
885214|NCT01959035|2141633|P1|STARTED|Overall Study||88
885215|NCT01958827|2141659|P1|NOT COMPLETED|Overall Study||10
885216|NCT01958827|2141659|P1|COMPLETED|Overall Study||18
885217|NCT01958827|2141659|P1|STARTED|Overall Study||28
885218|NCT01958788|2141677|P1|NOT COMPLETED|Overall Study||0
885219|NCT01958788|2141677|P1|COMPLETED|Overall Study||7
885220|NCT01958788|2141677|P1|STARTED|Overall Study||7
885221|NCT01958671|2141690|P3|NOT COMPLETED|Overall Study||32
885222|NCT01958671|2141691|P2|NOT COMPLETED|Overall Study||24
885223|NCT01958671|2141692|P1|NOT COMPLETED|Overall Study||19
885224|NCT01958671|2141690|P3|COMPLETED|Overall Study||121
885225|NCT01958671|2141691|P2|COMPLETED|Overall Study||128
885226|NCT01958671|2141692|P1|COMPLETED|Overall Study||137
885227|NCT01958671|2141690|P3|STARTED|Overall Study||153
885228|NCT01958671|2141691|P2|STARTED|Overall Study||152
885229|NCT01958671|2141692|P1|STARTED|Overall Study||156
885230|NCT01958645|2141736|P3|NOT COMPLETED|Overall Study||0
885231|NCT01958645|2141737|P2|NOT COMPLETED|Overall Study||0
885232|NCT01958645|2141738|P1|NOT COMPLETED|Overall Study||0
885233|NCT01958645|2141736|P3|COMPLETED|Overall Study||4
885234|NCT01958645|2141737|P2|COMPLETED|Overall Study||4
885235|NCT01958645|2141738|P1|COMPLETED|Overall Study||4
885236|NCT01958645|2141736|P3|STARTED|Overall Study||4
885237|NCT01958645|2141737|P2|STARTED|Overall Study||4
885238|NCT01958645|2141738|P1|STARTED|Overall Study||4
885239|NCT01958619|2141766|P4|NOT COMPLETED|Overall Study||0
885240|NCT01958619|2141767|P3|NOT COMPLETED|Overall Study||1
885241|NCT01958619|2141768|P2|NOT COMPLETED|Overall Study||0
885242|NCT01958619|2141769|P1|NOT COMPLETED|Overall Study||2
885243|NCT01958619|2141766|P4|COMPLETED|Overall Study||12
885244|NCT01958619|2141767|P3|COMPLETED|Overall Study||13
885245|NCT01958619|2141768|P2|COMPLETED|Overall Study||14
885246|NCT01958619|2141769|P1|COMPLETED|Overall Study||13
885247|NCT01958619|2141766|P4|STARTED|Overall Study||12
885248|NCT01958619|2141767|P3|STARTED|Overall Study||14
885249|NCT01958619|2141768|P2|STARTED|Overall Study||14
885250|NCT01958619|2141769|P1|STARTED|Overall Study||15
885251|NCT01958606|2141791|P2|NOT COMPLETED|Overall Study||0
885252|NCT01958606|2141792|P1|NOT COMPLETED|Overall Study||2
885253|NCT01958606|2141791|P2|COMPLETED|Overall Study||5
885254|NCT01958606|2141792|P1|COMPLETED|Overall Study||11
885255|NCT01958606|2141791|P2|STARTED|Overall Study||5
885256|NCT01958606|2141792|P1|STARTED|Overall Study||13
885257|NCT01958346|2141832|P2|NOT COMPLETED|Overall Study||0
885258|NCT01958346|2141833|P1|NOT COMPLETED|Overall Study||0
885259|NCT01958346|2141832|P2|COMPLETED|Overall Study||39
885260|NCT01958346|2141833|P1|COMPLETED|Overall Study||39
885261|NCT01958346|2141832|P2|STARTED|Overall Study||39
885262|NCT01958346|2141833|P1|STARTED|Overall Study||39
885263|NCT01958164|2141843|P2|NOT COMPLETED|Overall Study||5
885264|NCT01958164|2141844|P1|NOT COMPLETED|Overall Study||2
885265|NCT01958164|2141843|P2|COMPLETED|Overall Study||5
885266|NCT01958164|2141844|P1|COMPLETED|Overall Study||4
885267|NCT01958164|2141843|P2|STARTED|Overall Study|Randomised and treated|10
885268|NCT01958164|2141844|P1|STARTED|Overall Study|Randomised and treated|6
885269|NCT01958060|2141863|P6|NOT COMPLETED|Overall Study||0
885270|NCT01958060|2141864|P5|NOT COMPLETED|Overall Study||1
885271|NCT01958060|2141865|P4|NOT COMPLETED|Overall Study||0
885272|NCT01958060|2141866|P3|NOT COMPLETED|Overall Study||0
885273|NCT01958060|2141867|P2|NOT COMPLETED|Overall Study||0
885274|NCT01958060|2141868|P1|NOT COMPLETED|Overall Study||2
885275|NCT01958060|2141863|P6|COMPLETED|Overall Study|One subject in the 100 mg iv dose group did not receive complete dose of trial medication.|1
885276|NCT01958060|2141864|P5|COMPLETED|Overall Study|One subject in the 50 mg iv dose group did not receive complete dose of trial medication.|6
885277|NCT01958060|2141865|P4|COMPLETED|Overall Study||5
885278|NCT01958060|2141866|P3|COMPLETED|Overall Study||6
885279|NCT01958060|2141867|P2|COMPLETED|Overall Study||6
885280|NCT01958060|2141868|P1|COMPLETED|Overall Study||8
885281|NCT01958060|2141863|P6|STARTED|Overall Study||1
885282|NCT01958060|2141864|P5|STARTED|Overall Study||7
885283|NCT01958060|2141865|P4|STARTED|Overall Study||5
885284|NCT01958060|2141866|P3|STARTED|Overall Study||6
885285|NCT01958060|2141867|P2|STARTED|Overall Study||6
885286|NCT01958060|2141868|P1|STARTED|Overall Study||10
885287|NCT01958021|2141893|P2|NOT COMPLETED|Overall Study||180
885288|NCT01958021|2141894|P1|NOT COMPLETED|Overall Study||139
885289|NCT01958021|2141893|P2|COMPLETED|Overall Study|Completed = Treatment ongoing|154
885290|NCT01958021|2141894|P1|COMPLETED|Overall Study|Completed = Treatment ongoing|195
885291|NCT01958021|2141893|P2|Patients Treated|Overall Study||330
885292|NCT01958021|2141894|P1|Patients Treated|Overall Study||334
885293|NCT01958021|2141893|P2|Patients Untreated|Overall Study||4
885294|NCT01958021|2141894|P1|Patients Untreated|Overall Study||0
885295|NCT01958021|2141893|P2|STARTED|Overall Study||334
885296|NCT01958021|2141894|P1|STARTED|Overall Study||334
885297|NCT01958008|2141906|P4|NOT COMPLETED|Overall Study||0
885298|NCT01958008|2141907|P3|NOT COMPLETED|Overall Study||1
885299|NCT01958008|2141908|P2|NOT COMPLETED|Overall Study||0
885300|NCT01958008|2141909|P1|NOT COMPLETED|Overall Study||1
885301|NCT01958008|2141906|P4|COMPLETED|Overall Study||21
885302|NCT01958008|2141907|P3|COMPLETED|Overall Study||20
885303|NCT01958008|2141908|P2|COMPLETED|Overall Study||21
885304|NCT01958008|2141909|P1|COMPLETED|Overall Study||20
885305|NCT01958008|2141906|P4|STARTED|Overall Study||21
885306|NCT01958008|2141907|P3|STARTED|Overall Study||21
885307|NCT01958008|2141908|P2|STARTED|Overall Study||21
885308|NCT01958008|2141909|P1|STARTED|Overall Study||21
885309|NCT01957930|2141939|P2|NOT COMPLETED|Overall Study||0
885310|NCT01957930|2141940|P1|NOT COMPLETED|Overall Study||0
885311|NCT01957930|2141939|P2|COMPLETED|Overall Study||37
885312|NCT01957930|2141940|P1|COMPLETED|Overall Study||35
885313|NCT01957930|2141939|P2|STARTED|Overall Study||37
885314|NCT01957930|2141940|P1|STARTED|Overall Study||35
885315|NCT01957865|2141949|P3|NOT COMPLETED|Overall Study||3
885316|NCT01957865|2141950|P2|NOT COMPLETED|Overall Study||2
885317|NCT01957865|2141951|P1|NOT COMPLETED|Overall Study||0
885318|NCT01957865|2141949|P3|COMPLETED|Overall Study||19
885319|NCT01957865|2141950|P2|COMPLETED|Overall Study||18
885320|NCT01957865|2141951|P1|COMPLETED|Overall Study||21
885321|NCT01957865|2141949|P3|STARTED|Overall Study||22
885322|NCT01957865|2141950|P2|STARTED|Overall Study||20
885323|NCT01957865|2141951|P1|STARTED|Overall Study||21
885324|NCT01957761|2141962|P1|NOT COMPLETED|Overall Study||0
885325|NCT01957761|2141962|P1|COMPLETED|Overall Study||189
885326|NCT01957761|2141962|P1|STARTED|Overall Study||189
885327|NCT01957657|2141966|P1|NOT COMPLETED|Overall Study||0
885328|NCT01957657|2141966|P1|COMPLETED|Overall Study||4
885329|NCT01957657|2141966|P1|STARTED|Overall Study||4
885330|NCT01957579|2141984|P4|NOT COMPLETED|Overall Study||0
885331|NCT01957579|2141985|P3|NOT COMPLETED|Overall Study||2
885332|NCT01957579|2141986|P2|NOT COMPLETED|Overall Study||1
885333|NCT01957579|2141987|P1|NOT COMPLETED|Overall Study||0
885334|NCT01957579|2141984|P4|COMPLETED|Overall Study||6
885335|NCT01957579|2141985|P3|COMPLETED|Overall Study||2
885336|NCT01957579|2141986|P2|COMPLETED|Overall Study||6
885337|NCT01957579|2141987|P1|COMPLETED|Overall Study||3
885338|NCT01957579|2141984|P4|STARTED|Overall Study||6
885339|NCT01957579|2141985|P3|STARTED|Overall Study||4
885340|NCT01957579|2141986|P2|STARTED|Overall Study||7
885341|NCT01957579|2141987|P1|STARTED|Overall Study||3
885342|NCT01957553|2142054|P2|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||7
885343|NCT01957553|2142055|P1|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||3
885344|NCT01957553|2142054|P2|COMPLETED|Test Period 2 (21 +- 1 Days)||56
885345|NCT01957553|2142055|P1|COMPLETED|Test Period 2 (21 +- 1 Days)||51
885346|NCT01957553|2142054|P2|STARTED|Test Period 2 (21 +- 1 Days)||63
885347|NCT01957553|2142055|P1|STARTED|Test Period 2 (21 +- 1 Days)||54
885348|NCT01957553|2142054|P2|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||3
885349|NCT01957553|2142055|P1|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||7
885350|NCT01957553|2142054|P2|COMPLETED|Test Period 1 (21 +- 1 Days)||63
885351|NCT01957553|2142055|P1|COMPLETED|Test Period 1 (21 +- 1 Days)||54
885352|NCT01957553|2142054|P2|STARTED|Test Period 1 (21 +- 1 Days)||66
885353|NCT01957553|2142055|P1|STARTED|Test Period 1 (21 +- 1 Days)||61
885354|NCT01957488|2142061|P6|NOT COMPLETED|Test Period 3||0
885355|NCT01957488|2142062|P5|NOT COMPLETED|Test Period 3||0
885356|NCT01957488|2142063|P4|NOT COMPLETED|Test Period 3||0
885357|NCT01957488|2142064|P3|NOT COMPLETED|Test Period 3||0
885358|NCT01957488|2142065|P2|NOT COMPLETED|Test Period 3||1
885359|NCT01957488|2142066|P1|NOT COMPLETED|Test Period 3||1
885360|NCT01957488|2142061|P6|COMPLETED|Test Period 3||23
885361|NCT01957488|2142062|P5|COMPLETED|Test Period 3||25
885362|NCT01957488|2142063|P4|COMPLETED|Test Period 3||28
885363|NCT01957488|2142064|P3|COMPLETED|Test Period 3||25
885364|NCT01957488|2142065|P2|COMPLETED|Test Period 3||26
885365|NCT01957488|2142066|P1|COMPLETED|Test Period 3||23
885366|NCT01957488|2142061|P6|STARTED|Test Period 3||23
885367|NCT01957488|2142062|P5|STARTED|Test Period 3||25
885368|NCT01957488|2142063|P4|STARTED|Test Period 3||28
885369|NCT01957488|2142064|P3|STARTED|Test Period 3||25
885370|NCT01957488|2142065|P2|STARTED|Test Period 3||27
885371|NCT01957488|2142066|P1|STARTED|Test Period 3||24
885372|NCT01957488|2142061|P6|NOT COMPLETED|Test Period 2||1
885373|NCT01957488|2142062|P5|NOT COMPLETED|Test Period 2||2
885374|NCT01957488|2142063|P4|NOT COMPLETED|Test Period 2||1
885375|NCT01957488|2142064|P3|NOT COMPLETED|Test Period 2||1
885376|NCT01957488|2142065|P2|NOT COMPLETED|Test Period 2||1
885377|NCT01957488|2142066|P1|NOT COMPLETED|Test Period 2||3
885378|NCT01957488|2142061|P6|COMPLETED|Test Period 2||23
885379|NCT01957488|2142062|P5|COMPLETED|Test Period 2||25
885380|NCT01957488|2142063|P4|COMPLETED|Test Period 2||28
885381|NCT01957488|2142064|P3|COMPLETED|Test Period 2||25
885382|NCT01957488|2142065|P2|COMPLETED|Test Period 2||27
885383|NCT01957488|2142066|P1|COMPLETED|Test Period 2||24
885384|NCT01957488|2142061|P6|STARTED|Test Period 2||24
885385|NCT01957488|2142062|P5|STARTED|Test Period 2||27
885386|NCT01957488|2142063|P4|STARTED|Test Period 2||29
885387|NCT01957488|2142064|P3|STARTED|Test Period 2||26
885388|NCT01957488|2142065|P2|STARTED|Test Period 2||28
885389|NCT01957488|2142066|P1|STARTED|Test Period 2||27
885390|NCT01957488|2142061|P6|NOT COMPLETED|Test Period 1||6
885391|NCT01957488|2142062|P5|NOT COMPLETED|Test Period 1||3
885392|NCT01957488|2142063|P4|NOT COMPLETED|Test Period 1||3
885393|NCT01957488|2142064|P3|NOT COMPLETED|Test Period 1||4
885394|NCT01957488|2142065|P2|NOT COMPLETED|Test Period 1||3
885395|NCT01957488|2142066|P1|NOT COMPLETED|Test Period 1||3
885396|NCT01957488|2142061|P6|COMPLETED|Test Period 1||24
885397|NCT01957488|2142062|P5|COMPLETED|Test Period 1||27
885398|NCT01957488|2142063|P4|COMPLETED|Test Period 1||29
885399|NCT01957488|2142064|P3|COMPLETED|Test Period 1||26
885400|NCT01957488|2142065|P2|COMPLETED|Test Period 1||28
885401|NCT01957488|2142066|P1|COMPLETED|Test Period 1||27
885402|NCT01957488|2142061|P6|STARTED|Test Period 1||30
885403|NCT01957488|2142062|P5|STARTED|Test Period 1||30
885404|NCT01957488|2142063|P4|STARTED|Test Period 1||32
885405|NCT01957488|2142064|P3|STARTED|Test Period 1||30
885406|NCT01957488|2142065|P2|STARTED|Test Period 1||31
885407|NCT01957488|2142066|P1|STARTED|Test Period 1||30
885408|NCT01957475|2142074|P2|NOT COMPLETED|Test Period 2||0
885409|NCT01957475|2142075|P1|NOT COMPLETED|Test Period 2||1
885410|NCT01957475|2142074|P2|COMPLETED|Test Period 2||8
885411|NCT01957475|2142075|P1|COMPLETED|Test Period 2||8
885412|NCT01957475|2142074|P2|STARTED|Test Period 2||8
885413|NCT01957475|2142075|P1|STARTED|Test Period 2||9
885414|NCT01957475|2142074|P2|NOT COMPLETED|Test Period 1||1
885415|NCT01957475|2142075|P1|NOT COMPLETED|Test Period 1||2
885416|NCT01957475|2142074|P2|COMPLETED|Test Period 1||9
885417|NCT01957475|2142075|P1|COMPLETED|Test Period 1||8
885418|NCT01957475|2142074|P2|STARTED|Test Period 1||10
885419|NCT01957475|2142075|P1|STARTED|Test Period 1||10
885420|NCT01957462|2142081|P2|NOT COMPLETED|Test Period 2||0
885421|NCT01957462|2142082|P1|NOT COMPLETED|Test Period 2||0
885422|NCT01957462|2142081|P2|COMPLETED|Test Period 2||15
885423|NCT01957462|2142082|P1|COMPLETED|Test Period 2||14
885424|NCT01957462|2142081|P2|STARTED|Test Period 2||15
885425|NCT01957462|2142082|P1|STARTED|Test Period 2||14
885426|NCT01957462|2142081|P2|NOT COMPLETED|Test Period 1||0
885427|NCT01957462|2142082|P1|NOT COMPLETED|Test Period 1||2
885428|NCT01957462|2142081|P2|COMPLETED|Test Period 1||15
885429|NCT01957462|2142082|P1|COMPLETED|Test Period 1||14
885430|NCT01957462|2142081|P2|STARTED|Test Period 1||15
885431|NCT01957462|2142082|P1|STARTED|Test Period 1||16
885432|NCT01957410|2142088|P1|NOT COMPLETED|Optional Open Label||0
885433|NCT01957410|2142088|P1|COMPLETED|Optional Open Label||13
885434|NCT01957410|2142088|P1|STARTED|Optional Open Label||13
885435|NCT01957410|2142088|P1|NOT COMPLETED|Open Label||0
885436|NCT01957410|2142088|P1|COMPLETED|Open Label||13
885437|NCT01957410|2142088|P1|STARTED|Open Label||13
885438|NCT01957397|2142093|P2|NOT COMPLETED|Test Period 3||2
885439|NCT01957397|2142094|P1|NOT COMPLETED|Test Period 3||2
885440|NCT01957397|2142093|P2|COMPLETED|Test Period 3||9
885441|NCT01957397|2142094|P1|COMPLETED|Test Period 3||9
885442|NCT01957397|2142093|P2|STARTED|Test Period 3||11
885443|NCT01957397|2142094|P1|STARTED|Test Period 3||11
885444|NCT01957397|2142093|P2|NOT COMPLETED|Test Period 2||1
885445|NCT01957397|2142094|P1|NOT COMPLETED|Test Period 2||0
885446|NCT01957397|2142093|P2|COMPLETED|Test Period 2||11
885447|NCT01957397|2142094|P1|COMPLETED|Test Period 2||11
885448|NCT01957397|2142093|P2|STARTED|Test Period 2||12
885449|NCT01957397|2142094|P1|STARTED|Test Period 2||11
885450|NCT01957397|2142093|P2|NOT COMPLETED|Test Period 1||1
885451|NCT01957397|2142094|P1|NOT COMPLETED|Test Period 1||2
885452|NCT01957397|2142093|P2|COMPLETED|Test Period 1||12
885453|NCT01957397|2142094|P1|COMPLETED|Test Period 1||11
885454|NCT01957397|2142093|P2|STARTED|Test Period 1||13
885455|NCT01957397|2142094|P1|STARTED|Test Period 1||13
885456|NCT01957397|2142093|P2|NOT COMPLETED|Baseline Own Product||0
885457|NCT01957397|2142094|P1|NOT COMPLETED|Baseline Own Product||0
885458|NCT01957397|2142093|P2|COMPLETED|Baseline Own Product||13
885459|NCT01957397|2142094|P1|COMPLETED|Baseline Own Product||13
885460|NCT01957397|2142093|P2|STARTED|Baseline Own Product||13
885461|NCT01957397|2142094|P1|STARTED|Baseline Own Product||13
885462|NCT01957384|2142104|P6|NOT COMPLETED|Test Period 3 (14 Days)||0
885463|NCT01957384|2142105|P5|NOT COMPLETED|Test Period 3 (14 Days)||0
885464|NCT01957384|2142106|P4|NOT COMPLETED|Test Period 3 (14 Days)||0
885465|NCT01957384|2142107|P3|NOT COMPLETED|Test Period 3 (14 Days)||0
885466|NCT01957384|2142108|P2|NOT COMPLETED|Test Period 3 (14 Days)||0
885467|NCT01957384|2142109|P1|NOT COMPLETED|Test Period 3 (14 Days)||0
885468|NCT01957384|2142104|P6|COMPLETED|Test Period 3 (14 Days)||3
885469|NCT01957384|2142105|P5|COMPLETED|Test Period 3 (14 Days)||3
885470|NCT01957384|2142106|P4|COMPLETED|Test Period 3 (14 Days)||4
885471|NCT01957384|2142107|P3|COMPLETED|Test Period 3 (14 Days)||4
885472|NCT01957384|2142108|P2|COMPLETED|Test Period 3 (14 Days)||4
885473|NCT01957384|2142109|P1|COMPLETED|Test Period 3 (14 Days)||4
885474|NCT01957384|2142104|P6|STARTED|Test Period 3 (14 Days)||3
885475|NCT01957384|2142105|P5|STARTED|Test Period 3 (14 Days)||3
885476|NCT01957384|2142106|P4|STARTED|Test Period 3 (14 Days)||4
885477|NCT01957384|2142107|P3|STARTED|Test Period 3 (14 Days)||4
885478|NCT01957384|2142108|P2|STARTED|Test Period 3 (14 Days)||4
885479|NCT01957384|2142109|P1|STARTED|Test Period 3 (14 Days)||4
885480|NCT01957384|2142104|P6|NOT COMPLETED|Test Period 2 (14 Days)||0
885481|NCT01957384|2142105|P5|NOT COMPLETED|Test Period 2 (14 Days)||0
885482|NCT01957384|2142106|P4|NOT COMPLETED|Test Period 2 (14 Days)||0
885483|NCT01957384|2142107|P3|NOT COMPLETED|Test Period 2 (14 Days)||0
885484|NCT01957384|2142108|P2|NOT COMPLETED|Test Period 2 (14 Days)||0
885485|NCT01957384|2142109|P1|NOT COMPLETED|Test Period 2 (14 Days)||0
885486|NCT01957384|2142104|P6|COMPLETED|Test Period 2 (14 Days)||3
885487|NCT01957384|2142105|P5|COMPLETED|Test Period 2 (14 Days)||3
885488|NCT01957384|2142106|P4|COMPLETED|Test Period 2 (14 Days)||4
885489|NCT01957384|2142107|P3|COMPLETED|Test Period 2 (14 Days)||4
885490|NCT01957384|2142108|P2|COMPLETED|Test Period 2 (14 Days)||4
885491|NCT01957384|2142109|P1|COMPLETED|Test Period 2 (14 Days)||4
885492|NCT01957384|2142104|P6|STARTED|Test Period 2 (14 Days)||3
885493|NCT01957384|2142105|P5|STARTED|Test Period 2 (14 Days)||3
885494|NCT01957384|2142106|P4|STARTED|Test Period 2 (14 Days)||4
885495|NCT01957384|2142107|P3|STARTED|Test Period 2 (14 Days)||4
885496|NCT01957384|2142108|P2|STARTED|Test Period 2 (14 Days)||4
885497|NCT01957384|2142109|P1|STARTED|Test Period 2 (14 Days)||4
885498|NCT01957384|2142104|P6|NOT COMPLETED|Test Period 1 (14 Days)||0
885499|NCT01957384|2142105|P5|NOT COMPLETED|Test Period 1 (14 Days)||0
885500|NCT01957384|2142106|P4|NOT COMPLETED|Test Period 1 (14 Days)||0
885501|NCT01957384|2142107|P3|NOT COMPLETED|Test Period 1 (14 Days)||0
885502|NCT01957384|2142108|P2|NOT COMPLETED|Test Period 1 (14 Days)||0
885503|NCT01957384|2142109|P1|NOT COMPLETED|Test Period 1 (14 Days)||0
885504|NCT01957384|2142104|P6|COMPLETED|Test Period 1 (14 Days)||3
885505|NCT01957384|2142105|P5|COMPLETED|Test Period 1 (14 Days)||3
885506|NCT01957384|2142106|P4|COMPLETED|Test Period 1 (14 Days)||4
885507|NCT01957384|2142107|P3|COMPLETED|Test Period 1 (14 Days)||4
885508|NCT01957384|2142108|P2|COMPLETED|Test Period 1 (14 Days)||4
885509|NCT01957384|2142109|P1|COMPLETED|Test Period 1 (14 Days)||4
885510|NCT01957384|2142104|P6|STARTED|Test Period 1 (14 Days)||3
885511|NCT01957384|2142105|P5|STARTED|Test Period 1 (14 Days)||3
885512|NCT01957384|2142106|P4|STARTED|Test Period 1 (14 Days)||4
885513|NCT01957384|2142107|P3|STARTED|Test Period 1 (14 Days)||4
885514|NCT01957384|2142108|P2|STARTED|Test Period 1 (14 Days)||4
885515|NCT01957384|2142109|P1|STARTED|Test Period 1 (14 Days)||4
885516|NCT01957215|2142119|P2|NOT COMPLETED|Overall Study||12
885517|NCT01957215|2142120|P1|NOT COMPLETED|Overall Study||13
885518|NCT01957215|2142119|P2|COMPLETED|Overall Study||123
885519|NCT01957215|2142120|P1|COMPLETED|Overall Study||122
885520|NCT01957215|2142119|P2|STARTED|Overall Study||135
885521|NCT01957215|2142120|P1|STARTED|Overall Study||135
885522|NCT01957202|2142148|P18|NOT COMPLETED|Treatment Period 3 (8 Days)||0
885523|NCT01957202|2142149|P17|NOT COMPLETED|Treatment Period 3 (8 Days)||1
885524|NCT01957202|2142150|P16|NOT COMPLETED|Treatment Period 3 (8 Days)||0
885525|NCT01957202|2142151|P15|NOT COMPLETED|Treatment Period 3 (8 Days)||0
885526|NCT01957202|2142152|P14|NOT COMPLETED|Treatment Period 3 (8 Days)||0
885527|NCT01957202|2142153|P13|NOT COMPLETED|Treatment Period 3 (8 Days)||0
885528|NCT01957202|2142154|P12|NOT COMPLETED|Treatment Period 3 (8 Days)||0
885529|NCT01957202|2142155|P11|NOT COMPLETED|Treatment Period 3 (8 Days)||0
885530|NCT01957202|2142156|P10|NOT COMPLETED|Treatment Period 3 (8 Days)||0
885531|NCT01957202|2142157|P9|NOT COMPLETED|Treatment Period 3 (8 Days)||0
885532|NCT01957202|2142158|P8|NOT COMPLETED|Treatment Period 3 (8 Days)||0
885533|NCT01957202|2142159|P7|NOT COMPLETED|Treatment Period 3 (8 Days)||0
885534|NCT01957202|2142160|P6|NOT COMPLETED|Treatment Period 3 (8 Days)||0
885535|NCT01957202|2142161|P5|NOT COMPLETED|Treatment Period 3 (8 Days)||0
885536|NCT01957202|2142162|P4|NOT COMPLETED|Treatment Period 3 (8 Days)||0
885537|NCT01957202|2142163|P3|NOT COMPLETED|Treatment Period 3 (8 Days)||0
885538|NCT01957202|2142164|P2|NOT COMPLETED|Treatment Period 3 (8 Days)||0
885539|NCT01957202|2142165|P1|NOT COMPLETED|Treatment Period 3 (8 Days)||0
885540|NCT01957202|2142148|P18|COMPLETED|Treatment Period 3 (8 Days)||3
885541|NCT01957202|2142149|P17|COMPLETED|Treatment Period 3 (8 Days)||4
885542|NCT01957202|2142150|P16|COMPLETED|Treatment Period 3 (8 Days)||3
885543|NCT01957202|2142151|P15|COMPLETED|Treatment Period 3 (8 Days)||6
885544|NCT01957202|2142152|P14|COMPLETED|Treatment Period 3 (8 Days)||3
885545|NCT01957202|2142153|P13|COMPLETED|Treatment Period 3 (8 Days)||3
885546|NCT01957202|2142154|P12|COMPLETED|Treatment Period 3 (8 Days)||6
885547|NCT01957202|2142155|P11|COMPLETED|Treatment Period 3 (8 Days)||3
885548|NCT01957202|2142156|P10|COMPLETED|Treatment Period 3 (8 Days)||6
885549|NCT01957202|2142157|P9|COMPLETED|Treatment Period 3 (8 Days)||3
885550|NCT01957202|2142158|P8|COMPLETED|Treatment Period 3 (8 Days)||3
885551|NCT01957202|2142159|P7|COMPLETED|Treatment Period 3 (8 Days)||3
885552|NCT01957202|2142160|P6|COMPLETED|Treatment Period 3 (8 Days)||2
885553|NCT01957202|2142161|P5|COMPLETED|Treatment Period 3 (8 Days)||3
885554|NCT01957202|2142162|P4|COMPLETED|Treatment Period 3 (8 Days)||3
885555|NCT01957202|2142163|P3|COMPLETED|Treatment Period 3 (8 Days)||6
885556|NCT01957202|2142164|P2|COMPLETED|Treatment Period 3 (8 Days)||5
885557|NCT01957202|2142165|P1|COMPLETED|Treatment Period 3 (8 Days)||3
885558|NCT01957202|2142148|P18|STARTED|Treatment Period 3 (8 Days)||3
885559|NCT01957202|2142149|P17|STARTED|Treatment Period 3 (8 Days)||5
885560|NCT01957202|2142150|P16|STARTED|Treatment Period 3 (8 Days)||3
885561|NCT01957202|2142151|P15|STARTED|Treatment Period 3 (8 Days)||6
885562|NCT01957202|2142152|P14|STARTED|Treatment Period 3 (8 Days)||3
885563|NCT01957202|2142153|P13|STARTED|Treatment Period 3 (8 Days)||3
885564|NCT01957202|2142154|P12|STARTED|Treatment Period 3 (8 Days)||6
885565|NCT01957202|2142155|P11|STARTED|Treatment Period 3 (8 Days)||3
885566|NCT01957202|2142156|P10|STARTED|Treatment Period 3 (8 Days)||6
885567|NCT01957202|2142157|P9|STARTED|Treatment Period 3 (8 Days)||3
885568|NCT01957202|2142158|P8|STARTED|Treatment Period 3 (8 Days)||3
885569|NCT01957202|2142159|P7|STARTED|Treatment Period 3 (8 Days)||3
885570|NCT01957202|2142160|P6|STARTED|Treatment Period 3 (8 Days)||2
885571|NCT01957202|2142161|P5|STARTED|Treatment Period 3 (8 Days)||3
885572|NCT01957202|2142162|P4|STARTED|Treatment Period 3 (8 Days)||3
885573|NCT01957202|2142163|P3|STARTED|Treatment Period 3 (8 Days)||6
885574|NCT01957202|2142164|P2|STARTED|Treatment Period 3 (8 Days)||5
885575|NCT01957202|2142165|P1|STARTED|Treatment Period 3 (8 Days)||3
885576|NCT01957202|2142148|P18|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
885577|NCT01957202|2142149|P17|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
885578|NCT01957202|2142150|P16|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
885579|NCT01957202|2142151|P15|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
885580|NCT01957202|2142152|P14|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
885581|NCT01957202|2142153|P13|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
885582|NCT01957202|2142154|P12|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
885583|NCT01957202|2142155|P11|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
885584|NCT01957202|2142156|P10|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
885585|NCT01957202|2142157|P9|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
885586|NCT01957202|2142158|P8|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
885587|NCT01957202|2142159|P7|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
885588|NCT01957202|2142160|P6|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
885589|NCT01957202|2142161|P5|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
885590|NCT01957202|2142162|P4|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
885591|NCT01957202|2142163|P3|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
885592|NCT01957202|2142164|P2|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
885593|NCT01957202|2142165|P1|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
885594|NCT01957202|2142148|P18|COMPLETED|Washout Period 2 (14 to 28 Days)||3
885595|NCT01957202|2142149|P17|COMPLETED|Washout Period 2 (14 to 28 Days)||5
885596|NCT01957202|2142150|P16|COMPLETED|Washout Period 2 (14 to 28 Days)||3
885597|NCT01957202|2142151|P15|COMPLETED|Washout Period 2 (14 to 28 Days)||6
885598|NCT01957202|2142152|P14|COMPLETED|Washout Period 2 (14 to 28 Days)||3
885599|NCT01957202|2142153|P13|COMPLETED|Washout Period 2 (14 to 28 Days)||3
885600|NCT01957202|2142154|P12|COMPLETED|Washout Period 2 (14 to 28 Days)||6
885601|NCT01957202|2142155|P11|COMPLETED|Washout Period 2 (14 to 28 Days)||3
885602|NCT01957202|2142156|P10|COMPLETED|Washout Period 2 (14 to 28 Days)||6
885603|NCT01957202|2142157|P9|COMPLETED|Washout Period 2 (14 to 28 Days)||3
885604|NCT01957202|2142158|P8|COMPLETED|Washout Period 2 (14 to 28 Days)||3
885605|NCT01957202|2142159|P7|COMPLETED|Washout Period 2 (14 to 28 Days)||3
885606|NCT01957202|2142160|P6|COMPLETED|Washout Period 2 (14 to 28 Days)||2
885607|NCT01957202|2142161|P5|COMPLETED|Washout Period 2 (14 to 28 Days)||3
885608|NCT01957202|2142162|P4|COMPLETED|Washout Period 2 (14 to 28 Days)||3
885609|NCT01957202|2142163|P3|COMPLETED|Washout Period 2 (14 to 28 Days)||6
885610|NCT01957202|2142164|P2|COMPLETED|Washout Period 2 (14 to 28 Days)||5
885611|NCT01957202|2142165|P1|COMPLETED|Washout Period 2 (14 to 28 Days)||3
885612|NCT01957202|2142148|P18|STARTED|Washout Period 2 (14 to 28 Days)||3
885613|NCT01957202|2142149|P17|STARTED|Washout Period 2 (14 to 28 Days)||5
885614|NCT01957202|2142150|P16|STARTED|Washout Period 2 (14 to 28 Days)||3
885615|NCT01957202|2142151|P15|STARTED|Washout Period 2 (14 to 28 Days)||6
885616|NCT01957202|2142152|P14|STARTED|Washout Period 2 (14 to 28 Days)||3
885617|NCT01957202|2142153|P13|STARTED|Washout Period 2 (14 to 28 Days)||3
885618|NCT01957202|2142154|P12|STARTED|Washout Period 2 (14 to 28 Days)||6
885619|NCT01957202|2142155|P11|STARTED|Washout Period 2 (14 to 28 Days)||3
885620|NCT01957202|2142156|P10|STARTED|Washout Period 2 (14 to 28 Days)||6
885621|NCT01957202|2142157|P9|STARTED|Washout Period 2 (14 to 28 Days)||3
885622|NCT01957202|2142158|P8|STARTED|Washout Period 2 (14 to 28 Days)||3
885623|NCT01957202|2142159|P7|STARTED|Washout Period 2 (14 to 28 Days)||3
885624|NCT01957202|2142160|P6|STARTED|Washout Period 2 (14 to 28 Days)||2
885625|NCT01957202|2142161|P5|STARTED|Washout Period 2 (14 to 28 Days)||3
885626|NCT01957202|2142162|P4|STARTED|Washout Period 2 (14 to 28 Days)||3
885627|NCT01957202|2142163|P3|STARTED|Washout Period 2 (14 to 28 Days)||6
885628|NCT01957202|2142164|P2|STARTED|Washout Period 2 (14 to 28 Days)||5
885629|NCT01957202|2142165|P1|STARTED|Washout Period 2 (14 to 28 Days)||3
885630|NCT01957202|2142148|P18|NOT COMPLETED|Treatment Period 2 (8 Days)||0
885631|NCT01957202|2142149|P17|NOT COMPLETED|Treatment Period 2 (8 Days)||1
885632|NCT01957202|2142150|P16|NOT COMPLETED|Treatment Period 2 (8 Days)||0
885633|NCT01957202|2142151|P15|NOT COMPLETED|Treatment Period 2 (8 Days)||0
885634|NCT01957202|2142152|P14|NOT COMPLETED|Treatment Period 2 (8 Days)||0
885635|NCT01957202|2142153|P13|NOT COMPLETED|Treatment Period 2 (8 Days)||0
885636|NCT01957202|2142154|P12|NOT COMPLETED|Treatment Period 2 (8 Days)||0
885637|NCT01957202|2142155|P11|NOT COMPLETED|Treatment Period 2 (8 Days)||0
885638|NCT01957202|2142156|P10|NOT COMPLETED|Treatment Period 2 (8 Days)||0
885639|NCT01957202|2142157|P9|NOT COMPLETED|Treatment Period 2 (8 Days)||0
885640|NCT01957202|2142158|P8|NOT COMPLETED|Treatment Period 2 (8 Days)||0
885641|NCT01957202|2142159|P7|NOT COMPLETED|Treatment Period 2 (8 Days)||0
885642|NCT01957202|2142160|P6|NOT COMPLETED|Treatment Period 2 (8 Days)||0
885643|NCT01957202|2142161|P5|NOT COMPLETED|Treatment Period 2 (8 Days)||0
885644|NCT01957202|2142162|P4|NOT COMPLETED|Treatment Period 2 (8 Days)||0
885645|NCT01957202|2142163|P3|NOT COMPLETED|Treatment Period 2 (8 Days)||0
885646|NCT01957202|2142164|P2|NOT COMPLETED|Treatment Period 2 (8 Days)||1
885647|NCT01957202|2142165|P1|NOT COMPLETED|Treatment Period 2 (8 Days)||0
885648|NCT01957202|2142148|P18|COMPLETED|Treatment Period 2 (8 Days)||3
885649|NCT01957202|2142149|P17|COMPLETED|Treatment Period 2 (8 Days)||5
885650|NCT01957202|2142150|P16|COMPLETED|Treatment Period 2 (8 Days)||3
885651|NCT01957202|2142151|P15|COMPLETED|Treatment Period 2 (8 Days)||6
885652|NCT01957202|2142152|P14|COMPLETED|Treatment Period 2 (8 Days)||3
885653|NCT01957202|2142153|P13|COMPLETED|Treatment Period 2 (8 Days)||3
885654|NCT01957202|2142154|P12|COMPLETED|Treatment Period 2 (8 Days)||6
885655|NCT01957202|2142155|P11|COMPLETED|Treatment Period 2 (8 Days)||3
885656|NCT01957202|2142156|P10|COMPLETED|Treatment Period 2 (8 Days)||6
885657|NCT01957202|2142157|P9|COMPLETED|Treatment Period 2 (8 Days)||3
885658|NCT01957202|2142158|P8|COMPLETED|Treatment Period 2 (8 Days)||3
885659|NCT01957202|2142159|P7|COMPLETED|Treatment Period 2 (8 Days)||3
885660|NCT01957202|2142160|P6|COMPLETED|Treatment Period 2 (8 Days)||2
885661|NCT01957202|2142161|P5|COMPLETED|Treatment Period 2 (8 Days)||3
885662|NCT01957202|2142162|P4|COMPLETED|Treatment Period 2 (8 Days)||3
885663|NCT01957202|2142163|P3|COMPLETED|Treatment Period 2 (8 Days)||6
885664|NCT01957202|2142164|P2|COMPLETED|Treatment Period 2 (8 Days)||5
885665|NCT01957202|2142165|P1|COMPLETED|Treatment Period 2 (8 Days)||3
885666|NCT01957202|2142148|P18|STARTED|Treatment Period 2 (8 Days)||3
885667|NCT01957202|2142149|P17|STARTED|Treatment Period 2 (8 Days)||6
885668|NCT01957202|2142150|P16|STARTED|Treatment Period 2 (8 Days)||3
885669|NCT01957202|2142151|P15|STARTED|Treatment Period 2 (8 Days)||6
885670|NCT01957202|2142152|P14|STARTED|Treatment Period 2 (8 Days)||3
885671|NCT01957202|2142153|P13|STARTED|Treatment Period 2 (8 Days)||3
885672|NCT01957202|2142154|P12|STARTED|Treatment Period 2 (8 Days)||6
885673|NCT01957202|2142155|P11|STARTED|Treatment Period 2 (8 Days)||3
885674|NCT01957202|2142156|P10|STARTED|Treatment Period 2 (8 Days)||6
885675|NCT01957202|2142157|P9|STARTED|Treatment Period 2 (8 Days)||3
885676|NCT01957202|2142158|P8|STARTED|Treatment Period 2 (8 Days)||3
885677|NCT01957202|2142159|P7|STARTED|Treatment Period 2 (8 Days)||3
885678|NCT01957202|2142160|P6|STARTED|Treatment Period 2 (8 Days)||2
885679|NCT01957202|2142161|P5|STARTED|Treatment Period 2 (8 Days)||3
885680|NCT01957202|2142162|P4|STARTED|Treatment Period 2 (8 Days)||3
885681|NCT01957202|2142163|P3|STARTED|Treatment Period 2 (8 Days)||6
885682|NCT01957202|2142164|P2|STARTED|Treatment Period 2 (8 Days)||6
885683|NCT01957202|2142165|P1|STARTED|Treatment Period 2 (8 Days)||3
885684|NCT01957202|2142148|P18|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
885685|NCT01957202|2142149|P17|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
885686|NCT01957202|2142150|P16|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
885687|NCT01957202|2142151|P15|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
885688|NCT01957202|2142152|P14|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
885689|NCT01957202|2142153|P13|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
885690|NCT01957202|2142154|P12|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
885691|NCT01957202|2142155|P11|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
885692|NCT01957202|2142156|P10|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
885693|NCT01957202|2142157|P9|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
885694|NCT01957202|2142158|P8|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
885695|NCT01957202|2142159|P7|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
885696|NCT01957202|2142160|P6|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
885697|NCT01957202|2142161|P5|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
885698|NCT01957202|2142162|P4|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
885699|NCT01957202|2142163|P3|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
885700|NCT01957202|2142164|P2|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
885701|NCT01957202|2142165|P1|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
885702|NCT01957202|2142148|P18|COMPLETED|Washout Period 1 (14 to 28 Days)||3
885703|NCT01957202|2142149|P17|COMPLETED|Washout Period 1 (14 to 28 Days)||6
885704|NCT01957202|2142150|P16|COMPLETED|Washout Period 1 (14 to 28 Days)||3
885705|NCT01957202|2142151|P15|COMPLETED|Washout Period 1 (14 to 28 Days)||6
885706|NCT01957202|2142152|P14|COMPLETED|Washout Period 1 (14 to 28 Days)||3
885707|NCT01957202|2142153|P13|COMPLETED|Washout Period 1 (14 to 28 Days)||3
885708|NCT01957202|2142154|P12|COMPLETED|Washout Period 1 (14 to 28 Days)||6
885709|NCT01957202|2142155|P11|COMPLETED|Washout Period 1 (14 to 28 Days)||3
885710|NCT01957202|2142156|P10|COMPLETED|Washout Period 1 (14 to 28 Days)||6
885711|NCT01957202|2142157|P9|COMPLETED|Washout Period 1 (14 to 28 Days)||3
885712|NCT01957202|2142158|P8|COMPLETED|Washout Period 1 (14 to 28 Days)||3
885713|NCT01957202|2142159|P7|COMPLETED|Washout Period 1 (14 to 28 Days)||3
885714|NCT01957202|2142160|P6|COMPLETED|Washout Period 1 (14 to 28 Days)||2
885715|NCT01957202|2142161|P5|COMPLETED|Washout Period 1 (14 to 28 Days)||3
885716|NCT01957202|2142162|P4|COMPLETED|Washout Period 1 (14 to 28 Days)||3
885717|NCT01957202|2142163|P3|COMPLETED|Washout Period 1 (14 to 28 Days)||6
885718|NCT01957202|2142164|P2|COMPLETED|Washout Period 1 (14 to 28 Days)||6
885719|NCT01957202|2142165|P1|COMPLETED|Washout Period 1 (14 to 28 Days)||3
885720|NCT01957202|2142148|P18|STARTED|Washout Period 1 (14 to 28 Days)||3
885721|NCT01957202|2142149|P17|STARTED|Washout Period 1 (14 to 28 Days)||6
885722|NCT01957202|2142150|P16|STARTED|Washout Period 1 (14 to 28 Days)||3
885723|NCT01957202|2142151|P15|STARTED|Washout Period 1 (14 to 28 Days)||6
885724|NCT01957202|2142152|P14|STARTED|Washout Period 1 (14 to 28 Days)||3
885725|NCT01957202|2142153|P13|STARTED|Washout Period 1 (14 to 28 Days)||3
885726|NCT01957202|2142154|P12|STARTED|Washout Period 1 (14 to 28 Days)||6
885727|NCT01957202|2142155|P11|STARTED|Washout Period 1 (14 to 28 Days)||3
885728|NCT01957202|2142156|P10|STARTED|Washout Period 1 (14 to 28 Days)||6
885729|NCT01957202|2142157|P9|STARTED|Washout Period 1 (14 to 28 Days)||3
885730|NCT01957202|2142158|P8|STARTED|Washout Period 1 (14 to 28 Days)||3
885731|NCT01957202|2142159|P7|STARTED|Washout Period 1 (14 to 28 Days)||3
885732|NCT01957202|2142160|P6|STARTED|Washout Period 1 (14 to 28 Days)||2
885733|NCT01957202|2142161|P5|STARTED|Washout Period 1 (14 to 28 Days)||3
885734|NCT01957202|2142162|P4|STARTED|Washout Period 1 (14 to 28 Days)||3
885735|NCT01957202|2142163|P3|STARTED|Washout Period 1 (14 to 28 Days)||6
885736|NCT01957202|2142164|P2|STARTED|Washout Period 1 (14 to 28 Days)||6
885737|NCT01957202|2142165|P1|STARTED|Washout Period 1 (14 to 28 Days)||3
885738|NCT01957202|2142148|P18|NOT COMPLETED|Treatment Period 1 (8 Days)||0
885739|NCT01957202|2142149|P17|NOT COMPLETED|Treatment Period 1 (8 Days)||0
885740|NCT01957202|2142150|P16|NOT COMPLETED|Treatment Period 1 (8 Days)||0
885741|NCT01957202|2142151|P15|NOT COMPLETED|Treatment Period 1 (8 Days)||0
885742|NCT01957202|2142152|P14|NOT COMPLETED|Treatment Period 1 (8 Days)||0
885743|NCT01957202|2142153|P13|NOT COMPLETED|Treatment Period 1 (8 Days)||0
885744|NCT01957202|2142154|P12|NOT COMPLETED|Treatment Period 1 (8 Days)||0
885745|NCT01957202|2142155|P11|NOT COMPLETED|Treatment Period 1 (8 Days)||0
885746|NCT01957202|2142156|P10|NOT COMPLETED|Treatment Period 1 (8 Days)||0
885747|NCT01957202|2142157|P9|NOT COMPLETED|Treatment Period 1 (8 Days)||0
885748|NCT01957202|2142158|P8|NOT COMPLETED|Treatment Period 1 (8 Days)||0
885749|NCT01957202|2142159|P7|NOT COMPLETED|Treatment Period 1 (8 Days)||0
885750|NCT01957202|2142160|P6|NOT COMPLETED|Treatment Period 1 (8 Days)||0
885751|NCT01957202|2142161|P5|NOT COMPLETED|Treatment Period 1 (8 Days)||0
885752|NCT01957202|2142162|P4|NOT COMPLETED|Treatment Period 1 (8 Days)||0
885753|NCT01957202|2142163|P3|NOT COMPLETED|Treatment Period 1 (8 Days)||0
885754|NCT01957202|2142164|P2|NOT COMPLETED|Treatment Period 1 (8 Days)||0
885755|NCT01957202|2142165|P1|NOT COMPLETED|Treatment Period 1 (8 Days)||0
885756|NCT01957202|2142148|P18|COMPLETED|Treatment Period 1 (8 Days)||3
885757|NCT01957202|2142149|P17|COMPLETED|Treatment Period 1 (8 Days)||6
885758|NCT01957202|2142150|P16|COMPLETED|Treatment Period 1 (8 Days)||3
885759|NCT01957202|2142151|P15|COMPLETED|Treatment Period 1 (8 Days)||6
885760|NCT01957202|2142152|P14|COMPLETED|Treatment Period 1 (8 Days)||3
885761|NCT01957202|2142153|P13|COMPLETED|Treatment Period 1 (8 Days)||3
885762|NCT01957202|2142154|P12|COMPLETED|Treatment Period 1 (8 Days)||6
885763|NCT01957202|2142155|P11|COMPLETED|Treatment Period 1 (8 Days)||3
885764|NCT01957202|2142156|P10|COMPLETED|Treatment Period 1 (8 Days)||6
885765|NCT01957202|2142157|P9|COMPLETED|Treatment Period 1 (8 Days)||3
885766|NCT01957202|2142158|P8|COMPLETED|Treatment Period 1 (8 Days)||3
885767|NCT01957202|2142159|P7|COMPLETED|Treatment Period 1 (8 Days)||3
885768|NCT01957202|2142160|P6|COMPLETED|Treatment Period 1 (8 Days)||2
885769|NCT01957202|2142161|P5|COMPLETED|Treatment Period 1 (8 Days)||3
885770|NCT01957202|2142162|P4|COMPLETED|Treatment Period 1 (8 Days)||3
885771|NCT01957202|2142163|P3|COMPLETED|Treatment Period 1 (8 Days)||6
885772|NCT01957202|2142164|P2|COMPLETED|Treatment Period 1 (8 Days)||6
885773|NCT01957202|2142165|P1|COMPLETED|Treatment Period 1 (8 Days)||3
885774|NCT01957202|2142148|P18|STARTED|Treatment Period 1 (8 Days)||3
885775|NCT01957202|2142149|P17|STARTED|Treatment Period 1 (8 Days)||6
885776|NCT01957202|2142150|P16|STARTED|Treatment Period 1 (8 Days)||3
885777|NCT01957202|2142151|P15|STARTED|Treatment Period 1 (8 Days)||6
885778|NCT01957202|2142152|P14|STARTED|Treatment Period 1 (8 Days)||3
885779|NCT01957202|2142153|P13|STARTED|Treatment Period 1 (8 Days)||3
885780|NCT01957202|2142154|P12|STARTED|Treatment Period 1 (8 Days)||6
885781|NCT01957202|2142155|P11|STARTED|Treatment Period 1 (8 Days)||3
885782|NCT01957202|2142156|P10|STARTED|Treatment Period 1 (8 Days)||6
885783|NCT01957202|2142157|P9|STARTED|Treatment Period 1 (8 Days)||3
885784|NCT01957202|2142158|P8|STARTED|Treatment Period 1 (8 Days)||3
885785|NCT01957202|2142159|P7|STARTED|Treatment Period 1 (8 Days)||3
885786|NCT01957202|2142160|P6|STARTED|Treatment Period 1 (8 Days)||2
885787|NCT01957202|2142161|P5|STARTED|Treatment Period 1 (8 Days)||3
885788|NCT01957202|2142162|P4|STARTED|Treatment Period 1 (8 Days)||3
885789|NCT01957202|2142163|P3|STARTED|Treatment Period 1 (8 Days)||6
885790|NCT01957202|2142164|P2|STARTED|Treatment Period 1 (8 Days)||6
885791|NCT01957202|2142165|P1|STARTED|Treatment Period 1 (8 Days)||3
885792|NCT01957163|2142190|P3|NOT COMPLETED|Overall Study||18
885793|NCT01957163|2142191|P2|NOT COMPLETED|Overall Study||11
885794|NCT01957163|2142192|P1|NOT COMPLETED|Overall Study||15
885795|NCT01957163|2142190|P3|COMPLETED|Overall Study||189
885796|NCT01957163|2142191|P2|COMPLETED|Overall Study||195
885797|NCT01957163|2142192|P1|COMPLETED|Overall Study||191
885798|NCT01957163|2142190|P3|STARTED|Overall Study||207
885799|NCT01957163|2142191|P2|STARTED|Overall Study||206
885800|NCT01957163|2142192|P1|STARTED|Overall Study||206
885801|NCT01957137|2142203|P1|NOT COMPLETED|No Stimulation||0
885802|NCT01957137|2142203|P1|COMPLETED|No Stimulation||28
885803|NCT01957137|2142203|P1|STARTED|No Stimulation|Following randomized portion, all subjects went through no stimulation for approximately 4 weeks.|28
885804|NCT01957137|2142203|P1|NOT COMPLETED|Randomized Portion||2
885805|NCT01957137|2142203|P1|COMPLETED|Randomized Portion||28
885806|NCT01957137|2142203|P1|Cycling Parameter #3|Randomized Portion|Subjects received Cycling Parameter #3 for approximately 4 weeks.|28
885807|NCT01957137|2142203|P1|Cycling Parameter #2|Randomized Portion|Subjects received Cycling Parameter #2 for approximately 4 weeks.|28
885808|NCT01957137|2142203|P1|Cycling Parameter #1|Randomized Portion|Subjects received Cycling Parameter #1 for approximately 4 weeks.|30
885809|NCT01957137|2142203|P1|Continuous Stimulation|Randomized Portion|Subjects received continuous stimulation for approximately 4 weeks.|29
885810|NCT01957137|2142203|P1|STARTED|Randomized Portion||30
885811|NCT01957111|2142233|P2|NOT COMPLETED|Overall Study||1
885812|NCT01957111|2142234|P1|NOT COMPLETED|Overall Study||1
885813|NCT01957111|2142233|P2|COMPLETED|Overall Study||15
885814|NCT01957111|2142234|P1|COMPLETED|Overall Study||15
885815|NCT01957111|2142233|P2|STARTED|Overall Study||16
885816|NCT01957111|2142234|P1|STARTED|Overall Study||16
885817|NCT01956240|2142244|P2|NOT COMPLETED|Overall Study||24
885818|NCT01956240|2142245|P1|NOT COMPLETED|Overall Study||23
885819|NCT01956240|2142244|P2|COMPLETED|Overall Study||25
885820|NCT01956240|2142245|P1|COMPLETED|Overall Study||25
885821|NCT01956240|2142244|P2|STARTED|Overall Study||49
885822|NCT01956240|2142245|P1|STARTED|Overall Study||48
885823|NCT01956097|2142256|P3|NOT COMPLETED|Overall Study||0
885824|NCT01956097|2142257|P2|NOT COMPLETED|Overall Study||2
885825|NCT01956097|2142258|P1|NOT COMPLETED|Overall Study||6
885826|NCT01956097|2142256|P3|COMPLETED|Overall Study||15
885827|NCT01956097|2142257|P2|COMPLETED|Overall Study||28
885828|NCT01956097|2142258|P1|COMPLETED|Overall Study||24
885829|NCT01956097|2142256|P3|STARTED|Overall Study||15
885830|NCT01956097|2142257|P2|STARTED|Overall Study||30
885831|NCT01956097|2142258|P1|STARTED|Overall Study||30
885832|NCT01956032|2142275|P1|NOT COMPLETED|Overall Study||0
885833|NCT01956032|2142275|P1|COMPLETED|Overall Study||15
885834|NCT01956032|2142275|P1|STARTED|Overall Study||15
885835|NCT01955720|2142322|P6|NOT COMPLETED|Overall Study||0
885836|NCT01955720|2142323|P5|NOT COMPLETED|Overall Study||0
885837|NCT01955720|2142324|P4|NOT COMPLETED|Overall Study||0
885838|NCT01955720|2142325|P3|NOT COMPLETED|Overall Study||0
885839|NCT01955720|2142326|P2|NOT COMPLETED|Overall Study||0
885840|NCT01955720|2142327|P1|NOT COMPLETED|Overall Study||0
885841|NCT01955720|2142322|P6|COMPLETED|Overall Study||7
885842|NCT01955720|2142323|P5|COMPLETED|Overall Study||7
885843|NCT01955720|2142324|P4|COMPLETED|Overall Study||3
885844|NCT01955720|2142325|P3|COMPLETED|Overall Study||3
885845|NCT01955720|2142326|P2|COMPLETED|Overall Study||13
885846|NCT01955720|2142327|P1|COMPLETED|Overall Study||13
885847|NCT01955720|2142322|P6|Subjects With Moderate Renal Impairment|Overall Study||0
885848|NCT01955720|2142323|P5|Subjects With Moderate Renal Impairment|Overall Study||0
885849|NCT01955720|2142324|P4|Subjects With Moderate Renal Impairment|Overall Study||0
885850|NCT01955720|2142325|P3|Subjects With Moderate Renal Impairment|Overall Study||0
885851|NCT01955720|2142326|P2|Subjects With Moderate Renal Impairment|Overall Study||3
885852|NCT01955720|2142327|P1|Subjects With Moderate Renal Impairment|Overall Study||3
885853|NCT01955720|2142322|P6|Subjects With Mild Renal Impairment|Overall Study||3
885854|NCT01955720|2142323|P5|Subjects With Mild Renal Impairment|Overall Study||3
885855|NCT01955720|2142324|P4|Subjects With Mild Renal Impairment|Overall Study||0
885856|NCT01955720|2142325|P3|Subjects With Mild Renal Impairment|Overall Study||0
885857|NCT01955720|2142326|P2|Subjects With Mild Renal Impairment|Overall Study||3
885858|NCT01955720|2142327|P1|Subjects With Mild Renal Impairment|Overall Study||3
885859|NCT01955720|2142322|P6|Healthy Subjects Aged 65-80|Overall Study||4
885860|NCT01955720|2142323|P5|Healthy Subjects Aged 65-80|Overall Study||4
885861|NCT01955720|2142324|P4|Healthy Subjects Aged 65-80|Overall Study||0
885862|NCT01955720|2142325|P3|Healthy Subjects Aged 65-80|Overall Study||0
885863|NCT01955720|2142326|P2|Healthy Subjects Aged 65-80|Overall Study||4
885864|NCT01955720|2142327|P1|Healthy Subjects Aged 65-80|Overall Study||4
885865|NCT01955720|2142322|P6|Healthy Subjects Aged 45-64|Overall Study||0
885866|NCT01955720|2142323|P5|Healthy Subjects Aged 45-64|Overall Study||0
885867|NCT01955720|2142324|P4|Healthy Subjects Aged 45-64|Overall Study||3
885868|NCT01955720|2142325|P3|Healthy Subjects Aged 45-64|Overall Study||3
885869|NCT01955720|2142326|P2|Healthy Subjects Aged 45-64|Overall Study||3
885870|NCT01955720|2142327|P1|Healthy Subjects Aged 45-64|Overall Study||3
885871|NCT01955720|2142322|P6|STARTED|Overall Study||7
885872|NCT01955720|2142323|P5|STARTED|Overall Study||7
885873|NCT01955720|2142324|P4|STARTED|Overall Study||3
885874|NCT01955720|2142325|P3|STARTED|Overall Study||3
885875|NCT01955720|2142326|P2|STARTED|Overall Study||13
885876|NCT01955720|2142327|P1|STARTED|Overall Study||13
885877|NCT01955707|2142395|P2|NOT COMPLETED|Overall Study||22
885878|NCT01955707|2142396|P1|NOT COMPLETED|Overall Study||20
885879|NCT01955707|2142395|P2|COMPLETED|Overall Study||57
885880|NCT01955707|2142396|P1|COMPLETED|Overall Study||62
885881|NCT01955707|2142395|P2|Received Total Volume of Study Drug|Overall Study||77
885882|NCT01955707|2142396|P1|Received Total Volume of Study Drug|Overall Study||82
885883|NCT01955707|2142395|P2|Dosed|Overall Study||78
885884|NCT01955707|2142396|P1|Dosed|Overall Study||82
885885|NCT01955707|2142395|P2|Withdrew Prior to Dosing|Overall Study||1
885886|NCT01955707|2142396|P1|Withdrew Prior to Dosing|Overall Study||0
885887|NCT01955707|2142395|P2|STARTED|Overall Study||79
885888|NCT01955707|2142396|P1|STARTED|Overall Study||82
885889|NCT01955629|2142420|P1|NOT COMPLETED|Overall Study||0
885890|NCT01955629|2142420|P1|COMPLETED|Overall Study|1 participant with DP and 3 with unacceptable toxicity were considered completed as per protocol.|4
885891|NCT01955629|2142420|P1|STARTED|Overall Study||4
885892|NCT01955564|2142439|P7|NOT COMPLETED|Overall Study||0
885893|NCT01955564|2142440|P6|NOT COMPLETED|Overall Study||0
885894|NCT01955564|2142441|P5|NOT COMPLETED|Overall Study||0
885895|NCT01955564|2142442|P4|NOT COMPLETED|Overall Study||0
885896|NCT01955564|2142443|P3|NOT COMPLETED|Overall Study||0
885897|NCT01955564|2142444|P2|NOT COMPLETED|Overall Study||0
885898|NCT01955564|2142445|P1|NOT COMPLETED|Overall Study||0
885899|NCT01955564|2142439|P7|COMPLETED|Overall Study||6
885900|NCT01955564|2142440|P6|COMPLETED|Overall Study||6
885901|NCT01955564|2142441|P5|COMPLETED|Overall Study||6
885902|NCT01955564|2142442|P4|COMPLETED|Overall Study||6
885903|NCT01955564|2142443|P3|COMPLETED|Overall Study||6
885904|NCT01955564|2142444|P2|COMPLETED|Overall Study||6
885905|NCT01955564|2142445|P1|COMPLETED|Overall Study||18
885906|NCT01955564|2142439|P7|STARTED|Overall Study||6
885907|NCT01955564|2142440|P6|STARTED|Overall Study||6
885908|NCT01955564|2142441|P5|STARTED|Overall Study||6
885909|NCT01955564|2142442|P4|STARTED|Overall Study||6
885910|NCT01955564|2142443|P3|STARTED|Overall Study||6
885911|NCT01955564|2142444|P2|STARTED|Overall Study||6
885912|NCT01955564|2142445|P1|STARTED|Overall Study||18
885913|NCT01955473|2142478|P5|NOT COMPLETED|Overall Study||0
885914|NCT01955473|2142479|P4|NOT COMPLETED|Overall Study||0
885915|NCT01955473|2142480|P3|NOT COMPLETED|Overall Study||0
885916|NCT01955473|2142481|P2|NOT COMPLETED|Overall Study||0
885917|NCT01955473|2142482|P1|NOT COMPLETED|Overall Study||0
885918|NCT01955473|2142478|P5|COMPLETED|Overall Study||30
885919|NCT01955473|2142479|P4|COMPLETED|Overall Study||6
885920|NCT01955473|2142480|P3|COMPLETED|Overall Study||6
885921|NCT01955473|2142481|P2|COMPLETED|Overall Study||6
885922|NCT01955473|2142482|P1|COMPLETED|Overall Study||3
885923|NCT01955473|2142478|P5|STARTED|Overall Study||30
885924|NCT01955473|2142479|P4|STARTED|Overall Study||6
885925|NCT01955473|2142480|P3|STARTED|Overall Study||6
885926|NCT01955473|2142481|P2|STARTED|Overall Study||6
885927|NCT01955473|2142482|P1|STARTED|Overall Study||3
885928|NCT01955369|2142636|P1|NOT COMPLETED|Overall Study||0
885929|NCT01955369|2142636|P1|COMPLETED|Overall Study||200
885930|NCT01955369|2142636|P1|STARTED|Overall Study||200
885931|NCT01955161|2142645|P3|NOT COMPLETED|Overall Study||35
885932|NCT01955161|2142646|P2|NOT COMPLETED|Overall Study||25
885933|NCT01955161|2142647|P1|NOT COMPLETED|Overall Study||27
885934|NCT01955161|2142645|P3|COMPLETED|Overall Study||275
885935|NCT01955161|2142646|P2|COMPLETED|Overall Study||288
885936|NCT01955161|2142647|P1|COMPLETED|Overall Study||283
885937|NCT01955161|2142645|P3|Treated|Overall Study||309
885938|NCT01955161|2142646|P2|Treated|Overall Study||313
885939|NCT01955161|2142647|P1|Treated|Overall Study||308
885940|NCT01955161|2142645|P3|STARTED|Overall Study||310
885941|NCT01955161|2142646|P2|STARTED|Overall Study||313
885942|NCT01955161|2142647|P1|STARTED|Overall Study||310
885943|NCT01955122|2142687|P2|NOT COMPLETED|Overall Study||5
885944|NCT01955122|2142688|P1|NOT COMPLETED|Overall Study||5
885945|NCT01955122|2142687|P2|COMPLETED|Overall Study||57
885946|NCT01955122|2142688|P1|COMPLETED|Overall Study||59
885947|NCT01955122|2142687|P2|No. Patients Completed Double Procedure|Overall Study||57
885948|NCT01955122|2142688|P1|No. Patients Completed Double Procedure|Overall Study||59
885949|NCT01955122|2142687|P2|No.Patients Enrolled|Overall Study||62
885950|NCT01955122|2142688|P1|No.Patients Enrolled|Overall Study||64
885951|NCT01955122|2142687|P2|STARTED|Overall Study|"Excluded (n = 5)
Included in analysis (n = 57)"|62
885952|NCT01955122|2142688|P1|STARTED|Overall Study|"Excluded (n = 5)
Included in analysis (n = 59)"|64
885953|NCT01955083|2142708|P2|NOT COMPLETED|Overall Study||1
885954|NCT01955083|2142709|P1|NOT COMPLETED|Overall Study||1
885955|NCT01955083|2142708|P2|COMPLETED|Overall Study||14
885956|NCT01955083|2142709|P1|COMPLETED|Overall Study||14
885957|NCT01955083|2142708|P2|STARTED|Overall Study||15
885958|NCT01955083|2142709|P1|STARTED|Overall Study||15
885959|NCT01955044|2142742|P3|NOT COMPLETED|Overall Study||0
885960|NCT01955044|2142743|P2|NOT COMPLETED|Overall Study||1
885961|NCT01955044|2142744|P1|NOT COMPLETED|Overall Study||1
885962|NCT01955044|2142742|P3|COMPLETED|Overall Study||10
885963|NCT01955044|2142743|P2|COMPLETED|Overall Study||9
885964|NCT01955044|2142744|P1|COMPLETED|Overall Study||9
885965|NCT01955044|2142742|P3|STARTED|Overall Study||10
885966|NCT01955044|2142743|P2|STARTED|Overall Study||10
885967|NCT01955044|2142744|P1|STARTED|Overall Study||10
885968|NCT01955005|2142757|P2|NOT COMPLETED|Overall Study||5
885969|NCT01955005|2142758|P1|NOT COMPLETED|Overall Study||3
885970|NCT01955005|2142757|P2|COMPLETED|Overall Study||25
885971|NCT01955005|2142758|P1|COMPLETED|Overall Study||27
885972|NCT01955005|2142757|P2|STARTED|Overall Study||30
885973|NCT01955005|2142758|P1|STARTED|Overall Study||30
885974|NCT01954771|2142771|P3|NOT COMPLETED|Overall Study||3
885975|NCT01954771|2142772|P2|NOT COMPLETED|Overall Study||3
885976|NCT01954771|2142773|P1|NOT COMPLETED|Overall Study||7
885977|NCT01954771|2142771|P3|COMPLETED|Overall Study||25
885978|NCT01954771|2142772|P2|COMPLETED|Overall Study||29
885979|NCT01954771|2142773|P1|COMPLETED|Overall Study||22
885980|NCT01954771|2142771|P3|STARTED|Overall Study||28
885981|NCT01954771|2142772|P2|STARTED|Overall Study||32
885982|NCT01954771|2142773|P1|STARTED|Overall Study||29
885983|NCT01954745|2142790|P1|NOT COMPLETED|Overall Study||19
885984|NCT01954745|2142790|P1|COMPLETED|Overall Study||0
885985|NCT01954745|2142790|P1|STARTED|Overall Study||19
885986|NCT01954628|2142799|P2|NOT COMPLETED|Overall Study||27
885987|NCT01954628|2142800|P1|NOT COMPLETED|Overall Study||31
885988|NCT01954628|2142799|P2|COMPLETED|Overall Study||173
885989|NCT01954628|2142800|P1|COMPLETED|Overall Study||169
885990|NCT01954628|2142799|P2|US 6 Month Ophthalmology Safety Visit|Overall Study||32
885991|NCT01954628|2142800|P1|US 6 Month Ophthalmology Safety Visit|Overall Study||37
885992|NCT01954628|2142799|P2|Pharmacokinetic Population|Overall Study||0
885993|NCT01954628|2142800|P1|Pharmacokinetic Population|Overall Study||181
885994|NCT01954628|2142799|P2|Safety Set|Overall Study||200
885995|NCT01954628|2142800|P1|Safety Set|Overall Study||200
885996|NCT01954628|2142799|P2|Full Analysis Set (FAS)|Overall Study||198
885997|NCT01954628|2142800|P1|Full Analysis Set (FAS)|Overall Study||200
885998|NCT01954628|2142799|P2|STARTED|Overall Study||200
885999|NCT01954628|2142800|P1|STARTED|Overall Study||200
886006|NCT01954160|2142858|P2|NOT COMPLETED|Overall Study||0
886007|NCT01954160|2142859|P1|NOT COMPLETED|Overall Study||5
886008|NCT01954160|2142858|P2|COMPLETED|Overall Study||0
886009|NCT01954160|2142859|P1|COMPLETED|Overall Study|Only 4 subjects completed the first early denervation. No subjects completed the late denervation.|0
886010|NCT01954160|2142858|P2|STARTED|Overall Study|Not started|0
886011|NCT01954160|2142859|P1|STARTED|Overall Study||5
886012|NCT01954121|2142919|P2|NOT COMPLETED|Overall Study||91
886013|NCT01954121|2142920|P1|NOT COMPLETED|Overall Study||127
886014|NCT01954121|2142919|P2|COMPLETED|Overall Study||125
886015|NCT01954121|2142920|P1|COMPLETED|Overall Study||93
886016|NCT01954121|2142919|P2|STARTED|Overall Study||216
886017|NCT01954121|2142920|P1|STARTED|Overall Study||220
886018|NCT01953354|2142936|P2|NOT COMPLETED|Overall Study||2
886019|NCT01953354|2142937|P1|NOT COMPLETED|Overall Study||1
886020|NCT01953354|2142936|P2|COMPLETED|Overall Study||5
886021|NCT01953354|2142937|P1|COMPLETED|Overall Study||8
886022|NCT01953354|2142936|P2|STARTED|Overall Study||7
886023|NCT01953354|2142937|P1|STARTED|Overall Study||9
886024|NCT01953328|2142965|P8|NOT COMPLETED|Overall Study||0
886025|NCT01953328|2142966|P7|NOT COMPLETED|Overall Study||0
886026|NCT01953328|2142967|P6|NOT COMPLETED|Overall Study||0
886027|NCT01953328|2142968|P5|NOT COMPLETED|Overall Study||2
886028|NCT01953328|2142969|P4|NOT COMPLETED|Overall Study||0
886029|NCT01953328|2142970|P3|NOT COMPLETED|Overall Study||0
886030|NCT01953328|2142971|P2|NOT COMPLETED|Overall Study||0
886031|NCT01953328|2142972|P1|NOT COMPLETED|Overall Study||0
886032|NCT01953328|2142965|P8|COMPLETED|Overall Study||51
886033|NCT01953328|2142966|P7|COMPLETED|Overall Study||51
886034|NCT01953328|2142967|P6|COMPLETED|Overall Study||51
886035|NCT01953328|2142968|P5|COMPLETED|Overall Study||50
886036|NCT01953328|2142969|P4|COMPLETED|Overall Study||50
886037|NCT01953328|2142970|P3|COMPLETED|Overall Study||50
886038|NCT01953328|2142971|P2|COMPLETED|Overall Study||50
886039|NCT01953328|2142972|P1|COMPLETED|Overall Study||49
886040|NCT01953328|2142965|P8|Received Treatment|Overall Study||51
886041|NCT01953328|2142966|P7|Received Treatment|Overall Study||51
886042|NCT01953328|2142967|P6|Received Treatment|Overall Study||51
886043|NCT01953328|2142968|P5|Received Treatment|Overall Study||52
886044|NCT01953328|2142969|P4|Received Treatment|Overall Study||50
886045|NCT01953328|2142970|P3|Received Treatment|Overall Study||50
886046|NCT01953328|2142971|P2|Received Treatment|Overall Study||50
886047|NCT01953328|2142972|P1|Received Treatment|Overall Study||49
886048|NCT01953328|2142965|P8|STARTED|Overall Study||51
886049|NCT01953328|2142966|P7|STARTED|Overall Study||51
886050|NCT01953328|2142967|P6|STARTED|Overall Study||51
886051|NCT01953328|2142968|P5|STARTED|Overall Study||52
886052|NCT01953328|2142969|P4|STARTED|Overall Study||50
886053|NCT01953328|2142970|P3|STARTED|Overall Study||50
886054|NCT01953328|2142971|P2|STARTED|Overall Study||50
886055|NCT01953328|2142972|P1|STARTED|Overall Study||49
886056|NCT01953237|2143176|P2|NOT COMPLETED|Overall Study||0
886057|NCT01953237|2143177|P1|NOT COMPLETED|Overall Study||0
886058|NCT01953237|2143176|P2|COMPLETED|Overall Study||21
886059|NCT01953237|2143177|P1|COMPLETED|Overall Study||10
886060|NCT01953237|2143176|P2|STARTED|Overall Study||21
886061|NCT01953237|2143177|P1|STARTED|Overall Study||10
886062|NCT01953081|2143185|P2|NOT COMPLETED|Overall Study||3
886063|NCT01953081|2143186|P1|NOT COMPLETED|Overall Study||2
886064|NCT01953081|2143185|P2|COMPLETED|Overall Study||3
886065|NCT01953081|2143186|P1|COMPLETED|Overall Study||5
886066|NCT01953081|2143185|P2|STARTED|Overall Study||6
886067|NCT01953081|2143186|P1|STARTED|Overall Study||7
886068|NCT01952834|2143202|P1|NOT COMPLETED|Overall Study||1
886069|NCT01952834|2143202|P1|COMPLETED|Overall Study||20
886070|NCT01952834|2143202|P1|STARTED|Overall Study||21
886071|NCT01952691|2143209|P1|NOT COMPLETED|Overall Study||2
886072|NCT01952691|2143209|P1|COMPLETED|Overall Study||20
886073|NCT01952691|2143209|P1|STARTED|Overall Study||22
886074|NCT01952665|2143217|P2|NOT COMPLETED|Overall Study||6
886075|NCT01952665|2143218|P1|NOT COMPLETED|Overall Study||6
886076|NCT01952665|2143217|P2|COMPLETED|Overall Study||20
886077|NCT01952665|2143218|P1|COMPLETED|Overall Study||31
886078|NCT01952665|2143217|P2|STARTED|Overall Study||26
886079|NCT01952665|2143218|P1|STARTED|Overall Study||37
886080|NCT01952600|2143359|P3|NOT COMPLETED|Overall Study||7
886081|NCT01952600|2143360|P2|NOT COMPLETED|Overall Study||13
886082|NCT01952600|2143361|P1|NOT COMPLETED|Overall Study||15
886083|NCT01952600|2143359|P3|COMPLETED|Overall Study||38
886084|NCT01952600|2143360|P2|COMPLETED|Overall Study||77
886085|NCT01952600|2143361|P1|COMPLETED|Overall Study||65
886086|NCT01952600|2143359|P3|STARTED|Overall Study||45
886087|NCT01952600|2143360|P2|STARTED|Overall Study||90
886088|NCT01952600|2143361|P1|STARTED|Overall Study||80
886089|NCT01952418|2143371|P2|NOT COMPLETED|Overall Study||0
886090|NCT01952418|2143372|P1|NOT COMPLETED|Overall Study||0
886091|NCT01952418|2143371|P2|COMPLETED|Overall Study||895
886092|NCT01952418|2143372|P1|COMPLETED|Overall Study||910
886093|NCT01952418|2143371|P2|STARTED|Overall Study||895
886094|NCT01952418|2143372|P1|STARTED|Overall Study||910
886095|NCT01952366|2143384|P1|NOT COMPLETED|Overall Study||31
886096|NCT01952366|2143384|P1|COMPLETED|Overall Study||138
886097|NCT01952366|2143384|P1|STARTED|Overall Study||169
886098|NCT01952301|2143390|P1|NOT COMPLETED|Overall Study||0
886099|NCT01952301|2143390|P1|COMPLETED|Overall Study||30
886100|NCT01952301|2143390|P1|STARTED|Overall Study|We designed and implemented a single-blind, randomized, controlled, split-mouth study of 30 subjects|30
886101|NCT01952145|2143398|P2|NOT COMPLETED|Overall Study||14
886102|NCT01952145|2143399|P1|NOT COMPLETED|Overall Study||28
886103|NCT01952145|2143398|P2|COMPLETED|Overall Study||265
886104|NCT01952145|2143399|P1|COMPLETED|Overall Study||250
886105|NCT01952145|2143398|P2|STARTED|Overall Study||279
886106|NCT01952145|2143399|P1|STARTED|Overall Study||278
886107|NCT01952080|2143413|P4|NOT COMPLETED|Overall Study||1
886108|NCT01952080|2143414|P3|NOT COMPLETED|Overall Study||0
886109|NCT01952080|2143415|P2|NOT COMPLETED|Overall Study||1
886110|NCT01952080|2143416|P1|NOT COMPLETED|Overall Study||0
886111|NCT01952080|2143413|P4|COMPLETED|Overall Study||14
886112|NCT01952080|2143414|P3|COMPLETED|Overall Study||14
886113|NCT01952080|2143415|P2|COMPLETED|Overall Study||7
886114|NCT01952080|2143416|P1|COMPLETED|Overall Study||5
886115|NCT01952080|2143413|P4|Treated|Overall Study||15
886116|NCT01952080|2143414|P3|Treated|Overall Study||14
886117|NCT01952080|2143415|P2|Treated|Overall Study||8
886118|NCT01952080|2143416|P1|Treated|Overall Study||5
886119|NCT01952080|2143413|P4|STARTED|Overall Study||15
886120|NCT01952080|2143414|P3|STARTED|Overall Study||14
886121|NCT01952080|2143415|P2|STARTED|Overall Study||8
886122|NCT01952080|2143416|P1|STARTED|Overall Study||5
886123|NCT01951950|2143464|P2|NOT COMPLETED|Overall Study||6
886124|NCT01951950|2143465|P1|NOT COMPLETED|Overall Study||6
886125|NCT01951950|2143464|P2|COMPLETED|Overall Study||20
886126|NCT01951950|2143465|P1|COMPLETED|Overall Study||20
886127|NCT01951950|2143464|P2|STARTED|Overall Study||26
886128|NCT01951950|2143465|P1|STARTED|Overall Study||26
886129|NCT01951820|2143473|P2|NOT COMPLETED|Overall Study||0
886130|NCT01951820|2143474|P1|NOT COMPLETED|Overall Study||0
886131|NCT01951820|2143473|P2|COMPLETED|Overall Study||30
886132|NCT01951820|2143474|P1|COMPLETED|Overall Study||34
886133|NCT01951820|2143473|P2|STARTED|Overall Study||30
886134|NCT01951820|2143474|P1|STARTED|Overall Study||34
886135|NCT01951703|2143482|P2|NOT COMPLETED|Second Intervention||2
886136|NCT01951703|2143483|P1|NOT COMPLETED|Second Intervention||0
886137|NCT01951703|2143482|P2|COMPLETED|Second Intervention||60
886138|NCT01951703|2143483|P1|COMPLETED|Second Intervention||61
886139|NCT01951703|2143482|P2|STARTED|Second Intervention||62
886140|NCT01951703|2143483|P1|STARTED|Second Intervention||61
886141|NCT01951703|2143482|P2|NOT COMPLETED|First Intervention||1
886142|NCT01951703|2143483|P1|NOT COMPLETED|First Intervention||3
886143|NCT01951703|2143482|P2|COMPLETED|First Intervention||62
886144|NCT01951703|2143483|P1|COMPLETED|First Intervention||61
886145|NCT01951703|2143482|P2|STARTED|First Intervention||63
886146|NCT01951703|2143483|P1|STARTED|First Intervention||64
886147|NCT01951651|2143493|P2|NOT COMPLETED|Overall Study||2
886148|NCT01951651|2143494|P1|NOT COMPLETED|Overall Study||4
886149|NCT01951651|2143493|P2|COMPLETED|Overall Study||10
886150|NCT01951651|2143494|P1|COMPLETED|Overall Study||8
886151|NCT01951651|2143493|P2|STARTED|Overall Study||12
886152|NCT01951651|2143494|P1|STARTED|Overall Study||12
886153|NCT01951586|2143508|P2|NOT COMPLETED|Overall Study||113
886154|NCT01951586|2143509|P1|NOT COMPLETED|Overall Study||59
886155|NCT01951586|2143508|P2|COMPLETED|Overall Study||35
886156|NCT01951586|2143509|P1|COMPLETED|Overall Study||19
886157|NCT01951586|2143508|P2|Received Study Drug|Overall Study||145
886158|NCT01951586|2143509|P1|Received Study Drug|Overall Study||76
886159|NCT01951586|2143508|P2|STARTED|Overall Study||148
886160|NCT01951586|2143509|P1|STARTED|Overall Study||78
886161|NCT01951573|2143533|P2|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
886162|NCT01951573|2143534|P1|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
886163|NCT01951573|2143533|P2|COMPLETED|Period 2, Second 9 Hours of Wear||16
886164|NCT01951573|2143534|P1|COMPLETED|Period 2, Second 9 Hours of Wear||17
886165|NCT01951573|2143533|P2|STARTED|Period 2, Second 9 Hours of Wear||16
886166|NCT01951573|2143534|P1|STARTED|Period 2, Second 9 Hours of Wear||17
886167|NCT01951573|2143533|P2|NOT COMPLETED|Washout Period||1
886168|NCT01951573|2143534|P1|NOT COMPLETED|Washout Period||0
886169|NCT01951573|2143533|P2|COMPLETED|Washout Period||16
886170|NCT01951573|2143534|P1|COMPLETED|Washout Period||17
886171|NCT01951573|2143533|P2|STARTED|Washout Period||17
886172|NCT01951573|2143534|P1|STARTED|Washout Period||17
886173|NCT01951573|2143533|P2|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
886174|NCT01951573|2143534|P1|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
886175|NCT01951573|2143533|P2|COMPLETED|Period 1, First 9 Hours of Wear||17
886176|NCT01951573|2143534|P1|COMPLETED|Period 1, First 9 Hours of Wear||17
886177|NCT01951573|2143533|P2|STARTED|Period 1, First 9 Hours of Wear||17
886178|NCT01951573|2143534|P1|STARTED|Period 1, First 9 Hours of Wear||17
886179|NCT01951417|2143544|P1|NOT COMPLETED|Overall Study||9
886180|NCT01951417|2143544|P1|COMPLETED|Overall Study||72
886181|NCT01951417|2143544|P1|STARTED|Overall Study||81
886182|NCT01951170|2143567|P1|NOT COMPLETED|Overall Study||1
886183|NCT01951170|2143567|P1|COMPLETED|Overall Study||51
886184|NCT01951170|2143567|P1|STARTED|Overall Study||52
886185|NCT01951092|2143590|P1|NOT COMPLETED|Overall Study||12
886186|NCT01951092|2143590|P1|COMPLETED|Overall Study||20
886187|NCT01951092|2143590|P1|STARTED|Overall Study||32
886188|NCT01951066|2143595|P2|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
886189|NCT01951066|2143596|P1|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
886190|NCT01951066|2143595|P2|COMPLETED|Second Intervention (Week 16 to Week 32)||10
886191|NCT01951066|2143596|P1|COMPLETED|Second Intervention (Week 16 to Week 32)||10
886192|NCT01951066|2143595|P2|STARTED|Second Intervention (Week 16 to Week 32)||10
886193|NCT01951066|2143596|P1|STARTED|Second Intervention (Week 16 to Week 32)||10
886194|NCT01951066|2143595|P2|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
886195|NCT01951066|2143596|P1|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
886196|NCT01951066|2143595|P2|COMPLETED|First Intervention (Baseline to Week 16)||10
886197|NCT01951066|2143596|P1|COMPLETED|First Intervention (Baseline to Week 16)||10
886198|NCT01951066|2143595|P2|STARTED|First Intervention (Baseline to Week 16)||10
886199|NCT01951066|2143596|P1|STARTED|First Intervention (Baseline to Week 16)||10
886200|NCT01950741|2143601|P1|NOT COMPLETED|Overall Study||3
886201|NCT01950741|2143601|P1|COMPLETED|Overall Study||45
886202|NCT01950741|2143601|P1|STARTED|Overall Study||48
886203|NCT01950663|2143610|P1|NOT COMPLETED|Overall Study||1
886204|NCT01950663|2143610|P1|COMPLETED|Overall Study||467
886205|NCT01950663|2143610|P1|STARTED|Overall Study||468
886206|NCT01950364|2143616|P2|NOT COMPLETED|Overall Study||10
886207|NCT01950364|2143617|P1|NOT COMPLETED|Overall Study||10
886208|NCT01950364|2143616|P2|COMPLETED|Overall Study||0
886209|NCT01950364|2143617|P1|COMPLETED|Overall Study||0
886210|NCT01950364|2143616|P2|STARTED|Overall Study||10
886211|NCT01950364|2143617|P1|STARTED|Overall Study||10
886212|NCT01950078|2143717|P2|NOT COMPLETED|Overall Study||12
886213|NCT01950078|2143718|P1|NOT COMPLETED|Overall Study||20
886214|NCT01950078|2143717|P2|COMPLETED|Overall Study||496
886215|NCT01950078|2143718|P1|COMPLETED|Overall Study||1005
886216|NCT01950078|2143717|P2|STARTED|Overall Study||508
886217|NCT01950078|2143718|P1|STARTED|Overall Study||1025
886218|NCT01949870|2143726|P1|NOT COMPLETED|Overall Study||6
886219|NCT01949870|2143726|P1|COMPLETED|Overall Study||0
886220|NCT01949870|2143726|P1|Received Treatment|Overall Study||4
886221|NCT01949870|2143726|P1|STARTED|Overall Study||6
886222|NCT01949545|2143734|P4|NOT COMPLETED|Overall Study||0
886223|NCT01949545|2143735|P3|NOT COMPLETED|Overall Study||0
886224|NCT01949545|2143736|P2|NOT COMPLETED|Overall Study||0
886225|NCT01949545|2143737|P1|NOT COMPLETED|Overall Study||0
886226|NCT01949545|2143734|P4|COMPLETED|Overall Study||4
886227|NCT01949545|2143735|P3|COMPLETED|Overall Study||14
886228|NCT01949545|2143736|P2|COMPLETED|Overall Study||17
886229|NCT01949545|2143737|P1|COMPLETED|Overall Study||11
886230|NCT01949545|2143734|P4|STARTED|Overall Study||4
886231|NCT01949545|2143735|P3|STARTED|Overall Study||14
886232|NCT01949545|2143736|P2|STARTED|Overall Study||17
886233|NCT01949545|2143737|P1|STARTED|Overall Study||11
886234|NCT01949532|2143885|P2|NOT COMPLETED|Overall Study||3
886235|NCT01949532|2143886|P1|NOT COMPLETED|Overall Study||3
886236|NCT01949532|2143885|P2|COMPLETED|Overall Study||8
886237|NCT01949532|2143886|P1|COMPLETED|Overall Study||12
886238|NCT01949532|2143885|P2|STARTED|Overall Study||11
886239|NCT01949532|2143886|P1|STARTED|Overall Study||15
886240|NCT01949389|2143954|P1|NOT COMPLETED|Overall Study||0
886241|NCT01949389|2143954|P1|COMPLETED|Overall Study||51
886242|NCT01949389|2143954|P1|STARTED|Overall Study||51
886243|NCT01949155|2143961|P2|NOT COMPLETED|Overall Study||0
886244|NCT01949155|2143962|P1|NOT COMPLETED|Overall Study||2
886245|NCT01949155|2143961|P2|COMPLETED|Overall Study||88
886246|NCT01949155|2143962|P1|COMPLETED|Overall Study||176
886247|NCT01949155|2143961|P2|STARTED|Overall Study||88
886248|NCT01949155|2143962|P1|STARTED|Overall Study||178
886249|NCT01949142|2143974|P2|NOT COMPLETED|Overall Study||1
886250|NCT01949142|2143975|P1|NOT COMPLETED|Overall Study||3
886251|NCT01949142|2143974|P2|COMPLETED|Overall Study||86
886252|NCT01949142|2143975|P1|COMPLETED|Overall Study||176
886253|NCT01949142|2143974|P2|STARTED|Overall Study||87
886254|NCT01949142|2143975|P1|STARTED|Overall Study||179
886255|NCT01949051|2143985|P6|NOT COMPLETED|Treatment Period 3 (7 Days)||0
886256|NCT01949051|2143986|P5|NOT COMPLETED|Treatment Period 3 (7 Days)||0
886257|NCT01949051|2143987|P4|NOT COMPLETED|Treatment Period 3 (7 Days)||0
886258|NCT01949051|2143988|P3|NOT COMPLETED|Treatment Period 3 (7 Days)||0
886259|NCT01949051|2143989|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||0
886260|NCT01949051|2143990|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
886261|NCT01949051|2143985|P6|COMPLETED|Treatment Period 3 (7 Days)||12
886262|NCT01949051|2143986|P5|COMPLETED|Treatment Period 3 (7 Days)||13
886263|NCT01949051|2143987|P4|COMPLETED|Treatment Period 3 (7 Days)||12
886264|NCT01949051|2143988|P3|COMPLETED|Treatment Period 3 (7 Days)||12
886265|NCT01949051|2143989|P2|COMPLETED|Treatment Period 3 (7 Days)||12
886266|NCT01949051|2143990|P1|COMPLETED|Treatment Period 3 (7 Days)||11
886267|NCT01949051|2143985|P6|STARTED|Treatment Period 3 (7 Days)||12
886268|NCT01949051|2143986|P5|STARTED|Treatment Period 3 (7 Days)||13
886269|NCT01949051|2143987|P4|STARTED|Treatment Period 3 (7 Days)||12
886270|NCT01949051|2143988|P3|STARTED|Treatment Period 3 (7 Days)||12
886271|NCT01949051|2143989|P2|STARTED|Treatment Period 3 (7 Days)||12
886272|NCT01949051|2143990|P1|STARTED|Treatment Period 3 (7 Days)||11
886273|NCT01949051|2143985|P6|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
886274|NCT01949051|2143986|P5|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
886275|NCT01949051|2143987|P4|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
886276|NCT01949051|2143988|P3|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
886277|NCT01949051|2143989|P2|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
886278|NCT01949051|2143990|P1|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
886279|NCT01949051|2143985|P6|COMPLETED|Washout Period 2 (14 to 20 Days)||12
886280|NCT01949051|2143986|P5|COMPLETED|Washout Period 2 (14 to 20 Days)||13
886281|NCT01949051|2143987|P4|COMPLETED|Washout Period 2 (14 to 20 Days)||12
886282|NCT01949051|2143988|P3|COMPLETED|Washout Period 2 (14 to 20 Days)||12
886283|NCT01949051|2143989|P2|COMPLETED|Washout Period 2 (14 to 20 Days)||12
886284|NCT01949051|2143990|P1|COMPLETED|Washout Period 2 (14 to 20 Days)||11
886285|NCT01949051|2143985|P6|STARTED|Washout Period 2 (14 to 20 Days)||12
886286|NCT01949051|2143986|P5|STARTED|Washout Period 2 (14 to 20 Days)||13
886287|NCT01949051|2143987|P4|STARTED|Washout Period 2 (14 to 20 Days)||12
886288|NCT01949051|2143988|P3|STARTED|Washout Period 2 (14 to 20 Days)||12
886289|NCT01949051|2143989|P2|STARTED|Washout Period 2 (14 to 20 Days)||12
886290|NCT01949051|2143990|P1|STARTED|Washout Period 2 (14 to 20 Days)||11
886291|NCT01949051|2143985|P6|NOT COMPLETED|Treatment Period 2 (7 Days)||1
886292|NCT01949051|2143986|P5|NOT COMPLETED|Treatment Period 2 (7 Days)||0
886293|NCT01949051|2143987|P4|NOT COMPLETED|Treatment Period 2 (7 Days)||0
886294|NCT01949051|2143988|P3|NOT COMPLETED|Treatment Period 2 (7 Days)||1
886295|NCT01949051|2143989|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||1
886296|NCT01949051|2143990|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
886297|NCT01949051|2143985|P6|COMPLETED|Treatment Period 2 (7 Days)||12
886298|NCT01949051|2143986|P5|COMPLETED|Treatment Period 2 (7 Days)||13
886299|NCT01949051|2143987|P4|COMPLETED|Treatment Period 2 (7 Days)||12
886300|NCT01949051|2143988|P3|COMPLETED|Treatment Period 2 (7 Days)||12
886301|NCT01949051|2143989|P2|COMPLETED|Treatment Period 2 (7 Days)||12
886302|NCT01949051|2143990|P1|COMPLETED|Treatment Period 2 (7 Days)||11
886303|NCT01949051|2143985|P6|STARTED|Treatment Period 2 (7 Days)||13
886304|NCT01949051|2143986|P5|STARTED|Treatment Period 2 (7 Days)||13
886305|NCT01949051|2143987|P4|STARTED|Treatment Period 2 (7 Days)||12
886306|NCT01949051|2143988|P3|STARTED|Treatment Period 2 (7 Days)||13
886307|NCT01949051|2143989|P2|STARTED|Treatment Period 2 (7 Days)||13
886308|NCT01949051|2143990|P1|STARTED|Treatment Period 2 (7 Days)||11
886309|NCT01949051|2143985|P6|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
886310|NCT01949051|2143986|P5|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
886311|NCT01949051|2143987|P4|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
886312|NCT01949051|2143988|P3|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
886313|NCT01949051|2143989|P2|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
886314|NCT01949051|2143990|P1|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
886315|NCT01949051|2143985|P6|COMPLETED|Washout Period 1 (14 to 20 Days)||13
886316|NCT01949051|2143986|P5|COMPLETED|Washout Period 1 (14 to 20 Days)||13
886317|NCT01949051|2143987|P4|COMPLETED|Washout Period 1 (14 to 20 Days)||12
886318|NCT01949051|2143988|P3|COMPLETED|Washout Period 1 (14 to 20 Days)||13
886319|NCT01949051|2143989|P2|COMPLETED|Washout Period 1 (14 to 20 Days)||13
886320|NCT01949051|2143990|P1|COMPLETED|Washout Period 1 (14 to 20 Days)||11
886321|NCT01949051|2143985|P6|STARTED|Washout Period 1 (14 to 20 Days)||13
886322|NCT01949051|2143986|P5|STARTED|Washout Period 1 (14 to 20 Days)||13
886323|NCT01949051|2143987|P4|STARTED|Washout Period 1 (14 to 20 Days)||12
886324|NCT01949051|2143988|P3|STARTED|Washout Period 1 (14 to 20 Days)||13
886325|NCT01949051|2143989|P2|STARTED|Washout Period 1 (14 to 20 Days)||13
886326|NCT01949051|2143990|P1|STARTED|Washout Period 1 (14 to 20 Days)||11
886327|NCT01949051|2143985|P6|NOT COMPLETED|Treatment Period 1 (7 Days)||0
886328|NCT01949051|2143986|P5|NOT COMPLETED|Treatment Period 1 (7 Days)||0
886329|NCT01949051|2143987|P4|NOT COMPLETED|Treatment Period 1 (7 Days)||1
886330|NCT01949051|2143988|P3|NOT COMPLETED|Treatment Period 1 (7 Days)||0
886331|NCT01949051|2143989|P2|NOT COMPLETED|Treatment Period 1 (7 Days)||0
886332|NCT01949051|2143990|P1|NOT COMPLETED|Treatment Period 1 (7 Days)||2
886333|NCT01949051|2143985|P6|COMPLETED|Treatment Period 1 (7 Days)||13
886334|NCT01949051|2143986|P5|COMPLETED|Treatment Period 1 (7 Days)||13
886335|NCT01949051|2143987|P4|COMPLETED|Treatment Period 1 (7 Days)||12
886336|NCT01949051|2143988|P3|COMPLETED|Treatment Period 1 (7 Days)||13
886337|NCT01949051|2143989|P2|COMPLETED|Treatment Period 1 (7 Days)||13
886338|NCT01949051|2143990|P1|COMPLETED|Treatment Period 1 (7 Days)||11
886339|NCT01949051|2143985|P6|STARTED|Treatment Period 1 (7 Days)||13
886340|NCT01949051|2143986|P5|STARTED|Treatment Period 1 (7 Days)||13
886341|NCT01949051|2143987|P4|STARTED|Treatment Period 1 (7 Days)||13
886342|NCT01949051|2143988|P3|STARTED|Treatment Period 1 (7 Days)||13
886343|NCT01949051|2143989|P2|STARTED|Treatment Period 1 (7 Days)||13
886344|NCT01949051|2143990|P1|STARTED|Treatment Period 1 (7 Days)||13
886345|NCT01948908|2144004|P3|NOT COMPLETED|Overall Study||2
886346|NCT01948908|2144005|P2|NOT COMPLETED|Overall Study||0
886347|NCT01948908|2144006|P1|NOT COMPLETED|Overall Study||1
886348|NCT01948908|2144004|P3|COMPLETED|Overall Study||31
886349|NCT01948908|2144005|P2|COMPLETED|Overall Study||33
886350|NCT01948908|2144006|P1|COMPLETED|Overall Study||32
886351|NCT01948908|2144004|P3|STARTED|Overall Study||33
886352|NCT01948908|2144005|P2|STARTED|Overall Study||33
886353|NCT01948908|2144006|P1|STARTED|Overall Study||33
886354|NCT01948830|2144022|P2|NOT COMPLETED|Overall Study||32
886355|NCT01948830|2144023|P1|NOT COMPLETED|Overall Study||33
886356|NCT01948830|2144022|P2|COMPLETED|Overall Study||295
886357|NCT01948830|2144023|P1|COMPLETED|Overall Study||290
886358|NCT01948830|2144022|P2|Safety Set|Overall Study||326
886359|NCT01948830|2144023|P1|Safety Set|Overall Study||323
886360|NCT01948830|2144022|P2|STARTED|Overall Study||327
886361|NCT01948830|2144023|P1|STARTED|Overall Study||323
886362|NCT01948791|2144055|P1|NOT COMPLETED|Overall Study||71
886363|NCT01948791|2144055|P1|COMPLETED|Overall Study||151
886364|NCT01948791|2144055|P1|STARTED|Overall Study||222
886365|NCT01948518|2144063|P1|NOT COMPLETED|Overall Study||0
886366|NCT01948518|2144063|P1|COMPLETED|Overall Study||15
886367|NCT01948518|2144063|P1|STARTED|Overall Study||15
886368|NCT01948375|2144070|P2|NOT COMPLETED|Overall Study||0
886369|NCT01948375|2144071|P1|NOT COMPLETED|Overall Study||0
886370|NCT01948375|2144070|P2|COMPLETED|Overall Study||30
886371|NCT01948375|2144071|P1|COMPLETED|Overall Study||30
886372|NCT01948375|2144070|P2|STARTED|Overall Study||30
886373|NCT01948375|2144071|P1|STARTED|Overall Study||30
886374|NCT01948193|2144085|P1|NOT COMPLETED|Overall Study||9
886375|NCT01948193|2144085|P1|COMPLETED|Overall Study||168
886376|NCT01948193|2144085|P1|STARTED|Overall Study||177
886377|NCT01948141|2144094|P1|NOT COMPLETED|Overall Study||0
886378|NCT01948141|2144094|P1|COMPLETED|Overall Study||6
886379|NCT01948141|2144094|P1|STARTED|Overall Study||6
886380|NCT01948076|2144107|P2|NOT COMPLETED|Overall Study||1
886381|NCT01948076|2144108|P1|NOT COMPLETED|Overall Study||0
886382|NCT01948076|2144107|P2|COMPLETED|Overall Study||19
886383|NCT01948076|2144108|P1|COMPLETED|Overall Study||20
886384|NCT01948076|2144107|P2|STARTED|Overall Study||20
886385|NCT01948076|2144108|P1|STARTED|Overall Study||20
886386|NCT01948063|2144118|P2|NOT COMPLETED|Overall Study||2
886387|NCT01948063|2144119|P1|NOT COMPLETED|Overall Study||1
886388|NCT01948063|2144118|P2|COMPLETED|Overall Study||19
886389|NCT01948063|2144119|P1|COMPLETED|Overall Study||19
886390|NCT01948063|2144118|P2|STARTED|Overall Study||21
886391|NCT01948063|2144119|P1|STARTED|Overall Study||20
886392|NCT01948050|2144127|P2|NOT COMPLETED|Overall Study||1
886393|NCT01948050|2144128|P1|NOT COMPLETED|Overall Study||0
886394|NCT01948050|2144127|P2|COMPLETED|Overall Study||7
886395|NCT01948050|2144128|P1|COMPLETED|Overall Study||16
886396|NCT01948050|2144127|P2|STARTED|Overall Study||8
886397|NCT01948050|2144128|P1|STARTED|Overall Study||16
886398|NCT01947946|2144137|P3|NOT COMPLETED|Overall Study||5
886399|NCT01947946|2144138|P2|NOT COMPLETED|Overall Study||5
886400|NCT01947946|2144139|P1|NOT COMPLETED|Overall Study||3
886401|NCT01947946|2144137|P3|COMPLETED|Overall Study||0
886402|NCT01947946|2144138|P2|COMPLETED|Overall Study||0
886403|NCT01947946|2144139|P1|COMPLETED|Overall Study|Study Stopped|0
886404|NCT01947946|2144137|P3|STARTED|Overall Study||5
886405|NCT01947946|2144138|P2|STARTED|Overall Study||5
886406|NCT01947946|2144139|P1|STARTED|Overall Study||3
886407|NCT01947907|2144151|P4|NOT COMPLETED|Overall Study||0
886408|NCT01947907|2144152|P3|NOT COMPLETED|Overall Study||0
886409|NCT01947907|2144153|P2|NOT COMPLETED|Overall Study||0
886410|NCT01947907|2144154|P1|NOT COMPLETED|Overall Study||0
886411|NCT01947907|2144151|P4|COMPLETED|Overall Study||13
886412|NCT01947907|2144152|P3|COMPLETED|Overall Study||14
886413|NCT01947907|2144153|P2|COMPLETED|Overall Study||14
886414|NCT01947907|2144154|P1|COMPLETED|Overall Study||12
886415|NCT01947907|2144151|P4|STARTED|Overall Study||13
886416|NCT01947907|2144152|P3|STARTED|Overall Study||14
886417|NCT01947907|2144153|P2|STARTED|Overall Study||14
886418|NCT01947907|2144154|P1|STARTED|Overall Study||12
886419|NCT01947855|2144196|P3|NOT COMPLETED|Overall Study||0
886420|NCT01947855|2144197|P2|NOT COMPLETED|Overall Study||0
886421|NCT01947855|2144198|P1|NOT COMPLETED|Overall Study||1
886422|NCT01947855|2144196|P3|COMPLETED|Overall Study||19
886423|NCT01947855|2144197|P2|COMPLETED|Overall Study||20
886424|NCT01947855|2144198|P1|COMPLETED|Overall Study||20
886425|NCT01947855|2144196|P3|STARTED|Overall Study||19
886426|NCT01947855|2144197|P2|STARTED|Overall Study||20
886427|NCT01947855|2144198|P1|STARTED|Overall Study||21
886428|NCT01947582|2144206|P1|NOT COMPLETED|Overall Study||1
886429|NCT01947582|2144206|P1|COMPLETED|Overall Study||1
886430|NCT01947582|2144206|P1|STARTED|Overall Study||2
886431|NCT01947517|2144215|P2|NOT COMPLETED|Overall Study||1
886432|NCT01947517|2144216|P1|NOT COMPLETED|Overall Study||1
886433|NCT01947517|2144215|P2|COMPLETED|Overall Study||25
886434|NCT01947517|2144216|P1|COMPLETED|Overall Study||25
886435|NCT01947517|2144215|P2|STARTED|Overall Study||26
886436|NCT01947517|2144216|P1|STARTED|Overall Study||26
886437|NCT01947491|2144234|P4|NOT COMPLETED|Overall Study||5
886438|NCT01947491|2144235|P3|NOT COMPLETED|Overall Study||2
886439|NCT01947491|2144236|P2|NOT COMPLETED|Overall Study||6
886440|NCT01947491|2144237|P1|NOT COMPLETED|Overall Study||8
886441|NCT01947491|2144234|P4|COMPLETED|Overall Study||38
886442|NCT01947491|2144235|P3|COMPLETED|Overall Study||88
886443|NCT01947491|2144236|P2|COMPLETED|Overall Study||81
886444|NCT01947491|2144237|P1|COMPLETED|Overall Study||166
886445|NCT01947491|2144234|P4|STARTED|Overall Study||43
886446|NCT01947491|2144235|P3|STARTED|Overall Study||90
886447|NCT01947491|2144236|P2|STARTED|Overall Study||87
886448|NCT01947491|2144237|P1|STARTED|Overall Study||174
886449|NCT01947335|2144249|P2|NOT COMPLETED|Overall Study||0
886450|NCT01947335|2144250|P1|NOT COMPLETED|Overall Study||0
886451|NCT01947335|2144249|P2|COMPLETED|Overall Study||41
886452|NCT01947335|2144250|P1|COMPLETED|Overall Study||42
886453|NCT01947335|2144249|P2|STARTED|Overall Study||41
886454|NCT01947335|2144250|P1|STARTED|Overall Study||42
886455|NCT01947153|2144260|P2|NOT COMPLETED|Test Period 2||0
886456|NCT01947153|2144261|P1|NOT COMPLETED|Test Period 2||0
886457|NCT01947153|2144260|P2|COMPLETED|Test Period 2||18
886458|NCT01947153|2144261|P1|COMPLETED|Test Period 2||18
886459|NCT01947153|2144260|P2|STARTED|Test Period 2||18
886460|NCT01947153|2144261|P1|STARTED|Test Period 2||18
886461|NCT01947153|2144260|P2|NOT COMPLETED|Test Period 1||0
886462|NCT01947153|2144261|P1|NOT COMPLETED|Test Period 1||0
886463|NCT01947153|2144260|P2|COMPLETED|Test Period 1||18
886464|NCT01947153|2144261|P1|COMPLETED|Test Period 1||18
886465|NCT01947153|2144260|P2|STARTED|Test Period 1||18
886466|NCT01947153|2144261|P1|STARTED|Test Period 1||18
886467|NCT01947127|2144281|P2|NOT COMPLETED|Overall Study||43
886468|NCT01947127|2144282|P1|NOT COMPLETED|Overall Study||23
886469|NCT01947127|2144281|P2|COMPLETED|Overall Study||249
886470|NCT01947127|2144282|P1|COMPLETED|Overall Study||143
886471|NCT01947127|2144281|P2|STARTED|Overall Study||292
886472|NCT01947127|2144282|P1|STARTED|Overall Study||166
886473|NCT01946542|2144294|P2|NOT COMPLETED|Testing Visit 2||0
886474|NCT01946542|2144295|P1|NOT COMPLETED|Testing Visit 2||0
886475|NCT01946542|2144294|P2|COMPLETED|Testing Visit 2||1
886476|NCT01946542|2144295|P1|COMPLETED|Testing Visit 2||1
886477|NCT01946542|2144294|P2|STARTED|Testing Visit 2||1
886478|NCT01946542|2144295|P1|STARTED|Testing Visit 2||1
886479|NCT01946542|2144294|P2|NOT COMPLETED|Testing Visit 1||0
886480|NCT01946542|2144295|P1|NOT COMPLETED|Testing Visit 1||0
886481|NCT01946542|2144294|P2|COMPLETED|Testing Visit 1||1
886482|NCT01946542|2144295|P1|COMPLETED|Testing Visit 1||1
886483|NCT01946542|2144294|P2|STARTED|Testing Visit 1||1
886484|NCT01946542|2144295|P1|STARTED|Testing Visit 1||1
886503|NCT01946438|2144319|P4|NOT COMPLETED|Overall Study||1
886504|NCT01946438|2144320|P3|NOT COMPLETED|Overall Study||1
886505|NCT01946438|2144321|P2|NOT COMPLETED|Overall Study||0
886506|NCT01946438|2144322|P1|NOT COMPLETED|Overall Study||2
886507|NCT01946438|2144319|P4|COMPLETED|Overall Study||51
886508|NCT01946438|2144320|P3|COMPLETED|Overall Study||51
886509|NCT01946438|2144321|P2|COMPLETED|Overall Study||52
886510|NCT01946438|2144322|P1|COMPLETED|Overall Study||50
886511|NCT01946438|2144319|P4|STARTED|Overall Study||52
886512|NCT01946438|2144320|P3|STARTED|Overall Study||52
886513|NCT01946438|2144321|P2|STARTED|Overall Study||52
886514|NCT01946438|2144322|P1|STARTED|Overall Study||52
886515|NCT01946425|2144350|P2|NOT COMPLETED|Overall Study||0
886516|NCT01946425|2144351|P1|NOT COMPLETED|Overall Study||2
886517|NCT01946425|2144350|P2|COMPLETED|Overall Study||30
886518|NCT01946425|2144351|P1|COMPLETED|Overall Study||28
886519|NCT01946425|2144350|P2|STARTED|Overall Study||30
886520|NCT01946425|2144351|P1|STARTED|Overall Study||30
886521|NCT01946412|2144365|P1|NOT COMPLETED|Overall Study||5
886522|NCT01946412|2144365|P1|COMPLETED|Overall Study||28
886523|NCT01946412|2144365|P1|STARTED|Overall Study||33
886524|NCT01946243|2144387|P1|NOT COMPLETED|Overall Study||0
886525|NCT01946243|2144387|P1|COMPLETED|Overall Study||96
886526|NCT01946243|2144387|P1|STARTED|Overall Study||96
886527|NCT01946178|2144408|P1|NOT COMPLETED|Overall Study||2
886528|NCT01946178|2144408|P1|COMPLETED|Overall Study||71
886529|NCT01946178|2144408|P1|STARTED|Overall Study||73
886530|NCT01946126|2144418|P2|NOT COMPLETED|Overall Study||0
886531|NCT01946126|2144419|P1|NOT COMPLETED|Overall Study||0
886532|NCT01946126|2144418|P2|COMPLETED|Overall Study||275
886533|NCT01946126|2144419|P1|COMPLETED|Overall Study||184
886534|NCT01946126|2144418|P2|STARTED|Overall Study||275
886535|NCT01946126|2144419|P1|STARTED|Overall Study||184
886536|NCT01945970|2144433|P6|NOT COMPLETED|Overall Study||0
886537|NCT01945970|2144434|P5|NOT COMPLETED|Overall Study||0
886538|NCT01945970|2144435|P4|NOT COMPLETED|Overall Study||0
886539|NCT01945970|2144436|P3|NOT COMPLETED|Overall Study||0
886540|NCT01945970|2144437|P2|NOT COMPLETED|Overall Study||0
886541|NCT01945970|2144438|P1|NOT COMPLETED|Overall Study||0
886542|NCT01945970|2144433|P6|COMPLETED|Overall Study||5
886543|NCT01945970|2144434|P5|COMPLETED|Overall Study||5
886544|NCT01945970|2144435|P4|COMPLETED|Overall Study||5
886545|NCT01945970|2144436|P3|COMPLETED|Overall Study||5
886546|NCT01945970|2144437|P2|COMPLETED|Overall Study||5
886547|NCT01945970|2144438|P1|COMPLETED|Overall Study||5
886548|NCT01945970|2144433|P6|STARTED|Overall Study||5
886549|NCT01945970|2144434|P5|STARTED|Overall Study||5
886550|NCT01945970|2144435|P4|STARTED|Overall Study||5
886551|NCT01945970|2144436|P3|STARTED|Overall Study||5
886552|NCT01945970|2144437|P2|STARTED|Overall Study||5
886553|NCT01945970|2144438|P1|STARTED|Overall Study||5
886554|NCT01945944|2144477|P2|NOT COMPLETED|Overall Study||3
886555|NCT01945944|2144478|P1|NOT COMPLETED|Overall Study||1
886556|NCT01945944|2144477|P2|COMPLETED|Overall Study||6
886557|NCT01945944|2144478|P1|COMPLETED|Overall Study||8
886558|NCT01945944|2144477|P2|STARTED|Overall Study||9
886559|NCT01945944|2144478|P1|STARTED|Overall Study||9
886560|NCT01945294|2144503|P4|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||6
886561|NCT01945294|2144504|P3|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||8
886562|NCT01945294|2144505|P2|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||5
886563|NCT01945294|2144506|P1|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
886564|NCT01945294|2144503|P4|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||23
886565|NCT01945294|2144504|P3|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
886566|NCT01945294|2144505|P2|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
886567|NCT01945294|2144506|P1|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
886568|NCT01945294|2144503|P4|STARTED|Period 2: BOC+ PR Treatment & Follow-up||29
886569|NCT01945294|2144504|P3|STARTED|Period 2: BOC+ PR Treatment & Follow-up||105
886570|NCT01945294|2144505|P2|STARTED|Period 2: BOC+ PR Treatment & Follow-up||102
886571|NCT01945294|2144506|P1|STARTED|Period 2: BOC+ PR Treatment & Follow-up|Participants were assigned to 1 of the 3 arms after upon the 12-week BOC + PR lead-in.|0
886572|NCT01945294|2144503|P4|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
886573|NCT01945294|2144504|P3|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
886574|NCT01945294|2144505|P2|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
886575|NCT01945294|2144506|P1|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||21
886576|NCT01945294|2144503|P4|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
886577|NCT01945294|2144504|P3|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
886578|NCT01945294|2144505|P2|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
886579|NCT01945294|2144506|P1|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||236
886580|NCT01945294|2144503|P4|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
886581|NCT01945294|2144504|P3|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
886582|NCT01945294|2144505|P2|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
886583|NCT01945294|2144506|P1|STARTED|Period 1: 12-Week PR + BOC Lead-In||257
886584|NCT01945242|2144537|P2|NOT COMPLETED|Overall Study||3
886585|NCT01945242|2144538|P1|NOT COMPLETED|Overall Study||3
886586|NCT01945242|2144537|P2|COMPLETED|Overall Study||120
886587|NCT01945242|2144538|P1|COMPLETED|Overall Study||1248
886588|NCT01945242|2144537|P2|STARTED|Overall Study||123
886589|NCT01945242|2144538|P1|STARTED|Overall Study||1251
886590|NCT01945138|2144552|P2|NOT COMPLETED|Overall Study||0
886591|NCT01945138|2144553|P1|NOT COMPLETED|Overall Study||0
886592|NCT01945138|2144552|P2|COMPLETED|Overall Study||7
886593|NCT01945138|2144553|P1|COMPLETED|Overall Study||7
886594|NCT01945138|2144552|P2|STARTED|Overall Study||7
886595|NCT01945138|2144553|P1|STARTED|Overall Study||7
886596|NCT01945112|2144587|P2|NOT COMPLETED|Overall Study||0
886597|NCT01945112|2144588|P1|NOT COMPLETED|Overall Study||0
886598|NCT01945112|2144587|P2|COMPLETED|Overall Study||51
886599|NCT01945112|2144588|P1|COMPLETED|Overall Study||77
886600|NCT01945112|2144587|P2|STARTED|Overall Study|total number of sites where tape was applied|51
886601|NCT01945112|2144588|P1|STARTED|Overall Study|total number of sites where tape was applied|77
886602|NCT01945086|2144596|P3|NOT COMPLETED|Overall Study||2
886603|NCT01945086|2144597|P2|NOT COMPLETED|Overall Study||0
886604|NCT01945086|2144598|P1|NOT COMPLETED|Overall Study||1
886605|NCT01945086|2144596|P3|COMPLETED|Overall Study||26
886606|NCT01945086|2144597|P2|COMPLETED|Overall Study||24
886607|NCT01945086|2144598|P1|COMPLETED|Overall Study||26
886608|NCT01945086|2144596|P3|STARTED|Overall Study||28
886609|NCT01945086|2144597|P2|STARTED|Overall Study||24
886610|NCT01945086|2144598|P1|STARTED|Overall Study||27
886611|NCT01945034|2144642|P3|NOT COMPLETED|Overall Study||7
886612|NCT01945034|2144643|P2|NOT COMPLETED|Overall Study||5
886613|NCT01945034|2144644|P1|NOT COMPLETED|Overall Study||1
886614|NCT01945034|2144642|P3|COMPLETED|Overall Study||145
886615|NCT01945034|2144643|P2|COMPLETED|Overall Study||80
886616|NCT01945034|2144644|P1|COMPLETED|Overall Study||66
886617|NCT01945034|2144642|P3|STARTED|Overall Study||152
886618|NCT01945034|2144643|P2|STARTED|Overall Study||85
886619|NCT01945034|2144644|P1|STARTED|Overall Study||67
886626|NCT01944969|2144708|P1|NOT COMPLETED|Overall Study||26
886627|NCT01944969|2144708|P1|COMPLETED|Overall Study||0
886628|NCT01944969|2144708|P1|STARTED|Overall Study||26
886629|NCT01944878|2144721|P2|NOT COMPLETED|Overall Study||0
886630|NCT01944878|2144722|P1|NOT COMPLETED|Overall Study||0
886631|NCT01944878|2144721|P2|COMPLETED|Overall Study||328
886632|NCT01944878|2144722|P1|COMPLETED|Overall Study||127
886633|NCT01944878|2144721|P2|STARTED|Overall Study||328
886634|NCT01944878|2144722|P1|STARTED|Overall Study||127
886635|NCT01944774|2144733|P3|NOT COMPLETED|Overall Study||8
886636|NCT01944774|2144734|P2|NOT COMPLETED|Overall Study||8
886637|NCT01944774|2144735|P1|NOT COMPLETED|Overall Study||6
886638|NCT01944774|2144733|P3|COMPLETED|Overall Study||62
886639|NCT01944774|2144734|P2|COMPLETED|Overall Study||60
886640|NCT01944774|2144735|P1|COMPLETED|Overall Study||63
886641|NCT01944774|2144733|P3|Received Treatment|Overall Study||70
886642|NCT01944774|2144734|P2|Received Treatment|Overall Study||67
886643|NCT01944774|2144735|P1|Received Treatment|Overall Study||68
886644|NCT01944774|2144733|P3|STARTED|Overall Study||70
886645|NCT01944774|2144734|P2|STARTED|Overall Study||68
886646|NCT01944774|2144735|P1|STARTED|Overall Study||69
886647|NCT01944670|2144776|P1|NOT COMPLETED|Overall Study||2
886648|NCT01944670|2144776|P1|COMPLETED|Overall Study||24
886649|NCT01944670|2144776|P1|STARTED|Overall Study||26
886650|NCT01944631|2144783|P2|NOT COMPLETED|Overall Study||2
886651|NCT01944631|2144784|P1|NOT COMPLETED|Overall Study||4
886652|NCT01944631|2144783|P2|COMPLETED|Overall Study||98
886653|NCT01944631|2144784|P1|COMPLETED|Overall Study||96
886654|NCT01944631|2144783|P2|STARTED|Overall Study||100
886655|NCT01944631|2144784|P1|STARTED|Overall Study||100
886656|NCT01944345|2144800|P1|NOT COMPLETED|Overall Study||0
886657|NCT01944345|2144800|P1|COMPLETED|Overall Study||69
886658|NCT01944345|2144800|P1|STARTED|Overall Study||69
886659|NCT01944319|2144808|P2|NOT COMPLETED|Overall Study||0
886660|NCT01944319|2144809|P1|NOT COMPLETED|Overall Study||0
886661|NCT01944319|2144808|P2|COMPLETED|Overall Study||39
886662|NCT01944319|2144809|P1|COMPLETED|Overall Study||40
886663|NCT01944319|2144808|P2|STARTED|Overall Study||39
886664|NCT01944319|2144809|P1|STARTED|Overall Study||40
886665|NCT01944059|2144819|P1|NOT COMPLETED|Overall Study||7
886666|NCT01944059|2144819|P1|COMPLETED|Overall Study||24
886667|NCT01944059|2144819|P1|STARTED|Overall Study||31
886668|NCT01943864|2144828|P1|NOT COMPLETED|Overall Study||0
886669|NCT01943864|2144828|P1|COMPLETED|Overall Study|Death or 1 year from randomization after progression was considered completion; 20 participants died|20
886670|NCT01943864|2144828|P1|STARTED|Overall Study||20
886671|NCT01943565|2144859|P3|NOT COMPLETED|Overall Study||0
886672|NCT01943565|2144860|P2|NOT COMPLETED|Overall Study||0
886673|NCT01943565|2144861|P1|NOT COMPLETED|Overall Study||0
886674|NCT01943565|2144859|P3|COMPLETED|Overall Study||9
886675|NCT01943565|2144860|P2|COMPLETED|Overall Study||9
886676|NCT01943565|2144861|P1|COMPLETED|Overall Study||11
886677|NCT01943565|2144859|P3|STARTED|Overall Study||9
886678|NCT01943565|2144860|P2|STARTED|Overall Study||9
886679|NCT01943565|2144861|P1|STARTED|Overall Study||11
886680|NCT01943552|2144892|P2|NOT COMPLETED|Overall Study||25
886681|NCT01943552|2144893|P1|NOT COMPLETED|Overall Study||25
886682|NCT01943552|2144892|P2|COMPLETED|Overall Study||69
886683|NCT01943552|2144893|P1|COMPLETED|Overall Study||71
886684|NCT01943552|2144892|P2|STARTED|Overall Study||94
886685|NCT01943552|2144893|P1|STARTED|Overall Study|One patient was randomised to the placebo group, but received nebulized ipratropium bromide.|96
886686|NCT01943474|2144911|P2|NOT COMPLETED|Overall Study||0
886687|NCT01943474|2144912|P1|NOT COMPLETED|Overall Study||0
886688|NCT01943474|2144911|P2|COMPLETED|Overall Study||125
886689|NCT01943474|2144912|P1|COMPLETED|Overall Study||123
886690|NCT01943474|2144911|P2|STARTED|Overall Study||125
886691|NCT01943474|2144912|P1|STARTED|Overall Study||123
886719|NCT01943344|2144952|P1|NOT COMPLETED|Overall Study||3
886720|NCT01943344|2144952|P1|COMPLETED|Overall Study||9
886721|NCT01943344|2144952|P1|STARTED|Overall Study||12
886722|NCT01943292|2144959|P3|NOT COMPLETED|Overall Study||0
886723|NCT01943292|2144960|P2|NOT COMPLETED|Overall Study||0
886724|NCT01943292|2144961|P1|NOT COMPLETED|Overall Study||1
886725|NCT01943292|2144959|P3|COMPLETED|Overall Study||3
886726|NCT01943292|2144960|P2|COMPLETED|Overall Study||3
886727|NCT01943292|2144961|P1|COMPLETED|Overall Study||2
886728|NCT01943292|2144959|P3|Completed Follow-Up|Overall Study||3
886729|NCT01943292|2144960|P2|Completed Follow-Up|Overall Study||3
886730|NCT01943292|2144961|P1|Completed Follow-Up|Overall Study||2
886731|NCT01943292|2144959|P3|Completed Treatment|Overall Study||3
886732|NCT01943292|2144960|P2|Completed Treatment|Overall Study||3
886733|NCT01943292|2144961|P1|Completed Treatment|Overall Study||3
886734|NCT01943292|2144959|P3|Completed Cycle 1|Overall Study||3
886735|NCT01943292|2144960|P2|Completed Cycle 1|Overall Study||3
886736|NCT01943292|2144961|P1|Completed Cycle 1|Overall Study||3
886737|NCT01943292|2144959|P3|STARTED|Overall Study||3
886738|NCT01943292|2144960|P2|STARTED|Overall Study||3
886739|NCT01943292|2144961|P1|STARTED|Overall Study||3
886740|NCT01943110|2144972|P1|NOT COMPLETED|Overall Study||0
886741|NCT01943110|2144972|P1|COMPLETED|Overall Study||30
886742|NCT01943110|2144972|P1|STARTED|Overall Study||30
886743|NCT01942785|2144988|P1|NOT COMPLETED|Overall Study||4
886744|NCT01942785|2144988|P1|COMPLETED|Overall Study||50
886745|NCT01942785|2144988|P1|STARTED|Overall Study||54
886746|NCT01942733|2145017|P1|NOT COMPLETED|Overall Study||3
886747|NCT01942733|2145017|P1|COMPLETED|Overall Study||41
886748|NCT01942733|2145017|P1|STARTED|Overall Study||44
886749|NCT01942720|2145046|P1|NOT COMPLETED|Overall Study||21
886750|NCT01942720|2145046|P1|COMPLETED|Overall Study||53
886751|NCT01942720|2145046|P1|STARTED|Overall Study||74
886752|NCT01942707|2145056|P2|NOT COMPLETED|Overall Study||0
886753|NCT01942707|2145057|P1|NOT COMPLETED|Overall Study||0
886754|NCT01942707|2145056|P2|COMPLETED|Overall Study||23
886755|NCT01942707|2145057|P1|COMPLETED|Overall Study||23
886756|NCT01942707|2145056|P2|STARTED|Overall Study||23
886757|NCT01942707|2145057|P1|STARTED|Overall Study||23
886758|NCT01942161|2145070|P3|NOT COMPLETED|Overall Study||6
886759|NCT01942161|2145071|P2|NOT COMPLETED|Overall Study||6
886760|NCT01942161|2145072|P1|NOT COMPLETED|Overall Study||8
886761|NCT01942161|2145070|P3|COMPLETED|Overall Study||35
886762|NCT01942161|2145071|P2|COMPLETED|Overall Study||24
886763|NCT01942161|2145072|P1|COMPLETED|Overall Study||27
886764|NCT01942161|2145070|P3|STARTED|Overall Study||41
886765|NCT01942161|2145071|P2|STARTED|Overall Study||30
886766|NCT01942161|2145072|P1|STARTED|Overall Study||35
886767|NCT01942148|2145092|P1|NOT COMPLETED|Overall Study||27
886768|NCT01942148|2145092|P1|COMPLETED|Overall Study||41
886769|NCT01942148|2145092|P1|STARTED|Overall Study||68
886770|NCT01942135|2145100|P2|NOT COMPLETED|Overall Study||174
886771|NCT01942135|2145101|P1|NOT COMPLETED|Overall Study||347
886772|NCT01942135|2145100|P2|COMPLETED|Overall Study||0
886773|NCT01942135|2145101|P1|COMPLETED|Overall Study||0
886774|NCT01942135|2145100|P2|STARTED|Overall Study||174
886775|NCT01942135|2145101|P1|STARTED|Overall Study||347
886776|NCT01941940|2145138|P1|NOT COMPLETED|Overall Study||33
886777|NCT01941940|2145138|P1|COMPLETED|Overall Study||194
886778|NCT01941940|2145138|P1|STARTED|Overall Study||227
886779|NCT01941615|2145178|P1|NOT COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
886780|NCT01941615|2145178|P1|COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
886781|NCT01941615|2145178|P1|STARTED|Microgynon® Plus Deleobuvir+Faldaprevir||0
886782|NCT01941615|2145178|P1|NOT COMPLETED|Reference Treatment: Microgynon®||0
886783|NCT01941615|2145178|P1|COMPLETED|Reference Treatment: Microgynon®||0
886784|NCT01941615|2145178|P1|STARTED|Reference Treatment: Microgynon®||0
886785|NCT01941615|2145178|P1|NOT COMPLETED|Run in Treatment: Microgynon®||0
886786|NCT01941615|2145178|P1|COMPLETED|Run in Treatment: Microgynon®||16
886787|NCT01941615|2145178|P1|STARTED|Run in Treatment: Microgynon®||16
886788|NCT01941498|2145187|P1|NOT COMPLETED|Overall Study||1
886789|NCT01941498|2145187|P1|COMPLETED|Overall Study||96
886790|NCT01941498|2145187|P1|STARTED|Overall Study||97
886791|NCT01941485|2145233|P1|NOT COMPLETED|Overall Study||0
886792|NCT01941485|2145233|P1|COMPLETED|Overall Study||59
886793|NCT01941485|2145233|P1|STARTED|Overall Study||59
886794|NCT01941472|2145299|P1|NOT COMPLETED|Overall Study||0
886795|NCT01941472|2145299|P1|COMPLETED|Overall Study||40
886796|NCT01941472|2145299|P1|STARTED|Overall Study||40
886797|NCT01941186|2145305|P2|NOT COMPLETED|Follow-up||0
886798|NCT01941186|2145306|P1|NOT COMPLETED|Follow-up||1
886799|NCT01941186|2145305|P2|COMPLETED|Follow-up||33
886800|NCT01941186|2145306|P1|COMPLETED|Follow-up||30
886801|NCT01941186|2145305|P2|STARTED|Follow-up||33
886802|NCT01941186|2145306|P1|STARTED|Follow-up||31
886803|NCT01941186|2145305|P2|NOT COMPLETED|Randomization/Allocation to Study Group||0
886804|NCT01941186|2145306|P1|NOT COMPLETED|Randomization/Allocation to Study Group||0
886805|NCT01941186|2145305|P2|COMPLETED|Randomization/Allocation to Study Group||33
886806|NCT01941186|2145306|P1|COMPLETED|Randomization/Allocation to Study Group||31
886807|NCT01941186|2145305|P2|STARTED|Randomization/Allocation to Study Group||33
886808|NCT01941186|2145306|P1|STARTED|Randomization/Allocation to Study Group||31
886809|NCT01940523|2145334|P2|NOT COMPLETED|Overall Study||0
886810|NCT01940523|2145335|P1|NOT COMPLETED|Overall Study||0
886811|NCT01940523|2145334|P2|COMPLETED|Overall Study||320
886812|NCT01940523|2145335|P1|COMPLETED|Overall Study||320
886813|NCT01940523|2145334|P2|STARTED|Overall Study||320
886814|NCT01940523|2145335|P1|STARTED|Overall Study||320
886815|NCT01940510|2145343|P1|NOT COMPLETED|Overall Study||0
886816|NCT01940510|2145343|P1|COMPLETED|Overall Study||24
886817|NCT01940510|2145343|P1|STARTED|Overall Study||24
886818|NCT01940497|2145376|P2|NOT COMPLETED|Overall Study||118
886819|NCT01940497|2145377|P1|NOT COMPLETED|Overall Study||120
886820|NCT01940497|2145376|P2|COMPLETED|Overall Study||1
886821|NCT01940497|2145377|P1|COMPLETED|Overall Study||1
886822|NCT01940497|2145376|P2|Treated: Neoadjuvant|Overall Study||21
886823|NCT01940497|2145377|P1|Treated: Neoadjuvant|Overall Study||20
886824|NCT01940497|2145376|P2|Treated: Adjuvant|Overall Study||92
886825|NCT01940497|2145377|P1|Treated: Adjuvant|Overall Study||95
886826|NCT01940497|2145376|P2|Treated|Overall Study||113
886827|NCT01940497|2145377|P1|Treated|Overall Study||115
886828|NCT01940497|2145376|P2|STARTED|Overall Study||119
886829|NCT01940497|2145377|P1|STARTED|Overall Study||121
886830|NCT01940484|2145416|P1|NOT COMPLETED|Overall Study||10
886831|NCT01940484|2145416|P1|COMPLETED|Overall Study||88
886832|NCT01940484|2145416|P1|STARTED|Overall Study||98
886833|NCT01940471|2145436|P2|NOT COMPLETED|Open-Label Extension||8
886834|NCT01940471|2145437|P1|NOT COMPLETED|Open-Label Extension||14
886835|NCT01940471|2145436|P2|COMPLETED|Open-Label Extension||0
886836|NCT01940471|2145437|P1|COMPLETED|Open-Label Extension||0
886837|NCT01940471|2145436|P2|STARTED|Open-Label Extension||8
886838|NCT01940471|2145437|P1|STARTED|Open-Label Extension||14
886839|NCT01940471|2145436|P2|NOT COMPLETED|Double-Blind Phase||285
886840|NCT01940471|2145437|P1|NOT COMPLETED|Double-Blind Phase||568
886841|NCT01940471|2145436|P2|COMPLETED|Double-Blind Phase||8
886842|NCT01940471|2145437|P1|COMPLETED|Double-Blind Phase||14
886843|NCT01940471|2145436|P2|STARTED|Double-Blind Phase||293
886844|NCT01940471|2145437|P1|STARTED|Double-Blind Phase||582
886845|NCT01940341|2145455|P2|NOT COMPLETED|Open-label Extension Phase||1
886846|NCT01940341|2145456|P1|NOT COMPLETED|Open-label Extension Phase||4
886847|NCT01940341|2145455|P2|COMPLETED|Open-label Extension Phase||0
886848|NCT01940341|2145456|P1|COMPLETED|Open-label Extension Phase||0
886849|NCT01940341|2145455|P2|STARTED|Open-label Extension Phase||1
886850|NCT01940341|2145456|P1|STARTED|Open-label Extension Phase||4
886851|NCT01940341|2145455|P2|NOT COMPLETED|Double-Blind Phase||140
886852|NCT01940341|2145456|P1|NOT COMPLETED|Double-Blind Phase||281
886853|NCT01940341|2145455|P2|COMPLETED|Double-Blind Phase||1
886854|NCT01940341|2145456|P1|COMPLETED|Double-Blind Phase||4
886855|NCT01940341|2145455|P2|STARTED|Double-Blind Phase||141
886856|NCT01940341|2145456|P1|STARTED|Double-Blind Phase||285
886857|NCT01940146|2145474|P4|NOT COMPLETED|Overall Study||2
886858|NCT01940146|2145475|P3|NOT COMPLETED|Overall Study||1
886859|NCT01940146|2145476|P2|NOT COMPLETED|Overall Study||0
886860|NCT01940146|2145477|P1|NOT COMPLETED|Overall Study||1
886861|NCT01940146|2145474|P4|COMPLETED|Overall Study||53
886862|NCT01940146|2145475|P3|COMPLETED|Overall Study||55
886863|NCT01940146|2145476|P2|COMPLETED|Overall Study||55
886864|NCT01940146|2145477|P1|COMPLETED|Overall Study||55
886865|NCT01940146|2145474|P4|STARTED|Overall Study||55
886866|NCT01940146|2145475|P3|STARTED|Overall Study||56
886867|NCT01940146|2145476|P2|STARTED|Overall Study||55
886868|NCT01940146|2145477|P1|STARTED|Overall Study||56
886869|NCT01940120|2145487|P1|NOT COMPLETED|Overall Study||44
886870|NCT01940120|2145487|P1|COMPLETED|Overall Study||34
886871|NCT01940120|2145487|P1|STARTED|Overall Study||78
886872|NCT01939938|2145609|P1|NOT COMPLETED|Overall Study||0
886873|NCT01939938|2145609|P1|COMPLETED|Overall Study||10
886874|NCT01939938|2145609|P1|STARTED|Overall Study||10
886875|NCT01939548|2145617|P3|NOT COMPLETED|Overall Study||30
886876|NCT01939548|2145618|P2|NOT COMPLETED|Overall Study||49
886877|NCT01939548|2145619|P1|NOT COMPLETED|Overall Study||37
886878|NCT01939548|2145617|P3|COMPLETED|Overall Study||50
886879|NCT01939548|2145618|P2|COMPLETED|Overall Study||33
886880|NCT01939548|2145619|P1|COMPLETED|Overall Study||41
886881|NCT01939548|2145617|P3|STARTED|Overall Study||80
886882|NCT01939548|2145618|P2|STARTED|Overall Study||82
886883|NCT01939548|2145619|P1|STARTED|Overall Study||78
886884|NCT01939496|2145693|P3|NOT COMPLETED|Overall Study||2
886885|NCT01939496|2145694|P2|NOT COMPLETED|Overall Study||3
886886|NCT01939496|2145695|P1|NOT COMPLETED|Overall Study||9
886887|NCT01939496|2145693|P3|COMPLETED|Overall Study||54
886888|NCT01939496|2145694|P2|COMPLETED|Overall Study||54
886889|NCT01939496|2145695|P1|COMPLETED|Overall Study||47
886890|NCT01939496|2145693|P3|STARTED|Overall Study||56
886891|NCT01939496|2145694|P2|STARTED|Overall Study||57
886892|NCT01939496|2145695|P1|STARTED|Overall Study||56
886893|NCT01939405|2145747|P2|NOT COMPLETED|Overall Study||2
886894|NCT01939405|2145748|P1|NOT COMPLETED|Overall Study||3
886895|NCT01939405|2145747|P2|COMPLETED|Overall Study||28
886896|NCT01939405|2145748|P1|COMPLETED|Overall Study||27
886897|NCT01939405|2145747|P2|STARTED|Overall Study||30
886898|NCT01939405|2145748|P1|STARTED|Overall Study||30
886899|NCT01939314|2145762|P2|NOT COMPLETED|Overall Study||8
886900|NCT01939314|2145763|P1|NOT COMPLETED|Overall Study||9
886901|NCT01939314|2145762|P2|COMPLETED|Overall Study||40
886902|NCT01939314|2145763|P1|COMPLETED|Overall Study||36
886903|NCT01939314|2145762|P2|24 Hour Endpoint|Overall Study||40
886904|NCT01939314|2145763|P1|24 Hour Endpoint|Overall Study||36
886905|NCT01939314|2145762|P2|15 Minute Endpoint|Overall Study||46
886906|NCT01939314|2145763|P1|15 Minute Endpoint|Overall Study||41
886907|NCT01939314|2145762|P2|STARTED|Overall Study||48
886908|NCT01939314|2145763|P1|STARTED|Overall Study||45
886909|NCT01939145|2145775|P2|NOT COMPLETED|Overall Study||7
886910|NCT01939145|2145776|P1|NOT COMPLETED|Overall Study||2
886911|NCT01939145|2145775|P2|COMPLETED|Overall Study||44
886912|NCT01939145|2145776|P1|COMPLETED|Overall Study||47
886913|NCT01939145|2145775|P2|STARTED|Overall Study||51
886914|NCT01939145|2145776|P1|STARTED|Overall Study||49
886915|NCT01939002|2145786|P2|NOT COMPLETED|Overall Study||18
886916|NCT01939002|2145787|P1|NOT COMPLETED|Overall Study||19
886917|NCT01939002|2145786|P2|COMPLETED|Overall Study||80
886918|NCT01939002|2145787|P1|COMPLETED|Overall Study||84
886919|NCT01939002|2145786|P2|STARTED|Overall Study||98
886920|NCT01939002|2145787|P1|STARTED|Overall Study||103
886921|NCT01938989|2145853|P2|NOT COMPLETED|Overall Study||0
886922|NCT01938989|2145854|P1|NOT COMPLETED|Overall Study||0
886923|NCT01938989|2145853|P2|COMPLETED|Overall Study||77
886924|NCT01938989|2145854|P1|COMPLETED|Overall Study||77
886925|NCT01938989|2145853|P2|STARTED|Overall Study||77
886926|NCT01938989|2145854|P1|STARTED|Overall Study||77
886927|NCT01938833|2145860|P1|NOT COMPLETED|Overall Study||0
886928|NCT01938833|2145860|P1|COMPLETED|Overall Study||9
886929|NCT01938833|2145860|P1|STARTED|Overall Study||9
886930|NCT01938430|2145882|P14|NOT COMPLETED|Overall Study||1
886931|NCT01938430|2145883|P13|NOT COMPLETED|Overall Study||0
886932|NCT01938430|2145884|P12|NOT COMPLETED|Overall Study||1
886933|NCT01938430|2145885|P11|NOT COMPLETED|Overall Study||3
886934|NCT01938430|2145886|P10|NOT COMPLETED|Overall Study||3
886935|NCT01938430|2145887|P9|NOT COMPLETED|Overall Study||4
886936|NCT01938430|2145888|P8|NOT COMPLETED|Overall Study||1
886937|NCT01938430|2145889|P7|NOT COMPLETED|Overall Study||2
886938|NCT01938430|2145890|P6|NOT COMPLETED|Overall Study||1
886939|NCT01938430|2145891|P5|NOT COMPLETED|Overall Study||0
886940|NCT01938430|2145892|P4|NOT COMPLETED|Overall Study||2
886941|NCT01938430|2145893|P3|NOT COMPLETED|Overall Study||5
886942|NCT01938430|2145894|P2|NOT COMPLETED|Overall Study||3
886943|NCT01938430|2145895|P1|NOT COMPLETED|Overall Study||4
886944|NCT01938430|2145882|P14|COMPLETED|Overall Study||2
886945|NCT01938430|2145883|P13|COMPLETED|Overall Study||4
886946|NCT01938430|2145884|P12|COMPLETED|Overall Study||3
886947|NCT01938430|2145885|P11|COMPLETED|Overall Study||3
886948|NCT01938430|2145886|P10|COMPLETED|Overall Study||23
886949|NCT01938430|2145887|P9|COMPLETED|Overall Study||22
886950|NCT01938430|2145888|P8|COMPLETED|Overall Study||24
886951|NCT01938430|2145889|P7|COMPLETED|Overall Study||24
886952|NCT01938430|2145890|P6|COMPLETED|Overall Study||55
886953|NCT01938430|2145891|P5|COMPLETED|Overall Study||55
886954|NCT01938430|2145892|P4|COMPLETED|Overall Study||24
886955|NCT01938430|2145893|P3|COMPLETED|Overall Study||18
886956|NCT01938430|2145894|P2|COMPLETED|Overall Study||26
886957|NCT01938430|2145895|P1|COMPLETED|Overall Study||26
886958|NCT01938430|2145882|P14|STARTED|Overall Study||3
886959|NCT01938430|2145883|P13|STARTED|Overall Study||4
886960|NCT01938430|2145884|P12|STARTED|Overall Study||4
886961|NCT01938430|2145885|P11|STARTED|Overall Study||6
886962|NCT01938430|2145886|P10|STARTED|Overall Study||26
886963|NCT01938430|2145887|P9|STARTED|Overall Study||26
886964|NCT01938430|2145888|P8|STARTED|Overall Study||25
886965|NCT01938430|2145889|P7|STARTED|Overall Study||26
886966|NCT01938430|2145890|P6|STARTED|Overall Study||56
886967|NCT01938430|2145891|P5|STARTED|Overall Study||55
886968|NCT01938430|2145892|P4|STARTED|Overall Study||26
886969|NCT01938430|2145893|P3|STARTED|Overall Study||23
886970|NCT01938430|2145894|P2|STARTED|Overall Study||29
886971|NCT01938430|2145895|P1|STARTED|Overall Study||30
886972|NCT01938391|2146220|P1|NOT COMPLETED|12 Month Follow up||2
886973|NCT01938391|2146220|P1|COMPLETED|12 Month Follow up||22
886974|NCT01938391|2146220|P1|STARTED|12 Month Follow up||24
886975|NCT01938391|2146220|P1|NOT COMPLETED|6 Month Follow up||1
886976|NCT01938391|2146220|P1|COMPLETED|6 Month Follow up||24
886977|NCT01938391|2146220|P1|STARTED|6 Month Follow up||25
886978|NCT01938391|2146220|P1|NOT COMPLETED|2 Week Follow up||0
886979|NCT01938391|2146220|P1|COMPLETED|2 Week Follow up||25
886980|NCT01938391|2146220|P1|STARTED|2 Week Follow up||25
886981|NCT01938391|2146220|P1|NOT COMPLETED|Baseline||0
886982|NCT01938391|2146220|P1|COMPLETED|Baseline||25
886983|NCT01938391|2146220|P1|STARTED|Baseline||25
886984|NCT01938170|2146230|P1|NOT COMPLETED|Overall Study||0
886985|NCT01938170|2146230|P1|COMPLETED|Overall Study||41
886986|NCT01938170|2146230|P1|STARTED|Overall Study||41
886987|NCT01938079|2146237|P2|NOT COMPLETED|Overall Study||0
886988|NCT01938079|2146238|P1|NOT COMPLETED|Overall Study||0
886989|NCT01938079|2146237|P2|COMPLETED|Overall Study||10
886990|NCT01938079|2146238|P1|COMPLETED|Overall Study||10
886991|NCT01938079|2146237|P2|STARTED|Overall Study||10
886992|NCT01938079|2146238|P1|STARTED|Overall Study||10
886993|NCT01938066|2146246|P2|NOT COMPLETED|Overall Study||2
886994|NCT01938066|2146247|P1|NOT COMPLETED|Overall Study||1
886995|NCT01938066|2146246|P2|COMPLETED|Overall Study||13
886996|NCT01938066|2146247|P1|COMPLETED|Overall Study||14
886997|NCT01938066|2146246|P2|STARTED|Overall Study||15
886998|NCT01938066|2146247|P1|STARTED|Overall Study||15
886999|NCT01938040|2146257|P2|NOT COMPLETED|Overall Study||0
887000|NCT01938040|2146258|P1|NOT COMPLETED|Overall Study||0
887001|NCT01938040|2146257|P2|COMPLETED|Overall Study||27
887002|NCT01938040|2146258|P1|COMPLETED|Overall Study||28
887003|NCT01938040|2146257|P2|Behavior Metrics|Overall Study||27
887004|NCT01938040|2146258|P1|Behavior Metrics|Overall Study||28
887005|NCT01938040|2146257|P2|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|25
887006|NCT01938040|2146258|P1|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|24
887007|NCT01938040|2146257|P2|STARTED|Overall Study||27
887008|NCT01938040|2146258|P1|STARTED|Overall Study||28
887009|NCT01937975|2146287|P3|NOT COMPLETED|Overall Study||0
887010|NCT01937975|2146288|P2|NOT COMPLETED|Overall Study||0
887011|NCT01937975|2146289|P1|NOT COMPLETED|Overall Study||0
887012|NCT01937975|2146287|P3|COMPLETED|Overall Study||8
887013|NCT01937975|2146288|P2|COMPLETED|Overall Study||8
887014|NCT01937975|2146289|P1|COMPLETED|Overall Study||8
887015|NCT01937975|2146287|P3|STARTED|Overall Study||8
887016|NCT01937975|2146288|P2|STARTED|Overall Study||8
887017|NCT01937975|2146289|P1|STARTED|Overall Study||8
887018|NCT01937871|2146339|P3|NOT COMPLETED|Overall Study||11
887019|NCT01937871|2146340|P2|NOT COMPLETED|Overall Study||17
887020|NCT01937871|2146341|P1|NOT COMPLETED|Overall Study||24
887021|NCT01937871|2146339|P3|COMPLETED|Overall Study||174
887022|NCT01937871|2146340|P2|COMPLETED|Overall Study||346
887023|NCT01937871|2146341|P1|COMPLETED|Overall Study||337
887024|NCT01937871|2146339|P3|Received at Least One Dose of Study Drug|Overall Study||185
887025|NCT01937871|2146340|P2|Received at Least One Dose of Study Drug|Overall Study||362
887026|NCT01937871|2146341|P1|Received at Least One Dose of Study Drug|Overall Study||361
887027|NCT01937871|2146339|P3|STARTED|Overall Study||185
887028|NCT01937871|2146340|P2|STARTED|Overall Study||363
887029|NCT01937871|2146341|P1|STARTED|Overall Study||361
887030|NCT01937715|2146417|P5|NOT COMPLETED|Overall Study||2
887031|NCT01937715|2146418|P4|NOT COMPLETED|Overall Study||4
887032|NCT01937715|2146419|P3|NOT COMPLETED|Overall Study||0
887033|NCT01937715|2146420|P2|NOT COMPLETED|Overall Study||1
887034|NCT01937715|2146421|P1|NOT COMPLETED|Overall Study||0
887035|NCT01937715|2146417|P5|COMPLETED|Overall Study||1
887036|NCT01937715|2146418|P4|COMPLETED|Overall Study||1
887037|NCT01937715|2146419|P3|COMPLETED|Overall Study||3
887038|NCT01937715|2146420|P2|COMPLETED|Overall Study||3
887039|NCT01937715|2146421|P1|COMPLETED|Overall Study||3
887040|NCT01937715|2146417|P5|STARTED|Overall Study||3
887041|NCT01937715|2146418|P4|STARTED|Overall Study||5
887042|NCT01937715|2146419|P3|STARTED|Overall Study||3
887043|NCT01937715|2146420|P2|STARTED|Overall Study||4
887044|NCT01937715|2146421|P1|STARTED|Overall Study||3
887045|NCT01937598|2146543|P2|NOT COMPLETED|Overall Study||0
887046|NCT01937598|2146544|P1|NOT COMPLETED|Overall Study||0
887047|NCT01937598|2146543|P2|COMPLETED|Overall Study||8
887048|NCT01937598|2146544|P1|COMPLETED|Overall Study||8
887049|NCT01937598|2146543|P2|STARTED|Overall Study||8
887050|NCT01937598|2146544|P1|STARTED|Overall Study||8
887051|NCT01937520|2146568|P2|NOT COMPLETED|Overall Study||0
887052|NCT01937520|2146569|P1|NOT COMPLETED|Overall Study||0
887053|NCT01937520|2146568|P2|COMPLETED|Overall Study||9
887054|NCT01937520|2146569|P1|COMPLETED|Overall Study||11
887055|NCT01937520|2146568|P2|STARTED|Overall Study||9
887056|NCT01937520|2146569|P1|STARTED|Overall Study||11
887057|NCT01937364|2146607|P2|NOT COMPLETED|Overall Study||1
887058|NCT01937364|2146608|P1|NOT COMPLETED|Overall Study||2
887059|NCT01937364|2146607|P2|COMPLETED|Overall Study||7
887060|NCT01937364|2146608|P1|COMPLETED|Overall Study||7
887061|NCT01937364|2146607|P2|STARTED|Overall Study||8
887062|NCT01937364|2146608|P1|STARTED|Overall Study||9
887063|NCT01937351|2146620|P2|NOT COMPLETED|Overall Study||2
887064|NCT01937351|2146621|P1|NOT COMPLETED|Overall Study||9
887065|NCT01937351|2146620|P2|COMPLETED|Overall Study||26
887066|NCT01937351|2146621|P1|COMPLETED|Overall Study||125
887067|NCT01937351|2146620|P2|6-Month Follow-up|Overall Study||26
887068|NCT01937351|2146621|P1|6-Month Follow-up|Overall Study||125
887069|NCT01937351|2146620|P2|30-Day Follow-up|Overall Study||27
887070|NCT01937351|2146621|P1|30-Day Follow-up|Overall Study||128
887071|NCT01937351|2146620|P2|Treated w Study Device|Overall Study||28
887072|NCT01937351|2146621|P1|Treated w Study Device|Overall Study||130
887073|NCT01937351|2146620|P2|STARTED|Overall Study||28
887074|NCT01937351|2146621|P1|STARTED|Overall Study||134
887075|NCT01937312|2146629|P2|NOT COMPLETED|Overall Study||3
887076|NCT01937312|2146630|P1|NOT COMPLETED|Overall Study||11
887077|NCT01937312|2146629|P2|COMPLETED|Overall Study||92
887078|NCT01937312|2146630|P1|COMPLETED|Overall Study||83
887079|NCT01937312|2146629|P2|Treated|Overall Study||95
887080|NCT01937312|2146630|P1|Treated|Overall Study||93
887081|NCT01937312|2146629|P2|STARTED|Overall Study||95
887082|NCT01937312|2146630|P1|STARTED|Overall Study||94
887083|NCT01937299|2146645|P2|NOT COMPLETED|Overall Study||4
887084|NCT01937299|2146646|P1|NOT COMPLETED|Overall Study||14
887085|NCT01937299|2146645|P2|COMPLETED|Overall Study||112
887086|NCT01937299|2146646|P1|COMPLETED|Overall Study||103
887087|NCT01937299|2146645|P2|STARTED|Overall Study||116
887088|NCT01937299|2146646|P1|STARTED|Overall Study||117
887089|NCT01937260|2146659|P2|NOT COMPLETED|Overall Study||0
887090|NCT01937260|2146660|P1|NOT COMPLETED|Overall Study||1
887091|NCT01937260|2146659|P2|COMPLETED|Overall Study||10
887092|NCT01937260|2146660|P1|COMPLETED|Overall Study||20
887093|NCT01937260|2146659|P2|STARTED|Overall Study||10
887094|NCT01937260|2146660|P1|STARTED|Overall Study||21
887095|NCT01937195|2146667|P1|NOT COMPLETED|Overall Study||0
887096|NCT01937195|2146667|P1|COMPLETED|Overall Study||95
887097|NCT01937195|2146667|P1|STARTED|Overall Study||95
887098|NCT01937130|2146681|P4|NOT COMPLETED|Overall Study||2
887099|NCT01937130|2146682|P3|NOT COMPLETED|Overall Study||3
887100|NCT01937130|2146683|P2|NOT COMPLETED|Overall Study||4
887101|NCT01937130|2146684|P1|NOT COMPLETED|Overall Study||5
887102|NCT01937130|2146681|P4|COMPLETED|Overall Study||2
887103|NCT01937130|2146682|P3|COMPLETED|Overall Study||2
887104|NCT01937130|2146683|P2|COMPLETED|Overall Study||3
887105|NCT01937130|2146684|P1|COMPLETED|Overall Study||0
887106|NCT01937130|2146681|P4|STARTED|Overall Study||4
887107|NCT01937130|2146682|P3|STARTED|Overall Study||5
887108|NCT01937130|2146683|P2|STARTED|Overall Study||7
887109|NCT01937130|2146684|P1|STARTED|Overall Study||5
887110|NCT01937026|2146711|P1|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||0
887111|NCT01937026|2146711|P1|COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||18
887112|NCT01937026|2146711|P1|Received Probenecid on Days 3 Through 7|Period 2 (At Dosing Day 3 Through Day 8)||18
887113|NCT01937026|2146711|P1|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day 8)||18
887114|NCT01937026|2146711|P1|STARTED|Period 2 (At Dosing Day 3 Through Day 8)||18
887115|NCT01937026|2146711|P1|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
887116|NCT01937026|2146711|P1|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||18
887117|NCT01937026|2146711|P1|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||18
887118|NCT01937026|2146711|P1|STARTED|Period 1 (Day 1 Through Predose Day 3)||18
887119|NCT01936896|2146720|P1|NOT COMPLETED|Overall Study||0
887120|NCT01936896|2146720|P1|COMPLETED|Overall Study||10
887121|NCT01936896|2146720|P1|STARTED|Overall Study||10
887122|NCT01936870|2146725|P1|NOT COMPLETED|Overall Study||189
887123|NCT01936870|2146725|P1|COMPLETED|Overall Study||2303
887124|NCT01936870|2146725|P1|STARTED|Overall Study||2492
887125|NCT01936844|2146740|P2|NOT COMPLETED|Overall Study||7
887126|NCT01936844|2146741|P1|NOT COMPLETED|Overall Study||6
887127|NCT01936844|2146740|P2|COMPLETED|Overall Study||8
887128|NCT01936844|2146741|P1|COMPLETED|Overall Study||9
887129|NCT01936844|2146740|P2|STARTED|Overall Study||15
887130|NCT01936844|2146741|P1|STARTED|Overall Study||15
887131|NCT01936662|2146753|P2|NOT COMPLETED|Overall Study||0
887132|NCT01936662|2146754|P1|NOT COMPLETED|Overall Study||0
887133|NCT01936662|2146753|P2|COMPLETED|Overall Study||42
887134|NCT01936662|2146754|P1|COMPLETED|Overall Study||42
887135|NCT01936662|2146753|P2|STARTED|Overall Study||42
887136|NCT01936662|2146754|P1|STARTED|Overall Study||42
887137|NCT01936649|2146762|P1|NOT COMPLETED|Overall Study||13
887138|NCT01936649|2146762|P1|COMPLETED|Overall Study||50
887139|NCT01936649|2146762|P1|Treated|Overall Study||51
887140|NCT01936649|2146762|P1|STARTED|Overall Study||63
887141|NCT01936623|2146769|P2|NOT COMPLETED|Overall Study||5
887142|NCT01936623|2146770|P1|NOT COMPLETED|Overall Study||0
887143|NCT01936623|2146769|P2|COMPLETED|Overall Study||35
887144|NCT01936623|2146770|P1|COMPLETED|Overall Study||40
887145|NCT01936623|2146769|P2|STARTED|Overall Study||40
887146|NCT01936623|2146770|P1|STARTED|Overall Study||40
887147|NCT01936467|2146784|P2|NOT COMPLETED|Overall Study||0
887148|NCT01936467|2146785|P1|NOT COMPLETED|Overall Study||0
887149|NCT01936467|2146784|P2|COMPLETED|Overall Study||61
887150|NCT01936467|2146785|P1|COMPLETED|Overall Study||60
887151|NCT01936467|2146784|P2|STARTED|Overall Study||61
887152|NCT01936467|2146785|P1|STARTED|Overall Study||60
887153|NCT01936389|2146805|P2|NOT COMPLETED|Overall Study||0
887154|NCT01936389|2146806|P1|NOT COMPLETED|Overall Study||1
887155|NCT01936389|2146805|P2|COMPLETED|Overall Study||5
887156|NCT01936389|2146806|P1|COMPLETED|Overall Study||4
887157|NCT01936389|2146805|P2|STARTED|Overall Study||5
887158|NCT01936389|2146806|P1|STARTED|Overall Study||5
887159|NCT01936363|2146814|P2|NOT COMPLETED|Overall Study||5
887160|NCT01936363|2146815|P1|NOT COMPLETED|Overall Study||7
887161|NCT01936363|2146814|P2|COMPLETED|Overall Study||28
887162|NCT01936363|2146815|P1|COMPLETED|Overall Study||25
887163|NCT01936363|2146814|P2|STARTED|Overall Study||33
887164|NCT01936363|2146815|P1|STARTED|Overall Study||32
887165|NCT01936181|2146841|P4|NOT COMPLETED|Transition-extension||5
887166|NCT01936181|2146842|P3|NOT COMPLETED|Transition-extension||6
887167|NCT01936181|2146843|P2|NOT COMPLETED|Transition-extension||0
887168|NCT01936181|2146844|P1|NOT COMPLETED|Transition-extension||15
887169|NCT01936181|2146841|P4|COMPLETED|Transition-extension||96
887170|NCT01936181|2146842|P3|COMPLETED|Transition-extension||88
887171|NCT01936181|2146843|P2|COMPLETED|Transition-extension||0
887172|NCT01936181|2146844|P1|COMPLETED|Transition-extension||186
887173|NCT01936181|2146841|P4|STARTED|Transition-extension||101
887174|NCT01936181|2146842|P3|STARTED|Transition-extension||94
887175|NCT01936181|2146843|P2|STARTED|Transition-extension||0
887176|NCT01936181|2146844|P1|STARTED|Transition-extension||201
887177|NCT01936181|2146841|P4|NOT COMPLETED|Randomised, Double-blind||0
887178|NCT01936181|2146842|P3|NOT COMPLETED|Randomised, Double-blind||0
887179|NCT01936181|2146843|P2|NOT COMPLETED|Randomised, Double-blind||68
887180|NCT01936181|2146844|P1|NOT COMPLETED|Randomised, Double-blind||64
887181|NCT01936181|2146841|P4|COMPLETED|Randomised, Double-blind||0
887182|NCT01936181|2146842|P3|COMPLETED|Randomised, Double-blind||0
887183|NCT01936181|2146843|P2|COMPLETED|Randomised, Double-blind||225
887184|NCT01936181|2146844|P1|COMPLETED|Randomised, Double-blind||227
887185|NCT01936181|2146841|P4|STARTED|Randomised, Double-blind||0
887186|NCT01936181|2146842|P3|STARTED|Randomised, Double-blind||0
887187|NCT01936181|2146843|P2|STARTED|Randomised, Double-blind||293
887188|NCT01936181|2146844|P1|STARTED|Randomised, Double-blind||291
887189|NCT01935622|2146858|P3|NOT COMPLETED|Overall Study||0
887190|NCT01935622|2146859|P2|NOT COMPLETED|Overall Study||2
887191|NCT01935622|2146860|P1|NOT COMPLETED|Overall Study||2
887192|NCT01935622|2146858|P3|COMPLETED|Overall Study||4
887193|NCT01935622|2146859|P2|COMPLETED|Overall Study||1
887194|NCT01935622|2146860|P1|COMPLETED|Overall Study||1
887195|NCT01935622|2146858|P3|STARTED|Overall Study||4
887196|NCT01935622|2146859|P2|STARTED|Overall Study||3
887197|NCT01935622|2146860|P1|STARTED|Overall Study||3
887198|NCT01935180|2146870|P2|NOT COMPLETED|Overall Study||14
887199|NCT01935180|2146871|P1|NOT COMPLETED|Overall Study||21
887200|NCT01935180|2146870|P2|COMPLETED|Overall Study||561
887201|NCT01935180|2146871|P1|COMPLETED|Overall Study||552
887202|NCT01935180|2146870|P2|STARTED|Overall Study||575
887203|NCT01935180|2146871|P1|STARTED|Overall Study||573
887204|NCT01934894|2146891|P2|NOT COMPLETED|Overall Study||5
887205|NCT01934894|2146892|P1|NOT COMPLETED|Overall Study||6
887206|NCT01934894|2146891|P2|COMPLETED|Overall Study||0
887207|NCT01934894|2146892|P1|COMPLETED|Overall Study||0
887208|NCT01934894|2146891|P2|STARTED|Overall Study||5
887209|NCT01934894|2146892|P1|STARTED|Overall Study||6
887210|NCT01934790|2146907|P1|NOT COMPLETED|Overall Study||16
887211|NCT01934790|2146907|P1|COMPLETED|Overall Study||29
887212|NCT01934790|2146907|P1|Participants Received Study Treatment|Overall Study||44
887213|NCT01934790|2146907|P1|STARTED|Overall Study|Eligible for treatment|45
887214|NCT01934582|2146927|P1|NOT COMPLETED|Overall Study||0
887215|NCT01934582|2146927|P1|COMPLETED|Overall Study||13
887216|NCT01934582|2146927|P1|STARTED|Overall Study||13
887217|NCT01934517|2146941|P1|NOT COMPLETED|Overall Study||0
887218|NCT01934517|2146941|P1|COMPLETED|Overall Study||25
887219|NCT01934517|2146941|P1|STARTED|Overall Study||25
887220|NCT01934504|2146953|P4|NOT COMPLETED|Overall Study||7
887221|NCT01934504|2146954|P3|NOT COMPLETED|Overall Study||5
887222|NCT01934504|2146955|P2|NOT COMPLETED|Overall Study||0
887223|NCT01934504|2146956|P1|NOT COMPLETED|Overall Study||1
887224|NCT01934504|2146953|P4|COMPLETED|Overall Study||1
887225|NCT01934504|2146954|P3|COMPLETED|Overall Study||11
887226|NCT01934504|2146955|P2|COMPLETED|Overall Study||3
887227|NCT01934504|2146956|P1|COMPLETED|Overall Study||5
887228|NCT01934504|2146953|P4|STARTED|Overall Study||8
887229|NCT01934504|2146954|P3|STARTED|Overall Study||16
887230|NCT01934504|2146955|P2|STARTED|Overall Study||3
887231|NCT01934504|2146956|P1|STARTED|Overall Study||6
887232|NCT01934231|2146978|P1|NOT COMPLETED|Overall Study||0
887233|NCT01934231|2146978|P1|COMPLETED|Overall Study||27
887234|NCT01934231|2146978|P1|STARTED|Overall Study||27
887235|NCT01934218|2146989|P2|NOT COMPLETED|Open-Label Phase||24
887236|NCT01934218|2146990|P1|NOT COMPLETED|Open-Label Phase||26
887237|NCT01934218|2146989|P2|COMPLETED|Open-Label Phase||304
887238|NCT01934218|2146990|P1|COMPLETED|Open-Label Phase||290
887239|NCT01934218|2146989|P2|STARTED|Open-Label Phase||328
887240|NCT01934218|2146990|P1|STARTED|Open-Label Phase||316
887241|NCT01934218|2146989|P2|NOT COMPLETED|Double-blind Phase||54
887242|NCT01934218|2146990|P1|NOT COMPLETED|Double-blind Phase||48
887243|NCT01934218|2146989|P2|COMPLETED|Double-blind Phase||356
887244|NCT01934218|2146990|P1|COMPLETED|Double-blind Phase||356
887245|NCT01934218|2146989|P2|Analyzed Participants|Double-blind Phase||407
887246|NCT01934218|2146990|P1|Analyzed Participants|Double-blind Phase||402
887247|NCT01934218|2146989|P2|STARTED|Double-blind Phase||410
887248|NCT01934218|2146990|P1|STARTED|Double-blind Phase||404
887249|NCT01933932|2146999|P2|NOT COMPLETED|Overall Study||178
887250|NCT01933932|2147000|P1|NOT COMPLETED|Overall Study||184
887251|NCT01933932|2146999|P2|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|78
887252|NCT01933932|2147000|P1|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|70
887253|NCT01933932|2146999|P2|STARTED|Overall Study||256
887254|NCT01933932|2147000|P1|STARTED|Overall Study||254
887255|NCT01933880|2147018|P2|NOT COMPLETED|Overall Study||1
887256|NCT01933880|2147019|P1|NOT COMPLETED|Overall Study||30
887257|NCT01933880|2147018|P2|COMPLETED|Overall Study||40
887258|NCT01933880|2147019|P1|COMPLETED|Overall Study||123
887259|NCT01933880|2147018|P2|STARTED|Overall Study||41
887260|NCT01933880|2147019|P1|STARTED|Overall Study||153
887261|NCT01933776|2147086|P2|NOT COMPLETED|Overall Study||0
887262|NCT01933776|2147087|P1|NOT COMPLETED|Overall Study||0
887263|NCT01933776|2147086|P2|COMPLETED|Overall Study||20
887264|NCT01933776|2147087|P1|COMPLETED|Overall Study||20
887265|NCT01933776|2147086|P2|STARTED|Overall Study||20
887266|NCT01933776|2147087|P1|STARTED|Overall Study||20
887267|NCT01933672|2147095|P7|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
887268|NCT01933672|2147096|P6|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
887269|NCT01933672|2147097|P5|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
887270|NCT01933672|2147098|P4|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
887271|NCT01933672|2147099|P3|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
887272|NCT01933672|2147100|P2|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
887273|NCT01933672|2147101|P1|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
887274|NCT01933672|2147095|P7|COMPLETED|Third Intervention Period (12-16 Days)||6
887275|NCT01933672|2147096|P6|COMPLETED|Third Intervention Period (12-16 Days)||4
887276|NCT01933672|2147097|P5|COMPLETED|Third Intervention Period (12-16 Days)||6
887277|NCT01933672|2147098|P4|COMPLETED|Third Intervention Period (12-16 Days)||4
887278|NCT01933672|2147099|P3|COMPLETED|Third Intervention Period (12-16 Days)||1
887279|NCT01933672|2147100|P2|COMPLETED|Third Intervention Period (12-16 Days)||5
887280|NCT01933672|2147101|P1|COMPLETED|Third Intervention Period (12-16 Days)||0
887281|NCT01933672|2147095|P7|STARTED|Third Intervention Period (12-16 Days)||6
887282|NCT01933672|2147096|P6|STARTED|Third Intervention Period (12-16 Days)||4
887283|NCT01933672|2147097|P5|STARTED|Third Intervention Period (12-16 Days)||6
887284|NCT01933672|2147098|P4|STARTED|Third Intervention Period (12-16 Days)||5
887285|NCT01933672|2147099|P3|STARTED|Third Intervention Period (12-16 Days)||1
887286|NCT01933672|2147100|P2|STARTED|Third Intervention Period (12-16 Days)||6
887287|NCT01933672|2147101|P1|STARTED|Third Intervention Period (12-16 Days)||0
887288|NCT01933672|2147095|P7|NOT COMPLETED|Second Washout Period (7-14 Days)||0
887289|NCT01933672|2147096|P6|NOT COMPLETED|Second Washout Period (7-14 Days)||0
887290|NCT01933672|2147097|P5|NOT COMPLETED|Second Washout Period (7-14 Days)||0
887291|NCT01933672|2147098|P4|NOT COMPLETED|Second Washout Period (7-14 Days)||0
887292|NCT01933672|2147099|P3|NOT COMPLETED|Second Washout Period (7-14 Days)||0
887293|NCT01933672|2147100|P2|NOT COMPLETED|Second Washout Period (7-14 Days)||0
887294|NCT01933672|2147101|P1|NOT COMPLETED|Second Washout Period (7-14 Days)||0
887295|NCT01933672|2147095|P7|COMPLETED|Second Washout Period (7-14 Days)||6
887296|NCT01933672|2147096|P6|COMPLETED|Second Washout Period (7-14 Days)||4
887297|NCT01933672|2147097|P5|COMPLETED|Second Washout Period (7-14 Days)||6
887298|NCT01933672|2147098|P4|COMPLETED|Second Washout Period (7-14 Days)||5
887299|NCT01933672|2147099|P3|COMPLETED|Second Washout Period (7-14 Days)||1
887300|NCT01933672|2147100|P2|COMPLETED|Second Washout Period (7-14 Days)||6
887301|NCT01933672|2147101|P1|COMPLETED|Second Washout Period (7-14 Days)||0
887302|NCT01933672|2147095|P7|STARTED|Second Washout Period (7-14 Days)||6
887303|NCT01933672|2147096|P6|STARTED|Second Washout Period (7-14 Days)||4
887304|NCT01933672|2147097|P5|STARTED|Second Washout Period (7-14 Days)||6
887305|NCT01933672|2147098|P4|STARTED|Second Washout Period (7-14 Days)||5
887306|NCT01933672|2147099|P3|STARTED|Second Washout Period (7-14 Days)||1
887307|NCT01933672|2147100|P2|STARTED|Second Washout Period (7-14 Days)||6
887308|NCT01933672|2147101|P1|STARTED|Second Washout Period (7-14 Days)||0
887309|NCT01933672|2147095|P7|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
887310|NCT01933672|2147096|P6|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
887311|NCT01933672|2147097|P5|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
887312|NCT01933672|2147098|P4|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
887313|NCT01933672|2147099|P3|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
887314|NCT01933672|2147100|P2|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
887315|NCT01933672|2147101|P1|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
887316|NCT01933672|2147095|P7|COMPLETED|Second Intervention Period (12-16 Days)||6
887317|NCT01933672|2147096|P6|COMPLETED|Second Intervention Period (12-16 Days)||4
887318|NCT01933672|2147097|P5|COMPLETED|Second Intervention Period (12-16 Days)||6
887319|NCT01933672|2147098|P4|COMPLETED|Second Intervention Period (12-16 Days)||5
887320|NCT01933672|2147099|P3|COMPLETED|Second Intervention Period (12-16 Days)||1
887321|NCT01933672|2147100|P2|COMPLETED|Second Intervention Period (12-16 Days)||6
887322|NCT01933672|2147101|P1|COMPLETED|Second Intervention Period (12-16 Days)||0
887323|NCT01933672|2147095|P7|STARTED|Second Intervention Period (12-16 Days)||6
887324|NCT01933672|2147096|P6|STARTED|Second Intervention Period (12-16 Days)||4
887325|NCT01933672|2147097|P5|STARTED|Second Intervention Period (12-16 Days)||6
887326|NCT01933672|2147098|P4|STARTED|Second Intervention Period (12-16 Days)||5
887327|NCT01933672|2147099|P3|STARTED|Second Intervention Period (12-16 Days)||2
887328|NCT01933672|2147100|P2|STARTED|Second Intervention Period (12-16 Days)||7
887329|NCT01933672|2147101|P1|STARTED|Second Intervention Period (12-16 Days)||0
887330|NCT01933672|2147095|P7|NOT COMPLETED|First Washout Period (7-14 Days)||0
887331|NCT01933672|2147096|P6|NOT COMPLETED|First Washout Period (7-14 Days)||0
887332|NCT01933672|2147097|P5|NOT COMPLETED|First Washout Period (7-14 Days)||0
887333|NCT01933672|2147098|P4|NOT COMPLETED|First Washout Period (7-14 Days)||0
887334|NCT01933672|2147099|P3|NOT COMPLETED|First Washout Period (7-14 Days)||0
887335|NCT01933672|2147100|P2|NOT COMPLETED|First Washout Period (7-14 Days)||0
887336|NCT01933672|2147101|P1|NOT COMPLETED|First Washout Period (7-14 Days)||0
887337|NCT01933672|2147095|P7|COMPLETED|First Washout Period (7-14 Days)||6
887338|NCT01933672|2147096|P6|COMPLETED|First Washout Period (7-14 Days)||4
887339|NCT01933672|2147097|P5|COMPLETED|First Washout Period (7-14 Days)||6
887340|NCT01933672|2147098|P4|COMPLETED|First Washout Period (7-14 Days)||5
887341|NCT01933672|2147099|P3|COMPLETED|First Washout Period (7-14 Days)||2
887342|NCT01933672|2147100|P2|COMPLETED|First Washout Period (7-14 Days)||7
887343|NCT01933672|2147101|P1|COMPLETED|First Washout Period (7-14 Days)||0
887344|NCT01933672|2147095|P7|STARTED|First Washout Period (7-14 Days)||6
887345|NCT01933672|2147096|P6|STARTED|First Washout Period (7-14 Days)||4
887346|NCT01933672|2147097|P5|STARTED|First Washout Period (7-14 Days)||6
887347|NCT01933672|2147098|P4|STARTED|First Washout Period (7-14 Days)||5
887348|NCT01933672|2147099|P3|STARTED|First Washout Period (7-14 Days)||2
887349|NCT01933672|2147100|P2|STARTED|First Washout Period (7-14 Days)||7
887350|NCT01933672|2147101|P1|STARTED|First Washout Period (7-14 Days)||0
887351|NCT01933672|2147095|P7|NOT COMPLETED|First Intervention Period (12-16 Days)||0
887352|NCT01933672|2147096|P6|NOT COMPLETED|First Intervention Period (12-16 Days)||1
887353|NCT01933672|2147097|P5|NOT COMPLETED|First Intervention Period (12-16 Days)||1
887354|NCT01933672|2147098|P4|NOT COMPLETED|First Intervention Period (12-16 Days)||0
887355|NCT01933672|2147099|P3|NOT COMPLETED|First Intervention Period (12-16 Days)||1
887356|NCT01933672|2147100|P2|NOT COMPLETED|First Intervention Period (12-16 Days)||0
887357|NCT01933672|2147101|P1|NOT COMPLETED|First Intervention Period (12-16 Days)||0
887358|NCT01933672|2147095|P7|COMPLETED|First Intervention Period (12-16 Days)||6
887359|NCT01933672|2147096|P6|COMPLETED|First Intervention Period (12-16 Days)||4
887360|NCT01933672|2147097|P5|COMPLETED|First Intervention Period (12-16 Days)||6
887361|NCT01933672|2147098|P4|COMPLETED|First Intervention Period (12-16 Days)||5
887362|NCT01933672|2147099|P3|COMPLETED|First Intervention Period (12-16 Days)||2
887363|NCT01933672|2147100|P2|COMPLETED|First Intervention Period (12-16 Days)||7
887364|NCT01933672|2147101|P1|COMPLETED|First Intervention Period (12-16 Days)||0
887365|NCT01933672|2147095|P7|STARTED|First Intervention Period (12-16 Days)||6
887366|NCT01933672|2147096|P6|STARTED|First Intervention Period (12-16 Days)||5
887367|NCT01933672|2147097|P5|STARTED|First Intervention Period (12-16 Days)||7
887368|NCT01933672|2147098|P4|STARTED|First Intervention Period (12-16 Days)||5
887369|NCT01933672|2147099|P3|STARTED|First Intervention Period (12-16 Days)||3
887370|NCT01933672|2147100|P2|STARTED|First Intervention Period (12-16 Days)||7
887371|NCT01933672|2147101|P1|STARTED|First Intervention Period (12-16 Days)||0
887372|NCT01933672|2147095|P7|NOT COMPLETED|Metformin Run-in Period||0
887373|NCT01933672|2147096|P6|NOT COMPLETED|Metformin Run-in Period||0
887374|NCT01933672|2147097|P5|NOT COMPLETED|Metformin Run-in Period||0
887375|NCT01933672|2147098|P4|NOT COMPLETED|Metformin Run-in Period||0
887376|NCT01933672|2147099|P3|NOT COMPLETED|Metformin Run-in Period||0
887377|NCT01933672|2147100|P2|NOT COMPLETED|Metformin Run-in Period||0
887378|NCT01933672|2147101|P1|NOT COMPLETED|Metformin Run-in Period||10
887379|NCT01933672|2147095|P7|COMPLETED|Metformin Run-in Period||0
887380|NCT01933672|2147096|P6|COMPLETED|Metformin Run-in Period||0
887381|NCT01933672|2147097|P5|COMPLETED|Metformin Run-in Period||0
887382|NCT01933672|2147098|P4|COMPLETED|Metformin Run-in Period||0
887383|NCT01933672|2147099|P3|COMPLETED|Metformin Run-in Period||0
887384|NCT01933672|2147100|P2|COMPLETED|Metformin Run-in Period||0
887385|NCT01933672|2147101|P1|COMPLETED|Metformin Run-in Period||33
887386|NCT01933672|2147095|P7|Received Treatment|Metformin Run-in Period||0
887387|NCT01933672|2147096|P6|Received Treatment|Metformin Run-in Period||0
887388|NCT01933672|2147097|P5|Received Treatment|Metformin Run-in Period||0
887389|NCT01933672|2147098|P4|Received Treatment|Metformin Run-in Period||0
887390|NCT01933672|2147099|P3|Received Treatment|Metformin Run-in Period||0
887391|NCT01933672|2147100|P2|Received Treatment|Metformin Run-in Period||0
887392|NCT01933672|2147101|P1|Received Treatment|Metformin Run-in Period||43
887393|NCT01933672|2147095|P7|STARTED|Metformin Run-in Period||0
887394|NCT01933672|2147096|P6|STARTED|Metformin Run-in Period||0
887395|NCT01933672|2147097|P5|STARTED|Metformin Run-in Period||0
887396|NCT01933672|2147098|P4|STARTED|Metformin Run-in Period||0
887397|NCT01933672|2147099|P3|STARTED|Metformin Run-in Period||0
887398|NCT01933672|2147100|P2|STARTED|Metformin Run-in Period||0
887399|NCT01933672|2147101|P1|STARTED|Metformin Run-in Period||43
887400|NCT01933425|2147147|P2|NOT COMPLETED|Overall Study||0
887401|NCT01933425|2147148|P1|NOT COMPLETED|Overall Study||0
887402|NCT01933425|2147147|P2|COMPLETED|Overall Study||7
887403|NCT01933425|2147148|P1|COMPLETED|Overall Study||7
887404|NCT01933425|2147147|P2|STARTED|Overall Study||7
887405|NCT01933425|2147148|P1|STARTED|Overall Study||7
887406|NCT01933399|2147161|P3|NOT COMPLETED|Overall Study||0
887407|NCT01933399|2147162|P2|NOT COMPLETED|Overall Study||0
887408|NCT01933399|2147163|P1|NOT COMPLETED|Overall Study||0
887409|NCT01933399|2147161|P3|COMPLETED|Overall Study||37
887410|NCT01933399|2147162|P2|COMPLETED|Overall Study||32
887411|NCT01933399|2147163|P1|COMPLETED|Overall Study||29
887412|NCT01933399|2147161|P3|STARTED|Overall Study||37
887413|NCT01933399|2147162|P2|STARTED|Overall Study||32
887414|NCT01933399|2147163|P1|STARTED|Overall Study||29
887415|NCT01933334|2147176|P2|NOT COMPLETED|Overall Study||2
887416|NCT01933334|2147177|P1|NOT COMPLETED|Overall Study||5
887417|NCT01933334|2147176|P2|COMPLETED|Overall Study||29
887418|NCT01933334|2147177|P1|COMPLETED|Overall Study||27
887419|NCT01933334|2147176|P2|STARTED|Overall Study||31
887420|NCT01933334|2147177|P1|STARTED|Overall Study||32
887421|NCT01933230|2147187|P1|NOT COMPLETED|Overall Study||0
887422|NCT01933230|2147187|P1|COMPLETED|Overall Study||2
887423|NCT01933230|2147187|P1|STARTED|Overall Study||2
887424|NCT01933048|2147193|P2|NOT COMPLETED|Overall Study||28
887425|NCT01933048|2147194|P1|NOT COMPLETED|Overall Study||25
887426|NCT01933048|2147193|P2|COMPLETED|Overall Study||501
887427|NCT01933048|2147194|P1|COMPLETED|Overall Study||523
887428|NCT01933048|2147193|P2|STARTED|Overall Study||529
887429|NCT01933048|2147194|P1|STARTED|Overall Study||548
887430|NCT01932970|2147207|P1|NOT COMPLETED|Overall Study||18
887431|NCT01932970|2147207|P1|COMPLETED|Overall Study||140
887432|NCT01932970|2147207|P1|Received Treatment|Overall Study|Includes participants who completed the washout period and received etelcalcetide|148
887433|NCT01932970|2147207|P1|STARTED|Overall Study|Includes all participants who enrolled into the washout period.|158
887434|NCT01932762|2147219|P4|NOT COMPLETED|Overall Study||1
887435|NCT01932762|2147220|P3|NOT COMPLETED|Overall Study||0
887436|NCT01932762|2147221|P2|NOT COMPLETED|Overall Study||2
887437|NCT01932762|2147222|P1|NOT COMPLETED|Overall Study||6
887438|NCT01932762|2147219|P4|COMPLETED|Overall Study||18
887439|NCT01932762|2147220|P3|COMPLETED|Overall Study||19
887440|NCT01932762|2147221|P2|COMPLETED|Overall Study||28
887441|NCT01932762|2147222|P1|COMPLETED|Overall Study||24
887442|NCT01932762|2147219|P4|STARTED|Overall Study||19
887443|NCT01932762|2147220|P3|STARTED|Overall Study||19
887444|NCT01932762|2147221|P2|STARTED|Overall Study||30
887445|NCT01932762|2147222|P1|STARTED|Overall Study||30
887446|NCT01932606|2147258|P2|NOT COMPLETED|Overall Study||0
887447|NCT01932606|2147259|P1|NOT COMPLETED|Overall Study||0
887448|NCT01932606|2147258|P2|COMPLETED|Overall Study||14
887449|NCT01932606|2147259|P1|COMPLETED|Overall Study||14
887450|NCT01932606|2147258|P2|STARTED|Overall Study||14
887451|NCT01932606|2147259|P1|STARTED|Overall Study||14
887452|NCT01932164|2147309|P1|NOT COMPLETED|Overall Study||0
887453|NCT01932164|2147309|P1|COMPLETED|Overall Study|In all 5 patients we observed bone formation closing the alveolar cleft after 6 months|5
887454|NCT01932164|2147309|P1|Cleft Lip and Palate|Overall Study|The surgeries were performed between december 2013 and june 2014.|5
887455|NCT01932164|2147309|P1|Cleft Lip and Palate|Overall Study|Alveolar bone graft surgeries were did using their dental pulp stem cells with biomaterial|5
887456|NCT01932164|2147309|P1|Cleft Lip and Palate|Overall Study|Mesenchymal stem cell obtained from dental pulp of 5patients was obtained, caractherized and frozen|5
887457|NCT01932164|2147309|P1|Cleft Lip and Palate|Overall Study|Dental pulp was obtained from teeth of 5 different patients (09/2013)|5
887458|NCT01932164|2147309|P1|Cleft Lip and Palate|Overall Study|It was performed de extraction of deciduous teeth of 5 cleft lip/palate patients (09/2013)|5
887459|NCT01932164|2147309|P1|STARTED|Overall Study|It was performed the selection of 5 patients to participate of these study (08/2013)|5
887460|NCT01932112|2147314|P1|NOT COMPLETED|Overall Study||0
887461|NCT01932112|2147314|P1|COMPLETED|Overall Study||378
887462|NCT01932112|2147314|P1|STARTED|Overall Study||378
887463|NCT01932060|2147320|P2|NOT COMPLETED|Overall Study||0
887464|NCT01932060|2147321|P1|NOT COMPLETED|Overall Study||0
887465|NCT01932060|2147320|P2|COMPLETED|Overall Study||24
887466|NCT01932060|2147321|P1|COMPLETED|Overall Study||27
887467|NCT01932060|2147320|P2|STARTED|Overall Study||24
887468|NCT01932060|2147321|P1|STARTED|Overall Study||27
887469|NCT01931956|2147331|P2|NOT COMPLETED|Overall Study||6
887470|NCT01931956|2147332|P1|NOT COMPLETED|Overall Study||23
887471|NCT01931956|2147331|P2|COMPLETED|Overall Study||1
887472|NCT01931956|2147332|P1|COMPLETED|Overall Study||36
887473|NCT01931956|2147331|P2|STARTED|Overall Study||7
887474|NCT01931956|2147332|P1|STARTED|Overall Study||59
887475|NCT01931878|2147378|P2|NOT COMPLETED|Second Intervention (After 3 Months)||2
887476|NCT01931878|2147379|P1|NOT COMPLETED|Second Intervention (After 3 Months)||0
887477|NCT01931878|2147378|P2|COMPLETED|Second Intervention (After 3 Months)||12
887478|NCT01931878|2147379|P1|COMPLETED|Second Intervention (After 3 Months)||9
887479|NCT01931878|2147378|P2|STARTED|Second Intervention (After 3 Months)||14
887480|NCT01931878|2147379|P1|STARTED|Second Intervention (After 3 Months)||9
887481|NCT01931878|2147378|P2|NOT COMPLETED|First Intervention||0
887482|NCT01931878|2147379|P1|NOT COMPLETED|First Intervention||1
887483|NCT01931878|2147378|P2|COMPLETED|First Intervention||14
887484|NCT01931878|2147379|P1|COMPLETED|First Intervention||9
887485|NCT01931878|2147378|P2|STARTED|First Intervention||14
887486|NCT01931878|2147379|P1|STARTED|First Intervention||10
887487|NCT01931865|2147389|P1|NOT COMPLETED|Overall Study||4
887488|NCT01931865|2147389|P1|COMPLETED|Overall Study||8
887489|NCT01931865|2147389|P1|STARTED|Overall Study||12
887490|NCT01931839|2147402|P7|NOT COMPLETED|Overall Study||4
887491|NCT01931839|2147403|P6|NOT COMPLETED|Overall Study||5
887492|NCT01931839|2147404|P5|NOT COMPLETED|Overall Study||1
887493|NCT01931839|2147405|P4|NOT COMPLETED|Overall Study||14
887494|NCT01931839|2147406|P3|NOT COMPLETED|Overall Study||39
887495|NCT01931839|2147407|P2|NOT COMPLETED|Overall Study||26
887496|NCT01931839|2147408|P1|NOT COMPLETED|Overall Study||41
887497|NCT01931839|2147402|P7|COMPLETED|Overall Study||56
887498|NCT01931839|2147403|P6|COMPLETED|Overall Study||50
887499|NCT01931839|2147404|P5|COMPLETED|Overall Study||18
887500|NCT01931839|2147405|P4|COMPLETED|Overall Study||162
887501|NCT01931839|2147406|P3|COMPLETED|Overall Study||301
887502|NCT01931839|2147407|P2|COMPLETED|Overall Study||152
887503|NCT01931839|2147408|P1|COMPLETED|Overall Study||294
887504|NCT01931839|2147402|P7|Safety Analysis Set (As Dosed)|Overall Study||60
887505|NCT01931839|2147403|P6|Safety Analysis Set (As Dosed)|Overall Study||55
887506|NCT01931839|2147404|P5|Safety Analysis Set (As Dosed)|Overall Study||19
887507|NCT01931839|2147405|P4|Safety Analysis Set (As Dosed)|Overall Study||176
887508|NCT01931839|2147406|P3|Safety Analysis Set (As Dosed)|Overall Study||340
887509|NCT01931839|2147407|P2|Safety Analysis Set (As Dosed)|Overall Study||178
887510|NCT01931839|2147408|P1|Safety Analysis Set (As Dosed)|Overall Study||335
887511|NCT01931839|2147402|P7|Full Analysis Set (As Randomized)|Overall Study||60
887512|NCT01931839|2147403|P6|Full Analysis Set (As Randomized)|Overall Study||55
887513|NCT01931839|2147404|P5|Full Analysis Set (As Randomized)|Overall Study||19
887514|NCT01931839|2147405|P4|Full Analysis Set (As Randomized)|Overall Study||176
887515|NCT01931839|2147406|P3|Full Analysis Set (As Randomized)|Overall Study||340
887516|NCT01931839|2147407|P2|Full Analysis Set (As Randomized)|Overall Study||179
887517|NCT01931839|2147408|P1|Full Analysis Set (As Randomized)|Overall Study||334
887518|NCT01931839|2147402|P7|STARTED|Overall Study||60
887519|NCT01931839|2147403|P6|STARTED|Overall Study||55
887520|NCT01931839|2147404|P5|STARTED|Overall Study||19
887521|NCT01931839|2147405|P4|STARTED|Overall Study||176
887522|NCT01931839|2147406|P3|STARTED|Overall Study||340
887523|NCT01931839|2147407|P2|STARTED|Overall Study||178
887524|NCT01931839|2147408|P1|STARTED|Overall Study||335
887525|NCT01931709|2147476|P1|NOT COMPLETED|Overall Study||0
887526|NCT01931709|2147476|P1|COMPLETED|Overall Study||35
887527|NCT01931709|2147476|P1|STARTED|Overall Study||35
887528|NCT01931527|2147488|P2|NOT COMPLETED|Overall Study||0
887529|NCT01931527|2147489|P1|NOT COMPLETED|Overall Study||0
887530|NCT01931527|2147488|P2|COMPLETED|Overall Study||15
887531|NCT01931527|2147489|P1|COMPLETED|Overall Study||16
887532|NCT01931527|2147488|P2|STARTED|Overall Study||15
887533|NCT01931527|2147489|P1|STARTED|Overall Study||16
887534|NCT01931475|2147499|P2|NOT COMPLETED|Period 2: Extension Treatment Phase||19
887535|NCT01931475|2147500|P1|NOT COMPLETED|Period 2: Extension Treatment Phase||4
887536|NCT01931475|2147499|P2|COMPLETED|Period 2: Extension Treatment Phase||157
887537|NCT01931475|2147500|P1|COMPLETED|Period 2: Extension Treatment Phase||162
887538|NCT01931475|2147499|P2|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||175
887539|NCT01931475|2147500|P1|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||166
887540|NCT01931475|2147499|P2|STARTED|Period 2: Extension Treatment Phase||176
887541|NCT01931475|2147500|P1|STARTED|Period 2: Extension Treatment Phase||166
887542|NCT01931475|2147499|P2|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||26
887543|NCT01931475|2147500|P1|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||39
887544|NCT01931475|2147499|P2|COMPLETED|Period 1: Double-Blind Treatment Phase||176
887545|NCT01931475|2147500|P1|COMPLETED|Period 1: Double-Blind Treatment Phase||166
887546|NCT01931475|2147499|P2|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||198
887547|NCT01931475|2147500|P1|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||199
887548|NCT01931475|2147499|P2|STARTED|Period 1: Double-Blind Treatment Phase||202
887549|NCT01931475|2147500|P1|STARTED|Period 1: Double-Blind Treatment Phase||205
887550|NCT01931397|2147527|P1|NOT COMPLETED|Overall Study||11
887551|NCT01931397|2147527|P1|COMPLETED|Overall Study||19
887552|NCT01931397|2147527|P1|STARTED|Overall Study||30
887553|NCT01931150|2147538|P2|NOT COMPLETED|Overall Study||2
887554|NCT01931150|2147539|P1|NOT COMPLETED|Overall Study||1
887555|NCT01931150|2147538|P2|COMPLETED|Overall Study||4
887556|NCT01931150|2147539|P1|COMPLETED|Overall Study||4
887557|NCT01931150|2147538|P2|STARTED|Overall Study||6
887558|NCT01931150|2147539|P1|STARTED|Overall Study||5
887559|NCT01930890|2147549|P4|NOT COMPLETED|Overall Study||27
887560|NCT01930890|2147550|P3|NOT COMPLETED|Overall Study||13
887561|NCT01930890|2147551|P2|NOT COMPLETED|Overall Study||33
887562|NCT01930890|2147552|P1|NOT COMPLETED|Overall Study||14
887563|NCT01930890|2147549|P4|COMPLETED|Overall Study||0
887564|NCT01930890|2147550|P3|COMPLETED|Overall Study||0
887565|NCT01930890|2147551|P2|COMPLETED|Overall Study||0
887566|NCT01930890|2147552|P1|COMPLETED|Overall Study||0
887567|NCT01930890|2147549|P4|STARTED|Overall Study||27
887568|NCT01930890|2147550|P3|STARTED|Overall Study||13
887569|NCT01930890|2147551|P2|STARTED|Overall Study||33
887570|NCT01930890|2147552|P1|STARTED|Overall Study||14
887571|NCT01930799|2147566|P1|NOT COMPLETED|Overall Study||8
887572|NCT01930799|2147566|P1|COMPLETED|Overall Study||112
887573|NCT01930799|2147566|P1|STARTED|Overall Study||120
887574|NCT01930487|2147571|P2|NOT COMPLETED|Second Intervention (30 Days)||0
887575|NCT01930487|2147572|P1|NOT COMPLETED|Second Intervention (30 Days)||0
887576|NCT01930487|2147571|P2|COMPLETED|Second Intervention (30 Days)||23
887577|NCT01930487|2147572|P1|COMPLETED|Second Intervention (30 Days)||19
887578|NCT01930487|2147571|P2|STARTED|Second Intervention (30 Days)||23
887579|NCT01930487|2147572|P1|STARTED|Second Intervention (30 Days)||19
887580|NCT01930487|2147571|P2|NOT COMPLETED|Washout Period (3 Weeks)||0
887581|NCT01930487|2147572|P1|NOT COMPLETED|Washout Period (3 Weeks)||0
887582|NCT01930487|2147571|P2|COMPLETED|Washout Period (3 Weeks)||23
887583|NCT01930487|2147572|P1|COMPLETED|Washout Period (3 Weeks)||19
887584|NCT01930487|2147571|P2|STARTED|Washout Period (3 Weeks)||23
887585|NCT01930487|2147572|P1|STARTED|Washout Period (3 Weeks)||19
887586|NCT01930487|2147571|P2|NOT COMPLETED|First Intervention (30 Days)||2
887587|NCT01930487|2147572|P1|NOT COMPLETED|First Intervention (30 Days)||2
887588|NCT01930487|2147571|P2|COMPLETED|First Intervention (30 Days)||23
887589|NCT01930487|2147572|P1|COMPLETED|First Intervention (30 Days)||19
887590|NCT01930487|2147571|P2|STARTED|First Intervention (30 Days)||25
887591|NCT01930487|2147572|P1|STARTED|First Intervention (30 Days)||21
887592|NCT01930435|2147666|P1|NOT COMPLETED|Overall Study||0
887593|NCT01930435|2147666|P1|COMPLETED|Overall Study||20
887594|NCT01930435|2147666|P1|STARTED|Overall Study||20
887595|NCT01930162|2147674|P1|NOT COMPLETED|Overall Study||5
887596|NCT01930162|2147674|P1|COMPLETED|Overall Study||4
887597|NCT01930162|2147674|P1|STARTED|Overall Study||9
887598|NCT01930058|2147686|P3|NOT COMPLETED|Overall Study||0
887599|NCT01930058|2147687|P2|NOT COMPLETED|Overall Study||0
887600|NCT01930058|2147688|P1|NOT COMPLETED|Overall Study||0
887601|NCT01930058|2147686|P3|COMPLETED|Overall Study||3
887602|NCT01930058|2147687|P2|COMPLETED|Overall Study||3
887603|NCT01930058|2147688|P1|COMPLETED|Overall Study||3
887604|NCT01930058|2147686|P3|STARTED|Overall Study||3
887605|NCT01930058|2147687|P2|STARTED|Overall Study||3
887606|NCT01930058|2147688|P1|STARTED|Overall Study||3
887607|NCT01930045|2147710|P6|NOT COMPLETED|Part 2 - Period 5||0
887608|NCT01930045|2147711|P5|NOT COMPLETED|Part 2 - Period 5||0
887609|NCT01930045|2147712|P4|NOT COMPLETED|Part 2 - Period 5||0
887610|NCT01930045|2147713|P3|NOT COMPLETED|Part 2 - Period 5||0
887611|NCT01930045|2147714|P2|NOT COMPLETED|Part 2 - Period 5||0
887612|NCT01930045|2147715|P1|NOT COMPLETED|Part 2 - Period 5||0
887613|NCT01930045|2147710|P6|COMPLETED|Part 2 - Period 5||1
887614|NCT01930045|2147711|P5|COMPLETED|Part 2 - Period 5||3
887615|NCT01930045|2147712|P4|COMPLETED|Part 2 - Period 5||3
887616|NCT01930045|2147713|P3|COMPLETED|Part 2 - Period 5||3
887617|NCT01930045|2147714|P2|COMPLETED|Part 2 - Period 5||3
887618|NCT01930045|2147715|P1|COMPLETED|Part 2 - Period 5||3
887619|NCT01930045|2147710|P6|STARTED|Part 2 - Period 5||1
887620|NCT01930045|2147711|P5|STARTED|Part 2 - Period 5||3
887621|NCT01930045|2147712|P4|STARTED|Part 2 - Period 5||3
887622|NCT01930045|2147713|P3|STARTED|Part 2 - Period 5||3
887623|NCT01930045|2147714|P2|STARTED|Part 2 - Period 5||3
887624|NCT01930045|2147715|P1|STARTED|Part 2 - Period 5||3
887625|NCT01930045|2147710|P6|NOT COMPLETED|Part 2 - Period 4||0
887626|NCT01930045|2147711|P5|NOT COMPLETED|Part 2 - Period 4||0
887627|NCT01930045|2147712|P4|NOT COMPLETED|Part 2 - Period 4||0
887628|NCT01930045|2147713|P3|NOT COMPLETED|Part 2 - Period 4||0
887629|NCT01930045|2147714|P2|NOT COMPLETED|Part 2 - Period 4||0
887630|NCT01930045|2147715|P1|NOT COMPLETED|Part 2 - Period 4||0
887631|NCT01930045|2147710|P6|COMPLETED|Part 2 - Period 4||1
887632|NCT01930045|2147711|P5|COMPLETED|Part 2 - Period 4||3
887633|NCT01930045|2147712|P4|COMPLETED|Part 2 - Period 4||3
887634|NCT01930045|2147713|P3|COMPLETED|Part 2 - Period 4||3
887635|NCT01930045|2147714|P2|COMPLETED|Part 2 - Period 4||3
887636|NCT01930045|2147715|P1|COMPLETED|Part 2 - Period 4||3
887637|NCT01930045|2147710|P6|STARTED|Part 2 - Period 4||1
887638|NCT01930045|2147711|P5|STARTED|Part 2 - Period 4||3
887639|NCT01930045|2147712|P4|STARTED|Part 2 - Period 4||3
887640|NCT01930045|2147713|P3|STARTED|Part 2 - Period 4||3
887641|NCT01930045|2147714|P2|STARTED|Part 2 - Period 4||3
887642|NCT01930045|2147715|P1|STARTED|Part 2 - Period 4||3
887643|NCT01930045|2147710|P6|NOT COMPLETED|Pause (up to 37 Days)||2
887644|NCT01930045|2147711|P5|NOT COMPLETED|Pause (up to 37 Days)||0
887645|NCT01930045|2147712|P4|NOT COMPLETED|Pause (up to 37 Days)||0
887646|NCT01930045|2147713|P3|NOT COMPLETED|Pause (up to 37 Days)||0
887647|NCT01930045|2147714|P2|NOT COMPLETED|Pause (up to 37 Days)||0
887648|NCT01930045|2147715|P1|NOT COMPLETED|Pause (up to 37 Days)||0
887649|NCT01930045|2147710|P6|COMPLETED|Pause (up to 37 Days)||1
887650|NCT01930045|2147711|P5|COMPLETED|Pause (up to 37 Days)||3
887651|NCT01930045|2147712|P4|COMPLETED|Pause (up to 37 Days)||3
887652|NCT01930045|2147713|P3|COMPLETED|Pause (up to 37 Days)||3
887653|NCT01930045|2147714|P2|COMPLETED|Pause (up to 37 Days)||3
887654|NCT01930045|2147715|P1|COMPLETED|Pause (up to 37 Days)||3
887655|NCT01930045|2147710|P6|STARTED|Pause (up to 37 Days)||3
887656|NCT01930045|2147711|P5|STARTED|Pause (up to 37 Days)||3
887657|NCT01930045|2147712|P4|STARTED|Pause (up to 37 Days)||3
887658|NCT01930045|2147713|P3|STARTED|Pause (up to 37 Days)|The participant who missed treatment in Period 3, resumed the study|3
887659|NCT01930045|2147714|P2|STARTED|Pause (up to 37 Days)||3
887660|NCT01930045|2147715|P1|STARTED|Pause (up to 37 Days)||3
887661|NCT01930045|2147710|P6|NOT COMPLETED|Part 1 - Period 3||0
887662|NCT01930045|2147711|P5|NOT COMPLETED|Part 1 - Period 3||0
887663|NCT01930045|2147712|P4|NOT COMPLETED|Part 1 - Period 3||0
887664|NCT01930045|2147713|P3|NOT COMPLETED|Part 1 - Period 3||0
887665|NCT01930045|2147714|P2|NOT COMPLETED|Part 1 - Period 3||0
887666|NCT01930045|2147715|P1|NOT COMPLETED|Part 1 - Period 3||0
887667|NCT01930045|2147710|P6|COMPLETED|Part 1 - Period 3||3
887668|NCT01930045|2147711|P5|COMPLETED|Part 1 - Period 3||3
887669|NCT01930045|2147712|P4|COMPLETED|Part 1 - Period 3||3
887670|NCT01930045|2147713|P3|COMPLETED|Part 1 - Period 3||2
887671|NCT01930045|2147714|P2|COMPLETED|Part 1 - Period 3||3
887672|NCT01930045|2147715|P1|COMPLETED|Part 1 - Period 3||3
887673|NCT01930045|2147710|P6|STARTED|Part 1 - Period 3||3
887674|NCT01930045|2147711|P5|STARTED|Part 1 - Period 3||3
887675|NCT01930045|2147712|P4|STARTED|Part 1 - Period 3||3
887676|NCT01930045|2147713|P3|STARTED|Part 1 - Period 3|One participant missed treatment during Period 3 only.|2
887677|NCT01930045|2147714|P2|STARTED|Part 1 - Period 3||3
887678|NCT01930045|2147715|P1|STARTED|Part 1 - Period 3||3
887679|NCT01930045|2147710|P6|NOT COMPLETED|Part 1 - Period 2||0
887680|NCT01930045|2147711|P5|NOT COMPLETED|Part 1 - Period 2||0
887681|NCT01930045|2147712|P4|NOT COMPLETED|Part 1 - Period 2||0
887682|NCT01930045|2147713|P3|NOT COMPLETED|Part 1 - Period 2||0
887683|NCT01930045|2147714|P2|NOT COMPLETED|Part 1 - Period 2||0
887684|NCT01930045|2147715|P1|NOT COMPLETED|Part 1 - Period 2||0
887685|NCT01930045|2147710|P6|COMPLETED|Part 1 - Period 2||3
887686|NCT01930045|2147711|P5|COMPLETED|Part 1 - Period 2||3
887687|NCT01930045|2147712|P4|COMPLETED|Part 1 - Period 2||3
887688|NCT01930045|2147713|P3|COMPLETED|Part 1 - Period 2||3
887689|NCT01930045|2147714|P2|COMPLETED|Part 1 - Period 2||3
887690|NCT01930045|2147715|P1|COMPLETED|Part 1 - Period 2||3
887691|NCT01930045|2147710|P6|STARTED|Part 1 - Period 2||3
887692|NCT01930045|2147711|P5|STARTED|Part 1 - Period 2||3
887693|NCT01930045|2147712|P4|STARTED|Part 1 - Period 2||3
887694|NCT01930045|2147713|P3|STARTED|Part 1 - Period 2||3
887695|NCT01930045|2147714|P2|STARTED|Part 1 - Period 2||3
887696|NCT01930045|2147715|P1|STARTED|Part 1 - Period 2||3
887697|NCT01930045|2147710|P6|NOT COMPLETED|Part 1 - Period 1||0
887698|NCT01930045|2147711|P5|NOT COMPLETED|Part 1 - Period 1||0
887699|NCT01930045|2147712|P4|NOT COMPLETED|Part 1 - Period 1||0
887700|NCT01930045|2147713|P3|NOT COMPLETED|Part 1 - Period 1||0
887701|NCT01930045|2147714|P2|NOT COMPLETED|Part 1 - Period 1||0
887702|NCT01930045|2147715|P1|NOT COMPLETED|Part 1 - Period 1||0
887703|NCT01930045|2147710|P6|COMPLETED|Part 1 - Period 1||3
887704|NCT01930045|2147711|P5|COMPLETED|Part 1 - Period 1||3
887705|NCT01930045|2147712|P4|COMPLETED|Part 1 - Period 1||3
887706|NCT01930045|2147713|P3|COMPLETED|Part 1 - Period 1||3
887707|NCT01930045|2147714|P2|COMPLETED|Part 1 - Period 1||3
887708|NCT01930045|2147715|P1|COMPLETED|Part 1 - Period 1||3
887709|NCT01930045|2147710|P6|STARTED|Part 1 - Period 1||3
887710|NCT01930045|2147711|P5|STARTED|Part 1 - Period 1||3
887711|NCT01930045|2147712|P4|STARTED|Part 1 - Period 1||3
887712|NCT01930045|2147713|P3|STARTED|Part 1 - Period 1||3
887713|NCT01930045|2147714|P2|STARTED|Part 1 - Period 1||3
887714|NCT01930045|2147715|P1|STARTED|Part 1 - Period 1||3
887715|NCT01929993|2147742|P2|NOT COMPLETED|Overall Study||28
887716|NCT01929993|2147743|P1|NOT COMPLETED|Overall Study||30
887717|NCT01929993|2147742|P2|COMPLETED|Overall Study||54
887718|NCT01929993|2147743|P1|COMPLETED|Overall Study||52
887719|NCT01929993|2147742|P2|STARTED|Overall Study||82
887720|NCT01929993|2147743|P1|STARTED|Overall Study||82
887721|NCT01929980|2147749|P1|NOT COMPLETED|Overall Study||1
887722|NCT01929980|2147749|P1|COMPLETED|Overall Study||3
887723|NCT01929980|2147749|P1|STARTED|Overall Study||4
887724|NCT01929889|2147753|P1|NOT COMPLETED|Overall Study||5
887725|NCT01929889|2147753|P1|COMPLETED|Overall Study|3 subjects completed the study.|3
887726|NCT01929889|2147753|P1|STARTED|Overall Study|Target enrollment goal was 20 completed subjects.|8
887727|NCT01929876|2147757|P1|NOT COMPLETED|Period 2||1
887728|NCT01929876|2147757|P1|COMPLETED|Period 2||15
887729|NCT01929876|2147757|P1|STARTED|Period 2||16
887730|NCT01929876|2147757|P1|NOT COMPLETED|Period 1||0
887731|NCT01929876|2147757|P1|COMPLETED|Period 1||16
887732|NCT01929876|2147757|P1|STARTED|Period 1||16
887733|NCT01929863|2147770|P2|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
887734|NCT01929863|2147771|P1|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
887735|NCT01929863|2147770|P2|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
887736|NCT01929863|2147771|P1|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
887737|NCT01929863|2147770|P2|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
887738|NCT01929863|2147771|P1|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
887739|NCT01929863|2147770|P2|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||1
887740|NCT01929863|2147771|P1|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||0
887741|NCT01929863|2147770|P2|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
887742|NCT01929863|2147771|P1|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
887743|NCT01929863|2147770|P2|STARTED|Period 3:Intervention Period 2 (7 Days)||7
887744|NCT01929863|2147771|P1|STARTED|Period 3:Intervention Period 2 (7 Days)||6
887745|NCT01929863|2147770|P2|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
887746|NCT01929863|2147771|P1|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
887747|NCT01929863|2147770|P2|COMPLETED|Period 2:Washout Period (13-15 Days)||7
887748|NCT01929863|2147771|P1|COMPLETED|Period 2:Washout Period (13-15 Days)||6
887749|NCT01929863|2147770|P2|STARTED|Period 2:Washout Period (13-15 Days)||7
887750|NCT01929863|2147771|P1|STARTED|Period 2:Washout Period (13-15 Days)||6
887751|NCT01929863|2147770|P2|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
887752|NCT01929863|2147771|P1|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
887753|NCT01929863|2147770|P2|COMPLETED|Period 1:Intervention Period 1 (7 Days)||7
887754|NCT01929863|2147771|P1|COMPLETED|Period 1:Intervention Period 1 (7 Days)||6
887755|NCT01929863|2147770|P2|STARTED|Period 1:Intervention Period 1 (7 Days)||8
887756|NCT01929863|2147771|P1|STARTED|Period 1:Intervention Period 1 (7 Days)||7
887757|NCT01929759|2147814|P1|NOT COMPLETED|Overall Study||0
887758|NCT01929759|2147814|P1|COMPLETED|Overall Study||10
887759|NCT01929759|2147814|P1|STARTED|Overall Study||10
887760|NCT01929681|2147828|P2|NOT COMPLETED|Overall Study||1
887761|NCT01929681|2147829|P1|NOT COMPLETED|Overall Study||2
887762|NCT01929681|2147828|P2|COMPLETED|Overall Study||24
887763|NCT01929681|2147829|P1|COMPLETED|Overall Study||26
887764|NCT01929681|2147828|P2|STARTED|Overall Study||25
887765|NCT01929681|2147829|P1|STARTED|Overall Study||28
887766|NCT01929473|2147843|P1|NOT COMPLETED|Overall Study||587
887767|NCT01929473|2147843|P1|COMPLETED|Overall Study||3243
887768|NCT01929473|2147843|P1|365 Day|Overall Study||3589
887769|NCT01929473|2147843|P1|STARTED|Overall Study|0 day|3830
887770|NCT01929460|2147849|P2|NOT COMPLETED|Overall Study||0
887771|NCT01929460|2147850|P1|NOT COMPLETED|Overall Study||0
887772|NCT01929460|2147849|P2|COMPLETED|Overall Study||13
887773|NCT01929460|2147850|P1|COMPLETED|Overall Study||13
887774|NCT01929460|2147849|P2|STARTED|Overall Study||13
887775|NCT01929460|2147850|P1|STARTED|Overall Study||13
887776|NCT01929317|2147874|P2|NOT COMPLETED|Long-term Phase||4
887777|NCT01929317|2147875|P1|NOT COMPLETED|Long-term Phase||19
887778|NCT01929317|2147874|P2|COMPLETED|Long-term Phase||14
887779|NCT01929317|2147875|P1|COMPLETED|Long-term Phase||25
887780|NCT01929317|2147874|P2|STARTED|Long-term Phase||18
887781|NCT01929317|2147875|P1|STARTED|Long-term Phase||44
887782|NCT01929317|2147874|P2|NOT COMPLETED|Dose Increase Effect Verification Phase||1
887783|NCT01929317|2147875|P1|NOT COMPLETED|Dose Increase Effect Verification Phase||9
887784|NCT01929317|2147874|P2|COMPLETED|Dose Increase Effect Verification Phase||19
887785|NCT01929317|2147875|P1|COMPLETED|Dose Increase Effect Verification Phase||52
887786|NCT01929317|2147874|P2|STARTED|Dose Increase Effect Verification Phase||20
887787|NCT01929317|2147875|P1|STARTED|Dose Increase Effect Verification Phase||61
887788|NCT01929135|2147944|P2|NOT COMPLETED|Overall Study||1
887789|NCT01929135|2147945|P1|NOT COMPLETED|Overall Study||1
887790|NCT01929135|2147944|P2|COMPLETED|Overall Study||18
887791|NCT01929135|2147945|P1|COMPLETED|Overall Study||18
887792|NCT01929135|2147944|P2|STARTED|Overall Study||19
887793|NCT01929135|2147945|P1|STARTED|Overall Study||19
887794|NCT01929083|2147959|P2|NOT COMPLETED|Intervention 2||1
887795|NCT01929083|2147960|P1|NOT COMPLETED|Intervention 2||0
887796|NCT01929083|2147959|P2|COMPLETED|Intervention 2||8
887797|NCT01929083|2147960|P1|COMPLETED|Intervention 2||7
887798|NCT01929083|2147959|P2|Returned for 2nd Ibutilide Administratio|Intervention 2||8
887799|NCT01929083|2147960|P1|Returned for 2nd Ibutilide Administratio|Intervention 2||7
887800|NCT01929083|2147959|P2|STARTED|Intervention 2||9
887801|NCT01929083|2147960|P1|STARTED|Intervention 2||7
887802|NCT01929083|2147959|P2|NOT COMPLETED|Intervention 1||0
887803|NCT01929083|2147960|P1|NOT COMPLETED|Intervention 1||3
887804|NCT01929083|2147959|P2|COMPLETED|Intervention 1||9
887805|NCT01929083|2147960|P1|COMPLETED|Intervention 1||7
887806|NCT01929083|2147959|P2|Returned for 1st Ibutilide Administratio|Intervention 1||9
887807|NCT01929083|2147960|P1|Returned for 1st Ibutilide Administratio|Intervention 1||7
887808|NCT01929083|2147959|P2|STARTED|Intervention 1||9
887809|NCT01929083|2147960|P1|STARTED|Intervention 1|Number of patients randomized to receive progesterone first|10
887810|NCT01929044|2147986|P2|NOT COMPLETED|Overall Study||17
887811|NCT01929044|2147987|P1|NOT COMPLETED|Overall Study||11
887812|NCT01929044|2147986|P2|COMPLETED|Overall Study||129
887813|NCT01929044|2147987|P1|COMPLETED|Overall Study||142
887814|NCT01929044|2147986|P2|STARTED|Overall Study||146
887815|NCT01929044|2147987|P1|STARTED|Overall Study||153
887816|NCT01929031|2148009|P6|NOT COMPLETED|Overall Study||1
887817|NCT01929031|2148010|P5|NOT COMPLETED|Overall Study||1
887818|NCT01929031|2148011|P4|NOT COMPLETED|Overall Study||0
887819|NCT01929031|2148012|P3|NOT COMPLETED|Overall Study||1
887820|NCT01929031|2148013|P2|NOT COMPLETED|Overall Study||2
887821|NCT01929031|2148014|P1|NOT COMPLETED|Overall Study||4
887822|NCT01929031|2148009|P6|COMPLETED|Overall Study||35
887823|NCT01929031|2148010|P5|COMPLETED|Overall Study||33
887824|NCT01929031|2148011|P4|COMPLETED|Overall Study||35
887825|NCT01929031|2148012|P3|COMPLETED|Overall Study||34
887826|NCT01929031|2148013|P2|COMPLETED|Overall Study||207
887827|NCT01929031|2148014|P1|COMPLETED|Overall Study||209
887828|NCT01929031|2148009|P6|STARTED|Overall Study||36
887829|NCT01929031|2148010|P5|STARTED|Overall Study||34
887830|NCT01929031|2148011|P4|STARTED|Overall Study||35
887831|NCT01929031|2148012|P3|STARTED|Overall Study||35
887832|NCT01929031|2148013|P2|STARTED|Overall Study||209
887833|NCT01929031|2148014|P1|STARTED|Overall Study||213
887834|NCT01928940|2148038|P2|NOT COMPLETED|Overall Study||1
887835|NCT01928940|2148039|P1|NOT COMPLETED|Overall Study||0
887836|NCT01928940|2148038|P2|COMPLETED|Overall Study||5
887837|NCT01928940|2148039|P1|COMPLETED|Overall Study||6
887838|NCT01928940|2148038|P2|STARTED|Overall Study||6
887839|NCT01928940|2148039|P1|STARTED|Overall Study||6
887840|NCT01928927|2148082|P2|NOT COMPLETED|Overall Study||1
887841|NCT01928927|2148083|P1|NOT COMPLETED|Overall Study||2
887842|NCT01928927|2148082|P2|COMPLETED|Overall Study||14
887843|NCT01928927|2148083|P1|COMPLETED|Overall Study||27
887844|NCT01928927|2148082|P2|STARTED|Overall Study||15
887845|NCT01928927|2148083|P1|STARTED|Overall Study||29
887846|NCT01928797|2148207|P2|NOT COMPLETED|Overall Study||0
887847|NCT01928797|2148208|P1|NOT COMPLETED|Overall Study||0
887848|NCT01928797|2148207|P2|COMPLETED|Overall Study||30
887849|NCT01928797|2148208|P1|COMPLETED|Overall Study||30
887850|NCT01928797|2148207|P2|STARTED|Overall Study||30
887851|NCT01928797|2148208|P1|STARTED|Overall Study||30
887852|NCT01928771|2148221|P3|NOT COMPLETED|Overall Study||40
887853|NCT01928771|2148222|P2|NOT COMPLETED|Overall Study||40
887854|NCT01928771|2148223|P1|NOT COMPLETED|Overall Study||46
887855|NCT01928771|2148221|P3|COMPLETED|Overall Study||367
887856|NCT01928771|2148222|P2|COMPLETED|Overall Study||358
887857|NCT01928771|2148223|P1|COMPLETED|Overall Study||354
887858|NCT01928771|2148221|P3|Received Treatment|Overall Study||407
887859|NCT01928771|2148222|P2|Received Treatment|Overall Study||398
887860|NCT01928771|2148223|P1|Received Treatment|Overall Study||399
887861|NCT01928771|2148221|P3|STARTED|Overall Study||407
887862|NCT01928771|2148222|P2|STARTED|Overall Study||398
887863|NCT01928771|2148223|P1|STARTED|Overall Study||400
887864|NCT01928693|2148303|P3|NOT COMPLETED|Overall Study||0
887865|NCT01928693|2148304|P2|NOT COMPLETED|Overall Study||0
887866|NCT01928693|2148305|P1|NOT COMPLETED|Overall Study||0
887867|NCT01928693|2148303|P3|COMPLETED|Overall Study||1
887868|NCT01928693|2148304|P2|COMPLETED|Overall Study||1
887869|NCT01928693|2148305|P1|COMPLETED|Overall Study||0
887870|NCT01928693|2148303|P3|STARTED|Overall Study||1
887871|NCT01928693|2148304|P2|STARTED|Overall Study||1
887872|NCT01928693|2148305|P1|STARTED|Overall Study||0
887873|NCT01928680|2148331|P1|NOT COMPLETED|Overall Study||0
887874|NCT01928680|2148331|P1|COMPLETED|Overall Study||33
887875|NCT01928680|2148331|P1|STARTED|Overall Study||33
887876|NCT01928615|2148335|P1|NOT COMPLETED|Overall Study||2
887877|NCT01928615|2148335|P1|COMPLETED|Overall Study||0
887878|NCT01928615|2148335|P1|STARTED|Overall Study||2
887879|NCT01928472|2148354|P4|NOT COMPLETED|Overall Study||2
887880|NCT01928472|2148355|P3|NOT COMPLETED|Overall Study||7
887881|NCT01928472|2148356|P2|NOT COMPLETED|Overall Study||8
887882|NCT01928472|2148357|P1|NOT COMPLETED|Overall Study||8
887883|NCT01928472|2148354|P4|COMPLETED|Overall Study||100
887884|NCT01928472|2148355|P3|COMPLETED|Overall Study||91
887885|NCT01928472|2148356|P2|COMPLETED|Overall Study||96
887886|NCT01928472|2148357|P1|COMPLETED|Overall Study||90
887887|NCT01928472|2148354|P4|STARTED|Overall Study||102
887888|NCT01928472|2148355|P3|STARTED|Overall Study||98
887889|NCT01928472|2148356|P2|STARTED|Overall Study||104
887890|NCT01928472|2148357|P1|STARTED|Overall Study||98
887891|NCT01928433|2148427|P3|NOT COMPLETED|Overall Study||28
887892|NCT01928433|2148428|P2|NOT COMPLETED|Overall Study||21
887893|NCT01928433|2148429|P1|NOT COMPLETED|Overall Study||20
887894|NCT01928433|2148427|P3|COMPLETED|Overall Study||46
887895|NCT01928433|2148428|P2|COMPLETED|Overall Study||54
887896|NCT01928433|2148429|P1|COMPLETED|Overall Study||56
887897|NCT01928433|2148427|P3|STARTED|Overall Study||74
887898|NCT01928433|2148428|P2|STARTED|Overall Study||75
887899|NCT01928433|2148429|P1|STARTED|Overall Study||76
887900|NCT01928381|2148452|P7|NOT COMPLETED|Part 2 - Post Third Intervention||0
887901|NCT01928381|2148453|P6|NOT COMPLETED|Part 2 - Post Third Intervention||0
887902|NCT01928381|2148454|P5|NOT COMPLETED|Part 2 - Post Third Intervention||0
887903|NCT01928381|2148455|P4|NOT COMPLETED|Part 2 - Post Third Intervention||0
887904|NCT01928381|2148456|P3|NOT COMPLETED|Part 2 - Post Third Intervention||1
887905|NCT01928381|2148457|P2|NOT COMPLETED|Part 2 - Post Third Intervention||0
887906|NCT01928381|2148458|P1|NOT COMPLETED|Part 2 - Post Third Intervention||0
887907|NCT01928381|2148452|P7|COMPLETED|Part 2 - Post Third Intervention||5
887908|NCT01928381|2148453|P6|COMPLETED|Part 2 - Post Third Intervention||5
887909|NCT01928381|2148454|P5|COMPLETED|Part 2 - Post Third Intervention||3
887910|NCT01928381|2148455|P4|COMPLETED|Part 2 - Post Third Intervention||4
887911|NCT01928381|2148456|P3|COMPLETED|Part 2 - Post Third Intervention||3
887912|NCT01928381|2148457|P2|COMPLETED|Part 2 - Post Third Intervention||5
887913|NCT01928381|2148458|P1|COMPLETED|Part 2 - Post Third Intervention||0
887914|NCT01928381|2148452|P7|STARTED|Part 2 - Post Third Intervention||5
887915|NCT01928381|2148453|P6|STARTED|Part 2 - Post Third Intervention||5
887916|NCT01928381|2148454|P5|STARTED|Part 2 - Post Third Intervention||3
887917|NCT01928381|2148455|P4|STARTED|Part 2 - Post Third Intervention||4
887918|NCT01928381|2148456|P3|STARTED|Part 2 - Post Third Intervention||4
887919|NCT01928381|2148457|P2|STARTED|Part 2 - Post Third Intervention||5
887920|NCT01928381|2148458|P1|STARTED|Part 2 - Post Third Intervention||0
887921|NCT01928381|2148452|P7|NOT COMPLETED|Part 2 - Third Intervention||0
887922|NCT01928381|2148453|P6|NOT COMPLETED|Part 2 - Third Intervention||0
887923|NCT01928381|2148454|P5|NOT COMPLETED|Part 2 - Third Intervention||0
887924|NCT01928381|2148455|P4|NOT COMPLETED|Part 2 - Third Intervention||0
887925|NCT01928381|2148456|P3|NOT COMPLETED|Part 2 - Third Intervention||0
887926|NCT01928381|2148457|P2|NOT COMPLETED|Part 2 - Third Intervention||0
887927|NCT01928381|2148458|P1|NOT COMPLETED|Part 2 - Third Intervention||0
887928|NCT01928381|2148452|P7|COMPLETED|Part 2 - Third Intervention||5
887929|NCT01928381|2148453|P6|COMPLETED|Part 2 - Third Intervention||5
887930|NCT01928381|2148454|P5|COMPLETED|Part 2 - Third Intervention||3
887931|NCT01928381|2148455|P4|COMPLETED|Part 2 - Third Intervention||4
887932|NCT01928381|2148456|P3|COMPLETED|Part 2 - Third Intervention||4
887933|NCT01928381|2148457|P2|COMPLETED|Part 2 - Third Intervention||5
887934|NCT01928381|2148458|P1|COMPLETED|Part 2 - Third Intervention||0
887935|NCT01928381|2148452|P7|STARTED|Part 2 - Third Intervention||5
887936|NCT01928381|2148453|P6|STARTED|Part 2 - Third Intervention||5
887937|NCT01928381|2148454|P5|STARTED|Part 2 - Third Intervention||3
887938|NCT01928381|2148455|P4|STARTED|Part 2 - Third Intervention||4
887939|NCT01928381|2148456|P3|STARTED|Part 2 - Third Intervention||4
887940|NCT01928381|2148457|P2|STARTED|Part 2 - Third Intervention||5
887941|NCT01928381|2148458|P1|STARTED|Part 2 - Third Intervention||0
887942|NCT01928381|2148452|P7|NOT COMPLETED|Washout Second Intervention||0
887943|NCT01928381|2148453|P6|NOT COMPLETED|Washout Second Intervention||0
887944|NCT01928381|2148454|P5|NOT COMPLETED|Washout Second Intervention||0
887945|NCT01928381|2148455|P4|NOT COMPLETED|Washout Second Intervention||0
887946|NCT01928381|2148456|P3|NOT COMPLETED|Washout Second Intervention||0
887947|NCT01928381|2148457|P2|NOT COMPLETED|Washout Second Intervention||0
887948|NCT01928381|2148458|P1|NOT COMPLETED|Washout Second Intervention||0
887949|NCT01928381|2148452|P7|COMPLETED|Washout Second Intervention||5
887950|NCT01928381|2148453|P6|COMPLETED|Washout Second Intervention||5
887951|NCT01928381|2148454|P5|COMPLETED|Washout Second Intervention||3
887952|NCT01928381|2148455|P4|COMPLETED|Washout Second Intervention||4
887953|NCT01928381|2148456|P3|COMPLETED|Washout Second Intervention||4
887954|NCT01928381|2148457|P2|COMPLETED|Washout Second Intervention||5
887955|NCT01928381|2148458|P1|COMPLETED|Washout Second Intervention||0
887956|NCT01928381|2148452|P7|STARTED|Washout Second Intervention||5
887957|NCT01928381|2148453|P6|STARTED|Washout Second Intervention||5
887958|NCT01928381|2148454|P5|STARTED|Washout Second Intervention||3
887959|NCT01928381|2148455|P4|STARTED|Washout Second Intervention||4
887960|NCT01928381|2148456|P3|STARTED|Washout Second Intervention||4
887961|NCT01928381|2148457|P2|STARTED|Washout Second Intervention||5
887962|NCT01928381|2148458|P1|STARTED|Washout Second Intervention||0
887963|NCT01928381|2148452|P7|NOT COMPLETED|Part 2 - Second Intervention||0
887964|NCT01928381|2148453|P6|NOT COMPLETED|Part 2 - Second Intervention||0
887965|NCT01928381|2148454|P5|NOT COMPLETED|Part 2 - Second Intervention||0
887966|NCT01928381|2148455|P4|NOT COMPLETED|Part 2 - Second Intervention||1
887967|NCT01928381|2148456|P3|NOT COMPLETED|Part 2 - Second Intervention||0
887968|NCT01928381|2148457|P2|NOT COMPLETED|Part 2 - Second Intervention||1
887969|NCT01928381|2148458|P1|NOT COMPLETED|Part 2 - Second Intervention||0
887970|NCT01928381|2148452|P7|COMPLETED|Part 2 - Second Intervention||5
887971|NCT01928381|2148453|P6|COMPLETED|Part 2 - Second Intervention||5
887972|NCT01928381|2148454|P5|COMPLETED|Part 2 - Second Intervention||3
887973|NCT01928381|2148455|P4|COMPLETED|Part 2 - Second Intervention||4
887974|NCT01928381|2148456|P3|COMPLETED|Part 2 - Second Intervention||4
887975|NCT01928381|2148457|P2|COMPLETED|Part 2 - Second Intervention||5
887976|NCT01928381|2148458|P1|COMPLETED|Part 2 - Second Intervention||0
887977|NCT01928381|2148452|P7|STARTED|Part 2 - Second Intervention||5
887978|NCT01928381|2148453|P6|STARTED|Part 2 - Second Intervention||5
887979|NCT01928381|2148454|P5|STARTED|Part 2 - Second Intervention||3
887980|NCT01928381|2148455|P4|STARTED|Part 2 - Second Intervention||5
887981|NCT01928381|2148456|P3|STARTED|Part 2 - Second Intervention||4
887982|NCT01928381|2148457|P2|STARTED|Part 2 - Second Intervention||6
887983|NCT01928381|2148458|P1|STARTED|Part 2 - Second Intervention||0
887984|NCT01928381|2148452|P7|NOT COMPLETED|Washout First Intervention||0
887985|NCT01928381|2148453|P6|NOT COMPLETED|Washout First Intervention||0
887986|NCT01928381|2148454|P5|NOT COMPLETED|Washout First Intervention||1
887987|NCT01928381|2148455|P4|NOT COMPLETED|Washout First Intervention||0
887988|NCT01928381|2148456|P3|NOT COMPLETED|Washout First Intervention||0
887989|NCT01928381|2148457|P2|NOT COMPLETED|Washout First Intervention||0
887990|NCT01928381|2148458|P1|NOT COMPLETED|Washout First Intervention||0
887991|NCT01928381|2148452|P7|COMPLETED|Washout First Intervention||5
887992|NCT01928381|2148453|P6|COMPLETED|Washout First Intervention||5
887993|NCT01928381|2148454|P5|COMPLETED|Washout First Intervention||3
887994|NCT01928381|2148455|P4|COMPLETED|Washout First Intervention||5
887995|NCT01928381|2148456|P3|COMPLETED|Washout First Intervention||4
887996|NCT01928381|2148457|P2|COMPLETED|Washout First Intervention||6
887997|NCT01928381|2148458|P1|COMPLETED|Washout First Intervention||0
887998|NCT01928381|2148452|P7|STARTED|Washout First Intervention||5
887999|NCT01928381|2148453|P6|STARTED|Washout First Intervention||5
888000|NCT01928381|2148454|P5|STARTED|Washout First Intervention||4
888001|NCT01928381|2148455|P4|STARTED|Washout First Intervention||5
888002|NCT01928381|2148456|P3|STARTED|Washout First Intervention||4
888003|NCT01928381|2148457|P2|STARTED|Washout First Intervention||6
888004|NCT01928381|2148458|P1|STARTED|Washout First Intervention||0
888005|NCT01928381|2148452|P7|NOT COMPLETED|Part 2 - First Intervention||1
888006|NCT01928381|2148453|P6|NOT COMPLETED|Part 2 - First Intervention||1
888007|NCT01928381|2148454|P5|NOT COMPLETED|Part 2 - First Intervention||0
888008|NCT01928381|2148455|P4|NOT COMPLETED|Part 2 - First Intervention||1
888009|NCT01928381|2148456|P3|NOT COMPLETED|Part 2 - First Intervention||2
888010|NCT01928381|2148457|P2|NOT COMPLETED|Part 2 - First Intervention||0
888011|NCT01928381|2148458|P1|NOT COMPLETED|Part 2 - First Intervention||0
888012|NCT01928381|2148452|P7|COMPLETED|Part 2 - First Intervention||5
888013|NCT01928381|2148453|P6|COMPLETED|Part 2 - First Intervention||5
888014|NCT01928381|2148454|P5|COMPLETED|Part 2 - First Intervention||4
888015|NCT01928381|2148455|P4|COMPLETED|Part 2 - First Intervention||5
888016|NCT01928381|2148456|P3|COMPLETED|Part 2 - First Intervention||4
888017|NCT01928381|2148457|P2|COMPLETED|Part 2 - First Intervention||6
888018|NCT01928381|2148458|P1|COMPLETED|Part 2 - First Intervention||0
888019|NCT01928381|2148452|P7|STARTED|Part 2 - First Intervention||6
888020|NCT01928381|2148453|P6|STARTED|Part 2 - First Intervention||6
888021|NCT01928381|2148454|P5|STARTED|Part 2 - First Intervention||4
888022|NCT01928381|2148455|P4|STARTED|Part 2 - First Intervention||6
888023|NCT01928381|2148456|P3|STARTED|Part 2 - First Intervention||6
888024|NCT01928381|2148457|P2|STARTED|Part 2 - First Intervention||6
888025|NCT01928381|2148458|P1|STARTED|Part 2 - First Intervention||0
888026|NCT01928381|2148452|P7|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
888027|NCT01928381|2148453|P6|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
888028|NCT01928381|2148454|P5|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
888029|NCT01928381|2148455|P4|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
888030|NCT01928381|2148456|P3|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
888031|NCT01928381|2148457|P2|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
888032|NCT01928381|2148458|P1|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||14
888033|NCT01928381|2148452|P7|COMPLETED|Placebo run-in & Part 2 Eligibility||0
888034|NCT01928381|2148453|P6|COMPLETED|Placebo run-in & Part 2 Eligibility||0
888035|NCT01928381|2148454|P5|COMPLETED|Placebo run-in & Part 2 Eligibility||0
888036|NCT01928381|2148455|P4|COMPLETED|Placebo run-in & Part 2 Eligibility||0
888037|NCT01928381|2148456|P3|COMPLETED|Placebo run-in & Part 2 Eligibility||0
888038|NCT01928381|2148457|P2|COMPLETED|Placebo run-in & Part 2 Eligibility||0
888039|NCT01928381|2148458|P1|COMPLETED|Placebo run-in & Part 2 Eligibility||34
888040|NCT01928381|2148452|P7|STARTED|Placebo run-in & Part 2 Eligibility||0
888041|NCT01928381|2148453|P6|STARTED|Placebo run-in & Part 2 Eligibility||0
888042|NCT01928381|2148454|P5|STARTED|Placebo run-in & Part 2 Eligibility||0
888043|NCT01928381|2148455|P4|STARTED|Placebo run-in & Part 2 Eligibility||0
888044|NCT01928381|2148456|P3|STARTED|Placebo run-in & Part 2 Eligibility||0
888045|NCT01928381|2148457|P2|STARTED|Placebo run-in & Part 2 Eligibility||0
888046|NCT01928381|2148458|P1|STARTED|Placebo run-in & Part 2 Eligibility||48
888047|NCT01928381|2148452|P7|NOT COMPLETED|Part 1 - Pain Training||0
888048|NCT01928381|2148453|P6|NOT COMPLETED|Part 1 - Pain Training||0
888049|NCT01928381|2148454|P5|NOT COMPLETED|Part 1 - Pain Training||0
888050|NCT01928381|2148455|P4|NOT COMPLETED|Part 1 - Pain Training||0
888051|NCT01928381|2148456|P3|NOT COMPLETED|Part 1 - Pain Training||0
888052|NCT01928381|2148457|P2|NOT COMPLETED|Part 1 - Pain Training||0
888053|NCT01928381|2148458|P1|NOT COMPLETED|Part 1 - Pain Training||35
888054|NCT01928381|2148452|P7|COMPLETED|Part 1 - Pain Training||0
888055|NCT01928381|2148453|P6|COMPLETED|Part 1 - Pain Training||0
888056|NCT01928381|2148454|P5|COMPLETED|Part 1 - Pain Training||0
888057|NCT01928381|2148455|P4|COMPLETED|Part 1 - Pain Training||0
888058|NCT01928381|2148456|P3|COMPLETED|Part 1 - Pain Training||0
888059|NCT01928381|2148457|P2|COMPLETED|Part 1 - Pain Training||0
888060|NCT01928381|2148458|P1|COMPLETED|Part 1 - Pain Training||48
888061|NCT01928381|2148452|P7|STARTED|Part 1 - Pain Training||0
888062|NCT01928381|2148453|P6|STARTED|Part 1 - Pain Training||0
888063|NCT01928381|2148454|P5|STARTED|Part 1 - Pain Training||0
888064|NCT01928381|2148455|P4|STARTED|Part 1 - Pain Training||0
888065|NCT01928381|2148456|P3|STARTED|Part 1 - Pain Training||0
888066|NCT01928381|2148457|P2|STARTED|Part 1 - Pain Training||0
888067|NCT01928381|2148458|P1|STARTED|Part 1 - Pain Training||83
888068|NCT01928381|2148452|P7|NOT COMPLETED|Screening for Pain Training||0
888069|NCT01928381|2148453|P6|NOT COMPLETED|Screening for Pain Training||0
888070|NCT01928381|2148454|P5|NOT COMPLETED|Screening for Pain Training||0
888071|NCT01928381|2148455|P4|NOT COMPLETED|Screening for Pain Training||0
888072|NCT01928381|2148456|P3|NOT COMPLETED|Screening for Pain Training||0
888073|NCT01928381|2148457|P2|NOT COMPLETED|Screening for Pain Training||0
888074|NCT01928381|2148458|P1|NOT COMPLETED|Screening for Pain Training||60
888075|NCT01928381|2148452|P7|COMPLETED|Screening for Pain Training||0
888076|NCT01928381|2148453|P6|COMPLETED|Screening for Pain Training||0
888077|NCT01928381|2148454|P5|COMPLETED|Screening for Pain Training||0
888078|NCT01928381|2148455|P4|COMPLETED|Screening for Pain Training||0
888079|NCT01928381|2148456|P3|COMPLETED|Screening for Pain Training||0
888080|NCT01928381|2148457|P2|COMPLETED|Screening for Pain Training||0
888081|NCT01928381|2148458|P1|COMPLETED|Screening for Pain Training||83
888082|NCT01928381|2148452|P7|STARTED|Screening for Pain Training||0
888083|NCT01928381|2148453|P6|STARTED|Screening for Pain Training||0
888084|NCT01928381|2148454|P5|STARTED|Screening for Pain Training||0
888085|NCT01928381|2148455|P4|STARTED|Screening for Pain Training||0
888086|NCT01928381|2148456|P3|STARTED|Screening for Pain Training||0
888087|NCT01928381|2148457|P2|STARTED|Screening for Pain Training||0
888088|NCT01928381|2148458|P1|STARTED|Screening for Pain Training||143
888089|NCT01928186|2148471|P1|NOT COMPLETED|Overall Study||0
888090|NCT01928186|2148471|P1|COMPLETED|Overall Study||28
888091|NCT01928186|2148471|P1|STARTED|Overall Study||28
888092|NCT01928030|2148485|P3|NOT COMPLETED|Overall Study||0
888093|NCT01928030|2148486|P2|NOT COMPLETED|Overall Study||0
888094|NCT01928030|2148487|P1|NOT COMPLETED|Overall Study||0
888095|NCT01928030|2148485|P3|COMPLETED|Overall Study||0
888096|NCT01928030|2148486|P2|COMPLETED|Overall Study||0
888097|NCT01928030|2148487|P1|COMPLETED|Overall Study||3
888098|NCT01928030|2148485|P3|STARTED|Overall Study||0
888099|NCT01928030|2148486|P2|STARTED|Overall Study||0
888100|NCT01928030|2148487|P1|STARTED|Overall Study||3
888101|NCT01927887|2148494|P1|NOT COMPLETED|Overall Study||0
888102|NCT01927887|2148494|P1|COMPLETED|Overall Study||12
888103|NCT01927887|2148494|P1|STARTED|Overall Study||12
888104|NCT01927757|2148499|P1|NOT COMPLETED|Overall Study||23
888105|NCT01927757|2148499|P1|COMPLETED|Overall Study||67
888106|NCT01927757|2148499|P1|Received Etanercept|Overall Study||88
888107|NCT01927757|2148499|P1|STARTED|Overall Study||90
888108|NCT01927575|2148517|P1|NOT COMPLETED|Overall Study||0
888109|NCT01927575|2148517|P1|COMPLETED|Overall Study||1
888110|NCT01927575|2148517|P1|STARTED|Overall Study||1
888111|NCT01927419|2148527|P2|NOT COMPLETED|Overall Study||28
888112|NCT01927419|2148528|P1|NOT COMPLETED|Overall Study||70
888113|NCT01927419|2148527|P2|COMPLETED|Overall Study|All participants who did not discontinue study drug during treatment period (Parts 1 and 2)|19
888114|NCT01927419|2148528|P1|COMPLETED|Overall Study|All participants who did not discontinue study drug during treatment period (Parts 1 and 2)|25
888115|NCT01927419|2148527|P2|Received Treatment|Overall Study||46
888116|NCT01927419|2148528|P1|Received Treatment|Overall Study||94
888117|NCT01927419|2148527|P2|STARTED|Overall Study||47
888118|NCT01927419|2148528|P1|STARTED|Overall Study||95
888119|NCT01927120|2148544|P1|NOT COMPLETED|Overall Study||10
888120|NCT01927120|2148544|P1|COMPLETED|Overall Study||10
888121|NCT01927120|2148544|P1|STARTED|Overall Study||20
888122|NCT01927055|2148562|P3|NOT COMPLETED|Double-Blind||13
888123|NCT01927055|2148563|P2|NOT COMPLETED|Double-Blind||11
888124|NCT01927055|2148564|P1|NOT COMPLETED|Double-Blind||0
888125|NCT01927055|2148562|P3|COMPLETED|Double-Blind||10
888126|NCT01927055|2148563|P2|COMPLETED|Double-Blind||11
888127|NCT01927055|2148564|P1|COMPLETED|Double-Blind||0
888128|NCT01927055|2148562|P3|STARTED|Double-Blind||23
888129|NCT01927055|2148563|P2|STARTED|Double-Blind||22
888130|NCT01927055|2148564|P1|STARTED|Double-Blind||0
888131|NCT01927055|2148562|P3|NOT COMPLETED|Open-label||0
888132|NCT01927055|2148563|P2|NOT COMPLETED|Open-label||0
888133|NCT01927055|2148564|P1|NOT COMPLETED|Open-label||16
888134|NCT01927055|2148562|P3|COMPLETED|Open-label||0
888135|NCT01927055|2148563|P2|COMPLETED|Open-label||0
888136|NCT01927055|2148564|P1|COMPLETED|Open-label||45
888137|NCT01927055|2148562|P3|STARTED|Open-label||0
888138|NCT01927055|2148563|P2|STARTED|Open-label||0
888139|NCT01927055|2148564|P1|STARTED|Open-label||61
888140|NCT01926977|2148573|P2|NOT COMPLETED|Overall Study||0
888141|NCT01926977|2148574|P1|NOT COMPLETED|Overall Study||0
888142|NCT01926977|2148573|P2|COMPLETED|Overall Study||53
888143|NCT01926977|2148574|P1|COMPLETED|Overall Study||47
888144|NCT01926977|2148573|P2|STARTED|Overall Study||53
888145|NCT01926977|2148574|P1|STARTED|Overall Study||47
888146|NCT01926782|2148588|P6|NOT COMPLETED|Overall Study||41
888147|NCT01926782|2148589|P5|NOT COMPLETED|Overall Study||8
888148|NCT01926782|2148590|P4|NOT COMPLETED|Overall Study||20
888149|NCT01926782|2148591|P3|NOT COMPLETED|Overall Study||40
888150|NCT01926782|2148592|P2|NOT COMPLETED|Overall Study||13
888151|NCT01926782|2148593|P1|NOT COMPLETED|Overall Study||28
888152|NCT01926782|2148588|P6|COMPLETED|Overall Study||105
888153|NCT01926782|2148589|P5|COMPLETED|Overall Study||29
888154|NCT01926782|2148590|P4|COMPLETED|Overall Study||53
888155|NCT01926782|2148591|P3|COMPLETED|Overall Study||272
888156|NCT01926782|2148592|P2|COMPLETED|Overall Study||65
888157|NCT01926782|2148593|P1|COMPLETED|Overall Study||129
888158|NCT01926782|2148588|P6|Completed 24 Weeks Treatment Period|Overall Study||120
888159|NCT01926782|2148589|P5|Completed 24 Weeks Treatment Period|Overall Study||31
888160|NCT01926782|2148590|P4|Completed 24 Weeks Treatment Period|Overall Study||58
888161|NCT01926782|2148591|P3|Completed 24 Weeks Treatment Period|Overall Study||285
888162|NCT01926782|2148592|P2|Completed 24 Weeks Treatment Period|Overall Study||68
888163|NCT01926782|2148593|P1|Completed 24 Weeks Treatment Period|Overall Study||137
888164|NCT01926782|2148588|P6|Treated|Overall Study||146
888165|NCT01926782|2148589|P5|Treated|Overall Study||37
888166|NCT01926782|2148590|P4|Treated|Overall Study||72
888167|NCT01926782|2148591|P3|Treated|Overall Study||312
888168|NCT01926782|2148592|P2|Treated|Overall Study||78
888169|NCT01926782|2148593|P1|Treated|Overall Study||157
888170|NCT01926782|2148588|P6|STARTED|Overall Study||146
888171|NCT01926782|2148589|P5|STARTED|Overall Study||37
888172|NCT01926782|2148590|P4|STARTED|Overall Study||73
888173|NCT01926782|2148591|P3|STARTED|Overall Study||312
888174|NCT01926782|2148592|P2|STARTED|Overall Study||78
888175|NCT01926782|2148593|P1|STARTED|Overall Study||157
888176|NCT01926626|2148742|P1|NOT COMPLETED|Overall Study||22
888177|NCT01926626|2148742|P1|COMPLETED|Overall Study||16
888178|NCT01926626|2148742|P1|Received Moclobemide|Overall Study||37
888179|NCT01926626|2148742|P1|STARTED|Overall Study||38
888180|NCT01926119|2148752|P1|NOT COMPLETED|Overall Study||1
888181|NCT01926119|2148752|P1|COMPLETED|Overall Study||3
888182|NCT01926119|2148752|P1|STARTED|Overall Study||4
888183|NCT01926015|2148764|P2|NOT COMPLETED|Overall Study||1
888184|NCT01926015|2148765|P1|NOT COMPLETED|Overall Study||2
888185|NCT01926015|2148764|P2|COMPLETED|Overall Study||95
888186|NCT01926015|2148765|P1|COMPLETED|Overall Study||94
888187|NCT01926015|2148764|P2|Received >=1 Vaccination|Overall Study||96
888188|NCT01926015|2148765|P1|Received >=1 Vaccination|Overall Study||94
888189|NCT01926015|2148764|P2|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
888190|NCT01926015|2148765|P1|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
888191|NCT01925781|2148797|P2|NOT COMPLETED|Overall Study||4
888192|NCT01925781|2148798|P1|NOT COMPLETED|Overall Study||2
888193|NCT01925781|2148797|P2|COMPLETED|Overall Study||1
888194|NCT01925781|2148798|P1|COMPLETED|Overall Study||3
888195|NCT01925781|2148797|P2|STARTED|Overall Study||5
888196|NCT01925781|2148798|P1|STARTED|Overall Study||5
888197|NCT01925768|2148808|P2|NOT COMPLETED|Overall Study||23
888198|NCT01925768|2148809|P1|NOT COMPLETED|Overall Study||11
888199|NCT01925768|2148808|P2|COMPLETED|Overall Study|Completed = participants who completed week 24|87
888200|NCT01925768|2148809|P1|COMPLETED|Overall Study|Completed = participants who completed week 24|98
888201|NCT01925768|2148808|P2|Escaped Early (EE)|Overall Study|EE= investigator’s discretion plus <10% improvement in both swollen & tender joint counts at Week16|13
888202|NCT01925768|2148809|P1|Escaped Early (EE)|Overall Study|EE= investigator’s discretion plus <10% improvement in both swollen & tender joint counts at Week16|35
888203|NCT01925768|2148808|P2|Completed Week 16|Overall Study||91
888204|NCT01925768|2148809|P1|Completed Week 16|Overall Study||101
888205|NCT01925768|2148808|P2|Safety Population|Overall Study|Safety population = participants who were randomized and received at least one dose of study drug.|109
888206|NCT01925768|2148809|P1|Safety Population|Overall Study|Safety population = participants who were randomized and received at least one dose of study drug.|109
888207|NCT01925768|2148808|P2|Received Treatment|Overall Study||109
888208|NCT01925768|2148809|P1|Received Treatment|Overall Study||109
888209|NCT01925768|2148808|P2|STARTED|Overall Study||110
888210|NCT01925768|2148809|P1|STARTED|Overall Study||109
888211|NCT01925703|2148817|P1|NOT COMPLETED|Overall Study||4
888212|NCT01925703|2148817|P1|COMPLETED|Overall Study||9
888213|NCT01925703|2148817|P1|Follow-up Completed|Overall Study||9
888214|NCT01925703|2148817|P1|Full Iron Repletion Achieved|Overall Study||11
888215|NCT01925703|2148817|P1|Dosing Regimen Completed|Overall Study||12
888216|NCT01925703|2148817|P1|STARTED|Overall Study||13
888217|NCT01925469|2148825|P2|NOT COMPLETED|Overall Study||0
888218|NCT01925469|2148826|P1|NOT COMPLETED|Overall Study||1
888219|NCT01925469|2148825|P2|COMPLETED|Overall Study||15
888220|NCT01925469|2148826|P1|COMPLETED|Overall Study||14
888221|NCT01925469|2148825|P2|STARTED|Overall Study||15
888222|NCT01925469|2148826|P1|STARTED|Overall Study||15
888223|NCT01925417|2148836|P1|NOT COMPLETED|Overall Study||3
888224|NCT01925417|2148836|P1|COMPLETED|Overall Study||31
888225|NCT01925417|2148836|P1|STARTED|Overall Study||34
888226|NCT01925274|2148846|P3|NOT COMPLETED|Overall Study||6
888227|NCT01925274|2148847|P2|NOT COMPLETED|Overall Study||6
888228|NCT01925274|2148848|P1|NOT COMPLETED|Overall Study||7
888229|NCT01925274|2148846|P3|COMPLETED|Overall Study||0
888230|NCT01925274|2148847|P2|COMPLETED|Overall Study||0
888231|NCT01925274|2148848|P1|COMPLETED|Overall Study||0
888232|NCT01925274|2148846|P3|STARTED|Overall Study||6
888233|NCT01925274|2148847|P2|STARTED|Overall Study||6
888234|NCT01925274|2148848|P1|STARTED|Overall Study||7
888235|NCT01925209|2148929|P4|NOT COMPLETED|Follow-up||4
888236|NCT01925209|2148930|P3|NOT COMPLETED|Follow-up||1
888237|NCT01925209|2148931|P2|NOT COMPLETED|Follow-up||6
888238|NCT01925209|2148932|P1|NOT COMPLETED|Follow-up||1
888239|NCT01925209|2148929|P4|COMPLETED|Follow-up||54
888240|NCT01925209|2148930|P3|COMPLETED|Follow-up||55
888241|NCT01925209|2148931|P2|COMPLETED|Follow-up||55
888242|NCT01925209|2148932|P1|COMPLETED|Follow-up||56
888243|NCT01925209|2148929|P4|STARTED|Follow-up||58
888244|NCT01925209|2148930|P3|STARTED|Follow-up||56
888245|NCT01925209|2148931|P2|STARTED|Follow-up||61
888246|NCT01925209|2148932|P1|STARTED|Follow-up||57
888247|NCT01925209|2148929|P4|NOT COMPLETED|Maintenance Treatment Epoch||2
888248|NCT01925209|2148930|P3|NOT COMPLETED|Maintenance Treatment Epoch||2
888249|NCT01925209|2148931|P2|NOT COMPLETED|Maintenance Treatment Epoch||1
888250|NCT01925209|2148932|P1|NOT COMPLETED|Maintenance Treatment Epoch||0
888251|NCT01925209|2148929|P4|COMPLETED|Maintenance Treatment Epoch||48
888252|NCT01925209|2148930|P3|COMPLETED|Maintenance Treatment Epoch||50
888253|NCT01925209|2148931|P2|COMPLETED|Maintenance Treatment Epoch||45
888254|NCT01925209|2148932|P1|COMPLETED|Maintenance Treatment Epoch||49
888255|NCT01925209|2148929|P4|STARTED|Maintenance Treatment Epoch||50
888256|NCT01925209|2148930|P3|STARTED|Maintenance Treatment Epoch||52
888257|NCT01925209|2148931|P2|STARTED|Maintenance Treatment Epoch||46
888258|NCT01925209|2148932|P1|STARTED|Maintenance Treatment Epoch||49
888259|NCT01925209|2148929|P4|NOT COMPLETED|Treatment Epoch||5
888260|NCT01925209|2148930|P3|NOT COMPLETED|Treatment Epoch||7
888261|NCT01925209|2148931|P2|NOT COMPLETED|Treatment Epoch||8
888262|NCT01925209|2148932|P1|NOT COMPLETED|Treatment Epoch||9
888263|NCT01925209|2148929|P4|COMPLETED|Treatment Epoch||57
888264|NCT01925209|2148930|P3|COMPLETED|Treatment Epoch||56
888265|NCT01925209|2148931|P2|COMPLETED|Treatment Epoch||55
888266|NCT01925209|2148932|P1|COMPLETED|Treatment Epoch||54
888267|NCT01925209|2148929|P4|Full Analysis Set|Treatment Epoch||62
888268|NCT01925209|2148930|P3|Full Analysis Set|Treatment Epoch||63
888269|NCT01925209|2148931|P2|Full Analysis Set|Treatment Epoch||63
888270|NCT01925209|2148932|P1|Full Analysis Set|Treatment Epoch||63
888271|NCT01925209|2148929|P4|STARTED|Treatment Epoch||62
888272|NCT01925209|2148930|P3|STARTED|Treatment Epoch||63
888273|NCT01925209|2148931|P2|STARTED|Treatment Epoch||63
888274|NCT01925209|2148932|P1|STARTED|Treatment Epoch||63
888275|NCT01925183|2148964|P2|NOT COMPLETED|Overall Study||0
888276|NCT01925183|2148965|P1|NOT COMPLETED|Overall Study||1
888277|NCT01925183|2148964|P2|COMPLETED|Overall Study||3
888278|NCT01925183|2148965|P1|COMPLETED|Overall Study||2
888279|NCT01925183|2148964|P2|STARTED|Overall Study||3
888280|NCT01925183|2148965|P1|STARTED|Overall Study||3
888281|NCT01925170|2148973|P1|NOT COMPLETED|Overall Study||53
888282|NCT01925170|2148973|P1|COMPLETED|Overall Study||1585
888283|NCT01925170|2148973|P1|STARTED|Overall Study||1638
888284|NCT01925144|2148991|P1|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||0
888285|NCT01925144|2148991|P1|COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||30
888286|NCT01925144|2148991|P1|Received 8 Doses of Omeprazole|Period 2 (At Dosing Day 3 Through Day12)||30
888287|NCT01925144|2148991|P1|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day12)||30
888288|NCT01925144|2148991|P1|STARTED|Period 2 (At Dosing Day 3 Through Day12)||30
888289|NCT01925144|2148991|P1|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
888290|NCT01925144|2148991|P1|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||30
888291|NCT01925144|2148991|P1|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||30
888292|NCT01925144|2148991|P1|STARTED|Period 1 (Day 1 Through Predose Day 3)||30
888293|NCT01924975|2149004|P2|NOT COMPLETED|Overall Study||0
888294|NCT01924975|2149005|P1|NOT COMPLETED|Overall Study||0
888295|NCT01924975|2149004|P2|COMPLETED|Overall Study||51
888296|NCT01924975|2149005|P1|COMPLETED|Overall Study||51
888297|NCT01924975|2149004|P2|STARTED|Overall Study||51
888298|NCT01924975|2149005|P1|STARTED|Overall Study||51
888299|NCT01924949|2149011|P1|NOT COMPLETED|Overall Study||0
888300|NCT01924949|2149011|P1|COMPLETED|Overall Study||5
888301|NCT01924949|2149011|P1|STARTED|Overall Study||5
888302|NCT01924871|2149022|P2|NOT COMPLETED|Overall Study||2
888303|NCT01924871|2149023|P1|NOT COMPLETED|Overall Study||6
888304|NCT01924871|2149022|P2|COMPLETED|Overall Study||29
888305|NCT01924871|2149023|P1|COMPLETED|Overall Study||25
888306|NCT01924871|2149022|P2|STARTED|Overall Study||31
888307|NCT01924871|2149023|P1|STARTED|Overall Study||31
888308|NCT01924767|2149034|P5|NOT COMPLETED|Overall Study||0
888309|NCT01924767|2149035|P4|NOT COMPLETED|Overall Study||0
888310|NCT01924767|2149036|P3|NOT COMPLETED|Overall Study||1
888311|NCT01924767|2149037|P2|NOT COMPLETED|Overall Study||0
888312|NCT01924767|2149038|P1|NOT COMPLETED|Overall Study||1
888313|NCT01924767|2149034|P5|COMPLETED|Overall Study||9
888314|NCT01924767|2149035|P4|COMPLETED|Overall Study||9
888315|NCT01924767|2149036|P3|COMPLETED|Overall Study||8
888316|NCT01924767|2149037|P2|COMPLETED|Overall Study||9
888317|NCT01924767|2149038|P1|COMPLETED|Overall Study||11
888318|NCT01924767|2149034|P5|STARTED|Overall Study||9
888319|NCT01924767|2149035|P4|STARTED|Overall Study||9
888320|NCT01924767|2149036|P3|STARTED|Overall Study||9
888321|NCT01924767|2149037|P2|STARTED|Overall Study||9
888322|NCT01924767|2149038|P1|STARTED|Overall Study||12
888323|NCT01924559|2149138|P1|NOT COMPLETED|Overall Study||0
888324|NCT01924559|2149138|P1|COMPLETED|Overall Study|The order in which subjects started scenarios (in biohazard gear vs street clothing) was randomized|37
888325|NCT01924559|2149138|P1|STARTED|Overall Study|All 37 participants were scored under the same six scenarios, resulting in 222 observations.|37
888326|NCT01924390|2149154|P2|NOT COMPLETED|Overall Study||1
888327|NCT01924390|2149155|P1|NOT COMPLETED|Overall Study||1
888328|NCT01924390|2149154|P2|COMPLETED|Overall Study||21
888329|NCT01924390|2149155|P1|COMPLETED|Overall Study||21
888330|NCT01924390|2149154|P2|STARTED|Overall Study||22
888331|NCT01924390|2149155|P1|STARTED|Overall Study||22
888332|NCT01924299|2149167|P2|NOT COMPLETED|Period 2||1
888333|NCT01924299|2149168|P1|NOT COMPLETED|Period 2||1
888334|NCT01924299|2149167|P2|COMPLETED|Period 2||17
888335|NCT01924299|2149168|P1|COMPLETED|Period 2||17
888336|NCT01924299|2149167|P2|Received Baricitinib|Period 2||17
888337|NCT01924299|2149168|P1|Received Baricitinib|Period 2||17
888338|NCT01924299|2149167|P2|Received at Least 1 Dose of Study Drug|Period 2||18
888339|NCT01924299|2149168|P1|Received at Least 1 Dose of Study Drug|Period 2||18
888340|NCT01924299|2149167|P2|STARTED|Period 2||18
888341|NCT01924299|2149168|P1|STARTED|Period 2||18
888342|NCT01924299|2149167|P2|NOT COMPLETED|Period 1||0
888343|NCT01924299|2149168|P1|NOT COMPLETED|Period 1||0
888344|NCT01924299|2149167|P2|COMPLETED|Period 1||18
888345|NCT01924299|2149168|P1|COMPLETED|Period 1||18
888346|NCT01924299|2149167|P2|Received Baricitinib|Period 1||18
888347|NCT01924299|2149168|P1|Received Baricitinib|Period 1||18
888348|NCT01924299|2149167|P2|STARTED|Period 1||18
888349|NCT01924299|2149168|P1|STARTED|Period 1||18
888350|NCT01924182|2149190|P2|NOT COMPLETED|Overall Study||0
888351|NCT01924182|2149191|P1|NOT COMPLETED|Overall Study||1
888352|NCT01924182|2149190|P2|COMPLETED|Overall Study||0
888353|NCT01924182|2149191|P1|COMPLETED|Overall Study||2
888354|NCT01924182|2149190|P2|STARTED|Overall Study||0
888355|NCT01924182|2149191|P1|STARTED|Overall Study||3
888356|NCT01923896|2149199|P2|NOT COMPLETED|Overall Study||0
888357|NCT01923896|2149200|P1|NOT COMPLETED|Overall Study||1
888358|NCT01923896|2149199|P2|COMPLETED|Overall Study||8
888359|NCT01923896|2149200|P1|COMPLETED|Overall Study||7
888360|NCT01923896|2149199|P2|STARTED|Overall Study||8
888361|NCT01923896|2149200|P1|STARTED|Overall Study||8
888362|NCT01923805|2149214|P2|NOT COMPLETED|Overall Study||5
888363|NCT01923805|2149215|P1|NOT COMPLETED|Overall Study||3
888364|NCT01923805|2149214|P2|COMPLETED|Overall Study||0
888365|NCT01923805|2149215|P1|COMPLETED|Overall Study||0
888366|NCT01923805|2149214|P2|STARTED|Overall Study|early termination|5
888367|NCT01923805|2149215|P1|STARTED|Overall Study|early termination|3
888368|NCT01923480|2149224|P6|NOT COMPLETED|Period 2 (Hours 1-7)||0
888369|NCT01923480|2149225|P5|NOT COMPLETED|Period 2 (Hours 1-7)||0
888370|NCT01923480|2149226|P4|NOT COMPLETED|Period 2 (Hours 1-7)||0
888371|NCT01923480|2149227|P3|NOT COMPLETED|Period 2 (Hours 1-7)||0
888372|NCT01923480|2149228|P2|NOT COMPLETED|Period 2 (Hours 1-7)||0
888373|NCT01923480|2149229|P1|NOT COMPLETED|Period 2 (Hours 1-7)||0
888374|NCT01923480|2149224|P6|COMPLETED|Period 2 (Hours 1-7)||2
888375|NCT01923480|2149225|P5|COMPLETED|Period 2 (Hours 1-7)||2
888376|NCT01923480|2149226|P4|COMPLETED|Period 2 (Hours 1-7)||2
888377|NCT01923480|2149227|P3|COMPLETED|Period 2 (Hours 1-7)||2
888378|NCT01923480|2149228|P2|COMPLETED|Period 2 (Hours 1-7)||1
888379|NCT01923480|2149229|P1|COMPLETED|Period 2 (Hours 1-7)||1
888380|NCT01923480|2149224|P6|STARTED|Period 2 (Hours 1-7)||2
888381|NCT01923480|2149225|P5|STARTED|Period 2 (Hours 1-7)||2
888382|NCT01923480|2149226|P4|STARTED|Period 2 (Hours 1-7)||2
888383|NCT01923480|2149227|P3|STARTED|Period 2 (Hours 1-7)||2
888384|NCT01923480|2149228|P2|STARTED|Period 2 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|1
888385|NCT01923480|2149229|P1|STARTED|Period 2 (Hours 1-7)||1
888386|NCT01923480|2149224|P6|NOT COMPLETED|Period 1 (Hours 1-7)||0
888387|NCT01923480|2149225|P5|NOT COMPLETED|Period 1 (Hours 1-7)||0
888388|NCT01923480|2149226|P4|NOT COMPLETED|Period 1 (Hours 1-7)||0
888389|NCT01923480|2149227|P3|NOT COMPLETED|Period 1 (Hours 1-7)||0
888390|NCT01923480|2149228|P2|NOT COMPLETED|Period 1 (Hours 1-7)||0
888391|NCT01923480|2149229|P1|NOT COMPLETED|Period 1 (Hours 1-7)||0
888392|NCT01923480|2149224|P6|COMPLETED|Period 1 (Hours 1-7)||2
888393|NCT01923480|2149225|P5|COMPLETED|Period 1 (Hours 1-7)||2
888394|NCT01923480|2149226|P4|COMPLETED|Period 1 (Hours 1-7)||2
888395|NCT01923480|2149227|P3|COMPLETED|Period 1 (Hours 1-7)||2
888396|NCT01923480|2149228|P2|COMPLETED|Period 1 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|2
888397|NCT01923480|2149229|P1|COMPLETED|Period 1 (Hours 1-7)||1
888398|NCT01923480|2149224|P6|STARTED|Period 1 (Hours 1-7)||2
888399|NCT01923480|2149225|P5|STARTED|Period 1 (Hours 1-7)||2
888400|NCT01923480|2149226|P4|STARTED|Period 1 (Hours 1-7)||2
888401|NCT01923480|2149227|P3|STARTED|Period 1 (Hours 1-7)||2
888402|NCT01923480|2149228|P2|STARTED|Period 1 (Hours 1-7)||2
888403|NCT01923480|2149229|P1|STARTED|Period 1 (Hours 1-7)||1
888404|NCT01923467|2149384|P1|NOT COMPLETED|Overall Study||541
888405|NCT01923467|2149384|P1|COMPLETED|Overall Study|Completed 3-month follow up survey|226
888406|NCT01923467|2149384|P1|Baseline Completed, Enrolled|Overall Study||288
888407|NCT01923467|2149384|P1|STARTED|Overall Study|Offered stop smoking program|767
888408|NCT01923389|2149390|P2|NOT COMPLETED|Overall Study||0
888409|NCT01923389|2149391|P1|NOT COMPLETED|Overall Study||1
888410|NCT01923389|2149390|P2|COMPLETED|Overall Study||2
888411|NCT01923389|2149391|P1|COMPLETED|Overall Study||1
888412|NCT01923389|2149390|P2|STARTED|Overall Study||2
888413|NCT01923389|2149391|P1|STARTED|Overall Study||2
888414|NCT01922986|2149415|P2|NOT COMPLETED|Overall Study||0
888415|NCT01922986|2149416|P1|NOT COMPLETED|Overall Study||0
888416|NCT01922986|2149415|P2|COMPLETED|Overall Study||2
888417|NCT01922986|2149416|P1|COMPLETED|Overall Study||2
888418|NCT01922986|2149415|P2|STARTED|Overall Study||2
888419|NCT01922986|2149416|P1|STARTED|Overall Study||2
888420|NCT01922934|2149428|P2|NOT COMPLETED|Visit 12 / Final Visits||290
888421|NCT01922934|2149429|P1|NOT COMPLETED|Visit 12 / Final Visits||6
888422|NCT01922934|2149428|P2|COMPLETED|Visit 12 / Final Visits|290 patients did not have a second weight recorded at one year (+/- 6months) of first weight|2640
888423|NCT01922934|2149429|P1|COMPLETED|Visit 12 / Final Visits|6 patients did not return for final visit and weight measure|113
888424|NCT01922934|2149428|P2|STARTED|Visit 12 / Final Visits||2930
888425|NCT01922934|2149429|P1|STARTED|Visit 12 / Final Visits||119
888426|NCT01922934|2149428|P2|NOT COMPLETED|Visit 1- Weight Measured||1284
888427|NCT01922934|2149429|P1|NOT COMPLETED|Visit 1- Weight Measured||21
888428|NCT01922934|2149428|P2|COMPLETED|Visit 1- Weight Measured|1284 patients did not have any weights recorded in EMR during study timeframe|2930
888429|NCT01922934|2149429|P1|COMPLETED|Visit 1- Weight Measured|Patients first received tool and were weighed at Visit 1|119
888430|NCT01922934|2149428|P2|STARTED|Visit 1- Weight Measured||4214
888431|NCT01922934|2149429|P1|STARTED|Visit 1- Weight Measured|21 patients did not return for Visit 1 to receive tool or have weight measured.|140
888432|NCT01922934|2149428|P2|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||0
888433|NCT01922934|2149429|P1|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||235
888434|NCT01922934|2149428|P2|COMPLETED|Visit 0 - Patient Contacted & Consented||4214
888435|NCT01922934|2149429|P1|COMPLETED|Visit 0 - Patient Contacted & Consented|reflects number of patients that were contacted and agreed to attend Visit 0|140
888436|NCT01922934|2149428|P2|STARTED|Visit 0 - Patient Contacted & Consented|Control group patients were not contacted or offered intervention|4214
888437|NCT01922934|2149429|P1|STARTED|Visit 0 - Patient Contacted & Consented||375
888438|NCT01922934|2149428|P2|NOT COMPLETED|Eligible Patients||88
888439|NCT01922934|2149429|P1|NOT COMPLETED|Eligible Patients||53
888440|NCT01922934|2149428|P2|COMPLETED|Eligible Patients|81 patients did not meet inclusion criteria as they were 80 years or older. 7 patients had died.|4214
888441|NCT01922934|2149429|P1|COMPLETED|Eligible Patients|375 patients determined eligible after original random selection from DHHA data warehouse.|375
888442|NCT01922934|2149428|P2|STARTED|Eligible Patients||4302
888443|NCT01922934|2149429|P1|STARTED|Eligible Patients||428
888444|NCT01922739|2149441|P1|NOT COMPLETED|Open-label Treatment Period||34
888445|NCT01922739|2149441|P1|COMPLETED|Open-label Treatment Period||136
888446|NCT01922739|2149441|P1|Treatment SAS and FAS|Open-label Treatment Period|SAS = safety analysis set FAS = full analysis set|170
888447|NCT01922739|2149441|P1|STARTED|Open-label Treatment Period||170
888448|NCT01922739|2149441|P1|NOT COMPLETED|Titration/Adjustment Period||12
888449|NCT01922739|2149441|P1|COMPLETED|Titration/Adjustment Period||170
888450|NCT01922739|2149441|P1|Safety Analysis Set|Titration/Adjustment Period||182
888451|NCT01922739|2149441|P1|STARTED|Titration/Adjustment Period||182
888452|NCT01922349|2149470|P4|NOT COMPLETED|Multiple Rising Dose (MRD) Period||1
888453|NCT01922349|2149471|P3|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
888454|NCT01922349|2149472|P2|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
888455|NCT01922349|2149473|P1|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
888456|NCT01922349|2149470|P4|COMPLETED|Multiple Rising Dose (MRD) Period||26
888457|NCT01922349|2149471|P3|COMPLETED|Multiple Rising Dose (MRD) Period||18
888458|NCT01922349|2149472|P2|COMPLETED|Multiple Rising Dose (MRD) Period||27
888459|NCT01922349|2149473|P1|COMPLETED|Multiple Rising Dose (MRD) Period||24
888460|NCT01922349|2149470|P4|STARTED|Multiple Rising Dose (MRD) Period||27
888461|NCT01922349|2149471|P3|STARTED|Multiple Rising Dose (MRD) Period||18
888462|NCT01922349|2149472|P2|STARTED|Multiple Rising Dose (MRD) Period||27
888463|NCT01922349|2149473|P1|STARTED|Multiple Rising Dose (MRD) Period|One subject discontinued the trial after the SRD period due to non-compliance with the protocol.|24
888464|NCT01922349|2149470|P4|NOT COMPLETED|Single Rising Dose (SRD) Period||0
888465|NCT01922349|2149471|P3|NOT COMPLETED|Single Rising Dose (SRD) Period||0
888466|NCT01922349|2149472|P2|NOT COMPLETED|Single Rising Dose (SRD) Period||0
888467|NCT01922349|2149473|P1|NOT COMPLETED|Single Rising Dose (SRD) Period||0
888468|NCT01922349|2149470|P4|COMPLETED|Single Rising Dose (SRD) Period||27
888469|NCT01922349|2149471|P3|COMPLETED|Single Rising Dose (SRD) Period||18
888470|NCT01922349|2149472|P2|COMPLETED|Single Rising Dose (SRD) Period||27
888471|NCT01922349|2149473|P1|COMPLETED|Single Rising Dose (SRD) Period||25
888472|NCT01922349|2149470|P4|STARTED|Single Rising Dose (SRD) Period||27
888473|NCT01922349|2149471|P3|STARTED|Single Rising Dose (SRD) Period||18
888474|NCT01922349|2149472|P2|STARTED|Single Rising Dose (SRD) Period||27
888475|NCT01922349|2149473|P1|STARTED|Single Rising Dose (SRD) Period||25
888476|NCT01922271|2149580|P2|NOT COMPLETED|PERIOD 2||0
888477|NCT01922271|2149581|P1|NOT COMPLETED|PERIOD 2||0
888478|NCT01922271|2149580|P2|COMPLETED|PERIOD 2||76
888479|NCT01922271|2149581|P1|COMPLETED|PERIOD 2||75
888480|NCT01922271|2149580|P2|STARTED|PERIOD 2||76
888481|NCT01922271|2149581|P1|STARTED|PERIOD 2||75
888482|NCT01922271|2149580|P2|NOT COMPLETED|WASHOUT Period||0
888483|NCT01922271|2149581|P1|NOT COMPLETED|WASHOUT Period||1
888484|NCT01922271|2149580|P2|COMPLETED|WASHOUT Period||76
888485|NCT01922271|2149581|P1|COMPLETED|WASHOUT Period||75
888486|NCT01922271|2149580|P2|STARTED|WASHOUT Period||76
888487|NCT01922271|2149581|P1|STARTED|WASHOUT Period||76
888488|NCT01922271|2149580|P2|NOT COMPLETED|PERIOD 1||0
888489|NCT01922271|2149581|P1|NOT COMPLETED|PERIOD 1||0
888490|NCT01922271|2149580|P2|COMPLETED|PERIOD 1||76
888491|NCT01922271|2149581|P1|COMPLETED|PERIOD 1||76
888492|NCT01922271|2149580|P2|STARTED|PERIOD 1||76
888493|NCT01922271|2149581|P1|STARTED|PERIOD 1||76
888494|NCT01922219|2149599|P1|NOT COMPLETED|Overall Study||9
888495|NCT01922219|2149599|P1|COMPLETED|Overall Study||28
888496|NCT01922219|2149599|P1|STARTED|Overall Study||37
888497|NCT01922115|2149607|P2|NOT COMPLETED|Overall Study||7
888498|NCT01922115|2149608|P1|NOT COMPLETED|Overall Study||7
888499|NCT01922115|2149607|P2|COMPLETED|Overall Study||24
888500|NCT01922115|2149608|P1|COMPLETED|Overall Study||21
888501|NCT01922115|2149607|P2|STARTED|Overall Study||31
888502|NCT01922115|2149608|P1|STARTED|Overall Study||28
888503|NCT01922089|2149622|P2|NOT COMPLETED|Overall Study||30
888504|NCT01922089|2149623|P1|NOT COMPLETED|Overall Study||39
888505|NCT01922089|2149622|P2|COMPLETED|Overall Study||221
888506|NCT01922089|2149623|P1|COMPLETED|Overall Study||208
888507|NCT01922089|2149622|P2|Safety Set|Overall Study||251
888508|NCT01922089|2149623|P1|Safety Set|Overall Study||246
888509|NCT01922089|2149622|P2|STARTED|Overall Study||251
888510|NCT01922089|2149623|P1|STARTED|Overall Study||247
888511|NCT01922011|2149635|P2|NOT COMPLETED|Overall Study||5
888512|NCT01922011|2149636|P1|NOT COMPLETED|Overall Study||6
888513|NCT01922011|2149635|P2|COMPLETED|Overall Study||69
888514|NCT01922011|2149636|P1|COMPLETED|Overall Study||69
888515|NCT01922011|2149635|P2|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|72
888516|NCT01922011|2149636|P1|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|74
888517|NCT01922011|2149635|P2|Treated|Overall Study|Treated Participants|73
888518|NCT01922011|2149636|P1|Treated|Overall Study|Treated Participants|73
888519|NCT01922011|2149635|P2|STARTED|Overall Study|Randomized participants|74
888520|NCT01922011|2149636|P1|STARTED|Overall Study|Randomized participants|75
888521|NCT01921894|2149679|P3|NOT COMPLETED|Overall Study||0
888522|NCT01921894|2149680|P2|NOT COMPLETED|Overall Study||0
888523|NCT01921894|2149681|P1|NOT COMPLETED|Overall Study||0
888524|NCT01921894|2149679|P3|COMPLETED|Overall Study||8
888525|NCT01921894|2149680|P2|COMPLETED|Overall Study||8
888526|NCT01921894|2149681|P1|COMPLETED|Overall Study||8
888527|NCT01921894|2149679|P3|STARTED|Overall Study||8
888528|NCT01921894|2149680|P2|STARTED|Overall Study||8
888529|NCT01921894|2149681|P1|STARTED|Overall Study||8
888530|NCT01921829|2149703|P2|NOT COMPLETED|Overall Study||1
888531|NCT01921829|2149704|P1|NOT COMPLETED|Overall Study||0
888532|NCT01921829|2149703|P2|COMPLETED|Overall Study||8
888533|NCT01921829|2149704|P1|COMPLETED|Overall Study||10
888534|NCT01921829|2149703|P2|STARTED|Overall Study||9
888535|NCT01921829|2149704|P1|STARTED|Overall Study||10
888536|NCT01921452|2149750|P1|NOT COMPLETED|Overall Study||0
888537|NCT01921452|2149750|P1|COMPLETED|Overall Study||283
888538|NCT01921452|2149750|P1|STARTED|Overall Study||283
888539|NCT01921348|2149757|P2|NOT COMPLETED|Overall Study||2
888540|NCT01921348|2149758|P1|NOT COMPLETED|Overall Study||1
888541|NCT01921348|2149757|P2|COMPLETED|Overall Study||7
888542|NCT01921348|2149758|P1|COMPLETED|Overall Study||8
888543|NCT01921348|2149757|P2|STARTED|Overall Study||9
888544|NCT01921348|2149758|P1|STARTED|Overall Study||9
888545|NCT01921322|2149770|P2|NOT COMPLETED|Overall Study||17
888546|NCT01921322|2149771|P1|NOT COMPLETED|Overall Study||15
888547|NCT01921322|2149770|P2|COMPLETED|Overall Study||44
888548|NCT01921322|2149771|P1|COMPLETED|Overall Study||42
888549|NCT01921322|2149770|P2|STARTED|Overall Study||61
888550|NCT01921322|2149771|P1|STARTED|Overall Study||57
888551|NCT01921296|2149779|P1|NOT COMPLETED|Overall Study||0
888552|NCT01921296|2149779|P1|COMPLETED|Overall Study||2
888553|NCT01921296|2149779|P1|STARTED|Overall Study||2
888554|NCT01921101|2149789|P2|NOT COMPLETED|Overall Study||6
888555|NCT01921101|2149790|P1|NOT COMPLETED|Overall Study||16
888556|NCT01921101|2149789|P2|COMPLETED|Overall Study||32
888557|NCT01921101|2149790|P1|COMPLETED|Overall Study||24
888558|NCT01921101|2149789|P2|STARTED|Overall Study||38
888559|NCT01921101|2149790|P1|STARTED|Overall Study||40
888560|NCT01920958|2149798|P1|NOT COMPLETED|Overall Study||5
888561|NCT01920958|2149798|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|228
888562|NCT01920958|2149798|P1|STARTED|Overall Study||233
888563|NCT01920893|2149816|P2|NOT COMPLETED|Overall Study||2
888564|NCT01920893|2149817|P1|NOT COMPLETED|Overall Study||7
888565|NCT01920893|2149816|P2|COMPLETED|Overall Study||28
888566|NCT01920893|2149817|P1|COMPLETED|Overall Study||23
888567|NCT01920893|2149816|P2|Treated (Safety Population)|Overall Study||30
888568|NCT01920893|2149817|P1|Treated (Safety Population)|Overall Study||30
888569|NCT01920893|2149816|P2|STARTED|Overall Study||30
888570|NCT01920893|2149817|P1|STARTED|Overall Study||30
888571|NCT01920854|2149850|P7|NOT COMPLETED|Overall Study||1
888572|NCT01920854|2149851|P6|NOT COMPLETED|Overall Study||0
888573|NCT01920854|2149852|P5|NOT COMPLETED|Overall Study||1
888574|NCT01920854|2149853|P4|NOT COMPLETED|Overall Study||0
888575|NCT01920854|2149854|P3|NOT COMPLETED|Overall Study||0
888576|NCT01920854|2149855|P2|NOT COMPLETED|Overall Study||0
888577|NCT01920854|2149856|P1|NOT COMPLETED|Overall Study||1
888578|NCT01920854|2149850|P7|COMPLETED|Overall Study||5
888579|NCT01920854|2149851|P6|COMPLETED|Overall Study||6
888580|NCT01920854|2149852|P5|COMPLETED|Overall Study||5
888581|NCT01920854|2149853|P4|COMPLETED|Overall Study||6
888582|NCT01920854|2149854|P3|COMPLETED|Overall Study||6
888583|NCT01920854|2149855|P2|COMPLETED|Overall Study||6
888584|NCT01920854|2149856|P1|COMPLETED|Overall Study||11
888585|NCT01920854|2149850|P7|STARTED|Overall Study||6
888586|NCT01920854|2149851|P6|STARTED|Overall Study||6
888587|NCT01920854|2149852|P5|STARTED|Overall Study||6
888588|NCT01920854|2149853|P4|STARTED|Overall Study||6
888589|NCT01920854|2149854|P3|STARTED|Overall Study||6
888590|NCT01920854|2149855|P2|STARTED|Overall Study||6
888591|NCT01920854|2149856|P1|STARTED|Overall Study||12
888592|NCT01920802|2149983|P3|NOT COMPLETED|Overall Study||1
888593|NCT01920802|2149984|P2|NOT COMPLETED|Overall Study||2
888594|NCT01920802|2149985|P1|NOT COMPLETED|Overall Study||4
888595|NCT01920802|2149983|P3|COMPLETED|Overall Study||10
888596|NCT01920802|2149984|P2|COMPLETED|Overall Study||7
888597|NCT01920802|2149985|P1|COMPLETED|Overall Study||7
888598|NCT01920802|2149983|P3|STARTED|Overall Study||11
888599|NCT01920802|2149984|P2|STARTED|Overall Study||9
888600|NCT01920802|2149985|P1|STARTED|Overall Study||11
888601|NCT01920568|2150016|P2|NOT COMPLETED|Overall Study||84
888602|NCT01920568|2150017|P1|NOT COMPLETED|Overall Study||151
888603|NCT01920568|2150016|P2|COMPLETED|Overall Study||75
888604|NCT01920568|2150017|P1|COMPLETED|Overall Study||175
888605|NCT01920568|2150016|P2|STARTED|Overall Study||159
888606|NCT01920568|2150017|P1|STARTED|Overall Study||326
888607|NCT01920282|2150041|P3|NOT COMPLETED|Overall Study||0
888608|NCT01920282|2150042|P2|NOT COMPLETED|Overall Study||0
888609|NCT01920282|2150043|P1|NOT COMPLETED|Overall Study||0
888610|NCT01920282|2150041|P3|COMPLETED|Overall Study||15
888611|NCT01920282|2150042|P2|COMPLETED|Overall Study||15
888612|NCT01920282|2150043|P1|COMPLETED|Overall Study||15
888613|NCT01920282|2150041|P3|STARTED|Overall Study||15
888614|NCT01920282|2150042|P2|STARTED|Overall Study||15
888615|NCT01920282|2150043|P1|STARTED|Overall Study||15
888616|NCT01920178|2150056|P2|NOT COMPLETED|Overall Study||1
888617|NCT01920178|2150057|P1|NOT COMPLETED|Overall Study||2
888618|NCT01920178|2150056|P2|COMPLETED|Overall Study||1
888619|NCT01920178|2150057|P1|COMPLETED|Overall Study||3
888620|NCT01920178|2150056|P2|STARTED|Overall Study||2
888621|NCT01920178|2150057|P1|STARTED|Overall Study||5
888622|NCT01919996|2150067|P1|NOT COMPLETED|Overall Study||0
888623|NCT01919996|2150067|P1|COMPLETED|Overall Study||8
888624|NCT01919996|2150067|P1|STARTED|Overall Study||8
888625|NCT01919801|2150075|P2|NOT COMPLETED|Overall Study||3
888626|NCT01919801|2150076|P1|NOT COMPLETED|Overall Study||1
888627|NCT01919801|2150075|P2|COMPLETED|Overall Study||57
888628|NCT01919801|2150076|P1|COMPLETED|Overall Study||60
888629|NCT01919801|2150075|P2|STARTED|Overall Study||60
888630|NCT01919801|2150076|P1|STARTED|Overall Study||61
888631|NCT01919723|2150101|P2|NOT COMPLETED|Overall Study||2
888632|NCT01919723|2150102|P1|NOT COMPLETED|Overall Study||2
888633|NCT01919723|2150101|P2|COMPLETED|Overall Study||33
888634|NCT01919723|2150102|P1|COMPLETED|Overall Study||33
888635|NCT01919723|2150101|P2|STARTED|Overall Study||35
888636|NCT01919723|2150102|P1|STARTED|Overall Study||35
888637|NCT01919606|2150116|P2|NOT COMPLETED|Overall Study||0
888638|NCT01919606|2150117|P1|NOT COMPLETED|Overall Study||0
888639|NCT01919606|2150116|P2|COMPLETED|Overall Study||0
888640|NCT01919606|2150117|P1|COMPLETED|Overall Study||1
888641|NCT01919606|2150116|P2|STARTED|Overall Study||0
888642|NCT01919606|2150117|P1|STARTED|Overall Study||1
888643|NCT01919450|2150129|P4|NOT COMPLETED|Overall Study||1
888644|NCT01919450|2150130|P3|NOT COMPLETED|Overall Study||0
888645|NCT01919450|2150131|P2|NOT COMPLETED|Overall Study||0
888646|NCT01919450|2150132|P1|NOT COMPLETED|Overall Study||0
888647|NCT01919450|2150129|P4|COMPLETED|Overall Study||19
888648|NCT01919450|2150130|P3|COMPLETED|Overall Study||20
888649|NCT01919450|2150131|P2|COMPLETED|Overall Study||20
888650|NCT01919450|2150132|P1|COMPLETED|Overall Study||20
888651|NCT01919450|2150129|P4|STARTED|Overall Study||20
888652|NCT01919450|2150130|P3|STARTED|Overall Study||20
888653|NCT01919450|2150131|P2|STARTED|Overall Study||20
888654|NCT01919450|2150132|P1|STARTED|Overall Study||20
888655|NCT01919229|2150145|P3|NOT COMPLETED|Overall Study||1
888656|NCT01919229|2150146|P2|NOT COMPLETED|Overall Study||0
888657|NCT01919229|2150147|P1|NOT COMPLETED|Overall Study||0
888658|NCT01919229|2150145|P3|COMPLETED|Overall Study||3
888659|NCT01919229|2150146|P2|COMPLETED|Overall Study||6
888660|NCT01919229|2150147|P1|COMPLETED|Overall Study||4
888661|NCT01919229|2150145|P3|STARTED|Overall Study||4
888662|NCT01919229|2150146|P2|STARTED|Overall Study||6
888663|NCT01919229|2150147|P1|STARTED|Overall Study||4
888664|NCT01918800|2150178|P2|NOT COMPLETED|Overall Study||5
888665|NCT01918800|2150179|P1|NOT COMPLETED|Overall Study||9
888666|NCT01918800|2150178|P2|COMPLETED|Overall Study||104
888667|NCT01918800|2150179|P1|COMPLETED|Overall Study||100
888668|NCT01918800|2150178|P2|STARTED|Overall Study||109
888669|NCT01918800|2150179|P1|STARTED|Overall Study||109
888670|NCT01918371|2150199|P2|NOT COMPLETED|Overall Study||1
888671|NCT01918371|2150200|P1|NOT COMPLETED|Overall Study||1
888672|NCT01918371|2150199|P2|COMPLETED|Overall Study||156
888673|NCT01918371|2150200|P1|COMPLETED|Overall Study||165
888674|NCT01918371|2150199|P2|Participants With Complete Data|Overall Study||156
888675|NCT01918371|2150200|P1|Participants With Complete Data|Overall Study||165
888676|NCT01918371|2150199|P2|STARTED|Overall Study||157
888677|NCT01918371|2150200|P1|STARTED|Overall Study||166
888678|NCT01918332|2150278|P4|NOT COMPLETED|Overall Study||7
888679|NCT01918332|2150279|P3|NOT COMPLETED|Overall Study||9
888680|NCT01918332|2150280|P2|NOT COMPLETED|Overall Study||5
888681|NCT01918332|2150281|P1|NOT COMPLETED|Overall Study||8
888682|NCT01918332|2150278|P4|COMPLETED|Overall Study||38
888683|NCT01918332|2150279|P3|COMPLETED|Overall Study||30
888684|NCT01918332|2150280|P2|COMPLETED|Overall Study||36
888685|NCT01918332|2150281|P1|COMPLETED|Overall Study||35
888686|NCT01918332|2150278|P4|STARTED|Overall Study||45
888687|NCT01918332|2150279|P3|STARTED|Overall Study||39
888688|NCT01918332|2150280|P2|STARTED|Overall Study||41
888689|NCT01918332|2150281|P1|STARTED|Overall Study||43
888690|NCT01918306|2150293|P4|NOT COMPLETED|Overall Study||3
888691|NCT01918306|2150294|P3|NOT COMPLETED|Overall Study||2
888692|NCT01918306|2150295|P2|NOT COMPLETED|Overall Study||0
888693|NCT01918306|2150296|P1|NOT COMPLETED|Overall Study||6
888694|NCT01918306|2150293|P4|COMPLETED|Overall Study||0
888695|NCT01918306|2150294|P3|COMPLETED|Overall Study||0
888696|NCT01918306|2150295|P2|COMPLETED|Overall Study||0
888697|NCT01918306|2150296|P1|COMPLETED|Overall Study||0
888698|NCT01918306|2150293|P4|STARTED|Overall Study||3
888699|NCT01918306|2150294|P3|STARTED|Overall Study|1 participant Crossed-over to ARM 2|2
888700|NCT01918306|2150295|P2|STARTED|Overall Study|No patients enrolled|0
888701|NCT01918306|2150296|P1|STARTED|Overall Study||6
888702|NCT01918085|2150318|P2|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
888703|NCT01918085|2150319|P1|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
888704|NCT01918085|2150318|P2|COMPLETED|Test Period 2: Hydrocolloid Strip||11
888705|NCT01918085|2150319|P1|COMPLETED|Test Period 2: Hydrocolloid Strip||10
888706|NCT01918085|2150318|P2|STARTED|Test Period 2: Hydrocolloid Strip||11
888707|NCT01918085|2150319|P1|STARTED|Test Period 2: Hydrocolloid Strip||10
888708|NCT01918085|2150318|P2|NOT COMPLETED|Test Period 2: Strata Strip||0
888709|NCT01918085|2150319|P1|NOT COMPLETED|Test Period 2: Strata Strip||0
888710|NCT01918085|2150318|P2|COMPLETED|Test Period 2: Strata Strip||11
888711|NCT01918085|2150319|P1|COMPLETED|Test Period 2: Strata Strip||10
888712|NCT01918085|2150318|P2|STARTED|Test Period 2: Strata Strip||11
888713|NCT01918085|2150319|P1|STARTED|Test Period 2: Strata Strip||10
888714|NCT01918085|2150318|P2|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
888715|NCT01918085|2150319|P1|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
888716|NCT01918085|2150318|P2|COMPLETED|Test Period 1: Hydrocolloid Strip||11
888717|NCT01918085|2150319|P1|COMPLETED|Test Period 1: Hydrocolloid Strip||10
888718|NCT01918085|2150318|P2|STARTED|Test Period 1: Hydrocolloid Strip||11
888719|NCT01918085|2150319|P1|STARTED|Test Period 1: Hydrocolloid Strip||10
888720|NCT01918085|2150318|P2|NOT COMPLETED|Test Period 1: Strata Strip||1
888721|NCT01918085|2150319|P1|NOT COMPLETED|Test Period 1: Strata Strip||0
888722|NCT01918085|2150318|P2|COMPLETED|Test Period 1: Strata Strip||11
888723|NCT01918085|2150319|P1|COMPLETED|Test Period 1: Strata Strip||10
888724|NCT01918085|2150318|P2|STARTED|Test Period 1: Strata Strip||12
888725|NCT01918085|2150319|P1|STARTED|Test Period 1: Strata Strip||10
888726|NCT01918033|2150330|P3|NOT COMPLETED|Overall Study||3
888727|NCT01918033|2150331|P2|NOT COMPLETED|Overall Study||2
888728|NCT01918033|2150332|P1|NOT COMPLETED|Overall Study||5
888729|NCT01918033|2150330|P3|COMPLETED|Overall Study||199
888730|NCT01918033|2150331|P2|COMPLETED|Overall Study||201
888731|NCT01918033|2150332|P1|COMPLETED|Overall Study||198
888732|NCT01918033|2150330|P3|Treated|Overall Study|One randomized participant did not receive study drug.|201
888733|NCT01918033|2150331|P2|Treated|Overall Study||203
888734|NCT01918033|2150332|P1|Treated|Overall Study|One randomized participant did not receive study drug.|202
888735|NCT01918033|2150330|P3|STARTED|Overall Study||202
888736|NCT01918033|2150331|P2|STARTED|Overall Study||203
888737|NCT01918033|2150332|P1|STARTED|Overall Study||203
888738|NCT01917812|2150373|P3|NOT COMPLETED|Overall Study||0
888739|NCT01917812|2150374|P2|NOT COMPLETED|Overall Study||0
888740|NCT01917812|2150375|P1|NOT COMPLETED|Overall Study||1
888741|NCT01917812|2150373|P3|COMPLETED|Overall Study||16
888742|NCT01917812|2150374|P2|COMPLETED|Overall Study||16
888743|NCT01917812|2150375|P1|COMPLETED|Overall Study||15
888744|NCT01917812|2150373|P3|STARTED|Overall Study||16
888745|NCT01917812|2150374|P2|STARTED|Overall Study||16
888746|NCT01917812|2150375|P1|STARTED|Overall Study||16
888747|NCT01917773|2150395|P1|NOT COMPLETED|Overall Study||0
888748|NCT01917773|2150395|P1|COMPLETED|Overall Study||13
888749|NCT01917773|2150395|P1|STARTED|Overall Study||13
888750|NCT01917656|2150403|P2|NOT COMPLETED|Overall Study||24
888751|NCT01917656|2150404|P1|NOT COMPLETED|Overall Study||26
888752|NCT01917656|2150403|P2|COMPLETED|Overall Study||147
888753|NCT01917656|2150404|P1|COMPLETED|Overall Study||146
888754|NCT01917656|2150403|P2|Exposed During Ramadan (Fasting)|Overall Study||163
888755|NCT01917656|2150404|P1|Exposed During Ramadan (Fasting)|Overall Study||152
888756|NCT01917656|2150403|P2|Exposed|Overall Study|1 subject was withdrawn prior to exposure to first SU dose after randomisation|170
888757|NCT01917656|2150404|P1|Exposed|Overall Study|1 subject was withdrawn prior to exposure to trial products|171
888758|NCT01917656|2150403|P2|STARTED|Overall Study||171
888759|NCT01917656|2150404|P1|STARTED|Overall Study||172
888760|NCT01917526|2150430|P2|NOT COMPLETED|Overall Study||1
888761|NCT01917526|2150431|P1|NOT COMPLETED|Overall Study||1
888762|NCT01917526|2150430|P2|COMPLETED|Overall Study|1 patient in oxygen cannula group receive oxygen mask|249
888763|NCT01917526|2150431|P1|COMPLETED|Overall Study|One patient in oxygen mask received oxygen cannula|249
888764|NCT01917526|2150430|P2|STARTED|Overall Study||250
888765|NCT01917526|2150431|P1|STARTED|Overall Study||250
888766|NCT01917344|2150439|P1|NOT COMPLETED|Overall Study||1
888767|NCT01917344|2150439|P1|COMPLETED|Overall Study||9
888768|NCT01917344|2150439|P1|STARTED|Overall Study||10
888769|NCT01917214|2150443|P1|NOT COMPLETED|Overall Study||0
888770|NCT01917214|2150443|P1|COMPLETED|Overall Study||212
888771|NCT01917214|2150443|P1|STARTED|Overall Study||212
888787|NCT01916928|2150517|P1|NOT COMPLETED|Overall Study||0
888788|NCT01916928|2150517|P1|COMPLETED|Overall Study||50
888789|NCT01916928|2150517|P1|STARTED|Overall Study||50
888790|NCT01916681|2150525|P4|NOT COMPLETED|Overall Study||0
888791|NCT01916681|2150526|P3|NOT COMPLETED|Overall Study||0
888792|NCT01916681|2150527|P2|NOT COMPLETED|Overall Study||0
888793|NCT01916681|2150528|P1|NOT COMPLETED|Overall Study||0
888794|NCT01916681|2150525|P4|COMPLETED|Overall Study||125
888795|NCT01916681|2150526|P3|COMPLETED|Overall Study||123
888796|NCT01916681|2150527|P2|COMPLETED|Overall Study||120
888797|NCT01916681|2150528|P1|COMPLETED|Overall Study||123
888798|NCT01916681|2150525|P4|STARTED|Overall Study||125
888799|NCT01916681|2150526|P3|STARTED|Overall Study||123
888800|NCT01916681|2150527|P2|STARTED|Overall Study||120
888801|NCT01916681|2150528|P1|STARTED|Overall Study||123
888802|NCT01916629|2150568|P2|NOT COMPLETED|Overall Study||0
888803|NCT01916629|2150569|P1|NOT COMPLETED|Overall Study||0
888804|NCT01916629|2150568|P2|COMPLETED|Overall Study||5
888805|NCT01916629|2150569|P1|COMPLETED|Overall Study||7
888806|NCT01916629|2150568|P2|STARTED|Overall Study||5
888807|NCT01916629|2150569|P1|STARTED|Overall Study||7
888808|NCT01916590|2150577|P2|NOT COMPLETED|Overall Study||0
888809|NCT01916590|2150578|P1|NOT COMPLETED|Overall Study||0
888810|NCT01916590|2150577|P2|COMPLETED|Overall Study||3
888811|NCT01916590|2150578|P1|COMPLETED|Overall Study||4
888812|NCT01916590|2150577|P2|STARTED|Overall Study||3
888813|NCT01916590|2150578|P1|STARTED|Overall Study||4
888814|NCT01916304|2150584|P1|NOT COMPLETED|Overall Study||17
888815|NCT01916304|2150584|P1|COMPLETED|Overall Study||84
888816|NCT01916304|2150584|P1|Intent-to-Treat Set|Overall Study||84
888817|NCT01916304|2150584|P1|Safety Set|Overall Study||101
888818|NCT01916304|2150584|P1|STARTED|Overall Study||101
888819|NCT01916226|2150596|P4|NOT COMPLETED|Overall Study||4
888820|NCT01916226|2150597|P3|NOT COMPLETED|Overall Study||3
888821|NCT01916226|2150598|P2|NOT COMPLETED|Overall Study||1
888822|NCT01916226|2150599|P1|NOT COMPLETED|Overall Study||1
888823|NCT01916226|2150596|P4|COMPLETED|Overall Study||167
888824|NCT01916226|2150597|P3|COMPLETED|Overall Study||168
888825|NCT01916226|2150598|P2|COMPLETED|Overall Study||169
888826|NCT01916226|2150599|P1|COMPLETED|Overall Study||169
888827|NCT01916226|2150596|P4|STARTED|Overall Study||171
888828|NCT01916226|2150597|P3|STARTED|Overall Study||171
888829|NCT01916226|2150598|P2|STARTED|Overall Study||170
888830|NCT01916226|2150599|P1|STARTED|Overall Study||170
888831|NCT01916109|2150633|P1|NOT COMPLETED|Overall Study||1
888832|NCT01916109|2150633|P1|COMPLETED|Overall Study||3
888833|NCT01916109|2150633|P1|STARTED|Overall Study||4
888834|NCT01914926|2150639|P2|NOT COMPLETED|Overall Study||1
888835|NCT01914926|2150640|P1|NOT COMPLETED|Overall Study||1
888836|NCT01914926|2150639|P2|COMPLETED|Overall Study||24
888837|NCT01914926|2150640|P1|COMPLETED|Overall Study||28
888838|NCT01914926|2150639|P2|STARTED|Overall Study||25
888839|NCT01914926|2150640|P1|STARTED|Overall Study||29
888840|NCT01915914|2150646|P4|NOT COMPLETED|Follow-up Phase||2
888841|NCT01915914|2150647|P3|NOT COMPLETED|Follow-up Phase||0
888842|NCT01915914|2150648|P2|NOT COMPLETED|Follow-up Phase||0
888843|NCT01915914|2150649|P1|NOT COMPLETED|Follow-up Phase||0
888844|NCT01915914|2150646|P4|COMPLETED|Follow-up Phase||64
888845|NCT01915914|2150647|P3|COMPLETED|Follow-up Phase||0
888846|NCT01915914|2150648|P2|COMPLETED|Follow-up Phase||0
888847|NCT01915914|2150649|P1|COMPLETED|Follow-up Phase||0
888848|NCT01915914|2150646|P4|STARTED|Follow-up Phase||66
888849|NCT01915914|2150647|P3|STARTED|Follow-up Phase||0
888850|NCT01915914|2150648|P2|STARTED|Follow-up Phase||0
888851|NCT01915914|2150649|P1|STARTED|Follow-up Phase||0
888852|NCT01915914|2150646|P4|NOT COMPLETED|Maintenance Phase||0
888853|NCT01915914|2150647|P3|NOT COMPLETED|Maintenance Phase||2
888854|NCT01915914|2150648|P2|NOT COMPLETED|Maintenance Phase||6
888855|NCT01915914|2150649|P1|NOT COMPLETED|Maintenance Phase||0
888856|NCT01915914|2150646|P4|COMPLETED|Maintenance Phase||0
888857|NCT01915914|2150647|P3|COMPLETED|Maintenance Phase||51
888858|NCT01915914|2150648|P2|COMPLETED|Maintenance Phase||48
888859|NCT01915914|2150649|P1|COMPLETED|Maintenance Phase||0
888860|NCT01915914|2150646|P4|STARTED|Maintenance Phase||0
888861|NCT01915914|2150647|P3|STARTED|Maintenance Phase||53
888862|NCT01915914|2150648|P2|STARTED|Maintenance Phase||54
888863|NCT01915914|2150649|P1|STARTED|Maintenance Phase||0
888864|NCT01915914|2150646|P4|NOT COMPLETED|Acute Phase||0
888865|NCT01915914|2150647|P3|NOT COMPLETED|Acute Phase||0
888866|NCT01915914|2150648|P2|NOT COMPLETED|Acute Phase||0
888867|NCT01915914|2150649|P1|NOT COMPLETED|Acute Phase||12
888868|NCT01915914|2150646|P4|COMPLETED|Acute Phase||0
888869|NCT01915914|2150647|P3|COMPLETED|Acute Phase||0
888870|NCT01915914|2150648|P2|COMPLETED|Acute Phase||0
888871|NCT01915914|2150649|P1|COMPLETED|Acute Phase||111
888872|NCT01915914|2150646|P4|Completed–Not Entered Maintenance Phase|Acute Phase||0
888873|NCT01915914|2150647|P3|Completed–Not Entered Maintenance Phase|Acute Phase||0
888874|NCT01915914|2150648|P2|Completed–Not Entered Maintenance Phase|Acute Phase||0
888875|NCT01915914|2150649|P1|Completed–Not Entered Maintenance Phase|Acute Phase||4
888876|NCT01915914|2150646|P4|STARTED|Acute Phase||0
888877|NCT01915914|2150647|P3|STARTED|Acute Phase||0
888878|NCT01915914|2150648|P2|STARTED|Acute Phase||0
888879|NCT01915914|2150649|P1|STARTED|Acute Phase||123
888880|NCT01915849|2150681|P4|NOT COMPLETED|Treatment Period 4 (4 Days)||0
888881|NCT01915849|2150682|P3|NOT COMPLETED|Treatment Period 4 (4 Days)||0
888882|NCT01915849|2150683|P2|NOT COMPLETED|Treatment Period 4 (4 Days)||0
888883|NCT01915849|2150684|P1|NOT COMPLETED|Treatment Period 4 (4 Days)||0
888884|NCT01915849|2150681|P4|COMPLETED|Treatment Period 4 (4 Days)||3
888885|NCT01915849|2150682|P3|COMPLETED|Treatment Period 4 (4 Days)||3
888886|NCT01915849|2150683|P2|COMPLETED|Treatment Period 4 (4 Days)||3
888887|NCT01915849|2150684|P1|COMPLETED|Treatment Period 4 (4 Days)||3
888888|NCT01915849|2150681|P4|STARTED|Treatment Period 4 (4 Days)||3
888889|NCT01915849|2150682|P3|STARTED|Treatment Period 4 (4 Days)||3
888890|NCT01915849|2150683|P2|STARTED|Treatment Period 4 (4 Days)||3
888891|NCT01915849|2150684|P1|STARTED|Treatment Period 4 (4 Days)||3
888892|NCT01915849|2150681|P4|NOT COMPLETED|Treatment Period 3 (4 Days)||0
888893|NCT01915849|2150682|P3|NOT COMPLETED|Treatment Period 3 (4 Days)||0
888894|NCT01915849|2150683|P2|NOT COMPLETED|Treatment Period 3 (4 Days)||0
888895|NCT01915849|2150684|P1|NOT COMPLETED|Treatment Period 3 (4 Days)||0
888896|NCT01915849|2150681|P4|COMPLETED|Treatment Period 3 (4 Days)||3
888897|NCT01915849|2150682|P3|COMPLETED|Treatment Period 3 (4 Days)||3
888898|NCT01915849|2150683|P2|COMPLETED|Treatment Period 3 (4 Days)||3
888899|NCT01915849|2150684|P1|COMPLETED|Treatment Period 3 (4 Days)||3
888900|NCT01915849|2150681|P4|STARTED|Treatment Period 3 (4 Days)||3
888901|NCT01915849|2150682|P3|STARTED|Treatment Period 3 (4 Days)||3
888902|NCT01915849|2150683|P2|STARTED|Treatment Period 3 (4 Days)||3
888903|NCT01915849|2150684|P1|STARTED|Treatment Period 3 (4 Days)||3
888904|NCT01915849|2150681|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
888905|NCT01915849|2150682|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
888906|NCT01915849|2150683|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
888907|NCT01915849|2150684|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
888908|NCT01915849|2150681|P4|COMPLETED|Treatment Period 2 (4 Days)||3
888909|NCT01915849|2150682|P3|COMPLETED|Treatment Period 2 (4 Days)||3
888910|NCT01915849|2150683|P2|COMPLETED|Treatment Period 2 (4 Days)||3
888911|NCT01915849|2150684|P1|COMPLETED|Treatment Period 2 (4 Days)||3
888912|NCT01915849|2150681|P4|STARTED|Treatment Period 2 (4 Days)||3
888913|NCT01915849|2150682|P3|STARTED|Treatment Period 2 (4 Days)||3
888914|NCT01915849|2150683|P2|STARTED|Treatment Period 2 (4 Days)||3
888915|NCT01915849|2150684|P1|STARTED|Treatment Period 2 (4 Days)||3
888916|NCT01915849|2150681|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
888917|NCT01915849|2150682|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
888918|NCT01915849|2150683|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
888919|NCT01915849|2150684|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||2
888920|NCT01915849|2150681|P4|COMPLETED|Treatment Period 1 (4 Days)||3
888921|NCT01915849|2150682|P3|COMPLETED|Treatment Period 1 (4 Days)||3
888922|NCT01915849|2150683|P2|COMPLETED|Treatment Period 1 (4 Days)||3
888923|NCT01915849|2150684|P1|COMPLETED|Treatment Period 1 (4 Days)||3
888924|NCT01915849|2150681|P4|STARTED|Treatment Period 1 (4 Days)||3
888925|NCT01915849|2150682|P3|STARTED|Treatment Period 1 (4 Days)||3
888926|NCT01915849|2150683|P2|STARTED|Treatment Period 1 (4 Days)||3
888927|NCT01915849|2150684|P1|STARTED|Treatment Period 1 (4 Days)||5
888928|NCT01915823|2150696|P2|NOT COMPLETED|Overall Study||2
888929|NCT01915823|2150697|P1|NOT COMPLETED|Overall Study||2
888930|NCT01915823|2150696|P2|COMPLETED|Overall Study||173
888931|NCT01915823|2150697|P1|COMPLETED|Overall Study||171
888932|NCT01915823|2150696|P2|STARTED|Overall Study||175
888933|NCT01915823|2150697|P1|STARTED|Overall Study||173
888934|NCT01915732|2150709|P2|NOT COMPLETED|Overall Study||71
888935|NCT01915732|2150710|P1|NOT COMPLETED|Overall Study||70
888936|NCT01915732|2150709|P2|COMPLETED|Overall Study||445
888937|NCT01915732|2150710|P1|COMPLETED|Overall Study||430
888938|NCT01915732|2150709|P2|STARTED|Overall Study||516
888939|NCT01915732|2150710|P1|STARTED|Overall Study||500
888940|NCT01915173|2150738|P4|NOT COMPLETED|Overall Study||0
888941|NCT01915173|2150739|P3|NOT COMPLETED|Overall Study||0
888942|NCT01915173|2150740|P2|NOT COMPLETED|Overall Study||0
888943|NCT01915173|2150741|P1|NOT COMPLETED|Overall Study||0
888944|NCT01915173|2150738|P4|COMPLETED|Overall Study||6
888945|NCT01915173|2150739|P3|COMPLETED|Overall Study||6
888946|NCT01915173|2150740|P2|COMPLETED|Overall Study||6
888947|NCT01915173|2150741|P1|COMPLETED|Overall Study||6
888948|NCT01915173|2150738|P4|STARTED|Overall Study||6
888949|NCT01915173|2150739|P3|STARTED|Overall Study||6
888950|NCT01915173|2150740|P2|STARTED|Overall Study||6
888951|NCT01915173|2150741|P1|STARTED|Overall Study||6
888952|NCT01915108|2150763|P4|NOT COMPLETED|Overall Study||2
888953|NCT01915108|2150764|P3|NOT COMPLETED|Overall Study||1
888954|NCT01915108|2150765|P2|NOT COMPLETED|Overall Study||3
888955|NCT01915108|2150766|P1|NOT COMPLETED|Overall Study||2
888956|NCT01915108|2150763|P4|COMPLETED|Overall Study|two patients were excluded from the study|30
888957|NCT01915108|2150764|P3|COMPLETED|Overall Study|one patients were excluded from the study|31
888958|NCT01915108|2150765|P2|COMPLETED|Overall Study|three patients were excluded from the study|29
888959|NCT01915108|2150766|P1|COMPLETED|Overall Study|two patients were excluded from the study|30
888960|NCT01915108|2150763|P4|STARTED|Overall Study||32
888961|NCT01915108|2150764|P3|STARTED|Overall Study||32
888962|NCT01915108|2150765|P2|STARTED|Overall Study||32
888963|NCT01915108|2150766|P1|STARTED|Overall Study||32
888964|NCT01914757|2150779|P3|NOT COMPLETED|Overall Study||38
888965|NCT01914757|2150780|P2|NOT COMPLETED|Overall Study||51
888966|NCT01914757|2150781|P1|NOT COMPLETED|Overall Study||36
888967|NCT01914757|2150779|P3|COMPLETED|Overall Study||402
888968|NCT01914757|2150780|P2|COMPLETED|Overall Study||390
888969|NCT01914757|2150781|P1|COMPLETED|Overall Study||389
888970|NCT01914757|2150779|P3|STARTED|Overall Study||440
888971|NCT01914757|2150780|P2|STARTED|Overall Study||441
888972|NCT01914757|2150781|P1|STARTED|Overall Study||425
888973|NCT01914679|2150855|P1|NOT COMPLETED|Overall Study||5
888974|NCT01914679|2150855|P1|COMPLETED|Overall Study||12
888975|NCT01914679|2150855|P1|Began 12 Week Actual RINCE Treatment|Overall Study||17
888976|NCT01914679|2150855|P1|STARTED|Overall Study||17
888977|NCT01914666|2150862|P3|NOT COMPLETED|Tapering Period||0
888978|NCT01914666|2150863|P2|NOT COMPLETED|Tapering Period||0
888979|NCT01914666|2150864|P1|NOT COMPLETED|Tapering Period||0
888980|NCT01914666|2150862|P3|COMPLETED|Tapering Period||40
888981|NCT01914666|2150863|P2|COMPLETED|Tapering Period||39
888982|NCT01914666|2150864|P1|COMPLETED|Tapering Period||59
888983|NCT01914666|2150862|P3|STARTED|Tapering Period|7 Pts who discontinued, and 33 Pts who completed Treatment Period entered Tapering Period.|40
888984|NCT01914666|2150863|P2|STARTED|Tapering Period|3 Pts who discontinued, and 36 Pts who completed Treatment Period entered Tapering Period.|39
888985|NCT01914666|2150864|P1|STARTED|Tapering Period|4 Pts who discontinued, and 55 Pts who completed Treatment Period entered Tapering Period.|59
888986|NCT01914666|2150862|P3|NOT COMPLETED|Treatment Period||8
888987|NCT01914666|2150863|P2|NOT COMPLETED|Treatment Period||6
888988|NCT01914666|2150864|P1|NOT COMPLETED|Treatment Period||13
888989|NCT01914666|2150862|P3|COMPLETED|Treatment Period||33
888990|NCT01914666|2150863|P2|COMPLETED|Treatment Period||36
888991|NCT01914666|2150864|P1|COMPLETED|Treatment Period||55
888992|NCT01914666|2150862|P3|Received at Least 1 Dose of Study Drug|Treatment Period||41
888993|NCT01914666|2150863|P2|Received at Least 1 Dose of Study Drug|Treatment Period||42
888994|NCT01914666|2150864|P1|Received at Least 1 Dose of Study Drug|Treatment Period||68
888995|NCT01914666|2150862|P3|STARTED|Treatment Period||41
888996|NCT01914666|2150863|P2|STARTED|Treatment Period||42
888997|NCT01914666|2150864|P1|STARTED|Treatment Period||68
888998|NCT01914003|2150899|P2|NOT COMPLETED|Overall Study||12
888999|NCT01914003|2150900|P1|NOT COMPLETED|Overall Study||8
889000|NCT01914003|2150899|P2|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|14
889001|NCT01914003|2150900|P1|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|19
889002|NCT01914003|2150899|P2|STARTED|Overall Study||26
889003|NCT01914003|2150900|P1|STARTED|Overall Study||27
889004|NCT01913795|2150910|P4|NOT COMPLETED|Overall Study||1
889005|NCT01913795|2150911|P3|NOT COMPLETED|Overall Study||0
889006|NCT01913795|2150912|P2|NOT COMPLETED|Overall Study||3
889007|NCT01913795|2150913|P1|NOT COMPLETED|Overall Study||0
889008|NCT01913795|2150910|P4|COMPLETED|Overall Study||5
889009|NCT01913795|2150911|P3|COMPLETED|Overall Study||9
889010|NCT01913795|2150912|P2|COMPLETED|Overall Study||7
889011|NCT01913795|2150913|P1|COMPLETED|Overall Study||4
889012|NCT01913795|2150910|P4|STARTED|Overall Study||6
889013|NCT01913795|2150911|P3|STARTED|Overall Study||9
889014|NCT01913795|2150912|P2|STARTED|Overall Study||10
889015|NCT01913795|2150913|P1|STARTED|Overall Study||4
889016|NCT01913535|2150932|P5|NOT COMPLETED|Phase 2 (Days 3-5)||0
889017|NCT01913535|2150933|P4|NOT COMPLETED|Phase 2 (Days 3-5)||0
889018|NCT01913535|2150934|P3|NOT COMPLETED|Phase 2 (Days 3-5)||0
889019|NCT01913535|2150935|P2|NOT COMPLETED|Phase 2 (Days 3-5)||0
889020|NCT01913535|2150936|P1|NOT COMPLETED|Phase 2 (Days 3-5)||0
889021|NCT01913535|2150932|P5|COMPLETED|Phase 2 (Days 3-5)||1
889022|NCT01913535|2150933|P4|COMPLETED|Phase 2 (Days 3-5)||2
889023|NCT01913535|2150934|P3|COMPLETED|Phase 2 (Days 3-5)||1
889024|NCT01913535|2150935|P2|COMPLETED|Phase 2 (Days 3-5)||2
889025|NCT01913535|2150936|P1|COMPLETED|Phase 2 (Days 3-5)||2
889026|NCT01913535|2150932|P5|STARTED|Phase 2 (Days 3-5)||1
889027|NCT01913535|2150933|P4|STARTED|Phase 2 (Days 3-5)||2
889028|NCT01913535|2150934|P3|STARTED|Phase 2 (Days 3-5)||1
889029|NCT01913535|2150935|P2|STARTED|Phase 2 (Days 3-5)||2
889030|NCT01913535|2150936|P1|STARTED|Phase 2 (Days 3-5)||2
889031|NCT01913535|2150932|P5|NOT COMPLETED|Phase 1 (Days 0-2)||0
889032|NCT01913535|2150933|P4|NOT COMPLETED|Phase 1 (Days 0-2)||0
889033|NCT01913535|2150934|P3|NOT COMPLETED|Phase 1 (Days 0-2)||0
889034|NCT01913535|2150935|P2|NOT COMPLETED|Phase 1 (Days 0-2)||0
889035|NCT01913535|2150936|P1|NOT COMPLETED|Phase 1 (Days 0-2)||0
889036|NCT01913535|2150932|P5|COMPLETED|Phase 1 (Days 0-2)||1
889037|NCT01913535|2150933|P4|COMPLETED|Phase 1 (Days 0-2)||2
889038|NCT01913535|2150934|P3|COMPLETED|Phase 1 (Days 0-2)||1
889039|NCT01913535|2150935|P2|COMPLETED|Phase 1 (Days 0-2)||2
889040|NCT01913535|2150936|P1|COMPLETED|Phase 1 (Days 0-2)||2
889041|NCT01913535|2150932|P5|STARTED|Phase 1 (Days 0-2)||1
889042|NCT01913535|2150933|P4|STARTED|Phase 1 (Days 0-2)||2
889043|NCT01913535|2150934|P3|STARTED|Phase 1 (Days 0-2)||1
889044|NCT01913535|2150935|P2|STARTED|Phase 1 (Days 0-2)||2
889045|NCT01913535|2150936|P1|STARTED|Phase 1 (Days 0-2)||2
889046|NCT01913483|2150969|P2|NOT COMPLETED|Overall Study||22
889047|NCT01913483|2150970|P1|NOT COMPLETED|Overall Study||21
889048|NCT01913483|2150969|P2|COMPLETED|Overall Study||343
889049|NCT01913483|2150970|P1|COMPLETED|Overall Study||346
889050|NCT01913483|2150969|P2|Received at Least 1 Dose of Study Drug|Overall Study||321
889051|NCT01913483|2150970|P1|Received at Least 1 Dose of Study Drug|Overall Study||335
889052|NCT01913483|2150969|P2|STARTED|Overall Study||365
889053|NCT01913483|2150970|P1|STARTED|Overall Study||367
889054|NCT01913470|2150982|P2|NOT COMPLETED|Overall Study||3
889055|NCT01913470|2150983|P1|NOT COMPLETED|Overall Study||0
889056|NCT01913470|2150982|P2|COMPLETED|Overall Study||4
889057|NCT01913470|2150983|P1|COMPLETED|Overall Study||5
889058|NCT01913470|2150982|P2|STARTED|Overall Study||7
889059|NCT01913470|2150983|P1|STARTED|Overall Study||5
889060|NCT01913041|2151001|P1|NOT COMPLETED|Overall Study||39
889061|NCT01913041|2151001|P1|COMPLETED|Overall Study||830
889062|NCT01913041|2151001|P1|STARTED|Overall Study||869
889063|NCT01912781|2151007|P2|NOT COMPLETED|Overall Study||0
889064|NCT01912781|2151008|P1|NOT COMPLETED|Overall Study||2
889065|NCT01912781|2151007|P2|COMPLETED|Overall Study||35
889066|NCT01912781|2151008|P1|COMPLETED|Overall Study||69
889067|NCT01912781|2151007|P2|STARTED|Overall Study||35
889068|NCT01912781|2151008|P1|STARTED|Overall Study||71
889069|NCT01912768|2151039|P2|NOT COMPLETED|Overall Study||4
889070|NCT01912768|2151040|P1|NOT COMPLETED|Overall Study||10
889071|NCT01912768|2151039|P2|COMPLETED|Overall Study||109
889072|NCT01912768|2151040|P1|COMPLETED|Overall Study||229
889073|NCT01912768|2151039|P2|STARTED|Overall Study||113
889074|NCT01912768|2151040|P1|STARTED|Overall Study||239
889075|NCT01912599|2151071|P2|NOT COMPLETED|Overall Study||1
889076|NCT01912599|2151072|P1|NOT COMPLETED|Overall Study||0
889077|NCT01912599|2151071|P2|COMPLETED|Overall Study||15
889078|NCT01912599|2151072|P1|COMPLETED|Overall Study||20
889079|NCT01912599|2151071|P2|STARTED|Overall Study||16
889080|NCT01912599|2151072|P1|STARTED|Overall Study||20
889081|NCT01912495|2151086|P1|NOT COMPLETED|Overall Study||0
889082|NCT01912495|2151086|P1|COMPLETED|Overall Study||57
889083|NCT01912495|2151086|P1|STARTED|Overall Study|8 patients had only screening visit, total enrollment: 65|57
889084|NCT01912404|2151097|P2|NOT COMPLETED|Overall Study||0
889085|NCT01912404|2151098|P1|NOT COMPLETED|Overall Study||1
889086|NCT01912404|2151097|P2|COMPLETED|Overall Study||2
889087|NCT01912404|2151098|P1|COMPLETED|Overall Study||2
889088|NCT01912404|2151097|P2|STARTED|Overall Study||2
889089|NCT01912404|2151098|P1|STARTED|Overall Study||3
889090|NCT01912352|2151104|P1|NOT COMPLETED|Overall Study||5
889091|NCT01912352|2151104|P1|COMPLETED|Overall Study||78
889092|NCT01912352|2151104|P1|STARTED|Overall Study||83
889093|NCT01912339|2151111|P3|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||53
889094|NCT01912339|2151112|P2|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
889095|NCT01912339|2151113|P1|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||133
889096|NCT01912339|2151111|P3|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
889097|NCT01912339|2151112|P2|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
889098|NCT01912339|2151113|P1|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
889099|NCT01912339|2151111|P3|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|Control subjects that have crossed over.|53
889100|NCT01912339|2151112|P2|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|All subjects for the control group either completed study or crossed over.|0
889101|NCT01912339|2151113|P1|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)||133
889102|NCT01912339|2151111|P3|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
889103|NCT01912339|2151112|P2|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
889104|NCT01912339|2151113|P1|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||1
889105|NCT01912339|2151111|P3|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|0
889106|NCT01912339|2151112|P2|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Of the 61 subjects, there were 53 crossover subjects and 8 that completed their study participation.|61
889107|NCT01912339|2151113|P1|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|133
889108|NCT01912339|2151111|P3|STARTED|Unblinded (3 to 6 Months/Crossover)||0
889109|NCT01912339|2151112|P2|STARTED|Unblinded (3 to 6 Months/Crossover)||61
889110|NCT01912339|2151113|P1|STARTED|Unblinded (3 to 6 Months/Crossover)||134
889111|NCT01912339|2151111|P3|NOT COMPLETED|Blinded (0 to 3 Months)||0
889112|NCT01912339|2151112|P2|NOT COMPLETED|Blinded (0 to 3 Months)||0
889113|NCT01912339|2151113|P1|NOT COMPLETED|Blinded (0 to 3 Months)||2
889114|NCT01912339|2151111|P3|COMPLETED|Blinded (0 to 3 Months)||0
889115|NCT01912339|2151112|P2|COMPLETED|Blinded (0 to 3 Months)||61
889116|NCT01912339|2151113|P1|COMPLETED|Blinded (0 to 3 Months)||134
889117|NCT01912339|2151111|P3|STARTED|Blinded (0 to 3 Months)||0
889118|NCT01912339|2151112|P2|STARTED|Blinded (0 to 3 Months)||61
889119|NCT01912339|2151113|P1|STARTED|Blinded (0 to 3 Months)||136
889120|NCT01912222|2151130|P3|NOT COMPLETED|Part B: Treatment Period||20
889121|NCT01912222|2151131|P2|NOT COMPLETED|Part B: Treatment Period||15
889122|NCT01912222|2151132|P1|NOT COMPLETED|Part B: Treatment Period||13
889123|NCT01912222|2151130|P3|COMPLETED|Part B: Treatment Period||0
889124|NCT01912222|2151131|P2|COMPLETED|Part B: Treatment Period||0
889125|NCT01912222|2151132|P1|COMPLETED|Part B: Treatment Period||0
889126|NCT01912222|2151130|P3|STARTED|Part B: Treatment Period||20
889127|NCT01912222|2151131|P2|STARTED|Part B: Treatment Period||15
889128|NCT01912222|2151132|P1|STARTED|Part B: Treatment Period||13
889129|NCT01912222|2151130|P3|NOT COMPLETED|Part A: Pharmacokinetic Period||2
889130|NCT01912222|2151131|P2|NOT COMPLETED|Part A: Pharmacokinetic Period||2
889131|NCT01912222|2151132|P1|NOT COMPLETED|Part A: Pharmacokinetic Period||1
889132|NCT01912222|2151130|P3|COMPLETED|Part A: Pharmacokinetic Period||18
889133|NCT01912222|2151131|P2|COMPLETED|Part A: Pharmacokinetic Period||13
889134|NCT01912222|2151132|P1|COMPLETED|Part A: Pharmacokinetic Period||12
889135|NCT01912222|2151130|P3|STARTED|Part A: Pharmacokinetic Period||20
889136|NCT01912222|2151131|P2|STARTED|Part A: Pharmacokinetic Period||15
889137|NCT01912222|2151132|P1|STARTED|Part A: Pharmacokinetic Period||13
889138|NCT01911845|2151155|P1|NOT COMPLETED|Overall Study||6
889139|NCT01911845|2151155|P1|COMPLETED|Overall Study||32
889140|NCT01911845|2151155|P1|Completed Study Drug|Overall Study||37
889141|NCT01911845|2151155|P1|STARTED|Overall Study||38
889142|NCT01911793|2151171|P2|NOT COMPLETED|Overall Study||5
889143|NCT01911793|2151172|P1|NOT COMPLETED|Overall Study||1
889144|NCT01911793|2151171|P2|COMPLETED|Overall Study||0
889145|NCT01911793|2151172|P1|COMPLETED|Overall Study||0
889146|NCT01911793|2151171|P2|STARTED|Overall Study||5
889147|NCT01911793|2151172|P1|STARTED|Overall Study||1
889148|NCT01911780|2151194|P2|NOT COMPLETED|Extension Period (52 Weeks)||3
889149|NCT01911780|2151195|P1|NOT COMPLETED|Extension Period (52 Weeks)||4
889150|NCT01911780|2151194|P2|COMPLETED|Extension Period (52 Weeks)||58
889151|NCT01911780|2151195|P1|COMPLETED|Extension Period (52 Weeks)||61
889152|NCT01911780|2151194|P2|STARTED|Extension Period (52 Weeks)||61
889153|NCT01911780|2151195|P1|STARTED|Extension Period (52 Weeks)||65
889154|NCT01911780|2151194|P2|NOT COMPLETED|Double-blind Period (8 Weeks)||3
889155|NCT01911780|2151195|P1|NOT COMPLETED|Double-blind Period (8 Weeks)||3
889156|NCT01911780|2151194|P2|COMPLETED|Double-blind Period (8 Weeks)||61
889157|NCT01911780|2151195|P1|COMPLETED|Double-blind Period (8 Weeks)||65
889158|NCT01911780|2151194|P2|STARTED|Double-blind Period (8 Weeks)||64
889159|NCT01911780|2151195|P1|STARTED|Double-blind Period (8 Weeks)||68
889160|NCT01911689|2151215|P2|NOT COMPLETED|Overall Study||0
889161|NCT01911689|2151216|P1|NOT COMPLETED|Overall Study||0
889162|NCT01911689|2151215|P2|COMPLETED|Overall Study||51
889163|NCT01911689|2151216|P1|COMPLETED|Overall Study||117
889164|NCT01911689|2151215|P2|STARTED|Overall Study||51
889165|NCT01911689|2151216|P1|STARTED|Overall Study||117
889166|NCT01911442|2151232|P3|NOT COMPLETED|Overall Study||12
889167|NCT01911442|2151233|P2|NOT COMPLETED|Overall Study||4
889168|NCT01911442|2151234|P1|NOT COMPLETED|Overall Study||6
889169|NCT01911442|2151232|P3|COMPLETED|Overall Study||38
889170|NCT01911442|2151233|P2|COMPLETED|Overall Study||47
889171|NCT01911442|2151234|P1|COMPLETED|Overall Study||43
889172|NCT01911442|2151232|P3|STARTED|Overall Study||50
889173|NCT01911442|2151233|P2|STARTED|Overall Study||51
889174|NCT01911442|2151234|P1|STARTED|Overall Study||49
889175|NCT01911429|2151263|P3|NOT COMPLETED|Overall Study||20
889176|NCT01911429|2151264|P2|NOT COMPLETED|Overall Study||10
889177|NCT01911429|2151265|P1|NOT COMPLETED|Overall Study||12
889178|NCT01911429|2151263|P3|COMPLETED|Overall Study||93
889179|NCT01911429|2151264|P2|COMPLETED|Overall Study||96
889180|NCT01911429|2151265|P1|COMPLETED|Overall Study||96
889181|NCT01911429|2151263|P3|STARTED|Overall Study|one subject randomized to Placebo group was never dosed for study medication, making the total 112|113
889182|NCT01911429|2151264|P2|STARTED|Overall Study|Subjects received lurasidone 40/mg day from Days 1-3, and 80mg/day from days 4 to Week 6 visit|106
889183|NCT01911429|2151265|P1|STARTED|Overall Study||108
889184|NCT01911403|2151299|P2|NOT COMPLETED|Overall Study||3
889185|NCT01911403|2151300|P1|NOT COMPLETED|Overall Study||9
889186|NCT01911403|2151299|P2|COMPLETED|Overall Study||59
889187|NCT01911403|2151300|P1|COMPLETED|Overall Study||52
889188|NCT01911403|2151299|P2|STARTED|Overall Study||62
889189|NCT01911403|2151300|P1|STARTED|Overall Study||61
889190|NCT01911390|2151321|P4|NOT COMPLETED|Overall Study||1
889191|NCT01911390|2151322|P3|NOT COMPLETED|Overall Study||1
889192|NCT01911390|2151323|P2|NOT COMPLETED|Overall Study||0
889193|NCT01911390|2151324|P1|NOT COMPLETED|Overall Study||1
889194|NCT01911390|2151321|P4|COMPLETED|Overall Study||10
889195|NCT01911390|2151322|P3|COMPLETED|Overall Study||9
889196|NCT01911390|2151323|P2|COMPLETED|Overall Study||10
889197|NCT01911390|2151324|P1|COMPLETED|Overall Study||9
889198|NCT01911390|2151321|P4|STARTED|Overall Study||11
889199|NCT01911390|2151322|P3|STARTED|Overall Study||10
889200|NCT01911390|2151323|P2|STARTED|Overall Study||10
889201|NCT01911390|2151324|P1|STARTED|Overall Study||10
889202|NCT01911351|2151340|P2|NOT COMPLETED|Overall Study||0
889203|NCT01911351|2151341|P1|NOT COMPLETED|Overall Study||0
889204|NCT01911351|2151340|P2|COMPLETED|Overall Study||43
889205|NCT01911351|2151341|P1|COMPLETED|Overall Study||39
889206|NCT01911351|2151340|P2|STARTED|Overall Study||43
889207|NCT01911351|2151341|P1|STARTED|Overall Study||39
889208|NCT01911273|2151357|P2|NOT COMPLETED|Overall Study||2
889209|NCT01911273|2151358|P1|NOT COMPLETED|Overall Study||1
889210|NCT01911273|2151357|P2|COMPLETED|Overall Study||0
889211|NCT01911273|2151358|P1|COMPLETED|Overall Study||0
889212|NCT01911273|2151357|P2|STARTED|Overall Study||2
889213|NCT01911273|2151358|P1|STARTED|Overall Study||1
889214|NCT01911260|2151392|P4|NOT COMPLETED|Follow-up Period||12
889215|NCT01911260|2151393|P3|NOT COMPLETED|Follow-up Period||15
889216|NCT01911260|2151394|P2|NOT COMPLETED|Follow-up Period||20
889217|NCT01911260|2151395|P1|NOT COMPLETED|Follow-up Period||13
889218|NCT01911260|2151392|P4|COMPLETED|Follow-up Period||30
889219|NCT01911260|2151393|P3|COMPLETED|Follow-up Period||24
889220|NCT01911260|2151394|P2|COMPLETED|Follow-up Period||18
889221|NCT01911260|2151395|P1|COMPLETED|Follow-up Period||27
889222|NCT01911260|2151392|P4|STARTED|Follow-up Period||42
889223|NCT01911260|2151393|P3|STARTED|Follow-up Period||39
889224|NCT01911260|2151394|P2|STARTED|Follow-up Period||38
889225|NCT01911260|2151395|P1|STARTED|Follow-up Period||40
889226|NCT01911260|2151392|P4|NOT COMPLETED|Supplementation Period||8
889227|NCT01911260|2151393|P3|NOT COMPLETED|Supplementation Period||10
889228|NCT01911260|2151394|P2|NOT COMPLETED|Supplementation Period||12
889229|NCT01911260|2151395|P1|NOT COMPLETED|Supplementation Period||10
889230|NCT01911260|2151392|P4|COMPLETED|Supplementation Period||42
889231|NCT01911260|2151393|P3|COMPLETED|Supplementation Period||39
889232|NCT01911260|2151394|P2|COMPLETED|Supplementation Period||38
889233|NCT01911260|2151395|P1|COMPLETED|Supplementation Period||40
889234|NCT01911260|2151392|P4|STARTED|Supplementation Period||50
889235|NCT01911260|2151393|P3|STARTED|Supplementation Period||49
889236|NCT01911260|2151394|P2|STARTED|Supplementation Period||50
889237|NCT01911260|2151395|P1|STARTED|Supplementation Period||50
889238|NCT01911221|2151405|P1|NOT COMPLETED|Overall Study||0
889239|NCT01911221|2151405|P1|COMPLETED|Overall Study||13
889240|NCT01911221|2151405|P1|STARTED|Overall Study||13
889241|NCT01911065|2151421|P2|NOT COMPLETED|Overall Study||0
889242|NCT01911065|2151422|P1|NOT COMPLETED|Overall Study||0
889243|NCT01911065|2151421|P2|COMPLETED|Overall Study||9
889244|NCT01911065|2151422|P1|COMPLETED|Overall Study||45
889245|NCT01911065|2151421|P2|STARTED|Overall Study||9
889246|NCT01911065|2151422|P1|STARTED|Overall Study||45
889247|NCT01910831|2151430|P1|NOT COMPLETED|Overall Study||1
889248|NCT01910831|2151430|P1|COMPLETED|Overall Study||19
889249|NCT01910831|2151430|P1|STARTED|Overall Study||20
889250|NCT01910792|2151439|P2|NOT COMPLETED|Overall Study||0
889251|NCT01910792|2151440|P1|NOT COMPLETED|Overall Study||0
889252|NCT01910792|2151439|P2|COMPLETED|Overall Study||10
889253|NCT01910792|2151440|P1|COMPLETED|Overall Study||9
889254|NCT01910792|2151439|P2|STARTED|Overall Study||10
889255|NCT01910792|2151440|P1|STARTED|Overall Study||9
889256|NCT01910688|2151446|P1|NOT COMPLETED|Overall Study||5
889257|NCT01910688|2151446|P1|COMPLETED|Overall Study||20
889258|NCT01910688|2151446|P1|12months|Overall Study||22
889259|NCT01910688|2151446|P1|3rd RFA Treatment|Overall Study||18
889260|NCT01910688|2151446|P1|7.5months|Overall Study||24
889261|NCT01910688|2151446|P1|2nd RFA Treatment|Overall Study||22
889262|NCT01910688|2151446|P1|3.5month|Overall Study||25
889263|NCT01910688|2151446|P1|STARTED|Overall Study||25
889264|NCT01910636|2151455|P2|NOT COMPLETED|Overall Study||0
889265|NCT01910636|2151456|P1|NOT COMPLETED|Overall Study||0
889266|NCT01910636|2151455|P2|COMPLETED|Overall Study||63
889267|NCT01910636|2151456|P1|COMPLETED|Overall Study||90
889268|NCT01910636|2151455|P2|STARTED|Overall Study||63
889269|NCT01910636|2151456|P1|STARTED|Overall Study||90
889270|NCT01910441|2151470|P2|NOT COMPLETED|Overall Study||10
889271|NCT01910441|2151471|P1|NOT COMPLETED|Overall Study||7
889272|NCT01910441|2151470|P2|COMPLETED|Overall Study||37
889273|NCT01910441|2151471|P1|COMPLETED|Overall Study||41
889274|NCT01910441|2151470|P2|STARTED|Overall Study||47
889275|NCT01910441|2151471|P1|STARTED|Overall Study||48
889276|NCT01910402|2151479|P2|NOT COMPLETED|Continuation Phase||0
889277|NCT01910402|2151480|P1|NOT COMPLETED|Continuation Phase||90
889278|NCT01910402|2151479|P2|COMPLETED|Continuation Phase||0
889279|NCT01910402|2151480|P1|COMPLETED|Continuation Phase||30
889280|NCT01910402|2151479|P2|STARTED|Continuation Phase||0
889281|NCT01910402|2151480|P1|STARTED|Continuation Phase||120
889282|NCT01910402|2151479|P2|NOT COMPLETED|Randomized Phase||55
889283|NCT01910402|2151480|P1|NOT COMPLETED|Randomized Phase||42
889284|NCT01910402|2151479|P2|COMPLETED|Randomized Phase||192
889285|NCT01910402|2151480|P1|COMPLETED|Randomized Phase||206
889286|NCT01910402|2151479|P2|STARTED|Randomized Phase||247
889287|NCT01910402|2151480|P1|STARTED|Randomized Phase||248
889288|NCT01910389|2151550|P2|NOT COMPLETED|Overall Study||8
889289|NCT01910389|2151551|P1|NOT COMPLETED|Overall Study||15
889290|NCT01910389|2151550|P2|COMPLETED|Overall Study||0
889291|NCT01910389|2151551|P1|COMPLETED|Overall Study||0
889292|NCT01910389|2151550|P2|STARTED|Overall Study||8
889293|NCT01910389|2151551|P1|STARTED|Overall Study||15
889294|NCT01910311|2151581|P1|NOT COMPLETED|Period 2 (Days 3-32)||0
889295|NCT01910311|2151581|P1|COMPLETED|Period 2 (Days 3-32)||18
889296|NCT01910311|2151581|P1|Received At Least 1 Dose of Rifampicin|Period 2 (Days 3-32)||18
889297|NCT01910311|2151581|P1|Received Baricitinib|Period 2 (Days 3-32)||18
889298|NCT01910311|2151581|P1|STARTED|Period 2 (Days 3-32)||18
889299|NCT01910311|2151581|P1|NOT COMPLETED|Period 1 (Days 1-2)||0
889300|NCT01910311|2151581|P1|COMPLETED|Period 1 (Days 1-2)||18
889301|NCT01910311|2151581|P1|Received Baricitinib|Period 1 (Days 1-2)||18
889302|NCT01910311|2151581|P1|STARTED|Period 1 (Days 1-2)||18
889303|NCT01910181|2151592|P1|NOT COMPLETED|Overall Study||46
889304|NCT01910181|2151592|P1|COMPLETED|Overall Study||0
889305|NCT01910181|2151592|P1|Expansion Cohort|Overall Study||26
889306|NCT01910181|2151592|P1|PK Cohort|Overall Study||20
889307|NCT01910181|2151592|P1|STARTED|Overall Study||46
889308|NCT01910116|2151619|P2|NOT COMPLETED|Overall Study||16
889309|NCT01910116|2151620|P1|NOT COMPLETED|Overall Study||14
889310|NCT01910116|2151619|P2|COMPLETED|Overall Study||94
889311|NCT01910116|2151620|P1|COMPLETED|Overall Study||96
889312|NCT01910116|2151619|P2|Week 16|Overall Study||94
889313|NCT01910116|2151620|P1|Week 16|Overall Study||96
889314|NCT01910116|2151619|P2|Week 12|Overall Study||96
889315|NCT01910116|2151620|P1|Week 12|Overall Study||97
889316|NCT01910116|2151619|P2|Week 8|Overall Study||99
889317|NCT01910116|2151620|P1|Week 8|Overall Study||98
889318|NCT01910116|2151619|P2|Week 4|Overall Study||102
889319|NCT01910116|2151620|P1|Week 4|Overall Study||106
889320|NCT01910116|2151619|P2|STARTED|Overall Study||110
889321|NCT01910116|2151620|P1|STARTED|Overall Study||110
889322|NCT01910064|2151696|P1|NOT COMPLETED|Overall Study||45
889323|NCT01910064|2151696|P1|COMPLETED|Overall Study||391
889324|NCT01910064|2151696|P1|STARTED|Overall Study||436
889325|NCT01909804|2151717|P12|NOT COMPLETED|Overall Study||3
889326|NCT01909804|2151718|P11|NOT COMPLETED|Overall Study||1
889327|NCT01909804|2151719|P10|NOT COMPLETED|Overall Study||1
889328|NCT01909804|2151720|P9|NOT COMPLETED|Overall Study||0
889329|NCT01909804|2151721|P8|NOT COMPLETED|Overall Study||1
889330|NCT01909804|2151722|P7|NOT COMPLETED|Overall Study||2
889331|NCT01909804|2151723|P6|NOT COMPLETED|Overall Study||4
889332|NCT01909804|2151724|P5|NOT COMPLETED|Overall Study||8
889333|NCT01909804|2151725|P4|NOT COMPLETED|Overall Study||0
889334|NCT01909804|2151726|P3|NOT COMPLETED|Overall Study||0
889335|NCT01909804|2151727|P2|NOT COMPLETED|Overall Study||1
889336|NCT01909804|2151728|P1|NOT COMPLETED|Overall Study||4
889337|NCT01909804|2151717|P12|COMPLETED|Overall Study||26
889338|NCT01909804|2151718|P11|COMPLETED|Overall Study||26
889339|NCT01909804|2151719|P10|COMPLETED|Overall Study||28
889340|NCT01909804|2151720|P9|COMPLETED|Overall Study||27
889341|NCT01909804|2151721|P8|COMPLETED|Overall Study||25
889342|NCT01909804|2151722|P7|COMPLETED|Overall Study||25
889343|NCT01909804|2151723|P6|COMPLETED|Overall Study||21
889344|NCT01909804|2151724|P5|COMPLETED|Overall Study||18
889345|NCT01909804|2151725|P4|COMPLETED|Overall Study||26
889346|NCT01909804|2151726|P3|COMPLETED|Overall Study||27
889347|NCT01909804|2151727|P2|COMPLETED|Overall Study||27
889348|NCT01909804|2151728|P1|COMPLETED|Overall Study||22
889349|NCT01909804|2151717|P12|STARTED|Overall Study||29
889350|NCT01909804|2151718|P11|STARTED|Overall Study||27
889351|NCT01909804|2151719|P10|STARTED|Overall Study||29
889352|NCT01909804|2151720|P9|STARTED|Overall Study||27
889353|NCT01909804|2151721|P8|STARTED|Overall Study||26
889354|NCT01909804|2151722|P7|STARTED|Overall Study||27
889355|NCT01909804|2151723|P6|STARTED|Overall Study||25
889356|NCT01909804|2151724|P5|STARTED|Overall Study||26
889357|NCT01909804|2151725|P4|STARTED|Overall Study||26
889358|NCT01909804|2151726|P3|STARTED|Overall Study||27
889359|NCT01909804|2151727|P2|STARTED|Overall Study||28
889360|NCT01909804|2151728|P1|STARTED|Overall Study||26
889361|NCT01909778|2151774|P1|NOT COMPLETED|Overall Study||1
889362|NCT01909778|2151774|P1|COMPLETED|Overall Study||1
889363|NCT01909778|2151774|P1|STARTED|Overall Study||2
889364|NCT01909713|2151798|P1|NOT COMPLETED|Overall Study||0
889365|NCT01909713|2151798|P1|COMPLETED|Overall Study||35
889366|NCT01909713|2151798|P1|STARTED|Overall Study||35
889367|NCT01909674|2151853|P2|NOT COMPLETED|Overall Study||2
889368|NCT01909674|2151854|P1|NOT COMPLETED|Overall Study||5
889369|NCT01909674|2151853|P2|COMPLETED|Overall Study||7
889370|NCT01909674|2151854|P1|COMPLETED|Overall Study||7
889371|NCT01909674|2151853|P2|STARTED|Overall Study||9
889372|NCT01909674|2151854|P1|STARTED|Overall Study||12
889373|NCT01909570|2151862|P2|NOT COMPLETED|Overall Study||27
889374|NCT01909570|2151863|P1|NOT COMPLETED|Overall Study||27
889375|NCT01909570|2151862|P2|COMPLETED|Overall Study||64
889376|NCT01909570|2151863|P1|COMPLETED|Overall Study||57
889377|NCT01909570|2151862|P2|STARTED|Overall Study||91
889378|NCT01909570|2151863|P1|STARTED|Overall Study||84
889379|NCT01909466|2151873|P2|NOT COMPLETED|Overall Study||23
889380|NCT01909466|2151874|P1|NOT COMPLETED|Overall Study||22
889381|NCT01909466|2151873|P2|COMPLETED|Overall Study||50
889382|NCT01909466|2151874|P1|COMPLETED|Overall Study||46
889383|NCT01909466|2151873|P2|STARTED|Overall Study||73
889384|NCT01909466|2151874|P1|STARTED|Overall Study||68
889385|NCT01909336|2151897|P3|NOT COMPLETED|Overall Study||3
889386|NCT01909336|2151898|P2|NOT COMPLETED|Overall Study||3
889387|NCT01909336|2151899|P1|NOT COMPLETED|Overall Study||4
889388|NCT01909336|2151897|P3|COMPLETED|Overall Study||52
889389|NCT01909336|2151898|P2|COMPLETED|Overall Study||50
889390|NCT01909336|2151899|P1|COMPLETED|Overall Study||49
889391|NCT01909336|2151897|P3|STARTED|Overall Study||55
889392|NCT01909336|2151898|P2|STARTED|Overall Study||53
889393|NCT01909336|2151899|P1|STARTED|Overall Study||53
889394|NCT01909180|2151913|P1|NOT COMPLETED|Overall Study||0
889395|NCT01909180|2151913|P1|COMPLETED|Overall Study||49
889396|NCT01909180|2151913|P1|STARTED|Overall Study||49
889397|NCT01909141|2151921|P2|NOT COMPLETED|Overall Study||0
889398|NCT01909141|2151922|P1|NOT COMPLETED|Overall Study||0
889399|NCT01909141|2151921|P2|COMPLETED|Overall Study||50
889400|NCT01909141|2151922|P1|COMPLETED|Overall Study||50
889401|NCT01909141|2151921|P2|STARTED|Overall Study||50
889402|NCT01909141|2151922|P1|STARTED|Overall Study||50
889403|NCT01909011|2151938|P2|NOT COMPLETED|Overall Study||0
889404|NCT01909011|2151939|P1|NOT COMPLETED|Overall Study||0
889405|NCT01909011|2151938|P2|COMPLETED|Overall Study||9
889406|NCT01909011|2151939|P1|COMPLETED|Overall Study||7
889407|NCT01909011|2151938|P2|STARTED|Overall Study||9
889408|NCT01909011|2151939|P1|STARTED|Overall Study||7
889409|NCT01908842|2151951|P2|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||17
889410|NCT01908842|2151952|P1|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||25
889411|NCT01908842|2151951|P2|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
889412|NCT01908842|2151952|P1|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
889413|NCT01908842|2151951|P2|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||279
889414|NCT01908842|2151952|P1|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||287
889415|NCT01908842|2151951|P2|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||65
889416|NCT01908842|2151952|P1|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||70
889417|NCT01908842|2151951|P2|COMPLETED|Switch to Other BNX Formulation (Day 15)||279
889418|NCT01908842|2151952|P1|COMPLETED|Switch to Other BNX Formulation (Day 15)||287
889419|NCT01908842|2151951|P2|STARTED|Switch to Other BNX Formulation (Day 15)||344
889420|NCT01908842|2151952|P1|STARTED|Switch to Other BNX Formulation (Day 15)||357
889421|NCT01908842|2151951|P2|NOT COMPLETED|Induction||31
889422|NCT01908842|2151952|P1|NOT COMPLETED|Induction||26
889423|NCT01908842|2151951|P2|COMPLETED|Induction||344
889424|NCT01908842|2151952|P1|COMPLETED|Induction||357
889425|NCT01908842|2151951|P2|STARTED|Induction||375
889426|NCT01908842|2151952|P1|STARTED|Induction||383
889439|NCT01908803|2152090|P2|NOT COMPLETED|Overall Study||1
889440|NCT01908803|2152091|P1|NOT COMPLETED|Overall Study||4
889441|NCT01908803|2152090|P2|COMPLETED|Overall Study||23
889442|NCT01908803|2152091|P1|COMPLETED|Overall Study||42
889443|NCT01908803|2152090|P2|Treated|Overall Study||24
889444|NCT01908803|2152091|P1|Treated|Overall Study|Two randomized subjects discontinued prior to receiving investigational product.|44
889445|NCT01908803|2152090|P2|STARTED|Overall Study||24
889446|NCT01908803|2152091|P1|STARTED|Overall Study||46
889447|NCT01908140|2152104|P2|NOT COMPLETED|Overall Study||79
889448|NCT01908140|2152105|P1|NOT COMPLETED|Overall Study||66
889449|NCT01908140|2152104|P2|COMPLETED|Overall Study||386
889450|NCT01908140|2152105|P1|COMPLETED|Overall Study||402
889451|NCT01908140|2152104|P2|STARTED|Overall Study||465
889452|NCT01908140|2152105|P1|STARTED|Overall Study||468
889453|NCT01908127|2152115|P2|NOT COMPLETED|Overall Study||0
889454|NCT01908127|2152116|P1|NOT COMPLETED|Overall Study||1
889455|NCT01908127|2152115|P2|COMPLETED|Overall Study||23
889456|NCT01908127|2152116|P1|COMPLETED|Overall Study||22
889457|NCT01908127|2152115|P2|STARTED|Overall Study||23
889458|NCT01908127|2152116|P1|STARTED|Overall Study||23
889459|NCT01907906|2152126|P2|NOT COMPLETED|Overall Study||1
889460|NCT01907906|2152127|P1|NOT COMPLETED|Overall Study||4
889461|NCT01907906|2152126|P2|COMPLETED|Overall Study||12
889462|NCT01907906|2152127|P1|COMPLETED|Overall Study||12
889463|NCT01907906|2152126|P2|STARTED|Overall Study||13
889464|NCT01907906|2152127|P1|STARTED|Overall Study||16
889465|NCT01907854|2152207|P2|NOT COMPLETED|Overall Study||13
889466|NCT01907854|2152208|P1|NOT COMPLETED|Overall Study||16
889467|NCT01907854|2152207|P2|COMPLETED|Overall Study||191
889468|NCT01907854|2152208|P1|COMPLETED|Overall Study||187
889469|NCT01907854|2152207|P2|Exposed|Overall Study||204
889470|NCT01907854|2152208|P1|Exposed|Overall Study|One subject in lira arm was not exposed (Reason: withdrawal by subject)|202
889471|NCT01907854|2152207|P2|STARTED|Overall Study||204
889472|NCT01907854|2152208|P1|STARTED|Overall Study||203
889473|NCT01907516|2152228|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
889474|NCT01907516|2152229|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
889475|NCT01907516|2152228|P2|COMPLETED|Second Intervention (3 Weeks)||34
889476|NCT01907516|2152229|P1|COMPLETED|Second Intervention (3 Weeks)||40
889477|NCT01907516|2152228|P2|STARTED|Second Intervention (3 Weeks)||34
889478|NCT01907516|2152229|P1|STARTED|Second Intervention (3 Weeks)||40
889479|NCT01907516|2152228|P2|NOT COMPLETED|First Intervention (3 Weeks)||16
889480|NCT01907516|2152229|P1|NOT COMPLETED|First Intervention (3 Weeks)||10
889481|NCT01907516|2152228|P2|COMPLETED|First Intervention (3 Weeks)||34
889482|NCT01907516|2152229|P1|COMPLETED|First Intervention (3 Weeks)||40
889483|NCT01907516|2152228|P2|STARTED|First Intervention (3 Weeks)||50
889484|NCT01907516|2152229|P1|STARTED|First Intervention (3 Weeks)||50
889485|NCT01907490|2152236|P1|NOT COMPLETED|Overall Study||0
889486|NCT01907490|2152236|P1|COMPLETED|Overall Study||38
889487|NCT01907490|2152236|P1|STARTED|Overall Study||38
889488|NCT01907334|2152240|P2|NOT COMPLETED|Overall Study||0
889489|NCT01907334|2152241|P1|NOT COMPLETED|Overall Study||0
889490|NCT01907334|2152240|P2|COMPLETED|Overall Study||4
889491|NCT01907334|2152241|P1|COMPLETED|Overall Study||6
889492|NCT01907334|2152240|P2|STARTED|Overall Study||4
889493|NCT01907334|2152241|P1|STARTED|Overall Study||6
889494|NCT01907321|2152246|P1|NOT COMPLETED|Overall Study||2
889495|NCT01907321|2152246|P1|COMPLETED|Overall Study||12
889496|NCT01907321|2152246|P1|STARTED|Overall Study||14
889497|NCT01907113|2152256|P5|NOT COMPLETED|Overall Study||0
889498|NCT01907113|2152257|P4|NOT COMPLETED|Overall Study||0
889499|NCT01907113|2152258|P3|NOT COMPLETED|Overall Study||0
889500|NCT01907113|2152259|P2|NOT COMPLETED|Overall Study||0
889501|NCT01907113|2152260|P1|NOT COMPLETED|Overall Study||0
889502|NCT01907113|2152256|P5|COMPLETED|Overall Study||8
889503|NCT01907113|2152257|P4|COMPLETED|Overall Study||8
889504|NCT01907113|2152258|P3|COMPLETED|Overall Study||7
889505|NCT01907113|2152259|P2|COMPLETED|Overall Study||9
889506|NCT01907113|2152260|P1|COMPLETED|Overall Study||8
889507|NCT01907113|2152256|P5|STARTED|Overall Study||8
889508|NCT01907113|2152257|P4|STARTED|Overall Study||8
889509|NCT01907113|2152258|P3|STARTED|Overall Study||7
889510|NCT01907113|2152259|P2|STARTED|Overall Study||9
889511|NCT01907113|2152260|P1|STARTED|Overall Study||8
889512|NCT01906658|2152351|P4|NOT COMPLETED|Overall Study||0
889513|NCT01906658|2152352|P3|NOT COMPLETED|Overall Study||3
889514|NCT01906658|2152353|P2|NOT COMPLETED|Overall Study||1
889515|NCT01906658|2152354|P1|NOT COMPLETED|Overall Study||2
889516|NCT01906658|2152351|P4|COMPLETED|Overall Study||11
889517|NCT01906658|2152352|P3|COMPLETED|Overall Study||7
889518|NCT01906658|2152353|P2|COMPLETED|Overall Study||10
889519|NCT01906658|2152354|P1|COMPLETED|Overall Study||9
889520|NCT01906658|2152351|P4|STARTED|Overall Study||11
889521|NCT01906658|2152352|P3|STARTED|Overall Study||10
889522|NCT01906658|2152353|P2|STARTED|Overall Study||11
889523|NCT01906658|2152354|P1|STARTED|Overall Study||11
889524|NCT01906515|2152378|P2|NOT COMPLETED|Overall Study||0
889525|NCT01906515|2152379|P1|NOT COMPLETED|Overall Study||0
889526|NCT01906515|2152378|P2|COMPLETED|Overall Study||61
889527|NCT01906515|2152379|P1|COMPLETED|Overall Study||45
889528|NCT01906515|2152378|P2|STARTED|Overall Study||61
889529|NCT01906515|2152379|P1|STARTED|Overall Study||45
889530|NCT01906372|2152387|P1|NOT COMPLETED|Overall Study||2
889531|NCT01906372|2152387|P1|COMPLETED|Overall Study||10
889532|NCT01906372|2152387|P1|Visit 10: Follow up Phase Completed|Overall Study||8
889533|NCT01906372|2152387|P1|Visit 7: Treatment Phase Completed|Overall Study||10
889534|NCT01906372|2152387|P1|STARTED|Overall Study||12
889535|NCT01905956|2152394|P2|NOT COMPLETED|Overall Study||11
889536|NCT01905956|2152395|P1|NOT COMPLETED|Overall Study||6
889537|NCT01905956|2152394|P2|COMPLETED|Overall Study|Per-protocol population|48
889538|NCT01905956|2152395|P1|COMPLETED|Overall Study|Per-protocol population|54
889539|NCT01905956|2152394|P2|Intention-to-treat Population|Overall Study|Intention-to-treat population|54
889540|NCT01905956|2152395|P1|Intention-to-treat Population|Overall Study|Intention-to-treat population|57
889541|NCT01905956|2152394|P2|STARTED|Overall Study|Randomized|59
889542|NCT01905956|2152395|P1|STARTED|Overall Study|Randomized|60
889543|NCT01905657|2152420|P3|NOT COMPLETED|Overall Study||328
889544|NCT01905657|2152421|P2|NOT COMPLETED|Overall Study||346
889545|NCT01905657|2152422|P1|NOT COMPLETED|Overall Study||345
889546|NCT01905657|2152420|P3|COMPLETED|Overall Study||15
889547|NCT01905657|2152421|P2|COMPLETED|Overall Study||0
889548|NCT01905657|2152422|P1|COMPLETED|Overall Study||0
889549|NCT01905657|2152420|P3|Treated|Overall Study||309
889550|NCT01905657|2152421|P2|Treated|Overall Study||343
889551|NCT01905657|2152422|P1|Treated|Overall Study||339
889552|NCT01905657|2152420|P3|STARTED|Overall Study||343
889553|NCT01905657|2152421|P2|STARTED|Overall Study||346
889554|NCT01905657|2152422|P1|STARTED|Overall Study||345
889555|NCT01905553|2152447|P2|NOT COMPLETED|Period 2||0
889556|NCT01905553|2152448|P1|NOT COMPLETED|Period 2||1
889557|NCT01905553|2152447|P2|COMPLETED|Period 2||4
889558|NCT01905553|2152448|P1|COMPLETED|Period 2||4
889559|NCT01905553|2152447|P2|STARTED|Period 2||4
889560|NCT01905553|2152448|P1|STARTED|Period 2||5
889561|NCT01905553|2152447|P2|NOT COMPLETED|Period 1||0
889562|NCT01905553|2152448|P1|NOT COMPLETED|Period 1||0
889563|NCT01905553|2152447|P2|COMPLETED|Period 1||4
889564|NCT01905553|2152448|P1|COMPLETED|Period 1||5
889565|NCT01905553|2152447|P2|STARTED|Period 1||4
889566|NCT01905553|2152448|P1|STARTED|Period 1||5
889567|NCT01905540|2152462|P4|NOT COMPLETED|Period 3||1
889568|NCT01905540|2152463|P3|NOT COMPLETED|Period 3||1
889569|NCT01905540|2152464|P2|NOT COMPLETED|Period 3||0
889570|NCT01905540|2152465|P1|NOT COMPLETED|Period 3||1
889571|NCT01905540|2152462|P4|COMPLETED|Period 3||6
889572|NCT01905540|2152463|P3|COMPLETED|Period 3||6
889573|NCT01905540|2152464|P2|COMPLETED|Period 3||7
889574|NCT01905540|2152465|P1|COMPLETED|Period 3||6
889575|NCT01905540|2152462|P4|STARTED|Period 3||7
889576|NCT01905540|2152463|P3|STARTED|Period 3||7
889577|NCT01905540|2152464|P2|STARTED|Period 3||7
889578|NCT01905540|2152465|P1|STARTED|Period 3||7
889579|NCT01905540|2152462|P4|NOT COMPLETED|Period 2||0
889580|NCT01905540|2152463|P3|NOT COMPLETED|Period 2||0
889581|NCT01905540|2152464|P2|NOT COMPLETED|Period 2||0
889582|NCT01905540|2152465|P1|NOT COMPLETED|Period 2||0
889583|NCT01905540|2152462|P4|COMPLETED|Period 2||7
889584|NCT01905540|2152463|P3|COMPLETED|Period 2||7
889585|NCT01905540|2152464|P2|COMPLETED|Period 2||7
889586|NCT01905540|2152465|P1|COMPLETED|Period 2||7
889587|NCT01905540|2152462|P4|STARTED|Period 2||7
889588|NCT01905540|2152463|P3|STARTED|Period 2||7
889589|NCT01905540|2152464|P2|STARTED|Period 2||7
889590|NCT01905540|2152465|P1|STARTED|Period 2||7
889591|NCT01905540|2152462|P4|NOT COMPLETED|Period 1||0
889592|NCT01905540|2152463|P3|NOT COMPLETED|Period 1||0
889593|NCT01905540|2152464|P2|NOT COMPLETED|Period 1||0
889594|NCT01905540|2152465|P1|NOT COMPLETED|Period 1||0
889595|NCT01905540|2152462|P4|COMPLETED|Period 1||7
889596|NCT01905540|2152463|P3|COMPLETED|Period 1||7
889597|NCT01905540|2152464|P2|COMPLETED|Period 1||7
889598|NCT01905540|2152465|P1|COMPLETED|Period 1||7
889599|NCT01905540|2152462|P4|STARTED|Period 1||7
889600|NCT01905540|2152463|P3|STARTED|Period 1||7
889601|NCT01905540|2152464|P2|STARTED|Period 1||7
889602|NCT01905540|2152465|P1|STARTED|Period 1||7
889603|NCT01905254|2152483|P1|NOT COMPLETED|Overall Study||0
889604|NCT01905254|2152483|P1|COMPLETED|Overall Study||34
889605|NCT01905254|2152483|P1|STARTED|Overall Study||34
889606|NCT01904864|2152489|P2|NOT COMPLETED|Overall Study||12
889607|NCT01904864|2152490|P1|NOT COMPLETED|Overall Study||9
889608|NCT01904864|2152489|P2|COMPLETED|Overall Study||28
889609|NCT01904864|2152490|P1|COMPLETED|Overall Study||31
889610|NCT01904864|2152489|P2|STARTED|Overall Study||40
889611|NCT01904864|2152490|P1|STARTED|Overall Study||40
889612|NCT01904773|2152496|P9|NOT COMPLETED|Sixth Intervention||0
889613|NCT01904773|2152497|P8|NOT COMPLETED|Sixth Intervention||0
889614|NCT01904773|2152498|P7|NOT COMPLETED|Sixth Intervention||0
889615|NCT01904773|2152499|P6|NOT COMPLETED|Sixth Intervention||0
889616|NCT01904773|2152500|P5|NOT COMPLETED|Sixth Intervention||0
889617|NCT01904773|2152501|P4|NOT COMPLETED|Sixth Intervention||0
889618|NCT01904773|2152502|P3|NOT COMPLETED|Sixth Intervention||0
889619|NCT01904773|2152503|P2|NOT COMPLETED|Sixth Intervention||0
889620|NCT01904773|2152504|P1|NOT COMPLETED|Sixth Intervention||0
889621|NCT01904773|2152496|P9|COMPLETED|Sixth Intervention||4
889622|NCT01904773|2152497|P8|COMPLETED|Sixth Intervention||2
889623|NCT01904773|2152498|P7|COMPLETED|Sixth Intervention||3
889624|NCT01904773|2152499|P6|COMPLETED|Sixth Intervention||4
889625|NCT01904773|2152500|P5|COMPLETED|Sixth Intervention||3
889626|NCT01904773|2152501|P4|COMPLETED|Sixth Intervention||2
889627|NCT01904773|2152502|P3|COMPLETED|Sixth Intervention||1
889628|NCT01904773|2152503|P2|COMPLETED|Sixth Intervention||0
889629|NCT01904773|2152504|P1|COMPLETED|Sixth Intervention||0
889630|NCT01904773|2152496|P9|STARTED|Sixth Intervention||4
889631|NCT01904773|2152497|P8|STARTED|Sixth Intervention||2
889632|NCT01904773|2152498|P7|STARTED|Sixth Intervention||3
889633|NCT01904773|2152499|P6|STARTED|Sixth Intervention||4
889634|NCT01904773|2152500|P5|STARTED|Sixth Intervention||3
889635|NCT01904773|2152501|P4|STARTED|Sixth Intervention||2
889636|NCT01904773|2152502|P3|STARTED|Sixth Intervention||1
889637|NCT01904773|2152503|P2|STARTED|Sixth Intervention||0
889638|NCT01904773|2152504|P1|STARTED|Sixth Intervention||0
889639|NCT01904773|2152496|P9|NOT COMPLETED|Placebo Washout Fifth Intervention||0
889640|NCT01904773|2152497|P8|NOT COMPLETED|Placebo Washout Fifth Intervention||0
889641|NCT01904773|2152498|P7|NOT COMPLETED|Placebo Washout Fifth Intervention||0
889642|NCT01904773|2152499|P6|NOT COMPLETED|Placebo Washout Fifth Intervention||0
889643|NCT01904773|2152500|P5|NOT COMPLETED|Placebo Washout Fifth Intervention||0
889644|NCT01904773|2152501|P4|NOT COMPLETED|Placebo Washout Fifth Intervention||0
889645|NCT01904773|2152502|P3|NOT COMPLETED|Placebo Washout Fifth Intervention||0
889646|NCT01904773|2152503|P2|NOT COMPLETED|Placebo Washout Fifth Intervention||1
889647|NCT01904773|2152504|P1|NOT COMPLETED|Placebo Washout Fifth Intervention||0
889648|NCT01904773|2152496|P9|COMPLETED|Placebo Washout Fifth Intervention||4
889649|NCT01904773|2152497|P8|COMPLETED|Placebo Washout Fifth Intervention||2
889650|NCT01904773|2152498|P7|COMPLETED|Placebo Washout Fifth Intervention||3
889651|NCT01904773|2152499|P6|COMPLETED|Placebo Washout Fifth Intervention||4
889652|NCT01904773|2152500|P5|COMPLETED|Placebo Washout Fifth Intervention||3
889653|NCT01904773|2152501|P4|COMPLETED|Placebo Washout Fifth Intervention||2
889654|NCT01904773|2152502|P3|COMPLETED|Placebo Washout Fifth Intervention||1
889655|NCT01904773|2152503|P2|COMPLETED|Placebo Washout Fifth Intervention||0
889656|NCT01904773|2152504|P1|COMPLETED|Placebo Washout Fifth Intervention||0
889657|NCT01904773|2152496|P9|STARTED|Placebo Washout Fifth Intervention||4
889658|NCT01904773|2152497|P8|STARTED|Placebo Washout Fifth Intervention||2
889659|NCT01904773|2152498|P7|STARTED|Placebo Washout Fifth Intervention||3
889660|NCT01904773|2152499|P6|STARTED|Placebo Washout Fifth Intervention||4
889661|NCT01904773|2152500|P5|STARTED|Placebo Washout Fifth Intervention||3
889662|NCT01904773|2152501|P4|STARTED|Placebo Washout Fifth Intervention||2
889663|NCT01904773|2152502|P3|STARTED|Placebo Washout Fifth Intervention||1
889664|NCT01904773|2152503|P2|STARTED|Placebo Washout Fifth Intervention||1
889665|NCT01904773|2152504|P1|STARTED|Placebo Washout Fifth Intervention||0
889666|NCT01904773|2152496|P9|NOT COMPLETED|Fifth Intervention||0
889667|NCT01904773|2152497|P8|NOT COMPLETED|Fifth Intervention||1
889668|NCT01904773|2152498|P7|NOT COMPLETED|Fifth Intervention||0
889669|NCT01904773|2152499|P6|NOT COMPLETED|Fifth Intervention||0
889670|NCT01904773|2152500|P5|NOT COMPLETED|Fifth Intervention||0
889671|NCT01904773|2152501|P4|NOT COMPLETED|Fifth Intervention||0
889672|NCT01904773|2152502|P3|NOT COMPLETED|Fifth Intervention||0
889673|NCT01904773|2152503|P2|NOT COMPLETED|Fifth Intervention||0
889674|NCT01904773|2152504|P1|NOT COMPLETED|Fifth Intervention||0
889675|NCT01904773|2152496|P9|COMPLETED|Fifth Intervention||4
889676|NCT01904773|2152497|P8|COMPLETED|Fifth Intervention||2
889677|NCT01904773|2152498|P7|COMPLETED|Fifth Intervention||3
889678|NCT01904773|2152499|P6|COMPLETED|Fifth Intervention||4
889679|NCT01904773|2152500|P5|COMPLETED|Fifth Intervention||3
889680|NCT01904773|2152501|P4|COMPLETED|Fifth Intervention||2
889681|NCT01904773|2152502|P3|COMPLETED|Fifth Intervention||1
889682|NCT01904773|2152503|P2|COMPLETED|Fifth Intervention||1
889683|NCT01904773|2152504|P1|COMPLETED|Fifth Intervention||0
889684|NCT01904773|2152496|P9|STARTED|Fifth Intervention||4
889685|NCT01904773|2152497|P8|STARTED|Fifth Intervention||3
889686|NCT01904773|2152498|P7|STARTED|Fifth Intervention||3
889687|NCT01904773|2152499|P6|STARTED|Fifth Intervention||4
889688|NCT01904773|2152500|P5|STARTED|Fifth Intervention||3
889689|NCT01904773|2152501|P4|STARTED|Fifth Intervention||2
889690|NCT01904773|2152502|P3|STARTED|Fifth Intervention||1
889691|NCT01904773|2152503|P2|STARTED|Fifth Intervention||1
889692|NCT01904773|2152504|P1|STARTED|Fifth Intervention||0
889693|NCT01904773|2152496|P9|NOT COMPLETED|Placebo Washout Fourth Intervention||0
889694|NCT01904773|2152497|P8|NOT COMPLETED|Placebo Washout Fourth Intervention||0
889695|NCT01904773|2152498|P7|NOT COMPLETED|Placebo Washout Fourth Intervention||0
889696|NCT01904773|2152499|P6|NOT COMPLETED|Placebo Washout Fourth Intervention||0
889697|NCT01904773|2152500|P5|NOT COMPLETED|Placebo Washout Fourth Intervention||0
889698|NCT01904773|2152501|P4|NOT COMPLETED|Placebo Washout Fourth Intervention||0
889699|NCT01904773|2152502|P3|NOT COMPLETED|Placebo Washout Fourth Intervention||0
889700|NCT01904773|2152503|P2|NOT COMPLETED|Placebo Washout Fourth Intervention||0
889701|NCT01904773|2152504|P1|NOT COMPLETED|Placebo Washout Fourth Intervention||0
889702|NCT01904773|2152496|P9|COMPLETED|Placebo Washout Fourth Intervention||4
889703|NCT01904773|2152497|P8|COMPLETED|Placebo Washout Fourth Intervention||3
889704|NCT01904773|2152498|P7|COMPLETED|Placebo Washout Fourth Intervention||3
889705|NCT01904773|2152499|P6|COMPLETED|Placebo Washout Fourth Intervention||4
889706|NCT01904773|2152500|P5|COMPLETED|Placebo Washout Fourth Intervention||3
889707|NCT01904773|2152501|P4|COMPLETED|Placebo Washout Fourth Intervention||2
889708|NCT01904773|2152502|P3|COMPLETED|Placebo Washout Fourth Intervention||1
889709|NCT01904773|2152503|P2|COMPLETED|Placebo Washout Fourth Intervention||1
889710|NCT01904773|2152504|P1|COMPLETED|Placebo Washout Fourth Intervention||0
889711|NCT01904773|2152496|P9|STARTED|Placebo Washout Fourth Intervention||4
889712|NCT01904773|2152497|P8|STARTED|Placebo Washout Fourth Intervention||3
889713|NCT01904773|2152498|P7|STARTED|Placebo Washout Fourth Intervention||3
889714|NCT01904773|2152499|P6|STARTED|Placebo Washout Fourth Intervention||4
889715|NCT01904773|2152500|P5|STARTED|Placebo Washout Fourth Intervention||3
889716|NCT01904773|2152501|P4|STARTED|Placebo Washout Fourth Intervention||2
889717|NCT01904773|2152502|P3|STARTED|Placebo Washout Fourth Intervention||1
889718|NCT01904773|2152503|P2|STARTED|Placebo Washout Fourth Intervention||1
889719|NCT01904773|2152504|P1|STARTED|Placebo Washout Fourth Intervention||0
889720|NCT01904773|2152496|P9|NOT COMPLETED|Fourth Intervention||0
889721|NCT01904773|2152497|P8|NOT COMPLETED|Fourth Intervention||0
889722|NCT01904773|2152498|P7|NOT COMPLETED|Fourth Intervention||0
889723|NCT01904773|2152499|P6|NOT COMPLETED|Fourth Intervention||0
889724|NCT01904773|2152500|P5|NOT COMPLETED|Fourth Intervention||0
889725|NCT01904773|2152501|P4|NOT COMPLETED|Fourth Intervention||0
889726|NCT01904773|2152502|P3|NOT COMPLETED|Fourth Intervention||0
889727|NCT01904773|2152503|P2|NOT COMPLETED|Fourth Intervention||0
889728|NCT01904773|2152504|P1|NOT COMPLETED|Fourth Intervention||0
889729|NCT01904773|2152496|P9|COMPLETED|Fourth Intervention||4
889730|NCT01904773|2152497|P8|COMPLETED|Fourth Intervention||3
889731|NCT01904773|2152498|P7|COMPLETED|Fourth Intervention||3
889732|NCT01904773|2152499|P6|COMPLETED|Fourth Intervention||4
889733|NCT01904773|2152500|P5|COMPLETED|Fourth Intervention||3
889734|NCT01904773|2152501|P4|COMPLETED|Fourth Intervention||2
889735|NCT01904773|2152502|P3|COMPLETED|Fourth Intervention||1
889736|NCT01904773|2152503|P2|COMPLETED|Fourth Intervention||1
889737|NCT01904773|2152504|P1|COMPLETED|Fourth Intervention||0
889738|NCT01904773|2152496|P9|STARTED|Fourth Intervention||4
889739|NCT01904773|2152497|P8|STARTED|Fourth Intervention||3
889740|NCT01904773|2152498|P7|STARTED|Fourth Intervention||3
889741|NCT01904773|2152499|P6|STARTED|Fourth Intervention||4
889742|NCT01904773|2152500|P5|STARTED|Fourth Intervention||3
889743|NCT01904773|2152501|P4|STARTED|Fourth Intervention||2
889744|NCT01904773|2152502|P3|STARTED|Fourth Intervention||1
889745|NCT01904773|2152503|P2|STARTED|Fourth Intervention||1
889746|NCT01904773|2152504|P1|STARTED|Fourth Intervention||0
889747|NCT01904773|2152496|P9|NOT COMPLETED|Placebo Washout Third Intervention||0
889748|NCT01904773|2152497|P8|NOT COMPLETED|Placebo Washout Third Intervention||0
889749|NCT01904773|2152498|P7|NOT COMPLETED|Placebo Washout Third Intervention||0
889750|NCT01904773|2152499|P6|NOT COMPLETED|Placebo Washout Third Intervention||0
889751|NCT01904773|2152500|P5|NOT COMPLETED|Placebo Washout Third Intervention||0
889752|NCT01904773|2152501|P4|NOT COMPLETED|Placebo Washout Third Intervention||0
889753|NCT01904773|2152502|P3|NOT COMPLETED|Placebo Washout Third Intervention||0
889754|NCT01904773|2152503|P2|NOT COMPLETED|Placebo Washout Third Intervention||0
889755|NCT01904773|2152504|P1|NOT COMPLETED|Placebo Washout Third Intervention||0
889756|NCT01904773|2152496|P9|COMPLETED|Placebo Washout Third Intervention||4
889757|NCT01904773|2152497|P8|COMPLETED|Placebo Washout Third Intervention||3
889758|NCT01904773|2152498|P7|COMPLETED|Placebo Washout Third Intervention||3
889759|NCT01904773|2152499|P6|COMPLETED|Placebo Washout Third Intervention||4
889760|NCT01904773|2152500|P5|COMPLETED|Placebo Washout Third Intervention||3
889761|NCT01904773|2152501|P4|COMPLETED|Placebo Washout Third Intervention||2
889762|NCT01904773|2152502|P3|COMPLETED|Placebo Washout Third Intervention||1
889763|NCT01904773|2152503|P2|COMPLETED|Placebo Washout Third Intervention||1
889764|NCT01904773|2152504|P1|COMPLETED|Placebo Washout Third Intervention||0
889765|NCT01904773|2152496|P9|STARTED|Placebo Washout Third Intervention||4
889766|NCT01904773|2152497|P8|STARTED|Placebo Washout Third Intervention||3
889767|NCT01904773|2152498|P7|STARTED|Placebo Washout Third Intervention||3
889768|NCT01904773|2152499|P6|STARTED|Placebo Washout Third Intervention||4
889769|NCT01904773|2152500|P5|STARTED|Placebo Washout Third Intervention||3
889770|NCT01904773|2152501|P4|STARTED|Placebo Washout Third Intervention||2
889771|NCT01904773|2152502|P3|STARTED|Placebo Washout Third Intervention||1
889772|NCT01904773|2152503|P2|STARTED|Placebo Washout Third Intervention||1
889773|NCT01904773|2152504|P1|STARTED|Placebo Washout Third Intervention||0
889774|NCT01904773|2152496|P9|NOT COMPLETED|Third Intervention||0
889775|NCT01904773|2152497|P8|NOT COMPLETED|Third Intervention||0
889776|NCT01904773|2152498|P7|NOT COMPLETED|Third Intervention||0
889777|NCT01904773|2152499|P6|NOT COMPLETED|Third Intervention||0
889778|NCT01904773|2152500|P5|NOT COMPLETED|Third Intervention||0
889779|NCT01904773|2152501|P4|NOT COMPLETED|Third Intervention||0
889780|NCT01904773|2152502|P3|NOT COMPLETED|Third Intervention||0
889781|NCT01904773|2152503|P2|NOT COMPLETED|Third Intervention||0
889782|NCT01904773|2152504|P1|NOT COMPLETED|Third Intervention||0
889783|NCT01904773|2152496|P9|COMPLETED|Third Intervention||4
889784|NCT01904773|2152497|P8|COMPLETED|Third Intervention||3
889785|NCT01904773|2152498|P7|COMPLETED|Third Intervention||3
889786|NCT01904773|2152499|P6|COMPLETED|Third Intervention||4
889787|NCT01904773|2152500|P5|COMPLETED|Third Intervention||3
889788|NCT01904773|2152501|P4|COMPLETED|Third Intervention||2
889789|NCT01904773|2152502|P3|COMPLETED|Third Intervention||1
889790|NCT01904773|2152503|P2|COMPLETED|Third Intervention||1
889791|NCT01904773|2152504|P1|COMPLETED|Third Intervention||0
889792|NCT01904773|2152496|P9|STARTED|Third Intervention||4
889793|NCT01904773|2152497|P8|STARTED|Third Intervention||3
889794|NCT01904773|2152498|P7|STARTED|Third Intervention||3
889795|NCT01904773|2152499|P6|STARTED|Third Intervention||4
889796|NCT01904773|2152500|P5|STARTED|Third Intervention||3
889797|NCT01904773|2152501|P4|STARTED|Third Intervention||2
889798|NCT01904773|2152502|P3|STARTED|Third Intervention||1
889799|NCT01904773|2152503|P2|STARTED|Third Intervention||1
889800|NCT01904773|2152504|P1|STARTED|Third Intervention||0
889801|NCT01904773|2152496|P9|NOT COMPLETED|Placebo Washout Second Intervention||0
889802|NCT01904773|2152497|P8|NOT COMPLETED|Placebo Washout Second Intervention||0
889803|NCT01904773|2152498|P7|NOT COMPLETED|Placebo Washout Second Intervention||0
889804|NCT01904773|2152499|P6|NOT COMPLETED|Placebo Washout Second Intervention||0
889805|NCT01904773|2152500|P5|NOT COMPLETED|Placebo Washout Second Intervention||0
889806|NCT01904773|2152501|P4|NOT COMPLETED|Placebo Washout Second Intervention||0
889807|NCT01904773|2152502|P3|NOT COMPLETED|Placebo Washout Second Intervention||0
889808|NCT01904773|2152503|P2|NOT COMPLETED|Placebo Washout Second Intervention||0
889809|NCT01904773|2152504|P1|NOT COMPLETED|Placebo Washout Second Intervention||0
889810|NCT01904773|2152496|P9|COMPLETED|Placebo Washout Second Intervention||4
889811|NCT01904773|2152497|P8|COMPLETED|Placebo Washout Second Intervention||3
889812|NCT01904773|2152498|P7|COMPLETED|Placebo Washout Second Intervention||3
889813|NCT01904773|2152499|P6|COMPLETED|Placebo Washout Second Intervention||4
889814|NCT01904773|2152500|P5|COMPLETED|Placebo Washout Second Intervention||3
889815|NCT01904773|2152501|P4|COMPLETED|Placebo Washout Second Intervention||2
889816|NCT01904773|2152502|P3|COMPLETED|Placebo Washout Second Intervention||1
889817|NCT01904773|2152503|P2|COMPLETED|Placebo Washout Second Intervention||1
889818|NCT01904773|2152504|P1|COMPLETED|Placebo Washout Second Intervention||0
889819|NCT01904773|2152496|P9|STARTED|Placebo Washout Second Intervention||4
889820|NCT01904773|2152497|P8|STARTED|Placebo Washout Second Intervention||3
889821|NCT01904773|2152498|P7|STARTED|Placebo Washout Second Intervention||3
889822|NCT01904773|2152499|P6|STARTED|Placebo Washout Second Intervention||4
889823|NCT01904773|2152500|P5|STARTED|Placebo Washout Second Intervention||3
889824|NCT01904773|2152501|P4|STARTED|Placebo Washout Second Intervention||2
889825|NCT01904773|2152502|P3|STARTED|Placebo Washout Second Intervention||1
889826|NCT01904773|2152503|P2|STARTED|Placebo Washout Second Intervention||1
889827|NCT01904773|2152504|P1|STARTED|Placebo Washout Second Intervention||0
889828|NCT01904773|2152496|P9|NOT COMPLETED|Second Intervention||0
889829|NCT01904773|2152497|P8|NOT COMPLETED|Second Intervention||0
889830|NCT01904773|2152498|P7|NOT COMPLETED|Second Intervention||0
889831|NCT01904773|2152499|P6|NOT COMPLETED|Second Intervention||0
889832|NCT01904773|2152500|P5|NOT COMPLETED|Second Intervention||0
889833|NCT01904773|2152501|P4|NOT COMPLETED|Second Intervention||0
889834|NCT01904773|2152502|P3|NOT COMPLETED|Second Intervention||0
889835|NCT01904773|2152503|P2|NOT COMPLETED|Second Intervention||0
889836|NCT01904773|2152504|P1|NOT COMPLETED|Second Intervention||0
889837|NCT01904773|2152496|P9|COMPLETED|Second Intervention||4
889838|NCT01904773|2152497|P8|COMPLETED|Second Intervention||3
889839|NCT01904773|2152498|P7|COMPLETED|Second Intervention||3
889840|NCT01904773|2152499|P6|COMPLETED|Second Intervention||4
889841|NCT01904773|2152500|P5|COMPLETED|Second Intervention||3
889842|NCT01904773|2152501|P4|COMPLETED|Second Intervention||2
889843|NCT01904773|2152502|P3|COMPLETED|Second Intervention||1
889844|NCT01904773|2152503|P2|COMPLETED|Second Intervention||1
889845|NCT01904773|2152504|P1|COMPLETED|Second Intervention||0
889846|NCT01904773|2152496|P9|STARTED|Second Intervention||4
889847|NCT01904773|2152497|P8|STARTED|Second Intervention||3
889848|NCT01904773|2152498|P7|STARTED|Second Intervention||3
889849|NCT01904773|2152499|P6|STARTED|Second Intervention||4
889850|NCT01904773|2152500|P5|STARTED|Second Intervention||3
889851|NCT01904773|2152501|P4|STARTED|Second Intervention||2
889852|NCT01904773|2152502|P3|STARTED|Second Intervention||1
889853|NCT01904773|2152503|P2|STARTED|Second Intervention||1
889854|NCT01904773|2152504|P1|STARTED|Second Intervention||0
889855|NCT01904773|2152496|P9|NOT COMPLETED|Placebo Washout First Intervention||0
889856|NCT01904773|2152497|P8|NOT COMPLETED|Placebo Washout First Intervention||0
889857|NCT01904773|2152498|P7|NOT COMPLETED|Placebo Washout First Intervention||0
889858|NCT01904773|2152499|P6|NOT COMPLETED|Placebo Washout First Intervention||0
889859|NCT01904773|2152500|P5|NOT COMPLETED|Placebo Washout First Intervention||0
889860|NCT01904773|2152501|P4|NOT COMPLETED|Placebo Washout First Intervention||0
889861|NCT01904773|2152502|P3|NOT COMPLETED|Placebo Washout First Intervention||0
889862|NCT01904773|2152503|P2|NOT COMPLETED|Placebo Washout First Intervention||1
889863|NCT01904773|2152504|P1|NOT COMPLETED|Placebo Washout First Intervention||0
889864|NCT01904773|2152496|P9|COMPLETED|Placebo Washout First Intervention||4
889865|NCT01904773|2152497|P8|COMPLETED|Placebo Washout First Intervention||3
889866|NCT01904773|2152498|P7|COMPLETED|Placebo Washout First Intervention||3
889867|NCT01904773|2152499|P6|COMPLETED|Placebo Washout First Intervention||4
889868|NCT01904773|2152500|P5|COMPLETED|Placebo Washout First Intervention||3
889869|NCT01904773|2152501|P4|COMPLETED|Placebo Washout First Intervention||2
889870|NCT01904773|2152502|P3|COMPLETED|Placebo Washout First Intervention||1
889871|NCT01904773|2152503|P2|COMPLETED|Placebo Washout First Intervention||1
889872|NCT01904773|2152504|P1|COMPLETED|Placebo Washout First Intervention||0
889873|NCT01904773|2152496|P9|STARTED|Placebo Washout First Intervention||4
889874|NCT01904773|2152497|P8|STARTED|Placebo Washout First Intervention||3
889875|NCT01904773|2152498|P7|STARTED|Placebo Washout First Intervention||3
889876|NCT01904773|2152499|P6|STARTED|Placebo Washout First Intervention||4
889877|NCT01904773|2152500|P5|STARTED|Placebo Washout First Intervention||3
889878|NCT01904773|2152501|P4|STARTED|Placebo Washout First Intervention||2
889879|NCT01904773|2152502|P3|STARTED|Placebo Washout First Intervention||1
889880|NCT01904773|2152503|P2|STARTED|Placebo Washout First Intervention||2
889881|NCT01904773|2152504|P1|STARTED|Placebo Washout First Intervention||0
889882|NCT01904773|2152496|P9|NOT COMPLETED|First Intervention||0
889883|NCT01904773|2152497|P8|NOT COMPLETED|First Intervention||0
889884|NCT01904773|2152498|P7|NOT COMPLETED|First Intervention||1
889885|NCT01904773|2152499|P6|NOT COMPLETED|First Intervention||0
889886|NCT01904773|2152500|P5|NOT COMPLETED|First Intervention||0
889887|NCT01904773|2152501|P4|NOT COMPLETED|First Intervention||0
889888|NCT01904773|2152502|P3|NOT COMPLETED|First Intervention||0
889889|NCT01904773|2152503|P2|NOT COMPLETED|First Intervention||0
889890|NCT01904773|2152504|P1|NOT COMPLETED|First Intervention||0
889891|NCT01904773|2152496|P9|COMPLETED|First Intervention||4
889892|NCT01904773|2152497|P8|COMPLETED|First Intervention||3
889893|NCT01904773|2152498|P7|COMPLETED|First Intervention||3
889894|NCT01904773|2152499|P6|COMPLETED|First Intervention||4
889895|NCT01904773|2152500|P5|COMPLETED|First Intervention||3
889896|NCT01904773|2152501|P4|COMPLETED|First Intervention||2
889897|NCT01904773|2152502|P3|COMPLETED|First Intervention||1
889898|NCT01904773|2152503|P2|COMPLETED|First Intervention||2
889899|NCT01904773|2152504|P1|COMPLETED|First Intervention||0
889900|NCT01904773|2152496|P9|STARTED|First Intervention||4
889901|NCT01904773|2152497|P8|STARTED|First Intervention||3
889902|NCT01904773|2152498|P7|STARTED|First Intervention||4
889903|NCT01904773|2152499|P6|STARTED|First Intervention||4
889904|NCT01904773|2152500|P5|STARTED|First Intervention||3
889905|NCT01904773|2152501|P4|STARTED|First Intervention||2
889906|NCT01904773|2152502|P3|STARTED|First Intervention||1
889907|NCT01904773|2152503|P2|STARTED|First Intervention||2
889908|NCT01904773|2152504|P1|STARTED|First Intervention||0
889909|NCT01904773|2152496|P9|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889910|NCT01904773|2152497|P8|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889911|NCT01904773|2152498|P7|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889912|NCT01904773|2152499|P6|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889913|NCT01904773|2152500|P5|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889914|NCT01904773|2152501|P4|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889915|NCT01904773|2152502|P3|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889916|NCT01904773|2152503|P2|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889917|NCT01904773|2152504|P1|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||1
889918|NCT01904773|2152496|P9|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889919|NCT01904773|2152497|P8|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889920|NCT01904773|2152498|P7|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889921|NCT01904773|2152499|P6|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889922|NCT01904773|2152500|P5|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889923|NCT01904773|2152501|P4|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889924|NCT01904773|2152502|P3|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889925|NCT01904773|2152503|P2|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889926|NCT01904773|2152504|P1|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||23
889927|NCT01904773|2152496|P9|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889928|NCT01904773|2152497|P8|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889929|NCT01904773|2152498|P7|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889930|NCT01904773|2152499|P6|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889931|NCT01904773|2152500|P5|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889932|NCT01904773|2152501|P4|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889933|NCT01904773|2152502|P3|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889934|NCT01904773|2152503|P2|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889935|NCT01904773|2152504|P1|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||4
889936|NCT01904773|2152496|P9|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889937|NCT01904773|2152497|P8|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889938|NCT01904773|2152498|P7|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889939|NCT01904773|2152499|P6|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889940|NCT01904773|2152500|P5|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889941|NCT01904773|2152501|P4|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889942|NCT01904773|2152502|P3|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889943|NCT01904773|2152503|P2|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889944|NCT01904773|2152504|P1|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||20
889945|NCT01904773|2152496|P9|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889946|NCT01904773|2152497|P8|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889947|NCT01904773|2152498|P7|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889948|NCT01904773|2152499|P6|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889949|NCT01904773|2152500|P5|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889950|NCT01904773|2152501|P4|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889951|NCT01904773|2152502|P3|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889952|NCT01904773|2152503|P2|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
889953|NCT01904773|2152504|P1|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||24
889954|NCT01904773|2152496|P9|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
889955|NCT01904773|2152497|P8|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
889956|NCT01904773|2152498|P7|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
889957|NCT01904773|2152499|P6|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
889958|NCT01904773|2152500|P5|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
889959|NCT01904773|2152501|P4|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
889960|NCT01904773|2152502|P3|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
889961|NCT01904773|2152503|P2|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
889962|NCT01904773|2152504|P1|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
889963|NCT01904773|2152496|P9|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
889964|NCT01904773|2152497|P8|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
889965|NCT01904773|2152498|P7|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
889966|NCT01904773|2152499|P6|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
889967|NCT01904773|2152500|P5|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
889968|NCT01904773|2152501|P4|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
889969|NCT01904773|2152502|P3|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
889970|NCT01904773|2152503|P2|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
889971|NCT01904773|2152504|P1|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||24
889972|NCT01904773|2152496|P9|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
889973|NCT01904773|2152497|P8|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
889974|NCT01904773|2152498|P7|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
889975|NCT01904773|2152499|P6|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
889976|NCT01904773|2152500|P5|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
889977|NCT01904773|2152501|P4|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
889978|NCT01904773|2152502|P3|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
889979|NCT01904773|2152503|P2|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
889980|NCT01904773|2152504|P1|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||24
889981|NCT01904773|2152496|P9|NOT COMPLETED|Screen||0
889982|NCT01904773|2152497|P8|NOT COMPLETED|Screen||0
889983|NCT01904773|2152498|P7|NOT COMPLETED|Screen||0
889984|NCT01904773|2152499|P6|NOT COMPLETED|Screen||0
889985|NCT01904773|2152500|P5|NOT COMPLETED|Screen||0
889986|NCT01904773|2152501|P4|NOT COMPLETED|Screen||0
889987|NCT01904773|2152502|P3|NOT COMPLETED|Screen||0
889988|NCT01904773|2152503|P2|NOT COMPLETED|Screen||0
889989|NCT01904773|2152504|P1|NOT COMPLETED|Screen||4
889990|NCT01904773|2152496|P9|COMPLETED|Screen||0
889991|NCT01904773|2152497|P8|COMPLETED|Screen||0
889992|NCT01904773|2152498|P7|COMPLETED|Screen||0
889993|NCT01904773|2152499|P6|COMPLETED|Screen||0
889994|NCT01904773|2152500|P5|COMPLETED|Screen||0
889995|NCT01904773|2152501|P4|COMPLETED|Screen||0
889996|NCT01904773|2152502|P3|COMPLETED|Screen||0
889997|NCT01904773|2152503|P2|COMPLETED|Screen||0
889998|NCT01904773|2152504|P1|COMPLETED|Screen||24
889999|NCT01904773|2152496|P9|STARTED|Screen||0
890000|NCT01904773|2152497|P8|STARTED|Screen||0
890001|NCT01904773|2152498|P7|STARTED|Screen||0
890002|NCT01904773|2152499|P6|STARTED|Screen||0
890003|NCT01904773|2152500|P5|STARTED|Screen||0
890004|NCT01904773|2152501|P4|STARTED|Screen||0
890005|NCT01904773|2152502|P3|STARTED|Screen||0
890006|NCT01904773|2152503|P2|STARTED|Screen||0
890007|NCT01904773|2152504|P1|STARTED|Screen||28
890008|NCT01904760|2152521|P2|NOT COMPLETED|Overall Study||0
890009|NCT01904760|2152522|P1|NOT COMPLETED|Overall Study||1
890010|NCT01904760|2152521|P2|COMPLETED|Overall Study||40
890011|NCT01904760|2152522|P1|COMPLETED|Overall Study||39
890012|NCT01904760|2152521|P2|STARTED|Overall Study||40
890013|NCT01904760|2152522|P1|STARTED|Overall Study||40
890014|NCT01904721|2152537|P7|NOT COMPLETED|Overall Study||7
890015|NCT01904721|2152538|P6|NOT COMPLETED|Overall Study||9
890016|NCT01904721|2152539|P5|NOT COMPLETED|Overall Study||8
890017|NCT01904721|2152540|P4|NOT COMPLETED|Overall Study||1
890018|NCT01904721|2152541|P3|NOT COMPLETED|Overall Study||1
890019|NCT01904721|2152542|P2|NOT COMPLETED|Overall Study||0
890020|NCT01904721|2152543|P1|NOT COMPLETED|Overall Study||0
890021|NCT01904721|2152537|P7|COMPLETED|Overall Study||57
890022|NCT01904721|2152538|P6|COMPLETED|Overall Study||56
890023|NCT01904721|2152539|P5|COMPLETED|Overall Study||57
890024|NCT01904721|2152540|P4|COMPLETED|Overall Study||11
890025|NCT01904721|2152541|P3|COMPLETED|Overall Study||11
890026|NCT01904721|2152542|P2|COMPLETED|Overall Study||13
890027|NCT01904721|2152543|P1|COMPLETED|Overall Study||13
890028|NCT01904721|2152537|P7|STARTED|Overall Study||64
890029|NCT01904721|2152538|P6|STARTED|Overall Study||65
890030|NCT01904721|2152539|P5|STARTED|Overall Study||65
890031|NCT01904721|2152540|P4|STARTED|Overall Study||12
890032|NCT01904721|2152541|P3|STARTED|Overall Study||12
890033|NCT01904721|2152542|P2|STARTED|Overall Study||13
890034|NCT01904721|2152543|P1|STARTED|Overall Study||13
890035|NCT01904604|2152573|P3|NOT COMPLETED|Overall Study||0
890036|NCT01904604|2152574|P2|NOT COMPLETED|Overall Study||4
890037|NCT01904604|2152575|P1|NOT COMPLETED|Overall Study||3
890038|NCT01904604|2152573|P3|COMPLETED|Overall Study|COMPLETED: Completed the Week 52 Oral Food Challenge (OFC).|25
890039|NCT01904604|2152574|P2|COMPLETED|Overall Study|COMPLETED: Completed the Week 52 Oral Food Challenge (OFC).|21
890040|NCT01904604|2152575|P1|COMPLETED|Overall Study|COMPLETED: Completed the Week 52 Oral Food Challenge (OFC).|22
890041|NCT01904604|2152573|P3|STARTED|Overall Study||25
890042|NCT01904604|2152574|P2|STARTED|Overall Study||25
890043|NCT01904604|2152575|P1|STARTED|Overall Study||25
890044|NCT01904279|2152593|P2|NOT COMPLETED|Overall Study||3
890045|NCT01904279|2152594|P1|NOT COMPLETED|Overall Study||3
890046|NCT01904279|2152593|P2|COMPLETED|Overall Study||22
890047|NCT01904279|2152594|P1|COMPLETED|Overall Study||24
890048|NCT01904279|2152593|P2|STARTED|Overall Study||25
890049|NCT01904279|2152594|P1|STARTED|Overall Study||27
890050|NCT01904149|2152620|P6|NOT COMPLETED|Overall Study||3
890051|NCT01904149|2152621|P5|NOT COMPLETED|Overall Study||5
890052|NCT01904149|2152622|P4|NOT COMPLETED|Overall Study||4
890053|NCT01904149|2152623|P3|NOT COMPLETED|Overall Study||2
890054|NCT01904149|2152624|P2|NOT COMPLETED|Overall Study||11
890055|NCT01904149|2152625|P1|NOT COMPLETED|Overall Study||5
890056|NCT01904149|2152620|P6|COMPLETED|Overall Study||48
890057|NCT01904149|2152621|P5|COMPLETED|Overall Study||46
890058|NCT01904149|2152622|P4|COMPLETED|Overall Study||47
890059|NCT01904149|2152623|P3|COMPLETED|Overall Study||148
890060|NCT01904149|2152624|P2|COMPLETED|Overall Study||140
890061|NCT01904149|2152625|P1|COMPLETED|Overall Study||147
890062|NCT01904149|2152620|P6|Multiple-dose Phase|Overall Study||49
890063|NCT01904149|2152621|P5|Multiple-dose Phase|Overall Study||48
890064|NCT01904149|2152622|P4|Multiple-dose Phase|Overall Study||48
890065|NCT01904149|2152623|P3|Multiple-dose Phase|Overall Study||149
890066|NCT01904149|2152624|P2|Multiple-dose Phase|Overall Study||146
890067|NCT01904149|2152625|P1|Multiple-dose Phase|Overall Study||150
890068|NCT01904149|2152620|P6|Single-dose Phase|Overall Study||51
890069|NCT01904149|2152621|P5|Single-dose Phase|Overall Study||51
890070|NCT01904149|2152622|P4|Single-dose Phase|Overall Study||51
890071|NCT01904149|2152623|P3|Single-dose Phase|Overall Study||150
890072|NCT01904149|2152624|P2|Single-dose Phase|Overall Study||151
890073|NCT01904149|2152625|P1|Single-dose Phase|Overall Study||152
890074|NCT01904149|2152620|P6|STARTED|Overall Study||51
890075|NCT01904149|2152621|P5|STARTED|Overall Study||51
890076|NCT01904149|2152622|P4|STARTED|Overall Study||51
890077|NCT01904149|2152623|P3|STARTED|Overall Study||150
890078|NCT01904149|2152624|P2|STARTED|Overall Study||151
890079|NCT01904149|2152625|P1|STARTED|Overall Study||152
890080|NCT01904071|2152650|P3|NOT COMPLETED|Overall Study||0
890081|NCT01904071|2152651|P2|NOT COMPLETED|Overall Study||0
890082|NCT01904071|2152652|P1|NOT COMPLETED|Overall Study||0
890083|NCT01904071|2152650|P3|COMPLETED|Overall Study||20
890084|NCT01904071|2152651|P2|COMPLETED|Overall Study||20
890085|NCT01904071|2152652|P1|COMPLETED|Overall Study||24
890086|NCT01904071|2152650|P3|STARTED|Overall Study||20
890087|NCT01904071|2152651|P2|STARTED|Overall Study||20
890088|NCT01904071|2152652|P1|STARTED|Overall Study||24
890089|NCT01904058|2152676|P4|NOT COMPLETED|Overall Study||1
890090|NCT01904058|2152677|P3|NOT COMPLETED|Overall Study||1
890091|NCT01904058|2152678|P2|NOT COMPLETED|Overall Study||0
890092|NCT01904058|2152679|P1|NOT COMPLETED|Overall Study||3
890093|NCT01904058|2152676|P4|COMPLETED|Overall Study||12
890094|NCT01904058|2152677|P3|COMPLETED|Overall Study||10
890095|NCT01904058|2152678|P2|COMPLETED|Overall Study||21
890096|NCT01904058|2152679|P1|COMPLETED|Overall Study||18
890097|NCT01904058|2152676|P4|STARTED|Overall Study||13
890098|NCT01904058|2152677|P3|STARTED|Overall Study||11
890099|NCT01904058|2152678|P2|STARTED|Overall Study||21
890100|NCT01904058|2152679|P1|STARTED|Overall Study||21
890101|NCT01903993|2152719|P2|NOT COMPLETED|Overall Study||95
890102|NCT01903993|2152720|P1|NOT COMPLETED|Overall Study||123
890103|NCT01903993|2152719|P2|COMPLETED|Overall Study||49
890104|NCT01903993|2152720|P1|COMPLETED|Overall Study||20
890105|NCT01903993|2152719|P2|Received Treatment|Overall Study||142
890106|NCT01903993|2152720|P1|Received Treatment|Overall Study||135
890107|NCT01903993|2152719|P2|STARTED|Overall Study||144
890108|NCT01903993|2152720|P1|STARTED|Overall Study||143
890109|NCT01903876|2152737|P2|NOT COMPLETED|Six-Month Follow-up Period||145
890110|NCT01903876|2152738|P1|NOT COMPLETED|Six-Month Follow-up Period||91
890111|NCT01903876|2152737|P2|COMPLETED|Six-Month Follow-up Period||123
890112|NCT01903876|2152738|P1|COMPLETED|Six-Month Follow-up Period||92
890113|NCT01903876|2152737|P2|STARTED|Six-Month Follow-up Period||268
890114|NCT01903876|2152738|P1|STARTED|Six-Month Follow-up Period||183
890115|NCT01903876|2152737|P2|NOT COMPLETED|Baseline to Post-Intervention Period||108
890116|NCT01903876|2152738|P1|NOT COMPLETED|Baseline to Post-Intervention Period||184
890117|NCT01903876|2152737|P2|COMPLETED|Baseline to Post-Intervention Period||268
890118|NCT01903876|2152738|P1|COMPLETED|Baseline to Post-Intervention Period||183
890119|NCT01903876|2152737|P2|STARTED|Baseline to Post-Intervention Period||376
890120|NCT01903876|2152738|P1|STARTED|Baseline to Post-Intervention Period||367
890121|NCT01903863|2152748|P2|NOT COMPLETED|Overall Study||0
890122|NCT01903863|2152749|P1|NOT COMPLETED|Overall Study||2
890123|NCT01903863|2152748|P2|COMPLETED|Overall Study||16
890124|NCT01903863|2152749|P1|COMPLETED|Overall Study||13
890125|NCT01903863|2152748|P2|STARTED|Overall Study||16
890126|NCT01903863|2152749|P1|STARTED|Overall Study||15
890130|NCT01903460|2152788|P4|NOT COMPLETED|Overall Study||1
890131|NCT01903460|2152789|P3|NOT COMPLETED|Overall Study||0
890132|NCT01903460|2152790|P2|NOT COMPLETED|Overall Study||0
890133|NCT01903460|2152791|P1|NOT COMPLETED|Overall Study||0
890134|NCT01903460|2152788|P4|COMPLETED|Overall Study||2
890135|NCT01903460|2152789|P3|COMPLETED|Overall Study||3
890136|NCT01903460|2152790|P2|COMPLETED|Overall Study||8
890137|NCT01903460|2152791|P1|COMPLETED|Overall Study||6
890138|NCT01903460|2152788|P4|STARTED|Overall Study||3
890139|NCT01903460|2152789|P3|STARTED|Overall Study||3
890140|NCT01903460|2152790|P2|STARTED|Overall Study||8
890141|NCT01903460|2152791|P1|STARTED|Overall Study||6
890142|NCT01903265|2152810|P2|NOT COMPLETED|Overall Study||17
890143|NCT01903265|2152811|P1|NOT COMPLETED|Overall Study||14
890144|NCT01903265|2152810|P2|COMPLETED|Overall Study||85
890145|NCT01903265|2152811|P1|COMPLETED|Overall Study||89
890146|NCT01903265|2152810|P2|STARTED|Overall Study||102
890147|NCT01903265|2152811|P1|STARTED|Overall Study||103
890148|NCT01903187|2152827|P2|NOT COMPLETED|12 Month||0
890149|NCT01903187|2152828|P1|NOT COMPLETED|12 Month||0
890150|NCT01903187|2152827|P2|COMPLETED|12 Month||0
890151|NCT01903187|2152828|P1|COMPLETED|12 Month||2
890152|NCT01903187|2152827|P2|STARTED|12 Month||0
890153|NCT01903187|2152828|P1|STARTED|12 Month||2
890154|NCT01903187|2152827|P2|NOT COMPLETED|6 Month||0
890155|NCT01903187|2152828|P1|NOT COMPLETED|6 Month||0
890156|NCT01903187|2152827|P2|COMPLETED|6 Month||0
890157|NCT01903187|2152828|P1|COMPLETED|6 Month||2
890158|NCT01903187|2152827|P2|STARTED|6 Month||0
890159|NCT01903187|2152828|P1|STARTED|6 Month||2
890160|NCT01903187|2152827|P2|NOT COMPLETED|3 Month||0
890161|NCT01903187|2152828|P1|NOT COMPLETED|3 Month||0
890162|NCT01903187|2152827|P2|COMPLETED|3 Month||0
890163|NCT01903187|2152828|P1|COMPLETED|3 Month||2
890164|NCT01903187|2152827|P2|STARTED|3 Month||0
890165|NCT01903187|2152828|P1|STARTED|3 Month||2
890166|NCT01903187|2152827|P2|NOT COMPLETED|1 Month||0
890167|NCT01903187|2152828|P1|NOT COMPLETED|1 Month||0
890168|NCT01903187|2152827|P2|COMPLETED|1 Month||2
890169|NCT01903187|2152828|P1|COMPLETED|1 Month||2
890170|NCT01903187|2152827|P2|STARTED|1 Month||2
890171|NCT01903187|2152828|P1|STARTED|1 Month||2
890172|NCT01903187|2152827|P2|NOT COMPLETED|Procedure||0
890173|NCT01903187|2152828|P1|NOT COMPLETED|Procedure||0
890174|NCT01903187|2152827|P2|COMPLETED|Procedure||2
890175|NCT01903187|2152828|P1|COMPLETED|Procedure||2
890176|NCT01903187|2152827|P2|STARTED|Procedure||2
890177|NCT01903187|2152828|P1|STARTED|Procedure||2
890178|NCT01903148|2152842|P1|NOT COMPLETED|Overall Study||0
890179|NCT01903148|2152842|P1|COMPLETED|Overall Study||441
890180|NCT01903148|2152842|P1|STARTED|Overall Study||441
890181|NCT01903005|2152860|P1|NOT COMPLETED|Overall Study||373
890182|NCT01903005|2152860|P1|COMPLETED|Overall Study|Primary study OX219-006 (n=194); Primary study OX219-007 (n=98)|292
890183|NCT01903005|2152860|P1|STARTED|Overall Study|Primary study OX219-006 (n=475); Primary study OX219-007 (n=190)|665
890184|NCT01902888|2152874|P1|NOT COMPLETED|Overall Study||3
890185|NCT01902888|2152874|P1|COMPLETED|Overall Study||0
890186|NCT01902888|2152874|P1|STARTED|Overall Study||3
890187|NCT01902758|2152881|P2|NOT COMPLETED|Overall Study||0
890188|NCT01902758|2152882|P1|NOT COMPLETED|Overall Study||0
890189|NCT01902758|2152881|P2|COMPLETED|Overall Study||14
890190|NCT01902758|2152882|P1|COMPLETED|Overall Study||14
890191|NCT01902758|2152881|P2|STARTED|Overall Study||14
890192|NCT01902758|2152882|P1|STARTED|Overall Study||14
890193|NCT01902303|2152890|P2|NOT COMPLETED|Overall Study||24
890194|NCT01902303|2152891|P1|NOT COMPLETED|Overall Study||23
890195|NCT01902303|2152890|P2|COMPLETED|Overall Study|19 not treated /did not use medication as they did not develop a cold sore|57
890196|NCT01902303|2152891|P1|COMPLETED|Overall Study|21 not treated - did not use placebo medication as they did not develop cold sore|54
890197|NCT01902303|2152890|P2|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|62
890198|NCT01902303|2152891|P1|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|56
890199|NCT01902303|2152890|P2|STARTED|Overall Study|Allocated to active treatment|81
890200|NCT01902303|2152891|P1|STARTED|Overall Study|Allocated to placebo|77
890201|NCT01902134|2152905|P6|NOT COMPLETED|Overall Study||9
890202|NCT01902134|2152906|P5|NOT COMPLETED|Overall Study||7
890203|NCT01902134|2152907|P4|NOT COMPLETED|Overall Study||2
890204|NCT01902134|2152908|P3|NOT COMPLETED|Overall Study||15
890205|NCT01902134|2152909|P2|NOT COMPLETED|Overall Study||11
890206|NCT01902134|2152910|P1|NOT COMPLETED|Overall Study||8
890207|NCT01902134|2152905|P6|COMPLETED|Overall Study||45
890208|NCT01902134|2152906|P5|COMPLETED|Overall Study||46
890209|NCT01902134|2152907|P4|COMPLETED|Overall Study||52
890210|NCT01902134|2152908|P3|COMPLETED|Overall Study||145
890211|NCT01902134|2152909|P2|COMPLETED|Overall Study||150
890212|NCT01902134|2152910|P1|COMPLETED|Overall Study||151
890213|NCT01902134|2152905|P6|Multiple-dose Phase|Overall Study||52
890214|NCT01902134|2152906|P5|Multiple-dose Phase|Overall Study||53
890215|NCT01902134|2152907|P4|Multiple-dose Phase|Overall Study||54
890216|NCT01902134|2152908|P3|Multiple-dose Phase|Overall Study||160
890217|NCT01902134|2152909|P2|Multiple-dose Phase|Overall Study||160
890218|NCT01902134|2152910|P1|Multiple-dose Phase|Overall Study||159
890219|NCT01902134|2152905|P6|Single-dose Phase|Overall Study||54
890220|NCT01902134|2152906|P5|Single-dose Phase|Overall Study||53
890221|NCT01902134|2152907|P4|Single-dose Phase|Overall Study||54
890222|NCT01902134|2152908|P3|Single-dose Phase|Overall Study||160
890223|NCT01902134|2152909|P2|Single-dose Phase|Overall Study||161
890224|NCT01902134|2152910|P1|Single-dose Phase|Overall Study||159
890225|NCT01902134|2152905|P6|STARTED|Overall Study||54
890226|NCT01902134|2152906|P5|STARTED|Overall Study||53
890227|NCT01902134|2152907|P4|STARTED|Overall Study||54
890228|NCT01902134|2152908|P3|STARTED|Overall Study||160
890229|NCT01902134|2152909|P2|STARTED|Overall Study||161
890230|NCT01902134|2152910|P1|STARTED|Overall Study||159
890231|NCT01901588|2152934|P2|NOT COMPLETED|Overall Study||0
890232|NCT01901588|2152935|P1|NOT COMPLETED|Overall Study||0
890233|NCT01901588|2152934|P2|COMPLETED|Overall Study||31
890234|NCT01901588|2152935|P1|COMPLETED|Overall Study||32
890235|NCT01901588|2152934|P2|STARTED|Overall Study||31
890236|NCT01901588|2152935|P1|STARTED|Overall Study||32
890237|NCT01901575|2152951|P1|NOT COMPLETED|Overall Study||0
890238|NCT01901575|2152951|P1|COMPLETED|Overall Study||16
890239|NCT01901575|2152951|P1|STARTED|Overall Study|enrolled patients with PVC's present prior to sedation with remifentanil IVPCA|16
890240|NCT01901393|2152957|P2|NOT COMPLETED|Overall Study||0
890241|NCT01901393|2152958|P1|NOT COMPLETED|Overall Study||1
890242|NCT01901393|2152957|P2|COMPLETED|Overall Study||49
890243|NCT01901393|2152958|P1|COMPLETED|Overall Study||50
890244|NCT01901393|2152957|P2|STARTED|Overall Study||49
890245|NCT01901393|2152958|P1|STARTED|Overall Study||51
890246|NCT01901341|2152976|P2|NOT COMPLETED|Overall Study||21
890247|NCT01901341|2152977|P1|NOT COMPLETED|Overall Study||20
890248|NCT01901341|2152976|P2|COMPLETED|Overall Study||1
890249|NCT01901341|2152977|P1|COMPLETED|Overall Study||2
890250|NCT01901341|2152976|P2|Received at Least 1 Dose of Study Drug|Overall Study||22
890251|NCT01901341|2152977|P1|Received at Least 1 Dose of Study Drug|Overall Study||22
890252|NCT01901341|2152976|P2|STARTED|Overall Study||22
890253|NCT01901341|2152977|P1|STARTED|Overall Study||22
890254|NCT01901328|2152991|P2|NOT COMPLETED|Overall Study||21
890255|NCT01901328|2152992|P1|NOT COMPLETED|Overall Study||22
890256|NCT01901328|2152991|P2|COMPLETED|Overall Study||2
890257|NCT01901328|2152992|P1|COMPLETED|Overall Study||4
890258|NCT01901328|2152991|P2|Received at Least 1 Dose of Study Drug|Overall Study||23
890259|NCT01901328|2152992|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
890260|NCT01901328|2152991|P2|STARTED|Overall Study||23
890261|NCT01901328|2152992|P1|STARTED|Overall Study||26
890262|NCT01901302|2153006|P2|NOT COMPLETED|Overall Study||23
890263|NCT01901302|2153007|P1|NOT COMPLETED|Overall Study||27
890264|NCT01901302|2153006|P2|COMPLETED|Overall Study||7
890265|NCT01901302|2153007|P1|COMPLETED|Overall Study||4
890266|NCT01901302|2153006|P2|Received at Least 1 Dose of Study Drug|Overall Study||30
890267|NCT01901302|2153007|P1|Received at Least 1 Dose of Study Drug|Overall Study||31
890268|NCT01901302|2153006|P2|STARTED|Overall Study||30
890269|NCT01901302|2153007|P1|STARTED|Overall Study||31
890270|NCT01901250|2153021|P2|NOT COMPLETED|Overall Study||126
890271|NCT01901250|2153022|P1|NOT COMPLETED|Overall Study||138
890272|NCT01901250|2153021|P2|COMPLETED|Overall Study||139
890273|NCT01901250|2153022|P1|COMPLETED|Overall Study||122
890274|NCT01901250|2153021|P2|End of 1st Grade|Overall Study||151
890275|NCT01901250|2153022|P1|End of 1st Grade|Overall Study||143
890276|NCT01901250|2153021|P2|Start of 1st Grade|Overall Study||176
890277|NCT01901250|2153022|P1|Start of 1st Grade|Overall Study||173
890278|NCT01901250|2153021|P2|End of Kidergarten|Overall Study||212
890279|NCT01901250|2153022|P1|End of Kidergarten|Overall Study||215
890280|NCT01901250|2153021|P2|STARTED|Overall Study||265
890281|NCT01901250|2153022|P1|STARTED|Overall Study||260
890282|NCT01901211|2153030|P2|NOT COMPLETED|Second Ten-week Period||0
890283|NCT01901211|2153031|P1|NOT COMPLETED|Second Ten-week Period||0
890284|NCT01901211|2153030|P2|COMPLETED|Second Ten-week Period||5
890285|NCT01901211|2153031|P1|COMPLETED|Second Ten-week Period||6
890286|NCT01901211|2153030|P2|STARTED|Second Ten-week Period||5
890287|NCT01901211|2153031|P1|STARTED|Second Ten-week Period||6
890288|NCT01901211|2153030|P2|NOT COMPLETED|Washout (6 Weeks)||0
890289|NCT01901211|2153031|P1|NOT COMPLETED|Washout (6 Weeks)||0
890290|NCT01901211|2153030|P2|COMPLETED|Washout (6 Weeks)||5
890291|NCT01901211|2153031|P1|COMPLETED|Washout (6 Weeks)||6
890292|NCT01901211|2153030|P2|STARTED|Washout (6 Weeks)||5
890293|NCT01901211|2153031|P1|STARTED|Washout (6 Weeks)||6
890294|NCT01901211|2153030|P2|NOT COMPLETED|First Ten-week Period||0
890295|NCT01901211|2153031|P1|NOT COMPLETED|First Ten-week Period||0
890296|NCT01901211|2153030|P2|COMPLETED|First Ten-week Period||5
890297|NCT01901211|2153031|P1|COMPLETED|First Ten-week Period||6
890298|NCT01901211|2153030|P2|STARTED|First Ten-week Period||5
890299|NCT01901211|2153031|P1|STARTED|First Ten-week Period||6
890300|NCT01901185|2153037|P1|NOT COMPLETED|Overall Study||2
890301|NCT01901185|2153037|P1|COMPLETED|Overall Study||75
890302|NCT01901185|2153037|P1|Received Etanercept With Autoinjector A|Overall Study||75
890303|NCT01901185|2153037|P1|STARTED|Overall Study||77
890304|NCT01900431|2153046|P3|NOT COMPLETED|Open-Label Treatment Period (Part C)||8
890305|NCT01900431|2153047|P2|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
890306|NCT01900431|2153048|P1|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
890307|NCT01900431|2153046|P3|COMPLETED|Open-Label Treatment Period (Part C)||13
890308|NCT01900431|2153047|P2|COMPLETED|Open-Label Treatment Period (Part C)||0
890309|NCT01900431|2153048|P1|COMPLETED|Open-Label Treatment Period (Part C)||0
890310|NCT01900431|2153046|P3|STARTED|Open-Label Treatment Period (Part C)|10 non-responders (5 Placebo, 5 Sarilumab) & 11 non-completers (6 Placebo, 5 Sarilumab) from Part A.|21
890311|NCT01900431|2153047|P2|STARTED|Open-Label Treatment Period (Part C)||0
890312|NCT01900431|2153048|P1|STARTED|Open-Label Treatment Period (Part C)||0
890313|NCT01900431|2153046|P3|NOT COMPLETED|Extended Treatment Period (Part B)||0
890314|NCT01900431|2153047|P2|NOT COMPLETED|Extended Treatment Period (Part B)||10
890315|NCT01900431|2153048|P1|NOT COMPLETED|Extended Treatment Period (Part B)||1
890316|NCT01900431|2153046|P3|COMPLETED|Extended Treatment Period (Part B)||0
890317|NCT01900431|2153047|P2|COMPLETED|Extended Treatment Period (Part B)||12
890318|NCT01900431|2153048|P1|COMPLETED|Extended Treatment Period (Part B)||7
890319|NCT01900431|2153046|P3|STARTED|Extended Treatment Period (Part B)||0
890320|NCT01900431|2153047|P2|STARTED|Extended Treatment Period (Part B)||22
890321|NCT01900431|2153048|P1|STARTED|Extended Treatment Period (Part B)||8
890322|NCT01900431|2153046|P3|NOT COMPLETED|Principal Treatment Period (Part A)||0
890323|NCT01900431|2153047|P2|NOT COMPLETED|Principal Treatment Period (Part A)||10
890324|NCT01900431|2153048|P1|NOT COMPLETED|Principal Treatment Period (Part A)||7
890325|NCT01900431|2153046|P3|COMPLETED|Principal Treatment Period (Part A)||0
890326|NCT01900431|2153047|P2|COMPLETED|Principal Treatment Period (Part A)|22 responders entered Part B, 5 non-responders entered Part C, 1 discontinued the study.|28
890327|NCT01900431|2153048|P1|COMPLETED|Principal Treatment Period (Part A)|8 responders entered Part B and 5 non-responders entered Part C.|13
890328|NCT01900431|2153046|P3|STARTED|Principal Treatment Period (Part A)||0
890329|NCT01900431|2153047|P2|STARTED|Principal Treatment Period (Part A)||38
890330|NCT01900431|2153048|P1|STARTED|Principal Treatment Period (Part A)||20
890331|NCT01900314|2153074|P2|NOT COMPLETED|Overall Study||4
890332|NCT01900314|2153075|P1|NOT COMPLETED|Overall Study||4
890333|NCT01900314|2153074|P2|COMPLETED|Overall Study|1 patient had 4 TMS Tx, but missed too many for protocol requirements,|16
890334|NCT01900314|2153075|P1|COMPLETED|Overall Study|1 patient had MRI, then moved away after 5 TMS treatments|16
890335|NCT01900314|2153074|P2|Completed MRI#1|Overall Study|2 withdrew consent, 1 patient was unable to tolerate MRI|17
890336|NCT01900314|2153075|P1|Completed MRI#1|Overall Study|2 withdrew consent prior to MRI, 1 had MRI technical failure|17
890337|NCT01900314|2153074|P2|STARTED|Overall Study||20
890338|NCT01900314|2153075|P1|STARTED|Overall Study||20
890339|NCT01900249|2153086|P3|NOT COMPLETED|Overall Study||4
890340|NCT01900249|2153087|P2|NOT COMPLETED|Overall Study||5
890341|NCT01900249|2153088|P1|NOT COMPLETED|Overall Study||3
890342|NCT01900249|2153086|P3|COMPLETED|Overall Study||65
890343|NCT01900249|2153087|P2|COMPLETED|Overall Study||63
890344|NCT01900249|2153088|P1|COMPLETED|Overall Study||64
890345|NCT01900249|2153086|P3|STARTED|Overall Study||69
890346|NCT01900249|2153087|P2|STARTED|Overall Study||68
890347|NCT01900249|2153088|P1|STARTED|Overall Study||67
890348|NCT01900067|2153098|P2|NOT COMPLETED|Overall Study||13
890349|NCT01900067|2153099|P1|NOT COMPLETED|Overall Study||12
890350|NCT01900067|2153098|P2|COMPLETED|Overall Study||124
890351|NCT01900067|2153099|P1|COMPLETED|Overall Study||122
890352|NCT01900067|2153098|P2|STARTED|Overall Study||137
890353|NCT01900067|2153099|P1|STARTED|Overall Study||134
890354|NCT01900054|2153105|P1|NOT COMPLETED|Overall Study||2
890355|NCT01900054|2153105|P1|COMPLETED|Overall Study||56
890356|NCT01900054|2153105|P1|STARTED|Overall Study||58
890357|NCT01899911|2153110|P1|NOT COMPLETED|Overall Study||0
890358|NCT01899911|2153110|P1|COMPLETED|Overall Study||12
890359|NCT01899911|2153110|P1|STARTED|Overall Study||12
890360|NCT01899768|2153114|P1|NOT COMPLETED|Part C||0
890361|NCT01899768|2153114|P1|COMPLETED|Part C||11
890362|NCT01899768|2153114|P1|STARTED|Part C||11
890363|NCT01899768|2153114|P1|NOT COMPLETED|Part B||2
890364|NCT01899768|2153114|P1|COMPLETED|Part B||11
890365|NCT01899768|2153114|P1|STARTED|Part B||13
890366|NCT01899768|2153114|P1|NOT COMPLETED|Part A||3
890367|NCT01899768|2153114|P1|COMPLETED|Part A||13
890368|NCT01899768|2153114|P1|STARTED|Part A||16
890369|NCT01899742|2153188|P2|NOT COMPLETED|Overall Study||16
890370|NCT01899742|2153189|P1|NOT COMPLETED|Overall Study||17
890371|NCT01899742|2153188|P2|COMPLETED|Overall Study||231
890372|NCT01899742|2153189|P1|COMPLETED|Overall Study||230
890373|NCT01899742|2153188|P2|STARTED|Overall Study||247
890374|NCT01899742|2153189|P1|STARTED|Overall Study||247
890375|NCT01899677|2153199|P2|NOT COMPLETED|Overall Study||7
890376|NCT01899677|2153200|P1|NOT COMPLETED|Overall Study||10
890377|NCT01899677|2153199|P2|COMPLETED|Overall Study||28
890378|NCT01899677|2153200|P1|COMPLETED|Overall Study||25
890379|NCT01899677|2153199|P2|STARTED|Overall Study||35
890380|NCT01899677|2153200|P1|STARTED|Overall Study||35
890381|NCT01899144|2153228|P1|NOT COMPLETED|Treatment Period 5||1
890382|NCT01899144|2153228|P1|COMPLETED|Treatment Period 5|Last treatment taken by the patient who discontinued was ABS Spiromax 180 mcg.|57
890383|NCT01899144|2153228|P1|STARTED|Treatment Period 5||58
890384|NCT01899144|2153228|P1|NOT COMPLETED|Treatment Period 4||0
890385|NCT01899144|2153228|P1|COMPLETED|Treatment Period 4||58
890386|NCT01899144|2153228|P1|STARTED|Treatment Period 4||58
890387|NCT01899144|2153228|P1|NOT COMPLETED|Treatment Period 3||2
890388|NCT01899144|2153228|P1|COMPLETED|Treatment Period 3|Last treatment taken by patients who discontinued were ABS Spiromax 180 mcg and ABS Spiromax 90 mcg.|58
890389|NCT01899144|2153228|P1|STARTED|Treatment Period 3||60
890390|NCT01899144|2153228|P1|NOT COMPLETED|Treatment Period 2||1
890391|NCT01899144|2153228|P1|COMPLETED|Treatment Period 2|Last treatment taken by the patient who discontinued was placebo.|60
890392|NCT01899144|2153228|P1|STARTED|Treatment Period 2||61
890393|NCT01899144|2153228|P1|NOT COMPLETED|Treatment Period 1||0
890394|NCT01899144|2153228|P1|COMPLETED|Treatment Period 1||61
890395|NCT01899144|2153228|P1|STARTED|Treatment Period 1||61
890396|NCT01898884|2153255|P9|NOT COMPLETED|Multiple Dose Period||1
890397|NCT01898884|2153256|P8|NOT COMPLETED|Multiple Dose Period||0
890398|NCT01898884|2153257|P7|NOT COMPLETED|Multiple Dose Period||1
890399|NCT01898884|2153258|P6|NOT COMPLETED|Multiple Dose Period||0
890400|NCT01898884|2153259|P5|NOT COMPLETED|Multiple Dose Period||0
890401|NCT01898884|2153260|P4|NOT COMPLETED|Multiple Dose Period||0
890402|NCT01898884|2153261|P3|NOT COMPLETED|Multiple Dose Period||0
890403|NCT01898884|2153262|P2|NOT COMPLETED|Multiple Dose Period||0
890404|NCT01898884|2153263|P1|NOT COMPLETED|Multiple Dose Period||0
890405|NCT01898884|2153255|P9|COMPLETED|Multiple Dose Period||5
890406|NCT01898884|2153256|P8|COMPLETED|Multiple Dose Period||6
890407|NCT01898884|2153257|P7|COMPLETED|Multiple Dose Period||5
890408|NCT01898884|2153258|P6|COMPLETED|Multiple Dose Period||6
890409|NCT01898884|2153259|P5|COMPLETED|Multiple Dose Period||0
890410|NCT01898884|2153260|P4|COMPLETED|Multiple Dose Period||0
890411|NCT01898884|2153261|P3|COMPLETED|Multiple Dose Period||0
890412|NCT01898884|2153262|P2|COMPLETED|Multiple Dose Period||0
890413|NCT01898884|2153263|P1|COMPLETED|Multiple Dose Period||0
890414|NCT01898884|2153255|P9|Treated|Multiple Dose Period||5
890415|NCT01898884|2153256|P8|Treated|Multiple Dose Period||6
890416|NCT01898884|2153257|P7|Treated|Multiple Dose Period||6
890417|NCT01898884|2153258|P6|Treated|Multiple Dose Period||6
890418|NCT01898884|2153259|P5|Treated|Multiple Dose Period||0
890419|NCT01898884|2153260|P4|Treated|Multiple Dose Period||0
890420|NCT01898884|2153261|P3|Treated|Multiple Dose Period||0
890421|NCT01898884|2153262|P2|Treated|Multiple Dose Period||0
890422|NCT01898884|2153263|P1|Treated|Multiple Dose Period||0
890423|NCT01898884|2153255|P9|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
890424|NCT01898884|2153256|P8|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
890425|NCT01898884|2153257|P7|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
890426|NCT01898884|2153258|P6|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
890427|NCT01898884|2153259|P5|STARTED|Multiple Dose Period||0
890428|NCT01898884|2153260|P4|STARTED|Multiple Dose Period||0
890429|NCT01898884|2153261|P3|STARTED|Multiple Dose Period||0
890430|NCT01898884|2153262|P2|STARTED|Multiple Dose Period||0
890431|NCT01898884|2153263|P1|STARTED|Multiple Dose Period||0
890432|NCT01898884|2153255|P9|NOT COMPLETED|Single Dose Period||0
890433|NCT01898884|2153256|P8|NOT COMPLETED|Single Dose Period||0
890434|NCT01898884|2153257|P7|NOT COMPLETED|Single Dose Period||0
890435|NCT01898884|2153258|P6|NOT COMPLETED|Single Dose Period||0
890436|NCT01898884|2153259|P5|NOT COMPLETED|Single Dose Period||0
890437|NCT01898884|2153260|P4|NOT COMPLETED|Single Dose Period||0
890438|NCT01898884|2153261|P3|NOT COMPLETED|Single Dose Period||0
890439|NCT01898884|2153262|P2|NOT COMPLETED|Single Dose Period||0
890440|NCT01898884|2153263|P1|NOT COMPLETED|Single Dose Period||0
890441|NCT01898884|2153255|P9|COMPLETED|Single Dose Period||0
890442|NCT01898884|2153256|P8|COMPLETED|Single Dose Period||0
890443|NCT01898884|2153257|P7|COMPLETED|Single Dose Period||0
890444|NCT01898884|2153258|P6|COMPLETED|Single Dose Period||0
890445|NCT01898884|2153259|P5|COMPLETED|Single Dose Period||6
890446|NCT01898884|2153260|P4|COMPLETED|Single Dose Period||6
890447|NCT01898884|2153261|P3|COMPLETED|Single Dose Period||6
890448|NCT01898884|2153262|P2|COMPLETED|Single Dose Period||6
890449|NCT01898884|2153263|P1|COMPLETED|Single Dose Period||8
890450|NCT01898884|2153255|P9|STARTED|Single Dose Period||0
890451|NCT01898884|2153256|P8|STARTED|Single Dose Period||0
890452|NCT01898884|2153257|P7|STARTED|Single Dose Period||0
890453|NCT01898884|2153258|P6|STARTED|Single Dose Period||0
890454|NCT01898884|2153259|P5|STARTED|Single Dose Period||6
890455|NCT01898884|2153260|P4|STARTED|Single Dose Period||6
890456|NCT01898884|2153261|P3|STARTED|Single Dose Period||6
890457|NCT01898884|2153262|P2|STARTED|Single Dose Period||6
890458|NCT01898884|2153263|P1|STARTED|Single Dose Period||8
890459|NCT01898598|2153415|P2|NOT COMPLETED|Overall Study||2
890460|NCT01898598|2153416|P1|NOT COMPLETED|Overall Study||4
890461|NCT01898598|2153415|P2|COMPLETED|Overall Study||4
890462|NCT01898598|2153416|P1|COMPLETED|Overall Study||8
890463|NCT01898598|2153415|P2|Treated|Overall Study||5
890464|NCT01898598|2153416|P1|Treated|Overall Study||11
890465|NCT01898598|2153415|P2|STARTED|Overall Study||6
890466|NCT01898598|2153416|P1|STARTED|Overall Study||12
890467|NCT01898442|2153435|P3|NOT COMPLETED|Overall Study||3
890468|NCT01898442|2153436|P2|NOT COMPLETED|Overall Study||2
890469|NCT01898442|2153437|P1|NOT COMPLETED|Overall Study||1
890470|NCT01898442|2153435|P3|COMPLETED|Overall Study||15
890471|NCT01898442|2153436|P2|COMPLETED|Overall Study||15
890472|NCT01898442|2153437|P1|COMPLETED|Overall Study||16
890473|NCT01898442|2153435|P3|STARTED|Overall Study||18
890474|NCT01898442|2153436|P2|STARTED|Overall Study||17
890475|NCT01898442|2153437|P1|STARTED|Overall Study||17
890476|NCT01898403|2153460|P1|NOT COMPLETED|Overall Study||0
890477|NCT01898403|2153460|P1|COMPLETED|Overall Study||50
890478|NCT01898403|2153460|P1|STARTED|Overall Study||50
890479|NCT01898286|2153466|P1|NOT COMPLETED|Overall Study||3
890480|NCT01898286|2153466|P1|COMPLETED|Overall Study|"For this study completed is defined as completing the Early Termination visit"|35
890481|NCT01898286|2153466|P1|STARTED|Overall Study||38
890482|NCT01898208|2153476|P3|NOT COMPLETED|Overall Study||37
890483|NCT01898208|2153477|P2|NOT COMPLETED|Overall Study||49
890484|NCT01898208|2153478|P1|NOT COMPLETED|Overall Study||40
890485|NCT01898208|2153476|P3|COMPLETED|Overall Study||212
890486|NCT01898208|2153477|P2|COMPLETED|Overall Study||198
890487|NCT01898208|2153478|P1|COMPLETED|Overall Study||207
890488|NCT01898208|2153476|P3|STARTED|Overall Study||249
890489|NCT01898208|2153477|P2|STARTED|Overall Study||247
890490|NCT01898208|2153478|P1|STARTED|Overall Study||247
890491|NCT01898195|2153525|P3|NOT COMPLETED|Smoking Abstinence||36
890492|NCT01898195|2153526|P2|NOT COMPLETED|Smoking Abstinence||38
890493|NCT01898195|2153527|P1|NOT COMPLETED|Smoking Abstinence||35
890494|NCT01898195|2153525|P3|COMPLETED|Smoking Abstinence||15
890495|NCT01898195|2153526|P2|COMPLETED|Smoking Abstinence||16
890496|NCT01898195|2153527|P1|COMPLETED|Smoking Abstinence||18
890497|NCT01898195|2153525|P3|STARTED|Smoking Abstinence||51
890498|NCT01898195|2153526|P2|STARTED|Smoking Abstinence||54
890499|NCT01898195|2153527|P1|STARTED|Smoking Abstinence||53
890500|NCT01898195|2153525|P3|NOT COMPLETED|Varenicline Adherence||36
890501|NCT01898195|2153526|P2|NOT COMPLETED|Varenicline Adherence||38
890502|NCT01898195|2153527|P1|NOT COMPLETED|Varenicline Adherence||35
890503|NCT01898195|2153525|P3|COMPLETED|Varenicline Adherence||15
890504|NCT01898195|2153526|P2|COMPLETED|Varenicline Adherence||16
890505|NCT01898195|2153527|P1|COMPLETED|Varenicline Adherence||18
890506|NCT01898195|2153525|P3|STARTED|Varenicline Adherence||51
890507|NCT01898195|2153526|P2|STARTED|Varenicline Adherence||54
890508|NCT01898195|2153527|P1|STARTED|Varenicline Adherence||53
890509|NCT01898091|2153540|P2|NOT COMPLETED|Overall Study||6
890510|NCT01898091|2153541|P1|NOT COMPLETED|Overall Study||2
890511|NCT01898091|2153540|P2|COMPLETED|Overall Study||19
890512|NCT01898091|2153541|P1|COMPLETED|Overall Study||23
890513|NCT01898091|2153540|P2|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
890514|NCT01898091|2153541|P1|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
890515|NCT01897792|2153549|P2|NOT COMPLETED|Overall Study||0
890516|NCT01897792|2153550|P1|NOT COMPLETED|Overall Study||0
890517|NCT01897792|2153549|P2|COMPLETED|Overall Study||5
890518|NCT01897792|2153550|P1|COMPLETED|Overall Study||6
890519|NCT01897792|2153549|P2|STARTED|Overall Study||5
890520|NCT01897792|2153550|P1|STARTED|Overall Study||6
890521|NCT01897727|2153576|P2|NOT COMPLETED|Overall Study||1
890522|NCT01897727|2153577|P1|NOT COMPLETED|Overall Study||0
890523|NCT01897727|2153576|P2|COMPLETED|Overall Study||8
890524|NCT01897727|2153577|P1|COMPLETED|Overall Study||8
890525|NCT01897727|2153576|P2|STARTED|Overall Study||9
890526|NCT01897727|2153577|P1|STARTED|Overall Study||8
890527|NCT01897402|2153585|P2|NOT COMPLETED|Overall Study||16
890528|NCT01897402|2153586|P1|NOT COMPLETED|Overall Study||19
890529|NCT01897402|2153585|P2|COMPLETED|Overall Study||244
890530|NCT01897402|2153586|P1|COMPLETED|Overall Study||246
890531|NCT01897402|2153585|P2|STARTED|Overall Study||260
890532|NCT01897402|2153586|P1|STARTED|Overall Study||265
890533|NCT01897285|2153598|P1|NOT COMPLETED|Overall Study||0
890534|NCT01897285|2153598|P1|COMPLETED|Overall Study||20
890535|NCT01897285|2153598|P1|STARTED|Overall Study|All 20 participants received original AND test adhesive dressings on upper arms and lower back.|20
890536|NCT01897233|2153606|P1|NOT COMPLETED|Part B (24 Weeks)||4
890537|NCT01897233|2153606|P1|COMPLETED|Part B (24 Weeks)||54
890538|NCT01897233|2153606|P1|STARTED|Part B (24 Weeks)|6 participants from Part A also participated in Part B of the study.|58
890539|NCT01897233|2153606|P1|NOT COMPLETED|Part A (14 Days)||0
890540|NCT01897233|2153606|P1|COMPLETED|Part A (14 Days)||10
890541|NCT01897233|2153606|P1|Part A Cohort 2 (9 to 11 Years)|Part A (14 Days)||5
890542|NCT01897233|2153606|P1|Part A Cohort 1 (6 to 8 Years)|Part A (14 Days)||5
890543|NCT01897233|2153606|P1|STARTED|Part A (14 Days)||10
890544|NCT01897025|2153630|P2|NOT COMPLETED|Overall Study||0
890545|NCT01897025|2153631|P1|NOT COMPLETED|Overall Study||0
890546|NCT01897025|2153630|P2|COMPLETED|Overall Study||9
890547|NCT01897025|2153631|P1|COMPLETED|Overall Study||10
890548|NCT01897025|2153630|P2|STARTED|Overall Study||9
890549|NCT01897025|2153631|P1|STARTED|Overall Study||10
890550|NCT01896986|2153639|P2|NOT COMPLETED|Overall Study||23
890551|NCT01896986|2153640|P1|NOT COMPLETED|Overall Study||14
890552|NCT01896986|2153639|P2|COMPLETED|Overall Study||0
890553|NCT01896986|2153640|P1|COMPLETED|Overall Study||0
890554|NCT01896986|2153639|P2|STARTED|Overall Study||23
890555|NCT01896986|2153640|P1|STARTED|Overall Study||14
890556|NCT01896934|2153646|P1|NOT COMPLETED|Overall Study||2
890557|NCT01896934|2153646|P1|COMPLETED|Overall Study||19
890558|NCT01896934|2153646|P1|STARTED|Overall Study||21
890559|NCT01896726|2153652|P1|NOT COMPLETED|Treatment Period 2 (Days 23-31)||2
890560|NCT01896726|2153652|P1|COMPLETED|Treatment Period 2 (Days 23-31)||18
890561|NCT01896726|2153652|P1|Received Microgynon|Treatment Period 2 (Days 23-31)||18
890562|NCT01896726|2153652|P1|Received at Least 1 Dose of Baricitinib|Treatment Period 2 (Days 23-31)||20
890563|NCT01896726|2153652|P1|STARTED|Treatment Period 2 (Days 23-31)||20
890564|NCT01896726|2153652|P1|NOT COMPLETED|Treatment Period 1 (Days 1-22)||0
890565|NCT01896726|2153652|P1|COMPLETED|Treatment Period 1 (Days 1-22)||20
890566|NCT01896726|2153652|P1|Received Microgynon|Treatment Period 1 (Days 1-22)||20
890567|NCT01896726|2153652|P1|STARTED|Treatment Period 1 (Days 1-22)||20
890568|NCT01896687|2153667|P2|NOT COMPLETED|Overall Study||0
890569|NCT01896687|2153668|P1|NOT COMPLETED|Overall Study||0
890570|NCT01896687|2153667|P2|COMPLETED|Overall Study||15
890571|NCT01896687|2153668|P1|COMPLETED|Overall Study||15
890572|NCT01896687|2153667|P2|STARTED|Overall Study||15
890573|NCT01896687|2153668|P1|STARTED|Overall Study||15
890574|NCT01896557|2153676|P2|NOT COMPLETED|Clopidogrel + GI Protector||4
890575|NCT01896557|2153677|P1|NOT COMPLETED|Clopidogrel + GI Protector||2
890576|NCT01896557|2153676|P2|COMPLETED|Clopidogrel + GI Protector||44
890577|NCT01896557|2153677|P1|COMPLETED|Clopidogrel + GI Protector||41
890578|NCT01896557|2153676|P2|STARTED|Clopidogrel + GI Protector||48
890579|NCT01896557|2153677|P1|STARTED|Clopidogrel + GI Protector||43
890580|NCT01896557|2153676|P2|NOT COMPLETED|Clopidogrel Alone||0
890581|NCT01896557|2153677|P1|NOT COMPLETED|Clopidogrel Alone||1
890582|NCT01896557|2153676|P2|COMPLETED|Clopidogrel Alone||48
890583|NCT01896557|2153677|P1|COMPLETED|Clopidogrel Alone||43
890584|NCT01896557|2153676|P2|STARTED|Clopidogrel Alone||48
890585|NCT01896557|2153677|P1|STARTED|Clopidogrel Alone||44
890586|NCT01896544|2153688|P3|NOT COMPLETED|Overall Study||0
890587|NCT01896544|2153689|P2|NOT COMPLETED|Overall Study||0
890588|NCT01896544|2153690|P1|NOT COMPLETED|Overall Study||0
890589|NCT01896544|2153688|P3|COMPLETED|Overall Study||10
890590|NCT01896544|2153689|P2|COMPLETED|Overall Study||10
890591|NCT01896544|2153690|P1|COMPLETED|Overall Study||10
890592|NCT01896544|2153688|P3|STARTED|Overall Study||10
890593|NCT01896544|2153689|P2|STARTED|Overall Study||10
890594|NCT01896544|2153690|P1|STARTED|Overall Study||10
890595|NCT01896297|2153710|P1|NOT COMPLETED|Overall Study||1
890596|NCT01896297|2153710|P1|COMPLETED|Overall Study||59
890597|NCT01896297|2153710|P1|STARTED|Overall Study||60
890598|NCT01896232|2153717|P2|NOT COMPLETED|Overall Study||53
890599|NCT01896232|2153718|P1|NOT COMPLETED|Overall Study||49
890600|NCT01896232|2153717|P2|COMPLETED|Overall Study||287
890601|NCT01896232|2153718|P1|COMPLETED|Overall Study||294
890602|NCT01896232|2153717|P2|Received Treatment|Overall Study||338
890603|NCT01896232|2153718|P1|Received Treatment|Overall Study||341
890604|NCT01896232|2153717|P2|STARTED|Overall Study||340
890605|NCT01896232|2153718|P1|STARTED|Overall Study||343
890606|NCT01896206|2153738|P1|NOT COMPLETED|Overall Study||0
890607|NCT01896206|2153738|P1|COMPLETED|Overall Study||21
890608|NCT01896206|2153738|P1|STARTED|Overall Study||21
890609|NCT01896193|2153746|P2|NOT COMPLETED|Overall Study||12
890610|NCT01896193|2153747|P1|NOT COMPLETED|Overall Study||21
890611|NCT01896193|2153746|P2|COMPLETED|Overall Study||53
890612|NCT01896193|2153747|P1|COMPLETED|Overall Study||41
890613|NCT01896193|2153746|P2|STARTED|Overall Study||65
890614|NCT01896193|2153747|P1|STARTED|Overall Study||62
890615|NCT01896115|2153771|P1|NOT COMPLETED|Overall Study||1
890616|NCT01896115|2153771|P1|COMPLETED|Overall Study||15
890617|NCT01896115|2153771|P1|Ventral Steering|Overall Study||15
890618|NCT01896115|2153771|P1|Dorsal Steering|Overall Study||15
890619|NCT01896115|2153771|P1|Conventional PW|Overall Study||15
890620|NCT01896115|2153771|P1|Short PW|Overall Study||15
890621|NCT01896115|2153771|P1|STARTED|Overall Study||16
890622|NCT01896050|2153796|P2|NOT COMPLETED|Overall Study||2
890623|NCT01896050|2153797|P1|NOT COMPLETED|Overall Study||38
890624|NCT01896050|2153796|P2|COMPLETED|Overall Study||20
890625|NCT01896050|2153797|P1|COMPLETED|Overall Study|This includes only patients who remained on the same aromatase inhibitor medication for 12 months|55
890626|NCT01896050|2153796|P2|STARTED|Overall Study||22
890627|NCT01896050|2153797|P1|STARTED|Overall Study||93
890628|NCT01895946|2153809|P2|NOT COMPLETED|Overall Study||0
890629|NCT01895946|2153810|P1|NOT COMPLETED|Overall Study||0
890630|NCT01895946|2153809|P2|COMPLETED|Overall Study||12
890631|NCT01895946|2153810|P1|COMPLETED|Overall Study||18
890632|NCT01895946|2153809|P2|STARTED|Overall Study||12
890633|NCT01895946|2153810|P1|STARTED|Overall Study||18
890634|NCT01895634|2153828|P1|NOT COMPLETED|Overall Study||3
890635|NCT01895634|2153828|P1|COMPLETED|Overall Study||46
890636|NCT01895634|2153828|P1|STARTED|Overall Study||49
890637|NCT01895608|2153840|P4|NOT COMPLETED|Overall Study||0
890638|NCT01895608|2153841|P3|NOT COMPLETED|Overall Study||3
890639|NCT01895608|2153842|P2|NOT COMPLETED|Overall Study||1
890640|NCT01895608|2153843|P1|NOT COMPLETED|Overall Study||0
890641|NCT01895608|2153840|P4|COMPLETED|Overall Study||6
890642|NCT01895608|2153841|P3|COMPLETED|Overall Study||8
890643|NCT01895608|2153842|P2|COMPLETED|Overall Study||6
890644|NCT01895608|2153843|P1|COMPLETED|Overall Study||10
890645|NCT01895608|2153840|P4|STARTED|Overall Study||6
890646|NCT01895608|2153841|P3|STARTED|Overall Study||11
890647|NCT01895608|2153842|P2|STARTED|Overall Study||7
890648|NCT01895608|2153843|P1|STARTED|Overall Study||10
890649|NCT01895543|2153873|P1|NOT COMPLETED|Overall Study||129
890650|NCT01895543|2153873|P1|COMPLETED|Overall Study||282
890651|NCT01895543|2153873|P1|Per Protocol Analysis Set|Overall Study|Set included all enrolled patients who had no major protocol deviations.|380
890652|NCT01895543|2153873|P1|Safety Analysis Set|Overall Study|Set included all enrolled patients who took at least one dose of Investigational Medicinal Product.|409
890653|NCT01895543|2153873|P1|STARTED|Overall Study||411
890654|NCT01895452|2153889|P2|NOT COMPLETED|Overall Study||28
890655|NCT01895452|2153890|P1|NOT COMPLETED|Overall Study||4
890656|NCT01895452|2153889|P2|COMPLETED|Overall Study||198
890657|NCT01895452|2153890|P1|COMPLETED|Overall Study||61
890658|NCT01895452|2153889|P2|STARTED|Overall Study||226
890659|NCT01895452|2153890|P1|STARTED|Overall Study||65
890660|NCT01895335|2153900|P1|NOT COMPLETED|Overall Study||215
890661|NCT01895335|2153900|P1|COMPLETED|Overall Study||786
890662|NCT01895335|2153900|P1|Treated|Overall Study||1000
890663|NCT01895335|2153900|P1|STARTED|Overall Study||1001
890664|NCT01895322|2153917|P1|NOT COMPLETED|Overall Study||13
890665|NCT01895322|2153917|P1|COMPLETED|Overall Study||7
890666|NCT01895322|2153917|P1|STARTED|Overall Study||20
890667|NCT01895309|2153926|P2|NOT COMPLETED|Overall Study||51
890668|NCT01895309|2153927|P1|NOT COMPLETED|Overall Study||40
890669|NCT01895309|2153926|P2|COMPLETED|Overall Study||246
890670|NCT01895309|2153927|P1|COMPLETED|Overall Study||259
890671|NCT01895309|2153926|P2|STARTED|Overall Study||297
890672|NCT01895309|2153927|P1|STARTED|Overall Study||299
890673|NCT01895270|2153941|P2|NOT COMPLETED|Isradipine Taper (W7-8)||2
890674|NCT01895270|2153942|P1|NOT COMPLETED|Isradipine Taper (W7-8)||0
890675|NCT01895270|2153941|P2|COMPLETED|Isradipine Taper (W7-8)||0
890676|NCT01895270|2153942|P1|COMPLETED|Isradipine Taper (W7-8)||2
890677|NCT01895270|2153941|P2|STARTED|Isradipine Taper (W7-8)||2
890678|NCT01895270|2153942|P1|STARTED|Isradipine Taper (W7-8)||2
890679|NCT01895270|2153941|P2|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||5
890680|NCT01895270|2153942|P1|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||3
890681|NCT01895270|2153941|P2|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
890682|NCT01895270|2153942|P1|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
890683|NCT01895270|2153941|P2|STARTED|Buprenorphine Taper (W5 to W6D3)|1 subject missed meds prior to bup taper so did not start this phase|7
890684|NCT01895270|2153942|P1|STARTED|Buprenorphine Taper (W5 to W6D3)||5
890685|NCT01895270|2153941|P2|NOT COMPLETED|Study Medications Induction (W1-4)||6
890686|NCT01895270|2153942|P1|NOT COMPLETED|Study Medications Induction (W1-4)||6
890687|NCT01895270|2153941|P2|COMPLETED|Study Medications Induction (W1-4)||8
890688|NCT01895270|2153942|P1|COMPLETED|Study Medications Induction (W1-4)||5
890689|NCT01895270|2153941|P2|STARTED|Study Medications Induction (W1-4)||14
890690|NCT01895270|2153942|P1|STARTED|Study Medications Induction (W1-4)||11
890691|NCT01895127|2153950|P2|NOT COMPLETED|Long Term Follow-up (Month 3-12)||3
890692|NCT01895127|2153951|P1|NOT COMPLETED|Long Term Follow-up (Month 3-12)||2
890693|NCT01895127|2153950|P2|COMPLETED|Long Term Follow-up (Month 3-12)||4
890694|NCT01895127|2153951|P1|COMPLETED|Long Term Follow-up (Month 3-12)||1
890695|NCT01895127|2153950|P2|STARTED|Long Term Follow-up (Month 3-12)||7
890696|NCT01895127|2153951|P1|STARTED|Long Term Follow-up (Month 3-12)||3
890697|NCT01895127|2153950|P2|NOT COMPLETED|Month 3 Follow-up & Biopsy||0
890698|NCT01895127|2153951|P1|NOT COMPLETED|Month 3 Follow-up & Biopsy||0
890699|NCT01895127|2153950|P2|COMPLETED|Month 3 Follow-up & Biopsy||7
890700|NCT01895127|2153951|P1|COMPLETED|Month 3 Follow-up & Biopsy||3
890701|NCT01895127|2153950|P2|STARTED|Month 3 Follow-up & Biopsy||7
890702|NCT01895127|2153951|P1|STARTED|Month 3 Follow-up & Biopsy||3
890703|NCT01895127|2153950|P2|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0
890704|NCT01895127|2153951|P1|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0
890705|NCT01895127|2153950|P2|COMPLETED|Treatment Period (Week 0-Month 3)||7
890706|NCT01895127|2153951|P1|COMPLETED|Treatment Period (Week 0-Month 3)||3
890707|NCT01895127|2153950|P2|STARTED|Treatment Period (Week 0-Month 3)||7
890708|NCT01895127|2153951|P1|STARTED|Treatment Period (Week 0-Month 3)||3
890709|NCT01895127|2153950|P2|NOT COMPLETED|Screening||0
890710|NCT01895127|2153951|P1|NOT COMPLETED|Screening||0
890711|NCT01895127|2153950|P2|COMPLETED|Screening||7
890712|NCT01895127|2153951|P1|COMPLETED|Screening|One subject was found to be pregnant at screening so was withdrawn from the study prior to treatment|4
890713|NCT01895127|2153950|P2|STARTED|Screening||7
890714|NCT01895127|2153951|P1|STARTED|Screening||4
890715|NCT01895101|2153961|P3|NOT COMPLETED|Overall Study||5
890716|NCT01895101|2153962|P2|NOT COMPLETED|Overall Study||5
890717|NCT01895101|2153963|P1|NOT COMPLETED|Overall Study||1
890718|NCT01895101|2153961|P3|COMPLETED|Overall Study||245
890719|NCT01895101|2153962|P2|COMPLETED|Overall Study||245
890720|NCT01895101|2153963|P1|COMPLETED|Overall Study||249
890721|NCT01895101|2153961|P3|STARTED|Overall Study||250
890722|NCT01895101|2153962|P2|STARTED|Overall Study||250
890723|NCT01895101|2153963|P1|STARTED|Overall Study||250
890724|NCT01895088|2153977|P1|NOT COMPLETED|Overall Study||18
890725|NCT01895088|2153977|P1|COMPLETED|Overall Study||253
890726|NCT01895088|2153977|P1|STARTED|Overall Study|1 subject consented for monitoring after device removal (not included in cohort), per FDA request.|271
890727|NCT01895062|2153983|P2|NOT COMPLETED|Overall Study||0
890728|NCT01895062|2153984|P1|NOT COMPLETED|Overall Study||0
890729|NCT01895062|2153983|P2|COMPLETED|Overall Study||24
890730|NCT01895062|2153984|P1|COMPLETED|Overall Study||30
890731|NCT01895062|2153983|P2|STARTED|Overall Study||24
890732|NCT01895062|2153984|P1|STARTED|Overall Study||30
890733|NCT01895036|2153992|P1|NOT COMPLETED|Overall Study||0
890734|NCT01895036|2153992|P1|COMPLETED|Overall Study||6
890735|NCT01895036|2153992|P1|STARTED|Overall Study||6
890736|NCT01894984|2153998|P2|NOT COMPLETED|Overall Study||175
890737|NCT01894984|2153999|P1|NOT COMPLETED|Overall Study||314
890738|NCT01894984|2153998|P2|COMPLETED|Overall Study||69
890739|NCT01894984|2153999|P1|COMPLETED|Overall Study||82
890740|NCT01894984|2153998|P2|STARTED|Overall Study||244
890741|NCT01894984|2153999|P1|STARTED|Overall Study||396
890742|NCT01894906|2154017|P2|NOT COMPLETED|Overall Study||0
890743|NCT01894906|2154018|P1|NOT COMPLETED|Overall Study||0
890744|NCT01894906|2154017|P2|COMPLETED|Overall Study||6
890745|NCT01894906|2154018|P1|COMPLETED|Overall Study||6
890746|NCT01894906|2154017|P2|Treatment F|Overall Study||6
890747|NCT01894906|2154018|P1|Treatment F|Overall Study||6
890748|NCT01894906|2154017|P2|Treatment E|Overall Study||6
890749|NCT01894906|2154018|P1|Treatment E|Overall Study||6
890750|NCT01894906|2154017|P2|Treatment D|Overall Study||6
890751|NCT01894906|2154018|P1|Treatment D|Overall Study||6
890752|NCT01894906|2154017|P2|Treatment C|Overall Study||6
890753|NCT01894906|2154018|P1|Treatment C|Overall Study||6
890754|NCT01894906|2154017|P2|Treatment B|Overall Study||6
890755|NCT01894906|2154018|P1|Treatment B|Overall Study||6
890756|NCT01894906|2154017|P2|Treatment A|Overall Study||6
890757|NCT01894906|2154018|P1|Treatment A|Overall Study||6
890758|NCT01894906|2154017|P2|STARTED|Overall Study||6
890759|NCT01894906|2154018|P1|STARTED|Overall Study||6
890760|NCT01894672|2154048|P1|NOT COMPLETED|Overall Study||0
890761|NCT01894672|2154048|P1|COMPLETED|Overall Study||7
890762|NCT01894672|2154048|P1|STARTED|Overall Study||7
890763|NCT01894607|2154054|P1|NOT COMPLETED|Overall Study||1
890764|NCT01894607|2154054|P1|COMPLETED|Overall Study||10
890765|NCT01894607|2154054|P1|STARTED|Overall Study||11
890766|NCT01894581|2154061|P2|NOT COMPLETED|Overall Study||7
890767|NCT01894581|2154062|P1|NOT COMPLETED|Overall Study||5
890768|NCT01894581|2154061|P2|COMPLETED|Overall Study||12
890769|NCT01894581|2154062|P1|COMPLETED|Overall Study||15
890770|NCT01894581|2154061|P2|STARTED|Overall Study||19
890771|NCT01894581|2154062|P1|STARTED|Overall Study||20
890772|NCT01894555|2154068|P1|NOT COMPLETED|Overall Study||0
890773|NCT01894555|2154068|P1|COMPLETED|Overall Study||33
890774|NCT01894555|2154068|P1|STARTED|Overall Study||33
890775|NCT01894256|2154075|P3|NOT COMPLETED|Part B||14
890776|NCT01894256|2154076|P2|NOT COMPLETED|Part B||14
890777|NCT01894256|2154077|P1|NOT COMPLETED|Part B||15
890778|NCT01894256|2154075|P3|COMPLETED|Part B||0
890779|NCT01894256|2154076|P2|COMPLETED|Part B||0
890780|NCT01894256|2154077|P1|COMPLETED|Part B||0
890781|NCT01894256|2154075|P3|STARTED|Part B||14
890782|NCT01894256|2154076|P2|STARTED|Part B||14
890783|NCT01894256|2154077|P1|STARTED|Part B||15
890784|NCT01894256|2154075|P3|NOT COMPLETED|Part A||0
890785|NCT01894256|2154076|P2|NOT COMPLETED|Part A||1
890786|NCT01894256|2154077|P1|NOT COMPLETED|Part A||0
890787|NCT01894256|2154075|P3|COMPLETED|Part A||14
890788|NCT01894256|2154076|P2|COMPLETED|Part A||14
890789|NCT01894256|2154077|P1|COMPLETED|Part A||15
890790|NCT01894256|2154075|P3|STARTED|Part A||14
890791|NCT01894256|2154076|P2|STARTED|Part A||15
890792|NCT01894256|2154077|P1|STARTED|Part A||15
890793|NCT01894230|2154123|P2|NOT COMPLETED|Overall Study||7
890794|NCT01894230|2154124|P1|NOT COMPLETED|Overall Study||7
890795|NCT01894230|2154123|P2|COMPLETED|Overall Study||69
890796|NCT01894230|2154124|P1|COMPLETED|Overall Study||76
890797|NCT01894230|2154123|P2|STARTED|Overall Study||76
890798|NCT01894230|2154124|P1|STARTED|Overall Study||83
890799|NCT01894100|2154150|P2|NOT COMPLETED|Overall Study||1
890800|NCT01894100|2154151|P1|NOT COMPLETED|Overall Study||3
890801|NCT01894100|2154150|P2|COMPLETED|Overall Study||14
890802|NCT01894100|2154151|P1|COMPLETED|Overall Study||12
890803|NCT01894100|2154150|P2|STARTED|Overall Study||15
890804|NCT01894100|2154151|P1|STARTED|Overall Study||15
890805|NCT01894022|2154161|P2|NOT COMPLETED|Overall Study||10
890806|NCT01894022|2154162|P1|NOT COMPLETED|Overall Study||9
890807|NCT01894022|2154161|P2|COMPLETED|Overall Study||0
890808|NCT01894022|2154162|P1|COMPLETED|Overall Study||0
890809|NCT01894022|2154161|P2|STARTED|Overall Study||10
890810|NCT01894022|2154162|P1|STARTED|Overall Study||9
890811|NCT01893905|2154216|P2|NOT COMPLETED|Overall Study||14
890812|NCT01893905|2154217|P1|NOT COMPLETED|Overall Study||25
890813|NCT01893905|2154216|P2|COMPLETED|Overall Study||64
890814|NCT01893905|2154217|P1|COMPLETED|Overall Study||55
890815|NCT01893905|2154216|P2|STARTED|Overall Study||78
890816|NCT01893905|2154217|P1|STARTED|Overall Study||80
890817|NCT01893879|2154225|P2|NOT COMPLETED|Overall Study||3
890818|NCT01893879|2154226|P1|NOT COMPLETED|Overall Study||2
890819|NCT01893879|2154225|P2|COMPLETED|Overall Study||4
890820|NCT01893879|2154226|P1|COMPLETED|Overall Study||5
890821|NCT01893879|2154225|P2|STARTED|Overall Study||7
890822|NCT01893879|2154226|P1|STARTED|Overall Study||7
890823|NCT01893567|2154232|P1|NOT COMPLETED|Overall Study||0
890824|NCT01893567|2154232|P1|COMPLETED|Overall Study||28
890825|NCT01893567|2154232|P1|STARTED|Overall Study||28
890826|NCT01893411|2154239|P3|NOT COMPLETED|Overall Study||9
890827|NCT01893411|2154240|P2|NOT COMPLETED|Overall Study||7
890828|NCT01893411|2154241|P1|NOT COMPLETED|Overall Study||17
890829|NCT01893411|2154239|P3|COMPLETED|Overall Study||69
890830|NCT01893411|2154240|P2|COMPLETED|Overall Study||70
890831|NCT01893411|2154241|P1|COMPLETED|Overall Study||139
890832|NCT01893411|2154239|P3|STARTED|Overall Study||78
890833|NCT01893411|2154240|P2|STARTED|Overall Study||77
890834|NCT01893411|2154241|P1|STARTED|Overall Study||156
890835|NCT01893359|2154306|P3|NOT COMPLETED|Overall Study||0
890836|NCT01893359|2154307|P2|NOT COMPLETED|Overall Study||0
890837|NCT01893359|2154308|P1|NOT COMPLETED|Overall Study||0
890838|NCT01893359|2154306|P3|COMPLETED|Overall Study||0
890839|NCT01893359|2154307|P2|COMPLETED|Overall Study||2
890840|NCT01893359|2154308|P1|COMPLETED|Overall Study||0
890841|NCT01893359|2154306|P3|STARTED|Overall Study||0
890842|NCT01893359|2154307|P2|STARTED|Overall Study||2
890843|NCT01893359|2154308|P1|STARTED|Overall Study||0
890844|NCT01893346|2154323|P4|NOT COMPLETED|Overall Study||0
890845|NCT01893346|2154324|P3|NOT COMPLETED|Overall Study||0
890846|NCT01893346|2154325|P2|NOT COMPLETED|Overall Study||1
890847|NCT01893346|2154326|P1|NOT COMPLETED|Overall Study||3
890848|NCT01893346|2154323|P4|COMPLETED|Overall Study||8
890849|NCT01893346|2154324|P3|COMPLETED|Overall Study||8
890850|NCT01893346|2154325|P2|COMPLETED|Overall Study||7
890851|NCT01893346|2154326|P1|COMPLETED|Overall Study||8
890852|NCT01893346|2154323|P4|Patients Who Received Full Infusion|Overall Study||8
890853|NCT01893346|2154324|P3|Patients Who Received Full Infusion|Overall Study||8
890854|NCT01893346|2154325|P2|Patients Who Received Full Infusion|Overall Study||8
890855|NCT01893346|2154326|P1|Patients Who Received Full Infusion|Overall Study||8
890856|NCT01893346|2154323|P4|STARTED|Overall Study||8
890857|NCT01893346|2154324|P3|STARTED|Overall Study||8
890858|NCT01893346|2154325|P2|STARTED|Overall Study||8
890859|NCT01893346|2154326|P1|STARTED|Overall Study||11
890860|NCT01893281|2154340|P1|NOT COMPLETED|Overall Study||3
890861|NCT01893281|2154340|P1|COMPLETED|Overall Study||75
890862|NCT01893281|2154340|P1|Received at Least 1 Dose of Study Drug|Overall Study||78
890863|NCT01893281|2154340|P1|STARTED|Overall Study||78
890864|NCT01893203|2154347|P1|NOT COMPLETED|Overall Study||1
890865|NCT01893203|2154347|P1|COMPLETED|Overall Study||13
890866|NCT01893203|2154347|P1|STARTED|Overall Study||14
890867|NCT01892657|2154354|P1|NOT COMPLETED|Overall Study||18
890868|NCT01892657|2154354|P1|COMPLETED|Overall Study||110
890869|NCT01892657|2154354|P1|STARTED|Overall Study||128
890870|NCT01892306|2154372|P2|NOT COMPLETED|Overall Study||6
890871|NCT01892306|2154373|P1|NOT COMPLETED|Overall Study||5
890872|NCT01892306|2154372|P2|COMPLETED|Overall Study||10
890873|NCT01892306|2154373|P1|COMPLETED|Overall Study||8
890874|NCT01892306|2154372|P2|STARTED|Overall Study||16
890875|NCT01892306|2154373|P1|STARTED|Overall Study||13
890876|NCT01892267|2154395|P2|NOT COMPLETED|Overall Study||0
890877|NCT01892267|2154396|P1|NOT COMPLETED|Overall Study||0
890878|NCT01892267|2154395|P2|COMPLETED|Overall Study||10
890879|NCT01892267|2154396|P1|COMPLETED|Overall Study||9
890880|NCT01892267|2154395|P2|STARTED|Overall Study||10
890881|NCT01892267|2154396|P1|STARTED|Overall Study||9
890882|NCT01892189|2154431|P9|NOT COMPLETED|Third Intervention Period (1 Day)||0
890883|NCT01892189|2154432|P8|NOT COMPLETED|Third Intervention Period (1 Day)||0
890884|NCT01892189|2154433|P7|NOT COMPLETED|Third Intervention Period (1 Day)||0
890885|NCT01892189|2154434|P6|NOT COMPLETED|Third Intervention Period (1 Day)||0
890886|NCT01892189|2154435|P5|NOT COMPLETED|Third Intervention Period (1 Day)||0
890887|NCT01892189|2154436|P4|NOT COMPLETED|Third Intervention Period (1 Day)||0
890888|NCT01892189|2154437|P3|NOT COMPLETED|Third Intervention Period (1 Day)||0
890889|NCT01892189|2154438|P2|NOT COMPLETED|Third Intervention Period (1 Day)||0
890890|NCT01892189|2154439|P1|NOT COMPLETED|Third Intervention Period (1 Day)||0
890891|NCT01892189|2154431|P9|COMPLETED|Third Intervention Period (1 Day)||1
890892|NCT01892189|2154432|P8|COMPLETED|Third Intervention Period (1 Day)||3
890893|NCT01892189|2154433|P7|COMPLETED|Third Intervention Period (1 Day)||2
890894|NCT01892189|2154434|P6|COMPLETED|Third Intervention Period (1 Day)||2
890895|NCT01892189|2154435|P5|COMPLETED|Third Intervention Period (1 Day)||3
890896|NCT01892189|2154436|P4|COMPLETED|Third Intervention Period (1 Day)||2
890897|NCT01892189|2154437|P3|COMPLETED|Third Intervention Period (1 Day)||1
890898|NCT01892189|2154438|P2|COMPLETED|Third Intervention Period (1 Day)||3
890899|NCT01892189|2154439|P1|COMPLETED|Third Intervention Period (1 Day)||3
890900|NCT01892189|2154431|P9|STARTED|Third Intervention Period (1 Day)||1
890901|NCT01892189|2154432|P8|STARTED|Third Intervention Period (1 Day)||3
890902|NCT01892189|2154433|P7|STARTED|Third Intervention Period (1 Day)||2
890903|NCT01892189|2154434|P6|STARTED|Third Intervention Period (1 Day)||2
890904|NCT01892189|2154435|P5|STARTED|Third Intervention Period (1 Day)||3
890905|NCT01892189|2154436|P4|STARTED|Third Intervention Period (1 Day)||2
890906|NCT01892189|2154437|P3|STARTED|Third Intervention Period (1 Day)||1
890907|NCT01892189|2154438|P2|STARTED|Third Intervention Period (1 Day)||3
890908|NCT01892189|2154439|P1|STARTED|Third Intervention Period (1 Day)||3
890909|NCT01892189|2154431|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
890910|NCT01892189|2154432|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
890911|NCT01892189|2154433|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
890912|NCT01892189|2154434|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
890913|NCT01892189|2154435|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
890914|NCT01892189|2154436|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
890915|NCT01892189|2154437|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
890916|NCT01892189|2154438|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
890917|NCT01892189|2154439|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
890918|NCT01892189|2154431|P9|COMPLETED|Washout Period 2 (7 Days)||1
890919|NCT01892189|2154432|P8|COMPLETED|Washout Period 2 (7 Days)||3
890920|NCT01892189|2154433|P7|COMPLETED|Washout Period 2 (7 Days)||2
890921|NCT01892189|2154434|P6|COMPLETED|Washout Period 2 (7 Days)||2
890922|NCT01892189|2154435|P5|COMPLETED|Washout Period 2 (7 Days)||3
890923|NCT01892189|2154436|P4|COMPLETED|Washout Period 2 (7 Days)||2
890924|NCT01892189|2154437|P3|COMPLETED|Washout Period 2 (7 Days)||1
890925|NCT01892189|2154438|P2|COMPLETED|Washout Period 2 (7 Days)||3
890926|NCT01892189|2154439|P1|COMPLETED|Washout Period 2 (7 Days)||3
890927|NCT01892189|2154431|P9|STARTED|Washout Period 2 (7 Days)||1
890928|NCT01892189|2154432|P8|STARTED|Washout Period 2 (7 Days)||3
890929|NCT01892189|2154433|P7|STARTED|Washout Period 2 (7 Days)||2
890930|NCT01892189|2154434|P6|STARTED|Washout Period 2 (7 Days)||2
890931|NCT01892189|2154435|P5|STARTED|Washout Period 2 (7 Days)||3
890932|NCT01892189|2154436|P4|STARTED|Washout Period 2 (7 Days)||2
890933|NCT01892189|2154437|P3|STARTED|Washout Period 2 (7 Days)||1
890934|NCT01892189|2154438|P2|STARTED|Washout Period 2 (7 Days)||3
890935|NCT01892189|2154439|P1|STARTED|Washout Period 2 (7 Days)||3
890936|NCT01892189|2154431|P9|NOT COMPLETED|Second Intervention Period (1 Day)||0
890937|NCT01892189|2154432|P8|NOT COMPLETED|Second Intervention Period (1 Day)||0
890938|NCT01892189|2154433|P7|NOT COMPLETED|Second Intervention Period (1 Day)||0
890939|NCT01892189|2154434|P6|NOT COMPLETED|Second Intervention Period (1 Day)||0
890940|NCT01892189|2154435|P5|NOT COMPLETED|Second Intervention Period (1 Day)||0
890941|NCT01892189|2154436|P4|NOT COMPLETED|Second Intervention Period (1 Day)||0
890942|NCT01892189|2154437|P3|NOT COMPLETED|Second Intervention Period (1 Day)||0
890943|NCT01892189|2154438|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
890944|NCT01892189|2154439|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
890945|NCT01892189|2154431|P9|COMPLETED|Second Intervention Period (1 Day)||1
890946|NCT01892189|2154432|P8|COMPLETED|Second Intervention Period (1 Day)||3
890947|NCT01892189|2154433|P7|COMPLETED|Second Intervention Period (1 Day)||2
890948|NCT01892189|2154434|P6|COMPLETED|Second Intervention Period (1 Day)||2
890949|NCT01892189|2154435|P5|COMPLETED|Second Intervention Period (1 Day)||3
890950|NCT01892189|2154436|P4|COMPLETED|Second Intervention Period (1 Day)||2
890951|NCT01892189|2154437|P3|COMPLETED|Second Intervention Period (1 Day)||1
890952|NCT01892189|2154438|P2|COMPLETED|Second Intervention Period (1 Day)||3
890953|NCT01892189|2154439|P1|COMPLETED|Second Intervention Period (1 Day)||3
890954|NCT01892189|2154431|P9|STARTED|Second Intervention Period (1 Day)||1
890955|NCT01892189|2154432|P8|STARTED|Second Intervention Period (1 Day)||3
890956|NCT01892189|2154433|P7|STARTED|Second Intervention Period (1 Day)||2
890957|NCT01892189|2154434|P6|STARTED|Second Intervention Period (1 Day)||2
890958|NCT01892189|2154435|P5|STARTED|Second Intervention Period (1 Day)||3
890959|NCT01892189|2154436|P4|STARTED|Second Intervention Period (1 Day)||2
890960|NCT01892189|2154437|P3|STARTED|Second Intervention Period (1 Day)||1
890961|NCT01892189|2154438|P2|STARTED|Second Intervention Period (1 Day)||3
890962|NCT01892189|2154439|P1|STARTED|Second Intervention Period (1 Day)||3
890963|NCT01892189|2154431|P9|NOT COMPLETED|Washout Period 1 (7 Days)||2
890964|NCT01892189|2154432|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
890965|NCT01892189|2154433|P7|NOT COMPLETED|Washout Period 1 (7 Days)||1
890966|NCT01892189|2154434|P6|NOT COMPLETED|Washout Period 1 (7 Days)||1
890967|NCT01892189|2154435|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
890968|NCT01892189|2154436|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
890969|NCT01892189|2154437|P3|NOT COMPLETED|Washout Period 1 (7 Days)||2
890970|NCT01892189|2154438|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
890971|NCT01892189|2154439|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
890972|NCT01892189|2154431|P9|COMPLETED|Washout Period 1 (7 Days)||1
890973|NCT01892189|2154432|P8|COMPLETED|Washout Period 1 (7 Days)||3
890974|NCT01892189|2154433|P7|COMPLETED|Washout Period 1 (7 Days)||2
890975|NCT01892189|2154434|P6|COMPLETED|Washout Period 1 (7 Days)||2
890976|NCT01892189|2154435|P5|COMPLETED|Washout Period 1 (7 Days)||3
890977|NCT01892189|2154436|P4|COMPLETED|Washout Period 1 (7 Days)||2
890978|NCT01892189|2154437|P3|COMPLETED|Washout Period 1 (7 Days)||1
890979|NCT01892189|2154438|P2|COMPLETED|Washout Period 1 (7 Days)||3
890980|NCT01892189|2154439|P1|COMPLETED|Washout Period 1 (7 Days)||3
890981|NCT01892189|2154431|P9|STARTED|Washout Period 1 (7 Days)||3
890982|NCT01892189|2154432|P8|STARTED|Washout Period 1 (7 Days)||3
890983|NCT01892189|2154433|P7|STARTED|Washout Period 1 (7 Days)||3
890984|NCT01892189|2154434|P6|STARTED|Washout Period 1 (7 Days)||3
890985|NCT01892189|2154435|P5|STARTED|Washout Period 1 (7 Days)||3
890986|NCT01892189|2154436|P4|STARTED|Washout Period 1 (7 Days)||3
890987|NCT01892189|2154437|P3|STARTED|Washout Period 1 (7 Days)||3
890988|NCT01892189|2154438|P2|STARTED|Washout Period 1 (7 Days)||3
890989|NCT01892189|2154439|P1|STARTED|Washout Period 1 (7 Days)||3
890990|NCT01892189|2154431|P9|NOT COMPLETED|First Intervention Period (1 Day)||0
890991|NCT01892189|2154432|P8|NOT COMPLETED|First Intervention Period (1 Day)||0
890992|NCT01892189|2154433|P7|NOT COMPLETED|First Intervention Period (1 Day)||0
890993|NCT01892189|2154434|P6|NOT COMPLETED|First Intervention Period (1 Day)||0
890994|NCT01892189|2154435|P5|NOT COMPLETED|First Intervention Period (1 Day)||0
890995|NCT01892189|2154436|P4|NOT COMPLETED|First Intervention Period (1 Day)||0
890996|NCT01892189|2154437|P3|NOT COMPLETED|First Intervention Period (1 Day)||0
890997|NCT01892189|2154438|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
890998|NCT01892189|2154439|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
890999|NCT01892189|2154431|P9|COMPLETED|First Intervention Period (1 Day)||3
891000|NCT01892189|2154432|P8|COMPLETED|First Intervention Period (1 Day)||3
891001|NCT01892189|2154433|P7|COMPLETED|First Intervention Period (1 Day)||3
891002|NCT01892189|2154434|P6|COMPLETED|First Intervention Period (1 Day)||3
891003|NCT01892189|2154435|P5|COMPLETED|First Intervention Period (1 Day)||3
891004|NCT01892189|2154436|P4|COMPLETED|First Intervention Period (1 Day)||3
891005|NCT01892189|2154437|P3|COMPLETED|First Intervention Period (1 Day)||3
891006|NCT01892189|2154438|P2|COMPLETED|First Intervention Period (1 Day)||3
891007|NCT01892189|2154439|P1|COMPLETED|First Intervention Period (1 Day)||3
891008|NCT01892189|2154431|P9|STARTED|First Intervention Period (1 Day)||3
891009|NCT01892189|2154432|P8|STARTED|First Intervention Period (1 Day)||3
891010|NCT01892189|2154433|P7|STARTED|First Intervention Period (1 Day)||3
891011|NCT01892189|2154434|P6|STARTED|First Intervention Period (1 Day)||3
891012|NCT01892189|2154435|P5|STARTED|First Intervention Period (1 Day)||3
891013|NCT01892189|2154436|P4|STARTED|First Intervention Period (1 Day)||3
891014|NCT01892189|2154437|P3|STARTED|First Intervention Period (1 Day)||3
891015|NCT01892189|2154438|P2|STARTED|First Intervention Period (1 Day)||3
891016|NCT01892189|2154439|P1|STARTED|First Intervention Period (1 Day)||3
891017|NCT01892163|2154481|P2|NOT COMPLETED|Overall Study||1
891018|NCT01892163|2154482|P1|NOT COMPLETED|Overall Study||2
891019|NCT01892163|2154481|P2|COMPLETED|Overall Study||49
891020|NCT01892163|2154482|P1|COMPLETED|Overall Study||48
891021|NCT01892163|2154481|P2|STARTED|Overall Study||50
891022|NCT01892163|2154482|P1|STARTED|Overall Study||50
891023|NCT01892020|2154494|P2|NOT COMPLETED|Period 2||0
891024|NCT01892020|2154495|P1|NOT COMPLETED|Period 2||1
891025|NCT01892020|2154494|P2|COMPLETED|Period 2||74
891026|NCT01892020|2154495|P1|COMPLETED|Period 2||77
891027|NCT01892020|2154494|P2|STARTED|Period 2||74
891028|NCT01892020|2154495|P1|STARTED|Period 2||78
891029|NCT01892020|2154494|P2|NOT COMPLETED|Period 1||6
891030|NCT01892020|2154495|P1|NOT COMPLETED|Period 1||3
891031|NCT01892020|2154494|P2|COMPLETED|Period 1||74
891032|NCT01892020|2154495|P1|COMPLETED|Period 1||78
891033|NCT01892020|2154494|P2|STARTED|Period 1||80
891034|NCT01892020|2154495|P1|STARTED|Period 1||81
891035|NCT01891890|2154516|P3|NOT COMPLETED|Overall Study||7
891036|NCT01891890|2154517|P2|NOT COMPLETED|Overall Study||3
891037|NCT01891890|2154518|P1|NOT COMPLETED|Overall Study||7
891038|NCT01891890|2154516|P3|COMPLETED|Overall Study||14
891039|NCT01891890|2154517|P2|COMPLETED|Overall Study||24
891040|NCT01891890|2154518|P1|COMPLETED|Overall Study||17
891041|NCT01891890|2154516|P3|STARTED|Overall Study||21
891042|NCT01891890|2154517|P2|STARTED|Overall Study||27
891043|NCT01891890|2154518|P1|STARTED|Overall Study||24
891044|NCT01891864|2154561|P6|NOT COMPLETED|Extension Period||0
891045|NCT01891864|2154562|P5|NOT COMPLETED|Extension Period||7
891046|NCT01891864|2154563|P4|NOT COMPLETED|Extension Period||5
891047|NCT01891864|2154564|P3|NOT COMPLETED|Extension Period||8
891048|NCT01891864|2154565|P2|NOT COMPLETED|Extension Period||0
891049|NCT01891864|2154566|P1|NOT COMPLETED|Extension Period||0
891050|NCT01891864|2154561|P6|COMPLETED|Extension Period||90
891051|NCT01891864|2154562|P5|COMPLETED|Extension Period||88
891052|NCT01891864|2154563|P4|COMPLETED|Extension Period||137
891053|NCT01891864|2154564|P3|COMPLETED|Extension Period||132
891054|NCT01891864|2154565|P2|COMPLETED|Extension Period||0
891055|NCT01891864|2154566|P1|COMPLETED|Extension Period||0
891056|NCT01891864|2154561|P6|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to an adverse event|90
891057|NCT01891864|2154562|P5|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to lack of efficacy|95
891058|NCT01891864|2154563|P4|STARTED|Extension Period||142
891059|NCT01891864|2154564|P3|STARTED|Extension Period|2 patients withdrew consent 1 patient lost to FU between Treatment Period 2 and the Extension period|140
891060|NCT01891864|2154565|P2|STARTED|Extension Period||0
891061|NCT01891864|2154566|P1|STARTED|Extension Period||0
891062|NCT01891864|2154561|P6|NOT COMPLETED|Treatment Period 2||5
891063|NCT01891864|2154562|P5|NOT COMPLETED|Treatment Period 2||4
891064|NCT01891864|2154563|P4|NOT COMPLETED|Treatment Period 2||9
891065|NCT01891864|2154564|P3|NOT COMPLETED|Treatment Period 2||7
891066|NCT01891864|2154565|P2|NOT COMPLETED|Treatment Period 2||0
891067|NCT01891864|2154566|P1|NOT COMPLETED|Treatment Period 2||0
891068|NCT01891864|2154561|P6|COMPLETED|Treatment Period 2||91
891069|NCT01891864|2154562|P5|COMPLETED|Treatment Period 2||96
891070|NCT01891864|2154563|P4|COMPLETED|Treatment Period 2||142
891071|NCT01891864|2154564|P3|COMPLETED|Treatment Period 2||143
891072|NCT01891864|2154565|P2|COMPLETED|Treatment Period 2||0
891073|NCT01891864|2154566|P1|COMPLETED|Treatment Period 2||0
891074|NCT01891864|2154561|P6|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|96
891075|NCT01891864|2154562|P5|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|100
891076|NCT01891864|2154563|P4|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|151
891077|NCT01891864|2154564|P3|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|150
891078|NCT01891864|2154565|P2|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
891079|NCT01891864|2154566|P1|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
891080|NCT01891864|2154561|P6|NOT COMPLETED|Treatment Period 1||0
891081|NCT01891864|2154562|P5|NOT COMPLETED|Treatment Period 1||0
891082|NCT01891864|2154563|P4|NOT COMPLETED|Treatment Period 1||0
891083|NCT01891864|2154564|P3|NOT COMPLETED|Treatment Period 1||0
891084|NCT01891864|2154565|P2|NOT COMPLETED|Treatment Period 1||12
891085|NCT01891864|2154566|P1|NOT COMPLETED|Treatment Period 1||8
891086|NCT01891864|2154561|P6|COMPLETED|Treatment Period 1||0
891087|NCT01891864|2154562|P5|COMPLETED|Treatment Period 1||0
891088|NCT01891864|2154563|P4|COMPLETED|Treatment Period 1||0
891089|NCT01891864|2154564|P3|COMPLETED|Treatment Period 1||0
891090|NCT01891864|2154565|P2|COMPLETED|Treatment Period 1|8 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|255
891091|NCT01891864|2154566|P1|COMPLETED|Treatment Period 1|6 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|256
891092|NCT01891864|2154561|P6|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
891093|NCT01891864|2154562|P5|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
891094|NCT01891864|2154563|P4|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
891095|NCT01891864|2154564|P3|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
891096|NCT01891864|2154565|P2|STARTED|Treatment Period 1||267
891097|NCT01891864|2154566|P1|STARTED|Treatment Period 1||264
891098|NCT01891734|2154588|P2|NOT COMPLETED|Overall Study||3
891099|NCT01891734|2154589|P1|NOT COMPLETED|Overall Study||3
891100|NCT01891734|2154588|P2|COMPLETED|Overall Study||13
891101|NCT01891734|2154589|P1|COMPLETED|Overall Study||14
891102|NCT01891734|2154588|P2|STARTED|Overall Study||16
891103|NCT01891734|2154589|P1|STARTED|Overall Study||17
891104|NCT01891669|2154609|P10|NOT COMPLETED|Overall Study||2
891105|NCT01891669|2154610|P9|NOT COMPLETED|Overall Study||1
891106|NCT01891669|2154611|P8|NOT COMPLETED|Overall Study||4
891107|NCT01891669|2154612|P7|NOT COMPLETED|Overall Study||1
891108|NCT01891669|2154613|P6|NOT COMPLETED|Overall Study||0
891109|NCT01891669|2154614|P5|NOT COMPLETED|Overall Study||0
891110|NCT01891669|2154615|P4|NOT COMPLETED|Overall Study||0
891111|NCT01891669|2154616|P3|NOT COMPLETED|Overall Study||0
891112|NCT01891669|2154617|P2|NOT COMPLETED|Overall Study||1
891113|NCT01891669|2154618|P1|NOT COMPLETED|Overall Study||2
891114|NCT01891669|2154609|P10|COMPLETED|Overall Study||1
891115|NCT01891669|2154610|P9|COMPLETED|Overall Study||2
891116|NCT01891669|2154611|P8|COMPLETED|Overall Study||2
891117|NCT01891669|2154612|P7|COMPLETED|Overall Study||1
891118|NCT01891669|2154613|P6|COMPLETED|Overall Study||2
891119|NCT01891669|2154614|P5|COMPLETED|Overall Study||2
891120|NCT01891669|2154615|P4|COMPLETED|Overall Study||2
891121|NCT01891669|2154616|P3|COMPLETED|Overall Study||2
891122|NCT01891669|2154617|P2|COMPLETED|Overall Study||1
891123|NCT01891669|2154618|P1|COMPLETED|Overall Study||0
891124|NCT01891669|2154609|P10|STARTED|Overall Study||3
891125|NCT01891669|2154610|P9|STARTED|Overall Study||3
891126|NCT01891669|2154611|P8|STARTED|Overall Study||6
891127|NCT01891669|2154612|P7|STARTED|Overall Study||2
891128|NCT01891669|2154613|P6|STARTED|Overall Study||2
891129|NCT01891669|2154614|P5|STARTED|Overall Study||2
891130|NCT01891669|2154615|P4|STARTED|Overall Study||2
891131|NCT01891669|2154616|P3|STARTED|Overall Study||2
891132|NCT01891669|2154617|P2|STARTED|Overall Study||2
891133|NCT01891669|2154618|P1|STARTED|Overall Study||2
891134|NCT01890967|2154775|P6|NOT COMPLETED|Overall Study||13
891135|NCT01890967|2154776|P5|NOT COMPLETED|Overall Study||10
891136|NCT01890967|2154777|P4|NOT COMPLETED|Overall Study||11
891137|NCT01890967|2154778|P3|NOT COMPLETED|Overall Study||10
891138|NCT01890967|2154779|P2|NOT COMPLETED|Overall Study||11
891139|NCT01890967|2154780|P1|NOT COMPLETED|Overall Study||10
891140|NCT01890967|2154775|P6|COMPLETED|Overall Study||75
891141|NCT01890967|2154776|P5|COMPLETED|Overall Study||77
891142|NCT01890967|2154777|P4|COMPLETED|Overall Study||77
891143|NCT01890967|2154778|P3|COMPLETED|Overall Study||78
891144|NCT01890967|2154779|P2|COMPLETED|Overall Study||77
891145|NCT01890967|2154780|P1|COMPLETED|Overall Study||78
891146|NCT01890967|2154775|P6|Received at Least One Dose of Study Drug|Overall Study||87
891147|NCT01890967|2154776|P5|Received at Least One Dose of Study Drug|Overall Study||86
891148|NCT01890967|2154777|P4|Received at Least One Dose of Study Drug|Overall Study||86
891149|NCT01890967|2154778|P3|Received at Least One Dose of Study Drug|Overall Study||86
891150|NCT01890967|2154779|P2|Received at Least One Dose of Study Drug|Overall Study||87
891151|NCT01890967|2154780|P1|Received at Least One Dose of Study Drug|Overall Study||87
891152|NCT01890967|2154775|P6|STARTED|Overall Study||88
891153|NCT01890967|2154776|P5|STARTED|Overall Study||87
891154|NCT01890967|2154777|P4|STARTED|Overall Study||88
891155|NCT01890967|2154778|P3|STARTED|Overall Study||88
891156|NCT01890967|2154779|P2|STARTED|Overall Study||88
891157|NCT01890967|2154780|P1|STARTED|Overall Study||88
891158|NCT01890954|2154849|P2|NOT COMPLETED|Overall Study||0
891159|NCT01890954|2154850|P1|NOT COMPLETED|Overall Study||1
891160|NCT01890954|2154849|P2|COMPLETED|Overall Study||8
891161|NCT01890954|2154850|P1|COMPLETED|Overall Study||8
891162|NCT01890954|2154849|P2|STARTED|Overall Study||8
891163|NCT01890954|2154850|P1|STARTED|Overall Study||9
891164|NCT01890915|2154858|P2|NOT COMPLETED|Overall Study||1
891165|NCT01890915|2154859|P1|NOT COMPLETED|Overall Study||3
891166|NCT01890915|2154858|P2|COMPLETED|Overall Study||9
891167|NCT01890915|2154859|P1|COMPLETED|Overall Study||8
891168|NCT01890915|2154858|P2|STARTED|Overall Study||10
891169|NCT01890915|2154859|P1|STARTED|Overall Study||11
891170|NCT01890785|2154875|P6|NOT COMPLETED|Third Intervention||0
891171|NCT01890785|2154876|P5|NOT COMPLETED|Third Intervention||0
891172|NCT01890785|2154877|P4|NOT COMPLETED|Third Intervention||0
891173|NCT01890785|2154878|P3|NOT COMPLETED|Third Intervention||0
891174|NCT01890785|2154879|P2|NOT COMPLETED|Third Intervention||1
891175|NCT01890785|2154880|P1|NOT COMPLETED|Third Intervention||0
891176|NCT01890785|2154875|P6|COMPLETED|Third Intervention||5
891177|NCT01890785|2154876|P5|COMPLETED|Third Intervention||5
891178|NCT01890785|2154877|P4|COMPLETED|Third Intervention||5
891179|NCT01890785|2154878|P3|COMPLETED|Third Intervention||5
891180|NCT01890785|2154879|P2|COMPLETED|Third Intervention||4
891181|NCT01890785|2154880|P1|COMPLETED|Third Intervention||5
891182|NCT01890785|2154875|P6|STARTED|Third Intervention||5
891183|NCT01890785|2154876|P5|STARTED|Third Intervention||5
891184|NCT01890785|2154877|P4|STARTED|Third Intervention||5
891185|NCT01890785|2154878|P3|STARTED|Third Intervention||5
891186|NCT01890785|2154879|P2|STARTED|Third Intervention||5
891187|NCT01890785|2154880|P1|STARTED|Third Intervention||5
891188|NCT01890785|2154875|P6|NOT COMPLETED|Second Intervention||0
891189|NCT01890785|2154876|P5|NOT COMPLETED|Second Intervention||0
891190|NCT01890785|2154877|P4|NOT COMPLETED|Second Intervention||0
891191|NCT01890785|2154878|P3|NOT COMPLETED|Second Intervention||0
891192|NCT01890785|2154879|P2|NOT COMPLETED|Second Intervention||0
891193|NCT01890785|2154880|P1|NOT COMPLETED|Second Intervention||0
891194|NCT01890785|2154875|P6|COMPLETED|Second Intervention||5
891195|NCT01890785|2154876|P5|COMPLETED|Second Intervention||5
891196|NCT01890785|2154877|P4|COMPLETED|Second Intervention||5
891197|NCT01890785|2154878|P3|COMPLETED|Second Intervention||5
891198|NCT01890785|2154879|P2|COMPLETED|Second Intervention||5
891199|NCT01890785|2154880|P1|COMPLETED|Second Intervention||5
891200|NCT01890785|2154875|P6|STARTED|Second Intervention||5
891201|NCT01890785|2154876|P5|STARTED|Second Intervention||5
891202|NCT01890785|2154877|P4|STARTED|Second Intervention||5
891203|NCT01890785|2154878|P3|STARTED|Second Intervention||5
891204|NCT01890785|2154879|P2|STARTED|Second Intervention||5
891205|NCT01890785|2154880|P1|STARTED|Second Intervention||5
891206|NCT01890785|2154875|P6|NOT COMPLETED|First Intervention||0
891207|NCT01890785|2154876|P5|NOT COMPLETED|First Intervention||0
891208|NCT01890785|2154877|P4|NOT COMPLETED|First Intervention||0
891209|NCT01890785|2154878|P3|NOT COMPLETED|First Intervention||0
891210|NCT01890785|2154879|P2|NOT COMPLETED|First Intervention||0
891211|NCT01890785|2154880|P1|NOT COMPLETED|First Intervention||0
891212|NCT01890785|2154875|P6|COMPLETED|First Intervention||5
891213|NCT01890785|2154876|P5|COMPLETED|First Intervention||5
891214|NCT01890785|2154877|P4|COMPLETED|First Intervention||5
891215|NCT01890785|2154878|P3|COMPLETED|First Intervention||5
891216|NCT01890785|2154879|P2|COMPLETED|First Intervention||5
891217|NCT01890785|2154880|P1|COMPLETED|First Intervention||5
891218|NCT01890785|2154875|P6|STARTED|First Intervention||5
891219|NCT01890785|2154876|P5|STARTED|First Intervention||5
891220|NCT01890785|2154877|P4|STARTED|First Intervention||5
891221|NCT01890785|2154878|P3|STARTED|First Intervention||5
891222|NCT01890785|2154879|P2|STARTED|First Intervention||5
891223|NCT01890785|2154880|P1|STARTED|First Intervention||5
891224|NCT01890759|2154899|P2|NOT COMPLETED|Overall Study||12
891225|NCT01890759|2154900|P1|NOT COMPLETED|Overall Study||2
891226|NCT01890759|2154899|P2|COMPLETED|Overall Study||188
891227|NCT01890759|2154900|P1|COMPLETED|Overall Study||98
891228|NCT01890759|2154899|P2|STARTED|Overall Study||200
891229|NCT01890759|2154900|P1|STARTED|Overall Study||100
891230|NCT01890746|2154934|P2|NOT COMPLETED|Overall Study||74
891231|NCT01890746|2154935|P1|NOT COMPLETED|Overall Study||74
891232|NCT01890746|2154934|P2|COMPLETED|Overall Study||0
891233|NCT01890746|2154935|P1|COMPLETED|Overall Study||0
891234|NCT01890746|2154934|P2|STARTED|Overall Study||74
891235|NCT01890746|2154935|P1|STARTED|Overall Study||74
891236|NCT01890694|2154961|P2|NOT COMPLETED|Overall Study||1
891237|NCT01890694|2154962|P1|NOT COMPLETED|Overall Study||1
891238|NCT01890694|2154961|P2|COMPLETED|Overall Study||0
891239|NCT01890694|2154962|P1|COMPLETED|Overall Study||0
891240|NCT01890694|2154961|P2|STARTED|Overall Study||1
891241|NCT01890694|2154962|P1|STARTED|Overall Study||1
891242|NCT01890642|2154972|P3|NOT COMPLETED|Overall Study||0
891243|NCT01890642|2154973|P2|NOT COMPLETED|Overall Study||0
891244|NCT01890642|2154974|P1|NOT COMPLETED|Overall Study||0
891245|NCT01890642|2154972|P3|COMPLETED|Overall Study||96
891246|NCT01890642|2154973|P2|COMPLETED|Overall Study||53
891247|NCT01890642|2154974|P1|COMPLETED|Overall Study||56
891248|NCT01890642|2154972|P3|STARTED|Overall Study||96
891249|NCT01890642|2154973|P2|STARTED|Overall Study||53
891250|NCT01890642|2154974|P1|STARTED|Overall Study||56
891251|NCT01890577|2154994|P1|NOT COMPLETED|Overall Study||28
891252|NCT01890577|2154994|P1|COMPLETED|Overall Study||0
891253|NCT01890577|2154994|P1|STARTED|Overall Study||28
891254|NCT01890512|2155007|P1|NOT COMPLETED|Overall Study||3
891255|NCT01890512|2155007|P1|COMPLETED|Overall Study||17
891256|NCT01890512|2155007|P1|STARTED|Overall Study||20
891257|NCT01890473|2155013|P2|NOT COMPLETED|Overall Study||0
891258|NCT01890473|2155014|P1|NOT COMPLETED|Overall Study||2
891259|NCT01890473|2155013|P2|COMPLETED|Overall Study||113
891260|NCT01890473|2155014|P1|COMPLETED|Overall Study||109
891261|NCT01890473|2155013|P2|STARTED|Overall Study||113
891262|NCT01890473|2155014|P1|STARTED|Overall Study||111
891263|NCT01890343|2155043|P3|NOT COMPLETED|Overall Study||0
891264|NCT01890343|2155044|P2|NOT COMPLETED|Overall Study||0
891265|NCT01890343|2155045|P1|NOT COMPLETED|Overall Study||0
891266|NCT01890343|2155043|P3|COMPLETED|Overall Study||10
891267|NCT01890343|2155044|P2|COMPLETED|Overall Study||10
891268|NCT01890343|2155045|P1|COMPLETED|Overall Study||8
891269|NCT01890343|2155043|P3|STARTED|Overall Study||10
891270|NCT01890343|2155044|P2|STARTED|Overall Study||10
891271|NCT01890343|2155045|P1|STARTED|Overall Study||8
891272|NCT01890148|2155056|P1|NOT COMPLETED|Overall Study||1
891273|NCT01890148|2155056|P1|COMPLETED|Overall Study||4
891274|NCT01890148|2155056|P1|STARTED|Overall Study||5
891275|NCT01890122|2155076|P4|NOT COMPLETED|Overall Study||59
891276|NCT01890122|2155077|P3|NOT COMPLETED|Overall Study||13
891277|NCT01890122|2155078|P2|NOT COMPLETED|Overall Study||37
891278|NCT01890122|2155079|P1|NOT COMPLETED|Overall Study||27
891279|NCT01890122|2155076|P4|COMPLETED|Overall Study||104
891280|NCT01890122|2155077|P3|COMPLETED|Overall Study||146
891281|NCT01890122|2155078|P2|COMPLETED|Overall Study||126
891282|NCT01890122|2155079|P1|COMPLETED|Overall Study||135
891283|NCT01890122|2155076|P4|Treated|Overall Study||163
891284|NCT01890122|2155077|P3|Treated|Overall Study||159
891285|NCT01890122|2155078|P2|Treated|Overall Study||162
891286|NCT01890122|2155079|P1|Treated|Overall Study|Treated = Randomized participants who received at least one dose of study drug.|161
891287|NCT01890122|2155076|P4|STARTED|Overall Study||163
891288|NCT01890122|2155077|P3|STARTED|Overall Study||159
891289|NCT01890122|2155078|P2|STARTED|Overall Study||163
891386|NCT01887470|2155382|P2|NOT COMPLETED|Overall Study||0
891290|NCT01890122|2155079|P1|STARTED|Overall Study|Started = Enrolled set which included all participants who signed informed consent.|162
891291|NCT01890031|2155146|P5|NOT COMPLETED|Overall Study||0
891292|NCT01890031|2155147|P4|NOT COMPLETED|Overall Study||0
891293|NCT01890031|2155148|P3|NOT COMPLETED|Overall Study||0
891294|NCT01890031|2155149|P2|NOT COMPLETED|Overall Study||0
891295|NCT01890031|2155150|P1|NOT COMPLETED|Overall Study||0
891296|NCT01890031|2155146|P5|COMPLETED|Overall Study||8
891297|NCT01890031|2155147|P4|COMPLETED|Overall Study||11
891298|NCT01890031|2155148|P3|COMPLETED|Overall Study||12
891299|NCT01890031|2155149|P2|COMPLETED|Overall Study||50
891300|NCT01890031|2155150|P1|COMPLETED|Overall Study||50
891301|NCT01890031|2155146|P5|STARTED|Overall Study||8
891302|NCT01890031|2155147|P4|STARTED|Overall Study||11
891303|NCT01890031|2155148|P3|STARTED|Overall Study||12
891304|NCT01890031|2155149|P2|STARTED|Overall Study||50
891305|NCT01890031|2155150|P1|STARTED|Overall Study||50
891306|NCT01889797|2155169|P2|NOT COMPLETED|Overall Study||0
891307|NCT01889797|2155170|P1|NOT COMPLETED|Overall Study||0
891308|NCT01889797|2155169|P2|COMPLETED|Overall Study||16
891309|NCT01889797|2155170|P1|COMPLETED|Overall Study||16
891310|NCT01889797|2155169|P2|STARTED|Overall Study||16
891311|NCT01889797|2155170|P1|STARTED|Overall Study||16
891312|NCT01889667|2155185|P3|NOT COMPLETED|Overall Study||0
891313|NCT01889667|2155186|P2|NOT COMPLETED|Overall Study||0
891314|NCT01889667|2155187|P1|NOT COMPLETED|Overall Study||0
891315|NCT01889667|2155185|P3|COMPLETED|Overall Study||10
891316|NCT01889667|2155186|P2|COMPLETED|Overall Study||10
891317|NCT01889667|2155187|P1|COMPLETED|Overall Study||10
891318|NCT01889667|2155185|P3|STARTED|Overall Study||10
891319|NCT01889667|2155186|P2|STARTED|Overall Study||10
891320|NCT01889667|2155187|P1|STARTED|Overall Study||10
891321|NCT01889563|2155209|P2|NOT COMPLETED|Overall Study||5
891322|NCT01889563|2155210|P1|NOT COMPLETED|Overall Study||7
891323|NCT01889563|2155209|P2|COMPLETED|Overall Study||10
891324|NCT01889563|2155210|P1|COMPLETED|Overall Study||10
891325|NCT01889563|2155209|P2|STARTED|Overall Study||15
891326|NCT01889563|2155210|P1|STARTED|Overall Study||17
891327|NCT01889420|2155218|P1|NOT COMPLETED|Overall Study||0
891328|NCT01889420|2155218|P1|COMPLETED|Overall Study||1
891329|NCT01889420|2155218|P1|STARTED|Overall Study||1
891330|NCT01889251|2155226|P2|NOT COMPLETED|Overall Study||0
891331|NCT01889251|2155227|P1|NOT COMPLETED|Overall Study||1
891332|NCT01889251|2155226|P2|COMPLETED|Overall Study||57
891333|NCT01889251|2155227|P1|COMPLETED|Overall Study||114
891334|NCT01889251|2155226|P2|STARTED|Overall Study||57
891335|NCT01889251|2155227|P1|STARTED|Overall Study||115
891336|NCT01888965|2155233|P1|NOT COMPLETED|Overall Study||9
891337|NCT01888965|2155233|P1|COMPLETED|Overall Study||0
891338|NCT01888965|2155233|P1|STARTED|Overall Study||9
891339|NCT01888952|2155239|P1|NOT COMPLETED|Overall Study||0
891340|NCT01888952|2155239|P1|COMPLETED|Overall Study||10
891341|NCT01888952|2155239|P1|STARTED|Overall Study||10
891342|NCT01888900|2155245|P2|NOT COMPLETED|Overall Study||2
891343|NCT01888900|2155246|P1|NOT COMPLETED|Overall Study||0
891344|NCT01888900|2155245|P2|COMPLETED|Overall Study||11
891345|NCT01888900|2155246|P1|COMPLETED|Overall Study||22
891346|NCT01888900|2155245|P2|STARTED|Overall Study||13
891347|NCT01888900|2155246|P1|STARTED|Overall Study||22
891348|NCT01888367|2155269|P3|NOT COMPLETED|Overall Study||5
891349|NCT01888367|2155270|P2|NOT COMPLETED|Overall Study||5
891350|NCT01888367|2155271|P1|NOT COMPLETED|Overall Study||8
891351|NCT01888367|2155269|P3|COMPLETED|Overall Study||73
891352|NCT01888367|2155270|P2|COMPLETED|Overall Study||66
891353|NCT01888367|2155271|P1|COMPLETED|Overall Study||288
891354|NCT01888367|2155269|P3|STARTED|Overall Study||78
891355|NCT01888367|2155270|P2|STARTED|Overall Study||71
891356|NCT01888367|2155271|P1|STARTED|Overall Study||296
891357|NCT01888003|2155291|P3|NOT COMPLETED|Overall Study||40
891358|NCT01888003|2155292|P2|NOT COMPLETED|Overall Study||6
891359|NCT01888003|2155293|P1|NOT COMPLETED|Overall Study||5
891360|NCT01888003|2155291|P3|COMPLETED|Overall Study||0
891361|NCT01888003|2155292|P2|COMPLETED|Overall Study||0
891362|NCT01888003|2155293|P1|COMPLETED|Overall Study||0
891363|NCT01888003|2155291|P3|STARTED|Overall Study||40
891364|NCT01888003|2155292|P2|STARTED|Overall Study||6
891365|NCT01888003|2155293|P1|STARTED|Overall Study||5
891366|NCT01887990|2155314|P4|NOT COMPLETED|Overall Study||0
891367|NCT01887990|2155315|P3|NOT COMPLETED|Overall Study||0
891368|NCT01887990|2155316|P2|NOT COMPLETED|Overall Study||0
891369|NCT01887990|2155317|P1|NOT COMPLETED|Overall Study||0
891370|NCT01887990|2155314|P4|COMPLETED|Overall Study||2
891371|NCT01887990|2155315|P3|COMPLETED|Overall Study||2
891372|NCT01887990|2155316|P2|COMPLETED|Overall Study||7
891373|NCT01887990|2155317|P1|COMPLETED|Overall Study||7
891374|NCT01887990|2155314|P4|STARTED|Overall Study||2
891375|NCT01887990|2155315|P3|STARTED|Overall Study||2
891376|NCT01887990|2155316|P2|STARTED|Overall Study||7
891377|NCT01887990|2155317|P1|STARTED|Overall Study||7
891378|NCT01887678|2155333|P2|NOT COMPLETED|Overall Study||28
891379|NCT01887678|2155334|P1|NOT COMPLETED|Overall Study||17
891380|NCT01887678|2155333|P2|COMPLETED|Overall Study||85
891381|NCT01887678|2155334|P1|COMPLETED|Overall Study||102
891382|NCT01887678|2155333|P2|STARTED|Overall Study||113
891383|NCT01887678|2155334|P1|STARTED|Overall Study||119
891384|NCT01887470|2155380|P4|NOT COMPLETED|Overall Study||0
891385|NCT01887470|2155381|P3|NOT COMPLETED|Overall Study||0
891387|NCT01887470|2155383|P1|NOT COMPLETED|Overall Study||0
891388|NCT01887470|2155380|P4|COMPLETED|Overall Study||10
891389|NCT01887470|2155381|P3|COMPLETED|Overall Study||10
891390|NCT01887470|2155382|P2|COMPLETED|Overall Study||10
891391|NCT01887470|2155383|P1|COMPLETED|Overall Study||10
891392|NCT01887470|2155380|P4|STARTED|Overall Study||10
891393|NCT01887470|2155381|P3|STARTED|Overall Study||10
891394|NCT01887470|2155382|P2|STARTED|Overall Study||10
891395|NCT01887470|2155383|P1|STARTED|Overall Study||10
891396|NCT01887418|2155402|P3|NOT COMPLETED|Overall Study||1
891397|NCT01887418|2155403|P2|NOT COMPLETED|Overall Study||0
891398|NCT01887418|2155404|P1|NOT COMPLETED|Overall Study||0
891399|NCT01887418|2155402|P3|COMPLETED|Overall Study||9
891400|NCT01887418|2155403|P2|COMPLETED|Overall Study||14
891401|NCT01887418|2155404|P1|COMPLETED|Overall Study||15
891402|NCT01887418|2155402|P3|STARTED|Overall Study||10
891403|NCT01887418|2155403|P2|STARTED|Overall Study||14
891404|NCT01887418|2155404|P1|STARTED|Overall Study||15
891405|NCT01887353|2155423|P2|NOT COMPLETED|Overall Study||3
891406|NCT01887353|2155424|P1|NOT COMPLETED|Overall Study||4
891407|NCT01887353|2155423|P2|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|1
891408|NCT01887353|2155424|P1|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|0
891409|NCT01887353|2155423|P2|STARTED|Overall Study||4
891410|NCT01887353|2155424|P1|STARTED|Overall Study||4
891411|NCT01887171|2155432|P2|NOT COMPLETED|Overall Study||0
891412|NCT01887171|2155433|P1|NOT COMPLETED|Overall Study||0
891413|NCT01887171|2155432|P2|COMPLETED|Overall Study||43
891414|NCT01887171|2155433|P1|COMPLETED|Overall Study||43
891415|NCT01887171|2155432|P2|STARTED|Overall Study||43
891416|NCT01887171|2155433|P1|STARTED|Overall Study||43
891417|NCT01887132|2155439|P1|NOT COMPLETED|Overall Study||0
891418|NCT01887132|2155439|P1|COMPLETED|Overall Study||4
891419|NCT01887132|2155439|P1|STARTED|Overall Study||4
891420|NCT01886963|2155446|P2|NOT COMPLETED|Overall Study||4
891421|NCT01886963|2155447|P1|NOT COMPLETED|Overall Study||5
891422|NCT01886963|2155446|P2|COMPLETED|Overall Study||49
891423|NCT01886963|2155447|P1|COMPLETED|Overall Study||46
891424|NCT01886963|2155446|P2|12 Week Follow Up|Overall Study||22
891425|NCT01886963|2155447|P1|12 Week Follow Up|Overall Study||24
891426|NCT01886963|2155446|P2|4 Week Follow Up|Overall Study||26
891427|NCT01886963|2155447|P1|4 Week Follow Up|Overall Study||24
891428|NCT01886963|2155446|P2|2 Week Follow Up|Overall Study||35
891429|NCT01886963|2155447|P1|2 Week Follow Up|Overall Study||38
891430|NCT01886963|2155446|P2|STARTED|Overall Study||53
891431|NCT01886963|2155447|P1|STARTED|Overall Study||51
891432|NCT01886937|2155455|P2|NOT COMPLETED|Overall Study||0
891433|NCT01886937|2155456|P1|NOT COMPLETED|Overall Study||0
891434|NCT01886937|2155455|P2|COMPLETED|Overall Study||6
891435|NCT01886937|2155456|P1|COMPLETED|Overall Study||7
891436|NCT01886937|2155455|P2|STARTED|Overall Study||6
891437|NCT01886937|2155456|P1|STARTED|Overall Study||7
891438|NCT01886807|2155465|P3|NOT COMPLETED|Overall Study||10
891439|NCT01886807|2155466|P2|NOT COMPLETED|Overall Study||10
891440|NCT01886807|2155467|P1|NOT COMPLETED|Overall Study||5
891441|NCT01886807|2155465|P3|COMPLETED|Overall Study||153
891442|NCT01886807|2155466|P2|COMPLETED|Overall Study||145
891443|NCT01886807|2155467|P1|COMPLETED|Overall Study||159
891444|NCT01886807|2155465|P3|STARTED|Overall Study||163
891445|NCT01886807|2155466|P2|STARTED|Overall Study||155
891446|NCT01886807|2155467|P1|STARTED|Overall Study||164
891447|NCT01886781|2155477|P2|NOT COMPLETED|Overall Study||2
891448|NCT01886781|2155478|P1|NOT COMPLETED|Overall Study||14
891449|NCT01886781|2155477|P2|COMPLETED|Overall Study||25
891450|NCT01886781|2155478|P1|COMPLETED|Overall Study||40
891451|NCT01886781|2155477|P2|STARTED|Overall Study||27
891452|NCT01886781|2155478|P1|STARTED|Overall Study||54
891453|NCT01886716|2155488|P4|NOT COMPLETED|1-Month Post Follow-Up||0
891454|NCT01886716|2155489|P3|NOT COMPLETED|1-Month Post Follow-Up||0
891455|NCT01886716|2155490|P2|NOT COMPLETED|1-Month Post Follow-Up||0
891456|NCT01886716|2155491|P1|NOT COMPLETED|1-Month Post Follow-Up||0
891457|NCT01886716|2155488|P4|COMPLETED|1-Month Post Follow-Up||14
891458|NCT01886716|2155489|P3|COMPLETED|1-Month Post Follow-Up||19
891459|NCT01886716|2155490|P2|COMPLETED|1-Month Post Follow-Up||17
891460|NCT01886716|2155491|P1|COMPLETED|1-Month Post Follow-Up||20
891461|NCT01886716|2155488|P4|STARTED|1-Month Post Follow-Up||14
891462|NCT01886716|2155489|P3|STARTED|1-Month Post Follow-Up||19
891463|NCT01886716|2155490|P2|STARTED|1-Month Post Follow-Up||17
891464|NCT01886716|2155491|P1|STARTED|1-Month Post Follow-Up||20
891465|NCT01886716|2155488|P4|NOT COMPLETED|1-Week Post Follow-Up||0
891466|NCT01886716|2155489|P3|NOT COMPLETED|1-Week Post Follow-Up||0
891467|NCT01886716|2155490|P2|NOT COMPLETED|1-Week Post Follow-Up||0
891468|NCT01886716|2155491|P1|NOT COMPLETED|1-Week Post Follow-Up||0
891469|NCT01886716|2155488|P4|COMPLETED|1-Week Post Follow-Up||14
891470|NCT01886716|2155489|P3|COMPLETED|1-Week Post Follow-Up||19
891471|NCT01886716|2155490|P2|COMPLETED|1-Week Post Follow-Up||17
891472|NCT01886716|2155491|P1|COMPLETED|1-Week Post Follow-Up||20
891473|NCT01886716|2155488|P4|STARTED|1-Week Post Follow-Up||14
891474|NCT01886716|2155489|P3|STARTED|1-Week Post Follow-Up||19
891475|NCT01886716|2155490|P2|STARTED|1-Week Post Follow-Up||17
891476|NCT01886716|2155491|P1|STARTED|1-Week Post Follow-Up||20
891477|NCT01886716|2155488|P4|NOT COMPLETED|Week 4||0
891478|NCT01886716|2155489|P3|NOT COMPLETED|Week 4||0
891479|NCT01886716|2155490|P2|NOT COMPLETED|Week 4||0
891480|NCT01886716|2155491|P1|NOT COMPLETED|Week 4||0
891481|NCT01886716|2155488|P4|COMPLETED|Week 4||14
891482|NCT01886716|2155489|P3|COMPLETED|Week 4||19
891483|NCT01886716|2155490|P2|COMPLETED|Week 4||17
891484|NCT01886716|2155491|P1|COMPLETED|Week 4||20
891485|NCT01886716|2155488|P4|STARTED|Week 4||14
891486|NCT01886716|2155489|P3|STARTED|Week 4||19
891487|NCT01886716|2155490|P2|STARTED|Week 4||17
891488|NCT01886716|2155491|P1|STARTED|Week 4||20
891489|NCT01886716|2155488|P4|NOT COMPLETED|Week 3||1
891490|NCT01886716|2155489|P3|NOT COMPLETED|Week 3||0
891491|NCT01886716|2155490|P2|NOT COMPLETED|Week 3||1
891492|NCT01886716|2155491|P1|NOT COMPLETED|Week 3||1
891493|NCT01886716|2155488|P4|COMPLETED|Week 3||14
891494|NCT01886716|2155489|P3|COMPLETED|Week 3||19
891495|NCT01886716|2155490|P2|COMPLETED|Week 3||17
891496|NCT01886716|2155491|P1|COMPLETED|Week 3||20
891497|NCT01886716|2155488|P4|STARTED|Week 3||15
891498|NCT01886716|2155489|P3|STARTED|Week 3||19
891499|NCT01886716|2155490|P2|STARTED|Week 3||18
891500|NCT01886716|2155491|P1|STARTED|Week 3||21
891501|NCT01886716|2155488|P4|NOT COMPLETED|Week 2||3
891502|NCT01886716|2155489|P3|NOT COMPLETED|Week 2||1
891503|NCT01886716|2155490|P2|NOT COMPLETED|Week 2||2
891504|NCT01886716|2155491|P1|NOT COMPLETED|Week 2||3
891505|NCT01886716|2155488|P4|COMPLETED|Week 2||15
891506|NCT01886716|2155489|P3|COMPLETED|Week 2||19
891507|NCT01886716|2155490|P2|COMPLETED|Week 2||18
891508|NCT01886716|2155491|P1|COMPLETED|Week 2||21
891509|NCT01886716|2155488|P4|STARTED|Week 2||18
891510|NCT01886716|2155489|P3|STARTED|Week 2||20
891511|NCT01886716|2155490|P2|STARTED|Week 2||20
891512|NCT01886716|2155491|P1|STARTED|Week 2||24
891513|NCT01886716|2155488|P4|NOT COMPLETED|Week 1||2
891514|NCT01886716|2155489|P3|NOT COMPLETED|Week 1||2
891515|NCT01886716|2155490|P2|NOT COMPLETED|Week 1||0
891516|NCT01886716|2155491|P1|NOT COMPLETED|Week 1||0
891517|NCT01886716|2155488|P4|COMPLETED|Week 1||18
891518|NCT01886716|2155489|P3|COMPLETED|Week 1||20
891519|NCT01886716|2155490|P2|COMPLETED|Week 1||20
891520|NCT01886716|2155491|P1|COMPLETED|Week 1||24
891521|NCT01886716|2155488|P4|STARTED|Week 1||20
891522|NCT01886716|2155489|P3|STARTED|Week 1||22
891523|NCT01886716|2155490|P2|STARTED|Week 1||20
891524|NCT01886716|2155491|P1|STARTED|Week 1||24
891525|NCT01886690|2155507|P2|NOT COMPLETED|Overall Study||2
891526|NCT01886690|2155508|P1|NOT COMPLETED|Overall Study||0
891527|NCT01886690|2155507|P2|COMPLETED|Overall Study||71
891528|NCT01886690|2155508|P1|COMPLETED|Overall Study||75
891529|NCT01886690|2155507|P2|STARTED|Overall Study||73
891530|NCT01886690|2155508|P1|STARTED|Overall Study||75
891531|NCT01886313|2155524|P2|NOT COMPLETED|Overall Study||1
891532|NCT01886313|2155525|P1|NOT COMPLETED|Overall Study||1
891533|NCT01886313|2155524|P2|COMPLETED|Overall Study||4
891534|NCT01886313|2155525|P1|COMPLETED|Overall Study||5
891535|NCT01886313|2155524|P2|STARTED|Overall Study||5
891536|NCT01886313|2155525|P1|STARTED|Overall Study||6
891537|NCT01886300|2155531|P1|NOT COMPLETED|Overall Study||16
891538|NCT01886300|2155531|P1|COMPLETED|Overall Study||0
891539|NCT01886300|2155531|P1|STARTED|Overall Study||16
891540|NCT01886287|2155542|P1|NOT COMPLETED|Overall Study||2
891541|NCT01886287|2155542|P1|COMPLETED|Overall Study||0
891542|NCT01886287|2155542|P1|STARTED|Overall Study||2
891543|NCT01886235|2155547|P1|NOT COMPLETED|Overall Study||0
891544|NCT01886235|2155547|P1|COMPLETED|Overall Study||10
891545|NCT01886235|2155547|P1|STARTED|Overall Study||10
891546|NCT01885910|2155558|P1|NOT COMPLETED|Overall Study||8
891547|NCT01885910|2155558|P1|COMPLETED|Overall Study||24
891548|NCT01885910|2155558|P1|STARTED|Overall Study||32
891549|NCT01885871|2155572|P1|NOT COMPLETED|Overall Study||0
891550|NCT01885871|2155572|P1|COMPLETED|Overall Study||20
891551|NCT01885871|2155572|P1|STARTED|Overall Study||20
891552|NCT01885559|2155582|P2|NOT COMPLETED|Overall Study||36
891553|NCT01885559|2155583|P1|NOT COMPLETED|Overall Study||24
891554|NCT01885559|2155582|P2|COMPLETED|Overall Study||208
891555|NCT01885559|2155583|P1|COMPLETED|Overall Study||218
891556|NCT01885559|2155582|P2|STARTED|Overall Study||244
891557|NCT01885559|2155583|P1|STARTED|Overall Study||242
891558|NCT01885117|2155605|P2|NOT COMPLETED|Overall Study||0
891559|NCT01885117|2155606|P1|NOT COMPLETED|Overall Study||0
891560|NCT01885117|2155605|P2|COMPLETED|Overall Study||64
891561|NCT01885117|2155606|P1|COMPLETED|Overall Study||61
891562|NCT01885117|2155605|P2|STARTED|Overall Study||64
891563|NCT01885117|2155606|P1|STARTED|Overall Study||61
891564|NCT01885104|2155628|P2|NOT COMPLETED|Overall Study||1
891565|NCT01885104|2155629|P1|NOT COMPLETED|Overall Study||2
891566|NCT01885104|2155628|P2|COMPLETED|Overall Study||33
891567|NCT01885104|2155629|P1|COMPLETED|Overall Study||29
891568|NCT01885104|2155628|P2|STARTED|Overall Study||34
891569|NCT01885104|2155629|P1|STARTED|Overall Study||31
891570|NCT01885000|2155639|P2|NOT COMPLETED|Overall Study||2
891571|NCT01885000|2155640|P1|NOT COMPLETED|Overall Study||2
891572|NCT01885000|2155639|P2|COMPLETED|Overall Study||42
891573|NCT01885000|2155640|P1|COMPLETED|Overall Study||46
891574|NCT01885000|2155639|P2|STARTED|Overall Study||44
891575|NCT01885000|2155640|P1|STARTED|Overall Study||48
891576|NCT01884688|2155652|P1|NOT COMPLETED|Overall Study||2
891577|NCT01884688|2155652|P1|COMPLETED|Overall Study||1
891578|NCT01884688|2155652|P1|STARTED|Overall Study||3
891579|NCT01884675|2155658|P2|NOT COMPLETED|Overall Study||2
891580|NCT01884675|2155659|P1|NOT COMPLETED|Overall Study||3
891581|NCT01884675|2155658|P2|COMPLETED|Overall Study||15
891582|NCT01884675|2155659|P1|COMPLETED|Overall Study||13
891583|NCT01884675|2155658|P2|STARTED|Overall Study||17
891584|NCT01884675|2155659|P1|STARTED|Overall Study||16
891594|NCT01884571|2155733|P1|NOT COMPLETED|Overall Study||8
891595|NCT01884571|2155733|P1|COMPLETED|Overall Study||23
891596|NCT01884571|2155733|P1|STARTED|Overall Study||31
891597|NCT01884519|2155739|P2|NOT COMPLETED|Overall Study||0
891598|NCT01884519|2155740|P1|NOT COMPLETED|Overall Study||0
891599|NCT01884519|2155739|P2|COMPLETED|Overall Study||60
891600|NCT01884519|2155740|P1|COMPLETED|Overall Study||60
891601|NCT01884519|2155739|P2|STARTED|Overall Study||60
891602|NCT01884519|2155740|P1|STARTED|Overall Study||60
891603|NCT01884064|2155784|P2|NOT COMPLETED|Overall Study||0
891604|NCT01884064|2155785|P1|NOT COMPLETED|Overall Study||0
891605|NCT01884064|2155784|P2|COMPLETED|Overall Study||5
891606|NCT01884064|2155785|P1|COMPLETED|Overall Study||12
891607|NCT01884064|2155784|P2|STARTED|Overall Study||5
891608|NCT01884064|2155785|P1|STARTED|Overall Study||12
891609|NCT01883999|2155791|P1|NOT COMPLETED|Overall Study||3
891610|NCT01883999|2155791|P1|COMPLETED|Overall Study||61
891611|NCT01883999|2155791|P1|STARTED|Overall Study||64
891612|NCT01883986|2155799|P2|NOT COMPLETED|Overall Study||1
891613|NCT01883986|2155800|P1|NOT COMPLETED|Overall Study||3
891614|NCT01883986|2155799|P2|COMPLETED|Overall Study|Completed study|19
891615|NCT01883986|2155800|P1|COMPLETED|Overall Study|Received allocated intervention|17
891616|NCT01883986|2155799|P2|Did Not Complete Study|Overall Study|Did not completed study|1
891617|NCT01883986|2155800|P1|Did Not Complete Study|Overall Study||3
891618|NCT01883986|2155799|P2|STARTED|Overall Study|Allocated to usual care arm|20
891619|NCT01883986|2155800|P1|STARTED|Overall Study|Allocated to intervention arm|20
891620|NCT01883908|2155814|P2|NOT COMPLETED|Overall Study||0
891621|NCT01883908|2155815|P1|NOT COMPLETED|Overall Study||0
891622|NCT01883908|2155814|P2|COMPLETED|Overall Study||1
891623|NCT01883908|2155815|P1|COMPLETED|Overall Study||3
891624|NCT01883908|2155814|P2|STARTED|Overall Study||1
891625|NCT01883908|2155815|P1|STARTED|Overall Study||3
891626|NCT01883895|2155823|P1|NOT COMPLETED|Overall Study||2
891627|NCT01883895|2155823|P1|COMPLETED|Overall Study||32
891628|NCT01883895|2155823|P1|STARTED|Overall Study||34
891629|NCT01883635|2155830|P2|NOT COMPLETED|Overall Study||0
891630|NCT01883635|2155831|P1|NOT COMPLETED|Overall Study||4
891631|NCT01883635|2155830|P2|COMPLETED|Overall Study||20
891632|NCT01883635|2155831|P1|COMPLETED|Overall Study||20
891633|NCT01883635|2155830|P2|STARTED|Overall Study||20
891634|NCT01883635|2155831|P1|STARTED|Overall Study||24
891635|NCT01883453|2155845|P2|NOT COMPLETED|Overall Study||23
891636|NCT01883453|2155846|P1|NOT COMPLETED|Overall Study||25
891637|NCT01883453|2155845|P2|COMPLETED|Overall Study||50
891638|NCT01883453|2155846|P1|COMPLETED|Overall Study||48
891639|NCT01883453|2155845|P2|STARTED|Overall Study||73
891640|NCT01883453|2155846|P1|STARTED|Overall Study||73
891641|NCT01883440|2155854|P2|NOT COMPLETED|Overall Study||0
891642|NCT01883440|2155855|P1|NOT COMPLETED|Overall Study||3
891643|NCT01883440|2155854|P2|COMPLETED|Overall Study||45
891644|NCT01883440|2155855|P1|COMPLETED|Overall Study||42
891645|NCT01883440|2155854|P2|STARTED|Overall Study||45
891646|NCT01883440|2155855|P1|STARTED|Overall Study||45
891647|NCT01883427|2155865|P2|NOT COMPLETED|Overall Study||0
891648|NCT01883427|2155866|P1|NOT COMPLETED|Overall Study||0
891649|NCT01883427|2155865|P2|COMPLETED|Overall Study||20
891650|NCT01883427|2155866|P1|COMPLETED|Overall Study||20
891651|NCT01883427|2155865|P2|STARTED|Overall Study||20
891652|NCT01883427|2155866|P1|STARTED|Overall Study||20
891653|NCT01882907|2155874|P2|NOT COMPLETED|Overall Study||28
891654|NCT01882907|2155875|P1|NOT COMPLETED|Overall Study||14
891655|NCT01882907|2155874|P2|COMPLETED|Overall Study||83
891656|NCT01882907|2155875|P1|COMPLETED|Overall Study||103
891657|NCT01882907|2155874|P2|STARTED|Overall Study||111
891658|NCT01882907|2155875|P1|STARTED|Overall Study||117
891659|NCT01882868|2155881|P1|NOT COMPLETED|Overall Study||0
891660|NCT01882868|2155881|P1|COMPLETED|Overall Study||62
891661|NCT01882868|2155881|P1|STARTED|Overall Study||62
891662|NCT01882725|2155911|P1|NOT COMPLETED|Overall Study||0
891663|NCT01882725|2155911|P1|COMPLETED|Overall Study||14
891664|NCT01882725|2155911|P1|STARTED|Overall Study||14
891665|NCT01882647|2155918|P2|NOT COMPLETED|Overall Study||6
891666|NCT01882647|2155919|P1|NOT COMPLETED|Overall Study||2
891667|NCT01882647|2155918|P2|COMPLETED|Overall Study||106
891668|NCT01882647|2155919|P1|COMPLETED|Overall Study||108
891669|NCT01882647|2155918|P2|STARTED|Overall Study||112
891670|NCT01882647|2155919|P1|STARTED|Overall Study||110
891671|NCT01882543|2155937|P2|NOT COMPLETED|Overall Study||3
891672|NCT01882543|2155938|P1|NOT COMPLETED|Overall Study||4
891673|NCT01882543|2155937|P2|COMPLETED|Overall Study||29
891674|NCT01882543|2155938|P1|COMPLETED|Overall Study||33
891675|NCT01882543|2155937|P2|STARTED|Overall Study||32
891676|NCT01882543|2155938|P1|STARTED|Overall Study||37
891677|NCT01882465|2155959|P7|NOT COMPLETED|Period 3||0
891678|NCT01882465|2155960|P6|NOT COMPLETED|Period 3||0
891679|NCT01882465|2155961|P5|NOT COMPLETED|Period 3||0
891680|NCT01882465|2155962|P4|NOT COMPLETED|Period 3||0
891681|NCT01882465|2155963|P3|NOT COMPLETED|Period 3||0
891682|NCT01882465|2155964|P2|NOT COMPLETED|Period 3||0
891683|NCT01882465|2155965|P1|NOT COMPLETED|Period 3||0
891684|NCT01882465|2155959|P7|COMPLETED|Period 3||0
891685|NCT01882465|2155960|P6|COMPLETED|Period 3||5
891686|NCT01882465|2155961|P5|COMPLETED|Period 3||4
891687|NCT01882465|2155962|P4|COMPLETED|Period 3||5
891688|NCT01882465|2155963|P3|COMPLETED|Period 3||5
891689|NCT01882465|2155964|P2|COMPLETED|Period 3||6
891690|NCT01882465|2155965|P1|COMPLETED|Period 3||6
891691|NCT01882465|2155959|P7|STARTED|Period 3||0
891692|NCT01882465|2155960|P6|STARTED|Period 3||5
891693|NCT01882465|2155961|P5|STARTED|Period 3||4
891694|NCT01882465|2155962|P4|STARTED|Period 3||5
891695|NCT01882465|2155963|P3|STARTED|Period 3||5
891696|NCT01882465|2155964|P2|STARTED|Period 3||6
891697|NCT01882465|2155965|P1|STARTED|Period 3||6
891698|NCT01882465|2155959|P7|NOT COMPLETED|Period 2||0
891699|NCT01882465|2155960|P6|NOT COMPLETED|Period 2||0
891700|NCT01882465|2155961|P5|NOT COMPLETED|Period 2||1
891701|NCT01882465|2155962|P4|NOT COMPLETED|Period 2||0
891702|NCT01882465|2155963|P3|NOT COMPLETED|Period 2||0
891703|NCT01882465|2155964|P2|NOT COMPLETED|Period 2||0
891704|NCT01882465|2155965|P1|NOT COMPLETED|Period 2||0
891705|NCT01882465|2155959|P7|COMPLETED|Period 2||0
891706|NCT01882465|2155960|P6|COMPLETED|Period 2||5
891707|NCT01882465|2155961|P5|COMPLETED|Period 2||4
891708|NCT01882465|2155962|P4|COMPLETED|Period 2||5
891709|NCT01882465|2155963|P3|COMPLETED|Period 2||5
891710|NCT01882465|2155964|P2|COMPLETED|Period 2||6
891711|NCT01882465|2155965|P1|COMPLETED|Period 2||6
891712|NCT01882465|2155959|P7|STARTED|Period 2||0
891713|NCT01882465|2155960|P6|STARTED|Period 2||5
891714|NCT01882465|2155961|P5|STARTED|Period 2||5
891715|NCT01882465|2155962|P4|STARTED|Period 2||5
891716|NCT01882465|2155963|P3|STARTED|Period 2||5
891717|NCT01882465|2155964|P2|STARTED|Period 2||6
891718|NCT01882465|2155965|P1|STARTED|Period 2||6
891719|NCT01882465|2155959|P7|NOT COMPLETED|Period 1||1
891720|NCT01882465|2155960|P6|NOT COMPLETED|Period 1||0
891721|NCT01882465|2155961|P5|NOT COMPLETED|Period 1||0
891722|NCT01882465|2155962|P4|NOT COMPLETED|Period 1||1
891723|NCT01882465|2155963|P3|NOT COMPLETED|Period 1||0
891724|NCT01882465|2155964|P2|NOT COMPLETED|Period 1||0
891725|NCT01882465|2155965|P1|NOT COMPLETED|Period 1||0
891726|NCT01882465|2155959|P7|COMPLETED|Period 1||0
891727|NCT01882465|2155960|P6|COMPLETED|Period 1||5
891728|NCT01882465|2155961|P5|COMPLETED|Period 1||5
891729|NCT01882465|2155962|P4|COMPLETED|Period 1||5
891730|NCT01882465|2155963|P3|COMPLETED|Period 1||5
891731|NCT01882465|2155964|P2|COMPLETED|Period 1||6
891732|NCT01882465|2155965|P1|COMPLETED|Period 1||6
891733|NCT01882465|2155959|P7|STARTED|Period 1||1
891734|NCT01882465|2155960|P6|STARTED|Period 1||5
891735|NCT01882465|2155961|P5|STARTED|Period 1||5
891736|NCT01882465|2155962|P4|STARTED|Period 1||6
891737|NCT01882465|2155963|P3|STARTED|Period 1||5
891738|NCT01882465|2155964|P2|STARTED|Period 1||6
891739|NCT01882465|2155965|P1|STARTED|Period 1||6
891740|NCT01882439|2155977|P4|NOT COMPLETED|Overall Study||9
891741|NCT01882439|2155978|P3|NOT COMPLETED|Overall Study||10
891742|NCT01882439|2155979|P2|NOT COMPLETED|Overall Study||21
891743|NCT01882439|2155980|P1|NOT COMPLETED|Overall Study||9
891744|NCT01882439|2155977|P4|COMPLETED|Overall Study||56
891745|NCT01882439|2155978|P3|COMPLETED|Overall Study||56
891746|NCT01882439|2155979|P2|COMPLETED|Overall Study||111
891747|NCT01882439|2155980|P1|COMPLETED|Overall Study||122
891748|NCT01882439|2155977|P4|STARTED|Overall Study|Received treatment|65
891749|NCT01882439|2155978|P3|STARTED|Overall Study|Received treatment|66
891750|NCT01882439|2155979|P2|STARTED|Overall Study|Received treatment|132
891751|NCT01882439|2155980|P1|STARTED|Overall Study|Received treatment|131
891752|NCT01882413|2156160|P1|NOT COMPLETED|Overall Study||0
891753|NCT01882413|2156160|P1|COMPLETED|Overall Study||204
891754|NCT01882413|2156160|P1|STARTED|Overall Study||204
891755|NCT01882257|2156177|P3|NOT COMPLETED|Therapy Portion of Study (12 Months)||4
891756|NCT01882257|2156178|P2|NOT COMPLETED|Therapy Portion of Study (12 Months)||11
891757|NCT01882257|2156179|P1|NOT COMPLETED|Therapy Portion of Study (12 Months)||0
891758|NCT01882257|2156177|P3|COMPLETED|Therapy Portion of Study (12 Months)||18
891759|NCT01882257|2156178|P2|COMPLETED|Therapy Portion of Study (12 Months)||27
891760|NCT01882257|2156179|P1|COMPLETED|Therapy Portion of Study (12 Months)||11
891761|NCT01882257|2156177|P3|STARTED|Therapy Portion of Study (12 Months)||22
891762|NCT01882257|2156178|P2|STARTED|Therapy Portion of Study (12 Months)||38
891763|NCT01882257|2156179|P1|STARTED|Therapy Portion of Study (12 Months)||11
891764|NCT01882257|2156177|P3|NOT COMPLETED|Study Origination to Beginning Therapy||1
891765|NCT01882257|2156178|P2|NOT COMPLETED|Study Origination to Beginning Therapy||2
891766|NCT01882257|2156179|P1|NOT COMPLETED|Study Origination to Beginning Therapy||0
891767|NCT01882257|2156177|P3|COMPLETED|Study Origination to Beginning Therapy||22
891768|NCT01882257|2156178|P2|COMPLETED|Study Origination to Beginning Therapy||38
891861|NCT01880437|2156385|P3|STARTED|Overall Study||19
891769|NCT01882257|2156179|P1|COMPLETED|Study Origination to Beginning Therapy||11
891770|NCT01882257|2156177|P3|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 23 who were given the device, 1 chose not to begin the actual therapy|22
891771|NCT01882257|2156178|P2|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 40 who were given the device, 2 chose not to begin the actual therapy|38
891772|NCT01882257|2156179|P1|Started Therapy Using Device|Study Origination to Beginning Therapy||11
891773|NCT01882257|2156177|P3|STARTED|Study Origination to Beginning Therapy||23
891774|NCT01882257|2156178|P2|STARTED|Study Origination to Beginning Therapy||40
891775|NCT01882257|2156179|P1|STARTED|Study Origination to Beginning Therapy||11
891776|NCT01882062|2156186|P1|NOT COMPLETED|Overall Study||0
891777|NCT01882062|2156186|P1|COMPLETED|Overall Study|18th of july 2013|10
891778|NCT01882062|2156186|P1|STARTED|Overall Study|16th of may 2013|10
891779|NCT01881984|2156190|P1|NOT COMPLETED|Overall Study||0
891780|NCT01881984|2156190|P1|COMPLETED|Overall Study||4
891781|NCT01881984|2156190|P1|STARTED|Overall Study||4
891782|NCT01881932|2156198|P3|NOT COMPLETED|Overall Study||0
891783|NCT01881932|2156199|P2|NOT COMPLETED|Overall Study||0
891784|NCT01881932|2156200|P1|NOT COMPLETED|Overall Study||0
891785|NCT01881932|2156198|P3|COMPLETED|Overall Study||13
891786|NCT01881932|2156199|P2|COMPLETED|Overall Study||4
891787|NCT01881932|2156200|P1|COMPLETED|Overall Study||2
891788|NCT01881932|2156198|P3|STARTED|Overall Study||13
891789|NCT01881932|2156199|P2|STARTED|Overall Study||4
891790|NCT01881932|2156200|P1|STARTED|Overall Study||2
891791|NCT01881776|2156211|P3|NOT COMPLETED|Overall Study||2
891792|NCT01881776|2156212|P2|NOT COMPLETED|Overall Study||4
891793|NCT01881776|2156213|P1|NOT COMPLETED|Overall Study||1
891794|NCT01881776|2156211|P3|COMPLETED|Overall Study||20
891795|NCT01881776|2156212|P2|COMPLETED|Overall Study||20
891796|NCT01881776|2156213|P1|COMPLETED|Overall Study||23
891797|NCT01881776|2156211|P3|STARTED|Overall Study||22
891798|NCT01881776|2156212|P2|STARTED|Overall Study||24
891799|NCT01881776|2156213|P1|STARTED|Overall Study||24
891800|NCT01881737|2156239|P1|NOT COMPLETED|Overall Study||5
891801|NCT01881737|2156239|P1|COMPLETED|Overall Study||10
891802|NCT01881737|2156239|P1|Number Screened|Overall Study||15
891803|NCT01881737|2156239|P1|STARTED|Overall Study|This is a pilot study|15
891804|NCT01881126|2156250|P2|NOT COMPLETED|Overall Study||2
891805|NCT01881126|2156251|P1|NOT COMPLETED|Overall Study||1
891806|NCT01881126|2156250|P2|COMPLETED|Overall Study||44
891807|NCT01881126|2156251|P1|COMPLETED|Overall Study||46
891808|NCT01881126|2156250|P2|STARTED|Overall Study||46
891809|NCT01881126|2156251|P1|STARTED|Overall Study||47
891810|NCT01881087|2156260|P3|NOT COMPLETED|Overall Study||2
891811|NCT01881087|2156261|P2|NOT COMPLETED|Overall Study||0
891812|NCT01881087|2156262|P1|NOT COMPLETED|Overall Study||1
891813|NCT01881087|2156260|P3|COMPLETED|Overall Study||60
891814|NCT01881087|2156261|P2|COMPLETED|Overall Study||61
891815|NCT01881087|2156262|P1|COMPLETED|Overall Study||59
891816|NCT01881087|2156260|P3|STARTED|Overall Study||62
891817|NCT01881087|2156261|P2|STARTED|Overall Study||61
891818|NCT01881087|2156262|P1|STARTED|Overall Study||60
891819|NCT01880840|2156275|P2|NOT COMPLETED|Overall Study||5
891820|NCT01880840|2156276|P1|NOT COMPLETED|Overall Study||8
891821|NCT01880840|2156275|P2|COMPLETED|Overall Study||91
891822|NCT01880840|2156276|P1|COMPLETED|Overall Study||87
891823|NCT01880840|2156275|P2|STARTED|Overall Study||96
891824|NCT01880840|2156276|P1|STARTED|Overall Study||95
891825|NCT01880736|2156286|P4|NOT COMPLETED|Overall Study||6
891826|NCT01880736|2156287|P3|NOT COMPLETED|Overall Study||1
891827|NCT01880736|2156288|P2|NOT COMPLETED|Overall Study||2
891828|NCT01880736|2156289|P1|NOT COMPLETED|Overall Study||1
891829|NCT01880736|2156286|P4|COMPLETED|Overall Study||108
891830|NCT01880736|2156287|P3|COMPLETED|Overall Study||114
891831|NCT01880736|2156288|P2|COMPLETED|Overall Study||113
891832|NCT01880736|2156289|P1|COMPLETED|Overall Study||113
891833|NCT01880736|2156286|P4|STARTED|Overall Study||114
891834|NCT01880736|2156287|P3|STARTED|Overall Study||115
891835|NCT01880736|2156288|P2|STARTED|Overall Study||115
891836|NCT01880736|2156289|P1|STARTED|Overall Study||114
891837|NCT01880723|2156333|P2|NOT COMPLETED|Overall Study||0
891838|NCT01880723|2156334|P1|NOT COMPLETED|Overall Study||0
891839|NCT01880723|2156333|P2|COMPLETED|Overall Study||16
891840|NCT01880723|2156334|P1|COMPLETED|Overall Study||16
891841|NCT01880723|2156333|P2|STARTED|Overall Study||16
891842|NCT01880723|2156334|P1|STARTED|Overall Study||16
891843|NCT01880697|2156350|P2|NOT COMPLETED|Overall Study||1
891844|NCT01880697|2156351|P1|NOT COMPLETED|Overall Study||0
891845|NCT01880697|2156350|P2|COMPLETED|Overall Study||62
891846|NCT01880697|2156351|P1|COMPLETED|Overall Study||63
891847|NCT01880697|2156350|P2|STARTED|Overall Study||63
891848|NCT01880697|2156351|P1|STARTED|Overall Study||63
891849|NCT01880515|2156373|P2|NOT COMPLETED|Overall Study||9
891850|NCT01880515|2156374|P1|NOT COMPLETED|Overall Study||8
891851|NCT01880515|2156373|P2|COMPLETED|Overall Study||45
891852|NCT01880515|2156374|P1|COMPLETED|Overall Study||45
891853|NCT01880515|2156373|P2|STARTED|Overall Study||54
891854|NCT01880515|2156374|P1|STARTED|Overall Study||53
891855|NCT01880437|2156385|P3|NOT COMPLETED|Overall Study||19
891856|NCT01880437|2156386|P2|NOT COMPLETED|Overall Study||4
891857|NCT01880437|2156387|P1|NOT COMPLETED|Overall Study||15
891858|NCT01880437|2156385|P3|COMPLETED|Overall Study||0
891859|NCT01880437|2156386|P2|COMPLETED|Overall Study||0
891860|NCT01880437|2156387|P1|COMPLETED|Overall Study||0
891862|NCT01880437|2156386|P2|STARTED|Overall Study||4
891863|NCT01880437|2156387|P1|STARTED|Overall Study||15
891864|NCT01880424|2156413|P2|NOT COMPLETED|Overall Study||55
891865|NCT01880424|2156414|P1|NOT COMPLETED|Overall Study||33
891866|NCT01880424|2156413|P2|COMPLETED|Overall Study||367
891867|NCT01880424|2156414|P1|COMPLETED|Overall Study||384
891868|NCT01880424|2156413|P2|STARTED|Overall Study||422
891869|NCT01880424|2156414|P1|STARTED|Overall Study||417
891870|NCT01880320|2156439|P3|NOT COMPLETED|Overall Study||8
891871|NCT01880320|2156440|P2|NOT COMPLETED|Overall Study||25
891872|NCT01880320|2156441|P1|NOT COMPLETED|Overall Study||20
891873|NCT01880320|2156439|P3|COMPLETED|Overall Study||61
891874|NCT01880320|2156440|P2|COMPLETED|Overall Study||192
891875|NCT01880320|2156441|P1|COMPLETED|Overall Study||197
891876|NCT01880320|2156439|P3|STARTED|Overall Study||69
891877|NCT01880320|2156440|P2|STARTED|Overall Study||217
891878|NCT01880320|2156441|P1|STARTED|Overall Study||217
891879|NCT01880099|2156458|P3|NOT COMPLETED|Overall Study||7
891880|NCT01880099|2156459|P2|NOT COMPLETED|Overall Study||10
891881|NCT01880099|2156460|P1|NOT COMPLETED|Overall Study||8
891882|NCT01880099|2156458|P3|COMPLETED|Overall Study||15
891883|NCT01880099|2156459|P2|COMPLETED|Overall Study||11
891884|NCT01880099|2156460|P1|COMPLETED|Overall Study||9
891885|NCT01880099|2156458|P3|STARTED|Overall Study||22
891886|NCT01880099|2156459|P2|STARTED|Overall Study||21
891887|NCT01880099|2156460|P1|STARTED|Overall Study||17
891888|NCT01880086|2156470|P2|NOT COMPLETED|Overall Study||1
891889|NCT01880086|2156471|P1|NOT COMPLETED|Overall Study||1
891890|NCT01880086|2156470|P2|COMPLETED|Overall Study||6
891891|NCT01880086|2156471|P1|COMPLETED|Overall Study||5
891892|NCT01880086|2156470|P2|STARTED|Overall Study||7
891893|NCT01880086|2156471|P1|STARTED|Overall Study||6
891894|NCT01879852|2156491|P2|NOT COMPLETED|Overall Study||0
891895|NCT01879852|2156492|P1|NOT COMPLETED|Overall Study||2
891896|NCT01879852|2156491|P2|COMPLETED|Overall Study||13
891897|NCT01879852|2156492|P1|COMPLETED|Overall Study||12
891898|NCT01879852|2156491|P2|STARTED|Overall Study||13
891899|NCT01879852|2156492|P1|STARTED|Overall Study||14
891900|NCT01879800|2156506|P2|NOT COMPLETED|Overall Study||4
891901|NCT01879800|2156507|P1|NOT COMPLETED|Overall Study||0
891902|NCT01879800|2156506|P2|COMPLETED|Overall Study||26
891903|NCT01879800|2156507|P1|COMPLETED|Overall Study||14
891904|NCT01879800|2156506|P2|STARTED|Overall Study||30
891905|NCT01879800|2156507|P1|STARTED|Overall Study||14
891906|NCT01879735|2156519|P2|NOT COMPLETED|Overall Study||0
891907|NCT01879735|2156520|P1|NOT COMPLETED|Overall Study||0
891908|NCT01879735|2156519|P2|COMPLETED|Overall Study||16
891909|NCT01879735|2156520|P1|COMPLETED|Overall Study||6
891910|NCT01879735|2156519|P2|STARTED|Overall Study||16
891911|NCT01879735|2156520|P1|STARTED|Overall Study||6
891912|NCT01879722|2156536|P10|NOT COMPLETED|Overall Study||0
891913|NCT01879722|2156537|P9|NOT COMPLETED|Overall Study||2
891914|NCT01879722|2156538|P8|NOT COMPLETED|Overall Study||1
891915|NCT01879722|2156539|P7|NOT COMPLETED|Overall Study||0
891916|NCT01879722|2156540|P6|NOT COMPLETED|Overall Study||0
891917|NCT01879722|2156541|P5|NOT COMPLETED|Overall Study||1
891918|NCT01879722|2156542|P4|NOT COMPLETED|Overall Study||1
891919|NCT01879722|2156543|P3|NOT COMPLETED|Overall Study||0
891920|NCT01879722|2156544|P2|NOT COMPLETED|Overall Study||1
891921|NCT01879722|2156545|P1|NOT COMPLETED|Overall Study||0
891922|NCT01879722|2156536|P10|COMPLETED|Overall Study||6
891923|NCT01879722|2156537|P9|COMPLETED|Overall Study||6
891924|NCT01879722|2156538|P8|COMPLETED|Overall Study||7
891925|NCT01879722|2156539|P7|COMPLETED|Overall Study||8
891926|NCT01879722|2156540|P6|COMPLETED|Overall Study||9
891927|NCT01879722|2156541|P5|COMPLETED|Overall Study||7
891928|NCT01879722|2156542|P4|COMPLETED|Overall Study||7
891929|NCT01879722|2156543|P3|COMPLETED|Overall Study||7
891930|NCT01879722|2156544|P2|COMPLETED|Overall Study||7
891931|NCT01879722|2156545|P1|COMPLETED|Overall Study||7
891932|NCT01879722|2156536|P10|STARTED|Overall Study||6
891933|NCT01879722|2156537|P9|STARTED|Overall Study||8
891934|NCT01879722|2156538|P8|STARTED|Overall Study||8
891935|NCT01879722|2156539|P7|STARTED|Overall Study||8
891936|NCT01879722|2156540|P6|STARTED|Overall Study||9
891937|NCT01879722|2156541|P5|STARTED|Overall Study||8
891938|NCT01879722|2156542|P4|STARTED|Overall Study||8
891939|NCT01879722|2156543|P3|STARTED|Overall Study||7
891940|NCT01879722|2156544|P2|STARTED|Overall Study||8
891941|NCT01879722|2156545|P1|STARTED|Overall Study||7
891942|NCT01879683|2156693|P1|NOT COMPLETED|Overall Study||1
891943|NCT01879683|2156693|P1|COMPLETED|Overall Study||9
891944|NCT01879683|2156693|P1|STARTED|Overall Study||10
891945|NCT01879618|2156700|P1|NOT COMPLETED|Overall Study||21
891946|NCT01879618|2156700|P1|COMPLETED|Overall Study||131
891947|NCT01879618|2156700|P1|STARTED|Overall Study||152
891948|NCT01879579|2156707|P2|NOT COMPLETED|Overall Study||2
891949|NCT01879579|2156708|P1|NOT COMPLETED|Overall Study||5
891950|NCT01879579|2156707|P2|COMPLETED|Overall Study||26
891951|NCT01879579|2156708|P1|COMPLETED|Overall Study||28
891952|NCT01879579|2156707|P2|STARTED|Overall Study||28
891953|NCT01879579|2156708|P1|STARTED|Overall Study||33
891954|NCT01879553|2156738|P2|NOT COMPLETED|Overall Study||0
891955|NCT01879553|2156739|P1|NOT COMPLETED|Overall Study||1
891956|NCT01879553|2156738|P2|COMPLETED|Overall Study||63
891957|NCT01879553|2156739|P1|COMPLETED|Overall Study||62
891958|NCT01879553|2156738|P2|STARTED|Overall Study||63
891959|NCT01879553|2156739|P1|STARTED|Overall Study||63
891960|NCT01879540|2156760|P1|NOT COMPLETED|Overall Study||0
891961|NCT01879540|2156760|P1|COMPLETED|Overall Study||63
891962|NCT01879540|2156760|P1|STARTED|Overall Study||63
891963|NCT01879410|2156773|P2|NOT COMPLETED|Overall Study||38
891964|NCT01879410|2156774|P1|NOT COMPLETED|Overall Study||24
891965|NCT01879410|2156773|P2|COMPLETED|Overall Study||312
891966|NCT01879410|2156774|P1|COMPLETED|Overall Study||326
891967|NCT01879410|2156773|P2|Intent-to-Treat Population|Overall Study||348
891968|NCT01879410|2156774|P1|Intent-to-Treat Population|Overall Study||349
891969|NCT01879410|2156773|P2|STARTED|Overall Study||350
891970|NCT01879410|2156774|P1|STARTED|Overall Study||350
891971|NCT01879371|2156788|P6|NOT COMPLETED|Overall Study||0
891972|NCT01879371|2156789|P5|NOT COMPLETED|Overall Study||0
891973|NCT01879371|2156790|P4|NOT COMPLETED|Overall Study||0
891974|NCT01879371|2156791|P3|NOT COMPLETED|Overall Study||0
891975|NCT01879371|2156792|P2|NOT COMPLETED|Overall Study||0
891976|NCT01879371|2156793|P1|NOT COMPLETED|Overall Study||0
891977|NCT01879371|2156788|P6|COMPLETED|Overall Study||6
891978|NCT01879371|2156789|P5|COMPLETED|Overall Study||6
891979|NCT01879371|2156790|P4|COMPLETED|Overall Study||6
891980|NCT01879371|2156791|P3|COMPLETED|Overall Study||6
891981|NCT01879371|2156792|P2|COMPLETED|Overall Study||6
891982|NCT01879371|2156793|P1|COMPLETED|Overall Study||6
891983|NCT01879371|2156788|P6|STARTED|Overall Study||6
891984|NCT01879371|2156789|P5|STARTED|Overall Study||6
891985|NCT01879371|2156790|P4|STARTED|Overall Study||6
891986|NCT01879371|2156791|P3|STARTED|Overall Study||6
891987|NCT01879371|2156792|P2|STARTED|Overall Study||6
891988|NCT01879371|2156793|P1|STARTED|Overall Study||6
891989|NCT01879345|2156810|P3|NOT COMPLETED|7-day Multiple-dose Period||0
891990|NCT01879345|2156811|P2|NOT COMPLETED|7-day Multiple-dose Period||0
891991|NCT01879345|2156812|P1|NOT COMPLETED|7-day Multiple-dose Period||0
891992|NCT01879345|2156810|P3|COMPLETED|7-day Multiple-dose Period||6
891993|NCT01879345|2156811|P2|COMPLETED|7-day Multiple-dose Period||6
891994|NCT01879345|2156812|P1|COMPLETED|7-day Multiple-dose Period||6
891995|NCT01879345|2156810|P3|STARTED|7-day Multiple-dose Period||6
891996|NCT01879345|2156811|P2|STARTED|7-day Multiple-dose Period||6
891997|NCT01879345|2156812|P1|STARTED|7-day Multiple-dose Period||6
891998|NCT01879345|2156810|P3|NOT COMPLETED|Single-dose Period||0
891999|NCT01879345|2156811|P2|NOT COMPLETED|Single-dose Period||0
892000|NCT01879345|2156812|P1|NOT COMPLETED|Single-dose Period||0
892001|NCT01879345|2156810|P3|COMPLETED|Single-dose Period||6
892002|NCT01879345|2156811|P2|COMPLETED|Single-dose Period||6
892003|NCT01879345|2156812|P1|COMPLETED|Single-dose Period||6
892004|NCT01879345|2156810|P3|STARTED|Single-dose Period||6
892005|NCT01879345|2156811|P2|STARTED|Single-dose Period||6
892006|NCT01879345|2156812|P1|STARTED|Single-dose Period||6
892007|NCT01879332|2156829|P3|NOT COMPLETED|Overall Study||4
892008|NCT01879332|2156830|P2|NOT COMPLETED|Overall Study||6
892009|NCT01879332|2156831|P1|NOT COMPLETED|Overall Study||6
892010|NCT01879332|2156829|P3|COMPLETED|Overall Study||0
892011|NCT01879332|2156830|P2|COMPLETED|Overall Study||0
892012|NCT01879332|2156831|P1|COMPLETED|Overall Study||0
892013|NCT01879332|2156829|P3|STARTED|Overall Study||4
892014|NCT01879332|2156830|P2|STARTED|Overall Study||6
892015|NCT01879332|2156831|P1|STARTED|Overall Study||6
892016|NCT01879319|2156841|P2|NOT COMPLETED|Overall Study||5
892017|NCT01879319|2156842|P1|NOT COMPLETED|Overall Study||2
892018|NCT01879319|2156841|P2|COMPLETED|Overall Study||77
892019|NCT01879319|2156842|P1|COMPLETED|Overall Study||80
892020|NCT01879319|2156841|P2|Received Treatment|Overall Study||82
892021|NCT01879319|2156842|P1|Received Treatment|Overall Study||82
892022|NCT01879319|2156841|P2|STARTED|Overall Study||82
892023|NCT01879319|2156842|P1|STARTED|Overall Study||82
892024|NCT01879176|2156852|P2|NOT COMPLETED|Overall Study||6
892025|NCT01879176|2156853|P1|NOT COMPLETED|Overall Study||8
892026|NCT01879176|2156852|P2|COMPLETED|Overall Study||16
892027|NCT01879176|2156853|P1|COMPLETED|Overall Study||16
892028|NCT01879176|2156852|P2|STARTED|Overall Study||22
892029|NCT01879176|2156853|P1|STARTED|Overall Study||24
892030|NCT01879059|2156859|P1|NOT COMPLETED|Overall Study||0
892031|NCT01879059|2156859|P1|COMPLETED|Overall Study||13
892032|NCT01879059|2156859|P1|STARTED|Overall Study||13
892033|NCT01878825|2156865|P2|NOT COMPLETED|Overall Study||0
892034|NCT01878825|2156866|P1|NOT COMPLETED|Overall Study||0
892035|NCT01878825|2156865|P2|COMPLETED|Overall Study||60
892036|NCT01878825|2156866|P1|COMPLETED|Overall Study||60
892037|NCT01878825|2156865|P2|STARTED|Overall Study||60
892038|NCT01878825|2156866|P1|STARTED|Overall Study||60
892039|NCT01878812|2156904|P2|NOT COMPLETED|Overall Study||0
892040|NCT01878812|2156905|P1|NOT COMPLETED|Overall Study||0
892041|NCT01878812|2156904|P2|COMPLETED|Overall Study||57
892042|NCT01878812|2156905|P1|COMPLETED|Overall Study||60
892043|NCT01878812|2156904|P2|STARTED|Overall Study||57
892044|NCT01878812|2156905|P1|STARTED|Overall Study||60
892045|NCT01878799|2156941|P2|NOT COMPLETED|Overall Study||0
892046|NCT01878799|2156942|P1|NOT COMPLETED|Overall Study||1
892047|NCT01878799|2156941|P2|COMPLETED|Overall Study||13
892048|NCT01878799|2156942|P1|COMPLETED|Overall Study||36
892049|NCT01878799|2156941|P2|STARTED|Overall Study||13
892050|NCT01878799|2156942|P1|STARTED|Overall Study||37
892051|NCT01878656|2156950|P2|NOT COMPLETED|Overall Study||0
892052|NCT01878656|2156951|P1|NOT COMPLETED|Overall Study||0
892053|NCT01878656|2156950|P2|COMPLETED|Overall Study||72
892054|NCT01878656|2156951|P1|COMPLETED|Overall Study||72
892055|NCT01878656|2156950|P2|STARTED|Overall Study||72
892056|NCT01878656|2156951|P1|STARTED|Overall Study||72
892057|NCT01878604|2156957|P1|NOT COMPLETED|Overall Study||0
892058|NCT01878604|2156957|P1|COMPLETED|Overall Study||5
892059|NCT01878604|2156957|P1|STARTED|Overall Study||5
892060|NCT01878526|2156964|P2|NOT COMPLETED|Overall Study||2
892061|NCT01878526|2156965|P1|NOT COMPLETED|Overall Study||3
892062|NCT01878526|2156964|P2|COMPLETED|Overall Study||38
892063|NCT01878526|2156965|P1|COMPLETED|Overall Study||37
892064|NCT01878526|2156964|P2|STARTED|Overall Study||40
892065|NCT01878526|2156965|P1|STARTED|Overall Study||40
892066|NCT01878214|2156980|P2|NOT COMPLETED|Overall Study||44
892067|NCT01878214|2156981|P1|NOT COMPLETED|Overall Study||53
892068|NCT01878214|2156980|P2|COMPLETED|Overall Study||175
892069|NCT01878214|2156981|P1|COMPLETED|Overall Study||170
892070|NCT01878214|2156980|P2|STARTED|Overall Study||219
892071|NCT01878214|2156981|P1|STARTED|Overall Study||223
892072|NCT01878175|2156995|P1|NOT COMPLETED|Overall Study||2
892073|NCT01878175|2156995|P1|COMPLETED|Overall Study||13
892074|NCT01878175|2156995|P1|STARTED|Overall Study||15
892075|NCT01878149|2157014|P2|NOT COMPLETED|Overall Study||2
892076|NCT01878149|2157015|P1|NOT COMPLETED|Overall Study||2
892077|NCT01878149|2157014|P2|COMPLETED|Overall Study||15
892078|NCT01878149|2157015|P1|COMPLETED|Overall Study||19
892079|NCT01878149|2157014|P2|STARTED|Overall Study||17
892080|NCT01878149|2157015|P1|STARTED|Overall Study||21
892081|NCT01878097|2157023|P2|NOT COMPLETED|Implementation Year 5||3007
892082|NCT01878097|2157024|P1|NOT COMPLETED|Implementation Year 5||3604
892083|NCT01878097|2157023|P2|COMPLETED|Implementation Year 5||6607
892084|NCT01878097|2157024|P1|COMPLETED|Implementation Year 5||6981
892085|NCT01878097|2157023|P2|STARTED|Implementation Year 5||9614
892086|NCT01878097|2157024|P1|STARTED|Implementation Year 5||10585
892087|NCT01878097|2157023|P2|NOT COMPLETED|Implementation Year 3||2980
892088|NCT01878097|2157024|P1|NOT COMPLETED|Implementation Year 3||3494
892089|NCT01878097|2157023|P2|COMPLETED|Implementation Year 3||6770
892090|NCT01878097|2157024|P1|COMPLETED|Implementation Year 3||7046
892091|NCT01878097|2157023|P2|STARTED|Implementation Year 3||9750
892092|NCT01878097|2157024|P1|STARTED|Implementation Year 3||10540
892093|NCT01878097|2157023|P2|NOT COMPLETED|Implementation Year 2||2841
892094|NCT01878097|2157024|P1|NOT COMPLETED|Implementation Year 2||3281
892095|NCT01878097|2157023|P2|COMPLETED|Implementation Year 2||6770
892096|NCT01878097|2157024|P1|COMPLETED|Implementation Year 2||8286
892097|NCT01878097|2157023|P2|STARTED|Implementation Year 2||9611
892098|NCT01878097|2157024|P1|STARTED|Implementation Year 2||11567
892099|NCT01878097|2157023|P2|NOT COMPLETED|Implementation Year 1||2549
892100|NCT01878097|2157024|P1|NOT COMPLETED|Implementation Year 1||3202
892101|NCT01878097|2157023|P2|COMPLETED|Implementation Year 1||7317
892102|NCT01878097|2157024|P1|COMPLETED|Implementation Year 1||8540
892103|NCT01878097|2157023|P2|STARTED|Implementation Year 1||9866
892104|NCT01878097|2157024|P1|STARTED|Implementation Year 1||11742
892105|NCT01878097|2157023|P2|NOT COMPLETED|Baseline||1800
892106|NCT01878097|2157024|P1|NOT COMPLETED|Baseline||2497
892107|NCT01878097|2157023|P2|COMPLETED|Baseline|Anonymous surveys; sum of all completed surveys.|8281
892108|NCT01878097|2157024|P1|COMPLETED|Baseline|Anonymous surveys so only last year data provided as annual completed.|8228
892109|NCT01878097|2157023|P2|STARTED|Baseline|number of students in 13 control schools completing anonymous surveys with non missing data|10081
892110|NCT01878097|2157024|P1|STARTED|Baseline|number of students in 13 intervention schools completing anonymous surveys with non missing data|10725
892111|NCT01877941|2157034|P1|NOT COMPLETED|Overall Study||0
892112|NCT01877941|2157034|P1|COMPLETED|Overall Study||39
892113|NCT01877941|2157034|P1|STARTED|Overall Study||39
892114|NCT01877720|2157040|P2|NOT COMPLETED|Overall Study||0
892115|NCT01877720|2157041|P1|NOT COMPLETED|Overall Study||1
892116|NCT01877720|2157040|P2|COMPLETED|Overall Study||8
892117|NCT01877720|2157041|P1|COMPLETED|Overall Study||7
892118|NCT01877720|2157040|P2|2nd Intervention|Overall Study||8
892119|NCT01877720|2157041|P1|2nd Intervention|Overall Study||7
892120|NCT01877720|2157040|P2|1st Intervention|Overall Study||8
892121|NCT01877720|2157041|P1|1st Intervention|Overall Study||7
892122|NCT01877720|2157040|P2|STARTED|Overall Study||8
892123|NCT01877720|2157041|P1|STARTED|Overall Study||8
892124|NCT01877668|2157070|P5|NOT COMPLETED|Overall Study||10
892125|NCT01877668|2157071|P4|NOT COMPLETED|Overall Study||8
892126|NCT01877668|2157072|P3|NOT COMPLETED|Overall Study||12
892127|NCT01877668|2157073|P2|NOT COMPLETED|Overall Study||8
892128|NCT01877668|2157074|P1|NOT COMPLETED|Overall Study||11
892129|NCT01877668|2157070|P5|COMPLETED|Overall Study||43
892130|NCT01877668|2157071|P4|COMPLETED|Overall Study||44
892131|NCT01877668|2157072|P3|COMPLETED|Overall Study||94
892132|NCT01877668|2157073|P2|COMPLETED|Overall Study||96
892133|NCT01877668|2157074|P1|COMPLETED|Overall Study||96
892134|NCT01877668|2157070|P5|STARTED|Overall Study|Received treatment|53
892135|NCT01877668|2157071|P4|STARTED|Overall Study|Received treatment|52
892136|NCT01877668|2157072|P3|STARTED|Overall Study|Received treatment|106
892137|NCT01877668|2157073|P2|STARTED|Overall Study|Received treatment|104
892138|NCT01877668|2157074|P1|STARTED|Overall Study|Received treatment|107
892139|NCT01877538|2157303|P1|NOT COMPLETED|Overall Study||0
892140|NCT01877538|2157303|P1|COMPLETED|Overall Study||7
892141|NCT01877538|2157303|P1|STARTED|Overall Study||7
892142|NCT01877421|2157340|P18|NOT COMPLETED|Phase 2||0
892143|NCT01877421|2157341|P17|NOT COMPLETED|Phase 2||0
892144|NCT01877421|2157342|P16|NOT COMPLETED|Phase 2||1
892145|NCT01877421|2157343|P15|NOT COMPLETED|Phase 2||0
892146|NCT01877421|2157344|P14|NOT COMPLETED|Phase 2||0
892147|NCT01877421|2157345|P13|NOT COMPLETED|Phase 2||1
892148|NCT01877421|2157346|P12|NOT COMPLETED|Phase 2||0
892149|NCT01877421|2157347|P11|NOT COMPLETED|Phase 2||2
892150|NCT01877421|2157348|P10|NOT COMPLETED|Phase 2||0
892151|NCT01877421|2157349|P9|NOT COMPLETED|Phase 2||1
892152|NCT01877421|2157350|P8|NOT COMPLETED|Phase 2||0
892153|NCT01877421|2157351|P7|NOT COMPLETED|Phase 2||1
892154|NCT01877421|2157352|P6|NOT COMPLETED|Phase 2||0
892155|NCT01877421|2157353|P5|NOT COMPLETED|Phase 2||0
892156|NCT01877421|2157354|P4|NOT COMPLETED|Phase 2||0
892157|NCT01877421|2157355|P3|NOT COMPLETED|Phase 2||0
892158|NCT01877421|2157356|P2|NOT COMPLETED|Phase 2||0
892159|NCT01877421|2157357|P1|NOT COMPLETED|Phase 2||0
892160|NCT01877421|2157340|P18|COMPLETED|Phase 2||0
892161|NCT01877421|2157341|P17|COMPLETED|Phase 2||0
892162|NCT01877421|2157342|P16|COMPLETED|Phase 2||2
892163|NCT01877421|2157343|P15|COMPLETED|Phase 2||7
892164|NCT01877421|2157344|P14|COMPLETED|Phase 2||3
892165|NCT01877421|2157345|P13|COMPLETED|Phase 2||6
892166|NCT01877421|2157346|P12|COMPLETED|Phase 2||3
892167|NCT01877421|2157347|P11|COMPLETED|Phase 2||5
892168|NCT01877421|2157348|P10|COMPLETED|Phase 2||3
892169|NCT01877421|2157349|P9|COMPLETED|Phase 2||5
892170|NCT01877421|2157350|P8|COMPLETED|Phase 2||2
892171|NCT01877421|2157351|P7|COMPLETED|Phase 2||6
892172|NCT01877421|2157352|P6|COMPLETED|Phase 2||3
892173|NCT01877421|2157353|P5|COMPLETED|Phase 2||7
892174|NCT01877421|2157354|P4|COMPLETED|Phase 2||2
892175|NCT01877421|2157355|P3|COMPLETED|Phase 2||4
892176|NCT01877421|2157356|P2|COMPLETED|Phase 2||0
892177|NCT01877421|2157357|P1|COMPLETED|Phase 2||0
892178|NCT01877421|2157340|P18|STARTED|Phase 2||0
892179|NCT01877421|2157341|P17|STARTED|Phase 2||0
892180|NCT01877421|2157342|P16|STARTED|Phase 2||3
892181|NCT01877421|2157343|P15|STARTED|Phase 2||7
892182|NCT01877421|2157344|P14|STARTED|Phase 2||3
892183|NCT01877421|2157345|P13|STARTED|Phase 2||7
892184|NCT01877421|2157346|P12|STARTED|Phase 2||3
892185|NCT01877421|2157347|P11|STARTED|Phase 2||7
892186|NCT01877421|2157348|P10|STARTED|Phase 2||3
892187|NCT01877421|2157349|P9|STARTED|Phase 2||6
892188|NCT01877421|2157350|P8|STARTED|Phase 2||2
892189|NCT01877421|2157351|P7|STARTED|Phase 2||7
892190|NCT01877421|2157352|P6|STARTED|Phase 2||3
892191|NCT01877421|2157353|P5|STARTED|Phase 2||7
892192|NCT01877421|2157354|P4|STARTED|Phase 2||2
892193|NCT01877421|2157355|P3|STARTED|Phase 2||4
892194|NCT01877421|2157356|P2|STARTED|Phase 2||0
892195|NCT01877421|2157357|P1|STARTED|Phase 2||0
892196|NCT01877421|2157340|P18|NOT COMPLETED|Phase 1||0
892197|NCT01877421|2157341|P17|NOT COMPLETED|Phase 1||0
892198|NCT01877421|2157342|P16|NOT COMPLETED|Phase 1||0
892199|NCT01877421|2157343|P15|NOT COMPLETED|Phase 1||0
892200|NCT01877421|2157344|P14|NOT COMPLETED|Phase 1||0
892201|NCT01877421|2157345|P13|NOT COMPLETED|Phase 1||0
892202|NCT01877421|2157346|P12|NOT COMPLETED|Phase 1||0
892203|NCT01877421|2157347|P11|NOT COMPLETED|Phase 1||0
892204|NCT01877421|2157348|P10|NOT COMPLETED|Phase 1||0
892205|NCT01877421|2157349|P9|NOT COMPLETED|Phase 1||0
892206|NCT01877421|2157350|P8|NOT COMPLETED|Phase 1||0
892207|NCT01877421|2157351|P7|NOT COMPLETED|Phase 1||0
892208|NCT01877421|2157352|P6|NOT COMPLETED|Phase 1||0
892209|NCT01877421|2157353|P5|NOT COMPLETED|Phase 1||0
892210|NCT01877421|2157354|P4|NOT COMPLETED|Phase 1||0
892211|NCT01877421|2157355|P3|NOT COMPLETED|Phase 1||0
892212|NCT01877421|2157356|P2|NOT COMPLETED|Phase 1||0
892213|NCT01877421|2157357|P1|NOT COMPLETED|Phase 1||0
892214|NCT01877421|2157340|P18|COMPLETED|Phase 1||3
892215|NCT01877421|2157341|P17|COMPLETED|Phase 1||7
892216|NCT01877421|2157342|P16|COMPLETED|Phase 1||3
892217|NCT01877421|2157343|P15|COMPLETED|Phase 1||7
892218|NCT01877421|2157344|P14|COMPLETED|Phase 1||3
892219|NCT01877421|2157345|P13|COMPLETED|Phase 1||7
892220|NCT01877421|2157346|P12|COMPLETED|Phase 1||3
892221|NCT01877421|2157347|P11|COMPLETED|Phase 1||7
892222|NCT01877421|2157348|P10|COMPLETED|Phase 1||3
892223|NCT01877421|2157349|P9|COMPLETED|Phase 1||7
892224|NCT01877421|2157350|P8|COMPLETED|Phase 1||2
892225|NCT01877421|2157351|P7|COMPLETED|Phase 1||4
892226|NCT01877421|2157352|P6|COMPLETED|Phase 1||2
892227|NCT01877421|2157353|P5|COMPLETED|Phase 1||4
892228|NCT01877421|2157354|P4|COMPLETED|Phase 1||2
892229|NCT01877421|2157355|P3|COMPLETED|Phase 1||4
892230|NCT01877421|2157356|P2|COMPLETED|Phase 1||1
892231|NCT01877421|2157357|P1|COMPLETED|Phase 1||2
892232|NCT01877421|2157340|P18|STARTED|Phase 1||3
892233|NCT01877421|2157341|P17|STARTED|Phase 1||7
892234|NCT01877421|2157342|P16|STARTED|Phase 1||3
892235|NCT01877421|2157343|P15|STARTED|Phase 1||7
892236|NCT01877421|2157344|P14|STARTED|Phase 1||3
892237|NCT01877421|2157345|P13|STARTED|Phase 1||7
892238|NCT01877421|2157346|P12|STARTED|Phase 1||3
892239|NCT01877421|2157347|P11|STARTED|Phase 1||7
892240|NCT01877421|2157348|P10|STARTED|Phase 1||3
892241|NCT01877421|2157349|P9|STARTED|Phase 1||7
892242|NCT01877421|2157350|P8|STARTED|Phase 1||2
892243|NCT01877421|2157351|P7|STARTED|Phase 1||4
892244|NCT01877421|2157352|P6|STARTED|Phase 1||2
892245|NCT01877421|2157353|P5|STARTED|Phase 1||4
892246|NCT01877421|2157354|P4|STARTED|Phase 1||2
892247|NCT01877421|2157355|P3|STARTED|Phase 1||4
892248|NCT01877421|2157356|P2|STARTED|Phase 1||1
892249|NCT01877421|2157357|P1|STARTED|Phase 1||2
892250|NCT01877408|2157467|P2|NOT COMPLETED|Overall Study||2
892251|NCT01877408|2157468|P1|NOT COMPLETED|Overall Study||0
892252|NCT01877408|2157467|P2|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|98
892253|NCT01877408|2157468|P1|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|50
892254|NCT01877408|2157467|P2|STARTED|Overall Study||100
892255|NCT01877408|2157468|P1|STARTED|Overall Study||50
892256|NCT01877343|2157488|P7|NOT COMPLETED|Overall Study||0
892257|NCT01877343|2157489|P6|NOT COMPLETED|Overall Study||0
892258|NCT01877343|2157490|P5|NOT COMPLETED|Overall Study||0
892259|NCT01877343|2157491|P4|NOT COMPLETED|Overall Study||0
892260|NCT01877343|2157492|P3|NOT COMPLETED|Overall Study||0
892261|NCT01877343|2157493|P2|NOT COMPLETED|Overall Study||0
892262|NCT01877343|2157494|P1|NOT COMPLETED|Overall Study||0
892263|NCT01877343|2157488|P7|COMPLETED|Overall Study||0
892264|NCT01877343|2157489|P6|COMPLETED|Overall Study||5
892265|NCT01877343|2157490|P5|COMPLETED|Overall Study||0
892266|NCT01877343|2157491|P4|COMPLETED|Overall Study||0
892267|NCT01877343|2157492|P3|COMPLETED|Overall Study||0
892268|NCT01877343|2157493|P2|COMPLETED|Overall Study||3
892269|NCT01877343|2157494|P1|COMPLETED|Overall Study||2
892270|NCT01877343|2157488|P7|STARTED|Overall Study||0
892271|NCT01877343|2157489|P6|STARTED|Overall Study||5
892272|NCT01877343|2157490|P5|STARTED|Overall Study||0
892273|NCT01877343|2157491|P4|STARTED|Overall Study||0
892274|NCT01877343|2157492|P3|STARTED|Overall Study||0
892275|NCT01877343|2157493|P2|STARTED|Overall Study||3
892276|NCT01877343|2157494|P1|STARTED|Overall Study||2
892277|NCT01877278|2157501|P2|NOT COMPLETED|Overall Study||3
892278|NCT01877278|2157502|P1|NOT COMPLETED|Overall Study||3
892279|NCT01877278|2157501|P2|COMPLETED|Overall Study||30
892280|NCT01877278|2157502|P1|COMPLETED|Overall Study||30
892281|NCT01877278|2157501|P2|STARTED|Overall Study||33
892282|NCT01877278|2157502|P1|STARTED|Overall Study||33
892283|NCT01877161|2157510|P1|NOT COMPLETED|Third Session of Stimulation||0
892284|NCT01877161|2157510|P1|COMPLETED|Third Session of Stimulation||12
892285|NCT01877161|2157510|P1|STARTED|Third Session of Stimulation||12
892286|NCT01877161|2157510|P1|NOT COMPLETED|Washout (at Least 3 Days)||0
892287|NCT01877161|2157510|P1|COMPLETED|Washout (at Least 3 Days)||12
892288|NCT01877161|2157510|P1|STARTED|Washout (at Least 3 Days)||12
892289|NCT01877161|2157510|P1|NOT COMPLETED|Second Session of Stimulation||0
892290|NCT01877161|2157510|P1|COMPLETED|Second Session of Stimulation||12
892291|NCT01877161|2157510|P1|STARTED|Second Session of Stimulation||12
892292|NCT01877161|2157510|P1|NOT COMPLETED|Washout (at Least 3 Days)||0
892293|NCT01877161|2157510|P1|COMPLETED|Washout (at Least 3 Days)||12
892294|NCT01877161|2157510|P1|STARTED|Washout (at Least 3 Days)||12
892295|NCT01877161|2157510|P1|NOT COMPLETED|First Session of Stimulation||0
892296|NCT01877161|2157510|P1|COMPLETED|First Session of Stimulation||12
892297|NCT01877161|2157510|P1|STARTED|First Session of Stimulation||12
892298|NCT01877148|2157520|P2|NOT COMPLETED|Overall Study||1
892299|NCT01877148|2157521|P1|NOT COMPLETED|Overall Study||1
892300|NCT01877148|2157520|P2|COMPLETED|Overall Study||5
892301|NCT01877148|2157521|P1|COMPLETED|Overall Study||5
892302|NCT01877148|2157520|P2|STARTED|Overall Study||6
892303|NCT01877148|2157521|P1|STARTED|Overall Study||6
892304|NCT01876992|2157535|P2|NOT COMPLETED|Overall Study||0
892305|NCT01876992|2157536|P1|NOT COMPLETED|Overall Study||0
892306|NCT01876992|2157535|P2|COMPLETED|Overall Study||5
892307|NCT01876992|2157536|P1|COMPLETED|Overall Study||5
892308|NCT01876992|2157535|P2|STARTED|Overall Study||5
892309|NCT01876992|2157536|P1|STARTED|Overall Study||5
892310|NCT01876979|2157550|P2|NOT COMPLETED|Overall Study||3
892311|NCT01876979|2157551|P1|NOT COMPLETED|Overall Study||2
892312|NCT01876979|2157550|P2|COMPLETED|Overall Study||0
892313|NCT01876979|2157551|P1|COMPLETED|Overall Study||0
892314|NCT01876979|2157550|P2|STARTED|Overall Study||3
892315|NCT01876979|2157551|P1|STARTED|Overall Study||2
892316|NCT01876823|2157557|P1|NOT COMPLETED|Overall Study||9
892317|NCT01876823|2157557|P1|COMPLETED|Overall Study||26
892318|NCT01876823|2157557|P1|STARTED|Overall Study||35
892319|NCT01876810|2157570|P2|NOT COMPLETED|Overall Study||1
892320|NCT01876810|2157571|P1|NOT COMPLETED|Overall Study||0
892321|NCT01876810|2157570|P2|COMPLETED|Overall Study||13
892322|NCT01876810|2157571|P1|COMPLETED|Overall Study||14
892323|NCT01876810|2157570|P2|STARTED|Overall Study||14
892324|NCT01876810|2157571|P1|STARTED|Overall Study||14
892325|NCT01876784|2157583|P2|NOT COMPLETED|Overall Study||119
892326|NCT01876784|2157584|P1|NOT COMPLETED|Overall Study||119
892327|NCT01876784|2157583|P2|COMPLETED|Overall Study||0
892328|NCT01876784|2157584|P1|COMPLETED|Overall Study||0
892329|NCT01876784|2157583|P2|Treated|Overall Study||118
892330|NCT01876784|2157584|P1|Treated|Overall Study||117
892331|NCT01876784|2157583|P2|STARTED|Overall Study||119
892332|NCT01876784|2157584|P1|STARTED|Overall Study||119
892333|NCT01876732|2157590|P1|NOT COMPLETED|Overall Study||75
892334|NCT01876732|2157590|P1|COMPLETED|Overall Study||57
892335|NCT01876732|2157590|P1|STARTED|Overall Study||132
892336|NCT01876706|2157595|P1|NOT COMPLETED|Overall Study||4
892337|NCT01876706|2157595|P1|COMPLETED|Overall Study||47
892338|NCT01876706|2157595|P1|12 Months|Overall Study||41
892339|NCT01876706|2157595|P1|1 Month|Overall Study||51
892340|NCT01876706|2157595|P1|STARTED|Overall Study||51
892341|NCT01876368|2157614|P2|NOT COMPLETED|Overall Study||13
892342|NCT01876368|2157615|P1|NOT COMPLETED|Overall Study||9
892343|NCT01876368|2157614|P2|COMPLETED|Overall Study||175
892344|NCT01876368|2157615|P1|COMPLETED|Overall Study||179
892345|NCT01876368|2157614|P2|Safety Set (SAF)|Overall Study||187
892346|NCT01876368|2157615|P1|Safety Set (SAF)|Overall Study||188
892347|NCT01876368|2157614|P2|Full Analysis Set (FAS)|Overall Study|One patient was not included in the SAF and FAS due to mis-randomization.|187
892348|NCT01876368|2157615|P1|Full Analysis Set (FAS)|Overall Study||188
892349|NCT01876368|2157614|P2|STARTED|Overall Study||188
892350|NCT01876368|2157615|P1|STARTED|Overall Study||188
892351|NCT01876329|2157644|P3|NOT COMPLETED|Overall Study||0
892352|NCT01876329|2157645|P2|NOT COMPLETED|Overall Study||0
892353|NCT01876329|2157646|P1|NOT COMPLETED|Overall Study||0
892354|NCT01876329|2157644|P3|COMPLETED|Overall Study||44
892355|NCT01876329|2157645|P2|COMPLETED|Overall Study||36
892356|NCT01876329|2157646|P1|COMPLETED|Overall Study||45
892357|NCT01876329|2157644|P3|STARTED|Overall Study||44
892358|NCT01876329|2157645|P2|STARTED|Overall Study||36
892359|NCT01876329|2157646|P1|STARTED|Overall Study||45
892360|NCT01875991|2157659|P2|NOT COMPLETED|Overall Study||6
892361|NCT01875991|2157660|P1|NOT COMPLETED|Overall Study||7
892362|NCT01875991|2157659|P2|COMPLETED|Overall Study||103
892363|NCT01875991|2157660|P1|COMPLETED|Overall Study||101
892364|NCT01875991|2157659|P2|Received Etanercept in Period 2|Overall Study||103
892365|NCT01875991|2157660|P1|Received Etanercept in Period 2|Overall Study||102
892366|NCT01875991|2157659|P2|Received Etanercept in Period 1|Overall Study||108
892367|NCT01875991|2157660|P1|Received Etanercept in Period 1|Overall Study||108
892368|NCT01875991|2157659|P2|STARTED|Overall Study||109
892369|NCT01875991|2157660|P1|STARTED|Overall Study||108
892370|NCT01875978|2157683|P2|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
892371|NCT01875978|2157684|P1|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
892372|NCT01875978|2157683|P2|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
892373|NCT01875978|2157684|P1|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
892374|NCT01875978|2157683|P2|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
892375|NCT01875978|2157684|P1|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
892376|NCT01875978|2157683|P2|NOT COMPLETED|Study 4weeks||0
892377|NCT01875978|2157684|P1|NOT COMPLETED|Study 4weeks||0
892378|NCT01875978|2157683|P2|COMPLETED|Study 4weeks||20
892379|NCT01875978|2157684|P1|COMPLETED|Study 4weeks||20
892380|NCT01875978|2157683|P2|STARTED|Study 4weeks||20
892381|NCT01875978|2157684|P1|STARTED|Study 4weeks||20
892382|NCT01875848|2157698|P2|NOT COMPLETED|Overall Study||0
892383|NCT01875848|2157699|P1|NOT COMPLETED|Overall Study||2
892384|NCT01875848|2157698|P2|COMPLETED|Overall Study|4 patients completed the opioid dose escalation arm of the study|4
892385|NCT01875848|2157699|P1|COMPLETED|Overall Study|1 patient completed the Buprenorphine arm of the study. 2 patients withdrew|1
892386|NCT01875848|2157698|P2|STARTED|Overall Study|4 patients were enrolled in the opioid dose escalation arm of the study|4
892387|NCT01875848|2157699|P1|STARTED|Overall Study|3 patients were enrolled in the Buprenorphine arm of the study|3
892388|NCT01875783|2157707|P1|NOT COMPLETED|Overall Study||0
892389|NCT01875783|2157707|P1|COMPLETED|Overall Study||385
892390|NCT01875783|2157707|P1|STARTED|Overall Study||385
892391|NCT01875731|2157713|P2|NOT COMPLETED|Overall Study||0
892392|NCT01875731|2157714|P1|NOT COMPLETED|Overall Study||1
892393|NCT01875731|2157713|P2|COMPLETED|Overall Study||32
892394|NCT01875731|2157714|P1|COMPLETED|Overall Study||33
892395|NCT01875731|2157713|P2|STARTED|Overall Study||32
892396|NCT01875731|2157714|P1|STARTED|Overall Study||34
892397|NCT01875510|2157724|P2|NOT COMPLETED|Overall Study||0
892398|NCT01875510|2157725|P1|NOT COMPLETED|Overall Study||0
892399|NCT01875510|2157724|P2|COMPLETED|Overall Study||40
892400|NCT01875510|2157725|P1|COMPLETED|Overall Study||40
892401|NCT01875510|2157724|P2|STARTED|Overall Study||40
892402|NCT01875510|2157725|P1|STARTED|Overall Study||40
892403|NCT01875471|2157733|P2|NOT COMPLETED|Overall Study||1
892404|NCT01875471|2157734|P1|NOT COMPLETED|Overall Study||1
892405|NCT01875471|2157733|P2|COMPLETED|Overall Study||137
892406|NCT01875471|2157734|P1|COMPLETED|Overall Study||136
892407|NCT01875471|2157733|P2|Completed Per Protocol|Overall Study||123
892408|NCT01875471|2157734|P1|Completed Per Protocol|Overall Study||127
892409|NCT01875471|2157733|P2|STARTED|Overall Study||138
892410|NCT01875471|2157734|P1|STARTED|Overall Study||137
892411|NCT01875445|2157742|P2|NOT COMPLETED|Overall Study||0
892412|NCT01875445|2157743|P1|NOT COMPLETED|Overall Study||7
892413|NCT01875445|2157742|P2|COMPLETED|Overall Study||19
892414|NCT01875445|2157743|P1|COMPLETED|Overall Study||12
892415|NCT01875445|2157742|P2|STARTED|Overall Study||19
892416|NCT01875445|2157743|P1|STARTED|Overall Study||19
892417|NCT01875159|2157753|P2|NOT COMPLETED|Overall Study||0
892418|NCT01875159|2157754|P1|NOT COMPLETED|Overall Study||3
892419|NCT01875159|2157753|P2|COMPLETED|Overall Study||53
892420|NCT01875159|2157754|P1|COMPLETED|Overall Study||42
892421|NCT01875159|2157753|P2|STARTED|Overall Study||53
892422|NCT01875159|2157754|P1|STARTED|Overall Study||45
892423|NCT01874951|2157764|P2|NOT COMPLETED|Overall Study||0
892424|NCT01874951|2157765|P1|NOT COMPLETED|Overall Study||0
892425|NCT01874951|2157764|P2|COMPLETED|Overall Study||6
892426|NCT01874951|2157765|P1|COMPLETED|Overall Study||6
892427|NCT01874951|2157764|P2|STARTED|Overall Study||6
892428|NCT01874951|2157765|P1|STARTED|Overall Study||6
892429|NCT01874665|2157787|P2|NOT COMPLETED|Overall Study||2
892430|NCT01874665|2157788|P1|NOT COMPLETED|Overall Study||4
892431|NCT01874665|2157787|P2|COMPLETED|Overall Study|Completed = off treatment|13
892432|NCT01874665|2157788|P1|COMPLETED|Overall Study|Completed = off treatment|26
892433|NCT01874665|2157787|P2|STARTED|Overall Study||15
892434|NCT01874665|2157788|P1|STARTED|Overall Study||30
892435|NCT01874340|2157797|P4|NOT COMPLETED|Overall Study||5
892436|NCT01874340|2157798|P3|NOT COMPLETED|Overall Study||8
892437|NCT01874340|2157799|P2|NOT COMPLETED|Overall Study||8
892438|NCT01874340|2157800|P1|NOT COMPLETED|Overall Study||6
892439|NCT01874340|2157797|P4|COMPLETED|Overall Study||1
892440|NCT01874340|2157798|P3|COMPLETED|Overall Study||0
892441|NCT01874340|2157799|P2|COMPLETED|Overall Study||0
892442|NCT01874340|2157800|P1|COMPLETED|Overall Study||0
892443|NCT01874340|2157797|P4|STARTED|Overall Study||6
892444|NCT01874340|2157798|P3|STARTED|Overall Study||8
892445|NCT01874340|2157799|P2|STARTED|Overall Study||8
892446|NCT01874340|2157800|P1|STARTED|Overall Study||6
892447|NCT01874275|2157828|P2|NOT COMPLETED|Overall Study||0
892448|NCT01874275|2157829|P1|NOT COMPLETED|Overall Study||1
892449|NCT01874275|2157828|P2|COMPLETED|Overall Study||2
892450|NCT01874275|2157829|P1|COMPLETED|Overall Study||3
892451|NCT01874275|2157828|P2|STARTED|Overall Study||2
892452|NCT01874275|2157829|P1|STARTED|Overall Study||4
892453|NCT01874262|2157843|P2|NOT COMPLETED|Overall Study||3
892454|NCT01874262|2157844|P1|NOT COMPLETED|Overall Study||5
892455|NCT01874262|2157843|P2|COMPLETED|Overall Study||80
892456|NCT01874262|2157844|P1|COMPLETED|Overall Study||86
892457|NCT01874262|2157843|P2|Not Included Due to Tehnical Issues|Overall Study||3
892458|NCT01874262|2157844|P1|Not Included Due to Tehnical Issues|Overall Study||3
892459|NCT01874262|2157843|P2|Not Correctly Randomised|Overall Study||0
892460|NCT01874262|2157844|P1|Not Correctly Randomised|Overall Study||2
892461|NCT01874262|2157843|P2|STARTED|Overall Study||83
892462|NCT01874262|2157844|P1|STARTED|Overall Study||91
892463|NCT01874145|2157852|P2|NOT COMPLETED|Extension Period||4
892464|NCT01874145|2157853|P1|NOT COMPLETED|Extension Period||6
892465|NCT01874145|2157852|P2|COMPLETED|Extension Period||97
892466|NCT01874145|2157853|P1|COMPLETED|Extension Period||91
892467|NCT01874145|2157852|P2|Full Analysis Set|Extension Period||101
892468|NCT01874145|2157853|P1|Full Analysis Set|Extension Period||95
892469|NCT01874145|2157852|P2|STARTED|Extension Period|Non-Switchers|101
892470|NCT01874145|2157853|P1|STARTED|Extension Period|Switchers|97
892471|NCT01874145|2157852|P2|NOT COMPLETED|Core Period||7
892472|NCT01874145|2157853|P1|NOT COMPLETED|Core Period||3
892473|NCT01874145|2157852|P2|COMPLETED|Core Period||101
892474|NCT01874145|2157853|P1|COMPLETED|Core Period||98
892475|NCT01874145|2157852|P2|Full Analysis Set|Core Period||108
892476|NCT01874145|2157853|P1|Full Analysis Set|Core Period||100
892477|NCT01874145|2157852|P2|STARTED|Core Period||108
892478|NCT01874145|2157853|P1|STARTED|Core Period||101
892479|NCT01874132|2157892|P3|NOT COMPLETED|Overall Study||3
892480|NCT01874132|2157893|P2|NOT COMPLETED|Overall Study||4
892481|NCT01874132|2157894|P1|NOT COMPLETED|Overall Study||4
892482|NCT01874132|2157892|P3|COMPLETED|Overall Study||19
892483|NCT01874132|2157893|P2|COMPLETED|Overall Study||18
892484|NCT01874132|2157894|P1|COMPLETED|Overall Study||18
892485|NCT01874132|2157892|P3|STARTED|Overall Study||22
892486|NCT01874132|2157893|P2|STARTED|Overall Study||22
892487|NCT01874132|2157894|P1|STARTED|Overall Study||22
892488|NCT01874054|2157905|P1|NOT COMPLETED|Follow-up Period||49
892489|NCT01874054|2157905|P1|COMPLETED|Follow-up Period||2
892490|NCT01874054|2157905|P1|STARTED|Follow-up Period|4 patients withdrew consent and did not enter the follow-up period.|51
892491|NCT01874054|2157905|P1|NOT COMPLETED|Treatment Period||38
892492|NCT01874054|2157905|P1|COMPLETED|Treatment Period||17
892493|NCT01874054|2157905|P1|STARTED|Treatment Period||55
892494|NCT01873989|2157916|P2|NOT COMPLETED|Overall Study||1
892495|NCT01873989|2157917|P1|NOT COMPLETED|Overall Study||1
892496|NCT01873989|2157916|P2|COMPLETED|Overall Study||6
892497|NCT01873989|2157917|P1|COMPLETED|Overall Study||7
892498|NCT01873989|2157916|P2|STARTED|Overall Study||7
892499|NCT01873989|2157917|P1|STARTED|Overall Study||8
892500|NCT01873950|2157927|P5|NOT COMPLETED|Period 5||0
892501|NCT01873950|2157928|P4|NOT COMPLETED|Period 5||1
892502|NCT01873950|2157929|P3|NOT COMPLETED|Period 5||0
892503|NCT01873950|2157930|P2|NOT COMPLETED|Period 5||0
892504|NCT01873950|2157931|P1|NOT COMPLETED|Period 5||0
892505|NCT01873950|2157927|P5|COMPLETED|Period 5||4
892506|NCT01873950|2157928|P4|COMPLETED|Period 5||3
892507|NCT01873950|2157929|P3|COMPLETED|Period 5||4
892508|NCT01873950|2157930|P2|COMPLETED|Period 5||5
892509|NCT01873950|2157931|P1|COMPLETED|Period 5||4
892510|NCT01873950|2157927|P5|STARTED|Period 5||4
892511|NCT01873950|2157928|P4|STARTED|Period 5||4
892512|NCT01873950|2157929|P3|STARTED|Period 5||4
892513|NCT01873950|2157930|P2|STARTED|Period 5||5
892514|NCT01873950|2157931|P1|STARTED|Period 5||4
892515|NCT01873950|2157927|P5|NOT COMPLETED|Period 4||0
892516|NCT01873950|2157928|P4|NOT COMPLETED|Period 4||0
892517|NCT01873950|2157929|P3|NOT COMPLETED|Period 4||0
892518|NCT01873950|2157930|P2|NOT COMPLETED|Period 4||0
892519|NCT01873950|2157931|P1|NOT COMPLETED|Period 4||0
892520|NCT01873950|2157927|P5|COMPLETED|Period 4||5
892521|NCT01873950|2157928|P4|COMPLETED|Period 4||4
892522|NCT01873950|2157929|P3|COMPLETED|Period 4||4
892523|NCT01873950|2157930|P2|COMPLETED|Period 4||5
892524|NCT01873950|2157931|P1|COMPLETED|Period 4||4
892525|NCT01873950|2157927|P5|STARTED|Period 4||5
892526|NCT01873950|2157928|P4|STARTED|Period 4||4
892527|NCT01873950|2157929|P3|STARTED|Period 4||4
892528|NCT01873950|2157930|P2|STARTED|Period 4||5
892529|NCT01873950|2157931|P1|STARTED|Period 4||4
892530|NCT01873950|2157927|P5|NOT COMPLETED|Period 3||0
892531|NCT01873950|2157928|P4|NOT COMPLETED|Period 3||0
892532|NCT01873950|2157929|P3|NOT COMPLETED|Period 3||0
892533|NCT01873950|2157930|P2|NOT COMPLETED|Period 3||0
892534|NCT01873950|2157931|P1|NOT COMPLETED|Period 3||0
892535|NCT01873950|2157927|P5|COMPLETED|Period 3||4
892536|NCT01873950|2157928|P4|COMPLETED|Period 3||5
892537|NCT01873950|2157929|P3|COMPLETED|Period 3||5
892538|NCT01873950|2157930|P2|COMPLETED|Period 3||4
892539|NCT01873950|2157931|P1|COMPLETED|Period 3||4
892540|NCT01873950|2157927|P5|STARTED|Period 3||4
892541|NCT01873950|2157928|P4|STARTED|Period 3||5
892542|NCT01873950|2157929|P3|STARTED|Period 3||5
892543|NCT01873950|2157930|P2|STARTED|Period 3||4
892544|NCT01873950|2157931|P1|STARTED|Period 3||4
892545|NCT01873950|2157927|P5|NOT COMPLETED|Period 2||0
892546|NCT01873950|2157928|P4|NOT COMPLETED|Period 2||0
892547|NCT01873950|2157929|P3|NOT COMPLETED|Period 2||0
892548|NCT01873950|2157930|P2|NOT COMPLETED|Period 2||0
892549|NCT01873950|2157931|P1|NOT COMPLETED|Period 2||0
892550|NCT01873950|2157927|P5|COMPLETED|Period 2||5
892551|NCT01873950|2157928|P4|COMPLETED|Period 2||4
892552|NCT01873950|2157929|P3|COMPLETED|Period 2||4
892553|NCT01873950|2157930|P2|COMPLETED|Period 2||4
892554|NCT01873950|2157931|P1|COMPLETED|Period 2||5
892555|NCT01873950|2157927|P5|STARTED|Period 2||5
892556|NCT01873950|2157928|P4|STARTED|Period 2||4
892557|NCT01873950|2157929|P3|STARTED|Period 2||4
892558|NCT01873950|2157930|P2|STARTED|Period 2||4
892559|NCT01873950|2157931|P1|STARTED|Period 2||5
892560|NCT01873950|2157927|P5|NOT COMPLETED|Period 1||0
892561|NCT01873950|2157928|P4|NOT COMPLETED|Period 1||0
892562|NCT01873950|2157929|P3|NOT COMPLETED|Period 1||0
892563|NCT01873950|2157930|P2|NOT COMPLETED|Period 1||0
892564|NCT01873950|2157931|P1|NOT COMPLETED|Period 1||0
892565|NCT01873950|2157927|P5|COMPLETED|Period 1||4
892566|NCT01873950|2157928|P4|COMPLETED|Period 1||4
892567|NCT01873950|2157929|P3|COMPLETED|Period 1||5
892568|NCT01873950|2157930|P2|COMPLETED|Period 1||4
892569|NCT01873950|2157931|P1|COMPLETED|Period 1||5
892570|NCT01873950|2157927|P5|STARTED|Period 1||4
892571|NCT01873950|2157928|P4|STARTED|Period 1||4
892572|NCT01873950|2157929|P3|STARTED|Period 1||5
892573|NCT01873950|2157930|P2|STARTED|Period 1||4
892574|NCT01873950|2157931|P1|STARTED|Period 1||5
892575|NCT01873859|2157952|P2|NOT COMPLETED|Overall Study||4
892576|NCT01873859|2157953|P1|NOT COMPLETED|Overall Study||0
892577|NCT01873859|2157952|P2|COMPLETED|Overall Study||79
892578|NCT01873859|2157953|P1|COMPLETED|Overall Study||83
892579|NCT01873859|2157952|P2|STARTED|Overall Study||83
892580|NCT01873859|2157953|P1|STARTED|Overall Study||83
892581|NCT01873729|2157961|P1|NOT COMPLETED|Overall Study||1
892582|NCT01873729|2157961|P1|COMPLETED|Overall Study||2
892583|NCT01873729|2157961|P1|STARTED|Overall Study||3
892584|NCT01873417|2157966|P1|NOT COMPLETED|Overall Study||35
892585|NCT01873417|2157966|P1|COMPLETED|Overall Study||202
892586|NCT01873417|2157966|P1|Safety Population|Overall Study|Participants who received at least 1 dose of dimethyl fumarate (DMF), recorded in diary data.|233
892587|NCT01873417|2157966|P1|STARTED|Overall Study||237
892588|NCT01872819|2157977|P1|NOT COMPLETED|Overall Study||0
892589|NCT01872819|2157977|P1|COMPLETED|Overall Study||15
892590|NCT01872819|2157977|P1|STARTED|Overall Study||15
892591|NCT01872715|2157981|P1|NOT COMPLETED|Overall Study||4
892592|NCT01872715|2157981|P1|COMPLETED|Overall Study||20
892593|NCT01872715|2157981|P1|STARTED|Overall Study||24
892594|NCT01872611|2157998|P2|NOT COMPLETED|Overall Study||12
892595|NCT01872611|2157999|P1|NOT COMPLETED|Overall Study||24
892596|NCT01872611|2157998|P2|COMPLETED|Overall Study||292
892597|NCT01872611|2157999|P1|COMPLETED|Overall Study||277
892598|NCT01872611|2157998|P2|Full Analysis Set|Overall Study||293
892599|NCT01872611|2157999|P1|Full Analysis Set|Overall Study||289
892600|NCT01872611|2157998|P2|Treated (Safety Analysis Set)|Overall Study||295
892601|NCT01872611|2157999|P1|Treated (Safety Analysis Set)|Overall Study||293
892602|NCT01872611|2157998|P2|Randomized|Overall Study||304
892603|NCT01872611|2157999|P1|Randomized|Overall Study||301
892604|NCT01872611|2157998|P2|STARTED|Overall Study||304
892605|NCT01872611|2157999|P1|STARTED|Overall Study||301
892606|NCT01872078|2158021|P4|NOT COMPLETED|Overall Study||2
892607|NCT01872078|2158022|P3|NOT COMPLETED|Overall Study||3
892608|NCT01872078|2158023|P2|NOT COMPLETED|Overall Study||0
892609|NCT01872078|2158024|P1|NOT COMPLETED|Overall Study||0
892610|NCT01872078|2158021|P4|COMPLETED|Overall Study||15
892611|NCT01872078|2158022|P3|COMPLETED|Overall Study||14
892612|NCT01872078|2158023|P2|COMPLETED|Overall Study||15
892613|NCT01872078|2158024|P1|COMPLETED|Overall Study||16
892614|NCT01872078|2158021|P4|STARTED|Overall Study||17
892615|NCT01872078|2158022|P3|STARTED|Overall Study||17
892616|NCT01872078|2158023|P2|STARTED|Overall Study||15
892617|NCT01872078|2158024|P1|STARTED|Overall Study||16
892618|NCT01871870|2158034|P1|NOT COMPLETED|Overall Study||9
892619|NCT01871870|2158034|P1|COMPLETED|Overall Study||11
892620|NCT01871870|2158034|P1|STARTED|Overall Study||20
892657|NCT01871558|2158118|P2|NOT COMPLETED|Overall Study||2
892658|NCT01871558|2158119|P1|NOT COMPLETED|Overall Study||3
892659|NCT01871558|2158118|P2|COMPLETED|Overall Study||19
892660|NCT01871558|2158119|P1|COMPLETED|Overall Study||18
892661|NCT01871558|2158118|P2|STARTED|Overall Study||21
892662|NCT01871558|2158119|P1|STARTED|Overall Study||21
892663|NCT01871532|2158139|P2|NOT COMPLETED|Overall Study||2
892664|NCT01871532|2158140|P1|NOT COMPLETED|Overall Study||1
892665|NCT01871532|2158139|P2|COMPLETED|Overall Study||10
892666|NCT01871532|2158140|P1|COMPLETED|Overall Study||11
892667|NCT01871532|2158139|P2|Subjects Received hCG Treatment|Overall Study||9
892668|NCT01871532|2158140|P1|Subjects Received hCG Treatment|Overall Study||11
892669|NCT01871532|2158139|P2|STARTED|Overall Study||12
892670|NCT01871532|2158140|P1|STARTED|Overall Study||12
892671|NCT01871519|2158174|P1|NOT COMPLETED|Overall Study||90
892672|NCT01871519|2158174|P1|COMPLETED|Overall Study||260
892673|NCT01871519|2158174|P1|STARTED|Overall Study||350
892674|NCT01871402|2158197|P2|NOT COMPLETED|Overall Study||3
892675|NCT01871402|2158198|P1|NOT COMPLETED|Overall Study||1
892676|NCT01871402|2158197|P2|COMPLETED|Overall Study||108
892677|NCT01871402|2158198|P1|COMPLETED|Overall Study||109
892678|NCT01871402|2158197|P2|STARTED|Overall Study||111
892679|NCT01871402|2158198|P1|STARTED|Overall Study||110
892680|NCT01871285|2158216|P4|NOT COMPLETED|Second Intervention (1 Day)||0
892681|NCT01871285|2158217|P3|NOT COMPLETED|Second Intervention (1 Day)||0
892682|NCT01871285|2158218|P2|NOT COMPLETED|Second Intervention (1 Day)||0
892683|NCT01871285|2158219|P1|NOT COMPLETED|Second Intervention (1 Day)||0
892684|NCT01871285|2158216|P4|COMPLETED|Second Intervention (1 Day)||2
892685|NCT01871285|2158217|P3|COMPLETED|Second Intervention (1 Day)||3
892686|NCT01871285|2158218|P2|COMPLETED|Second Intervention (1 Day)||14
892687|NCT01871285|2158219|P1|COMPLETED|Second Intervention (1 Day)||17
892688|NCT01871285|2158216|P4|STARTED|Second Intervention (1 Day)||2
892689|NCT01871285|2158217|P3|STARTED|Second Intervention (1 Day)||3
892690|NCT01871285|2158218|P2|STARTED|Second Intervention (1 Day)||14
892691|NCT01871285|2158219|P1|STARTED|Second Intervention (1 Day)||17
892692|NCT01871285|2158216|P4|NOT COMPLETED|First Intervention (1 Day)||0
892693|NCT01871285|2158217|P3|NOT COMPLETED|First Intervention (1 Day)||1
892694|NCT01871285|2158218|P2|NOT COMPLETED|First Intervention (1 Day)||1
892695|NCT01871285|2158219|P1|NOT COMPLETED|First Intervention (1 Day)||1
892696|NCT01871285|2158216|P4|COMPLETED|First Intervention (1 Day)||2
892697|NCT01871285|2158217|P3|COMPLETED|First Intervention (1 Day)||3
892698|NCT01871285|2158218|P2|COMPLETED|First Intervention (1 Day)||14
892699|NCT01871285|2158219|P1|COMPLETED|First Intervention (1 Day)||17
892700|NCT01871285|2158216|P4|STARTED|First Intervention (1 Day)||2
892701|NCT01871285|2158217|P3|STARTED|First Intervention (1 Day)||4
892702|NCT01871285|2158218|P2|STARTED|First Intervention (1 Day)||15
892703|NCT01871285|2158219|P1|STARTED|First Intervention (1 Day)||18
892704|NCT01871142|2158245|P1|NOT COMPLETED|Overall Study||1
892705|NCT01871142|2158245|P1|COMPLETED|Overall Study||11
892706|NCT01871142|2158245|P1|Received 3000mg Aes-103 + Hypoxia|Overall Study||12
892707|NCT01871142|2158245|P1|Received 1000mg Aes 103+ Hypoxia|Overall Study||11
892708|NCT01871142|2158245|P1|Received Placebo + Hypoxia|Overall Study||12
892709|NCT01871142|2158245|P1|Received Placebo + Normoixa|Overall Study||11
892710|NCT01871142|2158245|P1|STARTED|Overall Study||12
892711|NCT01871090|2158261|P2|NOT COMPLETED|Overall Study||23
892712|NCT01871090|2158262|P1|NOT COMPLETED|Overall Study||2
892713|NCT01871090|2158261|P2|COMPLETED|Overall Study||25
892714|NCT01871090|2158262|P1|COMPLETED|Overall Study||33
892715|NCT01871090|2158261|P2|STARTED|Overall Study||48
892716|NCT01871090|2158262|P1|STARTED|Overall Study||35
892717|NCT01870999|2158275|P3|NOT COMPLETED|Overall Study||7
892718|NCT01870999|2158276|P2|NOT COMPLETED|Overall Study||8
892719|NCT01870999|2158277|P1|NOT COMPLETED|Overall Study||4
892720|NCT01870999|2158275|P3|COMPLETED|Overall Study||4
892721|NCT01870999|2158276|P2|COMPLETED|Overall Study||8
892722|NCT01870999|2158277|P1|COMPLETED|Overall Study||10
892723|NCT01870999|2158275|P3|Safety Population; Received Study Drug|Overall Study||10
892724|NCT01870999|2158276|P2|Safety Population; Received Study Drug|Overall Study||15
892725|NCT01870999|2158277|P1|Safety Population; Received Study Drug|Overall Study||14
892726|NCT01870999|2158275|P3|STARTED|Overall Study||11
892727|NCT01870999|2158276|P2|STARTED|Overall Study||16
892728|NCT01870999|2158277|P1|STARTED|Overall Study||14
892729|NCT01870973|2158335|P2|NOT COMPLETED|Overall Study||3
892730|NCT01870973|2158336|P1|NOT COMPLETED|Overall Study||10
892731|NCT01870973|2158335|P2|COMPLETED|Overall Study||49
892732|NCT01870973|2158336|P1|COMPLETED|Overall Study||46
892733|NCT01870973|2158335|P2|STARTED|Overall Study||52
892734|NCT01870973|2158336|P1|STARTED|Overall Study||56
892735|NCT01870921|2158342|P1|NOT COMPLETED|Overall Study||90
892736|NCT01870921|2158342|P1|COMPLETED|Overall Study||1914
892737|NCT01870921|2158342|P1|STARTED|Overall Study||2004
892738|NCT01870856|2158350|P2|NOT COMPLETED|Overall Study||0
892739|NCT01870856|2158351|P1|NOT COMPLETED|Overall Study||0
892740|NCT01870856|2158350|P2|COMPLETED|Overall Study||27
892741|NCT01870856|2158351|P1|COMPLETED|Overall Study||25
892742|NCT01870856|2158350|P2|STARTED|Overall Study||27
892743|NCT01870856|2158351|P1|STARTED|Overall Study||25
892744|NCT01870843|2158361|P1|NOT COMPLETED|Overall Study||53
892745|NCT01870843|2158361|P1|COMPLETED|Overall Study||208
892746|NCT01870843|2158361|P1|STARTED|Overall Study||261
892747|NCT01870739|2158376|P2|NOT COMPLETED|Add-on Period (40 Weeks)||2
892748|NCT01870739|2158377|P1|NOT COMPLETED|Add-on Period (40 Weeks)||3
892749|NCT01870739|2158376|P2|COMPLETED|Add-on Period (40 Weeks)||51
892750|NCT01870739|2158377|P1|COMPLETED|Add-on Period (40 Weeks)||51
892751|NCT01870739|2158376|P2|STARTED|Add-on Period (40 Weeks)||53
892752|NCT01870739|2158377|P1|STARTED|Add-on Period (40 Weeks)||54
892753|NCT01870739|2158376|P2|NOT COMPLETED|Single Drug Treatment (12 Weeks)||4
892754|NCT01870739|2158377|P1|NOT COMPLETED|Single Drug Treatment (12 Weeks)||3
892755|NCT01870739|2158376|P2|COMPLETED|Single Drug Treatment (12 Weeks)||53
892756|NCT01870739|2158377|P1|COMPLETED|Single Drug Treatment (12 Weeks)|"Completed indicates maintenance dose complete"|54
892757|NCT01870739|2158376|P2|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||56
892758|NCT01870739|2158377|P1|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||57
892759|NCT01870739|2158376|P2|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||56
892760|NCT01870739|2158377|P1|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||57
892761|NCT01870739|2158376|P2|STARTED|Single Drug Treatment (12 Weeks)||57
892762|NCT01870739|2158377|P1|STARTED|Single Drug Treatment (12 Weeks)|"Start = Safety/Pharmacokinetic/Pharmacodynamic analysis set"|57
892763|NCT01870596|2158411|P2|NOT COMPLETED|Overall Study||0
892764|NCT01870596|2158412|P1|NOT COMPLETED|Overall Study||0
892765|NCT01870596|2158411|P2|COMPLETED|Overall Study||18
892766|NCT01870596|2158412|P1|COMPLETED|Overall Study||14
892767|NCT01870596|2158411|P2|STARTED|Overall Study||18
892768|NCT01870596|2158412|P1|STARTED|Overall Study||14
892769|NCT01870583|2158421|P3|NOT COMPLETED|Overall Study||8
892770|NCT01870583|2158422|P2|NOT COMPLETED|Overall Study||18
892771|NCT01870583|2158423|P1|NOT COMPLETED|Overall Study||11
892772|NCT01870583|2158421|P3|COMPLETED|Overall Study||455
892773|NCT01870583|2158422|P2|COMPLETED|Overall Study||456
892774|NCT01870583|2158423|P1|COMPLETED|Overall Study||456
892775|NCT01870583|2158421|P3|STARTED|Overall Study||463
892776|NCT01870583|2158422|P2|STARTED|Overall Study||474
892777|NCT01870583|2158423|P1|STARTED|Overall Study||467
892778|NCT01870388|2158433|P2|NOT COMPLETED|Overall Study||0
892779|NCT01870388|2158434|P1|NOT COMPLETED|Overall Study||0
892780|NCT01870388|2158433|P2|COMPLETED|Overall Study||8
892781|NCT01870388|2158434|P1|COMPLETED|Overall Study||8
892782|NCT01870388|2158433|P2|Received 1 Dose of Study Drug|Overall Study||8
892783|NCT01870388|2158434|P1|Received 1 Dose of Study Drug|Overall Study||8
892784|NCT01870388|2158433|P2|STARTED|Overall Study||8
892785|NCT01870388|2158434|P1|STARTED|Overall Study||8
892786|NCT01869959|2158446|P5|NOT COMPLETED|Treatment Period||0
892787|NCT01869959|2158447|P4|NOT COMPLETED|Treatment Period||2
892788|NCT01869959|2158448|P3|NOT COMPLETED|Treatment Period||3
892789|NCT01869959|2158449|P2|NOT COMPLETED|Treatment Period||2
892790|NCT01869959|2158450|P1|NOT COMPLETED|Treatment Period||1
892791|NCT01869959|2158446|P5|COMPLETED|Treatment Period||0
892792|NCT01869959|2158447|P4|COMPLETED|Treatment Period||8
892793|NCT01869959|2158448|P3|COMPLETED|Treatment Period||12
892794|NCT01869959|2158449|P2|COMPLETED|Treatment Period||8
892795|NCT01869959|2158450|P1|COMPLETED|Treatment Period||10
892796|NCT01869959|2158446|P5|Received at Least 1 Dose of Study Drug|Treatment Period||0
892797|NCT01869959|2158447|P4|Received at Least 1 Dose of Study Drug|Treatment Period||10
892798|NCT01869959|2158448|P3|Received at Least 1 Dose of Study Drug|Treatment Period||15
892799|NCT01869959|2158449|P2|Received at Least 1 Dose of Study Drug|Treatment Period||10
892800|NCT01869959|2158450|P1|Received at Least 1 Dose of Study Drug|Treatment Period||11
892801|NCT01869959|2158446|P5|STARTED|Treatment Period|Participants were randomized to treatment groups for the Treatment Period.|0
892802|NCT01869959|2158447|P4|STARTED|Treatment Period||10
892803|NCT01869959|2158448|P3|STARTED|Treatment Period||15
892804|NCT01869959|2158449|P2|STARTED|Treatment Period||10
892805|NCT01869959|2158450|P1|STARTED|Treatment Period||11
892806|NCT01869959|2158446|P5|NOT COMPLETED|Randomization Period||1
892807|NCT01869959|2158447|P4|NOT COMPLETED|Randomization Period||0
892808|NCT01869959|2158448|P3|NOT COMPLETED|Randomization Period||0
892809|NCT01869959|2158449|P2|NOT COMPLETED|Randomization Period||0
892810|NCT01869959|2158450|P1|NOT COMPLETED|Randomization Period||0
892811|NCT01869959|2158446|P5|COMPLETED|Randomization Period|One participant discontinued after randomization but did not receive study drug.|46
892812|NCT01869959|2158447|P4|COMPLETED|Randomization Period||0
892813|NCT01869959|2158448|P3|COMPLETED|Randomization Period||0
892814|NCT01869959|2158449|P2|COMPLETED|Randomization Period||0
892815|NCT01869959|2158450|P1|COMPLETED|Randomization Period||0
892816|NCT01869959|2158446|P5|STARTED|Randomization Period||47
892817|NCT01869959|2158447|P4|STARTED|Randomization Period||0
892818|NCT01869959|2158448|P3|STARTED|Randomization Period||0
892819|NCT01869959|2158449|P2|STARTED|Randomization Period||0
892820|NCT01869959|2158450|P1|STARTED|Randomization Period||0
892821|NCT01869699|2158520|P2|NOT COMPLETED|Overall Study||0
892822|NCT01869699|2158521|P1|NOT COMPLETED|Overall Study||1
892823|NCT01869699|2158520|P2|COMPLETED|Overall Study||20
892824|NCT01869699|2158521|P1|COMPLETED|Overall Study||20
892825|NCT01869699|2158520|P2|STARTED|Overall Study||20
892826|NCT01869699|2158521|P1|STARTED|Overall Study||21
892827|NCT01869686|2158539|P1|NOT COMPLETED|Overall Study||0
892828|NCT01869686|2158539|P1|COMPLETED|Overall Study||12
892829|NCT01869686|2158539|P1|STARTED|Overall Study||12
892830|NCT01869647|2158554|P3|NOT COMPLETED|Overall Study||0
892831|NCT01869647|2158555|P2|NOT COMPLETED|Overall Study||6
892832|NCT01869647|2158556|P1|NOT COMPLETED|Overall Study||1
892833|NCT01869647|2158554|P3|COMPLETED|Overall Study||62
892834|NCT01869647|2158555|P2|COMPLETED|Overall Study||130
892835|NCT01869647|2158556|P1|COMPLETED|Overall Study||65
892836|NCT01869647|2158554|P3|STARTED|Overall Study||62
892837|NCT01869647|2158555|P2|STARTED|Overall Study||136
892838|NCT01869647|2158556|P1|STARTED|Overall Study||66
892839|NCT01869478|2158569|P2|NOT COMPLETED|Overall Study||0
892840|NCT01869478|2158570|P1|NOT COMPLETED|Overall Study||0
892841|NCT01869478|2158569|P2|COMPLETED|Overall Study||1
892842|NCT01869478|2158570|P1|COMPLETED|Overall Study||0
892843|NCT01869478|2158569|P2|STARTED|Overall Study||1
892844|NCT01869478|2158570|P1|STARTED|Overall Study||0
892845|NCT01869348|2158580|P2|NOT COMPLETED|Overall Study||1
892846|NCT01869348|2158581|P1|NOT COMPLETED|Overall Study||1
892847|NCT01869348|2158580|P2|COMPLETED|Overall Study||19
892848|NCT01869348|2158581|P1|COMPLETED|Overall Study||19
892849|NCT01869348|2158580|P2|STARTED|Overall Study||20
892850|NCT01869348|2158581|P1|STARTED|Overall Study||20
892851|NCT01869075|2158593|P6|NOT COMPLETED|Phase 2||0
892852|NCT01869075|2158594|P5|NOT COMPLETED|Phase 2||0
892853|NCT01869075|2158595|P4|NOT COMPLETED|Phase 2||0
892854|NCT01869075|2158596|P3|NOT COMPLETED|Phase 2||0
892855|NCT01869075|2158597|P2|NOT COMPLETED|Phase 2||0
892856|NCT01869075|2158598|P1|NOT COMPLETED|Phase 2||0
892857|NCT01869075|2158593|P6|COMPLETED|Phase 2||45
892858|NCT01869075|2158594|P5|COMPLETED|Phase 2||75
892859|NCT01869075|2158595|P4|COMPLETED|Phase 2||45
892860|NCT01869075|2158596|P3|COMPLETED|Phase 2||75
892861|NCT01869075|2158597|P2|COMPLETED|Phase 2||30
892862|NCT01869075|2158598|P1|COMPLETED|Phase 2||90
892863|NCT01869075|2158593|P6|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
892864|NCT01869075|2158594|P5|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
892865|NCT01869075|2158595|P4|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
892866|NCT01869075|2158596|P3|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
892867|NCT01869075|2158597|P2|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|30
892868|NCT01869075|2158598|P1|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|90
892869|NCT01869075|2158593|P6|NOT COMPLETED|Phase 1||0
892870|NCT01869075|2158594|P5|NOT COMPLETED|Phase 1||0
892871|NCT01869075|2158595|P4|NOT COMPLETED|Phase 1||0
892872|NCT01869075|2158596|P3|NOT COMPLETED|Phase 1||0
892873|NCT01869075|2158597|P2|NOT COMPLETED|Phase 1||0
892874|NCT01869075|2158598|P1|NOT COMPLETED|Phase 1||0
892875|NCT01869075|2158593|P6|COMPLETED|Phase 1||90
892876|NCT01869075|2158594|P5|COMPLETED|Phase 1||30
892877|NCT01869075|2158595|P4|COMPLETED|Phase 1||75
892878|NCT01869075|2158596|P3|COMPLETED|Phase 1||45
892879|NCT01869075|2158597|P2|COMPLETED|Phase 1||75
892880|NCT01869075|2158598|P1|COMPLETED|Phase 1||45
892881|NCT01869075|2158593|P6|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|90
892882|NCT01869075|2158594|P5|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|30
892883|NCT01869075|2158595|P4|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
892884|NCT01869075|2158596|P3|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
892885|NCT01869075|2158597|P2|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
892886|NCT01869075|2158598|P1|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
892887|NCT01869075|2158593|P6|NOT COMPLETED|Phase 0 (Baseline)||0
892888|NCT01869075|2158594|P5|NOT COMPLETED|Phase 0 (Baseline)||0
892889|NCT01869075|2158595|P4|NOT COMPLETED|Phase 0 (Baseline)||0
892890|NCT01869075|2158596|P3|NOT COMPLETED|Phase 0 (Baseline)||0
892891|NCT01869075|2158597|P2|NOT COMPLETED|Phase 0 (Baseline)||0
892892|NCT01869075|2158598|P1|NOT COMPLETED|Phase 0 (Baseline)||0
892893|NCT01869075|2158593|P6|COMPLETED|Phase 0 (Baseline)||341
892894|NCT01869075|2158594|P5|COMPLETED|Phase 0 (Baseline)||0
892895|NCT01869075|2158595|P4|COMPLETED|Phase 0 (Baseline)||416
892896|NCT01869075|2158596|P3|COMPLETED|Phase 0 (Baseline)||0
892897|NCT01869075|2158597|P2|COMPLETED|Phase 0 (Baseline)||418
892898|NCT01869075|2158598|P1|COMPLETED|Phase 0 (Baseline)||0
892899|NCT01869075|2158593|P6|STARTED|Phase 0 (Baseline)||341
892900|NCT01869075|2158594|P5|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
892901|NCT01869075|2158595|P4|STARTED|Phase 0 (Baseline)||416
892902|NCT01869075|2158596|P3|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
892903|NCT01869075|2158597|P2|STARTED|Phase 0 (Baseline)||418
892904|NCT01869075|2158598|P1|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
892905|NCT01868997|2158614|P2|NOT COMPLETED|Overall Study||6
892906|NCT01868997|2158615|P1|NOT COMPLETED|Overall Study||5
892907|NCT01868997|2158614|P2|COMPLETED|Overall Study|completed treatment to Week 24|37
892908|NCT01868997|2158615|P1|COMPLETED|Overall Study|completed treatment to Week 24|39
892909|NCT01868997|2158614|P2|STARTED|Overall Study|randomized and treated|43
892910|NCT01868997|2158615|P1|STARTED|Overall Study|randomized and treated|44
892911|NCT01868893|2158631|P1|NOT COMPLETED|Overall Study||20
892912|NCT01868893|2158631|P1|COMPLETED|Overall Study||0
892913|NCT01868893|2158631|P1|STARTED|Overall Study||20
892914|NCT01868776|2158640|P2|NOT COMPLETED|Overall Study||0
892915|NCT01868776|2158641|P1|NOT COMPLETED|Overall Study||0
892916|NCT01868776|2158640|P2|COMPLETED|Overall Study||50
892917|NCT01868776|2158641|P1|COMPLETED|Overall Study||50
892918|NCT01868776|2158640|P2|STARTED|Overall Study||50
892919|NCT01868776|2158641|P1|STARTED|Overall Study||50
892920|NCT01868633|2158649|P2|NOT COMPLETED|Overall Study||0
892921|NCT01868633|2158650|P1|NOT COMPLETED|Overall Study||0
892922|NCT01868633|2158649|P2|COMPLETED|Overall Study||26
892923|NCT01868633|2158650|P1|COMPLETED|Overall Study||26
892924|NCT01868633|2158649|P2|STARTED|Overall Study||26
892925|NCT01868633|2158650|P1|STARTED|Overall Study||26
892926|NCT01868542|2158666|P2|NOT COMPLETED|Overall Study||2
892927|NCT01868542|2158667|P1|NOT COMPLETED|Overall Study||0
892928|NCT01868542|2158666|P2|COMPLETED|Overall Study||21
892929|NCT01868542|2158667|P1|COMPLETED|Overall Study||23
892930|NCT01868542|2158666|P2|STARTED|Overall Study||23
892931|NCT01868542|2158667|P1|STARTED|Overall Study||23
892932|NCT01868503|2158685|P1|NOT COMPLETED|Overall Study||2
892933|NCT01868503|2158685|P1|COMPLETED|Overall Study||5
892934|NCT01868503|2158685|P1|STARTED|Overall Study||7
892935|NCT01868334|2158697|P4|NOT COMPLETED|Year 2 Pre-post Study||0
892936|NCT01868334|2158698|P3|NOT COMPLETED|Year 2 Pre-post Study||0
892937|NCT01868334|2158699|P2|NOT COMPLETED|Year 2 Pre-post Study||0
892938|NCT01868334|2158700|P1|NOT COMPLETED|Year 2 Pre-post Study||0
892939|NCT01868334|2158697|P4|COMPLETED|Year 2 Pre-post Study||19274
892940|NCT01868334|2158698|P3|COMPLETED|Year 2 Pre-post Study||20904
892941|NCT01868334|2158699|P2|COMPLETED|Year 2 Pre-post Study||8047
892942|NCT01868334|2158700|P1|COMPLETED|Year 2 Pre-post Study||22324
892943|NCT01868334|2158697|P4|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Intervention sites who chose not to actively engage Year 2|19274
892944|NCT01868334|2158698|P3|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Control sites who became active in the intervention during Year 2|20904
892945|NCT01868334|2158699|P2|STARTED|Year 2 Pre-post Study|Reflects: the six Year 1 Intervention sites who chose not to actively engage Year 2|8047
892946|NCT01868334|2158700|P1|STARTED|Year 2 Pre-post Study|Reflects: control sites from Year 1 (N=8) and Year 1 Intervention sites who continued in Y2 (N=4)|22324
892947|NCT01868334|2158697|P4|NOT COMPLETED|Year 1 RCCT Study||0
892948|NCT01868334|2158698|P3|NOT COMPLETED|Year 1 RCCT Study||0
892949|NCT01868334|2158699|P2|NOT COMPLETED|Year 1 RCCT Study||0
892950|NCT01868334|2158700|P1|NOT COMPLETED|Year 1 RCCT Study||0
892951|NCT01868334|2158697|P4|COMPLETED|Year 1 RCCT Study||20904
892952|NCT01868334|2158698|P3|COMPLETED|Year 1 RCCT Study||19274
892953|NCT01868334|2158699|P2|COMPLETED|Year 1 RCCT Study||17185
892954|NCT01868334|2158700|P1|COMPLETED|Year 1 RCCT Study||13186
892955|NCT01868334|2158697|P4|STARTED|Year 1 RCCT Study||20904
892956|NCT01868334|2158698|P3|STARTED|Year 1 RCCT Study||19274
892957|NCT01868334|2158699|P2|STARTED|Year 1 RCCT Study||17185
892958|NCT01868334|2158700|P1|STARTED|Year 1 RCCT Study||13186
892959|NCT01868243|2158732|P2|NOT COMPLETED|Overall Study||1
892960|NCT01868243|2158733|P1|NOT COMPLETED|Overall Study||0
892961|NCT01868243|2158732|P2|COMPLETED|Overall Study||11
892962|NCT01868243|2158733|P1|COMPLETED|Overall Study||15
892963|NCT01868243|2158732|P2|STARTED|Overall Study||12
892964|NCT01868243|2158733|P1|STARTED|Overall Study||15
892965|NCT01868074|2158743|P2|NOT COMPLETED|Overall Study||4
892966|NCT01868074|2158744|P1|NOT COMPLETED|Overall Study||7
892967|NCT01868074|2158743|P2|COMPLETED|Overall Study||32
892968|NCT01868074|2158744|P1|COMPLETED|Overall Study||29
892969|NCT01868074|2158743|P2|STARTED|Overall Study||36
892970|NCT01868074|2158744|P1|STARTED|Overall Study||36
892971|NCT01868035|2158754|P1|NOT COMPLETED|Overall Study||7
892972|NCT01868035|2158754|P1|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|8
892973|NCT01868035|2158754|P1|STARTED|Overall Study||15
892974|NCT01868009|2158770|P2|NOT COMPLETED|Period 2 (5-9 Days)||0
892975|NCT01868009|2158771|P1|NOT COMPLETED|Period 2 (5-9 Days)||2
892976|NCT01868009|2158770|P2|COMPLETED|Period 2 (5-9 Days)||142
892977|NCT01868009|2158771|P1|COMPLETED|Period 2 (5-9 Days)||141
892978|NCT01868009|2158770|P2|STARTED|Period 2 (5-9 Days)||142
892979|NCT01868009|2158771|P1|STARTED|Period 2 (5-9 Days)||143
892980|NCT01868009|2158770|P2|NOT COMPLETED|Period 1 (5-9 Days)||2
892981|NCT01868009|2158771|P1|NOT COMPLETED|Period 1 (5-9 Days)||0
892982|NCT01868009|2158770|P2|COMPLETED|Period 1 (5-9 Days)||142
892983|NCT01868009|2158771|P1|COMPLETED|Period 1 (5-9 Days)||143
892984|NCT01868009|2158770|P2|STARTED|Period 1 (5-9 Days)||144
892985|NCT01868009|2158771|P1|STARTED|Period 1 (5-9 Days)||143
893002|NCT01867658|2158802|P1|NOT COMPLETED|Overall Study||9
893003|NCT01867658|2158802|P1|COMPLETED|Overall Study||103
893004|NCT01867658|2158802|P1|STARTED|Overall Study||112
893005|NCT01867632|2158815|P2|NOT COMPLETED|Overall Study||0
893006|NCT01867632|2158816|P1|NOT COMPLETED|Overall Study||0
893007|NCT01867632|2158815|P2|COMPLETED|Overall Study||66
893008|NCT01867632|2158816|P1|COMPLETED|Overall Study||65
893009|NCT01867632|2158815|P2|STARTED|Overall Study||66
893010|NCT01867632|2158816|P1|STARTED|Overall Study||65
893017|NCT01867164|2158835|P2|NOT COMPLETED|Overall Study||0
893018|NCT01867164|2158836|P1|NOT COMPLETED|Overall Study||0
893019|NCT01867164|2158835|P2|COMPLETED|Overall Study||79
893020|NCT01867164|2158836|P1|COMPLETED|Overall Study||81
893021|NCT01867164|2158835|P2|STARTED|Overall Study||79
893022|NCT01867164|2158836|P1|STARTED|Overall Study||81
893029|NCT01867021|2158873|P2|NOT COMPLETED|Overall Study||10
893030|NCT01867021|2158874|P1|NOT COMPLETED|Overall Study||2
893031|NCT01867021|2158873|P2|COMPLETED|Overall Study||1440
893032|NCT01867021|2158874|P1|COMPLETED|Overall Study||1450
893033|NCT01867021|2158873|P2|STARTED|Overall Study||1450
893034|NCT01867021|2158874|P1|STARTED|Overall Study||1452
893035|NCT01866709|2158895|P2|NOT COMPLETED|Overall Study||0
893036|NCT01866709|2158896|P1|NOT COMPLETED|Overall Study||1
893037|NCT01866709|2158895|P2|COMPLETED|Overall Study||17
893038|NCT01866709|2158896|P1|COMPLETED|Overall Study||14
893039|NCT01866709|2158895|P2|STARTED|Overall Study||17
893040|NCT01866709|2158896|P1|STARTED|Overall Study||15
893041|NCT01866423|2158904|P1|NOT COMPLETED|Overall Study||4
893042|NCT01866423|2158904|P1|COMPLETED|Overall Study||0
893043|NCT01866423|2158904|P1|STARTED|Overall Study||4
893044|NCT01866319|2158917|P3|NOT COMPLETED|Overall Study||277
893045|NCT01866319|2158918|P2|NOT COMPLETED|Overall Study||279
893046|NCT01866319|2158919|P1|NOT COMPLETED|Overall Study||277
893047|NCT01866319|2158917|P3|COMPLETED|Overall Study||0
893048|NCT01866319|2158918|P2|COMPLETED|Overall Study||0
893049|NCT01866319|2158919|P1|COMPLETED|Overall Study||1
893050|NCT01866319|2158917|P3|Treated|Overall Study||277
893051|NCT01866319|2158918|P2|Treated|Overall Study||278
893052|NCT01866319|2158919|P1|Treated|Overall Study||256
893053|NCT01866319|2158917|P3|STARTED|Overall Study||277
893054|NCT01866319|2158918|P2|STARTED|Overall Study||279
893055|NCT01866319|2158919|P1|STARTED|Overall Study||278
893056|NCT01866306|2158940|P7|NOT COMPLETED|Overall Study||0
893057|NCT01866306|2158941|P6|NOT COMPLETED|Overall Study||0
893058|NCT01866306|2158942|P5|NOT COMPLETED|Overall Study||0
893059|NCT01866306|2158943|P4|NOT COMPLETED|Overall Study||0
893060|NCT01866306|2158944|P3|NOT COMPLETED|Overall Study||0
893061|NCT01866306|2158945|P2|NOT COMPLETED|Overall Study||0
893062|NCT01866306|2158946|P1|NOT COMPLETED|Overall Study||0
893063|NCT01866306|2158940|P7|COMPLETED|Overall Study||23
893064|NCT01866306|2158941|P6|COMPLETED|Overall Study||6
893065|NCT01866306|2158942|P5|COMPLETED|Overall Study||6
893066|NCT01866306|2158943|P4|COMPLETED|Overall Study||6
893067|NCT01866306|2158944|P3|COMPLETED|Overall Study||6
893068|NCT01866306|2158945|P2|COMPLETED|Overall Study||6
893069|NCT01866306|2158946|P1|COMPLETED|Overall Study||6
893070|NCT01866306|2158940|P7|STARTED|Overall Study||23
893071|NCT01866306|2158941|P6|STARTED|Overall Study||6
893072|NCT01866306|2158942|P5|STARTED|Overall Study||6
893073|NCT01866306|2158943|P4|STARTED|Overall Study||6
893074|NCT01866306|2158944|P3|STARTED|Overall Study||6
893075|NCT01866306|2158945|P2|STARTED|Overall Study||6
893076|NCT01866306|2158946|P1|STARTED|Overall Study||6
893077|NCT01866293|2159018|P1|NOT COMPLETED|Overall Study||2
893078|NCT01866293|2159018|P1|COMPLETED|Overall Study||9
893079|NCT01866293|2159018|P1|STARTED|Overall Study||11
893080|NCT01866163|2159028|P2|NOT COMPLETED|Overall Study||4
893081|NCT01866163|2159029|P1|NOT COMPLETED|Overall Study||10
893082|NCT01866163|2159028|P2|COMPLETED|Overall Study||99
893083|NCT01866163|2159029|P1|COMPLETED|Overall Study||313
893084|NCT01866163|2159028|P2|STARTED|Overall Study||103
893085|NCT01866163|2159029|P1|STARTED|Overall Study||323
893086|NCT01866150|2159039|P1|NOT COMPLETED|Overall Study||0
893087|NCT01866150|2159039|P1|COMPLETED|Overall Study||450
893088|NCT01866150|2159039|P1|STARTED|Overall Study||450
893089|NCT01865812|2159060|P1|NOT COMPLETED|Overall Study||2
893090|NCT01865812|2159060|P1|COMPLETED|Overall Study||24
893091|NCT01865812|2159060|P1|STARTED|Overall Study||26
893092|NCT01865747|2159068|P2|NOT COMPLETED|Primary Intent to Treat (PITT)||152
893093|NCT01865747|2159069|P1|NOT COMPLETED|Primary Intent to Treat (PITT)||131
893094|NCT01865747|2159068|P2|COMPLETED|Primary Intent to Treat (PITT)||36
893095|NCT01865747|2159069|P1|COMPLETED|Primary Intent to Treat (PITT)||56
893096|NCT01865747|2159068|P2|STARTED|Primary Intent to Treat (PITT)|Three subjects in the everolimus arm were randomized but not treated.|188
893097|NCT01865747|2159069|P1|STARTED|Primary Intent to Treat (PITT)||187
893098|NCT01865747|2159068|P2|NOT COMPLETED|Overall Study (ITT)||255
893099|NCT01865747|2159069|P1|NOT COMPLETED|Overall Study (ITT)||198
893100|NCT01865747|2159068|P2|COMPLETED|Overall Study (ITT)|Five subjects were randomized but not treated|73
893101|NCT01865747|2159069|P1|COMPLETED|Overall Study (ITT)|One subject randomized to everolimus arm received cabozantinib discontd due to clin. deterioration|132
893102|NCT01865747|2159068|P2|STARTED|Overall Study (ITT)||328
893103|NCT01865747|2159069|P1|STARTED|Overall Study (ITT)||330
893104|NCT01865084|2159082|P3|NOT COMPLETED|Open Label Extension (OLE) Period||7
893105|NCT01865084|2159083|P2|NOT COMPLETED|Open Label Extension (OLE) Period||11
893106|NCT01865084|2159084|P1|NOT COMPLETED|Open Label Extension (OLE) Period||0
893107|NCT01865084|2159082|P3|COMPLETED|Open Label Extension (OLE) Period||158
893108|NCT01865084|2159083|P2|COMPLETED|Open Label Extension (OLE) Period||139
893109|NCT01865084|2159084|P1|COMPLETED|Open Label Extension (OLE) Period||0
893110|NCT01865084|2159082|P3|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|165
893111|NCT01865084|2159083|P2|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|150
893112|NCT01865084|2159084|P1|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|0
893113|NCT01865084|2159082|P3|NOT COMPLETED|Double Blind Period (DB)||6
893114|NCT01865084|2159083|P2|NOT COMPLETED|Double Blind Period (DB)||4
893115|NCT01865084|2159084|P1|NOT COMPLETED|Double Blind Period (DB)||5
893116|NCT01865084|2159082|P3|COMPLETED|Double Blind Period (DB)||107
893117|NCT01865084|2159083|P2|COMPLETED|Double Blind Period (DB)|One participant stopped therapy during the DB period but remained in the study for follow-up.|98
893118|NCT01865084|2159084|P1|COMPLETED|Double Blind Period (DB)||111
893119|NCT01865084|2159082|P3|Received at Least One Dose of Study Drug|Double Blind Period (DB)||112
893120|NCT01865084|2159083|P2|Received at Least One Dose of Study Drug|Double Blind Period (DB)||102
893121|NCT01865084|2159084|P1|Received at Least One Dose of Study Drug|Double Blind Period (DB)||116
893122|NCT01865084|2159082|P3|STARTED|Double Blind Period (DB)||113
893123|NCT01865084|2159083|P2|STARTED|Double Blind Period (DB)||102
893124|NCT01865084|2159084|P1|STARTED|Double Blind Period (DB)||116
893125|NCT01864538|2159110|P1|NOT COMPLETED|Overall Study||11
893126|NCT01864538|2159110|P1|COMPLETED|Overall Study||0
893127|NCT01864538|2159110|P1|STARTED|Overall Study||11
893128|NCT01864434|2159116|P2|NOT COMPLETED|Overall Study||0
893129|NCT01864434|2159117|P1|NOT COMPLETED|Overall Study||0
893130|NCT01864434|2159116|P2|COMPLETED|Overall Study||25
893131|NCT01864434|2159117|P1|COMPLETED|Overall Study||25
893132|NCT01864434|2159116|P2|STARTED|Overall Study||25
893133|NCT01864434|2159117|P1|STARTED|Overall Study||25
893134|NCT01864174|2159129|P2|NOT COMPLETED|Off Treatment Follow-Up||0
893135|NCT01864174|2159130|P1|NOT COMPLETED|Off Treatment Follow-Up||3
893136|NCT01864174|2159129|P2|COMPLETED|Off Treatment Follow-Up||1
893137|NCT01864174|2159130|P1|COMPLETED|Off Treatment Follow-Up||6
893138|NCT01864174|2159129|P2|STARTED|Off Treatment Follow-Up||1
893139|NCT01864174|2159130|P1|STARTED|Off Treatment Follow-Up||9
893140|NCT01864174|2159129|P2|NOT COMPLETED|Double Blind - Compliant Randomized||26
893141|NCT01864174|2159130|P1|NOT COMPLETED|Double Blind - Compliant Randomized||23
893142|NCT01864174|2159129|P2|COMPLETED|Double Blind - Compliant Randomized||245
893143|NCT01864174|2159130|P1|COMPLETED|Double Blind - Compliant Randomized||245
893144|NCT01864174|2159129|P2|STARTED|Double Blind - Compliant Randomized||271
893145|NCT01864174|2159130|P1|STARTED|Double Blind - Compliant Randomized||268
893146|NCT01864174|2159129|P2|NOT COMPLETED|Double Blind Treatment - All Treated||14
893147|NCT01864174|2159130|P1|NOT COMPLETED|Double Blind Treatment - All Treated||15
893148|NCT01864174|2159129|P2|COMPLETED|Double Blind Treatment - All Treated||271
893149|NCT01864174|2159130|P1|COMPLETED|Double Blind Treatment - All Treated||268
893150|NCT01864174|2159129|P2|STARTED|Double Blind Treatment - All Treated||285
893151|NCT01864174|2159130|P1|STARTED|Double Blind Treatment - All Treated||283
893152|NCT01864148|2159149|P5|NOT COMPLETED|Overall Study||23
893153|NCT01864148|2159150|P4|NOT COMPLETED|Overall Study||26
893154|NCT01864148|2159151|P3|NOT COMPLETED|Overall Study||11
893155|NCT01864148|2159152|P2|NOT COMPLETED|Overall Study||5
893156|NCT01864148|2159153|P1|NOT COMPLETED|Overall Study||20
893157|NCT01864148|2159149|P5|COMPLETED|Overall Study||69
893158|NCT01864148|2159150|P4|COMPLETED|Overall Study||68
893159|NCT01864148|2159151|P3|COMPLETED|Overall Study||84
893160|NCT01864148|2159152|P2|COMPLETED|Overall Study||40
893161|NCT01864148|2159153|P1|COMPLETED|Overall Study||73
893162|NCT01864148|2159149|P5|Randomized and Dosed|Overall Study||92
893163|NCT01864148|2159150|P4|Randomized and Dosed|Overall Study||93
893164|NCT01864148|2159151|P3|Randomized and Dosed|Overall Study||95
893165|NCT01864148|2159152|P2|Randomized and Dosed|Overall Study||45
893166|NCT01864148|2159153|P1|Randomized and Dosed|Overall Study||93
893167|NCT01864148|2159149|P5|STARTED|Overall Study||92
893168|NCT01864148|2159150|P4|STARTED|Overall Study||94
893169|NCT01864148|2159151|P3|STARTED|Overall Study||95
893170|NCT01864148|2159152|P2|STARTED|Overall Study||45
893171|NCT01864148|2159153|P1|STARTED|Overall Study||93
893172|NCT01864005|2159182|P2|NOT COMPLETED|Overall Study||6
893173|NCT01864005|2159183|P1|NOT COMPLETED|Overall Study||3
893174|NCT01864005|2159182|P2|COMPLETED|Overall Study||25
893175|NCT01864005|2159183|P1|COMPLETED|Overall Study||26
893176|NCT01864005|2159182|P2|STARTED|Overall Study||31
893177|NCT01864005|2159183|P1|STARTED|Overall Study||29
893178|NCT01863953|2159200|P3|NOT COMPLETED|Overall Study||1
893179|NCT01863953|2159201|P2|NOT COMPLETED|Overall Study||0
893180|NCT01863953|2159202|P1|NOT COMPLETED|Overall Study||0
893181|NCT01863953|2159200|P3|COMPLETED|Overall Study||37
893182|NCT01863953|2159201|P2|COMPLETED|Overall Study||36
893183|NCT01863953|2159202|P1|COMPLETED|Overall Study||38
893184|NCT01863953|2159200|P3|STARTED|Overall Study||38
893185|NCT01863953|2159201|P2|STARTED|Overall Study||36
893186|NCT01863953|2159202|P1|STARTED|Overall Study||38
893187|NCT01863771|2159216|P4|NOT COMPLETED|Maintenance Phase||43
893188|NCT01863771|2159217|P3|NOT COMPLETED|Maintenance Phase||12
893189|NCT01863771|2159218|P2|NOT COMPLETED|Maintenance Phase||5
893190|NCT01863771|2159219|P1|NOT COMPLETED|Maintenance Phase||0
893191|NCT01863771|2159216|P4|COMPLETED|Maintenance Phase||17
893192|NCT01863771|2159217|P3|COMPLETED|Maintenance Phase||19
893193|NCT01863771|2159218|P2|COMPLETED|Maintenance Phase||27
893194|NCT01863771|2159219|P1|COMPLETED|Maintenance Phase||0
893195|NCT01863771|2159216|P4|STARTED|Maintenance Phase||60
893196|NCT01863771|2159217|P3|STARTED|Maintenance Phase||31
893197|NCT01863771|2159218|P2|STARTED|Maintenance Phase||32
893198|NCT01863771|2159219|P1|STARTED|Maintenance Phase||0
893199|NCT01863771|2159216|P4|NOT COMPLETED|Induction Phase||0
893200|NCT01863771|2159217|P3|NOT COMPLETED|Induction Phase||0
893201|NCT01863771|2159218|P2|NOT COMPLETED|Induction Phase||0
893202|NCT01863771|2159219|P1|NOT COMPLETED|Induction Phase||21
893203|NCT01863771|2159216|P4|COMPLETED|Induction Phase||0
893204|NCT01863771|2159217|P3|COMPLETED|Induction Phase||0
893205|NCT01863771|2159218|P2|COMPLETED|Induction Phase||0
893206|NCT01863771|2159219|P1|COMPLETED|Induction Phase|Same participants who completed the induction phase participated in the maintenance phase.|123
893207|NCT01863771|2159216|P4|STARTED|Induction Phase||0
893208|NCT01863771|2159217|P3|STARTED|Induction Phase||0
893209|NCT01863771|2159218|P2|STARTED|Induction Phase||0
893210|NCT01863771|2159219|P1|STARTED|Induction Phase||144
893211|NCT01863680|2159231|P1|NOT COMPLETED|Overall Study||57
893212|NCT01863680|2159231|P1|COMPLETED|Overall Study||121
893213|NCT01863680|2159231|P1|Subjects Who Have Undergone IVF/ET|Overall Study||123
893214|NCT01863680|2159231|P1|Subjects Received Study Drug|Overall Study||149
893215|NCT01863680|2159231|P1|Subjects Received hCG Injection|Overall Study||162
893216|NCT01863680|2159231|P1|Subjects Started COS Treatment|Overall Study||169
893217|NCT01863680|2159231|P1|STARTED|Overall Study||178
893218|NCT01863667|2159239|P2|NOT COMPLETED|Overall Study||32
893219|NCT01863667|2159240|P1|NOT COMPLETED|Overall Study||33
893220|NCT01863667|2159239|P2|COMPLETED|Overall Study||0
893221|NCT01863667|2159240|P1|COMPLETED|Overall Study||0
893222|NCT01863667|2159239|P2|STARTED|Overall Study||32
893223|NCT01863667|2159240|P1|STARTED|Overall Study||33
893224|NCT01863433|2159260|P1|NOT COMPLETED|Overall Study||1
893225|NCT01863433|2159260|P1|COMPLETED|Overall Study|1 subject was withdrawn from the study due to evidence of substance abuse.|119
893226|NCT01863433|2159260|P1|STARTED|Overall Study||120
893227|NCT01863368|2159270|P2|NOT COMPLETED|Phase II, Day 35 to Day 90||0
893228|NCT01863368|2159271|P1|NOT COMPLETED|Phase II, Day 35 to Day 90||2
893229|NCT01863368|2159270|P2|COMPLETED|Phase II, Day 35 to Day 90||41
893230|NCT01863368|2159271|P1|COMPLETED|Phase II, Day 35 to Day 90||41
893231|NCT01863368|2159270|P2|STARTED|Phase II, Day 35 to Day 90||41
893232|NCT01863368|2159271|P1|STARTED|Phase II, Day 35 to Day 90||43
893233|NCT01863368|2159270|P2|NOT COMPLETED|Phase I, Day 0 to Day 35||7
893234|NCT01863368|2159271|P1|NOT COMPLETED|Phase I, Day 0 to Day 35||3
893235|NCT01863368|2159270|P2|COMPLETED|Phase I, Day 0 to Day 35||41
893236|NCT01863368|2159271|P1|COMPLETED|Phase I, Day 0 to Day 35||43
893237|NCT01863368|2159270|P2|Treated|Phase I, Day 0 to Day 35||47
893238|NCT01863368|2159271|P1|Treated|Phase I, Day 0 to Day 35||46
893239|NCT01863368|2159270|P2|STARTED|Phase I, Day 0 to Day 35||48
893240|NCT01863368|2159271|P1|STARTED|Phase I, Day 0 to Day 35||46
893241|NCT01863134|2159286|P2|NOT COMPLETED|Overall Study||0
893242|NCT01863134|2159287|P1|NOT COMPLETED|Overall Study||0
893243|NCT01863134|2159286|P2|COMPLETED|Overall Study||68
893244|NCT01863134|2159287|P1|COMPLETED|Overall Study||72
893245|NCT01863134|2159286|P2|STARTED|Overall Study||68
893246|NCT01863134|2159287|P1|STARTED|Overall Study||72
893247|NCT01862991|2159296|P3|NOT COMPLETED|Overall Study||1
893248|NCT01862991|2159297|P2|NOT COMPLETED|Overall Study||1
893249|NCT01862991|2159298|P1|NOT COMPLETED|Overall Study||3
893250|NCT01862991|2159296|P3|COMPLETED|Overall Study||27
893251|NCT01862991|2159297|P2|COMPLETED|Overall Study||27
893252|NCT01862991|2159298|P1|COMPLETED|Overall Study||21
893253|NCT01862991|2159296|P3|STARTED|Overall Study||28
893254|NCT01862991|2159297|P2|STARTED|Overall Study||28
893255|NCT01862991|2159298|P1|STARTED|Overall Study||24
893256|NCT01862484|2159311|P2|NOT COMPLETED|Overall Study||8
893257|NCT01862484|2159312|P1|NOT COMPLETED|Overall Study||2
893258|NCT01862484|2159311|P2|COMPLETED|Overall Study||6
893259|NCT01862484|2159312|P1|COMPLETED|Overall Study||13
893260|NCT01862484|2159311|P2|STARTED|Overall Study||14
893261|NCT01862484|2159312|P1|STARTED|Overall Study||15
893262|NCT01862419|2159320|P2|NOT COMPLETED|Overall Study||0
893263|NCT01862419|2159321|P1|NOT COMPLETED|Overall Study||0
893264|NCT01862419|2159320|P2|COMPLETED|Overall Study||1192
893265|NCT01862419|2159321|P1|COMPLETED|Overall Study||1201
893266|NCT01862419|2159320|P2|STARTED|Overall Study||1192
893267|NCT01862419|2159321|P1|STARTED|Overall Study||1201
893268|NCT01862159|2159331|P1|NOT COMPLETED|Overall Study||0
893269|NCT01862159|2159331|P1|COMPLETED|Overall Study||25038
893270|NCT01862159|2159331|P1|STARTED|Overall Study||25038
893271|NCT01862133|2159338|P2|NOT COMPLETED|Overall Study||0
893272|NCT01862133|2159339|P1|NOT COMPLETED|Overall Study||0
893273|NCT01862133|2159338|P2|COMPLETED|Overall Study||31
893274|NCT01862133|2159339|P1|COMPLETED|Overall Study|All 105 patients recorded preferences; 92 (88%) returned to the study clinic during the 6 mo. study|105
893275|NCT01862133|2159338|P2|Returned During 6 mo Study|Overall Study||31
893276|NCT01862133|2159339|P1|Returned During 6 mo Study|Overall Study||92
893277|NCT01862133|2159338|P2|STARTED|Overall Study||31
893278|NCT01862133|2159339|P1|STARTED|Overall Study||105
893279|NCT01861925|2159348|P3|NOT COMPLETED|Overall Study||0
893280|NCT01861925|2159349|P2|NOT COMPLETED|Overall Study||0
893281|NCT01861925|2159350|P1|NOT COMPLETED|Overall Study||0
893282|NCT01861925|2159348|P3|COMPLETED|Overall Study||8
893283|NCT01861925|2159349|P2|COMPLETED|Overall Study||8
893284|NCT01861925|2159350|P1|COMPLETED|Overall Study||34
893285|NCT01861925|2159348|P3|STARTED|Overall Study||8
893286|NCT01861925|2159349|P2|STARTED|Overall Study||8
893287|NCT01861925|2159350|P1|STARTED|Overall Study||34
893288|NCT01861756|2159373|P2|NOT COMPLETED|Overall Study||18
893289|NCT01861756|2159374|P1|NOT COMPLETED|Overall Study||13
893290|NCT01861756|2159373|P2|COMPLETED|Overall Study||85
893291|NCT01861756|2159374|P1|COMPLETED|Overall Study||88
893292|NCT01861756|2159373|P2|STARTED|Overall Study||103
893293|NCT01861756|2159374|P1|STARTED|Overall Study||101
893294|NCT01861704|2159382|P2|NOT COMPLETED|Overall Study||3
893295|NCT01861704|2159383|P1|NOT COMPLETED|Overall Study||3
893296|NCT01861704|2159382|P2|COMPLETED|Overall Study||104
893297|NCT01861704|2159383|P1|COMPLETED|Overall Study||67
893298|NCT01861704|2159382|P2|STARTED|Overall Study||107
893299|NCT01861704|2159383|P1|STARTED|Overall Study||70
893300|NCT01861522|2159391|P2|NOT COMPLETED|Overall Study||0
893301|NCT01861522|2159392|P1|NOT COMPLETED|Overall Study||3
893302|NCT01861522|2159391|P2|COMPLETED|Overall Study||232
893303|NCT01861522|2159392|P1|COMPLETED|Overall Study||237
893304|NCT01861522|2159391|P2|STARTED|Overall Study|One subject who did not receive any study drug was excluded from the FAS and the Safety Analysis Set|232
893305|NCT01861522|2159392|P1|STARTED|Overall Study||240
893306|NCT01861457|2159400|P2|NOT COMPLETED|Overall Study||0
893307|NCT01861457|2159401|P1|NOT COMPLETED|Overall Study||0
893308|NCT01861457|2159400|P2|COMPLETED|Overall Study||19
893309|NCT01861457|2159401|P1|COMPLETED|Overall Study||20
893310|NCT01861457|2159400|P2|STARTED|Overall Study||19
893311|NCT01861457|2159401|P1|STARTED|Overall Study||20
893312|NCT01861301|2159409|P1|NOT COMPLETED|Overall Study||0
893313|NCT01861301|2159409|P1|COMPLETED|Overall Study||18
893314|NCT01861301|2159409|P1|STARTED|Overall Study||18
893315|NCT01860989|2159416|P1|NOT COMPLETED|Overall Study||5
893316|NCT01860989|2159416|P1|COMPLETED|Overall Study||6
893317|NCT01860989|2159416|P1|STARTED|Overall Study||11
893318|NCT01860976|2159422|P2|NOT COMPLETED|Long Term Extension||107
893319|NCT01860976|2159423|P1|NOT COMPLETED|Long Term Extension||113
893320|NCT01860976|2159422|P2|COMPLETED|Long Term Extension||8
893321|NCT01860976|2159423|P1|COMPLETED|Long Term Extension||0
893322|NCT01860976|2159422|P2|STARTED|Long Term Extension||115
893323|NCT01860976|2159423|P1|STARTED|Long Term Extension||113
893324|NCT01860976|2159422|P2|NOT COMPLETED|Open-Label||64
893325|NCT01860976|2159423|P1|NOT COMPLETED|Open-Label||74
893326|NCT01860976|2159422|P2|COMPLETED|Open-Label||121
893327|NCT01860976|2159423|P1|COMPLETED|Open-Label||123
893328|NCT01860976|2159422|P2|STARTED|Open-Label||185
893329|NCT01860976|2159423|P1|STARTED|Open-Label||197
893330|NCT01860976|2159422|P2|NOT COMPLETED|Blinded Treatment||113
893331|NCT01860976|2159423|P1|NOT COMPLETED|Blinded Treatment||88
893332|NCT01860976|2159422|P2|COMPLETED|Blinded Treatment||98
893333|NCT01860976|2159423|P1|COMPLETED|Blinded Treatment||125
893334|NCT01860976|2159422|P2|STARTED|Blinded Treatment||211
893335|NCT01860976|2159423|P1|STARTED|Blinded Treatment||213
893336|NCT01860846|2159445|P1|NOT COMPLETED|Overall Study||33
893337|NCT01860846|2159445|P1|COMPLETED|Overall Study||73
893338|NCT01860846|2159445|P1|Month 12|Overall Study||73
893339|NCT01860846|2159445|P1|Month 6|Overall Study||85
893340|NCT01860846|2159445|P1|Month 4|Overall Study||82
893341|NCT01860846|2159445|P1|Month 2|Overall Study||83
893342|NCT01860846|2159445|P1|Month 1|Overall Study||97
893343|NCT01860846|2159445|P1|STARTED|Overall Study||106
893344|NCT01860703|2159456|P4|NOT COMPLETED|Overall Study||2
893345|NCT01860703|2159457|P3|NOT COMPLETED|Overall Study||1
893346|NCT01860703|2159458|P2|NOT COMPLETED|Overall Study||5
893347|NCT01860703|2159459|P1|NOT COMPLETED|Overall Study||2
893348|NCT01860703|2159456|P4|COMPLETED|Overall Study||10
893349|NCT01860703|2159457|P3|COMPLETED|Overall Study||11
893350|NCT01860703|2159458|P2|COMPLETED|Overall Study||8
893351|NCT01860703|2159459|P1|COMPLETED|Overall Study||11
893352|NCT01860703|2159456|P4|STARTED|Overall Study||12
893353|NCT01860703|2159457|P3|STARTED|Overall Study||12
893354|NCT01860703|2159458|P2|STARTED|Overall Study||13
893355|NCT01860703|2159459|P1|STARTED|Overall Study||13
893356|NCT01860677|2159491|P2|NOT COMPLETED|Second Intervention (1 Day)||0
893357|NCT01860677|2159492|P1|NOT COMPLETED|Second Intervention (1 Day)||7
893358|NCT01860677|2159491|P2|COMPLETED|Second Intervention (1 Day)||0
893359|NCT01860677|2159492|P1|COMPLETED|Second Intervention (1 Day)||1
893360|NCT01860677|2159491|P2|STARTED|Second Intervention (1 Day)||0
893361|NCT01860677|2159492|P1|STARTED|Second Intervention (1 Day)||8
893362|NCT01860677|2159491|P2|NOT COMPLETED|First Intervention (1 Day)||0
893363|NCT01860677|2159492|P1|NOT COMPLETED|First Intervention (1 Day)||0
893364|NCT01860677|2159491|P2|COMPLETED|First Intervention (1 Day)||0
893365|NCT01860677|2159492|P1|COMPLETED|First Intervention (1 Day)||8
893366|NCT01860677|2159491|P2|STARTED|First Intervention (1 Day)||0
893367|NCT01860677|2159492|P1|STARTED|First Intervention (1 Day)||8
893368|NCT01860586|2159501|P1|NOT COMPLETED|Overall Study||0
893369|NCT01860586|2159501|P1|COMPLETED|Overall Study||20
893370|NCT01860586|2159501|P1|STARTED|Overall Study||20
893371|NCT01860573|2159509|P2|NOT COMPLETED|Overall Study||0
893372|NCT01860573|2159510|P1|NOT COMPLETED|Overall Study||0
893373|NCT01860573|2159509|P2|COMPLETED|Overall Study||85
893374|NCT01860573|2159510|P1|COMPLETED|Overall Study||83
893375|NCT01860573|2159509|P2|STARTED|Overall Study||85
893376|NCT01860573|2159510|P1|STARTED|Overall Study||83
893377|NCT01860534|2159530|P2|NOT COMPLETED|ROP #2||0
893378|NCT01860534|2159531|P1|NOT COMPLETED|ROP #2||1
893379|NCT01860534|2159530|P2|COMPLETED|ROP #2||13
893380|NCT01860534|2159531|P1|COMPLETED|ROP #2||13
893381|NCT01860534|2159530|P2|STARTED|ROP #2||13
893382|NCT01860534|2159531|P1|STARTED|ROP #2||14
893383|NCT01860534|2159530|P2|NOT COMPLETED|ROP #1||1
893384|NCT01860534|2159531|P1|NOT COMPLETED|ROP #1||0
893385|NCT01860534|2159530|P2|COMPLETED|ROP #1||13
893386|NCT01860534|2159531|P1|COMPLETED|ROP #1||14
893387|NCT01860534|2159530|P2|STARTED|ROP #1||14
893388|NCT01860534|2159531|P1|STARTED|ROP #1||14
893389|NCT01860521|2159545|P2|NOT COMPLETED|Overall Study||0
893390|NCT01860521|2159546|P1|NOT COMPLETED|Overall Study||0
893391|NCT01860521|2159545|P2|COMPLETED|Overall Study|June 2013|52
893392|NCT01860521|2159546|P1|COMPLETED|Overall Study|June 2013|52
893393|NCT01860521|2159545|P2|STARTED|Overall Study|September 2011|52
893394|NCT01860521|2159546|P1|STARTED|Overall Study|September 2011|52
893395|NCT01860170|2159561|P3|NOT COMPLETED|Overall Study||0
893396|NCT01860170|2159562|P2|NOT COMPLETED|Overall Study||0
893397|NCT01860170|2159563|P1|NOT COMPLETED|Overall Study||0
893398|NCT01860170|2159561|P3|COMPLETED|Overall Study||22
893399|NCT01860170|2159562|P2|COMPLETED|Overall Study||3
893400|NCT01860170|2159563|P1|COMPLETED|Overall Study||3
893401|NCT01860170|2159561|P3|STARTED|Overall Study||22
893402|NCT01860170|2159562|P2|STARTED|Overall Study||3
893403|NCT01860170|2159563|P1|STARTED|Overall Study||3
893404|NCT01860079|2159579|P2|NOT COMPLETED|Overall Study||22
893405|NCT01860079|2159580|P1|NOT COMPLETED|Overall Study||14
893406|NCT01860079|2159579|P2|COMPLETED|Overall Study||363
893407|NCT01860079|2159580|P1|COMPLETED|Overall Study||370
893408|NCT01860079|2159579|P2|STARTED|Overall Study||385
893409|NCT01860079|2159580|P1|STARTED|Overall Study||384
893410|NCT01859988|2159592|P6|NOT COMPLETED|Overall Study||19
893411|NCT01859988|2159593|P5|NOT COMPLETED|Overall Study||23
893412|NCT01859988|2159594|P4|NOT COMPLETED|Overall Study||10
893413|NCT01859988|2159595|P3|NOT COMPLETED|Overall Study||28
893414|NCT01859988|2159596|P2|NOT COMPLETED|Overall Study||12
893415|NCT01859988|2159597|P1|NOT COMPLETED|Overall Study||11
893416|NCT01859988|2159592|P6|COMPLETED|Overall Study||42
893417|NCT01859988|2159593|P5|COMPLETED|Overall Study||42
893418|NCT01859988|2159594|P4|COMPLETED|Overall Study||55
893419|NCT01859988|2159595|P3|COMPLETED|Overall Study||34
893420|NCT01859988|2159596|P2|COMPLETED|Overall Study||52
893421|NCT01859988|2159597|P1|COMPLETED|Overall Study||52
893422|NCT01859988|2159592|P6|Treated|Overall Study||61
893423|NCT01859988|2159593|P5|Treated|Overall Study||65
893424|NCT01859988|2159594|P4|Treated|Overall Study||65
893425|NCT01859988|2159595|P3|Treated|Overall Study||61
893426|NCT01859988|2159596|P2|Treated|Overall Study||64
893427|NCT01859988|2159597|P1|Treated|Overall Study||63
893428|NCT01859988|2159592|P6|STARTED|Overall Study||61
893429|NCT01859988|2159593|P5|STARTED|Overall Study||65
893430|NCT01859988|2159594|P4|STARTED|Overall Study||65
893431|NCT01859988|2159595|P3|STARTED|Overall Study||62
893432|NCT01859988|2159596|P2|STARTED|Overall Study||64
893433|NCT01859988|2159597|P1|STARTED|Overall Study||63
893434|NCT01859949|2159691|P2|NOT COMPLETED|Overall Study||17
893435|NCT01859949|2159692|P1|NOT COMPLETED|Overall Study||14
893436|NCT01859949|2159691|P2|COMPLETED|Overall Study||15
893437|NCT01859949|2159692|P1|COMPLETED|Overall Study||15
893438|NCT01859949|2159691|P2|STARTED|Overall Study|Treated participants|32
893439|NCT01859949|2159692|P1|STARTED|Overall Study|Treated participants|29
893440|NCT01859793|2159710|P2|NOT COMPLETED|2nd Intervention Period||0
893441|NCT01859793|2159711|P1|NOT COMPLETED|2nd Intervention Period||0
893442|NCT01859793|2159710|P2|COMPLETED|2nd Intervention Period||16
893443|NCT01859793|2159711|P1|COMPLETED|2nd Intervention Period||14
893444|NCT01859793|2159710|P2|STARTED|2nd Intervention Period||16
893445|NCT01859793|2159711|P1|STARTED|2nd Intervention Period||14
893446|NCT01859793|2159710|P2|NOT COMPLETED|Washout Period (4 Weeks)||1
893447|NCT01859793|2159711|P1|NOT COMPLETED|Washout Period (4 Weeks)||1
893448|NCT01859793|2159710|P2|COMPLETED|Washout Period (4 Weeks)||16
893449|NCT01859793|2159711|P1|COMPLETED|Washout Period (4 Weeks)||14
893450|NCT01859793|2159710|P2|STARTED|Washout Period (4 Weeks)||17
893451|NCT01859793|2159711|P1|STARTED|Washout Period (4 Weeks)||15
893452|NCT01859793|2159710|P2|NOT COMPLETED|First Intervention (8 Weeks)||1
893453|NCT01859793|2159711|P1|NOT COMPLETED|First Intervention (8 Weeks)||5
893454|NCT01859793|2159710|P2|COMPLETED|First Intervention (8 Weeks)||17
893455|NCT01859793|2159711|P1|COMPLETED|First Intervention (8 Weeks)||15
893456|NCT01859793|2159710|P2|STARTED|First Intervention (8 Weeks)||18
893457|NCT01859793|2159711|P1|STARTED|First Intervention (8 Weeks)||20
893458|NCT01859715|2159724|P3|NOT COMPLETED|Overall Study||23
893459|NCT01859715|2159725|P2|NOT COMPLETED|Overall Study||8
893460|NCT01859715|2159726|P1|NOT COMPLETED|Overall Study||16
893461|NCT01859715|2159724|P3|COMPLETED|Overall Study||93
893462|NCT01859715|2159725|P2|COMPLETED|Overall Study||83
893463|NCT01859715|2159726|P1|COMPLETED|Overall Study||125
893464|NCT01859715|2159724|P3|STARTED|Overall Study||116
893465|NCT01859715|2159725|P2|STARTED|Overall Study||91
893466|NCT01859715|2159726|P1|STARTED|Overall Study||141
893467|NCT01859702|2159737|P1|NOT COMPLETED|Overall Study||5
893468|NCT01859702|2159737|P1|COMPLETED|Overall Study||31
893469|NCT01859702|2159737|P1|STARTED|Overall Study||36
893470|NCT01859637|2159741|P1|NOT COMPLETED|Overall Study||0
893471|NCT01859637|2159741|P1|COMPLETED|Overall Study||6
893472|NCT01859637|2159741|P1|STARTED|Overall Study||6
893473|NCT01859611|2159747|P1|NOT COMPLETED|Overall Study||8
893474|NCT01859611|2159747|P1|COMPLETED|Overall Study||43
893475|NCT01859611|2159747|P1|STARTED|Overall Study||51
893476|NCT01859598|2159751|P1|NOT COMPLETED|Visit 3 at 6 Months||912
893477|NCT01859598|2159751|P1|COMPLETED|Visit 3 at 6 Months|Loss to follow-up, N=1517; Come back at visit 3, N=605;|16341
893478|NCT01859598|2159751|P1|STARTED|Visit 3 at 6 Months||17253
893479|NCT01859598|2159751|P1|NOT COMPLETED|Visit 2 at 3 Months||1742
893480|NCT01859598|2159751|P1|COMPLETED|Visit 2 at 3 Months||17253
893481|NCT01859598|2159751|P1|STARTED|Visit 2 at 3 Months|At visit 1, patients remained at baseline, N=18995|18995
893482|NCT01859507|2159759|P1|NOT COMPLETED|Overall Study||4
893483|NCT01859507|2159759|P1|COMPLETED|Overall Study||28
893484|NCT01859507|2159759|P1|STARTED|Overall Study||32
893485|NCT01859494|2159764|P1|NOT COMPLETED|Overall Study||1
893486|NCT01859494|2159764|P1|COMPLETED|Overall Study||218
893487|NCT01859494|2159764|P1|STARTED|Overall Study||219
893488|NCT01859390|2159775|P2|NOT COMPLETED|Overall Study||7
893489|NCT01859390|2159776|P1|NOT COMPLETED|Overall Study||1
893490|NCT01859390|2159775|P2|COMPLETED|Overall Study||30
893491|NCT01859390|2159776|P1|COMPLETED|Overall Study||35
893492|NCT01859390|2159775|P2|Withdrawals|Overall Study||2
893493|NCT01859390|2159776|P1|Withdrawals|Overall Study||2
893494|NCT01859390|2159775|P2|STARTED|Overall Study||37
893495|NCT01859390|2159776|P1|STARTED|Overall Study||36
893496|NCT01859247|2159806|P8|NOT COMPLETED|Overall Study||0
893497|NCT01859247|2159807|P7|NOT COMPLETED|Overall Study||0
893498|NCT01859247|2159808|P6|NOT COMPLETED|Overall Study||0
893499|NCT01859247|2159809|P5|NOT COMPLETED|Overall Study||0
893500|NCT01859247|2159810|P4|NOT COMPLETED|Overall Study||0
893501|NCT01859247|2159811|P3|NOT COMPLETED|Overall Study||0
893502|NCT01859247|2159812|P2|NOT COMPLETED|Overall Study||0
893503|NCT01859247|2159813|P1|NOT COMPLETED|Overall Study||0
893504|NCT01859247|2159806|P8|COMPLETED|Overall Study||1
893505|NCT01859247|2159807|P7|COMPLETED|Overall Study||1
893506|NCT01859247|2159808|P6|COMPLETED|Overall Study||1
893507|NCT01859247|2159809|P5|COMPLETED|Overall Study||1
893508|NCT01859247|2159810|P4|COMPLETED|Overall Study||1
893509|NCT01859247|2159811|P3|COMPLETED|Overall Study||1
893510|NCT01859247|2159812|P2|COMPLETED|Overall Study||1
893511|NCT01859247|2159813|P1|COMPLETED|Overall Study||1
893512|NCT01859247|2159806|P8|STARTED|Overall Study||1
893513|NCT01859247|2159807|P7|STARTED|Overall Study||1
893514|NCT01859247|2159808|P6|STARTED|Overall Study||1
893515|NCT01859247|2159809|P5|STARTED|Overall Study||1
893516|NCT01859247|2159810|P4|STARTED|Overall Study||1
893517|NCT01859247|2159811|P3|STARTED|Overall Study||1
893518|NCT01859247|2159812|P2|STARTED|Overall Study||1
893519|NCT01859247|2159813|P1|STARTED|Overall Study||1
893520|NCT01859143|2159840|P2|NOT COMPLETED|Overall Study||0
893521|NCT01859143|2159841|P1|NOT COMPLETED|Overall Study||2
893522|NCT01859143|2159840|P2|COMPLETED|Overall Study||60
893523|NCT01859143|2159841|P1|COMPLETED|Overall Study||238
893524|NCT01859143|2159840|P2|STARTED|Overall Study|One participant in this group received trivalent influenza vaccine on Day 1.|60
893525|NCT01859143|2159841|P1|STARTED|Overall Study||240
893526|NCT01859078|2159855|P1|NOT COMPLETED|Overall Study||0
893527|NCT01859078|2159855|P1|COMPLETED|Overall Study||28
893528|NCT01859078|2159855|P1|STARTED|Overall Study||28
893529|NCT01859013|2159871|P2|NOT COMPLETED|Overall Study||5
893530|NCT01859013|2159872|P1|NOT COMPLETED|Overall Study||4
893531|NCT01859013|2159871|P2|COMPLETED|Overall Study||9
893532|NCT01859013|2159872|P1|COMPLETED|Overall Study||12
893533|NCT01859013|2159871|P2|STARTED|Overall Study||14
893534|NCT01859013|2159872|P1|STARTED|Overall Study||16
893535|NCT01858766|2159897|P19|NOT COMPLETED|Overall Study||4
893536|NCT01858766|2159898|P18|NOT COMPLETED|Overall Study||4
893537|NCT01858766|2159899|P17|NOT COMPLETED|Overall Study||3
893538|NCT01858766|2159900|P16|NOT COMPLETED|Overall Study||6
893539|NCT01858766|2159901|P15|NOT COMPLETED|Overall Study||8
893540|NCT01858766|2159902|P14|NOT COMPLETED|Overall Study||3
893541|NCT01858766|2159903|P13|NOT COMPLETED|Overall Study||5
893542|NCT01858766|2159904|P12|NOT COMPLETED|Overall Study||5
893543|NCT01858766|2159905|P11|NOT COMPLETED|Overall Study||0
893544|NCT01858766|2159906|P10|NOT COMPLETED|Overall Study||0
893545|NCT01858766|2159907|P9|NOT COMPLETED|Overall Study||0
893546|NCT01858766|2159908|P8|NOT COMPLETED|Overall Study||2
893547|NCT01858766|2159909|P7|NOT COMPLETED|Overall Study||0
893548|NCT01858766|2159910|P6|NOT COMPLETED|Overall Study||4
893549|NCT01858766|2159911|P5|NOT COMPLETED|Overall Study||1
893550|NCT01858766|2159912|P4|NOT COMPLETED|Overall Study||0
893551|NCT01858766|2159913|P3|NOT COMPLETED|Overall Study||1
893552|NCT01858766|2159914|P2|NOT COMPLETED|Overall Study||0
893553|NCT01858766|2159915|P1|NOT COMPLETED|Overall Study||1
893554|NCT01858766|2159897|P19|COMPLETED|Overall Study||22
893555|NCT01858766|2159898|P18|COMPLETED|Overall Study||23
893556|NCT01858766|2159899|P17|COMPLETED|Overall Study||22
893557|NCT01858766|2159900|P16|COMPLETED|Overall Study||20
893558|NCT01858766|2159901|P15|COMPLETED|Overall Study||23
893559|NCT01858766|2159902|P14|COMPLETED|Overall Study||26
893560|NCT01858766|2159903|P13|COMPLETED|Overall Study||25
893561|NCT01858766|2159904|P12|COMPLETED|Overall Study||25
893562|NCT01858766|2159905|P11|COMPLETED|Overall Study||5
893563|NCT01858766|2159906|P10|COMPLETED|Overall Study||4
893564|NCT01858766|2159907|P9|COMPLETED|Overall Study||1
893565|NCT01858766|2159908|P8|COMPLETED|Overall Study||5
893566|NCT01858766|2159909|P7|COMPLETED|Overall Study||7
893567|NCT01858766|2159910|P6|COMPLETED|Overall Study||24
893568|NCT01858766|2159911|P5|COMPLETED|Overall Study||26
893569|NCT01858766|2159912|P4|COMPLETED|Overall Study||10
893570|NCT01858766|2159913|P3|COMPLETED|Overall Study||10
893571|NCT01858766|2159914|P2|COMPLETED|Overall Study||28
893572|NCT01858766|2159915|P1|COMPLETED|Overall Study||26
893573|NCT01858766|2159897|P19|STARTED|Overall Study||26
893574|NCT01858766|2159898|P18|STARTED|Overall Study||27
893575|NCT01858766|2159899|P17|STARTED|Overall Study||25
893576|NCT01858766|2159900|P16|STARTED|Overall Study||26
893577|NCT01858766|2159901|P15|STARTED|Overall Study||31
893578|NCT01858766|2159902|P14|STARTED|Overall Study||29
893579|NCT01858766|2159903|P13|STARTED|Overall Study||30
893580|NCT01858766|2159904|P12|STARTED|Overall Study||30
893581|NCT01858766|2159905|P11|STARTED|Overall Study||5
893582|NCT01858766|2159906|P10|STARTED|Overall Study||4
893583|NCT01858766|2159907|P9|STARTED|Overall Study||1
893584|NCT01858766|2159908|P8|STARTED|Overall Study||7
893585|NCT01858766|2159909|P7|STARTED|Overall Study||7
893586|NCT01858766|2159910|P6|STARTED|Overall Study||28
893587|NCT01858766|2159911|P5|STARTED|Overall Study||27
893588|NCT01858766|2159912|P4|STARTED|Overall Study||10
893589|NCT01858766|2159913|P3|STARTED|Overall Study||11
893590|NCT01858766|2159914|P2|STARTED|Overall Study||28
893591|NCT01858766|2159915|P1|STARTED|Overall Study||27
893592|NCT01858701|2159986|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
893593|NCT01858701|2159987|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
893594|NCT01858701|2159986|P2|COMPLETED|Period 2, Second 30 Days of Wear||16
893595|NCT01858701|2159987|P1|COMPLETED|Period 2, Second 30 Days of Wear||18
893596|NCT01858701|2159986|P2|STARTED|Period 2, Second 30 Days of Wear||17
893597|NCT01858701|2159987|P1|STARTED|Period 2, Second 30 Days of Wear||18
893598|NCT01858701|2159986|P2|NOT COMPLETED|Washout Period, 1-13 Days||2
893599|NCT01858701|2159987|P1|NOT COMPLETED|Washout Period, 1-13 Days||2
893600|NCT01858701|2159986|P2|COMPLETED|Washout Period, 1-13 Days||17
893601|NCT01858701|2159987|P1|COMPLETED|Washout Period, 1-13 Days||18
893602|NCT01858701|2159986|P2|STARTED|Washout Period, 1-13 Days||19
893603|NCT01858701|2159987|P1|STARTED|Washout Period, 1-13 Days||20
893604|NCT01858701|2159986|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||1
893605|NCT01858701|2159987|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
893606|NCT01858701|2159986|P2|COMPLETED|Period 1, First 30 Days of Wear||19
893607|NCT01858701|2159987|P1|COMPLETED|Period 1, First 30 Days of Wear||20
893608|NCT01858701|2159986|P2|STARTED|Period 1, First 30 Days of Wear||20
893609|NCT01858701|2159987|P1|STARTED|Period 1, First 30 Days of Wear||20
893610|NCT01858636|2159993|P1|NOT COMPLETED|Overall Study||28
893611|NCT01858636|2159993|P1|COMPLETED|Overall Study||207
893612|NCT01858636|2159993|P1|Device Deployment|Overall Study||211
893613|NCT01858636|2159993|P1|STARTED|Overall Study|Subjects consented|235
893614|NCT01858389|2160000|P2|NOT COMPLETED|Overall Study||25
893615|NCT01858389|2160001|P1|NOT COMPLETED|Overall Study||16
893616|NCT01858389|2160000|P2|COMPLETED|Overall Study||0
893617|NCT01858389|2160001|P1|COMPLETED|Overall Study||0
893618|NCT01858389|2160000|P2|Received Treatment|Overall Study||22
893619|NCT01858389|2160001|P1|Received Treatment|Overall Study||16
893620|NCT01858389|2160000|P2|STARTED|Overall Study|Enrolled|25
893621|NCT01858389|2160001|P1|STARTED|Overall Study|Enrolled|16
893622|NCT01858376|2160016|P1|NOT COMPLETED|Overall Study||4
893623|NCT01858376|2160016|P1|COMPLETED|Overall Study||20
893624|NCT01858376|2160016|P1|STARTED|Overall Study||24
893625|NCT01857986|2160024|P2|NOT COMPLETED|Overall Study||7
893626|NCT01857986|2160025|P1|NOT COMPLETED|Overall Study||5
893627|NCT01857986|2160024|P2|COMPLETED|Overall Study||30
893628|NCT01857986|2160025|P1|COMPLETED|Overall Study||34
893629|NCT01857986|2160024|P2|STARTED|Overall Study||37
893630|NCT01857986|2160025|P1|STARTED|Overall Study||39
893631|NCT01857882|2160037|P2|NOT COMPLETED|Overall Study||0
893632|NCT01857882|2160038|P1|NOT COMPLETED|Overall Study||0
893633|NCT01857882|2160037|P2|COMPLETED|Overall Study||20
893634|NCT01857882|2160038|P1|COMPLETED|Overall Study||21
893635|NCT01857882|2160037|P2|STARTED|Overall Study||20
893636|NCT01857882|2160038|P1|STARTED|Overall Study||21
893637|NCT01857713|2160044|P1|NOT COMPLETED|Overall Study||6
893638|NCT01857713|2160044|P1|COMPLETED|Overall Study||89
893639|NCT01857713|2160044|P1|STARTED|Overall Study||95
893640|NCT01857622|2160054|P3|NOT COMPLETED|Overall Study||2
893641|NCT01857622|2160055|P2|NOT COMPLETED|Overall Study||1
893642|NCT01857622|2160056|P1|NOT COMPLETED|Overall Study||11
893643|NCT01857622|2160054|P3|COMPLETED|Overall Study||19
893644|NCT01857622|2160055|P2|COMPLETED|Overall Study||21
893645|NCT01857622|2160056|P1|COMPLETED|Overall Study||39
893646|NCT01857622|2160054|P3|STARTED|Overall Study||21
893647|NCT01857622|2160055|P2|STARTED|Overall Study||22
893648|NCT01857622|2160056|P1|STARTED|Overall Study||50
893649|NCT01857583|2160068|P4|NOT COMPLETED|Overall Study||4
893650|NCT01857583|2160069|P3|NOT COMPLETED|Overall Study||3
893651|NCT01857583|2160070|P2|NOT COMPLETED|Overall Study||1
893652|NCT01857583|2160071|P1|NOT COMPLETED|Overall Study||1
893653|NCT01857583|2160068|P4|COMPLETED|Overall Study||17
893654|NCT01857583|2160069|P3|COMPLETED|Overall Study||19
893655|NCT01857583|2160070|P2|COMPLETED|Overall Study||6
893656|NCT01857583|2160071|P1|COMPLETED|Overall Study||29
893657|NCT01857583|2160068|P4|Safety Analysis Population|Overall Study||20
893658|NCT01857583|2160069|P3|Safety Analysis Population|Overall Study||22
893659|NCT01857583|2160070|P2|Safety Analysis Population|Overall Study||7
893660|NCT01857583|2160071|P1|Safety Analysis Population|Overall Study||30
893661|NCT01857583|2160068|P4|STARTED|Overall Study||21
893662|NCT01857583|2160069|P3|STARTED|Overall Study||22
893663|NCT01857583|2160070|P2|STARTED|Overall Study||7
893664|NCT01857583|2160071|P1|STARTED|Overall Study||30
893665|NCT01857531|2160081|P1|NOT COMPLETED|Overall Study||4
893666|NCT01857531|2160081|P1|COMPLETED|Overall Study||12
893667|NCT01857531|2160081|P1|STARTED|Overall Study||16
893668|NCT01857362|2160090|P2|NOT COMPLETED|Overall Study||0
893669|NCT01857362|2160091|P1|NOT COMPLETED|Overall Study||0
893670|NCT01857362|2160090|P2|COMPLETED|Overall Study||6
893671|NCT01857362|2160091|P1|COMPLETED|Overall Study||6
893672|NCT01857362|2160090|P2|STARTED|Overall Study||6
893673|NCT01857362|2160091|P1|STARTED|Overall Study||6
893674|NCT01857323|2160099|P1|NOT COMPLETED|Overall Study||64
893675|NCT01857323|2160099|P1|COMPLETED|Overall Study||253
893676|NCT01857323|2160099|P1|Safety Population|Overall Study|One enrolled participant was lost to follow-up.|316
893677|NCT01857323|2160099|P1|STARTED|Overall Study|36 day treatment cohort: 45 participants 50 day treatment cohort: 272 participants|317
893678|NCT01857297|2160110|P2|NOT COMPLETED|Overall Study||0
893679|NCT01857297|2160111|P1|NOT COMPLETED|Overall Study||0
893680|NCT01857297|2160110|P2|COMPLETED|Overall Study||60
893681|NCT01857297|2160111|P1|COMPLETED|Overall Study||60
893682|NCT01857297|2160110|P2|STARTED|Overall Study||60
893683|NCT01857297|2160111|P1|STARTED|Overall Study||60
893684|NCT01857258|2160125|P2|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
893685|NCT01857258|2160126|P1|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
893686|NCT01857258|2160125|P2|COMPLETED|Second Intervention (3 h Postprandially)||7
893687|NCT01857258|2160126|P1|COMPLETED|Second Intervention (3 h Postprandially)||8
893688|NCT01857258|2160125|P2|STARTED|Second Intervention (3 h Postprandially)||7
893689|NCT01857258|2160126|P1|STARTED|Second Intervention (3 h Postprandially)||8
893690|NCT01857258|2160125|P2|NOT COMPLETED|Wash-out Period (7 Days)||0
893691|NCT01857258|2160126|P1|NOT COMPLETED|Wash-out Period (7 Days)||0
893692|NCT01857258|2160125|P2|COMPLETED|Wash-out Period (7 Days)||7
893693|NCT01857258|2160126|P1|COMPLETED|Wash-out Period (7 Days)||8
893694|NCT01857258|2160125|P2|STARTED|Wash-out Period (7 Days)||7
893695|NCT01857258|2160126|P1|STARTED|Wash-out Period (7 Days)||8
893696|NCT01857258|2160125|P2|NOT COMPLETED|First Intervention (3 h Postprandially)||0
893697|NCT01857258|2160126|P1|NOT COMPLETED|First Intervention (3 h Postprandially)||0
893698|NCT01857258|2160125|P2|COMPLETED|First Intervention (3 h Postprandially)||7
893699|NCT01857258|2160126|P1|COMPLETED|First Intervention (3 h Postprandially)||8
893700|NCT01857258|2160125|P2|STARTED|First Intervention (3 h Postprandially)||7
893701|NCT01857258|2160126|P1|STARTED|First Intervention (3 h Postprandially)||8
893702|NCT01857206|2160148|P2|NOT COMPLETED|Overall Study||10
893703|NCT01857206|2160149|P1|NOT COMPLETED|Overall Study||13
893704|NCT01857206|2160148|P2|COMPLETED|Overall Study||673
893705|NCT01857206|2160149|P1|COMPLETED|Overall Study||1359
893706|NCT01857206|2160148|P2|STARTED|Overall Study||683
893707|NCT01857206|2160149|P1|STARTED|Overall Study||1372
893708|NCT01857102|2160167|P2|NOT COMPLETED|Period 2||0
893709|NCT01857102|2160168|P1|NOT COMPLETED|Period 2||2
893710|NCT01857102|2160167|P2|COMPLETED|Period 2||51
893711|NCT01857102|2160168|P1|COMPLETED|Period 2||53
893712|NCT01857102|2160167|P2|Neophytes|Period 2||4
893713|NCT01857102|2160168|P1|Neophytes|Period 2||7
893714|NCT01857102|2160167|P2|Habitual Users|Period 2||47
893715|NCT01857102|2160168|P1|Habitual Users|Period 2||48
893716|NCT01857102|2160167|P2|STARTED|Period 2||51
893717|NCT01857102|2160168|P1|STARTED|Period 2||55
893718|NCT01857102|2160167|P2|NOT COMPLETED|Period 1||5
893719|NCT01857102|2160168|P1|NOT COMPLETED|Period 1||3
893720|NCT01857102|2160167|P2|COMPLETED|Period 1||51
893721|NCT01857102|2160168|P1|COMPLETED|Period 1||55
893722|NCT01857102|2160167|P2|Neophtyes|Period 1||4
893723|NCT01857102|2160168|P1|Neophtyes|Period 1||7
893724|NCT01857102|2160167|P2|Habitual Users|Period 1||52
893725|NCT01857102|2160168|P1|Habitual Users|Period 1||51
893726|NCT01857102|2160167|P2|STARTED|Period 1||56
893727|NCT01857102|2160168|P1|STARTED|Period 1||58
893728|NCT01857063|2160178|P2|NOT COMPLETED|Period 2 (7 Days)||2
893729|NCT01857063|2160179|P1|NOT COMPLETED|Period 2 (7 Days)||4
893730|NCT01857063|2160178|P2|COMPLETED|Period 2 (7 Days)||104
893731|NCT01857063|2160179|P1|COMPLETED|Period 2 (7 Days)||104
893732|NCT01857063|2160178|P2|STARTED|Period 2 (7 Days)||106
893733|NCT01857063|2160179|P1|STARTED|Period 2 (7 Days)||108
893734|NCT01857063|2160178|P2|NOT COMPLETED|Period 1 (7 Days)||4
893735|NCT01857063|2160179|P1|NOT COMPLETED|Period 1 (7 Days)||2
893736|NCT01857063|2160178|P2|COMPLETED|Period 1 (7 Days)||106
893737|NCT01857063|2160179|P1|COMPLETED|Period 1 (7 Days)||108
893738|NCT01857063|2160178|P2|STARTED|Period 1 (7 Days)||110
893739|NCT01857063|2160179|P1|STARTED|Period 1 (7 Days)||110
893740|NCT01856933|2160205|P1|NOT COMPLETED|Overall Study||0
893741|NCT01856933|2160205|P1|COMPLETED|Overall Study||6
893742|NCT01856933|2160205|P1|STARTED|Overall Study||6
893743|NCT01856764|2160211|P2|NOT COMPLETED|Overall Study||0
893744|NCT01856764|2160212|P1|NOT COMPLETED|Overall Study||0
893745|NCT01856764|2160211|P2|COMPLETED|Overall Study||20
893746|NCT01856764|2160212|P1|COMPLETED|Overall Study||20
893747|NCT01856764|2160211|P2|STARTED|Overall Study||20
893748|NCT01856764|2160212|P1|STARTED|Overall Study||20
893755|NCT01856673|2160268|P3|NOT COMPLETED|Overall Study||34
893756|NCT01856673|2160269|P2|NOT COMPLETED|Overall Study||85
893757|NCT01856673|2160270|P1|NOT COMPLETED|Overall Study||98
893758|NCT01856673|2160268|P3|COMPLETED|Overall Study||137
893759|NCT01856673|2160269|P2|COMPLETED|Overall Study|A percentage of 80.9% completed the follow-up (exit survey)|90
893760|NCT01856673|2160270|P1|COMPLETED|Overall Study|A percentage of 75.1% completed the follow-up (exit survey)|77
893761|NCT01856673|2160268|P3|Quibdó Participants|Overall Study||83
893762|NCT01856673|2160269|P2|Quibdó Participants|Overall Study||86
893763|NCT01856673|2160270|P1|Quibdó Participants|Overall Study||83
893764|NCT01856673|2160268|P3|Buenaventura Participants|Overall Study||88
893765|NCT01856673|2160269|P2|Buenaventura Participants|Overall Study||89
893766|NCT01856673|2160270|P1|Buenaventura Participants|Overall Study||92
893767|NCT01856673|2160268|P3|STARTED|Overall Study||171
893768|NCT01856673|2160269|P2|STARTED|Overall Study||175
893769|NCT01856673|2160270|P1|STARTED|Overall Study||175
893770|NCT01856569|2160281|P1|NOT COMPLETED|Overall Study||13
893771|NCT01856569|2160281|P1|COMPLETED|Overall Study||139
893772|NCT01856569|2160281|P1|Full Analysis Set|Overall Study||144
893773|NCT01856569|2160281|P1|STARTED|Overall Study||152
893774|NCT01856530|2160292|P2|NOT COMPLETED|Overall Study||0
893775|NCT01856530|2160293|P1|NOT COMPLETED|Overall Study||0
893776|NCT01856530|2160292|P2|COMPLETED|Overall Study||27
893777|NCT01856530|2160293|P1|COMPLETED|Overall Study||27
893778|NCT01856530|2160292|P2|STARTED|Overall Study||27
893779|NCT01856530|2160293|P1|STARTED|Overall Study||27
893780|NCT01856361|2160311|P2|NOT COMPLETED|Overall Study||0
893781|NCT01856361|2160312|P1|NOT COMPLETED|Overall Study||0
893782|NCT01856361|2160311|P2|COMPLETED|Overall Study||1
893783|NCT01856361|2160312|P1|COMPLETED|Overall Study||1
893784|NCT01856361|2160311|P2|STARTED|Overall Study||1
893785|NCT01856361|2160312|P1|STARTED|Overall Study||1
893786|NCT01856322|2160329|P3|NOT COMPLETED|Overall Study||3
893787|NCT01856322|2160330|P2|NOT COMPLETED|Overall Study||0
893788|NCT01856322|2160331|P1|NOT COMPLETED|Overall Study||0
893789|NCT01856322|2160329|P3|COMPLETED|Overall Study||0
893790|NCT01856322|2160330|P2|COMPLETED|Overall Study||0
893791|NCT01856322|2160331|P1|COMPLETED|Overall Study||0
893792|NCT01856322|2160329|P3|STARTED|Overall Study||3
893793|NCT01856322|2160330|P2|STARTED|Overall Study||0
893794|NCT01856322|2160331|P1|STARTED|Overall Study||0
893795|NCT01856257|2160341|P4|NOT COMPLETED|Overall Study||2
893796|NCT01856257|2160342|P3|NOT COMPLETED|Overall Study||0
893797|NCT01856257|2160343|P2|NOT COMPLETED|Overall Study||1
893798|NCT01856257|2160344|P1|NOT COMPLETED|Overall Study||3
893799|NCT01856257|2160341|P4|COMPLETED|Overall Study||0
893800|NCT01856257|2160342|P3|COMPLETED|Overall Study||11
893801|NCT01856257|2160343|P2|COMPLETED|Overall Study||28
893802|NCT01856257|2160344|P1|COMPLETED|Overall Study||26
893803|NCT01856257|2160341|P4|STARTED|Overall Study||2
893804|NCT01856257|2160342|P3|STARTED|Overall Study||11
893805|NCT01856257|2160343|P2|STARTED|Overall Study||29
893806|NCT01856257|2160344|P1|STARTED|Overall Study||29
893807|NCT01855997|2160443|P1|NOT COMPLETED|Overall Study||0
893808|NCT01855997|2160443|P1|COMPLETED|Overall Study||1669
893809|NCT01855997|2160443|P1|STARTED|Overall Study||1669
893810|NCT01855958|2160498|P2|NOT COMPLETED|Overall Study||0
893811|NCT01855958|2160499|P1|NOT COMPLETED|Overall Study||1
893812|NCT01855958|2160498|P2|COMPLETED|Overall Study||13
893813|NCT01855958|2160499|P1|COMPLETED|Overall Study||12
893814|NCT01855958|2160498|P2|STARTED|Overall Study||13
893815|NCT01855958|2160499|P1|STARTED|Overall Study||13
893816|NCT01855945|2160529|P12|NOT COMPLETED|Overall Study||3
893817|NCT01855945|2160530|P11|NOT COMPLETED|Overall Study||5
893818|NCT01855945|2160531|P10|NOT COMPLETED|Overall Study||2
893819|NCT01855945|2160532|P9|NOT COMPLETED|Overall Study||2
893820|NCT01855945|2160533|P8|NOT COMPLETED|Overall Study||8
893821|NCT01855945|2160534|P7|NOT COMPLETED|Overall Study||10
893822|NCT01855945|2160535|P6|NOT COMPLETED|Overall Study||3
893823|NCT01855945|2160536|P5|NOT COMPLETED|Overall Study||1
893824|NCT01855945|2160537|P4|NOT COMPLETED|Overall Study||4
893825|NCT01855945|2160538|P3|NOT COMPLETED|Overall Study||12
893826|NCT01855945|2160539|P2|NOT COMPLETED|Overall Study||11
893827|NCT01855945|2160540|P1|NOT COMPLETED|Overall Study||16
893828|NCT01855945|2160529|P12|COMPLETED|Overall Study||49
893829|NCT01855945|2160530|P11|COMPLETED|Overall Study||46
893830|NCT01855945|2160531|P10|COMPLETED|Overall Study||49
893831|NCT01855945|2160532|P9|COMPLETED|Overall Study||46
893832|NCT01855945|2160533|P8|COMPLETED|Overall Study||47
893833|NCT01855945|2160534|P7|COMPLETED|Overall Study||43
893834|NCT01855945|2160535|P6|COMPLETED|Overall Study||50
893835|NCT01855945|2160536|P5|COMPLETED|Overall Study||50
893836|NCT01855945|2160537|P4|COMPLETED|Overall Study||49
893837|NCT01855945|2160538|P3|COMPLETED|Overall Study||39
893838|NCT01855945|2160539|P2|COMPLETED|Overall Study||44
893839|NCT01855945|2160540|P1|COMPLETED|Overall Study||38
893840|NCT01855945|2160529|P12|STARTED|Overall Study||52
893841|NCT01855945|2160530|P11|STARTED|Overall Study||51
893842|NCT01855945|2160531|P10|STARTED|Overall Study||51
893843|NCT01855945|2160532|P9|STARTED|Overall Study||48
893844|NCT01855945|2160533|P8|STARTED|Overall Study||55
893845|NCT01855945|2160534|P7|STARTED|Overall Study||53
893846|NCT01855945|2160535|P6|STARTED|Overall Study||53
893847|NCT01855945|2160536|P5|STARTED|Overall Study||51
893848|NCT01855945|2160537|P4|STARTED|Overall Study||53
893849|NCT01855945|2160538|P3|STARTED|Overall Study||51
893850|NCT01855945|2160539|P2|STARTED|Overall Study||55
893851|NCT01855945|2160540|P1|STARTED|Overall Study||54
893852|NCT01855919|2160676|P2|NOT COMPLETED|Overall Study||26
893853|NCT01855919|2160677|P1|NOT COMPLETED|Overall Study||23
893854|NCT01855919|2160676|P2|COMPLETED|Overall Study||200
893855|NCT01855919|2160677|P1|COMPLETED|Overall Study||209
893856|NCT01855919|2160676|P2|Received at Least 1 Dose of Study Drug|Overall Study||226
893857|NCT01855919|2160677|P1|Received at Least 1 Dose of Study Drug|Overall Study||232
893858|NCT01855919|2160676|P2|STARTED|Overall Study||226
893859|NCT01855919|2160677|P1|STARTED|Overall Study||232
893860|NCT01855074|2160709|P1|NOT COMPLETED|Overall Study||14
893861|NCT01855074|2160709|P1|COMPLETED|Overall Study||66
893862|NCT01855074|2160709|P1|Treated|Overall Study||79
893863|NCT01855074|2160709|P1|STARTED|Overall Study||80
893864|NCT01854944|2160721|P3|NOT COMPLETED|Overall Study||1
893865|NCT01854944|2160722|P2|NOT COMPLETED|Overall Study||0
893866|NCT01854944|2160723|P1|NOT COMPLETED|Overall Study||0
893867|NCT01854944|2160721|P3|COMPLETED|Overall Study||3
893868|NCT01854944|2160722|P2|COMPLETED|Overall Study||4
893869|NCT01854944|2160723|P1|COMPLETED|Overall Study||4
893870|NCT01854944|2160721|P3|STARTED|Overall Study||4
893871|NCT01854944|2160722|P2|STARTED|Overall Study||4
893872|NCT01854944|2160723|P1|STARTED|Overall Study||4
893873|NCT01854905|2160773|P1|NOT COMPLETED|Overall Study||0
893874|NCT01854905|2160773|P1|COMPLETED|Overall Study||400
893875|NCT01854905|2160773|P1|STARTED|Overall Study||400
893876|NCT01854697|2160782|P5|NOT COMPLETED|Overall Study||2
893877|NCT01854697|2160783|P4|NOT COMPLETED|Overall Study||3
893878|NCT01854697|2160784|P3|NOT COMPLETED|Overall Study||2
893879|NCT01854697|2160785|P2|NOT COMPLETED|Overall Study||3
893880|NCT01854697|2160786|P1|NOT COMPLETED|Overall Study||6
893881|NCT01854697|2160782|P5|COMPLETED|Overall Study||39
893882|NCT01854697|2160783|P4|COMPLETED|Overall Study||80
893883|NCT01854697|2160784|P3|COMPLETED|Overall Study||82
893884|NCT01854697|2160785|P2|COMPLETED|Overall Study||31
893885|NCT01854697|2160786|P1|COMPLETED|Overall Study||63
893886|NCT01854697|2160782|P5|STARTED|Overall Study||41
893887|NCT01854697|2160783|P4|STARTED|Overall Study||83
893888|NCT01854697|2160784|P3|STARTED|Overall Study||84
893889|NCT01854697|2160785|P2|STARTED|Overall Study||34
893890|NCT01854697|2160786|P1|STARTED|Overall Study||69
893891|NCT01854658|2160830|P4|NOT COMPLETED|Overall Study||59
893892|NCT01854658|2160831|P3|NOT COMPLETED|Overall Study||80
893893|NCT01854658|2160832|P2|NOT COMPLETED|Overall Study||75
893894|NCT01854658|2160833|P1|NOT COMPLETED|Overall Study||93
893895|NCT01854658|2160830|P4|COMPLETED|Overall Study||165
893896|NCT01854658|2160831|P3|COMPLETED|Overall Study||432
893897|NCT01854658|2160832|P2|COMPLETED|Overall Study||365
893898|NCT01854658|2160833|P1|COMPLETED|Overall Study||346
893899|NCT01854658|2160830|P4|STARTED|Overall Study||224
893900|NCT01854658|2160831|P3|STARTED|Overall Study||512
893901|NCT01854658|2160832|P2|STARTED|Overall Study||440
893902|NCT01854658|2160833|P1|STARTED|Overall Study||439
893903|NCT01854645|2160868|P5|NOT COMPLETED|Overall Study||60
893904|NCT01854645|2160869|P4|NOT COMPLETED|Overall Study||62
893905|NCT01854645|2160870|P3|NOT COMPLETED|Overall Study||82
893906|NCT01854645|2160871|P2|NOT COMPLETED|Overall Study||106
893907|NCT01854645|2160872|P1|NOT COMPLETED|Overall Study||98
893908|NCT01854645|2160868|P5|COMPLETED|Overall Study||160
893909|NCT01854645|2160869|P4|COMPLETED|Overall Study||391
893910|NCT01854645|2160870|P3|COMPLETED|Overall Study||370
893911|NCT01854645|2160871|P2|COMPLETED|Overall Study||345
893912|NCT01854645|2160872|P1|COMPLETED|Overall Study||429
893913|NCT01854645|2160868|P5|STARTED|Overall Study||220
893914|NCT01854645|2160869|P4|STARTED|Overall Study||453
893915|NCT01854645|2160870|P3|STARTED|Overall Study||452
893916|NCT01854645|2160871|P2|STARTED|Overall Study||451
893917|NCT01854645|2160872|P1|STARTED|Overall Study||527
893918|NCT01854632|2160911|P2|NOT COMPLETED|Overall Study||13
893919|NCT01854632|2160912|P1|NOT COMPLETED|Overall Study||26
893920|NCT01854632|2160911|P2|COMPLETED|Overall Study||574
893921|NCT01854632|2160912|P1|COMPLETED|Overall Study||1148
893922|NCT01854632|2160911|P2|STARTED|Overall Study||587
893923|NCT01854632|2160912|P1|STARTED|Overall Study||1174
893924|NCT01854593|2160920|P2|NOT COMPLETED|Overall Study||1
893925|NCT01854593|2160921|P1|NOT COMPLETED|Overall Study||2
893926|NCT01854593|2160920|P2|COMPLETED|Overall Study||34
893927|NCT01854593|2160921|P1|COMPLETED|Overall Study||32
893928|NCT01854593|2160920|P2|STARTED|Overall Study||35
893929|NCT01854593|2160921|P1|STARTED|Overall Study||34
893930|NCT01854528|2160953|P2|NOT COMPLETED|Overall Study||15
893931|NCT01854528|2160954|P1|NOT COMPLETED|Overall Study||0
893932|NCT01854528|2160953|P2|COMPLETED|Overall Study||32
893933|NCT01854528|2160954|P1|COMPLETED|Overall Study||101
893934|NCT01854528|2160953|P2|STARTED|Overall Study||47
893935|NCT01854528|2160954|P1|STARTED|Overall Study||101
893936|NCT01854281|2160974|P4|NOT COMPLETED|Overall Study||0
893937|NCT01854281|2160975|P3|NOT COMPLETED|Overall Study||0
893938|NCT01854281|2160976|P2|NOT COMPLETED|Overall Study||0
893939|NCT01854281|2160977|P1|NOT COMPLETED|Overall Study||0
893940|NCT01854281|2160974|P4|COMPLETED|Overall Study||8
893941|NCT01854281|2160975|P3|COMPLETED|Overall Study||5
893942|NCT01854281|2160976|P2|COMPLETED|Overall Study||19
893943|NCT01854281|2160977|P1|COMPLETED|Overall Study||15
893944|NCT01854281|2160974|P4|STARTED|Overall Study||8
893945|NCT01854281|2160975|P3|STARTED|Overall Study||5
893946|NCT01854281|2160976|P2|STARTED|Overall Study||19
893947|NCT01854281|2160977|P1|STARTED|Overall Study||15
893948|NCT01854268|2160987|P1|NOT COMPLETED|Overall Study||0
893949|NCT01854268|2160987|P1|COMPLETED|Overall Study||25
893950|NCT01854268|2160987|P1|STARTED|Overall Study||25
893951|NCT01854242|2160993|P1|NOT COMPLETED|Overall Study||0
893952|NCT01854242|2160993|P1|COMPLETED|Overall Study||50
893953|NCT01854242|2160993|P1|STARTED|Overall Study||50
893954|NCT01854047|2161002|P5|NOT COMPLETED|Overall Study||19
893955|NCT01854047|2161003|P4|NOT COMPLETED|Overall Study||15
893956|NCT01854047|2161004|P3|NOT COMPLETED|Overall Study||13
893957|NCT01854047|2161005|P2|NOT COMPLETED|Overall Study||8
893958|NCT01854047|2161006|P1|NOT COMPLETED|Overall Study||12
893959|NCT01854047|2161002|P5|COMPLETED|Overall Study||135
893960|NCT01854047|2161003|P4|COMPLETED|Overall Study||142
893961|NCT01854047|2161004|P3|COMPLETED|Overall Study||137
893962|NCT01854047|2161005|P2|COMPLETED|Overall Study||149
893963|NCT01854047|2161006|P1|COMPLETED|Overall Study||146
893964|NCT01854047|2161002|P5|Completed 12-week Study Treatment|Overall Study||143
893965|NCT01854047|2161003|P4|Completed 12-week Study Treatment|Overall Study||146
893966|NCT01854047|2161004|P3|Completed 12-week Study Treatment|Overall Study||141
893967|NCT01854047|2161005|P2|Completed 12-week Study Treatment|Overall Study||149
893968|NCT01854047|2161006|P1|Completed 12-week Study Treatment|Overall Study||153
893969|NCT01854047|2161002|P5|Treated|Overall Study||150
893970|NCT01854047|2161003|P4|Treated|Overall Study||157
893971|NCT01854047|2161004|P3|Treated|Overall Study||148
893972|NCT01854047|2161005|P2|Treated|Overall Study||156
893973|NCT01854047|2161006|P1|Treated|Overall Study||158
893974|NCT01854047|2161002|P5|STARTED|Overall Study||154
893975|NCT01854047|2161003|P4|STARTED|Overall Study||157
893976|NCT01854047|2161004|P3|STARTED|Overall Study||150
893977|NCT01854047|2161005|P2|STARTED|Overall Study||157
893978|NCT01854047|2161006|P1|STARTED|Overall Study||158
893979|NCT01853982|2161130|P2|NOT COMPLETED|Overall Study||1
893980|NCT01853982|2161131|P1|NOT COMPLETED|Overall Study||2
893981|NCT01853982|2161130|P2|COMPLETED|Overall Study||1
893982|NCT01853982|2161131|P1|COMPLETED|Overall Study||0
893983|NCT01853982|2161130|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
893984|NCT01853982|2161131|P1|Received at Least 1 Dose of Study Drug|Overall Study||2
893985|NCT01853982|2161130|P2|STARTED|Overall Study||2
893986|NCT01853982|2161131|P1|STARTED|Overall Study||2
893987|NCT01853839|2161137|P1|NOT COMPLETED|Overall Study||429
893988|NCT01853839|2161137|P1|COMPLETED|Overall Study||1663
893989|NCT01853839|2161137|P1|STARTED|Overall Study||2092
893990|NCT01853696|2161159|P2|NOT COMPLETED|Overall Study||5
893991|NCT01853696|2161160|P1|NOT COMPLETED|Overall Study||6
893992|NCT01853696|2161159|P2|COMPLETED|Overall Study||78
893993|NCT01853696|2161160|P1|COMPLETED|Overall Study||78
893994|NCT01853696|2161159|P2|STARTED|Overall Study||83
893995|NCT01853696|2161160|P1|STARTED|Overall Study||84
893996|NCT01853605|2161172|P4|NOT COMPLETED|Overall Study||0
893997|NCT01853605|2161173|P3|NOT COMPLETED|Overall Study||0
893998|NCT01853605|2161174|P2|NOT COMPLETED|Overall Study||0
893999|NCT01853605|2161175|P1|NOT COMPLETED|Overall Study||0
894000|NCT01853605|2161172|P4|COMPLETED|Overall Study||428
894001|NCT01853605|2161173|P3|COMPLETED|Overall Study||751
894002|NCT01853605|2161174|P2|COMPLETED|Overall Study||693
894003|NCT01853605|2161175|P1|COMPLETED|Overall Study||1939
894004|NCT01853605|2161172|P4|STARTED|Overall Study||428
894005|NCT01853605|2161173|P3|STARTED|Overall Study||751
894006|NCT01853605|2161174|P2|STARTED|Overall Study||693
894007|NCT01853605|2161175|P1|STARTED|Overall Study||1939
894008|NCT01853475|2161196|P3|NOT COMPLETED|Overall Study||0
894009|NCT01853475|2161197|P2|NOT COMPLETED|Overall Study||1
894010|NCT01853475|2161198|P1|NOT COMPLETED|Overall Study||0
894011|NCT01853475|2161196|P3|COMPLETED|Overall Study||8
894012|NCT01853475|2161197|P2|COMPLETED|Overall Study||7
894013|NCT01853475|2161198|P1|COMPLETED|Overall Study||8
894014|NCT01853475|2161196|P3|STARTED|Overall Study||8
894015|NCT01853475|2161197|P2|STARTED|Overall Study||8
894016|NCT01853475|2161198|P1|STARTED|Overall Study||8
894017|NCT01853397|2161219|P4|NOT COMPLETED|Overall Study||2
894018|NCT01853397|2161220|P3|NOT COMPLETED|Overall Study||0
894019|NCT01853397|2161221|P2|NOT COMPLETED|Overall Study||0
894020|NCT01853397|2161222|P1|NOT COMPLETED|Overall Study||0
894021|NCT01853397|2161219|P4|COMPLETED|Overall Study||15
894022|NCT01853397|2161220|P3|COMPLETED|Overall Study||17
894023|NCT01853397|2161221|P2|COMPLETED|Overall Study||20
894024|NCT01853397|2161222|P1|COMPLETED|Overall Study||18
894025|NCT01853397|2161219|P4|STARTED|Overall Study||17
894026|NCT01853397|2161220|P3|STARTED|Overall Study||17
894027|NCT01853397|2161221|P2|STARTED|Overall Study||20
894028|NCT01853397|2161222|P1|STARTED|Overall Study||18
894029|NCT01853384|2161250|P2|NOT COMPLETED|Completed Follow up Visit 2||3
894030|NCT01853384|2161251|P1|NOT COMPLETED|Completed Follow up Visit 2||3
894031|NCT01853384|2161250|P2|COMPLETED|Completed Follow up Visit 2||91
894032|NCT01853384|2161251|P1|COMPLETED|Completed Follow up Visit 2||93
894033|NCT01853384|2161250|P2|STARTED|Completed Follow up Visit 2||94
894034|NCT01853384|2161251|P1|STARTED|Completed Follow up Visit 2||96
894035|NCT01853384|2161250|P2|NOT COMPLETED|Completed Follow up Visit 1||9
894036|NCT01853384|2161251|P1|NOT COMPLETED|Completed Follow up Visit 1||14
894037|NCT01853384|2161250|P2|COMPLETED|Completed Follow up Visit 1||85
894038|NCT01853384|2161251|P1|COMPLETED|Completed Follow up Visit 1||82
894039|NCT01853384|2161250|P2|STARTED|Completed Follow up Visit 1||94
894040|NCT01853384|2161251|P1|STARTED|Completed Follow up Visit 1||96
894041|NCT01853384|2161250|P2|NOT COMPLETED|Enrolled in Follow up Period||0
894042|NCT01853384|2161251|P1|NOT COMPLETED|Enrolled in Follow up Period||0
894043|NCT01853384|2161250|P2|COMPLETED|Enrolled in Follow up Period||94
894044|NCT01853384|2161251|P1|COMPLETED|Enrolled in Follow up Period||96
894045|NCT01853384|2161250|P2|Not Enrolled in Follow-up|Enrolled in Follow up Period||27
894046|NCT01853384|2161251|P1|Not Enrolled in Follow-up|Enrolled in Follow up Period||35
894047|NCT01853384|2161250|P2|STARTED|Enrolled in Follow up Period||94
894048|NCT01853384|2161251|P1|STARTED|Enrolled in Follow up Period||96
894049|NCT01853384|2161250|P2|NOT COMPLETED|Randomized||46
894050|NCT01853384|2161251|P1|NOT COMPLETED|Randomized||62
894051|NCT01853384|2161250|P2|COMPLETED|Randomized||75
894052|NCT01853384|2161251|P1|COMPLETED|Randomized||69
894053|NCT01853384|2161250|P2|STARTED|Randomized||121
894054|NCT01853384|2161251|P1|STARTED|Randomized||131
894055|NCT01853371|2161271|P2|NOT COMPLETED|Overall Study||2
894056|NCT01853371|2161272|P1|NOT COMPLETED|Overall Study||0
894057|NCT01853371|2161271|P2|COMPLETED|Overall Study||8
894058|NCT01853371|2161272|P1|COMPLETED|Overall Study||10
894059|NCT01853371|2161271|P2|STARTED|Overall Study||10
894060|NCT01853371|2161272|P1|STARTED|Overall Study||10
894061|NCT01853332|2161280|P1|NOT COMPLETED|Overall Study||59
894062|NCT01853332|2161280|P1|COMPLETED|Overall Study||151
894063|NCT01853332|2161280|P1|STARTED|Overall Study||210
894064|NCT01853254|2161289|P1|NOT COMPLETED|Overall Study||104
894065|NCT01853254|2161289|P1|COMPLETED|Overall Study||168
894066|NCT01853254|2161289|P1|STARTED|Overall Study||272
894067|NCT01853215|2161293|P1|NOT COMPLETED|Overall Study||0
894068|NCT01853215|2161293|P1|COMPLETED|Overall Study||24
894069|NCT01853215|2161293|P1|STARTED|Overall Study||24
894070|NCT01853176|2161306|P2|NOT COMPLETED|Overall Study||0
894071|NCT01853176|2161307|P1|NOT COMPLETED|Overall Study||4
894072|NCT01853176|2161306|P2|COMPLETED|Overall Study||0
894073|NCT01853176|2161307|P1|COMPLETED|Overall Study||0
894074|NCT01853176|2161306|P2|STARTED|Overall Study||0
894075|NCT01853176|2161307|P1|STARTED|Overall Study||4
894076|NCT01853085|2161313|P1|NOT COMPLETED|Overall Study||235
894077|NCT01853085|2161313|P1|COMPLETED|Overall Study||1595
894078|NCT01853085|2161313|P1|STARTED|Overall Study||1830
894079|NCT01853072|2161326|P2|NOT COMPLETED|Overall Study||21
894080|NCT01853072|2161327|P1|NOT COMPLETED|Overall Study||12
894081|NCT01853072|2161326|P2|COMPLETED|Overall Study||286
894082|NCT01853072|2161327|P1|COMPLETED|Overall Study||296
894083|NCT01853072|2161326|P2|Full Analysis Set|Overall Study||300
894084|NCT01853072|2161327|P1|Full Analysis Set|Overall Study||298
894085|NCT01853072|2161326|P2|Treated (Safety Analysis Set)|Overall Study||302
894086|NCT01853072|2161327|P1|Treated (Safety Analysis Set)|Overall Study||301
894087|NCT01853072|2161326|P2|Randomized|Overall Study||307
894088|NCT01853072|2161327|P1|Randomized|Overall Study||308
894089|NCT01853072|2161326|P2|STARTED|Overall Study||307
894090|NCT01853072|2161327|P1|STARTED|Overall Study||308
894091|NCT01853046|2161347|P2|NOT COMPLETED|Overall Study||6
894092|NCT01853046|2161348|P1|NOT COMPLETED|Overall Study||18
894093|NCT01853046|2161347|P2|COMPLETED|Overall Study||0
894094|NCT01853046|2161348|P1|COMPLETED|Overall Study||0
894095|NCT01853046|2161347|P2|Received Treatment|Overall Study||6
894096|NCT01853046|2161348|P1|Received Treatment|Overall Study||18
894097|NCT01853046|2161347|P2|STARTED|Overall Study||6
894098|NCT01853046|2161348|P1|STARTED|Overall Study||18
894099|NCT01852955|2161402|P2|NOT COMPLETED|Overall Study||3
894100|NCT01852955|2161403|P1|NOT COMPLETED|Overall Study||2
894101|NCT01852955|2161402|P2|COMPLETED|Overall Study||32
894102|NCT01852955|2161403|P1|COMPLETED|Overall Study||33
894103|NCT01852955|2161402|P2|STARTED|Overall Study||35
894104|NCT01852955|2161403|P1|STARTED|Overall Study||35
894105|NCT01852825|2161416|P3|NOT COMPLETED|Overall Study||0
894106|NCT01852825|2161417|P2|NOT COMPLETED|Overall Study||0
894107|NCT01852825|2161418|P1|NOT COMPLETED|Overall Study||2
894108|NCT01852825|2161416|P3|COMPLETED|Overall Study||3
894109|NCT01852825|2161417|P2|COMPLETED|Overall Study||7
894110|NCT01852825|2161418|P1|COMPLETED|Overall Study||14
894111|NCT01852825|2161416|P3|STARTED|Overall Study||3
894112|NCT01852825|2161417|P2|STARTED|Overall Study||7
894113|NCT01852825|2161418|P1|STARTED|Overall Study||16
894114|NCT01852812|2161444|P3|NOT COMPLETED|Overall Study||1
894115|NCT01852812|2161445|P2|NOT COMPLETED|Overall Study||1
894116|NCT01852812|2161446|P1|NOT COMPLETED|Overall Study||0
894117|NCT01852812|2161444|P3|COMPLETED|Overall Study||17
894118|NCT01852812|2161445|P2|COMPLETED|Overall Study||17
894119|NCT01852812|2161446|P1|COMPLETED|Overall Study||51
894120|NCT01852812|2161444|P3|STARTED|Overall Study||18
894121|NCT01852812|2161445|P2|STARTED|Overall Study||18
894122|NCT01852812|2161446|P1|STARTED|Overall Study||51
894123|NCT01852669|2161468|P2|NOT COMPLETED|Overall Study||1
894124|NCT01852669|2161469|P1|NOT COMPLETED|Overall Study||0
894125|NCT01852669|2161468|P2|COMPLETED|Overall Study|Randomisation error. Patient has protocol violation which necessitated exclusion from analysis|68
894126|NCT01852669|2161469|P1|COMPLETED|Overall Study||71
894127|NCT01852669|2161468|P2|STARTED|Overall Study||69
894128|NCT01852669|2161469|P1|STARTED|Overall Study||71
894129|NCT01852591|2161475|P1|NOT COMPLETED|Overall Study||3
894130|NCT01852591|2161475|P1|COMPLETED|Overall Study||5
894131|NCT01852591|2161475|P1|STARTED|Overall Study||8
894132|NCT01852383|2161482|P1|NOT COMPLETED|Overall Study||11
894133|NCT01852383|2161482|P1|COMPLETED|Overall Study||19
894134|NCT01852383|2161482|P1|STARTED|Overall Study||30
894135|NCT01852214|2161489|P2|NOT COMPLETED|Period 2||0
894136|NCT01852214|2161490|P1|NOT COMPLETED|Period 2||0
894137|NCT01852214|2161489|P2|COMPLETED|Period 2||20
894138|NCT01852214|2161490|P1|COMPLETED|Period 2||25
894139|NCT01852214|2161489|P2|STARTED|Period 2||20
894140|NCT01852214|2161490|P1|STARTED|Period 2||25
894141|NCT01852214|2161489|P2|NOT COMPLETED|Washout Period||1
894142|NCT01852214|2161490|P1|NOT COMPLETED|Washout Period||0
894143|NCT01852214|2161489|P2|COMPLETED|Washout Period||20
894144|NCT01852214|2161490|P1|COMPLETED|Washout Period||25
894145|NCT01852214|2161489|P2|STARTED|Washout Period||21
894146|NCT01852214|2161490|P1|STARTED|Washout Period||25
894147|NCT01852214|2161489|P2|NOT COMPLETED|Period 1||3
894148|NCT01852214|2161490|P1|NOT COMPLETED|Period 1||1
894149|NCT01852214|2161489|P2|COMPLETED|Period 1||21
894150|NCT01852214|2161490|P1|COMPLETED|Period 1||25
894151|NCT01852214|2161489|P2|STARTED|Period 1||24
894152|NCT01852214|2161490|P1|STARTED|Period 1||26
894153|NCT01852175|2161504|P2|NOT COMPLETED|Overall Study||0
894154|NCT01852175|2161505|P1|NOT COMPLETED|Overall Study||0
894155|NCT01852175|2161504|P2|COMPLETED|Overall Study||55
894156|NCT01852175|2161505|P1|COMPLETED|Overall Study||55
894157|NCT01852175|2161504|P2|STARTED|Overall Study||55
894158|NCT01852175|2161505|P1|STARTED|Overall Study||55
894159|NCT01852162|2161517|P2|NOT COMPLETED|Overall Study||1
894160|NCT01852162|2161518|P1|NOT COMPLETED|Overall Study||4
894161|NCT01852162|2161517|P2|COMPLETED|Overall Study||16
894162|NCT01852162|2161518|P1|COMPLETED|Overall Study||14
894163|NCT01852162|2161517|P2|STARTED|Overall Study||17
894164|NCT01852162|2161518|P1|STARTED|Overall Study||18
894165|NCT01852019|2161534|P5|NOT COMPLETED|Day 8||0
894166|NCT01852019|2161535|P4|NOT COMPLETED|Day 8||0
894167|NCT01852019|2161536|P3|NOT COMPLETED|Day 8||0
894168|NCT01852019|2161537|P2|NOT COMPLETED|Day 8||0
894169|NCT01852019|2161538|P1|NOT COMPLETED|Day 8||0
894170|NCT01852019|2161534|P5|COMPLETED|Day 8||6
894171|NCT01852019|2161535|P4|COMPLETED|Day 8||6
894172|NCT01852019|2161536|P3|COMPLETED|Day 8||0
894173|NCT01852019|2161537|P2|COMPLETED|Day 8||0
894174|NCT01852019|2161538|P1|COMPLETED|Day 8||0
894175|NCT01852019|2161534|P5|STARTED|Day 8||6
894176|NCT01852019|2161535|P4|STARTED|Day 8||6
894177|NCT01852019|2161536|P3|STARTED|Day 8||0
894178|NCT01852019|2161537|P2|STARTED|Day 8||0
894179|NCT01852019|2161538|P1|STARTED|Day 8||0
894180|NCT01852019|2161534|P5|NOT COMPLETED|Day 1||0
894181|NCT01852019|2161535|P4|NOT COMPLETED|Day 1||0
894182|NCT01852019|2161536|P3|NOT COMPLETED|Day 1||0
894183|NCT01852019|2161537|P2|NOT COMPLETED|Day 1||0
894184|NCT01852019|2161538|P1|NOT COMPLETED|Day 1||0
894185|NCT01852019|2161534|P5|COMPLETED|Day 1||0
894186|NCT01852019|2161535|P4|COMPLETED|Day 1||0
894187|NCT01852019|2161536|P3|COMPLETED|Day 1||6
894188|NCT01852019|2161537|P2|COMPLETED|Day 1||3
894189|NCT01852019|2161538|P1|COMPLETED|Day 1||3
894190|NCT01852019|2161534|P5|STARTED|Day 1||0
894191|NCT01852019|2161535|P4|STARTED|Day 1||0
894192|NCT01852019|2161536|P3|STARTED|Day 1||6
894193|NCT01852019|2161537|P2|STARTED|Day 1||3
894194|NCT01852019|2161538|P1|STARTED|Day 1||3
894195|NCT01851876|2161559|P2|NOT COMPLETED|Overall Study||0
894196|NCT01851876|2161560|P1|NOT COMPLETED|Overall Study||0
894197|NCT01851876|2161559|P2|COMPLETED|Overall Study||62
894198|NCT01851876|2161560|P1|COMPLETED|Overall Study||56
894199|NCT01851876|2161559|P2|STARTED|Overall Study||62
894200|NCT01851876|2161560|P1|STARTED|Overall Study||56
894201|NCT01851863|2161570|P4|NOT COMPLETED|Overall Study||3
894202|NCT01851863|2161571|P3|NOT COMPLETED|Overall Study||5
894203|NCT01851863|2161572|P2|NOT COMPLETED|Overall Study||9
894204|NCT01851863|2161573|P1|NOT COMPLETED|Overall Study||5
894205|NCT01851863|2161570|P4|COMPLETED|Overall Study||63
894206|NCT01851863|2161571|P3|COMPLETED|Overall Study||60
894207|NCT01851863|2161572|P2|COMPLETED|Overall Study||57
894208|NCT01851863|2161573|P1|COMPLETED|Overall Study||60
894209|NCT01851863|2161570|P4|STARTED|Overall Study||66
894210|NCT01851863|2161571|P3|STARTED|Overall Study||65
894211|NCT01851863|2161572|P2|STARTED|Overall Study||66
894212|NCT01851863|2161573|P1|STARTED|Overall Study||65
894213|NCT01851772|2161594|P1|NOT COMPLETED|Overall Study||0
894214|NCT01851772|2161594|P1|COMPLETED|Overall Study||3
894215|NCT01851772|2161594|P1|STARTED|Overall Study||3
894216|NCT01851720|2161602|P2|NOT COMPLETED|Overall Study||1
894217|NCT01851720|2161603|P1|NOT COMPLETED|Overall Study||0
894218|NCT01851720|2161602|P2|COMPLETED|Overall Study||0
894219|NCT01851720|2161603|P1|COMPLETED|Overall Study||0
894220|NCT01851720|2161602|P2|STARTED|Overall Study||1
894221|NCT01851720|2161603|P1|STARTED|Overall Study||0
894222|NCT01851655|2161611|P2|NOT COMPLETED|Overall Study||0
894223|NCT01851655|2161612|P1|NOT COMPLETED|Overall Study||0
894224|NCT01851655|2161611|P2|COMPLETED|Overall Study||12
894225|NCT01851655|2161612|P1|COMPLETED|Overall Study||12
894226|NCT01851655|2161611|P2|STARTED|Overall Study||12
894227|NCT01851655|2161612|P1|STARTED|Overall Study||12
894228|NCT01851590|2161633|P3|NOT COMPLETED|Overall Study||3
894229|NCT01851590|2161634|P2|NOT COMPLETED|Overall Study||1
894230|NCT01851590|2161635|P1|NOT COMPLETED|Overall Study||0
894231|NCT01851590|2161633|P3|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|22
894232|NCT01851590|2161634|P2|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|24
894233|NCT01851590|2161635|P1|COMPLETED|Overall Study|All patients (23) were included in the ITT population and final outcome analyses.|23
894234|NCT01851590|2161633|P3|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|22
894235|NCT01851590|2161634|P2|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|24
894236|NCT01851590|2161635|P1|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|23
894237|NCT01851590|2161633|P3|At 9 Month: End of Topical Treatments|Overall Study|Washout period of the Terbinafine treatment arm continues.|22
894238|NCT01851590|2161634|P2|At 9 Month: End of Topical Treatments|Overall Study|End of topical Amorolfine Lacquer treatment. Washout period of the Amorolfine treatment arm begins.|24
894239|NCT01851590|2161635|P1|At 9 Month: End of Topical Treatments|Overall Study|End of topical Resin Lacquer treatment. Washout period of the Resin Lacquer treatment arm begins.|23
894240|NCT01851590|2161633|P3|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|22
894241|NCT01851590|2161634|P2|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|24
894242|NCT01851590|2161635|P1|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|23
894243|NCT01851590|2161633|P3|At 3 Month: End of Terbinafine Treatment|Overall Study|End of oral Terbinafine treatment. Washout period of the Terbinafine treatment arm begins.|22
894244|NCT01851590|2161634|P2|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Amorolfine Lacquer Treatment continues ->|24
894245|NCT01851590|2161635|P1|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Resin Lacquer treatment continues ->|23
894246|NCT01851590|2161633|P3|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
894247|NCT01851590|2161634|P2|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
894248|NCT01851590|2161635|P1|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|23
894249|NCT01851330|2161658|P3|NOT COMPLETED|Overall Study||12
894250|NCT01851330|2161659|P2|NOT COMPLETED|Overall Study||16
894251|NCT01851330|2161660|P1|NOT COMPLETED|Overall Study||13
894252|NCT01851330|2161658|P3|COMPLETED|Overall Study||204
894253|NCT01851330|2161659|P2|COMPLETED|Overall Study||200
894254|NCT01851330|2161660|P1|COMPLETED|Overall Study||202
894255|NCT01851330|2161658|P3|STARTED|Overall Study||216
894256|NCT01851330|2161659|P2|STARTED|Overall Study||216
894257|NCT01851330|2161660|P1|STARTED|Overall Study||215
894258|NCT01850589|2161697|P2|NOT COMPLETED|Overall Study||0
894259|NCT01850589|2161698|P1|NOT COMPLETED|Overall Study||8
894260|NCT01850589|2161697|P2|COMPLETED|Overall Study||22
894261|NCT01850589|2161698|P1|COMPLETED|Overall Study||14
894262|NCT01850589|2161697|P2|STARTED|Overall Study||22
894263|NCT01850589|2161698|P1|STARTED|Overall Study||22
894264|NCT01850550|2161706|P2|NOT COMPLETED|Overall Study||3
894265|NCT01850550|2161707|P1|NOT COMPLETED|Overall Study||0
894266|NCT01850550|2161706|P2|COMPLETED|Overall Study||37
894267|NCT01850550|2161707|P1|COMPLETED|Overall Study||40
894268|NCT01850550|2161706|P2|STARTED|Overall Study||40
894269|NCT01850550|2161707|P1|STARTED|Overall Study||40
894270|NCT01850485|2161717|P2|NOT COMPLETED|Overall Study||0
894271|NCT01850485|2161718|P1|NOT COMPLETED|Overall Study||0
894272|NCT01850485|2161717|P2|COMPLETED|Overall Study||13
894273|NCT01850485|2161718|P1|COMPLETED|Overall Study||9
894274|NCT01850485|2161717|P2|STARTED|Overall Study||13
894275|NCT01850485|2161718|P1|STARTED|Overall Study||9
894276|NCT01850394|2161739|P3|NOT COMPLETED|Overall Study||0
894277|NCT01850394|2161740|P2|NOT COMPLETED|Overall Study||0
894278|NCT01850394|2161741|P1|NOT COMPLETED|Overall Study||0
894279|NCT01850394|2161739|P3|COMPLETED|Overall Study||45
894280|NCT01850394|2161740|P2|COMPLETED|Overall Study||45
894281|NCT01850394|2161741|P1|COMPLETED|Overall Study||45
894282|NCT01850394|2161739|P3|STARTED|Overall Study||45
894283|NCT01850394|2161740|P2|STARTED|Overall Study||45
894284|NCT01850394|2161741|P1|STARTED|Overall Study||45
894285|NCT01849848|2161761|P1|NOT COMPLETED|Overall Study||4
894286|NCT01849848|2161761|P1|COMPLETED|Overall Study||13
894287|NCT01849848|2161761|P1|STARTED|Overall Study||17
894288|NCT01849770|2161778|P3|NOT COMPLETED|Overall Study||1
894289|NCT01849770|2161779|P2|NOT COMPLETED|Overall Study||4
894290|NCT01849770|2161780|P1|NOT COMPLETED|Overall Study||0
894291|NCT01849770|2161778|P3|COMPLETED|Overall Study||19
894292|NCT01849770|2161779|P2|COMPLETED|Overall Study||15
894293|NCT01849770|2161780|P1|COMPLETED|Overall Study||20
894294|NCT01849770|2161778|P3|STARTED|Overall Study||20
894295|NCT01849770|2161779|P2|STARTED|Overall Study||19
894296|NCT01849770|2161780|P1|STARTED|Overall Study||20
894297|NCT01849692|2161823|P8|NOT COMPLETED|Overall Study||0
894298|NCT01849692|2161824|P7|NOT COMPLETED|Overall Study||0
894299|NCT01849692|2161825|P6|NOT COMPLETED|Overall Study||0
894300|NCT01849692|2161826|P5|NOT COMPLETED|Overall Study||0
894301|NCT01849692|2161827|P4|NOT COMPLETED|Overall Study||0
894302|NCT01849692|2161828|P3|NOT COMPLETED|Overall Study||0
894303|NCT01849692|2161829|P2|NOT COMPLETED|Overall Study||0
894304|NCT01849692|2161830|P1|NOT COMPLETED|Overall Study||0
894305|NCT01849692|2161823|P8|COMPLETED|Overall Study||3
894306|NCT01849692|2161824|P7|COMPLETED|Overall Study||10
894307|NCT01849692|2161825|P6|COMPLETED|Overall Study||3
894308|NCT01849692|2161826|P5|COMPLETED|Overall Study||10
894309|NCT01849692|2161827|P4|COMPLETED|Overall Study||3
894310|NCT01849692|2161828|P3|COMPLETED|Overall Study||10
894311|NCT01849692|2161829|P2|COMPLETED|Overall Study||3
894312|NCT01849692|2161830|P1|COMPLETED|Overall Study||10
894313|NCT01849692|2161823|P8|STARTED|Overall Study||3
894314|NCT01849692|2161824|P7|STARTED|Overall Study||10
894315|NCT01849692|2161825|P6|STARTED|Overall Study||3
894316|NCT01849692|2161826|P5|STARTED|Overall Study||10
894317|NCT01849692|2161827|P4|STARTED|Overall Study||3
894318|NCT01849692|2161828|P3|STARTED|Overall Study||10
894319|NCT01849692|2161829|P2|STARTED|Overall Study||3
894320|NCT01849692|2161830|P1|STARTED|Overall Study||10
894321|NCT01849588|2161859|P1|NOT COMPLETED|Overall Study||3
894322|NCT01849588|2161859|P1|COMPLETED|Overall Study||0
894323|NCT01849588|2161859|P1|STARTED|Overall Study||3
894324|NCT01849562|2161869|P3|NOT COMPLETED|Overall Study||0
894325|NCT01849562|2161870|P2|NOT COMPLETED|Overall Study||0
894326|NCT01849562|2161871|P1|NOT COMPLETED|Overall Study||2
894327|NCT01849562|2161869|P3|COMPLETED|Overall Study||10
894328|NCT01849562|2161870|P2|COMPLETED|Overall Study||10
894329|NCT01849562|2161871|P1|COMPLETED|Overall Study||8
894330|NCT01849562|2161869|P3|STARTED|Overall Study||10
894331|NCT01849562|2161870|P2|STARTED|Overall Study||10
894332|NCT01849562|2161871|P1|STARTED|Overall Study||10
894333|NCT01849497|2161884|P2|NOT COMPLETED|Overall Study||4
894334|NCT01849497|2161885|P1|NOT COMPLETED|Overall Study||1
894335|NCT01849497|2161884|P2|COMPLETED|Overall Study||70
894336|NCT01849497|2161885|P1|COMPLETED|Overall Study||74
894337|NCT01849497|2161884|P2|Received Treatment|Overall Study||74
894338|NCT01849497|2161885|P1|Received Treatment|Overall Study||75
894339|NCT01849497|2161884|P2|STARTED|Overall Study||74
894340|NCT01849497|2161885|P1|STARTED|Overall Study||75
894341|NCT01849458|2161893|P1|NOT COMPLETED|Overall Study||4
894342|NCT01849458|2161893|P1|COMPLETED|Overall Study||46
894343|NCT01849458|2161893|P1|6 Months Follow-up|Overall Study||50
894344|NCT01849458|2161893|P1|STARTED|Overall Study||50
894345|NCT01849419|2161903|P1|NOT COMPLETED|Overall Study||0
894346|NCT01849419|2161903|P1|COMPLETED|Overall Study||65
894347|NCT01849419|2161903|P1|STARTED|Overall Study||65
894348|NCT01849289|2161932|P2|NOT COMPLETED|Overall Study||24
894349|NCT01849289|2161933|P1|NOT COMPLETED|Overall Study||32
894350|NCT01849289|2161932|P2|COMPLETED|Overall Study||254
894351|NCT01849289|2161933|P1|COMPLETED|Overall Study||523
894352|NCT01849289|2161932|P2|Exposed|Overall Study||278
894353|NCT01849289|2161933|P1|Exposed|Overall Study|2 subjects withdrew prior to exposure of trial products|553
894354|NCT01849289|2161932|P2|STARTED|Overall Study||278
894355|NCT01849289|2161933|P1|STARTED|Overall Study||555
894356|NCT01849068|2161951|P2|NOT COMPLETED|Overall Study||0
894357|NCT01849068|2161952|P1|NOT COMPLETED|Overall Study||0
894358|NCT01849068|2161951|P2|COMPLETED|Overall Study||10
894359|NCT01849068|2161952|P1|COMPLETED|Overall Study||10
894360|NCT01849068|2161951|P2|STARTED|Overall Study||10
894361|NCT01849068|2161952|P1|STARTED|Overall Study||10
894362|NCT01848990|2161967|P3|NOT COMPLETED|Overall Study||11
894363|NCT01848990|2161968|P2|NOT COMPLETED|Overall Study||9
894364|NCT01848990|2161969|P1|NOT COMPLETED|Overall Study||33
894365|NCT01848990|2161967|P3|COMPLETED|Overall Study||103
894366|NCT01848990|2161968|P2|COMPLETED|Overall Study||106
894367|NCT01848990|2161969|P1|COMPLETED|Overall Study||194
894368|NCT01848990|2161967|P3|Received at Least 1 Dose of Study Drug|Overall Study||113
894369|NCT01848990|2161968|P2|Received at Least 1 Dose of Study Drug|Overall Study||115
894370|NCT01848990|2161969|P1|Received at Least 1 Dose of Study Drug|Overall Study||227
894371|NCT01848990|2161967|P3|STARTED|Overall Study|One participant was randomized and withdrew consent before start of study treatment.|114
894372|NCT01848990|2161968|P2|STARTED|Overall Study||115
894373|NCT01848990|2161969|P1|STARTED|Overall Study||227
894374|NCT01848977|2161984|P1|NOT COMPLETED|Overall Study||0
894375|NCT01848977|2161984|P1|COMPLETED|Overall Study||20
894376|NCT01848977|2161984|P1|STARTED|Overall Study||20
894377|NCT01848938|2161995|P2|NOT COMPLETED|Overall Study||1
894378|NCT01848938|2161996|P1|NOT COMPLETED|Overall Study||1
894379|NCT01848938|2161995|P2|COMPLETED|Overall Study||60
894380|NCT01848938|2161996|P1|COMPLETED|Overall Study||61
894381|NCT01848938|2161995|P2|STARTED|Overall Study||61
894382|NCT01848938|2161996|P1|STARTED|Overall Study||62
894383|NCT01848899|2162014|P2|NOT COMPLETED|Overall Study||0
894384|NCT01848899|2162015|P1|NOT COMPLETED|Overall Study||0
894385|NCT01848899|2162014|P2|COMPLETED|Overall Study||50
894386|NCT01848899|2162015|P1|COMPLETED|Overall Study||50
894387|NCT01848899|2162014|P2|STARTED|Overall Study||50
894388|NCT01848899|2162015|P1|STARTED|Overall Study||50
894389|NCT01848847|2162031|P2|NOT COMPLETED|Overall Study||3
894390|NCT01848847|2162032|P1|NOT COMPLETED|Overall Study||2
894391|NCT01848847|2162031|P2|COMPLETED|Overall Study||48
894392|NCT01848847|2162032|P1|COMPLETED|Overall Study||49
894393|NCT01848847|2162031|P2|STARTED|Overall Study||51
894394|NCT01848847|2162032|P1|STARTED|Overall Study||51
894395|NCT01848834|2162045|P5|NOT COMPLETED|Overall Study||132
894396|NCT01848834|2162046|P4|NOT COMPLETED|Overall Study||37
894397|NCT01848834|2162047|P3|NOT COMPLETED|Overall Study||32
894398|NCT01848834|2162048|P2|NOT COMPLETED|Overall Study||60
894399|NCT01848834|2162049|P1|NOT COMPLETED|Overall Study||30
894400|NCT01848834|2162045|P5|COMPLETED|Overall Study|Completed means two-year treatment completed|0
894401|NCT01848834|2162046|P4|COMPLETED|Overall Study|Completed means two-year treatment completed|2
894402|NCT01848834|2162047|P3|COMPLETED|Overall Study|Completed means two-year treatment completed|1
894403|NCT01848834|2162048|P2|COMPLETED|Overall Study|Completed means two-year treatment completed|1
894404|NCT01848834|2162049|P1|COMPLETED|Overall Study|Completed means two-year treatment completed|2
894405|NCT01848834|2162045|P5|Treated|Overall Study||132
894406|NCT01848834|2162046|P4|Treated|Overall Study||39
894407|NCT01848834|2162047|P3|Treated|Overall Study||33
894408|NCT01848834|2162048|P2|Treated|Overall Study||60
894409|NCT01848834|2162049|P1|Treated|Overall Study||32
894410|NCT01848834|2162045|P5|STARTED|Overall Study||132
894411|NCT01848834|2162046|P4|STARTED|Overall Study||39
894412|NCT01848834|2162047|P3|STARTED|Overall Study||33
894413|NCT01848834|2162048|P2|STARTED|Overall Study||61
894414|NCT01848834|2162049|P1|STARTED|Overall Study||32
894415|NCT01848756|2162084|P1|NOT COMPLETED|Overall Study||3
894416|NCT01848756|2162084|P1|COMPLETED|Overall Study|Cycle 1|12
894417|NCT01848756|2162084|P1|STARTED|Overall Study||15
894418|NCT01848366|2162094|P1|NOT COMPLETED|Overall Study||0
894419|NCT01848366|2162094|P1|COMPLETED|Overall Study||8
894420|NCT01848366|2162094|P1|STARTED|Overall Study||8
894421|NCT01848288|2162098|P1|NOT COMPLETED|Overall Study||3
894422|NCT01848288|2162098|P1|COMPLETED|Overall Study|Two subjects were discontinued prior to undergoing surgery.|97
894423|NCT01848288|2162098|P1|STARTED|Overall Study||100
894424|NCT01848210|2162109|P2|NOT COMPLETED|Overall Study||78
894425|NCT01848210|2162110|P1|NOT COMPLETED|Overall Study||88
894426|NCT01848210|2162109|P2|COMPLETED|Overall Study||340
894427|NCT01848210|2162110|P1|COMPLETED|Overall Study||323
894428|NCT01848210|2162109|P2|Per Protocol Population|Overall Study||245
894429|NCT01848210|2162110|P1|Per Protocol Population|Overall Study||222
894430|NCT01848210|2162109|P2|Intent-to-Treat (ITT) Population|Overall Study||388
894431|NCT01848210|2162110|P1|Intent-to-Treat (ITT) Population|Overall Study||383
894432|NCT01848210|2162109|P2|Safety Population-Received Study Drug|Overall Study||398
894433|NCT01848210|2162110|P1|Safety Population-Received Study Drug|Overall Study||394
894434|NCT01848210|2162109|P2|STARTED|Overall Study||418
894435|NCT01848210|2162110|P1|STARTED|Overall Study||411
894436|NCT01848145|2162122|P1|NOT COMPLETED|Subsequent Infusions: Weeks 3-8||10
894437|NCT01848145|2162122|P1|COMPLETED|Subsequent Infusions: Weeks 3-8||20
894438|NCT01848145|2162122|P1|STARTED|Subsequent Infusions: Weeks 3-8||30
894439|NCT01848145|2162122|P1|NOT COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||1
894440|NCT01848145|2162122|P1|COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||30
894441|NCT01848145|2162122|P1|Completed Within 15min of Infusion Time|Infusion 3: Week 2, Day 1 - 120 Minutes||26
894442|NCT01848145|2162122|P1|STARTED|Infusion 3: Week 2, Day 1 - 120 Minutes||31
894443|NCT01848145|2162122|P1|NOT COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes||2
894444|NCT01848145|2162122|P1|COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes|Includes participants that completed Infusion 2 and proceeded to the next infusion, Infusion 3.|31
894445|NCT01848145|2162122|P1|Completed Within 15min of Infusion Time|Infusion 2: Week 1, Day 3 - 167 Minutes||24
894446|NCT01848145|2162122|P1|STARTED|Infusion 2: Week 1, Day 3 - 167 Minutes||33
894447|NCT01848145|2162122|P1|NOT COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes||1
894448|NCT01848145|2162122|P1|COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes|Includes participants that completed Infusion 1 and proceeded to the next infusion, Infusion 2.|33
894449|NCT01848145|2162122|P1|Completed Within 15min of Infusion Time|Infusion 1: Week 1, Day 1 - 226 Minutes|Number of patients who completed within 15 minutes (min) of infusion time.|1
894450|NCT01848145|2162122|P1|STARTED|Infusion 1: Week 1, Day 1 - 226 Minutes||34
894451|NCT01848054|2162133|P2|NOT COMPLETED|Stabilization/Maintenance||40
894452|NCT01848054|2162134|P1|NOT COMPLETED|Stabilization/Maintenance||40
894453|NCT01848054|2162133|P2|COMPLETED|Stabilization/Maintenance||107
894454|NCT01848054|2162134|P1|COMPLETED|Stabilization/Maintenance||92
894455|NCT01848054|2162133|P2|STARTED|Stabilization/Maintenance||147
894456|NCT01848054|2162134|P1|STARTED|Stabilization/Maintenance||132
894457|NCT01848054|2162133|P2|NOT COMPLETED|Induction Phase||8
894458|NCT01848054|2162134|P1|NOT COMPLETED|Induction Phase||23
894459|NCT01848054|2162133|P2|COMPLETED|Induction Phase||147
894460|NCT01848054|2162134|P1|COMPLETED|Induction Phase||132
894461|NCT01848054|2162133|P2|STARTED|Induction Phase||155
894462|NCT01848054|2162134|P1|STARTED|Induction Phase||155
894463|NCT01847547|2162156|P2|NOT COMPLETED|Overall Study||0
894464|NCT01847547|2162157|P1|NOT COMPLETED|Overall Study||0
894465|NCT01847547|2162156|P2|COMPLETED|Overall Study||2991
894466|NCT01847547|2162157|P1|COMPLETED|Overall Study||2991
894467|NCT01847547|2162156|P2|STARTED|Overall Study||2991
894468|NCT01847547|2162157|P1|STARTED|Overall Study||2991
894469|NCT01847443|2162199|P4|NOT COMPLETED|Study Period 4||0
894470|NCT01847443|2162200|P3|NOT COMPLETED|Study Period 4||0
894471|NCT01847443|2162201|P2|NOT COMPLETED|Study Period 4||0
894472|NCT01847443|2162202|P1|NOT COMPLETED|Study Period 4||0
894473|NCT01847443|2162199|P4|COMPLETED|Study Period 4||21
894474|NCT01847443|2162200|P3|COMPLETED|Study Period 4||21
894475|NCT01847443|2162201|P2|COMPLETED|Study Period 4||19
894476|NCT01847443|2162202|P1|COMPLETED|Study Period 4||16
894477|NCT01847443|2162199|P4|STARTED|Study Period 4||21
894478|NCT01847443|2162200|P3|STARTED|Study Period 4||21
894479|NCT01847443|2162201|P2|STARTED|Study Period 4||19
894480|NCT01847443|2162202|P1|STARTED|Study Period 4||16
894481|NCT01847443|2162199|P4|NOT COMPLETED|Washout Period Before Study Period 4||0
894482|NCT01847443|2162200|P3|NOT COMPLETED|Washout Period Before Study Period 4||0
894483|NCT01847443|2162201|P2|NOT COMPLETED|Washout Period Before Study Period 4||0
894484|NCT01847443|2162202|P1|NOT COMPLETED|Washout Period Before Study Period 4||2
894485|NCT01847443|2162199|P4|COMPLETED|Washout Period Before Study Period 4||21
894486|NCT01847443|2162200|P3|COMPLETED|Washout Period Before Study Period 4||21
894487|NCT01847443|2162201|P2|COMPLETED|Washout Period Before Study Period 4||19
894488|NCT01847443|2162202|P1|COMPLETED|Washout Period Before Study Period 4||16
894489|NCT01847443|2162199|P4|STARTED|Washout Period Before Study Period 4||21
894490|NCT01847443|2162200|P3|STARTED|Washout Period Before Study Period 4||21
894491|NCT01847443|2162201|P2|STARTED|Washout Period Before Study Period 4||19
894492|NCT01847443|2162202|P1|STARTED|Washout Period Before Study Period 4||18
894493|NCT01847443|2162199|P4|NOT COMPLETED|Study Period 3||0
894494|NCT01847443|2162200|P3|NOT COMPLETED|Study Period 3||0
894495|NCT01847443|2162201|P2|NOT COMPLETED|Study Period 3||0
894496|NCT01847443|2162202|P1|NOT COMPLETED|Study Period 3||0
894497|NCT01847443|2162199|P4|COMPLETED|Study Period 3||21
894498|NCT01847443|2162200|P3|COMPLETED|Study Period 3||21
894499|NCT01847443|2162201|P2|COMPLETED|Study Period 3||19
894500|NCT01847443|2162202|P1|COMPLETED|Study Period 3||18
894501|NCT01847443|2162199|P4|STARTED|Study Period 3||21
894502|NCT01847443|2162200|P3|STARTED|Study Period 3||21
894503|NCT01847443|2162201|P2|STARTED|Study Period 3||19
894504|NCT01847443|2162202|P1|STARTED|Study Period 3||18
894505|NCT01847443|2162199|P4|NOT COMPLETED|Washout Period Before Study Period 3||0
894506|NCT01847443|2162200|P3|NOT COMPLETED|Washout Period Before Study Period 3||0
894507|NCT01847443|2162201|P2|NOT COMPLETED|Washout Period Before Study Period 3||0
894508|NCT01847443|2162202|P1|NOT COMPLETED|Washout Period Before Study Period 3||1
894509|NCT01847443|2162199|P4|COMPLETED|Washout Period Before Study Period 3||21
894510|NCT01847443|2162200|P3|COMPLETED|Washout Period Before Study Period 3||21
894511|NCT01847443|2162201|P2|COMPLETED|Washout Period Before Study Period 3||19
894512|NCT01847443|2162202|P1|COMPLETED|Washout Period Before Study Period 3||18
894513|NCT01847443|2162199|P4|STARTED|Washout Period Before Study Period 3||21
894514|NCT01847443|2162200|P3|STARTED|Washout Period Before Study Period 3||21
894515|NCT01847443|2162201|P2|STARTED|Washout Period Before Study Period 3||19
894516|NCT01847443|2162202|P1|STARTED|Washout Period Before Study Period 3||19
894517|NCT01847443|2162199|P4|NOT COMPLETED|Study Period 2||0
894518|NCT01847443|2162200|P3|NOT COMPLETED|Study Period 2||0
894519|NCT01847443|2162201|P2|NOT COMPLETED|Study Period 2||0
894520|NCT01847443|2162202|P1|NOT COMPLETED|Study Period 2||0
894521|NCT01847443|2162199|P4|COMPLETED|Study Period 2||21
894522|NCT01847443|2162200|P3|COMPLETED|Study Period 2||21
894523|NCT01847443|2162201|P2|COMPLETED|Study Period 2||19
894524|NCT01847443|2162202|P1|COMPLETED|Study Period 2||19
894525|NCT01847443|2162199|P4|STARTED|Study Period 2||21
894526|NCT01847443|2162200|P3|STARTED|Study Period 2||21
894527|NCT01847443|2162201|P2|STARTED|Study Period 2||19
894528|NCT01847443|2162202|P1|STARTED|Study Period 2||19
894529|NCT01847443|2162199|P4|NOT COMPLETED|Washout Period Before Study Period 2||0
894530|NCT01847443|2162200|P3|NOT COMPLETED|Washout Period Before Study Period 2||0
894531|NCT01847443|2162201|P2|NOT COMPLETED|Washout Period Before Study Period 2||1
894532|NCT01847443|2162202|P1|NOT COMPLETED|Washout Period Before Study Period 2||2
894533|NCT01847443|2162199|P4|COMPLETED|Washout Period Before Study Period 2||21
894534|NCT01847443|2162200|P3|COMPLETED|Washout Period Before Study Period 2||21
894535|NCT01847443|2162201|P2|COMPLETED|Washout Period Before Study Period 2||19
894536|NCT01847443|2162202|P1|COMPLETED|Washout Period Before Study Period 2||19
894537|NCT01847443|2162199|P4|STARTED|Washout Period Before Study Period 2||21
894538|NCT01847443|2162200|P3|STARTED|Washout Period Before Study Period 2||21
894539|NCT01847443|2162201|P2|STARTED|Washout Period Before Study Period 2||20
894540|NCT01847443|2162202|P1|STARTED|Washout Period Before Study Period 2||21
894541|NCT01847443|2162199|P4|NOT COMPLETED|Study Period 1||0
894542|NCT01847443|2162200|P3|NOT COMPLETED|Study Period 1||0
894543|NCT01847443|2162201|P2|NOT COMPLETED|Study Period 1||1
894544|NCT01847443|2162202|P1|NOT COMPLETED|Study Period 1||0
894545|NCT01847443|2162199|P4|COMPLETED|Study Period 1||21
894546|NCT01847443|2162200|P3|COMPLETED|Study Period 1||21
894547|NCT01847443|2162201|P2|COMPLETED|Study Period 1||20
894548|NCT01847443|2162202|P1|COMPLETED|Study Period 1||21
894549|NCT01847443|2162199|P4|STARTED|Study Period 1||21
894550|NCT01847443|2162200|P3|STARTED|Study Period 1||21
894551|NCT01847443|2162201|P2|STARTED|Study Period 1||21
894552|NCT01847443|2162202|P1|STARTED|Study Period 1||21
894553|NCT01847430|2162232|P1|NOT COMPLETED|Overall Study||0
894554|NCT01847430|2162232|P1|COMPLETED|Overall Study||302
894555|NCT01847430|2162232|P1|STARTED|Overall Study||302
894556|NCT01847196|2162243|P1|NOT COMPLETED|Overall Study||0
894557|NCT01847196|2162243|P1|COMPLETED|Overall Study||5
894558|NCT01847196|2162243|P1|STARTED|Overall Study|Includes all subjects in which Angel Catheter placement was attempted.|5
894559|NCT01847131|2162250|P2|NOT COMPLETED|Overall Study||0
894560|NCT01847131|2162251|P1|NOT COMPLETED|Overall Study||0
894561|NCT01847131|2162250|P2|COMPLETED|Overall Study||25
894562|NCT01847131|2162251|P1|COMPLETED|Overall Study||25
894563|NCT01847131|2162250|P2|STARTED|Overall Study||25
894564|NCT01847131|2162251|P1|STARTED|Overall Study||25
894565|NCT01846741|2162259|P1|NOT COMPLETED|Implantation to 18-Month/End of Study||0
894566|NCT01846741|2162259|P1|COMPLETED|Implantation to 18-Month/End of Study||20
894567|NCT01846741|2162259|P1|STARTED|Implantation to 18-Month/End of Study||20
894568|NCT01846741|2162259|P1|NOT COMPLETED|Baseline Visit||2
894569|NCT01846741|2162259|P1|COMPLETED|Baseline Visit||20
894570|NCT01846741|2162259|P1|STARTED|Baseline Visit||22
894571|NCT01846455|2162320|P5|NOT COMPLETED|Overall Study||0
894572|NCT01846455|2162321|P4|NOT COMPLETED|Overall Study||0
894573|NCT01846455|2162322|P3|NOT COMPLETED|Overall Study||0
894574|NCT01846455|2162323|P2|NOT COMPLETED|Overall Study||0
894575|NCT01846455|2162324|P1|NOT COMPLETED|Overall Study||0
894576|NCT01846455|2162320|P5|COMPLETED|Overall Study||8
894577|NCT01846455|2162321|P4|COMPLETED|Overall Study||10
894578|NCT01846455|2162322|P3|COMPLETED|Overall Study||8
894579|NCT01846455|2162323|P2|COMPLETED|Overall Study||8
894580|NCT01846455|2162324|P1|COMPLETED|Overall Study||9
894581|NCT01846455|2162320|P5|PK Population|Overall Study||8
894582|NCT01846455|2162321|P4|PK Population|Overall Study||6
894583|NCT01846455|2162322|P3|PK Population|Overall Study||6
894584|NCT01846455|2162323|P2|PK Population|Overall Study||7
894585|NCT01846455|2162324|P1|PK Population|Overall Study||6
894586|NCT01846455|2162320|P5|STARTED|Overall Study||8
894587|NCT01846455|2162321|P4|STARTED|Overall Study||10
894588|NCT01846455|2162322|P3|STARTED|Overall Study||8
894589|NCT01846455|2162323|P2|STARTED|Overall Study||8
894590|NCT01846455|2162324|P1|STARTED|Overall Study||9
894591|NCT01846442|2162385|P4|NOT COMPLETED|Overall Study||3
894592|NCT01846442|2162386|P3|NOT COMPLETED|Overall Study||4
894593|NCT01846442|2162387|P2|NOT COMPLETED|Overall Study||6
894594|NCT01846442|2162388|P1|NOT COMPLETED|Overall Study||6
894595|NCT01846442|2162385|P4|COMPLETED|Overall Study||51
894596|NCT01846442|2162386|P3|COMPLETED|Overall Study||52
894597|NCT01846442|2162387|P2|COMPLETED|Overall Study||48
894598|NCT01846442|2162388|P1|COMPLETED|Overall Study||48
894599|NCT01846442|2162385|P4|ITT Population|Overall Study||54
894600|NCT01846442|2162386|P3|ITT Population|Overall Study||56
894601|NCT01846442|2162387|P2|ITT Population|Overall Study||53
894602|NCT01846442|2162388|P1|ITT Population|Overall Study||53
894603|NCT01846442|2162385|P4|Safety Population|Overall Study||54
894604|NCT01846442|2162386|P3|Safety Population|Overall Study||56
894605|NCT01846442|2162387|P2|Safety Population|Overall Study||53
894606|NCT01846442|2162388|P1|Safety Population|Overall Study||54
894607|NCT01846442|2162385|P4|STARTED|Overall Study||54
894608|NCT01846442|2162386|P3|STARTED|Overall Study||56
894609|NCT01846442|2162387|P2|STARTED|Overall Study||54
894610|NCT01846442|2162388|P1|STARTED|Overall Study||54
894611|NCT01846416|2162429|P3|NOT COMPLETED|Overall Study||13
894612|NCT01846416|2162430|P2|NOT COMPLETED|Overall Study||93
894613|NCT01846416|2162431|P1|NOT COMPLETED|Overall Study||31
894614|NCT01846416|2162429|P3|COMPLETED|Overall Study||0
894615|NCT01846416|2162430|P2|COMPLETED|Overall Study||0
894616|NCT01846416|2162431|P1|COMPLETED|Overall Study||0
894617|NCT01846416|2162429|P3|STARTED|Overall Study||13
894618|NCT01846416|2162430|P2|STARTED|Overall Study||93
894619|NCT01846416|2162431|P1|STARTED|Overall Study||31
894620|NCT01846299|2162476|P2|NOT COMPLETED|Overall Study||10
894621|NCT01846299|2162477|P1|NOT COMPLETED|Overall Study||12
894622|NCT01846299|2162476|P2|COMPLETED|Overall Study||50
894623|NCT01846299|2162477|P1|COMPLETED|Overall Study||106
894624|NCT01846299|2162476|P2|Safety Set|Overall Study||58
894625|NCT01846299|2162477|P1|Safety Set|Overall Study|Two participants randomized to sham received ranibizumab at Month 1.|119
894626|NCT01846299|2162476|P2|Full Analysis Set|Overall Study||60
894627|NCT01846299|2162477|P1|Full Analysis Set|Overall Study|One participant did not receive study treatment prior to discontinuation.|117
894628|NCT01846299|2162476|P2|STARTED|Overall Study||60
894629|NCT01846299|2162477|P1|STARTED|Overall Study||118
894630|NCT01846104|2162513|P1|NOT COMPLETED|Overall Study||1
894631|NCT01846104|2162513|P1|COMPLETED|Overall Study||3
894632|NCT01846104|2162513|P1|STARTED|Overall Study||4
894633|NCT01846039|2162519|P1|NOT COMPLETED|Overall Study||2
894634|NCT01846039|2162519|P1|COMPLETED|Overall Study||27
894635|NCT01846039|2162519|P1|STARTED|Overall Study||29
894636|NCT01845831|2162531|P5|NOT COMPLETED|Outpatient Phase||0
894637|NCT01845831|2162532|P4|NOT COMPLETED|Outpatient Phase||0
894638|NCT01845831|2162533|P3|NOT COMPLETED|Outpatient Phase||0
894639|NCT01845831|2162534|P2|NOT COMPLETED|Outpatient Phase||0
894640|NCT01845831|2162535|P1|NOT COMPLETED|Outpatient Phase||0
894641|NCT01845831|2162531|P5|COMPLETED|Outpatient Phase||87
894642|NCT01845831|2162532|P4|COMPLETED|Outpatient Phase||98
894643|NCT01845831|2162533|P3|COMPLETED|Outpatient Phase||68
894644|NCT01845831|2162534|P2|COMPLETED|Outpatient Phase||0
894645|NCT01845831|2162535|P1|COMPLETED|Outpatient Phase||0
894646|NCT01845831|2162531|P5|STARTED|Outpatient Phase||87
894647|NCT01845831|2162532|P4|STARTED|Outpatient Phase||98
894648|NCT01845831|2162533|P3|STARTED|Outpatient Phase||68
894649|NCT01845831|2162534|P2|STARTED|Outpatient Phase||0
894650|NCT01845831|2162535|P1|STARTED|Outpatient Phase||0
894651|NCT01845831|2162531|P5|NOT COMPLETED|Inpatient Phase||0
894652|NCT01845831|2162532|P4|NOT COMPLETED|Inpatient Phase||0
894653|NCT01845831|2162533|P3|NOT COMPLETED|Inpatient Phase||0
894654|NCT01845831|2162534|P2|NOT COMPLETED|Inpatient Phase||1
894655|NCT01845831|2162535|P1|NOT COMPLETED|Inpatient Phase||1
894656|NCT01845831|2162531|P5|COMPLETED|Inpatient Phase||0
894657|NCT01845831|2162532|P4|COMPLETED|Inpatient Phase||0
894658|NCT01845831|2162533|P3|COMPLETED|Inpatient Phase||0
894659|NCT01845831|2162534|P2|COMPLETED|Inpatient Phase||138
894660|NCT01845831|2162535|P1|COMPLETED|Inpatient Phase||139
894661|NCT01845831|2162531|P5|STARTED|Inpatient Phase||0
894662|NCT01845831|2162532|P4|STARTED|Inpatient Phase||0
894663|NCT01845831|2162533|P3|STARTED|Inpatient Phase||0
894664|NCT01845831|2162534|P2|STARTED|Inpatient Phase||139
894665|NCT01845831|2162535|P1|STARTED|Inpatient Phase||140
894666|NCT01845220|2162562|P2|NOT COMPLETED|Overall Study||0
894667|NCT01845220|2162563|P1|NOT COMPLETED|Overall Study||0
894668|NCT01845220|2162562|P2|COMPLETED|Overall Study||30
894669|NCT01845220|2162563|P1|COMPLETED|Overall Study||30
894670|NCT01845220|2162562|P2|STARTED|Overall Study||30
894671|NCT01845220|2162563|P1|STARTED|Overall Study||30
894672|NCT01845155|2162571|P2|NOT COMPLETED|Overall Study||0
894673|NCT01845155|2162572|P1|NOT COMPLETED|Overall Study||1
894674|NCT01845155|2162571|P2|COMPLETED|Overall Study||144
894675|NCT01845155|2162572|P1|COMPLETED|Overall Study||145
894676|NCT01845155|2162571|P2|STARTED|Overall Study||144
894677|NCT01845155|2162572|P1|STARTED|Overall Study||146
894678|NCT01845103|2162580|P1|NOT COMPLETED|Overall Study||0
894679|NCT01845103|2162580|P1|COMPLETED|Overall Study||1
894680|NCT01845103|2162580|P1|STARTED|Overall Study||1
894681|NCT01845077|2162588|P6|NOT COMPLETED|Treatment Period 2||0
894682|NCT01845077|2162589|P5|NOT COMPLETED|Treatment Period 2||0
894683|NCT01845077|2162590|P4|NOT COMPLETED|Treatment Period 2||0
894684|NCT01845077|2162591|P3|NOT COMPLETED|Treatment Period 2||0
894685|NCT01845077|2162592|P2|NOT COMPLETED|Treatment Period 2||0
894686|NCT01845077|2162593|P1|NOT COMPLETED|Treatment Period 2||0
894687|NCT01845077|2162588|P6|COMPLETED|Treatment Period 2||11
894688|NCT01845077|2162589|P5|COMPLETED|Treatment Period 2||11
894689|NCT01845077|2162590|P4|COMPLETED|Treatment Period 2||10
894690|NCT01845077|2162591|P3|COMPLETED|Treatment Period 2||11
894691|NCT01845077|2162592|P2|COMPLETED|Treatment Period 2||11
894692|NCT01845077|2162593|P1|COMPLETED|Treatment Period 2||11
894693|NCT01845077|2162588|P6|STARTED|Treatment Period 2||11
894694|NCT01845077|2162589|P5|STARTED|Treatment Period 2||11
894695|NCT01845077|2162590|P4|STARTED|Treatment Period 2||10
894696|NCT01845077|2162591|P3|STARTED|Treatment Period 2||11
894697|NCT01845077|2162592|P2|STARTED|Treatment Period 2||11
894698|NCT01845077|2162593|P1|STARTED|Treatment Period 2||11
894699|NCT01845077|2162588|P6|NOT COMPLETED|Washout Period||1
894700|NCT01845077|2162589|P5|NOT COMPLETED|Washout Period||1
894701|NCT01845077|2162590|P4|NOT COMPLETED|Washout Period||2
894702|NCT01845077|2162591|P3|NOT COMPLETED|Washout Period||1
894703|NCT01845077|2162592|P2|NOT COMPLETED|Washout Period||1
894704|NCT01845077|2162593|P1|NOT COMPLETED|Washout Period||1
894705|NCT01845077|2162588|P6|COMPLETED|Washout Period||11
894706|NCT01845077|2162589|P5|COMPLETED|Washout Period||11
894707|NCT01845077|2162590|P4|COMPLETED|Washout Period||10
894708|NCT01845077|2162591|P3|COMPLETED|Washout Period||11
894709|NCT01845077|2162592|P2|COMPLETED|Washout Period||11
894710|NCT01845077|2162593|P1|COMPLETED|Washout Period||11
894711|NCT01845077|2162588|P6|STARTED|Washout Period||12
894712|NCT01845077|2162589|P5|STARTED|Washout Period||12
894713|NCT01845077|2162590|P4|STARTED|Washout Period||12
894714|NCT01845077|2162591|P3|STARTED|Washout Period||12
894715|NCT01845077|2162592|P2|STARTED|Washout Period||12
894716|NCT01845077|2162593|P1|STARTED|Washout Period||12
894717|NCT01845077|2162588|P6|NOT COMPLETED|Treatment Period 1||0
894718|NCT01845077|2162589|P5|NOT COMPLETED|Treatment Period 1||0
894719|NCT01845077|2162590|P4|NOT COMPLETED|Treatment Period 1||0
894720|NCT01845077|2162591|P3|NOT COMPLETED|Treatment Period 1||0
894721|NCT01845077|2162592|P2|NOT COMPLETED|Treatment Period 1||0
894722|NCT01845077|2162593|P1|NOT COMPLETED|Treatment Period 1||0
894723|NCT01845077|2162588|P6|COMPLETED|Treatment Period 1||12
894724|NCT01845077|2162589|P5|COMPLETED|Treatment Period 1||12
894725|NCT01845077|2162590|P4|COMPLETED|Treatment Period 1||12
894726|NCT01845077|2162591|P3|COMPLETED|Treatment Period 1||12
894727|NCT01845077|2162592|P2|COMPLETED|Treatment Period 1||12
894728|NCT01845077|2162593|P1|COMPLETED|Treatment Period 1||12
894729|NCT01845077|2162588|P6|STARTED|Treatment Period 1||12
894730|NCT01845077|2162589|P5|STARTED|Treatment Period 1||12
894731|NCT01845077|2162590|P4|STARTED|Treatment Period 1||12
894732|NCT01845077|2162591|P3|STARTED|Treatment Period 1||12
894733|NCT01845077|2162592|P2|STARTED|Treatment Period 1||12
894734|NCT01845077|2162593|P1|STARTED|Treatment Period 1||12
894735|NCT01845025|2162639|P2|NOT COMPLETED|Overall Study||77
894736|NCT01845025|2162640|P1|NOT COMPLETED|Overall Study||85
894737|NCT01845025|2162639|P2|COMPLETED|Overall Study||332
894738|NCT01845025|2162640|P1|COMPLETED|Overall Study||326
894739|NCT01845025|2162639|P2|STARTED|Overall Study||409
894740|NCT01845025|2162640|P1|STARTED|Overall Study||411
894741|NCT01844895|2162662|P1|NOT COMPLETED|Day 29 - Day113 - Autoinjector||6
894742|NCT01844895|2162662|P1|COMPLETED|Day 29 - Day113 - Autoinjector||111
894743|NCT01844895|2162662|P1|STARTED|Day 29 - Day113 - Autoinjector||117
894744|NCT01844895|2162662|P1|NOT COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||3
894745|NCT01844895|2162662|P1|COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||117
894746|NCT01844895|2162662|P1|STARTED|Day 1 to Day 28 - Pre-filled Syringe||120
894747|NCT01844856|2162680|P2|NOT COMPLETED|Overall Study||16
894748|NCT01844856|2162681|P1|NOT COMPLETED|Overall Study||24
894749|NCT01844856|2162680|P2|COMPLETED|Overall Study||255
894750|NCT01844856|2162681|P1|COMPLETED|Overall Study||246
894751|NCT01844856|2162680|P2|Received at Least 1 Dose of Study Drug|Overall Study||268
894752|NCT01844856|2162681|P1|Received at Least 1 Dose of Study Drug|Overall Study||270
894753|NCT01844856|2162680|P2|STARTED|Overall Study||271
894754|NCT01844856|2162681|P1|STARTED|Overall Study||270
894755|NCT01844830|2162693|P2|NOT COMPLETED|Overall Study||0
894756|NCT01844830|2162694|P1|NOT COMPLETED|Overall Study||1
894757|NCT01844830|2162693|P2|COMPLETED|Overall Study||30
894758|NCT01844830|2162694|P1|COMPLETED|Overall Study||59
894759|NCT01844830|2162693|P2|400 µL Dose|Overall Study||10
894760|NCT01844830|2162694|P1|400 µL Dose|Overall Study||20
894761|NCT01844830|2162693|P2|200 µL Dose|Overall Study||12
894762|NCT01844830|2162694|P1|200 µL Dose|Overall Study||24
894763|NCT01844830|2162693|P2|100 µL Dose|Overall Study||8
894764|NCT01844830|2162694|P1|100 µL Dose|Overall Study||16
894765|NCT01844830|2162693|P2|STARTED|Overall Study||30
894766|NCT01844830|2162694|P1|STARTED|Overall Study||60
894767|NCT01844817|2162724|P2|NOT COMPLETED|Treatment||63
894768|NCT01844817|2162725|P1|NOT COMPLETED|Treatment||64
894769|NCT01844817|2162724|P2|COMPLETED|Treatment||0
894770|NCT01844817|2162725|P1|COMPLETED|Treatment||0
894771|NCT01844817|2162724|P2|STARTED|Treatment||63
894772|NCT01844817|2162725|P1|STARTED|Treatment||64
894773|NCT01844817|2162724|P2|NOT COMPLETED|Enrolled and Randomized||3
894774|NCT01844817|2162725|P1|NOT COMPLETED|Enrolled and Randomized||2
894775|NCT01844817|2162724|P2|COMPLETED|Enrolled and Randomized||63
894776|NCT01844817|2162725|P1|COMPLETED|Enrolled and Randomized||64
894777|NCT01844817|2162724|P2|STARTED|Enrolled and Randomized||66
894778|NCT01844817|2162725|P1|STARTED|Enrolled and Randomized||66
894779|NCT01844778|2162738|P3|NOT COMPLETED|Overall Study||4
894780|NCT01844778|2162739|P2|NOT COMPLETED|Overall Study||3
894781|NCT01844778|2162740|P1|NOT COMPLETED|Overall Study||2
894782|NCT01844778|2162738|P3|COMPLETED|Overall Study||14
894783|NCT01844778|2162739|P2|COMPLETED|Overall Study||25
894784|NCT01844778|2162740|P1|COMPLETED|Overall Study||12
894785|NCT01844778|2162738|P3|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||15
894786|NCT01844778|2162739|P2|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||25
894787|NCT01844778|2162740|P1|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||12
894788|NCT01844778|2162738|P3|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||18
894789|NCT01844778|2162739|P2|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||28
894790|NCT01844778|2162740|P1|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||14
894791|NCT01844778|2162738|P3|STARTED|Overall Study||18
894792|NCT01844778|2162739|P2|STARTED|Overall Study||28
894793|NCT01844778|2162740|P1|STARTED|Overall Study||14
894794|NCT01844700|2162766|P2|NOT COMPLETED|Overall Study||1
894795|NCT01844700|2162767|P1|NOT COMPLETED|Overall Study||3
894796|NCT01844700|2162766|P2|COMPLETED|Overall Study||2
894797|NCT01844700|2162767|P1|COMPLETED|Overall Study||1
894798|NCT01844700|2162766|P2|STARTED|Overall Study||3
894799|NCT01844700|2162767|P1|STARTED|Overall Study||4
894800|NCT01844687|2162779|P1|NOT COMPLETED|Visit 8||0
894801|NCT01844687|2162779|P1|COMPLETED|Visit 8||31
894802|NCT01844687|2162779|P1|STARTED|Visit 8||31
894803|NCT01844687|2162779|P1|NOT COMPLETED|Visit 7||0
894804|NCT01844687|2162779|P1|COMPLETED|Visit 7||31
894805|NCT01844687|2162779|P1|STARTED|Visit 7||31
894806|NCT01844687|2162779|P1|NOT COMPLETED|Visit 6||0
894807|NCT01844687|2162779|P1|COMPLETED|Visit 6||31
894808|NCT01844687|2162779|P1|STARTED|Visit 6||31
894809|NCT01844687|2162779|P1|NOT COMPLETED|Visit 5||0
894810|NCT01844687|2162779|P1|COMPLETED|Visit 5||31
894811|NCT01844687|2162779|P1|STARTED|Visit 5||31
894812|NCT01844687|2162779|P1|NOT COMPLETED|Visit 4||4
894813|NCT01844687|2162779|P1|COMPLETED|Visit 4||31
894814|NCT01844687|2162779|P1|STARTED|Visit 4||35
894815|NCT01844687|2162779|P1|NOT COMPLETED|Visit 3||5
894816|NCT01844687|2162779|P1|COMPLETED|Visit 3||35
894817|NCT01844687|2162779|P1|STARTED|Visit 3||40
894818|NCT01844687|2162779|P1|NOT COMPLETED|Visit 2||2
894819|NCT01844687|2162779|P1|COMPLETED|Visit 2||40
894820|NCT01844687|2162779|P1|STARTED|Visit 2||42
894821|NCT01844687|2162779|P1|NOT COMPLETED|Visit 1||8
894822|NCT01844687|2162779|P1|COMPLETED|Visit 1||42
894823|NCT01844687|2162779|P1|STARTED|Visit 1||50
894824|NCT01844531|2162842|P4|NOT COMPLETED|Overall Study||0
894825|NCT01844531|2162843|P3|NOT COMPLETED|Overall Study||0
894826|NCT01844531|2162844|P2|NOT COMPLETED|Overall Study||1
894827|NCT01844531|2162845|P1|NOT COMPLETED|Overall Study||0
894828|NCT01844531|2162842|P4|COMPLETED|Overall Study||6
894829|NCT01844531|2162843|P3|COMPLETED|Overall Study||6
894830|NCT01844531|2162844|P2|COMPLETED|Overall Study||5
894831|NCT01844531|2162845|P1|COMPLETED|Overall Study||6
894832|NCT01844531|2162842|P4|STARTED|Overall Study||6
894833|NCT01844531|2162843|P3|STARTED|Overall Study||6
894834|NCT01844531|2162844|P2|STARTED|Overall Study||6
894835|NCT01844531|2162845|P1|STARTED|Overall Study||6
894836|NCT01844518|2162875|P1|NOT COMPLETED|Long-Term Extension||157
894837|NCT01844518|2162875|P1|COMPLETED|Long-Term Extension|Study is on-going|0
894838|NCT01844518|2162875|P1|STARTED|Long-Term Extension|7 participants completed ST but did not continue in study.|157
894839|NCT01844518|2162875|P1|NOT COMPLETED|Short-Term (ST) Period||9
894840|NCT01844518|2162875|P1|COMPLETED|Short-Term (ST) Period||164
894841|NCT01844518|2162875|P1|STARTED|Short-Term (ST) Period||173
894842|NCT01844505|2162892|P3|NOT COMPLETED|Overall Study||295
894843|NCT01844505|2162893|P2|NOT COMPLETED|Overall Study||269
894844|NCT01844505|2162894|P1|NOT COMPLETED|Overall Study||249
894845|NCT01844505|2162892|P3|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|16
894846|NCT01844505|2162893|P2|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|44
894847|NCT01844505|2162894|P1|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|64
894848|NCT01844505|2162892|P3|STARTED|Overall Study||311
894849|NCT01844505|2162893|P2|STARTED|Overall Study||313
894850|NCT01844505|2162894|P1|STARTED|Overall Study||313
894851|NCT01844479|2162944|P2|NOT COMPLETED|Second Intervention up to 30 Minutes||0
894852|NCT01844479|2162945|P1|NOT COMPLETED|Second Intervention up to 30 Minutes||0
894853|NCT01844479|2162944|P2|COMPLETED|Second Intervention up to 30 Minutes||13
894854|NCT01844479|2162945|P1|COMPLETED|Second Intervention up to 30 Minutes||14
894855|NCT01844479|2162944|P2|STARTED|Second Intervention up to 30 Minutes||13
894856|NCT01844479|2162945|P1|STARTED|Second Intervention up to 30 Minutes||14
894857|NCT01844479|2162944|P2|NOT COMPLETED|First Intervention up to 30 Minutes||0
894858|NCT01844479|2162945|P1|NOT COMPLETED|First Intervention up to 30 Minutes||0
894859|NCT01844479|2162944|P2|COMPLETED|First Intervention up to 30 Minutes||13
894860|NCT01844479|2162945|P1|COMPLETED|First Intervention up to 30 Minutes||14
894861|NCT01844479|2162944|P2|STARTED|First Intervention up to 30 Minutes||13
894862|NCT01844479|2162945|P1|STARTED|First Intervention up to 30 Minutes||14
894863|NCT01844388|2162975|P2|NOT COMPLETED|Overall Study||7
894864|NCT01844388|2162976|P1|NOT COMPLETED|Overall Study||8
894865|NCT01844388|2162975|P2|COMPLETED|Overall Study||114
894866|NCT01844388|2162976|P1|COMPLETED|Overall Study||236
894867|NCT01844388|2162975|P2|STARTED|Overall Study||121
894868|NCT01844388|2162976|P1|STARTED|Overall Study||244
894869|NCT01844206|2162988|P2|NOT COMPLETED|Overall Study||1
894870|NCT01844206|2162989|P1|NOT COMPLETED|Overall Study||0
894871|NCT01844206|2162988|P2|COMPLETED|Overall Study|One patient requested that epidural catheter be removed during the first post-operative day.|2
894872|NCT01844206|2162989|P1|COMPLETED|Overall Study||2
894873|NCT01844206|2162988|P2|STARTED|Overall Study||3
894874|NCT01844206|2162989|P1|STARTED|Overall Study||2
894875|NCT01843972|2163005|P10|NOT COMPLETED|Overall Study||0
894876|NCT01843972|2163006|P9|NOT COMPLETED|Overall Study||0
894877|NCT01843972|2163007|P8|NOT COMPLETED|Overall Study||0
894878|NCT01843972|2163008|P7|NOT COMPLETED|Overall Study||0
894879|NCT01843972|2163009|P6|NOT COMPLETED|Overall Study||0
894880|NCT01843972|2163010|P5|NOT COMPLETED|Overall Study||1
894881|NCT01843972|2163011|P4|NOT COMPLETED|Overall Study||0
894882|NCT01843972|2163012|P3|NOT COMPLETED|Overall Study||0
894883|NCT01843972|2163013|P2|NOT COMPLETED|Overall Study||0
894884|NCT01843972|2163014|P1|NOT COMPLETED|Overall Study||0
894885|NCT01843972|2163005|P10|COMPLETED|Overall Study||12
894886|NCT01843972|2163006|P9|COMPLETED|Overall Study||17
894887|NCT01843972|2163007|P8|COMPLETED|Overall Study||5
894888|NCT01843972|2163008|P7|COMPLETED|Overall Study||5
894889|NCT01843972|2163009|P6|COMPLETED|Overall Study||6
894890|NCT01843972|2163010|P5|COMPLETED|Overall Study||5
894891|NCT01843972|2163011|P4|COMPLETED|Overall Study||6
894892|NCT01843972|2163012|P3|COMPLETED|Overall Study||5
894893|NCT01843972|2163013|P2|COMPLETED|Overall Study||6
894894|NCT01843972|2163014|P1|COMPLETED|Overall Study||13
894895|NCT01843972|2163005|P10|STARTED|Overall Study||12
894896|NCT01843972|2163006|P9|STARTED|Overall Study||17
894897|NCT01843972|2163007|P8|STARTED|Overall Study||5
894898|NCT01843972|2163008|P7|STARTED|Overall Study||5
894899|NCT01843972|2163009|P6|STARTED|Overall Study||6
894900|NCT01843972|2163010|P5|STARTED|Overall Study||6
894901|NCT01843972|2163011|P4|STARTED|Overall Study||6
894902|NCT01843972|2163012|P3|STARTED|Overall Study||5
894903|NCT01843972|2163013|P2|STARTED|Overall Study||6
894904|NCT01843972|2163014|P1|STARTED|Overall Study||13
894905|NCT01843933|2163084|P2|NOT COMPLETED|Overall Study||4
894906|NCT01843933|2163085|P1|NOT COMPLETED|Overall Study||6
894907|NCT01843933|2163084|P2|COMPLETED|Overall Study||103
894908|NCT01843933|2163085|P1|COMPLETED|Overall Study||98
894909|NCT01843933|2163084|P2|STARTED|Overall Study||107
894910|NCT01843933|2163085|P1|STARTED|Overall Study||104
894911|NCT01843920|2163093|P2|NOT COMPLETED|Overall Study||0
894912|NCT01843920|2163094|P1|NOT COMPLETED|Overall Study||0
894913|NCT01843920|2163093|P2|COMPLETED|Overall Study||9
894914|NCT01843920|2163094|P1|COMPLETED|Overall Study||12
894915|NCT01843920|2163093|P2|STARTED|Overall Study||9
894916|NCT01843920|2163094|P1|STARTED|Overall Study||12
894917|NCT01843777|2163102|P2|NOT COMPLETED|Overall Study||0
894918|NCT01843777|2163103|P1|NOT COMPLETED|Overall Study||1
894919|NCT01843777|2163102|P2|COMPLETED|Overall Study|Number of subjects who received the treatment that completed collection of outcome measures|10
894920|NCT01843777|2163103|P1|COMPLETED|Overall Study|Final number of standard-of-care participants.|10
894921|NCT01843777|2163102|P2|Per Protocol Population|Overall Study|A subject was randomized to treatment but received standard of care and is not in the analyses.|9
894922|NCT01843777|2163103|P1|Per Protocol Population|Overall Study||11
894923|NCT01843777|2163102|P2|STARTED|Overall Study|Number of participants randomized to treatment.|10
894924|NCT01843777|2163103|P1|STARTED|Overall Study|Number of participants randomized to standard-of-care.|11
894925|NCT01843673|2163111|P1|NOT COMPLETED|Overall Study||6
894926|NCT01843673|2163111|P1|COMPLETED|Overall Study||10
894927|NCT01843673|2163111|P1|STARTED|Overall Study||16
894928|NCT01843660|2163123|P1|NOT COMPLETED|Overall Study||30
894929|NCT01843660|2163123|P1|COMPLETED|Overall Study||1029
894930|NCT01843660|2163123|P1|STARTED|Overall Study||1059
894931|NCT01843465|2163141|P1|NOT COMPLETED|Overall Study||0
894932|NCT01843465|2163141|P1|COMPLETED|Overall Study||34
894933|NCT01843465|2163141|P1|STARTED|Overall Study|This study had no follow-up. It focused in the acute setting of cryoballoon ablation.|34
894934|NCT01843374|2163147|P2|NOT COMPLETED|Overall Study||321
894935|NCT01843374|2163148|P1|NOT COMPLETED|Overall Study||164
894936|NCT01843374|2163147|P2|COMPLETED|Overall Study||61
894937|NCT01843374|2163148|P1|COMPLETED|Overall Study||25
894938|NCT01843374|2163147|P2|RANDOMIZED|Overall Study||382
894939|NCT01843374|2163148|P1|RANDOMIZED|Overall Study||189
894940|NCT01843374|2163147|P2|STARTED|Overall Study||382
894941|NCT01843374|2163148|P1|STARTED|Overall Study||189
894942|NCT01843348|2163175|P3|NOT COMPLETED|Overall Study||41
894943|NCT01843348|2163176|P2|NOT COMPLETED|Overall Study||40
894944|NCT01843348|2163177|P1|NOT COMPLETED|Overall Study||23
894945|NCT01843348|2163175|P3|COMPLETED|Overall Study||158
894946|NCT01843348|2163176|P2|COMPLETED|Overall Study||168
894947|NCT01843348|2163177|P1|COMPLETED|Overall Study||182
894948|NCT01843348|2163175|P3|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|80
894949|NCT01843348|2163176|P2|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|111
894950|NCT01843348|2163177|P1|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|147
894951|NCT01843348|2163175|P3|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|199
894952|NCT01843348|2163176|P2|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|208
894953|NCT01843348|2163177|P1|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|205
894954|NCT01843348|2163175|P3|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|198
894955|NCT01843348|2163176|P2|Safety Analysis Set (SAS)|Overall Study|Two participants received TAC + Certican in other arms in errorr - analyzed with TAC + Certican arm|210
894956|NCT01843348|2163177|P1|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|204
894957|NCT01843348|2163175|P3|STARTED|Overall Study||199
894958|NCT01843348|2163176|P2|STARTED|Overall Study||208
894959|NCT01843348|2163177|P1|STARTED|Overall Study||205
894960|NCT01843192|2163220|P3|NOT COMPLETED|Overall Study||2
894961|NCT01843192|2163221|P2|NOT COMPLETED|Overall Study||6
894962|NCT01843192|2163222|P1|NOT COMPLETED|Overall Study||2
894963|NCT01843192|2163220|P3|COMPLETED|Overall Study||9
894964|NCT01843192|2163221|P2|COMPLETED|Overall Study||28
894965|NCT01843192|2163222|P1|COMPLETED|Overall Study||24
894966|NCT01843192|2163220|P3|STARTED|Overall Study||11
894967|NCT01843192|2163221|P2|STARTED|Overall Study||34
894968|NCT01843192|2163222|P1|STARTED|Overall Study||26
894969|NCT01842906|2163253|P2|NOT COMPLETED|Overall Study||0
894970|NCT01842906|2163254|P1|NOT COMPLETED|Overall Study||0
894971|NCT01842906|2163253|P2|COMPLETED|Overall Study||104
894972|NCT01842906|2163254|P1|COMPLETED|Overall Study||115
894973|NCT01842906|2163253|P2|STARTED|Overall Study||104
894974|NCT01842906|2163254|P1|STARTED|Overall Study||115
894975|NCT01842841|2163266|P1|NOT COMPLETED|Overall Study||0
894976|NCT01842841|2163266|P1|COMPLETED|Overall Study||5
894977|NCT01842841|2163266|P1|STARTED|Overall Study||5
894978|NCT01842789|2163287|P2|NOT COMPLETED|Overall Study||0
894979|NCT01842789|2163288|P1|NOT COMPLETED|Overall Study||0
894980|NCT01842789|2163287|P2|COMPLETED|Overall Study||8
894981|NCT01842789|2163288|P1|COMPLETED|Overall Study||10
894982|NCT01842789|2163287|P2|STARTED|Overall Study||8
894983|NCT01842789|2163288|P1|STARTED|Overall Study||10
894984|NCT01842646|2163297|P1|NOT COMPLETED|Overall Study||0
894985|NCT01842646|2163297|P1|COMPLETED|Overall Study||35
894986|NCT01842646|2163297|P1|STARTED|Overall Study||35
894987|NCT01842633|2163306|P3|NOT COMPLETED|Overall Study||0
894988|NCT01842633|2163307|P2|NOT COMPLETED|Overall Study||2
894989|NCT01842633|2163308|P1|NOT COMPLETED|Overall Study||3
894990|NCT01842633|2163306|P3|COMPLETED|Overall Study||34
894991|NCT01842633|2163307|P2|COMPLETED|Overall Study||64
894992|NCT01842633|2163308|P1|COMPLETED|Overall Study||62
894993|NCT01842633|2163306|P3|STARTED|Overall Study||34
894994|NCT01842633|2163307|P2|STARTED|Overall Study||66
894995|NCT01842633|2163308|P1|STARTED|Overall Study||65
894996|NCT01842607|2163355|P1|NOT COMPLETED|Overall Study||66
894997|NCT01842607|2163355|P1|COMPLETED|Overall Study||585
894998|NCT01842607|2163355|P1|STARTED|Overall Study||651
894999|NCT01842594|2163374|P1|NOT COMPLETED|Overall Study||3
895000|NCT01842594|2163374|P1|COMPLETED|Overall Study||10
895001|NCT01842594|2163374|P1|STARTED|Overall Study||13
895002|NCT01842464|2163379|P1|NOT COMPLETED|Overall Study||0
895003|NCT01842464|2163379|P1|COMPLETED|Overall Study||44
895004|NCT01842464|2163379|P1|STARTED|Overall Study||44
895005|NCT01842438|2163387|P2|NOT COMPLETED|T2: 6month Follow-up||4
895006|NCT01842438|2163388|P1|NOT COMPLETED|T2: 6month Follow-up||4
895007|NCT01842438|2163387|P2|COMPLETED|T2: 6month Follow-up||32
895008|NCT01842438|2163388|P1|COMPLETED|T2: 6month Follow-up||32
895009|NCT01842438|2163387|P2|STARTED|T2: 6month Follow-up||36
895010|NCT01842438|2163388|P1|STARTED|T2: 6month Follow-up||36
895011|NCT01842438|2163387|P2|NOT COMPLETED|T1: Immediately After the Intervention||8
895012|NCT01842438|2163388|P1|NOT COMPLETED|T1: Immediately After the Intervention||6
895013|NCT01842438|2163387|P2|COMPLETED|T1: Immediately After the Intervention||36
895014|NCT01842438|2163388|P1|COMPLETED|T1: Immediately After the Intervention||36
895015|NCT01842438|2163387|P2|STARTED|T1: Immediately After the Intervention||44
895016|NCT01842438|2163388|P1|STARTED|T1: Immediately After the Intervention||42
895017|NCT01841970|2163400|P1|NOT COMPLETED|Overall Study||11
895018|NCT01841970|2163400|P1|COMPLETED|Overall Study||9
895019|NCT01841970|2163400|P1|STARTED|Overall Study||20
895020|NCT01841697|2163418|P2|NOT COMPLETED|Overall Study||18
895021|NCT01841697|2163419|P1|NOT COMPLETED|Overall Study||20
895022|NCT01841697|2163418|P2|COMPLETED|Overall Study||302
895023|NCT01841697|2163419|P1|COMPLETED|Overall Study||302
895024|NCT01841697|2163418|P2|STARTED|Overall Study||320
895025|NCT01841697|2163419|P1|STARTED|Overall Study||322
895026|NCT01841619|2163435|P1|NOT COMPLETED|Overall Study||0
895027|NCT01841619|2163435|P1|COMPLETED|Overall Study||16
895028|NCT01841619|2163435|P1|STARTED|Overall Study||16
895029|NCT01841593|2163445|P2|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
895030|NCT01841593|2163446|P1|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
895031|NCT01841593|2163445|P2|COMPLETED|Third Intervention (Days 15 to 21)||6
895032|NCT01841593|2163446|P1|COMPLETED|Third Intervention (Days 15 to 21)||11
895033|NCT01841593|2163445|P2|STARTED|Third Intervention (Days 15 to 21)||6
895034|NCT01841593|2163446|P1|STARTED|Third Intervention (Days 15 to 21)||11
895035|NCT01841593|2163445|P2|NOT COMPLETED|Second Intervention (Days 8 to 14)||0
895036|NCT01841593|2163446|P1|NOT COMPLETED|Second Intervention (Days 8 to 14)||1
895037|NCT01841593|2163445|P2|COMPLETED|Second Intervention (Days 8 to 14)||6
895038|NCT01841593|2163446|P1|COMPLETED|Second Intervention (Days 8 to 14)||11
895039|NCT01841593|2163445|P2|STARTED|Second Intervention (Days 8 to 14)||6
895040|NCT01841593|2163446|P1|STARTED|Second Intervention (Days 8 to 14)||12
895041|NCT01841593|2163445|P2|NOT COMPLETED|First Intervention (Days 1 to 7)||1
895042|NCT01841593|2163446|P1|NOT COMPLETED|First Intervention (Days 1 to 7)||0
895043|NCT01841593|2163445|P2|COMPLETED|First Intervention (Days 1 to 7)||6
895044|NCT01841593|2163446|P1|COMPLETED|First Intervention (Days 1 to 7)||12
895045|NCT01841593|2163445|P2|STARTED|First Intervention (Days 1 to 7)||7
895046|NCT01841593|2163446|P1|STARTED|First Intervention (Days 1 to 7)||12
895047|NCT01841567|2163462|P1|NOT COMPLETED|Overall Study||3
895048|NCT01841567|2163462|P1|COMPLETED|Overall Study||57
895049|NCT01841567|2163462|P1|STARTED|Overall Study||60
895050|NCT01841216|2163469|P2|NOT COMPLETED|Overall Study||0
895051|NCT01841216|2163470|P1|NOT COMPLETED|Overall Study||0
895052|NCT01841216|2163469|P2|COMPLETED|Overall Study||15
895053|NCT01841216|2163470|P1|COMPLETED|Overall Study||15
895054|NCT01841216|2163469|P2|STARTED|Overall Study||15
895055|NCT01841216|2163470|P1|STARTED|Overall Study||15
895056|NCT01841021|2163478|P1|NOT COMPLETED|Overall Study||0
895057|NCT01841021|2163478|P1|COMPLETED|Overall Study||1
895058|NCT01841021|2163478|P1|STARTED|Overall Study||1
895059|NCT01840943|2163490|P2|NOT COMPLETED|Overall Study||12
895060|NCT01840943|2163491|P1|NOT COMPLETED|Overall Study||13
895061|NCT01840943|2163490|P2|COMPLETED|Overall Study||0
895062|NCT01840943|2163491|P1|COMPLETED|Overall Study||1
895063|NCT01840943|2163490|P2|STARTED|Overall Study||12
895064|NCT01840943|2163491|P1|STARTED|Overall Study||14
895065|NCT01840605|2163527|P2|NOT COMPLETED|Overall Study||2
895066|NCT01840605|2163528|P1|NOT COMPLETED|Overall Study||2
895067|NCT01840605|2163527|P2|COMPLETED|Overall Study||150
895068|NCT01840605|2163528|P1|COMPLETED|Overall Study||149
895069|NCT01840605|2163527|P2|STARTED|Overall Study||152
895070|NCT01840605|2163528|P1|STARTED|Overall Study||151
895071|NCT01840410|2163536|P2|NOT COMPLETED|Overall Study||4
895072|NCT01840410|2163537|P1|NOT COMPLETED|Overall Study||7
895073|NCT01840410|2163536|P2|COMPLETED|Overall Study||55
895074|NCT01840410|2163537|P1|COMPLETED|Overall Study||112
895075|NCT01840410|2163536|P2|Full Analysis Set|Overall Study||59
895076|NCT01840410|2163537|P1|Full Analysis Set|Overall Study||119
895077|NCT01840410|2163536|P2|Safety Set|Overall Study|52 received ranibizumab at or after Month 2;7 did not receive ranibizumab any time during the study|59
895078|NCT01840410|2163537|P1|Safety Set|Overall Study||119
895079|NCT01840410|2163536|P2|STARTED|Overall Study||59
895080|NCT01840410|2163537|P1|STARTED|Overall Study||119
895081|NCT01840319|2163573|P1|NOT COMPLETED|Overall Study||0
895082|NCT01840319|2163573|P1|COMPLETED|Overall Study||156
895083|NCT01840319|2163573|P1|STARTED|Overall Study||156
895084|NCT01840072|2163579|P2|NOT COMPLETED|Overall Study||47
895085|NCT01840072|2163580|P1|NOT COMPLETED|Overall Study||7
895086|NCT01840072|2163579|P2|COMPLETED|Overall Study||1986
895087|NCT01840072|2163580|P1|COMPLETED|Overall Study||2031
895088|NCT01840072|2163579|P2|STARTED|Overall Study||2033
895089|NCT01840072|2163580|P1|STARTED|Overall Study||2038
895090|NCT01839695|2163602|P1|NOT COMPLETED|Overall Study||0
895091|NCT01839695|2163602|P1|COMPLETED|Overall Study||9
895092|NCT01839695|2163602|P1|STARTED|Overall Study||9
895093|NCT01839604|2163612|P5|NOT COMPLETED|Overall Study||0
895094|NCT01839604|2163613|P4|NOT COMPLETED|Overall Study||0
895095|NCT01839604|2163614|P3|NOT COMPLETED|Overall Study||0
895096|NCT01839604|2163615|P2|NOT COMPLETED|Overall Study||0
895097|NCT01839604|2163616|P1|NOT COMPLETED|Overall Study||0
895098|NCT01839604|2163612|P5|COMPLETED|Overall Study||15
895099|NCT01839604|2163613|P4|COMPLETED|Overall Study||5
895100|NCT01839604|2163614|P3|COMPLETED|Overall Study||7
895101|NCT01839604|2163615|P2|COMPLETED|Overall Study||6
895102|NCT01839604|2163616|P1|COMPLETED|Overall Study||6
895103|NCT01839604|2163612|P5|STARTED|Overall Study||15
895104|NCT01839604|2163613|P4|STARTED|Overall Study||5
895105|NCT01839604|2163614|P3|STARTED|Overall Study||7
895106|NCT01839604|2163615|P2|STARTED|Overall Study||6
895107|NCT01839604|2163616|P1|STARTED|Overall Study||6
895108|NCT01839318|2163643|P6|NOT COMPLETED|Period 3, Third Day of Wear||0
895109|NCT01839318|2163644|P5|NOT COMPLETED|Period 3, Third Day of Wear||0
895110|NCT01839318|2163645|P4|NOT COMPLETED|Period 3, Third Day of Wear||0
895111|NCT01839318|2163646|P3|NOT COMPLETED|Period 3, Third Day of Wear||0
895112|NCT01839318|2163647|P2|NOT COMPLETED|Period 3, Third Day of Wear||0
895113|NCT01839318|2163648|P1|NOT COMPLETED|Period 3, Third Day of Wear||0
895114|NCT01839318|2163643|P6|COMPLETED|Period 3, Third Day of Wear||2
895115|NCT01839318|2163644|P5|COMPLETED|Period 3, Third Day of Wear||7
895116|NCT01839318|2163645|P4|COMPLETED|Period 3, Third Day of Wear||6
895117|NCT01839318|2163646|P3|COMPLETED|Period 3, Third Day of Wear||5
895118|NCT01839318|2163647|P2|COMPLETED|Period 3, Third Day of Wear||4
895119|NCT01839318|2163648|P1|COMPLETED|Period 3, Third Day of Wear||4
895120|NCT01839318|2163643|P6|STARTED|Period 3, Third Day of Wear||2
895121|NCT01839318|2163644|P5|STARTED|Period 3, Third Day of Wear||7
895122|NCT01839318|2163645|P4|STARTED|Period 3, Third Day of Wear||6
895123|NCT01839318|2163646|P3|STARTED|Period 3, Third Day of Wear||5
895124|NCT01839318|2163647|P2|STARTED|Period 3, Third Day of Wear||4
895125|NCT01839318|2163648|P1|STARTED|Period 3, Third Day of Wear||4
895126|NCT01839318|2163643|P6|NOT COMPLETED|Period 2, Second Day of Wear||0
895127|NCT01839318|2163644|P5|NOT COMPLETED|Period 2, Second Day of Wear||0
895128|NCT01839318|2163645|P4|NOT COMPLETED|Period 2, Second Day of Wear||0
895129|NCT01839318|2163646|P3|NOT COMPLETED|Period 2, Second Day of Wear||0
895130|NCT01839318|2163647|P2|NOT COMPLETED|Period 2, Second Day of Wear||0
895131|NCT01839318|2163648|P1|NOT COMPLETED|Period 2, Second Day of Wear||0
895132|NCT01839318|2163643|P6|COMPLETED|Period 2, Second Day of Wear||2
895133|NCT01839318|2163644|P5|COMPLETED|Period 2, Second Day of Wear||7
895134|NCT01839318|2163645|P4|COMPLETED|Period 2, Second Day of Wear||6
895135|NCT01839318|2163646|P3|COMPLETED|Period 2, Second Day of Wear||5
895136|NCT01839318|2163647|P2|COMPLETED|Period 2, Second Day of Wear||4
895137|NCT01839318|2163648|P1|COMPLETED|Period 2, Second Day of Wear||4
895138|NCT01839318|2163643|P6|STARTED|Period 2, Second Day of Wear||2
895139|NCT01839318|2163644|P5|STARTED|Period 2, Second Day of Wear||7
895140|NCT01839318|2163645|P4|STARTED|Period 2, Second Day of Wear||6
895141|NCT01839318|2163646|P3|STARTED|Period 2, Second Day of Wear||5
895142|NCT01839318|2163647|P2|STARTED|Period 2, Second Day of Wear||4
895143|NCT01839318|2163648|P1|STARTED|Period 2, Second Day of Wear||4
895144|NCT01839318|2163643|P6|NOT COMPLETED|Period 1, First Day of Wear||0
895145|NCT01839318|2163644|P5|NOT COMPLETED|Period 1, First Day of Wear||0
895146|NCT01839318|2163645|P4|NOT COMPLETED|Period 1, First Day of Wear||0
895147|NCT01839318|2163646|P3|NOT COMPLETED|Period 1, First Day of Wear||0
895148|NCT01839318|2163647|P2|NOT COMPLETED|Period 1, First Day of Wear||0
895149|NCT01839318|2163648|P1|NOT COMPLETED|Period 1, First Day of Wear||0
895150|NCT01839318|2163643|P6|COMPLETED|Period 1, First Day of Wear||2
895151|NCT01839318|2163644|P5|COMPLETED|Period 1, First Day of Wear||7
895152|NCT01839318|2163645|P4|COMPLETED|Period 1, First Day of Wear||6
895153|NCT01839318|2163646|P3|COMPLETED|Period 1, First Day of Wear||5
895154|NCT01839318|2163647|P2|COMPLETED|Period 1, First Day of Wear||4
895155|NCT01839318|2163648|P1|COMPLETED|Period 1, First Day of Wear||4
895156|NCT01839318|2163643|P6|STARTED|Period 1, First Day of Wear||2
895157|NCT01839318|2163644|P5|STARTED|Period 1, First Day of Wear||7
895158|NCT01839318|2163645|P4|STARTED|Period 1, First Day of Wear||6
895159|NCT01839318|2163646|P3|STARTED|Period 1, First Day of Wear||5
895160|NCT01839318|2163647|P2|STARTED|Period 1, First Day of Wear||4
895161|NCT01839318|2163648|P1|STARTED|Period 1, First Day of Wear||4
895162|NCT01839279|2163662|P3|NOT COMPLETED|Overall Study||2
895163|NCT01839279|2163663|P2|NOT COMPLETED|Overall Study||2
895164|NCT01839279|2163664|P1|NOT COMPLETED|Overall Study||13
895165|NCT01839279|2163662|P3|COMPLETED|Overall Study||30
895166|NCT01839279|2163663|P2|COMPLETED|Overall Study||30
895167|NCT01839279|2163664|P1|COMPLETED|Overall Study||59
895168|NCT01839279|2163662|P3|PK/QTc Analysis Set|Overall Study||0
895169|NCT01839279|2163663|P2|PK/QTc Analysis Set|Overall Study||0
895170|NCT01839279|2163664|P1|PK/QTc Analysis Set|Overall Study||70
895171|NCT01839279|2163662|P3|Moxifloxacin/Placebo Analysis Set|Overall Study||30
895172|NCT01839279|2163663|P2|Moxifloxacin/Placebo Analysis Set|Overall Study||31
895173|NCT01839279|2163664|P1|Moxifloxacin/Placebo Analysis Set|Overall Study||0
895174|NCT01839279|2163662|P3|PK Analysis Set|Overall Study||0
895175|NCT01839279|2163663|P2|PK Analysis Set|Overall Study||0
895176|NCT01839279|2163664|P1|PK Analysis Set|Overall Study||70
895177|NCT01839279|2163662|P3|QT/QTc Analysis Set|Overall Study||32
895178|NCT01839279|2163663|P2|QT/QTc Analysis Set|Overall Study||32
895179|NCT01839279|2163664|P1|QT/QTc Analysis Set|Overall Study||72
895180|NCT01839279|2163662|P3|STARTED|Overall Study||32
895181|NCT01839279|2163663|P2|STARTED|Overall Study||32
895182|NCT01839279|2163664|P1|STARTED|Overall Study||72
895183|NCT01839058|2163685|P2|NOT COMPLETED|Overall Study||3
895184|NCT01839058|2163686|P1|NOT COMPLETED|Overall Study||4
895185|NCT01839058|2163685|P2|COMPLETED|Overall Study||16
895186|NCT01839058|2163686|P1|COMPLETED|Overall Study||17
895187|NCT01839058|2163685|P2|STARTED|Overall Study||19
895188|NCT01839058|2163686|P1|STARTED|Overall Study||21
895189|NCT01838980|2163692|P1|NOT COMPLETED|Overall Study||0
895190|NCT01838980|2163692|P1|COMPLETED|Overall Study||15
895191|NCT01838980|2163692|P1|STARTED|Overall Study||15
895192|NCT01838941|2163696|P1|NOT COMPLETED|Overall Study||2
895193|NCT01838941|2163696|P1|COMPLETED|Overall Study||10
895194|NCT01838941|2163696|P1|STARTED|Overall Study||12
895195|NCT01838785|2163701|P1|NOT COMPLETED|Overall Study||0
895196|NCT01838785|2163701|P1|COMPLETED|Overall Study||25
895197|NCT01838785|2163701|P1|STARTED|Overall Study||25
895198|NCT01838694|2163708|P2|NOT COMPLETED|Overall Study||1
895199|NCT01838694|2163709|P1|NOT COMPLETED|Overall Study||0
895200|NCT01838694|2163708|P2|COMPLETED|Overall Study||21
895201|NCT01838694|2163709|P1|COMPLETED|Overall Study||8
895202|NCT01838694|2163708|P2|STARTED|Overall Study||22
895203|NCT01838694|2163709|P1|STARTED|Overall Study||8
895204|NCT01838681|2163718|P4|NOT COMPLETED|Period B/A+||117
895205|NCT01838681|2163719|P3|NOT COMPLETED|Period B/A+||95
895206|NCT01838681|2163720|P2|NOT COMPLETED|Period B/A+||62
895207|NCT01838681|2163721|P1|NOT COMPLETED|Period B/A+||0
895208|NCT01838681|2163718|P4|COMPLETED|Period B/A+||653
895209|NCT01838681|2163719|P3|COMPLETED|Period B/A+||349
895210|NCT01838681|2163720|P2|COMPLETED|Period B/A+||380
895211|NCT01838681|2163721|P1|COMPLETED|Period B/A+||0
895212|NCT01838681|2163718|P4|STARTED|Period B/A+||770
895213|NCT01838681|2163719|P3|STARTED|Period B/A+||444
895214|NCT01838681|2163720|P2|STARTED|Period B/A+||442
895215|NCT01838681|2163721|P1|STARTED|Period B/A+||0
895216|NCT01838681|2163718|P4|NOT COMPLETED|Period A||0
895217|NCT01838681|2163719|P3|NOT COMPLETED|Period A||0
895218|NCT01838681|2163720|P2|NOT COMPLETED|Period A||0
895219|NCT01838681|2163721|P1|NOT COMPLETED|Period A||325
895220|NCT01838681|2163718|P4|COMPLETED|Period A||0
895221|NCT01838681|2163719|P3|COMPLETED|Period A||0
895222|NCT01838681|2163720|P2|COMPLETED|Period A||0
895223|NCT01838681|2163721|P1|COMPLETED|Period A||1661
895224|NCT01838681|2163718|P4|STARTED|Period A||0
895225|NCT01838681|2163719|P3|STARTED|Period A||0
895226|NCT01838681|2163720|P2|STARTED|Period A||0
895227|NCT01838681|2163721|P1|STARTED|Period A||1986
895228|NCT01838642|2163761|P1|NOT COMPLETED|Overall Study||1
895229|NCT01838642|2163761|P1|COMPLETED|Overall Study||2
895230|NCT01838642|2163761|P1|STARTED|Overall Study||3
895231|NCT01838616|2163774|P2|NOT COMPLETED|Pick-up Arm||0
895232|NCT01838616|2163775|P1|NOT COMPLETED|Pick-up Arm||15
895233|NCT01838616|2163774|P2|COMPLETED|Pick-up Arm||0
895328|NCT01837797|2163937|P5|COMPLETED|Period 1||0
895234|NCT01838616|2163775|P1|COMPLETED|Pick-up Arm|Participants completed the tapentadol pick-up arm after initially on oxycodone/naloxone PR treatment|35
895235|NCT01838616|2163774|P2|Full Analysis Set|Pick-up Arm||0
895236|NCT01838616|2163775|P1|Full Analysis Set|Pick-up Arm||49
895237|NCT01838616|2163774|P2|STARTED|Pick-up Arm||0
895238|NCT01838616|2163775|P1|STARTED|Pick-up Arm|Switch to Tapentadol (PR) after Oxycodone/Naloxone (PR) treatment discontinuation.|50
895239|NCT01838616|2163774|P2|NOT COMPLETED|Continuation Period||14
895240|NCT01838616|2163775|P1|NOT COMPLETED|Continuation Period||14
895241|NCT01838616|2163774|P2|COMPLETED|Continuation Period||48
895242|NCT01838616|2163775|P1|COMPLETED|Continuation Period||86
895243|NCT01838616|2163774|P2|Switched to Pick-up Arm|Continuation Period||7
895244|NCT01838616|2163775|P1|Switched to Pick-up Arm|Continuation Period||0
895245|NCT01838616|2163774|P2|STARTED|Continuation Period||62
895246|NCT01838616|2163775|P1|STARTED|Continuation Period||100
895247|NCT01838616|2163774|P2|NOT COMPLETED|Titration Period||66
895248|NCT01838616|2163775|P1|NOT COMPLETED|Titration Period||30
895249|NCT01838616|2163774|P2|COMPLETED|Titration Period||62
895250|NCT01838616|2163775|P1|COMPLETED|Titration Period||100
895251|NCT01838616|2163774|P2|Per Protocol Set|Titration Period||112
895252|NCT01838616|2163775|P1|Per Protocol Set|Titration Period||117
895253|NCT01838616|2163774|P2|Full Analysis Set|Titration Period||128
895254|NCT01838616|2163775|P1|Full Analysis Set|Titration Period||130
895255|NCT01838616|2163774|P2|Switched to Pick-up Arm|Titration Period||43
895256|NCT01838616|2163775|P1|Switched to Pick-up Arm|Titration Period||0
895257|NCT01838616|2163774|P2|Major Protocol Deviations|Titration Period||16
895258|NCT01838616|2163775|P1|Major Protocol Deviations|Titration Period||13
895259|NCT01838616|2163774|P2|No Post Baseline Pain Intensity Values|Titration Period||2
895260|NCT01838616|2163775|P1|No Post Baseline Pain Intensity Values|Titration Period||0
895261|NCT01838616|2163774|P2|STARTED|Titration Period||128
895262|NCT01838616|2163775|P1|STARTED|Titration Period||130
895263|NCT01838590|2163846|P2|NOT COMPLETED|Overall Study||5
895264|NCT01838590|2163847|P1|NOT COMPLETED|Overall Study||12
895265|NCT01838590|2163846|P2|COMPLETED|Overall Study||46
895266|NCT01838590|2163847|P1|COMPLETED|Overall Study||40
895267|NCT01838590|2163846|P2|STARTED|Overall Study||51
895268|NCT01838590|2163847|P1|STARTED|Overall Study||52
895269|NCT01838499|2163871|P2|NOT COMPLETED|Overall Study||17
895270|NCT01838499|2163872|P1|NOT COMPLETED|Overall Study||24
895271|NCT01838499|2163871|P2|COMPLETED|Overall Study||37
895272|NCT01838499|2163872|P1|COMPLETED|Overall Study||31
895273|NCT01838499|2163871|P2|STARTED|Overall Study||54
895274|NCT01838499|2163872|P1|STARTED|Overall Study||55
895275|NCT01838213|2163884|P2|NOT COMPLETED|Overall Study||191
895276|NCT01838213|2163885|P1|NOT COMPLETED|Overall Study||166
895277|NCT01838213|2163884|P2|COMPLETED|Overall Study||262
895278|NCT01838213|2163885|P1|COMPLETED|Overall Study||81
895279|NCT01838213|2163884|P2|STARTED|Overall Study||453
895280|NCT01838213|2163885|P1|STARTED|Overall Study||247
895281|NCT01838044|2163893|P2|NOT COMPLETED|Overall Study||16
895282|NCT01838044|2163894|P1|NOT COMPLETED|Overall Study||8
895283|NCT01838044|2163893|P2|COMPLETED|Overall Study||75
895284|NCT01838044|2163894|P1|COMPLETED|Overall Study||81
895285|NCT01838044|2163893|P2|STARTED|Overall Study||91
895286|NCT01838044|2163894|P1|STARTED|Overall Study||89
895287|NCT01837966|2163927|P2|NOT COMPLETED|Overall Study||1
895288|NCT01837966|2163928|P1|NOT COMPLETED|Overall Study||2
895289|NCT01837966|2163927|P2|COMPLETED|Overall Study||45
895290|NCT01837966|2163928|P1|COMPLETED|Overall Study||45
895291|NCT01837966|2163927|P2|STARTED|Overall Study||46
895292|NCT01837966|2163928|P1|STARTED|Overall Study||47
895293|NCT01837797|2163937|P5|NOT COMPLETED|Period 3||23
895294|NCT01837797|2163938|P4|NOT COMPLETED|Period 3||0
895295|NCT01837797|2163939|P3|NOT COMPLETED|Period 3||0
895296|NCT01837797|2163940|P2|NOT COMPLETED|Period 3||0
895297|NCT01837797|2163941|P1|NOT COMPLETED|Period 3||0
895298|NCT01837797|2163937|P5|COMPLETED|Period 3||24
895299|NCT01837797|2163938|P4|COMPLETED|Period 3||0
895300|NCT01837797|2163939|P3|COMPLETED|Period 3||0
895301|NCT01837797|2163940|P2|COMPLETED|Period 3||0
895302|NCT01837797|2163941|P1|COMPLETED|Period 3||0
895303|NCT01837797|2163937|P5|STARTED|Period 3||47
895304|NCT01837797|2163938|P4|STARTED|Period 3||0
895305|NCT01837797|2163939|P3|STARTED|Period 3||0
895306|NCT01837797|2163940|P2|STARTED|Period 3||0
895307|NCT01837797|2163941|P1|STARTED|Period 3||0
895308|NCT01837797|2163937|P5|NOT COMPLETED|Period 2||0
895309|NCT01837797|2163938|P4|NOT COMPLETED|Period 2||5
895310|NCT01837797|2163939|P3|NOT COMPLETED|Period 2||2
895311|NCT01837797|2163940|P2|NOT COMPLETED|Period 2||5
895312|NCT01837797|2163941|P1|NOT COMPLETED|Period 2||0
895313|NCT01837797|2163937|P5|COMPLETED|Period 2||0
895314|NCT01837797|2163938|P4|COMPLETED|Period 2||1
895315|NCT01837797|2163939|P3|COMPLETED|Period 2||1
895316|NCT01837797|2163940|P2|COMPLETED|Period 2||1
895317|NCT01837797|2163941|P1|COMPLETED|Period 2||0
895318|NCT01837797|2163937|P5|STARTED|Period 2||0
895319|NCT01837797|2163938|P4|STARTED|Period 2||6
895320|NCT01837797|2163939|P3|STARTED|Period 2||3
895321|NCT01837797|2163940|P2|STARTED|Period 2||6
895322|NCT01837797|2163941|P1|STARTED|Period 2||0
895323|NCT01837797|2163937|P5|NOT COMPLETED|Period 1||0
895324|NCT01837797|2163938|P4|NOT COMPLETED|Period 1||0
895325|NCT01837797|2163939|P3|NOT COMPLETED|Period 1||0
895326|NCT01837797|2163940|P2|NOT COMPLETED|Period 1||0
895327|NCT01837797|2163941|P1|NOT COMPLETED|Period 1||102
895329|NCT01837797|2163938|P4|COMPLETED|Period 1||0
895330|NCT01837797|2163939|P3|COMPLETED|Period 1||0
895331|NCT01837797|2163940|P2|COMPLETED|Period 1||0
895332|NCT01837797|2163941|P1|COMPLETED|Period 1||27
895333|NCT01837797|2163937|P5|STARTED|Period 1||0
895334|NCT01837797|2163938|P4|STARTED|Period 1||0
895335|NCT01837797|2163939|P3|STARTED|Period 1||0
895336|NCT01837797|2163940|P2|STARTED|Period 1||0
895337|NCT01837797|2163941|P1|STARTED|Period 1||129
895338|NCT01837719|2163976|P1|NOT COMPLETED|Period 5: Days 29-31 (Treatment E)||1
895339|NCT01837719|2163976|P1|COMPLETED|Period 5: Days 29-31 (Treatment E)||30
895340|NCT01837719|2163976|P1|STARTED|Period 5: Days 29-31 (Treatment E)|Reflects the 31 patients remaining after 32 were discharged at the end of Period 4, as per protocol|31
895341|NCT01837719|2163976|P1|NOT COMPLETED|Period 4: Days 22-28 (Treatment D or C)||0
895342|NCT01837719|2163976|P1|COMPLETED|Period 4: Days 22-28 (Treatment D or C)|Number finishing period; 32 patients were discharged following Period 4, as per protocol|63
895343|NCT01837719|2163976|P1|STARTED|Period 4: Days 22-28 (Treatment D or C)||63
895344|NCT01837719|2163976|P1|NOT COMPLETED|Period 3: Days 15-21 (Treatment C or D)||0
895345|NCT01837719|2163976|P1|COMPLETED|Period 3: Days 15-21 (Treatment C or D)||63
895346|NCT01837719|2163976|P1|STARTED|Period 3: Days 15-21 (Treatment C or D)||63
895347|NCT01837719|2163976|P1|NOT COMPLETED|Period 2: Days 8-14 (Treatment B or A)||1
895348|NCT01837719|2163976|P1|COMPLETED|Period 2: Days 8-14 (Treatment B or A)||63
895349|NCT01837719|2163976|P1|STARTED|Period 2: Days 8-14 (Treatment B or A)||64
895350|NCT01837719|2163976|P1|NOT COMPLETED|Period 1: Days 1-7 (Treatment A or B)||0
895351|NCT01837719|2163976|P1|COMPLETED|Period 1: Days 1-7 (Treatment A or B)||64
895352|NCT01837719|2163976|P1|STARTED|Period 1: Days 1-7 (Treatment A or B)|Received treatment|64
895353|NCT01837680|2164045|P2|NOT COMPLETED|Overall Study||8
895354|NCT01837680|2164046|P1|NOT COMPLETED|Overall Study||10
895355|NCT01837680|2164045|P2|COMPLETED|Overall Study||45
895356|NCT01837680|2164046|P1|COMPLETED|Overall Study||42
895357|NCT01837680|2164045|P2|STARTED|Overall Study||53
895358|NCT01837680|2164046|P1|STARTED|Overall Study||52
895359|NCT01837550|2164084|P2|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
895360|NCT01837550|2164085|P1|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
895361|NCT01837550|2164084|P2|COMPLETED|T0-T2, 6 Months Follow-up||37
895362|NCT01837550|2164085|P1|COMPLETED|T0-T2, 6 Months Follow-up||37
895363|NCT01837550|2164084|P2|STARTED|T0-T2, 6 Months Follow-up||37
895364|NCT01837550|2164085|P1|STARTED|T0-T2, 6 Months Follow-up||37
895365|NCT01837550|2164084|P2|NOT COMPLETED|T0-T1, 5 Weeks||0
895366|NCT01837550|2164085|P1|NOT COMPLETED|T0-T1, 5 Weeks||0
895367|NCT01837550|2164084|P2|COMPLETED|T0-T1, 5 Weeks||37
895368|NCT01837550|2164085|P1|COMPLETED|T0-T1, 5 Weeks||37
895369|NCT01837550|2164084|P2|STARTED|T0-T1, 5 Weeks||37
895370|NCT01837550|2164085|P1|STARTED|T0-T1, 5 Weeks||37
895371|NCT01837537|2164097|P1|NOT COMPLETED|Overall Study||0
895372|NCT01837537|2164097|P1|COMPLETED|Overall Study||90
895373|NCT01837537|2164097|P1|STARTED|Overall Study||90
895374|NCT01837524|2164104|P2|NOT COMPLETED|Overall Study||2
895375|NCT01837524|2164105|P1|NOT COMPLETED|Overall Study||3
895376|NCT01837524|2164104|P2|COMPLETED|Overall Study||25
895377|NCT01837524|2164105|P1|COMPLETED|Overall Study||25
895378|NCT01837524|2164104|P2|STARTED|Overall Study||27
895379|NCT01837524|2164105|P1|STARTED|Overall Study||28
895380|NCT01836809|2164115|P4|NOT COMPLETED|Overall Study||2
895381|NCT01836809|2164116|P3|NOT COMPLETED|Overall Study||0
895382|NCT01836809|2164117|P2|NOT COMPLETED|Overall Study||0
895383|NCT01836809|2164118|P1|NOT COMPLETED|Overall Study||0
895384|NCT01836809|2164115|P4|COMPLETED|Overall Study||0
895385|NCT01836809|2164116|P3|COMPLETED|Overall Study||0
895386|NCT01836809|2164117|P2|COMPLETED|Overall Study||0
895387|NCT01836809|2164118|P1|COMPLETED|Overall Study||0
895388|NCT01836809|2164115|P4|STARTED|Overall Study||2
895389|NCT01836809|2164116|P3|STARTED|Overall Study||0
895390|NCT01836809|2164117|P2|STARTED|Overall Study||0
895391|NCT01836809|2164118|P1|STARTED|Overall Study||0
895392|NCT01836523|2164152|P4|NOT COMPLETED|Overall Study||74
895393|NCT01836523|2164153|P3|NOT COMPLETED|Overall Study||91
895394|NCT01836523|2164154|P2|NOT COMPLETED|Overall Study||85
895395|NCT01836523|2164155|P1|NOT COMPLETED|Overall Study||51
895396|NCT01836523|2164152|P4|COMPLETED|Overall Study||274
895397|NCT01836523|2164153|P3|COMPLETED|Overall Study||258
895398|NCT01836523|2164154|P2|COMPLETED|Overall Study||265
895399|NCT01836523|2164155|P1|COMPLETED|Overall Study||300
895400|NCT01836523|2164152|P4|Exposed|Overall Study||348
895401|NCT01836523|2164153|P3|Exposed|Overall Study||347
895402|NCT01836523|2164154|P2|Exposed|Overall Study||348
895403|NCT01836523|2164155|P1|Exposed|Overall Study||350
895404|NCT01836523|2164152|P4|STARTED|Overall Study||348
895405|NCT01836523|2164153|P3|STARTED|Overall Study||349
895406|NCT01836523|2164154|P2|STARTED|Overall Study||350
895407|NCT01836523|2164155|P1|STARTED|Overall Study||351
895408|NCT01836471|2164182|P5|NOT COMPLETED|Overall Study||5
895409|NCT01836471|2164183|P4|NOT COMPLETED|Overall Study||2
895410|NCT01836471|2164184|P3|NOT COMPLETED|Overall Study||2
895411|NCT01836471|2164185|P2|NOT COMPLETED|Overall Study||9
895412|NCT01836471|2164186|P1|NOT COMPLETED|Overall Study||11
895413|NCT01836471|2164182|P5|COMPLETED|Overall Study||49
895414|NCT01836471|2164183|P4|COMPLETED|Overall Study||40
895415|NCT01836471|2164184|P3|COMPLETED|Overall Study||49
895416|NCT01836471|2164185|P2|COMPLETED|Overall Study||85
895417|NCT01836471|2164186|P1|COMPLETED|Overall Study||82
895418|NCT01836471|2164182|P5|STARTED|Overall Study||54
895419|NCT01836471|2164183|P4|STARTED|Overall Study||42
895420|NCT01836471|2164184|P3|STARTED|Overall Study||51
895421|NCT01836471|2164185|P2|STARTED|Overall Study||94
895422|NCT01836471|2164186|P1|STARTED|Overall Study||93
895423|NCT01836458|2164215|P4|NOT COMPLETED|Overall Study||6
895424|NCT01836458|2164216|P3|NOT COMPLETED|Overall Study||5
895425|NCT01836458|2164217|P2|NOT COMPLETED|Overall Study||2
895426|NCT01836458|2164218|P1|NOT COMPLETED|Overall Study||3
895427|NCT01836458|2164215|P4|COMPLETED|Overall Study||1
895428|NCT01836458|2164216|P3|COMPLETED|Overall Study||2
895429|NCT01836458|2164217|P2|COMPLETED|Overall Study||2
895430|NCT01836458|2164218|P1|COMPLETED|Overall Study||4
895431|NCT01836458|2164215|P4|STARTED|Overall Study||7
895432|NCT01836458|2164216|P3|STARTED|Overall Study||7
895433|NCT01836458|2164217|P2|STARTED|Overall Study||4
895434|NCT01836458|2164218|P1|STARTED|Overall Study||7
895435|NCT01836133|2164240|P1|NOT COMPLETED|Overall Study||0
895436|NCT01836133|2164240|P1|COMPLETED|Overall Study||70
895437|NCT01836133|2164240|P1|STARTED|Overall Study||70
895438|NCT01836042|2164249|P3|NOT COMPLETED|Overall Study||0
895439|NCT01836042|2164250|P2|NOT COMPLETED|Overall Study||0
895440|NCT01836042|2164251|P1|NOT COMPLETED|Overall Study||0
895441|NCT01836042|2164249|P3|COMPLETED|Overall Study||22
895442|NCT01836042|2164250|P2|COMPLETED|Overall Study||35
895443|NCT01836042|2164251|P1|COMPLETED|Overall Study||51
895444|NCT01836042|2164249|P3|STARTED|Overall Study||22
895445|NCT01836042|2164250|P2|STARTED|Overall Study||35
895446|NCT01836042|2164251|P1|STARTED|Overall Study||51
895447|NCT01835912|2164259|P1|NOT COMPLETED|Overall Study||0
895448|NCT01835912|2164259|P1|COMPLETED|Overall Study||10
895449|NCT01835912|2164259|P1|Chronic Placebo|Overall Study||10
895450|NCT01835912|2164259|P1|Chronic|Overall Study||10
895451|NCT01835912|2164259|P1|Acute Placebo|Overall Study||10
895452|NCT01835912|2164259|P1|Acute|Overall Study||10
895453|NCT01835912|2164259|P1|STARTED|Overall Study||10
895454|NCT01835899|2164280|P3|NOT COMPLETED|Overall Study||1
895455|NCT01835899|2164281|P2|NOT COMPLETED|Overall Study||1
895456|NCT01835899|2164282|P1|NOT COMPLETED|Overall Study||0
895457|NCT01835899|2164280|P3|COMPLETED|Overall Study||8
895458|NCT01835899|2164281|P2|COMPLETED|Overall Study||8
895459|NCT01835899|2164282|P1|COMPLETED|Overall Study||6
895460|NCT01835899|2164280|P3|STARTED|Overall Study||9
895461|NCT01835899|2164281|P2|STARTED|Overall Study||9
895462|NCT01835899|2164282|P1|STARTED|Overall Study||6
895463|NCT01835756|2164302|P2|NOT COMPLETED|Overall Study||0
895464|NCT01835756|2164303|P1|NOT COMPLETED|Overall Study||0
895465|NCT01835756|2164302|P2|COMPLETED|Overall Study||31
895466|NCT01835756|2164303|P1|COMPLETED|Overall Study||31
895467|NCT01835756|2164302|P2|STARTED|Overall Study||31
895468|NCT01835756|2164303|P1|STARTED|Overall Study||31
895469|NCT01835743|2164315|P2|NOT COMPLETED|Overall Study||0
895470|NCT01835743|2164316|P1|NOT COMPLETED|Overall Study||0
895471|NCT01835743|2164315|P2|COMPLETED|Overall Study||32
895472|NCT01835743|2164316|P1|COMPLETED|Overall Study||37
895473|NCT01835743|2164315|P2|STARTED|Overall Study||32
895474|NCT01835743|2164316|P1|STARTED|Overall Study||37
895475|NCT01835496|2164324|P1|NOT COMPLETED|Overall Study||0
895476|NCT01835496|2164324|P1|COMPLETED|Overall Study||8
895477|NCT01835496|2164324|P1|STARTED|Overall Study||8
895478|NCT01835470|2164333|P1|NOT COMPLETED|Long Term Treatment Period||2
895479|NCT01835470|2164333|P1|COMPLETED|Long Term Treatment Period|Completed=Still on Treatment|18
895480|NCT01835470|2164333|P1|STARTED|Long Term Treatment Period||20
895481|NCT01835470|2164333|P1|NOT COMPLETED|Short Term Treatment Period (to Week 16)||0
895482|NCT01835470|2164333|P1|COMPLETED|Short Term Treatment Period (to Week 16)||20
895483|NCT01835470|2164333|P1|STARTED|Short Term Treatment Period (to Week 16)||20
895484|NCT01835431|2164345|P2|NOT COMPLETED|Overall Study||12
895485|NCT01835431|2164346|P1|NOT COMPLETED|Overall Study||8
895486|NCT01835431|2164345|P2|COMPLETED|Overall Study||168
895487|NCT01835431|2164346|P1|COMPLETED|Overall Study||174
895488|NCT01835431|2164345|P2|Exposed|Overall Study|One subject was withdrawn before exposure|179
895489|NCT01835431|2164346|P1|Exposed|Overall Study|One subject was withdrawn before exposure.|181
895490|NCT01835431|2164345|P2|STARTED|Overall Study||180
895491|NCT01835431|2164346|P1|STARTED|Overall Study||182
895492|NCT01835379|2164366|P2|NOT COMPLETED|Overall Study||0
895493|NCT01835379|2164367|P1|NOT COMPLETED|Overall Study||0
895494|NCT01835379|2164366|P2|COMPLETED|Overall Study||41
895495|NCT01835379|2164367|P1|COMPLETED|Overall Study||41
895496|NCT01835379|2164366|P2|STARTED|Overall Study||41
895497|NCT01835379|2164367|P1|STARTED|Overall Study||41
895498|NCT01835262|2164377|P2|NOT COMPLETED|Overall Study||0
895499|NCT01835262|2164378|P1|NOT COMPLETED|Overall Study||0
895500|NCT01835262|2164377|P2|COMPLETED|Overall Study||45
895501|NCT01835262|2164378|P1|COMPLETED|Overall Study||45
895502|NCT01835262|2164377|P2|STARTED|Overall Study||45
895503|NCT01835262|2164378|P1|STARTED|Overall Study||45
895504|NCT01835132|2164384|P1|NOT COMPLETED|2nd Extension Phase - As Needed (PRN)||0
895505|NCT01835132|2164384|P1|COMPLETED|2nd Extension Phase - As Needed (PRN)||3
895506|NCT01835132|2164384|P1|STARTED|2nd Extension Phase - As Needed (PRN)|PRN extension - Participants starting this phase may not equal those who completed the 1st extension|3
895507|NCT01835132|2164384|P1|NOT COMPLETED|1st Extension Phase||0
895508|NCT01835132|2164384|P1|COMPLETED|1st Extension Phase|Completed 52 Weeks|6
895509|NCT01835132|2164384|P1|STARTED|1st Extension Phase||6
895510|NCT01835132|2164384|P1|NOT COMPLETED|Initial Phase||2
895511|NCT01835132|2164384|P1|COMPLETED|Initial Phase||6
895512|NCT01835132|2164384|P1|STARTED|Initial Phase||8
895513|NCT01835015|2164428|P5|NOT COMPLETED|Overall Study||0
895514|NCT01835015|2164429|P4|NOT COMPLETED|Overall Study||0
895515|NCT01835015|2164430|P3|NOT COMPLETED|Overall Study||1
895516|NCT01835015|2164431|P2|NOT COMPLETED|Overall Study||0
895517|NCT01835015|2164432|P1|NOT COMPLETED|Overall Study||0
895518|NCT01835015|2164428|P5|COMPLETED|Overall Study||6
895519|NCT01835015|2164429|P4|COMPLETED|Overall Study||6
895520|NCT01835015|2164430|P3|COMPLETED|Overall Study||6
895521|NCT01835015|2164431|P2|COMPLETED|Overall Study||6
895522|NCT01835015|2164432|P1|COMPLETED|Overall Study||6
895523|NCT01835015|2164428|P5|STARTED|Overall Study||6
895524|NCT01835015|2164429|P4|STARTED|Overall Study||6
895525|NCT01835015|2164430|P3|STARTED|Overall Study||7
895526|NCT01835015|2164431|P2|STARTED|Overall Study||6
895527|NCT01835015|2164432|P1|STARTED|Overall Study||6
895528|NCT01834651|2164505|P1|NOT COMPLETED|Overall Study||1
895529|NCT01834651|2164505|P1|COMPLETED|Overall Study|Evaluable for primary outcome assessment at 12 weeks|16
895530|NCT01834651|2164505|P1|STARTED|Overall Study||17
895531|NCT01834404|2164517|P2|NOT COMPLETED|Overall Study||0
895532|NCT01834404|2164518|P1|NOT COMPLETED|Overall Study||0
895533|NCT01834404|2164517|P2|COMPLETED|Overall Study||12
895534|NCT01834404|2164518|P1|COMPLETED|Overall Study||12
895535|NCT01834404|2164517|P2|STARTED|Overall Study||12
895536|NCT01834404|2164518|P1|STARTED|Overall Study||12
895537|NCT01834274|2164550|P2|NOT COMPLETED|Overall Study||41
895538|NCT01834274|2164551|P1|NOT COMPLETED|Overall Study||47
895539|NCT01834274|2164550|P2|COMPLETED|Overall Study||5
895540|NCT01834274|2164551|P1|COMPLETED|Overall Study||3
895541|NCT01834274|2164550|P2|STARTED|Overall Study||46
895542|NCT01834274|2164551|P1|STARTED|Overall Study||50
895543|NCT01834261|2164563|P2|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
895544|NCT01834261|2164564|P1|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
895545|NCT01834261|2164563|P2|COMPLETED|MGH Rest + Nueroeconomic Task fMRI||10
895546|NCT01834261|2164564|P1|COMPLETED|MGH Rest + Nueroeconomic Task fMRI|Enrollment completed in May 2015.|10
895547|NCT01834261|2164563|P2|STARTED|MGH Rest + Nueroeconomic Task fMRI||10
895548|NCT01834261|2164564|P1|STARTED|MGH Rest + Nueroeconomic Task fMRI|Subjects who dropped out/were excluded (10), did so before they received either Oxytocin or Placebo.|10
895549|NCT01834261|2164563|P2|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
895550|NCT01834261|2164564|P1|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
895551|NCT01834261|2164563|P2|COMPLETED|MIT fMRI and MEG Resting State Study||9
895552|NCT01834261|2164564|P1|COMPLETED|MIT fMRI and MEG Resting State Study|Enrollment completed in March 2014.|10
895553|NCT01834261|2164563|P2|STARTED|MIT fMRI and MEG Resting State Study||10
895554|NCT01834261|2164564|P1|STARTED|MIT fMRI and MEG Resting State Study||11
895555|NCT01834222|2164574|P1|NOT COMPLETED|Overall Study||1
895556|NCT01834222|2164574|P1|COMPLETED|Overall Study||658
895557|NCT01834222|2164574|P1|Treated|Overall Study||658
895558|NCT01834222|2164574|P1|STARTED|Overall Study||659
895559|NCT01834027|2164585|P2|NOT COMPLETED|Overall Study||0
895560|NCT01834027|2164586|P1|NOT COMPLETED|Overall Study||0
895561|NCT01834027|2164585|P2|COMPLETED|Overall Study||28
895562|NCT01834027|2164586|P1|COMPLETED|Overall Study||28
895563|NCT01834027|2164585|P2|STARTED|Overall Study||28
895564|NCT01834027|2164586|P1|STARTED|Overall Study||28
895565|NCT01833988|2164596|P2|NOT COMPLETED|Overall Study||0
895566|NCT01833988|2164597|P1|NOT COMPLETED|Overall Study||0
895567|NCT01833988|2164596|P2|COMPLETED|Overall Study||16
895568|NCT01833988|2164597|P1|COMPLETED|Overall Study||16
895569|NCT01833988|2164596|P2|STARTED|Overall Study||16
895570|NCT01833988|2164597|P1|STARTED|Overall Study||16
895571|NCT01833897|2164651|P1|NOT COMPLETED|Overall Study||1
895572|NCT01833897|2164651|P1|COMPLETED|Overall Study||7
895573|NCT01833897|2164651|P1|STARTED|Overall Study||8
895574|NCT01833845|2164659|P1|NOT COMPLETED|Overall Study||0
895575|NCT01833845|2164659|P1|COMPLETED|Overall Study||4
895576|NCT01833845|2164659|P1|STARTED|Overall Study||4
895577|NCT01833741|2164663|P1|NOT COMPLETED|Overall Study||140
895578|NCT01833741|2164663|P1|COMPLETED|Overall Study||997
895579|NCT01833741|2164663|P1|STARTED|Overall Study||1137
895580|NCT01833533|2164678|P2|NOT COMPLETED|Overall Study||21
895581|NCT01833533|2164679|P1|NOT COMPLETED|Overall Study||6
895582|NCT01833533|2164678|P2|COMPLETED|Overall Study||184
895583|NCT01833533|2164679|P1|COMPLETED|Overall Study||94
895584|NCT01833533|2164678|P2|STARTED|Overall Study||205
895585|NCT01833533|2164679|P1|STARTED|Overall Study||100
895586|NCT01833481|2164696|P3|NOT COMPLETED|Overall Study||0
895587|NCT01833481|2164697|P2|NOT COMPLETED|Overall Study||0
895588|NCT01833481|2164698|P1|NOT COMPLETED|Overall Study||0
895589|NCT01833481|2164696|P3|COMPLETED|Overall Study||10
895590|NCT01833481|2164697|P2|COMPLETED|Overall Study||10
895591|NCT01833481|2164698|P1|COMPLETED|Overall Study||10
895592|NCT01833481|2164696|P3|STARTED|Overall Study||10
895593|NCT01833481|2164697|P2|STARTED|Overall Study||10
895594|NCT01833481|2164698|P1|STARTED|Overall Study||10
895595|NCT01833403|2164712|P1|NOT COMPLETED|Overall Study||0
895596|NCT01833403|2164712|P1|COMPLETED|Overall Study||4
895597|NCT01833403|2164712|P1|STARTED|Overall Study||4
895598|NCT01833247|2164717|P1|NOT COMPLETED|Overall Study||0
895599|NCT01833247|2164717|P1|COMPLETED|Overall Study||12
895600|NCT01833247|2164717|P1|STARTED|Overall Study||12
895601|NCT01833130|2164725|P2|NOT COMPLETED|Overall Study||19
895602|NCT01833130|2164726|P1|NOT COMPLETED|Overall Study||10
895603|NCT01833130|2164725|P2|COMPLETED|Overall Study||8
895604|NCT01833130|2164726|P1|COMPLETED|Overall Study||15
895605|NCT01833130|2164725|P2|STARTED|Overall Study||27
895606|NCT01833130|2164726|P1|STARTED|Overall Study||25
895607|NCT01833117|2164764|P2|NOT COMPLETED|Overall Study||0
895608|NCT01833117|2164765|P1|NOT COMPLETED|Overall Study||0
895609|NCT01833117|2164764|P2|COMPLETED|Overall Study||19
895610|NCT01833117|2164765|P1|COMPLETED|Overall Study||43
895611|NCT01833117|2164764|P2|STARTED|Overall Study||19
895612|NCT01833117|2164765|P1|STARTED|Overall Study||43
895613|NCT01833078|2164773|P1|NOT COMPLETED|Overall Study||0
895614|NCT01833078|2164773|P1|COMPLETED|Overall Study||5
895615|NCT01833078|2164773|P1|STARTED|Overall Study||5
895616|NCT01833065|2164781|P5|NOT COMPLETED|Overall Study||36
895617|NCT01833065|2164782|P4|NOT COMPLETED|Overall Study||9
895618|NCT01833065|2164783|P3|NOT COMPLETED|Overall Study||12
895619|NCT01833065|2164784|P2|NOT COMPLETED|Overall Study||13
895620|NCT01833065|2164785|P1|NOT COMPLETED|Overall Study||24
895621|NCT01833065|2164781|P5|COMPLETED|Overall Study||74
895622|NCT01833065|2164782|P4|COMPLETED|Overall Study||41
895623|NCT01833065|2164783|P3|COMPLETED|Overall Study||23
895624|NCT01833065|2164784|P2|COMPLETED|Overall Study||40
895625|NCT01833065|2164785|P1|COMPLETED|Overall Study||41
895626|NCT01833065|2164781|P5|Intention-to-treat Analysis Set|Overall Study|Randomized patients|111
895627|NCT01833065|2164782|P4|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
895628|NCT01833065|2164783|P3|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
895629|NCT01833065|2164784|P2|Intention-to-treat Analysis Set|Overall Study|Randomized patients|53
895630|NCT01833065|2164785|P1|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
895631|NCT01833065|2164781|P5|STARTED|Overall Study|Randomized patients - As treated|110
895632|NCT01833065|2164782|P4|STARTED|Overall Study|Randomized patients - As treated|50
895633|NCT01833065|2164783|P3|STARTED|Overall Study|Randomized patients - As treated|35
895634|NCT01833065|2164784|P2|STARTED|Overall Study|Randomized patients - As treated|53
895635|NCT01833065|2164785|P1|STARTED|Overall Study|Randomized patients - As treated|65
895636|NCT01832766|2164816|P2|NOT COMPLETED|Second Intervention||0
895637|NCT01832766|2164817|P1|NOT COMPLETED|Second Intervention||0
895638|NCT01832766|2164816|P2|COMPLETED|Second Intervention||5
895639|NCT01832766|2164817|P1|COMPLETED|Second Intervention||7
895640|NCT01832766|2164816|P2|STARTED|Second Intervention||5
895641|NCT01832766|2164817|P1|STARTED|Second Intervention||7
895642|NCT01832766|2164816|P2|NOT COMPLETED|Washout||1
895643|NCT01832766|2164817|P1|NOT COMPLETED|Washout||0
895644|NCT01832766|2164816|P2|COMPLETED|Washout||5
895645|NCT01832766|2164817|P1|COMPLETED|Washout||7
895646|NCT01832766|2164816|P2|STARTED|Washout||6
895647|NCT01832766|2164817|P1|STARTED|Washout||7
895648|NCT01832766|2164816|P2|NOT COMPLETED|First Intervention||0
895649|NCT01832766|2164817|P1|NOT COMPLETED|First Intervention||0
895650|NCT01832766|2164816|P2|COMPLETED|First Intervention|one participant did not return for cross over visit|6
895651|NCT01832766|2164817|P1|COMPLETED|First Intervention||7
895652|NCT01832766|2164816|P2|STARTED|First Intervention||6
895653|NCT01832766|2164817|P1|STARTED|First Intervention||7
895654|NCT01832506|2164830|P3|NOT COMPLETED|Overall Study||0
895655|NCT01832506|2164831|P2|NOT COMPLETED|Overall Study||0
895656|NCT01832506|2164832|P1|NOT COMPLETED|Overall Study||0
895657|NCT01832506|2164830|P3|COMPLETED|Overall Study||6
895658|NCT01832506|2164831|P2|COMPLETED|Overall Study||3
895659|NCT01832506|2164832|P1|COMPLETED|Overall Study||3
895660|NCT01832506|2164830|P3|STARTED|Overall Study||6
895661|NCT01832506|2164831|P2|STARTED|Overall Study||3
895662|NCT01832506|2164832|P1|STARTED|Overall Study||3
895663|NCT01832493|2164883|P1|NOT COMPLETED|Overall Study||8
895664|NCT01832493|2164883|P1|COMPLETED|Overall Study||42
895665|NCT01832493|2164883|P1|STARTED|Overall Study||50
895666|NCT01832155|2164892|P2|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
895667|NCT01832155|2164893|P1|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
895668|NCT01832155|2164892|P2|COMPLETED|End of Study: 4 - 8 Weeks||18
895669|NCT01832155|2164893|P1|COMPLETED|End of Study: 4 - 8 Weeks||16
895670|NCT01832155|2164892|P2|STARTED|End of Study: 4 - 8 Weeks||18
895671|NCT01832155|2164893|P1|STARTED|End of Study: 4 - 8 Weeks||16
895672|NCT01832155|2164892|P2|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||0
895673|NCT01832155|2164893|P1|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||1
895674|NCT01832155|2164892|P2|COMPLETED|Mid-point of Study: 0 - 4 Weeks||18
895675|NCT01832155|2164893|P1|COMPLETED|Mid-point of Study: 0 - 4 Weeks||16
895676|NCT01832155|2164892|P2|STARTED|Mid-point of Study: 0 - 4 Weeks||18
895677|NCT01832155|2164893|P1|STARTED|Mid-point of Study: 0 - 4 Weeks||17
895678|NCT01832155|2164892|P2|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||0
895679|NCT01832155|2164893|P1|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||1
895680|NCT01832155|2164892|P2|COMPLETED|Beginning of Study: Baseline at 0 Week||18
895681|NCT01832155|2164893|P1|COMPLETED|Beginning of Study: Baseline at 0 Week||17
895682|NCT01832155|2164892|P2|STARTED|Beginning of Study: Baseline at 0 Week||18
895683|NCT01832155|2164893|P1|STARTED|Beginning of Study: Baseline at 0 Week||18
895684|NCT01831934|2164916|P2|NOT COMPLETED|Overall Study||0
895685|NCT01831934|2164917|P1|NOT COMPLETED|Overall Study||1
895686|NCT01831934|2164916|P2|COMPLETED|Overall Study||10
895687|NCT01831934|2164917|P1|COMPLETED|Overall Study|Volunteer consented but not enrolled after reporting a prior bad reaction to influenza vaccine.|11
895688|NCT01831934|2164916|P2|STARTED|Overall Study||10
895689|NCT01831934|2164917|P1|STARTED|Overall Study||12
895690|NCT01831817|2164927|P4|NOT COMPLETED|Overall Study||0
895691|NCT01831817|2164928|P3|NOT COMPLETED|Overall Study||0
895692|NCT01831817|2164929|P2|NOT COMPLETED|Overall Study||0
895693|NCT01831817|2164930|P1|NOT COMPLETED|Overall Study||4
895694|NCT01831817|2164927|P4|COMPLETED|Overall Study||36
895695|NCT01831817|2164928|P3|COMPLETED|Overall Study||35
895696|NCT01831817|2164929|P2|COMPLETED|Overall Study||34
895697|NCT01831817|2164930|P1|COMPLETED|Overall Study||31
895698|NCT01831817|2164927|P4|STARTED|Overall Study||36
895699|NCT01831817|2164928|P3|STARTED|Overall Study||35
895700|NCT01831817|2164929|P2|STARTED|Overall Study||34
895701|NCT01831817|2164930|P1|STARTED|Overall Study||35
895702|NCT01831791|2164968|P1|NOT COMPLETED|Overall Study||10
895703|NCT01831791|2164968|P1|COMPLETED|Overall Study||110
895704|NCT01831791|2164968|P1|STARTED|Overall Study||120
895705|NCT01831726|2164994|P1|NOT COMPLETED|Overall Study||80
895706|NCT01831726|2164994|P1|COMPLETED|Overall Study||0
895707|NCT01831726|2164994|P1|STARTED|Overall Study||80
895708|NCT01831466|2165013|P12|NOT COMPLETED|Overall Study||4
895709|NCT01831466|2165014|P11|NOT COMPLETED|Overall Study||2
895710|NCT01831466|2165015|P10|NOT COMPLETED|Overall Study||5
895711|NCT01831466|2165016|P9|NOT COMPLETED|Overall Study||3
895712|NCT01831466|2165017|P8|NOT COMPLETED|Overall Study||2
895713|NCT01831466|2165018|P7|NOT COMPLETED|Overall Study||1
895714|NCT01831466|2165019|P6|NOT COMPLETED|Overall Study||26
895715|NCT01831466|2165020|P5|NOT COMPLETED|Overall Study||17
895716|NCT01831466|2165021|P4|NOT COMPLETED|Overall Study||19
895717|NCT01831466|2165022|P3|NOT COMPLETED|Overall Study||23
895718|NCT01831466|2165023|P2|NOT COMPLETED|Overall Study||18
895719|NCT01831466|2165024|P1|NOT COMPLETED|Overall Study||16
895720|NCT01831466|2165013|P12|COMPLETED|Overall Study||3
895721|NCT01831466|2165014|P11|COMPLETED|Overall Study||4
895722|NCT01831466|2165015|P10|COMPLETED|Overall Study||2
895723|NCT01831466|2165016|P9|COMPLETED|Overall Study||4
895724|NCT01831466|2165017|P8|COMPLETED|Overall Study||5
895725|NCT01831466|2165018|P7|COMPLETED|Overall Study||6
895726|NCT01831466|2165019|P6|COMPLETED|Overall Study||48
895727|NCT01831466|2165020|P5|COMPLETED|Overall Study||57
895728|NCT01831466|2165021|P4|COMPLETED|Overall Study||51
895729|NCT01831466|2165022|P3|COMPLETED|Overall Study||48
895730|NCT01831466|2165023|P2|COMPLETED|Overall Study||52
895731|NCT01831466|2165024|P1|COMPLETED|Overall Study||55
895732|NCT01831466|2165013|P12|STARTED|Overall Study|Treated|7
895733|NCT01831466|2165014|P11|STARTED|Overall Study|Treated|6
895734|NCT01831466|2165015|P10|STARTED|Overall Study|Treated|7
895735|NCT01831466|2165016|P9|STARTED|Overall Study|Treated|7
895736|NCT01831466|2165017|P8|STARTED|Overall Study|Treated|7
895737|NCT01831466|2165018|P7|STARTED|Overall Study|Treated|7
895738|NCT01831466|2165019|P6|STARTED|Overall Study|Treated|74
895739|NCT01831466|2165020|P5|STARTED|Overall Study|Treated|74
895740|NCT01831466|2165021|P4|STARTED|Overall Study|Treated|70
895741|NCT01831466|2165022|P3|STARTED|Overall Study|Treated|71
895742|NCT01831466|2165023|P2|STARTED|Overall Study|Treated|70
895743|NCT01831466|2165024|P1|STARTED|Overall Study|Treated|71
895744|NCT01831258|2165146|P2|NOT COMPLETED|Overall Study||3
895745|NCT01831258|2165147|P1|NOT COMPLETED|Overall Study||5
895746|NCT01831258|2165146|P2|COMPLETED|Overall Study||32
895747|NCT01831258|2165147|P1|COMPLETED|Overall Study||30
895748|NCT01831258|2165146|P2|STARTED|Overall Study||35
895749|NCT01831258|2165147|P1|STARTED|Overall Study||35
895750|NCT01831219|2165175|P2|NOT COMPLETED|Overall Study||24
895751|NCT01831219|2165176|P1|NOT COMPLETED|Overall Study||33
895752|NCT01831219|2165175|P2|COMPLETED|Overall Study||21
895753|NCT01831219|2165176|P1|COMPLETED|Overall Study||40
895754|NCT01831219|2165175|P2|STARTED|Overall Study||45
895755|NCT01831219|2165176|P1|STARTED|Overall Study||73
895756|NCT01831154|2165197|P3|NOT COMPLETED|Overall Study||0
895757|NCT01831154|2165198|P2|NOT COMPLETED|Overall Study||0
895758|NCT01831154|2165199|P1|NOT COMPLETED|Overall Study||0
895759|NCT01831154|2165197|P3|COMPLETED|Overall Study||11
895760|NCT01831154|2165198|P2|COMPLETED|Overall Study||11
895761|NCT01831154|2165199|P1|COMPLETED|Overall Study||15
895762|NCT01831154|2165197|P3|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
895763|NCT01831154|2165198|P2|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
895764|NCT01831154|2165199|P1|STARTED|Overall Study|Study Institutional Review Board (IRB) approval 11-11-2009, first subjects enrolled 6-7-2010|15
895765|NCT01830933|2165224|P2|NOT COMPLETED|Overall Study||232
895766|NCT01830933|2165225|P1|NOT COMPLETED|Overall Study||168
895767|NCT01830933|2165224|P2|COMPLETED|Overall Study||580
895768|NCT01830933|2165225|P1|COMPLETED|Overall Study||655
895769|NCT01830933|2165224|P2|Completed Meet-up|Overall Study||603
895770|NCT01830933|2165225|P1|Completed Meet-up|Overall Study||675
895771|NCT01830933|2165224|P2|STARTED|Overall Study||812
895772|NCT01830933|2165225|P1|STARTED|Overall Study||823
895773|NCT01830920|2165242|P5|NOT COMPLETED|Overall Study||8
895774|NCT01830920|2165243|P4|NOT COMPLETED|Overall Study||16
895775|NCT01830920|2165244|P3|NOT COMPLETED|Overall Study||8
895776|NCT01830920|2165245|P2|NOT COMPLETED|Overall Study||6
895777|NCT01830920|2165246|P1|NOT COMPLETED|Overall Study||21
895778|NCT01830920|2165242|P5|COMPLETED|Overall Study||99
895779|NCT01830920|2165243|P4|COMPLETED|Overall Study||109
895780|NCT01830920|2165244|P3|COMPLETED|Overall Study||40
895781|NCT01830920|2165245|P2|COMPLETED|Overall Study||40
895782|NCT01830920|2165246|P1|COMPLETED|Overall Study||105
895783|NCT01830920|2165242|P5|Received Allocated Drug|Overall Study||105
895784|NCT01830920|2165243|P4|Received Allocated Drug|Overall Study||119
895785|NCT01830920|2165244|P3|Received Allocated Drug|Overall Study||47
895786|NCT01830920|2165245|P2|Received Allocated Drug|Overall Study||45
895787|NCT01830920|2165246|P1|Received Allocated Drug|Overall Study||115
895788|NCT01830920|2165242|P5|STARTED|Overall Study||107
895789|NCT01830920|2165243|P4|STARTED|Overall Study||125
895790|NCT01830920|2165244|P3|STARTED|Overall Study||48
895791|NCT01830920|2165245|P2|STARTED|Overall Study||46
895792|NCT01830920|2165246|P1|STARTED|Overall Study||126
895793|NCT01830881|2165285|P2|NOT COMPLETED|Overall Study||1
895794|NCT01830881|2165286|P1|NOT COMPLETED|Overall Study||0
895795|NCT01830881|2165285|P2|COMPLETED|Overall Study||61
895796|NCT01830881|2165286|P1|COMPLETED|Overall Study||62
895797|NCT01830881|2165285|P2|STARTED|Overall Study||62
895798|NCT01830881|2165286|P1|STARTED|Overall Study||62
895799|NCT01830855|2165330|P4|NOT COMPLETED|Overall Study||82
895800|NCT01830855|2165331|P3|NOT COMPLETED|Overall Study||66
895801|NCT01830855|2165332|P2|NOT COMPLETED|Overall Study||61
895802|NCT01830855|2165333|P1|NOT COMPLETED|Overall Study||155
895803|NCT01830855|2165330|P4|COMPLETED|Overall Study||815
895804|NCT01830855|2165331|P3|COMPLETED|Overall Study||521
895805|NCT01830855|2165332|P2|COMPLETED|Overall Study||537
895806|NCT01830855|2165333|P1|COMPLETED|Overall Study||1353
895807|NCT01830855|2165330|P4|STARTED|Overall Study||897
895808|NCT01830855|2165331|P3|STARTED|Overall Study||587
895809|NCT01830855|2165332|P2|STARTED|Overall Study||598
895810|NCT01830855|2165333|P1|STARTED|Overall Study||1508
895811|NCT01830790|2165439|P2|NOT COMPLETED|Overall Study||0
895812|NCT01830790|2165440|P1|NOT COMPLETED|Overall Study||0
895813|NCT01830790|2165439|P2|COMPLETED|Overall Study||10
895814|NCT01830790|2165440|P1|COMPLETED|Overall Study||0
895815|NCT01830790|2165439|P2|STARTED|Overall Study||10
895816|NCT01830790|2165440|P1|STARTED|Overall Study||0
895817|NCT01830699|2165450|P2|NOT COMPLETED|Overall Study||0
895818|NCT01830699|2165451|P1|NOT COMPLETED|Overall Study||0
895819|NCT01830699|2165450|P2|COMPLETED|Overall Study||20
895820|NCT01830699|2165451|P1|COMPLETED|Overall Study||13
895821|NCT01830699|2165450|P2|STARTED|Overall Study||20
895822|NCT01830699|2165451|P1|STARTED|Overall Study||13
895823|NCT01830543|2165464|P3|NOT COMPLETED|Overall Study||214
895824|NCT01830543|2165465|P2|NOT COMPLETED|Overall Study||152
895825|NCT01830543|2165466|P1|NOT COMPLETED|Overall Study||159
895826|NCT01830543|2165464|P3|COMPLETED|Overall Study||492
895827|NCT01830543|2165465|P2|COMPLETED|Overall Study||557
895828|NCT01830543|2165466|P1|COMPLETED|Overall Study||550
895829|NCT01830543|2165464|P3|Treated|Overall Study||697
895830|NCT01830543|2165465|P2|Treated|Overall Study||706
895831|NCT01830543|2165466|P1|Treated|Overall Study||696
895832|NCT01830543|2165464|P3|STARTED|Overall Study||706
895833|NCT01830543|2165465|P2|STARTED|Overall Study||709
895834|NCT01830543|2165466|P1|STARTED|Overall Study||709
895835|NCT01830205|2165502|P4|NOT COMPLETED|Overall Study||0
895836|NCT01830205|2165503|P3|NOT COMPLETED|Overall Study||0
895837|NCT01830205|2165504|P2|NOT COMPLETED|Overall Study||0
895838|NCT01830205|2165505|P1|NOT COMPLETED|Overall Study||0
895839|NCT01830205|2165502|P4|COMPLETED|Overall Study||12
895840|NCT01830205|2165503|P3|COMPLETED|Overall Study||6
895841|NCT01830205|2165504|P2|COMPLETED|Overall Study||6
895842|NCT01830205|2165505|P1|COMPLETED|Overall Study||12
895843|NCT01830205|2165502|P4|STARTED|Overall Study||12
895844|NCT01830205|2165503|P3|STARTED|Overall Study||6
895845|NCT01830205|2165504|P2|STARTED|Overall Study||6
895846|NCT01830205|2165505|P1|STARTED|Overall Study||12
895847|NCT01830140|2165589|P2|NOT COMPLETED|Overall Study||4
895848|NCT01830140|2165590|P1|NOT COMPLETED|Overall Study||7
895849|NCT01830140|2165589|P2|COMPLETED|Overall Study||229
895850|NCT01830140|2165590|P1|COMPLETED|Overall Study||226
895851|NCT01830140|2165589|P2|STARTED|Overall Study||233
895852|NCT01830140|2165590|P1|STARTED|Overall Study||233
895853|NCT01830127|2165598|P2|NOT COMPLETED|Overall Study||9
895854|NCT01830127|2165599|P1|NOT COMPLETED|Overall Study||5
895855|NCT01830127|2165598|P2|COMPLETED|Overall Study||8
895856|NCT01830127|2165599|P1|COMPLETED|Overall Study||13
895857|NCT01830127|2165598|P2|STARTED|Overall Study||17
895858|NCT01830127|2165599|P1|STARTED|Overall Study||18
895859|NCT01829919|2165607|P1|NOT COMPLETED|Overall Study||0
895860|NCT01829919|2165607|P1|COMPLETED|Overall Study||24
895861|NCT01829919|2165607|P1|STARTED|Overall Study||24
895862|NCT01829516|2165623|P2|NOT COMPLETED|2nd Intervention||0
895863|NCT01829516|2165624|P1|NOT COMPLETED|2nd Intervention||0
895864|NCT01829516|2165623|P2|COMPLETED|2nd Intervention||14
895865|NCT01829516|2165624|P1|COMPLETED|2nd Intervention||18
895866|NCT01829516|2165623|P2|STARTED|2nd Intervention||14
895867|NCT01829516|2165624|P1|STARTED|2nd Intervention||18
895868|NCT01829516|2165623|P2|NOT COMPLETED|Washout Period - 1 Week||0
895869|NCT01829516|2165624|P1|NOT COMPLETED|Washout Period - 1 Week||0
895870|NCT01829516|2165623|P2|COMPLETED|Washout Period - 1 Week||14
895871|NCT01829516|2165624|P1|COMPLETED|Washout Period - 1 Week||18
895872|NCT01829516|2165623|P2|STARTED|Washout Period - 1 Week||14
895873|NCT01829516|2165624|P1|STARTED|Washout Period - 1 Week||18
895874|NCT01829516|2165623|P2|NOT COMPLETED|First Intervention||0
895875|NCT01829516|2165624|P1|NOT COMPLETED|First Intervention||0
895876|NCT01829516|2165623|P2|COMPLETED|First Intervention||14
895877|NCT01829516|2165624|P1|COMPLETED|First Intervention||18
895878|NCT01829516|2165623|P2|STARTED|First Intervention||14
895879|NCT01829516|2165624|P1|STARTED|First Intervention||18
895880|NCT01829503|2165632|P1|NOT COMPLETED|Overall Study||0
895881|NCT01829503|2165632|P1|COMPLETED|Overall Study||44
895882|NCT01829503|2165632|P1|STARTED|Overall Study||44
895883|NCT01829477|2165648|P2|NOT COMPLETED|Overall Study||15
895884|NCT01829477|2165649|P1|NOT COMPLETED|Overall Study||16
895885|NCT01829477|2165648|P2|COMPLETED|Overall Study||1
895886|NCT01829477|2165649|P1|COMPLETED|Overall Study||1
895887|NCT01829477|2165648|P2|STARTED|Overall Study||16
895888|NCT01829477|2165649|P1|STARTED|Overall Study||17
895889|NCT01829464|2165662|P3|NOT COMPLETED|Overall Study||26
895890|NCT01829464|2165663|P2|NOT COMPLETED|Overall Study||29
895891|NCT01829464|2165664|P1|NOT COMPLETED|Overall Study||28
895892|NCT01829464|2165662|P3|COMPLETED|Overall Study||3
895893|NCT01829464|2165663|P2|COMPLETED|Overall Study||2
895894|NCT01829464|2165664|P1|COMPLETED|Overall Study||2
895895|NCT01829464|2165662|P3|STARTED|Overall Study||29
895896|NCT01829464|2165663|P2|STARTED|Overall Study||31
895897|NCT01829464|2165664|P1|STARTED|Overall Study||30
895898|NCT01829399|2165680|P2|NOT COMPLETED|Visit 2 (One Month Later)||0
895899|NCT01829399|2165681|P1|NOT COMPLETED|Visit 2 (One Month Later)||0
895900|NCT01829399|2165680|P2|COMPLETED|Visit 2 (One Month Later)||12
895901|NCT01829399|2165681|P1|COMPLETED|Visit 2 (One Month Later)||12
895902|NCT01829399|2165680|P2|STARTED|Visit 2 (One Month Later)||12
895903|NCT01829399|2165681|P1|STARTED|Visit 2 (One Month Later)||12
895904|NCT01829399|2165680|P2|NOT COMPLETED|Visit 1||0
895905|NCT01829399|2165681|P1|NOT COMPLETED|Visit 1||0
895906|NCT01829399|2165680|P2|COMPLETED|Visit 1||12
895907|NCT01829399|2165681|P1|COMPLETED|Visit 1||12
895908|NCT01829399|2165680|P2|STARTED|Visit 1||12
895909|NCT01829399|2165681|P1|STARTED|Visit 1||12
895910|NCT01829243|2165689|P2|NOT COMPLETED|Second Intervention||0
895911|NCT01829243|2165690|P1|NOT COMPLETED|Second Intervention||0
895912|NCT01829243|2165689|P2|COMPLETED|Second Intervention||13
895913|NCT01829243|2165690|P1|COMPLETED|Second Intervention||7
895914|NCT01829243|2165689|P2|STARTED|Second Intervention||13
895915|NCT01829243|2165690|P1|STARTED|Second Intervention||7
895916|NCT01829243|2165689|P2|NOT COMPLETED|Washout Period of 1 Week||0
895917|NCT01829243|2165690|P1|NOT COMPLETED|Washout Period of 1 Week||0
895918|NCT01829243|2165689|P2|COMPLETED|Washout Period of 1 Week||13
895919|NCT01829243|2165690|P1|COMPLETED|Washout Period of 1 Week||7
895920|NCT01829243|2165689|P2|STARTED|Washout Period of 1 Week||13
895921|NCT01829243|2165690|P1|STARTED|Washout Period of 1 Week||7
895922|NCT01829243|2165689|P2|NOT COMPLETED|First Intervention||2
895923|NCT01829243|2165690|P1|NOT COMPLETED|First Intervention||4
895924|NCT01829243|2165689|P2|COMPLETED|First Intervention||13
895925|NCT01829243|2165690|P1|COMPLETED|First Intervention||7
895926|NCT01829243|2165689|P2|STARTED|First Intervention||15
895927|NCT01829243|2165690|P1|STARTED|First Intervention||11
895928|NCT01829230|2165704|P2|NOT COMPLETED|Overall Study||4
895929|NCT01829230|2165705|P1|NOT COMPLETED|Overall Study||1
895930|NCT01829230|2165704|P2|COMPLETED|Overall Study||38
895931|NCT01829230|2165705|P1|COMPLETED|Overall Study||39
895932|NCT01829230|2165704|P2|STARTED|Overall Study||42
895933|NCT01829230|2165705|P1|STARTED|Overall Study||40
895934|NCT01829191|2165715|P2|NOT COMPLETED|Overall Study||14
895935|NCT01829191|2165716|P1|NOT COMPLETED|Overall Study||7
895936|NCT01829191|2165715|P2|COMPLETED|Overall Study||50
895937|NCT01829191|2165716|P1|COMPLETED|Overall Study||56
895938|NCT01829191|2165715|P2|STARTED|Overall Study||64
895939|NCT01829191|2165716|P1|STARTED|Overall Study||63
895940|NCT01828593|2165726|P3|NOT COMPLETED|Placebo-Free Phase||6
895941|NCT01828593|2165727|P2|NOT COMPLETED|Placebo-Free Phase||6
895942|NCT01828593|2165728|P1|NOT COMPLETED|Placebo-Free Phase||0
895943|NCT01828593|2165726|P3|COMPLETED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|41
895944|NCT01828593|2165727|P2|COMPLETED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|49
895945|NCT01828593|2165728|P1|COMPLETED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
895946|NCT01828593|2165726|P3|STARTED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|47
895947|NCT01828593|2165727|P2|STARTED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|55
895948|NCT01828593|2165728|P1|STARTED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
895949|NCT01828593|2165726|P3|NOT COMPLETED|Placebo-Controlled Phase||1
895950|NCT01828593|2165727|P2|NOT COMPLETED|Placebo-Controlled Phase||0
895951|NCT01828593|2165728|P1|NOT COMPLETED|Placebo-Controlled Phase||0
895952|NCT01828593|2165726|P3|COMPLETED|Placebo-Controlled Phase||32
895953|NCT01828593|2165727|P2|COMPLETED|Placebo-Controlled Phase||34
895954|NCT01828593|2165728|P1|COMPLETED|Placebo-Controlled Phase||36
895955|NCT01828593|2165726|P3|STARTED|Placebo-Controlled Phase||33
895956|NCT01828593|2165727|P2|STARTED|Placebo-Controlled Phase||34
895957|NCT01828593|2165728|P1|STARTED|Placebo-Controlled Phase||36
895958|NCT01828476|2165751|P2|NOT COMPLETED|Overall Study||0
895959|NCT01828476|2165752|P1|NOT COMPLETED|Overall Study||0
895960|NCT01828476|2165751|P2|COMPLETED|Overall Study||0
895961|NCT01828476|2165752|P1|COMPLETED|Overall Study||13
895962|NCT01828476|2165751|P2|STARTED|Overall Study||0
895963|NCT01828476|2165752|P1|STARTED|Overall Study||13
895964|NCT01828281|2165774|P2|NOT COMPLETED|Overall Study||0
895965|NCT01828281|2165775|P1|NOT COMPLETED|Overall Study||1
895966|NCT01828281|2165774|P2|COMPLETED|Overall Study||45
895967|NCT01828281|2165775|P1|COMPLETED|Overall Study||44
895968|NCT01828281|2165774|P2|STARTED|Overall Study||45
895969|NCT01828281|2165775|P1|STARTED|Overall Study||45
895970|NCT01828216|2165787|P2|NOT COMPLETED|Overall Study||0
895971|NCT01828216|2165788|P1|NOT COMPLETED|Overall Study||0
895972|NCT01828216|2165787|P2|COMPLETED|Overall Study||157
895973|NCT01828216|2165788|P1|COMPLETED|Overall Study||159
895974|NCT01828216|2165787|P2|STARTED|Overall Study||157
895975|NCT01828216|2165788|P1|STARTED|Overall Study||159
895976|NCT01828164|2165796|P1|NOT COMPLETED|Overall Study||17
895977|NCT01828164|2165796|P1|COMPLETED|Overall Study||32
895978|NCT01828164|2165796|P1|STARTED|Overall Study|11 out of 60 subjects did not meet inclusion criteria after enrollment.|49
895979|NCT01828112|2165808|P2|NOT COMPLETED|Overall Study||108
895980|NCT01828112|2165809|P1|NOT COMPLETED|Overall Study||82
895981|NCT01828112|2165808|P2|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|8
895982|NCT01828112|2165809|P1|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|33
895983|NCT01828112|2165808|P2|Treated|Overall Study||113
895984|NCT01828112|2165809|P1|Treated|Overall Study||115
895985|NCT01828112|2165808|P2|Untreated|Overall Study||3
895986|NCT01828112|2165809|P1|Untreated|Overall Study||0
895987|NCT01828112|2165808|P2|Untreated Patients|Overall Study|untreated = did not receive study drug|3
895988|NCT01828112|2165809|P1|Untreated Patients|Overall Study||0
895989|NCT01828112|2165808|P2|Discontinued From Study|Overall Study||10
895990|NCT01828112|2165809|P1|Discontinued From Study|Overall Study||14
895991|NCT01828112|2165808|P2|Entered Survival Follow-up Phase|Overall Study||19
895992|NCT01828112|2165809|P1|Entered Survival Follow-up Phase|Overall Study||61
895993|NCT01828112|2165808|P2|Entered Post-treatment Follow-up Phase|Overall Study||5
895994|NCT01828112|2165809|P1|Entered Post-treatment Follow-up Phase|Overall Study||7
895995|NCT01828112|2165808|P2|Entered Extension Treatment Phase|Overall Study||74
895996|NCT01828112|2165809|P1|Entered Extension Treatment Phase|Overall Study||0
895997|NCT01828112|2165808|P2|STARTED|Overall Study||116
895998|NCT01828112|2165809|P1|STARTED|Overall Study||115
895999|NCT01828099|2165817|P2|NOT COMPLETED|Overall Study||157
896000|NCT01828099|2165818|P1|NOT COMPLETED|Overall Study||94
896001|NCT01828099|2165817|P2|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|30
896002|NCT01828099|2165818|P1|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|95
896003|NCT01828099|2165817|P2|Discontinued From Study|Overall Study||29
896004|NCT01828099|2165818|P1|Discontinued From Study|Overall Study||20
896005|NCT01828099|2165817|P2|Entered Survival Follow-up Phase|Overall Study||31
896006|NCT01828099|2165818|P1|Entered Survival Follow-up Phase|Overall Study||64
896007|NCT01828099|2165817|P2|Entered Post-treatment Follow-up Phase|Overall Study||16
896008|NCT01828099|2165818|P1|Entered Post-treatment Follow-up Phase|Overall Study||10
896009|NCT01828099|2165817|P2|Entered Extension-treatment Phase|Overall Study||81
896010|NCT01828099|2165818|P1|Entered Extension-treatment Phase|Overall Study||0
896011|NCT01828099|2165817|P2|Discontinued From Treatment Phase|Overall Study||157
896012|NCT01828099|2165818|P1|Discontinued From Treatment Phase|Overall Study||94
896013|NCT01828099|2165817|P2|Treated|Overall Study||175
896014|NCT01828099|2165818|P1|Treated|Overall Study|discontinued from treatment phase = Not completed|189
896015|NCT01828099|2165817|P2|Untreated Patients|Overall Study||12
896016|NCT01828099|2165818|P1|Untreated Patients|Overall Study||0
896017|NCT01828099|2165817|P2|STARTED|Overall Study||187
896018|NCT01828099|2165818|P1|STARTED|Overall Study||189
896019|NCT01827839|2165824|P1|NOT COMPLETED|Overall Study||3
896020|NCT01827839|2165824|P1|COMPLETED|Overall Study||93
896021|NCT01827839|2165824|P1|STARTED|Overall Study||96
896022|NCT01827670|2165848|P2|NOT COMPLETED|Overall Study||3
896023|NCT01827670|2165849|P1|NOT COMPLETED|Overall Study||3
896024|NCT01827670|2165848|P2|COMPLETED|Overall Study||56
896025|NCT01827670|2165849|P1|COMPLETED|Overall Study||57
896026|NCT01827670|2165848|P2|STARTED|Overall Study||59
896027|NCT01827670|2165849|P1|STARTED|Overall Study||60
896028|NCT01827592|2165868|P3|NOT COMPLETED|Overall Study||76
896029|NCT01827592|2165869|P2|NOT COMPLETED|Overall Study||80
896030|NCT01827592|2165870|P1|NOT COMPLETED|Overall Study||74
896031|NCT01827592|2165868|P3|COMPLETED|Overall Study||48
896032|NCT01827592|2165869|P2|COMPLETED|Overall Study||46
896033|NCT01827592|2165870|P1|COMPLETED|Overall Study||52
896034|NCT01827592|2165868|P3|Safety Analysis Set|Overall Study||124
896035|NCT01827592|2165869|P2|Safety Analysis Set|Overall Study||126
896036|NCT01827592|2165870|P1|Safety Analysis Set|Overall Study|1 patient withdrew consent before getting the treatment.|125
896037|NCT01827592|2165868|P3|STARTED|Overall Study|Randomized patients.|124
896038|NCT01827592|2165869|P2|STARTED|Overall Study|Randomized patients.|126
896039|NCT01827592|2165870|P1|STARTED|Overall Study|Randomized patients.|126
896040|NCT01826370|2165899|P1|NOT COMPLETED|Overall Study||20
896041|NCT01826370|2165899|P1|COMPLETED|Overall Study||658
896042|NCT01826370|2165899|P1|STARTED|Overall Study||678
896043|NCT01827475|2165908|P3|NOT COMPLETED|Overall Study||0
896044|NCT01827475|2165909|P2|NOT COMPLETED|Overall Study||0
896045|NCT01827475|2165910|P1|NOT COMPLETED|Overall Study||0
896046|NCT01827475|2165908|P3|COMPLETED|Overall Study||30
896047|NCT01827475|2165909|P2|COMPLETED|Overall Study||30
896048|NCT01827475|2165910|P1|COMPLETED|Overall Study||30
896049|NCT01827475|2165908|P3|STARTED|Overall Study||30
896050|NCT01827475|2165909|P2|STARTED|Overall Study||30
896051|NCT01827475|2165910|P1|STARTED|Overall Study||30
896052|NCT01827462|2165924|P3|NOT COMPLETED|Overall Study||28
896053|NCT01827462|2165925|P2|NOT COMPLETED|Overall Study||18
896054|NCT01827462|2165926|P1|NOT COMPLETED|Overall Study||41
896055|NCT01827462|2165924|P3|COMPLETED|Overall Study||12
896056|NCT01827462|2165925|P2|COMPLETED|Overall Study||19
896057|NCT01827462|2165926|P1|COMPLETED|Overall Study||18
896058|NCT01827462|2165924|P3|STARTED|Overall Study||40
896059|NCT01827462|2165925|P2|STARTED|Overall Study||37
896060|NCT01827462|2165926|P1|STARTED|Overall Study||59
896061|NCT01827371|2165941|P4|NOT COMPLETED|Overall Study||23
896062|NCT01827371|2165942|P3|NOT COMPLETED|Overall Study||11
896063|NCT01827371|2165943|P2|NOT COMPLETED|Overall Study||7
896064|NCT01827371|2165944|P1|NOT COMPLETED|Overall Study||13
896065|NCT01827371|2165941|P4|COMPLETED|Overall Study||97
896066|NCT01827371|2165942|P3|COMPLETED|Overall Study||93
896067|NCT01827371|2165943|P2|COMPLETED|Overall Study||89
896068|NCT01827371|2165944|P1|COMPLETED|Overall Study||102
896069|NCT01827371|2165941|P4|STARTED|Overall Study||120
896070|NCT01827371|2165942|P3|STARTED|Overall Study||104
896071|NCT01827371|2165943|P2|STARTED|Overall Study||96
896072|NCT01827371|2165944|P1|STARTED|Overall Study||115
896073|NCT01827358|2165968|P2|NOT COMPLETED|Overall Study||31
896074|NCT01827358|2165969|P1|NOT COMPLETED|Overall Study||35
896075|NCT01827358|2165968|P2|COMPLETED|Overall Study||44
896076|NCT01827358|2165969|P1|COMPLETED|Overall Study||45
896077|NCT01827358|2165968|P2|STARTED|Overall Study||75
896078|NCT01827358|2165969|P1|STARTED|Overall Study||80
896079|NCT01827332|2166003|P2|NOT COMPLETED|Overall Study||1
896080|NCT01827332|2166004|P1|NOT COMPLETED|Overall Study||2
896081|NCT01827332|2166003|P2|COMPLETED|Overall Study||7
896082|NCT01827332|2166004|P1|COMPLETED|Overall Study||6
896083|NCT01827332|2166003|P2|STARTED|Overall Study||8
896084|NCT01827332|2166004|P1|STARTED|Overall Study||8
896085|NCT01827319|2166012|P1|NOT COMPLETED|Overall Study||3
896086|NCT01827319|2166012|P1|COMPLETED|Overall Study||200
896087|NCT01827319|2166012|P1|STARTED|Overall Study||203
896088|NCT01827306|2166020|P2|NOT COMPLETED|Overall Study||5
896089|NCT01827306|2166021|P1|NOT COMPLETED|Overall Study||11
896090|NCT01827306|2166020|P2|COMPLETED|Overall Study||8
896091|NCT01827306|2166021|P1|COMPLETED|Overall Study||10
896092|NCT01827306|2166020|P2|STARTED|Overall Study||13
896093|NCT01827306|2166021|P1|STARTED|Overall Study||21
896094|NCT01827267|2166035|P2|NOT COMPLETED|Overall Study||12
896095|NCT01827267|2166036|P1|NOT COMPLETED|Overall Study||5
896096|NCT01827267|2166035|P2|COMPLETED|Overall Study||32
896097|NCT01827267|2166036|P1|COMPLETED|Overall Study||13
896098|NCT01827267|2166035|P2|Recieved Study Drug|Overall Study||43
896099|NCT01827267|2166036|P1|Recieved Study Drug|Overall Study||17
896100|NCT01827267|2166035|P2|STARTED|Overall Study|44 subjects were randomized; 43 subjects were treated.|44
896101|NCT01827267|2166036|P1|STARTED|Overall Study|18 subjects were randomized but 17 received treatment.|18
896102|NCT01827254|2166051|P1|NOT COMPLETED|Overall Study||59
896103|NCT01827254|2166051|P1|COMPLETED|Overall Study||2
896104|NCT01827254|2166051|P1|Evaluable Population|Overall Study||52
896105|NCT01827254|2166051|P1|STARTED|Overall Study||61
896106|NCT01826981|2166076|P15|NOT COMPLETED|Overall Study||0
896107|NCT01826981|2166077|P14|NOT COMPLETED|Overall Study||5
896108|NCT01826981|2166078|P13|NOT COMPLETED|Overall Study||1
896109|NCT01826981|2166079|P12|NOT COMPLETED|Overall Study||2
896110|NCT01826981|2166080|P11|NOT COMPLETED|Overall Study||2
896111|NCT01826981|2166081|P10|NOT COMPLETED|Overall Study||1
896112|NCT01826981|2166082|P9|NOT COMPLETED|Overall Study||7
896113|NCT01826981|2166083|P8|NOT COMPLETED|Overall Study||11
896114|NCT01826981|2166084|P7|NOT COMPLETED|Overall Study||1
896115|NCT01826981|2166085|P6|NOT COMPLETED|Overall Study||1
896116|NCT01826981|2166086|P5|NOT COMPLETED|Overall Study||7
896117|NCT01826981|2166087|P4|NOT COMPLETED|Overall Study||0
896118|NCT01826981|2166088|P3|NOT COMPLETED|Overall Study||0
896119|NCT01826981|2166089|P2|NOT COMPLETED|Overall Study||1
896120|NCT01826981|2166090|P1|NOT COMPLETED|Overall Study||0
896121|NCT01826981|2166076|P15|COMPLETED|Overall Study||8
896122|NCT01826981|2166077|P14|COMPLETED|Overall Study||15
896123|NCT01826981|2166078|P13|COMPLETED|Overall Study||25
896124|NCT01826981|2166079|P12|COMPLETED|Overall Study||25
896125|NCT01826981|2166080|P11|COMPLETED|Overall Study||22
896126|NCT01826981|2166081|P10|COMPLETED|Overall Study||26
896127|NCT01826981|2166082|P9|COMPLETED|Overall Study||13
896128|NCT01826981|2166083|P8|COMPLETED|Overall Study||40
896129|NCT01826981|2166084|P7|COMPLETED|Overall Study||24
896130|NCT01826981|2166085|P6|COMPLETED|Overall Study||25
896131|NCT01826981|2166086|P5|COMPLETED|Overall Study||18
896132|NCT01826981|2166087|P4|COMPLETED|Overall Study||26
896133|NCT01826981|2166088|P3|COMPLETED|Overall Study||25
896134|NCT01826981|2166089|P2|COMPLETED|Overall Study||9
896135|NCT01826981|2166090|P1|COMPLETED|Overall Study||19
896136|NCT01826981|2166076|P15|STARTED|Overall Study||8
896137|NCT01826981|2166077|P14|STARTED|Overall Study||20
896138|NCT01826981|2166078|P13|STARTED|Overall Study||26
896139|NCT01826981|2166079|P12|STARTED|Overall Study||27
896140|NCT01826981|2166080|P11|STARTED|Overall Study||24
896141|NCT01826981|2166081|P10|STARTED|Overall Study||27
896142|NCT01826981|2166082|P9|STARTED|Overall Study||20
896143|NCT01826981|2166083|P8|STARTED|Overall Study||51
896144|NCT01826981|2166084|P7|STARTED|Overall Study||25
896145|NCT01826981|2166085|P6|STARTED|Overall Study||26
896146|NCT01826981|2166086|P5|STARTED|Overall Study||25
896147|NCT01826981|2166087|P4|STARTED|Overall Study||26
896148|NCT01826981|2166088|P3|STARTED|Overall Study||25
896149|NCT01826981|2166089|P2|STARTED|Overall Study||10
896150|NCT01826981|2166090|P1|STARTED|Overall Study||19
896151|NCT01826812|2166238|P2|NOT COMPLETED|Overall Study||1
896152|NCT01826812|2166239|P1|NOT COMPLETED|Overall Study||0
896153|NCT01826812|2166238|P2|COMPLETED|Overall Study||32
896154|NCT01826812|2166239|P1|COMPLETED|Overall Study||167
896155|NCT01826812|2166238|P2|STARTED|Overall Study||33
896156|NCT01826812|2166239|P1|STARTED|Overall Study||167
896157|NCT01826604|2166253|P2|NOT COMPLETED|Overall Study||9
896158|NCT01826604|2166254|P1|NOT COMPLETED|Overall Study||8
896159|NCT01826604|2166253|P2|COMPLETED|Overall Study||148
896160|NCT01826604|2166254|P1|COMPLETED|Overall Study||136
896161|NCT01826604|2166253|P2|STARTED|Overall Study||157
896162|NCT01826604|2166254|P1|STARTED|Overall Study||144
896163|NCT01826513|2166265|P3|NOT COMPLETED|Overall Study||0
896164|NCT01826513|2166266|P2|NOT COMPLETED|Overall Study||0
896165|NCT01826513|2166267|P1|NOT COMPLETED|Overall Study||0
896166|NCT01826513|2166265|P3|COMPLETED|Overall Study||10
896167|NCT01826513|2166266|P2|COMPLETED|Overall Study||10
896168|NCT01826513|2166267|P1|COMPLETED|Overall Study||5
896169|NCT01826513|2166265|P3|STARTED|Overall Study||10
896170|NCT01826513|2166266|P2|STARTED|Overall Study||10
896171|NCT01826513|2166267|P1|STARTED|Overall Study||5
896172|NCT01826214|2166298|P2|NOT COMPLETED|Overall Study||34
896173|NCT01826214|2166299|P1|NOT COMPLETED|Overall Study||35
896174|NCT01826214|2166298|P2|COMPLETED|Overall Study||0
896175|NCT01826214|2166299|P1|COMPLETED|Overall Study||0
896176|NCT01826214|2166298|P2|Treated|Overall Study|Treated = received at least one dose of study drug|34
896177|NCT01826214|2166299|P1|Treated|Overall Study|Treated = received at least one dose of study drug|35
896178|NCT01826214|2166298|P2|Untreated|Overall Study|Untreated = did not receive study drug|1
896179|NCT01826214|2166299|P1|Untreated|Overall Study|Untreated = did not receive study drug|0
896180|NCT01826214|2166298|P2|STARTED|Overall Study|35 patients were randomized but only 34 patients received at least one dose of study drug|34
896181|NCT01826214|2166299|P1|STARTED|Overall Study||35
896182|NCT01826201|2166317|P1|NOT COMPLETED|Overall Study||4
896183|NCT01826201|2166317|P1|COMPLETED|Overall Study||17
896184|NCT01826201|2166317|P1|STARTED|Overall Study|Subjects in each arm are same|21
896185|NCT01825837|2166327|P4|NOT COMPLETED|PART II||0
896186|NCT01825837|2166328|P3|NOT COMPLETED|PART II||19
896187|NCT01825837|2166329|P2|NOT COMPLETED|PART II||14
896188|NCT01825837|2166330|P1|NOT COMPLETED|PART II||19
896189|NCT01825837|2166327|P4|COMPLETED|PART II||0
896190|NCT01825837|2166328|P3|COMPLETED|PART II||7
896191|NCT01825837|2166329|P2|COMPLETED|PART II||12
896192|NCT01825837|2166330|P1|COMPLETED|PART II||16
896193|NCT01825837|2166327|P4|Per-Protocol Population|PART II||0
896194|NCT01825837|2166328|P3|Per-Protocol Population|PART II||24
896195|NCT01825837|2166329|P2|Per-Protocol Population|PART II||23
896196|NCT01825837|2166330|P1|Per-Protocol Population|PART II||32
896197|NCT01825837|2166327|P4|Intent-to-Treat Population|PART II||0
896198|NCT01825837|2166328|P3|Intent-to-Treat Population|PART II||26
896199|NCT01825837|2166329|P2|Intent-to-Treat Population|PART II||25
896200|NCT01825837|2166330|P1|Intent-to-Treat Population|PART II||34
896201|NCT01825837|2166327|P4|Safety Population (Double-Blind)|PART II||0
896202|NCT01825837|2166328|P3|Safety Population (Double-Blind)|PART II||26
896203|NCT01825837|2166329|P2|Safety Population (Double-Blind)|PART II||26
896204|NCT01825837|2166330|P1|Safety Population (Double-Blind)|PART II||35
896205|NCT01825837|2166327|P4|Randomized Patients|PART II||0
896206|NCT01825837|2166328|P3|Randomized Patients|PART II||26
896207|NCT01825837|2166329|P2|Randomized Patients|PART II||26
896208|NCT01825837|2166330|P1|Randomized Patients|PART II||35
896209|NCT01825837|2166327|P4|STARTED|PART II||0
896210|NCT01825837|2166328|P3|STARTED|PART II||26
896211|NCT01825837|2166329|P2|STARTED|PART II||26
896212|NCT01825837|2166330|P1|STARTED|PART II||35
896213|NCT01825837|2166327|P4|NOT COMPLETED|PART I||17
896214|NCT01825837|2166328|P3|NOT COMPLETED|PART I||0
896215|NCT01825837|2166329|P2|NOT COMPLETED|PART I||0
896216|NCT01825837|2166330|P1|NOT COMPLETED|PART I||0
896217|NCT01825837|2166327|P4|COMPLETED|PART I||87
896218|NCT01825837|2166328|P3|COMPLETED|PART I||0
896219|NCT01825837|2166329|P2|COMPLETED|PART I||0
896220|NCT01825837|2166330|P1|COMPLETED|PART I||0
896221|NCT01825837|2166327|P4|Safety Population (Open-Label)|PART I||104
896222|NCT01825837|2166328|P3|Safety Population (Open-Label)|PART I||0
896223|NCT01825837|2166329|P2|Safety Population (Open-Label)|PART I||0
896224|NCT01825837|2166330|P1|Safety Population (Open-Label)|PART I||0
896225|NCT01825837|2166327|P4|Enrolled|PART I||104
896226|NCT01825837|2166328|P3|Enrolled|PART I||0
896227|NCT01825837|2166329|P2|Enrolled|PART I||0
896228|NCT01825837|2166330|P1|Enrolled|PART I||0
896229|NCT01825837|2166327|P4|STARTED|PART I||104
896230|NCT01825837|2166328|P3|STARTED|PART I||0
896231|NCT01825837|2166329|P2|STARTED|PART I||0
896232|NCT01825837|2166330|P1|STARTED|PART I||0
896233|NCT01825577|2166338|P1|NOT COMPLETED|Overall Study||8
896234|NCT01825577|2166338|P1|COMPLETED|Overall Study||6
896235|NCT01825577|2166338|P1|STARTED|Overall Study||14
896236|NCT01825408|2166347|P4|NOT COMPLETED|Overall Study||0
896237|NCT01825408|2166348|P3|NOT COMPLETED|Overall Study||0
896238|NCT01825408|2166349|P2|NOT COMPLETED|Overall Study||0
896239|NCT01825408|2166350|P1|NOT COMPLETED|Overall Study||0
896240|NCT01825408|2166347|P4|COMPLETED|Overall Study||12
896241|NCT01825408|2166348|P3|COMPLETED|Overall Study||14
896242|NCT01825408|2166349|P2|COMPLETED|Overall Study||7
896243|NCT01825408|2166350|P1|COMPLETED|Overall Study||7
896244|NCT01825408|2166347|P4|STARTED|Overall Study||12
896245|NCT01825408|2166348|P3|STARTED|Overall Study||14
896246|NCT01825408|2166349|P2|STARTED|Overall Study||7
896247|NCT01825408|2166350|P1|STARTED|Overall Study||7
896248|NCT01825200|2166362|P2|NOT COMPLETED|Overall Study||7
896249|NCT01825200|2166363|P1|NOT COMPLETED|Overall Study||5
896250|NCT01825200|2166362|P2|COMPLETED|Overall Study||1314
896251|NCT01825200|2166363|P1|COMPLETED|Overall Study||1314
896252|NCT01825200|2166362|P2|STARTED|Overall Study||1321
896253|NCT01825200|2166363|P1|STARTED|Overall Study||1319
896254|NCT01825122|2166377|P2|NOT COMPLETED|Overall Study||19
896255|NCT01825122|2166378|P1|NOT COMPLETED|Overall Study||10
896256|NCT01825122|2166377|P2|COMPLETED|Overall Study||59
896257|NCT01825122|2166378|P1|COMPLETED|Overall Study||67
896258|NCT01825122|2166377|P2|STARTED|Overall Study||78
896259|NCT01825122|2166378|P1|STARTED|Overall Study||77
896260|NCT01824901|2166384|P4|NOT COMPLETED|Overall Study||0
896261|NCT01824901|2166385|P3|NOT COMPLETED|Overall Study||0
896262|NCT01824901|2166386|P2|NOT COMPLETED|Overall Study||0
896263|NCT01824901|2166387|P1|NOT COMPLETED|Overall Study||0
896264|NCT01824901|2166384|P4|COMPLETED|Overall Study||0
896265|NCT01824901|2166385|P3|COMPLETED|Overall Study||0
896266|NCT01824901|2166386|P2|COMPLETED|Overall Study||0
896267|NCT01824901|2166387|P1|COMPLETED|Overall Study||2
896268|NCT01824901|2166384|P4|STARTED|Overall Study||0
896269|NCT01824901|2166385|P3|STARTED|Overall Study||0
896270|NCT01824901|2166386|P2|STARTED|Overall Study||0
896271|NCT01824901|2166387|P1|STARTED|Overall Study||2
896272|NCT01824823|2166393|P2|NOT COMPLETED|Overall Study||1
896273|NCT01824823|2166394|P1|NOT COMPLETED|Overall Study||2
896274|NCT01824823|2166393|P2|COMPLETED|Overall Study||0
896275|NCT01824823|2166394|P1|COMPLETED|Overall Study||0
896276|NCT01824823|2166393|P2|STARTED|Overall Study||1
896277|NCT01824823|2166394|P1|STARTED|Overall Study||2
896278|NCT01824602|2166404|P4|NOT COMPLETED|Overall Study||5
896279|NCT01824602|2166405|P3|NOT COMPLETED|Overall Study||4
896280|NCT01824602|2166406|P2|NOT COMPLETED|Overall Study||0
896281|NCT01824602|2166407|P1|NOT COMPLETED|Overall Study||1
896282|NCT01824602|2166404|P4|COMPLETED|Overall Study||5
896283|NCT01824602|2166405|P3|COMPLETED|Overall Study||5
896284|NCT01824602|2166406|P2|COMPLETED|Overall Study||8
896285|NCT01824602|2166407|P1|COMPLETED|Overall Study||10
896286|NCT01824602|2166404|P4|Intent-to-treat Population|Overall Study||9
896287|NCT01824602|2166405|P3|Intent-to-treat Population|Overall Study||9
896288|NCT01824602|2166406|P2|Intent-to-treat Population|Overall Study||8
896289|NCT01824602|2166407|P1|Intent-to-treat Population|Overall Study||11
896290|NCT01824602|2166404|P4|Safety Population|Overall Study||10
896291|NCT01824602|2166405|P3|Safety Population|Overall Study||9
896292|NCT01824602|2166406|P2|Safety Population|Overall Study||8
896293|NCT01824602|2166407|P1|Safety Population|Overall Study||11
896294|NCT01824602|2166404|P4|STARTED|Overall Study||10
896295|NCT01824602|2166405|P3|STARTED|Overall Study||9
896296|NCT01824602|2166406|P2|STARTED|Overall Study||8
896297|NCT01824602|2166407|P1|STARTED|Overall Study||11
896298|NCT01824589|2166421|P4|NOT COMPLETED|Overall Study||0
896299|NCT01824589|2166422|P3|NOT COMPLETED|Overall Study||0
896300|NCT01824589|2166423|P2|NOT COMPLETED|Overall Study||0
896301|NCT01824589|2166424|P1|NOT COMPLETED|Overall Study||0
896302|NCT01824589|2166421|P4|COMPLETED|Overall Study||0
896303|NCT01824589|2166422|P3|COMPLETED|Overall Study||0
896304|NCT01824589|2166423|P2|COMPLETED|Overall Study||0
896305|NCT01824589|2166424|P1|COMPLETED|Overall Study||1
896306|NCT01824589|2166421|P4|STARTED|Overall Study||0
896307|NCT01824589|2166422|P3|STARTED|Overall Study||0
896308|NCT01824589|2166423|P2|STARTED|Overall Study||0
896309|NCT01824589|2166424|P1|STARTED|Overall Study||1
896310|NCT01824576|2166446|P1|NOT COMPLETED|Overall Study||2
896311|NCT01824576|2166446|P1|COMPLETED|Overall Study||7
896312|NCT01824576|2166446|P1|STARTED|Overall Study||9
896313|NCT01824498|2166464|P6|NOT COMPLETED|3rd Intervention (8 Weeks)||0
896314|NCT01824498|2166465|P5|NOT COMPLETED|3rd Intervention (8 Weeks)||0
896315|NCT01824498|2166466|P4|NOT COMPLETED|3rd Intervention (8 Weeks)||0
896316|NCT01824498|2166467|P3|NOT COMPLETED|3rd Intervention (8 Weeks)||0
896317|NCT01824498|2166468|P2|NOT COMPLETED|3rd Intervention (8 Weeks)||0
896318|NCT01824498|2166469|P1|NOT COMPLETED|3rd Intervention (8 Weeks)||0
896319|NCT01824498|2166464|P6|COMPLETED|3rd Intervention (8 Weeks)||4
896320|NCT01824498|2166465|P5|COMPLETED|3rd Intervention (8 Weeks)||3
896321|NCT01824498|2166466|P4|COMPLETED|3rd Intervention (8 Weeks)||2
896322|NCT01824498|2166467|P3|COMPLETED|3rd Intervention (8 Weeks)||4
896323|NCT01824498|2166468|P2|COMPLETED|3rd Intervention (8 Weeks)||2
896324|NCT01824498|2166469|P1|COMPLETED|3rd Intervention (8 Weeks)||3
896325|NCT01824498|2166464|P6|STARTED|3rd Intervention (8 Weeks)||4
896326|NCT01824498|2166465|P5|STARTED|3rd Intervention (8 Weeks)||3
896327|NCT01824498|2166466|P4|STARTED|3rd Intervention (8 Weeks)||2
896328|NCT01824498|2166467|P3|STARTED|3rd Intervention (8 Weeks)||4
896329|NCT01824498|2166468|P2|STARTED|3rd Intervention (8 Weeks)||2
896330|NCT01824498|2166469|P1|STARTED|3rd Intervention (8 Weeks)||3
896331|NCT01824498|2166464|P6|NOT COMPLETED|Washout (8 Weeks)||0
896332|NCT01824498|2166465|P5|NOT COMPLETED|Washout (8 Weeks)||0
896333|NCT01824498|2166466|P4|NOT COMPLETED|Washout (8 Weeks)||0
896334|NCT01824498|2166467|P3|NOT COMPLETED|Washout (8 Weeks)||0
896335|NCT01824498|2166468|P2|NOT COMPLETED|Washout (8 Weeks)||0
896336|NCT01824498|2166469|P1|NOT COMPLETED|Washout (8 Weeks)||0
896337|NCT01824498|2166464|P6|COMPLETED|Washout (8 Weeks)||4
896338|NCT01824498|2166465|P5|COMPLETED|Washout (8 Weeks)||3
896339|NCT01824498|2166466|P4|COMPLETED|Washout (8 Weeks)||2
896340|NCT01824498|2166467|P3|COMPLETED|Washout (8 Weeks)||4
896341|NCT01824498|2166468|P2|COMPLETED|Washout (8 Weeks)||2
896342|NCT01824498|2166469|P1|COMPLETED|Washout (8 Weeks)||3
896343|NCT01824498|2166464|P6|STARTED|Washout (8 Weeks)||4
896344|NCT01824498|2166465|P5|STARTED|Washout (8 Weeks)||3
896345|NCT01824498|2166466|P4|STARTED|Washout (8 Weeks)||2
896346|NCT01824498|2166467|P3|STARTED|Washout (8 Weeks)||4
896347|NCT01824498|2166468|P2|STARTED|Washout (8 Weeks)||2
896348|NCT01824498|2166469|P1|STARTED|Washout (8 Weeks)||3
896349|NCT01824498|2166464|P6|NOT COMPLETED|2nd Intervention (8 Weeks)||0
896350|NCT01824498|2166465|P5|NOT COMPLETED|2nd Intervention (8 Weeks)||0
896351|NCT01824498|2166466|P4|NOT COMPLETED|2nd Intervention (8 Weeks)||0
896352|NCT01824498|2166467|P3|NOT COMPLETED|2nd Intervention (8 Weeks)||0
896353|NCT01824498|2166468|P2|NOT COMPLETED|2nd Intervention (8 Weeks)||0
896354|NCT01824498|2166469|P1|NOT COMPLETED|2nd Intervention (8 Weeks)||0
896355|NCT01824498|2166464|P6|COMPLETED|2nd Intervention (8 Weeks)||4
896356|NCT01824498|2166465|P5|COMPLETED|2nd Intervention (8 Weeks)||3
896357|NCT01824498|2166466|P4|COMPLETED|2nd Intervention (8 Weeks)||2
896358|NCT01824498|2166467|P3|COMPLETED|2nd Intervention (8 Weeks)||4
896359|NCT01824498|2166468|P2|COMPLETED|2nd Intervention (8 Weeks)||2
896360|NCT01824498|2166469|P1|COMPLETED|2nd Intervention (8 Weeks)||3
896361|NCT01824498|2166464|P6|STARTED|2nd Intervention (8 Weeks)||4
896362|NCT01824498|2166465|P5|STARTED|2nd Intervention (8 Weeks)||3
896363|NCT01824498|2166466|P4|STARTED|2nd Intervention (8 Weeks)||2
896364|NCT01824498|2166467|P3|STARTED|2nd Intervention (8 Weeks)||4
896365|NCT01824498|2166468|P2|STARTED|2nd Intervention (8 Weeks)||2
896366|NCT01824498|2166469|P1|STARTED|2nd Intervention (8 Weeks)||3
896367|NCT01824498|2166464|P6|NOT COMPLETED|Washout (8 Weeks)||0
896368|NCT01824498|2166465|P5|NOT COMPLETED|Washout (8 Weeks)||1
896369|NCT01824498|2166466|P4|NOT COMPLETED|Washout (8 Weeks)||1
896370|NCT01824498|2166467|P3|NOT COMPLETED|Washout (8 Weeks)||2
896371|NCT01824498|2166468|P2|NOT COMPLETED|Washout (8 Weeks)||0
896372|NCT01824498|2166469|P1|NOT COMPLETED|Washout (8 Weeks)||2
896373|NCT01824498|2166464|P6|COMPLETED|Washout (8 Weeks)||4
896374|NCT01824498|2166465|P5|COMPLETED|Washout (8 Weeks)||3
896375|NCT01824498|2166466|P4|COMPLETED|Washout (8 Weeks)||2
896376|NCT01824498|2166467|P3|COMPLETED|Washout (8 Weeks)||4
896377|NCT01824498|2166468|P2|COMPLETED|Washout (8 Weeks)||2
896378|NCT01824498|2166469|P1|COMPLETED|Washout (8 Weeks)||3
896379|NCT01824498|2166464|P6|STARTED|Washout (8 Weeks)||4
896380|NCT01824498|2166465|P5|STARTED|Washout (8 Weeks)|1 dropped out|4
896381|NCT01824498|2166466|P4|STARTED|Washout (8 Weeks)|1 dropped out|3
896382|NCT01824498|2166467|P3|STARTED|Washout (8 Weeks)|2 dropped out|6
896383|NCT01824498|2166468|P2|STARTED|Washout (8 Weeks)||2
896384|NCT01824498|2166469|P1|STARTED|Washout (8 Weeks)|2 dropped out|5
896385|NCT01824498|2166464|P6|NOT COMPLETED|1st Intervention (8 Weeks)||0
896386|NCT01824498|2166465|P5|NOT COMPLETED|1st Intervention (8 Weeks)||0
896387|NCT01824498|2166466|P4|NOT COMPLETED|1st Intervention (8 Weeks)||0
896388|NCT01824498|2166467|P3|NOT COMPLETED|1st Intervention (8 Weeks)||0
896389|NCT01824498|2166468|P2|NOT COMPLETED|1st Intervention (8 Weeks)||0
896390|NCT01824498|2166469|P1|NOT COMPLETED|1st Intervention (8 Weeks)||0
896391|NCT01824498|2166464|P6|COMPLETED|1st Intervention (8 Weeks)||4
896392|NCT01824498|2166465|P5|COMPLETED|1st Intervention (8 Weeks)||4
896393|NCT01824498|2166466|P4|COMPLETED|1st Intervention (8 Weeks)||3
896394|NCT01824498|2166467|P3|COMPLETED|1st Intervention (8 Weeks)||6
896395|NCT01824498|2166468|P2|COMPLETED|1st Intervention (8 Weeks)||2
896396|NCT01824498|2166469|P1|COMPLETED|1st Intervention (8 Weeks)||5
896397|NCT01824498|2166464|P6|STARTED|1st Intervention (8 Weeks)||4
896398|NCT01824498|2166465|P5|STARTED|1st Intervention (8 Weeks)||4
896399|NCT01824498|2166466|P4|STARTED|1st Intervention (8 Weeks)||3
896400|NCT01824498|2166467|P3|STARTED|1st Intervention (8 Weeks)||6
896401|NCT01824498|2166468|P2|STARTED|1st Intervention (8 Weeks)||2
896402|NCT01824498|2166469|P1|STARTED|1st Intervention (8 Weeks)||5
896403|NCT01824446|2166477|P1|NOT COMPLETED|Overall Study||0
896404|NCT01824446|2166477|P1|COMPLETED|Overall Study||6
896405|NCT01824446|2166477|P1|STARTED|Overall Study||6
896406|NCT01824355|2166500|P1|NOT COMPLETED|Overall Study||3
896407|NCT01824355|2166500|P1|COMPLETED|Overall Study||110
896408|NCT01824355|2166500|P1|STARTED|Overall Study||113
896409|NCT01824342|2166511|P2|NOT COMPLETED|Overall Study||5
896410|NCT01824342|2166512|P1|NOT COMPLETED|Overall Study||9
896411|NCT01824342|2166511|P2|COMPLETED|Overall Study||2
896412|NCT01824342|2166512|P1|COMPLETED|Overall Study||2
896413|NCT01824342|2166511|P2|STARTED|Overall Study||7
896414|NCT01824342|2166512|P1|STARTED|Overall Study||11
896415|NCT01824303|2166526|P2|NOT COMPLETED|Open Label Extension||0
896416|NCT01824303|2166527|P1|NOT COMPLETED|Open Label Extension||0
896417|NCT01824303|2166526|P2|COMPLETED|Open Label Extension||11
896418|NCT01824303|2166527|P1|COMPLETED|Open Label Extension||12
896419|NCT01824303|2166526|P2|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|11
896420|NCT01824303|2166527|P1|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|12
896421|NCT01824303|2166526|P2|NOT COMPLETED|Randomized Study||1
896422|NCT01824303|2166527|P1|NOT COMPLETED|Randomized Study||2
896423|NCT01824303|2166526|P2|COMPLETED|Randomized Study||13
896424|NCT01824303|2166527|P1|COMPLETED|Randomized Study||14
896425|NCT01824303|2166526|P2|STARTED|Randomized Study||14
896426|NCT01824303|2166527|P1|STARTED|Randomized Study||16
896427|NCT01824160|2166551|P1|NOT COMPLETED|Overall Study||0
896428|NCT01824160|2166551|P1|COMPLETED|Overall Study||50
896429|NCT01824160|2166551|P1|STARTED|Overall Study||50
896430|NCT01823679|2166555|P1|NOT COMPLETED|Overall Study||1
896431|NCT01823679|2166555|P1|COMPLETED|Overall Study||1
896432|NCT01823679|2166555|P1|STARTED|Overall Study||2
896433|NCT01823653|2166563|P1|NOT COMPLETED|Overall Study||0
896434|NCT01823653|2166563|P1|COMPLETED|Overall Study||60
896435|NCT01823653|2166563|P1|STARTED|Overall Study||60
896436|NCT01823614|2166577|P6|NOT COMPLETED|Overall Study||0
896437|NCT01823614|2166578|P5|NOT COMPLETED|Overall Study||0
896438|NCT01823614|2166579|P4|NOT COMPLETED|Overall Study||0
896439|NCT01823614|2166580|P3|NOT COMPLETED|Overall Study||0
896440|NCT01823614|2166581|P2|NOT COMPLETED|Overall Study||0
896441|NCT01823614|2166582|P1|NOT COMPLETED|Overall Study||0
896442|NCT01823614|2166577|P6|COMPLETED|Overall Study||154
896443|NCT01823614|2166578|P5|COMPLETED|Overall Study||172
896444|NCT01823614|2166579|P4|COMPLETED|Overall Study||122
896445|NCT01823614|2166580|P3|COMPLETED|Overall Study||176
896446|NCT01823614|2166581|P2|COMPLETED|Overall Study||140
896447|NCT01823614|2166582|P1|COMPLETED|Overall Study||179
896448|NCT01823614|2166577|P6|STARTED|Overall Study||154
896449|NCT01823614|2166578|P5|STARTED|Overall Study||172
896450|NCT01823614|2166579|P4|STARTED|Overall Study||122
896451|NCT01823614|2166580|P3|STARTED|Overall Study||176
896452|NCT01823614|2166581|P2|STARTED|Overall Study||140
896453|NCT01823614|2166582|P1|STARTED|Overall Study||179
896454|NCT01823536|2166608|P6|NOT COMPLETED|Overall Study||0
896455|NCT01823536|2166609|P5|NOT COMPLETED|Overall Study||2
896456|NCT01823536|2166610|P4|NOT COMPLETED|Overall Study||2
896457|NCT01823536|2166611|P3|NOT COMPLETED|Overall Study||1
896458|NCT01823536|2166612|P2|NOT COMPLETED|Overall Study||2
896459|NCT01823536|2166613|P1|NOT COMPLETED|Overall Study||2
896460|NCT01823536|2166608|P6|COMPLETED|Overall Study||2
896461|NCT01823536|2166609|P5|COMPLETED|Overall Study||99
896462|NCT01823536|2166610|P4|COMPLETED|Overall Study||64
896463|NCT01823536|2166611|P3|COMPLETED|Overall Study||119
896464|NCT01823536|2166612|P2|COMPLETED|Overall Study||101
896465|NCT01823536|2166613|P1|COMPLETED|Overall Study||71
896466|NCT01823536|2166608|P6|STARTED|Overall Study||2
896467|NCT01823536|2166609|P5|STARTED|Overall Study||101
896468|NCT01823536|2166610|P4|STARTED|Overall Study||66
896469|NCT01823536|2166611|P3|STARTED|Overall Study||120
896470|NCT01823536|2166612|P2|STARTED|Overall Study||103
896471|NCT01823536|2166613|P1|STARTED|Overall Study||73
896472|NCT01823510|2166651|P2|NOT COMPLETED|Days 22-28||0
896473|NCT01823510|2166652|P1|NOT COMPLETED|Days 22-28||0
896474|NCT01823510|2166651|P2|COMPLETED|Days 22-28||10
896475|NCT01823510|2166652|P1|COMPLETED|Days 22-28||10
896476|NCT01823510|2166651|P2|STARTED|Days 22-28||10
896477|NCT01823510|2166652|P1|STARTED|Days 22-28||10
896478|NCT01823510|2166651|P2|NOT COMPLETED|Days 8-21||0
896479|NCT01823510|2166652|P1|NOT COMPLETED|Days 8-21||0
896480|NCT01823510|2166651|P2|COMPLETED|Days 8-21||10
896481|NCT01823510|2166652|P1|COMPLETED|Days 8-21||10
896482|NCT01823510|2166651|P2|STARTED|Days 8-21||10
896483|NCT01823510|2166652|P1|STARTED|Days 8-21||10
896484|NCT01823510|2166651|P2|NOT COMPLETED|Days 1-7||0
896485|NCT01823510|2166652|P1|NOT COMPLETED|Days 1-7||0
896486|NCT01823510|2166651|P2|COMPLETED|Days 1-7||10
896487|NCT01823510|2166652|P1|COMPLETED|Days 1-7||10
896488|NCT01823510|2166651|P2|STARTED|Days 1-7||10
896489|NCT01823510|2166652|P1|STARTED|Days 1-7||10
896490|NCT01823341|2166664|P1|NOT COMPLETED|Overall Study||15
896491|NCT01823341|2166664|P1|COMPLETED|Overall Study||82
896492|NCT01823341|2166664|P1|STARTED|Overall Study||97
896493|NCT01823289|2166707|P1|NOT COMPLETED|Overall Study||24
896494|NCT01823289|2166707|P1|COMPLETED|Overall Study||47
896495|NCT01823289|2166707|P1|STARTED|Overall Study||71
896496|NCT01823224|2166715|P2|NOT COMPLETED|Overall Study||11
896497|NCT01823224|2166716|P1|NOT COMPLETED|Overall Study||6
896498|NCT01823224|2166715|P2|COMPLETED|Overall Study||22
896499|NCT01823224|2166716|P1|COMPLETED|Overall Study||28
896500|NCT01823224|2166715|P2|STARTED|Overall Study||33
896501|NCT01823224|2166716|P1|STARTED|Overall Study||34
896502|NCT01823146|2166726|P2|NOT COMPLETED|Overall Study||2
896503|NCT01823146|2166727|P1|NOT COMPLETED|Overall Study||2
896504|NCT01823146|2166726|P2|COMPLETED|Overall Study||49
896505|NCT01823146|2166727|P1|COMPLETED|Overall Study||53
896506|NCT01823146|2166726|P2|STARTED|Overall Study||51
896507|NCT01823146|2166727|P1|STARTED|Overall Study||55
896508|NCT01822899|2166739|P2|NOT COMPLETED|Overall Study||18
896509|NCT01822899|2166740|P1|NOT COMPLETED|Overall Study||24
896510|NCT01822899|2166739|P2|COMPLETED|Overall Study||340
896511|NCT01822899|2166740|P1|COMPLETED|Overall Study||334
896512|NCT01822899|2166739|P2|STARTED|Overall Study||358
896513|NCT01822899|2166740|P1|STARTED|Overall Study||358
896514|NCT01822821|2166750|P2|NOT COMPLETED|Overall Study||1
896515|NCT01822821|2166751|P1|NOT COMPLETED|Overall Study||2
896516|NCT01822821|2166750|P2|COMPLETED|Overall Study||74
896517|NCT01822821|2166751|P1|COMPLETED|Overall Study||73
896518|NCT01822821|2166750|P2|STARTED|Overall Study||75
896519|NCT01822821|2166751|P1|STARTED|Overall Study||75
896520|NCT01822756|2166780|P5|NOT COMPLETED|Overall Study||7
896521|NCT01822756|2166781|P4|NOT COMPLETED|Overall Study||4
896522|NCT01822756|2166782|P3|NOT COMPLETED|Overall Study||10
896523|NCT01822756|2166783|P2|NOT COMPLETED|Overall Study||4
896524|NCT01822756|2166784|P1|NOT COMPLETED|Overall Study||16
896525|NCT01822756|2166780|P5|COMPLETED|Overall Study||1
896526|NCT01822756|2166781|P4|COMPLETED|Overall Study||0
896527|NCT01822756|2166782|P3|COMPLETED|Overall Study||0
896528|NCT01822756|2166783|P2|COMPLETED|Overall Study||0
896529|NCT01822756|2166784|P1|COMPLETED|Overall Study||0
896530|NCT01822756|2166780|P5|Discontinued From the Study|Overall Study||7
896531|NCT01822756|2166781|P4|Discontinued From the Study|Overall Study||4
896532|NCT01822756|2166782|P3|Discontinued From the Study|Overall Study||10
896533|NCT01822756|2166783|P2|Discontinued From the Study|Overall Study||4
896534|NCT01822756|2166784|P1|Discontinued From the Study|Overall Study||16
896535|NCT01822756|2166780|P5|STARTED|Overall Study||8
896536|NCT01822756|2166781|P4|STARTED|Overall Study||4
896537|NCT01822756|2166782|P3|STARTED|Overall Study||10
896538|NCT01822756|2166783|P2|STARTED|Overall Study||4
896539|NCT01822756|2166784|P1|STARTED|Overall Study||16
896540|NCT01822691|2166826|P1|NOT COMPLETED|Overall Study||2
896541|NCT01822691|2166826|P1|COMPLETED|Overall Study||13
896542|NCT01822691|2166826|P1|STARTED|Overall Study||15
896543|NCT01822678|2166837|P3|NOT COMPLETED|Overall Study||11
896544|NCT01822678|2166838|P2|NOT COMPLETED|Overall Study||15
896545|NCT01822678|2166839|P1|NOT COMPLETED|Overall Study||12
896546|NCT01822678|2166837|P3|COMPLETED|Overall Study||29
896547|NCT01822678|2166838|P2|COMPLETED|Overall Study||49
896548|NCT01822678|2166839|P1|COMPLETED|Overall Study||45
896549|NCT01822678|2166837|P3|Per Protocol Population|Overall Study||34
896550|NCT01822678|2166838|P2|Per Protocol Population|Overall Study||52
896551|NCT01822678|2166839|P1|Per Protocol Population|Overall Study||45
896552|NCT01822678|2166837|P3|Intention-to-Treat Population (ITT)|Overall Study||40
896553|NCT01822678|2166838|P2|Intention-to-Treat Population (ITT)|Overall Study|1 patient was excluded from the ITT population because he did not have post baseline efficacy data|63
896554|NCT01822678|2166839|P1|Intention-to-Treat Population (ITT)|Overall Study||57
896555|NCT01822678|2166837|P3|Safety Population|Overall Study||40
896556|NCT01822678|2166838|P2|Safety Population|Overall Study||64
896557|NCT01822678|2166839|P1|Safety Population|Overall Study||57
896558|NCT01822678|2166837|P3|Treated|Overall Study||40
896559|NCT01822678|2166838|P2|Treated|Overall Study||64
896560|NCT01822678|2166839|P1|Treated|Overall Study||57
896561|NCT01822678|2166837|P3|STARTED|Overall Study||40
896562|NCT01822678|2166838|P2|STARTED|Overall Study||64
896563|NCT01822678|2166839|P1|STARTED|Overall Study||57
896564|NCT01822665|2166847|P1|NOT COMPLETED|Overall Study||8
896565|NCT01822665|2166847|P1|COMPLETED|Overall Study||20
896566|NCT01822665|2166847|P1|Received Paracetamol Tablet (1000 mg)|Overall Study||28
896567|NCT01822665|2166847|P1|Received Ibuprofen Capsule (400 mg)|Overall Study|Two participants, each in period 3 and period 4 did not complete treatment for 'other reason'.|24
896568|NCT01822665|2166847|P1|Received Placebo Tablet|Overall Study|5 participants did not complete; Period 2(1:other reason); Period 4(3:adverse event; 1:other reason)|23
896569|NCT01822665|2166847|P1|Received Ibuprofen Tablet (400 mg)|Overall Study|5 participants did not complete; Period 3(2:adverse events;1:other reason); Period 4(2:other reason)|23
896570|NCT01822665|2166847|P1|STARTED|Overall Study||28
896571|NCT01822574|2166874|P3|NOT COMPLETED|Overall Study||0
896572|NCT01822574|2166875|P2|NOT COMPLETED|Overall Study||0
896573|NCT01822574|2166876|P1|NOT COMPLETED|Overall Study||0
896574|NCT01822574|2166874|P3|COMPLETED|Overall Study||30
896575|NCT01822574|2166875|P2|COMPLETED|Overall Study||30
896576|NCT01822574|2166876|P1|COMPLETED|Overall Study||30
896577|NCT01822574|2166874|P3|STARTED|Overall Study||30
896578|NCT01822574|2166875|P2|STARTED|Overall Study||30
896579|NCT01822574|2166876|P1|STARTED|Overall Study||30
896580|NCT01822548|2166892|P2|NOT COMPLETED|Overall Study||0
896581|NCT01822548|2166893|P1|NOT COMPLETED|Overall Study||0
896582|NCT01822548|2166892|P2|COMPLETED|Overall Study||24
896583|NCT01822548|2166893|P1|COMPLETED|Overall Study||40
896584|NCT01822548|2166892|P2|Discontinued Intervention|Overall Study||5
896585|NCT01822548|2166893|P1|Discontinued Intervention|Overall Study||0
896586|NCT01822548|2166892|P2|STARTED|Overall Study||24
896587|NCT01822548|2166893|P1|STARTED|Overall Study|Received allocated intervention n=38 Did not receive allocated intervention (only metformin) n=2|40
896588|NCT01822535|2166903|P2|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
896589|NCT01822535|2166904|P1|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||1
896590|NCT01822535|2166903|P2|COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
896591|NCT01822535|2166904|P1|COMPLETED|Visit 2 - Tetraplegia Only - Drug||10
896592|NCT01822535|2166903|P2|STARTED|Visit 2 - Tetraplegia Only - Drug|Able-bodied subjects were not enrolled for a second visit.|0
896593|NCT01822535|2166904|P1|STARTED|Visit 2 - Tetraplegia Only - Drug|These subjects were individuals who completed Visit 1 of testing.|11
896594|NCT01822535|2166903|P2|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||2
896595|NCT01822535|2166904|P1|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||6
896596|NCT01822535|2166903|P2|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
896597|NCT01822535|2166904|P1|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
896598|NCT01822535|2166903|P2|STARTED|Visit 1 - Tetraplegia and Able-Bodied||13
896599|NCT01822535|2166904|P1|STARTED|Visit 1 - Tetraplegia and Able-Bodied||17
896600|NCT01822301|2166916|P1|NOT COMPLETED|Overall Study||0
896601|NCT01822301|2166916|P1|COMPLETED|Overall Study||5
896602|NCT01822301|2166916|P1|STARTED|Overall Study||5
896603|NCT01822223|2166928|P2|NOT COMPLETED|Overall Study||1
896604|NCT01822223|2166929|P1|NOT COMPLETED|Overall Study||0
896605|NCT01822223|2166928|P2|COMPLETED|Overall Study||9
896606|NCT01822223|2166929|P1|COMPLETED|Overall Study||10
896607|NCT01822223|2166928|P2|STARTED|Overall Study||10
896608|NCT01822223|2166929|P1|STARTED|Overall Study||10
896609|NCT01822197|2166945|P1|NOT COMPLETED|Overall Study||0
896610|NCT01822197|2166945|P1|COMPLETED|Overall Study||30
896611|NCT01822197|2166945|P1|STARTED|Overall Study||30
896612|NCT01822119|2166951|P1|NOT COMPLETED|Overall Study||0
896613|NCT01822119|2166951|P1|COMPLETED|Overall Study||27
896614|NCT01822119|2166951|P1|STARTED|Overall Study||27
896615|NCT01821963|2166974|P1|NOT COMPLETED|Overall Study||1
896616|NCT01821963|2166974|P1|COMPLETED|Overall Study||0
896617|NCT01821963|2166974|P1|STARTED|Overall Study||1
896618|NCT01821937|2166980|P2|NOT COMPLETED|Overall Study||3
896619|NCT01821937|2166981|P1|NOT COMPLETED|Overall Study||0
896620|NCT01821937|2166980|P2|COMPLETED|Overall Study|2 patients discontinued during Single dose period,1 Patient discontinued during Multiple dose period|12
896621|NCT01821937|2166981|P1|COMPLETED|Overall Study||10
896622|NCT01821937|2166980|P2|STARTED|Overall Study||15
896623|NCT01821937|2166981|P1|STARTED|Overall Study||10
896624|NCT01821859|2166999|P1|NOT COMPLETED|Overall Study||5
896625|NCT01821859|2166999|P1|COMPLETED|Overall Study||0
896626|NCT01821859|2166999|P1|STARTED|Overall Study||5
896627|NCT01821807|2167005|P2|NOT COMPLETED|Overall Study||1
896628|NCT01821807|2167006|P1|NOT COMPLETED|Overall Study||3
896629|NCT01821807|2167005|P2|COMPLETED|Overall Study||109
896630|NCT01821807|2167006|P1|COMPLETED|Overall Study||147
896631|NCT01821807|2167005|P2|STARTED|Overall Study||110
896632|NCT01821807|2167006|P1|STARTED|Overall Study||150
896633|NCT01821534|2167014|P1|NOT COMPLETED|Overall Study||0
896634|NCT01821534|2167014|P1|COMPLETED|Overall Study||201
896635|NCT01821534|2167014|P1|STARTED|Overall Study||201
896636|NCT01821417|2167023|P2|NOT COMPLETED|Overall Study||0
896637|NCT01821417|2167024|P1|NOT COMPLETED|Overall Study||0
896638|NCT01821417|2167023|P2|COMPLETED|Overall Study||31
896639|NCT01821417|2167024|P1|COMPLETED|Overall Study||37
896640|NCT01821417|2167023|P2|STARTED|Overall Study||31
896641|NCT01821417|2167024|P1|STARTED|Overall Study||37
896642|NCT01821378|2167037|P3|NOT COMPLETED|Overall Study||42
896643|NCT01821378|2167038|P2|NOT COMPLETED|Overall Study||54
896644|NCT01821378|2167039|P1|NOT COMPLETED|Overall Study||27
896645|NCT01821378|2167037|P3|COMPLETED|Overall Study||70
896646|NCT01821378|2167038|P2|COMPLETED|Overall Study||145
896647|NCT01821378|2167039|P1|COMPLETED|Overall Study||74
896648|NCT01821378|2167037|P3|STARTED|Overall Study||112
896649|NCT01821378|2167038|P2|STARTED|Overall Study||199
896650|NCT01821378|2167039|P1|STARTED|Overall Study||101
896651|NCT01821352|2167077|P2|NOT COMPLETED|Overall Study||0
896652|NCT01821352|2167078|P1|NOT COMPLETED|Overall Study||0
896653|NCT01821352|2167077|P2|COMPLETED|Overall Study||25
896654|NCT01821352|2167078|P1|COMPLETED|Overall Study||28
896655|NCT01821352|2167077|P2|STARTED|Overall Study||25
896656|NCT01821352|2167078|P1|STARTED|Overall Study||28
896657|NCT01821326|2167088|P1|NOT COMPLETED|Overall Study||0
896658|NCT01821326|2167088|P1|COMPLETED|Overall Study||339
896659|NCT01821326|2167088|P1|STARTED|Overall Study||339
896660|NCT01821118|2167094|P2|NOT COMPLETED|Overall Study||1
896661|NCT01821118|2167095|P1|NOT COMPLETED|Overall Study||0
896662|NCT01821118|2167094|P2|COMPLETED|Overall Study||11
896663|NCT01821118|2167095|P1|COMPLETED|Overall Study||24
896664|NCT01821118|2167094|P2|STARTED|Overall Study||12
896665|NCT01821118|2167095|P1|STARTED|Overall Study||24
896666|NCT01821105|2167128|P1|NOT COMPLETED|Overall Study||0
896667|NCT01821105|2167128|P1|COMPLETED|Overall Study||21
896668|NCT01821105|2167128|P1|STARTED|Overall Study||21
896669|NCT01820585|2167138|P4|NOT COMPLETED|Overall Study||49
896670|NCT01820585|2167139|P3|NOT COMPLETED|Overall Study||34
896671|NCT01820585|2167140|P2|NOT COMPLETED|Overall Study||32
896672|NCT01820585|2167141|P1|NOT COMPLETED|Overall Study||27
896673|NCT01820585|2167138|P4|COMPLETED|Overall Study||83
896674|NCT01820585|2167139|P3|COMPLETED|Overall Study||101
896675|NCT01820585|2167140|P2|COMPLETED|Overall Study||98
896676|NCT01820585|2167141|P1|COMPLETED|Overall Study||104
896677|NCT01820585|2167138|P4|Completed Maintenance Period|Overall Study||84
896678|NCT01820585|2167139|P3|Completed Maintenance Period|Overall Study||101
896679|NCT01820585|2167140|P2|Completed Maintenance Period|Overall Study||98
896680|NCT01820585|2167141|P1|Completed Maintenance Period|Overall Study||105
896681|NCT01820585|2167138|P4|Entered Maintenance Period|Overall Study||123
896682|NCT01820585|2167139|P3|Entered Maintenance Period|Overall Study||131
896683|NCT01820585|2167140|P2|Entered Maintenance Period|Overall Study||124
896684|NCT01820585|2167141|P1|Entered Maintenance Period|Overall Study||128
896685|NCT01820585|2167138|P4|Completed Titration Period|Overall Study||126
896686|NCT01820585|2167139|P3|Completed Titration Period|Overall Study||131
896687|NCT01820585|2167140|P2|Completed Titration Period|Overall Study||125
896688|NCT01820585|2167141|P1|Completed Titration Period|Overall Study||128
896689|NCT01820585|2167138|P4|Full Analysis Set|Overall Study||129
896690|NCT01820585|2167139|P3|Full Analysis Set|Overall Study||135
896691|NCT01820585|2167140|P2|Full Analysis Set|Overall Study||130
896692|NCT01820585|2167141|P1|Full Analysis Set|Overall Study||131
896693|NCT01820585|2167138|P4|Randomized and Treated|Overall Study||132
896694|NCT01820585|2167139|P3|Randomized and Treated|Overall Study||135
896695|NCT01820585|2167140|P2|Randomized and Treated|Overall Study||130
896696|NCT01820585|2167141|P1|Randomized and Treated|Overall Study||131
896697|NCT01820585|2167138|P4|STARTED|Overall Study||132
896698|NCT01820585|2167139|P3|STARTED|Overall Study||135
896699|NCT01820585|2167140|P2|STARTED|Overall Study||130
896700|NCT01820585|2167141|P1|STARTED|Overall Study||131
896701|NCT01820559|2167154|P3|NOT COMPLETED|Overall Study||29
896702|NCT01820559|2167155|P2|NOT COMPLETED|Overall Study||13
896703|NCT01820559|2167156|P1|NOT COMPLETED|Overall Study||14
896704|NCT01820559|2167154|P3|COMPLETED|Overall Study||110
896705|NCT01820559|2167155|P2|COMPLETED|Overall Study||122
896706|NCT01820559|2167156|P1|COMPLETED|Overall Study||122
896707|NCT01820559|2167154|P3|Completed Maintenance Period|Overall Study||110
896708|NCT01820559|2167155|P2|Completed Maintenance Period|Overall Study||123
896709|NCT01820559|2167156|P1|Completed Maintenance Period|Overall Study||122
896710|NCT01820559|2167154|P3|Entered Maintenance Period|Overall Study||129
896711|NCT01820559|2167155|P2|Entered Maintenance Period|Overall Study||133
896712|NCT01820559|2167156|P1|Entered Maintenance Period|Overall Study||129
896713|NCT01820559|2167154|P3|Completed Tutration Period|Overall Study||131
896714|NCT01820559|2167155|P2|Completed Tutration Period|Overall Study||134
896715|NCT01820559|2167156|P1|Completed Tutration Period|Overall Study||130
896716|NCT01820559|2167154|P3|Randomized and Treated|Overall Study||139
896717|NCT01820559|2167155|P2|Randomized and Treated|Overall Study||135
896718|NCT01820559|2167156|P1|Randomized and Treated|Overall Study||136
896719|NCT01820559|2167154|P3|STARTED|Overall Study||139
896720|NCT01820559|2167155|P2|STARTED|Overall Study||135
896721|NCT01820559|2167156|P1|STARTED|Overall Study||136
896722|NCT01820416|2167167|P3|NOT COMPLETED|Overall Study||0
896723|NCT01820416|2167168|P2|NOT COMPLETED|Overall Study||2
896724|NCT01820416|2167169|P1|NOT COMPLETED|Overall Study||3
896725|NCT01820416|2167167|P3|COMPLETED|Overall Study||11
896726|NCT01820416|2167168|P2|COMPLETED|Overall Study||10
896727|NCT01820416|2167169|P1|COMPLETED|Overall Study||9
896728|NCT01820416|2167167|P3|STARTED|Overall Study||11
896729|NCT01820416|2167168|P2|STARTED|Overall Study||12
896730|NCT01820416|2167169|P1|STARTED|Overall Study||12
896731|NCT01820364|2167177|P2|NOT COMPLETED|Part II: LGX818 + MEK162||1
896732|NCT01820364|2167178|P1|NOT COMPLETED|Part II: LGX818 + MEK162||0
896733|NCT01820364|2167177|P2|COMPLETED|Part II: LGX818 + MEK162||0
896734|NCT01820364|2167178|P1|COMPLETED|Part II: LGX818 + MEK162||0
896735|NCT01820364|2167177|P2|STARTED|Part II: LGX818 + MEK162||1
896736|NCT01820364|2167178|P1|STARTED|Part II: LGX818 + MEK162||0
896737|NCT01820364|2167177|P2|NOT COMPLETED|Part I: LGX818||0
896738|NCT01820364|2167178|P1|NOT COMPLETED|Part I: LGX818||14
896739|NCT01820364|2167177|P2|COMPLETED|Part I: LGX818||0
896740|NCT01820364|2167178|P1|COMPLETED|Part I: LGX818||1
896741|NCT01820364|2167177|P2|STARTED|Part I: LGX818||0
896742|NCT01820364|2167178|P1|STARTED|Part I: LGX818||15
896743|NCT01819935|2167192|P2|NOT COMPLETED|Overall Study||0
896744|NCT01819935|2167193|P1|NOT COMPLETED|Overall Study||0
896745|NCT01819935|2167192|P2|COMPLETED|Overall Study||4943
896746|NCT01819935|2167193|P1|COMPLETED|Overall Study||328
896747|NCT01819935|2167192|P2|STARTED|Overall Study||4943
896748|NCT01819935|2167193|P1|STARTED|Overall Study||328
896749|NCT01819922|2167213|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
896750|NCT01819922|2167214|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
896751|NCT01819922|2167213|P2|COMPLETED|Second Intervention Period (1 Day)||6
896752|NCT01819922|2167214|P1|COMPLETED|Second Intervention Period (1 Day)||6
896753|NCT01819922|2167213|P2|STARTED|Second Intervention Period (1 Day)||6
896754|NCT01819922|2167214|P1|STARTED|Second Intervention Period (1 Day)||6
896755|NCT01819922|2167213|P2|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
896756|NCT01819922|2167214|P1|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
896757|NCT01819922|2167213|P2|COMPLETED|Washout Period (at Least 7-10 Days)||6
896758|NCT01819922|2167214|P1|COMPLETED|Washout Period (at Least 7-10 Days)||6
896759|NCT01819922|2167213|P2|STARTED|Washout Period (at Least 7-10 Days)||6
896760|NCT01819922|2167214|P1|STARTED|Washout Period (at Least 7-10 Days)||6
896761|NCT01819922|2167213|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
896762|NCT01819922|2167214|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
896763|NCT01819922|2167213|P2|COMPLETED|First Intervention Period (1 Day)||6
896764|NCT01819922|2167214|P1|COMPLETED|First Intervention Period (1 Day)||6
896765|NCT01819922|2167213|P2|STARTED|First Intervention Period (1 Day)||6
896766|NCT01819922|2167214|P1|STARTED|First Intervention Period (1 Day)||6
896767|NCT01819844|2167298|P1|NOT COMPLETED|Overall Study||0
896768|NCT01819844|2167298|P1|COMPLETED|Overall Study||12
896769|NCT01819844|2167298|P1|STARTED|Overall Study||12
896770|NCT01819415|2167315|P4|NOT COMPLETED|Overall Study||2
896771|NCT01819415|2167316|P3|NOT COMPLETED|Overall Study||1
896772|NCT01819415|2167317|P2|NOT COMPLETED|Overall Study||4
896773|NCT01819415|2167318|P1|NOT COMPLETED|Overall Study||3
896774|NCT01819415|2167315|P4|COMPLETED|Overall Study||8
896775|NCT01819415|2167316|P3|COMPLETED|Overall Study||9
896776|NCT01819415|2167317|P2|COMPLETED|Overall Study||6
896777|NCT01819415|2167318|P1|COMPLETED|Overall Study||7
896778|NCT01819415|2167315|P4|STARTED|Overall Study||10
896779|NCT01819415|2167316|P3|STARTED|Overall Study||10
896780|NCT01819415|2167317|P2|STARTED|Overall Study||10
896781|NCT01819415|2167318|P1|STARTED|Overall Study||10
896794|NCT01819272|2167353|P6|NOT COMPLETED|Overall Study||7
896795|NCT01819272|2167354|P5|NOT COMPLETED|Overall Study||4
896796|NCT01819272|2167355|P4|NOT COMPLETED|Overall Study||5
896797|NCT01819272|2167356|P3|NOT COMPLETED|Overall Study||3
896798|NCT01819272|2167357|P2|NOT COMPLETED|Overall Study||3
896799|NCT01819272|2167358|P1|NOT COMPLETED|Overall Study||6
896800|NCT01819272|2167353|P6|COMPLETED|Overall Study||33
896801|NCT01819272|2167354|P5|COMPLETED|Overall Study||36
896802|NCT01819272|2167355|P4|COMPLETED|Overall Study||35
896803|NCT01819272|2167356|P3|COMPLETED|Overall Study||37
896804|NCT01819272|2167357|P2|COMPLETED|Overall Study||36
896805|NCT01819272|2167358|P1|COMPLETED|Overall Study||35
896806|NCT01819272|2167353|P6|STARTED|Overall Study||40
896807|NCT01819272|2167354|P5|STARTED|Overall Study||40
896808|NCT01819272|2167355|P4|STARTED|Overall Study||40
896809|NCT01819272|2167356|P3|STARTED|Overall Study||40
896810|NCT01819272|2167357|P2|STARTED|Overall Study||39
896811|NCT01819272|2167358|P1|STARTED|Overall Study||41
896812|NCT01819194|2167384|P1|NOT COMPLETED|Overall Study||2
896813|NCT01819194|2167384|P1|COMPLETED|Overall Study||60
896814|NCT01819194|2167384|P1|STARTED|Overall Study||62
896815|NCT01818752|2167391|P2|NOT COMPLETED|Overall Study||198
896816|NCT01818752|2167392|P1|NOT COMPLETED|Overall Study||187
896817|NCT01818752|2167391|P2|COMPLETED|Overall Study|Completed treatment|280
896818|NCT01818752|2167392|P1|COMPLETED|Overall Study|Completed treatment|290
896819|NCT01818752|2167391|P2|Received Treatment|Overall Study||474
896820|NCT01818752|2167392|P1|Received Treatment|Overall Study||470
896821|NCT01818752|2167391|P2|STARTED|Overall Study||478
896822|NCT01818752|2167392|P1|STARTED|Overall Study||477
896823|NCT01818700|2167410|P1|NOT COMPLETED|Overall Study||104
896824|NCT01818700|2167410|P1|COMPLETED|Overall Study|104 subjects dropped out this study prior to study completion.|141
896825|NCT01818700|2167410|P1|PP Set|Overall Study|105 subjects excluded from PP set due to various reasons.|105
896826|NCT01818700|2167410|P1|FAS Set|Overall Study|31 subjects excluded from FAS due to no assessment of primary efficacy(26) and IC/EC violation(5).|210
896827|NCT01818700|2167410|P1|Safety Set|Overall Study|4 subjects were not study drug administered.|241
896828|NCT01818700|2167410|P1|STARTED|Overall Study|The No. of enrolled patients|245
896829|NCT01818596|2167421|P2|NOT COMPLETED|Overall Study||6
896830|NCT01818596|2167422|P1|NOT COMPLETED|Overall Study||246
896831|NCT01818596|2167421|P2|COMPLETED|Overall Study||0
896832|NCT01818596|2167422|P1|COMPLETED|Overall Study||0
896833|NCT01818596|2167421|P2|STARTED|Overall Study||6
896834|NCT01818596|2167422|P1|STARTED|Overall Study||246
896835|NCT01818414|2167455|P2|NOT COMPLETED|Overall Study||0
896836|NCT01818414|2167456|P1|NOT COMPLETED|Overall Study||0
896837|NCT01818414|2167455|P2|COMPLETED|Overall Study||15
896838|NCT01818414|2167456|P1|COMPLETED|Overall Study||14
896839|NCT01818414|2167455|P2|STARTED|Overall Study||15
896840|NCT01818414|2167456|P1|STARTED|Overall Study||14
896841|NCT01818336|2167470|P2|NOT COMPLETED|Overall Study||12
896842|NCT01818336|2167471|P1|NOT COMPLETED|Overall Study||0
896843|NCT01818336|2167470|P2|COMPLETED|Overall Study||47
896844|NCT01818336|2167471|P1|COMPLETED|Overall Study||391
896845|NCT01818336|2167470|P2|STARTED|Overall Study||59
896846|NCT01818336|2167471|P1|STARTED|Overall Study||391
896847|NCT01818297|2167479|P2|NOT COMPLETED|Open Label Phase (3-12 Months)||10
896848|NCT01818297|2167480|P1|NOT COMPLETED|Open Label Phase (3-12 Months)||18
896849|NCT01818297|2167479|P2|COMPLETED|Open Label Phase (3-12 Months)||19
896850|NCT01818297|2167480|P1|COMPLETED|Open Label Phase (3-12 Months)||14
896851|NCT01818297|2167479|P2|STARTED|Open Label Phase (3-12 Months)||29
896852|NCT01818297|2167480|P1|STARTED|Open Label Phase (3-12 Months)||32
896853|NCT01818297|2167479|P2|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||1
896854|NCT01818297|2167480|P1|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||0
896855|NCT01818297|2167479|P2|COMPLETED|Blinded Phase (Randomization - 3 Months)||29
896856|NCT01818297|2167480|P1|COMPLETED|Blinded Phase (Randomization - 3 Months)||32
896857|NCT01818297|2167479|P2|Week 6|Blinded Phase (Randomization - 3 Months)||29
896858|NCT01818297|2167480|P1|Week 6|Blinded Phase (Randomization - 3 Months)||32
896859|NCT01818297|2167479|P2|Week 1|Blinded Phase (Randomization - 3 Months)||30
896860|NCT01818297|2167480|P1|Week 1|Blinded Phase (Randomization - 3 Months)||32
896861|NCT01818297|2167479|P2|STARTED|Blinded Phase (Randomization - 3 Months)||30
896862|NCT01818297|2167480|P1|STARTED|Blinded Phase (Randomization - 3 Months)||32
896863|NCT01818141|2167498|P2|NOT COMPLETED|Overall Study||3
896864|NCT01818141|2167499|P1|NOT COMPLETED|Overall Study||3
896865|NCT01818141|2167498|P2|COMPLETED|Overall Study||13
896866|NCT01818141|2167499|P1|COMPLETED|Overall Study||15
896867|NCT01818141|2167498|P2|STARTED|Overall Study||16
896868|NCT01818141|2167499|P1|STARTED|Overall Study||18
896869|NCT01817907|2167509|P2|NOT COMPLETED|Second Intervention||0
896870|NCT01817907|2167510|P1|NOT COMPLETED|Second Intervention||0
896871|NCT01817907|2167509|P2|COMPLETED|Second Intervention||7
896872|NCT01817907|2167510|P1|COMPLETED|Second Intervention||8
896873|NCT01817907|2167509|P2|STARTED|Second Intervention||7
896874|NCT01817907|2167510|P1|STARTED|Second Intervention||8
896875|NCT01817907|2167509|P2|NOT COMPLETED|Washout Period||0
896876|NCT01817907|2167510|P1|NOT COMPLETED|Washout Period||0
896877|NCT01817907|2167509|P2|COMPLETED|Washout Period||7
896878|NCT01817907|2167510|P1|COMPLETED|Washout Period||8
896879|NCT01817907|2167509|P2|STARTED|Washout Period||7
896880|NCT01817907|2167510|P1|STARTED|Washout Period||8
896881|NCT01817907|2167509|P2|NOT COMPLETED|First Intervention||0
896882|NCT01817907|2167510|P1|NOT COMPLETED|First Intervention||0
896883|NCT01817907|2167509|P2|COMPLETED|First Intervention||7
896884|NCT01817907|2167510|P1|COMPLETED|First Intervention||8
896885|NCT01817907|2167509|P2|STARTED|First Intervention||7
896886|NCT01817907|2167510|P1|STARTED|First Intervention||8
896887|NCT01817855|2167522|P4|NOT COMPLETED|Overall Study||0
896888|NCT01817855|2167523|P3|NOT COMPLETED|Overall Study||2
896889|NCT01817855|2167524|P2|NOT COMPLETED|Overall Study||2
896890|NCT01817855|2167525|P1|NOT COMPLETED|Overall Study||0
896891|NCT01817855|2167522|P4|COMPLETED|Overall Study||5
896892|NCT01817855|2167523|P3|COMPLETED|Overall Study||9
896893|NCT01817855|2167524|P2|COMPLETED|Overall Study||6
896894|NCT01817855|2167525|P1|COMPLETED|Overall Study||23
896895|NCT01817855|2167522|P4|STARTED|Overall Study||5
896896|NCT01817855|2167523|P3|STARTED|Overall Study||11
896897|NCT01817855|2167524|P2|STARTED|Overall Study||8
896898|NCT01817855|2167525|P1|STARTED|Overall Study||23
896899|NCT01817790|2167555|P2|NOT COMPLETED|Overall Study||8
896900|NCT01817790|2167556|P1|NOT COMPLETED|Overall Study||4
896901|NCT01817790|2167555|P2|COMPLETED|Overall Study||304
896902|NCT01817790|2167556|P1|COMPLETED|Overall Study||310
896903|NCT01817790|2167555|P2|STARTED|Overall Study||312
896904|NCT01817790|2167556|P1|STARTED|Overall Study||314
896905|NCT01817777|2167600|P3|NOT COMPLETED|Interventional Phase (20 Weeks)||5
896906|NCT01817777|2167601|P2|NOT COMPLETED|Interventional Phase (20 Weeks)||5
896907|NCT01817777|2167602|P1|NOT COMPLETED|Interventional Phase (20 Weeks)||0
896908|NCT01817777|2167600|P3|COMPLETED|Interventional Phase (20 Weeks)||10
896909|NCT01817777|2167601|P2|COMPLETED|Interventional Phase (20 Weeks)||11
896910|NCT01817777|2167602|P1|COMPLETED|Interventional Phase (20 Weeks)||0
896911|NCT01817777|2167600|P3|STARTED|Interventional Phase (20 Weeks)||15
896912|NCT01817777|2167601|P2|STARTED|Interventional Phase (20 Weeks)||16
896913|NCT01817777|2167602|P1|STARTED|Interventional Phase (20 Weeks)||0
896914|NCT01817777|2167600|P3|NOT COMPLETED|Observational Phase (8 Weeks)||0
896915|NCT01817777|2167601|P2|NOT COMPLETED|Observational Phase (8 Weeks)||0
896916|NCT01817777|2167602|P1|NOT COMPLETED|Observational Phase (8 Weeks)||5
896917|NCT01817777|2167600|P3|COMPLETED|Observational Phase (8 Weeks)||0
896918|NCT01817777|2167601|P2|COMPLETED|Observational Phase (8 Weeks)||0
896919|NCT01817777|2167602|P1|COMPLETED|Observational Phase (8 Weeks)||31
896920|NCT01817777|2167600|P3|STARTED|Observational Phase (8 Weeks)||0
896921|NCT01817777|2167601|P2|STARTED|Observational Phase (8 Weeks)||0
896922|NCT01817777|2167602|P1|STARTED|Observational Phase (8 Weeks)||36
896923|NCT01817764|2167626|P2|NOT COMPLETED|Overall Study||38
896924|NCT01817764|2167627|P1|NOT COMPLETED|Overall Study||34
896925|NCT01817764|2167626|P2|COMPLETED|Overall Study||315
896926|NCT01817764|2167627|P1|COMPLETED|Overall Study||319
896927|NCT01817764|2167626|P2|STARTED|Overall Study||353
896928|NCT01817764|2167627|P1|STARTED|Overall Study||353
896929|NCT01817725|2167635|P1|NOT COMPLETED|Overall Study||1
896930|NCT01817725|2167635|P1|COMPLETED|Overall Study||19
896931|NCT01817725|2167635|P1|STARTED|Overall Study||20
896932|NCT01816776|2167642|P2|NOT COMPLETED|Overall Study||8
896933|NCT01816776|2167643|P1|NOT COMPLETED|Overall Study||13
896934|NCT01816776|2167642|P2|COMPLETED|Overall Study||70
896935|NCT01816776|2167643|P1|COMPLETED|Overall Study||60
896936|NCT01816776|2167642|P2|6 Month Primary Effectiveness Assessed|Overall Study||73
896937|NCT01816776|2167643|P1|6 Month Primary Effectiveness Assessed|Overall Study||68
896938|NCT01816776|2167642|P2|STARTED|Overall Study||78
896939|NCT01816776|2167643|P1|STARTED|Overall Study||73
896940|NCT01816685|2167665|P2|NOT COMPLETED|Overall Study||11
896941|NCT01816685|2167666|P1|NOT COMPLETED|Overall Study||10
896942|NCT01816685|2167665|P2|COMPLETED|Overall Study||56
896943|NCT01816685|2167666|P1|COMPLETED|Overall Study||58
896944|NCT01816685|2167665|P2|STARTED|Overall Study||67
896945|NCT01816685|2167666|P1|STARTED|Overall Study||68
896946|NCT01816477|2167676|P2|NOT COMPLETED|Overall Study||1
896947|NCT01816477|2167677|P1|NOT COMPLETED|Overall Study||16
896948|NCT01816477|2167676|P2|COMPLETED|Overall Study||41
896949|NCT01816477|2167677|P1|COMPLETED|Overall Study||27
896950|NCT01816477|2167676|P2|STARTED|Overall Study||42
896951|NCT01816477|2167677|P1|STARTED|Overall Study||43
896952|NCT01816451|2167690|P3|NOT COMPLETED|Overall Study||0
896953|NCT01816451|2167691|P2|NOT COMPLETED|Overall Study||0
896954|NCT01816451|2167692|P1|NOT COMPLETED|Overall Study||0
896955|NCT01816451|2167690|P3|COMPLETED|Overall Study||8
896956|NCT01816451|2167691|P2|COMPLETED|Overall Study||11
896957|NCT01816451|2167692|P1|COMPLETED|Overall Study||13
896958|NCT01816451|2167690|P3|STARTED|Overall Study||8
896959|NCT01816451|2167691|P2|STARTED|Overall Study||11
896960|NCT01816451|2167692|P1|STARTED|Overall Study||13
896961|NCT01816295|2167731|P2|NOT COMPLETED|OLE Phase||56
896962|NCT01816295|2167732|P1|NOT COMPLETED|OLE Phase||53
896963|NCT01816295|2167731|P2|COMPLETED|OLE Phase||227
896964|NCT01816295|2167732|P1|COMPLETED|OLE Phase||222
896965|NCT01816295|2167731|P2|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|283
896966|NCT01816295|2167732|P1|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|275
896967|NCT01816295|2167731|P2|NOT COMPLETED|Double Blind Phase||56
896968|NCT01816295|2167732|P1|NOT COMPLETED|Double Blind Phase||63
896969|NCT01816295|2167731|P2|COMPLETED|Double Blind Phase||302
896970|NCT01816295|2167732|P1|COMPLETED|Double Blind Phase||294
896971|NCT01816295|2167731|P2|Received Study Drug|Double Blind Phase||354
896972|NCT01816295|2167732|P1|Received Study Drug|Double Blind Phase||356
896973|NCT01816295|2167731|P2|STARTED|Double Blind Phase||358
896974|NCT01816295|2167732|P1|STARTED|Double Blind Phase||357
896975|NCT01816243|2167747|P1|NOT COMPLETED|Overall Study||12
896976|NCT01816243|2167747|P1|COMPLETED|Overall Study||27
896977|NCT01816243|2167747|P1|STARTED|Overall Study||39
896981|NCT01815918|2167769|P2|NOT COMPLETED|Overall Study||19
896982|NCT01815918|2167770|P1|NOT COMPLETED|Overall Study||18
896983|NCT01815918|2167769|P2|COMPLETED|Overall Study||11
896984|NCT01815918|2167770|P1|COMPLETED|Overall Study||12
896985|NCT01815918|2167769|P2|STARTED|Overall Study||30
896986|NCT01815918|2167770|P1|STARTED|Overall Study||30
896987|NCT01815840|2167786|P2|NOT COMPLETED|Overall Study||63
896988|NCT01815840|2167787|P1|NOT COMPLETED|Overall Study||59
896989|NCT01815840|2167786|P2|COMPLETED|Overall Study||50
896990|NCT01815840|2167787|P1|COMPLETED|Overall Study||57
896991|NCT01815840|2167786|P2|STARTED|Overall Study||113
896992|NCT01815840|2167787|P1|STARTED|Overall Study||116
896993|NCT01815736|2167817|P2|NOT COMPLETED|Overall Study||478
896994|NCT01815736|2167818|P1|NOT COMPLETED|Overall Study||961
896995|NCT01815736|2167817|P2|COMPLETED|Overall Study||2
896996|NCT01815736|2167818|P1|COMPLETED|Overall Study||2
896997|NCT01815736|2167817|P2|STARTED|Overall Study||480
896998|NCT01815736|2167818|P1|STARTED|Overall Study||963
896999|NCT01815671|2167834|P2|NOT COMPLETED|Overall Study||0
897000|NCT01815671|2167835|P1|NOT COMPLETED|Overall Study||0
897001|NCT01815671|2167834|P2|COMPLETED|Overall Study||85
897002|NCT01815671|2167835|P1|COMPLETED|Overall Study||88
897003|NCT01815671|2167834|P2|STARTED|Overall Study||85
897004|NCT01815671|2167835|P1|STARTED|Overall Study||88
897005|NCT01815645|2167847|P2|NOT COMPLETED|Overall Study||0
897006|NCT01815645|2167848|P1|NOT COMPLETED|Overall Study||0
897007|NCT01815645|2167847|P2|COMPLETED|Overall Study||33
897008|NCT01815645|2167848|P1|COMPLETED|Overall Study||32
897009|NCT01815645|2167847|P2|STARTED|Overall Study||33
897010|NCT01815645|2167848|P1|STARTED|Overall Study||32
897011|NCT01815138|2167866|P2|NOT COMPLETED|Overall Study||6
897012|NCT01815138|2167867|P1|NOT COMPLETED|Overall Study||8
897013|NCT01815138|2167866|P2|COMPLETED|Overall Study||31
897014|NCT01815138|2167867|P1|COMPLETED|Overall Study||26
897015|NCT01815138|2167866|P2|STARTED|Overall Study||37
897016|NCT01815138|2167867|P1|STARTED|Overall Study||34
897017|NCT01815099|2167879|P1|NOT COMPLETED|Overall Study||2
897018|NCT01815099|2167879|P1|COMPLETED|Overall Study||2
897019|NCT01815099|2167879|P1|Began rTMS Treatment|Overall Study||3
897020|NCT01815099|2167879|P1|STARTED|Overall Study||4
897021|NCT01815008|2167884|P1|NOT COMPLETED|Overall Study||4
897022|NCT01815008|2167884|P1|COMPLETED|Overall Study|transcriptomic data was available on 9 participants only|15
897023|NCT01815008|2167884|P1|STARTED|Overall Study|Had difficulty in completing enrollment|19
897024|NCT01814878|2167893|P2|NOT COMPLETED|Overall Study||30
897025|NCT01814878|2167894|P1|NOT COMPLETED|Overall Study||46
897026|NCT01814878|2167893|P2|COMPLETED|Overall Study||128
897027|NCT01814878|2167894|P1|COMPLETED|Overall Study||116
897028|NCT01814878|2167893|P2|STARTED|Overall Study||158
897029|NCT01814878|2167894|P1|STARTED|Overall Study||162
897030|NCT01814800|2167914|P1|NOT COMPLETED|Overall Study||5
897031|NCT01814800|2167914|P1|COMPLETED|Overall Study||54
897032|NCT01814800|2167914|P1|STARTED|Overall Study||59
897033|NCT01814787|2167953|P2|NOT COMPLETED|Overall Study||0
897034|NCT01814787|2167954|P1|NOT COMPLETED|Overall Study||0
897035|NCT01814787|2167953|P2|COMPLETED|Overall Study||684
897036|NCT01814787|2167954|P1|COMPLETED|Overall Study||685
897037|NCT01814787|2167953|P2|STARTED|Overall Study||684
897038|NCT01814787|2167954|P1|STARTED|Overall Study||685
897039|NCT01814774|2167960|P1|NOT COMPLETED|Overall Study||0
897040|NCT01814774|2167960|P1|COMPLETED|Overall Study||48
897041|NCT01814774|2167960|P1|STARTED|Overall Study||48
897042|NCT01814761|2167974|P2|NOT COMPLETED|Overall Study||30
897043|NCT01814761|2167975|P1|NOT COMPLETED|Overall Study||8
897044|NCT01814761|2167974|P2|COMPLETED|Overall Study||240
897045|NCT01814761|2167975|P1|COMPLETED|Overall Study||34
897046|NCT01814761|2167974|P2|STARTED|Overall Study||270
897047|NCT01814761|2167975|P1|STARTED|Overall Study||42
897048|NCT01814748|2167989|P2|NOT COMPLETED|Overall Study||7
897049|NCT01814748|2167990|P1|NOT COMPLETED|Overall Study||8
897050|NCT01814748|2167989|P2|COMPLETED|Overall Study||94
897051|NCT01814748|2167990|P1|COMPLETED|Overall Study||94
897052|NCT01814748|2167989|P2|STARTED|Overall Study||101
897053|NCT01814748|2167990|P1|STARTED|Overall Study||102
897054|NCT01814722|2168013|P3|NOT COMPLETED|Overall Study||0
897055|NCT01814722|2168014|P2|NOT COMPLETED|Overall Study||0
897056|NCT01814722|2168015|P1|NOT COMPLETED|Overall Study||0
897057|NCT01814722|2168013|P3|COMPLETED|Overall Study||6
897058|NCT01814722|2168014|P2|COMPLETED|Overall Study||21
897059|NCT01814722|2168015|P1|COMPLETED|Overall Study||36
897060|NCT01814722|2168013|P3|STARTED|Overall Study||6
897061|NCT01814722|2168014|P2|STARTED|Overall Study||21
897062|NCT01814722|2168015|P1|STARTED|Overall Study||36
897063|NCT01814696|2168034|P2|NOT COMPLETED|Overall Study||0
897064|NCT01814696|2168035|P1|NOT COMPLETED|Overall Study||2
897065|NCT01814696|2168034|P2|COMPLETED|Overall Study||11
897066|NCT01814696|2168035|P1|COMPLETED|Overall Study||13
897067|NCT01814696|2168034|P2|STARTED|Overall Study||11
897068|NCT01814696|2168035|P1|STARTED|Overall Study||15
897069|NCT01814670|2168053|P1|NOT COMPLETED|Overall Study||12
897070|NCT01814670|2168053|P1|COMPLETED|Overall Study||173
897071|NCT01814670|2168053|P1|STARTED|Overall Study||185
897072|NCT01814553|2168063|P2|NOT COMPLETED|Overall Study||22
897073|NCT01814553|2168064|P1|NOT COMPLETED|Overall Study||18
897074|NCT01814553|2168063|P2|COMPLETED|Overall Study||0
897075|NCT01814553|2168064|P1|COMPLETED|Overall Study||0
897076|NCT01814553|2168063|P2|STARTED|Overall Study||22
897077|NCT01814553|2168064|P1|STARTED|Overall Study||18
897078|NCT01814397|2168078|P1|NOT COMPLETED|Overall Study||14
897079|NCT01814397|2168078|P1|COMPLETED|Overall Study||36
897080|NCT01814397|2168078|P1|3 Month Evaluation|Overall Study||43
897081|NCT01814397|2168078|P1|STARTED|Overall Study||50
897082|NCT01814332|2168087|P2|NOT COMPLETED|Overall Study||16
897083|NCT01814332|2168088|P1|NOT COMPLETED|Overall Study||16
897084|NCT01814332|2168087|P2|COMPLETED|Overall Study||49
897085|NCT01814332|2168088|P1|COMPLETED|Overall Study||47
897086|NCT01814332|2168087|P2|STARTED|Overall Study||65
897087|NCT01814332|2168088|P1|STARTED|Overall Study||63
897088|NCT01814241|2168100|P1|NOT COMPLETED|Overall Study||4
897089|NCT01814241|2168100|P1|COMPLETED|Overall Study||16
897090|NCT01814241|2168100|P1|STARTED|Overall Study||20
897091|NCT01814137|2168110|P2|NOT COMPLETED|Overall Study||5
897092|NCT01814137|2168111|P1|NOT COMPLETED|Overall Study||5
897093|NCT01814137|2168110|P2|COMPLETED|Overall Study||15
897094|NCT01814137|2168111|P1|COMPLETED|Overall Study||15
897095|NCT01814137|2168110|P2|STARTED|Overall Study||20
897096|NCT01814137|2168111|P1|STARTED|Overall Study||20
897097|NCT01814046|2168127|P3|NOT COMPLETED|Retreatment||0
897098|NCT01814046|2168128|P2|NOT COMPLETED|Retreatment||0
897099|NCT01814046|2168129|P1|NOT COMPLETED|Retreatment||0
897100|NCT01814046|2168127|P3|COMPLETED|Retreatment||3
897101|NCT01814046|2168128|P2|COMPLETED|Retreatment||0
897102|NCT01814046|2168129|P1|COMPLETED|Retreatment||0
897103|NCT01814046|2168127|P3|STARTED|Retreatment||3
897104|NCT01814046|2168128|P2|STARTED|Retreatment||0
897105|NCT01814046|2168129|P1|STARTED|Retreatment||0
897106|NCT01814046|2168127|P3|NOT COMPLETED|Drug Administration||0
897107|NCT01814046|2168128|P2|NOT COMPLETED|Drug Administration||0
897108|NCT01814046|2168129|P1|NOT COMPLETED|Drug Administration||1
897109|NCT01814046|2168127|P3|COMPLETED|Drug Administration||0
897110|NCT01814046|2168128|P2|COMPLETED|Drug Administration||2
897111|NCT01814046|2168129|P1|COMPLETED|Drug Administration||21
897112|NCT01814046|2168127|P3|STARTED|Drug Administration||0
897113|NCT01814046|2168128|P2|STARTED|Drug Administration||2
897114|NCT01814046|2168129|P1|STARTED|Drug Administration||22
897115|NCT01813890|2168143|P3|NOT COMPLETED|Overall Study||6
897116|NCT01813890|2168144|P2|NOT COMPLETED|Overall Study||4
897117|NCT01813890|2168145|P1|NOT COMPLETED|Overall Study||9
897118|NCT01813890|2168143|P3|COMPLETED|Overall Study||13
897119|NCT01813890|2168144|P2|COMPLETED|Overall Study||17
897120|NCT01813890|2168145|P1|COMPLETED|Overall Study||11
897121|NCT01813890|2168143|P3|STARTED|Overall Study||19
897122|NCT01813890|2168144|P2|STARTED|Overall Study||21
897123|NCT01813890|2168145|P1|STARTED|Overall Study||20
897124|NCT01813721|2168174|P1|NOT COMPLETED|Overall Study||64
897125|NCT01813721|2168174|P1|COMPLETED|Overall Study||943
897126|NCT01813721|2168174|P1|STARTED|Overall Study|Indicates number of participants enrolled|1007
897127|NCT01813110|2168226|P2|NOT COMPLETED|Overall Study||1
897128|NCT01813110|2168227|P1|NOT COMPLETED|Overall Study||0
897129|NCT01813110|2168226|P2|COMPLETED|Overall Study||10
897130|NCT01813110|2168227|P1|COMPLETED|Overall Study||10
897131|NCT01813110|2168226|P2|STARTED|Overall Study||11
897132|NCT01813110|2168227|P1|STARTED|Overall Study||10
897133|NCT01813019|2168235|P2|NOT COMPLETED|Overall Study||6
897134|NCT01813019|2168236|P1|NOT COMPLETED|Overall Study||7
897135|NCT01813019|2168235|P2|COMPLETED|Overall Study||20
897136|NCT01813019|2168236|P1|COMPLETED|Overall Study||17
897137|NCT01813019|2168235|P2|STARTED|Overall Study||26
897138|NCT01813019|2168236|P1|STARTED|Overall Study||24
897139|NCT01812837|2168247|P3|NOT COMPLETED|Overall Study||0
897140|NCT01812837|2168248|P2|NOT COMPLETED|Overall Study||1
897141|NCT01812837|2168249|P1|NOT COMPLETED|Overall Study||2
897142|NCT01812837|2168247|P3|COMPLETED|Overall Study||17
897143|NCT01812837|2168248|P2|COMPLETED|Overall Study||16
897144|NCT01812837|2168249|P1|COMPLETED|Overall Study||15
897145|NCT01812837|2168247|P3|STARTED|Overall Study||17
897146|NCT01812837|2168248|P2|STARTED|Overall Study||17
897147|NCT01812837|2168249|P1|STARTED|Overall Study||17
897148|NCT01812707|2168261|P4|NOT COMPLETED|Overall Study||2
897149|NCT01812707|2168262|P3|NOT COMPLETED|Overall Study||0
897150|NCT01812707|2168263|P2|NOT COMPLETED|Overall Study||0
897151|NCT01812707|2168264|P1|NOT COMPLETED|Overall Study||2
897152|NCT01812707|2168261|P4|COMPLETED|Overall Study||23
897153|NCT01812707|2168262|P3|COMPLETED|Overall Study||25
897154|NCT01812707|2168263|P2|COMPLETED|Overall Study||25
897155|NCT01812707|2168264|P1|COMPLETED|Overall Study||23
897156|NCT01812707|2168261|P4|Treated|Overall Study||25
897157|NCT01812707|2168262|P3|Treated|Overall Study||25
897158|NCT01812707|2168263|P2|Treated|Overall Study||25
897159|NCT01812707|2168264|P1|Treated|Overall Study||25
897160|NCT01812707|2168261|P4|STARTED|Overall Study||25
897161|NCT01812707|2168262|P3|STARTED|Overall Study||25
897162|NCT01812707|2168263|P2|STARTED|Overall Study||25
897163|NCT01812707|2168264|P1|STARTED|Overall Study||25
897164|NCT01812681|2168300|P2|NOT COMPLETED|Overall Study||0
897165|NCT01812681|2168301|P1|NOT COMPLETED|Overall Study||3
897166|NCT01812681|2168300|P2|COMPLETED|Overall Study||24
897167|NCT01812681|2168301|P1|COMPLETED|Overall Study||57
897168|NCT01812681|2168300|P2|STARTED|Overall Study||24
897169|NCT01812681|2168301|P1|STARTED|Overall Study||60
897170|NCT01812655|2168312|P3|NOT COMPLETED|Overall Study||0
897171|NCT01812655|2168313|P2|NOT COMPLETED|Overall Study||1
897172|NCT01812655|2168314|P1|NOT COMPLETED|Overall Study||1
897173|NCT01812655|2168312|P3|COMPLETED|Overall Study||10
897174|NCT01812655|2168313|P2|COMPLETED|Overall Study||10
897175|NCT01812655|2168314|P1|COMPLETED|Overall Study||8
897176|NCT01812655|2168312|P3|STARTED|Overall Study|Nurses provided their usual, standard care throughout the entire burn wound care.|10
897177|NCT01812655|2168313|P2|STARTED|Overall Study|Passive Distraction-Patients watched a movie during their burn wound care.|11
897178|NCT01812655|2168314|P1|STARTED|Overall Study|Virtual Reality-Patients used an interactive VR program during their burn wound care procedure.|9
897179|NCT01812473|2168330|P2|NOT COMPLETED|Overall Study||0
897180|NCT01812473|2168331|P1|NOT COMPLETED|Overall Study||0
897181|NCT01812473|2168330|P2|COMPLETED|Overall Study||13
897182|NCT01812473|2168331|P1|COMPLETED|Overall Study||22
897183|NCT01812473|2168330|P2|STARTED|Overall Study||13
897184|NCT01812473|2168331|P1|STARTED|Overall Study||22
897185|NCT01812057|2168339|P2|NOT COMPLETED|Overall Study||0
897186|NCT01812057|2168340|P1|NOT COMPLETED|Overall Study||2
897187|NCT01812057|2168339|P2|COMPLETED|Overall Study||24
897188|NCT01812057|2168340|P1|COMPLETED|Overall Study||23
897189|NCT01812057|2168339|P2|STARTED|Overall Study||24
897190|NCT01812057|2168340|P1|STARTED|Overall Study||25
897191|NCT01812044|2168381|P3|NOT COMPLETED|Overall Study||0
897192|NCT01812044|2168382|P2|NOT COMPLETED|Overall Study||0
897193|NCT01812044|2168383|P1|NOT COMPLETED|Overall Study||0
897194|NCT01812044|2168381|P3|COMPLETED|Overall Study||16
897195|NCT01812044|2168382|P2|COMPLETED|Overall Study||17
897196|NCT01812044|2168383|P1|COMPLETED|Overall Study||17
897197|NCT01812044|2168381|P3|STARTED|Overall Study||16
897198|NCT01812044|2168382|P2|STARTED|Overall Study||17
897199|NCT01812044|2168383|P1|STARTED|Overall Study||17
897200|NCT01811953|2168418|P6|NOT COMPLETED|Overall Study||1
897201|NCT01811953|2168419|P5|NOT COMPLETED|Overall Study||1
897202|NCT01811953|2168420|P4|NOT COMPLETED|Overall Study||1
897203|NCT01811953|2168421|P3|NOT COMPLETED|Overall Study||0
897204|NCT01811953|2168422|P2|NOT COMPLETED|Overall Study||0
897205|NCT01811953|2168423|P1|NOT COMPLETED|Overall Study||0
897206|NCT01811953|2168418|P6|COMPLETED|Overall Study||11
897207|NCT01811953|2168419|P5|COMPLETED|Overall Study||11
897208|NCT01811953|2168420|P4|COMPLETED|Overall Study||5
897209|NCT01811953|2168421|P3|COMPLETED|Overall Study||6
897210|NCT01811953|2168422|P2|COMPLETED|Overall Study||6
897211|NCT01811953|2168423|P1|COMPLETED|Overall Study||6
897212|NCT01811953|2168418|P6|STARTED|Overall Study||12
897213|NCT01811953|2168419|P5|STARTED|Overall Study||12
897214|NCT01811953|2168420|P4|STARTED|Overall Study||6
897215|NCT01811953|2168421|P3|STARTED|Overall Study||6
897216|NCT01811953|2168422|P2|STARTED|Overall Study||6
897217|NCT01811953|2168423|P1|STARTED|Overall Study||6
897218|NCT01811732|2168469|P2|NOT COMPLETED|Overall Study||58
897219|NCT01811732|2168470|P1|NOT COMPLETED|Overall Study||55
897220|NCT01811732|2168469|P2|COMPLETED|Overall Study||271
897221|NCT01811732|2168470|P1|COMPLETED|Overall Study||276
897222|NCT01811732|2168469|P2|STARTED|Overall Study||329
897223|NCT01811732|2168470|P1|STARTED|Overall Study||331
897224|NCT01811706|2168480|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
897225|NCT01811706|2168481|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
897226|NCT01811706|2168480|P2|COMPLETED|Second Intervention (4 Weeks)||10
897227|NCT01811706|2168481|P1|COMPLETED|Second Intervention (4 Weeks)||9
897228|NCT01811706|2168480|P2|STARTED|Second Intervention (4 Weeks)||10
897229|NCT01811706|2168481|P1|STARTED|Second Intervention (4 Weeks)||9
897230|NCT01811706|2168480|P2|NOT COMPLETED|Washout ( 2 Weeks)||0
897231|NCT01811706|2168481|P1|NOT COMPLETED|Washout ( 2 Weeks)||0
897232|NCT01811706|2168480|P2|COMPLETED|Washout ( 2 Weeks)||10
897233|NCT01811706|2168481|P1|COMPLETED|Washout ( 2 Weeks)||9
897234|NCT01811706|2168480|P2|STARTED|Washout ( 2 Weeks)||10
897235|NCT01811706|2168481|P1|STARTED|Washout ( 2 Weeks)||9
897236|NCT01811706|2168480|P2|NOT COMPLETED|First Intervention ( 4 Weeks)||0
897237|NCT01811706|2168481|P1|NOT COMPLETED|First Intervention ( 4 Weeks)||1
897238|NCT01811706|2168480|P2|COMPLETED|First Intervention ( 4 Weeks)||10
897239|NCT01811706|2168481|P1|COMPLETED|First Intervention ( 4 Weeks)||9
897240|NCT01811706|2168480|P2|STARTED|First Intervention ( 4 Weeks)||10
897241|NCT01811706|2168481|P1|STARTED|First Intervention ( 4 Weeks)||10
897242|NCT01811680|2168491|P1|NOT COMPLETED|Overall Study||0
897243|NCT01811680|2168491|P1|COMPLETED|Overall Study||10
897244|NCT01811680|2168491|P1|STARTED|Overall Study||10
897245|NCT01811563|2168498|P2|NOT COMPLETED|Overall Study||3
897246|NCT01811563|2168499|P1|NOT COMPLETED|Overall Study||5
897247|NCT01811563|2168498|P2|COMPLETED|Overall Study||20
897248|NCT01811563|2168499|P1|COMPLETED|Overall Study||20
897249|NCT01811563|2168498|P2|STARTED|Overall Study||23
897250|NCT01811563|2168499|P1|STARTED|Overall Study||25
897251|NCT01811485|2168528|P3|NOT COMPLETED|Overall Study||5
897252|NCT01811485|2168529|P2|NOT COMPLETED|Overall Study||4
897253|NCT01811485|2168530|P1|NOT COMPLETED|Overall Study||2
897254|NCT01811485|2168528|P3|COMPLETED|Overall Study||51
897255|NCT01811485|2168529|P2|COMPLETED|Overall Study||55
897256|NCT01811485|2168530|P1|COMPLETED|Overall Study||54
897257|NCT01811485|2168528|P3|STARTED|Overall Study||56
897258|NCT01811485|2168529|P2|STARTED|Overall Study||59
897259|NCT01811485|2168530|P1|STARTED|Overall Study|"Started indicates randomized patients"|56
897260|NCT01811472|2168550|P3|NOT COMPLETED|Overall Study||5
897261|NCT01811472|2168551|P2|NOT COMPLETED|Overall Study||0
897262|NCT01811472|2168552|P1|NOT COMPLETED|Overall Study||2
897263|NCT01811472|2168550|P3|COMPLETED|Overall Study||16
897264|NCT01811472|2168551|P2|COMPLETED|Overall Study||11
897265|NCT01811472|2168552|P1|COMPLETED|Overall Study||18
897266|NCT01811472|2168550|P3|STARTED|Overall Study||21
897267|NCT01811472|2168551|P2|STARTED|Overall Study||11
897268|NCT01811472|2168552|P1|STARTED|Overall Study||20
897269|NCT01811355|2168597|P2|NOT COMPLETED|Second Dose||0
897270|NCT01811355|2168598|P1|NOT COMPLETED|Second Dose||0
897271|NCT01811355|2168597|P2|COMPLETED|Second Dose||12
897272|NCT01811355|2168598|P1|COMPLETED|Second Dose||9
897273|NCT01811355|2168597|P2|STARTED|Second Dose||12
897274|NCT01811355|2168598|P1|STARTED|Second Dose||9
897275|NCT01811355|2168597|P2|NOT COMPLETED|Washout||0
897276|NCT01811355|2168598|P1|NOT COMPLETED|Washout||0
897277|NCT01811355|2168597|P2|COMPLETED|Washout||12
897278|NCT01811355|2168598|P1|COMPLETED|Washout||9
897279|NCT01811355|2168597|P2|STARTED|Washout||12
897280|NCT01811355|2168598|P1|STARTED|Washout||9
897281|NCT01811355|2168597|P2|NOT COMPLETED|First Dose||0
897282|NCT01811355|2168598|P1|NOT COMPLETED|First Dose||2
897283|NCT01811355|2168597|P2|COMPLETED|First Dose||12
897284|NCT01811355|2168598|P1|COMPLETED|First Dose||9
897285|NCT01811355|2168597|P2|STARTED|First Dose||12
897286|NCT01811355|2168598|P1|STARTED|First Dose||11
897302|NCT01811303|2168628|P4|NOT COMPLETED|Fourth Intervention (1 Day)||0
897303|NCT01811303|2168629|P3|NOT COMPLETED|Fourth Intervention (1 Day)||0
897304|NCT01811303|2168630|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
897305|NCT01811303|2168631|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
897306|NCT01811303|2168628|P4|COMPLETED|Fourth Intervention (1 Day)||2
897307|NCT01811303|2168629|P3|COMPLETED|Fourth Intervention (1 Day)||4
897308|NCT01811303|2168630|P2|COMPLETED|Fourth Intervention (1 Day)||4
897309|NCT01811303|2168631|P1|COMPLETED|Fourth Intervention (1 Day)||4
897310|NCT01811303|2168628|P4|STARTED|Fourth Intervention (1 Day)||2
897311|NCT01811303|2168629|P3|STARTED|Fourth Intervention (1 Day)||4
897312|NCT01811303|2168630|P2|STARTED|Fourth Intervention (1 Day)||4
897313|NCT01811303|2168631|P1|STARTED|Fourth Intervention (1 Day)||4
897314|NCT01811303|2168628|P4|NOT COMPLETED|Washout (2 Days or More)||0
897315|NCT01811303|2168629|P3|NOT COMPLETED|Washout (2 Days or More)||0
897316|NCT01811303|2168630|P2|NOT COMPLETED|Washout (2 Days or More)||0
897317|NCT01811303|2168631|P1|NOT COMPLETED|Washout (2 Days or More)||0
897318|NCT01811303|2168628|P4|COMPLETED|Washout (2 Days or More)||2
897319|NCT01811303|2168629|P3|COMPLETED|Washout (2 Days or More)||4
897320|NCT01811303|2168630|P2|COMPLETED|Washout (2 Days or More)||4
897321|NCT01811303|2168631|P1|COMPLETED|Washout (2 Days or More)||4
897322|NCT01811303|2168628|P4|STARTED|Washout (2 Days or More)||2
897323|NCT01811303|2168629|P3|STARTED|Washout (2 Days or More)||4
897324|NCT01811303|2168630|P2|STARTED|Washout (2 Days or More)||4
897325|NCT01811303|2168631|P1|STARTED|Washout (2 Days or More)||4
897326|NCT01811303|2168628|P4|NOT COMPLETED|Third Intervention (1 Day)||0
897327|NCT01811303|2168629|P3|NOT COMPLETED|Third Intervention (1 Day)||0
897328|NCT01811303|2168630|P2|NOT COMPLETED|Third Intervention (1 Day)||0
897329|NCT01811303|2168631|P1|NOT COMPLETED|Third Intervention (1 Day)||0
897330|NCT01811303|2168628|P4|COMPLETED|Third Intervention (1 Day)||2
897331|NCT01811303|2168629|P3|COMPLETED|Third Intervention (1 Day)||4
897332|NCT01811303|2168630|P2|COMPLETED|Third Intervention (1 Day)||4
897333|NCT01811303|2168631|P1|COMPLETED|Third Intervention (1 Day)||4
897334|NCT01811303|2168628|P4|STARTED|Third Intervention (1 Day)||2
897335|NCT01811303|2168629|P3|STARTED|Third Intervention (1 Day)||4
897336|NCT01811303|2168630|P2|STARTED|Third Intervention (1 Day)||4
897337|NCT01811303|2168631|P1|STARTED|Third Intervention (1 Day)||4
897338|NCT01811303|2168628|P4|NOT COMPLETED|Washout (2 Days or More)||0
897339|NCT01811303|2168629|P3|NOT COMPLETED|Washout (2 Days or More)||0
897340|NCT01811303|2168630|P2|NOT COMPLETED|Washout (2 Days or More)||0
897341|NCT01811303|2168631|P1|NOT COMPLETED|Washout (2 Days or More)||0
897342|NCT01811303|2168628|P4|COMPLETED|Washout (2 Days or More)||2
897343|NCT01811303|2168629|P3|COMPLETED|Washout (2 Days or More)||4
897344|NCT01811303|2168630|P2|COMPLETED|Washout (2 Days or More)||4
897345|NCT01811303|2168631|P1|COMPLETED|Washout (2 Days or More)||4
897346|NCT01811303|2168628|P4|STARTED|Washout (2 Days or More)||2
897347|NCT01811303|2168629|P3|STARTED|Washout (2 Days or More)||4
897348|NCT01811303|2168630|P2|STARTED|Washout (2 Days or More)||4
897349|NCT01811303|2168631|P1|STARTED|Washout (2 Days or More)||4
897350|NCT01811303|2168628|P4|NOT COMPLETED|Second Intervention (1 Day)||0
897351|NCT01811303|2168629|P3|NOT COMPLETED|Second Intervention (1 Day)||0
897352|NCT01811303|2168630|P2|NOT COMPLETED|Second Intervention (1 Day)||0
897353|NCT01811303|2168631|P1|NOT COMPLETED|Second Intervention (1 Day)||0
897354|NCT01811303|2168628|P4|COMPLETED|Second Intervention (1 Day)||2
897355|NCT01811303|2168629|P3|COMPLETED|Second Intervention (1 Day)||4
897356|NCT01811303|2168630|P2|COMPLETED|Second Intervention (1 Day)||4
897357|NCT01811303|2168631|P1|COMPLETED|Second Intervention (1 Day)||4
897358|NCT01811303|2168628|P4|STARTED|Second Intervention (1 Day)||2
897359|NCT01811303|2168629|P3|STARTED|Second Intervention (1 Day)||4
897360|NCT01811303|2168630|P2|STARTED|Second Intervention (1 Day)||4
897361|NCT01811303|2168631|P1|STARTED|Second Intervention (1 Day)||4
897362|NCT01811303|2168628|P4|NOT COMPLETED|Washout (2 Days or More)||0
897363|NCT01811303|2168629|P3|NOT COMPLETED|Washout (2 Days or More)||0
897364|NCT01811303|2168630|P2|NOT COMPLETED|Washout (2 Days or More)||0
897365|NCT01811303|2168631|P1|NOT COMPLETED|Washout (2 Days or More)||0
897366|NCT01811303|2168628|P4|COMPLETED|Washout (2 Days or More)||2
897367|NCT01811303|2168629|P3|COMPLETED|Washout (2 Days or More)||4
897368|NCT01811303|2168630|P2|COMPLETED|Washout (2 Days or More)||4
897369|NCT01811303|2168631|P1|COMPLETED|Washout (2 Days or More)||4
897370|NCT01811303|2168628|P4|STARTED|Washout (2 Days or More)||2
897371|NCT01811303|2168629|P3|STARTED|Washout (2 Days or More)||4
897372|NCT01811303|2168630|P2|STARTED|Washout (2 Days or More)||4
897373|NCT01811303|2168631|P1|STARTED|Washout (2 Days or More)||4
897374|NCT01811303|2168628|P4|NOT COMPLETED|First Intervention (1 Day)||0
897375|NCT01811303|2168629|P3|NOT COMPLETED|First Intervention (1 Day)||0
897376|NCT01811303|2168630|P2|NOT COMPLETED|First Intervention (1 Day)||0
897377|NCT01811303|2168631|P1|NOT COMPLETED|First Intervention (1 Day)||0
897378|NCT01811303|2168628|P4|COMPLETED|First Intervention (1 Day)||2
897379|NCT01811303|2168629|P3|COMPLETED|First Intervention (1 Day)||4
897380|NCT01811303|2168630|P2|COMPLETED|First Intervention (1 Day)||4
897381|NCT01811303|2168631|P1|COMPLETED|First Intervention (1 Day)||4
897382|NCT01811303|2168628|P4|STARTED|First Intervention (1 Day)||2
897383|NCT01811303|2168629|P3|STARTED|First Intervention (1 Day)||4
897384|NCT01811303|2168630|P2|STARTED|First Intervention (1 Day)||4
897385|NCT01811303|2168631|P1|STARTED|First Intervention (1 Day)||4
897386|NCT01811238|2168639|P1|NOT COMPLETED|Overall Study||81
897387|NCT01811238|2168639|P1|COMPLETED|Overall Study|159 subjects regardless PP set completed study visit.|159
897388|NCT01811238|2168639|P1|PP Set|Overall Study|89 subjects excluded from PP set due to various reasons.|120
897389|NCT01811238|2168639|P1|ITT Set|Overall Study|11 subjects excluded from ITT set due to no primary efficacy assessment(5) and IC/EC violation(6).|209
897390|NCT01811238|2168639|P1|Safety Set|Overall Study|20 subjects excluded from the safety set due to study drug not administered.|220
897391|NCT01811238|2168639|P1|STARTED|Overall Study|First patient was recruited on 26 Sep. 2012.|240
897392|NCT01811186|2168650|P2|NOT COMPLETED|Overall Study||62
897393|NCT01811186|2168651|P1|NOT COMPLETED|Overall Study||71
897394|NCT01811186|2168650|P2|COMPLETED|Overall Study||64
897395|NCT01811186|2168651|P1|COMPLETED|Overall Study||61
897396|NCT01811186|2168650|P2|STARTED|Overall Study||126
897397|NCT01811186|2168651|P1|STARTED|Overall Study||132
897398|NCT01810952|2168669|P2|NOT COMPLETED|Overall Study||0
897399|NCT01810952|2168670|P1|NOT COMPLETED|Overall Study||0
897400|NCT01810952|2168669|P2|COMPLETED|Overall Study||17
897401|NCT01810952|2168670|P1|COMPLETED|Overall Study||20
897402|NCT01810952|2168669|P2|STARTED|Overall Study||17
897403|NCT01810952|2168670|P1|STARTED|Overall Study||20
897404|NCT01810939|2168684|P3|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||22
897405|NCT01810939|2168685|P2|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||10
897406|NCT01810939|2168686|P1|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||0
897407|NCT01810939|2168684|P3|COMPLETED|Part B Placebo-Controlled Withdrawal||30
897408|NCT01810939|2168685|P2|COMPLETED|Part B Placebo-Controlled Withdrawal||45
897409|NCT01810939|2168686|P1|COMPLETED|Part B Placebo-Controlled Withdrawal||0
897498|NCT01809327|2168876|P1|NOT COMPLETED|Overall Study||32
897410|NCT01810939|2168684|P3|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|52
897411|NCT01810939|2168685|P2|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|55
897412|NCT01810939|2168686|P1|STARTED|Part B Placebo-Controlled Withdrawal||0
897413|NCT01810939|2168684|P3|NOT COMPLETED|Part A Treatment Period||0
897414|NCT01810939|2168685|P2|NOT COMPLETED|Part A Treatment Period||0
897415|NCT01810939|2168686|P1|NOT COMPLETED|Part A Treatment Period||24
897416|NCT01810939|2168684|P3|COMPLETED|Part A Treatment Period||0
897417|NCT01810939|2168685|P2|COMPLETED|Part A Treatment Period||0
897418|NCT01810939|2168686|P1|COMPLETED|Part A Treatment Period||219
897419|NCT01810939|2168684|P3|STARTED|Part A Treatment Period||0
897420|NCT01810939|2168685|P2|STARTED|Part A Treatment Period||0
897421|NCT01810939|2168686|P1|STARTED|Part A Treatment Period||243
897422|NCT01810783|2168699|P1|NOT COMPLETED|Overall Study||109
897423|NCT01810783|2168699|P1|COMPLETED|Overall Study||101
897424|NCT01810783|2168699|P1|STARTED|Overall Study||210
897425|NCT01810692|2168705|P2|NOT COMPLETED|Overall Study||0
897426|NCT01810692|2168706|P1|NOT COMPLETED|Overall Study||0
897427|NCT01810692|2168705|P2|COMPLETED|Overall Study||77
897428|NCT01810692|2168706|P1|COMPLETED|Overall Study||77
897429|NCT01810692|2168705|P2|STARTED|Overall Study||77
897430|NCT01810692|2168706|P1|STARTED|Overall Study||77
897431|NCT01810666|2168718|P1|NOT COMPLETED|Overall Study||0
897432|NCT01810666|2168718|P1|COMPLETED|Overall Study||30
897433|NCT01810666|2168718|P1|STARTED|Overall Study||30
897434|NCT01810380|2168727|P3|NOT COMPLETED|Overall Study||32
897435|NCT01810380|2168728|P2|NOT COMPLETED|Overall Study||38
897436|NCT01810380|2168729|P1|NOT COMPLETED|Overall Study||55
897437|NCT01810380|2168727|P3|COMPLETED|Overall Study||122
897438|NCT01810380|2168728|P2|COMPLETED|Overall Study||113
897439|NCT01810380|2168729|P1|COMPLETED|Overall Study||108
897440|NCT01810380|2168727|P3|Treated|Overall Study||153
897441|NCT01810380|2168728|P2|Treated|Overall Study||150
897442|NCT01810380|2168729|P1|Treated|Overall Study||161
897443|NCT01810380|2168727|P3|STARTED|Overall Study||154
897444|NCT01810380|2168728|P2|STARTED|Overall Study||151
897445|NCT01810380|2168729|P1|STARTED|Overall Study||163
897446|NCT01810302|2168790|P2|NOT COMPLETED|Overall Study||1
897447|NCT01810302|2168791|P1|NOT COMPLETED|Overall Study||1
897448|NCT01810302|2168790|P2|COMPLETED|Overall Study||0
897449|NCT01810302|2168791|P1|COMPLETED|Overall Study||0
897450|NCT01810302|2168790|P2|STARTED|Overall Study||1
897451|NCT01810302|2168791|P1|STARTED|Overall Study||1
897452|NCT01810289|2168801|P2|NOT COMPLETED|Overall Study||0
897453|NCT01810289|2168802|P1|NOT COMPLETED|Overall Study||0
897454|NCT01810289|2168801|P2|COMPLETED|Overall Study||4747
897455|NCT01810289|2168802|P1|COMPLETED|Overall Study||7277
897456|NCT01810289|2168801|P2|STARTED|Overall Study||4747
897457|NCT01810289|2168802|P1|STARTED|Overall Study||7277
897458|NCT01810263|2168810|P2|NOT COMPLETED|Overall Study||7
897459|NCT01810263|2168811|P1|NOT COMPLETED|Overall Study||8
897460|NCT01810263|2168810|P2|COMPLETED|Overall Study||11
897461|NCT01810263|2168811|P1|COMPLETED|Overall Study|2014 July|8
897462|NCT01810263|2168810|P2|STARTED|Overall Study||18
897463|NCT01810263|2168811|P1|STARTED|Overall Study||16
897464|NCT01810042|2168817|P1|NOT COMPLETED|Overall Study||10
897465|NCT01810042|2168817|P1|COMPLETED|Overall Study||39
897466|NCT01810042|2168817|P1|STARTED|Overall Study||49
897467|NCT01809938|2168824|P2|NOT COMPLETED|Second Intervention (170 Minutes)||0
897468|NCT01809938|2168825|P1|NOT COMPLETED|Second Intervention (170 Minutes)||0
897469|NCT01809938|2168824|P2|COMPLETED|Second Intervention (170 Minutes)||5
897470|NCT01809938|2168825|P1|COMPLETED|Second Intervention (170 Minutes)||5
897471|NCT01809938|2168824|P2|STARTED|Second Intervention (170 Minutes)||5
897472|NCT01809938|2168825|P1|STARTED|Second Intervention (170 Minutes)||5
897473|NCT01809938|2168824|P2|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
897474|NCT01809938|2168825|P1|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
897475|NCT01809938|2168824|P2|COMPLETED|Washout (Not Less Than 24 Hours)||5
897476|NCT01809938|2168825|P1|COMPLETED|Washout (Not Less Than 24 Hours)||5
897477|NCT01809938|2168824|P2|STARTED|Washout (Not Less Than 24 Hours)||5
897478|NCT01809938|2168825|P1|STARTED|Washout (Not Less Than 24 Hours)||5
897479|NCT01809938|2168824|P2|NOT COMPLETED|First Intervention (170 Minutes)||0
897480|NCT01809938|2168825|P1|NOT COMPLETED|First Intervention (170 Minutes)||0
897481|NCT01809938|2168824|P2|COMPLETED|First Intervention (170 Minutes)||5
897482|NCT01809938|2168825|P1|COMPLETED|First Intervention (170 Minutes)||5
897483|NCT01809938|2168824|P2|STARTED|First Intervention (170 Minutes)||5
897484|NCT01809938|2168825|P1|STARTED|First Intervention (170 Minutes)||5
897485|NCT01809834|2168832|P1|NOT COMPLETED|Overall Study||0
897486|NCT01809834|2168832|P1|COMPLETED|Overall Study||44
897487|NCT01809834|2168832|P1|STARTED|Overall Study||44
897488|NCT01809639|2168860|P2|NOT COMPLETED|Overall Study||0
897489|NCT01809639|2168861|P1|NOT COMPLETED|Overall Study||0
897490|NCT01809639|2168860|P2|COMPLETED|Overall Study||7
897491|NCT01809639|2168861|P1|COMPLETED|Overall Study||18
897492|NCT01809639|2168860|P2|STARTED|Overall Study||7
897493|NCT01809639|2168861|P1|STARTED|Overall Study||18
897494|NCT01809327|2168872|P5|NOT COMPLETED|Overall Study||25
897495|NCT01809327|2168873|P4|NOT COMPLETED|Overall Study||12
897496|NCT01809327|2168874|P3|NOT COMPLETED|Overall Study||22
897497|NCT01809327|2168875|P2|NOT COMPLETED|Overall Study||26
897499|NCT01809327|2168872|P5|COMPLETED|Overall Study||212
897500|NCT01809327|2168873|P4|COMPLETED|Overall Study||225
897501|NCT01809327|2168874|P3|COMPLETED|Overall Study||216
897502|NCT01809327|2168875|P2|COMPLETED|Overall Study||211
897503|NCT01809327|2168876|P1|COMPLETED|Overall Study||205
897504|NCT01809327|2168872|P5|STARTED|Overall Study||237
897505|NCT01809327|2168873|P4|STARTED|Overall Study||237
897506|NCT01809327|2168874|P3|STARTED|Overall Study||238
897507|NCT01809327|2168875|P2|STARTED|Overall Study||237
897508|NCT01809327|2168876|P1|STARTED|Overall Study||237
897509|NCT01809314|2168918|P1|NOT COMPLETED|Overall Study||745
897510|NCT01809314|2168918|P1|COMPLETED|Overall Study||422
897511|NCT01809314|2168918|P1|STARTED|Overall Study||1167
897512|NCT01809262|2168924|P10|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
897513|NCT01809262|2168925|P9|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
897514|NCT01809262|2168926|P8|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
897515|NCT01809262|2168927|P7|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
897516|NCT01809262|2168928|P6|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
897517|NCT01809262|2168929|P5|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
897518|NCT01809262|2168930|P4|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
897519|NCT01809262|2168931|P3|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
897520|NCT01809262|2168932|P2|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
897521|NCT01809262|2168933|P1|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
897522|NCT01809262|2168924|P10|COMPLETED|Period 5 (Fifth Dose + Washout)||4
897523|NCT01809262|2168925|P9|COMPLETED|Period 5 (Fifth Dose + Washout)||3
897524|NCT01809262|2168926|P8|COMPLETED|Period 5 (Fifth Dose + Washout)||4
897525|NCT01809262|2168927|P7|COMPLETED|Period 5 (Fifth Dose + Washout)||3
897526|NCT01809262|2168928|P6|COMPLETED|Period 5 (Fifth Dose + Washout)||3
897527|NCT01809262|2168929|P5|COMPLETED|Period 5 (Fifth Dose + Washout)||3
897528|NCT01809262|2168930|P4|COMPLETED|Period 5 (Fifth Dose + Washout)||3
897529|NCT01809262|2168931|P3|COMPLETED|Period 5 (Fifth Dose + Washout)||4
897530|NCT01809262|2168932|P2|COMPLETED|Period 5 (Fifth Dose + Washout)||3
897531|NCT01809262|2168933|P1|COMPLETED|Period 5 (Fifth Dose + Washout)||4
897532|NCT01809262|2168924|P10|STARTED|Period 5 (Fifth Dose + Washout)||4
897533|NCT01809262|2168925|P9|STARTED|Period 5 (Fifth Dose + Washout)||3
897534|NCT01809262|2168926|P8|STARTED|Period 5 (Fifth Dose + Washout)||4
897535|NCT01809262|2168927|P7|STARTED|Period 5 (Fifth Dose + Washout)||3
897536|NCT01809262|2168928|P6|STARTED|Period 5 (Fifth Dose + Washout)||3
897537|NCT01809262|2168929|P5|STARTED|Period 5 (Fifth Dose + Washout)||3
897538|NCT01809262|2168930|P4|STARTED|Period 5 (Fifth Dose + Washout)||3
897539|NCT01809262|2168931|P3|STARTED|Period 5 (Fifth Dose + Washout)||4
897540|NCT01809262|2168932|P2|STARTED|Period 5 (Fifth Dose + Washout)||3
897541|NCT01809262|2168933|P1|STARTED|Period 5 (Fifth Dose + Washout)||4
897542|NCT01809262|2168924|P10|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
897543|NCT01809262|2168925|P9|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
897544|NCT01809262|2168926|P8|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
897545|NCT01809262|2168927|P7|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
897546|NCT01809262|2168928|P6|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
897547|NCT01809262|2168929|P5|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
897548|NCT01809262|2168930|P4|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
897549|NCT01809262|2168931|P3|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
897550|NCT01809262|2168932|P2|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
897551|NCT01809262|2168933|P1|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
897552|NCT01809262|2168924|P10|COMPLETED|Period 4 (Fourth Dose + Washout)||4
897553|NCT01809262|2168925|P9|COMPLETED|Period 4 (Fourth Dose + Washout)||3
897554|NCT01809262|2168926|P8|COMPLETED|Period 4 (Fourth Dose + Washout)||4
897555|NCT01809262|2168927|P7|COMPLETED|Period 4 (Fourth Dose + Washout)||3
897556|NCT01809262|2168928|P6|COMPLETED|Period 4 (Fourth Dose + Washout)||3
897557|NCT01809262|2168929|P5|COMPLETED|Period 4 (Fourth Dose + Washout)||3
897558|NCT01809262|2168930|P4|COMPLETED|Period 4 (Fourth Dose + Washout)||3
897559|NCT01809262|2168931|P3|COMPLETED|Period 4 (Fourth Dose + Washout)||4
897560|NCT01809262|2168932|P2|COMPLETED|Period 4 (Fourth Dose + Washout)||3
897561|NCT01809262|2168933|P1|COMPLETED|Period 4 (Fourth Dose + Washout)||4
897562|NCT01809262|2168924|P10|STARTED|Period 4 (Fourth Dose + Washout)||4
897563|NCT01809262|2168925|P9|STARTED|Period 4 (Fourth Dose + Washout)||3
897564|NCT01809262|2168926|P8|STARTED|Period 4 (Fourth Dose + Washout)||4
897565|NCT01809262|2168927|P7|STARTED|Period 4 (Fourth Dose + Washout)||3
897566|NCT01809262|2168928|P6|STARTED|Period 4 (Fourth Dose + Washout)||3
897567|NCT01809262|2168929|P5|STARTED|Period 4 (Fourth Dose + Washout)||3
897568|NCT01809262|2168930|P4|STARTED|Period 4 (Fourth Dose + Washout)||3
897569|NCT01809262|2168931|P3|STARTED|Period 4 (Fourth Dose + Washout)||4
897570|NCT01809262|2168932|P2|STARTED|Period 4 (Fourth Dose + Washout)||3
897571|NCT01809262|2168933|P1|STARTED|Period 4 (Fourth Dose + Washout)||4
897572|NCT01809262|2168924|P10|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
897573|NCT01809262|2168925|P9|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
897574|NCT01809262|2168926|P8|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
897575|NCT01809262|2168927|P7|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
897576|NCT01809262|2168928|P6|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
897577|NCT01809262|2168929|P5|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
897578|NCT01809262|2168930|P4|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
897579|NCT01809262|2168931|P3|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
897580|NCT01809262|2168932|P2|NOT COMPLETED|Period 3 (Third Dose + Washout)||1
897581|NCT01809262|2168933|P1|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
897582|NCT01809262|2168924|P10|COMPLETED|Period 3 (Third Dose + Washout)||4
897583|NCT01809262|2168925|P9|COMPLETED|Period 3 (Third Dose + Washout)||3
897584|NCT01809262|2168926|P8|COMPLETED|Period 3 (Third Dose + Washout)||4
897585|NCT01809262|2168927|P7|COMPLETED|Period 3 (Third Dose + Washout)||3
897586|NCT01809262|2168928|P6|COMPLETED|Period 3 (Third Dose + Washout)||3
897587|NCT01809262|2168929|P5|COMPLETED|Period 3 (Third Dose + Washout)||3
897588|NCT01809262|2168930|P4|COMPLETED|Period 3 (Third Dose + Washout)||3
897589|NCT01809262|2168931|P3|COMPLETED|Period 3 (Third Dose + Washout)||4
897590|NCT01809262|2168932|P2|COMPLETED|Period 3 (Third Dose + Washout)||3
897591|NCT01809262|2168933|P1|COMPLETED|Period 3 (Third Dose + Washout)||4
897592|NCT01809262|2168924|P10|STARTED|Period 3 (Third Dose + Washout)||4
897593|NCT01809262|2168925|P9|STARTED|Period 3 (Third Dose + Washout)||3
897594|NCT01809262|2168926|P8|STARTED|Period 3 (Third Dose + Washout)||4
897595|NCT01809262|2168927|P7|STARTED|Period 3 (Third Dose + Washout)||3
897596|NCT01809262|2168928|P6|STARTED|Period 3 (Third Dose + Washout)||3
897597|NCT01809262|2168929|P5|STARTED|Period 3 (Third Dose + Washout)||3
897598|NCT01809262|2168930|P4|STARTED|Period 3 (Third Dose + Washout)||3
897599|NCT01809262|2168931|P3|STARTED|Period 3 (Third Dose + Washout)||4
897600|NCT01809262|2168932|P2|STARTED|Period 3 (Third Dose + Washout)||4
897601|NCT01809262|2168933|P1|STARTED|Period 3 (Third Dose + Washout)||4
897602|NCT01809262|2168924|P10|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
897603|NCT01809262|2168925|P9|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
897604|NCT01809262|2168926|P8|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
897605|NCT01809262|2168927|P7|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
897606|NCT01809262|2168928|P6|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
897607|NCT01809262|2168929|P5|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
897608|NCT01809262|2168930|P4|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
897609|NCT01809262|2168931|P3|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
897610|NCT01809262|2168932|P2|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
897611|NCT01809262|2168933|P1|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
897612|NCT01809262|2168924|P10|COMPLETED|Period 2 (Second Dose + Washout)||4
897613|NCT01809262|2168925|P9|COMPLETED|Period 2 (Second Dose + Washout)||3
897614|NCT01809262|2168926|P8|COMPLETED|Period 2 (Second Dose + Washout)||4
897615|NCT01809262|2168927|P7|COMPLETED|Period 2 (Second Dose + Washout)||3
897616|NCT01809262|2168928|P6|COMPLETED|Period 2 (Second Dose + Washout)||3
897617|NCT01809262|2168929|P5|COMPLETED|Period 2 (Second Dose + Washout)||3
897618|NCT01809262|2168930|P4|COMPLETED|Period 2 (Second Dose + Washout)||3
897619|NCT01809262|2168931|P3|COMPLETED|Period 2 (Second Dose + Washout)||4
897620|NCT01809262|2168932|P2|COMPLETED|Period 2 (Second Dose + Washout)||4
897621|NCT01809262|2168933|P1|COMPLETED|Period 2 (Second Dose + Washout)||4
897622|NCT01809262|2168924|P10|STARTED|Period 2 (Second Dose + Washout)||4
897623|NCT01809262|2168925|P9|STARTED|Period 2 (Second Dose + Washout)||3
897624|NCT01809262|2168926|P8|STARTED|Period 2 (Second Dose + Washout)||4
897625|NCT01809262|2168927|P7|STARTED|Period 2 (Second Dose + Washout)||3
897626|NCT01809262|2168928|P6|STARTED|Period 2 (Second Dose + Washout)||3
897627|NCT01809262|2168929|P5|STARTED|Period 2 (Second Dose + Washout)||3
897628|NCT01809262|2168930|P4|STARTED|Period 2 (Second Dose + Washout)||3
897629|NCT01809262|2168931|P3|STARTED|Period 2 (Second Dose + Washout)||4
897630|NCT01809262|2168932|P2|STARTED|Period 2 (Second Dose + Washout)||4
897631|NCT01809262|2168933|P1|STARTED|Period 2 (Second Dose + Washout)||4
897632|NCT01809262|2168924|P10|NOT COMPLETED|Period 1 (First Dose + Washout)||0
897633|NCT01809262|2168925|P9|NOT COMPLETED|Period 1 (First Dose + Washout)||0
897634|NCT01809262|2168926|P8|NOT COMPLETED|Period 1 (First Dose + Washout)||0
897635|NCT01809262|2168927|P7|NOT COMPLETED|Period 1 (First Dose + Washout)||0
897636|NCT01809262|2168928|P6|NOT COMPLETED|Period 1 (First Dose + Washout)||0
897637|NCT01809262|2168929|P5|NOT COMPLETED|Period 1 (First Dose + Washout)||1
897638|NCT01809262|2168930|P4|NOT COMPLETED|Period 1 (First Dose + Washout)||0
897639|NCT01809262|2168931|P3|NOT COMPLETED|Period 1 (First Dose + Washout)||0
897640|NCT01809262|2168932|P2|NOT COMPLETED|Period 1 (First Dose + Washout)||0
897641|NCT01809262|2168933|P1|NOT COMPLETED|Period 1 (First Dose + Washout)||0
897642|NCT01809262|2168924|P10|COMPLETED|Period 1 (First Dose + Washout)||4
897643|NCT01809262|2168925|P9|COMPLETED|Period 1 (First Dose + Washout)||3
897644|NCT01809262|2168926|P8|COMPLETED|Period 1 (First Dose + Washout)||4
897645|NCT01809262|2168927|P7|COMPLETED|Period 1 (First Dose + Washout)||3
897646|NCT01809262|2168928|P6|COMPLETED|Period 1 (First Dose + Washout)||3
897647|NCT01809262|2168929|P5|COMPLETED|Period 1 (First Dose + Washout)||3
897648|NCT01809262|2168930|P4|COMPLETED|Period 1 (First Dose + Washout)||3
897649|NCT01809262|2168931|P3|COMPLETED|Period 1 (First Dose + Washout)||4
897650|NCT01809262|2168932|P2|COMPLETED|Period 1 (First Dose + Washout)||4
897651|NCT01809262|2168933|P1|COMPLETED|Period 1 (First Dose + Washout)||4
897652|NCT01809262|2168924|P10|STARTED|Period 1 (First Dose + Washout)||4
897653|NCT01809262|2168925|P9|STARTED|Period 1 (First Dose + Washout)||3
897654|NCT01809262|2168926|P8|STARTED|Period 1 (First Dose + Washout)||4
897655|NCT01809262|2168927|P7|STARTED|Period 1 (First Dose + Washout)||3
897656|NCT01809262|2168928|P6|STARTED|Period 1 (First Dose + Washout)||3
897657|NCT01809262|2168929|P5|STARTED|Period 1 (First Dose + Washout)||4
897658|NCT01809262|2168930|P4|STARTED|Period 1 (First Dose + Washout)||3
897659|NCT01809262|2168931|P3|STARTED|Period 1 (First Dose + Washout)||4
897660|NCT01809262|2168932|P2|STARTED|Period 1 (First Dose + Washout)||4
897661|NCT01809262|2168933|P1|STARTED|Period 1 (First Dose + Washout)||4
897662|NCT01809197|2169002|P2|NOT COMPLETED|Overall Study||8
897663|NCT01809197|2169003|P1|NOT COMPLETED|Overall Study||10
897664|NCT01809197|2169002|P2|COMPLETED|Overall Study||177
897665|NCT01809197|2169003|P1|COMPLETED|Overall Study||177
897666|NCT01809197|2169002|P2|STARTED|Overall Study||185
897667|NCT01809197|2169003|P1|STARTED|Overall Study||187
897668|NCT01809106|2169013|P4|NOT COMPLETED|Overall Study||4
897669|NCT01809106|2169014|P3|NOT COMPLETED|Overall Study||3
897670|NCT01809106|2169015|P2|NOT COMPLETED|Overall Study||5
897671|NCT01809106|2169016|P1|NOT COMPLETED|Overall Study||8
897672|NCT01809106|2169013|P4|COMPLETED|Overall Study||124
897673|NCT01809106|2169014|P3|COMPLETED|Overall Study||127
897674|NCT01809106|2169015|P2|COMPLETED|Overall Study||125
897675|NCT01809106|2169016|P1|COMPLETED|Overall Study||122
897676|NCT01809106|2169013|P4|STARTED|Overall Study||128
897677|NCT01809106|2169014|P3|STARTED|Overall Study||130
897678|NCT01809106|2169015|P2|STARTED|Overall Study||130
897679|NCT01809106|2169016|P1|STARTED|Overall Study||130
897680|NCT01809054|2169036|P2|NOT COMPLETED|Overall Study||0
897681|NCT01809054|2169037|P1|NOT COMPLETED|Overall Study||0
897682|NCT01809054|2169036|P2|COMPLETED|Overall Study||22
897683|NCT01809054|2169037|P1|COMPLETED|Overall Study||27
897684|NCT01809054|2169036|P2|STARTED|Overall Study||22
897685|NCT01809054|2169037|P1|STARTED|Overall Study||27
897686|NCT01808963|2169045|P1|NOT COMPLETED|Overall Study||0
897687|NCT01808963|2169045|P1|COMPLETED|Overall Study||13
897688|NCT01808963|2169045|P1|STARTED|Overall Study||13
897689|NCT01808950|2169052|P3|NOT COMPLETED|Overall Study||0
897690|NCT01808950|2169053|P2|NOT COMPLETED|Overall Study||0
897691|NCT01808950|2169054|P1|NOT COMPLETED|Overall Study||0
897692|NCT01808950|2169052|P3|COMPLETED|Overall Study||0
897693|NCT01808950|2169053|P2|COMPLETED|Overall Study||3
897694|NCT01808950|2169054|P1|COMPLETED|Overall Study||1
897695|NCT01808950|2169052|P3|STARTED|Overall Study||0
897696|NCT01808950|2169053|P2|STARTED|Overall Study||3
897697|NCT01808950|2169054|P1|STARTED|Overall Study||1
897698|NCT01808755|2169065|P2|NOT COMPLETED|Overall Study||0
897699|NCT01808755|2169066|P1|NOT COMPLETED|Overall Study||0
897700|NCT01808755|2169065|P2|COMPLETED|Overall Study||30
897701|NCT01808755|2169066|P1|COMPLETED|Overall Study||30
897702|NCT01808755|2169065|P2|STARTED|Overall Study||30
897703|NCT01808755|2169066|P1|STARTED|Overall Study||30
897704|NCT01808651|2169074|P3|NOT COMPLETED|Study Period 2||0
897705|NCT01808651|2169075|P2|NOT COMPLETED|Study Period 2||0
897706|NCT01808651|2169076|P1|NOT COMPLETED|Study Period 2||0
897707|NCT01808651|2169074|P3|COMPLETED|Study Period 2|3 Pts who DC'd from Study Period 1 and 30 pts who completed Study Period 1 entered Study Period 2.|33
897708|NCT01808651|2169075|P2|COMPLETED|Study Period 2|5 Pts who DC'd from Study Period 1 and 47 Pts who completed Study Period 1 entered Study Period 2.|52
897709|NCT01808651|2169076|P1|COMPLETED|Study Period 2|9 Pts who DC'd from Study Period 1 and 68 Pts who completed Study Period 1 entered Study Period 2.|77
897710|NCT01808651|2169074|P3|STARTED|Study Period 2||33
897711|NCT01808651|2169075|P2|STARTED|Study Period 2||52
897712|NCT01808651|2169076|P1|STARTED|Study Period 2||77
897713|NCT01808651|2169074|P3|NOT COMPLETED|Study Period 1||5
897714|NCT01808651|2169075|P2|NOT COMPLETED|Study Period 1||17
897715|NCT01808651|2169076|P1|NOT COMPLETED|Study Period 1||26
897716|NCT01808651|2169074|P3|COMPLETED|Study Period 1||31
897717|NCT01808651|2169075|P2|COMPLETED|Study Period 1||48
897718|NCT01808651|2169076|P1|COMPLETED|Study Period 1||73
897719|NCT01808651|2169074|P3|Received at Least One Dose of Study Drug|Study Period 1||36
897720|NCT01808651|2169075|P2|Received at Least One Dose of Study Drug|Study Period 1||65
897721|NCT01808651|2169076|P1|Received at Least One Dose of Study Drug|Study Period 1||98
897722|NCT01808651|2169074|P3|STARTED|Study Period 1||36
897723|NCT01808651|2169075|P2|STARTED|Study Period 1||65
897724|NCT01808651|2169076|P1|STARTED|Study Period 1||99
897725|NCT01808612|2169111|P3|NOT COMPLETED|Discontinuation Period||0
897726|NCT01808612|2169112|P2|NOT COMPLETED|Discontinuation Period||1
897727|NCT01808612|2169113|P1|NOT COMPLETED|Discontinuation Period||2
897728|NCT01808612|2169111|P3|COMPLETED|Discontinuation Period||145
897729|NCT01808612|2169112|P2|COMPLETED|Discontinuation Period||37
897730|NCT01808612|2169113|P1|COMPLETED|Discontinuation Period||85
897731|NCT01808612|2169111|P3|STARTED|Discontinuation Period||145
897732|NCT01808612|2169112|P2|STARTED|Discontinuation Period||38
897733|NCT01808612|2169113|P1|STARTED|Discontinuation Period||87
897734|NCT01808612|2169111|P3|NOT COMPLETED|Treatment Period||14
897735|NCT01808612|2169112|P2|NOT COMPLETED|Treatment Period||7
897736|NCT01808612|2169113|P1|NOT COMPLETED|Treatment Period||15
897737|NCT01808612|2169111|P3|COMPLETED|Treatment Period|101 participants who completed the Treatment Period did not enter the Discontinuation Period.|246
897738|NCT01808612|2169112|P2|COMPLETED|Treatment Period|39 participants who completed the Treatment Period did not enter the Discontinuation Period.|77
897739|NCT01808612|2169113|P1|COMPLETED|Treatment Period|67 participants who completed the Treatment Period did not enter the Discontinuation Period.|154
897740|NCT01808612|2169111|P3|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|259
897741|NCT01808612|2169112|P2|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|83
897742|NCT01808612|2169113|P1|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|168
897743|NCT01808612|2169111|P3|STARTED|Treatment Period||260
897744|NCT01808612|2169112|P2|STARTED|Treatment Period||84
897745|NCT01808612|2169113|P1|STARTED|Treatment Period||169
897746|NCT01808547|2169144|P2|NOT COMPLETED|Overall Study||46
897747|NCT01808547|2169145|P1|NOT COMPLETED|Overall Study||37
897748|NCT01808547|2169144|P2|COMPLETED|Overall Study||48
897749|NCT01808547|2169145|P1|COMPLETED|Overall Study||137
897750|NCT01808547|2169144|P2|mITT Population|Overall Study||85
897751|NCT01808547|2169145|P1|mITT Population|Overall Study||168
897752|NCT01808547|2169144|P2|Safety Population|Overall Study||85
897753|NCT01808547|2169145|P1|Safety Population|Overall Study||170
897754|NCT01808547|2169144|P2|STARTED|Overall Study||94
897755|NCT01808547|2169145|P1|STARTED|Overall Study||174
897756|NCT01808534|2169151|P1|NOT COMPLETED|Overall Study||4
897757|NCT01808534|2169151|P1|COMPLETED|Overall Study||1
897758|NCT01808534|2169151|P1|STARTED|Overall Study||5
897759|NCT01808508|2169162|P3|NOT COMPLETED|Overall Study||0
897760|NCT01808508|2169163|P2|NOT COMPLETED|Overall Study||0
897761|NCT01808508|2169164|P1|NOT COMPLETED|Overall Study||1
897762|NCT01808508|2169162|P3|COMPLETED|Overall Study||3
897763|NCT01808508|2169163|P2|COMPLETED|Overall Study||9
897764|NCT01808508|2169164|P1|COMPLETED|Overall Study||10
897765|NCT01808508|2169162|P3|STARTED|Overall Study||3
897766|NCT01808508|2169163|P2|STARTED|Overall Study||9
897767|NCT01808508|2169164|P1|STARTED|Overall Study||11
897768|NCT01808339|2169181|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||0
897769|NCT01808339|2169182|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
897770|NCT01808339|2169183|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
897771|NCT01808339|2169184|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
897772|NCT01808339|2169185|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||0
897773|NCT01808339|2169186|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
897774|NCT01808339|2169181|P6|COMPLETED|Treatment Period 3 (14 Days)||5
897775|NCT01808339|2169182|P5|COMPLETED|Treatment Period 3 (14 Days)||4
897776|NCT01808339|2169183|P4|COMPLETED|Treatment Period 3 (14 Days)||2
897777|NCT01808339|2169184|P3|COMPLETED|Treatment Period 3 (14 Days)||3
897778|NCT01808339|2169185|P2|COMPLETED|Treatment Period 3 (14 Days)||3
897779|NCT01808339|2169186|P1|COMPLETED|Treatment Period 3 (14 Days)||4
897780|NCT01808339|2169181|P6|STARTED|Treatment Period 3 (14 Days)||5
897781|NCT01808339|2169182|P5|STARTED|Treatment Period 3 (14 Days)||4
897782|NCT01808339|2169183|P4|STARTED|Treatment Period 3 (14 Days)||2
897783|NCT01808339|2169184|P3|STARTED|Treatment Period 3 (14 Days)||4
897784|NCT01808339|2169185|P2|STARTED|Treatment Period 3 (14 Days)||3
897785|NCT01808339|2169186|P1|STARTED|Treatment Period 3 (14 Days)||4
897786|NCT01808339|2169181|P6|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
897787|NCT01808339|2169182|P5|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
897788|NCT01808339|2169183|P4|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
897789|NCT01808339|2169184|P3|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
897790|NCT01808339|2169185|P2|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
897791|NCT01808339|2169186|P1|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
897792|NCT01808339|2169181|P6|COMPLETED|Washout Period 2 (14-21 Days)||5
897793|NCT01808339|2169182|P5|COMPLETED|Washout Period 2 (14-21 Days)||4
897794|NCT01808339|2169183|P4|COMPLETED|Washout Period 2 (14-21 Days)||2
897795|NCT01808339|2169184|P3|COMPLETED|Washout Period 2 (14-21 Days)||4
897796|NCT01808339|2169185|P2|COMPLETED|Washout Period 2 (14-21 Days)||3
897797|NCT01808339|2169186|P1|COMPLETED|Washout Period 2 (14-21 Days)||4
897798|NCT01808339|2169181|P6|STARTED|Washout Period 2 (14-21 Days)||5
897799|NCT01808339|2169182|P5|STARTED|Washout Period 2 (14-21 Days)||4
897800|NCT01808339|2169183|P4|STARTED|Washout Period 2 (14-21 Days)||2
897801|NCT01808339|2169184|P3|STARTED|Washout Period 2 (14-21 Days)||4
897802|NCT01808339|2169185|P2|STARTED|Washout Period 2 (14-21 Days)||3
897803|NCT01808339|2169186|P1|STARTED|Washout Period 2 (14-21 Days)||4
897804|NCT01808339|2169181|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
897805|NCT01808339|2169182|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
897806|NCT01808339|2169183|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||0
897807|NCT01808339|2169184|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||0
897808|NCT01808339|2169185|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||0
897809|NCT01808339|2169186|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
897810|NCT01808339|2169181|P6|COMPLETED|Treatment Period 2 (14 Days)||5
897811|NCT01808339|2169182|P5|COMPLETED|Treatment Period 2 (14 Days)||4
897812|NCT01808339|2169183|P4|COMPLETED|Treatment Period 2 (14 Days)||2
897813|NCT01808339|2169184|P3|COMPLETED|Treatment Period 2 (14 Days)||4
897814|NCT01808339|2169185|P2|COMPLETED|Treatment Period 2 (14 Days)||3
897815|NCT01808339|2169186|P1|COMPLETED|Treatment Period 2 (14 Days)||4
897816|NCT01808339|2169181|P6|STARTED|Treatment Period 2 (14 Days)||5
897817|NCT01808339|2169182|P5|STARTED|Treatment Period 2 (14 Days)||4
897818|NCT01808339|2169183|P4|STARTED|Treatment Period 2 (14 Days)||2
897819|NCT01808339|2169184|P3|STARTED|Treatment Period 2 (14 Days)||4
897820|NCT01808339|2169185|P2|STARTED|Treatment Period 2 (14 Days)||3
897821|NCT01808339|2169186|P1|STARTED|Treatment Period 2 (14 Days)||4
897822|NCT01808339|2169181|P6|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
897823|NCT01808339|2169182|P5|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
897824|NCT01808339|2169183|P4|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
897825|NCT01808339|2169184|P3|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
897826|NCT01808339|2169185|P2|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
897827|NCT01808339|2169186|P1|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
897828|NCT01808339|2169181|P6|COMPLETED|Washout Period 1 (14-21 Days)||5
897829|NCT01808339|2169182|P5|COMPLETED|Washout Period 1 (14-21 Days)||4
897830|NCT01808339|2169183|P4|COMPLETED|Washout Period 1 (14-21 Days)||2
897831|NCT01808339|2169184|P3|COMPLETED|Washout Period 1 (14-21 Days)||4
897832|NCT01808339|2169185|P2|COMPLETED|Washout Period 1 (14-21 Days)||3
897833|NCT01808339|2169186|P1|COMPLETED|Washout Period 1 (14-21 Days)||4
897834|NCT01808339|2169181|P6|STARTED|Washout Period 1 (14-21 Days)||5
897835|NCT01808339|2169182|P5|STARTED|Washout Period 1 (14-21 Days)||4
897836|NCT01808339|2169183|P4|STARTED|Washout Period 1 (14-21 Days)||2
897837|NCT01808339|2169184|P3|STARTED|Washout Period 1 (14-21 Days)||4
897838|NCT01808339|2169185|P2|STARTED|Washout Period 1 (14-21 Days)||3
897839|NCT01808339|2169186|P1|STARTED|Washout Period 1 (14-21 Days)||4
897840|NCT01808339|2169181|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||1
897841|NCT01808339|2169182|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||2
897842|NCT01808339|2169183|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||2
897843|NCT01808339|2169184|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||0
897844|NCT01808339|2169185|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
897845|NCT01808339|2169186|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||0
897846|NCT01808339|2169181|P6|COMPLETED|Treatment Period 1 (14 Days)||5
897847|NCT01808339|2169182|P5|COMPLETED|Treatment Period 1 (14 Days)||4
897848|NCT01808339|2169183|P4|COMPLETED|Treatment Period 1 (14 Days)||2
897849|NCT01808339|2169184|P3|COMPLETED|Treatment Period 1 (14 Days)||4
897850|NCT01808339|2169185|P2|COMPLETED|Treatment Period 1 (14 Days)||3
897851|NCT01808339|2169186|P1|COMPLETED|Treatment Period 1 (14 Days)||4
897852|NCT01808339|2169181|P6|STARTED|Treatment Period 1 (14 Days)||6
897853|NCT01808339|2169182|P5|STARTED|Treatment Period 1 (14 Days)||6
897854|NCT01808339|2169183|P4|STARTED|Treatment Period 1 (14 Days)||4
897855|NCT01808339|2169184|P3|STARTED|Treatment Period 1 (14 Days)||4
897856|NCT01808339|2169185|P2|STARTED|Treatment Period 1 (14 Days)||4
897857|NCT01808339|2169186|P1|STARTED|Treatment Period 1 (14 Days)||4
897858|NCT01808326|2169203|P1|NOT COMPLETED|Overall Study||0
897859|NCT01808326|2169203|P1|COMPLETED|Overall Study||5
897860|NCT01808326|2169203|P1|STARTED|Overall Study||5
897861|NCT01808313|2169230|P1|NOT COMPLETED|Overall Study||10
897862|NCT01808313|2169230|P1|COMPLETED|Overall Study||123
897863|NCT01808313|2169230|P1|STARTED|Overall Study||133
897864|NCT01808261|2169260|P2|NOT COMPLETED|Overall Study||33
897865|NCT01808261|2169261|P1|NOT COMPLETED|Overall Study||36
897866|NCT01808261|2169260|P2|COMPLETED|Overall Study||32
897867|NCT01808261|2169261|P1|COMPLETED|Overall Study||32
897868|NCT01808261|2169260|P2|STARTED|Overall Study||65
897869|NCT01808261|2169261|P1|STARTED|Overall Study||68
897870|NCT01808248|2169317|P1|NOT COMPLETED|Overall Study||5
897871|NCT01808248|2169317|P1|COMPLETED|Overall Study||42
897872|NCT01808248|2169317|P1|Completed Posttreatment Week 12 Visit|Overall Study||45
897873|NCT01808248|2169317|P1|STARTED|Overall Study||47
897874|NCT01808209|2169331|P2|NOT COMPLETED|Overall Study||1
897875|NCT01808209|2169332|P1|NOT COMPLETED|Overall Study||0
897876|NCT01808209|2169331|P2|COMPLETED|Overall Study||26
897877|NCT01808209|2169332|P1|COMPLETED|Overall Study||33
897878|NCT01808209|2169331|P2|STARTED|Overall Study||27
897879|NCT01808209|2169332|P1|STARTED|Overall Study||33
897880|NCT01808092|2169376|P2|NOT COMPLETED|Overall Study||45
897881|NCT01808092|2169377|P1|NOT COMPLETED|Overall Study||54
897882|NCT01808092|2169376|P2|COMPLETED|Overall Study||363
897883|NCT01808092|2169377|P1|COMPLETED|Overall Study||355
897884|NCT01808092|2169376|P2|STARTED|Overall Study||408
897885|NCT01808092|2169377|P1|STARTED|Overall Study||409
897886|NCT01808066|2169479|P1|NOT COMPLETED|Overall Study||15
897887|NCT01808066|2169479|P1|COMPLETED|Overall Study||6
897888|NCT01808066|2169479|P1|STARTED|Overall Study||21
897889|NCT01807949|2169486|P3|NOT COMPLETED|Overall Study||9
897890|NCT01807949|2169487|P2|NOT COMPLETED|Overall Study||7
897891|NCT01807949|2169488|P1|NOT COMPLETED|Overall Study||2
897892|NCT01807949|2169486|P3|COMPLETED|Overall Study||180
897893|NCT01807949|2169487|P2|COMPLETED|Overall Study||180
897894|NCT01807949|2169488|P1|COMPLETED|Overall Study||185
897895|NCT01807949|2169486|P3|STARTED|Overall Study||189
897896|NCT01807949|2169487|P2|STARTED|Overall Study||187
897897|NCT01807949|2169488|P1|STARTED|Overall Study||187
897898|NCT01807923|2169540|P3|NOT COMPLETED|Overall Study||11
897899|NCT01807923|2169541|P2|NOT COMPLETED|Overall Study||6
897900|NCT01807923|2169542|P1|NOT COMPLETED|Overall Study||5
897901|NCT01807923|2169540|P3|COMPLETED|Overall Study||176
897902|NCT01807923|2169541|P2|COMPLETED|Overall Study||179
897903|NCT01807923|2169542|P1|COMPLETED|Overall Study||182
897904|NCT01807923|2169540|P3|STARTED|Overall Study||187
897905|NCT01807923|2169541|P2|STARTED|Overall Study||185
897906|NCT01807923|2169542|P1|STARTED|Overall Study||187
897913|NCT01807624|2169604|P1|NOT COMPLETED|Overall Study||0
897914|NCT01807624|2169604|P1|COMPLETED|Overall Study||24
897915|NCT01807624|2169604|P1|STARTED|Overall Study||24
897916|NCT01807455|2169620|P1|NOT COMPLETED|Overall Study||0
897917|NCT01807455|2169620|P1|COMPLETED|Overall Study||12
897918|NCT01807455|2169620|P1|STARTED|Overall Study||12
897919|NCT01807234|2169634|P6|NOT COMPLETED|Overall Study||4
897920|NCT01807234|2169635|P5|NOT COMPLETED|Overall Study||4
897921|NCT01807234|2169636|P4|NOT COMPLETED|Overall Study||2
897922|NCT01807234|2169637|P3|NOT COMPLETED|Overall Study||2
897923|NCT01807234|2169638|P2|NOT COMPLETED|Overall Study||6
897924|NCT01807234|2169639|P1|NOT COMPLETED|Overall Study||5
897925|NCT01807234|2169634|P6|COMPLETED|Overall Study||8
897926|NCT01807234|2169635|P5|COMPLETED|Overall Study||8
897927|NCT01807234|2169636|P4|COMPLETED|Overall Study||10
897928|NCT01807234|2169637|P3|COMPLETED|Overall Study||10
897929|NCT01807234|2169638|P2|COMPLETED|Overall Study||6
897930|NCT01807234|2169639|P1|COMPLETED|Overall Study||7
897931|NCT01807234|2169634|P6|Completed Only 1 Attack|Overall Study||1
897932|NCT01807234|2169635|P5|Completed Only 1 Attack|Overall Study||0
897933|NCT01807234|2169636|P4|Completed Only 1 Attack|Overall Study||1
897934|NCT01807234|2169637|P3|Completed Only 1 Attack|Overall Study||0
897935|NCT01807234|2169638|P2|Completed Only 1 Attack|Overall Study||1
897936|NCT01807234|2169639|P1|Completed Only 1 Attack|Overall Study||2
897937|NCT01807234|2169634|P6|Randomized, But Did Not Take Drug|Overall Study||3
897938|NCT01807234|2169635|P5|Randomized, But Did Not Take Drug|Overall Study||4
897939|NCT01807234|2169636|P4|Randomized, But Did Not Take Drug|Overall Study||1
897940|NCT01807234|2169637|P3|Randomized, But Did Not Take Drug|Overall Study||2
897941|NCT01807234|2169638|P2|Randomized, But Did Not Take Drug|Overall Study||5
897942|NCT01807234|2169639|P1|Randomized, But Did Not Take Drug|Overall Study||3
897943|NCT01807234|2169634|P6|STARTED|Overall Study||12
897944|NCT01807234|2169635|P5|STARTED|Overall Study||12
897945|NCT01807234|2169636|P4|STARTED|Overall Study||12
897946|NCT01807234|2169637|P3|STARTED|Overall Study||12
897947|NCT01807234|2169638|P2|STARTED|Overall Study||12
897948|NCT01807234|2169639|P1|STARTED|Overall Study||12
897949|NCT01807156|2169674|P1|NOT COMPLETED|Overall Study||1
897950|NCT01807156|2169674|P1|COMPLETED|Overall Study||6
897951|NCT01807156|2169674|P1|STARTED|Overall Study||7
897952|NCT01807000|2169679|P1|NOT COMPLETED|Overall Study||0
897953|NCT01807000|2169679|P1|COMPLETED|Overall Study||6
897954|NCT01807000|2169679|P1|STARTED|Overall Study||6
897955|NCT01806961|2169698|P1|NOT COMPLETED|Overall Study||16
897956|NCT01806961|2169698|P1|COMPLETED|Overall Study||0
897957|NCT01806961|2169698|P1|STARTED|Overall Study||16
897958|NCT01806857|2169702|P2|NOT COMPLETED|Overall Study||0
897959|NCT01806857|2169703|P1|NOT COMPLETED|Overall Study||1
897960|NCT01806857|2169702|P2|COMPLETED|Overall Study||29
897961|NCT01806857|2169703|P1|COMPLETED|Overall Study||30
897962|NCT01806857|2169702|P2|STARTED|Overall Study||29
897963|NCT01806857|2169703|P1|STARTED|Overall Study||31
897964|NCT01806779|2169741|P3|NOT COMPLETED|Overall Study||23
897965|NCT01806779|2169742|P2|NOT COMPLETED|Overall Study||44
897966|NCT01806779|2169743|P1|NOT COMPLETED|Overall Study||42
897967|NCT01806779|2169741|P3|COMPLETED|Overall Study||0
897968|NCT01806779|2169742|P2|COMPLETED|Overall Study||40
897969|NCT01806779|2169743|P1|COMPLETED|Overall Study||48
897970|NCT01806779|2169741|P3|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|0
897971|NCT01806779|2169742|P2|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|83
897972|NCT01806779|2169743|P1|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|87
897973|NCT01806779|2169741|P3|Randomized at Visit 2|Overall Study||0
897974|NCT01806779|2169742|P2|Randomized at Visit 2|Overall Study||84
897975|NCT01806779|2169743|P1|Randomized at Visit 2|Overall Study||90
897976|NCT01806779|2169741|P3|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|2
897977|NCT01806779|2169742|P2|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|84
897978|NCT01806779|2169743|P1|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|90
897979|NCT01806779|2169741|P3|STARTED|Overall Study|All 197 subjects received nicotine patches but 23 dropped before receiving other study drugs.|23
897980|NCT01806779|2169742|P2|STARTED|Overall Study||84
897981|NCT01806779|2169743|P1|STARTED|Overall Study||90
897982|NCT01806714|2169758|P2|NOT COMPLETED|Overall Study||170
897983|NCT01806714|2169759|P1|NOT COMPLETED|Overall Study||200
897984|NCT01806714|2169758|P2|COMPLETED|Overall Study||1919
897985|NCT01806714|2169759|P1|COMPLETED|Overall Study||1893
897986|NCT01806714|2169758|P2|STARTED|Overall Study||2089
897987|NCT01806714|2169759|P1|STARTED|Overall Study||2093
897988|NCT01806623|2169769|P1|NOT COMPLETED|Overall Study||58
897989|NCT01806623|2169769|P1|COMPLETED|Overall Study||99
897990|NCT01806623|2169769|P1|STARTED|Overall Study||157
897991|NCT01806584|2169788|P2|NOT COMPLETED|Overall Study||18
897992|NCT01806584|2169789|P1|NOT COMPLETED|Overall Study||14
897993|NCT01806584|2169788|P2|COMPLETED|Overall Study||0
897994|NCT01806584|2169789|P1|COMPLETED|Overall Study||0
897995|NCT01806584|2169788|P2|STARTED|Overall Study||18
897996|NCT01806584|2169789|P1|STARTED|Overall Study||14
897997|NCT01806545|2169803|P2|NOT COMPLETED|Overall Study||5
897998|NCT01806545|2169804|P1|NOT COMPLETED|Overall Study||6
897999|NCT01806545|2169803|P2|COMPLETED|Overall Study||30
898000|NCT01806545|2169804|P1|COMPLETED|Overall Study||23
898001|NCT01806545|2169803|P2|STARTED|Overall Study||35
898002|NCT01806545|2169804|P1|STARTED|Overall Study||29
898003|NCT01806389|2169826|P1|NOT COMPLETED|Overall Study||4
898004|NCT01806389|2169826|P1|COMPLETED|Overall Study||10
898005|NCT01806389|2169826|P1|STARTED|Overall Study||14
898006|NCT01806298|2169840|P1|NOT COMPLETED|Overall Study||10
898007|NCT01806298|2169840|P1|COMPLETED|Overall Study||68
898008|NCT01806298|2169840|P1|STARTED|Overall Study||78
898009|NCT01806051|2169850|P1|NOT COMPLETED|Overall Study||6
898010|NCT01806051|2169850|P1|COMPLETED|Overall Study||0
898011|NCT01806051|2169850|P1|STARTED|Overall Study||6
898012|NCT01805882|2169865|P9|NOT COMPLETED|Overall Study||1
898013|NCT01805882|2169866|P8|NOT COMPLETED|Overall Study||0
898014|NCT01805882|2169867|P7|NOT COMPLETED|Overall Study||2
898015|NCT01805882|2169868|P6|NOT COMPLETED|Overall Study||1
898016|NCT01805882|2169869|P5|NOT COMPLETED|Overall Study||0
898017|NCT01805882|2169870|P4|NOT COMPLETED|Overall Study||2
898018|NCT01805882|2169871|P3|NOT COMPLETED|Overall Study||1
898019|NCT01805882|2169872|P2|NOT COMPLETED|Overall Study||0
898020|NCT01805882|2169873|P1|NOT COMPLETED|Overall Study||0
898021|NCT01805882|2169865|P9|COMPLETED|Overall Study||24
898022|NCT01805882|2169866|P8|COMPLETED|Overall Study||25
898023|NCT01805882|2169867|P7|COMPLETED|Overall Study||48
898024|NCT01805882|2169868|P6|COMPLETED|Overall Study||20
898025|NCT01805882|2169869|P5|COMPLETED|Overall Study||14
898026|NCT01805882|2169870|P4|COMPLETED|Overall Study||32
898027|NCT01805882|2169871|P3|COMPLETED|Overall Study||19
898028|NCT01805882|2169872|P2|COMPLETED|Overall Study||20
898029|NCT01805882|2169873|P1|COMPLETED|Overall Study||20
898030|NCT01805882|2169865|P9|STARTED|Overall Study||25
898031|NCT01805882|2169866|P8|STARTED|Overall Study||25
898032|NCT01805882|2169867|P7|STARTED|Overall Study||50
898033|NCT01805882|2169868|P6|STARTED|Overall Study||21
898034|NCT01805882|2169869|P5|STARTED|Overall Study||14
898035|NCT01805882|2169870|P4|STARTED|Overall Study||34
898036|NCT01805882|2169871|P3|STARTED|Overall Study||20
898037|NCT01805882|2169872|P2|STARTED|Overall Study||20
898038|NCT01805882|2169873|P1|STARTED|Overall Study||20
898039|NCT01805687|2169893|P1|NOT COMPLETED|Overall Study||0
898040|NCT01805687|2169893|P1|COMPLETED|Overall Study||25
898041|NCT01805687|2169893|P1|STARTED|Overall Study||25
898042|NCT01805323|2169897|P1|NOT COMPLETED|Overall Study||0
898043|NCT01805323|2169897|P1|COMPLETED|Overall Study||101
898044|NCT01805323|2169897|P1|STARTED|Overall Study||101
898045|NCT01805297|2169904|P2|NOT COMPLETED|Overall Study||3
898046|NCT01805297|2169905|P1|NOT COMPLETED|Overall Study||2
898047|NCT01805297|2169904|P2|COMPLETED|Overall Study||3
898048|NCT01805297|2169905|P1|COMPLETED|Overall Study||4
898049|NCT01805297|2169904|P2|STARTED|Overall Study||6
898050|NCT01805297|2169905|P1|STARTED|Overall Study||6
898051|NCT01805180|2169919|P3|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
898052|NCT01805180|2169920|P2|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
898053|NCT01805180|2169921|P1|NOT COMPLETED|Pivotal Randomization Through Study Exit||0
898054|NCT01805180|2169919|P3|COMPLETED|Pivotal Randomization Through Study Exit||15
898055|NCT01805180|2169920|P2|COMPLETED|Pivotal Randomization Through Study Exit||17
898056|NCT01805180|2169921|P1|COMPLETED|Pivotal Randomization Through Study Exit||0
898057|NCT01805180|2169919|P3|STARTED|Pivotal Randomization Through Study Exit||20
898058|NCT01805180|2169920|P2|STARTED|Pivotal Randomization Through Study Exit||22
898059|NCT01805180|2169921|P1|STARTED|Pivotal Randomization Through Study Exit|lead-in donors were not randomized and did not participate in this period.|0
898060|NCT01805180|2169919|P3|NOT COMPLETED|Lead-in Donor Phase||0
898061|NCT01805180|2169920|P2|NOT COMPLETED|Lead-in Donor Phase||0
898062|NCT01805180|2169921|P1|NOT COMPLETED|Lead-in Donor Phase||1
898063|NCT01805180|2169919|P3|COMPLETED|Lead-in Donor Phase||0
898064|NCT01805180|2169920|P2|COMPLETED|Lead-in Donor Phase||0
898065|NCT01805180|2169921|P1|COMPLETED|Lead-in Donor Phase||6
898066|NCT01805180|2169919|P3|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
898067|NCT01805180|2169920|P2|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
898068|NCT01805180|2169921|P1|STARTED|Lead-in Donor Phase||7
898069|NCT01805089|2169946|P2|NOT COMPLETED|Overall Study||4
898070|NCT01805089|2169947|P1|NOT COMPLETED|Overall Study||5
898071|NCT01805089|2169946|P2|COMPLETED|Overall Study||43
898072|NCT01805089|2169947|P1|COMPLETED|Overall Study||43
898073|NCT01805089|2169946|P2|STARTED|Overall Study||47
898074|NCT01805089|2169947|P1|STARTED|Overall Study||48
898075|NCT01804946|2169959|P2|NOT COMPLETED|Overall Study||4
898076|NCT01804946|2169960|P1|NOT COMPLETED|Overall Study||2
898077|NCT01804946|2169959|P2|COMPLETED|Overall Study||76
898078|NCT01804946|2169960|P1|COMPLETED|Overall Study||79
898079|NCT01804946|2169959|P2|STARTED|Overall Study||80
898080|NCT01804946|2169960|P1|STARTED|Overall Study||81
898081|NCT01804881|2169984|P2|NOT COMPLETED|Overall Study||4
898082|NCT01804881|2169985|P1|NOT COMPLETED|Overall Study||5
898083|NCT01804881|2169984|P2|COMPLETED|Overall Study||10
898084|NCT01804881|2169985|P1|COMPLETED|Overall Study||11
898085|NCT01804881|2169984|P2|STARTED|Overall Study||14
898086|NCT01804881|2169985|P1|STARTED|Overall Study||16
898105|NCT01804673|2170017|P1|NOT COMPLETED|Overall Study||140
898106|NCT01804673|2170017|P1|COMPLETED|Overall Study||34
898107|NCT01804673|2170017|P1|Completed Hour 72|Overall Study||36
898108|NCT01804673|2170017|P1|Completed Hour 48|Overall Study||79
898109|NCT01804673|2170017|P1|Completed Hour 24|Overall Study||170
898110|NCT01804673|2170017|P1|STARTED|Overall Study||174
898111|NCT01804257|2170033|P1|NOT COMPLETED|Overall Study||1
898112|NCT01804257|2170033|P1|COMPLETED|Overall Study||27
898113|NCT01804257|2170033|P1|STARTED|Overall Study||28
898114|NCT01804140|2170037|P1|NOT COMPLETED|Overall Study||114
898115|NCT01804140|2170037|P1|COMPLETED|Overall Study|This includes all the participants with mutation results from the sampling or biopsy procedures.|548
898116|NCT01804140|2170037|P1|STARTED|Overall Study|This includes all the participants who were enrolled for this study.|662
898117|NCT01804075|2170044|P2|NOT COMPLETED|Overall Study||0
898118|NCT01804075|2170045|P1|NOT COMPLETED|Overall Study||0
898119|NCT01804075|2170044|P2|COMPLETED|Overall Study||16
898120|NCT01804075|2170045|P1|COMPLETED|Overall Study||15
898121|NCT01804075|2170044|P2|STARTED|Overall Study||16
898122|NCT01804075|2170045|P1|STARTED|Overall Study||15
898123|NCT01804062|2170053|P1|NOT COMPLETED|Overall Study||0
898124|NCT01804062|2170053|P1|COMPLETED|Overall Study||30
898125|NCT01804062|2170053|P1|STARTED|Overall Study||30
898126|NCT01804036|2170060|P2|NOT COMPLETED|Overall Study||20
898127|NCT01804036|2170061|P1|NOT COMPLETED|Overall Study||13
898128|NCT01804036|2170060|P2|COMPLETED|Overall Study||21
898129|NCT01804036|2170061|P1|COMPLETED|Overall Study||18
898130|NCT01804036|2170060|P2|STARTED|Overall Study||41
898131|NCT01804036|2170061|P1|STARTED|Overall Study||31
898132|NCT01803737|2170095|P2|NOT COMPLETED|Overall Study||3
898133|NCT01803737|2170096|P1|NOT COMPLETED|Overall Study||1
898134|NCT01803737|2170095|P2|COMPLETED|Overall Study||10
898135|NCT01803737|2170096|P1|COMPLETED|Overall Study||12
898136|NCT01803737|2170095|P2|STARTED|Overall Study||13
898137|NCT01803737|2170096|P1|STARTED|Overall Study||13
898138|NCT01803607|2170120|P2|NOT COMPLETED|Overall Study||67
898139|NCT01803607|2170121|P1|NOT COMPLETED|Overall Study||68
898140|NCT01803607|2170120|P2|COMPLETED|Overall Study||0
898141|NCT01803607|2170121|P1|COMPLETED|Overall Study||0
898142|NCT01803607|2170120|P2|STARTED|Overall Study||67
898143|NCT01803607|2170121|P1|STARTED|Overall Study||68
898144|NCT01802632|2170147|P6|NOT COMPLETED|Overall Study||28
898145|NCT01802632|2170148|P5|NOT COMPLETED|Overall Study||12
898146|NCT01802632|2170149|P4|NOT COMPLETED|Overall Study||60
898147|NCT01802632|2170150|P3|NOT COMPLETED|Overall Study||271
898148|NCT01802632|2170151|P2|NOT COMPLETED|Overall Study||31
898149|NCT01802632|2170152|P1|NOT COMPLETED|Overall Study||201
898150|NCT01802632|2170147|P6|COMPLETED|Overall Study||0
898151|NCT01802632|2170148|P5|COMPLETED|Overall Study||0
898152|NCT01802632|2170149|P4|COMPLETED|Overall Study||0
898153|NCT01802632|2170150|P3|COMPLETED|Overall Study||0
898154|NCT01802632|2170151|P2|COMPLETED|Overall Study||0
898155|NCT01802632|2170152|P1|COMPLETED|Overall Study||0
898156|NCT01802632|2170147|P6|STARTED|Overall Study||28
898157|NCT01802632|2170148|P5|STARTED|Overall Study||12
898158|NCT01802632|2170149|P4|STARTED|Overall Study||60
898159|NCT01802632|2170150|P3|STARTED|Overall Study||271
898160|NCT01802632|2170151|P2|STARTED|Overall Study||31
898161|NCT01802632|2170152|P1|STARTED|Overall Study||201
898162|NCT01802554|2170168|P2|NOT COMPLETED|Overall Study||6
898163|NCT01802554|2170169|P1|NOT COMPLETED|Overall Study||8
898164|NCT01802554|2170168|P2|COMPLETED|Overall Study||43
898165|NCT01802554|2170169|P1|COMPLETED|Overall Study||43
898166|NCT01802554|2170168|P2|STARTED|Overall Study||49
898167|NCT01802554|2170169|P1|STARTED|Overall Study||51
898168|NCT01802515|2170186|P3|NOT COMPLETED|Overall Study||0
898169|NCT01802515|2170187|P2|NOT COMPLETED|Overall Study||0
898170|NCT01802515|2170188|P1|NOT COMPLETED|Overall Study||3
898171|NCT01802515|2170186|P3|COMPLETED|Overall Study||4
898172|NCT01802515|2170187|P2|COMPLETED|Overall Study||5
898173|NCT01802515|2170188|P1|COMPLETED|Overall Study||2
898174|NCT01802515|2170186|P3|STARTED|Overall Study||4
898175|NCT01802515|2170187|P2|STARTED|Overall Study||5
898176|NCT01802515|2170188|P1|STARTED|Overall Study||5
898177|NCT01802320|2170199|P1|NOT COMPLETED|Overall Study||2
898178|NCT01802320|2170199|P1|COMPLETED|Overall Study||16
898179|NCT01802320|2170199|P1|STARTED|Overall Study||18
898180|NCT01802151|2170208|P4|NOT COMPLETED|Overall Study||0
898181|NCT01802151|2170209|P3|NOT COMPLETED|Overall Study||2
898182|NCT01802151|2170210|P2|NOT COMPLETED|Overall Study||0
898183|NCT01802151|2170211|P1|NOT COMPLETED|Overall Study||0
898184|NCT01802151|2170208|P4|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
898185|NCT01802151|2170209|P3|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
898186|NCT01802151|2170210|P2|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|21
898187|NCT01802151|2170211|P1|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
898188|NCT01802151|2170208|P4|STARTED|Overall Study||20
898189|NCT01802151|2170209|P3|STARTED|Overall Study||22
898190|NCT01802151|2170210|P2|STARTED|Overall Study||21
898191|NCT01802151|2170211|P1|STARTED|Overall Study||20
898192|NCT01801982|2170273|P1|NOT COMPLETED|Overall Study||1
898193|NCT01801982|2170273|P1|COMPLETED|Overall Study||0
898194|NCT01801982|2170273|P1|STARTED|Overall Study||1
898195|NCT01801735|2170283|P1|NOT COMPLETED|Overall Study||210
898196|NCT01801735|2170283|P1|COMPLETED|Overall Study||390
898197|NCT01801735|2170283|P1|STARTED|Overall Study||600
898198|NCT01801475|2170290|P5|NOT COMPLETED|Overall Study||1
898199|NCT01801475|2170291|P4|NOT COMPLETED|Overall Study||0
898200|NCT01801475|2170292|P3|NOT COMPLETED|Overall Study||0
898201|NCT01801475|2170293|P2|NOT COMPLETED|Overall Study||0
898202|NCT01801475|2170294|P1|NOT COMPLETED|Overall Study||0
898203|NCT01801475|2170290|P5|COMPLETED|Overall Study||39
898204|NCT01801475|2170291|P4|COMPLETED|Overall Study||10
898205|NCT01801475|2170292|P3|COMPLETED|Overall Study||10
898206|NCT01801475|2170293|P2|COMPLETED|Overall Study||30
898207|NCT01801475|2170294|P1|COMPLETED|Overall Study||10
898208|NCT01801475|2170290|P5|STARTED|Overall Study||40
898209|NCT01801475|2170291|P4|STARTED|Overall Study||10
898210|NCT01801475|2170292|P3|STARTED|Overall Study||10
898211|NCT01801475|2170293|P2|STARTED|Overall Study||30
898212|NCT01801475|2170294|P1|STARTED|Overall Study||10
898213|NCT01801436|2170305|P1|NOT COMPLETED|Overall Study||9
898214|NCT01801436|2170305|P1|COMPLETED|Overall Study||5
898215|NCT01801436|2170305|P1|STARTED|Overall Study||14
898216|NCT01801358|2170343|P6|NOT COMPLETED|Overall Study||8
898217|NCT01801358|2170344|P5|NOT COMPLETED|Overall Study||6
898218|NCT01801358|2170345|P4|NOT COMPLETED|Overall Study||6
898219|NCT01801358|2170346|P3|NOT COMPLETED|Overall Study||6
898220|NCT01801358|2170347|P2|NOT COMPLETED|Overall Study||6
898221|NCT01801358|2170348|P1|NOT COMPLETED|Overall Study||6
898222|NCT01801358|2170343|P6|COMPLETED|Overall Study||0
898223|NCT01801358|2170344|P5|COMPLETED|Overall Study||0
898224|NCT01801358|2170345|P4|COMPLETED|Overall Study||0
898225|NCT01801358|2170346|P3|COMPLETED|Overall Study||0
898226|NCT01801358|2170347|P2|COMPLETED|Overall Study||0
898227|NCT01801358|2170348|P1|COMPLETED|Overall Study||0
898228|NCT01801358|2170343|P6|STARTED|Overall Study||8
898229|NCT01801358|2170344|P5|STARTED|Overall Study||6
898230|NCT01801358|2170345|P4|STARTED|Overall Study||6
898231|NCT01801358|2170346|P3|STARTED|Overall Study||6
898232|NCT01801358|2170347|P2|STARTED|Overall Study||6
898233|NCT01801358|2170348|P1|STARTED|Overall Study||6
898234|NCT01801280|2170470|P4|NOT COMPLETED|Period 4||0
898235|NCT01801280|2170471|P3|NOT COMPLETED|Period 4||1
898236|NCT01801280|2170472|P2|NOT COMPLETED|Period 4||0
898237|NCT01801280|2170473|P1|NOT COMPLETED|Period 4||0
898238|NCT01801280|2170470|P4|COMPLETED|Period 4||5
898239|NCT01801280|2170471|P3|COMPLETED|Period 4||4
898240|NCT01801280|2170472|P2|COMPLETED|Period 4||4
898241|NCT01801280|2170473|P1|COMPLETED|Period 4||4
898242|NCT01801280|2170470|P4|STARTED|Period 4||5
898243|NCT01801280|2170471|P3|STARTED|Period 4||5
898244|NCT01801280|2170472|P2|STARTED|Period 4||4
898245|NCT01801280|2170473|P1|STARTED|Period 4||4
898246|NCT01801280|2170470|P4|NOT COMPLETED|Period 3||0
898247|NCT01801280|2170471|P3|NOT COMPLETED|Period 3||0
898248|NCT01801280|2170472|P2|NOT COMPLETED|Period 3||0
898249|NCT01801280|2170473|P1|NOT COMPLETED|Period 3||0
898250|NCT01801280|2170470|P4|COMPLETED|Period 3||5
898251|NCT01801280|2170471|P3|COMPLETED|Period 3||5
898252|NCT01801280|2170472|P2|COMPLETED|Period 3||4
898253|NCT01801280|2170473|P1|COMPLETED|Period 3||4
898254|NCT01801280|2170470|P4|STARTED|Period 3||5
898255|NCT01801280|2170471|P3|STARTED|Period 3||5
898256|NCT01801280|2170472|P2|STARTED|Period 3||4
898257|NCT01801280|2170473|P1|STARTED|Period 3||4
898258|NCT01801280|2170470|P4|NOT COMPLETED|Period 2||0
898259|NCT01801280|2170471|P3|NOT COMPLETED|Period 2||0
898260|NCT01801280|2170472|P2|NOT COMPLETED|Period 2||0
898261|NCT01801280|2170473|P1|NOT COMPLETED|Period 2||1
898262|NCT01801280|2170470|P4|COMPLETED|Period 2||5
898263|NCT01801280|2170471|P3|COMPLETED|Period 2||5
898264|NCT01801280|2170472|P2|COMPLETED|Period 2||4
898265|NCT01801280|2170473|P1|COMPLETED|Period 2||4
898266|NCT01801280|2170470|P4|STARTED|Period 2||5
898267|NCT01801280|2170471|P3|STARTED|Period 2||5
898268|NCT01801280|2170472|P2|STARTED|Period 2||4
898269|NCT01801280|2170473|P1|STARTED|Period 2||5
898270|NCT01801280|2170470|P4|NOT COMPLETED|Period 1||0
898271|NCT01801280|2170471|P3|NOT COMPLETED|Period 1||0
898272|NCT01801280|2170472|P2|NOT COMPLETED|Period 1||1
898273|NCT01801280|2170473|P1|NOT COMPLETED|Period 1||0
898274|NCT01801280|2170470|P4|COMPLETED|Period 1||5
898275|NCT01801280|2170471|P3|COMPLETED|Period 1||5
898276|NCT01801280|2170472|P2|COMPLETED|Period 1||4
898277|NCT01801280|2170473|P1|COMPLETED|Period 1||5
898278|NCT01801280|2170470|P4|STARTED|Period 1||5
898279|NCT01801280|2170471|P3|STARTED|Period 1||5
898280|NCT01801280|2170472|P2|STARTED|Period 1||5
898281|NCT01801280|2170473|P1|STARTED|Period 1|Each period lasted 10-14 weeks|5
898282|NCT01801124|2170483|P1|NOT COMPLETED|Overall Study||0
898283|NCT01801124|2170483|P1|COMPLETED|Overall Study||13
898284|NCT01801124|2170483|P1|STARTED|Overall Study||13
898285|NCT01801111|2170488|P1|NOT COMPLETED|Overall Study||138
898286|NCT01801111|2170488|P1|COMPLETED|Overall Study||0
898287|NCT01801111|2170488|P1|STARTED|Overall Study||138
898288|NCT01800968|2170513|P2|NOT COMPLETED|Overall Study||32
898289|NCT01800968|2170514|P1|NOT COMPLETED|Overall Study||36
898290|NCT01800968|2170513|P2|COMPLETED|Overall Study||114
898291|NCT01800968|2170514|P1|COMPLETED|Overall Study||118
898292|NCT01800968|2170513|P2|STARTED|Overall Study||146
898293|NCT01800968|2170514|P1|STARTED|Overall Study||154
898294|NCT01800916|2170556|P9|NOT COMPLETED|Test Period 3 (1 Week)||0
898295|NCT01800916|2170557|P8|NOT COMPLETED|Test Period 3 (1 Week)||0
898296|NCT01800916|2170558|P7|NOT COMPLETED|Test Period 3 (1 Week)||0
898297|NCT01800916|2170559|P6|NOT COMPLETED|Test Period 3 (1 Week)||0
898298|NCT01800916|2170560|P5|NOT COMPLETED|Test Period 3 (1 Week)||0
898299|NCT01800916|2170561|P4|NOT COMPLETED|Test Period 3 (1 Week)||0
898300|NCT01800916|2170562|P3|NOT COMPLETED|Test Period 3 (1 Week)||0
898301|NCT01800916|2170563|P2|NOT COMPLETED|Test Period 3 (1 Week)||0
898302|NCT01800916|2170564|P1|NOT COMPLETED|Test Period 3 (1 Week)||0
898303|NCT01800916|2170556|P9|COMPLETED|Test Period 3 (1 Week)||7
898304|NCT01800916|2170557|P8|COMPLETED|Test Period 3 (1 Week)||7
898305|NCT01800916|2170558|P7|COMPLETED|Test Period 3 (1 Week)||7
898306|NCT01800916|2170559|P6|COMPLETED|Test Period 3 (1 Week)||7
898307|NCT01800916|2170560|P5|COMPLETED|Test Period 3 (1 Week)||7
898308|NCT01800916|2170561|P4|COMPLETED|Test Period 3 (1 Week)||6
898309|NCT01800916|2170562|P3|COMPLETED|Test Period 3 (1 Week)||7
898310|NCT01800916|2170563|P2|COMPLETED|Test Period 3 (1 Week)||7
898311|NCT01800916|2170564|P1|COMPLETED|Test Period 3 (1 Week)||7
898312|NCT01800916|2170556|P9|STARTED|Test Period 3 (1 Week)||7
898313|NCT01800916|2170557|P8|STARTED|Test Period 3 (1 Week)||7
898314|NCT01800916|2170558|P7|STARTED|Test Period 3 (1 Week)||7
898315|NCT01800916|2170559|P6|STARTED|Test Period 3 (1 Week)||7
898316|NCT01800916|2170560|P5|STARTED|Test Period 3 (1 Week)||7
898317|NCT01800916|2170561|P4|STARTED|Test Period 3 (1 Week)||6
898318|NCT01800916|2170562|P3|STARTED|Test Period 3 (1 Week)||7
898319|NCT01800916|2170563|P2|STARTED|Test Period 3 (1 Week)||7
898320|NCT01800916|2170564|P1|STARTED|Test Period 3 (1 Week)||7
898321|NCT01800916|2170556|P9|NOT COMPLETED|Test Period 2 (1 Week)||0
898322|NCT01800916|2170557|P8|NOT COMPLETED|Test Period 2 (1 Week)||0
898323|NCT01800916|2170558|P7|NOT COMPLETED|Test Period 2 (1 Week)||0
898324|NCT01800916|2170559|P6|NOT COMPLETED|Test Period 2 (1 Week)||0
898325|NCT01800916|2170560|P5|NOT COMPLETED|Test Period 2 (1 Week)||0
898326|NCT01800916|2170561|P4|NOT COMPLETED|Test Period 2 (1 Week)||0
898327|NCT01800916|2170562|P3|NOT COMPLETED|Test Period 2 (1 Week)||0
898328|NCT01800916|2170563|P2|NOT COMPLETED|Test Period 2 (1 Week)||0
898329|NCT01800916|2170564|P1|NOT COMPLETED|Test Period 2 (1 Week)||0
898330|NCT01800916|2170556|P9|COMPLETED|Test Period 2 (1 Week)||7
898331|NCT01800916|2170557|P8|COMPLETED|Test Period 2 (1 Week)||7
898332|NCT01800916|2170558|P7|COMPLETED|Test Period 2 (1 Week)||7
898333|NCT01800916|2170559|P6|COMPLETED|Test Period 2 (1 Week)||7
898334|NCT01800916|2170560|P5|COMPLETED|Test Period 2 (1 Week)||7
898335|NCT01800916|2170561|P4|COMPLETED|Test Period 2 (1 Week)||6
898336|NCT01800916|2170562|P3|COMPLETED|Test Period 2 (1 Week)||7
898337|NCT01800916|2170563|P2|COMPLETED|Test Period 2 (1 Week)||7
898338|NCT01800916|2170564|P1|COMPLETED|Test Period 2 (1 Week)||7
898339|NCT01800916|2170556|P9|STARTED|Test Period 2 (1 Week)||7
898340|NCT01800916|2170557|P8|STARTED|Test Period 2 (1 Week)||7
898341|NCT01800916|2170558|P7|STARTED|Test Period 2 (1 Week)||7
898342|NCT01800916|2170559|P6|STARTED|Test Period 2 (1 Week)||7
898343|NCT01800916|2170560|P5|STARTED|Test Period 2 (1 Week)||7
898344|NCT01800916|2170561|P4|STARTED|Test Period 2 (1 Week)||6
898345|NCT01800916|2170562|P3|STARTED|Test Period 2 (1 Week)||7
898346|NCT01800916|2170563|P2|STARTED|Test Period 2 (1 Week)||7
898347|NCT01800916|2170564|P1|STARTED|Test Period 2 (1 Week)||7
898348|NCT01800916|2170556|P9|NOT COMPLETED|Test Period 1 (1 Week)||0
898349|NCT01800916|2170557|P8|NOT COMPLETED|Test Period 1 (1 Week)||0
898350|NCT01800916|2170558|P7|NOT COMPLETED|Test Period 1 (1 Week)||0
898351|NCT01800916|2170559|P6|NOT COMPLETED|Test Period 1 (1 Week)||0
898352|NCT01800916|2170560|P5|NOT COMPLETED|Test Period 1 (1 Week)||1
898353|NCT01800916|2170561|P4|NOT COMPLETED|Test Period 1 (1 Week)||1
898354|NCT01800916|2170562|P3|NOT COMPLETED|Test Period 1 (1 Week)||0
898355|NCT01800916|2170563|P2|NOT COMPLETED|Test Period 1 (1 Week)||0
898356|NCT01800916|2170564|P1|NOT COMPLETED|Test Period 1 (1 Week)||0
898357|NCT01800916|2170556|P9|COMPLETED|Test Period 1 (1 Week)||7
898358|NCT01800916|2170557|P8|COMPLETED|Test Period 1 (1 Week)||7
898359|NCT01800916|2170558|P7|COMPLETED|Test Period 1 (1 Week)||7
898360|NCT01800916|2170559|P6|COMPLETED|Test Period 1 (1 Week)||7
898361|NCT01800916|2170560|P5|COMPLETED|Test Period 1 (1 Week)||7
898362|NCT01800916|2170561|P4|COMPLETED|Test Period 1 (1 Week)||6
898363|NCT01800916|2170562|P3|COMPLETED|Test Period 1 (1 Week)||7
898364|NCT01800916|2170563|P2|COMPLETED|Test Period 1 (1 Week)||7
898365|NCT01800916|2170564|P1|COMPLETED|Test Period 1 (1 Week)||7
898366|NCT01800916|2170556|P9|STARTED|Test Period 1 (1 Week)||7
898367|NCT01800916|2170557|P8|STARTED|Test Period 1 (1 Week)||7
898368|NCT01800916|2170558|P7|STARTED|Test Period 1 (1 Week)||7
898369|NCT01800916|2170559|P6|STARTED|Test Period 1 (1 Week)||7
898370|NCT01800916|2170560|P5|STARTED|Test Period 1 (1 Week)||8
898371|NCT01800916|2170561|P4|STARTED|Test Period 1 (1 Week)||7
898372|NCT01800916|2170562|P3|STARTED|Test Period 1 (1 Week)||7
898373|NCT01800916|2170563|P2|STARTED|Test Period 1 (1 Week)||7
898374|NCT01800916|2170564|P1|STARTED|Test Period 1 (1 Week)||7
898375|NCT01800903|2170574|P6|NOT COMPLETED|Third Test Period||0
898376|NCT01800903|2170575|P5|NOT COMPLETED|Third Test Period||0
898377|NCT01800903|2170576|P4|NOT COMPLETED|Third Test Period||0
898378|NCT01800903|2170577|P3|NOT COMPLETED|Third Test Period||0
898379|NCT01800903|2170578|P2|NOT COMPLETED|Third Test Period||0
898380|NCT01800903|2170579|P1|NOT COMPLETED|Third Test Period||0
898381|NCT01800903|2170574|P6|COMPLETED|Third Test Period||6
898382|NCT01800903|2170575|P5|COMPLETED|Third Test Period||6
898383|NCT01800903|2170576|P4|COMPLETED|Third Test Period||7
898384|NCT01800903|2170577|P3|COMPLETED|Third Test Period||4
898385|NCT01800903|2170578|P2|COMPLETED|Third Test Period||6
898386|NCT01800903|2170579|P1|COMPLETED|Third Test Period||6
898387|NCT01800903|2170574|P6|STARTED|Third Test Period||6
898388|NCT01800903|2170575|P5|STARTED|Third Test Period||6
898389|NCT01800903|2170576|P4|STARTED|Third Test Period||7
898390|NCT01800903|2170577|P3|STARTED|Third Test Period||4
898391|NCT01800903|2170578|P2|STARTED|Third Test Period||6
898392|NCT01800903|2170579|P1|STARTED|Third Test Period||6
898393|NCT01800903|2170574|P6|NOT COMPLETED|Second Test Period||0
898394|NCT01800903|2170575|P5|NOT COMPLETED|Second Test Period||0
898395|NCT01800903|2170576|P4|NOT COMPLETED|Second Test Period||0
898396|NCT01800903|2170577|P3|NOT COMPLETED|Second Test Period||0
898397|NCT01800903|2170578|P2|NOT COMPLETED|Second Test Period||0
898398|NCT01800903|2170579|P1|NOT COMPLETED|Second Test Period||1
898399|NCT01800903|2170574|P6|COMPLETED|Second Test Period||6
898400|NCT01800903|2170575|P5|COMPLETED|Second Test Period||6
898401|NCT01800903|2170576|P4|COMPLETED|Second Test Period||7
898402|NCT01800903|2170577|P3|COMPLETED|Second Test Period||4
898403|NCT01800903|2170578|P2|COMPLETED|Second Test Period||6
898404|NCT01800903|2170579|P1|COMPLETED|Second Test Period||6
898405|NCT01800903|2170574|P6|STARTED|Second Test Period||6
898406|NCT01800903|2170575|P5|STARTED|Second Test Period||6
898407|NCT01800903|2170576|P4|STARTED|Second Test Period||7
898408|NCT01800903|2170577|P3|STARTED|Second Test Period||4
898409|NCT01800903|2170578|P2|STARTED|Second Test Period||6
898410|NCT01800903|2170579|P1|STARTED|Second Test Period||7
898411|NCT01800903|2170574|P6|NOT COMPLETED|First Test Period||0
898412|NCT01800903|2170575|P5|NOT COMPLETED|First Test Period||0
898413|NCT01800903|2170576|P4|NOT COMPLETED|First Test Period||0
898414|NCT01800903|2170577|P3|NOT COMPLETED|First Test Period||0
898415|NCT01800903|2170578|P2|NOT COMPLETED|First Test Period||0
898416|NCT01800903|2170579|P1|NOT COMPLETED|First Test Period||0
898417|NCT01800903|2170574|P6|COMPLETED|First Test Period||6
898418|NCT01800903|2170575|P5|COMPLETED|First Test Period||6
898419|NCT01800903|2170576|P4|COMPLETED|First Test Period||7
898420|NCT01800903|2170577|P3|COMPLETED|First Test Period||4
898421|NCT01800903|2170578|P2|COMPLETED|First Test Period||6
898422|NCT01800903|2170579|P1|COMPLETED|First Test Period||7
898423|NCT01800903|2170574|P6|STARTED|First Test Period||6
898424|NCT01800903|2170575|P5|STARTED|First Test Period||6
898425|NCT01800903|2170576|P4|STARTED|First Test Period||7
898426|NCT01800903|2170577|P3|STARTED|First Test Period||4
898427|NCT01800903|2170578|P2|STARTED|First Test Period||6
898428|NCT01800903|2170579|P1|STARTED|First Test Period||7
898429|NCT01800890|2170585|P9|NOT COMPLETED|Test Period 3||0
898430|NCT01800890|2170586|P8|NOT COMPLETED|Test Period 3||0
898431|NCT01800890|2170587|P7|NOT COMPLETED|Test Period 3||0
898432|NCT01800890|2170588|P6|NOT COMPLETED|Test Period 3||0
898433|NCT01800890|2170589|P5|NOT COMPLETED|Test Period 3||0
898434|NCT01800890|2170590|P4|NOT COMPLETED|Test Period 3||0
898435|NCT01800890|2170591|P3|NOT COMPLETED|Test Period 3||0
898436|NCT01800890|2170592|P2|NOT COMPLETED|Test Period 3||0
898437|NCT01800890|2170593|P1|NOT COMPLETED|Test Period 3||0
898438|NCT01800890|2170585|P9|COMPLETED|Test Period 3||3
898439|NCT01800890|2170586|P8|COMPLETED|Test Period 3||3
898440|NCT01800890|2170587|P7|COMPLETED|Test Period 3||3
898441|NCT01800890|2170588|P6|COMPLETED|Test Period 3||4
898442|NCT01800890|2170589|P5|COMPLETED|Test Period 3||4
898443|NCT01800890|2170590|P4|COMPLETED|Test Period 3||2
898444|NCT01800890|2170591|P3|COMPLETED|Test Period 3||3
898445|NCT01800890|2170592|P2|COMPLETED|Test Period 3||3
898446|NCT01800890|2170593|P1|COMPLETED|Test Period 3||3
898447|NCT01800890|2170585|P9|STARTED|Test Period 3||3
898448|NCT01800890|2170586|P8|STARTED|Test Period 3||3
898449|NCT01800890|2170587|P7|STARTED|Test Period 3||3
898450|NCT01800890|2170588|P6|STARTED|Test Period 3||4
898451|NCT01800890|2170589|P5|STARTED|Test Period 3||4
898452|NCT01800890|2170590|P4|STARTED|Test Period 3||2
898453|NCT01800890|2170591|P3|STARTED|Test Period 3||3
898454|NCT01800890|2170592|P2|STARTED|Test Period 3||3
898455|NCT01800890|2170593|P1|STARTED|Test Period 3||3
898456|NCT01800890|2170585|P9|NOT COMPLETED|Test Period 2||0
898457|NCT01800890|2170586|P8|NOT COMPLETED|Test Period 2||0
898458|NCT01800890|2170587|P7|NOT COMPLETED|Test Period 2||0
898459|NCT01800890|2170588|P6|NOT COMPLETED|Test Period 2||0
898460|NCT01800890|2170589|P5|NOT COMPLETED|Test Period 2||0
898461|NCT01800890|2170590|P4|NOT COMPLETED|Test Period 2||0
898462|NCT01800890|2170591|P3|NOT COMPLETED|Test Period 2||0
898463|NCT01800890|2170592|P2|NOT COMPLETED|Test Period 2||0
898464|NCT01800890|2170593|P1|NOT COMPLETED|Test Period 2||0
898465|NCT01800890|2170585|P9|COMPLETED|Test Period 2||3
898466|NCT01800890|2170586|P8|COMPLETED|Test Period 2||3
898467|NCT01800890|2170587|P7|COMPLETED|Test Period 2||3
898468|NCT01800890|2170588|P6|COMPLETED|Test Period 2||4
898469|NCT01800890|2170589|P5|COMPLETED|Test Period 2||4
898470|NCT01800890|2170590|P4|COMPLETED|Test Period 2||2
898471|NCT01800890|2170591|P3|COMPLETED|Test Period 2||3
898472|NCT01800890|2170592|P2|COMPLETED|Test Period 2||3
898473|NCT01800890|2170593|P1|COMPLETED|Test Period 2||3
898474|NCT01800890|2170585|P9|STARTED|Test Period 2||3
898475|NCT01800890|2170586|P8|STARTED|Test Period 2||3
898476|NCT01800890|2170587|P7|STARTED|Test Period 2||3
898477|NCT01800890|2170588|P6|STARTED|Test Period 2||4
898478|NCT01800890|2170589|P5|STARTED|Test Period 2||4
898479|NCT01800890|2170590|P4|STARTED|Test Period 2||2
898480|NCT01800890|2170591|P3|STARTED|Test Period 2||3
898481|NCT01800890|2170592|P2|STARTED|Test Period 2||3
898482|NCT01800890|2170593|P1|STARTED|Test Period 2||3
898483|NCT01800890|2170585|P9|NOT COMPLETED|Test Period 1||0
898484|NCT01800890|2170586|P8|NOT COMPLETED|Test Period 1||0
898485|NCT01800890|2170587|P7|NOT COMPLETED|Test Period 1||0
898486|NCT01800890|2170588|P6|NOT COMPLETED|Test Period 1||0
898487|NCT01800890|2170589|P5|NOT COMPLETED|Test Period 1||0
898488|NCT01800890|2170590|P4|NOT COMPLETED|Test Period 1||1
898489|NCT01800890|2170591|P3|NOT COMPLETED|Test Period 1||0
898490|NCT01800890|2170592|P2|NOT COMPLETED|Test Period 1||0
898491|NCT01800890|2170593|P1|NOT COMPLETED|Test Period 1||0
898492|NCT01800890|2170585|P9|COMPLETED|Test Period 1||3
898493|NCT01800890|2170586|P8|COMPLETED|Test Period 1||3
898494|NCT01800890|2170587|P7|COMPLETED|Test Period 1||3
898495|NCT01800890|2170588|P6|COMPLETED|Test Period 1||4
898496|NCT01800890|2170589|P5|COMPLETED|Test Period 1||4
898497|NCT01800890|2170590|P4|COMPLETED|Test Period 1||2
898498|NCT01800890|2170591|P3|COMPLETED|Test Period 1||3
898499|NCT01800890|2170592|P2|COMPLETED|Test Period 1||3
898500|NCT01800890|2170593|P1|COMPLETED|Test Period 1||3
898501|NCT01800890|2170585|P9|STARTED|Test Period 1||3
898502|NCT01800890|2170586|P8|STARTED|Test Period 1||3
898503|NCT01800890|2170587|P7|STARTED|Test Period 1||3
898504|NCT01800890|2170588|P6|STARTED|Test Period 1||4
898505|NCT01800890|2170589|P5|STARTED|Test Period 1||4
898506|NCT01800890|2170590|P4|STARTED|Test Period 1||3
898507|NCT01800890|2170591|P3|STARTED|Test Period 1||3
898508|NCT01800890|2170592|P2|STARTED|Test Period 1||3
898509|NCT01800890|2170593|P1|STARTED|Test Period 1||3
898510|NCT01800786|2170605|P2|NOT COMPLETED|Overall Study||1
898511|NCT01800786|2170606|P1|NOT COMPLETED|Overall Study||2
898512|NCT01800786|2170605|P2|COMPLETED|Overall Study||15
898513|NCT01800786|2170606|P1|COMPLETED|Overall Study||15
898514|NCT01800786|2170605|P2|STARTED|Overall Study||16
898515|NCT01800786|2170606|P1|STARTED|Overall Study||17
898516|NCT01800318|2170616|P4|NOT COMPLETED|Overall Study||1
898517|NCT01800318|2170617|P3|NOT COMPLETED|Overall Study||1
898518|NCT01800318|2170618|P2|NOT COMPLETED|Overall Study||5
898519|NCT01800318|2170619|P1|NOT COMPLETED|Overall Study||2
898520|NCT01800318|2170616|P4|COMPLETED|Overall Study||39
898521|NCT01800318|2170617|P3|COMPLETED|Overall Study||40
898522|NCT01800318|2170618|P2|COMPLETED|Overall Study||37
898523|NCT01800318|2170619|P1|COMPLETED|Overall Study||37
898524|NCT01800318|2170616|P4|STARTED|Overall Study||40
898525|NCT01800318|2170617|P3|STARTED|Overall Study||41
898526|NCT01800318|2170618|P2|STARTED|Overall Study||42
898527|NCT01800318|2170619|P1|STARTED|Overall Study||39
898537|NCT01799941|2170656|P1|NOT COMPLETED|Overall Study||96
898538|NCT01799941|2170656|P1|COMPLETED|Overall Study||271
898539|NCT01799941|2170656|P1|STARTED|Overall Study||367
898540|NCT01799720|2170713|P3|NOT COMPLETED|Overall Study||1
898541|NCT01799720|2170714|P2|NOT COMPLETED|Overall Study||1
898542|NCT01799720|2170715|P1|NOT COMPLETED|Overall Study||3
898543|NCT01799720|2170713|P3|COMPLETED|Overall Study||18
898544|NCT01799720|2170714|P2|COMPLETED|Overall Study||17
898545|NCT01799720|2170715|P1|COMPLETED|Overall Study||17
898546|NCT01799720|2170713|P3|Began the Treatment and Finished it|Overall Study||18
898547|NCT01799720|2170714|P2|Began the Treatment and Finished it|Overall Study||17
898548|NCT01799720|2170715|P1|Began the Treatment and Finished it|Overall Study||17
898549|NCT01799720|2170713|P3|Began the Treatment|Overall Study||19
898550|NCT01799720|2170714|P2|Began the Treatment|Overall Study||18
898551|NCT01799720|2170715|P1|Began the Treatment|Overall Study||20
898552|NCT01799720|2170713|P3|STARTED|Overall Study||19
898553|NCT01799720|2170714|P2|STARTED|Overall Study||18
898554|NCT01799720|2170715|P1|STARTED|Overall Study||20
898555|NCT01799590|2170753|P3|NOT COMPLETED|Overall Study||14
898556|NCT01799590|2170754|P2|NOT COMPLETED|Overall Study||16
898557|NCT01799590|2170755|P1|NOT COMPLETED|Overall Study||26
898558|NCT01799590|2170753|P3|COMPLETED|Overall Study||77
898559|NCT01799590|2170754|P2|COMPLETED|Overall Study||78
898560|NCT01799590|2170755|P1|COMPLETED|Overall Study||85
898561|NCT01799590|2170753|P3|STARTED|Overall Study||91
898562|NCT01799590|2170754|P2|STARTED|Overall Study||94
898563|NCT01799590|2170755|P1|STARTED|Overall Study||111
898564|NCT01799239|2170790|P2|NOT COMPLETED|Period 2 (7 Days)||1
898565|NCT01799239|2170791|P1|NOT COMPLETED|Period 2 (7 Days)||2
898566|NCT01799239|2170790|P2|COMPLETED|Period 2 (7 Days)||14
898567|NCT01799239|2170791|P1|COMPLETED|Period 2 (7 Days)||11
898568|NCT01799239|2170790|P2|STARTED|Period 2 (7 Days)||15
898569|NCT01799239|2170791|P1|STARTED|Period 2 (7 Days)||13
898570|NCT01799239|2170790|P2|NOT COMPLETED|Period 1 (7 Days)||1
898571|NCT01799239|2170791|P1|NOT COMPLETED|Period 1 (7 Days)||3
898572|NCT01799239|2170790|P2|COMPLETED|Period 1 (7 Days)||15
898573|NCT01799239|2170791|P1|COMPLETED|Period 1 (7 Days)||12
898574|NCT01799239|2170790|P2|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|16
898575|NCT01799239|2170791|P1|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|15
898576|NCT01799226|2170799|P2|NOT COMPLETED|Overall Study||0
898577|NCT01799226|2170800|P1|NOT COMPLETED|Overall Study||2
898578|NCT01799226|2170799|P2|COMPLETED|Overall Study||16
898579|NCT01799226|2170800|P1|COMPLETED|Overall Study||14
898580|NCT01799226|2170799|P2|Left Stent Side|Overall Study||8
898581|NCT01799226|2170800|P1|Left Stent Side|Overall Study||8
898582|NCT01799226|2170799|P2|Right Stent Side|Overall Study||8
898583|NCT01799226|2170800|P1|Right Stent Side|Overall Study||8
898584|NCT01799226|2170799|P2|STARTED|Overall Study||16
898585|NCT01799226|2170800|P1|STARTED|Overall Study||16
898586|NCT01798992|2170812|P4|NOT COMPLETED|Overall Study||1
898587|NCT01798992|2170813|P3|NOT COMPLETED|Overall Study||2
898588|NCT01798992|2170814|P2|NOT COMPLETED|Overall Study||2
898589|NCT01798992|2170815|P1|NOT COMPLETED|Overall Study||0
898590|NCT01798992|2170812|P4|COMPLETED|Overall Study||16
898591|NCT01798992|2170813|P3|COMPLETED|Overall Study||14
898592|NCT01798992|2170814|P2|COMPLETED|Overall Study||17
898593|NCT01798992|2170815|P1|COMPLETED|Overall Study||4
898594|NCT01798992|2170812|P4|STARTED|Overall Study||17
898595|NCT01798992|2170813|P3|STARTED|Overall Study||16
898596|NCT01798992|2170814|P2|STARTED|Overall Study||19
898597|NCT01798992|2170815|P1|STARTED|Overall Study||4
898598|NCT01798966|2170829|P1|NOT COMPLETED|Overall Study||0
898599|NCT01798966|2170829|P1|COMPLETED|Overall Study||10
898600|NCT01798966|2170829|P1|STARTED|Overall Study||10
898601|NCT01798927|2170835|P1|NOT COMPLETED|Overall Study||1
898602|NCT01798927|2170835|P1|COMPLETED|Overall Study||3
898603|NCT01798927|2170835|P1|STARTED|Overall Study||4
898604|NCT01798706|2170843|P2|NOT COMPLETED|Overall Study||21
898605|NCT01798706|2170844|P1|NOT COMPLETED|Overall Study||21
898606|NCT01798706|2170843|P2|COMPLETED|Overall Study||153
898607|NCT01798706|2170844|P1|COMPLETED|Overall Study||155
898608|NCT01798706|2170843|P2|STARTED|Overall Study||174
898609|NCT01798706|2170844|P1|STARTED|Overall Study||176
898610|NCT01798485|2170872|P2|NOT COMPLETED|Overall Study||290
898611|NCT01798485|2170873|P1|NOT COMPLETED|Overall Study||346
898612|NCT01798485|2170872|P2|COMPLETED|Overall Study||59
898613|NCT01798485|2170873|P1|COMPLETED|Overall Study||1
898614|NCT01798485|2170872|P2|Randomized as of 19 October 2015|Overall Study||337
898615|NCT01798485|2170873|P1|Randomized as of 19 October 2015|Overall Study||335
898616|NCT01798485|2170872|P2|Safety Population as of 23 Dec 2015|Overall Study||342
898617|NCT01798485|2170873|P1|Safety Population as of 23 Dec 2015|Overall Study||338
898618|NCT01798485|2170872|P2|STARTED|Overall Study||349
898619|NCT01798485|2170873|P1|STARTED|Overall Study||347
898620|NCT01798394|2170909|P2|NOT COMPLETED|Overall Study||3
898621|NCT01798394|2170910|P1|NOT COMPLETED|Overall Study||3
898622|NCT01798394|2170909|P2|COMPLETED|Overall Study||19
898623|NCT01798394|2170910|P1|COMPLETED|Overall Study||21
898624|NCT01798394|2170909|P2|STARTED|Overall Study||22
898625|NCT01798394|2170910|P1|STARTED|Overall Study||24
898626|NCT01798316|2170930|P2|NOT COMPLETED|Overall Study||0
898627|NCT01798316|2170931|P1|NOT COMPLETED|Overall Study||0
898628|NCT01798316|2170930|P2|COMPLETED|Overall Study||53
898629|NCT01798316|2170931|P1|COMPLETED|Overall Study||52
898630|NCT01798316|2170930|P2|STARTED|Overall Study||53
898631|NCT01798316|2170931|P1|STARTED|Overall Study||52
898632|NCT01798264|2170953|P4|NOT COMPLETED|Overall Study||4
898633|NCT01798264|2170954|P3|NOT COMPLETED|Overall Study||0
898634|NCT01798264|2170955|P2|NOT COMPLETED|Overall Study||0
898635|NCT01798264|2170956|P1|NOT COMPLETED|Overall Study||1
898636|NCT01798264|2170953|P4|COMPLETED|Overall Study||7
898637|NCT01798264|2170954|P3|COMPLETED|Overall Study||10
898638|NCT01798264|2170955|P2|COMPLETED|Overall Study||11
898639|NCT01798264|2170956|P1|COMPLETED|Overall Study||11
898640|NCT01798264|2170953|P4|STARTED|Overall Study||11
898641|NCT01798264|2170954|P3|STARTED|Overall Study||10
898642|NCT01798264|2170955|P2|STARTED|Overall Study||11
898643|NCT01798264|2170956|P1|STARTED|Overall Study||12
898644|NCT01798186|2170982|P4|NOT COMPLETED|Overall Study||0
898645|NCT01798186|2170983|P3|NOT COMPLETED|Overall Study||0
898646|NCT01798186|2170984|P2|NOT COMPLETED|Overall Study||0
898647|NCT01798186|2170985|P1|NOT COMPLETED|Overall Study||0
898648|NCT01798186|2170982|P4|COMPLETED|Overall Study||8
898649|NCT01798186|2170983|P3|COMPLETED|Overall Study||6
898650|NCT01798186|2170984|P2|COMPLETED|Overall Study||6
898651|NCT01798186|2170985|P1|COMPLETED|Overall Study||6
898652|NCT01798186|2170982|P4|STARTED|Overall Study||8
898653|NCT01798186|2170983|P3|STARTED|Overall Study||6
898654|NCT01798186|2170984|P2|STARTED|Overall Study||6
898655|NCT01798186|2170985|P1|STARTED|Overall Study||6
898656|NCT01798134|2170999|P1|NOT COMPLETED|Overall Study||16
898657|NCT01798134|2170999|P1|COMPLETED|Overall Study||9
898658|NCT01798134|2170999|P1|STARTED|Overall Study||25
898659|NCT01798004|2171006|P1|NOT COMPLETED|Overall Study||87
898660|NCT01798004|2171006|P1|COMPLETED|Overall Study||63
898661|NCT01798004|2171006|P1|STARTED|Overall Study||150
898662|NCT01797783|2171012|P2|NOT COMPLETED|Overall Study||1
898663|NCT01797783|2171013|P1|NOT COMPLETED|Overall Study||2
898664|NCT01797783|2171012|P2|COMPLETED|Overall Study||26
898665|NCT01797783|2171013|P1|COMPLETED|Overall Study||50
898666|NCT01797783|2171012|P2|STARTED|Overall Study||27
898667|NCT01797783|2171013|P1|STARTED|Overall Study||52
898668|NCT01797731|2171037|P2|NOT COMPLETED|Overall Study||3
898669|NCT01797731|2171038|P1|NOT COMPLETED|Overall Study||3
898670|NCT01797731|2171037|P2|COMPLETED|Overall Study|3 excluded due to not having proper radiographs for adequate follow up|47
898671|NCT01797731|2171038|P1|COMPLETED|Overall Study|3 were excluded due to not having proper radiographs for adequate follow up|47
898672|NCT01797731|2171037|P2|STARTED|Overall Study||50
898673|NCT01797731|2171038|P1|STARTED|Overall Study||50
898674|NCT01797705|2171046|P1|NOT COMPLETED|Overall Study||5
898675|NCT01797705|2171046|P1|COMPLETED|Overall Study||28
898676|NCT01797705|2171046|P1|STARTED|Overall Study||33
898677|NCT01797536|2171054|P4|NOT COMPLETED|Overall Study||0
898678|NCT01797536|2171055|P3|NOT COMPLETED|Overall Study||0
898679|NCT01797536|2171056|P2|NOT COMPLETED|Overall Study||1
898680|NCT01797536|2171057|P1|NOT COMPLETED|Overall Study||0
898681|NCT01797536|2171054|P4|COMPLETED|Overall Study||8
898682|NCT01797536|2171055|P3|COMPLETED|Overall Study||7
898683|NCT01797536|2171056|P2|COMPLETED|Overall Study||10
898684|NCT01797536|2171057|P1|COMPLETED|Overall Study||8
898685|NCT01797536|2171054|P4|STARTED|Overall Study||8
898686|NCT01797536|2171055|P3|STARTED|Overall Study||7
898687|NCT01797536|2171056|P2|STARTED|Overall Study|Includes 3 participants from mild arm who were mistakenly re-enrolled and also dosed in moderate arm|11
898688|NCT01797536|2171057|P1|STARTED|Overall Study||8
898698|NCT01797445|2171111|P2|NOT COMPLETED|Overall Study||437
898699|NCT01797445|2171112|P1|NOT COMPLETED|Overall Study||435
898700|NCT01797445|2171111|P2|COMPLETED|Overall Study||0
898701|NCT01797445|2171112|P1|COMPLETED|Overall Study||0
898702|NCT01797445|2171111|P2|STARTED|Overall Study||437
898703|NCT01797445|2171112|P1|STARTED|Overall Study||435
898704|NCT01797380|2171152|P2|NOT COMPLETED|Overall Study||2
898705|NCT01797380|2171153|P1|NOT COMPLETED|Overall Study||3
898706|NCT01797380|2171152|P2|COMPLETED|Overall Study||0
898707|NCT01797380|2171153|P1|COMPLETED|Overall Study|Terminated due to lack of enrollment|0
898708|NCT01797380|2171152|P2|STARTED|Overall Study||2
898709|NCT01797380|2171153|P1|STARTED|Overall Study|Terminated due to lack of enrollment|3
898710|NCT01797328|2171161|P2|NOT COMPLETED|Overall Study||0
898711|NCT01797328|2171162|P1|NOT COMPLETED|Overall Study||2
898712|NCT01797328|2171161|P2|COMPLETED|Overall Study||12
898713|NCT01797328|2171162|P1|COMPLETED|Overall Study||14
898714|NCT01797328|2171161|P2|STARTED|Overall Study||12
898715|NCT01797328|2171162|P1|STARTED|Overall Study||16
898734|NCT01797029|2171215|P2|NOT COMPLETED|Overall Study||61
898735|NCT01797029|2171216|P1|NOT COMPLETED|Overall Study||159
898736|NCT01797029|2171215|P2|COMPLETED|Overall Study||526
898737|NCT01797029|2171216|P1|COMPLETED|Overall Study||1015
898738|NCT01797029|2171215|P2|STARTED|Overall Study||587
898739|NCT01797029|2171216|P1|STARTED|Overall Study||1174
898740|NCT01796977|2171224|P1|NOT COMPLETED|Overall Study||0
898741|NCT01796977|2171224|P1|COMPLETED|Overall Study||27
898742|NCT01796977|2171224|P1|STARTED|Overall Study||27
898743|NCT01796964|2171237|P2|NOT COMPLETED|Overall Study||3
898744|NCT01796964|2171238|P1|NOT COMPLETED|Overall Study||3
898745|NCT01796964|2171237|P2|COMPLETED|Overall Study||42
898746|NCT01796964|2171238|P1|COMPLETED|Overall Study||41
898747|NCT01796964|2171237|P2|STARTED|Overall Study||45
898748|NCT01796964|2171238|P1|STARTED|Overall Study||44
898749|NCT01796860|2171260|P1|NOT COMPLETED|Overall Study||3
898750|NCT01796860|2171260|P1|COMPLETED|Overall Study||7
898751|NCT01796860|2171260|P1|STARTED|Overall Study||10
898752|NCT01796548|2171266|P1|NOT COMPLETED|Overall Study||3
898753|NCT01796548|2171266|P1|COMPLETED|Overall Study||14
898754|NCT01796548|2171266|P1|Treated|Overall Study||15
898755|NCT01796548|2171266|P1|STARTED|Overall Study||17
898756|NCT01796236|2171280|P2|NOT COMPLETED|Overall Study||2
898757|NCT01796236|2171281|P1|NOT COMPLETED|Overall Study||2
898758|NCT01796236|2171280|P2|COMPLETED|Overall Study||50
898759|NCT01796236|2171281|P1|COMPLETED|Overall Study||49
898760|NCT01796236|2171280|P2|STARTED|Overall Study||52
898761|NCT01796236|2171281|P1|STARTED|Overall Study||51
898762|NCT01795937|2171300|P3|NOT COMPLETED|Overall Study||0
898763|NCT01795937|2171301|P2|NOT COMPLETED|Overall Study||1
898764|NCT01795937|2171302|P1|NOT COMPLETED|Overall Study||1
898765|NCT01795937|2171300|P3|COMPLETED|Overall Study||17
898766|NCT01795937|2171301|P2|COMPLETED|Overall Study||15
898767|NCT01795937|2171302|P1|COMPLETED|Overall Study||17
898768|NCT01795937|2171300|P3|STARTED|Overall Study||17
898769|NCT01795937|2171301|P2|STARTED|Overall Study||16
898770|NCT01795937|2171302|P1|STARTED|Overall Study||18
898771|NCT01795898|2171331|P1|NOT COMPLETED|Overall Study||60
898772|NCT01795898|2171331|P1|COMPLETED|Overall Study||177
898773|NCT01795898|2171331|P1|STARTED|Overall Study||237
898774|NCT01795859|2171341|P2|NOT COMPLETED|Overall Study||2
898775|NCT01795859|2171342|P1|NOT COMPLETED|Overall Study||1
898776|NCT01795859|2171341|P2|COMPLETED|Overall Study||43
898777|NCT01795859|2171342|P1|COMPLETED|Overall Study||44
898778|NCT01795859|2171341|P2|STARTED|Overall Study||45
898779|NCT01795859|2171342|P1|STARTED|Overall Study||45
898780|NCT01795716|2171358|P2|NOT COMPLETED|Second Intervention (13 Days)||0
898781|NCT01795716|2171359|P1|NOT COMPLETED|Second Intervention (13 Days)||0
898782|NCT01795716|2171358|P2|COMPLETED|Second Intervention (13 Days)||11
898783|NCT01795716|2171359|P1|COMPLETED|Second Intervention (13 Days)||10
898784|NCT01795716|2171358|P2|STARTED|Second Intervention (13 Days)||11
898785|NCT01795716|2171359|P1|STARTED|Second Intervention (13 Days)||10
898786|NCT01795716|2171358|P2|NOT COMPLETED|Washout (10 Days)||0
898787|NCT01795716|2171359|P1|NOT COMPLETED|Washout (10 Days)||0
898788|NCT01795716|2171358|P2|COMPLETED|Washout (10 Days)||11
898789|NCT01795716|2171359|P1|COMPLETED|Washout (10 Days)||10
898790|NCT01795716|2171358|P2|STARTED|Washout (10 Days)||11
898791|NCT01795716|2171359|P1|STARTED|Washout (10 Days)||10
898792|NCT01795716|2171358|P2|NOT COMPLETED|First Intervention (13 Days)||0
898793|NCT01795716|2171359|P1|NOT COMPLETED|First Intervention (13 Days)||0
898794|NCT01795716|2171358|P2|COMPLETED|First Intervention (13 Days)||11
898795|NCT01795716|2171359|P1|COMPLETED|First Intervention (13 Days)||10
898796|NCT01795716|2171358|P2|STARTED|First Intervention (13 Days)||11
898797|NCT01795716|2171359|P1|STARTED|First Intervention (13 Days)||10
898798|NCT01795547|2171367|P2|NOT COMPLETED|Overall Study||64
898799|NCT01795547|2171368|P1|NOT COMPLETED|Overall Study||48
898800|NCT01795547|2171367|P2|COMPLETED|Overall Study||83
898801|NCT01795547|2171368|P1|COMPLETED|Overall Study||100
898802|NCT01795547|2171367|P2|STARTED|Overall Study||147
898803|NCT01795547|2171368|P1|STARTED|Overall Study||148
898804|NCT01795534|2171390|P2|NOT COMPLETED|Second Intervention (Second Shot)||0
898805|NCT01795534|2171391|P1|NOT COMPLETED|Second Intervention (Second Shot)||0
898806|NCT01795534|2171390|P2|COMPLETED|Second Intervention (Second Shot)||5
898807|NCT01795534|2171391|P1|COMPLETED|Second Intervention (Second Shot)||5
898808|NCT01795534|2171390|P2|STARTED|Second Intervention (Second Shot)||5
898809|NCT01795534|2171391|P1|STARTED|Second Intervention (Second Shot)||5
898810|NCT01795534|2171390|P2|NOT COMPLETED|Wash Out Period (4 Days)||0
898811|NCT01795534|2171391|P1|NOT COMPLETED|Wash Out Period (4 Days)||0
898812|NCT01795534|2171390|P2|COMPLETED|Wash Out Period (4 Days)||5
898813|NCT01795534|2171391|P1|COMPLETED|Wash Out Period (4 Days)||5
898814|NCT01795534|2171390|P2|STARTED|Wash Out Period (4 Days)||5
898815|NCT01795534|2171391|P1|STARTED|Wash Out Period (4 Days)||5
898816|NCT01795534|2171390|P2|NOT COMPLETED|First Intervention (First Shot)||0
898817|NCT01795534|2171391|P1|NOT COMPLETED|First Intervention (First Shot)||0
898818|NCT01795534|2171390|P2|COMPLETED|First Intervention (First Shot)||5
898819|NCT01795534|2171391|P1|COMPLETED|First Intervention (First Shot)||5
898820|NCT01795534|2171390|P2|STARTED|First Intervention (First Shot)||5
898821|NCT01795534|2171391|P1|STARTED|First Intervention (First Shot)||5
898822|NCT01794949|2171399|P2|NOT COMPLETED|Overall Study||0
898823|NCT01794949|2171400|P1|NOT COMPLETED|Overall Study||1
898824|NCT01794949|2171399|P2|COMPLETED|Overall Study||1
898825|NCT01794949|2171400|P1|COMPLETED|Overall Study||6
898826|NCT01794949|2171399|P2|6 Month Follow-up|Overall Study||1
898827|NCT01794949|2171400|P1|6 Month Follow-up|Overall Study||6
898828|NCT01794949|2171399|P2|STARTED|Overall Study||1
898829|NCT01794949|2171400|P1|STARTED|Overall Study||7
898830|NCT01794936|2171406|P1|NOT COMPLETED|Overall Study||0
898831|NCT01794936|2171406|P1|COMPLETED|Overall Study||9
898832|NCT01794936|2171406|P1|STARTED|Overall Study||9
898833|NCT01794845|2171411|P1|NOT COMPLETED|Overall Study||1
898834|NCT01794845|2171411|P1|COMPLETED|Overall Study||4
898835|NCT01794845|2171411|P1|STARTED|Overall Study||5
898836|NCT01794806|2171420|P2|NOT COMPLETED|Overall Study||1
898837|NCT01794806|2171421|P1|NOT COMPLETED|Overall Study||5
898838|NCT01794806|2171420|P2|COMPLETED|Overall Study||27
898839|NCT01794806|2171421|P1|COMPLETED|Overall Study||26
898840|NCT01794806|2171420|P2|4 Weeks|Overall Study||27
898841|NCT01794806|2171421|P1|4 Weeks|Overall Study||26
898842|NCT01794806|2171420|P2|1 Week|Overall Study||28
898843|NCT01794806|2171421|P1|1 Week|Overall Study||28
898844|NCT01794806|2171420|P2|STARTED|Overall Study||28
898845|NCT01794806|2171421|P1|STARTED|Overall Study||31
898846|NCT01794741|2171433|P2|NOT COMPLETED|Overall Study||9
898847|NCT01794741|2171434|P1|NOT COMPLETED|Overall Study||19
898848|NCT01794741|2171433|P2|COMPLETED|Overall Study||92
898849|NCT01794741|2171434|P1|COMPLETED|Overall Study||285
898850|NCT01794741|2171433|P2|STARTED|Overall Study||101
898851|NCT01794741|2171434|P1|STARTED|Overall Study||304
898852|NCT01794455|2171442|P2|NOT COMPLETED|Overall Study||0
898853|NCT01794455|2171443|P1|NOT COMPLETED|Overall Study||0
898854|NCT01794455|2171442|P2|COMPLETED|Overall Study||1
898855|NCT01794455|2171443|P1|COMPLETED|Overall Study||0
898856|NCT01794455|2171442|P2|STARTED|Overall Study||1
898857|NCT01794455|2171443|P1|STARTED|Overall Study||0
898858|NCT01794000|2171461|P2|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
898859|NCT01794000|2171462|P1|NOT COMPLETED|Open-Label Extension Phase (OLE)||3
898860|NCT01794000|2171461|P2|COMPLETED|Open-Label Extension Phase (OLE)||0
898861|NCT01794000|2171462|P1|COMPLETED|Open-Label Extension Phase (OLE)||0
898862|NCT01794000|2171461|P2|STARTED|Open-Label Extension Phase (OLE)|Placebo arm was not applicable to Open-Label Extension Phase|0
898863|NCT01794000|2171462|P1|STARTED|Open-Label Extension Phase (OLE)|Pts. who had not permanently discontinued study drug and concluded DBP were eligible to enter OLE|3
898864|NCT01794000|2171461|P2|NOT COMPLETED|Double-Blind Phase (DBP)||166
898865|NCT01794000|2171462|P1|NOT COMPLETED|Double-Blind Phase (DBP)||169
898866|NCT01794000|2171461|P2|COMPLETED|Double-Blind Phase (DBP)||4
898867|NCT01794000|2171462|P1|COMPLETED|Double-Blind Phase (DBP)||2
898868|NCT01794000|2171461|P2|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||166
898869|NCT01794000|2171462|P1|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||169
898870|NCT01794000|2171461|P2|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
898871|NCT01794000|2171462|P1|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
898872|NCT01794000|2171461|P2|STARTED|Double-Blind Phase (DBP)||170
898873|NCT01794000|2171462|P1|STARTED|Double-Blind Phase (DBP)||171
898874|NCT01793883|2171496|P3|NOT COMPLETED|Overall Study||8
898875|NCT01793883|2171497|P2|NOT COMPLETED|Overall Study||10
898876|NCT01793883|2171498|P1|NOT COMPLETED|Overall Study||12
898877|NCT01793883|2171496|P3|COMPLETED|Overall Study||204
898878|NCT01793883|2171497|P2|COMPLETED|Overall Study||204
898879|NCT01793883|2171498|P1|COMPLETED|Overall Study||201
898880|NCT01793883|2171496|P3|STARTED|Overall Study||212
898881|NCT01793883|2171497|P2|STARTED|Overall Study||214
898882|NCT01793883|2171498|P1|STARTED|Overall Study||213
898883|NCT01793688|2171506|P1|NOT COMPLETED|Overall Study||2
898884|NCT01793688|2171506|P1|COMPLETED|Overall Study||980
898885|NCT01793688|2171506|P1|STARTED|Overall Study||982
898886|NCT01793285|2171513|P1|NOT COMPLETED|Overall Study||0
898887|NCT01793285|2171513|P1|COMPLETED|Overall Study||85
898888|NCT01793285|2171513|P1|STARTED|Overall Study||85
898889|NCT01792986|2171533|P1|NOT COMPLETED|Overall Study||0
898890|NCT01792986|2171533|P1|COMPLETED|Overall Study||12
898891|NCT01792986|2171533|P1|STARTED|Overall Study||12
898892|NCT01792830|2171548|P7|NOT COMPLETED|Overall Study||3
898893|NCT01792830|2171549|P6|NOT COMPLETED|Overall Study||0
898894|NCT01792830|2171550|P5|NOT COMPLETED|Overall Study||12
898895|NCT01792830|2171551|P4|NOT COMPLETED|Overall Study||5
898896|NCT01792830|2171552|P3|NOT COMPLETED|Overall Study||0
898897|NCT01792830|2171553|P2|NOT COMPLETED|Overall Study||0
898898|NCT01792830|2171554|P1|NOT COMPLETED|Overall Study||25
898899|NCT01792830|2171548|P7|COMPLETED|Overall Study||9
898900|NCT01792830|2171549|P6|COMPLETED|Overall Study||4
898901|NCT01792830|2171550|P5|COMPLETED|Overall Study||29
898902|NCT01792830|2171551|P4|COMPLETED|Overall Study||22
898903|NCT01792830|2171552|P3|COMPLETED|Overall Study||4
898904|NCT01792830|2171553|P2|COMPLETED|Overall Study||3
898905|NCT01792830|2171554|P1|COMPLETED|Overall Study||59
898906|NCT01792830|2171548|P7|STARTED|Overall Study||12
898907|NCT01792830|2171549|P6|STARTED|Overall Study||4
898908|NCT01792830|2171550|P5|STARTED|Overall Study||41
898909|NCT01792830|2171551|P4|STARTED|Overall Study||27
898910|NCT01792830|2171552|P3|STARTED|Overall Study||4
898911|NCT01792830|2171553|P2|STARTED|Overall Study||3
898912|NCT01792830|2171554|P1|STARTED|Overall Study||84
898913|NCT01792635|2171585|P3|NOT COMPLETED|Part B||4
898914|NCT01792635|2171586|P2|NOT COMPLETED|Part B||4
898915|NCT01792635|2171587|P1|NOT COMPLETED|Part B||0
898916|NCT01792635|2171585|P3|COMPLETED|Part B||3
898917|NCT01792635|2171586|P2|COMPLETED|Part B||2
898918|NCT01792635|2171587|P1|COMPLETED|Part B||0
898919|NCT01792635|2171585|P3|STARTED|Part B||7
898920|NCT01792635|2171586|P2|STARTED|Part B||6
898921|NCT01792635|2171587|P1|STARTED|Part B||0
898922|NCT01792635|2171585|P3|NOT COMPLETED|Part A||0
898923|NCT01792635|2171586|P2|NOT COMPLETED|Part A||0
898924|NCT01792635|2171587|P1|NOT COMPLETED|Part A||0
898925|NCT01792635|2171585|P3|COMPLETED|Part A||0
898926|NCT01792635|2171586|P2|COMPLETED|Part A||0
898927|NCT01792635|2171587|P1|COMPLETED|Part A||6
898928|NCT01792635|2171585|P3|STARTED|Part A||0
898929|NCT01792635|2171586|P2|STARTED|Part A||0
898930|NCT01792635|2171587|P1|STARTED|Part A||6
898931|NCT01792518|2171615|P2|NOT COMPLETED|Overall Study||7
898932|NCT01792518|2171616|P1|NOT COMPLETED|Overall Study||8
898933|NCT01792518|2171615|P2|COMPLETED|Overall Study||175
898934|NCT01792518|2171616|P1|COMPLETED|Overall Study||170
898935|NCT01792518|2171615|P2|STARTED|Overall Study||182
898936|NCT01792518|2171616|P1|STARTED|Overall Study||178
898937|NCT01791972|2171628|P2|NOT COMPLETED|Overall Study||0
898938|NCT01791972|2171629|P1|NOT COMPLETED|Overall Study||0
898939|NCT01791972|2171628|P2|COMPLETED|Overall Study||19
898940|NCT01791972|2171629|P1|COMPLETED|Overall Study||19
898941|NCT01791972|2171628|P2|STARTED|Overall Study||19
898942|NCT01791972|2171629|P1|STARTED|Overall Study||19
898943|NCT01791894|2171639|P1|NOT COMPLETED|Overall Study||1
898944|NCT01791894|2171639|P1|COMPLETED|Overall Study||4
898945|NCT01791894|2171639|P1|STARTED|Overall Study||5
898946|NCT01791803|2171650|P4|NOT COMPLETED|Overall Study||5
898947|NCT01791803|2171651|P3|NOT COMPLETED|Overall Study||2
898948|NCT01791803|2171652|P2|NOT COMPLETED|Overall Study||2
898949|NCT01791803|2171653|P1|NOT COMPLETED|Overall Study||0
898950|NCT01791803|2171650|P4|COMPLETED|Overall Study||37
898951|NCT01791803|2171651|P3|COMPLETED|Overall Study||38
898952|NCT01791803|2171652|P2|COMPLETED|Overall Study||39
898953|NCT01791803|2171653|P1|COMPLETED|Overall Study||41
898954|NCT01791803|2171650|P4|STARTED|Overall Study||42
898955|NCT01791803|2171651|P3|STARTED|Overall Study||40
898956|NCT01791803|2171652|P2|STARTED|Overall Study||41
898957|NCT01791803|2171653|P1|STARTED|Overall Study||41
898958|NCT01791725|2171671|P3|NOT COMPLETED|Overall Study||0
898959|NCT01791725|2171672|P2|NOT COMPLETED|Overall Study||1
898960|NCT01791725|2171673|P1|NOT COMPLETED|Overall Study||0
898961|NCT01791725|2171671|P3|COMPLETED|Overall Study||6
898962|NCT01791725|2171672|P2|COMPLETED|Overall Study||4
898963|NCT01791725|2171673|P1|COMPLETED|Overall Study||12
898964|NCT01791725|2171671|P3|STARTED|Overall Study||6
898965|NCT01791725|2171672|P2|STARTED|Overall Study||5
898966|NCT01791725|2171673|P1|STARTED|Overall Study||12
898967|NCT01791491|2171693|P1|NOT COMPLETED|Overall Study||0
898968|NCT01791491|2171693|P1|COMPLETED|Overall Study||9
898969|NCT01791491|2171693|P1|STARTED|Overall Study|Reasons for enrollment and non-treatment: 1 withdrew consent and 6 no longer met study criteria.|9
898970|NCT01791465|2171705|P1|NOT COMPLETED|Overall Study||0
898971|NCT01791465|2171705|P1|COMPLETED|Overall Study||6
898972|NCT01791465|2171705|P1|STARTED|Overall Study||6
898973|NCT01791413|2171731|P2|NOT COMPLETED|Overall Study||1
898974|NCT01791413|2171732|P1|NOT COMPLETED|Overall Study||5
898975|NCT01791413|2171731|P2|COMPLETED|Overall Study||19
898976|NCT01791413|2171732|P1|COMPLETED|Overall Study||15
898977|NCT01791413|2171731|P2|STARTED|Overall Study||20
898978|NCT01791413|2171732|P1|STARTED|Overall Study||20
898979|NCT01791244|2171741|P2|NOT COMPLETED|Overall Study||18
898980|NCT01791244|2171742|P1|NOT COMPLETED|Overall Study||15
898981|NCT01791244|2171741|P2|COMPLETED|Overall Study||29
898982|NCT01791244|2171742|P1|COMPLETED|Overall Study||31
898983|NCT01791244|2171741|P2|Intent to Treat (ITT)|Overall Study||39
898984|NCT01791244|2171742|P1|Intent to Treat (ITT)|Overall Study||38
898985|NCT01791244|2171741|P2|STARTED|Overall Study||47
898986|NCT01791244|2171742|P1|STARTED|Overall Study||46
898987|NCT01791205|2171778|P2|NOT COMPLETED|Phase II||0
898988|NCT01791205|2171779|P1|NOT COMPLETED|Phase II||12
898989|NCT01791205|2171778|P2|COMPLETED|Phase II||0
898990|NCT01791205|2171779|P1|COMPLETED|Phase II||92
898991|NCT01791205|2171778|P2|STARTED|Phase II||0
898992|NCT01791205|2171779|P1|STARTED|Phase II|Participants who received tocilizumab monotherapy in Phase I was observed in Phase II.|104
898993|NCT01791205|2171778|P2|NOT COMPLETED|Phase I||0
898994|NCT01791205|2171779|P1|NOT COMPLETED|Phase I||0
898995|NCT01791205|2171778|P2|COMPLETED|Phase I||152
898996|NCT01791205|2171779|P1|COMPLETED|Phase I||152
898997|NCT01791205|2171778|P2|STARTED|Phase I||152
898998|NCT01791205|2171779|P1|STARTED|Phase I||152
898999|NCT01791153|2171863|P4|NOT COMPLETED|Overall Study||5
899000|NCT01791153|2171864|P3|NOT COMPLETED|Overall Study||6
899001|NCT01791153|2171865|P2|NOT COMPLETED|Overall Study||8
899002|NCT01791153|2171866|P1|NOT COMPLETED|Overall Study||15
899003|NCT01791153|2171863|P4|COMPLETED|Overall Study|Completed Study to Week 52|46
899004|NCT01791153|2171864|P3|COMPLETED|Overall Study|Completed Study to Week 52|44
899005|NCT01791153|2171865|P2|COMPLETED|Overall Study|Completed Study to Week 52|41
899006|NCT01791153|2171866|P1|COMPLETED|Overall Study|Completed Study to Week 52|85
899007|NCT01791153|2171863|P4|STARTED|Overall Study||51
899008|NCT01791153|2171864|P3|STARTED|Overall Study||50
899009|NCT01791153|2171865|P2|STARTED|Overall Study||49
899010|NCT01791153|2171866|P1|STARTED|Overall Study||100
899011|NCT01789775|2171924|P2|NOT COMPLETED|Overall Study||7
899012|NCT01789775|2171925|P1|NOT COMPLETED|Overall Study||2
899013|NCT01789775|2171924|P2|COMPLETED|Overall Study||50
899014|NCT01789775|2171925|P1|COMPLETED|Overall Study||53
899015|NCT01789775|2171924|P2|STARTED|Overall Study||57
899016|NCT01789775|2171925|P1|STARTED|Overall Study||55
899017|NCT01790828|2171931|P1|NOT COMPLETED|Overall Study||34
899018|NCT01790828|2171931|P1|COMPLETED|Overall Study||8
899019|NCT01790828|2171931|P1|STARTED|Overall Study||42
899020|NCT01790750|2171954|P1|NOT COMPLETED|Overall Study||0
899021|NCT01790750|2171954|P1|COMPLETED|Overall Study||50
899022|NCT01790750|2171954|P1|STARTED|Overall Study||50
899023|NCT01790685|2171961|P2|NOT COMPLETED|Overall Study||0
899024|NCT01790685|2171962|P1|NOT COMPLETED|Overall Study||0
899025|NCT01790685|2171961|P2|COMPLETED|Overall Study||17
899026|NCT01790685|2171962|P1|COMPLETED|Overall Study||23
899027|NCT01790685|2171961|P2|STARTED|Overall Study||17
899028|NCT01790685|2171962|P1|STARTED|Overall Study||23
899035|NCT01790633|2171991|P2|NOT COMPLETED|Overall Study||5
899036|NCT01790633|2171992|P1|NOT COMPLETED|Overall Study||48
899037|NCT01790633|2171991|P2|COMPLETED|Overall Study||159
899038|NCT01790633|2171992|P1|COMPLETED|Overall Study||115
899039|NCT01790633|2171991|P2|STARTED|Overall Study||164
899040|NCT01790633|2171992|P1|STARTED|Overall Study||163
899041|NCT01790581|2172005|P2|NOT COMPLETED|Overall Study||0
899042|NCT01790581|2172006|P1|NOT COMPLETED|Overall Study||0
899043|NCT01790581|2172005|P2|COMPLETED|Overall Study||12
899044|NCT01790581|2172006|P1|COMPLETED|Overall Study||12
899045|NCT01790581|2172005|P2|STARTED|Overall Study||12
899046|NCT01790581|2172006|P1|STARTED|Overall Study||12
899047|NCT01790516|2172016|P2|NOT COMPLETED|Overall Study||0
899048|NCT01790516|2172017|P1|NOT COMPLETED|Overall Study||1
899049|NCT01790516|2172016|P2|COMPLETED|Overall Study||1
899050|NCT01790516|2172017|P1|COMPLETED|Overall Study||0
899051|NCT01790516|2172016|P2|STARTED|Overall Study||1
899052|NCT01790516|2172017|P1|STARTED|Overall Study||1
899053|NCT01790490|2172026|P3|NOT COMPLETED|Overall Study||0
899054|NCT01790490|2172027|P2|NOT COMPLETED|Overall Study||0
899055|NCT01790490|2172028|P1|NOT COMPLETED|Overall Study||0
899056|NCT01790490|2172026|P3|COMPLETED|Overall Study||2
899057|NCT01790490|2172027|P2|COMPLETED|Overall Study||3
899058|NCT01790490|2172028|P1|COMPLETED|Overall Study||3
899059|NCT01790490|2172026|P3|STARTED|Overall Study||2
899060|NCT01790490|2172027|P2|STARTED|Overall Study||3
899061|NCT01790490|2172028|P1|STARTED|Overall Study||3
899062|NCT01790178|2172041|P2|NOT COMPLETED|Overall Study||0
899063|NCT01790178|2172042|P1|NOT COMPLETED|Overall Study||0
899064|NCT01790178|2172041|P2|COMPLETED|Overall Study||24
899065|NCT01790178|2172042|P1|COMPLETED|Overall Study||16
899066|NCT01790178|2172041|P2|STARTED|Overall Study||24
899067|NCT01790178|2172042|P1|STARTED|Overall Study||16
899068|NCT01789970|2172058|P3|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||44
899069|NCT01789970|2172059|P2|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||50
899070|NCT01789970|2172060|P1|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
899071|NCT01789970|2172058|P3|COMPLETED|Double-blind Treatment Period (12 Weeks)||147
899072|NCT01789970|2172059|P2|COMPLETED|Double-blind Treatment Period (12 Weeks)||130
899073|NCT01789970|2172060|P1|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
899074|NCT01789970|2172058|P3|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||191
899075|NCT01789970|2172059|P2|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)|One participant was randomized but not treated.|179
899076|NCT01789970|2172060|P1|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||0
899077|NCT01789970|2172058|P3|STARTED|Double-blind Treatment Period (12 Weeks)||191
899078|NCT01789970|2172059|P2|STARTED|Double-blind Treatment Period (12 Weeks)||180
899079|NCT01789970|2172060|P1|STARTED|Double-blind Treatment Period (12 Weeks)||0
899080|NCT01789970|2172058|P3|NOT COMPLETED|Open-label Titration Period||0
899081|NCT01789970|2172059|P2|NOT COMPLETED|Open-label Titration Period||0
899082|NCT01789970|2172060|P1|NOT COMPLETED|Open-label Titration Period||254
899083|NCT01789970|2172058|P3|COMPLETED|Open-label Titration Period||0
899084|NCT01789970|2172059|P2|COMPLETED|Open-label Titration Period||0
899085|NCT01789970|2172060|P1|COMPLETED|Open-label Titration Period||371
899086|NCT01789970|2172058|P3|Safety Analysis Set|Open-label Titration Period||0
899087|NCT01789970|2172059|P2|Safety Analysis Set|Open-label Titration Period||0
899088|NCT01789970|2172060|P1|Safety Analysis Set|Open-label Titration Period|Two enrolled patients were not treated|623
899089|NCT01789970|2172058|P3|STARTED|Open-label Titration Period||0
899090|NCT01789970|2172059|P2|STARTED|Open-label Titration Period||0
899091|NCT01789970|2172060|P1|STARTED|Open-label Titration Period||625
899092|NCT01789814|2172094|P2|NOT COMPLETED|Overall Study||0
899093|NCT01789814|2172095|P1|NOT COMPLETED|Overall Study||0
899094|NCT01789814|2172094|P2|COMPLETED|Overall Study||12
899095|NCT01789814|2172095|P1|COMPLETED|Overall Study||12
899096|NCT01789814|2172094|P2|STARTED|Overall Study||12
899097|NCT01789814|2172095|P1|STARTED|Overall Study||12
899098|NCT01789606|2172103|P2|NOT COMPLETED|Overall Study||450
899099|NCT01789606|2172104|P1|NOT COMPLETED|Overall Study||23
899100|NCT01789606|2172103|P2|COMPLETED|Overall Study||382
899101|NCT01789606|2172104|P1|COMPLETED|Overall Study||228
899102|NCT01789606|2172103|P2|STARTED|Overall Study||832
899103|NCT01789606|2172104|P1|STARTED|Overall Study||251
899104|NCT01789476|2172124|P2|NOT COMPLETED|Overall Study||2
899105|NCT01789476|2172125|P1|NOT COMPLETED|Overall Study||8
899106|NCT01789476|2172124|P2|COMPLETED|Overall Study||15
899107|NCT01789476|2172125|P1|COMPLETED|Overall Study||26
899108|NCT01789476|2172124|P2|STARTED|Overall Study||17
899109|NCT01789476|2172125|P1|STARTED|Overall Study||34
899110|NCT01789255|2172135|P1|NOT COMPLETED|Overall Study||0
899111|NCT01789255|2172135|P1|COMPLETED|Overall Study||12
899112|NCT01789255|2172135|P1|STARTED|Overall Study||12
899113|NCT01789138|2172142|P2|NOT COMPLETED|Overall Study||52
899114|NCT01789138|2172143|P1|NOT COMPLETED|Overall Study||41
899115|NCT01789138|2172142|P2|COMPLETED|Overall Study||206
899116|NCT01789138|2172143|P1|COMPLETED|Overall Study||213
899117|NCT01789138|2172142|P2|STARTED|Overall Study||258
899118|NCT01789138|2172143|P1|STARTED|Overall Study||254
899119|NCT01788566|2172151|P1|NOT COMPLETED|Overall Study||8
899120|NCT01788566|2172151|P1|COMPLETED|Overall Study||53
899121|NCT01788566|2172151|P1|STARTED|Overall Study||61
899129|NCT01788228|2172175|P2|NOT COMPLETED|Overall Study||0
899130|NCT01788228|2172176|P1|NOT COMPLETED|Overall Study||1
899131|NCT01788228|2172175|P2|COMPLETED|Overall Study||1
899132|NCT01788228|2172176|P1|COMPLETED|Overall Study||48
899133|NCT01788228|2172175|P2|STARTED|Overall Study||1
899134|NCT01788228|2172176|P1|STARTED|Overall Study||49
899135|NCT01788215|2172195|P2|NOT COMPLETED|Overall Study||1
899136|NCT01788215|2172196|P1|NOT COMPLETED|Overall Study||2
899137|NCT01788215|2172195|P2|COMPLETED|Overall Study||4
899138|NCT01788215|2172196|P1|COMPLETED|Overall Study||3
899139|NCT01788215|2172195|P2|12 Weeks of Doxycycline or Placebo|Overall Study||5
899140|NCT01788215|2172196|P1|12 Weeks of Doxycycline or Placebo|Overall Study||5
899141|NCT01788215|2172195|P2|STARTED|Overall Study||5
899142|NCT01788215|2172196|P1|STARTED|Overall Study||5
899143|NCT01788163|2172225|P9|NOT COMPLETED|Overall Study||16
899144|NCT01788163|2172226|P8|NOT COMPLETED|Overall Study||48
899145|NCT01788163|2172227|P7|NOT COMPLETED|Overall Study||1
899146|NCT01788163|2172228|P6|NOT COMPLETED|Overall Study||7
899147|NCT01788163|2172229|P5|NOT COMPLETED|Overall Study||0
899148|NCT01788163|2172230|P4|NOT COMPLETED|Overall Study||0
899149|NCT01788163|2172231|P3|NOT COMPLETED|Overall Study||0
899150|NCT01788163|2172232|P2|NOT COMPLETED|Overall Study||0
899151|NCT01788163|2172233|P1|NOT COMPLETED|Overall Study||55
899152|NCT01788163|2172225|P9|COMPLETED|Overall Study||956
899153|NCT01788163|2172226|P8|COMPLETED|Overall Study||254
899154|NCT01788163|2172227|P7|COMPLETED|Overall Study||49
899155|NCT01788163|2172228|P6|COMPLETED|Overall Study||95
899156|NCT01788163|2172229|P5|COMPLETED|Overall Study||94
899157|NCT01788163|2172230|P4|COMPLETED|Overall Study||71
899158|NCT01788163|2172231|P3|COMPLETED|Overall Study||62
899159|NCT01788163|2172232|P2|COMPLETED|Overall Study||271
899160|NCT01788163|2172233|P1|COMPLETED|Overall Study||1403
899161|NCT01788163|2172225|P9|STARTED|Overall Study||972
899162|NCT01788163|2172226|P8|STARTED|Overall Study||302
899163|NCT01788163|2172227|P7|STARTED|Overall Study||50
899164|NCT01788163|2172228|P6|STARTED|Overall Study||102
899165|NCT01788163|2172229|P5|STARTED|Overall Study||94
899166|NCT01788163|2172230|P4|STARTED|Overall Study||71
899167|NCT01788163|2172231|P3|STARTED|Overall Study||62
899168|NCT01788163|2172232|P2|STARTED|Overall Study||271
899169|NCT01788163|2172233|P1|STARTED|Overall Study||1458
899170|NCT01788046|2172396|P2|NOT COMPLETED|Overall Study||37
899171|NCT01788046|2172397|P1|NOT COMPLETED|Overall Study||56
899172|NCT01788046|2172396|P2|COMPLETED|Overall Study||218
899173|NCT01788046|2172397|P1|COMPLETED|Overall Study||204
899174|NCT01788046|2172396|P2|Received Treatment|Overall Study||252
899175|NCT01788046|2172397|P1|Received Treatment|Overall Study||259
899176|NCT01788046|2172396|P2|STARTED|Overall Study||255
899177|NCT01788046|2172397|P1|STARTED|Overall Study||260
899178|NCT01787838|2172413|P1|NOT COMPLETED|Overall Study||1413
899179|NCT01787838|2172413|P1|COMPLETED|Overall Study|This is the number of patients successfully immunized in a one year period.|1096
899180|NCT01787838|2172413|P1|STARTED|Overall Study|This is the number who met Centers for Disease Control and Prevention guidelines for vaccine.|2509
899181|NCT01787825|2172417|P2|NOT COMPLETED|Overall Study||1
899182|NCT01787825|2172418|P1|NOT COMPLETED|Overall Study||6
899183|NCT01787825|2172417|P2|COMPLETED|Overall Study||60
899184|NCT01787825|2172418|P1|COMPLETED|Overall Study||54
899185|NCT01787825|2172417|P2|STARTED|Overall Study||61
899186|NCT01787825|2172418|P1|STARTED|Overall Study||60
899187|NCT01787799|2172429|P1|NOT COMPLETED|Overall Study||0
899188|NCT01787799|2172429|P1|COMPLETED|Overall Study||100
899189|NCT01787799|2172429|P1|STARTED|Overall Study||100
899190|NCT01787760|2172436|P3|NOT COMPLETED|Overall Study||5
899191|NCT01787760|2172437|P2|NOT COMPLETED|Overall Study||16
899192|NCT01787760|2172438|P1|NOT COMPLETED|Overall Study||26
899193|NCT01787760|2172436|P3|COMPLETED|Overall Study||46
899194|NCT01787760|2172437|P2|COMPLETED|Overall Study||34
899195|NCT01787760|2172438|P1|COMPLETED|Overall Study||25
899196|NCT01787760|2172436|P3|STARTED|Overall Study||51
899197|NCT01787760|2172437|P2|STARTED|Overall Study||50
899198|NCT01787760|2172438|P1|STARTED|Overall Study||51
899199|NCT01787591|2172452|P4|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
899200|NCT01787591|2172453|P3|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
899201|NCT01787591|2172454|P2|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
899202|NCT01787591|2172455|P1|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
899203|NCT01787591|2172452|P4|COMPLETED|Period 4 (Cross-over Arm 4)||5
899204|NCT01787591|2172453|P3|COMPLETED|Period 4 (Cross-over Arm 4)||5
899205|NCT01787591|2172454|P2|COMPLETED|Period 4 (Cross-over Arm 4)||5
899206|NCT01787591|2172455|P1|COMPLETED|Period 4 (Cross-over Arm 4)||5
899207|NCT01787591|2172452|P4|STARTED|Period 4 (Cross-over Arm 4)||5
899208|NCT01787591|2172453|P3|STARTED|Period 4 (Cross-over Arm 4)||5
899209|NCT01787591|2172454|P2|STARTED|Period 4 (Cross-over Arm 4)||5
899210|NCT01787591|2172455|P1|STARTED|Period 4 (Cross-over Arm 4)||5
899211|NCT01787591|2172452|P4|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
899212|NCT01787591|2172453|P3|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
899213|NCT01787591|2172454|P2|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
899214|NCT01787591|2172455|P1|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
899215|NCT01787591|2172452|P4|COMPLETED|Period 3 (Cross-over Arm 3)||5
899216|NCT01787591|2172453|P3|COMPLETED|Period 3 (Cross-over Arm 3)||5
899217|NCT01787591|2172454|P2|COMPLETED|Period 3 (Cross-over Arm 3)||5
899218|NCT01787591|2172455|P1|COMPLETED|Period 3 (Cross-over Arm 3)||5
899219|NCT01787591|2172452|P4|STARTED|Period 3 (Cross-over Arm 3)||5
899220|NCT01787591|2172453|P3|STARTED|Period 3 (Cross-over Arm 3)||5
899221|NCT01787591|2172454|P2|STARTED|Period 3 (Cross-over Arm 3)||5
899222|NCT01787591|2172455|P1|STARTED|Period 3 (Cross-over Arm 3)||5
899223|NCT01787591|2172452|P4|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
899224|NCT01787591|2172453|P3|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
899225|NCT01787591|2172454|P2|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
899226|NCT01787591|2172455|P1|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
899227|NCT01787591|2172452|P4|COMPLETED|Period 2 (Cross-over Arm 2)||5
899228|NCT01787591|2172453|P3|COMPLETED|Period 2 (Cross-over Arm 2)||5
899229|NCT01787591|2172454|P2|COMPLETED|Period 2 (Cross-over Arm 2)||5
899230|NCT01787591|2172455|P1|COMPLETED|Period 2 (Cross-over Arm 2)||5
899231|NCT01787591|2172452|P4|STARTED|Period 2 (Cross-over Arm 2)||5
899232|NCT01787591|2172453|P3|STARTED|Period 2 (Cross-over Arm 2)||5
899233|NCT01787591|2172454|P2|STARTED|Period 2 (Cross-over Arm 2)||5
899234|NCT01787591|2172455|P1|STARTED|Period 2 (Cross-over Arm 2)||5
899235|NCT01787591|2172452|P4|NOT COMPLETED|Period 1 (Cross-over Arm 1)||1
899236|NCT01787591|2172453|P3|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
899237|NCT01787591|2172454|P2|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
899238|NCT01787591|2172455|P1|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
899239|NCT01787591|2172452|P4|COMPLETED|Period 1 (Cross-over Arm 1)||5
899240|NCT01787591|2172453|P3|COMPLETED|Period 1 (Cross-over Arm 1)||5
899241|NCT01787591|2172454|P2|COMPLETED|Period 1 (Cross-over Arm 1)||5
899242|NCT01787591|2172455|P1|COMPLETED|Period 1 (Cross-over Arm 1)||5
899243|NCT01787591|2172452|P4|STARTED|Period 1 (Cross-over Arm 1)||6
899244|NCT01787591|2172453|P3|STARTED|Period 1 (Cross-over Arm 1)||5
899245|NCT01787591|2172454|P2|STARTED|Period 1 (Cross-over Arm 1)||5
899246|NCT01787591|2172455|P1|STARTED|Period 1 (Cross-over Arm 1)||5
899247|NCT01787461|2172483|P2|NOT COMPLETED|Overall Study||9
899248|NCT01787461|2172484|P1|NOT COMPLETED|Overall Study||14
899249|NCT01787461|2172483|P2|COMPLETED|Overall Study||89
899250|NCT01787461|2172484|P1|COMPLETED|Overall Study||82
899251|NCT01787461|2172483|P2|STARTED|Overall Study||98
899252|NCT01787461|2172484|P1|STARTED|Overall Study||96
899253|NCT01787383|2172512|P2|NOT COMPLETED|Overall Study||22
899254|NCT01787383|2172513|P1|NOT COMPLETED|Overall Study||9
899255|NCT01787383|2172512|P2|COMPLETED|Overall Study||76
899256|NCT01787383|2172513|P1|COMPLETED|Overall Study||92
899257|NCT01787383|2172512|P2|STARTED|Overall Study||98
899258|NCT01787383|2172513|P1|STARTED|Overall Study||101
899259|NCT01787279|2172533|P1|NOT COMPLETED|Overall Study||3
899260|NCT01787279|2172533|P1|COMPLETED|Overall Study||56
899261|NCT01787279|2172533|P1|STARTED|Overall Study||59
899262|NCT01787240|2172544|P2|NOT COMPLETED|Overall Study||1
899263|NCT01787240|2172545|P1|NOT COMPLETED|Overall Study||5
899264|NCT01787240|2172544|P2|COMPLETED|Overall Study||4
899265|NCT01787240|2172545|P1|COMPLETED|Overall Study||10
899266|NCT01787240|2172544|P2|STARTED|Overall Study||5
899267|NCT01787240|2172545|P1|STARTED|Overall Study||15
899268|NCT01787188|2172559|P3|NOT COMPLETED|Overall Study||18
899269|NCT01787188|2172560|P2|NOT COMPLETED|Overall Study||18
899270|NCT01787188|2172561|P1|NOT COMPLETED|Overall Study||17
899271|NCT01787188|2172559|P3|COMPLETED|Overall Study||116
899272|NCT01787188|2172560|P2|COMPLETED|Overall Study||112
899273|NCT01787188|2172561|P1|COMPLETED|Overall Study||122
899274|NCT01787188|2172559|P3|STARTED|Overall Study||134
899275|NCT01787188|2172560|P2|STARTED|Overall Study||130
899276|NCT01787188|2172561|P1|STARTED|Overall Study||139
899277|NCT01787175|2172616|P2|NOT COMPLETED|Overall Study||0
899278|NCT01787175|2172617|P1|NOT COMPLETED|Overall Study||0
899279|NCT01787175|2172616|P2|COMPLETED|Overall Study||28
899280|NCT01787175|2172617|P1|COMPLETED|Overall Study||30
899281|NCT01787175|2172616|P2|STARTED|Overall Study||28
899282|NCT01787175|2172617|P1|STARTED|Overall Study||30
899283|NCT01787032|2172633|P6|NOT COMPLETED|Overall Study||1
899284|NCT01787032|2172634|P5|NOT COMPLETED|Overall Study||1
899285|NCT01787032|2172635|P4|NOT COMPLETED|Overall Study||0
899286|NCT01787032|2172636|P3|NOT COMPLETED|Overall Study||0
899287|NCT01787032|2172637|P2|NOT COMPLETED|Overall Study||0
899288|NCT01787032|2172638|P1|NOT COMPLETED|Overall Study||0
899289|NCT01787032|2172633|P6|COMPLETED|Overall Study||3
899290|NCT01787032|2172634|P5|COMPLETED|Overall Study||3
899291|NCT01787032|2172635|P4|COMPLETED|Overall Study||3
899292|NCT01787032|2172636|P3|COMPLETED|Overall Study||3
899293|NCT01787032|2172637|P2|COMPLETED|Overall Study||3
899294|NCT01787032|2172638|P1|COMPLETED|Overall Study||3
899295|NCT01787032|2172633|P6|Received T2|Overall Study||4
899296|NCT01787032|2172634|P5|Received T2|Overall Study||4
899297|NCT01787032|2172635|P4|Received T2|Overall Study||3
899298|NCT01787032|2172636|P3|Received T2|Overall Study||3
899299|NCT01787032|2172637|P2|Received T2|Overall Study||3
899300|NCT01787032|2172638|P1|Received T2|Overall Study||3
899301|NCT01787032|2172633|P6|Received T1|Overall Study||4
899302|NCT01787032|2172634|P5|Received T1|Overall Study||3
899303|NCT01787032|2172635|P4|Received T1|Overall Study||3
899304|NCT01787032|2172636|P3|Received T1|Overall Study||3
899305|NCT01787032|2172637|P2|Received T1|Overall Study||3
899306|NCT01787032|2172638|P1|Received T1|Overall Study||3
899307|NCT01787032|2172633|P6|Received R|Overall Study||3
899308|NCT01787032|2172634|P5|Received R|Overall Study||4
899309|NCT01787032|2172635|P4|Received R|Overall Study||3
899310|NCT01787032|2172636|P3|Received R|Overall Study||3
899311|NCT01787032|2172637|P2|Received R|Overall Study||3
899312|NCT01787032|2172638|P1|Received R|Overall Study||3
899313|NCT01787032|2172633|P6|STARTED|Overall Study||4
899314|NCT01787032|2172634|P5|STARTED|Overall Study||4
899315|NCT01787032|2172635|P4|STARTED|Overall Study||3
899316|NCT01787032|2172636|P3|STARTED|Overall Study||3
899317|NCT01787032|2172637|P2|STARTED|Overall Study||3
899318|NCT01787032|2172638|P1|STARTED|Overall Study||3
899319|NCT01786993|2172662|P2|NOT COMPLETED|Overall Study||10
899320|NCT01786993|2172663|P1|NOT COMPLETED|Overall Study||12
899321|NCT01786993|2172662|P2|COMPLETED|Overall Study||170
899322|NCT01786993|2172663|P1|COMPLETED|Overall Study||189
899323|NCT01786993|2172662|P2|Per Protocol Population at 9 Months|Overall Study||170
899324|NCT01786993|2172663|P1|Per Protocol Population at 9 Months|Overall Study||189
899325|NCT01786993|2172662|P2|STARTED|Overall Study||180
899326|NCT01786993|2172663|P1|STARTED|Overall Study||201
899327|NCT01786954|2172670|P2|NOT COMPLETED|Overall Study||0
899328|NCT01786954|2172671|P1|NOT COMPLETED|Overall Study||0
899329|NCT01786954|2172670|P2|COMPLETED|Overall Study||34
899330|NCT01786954|2172671|P1|COMPLETED|Overall Study||34
899331|NCT01786954|2172670|P2|STARTED|Overall Study||34
899332|NCT01786954|2172671|P1|STARTED|Overall Study||34
899339|NCT01786876|2172694|P1|NOT COMPLETED|Overall Study||0
899340|NCT01786876|2172694|P1|COMPLETED|Overall Study||6
899341|NCT01786876|2172694|P1|STARTED|Overall Study||6
899342|NCT01786707|2172713|P2|NOT COMPLETED|Overall Study||1
899343|NCT01786707|2172714|P1|NOT COMPLETED|Overall Study||1
899344|NCT01786707|2172713|P2|COMPLETED|Overall Study||0
899345|NCT01786707|2172714|P1|COMPLETED|Overall Study||0
899346|NCT01786707|2172713|P2|STARTED|Overall Study||1
899347|NCT01786707|2172714|P1|STARTED|Overall Study||1
899348|NCT01786668|2172726|P4|NOT COMPLETED|Overall Study||4
899349|NCT01786668|2172727|P3|NOT COMPLETED|Overall Study||5
899350|NCT01786668|2172728|P2|NOT COMPLETED|Overall Study||1
899351|NCT01786668|2172729|P1|NOT COMPLETED|Overall Study||1
899352|NCT01786668|2172726|P4|COMPLETED|Overall Study||47
899353|NCT01786668|2172727|P3|COMPLETED|Overall Study||47
899354|NCT01786668|2172728|P2|COMPLETED|Overall Study||51
899355|NCT01786668|2172729|P1|COMPLETED|Overall Study||51
899356|NCT01786668|2172726|P4|STARTED|Overall Study||51
899357|NCT01786668|2172727|P3|STARTED|Overall Study||52
899358|NCT01786668|2172728|P2|STARTED|Overall Study||52
899359|NCT01786668|2172729|P1|STARTED|Overall Study||52
899360|NCT01786629|2172829|P2|NOT COMPLETED|Overall Study||5
899361|NCT01786629|2172830|P1|NOT COMPLETED|Overall Study||0
899362|NCT01786629|2172829|P2|COMPLETED|Overall Study||164
899363|NCT01786629|2172830|P1|COMPLETED|Overall Study||169
899364|NCT01786629|2172829|P2|STARTED|Overall Study||169
899365|NCT01786629|2172830|P1|STARTED|Overall Study||169
899366|NCT01786551|2172836|P1|NOT COMPLETED|Overall Study||2
899367|NCT01786551|2172836|P1|COMPLETED|Overall Study||14
899368|NCT01786551|2172836|P1|STARTED|Overall Study||16
899369|NCT01786330|2172844|P2|NOT COMPLETED|Overall Study||3
899370|NCT01786330|2172845|P1|NOT COMPLETED|Overall Study||1
899371|NCT01786330|2172844|P2|COMPLETED|Overall Study||27
899372|NCT01786330|2172845|P1|COMPLETED|Overall Study||29
899373|NCT01786330|2172844|P2|STARTED|Overall Study||30
899374|NCT01786330|2172845|P1|STARTED|Overall Study||30
899375|NCT01786252|2172859|P2|NOT COMPLETED|Overall Study||0
899376|NCT01786252|2172860|P1|NOT COMPLETED|Overall Study||0
899377|NCT01786252|2172859|P2|COMPLETED|Overall Study||8
899378|NCT01786252|2172860|P1|COMPLETED|Overall Study||7
899379|NCT01786252|2172859|P2|STARTED|Overall Study||8
899380|NCT01786252|2172860|P1|STARTED|Overall Study||7
899381|NCT01786239|2172874|P2|NOT COMPLETED|Overall Study||11
899382|NCT01786239|2172875|P1|NOT COMPLETED|Overall Study||11
899383|NCT01786239|2172874|P2|COMPLETED|Overall Study||14
899384|NCT01786239|2172875|P1|COMPLETED|Overall Study||14
899385|NCT01786239|2172874|P2|STARTED|Overall Study||25
899386|NCT01786239|2172875|P1|STARTED|Overall Study||25
899387|NCT01786174|2172883|P2|NOT COMPLETED|Overall Study||0
899388|NCT01786174|2172884|P1|NOT COMPLETED|Overall Study||2
899389|NCT01786174|2172883|P2|COMPLETED|Overall Study||10
899390|NCT01786174|2172884|P1|COMPLETED|Overall Study||16
899391|NCT01786174|2172883|P2|Randomized|Overall Study||11
899392|NCT01786174|2172884|P1|Randomized|Overall Study||19
899393|NCT01786174|2172883|P2|STARTED|Overall Study||10
899394|NCT01786174|2172884|P1|STARTED|Overall Study||18
899395|NCT01786161|2172900|P2|NOT COMPLETED|Overall Study||0
899396|NCT01786161|2172901|P1|NOT COMPLETED|Overall Study||0
899397|NCT01786161|2172900|P2|COMPLETED|Overall Study||22
899398|NCT01786161|2172901|P1|COMPLETED|Overall Study||22
899399|NCT01786161|2172900|P2|STARTED|Overall Study||22
899400|NCT01786161|2172901|P1|STARTED|Overall Study||22
899401|NCT01786109|2172914|P3|NOT COMPLETED|Overall Study||2
899402|NCT01786109|2172915|P2|NOT COMPLETED|Overall Study||0
899403|NCT01786109|2172916|P1|NOT COMPLETED|Overall Study||1
899404|NCT01786109|2172914|P3|COMPLETED|Overall Study||25
899405|NCT01786109|2172915|P2|COMPLETED|Overall Study||24
899406|NCT01786109|2172916|P1|COMPLETED|Overall Study||23
899407|NCT01786109|2172914|P3|STARTED|Overall Study||27
899408|NCT01786109|2172915|P2|STARTED|Overall Study||24
899409|NCT01786109|2172916|P1|STARTED|Overall Study||24
899410|NCT01785875|2172945|P3|NOT COMPLETED|Overall Study||107
899411|NCT01785875|2172946|P2|NOT COMPLETED|Overall Study||289
899412|NCT01785875|2172947|P1|NOT COMPLETED|Overall Study||294
899413|NCT01785875|2172945|P3|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|16
899414|NCT01785875|2172946|P2|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|95
899415|NCT01785875|2172947|P1|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|90
899416|NCT01785875|2172945|P3|Received Etelcalcetide|Overall Study||123
899417|NCT01785875|2172946|P2|Received Etelcalcetide|Overall Study||384
899418|NCT01785875|2172947|P1|Received Etelcalcetide|Overall Study||383
899419|NCT01785875|2172945|P3|STARTED|Overall Study||123
899420|NCT01785875|2172946|P2|STARTED|Overall Study||384
899421|NCT01785875|2172947|P1|STARTED|Overall Study||384
899422|NCT01785849|2173016|P2|NOT COMPLETED|Overall Study||34
899423|NCT01785849|2173017|P1|NOT COMPLETED|Overall Study||61
899424|NCT01785849|2173016|P2|COMPLETED|Overall Study||220
899425|NCT01785849|2173017|P1|COMPLETED|Overall Study||193
899426|NCT01785849|2173016|P2|Received Treatment|Overall Study||251
899427|NCT01785849|2173017|P1|Received Treatment|Overall Study||254
899428|NCT01785849|2173016|P2|STARTED|Overall Study||254
899429|NCT01785849|2173017|P1|STARTED|Overall Study||254
899430|NCT01785628|2173035|P2|NOT COMPLETED|Overall Study||3
899431|NCT01785628|2173036|P1|NOT COMPLETED|Overall Study||2
899432|NCT01785628|2173035|P2|COMPLETED|Overall Study||12
899433|NCT01785628|2173036|P1|COMPLETED|Overall Study||13
899434|NCT01785628|2173035|P2|STARTED|Overall Study||15
899435|NCT01785628|2173036|P1|STARTED|Overall Study||15
899436|NCT01785615|2173059|P4|NOT COMPLETED|Atorvastatin Phase||0
899437|NCT01785615|2173060|P3|NOT COMPLETED|Atorvastatin Phase||0
899438|NCT01785615|2173061|P2|NOT COMPLETED|Atorvastatin Phase||0
899439|NCT01785615|2173062|P1|NOT COMPLETED|Atorvastatin Phase||0
899440|NCT01785615|2173059|P4|COMPLETED|Atorvastatin Phase||0
899441|NCT01785615|2173060|P3|COMPLETED|Atorvastatin Phase||0
899442|NCT01785615|2173061|P2|COMPLETED|Atorvastatin Phase||44
899443|NCT01785615|2173062|P1|COMPLETED|Atorvastatin Phase||44
899444|NCT01785615|2173059|P4|STARTED|Atorvastatin Phase||0
899445|NCT01785615|2173060|P3|STARTED|Atorvastatin Phase||0
899446|NCT01785615|2173061|P2|STARTED|Atorvastatin Phase||44
899447|NCT01785615|2173062|P1|STARTED|Atorvastatin Phase||44
899448|NCT01785615|2173059|P4|NOT COMPLETED|Dietary Phase||24
899449|NCT01785615|2173060|P3|NOT COMPLETED|Dietary Phase||0
899450|NCT01785615|2173061|P2|NOT COMPLETED|Dietary Phase||0
899451|NCT01785615|2173062|P1|NOT COMPLETED|Dietary Phase||0
899452|NCT01785615|2173059|P4|COMPLETED|Dietary Phase||116
899453|NCT01785615|2173060|P3|COMPLETED|Dietary Phase||35
899454|NCT01785615|2173061|P2|COMPLETED|Dietary Phase||0
899455|NCT01785615|2173062|P1|COMPLETED|Dietary Phase||0
899456|NCT01785615|2173059|P4|STARTED|Dietary Phase||140
899457|NCT01785615|2173060|P3|STARTED|Dietary Phase||35
899458|NCT01785615|2173061|P2|STARTED|Dietary Phase||0
899459|NCT01785615|2173062|P1|STARTED|Dietary Phase||0
899460|NCT01785602|2173134|P2|NOT COMPLETED|Overall Study||9
899461|NCT01785602|2173135|P1|NOT COMPLETED|Overall Study||13
899462|NCT01785602|2173134|P2|COMPLETED|Overall Study||18
899463|NCT01785602|2173135|P1|COMPLETED|Overall Study||63
899464|NCT01785602|2173134|P2|STARTED|Overall Study||27
899465|NCT01785602|2173135|P1|STARTED|Overall Study||76
899466|NCT01785524|2173145|P2|NOT COMPLETED|Overall Study||2
899467|NCT01785524|2173146|P1|NOT COMPLETED|Overall Study||2
899468|NCT01785524|2173145|P2|COMPLETED|Overall Study||2
899469|NCT01785524|2173146|P1|COMPLETED|Overall Study||5
899470|NCT01785524|2173145|P2|STARTED|Overall Study||4
899471|NCT01785524|2173146|P1|STARTED|Overall Study||7
899472|NCT01785472|2173165|P3|NOT COMPLETED|Overall Study||22
899473|NCT01785472|2173166|P2|NOT COMPLETED|Overall Study||19
899474|NCT01785472|2173167|P1|NOT COMPLETED|Overall Study||24
899475|NCT01785472|2173165|P3|COMPLETED|Overall Study||464
899476|NCT01785472|2173166|P2|COMPLETED|Overall Study||454
899477|NCT01785472|2173167|P1|COMPLETED|Overall Study||455
899478|NCT01785472|2173165|P3|Safety Set (SAF)|Overall Study||484
899479|NCT01785472|2173166|P2|Safety Set (SAF)|Overall Study||472
899480|NCT01785472|2173167|P1|Safety Set (SAF)|Overall Study||478
899481|NCT01785472|2173165|P3|Full Analysis Set (FAS)|Overall Study||484
899482|NCT01785472|2173166|P2|Full Analysis Set (FAS)|Overall Study||472
899483|NCT01785472|2173167|P1|Full Analysis Set (FAS)|Overall Study||479
899484|NCT01785472|2173165|P3|STARTED|Overall Study||486
899485|NCT01785472|2173166|P2|STARTED|Overall Study||473
899486|NCT01785472|2173167|P1|STARTED|Overall Study||479
899487|NCT01785186|2173214|P5|NOT COMPLETED|Overall Study||6
899488|NCT01785186|2173215|P4|NOT COMPLETED|Overall Study||5
899489|NCT01785186|2173216|P3|NOT COMPLETED|Overall Study||5
899490|NCT01785186|2173217|P2|NOT COMPLETED|Overall Study||6
899491|NCT01785186|2173218|P1|NOT COMPLETED|Overall Study||6
899492|NCT01785186|2173214|P5|COMPLETED|Overall Study||117
899493|NCT01785186|2173215|P4|COMPLETED|Overall Study||58
899494|NCT01785186|2173216|P3|COMPLETED|Overall Study||52
899495|NCT01785186|2173217|P2|COMPLETED|Overall Study||57
899496|NCT01785186|2173218|P1|COMPLETED|Overall Study||53
899497|NCT01785186|2173214|P5|STARTED|Overall Study||123
899498|NCT01785186|2173215|P4|STARTED|Overall Study||63
899499|NCT01785186|2173216|P3|STARTED|Overall Study||57
899500|NCT01785186|2173217|P2|STARTED|Overall Study||63
899501|NCT01785186|2173218|P1|STARTED|Overall Study||59
899502|NCT01785160|2173240|P1|NOT COMPLETED|Treatment Period 2: Raltegravir + Faldap||0
899503|NCT01785160|2173240|P1|COMPLETED|Treatment Period 2: Raltegravir + Faldap||23
899504|NCT01785160|2173240|P1|STARTED|Treatment Period 2: Raltegravir + Faldap||23
899505|NCT01785160|2173240|P1|NOT COMPLETED|Washout Period of at Least 7 Days||1
899506|NCT01785160|2173240|P1|COMPLETED|Washout Period of at Least 7 Days||23
899507|NCT01785160|2173240|P1|STARTED|Washout Period of at Least 7 Days||24
899508|NCT01785160|2173240|P1|NOT COMPLETED|Treatment Period 1: Raltegravir||1
899509|NCT01785160|2173240|P1|COMPLETED|Treatment Period 1: Raltegravir||24
899510|NCT01785160|2173240|P1|STARTED|Treatment Period 1: Raltegravir||25
899511|NCT01785134|2173250|P2|NOT COMPLETED|Overall Study||7
899512|NCT01785134|2173251|P1|NOT COMPLETED|Overall Study||12
899513|NCT01785134|2173250|P2|COMPLETED|Overall Study||33
899514|NCT01785134|2173251|P1|COMPLETED|Overall Study||29
899515|NCT01785134|2173250|P2|STARTED|Overall Study||40
899516|NCT01785134|2173251|P1|STARTED|Overall Study||41
899517|NCT01785095|2173265|P1|NOT COMPLETED|Overall Study||3
899518|NCT01785095|2173265|P1|COMPLETED|Overall Study||24
899519|NCT01785095|2173265|P1|STARTED|Overall Study||27
899520|NCT01784965|2173275|P2|NOT COMPLETED|Overall Study||11
899521|NCT01784965|2173276|P1|NOT COMPLETED|Overall Study||6
899522|NCT01784965|2173275|P2|COMPLETED|Overall Study||24
899523|NCT01784965|2173276|P1|COMPLETED|Overall Study||27
899524|NCT01784965|2173275|P2|STARTED|Overall Study||35
899525|NCT01784965|2173276|P1|STARTED|Overall Study||33
899526|NCT01784666|2173289|P3|NOT COMPLETED|Overall Study||0
899527|NCT01784666|2173290|P2|NOT COMPLETED|Overall Study||0
899528|NCT01784666|2173291|P1|NOT COMPLETED|Overall Study||0
899529|NCT01784666|2173289|P3|COMPLETED|Overall Study||1
899530|NCT01784666|2173290|P2|COMPLETED|Overall Study||0
899531|NCT01784666|2173291|P1|COMPLETED|Overall Study||1
899532|NCT01784666|2173289|P3|STARTED|Overall Study||1
899533|NCT01784666|2173290|P2|STARTED|Overall Study||0
899534|NCT01784666|2173291|P1|STARTED|Overall Study||1
899535|NCT01784614|2173299|P8|NOT COMPLETED|Period 4||0
899536|NCT01784614|2173300|P7|NOT COMPLETED|Period 4||0
899537|NCT01784614|2173301|P6|NOT COMPLETED|Period 4||0
899538|NCT01784614|2173302|P5|NOT COMPLETED|Period 4||0
899539|NCT01784614|2173303|P4|NOT COMPLETED|Period 4||0
899540|NCT01784614|2173304|P3|NOT COMPLETED|Period 4||0
899541|NCT01784614|2173305|P2|NOT COMPLETED|Period 4||0
899542|NCT01784614|2173306|P1|NOT COMPLETED|Period 4||0
899543|NCT01784614|2173299|P8|COMPLETED|Period 4||2
899544|NCT01784614|2173300|P7|COMPLETED|Period 4||3
899545|NCT01784614|2173301|P6|COMPLETED|Period 4||3
899546|NCT01784614|2173302|P5|COMPLETED|Period 4||3
899547|NCT01784614|2173303|P4|COMPLETED|Period 4||3
899548|NCT01784614|2173304|P3|COMPLETED|Period 4||3
899549|NCT01784614|2173305|P2|COMPLETED|Period 4||2
899550|NCT01784614|2173306|P1|COMPLETED|Period 4||3
899551|NCT01784614|2173299|P8|STARTED|Period 4||2
899552|NCT01784614|2173300|P7|STARTED|Period 4||3
899553|NCT01784614|2173301|P6|STARTED|Period 4||3
899554|NCT01784614|2173302|P5|STARTED|Period 4||3
899555|NCT01784614|2173303|P4|STARTED|Period 4||3
899556|NCT01784614|2173304|P3|STARTED|Period 4||3
899557|NCT01784614|2173305|P2|STARTED|Period 4||2
899558|NCT01784614|2173306|P1|STARTED|Period 4||3
899559|NCT01784614|2173299|P8|NOT COMPLETED|Period 3||0
899560|NCT01784614|2173300|P7|NOT COMPLETED|Period 3||0
899561|NCT01784614|2173301|P6|NOT COMPLETED|Period 3||0
899562|NCT01784614|2173302|P5|NOT COMPLETED|Period 3||0
899563|NCT01784614|2173303|P4|NOT COMPLETED|Period 3||0
899564|NCT01784614|2173304|P3|NOT COMPLETED|Period 3||0
899565|NCT01784614|2173305|P2|NOT COMPLETED|Period 3||0
899566|NCT01784614|2173306|P1|NOT COMPLETED|Period 3||0
899567|NCT01784614|2173299|P8|COMPLETED|Period 3||2
899568|NCT01784614|2173300|P7|COMPLETED|Period 3||3
899569|NCT01784614|2173301|P6|COMPLETED|Period 3||3
899570|NCT01784614|2173302|P5|COMPLETED|Period 3||3
899571|NCT01784614|2173303|P4|COMPLETED|Period 3||3
899572|NCT01784614|2173304|P3|COMPLETED|Period 3||3
899573|NCT01784614|2173305|P2|COMPLETED|Period 3||2
899574|NCT01784614|2173306|P1|COMPLETED|Period 3||3
899575|NCT01784614|2173299|P8|STARTED|Period 3||2
899576|NCT01784614|2173300|P7|STARTED|Period 3||3
899577|NCT01784614|2173301|P6|STARTED|Period 3||3
899578|NCT01784614|2173302|P5|STARTED|Period 3||3
899579|NCT01784614|2173303|P4|STARTED|Period 3||3
899580|NCT01784614|2173304|P3|STARTED|Period 3||3
899581|NCT01784614|2173305|P2|STARTED|Period 3||2
899582|NCT01784614|2173306|P1|STARTED|Period 3||3
899583|NCT01784614|2173299|P8|NOT COMPLETED|Period 2||0
899584|NCT01784614|2173300|P7|NOT COMPLETED|Period 2||0
899585|NCT01784614|2173301|P6|NOT COMPLETED|Period 2||0
899586|NCT01784614|2173302|P5|NOT COMPLETED|Period 2||0
899587|NCT01784614|2173303|P4|NOT COMPLETED|Period 2||0
899588|NCT01784614|2173304|P3|NOT COMPLETED|Period 2||0
899589|NCT01784614|2173305|P2|NOT COMPLETED|Period 2||0
899590|NCT01784614|2173306|P1|NOT COMPLETED|Period 2||0
899591|NCT01784614|2173299|P8|COMPLETED|Period 2||2
899592|NCT01784614|2173300|P7|COMPLETED|Period 2||3
899593|NCT01784614|2173301|P6|COMPLETED|Period 2||3
899594|NCT01784614|2173302|P5|COMPLETED|Period 2||3
899595|NCT01784614|2173303|P4|COMPLETED|Period 2||3
899596|NCT01784614|2173304|P3|COMPLETED|Period 2||3
899597|NCT01784614|2173305|P2|COMPLETED|Period 2|One participant withdrew consent after completed Period 2 and did not enter Period 3.|3
899598|NCT01784614|2173306|P1|COMPLETED|Period 2||3
899599|NCT01784614|2173299|P8|STARTED|Period 2||2
899600|NCT01784614|2173300|P7|STARTED|Period 2||3
899601|NCT01784614|2173301|P6|STARTED|Period 2||3
899602|NCT01784614|2173302|P5|STARTED|Period 2||3
899603|NCT01784614|2173303|P4|STARTED|Period 2||3
899604|NCT01784614|2173304|P3|STARTED|Period 2||3
899605|NCT01784614|2173305|P2|STARTED|Period 2||3
899606|NCT01784614|2173306|P1|STARTED|Period 2||3
899607|NCT01784614|2173299|P8|NOT COMPLETED|Period 1||0
899608|NCT01784614|2173300|P7|NOT COMPLETED|Period 1||0
899609|NCT01784614|2173301|P6|NOT COMPLETED|Period 1||0
899610|NCT01784614|2173302|P5|NOT COMPLETED|Period 1||0
899611|NCT01784614|2173303|P4|NOT COMPLETED|Period 1||0
899612|NCT01784614|2173304|P3|NOT COMPLETED|Period 1||0
899613|NCT01784614|2173305|P2|NOT COMPLETED|Period 1||0
899614|NCT01784614|2173306|P1|NOT COMPLETED|Period 1||0
899615|NCT01784614|2173299|P8|COMPLETED|Period 1|One participant withdrew consent after completed Period 1 and did not enter Period 2.|3
899616|NCT01784614|2173300|P7|COMPLETED|Period 1||3
899617|NCT01784614|2173301|P6|COMPLETED|Period 1||3
899618|NCT01784614|2173302|P5|COMPLETED|Period 1||3
899619|NCT01784614|2173303|P4|COMPLETED|Period 1||3
899620|NCT01784614|2173304|P3|COMPLETED|Period 1||3
899621|NCT01784614|2173305|P2|COMPLETED|Period 1||3
899622|NCT01784614|2173306|P1|COMPLETED|Period 1||3
899623|NCT01784614|2173299|P8|Received at Least 1 Dose of Study Drug|Period 1||3
899624|NCT01784614|2173300|P7|Received at Least 1 Dose of Study Drug|Period 1||3
899625|NCT01784614|2173301|P6|Received at Least 1 Dose of Study Drug|Period 1||3
899626|NCT01784614|2173302|P5|Received at Least 1 Dose of Study Drug|Period 1||3
899627|NCT01784614|2173303|P4|Received at Least 1 Dose of Study Drug|Period 1||3
899628|NCT01784614|2173304|P3|Received at Least 1 Dose of Study Drug|Period 1||3
899629|NCT01784614|2173305|P2|Received at Least 1 Dose of Study Drug|Period 1||3
899630|NCT01784614|2173306|P1|Received at Least 1 Dose of Study Drug|Period 1||3
899631|NCT01784614|2173299|P8|STARTED|Period 1||3
899632|NCT01784614|2173300|P7|STARTED|Period 1||3
899633|NCT01784614|2173301|P6|STARTED|Period 1||3
899634|NCT01784614|2173302|P5|STARTED|Period 1||3
899635|NCT01784614|2173303|P4|STARTED|Period 1||3
899636|NCT01784614|2173304|P3|STARTED|Period 1||3
899637|NCT01784614|2173305|P2|STARTED|Period 1||3
899638|NCT01784614|2173306|P1|STARTED|Period 1||3
899639|NCT01783938|2173342|P2|NOT COMPLETED|Overall Study||53
899640|NCT01783938|2173343|P1|NOT COMPLETED|Overall Study||47
899641|NCT01783938|2173342|P2|COMPLETED|Overall Study|Completed=continuing treatment; did not permanently discontinue both study drugs in treatment period|17
899642|NCT01783938|2173343|P1|COMPLETED|Overall Study|Completed=continuing treatment; did not permanently discontinue both study drugs in treatment period|21
899643|NCT01783938|2173342|P2|STARTED|Overall Study||70
899644|NCT01783938|2173343|P1|STARTED|Overall Study||68
899645|NCT01783912|2173358|P3|NOT COMPLETED|Overall Study||23
899646|NCT01783912|2173359|P2|NOT COMPLETED|Overall Study||46
899647|NCT01783912|2173360|P1|NOT COMPLETED|Overall Study||30
899648|NCT01783912|2173358|P3|COMPLETED|Overall Study||25
899649|NCT01783912|2173359|P2|COMPLETED|Overall Study||58
899650|NCT01783912|2173360|P1|COMPLETED|Overall Study||88
899651|NCT01783912|2173358|P3|STARTED|Overall Study||48
899652|NCT01783912|2173359|P2|STARTED|Overall Study||104
899653|NCT01783912|2173360|P1|STARTED|Overall Study||118
899654|NCT01783886|2173371|P3|NOT COMPLETED|Overall Study||10
899655|NCT01783886|2173372|P2|NOT COMPLETED|Overall Study||11
899656|NCT01783886|2173373|P1|NOT COMPLETED|Overall Study||5
899657|NCT01783886|2173371|P3|COMPLETED|Overall Study||117
899658|NCT01783886|2173372|P2|COMPLETED|Overall Study||116
899659|NCT01783886|2173373|P1|COMPLETED|Overall Study||122
899660|NCT01783886|2173371|P3|Participants Received Treatment|Overall Study||124
899661|NCT01783886|2173372|P2|Participants Received Treatment|Overall Study||127
899662|NCT01783886|2173373|P1|Participants Received Treatment|Overall Study||127
899663|NCT01783886|2173371|P3|STARTED|Overall Study||127
899664|NCT01783886|2173372|P2|STARTED|Overall Study||127
899665|NCT01783886|2173373|P1|STARTED|Overall Study||127
899666|NCT01783860|2173401|P2|NOT COMPLETED|Overall Study||0
899667|NCT01783860|2173402|P1|NOT COMPLETED|Overall Study||0
899668|NCT01783860|2173401|P2|COMPLETED|Overall Study||50
899669|NCT01783860|2173402|P1|COMPLETED|Overall Study||50
899670|NCT01783860|2173401|P2|STARTED|Overall Study||50
899671|NCT01783860|2173402|P1|STARTED|Overall Study||50
899672|NCT01783821|2173420|P2|NOT COMPLETED|Overall Study||1
899673|NCT01783821|2173421|P1|NOT COMPLETED|Overall Study||1
899674|NCT01783821|2173420|P2|COMPLETED|Overall Study||30
899675|NCT01783821|2173421|P1|COMPLETED|Overall Study||29
899676|NCT01783821|2173420|P2|STARTED|Overall Study||31
899677|NCT01783821|2173421|P1|STARTED|Overall Study||30
899678|NCT01783730|2173437|P1|NOT COMPLETED|Overall Study||6
899679|NCT01783730|2173437|P1|COMPLETED|Overall Study||157
899680|NCT01783730|2173437|P1|STARTED|Overall Study||163
899681|NCT01783678|2173462|P6|NOT COMPLETED|Overall Study||5
899682|NCT01783678|2173463|P5|NOT COMPLETED|Overall Study||7
899683|NCT01783678|2173464|P4|NOT COMPLETED|Overall Study||8
899684|NCT01783678|2173465|P3|NOT COMPLETED|Overall Study||1
899685|NCT01783678|2173466|P2|NOT COMPLETED|Overall Study||18
899686|NCT01783678|2173467|P1|NOT COMPLETED|Overall Study||2
899687|NCT01783678|2173462|P6|COMPLETED|Overall Study||26
899688|NCT01783678|2173463|P5|COMPLETED|Overall Study||42
899689|NCT01783678|2173464|P4|COMPLETED|Overall Study||50
899690|NCT01783678|2173465|P3|COMPLETED|Overall Study||5
899691|NCT01783678|2173466|P2|COMPLETED|Overall Study||94
899692|NCT01783678|2173467|P1|COMPLETED|Overall Study||17
899693|NCT01783678|2173462|P6|STARTED|Overall Study||31
899694|NCT01783678|2173463|P5|STARTED|Overall Study||49
899695|NCT01783678|2173464|P4|STARTED|Overall Study||58
899696|NCT01783678|2173465|P3|STARTED|Overall Study||6
899697|NCT01783678|2173466|P2|STARTED|Overall Study||112
899698|NCT01783678|2173467|P1|STARTED|Overall Study||19
899699|NCT01783639|2173539|P1|NOT COMPLETED|Overall Study||0
899700|NCT01783639|2173539|P1|COMPLETED|Overall Study||120
899701|NCT01783639|2173539|P1|STARTED|Overall Study||120
899702|NCT01783561|2173545|P2|NOT COMPLETED|Overall Study||0
899703|NCT01783561|2173546|P1|NOT COMPLETED|Overall Study||0
899704|NCT01783561|2173545|P2|COMPLETED|Overall Study||10
899705|NCT01783561|2173546|P1|COMPLETED|Overall Study||11
899706|NCT01783561|2173545|P2|STARTED|Overall Study||10
899707|NCT01783561|2173546|P1|STARTED|Overall Study||11
899708|NCT01783548|2173556|P2|NOT COMPLETED|Overall Study||18
899709|NCT01783548|2173557|P1|NOT COMPLETED|Overall Study||34
899710|NCT01783548|2173556|P2|COMPLETED|Overall Study||167
899711|NCT01783548|2173557|P1|COMPLETED|Overall Study||328
899712|NCT01783548|2173556|P2|Full Analysis Set (FAS)|Overall Study||184
899713|NCT01783548|2173557|P1|Full Analysis Set (FAS)|Overall Study||358
899714|NCT01783548|2173556|P2|STARTED|Overall Study|Randomized|185
899715|NCT01783548|2173557|P1|STARTED|Overall Study|Randomized|362
899716|NCT01783496|2173575|P6|NOT COMPLETED|Overall Study||1
899717|NCT01783496|2173576|P5|NOT COMPLETED|Overall Study||0
899718|NCT01783496|2173577|P4|NOT COMPLETED|Overall Study||2
899719|NCT01783496|2173578|P3|NOT COMPLETED|Overall Study||0
899720|NCT01783496|2173579|P2|NOT COMPLETED|Overall Study||0
899721|NCT01783496|2173580|P1|NOT COMPLETED|Overall Study||1
899722|NCT01783496|2173575|P6|COMPLETED|Overall Study||4
899723|NCT01783496|2173576|P5|COMPLETED|Overall Study||5
899724|NCT01783496|2173577|P4|COMPLETED|Overall Study||8
899725|NCT01783496|2173578|P3|COMPLETED|Overall Study||10
899726|NCT01783496|2173579|P2|COMPLETED|Overall Study||10
899727|NCT01783496|2173580|P1|COMPLETED|Overall Study||9
899728|NCT01783496|2173575|P6|STARTED|Overall Study||5
899729|NCT01783496|2173576|P5|STARTED|Overall Study||5
899730|NCT01783496|2173577|P4|STARTED|Overall Study||10
899731|NCT01783496|2173578|P3|STARTED|Overall Study||10
899732|NCT01783496|2173579|P2|STARTED|Overall Study||10
899733|NCT01783496|2173580|P1|STARTED|Overall Study||10
899734|NCT01783483|2173608|P2|NOT COMPLETED|Overall Study||15
899735|NCT01783483|2173609|P1|NOT COMPLETED|Overall Study||20
899736|NCT01783483|2173608|P2|COMPLETED|Overall Study||101
899737|NCT01783483|2173609|P1|COMPLETED|Overall Study||100
899738|NCT01783483|2173608|P2|STARTED|Overall Study||116
899739|NCT01783483|2173609|P1|STARTED|Overall Study||120
899740|NCT01783470|2173637|P2|NOT COMPLETED|Overall Study||0
899741|NCT01783470|2173638|P1|NOT COMPLETED|Overall Study||0
899742|NCT01783470|2173637|P2|COMPLETED|Overall Study||6
899743|NCT01783470|2173638|P1|COMPLETED|Overall Study||6
899744|NCT01783470|2173637|P2|STARTED|Overall Study|Single-dose|6
899745|NCT01783470|2173638|P1|STARTED|Overall Study||6
899746|NCT01783418|2173647|P2|NOT COMPLETED|Overall Study||0
899747|NCT01783418|2173648|P1|NOT COMPLETED|Overall Study||1
899748|NCT01783418|2173647|P2|COMPLETED|Overall Study||6
899749|NCT01783418|2173648|P1|COMPLETED|Overall Study||7
899750|NCT01783418|2173647|P2|STARTED|Overall Study||6
899751|NCT01783418|2173648|P1|STARTED|Overall Study||8
899752|NCT01783236|2173668|P2|NOT COMPLETED|Overall Study||0
899753|NCT01783236|2173669|P1|NOT COMPLETED|Overall Study||2
899754|NCT01783236|2173668|P2|COMPLETED|Overall Study||8
899755|NCT01783236|2173669|P1|COMPLETED|Overall Study||6
899756|NCT01783236|2173668|P2|STARTED|Overall Study||8
899757|NCT01783236|2173669|P1|STARTED|Overall Study||8
899758|NCT01783080|2173683|P1|NOT COMPLETED|Overall Study||0
899759|NCT01783080|2173683|P1|COMPLETED|Overall Study||16
899760|NCT01783080|2173683|P1|STARTED|Overall Study||16
899761|NCT01783054|2173690|P1|NOT COMPLETED|Overall Study||0
899762|NCT01783054|2173690|P1|COMPLETED|Overall Study||2
899763|NCT01783054|2173690|P1|STARTED|Overall Study||2
899764|NCT01783015|2173701|P3|NOT COMPLETED|Open Label Treatment||6
899765|NCT01783015|2173702|P2|NOT COMPLETED|Open Label Treatment||0
899766|NCT01783015|2173703|P1|NOT COMPLETED|Open Label Treatment||0
899767|NCT01783015|2173701|P3|COMPLETED|Open Label Treatment||5
899768|NCT01783015|2173702|P2|COMPLETED|Open Label Treatment||0
899769|NCT01783015|2173703|P1|COMPLETED|Open Label Treatment||0
899770|NCT01783015|2173701|P3|STARTED|Open Label Treatment||11
899771|NCT01783015|2173702|P2|STARTED|Open Label Treatment||0
899772|NCT01783015|2173703|P1|STARTED|Open Label Treatment||0
899773|NCT01783015|2173701|P3|NOT COMPLETED|Blinded Treatment||0
899774|NCT01783015|2173702|P2|NOT COMPLETED|Blinded Treatment||3
899775|NCT01783015|2173703|P1|NOT COMPLETED|Blinded Treatment||2
899776|NCT01783015|2173701|P3|COMPLETED|Blinded Treatment||0
899777|NCT01783015|2173702|P2|COMPLETED|Blinded Treatment||2
899778|NCT01783015|2173703|P1|COMPLETED|Blinded Treatment||9
899779|NCT01783015|2173701|P3|Treated|Blinded Treatment||0
899780|NCT01783015|2173702|P2|Treated|Blinded Treatment||5
899781|NCT01783015|2173703|P1|Treated|Blinded Treatment||11
899782|NCT01783015|2173701|P3|STARTED|Blinded Treatment||0
899783|NCT01783015|2173702|P2|STARTED|Blinded Treatment||5
899784|NCT01783015|2173703|P1|STARTED|Blinded Treatment||11
899785|NCT01782898|2173790|P2|NOT COMPLETED|Overall Study||6
899786|NCT01782898|2173791|P1|NOT COMPLETED|Overall Study||6
899787|NCT01782898|2173790|P2|COMPLETED|Overall Study||29
899788|NCT01782898|2173791|P1|COMPLETED|Overall Study||29
899789|NCT01782898|2173790|P2|STARTED|Overall Study||35
899790|NCT01782898|2173791|P1|STARTED|Overall Study||35
899791|NCT01782885|2173803|P2|NOT COMPLETED|Overall Study||6
899792|NCT01782885|2173804|P1|NOT COMPLETED|Overall Study||4
899793|NCT01782885|2173803|P2|COMPLETED|Overall Study||33
899794|NCT01782885|2173804|P1|COMPLETED|Overall Study||32
899795|NCT01782885|2173803|P2|STARTED|Overall Study||39
899796|NCT01782885|2173804|P1|STARTED|Overall Study||36
899797|NCT01782872|2173830|P4|NOT COMPLETED|Overall Study||1
899798|NCT01782872|2173831|P3|NOT COMPLETED|Overall Study||0
899799|NCT01782872|2173832|P2|NOT COMPLETED|Overall Study||1
899800|NCT01782872|2173833|P1|NOT COMPLETED|Overall Study||0
899801|NCT01782872|2173830|P4|COMPLETED|Overall Study||19
899802|NCT01782872|2173831|P3|COMPLETED|Overall Study||20
899803|NCT01782872|2173832|P2|COMPLETED|Overall Study||19
899804|NCT01782872|2173833|P1|COMPLETED|Overall Study||20
899805|NCT01782872|2173830|P4|STARTED|Overall Study||20
899806|NCT01782872|2173831|P3|STARTED|Overall Study||20
899807|NCT01782872|2173832|P2|STARTED|Overall Study||20
899808|NCT01782872|2173833|P1|STARTED|Overall Study||20
899809|NCT01782859|2173857|P2|NOT COMPLETED|Overall Study||7
899810|NCT01782859|2173858|P1|NOT COMPLETED|Overall Study||6
899811|NCT01782859|2173857|P2|COMPLETED|Overall Study||13
899812|NCT01782859|2173858|P1|COMPLETED|Overall Study||14
899813|NCT01782859|2173857|P2|STARTED|Overall Study||20
899814|NCT01782859|2173858|P1|STARTED|Overall Study||20
899815|NCT01782742|2173874|P2|NOT COMPLETED|Open Label Phase||0
899816|NCT01782742|2173875|P1|NOT COMPLETED|Open Label Phase||0
899817|NCT01782742|2173874|P2|COMPLETED|Open Label Phase||0
899818|NCT01782742|2173875|P1|COMPLETED|Open Label Phase||19
899819|NCT01782742|2173874|P2|STARTED|Open Label Phase||0
899820|NCT01782742|2173875|P1|STARTED|Open Label Phase||19
899821|NCT01782742|2173874|P2|NOT COMPLETED|Double-blind Treatment Phase||0
899822|NCT01782742|2173875|P1|NOT COMPLETED|Double-blind Treatment Phase||1
899823|NCT01782742|2173874|P2|COMPLETED|Double-blind Treatment Phase||4
899824|NCT01782742|2173875|P1|COMPLETED|Double-blind Treatment Phase||15
899825|NCT01782742|2173874|P2|STARTED|Double-blind Treatment Phase||4
899826|NCT01782742|2173875|P1|STARTED|Double-blind Treatment Phase||16
899827|NCT01782664|2173914|P6|NOT COMPLETED|Overall Study||0
899828|NCT01782664|2173915|P5|NOT COMPLETED|Overall Study||0
899829|NCT01782664|2173916|P4|NOT COMPLETED|Overall Study||5
899830|NCT01782664|2173917|P3|NOT COMPLETED|Overall Study||4
899831|NCT01782664|2173918|P2|NOT COMPLETED|Overall Study||5
899832|NCT01782664|2173919|P1|NOT COMPLETED|Overall Study||6
899833|NCT01782664|2173914|P6|COMPLETED|Overall Study||2
899834|NCT01782664|2173915|P5|COMPLETED|Overall Study||6
899835|NCT01782664|2173916|P4|COMPLETED|Overall Study||9
899836|NCT01782664|2173917|P3|COMPLETED|Overall Study||12
899837|NCT01782664|2173918|P2|COMPLETED|Overall Study||10
899838|NCT01782664|2173919|P1|COMPLETED|Overall Study||8
899839|NCT01782664|2173914|P6|STARTED|Overall Study||2
899840|NCT01782664|2173915|P5|STARTED|Overall Study||6
899841|NCT01782664|2173916|P4|STARTED|Overall Study||14
899842|NCT01782664|2173917|P3|STARTED|Overall Study||16
899843|NCT01782664|2173918|P2|STARTED|Overall Study||15
899844|NCT01782664|2173919|P1|STARTED|Overall Study||14
899845|NCT01782482|2174067|P2|NOT COMPLETED|Overall Study||10
899846|NCT01782482|2174068|P1|NOT COMPLETED|Overall Study||10
899847|NCT01782482|2174067|P2|COMPLETED|Overall Study||270
899848|NCT01782482|2174068|P1|COMPLETED|Overall Study||271
899849|NCT01782482|2174067|P2|STARTED|Overall Study||280
899850|NCT01782482|2174068|P1|STARTED|Overall Study||281
899851|NCT01782469|2174076|P1|NOT COMPLETED|Overall Study||1
899852|NCT01782469|2174076|P1|COMPLETED|Overall Study||15
899853|NCT01782469|2174076|P1|STARTED|Overall Study||16
899854|NCT01782326|2174086|P2|NOT COMPLETED|Double-blind Treatment||320
899855|NCT01782326|2174087|P1|NOT COMPLETED|Double-blind Treatment||278
899856|NCT01782326|2174086|P2|COMPLETED|Double-blind Treatment||1360
899857|NCT01782326|2174087|P1|COMPLETED|Double-blind Treatment||1400
899858|NCT01782326|2174086|P2|STARTED|Double-blind Treatment||1680
899859|NCT01782326|2174087|P1|STARTED|Double-blind Treatment||1678
899860|NCT01782326|2174086|P2|NOT COMPLETED|Planned Treatment Epoch||208
899861|NCT01782326|2174087|P1|NOT COMPLETED|Planned Treatment Epoch||202
899862|NCT01782326|2174086|P2|COMPLETED|Planned Treatment Epoch||1474
899863|NCT01782326|2174087|P1|COMPLETED|Planned Treatment Epoch||1478
899864|NCT01782326|2174086|P2|Urine Cortisol Set|Planned Treatment Epoch||269
899865|NCT01782326|2174087|P1|Urine Cortisol Set|Planned Treatment Epoch||266
899866|NCT01782326|2174086|P2|Safety Set (SAF)|Planned Treatment Epoch||1680
899867|NCT01782326|2174087|P1|Safety Set (SAF)|Planned Treatment Epoch||1678
899868|NCT01782326|2174086|P2|Serial Spirometry Set|Planned Treatment Epoch||279
899869|NCT01782326|2174087|P1|Serial Spirometry Set|Planned Treatment Epoch||280
899870|NCT01782326|2174086|P2|Per-protocol Set (PPS)|Planned Treatment Epoch||1556
899871|NCT01782326|2174087|P1|Per-protocol Set (PPS)|Planned Treatment Epoch||1528
899872|NCT01782326|2174086|P2|Full Analysis Set (FAS)|Planned Treatment Epoch||1679
899873|NCT01782326|2174087|P1|Full Analysis Set (FAS)|Planned Treatment Epoch||1675
899874|NCT01782326|2174086|P2|STARTED|Planned Treatment Epoch||1682
899875|NCT01782326|2174087|P1|STARTED|Planned Treatment Epoch||1680
899876|NCT01782222|2174150|P3|NOT COMPLETED|Overall Study||4
899877|NCT01782222|2174151|P2|NOT COMPLETED|Overall Study||11
899878|NCT01782222|2174152|P1|NOT COMPLETED|Overall Study||8
899879|NCT01782222|2174150|P3|COMPLETED|Overall Study||37
899880|NCT01782222|2174151|P2|COMPLETED|Overall Study||30
899881|NCT01782222|2174152|P1|COMPLETED|Overall Study||32
899882|NCT01782222|2174150|P3|STARTED|Overall Study||41
899883|NCT01782222|2174151|P2|STARTED|Overall Study||41
899884|NCT01782222|2174152|P1|STARTED|Overall Study||40
899885|NCT01781962|2174184|P1|NOT COMPLETED|Overall Study||5
899886|NCT01781962|2174184|P1|COMPLETED|Overall Study||201
899887|NCT01781962|2174184|P1|STARTED|Overall Study||206
899888|NCT01781806|2174192|P2|NOT COMPLETED|Overall Study||3
899889|NCT01781806|2174193|P1|NOT COMPLETED|Overall Study||75
899890|NCT01781806|2174192|P2|COMPLETED|Overall Study||1
899891|NCT01781806|2174193|P1|COMPLETED|Overall Study||222
899892|NCT01781806|2174192|P2|Week 36 Visit|Overall Study||1
899893|NCT01781806|2174193|P1|Week 36 Visit|Overall Study||247
899894|NCT01781806|2174192|P2|Week 24 Visit|Overall Study||1
899895|NCT01781806|2174193|P1|Week 24 Visit|Overall Study||259
899896|NCT01781806|2174192|P2|Week 12 Visit|Overall Study||2
899897|NCT01781806|2174193|P1|Week 12 Visit|Overall Study||273
899898|NCT01781806|2174192|P2|Week 8 Visit|Overall Study||4
899899|NCT01781806|2174193|P1|Week 8 Visit|Overall Study||277
899900|NCT01781806|2174192|P2|Week 4 Visit|Overall Study||4
899901|NCT01781806|2174193|P1|Week 4 Visit|Overall Study||284
899902|NCT01781806|2174192|P2|STARTED|Overall Study||4
899903|NCT01781806|2174193|P1|STARTED|Overall Study||297
899904|NCT01781637|2174203|P2|NOT COMPLETED|Overall Study||6
899905|NCT01781637|2174204|P1|NOT COMPLETED|Overall Study||4
899906|NCT01781637|2174203|P2|COMPLETED|Overall Study||2
899907|NCT01781637|2174204|P1|COMPLETED|Overall Study||24
899908|NCT01781637|2174203|P2|STARTED|Overall Study||8
899909|NCT01781637|2174204|P1|STARTED|Overall Study||28
899910|NCT01781481|2174212|P1|NOT COMPLETED|Overall Study||0
899911|NCT01781481|2174212|P1|COMPLETED|Overall Study||148
899912|NCT01781481|2174212|P1|STARTED|Overall Study||148
899913|NCT01781403|2174271|P3|NOT COMPLETED|Overall Study||0
899914|NCT01781403|2174272|P2|NOT COMPLETED|Overall Study||0
899915|NCT01781403|2174273|P1|NOT COMPLETED|Overall Study||0
899916|NCT01781403|2174271|P3|COMPLETED|Overall Study||18
899917|NCT01781403|2174272|P2|COMPLETED|Overall Study||2
899918|NCT01781403|2174273|P1|COMPLETED|Overall Study||2
899919|NCT01781403|2174271|P3|STARTED|Overall Study||18
899920|NCT01781403|2174272|P2|STARTED|Overall Study||2
899921|NCT01781403|2174273|P1|STARTED|Overall Study||2
899922|NCT01781299|2174291|P2|NOT COMPLETED|Overall Study||1
899923|NCT01781299|2174292|P1|NOT COMPLETED|Overall Study||0
899924|NCT01781299|2174291|P2|COMPLETED|Overall Study||4
899925|NCT01781299|2174292|P1|COMPLETED|Overall Study||4
899926|NCT01781299|2174291|P2|STARTED|Overall Study||5
899927|NCT01781299|2174292|P1|STARTED|Overall Study||4
899928|NCT01781208|2174300|P1|NOT COMPLETED|Overall Study||0
899929|NCT01781208|2174300|P1|COMPLETED|Overall Study||62
899930|NCT01781208|2174300|P1|Overall Study|Overall Study||62
899931|NCT01781208|2174300|P1|STARTED|Overall Study||62
899932|NCT01781169|2174307|P2|NOT COMPLETED|Overall Study||0
899933|NCT01781169|2174308|P1|NOT COMPLETED|Overall Study||1
899934|NCT01781169|2174307|P2|COMPLETED|Overall Study||21
899935|NCT01781169|2174308|P1|COMPLETED|Overall Study||21
899936|NCT01781169|2174307|P2|STARTED|Overall Study||21
899937|NCT01781169|2174308|P1|STARTED|Overall Study||22
899938|NCT01781078|2174316|P3|NOT COMPLETED|Overall Study||16
899939|NCT01781078|2174317|P2|NOT COMPLETED|Overall Study||5
899940|NCT01781078|2174318|P1|NOT COMPLETED|Overall Study||12
899941|NCT01781078|2174316|P3|COMPLETED|Overall Study||0
899942|NCT01781078|2174317|P2|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|113
899943|NCT01781078|2174318|P1|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|217
899944|NCT01781078|2174316|P3|STARTED|Overall Study||16
899945|NCT01781078|2174317|P2|STARTED|Overall Study|Randomized post implantation|118
899946|NCT01781078|2174318|P1|STARTED|Overall Study|Randomized post implantation|229
899947|NCT01781026|2174328|P1|NOT COMPLETED|Overall Study||2
899948|NCT01781026|2174328|P1|COMPLETED|Overall Study||0
899949|NCT01781026|2174328|P1|STARTED|Overall Study||2
899950|NCT01780987|2174334|P2|NOT COMPLETED|Overall Study||6
899951|NCT01780987|2174335|P1|NOT COMPLETED|Overall Study||3
899952|NCT01780987|2174334|P2|COMPLETED|Overall Study||34
899953|NCT01780987|2174335|P1|COMPLETED|Overall Study||37
899954|NCT01780987|2174334|P2|STARTED|Overall Study|Including one participant who withdrew from the study prior to receiving any study medication.|40
899955|NCT01780987|2174335|P1|STARTED|Overall Study||40
899956|NCT01780974|2174353|P2|NOT COMPLETED|Overall Study||3
899957|NCT01780974|2174354|P1|NOT COMPLETED|Overall Study||2
899958|NCT01780974|2174353|P2|COMPLETED|Overall Study||18
899959|NCT01780974|2174354|P1|COMPLETED|Overall Study||19
899960|NCT01780974|2174353|P2|STARTED|Overall Study||21
899961|NCT01780974|2174354|P1|STARTED|Overall Study||21
899962|NCT01780935|2174364|P2|NOT COMPLETED|Overall Study||336
899963|NCT01780935|2174365|P1|NOT COMPLETED|Overall Study||335
899964|NCT01780935|2174364|P2|COMPLETED|Overall Study||0
899965|NCT01780935|2174365|P1|COMPLETED|Overall Study||0
899966|NCT01780935|2174364|P2|Safety Set|Overall Study||336
899967|NCT01780935|2174365|P1|Safety Set|Overall Study||334
899968|NCT01780935|2174364|P2|STARTED|Overall Study||336
899969|NCT01780935|2174365|P1|STARTED|Overall Study||335
899970|NCT01780922|2174395|P6|NOT COMPLETED|Third Intervention (1 Day)||0
899971|NCT01780922|2174396|P5|NOT COMPLETED|Third Intervention (1 Day)||0
899972|NCT01780922|2174397|P4|NOT COMPLETED|Third Intervention (1 Day)||0
899973|NCT01780922|2174398|P3|NOT COMPLETED|Third Intervention (1 Day)||0
899974|NCT01780922|2174399|P2|NOT COMPLETED|Third Intervention (1 Day)||0
899975|NCT01780922|2174400|P1|NOT COMPLETED|Third Intervention (1 Day)||0
899976|NCT01780922|2174395|P6|COMPLETED|Third Intervention (1 Day)||2
899977|NCT01780922|2174396|P5|COMPLETED|Third Intervention (1 Day)||2
899978|NCT01780922|2174397|P4|COMPLETED|Third Intervention (1 Day)||2
899979|NCT01780922|2174398|P3|COMPLETED|Third Intervention (1 Day)||2
899980|NCT01780922|2174399|P2|COMPLETED|Third Intervention (1 Day)||2
899981|NCT01780922|2174400|P1|COMPLETED|Third Intervention (1 Day)||2
899982|NCT01780922|2174395|P6|STARTED|Third Intervention (1 Day)||2
899983|NCT01780922|2174396|P5|STARTED|Third Intervention (1 Day)||2
899984|NCT01780922|2174397|P4|STARTED|Third Intervention (1 Day)||2
899985|NCT01780922|2174398|P3|STARTED|Third Intervention (1 Day)||2
899986|NCT01780922|2174399|P2|STARTED|Third Intervention (1 Day)||2
899987|NCT01780922|2174400|P1|STARTED|Third Intervention (1 Day)||2
899988|NCT01780922|2174395|P6|NOT COMPLETED|Washout (7 Days)||0
899989|NCT01780922|2174396|P5|NOT COMPLETED|Washout (7 Days)||0
899990|NCT01780922|2174397|P4|NOT COMPLETED|Washout (7 Days)||0
899991|NCT01780922|2174398|P3|NOT COMPLETED|Washout (7 Days)||0
899992|NCT01780922|2174399|P2|NOT COMPLETED|Washout (7 Days)||0
899993|NCT01780922|2174400|P1|NOT COMPLETED|Washout (7 Days)||0
899994|NCT01780922|2174395|P6|COMPLETED|Washout (7 Days)||2
899995|NCT01780922|2174396|P5|COMPLETED|Washout (7 Days)||2
899996|NCT01780922|2174397|P4|COMPLETED|Washout (7 Days)||2
899997|NCT01780922|2174398|P3|COMPLETED|Washout (7 Days)||2
899998|NCT01780922|2174399|P2|COMPLETED|Washout (7 Days)||2
899999|NCT01780922|2174400|P1|COMPLETED|Washout (7 Days)||2
900000|NCT01780922|2174395|P6|STARTED|Washout (7 Days)||2
900001|NCT01780922|2174396|P5|STARTED|Washout (7 Days)||2
900002|NCT01780922|2174397|P4|STARTED|Washout (7 Days)||2
900003|NCT01780922|2174398|P3|STARTED|Washout (7 Days)||2
900004|NCT01780922|2174399|P2|STARTED|Washout (7 Days)||2
900005|NCT01780922|2174400|P1|STARTED|Washout (7 Days)||2
900006|NCT01780922|2174395|P6|NOT COMPLETED|Second Intervention (1 Day)||0
900007|NCT01780922|2174396|P5|NOT COMPLETED|Second Intervention (1 Day)||0
900008|NCT01780922|2174397|P4|NOT COMPLETED|Second Intervention (1 Day)||0
900009|NCT01780922|2174398|P3|NOT COMPLETED|Second Intervention (1 Day)||0
900010|NCT01780922|2174399|P2|NOT COMPLETED|Second Intervention (1 Day)||0
900011|NCT01780922|2174400|P1|NOT COMPLETED|Second Intervention (1 Day)||0
900012|NCT01780922|2174395|P6|COMPLETED|Second Intervention (1 Day)||2
900013|NCT01780922|2174396|P5|COMPLETED|Second Intervention (1 Day)||2
900014|NCT01780922|2174397|P4|COMPLETED|Second Intervention (1 Day)||2
900015|NCT01780922|2174398|P3|COMPLETED|Second Intervention (1 Day)||2
900016|NCT01780922|2174399|P2|COMPLETED|Second Intervention (1 Day)||2
900017|NCT01780922|2174400|P1|COMPLETED|Second Intervention (1 Day)||2
900018|NCT01780922|2174395|P6|STARTED|Second Intervention (1 Day)||2
900019|NCT01780922|2174396|P5|STARTED|Second Intervention (1 Day)||2
900020|NCT01780922|2174397|P4|STARTED|Second Intervention (1 Day)||2
900021|NCT01780922|2174398|P3|STARTED|Second Intervention (1 Day)||2
900022|NCT01780922|2174399|P2|STARTED|Second Intervention (1 Day)||2
900023|NCT01780922|2174400|P1|STARTED|Second Intervention (1 Day)||2
900024|NCT01780922|2174395|P6|NOT COMPLETED|Washout (7 Days)||0
900025|NCT01780922|2174396|P5|NOT COMPLETED|Washout (7 Days)||0
900026|NCT01780922|2174397|P4|NOT COMPLETED|Washout (7 Days)||0
900027|NCT01780922|2174398|P3|NOT COMPLETED|Washout (7 Days)||0
900028|NCT01780922|2174399|P2|NOT COMPLETED|Washout (7 Days)||0
900029|NCT01780922|2174400|P1|NOT COMPLETED|Washout (7 Days)||0
900030|NCT01780922|2174395|P6|COMPLETED|Washout (7 Days)||2
900031|NCT01780922|2174396|P5|COMPLETED|Washout (7 Days)||2
900032|NCT01780922|2174397|P4|COMPLETED|Washout (7 Days)||2
900033|NCT01780922|2174398|P3|COMPLETED|Washout (7 Days)||2
900034|NCT01780922|2174399|P2|COMPLETED|Washout (7 Days)||2
900035|NCT01780922|2174400|P1|COMPLETED|Washout (7 Days)||2
900036|NCT01780922|2174395|P6|STARTED|Washout (7 Days)||2
900037|NCT01780922|2174396|P5|STARTED|Washout (7 Days)||2
900038|NCT01780922|2174397|P4|STARTED|Washout (7 Days)||2
900039|NCT01780922|2174398|P3|STARTED|Washout (7 Days)||2
900040|NCT01780922|2174399|P2|STARTED|Washout (7 Days)||2
900041|NCT01780922|2174400|P1|STARTED|Washout (7 Days)||2
900042|NCT01780922|2174395|P6|NOT COMPLETED|First Intervention (1 Day)||0
900043|NCT01780922|2174396|P5|NOT COMPLETED|First Intervention (1 Day)||0
900044|NCT01780922|2174397|P4|NOT COMPLETED|First Intervention (1 Day)||0
900045|NCT01780922|2174398|P3|NOT COMPLETED|First Intervention (1 Day)||0
900046|NCT01780922|2174399|P2|NOT COMPLETED|First Intervention (1 Day)||0
900047|NCT01780922|2174400|P1|NOT COMPLETED|First Intervention (1 Day)||0
900048|NCT01780922|2174395|P6|COMPLETED|First Intervention (1 Day)||2
900049|NCT01780922|2174396|P5|COMPLETED|First Intervention (1 Day)||2
900050|NCT01780922|2174397|P4|COMPLETED|First Intervention (1 Day)||2
900051|NCT01780922|2174398|P3|COMPLETED|First Intervention (1 Day)||2
900052|NCT01780922|2174399|P2|COMPLETED|First Intervention (1 Day)||2
900053|NCT01780922|2174400|P1|COMPLETED|First Intervention (1 Day)||2
900054|NCT01780922|2174395|P6|STARTED|First Intervention (1 Day)||2
900055|NCT01780922|2174396|P5|STARTED|First Intervention (1 Day)||2
900056|NCT01780922|2174397|P4|STARTED|First Intervention (1 Day)||2
900057|NCT01780922|2174398|P3|STARTED|First Intervention (1 Day)||2
900058|NCT01780922|2174399|P2|STARTED|First Intervention (1 Day)||2
900059|NCT01780922|2174400|P1|STARTED|First Intervention (1 Day)||2
900060|NCT01780870|2174455|P2|NOT COMPLETED|Overall Study||0
900061|NCT01780870|2174456|P1|NOT COMPLETED|Overall Study||0
900062|NCT01780870|2174455|P2|COMPLETED|Overall Study||5
900063|NCT01780870|2174456|P1|COMPLETED|Overall Study||0
900064|NCT01780870|2174455|P2|STARTED|Overall Study||5
900065|NCT01780870|2174456|P1|STARTED|Overall Study||0
900066|NCT01780584|2174469|P3|NOT COMPLETED|Overall Study||2
900067|NCT01780584|2174470|P2|NOT COMPLETED|Overall Study||1
900068|NCT01780584|2174471|P1|NOT COMPLETED|Overall Study||1
900069|NCT01780584|2174469|P3|COMPLETED|Overall Study||13
900070|NCT01780584|2174470|P2|COMPLETED|Overall Study||14
900071|NCT01780584|2174471|P1|COMPLETED|Overall Study||14
900072|NCT01780584|2174469|P3|STARTED|Overall Study||15
900073|NCT01780584|2174470|P2|STARTED|Overall Study||15
900074|NCT01780584|2174471|P1|STARTED|Overall Study||15
900075|NCT01780506|2174493|P2|NOT COMPLETED|Overall Study||434
900076|NCT01780506|2174494|P1|NOT COMPLETED|Overall Study||438
900077|NCT01780506|2174493|P2|COMPLETED|Overall Study||0
900078|NCT01780506|2174494|P1|COMPLETED|Overall Study||0
900079|NCT01780506|2174493|P2|STARTED|Overall Study||434
900080|NCT01780506|2174494|P1|STARTED|Overall Study||438
900081|NCT01780389|2174532|P1|NOT COMPLETED|Overall Study||1
900082|NCT01780389|2174532|P1|COMPLETED|Overall Study|One patient discontinued due to adverse event.|4
900083|NCT01780389|2174532|P1|STARTED|Overall Study||5
900084|NCT01780350|2174543|P1|NOT COMPLETED|Overall Study||0
900085|NCT01780350|2174543|P1|COMPLETED|Overall Study||200
900086|NCT01780350|2174543|P1|STARTED|Overall Study||200
900087|NCT01780337|2174550|P2|NOT COMPLETED|Overall Study||0
900088|NCT01780337|2174551|P1|NOT COMPLETED|Overall Study||0
900089|NCT01780337|2174550|P2|COMPLETED|Overall Study||6
900090|NCT01780337|2174551|P1|COMPLETED|Overall Study||6
900091|NCT01780337|2174550|P2|STARTED|Overall Study||6
900092|NCT01780337|2174551|P1|STARTED|Overall Study||6
900093|NCT01780324|2174563|P2|NOT COMPLETED|Overall Study||6
900094|NCT01780324|2174564|P1|NOT COMPLETED|Overall Study||1
900095|NCT01780324|2174563|P2|COMPLETED|Overall Study||33
900096|NCT01780324|2174564|P1|COMPLETED|Overall Study||40
900097|NCT01780324|2174563|P2|STARTED|Overall Study||39
900098|NCT01780324|2174564|P1|STARTED|Overall Study||41
900099|NCT01779648|2174572|P2|NOT COMPLETED|Overall Study||0
900100|NCT01779648|2174573|P1|NOT COMPLETED|Overall Study||1
900101|NCT01779648|2174572|P2|COMPLETED|Overall Study||27
900102|NCT01779648|2174573|P1|COMPLETED|Overall Study||27
900103|NCT01779648|2174572|P2|STARTED|Overall Study||27
900104|NCT01779648|2174573|P1|STARTED|Overall Study||28
900105|NCT01779219|2174603|P2|NOT COMPLETED|Overall Study||0
900106|NCT01779219|2174604|P1|NOT COMPLETED|Overall Study||0
900107|NCT01779219|2174603|P2|COMPLETED|Overall Study|First interim analysis|21
900108|NCT01779219|2174604|P1|COMPLETED|Overall Study|First interim analysis|21
900109|NCT01779219|2174603|P2|STARTED|Overall Study|First interim analysis|21
900110|NCT01779219|2174604|P1|STARTED|Overall Study|First interim analysis|21
900111|NCT01779167|2174616|P1|NOT COMPLETED|Overall Study||1
900112|NCT01779167|2174616|P1|COMPLETED|Overall Study||3
900113|NCT01779167|2174616|P1|STARTED|Overall Study||4
900114|NCT01778985|2174623|P2|NOT COMPLETED|Overall Study||3
900115|NCT01778985|2174624|P1|NOT COMPLETED|Overall Study||7
900116|NCT01778985|2174623|P2|COMPLETED|Overall Study||12
900117|NCT01778985|2174624|P1|COMPLETED|Overall Study||8
900118|NCT01778985|2174623|P2|STARTED|Overall Study||15
900119|NCT01778985|2174624|P1|STARTED|Overall Study||15
900120|NCT01778855|2174670|P2|NOT COMPLETED|Overall Study||1
900121|NCT01778855|2174671|P1|NOT COMPLETED|Overall Study||0
900122|NCT01778855|2174670|P2|COMPLETED|Overall Study||3
900123|NCT01778855|2174671|P1|COMPLETED|Overall Study||2
900124|NCT01778855|2174670|P2|STARTED|Overall Study||4
900125|NCT01778855|2174671|P1|STARTED|Overall Study||2
900126|NCT01778751|2174679|P2|NOT COMPLETED|Overall Study||2
900127|NCT01778751|2174680|P1|NOT COMPLETED|Overall Study||2
900128|NCT01778751|2174679|P2|COMPLETED|Overall Study||23
900129|NCT01778751|2174680|P1|COMPLETED|Overall Study||23
900130|NCT01778751|2174679|P2|STARTED|Overall Study||25
900131|NCT01778751|2174680|P1|STARTED|Overall Study||25
900132|NCT01778530|2174692|P1|NOT COMPLETED|Overall Study||2
900133|NCT01778530|2174692|P1|COMPLETED|Overall Study||0
900134|NCT01778530|2174692|P1|STARTED|Overall Study||2
900135|NCT01778296|2174697|P1|NOT COMPLETED|Overall Study||0
900136|NCT01778296|2174697|P1|COMPLETED|Overall Study|No patient was lost to follow-up.|12
900137|NCT01778296|2174697|P1|STARTED|Overall Study|There were 12 patients included in the study in the initial stage.|12
900138|NCT01778127|2174704|P3|NOT COMPLETED|Overall Study||6
900139|NCT01778127|2174705|P2|NOT COMPLETED|Overall Study||2
900140|NCT01778127|2174706|P1|NOT COMPLETED|Overall Study||8
900141|NCT01778127|2174704|P3|COMPLETED|Overall Study||26
900142|NCT01778127|2174705|P2|COMPLETED|Overall Study||31
900143|NCT01778127|2174706|P1|COMPLETED|Overall Study||25
900144|NCT01778127|2174704|P3|STARTED|Overall Study||32
900145|NCT01778127|2174705|P2|STARTED|Overall Study||33
900146|NCT01778127|2174706|P1|STARTED|Overall Study||33
900147|NCT01778062|2174749|P2|NOT COMPLETED|Overall Study||11
900148|NCT01778062|2174750|P1|NOT COMPLETED|Overall Study||6
900149|NCT01778062|2174749|P2|COMPLETED|Overall Study||57
900150|NCT01778062|2174750|P1|COMPLETED|Overall Study||62
900151|NCT01778062|2174749|P2|Intent to Treat (ITT)|Overall Study|One failed to perform primary efficacy evaluation and was excluded, 135 were included in the ITT set|67
900152|NCT01778062|2174750|P1|Intent to Treat (ITT)|Overall Study||68
900153|NCT01778062|2174749|P2|Safety Set|Overall Study||68
900154|NCT01778062|2174750|P1|Safety Set|Overall Study||68
900155|NCT01778062|2174749|P2|STARTED|Overall Study||68
900156|NCT01778062|2174750|P1|STARTED|Overall Study||68
900157|NCT01778049|2174764|P6|NOT COMPLETED|Double Blind Treatment Period||7
900158|NCT01778049|2174765|P5|NOT COMPLETED|Double Blind Treatment Period||12
900159|NCT01778049|2174766|P4|NOT COMPLETED|Double Blind Treatment Period||12
900160|NCT01778049|2174767|P3|NOT COMPLETED|Double Blind Treatment Period||15
900161|NCT01778049|2174768|P2|NOT COMPLETED|Double Blind Treatment Period||0
900162|NCT01778049|2174769|P1|NOT COMPLETED|Double Blind Treatment Period||0
900163|NCT01778049|2174764|P6|COMPLETED|Double Blind Treatment Period||105
900164|NCT01778049|2174765|P5|COMPLETED|Double Blind Treatment Period||102
900165|NCT01778049|2174766|P4|COMPLETED|Double Blind Treatment Period||118
900166|NCT01778049|2174767|P3|COMPLETED|Double Blind Treatment Period||111
900167|NCT01778049|2174768|P2|COMPLETED|Double Blind Treatment Period||0
900168|NCT01778049|2174769|P1|COMPLETED|Double Blind Treatment Period||0
900169|NCT01778049|2174764|P6|STARTED|Double Blind Treatment Period||112
900170|NCT01778049|2174765|P5|STARTED|Double Blind Treatment Period||114
900171|NCT01778049|2174766|P4|STARTED|Double Blind Treatment Period||130
900172|NCT01778049|2174767|P3|STARTED|Double Blind Treatment Period||126
900173|NCT01778049|2174768|P2|STARTED|Double Blind Treatment Period||0
900174|NCT01778049|2174769|P1|STARTED|Double Blind Treatment Period||0
900175|NCT01778049|2174764|P6|NOT COMPLETED|Open Label Treatment Period||0
900176|NCT01778049|2174765|P5|NOT COMPLETED|Open Label Treatment Period||0
900177|NCT01778049|2174766|P4|NOT COMPLETED|Open Label Treatment Period||0
900178|NCT01778049|2174767|P3|NOT COMPLETED|Open Label Treatment Period||0
900179|NCT01778049|2174768|P2|NOT COMPLETED|Open Label Treatment Period||129
900180|NCT01778049|2174769|P1|NOT COMPLETED|Open Label Treatment Period||98
900181|NCT01778049|2174764|P6|COMPLETED|Open Label Treatment Period||0
900182|NCT01778049|2174765|P5|COMPLETED|Open Label Treatment Period||0
900183|NCT01778049|2174766|P4|COMPLETED|Open Label Treatment Period||0
900184|NCT01778049|2174767|P3|COMPLETED|Open Label Treatment Period||0
900185|NCT01778049|2174768|P2|COMPLETED|Open Label Treatment Period||226
900186|NCT01778049|2174769|P1|COMPLETED|Open Label Treatment Period||256
900187|NCT01778049|2174764|P6|STARTED|Open Label Treatment Period||0
900188|NCT01778049|2174765|P5|STARTED|Open Label Treatment Period||0
900189|NCT01778049|2174766|P4|STARTED|Open Label Treatment Period||0
900190|NCT01778049|2174767|P3|STARTED|Open Label Treatment Period||0
900191|NCT01778049|2174768|P2|STARTED|Open Label Treatment Period||355
900192|NCT01778049|2174769|P1|STARTED|Open Label Treatment Period||354
900193|NCT01778023|2174787|P2|NOT COMPLETED|Overall Study||3
900194|NCT01778023|2174788|P1|NOT COMPLETED|Overall Study||0
900195|NCT01778023|2174787|P2|COMPLETED|Overall Study||15
900196|NCT01778023|2174788|P1|COMPLETED|Overall Study||36
900197|NCT01778023|2174787|P2|Exposed|Overall Study||15
900198|NCT01778023|2174788|P1|Exposed|Overall Study||36
900199|NCT01778023|2174787|P2|STARTED|Overall Study||18
900200|NCT01778023|2174788|P1|STARTED|Overall Study||36
900201|NCT01777945|2174805|P1|NOT COMPLETED|Overall Study||0
900202|NCT01777945|2174805|P1|COMPLETED|Overall Study||46
900203|NCT01777945|2174805|P1|Evaluable Participants|Overall Study||45
900204|NCT01777945|2174805|P1|STARTED|Overall Study||46
900205|NCT01777932|2174815|P1|NOT COMPLETED|Overall Study||205
900206|NCT01777932|2174815|P1|COMPLETED|Overall Study||15
900207|NCT01777932|2174815|P1|STARTED|Overall Study||220
900208|NCT01777776|2174833|P4|NOT COMPLETED|Overall Study||4
900209|NCT01777776|2174834|P3|NOT COMPLETED|Overall Study||6
900210|NCT01777776|2174835|P2|NOT COMPLETED|Overall Study||12
900211|NCT01777776|2174836|P1|NOT COMPLETED|Overall Study||6
900212|NCT01777776|2174833|P4|COMPLETED|Overall Study||0
900213|NCT01777776|2174834|P3|COMPLETED|Overall Study||0
900214|NCT01777776|2174835|P2|COMPLETED|Overall Study||0
900215|NCT01777776|2174836|P1|COMPLETED|Overall Study||0
900216|NCT01777776|2174833|P4|STARTED|Overall Study||4
900217|NCT01777776|2174834|P3|STARTED|Overall Study||6
900218|NCT01777776|2174835|P2|STARTED|Overall Study||12
900219|NCT01777776|2174836|P1|STARTED|Overall Study||6
900220|NCT01777763|2174895|P2|NOT COMPLETED|Overall Study||47
900221|NCT01777763|2174896|P1|NOT COMPLETED|Overall Study||4
900222|NCT01777763|2174895|P2|COMPLETED|Overall Study||163
900223|NCT01777763|2174896|P1|COMPLETED|Overall Study||16
900224|NCT01777763|2174895|P2|STARTED|Overall Study||210
900225|NCT01777763|2174896|P1|STARTED|Overall Study||20
900226|NCT01777620|2174920|P2|NOT COMPLETED|Overall Study||0
900227|NCT01777620|2174921|P1|NOT COMPLETED|Overall Study||1
900228|NCT01777620|2174920|P2|COMPLETED|Overall Study||62
900229|NCT01777620|2174921|P1|COMPLETED|Overall Study||62
900230|NCT01777620|2174920|P2|STARTED|Overall Study||62
900231|NCT01777620|2174921|P1|STARTED|Overall Study||63
900232|NCT01777581|2174947|P2|NOT COMPLETED|Overall Study||2
900233|NCT01777581|2174948|P1|NOT COMPLETED|Overall Study||3
900234|NCT01777581|2174947|P2|COMPLETED|Overall Study||3
900235|NCT01777581|2174948|P1|COMPLETED|Overall Study||5
900236|NCT01777581|2174947|P2|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|5
900237|NCT01777581|2174948|P1|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|8
900238|NCT01777438|2174968|P2|NOT COMPLETED|Overall Study||0
900239|NCT01777438|2174969|P1|NOT COMPLETED|Overall Study||0
900240|NCT01777438|2174968|P2|COMPLETED|Overall Study||82
900241|NCT01777438|2174969|P1|COMPLETED|Overall Study||352
900242|NCT01777438|2174968|P2|STARTED|Overall Study||82
900243|NCT01777438|2174969|P1|STARTED|Overall Study||352
900244|NCT01777425|2174981|P1|NOT COMPLETED|Overall Study||0
900245|NCT01777425|2174981|P1|COMPLETED|Overall Study||389
900246|NCT01777425|2174981|P1|STARTED|Overall Study||389
900247|NCT01777412|2174987|P1|NOT COMPLETED|Overall Study||0
900248|NCT01777412|2174987|P1|COMPLETED|Overall Study||10
900249|NCT01777412|2174987|P1|STARTED|Overall Study||10
900250|NCT01777334|2174995|P2|NOT COMPLETED|Overall Study||63
900251|NCT01777334|2174996|P1|NOT COMPLETED|Overall Study||53
900252|NCT01777334|2174995|P2|COMPLETED|Overall Study||388
900253|NCT01777334|2174996|P1|COMPLETED|Overall Study||401
900254|NCT01777334|2174995|P2|STARTED|Overall Study||451
900255|NCT01777334|2174996|P1|STARTED|Overall Study||454
900256|NCT01777321|2175006|P2|NOT COMPLETED|Overall Study||1
900257|NCT01777321|2175007|P1|NOT COMPLETED|Overall Study||0
900258|NCT01777321|2175006|P2|COMPLETED|Overall Study||29
900259|NCT01777321|2175007|P1|COMPLETED|Overall Study||30
900260|NCT01777321|2175006|P2|STARTED|Overall Study||30
900261|NCT01777321|2175007|P1|STARTED|Overall Study||30
900262|NCT01777282|2175048|P5|NOT COMPLETED|Overall Study||7
900263|NCT01777282|2175049|P4|NOT COMPLETED|Overall Study||2
900264|NCT01777282|2175050|P3|NOT COMPLETED|Overall Study||6
900265|NCT01777282|2175051|P2|NOT COMPLETED|Overall Study||4
900266|NCT01777282|2175052|P1|NOT COMPLETED|Overall Study||11
900267|NCT01777282|2175048|P5|COMPLETED|Overall Study||54
900268|NCT01777282|2175049|P4|COMPLETED|Overall Study||59
900269|NCT01777282|2175050|P3|COMPLETED|Overall Study||59
900270|NCT01777282|2175051|P2|COMPLETED|Overall Study||63
900271|NCT01777282|2175052|P1|COMPLETED|Overall Study||109
900272|NCT01777282|2175048|P5|Completing Follow-up Period|Overall Study||54
900273|NCT01777282|2175049|P4|Completing Follow-up Period|Overall Study||59
900274|NCT01777282|2175050|P3|Completing Follow-up Period|Overall Study||59
900275|NCT01777282|2175051|P2|Completing Follow-up Period|Overall Study||63
900276|NCT01777282|2175052|P1|Completing Follow-up Period|Overall Study||109
900277|NCT01777282|2175048|P5|Completing Treatment Period|Overall Study||54
900278|NCT01777282|2175049|P4|Completing Treatment Period|Overall Study||59
900279|NCT01777282|2175050|P3|Completing Treatment Period|Overall Study||59
900280|NCT01777282|2175051|P2|Completing Treatment Period|Overall Study||63
900281|NCT01777282|2175052|P1|Completing Treatment Period|Overall Study||109
900282|NCT01777282|2175048|P5|STARTED|Overall Study||61
900283|NCT01777282|2175049|P4|STARTED|Overall Study||61
900284|NCT01777282|2175050|P3|STARTED|Overall Study||65
900285|NCT01777282|2175051|P2|STARTED|Overall Study||67
900286|NCT01777282|2175052|P1|STARTED|Overall Study||120
900287|NCT01777269|2175096|P2|NOT COMPLETED|Overall Study||59
900288|NCT01777269|2175097|P1|NOT COMPLETED|Overall Study||55
900289|NCT01777269|2175096|P2|COMPLETED|Overall Study||184
900290|NCT01777269|2175097|P1|COMPLETED|Overall Study||191
900291|NCT01777269|2175096|P2|STARTED|Overall Study||243
900292|NCT01777269|2175097|P1|STARTED|Overall Study||246
900293|NCT01777217|2175125|P2|NOT COMPLETED|Overall Study||0
900294|NCT01777217|2175126|P1|NOT COMPLETED|Overall Study||0
900295|NCT01777217|2175125|P2|COMPLETED|Overall Study||4
900296|NCT01777217|2175126|P1|COMPLETED|Overall Study||4
900297|NCT01777217|2175125|P2|STARTED|Overall Study||4
900298|NCT01777217|2175126|P1|STARTED|Overall Study||4
900299|NCT01777191|2175134|P2|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||13
900300|NCT01777191|2175135|P1|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||9
900301|NCT01777191|2175134|P2|COMPLETED|Safety Extension Per (Week 12-Week 48)||78
900302|NCT01777191|2175135|P1|COMPLETED|Safety Extension Per (Week 12-Week 48)||85
900303|NCT01777191|2175134|P2|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|91
900304|NCT01777191|2175135|P1|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|94
900305|NCT01777191|2175134|P2|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||8
900306|NCT01777191|2175135|P1|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||6
900307|NCT01777191|2175134|P2|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||94
900308|NCT01777191|2175135|P1|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||96
900309|NCT01777191|2175134|P2|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
900310|NCT01777191|2175135|P1|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
900311|NCT01777126|2175165|P2|NOT COMPLETED|Overall Study||0
900312|NCT01777126|2175166|P1|NOT COMPLETED|Overall Study||0
900313|NCT01777126|2175165|P2|COMPLETED|Overall Study||46
900314|NCT01777126|2175166|P1|COMPLETED|Overall Study||48
900315|NCT01777126|2175165|P2|STARTED|Overall Study||46
900316|NCT01777126|2175166|P1|STARTED|Overall Study||48
900317|NCT01776645|2175189|P2|NOT COMPLETED|Overall Study||14
900318|NCT01776645|2175190|P1|NOT COMPLETED|Overall Study||14
900319|NCT01776645|2175189|P2|COMPLETED|Overall Study||14
900320|NCT01776645|2175190|P1|COMPLETED|Overall Study||14
900321|NCT01776645|2175189|P2|STARTED|Overall Study||28
900322|NCT01776645|2175190|P1|STARTED|Overall Study||28
900323|NCT01776554|2175198|P2|NOT COMPLETED|Overall Study||23
900324|NCT01776554|2175199|P1|NOT COMPLETED|Overall Study||17
900325|NCT01776554|2175198|P2|COMPLETED|Overall Study||307
900326|NCT01776554|2175199|P1|COMPLETED|Overall Study||315
900327|NCT01776554|2175198|P2|STARTED|Overall Study||330
900328|NCT01776554|2175199|P1|STARTED|Overall Study||332
900329|NCT01776541|2175242|P2|NOT COMPLETED|Overall Study||75
900330|NCT01776541|2175243|P1|NOT COMPLETED|Overall Study||56
900331|NCT01776541|2175242|P2|COMPLETED|Overall Study||416
900332|NCT01776541|2175243|P1|COMPLETED|Overall Study||432
900333|NCT01776541|2175242|P2|STARTED|Overall Study||491
900334|NCT01776541|2175243|P1|STARTED|Overall Study||488
900335|NCT01776268|2175264|P2|NOT COMPLETED|Overall Study||0
900336|NCT01776268|2175265|P1|NOT COMPLETED|Overall Study||0
900337|NCT01776268|2175264|P2|COMPLETED|Overall Study||51
900338|NCT01776268|2175265|P1|COMPLETED|Overall Study||48
900339|NCT01776268|2175264|P2|STARTED|Overall Study||51
900340|NCT01776268|2175265|P1|STARTED|Overall Study||48
900341|NCT01775995|2175275|P2|NOT COMPLETED|Overall Study||1
900342|NCT01775995|2175276|P1|NOT COMPLETED|Overall Study||1
900343|NCT01775995|2175275|P2|COMPLETED|Overall Study|One control participant was unable to reach at 26 week follow up|13
900344|NCT01775995|2175276|P1|COMPLETED|Overall Study|One experimental participant was unable to reach at 26 week follow up|20
900345|NCT01775995|2175275|P2|STARTED|Overall Study||14
900346|NCT01775995|2175276|P1|STARTED|Overall Study||21
900347|NCT01775852|2175338|P2|NOT COMPLETED|Overall Study||1
900348|NCT01775852|2175339|P1|NOT COMPLETED|Overall Study||0
900349|NCT01775852|2175338|P2|COMPLETED|Overall Study||13
900350|NCT01775852|2175339|P1|COMPLETED|Overall Study||31
900351|NCT01775852|2175338|P2|STARTED|Overall Study||14
900352|NCT01775852|2175339|P1|STARTED|Overall Study||31
900353|NCT01775774|2175354|P3|NOT COMPLETED|Overall Study||0
900354|NCT01775774|2175355|P2|NOT COMPLETED|Overall Study||0
900355|NCT01775774|2175356|P1|NOT COMPLETED|Overall Study||0
900356|NCT01775774|2175354|P3|COMPLETED|Overall Study||3
900357|NCT01775774|2175355|P2|COMPLETED|Overall Study||3
900358|NCT01775774|2175356|P1|COMPLETED|Overall Study||3
900359|NCT01775774|2175354|P3|STARTED|Overall Study||3
900360|NCT01775774|2175355|P2|STARTED|Overall Study||3
900361|NCT01775774|2175356|P1|STARTED|Overall Study||3
900362|NCT01775670|2175384|P2|NOT COMPLETED|Overall Study||1
900363|NCT01775670|2175385|P1|NOT COMPLETED|Overall Study||1
900364|NCT01775670|2175384|P2|COMPLETED|Overall Study||2
900365|NCT01775670|2175385|P1|COMPLETED|Overall Study||0
900366|NCT01775670|2175384|P2|STARTED|Overall Study||3
900367|NCT01775670|2175385|P1|STARTED|Overall Study||1
900368|NCT01775553|2175411|P1|NOT COMPLETED|Overall Study||13
900369|NCT01775553|2175411|P1|COMPLETED|Overall Study||0
900370|NCT01775553|2175411|P1|STARTED|Overall Study||13
900371|NCT01775189|2175419|P7|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
900372|NCT01775189|2175420|P6|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
900373|NCT01775189|2175421|P5|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
900374|NCT01775189|2175422|P4|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
900375|NCT01775189|2175423|P3|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
900376|NCT01775189|2175424|P2|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
900377|NCT01775189|2175425|P1|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
900378|NCT01775189|2175419|P7|COMPLETED|Treatment Phase: Fourth Intervention||7
900379|NCT01775189|2175420|P6|COMPLETED|Treatment Phase: Fourth Intervention||7
900380|NCT01775189|2175421|P5|COMPLETED|Treatment Phase: Fourth Intervention||8
900381|NCT01775189|2175422|P4|COMPLETED|Treatment Phase: Fourth Intervention||6
900382|NCT01775189|2175423|P3|COMPLETED|Treatment Phase: Fourth Intervention||0
900383|NCT01775189|2175424|P2|COMPLETED|Treatment Phase: Fourth Intervention||0
900384|NCT01775189|2175425|P1|COMPLETED|Treatment Phase: Fourth Intervention||0
900385|NCT01775189|2175419|P7|STARTED|Treatment Phase: Fourth Intervention||7
900386|NCT01775189|2175420|P6|STARTED|Treatment Phase: Fourth Intervention||7
900387|NCT01775189|2175421|P5|STARTED|Treatment Phase: Fourth Intervention||8
900388|NCT01775189|2175422|P4|STARTED|Treatment Phase: Fourth Intervention||6
900389|NCT01775189|2175423|P3|STARTED|Treatment Phase: Fourth Intervention||0
900390|NCT01775189|2175424|P2|STARTED|Treatment Phase: Fourth Intervention||0
900391|NCT01775189|2175425|P1|STARTED|Treatment Phase: Fourth Intervention||0
900392|NCT01775189|2175419|P7|NOT COMPLETED|Treatment Phase: Washout Period 3||1
900393|NCT01775189|2175420|P6|NOT COMPLETED|Treatment Phase: Washout Period 3||0
900394|NCT01775189|2175421|P5|NOT COMPLETED|Treatment Phase: Washout Period 3||0
900395|NCT01775189|2175422|P4|NOT COMPLETED|Treatment Phase: Washout Period 3||1
900396|NCT01775189|2175423|P3|NOT COMPLETED|Treatment Phase: Washout Period 3||0
900397|NCT01775189|2175424|P2|NOT COMPLETED|Treatment Phase: Washout Period 3||0
900398|NCT01775189|2175425|P1|NOT COMPLETED|Treatment Phase: Washout Period 3||0
900399|NCT01775189|2175419|P7|COMPLETED|Treatment Phase: Washout Period 3||7
900400|NCT01775189|2175420|P6|COMPLETED|Treatment Phase: Washout Period 3||7
900401|NCT01775189|2175421|P5|COMPLETED|Treatment Phase: Washout Period 3||8
900402|NCT01775189|2175422|P4|COMPLETED|Treatment Phase: Washout Period 3||6
900403|NCT01775189|2175423|P3|COMPLETED|Treatment Phase: Washout Period 3||0
900404|NCT01775189|2175424|P2|COMPLETED|Treatment Phase: Washout Period 3||0
900405|NCT01775189|2175425|P1|COMPLETED|Treatment Phase: Washout Period 3||0
900406|NCT01775189|2175419|P7|STARTED|Treatment Phase: Washout Period 3||8
900407|NCT01775189|2175420|P6|STARTED|Treatment Phase: Washout Period 3||7
900408|NCT01775189|2175421|P5|STARTED|Treatment Phase: Washout Period 3||8
900409|NCT01775189|2175422|P4|STARTED|Treatment Phase: Washout Period 3||7
900410|NCT01775189|2175423|P3|STARTED|Treatment Phase: Washout Period 3||0
900411|NCT01775189|2175424|P2|STARTED|Treatment Phase: Washout Period 3||0
900412|NCT01775189|2175425|P1|STARTED|Treatment Phase: Washout Period 3||0
900413|NCT01775189|2175419|P7|NOT COMPLETED|Treatment Phase: Third Intervention||0
900414|NCT01775189|2175420|P6|NOT COMPLETED|Treatment Phase: Third Intervention||0
900415|NCT01775189|2175421|P5|NOT COMPLETED|Treatment Phase: Third Intervention||0
900416|NCT01775189|2175422|P4|NOT COMPLETED|Treatment Phase: Third Intervention||0
900417|NCT01775189|2175423|P3|NOT COMPLETED|Treatment Phase: Third Intervention||0
900418|NCT01775189|2175424|P2|NOT COMPLETED|Treatment Phase: Third Intervention||0
900419|NCT01775189|2175425|P1|NOT COMPLETED|Treatment Phase: Third Intervention||0
900420|NCT01775189|2175419|P7|COMPLETED|Treatment Phase: Third Intervention||8
900421|NCT01775189|2175420|P6|COMPLETED|Treatment Phase: Third Intervention||7
900422|NCT01775189|2175421|P5|COMPLETED|Treatment Phase: Third Intervention||8
900423|NCT01775189|2175422|P4|COMPLETED|Treatment Phase: Third Intervention||7
900424|NCT01775189|2175423|P3|COMPLETED|Treatment Phase: Third Intervention||0
900425|NCT01775189|2175424|P2|COMPLETED|Treatment Phase: Third Intervention||0
900426|NCT01775189|2175425|P1|COMPLETED|Treatment Phase: Third Intervention||0
900427|NCT01775189|2175419|P7|STARTED|Treatment Phase: Third Intervention||8
900428|NCT01775189|2175420|P6|STARTED|Treatment Phase: Third Intervention||7
900429|NCT01775189|2175421|P5|STARTED|Treatment Phase: Third Intervention||8
900430|NCT01775189|2175422|P4|STARTED|Treatment Phase: Third Intervention||7
900431|NCT01775189|2175423|P3|STARTED|Treatment Phase: Third Intervention||0
900432|NCT01775189|2175424|P2|STARTED|Treatment Phase: Third Intervention||0
900433|NCT01775189|2175425|P1|STARTED|Treatment Phase: Third Intervention||0
900434|NCT01775189|2175419|P7|NOT COMPLETED|Treatment Phase: Washout Period 2||0
900435|NCT01775189|2175420|P6|NOT COMPLETED|Treatment Phase: Washout Period 2||0
900436|NCT01775189|2175421|P5|NOT COMPLETED|Treatment Phase: Washout Period 2||0
900437|NCT01775189|2175422|P4|NOT COMPLETED|Treatment Phase: Washout Period 2||1
900438|NCT01775189|2175423|P3|NOT COMPLETED|Treatment Phase: Washout Period 2||0
900439|NCT01775189|2175424|P2|NOT COMPLETED|Treatment Phase: Washout Period 2||0
900440|NCT01775189|2175425|P1|NOT COMPLETED|Treatment Phase: Washout Period 2||0
900441|NCT01775189|2175419|P7|COMPLETED|Treatment Phase: Washout Period 2||8
900442|NCT01775189|2175420|P6|COMPLETED|Treatment Phase: Washout Period 2||7
900443|NCT01775189|2175421|P5|COMPLETED|Treatment Phase: Washout Period 2||8
900444|NCT01775189|2175422|P4|COMPLETED|Treatment Phase: Washout Period 2||7
900445|NCT01775189|2175423|P3|COMPLETED|Treatment Phase: Washout Period 2||0
900446|NCT01775189|2175424|P2|COMPLETED|Treatment Phase: Washout Period 2||0
900447|NCT01775189|2175425|P1|COMPLETED|Treatment Phase: Washout Period 2||0
900448|NCT01775189|2175419|P7|STARTED|Treatment Phase: Washout Period 2||8
900449|NCT01775189|2175420|P6|STARTED|Treatment Phase: Washout Period 2||7
900450|NCT01775189|2175421|P5|STARTED|Treatment Phase: Washout Period 2||8
900451|NCT01775189|2175422|P4|STARTED|Treatment Phase: Washout Period 2||8
900452|NCT01775189|2175423|P3|STARTED|Treatment Phase: Washout Period 2||0
900453|NCT01775189|2175424|P2|STARTED|Treatment Phase: Washout Period 2||0
900454|NCT01775189|2175425|P1|STARTED|Treatment Phase: Washout Period 2||0
900455|NCT01775189|2175419|P7|NOT COMPLETED|Treatment Phase: Second Intervention||0
900456|NCT01775189|2175420|P6|NOT COMPLETED|Treatment Phase: Second Intervention||0
900457|NCT01775189|2175421|P5|NOT COMPLETED|Treatment Phase: Second Intervention||0
900458|NCT01775189|2175422|P4|NOT COMPLETED|Treatment Phase: Second Intervention||0
900459|NCT01775189|2175423|P3|NOT COMPLETED|Treatment Phase: Second Intervention||0
900460|NCT01775189|2175424|P2|NOT COMPLETED|Treatment Phase: Second Intervention||0
900461|NCT01775189|2175425|P1|NOT COMPLETED|Treatment Phase: Second Intervention||0
900462|NCT01775189|2175419|P7|COMPLETED|Treatment Phase: Second Intervention||8
900463|NCT01775189|2175420|P6|COMPLETED|Treatment Phase: Second Intervention||7
900464|NCT01775189|2175421|P5|COMPLETED|Treatment Phase: Second Intervention||8
900465|NCT01775189|2175422|P4|COMPLETED|Treatment Phase: Second Intervention||8
900466|NCT01775189|2175423|P3|COMPLETED|Treatment Phase: Second Intervention||0
900467|NCT01775189|2175424|P2|COMPLETED|Treatment Phase: Second Intervention||0
900468|NCT01775189|2175425|P1|COMPLETED|Treatment Phase: Second Intervention||0
900469|NCT01775189|2175419|P7|STARTED|Treatment Phase: Second Intervention||8
900470|NCT01775189|2175420|P6|STARTED|Treatment Phase: Second Intervention||7
900471|NCT01775189|2175421|P5|STARTED|Treatment Phase: Second Intervention||8
900472|NCT01775189|2175422|P4|STARTED|Treatment Phase: Second Intervention||8
900473|NCT01775189|2175423|P3|STARTED|Treatment Phase: Second Intervention||0
900474|NCT01775189|2175424|P2|STARTED|Treatment Phase: Second Intervention||0
900475|NCT01775189|2175425|P1|STARTED|Treatment Phase: Second Intervention||0
900476|NCT01775189|2175419|P7|NOT COMPLETED|Treatment Phase: Washout Period 1||0
900477|NCT01775189|2175420|P6|NOT COMPLETED|Treatment Phase: Washout Period 1||1
900478|NCT01775189|2175421|P5|NOT COMPLETED|Treatment Phase: Washout Period 1||0
900479|NCT01775189|2175422|P4|NOT COMPLETED|Treatment Phase: Washout Period 1||0
900480|NCT01775189|2175423|P3|NOT COMPLETED|Treatment Phase: Washout Period 1||0
900481|NCT01775189|2175424|P2|NOT COMPLETED|Treatment Phase: Washout Period 1||0
900482|NCT01775189|2175425|P1|NOT COMPLETED|Treatment Phase: Washout Period 1||0
900483|NCT01775189|2175419|P7|COMPLETED|Treatment Phase: Washout Period 1||8
900484|NCT01775189|2175420|P6|COMPLETED|Treatment Phase: Washout Period 1||7
900485|NCT01775189|2175421|P5|COMPLETED|Treatment Phase: Washout Period 1||8
900486|NCT01775189|2175422|P4|COMPLETED|Treatment Phase: Washout Period 1||8
900487|NCT01775189|2175423|P3|COMPLETED|Treatment Phase: Washout Period 1||0
900488|NCT01775189|2175424|P2|COMPLETED|Treatment Phase: Washout Period 1||0
900489|NCT01775189|2175425|P1|COMPLETED|Treatment Phase: Washout Period 1||0
900490|NCT01775189|2175419|P7|STARTED|Treatment Phase: Washout Period 1||8
900491|NCT01775189|2175420|P6|STARTED|Treatment Phase: Washout Period 1||8
900492|NCT01775189|2175421|P5|STARTED|Treatment Phase: Washout Period 1||8
900493|NCT01775189|2175422|P4|STARTED|Treatment Phase: Washout Period 1||8
900494|NCT01775189|2175423|P3|STARTED|Treatment Phase: Washout Period 1||0
900495|NCT01775189|2175424|P2|STARTED|Treatment Phase: Washout Period 1||0
900496|NCT01775189|2175425|P1|STARTED|Treatment Phase: Washout Period 1||0
900497|NCT01775189|2175419|P7|NOT COMPLETED|Treatment Phase: First Intervention||0
900498|NCT01775189|2175420|P6|NOT COMPLETED|Treatment Phase: First Intervention||0
900499|NCT01775189|2175421|P5|NOT COMPLETED|Treatment Phase: First Intervention||0
900500|NCT01775189|2175422|P4|NOT COMPLETED|Treatment Phase: First Intervention||0
900501|NCT01775189|2175423|P3|NOT COMPLETED|Treatment Phase: First Intervention||0
900502|NCT01775189|2175424|P2|NOT COMPLETED|Treatment Phase: First Intervention||0
900503|NCT01775189|2175425|P1|NOT COMPLETED|Treatment Phase: First Intervention||0
900504|NCT01775189|2175419|P7|COMPLETED|Treatment Phase: First Intervention||8
900505|NCT01775189|2175420|P6|COMPLETED|Treatment Phase: First Intervention||8
900506|NCT01775189|2175421|P5|COMPLETED|Treatment Phase: First Intervention||8
900507|NCT01775189|2175422|P4|COMPLETED|Treatment Phase: First Intervention||8
900508|NCT01775189|2175423|P3|COMPLETED|Treatment Phase: First Intervention||0
900509|NCT01775189|2175424|P2|COMPLETED|Treatment Phase: First Intervention||0
900510|NCT01775189|2175425|P1|COMPLETED|Treatment Phase: First Intervention||0
900511|NCT01775189|2175419|P7|STARTED|Treatment Phase: First Intervention||8
900512|NCT01775189|2175420|P6|STARTED|Treatment Phase: First Intervention||8
900513|NCT01775189|2175421|P5|STARTED|Treatment Phase: First Intervention||8
900514|NCT01775189|2175422|P4|STARTED|Treatment Phase: First Intervention||8
900515|NCT01775189|2175423|P3|STARTED|Treatment Phase: First Intervention||0
900516|NCT01775189|2175424|P2|STARTED|Treatment Phase: First Intervention||0
900517|NCT01775189|2175425|P1|STARTED|Treatment Phase: First Intervention||0
900518|NCT01775189|2175419|P7|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
900519|NCT01775189|2175420|P6|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
900520|NCT01775189|2175421|P5|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
900521|NCT01775189|2175422|P4|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
900522|NCT01775189|2175423|P3|NOT COMPLETED|Drug Discrimination Phase: Day 2||7
900523|NCT01775189|2175424|P2|NOT COMPLETED|Drug Discrimination Phase: Day 2||3
900524|NCT01775189|2175425|P1|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
900525|NCT01775189|2175419|P7|COMPLETED|Drug Discrimination Phase: Day 2||0
900526|NCT01775189|2175420|P6|COMPLETED|Drug Discrimination Phase: Day 2||0
900527|NCT01775189|2175421|P5|COMPLETED|Drug Discrimination Phase: Day 2||0
900528|NCT01775189|2175422|P4|COMPLETED|Drug Discrimination Phase: Day 2||0
900529|NCT01775189|2175423|P3|COMPLETED|Drug Discrimination Phase: Day 2||16
900530|NCT01775189|2175424|P2|COMPLETED|Drug Discrimination Phase: Day 2||16
900531|NCT01775189|2175425|P1|COMPLETED|Drug Discrimination Phase: Day 2||0
900532|NCT01775189|2175419|P7|STARTED|Drug Discrimination Phase: Day 2||0
900533|NCT01775189|2175420|P6|STARTED|Drug Discrimination Phase: Day 2||0
900534|NCT01775189|2175421|P5|STARTED|Drug Discrimination Phase: Day 2||0
900535|NCT01775189|2175422|P4|STARTED|Drug Discrimination Phase: Day 2||0
900536|NCT01775189|2175423|P3|STARTED|Drug Discrimination Phase: Day 2||23
900537|NCT01775189|2175424|P2|STARTED|Drug Discrimination Phase: Day 2||19
900538|NCT01775189|2175425|P1|STARTED|Drug Discrimination Phase: Day 2||0
900539|NCT01775189|2175419|P7|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
900540|NCT01775189|2175420|P6|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
900541|NCT01775189|2175421|P5|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
900542|NCT01775189|2175422|P4|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
900543|NCT01775189|2175423|P3|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
900544|NCT01775189|2175424|P2|NOT COMPLETED|Drug Discrimination Phase: Day 1||3
900545|NCT01775189|2175425|P1|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
900546|NCT01775189|2175419|P7|COMPLETED|Drug Discrimination Phase: Day 1||0
900547|NCT01775189|2175420|P6|COMPLETED|Drug Discrimination Phase: Day 1||0
900548|NCT01775189|2175421|P5|COMPLETED|Drug Discrimination Phase: Day 1||0
900549|NCT01775189|2175422|P4|COMPLETED|Drug Discrimination Phase: Day 1||0
900550|NCT01775189|2175423|P3|COMPLETED|Drug Discrimination Phase: Day 1||23
900551|NCT01775189|2175424|P2|COMPLETED|Drug Discrimination Phase: Day 1||19
900552|NCT01775189|2175425|P1|COMPLETED|Drug Discrimination Phase: Day 1||0
900553|NCT01775189|2175419|P7|STARTED|Drug Discrimination Phase: Day 1||0
900554|NCT01775189|2175420|P6|STARTED|Drug Discrimination Phase: Day 1||0
900555|NCT01775189|2175421|P5|STARTED|Drug Discrimination Phase: Day 1||0
900556|NCT01775189|2175422|P4|STARTED|Drug Discrimination Phase: Day 1||0
900557|NCT01775189|2175423|P3|STARTED|Drug Discrimination Phase: Day 1||23
900558|NCT01775189|2175424|P2|STARTED|Drug Discrimination Phase: Day 1||22
900559|NCT01775189|2175425|P1|STARTED|Drug Discrimination Phase: Day 1||0
900560|NCT01775189|2175419|P7|NOT COMPLETED|Naloxone Challenge Phase||0
900561|NCT01775189|2175420|P6|NOT COMPLETED|Naloxone Challenge Phase||0
900562|NCT01775189|2175421|P5|NOT COMPLETED|Naloxone Challenge Phase||0
900563|NCT01775189|2175422|P4|NOT COMPLETED|Naloxone Challenge Phase||0
900564|NCT01775189|2175423|P3|NOT COMPLETED|Naloxone Challenge Phase||0
900565|NCT01775189|2175424|P2|NOT COMPLETED|Naloxone Challenge Phase||0
900566|NCT01775189|2175425|P1|NOT COMPLETED|Naloxone Challenge Phase||0
900567|NCT01775189|2175419|P7|COMPLETED|Naloxone Challenge Phase||0
900568|NCT01775189|2175420|P6|COMPLETED|Naloxone Challenge Phase||0
900569|NCT01775189|2175421|P5|COMPLETED|Naloxone Challenge Phase||0
900570|NCT01775189|2175422|P4|COMPLETED|Naloxone Challenge Phase||0
900571|NCT01775189|2175423|P3|COMPLETED|Naloxone Challenge Phase||0
900572|NCT01775189|2175424|P2|COMPLETED|Naloxone Challenge Phase||0
900573|NCT01775189|2175425|P1|COMPLETED|Naloxone Challenge Phase||45
900574|NCT01775189|2175419|P7|STARTED|Naloxone Challenge Phase||0
900575|NCT01775189|2175420|P6|STARTED|Naloxone Challenge Phase||0
900576|NCT01775189|2175421|P5|STARTED|Naloxone Challenge Phase||0
900577|NCT01775189|2175422|P4|STARTED|Naloxone Challenge Phase||0
900578|NCT01775189|2175423|P3|STARTED|Naloxone Challenge Phase||0
900579|NCT01775189|2175424|P2|STARTED|Naloxone Challenge Phase||0
900580|NCT01775189|2175425|P1|STARTED|Naloxone Challenge Phase||45
900581|NCT01775137|2175644|P1|NOT COMPLETED|Overall Study||11
900582|NCT01775137|2175644|P1|COMPLETED|Overall Study||34
900583|NCT01775137|2175644|P1|STARTED|Overall Study||45
900584|NCT01774981|2175677|P8|NOT COMPLETED|Overall Study||1
900585|NCT01774981|2175678|P7|NOT COMPLETED|Overall Study||0
900586|NCT01774981|2175679|P6|NOT COMPLETED|Overall Study||1
900587|NCT01774981|2175680|P5|NOT COMPLETED|Overall Study||1
900588|NCT01774981|2175681|P4|NOT COMPLETED|Overall Study||0
900589|NCT01774981|2175682|P3|NOT COMPLETED|Overall Study||0
900590|NCT01774981|2175683|P2|NOT COMPLETED|Overall Study||0
900591|NCT01774981|2175684|P1|NOT COMPLETED|Overall Study||0
900592|NCT01774981|2175677|P8|COMPLETED|Overall Study||11
900593|NCT01774981|2175678|P7|COMPLETED|Overall Study||13
900594|NCT01774981|2175679|P6|COMPLETED|Overall Study||13
900595|NCT01774981|2175680|P5|COMPLETED|Overall Study||5
900596|NCT01774981|2175681|P4|COMPLETED|Overall Study||4
900597|NCT01774981|2175682|P3|COMPLETED|Overall Study||4
900598|NCT01774981|2175683|P2|COMPLETED|Overall Study||4
900599|NCT01774981|2175684|P1|COMPLETED|Overall Study||3
900600|NCT01774981|2175677|P8|Received at Least 1 Dose of Study Drug|Overall Study||12
900601|NCT01774981|2175678|P7|Received at Least 1 Dose of Study Drug|Overall Study||13
900602|NCT01774981|2175679|P6|Received at Least 1 Dose of Study Drug|Overall Study||14
900603|NCT01774981|2175680|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
900604|NCT01774981|2175681|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
900605|NCT01774981|2175682|P3|Received at Least 1 Dose of Study Drug|Overall Study||4
900606|NCT01774981|2175683|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
900607|NCT01774981|2175684|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
900608|NCT01774981|2175677|P8|STARTED|Overall Study||12
900609|NCT01774981|2175678|P7|STARTED|Overall Study||13
900610|NCT01774981|2175679|P6|STARTED|Overall Study||14
900611|NCT01774981|2175680|P5|STARTED|Overall Study||6
900612|NCT01774981|2175681|P4|STARTED|Overall Study||4
900613|NCT01774981|2175682|P3|STARTED|Overall Study||4
900614|NCT01774981|2175683|P2|STARTED|Overall Study||4
900615|NCT01774981|2175684|P1|STARTED|Overall Study||3
900616|NCT01774968|2175716|P2|NOT COMPLETED|Overall Study||35
900617|NCT01774968|2175717|P1|NOT COMPLETED|Overall Study||30
900618|NCT01774968|2175716|P2|COMPLETED|Overall Study||128
900619|NCT01774968|2175717|P1|COMPLETED|Overall Study||132
900620|NCT01774968|2175716|P2|Received at Least 1 Dose of Study Drug|Overall Study||161
900621|NCT01774968|2175717|P1|Received at Least 1 Dose of Study Drug|Overall Study||162
900622|NCT01774968|2175716|P2|STARTED|Overall Study||163
900623|NCT01774968|2175717|P1|STARTED|Overall Study||162
900624|NCT01774929|2175751|P1|NOT COMPLETED|Overall Study||3
900625|NCT01774929|2175751|P1|COMPLETED|Overall Study||32
900626|NCT01774929|2175751|P1|STARTED|Overall Study||35
900627|NCT01774903|2175757|P1|NOT COMPLETED|Overall Study||11
900628|NCT01774903|2175757|P1|COMPLETED|Overall Study||34
900629|NCT01774903|2175757|P1|STARTED|Overall Study||45
900630|NCT01774851|2175766|P2|NOT COMPLETED|Overall Study||0
900631|NCT01774851|2175767|P1|NOT COMPLETED|Overall Study||0
900632|NCT01774851|2175766|P2|COMPLETED|Overall Study||42
900633|NCT01774851|2175767|P1|COMPLETED|Overall Study||42
900634|NCT01774851|2175766|P2|STARTED|Overall Study||42
900635|NCT01774851|2175767|P1|STARTED|Overall Study||42
900636|NCT01774604|2175775|P2|NOT COMPLETED|Overall Study||0
900637|NCT01774604|2175776|P1|NOT COMPLETED|Overall Study||0
900638|NCT01774604|2175775|P2|COMPLETED|Overall Study||226
900639|NCT01774604|2175776|P1|COMPLETED|Overall Study||223
900640|NCT01774604|2175775|P2|STARTED|Overall Study||226
900641|NCT01774604|2175776|P1|STARTED|Overall Study||223
900642|NCT01774344|2175796|P2|NOT COMPLETED|Overall Study||148
900643|NCT01774344|2175797|P1|NOT COMPLETED|Overall Study||32
900644|NCT01774344|2175796|P2|COMPLETED|Overall Study||231
900645|NCT01774344|2175797|P1|COMPLETED|Overall Study||162
900646|NCT01774344|2175796|P2|Treated|Overall Study||374
900647|NCT01774344|2175797|P1|Treated|Overall Study||193
900648|NCT01774344|2175796|P2|STARTED|Overall Study||379
900649|NCT01774344|2175797|P1|STARTED|Overall Study||194
900650|NCT01774305|2175813|P2|NOT COMPLETED|Overall Study||0
900651|NCT01774305|2175814|P1|NOT COMPLETED|Overall Study||1
900652|NCT01774305|2175813|P2|COMPLETED|Overall Study||71
900653|NCT01774305|2175814|P1|COMPLETED|Overall Study||70
900654|NCT01774305|2175813|P2|STARTED|Overall Study||71
900655|NCT01774305|2175814|P1|STARTED|Overall Study||71
900656|NCT01774253|2175822|P1|NOT COMPLETED|Overall Study||9
900657|NCT01774253|2175822|P1|COMPLETED|Overall Study||0
900658|NCT01774253|2175822|P1|STARTED|Overall Study||9
900659|NCT01774149|2175832|P2|NOT COMPLETED|Overall Study||3
900660|NCT01774149|2175833|P1|NOT COMPLETED|Overall Study||1
900661|NCT01774149|2175832|P2|COMPLETED|Overall Study||12
900662|NCT01774149|2175833|P1|COMPLETED|Overall Study||14
900663|NCT01774149|2175832|P2|STARTED|Overall Study||15
900664|NCT01774149|2175833|P1|STARTED|Overall Study||15
900665|NCT01774110|2175841|P1|NOT COMPLETED|Overall Study||7
900666|NCT01774110|2175841|P1|COMPLETED|Overall Study||5
900667|NCT01774110|2175841|P1|STARTED|Overall Study||12
900668|NCT01774097|2175849|P2|NOT COMPLETED|Overall Study||2
900669|NCT01774097|2175850|P1|NOT COMPLETED|Overall Study||2
900670|NCT01774097|2175849|P2|COMPLETED|Overall Study||40
900671|NCT01774097|2175850|P1|COMPLETED|Overall Study||38
900672|NCT01774097|2175849|P2|STARTED|Overall Study||42
900673|NCT01774097|2175850|P1|STARTED|Overall Study||40
900674|NCT01774084|2175880|P2|NOT COMPLETED|Overall Study||0
900675|NCT01774084|2175881|P1|NOT COMPLETED|Overall Study||1
900676|NCT01774084|2175880|P2|COMPLETED|Overall Study||12
900677|NCT01774084|2175881|P1|COMPLETED|Overall Study||10
900678|NCT01774084|2175880|P2|STARTED|Overall Study||12
900679|NCT01774084|2175881|P1|STARTED|Overall Study||11
900680|NCT01774045|2175891|P2|NOT COMPLETED|Overall Study||0
900681|NCT01774045|2175892|P1|NOT COMPLETED|Overall Study||0
900682|NCT01774045|2175891|P2|COMPLETED|Overall Study||7
900683|NCT01774045|2175892|P1|COMPLETED|Overall Study||23
900684|NCT01774045|2175891|P2|STARTED|Overall Study||7
900685|NCT01774045|2175892|P1|STARTED|Overall Study||23
900686|NCT01773889|2175906|P1|NOT COMPLETED|Overall Study||2
900687|NCT01773889|2175906|P1|COMPLETED|Overall Study||0
900688|NCT01773889|2175906|P1|STARTED|Overall Study||2
900689|NCT01773473|2175912|P2|NOT COMPLETED|Overall Study||19
900690|NCT01773473|2175913|P1|NOT COMPLETED|Overall Study||16
900691|NCT01773473|2175912|P2|COMPLETED|Overall Study||177
900692|NCT01773473|2175913|P1|COMPLETED|Overall Study||191
900693|NCT01773473|2175912|P2|Received at Least 1 Dose of Study Drug|Overall Study||196
900694|NCT01773473|2175913|P1|Received at Least 1 Dose of Study Drug|Overall Study||207
900695|NCT01773473|2175912|P2|STARTED|Overall Study||196
900696|NCT01773473|2175913|P1|STARTED|Overall Study||207
900697|NCT01773291|2175934|P3|NOT COMPLETED|Overall Study||1
900698|NCT01773291|2175935|P2|NOT COMPLETED|Overall Study||0
900699|NCT01773291|2175936|P1|NOT COMPLETED|Overall Study||1
900700|NCT01773291|2175934|P3|COMPLETED|Overall Study||6
900701|NCT01773291|2175935|P2|COMPLETED|Overall Study||9
900702|NCT01773291|2175936|P1|COMPLETED|Overall Study||7
900703|NCT01773291|2175934|P3|STARTED|Overall Study||7
900704|NCT01773291|2175935|P2|STARTED|Overall Study||9
900705|NCT01773291|2175936|P1|STARTED|Overall Study||8
900706|NCT01773226|2175947|P1|NOT COMPLETED|Overall Study||1
900707|NCT01773226|2175947|P1|COMPLETED|Overall Study|Withdrawal of one subject after one-month assessment due to persistent OA symptoms|10
900708|NCT01773226|2175947|P1|STARTED|Overall Study||11
900709|NCT01773135|2175957|P1|NOT COMPLETED|Overall Study||0
900710|NCT01773135|2175957|P1|COMPLETED|Overall Study||262
900711|NCT01773135|2175957|P1|STARTED|Overall Study||262
900712|NCT01773122|2175966|P4|NOT COMPLETED|Overall Study||1
900713|NCT01773122|2175967|P3|NOT COMPLETED|Overall Study||0
900714|NCT01773122|2175968|P2|NOT COMPLETED|Overall Study||1
900715|NCT01773122|2175969|P1|NOT COMPLETED|Overall Study||3
900716|NCT01773122|2175966|P4|COMPLETED|Overall Study||18
900717|NCT01773122|2175967|P3|COMPLETED|Overall Study||19
900718|NCT01773122|2175968|P2|COMPLETED|Overall Study||18
900719|NCT01773122|2175969|P1|COMPLETED|Overall Study||17
900720|NCT01773122|2175966|P4|STARTED|Overall Study||19
900721|NCT01773122|2175967|P3|STARTED|Overall Study||19
900722|NCT01773122|2175968|P2|STARTED|Overall Study||19
900723|NCT01773122|2175969|P1|STARTED|Overall Study||20
900724|NCT01772654|2175985|P2|NOT COMPLETED|Overall Study||0
900725|NCT01772654|2175986|P1|NOT COMPLETED|Overall Study||0
900726|NCT01772654|2175985|P2|COMPLETED|Overall Study||15
900727|NCT01772654|2175986|P1|COMPLETED|Overall Study||2
900728|NCT01772654|2175985|P2|STARTED|Overall Study||15
900729|NCT01772654|2175986|P1|STARTED|Overall Study||2
900730|NCT01772576|2175992|P1|NOT COMPLETED|Overall Study||34
900731|NCT01772576|2175992|P1|COMPLETED|Overall Study||133
900732|NCT01772576|2175992|P1|STARTED|Overall Study||167
900733|NCT01772550|2176004|P3|NOT COMPLETED|Overall Study||6
900734|NCT01772550|2176005|P2|NOT COMPLETED|Overall Study||1
900735|NCT01772550|2176006|P1|NOT COMPLETED|Overall Study||1
900736|NCT01772550|2176004|P3|COMPLETED|Overall Study||27
900737|NCT01772550|2176005|P2|COMPLETED|Overall Study||102
900738|NCT01772550|2176006|P1|COMPLETED|Overall Study||101
900739|NCT01772550|2176004|P3|CT Cardiac|Overall Study||1
900740|NCT01772550|2176005|P2|CT Cardiac|Overall Study||7
900741|NCT01772550|2176006|P1|CT Cardiac|Overall Study||7
900742|NCT01772550|2176004|P3|CT Kidney|Overall Study||6
900743|NCT01772550|2176005|P2|CT Kidney|Overall Study||19
900744|NCT01772550|2176006|P1|CT Kidney|Overall Study||12
900745|NCT01772550|2176004|P3|CT Liver|Overall Study||8
900746|NCT01772550|2176005|P2|CT Liver|Overall Study||14
900747|NCT01772550|2176006|P1|CT Liver|Overall Study||18
900748|NCT01772550|2176004|P3|CT Angiogram|Overall Study||4
900749|NCT01772550|2176005|P2|CT Angiogram|Overall Study||25
900750|NCT01772550|2176006|P1|CT Angiogram|Overall Study||24
900751|NCT01772550|2176004|P3|CT Pancreas|Overall Study||8
900752|NCT01772550|2176005|P2|CT Pancreas|Overall Study||36
900753|NCT01772550|2176006|P1|CT Pancreas|Overall Study||40
900754|NCT01772550|2176004|P3|STARTED|Overall Study||33
900755|NCT01772550|2176005|P2|STARTED|Overall Study||103
900756|NCT01772550|2176006|P1|STARTED|Overall Study||102
900757|NCT01772537|2176047|P3|NOT COMPLETED|Overall Study||0
900758|NCT01772537|2176048|P2|NOT COMPLETED|Overall Study||0
900759|NCT01772537|2176049|P1|NOT COMPLETED|Overall Study||1
900760|NCT01772537|2176047|P3|COMPLETED|Overall Study||6
900761|NCT01772537|2176048|P2|COMPLETED|Overall Study||3
900762|NCT01772537|2176049|P1|COMPLETED|Overall Study||4
900763|NCT01772537|2176047|P3|STARTED|Overall Study||6
900764|NCT01772537|2176048|P2|STARTED|Overall Study||3
900765|NCT01772537|2176049|P1|STARTED|Overall Study||5
900766|NCT01772368|2176063|P1|NOT COMPLETED|Overall Study||7
900767|NCT01772368|2176063|P1|COMPLETED|Overall Study||65
900768|NCT01772368|2176063|P1|Received Advair Diskus 100/50 mcg|Overall Study||66
900769|NCT01772368|2176063|P1|Received FS MDPI 100/50 mcg|Overall Study||68
900770|NCT01772368|2176063|P1|Received FS MDPI 100/25 mcg|Overall Study||67
900771|NCT01772368|2176063|P1|Received FS MDPI 100/12.5mcg|Overall Study||69
900772|NCT01772368|2176063|P1|Received FS MDPI 100/6.25 mcg|Overall Study||68
900773|NCT01772368|2176063|P1|Received Fp MDPI 100 mcg|Overall Study||67
900774|NCT01772368|2176063|P1|STARTED|Overall Study||72
900775|NCT01772316|2176109|P1|NOT COMPLETED|Overall Study||7
900776|NCT01772316|2176109|P1|COMPLETED|Overall Study||40
900777|NCT01772316|2176109|P1|STARTED|Overall Study||47
900778|NCT01772147|2176130|P3|NOT COMPLETED|Overall Study||18
900779|NCT01772147|2176131|P2|NOT COMPLETED|Overall Study||25
900780|NCT01772147|2176132|P1|NOT COMPLETED|Overall Study||31
900781|NCT01772147|2176130|P3|COMPLETED|Overall Study||184
900782|NCT01772147|2176131|P2|COMPLETED|Overall Study||178
900783|NCT01772147|2176132|P1|COMPLETED|Overall Study||170
900784|NCT01772147|2176130|P3|STARTED|Overall Study||202
900785|NCT01772147|2176131|P2|STARTED|Overall Study||203
900786|NCT01772147|2176132|P1|STARTED|Overall Study||201
900787|NCT01772134|2176152|P3|NOT COMPLETED|Overall Study||22
900788|NCT01772134|2176153|P2|NOT COMPLETED|Overall Study||14
900789|NCT01772134|2176154|P1|NOT COMPLETED|Overall Study||29
900790|NCT01772134|2176152|P3|COMPLETED|Overall Study||184
900791|NCT01772134|2176153|P2|COMPLETED|Overall Study||190
900792|NCT01772134|2176154|P1|COMPLETED|Overall Study||178
900793|NCT01772134|2176152|P3|Received Randomized Study Medication|Overall Study||205
900794|NCT01772134|2176153|P2|Received Randomized Study Medication|Overall Study||204
900795|NCT01772134|2176154|P1|Received Randomized Study Medication|Overall Study||205
900796|NCT01772134|2176152|P3|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|206
900797|NCT01772134|2176153|P2|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|204
900798|NCT01772134|2176154|P1|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|207
900799|NCT01771991|2176173|P2|NOT COMPLETED|Overall Study||6
900800|NCT01771991|2176174|P1|NOT COMPLETED|Overall Study||8
900801|NCT01771991|2176173|P2|COMPLETED|Overall Study||30
900802|NCT01771991|2176174|P1|COMPLETED|Overall Study||30
900803|NCT01771991|2176173|P2|Started Treatment|Overall Study||34
900804|NCT01771991|2176174|P1|Started Treatment|Overall Study||37
900805|NCT01771991|2176173|P2|STARTED|Overall Study||36
900806|NCT01771991|2176174|P1|STARTED|Overall Study||38
900807|NCT01771965|2176182|P2|NOT COMPLETED|Overall Study||5
900808|NCT01771965|2176183|P1|NOT COMPLETED|Overall Study||3
900809|NCT01771965|2176182|P2|COMPLETED|Overall Study||4
900810|NCT01771965|2176183|P1|COMPLETED|Overall Study||7
900811|NCT01771965|2176182|P2|STARTED|Overall Study||9
900812|NCT01771965|2176183|P1|STARTED|Overall Study||10
900813|NCT01771913|2176191|P2|NOT COMPLETED|Overall Study||0
900814|NCT01771913|2176192|P1|NOT COMPLETED|Overall Study||1
900815|NCT01771913|2176191|P2|COMPLETED|Overall Study||11
900816|NCT01771913|2176192|P1|COMPLETED|Overall Study||8
900817|NCT01771913|2176191|P2|STARTED|Overall Study||11
900818|NCT01771913|2176192|P1|STARTED|Overall Study||9
900819|NCT01771172|2176202|P1|NOT COMPLETED|Overall Study||2
900820|NCT01771172|2176202|P1|COMPLETED|Overall Study||46
900821|NCT01771172|2176202|P1|STARTED|Overall Study||48
900822|NCT01770860|2176206|P1|NOT COMPLETED|Overall Study||6
900823|NCT01770860|2176206|P1|COMPLETED|Overall Study||40
900824|NCT01770860|2176206|P1|Randomization|Overall Study|One participant withdrew before randomization|45
900825|NCT01770860|2176206|P1|STARTED|Overall Study|Forty-six subjects were enrolled but one subject withdrew before randomization.|46
900826|NCT01770743|2176254|P5|NOT COMPLETED|Overall Study||2
900827|NCT01770743|2176255|P4|NOT COMPLETED|Overall Study||2
900828|NCT01770743|2176256|P3|NOT COMPLETED|Overall Study||1
900829|NCT01770743|2176257|P2|NOT COMPLETED|Overall Study||3
900830|NCT01770743|2176258|P1|NOT COMPLETED|Overall Study||2
900831|NCT01770743|2176254|P5|COMPLETED|Overall Study||21
900832|NCT01770743|2176255|P4|COMPLETED|Overall Study||42
900833|NCT01770743|2176256|P3|COMPLETED|Overall Study||22
900834|NCT01770743|2176257|P2|COMPLETED|Overall Study||31
900835|NCT01770743|2176258|P1|COMPLETED|Overall Study||42
900836|NCT01770743|2176254|P5|Treated|Overall Study||23
900837|NCT01770743|2176255|P4|Treated|Overall Study||44
900838|NCT01770743|2176256|P3|Treated|Overall Study||23
900839|NCT01770743|2176257|P2|Treated|Overall Study||34
900840|NCT01770743|2176258|P1|Treated|Overall Study||44
900841|NCT01770743|2176254|P5|STARTED|Overall Study||23
900842|NCT01770743|2176255|P4|STARTED|Overall Study||44
900843|NCT01770743|2176256|P3|STARTED|Overall Study||23
900844|NCT01770743|2176257|P2|STARTED|Overall Study||34
900845|NCT01770743|2176258|P1|STARTED|Overall Study||44
900846|NCT01770691|2176310|P1|NOT COMPLETED|Overall Study||0
900847|NCT01770691|2176310|P1|COMPLETED|Overall Study||7
900848|NCT01770691|2176310|P1|STARTED|Overall Study||7
900849|NCT01770652|2176321|P4|NOT COMPLETED|Overall Study||0
900850|NCT01770652|2176322|P3|NOT COMPLETED|Overall Study||0
900851|NCT01770652|2176323|P2|NOT COMPLETED|Overall Study||0
900852|NCT01770652|2176324|P1|NOT COMPLETED|Overall Study||0
900853|NCT01770652|2176321|P4|COMPLETED|Overall Study||8
900854|NCT01770652|2176322|P3|COMPLETED|Overall Study||8
900855|NCT01770652|2176323|P2|COMPLETED|Overall Study||8
900856|NCT01770652|2176324|P1|COMPLETED|Overall Study||8
900857|NCT01770652|2176321|P4|STARTED|Overall Study||8
900858|NCT01770652|2176322|P3|STARTED|Overall Study||8
900859|NCT01770652|2176323|P2|STARTED|Overall Study||8
900860|NCT01770652|2176324|P1|STARTED|Overall Study||8
900861|NCT01770509|2176360|P2|NOT COMPLETED|Overall Study||3
900862|NCT01770509|2176361|P1|NOT COMPLETED|Overall Study||1
900863|NCT01770509|2176360|P2|COMPLETED|Overall Study||14
900864|NCT01770509|2176361|P1|COMPLETED|Overall Study||11
900865|NCT01770509|2176360|P2|STARTED|Overall Study||17
900866|NCT01770509|2176361|P1|STARTED|Overall Study||12
900867|NCT01770483|2176377|P2|NOT COMPLETED|Overall Study||0
900868|NCT01770483|2176378|P1|NOT COMPLETED|Overall Study||0
900869|NCT01770483|2176377|P2|COMPLETED|Overall Study||33
900870|NCT01770483|2176378|P1|COMPLETED|Overall Study||33
900871|NCT01770483|2176377|P2|STARTED|Overall Study||33
900872|NCT01770483|2176378|P1|STARTED|Overall Study||33
900873|NCT01770431|2176388|P2|NOT COMPLETED|Overall Study||32
900874|NCT01770431|2176389|P1|NOT COMPLETED|Overall Study||10
900875|NCT01770431|2176388|P2|COMPLETED|Overall Study||316
900876|NCT01770431|2176389|P1|COMPLETED|Overall Study||686
900877|NCT01770431|2176388|P2|STARTED|Overall Study||348
900878|NCT01770431|2176389|P1|STARTED|Overall Study||696
900879|NCT01770392|2176397|P1|NOT COMPLETED|Nintedanib+ Rifampicin||0
900880|NCT01770392|2176397|P1|COMPLETED|Nintedanib+ Rifampicin||25
900881|NCT01770392|2176397|P1|STARTED|Nintedanib+ Rifampicin||25
900882|NCT01770392|2176397|P1|NOT COMPLETED|Washout Period of at Least 14 Days||1
900883|NCT01770392|2176397|P1|COMPLETED|Washout Period of at Least 14 Days||25
900884|NCT01770392|2176397|P1|STARTED|Washout Period of at Least 14 Days||26
900885|NCT01770392|2176397|P1|NOT COMPLETED|Nintedanib||0
900886|NCT01770392|2176397|P1|COMPLETED|Nintedanib||26
900887|NCT01770392|2176397|P1|STARTED|Nintedanib||26
900888|NCT01770379|2176412|P3|NOT COMPLETED|Overall Study||42
900889|NCT01770379|2176413|P2|NOT COMPLETED|Overall Study||44
900890|NCT01770379|2176414|P1|NOT COMPLETED|Overall Study||39
900891|NCT01770379|2176412|P3|COMPLETED|Overall Study||39
900892|NCT01770379|2176413|P2|COMPLETED|Overall Study||37
900893|NCT01770379|2176414|P1|COMPLETED|Overall Study||41
900894|NCT01770379|2176412|P3|STARTED|Overall Study||81
900895|NCT01770379|2176413|P2|STARTED|Overall Study||81
900896|NCT01770379|2176414|P1|STARTED|Overall Study||80
900897|NCT01770366|2176433|P2|NOT COMPLETED|Overall Study||2
900898|NCT01770366|2176434|P1|NOT COMPLETED|Overall Study||2
900899|NCT01770366|2176433|P2|COMPLETED|Overall Study||4
900900|NCT01770366|2176434|P1|COMPLETED|Overall Study||2
900901|NCT01770366|2176433|P2|STARTED|Overall Study||6
900902|NCT01770366|2176434|P1|STARTED|Overall Study||4
900903|NCT01770314|2176442|P2|NOT COMPLETED|Overall Study||0
900904|NCT01770314|2176443|P1|NOT COMPLETED|Overall Study||0
900905|NCT01770314|2176442|P2|COMPLETED|Overall Study||90
900906|NCT01770314|2176443|P1|COMPLETED|Overall Study||86
900907|NCT01770314|2176442|P2|Contributed Data to One-month Follow-up|Overall Study||66
900908|NCT01770314|2176443|P1|Contributed Data to One-month Follow-up|Overall Study||61
900909|NCT01770314|2176442|P2|Contributed Data to Post-test|Overall Study||67
900910|NCT01770314|2176443|P1|Contributed Data to Post-test|Overall Study||65
900911|NCT01770314|2176442|P2|Contributed Data to Baseline|Overall Study||72
900912|NCT01770314|2176443|P1|Contributed Data to Baseline|Overall Study||68
900913|NCT01770314|2176442|P2|STARTED|Overall Study||90
900914|NCT01770314|2176443|P1|STARTED|Overall Study||86
900915|NCT01770145|2176451|P1|NOT COMPLETED|Treatment||4
900916|NCT01770145|2176451|P1|COMPLETED|Treatment||97
900917|NCT01770145|2176451|P1|STARTED|Treatment||101
900918|NCT01770145|2176451|P1|NOT COMPLETED|Baseline||26
900919|NCT01770145|2176451|P1|COMPLETED|Baseline||101
900920|NCT01770145|2176451|P1|STARTED|Baseline||127
900921|NCT01769612|2176456|P1|NOT COMPLETED|Overall Study||0
900922|NCT01769612|2176456|P1|COMPLETED|Overall Study||168
900923|NCT01769612|2176456|P1|STARTED|Overall Study||168
900924|NCT01769586|2176464|P2|NOT COMPLETED|Overall Study||0
900925|NCT01769586|2176465|P1|NOT COMPLETED|Overall Study||0
900926|NCT01769586|2176464|P2|COMPLETED|Overall Study||100
900927|NCT01769586|2176465|P1|COMPLETED|Overall Study||100
900928|NCT01769586|2176464|P2|STARTED|Overall Study||100
900929|NCT01769586|2176465|P1|STARTED|Overall Study||100
900930|NCT01769508|2176471|P1|NOT COMPLETED|Overall Study||6
900931|NCT01769508|2176471|P1|COMPLETED|Overall Study||6
900932|NCT01769508|2176471|P1|STARTED|Overall Study||12
900933|NCT01769443|2176482|P2|NOT COMPLETED|Overall Study||0
900934|NCT01769443|2176483|P1|NOT COMPLETED|Overall Study||1
900935|NCT01769443|2176482|P2|COMPLETED|Overall Study||1
900936|NCT01769443|2176483|P1|COMPLETED|Overall Study||0
900937|NCT01769443|2176482|P2|STARTED|Overall Study||1
900938|NCT01769443|2176483|P1|STARTED|Overall Study||1
900939|NCT01769391|2176527|P2|NOT COMPLETED|Overall Study||9
900940|NCT01769391|2176528|P1|NOT COMPLETED|Overall Study||20
900941|NCT01769391|2176527|P2|COMPLETED|Overall Study||48
900942|NCT01769391|2176528|P1|COMPLETED|Overall Study||90
900943|NCT01769391|2176527|P2|Received at Least One Dose of Study Drug|Overall Study||55
900944|NCT01769391|2176528|P1|Received at Least One Dose of Study Drug|Overall Study||106
900945|NCT01769391|2176527|P2|STARTED|Overall Study||57
900946|NCT01769391|2176528|P1|STARTED|Overall Study||110
900947|NCT01769378|2176547|P2|NOT COMPLETED|Overall Study||4
900948|NCT01769378|2176548|P1|NOT COMPLETED|Overall Study||25
900949|NCT01769378|2176547|P2|COMPLETED|Overall Study|Completed the study on study treatment|56
900950|NCT01769378|2176548|P1|COMPLETED|Overall Study|Completed the study on study treatment|215
900951|NCT01769378|2176547|P2|Received at Least 1 Dose of Study Drug|Overall Study||60
900952|NCT01769378|2176548|P1|Received at Least 1 Dose of Study Drug|Overall Study||239
900953|NCT01769378|2176547|P2|STARTED|Overall Study||60
900954|NCT01769378|2176548|P1|STARTED|Overall Study||240
900955|NCT01769365|2176586|P3|NOT COMPLETED|Overall Study||2
900956|NCT01769365|2176587|P2|NOT COMPLETED|Overall Study||2
900957|NCT01769365|2176588|P1|NOT COMPLETED|Overall Study||0
900958|NCT01769365|2176586|P3|COMPLETED|Overall Study||101
900959|NCT01769365|2176587|P2|COMPLETED|Overall Study||100
900960|NCT01769365|2176588|P1|COMPLETED|Overall Study||102
900961|NCT01769365|2176586|P3|STARTED|Overall Study||103
900962|NCT01769365|2176587|P2|STARTED|Overall Study||102
900963|NCT01769365|2176588|P1|STARTED|Overall Study||102
900964|NCT01769352|2176600|P4|NOT COMPLETED|Overall Study||0
900965|NCT01769352|2176601|P3|NOT COMPLETED|Overall Study||0
900966|NCT01769352|2176602|P2|NOT COMPLETED|Overall Study||0
900967|NCT01769352|2176603|P1|NOT COMPLETED|Overall Study||0
900968|NCT01769352|2176600|P4|COMPLETED|Overall Study||8
900969|NCT01769352|2176601|P3|COMPLETED|Overall Study||9
900970|NCT01769352|2176602|P2|COMPLETED|Overall Study||12
900971|NCT01769352|2176603|P1|COMPLETED|Overall Study||13
900972|NCT01769352|2176600|P4|STARTED|Overall Study||8
900973|NCT01769352|2176601|P3|STARTED|Overall Study||9
900974|NCT01769352|2176602|P2|STARTED|Overall Study||12
900975|NCT01769352|2176603|P1|STARTED|Overall Study||13
900976|NCT01769339|2176628|P1|NOT COMPLETED|Overall Study||43
900977|NCT01769339|2176628|P1|COMPLETED|Overall Study||72
900978|NCT01769339|2176628|P1|STARTED|Overall Study||115
900979|NCT01769326|2176639|P4|NOT COMPLETED|Overall Study||0
900980|NCT01769326|2176640|P3|NOT COMPLETED|Overall Study||1
900981|NCT01769326|2176641|P2|NOT COMPLETED|Overall Study||4
900982|NCT01769326|2176642|P1|NOT COMPLETED|Overall Study||2
900983|NCT01769326|2176639|P4|COMPLETED|Overall Study||8
900984|NCT01769326|2176640|P3|COMPLETED|Overall Study||8
900985|NCT01769326|2176641|P2|COMPLETED|Overall Study||8
900986|NCT01769326|2176642|P1|COMPLETED|Overall Study||9
900987|NCT01769326|2176639|P4|STARTED|Overall Study||8
900988|NCT01769326|2176640|P3|STARTED|Overall Study||9
900989|NCT01769326|2176641|P2|STARTED|Overall Study||12
900990|NCT01769326|2176642|P1|STARTED|Overall Study||11
900991|NCT01769248|2176654|P2|NOT COMPLETED|Overall Study||0
900992|NCT01769248|2176655|P1|NOT COMPLETED|Overall Study||0
900993|NCT01769248|2176654|P2|COMPLETED|Overall Study||70
900994|NCT01769248|2176655|P1|COMPLETED|Overall Study||70
900995|NCT01769248|2176654|P2|STARTED|Overall Study||70
900996|NCT01769248|2176655|P1|STARTED|Overall Study||70
900997|NCT01769222|2176663|P2|NOT COMPLETED|Overall Study||0
900998|NCT01769222|2176664|P1|NOT COMPLETED|Overall Study||0
900999|NCT01769222|2176663|P2|COMPLETED|Overall Study||0
901000|NCT01769222|2176664|P1|COMPLETED|Overall Study||3
901001|NCT01769222|2176663|P2|STARTED|Overall Study||0
901002|NCT01769222|2176664|P1|STARTED|Overall Study||3
901003|NCT01769196|2176680|P2|NOT COMPLETED|Overall Study||272
901004|NCT01769196|2176681|P1|NOT COMPLETED|Overall Study||272
901005|NCT01769196|2176680|P2|COMPLETED|Overall Study||0
901006|NCT01769196|2176681|P1|COMPLETED|Overall Study||0
901007|NCT01769196|2176680|P2|STARTED|Overall Study||272
901008|NCT01769196|2176681|P1|STARTED|Overall Study||272
901009|NCT01769105|2176711|P2|NOT COMPLETED|Cross-over||0
901010|NCT01769105|2176712|P1|NOT COMPLETED|Cross-over||5
901011|NCT01769105|2176711|P2|COMPLETED|Cross-over|Was not intended by the study protocol|0
901012|NCT01769105|2176712|P1|COMPLETED|Cross-over||9
901013|NCT01769105|2176711|P2|STARTED|Cross-over|Cross-over was only intended for the Lid margin hygiene group|0
901014|NCT01769105|2176712|P1|STARTED|Cross-over||14
901015|NCT01769105|2176711|P2|NOT COMPLETED|First Intervention||2
901016|NCT01769105|2176712|P1|NOT COMPLETED|First Intervention||2
901017|NCT01769105|2176711|P2|COMPLETED|First Intervention||17
901018|NCT01769105|2176712|P1|COMPLETED|First Intervention||14
901019|NCT01769105|2176711|P2|STARTED|First Intervention||19
901020|NCT01769105|2176712|P1|STARTED|First Intervention||16
901021|NCT01768676|2176733|P2|NOT COMPLETED|Overall Study||31
901022|NCT01768676|2176734|P1|NOT COMPLETED|Overall Study||24
901023|NCT01768676|2176733|P2|COMPLETED|Overall Study||60
901024|NCT01768676|2176734|P1|COMPLETED|Overall Study||66
901025|NCT01768676|2176733|P2|STARTED|Overall Study||91
901026|NCT01768676|2176734|P1|STARTED|Overall Study||90
901027|NCT01768572|2176751|P3|NOT COMPLETED|Overall Study||6
901028|NCT01768572|2176752|P2|NOT COMPLETED|Overall Study||12
901029|NCT01768572|2176753|P1|NOT COMPLETED|Overall Study||9
901030|NCT01768572|2176751|P3|COMPLETED|Overall Study||96
901031|NCT01768572|2176752|P2|COMPLETED|Overall Study||39
901032|NCT01768572|2176753|P1|COMPLETED|Overall Study||40
901033|NCT01768572|2176751|P3|STARTED|Overall Study||102
901034|NCT01768572|2176752|P2|STARTED|Overall Study||51
901035|NCT01768572|2176753|P1|STARTED|Overall Study||49
901036|NCT01768559|2176764|P3|NOT COMPLETED|Overall Study||13
901037|NCT01768559|2176765|P2|NOT COMPLETED|Overall Study||17
901038|NCT01768559|2176766|P1|NOT COMPLETED|Overall Study||30
901039|NCT01768559|2176764|P3|COMPLETED|Overall Study||285
901040|NCT01768559|2176765|P2|COMPLETED|Overall Study||281
901041|NCT01768559|2176766|P1|COMPLETED|Overall Study||268
901042|NCT01768559|2176764|P3|Treated|Overall Study|4 participants received Insulin Glulisine QD (for more than 50%)|297
901043|NCT01768559|2176765|P2|Treated|Overall Study|1 participant received Insulin Glulisine TID (for more than 50%)|298
901044|NCT01768559|2176766|P1|Treated|Overall Study||298
901045|NCT01768559|2176764|P3|STARTED|Overall Study||298
901046|NCT01768559|2176765|P2|STARTED|Overall Study||298
901047|NCT01768559|2176766|P1|STARTED|Overall Study||298
901048|NCT01768325|2176816|P2|NOT COMPLETED|Overall Study||0
901049|NCT01768325|2176817|P1|NOT COMPLETED|Overall Study||0
901050|NCT01768325|2176816|P2|COMPLETED|Overall Study||41
901051|NCT01768325|2176817|P1|COMPLETED|Overall Study||37
901052|NCT01768325|2176816|P2|STARTED|Overall Study||41
901053|NCT01768325|2176817|P1|STARTED|Overall Study||37
901054|NCT01768286|2176831|P4|NOT COMPLETED|Overall Study||1
901055|NCT01768286|2176832|P3|NOT COMPLETED|Overall Study||2
901056|NCT01768286|2176833|P2|NOT COMPLETED|Overall Study||4
901057|NCT01768286|2176834|P1|NOT COMPLETED|Overall Study||7
901058|NCT01768286|2176831|P4|COMPLETED|Overall Study||110
901059|NCT01768286|2176832|P3|COMPLETED|Overall Study||108
901060|NCT01768286|2176833|P2|COMPLETED|Overall Study||107
901061|NCT01768286|2176834|P1|COMPLETED|Overall Study||102
901062|NCT01768286|2176831|P4|STARTED|Overall Study||111
901063|NCT01768286|2176832|P3|STARTED|Overall Study||110
901064|NCT01768286|2176833|P2|STARTED|Overall Study||111
901065|NCT01768286|2176834|P1|STARTED|Overall Study||109
901066|NCT01768117|2176896|P1|NOT COMPLETED|Overall Study||6
901067|NCT01768117|2176896|P1|COMPLETED|Overall Study||7
901068|NCT01768117|2176896|P1|STARTED|Overall Study||13
901069|NCT01768013|2176904|P1|NOT COMPLETED|Overall Study||0
901070|NCT01768013|2176904|P1|COMPLETED|Overall Study||13
901071|NCT01768013|2176904|P1|STARTED|Overall Study||13
901072|NCT01768000|2176937|P4|NOT COMPLETED|Overall Study||2
901073|NCT01768000|2176938|P3|NOT COMPLETED|Overall Study||1
901074|NCT01768000|2176939|P2|NOT COMPLETED|Overall Study||2
901075|NCT01768000|2176940|P1|NOT COMPLETED|Overall Study||1
901076|NCT01768000|2176937|P4|COMPLETED|Overall Study||8
901077|NCT01768000|2176938|P3|COMPLETED|Overall Study||9
901078|NCT01768000|2176939|P2|COMPLETED|Overall Study||8
901079|NCT01768000|2176940|P1|COMPLETED|Overall Study||9
901080|NCT01768000|2176937|P4|STARTED|Overall Study||10
901081|NCT01768000|2176938|P3|STARTED|Overall Study||10
901082|NCT01768000|2176939|P2|STARTED|Overall Study||10
901083|NCT01768000|2176940|P1|STARTED|Overall Study||10
901084|NCT01767987|2176960|P2|NOT COMPLETED|Overall Study||1
901085|NCT01767987|2176961|P1|NOT COMPLETED|Overall Study||4
901086|NCT01767987|2176960|P2|COMPLETED|Overall Study||1
901087|NCT01767987|2176961|P1|COMPLETED|Overall Study||0
901088|NCT01767987|2176960|P2|STARTED|Overall Study||2
901089|NCT01767987|2176961|P1|STARTED|Overall Study||4
901090|NCT01767701|2176983|P1|NOT COMPLETED|Overall Study||0
901091|NCT01767701|2176983|P1|COMPLETED|Overall Study||20
901092|NCT01767701|2176983|P1|STARTED|Overall Study|All 20 patients who entered the treatment phase completed the six months trial period.|20
901093|NCT01767688|2176996|P2|NOT COMPLETED|Overall Study||0
901094|NCT01767688|2176997|P1|NOT COMPLETED|Overall Study||0
901095|NCT01767688|2176996|P2|COMPLETED|Overall Study||8
901096|NCT01767688|2176997|P1|COMPLETED|Overall Study||8
901097|NCT01767688|2176996|P2|STARTED|Overall Study||8
901098|NCT01767688|2176997|P1|STARTED|Overall Study||8
901099|NCT01767597|2177019|P2|NOT COMPLETED|Overall Study||1
901100|NCT01767597|2177020|P1|NOT COMPLETED|Overall Study||4
901101|NCT01767597|2177019|P2|COMPLETED|Overall Study||499
901102|NCT01767597|2177020|P1|COMPLETED|Overall Study||496
901103|NCT01767597|2177019|P2|STARTED|Overall Study||500
901104|NCT01767597|2177020|P1|STARTED|Overall Study||500
901105|NCT01767519|2177029|P3|NOT COMPLETED|Overall Study||5
901106|NCT01767519|2177030|P2|NOT COMPLETED|Overall Study||13
901107|NCT01767519|2177031|P1|NOT COMPLETED|Overall Study||14
901108|NCT01767519|2177029|P3|COMPLETED|Overall Study||55
901109|NCT01767519|2177030|P2|COMPLETED|Overall Study||138
901110|NCT01767519|2177031|P1|COMPLETED|Overall Study||131
901111|NCT01767519|2177029|P3|STARTED|Overall Study||60
901112|NCT01767519|2177030|P2|STARTED|Overall Study||151
901113|NCT01767519|2177031|P1|STARTED|Overall Study||145
901120|NCT01767467|2177072|P2|NOT COMPLETED|Overall Study||20
901121|NCT01767467|2177073|P1|NOT COMPLETED|Overall Study||17
901122|NCT01767467|2177072|P2|COMPLETED|Overall Study||259
901123|NCT01767467|2177073|P1|COMPLETED|Overall Study||266
901124|NCT01767467|2177072|P2|STARTED|Overall Study||279
901125|NCT01767467|2177073|P1|STARTED|Overall Study||283
901126|NCT01767376|2177104|P3|NOT COMPLETED|Overall Study||0
901127|NCT01767376|2177105|P2|NOT COMPLETED|Overall Study||3
901128|NCT01767376|2177106|P1|NOT COMPLETED|Overall Study||4
901129|NCT01767376|2177104|P3|COMPLETED|Overall Study||232
901130|NCT01767376|2177105|P2|COMPLETED|Overall Study||225
901131|NCT01767376|2177106|P1|COMPLETED|Overall Study||227
901132|NCT01767376|2177104|P3|STARTED|Overall Study||232
901133|NCT01767376|2177105|P2|STARTED|Overall Study||228
901134|NCT01767376|2177106|P1|STARTED|Overall Study||231
901135|NCT01767285|2177153|P2|NOT COMPLETED|Overall Study||6
901136|NCT01767285|2177154|P1|NOT COMPLETED|Overall Study||7
901137|NCT01767285|2177153|P2|COMPLETED|Overall Study||24
901138|NCT01767285|2177154|P1|COMPLETED|Overall Study||22
901139|NCT01767285|2177153|P2|STARTED|Overall Study||30
901140|NCT01767285|2177154|P1|STARTED|Overall Study||29
901141|NCT01767116|2177172|P2|NOT COMPLETED|Overall Study||2
901142|NCT01767116|2177173|P1|NOT COMPLETED|Overall Study||2
901143|NCT01767116|2177172|P2|COMPLETED|Overall Study||207
901144|NCT01767116|2177173|P1|COMPLETED|Overall Study||208
901145|NCT01767116|2177172|P2|STARTED|Overall Study||209
901146|NCT01767116|2177173|P1|STARTED|Overall Study||210
901147|NCT01767103|2177192|P3|NOT COMPLETED|Overall Study||0
901148|NCT01767103|2177193|P2|NOT COMPLETED|Overall Study||0
901149|NCT01767103|2177194|P1|NOT COMPLETED|Overall Study||0
901150|NCT01767103|2177192|P3|COMPLETED|Overall Study||7
901151|NCT01767103|2177193|P2|COMPLETED|Overall Study||7
901152|NCT01767103|2177194|P1|COMPLETED|Overall Study||7
901153|NCT01767103|2177192|P3|STARTED|Overall Study||7
901154|NCT01767103|2177193|P2|STARTED|Overall Study||7
901155|NCT01767103|2177194|P1|STARTED|Overall Study||7
901156|NCT01767064|2177222|P2|NOT COMPLETED|Overall Study||0
901157|NCT01767064|2177223|P1|NOT COMPLETED|Overall Study||0
901158|NCT01767064|2177222|P2|COMPLETED|Overall Study||7
901159|NCT01767064|2177223|P1|COMPLETED|Overall Study||7
901160|NCT01767064|2177222|P2|STARTED|Overall Study||7
901161|NCT01767064|2177223|P1|STARTED|Overall Study||7
901162|NCT01766921|2177231|P2|NOT COMPLETED|Overall Study||17
901163|NCT01766921|2177232|P1|NOT COMPLETED|Overall Study||24
901164|NCT01766921|2177231|P2|COMPLETED|Overall Study||676
901165|NCT01766921|2177232|P1|COMPLETED|Overall Study||676
901166|NCT01766921|2177231|P2|STARTED|Overall Study||693
901167|NCT01766921|2177232|P1|STARTED|Overall Study||700
901168|NCT01766778|2177253|P2|NOT COMPLETED|Overall Study||4
901169|NCT01766778|2177254|P1|NOT COMPLETED|Overall Study||5
901170|NCT01766778|2177253|P2|COMPLETED|Overall Study||57
901171|NCT01766778|2177254|P1|COMPLETED|Overall Study||51
901172|NCT01766778|2177253|P2|STARTED|Overall Study||61
901173|NCT01766778|2177254|P1|STARTED|Overall Study|Intent to treat population|56
901174|NCT01766713|2177272|P2|NOT COMPLETED|Overall Study||2
901175|NCT01766713|2177273|P1|NOT COMPLETED|Overall Study||2
901176|NCT01766713|2177272|P2|COMPLETED|Overall Study||23
901177|NCT01766713|2177273|P1|COMPLETED|Overall Study||23
901178|NCT01766713|2177272|P2|STARTED|Overall Study||25
901179|NCT01766713|2177273|P1|STARTED|Overall Study||25
901180|NCT01766466|2177281|P4|NOT COMPLETED|Day 5||0
901181|NCT01766466|2177282|P3|NOT COMPLETED|Day 5||0
901182|NCT01766466|2177283|P2|NOT COMPLETED|Day 5||0
901183|NCT01766466|2177284|P1|NOT COMPLETED|Day 5||0
901184|NCT01766466|2177281|P4|COMPLETED|Day 5||6
901185|NCT01766466|2177282|P3|COMPLETED|Day 5||0
901186|NCT01766466|2177283|P2|COMPLETED|Day 5||6
901187|NCT01766466|2177284|P1|COMPLETED|Day 5||0
901188|NCT01766466|2177281|P4|STARTED|Day 5||6
901189|NCT01766466|2177282|P3|STARTED|Day 5||0
901190|NCT01766466|2177283|P2|STARTED|Day 5||6
901191|NCT01766466|2177284|P1|STARTED|Day 5||0
901192|NCT01766466|2177281|P4|NOT COMPLETED|Day 1||0
901193|NCT01766466|2177282|P3|NOT COMPLETED|Day 1||0
901194|NCT01766466|2177283|P2|NOT COMPLETED|Day 1||0
901195|NCT01766466|2177284|P1|NOT COMPLETED|Day 1||0
901196|NCT01766466|2177281|P4|COMPLETED|Day 1||0
901197|NCT01766466|2177282|P3|COMPLETED|Day 1||6
901198|NCT01766466|2177283|P2|COMPLETED|Day 1||0
901199|NCT01766466|2177284|P1|COMPLETED|Day 1||6
901200|NCT01766466|2177281|P4|STARTED|Day 1||0
901201|NCT01766466|2177282|P3|STARTED|Day 1||6
901202|NCT01766466|2177283|P2|STARTED|Day 1||0
901203|NCT01766466|2177284|P1|STARTED|Day 1||6
901204|NCT01766440|2177297|P1|NOT COMPLETED|Overall Study||1
901205|NCT01766440|2177297|P1|COMPLETED|Overall Study||17
901206|NCT01766440|2177297|P1|STARTED|Overall Study||18
901207|NCT01766336|2177308|P2|NOT COMPLETED|Overall Study||75
901208|NCT01766336|2177309|P1|NOT COMPLETED|Overall Study||90
901209|NCT01766336|2177308|P2|COMPLETED|Overall Study||71
901210|NCT01766336|2177309|P1|COMPLETED|Overall Study||60
901211|NCT01766336|2177308|P2|STARTED|Overall Study||146
901212|NCT01766336|2177309|P1|STARTED|Overall Study||150
901213|NCT01766310|2177317|P2|NOT COMPLETED|Overall Study||3
901214|NCT01766310|2177318|P1|NOT COMPLETED|Overall Study||1
901215|NCT01766310|2177317|P2|COMPLETED|Overall Study||23
901216|NCT01766310|2177318|P1|COMPLETED|Overall Study||23
901217|NCT01766310|2177317|P2|STARTED|Overall Study||26
901218|NCT01766310|2177318|P1|STARTED|Overall Study||24
901219|NCT01766102|2177328|P2|NOT COMPLETED|Overall Study||0
901220|NCT01766102|2177329|P1|NOT COMPLETED|Overall Study||0
901221|NCT01766102|2177328|P2|COMPLETED|Overall Study||36
901222|NCT01766102|2177329|P1|COMPLETED|Overall Study||36
901223|NCT01766102|2177328|P2|STARTED|Overall Study||36
901224|NCT01766102|2177329|P1|STARTED|Overall Study||36
901225|NCT01766076|2177339|P2|NOT COMPLETED|Overall Study||0
901226|NCT01766076|2177340|P1|NOT COMPLETED|Overall Study||0
901227|NCT01766076|2177339|P2|COMPLETED|Overall Study||15
901228|NCT01766076|2177340|P1|COMPLETED|Overall Study||15
901229|NCT01766076|2177339|P2|STARTED|Overall Study||15
901230|NCT01766076|2177340|P1|STARTED|Overall Study||15
901231|NCT01766050|2177346|P1|NOT COMPLETED|Overall Study||4
901232|NCT01766050|2177346|P1|COMPLETED|Overall Study||18
901233|NCT01766050|2177346|P1|STARTED|Overall Study||22
901234|NCT01766037|2177481|P2|NOT COMPLETED|Overall Study||29
901235|NCT01766037|2177482|P1|NOT COMPLETED|Overall Study||29
901236|NCT01766037|2177481|P2|COMPLETED|Overall Study||31
901237|NCT01766037|2177482|P1|COMPLETED|Overall Study||82
901238|NCT01766037|2177481|P2|STARTED|Overall Study||60
901239|NCT01766037|2177482|P1|STARTED|Overall Study||111
901240|NCT01766024|2177519|P2|NOT COMPLETED|Overall Study||0
901241|NCT01766024|2177520|P1|NOT COMPLETED|Overall Study||0
901242|NCT01766024|2177519|P2|COMPLETED|Overall Study||16
901243|NCT01766024|2177520|P1|COMPLETED|Overall Study||16
901244|NCT01766024|2177519|P2|STARTED|Overall Study||16
901245|NCT01766024|2177520|P1|STARTED|Overall Study||16
901246|NCT01765972|2177530|P4|NOT COMPLETED|Overall Study||0
901247|NCT01765972|2177531|P3|NOT COMPLETED|Overall Study||0
901248|NCT01765972|2177532|P2|NOT COMPLETED|Overall Study||0
901249|NCT01765972|2177533|P1|NOT COMPLETED|Overall Study||0
901250|NCT01765972|2177530|P4|COMPLETED|Overall Study||6
901251|NCT01765972|2177531|P3|COMPLETED|Overall Study||6
901252|NCT01765972|2177532|P2|COMPLETED|Overall Study||6
901253|NCT01765972|2177533|P1|COMPLETED|Overall Study||6
901254|NCT01765972|2177530|P4|STARTED|Overall Study||6
901255|NCT01765972|2177531|P3|STARTED|Overall Study||6
901256|NCT01765972|2177532|P2|STARTED|Overall Study||6
901257|NCT01765972|2177533|P1|STARTED|Overall Study||6
901258|NCT01765803|2177543|P1|NOT COMPLETED|Overall Study||0
901259|NCT01765803|2177543|P1|COMPLETED|Overall Study||6
901260|NCT01765803|2177543|P1|STARTED|Overall Study||6
901261|NCT01765764|2177551|P3|NOT COMPLETED|Post-treatment Period||0
901262|NCT01765764|2177552|P2|NOT COMPLETED|Post-treatment Period||0
901263|NCT01765764|2177553|P1|NOT COMPLETED|Post-treatment Period||0
901264|NCT01765764|2177551|P3|COMPLETED|Post-treatment Period||112
901265|NCT01765764|2177552|P2|COMPLETED|Post-treatment Period||107
901266|NCT01765764|2177553|P1|COMPLETED|Post-treatment Period||114
901267|NCT01765764|2177551|P3|STARTED|Post-treatment Period|3 participants did not enter the Post-treatment Period [1 Personal Reasons,2 LFU].|112
901268|NCT01765764|2177552|P2|STARTED|Post-treatment Period|2 participants did not enter the Post-treatment Period [2 Lost-to-Follow-up (LFU)]|107
901269|NCT01765764|2177553|P1|STARTED|Post-treatment Period|1 participant did not enter the Post-treatment Period. [Personal Reasons]|114
901270|NCT01765764|2177551|P3|NOT COMPLETED|Treatment Period||6
901271|NCT01765764|2177552|P2|NOT COMPLETED|Treatment Period||9
901272|NCT01765764|2177553|P1|NOT COMPLETED|Treatment Period||3
901273|NCT01765764|2177551|P3|COMPLETED|Treatment Period||115
901274|NCT01765764|2177552|P2|COMPLETED|Treatment Period||109
901275|NCT01765764|2177553|P1|COMPLETED|Treatment Period||115
901276|NCT01765764|2177551|P3|STARTED|Treatment Period||121
901277|NCT01765764|2177552|P2|STARTED|Treatment Period||118
901278|NCT01765764|2177553|P1|STARTED|Treatment Period||118
901279|NCT01765582|2177573|P3|NOT COMPLETED|Overall Study||95
901280|NCT01765582|2177574|P2|NOT COMPLETED|Overall Study||92
901281|NCT01765582|2177575|P1|NOT COMPLETED|Overall Study||93
901282|NCT01765582|2177573|P3|COMPLETED|Overall Study||0
901283|NCT01765582|2177574|P2|COMPLETED|Overall Study||0
901284|NCT01765582|2177575|P1|COMPLETED|Overall Study||0
901285|NCT01765582|2177573|P3|STARTED|Overall Study||95
901286|NCT01765582|2177574|P2|STARTED|Overall Study||92
901287|NCT01765582|2177575|P1|STARTED|Overall Study||93
901288|NCT01765569|2177608|P1|NOT COMPLETED|Period C||1
901289|NCT01765569|2177608|P1|COMPLETED|Period C||27
901290|NCT01765569|2177608|P1|STARTED|Period C||28
901291|NCT01765569|2177608|P1|NOT COMPLETED|Period B||1
901292|NCT01765569|2177608|P1|COMPLETED|Period B||28
901293|NCT01765569|2177608|P1|STARTED|Period B||29
901294|NCT01765569|2177608|P1|NOT COMPLETED|Period A||0
901295|NCT01765569|2177608|P1|COMPLETED|Period A||29
901296|NCT01765569|2177608|P1|STARTED|Period A||29
901297|NCT01765543|2177629|P1|NOT COMPLETED|Overall Study||3
901298|NCT01765543|2177629|P1|COMPLETED|Overall Study||24
901299|NCT01765543|2177629|P1|STARTED|Overall Study||27
901306|NCT01765465|2177664|P2|NOT COMPLETED|Overall Study||4
901307|NCT01765465|2177665|P1|NOT COMPLETED|Overall Study||7
901308|NCT01765465|2177664|P2|COMPLETED|Overall Study||63
901309|NCT01765465|2177665|P1|COMPLETED|Overall Study||64
901310|NCT01765465|2177664|P2|STARTED|Overall Study||67
901311|NCT01765465|2177665|P1|STARTED|Overall Study||71
901312|NCT01765426|2177681|P4|NOT COMPLETED|Overall Study||0
901313|NCT01765426|2177682|P3|NOT COMPLETED|Overall Study||0
901314|NCT01765426|2177683|P2|NOT COMPLETED|Overall Study||1
901315|NCT01765426|2177684|P1|NOT COMPLETED|Overall Study||0
901316|NCT01765426|2177681|P4|COMPLETED|Overall Study||15
901317|NCT01765426|2177682|P3|COMPLETED|Overall Study||17
901318|NCT01765426|2177683|P2|COMPLETED|Overall Study||16
901319|NCT01765426|2177684|P1|COMPLETED|Overall Study||18
901320|NCT01765426|2177681|P4|Completed All Vaccinations|Overall Study||15
901321|NCT01765426|2177682|P3|Completed All Vaccinations|Overall Study||17
901322|NCT01765426|2177683|P2|Completed All Vaccinations|Overall Study||16
901323|NCT01765426|2177684|P1|Completed All Vaccinations|Overall Study||17
901324|NCT01765426|2177681|P4|STARTED|Overall Study||15
901325|NCT01765426|2177682|P3|STARTED|Overall Study||17
901326|NCT01765426|2177683|P2|STARTED|Overall Study||17
901327|NCT01765426|2177684|P1|STARTED|Overall Study||18
901328|NCT01765270|2177740|P2|NOT COMPLETED|Overall Study||1
901329|NCT01765270|2177741|P1|NOT COMPLETED|Overall Study||1
901330|NCT01765270|2177740|P2|COMPLETED|Overall Study||6
901331|NCT01765270|2177741|P1|COMPLETED|Overall Study||4
901332|NCT01765270|2177740|P2|STARTED|Overall Study||7
901333|NCT01765270|2177741|P1|STARTED|Overall Study||5
901334|NCT01765192|2177763|P2|NOT COMPLETED|End of Treatment Period 2 to Final Visit||1
901335|NCT01765192|2177764|P1|NOT COMPLETED|End of Treatment Period 2 to Final Visit||0
901336|NCT01765192|2177763|P2|COMPLETED|End of Treatment Period 2 to Final Visit||27
901337|NCT01765192|2177764|P1|COMPLETED|End of Treatment Period 2 to Final Visit||30
901338|NCT01765192|2177763|P2|STARTED|End of Treatment Period 2 to Final Visit||28
901339|NCT01765192|2177764|P1|STARTED|End of Treatment Period 2 to Final Visit||30
901340|NCT01765192|2177763|P2|NOT COMPLETED|Treatment Period 2||2
901341|NCT01765192|2177764|P1|NOT COMPLETED|Treatment Period 2||0
901342|NCT01765192|2177763|P2|COMPLETED|Treatment Period 2||28
901343|NCT01765192|2177764|P1|COMPLETED|Treatment Period 2||30
901344|NCT01765192|2177763|P2|STARTED|Treatment Period 2||30
901345|NCT01765192|2177764|P1|STARTED|Treatment Period 2||30
901346|NCT01765192|2177763|P2|NOT COMPLETED|Washout Period||1
901347|NCT01765192|2177764|P1|NOT COMPLETED|Washout Period||2
901348|NCT01765192|2177763|P2|COMPLETED|Washout Period||30
901349|NCT01765192|2177764|P1|COMPLETED|Washout Period||30
901350|NCT01765192|2177763|P2|STARTED|Washout Period||31
901351|NCT01765192|2177764|P1|STARTED|Washout Period||32
901352|NCT01765192|2177763|P2|NOT COMPLETED|Treatment Period 1||1
901353|NCT01765192|2177764|P1|NOT COMPLETED|Treatment Period 1||0
901354|NCT01765192|2177763|P2|COMPLETED|Treatment Period 1||31
901355|NCT01765192|2177764|P1|COMPLETED|Treatment Period 1||32
901356|NCT01765192|2177763|P2|STARTED|Treatment Period 1||32
901357|NCT01765192|2177764|P1|STARTED|Treatment Period 1||32
901358|NCT01765179|2177782|P1|NOT COMPLETED|Overall Study||27
901359|NCT01765179|2177782|P1|COMPLETED|Overall Study||117
901360|NCT01765179|2177782|P1|STARTED|Overall Study||144
901361|NCT01765153|2177789|P2|NOT COMPLETED|Rest Phase 2||1
901362|NCT01765153|2177790|P1|NOT COMPLETED|Rest Phase 2||2
901363|NCT01765153|2177789|P2|COMPLETED|Rest Phase 2||7
901364|NCT01765153|2177790|P1|COMPLETED|Rest Phase 2||8
901365|NCT01765153|2177789|P2|STARTED|Rest Phase 2||8
901366|NCT01765153|2177790|P1|STARTED|Rest Phase 2||10
901367|NCT01765153|2177789|P2|NOT COMPLETED|Training Phase 2||1
901368|NCT01765153|2177790|P1|NOT COMPLETED|Training Phase 2||0
901369|NCT01765153|2177789|P2|COMPLETED|Training Phase 2||8
901370|NCT01765153|2177790|P1|COMPLETED|Training Phase 2||10
901371|NCT01765153|2177789|P2|STARTED|Training Phase 2||9
901372|NCT01765153|2177790|P1|STARTED|Training Phase 2|1st subject didn't use same training(phase 1) as subsequent participants Phase 1 and 2 data removed.|10
901373|NCT01765153|2177789|P2|NOT COMPLETED|Rest Phase 1||1
901374|NCT01765153|2177790|P1|NOT COMPLETED|Rest Phase 1||0
901375|NCT01765153|2177789|P2|COMPLETED|Rest Phase 1||9
901376|NCT01765153|2177790|P1|COMPLETED|Rest Phase 1||9
901377|NCT01765153|2177789|P2|STARTED|Rest Phase 1||10
901378|NCT01765153|2177790|P1|STARTED|Rest Phase 1||9
901379|NCT01765153|2177789|P2|NOT COMPLETED|Training Phase 1||1
901380|NCT01765153|2177790|P1|NOT COMPLETED|Training Phase 1||1
901381|NCT01765153|2177789|P2|COMPLETED|Training Phase 1||10
901382|NCT01765153|2177790|P1|COMPLETED|Training Phase 1||9
901383|NCT01765153|2177789|P2|STARTED|Training Phase 1||11
901384|NCT01765153|2177790|P1|STARTED|Training Phase 1||10
901385|NCT01764997|2177897|P5|NOT COMPLETED|Study Drug Treatment Period||36
901386|NCT01764997|2177898|P4|NOT COMPLETED|Study Drug Treatment Period||0
901387|NCT01764997|2177899|P3|NOT COMPLETED|Study Drug Treatment Period||0
901388|NCT01764997|2177900|P2|NOT COMPLETED|Study Drug Treatment Period||1
901389|NCT01764997|2177901|P1|NOT COMPLETED|Study Drug Treatment Period||0
901390|NCT01764997|2177897|P5|COMPLETED|Study Drug Treatment Period||286
901391|NCT01764997|2177898|P4|COMPLETED|Study Drug Treatment Period||13
901392|NCT01764997|2177899|P3|COMPLETED|Study Drug Treatment Period||13
901393|NCT01764997|2177900|P2|COMPLETED|Study Drug Treatment Period||16
901394|NCT01764997|2177901|P1|COMPLETED|Study Drug Treatment Period||0
901395|NCT01764997|2177897|P5|STARTED|Study Drug Treatment Period||322
901396|NCT01764997|2177898|P4|STARTED|Study Drug Treatment Period||13
901397|NCT01764997|2177899|P3|STARTED|Study Drug Treatment Period||13
901398|NCT01764997|2177900|P2|STARTED|Study Drug Treatment Period||17
901399|NCT01764997|2177901|P1|STARTED|Study Drug Treatment Period||0
901400|NCT01764997|2177897|P5|NOT COMPLETED|Run-in Period||0
901401|NCT01764997|2177898|P4|NOT COMPLETED|Run-in Period||0
901402|NCT01764997|2177899|P3|NOT COMPLETED|Run-in Period||0
901403|NCT01764997|2177900|P2|NOT COMPLETED|Run-in Period||0
901404|NCT01764997|2177901|P1|NOT COMPLETED|Run-in Period||38
901405|NCT01764997|2177897|P5|COMPLETED|Run-in Period||0
901406|NCT01764997|2177898|P4|COMPLETED|Run-in Period||0
901407|NCT01764997|2177899|P3|COMPLETED|Run-in Period||0
901408|NCT01764997|2177900|P2|COMPLETED|Run-in Period||0
901409|NCT01764997|2177901|P1|COMPLETED|Run-in Period|43 participants proceeded to randomized treatment and 322 proceeded to open-label sub-study.|738
901410|NCT01764997|2177897|P5|STARTED|Run-in Period||0
901411|NCT01764997|2177898|P4|STARTED|Run-in Period||0
901412|NCT01764997|2177899|P3|STARTED|Run-in Period||0
901413|NCT01764997|2177900|P2|STARTED|Run-in Period||0
901414|NCT01764997|2177901|P1|STARTED|Run-in Period||776
901415|NCT01764945|2177928|P8|NOT COMPLETED|Overall Study||0
901416|NCT01764945|2177929|P7|NOT COMPLETED|Overall Study||1
901417|NCT01764945|2177930|P6|NOT COMPLETED|Overall Study||0
901418|NCT01764945|2177931|P5|NOT COMPLETED|Overall Study||0
901419|NCT01764945|2177932|P4|NOT COMPLETED|Overall Study||0
901420|NCT01764945|2177933|P3|NOT COMPLETED|Overall Study||0
901421|NCT01764945|2177934|P2|NOT COMPLETED|Overall Study||1
901422|NCT01764945|2177935|P1|NOT COMPLETED|Overall Study||0
901423|NCT01764945|2177928|P8|COMPLETED|Overall Study||9
901424|NCT01764945|2177929|P7|COMPLETED|Overall Study||8
901425|NCT01764945|2177930|P6|COMPLETED|Overall Study||8
901426|NCT01764945|2177931|P5|COMPLETED|Overall Study||10
901427|NCT01764945|2177932|P4|COMPLETED|Overall Study||5
901428|NCT01764945|2177933|P3|COMPLETED|Overall Study||5
901429|NCT01764945|2177934|P2|COMPLETED|Overall Study||4
901430|NCT01764945|2177935|P1|COMPLETED|Overall Study||5
901431|NCT01764945|2177928|P8|STARTED|Overall Study||9
901432|NCT01764945|2177929|P7|STARTED|Overall Study||9
901433|NCT01764945|2177930|P6|STARTED|Overall Study||8
901434|NCT01764945|2177931|P5|STARTED|Overall Study||10
901435|NCT01764945|2177932|P4|STARTED|Overall Study||5
901436|NCT01764945|2177933|P3|STARTED|Overall Study||5
901437|NCT01764945|2177934|P2|STARTED|Overall Study||5
901438|NCT01764945|2177935|P1|STARTED|Overall Study||5
901439|NCT01764919|2177969|P1|NOT COMPLETED|Overall Study||0
901440|NCT01764919|2177969|P1|COMPLETED|Overall Study||4
901441|NCT01764919|2177969|P1|STARTED|Overall Study||4
901442|NCT01764841|2177981|P4|NOT COMPLETED|Overall Study||19
901443|NCT01764841|2177982|P3|NOT COMPLETED|Overall Study||14
901444|NCT01764841|2177983|P2|NOT COMPLETED|Overall Study||26
901445|NCT01764841|2177984|P1|NOT COMPLETED|Overall Study||23
901446|NCT01764841|2177981|P4|COMPLETED|Overall Study||49
901447|NCT01764841|2177982|P3|COMPLETED|Overall Study||56
901448|NCT01764841|2177983|P2|COMPLETED|Overall Study||111
901449|NCT01764841|2177984|P1|COMPLETED|Overall Study||118
901450|NCT01764841|2177981|P4|Participants Received Treatment|Overall Study|safety population|68
901451|NCT01764841|2177982|P3|Participants Received Treatment|Overall Study|safety population|69
901452|NCT01764841|2177983|P2|Participants Received Treatment|Overall Study|safety population|136
901453|NCT01764841|2177984|P1|Participants Received Treatment|Overall Study|safety population|141
901454|NCT01764841|2177981|P4|STARTED|Overall Study||68
901455|NCT01764841|2177982|P3|STARTED|Overall Study||70
901456|NCT01764841|2177983|P2|STARTED|Overall Study||137
901457|NCT01764841|2177984|P1|STARTED|Overall Study||141
901458|NCT01764685|2178018|P2|NOT COMPLETED|Overall Study||1
901459|NCT01764685|2178019|P1|NOT COMPLETED|Overall Study||0
901460|NCT01764685|2178018|P2|COMPLETED|Overall Study||3
901461|NCT01764685|2178019|P1|COMPLETED|Overall Study||0
901462|NCT01764685|2178018|P2|STARTED|Overall Study||4
901463|NCT01764685|2178019|P1|STARTED|Overall Study||0
901464|NCT01764607|2178025|P1|NOT COMPLETED|Overall Study||0
901465|NCT01764607|2178025|P1|COMPLETED|Overall Study||1
901466|NCT01764607|2178025|P1|STARTED|Overall Study||1
901467|NCT01764386|2178032|P2|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||53
901468|NCT01764386|2178033|P1|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||16
901469|NCT01764386|2178032|P2|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|28
901470|NCT01764386|2178033|P1|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|55
901471|NCT01764386|2178032|P2|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||35
901472|NCT01764386|2178033|P1|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||61
901563|NCT01763866|2178368|P14|COMPLETED|Overall Study||57
901473|NCT01764386|2178032|P2|STARTED|Uncontrolled Treatment Period (UTP)|One subject completed the 26-week CTP, but did not continue in the UTP.|81
901474|NCT01764386|2178033|P1|STARTED|Uncontrolled Treatment Period (UTP)||71
901475|NCT01764386|2178032|P2|NOT COMPLETED|Controlled Treatment Period (CTP)||7
901476|NCT01764386|2178033|P1|NOT COMPLETED|Controlled Treatment Period (CTP)||82
901477|NCT01764386|2178032|P2|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|82
901478|NCT01764386|2178033|P1|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|71
901479|NCT01764386|2178032|P2|STARTED|Controlled Treatment Period (CTP)||89
901480|NCT01764386|2178033|P1|STARTED|Controlled Treatment Period (CTP)||153
901481|NCT01764022|2178076|P2|NOT COMPLETED|Overall Study||12
901482|NCT01764022|2178077|P1|NOT COMPLETED|Overall Study||21
901483|NCT01764022|2178076|P2|COMPLETED|Overall Study||49
901484|NCT01764022|2178077|P1|COMPLETED|Overall Study||44
901485|NCT01764022|2178076|P2|Received at Least 1 Dose of Study Drug|Overall Study||61
901486|NCT01764022|2178077|P1|Received at Least 1 Dose of Study Drug|Overall Study||63
901487|NCT01764022|2178076|P2|STARTED|Overall Study||61
901488|NCT01764022|2178077|P1|STARTED|Overall Study||65
901489|NCT01763996|2178105|P2|NOT COMPLETED|Treatment Period 2||1
901490|NCT01763996|2178106|P1|NOT COMPLETED|Treatment Period 2||0
901491|NCT01763996|2178105|P2|COMPLETED|Treatment Period 2||14
901492|NCT01763996|2178106|P1|COMPLETED|Treatment Period 2||15
901493|NCT01763996|2178105|P2|STARTED|Treatment Period 2||15
901494|NCT01763996|2178106|P1|STARTED|Treatment Period 2||15
901495|NCT01763996|2178105|P2|NOT COMPLETED|Treatment Period 1||0
901496|NCT01763996|2178106|P1|NOT COMPLETED|Treatment Period 1||0
901497|NCT01763996|2178105|P2|COMPLETED|Treatment Period 1||15
901498|NCT01763996|2178106|P1|COMPLETED|Treatment Period 1||15
901499|NCT01763996|2178105|P2|STARTED|Treatment Period 1||15
901500|NCT01763996|2178106|P1|STARTED|Treatment Period 1||15
901501|NCT01763918|2178136|P4|NOT COMPLETED|Overall Study||2
901502|NCT01763918|2178137|P3|NOT COMPLETED|Overall Study||10
901503|NCT01763918|2178138|P2|NOT COMPLETED|Overall Study||1
901504|NCT01763918|2178139|P1|NOT COMPLETED|Overall Study||6
901505|NCT01763918|2178136|P4|COMPLETED|Overall Study||108
901506|NCT01763918|2178137|P3|COMPLETED|Overall Study||101
901507|NCT01763918|2178138|P2|COMPLETED|Overall Study||54
901508|NCT01763918|2178139|P1|COMPLETED|Overall Study||49
901509|NCT01763918|2178136|P4|Received Treatment|Overall Study||110
901510|NCT01763918|2178137|P3|Received Treatment|Overall Study||110
901511|NCT01763918|2178138|P2|Received Treatment|Overall Study||55
901512|NCT01763918|2178139|P1|Received Treatment|Overall Study||54
901513|NCT01763918|2178136|P4|STARTED|Overall Study||110
901514|NCT01763918|2178137|P3|STARTED|Overall Study||111
901515|NCT01763918|2178138|P2|STARTED|Overall Study||55
901516|NCT01763918|2178139|P1|STARTED|Overall Study||55
901517|NCT01763905|2178237|P4|NOT COMPLETED|Overall Study||1
901518|NCT01763905|2178238|P3|NOT COMPLETED|Overall Study||9
901519|NCT01763905|2178239|P2|NOT COMPLETED|Overall Study||1
901520|NCT01763905|2178240|P1|NOT COMPLETED|Overall Study||6
901521|NCT01763905|2178237|P4|COMPLETED|Overall Study||101
901522|NCT01763905|2178238|P3|COMPLETED|Overall Study||94
901523|NCT01763905|2178239|P2|COMPLETED|Overall Study||50
901524|NCT01763905|2178240|P1|COMPLETED|Overall Study||45
901525|NCT01763905|2178237|P4|STARTED|Overall Study||102
901526|NCT01763905|2178238|P3|STARTED|Overall Study||103
901527|NCT01763905|2178239|P2|STARTED|Overall Study||51
901528|NCT01763905|2178240|P1|STARTED|Overall Study||51
901529|NCT01763866|2178358|P24|NOT COMPLETED|Overall Study||2
901530|NCT01763866|2178359|P23|NOT COMPLETED|Overall Study||3
901531|NCT01763866|2178360|P22|NOT COMPLETED|Overall Study||1
901532|NCT01763866|2178361|P21|NOT COMPLETED|Overall Study||4
901533|NCT01763866|2178362|P20|NOT COMPLETED|Overall Study||2
901534|NCT01763866|2178363|P19|NOT COMPLETED|Overall Study||6
901535|NCT01763866|2178364|P18|NOT COMPLETED|Overall Study||1
901536|NCT01763866|2178365|P17|NOT COMPLETED|Overall Study||1
901537|NCT01763866|2178366|P16|NOT COMPLETED|Overall Study||3
901538|NCT01763866|2178367|P15|NOT COMPLETED|Overall Study||12
901539|NCT01763866|2178368|P14|NOT COMPLETED|Overall Study||0
901540|NCT01763866|2178369|P13|NOT COMPLETED|Overall Study||4
901541|NCT01763866|2178370|P12|NOT COMPLETED|Overall Study||2
901542|NCT01763866|2178371|P11|NOT COMPLETED|Overall Study||8
901543|NCT01763866|2178372|P10|NOT COMPLETED|Overall Study||1
901544|NCT01763866|2178373|P9|NOT COMPLETED|Overall Study||3
901545|NCT01763866|2178374|P8|NOT COMPLETED|Overall Study||0
901546|NCT01763866|2178375|P7|NOT COMPLETED|Overall Study||7
901547|NCT01763866|2178376|P6|NOT COMPLETED|Overall Study||3
901548|NCT01763866|2178377|P5|NOT COMPLETED|Overall Study||2
901549|NCT01763866|2178378|P4|NOT COMPLETED|Overall Study||0
901550|NCT01763866|2178379|P3|NOT COMPLETED|Overall Study||5
901551|NCT01763866|2178380|P2|NOT COMPLETED|Overall Study||1
901552|NCT01763866|2178381|P1|NOT COMPLETED|Overall Study||2
901553|NCT01763866|2178358|P24|COMPLETED|Overall Study||113
901554|NCT01763866|2178359|P23|COMPLETED|Overall Study||109
901555|NCT01763866|2178360|P22|COMPLETED|Overall Study||54
901556|NCT01763866|2178361|P21|COMPLETED|Overall Study||52
901557|NCT01763866|2178362|P20|COMPLETED|Overall Study||110
901558|NCT01763866|2178363|P19|COMPLETED|Overall Study||105
901559|NCT01763866|2178364|P18|COMPLETED|Overall Study||55
901560|NCT01763866|2178365|P17|COMPLETED|Overall Study||55
901561|NCT01763866|2178366|P16|COMPLETED|Overall Study||112
901562|NCT01763866|2178367|P15|COMPLETED|Overall Study||102
901564|NCT01763866|2178369|P13|COMPLETED|Overall Study||54
901565|NCT01763866|2178370|P12|COMPLETED|Overall Study||108
901566|NCT01763866|2178371|P11|COMPLETED|Overall Study||102
901567|NCT01763866|2178372|P10|COMPLETED|Overall Study||53
901568|NCT01763866|2178373|P9|COMPLETED|Overall Study||53
901569|NCT01763866|2178374|P8|COMPLETED|Overall Study||55
901570|NCT01763866|2178375|P7|COMPLETED|Overall Study||48
901571|NCT01763866|2178376|P6|COMPLETED|Overall Study||107
901572|NCT01763866|2178377|P5|COMPLETED|Overall Study||108
901573|NCT01763866|2178378|P4|COMPLETED|Overall Study||55
901574|NCT01763866|2178379|P3|COMPLETED|Overall Study||51
901575|NCT01763866|2178380|P2|COMPLETED|Overall Study||54
901576|NCT01763866|2178381|P1|COMPLETED|Overall Study||54
901577|NCT01763866|2178358|P24|Received Treatment|Overall Study||115
901578|NCT01763866|2178359|P23|Received Treatment|Overall Study||112
901579|NCT01763866|2178360|P22|Received Treatment|Overall Study||55
901580|NCT01763866|2178361|P21|Received Treatment|Overall Study||56
901581|NCT01763866|2178362|P20|Received Treatment|Overall Study||112
901582|NCT01763866|2178363|P19|Received Treatment|Overall Study||111
901583|NCT01763866|2178364|P18|Received Treatment|Overall Study||55
901584|NCT01763866|2178365|P17|Received Treatment|Overall Study||56
901585|NCT01763866|2178366|P16|Received Treatment|Overall Study||115
901586|NCT01763866|2178367|P15|Received Treatment|Overall Study||113
901587|NCT01763866|2178368|P14|Received Treatment|Overall Study||57
901588|NCT01763866|2178369|P13|Received Treatment|Overall Study||58
901589|NCT01763866|2178370|P12|Received Treatment|Overall Study||110
901590|NCT01763866|2178371|P11|Received Treatment|Overall Study||109
901591|NCT01763866|2178372|P10|Received Treatment|Overall Study||54
901592|NCT01763866|2178373|P9|Received Treatment|Overall Study||56
901593|NCT01763866|2178374|P8|Received Treatment|Overall Study||55
901594|NCT01763866|2178375|P7|Received Treatment|Overall Study||55
901595|NCT01763866|2178376|P6|Received Treatment|Overall Study||110
901596|NCT01763866|2178377|P5|Received Treatment|Overall Study||110
901597|NCT01763866|2178378|P4|Received Treatment|Overall Study||55
901598|NCT01763866|2178379|P3|Received Treatment|Overall Study||56
901599|NCT01763866|2178380|P2|Received Treatment|Overall Study||55
901600|NCT01763866|2178381|P1|Received Treatment|Overall Study||56
901601|NCT01763866|2178358|P24|STARTED|Overall Study||115
901602|NCT01763866|2178359|P23|STARTED|Overall Study||112
901603|NCT01763866|2178360|P22|STARTED|Overall Study||55
901604|NCT01763866|2178361|P21|STARTED|Overall Study||56
901605|NCT01763866|2178362|P20|STARTED|Overall Study||112
901606|NCT01763866|2178363|P19|STARTED|Overall Study||111
901607|NCT01763866|2178364|P18|STARTED|Overall Study||56
901608|NCT01763866|2178365|P17|STARTED|Overall Study||56
901609|NCT01763866|2178366|P16|STARTED|Overall Study||115
901610|NCT01763866|2178367|P15|STARTED|Overall Study||114
901611|NCT01763866|2178368|P14|STARTED|Overall Study||57
901612|NCT01763866|2178369|P13|STARTED|Overall Study||58
901613|NCT01763866|2178370|P12|STARTED|Overall Study||110
901614|NCT01763866|2178371|P11|STARTED|Overall Study||110
901615|NCT01763866|2178372|P10|STARTED|Overall Study||54
901616|NCT01763866|2178373|P9|STARTED|Overall Study||56
901617|NCT01763866|2178374|P8|STARTED|Overall Study||55
901618|NCT01763866|2178375|P7|STARTED|Overall Study||55
901619|NCT01763866|2178376|P6|STARTED|Overall Study||110
901620|NCT01763866|2178377|P5|STARTED|Overall Study||110
901621|NCT01763866|2178378|P4|STARTED|Overall Study||55
901622|NCT01763866|2178379|P3|STARTED|Overall Study||56
901623|NCT01763866|2178380|P2|STARTED|Overall Study||55
901624|NCT01763866|2178381|P1|STARTED|Overall Study||56
901625|NCT01763827|2178941|P6|NOT COMPLETED|Overall Study||2
901626|NCT01763827|2178942|P5|NOT COMPLETED|Overall Study||6
901627|NCT01763827|2178943|P4|NOT COMPLETED|Overall Study||1
901628|NCT01763827|2178944|P3|NOT COMPLETED|Overall Study||4
901629|NCT01763827|2178945|P2|NOT COMPLETED|Overall Study||1
901630|NCT01763827|2178946|P1|NOT COMPLETED|Overall Study||3
901631|NCT01763827|2178941|P6|COMPLETED|Overall Study||151
901632|NCT01763827|2178942|P5|COMPLETED|Overall Study||147
901633|NCT01763827|2178943|P4|COMPLETED|Overall Study||76
901634|NCT01763827|2178944|P3|COMPLETED|Overall Study||73
901635|NCT01763827|2178945|P2|COMPLETED|Overall Study||77
901636|NCT01763827|2178946|P1|COMPLETED|Overall Study||74
901637|NCT01763827|2178941|P6|Received at Least 1 Dose of Study Drug|Overall Study||153
901638|NCT01763827|2178942|P5|Received at Least 1 Dose of Study Drug|Overall Study||153
901639|NCT01763827|2178943|P4|Received at Least 1 Dose of Study Drug|Overall Study||77
901640|NCT01763827|2178944|P3|Received at Least 1 Dose of Study Drug|Overall Study||77
901641|NCT01763827|2178945|P2|Received at Least 1 Dose of Study Drug|Overall Study||78
901642|NCT01763827|2178946|P1|Received at Least 1 Dose of Study Drug|Overall Study||76
901643|NCT01763827|2178941|P6|STARTED|Overall Study||153
901644|NCT01763827|2178942|P5|STARTED|Overall Study||153
901645|NCT01763827|2178943|P4|STARTED|Overall Study||77
901646|NCT01763827|2178944|P3|STARTED|Overall Study||77
901647|NCT01763827|2178945|P2|STARTED|Overall Study||78
901648|NCT01763827|2178946|P1|STARTED|Overall Study||77
901649|NCT01763645|2179088|P2|NOT COMPLETED|Overall Study||24
901650|NCT01763645|2179089|P1|NOT COMPLETED|Overall Study||26
901651|NCT01763645|2179088|P2|COMPLETED|Overall Study|Completed the study according the protocol.|45
901652|NCT01763645|2179089|P1|COMPLETED|Overall Study|Completed the study according the protocol.|43
901653|NCT01763645|2179088|P2|Received at Least 1 Dose of Study Drug|Overall Study||66
901749|NCT01760941|2179452|P1|STARTED|Overall Study||1
901654|NCT01763645|2179089|P1|Received at Least 1 Dose of Study Drug|Overall Study||68
901655|NCT01763645|2179088|P2|STARTED|Overall Study||69
901656|NCT01763645|2179089|P1|STARTED|Overall Study||69
901657|NCT01763567|2179107|P1|NOT COMPLETED|Overall Study||0
901658|NCT01763567|2179107|P1|COMPLETED|Overall Study||19
901659|NCT01763567|2179107|P1|STARTED|Overall Study||19
901660|NCT01763047|2179117|P2|NOT COMPLETED|Period 2||5
901661|NCT01763047|2179118|P1|NOT COMPLETED|Period 2||4
901662|NCT01763047|2179117|P2|COMPLETED|Period 2||121
901663|NCT01763047|2179118|P1|COMPLETED|Period 2||126
901664|NCT01763047|2179117|P2|Hyperopes|Period 2||54
901665|NCT01763047|2179118|P1|Hyperopes|Period 2||56
901666|NCT01763047|2179117|P2|Myopes|Period 2||72
901667|NCT01763047|2179118|P1|Myopes|Period 2||74
901668|NCT01763047|2179117|P2|STARTED|Period 2||126
901669|NCT01763047|2179118|P1|STARTED|Period 2||130
901670|NCT01763047|2179117|P2|NOT COMPLETED|Period 1||11
901671|NCT01763047|2179118|P1|NOT COMPLETED|Period 1||9
901672|NCT01763047|2179117|P2|COMPLETED|Period 1||126
901673|NCT01763047|2179118|P1|COMPLETED|Period 1||130
901674|NCT01763047|2179117|P2|Hyperopes|Period 1||61
901675|NCT01763047|2179118|P1|Hyperopes|Period 1||62
901676|NCT01763047|2179117|P2|Myopes|Period 1||76
901677|NCT01763047|2179118|P1|Myopes|Period 1||77
901678|NCT01763047|2179117|P2|STARTED|Period 1||137
901679|NCT01763047|2179118|P1|STARTED|Period 1||139
901680|NCT01762982|2179134|P1|NOT COMPLETED|Overall Study||0
901681|NCT01762982|2179134|P1|COMPLETED|Overall Study||36
901682|NCT01762982|2179134|P1|Received Empty Finn Chamber|Overall Study||36
901683|NCT01762982|2179134|P1|Received SLS|Overall Study||36
901684|NCT01762982|2179134|P1|Received Benzalkonium Chloride|Overall Study||36
901685|NCT01762982|2179134|P1|Received Saline Water|Overall Study||36
901686|NCT01762982|2179134|P1|STARTED|Overall Study||36
901687|NCT01762904|2179155|P1|NOT COMPLETED|Overall Study||0
901688|NCT01762904|2179155|P1|COMPLETED|Overall Study|October, 2013|135
901689|NCT01762904|2179155|P1|STARTED|Overall Study|January, 2013|135
901690|NCT01762800|2179164|P2|NOT COMPLETED|Overall Study||21
901691|NCT01762800|2179165|P1|NOT COMPLETED|Overall Study||19
901692|NCT01762800|2179164|P2|COMPLETED|Overall Study||183
901693|NCT01762800|2179165|P1|COMPLETED|Overall Study||183
901694|NCT01762800|2179164|P2|STARTED|Overall Study||204
901695|NCT01762800|2179165|P1|STARTED|Overall Study||202
901696|NCT01762761|2179239|P2|NOT COMPLETED|Overall Study||4
901697|NCT01762761|2179240|P1|NOT COMPLETED|Overall Study||2
901698|NCT01762761|2179239|P2|COMPLETED|Overall Study||100
901699|NCT01762761|2179240|P1|COMPLETED|Overall Study||49
901700|NCT01762761|2179239|P2|STARTED|Overall Study||104
901701|NCT01762761|2179240|P1|STARTED|Overall Study||51
901702|NCT01762722|2179294|P2|NOT COMPLETED|Overall Study||0
901703|NCT01762722|2179295|P1|NOT COMPLETED|Overall Study||0
901704|NCT01762722|2179294|P2|COMPLETED|Overall Study||11
901705|NCT01762722|2179295|P1|COMPLETED|Overall Study||12
901706|NCT01762722|2179294|P2|STARTED|Overall Study||11
901707|NCT01762722|2179295|P1|STARTED|Overall Study||12
901708|NCT01762501|2179303|P2|NOT COMPLETED|Overall Study||23
901709|NCT01762501|2179304|P1|NOT COMPLETED|Overall Study||27
901710|NCT01762501|2179303|P2|COMPLETED|Overall Study||336
901711|NCT01762501|2179304|P1|COMPLETED|Overall Study||332
901712|NCT01762501|2179303|P2|STARTED|Overall Study||359
901713|NCT01762501|2179304|P1|STARTED|Overall Study||359
901714|NCT01762345|2179318|P1|NOT COMPLETED|Overall Study||7
901715|NCT01762345|2179318|P1|COMPLETED|Overall Study||76
901716|NCT01762345|2179318|P1|STARTED|Overall Study||83
901717|NCT01762059|2179328|P1|NOT COMPLETED|Overall Study||0
901718|NCT01762059|2179328|P1|COMPLETED|Overall Study||20
901719|NCT01762059|2179328|P1|STARTED|Overall Study||20
901720|NCT01761747|2179355|P1|NOT COMPLETED|Overall Study||1
901721|NCT01761747|2179355|P1|COMPLETED|Overall Study||2
901722|NCT01761747|2179355|P1|STARTED|Overall Study||3
901723|NCT01761565|2179366|P1|NOT COMPLETED|40 Consecutive Doses of SUF 15 mcg||1
901724|NCT01761565|2179366|P1|COMPLETED|40 Consecutive Doses of SUF 15 mcg||38
901725|NCT01761565|2179366|P1|STARTED|40 Consecutive Doses of SUF 15 mcg|Subject was withdrawn from the study prior to the second arm/period due to non-compliance|39
901726|NCT01761565|2179366|P1|NOT COMPLETED|Single Dose of SUF NT 15 mcg||0
901727|NCT01761565|2179366|P1|COMPLETED|Single Dose of SUF NT 15 mcg||40
901728|NCT01761565|2179366|P1|STARTED|Single Dose of SUF NT 15 mcg||40
901729|NCT01761279|2179375|P1|NOT COMPLETED|Overall Study||0
901730|NCT01761279|2179375|P1|COMPLETED|Overall Study||84
901731|NCT01761279|2179375|P1|STARTED|Overall Study||84
901732|NCT01761175|2179390|P2|NOT COMPLETED|Overall Study||0
901733|NCT01761175|2179391|P1|NOT COMPLETED|Overall Study||0
901734|NCT01761175|2179390|P2|COMPLETED|Overall Study||112
901735|NCT01761175|2179391|P1|COMPLETED|Overall Study||112
901736|NCT01761175|2179390|P2|STARTED|Overall Study||112
901737|NCT01761175|2179391|P1|STARTED|Overall Study||112
901738|NCT01761162|2179419|P1|NOT COMPLETED|Overall Study||3
901739|NCT01761162|2179419|P1|COMPLETED|Overall Study||226
901740|NCT01761162|2179419|P1|STARTED|Overall Study||229
901741|NCT01761019|2179427|P1|NOT COMPLETED|Overall Study||0
901742|NCT01761019|2179427|P1|COMPLETED|Overall Study||8
901743|NCT01761019|2179427|P1|STARTED|Overall Study||8
901744|NCT01760993|2179435|P1|NOT COMPLETED|Overall Study||0
901745|NCT01760993|2179435|P1|COMPLETED|Overall Study||0
901746|NCT01760993|2179435|P1|STARTED|Overall Study||0
901747|NCT01760941|2179452|P1|NOT COMPLETED|Overall Study||0
901748|NCT01760941|2179452|P1|COMPLETED|Overall Study||1
901750|NCT01760889|2179462|P3|NOT COMPLETED|Overall Study||0
901751|NCT01760889|2179463|P2|NOT COMPLETED|Overall Study||0
901752|NCT01760889|2179464|P1|NOT COMPLETED|Overall Study||0
901753|NCT01760889|2179462|P3|COMPLETED|Overall Study||0
901754|NCT01760889|2179463|P2|COMPLETED|Overall Study||0
901755|NCT01760889|2179464|P1|COMPLETED|Overall Study||0
901756|NCT01760889|2179462|P3|STARTED|Overall Study||0
901757|NCT01760889|2179463|P2|STARTED|Overall Study||0
901758|NCT01760889|2179464|P1|STARTED|Overall Study||0
901759|NCT01760876|2179511|P1|NOT COMPLETED|Overall Study||6
901760|NCT01760876|2179511|P1|COMPLETED|Overall Study|12 months clinical FU of last patient in July 2015.|100
901761|NCT01760876|2179511|P1|STARTED|Overall Study||106
901762|NCT01760785|2179517|P2|NOT COMPLETED|Overall Study||0
901763|NCT01760785|2179518|P1|NOT COMPLETED|Overall Study||0
901764|NCT01760785|2179517|P2|COMPLETED|Overall Study||27
901765|NCT01760785|2179518|P1|COMPLETED|Overall Study||23
901766|NCT01760785|2179517|P2|STARTED|Overall Study||27
901767|NCT01760785|2179518|P1|STARTED|Overall Study||23
901768|NCT01760473|2179524|P1|NOT COMPLETED|Overall Study||15
901769|NCT01760473|2179524|P1|COMPLETED|Overall Study||12
901770|NCT01760473|2179524|P1|STARTED|Overall Study||27
901771|NCT01760304|2179547|P2|NOT COMPLETED|Overall Study||0
901772|NCT01760304|2179548|P1|NOT COMPLETED|Overall Study||0
901773|NCT01760304|2179547|P2|COMPLETED|Overall Study||3
901774|NCT01760304|2179548|P1|COMPLETED|Overall Study||2
901775|NCT01760304|2179547|P2|STARTED|Overall Study||3
901776|NCT01760304|2179548|P1|STARTED|Overall Study||2
901777|NCT01759602|2179558|P1|NOT COMPLETED|Overall Study||0
901778|NCT01759602|2179558|P1|COMPLETED|Overall Study||10
901779|NCT01759602|2179558|P1|STARTED|Overall Study||10
901780|NCT01759511|2179566|P1|NOT COMPLETED|Overall Study||34
901781|NCT01759511|2179566|P1|COMPLETED|Overall Study||0
901782|NCT01759511|2179566|P1|STARTED|Overall Study||34
901783|NCT01759420|2179574|P1|NOT COMPLETED|Overall Study||6
901784|NCT01759420|2179574|P1|COMPLETED|Overall Study||22
901785|NCT01759420|2179574|P1|STARTED|Overall Study||28
901786|NCT01759381|2179581|P2|NOT COMPLETED|Overall Study||0
901787|NCT01759381|2179582|P1|NOT COMPLETED|Overall Study||1
901788|NCT01759381|2179581|P2|COMPLETED|Overall Study||11
901789|NCT01759381|2179582|P1|COMPLETED|Overall Study||7
901790|NCT01759381|2179581|P2|STARTED|Overall Study||11
901791|NCT01759381|2179582|P1|STARTED|Overall Study||8
901792|NCT01759368|2179590|P2|NOT COMPLETED|Overall Study||0
901793|NCT01759368|2179591|P1|NOT COMPLETED|Overall Study||1
901794|NCT01759368|2179590|P2|COMPLETED|Overall Study||47
901795|NCT01759368|2179591|P1|COMPLETED|Overall Study||46
901796|NCT01759368|2179590|P2|STARTED|Overall Study||47
901797|NCT01759368|2179591|P1|STARTED|Overall Study||47
901798|NCT01759290|2179609|P1|NOT COMPLETED|Overall Study||81
901799|NCT01759290|2179609|P1|COMPLETED|Overall Study||1719
901800|NCT01759290|2179609|P1|STARTED|Overall Study||1800
901801|NCT01759264|2179669|P1|NOT COMPLETED|Overall Study||10
901802|NCT01759264|2179669|P1|COMPLETED|Overall Study||91
901803|NCT01759264|2179669|P1|STARTED|Overall Study||101
901804|NCT01759251|2179682|P1|NOT COMPLETED|Follow-up Period||0
901805|NCT01759251|2179682|P1|COMPLETED|Follow-up Period||305
901806|NCT01759251|2179682|P1|STARTED|Follow-up Period||305
901807|NCT01759251|2179682|P1|NOT COMPLETED|60 Days Treatment Period||0
901808|NCT01759251|2179682|P1|COMPLETED|60 Days Treatment Period||305
901809|NCT01759251|2179682|P1|STARTED|60 Days Treatment Period||305
901810|NCT01759251|2179682|P1|NOT COMPLETED|30 Days Treatment Period||4
901811|NCT01759251|2179682|P1|COMPLETED|30 Days Treatment Period||305
901812|NCT01759251|2179682|P1|STARTED|30 Days Treatment Period||309
901813|NCT01759160|2179688|P2|NOT COMPLETED|Overall Study||0
901814|NCT01759160|2179689|P1|NOT COMPLETED|Overall Study||0
901815|NCT01759160|2179688|P2|COMPLETED|Overall Study||30
901816|NCT01759160|2179689|P1|COMPLETED|Overall Study||30
901817|NCT01759160|2179688|P2|STARTED|Overall Study||30
901818|NCT01759160|2179689|P1|STARTED|Overall Study||30
901819|NCT01758900|2179697|P2|NOT COMPLETED|Overall Study||8
901820|NCT01758900|2179698|P1|NOT COMPLETED|Overall Study||7
901821|NCT01758900|2179697|P2|COMPLETED|Overall Study||100
901822|NCT01758900|2179698|P1|COMPLETED|Overall Study||99
901823|NCT01758900|2179697|P2|STARTED|Overall Study||108
901824|NCT01758900|2179698|P1|STARTED|Overall Study||106
901825|NCT01758289|2179716|P1|NOT COMPLETED|Overall Study||53
901826|NCT01758289|2179716|P1|COMPLETED|Overall Study||52
901827|NCT01758289|2179716|P1|STARTED|Overall Study||105
901828|NCT01757964|2179735|P2|NOT COMPLETED|Overall Study||0
901829|NCT01757964|2179736|P1|NOT COMPLETED|Overall Study||0
901830|NCT01757964|2179735|P2|COMPLETED|Overall Study||4
901831|NCT01757964|2179736|P1|COMPLETED|Overall Study||9
901832|NCT01757964|2179735|P2|STARTED|Overall Study||4
901833|NCT01757964|2179736|P1|STARTED|Overall Study||9
901834|NCT01757847|2179742|P2|NOT COMPLETED|Overall Study||4
901835|NCT01757847|2179743|P1|NOT COMPLETED|Overall Study||3
901836|NCT01757847|2179742|P2|COMPLETED|Overall Study||42
901837|NCT01757847|2179743|P1|COMPLETED|Overall Study||41
901838|NCT01757847|2179742|P2|STARTED|Overall Study||46
901839|NCT01757847|2179743|P1|STARTED|Overall Study||44
901840|NCT01757704|2179753|P2|NOT COMPLETED|Overall Study||3
901841|NCT01757704|2179754|P1|NOT COMPLETED|Overall Study||1
901842|NCT01757704|2179753|P2|COMPLETED|Overall Study||10
901843|NCT01757704|2179754|P1|COMPLETED|Overall Study||10
901933|NCT01756079|2179968|P1|NOT COMPLETED|Treatment / Follow-up: Week 4 to Week 72||35
901844|NCT01757704|2179753|P2|STARTED|Overall Study|Two patients excluded intraoperatively due to failure to obtain TCD signals and one due to adhesion.|13
901845|NCT01757704|2179754|P1|STARTED|Overall Study|One patient was excluded at start of surgery due to opening of the pleurae during sternotomy.|11
901846|NCT01757691|2179772|P2|NOT COMPLETED|Overall Study||0
901847|NCT01757691|2179773|P1|NOT COMPLETED|Overall Study||2
901848|NCT01757691|2179772|P2|COMPLETED|Overall Study||0
901849|NCT01757691|2179773|P1|COMPLETED|Overall Study||0
901850|NCT01757691|2179772|P2|STARTED|Overall Study||0
901851|NCT01757691|2179773|P1|STARTED|Overall Study||2
901852|NCT01757561|2179790|P4|NOT COMPLETED|Overall Study||9
901853|NCT01757561|2179791|P3|NOT COMPLETED|Overall Study||7
901854|NCT01757561|2179792|P2|NOT COMPLETED|Overall Study||6
901855|NCT01757561|2179793|P1|NOT COMPLETED|Overall Study||6
901856|NCT01757561|2179790|P4|COMPLETED|Overall Study||25
901857|NCT01757561|2179791|P3|COMPLETED|Overall Study||31
901858|NCT01757561|2179792|P2|COMPLETED|Overall Study||28
901859|NCT01757561|2179793|P1|COMPLETED|Overall Study||32
901860|NCT01757561|2179790|P4|STARTED|Overall Study||34
901861|NCT01757561|2179791|P3|STARTED|Overall Study||38
901862|NCT01757561|2179792|P2|STARTED|Overall Study||34
901863|NCT01757561|2179793|P1|STARTED|Overall Study||38
901870|NCT01757275|2179828|P2|NOT COMPLETED|Overall Study||13
901871|NCT01757275|2179829|P1|NOT COMPLETED|Overall Study||9
901872|NCT01757275|2179828|P2|COMPLETED|Overall Study||98
901873|NCT01757275|2179829|P1|COMPLETED|Overall Study||102
901874|NCT01757275|2179828|P2|STARTED|Overall Study||111
901875|NCT01757275|2179829|P1|STARTED|Overall Study||111
901876|NCT01757197|2179851|P1|NOT COMPLETED|Overall Study||2
901877|NCT01757197|2179851|P1|COMPLETED|Overall Study||0
901878|NCT01757197|2179851|P1|STARTED|Overall Study||2
901879|NCT01757184|2179858|P2|NOT COMPLETED|Open-Label Period||0
901880|NCT01757184|2179859|P1|NOT COMPLETED|Open-Label Period||0
901881|NCT01757184|2179858|P2|COMPLETED|Open-Label Period|This period is currently ongoing.|30
901882|NCT01757184|2179859|P1|COMPLETED|Open-Label Period|This period is currently ongoing.|35
901883|NCT01757184|2179858|P2|STARTED|Open-Label Period||30
901884|NCT01757184|2179859|P1|STARTED|Open-Label Period||35
901885|NCT01757184|2179858|P2|NOT COMPLETED|Double-Blind Period||0
901886|NCT01757184|2179859|P1|NOT COMPLETED|Double-Blind Period||1
901887|NCT01757184|2179858|P2|COMPLETED|Double-Blind Period||30
901888|NCT01757184|2179859|P1|COMPLETED|Double-Blind Period||35
901889|NCT01757184|2179858|P2|STARTED|Double-Blind Period||30
901890|NCT01757184|2179859|P1|STARTED|Double-Blind Period||36
901891|NCT01756976|2179883|P2|NOT COMPLETED|Overall Study||0
901892|NCT01756976|2179884|P1|NOT COMPLETED|Overall Study||3
901893|NCT01756976|2179883|P2|COMPLETED|Overall Study||8
901894|NCT01756976|2179884|P1|COMPLETED|Overall Study||73
901895|NCT01756976|2179883|P2|STARTED|Overall Study||8
901896|NCT01756976|2179884|P1|STARTED|Overall Study||76
901897|NCT01756586|2179892|P2|NOT COMPLETED|Overall Study||2
901898|NCT01756586|2179893|P1|NOT COMPLETED|Overall Study||2
901899|NCT01756586|2179892|P2|COMPLETED|Overall Study||0
901900|NCT01756586|2179893|P1|COMPLETED|Overall Study||0
901901|NCT01756586|2179892|P2|STARTED|Overall Study||2
901902|NCT01756586|2179893|P1|STARTED|Overall Study||2
901903|NCT01756391|2179899|P1|NOT COMPLETED|Overall Study||32
901904|NCT01756391|2179899|P1|COMPLETED|Overall Study||319
901905|NCT01756391|2179899|P1|STARTED|Overall Study||351
901906|NCT01756300|2179903|P1|NOT COMPLETED|Overall Study||2
901907|NCT01756300|2179903|P1|COMPLETED|Overall Study|Subjects with follow up available at 12 months|33
901908|NCT01756300|2179903|P1|STARTED|Overall Study|Subjects underwent renal denervation treatment with the study catheter.|35
901909|NCT01756274|2179925|P1|NOT COMPLETED|Overall Study||3
901910|NCT01756274|2179925|P1|COMPLETED|Overall Study||159
901911|NCT01756274|2179925|P1|STARTED|Overall Study||162
901912|NCT01756235|2179932|P1|NOT COMPLETED|Overall Study||2
901913|NCT01756235|2179932|P1|COMPLETED|Overall Study||460
901914|NCT01756235|2179932|P1|STARTED|Overall Study||462
901915|NCT01756157|2179953|P2|NOT COMPLETED|Second Intervention Period||0
901916|NCT01756157|2179954|P1|NOT COMPLETED|Second Intervention Period||0
901917|NCT01756157|2179953|P2|COMPLETED|Second Intervention Period||22
901918|NCT01756157|2179954|P1|COMPLETED|Second Intervention Period||22
901919|NCT01756157|2179953|P2|STARTED|Second Intervention Period||22
901920|NCT01756157|2179954|P1|STARTED|Second Intervention Period||22
901921|NCT01756157|2179953|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
901922|NCT01756157|2179954|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
901923|NCT01756157|2179953|P2|COMPLETED|Washout Period (at Least 7 Days)||22
901924|NCT01756157|2179954|P1|COMPLETED|Washout Period (at Least 7 Days)||22
901925|NCT01756157|2179953|P2|STARTED|Washout Period (at Least 7 Days)||22
901926|NCT01756157|2179954|P1|STARTED|Washout Period (at Least 7 Days)||22
901927|NCT01756157|2179953|P2|NOT COMPLETED|First Intervention Period||2
901928|NCT01756157|2179954|P1|NOT COMPLETED|First Intervention Period||1
901929|NCT01756157|2179953|P2|COMPLETED|First Intervention Period||22
901930|NCT01756157|2179954|P1|COMPLETED|First Intervention Period||22
901931|NCT01756157|2179953|P2|STARTED|First Intervention Period||24
901932|NCT01756157|2179954|P1|STARTED|First Intervention Period||23
901934|NCT01756079|2179968|P1|COMPLETED|Treatment / Follow-up: Week 4 to Week 72||23
901935|NCT01756079|2179968|P1|Treated in Treatment Period|Treatment / Follow-up: Week 4 to Week 72||54
901936|NCT01756079|2179968|P1|STARTED|Treatment / Follow-up: Week 4 to Week 72||58
901937|NCT01756079|2179968|P1|NOT COMPLETED|Lead-in: Day 0 to Week 4||0
901938|NCT01756079|2179968|P1|COMPLETED|Lead-in: Day 0 to Week 4||58
901939|NCT01756079|2179968|P1|STARTED|Lead-in: Day 0 to Week 4||58
901940|NCT01756053|2179974|P2|NOT COMPLETED|Period 2 (10 Days)||2
901941|NCT01756053|2179975|P1|NOT COMPLETED|Period 2 (10 Days)||0
901942|NCT01756053|2179974|P2|COMPLETED|Period 2 (10 Days)||6
901943|NCT01756053|2179975|P1|COMPLETED|Period 2 (10 Days)||7
901944|NCT01756053|2179974|P2|STARTED|Period 2 (10 Days)||8
901945|NCT01756053|2179975|P1|STARTED|Period 2 (10 Days)||7
901946|NCT01756053|2179974|P2|NOT COMPLETED|Washout Period (~21 Days)||0
901947|NCT01756053|2179975|P1|NOT COMPLETED|Washout Period (~21 Days)||0
901948|NCT01756053|2179974|P2|COMPLETED|Washout Period (~21 Days)||8
901949|NCT01756053|2179975|P1|COMPLETED|Washout Period (~21 Days)||7
901950|NCT01756053|2179974|P2|STARTED|Washout Period (~21 Days)||8
901951|NCT01756053|2179975|P1|STARTED|Washout Period (~21 Days)||7
901952|NCT01756053|2179974|P2|NOT COMPLETED|Period 1 (10 Days)||1
901953|NCT01756053|2179975|P1|NOT COMPLETED|Period 1 (10 Days)||1
901954|NCT01756053|2179974|P2|COMPLETED|Period 1 (10 Days)||8
901955|NCT01756053|2179975|P1|COMPLETED|Period 1 (10 Days)||7
901956|NCT01756053|2179974|P2|STARTED|Period 1 (10 Days)||9
901957|NCT01756053|2179975|P1|STARTED|Period 1 (10 Days)||8
901958|NCT01755702|2179995|P1|NOT COMPLETED|Period III||0
901959|NCT01755702|2179995|P1|COMPLETED|Period III||58
901960|NCT01755702|2179995|P1|Received Ibuprofen|Period III||18
901961|NCT01755702|2179995|P1|Received Paracetamol/Caffeine|Period III||10
901962|NCT01755702|2179995|P1|Received Placebo|Period III||13
901963|NCT01755702|2179995|P1|Received Paracetamol|Period III||17
901964|NCT01755702|2179995|P1|STARTED|Period III||58
901965|NCT01755702|2179995|P1|NOT COMPLETED|Washout Period II||5
901966|NCT01755702|2179995|P1|COMPLETED|Washout Period II||58
901967|NCT01755702|2179995|P1|STARTED|Washout Period II||63
901968|NCT01755702|2179995|P1|NOT COMPLETED|Period II||0
901969|NCT01755702|2179995|P1|COMPLETED|Period II||63
901970|NCT01755702|2179995|P1|Received Paracetamol|Period II||17
901971|NCT01755702|2179995|P1|Received Paracetamol/Caffeine|Period II||20
901972|NCT01755702|2179995|P1|Received Placebo|Period II||15
901973|NCT01755702|2179995|P1|Received Ibuprofen|Period II||11
901974|NCT01755702|2179995|P1|STARTED|Period II||63
901975|NCT01755702|2179995|P1|NOT COMPLETED|Wash Out Period I||3
901976|NCT01755702|2179995|P1|COMPLETED|Wash Out Period I||63
901977|NCT01755702|2179995|P1|STARTED|Wash Out Period I||66
901978|NCT01755702|2179995|P1|NOT COMPLETED|Period I||0
901979|NCT01755702|2179995|P1|COMPLETED|Period I||66
901980|NCT01755702|2179995|P1|Received Paracetamol/Caffeine|Period I||17
901981|NCT01755702|2179995|P1|Received Ibuprofen|Period I||16
901982|NCT01755702|2179995|P1|Received Placebo|Period I||17
901983|NCT01755702|2179995|P1|Received Paracetamol|Period I||16
901984|NCT01755702|2179995|P1|STARTED|Period I||66
901985|NCT01755637|2180037|P2|NOT COMPLETED|Period 2||0
901986|NCT01755637|2180038|P1|NOT COMPLETED|Period 2||0
901987|NCT01755637|2180037|P2|COMPLETED|Period 2||27
901988|NCT01755637|2180038|P1|COMPLETED|Period 2||28
901989|NCT01755637|2180037|P2|STARTED|Period 2||27
901990|NCT01755637|2180038|P1|STARTED|Period 2||28
901991|NCT01755637|2180037|P2|NOT COMPLETED|Period 1||1
901992|NCT01755637|2180038|P1|NOT COMPLETED|Period 1||0
901993|NCT01755637|2180037|P2|COMPLETED|Period 1||27
901994|NCT01755637|2180038|P1|COMPLETED|Period 1||28
901995|NCT01755637|2180037|P2|STARTED|Period 1||28
901996|NCT01755637|2180038|P1|STARTED|Period 1||28
901997|NCT01755455|2180056|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
901998|NCT01755455|2180057|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
901999|NCT01755455|2180056|P2|COMPLETED|Second Intervention (6 Weeks)||11
902000|NCT01755455|2180057|P1|COMPLETED|Second Intervention (6 Weeks)||11
902001|NCT01755455|2180056|P2|STARTED|Second Intervention (6 Weeks)||11
902002|NCT01755455|2180057|P1|STARTED|Second Intervention (6 Weeks)||11
902003|NCT01755455|2180056|P2|NOT COMPLETED|Washout (4 Weeks)||0
902004|NCT01755455|2180057|P1|NOT COMPLETED|Washout (4 Weeks)||0
902005|NCT01755455|2180056|P2|COMPLETED|Washout (4 Weeks)||11
902006|NCT01755455|2180057|P1|COMPLETED|Washout (4 Weeks)||11
902007|NCT01755455|2180056|P2|STARTED|Washout (4 Weeks)||11
902008|NCT01755455|2180057|P1|STARTED|Washout (4 Weeks)||11
902009|NCT01755455|2180056|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
902010|NCT01755455|2180057|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
902011|NCT01755455|2180056|P2|COMPLETED|First Intervention (6 Weeks)||11
902012|NCT01755455|2180057|P1|COMPLETED|First Intervention (6 Weeks)||11
902013|NCT01755455|2180056|P2|STARTED|First Intervention (6 Weeks)||11
902014|NCT01755455|2180057|P1|STARTED|First Intervention (6 Weeks)||11
902015|NCT01755234|2180071|P2|NOT COMPLETED|Overall Study||8
902016|NCT01755234|2180072|P1|NOT COMPLETED|Overall Study||15
902017|NCT01755234|2180071|P2|COMPLETED|Overall Study||37
902018|NCT01755234|2180072|P1|COMPLETED|Overall Study||30
902019|NCT01755234|2180071|P2|STARTED|Overall Study||45
902020|NCT01755234|2180072|P1|STARTED|Overall Study||45
902021|NCT01755169|2180088|P4|NOT COMPLETED|Overall Study||0
902022|NCT01755169|2180089|P3|NOT COMPLETED|Overall Study||0
902023|NCT01755169|2180090|P2|NOT COMPLETED|Overall Study||0
902024|NCT01755169|2180091|P1|NOT COMPLETED|Overall Study||0
902025|NCT01755169|2180088|P4|COMPLETED|Overall Study||1
902026|NCT01755169|2180089|P3|COMPLETED|Overall Study||0
902027|NCT01755169|2180090|P2|COMPLETED|Overall Study||1
902028|NCT01755169|2180091|P1|COMPLETED|Overall Study||2
902029|NCT01755169|2180088|P4|STARTED|Overall Study||1
902030|NCT01755169|2180089|P3|STARTED|Overall Study||0
902031|NCT01755169|2180090|P2|STARTED|Overall Study||1
902032|NCT01755169|2180091|P1|STARTED|Overall Study||2
902033|NCT01755156|2180103|P2|NOT COMPLETED|Phase B (Weeks 24-104)||36
902034|NCT01755156|2180104|P1|NOT COMPLETED|Phase B (Weeks 24-104)||39
902035|NCT01755156|2180103|P2|COMPLETED|Phase B (Weeks 24-104)||141
902036|NCT01755156|2180104|P1|COMPLETED|Phase B (Weeks 24-104)||144
902037|NCT01755156|2180103|P2|STARTED|Phase B (Weeks 24-104)||177
902038|NCT01755156|2180104|P1|STARTED|Phase B (Weeks 24-104)|1 participant who completed Phase A did not continue to Phase B.|183
902039|NCT01755156|2180103|P2|NOT COMPLETED|Phase A (Weeks 0-24)||24
902040|NCT01755156|2180104|P1|NOT COMPLETED|Phase A (Weeks 0-24)||17
902041|NCT01755156|2180103|P2|COMPLETED|Phase A (Weeks 0-24)||177
902042|NCT01755156|2180104|P1|COMPLETED|Phase A (Weeks 0-24)||184
902043|NCT01755156|2180103|P2|STARTED|Phase A (Weeks 0-24)||201
902044|NCT01755156|2180104|P1|STARTED|Phase A (Weeks 0-24)||201
902045|NCT01755143|2180150|P2|NOT COMPLETED|Overall Study||3
902046|NCT01755143|2180151|P1|NOT COMPLETED|Overall Study||11
902047|NCT01755143|2180150|P2|COMPLETED|Overall Study||86
902048|NCT01755143|2180151|P1|COMPLETED|Overall Study||166
902049|NCT01755143|2180150|P2|STARTED|Overall Study||89
902050|NCT01755143|2180151|P1|STARTED|Overall Study||177
902051|NCT01755026|2180167|P2|NOT COMPLETED|Overall Study||1
902052|NCT01755026|2180168|P1|NOT COMPLETED|Overall Study||2
902053|NCT01755026|2180167|P2|COMPLETED|Overall Study||11
902054|NCT01755026|2180168|P1|COMPLETED|Overall Study||9
902055|NCT01755026|2180167|P2|STARTED|Overall Study||12
902056|NCT01755026|2180168|P1|STARTED|Overall Study||11
902057|NCT01754922|2180176|P2|NOT COMPLETED|Overall Study||1
902058|NCT01754922|2180177|P1|NOT COMPLETED|Overall Study||0
902059|NCT01754922|2180176|P2|COMPLETED|Overall Study||17
902060|NCT01754922|2180177|P1|COMPLETED|Overall Study||32
902061|NCT01754922|2180176|P2|STARTED|Overall Study||18
902062|NCT01754922|2180177|P1|STARTED|Overall Study||32
902063|NCT01754766|2180190|P3|NOT COMPLETED|Overall Study||0
902064|NCT01754766|2180191|P2|NOT COMPLETED|Overall Study||1
902065|NCT01754766|2180192|P1|NOT COMPLETED|Overall Study||1
902066|NCT01754766|2180190|P3|COMPLETED|Overall Study||30
902067|NCT01754766|2180191|P2|COMPLETED|Overall Study||28
902068|NCT01754766|2180192|P1|COMPLETED|Overall Study||30
902069|NCT01754766|2180190|P3|STARTED|Overall Study||30
902070|NCT01754766|2180191|P2|STARTED|Overall Study||29
902071|NCT01754766|2180192|P1|STARTED|Overall Study||31
902072|NCT01754727|2180206|P1|NOT COMPLETED|Overall Study||2
902073|NCT01754727|2180206|P1|COMPLETED|Overall Study||450
902074|NCT01754727|2180206|P1|STARTED|Overall Study||452
902075|NCT01754714|2180224|P4|NOT COMPLETED|Overall Study||1
902076|NCT01754714|2180225|P3|NOT COMPLETED|Overall Study||2
902077|NCT01754714|2180226|P2|NOT COMPLETED|Overall Study||1
902078|NCT01754714|2180227|P1|NOT COMPLETED|Overall Study||0
902079|NCT01754714|2180224|P4|COMPLETED|Overall Study||27
902080|NCT01754714|2180225|P3|COMPLETED|Overall Study||24
902081|NCT01754714|2180226|P2|COMPLETED|Overall Study||26
902082|NCT01754714|2180227|P1|COMPLETED|Overall Study||27
902083|NCT01754714|2180224|P4|STARTED|Overall Study||28
902084|NCT01754714|2180225|P3|STARTED|Overall Study||26
902085|NCT01754714|2180226|P2|STARTED|Overall Study||27
902086|NCT01754714|2180227|P1|STARTED|Overall Study||27
902087|NCT01754623|2180317|P1|NOT COMPLETED|Overall Study||0
902088|NCT01754623|2180317|P1|COMPLETED|Overall Study||9
902089|NCT01754623|2180317|P1|STARTED|Overall Study||9
902090|NCT01754519|2180324|P1|NOT COMPLETED|Overall Study||0
902091|NCT01754519|2180324|P1|COMPLETED|Overall Study||1
902092|NCT01754519|2180324|P1|STARTED|Overall Study||1
902093|NCT01754493|2180333|P1|NOT COMPLETED|Overall Study||7
902094|NCT01754493|2180333|P1|COMPLETED|Overall Study||10
902095|NCT01754493|2180333|P1|STARTED|Overall Study||17
902096|NCT01754480|2180343|P2|NOT COMPLETED|Primary Part II||11
902097|NCT01754480|2180344|P1|NOT COMPLETED|Primary Part II||15
902098|NCT01754480|2180343|P2|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|102
902099|NCT01754480|2180344|P1|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|96
902100|NCT01754480|2180343|P2|Completed Study up to Week 6|Primary Part II||108
902101|NCT01754480|2180344|P1|Completed Study up to Week 6|Primary Part II||100
902102|NCT01754480|2180343|P2|STARTED|Primary Part II||113
902103|NCT01754480|2180344|P1|STARTED|Primary Part II||111
902104|NCT01754480|2180343|P2|NOT COMPLETED|Part I + Part II (Overall Study)||23
902105|NCT01754480|2180344|P1|NOT COMPLETED|Part I + Part II (Overall Study)||25
902106|NCT01754480|2180343|P2|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 3 pediatric subjects)|139
902107|NCT01754480|2180344|P1|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 2 pediatric subjects)|138
902108|NCT01754480|2180343|P2|Completed Study up to Week 6|Part I + Part II (Overall Study)||153
902109|NCT01754480|2180344|P1|Completed Study up to Week 6|Part I + Part II (Overall Study)||147
902110|NCT01754480|2180343|P2|STARTED|Part I + Part II (Overall Study)||162
902111|NCT01754480|2180344|P1|STARTED|Part I + Part II (Overall Study)||163
902112|NCT01754467|2180358|P1|NOT COMPLETED|Overall Study||1
902113|NCT01754467|2180358|P1|COMPLETED|Overall Study||8
902114|NCT01754467|2180358|P1|STARTED|Overall Study||9
902115|NCT01754402|2180368|P3|NOT COMPLETED|Overall Study||4
902116|NCT01754402|2180369|P2|NOT COMPLETED|Overall Study||2
902117|NCT01754402|2180370|P1|NOT COMPLETED|Overall Study||2
902118|NCT01754402|2180368|P3|COMPLETED|Overall Study||26
902119|NCT01754402|2180369|P2|COMPLETED|Overall Study||0
902120|NCT01754402|2180370|P1|COMPLETED|Overall Study||4
902121|NCT01754402|2180368|P3|STARTED|Overall Study||30
902122|NCT01754402|2180369|P2|STARTED|Overall Study||2
902123|NCT01754402|2180370|P1|STARTED|Overall Study||6
902124|NCT01754389|2180382|P3|NOT COMPLETED|Overall Study||0
902125|NCT01754389|2180383|P2|NOT COMPLETED|Overall Study||0
902126|NCT01754389|2180384|P1|NOT COMPLETED|Overall Study||0
902127|NCT01754389|2180382|P3|COMPLETED|Overall Study||47
902128|NCT01754389|2180383|P2|COMPLETED|Overall Study||45
902129|NCT01754389|2180384|P1|COMPLETED|Overall Study||46
902130|NCT01754389|2180382|P3|STARTED|Overall Study||47
902131|NCT01754389|2180383|P2|STARTED|Overall Study||45
902132|NCT01754389|2180384|P1|STARTED|Overall Study||46
902133|NCT01754376|2180404|P1|NOT COMPLETED|Overall Study||3
902134|NCT01754376|2180404|P1|COMPLETED|Overall Study||3
902135|NCT01754376|2180404|P1|Completed 2-week Lead in of Vemurafenib|Overall Study||6
902136|NCT01754376|2180404|P1|STARTED|Overall Study||6
902137|NCT01754259|2180415|P2|NOT COMPLETED|Overall Study||6
902138|NCT01754259|2180416|P1|NOT COMPLETED|Overall Study||5
902139|NCT01754259|2180415|P2|COMPLETED|Overall Study||18
902140|NCT01754259|2180416|P1|COMPLETED|Overall Study||18
902141|NCT01754259|2180415|P2|STARTED|Overall Study||24
902142|NCT01754259|2180416|P1|STARTED|Overall Study||23
902143|NCT01754194|2180426|P2|NOT COMPLETED|Overall Study||27
902144|NCT01754194|2180427|P1|NOT COMPLETED|Overall Study||52
902145|NCT01754194|2180426|P2|COMPLETED|Overall Study||97
902146|NCT01754194|2180427|P1|COMPLETED|Overall Study||117
902147|NCT01754194|2180426|P2|STARTED|Overall Study||124
902148|NCT01754194|2180427|P1|STARTED|Overall Study||169
902149|NCT01753856|2180449|P2|NOT COMPLETED|Overall Study||2
902150|NCT01753856|2180450|P1|NOT COMPLETED|Overall Study||3
902151|NCT01753856|2180449|P2|COMPLETED|Overall Study||34
902152|NCT01753856|2180450|P1|COMPLETED|Overall Study||30
902153|NCT01753856|2180449|P2|Completed 3-Month Bone Biopsy|Overall Study||35
902154|NCT01753856|2180450|P1|Completed 3-Month Bone Biopsy|Overall Study||31
902155|NCT01753856|2180449|P2|Received at Least 1 Dose of Study Drug|Overall Study||36
902156|NCT01753856|2180450|P1|Received at Least 1 Dose of Study Drug|Overall Study||33
902157|NCT01753856|2180449|P2|STARTED|Overall Study||36
902158|NCT01753856|2180450|P1|STARTED|Overall Study||33
902159|NCT01753713|2180502|P2|NOT COMPLETED|Overall Study||0
902160|NCT01753713|2180503|P1|NOT COMPLETED|Overall Study||0
902161|NCT01753713|2180502|P2|COMPLETED|Overall Study||19
902162|NCT01753713|2180503|P1|COMPLETED|Overall Study||14
902163|NCT01753713|2180502|P2|STARTED|Overall Study||19
902164|NCT01753713|2180503|P1|STARTED|Overall Study||14
902165|NCT01753557|2180521|P2|NOT COMPLETED|Overall Study||0
902166|NCT01753557|2180522|P1|NOT COMPLETED|Overall Study||0
902167|NCT01753557|2180521|P2|COMPLETED|Overall Study||19
902168|NCT01753557|2180522|P1|COMPLETED|Overall Study||35
902169|NCT01753557|2180521|P2|STARTED|Overall Study||19
902170|NCT01753557|2180522|P1|STARTED|Overall Study||35
902171|NCT01753518|2180540|P2|NOT COMPLETED|Postpartum Follow-up||15
902172|NCT01753518|2180541|P1|NOT COMPLETED|Postpartum Follow-up||22
902173|NCT01753518|2180540|P2|COMPLETED|Postpartum Follow-up||88
902174|NCT01753518|2180541|P1|COMPLETED|Postpartum Follow-up||81
902175|NCT01753518|2180540|P2|STARTED|Postpartum Follow-up||103
902176|NCT01753518|2180541|P1|STARTED|Postpartum Follow-up||103
902177|NCT01753518|2180540|P2|NOT COMPLETED|Intention-to-Treat Analysis||7
902178|NCT01753518|2180541|P1|NOT COMPLETED|Intention-to-Treat Analysis||7
902179|NCT01753518|2180540|P2|COMPLETED|Intention-to-Treat Analysis||103
902180|NCT01753518|2180541|P1|COMPLETED|Intention-to-Treat Analysis||103
902181|NCT01753518|2180540|P2|STARTED|Intention-to-Treat Analysis||110
902182|NCT01753518|2180541|P1|STARTED|Intention-to-Treat Analysis||110
902183|NCT01753336|2180563|P1|NOT COMPLETED|Overall Study||20
902184|NCT01753336|2180563|P1|COMPLETED|Overall Study||92
902185|NCT01753336|2180563|P1|Cycle 3|Overall Study||93
902186|NCT01753336|2180563|P1|Cycle 2|Overall Study||98
902187|NCT01753336|2180563|P1|Cycle 1|Overall Study||112
902188|NCT01753336|2180563|P1|STARTED|Overall Study||112
902189|NCT01753323|2180575|P3|NOT COMPLETED|Overall Study||9
902190|NCT01753323|2180576|P2|NOT COMPLETED|Overall Study||0
902191|NCT01753323|2180577|P1|NOT COMPLETED|Overall Study||1
902192|NCT01753323|2180575|P3|COMPLETED|Overall Study||13
902193|NCT01753323|2180576|P2|COMPLETED|Overall Study||10
902194|NCT01753323|2180577|P1|COMPLETED|Overall Study||10
902195|NCT01753323|2180575|P3|Intent-to-treat Analysis Set|Overall Study||22
902196|NCT01753323|2180576|P2|Intent-to-treat Analysis Set|Overall Study||10
902197|NCT01753323|2180577|P1|Intent-to-treat Analysis Set|Overall Study||11
902198|NCT01753323|2180575|P3|Safety Set|Overall Study||22
902199|NCT01753323|2180576|P2|Safety Set|Overall Study||10
902200|NCT01753323|2180577|P1|Safety Set|Overall Study||11
902201|NCT01753323|2180575|P3|Pharmacokinetic(PK) Set|Overall Study||21
902202|NCT01753323|2180576|P2|Pharmacokinetic(PK) Set|Overall Study||10
902203|NCT01753323|2180577|P1|Pharmacokinetic(PK) Set|Overall Study||10
902204|NCT01753323|2180575|P3|Pharmacodynamic (PD) Set|Overall Study||21
902205|NCT01753323|2180576|P2|Pharmacodynamic (PD) Set|Overall Study||10
902206|NCT01753323|2180577|P1|Pharmacodynamic (PD) Set|Overall Study||10
902207|NCT01753323|2180575|P3|STARTED|Overall Study||22
902208|NCT01753323|2180576|P2|STARTED|Overall Study||10
902209|NCT01753323|2180577|P1|STARTED|Overall Study||11
902210|NCT01753310|2180615|P2|NOT COMPLETED|Overall Study||24
902211|NCT01753310|2180616|P1|NOT COMPLETED|Overall Study||32
902212|NCT01753310|2180615|P2|COMPLETED|Overall Study||21
902213|NCT01753310|2180616|P1|COMPLETED|Overall Study||57
902214|NCT01753310|2180615|P2|STARTED|Overall Study||45
902215|NCT01753310|2180616|P1|STARTED|Overall Study||89
902216|NCT01753115|2180639|P3|NOT COMPLETED|Overall Study||14
902217|NCT01753115|2180640|P2|NOT COMPLETED|Overall Study||15
902218|NCT01753115|2180641|P1|NOT COMPLETED|Overall Study||12
902219|NCT01753115|2180639|P3|COMPLETED|Overall Study||56
902220|NCT01753115|2180640|P2|COMPLETED|Overall Study||25
902221|NCT01753115|2180641|P1|COMPLETED|Overall Study||32
902222|NCT01753115|2180639|P3|Treated|Overall Study||67
902223|NCT01753115|2180640|P2|Treated|Overall Study||39
902224|NCT01753115|2180641|P1|Treated|Overall Study||38
902225|NCT01753115|2180639|P3|STARTED|Overall Study||70
902226|NCT01753115|2180640|P2|STARTED|Overall Study||40
902227|NCT01753115|2180641|P1|STARTED|Overall Study||44
902228|NCT01753076|2180651|P2|NOT COMPLETED|Overall Study||46
902229|NCT01753076|2180652|P1|NOT COMPLETED|Overall Study||41
902230|NCT01753076|2180651|P2|COMPLETED|Overall Study||106
902231|NCT01753076|2180652|P1|COMPLETED|Overall Study||110
902232|NCT01753076|2180651|P2|STARTED|Overall Study||152
902233|NCT01753076|2180652|P1|STARTED|Overall Study||151
902234|NCT01752907|2180678|P2|NOT COMPLETED|Overall Study||20
902235|NCT01752907|2180679|P1|NOT COMPLETED|Overall Study||12
902236|NCT01752907|2180678|P2|COMPLETED|Overall Study||133
902237|NCT01752907|2180679|P1|COMPLETED|Overall Study||139
902238|NCT01752907|2180678|P2|Received Pegfilgrastim|Overall Study||151
902239|NCT01752907|2180679|P1|Received Pegfilgrastim|Overall Study||149
902240|NCT01752907|2180678|P2|STARTED|Overall Study||153
902241|NCT01752907|2180679|P1|STARTED|Overall Study||151
902242|NCT01752855|2180699|P2|NOT COMPLETED|Overall Study||4
902243|NCT01752855|2180700|P1|NOT COMPLETED|Overall Study||1
902244|NCT01752855|2180699|P2|COMPLETED|Overall Study||40
902245|NCT01752855|2180700|P1|COMPLETED|Overall Study||43
902246|NCT01752855|2180699|P2|STARTED|Overall Study||44
902247|NCT01752855|2180700|P1|STARTED|Overall Study||44
902248|NCT01752023|2180716|P2|NOT COMPLETED|Overall Study||1
902249|NCT01752023|2180717|P1|NOT COMPLETED|Overall Study||2
902250|NCT01752023|2180716|P2|COMPLETED|Overall Study||0
902251|NCT01752023|2180717|P1|COMPLETED|Overall Study||0
902252|NCT01752023|2180716|P2|STARTED|Overall Study||1
902253|NCT01752023|2180717|P1|STARTED|Overall Study||2
902254|NCT01751867|2180735|P2|NOT COMPLETED|Overall Study||99
902255|NCT01751867|2180736|P1|NOT COMPLETED|Overall Study||36
902256|NCT01751867|2180735|P2|COMPLETED|Overall Study||0
902257|NCT01751867|2180736|P1|COMPLETED|Overall Study||0
902258|NCT01751867|2180735|P2|Treated|Overall Study||98
902259|NCT01751867|2180736|P1|Treated|Overall Study||34
902260|NCT01751867|2180735|P2|STARTED|Overall Study||99
902261|NCT01751867|2180736|P1|STARTED|Overall Study||36
902262|NCT01751802|2180756|P2|NOT COMPLETED|Overall Study||2
902263|NCT01751802|2180757|P1|NOT COMPLETED|Overall Study||4
902264|NCT01751802|2180756|P2|COMPLETED|Overall Study||2
902265|NCT01751802|2180757|P1|COMPLETED|Overall Study||1
902266|NCT01751802|2180756|P2|Completed Period 3|Overall Study||1
902267|NCT01751802|2180757|P1|Completed Period 3|Overall Study||2
902268|NCT01751802|2180756|P2|Completed Period 2|Overall Study||1
902269|NCT01751802|2180757|P1|Completed Period 2|Overall Study||2
902270|NCT01751802|2180756|P2|Completed Period 1|Overall Study||4
902271|NCT01751802|2180757|P1|Completed Period 1|Overall Study||2
902272|NCT01751802|2180756|P2|STARTED|Overall Study||4
902273|NCT01751802|2180757|P1|STARTED|Overall Study||5
902274|NCT01751724|2180771|P2|NOT COMPLETED|Overall Study||2
902275|NCT01751724|2180772|P1|NOT COMPLETED|Overall Study||1
902276|NCT01751724|2180771|P2|COMPLETED|Overall Study||42
902277|NCT01751724|2180772|P1|COMPLETED|Overall Study||41
902278|NCT01751724|2180771|P2|STARTED|Overall Study||44
902279|NCT01751724|2180772|P1|STARTED|Overall Study||42
902280|NCT01751386|2180800|P2|NOT COMPLETED|Overall Study||3
902281|NCT01751386|2180801|P1|NOT COMPLETED|Overall Study||2
902282|NCT01751386|2180800|P2|COMPLETED|Overall Study||16
902283|NCT01751386|2180801|P1|COMPLETED|Overall Study||18
902284|NCT01751386|2180800|P2|STARTED|Overall Study||19
902285|NCT01751386|2180801|P1|STARTED|Overall Study||20
902286|NCT01751308|2180812|P5|NOT COMPLETED|Phase 2||0
902287|NCT01751308|2180813|P4|NOT COMPLETED|Phase 2||0
902288|NCT01751308|2180814|P3|NOT COMPLETED|Phase 2||0
902289|NCT01751308|2180815|P2|NOT COMPLETED|Phase 2||0
902290|NCT01751308|2180816|P1|NOT COMPLETED|Phase 2||0
902291|NCT01751308|2180812|P5|COMPLETED|Phase 2|DP, AE and death were considered as completed (defined in protocol)|16
902292|NCT01751308|2180813|P4|COMPLETED|Phase 2||0
902293|NCT01751308|2180814|P3|COMPLETED|Phase 2||0
902294|NCT01751308|2180815|P2|COMPLETED|Phase 2||0
902295|NCT01751308|2180816|P1|COMPLETED|Phase 2||0
902296|NCT01751308|2180812|P5|STARTED|Phase 2|Phase 1 and Phase 2 were separate populations.|16
902297|NCT01751308|2180813|P4|STARTED|Phase 2||0
902298|NCT01751308|2180814|P3|STARTED|Phase 2||0
902299|NCT01751308|2180815|P2|STARTED|Phase 2||0
902300|NCT01751308|2180816|P1|STARTED|Phase 2||0
902301|NCT01751308|2180812|P5|NOT COMPLETED|Phase 1||0
902302|NCT01751308|2180813|P4|NOT COMPLETED|Phase 1||0
902303|NCT01751308|2180814|P3|NOT COMPLETED|Phase 1||0
902304|NCT01751308|2180815|P2|NOT COMPLETED|Phase 1||0
902305|NCT01751308|2180816|P1|NOT COMPLETED|Phase 1||0
902306|NCT01751308|2180812|P5|COMPLETED|Phase 1||0
902307|NCT01751308|2180813|P4|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
902308|NCT01751308|2180814|P3|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
902309|NCT01751308|2180815|P2|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|3
902310|NCT01751308|2180816|P1|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|6
902311|NCT01751308|2180812|P5|STARTED|Phase 1|Phase 1 and Phase 2 were separate populations.|0
902312|NCT01751308|2180813|P4|STARTED|Phase 1||7
902313|NCT01751308|2180814|P3|STARTED|Phase 1||7
902314|NCT01751308|2180815|P2|STARTED|Phase 1||3
902315|NCT01751308|2180816|P1|STARTED|Phase 1||6
902316|NCT01751178|2180856|P3|NOT COMPLETED|Overall Study||2
902317|NCT01751178|2180857|P2|NOT COMPLETED|Overall Study||0
902318|NCT01751178|2180858|P1|NOT COMPLETED|Overall Study||3
902319|NCT01751178|2180856|P3|COMPLETED|Overall Study||105
902320|NCT01751178|2180857|P2|COMPLETED|Overall Study||109
902321|NCT01751178|2180858|P1|COMPLETED|Overall Study||105
902322|NCT01751178|2180856|P3|STARTED|Overall Study||107
902323|NCT01751178|2180857|P2|STARTED|Overall Study||109
902324|NCT01751178|2180858|P1|STARTED|Overall Study||108
902325|NCT01751165|2180878|P3|NOT COMPLETED|Overall Study||3
902326|NCT01751165|2180879|P2|NOT COMPLETED|Overall Study||3
902327|NCT01751165|2180880|P1|NOT COMPLETED|Overall Study||2
902328|NCT01751165|2180878|P3|COMPLETED|Overall Study||113
902329|NCT01751165|2180879|P2|COMPLETED|Overall Study||116
902330|NCT01751165|2180880|P1|COMPLETED|Overall Study||117
902331|NCT01751165|2180878|P3|STARTED|Overall Study||116
902332|NCT01751165|2180879|P2|STARTED|Overall Study||119
902333|NCT01751165|2180880|P1|STARTED|Overall Study||119
902334|NCT01751113|2180920|P6|NOT COMPLETED|Treatment Period 3 (4 Weeks)||1
902335|NCT01751113|2180921|P5|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
902336|NCT01751113|2180922|P4|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
902337|NCT01751113|2180923|P3|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
902338|NCT01751113|2180924|P2|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
902339|NCT01751113|2180925|P1|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
902340|NCT01751113|2180920|P6|COMPLETED|Treatment Period 3 (4 Weeks)||9
902341|NCT01751113|2180921|P5|COMPLETED|Treatment Period 3 (4 Weeks)||8
902342|NCT01751113|2180922|P4|COMPLETED|Treatment Period 3 (4 Weeks)||8
902343|NCT01751113|2180923|P3|COMPLETED|Treatment Period 3 (4 Weeks)||9
902344|NCT01751113|2180924|P2|COMPLETED|Treatment Period 3 (4 Weeks)||8
902345|NCT01751113|2180925|P1|COMPLETED|Treatment Period 3 (4 Weeks)||8
902346|NCT01751113|2180920|P6|STARTED|Treatment Period 3 (4 Weeks)||10
902347|NCT01751113|2180921|P5|STARTED|Treatment Period 3 (4 Weeks)||8
902348|NCT01751113|2180922|P4|STARTED|Treatment Period 3 (4 Weeks)||8
902349|NCT01751113|2180923|P3|STARTED|Treatment Period 3 (4 Weeks)||9
902350|NCT01751113|2180924|P2|STARTED|Treatment Period 3 (4 Weeks)||8
902351|NCT01751113|2180925|P1|STARTED|Treatment Period 3 (4 Weeks)||8
902352|NCT01751113|2180920|P6|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
902353|NCT01751113|2180921|P5|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
902354|NCT01751113|2180922|P4|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
902355|NCT01751113|2180923|P3|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
902356|NCT01751113|2180924|P2|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
902357|NCT01751113|2180925|P1|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
902358|NCT01751113|2180920|P6|COMPLETED|Washout Period 2 (2 Weeks)||10
902359|NCT01751113|2180921|P5|COMPLETED|Washout Period 2 (2 Weeks)||8
902360|NCT01751113|2180922|P4|COMPLETED|Washout Period 2 (2 Weeks)||8
902361|NCT01751113|2180923|P3|COMPLETED|Washout Period 2 (2 Weeks)||9
902362|NCT01751113|2180924|P2|COMPLETED|Washout Period 2 (2 Weeks)||8
902363|NCT01751113|2180925|P1|COMPLETED|Washout Period 2 (2 Weeks)||8
902364|NCT01751113|2180920|P6|STARTED|Washout Period 2 (2 Weeks)||10
902365|NCT01751113|2180921|P5|STARTED|Washout Period 2 (2 Weeks)||8
902366|NCT01751113|2180922|P4|STARTED|Washout Period 2 (2 Weeks)||8
902367|NCT01751113|2180923|P3|STARTED|Washout Period 2 (2 Weeks)||9
902368|NCT01751113|2180924|P2|STARTED|Washout Period 2 (2 Weeks)||8
902369|NCT01751113|2180925|P1|STARTED|Washout Period 2 (2 Weeks)||8
902370|NCT01751113|2180920|P6|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
902371|NCT01751113|2180921|P5|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
902372|NCT01751113|2180922|P4|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
902373|NCT01751113|2180923|P3|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
902374|NCT01751113|2180924|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
902375|NCT01751113|2180925|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
902376|NCT01751113|2180920|P6|COMPLETED|Treatment Period 2 (4 Weeks)||10
902377|NCT01751113|2180921|P5|COMPLETED|Treatment Period 2 (4 Weeks)||8
902378|NCT01751113|2180922|P4|COMPLETED|Treatment Period 2 (4 Weeks)||8
902379|NCT01751113|2180923|P3|COMPLETED|Treatment Period 2 (4 Weeks)||9
902380|NCT01751113|2180924|P2|COMPLETED|Treatment Period 2 (4 Weeks)||8
902381|NCT01751113|2180925|P1|COMPLETED|Treatment Period 2 (4 Weeks)||8
902382|NCT01751113|2180920|P6|STARTED|Treatment Period 2 (4 Weeks)||10
902383|NCT01751113|2180921|P5|STARTED|Treatment Period 2 (4 Weeks)||8
902384|NCT01751113|2180922|P4|STARTED|Treatment Period 2 (4 Weeks)||8
902385|NCT01751113|2180923|P3|STARTED|Treatment Period 2 (4 Weeks)||9
902386|NCT01751113|2180924|P2|STARTED|Treatment Period 2 (4 Weeks)||8
902387|NCT01751113|2180925|P1|STARTED|Treatment Period 2 (4 Weeks)||8
902388|NCT01751113|2180920|P6|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
902389|NCT01751113|2180921|P5|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
902390|NCT01751113|2180922|P4|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
902391|NCT01751113|2180923|P3|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
902392|NCT01751113|2180924|P2|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
902393|NCT01751113|2180925|P1|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
902394|NCT01751113|2180920|P6|COMPLETED|Washout Period 1 (2 Weeks)||10
902395|NCT01751113|2180921|P5|COMPLETED|Washout Period 1 (2 Weeks)||8
902396|NCT01751113|2180922|P4|COMPLETED|Washout Period 1 (2 Weeks)||8
902397|NCT01751113|2180923|P3|COMPLETED|Washout Period 1 (2 Weeks)||9
902398|NCT01751113|2180924|P2|COMPLETED|Washout Period 1 (2 Weeks)||8
902399|NCT01751113|2180925|P1|COMPLETED|Washout Period 1 (2 Weeks)||8
902400|NCT01751113|2180920|P6|STARTED|Washout Period 1 (2 Weeks)||10
902401|NCT01751113|2180921|P5|STARTED|Washout Period 1 (2 Weeks)||8
902402|NCT01751113|2180922|P4|STARTED|Washout Period 1 (2 Weeks)||8
902403|NCT01751113|2180923|P3|STARTED|Washout Period 1 (2 Weeks)||9
902404|NCT01751113|2180924|P2|STARTED|Washout Period 1 (2 Weeks)||8
902405|NCT01751113|2180925|P1|STARTED|Washout Period 1 (2 Weeks)||8
902406|NCT01751113|2180920|P6|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
902407|NCT01751113|2180921|P5|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
902408|NCT01751113|2180922|P4|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
902409|NCT01751113|2180923|P3|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
902410|NCT01751113|2180924|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
902411|NCT01751113|2180925|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
902412|NCT01751113|2180920|P6|COMPLETED|Treatment Period 1 (4 Weeks)||10
902413|NCT01751113|2180921|P5|COMPLETED|Treatment Period 1 (4 Weeks)||8
902414|NCT01751113|2180922|P4|COMPLETED|Treatment Period 1 (4 Weeks)||8
902415|NCT01751113|2180923|P3|COMPLETED|Treatment Period 1 (4 Weeks)||9
902416|NCT01751113|2180924|P2|COMPLETED|Treatment Period 1 (4 Weeks)||8
902417|NCT01751113|2180925|P1|COMPLETED|Treatment Period 1 (4 Weeks)||8
902418|NCT01751113|2180920|P6|STARTED|Treatment Period 1 (4 Weeks)||10
902419|NCT01751113|2180921|P5|STARTED|Treatment Period 1 (4 Weeks)||9
902420|NCT01751113|2180922|P4|STARTED|Treatment Period 1 (4 Weeks)||9
902421|NCT01751113|2180923|P3|STARTED|Treatment Period 1 (4 Weeks)||9
902422|NCT01751113|2180924|P2|STARTED|Treatment Period 1 (4 Weeks)||8
902423|NCT01751113|2180925|P1|STARTED|Treatment Period 1 (4 Weeks)||8
902424|NCT01751087|2180966|P3|NOT COMPLETED|Overall Study||1
902425|NCT01751087|2180967|P2|NOT COMPLETED|Overall Study||0
902426|NCT01751087|2180968|P1|NOT COMPLETED|Overall Study||1
902427|NCT01751087|2180966|P3|COMPLETED|Overall Study||99
902428|NCT01751087|2180967|P2|COMPLETED|Overall Study||100
902429|NCT01751087|2180968|P1|COMPLETED|Overall Study||99
902430|NCT01751087|2180966|P3|STARTED|Overall Study||100
902431|NCT01751087|2180967|P2|STARTED|Overall Study||100
902432|NCT01751087|2180968|P1|STARTED|Overall Study||100
902433|NCT01751022|2181003|P3|NOT COMPLETED|Overall Study||27
902434|NCT01751022|2181004|P2|NOT COMPLETED|Overall Study||44
902435|NCT01751022|2181005|P1|NOT COMPLETED|Overall Study||56
902436|NCT01751022|2181003|P3|COMPLETED|Overall Study|6 month visit|273
902437|NCT01751022|2181004|P2|COMPLETED|Overall Study|6 month visit|282
902438|NCT01751022|2181005|P1|COMPLETED|Overall Study|6 month visit|443
902439|NCT01751022|2181003|P3|STARTED|Overall Study||300
902440|NCT01751022|2181004|P2|STARTED|Overall Study||326
902441|NCT01751022|2181005|P1|STARTED|Overall Study||499
902442|NCT01750931|2181037|P2|NOT COMPLETED|Period 2||0
902443|NCT01750931|2181038|P1|NOT COMPLETED|Period 2||0
902444|NCT01750931|2181037|P2|COMPLETED|Period 2||14
902445|NCT01750931|2181038|P1|COMPLETED|Period 2||14
902446|NCT01750931|2181037|P2|STARTED|Period 2||14
902447|NCT01750931|2181038|P1|STARTED|Period 2||14
902448|NCT01750931|2181037|P2|NOT COMPLETED|Wash Out||0
902449|NCT01750931|2181038|P1|NOT COMPLETED|Wash Out||0
902450|NCT01750931|2181037|P2|COMPLETED|Wash Out||14
902451|NCT01750931|2181038|P1|COMPLETED|Wash Out||14
902452|NCT01750931|2181037|P2|STARTED|Wash Out||14
902453|NCT01750931|2181038|P1|STARTED|Wash Out||14
902454|NCT01750931|2181037|P2|NOT COMPLETED|Period 1||0
902455|NCT01750931|2181038|P1|NOT COMPLETED|Period 1||0
902456|NCT01750931|2181037|P2|COMPLETED|Period 1||14
902457|NCT01750931|2181038|P1|COMPLETED|Period 1||14
902458|NCT01750931|2181037|P2|STARTED|Period 1||14
902459|NCT01750931|2181038|P1|STARTED|Period 1||14
902460|NCT01750840|2181056|P1|NOT COMPLETED|Overall Study||4
902461|NCT01750840|2181056|P1|COMPLETED|Overall Study||4
902462|NCT01750840|2181056|P1|STARTED|Overall Study||8
902463|NCT01750684|2181063|P2|NOT COMPLETED|Overall Study||2
902464|NCT01750684|2181064|P1|NOT COMPLETED|Overall Study||2
902465|NCT01750684|2181063|P2|COMPLETED|Overall Study||5
902466|NCT01750684|2181064|P1|COMPLETED|Overall Study||4
902467|NCT01750684|2181063|P2|STARTED|Overall Study||7
902468|NCT01750684|2181064|P1|STARTED|Overall Study||6
902469|NCT01750502|2181072|P2|NOT COMPLETED|Overall Study||0
902470|NCT01750502|2181073|P1|NOT COMPLETED|Overall Study||0
902471|NCT01750502|2181072|P2|COMPLETED|Overall Study||186
902472|NCT01750502|2181073|P1|COMPLETED|Overall Study||70
902473|NCT01750502|2181072|P2|STARTED|Overall Study||186
902474|NCT01750502|2181073|P1|STARTED|Overall Study||70
902475|NCT01750398|2181086|P1|NOT COMPLETED|Bipolar Androgen Thearpy Phase||3
902476|NCT01750398|2181086|P1|COMPLETED|Bipolar Androgen Thearpy Phase||26
902477|NCT01750398|2181086|P1|STARTED|Bipolar Androgen Thearpy Phase||29
902478|NCT01750398|2181086|P1|NOT COMPLETED|ADT Lead In Phase||4
902479|NCT01750398|2181086|P1|COMPLETED|ADT Lead In Phase||29
902480|NCT01750398|2181086|P1|STARTED|ADT Lead In Phase||33
902481|NCT01750346|2181099|P3|NOT COMPLETED|Overall Study||0
902482|NCT01750346|2181100|P2|NOT COMPLETED|Overall Study||0
902483|NCT01750346|2181101|P1|NOT COMPLETED|Overall Study||1
902484|NCT01750346|2181099|P3|COMPLETED|Overall Study||3
902485|NCT01750346|2181100|P2|COMPLETED|Overall Study||2
902486|NCT01750346|2181101|P1|COMPLETED|Overall Study||2
902487|NCT01750346|2181099|P3|STARTED|Overall Study||3
902488|NCT01750346|2181100|P2|STARTED|Overall Study||2
902489|NCT01750346|2181101|P1|STARTED|Overall Study||3
902490|NCT01750294|2181127|P1|NOT COMPLETED|Overall Study||2
902491|NCT01750294|2181127|P1|COMPLETED|Overall Study||12
902492|NCT01750294|2181127|P1|STARTED|Overall Study||14
902493|NCT01750281|2181134|P3|NOT COMPLETED|Overall Study||84
902494|NCT01750281|2181135|P2|NOT COMPLETED|Overall Study||85
902495|NCT01750281|2181136|P1|NOT COMPLETED|Overall Study||43
902496|NCT01750281|2181134|P3|COMPLETED|Overall Study||0
902497|NCT01750281|2181135|P2|COMPLETED|Overall Study||0
902498|NCT01750281|2181136|P1|COMPLETED|Overall Study||0
902499|NCT01750281|2181134|P3|Did Not Receive Treatment|Overall Study||0
902500|NCT01750281|2181135|P2|Did Not Receive Treatment|Overall Study||1
902501|NCT01750281|2181136|P1|Did Not Receive Treatment|Overall Study||0
902502|NCT01750281|2181134|P3|Received Treatment|Overall Study||84
902503|NCT01750281|2181135|P2|Received Treatment|Overall Study||84
902504|NCT01750281|2181136|P1|Received Treatment|Overall Study||43
902505|NCT01750281|2181134|P3|STARTED|Overall Study||84
902506|NCT01750281|2181135|P2|STARTED|Overall Study||85
902507|NCT01750281|2181136|P1|STARTED|Overall Study||43
902508|NCT01750255|2181149|P2|NOT COMPLETED|Overall Study||5
902509|NCT01750255|2181150|P1|NOT COMPLETED|Overall Study||6
902510|NCT01750255|2181149|P2|COMPLETED|Overall Study||38
902511|NCT01750255|2181150|P1|COMPLETED|Overall Study||43
902512|NCT01750255|2181149|P2|STARTED|Overall Study||43
902513|NCT01750255|2181150|P1|STARTED|Overall Study||49
902514|NCT01750242|2181166|P1|NOT COMPLETED|Overall Study||3
902515|NCT01750242|2181166|P1|COMPLETED|Overall Study||20
902516|NCT01750242|2181166|P1|Readable Images|Overall Study|Subjects with readable images were analyzed and there were 3 subjects with unreadable images.|20
902517|NCT01750242|2181166|P1|STARTED|Overall Study||23
902518|NCT01750086|2181173|P2|NOT COMPLETED|Overall Study||1
902519|NCT01750086|2181174|P1|NOT COMPLETED|Overall Study||1
902520|NCT01750086|2181173|P2|COMPLETED|Overall Study||13
902521|NCT01750086|2181174|P1|COMPLETED|Overall Study||12
902522|NCT01750086|2181173|P2|STARTED|Overall Study||14
902523|NCT01750086|2181174|P1|STARTED|Overall Study||13
902524|NCT01749982|2181184|P4|NOT COMPLETED|Overall Study||3
902525|NCT01749982|2181185|P3|NOT COMPLETED|Overall Study||0
902526|NCT01749982|2181186|P2|NOT COMPLETED|Overall Study||0
902527|NCT01749982|2181187|P1|NOT COMPLETED|Overall Study||0
902528|NCT01749982|2181184|P4|COMPLETED|Overall Study||12
902529|NCT01749982|2181185|P3|COMPLETED|Overall Study||15
902530|NCT01749982|2181186|P2|COMPLETED|Overall Study||15
902531|NCT01749982|2181187|P1|COMPLETED|Overall Study||15
902532|NCT01749982|2181184|P4|STARTED|Overall Study||15
902533|NCT01749982|2181185|P3|STARTED|Overall Study||15
902534|NCT01749982|2181186|P2|STARTED|Overall Study||15
902535|NCT01749982|2181187|P1|STARTED|Overall Study||15
902536|NCT01749956|2181205|P1|NOT COMPLETED|Overall Study||15
902537|NCT01749956|2181205|P1|COMPLETED|Overall Study||24
902538|NCT01749956|2181205|P1|STARTED|Overall Study||39
902539|NCT01749800|2181218|P3|NOT COMPLETED|Overall Study||0
902540|NCT01749800|2181219|P2|NOT COMPLETED|Overall Study||1
902541|NCT01749800|2181220|P1|NOT COMPLETED|Overall Study||3
902542|NCT01749800|2181218|P3|COMPLETED|Overall Study||0
902543|NCT01749800|2181219|P2|COMPLETED|Overall Study||0
902544|NCT01749800|2181220|P1|COMPLETED|Overall Study||3
902545|NCT01749800|2181218|P3|STARTED|Overall Study||0
902546|NCT01749800|2181219|P2|STARTED|Overall Study|1 subject showed significant motor impairments but decided to undergo therapy (exclusion criterion)|1
902547|NCT01749800|2181220|P1|STARTED|Overall Study|3 subjects did not show significant attention span deficit (required inclusion criterion)|6
902548|NCT01749735|2181230|P2|NOT COMPLETED|Overall Study||0
902549|NCT01749735|2181231|P1|NOT COMPLETED|Overall Study||1
902550|NCT01749735|2181230|P2|COMPLETED|Overall Study||0
902551|NCT01749735|2181231|P1|COMPLETED|Overall Study||1
902552|NCT01749735|2181230|P2|STARTED|Overall Study||0
902553|NCT01749735|2181231|P1|STARTED|Overall Study||2
902554|NCT01749631|2181239|P1|NOT COMPLETED|Overall Study||0
902555|NCT01749631|2181239|P1|COMPLETED|Overall Study||97
902556|NCT01749631|2181239|P1|STARTED|Overall Study||97
902557|NCT01749605|2181251|P2|NOT COMPLETED|Overall Study||3
902558|NCT01749605|2181252|P1|NOT COMPLETED|Overall Study||4
902559|NCT01749605|2181251|P2|COMPLETED|Overall Study||14
902560|NCT01749605|2181252|P1|COMPLETED|Overall Study||14
902561|NCT01749605|2181251|P2|STARTED|Overall Study||17
902562|NCT01749605|2181252|P1|STARTED|Overall Study||18
902569|NCT01749410|2181269|P1|NOT COMPLETED|Overall Study||0
902570|NCT01749410|2181269|P1|COMPLETED|Overall Study||33
902571|NCT01749410|2181269|P1|STARTED|Overall Study||33
902572|NCT01748955|2181275|P2|NOT COMPLETED|Overall Study||5
902573|NCT01748955|2181276|P1|NOT COMPLETED|Overall Study||3
902574|NCT01748955|2181275|P2|COMPLETED|Overall Study||4
902575|NCT01748955|2181276|P1|COMPLETED|Overall Study||3
902576|NCT01748955|2181275|P2|STARTED|Overall Study||9
902577|NCT01748955|2181276|P1|STARTED|Overall Study||6
902578|NCT01748942|2181286|P2|NOT COMPLETED|Overall Study||4
902579|NCT01748942|2181287|P1|NOT COMPLETED|Overall Study||4
902580|NCT01748942|2181286|P2|COMPLETED|Overall Study||33
902581|NCT01748942|2181287|P1|COMPLETED|Overall Study||35
902582|NCT01748942|2181286|P2|STARTED|Overall Study||37
902583|NCT01748942|2181287|P1|STARTED|Overall Study||39
902584|NCT01748916|2181307|P6|NOT COMPLETED|Overall Study||0
902585|NCT01748916|2181308|P5|NOT COMPLETED|Overall Study||0
902586|NCT01748916|2181309|P4|NOT COMPLETED|Overall Study||0
902587|NCT01748916|2181310|P3|NOT COMPLETED|Overall Study||0
902588|NCT01748916|2181311|P2|NOT COMPLETED|Overall Study||0
902589|NCT01748916|2181312|P1|NOT COMPLETED|Overall Study||0
902590|NCT01748916|2181307|P6|COMPLETED|Overall Study||3
902591|NCT01748916|2181308|P5|COMPLETED|Overall Study||3
902592|NCT01748916|2181309|P4|COMPLETED|Overall Study||3
902593|NCT01748916|2181310|P3|COMPLETED|Overall Study||2
902594|NCT01748916|2181311|P2|COMPLETED|Overall Study||3
902595|NCT01748916|2181312|P1|COMPLETED|Overall Study||2
902596|NCT01748916|2181307|P6|STARTED|Overall Study||3
902597|NCT01748916|2181308|P5|STARTED|Overall Study||3
902598|NCT01748916|2181309|P4|STARTED|Overall Study||3
902599|NCT01748916|2181310|P3|STARTED|Overall Study||2
902600|NCT01748916|2181311|P2|STARTED|Overall Study||3
902601|NCT01748916|2181312|P1|STARTED|Overall Study||2
902605|NCT01748799|2181332|P8|NOT COMPLETED|Overall Study||0
902606|NCT01748799|2181333|P7|NOT COMPLETED|Overall Study||1
902607|NCT01748799|2181334|P6|NOT COMPLETED|Overall Study||1
902608|NCT01748799|2181335|P5|NOT COMPLETED|Overall Study||0
902609|NCT01748799|2181336|P4|NOT COMPLETED|Overall Study||0
902610|NCT01748799|2181337|P3|NOT COMPLETED|Overall Study||0
902611|NCT01748799|2181338|P2|NOT COMPLETED|Overall Study||0
902612|NCT01748799|2181339|P1|NOT COMPLETED|Overall Study||5
902613|NCT01748799|2181332|P8|COMPLETED|Overall Study||1
902614|NCT01748799|2181333|P7|COMPLETED|Overall Study||1
902615|NCT01748799|2181334|P6|COMPLETED|Overall Study||1
902616|NCT01748799|2181335|P5|COMPLETED|Overall Study||1
902617|NCT01748799|2181336|P4|COMPLETED|Overall Study||2
902618|NCT01748799|2181337|P3|COMPLETED|Overall Study||1
902619|NCT01748799|2181338|P2|COMPLETED|Overall Study||1
902620|NCT01748799|2181339|P1|COMPLETED|Overall Study||1
902621|NCT01748799|2181332|P8|Completed Self-titrated Sativex|Overall Study||1
902622|NCT01748799|2181333|P7|Completed Self-titrated Sativex|Overall Study||1
902623|NCT01748799|2181334|P6|Completed Self-titrated Sativex|Overall Study||1
902624|NCT01748799|2181335|P5|Completed Self-titrated Sativex|Overall Study||1
902625|NCT01748799|2181336|P4|Completed Self-titrated Sativex|Overall Study||2
902626|NCT01748799|2181337|P3|Completed Self-titrated Sativex|Overall Study||1
902627|NCT01748799|2181338|P2|Completed Self-titrated Sativex|Overall Study||1
902628|NCT01748799|2181339|P1|Completed Self-titrated Sativex|Overall Study||1
902629|NCT01748799|2181332|P8|Completed SAU of Self-titrated Sativex|Overall Study||1
902630|NCT01748799|2181333|P7|Completed SAU of Self-titrated Sativex|Overall Study||1
902631|NCT01748799|2181334|P6|Completed SAU of Self-titrated Sativex|Overall Study||2
902632|NCT01748799|2181335|P5|Completed SAU of Self-titrated Sativex|Overall Study||1
902633|NCT01748799|2181336|P4|Completed SAU of Self-titrated Sativex|Overall Study||2
902634|NCT01748799|2181337|P3|Completed SAU of Self-titrated Sativex|Overall Study||1
902635|NCT01748799|2181338|P2|Completed SAU of Self-titrated Sativex|Overall Study||1
902636|NCT01748799|2181339|P1|Completed SAU of Self-titrated Sativex|Overall Study||2
902637|NCT01748799|2181332|P8|Completed Self-titrated Placebo|Overall Study||1
902638|NCT01748799|2181333|P7|Completed Self-titrated Placebo|Overall Study||1
902639|NCT01748799|2181334|P6|Completed Self-titrated Placebo|Overall Study||2
902640|NCT01748799|2181335|P5|Completed Self-titrated Placebo|Overall Study||1
902641|NCT01748799|2181336|P4|Completed Self-titrated Placebo|Overall Study||2
902642|NCT01748799|2181337|P3|Completed Self-titrated Placebo|Overall Study||1
902643|NCT01748799|2181338|P2|Completed Self-titrated Placebo|Overall Study||1
902644|NCT01748799|2181339|P1|Completed Self-titrated Placebo|Overall Study||4
902645|NCT01748799|2181332|P8|Completed SAU of Self-titrated Placebo|Overall Study||1
902646|NCT01748799|2181333|P7|Completed SAU of Self-titrated Placebo|Overall Study||1
902647|NCT01748799|2181334|P6|Completed SAU of Self-titrated Placebo|Overall Study||2
902648|NCT01748799|2181335|P5|Completed SAU of Self-titrated Placebo|Overall Study||1
902649|NCT01748799|2181336|P4|Completed SAU of Self-titrated Placebo|Overall Study||2
902650|NCT01748799|2181337|P3|Completed SAU of Self-titrated Placebo|Overall Study||1
902651|NCT01748799|2181338|P2|Completed SAU of Self-titrated Placebo|Overall Study||1
902652|NCT01748799|2181339|P1|Completed SAU of Self-titrated Placebo|Overall Study||5
902653|NCT01748799|2181332|P8|Completed Fixed Dose Sativex|Overall Study||1
902654|NCT01748799|2181333|P7|Completed Fixed Dose Sativex|Overall Study||1
902655|NCT01748799|2181334|P6|Completed Fixed Dose Sativex|Overall Study||1
902656|NCT01748799|2181335|P5|Completed Fixed Dose Sativex|Overall Study||1
902657|NCT01748799|2181336|P4|Completed Fixed Dose Sativex|Overall Study||2
902658|NCT01748799|2181337|P3|Completed Fixed Dose Sativex|Overall Study||1
902659|NCT01748799|2181338|P2|Completed Fixed Dose Sativex|Overall Study||1
902660|NCT01748799|2181339|P1|Completed Fixed Dose Sativex|Overall Study||1
902661|NCT01748799|2181332|P8|Completed SAU of Fixed Dose Sativex|Overall Study||1
902662|NCT01748799|2181333|P7|Completed SAU of Fixed Dose Sativex|Overall Study||1
902663|NCT01748799|2181334|P6|Completed SAU of Fixed Dose Sativex|Overall Study||1
902664|NCT01748799|2181335|P5|Completed SAU of Fixed Dose Sativex|Overall Study||1
902665|NCT01748799|2181336|P4|Completed SAU of Fixed Dose Sativex|Overall Study||2
902666|NCT01748799|2181337|P3|Completed SAU of Fixed Dose Sativex|Overall Study||1
902667|NCT01748799|2181338|P2|Completed SAU of Fixed Dose Sativex|Overall Study||1
902668|NCT01748799|2181339|P1|Completed SAU of Fixed Dose Sativex|Overall Study||1
902669|NCT01748799|2181332|P8|Completed Fixed Dose Placebo|Overall Study||1
902670|NCT01748799|2181333|P7|Completed Fixed Dose Placebo|Overall Study||1
902671|NCT01748799|2181334|P6|Completed Fixed Dose Placebo|Overall Study||1
902672|NCT01748799|2181335|P5|Completed Fixed Dose Placebo|Overall Study||1
902673|NCT01748799|2181336|P4|Completed Fixed Dose Placebo|Overall Study||2
902674|NCT01748799|2181337|P3|Completed Fixed Dose Placebo|Overall Study||1
902675|NCT01748799|2181338|P2|Completed Fixed Dose Placebo|Overall Study||1
902676|NCT01748799|2181339|P1|Completed Fixed Dose Placebo|Overall Study||2
902677|NCT01748799|2181332|P8|Completed SAU of Fixed Dose Placebo|Overall Study||1
902678|NCT01748799|2181333|P7|Completed SAU of Fixed Dose Placebo|Overall Study||1
902679|NCT01748799|2181334|P6|Completed SAU of Fixed Dose Placebo|Overall Study||1
902680|NCT01748799|2181335|P5|Completed SAU of Fixed Dose Placebo|Overall Study||1
902681|NCT01748799|2181336|P4|Completed SAU of Fixed Dose Placebo|Overall Study||2
902682|NCT01748799|2181337|P3|Completed SAU of Fixed Dose Placebo|Overall Study||1
902683|NCT01748799|2181338|P2|Completed SAU of Fixed Dose Placebo|Overall Study||1
902684|NCT01748799|2181339|P1|Completed SAU of Fixed Dose Placebo|Overall Study||2
902685|NCT01748799|2181332|P8|STARTED|Overall Study||1
902686|NCT01748799|2181333|P7|STARTED|Overall Study||2
902687|NCT01748799|2181334|P6|STARTED|Overall Study||2
902688|NCT01748799|2181335|P5|STARTED|Overall Study||1
902689|NCT01748799|2181336|P4|STARTED|Overall Study||2
902690|NCT01748799|2181337|P3|STARTED|Overall Study||1
902691|NCT01748799|2181338|P2|STARTED|Overall Study||1
902692|NCT01748799|2181339|P1|STARTED|Overall Study||6
902693|NCT01748760|2181375|P2|NOT COMPLETED|Overall Study||2
902694|NCT01748760|2181376|P1|NOT COMPLETED|Overall Study||6
902695|NCT01748760|2181375|P2|COMPLETED|Overall Study||23
902696|NCT01748760|2181376|P1|COMPLETED|Overall Study||19
902697|NCT01748760|2181375|P2|STARTED|Overall Study||25
902698|NCT01748760|2181376|P1|STARTED|Overall Study||25
902699|NCT01748695|2181382|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
902700|NCT01748695|2181383|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
902701|NCT01748695|2181382|P2|COMPLETED|Second Intervention (4 Weeks)||11
902702|NCT01748695|2181383|P1|COMPLETED|Second Intervention (4 Weeks)||14
902703|NCT01748695|2181382|P2|STARTED|Second Intervention (4 Weeks)||11
902704|NCT01748695|2181383|P1|STARTED|Second Intervention (4 Weeks)||14
902705|NCT01748695|2181382|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
902706|NCT01748695|2181383|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
902707|NCT01748695|2181382|P2|COMPLETED|First Intervention (4 Weeks)||11
902708|NCT01748695|2181383|P1|COMPLETED|First Intervention (4 Weeks)||14
902709|NCT01748695|2181382|P2|STARTED|First Intervention (4 Weeks)||11
902710|NCT01748695|2181383|P1|STARTED|First Intervention (4 Weeks)||14
902711|NCT01748643|2181393|P2|NOT COMPLETED|Overall Study||0
902712|NCT01748643|2181394|P1|NOT COMPLETED|Overall Study||0
902713|NCT01748643|2181393|P2|COMPLETED|Overall Study||30
902714|NCT01748643|2181394|P1|COMPLETED|Overall Study||30
902715|NCT01748643|2181393|P2|STARTED|Overall Study||30
902716|NCT01748643|2181394|P1|STARTED|Overall Study||30
902717|NCT01748227|2181410|P1|NOT COMPLETED|Overall Study||3
902718|NCT01748227|2181410|P1|COMPLETED|Overall Study||17
902719|NCT01748227|2181410|P1|STARTED|Overall Study||20
902720|NCT01748071|2181421|P3|NOT COMPLETED|Overall Study||0
902721|NCT01748071|2181422|P2|NOT COMPLETED|Overall Study||2
902722|NCT01748071|2181423|P1|NOT COMPLETED|Overall Study||2
902723|NCT01748071|2181421|P3|COMPLETED|Overall Study||40
902724|NCT01748071|2181422|P2|COMPLETED|Overall Study||38
902725|NCT01748071|2181423|P1|COMPLETED|Overall Study||38
902726|NCT01748071|2181421|P3|STARTED|Overall Study||40
902727|NCT01748071|2181422|P2|STARTED|Overall Study||40
902728|NCT01748071|2181423|P1|STARTED|Overall Study||40
902729|NCT01748045|2181445|P2|NOT COMPLETED|Overall Study||0
902730|NCT01748045|2181446|P1|NOT COMPLETED|Overall Study||0
902731|NCT01748045|2181445|P2|COMPLETED|Overall Study||1
902732|NCT01748045|2181446|P1|COMPLETED|Overall Study||2
902733|NCT01748045|2181445|P2|STARTED|Overall Study||1
902734|NCT01748045|2181446|P1|STARTED|Overall Study||2
902735|NCT01747928|2181472|P8|NOT COMPLETED|Overall Study||0
902736|NCT01747928|2181473|P7|NOT COMPLETED|Overall Study||0
902737|NCT01747928|2181474|P6|NOT COMPLETED|Overall Study||0
902738|NCT01747928|2181475|P5|NOT COMPLETED|Overall Study||0
902739|NCT01747928|2181476|P4|NOT COMPLETED|Overall Study||0
902740|NCT01747928|2181477|P3|NOT COMPLETED|Overall Study||0
902741|NCT01747928|2181478|P2|NOT COMPLETED|Overall Study||0
902742|NCT01747928|2181479|P1|NOT COMPLETED|Overall Study||0
902743|NCT01747928|2181472|P8|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
902744|NCT01747928|2181473|P7|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
902745|NCT01747928|2181474|P6|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
902746|NCT01747928|2181475|P5|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
902747|NCT01747928|2181476|P4|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
902748|NCT01747928|2181477|P3|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
902749|NCT01747928|2181478|P2|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
902750|NCT01747928|2181479|P1|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
902751|NCT01747928|2181472|P8|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
902752|NCT01747928|2181473|P7|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
902753|NCT01747928|2181474|P6|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
902754|NCT01747928|2181475|P5|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
902755|NCT01747928|2181476|P4|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
902756|NCT01747928|2181477|P3|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
902757|NCT01747928|2181478|P2|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
902758|NCT01747928|2181479|P1|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
902759|NCT01747850|2181686|P3|NOT COMPLETED|Overall Study||6
902760|NCT01747850|2181687|P2|NOT COMPLETED|Overall Study||7
902761|NCT01747850|2181688|P1|NOT COMPLETED|Overall Study||1
902762|NCT01747850|2181686|P3|COMPLETED|Overall Study||14
902763|NCT01747850|2181687|P2|COMPLETED|Overall Study||13
902764|NCT01747850|2181688|P1|COMPLETED|Overall Study||4
902765|NCT01747850|2181686|P3|STARTED|Overall Study||20
902766|NCT01747850|2181687|P2|STARTED|Overall Study||20
902767|NCT01747850|2181688|P1|STARTED|Overall Study||5
902768|NCT01747811|2181710|P2|NOT COMPLETED|Overall Study||4
902769|NCT01747811|2181711|P1|NOT COMPLETED|Overall Study||2
902770|NCT01747811|2181710|P2|COMPLETED|Overall Study||12
902771|NCT01747811|2181711|P1|COMPLETED|Overall Study||14
902772|NCT01747811|2181710|P2|STARTED|Overall Study||16
902773|NCT01747811|2181711|P1|STARTED|Overall Study||16
902774|NCT01747772|2181727|P1|NOT COMPLETED|Overall Study||9
902775|NCT01747772|2181727|P1|COMPLETED|Overall Study||171
902776|NCT01747772|2181727|P1|Analysis Population|Overall Study|All participants who completed the study and had adequate SWE and liver biopsy data.|164
902777|NCT01747772|2181727|P1|STARTED|Overall Study||180
902778|NCT01747655|2181735|P2|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
902779|NCT01747655|2181736|P1|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
902780|NCT01747655|2181735|P2|COMPLETED|PEG-J Period (Continued Treatment)||15
902781|NCT01747655|2181736|P1|COMPLETED|PEG-J Period (Continued Treatment)||41
902782|NCT01747655|2181735|P2|STARTED|PEG-J Period (Continued Treatment)|SoC MAS: 6 SoC participants plus 9 participants who received Duodopa via PEG-J then returned to SoC|15
902783|NCT01747655|2181736|P1|STARTED|PEG-J Period (Continued Treatment)||41
902784|NCT01747655|2181735|P2|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||0
902785|NCT01747655|2181736|P1|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||14
902786|NCT01747655|2181735|P2|COMPLETED|PEG-J Period (Duodopa Treatment)||6
902787|NCT01747655|2181736|P1|COMPLETED|PEG-J Period (Duodopa Treatment)||44
902788|NCT01747655|2181735|P2|STARTED|PEG-J Period (Duodopa Treatment)|Participants in the MAS that returned to SoC (no PEG-J introduced; did not meet selection criteria)|6
902789|NCT01747655|2181736|P1|STARTED|PEG-J Period (Duodopa Treatment)|Dudopa MAS: Participants in the MAS that received Duodopa via PEG-J.|58
902790|NCT01747655|2181735|P2|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
902791|NCT01747655|2181736|P1|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
902792|NCT01747655|2181735|P2|COMPLETED|Temporary Naso-jejunal Tube Period||0
902793|NCT01747655|2181736|P1|COMPLETED|Temporary Naso-jejunal Tube Period||64
902794|NCT01747655|2181735|P2|STARTED|Temporary Naso-jejunal Tube Period||0
902795|NCT01747655|2181736|P1|STARTED|Temporary Naso-jejunal Tube Period|Main Analysis Set (MAS): participants with baseline and 1 further visit and ≥ 1 Duodopa treatment|64
902796|NCT01747629|2181766|P2|NOT COMPLETED|Overall Study||6
902797|NCT01747629|2181767|P1|NOT COMPLETED|Overall Study||8
902798|NCT01747629|2181766|P2|COMPLETED|Overall Study||69
902799|NCT01747629|2181767|P1|COMPLETED|Overall Study||77
902800|NCT01747629|2181766|P2|Treated|Overall Study|Safety set and full analysis set|75
902801|NCT01747629|2181767|P1|Treated|Overall Study|Safety set and full analysis set|84
902802|NCT01747629|2181766|P2|STARTED|Overall Study||75
902803|NCT01747629|2181767|P1|STARTED|Overall Study||85
902804|NCT01747343|2181799|P1|NOT COMPLETED|Underwear/Differential Reinforcement||0
902805|NCT01747343|2181799|P1|COMPLETED|Underwear/Differential Reinforcement||4
902806|NCT01747343|2181799|P1|STARTED|Underwear/Differential Reinforcement||4
902807|NCT01747343|2181799|P1|NOT COMPLETED|Underwear||0
902808|NCT01747343|2181799|P1|COMPLETED|Underwear||4
902809|NCT01747343|2181799|P1|STARTED|Underwear||4
902810|NCT01747343|2181799|P1|NOT COMPLETED|Baseline||0
902811|NCT01747343|2181799|P1|COMPLETED|Baseline||4
902812|NCT01747343|2181799|P1|STARTED|Baseline||4
902813|NCT01747330|2181805|P1|NOT COMPLETED|Overall Study||0
902814|NCT01747330|2181805|P1|COMPLETED|Overall Study||40
902815|NCT01747330|2181805|P1|STARTED|Overall Study||40
902816|NCT01746940|2181821|P4|NOT COMPLETED|Safety Second Phase||0
902817|NCT01746940|2181822|P3|NOT COMPLETED|Safety Second Phase||0
902818|NCT01746940|2181823|P2|NOT COMPLETED|Safety Second Phase||0
902819|NCT01746940|2181824|P1|NOT COMPLETED|Safety Second Phase||0
902820|NCT01746940|2181821|P4|COMPLETED|Safety Second Phase||0
902821|NCT01746940|2181822|P3|COMPLETED|Safety Second Phase||0
902822|NCT01746940|2181823|P2|COMPLETED|Safety Second Phase||18
902823|NCT01746940|2181824|P1|COMPLETED|Safety Second Phase||18
902824|NCT01746940|2181821|P4|STARTED|Safety Second Phase||0
902825|NCT01746940|2181822|P3|STARTED|Safety Second Phase||0
902826|NCT01746940|2181823|P2|STARTED|Safety Second Phase||18
902827|NCT01746940|2181824|P1|STARTED|Safety Second Phase||18
902828|NCT01746940|2181821|P4|NOT COMPLETED|Safety and Efficacy First Phase||3
902829|NCT01746940|2181822|P3|NOT COMPLETED|Safety and Efficacy First Phase||0
902830|NCT01746940|2181823|P2|NOT COMPLETED|Safety and Efficacy First Phase||0
902831|NCT01746940|2181824|P1|NOT COMPLETED|Safety and Efficacy First Phase||0
902832|NCT01746940|2181821|P4|COMPLETED|Safety and Efficacy First Phase||0
902833|NCT01746940|2181822|P3|COMPLETED|Safety and Efficacy First Phase||40
902834|NCT01746940|2181823|P2|COMPLETED|Safety and Efficacy First Phase||41
902835|NCT01746940|2181824|P1|COMPLETED|Safety and Efficacy First Phase||39
902836|NCT01746940|2181821|P4|STARTED|Safety and Efficacy First Phase||3
902837|NCT01746940|2181822|P3|STARTED|Safety and Efficacy First Phase||40
902838|NCT01746940|2181823|P2|STARTED|Safety and Efficacy First Phase||41
902839|NCT01746940|2181824|P1|STARTED|Safety and Efficacy First Phase||39
902840|NCT01746862|2181834|P2|NOT COMPLETED|Overall Study||3
902841|NCT01746862|2181835|P1|NOT COMPLETED|Overall Study||8
902842|NCT01746862|2181834|P2|COMPLETED|Overall Study||27
902843|NCT01746862|2181835|P1|COMPLETED|Overall Study||52
902844|NCT01746862|2181834|P2|Treated|Overall Study||30
902845|NCT01746862|2181835|P1|Treated|Overall Study||59
902846|NCT01746862|2181834|P2|STARTED|Overall Study||30
902847|NCT01746862|2181835|P1|STARTED|Overall Study||60
902848|NCT01746784|2181860|P5|NOT COMPLETED|Overall Study||0
902849|NCT01746784|2181861|P4|NOT COMPLETED|Overall Study||0
902850|NCT01746784|2181862|P3|NOT COMPLETED|Overall Study||0
902851|NCT01746784|2181863|P2|NOT COMPLETED|Overall Study||0
902852|NCT01746784|2181864|P1|NOT COMPLETED|Overall Study||0
902853|NCT01746784|2181860|P5|COMPLETED|Overall Study||19
902854|NCT01746784|2181861|P4|COMPLETED|Overall Study||9
902855|NCT01746784|2181862|P3|COMPLETED|Overall Study||9
902856|NCT01746784|2181863|P2|COMPLETED|Overall Study||10
902857|NCT01746784|2181864|P1|COMPLETED|Overall Study||19
902858|NCT01746784|2181860|P5|Enrolled|Overall Study||19
902859|NCT01746784|2181861|P4|Enrolled|Overall Study||9
902860|NCT01746784|2181862|P3|Enrolled|Overall Study||9
902861|NCT01746784|2181863|P2|Enrolled|Overall Study||10
902862|NCT01746784|2181864|P1|Enrolled|Overall Study||19
902863|NCT01746784|2181860|P5|STARTED|Overall Study||19
902864|NCT01746784|2181861|P4|STARTED|Overall Study||9
902865|NCT01746784|2181862|P3|STARTED|Overall Study||9
902866|NCT01746784|2181863|P2|STARTED|Overall Study||10
902867|NCT01746784|2181864|P1|STARTED|Overall Study||19
902868|NCT01746511|2181888|P2|NOT COMPLETED|Overall Study||0
902869|NCT01746511|2181889|P1|NOT COMPLETED|Overall Study||0
902870|NCT01746511|2181888|P2|COMPLETED|Overall Study||39
902871|NCT01746511|2181889|P1|COMPLETED|Overall Study||40
902872|NCT01746511|2181888|P2|STARTED|Overall Study||39
902873|NCT01746511|2181889|P1|STARTED|Overall Study||40
902874|NCT01746368|2181905|P2|NOT COMPLETED|Overall Study||1
902875|NCT01746368|2181906|P1|NOT COMPLETED|Overall Study||2
902876|NCT01746368|2181905|P2|COMPLETED|Overall Study||16
902877|NCT01746368|2181906|P1|COMPLETED|Overall Study||31
902878|NCT01746368|2181905|P2|Analyzed for Satisfaction|Overall Study||16
902879|NCT01746368|2181906|P1|Analyzed for Satisfaction|Overall Study||30
902880|NCT01746368|2181905|P2|Analyzed for AD Completion Rate|Overall Study||17
902881|NCT01746368|2181906|P1|Analyzed for AD Completion Rate|Overall Study||32
902882|NCT01746368|2181905|P2|Assessment Completed|Overall Study||16
902883|NCT01746368|2181906|P1|Assessment Completed|Overall Study||31
902884|NCT01746368|2181905|P2|Recieved Allocated Intervention|Overall Study||8
902885|NCT01746368|2181906|P1|Recieved Allocated Intervention|Overall Study||31
902886|NCT01746368|2181905|P2|STARTED|Overall Study||17
902887|NCT01746368|2181906|P1|STARTED|Overall Study||33
902888|NCT01746264|2181914|P1|NOT COMPLETED|Overall Study||0
902889|NCT01746264|2181914|P1|COMPLETED|Overall Study||19
902890|NCT01746264|2181914|P1|STARTED|Overall Study||19
902891|NCT01746173|2181933|P1|NOT COMPLETED|Overall Study||2
902892|NCT01746173|2181933|P1|COMPLETED|Overall Study||3
902893|NCT01746173|2181933|P1|STARTED|Overall Study||5
902894|NCT01746108|2181941|P3|NOT COMPLETED|Overall Study||0
902895|NCT01746108|2181942|P2|NOT COMPLETED|Overall Study||4
902896|NCT01746108|2181943|P1|NOT COMPLETED|Overall Study||0
902897|NCT01746108|2181941|P3|COMPLETED|Overall Study||6
902898|NCT01746108|2181942|P2|COMPLETED|Overall Study||24
902899|NCT01746108|2181943|P1|COMPLETED|Overall Study||18
902900|NCT01746108|2181941|P3|STARTED|Overall Study||6
902901|NCT01746108|2181942|P2|STARTED|Overall Study||28
902902|NCT01746108|2181943|P1|STARTED|Overall Study||18
902903|NCT01745952|2181979|P3|NOT COMPLETED|Overall Study||0
902904|NCT01745952|2181980|P2|NOT COMPLETED|Overall Study||1
902905|NCT01745952|2181981|P1|NOT COMPLETED|Overall Study||1
902906|NCT01745952|2181979|P3|COMPLETED|Overall Study||3
902907|NCT01745952|2181980|P2|COMPLETED|Overall Study|data of one patient not used due to no seizure diary entries on multiple occasions|3
902908|NCT01745952|2181981|P1|COMPLETED|Overall Study||3
902909|NCT01745952|2181979|P3|STARTED|Overall Study||3
902910|NCT01745952|2181980|P2|STARTED|Overall Study||4
902911|NCT01745952|2181981|P1|STARTED|Overall Study||4
902912|NCT01745913|2182007|P2|NOT COMPLETED|Overall Study||1
902913|NCT01745913|2182008|P1|NOT COMPLETED|Overall Study||1
902914|NCT01745913|2182007|P2|COMPLETED|Overall Study||0
902915|NCT01745913|2182008|P1|COMPLETED|Overall Study||0
902916|NCT01745913|2182007|P2|STARTED|Overall Study||1
902917|NCT01745913|2182008|P1|STARTED|Overall Study||1
902918|NCT01745848|2182016|P1|NOT COMPLETED|Overall Study||6
902919|NCT01745848|2182016|P1|COMPLETED|Overall Study||20
902920|NCT01745848|2182016|P1|STARTED|Overall Study||26
902921|NCT01745380|2182023|P2|NOT COMPLETED|Overall Study||1
902922|NCT01745380|2182024|P1|NOT COMPLETED|Overall Study||1
902923|NCT01745380|2182023|P2|COMPLETED|Overall Study||49
902924|NCT01745380|2182024|P1|COMPLETED|Overall Study||99
902925|NCT01745380|2182023|P2|STARTED|Overall Study||50
902926|NCT01745380|2182024|P1|STARTED|Overall Study||100
902927|NCT01745133|2182063|P3|NOT COMPLETED|Overall Study||4
902928|NCT01745133|2182064|P2|NOT COMPLETED|Overall Study||4
902929|NCT01745133|2182065|P1|NOT COMPLETED|Overall Study||6
902930|NCT01745133|2182063|P3|COMPLETED|Overall Study||15
902931|NCT01745133|2182064|P2|COMPLETED|Overall Study||16
902932|NCT01745133|2182065|P1|COMPLETED|Overall Study||13
902933|NCT01745133|2182063|P3|STARTED|Overall Study||19
902934|NCT01745133|2182064|P2|STARTED|Overall Study||20
902935|NCT01745133|2182065|P1|STARTED|Overall Study||19
902936|NCT01745055|2182073|P1|NOT COMPLETED|Overall Study||0
902937|NCT01745055|2182073|P1|COMPLETED|Overall Study||12
902938|NCT01745055|2182073|P1|STARTED|Overall Study||12
902939|NCT01744977|2182108|P2|NOT COMPLETED|Overall Study||5
902940|NCT01744977|2182109|P1|NOT COMPLETED|Overall Study||11
902941|NCT01744977|2182108|P2|COMPLETED|Overall Study||115
902942|NCT01744977|2182109|P1|COMPLETED|Overall Study||109
902943|NCT01744977|2182108|P2|6 Month Completed|Overall Study||115
902944|NCT01744977|2182109|P1|6 Month Completed|Overall Study||113
902945|NCT01744977|2182108|P2|STARTED|Overall Study||120
902946|NCT01744977|2182109|P1|STARTED|Overall Study||120
902947|NCT01744860|2182117|P1|NOT COMPLETED|Overall Study||0
902948|NCT01744860|2182117|P1|COMPLETED|Overall Study||420
902949|NCT01744860|2182117|P1|STARTED|Overall Study||420
902950|NCT01744821|2182155|P4|NOT COMPLETED|Overall Study||0
902951|NCT01744821|2182156|P3|NOT COMPLETED|Overall Study||0
902952|NCT01744821|2182157|P2|NOT COMPLETED|Overall Study||0
902953|NCT01744821|2182158|P1|NOT COMPLETED|Overall Study||0
902954|NCT01744821|2182155|P4|COMPLETED|Overall Study||1
902955|NCT01744821|2182156|P3|COMPLETED|Overall Study||2
902956|NCT01744821|2182157|P2|COMPLETED|Overall Study||3
902957|NCT01744821|2182158|P1|COMPLETED|Overall Study||1
902958|NCT01744821|2182155|P4|STARTED|Overall Study||1
902959|NCT01744821|2182156|P3|STARTED|Overall Study||2
902960|NCT01744821|2182157|P2|STARTED|Overall Study||3
902961|NCT01744821|2182158|P1|STARTED|Overall Study||1
902962|NCT01744730|2182185|P5|NOT COMPLETED|Overall Study||0
902963|NCT01744730|2182186|P4|NOT COMPLETED|Overall Study||0
902964|NCT01744730|2182187|P3|NOT COMPLETED|Overall Study||0
902965|NCT01744730|2182188|P2|NOT COMPLETED|Overall Study||0
902966|NCT01744730|2182189|P1|NOT COMPLETED|Overall Study||0
902967|NCT01744730|2182185|P5|COMPLETED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
902968|NCT01744730|2182186|P4|COMPLETED|Overall Study||11
902969|NCT01744730|2182187|P3|COMPLETED|Overall Study||4
902970|NCT01744730|2182188|P2|COMPLETED|Overall Study||3
902971|NCT01744730|2182189|P1|COMPLETED|Overall Study||4
902972|NCT01744730|2182185|P5|STARTED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
902973|NCT01744730|2182186|P4|STARTED|Overall Study||11
902974|NCT01744730|2182187|P3|STARTED|Overall Study||4
902975|NCT01744730|2182188|P2|STARTED|Overall Study||3
902976|NCT01744730|2182189|P1|STARTED|Overall Study||4
902977|NCT01744691|2182232|P1|NOT COMPLETED|Overall Study||43
902978|NCT01744691|2182232|P1|COMPLETED|Overall Study|Participants who were on study treatment at the time of the primary analysis|101
902979|NCT01744691|2182232|P1|STARTED|Overall Study|Participants who received study treatment|144
902980|NCT01744496|2182239|P2|NOT COMPLETED|Maintenance Period||4
902981|NCT01744496|2182240|P1|NOT COMPLETED|Maintenance Period||4
902982|NCT01744496|2182239|P2|COMPLETED|Maintenance Period||29
902983|NCT01744496|2182240|P1|COMPLETED|Maintenance Period||27
902984|NCT01744496|2182239|P2|STARTED|Maintenance Period||33
902985|NCT01744496|2182240|P1|STARTED|Maintenance Period||31
902986|NCT01744496|2182239|P2|NOT COMPLETED|Titration Period||2
902987|NCT01744496|2182240|P1|NOT COMPLETED|Titration Period||2
902988|NCT01744496|2182239|P2|COMPLETED|Titration Period||33
902989|NCT01744496|2182240|P1|COMPLETED|Titration Period||31
902990|NCT01744496|2182239|P2|STARTED|Titration Period||35
902991|NCT01744496|2182240|P1|STARTED|Titration Period||33
903001|NCT01744392|2182271|P1|NOT COMPLETED|Overall Study||1
903002|NCT01744392|2182271|P1|COMPLETED|Overall Study||22
903003|NCT01744392|2182271|P1|STARTED|Overall Study||23
903004|NCT01744353|2182287|P3|NOT COMPLETED|Overall Study||0
903005|NCT01744353|2182288|P2|NOT COMPLETED|Overall Study||0
903006|NCT01744353|2182289|P1|NOT COMPLETED|Overall Study||0
903007|NCT01744353|2182287|P3|COMPLETED|Overall Study||3
903008|NCT01744353|2182288|P2|COMPLETED|Overall Study||26
903009|NCT01744353|2182289|P1|COMPLETED|Overall Study||6
903010|NCT01744353|2182287|P3|STARTED|Overall Study||3
903011|NCT01744353|2182288|P2|STARTED|Overall Study||26
903012|NCT01744353|2182289|P1|STARTED|Overall Study||6
903013|NCT01744340|2182300|P2|NOT COMPLETED|Overall Study||0
903014|NCT01744340|2182301|P1|NOT COMPLETED|Overall Study||0
903015|NCT01744340|2182300|P2|COMPLETED|Overall Study||15
903016|NCT01744340|2182301|P1|COMPLETED|Overall Study||8
903017|NCT01744340|2182300|P2|STARTED|Overall Study||15
903018|NCT01744340|2182301|P1|STARTED|Overall Study||8
903019|NCT01744197|2182311|P2|NOT COMPLETED|Overall Study||3
903020|NCT01744197|2182312|P1|NOT COMPLETED|Overall Study||4
903021|NCT01744197|2182311|P2|COMPLETED|Overall Study||26
903022|NCT01744197|2182312|P1|COMPLETED|Overall Study||28
903023|NCT01744197|2182311|P2|STARTED|Overall Study||29
903024|NCT01744197|2182312|P1|STARTED|Overall Study||32
903025|NCT01743963|2182324|P2|NOT COMPLETED|Overall Study||0
903026|NCT01743963|2182325|P1|NOT COMPLETED|Overall Study||0
903027|NCT01743963|2182324|P2|COMPLETED|Overall Study||17
903028|NCT01743963|2182325|P1|COMPLETED|Overall Study||21
903029|NCT01743963|2182324|P2|STARTED|Overall Study||17
903030|NCT01743963|2182325|P1|STARTED|Overall Study||21
903031|NCT01743729|2182333|P2|NOT COMPLETED|Overall Study||12
903032|NCT01743729|2182334|P1|NOT COMPLETED|Overall Study||37
903033|NCT01743729|2182333|P2|COMPLETED|Overall Study||348
903034|NCT01743729|2182334|P1|COMPLETED|Overall Study||321
903035|NCT01743729|2182333|P2|STARTED|Overall Study|One placebo participant was considered for Lifitegrast arm; Placebo safety analysis set (N= 359).|360
903036|NCT01743729|2182334|P1|STARTED|Overall Study|One participant from placebo arm included in Lifitegrast arm for safety analysis set (N=359).|358
903037|NCT01743521|2182346|P4|NOT COMPLETED|Overall Study||0
903038|NCT01743521|2182347|P3|NOT COMPLETED|Overall Study||0
903039|NCT01743521|2182348|P2|NOT COMPLETED|Overall Study||0
903040|NCT01743521|2182349|P1|NOT COMPLETED|Overall Study||0
903041|NCT01743521|2182346|P4|COMPLETED|Overall Study||2
903042|NCT01743521|2182347|P3|COMPLETED|Overall Study||2
903043|NCT01743521|2182348|P2|COMPLETED|Overall Study||3
903044|NCT01743521|2182349|P1|COMPLETED|Overall Study||7
903045|NCT01743521|2182346|P4|STARTED|Overall Study||2
903046|NCT01743521|2182347|P3|STARTED|Overall Study||2
903047|NCT01743521|2182348|P2|STARTED|Overall Study||3
903048|NCT01743521|2182349|P1|STARTED|Overall Study||7
903049|NCT01743092|2182401|P2|NOT COMPLETED|Overall Study||15
903050|NCT01743092|2182402|P1|NOT COMPLETED|Overall Study||14
903051|NCT01743092|2182401|P2|COMPLETED|Overall Study||11
903052|NCT01743092|2182402|P1|COMPLETED|Overall Study||19
903053|NCT01743092|2182401|P2|STARTED|Overall Study||26
903054|NCT01743092|2182402|P1|STARTED|Overall Study||33
903055|NCT01743027|2182414|P4|NOT COMPLETED|Overall Study||1
903056|NCT01743027|2182415|P3|NOT COMPLETED|Overall Study||9
903057|NCT01743027|2182416|P2|NOT COMPLETED|Overall Study||5
903058|NCT01743027|2182417|P1|NOT COMPLETED|Overall Study||5
903059|NCT01743027|2182414|P4|COMPLETED|Overall Study||48
903060|NCT01743027|2182415|P3|COMPLETED|Overall Study||90
903061|NCT01743027|2182416|P2|COMPLETED|Overall Study||94
903062|NCT01743027|2182417|P1|COMPLETED|Overall Study||93
903063|NCT01743027|2182414|P4|STARTED|Overall Study||49
903064|NCT01743027|2182415|P3|STARTED|Overall Study||99
903065|NCT01743027|2182416|P2|STARTED|Overall Study||99
903066|NCT01743027|2182417|P1|STARTED|Overall Study||98
903067|NCT01742936|2182457|P2|NOT COMPLETED|Overall Study||0
903068|NCT01742936|2182458|P1|NOT COMPLETED|Overall Study||0
903069|NCT01742936|2182457|P2|COMPLETED|Overall Study||50
903070|NCT01742936|2182458|P1|COMPLETED|Overall Study||50
903071|NCT01742936|2182457|P2|STARTED|Overall Study||50
903072|NCT01742936|2182458|P1|STARTED|Overall Study||50
903073|NCT01742897|2182466|P1|NOT COMPLETED|Overall Study||5
903074|NCT01742897|2182466|P1|COMPLETED|Overall Study||30
903075|NCT01742897|2182466|P1|Treated|Overall Study||33
903076|NCT01742897|2182466|P1|STARTED|Overall Study||35
903077|NCT01742832|2182472|P2|NOT COMPLETED|Overall Study||5
903078|NCT01742832|2182473|P1|NOT COMPLETED|Overall Study||1
903079|NCT01742832|2182472|P2|COMPLETED|Overall Study||23
903080|NCT01742832|2182473|P1|COMPLETED|Overall Study||19
903081|NCT01742832|2182472|P2|STARTED|Overall Study||28
903082|NCT01742832|2182473|P1|STARTED|Overall Study||20
903083|NCT01742364|2182483|P4|NOT COMPLETED|Overall Study||0
903084|NCT01742364|2182484|P3|NOT COMPLETED|Overall Study||0
903085|NCT01742364|2182485|P2|NOT COMPLETED|Overall Study||0
903086|NCT01742364|2182486|P1|NOT COMPLETED|Overall Study||0
903087|NCT01742364|2182483|P4|COMPLETED|Overall Study||15
903088|NCT01742364|2182484|P3|COMPLETED|Overall Study||15
903089|NCT01742364|2182485|P2|COMPLETED|Overall Study||33
903090|NCT01742364|2182486|P1|COMPLETED|Overall Study||33
903091|NCT01742364|2182483|P4|STARTED|Overall Study||15
903092|NCT01742364|2182484|P3|STARTED|Overall Study||15
903093|NCT01742364|2182485|P2|STARTED|Overall Study||33
903094|NCT01742364|2182486|P1|STARTED|Overall Study||33
903095|NCT01741792|2182515|P3|NOT COMPLETED|Overall Study||12
903096|NCT01741792|2182516|P2|NOT COMPLETED|Overall Study||1
903097|NCT01741792|2182517|P1|NOT COMPLETED|Overall Study||6
903098|NCT01741792|2182515|P3|COMPLETED|Overall Study||2
903099|NCT01741792|2182516|P2|COMPLETED|Overall Study||1
903100|NCT01741792|2182517|P1|COMPLETED|Overall Study||3
903101|NCT01741792|2182515|P3|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|13
903102|NCT01741792|2182516|P2|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|1
903103|NCT01741792|2182517|P1|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|7
903104|NCT01741792|2182515|P3|STARTED|Overall Study||14
903105|NCT01741792|2182516|P2|STARTED|Overall Study|Cohort 2 was closed to enrollment on recommendation of the data monitoring committee|2
903106|NCT01741792|2182517|P1|STARTED|Overall Study|3 participants were not considered evaluable and were replaced as specified in the protocol.|9
903107|NCT01741701|2182584|P2|NOT COMPLETED|Overall Study||2
903108|NCT01741701|2182585|P1|NOT COMPLETED|Overall Study||5
903109|NCT01741701|2182584|P2|COMPLETED|Overall Study||13
903110|NCT01741701|2182585|P1|COMPLETED|Overall Study||13
903111|NCT01741701|2182584|P2|STARTED|Overall Study||15
903112|NCT01741701|2182585|P1|STARTED|Overall Study||18
903113|NCT01741688|2182601|P1|NOT COMPLETED|Overall Study||3
903114|NCT01741688|2182601|P1|COMPLETED|Overall Study||13
903115|NCT01741688|2182601|P1|STARTED|Overall Study||16
903116|NCT01741350|2182620|P2|NOT COMPLETED|12-Month Follow-up Assessment||2
903117|NCT01741350|2182621|P1|NOT COMPLETED|12-Month Follow-up Assessment||3
903118|NCT01741350|2182620|P2|COMPLETED|12-Month Follow-up Assessment||109
903119|NCT01741350|2182621|P1|COMPLETED|12-Month Follow-up Assessment||111
903120|NCT01741350|2182620|P2|STARTED|12-Month Follow-up Assessment||111
903121|NCT01741350|2182621|P1|STARTED|12-Month Follow-up Assessment||114
903122|NCT01741350|2182620|P2|NOT COMPLETED|6-Month Follow-up Assessment||8
903123|NCT01741350|2182621|P1|NOT COMPLETED|6-Month Follow-up Assessment||15
903124|NCT01741350|2182620|P2|COMPLETED|6-Month Follow-up Assessment||111
903125|NCT01741350|2182621|P1|COMPLETED|6-Month Follow-up Assessment||114
903126|NCT01741350|2182620|P2|STARTED|6-Month Follow-up Assessment||119
903127|NCT01741350|2182621|P1|STARTED|6-Month Follow-up Assessment||129
903128|NCT01741350|2182620|P2|NOT COMPLETED|3-Month Follow-up Assessment||22
903129|NCT01741350|2182621|P1|NOT COMPLETED|3-Month Follow-up Assessment||6
903130|NCT01741350|2182620|P2|COMPLETED|3-Month Follow-up Assessment||119
903131|NCT01741350|2182621|P1|COMPLETED|3-Month Follow-up Assessment||129
903132|NCT01741350|2182620|P2|STARTED|3-Month Follow-up Assessment||141
903133|NCT01741350|2182621|P1|STARTED|3-Month Follow-up Assessment||135
903134|NCT01741350|2182620|P2|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
903135|NCT01741350|2182621|P1|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
903136|NCT01741350|2182620|P2|COMPLETED|Post Intervention Assessment (at Week 4)||141
903137|NCT01741350|2182621|P1|COMPLETED|Post Intervention Assessment (at Week 4)||135
903138|NCT01741350|2182620|P2|STARTED|Post Intervention Assessment (at Week 4)||155
903139|NCT01741350|2182621|P1|STARTED|Post Intervention Assessment (at Week 4)||149
903140|NCT01741350|2182620|P2|NOT COMPLETED|Study Intervention||0
903141|NCT01741350|2182621|P1|NOT COMPLETED|Study Intervention||0
903142|NCT01741350|2182620|P2|COMPLETED|Study Intervention||155
903143|NCT01741350|2182621|P1|COMPLETED|Study Intervention||149
903144|NCT01741350|2182620|P2|STARTED|Study Intervention||155
903145|NCT01741350|2182621|P1|STARTED|Study Intervention||149
903146|NCT01741272|2182757|P2|NOT COMPLETED|Overall Study||0
903147|NCT01741272|2182758|P1|NOT COMPLETED|Overall Study||0
903148|NCT01741272|2182757|P2|COMPLETED|Overall Study||97
903149|NCT01741272|2182758|P1|COMPLETED|Overall Study||92
903150|NCT01741272|2182757|P2|STARTED|Overall Study||97
903151|NCT01741272|2182758|P1|STARTED|Overall Study||92
903152|NCT01740817|2182772|P2|NOT COMPLETED|Second Intervention (48 h)||0
903153|NCT01740817|2182773|P1|NOT COMPLETED|Second Intervention (48 h)||0
903154|NCT01740817|2182772|P2|COMPLETED|Second Intervention (48 h)||4
903155|NCT01740817|2182773|P1|COMPLETED|Second Intervention (48 h)||8
903156|NCT01740817|2182772|P2|STARTED|Second Intervention (48 h)||4
903157|NCT01740817|2182773|P1|STARTED|Second Intervention (48 h)||8
903158|NCT01740817|2182772|P2|NOT COMPLETED|Washout (4-6 Weeks)||0
903159|NCT01740817|2182773|P1|NOT COMPLETED|Washout (4-6 Weeks)||0
903160|NCT01740817|2182772|P2|COMPLETED|Washout (4-6 Weeks)||4
903161|NCT01740817|2182773|P1|COMPLETED|Washout (4-6 Weeks)||8
903162|NCT01740817|2182772|P2|STARTED|Washout (4-6 Weeks)||4
903163|NCT01740817|2182773|P1|STARTED|Washout (4-6 Weeks)||8
903164|NCT01740817|2182772|P2|NOT COMPLETED|First Intervention (48 h)||0
903165|NCT01740817|2182773|P1|NOT COMPLETED|First Intervention (48 h)||0
903166|NCT01740817|2182772|P2|COMPLETED|First Intervention (48 h)||4
903167|NCT01740817|2182773|P1|COMPLETED|First Intervention (48 h)||8
903168|NCT01740817|2182772|P2|STARTED|First Intervention (48 h)||4
903169|NCT01740817|2182773|P1|STARTED|First Intervention (48 h)||8
903170|NCT01740726|2182785|P2|NOT COMPLETED|Overall Study||0
903171|NCT01740726|2182786|P1|NOT COMPLETED|Overall Study||0
903172|NCT01740726|2182785|P2|COMPLETED|Overall Study||1
903173|NCT01740726|2182786|P1|COMPLETED|Overall Study||0
903174|NCT01740726|2182785|P2|STARTED|Overall Study||1
903175|NCT01740726|2182786|P1|STARTED|Overall Study||0
903176|NCT01740713|2182795|P3|NOT COMPLETED|Overall Study||1
903177|NCT01740713|2182796|P2|NOT COMPLETED|Overall Study||2
903178|NCT01740713|2182797|P1|NOT COMPLETED|Overall Study||0
903179|NCT01740713|2182795|P3|COMPLETED|Overall Study||6
903180|NCT01740713|2182796|P2|COMPLETED|Overall Study||6
903181|NCT01740713|2182797|P1|COMPLETED|Overall Study||6
903182|NCT01740713|2182795|P3|STARTED|Overall Study||7
903183|NCT01740713|2182796|P2|STARTED|Overall Study||8
903184|NCT01740713|2182797|P1|STARTED|Overall Study||6
903185|NCT01740440|2182821|P1|NOT COMPLETED|Overall Study||3
903186|NCT01740440|2182821|P1|COMPLETED|Overall Study||27
903187|NCT01740440|2182821|P1|STARTED|Overall Study||30
903194|NCT01740414|2182859|P2|NOT COMPLETED|Overall Study||8
903195|NCT01740414|2182860|P1|NOT COMPLETED|Overall Study||9
903196|NCT01740414|2182859|P2|COMPLETED|Overall Study||8
903197|NCT01740414|2182860|P1|COMPLETED|Overall Study||3
903198|NCT01740414|2182859|P2|STARTED|Overall Study||16
903199|NCT01740414|2182860|P1|STARTED|Overall Study||12
903200|NCT01740401|2182882|P1|NOT COMPLETED|Overall Study||10
903201|NCT01740401|2182882|P1|COMPLETED|Overall Study||0
903202|NCT01740401|2182882|P1|STARTED|Overall Study||10
903203|NCT01740388|2182891|P2|NOT COMPLETED|Overall Study||44
903204|NCT01740388|2182892|P1|NOT COMPLETED|Overall Study||46
903205|NCT01740388|2182891|P2|COMPLETED|Overall Study||28
903206|NCT01740388|2182892|P1|COMPLETED|Overall Study||18
903207|NCT01740388|2182891|P2|STARTED|Overall Study||72
903208|NCT01740388|2182892|P1|STARTED|Overall Study||64
903209|NCT01740362|2182912|P4|NOT COMPLETED|Overall Study||0
903210|NCT01740362|2182913|P3|NOT COMPLETED|Overall Study||0
903211|NCT01740362|2182914|P2|NOT COMPLETED|Overall Study||0
903212|NCT01740362|2182915|P1|NOT COMPLETED|Overall Study||0
903213|NCT01740362|2182912|P4|COMPLETED|Overall Study||6
903214|NCT01740362|2182913|P3|COMPLETED|Overall Study||6
903215|NCT01740362|2182914|P2|COMPLETED|Overall Study||6
903216|NCT01740362|2182915|P1|COMPLETED|Overall Study||6
903217|NCT01740362|2182912|P4|STARTED|Overall Study||6
903218|NCT01740362|2182913|P3|STARTED|Overall Study||6
903219|NCT01740362|2182914|P2|STARTED|Overall Study||6
903220|NCT01740362|2182915|P1|STARTED|Overall Study||6
903236|NCT01740206|2182978|P2|NOT COMPLETED|Overall Study||0
903237|NCT01740206|2182979|P1|NOT COMPLETED|Overall Study||0
903238|NCT01740206|2182978|P2|COMPLETED|Overall Study||34
903239|NCT01740206|2182979|P1|COMPLETED|Overall Study||14
903240|NCT01740206|2182978|P2|STARTED|Overall Study||34
903241|NCT01740206|2182979|P1|STARTED|Overall Study||14
903242|NCT01740089|2182998|P3|NOT COMPLETED|After 12 Weeks||11
903243|NCT01740089|2182999|P2|NOT COMPLETED|After 12 Weeks||3
903244|NCT01740089|2183000|P1|NOT COMPLETED|After 12 Weeks||7
903245|NCT01740089|2182998|P3|COMPLETED|After 12 Weeks|"Withdrawn due to:
No EVR (n=4) AE (n=5) Non-attendance of visit (n=1) Withdrawn consent (n=1)"|37
903246|NCT01740089|2182999|P2|COMPLETED|After 12 Weeks|"Withdrawn due to:
Withdrawn consent (n=1) No EVR (n=1) Non-compliance (n=1)"|45
903247|NCT01740089|2183000|P1|COMPLETED|After 12 Weeks|"Withdrawn due to:
No EVR (n=3) AE (n=2) No EOT (n=1) Non-compliance (n=1)"|43
903248|NCT01740089|2182998|P3|STARTED|After 12 Weeks||48
903249|NCT01740089|2182999|P2|STARTED|After 12 Weeks||48
903250|NCT01740089|2183000|P1|STARTED|After 12 Weeks||50
903251|NCT01740089|2182998|P3|NOT COMPLETED|First 12 Weeks of Treatment||2
903252|NCT01740089|2182999|P2|NOT COMPLETED|First 12 Weeks of Treatment||2
903253|NCT01740089|2183000|P1|NOT COMPLETED|First 12 Weeks of Treatment||0
903254|NCT01740089|2182998|P3|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:
AE before W12 (n=2)"|48
903255|NCT01740089|2182999|P2|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:
AE before W12 (n=1) Withdrew consent before W12 (n=1)"|48
903256|NCT01740089|2183000|P1|COMPLETED|First 12 Weeks of Treatment||50
903257|NCT01740089|2182998|P3|STARTED|First 12 Weeks of Treatment||50
903258|NCT01740089|2182999|P2|STARTED|First 12 Weeks of Treatment||50
903259|NCT01740089|2183000|P1|STARTED|First 12 Weeks of Treatment||50
903260|NCT01739803|2183018|P2|NOT COMPLETED|Overall Study||6
903261|NCT01739803|2183019|P1|NOT COMPLETED|Overall Study||9
903262|NCT01739803|2183018|P2|COMPLETED|Overall Study||68
903263|NCT01739803|2183019|P1|COMPLETED|Overall Study||67
903264|NCT01739803|2183018|P2|STARTED|Overall Study||74
903265|NCT01739803|2183019|P1|STARTED|Overall Study||76
903266|NCT01739790|2183031|P2|NOT COMPLETED|Overall Study||4
903267|NCT01739790|2183032|P1|NOT COMPLETED|Overall Study||2
903268|NCT01739790|2183031|P2|COMPLETED|Overall Study||23
903269|NCT01739790|2183032|P1|COMPLETED|Overall Study||22
903270|NCT01739790|2183031|P2|STARTED|Overall Study||27
903271|NCT01739790|2183032|P1|STARTED|Overall Study||24
903272|NCT01739595|2183041|P3|NOT COMPLETED|Overall Study||2
903273|NCT01739595|2183042|P2|NOT COMPLETED|Overall Study||1
903274|NCT01739595|2183043|P1|NOT COMPLETED|Overall Study||13
903275|NCT01739595|2183041|P3|COMPLETED|Overall Study||45
903276|NCT01739595|2183042|P2|COMPLETED|Overall Study||21
903277|NCT01739595|2183043|P1|COMPLETED|Overall Study||99
903278|NCT01739595|2183041|P3|STARTED|Overall Study||47
903279|NCT01739595|2183042|P2|STARTED|Overall Study||22
903280|NCT01739595|2183043|P1|STARTED|Overall Study||112
903281|NCT01739361|2183053|P2|NOT COMPLETED|Overall Study||1
903282|NCT01739361|2183054|P1|NOT COMPLETED|Overall Study||3
903283|NCT01739361|2183053|P2|COMPLETED|Overall Study||22
903284|NCT01739361|2183054|P1|COMPLETED|Overall Study||18
903285|NCT01739361|2183053|P2|STARTED|Overall Study||23
903286|NCT01739361|2183054|P1|STARTED|Overall Study||21
903287|NCT01738984|2183062|P2|NOT COMPLETED|Overall Study||39
903288|NCT01738984|2183063|P1|NOT COMPLETED|Overall Study||64
903289|NCT01738984|2183062|P2|COMPLETED|Overall Study||210
903290|NCT01738984|2183063|P1|COMPLETED|Overall Study||186
903291|NCT01738984|2183062|P2|STARTED|Overall Study||249
903292|NCT01738984|2183063|P1|STARTED|Overall Study||250
903293|NCT01738971|2183076|P3|NOT COMPLETED|Overall Study||17
903294|NCT01738971|2183077|P2|NOT COMPLETED|Overall Study||30
903295|NCT01738971|2183078|P1|NOT COMPLETED|Overall Study||19
903296|NCT01738971|2183076|P3|COMPLETED|Overall Study|39 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|39
903297|NCT01738971|2183077|P2|COMPLETED|Overall Study|28 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|28
903298|NCT01738971|2183078|P1|COMPLETED|Overall Study|35 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|35
903299|NCT01738971|2183076|P3|STARTED|Overall Study|56 participants recruited to this arm|56
903300|NCT01738971|2183077|P2|STARTED|Overall Study|58 participants recruited to this arm|58
903301|NCT01738971|2183078|P1|STARTED|Overall Study|54 participants recruited to this arm|54
903302|NCT01738919|2183094|P2|NOT COMPLETED|Overall Study||3
903303|NCT01738919|2183095|P1|NOT COMPLETED|Overall Study||1
903304|NCT01738919|2183094|P2|COMPLETED|Overall Study||14
903305|NCT01738919|2183095|P1|COMPLETED|Overall Study||14
903306|NCT01738919|2183094|P2|STARTED|Overall Study||17
903307|NCT01738919|2183095|P1|STARTED|Overall Study||15
903308|NCT01738750|2183113|P2|NOT COMPLETED|Overall Study||0
903309|NCT01738750|2183114|P1|NOT COMPLETED|Overall Study||0
903310|NCT01738750|2183113|P2|COMPLETED|Overall Study||51
903311|NCT01738750|2183114|P1|COMPLETED|Overall Study||49
903312|NCT01738750|2183113|P2|STARTED|Overall Study||51
903313|NCT01738750|2183114|P1|STARTED|Overall Study||49
903314|NCT01738737|2183127|P5|NOT COMPLETED|Overall Study||4
903315|NCT01738737|2183128|P4|NOT COMPLETED|Overall Study||4
903316|NCT01738737|2183129|P3|NOT COMPLETED|Overall Study||4
903317|NCT01738737|2183130|P2|NOT COMPLETED|Overall Study||4
903318|NCT01738737|2183131|P1|NOT COMPLETED|Overall Study||4
903319|NCT01738737|2183127|P5|COMPLETED|Overall Study||25
903320|NCT01738737|2183128|P4|COMPLETED|Overall Study||25
903321|NCT01738737|2183129|P3|COMPLETED|Overall Study||25
903322|NCT01738737|2183130|P2|COMPLETED|Overall Study||25
903323|NCT01738737|2183131|P1|COMPLETED|Overall Study||25
903324|NCT01738737|2183127|P5|STARTED|Overall Study||29
903325|NCT01738737|2183128|P4|STARTED|Overall Study||29
903326|NCT01738737|2183129|P3|STARTED|Overall Study||29
903327|NCT01738737|2183130|P2|STARTED|Overall Study||29
903328|NCT01738737|2183131|P1|STARTED|Overall Study||29
903329|NCT01738698|2183167|P4|NOT COMPLETED|Overall Study||0
903330|NCT01738698|2183168|P3|NOT COMPLETED|Overall Study||0
903331|NCT01738698|2183169|P2|NOT COMPLETED|Overall Study||0
903332|NCT01738698|2183170|P1|NOT COMPLETED|Overall Study||0
903333|NCT01738698|2183167|P4|COMPLETED|Overall Study||0
903334|NCT01738698|2183168|P3|COMPLETED|Overall Study||0
903335|NCT01738698|2183169|P2|COMPLETED|Overall Study||0
903336|NCT01738698|2183170|P1|COMPLETED|Overall Study||0
903337|NCT01738698|2183167|P4|STARTED|Overall Study||0
903338|NCT01738698|2183168|P3|STARTED|Overall Study||0
903339|NCT01738698|2183169|P2|STARTED|Overall Study||0
903340|NCT01738698|2183170|P1|STARTED|Overall Study||0
903341|NCT01738646|2183236|P1|NOT COMPLETED|Overall Study||2
903342|NCT01738646|2183236|P1|COMPLETED|Overall Study|Participants who discontinued study drug for any reason.|38
903343|NCT01738646|2183236|P1|STARTED|Overall Study||40
903344|NCT01738581|2183246|P2|NOT COMPLETED|Overall Study||0
903345|NCT01738581|2183247|P1|NOT COMPLETED|Overall Study||1
903346|NCT01738581|2183246|P2|COMPLETED|Overall Study||4
903347|NCT01738581|2183247|P1|COMPLETED|Overall Study||4
903348|NCT01738581|2183246|P2|STARTED|Overall Study||4
903349|NCT01738581|2183247|P1|STARTED|Overall Study||5
903350|NCT01738438|2183265|P1|NOT COMPLETED|Overall Study||35
903351|NCT01738438|2183265|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
903352|NCT01738438|2183265|P1|STARTED|Overall Study||35
903353|NCT01738321|2183273|P2|NOT COMPLETED|Overall Study||0
903354|NCT01738321|2183274|P1|NOT COMPLETED|Overall Study||0
903355|NCT01738321|2183273|P2|COMPLETED|Overall Study||30
903356|NCT01738321|2183274|P1|COMPLETED|Overall Study||33
903357|NCT01738321|2183273|P2|STARTED|Overall Study||30
903358|NCT01738321|2183274|P1|STARTED|Overall Study||33
903359|NCT01737996|2183283|P3|NOT COMPLETED|Overall Study||2
903360|NCT01737996|2183284|P2|NOT COMPLETED|Overall Study||1
903361|NCT01737996|2183285|P1|NOT COMPLETED|Overall Study||0
903362|NCT01737996|2183283|P3|COMPLETED|Overall Study|One patient withdrew consent after the first dose due to private reasons.|14
903363|NCT01737996|2183284|P2|COMPLETED|Overall Study||7
903364|NCT01737996|2183285|P1|COMPLETED|Overall Study||8
903365|NCT01737996|2183283|P3|STARTED|Overall Study||16
903366|NCT01737996|2183284|P2|STARTED|Overall Study||8
903367|NCT01737996|2183285|P1|STARTED|Overall Study||8
903368|NCT01737944|2183326|P4|NOT COMPLETED|Overall Study||0
903369|NCT01737944|2183327|P3|NOT COMPLETED|Overall Study||0
903370|NCT01737944|2183328|P2|NOT COMPLETED|Overall Study||0
903371|NCT01737944|2183329|P1|NOT COMPLETED|Overall Study||0
903372|NCT01737944|2183326|P4|COMPLETED|Overall Study||9
903373|NCT01737944|2183327|P3|COMPLETED|Overall Study||9
903374|NCT01737944|2183328|P2|COMPLETED|Overall Study||9
903375|NCT01737944|2183329|P1|COMPLETED|Overall Study||9
903376|NCT01737944|2183326|P4|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
903377|NCT01737944|2183327|P3|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
903378|NCT01737944|2183328|P2|STARTED|Overall Study||9
903379|NCT01737944|2183329|P1|STARTED|Overall Study||9
903380|NCT01737931|2183347|P3|NOT COMPLETED|Overall Study||1
903381|NCT01737931|2183348|P2|NOT COMPLETED|Overall Study||2
903382|NCT01737931|2183349|P1|NOT COMPLETED|Overall Study||0
903383|NCT01737931|2183347|P3|COMPLETED|Overall Study||38
903384|NCT01737931|2183348|P2|COMPLETED|Overall Study||38
903385|NCT01737931|2183349|P1|COMPLETED|Overall Study||38
903386|NCT01737931|2183347|P3|STARTED|Overall Study||39
903387|NCT01737931|2183348|P2|STARTED|Overall Study||40
903388|NCT01737931|2183349|P1|STARTED|Overall Study||38
903389|NCT01737879|2183364|P1|NOT COMPLETED|Overall Study||41
903390|NCT01737879|2183364|P1|COMPLETED|Overall Study||0
903391|NCT01737879|2183364|P1|Transitioned to Epoetin Alfa|Overall Study||0
903392|NCT01737879|2183364|P1|Received Peginesatide|Overall Study||34
903393|NCT01737879|2183364|P1|STARTED|Overall Study||41
903394|NCT01737840|2183373|P2|NOT COMPLETED|Overall Study||2
903395|NCT01737840|2183374|P1|NOT COMPLETED|Overall Study||2
903396|NCT01737840|2183373|P2|COMPLETED|Overall Study||33
903397|NCT01737840|2183374|P1|COMPLETED|Overall Study||33
903398|NCT01737840|2183373|P2|STARTED|Overall Study||35
903399|NCT01737840|2183374|P1|STARTED|Overall Study||35
903400|NCT01737762|2183384|P2|NOT COMPLETED|Overall Study||17
903401|NCT01737762|2183385|P1|NOT COMPLETED|Overall Study||20
903402|NCT01737762|2183384|P2|COMPLETED|Overall Study||61
903403|NCT01737762|2183385|P1|COMPLETED|Overall Study||57
903404|NCT01737762|2183384|P2|STARTED|Overall Study||78
903405|NCT01737762|2183385|P1|STARTED|Overall Study||77
903406|NCT01737710|2183398|P5|NOT COMPLETED|Overall Study||0
903407|NCT01737710|2183399|P4|NOT COMPLETED|Overall Study||0
903408|NCT01737710|2183400|P3|NOT COMPLETED|Overall Study||3
903409|NCT01737710|2183401|P2|NOT COMPLETED|Overall Study||4
903410|NCT01737710|2183402|P1|NOT COMPLETED|Overall Study||2
903411|NCT01737710|2183398|P5|COMPLETED|Overall Study||21
903412|NCT01737710|2183399|P4|COMPLETED|Overall Study||23
903413|NCT01737710|2183400|P3|COMPLETED|Overall Study||102
903414|NCT01737710|2183401|P2|COMPLETED|Overall Study||101
903415|NCT01737710|2183402|P1|COMPLETED|Overall Study||112
903416|NCT01737710|2183398|P5|STARTED|Overall Study||21
903417|NCT01737710|2183399|P4|STARTED|Overall Study||23
903418|NCT01737710|2183400|P3|STARTED|Overall Study||105
903419|NCT01737710|2183401|P2|STARTED|Overall Study||105
903420|NCT01737710|2183402|P1|STARTED|Overall Study||114
903421|NCT01737684|2183441|P3|NOT COMPLETED|Overall Study||0
903422|NCT01737684|2183442|P2|NOT COMPLETED|Overall Study||0
903423|NCT01737684|2183443|P1|NOT COMPLETED|Overall Study||0
903424|NCT01737684|2183441|P3|COMPLETED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
903425|NCT01737684|2183442|P2|COMPLETED|Overall Study||8
903426|NCT01737684|2183443|P1|COMPLETED|Overall Study||8
903427|NCT01737684|2183441|P3|STARTED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
903428|NCT01737684|2183442|P2|STARTED|Overall Study||8
903429|NCT01737684|2183443|P1|STARTED|Overall Study||8
903430|NCT01737593|2183462|P3|NOT COMPLETED|Overall Study||0
903431|NCT01737593|2183463|P2|NOT COMPLETED|Overall Study||0
903432|NCT01737593|2183464|P1|NOT COMPLETED|Overall Study||0
903433|NCT01737593|2183462|P3|COMPLETED|Overall Study||39
903434|NCT01737593|2183463|P2|COMPLETED|Overall Study||32
903435|NCT01737593|2183464|P1|COMPLETED|Overall Study||37
903436|NCT01737593|2183462|P3|STARTED|Overall Study||39
903437|NCT01737593|2183463|P2|STARTED|Overall Study||32
903438|NCT01737593|2183464|P1|STARTED|Overall Study||37
903439|NCT01737021|2183495|P2|NOT COMPLETED|Overall Study||3
903440|NCT01737021|2183496|P1|NOT COMPLETED|Overall Study||5
903441|NCT01737021|2183495|P2|COMPLETED|Overall Study||6
903442|NCT01737021|2183496|P1|COMPLETED|Overall Study||17
903443|NCT01737021|2183495|P2|STARTED|Overall Study||9
903444|NCT01737021|2183496|P1|STARTED|Overall Study||22
903445|NCT01736930|2183502|P1|NOT COMPLETED|Overall Study||1
903446|NCT01736930|2183502|P1|COMPLETED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|19
903447|NCT01736930|2183502|P1|STARTED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|20
903448|NCT01736917|2183542|P1|NOT COMPLETED|Overall Study||11
903449|NCT01736917|2183542|P1|COMPLETED|Overall Study||54
903450|NCT01736917|2183542|P1|STARTED|Overall Study||65
903451|NCT01736696|2183556|P7|NOT COMPLETED|Overall Study||0
903452|NCT01736696|2183557|P6|NOT COMPLETED|Overall Study||0
903453|NCT01736696|2183558|P5|NOT COMPLETED|Overall Study||0
903454|NCT01736696|2183559|P4|NOT COMPLETED|Overall Study||0
903455|NCT01736696|2183560|P3|NOT COMPLETED|Overall Study||1
903456|NCT01736696|2183561|P2|NOT COMPLETED|Overall Study||0
903457|NCT01736696|2183562|P1|NOT COMPLETED|Overall Study||0
903458|NCT01736696|2183556|P7|COMPLETED|Overall Study||13
903459|NCT01736696|2183557|P6|COMPLETED|Overall Study||8
903460|NCT01736696|2183558|P5|COMPLETED|Overall Study||9
903461|NCT01736696|2183559|P4|COMPLETED|Overall Study||9
903462|NCT01736696|2183560|P3|COMPLETED|Overall Study||9
903463|NCT01736696|2183561|P2|COMPLETED|Overall Study||5
903464|NCT01736696|2183562|P1|COMPLETED|Overall Study||5
903465|NCT01736696|2183556|P7|STARTED|Overall Study||13
903466|NCT01736696|2183557|P6|STARTED|Overall Study||8
903467|NCT01736696|2183558|P5|STARTED|Overall Study||9
903468|NCT01736696|2183559|P4|STARTED|Overall Study||9
903469|NCT01736696|2183560|P3|STARTED|Overall Study||10
903470|NCT01736696|2183561|P2|STARTED|Overall Study||5
903471|NCT01736696|2183562|P1|STARTED|Overall Study||5
903472|NCT01736657|2183879|P1|NOT COMPLETED|Overall Study||1
903473|NCT01736657|2183879|P1|COMPLETED|Overall Study||72
903474|NCT01736657|2183879|P1|STARTED|Overall Study||73
903481|NCT01736540|2183923|P1|NOT COMPLETED|Overall Study||15
903482|NCT01736540|2183923|P1|COMPLETED|Overall Study||228
903483|NCT01736540|2183923|P1|STARTED|Overall Study||243
903484|NCT01736527|2183980|P1|NOT COMPLETED|Overall Study||0
903485|NCT01736527|2183980|P1|COMPLETED|Overall Study||12
903486|NCT01736527|2183980|P1|STARTED|Overall Study||12
903487|NCT01736475|2183989|P2|NOT COMPLETED|Overall Study||0
903488|NCT01736475|2183990|P1|NOT COMPLETED|Overall Study||12
903489|NCT01736475|2183989|P2|COMPLETED|Overall Study||17
903490|NCT01736475|2183990|P1|COMPLETED|Overall Study||109
903491|NCT01736475|2183989|P2|STARTED|Overall Study||17
903492|NCT01736475|2183990|P1|STARTED|Overall Study||121
903493|NCT01736215|2184043|P1|NOT COMPLETED|Overall Study||14
903494|NCT01736215|2184043|P1|COMPLETED|Overall Study||19
903495|NCT01736215|2184043|P1|Treated|Overall Study||25
903496|NCT01736215|2184043|P1|STARTED|Overall Study||33
903497|NCT01736176|2184055|P1|NOT COMPLETED|Overall Study||11
903498|NCT01736176|2184055|P1|COMPLETED|Overall Study||28
903499|NCT01736176|2184055|P1|Received LCIG|Overall Study||38
903500|NCT01736176|2184055|P1|STARTED|Overall Study|Enrolled participants who underwent the PEG-J placement procedure|39
903501|NCT01735916|2184102|P3|NOT COMPLETED|Overall Study||7
903502|NCT01735916|2184103|P2|NOT COMPLETED|Overall Study||19
903503|NCT01735916|2184104|P1|NOT COMPLETED|Overall Study||18
903504|NCT01735916|2184102|P3|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
903505|NCT01735916|2184103|P2|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
903506|NCT01735916|2184104|P1|COMPLETED|Overall Study||0
903507|NCT01735916|2184102|P3|STARTED|Overall Study||7
903508|NCT01735916|2184103|P2|STARTED|Overall Study||19
903509|NCT01735916|2184104|P1|STARTED|Overall Study||18
903510|NCT01735877|2184125|P2|NOT COMPLETED|Overall Study||0
903511|NCT01735877|2184126|P1|NOT COMPLETED|Overall Study||1
903512|NCT01735877|2184125|P2|COMPLETED|Overall Study||21
903513|NCT01735877|2184126|P1|COMPLETED|Overall Study||26
903514|NCT01735877|2184125|P2|STARTED|Overall Study||21
903515|NCT01735877|2184126|P1|STARTED|Overall Study||27
903516|NCT01735630|2184142|P2|NOT COMPLETED|Overall Study||18
903517|NCT01735630|2184143|P1|NOT COMPLETED|Overall Study||18
903518|NCT01735630|2184142|P2|COMPLETED|Overall Study||157
903519|NCT01735630|2184143|P1|COMPLETED|Overall Study||157
903520|NCT01735630|2184142|P2|STARTED|Overall Study||175
903521|NCT01735630|2184143|P1|STARTED|Overall Study||175
903522|NCT01735617|2184157|P1|NOT COMPLETED|Overall Study||0
903523|NCT01735617|2184157|P1|COMPLETED|Overall Study||16
903524|NCT01735617|2184157|P1|STARTED|Overall Study||16
903525|NCT01735396|2184170|P1|NOT COMPLETED|Overall Study||1
903526|NCT01735396|2184170|P1|COMPLETED|Overall Study||10
903527|NCT01735396|2184170|P1|STARTED|Overall Study||11
903528|NCT01735214|2184179|P1|NOT COMPLETED|Overall Study||0
903529|NCT01735214|2184179|P1|COMPLETED|Overall Study||358
903530|NCT01735214|2184179|P1|STARTED|Overall Study||358
903531|NCT01735201|2184199|P8|NOT COMPLETED|Overall Study||2
903532|NCT01735201|2184200|P7|NOT COMPLETED|Overall Study||3
903533|NCT01735201|2184201|P6|NOT COMPLETED|Overall Study||5
903534|NCT01735201|2184202|P5|NOT COMPLETED|Overall Study||1
903535|NCT01735201|2184203|P4|NOT COMPLETED|Overall Study||2
903536|NCT01735201|2184204|P3|NOT COMPLETED|Overall Study||0
903537|NCT01735201|2184205|P2|NOT COMPLETED|Overall Study||1
903538|NCT01735201|2184206|P1|NOT COMPLETED|Overall Study||3
903539|NCT01735201|2184199|P8|COMPLETED|Overall Study||42
903540|NCT01735201|2184200|P7|COMPLETED|Overall Study||42
903541|NCT01735201|2184201|P6|COMPLETED|Overall Study||40
903542|NCT01735201|2184202|P5|COMPLETED|Overall Study||44
903543|NCT01735201|2184203|P4|COMPLETED|Overall Study||42
903544|NCT01735201|2184204|P3|COMPLETED|Overall Study||44
903545|NCT01735201|2184205|P2|COMPLETED|Overall Study||43
903546|NCT01735201|2184206|P1|COMPLETED|Overall Study||42
903547|NCT01735201|2184199|P8|STARTED|Overall Study||44
903548|NCT01735201|2184200|P7|STARTED|Overall Study||45
903549|NCT01735201|2184201|P6|STARTED|Overall Study||45
903550|NCT01735201|2184202|P5|STARTED|Overall Study||45
903551|NCT01735201|2184203|P4|STARTED|Overall Study||44
903552|NCT01735201|2184204|P3|STARTED|Overall Study||44
903553|NCT01735201|2184205|P2|STARTED|Overall Study||44
903554|NCT01735201|2184206|P1|STARTED|Overall Study||45
903555|NCT01735175|2184242|P2|NOT COMPLETED|Overall Study||13
903556|NCT01735175|2184243|P1|NOT COMPLETED|Overall Study||29
903557|NCT01735175|2184242|P2|COMPLETED|Overall Study||144
903558|NCT01735175|2184243|P1|COMPLETED|Overall Study||130
903559|NCT01735175|2184242|P2|Completed the 6-month SFU Visit|Overall Study||138
903560|NCT01735175|2184243|P1|Completed the 6-month SFU Visit|Overall Study||120
903561|NCT01735175|2184242|P2|Completed All Treatments as Planned|Overall Study||150
903562|NCT01735175|2184243|P1|Completed All Treatments as Planned|Overall Study||140
903563|NCT01735175|2184242|P2|Completed All Cycles|Overall Study||150
903564|NCT01735175|2184243|P1|Completed All Cycles|Overall Study||141
903565|NCT01735175|2184242|P2|STARTED|Overall Study||157
903566|NCT01735175|2184243|P1|STARTED|Overall Study||159
903567|NCT01734993|2184263|P1|NOT COMPLETED|Overall Study||2
903568|NCT01734993|2184263|P1|COMPLETED|Overall Study||9
903569|NCT01734993|2184263|P1|STARTED|Overall Study||11
903570|NCT01734889|2184289|P1|NOT COMPLETED|Overall Study||0
903571|NCT01734889|2184289|P1|COMPLETED|Overall Study||18
903572|NCT01734889|2184289|P1|STARTED|Overall Study||18
903573|NCT01734785|2184300|P4|NOT COMPLETED|Double−Blind Period||0
903574|NCT01734785|2184301|P3|NOT COMPLETED|Double−Blind Period||5
903575|NCT01734785|2184302|P2|NOT COMPLETED|Double−Blind Period||9
903576|NCT01734785|2184303|P1|NOT COMPLETED|Double−Blind Period||5
903577|NCT01734785|2184300|P4|COMPLETED|Double−Blind Period||0
903578|NCT01734785|2184301|P3|COMPLETED|Double−Blind Period||105
903579|NCT01734785|2184302|P2|COMPLETED|Double−Blind Period||103
903580|NCT01734785|2184303|P1|COMPLETED|Double−Blind Period||106
903581|NCT01734785|2184300|P4|STARTED|Double−Blind Period||0
903582|NCT01734785|2184301|P3|STARTED|Double−Blind Period||110
903583|NCT01734785|2184302|P2|STARTED|Double−Blind Period||112
903584|NCT01734785|2184303|P1|STARTED|Double−Blind Period||111
903585|NCT01734785|2184300|P4|NOT COMPLETED|Open−Label Period||273
903586|NCT01734785|2184301|P3|NOT COMPLETED|Open−Label Period||0
903587|NCT01734785|2184302|P2|NOT COMPLETED|Open−Label Period||0
903588|NCT01734785|2184303|P1|NOT COMPLETED|Open−Label Period||0
903589|NCT01734785|2184300|P4|COMPLETED|Open−Label Period||333
903590|NCT01734785|2184301|P3|COMPLETED|Open−Label Period||0
903591|NCT01734785|2184302|P2|COMPLETED|Open−Label Period||0
903592|NCT01734785|2184303|P1|COMPLETED|Open−Label Period||0
903593|NCT01734785|2184300|P4|STARTED|Open−Label Period||606
903594|NCT01734785|2184301|P3|STARTED|Open−Label Period||0
903595|NCT01734785|2184302|P2|STARTED|Open−Label Period||0
903596|NCT01734785|2184303|P1|STARTED|Open−Label Period||0
903597|NCT01734772|2184320|P2|NOT COMPLETED|Overall Study||3
903598|NCT01734772|2184321|P1|NOT COMPLETED|Overall Study||1
903599|NCT01734772|2184320|P2|COMPLETED|Overall Study||21
903600|NCT01734772|2184321|P1|COMPLETED|Overall Study||23
903601|NCT01734772|2184320|P2|STARTED|Overall Study||24
903602|NCT01734772|2184321|P1|STARTED|Overall Study||24
903603|NCT01734655|2184338|P1|NOT COMPLETED|Overall Study||0
903604|NCT01734655|2184338|P1|COMPLETED|Overall Study||40
903605|NCT01734655|2184338|P1|STARTED|Overall Study||40
903606|NCT01734551|2184349|P2|NOT COMPLETED|Overall Study||0
903607|NCT01734551|2184350|P1|NOT COMPLETED|Overall Study||0
903608|NCT01734551|2184349|P2|COMPLETED|Overall Study||16
903609|NCT01734551|2184350|P1|COMPLETED|Overall Study||15
903610|NCT01734551|2184349|P2|STARTED|Overall Study||16
903611|NCT01734551|2184350|P1|STARTED|Overall Study||15
903612|NCT01734395|2184362|P1|NOT COMPLETED|Overall Study||410
903613|NCT01734395|2184362|P1|COMPLETED|Overall Study||1472
903614|NCT01734395|2184362|P1|STARTED|Overall Study||1882
903615|NCT01734317|2184368|P1|NOT COMPLETED|Overall Study||0
903616|NCT01734317|2184368|P1|COMPLETED|Overall Study||10
903617|NCT01734317|2184368|P1|STARTED|Overall Study||10
903618|NCT01734239|2184374|P2|NOT COMPLETED|Overall Study||0
903619|NCT01734239|2184375|P1|NOT COMPLETED|Overall Study||0
903620|NCT01734239|2184374|P2|COMPLETED|Overall Study||50
903621|NCT01734239|2184375|P1|COMPLETED|Overall Study||52
903622|NCT01734239|2184374|P2|STARTED|Overall Study||50
903623|NCT01734239|2184375|P1|STARTED|Overall Study||52
903624|NCT01734161|2184390|P2|NOT COMPLETED|Overall Study||8
903625|NCT01734161|2184391|P1|NOT COMPLETED|Overall Study||6
903626|NCT01734161|2184390|P2|COMPLETED|Overall Study||53
903627|NCT01734161|2184391|P1|COMPLETED|Overall Study||55
903628|NCT01734161|2184390|P2|STARTED|Overall Study||61
903629|NCT01734161|2184391|P1|STARTED|Overall Study||61
903630|NCT01733953|2184399|P2|NOT COMPLETED|Overall Study||7
903631|NCT01733953|2184400|P1|NOT COMPLETED|Overall Study||5
903632|NCT01733953|2184399|P2|COMPLETED|Overall Study||6
903633|NCT01733953|2184400|P1|COMPLETED|Overall Study||9
903634|NCT01733953|2184399|P2|STARTED|Overall Study||13
903635|NCT01733953|2184400|P1|STARTED|Overall Study||14
903636|NCT01733758|2184420|P4|NOT COMPLETED|Overall Study||8
903637|NCT01733758|2184421|P3|NOT COMPLETED|Overall Study||15
903638|NCT01733758|2184422|P2|NOT COMPLETED|Overall Study||12
903639|NCT01733758|2184423|P1|NOT COMPLETED|Overall Study||15
903640|NCT01733758|2184420|P4|COMPLETED|Overall Study||95
903641|NCT01733758|2184421|P3|COMPLETED|Overall Study||135
903642|NCT01733758|2184422|P2|COMPLETED|Overall Study||148
903643|NCT01733758|2184423|P1|COMPLETED|Overall Study||62
903644|NCT01733758|2184420|P4|STARTED|Overall Study||103
903645|NCT01733758|2184421|P3|STARTED|Overall Study||150
903646|NCT01733758|2184422|P2|STARTED|Overall Study||160
903647|NCT01733758|2184423|P1|STARTED|Overall Study||77
903648|NCT01733745|2184476|P2|NOT COMPLETED|Overall Study||0
903649|NCT01733745|2184477|P1|NOT COMPLETED|Overall Study||0
903650|NCT01733745|2184476|P2|COMPLETED|Overall Study||13
903651|NCT01733745|2184477|P1|COMPLETED|Overall Study||13
903652|NCT01733745|2184476|P2|STARTED|Overall Study||13
903653|NCT01733745|2184477|P1|STARTED|Overall Study||13
903654|NCT01733732|2184489|P2|NOT COMPLETED|Overall Study||0
903655|NCT01733732|2184490|P1|NOT COMPLETED|Overall Study||2
903656|NCT01733732|2184489|P2|COMPLETED|Overall Study||27
903657|NCT01733732|2184490|P1|COMPLETED|Overall Study||25
903658|NCT01733732|2184489|P2|STARTED|Overall Study||27
903659|NCT01733732|2184490|P1|STARTED|Overall Study||27
903660|NCT01733329|2184526|P2|NOT COMPLETED|Overall Study||1
903661|NCT01733329|2184527|P1|NOT COMPLETED|Overall Study||2
903662|NCT01733329|2184526|P2|COMPLETED|Overall Study||60
903663|NCT01733329|2184527|P1|COMPLETED|Overall Study||60
903664|NCT01733329|2184526|P2|STARTED|Overall Study||61
903665|NCT01733329|2184527|P1|STARTED|Overall Study||62
903666|NCT01733316|2184539|P1|NOT COMPLETED|Overall Study||2
903667|NCT01733316|2184539|P1|COMPLETED|Overall Study||39
903668|NCT01733316|2184539|P1|STARTED|Overall Study||41
903669|NCT01733277|2184563|P2|NOT COMPLETED|Overall Study||0
903670|NCT01733277|2184564|P1|NOT COMPLETED|Overall Study||0
903671|NCT01733277|2184563|P2|COMPLETED|Overall Study||25
903672|NCT01733277|2184564|P1|COMPLETED|Overall Study||25
903673|NCT01733277|2184563|P2|STARTED|Overall Study||25
903674|NCT01733277|2184564|P1|STARTED|Overall Study||25
903675|NCT01732263|2184576|P2|NOT COMPLETED|Overall Study||0
903676|NCT01732263|2184577|P1|NOT COMPLETED|Overall Study||0
903677|NCT01732263|2184576|P2|COMPLETED|Overall Study||20
903678|NCT01732263|2184577|P1|COMPLETED|Overall Study||23
903679|NCT01732263|2184576|P2|STARTED|Overall Study||20
903680|NCT01732263|2184577|P1|STARTED|Overall Study||23
903681|NCT01733121|2184619|P2|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
903682|NCT01733121|2184620|P1|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
903683|NCT01733121|2184619|P2|COMPLETED|Follow-Up Period (Week 6 to 8)||46
903684|NCT01733121|2184620|P1|COMPLETED|Follow-Up Period (Week 6 to 8)||44
903685|NCT01733121|2184619|P2|STARTED|Follow-Up Period (Week 6 to 8)||46
903686|NCT01733121|2184620|P1|STARTED|Follow-Up Period (Week 6 to 8)||44
903687|NCT01733121|2184619|P2|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||5
903688|NCT01733121|2184620|P1|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7
903689|NCT01733121|2184619|P2|COMPLETED|Double-Blind Period (Week 0 to 6)||46
903690|NCT01733121|2184620|P1|COMPLETED|Double-Blind Period (Week 0 to 6)||44
903691|NCT01733121|2184619|P2|STARTED|Double-Blind Period (Week 0 to 6)||51
903692|NCT01733121|2184620|P1|STARTED|Double-Blind Period (Week 0 to 6)||51
903693|NCT01733069|2184634|P2|NOT COMPLETED|Overall Study||0
903694|NCT01733069|2184635|P1|NOT COMPLETED|Overall Study||0
903695|NCT01733069|2184634|P2|COMPLETED|Overall Study||1598
903696|NCT01733069|2184635|P1|COMPLETED|Overall Study||264
903697|NCT01733069|2184634|P2|STARTED|Overall Study||1598
903698|NCT01733069|2184635|P1|STARTED|Overall Study||264
903699|NCT01733056|2184644|P3|NOT COMPLETED|Overall Study||0
903700|NCT01733056|2184645|P2|NOT COMPLETED|Overall Study||0
903701|NCT01733056|2184646|P1|NOT COMPLETED|Overall Study||0
903702|NCT01733056|2184644|P3|COMPLETED|Overall Study||12
903703|NCT01733056|2184645|P2|COMPLETED|Overall Study||10
903704|NCT01733056|2184646|P1|COMPLETED|Overall Study||21
903705|NCT01733056|2184644|P3|STARTED|Overall Study||12
903706|NCT01733056|2184645|P2|STARTED|Overall Study||10
903707|NCT01733056|2184646|P1|STARTED|Overall Study||21
903708|NCT01732926|2184662|P2|NOT COMPLETED|Overall Study||110
903709|NCT01732926|2184663|P1|NOT COMPLETED|Overall Study||267
903710|NCT01732926|2184662|P2|COMPLETED|Overall Study||45
903711|NCT01732926|2184663|P1|COMPLETED|Overall Study||53
903712|NCT01732926|2184662|P2|STARTED|Overall Study||155
903713|NCT01732926|2184663|P1|STARTED|Overall Study||320
903714|NCT01732913|2184679|P2|NOT COMPLETED|Overall Study||69
903715|NCT01732913|2184680|P1|NOT COMPLETED|Overall Study||156
903716|NCT01732913|2184679|P2|COMPLETED|Overall Study||28
903717|NCT01732913|2184680|P1|COMPLETED|Overall Study||42
903718|NCT01732913|2184679|P2|STARTED|Overall Study||97
903719|NCT01732913|2184680|P1|STARTED|Overall Study||198
903720|NCT01732835|2184694|P1|NOT COMPLETED|2-year Extended Follow-up||5
903721|NCT01732835|2184694|P1|COMPLETED|2-year Extended Follow-up||39
903722|NCT01732835|2184694|P1|STARTED|2-year Extended Follow-up||44
903723|NCT01732835|2184694|P1|NOT COMPLETED|6-month Primary Endpoint||24
903724|NCT01732835|2184694|P1|COMPLETED|6-month Primary Endpoint||44
903725|NCT01732835|2184694|P1|STARTED|6-month Primary Endpoint||68
903726|NCT01732796|2184728|P3|NOT COMPLETED|Overall Study||13
903727|NCT01732796|2184729|P2|NOT COMPLETED|Overall Study||42
903728|NCT01732796|2184730|P1|NOT COMPLETED|Overall Study||46
903729|NCT01732796|2184728|P3|COMPLETED|Overall Study||38
903730|NCT01732796|2184729|P2|COMPLETED|Overall Study||169
903731|NCT01732796|2184730|P1|COMPLETED|Overall Study||162
903732|NCT01732796|2184728|P3|STARTED|Overall Study||51
903733|NCT01732796|2184729|P2|STARTED|Overall Study||211
903734|NCT01732796|2184730|P1|STARTED|Overall Study||208
903735|NCT01732770|2184748|P2|NOT COMPLETED|Overall Study||8
903736|NCT01732770|2184749|P1|NOT COMPLETED|Overall Study||10
903737|NCT01732770|2184748|P2|COMPLETED|Overall Study||313
903738|NCT01732770|2184749|P1|COMPLETED|Overall Study||312
903739|NCT01732770|2184748|P2|Received Study Treatment|Overall Study||320
903740|NCT01732770|2184749|P1|Received Study Treatment|Overall Study||320
903741|NCT01732770|2184748|P2|STARTED|Overall Study||321
903742|NCT01732770|2184749|P1|STARTED|Overall Study||322
903743|NCT01732757|2184764|P3|NOT COMPLETED|Overall Study||0
903744|NCT01732757|2184765|P2|NOT COMPLETED|Overall Study||0
903745|NCT01732757|2184766|P1|NOT COMPLETED|Overall Study||1
903746|NCT01732757|2184764|P3|COMPLETED|Overall Study||52
903747|NCT01732757|2184765|P2|COMPLETED|Overall Study||52
903748|NCT01732757|2184766|P1|COMPLETED|Overall Study||52
903749|NCT01732757|2184764|P3|STARTED|Overall Study||52
903750|NCT01732757|2184765|P2|STARTED|Overall Study||52
903751|NCT01732757|2184766|P1|STARTED|Overall Study||53
903752|NCT01732692|2184806|P2|NOT COMPLETED|Overall Study||1
903753|NCT01732692|2184807|P1|NOT COMPLETED|Overall Study||0
903754|NCT01732692|2184806|P2|COMPLETED|Overall Study||69
903755|NCT01732692|2184807|P1|COMPLETED|Overall Study||70
903756|NCT01732692|2184806|P2|STARTED|Overall Study||70
903757|NCT01732692|2184807|P1|STARTED|Overall Study||70
903758|NCT01732588|2184824|P3|NOT COMPLETED|Third Intervention (7 Days)||0
903759|NCT01732588|2184825|P2|NOT COMPLETED|Third Intervention (7 Days)||0
903760|NCT01732588|2184826|P1|NOT COMPLETED|Third Intervention (7 Days)||0
903761|NCT01732588|2184824|P3|COMPLETED|Third Intervention (7 Days)||4
903762|NCT01732588|2184825|P2|COMPLETED|Third Intervention (7 Days)||2
903763|NCT01732588|2184826|P1|COMPLETED|Third Intervention (7 Days)||4
903764|NCT01732588|2184824|P3|STARTED|Third Intervention (7 Days)||4
903765|NCT01732588|2184825|P2|STARTED|Third Intervention (7 Days)||2
903766|NCT01732588|2184826|P1|STARTED|Third Intervention (7 Days)||4
903767|NCT01732588|2184824|P3|NOT COMPLETED|Second Intervention (7 Days)||0
903768|NCT01732588|2184825|P2|NOT COMPLETED|Second Intervention (7 Days)||0
903769|NCT01732588|2184826|P1|NOT COMPLETED|Second Intervention (7 Days)||0
903770|NCT01732588|2184824|P3|COMPLETED|Second Intervention (7 Days)||4
903771|NCT01732588|2184825|P2|COMPLETED|Second Intervention (7 Days)||2
903772|NCT01732588|2184826|P1|COMPLETED|Second Intervention (7 Days)||4
903773|NCT01732588|2184824|P3|STARTED|Second Intervention (7 Days)||4
903774|NCT01732588|2184825|P2|STARTED|Second Intervention (7 Days)||2
903775|NCT01732588|2184826|P1|STARTED|Second Intervention (7 Days)||4
903776|NCT01732588|2184824|P3|NOT COMPLETED|First Intervention (7 Days)||0
903777|NCT01732588|2184825|P2|NOT COMPLETED|First Intervention (7 Days)||1
903778|NCT01732588|2184826|P1|NOT COMPLETED|First Intervention (7 Days)||0
903779|NCT01732588|2184824|P3|COMPLETED|First Intervention (7 Days)||4
903780|NCT01732588|2184825|P2|COMPLETED|First Intervention (7 Days)||2
903781|NCT01732588|2184826|P1|COMPLETED|First Intervention (7 Days)||4
903782|NCT01732588|2184824|P3|STARTED|First Intervention (7 Days)||4
903783|NCT01732588|2184825|P2|STARTED|First Intervention (7 Days)||3
903784|NCT01732588|2184826|P1|STARTED|First Intervention (7 Days)||4
903785|NCT01732549|2184842|P2|NOT COMPLETED|Overall Study||73
903786|NCT01732549|2184843|P1|NOT COMPLETED|Overall Study||71
903787|NCT01732549|2184842|P2|COMPLETED|Overall Study||0
903788|NCT01732549|2184843|P1|COMPLETED|Overall Study||0
903789|NCT01732549|2184842|P2|Withdrawn During Treatment:Final Analysi|Overall Study||73
903790|NCT01732549|2184843|P1|Withdrawn During Treatment:Final Analysi|Overall Study||71
903791|NCT01732549|2184842|P2|Ongoing Treatment Period:Final Analysis|Overall Study||0
903792|NCT01732549|2184843|P1|Ongoing Treatment Period:Final Analysis|Overall Study||0
903793|NCT01732549|2184842|P2|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 61 (AE 3, Consent withdrawn 6, Disease progression 46, Other 6)|61
903794|NCT01732549|2184843|P1|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 59 (AE 13, Consent withdrawn 13, Disease progression 31, Other 2)|59
903795|NCT01732549|2184842|P2|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
903796|NCT01732549|2184843|P1|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
903797|NCT01732549|2184842|P2|STARTED|Overall Study||73
903798|NCT01732549|2184843|P1|STARTED|Overall Study||71
903799|NCT01732510|2184870|P7|NOT COMPLETED|Overall Study||8
903800|NCT01732510|2184871|P6|NOT COMPLETED|Overall Study||13
903801|NCT01732510|2184872|P5|NOT COMPLETED|Overall Study||5
903802|NCT01732510|2184873|P4|NOT COMPLETED|Overall Study||5
903803|NCT01732510|2184874|P3|NOT COMPLETED|Overall Study||4
903804|NCT01732510|2184875|P2|NOT COMPLETED|Overall Study||5
903805|NCT01732510|2184876|P1|NOT COMPLETED|Overall Study||1
903806|NCT01732510|2184870|P7|COMPLETED|Overall Study||0
903807|NCT01732510|2184871|P6|COMPLETED|Overall Study||0
903808|NCT01732510|2184872|P5|COMPLETED|Overall Study||3
903809|NCT01732510|2184873|P4|COMPLETED|Overall Study||5
903810|NCT01732510|2184874|P3|COMPLETED|Overall Study||4
903811|NCT01732510|2184875|P2|COMPLETED|Overall Study||4
903812|NCT01732510|2184876|P1|COMPLETED|Overall Study||8
903813|NCT01732510|2184870|P7|STARTED|Overall Study||8
903814|NCT01732510|2184871|P6|STARTED|Overall Study||13
903815|NCT01732510|2184872|P5|STARTED|Overall Study||8
903816|NCT01732510|2184873|P4|STARTED|Overall Study||10
903817|NCT01732510|2184874|P3|STARTED|Overall Study||8
903818|NCT01732510|2184875|P2|STARTED|Overall Study||9
903819|NCT01732510|2184876|P1|STARTED|Overall Study||9
903820|NCT01732484|2184955|P1|NOT COMPLETED|Overall Study||26
903821|NCT01732484|2184955|P1|COMPLETED|Overall Study||74
903822|NCT01732484|2184955|P1|Allocation|Overall Study||100
903823|NCT01732484|2184955|P1|Randomized|Overall Study|Randomized implantation SN60WF IOL in on eye and iMics NY-60 in the other eye.|100
903824|NCT01732484|2184955|P1|STARTED|Overall Study||100
903825|NCT01732471|2184963|P1|NOT COMPLETED|Overall Study||1
903826|NCT01732471|2184963|P1|COMPLETED|Overall Study||89
903827|NCT01732471|2184963|P1|STARTED|Overall Study||90
903844|NCT01731990|2185041|P2|NOT COMPLETED|Overall Study||8
903845|NCT01731990|2185042|P1|NOT COMPLETED|Overall Study||4
903846|NCT01731990|2185041|P2|COMPLETED|Overall Study||12
903847|NCT01731990|2185042|P1|COMPLETED|Overall Study||14
903848|NCT01731990|2185041|P2|STARTED|Overall Study||20
903849|NCT01731990|2185042|P1|STARTED|Overall Study|"Started indicates Safety and Pharmacodynamics set ."|18
903850|NCT01731938|2185058|P2|NOT COMPLETED|Primary Part II||13
903851|NCT01731938|2185059|P1|NOT COMPLETED|Primary Part II||13
903852|NCT01731938|2185058|P2|COMPLETED|Primary Part II||95
903853|NCT01731938|2185059|P1|COMPLETED|Primary Part II||103
903854|NCT01731938|2185058|P2|STARTED|Primary Part II|Subjects from Preliminary Part I were not carried over to Primary Part II to assess safety/efficacy.|108
903855|NCT01731938|2185059|P1|STARTED|Primary Part II|Preliminary Part I was for study team familiarization with FS Grifols application.|116
903856|NCT01731938|2185058|P2|NOT COMPLETED|Preliminary Part I||8
903857|NCT01731938|2185059|P1|NOT COMPLETED|Preliminary Part I||3
903858|NCT01731938|2185058|P2|COMPLETED|Preliminary Part I||44
903859|NCT01731938|2185059|P1|COMPLETED|Preliminary Part I||48
903860|NCT01731938|2185058|P2|STARTED|Preliminary Part I||52
903861|NCT01731938|2185059|P1|STARTED|Preliminary Part I||51
903862|NCT01731470|2185071|P1|NOT COMPLETED|Overall Study||2
903863|NCT01731470|2185071|P1|COMPLETED|Overall Study|Number of patients enrolled in the study|14
903864|NCT01731470|2185071|P1|STARTED|Overall Study|Number of patients consented to participate in the study|16
903865|NCT01731119|2185076|P1|NOT COMPLETED|Overall Study||2
903866|NCT01731119|2185076|P1|COMPLETED|Overall Study||7
903867|NCT01731119|2185076|P1|STARTED|Overall Study||9
903868|NCT01731041|2185086|P2|NOT COMPLETED|Overall Study||0
903869|NCT01731041|2185087|P1|NOT COMPLETED|Overall Study||0
903870|NCT01731041|2185086|P2|COMPLETED|Overall Study||30
903871|NCT01731041|2185087|P1|COMPLETED|Overall Study||30
903872|NCT01731041|2185086|P2|STARTED|Overall Study||30
903873|NCT01731041|2185087|P1|STARTED|Overall Study||30
903874|NCT01730378|2185097|P2|NOT COMPLETED|Overall Study||0
903875|NCT01730378|2185098|P1|NOT COMPLETED|Overall Study||1
903876|NCT01730378|2185097|P2|COMPLETED|Overall Study||47
903877|NCT01730378|2185098|P1|COMPLETED|Overall Study||83
903878|NCT01730378|2185097|P2|STARTED|Overall Study||47
903879|NCT01730378|2185098|P1|STARTED|Overall Study||84
903880|NCT01730339|2185129|P2|NOT COMPLETED|Overall Study||3
903881|NCT01730339|2185130|P1|NOT COMPLETED|Overall Study||5
903882|NCT01730339|2185129|P2|COMPLETED|Overall Study||52
903883|NCT01730339|2185130|P1|COMPLETED|Overall Study||40
903884|NCT01730339|2185129|P2|STARTED|Overall Study||55
903885|NCT01730339|2185130|P1|STARTED|Overall Study||45
903886|NCT01730053|2185170|P6|NOT COMPLETED|Overall Study||13
903887|NCT01730053|2185171|P5|NOT COMPLETED|Overall Study||9
903888|NCT01730053|2185172|P4|NOT COMPLETED|Overall Study||8
903889|NCT01730053|2185173|P3|NOT COMPLETED|Overall Study||11
903890|NCT01730053|2185174|P2|NOT COMPLETED|Overall Study||14
903891|NCT01730053|2185175|P1|NOT COMPLETED|Overall Study||5
903892|NCT01730053|2185170|P6|COMPLETED|Overall Study||41
903893|NCT01730053|2185171|P5|COMPLETED|Overall Study||44
903894|NCT01730053|2185172|P4|COMPLETED|Overall Study||45
903895|NCT01730053|2185173|P3|COMPLETED|Overall Study||38
903896|NCT01730053|2185174|P2|COMPLETED|Overall Study||34
903897|NCT01730053|2185175|P1|COMPLETED|Overall Study||43
903898|NCT01730053|2185170|P6|Treated|Overall Study||54
903899|NCT01730053|2185171|P5|Treated|Overall Study||53
903900|NCT01730053|2185172|P4|Treated|Overall Study||53
903901|NCT01730053|2185173|P3|Treated|Overall Study||49
903902|NCT01730053|2185174|P2|Treated|Overall Study||48
903903|NCT01730053|2185175|P1|Treated|Overall Study||48
903904|NCT01730053|2185170|P6|STARTED|Overall Study||54
903905|NCT01730053|2185171|P5|STARTED|Overall Study||53
903906|NCT01730053|2185172|P4|STARTED|Overall Study||53
903907|NCT01730053|2185173|P3|STARTED|Overall Study||49
903908|NCT01730053|2185174|P2|STARTED|Overall Study||48
903909|NCT01730053|2185175|P1|STARTED|Overall Study||48
903910|NCT01730040|2185334|P7|NOT COMPLETED|Overall Study||9
903911|NCT01730040|2185335|P6|NOT COMPLETED|Overall Study||7
903912|NCT01730040|2185336|P5|NOT COMPLETED|Overall Study||6
903913|NCT01730040|2185337|P4|NOT COMPLETED|Overall Study||8
903914|NCT01730040|2185338|P3|NOT COMPLETED|Overall Study||11
903915|NCT01730040|2185339|P2|NOT COMPLETED|Overall Study||15
903916|NCT01730040|2185340|P1|NOT COMPLETED|Overall Study||13
903917|NCT01730040|2185334|P7|COMPLETED|Overall Study||38
903918|NCT01730040|2185335|P6|COMPLETED|Overall Study||40
903919|NCT01730040|2185336|P5|COMPLETED|Overall Study||39
903920|NCT01730040|2185337|P4|COMPLETED|Overall Study||39
903921|NCT01730040|2185338|P3|COMPLETED|Overall Study||46
903922|NCT01730040|2185339|P2|COMPLETED|Overall Study||40
903923|NCT01730040|2185340|P1|COMPLETED|Overall Study||44
903924|NCT01730040|2185334|P7|Treated|Overall Study||47
903925|NCT01730040|2185335|P6|Treated|Overall Study||46
903926|NCT01730040|2185336|P5|Treated|Overall Study||45
903927|NCT01730040|2185337|P4|Treated|Overall Study||47
903928|NCT01730040|2185338|P3|Treated|Overall Study||57
903929|NCT01730040|2185339|P2|Treated|Overall Study||55
903930|NCT01730040|2185340|P1|Treated|Overall Study||57
903931|NCT01730040|2185334|P7|STARTED|Overall Study||47
903932|NCT01730040|2185335|P6|STARTED|Overall Study||47
903933|NCT01730040|2185336|P5|STARTED|Overall Study||45
903934|NCT01730040|2185337|P4|STARTED|Overall Study||47
903935|NCT01730040|2185338|P3|STARTED|Overall Study||57
903936|NCT01730040|2185339|P2|STARTED|Overall Study||55
903937|NCT01730040|2185340|P1|STARTED|Overall Study||57
903938|NCT01729871|2185519|P2|NOT COMPLETED|Overall Study||23
903939|NCT01729871|2185520|P1|NOT COMPLETED|Overall Study||12
903940|NCT01729871|2185519|P2|COMPLETED|Overall Study||101
903941|NCT01729871|2185520|P1|COMPLETED|Overall Study||112
903942|NCT01729871|2185519|P2|STARTED|Overall Study||124
903943|NCT01729871|2185520|P1|STARTED|Overall Study||124
903944|NCT01729728|2185539|P3|NOT COMPLETED|Overall Study||1
903945|NCT01729728|2185540|P2|NOT COMPLETED|Overall Study||6
903946|NCT01729728|2185541|P1|NOT COMPLETED|Overall Study||1
903947|NCT01729728|2185539|P3|COMPLETED|Overall Study||16
903948|NCT01729728|2185540|P2|COMPLETED|Overall Study||22
903949|NCT01729728|2185541|P1|COMPLETED|Overall Study||20
903950|NCT01729728|2185539|P3|STARTED|Overall Study||17
903951|NCT01729728|2185540|P2|STARTED|Overall Study||28
903952|NCT01729728|2185541|P1|STARTED|Overall Study||21
903953|NCT01729559|2185674|P2|NOT COMPLETED|Overall Study||28
903954|NCT01729559|2185675|P1|NOT COMPLETED|Overall Study||31
903955|NCT01729559|2185674|P2|COMPLETED|Overall Study||216
903956|NCT01729559|2185675|P1|COMPLETED|Overall Study||220
903957|NCT01729559|2185674|P2|STARTED|Overall Study||244
903958|NCT01729559|2185675|P1|STARTED|Overall Study||251
903959|NCT01729338|2185687|P1|NOT COMPLETED|Overall Study||2
903960|NCT01729338|2185687|P1|COMPLETED|Overall Study||14
903961|NCT01729338|2185687|P1|STARTED|Overall Study||16
903962|NCT01729247|2185702|P1|NOT COMPLETED|Overall Study||0
903963|NCT01729247|2185702|P1|COMPLETED|Overall Study||50
903964|NCT01729247|2185702|P1|STARTED|Overall Study||50
903965|NCT01729026|2185718|P2|NOT COMPLETED|3-month to 6-month (Final) Follow-up||2
903966|NCT01729026|2185719|P1|NOT COMPLETED|3-month to 6-month (Final) Follow-up||1
903967|NCT01729026|2185718|P2|COMPLETED|3-month to 6-month (Final) Follow-up||6
903968|NCT01729026|2185719|P1|COMPLETED|3-month to 6-month (Final) Follow-up||6
903969|NCT01729026|2185718|P2|STARTED|3-month to 6-month (Final) Follow-up||8
903970|NCT01729026|2185719|P1|STARTED|3-month to 6-month (Final) Follow-up||7
903971|NCT01729026|2185718|P2|NOT COMPLETED|Randomization to 3-month Follow-up||2
903972|NCT01729026|2185719|P1|NOT COMPLETED|Randomization to 3-month Follow-up||2
903973|NCT01729026|2185718|P2|COMPLETED|Randomization to 3-month Follow-up||8
903974|NCT01729026|2185719|P1|COMPLETED|Randomization to 3-month Follow-up||7
903975|NCT01729026|2185718|P2|STARTED|Randomization to 3-month Follow-up||10
903976|NCT01729026|2185719|P1|STARTED|Randomization to 3-month Follow-up||9
903977|NCT01728792|2185730|P5|NOT COMPLETED|Overall Study||0
903978|NCT01728792|2185731|P4|NOT COMPLETED|Overall Study||3
903979|NCT01728792|2185732|P3|NOT COMPLETED|Overall Study||4
903980|NCT01728792|2185733|P2|NOT COMPLETED|Overall Study||2
903981|NCT01728792|2185734|P1|NOT COMPLETED|Overall Study||3
903982|NCT01728792|2185730|P5|COMPLETED|Overall Study||16
903983|NCT01728792|2185731|P4|COMPLETED|Overall Study||14
903984|NCT01728792|2185732|P3|COMPLETED|Overall Study||13
903985|NCT01728792|2185733|P2|COMPLETED|Overall Study||14
903986|NCT01728792|2185734|P1|COMPLETED|Overall Study||11
903987|NCT01728792|2185730|P5|STARTED|Overall Study||16
903988|NCT01728792|2185731|P4|STARTED|Overall Study||17
903989|NCT01728792|2185732|P3|STARTED|Overall Study||17
903990|NCT01728792|2185733|P2|STARTED|Overall Study||16
903991|NCT01728792|2185734|P1|STARTED|Overall Study||14
903992|NCT01728584|2185785|P4|NOT COMPLETED|Overall Study||1
903993|NCT01728584|2185786|P3|NOT COMPLETED|Overall Study||1
903994|NCT01728584|2185787|P2|NOT COMPLETED|Overall Study||0
903995|NCT01728584|2185788|P1|NOT COMPLETED|Overall Study||8
903996|NCT01728584|2185785|P4|COMPLETED|Overall Study||29
903997|NCT01728584|2185786|P3|COMPLETED|Overall Study||30
903998|NCT01728584|2185787|P2|COMPLETED|Overall Study||30
903999|NCT01728584|2185788|P1|COMPLETED|Overall Study||28
904000|NCT01728584|2185785|P4|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 5 (all to Deep/Std)|30
904001|NCT01728584|2185786|P3|STARTED|Overall Study|Randomized|31
904002|NCT01728584|2185787|P2|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 7 (2 to Std/Std, 4 to Deep/Std, 1 to Deep/Low)|30
904003|NCT01728584|2185788|P1|STARTED|Overall Study|Randomized|36
904004|NCT01728376|2185846|P6|NOT COMPLETED|Overall Study||2
904005|NCT01728376|2185847|P5|NOT COMPLETED|Overall Study||2
904006|NCT01728376|2185848|P4|NOT COMPLETED|Overall Study||2
904007|NCT01728376|2185849|P3|NOT COMPLETED|Overall Study||2
904008|NCT01728376|2185850|P2|NOT COMPLETED|Overall Study||2
904009|NCT01728376|2185851|P1|NOT COMPLETED|Overall Study||4
904010|NCT01728376|2185846|P6|COMPLETED|Overall Study||5
904011|NCT01728376|2185847|P5|COMPLETED|Overall Study||12
904012|NCT01728376|2185848|P4|COMPLETED|Overall Study||7
904013|NCT01728376|2185849|P3|COMPLETED|Overall Study||17
904014|NCT01728376|2185850|P2|COMPLETED|Overall Study||9
904015|NCT01728376|2185851|P1|COMPLETED|Overall Study||18
904016|NCT01728376|2185846|P6|Treated|Overall Study||7
904017|NCT01728376|2185847|P5|Treated|Overall Study||14
904018|NCT01728376|2185848|P4|Treated|Overall Study||9
904019|NCT01728376|2185849|P3|Treated|Overall Study||19
904020|NCT01728376|2185850|P2|Treated|Overall Study||10
904021|NCT01728376|2185851|P1|Treated|Overall Study||22
904022|NCT01728376|2185846|P6|STARTED|Overall Study||7
904023|NCT01728376|2185847|P5|STARTED|Overall Study||14
904024|NCT01728376|2185848|P4|STARTED|Overall Study||9
904025|NCT01728376|2185849|P3|STARTED|Overall Study||19
904026|NCT01728376|2185850|P2|STARTED|Overall Study||11
904027|NCT01728376|2185851|P1|STARTED|Overall Study||22
904028|NCT01728337|2185913|P1|NOT COMPLETED|Overall Study||0
904029|NCT01728337|2185913|P1|COMPLETED|Overall Study||80
904030|NCT01728337|2185913|P1|STARTED|Overall Study||80
904031|NCT01728324|2185924|P3|NOT COMPLETED|Termination of RBV||15
904032|NCT01728324|2185925|P2|NOT COMPLETED|Termination of RBV||37
904033|NCT01728324|2185926|P1|NOT COMPLETED|Termination of RBV||39
904034|NCT01728324|2185924|P3|COMPLETED|Termination of RBV||57
904035|NCT01728324|2185925|P2|COMPLETED|Termination of RBV||176
904036|NCT01728324|2185926|P1|COMPLETED|Termination of RBV||172
904037|NCT01728324|2185924|P3|STARTED|Termination of RBV||72
904038|NCT01728324|2185925|P2|STARTED|Termination of RBV||213
904039|NCT01728324|2185926|P1|STARTED|Termination of RBV||211
904040|NCT01728324|2185924|P3|NOT COMPLETED|Termination of FDV||14
904041|NCT01728324|2185925|P2|NOT COMPLETED|Termination of FDV||36
904042|NCT01728324|2185926|P1|NOT COMPLETED|Termination of FDV||38
904043|NCT01728324|2185924|P3|COMPLETED|Termination of FDV||58
904044|NCT01728324|2185925|P2|COMPLETED|Termination of FDV||177
904045|NCT01728324|2185926|P1|COMPLETED|Termination of FDV||173
904046|NCT01728324|2185924|P3|STARTED|Termination of FDV||72
904047|NCT01728324|2185925|P2|STARTED|Termination of FDV||213
904048|NCT01728324|2185926|P1|STARTED|Termination of FDV||211
904049|NCT01728324|2185924|P3|NOT COMPLETED|Termination of DBV||14
904050|NCT01728324|2185925|P2|NOT COMPLETED|Termination of DBV||36
904051|NCT01728324|2185926|P1|NOT COMPLETED|Termination of DBV||38
904052|NCT01728324|2185924|P3|COMPLETED|Termination of DBV||58
904053|NCT01728324|2185925|P2|COMPLETED|Termination of DBV||177
904054|NCT01728324|2185926|P1|COMPLETED|Termination of DBV||173
904055|NCT01728324|2185924|P3|STARTED|Termination of DBV||72
904056|NCT01728324|2185925|P2|STARTED|Termination of DBV||213
904057|NCT01728324|2185926|P1|STARTED|Termination of DBV||211
904058|NCT01728246|2185947|P2|NOT COMPLETED|Overall Study||36
904059|NCT01728246|2185948|P1|NOT COMPLETED|Overall Study||36
904060|NCT01728246|2185947|P2|COMPLETED|Overall Study||195
904061|NCT01728246|2185948|P1|COMPLETED|Overall Study||206
904062|NCT01728246|2185947|P2|STARTED|Overall Study||231
904063|NCT01728246|2185948|P1|STARTED|Overall Study||242
904064|NCT01728116|2185966|P2|NOT COMPLETED|Overall Study||47
904065|NCT01728116|2185967|P1|NOT COMPLETED|Overall Study||161
904066|NCT01728116|2185966|P2|COMPLETED|Overall Study|Completed to Week 52|60
904067|NCT01728116|2185967|P1|COMPLETED|Overall Study|Completed to Week 78|52
904068|NCT01728116|2185966|P2|STARTED|Overall Study|Sham mITT subjects|107
904069|NCT01728116|2185967|P1|STARTED|Overall Study|EndoBarrier mITT Subjects|213
904070|NCT01728077|2185992|P2|NOT COMPLETED|Overall Study||5
904071|NCT01728077|2185993|P1|NOT COMPLETED|Overall Study||8
904072|NCT01728077|2185992|P2|COMPLETED|Overall Study||2
904073|NCT01728077|2185993|P1|COMPLETED|Overall Study||11
904074|NCT01728077|2185992|P2|STARTED|Overall Study||7
904075|NCT01728077|2185993|P1|STARTED|Overall Study||19
904076|NCT01727895|2186008|P2|NOT COMPLETED|Overall Study||0
904077|NCT01727895|2186009|P1|NOT COMPLETED|Overall Study||0
904078|NCT01727895|2186008|P2|COMPLETED|Overall Study||5
904079|NCT01727895|2186009|P1|COMPLETED|Overall Study||10
904080|NCT01727895|2186008|P2|STARTED|Overall Study||5
904081|NCT01727895|2186009|P1|STARTED|Overall Study||10
904082|NCT01727791|2186015|P1|NOT COMPLETED|Overall Study||0
904083|NCT01727791|2186015|P1|COMPLETED|Overall Study||10
904084|NCT01727791|2186015|P1|STARTED|Overall Study||10
904085|NCT01727713|2186045|P1|NOT COMPLETED|Overall Study||35
904086|NCT01727713|2186045|P1|COMPLETED|Overall Study||75
904087|NCT01727713|2186045|P1|STARTED|Overall Study||110
904088|NCT01727700|2186072|P3|NOT COMPLETED|Overall Study||2
904089|NCT01727700|2186073|P2|NOT COMPLETED|Overall Study||10
904090|NCT01727700|2186074|P1|NOT COMPLETED|Overall Study||2
904091|NCT01727700|2186072|P3|COMPLETED|Overall Study||42
904092|NCT01727700|2186073|P2|COMPLETED|Overall Study||35
904093|NCT01727700|2186074|P1|COMPLETED|Overall Study||42
904094|NCT01727700|2186072|P3|STARTED|Overall Study||44
904095|NCT01727700|2186073|P2|STARTED|Overall Study||45
904096|NCT01727700|2186074|P1|STARTED|Overall Study||44
904097|NCT01727505|2186097|P2|NOT COMPLETED|Second 24 Hours||1
904098|NCT01727505|2186098|P1|NOT COMPLETED|Second 24 Hours||0
904099|NCT01727505|2186097|P2|COMPLETED|Second 24 Hours||10
904100|NCT01727505|2186098|P1|COMPLETED|Second 24 Hours||14
904101|NCT01727505|2186097|P2|STARTED|Second 24 Hours||11
904102|NCT01727505|2186098|P1|STARTED|Second 24 Hours||14
904103|NCT01727505|2186097|P2|NOT COMPLETED|First 24 Hours||1
904104|NCT01727505|2186098|P1|NOT COMPLETED|First 24 Hours||0
904105|NCT01727505|2186097|P2|COMPLETED|First 24 Hours||11
904106|NCT01727505|2186098|P1|COMPLETED|First 24 Hours||14
904107|NCT01727505|2186097|P2|STARTED|First 24 Hours||12
904108|NCT01727505|2186098|P1|STARTED|First 24 Hours||14
904109|NCT01727414|2186116|P2|NOT COMPLETED|Overall Study||0
904110|NCT01727414|2186117|P1|NOT COMPLETED|Overall Study||3
904111|NCT01727414|2186116|P2|COMPLETED|Overall Study||45
904112|NCT01727414|2186117|P1|COMPLETED|Overall Study||123
904113|NCT01727414|2186116|P2|STARTED|Overall Study||45
904114|NCT01727414|2186117|P1|STARTED|Overall Study||126
904115|NCT01727258|2186126|P3|NOT COMPLETED|Overall Study||1
904116|NCT01727258|2186127|P2|NOT COMPLETED|Overall Study||3
904117|NCT01727258|2186128|P1|NOT COMPLETED|Overall Study||2
904118|NCT01727258|2186126|P3|COMPLETED|Overall Study||50
904119|NCT01727258|2186127|P2|COMPLETED|Overall Study||48
904120|NCT01727258|2186128|P1|COMPLETED|Overall Study||49
904121|NCT01727258|2186126|P3|STARTED|Overall Study||51
904122|NCT01727258|2186127|P2|STARTED|Overall Study||51
904123|NCT01727258|2186128|P1|STARTED|Overall Study||51
904124|NCT01727180|2186151|P1|NOT COMPLETED|Overall Study||0
904125|NCT01727180|2186151|P1|COMPLETED|Overall Study||108
904126|NCT01727180|2186151|P1|STARTED|Overall Study||108
904127|NCT01727167|2186157|P2|NOT COMPLETED|Overall Study||0
904128|NCT01727167|2186158|P1|NOT COMPLETED|Overall Study||0
904129|NCT01727167|2186157|P2|COMPLETED|Overall Study||0
904130|NCT01727167|2186158|P1|COMPLETED|Overall Study||1
904131|NCT01727167|2186157|P2|STARTED|Overall Study||0
904132|NCT01727167|2186158|P1|STARTED|Overall Study||1
904133|NCT01727141|2186170|P4|NOT COMPLETED|Overall Study||15
904134|NCT01727141|2186171|P3|NOT COMPLETED|Overall Study||3
904135|NCT01727141|2186172|P2|NOT COMPLETED|Overall Study||9
904136|NCT01727141|2186173|P1|NOT COMPLETED|Overall Study||5
904137|NCT01727141|2186170|P4|COMPLETED|Overall Study||246
904138|NCT01727141|2186171|P3|COMPLETED|Overall Study||258
904139|NCT01727141|2186172|P2|COMPLETED|Overall Study||251
904140|NCT01727141|2186173|P1|COMPLETED|Overall Study||255
904141|NCT01727141|2186170|P4|Full Analysis Set|Overall Study||261
904142|NCT01727141|2186171|P3|Full Analysis Set|Overall Study||261
904143|NCT01727141|2186172|P2|Full Analysis Set|Overall Study||260
904144|NCT01727141|2186173|P1|Full Analysis Set|Overall Study||258
904145|NCT01727141|2186170|P4|Safety Set|Overall Study||260
904146|NCT01727141|2186171|P3|Safety Set|Overall Study||262
904147|NCT01727141|2186172|P2|Safety Set|Overall Study||260
904148|NCT01727141|2186173|P1|Safety Set|Overall Study||258
904149|NCT01727141|2186170|P4|STARTED|Overall Study||261
904150|NCT01727141|2186171|P3|STARTED|Overall Study||261
904151|NCT01727141|2186172|P2|STARTED|Overall Study||260
904152|NCT01727141|2186173|P1|STARTED|Overall Study||260
904153|NCT01727024|2186223|P2|NOT COMPLETED|Period 2||0
904154|NCT01727024|2186224|P1|NOT COMPLETED|Period 2||0
904155|NCT01727024|2186223|P2|COMPLETED|Period 2||64
904156|NCT01727024|2186224|P1|COMPLETED|Period 2||68
904157|NCT01727024|2186223|P2|STARTED|Period 2||64
904158|NCT01727024|2186224|P1|STARTED|Period 2||68
904159|NCT01727024|2186223|P2|NOT COMPLETED|Period 1||4
904160|NCT01727024|2186224|P1|NOT COMPLETED|Period 1||3
904161|NCT01727024|2186223|P2|COMPLETED|Period 1||64
904162|NCT01727024|2186224|P1|COMPLETED|Period 1||68
904163|NCT01727024|2186223|P2|STARTED|Period 1||68
904164|NCT01727024|2186224|P1|STARTED|Period 1||71
904165|NCT01726621|2186237|P1|NOT COMPLETED|Overall Study||4
904166|NCT01726621|2186237|P1|COMPLETED|Overall Study||51
904167|NCT01726621|2186237|P1|STARTED|Overall Study||55
904168|NCT01726517|2186246|P5|NOT COMPLETED|Overall Study||0
904169|NCT01726517|2186247|P4|NOT COMPLETED|Overall Study||0
904170|NCT01726517|2186248|P3|NOT COMPLETED|Overall Study||1
904171|NCT01726517|2186249|P2|NOT COMPLETED|Overall Study||0
904172|NCT01726517|2186250|P1|NOT COMPLETED|Overall Study||0
904173|NCT01726517|2186246|P5|COMPLETED|Overall Study||21
904174|NCT01726517|2186247|P4|COMPLETED|Overall Study||19
904175|NCT01726517|2186248|P3|COMPLETED|Overall Study||18
904176|NCT01726517|2186249|P2|COMPLETED|Overall Study||21
904177|NCT01726517|2186250|P1|COMPLETED|Overall Study||20
904178|NCT01726517|2186246|P5|STARTED|Overall Study||21
904179|NCT01726517|2186247|P4|STARTED|Overall Study||19
904180|NCT01726517|2186248|P3|STARTED|Overall Study||19
904181|NCT01726517|2186249|P2|STARTED|Overall Study||21
904182|NCT01726517|2186250|P1|STARTED|Overall Study||20
904183|NCT01726504|2186279|P2|NOT COMPLETED|Overall Study||28
904184|NCT01726504|2186280|P1|NOT COMPLETED|Overall Study||12
904185|NCT01726504|2186279|P2|COMPLETED|Overall Study||511
904186|NCT01726504|2186280|P1|COMPLETED|Overall Study||524
904187|NCT01726504|2186279|P2|STARTED|Overall Study||539
904188|NCT01726504|2186280|P1|STARTED|Overall Study||536
904189|NCT01726335|2186306|P1|NOT COMPLETED|Overall Study||24
904190|NCT01726335|2186306|P1|COMPLETED|Overall Study||29
904191|NCT01726335|2186306|P1|STARTED|Overall Study||53
904192|NCT01726049|2186324|P2|NOT COMPLETED|Overall Study||4
904193|NCT01726049|2186325|P1|NOT COMPLETED|Overall Study||5
904194|NCT01726049|2186324|P2|COMPLETED|Overall Study||22
904195|NCT01726049|2186325|P1|COMPLETED|Overall Study||21
904196|NCT01726049|2186324|P2|STARTED|Overall Study||26
904197|NCT01726049|2186325|P1|STARTED|Overall Study||26
904198|NCT01726023|2186339|P2|NOT COMPLETED|Overall Study||26
904199|NCT01726023|2186340|P1|NOT COMPLETED|Overall Study||29
904200|NCT01726023|2186339|P2|COMPLETED|Overall Study||196
904201|NCT01726023|2186340|P1|COMPLETED|Overall Study||190
904202|NCT01726023|2186339|P2|STARTED|Overall Study||222
904203|NCT01726023|2186340|P1|STARTED|Overall Study||219
904204|NCT01725984|2186432|P2|NOT COMPLETED|Overall Study||0
904205|NCT01725984|2186433|P1|NOT COMPLETED|Overall Study||0
904206|NCT01725984|2186432|P2|COMPLETED|Overall Study||41
904207|NCT01725984|2186433|P1|COMPLETED|Overall Study||39
904208|NCT01725984|2186432|P2|STARTED|Overall Study||41
904209|NCT01725984|2186433|P1|STARTED|Overall Study||39
904210|NCT01725529|2186460|P3|NOT COMPLETED|Overall Study||10
904211|NCT01725529|2186461|P2|NOT COMPLETED|Overall Study||16
904212|NCT01725529|2186462|P1|NOT COMPLETED|Overall Study||15
904213|NCT01725529|2186460|P3|COMPLETED|Overall Study||142
904214|NCT01725529|2186461|P2|COMPLETED|Overall Study||137
904215|NCT01725529|2186462|P1|COMPLETED|Overall Study||137
904216|NCT01725529|2186460|P3|STARTED|Overall Study||152
904217|NCT01725529|2186461|P2|STARTED|Overall Study||153
904218|NCT01725529|2186462|P1|STARTED|Overall Study||152
904219|NCT01725451|2186488|P4|NOT COMPLETED|Period 6||0
904220|NCT01725451|2186489|P3|NOT COMPLETED|Period 6||0
904221|NCT01725451|2186490|P2|NOT COMPLETED|Period 6||0
904222|NCT01725451|2186491|P1|NOT COMPLETED|Period 6||0
904223|NCT01725451|2186488|P4|COMPLETED|Period 6||7
904224|NCT01725451|2186489|P3|COMPLETED|Period 6||6
904225|NCT01725451|2186490|P2|COMPLETED|Period 6||6
904226|NCT01725451|2186491|P1|COMPLETED|Period 6||7
904227|NCT01725451|2186488|P4|STARTED|Period 6||7
904228|NCT01725451|2186489|P3|STARTED|Period 6||6
904229|NCT01725451|2186490|P2|STARTED|Period 6||6
904230|NCT01725451|2186491|P1|STARTED|Period 6||7
904231|NCT01725451|2186488|P4|NOT COMPLETED|Washout From Period 5||0
904232|NCT01725451|2186489|P3|NOT COMPLETED|Washout From Period 5||0
904233|NCT01725451|2186490|P2|NOT COMPLETED|Washout From Period 5||0
904234|NCT01725451|2186491|P1|NOT COMPLETED|Washout From Period 5||0
904235|NCT01725451|2186488|P4|COMPLETED|Washout From Period 5||7
904236|NCT01725451|2186489|P3|COMPLETED|Washout From Period 5||6
904237|NCT01725451|2186490|P2|COMPLETED|Washout From Period 5||6
904238|NCT01725451|2186491|P1|COMPLETED|Washout From Period 5||7
904239|NCT01725451|2186488|P4|STARTED|Washout From Period 5||7
904240|NCT01725451|2186489|P3|STARTED|Washout From Period 5||6
904241|NCT01725451|2186490|P2|STARTED|Washout From Period 5||6
904242|NCT01725451|2186491|P1|STARTED|Washout From Period 5||7
904243|NCT01725451|2186488|P4|NOT COMPLETED|Period 5||0
904244|NCT01725451|2186489|P3|NOT COMPLETED|Period 5||0
904245|NCT01725451|2186490|P2|NOT COMPLETED|Period 5||0
904246|NCT01725451|2186491|P1|NOT COMPLETED|Period 5||0
904247|NCT01725451|2186488|P4|COMPLETED|Period 5||7
904248|NCT01725451|2186489|P3|COMPLETED|Period 5||6
904249|NCT01725451|2186490|P2|COMPLETED|Period 5||6
904250|NCT01725451|2186491|P1|COMPLETED|Period 5||7
904251|NCT01725451|2186488|P4|STARTED|Period 5||7
904252|NCT01725451|2186489|P3|STARTED|Period 5||6
904253|NCT01725451|2186490|P2|STARTED|Period 5||6
904254|NCT01725451|2186491|P1|STARTED|Period 5||7
904255|NCT01725451|2186488|P4|NOT COMPLETED|Washout From Period 4||0
904256|NCT01725451|2186489|P3|NOT COMPLETED|Washout From Period 4||0
904257|NCT01725451|2186490|P2|NOT COMPLETED|Washout From Period 4||0
904258|NCT01725451|2186491|P1|NOT COMPLETED|Washout From Period 4||0
904259|NCT01725451|2186488|P4|COMPLETED|Washout From Period 4||7
904260|NCT01725451|2186489|P3|COMPLETED|Washout From Period 4||6
904261|NCT01725451|2186490|P2|COMPLETED|Washout From Period 4||6
904262|NCT01725451|2186491|P1|COMPLETED|Washout From Period 4||7
904263|NCT01725451|2186488|P4|STARTED|Washout From Period 4||7
904264|NCT01725451|2186489|P3|STARTED|Washout From Period 4||6
904265|NCT01725451|2186490|P2|STARTED|Washout From Period 4||6
904266|NCT01725451|2186491|P1|STARTED|Washout From Period 4||7
904267|NCT01725451|2186488|P4|NOT COMPLETED|Period 4||0
904268|NCT01725451|2186489|P3|NOT COMPLETED|Period 4||1
904269|NCT01725451|2186490|P2|NOT COMPLETED|Period 4||0
904270|NCT01725451|2186491|P1|NOT COMPLETED|Period 4||0
904271|NCT01725451|2186488|P4|COMPLETED|Period 4||7
904272|NCT01725451|2186489|P3|COMPLETED|Period 4||6
904273|NCT01725451|2186490|P2|COMPLETED|Period 4||6
904274|NCT01725451|2186491|P1|COMPLETED|Period 4||7
904275|NCT01725451|2186488|P4|STARTED|Period 4||7
904276|NCT01725451|2186489|P3|STARTED|Period 4||7
904277|NCT01725451|2186490|P2|STARTED|Period 4||6
904278|NCT01725451|2186491|P1|STARTED|Period 4||7
904279|NCT01725451|2186488|P4|NOT COMPLETED|Washout From Period 3||0
904280|NCT01725451|2186489|P3|NOT COMPLETED|Washout From Period 3||1
904281|NCT01725451|2186490|P2|NOT COMPLETED|Washout From Period 3||1
904282|NCT01725451|2186491|P1|NOT COMPLETED|Washout From Period 3||0
904283|NCT01725451|2186488|P4|COMPLETED|Washout From Period 3||7
904284|NCT01725451|2186489|P3|COMPLETED|Washout From Period 3||7
904285|NCT01725451|2186490|P2|COMPLETED|Washout From Period 3||6
904286|NCT01725451|2186491|P1|COMPLETED|Washout From Period 3||7
904287|NCT01725451|2186488|P4|STARTED|Washout From Period 3||7
904288|NCT01725451|2186489|P3|STARTED|Washout From Period 3||8
904289|NCT01725451|2186490|P2|STARTED|Washout From Period 3||7
904290|NCT01725451|2186491|P1|STARTED|Washout From Period 3||7
904291|NCT01725451|2186488|P4|NOT COMPLETED|Period 3||0
904292|NCT01725451|2186489|P3|NOT COMPLETED|Period 3||0
904293|NCT01725451|2186490|P2|NOT COMPLETED|Period 3||0
904294|NCT01725451|2186491|P1|NOT COMPLETED|Period 3||0
904295|NCT01725451|2186488|P4|COMPLETED|Period 3||7
904296|NCT01725451|2186489|P3|COMPLETED|Period 3||8
904297|NCT01725451|2186490|P2|COMPLETED|Period 3||7
904298|NCT01725451|2186491|P1|COMPLETED|Period 3||7
904299|NCT01725451|2186488|P4|STARTED|Period 3||7
904300|NCT01725451|2186489|P3|STARTED|Period 3||8
904301|NCT01725451|2186490|P2|STARTED|Period 3||7
904302|NCT01725451|2186491|P1|STARTED|Period 3||7
904303|NCT01725451|2186488|P4|NOT COMPLETED|Washout From Period 2||0
904304|NCT01725451|2186489|P3|NOT COMPLETED|Washout From Period 2||0
904305|NCT01725451|2186490|P2|NOT COMPLETED|Washout From Period 2||0
904306|NCT01725451|2186491|P1|NOT COMPLETED|Washout From Period 2||0
904307|NCT01725451|2186488|P4|COMPLETED|Washout From Period 2||7
904308|NCT01725451|2186489|P3|COMPLETED|Washout From Period 2||8
904309|NCT01725451|2186490|P2|COMPLETED|Washout From Period 2||7
904310|NCT01725451|2186491|P1|COMPLETED|Washout From Period 2||7
904311|NCT01725451|2186488|P4|STARTED|Washout From Period 2||7
904312|NCT01725451|2186489|P3|STARTED|Washout From Period 2||8
904313|NCT01725451|2186490|P2|STARTED|Washout From Period 2||7
904314|NCT01725451|2186491|P1|STARTED|Washout From Period 2||7
904315|NCT01725451|2186488|P4|NOT COMPLETED|Period 2||0
904316|NCT01725451|2186489|P3|NOT COMPLETED|Period 2||0
904317|NCT01725451|2186490|P2|NOT COMPLETED|Period 2||0
904318|NCT01725451|2186491|P1|NOT COMPLETED|Period 2||0
904319|NCT01725451|2186488|P4|COMPLETED|Period 2||7
904320|NCT01725451|2186489|P3|COMPLETED|Period 2||8
904321|NCT01725451|2186490|P2|COMPLETED|Period 2||7
904322|NCT01725451|2186491|P1|COMPLETED|Period 2||7
904323|NCT01725451|2186488|P4|STARTED|Period 2||7
904324|NCT01725451|2186489|P3|STARTED|Period 2||8
904325|NCT01725451|2186490|P2|STARTED|Period 2||7
904326|NCT01725451|2186491|P1|STARTED|Period 2||7
904327|NCT01725451|2186488|P4|NOT COMPLETED|Washout From Period 1||0
904328|NCT01725451|2186489|P3|NOT COMPLETED|Washout From Period 1||0
904329|NCT01725451|2186490|P2|NOT COMPLETED|Washout From Period 1||0
904330|NCT01725451|2186491|P1|NOT COMPLETED|Washout From Period 1||0
904331|NCT01725451|2186488|P4|COMPLETED|Washout From Period 1||7
904332|NCT01725451|2186489|P3|COMPLETED|Washout From Period 1||8
904333|NCT01725451|2186490|P2|COMPLETED|Washout From Period 1||7
904334|NCT01725451|2186491|P1|COMPLETED|Washout From Period 1||7
904335|NCT01725451|2186488|P4|STARTED|Washout From Period 1||7
904336|NCT01725451|2186489|P3|STARTED|Washout From Period 1||8
904337|NCT01725451|2186490|P2|STARTED|Washout From Period 1||7
904338|NCT01725451|2186491|P1|STARTED|Washout From Period 1||7
904339|NCT01725451|2186488|P4|NOT COMPLETED|Period 1||0
904340|NCT01725451|2186489|P3|NOT COMPLETED|Period 1||0
904341|NCT01725451|2186490|P2|NOT COMPLETED|Period 1||0
904342|NCT01725451|2186491|P1|NOT COMPLETED|Period 1||1
904343|NCT01725451|2186488|P4|COMPLETED|Period 1||7
904344|NCT01725451|2186489|P3|COMPLETED|Period 1||8
904345|NCT01725451|2186490|P2|COMPLETED|Period 1||7
904346|NCT01725451|2186491|P1|COMPLETED|Period 1||7
904347|NCT01725451|2186488|P4|STARTED|Period 1||7
904348|NCT01725451|2186489|P3|STARTED|Period 1||8
904349|NCT01725451|2186490|P2|STARTED|Period 1||7
904350|NCT01725451|2186491|P1|STARTED|Period 1||8
904351|NCT01725386|2186513|P2|NOT COMPLETED|Overall Study||46
904352|NCT01725386|2186514|P1|NOT COMPLETED|Overall Study||175
904353|NCT01725386|2186513|P2|COMPLETED|Overall Study||17
904354|NCT01725386|2186514|P1|COMPLETED|Overall Study||13
904355|NCT01725386|2186513|P2|STARTED|Overall Study||63
904356|NCT01725386|2186514|P1|STARTED|Overall Study||188
904357|NCT01725308|2186533|P3|NOT COMPLETED|Overall Study||41
904358|NCT01725308|2186534|P2|NOT COMPLETED|Overall Study||14
904359|NCT01725308|2186535|P1|NOT COMPLETED|Overall Study||44
904360|NCT01725308|2186533|P3|COMPLETED|Overall Study||138
904361|NCT01725308|2186534|P2|COMPLETED|Overall Study||60
904362|NCT01725308|2186535|P1|COMPLETED|Overall Study||134
904363|NCT01725308|2186533|P3|Treated|Overall Study||179
904364|NCT01725308|2186534|P2|Treated|Overall Study||74
904365|NCT01725308|2186535|P1|Treated|Overall Study||177
904366|NCT01725308|2186533|P3|STARTED|Overall Study||179
904367|NCT01725308|2186534|P2|STARTED|Overall Study||74
904368|NCT01725308|2186535|P1|STARTED|Overall Study||178
904369|NCT01725282|2186589|P4|NOT COMPLETED|Overall Study||7
904370|NCT01725282|2186590|P3|NOT COMPLETED|Overall Study||8
904371|NCT01725282|2186591|P2|NOT COMPLETED|Overall Study||5
904372|NCT01725282|2186592|P1|NOT COMPLETED|Overall Study||2
904373|NCT01725282|2186589|P4|COMPLETED|Overall Study||36
904374|NCT01725282|2186590|P3|COMPLETED|Overall Study||33
904375|NCT01725282|2186591|P2|COMPLETED|Overall Study||39
904376|NCT01725282|2186592|P1|COMPLETED|Overall Study||42
904377|NCT01725282|2186589|P4|STARTED|Overall Study||43
904378|NCT01725282|2186590|P3|STARTED|Overall Study||41
904379|NCT01725282|2186591|P2|STARTED|Overall Study||44
904380|NCT01725282|2186592|P1|STARTED|Overall Study||44
904381|NCT01725217|2186625|P3|NOT COMPLETED|Overall Study||0
904382|NCT01725217|2186626|P2|NOT COMPLETED|Overall Study||0
904383|NCT01725217|2186627|P1|NOT COMPLETED|Overall Study||1
904384|NCT01725217|2186625|P3|COMPLETED|Overall Study||66
904385|NCT01725217|2186626|P2|COMPLETED|Overall Study||66
904386|NCT01725217|2186627|P1|COMPLETED|Overall Study||65
904387|NCT01725217|2186625|P3|STARTED|Overall Study||66
904388|NCT01725217|2186626|P2|STARTED|Overall Study||66
904389|NCT01725217|2186627|P1|STARTED|Overall Study||66
904390|NCT01724528|2186657|P2|NOT COMPLETED|Overall Study||3
904391|NCT01724528|2186658|P1|NOT COMPLETED|Overall Study||4
904392|NCT01724528|2186657|P2|COMPLETED|Overall Study||170
904393|NCT01724528|2186658|P1|COMPLETED|Overall Study||169
904394|NCT01724528|2186657|P2|STARTED|Overall Study||173
904395|NCT01724528|2186658|P1|STARTED|Overall Study||173
904396|NCT01724359|2186672|P1|NOT COMPLETED|Overall Study||31
904397|NCT01724359|2186672|P1|COMPLETED|Overall Study||64
904398|NCT01724359|2186672|P1|STARTED|Overall Study||95
904399|NCT01724216|2186685|P1|NOT COMPLETED|Overall Study||1
904400|NCT01724216|2186685|P1|COMPLETED|Overall Study||10
904401|NCT01724216|2186685|P1|STARTED|Overall Study||11
904402|NCT01724177|2186689|P1|NOT COMPLETED|Overall Study||21
904403|NCT01724177|2186689|P1|COMPLETED|Overall Study|Completed includes participants who continue receiving oral lenalidomide|5
904404|NCT01724177|2186689|P1|Safety Population|Overall Study|Safety Population includes participants who received at least one dose of lenalidomide|26
904405|NCT01724177|2186689|P1|STARTED|Overall Study||26
904406|NCT01724021|2186701|P2|NOT COMPLETED|Overall Study||60
904407|NCT01724021|2186702|P1|NOT COMPLETED|Overall Study||48
904408|NCT01724021|2186701|P2|COMPLETED|Overall Study||309
904409|NCT01724021|2186702|P1|COMPLETED|Overall Study||323
904410|NCT01724021|2186701|P2|STARTED|Overall Study||369
904411|NCT01724021|2186702|P1|STARTED|Overall Study||371
904412|NCT01723904|2186734|P1|NOT COMPLETED|Overall Study||11
904413|NCT01723904|2186734|P1|COMPLETED|Overall Study||79
904414|NCT01723904|2186734|P1|STARTED|Overall Study||90
904415|NCT01723722|2186746|P2|NOT COMPLETED|Overall Study||0
904416|NCT01723722|2186747|P1|NOT COMPLETED|Overall Study||0
904417|NCT01723722|2186746|P2|COMPLETED|Overall Study||20
904418|NCT01723722|2186747|P1|COMPLETED|Overall Study||20
904419|NCT01723722|2186746|P2|STARTED|Overall Study||20
904420|NCT01723722|2186747|P1|STARTED|Overall Study||20
904421|NCT01723397|2186755|P2|NOT COMPLETED|Study Period 2||1
904422|NCT01723397|2186756|P1|NOT COMPLETED|Study Period 2||0
904423|NCT01723397|2186755|P2|COMPLETED|Study Period 2||5
904424|NCT01723397|2186756|P1|COMPLETED|Study Period 2||7
904425|NCT01723397|2186755|P2|STARTED|Study Period 2||6
904426|NCT01723397|2186756|P1|STARTED|Study Period 2||7
904427|NCT01723397|2186755|P2|NOT COMPLETED|Washout||0
904428|NCT01723397|2186756|P1|NOT COMPLETED|Washout||0
904429|NCT01723397|2186755|P2|COMPLETED|Washout||6
904430|NCT01723397|2186756|P1|COMPLETED|Washout||7
904431|NCT01723397|2186755|P2|STARTED|Washout||6
904432|NCT01723397|2186756|P1|STARTED|Washout||7
904433|NCT01723397|2186755|P2|NOT COMPLETED|Study Period 1||1
904434|NCT01723397|2186756|P1|NOT COMPLETED|Study Period 1||0
904435|NCT01723397|2186755|P2|COMPLETED|Study Period 1||6
904436|NCT01723397|2186756|P1|COMPLETED|Study Period 1||7
904437|NCT01723397|2186755|P2|STARTED|Study Period 1||7
904438|NCT01723397|2186756|P1|STARTED|Study Period 1||7
904439|NCT01723254|2186770|P8|NOT COMPLETED|Overall Study||3
904440|NCT01723254|2186771|P7|NOT COMPLETED|Overall Study||1
904441|NCT01723254|2186772|P6|NOT COMPLETED|Overall Study||2
904442|NCT01723254|2186773|P5|NOT COMPLETED|Overall Study||2
904443|NCT01723254|2186774|P4|NOT COMPLETED|Overall Study||2
904444|NCT01723254|2186775|P3|NOT COMPLETED|Overall Study||3
904445|NCT01723254|2186776|P2|NOT COMPLETED|Overall Study||3
904446|NCT01723254|2186777|P1|NOT COMPLETED|Overall Study||1
904447|NCT01723254|2186770|P8|COMPLETED|Overall Study||60
904448|NCT01723254|2186771|P7|COMPLETED|Overall Study||19
904449|NCT01723254|2186772|P6|COMPLETED|Overall Study||18
904450|NCT01723254|2186773|P5|COMPLETED|Overall Study||18
904451|NCT01723254|2186774|P4|COMPLETED|Overall Study||18
904452|NCT01723254|2186775|P3|COMPLETED|Overall Study||17
904453|NCT01723254|2186776|P2|COMPLETED|Overall Study||18
904454|NCT01723254|2186777|P1|COMPLETED|Overall Study||5
904455|NCT01723254|2186770|P8|STARTED|Overall Study||63
904456|NCT01723254|2186771|P7|STARTED|Overall Study||20
904457|NCT01723254|2186772|P6|STARTED|Overall Study||20
904458|NCT01723254|2186773|P5|STARTED|Overall Study||20
904459|NCT01723254|2186774|P4|STARTED|Overall Study||20
904460|NCT01723254|2186775|P3|STARTED|Overall Study||20
904461|NCT01723254|2186776|P2|STARTED|Overall Study||21
904462|NCT01723254|2186777|P1|STARTED|Overall Study||6
904463|NCT01723228|2186829|P2|NOT COMPLETED|Overall Study||11
904464|NCT01723228|2186830|P1|NOT COMPLETED|Overall Study||8
904465|NCT01723228|2186829|P2|COMPLETED|Overall Study||73
904466|NCT01723228|2186830|P1|COMPLETED|Overall Study||78
904467|NCT01723228|2186829|P2|STARTED|Overall Study||84
904468|NCT01723228|2186830|P1|STARTED|Overall Study||86
904469|NCT01722994|2186848|P2|NOT COMPLETED|Overall Study||17
904470|NCT01722994|2186849|P1|NOT COMPLETED|Overall Study||25
904471|NCT01722994|2186848|P2|COMPLETED|Overall Study||31
904472|NCT01722994|2186849|P1|COMPLETED|Overall Study||24
904473|NCT01722994|2186848|P2|STARTED|Overall Study||48
904474|NCT01722994|2186849|P1|STARTED|Overall Study||49
904475|NCT01722877|2186863|P1|NOT COMPLETED|Overall Study||2
904476|NCT01722877|2186863|P1|COMPLETED|Overall Study||27
904477|NCT01722877|2186863|P1|STARTED|Overall Study||29
904478|NCT01722734|2186873|P3|NOT COMPLETED|Overall Study||2
904479|NCT01722734|2186874|P2|NOT COMPLETED|Overall Study||1
904480|NCT01722734|2186875|P1|NOT COMPLETED|Overall Study||2
904481|NCT01722734|2186873|P3|COMPLETED|Overall Study||307
904482|NCT01722734|2186874|P2|COMPLETED|Overall Study||276
904483|NCT01722734|2186875|P1|COMPLETED|Overall Study||552
904484|NCT01722734|2186873|P3|STARTED|Overall Study||309
904485|NCT01722734|2186874|P2|STARTED|Overall Study||277
904486|NCT01722734|2186875|P1|STARTED|Overall Study||554
904487|NCT01722552|2186883|P1|NOT COMPLETED|Overall Study||4
904488|NCT01722552|2186883|P1|COMPLETED|Overall Study|Number of subjects who completed the intervention|116
904489|NCT01722552|2186883|P1|STARTED|Overall Study|Number of subjects enrolled|120
904490|NCT01722487|2186893|P2|NOT COMPLETED|Overall Study||7
904491|NCT01722487|2186894|P1|NOT COMPLETED|Overall Study||2
904492|NCT01722487|2186893|P2|COMPLETED|Overall Study|Participants who were still on study or died at study closure|126
904493|NCT01722487|2186894|P1|COMPLETED|Overall Study|Participants who were still on study or died at study closure|134
904494|NCT01722487|2186893|P2|STARTED|Overall Study||133
904495|NCT01722487|2186894|P1|STARTED|Overall Study||136
904496|NCT01722435|2186912|P1|NOT COMPLETED|Overall Study||0
904497|NCT01722435|2186912|P1|COMPLETED|Overall Study||78
904498|NCT01722435|2186912|P1|STARTED|Overall Study||78
904499|NCT01722266|2186924|P4|NOT COMPLETED|Overall Study||0
904500|NCT01722266|2186925|P3|NOT COMPLETED|Overall Study||5
904501|NCT01722266|2186926|P2|NOT COMPLETED|Overall Study||3
904502|NCT01722266|2186927|P1|NOT COMPLETED|Overall Study||1
904503|NCT01722266|2186924|P4|COMPLETED|Overall Study|3 subjects randomized to 1.2 mg group and 1 to 1.8 mg group tolerated only 0.6 mg|18
904504|NCT01722266|2186925|P3|COMPLETED|Overall Study||13
904505|NCT01722266|2186926|P2|COMPLETED|Overall Study||15
904506|NCT01722266|2186927|P1|COMPLETED|Overall Study||17
904507|NCT01722266|2186924|P4|STARTED|Overall Study|3 withdrew consent; 1 dropped out due to nausea|18
904508|NCT01722266|2186925|P3|STARTED|Overall Study||18
904509|NCT01722266|2186926|P2|STARTED|Overall Study||18
904510|NCT01722266|2186927|P1|STARTED|Overall Study||18
904511|NCT01722162|2186955|P2|NOT COMPLETED|Overall Study||6
904512|NCT01722162|2186956|P1|NOT COMPLETED|Overall Study||5
904513|NCT01722162|2186955|P2|COMPLETED|Overall Study||18
904514|NCT01722162|2186956|P1|COMPLETED|Overall Study||18
904515|NCT01722162|2186955|P2|STARTED|Overall Study||24
904516|NCT01722162|2186956|P1|STARTED|Overall Study||23
904517|NCT01722097|2186966|P2|NOT COMPLETED|Overall Study||5
904518|NCT01722097|2186967|P1|NOT COMPLETED|Overall Study||6
904519|NCT01722097|2186966|P2|COMPLETED|Overall Study||50
904520|NCT01722097|2186967|P1|COMPLETED|Overall Study||49
904521|NCT01722097|2186966|P2|STARTED|Overall Study||55
904522|NCT01722097|2186967|P1|STARTED|Overall Study||55
904523|NCT01722071|2186975|P2|NOT COMPLETED|Overall Study||0
904524|NCT01722071|2186976|P1|NOT COMPLETED|Overall Study||1
904525|NCT01722071|2186975|P2|COMPLETED|Overall Study||10
904526|NCT01722071|2186976|P1|COMPLETED|Overall Study||9
904527|NCT01722071|2186975|P2|STARTED|Overall Study||10
904528|NCT01722071|2186976|P1|STARTED|Overall Study||10
904529|NCT01721967|2186982|P1|NOT COMPLETED|Overall Study||3
904530|NCT01721967|2186982|P1|COMPLETED|Overall Study||11
904531|NCT01721967|2186982|P1|STARTED|Overall Study||14
904532|NCT01721837|2186991|P1|NOT COMPLETED|Overall Study||0
904533|NCT01721837|2186991|P1|COMPLETED|Overall Study||2120
904534|NCT01721837|2186991|P1|STARTED|Overall Study||2120
904535|NCT01721772|2186997|P2|NOT COMPLETED|Overall Study||192
904536|NCT01721772|2186998|P1|NOT COMPLETED|Overall Study||111
904537|NCT01721772|2186997|P2|COMPLETED|Overall Study|Continuing in treatment period|13
904538|NCT01721772|2186998|P1|COMPLETED|Overall Study|Continuing in treatment period|95
904539|NCT01721772|2186997|P2|STARTED|Overall Study||205
904540|NCT01721772|2186998|P1|STARTED|Overall Study||206
904562|NCT01721564|2187044|P1|NOT COMPLETED|Overall Study||0
904563|NCT01721564|2187044|P1|COMPLETED|Overall Study||8
904564|NCT01721564|2187044|P1|STARTED|Overall Study||8
904565|NCT01721486|2187051|P2|NOT COMPLETED|Overall Study||1
904566|NCT01721486|2187052|P1|NOT COMPLETED|Overall Study||1
904567|NCT01721486|2187051|P2|COMPLETED|Overall Study||19
904568|NCT01721486|2187052|P1|COMPLETED|Overall Study||20
904569|NCT01721486|2187051|P2|STARTED|Overall Study||20
904570|NCT01721486|2187052|P1|STARTED|Overall Study||21
904571|NCT01721330|2187066|P2|NOT COMPLETED|Overall Study||1
904572|NCT01721330|2187067|P1|NOT COMPLETED|Overall Study||0
904573|NCT01721330|2187066|P2|COMPLETED|Overall Study||1
904574|NCT01721330|2187067|P1|COMPLETED|Overall Study||1
904575|NCT01721330|2187066|P2|STARTED|Overall Study||2
904576|NCT01721330|2187067|P1|STARTED|Overall Study||1
904577|NCT01721317|2187075|P2|NOT COMPLETED|Overall Study||4
904578|NCT01721317|2187076|P1|NOT COMPLETED|Overall Study||2
904579|NCT01721317|2187075|P2|COMPLETED|Overall Study||0
904580|NCT01721317|2187076|P1|COMPLETED|Overall Study||0
904581|NCT01721317|2187075|P2|STARTED|Overall Study||4
904582|NCT01721317|2187076|P1|STARTED|Overall Study||2
904583|NCT01721226|2187144|P2|NOT COMPLETED|Overall Study||7
904584|NCT01721226|2187145|P1|NOT COMPLETED|Overall Study||5
904585|NCT01721226|2187144|P2|COMPLETED|Overall Study||50
904586|NCT01721226|2187145|P1|COMPLETED|Overall Study||50
904587|NCT01721226|2187144|P2|Week 24|Overall Study||50
904588|NCT01721226|2187145|P1|Week 24|Overall Study||50
904589|NCT01721226|2187144|P2|Week 12|Overall Study||53
904590|NCT01721226|2187145|P1|Week 12|Overall Study||48
904591|NCT01721226|2187144|P2|Baseline|Overall Study||57
904592|NCT01721226|2187145|P1|Baseline|Overall Study||53
904593|NCT01721226|2187144|P2|STARTED|Overall Study||57
904594|NCT01721226|2187145|P1|STARTED|Overall Study||55
904595|NCT01721161|2187155|P2|NOT COMPLETED|Overall Study||7
904596|NCT01721161|2187156|P1|NOT COMPLETED|Overall Study||4
904597|NCT01721161|2187155|P2|COMPLETED|Overall Study||34
904598|NCT01721161|2187156|P1|COMPLETED|Overall Study||37
904599|NCT01721161|2187155|P2|STARTED|Overall Study||41
904600|NCT01721161|2187156|P1|STARTED|Overall Study||41
904601|NCT01721109|2187179|P1|NOT COMPLETED|Extension Phase||37
904602|NCT01721109|2187179|P1|COMPLETED|Extension Phase|Participants turned 18 years old or the study drug became commercially available in their country.|3
904603|NCT01721109|2187179|P1|STARTED|Extension Phase|Only 40 participants entered the optional extension phase.|40
904604|NCT01721109|2187179|P1|NOT COMPLETED|Main Phase||1
904605|NCT01721109|2187179|P1|COMPLETED|Main Phase||49
904606|NCT01721109|2187179|P1|STARTED|Main Phase||50
904607|NCT01721096|2187194|P2|NOT COMPLETED|Follow-up Completed at 3 Year||204
904608|NCT01721096|2187195|P1|NOT COMPLETED|Follow-up Completed at 3 Year||302
904609|NCT01721096|2187194|P2|COMPLETED|Follow-up Completed at 3 Year||2
904610|NCT01721096|2187195|P1|COMPLETED|Follow-up Completed at 3 Year||5
904611|NCT01721096|2187194|P2|STARTED|Follow-up Completed at 3 Year||206
904612|NCT01721096|2187195|P1|STARTED|Follow-up Completed at 3 Year||307
904613|NCT01721096|2187194|P2|NOT COMPLETED|Follow-up Completed at 2 Year||1
904614|NCT01721096|2187195|P1|NOT COMPLETED|Follow-up Completed at 2 Year||8
904615|NCT01721096|2187194|P2|COMPLETED|Follow-up Completed at 2 Year||206
904616|NCT01721096|2187195|P1|COMPLETED|Follow-up Completed at 2 Year||307
904617|NCT01721096|2187194|P2|STARTED|Follow-up Completed at 2 Year||207
904618|NCT01721096|2187195|P1|STARTED|Follow-up Completed at 2 Year||315
904619|NCT01721096|2187194|P2|NOT COMPLETED|Follow-up Completed at 1 Year||1
904620|NCT01721096|2187195|P1|NOT COMPLETED|Follow-up Completed at 1 Year||4
904621|NCT01721096|2187194|P2|COMPLETED|Follow-up Completed at 1 Year||207
904622|NCT01721096|2187195|P1|COMPLETED|Follow-up Completed at 1 Year||315
904623|NCT01721096|2187194|P2|STARTED|Follow-up Completed at 1 Year||208
904624|NCT01721096|2187195|P1|STARTED|Follow-up Completed at 1 Year||319
904625|NCT01721096|2187194|P2|NOT COMPLETED|Follow-up Completed at 8 Months||5
904626|NCT01721096|2187195|P1|NOT COMPLETED|Follow-up Completed at 8 Months||4
904627|NCT01721096|2187194|P2|COMPLETED|Follow-up Completed at 8 Months||208
904628|NCT01721096|2187195|P1|COMPLETED|Follow-up Completed at 8 Months||319
904629|NCT01721096|2187194|P2|STARTED|Follow-up Completed at 8 Months||213
904630|NCT01721096|2187195|P1|STARTED|Follow-up Completed at 8 Months||323
904631|NCT01721070|2187285|P1|NOT COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||1
904632|NCT01721070|2187285|P1|COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||18
904633|NCT01721070|2187285|P1|STARTED|Ketoconazole 400 mg and SUF NT 15 mcg||19
904634|NCT01721070|2187285|P1|NOT COMPLETED|SUF NT 15 mcg||0
904635|NCT01721070|2187285|P1|COMPLETED|SUF NT 15 mcg||19
904636|NCT01721070|2187285|P1|STARTED|SUF NT 15 mcg||19
904637|NCT01721057|2187296|P7|NOT COMPLETED|Follow Up||0
904638|NCT01721057|2187297|P6|NOT COMPLETED|Follow Up||0
904639|NCT01721057|2187298|P5|NOT COMPLETED|Follow Up||0
904640|NCT01721057|2187299|P4|NOT COMPLETED|Follow Up||0
904641|NCT01721057|2187300|P3|NOT COMPLETED|Follow Up||0
904642|NCT01721057|2187301|P2|NOT COMPLETED|Follow Up||0
904643|NCT01721057|2187302|P1|NOT COMPLETED|Follow Up||0
904644|NCT01721057|2187296|P7|COMPLETED|Follow Up||22
904645|NCT01721057|2187297|P6|COMPLETED|Follow Up||19
904646|NCT01721057|2187298|P5|COMPLETED|Follow Up||17
904647|NCT01721057|2187299|P4|COMPLETED|Follow Up||0
904648|NCT01721057|2187300|P3|COMPLETED|Follow Up||0
904649|NCT01721057|2187301|P2|COMPLETED|Follow Up||0
904650|NCT01721057|2187302|P1|COMPLETED|Follow Up||0
904651|NCT01721057|2187296|P7|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|22
904652|NCT01721057|2187297|P6|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
904653|NCT01721057|2187298|P5|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|17
904654|NCT01721057|2187299|P4|STARTED|Follow Up|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4 mg FollowUp|0
904655|NCT01721057|2187300|P3|STARTED|Follow Up||0
904656|NCT01721057|2187301|P2|STARTED|Follow Up||0
904657|NCT01721057|2187302|P1|STARTED|Follow Up||0
904658|NCT01721057|2187296|P7|NOT COMPLETED|Rescue Period||0
904659|NCT01721057|2187297|P6|NOT COMPLETED|Rescue Period||0
904660|NCT01721057|2187298|P5|NOT COMPLETED|Rescue Period||0
904661|NCT01721057|2187299|P4|NOT COMPLETED|Rescue Period||3
904662|NCT01721057|2187300|P3|NOT COMPLETED|Rescue Period||0
904663|NCT01721057|2187301|P2|NOT COMPLETED|Rescue Period||0
904664|NCT01721057|2187302|P1|NOT COMPLETED|Rescue Period||0
904665|NCT01721057|2187296|P7|COMPLETED|Rescue Period||0
904666|NCT01721057|2187297|P6|COMPLETED|Rescue Period||0
904667|NCT01721057|2187298|P5|COMPLETED|Rescue Period||0
904668|NCT01721057|2187299|P4|COMPLETED|Rescue Period||88
904669|NCT01721057|2187300|P3|COMPLETED|Rescue Period||0
904670|NCT01721057|2187301|P2|COMPLETED|Rescue Period||0
904671|NCT01721057|2187302|P1|COMPLETED|Rescue Period||0
904672|NCT01721057|2187296|P7|STARTED|Rescue Period||0
904673|NCT01721057|2187297|P6|STARTED|Rescue Period||0
904674|NCT01721057|2187298|P5|STARTED|Rescue Period||0
904675|NCT01721057|2187299|P4|STARTED|Rescue Period|Participants who were determined to be nonresponders based on tender/swollen joint count.|91
904676|NCT01721057|2187300|P3|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
904677|NCT01721057|2187301|P2|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
904678|NCT01721057|2187302|P1|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
904679|NCT01721057|2187296|P7|NOT COMPLETED|Treatment Period||0
904680|NCT01721057|2187297|P6|NOT COMPLETED|Treatment Period||0
904681|NCT01721057|2187298|P5|NOT COMPLETED|Treatment Period||0
904682|NCT01721057|2187299|P4|NOT COMPLETED|Treatment Period||0
904683|NCT01721057|2187300|P3|NOT COMPLETED|Treatment Period||23
904684|NCT01721057|2187301|P2|NOT COMPLETED|Treatment Period||19
904685|NCT01721057|2187302|P1|NOT COMPLETED|Treatment Period||28
904686|NCT01721057|2187296|P7|COMPLETED|Treatment Period||0
904687|NCT01721057|2187297|P6|COMPLETED|Treatment Period||0
904688|NCT01721057|2187298|P5|COMPLETED|Treatment Period||0
904689|NCT01721057|2187299|P4|COMPLETED|Treatment Period||0
904690|NCT01721057|2187300|P3|COMPLETED|Treatment Period|"Completers include rescued participants."|204
904691|NCT01721057|2187301|P2|COMPLETED|Treatment Period|"Completers include rescued participants."|210
904692|NCT01721057|2187302|P1|COMPLETED|Treatment Period|"Completers include rescued participants."|200
904693|NCT01721057|2187296|P7|Rescued|Treatment Period||0
904694|NCT01721057|2187297|P6|Rescued|Treatment Period||0
904695|NCT01721057|2187298|P5|Rescued|Treatment Period||0
904696|NCT01721057|2187299|P4|Rescued|Treatment Period||0
904697|NCT01721057|2187300|P3|Rescued|Treatment Period||15
904698|NCT01721057|2187301|P2|Rescued|Treatment Period||21
904699|NCT01721057|2187302|P1|Rescued|Treatment Period||55
904700|NCT01721057|2187296|P7|Received at Least 1 Dose of Study Drug|Treatment Period||0
904701|NCT01721057|2187297|P6|Received at Least 1 Dose of Study Drug|Treatment Period||0
904702|NCT01721057|2187298|P5|Received at Least 1 Dose of Study Drug|Treatment Period||0
904703|NCT01721057|2187299|P4|Received at Least 1 Dose of Study Drug|Treatment Period||0
904704|NCT01721057|2187300|P3|Received at Least 1 Dose of Study Drug|Treatment Period||227
904705|NCT01721057|2187301|P2|Received at Least 1 Dose of Study Drug|Treatment Period||229
904706|NCT01721057|2187302|P1|Received at Least 1 Dose of Study Drug|Treatment Period||228
904707|NCT01721057|2187296|P7|STARTED|Treatment Period||0
904708|NCT01721057|2187297|P6|STARTED|Treatment Period||0
904709|NCT01721057|2187298|P5|STARTED|Treatment Period||0
904710|NCT01721057|2187299|P4|STARTED|Treatment Period||0
904711|NCT01721057|2187300|P3|STARTED|Treatment Period||227
904712|NCT01721057|2187301|P2|STARTED|Treatment Period||229
904713|NCT01721057|2187302|P1|STARTED|Treatment Period||228
904714|NCT01720797|2187374|P2|NOT COMPLETED|Overall Study||0
904715|NCT01720797|2187375|P1|NOT COMPLETED|Overall Study||3
904716|NCT01720797|2187374|P2|COMPLETED|Overall Study||9
904717|NCT01720797|2187375|P1|COMPLETED|Overall Study||9
904718|NCT01720797|2187374|P2|STARTED|Overall Study||9
904719|NCT01720797|2187375|P1|STARTED|Overall Study||12
904720|NCT01720602|2187381|P1|NOT COMPLETED|Overall Study||5
904721|NCT01720602|2187381|P1|COMPLETED|Overall Study||10
904722|NCT01720602|2187381|P1|STARTED|Overall Study||15
904723|NCT01720316|2187389|P2|NOT COMPLETED|Open-label Glycine||0
904724|NCT01720316|2187390|P1|NOT COMPLETED|Open-label Glycine||0
904725|NCT01720316|2187389|P2|COMPLETED|Open-label Glycine||1
904726|NCT01720316|2187390|P1|COMPLETED|Open-label Glycine||1
904727|NCT01720316|2187389|P2|STARTED|Open-label Glycine||1
904728|NCT01720316|2187390|P1|STARTED|Open-label Glycine||1
904729|NCT01720316|2187389|P2|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
904730|NCT01720316|2187390|P1|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
904731|NCT01720316|2187389|P2|COMPLETED|Double-Blind Glycine Placebo Crossover||1
904732|NCT01720316|2187390|P1|COMPLETED|Double-Blind Glycine Placebo Crossover||1
904733|NCT01720316|2187389|P2|STARTED|Double-Blind Glycine Placebo Crossover||1
904734|NCT01720316|2187390|P1|STARTED|Double-Blind Glycine Placebo Crossover||1
904735|NCT01720251|2187439|P3|NOT COMPLETED|Overall Study||0
904736|NCT01720251|2187440|P2|NOT COMPLETED|Overall Study||2
904737|NCT01720251|2187441|P1|NOT COMPLETED|Overall Study||1
904738|NCT01720251|2187439|P3|COMPLETED|Overall Study||82
904739|NCT01720251|2187440|P2|COMPLETED|Overall Study||77
904740|NCT01720251|2187441|P1|COMPLETED|Overall Study||78
904741|NCT01720251|2187439|P3|STARTED|Overall Study||82
904742|NCT01720251|2187440|P2|STARTED|Overall Study||79
904743|NCT01720251|2187441|P1|STARTED|Overall Study||79
904744|NCT01720043|2187449|P1|NOT COMPLETED|Overall Study||1
904745|NCT01720043|2187449|P1|COMPLETED|Overall Study||7
904746|NCT01720043|2187449|P1|STARTED|Overall Study||8
904747|NCT01719861|2187453|P1|NOT COMPLETED|Cycle 2||1
904748|NCT01719861|2187453|P1|COMPLETED|Cycle 2||1
904749|NCT01719861|2187453|P1|STARTED|Cycle 2||2
904750|NCT01719861|2187453|P1|NOT COMPLETED|Cycle 1||4
904751|NCT01719861|2187453|P1|COMPLETED|Cycle 1||2
904752|NCT01719861|2187453|P1|STARTED|Cycle 1||6
904753|NCT01719757|2187461|P1|NOT COMPLETED|Overall Study||101
904754|NCT01719757|2187461|P1|COMPLETED|Overall Study||258
904755|NCT01719757|2187461|P1|STARTED|Overall Study||359
904756|NCT01719653|2187474|P5|NOT COMPLETED|Overall Study||21
904757|NCT01719653|2187475|P4|NOT COMPLETED|Overall Study||18
904758|NCT01719653|2187476|P3|NOT COMPLETED|Overall Study||18
904759|NCT01719653|2187477|P2|NOT COMPLETED|Overall Study||13
904760|NCT01719653|2187478|P1|NOT COMPLETED|Overall Study||9
904761|NCT01719653|2187474|P5|COMPLETED|Overall Study||200
904762|NCT01719653|2187475|P4|COMPLETED|Overall Study||200
904763|NCT01719653|2187476|P3|COMPLETED|Overall Study||200
904764|NCT01719653|2187477|P2|COMPLETED|Overall Study||200
904765|NCT01719653|2187478|P1|COMPLETED|Overall Study||200
904766|NCT01719653|2187474|P5|STARTED|Overall Study||221
904767|NCT01719653|2187475|P4|STARTED|Overall Study||218
904768|NCT01719653|2187476|P3|STARTED|Overall Study||218
904769|NCT01719653|2187477|P2|STARTED|Overall Study||213
904770|NCT01719653|2187478|P1|STARTED|Overall Study||209
904771|NCT01719172|2187500|P1|NOT COMPLETED|Overall Study||2
904772|NCT01719172|2187500|P1|COMPLETED|Overall Study||28
904773|NCT01719172|2187500|P1|STARTED|Overall Study||30
904774|NCT01719003|2187514|P9|NOT COMPLETED|Overall Study||4
904775|NCT01719003|2187515|P8|NOT COMPLETED|Overall Study||20
904776|NCT01719003|2187516|P7|NOT COMPLETED|Overall Study||20
904777|NCT01719003|2187517|P6|NOT COMPLETED|Overall Study||12
904778|NCT01719003|2187518|P5|NOT COMPLETED|Overall Study||17
904779|NCT01719003|2187519|P4|NOT COMPLETED|Overall Study||13
904780|NCT01719003|2187520|P3|NOT COMPLETED|Overall Study||17
904781|NCT01719003|2187521|P2|NOT COMPLETED|Overall Study||17
904782|NCT01719003|2187522|P1|NOT COMPLETED|Overall Study||9
904783|NCT01719003|2187514|P9|COMPLETED|Overall Study||49
904784|NCT01719003|2187515|P8|COMPLETED|Overall Study||151
904785|NCT01719003|2187516|P7|COMPLETED|Overall Study||150
904786|NCT01719003|2187517|P6|COMPLETED|Overall Study||160
904787|NCT01719003|2187518|P5|COMPLETED|Overall Study||150
904788|NCT01719003|2187519|P4|COMPLETED|Overall Study||156
904789|NCT01719003|2187520|P3|COMPLETED|Overall Study||154
904790|NCT01719003|2187521|P2|COMPLETED|Overall Study||153
904791|NCT01719003|2187522|P1|COMPLETED|Overall Study||161
904792|NCT01719003|2187514|P9|STARTED|Overall Study||53
904793|NCT01719003|2187515|P8|STARTED|Overall Study||171
904794|NCT01719003|2187516|P7|STARTED|Overall Study||170
904795|NCT01719003|2187517|P6|STARTED|Overall Study||172
904796|NCT01719003|2187518|P5|STARTED|Overall Study||167
904797|NCT01719003|2187519|P4|STARTED|Overall Study||169
904798|NCT01719003|2187520|P3|STARTED|Overall Study||171
904799|NCT01719003|2187521|P2|STARTED|Overall Study||170
904800|NCT01719003|2187522|P1|STARTED|Overall Study||170
904801|NCT01718691|2187559|P2|NOT COMPLETED|Overall Study||1
904802|NCT01718691|2187560|P1|NOT COMPLETED|Overall Study||18
904803|NCT01718691|2187559|P2|COMPLETED|Overall Study||9
904804|NCT01718691|2187560|P1|COMPLETED|Overall Study||42
904805|NCT01718691|2187559|P2|STARTED|Overall Study||10
904806|NCT01718691|2187560|P1|STARTED|Overall Study||60
904807|NCT01718535|2187603|P10|NOT COMPLETED|Overall Study||0
904808|NCT01718535|2187604|P9|NOT COMPLETED|Overall Study||0
904809|NCT01718535|2187605|P8|NOT COMPLETED|Overall Study||0
904810|NCT01718535|2187606|P7|NOT COMPLETED|Overall Study||0
904811|NCT01718535|2187607|P6|NOT COMPLETED|Overall Study||0
904812|NCT01718535|2187608|P5|NOT COMPLETED|Overall Study||0
904813|NCT01718535|2187609|P4|NOT COMPLETED|Overall Study||1
904814|NCT01718535|2187610|P3|NOT COMPLETED|Overall Study||0
904815|NCT01718535|2187611|P2|NOT COMPLETED|Overall Study||0
904816|NCT01718535|2187612|P1|NOT COMPLETED|Overall Study||1
904817|NCT01718535|2187603|P10|COMPLETED|Overall Study||1
904818|NCT01718535|2187604|P9|COMPLETED|Overall Study||15
904819|NCT01718535|2187605|P8|COMPLETED|Overall Study||6
904820|NCT01718535|2187606|P7|COMPLETED|Overall Study||11
904821|NCT01718535|2187607|P6|COMPLETED|Overall Study||40
904822|NCT01718535|2187608|P5|COMPLETED|Overall Study||1
904823|NCT01718535|2187609|P4|COMPLETED|Overall Study||7
904824|NCT01718535|2187610|P3|COMPLETED|Overall Study||19
904825|NCT01718535|2187611|P2|COMPLETED|Overall Study||95
904826|NCT01718535|2187612|P1|COMPLETED|Overall Study||130
904827|NCT01718535|2187603|P10|First Pass|Overall Study||1
904828|NCT01718535|2187604|P9|First Pass|Overall Study||15
904829|NCT01718535|2187605|P8|First Pass|Overall Study||6
904830|NCT01718535|2187606|P7|First Pass|Overall Study||11
904831|NCT01718535|2187607|P6|First Pass|Overall Study||39
904832|NCT01718535|2187608|P5|First Pass|Overall Study||1
904833|NCT01718535|2187609|P4|First Pass|Overall Study||7
904834|NCT01718535|2187610|P3|First Pass|Overall Study||19
904835|NCT01718535|2187611|P2|First Pass|Overall Study||94
904836|NCT01718535|2187612|P1|First Pass|Overall Study||128
904837|NCT01718535|2187603|P10|STARTED|Overall Study||1
904838|NCT01718535|2187604|P9|STARTED|Overall Study||15
904839|NCT01718535|2187605|P8|STARTED|Overall Study||6
904840|NCT01718535|2187606|P7|STARTED|Overall Study||11
904841|NCT01718535|2187607|P6|STARTED|Overall Study||40
904842|NCT01718535|2187608|P5|STARTED|Overall Study||1
904843|NCT01718535|2187609|P4|STARTED|Overall Study||8
904844|NCT01718535|2187610|P3|STARTED|Overall Study||19
904845|NCT01718535|2187611|P2|STARTED|Overall Study||95
904846|NCT01718535|2187612|P1|STARTED|Overall Study||131
904847|NCT01718509|2187636|P2|NOT COMPLETED|Overall Study||48
904848|NCT01718509|2187637|P1|NOT COMPLETED|Overall Study||48
904849|NCT01718509|2187636|P2|COMPLETED|Overall Study||147
904850|NCT01718509|2187637|P1|COMPLETED|Overall Study||147
904851|NCT01718509|2187636|P2|STARTED|Overall Study||195
904852|NCT01718509|2187637|P1|STARTED|Overall Study||195
904853|NCT01718483|2187683|P2|NOT COMPLETED|Overall Study||34
904854|NCT01718483|2187684|P1|NOT COMPLETED|Overall Study||34
904855|NCT01718483|2187683|P2|COMPLETED|Overall Study||158
904856|NCT01718483|2187684|P1|COMPLETED|Overall Study||157
904857|NCT01718483|2187683|P2|Treated|Overall Study||192
904858|NCT01718483|2187684|P1|Treated|Overall Study||187
904859|NCT01718483|2187683|P2|STARTED|Overall Study||192
904860|NCT01718483|2187684|P1|STARTED|Overall Study||191
904861|NCT01718028|2187730|P2|NOT COMPLETED|Overall Study||0
904862|NCT01718028|2187731|P1|NOT COMPLETED|Overall Study||0
904863|NCT01718028|2187730|P2|COMPLETED|Overall Study||24
904864|NCT01718028|2187731|P1|COMPLETED|Overall Study||25
904865|NCT01718028|2187730|P2|STARTED|Overall Study||24
904866|NCT01718028|2187731|P1|STARTED|Overall Study||25
904867|NCT01717989|2187743|P1|NOT COMPLETED|Overall Study||1066
904868|NCT01717989|2187743|P1|COMPLETED|Overall Study||1182
904869|NCT01717989|2187743|P1|STARTED|Overall Study||2248
904870|NCT01717976|2187811|P2|NOT COMPLETED|Overall Study||1
904871|NCT01717976|2187812|P1|NOT COMPLETED|Overall Study||0
904872|NCT01717976|2187811|P2|COMPLETED|Overall Study||256
904873|NCT01717976|2187812|P1|COMPLETED|Overall Study||257
904874|NCT01717976|2187811|P2|STARTED|Overall Study||257
904875|NCT01717976|2187812|P1|STARTED|Overall Study||257
904876|NCT01717872|2187828|P2|NOT COMPLETED|Overall Study||0
904877|NCT01717872|2187829|P1|NOT COMPLETED|Overall Study||0
904878|NCT01717872|2187828|P2|COMPLETED|Overall Study||25
904879|NCT01717872|2187829|P1|COMPLETED|Overall Study||25
904880|NCT01717872|2187828|P2|STARTED|Overall Study||25
904881|NCT01717872|2187829|P1|STARTED|Overall Study||25
904882|NCT01717768|2187849|P12|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
904883|NCT01717768|2187850|P11|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
904884|NCT01717768|2187851|P10|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||1
904885|NCT01717768|2187852|P9|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
904886|NCT01717768|2187853|P8|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||2
904887|NCT01717768|2187854|P7|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
904888|NCT01717768|2187855|P6|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
904889|NCT01717768|2187856|P5|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
904890|NCT01717768|2187857|P4|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
904891|NCT01717768|2187858|P3|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
904892|NCT01717768|2187859|P2|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
904893|NCT01717768|2187860|P1|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
904894|NCT01717768|2187849|P12|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
904895|NCT01717768|2187850|P11|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
904896|NCT01717768|2187851|P10|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
904897|NCT01717768|2187852|P9|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
904898|NCT01717768|2187853|P8|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
904899|NCT01717768|2187854|P7|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
904900|NCT01717768|2187855|P6|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
904901|NCT01717768|2187856|P5|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
904902|NCT01717768|2187857|P4|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
904903|NCT01717768|2187858|P3|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
904904|NCT01717768|2187859|P2|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
904905|NCT01717768|2187860|P1|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
904906|NCT01717768|2187849|P12|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
904907|NCT01717768|2187850|P11|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
904908|NCT01717768|2187851|P10|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||16
904909|NCT01717768|2187852|P9|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
904910|NCT01717768|2187853|P8|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||17
904911|NCT01717768|2187854|P7|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
904912|NCT01717768|2187855|P6|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
904913|NCT01717768|2187856|P5|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
904914|NCT01717768|2187857|P4|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
904915|NCT01717768|2187858|P3|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
904916|NCT01717768|2187859|P2|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
904917|NCT01717768|2187860|P1|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
904918|NCT01717768|2187849|P12|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||1
904919|NCT01717768|2187850|P11|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
904920|NCT01717768|2187851|P10|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
904921|NCT01717768|2187852|P9|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
904922|NCT01717768|2187853|P8|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
904923|NCT01717768|2187854|P7|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
904924|NCT01717768|2187855|P6|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
904925|NCT01717768|2187856|P5|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
904926|NCT01717768|2187857|P4|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
904927|NCT01717768|2187858|P3|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
904928|NCT01717768|2187859|P2|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
904929|NCT01717768|2187860|P1|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
904930|NCT01717768|2187849|P12|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||15
904931|NCT01717768|2187850|P11|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
904932|NCT01717768|2187851|P10|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
904933|NCT01717768|2187852|P9|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
904934|NCT01717768|2187853|P8|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
904935|NCT01717768|2187854|P7|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||17
904936|NCT01717768|2187855|P6|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
904937|NCT01717768|2187856|P5|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
904938|NCT01717768|2187857|P4|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
904939|NCT01717768|2187858|P3|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
904940|NCT01717768|2187859|P2|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
904941|NCT01717768|2187860|P1|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
904942|NCT01717768|2187849|P12|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
904943|NCT01717768|2187850|P11|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
904944|NCT01717768|2187851|P10|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
904945|NCT01717768|2187852|P9|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
904946|NCT01717768|2187853|P8|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
904947|NCT01717768|2187854|P7|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||17
904948|NCT01717768|2187855|P6|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
904949|NCT01717768|2187856|P5|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
904950|NCT01717768|2187857|P4|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
904951|NCT01717768|2187858|P3|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
904952|NCT01717768|2187859|P2|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
904953|NCT01717768|2187860|P1|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
904954|NCT01717768|2187849|P12|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
904955|NCT01717768|2187850|P11|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
904956|NCT01717768|2187851|P10|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
904957|NCT01717768|2187852|P9|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
904958|NCT01717768|2187853|P8|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
904959|NCT01717768|2187854|P7|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
904960|NCT01717768|2187855|P6|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
904961|NCT01717768|2187856|P5|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
904962|NCT01717768|2187857|P4|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
904963|NCT01717768|2187858|P3|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
904964|NCT01717768|2187859|P2|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
904965|NCT01717768|2187860|P1|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
904966|NCT01717768|2187849|P12|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
904967|NCT01717768|2187850|P11|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
904968|NCT01717768|2187851|P10|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
904969|NCT01717768|2187852|P9|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
904970|NCT01717768|2187853|P8|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
904971|NCT01717768|2187854|P7|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
904972|NCT01717768|2187855|P6|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
904973|NCT01717768|2187856|P5|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
904974|NCT01717768|2187857|P4|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||4
904975|NCT01717768|2187858|P3|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
904976|NCT01717768|2187859|P2|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
904977|NCT01717768|2187860|P1|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
904978|NCT01717768|2187849|P12|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
904979|NCT01717768|2187850|P11|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
904980|NCT01717768|2187851|P10|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
904981|NCT01717768|2187852|P9|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
904982|NCT01717768|2187853|P8|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
904983|NCT01717768|2187854|P7|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
904984|NCT01717768|2187855|P6|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
904985|NCT01717768|2187856|P5|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
904986|NCT01717768|2187857|P4|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||4
904987|NCT01717768|2187858|P3|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
904988|NCT01717768|2187859|P2|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
904989|NCT01717768|2187860|P1|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
904990|NCT01717768|2187849|P12|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
904991|NCT01717768|2187850|P11|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
904992|NCT01717768|2187851|P10|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
904993|NCT01717768|2187852|P9|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
904994|NCT01717768|2187853|P8|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
904995|NCT01717768|2187854|P7|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
904996|NCT01717768|2187855|P6|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
904997|NCT01717768|2187856|P5|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
904998|NCT01717768|2187857|P4|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
904999|NCT01717768|2187858|P3|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
905000|NCT01717768|2187859|P2|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
905001|NCT01717768|2187860|P1|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
905002|NCT01717768|2187849|P12|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
905003|NCT01717768|2187850|P11|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
905004|NCT01717768|2187851|P10|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
905005|NCT01717768|2187852|P9|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
905006|NCT01717768|2187853|P8|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
905007|NCT01717768|2187854|P7|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
905008|NCT01717768|2187855|P6|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
905009|NCT01717768|2187856|P5|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
905010|NCT01717768|2187857|P4|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||4
905011|NCT01717768|2187858|P3|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
905012|NCT01717768|2187859|P2|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
905013|NCT01717768|2187860|P1|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
905014|NCT01717768|2187849|P12|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
905015|NCT01717768|2187850|P11|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
905016|NCT01717768|2187851|P10|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
905017|NCT01717768|2187852|P9|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
905018|NCT01717768|2187853|P8|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
905019|NCT01717768|2187854|P7|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
905020|NCT01717768|2187855|P6|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
905021|NCT01717768|2187856|P5|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
905022|NCT01717768|2187857|P4|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||4
905023|NCT01717768|2187858|P3|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
905024|NCT01717768|2187859|P2|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
905025|NCT01717768|2187860|P1|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
905026|NCT01717768|2187849|P12|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
905027|NCT01717768|2187850|P11|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
905028|NCT01717768|2187851|P10|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
905029|NCT01717768|2187852|P9|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
905030|NCT01717768|2187853|P8|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
905031|NCT01717768|2187854|P7|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
905032|NCT01717768|2187855|P6|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
905033|NCT01717768|2187856|P5|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
905034|NCT01717768|2187857|P4|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
905035|NCT01717768|2187858|P3|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
905036|NCT01717768|2187859|P2|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
905037|NCT01717768|2187860|P1|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
905038|NCT01717768|2187849|P12|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
905039|NCT01717768|2187850|P11|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
905040|NCT01717768|2187851|P10|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
905041|NCT01717768|2187852|P9|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
905042|NCT01717768|2187853|P8|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
905043|NCT01717768|2187854|P7|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
905044|NCT01717768|2187855|P6|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
905045|NCT01717768|2187856|P5|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
905046|NCT01717768|2187857|P4|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||4
905047|NCT01717768|2187858|P3|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
905048|NCT01717768|2187859|P2|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
905049|NCT01717768|2187860|P1|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
905050|NCT01717768|2187849|P12|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
905051|NCT01717768|2187850|P11|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
905052|NCT01717768|2187851|P10|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
905053|NCT01717768|2187852|P9|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
905054|NCT01717768|2187853|P8|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
905055|NCT01717768|2187854|P7|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
905056|NCT01717768|2187855|P6|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
905057|NCT01717768|2187856|P5|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
905058|NCT01717768|2187857|P4|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||4
905059|NCT01717768|2187858|P3|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
905060|NCT01717768|2187859|P2|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
905061|NCT01717768|2187860|P1|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
905062|NCT01717768|2187849|P12|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
905063|NCT01717768|2187850|P11|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
905064|NCT01717768|2187851|P10|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
905065|NCT01717768|2187852|P9|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
905066|NCT01717768|2187853|P8|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
905067|NCT01717768|2187854|P7|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
905068|NCT01717768|2187855|P6|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
905069|NCT01717768|2187856|P5|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
905070|NCT01717768|2187857|P4|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
905071|NCT01717768|2187858|P3|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
905072|NCT01717768|2187859|P2|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
905073|NCT01717768|2187860|P1|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
905074|NCT01717768|2187849|P12|COMPLETED|Part 2 (Duration of 15 Days)||0
905075|NCT01717768|2187850|P11|COMPLETED|Part 2 (Duration of 15 Days)||0
905076|NCT01717768|2187851|P10|COMPLETED|Part 2 (Duration of 15 Days)||0
905077|NCT01717768|2187852|P9|COMPLETED|Part 2 (Duration of 15 Days)||0
905078|NCT01717768|2187853|P8|COMPLETED|Part 2 (Duration of 15 Days)||0
905079|NCT01717768|2187854|P7|COMPLETED|Part 2 (Duration of 15 Days)||0
905080|NCT01717768|2187855|P6|COMPLETED|Part 2 (Duration of 15 Days)||0
905081|NCT01717768|2187856|P5|COMPLETED|Part 2 (Duration of 15 Days)||0
905082|NCT01717768|2187857|P4|COMPLETED|Part 2 (Duration of 15 Days)||0
905083|NCT01717768|2187858|P3|COMPLETED|Part 2 (Duration of 15 Days)||17
905084|NCT01717768|2187859|P2|COMPLETED|Part 2 (Duration of 15 Days)||0
905085|NCT01717768|2187860|P1|COMPLETED|Part 2 (Duration of 15 Days)||0
905086|NCT01717768|2187849|P12|STARTED|Part 2 (Duration of 15 Days)||0
905087|NCT01717768|2187850|P11|STARTED|Part 2 (Duration of 15 Days)||0
905088|NCT01717768|2187851|P10|STARTED|Part 2 (Duration of 15 Days)||0
905089|NCT01717768|2187852|P9|STARTED|Part 2 (Duration of 15 Days)||0
905090|NCT01717768|2187853|P8|STARTED|Part 2 (Duration of 15 Days)||0
905091|NCT01717768|2187854|P7|STARTED|Part 2 (Duration of 15 Days)||0
905092|NCT01717768|2187855|P6|STARTED|Part 2 (Duration of 15 Days)||0
905093|NCT01717768|2187856|P5|STARTED|Part 2 (Duration of 15 Days)||0
905094|NCT01717768|2187857|P4|STARTED|Part 2 (Duration of 15 Days)||0
905095|NCT01717768|2187858|P3|STARTED|Part 2 (Duration of 15 Days)||17
905096|NCT01717768|2187859|P2|STARTED|Part 2 (Duration of 15 Days)||0
905097|NCT01717768|2187860|P1|STARTED|Part 2 (Duration of 15 Days)||0
905098|NCT01717768|2187849|P12|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
905099|NCT01717768|2187850|P11|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
905100|NCT01717768|2187851|P10|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
905101|NCT01717768|2187852|P9|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
905102|NCT01717768|2187853|P8|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
905103|NCT01717768|2187854|P7|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
905104|NCT01717768|2187855|P6|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
905105|NCT01717768|2187856|P5|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
905106|NCT01717768|2187857|P4|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
905107|NCT01717768|2187858|P3|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
905108|NCT01717768|2187859|P2|NOT COMPLETED|Part 1 (Duration of 15 Days)||1
905109|NCT01717768|2187860|P1|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
905110|NCT01717768|2187849|P12|COMPLETED|Part 1 (Duration of 15 Days)||0
905111|NCT01717768|2187850|P11|COMPLETED|Part 1 (Duration of 15 Days)||0
905112|NCT01717768|2187851|P10|COMPLETED|Part 1 (Duration of 15 Days)||0
905113|NCT01717768|2187852|P9|COMPLETED|Part 1 (Duration of 15 Days)||0
905114|NCT01717768|2187853|P8|COMPLETED|Part 1 (Duration of 15 Days)||0
905115|NCT01717768|2187854|P7|COMPLETED|Part 1 (Duration of 15 Days)||0
905116|NCT01717768|2187855|P6|COMPLETED|Part 1 (Duration of 15 Days)||0
905117|NCT01717768|2187856|P5|COMPLETED|Part 1 (Duration of 15 Days)||0
905118|NCT01717768|2187857|P4|COMPLETED|Part 1 (Duration of 15 Days)||0
905119|NCT01717768|2187858|P3|COMPLETED|Part 1 (Duration of 15 Days)||0
905120|NCT01717768|2187859|P2|COMPLETED|Part 1 (Duration of 15 Days)||16
905121|NCT01717768|2187860|P1|COMPLETED|Part 1 (Duration of 15 Days)||17
905122|NCT01717768|2187849|P12|STARTED|Part 1 (Duration of 15 Days)||0
905123|NCT01717768|2187850|P11|STARTED|Part 1 (Duration of 15 Days)||0
905124|NCT01717768|2187851|P10|STARTED|Part 1 (Duration of 15 Days)||0
905125|NCT01717768|2187852|P9|STARTED|Part 1 (Duration of 15 Days)||0
905126|NCT01717768|2187853|P8|STARTED|Part 1 (Duration of 15 Days)||0
905127|NCT01717768|2187854|P7|STARTED|Part 1 (Duration of 15 Days)||0
905128|NCT01717768|2187855|P6|STARTED|Part 1 (Duration of 15 Days)||0
905129|NCT01717768|2187856|P5|STARTED|Part 1 (Duration of 15 Days)||0
905130|NCT01717768|2187857|P4|STARTED|Part 1 (Duration of 15 Days)||0
905131|NCT01717768|2187858|P3|STARTED|Part 1 (Duration of 15 Days)||0
905132|NCT01717768|2187859|P2|STARTED|Part 1 (Duration of 15 Days)||17
905133|NCT01717768|2187860|P1|STARTED|Part 1 (Duration of 15 Days)||17
905134|NCT01717638|2187911|P13|NOT COMPLETED|Overall Study||19
905135|NCT01717638|2187912|P12|NOT COMPLETED|Overall Study||0
905136|NCT01717638|2187913|P11|NOT COMPLETED|Overall Study||0
905137|NCT01717638|2187914|P10|NOT COMPLETED|Overall Study||1
905138|NCT01717638|2187915|P9|NOT COMPLETED|Overall Study||2
905139|NCT01717638|2187916|P8|NOT COMPLETED|Overall Study||1
905140|NCT01717638|2187917|P7|NOT COMPLETED|Overall Study||2
905141|NCT01717638|2187918|P6|NOT COMPLETED|Overall Study||1
905142|NCT01717638|2187919|P5|NOT COMPLETED|Overall Study||1
905143|NCT01717638|2187920|P4|NOT COMPLETED|Overall Study||0
905144|NCT01717638|2187921|P3|NOT COMPLETED|Overall Study||1
905145|NCT01717638|2187922|P2|NOT COMPLETED|Overall Study||1
905146|NCT01717638|2187923|P1|NOT COMPLETED|Overall Study||0
905147|NCT01717638|2187911|P13|COMPLETED|Overall Study||190
905148|NCT01717638|2187912|P12|COMPLETED|Overall Study||12
905149|NCT01717638|2187913|P11|COMPLETED|Overall Study||11
905150|NCT01717638|2187914|P10|COMPLETED|Overall Study||99
905151|NCT01717638|2187915|P9|COMPLETED|Overall Study||26
905152|NCT01717638|2187916|P8|COMPLETED|Overall Study||28
905153|NCT01717638|2187917|P7|COMPLETED|Overall Study||41
905154|NCT01717638|2187918|P6|COMPLETED|Overall Study||54
905155|NCT01717638|2187919|P5|COMPLETED|Overall Study||63
905156|NCT01717638|2187920|P4|COMPLETED|Overall Study||66
905157|NCT01717638|2187921|P3|COMPLETED|Overall Study||59
905158|NCT01717638|2187922|P2|COMPLETED|Overall Study||60
905159|NCT01717638|2187923|P1|COMPLETED|Overall Study||67
905160|NCT01717638|2187911|P13|STARTED|Overall Study||209
905161|NCT01717638|2187912|P12|STARTED|Overall Study||12
905162|NCT01717638|2187913|P11|STARTED|Overall Study||11
905163|NCT01717638|2187914|P10|STARTED|Overall Study||100
905164|NCT01717638|2187915|P9|STARTED|Overall Study||28
905165|NCT01717638|2187916|P8|STARTED|Overall Study||29
905166|NCT01717638|2187917|P7|STARTED|Overall Study||43
905167|NCT01717638|2187918|P6|STARTED|Overall Study||55
905168|NCT01717638|2187919|P5|STARTED|Overall Study||64
905169|NCT01717638|2187920|P4|STARTED|Overall Study||66
905170|NCT01717638|2187921|P3|STARTED|Overall Study||60
905171|NCT01717638|2187922|P2|STARTED|Overall Study||61
905172|NCT01717638|2187923|P1|STARTED|Overall Study||67
905173|NCT01717456|2188067|P2|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
905174|NCT01717456|2188068|P1|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
905175|NCT01717456|2188067|P2|COMPLETED|Follow-Up 6 Months After End of Tx||2
905176|NCT01717456|2188068|P1|COMPLETED|Follow-Up 6 Months After End of Tx||7
905177|NCT01717456|2188067|P2|STARTED|Follow-Up 6 Months After End of Tx||6
905178|NCT01717456|2188068|P1|STARTED|Follow-Up 6 Months After End of Tx||11
905179|NCT01717456|2188067|P2|NOT COMPLETED|End of Treatment||2
905180|NCT01717456|2188068|P1|NOT COMPLETED|End of Treatment||0
905181|NCT01717456|2188067|P2|COMPLETED|End of Treatment||6
905182|NCT01717456|2188068|P1|COMPLETED|End of Treatment||11
905183|NCT01717456|2188067|P2|STARTED|End of Treatment||8
905184|NCT01717456|2188068|P1|STARTED|End of Treatment||11
905185|NCT01717391|2188136|P1|NOT COMPLETED|Overall Study||9
905186|NCT01717391|2188136|P1|COMPLETED|Overall Study||27
905187|NCT01717391|2188136|P1|STARTED|Overall Study||36
905188|NCT01717326|2188165|P20|NOT COMPLETED|Overall Study||6
905189|NCT01717326|2188166|P19|NOT COMPLETED|Overall Study||4
905190|NCT01717326|2188167|P18|NOT COMPLETED|Overall Study||0
905191|NCT01717326|2188168|P17|NOT COMPLETED|Overall Study||1
905192|NCT01717326|2188169|P16|NOT COMPLETED|Overall Study||3
905193|NCT01717326|2188170|P15|NOT COMPLETED|Overall Study||0
905194|NCT01717326|2188171|P14|NOT COMPLETED|Overall Study||0
905195|NCT01717326|2188172|P13|NOT COMPLETED|Overall Study||1
905196|NCT01717326|2188173|P12|NOT COMPLETED|Overall Study||0
905197|NCT01717326|2188174|P11|NOT COMPLETED|Overall Study||2
905198|NCT01717326|2188175|P10|NOT COMPLETED|Overall Study||2
905199|NCT01717326|2188176|P9|NOT COMPLETED|Overall Study||0
905200|NCT01717326|2188177|P8|NOT COMPLETED|Overall Study||0
905201|NCT01717326|2188178|P7|NOT COMPLETED|Overall Study||1
905202|NCT01717326|2188179|P6|NOT COMPLETED|Overall Study||0
905203|NCT01717326|2188180|P5|NOT COMPLETED|Overall Study||2
905204|NCT01717326|2188181|P4|NOT COMPLETED|Overall Study||2
905205|NCT01717326|2188182|P3|NOT COMPLETED|Overall Study||0
905206|NCT01717326|2188183|P2|NOT COMPLETED|Overall Study||1
905207|NCT01717326|2188184|P1|NOT COMPLETED|Overall Study||3
905208|NCT01717326|2188165|P20|COMPLETED|Overall Study||15
905209|NCT01717326|2188166|P19|COMPLETED|Overall Study||16
905210|NCT01717326|2188167|P18|COMPLETED|Overall Study||31
905211|NCT01717326|2188168|P17|COMPLETED|Overall Study||29
905212|NCT01717326|2188169|P16|COMPLETED|Overall Study||27
905213|NCT01717326|2188170|P15|COMPLETED|Overall Study||29
905214|NCT01717326|2188171|P14|COMPLETED|Overall Study||32
905215|NCT01717326|2188172|P13|COMPLETED|Overall Study||32
905216|NCT01717326|2188173|P12|COMPLETED|Overall Study||33
905217|NCT01717326|2188174|P11|COMPLETED|Overall Study||30
905218|NCT01717326|2188175|P10|COMPLETED|Overall Study||29
905219|NCT01717326|2188176|P9|COMPLETED|Overall Study||32
905220|NCT01717326|2188177|P8|COMPLETED|Overall Study||29
905221|NCT01717326|2188178|P7|COMPLETED|Overall Study||30
905222|NCT01717326|2188179|P6|COMPLETED|Overall Study||31
905223|NCT01717326|2188180|P5|COMPLETED|Overall Study||31
905224|NCT01717326|2188181|P4|COMPLETED|Overall Study||28
905225|NCT01717326|2188182|P3|COMPLETED|Overall Study||13
905226|NCT01717326|2188183|P2|COMPLETED|Overall Study||26
905227|NCT01717326|2188184|P1|COMPLETED|Overall Study||22
905228|NCT01717326|2188165|P20|Treated|Overall Study||21
905229|NCT01717326|2188166|P19|Treated|Overall Study||20
905230|NCT01717326|2188167|P18|Treated|Overall Study||31
905231|NCT01717326|2188168|P17|Treated|Overall Study||30
905232|NCT01717326|2188169|P16|Treated|Overall Study||30
905233|NCT01717326|2188170|P15|Treated|Overall Study||29
905234|NCT01717326|2188171|P14|Treated|Overall Study||32
905235|NCT01717326|2188172|P13|Treated|Overall Study||33
905236|NCT01717326|2188173|P12|Treated|Overall Study||33
905237|NCT01717326|2188174|P11|Treated|Overall Study||32
905238|NCT01717326|2188175|P10|Treated|Overall Study||31
905239|NCT01717326|2188176|P9|Treated|Overall Study||32
905240|NCT01717326|2188177|P8|Treated|Overall Study||29
905241|NCT01717326|2188178|P7|Treated|Overall Study||31
905242|NCT01717326|2188179|P6|Treated|Overall Study||31
905243|NCT01717326|2188180|P5|Treated|Overall Study||33
905244|NCT01717326|2188181|P4|Treated|Overall Study||30
905245|NCT01717326|2188182|P3|Treated|Overall Study|Number excludes 1 participant randomized to A3 but treated on Arm A2|12
905246|NCT01717326|2188183|P2|Treated|Overall Study|Number includes 1 additional participant randomized to A3 but treated on A2|28
905247|NCT01717326|2188184|P1|Treated|Overall Study||25
905248|NCT01717326|2188165|P20|STARTED|Overall Study||21
905249|NCT01717326|2188166|P19|STARTED|Overall Study||20
905250|NCT01717326|2188167|P18|STARTED|Overall Study||31
905251|NCT01717326|2188168|P17|STARTED|Overall Study||30
905252|NCT01717326|2188169|P16|STARTED|Overall Study||30
905253|NCT01717326|2188170|P15|STARTED|Overall Study||29
905254|NCT01717326|2188171|P14|STARTED|Overall Study||32
905255|NCT01717326|2188172|P13|STARTED|Overall Study||33
905256|NCT01717326|2188173|P12|STARTED|Overall Study||33
905257|NCT01717326|2188174|P11|STARTED|Overall Study||32
905258|NCT01717326|2188175|P10|STARTED|Overall Study||31
905259|NCT01717326|2188176|P9|STARTED|Overall Study||32
905260|NCT01717326|2188177|P8|STARTED|Overall Study||29
905261|NCT01717326|2188178|P7|STARTED|Overall Study||31
905262|NCT01717326|2188179|P6|STARTED|Overall Study||31
905263|NCT01717326|2188180|P5|STARTED|Overall Study||33
905264|NCT01717326|2188181|P4|STARTED|Overall Study||30
905265|NCT01717326|2188182|P3|STARTED|Overall Study||13
905266|NCT01717326|2188183|P2|STARTED|Overall Study||27
905267|NCT01717326|2188184|P1|STARTED|Overall Study||25
905268|NCT01717313|2188448|P2|NOT COMPLETED|Phase B (Weeks 24 to 54)||16
905269|NCT01717313|2188449|P1|NOT COMPLETED|Phase B (Weeks 24 to 54)||12
905270|NCT01717313|2188448|P2|COMPLETED|Phase B (Weeks 24 to 54)||135
905271|NCT01717313|2188449|P1|COMPLETED|Phase B (Weeks 24 to 54)||134
905272|NCT01717313|2188448|P2|STARTED|Phase B (Weeks 24 to 54)||151
905273|NCT01717313|2188449|P1|STARTED|Phase B (Weeks 24 to 54)||146
905274|NCT01717313|2188448|P2|NOT COMPLETED|Interphase||0
905275|NCT01717313|2188449|P1|NOT COMPLETED|Interphase||1
905276|NCT01717313|2188448|P2|COMPLETED|Interphase||151
905277|NCT01717313|2188449|P1|COMPLETED|Interphase||146
905278|NCT01717313|2188448|P2|STARTED|Interphase||151
905279|NCT01717313|2188449|P1|STARTED|Interphase||147
905280|NCT01717313|2188448|P2|NOT COMPLETED|Phase A (Weeks 0 to 24)||13
905281|NCT01717313|2188449|P1|NOT COMPLETED|Phase A (Weeks 0 to 24)||18
905282|NCT01717313|2188448|P2|COMPLETED|Phase A (Weeks 0 to 24)||151
905283|NCT01717313|2188449|P1|COMPLETED|Phase A (Weeks 0 to 24)||147
905284|NCT01717313|2188448|P2|STARTED|Phase A (Weeks 0 to 24)||164
905285|NCT01717313|2188449|P1|STARTED|Phase A (Weeks 0 to 24)||165
905286|NCT01717287|2188487|P2|NOT COMPLETED|Overall Study||3
905287|NCT01717287|2188488|P1|NOT COMPLETED|Overall Study||0
905288|NCT01717287|2188487|P2|COMPLETED|Overall Study||25
905289|NCT01717287|2188488|P1|COMPLETED|Overall Study||4
905290|NCT01717287|2188487|P2|STARTED|Overall Study||28
905291|NCT01717287|2188488|P1|STARTED|Overall Study||4
905295|NCT01717040|2188521|P2|NOT COMPLETED|Overall Study||5
905296|NCT01717040|2188522|P1|NOT COMPLETED|Overall Study||5
905297|NCT01717040|2188521|P2|COMPLETED|Overall Study||15
905298|NCT01717040|2188522|P1|COMPLETED|Overall Study||12
905299|NCT01717040|2188521|P2|STARTED|Overall Study||20
905300|NCT01717040|2188522|P1|STARTED|Overall Study||17
905301|NCT01717014|2188528|P1|NOT COMPLETED|Overall Study||0
905302|NCT01717014|2188528|P1|COMPLETED|Overall Study||8
905303|NCT01717014|2188528|P1|STARTED|Overall Study||8
905304|NCT01716754|2188540|P4|NOT COMPLETED|Overall Study||8
905305|NCT01716754|2188541|P3|NOT COMPLETED|Overall Study||14
905306|NCT01716754|2188542|P2|NOT COMPLETED|Overall Study||4
905307|NCT01716754|2188543|P1|NOT COMPLETED|Overall Study||11
905308|NCT01716754|2188540|P4|COMPLETED|Overall Study||89
905309|NCT01716754|2188541|P3|COMPLETED|Overall Study||121
905310|NCT01716754|2188542|P2|COMPLETED|Overall Study||36
905311|NCT01716754|2188543|P1|COMPLETED|Overall Study||188
905312|NCT01716754|2188540|P4|Safety Set|Overall Study||96
905313|NCT01716754|2188541|P3|Safety Set|Overall Study||131
905314|NCT01716754|2188542|P2|Safety Set|Overall Study||40
905315|NCT01716754|2188543|P1|Safety Set|Overall Study||199
905316|NCT01716754|2188540|P4|FAS|Overall Study||96
905317|NCT01716754|2188541|P3|FAS|Overall Study||131
905318|NCT01716754|2188542|P2|FAS|Overall Study||40
905319|NCT01716754|2188543|P1|FAS|Overall Study||199
905320|NCT01716754|2188540|P4|STARTED|Overall Study||97
905321|NCT01716754|2188541|P3|STARTED|Overall Study||135
905322|NCT01716754|2188542|P2|STARTED|Overall Study||40
905323|NCT01716754|2188543|P1|STARTED|Overall Study||199
905324|NCT01716663|2188564|P1|NOT COMPLETED|Overall Study||6
905403|NCT01716520|2188599|P2|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
905325|NCT01716663|2188564|P1|COMPLETED|Overall Study|Effectiveness population = enrolled and treated (study device inserted and RF energy applied)|228
905326|NCT01716663|2188564|P1|Safety|Overall Study|Enrolled patients who had a study device inserted.|230
905327|NCT01716663|2188564|P1|STARTED|Overall Study|Enrolled = signed informed consent and met eligibility requirements|234
905328|NCT01716585|2188574|P2|NOT COMPLETED|Open-label Treatment||7
905329|NCT01716585|2188575|P1|NOT COMPLETED|Open-label Treatment||0
905330|NCT01716585|2188574|P2|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|150
905331|NCT01716585|2188575|P1|COMPLETED|Open-label Treatment|not applicable to this arm|0
905332|NCT01716585|2188574|P2|STARTED|Open-label Treatment||157
905333|NCT01716585|2188575|P1|STARTED|Open-label Treatment|not applicable to this arm|0
905334|NCT01716585|2188574|P2|NOT COMPLETED|Double-blind Treatment||2
905335|NCT01716585|2188575|P1|NOT COMPLETED|Double-blind Treatment||13
905336|NCT01716585|2188574|P2|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|157
905337|NCT01716585|2188575|P1|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|464
905338|NCT01716585|2188574|P2|Randomized But Not Treated|Double-blind Treatment||1
905339|NCT01716585|2188575|P1|Randomized But Not Treated|Double-blind Treatment||4
905340|NCT01716585|2188574|P2|STARTED|Double-blind Treatment||159
905341|NCT01716585|2188575|P1|STARTED|Double-blind Treatment||477
905342|NCT01716559|2188587|P1|NOT COMPLETED|Overall Study||111
905343|NCT01716559|2188587|P1|COMPLETED|Overall Study||49
905344|NCT01716559|2188587|P1|STARTED|Overall Study||160
905345|NCT01716520|2188595|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||2
905346|NCT01716520|2188596|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
905347|NCT01716520|2188597|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
905348|NCT01716520|2188598|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
905349|NCT01716520|2188599|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||0
905350|NCT01716520|2188600|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
905351|NCT01716520|2188595|P6|COMPLETED|Treatment Period 3 (14 Days)||23
905352|NCT01716520|2188596|P5|COMPLETED|Treatment Period 3 (14 Days)||29
905353|NCT01716520|2188597|P4|COMPLETED|Treatment Period 3 (14 Days)||28
905354|NCT01716520|2188598|P3|COMPLETED|Treatment Period 3 (14 Days)||25
905355|NCT01716520|2188599|P2|COMPLETED|Treatment Period 3 (14 Days)||27
905356|NCT01716520|2188600|P1|COMPLETED|Treatment Period 3 (14 Days)||27
905357|NCT01716520|2188595|P6|STARTED|Treatment Period 3 (14 Days)||25
905358|NCT01716520|2188596|P5|STARTED|Treatment Period 3 (14 Days)||29
905359|NCT01716520|2188597|P4|STARTED|Treatment Period 3 (14 Days)||28
905360|NCT01716520|2188598|P3|STARTED|Treatment Period 3 (14 Days)||26
905361|NCT01716520|2188599|P2|STARTED|Treatment Period 3 (14 Days)||27
905362|NCT01716520|2188600|P1|STARTED|Treatment Period 3 (14 Days)||27
905363|NCT01716520|2188595|P6|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
905364|NCT01716520|2188596|P5|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
905365|NCT01716520|2188597|P4|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
905366|NCT01716520|2188598|P3|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
905367|NCT01716520|2188599|P2|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
905368|NCT01716520|2188600|P1|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
905369|NCT01716520|2188595|P6|COMPLETED|Washout Period 2 (10 to 14 Days)||25
905370|NCT01716520|2188596|P5|COMPLETED|Washout Period 2 (10 to 14 Days)||29
905371|NCT01716520|2188597|P4|COMPLETED|Washout Period 2 (10 to 14 Days)||28
905372|NCT01716520|2188598|P3|COMPLETED|Washout Period 2 (10 to 14 Days)||26
905373|NCT01716520|2188599|P2|COMPLETED|Washout Period 2 (10 to 14 Days)||27
905374|NCT01716520|2188600|P1|COMPLETED|Washout Period 2 (10 to 14 Days)||27
905375|NCT01716520|2188595|P6|STARTED|Washout Period 2 (10 to 14 Days)||27
905376|NCT01716520|2188596|P5|STARTED|Washout Period 2 (10 to 14 Days)||29
905377|NCT01716520|2188597|P4|STARTED|Washout Period 2 (10 to 14 Days)||28
905378|NCT01716520|2188598|P3|STARTED|Washout Period 2 (10 to 14 Days)||27
905379|NCT01716520|2188599|P2|STARTED|Washout Period 2 (10 to 14 Days)||28
905380|NCT01716520|2188600|P1|STARTED|Washout Period 2 (10 to 14 Days)||29
905381|NCT01716520|2188595|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
905382|NCT01716520|2188596|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||2
905383|NCT01716520|2188597|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
905384|NCT01716520|2188598|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||0
905385|NCT01716520|2188599|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||0
905386|NCT01716520|2188600|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
905387|NCT01716520|2188595|P6|COMPLETED|Treatment Period 2 (14 Days)||27
905388|NCT01716520|2188596|P5|COMPLETED|Treatment Period 2 (14 Days)||29
905389|NCT01716520|2188597|P4|COMPLETED|Treatment Period 2 (14 Days)||28
905390|NCT01716520|2188598|P3|COMPLETED|Treatment Period 2 (14 Days)||27
905391|NCT01716520|2188599|P2|COMPLETED|Treatment Period 2 (14 Days)||28
905392|NCT01716520|2188600|P1|COMPLETED|Treatment Period 2 (14 Days)||29
905393|NCT01716520|2188595|P6|STARTED|Treatment Period 2 (14 Days)||27
905394|NCT01716520|2188596|P5|STARTED|Treatment Period 2 (14 Days)||31
905395|NCT01716520|2188597|P4|STARTED|Treatment Period 2 (14 Days)||29
905396|NCT01716520|2188598|P3|STARTED|Treatment Period 2 (14 Days)||27
905397|NCT01716520|2188599|P2|STARTED|Treatment Period 2 (14 Days)||28
905398|NCT01716520|2188600|P1|STARTED|Treatment Period 2 (14 Days)||29
905399|NCT01716520|2188595|P6|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||2
905400|NCT01716520|2188596|P5|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
905401|NCT01716520|2188597|P4|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
905402|NCT01716520|2188598|P3|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
905404|NCT01716520|2188600|P1|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
905405|NCT01716520|2188595|P6|COMPLETED|Washout Period 1 (10 to 14 Days)||27
905406|NCT01716520|2188596|P5|COMPLETED|Washout Period 1 (10 to 14 Days)||31
905407|NCT01716520|2188597|P4|COMPLETED|Washout Period 1 (10 to 14 Days)||29
905408|NCT01716520|2188598|P3|COMPLETED|Washout Period 1 (10 to 14 Days)||27
905409|NCT01716520|2188599|P2|COMPLETED|Washout Period 1 (10 to 14 Days)||28
905410|NCT01716520|2188600|P1|COMPLETED|Washout Period 1 (10 to 14 Days)||29
905411|NCT01716520|2188595|P6|STARTED|Washout Period 1 (10 to 14 Days)||29
905412|NCT01716520|2188596|P5|STARTED|Washout Period 1 (10 to 14 Days)||31
905413|NCT01716520|2188597|P4|STARTED|Washout Period 1 (10 to 14 Days)||29
905414|NCT01716520|2188598|P3|STARTED|Washout Period 1 (10 to 14 Days)||28
905415|NCT01716520|2188599|P2|STARTED|Washout Period 1 (10 to 14 Days)||29
905416|NCT01716520|2188600|P1|STARTED|Washout Period 1 (10 to 14 Days)||29
905417|NCT01716520|2188595|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||1
905418|NCT01716520|2188596|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||0
905419|NCT01716520|2188597|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||1
905420|NCT01716520|2188598|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||2
905421|NCT01716520|2188599|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
905422|NCT01716520|2188600|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
905423|NCT01716520|2188595|P6|COMPLETED|Treatment Period 1 (14 Days)||29
905424|NCT01716520|2188596|P5|COMPLETED|Treatment Period 1 (14 Days)||31
905425|NCT01716520|2188597|P4|COMPLETED|Treatment Period 1 (14 Days)||29
905426|NCT01716520|2188598|P3|COMPLETED|Treatment Period 1 (14 Days)||28
905427|NCT01716520|2188599|P2|COMPLETED|Treatment Period 1 (14 Days)||29
905428|NCT01716520|2188600|P1|COMPLETED|Treatment Period 1 (14 Days)||29
905429|NCT01716520|2188595|P6|STARTED|Treatment Period 1 (14 Days)||30
905430|NCT01716520|2188596|P5|STARTED|Treatment Period 1 (14 Days)||31
905431|NCT01716520|2188597|P4|STARTED|Treatment Period 1 (14 Days)||30
905432|NCT01716520|2188598|P3|STARTED|Treatment Period 1 (14 Days)||30
905433|NCT01716520|2188599|P2|STARTED|Treatment Period 1 (14 Days)||30
905434|NCT01716520|2188600|P1|STARTED|Treatment Period 1 (14 Days)||31
905435|NCT01716468|2188616|P1|NOT COMPLETED|Overall Study||6
905436|NCT01716468|2188616|P1|COMPLETED|Overall Study||11
905437|NCT01716468|2188616|P1|STARTED|Overall Study||17
905438|NCT01716455|2188626|P6|NOT COMPLETED|Overall Study||0
905439|NCT01716455|2188627|P5|NOT COMPLETED|Overall Study||0
905440|NCT01716455|2188628|P4|NOT COMPLETED|Overall Study||0
905441|NCT01716455|2188629|P3|NOT COMPLETED|Overall Study||0
905442|NCT01716455|2188630|P2|NOT COMPLETED|Overall Study||0
905443|NCT01716455|2188631|P1|NOT COMPLETED|Overall Study||0
905444|NCT01716455|2188626|P6|COMPLETED|Overall Study||8
905445|NCT01716455|2188627|P5|COMPLETED|Overall Study||26
905446|NCT01716455|2188628|P4|COMPLETED|Overall Study||8
905447|NCT01716455|2188629|P3|COMPLETED|Overall Study||8
905448|NCT01716455|2188630|P2|COMPLETED|Overall Study||8
905449|NCT01716455|2188631|P1|COMPLETED|Overall Study||8
905450|NCT01716455|2188626|P6|STARTED|Overall Study||8
905451|NCT01716455|2188627|P5|STARTED|Overall Study||26
905452|NCT01716455|2188628|P4|STARTED|Overall Study||8
905453|NCT01716455|2188629|P3|STARTED|Overall Study||8
905454|NCT01716455|2188630|P2|STARTED|Overall Study||8
905455|NCT01716455|2188631|P1|STARTED|Overall Study||8
905456|NCT01716234|2188655|P7|NOT COMPLETED|Overall Study||0
905457|NCT01716234|2188656|P6|NOT COMPLETED|Overall Study||14
905458|NCT01716234|2188657|P5|NOT COMPLETED|Overall Study||5
905459|NCT01716234|2188658|P4|NOT COMPLETED|Overall Study||12
905460|NCT01716234|2188659|P3|NOT COMPLETED|Overall Study||5
905461|NCT01716234|2188660|P2|NOT COMPLETED|Overall Study||10
905462|NCT01716234|2188661|P1|NOT COMPLETED|Overall Study||10
905463|NCT01716234|2188655|P7|COMPLETED|Overall Study||1
905464|NCT01716234|2188656|P6|COMPLETED|Overall Study||18
905465|NCT01716234|2188657|P5|COMPLETED|Overall Study||10
905466|NCT01716234|2188658|P4|COMPLETED|Overall Study||16
905467|NCT01716234|2188659|P3|COMPLETED|Overall Study||15
905468|NCT01716234|2188660|P2|COMPLETED|Overall Study||12
905469|NCT01716234|2188661|P1|COMPLETED|Overall Study||14
905470|NCT01716234|2188655|P7|Treated|Overall Study||1
905471|NCT01716234|2188656|P6|Treated|Overall Study||30
905472|NCT01716234|2188657|P5|Treated|Overall Study||15
905473|NCT01716234|2188658|P4|Treated|Overall Study||28
905474|NCT01716234|2188659|P3|Treated|Overall Study||19
905475|NCT01716234|2188660|P2|Treated|Overall Study||21
905476|NCT01716234|2188661|P1|Treated|Overall Study||22
905477|NCT01716234|2188655|P7|STARTED|Overall Study||1
905478|NCT01716234|2188656|P6|STARTED|Overall Study||32
905479|NCT01716234|2188657|P5|STARTED|Overall Study||15
905480|NCT01716234|2188658|P4|STARTED|Overall Study||28
905481|NCT01716234|2188659|P3|STARTED|Overall Study||20
905482|NCT01716234|2188660|P2|STARTED|Overall Study||22
905483|NCT01716234|2188661|P1|STARTED|Overall Study||24
905484|NCT01716221|2188698|P1|NOT COMPLETED|Overall Study||0
905485|NCT01716221|2188698|P1|COMPLETED|Overall Study||1
905486|NCT01716221|2188698|P1|STARTED|Overall Study||1
905487|NCT01716169|2188724|P1|NOT COMPLETED|Overall Study||4
905488|NCT01716169|2188724|P1|COMPLETED|Overall Study||6
905489|NCT01716169|2188724|P1|Standard of Care Dressings Used|Overall Study||7
905490|NCT01716169|2188724|P1|STARTED|Overall Study||10
905491|NCT01716156|2188733|P3|NOT COMPLETED|Overall Study||2
905492|NCT01716156|2188734|P2|NOT COMPLETED|Overall Study||1
905493|NCT01716156|2188735|P1|NOT COMPLETED|Overall Study||2
905494|NCT01716156|2188733|P3|COMPLETED|Overall Study||11
905495|NCT01716156|2188734|P2|COMPLETED|Overall Study||3
905496|NCT01716156|2188735|P1|COMPLETED|Overall Study||7
905497|NCT01716156|2188733|P3|STARTED|Overall Study||13
905498|NCT01716156|2188734|P2|STARTED|Overall Study||4
905499|NCT01716156|2188735|P1|STARTED|Overall Study||9
905500|NCT01716052|2188761|P2|NOT COMPLETED|Overall Study||1
905501|NCT01716052|2188762|P1|NOT COMPLETED|Overall Study||1
905502|NCT01716052|2188761|P2|COMPLETED|Overall Study||0
905503|NCT01716052|2188762|P1|COMPLETED|Overall Study||0
905504|NCT01716052|2188761|P2|STARTED|Overall Study||1
905505|NCT01716052|2188762|P1|STARTED|Overall Study||1
905506|NCT01716013|2188770|P2|NOT COMPLETED|Overall Study||0
905507|NCT01716013|2188771|P1|NOT COMPLETED|Overall Study||3
905508|NCT01716013|2188770|P2|COMPLETED|Overall Study||54
905509|NCT01716013|2188771|P1|COMPLETED|Overall Study||105
905510|NCT01716013|2188770|P2|STARTED|Overall Study||54
905511|NCT01716013|2188771|P1|STARTED|Overall Study||108
905512|NCT01715948|2188783|P1|NOT COMPLETED|Overall Study||1
905513|NCT01715948|2188783|P1|COMPLETED|Overall Study||8
905514|NCT01715948|2188783|P1|STARTED|Overall Study||9
905515|NCT01715896|2188804|P2|NOT COMPLETED|Overall Study||11
905516|NCT01715896|2188805|P1|NOT COMPLETED|Overall Study||3
905517|NCT01715896|2188804|P2|COMPLETED|Overall Study||59
905518|NCT01715896|2188805|P1|COMPLETED|Overall Study||65
905519|NCT01715896|2188804|P2|STARTED|Overall Study||70
905520|NCT01715896|2188805|P1|STARTED|Overall Study||68
905521|NCT01715857|2188868|P1|NOT COMPLETED|Overall Study||96
905522|NCT01715857|2188868|P1|COMPLETED|Overall Study||4004
905523|NCT01715857|2188868|P1|STARTED|Overall Study||4100
905524|NCT01715831|2188878|P1|NOT COMPLETED|Overall Study||1
905525|NCT01715831|2188878|P1|COMPLETED|Overall Study||25
905526|NCT01715831|2188878|P1|STARTED|Overall Study||26
905527|NCT01715415|2188896|P2|NOT COMPLETED|Open-label Treatment||2
905528|NCT01715415|2188897|P1|NOT COMPLETED|Open-label Treatment||0
905529|NCT01715415|2188896|P2|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|94
905530|NCT01715415|2188897|P1|COMPLETED|Open-label Treatment|not applicable to this arm|0
905531|NCT01715415|2188896|P2|STARTED|Open-label Treatment||96
905532|NCT01715415|2188897|P1|STARTED|Open-label Treatment|not applicable to this arm|0
905533|NCT01715415|2188896|P2|NOT COMPLETED|Double-blind Treatment||2
905534|NCT01715415|2188897|P1|NOT COMPLETED|Double-blind Treatment||5
905535|NCT01715415|2188896|P2|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|96
905536|NCT01715415|2188897|P1|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|292
905537|NCT01715415|2188896|P2|Randomized But Not Treated|Double-blind Treatment||1
905538|NCT01715415|2188897|P1|Randomized But Not Treated|Double-blind Treatment||0
905539|NCT01715415|2188896|P2|STARTED|Double-blind Treatment||98
905540|NCT01715415|2188897|P1|STARTED|Double-blind Treatment||297
905541|NCT01715298|2188911|P2|NOT COMPLETED|Overall Study||11
905542|NCT01715298|2188912|P1|NOT COMPLETED|Overall Study||7
905543|NCT01715298|2188911|P2|COMPLETED|Overall Study||205
905544|NCT01715298|2188912|P1|COMPLETED|Overall Study||209
905545|NCT01715298|2188911|P2|Full Analysis Set (FAS)|Overall Study||214
905546|NCT01715298|2188912|P1|Full Analysis Set (FAS)|Overall Study|patients were analyzed according to the treatment to which they were randomized|215
905547|NCT01715298|2188911|P2|STARTED|Overall Study||216
905548|NCT01715298|2188912|P1|STARTED|Overall Study||216
905549|NCT01715207|2188950|P2|NOT COMPLETED|Overall Study||1
905550|NCT01715207|2188951|P1|NOT COMPLETED|Overall Study||1
905551|NCT01715207|2188950|P2|COMPLETED|Overall Study||14
905552|NCT01715207|2188951|P1|COMPLETED|Overall Study||14
905553|NCT01715207|2188950|P2|STARTED|Overall Study||15
905554|NCT01715207|2188951|P1|STARTED|Overall Study||15
905555|NCT01715129|2188959|P1|NOT COMPLETED|Overall Study||9
905556|NCT01715129|2188959|P1|COMPLETED|Overall Study||117
905557|NCT01715129|2188959|P1|STARTED|Overall Study||126
905558|NCT01715064|2188978|P2|NOT COMPLETED|Overall Study||0
905559|NCT01715064|2188979|P1|NOT COMPLETED|Overall Study||0
905560|NCT01715064|2188978|P2|COMPLETED|Overall Study||18
905561|NCT01715064|2188979|P1|COMPLETED|Overall Study||18
905562|NCT01715064|2188978|P2|STARTED|Overall Study||18
905563|NCT01715064|2188979|P1|STARTED|Overall Study||18
905564|NCT01714635|2188988|P3|NOT COMPLETED|Overall Study||2
905565|NCT01714635|2188989|P2|NOT COMPLETED|Overall Study||0
905566|NCT01714635|2188990|P1|NOT COMPLETED|Overall Study||2
905567|NCT01714635|2188988|P3|COMPLETED|Overall Study||146
905568|NCT01714635|2188989|P2|COMPLETED|Overall Study||150
905569|NCT01714635|2188990|P1|COMPLETED|Overall Study||145
905570|NCT01714635|2188988|P3|STARTED|Overall Study||148
905571|NCT01714635|2188989|P2|STARTED|Overall Study||150
905572|NCT01714635|2188990|P1|STARTED|Overall Study||147
905573|NCT01714609|2189006|P2|NOT COMPLETED|Overall Study||0
905574|NCT01714609|2189007|P1|NOT COMPLETED|Overall Study||1
905575|NCT01714609|2189006|P2|COMPLETED|Overall Study||5
905576|NCT01714609|2189007|P1|COMPLETED|Overall Study||4
905577|NCT01714609|2189006|P2|STARTED|Overall Study||5
905578|NCT01714609|2189007|P1|STARTED|Overall Study||5
905579|NCT01714544|2189013|P1|NOT COMPLETED|Overall Study||3
905580|NCT01714544|2189013|P1|COMPLETED|Overall Study||57
905581|NCT01714544|2189013|P1|STARTED|Overall Study||60
905582|NCT01714505|2189017|P2|NOT COMPLETED|Admission 2 (40 Hours)||0
905583|NCT01714505|2189018|P1|NOT COMPLETED|Admission 2 (40 Hours)||0
905584|NCT01714505|2189017|P2|COMPLETED|Admission 2 (40 Hours)||9
905585|NCT01714505|2189018|P1|COMPLETED|Admission 2 (40 Hours)||9
905586|NCT01714505|2189017|P2|STARTED|Admission 2 (40 Hours)||9
905587|NCT01714505|2189018|P1|STARTED|Admission 2 (40 Hours)||9
905588|NCT01714505|2189017|P2|NOT COMPLETED|Admission 1 (40 Hours)||1
905589|NCT01714505|2189018|P1|NOT COMPLETED|Admission 1 (40 Hours)||1
905590|NCT01714505|2189017|P2|COMPLETED|Admission 1 (40 Hours)||9
905591|NCT01714505|2189018|P1|COMPLETED|Admission 1 (40 Hours)||9
905592|NCT01714505|2189017|P2|STARTED|Admission 1 (40 Hours)||10
905593|NCT01714505|2189018|P1|STARTED|Admission 1 (40 Hours)||10
905594|NCT01714492|2189028|P1|NOT COMPLETED|Overall Study||0
905595|NCT01714492|2189028|P1|COMPLETED|Overall Study||8
905596|NCT01714492|2189028|P1|STARTED|Overall Study||8
905597|NCT01714336|2189039|P2|NOT COMPLETED|Overall Study||0
905598|NCT01714336|2189040|P1|NOT COMPLETED|Overall Study||0
905599|NCT01714336|2189039|P2|COMPLETED|Overall Study||69
905600|NCT01714336|2189040|P1|COMPLETED|Overall Study||69
905601|NCT01714336|2189039|P2|STARTED|Overall Study||69
905602|NCT01714336|2189040|P1|STARTED|Overall Study||69
905603|NCT01714232|2189060|P1|NOT COMPLETED|Overall Study||0
905604|NCT01714232|2189060|P1|COMPLETED|Overall Study||106
905605|NCT01714232|2189060|P1|STARTED|Overall Study||106
905615|NCT01713998|2189085|P3|NOT COMPLETED|Overall Study||2
905616|NCT01713998|2189086|P2|NOT COMPLETED|Overall Study||0
905617|NCT01713998|2189087|P1|NOT COMPLETED|Overall Study||3
905618|NCT01713998|2189085|P3|COMPLETED|Overall Study||14
905619|NCT01713998|2189086|P2|COMPLETED|Overall Study||15
905620|NCT01713998|2189087|P1|COMPLETED|Overall Study||13
905621|NCT01713998|2189085|P3|STARTED|Overall Study||16
905622|NCT01713998|2189086|P2|STARTED|Overall Study||15
905623|NCT01713998|2189087|P1|STARTED|Overall Study||16
905624|NCT01713933|2189105|P1|NOT COMPLETED|Overall Study||6
905625|NCT01713933|2189105|P1|COMPLETED|Overall Study||31
905626|NCT01713933|2189105|P1|STARTED|Overall Study||37
905627|NCT01713686|2189117|P1|NOT COMPLETED|Overall Study||15
905628|NCT01713686|2189117|P1|COMPLETED|Overall Study||110
905629|NCT01713686|2189117|P1|STARTED|Overall Study|129 enrolled, 125 treated. 2 withdrew consent prior to treatment; 2 excluded after enrollment.|125
905630|NCT01713660|2189126|P1|NOT COMPLETED|Overall Study||0
905631|NCT01713660|2189126|P1|COMPLETED|Overall Study||37
905632|NCT01713660|2189126|P1|STARTED|Overall Study||37
905633|NCT01713621|2189134|P2|NOT COMPLETED|Overall Study||16
905634|NCT01713621|2189135|P1|NOT COMPLETED|Overall Study||7
905635|NCT01713621|2189134|P2|COMPLETED|Overall Study||1
905636|NCT01713621|2189135|P1|COMPLETED|Overall Study||1
905637|NCT01713621|2189134|P2|STARTED|Overall Study||17
905638|NCT01713621|2189135|P1|STARTED|Overall Study||8
905639|NCT01713608|2189145|P4|NOT COMPLETED|Overall Study||0
905640|NCT01713608|2189146|P3|NOT COMPLETED|Overall Study||0
905641|NCT01713608|2189147|P2|NOT COMPLETED|Overall Study||0
905642|NCT01713608|2189148|P1|NOT COMPLETED|Overall Study||0
905643|NCT01713608|2189145|P4|COMPLETED|Overall Study||12
905644|NCT01713608|2189146|P3|COMPLETED|Overall Study||8
905645|NCT01713608|2189147|P2|COMPLETED|Overall Study||6
905646|NCT01713608|2189148|P1|COMPLETED|Overall Study||8
905647|NCT01713608|2189145|P4|STARTED|Overall Study||12
905648|NCT01713608|2189146|P3|STARTED|Overall Study||8
905649|NCT01713608|2189147|P2|STARTED|Overall Study||6
905650|NCT01713608|2189148|P1|STARTED|Overall Study||8
905651|NCT01713530|2189168|P2|NOT COMPLETED|Overall Study||19
905652|NCT01713530|2189169|P1|NOT COMPLETED|Overall Study||25
905653|NCT01713530|2189168|P2|COMPLETED|Overall Study||117
905654|NCT01713530|2189169|P1|COMPLETED|Overall Study||113
905655|NCT01713530|2189168|P2|Exposed|Overall Study|One (1) subject was withdrawn by the investigator|135
905656|NCT01713530|2189169|P1|Exposed|Overall Study|One (1) subject was randomised in error and 1 subject withdrew consent|136
905657|NCT01713530|2189168|P2|STARTED|Overall Study||136
905658|NCT01713530|2189169|P1|STARTED|Overall Study||138
905659|NCT01713400|2189187|P2|NOT COMPLETED|Overall Study||0
905660|NCT01713400|2189188|P1|NOT COMPLETED|Overall Study||0
905661|NCT01713400|2189187|P2|COMPLETED|Overall Study||15
905662|NCT01713400|2189188|P1|COMPLETED|Overall Study||15
905663|NCT01713400|2189187|P2|STARTED|Overall Study||15
905664|NCT01713400|2189188|P1|STARTED|Overall Study||15
905665|NCT01713348|2189200|P4|NOT COMPLETED|Overall Study||0
905666|NCT01713348|2189201|P3|NOT COMPLETED|Overall Study||2
905667|NCT01713348|2189202|P2|NOT COMPLETED|Overall Study||2
905668|NCT01713348|2189203|P1|NOT COMPLETED|Overall Study||4
905669|NCT01713348|2189200|P4|COMPLETED|Overall Study||15
905670|NCT01713348|2189201|P3|COMPLETED|Overall Study||28
905671|NCT01713348|2189202|P2|COMPLETED|Overall Study||11
905672|NCT01713348|2189203|P1|COMPLETED|Overall Study||25
905673|NCT01713348|2189200|P4|STARTED|Overall Study||15
905674|NCT01713348|2189201|P3|STARTED|Overall Study||30
905675|NCT01713348|2189202|P2|STARTED|Overall Study||13
905676|NCT01713348|2189203|P1|STARTED|Overall Study||29
905677|NCT01713283|2189233|P2|NOT COMPLETED|Overall Study||3
905678|NCT01713283|2189234|P1|NOT COMPLETED|Overall Study||11
905679|NCT01713283|2189233|P2|COMPLETED|Overall Study||26
905680|NCT01713283|2189234|P1|COMPLETED|Overall Study||20
905681|NCT01713283|2189233|P2|STARTED|Overall Study||29
905682|NCT01713283|2189234|P1|STARTED|Overall Study||31
905683|NCT01713036|2189256|P1|NOT COMPLETED|Overall Study||1
905684|NCT01713036|2189256|P1|COMPLETED|Overall Study||5
905685|NCT01713036|2189256|P1|STARTED|Overall Study||6
905686|NCT01712984|2189296|P3|NOT COMPLETED|Overall Study||10
905687|NCT01712984|2189297|P2|NOT COMPLETED|Overall Study||16
905688|NCT01712984|2189298|P1|NOT COMPLETED|Overall Study||16
905689|NCT01712984|2189296|P3|COMPLETED|Overall Study||836
905690|NCT01712984|2189297|P2|COMPLETED|Overall Study||821
905691|NCT01712984|2189298|P1|COMPLETED|Overall Study||1656
905692|NCT01712984|2189296|P3|STARTED|Overall Study||846
905693|NCT01712984|2189297|P2|STARTED|Overall Study||837
905694|NCT01712984|2189298|P1|STARTED|Overall Study||1672
905695|NCT01712854|2189318|P1|NOT COMPLETED|Overall Study||1
905696|NCT01712854|2189318|P1|COMPLETED|Overall Study||8
905697|NCT01712854|2189318|P1|STARTED|Overall Study||9
905698|NCT01712776|2189325|P2|NOT COMPLETED|Overall Study||0
905699|NCT01712776|2189326|P1|NOT COMPLETED|Overall Study||0
905700|NCT01712776|2189325|P2|COMPLETED|Overall Study||50
905701|NCT01712776|2189326|P1|COMPLETED|Overall Study|trial to enroll 50 in each group for total of 100|50
905702|NCT01712776|2189325|P2|STARTED|Overall Study||50
905703|NCT01712776|2189326|P1|STARTED|Overall Study||50
905704|NCT01712711|2189334|P2|NOT COMPLETED|Overall Study||0
905705|NCT01712711|2189335|P1|NOT COMPLETED|Overall Study||0
905706|NCT01712711|2189334|P2|COMPLETED|Overall Study||20
905707|NCT01712711|2189335|P1|COMPLETED|Overall Study||20
905708|NCT01712711|2189334|P2|STARTED|Overall Study||20
905709|NCT01712711|2189335|P1|STARTED|Overall Study||20
905710|NCT01712685|2189341|P1|NOT COMPLETED|Overall Study||1
905711|NCT01712685|2189341|P1|COMPLETED|Overall Study||11
905712|NCT01712685|2189341|P1|STARTED|Overall Study||12
905713|NCT01712516|2189357|P4|NOT COMPLETED|Overall Study||13
905714|NCT01712516|2189358|P3|NOT COMPLETED|Overall Study||6
905715|NCT01712516|2189359|P2|NOT COMPLETED|Overall Study||10
905716|NCT01712516|2189360|P1|NOT COMPLETED|Overall Study||6
905717|NCT01712516|2189357|P4|COMPLETED|Overall Study||236
905718|NCT01712516|2189358|P3|COMPLETED|Overall Study||245
905719|NCT01712516|2189359|P2|COMPLETED|Overall Study||241
905720|NCT01712516|2189360|P1|COMPLETED|Overall Study||244
905721|NCT01712516|2189357|P4|Full Analysis Set|Overall Study||247
905722|NCT01712516|2189358|P3|Full Analysis Set|Overall Study||250
905723|NCT01712516|2189359|P2|Full Analysis Set|Overall Study||251
905724|NCT01712516|2189360|P1|Full Analysis Set|Overall Study||250
905725|NCT01712516|2189357|P4|Safety Set|Overall Study||248
905726|NCT01712516|2189358|P3|Safety Set|Overall Study||251
905727|NCT01712516|2189359|P2|Safety Set|Overall Study||251
905728|NCT01712516|2189360|P1|Safety Set|Overall Study||250
905729|NCT01712516|2189357|P4|STARTED|Overall Study||249
905730|NCT01712516|2189358|P3|STARTED|Overall Study||251
905731|NCT01712516|2189359|P2|STARTED|Overall Study||251
905732|NCT01712516|2189360|P1|STARTED|Overall Study||250
905733|NCT01712399|2189410|P1|NOT COMPLETED|Overall Study||397
905734|NCT01712399|2189410|P1|COMPLETED|Overall Study||0
905735|NCT01712399|2189410|P1|STARTED|Overall Study||397
905736|NCT01712360|2189427|P4|NOT COMPLETED|Overall Study||2
905737|NCT01712360|2189428|P3|NOT COMPLETED|Overall Study||0
905738|NCT01712360|2189429|P2|NOT COMPLETED|Overall Study||1
905739|NCT01712360|2189430|P1|NOT COMPLETED|Overall Study||0
905740|NCT01712360|2189427|P4|COMPLETED|Overall Study||4
905741|NCT01712360|2189428|P3|COMPLETED|Overall Study||6
905742|NCT01712360|2189429|P2|COMPLETED|Overall Study||21
905743|NCT01712360|2189430|P1|COMPLETED|Overall Study||22
905744|NCT01712360|2189427|P4|STARTED|Overall Study||6
905745|NCT01712360|2189428|P3|STARTED|Overall Study||6
905746|NCT01712360|2189429|P2|STARTED|Overall Study||22
905747|NCT01712360|2189430|P1|STARTED|Overall Study||22
905748|NCT01712334|2189456|P2|NOT COMPLETED|Treatment Period 2||0
905749|NCT01712334|2189457|P1|NOT COMPLETED|Treatment Period 2||0
905750|NCT01712334|2189456|P2|COMPLETED|Treatment Period 2||41
905751|NCT01712334|2189457|P1|COMPLETED|Treatment Period 2||44
905752|NCT01712334|2189456|P2|STARTED|Treatment Period 2||41
905753|NCT01712334|2189457|P1|STARTED|Treatment Period 2||44
905754|NCT01712334|2189456|P2|NOT COMPLETED|Treatment Period 1||2
905755|NCT01712334|2189457|P1|NOT COMPLETED|Treatment Period 1||0
905756|NCT01712334|2189456|P2|COMPLETED|Treatment Period 1||41
905757|NCT01712334|2189457|P1|COMPLETED|Treatment Period 1||44
905758|NCT01712334|2189456|P2|Received Treatment|Treatment Period 1||41
905759|NCT01712334|2189457|P1|Received Treatment|Treatment Period 1||44
905760|NCT01712334|2189456|P2|STARTED|Treatment Period 1||43
905761|NCT01712334|2189457|P1|STARTED|Treatment Period 1||44
905762|NCT01712256|2189465|P1|NOT COMPLETED|Overall Study||1
905763|NCT01712256|2189465|P1|COMPLETED|Overall Study||32
905764|NCT01712256|2189465|P1|STARTED|Overall Study||33
905765|NCT01712204|2189476|P2|NOT COMPLETED|Overall Study||5
905766|NCT01712204|2189477|P1|NOT COMPLETED|Overall Study||8
905767|NCT01712204|2189476|P2|COMPLETED|Overall Study||36
905768|NCT01712204|2189477|P1|COMPLETED|Overall Study||33
905769|NCT01712204|2189476|P2|STARTED|Overall Study||41
905770|NCT01712204|2189477|P1|STARTED|Overall Study||41
905771|NCT01712178|2189485|P2|NOT COMPLETED|Overall Study||3
905772|NCT01712178|2189486|P1|NOT COMPLETED|Overall Study||1
905773|NCT01712178|2189485|P2|COMPLETED|Overall Study||47
905774|NCT01712178|2189486|P1|COMPLETED|Overall Study||49
905775|NCT01712178|2189485|P2|STARTED|Overall Study||50
905776|NCT01712178|2189486|P1|STARTED|Overall Study||50
905777|NCT01712074|2189511|P3|NOT COMPLETED|Double Blind Period||8
905778|NCT01712074|2189512|P2|NOT COMPLETED|Double Blind Period||14
905779|NCT01712074|2189513|P1|NOT COMPLETED|Double Blind Period||0
905780|NCT01712074|2189511|P3|COMPLETED|Double Blind Period||86
905781|NCT01712074|2189512|P2|COMPLETED|Double Blind Period||77
905782|NCT01712074|2189513|P1|COMPLETED|Double Blind Period||0
905783|NCT01712074|2189511|P3|STARTED|Double Blind Period||94
905784|NCT01712074|2189512|P2|STARTED|Double Blind Period||91
905785|NCT01712074|2189513|P1|STARTED|Double Blind Period||0
905786|NCT01712074|2189511|P3|NOT COMPLETED|Placebo Run-in Period||0
905787|NCT01712074|2189512|P2|NOT COMPLETED|Placebo Run-in Period||0
905788|NCT01712074|2189513|P1|NOT COMPLETED|Placebo Run-in Period||10
905789|NCT01712074|2189511|P3|COMPLETED|Placebo Run-in Period||0
905790|NCT01712074|2189512|P2|COMPLETED|Placebo Run-in Period||0
905791|NCT01712074|2189513|P1|COMPLETED|Placebo Run-in Period||185
905792|NCT01712074|2189511|P3|STARTED|Placebo Run-in Period||0
905793|NCT01712074|2189512|P2|STARTED|Placebo Run-in Period||0
905794|NCT01712074|2189513|P1|STARTED|Placebo Run-in Period||195
905795|NCT01712061|2189569|P3|NOT COMPLETED|Overall Study||11
905796|NCT01712061|2189570|P2|NOT COMPLETED|Overall Study||26
905797|NCT01712061|2189571|P1|NOT COMPLETED|Overall Study||10
905798|NCT01712061|2189569|P3|COMPLETED|Overall Study||45
905799|NCT01712061|2189570|P2|COMPLETED|Overall Study||114
905800|NCT01712061|2189571|P1|COMPLETED|Overall Study||20
905801|NCT01712061|2189569|P3|STARTED|Overall Study||56
905802|NCT01712061|2189570|P2|STARTED|Overall Study||140
905803|NCT01712061|2189571|P1|STARTED|Overall Study||30
905804|NCT01712009|2189611|P3|NOT COMPLETED|Overall Study||21
905805|NCT01712009|2189612|P2|NOT COMPLETED|Overall Study||29
905806|NCT01712009|2189613|P1|NOT COMPLETED|Overall Study||38
905807|NCT01712009|2189611|P3|COMPLETED|Overall Study||181
905808|NCT01712009|2189612|P2|COMPLETED|Overall Study||171
905809|NCT01712009|2189613|P1|COMPLETED|Overall Study||160
905810|NCT01712009|2189611|P3|Received Naproxen / Loratadine|Overall Study||198
905811|NCT01712009|2189612|P2|Received Naproxen / Loratadine|Overall Study||193
905812|NCT01712009|2189613|P1|Received Naproxen / Loratadine|Overall Study||0
905813|NCT01712009|2189611|P3|Received Pegfilgrastim|Overall Study||200
905814|NCT01712009|2189612|P2|Received Pegfilgrastim|Overall Study||196
905815|NCT01712009|2189613|P1|Received Pegfilgrastim|Overall Study||191
905816|NCT01712009|2189611|P3|STARTED|Overall Study||202
905817|NCT01712009|2189612|P2|STARTED|Overall Study||200
905818|NCT01712009|2189613|P1|STARTED|Overall Study||198
905819|NCT01711918|2189639|P1|NOT COMPLETED|Overall Study||2
905820|NCT01711918|2189639|P1|COMPLETED|Overall Study||7
905821|NCT01711918|2189639|P1|STARTED|Overall Study||9
905822|NCT01711866|2189647|P1|NOT COMPLETED|Overall Study||8
905823|NCT01711866|2189647|P1|COMPLETED|Overall Study||79
905824|NCT01711866|2189647|P1|STARTED|Overall Study||87
905825|NCT01711853|2189652|P1|NOT COMPLETED|Overall Study||3
905826|NCT01711853|2189652|P1|COMPLETED|Overall Study||16
905827|NCT01711853|2189652|P1|STARTED|Overall Study||19
905828|NCT01711736|2189659|P2|NOT COMPLETED|Overall Study||8
905829|NCT01711736|2189660|P1|NOT COMPLETED|Overall Study||12
905830|NCT01711736|2189659|P2|COMPLETED|Overall Study|Up to Day 180|294
905831|NCT01711736|2189660|P1|COMPLETED|Overall Study|Up to Day 180|287
905832|NCT01711736|2189659|P2|STARTED|Overall Study||302
905833|NCT01711736|2189660|P1|STARTED|Overall Study||299
905834|NCT01711645|2189688|P1|NOT COMPLETED|Overall Study||19
905835|NCT01711645|2189688|P1|COMPLETED|Overall Study||36
905836|NCT01711645|2189688|P1|STARTED|Overall Study||55
905837|NCT01711424|2189723|P1|NOT COMPLETED|Overall Study||0
905838|NCT01711424|2189723|P1|COMPLETED|Overall Study||1209
905839|NCT01711424|2189723|P1|STARTED|Overall Study||1209
905840|NCT01711359|2189733|P3|NOT COMPLETED|Follow Up||28
905841|NCT01711359|2189734|P2|NOT COMPLETED|Follow Up||15
905842|NCT01711359|2189735|P1|NOT COMPLETED|Follow Up||25
905843|NCT01711359|2189733|P3|COMPLETED|Follow Up||0
905844|NCT01711359|2189734|P2|COMPLETED|Follow Up||0
905845|NCT01711359|2189735|P1|COMPLETED|Follow Up||0
905846|NCT01711359|2189733|P3|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|28
905847|NCT01711359|2189734|P2|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|15
905848|NCT01711359|2189735|P1|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|25
905849|NCT01711359|2189733|P3|NOT COMPLETED|Treatment Period||42
905850|NCT01711359|2189734|P2|NOT COMPLETED|Treatment Period||24
905851|NCT01711359|2189735|P1|NOT COMPLETED|Treatment Period||52
905852|NCT01711359|2189733|P3|COMPLETED|Treatment Period||173
905853|NCT01711359|2189734|P2|COMPLETED|Treatment Period||136
905854|NCT01711359|2189735|P1|COMPLETED|Treatment Period||161
905855|NCT01711359|2189733|P3|Rescued|Treatment Period||6
905856|NCT01711359|2189734|P2|Rescued|Treatment Period||7
905857|NCT01711359|2189735|P1|Rescued|Treatment Period||26
905858|NCT01711359|2189733|P3|Received at Least One Dose of Study Drug|Treatment Period||215
905859|NCT01711359|2189734|P2|Received at Least One Dose of Study Drug|Treatment Period||159
905860|NCT01711359|2189735|P1|Received at Least One Dose of Study Drug|Treatment Period||210
905861|NCT01711359|2189733|P3|STARTED|Treatment Period||215
905862|NCT01711359|2189734|P2|STARTED|Treatment Period||160
905863|NCT01711359|2189735|P1|STARTED|Treatment Period||213
905864|NCT01711216|2189806|P1|NOT COMPLETED|Overall Study||217
905865|NCT01711216|2189806|P1|COMPLETED|Overall Study||782
905866|NCT01711216|2189806|P1|STARTED|Overall Study||999
905867|NCT01711177|2189830|P3|NOT COMPLETED|Overall Study||0
905868|NCT01711177|2189831|P2|NOT COMPLETED|Overall Study||0
905869|NCT01711177|2189832|P1|NOT COMPLETED|Overall Study||0
905870|NCT01711177|2189830|P3|COMPLETED|Overall Study||3
905871|NCT01711177|2189831|P2|COMPLETED|Overall Study||3
905872|NCT01711177|2189832|P1|COMPLETED|Overall Study||10
905873|NCT01711177|2189830|P3|STARTED|Overall Study||3
905874|NCT01711177|2189831|P2|STARTED|Overall Study||3
905875|NCT01711177|2189832|P1|STARTED|Overall Study||10
905876|NCT01710839|2189842|P2|NOT COMPLETED|Overall Study||6
905877|NCT01710839|2189843|P1|NOT COMPLETED|Overall Study||1
905878|NCT01710839|2189842|P2|COMPLETED|Overall Study||0
905879|NCT01710839|2189843|P1|COMPLETED|Overall Study||23
905880|NCT01710839|2189842|P2|STARTED|Overall Study||6
905881|NCT01710839|2189843|P1|STARTED|Overall Study||24
905882|NCT01710800|2189865|P1|NOT COMPLETED|Overall Study||22
905883|NCT01710800|2189865|P1|COMPLETED|Overall Study|22 drop outs(consented but did not participate, refused 2nd intervention)|41
905884|NCT01710800|2189865|P1|Received Placebo Intervention|Overall Study||45
905885|NCT01710800|2189865|P1|Received PPI Intervention|Overall Study||44
905886|NCT01710800|2189865|P1|STARTED|Overall Study|63 patients consented to be part of the study|63
905887|NCT01710787|2189874|P3|NOT COMPLETED|Overall Study||0
905888|NCT01710787|2189875|P2|NOT COMPLETED|Overall Study||0
905889|NCT01710787|2189876|P1|NOT COMPLETED|Overall Study||0
905890|NCT01710787|2189874|P3|COMPLETED|Overall Study||22
905891|NCT01710787|2189875|P2|COMPLETED|Overall Study||44
905892|NCT01710787|2189876|P1|COMPLETED|Overall Study||44
905893|NCT01710787|2189874|P3|STARTED|Overall Study||22
905894|NCT01710787|2189875|P2|STARTED|Overall Study||44
905895|NCT01710787|2189876|P1|STARTED|Overall Study||44
905896|NCT01710657|2189932|P3|NOT COMPLETED|Overall Study||32
905897|NCT01710657|2189933|P2|NOT COMPLETED|Overall Study||12
905898|NCT01710657|2189934|P1|NOT COMPLETED|Overall Study||18
905899|NCT01710657|2189932|P3|COMPLETED|Overall Study||148
905900|NCT01710657|2189933|P2|COMPLETED|Overall Study||171
905901|NCT01710657|2189934|P1|COMPLETED|Overall Study||166
905902|NCT01710657|2189932|P3|Maintenance Period (12 Weeks)|Overall Study||168
905903|NCT01710657|2189933|P2|Maintenance Period (12 Weeks)|Overall Study||175
905904|NCT01710657|2189934|P1|Maintenance Period (12 Weeks)|Overall Study||176
905905|NCT01710657|2189932|P3|Titration Period (4 Weeks)|Overall Study||180
905906|NCT01710657|2189933|P2|Titration Period (4 Weeks)|Overall Study||183
905907|NCT01710657|2189934|P1|Titration Period (4 Weeks)|Overall Study||184
905908|NCT01710657|2189932|P3|STARTED|Overall Study||180
905909|NCT01710657|2189933|P2|STARTED|Overall Study||183
905910|NCT01710657|2189934|P1|STARTED|Overall Study||184
905911|NCT01710527|2189951|P2|NOT COMPLETED|Period 3: Intervention Period 2||0
905912|NCT01710527|2189952|P1|NOT COMPLETED|Period 3: Intervention Period 2||0
905913|NCT01710527|2189951|P2|COMPLETED|Period 3: Intervention Period 2||15
905914|NCT01710527|2189952|P1|COMPLETED|Period 3: Intervention Period 2||16
905915|NCT01710527|2189951|P2|STARTED|Period 3: Intervention Period 2||15
905916|NCT01710527|2189952|P1|STARTED|Period 3: Intervention Period 2||16
905917|NCT01710527|2189951|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||1
905918|NCT01710527|2189952|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
905919|NCT01710527|2189951|P2|COMPLETED|Period 2: Washout Period (7 Days)||15
905920|NCT01710527|2189952|P1|COMPLETED|Period 2: Washout Period (7 Days)||16
905921|NCT01710527|2189951|P2|STARTED|Period 2: Washout Period (7 Days)||16
905922|NCT01710527|2189952|P1|STARTED|Period 2: Washout Period (7 Days)||16
905923|NCT01710527|2189951|P2|NOT COMPLETED|Period 1: Intervention Period 1||0
905924|NCT01710527|2189952|P1|NOT COMPLETED|Period 1: Intervention Period 1||0
905925|NCT01710527|2189951|P2|COMPLETED|Period 1: Intervention Period 1||16
905926|NCT01710527|2189952|P1|COMPLETED|Period 1: Intervention Period 1||16
905927|NCT01710527|2189951|P2|STARTED|Period 1: Intervention Period 1||16
905928|NCT01710527|2189952|P1|STARTED|Period 1: Intervention Period 1||16
905929|NCT01710514|2189978|P2|NOT COMPLETED|Overall Study||7
905930|NCT01710514|2189979|P1|NOT COMPLETED|Overall Study||7
905931|NCT01710514|2189978|P2|COMPLETED|Overall Study||47
905932|NCT01710514|2189979|P1|COMPLETED|Overall Study||47
905933|NCT01710514|2189978|P2|Safety Analysis Set|Overall Study|All subjects received at least one dose of IMP.|54
905934|NCT01710514|2189979|P1|Safety Analysis Set|Overall Study|All subjects received at least one dose of Investigational Medicinal Product (IMP).|54
905935|NCT01710514|2189978|P2|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|47
905936|NCT01710514|2189979|P1|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|43
905937|NCT01710514|2189978|P2|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|48
905938|NCT01710514|2189979|P1|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|46
905939|NCT01710514|2189978|P2|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the ITT analysis set.|54
905940|NCT01710514|2189979|P1|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the Intent-To-Treat (ITT) analysis set.|54
905941|NCT01710514|2189978|P2|STARTED|Overall Study||54
905942|NCT01710514|2189979|P1|STARTED|Overall Study||54
905943|NCT01710501|2190000|P3|NOT COMPLETED|Overall Study||0
905944|NCT01710501|2190001|P2|NOT COMPLETED|Overall Study||0
905945|NCT01710501|2190002|P1|NOT COMPLETED|Overall Study||2
905946|NCT01710501|2190000|P3|COMPLETED|Overall Study||30
905947|NCT01710501|2190001|P2|COMPLETED|Overall Study||28
905948|NCT01710501|2190002|P1|COMPLETED|Overall Study||27
905949|NCT01710501|2190000|P3|STARTED|Overall Study||30
905950|NCT01710501|2190001|P2|STARTED|Overall Study||28
905951|NCT01710501|2190002|P1|STARTED|Overall Study||29
905952|NCT01710358|2190034|P3|NOT COMPLETED|Follow-up Period||0
905953|NCT01710358|2190035|P2|NOT COMPLETED|Follow-up Period||0
905954|NCT01710358|2190036|P1|NOT COMPLETED|Follow-up Period||0
905955|NCT01710358|2190034|P3|COMPLETED|Follow-up Period||20
905956|NCT01710358|2190035|P2|COMPLETED|Follow-up Period||76
905957|NCT01710358|2190036|P1|COMPLETED|Follow-up Period||33
905958|NCT01710358|2190034|P3|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|20
905959|NCT01710358|2190035|P2|STARTED|Follow-up Period|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4mg follow up.|76
905960|NCT01710358|2190036|P1|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|33
905961|NCT01710358|2190034|P3|NOT COMPLETED|Rescue Period||0
905962|NCT01710358|2190035|P2|NOT COMPLETED|Rescue Period||31
905963|NCT01710358|2190036|P1|NOT COMPLETED|Rescue Period||0
905964|NCT01710358|2190034|P3|COMPLETED|Rescue Period||0
905965|NCT01710358|2190035|P2|COMPLETED|Rescue Period||196
905966|NCT01710358|2190036|P1|COMPLETED|Rescue Period||0
905967|NCT01710358|2190034|P3|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
905968|NCT01710358|2190035|P2|STARTED|Rescue Period|Baricitinib 4 mg administered PO QD through Week 52. Participants continued background MTX therapy.|227
905969|NCT01710358|2190036|P1|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
905970|NCT01710358|2190034|P3|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||15
905971|NCT01710358|2190035|P2|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||22
905972|NCT01710358|2190036|P1|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||16
905973|NCT01710358|2190034|P3|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|252
905974|NCT01710358|2190035|P2|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|402
905975|NCT01710358|2190036|P1|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|294
905976|NCT01710358|2190034|P3|Rescued|Treatment Period Part B (Weeks 24 to 52)||11
905977|NCT01710358|2190035|P2|Rescued|Treatment Period Part B (Weeks 24 to 52)||8
905978|NCT01710358|2190036|P1|Rescued|Treatment Period Part B (Weeks 24 to 52)||5
905979|NCT01710358|2190034|P3|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||267
905980|NCT01710358|2190035|P2|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||424
905981|NCT01710358|2190036|P1|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)|Participants originally randomized to placebo received baricitinib during Part B.|306
905982|NCT01710358|2190034|P3|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|267
905983|NCT01710358|2190035|P2|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|424
905984|NCT01710358|2190036|P1|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|310
905985|NCT01710358|2190034|P3|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||23
905986|NCT01710358|2190035|P2|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||29
905987|NCT01710358|2190036|P1|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||51
905988|NCT01710358|2190034|P3|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|307
905989|NCT01710358|2190035|P2|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|459
905990|NCT01710358|2190036|P1|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|438
905991|NCT01710358|2190034|P3|Rescued|Treatment Period Part A (Weeks 0 to 24)||40
905992|NCT01710358|2190035|P2|Rescued|Treatment Period Part A (Weeks 0 to 24)||35
905993|NCT01710358|2190036|P1|Rescued|Treatment Period Part A (Weeks 0 to 24)||128
905994|NCT01710358|2190034|P3|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||330
905995|NCT01710358|2190035|P2|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||487
905996|NCT01710358|2190036|P1|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||488
905997|NCT01710358|2190034|P3|STARTED|Treatment Period Part A (Weeks 0 to 24)||330
905998|NCT01710358|2190035|P2|STARTED|Treatment Period Part A (Weeks 0 to 24)||488
905999|NCT01710358|2190036|P1|STARTED|Treatment Period Part A (Weeks 0 to 24)||489
906000|NCT01710345|2190107|P3|NOT COMPLETED|Overall Study||1
906001|NCT01710345|2190108|P2|NOT COMPLETED|Overall Study||5
906002|NCT01710345|2190109|P1|NOT COMPLETED|Overall Study||3
906003|NCT01710345|2190107|P3|COMPLETED|Overall Study||19
906004|NCT01710345|2190108|P2|COMPLETED|Overall Study||35
906005|NCT01710345|2190109|P1|COMPLETED|Overall Study||37
906006|NCT01710345|2190107|P3|STARTED|Overall Study||20
906007|NCT01710345|2190108|P2|STARTED|Overall Study||40
906008|NCT01710345|2190109|P1|STARTED|Overall Study|41 patients were randomized to sufentanil 20 mcg, one patient not dosed due to damaged medication.|40
906009|NCT01710332|2190119|P2|NOT COMPLETED|Overall Study||0
906010|NCT01710332|2190120|P1|NOT COMPLETED|Overall Study||0
906011|NCT01710332|2190119|P2|COMPLETED|Overall Study||6
906012|NCT01710332|2190120|P1|COMPLETED|Overall Study||6
906013|NCT01710332|2190119|P2|STARTED|Overall Study||6
906014|NCT01710332|2190120|P1|STARTED|Overall Study||6
906021|NCT01710033|2190171|P5|NOT COMPLETED|Stage 2||1
906022|NCT01710033|2190172|P4|NOT COMPLETED|Stage 2||0
906023|NCT01710033|2190173|P3|NOT COMPLETED|Stage 2||0
906024|NCT01710033|2190174|P2|NOT COMPLETED|Stage 2||0
906025|NCT01710033|2190175|P1|NOT COMPLETED|Stage 2||0
906026|NCT01710033|2190171|P5|COMPLETED|Stage 2||3
906027|NCT01710033|2190172|P4|COMPLETED|Stage 2||0
906028|NCT01710033|2190173|P3|COMPLETED|Stage 2||0
906029|NCT01710033|2190174|P2|COMPLETED|Stage 2||0
906030|NCT01710033|2190175|P1|COMPLETED|Stage 2||0
906031|NCT01710033|2190171|P5|STARTED|Stage 2||4
906032|NCT01710033|2190172|P4|STARTED|Stage 2||0
906033|NCT01710033|2190173|P3|STARTED|Stage 2||0
906034|NCT01710033|2190174|P2|STARTED|Stage 2||0
906035|NCT01710033|2190175|P1|STARTED|Stage 2||0
906036|NCT01710033|2190171|P5|NOT COMPLETED|Stage 1||0
906037|NCT01710033|2190172|P4|NOT COMPLETED|Stage 1||0
906038|NCT01710033|2190173|P3|NOT COMPLETED|Stage 1||0
906039|NCT01710033|2190174|P2|NOT COMPLETED|Stage 1||0
906040|NCT01710033|2190175|P1|NOT COMPLETED|Stage 1||0
906041|NCT01710033|2190171|P5|COMPLETED|Stage 1||0
906042|NCT01710033|2190172|P4|COMPLETED|Stage 1||6
906043|NCT01710033|2190173|P3|COMPLETED|Stage 1||6
906044|NCT01710033|2190174|P2|COMPLETED|Stage 1||6
906045|NCT01710033|2190175|P1|COMPLETED|Stage 1||6
906046|NCT01710033|2190171|P5|STARTED|Stage 1||0
906047|NCT01710033|2190172|P4|STARTED|Stage 1||6
906048|NCT01710033|2190173|P3|STARTED|Stage 1||6
906049|NCT01710033|2190174|P2|STARTED|Stage 1||6
906050|NCT01710033|2190175|P1|STARTED|Stage 1||6
906051|NCT01710020|2190256|P1|NOT COMPLETED|Period 2||0
906052|NCT01710020|2190256|P1|COMPLETED|Period 2||11
906053|NCT01710020|2190256|P1|STARTED|Period 2||11
906054|NCT01710020|2190256|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
906055|NCT01710020|2190256|P1|COMPLETED|Washout Period (at Least 14 Days)||11
906056|NCT01710020|2190256|P1|STARTED|Washout Period (at Least 14 Days)||11
906057|NCT01710020|2190256|P1|NOT COMPLETED|Period 1||1
906058|NCT01710020|2190256|P1|COMPLETED|Period 1||11
906059|NCT01710020|2190256|P1|STARTED|Period 1||12
906060|NCT01709903|2190275|P2|NOT COMPLETED|Overall Study||39
906061|NCT01709903|2190276|P1|NOT COMPLETED|Overall Study||29
906062|NCT01709903|2190275|P2|COMPLETED|Overall Study||333
906063|NCT01709903|2190276|P1|COMPLETED|Overall Study||343
906064|NCT01709903|2190275|P2|STARTED|Overall Study|Randomized set|372
906065|NCT01709903|2190276|P1|STARTED|Overall Study|Randomized set|372
906066|NCT01709864|2190300|P2|NOT COMPLETED|Overall Study||11
906067|NCT01709864|2190301|P1|NOT COMPLETED|Overall Study||7
906068|NCT01709864|2190300|P2|COMPLETED|Overall Study||208
906069|NCT01709864|2190301|P1|COMPLETED|Overall Study||215
906070|NCT01709864|2190300|P2|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|201
906071|NCT01709864|2190301|P1|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|204
906072|NCT01709864|2190300|P2|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|216
906073|NCT01709864|2190301|P1|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|222
906074|NCT01709864|2190300|P2|STARTED|Overall Study||219
906075|NCT01709864|2190301|P1|STARTED|Overall Study||222
906076|NCT01709799|2190338|P3|NOT COMPLETED|Overall Study||3
906077|NCT01709799|2190339|P2|NOT COMPLETED|Overall Study||3
906078|NCT01709799|2190340|P1|NOT COMPLETED|Overall Study||3
906079|NCT01709799|2190338|P3|COMPLETED|Overall Study||15
906080|NCT01709799|2190339|P2|COMPLETED|Overall Study||18
906081|NCT01709799|2190340|P1|COMPLETED|Overall Study||22
906082|NCT01709799|2190338|P3|STARTED|Overall Study||18
906083|NCT01709799|2190339|P2|STARTED|Overall Study||21
906084|NCT01709799|2190340|P1|STARTED|Overall Study||25
906085|NCT01709786|2190363|P1|NOT COMPLETED|Overall Study||0
906086|NCT01709786|2190363|P1|COMPLETED|Overall Study||88
906087|NCT01709786|2190363|P1|STARTED|Overall Study||88
906088|NCT01709708|2190372|P2|NOT COMPLETED|Overall Study||2
906089|NCT01709708|2190373|P1|NOT COMPLETED|Overall Study||1
906090|NCT01709708|2190372|P2|COMPLETED|Overall Study||12
906091|NCT01709708|2190373|P1|COMPLETED|Overall Study||26
906092|NCT01709708|2190372|P2|STARTED|Overall Study||14
906093|NCT01709708|2190373|P1|STARTED|Overall Study||27
906094|NCT01709578|2190382|P3|NOT COMPLETED|Overall Study||51
906095|NCT01709578|2190383|P2|NOT COMPLETED|Overall Study||56
906096|NCT01709578|2190384|P1|NOT COMPLETED|Overall Study||80
906097|NCT01709578|2190382|P3|COMPLETED|Overall Study||133
906098|NCT01709578|2190383|P2|COMPLETED|Overall Study||125
906099|NCT01709578|2190384|P1|COMPLETED|Overall Study||101
906100|NCT01709578|2190382|P3|STARTED|Overall Study||184
906101|NCT01709578|2190383|P2|STARTED|Overall Study||181
906102|NCT01709578|2190384|P1|STARTED|Overall Study||181
906103|NCT01709513|2190515|P3|NOT COMPLETED|Overall Study||30
906104|NCT01709513|2190516|P2|NOT COMPLETED|Overall Study||43
906105|NCT01709513|2190517|P1|NOT COMPLETED|Overall Study||21
906106|NCT01709513|2190515|P3|COMPLETED|Overall Study||96
906107|NCT01709513|2190516|P2|COMPLETED|Overall Study||82
906108|NCT01709513|2190517|P1|COMPLETED|Overall Study||42
906109|NCT01709513|2190515|P3|Treated|Overall Study||126
906110|NCT01709513|2190516|P2|Treated|Overall Study||124
906111|NCT01709513|2190517|P1|Treated|Overall Study||63
906112|NCT01709513|2190515|P3|STARTED|Overall Study||126
906113|NCT01709513|2190516|P2|STARTED|Overall Study||125
906114|NCT01709513|2190517|P1|STARTED|Overall Study||63
906115|NCT01709500|2190578|P2|NOT COMPLETED|Overall Study||82
906116|NCT01709500|2190579|P1|NOT COMPLETED|Overall Study||167
906117|NCT01709500|2190578|P2|COMPLETED|Overall Study||0
906118|NCT01709500|2190579|P1|COMPLETED|Overall Study||0
906119|NCT01709500|2190578|P2|Treated|Overall Study||81
906120|NCT01709500|2190579|P1|Treated|Overall Study||167
906121|NCT01709500|2190578|P2|STARTED|Overall Study||82
906122|NCT01709500|2190579|P1|STARTED|Overall Study||167
906123|NCT01709474|2190635|P2|NOT COMPLETED|Overall Study||0
906124|NCT01709474|2190636|P1|NOT COMPLETED|Overall Study||0
906125|NCT01709474|2190635|P2|COMPLETED|Overall Study||4
906126|NCT01709474|2190636|P1|COMPLETED|Overall Study||3
906127|NCT01709474|2190635|P2|STARTED|Overall Study||4
906128|NCT01709474|2190636|P1|STARTED|Overall Study||3
906129|NCT01709422|2190646|P2|NOT COMPLETED|Overall Study||0
906130|NCT01709422|2190647|P1|NOT COMPLETED|Overall Study||0
906131|NCT01709422|2190646|P2|COMPLETED|Overall Study||70
906132|NCT01709422|2190647|P1|COMPLETED|Overall Study||70
906133|NCT01709422|2190646|P2|STARTED|Overall Study||70
906134|NCT01709422|2190647|P1|STARTED|Overall Study||70
906135|NCT01709383|2190657|P2|NOT COMPLETED|Overall Study||0
906136|NCT01709383|2190658|P1|NOT COMPLETED|Overall Study||1
906137|NCT01709383|2190657|P2|COMPLETED|Overall Study||14
906138|NCT01709383|2190658|P1|COMPLETED|Overall Study||23
906139|NCT01709383|2190657|P2|Included in Analysis|Overall Study||13
906140|NCT01709383|2190658|P1|Included in Analysis|Overall Study||22
906141|NCT01709383|2190657|P2|Completed Follow-ups|Overall Study||14
906142|NCT01709383|2190658|P1|Completed Follow-ups|Overall Study||23
906143|NCT01709383|2190657|P2|Completed Treatment|Overall Study||14
906144|NCT01709383|2190658|P1|Completed Treatment|Overall Study||24
906145|NCT01709383|2190657|P2|STARTED|Overall Study||14
906146|NCT01709383|2190658|P1|STARTED|Overall Study||24
906147|NCT01709331|2190676|P1|NOT COMPLETED|Overall Study||1
906148|NCT01709331|2190676|P1|COMPLETED|Overall Study||17
906149|NCT01709331|2190676|P1|STARTED|Overall Study||18
906150|NCT01709305|2190682|P5|NOT COMPLETED|Phase 2||47
906151|NCT01709305|2190683|P4|NOT COMPLETED|Phase 2||48
906152|NCT01709305|2190684|P3|NOT COMPLETED|Phase 2||45
906153|NCT01709305|2190685|P2|NOT COMPLETED|Phase 2||52
906154|NCT01709305|2190686|P1|NOT COMPLETED|Phase 2||0
906155|NCT01709305|2190682|P5|COMPLETED|Phase 2||507
906156|NCT01709305|2190683|P4|COMPLETED|Phase 2||508
906157|NCT01709305|2190684|P3|COMPLETED|Phase 2||505
906158|NCT01709305|2190685|P2|COMPLETED|Phase 2||500
906159|NCT01709305|2190686|P1|COMPLETED|Phase 2||0
906160|NCT01709305|2190682|P5|STARTED|Phase 2||554
906161|NCT01709305|2190683|P4|STARTED|Phase 2||556
906162|NCT01709305|2190684|P3|STARTED|Phase 2||550
906163|NCT01709305|2190685|P2|STARTED|Phase 2||552
906164|NCT01709305|2190686|P1|STARTED|Phase 2||0
906165|NCT01709305|2190682|P5|NOT COMPLETED|Phase 1||0
906166|NCT01709305|2190683|P4|NOT COMPLETED|Phase 1||0
906167|NCT01709305|2190684|P3|NOT COMPLETED|Phase 1||0
906168|NCT01709305|2190685|P2|NOT COMPLETED|Phase 1||0
906169|NCT01709305|2190686|P1|NOT COMPLETED|Phase 1||637
906170|NCT01709305|2190682|P5|COMPLETED|Phase 1||0
906171|NCT01709305|2190683|P4|COMPLETED|Phase 1||0
906172|NCT01709305|2190684|P3|COMPLETED|Phase 1||0
906173|NCT01709305|2190685|P2|COMPLETED|Phase 1||0
906174|NCT01709305|2190686|P1|COMPLETED|Phase 1||4933
906175|NCT01709305|2190682|P5|STARTED|Phase 1||0
906176|NCT01709305|2190683|P4|STARTED|Phase 1||0
906177|NCT01709305|2190684|P3|STARTED|Phase 1||0
906178|NCT01709305|2190685|P2|STARTED|Phase 1||0
906179|NCT01709305|2190686|P1|STARTED|Phase 1||5570
906180|NCT01709227|2190723|P2|NOT COMPLETED|Overall Study||9
906181|NCT01709227|2190724|P1|NOT COMPLETED|Overall Study||1
906182|NCT01709227|2190723|P2|COMPLETED|Overall Study||32
906183|NCT01709227|2190724|P1|COMPLETED|Overall Study||31
906184|NCT01709227|2190723|P2|STARTED|Overall Study||41
906185|NCT01709227|2190724|P1|STARTED|Overall Study||32
906186|NCT01709162|2190750|P2|NOT COMPLETED|Overall Study||5
906187|NCT01709162|2190751|P1|NOT COMPLETED|Overall Study||6
906188|NCT01709162|2190750|P2|COMPLETED|Overall Study|Completed treatment as per protocol|0
906189|NCT01709162|2190751|P1|COMPLETED|Overall Study|Completed treatment as per protocol|12
906190|NCT01709162|2190750|P2|Still Receiving Treatment|Overall Study||0
906191|NCT01709162|2190751|P1|Still Receiving Treatment|Overall Study||0
906192|NCT01709162|2190750|P2|Received Treatment|Overall Study||4
906193|NCT01709162|2190751|P1|Received Treatment|Overall Study||18
906194|NCT01709162|2190750|P2|STARTED|Overall Study|Randomized|5
906195|NCT01709162|2190751|P1|STARTED|Overall Study|Randomized|18
906196|NCT01709136|2190763|P1|NOT COMPLETED|Overall Study||0
906197|NCT01709136|2190763|P1|COMPLETED|Overall Study||3
906198|NCT01709136|2190763|P1|STARTED|Overall Study||3
906199|NCT01709084|2190772|P2|NOT COMPLETED|Overall Study||15
906200|NCT01709084|2190773|P1|NOT COMPLETED|Overall Study||16
906201|NCT01709084|2190772|P2|COMPLETED|Overall Study||198
906202|NCT01709084|2190773|P1|COMPLETED|Overall Study||197
906203|NCT01709084|2190772|P2|Treated|Overall Study||211
906204|NCT01709084|2190773|P1|Treated|Overall Study||213
906205|NCT01709084|2190772|P2|STARTED|Overall Study||213
906206|NCT01709084|2190773|P1|STARTED|Overall Study||213
906207|NCT01708967|2190791|P2|NOT COMPLETED|Overall Study||7
906208|NCT01708967|2190792|P1|NOT COMPLETED|Overall Study||0
906209|NCT01708967|2190791|P2|COMPLETED|Overall Study||43
906210|NCT01708967|2190792|P1|COMPLETED|Overall Study||50
906211|NCT01708967|2190791|P2|STARTED|Overall Study||50
906212|NCT01708967|2190792|P1|STARTED|Overall Study||50
906213|NCT01708954|2190801|P3|NOT COMPLETED|Step 2||0
906214|NCT01708954|2190802|P2|NOT COMPLETED|Step 2||7
906215|NCT01708954|2190803|P1|NOT COMPLETED|Step 2||13
906216|NCT01708954|2190801|P3|COMPLETED|Step 2||0
906217|NCT01708954|2190802|P2|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
906218|NCT01708954|2190803|P1|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
906219|NCT01708954|2190801|P3|STARTED|Step 2|Only patients with disease progression on Arms A and B were allowed to register to Step 2.|0
906220|NCT01708954|2190802|P2|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|7
906221|NCT01708954|2190803|P1|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|13
906222|NCT01708954|2190801|P3|NOT COMPLETED|Step 1||43
906223|NCT01708954|2190802|P2|NOT COMPLETED|Step 1||40
906224|NCT01708954|2190803|P1|NOT COMPLETED|Step 1||42
906225|NCT01708954|2190801|P3|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
906226|NCT01708954|2190802|P2|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
906227|NCT01708954|2190803|P1|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
906228|NCT01708954|2190801|P3|Patients With MET Status Data Available|Step 1||24
906229|NCT01708954|2190802|P2|Patients With MET Status Data Available|Step 1||32
906230|NCT01708954|2190803|P1|Patients With MET Status Data Available|Step 1||30
906231|NCT01708954|2190801|P3|Eligible and Treated|Step 1||35
906232|NCT01708954|2190802|P2|Eligible and Treated|Step 1||38
906233|NCT01708954|2190803|P1|Eligible and Treated|Step 1||38
906234|NCT01708954|2190801|P3|Started Protocol Therapy|Step 1||39
906235|NCT01708954|2190802|P2|Started Protocol Therapy|Step 1||40
906236|NCT01708954|2190803|P1|Started Protocol Therapy|Step 1||40
906237|NCT01708954|2190801|P3|STARTED|Step 1||43
906238|NCT01708954|2190802|P2|STARTED|Step 1||40
906239|NCT01708954|2190803|P1|STARTED|Step 1||42
906240|NCT01708915|2190828|P4|NOT COMPLETED|Overall Study||33
906241|NCT01708915|2190829|P3|NOT COMPLETED|Overall Study||46
906242|NCT01708915|2190830|P2|NOT COMPLETED|Overall Study||62
906243|NCT01708915|2190831|P1|NOT COMPLETED|Overall Study||86
906244|NCT01708915|2190828|P4|COMPLETED|Overall Study||169
906245|NCT01708915|2190829|P3|COMPLETED|Overall Study||152
906246|NCT01708915|2190830|P2|COMPLETED|Overall Study||139
906247|NCT01708915|2190831|P1|COMPLETED|Overall Study||118
906248|NCT01708915|2190828|P4|STARTED|Overall Study||202
906249|NCT01708915|2190829|P3|STARTED|Overall Study||198
906250|NCT01708915|2190830|P2|STARTED|Overall Study||201
906251|NCT01708915|2190831|P1|STARTED|Overall Study||204
906252|NCT01708902|2190860|P7|NOT COMPLETED|Overall Study||7
906253|NCT01708902|2190861|P6|NOT COMPLETED|Overall Study||7
906254|NCT01708902|2190862|P5|NOT COMPLETED|Overall Study||16
906255|NCT01708902|2190863|P4|NOT COMPLETED|Overall Study||10
906256|NCT01708902|2190864|P3|NOT COMPLETED|Overall Study||17
906257|NCT01708902|2190865|P2|NOT COMPLETED|Overall Study||8
906258|NCT01708902|2190866|P1|NOT COMPLETED|Overall Study||17
906259|NCT01708902|2190860|P7|COMPLETED|Overall Study||65
906260|NCT01708902|2190861|P6|COMPLETED|Overall Study||64
906261|NCT01708902|2190862|P5|COMPLETED|Overall Study||131
906262|NCT01708902|2190863|P4|COMPLETED|Overall Study||137
906263|NCT01708902|2190864|P3|COMPLETED|Overall Study||127
906264|NCT01708902|2190865|P2|COMPLETED|Overall Study||137
906265|NCT01708902|2190866|P1|COMPLETED|Overall Study||130
906266|NCT01708902|2190860|P7|STARTED|Overall Study||72
906267|NCT01708902|2190861|P6|STARTED|Overall Study||71
906268|NCT01708902|2190862|P5|STARTED|Overall Study||147
906269|NCT01708902|2190863|P4|STARTED|Overall Study||147
906270|NCT01708902|2190864|P3|STARTED|Overall Study||144
906271|NCT01708902|2190865|P2|STARTED|Overall Study||145
906272|NCT01708902|2190866|P1|STARTED|Overall Study||147
906273|NCT01708525|2190925|P1|NOT COMPLETED|Overall Study||0
906274|NCT01708525|2190925|P1|COMPLETED|Overall Study||2
906275|NCT01708525|2190925|P1|STARTED|Overall Study||2
906276|NCT01708317|2190930|P1|NOT COMPLETED|Final Education Period||0
906277|NCT01708317|2190930|P1|COMPLETED|Final Education Period||909
906278|NCT01708317|2190930|P1|STARTED|Final Education Period|# of ED patients eligible for ACASI, had it been available, in final education period|909
906279|NCT01708317|2190930|P1|NOT COMPLETED|ACASI + Education Period||0
906280|NCT01708317|2190930|P1|COMPLETED|ACASI + Education Period||2601
906281|NCT01708317|2190930|P1|STARTED|ACASI + Education Period|# of ED patients eligible for ACASI in the period the ACASI was actually available.|2601
906282|NCT01708317|2190930|P1|NOT COMPLETED|Initial Education Period||0
906283|NCT01708317|2190930|P1|COMPLETED|Initial Education Period||982
906284|NCT01708317|2190930|P1|STARTED|Initial Education Period|# of ED patients eligible for ACASI, had it been available, in initial education period|982
906285|NCT01708317|2190930|P1|NOT COMPLETED|2010 Control Period||0
906286|NCT01708317|2190930|P1|COMPLETED|2010 Control Period||3929
906287|NCT01708317|2190930|P1|STARTED|2010 Control Period|# of ED patients eligible for ACASI, had it been available, in control period|3929
906288|NCT01708291|2190939|P2|NOT COMPLETED|Overall Study||1
906289|NCT01708291|2190940|P1|NOT COMPLETED|Overall Study||2
906290|NCT01708291|2190939|P2|COMPLETED|Overall Study||20
906291|NCT01708291|2190940|P1|COMPLETED|Overall Study||19
906292|NCT01708291|2190939|P2|STARTED|Overall Study||21
906293|NCT01708291|2190940|P1|STARTED|Overall Study||21
906294|NCT01708278|2190952|P6|NOT COMPLETED|Overall Study||0
906295|NCT01708278|2190953|P5|NOT COMPLETED|Overall Study||0
906296|NCT01708278|2190954|P4|NOT COMPLETED|Overall Study||0
906297|NCT01708278|2190955|P3|NOT COMPLETED|Overall Study||0
906298|NCT01708278|2190956|P2|NOT COMPLETED|Overall Study||0
906299|NCT01708278|2190957|P1|NOT COMPLETED|Overall Study||0
906300|NCT01708278|2190952|P6|COMPLETED|Overall Study||1
906301|NCT01708278|2190953|P5|COMPLETED|Overall Study||1
906302|NCT01708278|2190954|P4|COMPLETED|Overall Study||2
906303|NCT01708278|2190955|P3|COMPLETED|Overall Study||2
906304|NCT01708278|2190956|P2|COMPLETED|Overall Study||2
906305|NCT01708278|2190957|P1|COMPLETED|Overall Study||1
906306|NCT01708278|2190952|P6|STARTED|Overall Study||1
906307|NCT01708278|2190953|P5|STARTED|Overall Study||1
906308|NCT01708278|2190954|P4|STARTED|Overall Study||2
906309|NCT01708278|2190955|P3|STARTED|Overall Study||2
906310|NCT01708278|2190956|P2|STARTED|Overall Study||2
906311|NCT01708278|2190957|P1|STARTED|Overall Study||1
906312|NCT01708213|2190971|P1|NOT COMPLETED|Overall Study||1
906313|NCT01708213|2190971|P1|COMPLETED|Overall Study||71
906314|NCT01708213|2190971|P1|STARTED|Overall Study||72
906315|NCT01708187|2190979|P2|NOT COMPLETED|Overall Study||1
906316|NCT01708187|2190980|P1|NOT COMPLETED|Overall Study||0
906317|NCT01708187|2190979|P2|COMPLETED|Overall Study||0
906318|NCT01708187|2190980|P1|COMPLETED|Overall Study||1
906319|NCT01708187|2190979|P2|STARTED|Overall Study||1
906320|NCT01708187|2190980|P1|STARTED|Overall Study||1
906321|NCT01708174|2190989|P3|NOT COMPLETED|Survival Follow-up||0
906322|NCT01708174|2190990|P2|NOT COMPLETED|Survival Follow-up||0
906323|NCT01708174|2190991|P1|NOT COMPLETED|Survival Follow-up||0
906324|NCT01708174|2190989|P3|COMPLETED|Survival Follow-up||0
906325|NCT01708174|2190990|P2|COMPLETED|Survival Follow-up||10
906326|NCT01708174|2190991|P1|COMPLETED|Survival Follow-up||1
906327|NCT01708174|2190989|P3|STARTED|Survival Follow-up||0
906328|NCT01708174|2190990|P2|STARTED|Survival Follow-up||10
906329|NCT01708174|2190991|P1|STARTED|Survival Follow-up||1
906330|NCT01708174|2190989|P3|NOT COMPLETED|Treatment Period||1
906331|NCT01708174|2190990|P2|NOT COMPLETED|Treatment Period||2
906332|NCT01708174|2190991|P1|NOT COMPLETED|Treatment Period||1
906333|NCT01708174|2190989|P3|COMPLETED|Treatment Period||3
906334|NCT01708174|2190990|P2|COMPLETED|Treatment Period||14
906335|NCT01708174|2190991|P1|COMPLETED|Treatment Period||1
906336|NCT01708174|2190989|P3|Pharmacokinetic Analysis Set|Treatment Period||0
906337|NCT01708174|2190990|P2|Pharmacokinetic Analysis Set|Treatment Period||13
906338|NCT01708174|2190991|P1|Pharmacokinetic Analysis Set|Treatment Period||2
906339|NCT01708174|2190989|P3|STARTED|Treatment Period||4
906340|NCT01708174|2190990|P2|STARTED|Treatment Period||16
906341|NCT01708174|2190991|P1|STARTED|Treatment Period||2
906342|NCT01708122|2191019|P2|NOT COMPLETED|Overall Study||0
906343|NCT01708122|2191020|P1|NOT COMPLETED|Overall Study||0
906344|NCT01708122|2191019|P2|COMPLETED|Overall Study||26
906345|NCT01708122|2191020|P1|COMPLETED|Overall Study||27
906346|NCT01708122|2191019|P2|STARTED|Overall Study||26
906347|NCT01708122|2191020|P1|STARTED|Overall Study||27
906348|NCT01708057|2191028|P3|NOT COMPLETED|Overall Study||1
906349|NCT01708057|2191029|P2|NOT COMPLETED|Overall Study||1
906350|NCT01708057|2191030|P1|NOT COMPLETED|Overall Study||1
906351|NCT01708057|2191028|P3|COMPLETED|Overall Study||0
906352|NCT01708057|2191029|P2|COMPLETED|Overall Study||0
906353|NCT01708057|2191030|P1|COMPLETED|Overall Study||0
906354|NCT01708057|2191028|P3|STARTED|Overall Study||1
906355|NCT01708057|2191029|P2|STARTED|Overall Study||1
906356|NCT01708057|2191030|P1|STARTED|Overall Study||1
906357|NCT01707667|2191088|P2|NOT COMPLETED|Period 2||0
906358|NCT01707667|2191089|P1|NOT COMPLETED|Period 2||0
906359|NCT01707667|2191088|P2|COMPLETED|Period 2||6
906360|NCT01707667|2191089|P1|COMPLETED|Period 2||6
906361|NCT01707667|2191088|P2|STARTED|Period 2||6
906362|NCT01707667|2191089|P1|STARTED|Period 2||6
906363|NCT01707667|2191088|P2|NOT COMPLETED|Period 1||0
906364|NCT01707667|2191089|P1|NOT COMPLETED|Period 1||1
906365|NCT01707667|2191088|P2|COMPLETED|Period 1||6
906366|NCT01707667|2191089|P1|COMPLETED|Period 1||6
906367|NCT01707667|2191088|P2|STARTED|Period 1||6
906368|NCT01707667|2191089|P1|STARTED|Period 1||7
906369|NCT01707654|2191107|P1|NOT COMPLETED|Overall Study||0
906370|NCT01707654|2191107|P1|COMPLETED|Overall Study||9
906371|NCT01707654|2191107|P1|STARTED|Overall Study||9
906372|NCT01707290|2191113|P2|NOT COMPLETED|Overall Study||1
906373|NCT01707290|2191114|P1|NOT COMPLETED|Overall Study||86
906374|NCT01707290|2191113|P2|COMPLETED|Overall Study||3
906375|NCT01707290|2191114|P1|COMPLETED|Overall Study||35
906376|NCT01707290|2191113|P2|STARTED|Overall Study||4
906377|NCT01707290|2191114|P1|STARTED|Overall Study||121
906378|NCT01707238|2191137|P2|NOT COMPLETED|Overall Study||0
906379|NCT01707238|2191138|P1|NOT COMPLETED|Overall Study||0
906380|NCT01707238|2191137|P2|COMPLETED|Overall Study||52
906381|NCT01707238|2191138|P1|COMPLETED|Overall Study||48
906382|NCT01707238|2191137|P2|STARTED|Overall Study||52
906383|NCT01707238|2191138|P1|STARTED|Overall Study||48
906384|NCT01707225|2191154|P1|NOT COMPLETED|Overall Study||0
906385|NCT01707225|2191154|P1|COMPLETED|Overall Study||10
906386|NCT01707225|2191154|P1|STARTED|Overall Study||10
906387|NCT01707095|2191161|P2|NOT COMPLETED|Overall Study||0
906388|NCT01707095|2191162|P1|NOT COMPLETED|Overall Study||0
906389|NCT01707095|2191161|P2|COMPLETED|Overall Study||42
906390|NCT01707095|2191162|P1|COMPLETED|Overall Study||42
906391|NCT01707095|2191161|P2|STARTED|Overall Study||42
906392|NCT01707095|2191162|P1|STARTED|Overall Study||42
906393|NCT01707043|2191172|P2|NOT COMPLETED|Overall Study||0
906394|NCT01707043|2191173|P1|NOT COMPLETED|Overall Study||0
906395|NCT01707043|2191172|P2|COMPLETED|Overall Study||10
906396|NCT01707043|2191173|P1|COMPLETED|Overall Study||10
906397|NCT01707043|2191172|P2|STARTED|Overall Study||10
906398|NCT01707043|2191173|P1|STARTED|Overall Study||10
906399|NCT01706965|2191183|P2|NOT COMPLETED|Overall Study||1
906400|NCT01706965|2191184|P1|NOT COMPLETED|Overall Study||1
906401|NCT01706965|2191183|P2|COMPLETED|Overall Study||12
906402|NCT01706965|2191184|P1|COMPLETED|Overall Study||13
906403|NCT01706965|2191183|P2|STARTED|Overall Study||13
906404|NCT01706965|2191184|P1|STARTED|Overall Study||14
906405|NCT01706952|2191192|P1|NOT COMPLETED|Overall Study||8
906406|NCT01706952|2191192|P1|COMPLETED|Overall Study||37
906407|NCT01706952|2191192|P1|STARTED|Overall Study||45
906408|NCT01706926|2191208|P4|NOT COMPLETED|Overall Study||5
906409|NCT01706926|2191209|P3|NOT COMPLETED|Overall Study||6
906410|NCT01706926|2191210|P2|NOT COMPLETED|Overall Study||4
906411|NCT01706926|2191211|P1|NOT COMPLETED|Overall Study||6
906412|NCT01706926|2191208|P4|COMPLETED|Overall Study||74
906413|NCT01706926|2191209|P3|COMPLETED|Overall Study||79
906414|NCT01706926|2191210|P2|COMPLETED|Overall Study||77
906415|NCT01706926|2191211|P1|COMPLETED|Overall Study||75
906416|NCT01706926|2191208|P4|STARTED|Overall Study||79
906417|NCT01706926|2191209|P3|STARTED|Overall Study||85
906418|NCT01706926|2191210|P2|STARTED|Overall Study||81
906419|NCT01706926|2191211|P1|STARTED|Overall Study||81
906420|NCT01706822|2191320|P1|NOT COMPLETED|Overall Study||0
906421|NCT01706822|2191320|P1|COMPLETED|Overall Study||8
906422|NCT01706822|2191320|P1|STARTED|Overall Study||8
906423|NCT01706770|2191330|P2|NOT COMPLETED|Overall Study||0
906424|NCT01706770|2191331|P1|NOT COMPLETED|Overall Study||2
906425|NCT01706770|2191330|P2|COMPLETED|Overall Study||17
906426|NCT01706770|2191331|P1|COMPLETED|Overall Study||31
906427|NCT01706770|2191330|P2|STARTED|Overall Study||17
906428|NCT01706770|2191331|P1|STARTED|Overall Study||33
906429|NCT01706666|2191342|P3|NOT COMPLETED|Overall Study||0
906430|NCT01706666|2191343|P2|NOT COMPLETED|Overall Study||0
906431|NCT01706666|2191344|P1|NOT COMPLETED|Overall Study||0
906432|NCT01706666|2191342|P3|COMPLETED|Overall Study||1
906433|NCT01706666|2191343|P2|COMPLETED|Overall Study||1
906434|NCT01706666|2191344|P1|COMPLETED|Overall Study||1
906435|NCT01706666|2191342|P3|STARTED|Overall Study||1
906436|NCT01706666|2191343|P2|STARTED|Overall Study||1
906437|NCT01706666|2191344|P1|STARTED|Overall Study||1
906438|NCT01706588|2191363|P5|NOT COMPLETED|Overall Study||0
906439|NCT01706588|2191364|P4|NOT COMPLETED|Overall Study||0
906440|NCT01706588|2191365|P3|NOT COMPLETED|Overall Study||0
906441|NCT01706588|2191366|P2|NOT COMPLETED|Overall Study||0
906442|NCT01706588|2191367|P1|NOT COMPLETED|Overall Study||0
906443|NCT01706588|2191363|P5|COMPLETED|Overall Study||16
906444|NCT01706588|2191364|P4|COMPLETED|Overall Study||14
906445|NCT01706588|2191365|P3|COMPLETED|Overall Study||15
906446|NCT01706588|2191366|P2|COMPLETED|Overall Study||15
906447|NCT01706588|2191367|P1|COMPLETED|Overall Study||15
906448|NCT01706588|2191363|P5|STARTED|Overall Study||16
906449|NCT01706588|2191364|P4|STARTED|Overall Study||14
906450|NCT01706588|2191365|P3|STARTED|Overall Study||15
906451|NCT01706588|2191366|P2|STARTED|Overall Study||15
906452|NCT01706588|2191367|P1|STARTED|Overall Study||15
906453|NCT01706575|2191379|P1|NOT COMPLETED|Overall Study||12
906454|NCT01706575|2191379|P1|COMPLETED|Overall Study||64
906455|NCT01706575|2191379|P1|Treated|Overall Study||70
906456|NCT01706575|2191379|P1|STARTED|Overall Study||76
906457|NCT01706549|2191390|P1|NOT COMPLETED|Overall Study||0
906458|NCT01706549|2191390|P1|COMPLETED|Overall Study||16
906459|NCT01706549|2191390|P1|STARTED|Overall Study||16
906460|NCT01706328|2191397|P3|NOT COMPLETED|12-week Double-blind Treatment Period||45
906461|NCT01706328|2191398|P2|NOT COMPLETED|12-week Double-blind Treatment Period||46
906462|NCT01706328|2191399|P1|NOT COMPLETED|12-week Double-blind Treatment Period||0
906463|NCT01706328|2191397|P3|COMPLETED|12-week Double-blind Treatment Period||371
906464|NCT01706328|2191398|P2|COMPLETED|12-week Double-blind Treatment Period||366
906465|NCT01706328|2191399|P1|COMPLETED|12-week Double-blind Treatment Period||0
906466|NCT01706328|2191397|P3|STARTED|12-week Double-blind Treatment Period||416
906467|NCT01706328|2191398|P2|STARTED|12-week Double-blind Treatment Period||412
906468|NCT01706328|2191399|P1|STARTED|12-week Double-blind Treatment Period||0
906469|NCT01706328|2191397|P3|NOT COMPLETED|2-week Run-in Period||0
906470|NCT01706328|2191398|P2|NOT COMPLETED|2-week Run-in Period||0
906471|NCT01706328|2191399|P1|NOT COMPLETED|2-week Run-in Period||165
906472|NCT01706328|2191397|P3|COMPLETED|2-week Run-in Period||0
906473|NCT01706328|2191398|P2|COMPLETED|2-week Run-in Period||0
906474|NCT01706328|2191399|P1|COMPLETED|2-week Run-in Period||828
906475|NCT01706328|2191397|P3|STARTED|2-week Run-in Period||0
906476|NCT01706328|2191398|P2|STARTED|2-week Run-in Period||0
906477|NCT01706328|2191399|P1|STARTED|2-week Run-in Period||993
906478|NCT01706250|2191409|P1|NOT COMPLETED|Overall Study||2
906479|NCT01706250|2191409|P1|COMPLETED|Overall Study||18
906480|NCT01706250|2191409|P1|STARTED|Overall Study||20
906481|NCT01706159|2191440|P2|NOT COMPLETED|Overall Study||2
906482|NCT01706159|2191441|P1|NOT COMPLETED|Overall Study||8
906483|NCT01706159|2191440|P2|COMPLETED|Overall Study||4
906484|NCT01706159|2191441|P1|COMPLETED|Overall Study||6
906485|NCT01706159|2191440|P2|Completers (With Baron Score at Week 8)|Overall Study||3
906486|NCT01706159|2191441|P1|Completers (With Baron Score at Week 8)|Overall Study||6
906487|NCT01706159|2191440|P2|Exposed|Overall Study|One subject was not exposed to placebo.|5
906488|NCT01706159|2191441|P1|Exposed|Overall Study|One subject was not exposed to rFXIII.|13
906489|NCT01706159|2191440|P2|STARTED|Overall Study||6
906490|NCT01706159|2191441|P1|STARTED|Overall Study||14
906491|NCT01706146|2191455|P1|NOT COMPLETED|Overall Study||6
906492|NCT01706146|2191455|P1|COMPLETED|Overall Study|1 pt developed permanent AF; 1 pt needed dual antiplatelet therapy; 3 possible TIA; 1 withdraw|53
906493|NCT01706146|2191455|P1|STARTED|Overall Study||59
906494|NCT01705717|2191462|P2|NOT COMPLETED|Overall Study||5
906495|NCT01705717|2191463|P1|NOT COMPLETED|Overall Study||2
906496|NCT01705717|2191462|P2|COMPLETED|Overall Study||7
906497|NCT01705717|2191463|P1|COMPLETED|Overall Study||35
906498|NCT01705717|2191462|P2|STARTED|Overall Study||12
906499|NCT01705717|2191463|P1|STARTED|Overall Study||37
906500|NCT01705652|2191480|P2|NOT COMPLETED|Overall Study||3
906501|NCT01705652|2191481|P1|NOT COMPLETED|Overall Study||3
906502|NCT01705652|2191480|P2|COMPLETED|Overall Study||9
906503|NCT01705652|2191481|P1|COMPLETED|Overall Study||6
906504|NCT01705652|2191480|P2|STARTED|Overall Study||12
906505|NCT01705652|2191481|P1|STARTED|Overall Study||9
906506|NCT01705574|2191489|P2|NOT COMPLETED|Overall Study||163
906507|NCT01705574|2191490|P1|NOT COMPLETED|Overall Study||167
906508|NCT01705574|2191489|P2|COMPLETED|Overall Study||127
906509|NCT01705574|2191490|P1|COMPLETED|Overall Study||126
906510|NCT01705574|2191489|P2|STARTED|Overall Study||290
906511|NCT01705574|2191490|P1|STARTED|Overall Study||293
906512|NCT01705496|2191498|P1|NOT COMPLETED|Overall Study||4
906513|NCT01705496|2191498|P1|COMPLETED|Overall Study||19
906514|NCT01705496|2191498|P1|STARTED|Overall Study||23
906515|NCT01705145|2191508|P1|NOT COMPLETED|Part B||1
906516|NCT01705145|2191508|P1|COMPLETED|Part B||33
906517|NCT01705145|2191508|P1|STARTED|Part B|Eight participants from Part A continued in Part B of the study.|34
906518|NCT01705145|2191508|P1|NOT COMPLETED|Part A||0
906519|NCT01705145|2191508|P1|COMPLETED|Part A||9
906520|NCT01705145|2191508|P1|STARTED|Part A||9
906521|NCT01704976|2191538|P2|NOT COMPLETED|Overall Study||2
906522|NCT01704976|2191539|P1|NOT COMPLETED|Overall Study||1
906523|NCT01704976|2191538|P2|COMPLETED|Overall Study|2 participants completed < 11 SR-WBV sessions, they were excluded from statistical analysis|11
906524|NCT01704976|2191539|P1|COMPLETED|Overall Study|One participant completed < 11 SR-WBV sessions and was excluded from the statistical analysis|13
906525|NCT01704976|2191538|P2|STARTED|Overall Study||13
906526|NCT01704976|2191539|P1|STARTED|Overall Study||14
906527|NCT01704846|2191555|P2|NOT COMPLETED|Treatment Period 4||0
906528|NCT01704846|2191556|P1|NOT COMPLETED|Treatment Period 4||0
906529|NCT01704846|2191555|P2|COMPLETED|Treatment Period 4||29
906530|NCT01704846|2191556|P1|COMPLETED|Treatment Period 4||30
906531|NCT01704846|2191555|P2|STARTED|Treatment Period 4||29
906532|NCT01704846|2191556|P1|STARTED|Treatment Period 4||30
906533|NCT01704846|2191555|P2|NOT COMPLETED|Treatment Period 3||0
906534|NCT01704846|2191556|P1|NOT COMPLETED|Treatment Period 3||0
906535|NCT01704846|2191555|P2|COMPLETED|Treatment Period 3||29
906536|NCT01704846|2191556|P1|COMPLETED|Treatment Period 3||30
906537|NCT01704846|2191555|P2|STARTED|Treatment Period 3||29
906538|NCT01704846|2191556|P1|STARTED|Treatment Period 3||30
906539|NCT01704846|2191555|P2|NOT COMPLETED|Treatment Period 2||1
906540|NCT01704846|2191556|P1|NOT COMPLETED|Treatment Period 2||0
906541|NCT01704846|2191555|P2|COMPLETED|Treatment Period 2||29
906542|NCT01704846|2191556|P1|COMPLETED|Treatment Period 2||30
906543|NCT01704846|2191555|P2|STARTED|Treatment Period 2||30
906544|NCT01704846|2191556|P1|STARTED|Treatment Period 2||30
906545|NCT01704846|2191555|P2|NOT COMPLETED|Treatment Period 1||0
906546|NCT01704846|2191556|P1|NOT COMPLETED|Treatment Period 1||0
906547|NCT01704846|2191555|P2|COMPLETED|Treatment Period 1||30
906548|NCT01704846|2191556|P1|COMPLETED|Treatment Period 1||30
906549|NCT01704846|2191555|P2|STARTED|Treatment Period 1||30
906550|NCT01704846|2191556|P1|STARTED|Treatment Period 1||30
906551|NCT01704781|2191579|P5|NOT COMPLETED|Overall Study||0
906552|NCT01704781|2191580|P4|NOT COMPLETED|Overall Study||0
906553|NCT01704781|2191581|P3|NOT COMPLETED|Overall Study||0
906554|NCT01704781|2191582|P2|NOT COMPLETED|Overall Study||0
906555|NCT01704781|2191583|P1|NOT COMPLETED|Overall Study||0
906556|NCT01704781|2191579|P5|COMPLETED|Overall Study||12
906557|NCT01704781|2191580|P4|COMPLETED|Overall Study||12
906558|NCT01704781|2191581|P3|COMPLETED|Overall Study||6
906559|NCT01704781|2191582|P2|COMPLETED|Overall Study||3
906560|NCT01704781|2191583|P1|COMPLETED|Overall Study||3
906561|NCT01704781|2191579|P5|STARTED|Overall Study||12
906562|NCT01704781|2191580|P4|STARTED|Overall Study||12
906563|NCT01704781|2191581|P3|STARTED|Overall Study||6
906564|NCT01704781|2191582|P2|STARTED|Overall Study||3
906565|NCT01704781|2191583|P1|STARTED|Overall Study||3
906566|NCT01704755|2191611|P2|NOT COMPLETED|Overall Study||7
906567|NCT01704755|2191612|P1|NOT COMPLETED|Overall Study||12
906568|NCT01704755|2191611|P2|COMPLETED|Overall Study||165
906569|NCT01704755|2191612|P1|COMPLETED|Overall Study||196
906570|NCT01704755|2191611|P2|Completed Study Drug|Overall Study||163
906571|NCT01704755|2191612|P1|Completed Study Drug|Overall Study||204
906572|NCT01704755|2191611|P2|STARTED|Overall Study||172
906573|NCT01704755|2191612|P1|STARTED|Overall Study||208
906574|NCT01704651|2191626|P2|NOT COMPLETED|Overall Study||7
906575|NCT01704651|2191627|P1|NOT COMPLETED|Overall Study||5
906576|NCT01704651|2191626|P2|COMPLETED|Overall Study||68
906577|NCT01704651|2191627|P1|COMPLETED|Overall Study||66
906578|NCT01704651|2191626|P2|STARTED|Overall Study||75
906579|NCT01704651|2191627|P1|STARTED|Overall Study||71
906580|NCT01704599|2191635|P1|NOT COMPLETED|Overall Study||1
906581|NCT01704599|2191635|P1|COMPLETED|Overall Study|11 screened 8 entered study 1 terminated.|7
906582|NCT01704599|2191635|P1|STARTED|Overall Study|Study was started January 22, 2010|8
906583|NCT01704521|2191664|P2|NOT COMPLETED|Overall Study||0
906584|NCT01704521|2191665|P1|NOT COMPLETED|Overall Study||0
906585|NCT01704521|2191664|P2|COMPLETED|Overall Study||2
906586|NCT01704521|2191665|P1|COMPLETED|Overall Study||3
906587|NCT01704521|2191664|P2|STARTED|Overall Study||2
906588|NCT01704521|2191665|P1|STARTED|Overall Study||3
906589|NCT01704495|2191675|P4|NOT COMPLETED|Optional Safety Extension||31
906590|NCT01704495|2191676|P3|NOT COMPLETED|Optional Safety Extension||31
906591|NCT01704495|2191677|P2|NOT COMPLETED|Optional Safety Extension||33
906592|NCT01704495|2191678|P1|NOT COMPLETED|Optional Safety Extension||29
906593|NCT01704495|2191675|P4|COMPLETED|Optional Safety Extension||85
906594|NCT01704495|2191676|P3|COMPLETED|Optional Safety Extension||83
906595|NCT01704495|2191677|P2|COMPLETED|Optional Safety Extension||88
906596|NCT01704495|2191678|P1|COMPLETED|Optional Safety Extension||87
906597|NCT01704495|2191675|P4|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
906598|NCT01704495|2191676|P3|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|114
906599|NCT01704495|2191677|P2|STARTED|Optional Safety Extension|35 subjects did not enter safety extension|121
906600|NCT01704495|2191678|P1|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
906601|NCT01704495|2191675|P4|NOT COMPLETED|Subjects Randomized||17
906602|NCT01704495|2191676|P3|NOT COMPLETED|Subjects Randomized||16
906603|NCT01704495|2191677|P2|NOT COMPLETED|Subjects Randomized||15
906604|NCT01704495|2191678|P1|NOT COMPLETED|Subjects Randomized||22
906605|NCT01704495|2191675|P4|COMPLETED|Subjects Randomized||145
906606|NCT01704495|2191676|P3|COMPLETED|Subjects Randomized||144
906607|NCT01704495|2191677|P2|COMPLETED|Subjects Randomized||141
906608|NCT01704495|2191678|P1|COMPLETED|Subjects Randomized||140
906609|NCT01704495|2191675|P4|STARTED|Subjects Randomized||162
906610|NCT01704495|2191676|P3|STARTED|Subjects Randomized||160
906611|NCT01704495|2191677|P2|STARTED|Subjects Randomized||156
906612|NCT01704495|2191678|P1|STARTED|Subjects Randomized||162
906613|NCT01704404|2191852|P6|NOT COMPLETED|Overall Study||0
906614|NCT01704404|2191853|P5|NOT COMPLETED|Overall Study||1
906615|NCT01704404|2191854|P4|NOT COMPLETED|Overall Study||3
906616|NCT01704404|2191855|P3|NOT COMPLETED|Overall Study||1
906617|NCT01704404|2191856|P2|NOT COMPLETED|Overall Study||1
906618|NCT01704404|2191857|P1|NOT COMPLETED|Overall Study||1
906619|NCT01704404|2191852|P6|COMPLETED|Overall Study||9
906620|NCT01704404|2191853|P5|COMPLETED|Overall Study||10
906621|NCT01704404|2191854|P4|COMPLETED|Overall Study||8
906622|NCT01704404|2191855|P3|COMPLETED|Overall Study||9
906623|NCT01704404|2191856|P2|COMPLETED|Overall Study||9
906624|NCT01704404|2191857|P1|COMPLETED|Overall Study||10
906625|NCT01704404|2191852|P6|STARTED|Overall Study||9
906626|NCT01704404|2191853|P5|STARTED|Overall Study||11
906627|NCT01704404|2191854|P4|STARTED|Overall Study||11
906628|NCT01704404|2191855|P3|STARTED|Overall Study||10
906629|NCT01704404|2191856|P2|STARTED|Overall Study||10
906630|NCT01704404|2191857|P1|STARTED|Overall Study||11
906631|NCT01704287|2191894|P5|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||45
906632|NCT01704287|2191895|P4|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||53
906633|NCT01704287|2191896|P3|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
906634|NCT01704287|2191897|P2|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
906635|NCT01704287|2191898|P1|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
906636|NCT01704287|2191894|P5|COMPLETED|Switch to Pembrolizumab Treatment Period||0
906637|NCT01704287|2191895|P4|COMPLETED|Switch to Pembrolizumab Treatment Period||0
906638|NCT01704287|2191896|P3|COMPLETED|Switch to Pembrolizumab Treatment Period||0
906639|NCT01704287|2191897|P2|COMPLETED|Switch to Pembrolizumab Treatment Period||0
906640|NCT01704287|2191898|P1|COMPLETED|Switch to Pembrolizumab Treatment Period||0
906641|NCT01704287|2191894|P5|STARTED|Switch to Pembrolizumab Treatment Period||45
906642|NCT01704287|2191895|P4|STARTED|Switch to Pembrolizumab Treatment Period||53
906643|NCT01704287|2191896|P3|STARTED|Switch to Pembrolizumab Treatment Period||0
906644|NCT01704287|2191897|P2|STARTED|Switch to Pembrolizumab Treatment Period||0
906645|NCT01704287|2191898|P1|STARTED|Switch to Pembrolizumab Treatment Period||0
906646|NCT01704287|2191894|P5|NOT COMPLETED|Initial Treatment Period||0
906647|NCT01704287|2191895|P4|NOT COMPLETED|Initial Treatment Period||0
906648|NCT01704287|2191896|P3|NOT COMPLETED|Initial Treatment Period||179
906649|NCT01704287|2191897|P2|NOT COMPLETED|Initial Treatment Period||181
906650|NCT01704287|2191898|P1|NOT COMPLETED|Initial Treatment Period||180
906651|NCT01704287|2191894|P5|COMPLETED|Initial Treatment Period||0
906652|NCT01704287|2191895|P4|COMPLETED|Initial Treatment Period||0
906653|NCT01704287|2191896|P3|COMPLETED|Initial Treatment Period||0
906654|NCT01704287|2191897|P2|COMPLETED|Initial Treatment Period||0
906655|NCT01704287|2191898|P1|COMPLETED|Initial Treatment Period||0
906656|NCT01704287|2191894|P5|Treated|Initial Treatment Period||0
906657|NCT01704287|2191895|P4|Treated|Initial Treatment Period||0
906658|NCT01704287|2191896|P3|Treated|Initial Treatment Period||171
906659|NCT01704287|2191897|P2|Treated|Initial Treatment Period||179
906660|NCT01704287|2191898|P1|Treated|Initial Treatment Period||178
906661|NCT01704287|2191894|P5|STARTED|Initial Treatment Period||0
906662|NCT01704287|2191895|P4|STARTED|Initial Treatment Period||0
906663|NCT01704287|2191896|P3|STARTED|Initial Treatment Period||179
906664|NCT01704287|2191897|P2|STARTED|Initial Treatment Period||181
906665|NCT01704287|2191898|P1|STARTED|Initial Treatment Period||180
906666|NCT01704261|2191933|P2|NOT COMPLETED|Overall Study||15
906667|NCT01704261|2191934|P1|NOT COMPLETED|Overall Study||13
906668|NCT01704261|2191933|P2|COMPLETED|Overall Study||138
906669|NCT01704261|2191934|P1|COMPLETED|Overall Study||141
906670|NCT01704261|2191933|P2|STARTED|Overall Study||153
906671|NCT01704261|2191934|P1|STARTED|Overall Study||154
906672|NCT01704196|2191950|P2|NOT COMPLETED|Overall Study||24
906673|NCT01704196|2191951|P1|NOT COMPLETED|Overall Study||19
906674|NCT01704196|2191950|P2|COMPLETED|Overall Study||65
906675|NCT01704196|2191951|P1|COMPLETED|Overall Study||71
906676|NCT01704196|2191950|P2|STARTED|Overall Study||89
906677|NCT01704196|2191951|P1|STARTED|Overall Study||90
906678|NCT01704079|2191961|P2|NOT COMPLETED|Overall Study||23
906679|NCT01704079|2191962|P1|NOT COMPLETED|Overall Study||14
906680|NCT01704079|2191961|P2|COMPLETED|Overall Study||121
906681|NCT01704079|2191962|P1|COMPLETED|Overall Study||58
906682|NCT01704079|2191961|P2|Entered Extension Study|Overall Study||102
906683|NCT01704079|2191962|P1|Entered Extension Study|Overall Study||53
906684|NCT01704079|2191961|P2|STARTED|Overall Study||144
906685|NCT01704079|2191962|P1|STARTED|Overall Study||72
906686|NCT01703988|2191978|P4|NOT COMPLETED|Overall Study||1
906687|NCT01703988|2191979|P3|NOT COMPLETED|Overall Study||0
906688|NCT01703988|2191980|P2|NOT COMPLETED|Overall Study||0
906689|NCT01703988|2191981|P1|NOT COMPLETED|Overall Study||0
906690|NCT01703988|2191978|P4|COMPLETED|Overall Study||8
906691|NCT01703988|2191979|P3|COMPLETED|Overall Study||9
906692|NCT01703988|2191980|P2|COMPLETED|Overall Study||8
906693|NCT01703988|2191981|P1|COMPLETED|Overall Study||8
906694|NCT01703988|2191978|P4|STARTED|Overall Study||9
906695|NCT01703988|2191979|P3|STARTED|Overall Study||9
906696|NCT01703988|2191980|P2|STARTED|Overall Study||8
906697|NCT01703988|2191981|P1|STARTED|Overall Study||8
906698|NCT01703858|2192011|P3|NOT COMPLETED|Overall Study||0
906699|NCT01703858|2192012|P2|NOT COMPLETED|Overall Study||1
906700|NCT01703858|2192013|P1|NOT COMPLETED|Overall Study||0
906701|NCT01703858|2192011|P3|COMPLETED|Overall Study||5
906702|NCT01703858|2192012|P2|COMPLETED|Overall Study||4
906703|NCT01703858|2192013|P1|COMPLETED|Overall Study||5
906704|NCT01703858|2192011|P3|STARTED|Overall Study||5
906705|NCT01703858|2192012|P2|STARTED|Overall Study||5
906706|NCT01703858|2192013|P1|STARTED|Overall Study||5
906707|NCT01703845|2192038|P2|NOT COMPLETED|Overall Study||0
906708|NCT01703845|2192039|P1|NOT COMPLETED|Overall Study||3
906709|NCT01703845|2192038|P2|COMPLETED|Overall Study||16
906710|NCT01703845|2192039|P1|COMPLETED|Overall Study||13
906711|NCT01703845|2192038|P2|STARTED|Overall Study|started are actually the randomized|16
906712|NCT01703845|2192039|P1|STARTED|Overall Study|started are actually the randomized|16
906713|NCT01703832|2192076|P2|NOT COMPLETED|Overall Study||0
906714|NCT01703832|2192077|P1|NOT COMPLETED|Overall Study||1
906715|NCT01703832|2192076|P2|COMPLETED|Overall Study||32
906716|NCT01703832|2192077|P1|COMPLETED|Overall Study||32
906717|NCT01703832|2192076|P2|STARTED|Overall Study||32
906718|NCT01703832|2192077|P1|STARTED|Overall Study||33
906719|NCT01703819|2192109|P2|NOT COMPLETED|Overall Study||2
906720|NCT01703819|2192110|P1|NOT COMPLETED|Overall Study||0
906721|NCT01703819|2192109|P2|COMPLETED|Overall Study||30
906722|NCT01703819|2192110|P1|COMPLETED|Overall Study||34
906723|NCT01703819|2192109|P2|STARTED|Overall Study||32
906724|NCT01703819|2192110|P1|STARTED|Overall Study||34
906725|NCT01703741|2192140|P1|NOT COMPLETED|Overall Study||18
906726|NCT01703741|2192140|P1|COMPLETED|Overall Study||127
906727|NCT01703741|2192140|P1|Per Protocol (PP) Population|Overall Study|Subjects having 24 hr pharmacokinetic (PK) data for testosterone, with no major protocol violations.|106
906728|NCT01703741|2192140|P1|STARTED|Overall Study||145
906729|NCT01703702|2192158|P2|NOT COMPLETED|Overall Study||22
906730|NCT01703702|2192159|P1|NOT COMPLETED|Overall Study||36
906731|NCT01703702|2192158|P2|COMPLETED|Overall Study||288
906732|NCT01703702|2192159|P1|COMPLETED|Overall Study||272
906733|NCT01703702|2192158|P2|STARTED|Overall Study||310
906734|NCT01703702|2192159|P1|STARTED|Overall Study||308
906735|NCT01703663|2192176|P2|NOT COMPLETED|Second Treatment Period||0
906736|NCT01703663|2192177|P1|NOT COMPLETED|Second Treatment Period||0
906737|NCT01703663|2192176|P2|COMPLETED|Second Treatment Period||8
906738|NCT01703663|2192177|P1|COMPLETED|Second Treatment Period||11
906739|NCT01703663|2192176|P2|STARTED|Second Treatment Period||8
906740|NCT01703663|2192177|P1|STARTED|Second Treatment Period||11
906741|NCT01703663|2192176|P2|NOT COMPLETED|First Treatment Period||0
906742|NCT01703663|2192177|P1|NOT COMPLETED|First Treatment Period||0
906743|NCT01703663|2192176|P2|COMPLETED|First Treatment Period||20
906744|NCT01703663|2192177|P1|COMPLETED|First Treatment Period||20
906745|NCT01703663|2192176|P2|STARTED|First Treatment Period||20
906746|NCT01703663|2192177|P1|STARTED|First Treatment Period||20
906747|NCT01703286|2192183|P6|NOT COMPLETED|Period 3 Including Washout||0
906748|NCT01703286|2192184|P5|NOT COMPLETED|Period 3 Including Washout||0
906749|NCT01703286|2192185|P4|NOT COMPLETED|Period 3 Including Washout||0
906750|NCT01703286|2192186|P3|NOT COMPLETED|Period 3 Including Washout||0
906751|NCT01703286|2192187|P2|NOT COMPLETED|Period 3 Including Washout||0
906752|NCT01703286|2192188|P1|NOT COMPLETED|Period 3 Including Washout||0
906753|NCT01703286|2192183|P6|COMPLETED|Period 3 Including Washout||6
906754|NCT01703286|2192184|P5|COMPLETED|Period 3 Including Washout||7
906755|NCT01703286|2192185|P4|COMPLETED|Period 3 Including Washout||5
906756|NCT01703286|2192186|P3|COMPLETED|Period 3 Including Washout||7
906757|NCT01703286|2192187|P2|COMPLETED|Period 3 Including Washout||7
906758|NCT01703286|2192188|P1|COMPLETED|Period 3 Including Washout||7
906759|NCT01703286|2192183|P6|STARTED|Period 3 Including Washout||6
906760|NCT01703286|2192184|P5|STARTED|Period 3 Including Washout||7
906761|NCT01703286|2192185|P4|STARTED|Period 3 Including Washout||5
906762|NCT01703286|2192186|P3|STARTED|Period 3 Including Washout||7
906763|NCT01703286|2192187|P2|STARTED|Period 3 Including Washout||7
906764|NCT01703286|2192188|P1|STARTED|Period 3 Including Washout||7
906765|NCT01703286|2192183|P6|NOT COMPLETED|Period 2 Including Washout||0
906766|NCT01703286|2192184|P5|NOT COMPLETED|Period 2 Including Washout||0
906767|NCT01703286|2192185|P4|NOT COMPLETED|Period 2 Including Washout||1
906768|NCT01703286|2192186|P3|NOT COMPLETED|Period 2 Including Washout||0
906769|NCT01703286|2192187|P2|NOT COMPLETED|Period 2 Including Washout||0
906770|NCT01703286|2192188|P1|NOT COMPLETED|Period 2 Including Washout||0
906771|NCT01703286|2192183|P6|COMPLETED|Period 2 Including Washout||6
906772|NCT01703286|2192184|P5|COMPLETED|Period 2 Including Washout||7
906773|NCT01703286|2192185|P4|COMPLETED|Period 2 Including Washout||5
906774|NCT01703286|2192186|P3|COMPLETED|Period 2 Including Washout||7
906775|NCT01703286|2192187|P2|COMPLETED|Period 2 Including Washout||7
906776|NCT01703286|2192188|P1|COMPLETED|Period 2 Including Washout||7
906777|NCT01703286|2192183|P6|STARTED|Period 2 Including Washout||6
906778|NCT01703286|2192184|P5|STARTED|Period 2 Including Washout||7
906779|NCT01703286|2192185|P4|STARTED|Period 2 Including Washout||6
906780|NCT01703286|2192186|P3|STARTED|Period 2 Including Washout||7
906781|NCT01703286|2192187|P2|STARTED|Period 2 Including Washout||7
906782|NCT01703286|2192188|P1|STARTED|Period 2 Including Washout||7
906783|NCT01703286|2192183|P6|NOT COMPLETED|Period 1 Including Washout||1
906784|NCT01703286|2192184|P5|NOT COMPLETED|Period 1 Including Washout||0
906785|NCT01703286|2192185|P4|NOT COMPLETED|Period 1 Including Washout||1
906786|NCT01703286|2192186|P3|NOT COMPLETED|Period 1 Including Washout||0
906787|NCT01703286|2192187|P2|NOT COMPLETED|Period 1 Including Washout||0
906788|NCT01703286|2192188|P1|NOT COMPLETED|Period 1 Including Washout||0
906789|NCT01703286|2192183|P6|COMPLETED|Period 1 Including Washout||6
906790|NCT01703286|2192184|P5|COMPLETED|Period 1 Including Washout||7
906791|NCT01703286|2192185|P4|COMPLETED|Period 1 Including Washout||6
906792|NCT01703286|2192186|P3|COMPLETED|Period 1 Including Washout||7
906793|NCT01703286|2192187|P2|COMPLETED|Period 1 Including Washout||7
906794|NCT01703286|2192188|P1|COMPLETED|Period 1 Including Washout||7
906795|NCT01703286|2192183|P6|STARTED|Period 1 Including Washout||7
906796|NCT01703286|2192184|P5|STARTED|Period 1 Including Washout||7
906797|NCT01703286|2192185|P4|STARTED|Period 1 Including Washout||7
906798|NCT01703286|2192186|P3|STARTED|Period 1 Including Washout||7
906799|NCT01703286|2192187|P2|STARTED|Period 1 Including Washout||7
906800|NCT01703286|2192188|P1|STARTED|Period 1 Including Washout||7
906801|NCT01703260|2192211|P3|NOT COMPLETED|Overall Study||3
906802|NCT01703260|2192212|P2|NOT COMPLETED|Overall Study||4
906803|NCT01703260|2192213|P1|NOT COMPLETED|Overall Study||3
906804|NCT01703260|2192211|P3|COMPLETED|Overall Study||3
906805|NCT01703260|2192212|P2|COMPLETED|Overall Study||3
906806|NCT01703260|2192213|P1|COMPLETED|Overall Study||4
906807|NCT01703260|2192211|P3|STARTED|Overall Study||6
906808|NCT01703260|2192212|P2|STARTED|Overall Study||7
906809|NCT01703260|2192213|P1|STARTED|Overall Study||7
906810|NCT01703221|2192239|P3|NOT COMPLETED|Phase B - (Week 25 to 52)||5
906811|NCT01703221|2192240|P2|NOT COMPLETED|Phase B - (Week 25 to 52)||14
906812|NCT01703221|2192241|P1|NOT COMPLETED|Phase B - (Week 25 to 52)||16
906813|NCT01703221|2192239|P3|COMPLETED|Phase B - (Week 25 to 52)||75
906814|NCT01703221|2192240|P2|COMPLETED|Phase B - (Week 25 to 52)||147
906815|NCT01703221|2192241|P1|COMPLETED|Phase B - (Week 25 to 52)||143
906816|NCT01703221|2192239|P3|STARTED|Phase B - (Week 25 to 52)||80
906817|NCT01703221|2192240|P2|STARTED|Phase B - (Week 25 to 52)||161
906818|NCT01703221|2192241|P1|STARTED|Phase B - (Week 25 to 52)||159
906819|NCT01703221|2192239|P3|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
906820|NCT01703221|2192240|P2|NOT COMPLETED|Phase A (Up to 24 Weeks)||4
906821|NCT01703221|2192241|P1|NOT COMPLETED|Phase A (Up to 24 Weeks)||7
906822|NCT01703221|2192239|P3|COMPLETED|Phase A (Up to 24 Weeks)||80
906823|NCT01703221|2192240|P2|COMPLETED|Phase A (Up to 24 Weeks)||161
906824|NCT01703221|2192241|P1|COMPLETED|Phase A (Up to 24 Weeks)||159
906825|NCT01703221|2192239|P3|STARTED|Phase A (Up to 24 Weeks)||83
906826|NCT01703221|2192240|P2|STARTED|Phase A (Up to 24 Weeks)||165
906827|NCT01703221|2192241|P1|STARTED|Phase A (Up to 24 Weeks)||166
906828|NCT01703091|2192272|P2|NOT COMPLETED|Overall Study||4
906829|NCT01703091|2192273|P1|NOT COMPLETED|Overall Study||9
906830|NCT01703091|2192272|P2|COMPLETED|Overall Study||95
906831|NCT01703091|2192273|P1|COMPLETED|Overall Study||89
906832|NCT01703091|2192272|P2|Received at Least One Dose of Study Drug|Overall Study||98
906833|NCT01703091|2192273|P1|Received at Least One Dose of Study Drug|Overall Study||94
906834|NCT01703091|2192272|P2|STARTED|Overall Study||99
906835|NCT01703091|2192273|P1|STARTED|Overall Study||98
906836|NCT01703000|2192289|P1|NOT COMPLETED|Overall Study||1
906837|NCT01703000|2192289|P1|COMPLETED|Overall Study||99
906838|NCT01703000|2192289|P1|STARTED|Overall Study||100
906839|NCT01702987|2192322|P2|NOT COMPLETED|Overall Study||0
906840|NCT01702987|2192323|P1|NOT COMPLETED|Overall Study||1
906841|NCT01702987|2192322|P2|COMPLETED|Overall Study||12
906842|NCT01702987|2192323|P1|COMPLETED|Overall Study||9
906843|NCT01702987|2192322|P2|STARTED|Overall Study||12
906844|NCT01702987|2192323|P1|STARTED|Overall Study||10
906845|NCT01702961|2192329|P1|NOT COMPLETED|Overall Study||47
906846|NCT01702961|2192329|P1|COMPLETED|Overall Study||28
906847|NCT01702961|2192329|P1|STARTED|Overall Study||75
906851|NCT01702532|2192342|P2|NOT COMPLETED|Overall Study||1
906852|NCT01702532|2192343|P1|NOT COMPLETED|Overall Study||0
906853|NCT01702532|2192342|P2|COMPLETED|Overall Study||160
906854|NCT01702532|2192343|P1|COMPLETED|Overall Study||161
906855|NCT01702532|2192342|P2|Safety Population|Overall Study|One subject randomized but did not receive the study treatment.|160
906856|NCT01702532|2192343|P1|Safety Population|Overall Study||161
906857|NCT01702532|2192342|P2|STARTED|Overall Study||161
906858|NCT01702532|2192343|P1|STARTED|Overall Study||161
906859|NCT01702519|2192353|P2|NOT COMPLETED|Period 2||0
906860|NCT01702519|2192354|P1|NOT COMPLETED|Period 2||0
906861|NCT01702519|2192353|P2|COMPLETED|Period 2||18
906862|NCT01702519|2192354|P1|COMPLETED|Period 2||19
906863|NCT01702519|2192353|P2|STARTED|Period 2||18
906864|NCT01702519|2192354|P1|STARTED|Period 2||19
906865|NCT01702519|2192353|P2|NOT COMPLETED|Washout Period||2
906866|NCT01702519|2192354|P1|NOT COMPLETED|Washout Period||1
906867|NCT01702519|2192353|P2|COMPLETED|Washout Period||18
906868|NCT01702519|2192354|P1|COMPLETED|Washout Period||19
906869|NCT01702519|2192353|P2|STARTED|Washout Period||20
906870|NCT01702519|2192354|P1|STARTED|Washout Period||20
906871|NCT01702519|2192353|P2|NOT COMPLETED|Period 1||0
906872|NCT01702519|2192354|P1|NOT COMPLETED|Period 1||0
906873|NCT01702519|2192353|P2|COMPLETED|Period 1||20
906874|NCT01702519|2192354|P1|COMPLETED|Period 1||20
906875|NCT01702519|2192353|P2|STARTED|Period 1||20
906876|NCT01702519|2192354|P1|STARTED|Period 1||20
906877|NCT01702454|2192372|P2|NOT COMPLETED|Overall Study||8
906878|NCT01702454|2192373|P1|NOT COMPLETED|Overall Study||3
906879|NCT01702454|2192372|P2|COMPLETED|Overall Study||221
906880|NCT01702454|2192373|P1|COMPLETED|Overall Study||238
906881|NCT01702454|2192372|P2|STARTED|Overall Study||229
906882|NCT01702454|2192373|P1|STARTED|Overall Study||241
906883|NCT01702363|2192451|P1|NOT COMPLETED|Overall Study||20
906884|NCT01702363|2192451|P1|COMPLETED|Overall Study||111
906885|NCT01702363|2192451|P1|STARTED|Overall Study||131
906886|NCT01702311|2192468|P2|NOT COMPLETED|Overall Study||13
906887|NCT01702311|2192469|P1|NOT COMPLETED|Overall Study||16
906888|NCT01702311|2192468|P2|COMPLETED|Overall Study||100
906889|NCT01702311|2192469|P1|COMPLETED|Overall Study||106
906890|NCT01702311|2192468|P2|STARTED|Overall Study||113
906891|NCT01702311|2192469|P1|STARTED|Overall Study||122
906892|NCT01702298|2192475|P1|NOT COMPLETED|Overall Study||1
906893|NCT01702298|2192475|P1|COMPLETED|Overall Study||41
906894|NCT01702298|2192475|P1|STARTED|Overall Study||42
906895|NCT01702259|2192488|P2|NOT COMPLETED|Overall Study||0
906896|NCT01702259|2192489|P1|NOT COMPLETED|Overall Study||0
906897|NCT01702259|2192488|P2|COMPLETED|Overall Study||34
906898|NCT01702259|2192489|P1|COMPLETED|Overall Study||34
906899|NCT01702259|2192488|P2|STARTED|Overall Study||34
906900|NCT01702259|2192489|P1|STARTED|Overall Study||34
906901|NCT01702246|2192503|P1|NOT COMPLETED|Overall Study||5
906902|NCT01702246|2192503|P1|COMPLETED|Overall Study||19
906903|NCT01702246|2192503|P1|STARTED|Overall Study||24
906904|NCT01702233|2192515|P3|NOT COMPLETED|Overall Study||5
906905|NCT01702233|2192516|P2|NOT COMPLETED|Overall Study||3
906906|NCT01702233|2192517|P1|NOT COMPLETED|Overall Study||6
906907|NCT01702233|2192515|P3|COMPLETED|Overall Study||31
906908|NCT01702233|2192516|P2|COMPLETED|Overall Study|One of these Patient completed the Trial but had no valid outcome measure after enrolment|64
906909|NCT01702233|2192517|P1|COMPLETED|Overall Study||66
906910|NCT01702233|2192515|P3|Per Protocol Set|Overall Study||27
906911|NCT01702233|2192516|P2|Per Protocol Set|Overall Study||58
906912|NCT01702233|2192517|P1|Per Protocol Set|Overall Study||58
906913|NCT01702233|2192515|P3|Full Analysis Set (ITT)|Overall Study||31
906914|NCT01702233|2192516|P2|Full Analysis Set (ITT)|Overall Study||63
906915|NCT01702233|2192517|P1|Full Analysis Set (ITT)|Overall Study||66
906916|NCT01702233|2192515|P3|STARTED|Overall Study||36
906917|NCT01702233|2192516|P2|STARTED|Overall Study||67
906918|NCT01702233|2192517|P1|STARTED|Overall Study||72
906919|NCT01702025|2192557|P4|NOT COMPLETED|Overall Study||0
906920|NCT01702025|2192558|P3|NOT COMPLETED|Overall Study||1
906921|NCT01702025|2192559|P2|NOT COMPLETED|Overall Study||1
906922|NCT01702025|2192560|P1|NOT COMPLETED|Overall Study||2
906923|NCT01702025|2192557|P4|COMPLETED|Overall Study||10
906924|NCT01702025|2192558|P3|COMPLETED|Overall Study||9
906925|NCT01702025|2192559|P2|COMPLETED|Overall Study||9
906926|NCT01702025|2192560|P1|COMPLETED|Overall Study||9
906927|NCT01702025|2192557|P4|STARTED|Overall Study||10
906928|NCT01702025|2192558|P3|STARTED|Overall Study||10
906929|NCT01702025|2192559|P2|STARTED|Overall Study||10
906930|NCT01702025|2192560|P1|STARTED|Overall Study||11
906931|NCT01701999|2192576|P2|NOT COMPLETED|Overall Study||0
906932|NCT01701999|2192577|P1|NOT COMPLETED|Overall Study||0
906933|NCT01701999|2192576|P2|COMPLETED|Overall Study||37
906934|NCT01701999|2192577|P1|COMPLETED|Overall Study||8
906935|NCT01701999|2192576|P2|STARTED|Overall Study||37
906936|NCT01701999|2192577|P1|STARTED|Overall Study||8
906937|NCT01701674|2192589|P1|NOT COMPLETED|Overall Study||1
906938|NCT01701674|2192589|P1|COMPLETED|Overall Study||12
906939|NCT01701674|2192589|P1|STARTED|Overall Study||13
906940|NCT01701622|2192594|P1|NOT COMPLETED|Overall Study||0
906941|NCT01701622|2192594|P1|COMPLETED|Overall Study||1
906942|NCT01701622|2192594|P1|STARTED|Overall Study||1
906943|NCT01701505|2192605|P6|NOT COMPLETED|Overall Study||0
906944|NCT01701505|2192606|P5|NOT COMPLETED|Overall Study||0
906945|NCT01701505|2192607|P4|NOT COMPLETED|Overall Study||0
906946|NCT01701505|2192608|P3|NOT COMPLETED|Overall Study||0
906947|NCT01701505|2192609|P2|NOT COMPLETED|Overall Study||0
906948|NCT01701505|2192610|P1|NOT COMPLETED|Overall Study||0
906949|NCT01701505|2192605|P6|COMPLETED|Overall Study||8
906950|NCT01701505|2192606|P5|COMPLETED|Overall Study||8
906951|NCT01701505|2192607|P4|COMPLETED|Overall Study||8
906952|NCT01701505|2192608|P3|COMPLETED|Overall Study||8
906953|NCT01701505|2192609|P2|COMPLETED|Overall Study||8
906954|NCT01701505|2192610|P1|COMPLETED|Overall Study||8
906955|NCT01701505|2192605|P6|STARTED|Overall Study||8
906956|NCT01701505|2192606|P5|STARTED|Overall Study||8
906957|NCT01701505|2192607|P4|STARTED|Overall Study||8
906958|NCT01701505|2192608|P3|STARTED|Overall Study||8
906959|NCT01701505|2192609|P2|STARTED|Overall Study||8
906960|NCT01701505|2192610|P1|STARTED|Overall Study||8
906961|NCT01701414|2192662|P2|NOT COMPLETED|Overall Study||1
906962|NCT01701414|2192663|P1|NOT COMPLETED|Overall Study||1
906963|NCT01701414|2192662|P2|COMPLETED|Overall Study||18
906964|NCT01701414|2192663|P1|COMPLETED|Overall Study||18
906965|NCT01701414|2192662|P2|STARTED|Overall Study||19
906966|NCT01701414|2192663|P1|STARTED|Overall Study||19
906967|NCT01701401|2192673|P4|NOT COMPLETED|Overall Study||6
906968|NCT01701401|2192674|P3|NOT COMPLETED|Overall Study||5
906969|NCT01701401|2192675|P2|NOT COMPLETED|Overall Study||9
906970|NCT01701401|2192676|P1|NOT COMPLETED|Overall Study||10
906971|NCT01701401|2192673|P4|COMPLETED|Overall Study||212
906972|NCT01701401|2192674|P3|COMPLETED|Overall Study||212
906973|NCT01701401|2192675|P2|COMPLETED|Overall Study||209
906974|NCT01701401|2192676|P1|COMPLETED|Overall Study||207
906975|NCT01701401|2192673|P4|STARTED|Overall Study||218
906976|NCT01701401|2192674|P3|STARTED|Overall Study||217
906977|NCT01701401|2192675|P2|STARTED|Overall Study||218
906978|NCT01701401|2192676|P1|STARTED|Overall Study||217
906979|NCT01701375|2192722|P1|NOT COMPLETED|Overall Study||0
906980|NCT01701375|2192722|P1|COMPLETED|Overall Study||2
906981|NCT01701375|2192722|P1|STARTED|Overall Study||2
906982|NCT01701362|2192728|P2|NOT COMPLETED|Overall Study||56
906983|NCT01701362|2192729|P1|NOT COMPLETED|Overall Study||42
906984|NCT01701362|2192728|P2|COMPLETED|Overall Study||211
906985|NCT01701362|2192729|P1|COMPLETED|Overall Study||233
906986|NCT01701362|2192728|P2|TREATED|Overall Study||265
906987|NCT01701362|2192729|P1|TREATED|Overall Study||274
906988|NCT01701362|2192728|P2|STARTED|Overall Study||267
906989|NCT01701362|2192729|P1|STARTED|Overall Study||275
906990|NCT01701271|2192757|P1|NOT COMPLETED|Overall Study||0
906991|NCT01701271|2192757|P1|COMPLETED|Overall Study||20
906992|NCT01701271|2192757|P1|STARTED|Overall Study||20
906993|NCT01701245|2192765|P2|NOT COMPLETED|Overall Study||15
906994|NCT01701245|2192766|P1|NOT COMPLETED|Overall Study||12
906995|NCT01701245|2192765|P2|COMPLETED|Overall Study||33
906996|NCT01701245|2192766|P1|COMPLETED|Overall Study||37
906997|NCT01701245|2192765|P2|FAS Matched Data|Overall Study||32
906998|NCT01701245|2192766|P1|FAS Matched Data|Overall Study||42
906999|NCT01701245|2192765|P2|FAS Unmatched Data|Overall Study|3 patients protocol violation|45
907000|NCT01701245|2192766|P1|FAS Unmatched Data|Overall Study|1 patient protocol violation|48
907001|NCT01701245|2192765|P2|STARTED|Overall Study||48
907002|NCT01701245|2192766|P1|STARTED|Overall Study||49
907003|NCT01701115|2192780|P2|NOT COMPLETED|Overall Study||0
907004|NCT01701115|2192781|P1|NOT COMPLETED|Overall Study||2
907005|NCT01701115|2192780|P2|COMPLETED|Overall Study||77
907006|NCT01701115|2192781|P1|COMPLETED|Overall Study||75
907007|NCT01701115|2192780|P2|STARTED|Overall Study||77
907008|NCT01701115|2192781|P1|STARTED|Overall Study||77
907009|NCT01701102|2192797|P4|NOT COMPLETED|Overall Study||0
907010|NCT01701102|2192798|P3|NOT COMPLETED|Overall Study||0
907011|NCT01701102|2192799|P2|NOT COMPLETED|Overall Study||0
907012|NCT01701102|2192800|P1|NOT COMPLETED|Overall Study||0
907013|NCT01701102|2192797|P4|COMPLETED|Overall Study||18
907014|NCT01701102|2192798|P3|COMPLETED|Overall Study||10
907015|NCT01701102|2192799|P2|COMPLETED|Overall Study||6
907016|NCT01701102|2192800|P1|COMPLETED|Overall Study||22
907017|NCT01701102|2192797|P4|STARTED|Overall Study||18
907018|NCT01701102|2192798|P3|STARTED|Overall Study||10
907019|NCT01701102|2192799|P2|STARTED|Overall Study||6
907020|NCT01701102|2192800|P1|STARTED|Overall Study||22
907021|NCT01701063|2192813|P3|NOT COMPLETED|Overall Study||2
907022|NCT01701063|2192814|P2|NOT COMPLETED|Overall Study||1
907023|NCT01701063|2192815|P1|NOT COMPLETED|Overall Study||0
907024|NCT01701063|2192813|P3|COMPLETED|Overall Study||8
907025|NCT01701063|2192814|P2|COMPLETED|Overall Study||18
907026|NCT01701063|2192815|P1|COMPLETED|Overall Study||13
907027|NCT01701063|2192813|P3|STARTED|Overall Study||10
907028|NCT01701063|2192814|P2|STARTED|Overall Study||19
907029|NCT01701063|2192815|P1|STARTED|Overall Study||13
907030|NCT01701037|2192857|P1|NOT COMPLETED|Overall Study||0
907031|NCT01701037|2192857|P1|COMPLETED|Overall Study||13
907032|NCT01701037|2192857|P1|STARTED|Overall Study||13
907033|NCT01701024|2192868|P2|NOT COMPLETED|Overall Study||9
907034|NCT01701024|2192869|P1|NOT COMPLETED|Overall Study||10
907035|NCT01701024|2192868|P2|COMPLETED|Overall Study||236
907036|NCT01701024|2192869|P1|COMPLETED|Overall Study||243
907037|NCT01701024|2192868|P2|STARTED|Overall Study||245
907038|NCT01701024|2192869|P1|STARTED|Overall Study||253
907039|NCT01701011|2192884|P3|NOT COMPLETED|Overall Study||34
907040|NCT01701011|2192885|P2|NOT COMPLETED|Overall Study||24
907041|NCT01701011|2192886|P1|NOT COMPLETED|Overall Study||35
907042|NCT01701011|2192884|P3|COMPLETED|Overall Study||90
907043|NCT01701011|2192885|P2|COMPLETED|Overall Study||102
907044|NCT01701011|2192886|P1|COMPLETED|Overall Study||92
907045|NCT01701011|2192884|P3|STARTED|Overall Study||124
907046|NCT01701011|2192885|P2|STARTED|Overall Study||126
907047|NCT01701011|2192886|P1|STARTED|Overall Study||127
907048|NCT01700907|2192899|P2|NOT COMPLETED|Overall Study||0
907049|NCT01700907|2192900|P1|NOT COMPLETED|Overall Study||0
907050|NCT01700907|2192899|P2|COMPLETED|Overall Study||10
907051|NCT01700907|2192900|P1|COMPLETED|Overall Study||10
907052|NCT01700907|2192899|P2|STARTED|Overall Study||10
907053|NCT01700907|2192900|P1|STARTED|Overall Study||10
907054|NCT01700816|2192916|P2|NOT COMPLETED|Overall Study||0
907055|NCT01700816|2192917|P1|NOT COMPLETED|Overall Study||0
907056|NCT01700816|2192916|P2|COMPLETED|Overall Study||19
907057|NCT01700816|2192917|P1|COMPLETED|Overall Study||21
907058|NCT01700816|2192916|P2|STARTED|Overall Study||19
907059|NCT01700816|2192917|P1|STARTED|Overall Study||21
907060|NCT01700530|2192946|P3|NOT COMPLETED|Overall Study||1
907061|NCT01700530|2192947|P2|NOT COMPLETED|Overall Study||3
907062|NCT01700530|2192948|P1|NOT COMPLETED|Overall Study||0
907063|NCT01700530|2192946|P3|COMPLETED|Overall Study||19
907064|NCT01700530|2192947|P2|COMPLETED|Overall Study||18
907065|NCT01700530|2192948|P1|COMPLETED|Overall Study||9
907066|NCT01700530|2192946|P3|STARTED|Overall Study||20
907067|NCT01700530|2192947|P2|STARTED|Overall Study||21
907068|NCT01700530|2192948|P1|STARTED|Overall Study||9
907069|NCT01700517|2192962|P3|NOT COMPLETED|Overall Study||0
907070|NCT01700517|2192963|P2|NOT COMPLETED|Overall Study||0
907071|NCT01700517|2192964|P1|NOT COMPLETED|Overall Study||0
907072|NCT01700517|2192962|P3|COMPLETED|Overall Study||40
907073|NCT01700517|2192963|P2|COMPLETED|Overall Study||40
907074|NCT01700517|2192964|P1|COMPLETED|Overall Study||40
907075|NCT01700517|2192962|P3|STARTED|Overall Study||40
907076|NCT01700517|2192963|P2|STARTED|Overall Study||40
907077|NCT01700517|2192964|P1|STARTED|Overall Study||40
907078|NCT01700387|2192974|P2|NOT COMPLETED|Overall Study||4
907079|NCT01700387|2192975|P1|NOT COMPLETED|Overall Study||4
907080|NCT01700387|2192974|P2|COMPLETED|Overall Study||6
907081|NCT01700387|2192975|P1|COMPLETED|Overall Study||6
907082|NCT01700387|2192974|P2|STARTED|Overall Study||10
907083|NCT01700387|2192975|P1|STARTED|Overall Study||10
907084|NCT01700348|2192985|P1|NOT COMPLETED|Overall Study||23
907085|NCT01700348|2192985|P1|COMPLETED|Overall Study||93
907086|NCT01700348|2192985|P1|STARTED|Overall Study||116
907087|NCT01700335|2192989|P2|NOT COMPLETED|Overall Study||4
907088|NCT01700335|2192990|P1|NOT COMPLETED|Overall Study||1
907089|NCT01700335|2192989|P2|COMPLETED|Overall Study||2
907090|NCT01700335|2192990|P1|COMPLETED|Overall Study||2
907091|NCT01700335|2192989|P2|STARTED|Overall Study||6
907092|NCT01700335|2192990|P1|STARTED|Overall Study||3
907093|NCT01700192|2193003|P2|NOT COMPLETED|Overall Study||128
907094|NCT01700192|2193004|P1|NOT COMPLETED|Overall Study||180
907095|NCT01700192|2193003|P2|COMPLETED|Overall Study||613
907096|NCT01700192|2193004|P1|COMPLETED|Overall Study||561
907097|NCT01700192|2193003|P2|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|738
907098|NCT01700192|2193004|P1|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|743
907099|NCT01700192|2193003|P2|Treated|Overall Study||741
907100|NCT01700192|2193004|P1|Treated|Overall Study||740
907101|NCT01700192|2193003|P2|STARTED|Overall Study||741
907102|NCT01700192|2193004|P1|STARTED|Overall Study||741
907103|NCT01700179|2193022|P1|NOT COMPLETED|Overall Study||2
907104|NCT01700179|2193022|P1|COMPLETED|Overall Study||6
907105|NCT01700179|2193022|P1|STARTED|Overall Study||8
907106|NCT01700140|2193029|P3|NOT COMPLETED|Overall Study||1
907107|NCT01700140|2193030|P2|NOT COMPLETED|Overall Study||9
907108|NCT01700140|2193031|P1|NOT COMPLETED|Overall Study||6
907109|NCT01700140|2193029|P3|COMPLETED|Overall Study||61
907110|NCT01700140|2193030|P2|COMPLETED|Overall Study||57
907111|NCT01700140|2193031|P1|COMPLETED|Overall Study||55
907112|NCT01700140|2193029|P3|STARTED|Overall Study||62
907113|NCT01700140|2193030|P2|STARTED|Overall Study||66
907114|NCT01700140|2193031|P1|STARTED|Overall Study||61
907115|NCT01699867|2193063|P1|NOT COMPLETED|Overall Study||3
907116|NCT01699867|2193063|P1|COMPLETED|Overall Study||47
907117|NCT01699867|2193063|P1|STARTED|Overall Study||50
907118|NCT01699815|2193070|P2|NOT COMPLETED|Overall Study||8
907119|NCT01699815|2193071|P1|NOT COMPLETED|Overall Study||5
907120|NCT01699815|2193070|P2|COMPLETED|Overall Study||56
907121|NCT01699815|2193071|P1|COMPLETED|Overall Study||57
907122|NCT01699815|2193070|P2|STARTED|Overall Study||64
907123|NCT01699815|2193071|P1|STARTED|Overall Study||62
907124|NCT01699789|2193083|P2|NOT COMPLETED|Overall Study||126
907125|NCT01699789|2193084|P1|NOT COMPLETED|Overall Study||102
907126|NCT01699789|2193083|P2|COMPLETED|Overall Study|Clients in 46 programs with complete or partially complete data at baseline, 6 and 12 mo FU analyzed|514
907127|NCT01699789|2193084|P1|COMPLETED|Overall Study|Clients in 44 programs with complete or partially complete data at baseline, 6 and 12 mo FU analyzed|504
907128|NCT01699789|2193083|P2|12-Month Follow-Up|Overall Study||369
907129|NCT01699789|2193084|P1|12-Month Follow-Up|Overall Study||364
907130|NCT01699789|2193083|P2|6-Month Follow-Up|Overall Study||379
907131|NCT01699789|2193084|P1|6-Month Follow-Up|Overall Study||380
907132|NCT01699789|2193083|P2|Baseline|Overall Study||488
907133|NCT01699789|2193084|P1|Baseline|Overall Study||492
907134|NCT01699789|2193083|P2|STARTED|Overall Study|640 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in CEP arm|640
907135|NCT01699789|2193084|P1|STARTED|Overall Study|606 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in RS arm|606
907136|NCT01699763|2193146|P1|NOT COMPLETED|Overall Study||0
907137|NCT01699763|2193146|P1|COMPLETED|Overall Study||112
907138|NCT01699763|2193146|P1|STARTED|Overall Study||112
907139|NCT01699750|2193154|P2|NOT COMPLETED|Overall Study||3
907140|NCT01699750|2193155|P1|NOT COMPLETED|Overall Study||0
907141|NCT01699750|2193154|P2|COMPLETED|Overall Study||33
907142|NCT01699750|2193155|P1|COMPLETED|Overall Study||34
907143|NCT01699750|2193154|P2|STARTED|Overall Study||36
907144|NCT01699750|2193155|P1|STARTED|Overall Study||34
907145|NCT01699698|2193179|P2|NOT COMPLETED|Overall Study||5
907146|NCT01699698|2193180|P1|NOT COMPLETED|Overall Study||2
907147|NCT01699698|2193179|P2|COMPLETED|Overall Study||56
907148|NCT01699698|2193180|P1|COMPLETED|Overall Study||42
907149|NCT01699698|2193179|P2|STARTED|Overall Study||61
907150|NCT01699698|2193180|P1|STARTED|Overall Study||44
907151|NCT01699685|2193190|P2|NOT COMPLETED|Period 2||0
907152|NCT01699685|2193191|P1|NOT COMPLETED|Period 2||1
907153|NCT01699685|2193190|P2|COMPLETED|Period 2||36
907154|NCT01699685|2193191|P1|COMPLETED|Period 2||35
907155|NCT01699685|2193190|P2|STARTED|Period 2||36
907156|NCT01699685|2193191|P1|STARTED|Period 2||36
907157|NCT01699685|2193190|P2|NOT COMPLETED|Period 1||3
907158|NCT01699685|2193191|P1|NOT COMPLETED|Period 1||3
907159|NCT01699685|2193190|P2|COMPLETED|Period 1||36
907160|NCT01699685|2193191|P1|COMPLETED|Period 1||36
907161|NCT01699685|2193190|P2|Full Analysis Population (FAS)|Period 1||38
907162|NCT01699685|2193191|P1|Full Analysis Population (FAS)|Period 1||38
907163|NCT01699685|2193190|P2|Safety Population|Period 1||38
907164|NCT01699685|2193191|P1|Safety Population|Period 1||39
907165|NCT01699685|2193190|P2|STARTED|Period 1||39
907166|NCT01699685|2193191|P1|STARTED|Period 1||39
907167|NCT01699607|2193209|P2|NOT COMPLETED|Overall Study||0
907168|NCT01699607|2193210|P1|NOT COMPLETED|Overall Study||0
907169|NCT01699607|2193209|P2|COMPLETED|Overall Study||4
907170|NCT01699607|2193210|P1|COMPLETED|Overall Study||6
907171|NCT01699607|2193209|P2|STARTED|Overall Study||4
907172|NCT01699607|2193210|P1|STARTED|Overall Study||6
907173|NCT01699373|2193217|P2|NOT COMPLETED|Overall Study||0
907174|NCT01699373|2193218|P1|NOT COMPLETED|Overall Study||0
907175|NCT01699373|2193217|P2|COMPLETED|Overall Study||85
907176|NCT01699373|2193218|P1|COMPLETED|Overall Study||85
907177|NCT01699373|2193217|P2|STARTED|Overall Study||85
907178|NCT01699373|2193218|P1|STARTED|Overall Study||85
907179|NCT01699087|2193224|P1|NOT COMPLETED|Overall Study||24
907180|NCT01699087|2193224|P1|COMPLETED|Overall Study||152
907181|NCT01699087|2193224|P1|Treated|Overall Study||161
907182|NCT01699087|2193224|P1|STARTED|Overall Study||176
907183|NCT01699022|2193238|P1|NOT COMPLETED|Overall Study||3
907184|NCT01699022|2193238|P1|COMPLETED|Overall Study||14
907185|NCT01699022|2193238|P1|STARTED|Overall Study||17
907186|NCT01698814|2193253|P2|NOT COMPLETED|Overall Study||3
907187|NCT01698814|2193254|P1|NOT COMPLETED|Overall Study||2
907188|NCT01698814|2193253|P2|COMPLETED|Overall Study||166
907189|NCT01698814|2193254|P1|COMPLETED|Overall Study||329
907190|NCT01698814|2193253|P2|STARTED|Overall Study||169
907191|NCT01698814|2193254|P1|STARTED|Overall Study||331
907192|NCT01698801|2193260|P1|NOT COMPLETED|Follow Up Phase||5
907193|NCT01698801|2193260|P1|COMPLETED|Follow Up Phase|Completed includes participants who remain in follow-up for up to 5 years from start of treatment|6
907194|NCT01698801|2193260|P1|STARTED|Follow Up Phase|11 participants did not complete the study and moved into the follow up phase lasting up to 5 years.|11
907195|NCT01698801|2193260|P1|NOT COMPLETED|Treatment Phase||11
907196|NCT01698801|2193260|P1|COMPLETED|Treatment Phase|Completed includes participants who continued to receive study medication and treatment is ongoing.|15
907197|NCT01698801|2193260|P1|STARTED|Treatment Phase||26
907198|NCT01698775|2193271|P2|NOT COMPLETED|Phase B||11
907199|NCT01698775|2193272|P1|NOT COMPLETED|Phase B||14
907200|NCT01698775|2193271|P2|COMPLETED|Phase B||86
907201|NCT01698775|2193272|P1|COMPLETED|Phase B||84
907202|NCT01698775|2193271|P2|STARTED|Phase B||97
907203|NCT01698775|2193272|P1|STARTED|Phase B||98
907204|NCT01698775|2193271|P2|NOT COMPLETED|Phase A||9
907205|NCT01698775|2193272|P1|NOT COMPLETED|Phase A||9
907206|NCT01698775|2193271|P2|COMPLETED|Phase A||97
907207|NCT01698775|2193272|P1|COMPLETED|Phase A||98
907208|NCT01698775|2193271|P2|STARTED|Phase A||106
907209|NCT01698775|2193272|P1|STARTED|Phase A||107
907210|NCT01698710|2193298|P1|NOT COMPLETED|Overall Study||0
907211|NCT01698710|2193298|P1|COMPLETED|Overall Study||5
907212|NCT01698710|2193298|P1|STARTED|Overall Study||5
907213|NCT01698684|2193307|P3|NOT COMPLETED|Overall Study||21
907214|NCT01698684|2193308|P2|NOT COMPLETED|Overall Study||23
907215|NCT01698684|2193309|P1|NOT COMPLETED|Overall Study||29
907216|NCT01698684|2193307|P3|COMPLETED|Overall Study||127
907217|NCT01698684|2193308|P2|COMPLETED|Overall Study||124
907218|NCT01698684|2193309|P1|COMPLETED|Overall Study||116
907219|NCT01698684|2193307|P3|Safety Population|Overall Study||146
907220|NCT01698684|2193308|P2|Safety Population|Overall Study||146
907221|NCT01698684|2193309|P1|Safety Population|Overall Study||143
907222|NCT01698684|2193307|P3|ITT Population|Overall Study||139
907223|NCT01698684|2193308|P2|ITT Population|Overall Study||139
907224|NCT01698684|2193309|P1|ITT Population|Overall Study||136
907225|NCT01698684|2193307|P3|STARTED|Overall Study||148
907226|NCT01698684|2193308|P2|STARTED|Overall Study||147
907227|NCT01698684|2193309|P1|STARTED|Overall Study||145
907228|NCT01698554|2193321|P4|NOT COMPLETED|Overall Study||2
907229|NCT01698554|2193322|P3|NOT COMPLETED|Overall Study||2
907230|NCT01698554|2193323|P2|NOT COMPLETED|Overall Study||10
907231|NCT01698554|2193324|P1|NOT COMPLETED|Overall Study||6
907232|NCT01698554|2193321|P4|COMPLETED|Overall Study||77
907233|NCT01698554|2193322|P3|COMPLETED|Overall Study||73
907234|NCT01698554|2193323|P2|COMPLETED|Overall Study||147
907235|NCT01698554|2193324|P1|COMPLETED|Overall Study||147
907236|NCT01698554|2193321|P4|STARTED|Overall Study||79
907237|NCT01698554|2193322|P3|STARTED|Overall Study||75
907238|NCT01698554|2193323|P2|STARTED|Overall Study||157
907239|NCT01698554|2193324|P1|STARTED|Overall Study||153
907240|NCT01698528|2193352|P2|NOT COMPLETED|Overall Study||4
907241|NCT01698528|2193353|P1|NOT COMPLETED|Overall Study||1
907242|NCT01698528|2193352|P2|COMPLETED|Overall Study||16
907243|NCT01698528|2193353|P1|COMPLETED|Overall Study||19
907244|NCT01698528|2193352|P2|STARTED|Overall Study||20
907245|NCT01698528|2193353|P1|STARTED|Overall Study||20
907246|NCT01698502|2193369|P2|NOT COMPLETED|Overall Study||0
907247|NCT01698502|2193370|P1|NOT COMPLETED|Overall Study||0
907248|NCT01698502|2193369|P2|COMPLETED|Overall Study||10
907249|NCT01698502|2193370|P1|COMPLETED|Overall Study||11
907250|NCT01698502|2193369|P2|STARTED|Overall Study||10
907251|NCT01698502|2193370|P1|STARTED|Overall Study||11
907252|NCT01698320|2193380|P3|NOT COMPLETED|40-Week Open-Label Period||10
907253|NCT01698320|2193381|P2|NOT COMPLETED|40-Week Open-Label Period||19
907254|NCT01698320|2193382|P1|NOT COMPLETED|40-Week Open-Label Period||0
907255|NCT01698320|2193380|P3|COMPLETED|40-Week Open-Label Period||146
907256|NCT01698320|2193381|P2|COMPLETED|40-Week Open-Label Period||146
907257|NCT01698320|2193382|P1|COMPLETED|40-Week Open-Label Period||0
907258|NCT01698320|2193380|P3|STARTED|40-Week Open-Label Period||156
907259|NCT01698320|2193381|P2|STARTED|40-Week Open-Label Period||165
907260|NCT01698320|2193382|P1|STARTED|40-Week Open-Label Period||0
907261|NCT01698320|2193380|P3|NOT COMPLETED|12-Week Double-Blind Period||12
907262|NCT01698320|2193381|P2|NOT COMPLETED|12-Week Double-Blind Period||4
907263|NCT01698320|2193382|P1|NOT COMPLETED|12-Week Double-Blind Period||0
907264|NCT01698320|2193380|P3|COMPLETED|12-Week Double-Blind Period||156
907265|NCT01698320|2193381|P2|COMPLETED|12-Week Double-Blind Period||165
907266|NCT01698320|2193382|P1|COMPLETED|12-Week Double-Blind Period||0
907267|NCT01698320|2193380|P3|Safety Population|12-Week Double-Blind Period||168
907268|NCT01698320|2193381|P2|Safety Population|12-Week Double-Blind Period|One participant took both placebo and albuterol so is counted in both treatment groups for safety.|170
907269|NCT01698320|2193382|P1|Safety Population|12-Week Double-Blind Period||0
907270|NCT01698320|2193380|P3|STARTED|12-Week Double-Blind Period||168
907271|NCT01698320|2193381|P2|STARTED|12-Week Double-Blind Period||169
907272|NCT01698320|2193382|P1|STARTED|12-Week Double-Blind Period||0
907273|NCT01698320|2193380|P3|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
907274|NCT01698320|2193381|P2|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
907275|NCT01698320|2193382|P1|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||27
907276|NCT01698320|2193380|P3|COMPLETED|Run-In Period (Week -1 to Day 0)||0
907277|NCT01698320|2193381|P2|COMPLETED|Run-In Period (Week -1 to Day 0)||0
907278|NCT01698320|2193382|P1|COMPLETED|Run-In Period (Week -1 to Day 0)||337
907279|NCT01698320|2193380|P3|STARTED|Run-In Period (Week -1 to Day 0)||0
907280|NCT01698320|2193381|P2|STARTED|Run-In Period (Week -1 to Day 0)||0
907281|NCT01698320|2193382|P1|STARTED|Run-In Period (Week -1 to Day 0)||364
907282|NCT01698268|2193402|P2|NOT COMPLETED|Overall Study||1
907283|NCT01698268|2193403|P1|NOT COMPLETED|Overall Study||2
907284|NCT01698268|2193402|P2|COMPLETED|Overall Study||24
907285|NCT01698268|2193403|P1|COMPLETED|Overall Study||23
907286|NCT01698268|2193402|P2|STARTED|Overall Study||25
907287|NCT01698268|2193403|P1|STARTED|Overall Study||25
907288|NCT01697969|2193409|P1|NOT COMPLETED|Overall Study||3
907289|NCT01697969|2193409|P1|COMPLETED|Overall Study||10
907290|NCT01697969|2193409|P1|STARTED|Overall Study||13
907291|NCT01697956|2193416|P2|NOT COMPLETED|Overall Study||1
907292|NCT01697956|2193417|P1|NOT COMPLETED|Overall Study||1
907293|NCT01697956|2193416|P2|COMPLETED|Overall Study||31
907294|NCT01697956|2193417|P1|COMPLETED|Overall Study||66
907295|NCT01697956|2193416|P2|Per Protocol Population|Overall Study||31
907296|NCT01697956|2193417|P1|Per Protocol Population|Overall Study||66
907297|NCT01697956|2193416|P2|STARTED|Overall Study|enrolled and randomized|32
907298|NCT01697956|2193417|P1|STARTED|Overall Study|enrolled and randomized|67
907299|NCT01697696|2193447|P2|NOT COMPLETED|Overall Study||47
907300|NCT01697696|2193448|P1|NOT COMPLETED|Overall Study||47
907301|NCT01697696|2193447|P2|COMPLETED|Overall Study||210
907302|NCT01697696|2193448|P1|COMPLETED|Overall Study||207
907303|NCT01697696|2193447|P2|Full Analysis Set (FAS)|Overall Study||255
907304|NCT01697696|2193448|P1|Full Analysis Set (FAS)|Overall Study||251
907305|NCT01697696|2193447|P2|Safety Set|Overall Study|Safety set included a patient that was treated, but not randomized|256
907306|NCT01697696|2193448|P1|Safety Set|Overall Study||251
907307|NCT01697696|2193447|P2|STARTED|Overall Study||257
907308|NCT01697696|2193448|P1|STARTED|Overall Study||254
907309|NCT01697592|2193480|P10|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
907310|NCT01697592|2193481|P9|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
907311|NCT01697592|2193482|P8|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
907312|NCT01697592|2193483|P7|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
907313|NCT01697592|2193484|P6|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
907314|NCT01697592|2193485|P5|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
907315|NCT01697592|2193486|P4|NOT COMPLETED|Phase B (Week 25 to Week 52)||3
907316|NCT01697592|2193487|P3|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
907317|NCT01697592|2193488|P2|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
907318|NCT01697592|2193489|P1|NOT COMPLETED|Phase B (Week 25 to Week 52)||5
907319|NCT01697592|2193480|P10|COMPLETED|Phase B (Week 25 to Week 52)||30
907320|NCT01697592|2193481|P9|COMPLETED|Phase B (Week 25 to Week 52)||32
907321|NCT01697592|2193482|P8|COMPLETED|Phase B (Week 25 to Week 52)||32
907322|NCT01697592|2193483|P7|COMPLETED|Phase B (Week 25 to Week 52)||31
907323|NCT01697592|2193484|P6|COMPLETED|Phase B (Week 25 to Week 52)||60
907324|NCT01697592|2193485|P5|COMPLETED|Phase B (Week 25 to Week 52)||67
907325|NCT01697592|2193486|P4|COMPLETED|Phase B (Week 25 to Week 52)||60
907326|NCT01697592|2193487|P3|COMPLETED|Phase B (Week 25 to Week 52)||64
907327|NCT01697592|2193488|P2|COMPLETED|Phase B (Week 25 to Week 52)||61
907328|NCT01697592|2193489|P1|COMPLETED|Phase B (Week 25 to Week 52)||118
907329|NCT01697592|2193480|P10|STARTED|Phase B (Week 25 to Week 52)||30
907330|NCT01697592|2193481|P9|STARTED|Phase B (Week 25 to Week 52)||34
907331|NCT01697592|2193482|P8|STARTED|Phase B (Week 25 to Week 52)||33
907332|NCT01697592|2193483|P7|STARTED|Phase B (Week 25 to Week 52)||32
907333|NCT01697592|2193484|P6|STARTED|Phase B (Week 25 to Week 52)||62
907334|NCT01697592|2193485|P5|STARTED|Phase B (Week 25 to Week 52)||67
907335|NCT01697592|2193486|P4|STARTED|Phase B (Week 25 to Week 52)||63
907336|NCT01697592|2193487|P3|STARTED|Phase B (Week 25 to Week 52)||65
907337|NCT01697592|2193488|P2|STARTED|Phase B (Week 25 to Week 52)||62
907338|NCT01697592|2193489|P1|STARTED|Phase B (Week 25 to Week 52)||123
907339|NCT01697592|2193480|P10|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
907340|NCT01697592|2193481|P9|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
907341|NCT01697592|2193482|P8|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
907342|NCT01697592|2193483|P7|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
907343|NCT01697592|2193484|P6|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
907344|NCT01697592|2193485|P5|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
907345|NCT01697592|2193486|P4|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
907346|NCT01697592|2193487|P3|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
907347|NCT01697592|2193488|P2|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
907348|NCT01697592|2193489|P1|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
907349|NCT01697592|2193480|P10|COMPLETED|Phase A (Up to 24 Weeks)||30
907350|NCT01697592|2193481|P9|COMPLETED|Phase A (Up to 24 Weeks)||34
907351|NCT01697592|2193482|P8|COMPLETED|Phase A (Up to 24 Weeks)||33
907352|NCT01697592|2193483|P7|COMPLETED|Phase A (Up to 24 Weeks)||32
907353|NCT01697592|2193484|P6|COMPLETED|Phase A (Up to 24 Weeks)||62
907354|NCT01697592|2193485|P5|COMPLETED|Phase A (Up to 24 Weeks)||67
907355|NCT01697592|2193486|P4|COMPLETED|Phase A (Up to 24 Weeks)||63
907356|NCT01697592|2193487|P3|COMPLETED|Phase A (Up to 24 Weeks)||65
907357|NCT01697592|2193488|P2|COMPLETED|Phase A (Up to 24 Weeks)||62
907358|NCT01697592|2193489|P1|COMPLETED|Phase A (Up to 24 Weeks)||123
907359|NCT01697592|2193480|P10|STARTED|Phase A (Up to 24 Weeks)||32
907360|NCT01697592|2193481|P9|STARTED|Phase A (Up to 24 Weeks)||34
907361|NCT01697592|2193482|P8|STARTED|Phase A (Up to 24 Weeks)||33
907362|NCT01697592|2193483|P7|STARTED|Phase A (Up to 24 Weeks)||34
907363|NCT01697592|2193484|P6|STARTED|Phase A (Up to 24 Weeks)||63
907364|NCT01697592|2193485|P5|STARTED|Phase A (Up to 24 Weeks)||67
907365|NCT01697592|2193486|P4|STARTED|Phase A (Up to 24 Weeks)||65
907366|NCT01697592|2193487|P3|STARTED|Phase A (Up to 24 Weeks)||66
907367|NCT01697592|2193488|P2|STARTED|Phase A (Up to 24 Weeks)||65
907368|NCT01697592|2193489|P1|STARTED|Phase A (Up to 24 Weeks)||126
907369|NCT01697501|2193553|P1|NOT COMPLETED|Overall Study||2
907370|NCT01697501|2193553|P1|COMPLETED|Overall Study||86
907371|NCT01697501|2193553|P1|STARTED|Overall Study||88
907372|NCT01697462|2193596|P1|NOT COMPLETED|Overall Study||77
907373|NCT01697462|2193596|P1|COMPLETED|Overall Study||181
907374|NCT01697462|2193596|P1|STARTED|Overall Study||258
907375|NCT01697449|2193603|P1|NOT COMPLETED|Overall Study||90
907376|NCT01697449|2193603|P1|COMPLETED|Overall Study||101
907377|NCT01697449|2193603|P1|STARTED|Overall Study||191
907378|NCT01697358|2193614|P2|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||55
907379|NCT01697358|2193615|P1|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||49
907380|NCT01697358|2193614|P2|COMPLETED|Period II: 6-24M Long-term Follow-up||52
907381|NCT01697358|2193615|P1|COMPLETED|Period II: 6-24M Long-term Follow-up||48
907382|NCT01697358|2193614|P2|STARTED|Period II: 6-24M Long-term Follow-up||107
907383|NCT01697358|2193615|P1|STARTED|Period II: 6-24M Long-term Follow-up||97
907384|NCT01697358|2193614|P2|NOT COMPLETED|Period I: Randomization to 6 Months||1
907385|NCT01697358|2193615|P1|NOT COMPLETED|Period I: Randomization to 6 Months||13
907386|NCT01697358|2193614|P2|COMPLETED|Period I: Randomization to 6 Months||107
907387|NCT01697358|2193615|P1|COMPLETED|Period I: Randomization to 6 Months||97
907388|NCT01697358|2193614|P2|STARTED|Period I: Randomization to 6 Months||108
907389|NCT01697358|2193615|P1|STARTED|Period I: Randomization to 6 Months||110
907390|NCT01697345|2193631|P1|NOT COMPLETED|Overall Study||1
907391|NCT01697345|2193631|P1|COMPLETED|Overall Study|One patient withdrew due to symptoms of recurrent Gardnerella vaginalis.|12
907392|NCT01697345|2193631|P1|STARTED|Overall Study||13
907393|NCT01697319|2193650|P1|NOT COMPLETED|Extension Phase||15
907394|NCT01697319|2193650|P1|COMPLETED|Extension Phase||0
907395|NCT01697319|2193650|P1|STARTED|Extension Phase||15
907396|NCT01697319|2193650|P1|NOT COMPLETED|Primary Phase||1
907397|NCT01697319|2193650|P1|COMPLETED|Primary Phase||15
907398|NCT01697319|2193650|P1|STARTED|Primary Phase|One subject enrolled but did not receive a single dose of study drug|16
907399|NCT01696994|2193659|P2|NOT COMPLETED|Overall Study||8437
907400|NCT01696994|2193660|P1|NOT COMPLETED|Overall Study||5192
907401|NCT01696994|2193659|P2|COMPLETED|Overall Study||30668
907402|NCT01696994|2193660|P1|COMPLETED|Overall Study||33919
907403|NCT01696994|2193659|P2|STARTED|Overall Study||39105
907404|NCT01696994|2193660|P1|STARTED|Overall Study||39111
907405|NCT01696981|2193688|P2|NOT COMPLETED|Overall Study||10374
907406|NCT01696981|2193689|P1|NOT COMPLETED|Overall Study||1201
907407|NCT01696981|2193688|P2|COMPLETED|Overall Study||67071
907408|NCT01696981|2193689|P1|COMPLETED|Overall Study||76254
907409|NCT01696981|2193688|P2|STARTED|Overall Study||77445
907410|NCT01696981|2193689|P1|STARTED|Overall Study||77455
907411|NCT01696968|2193709|P2|NOT COMPLETED|Overall Study||6812
907412|NCT01696968|2193710|P1|NOT COMPLETED|Overall Study||1201
907413|NCT01696968|2193709|P2|COMPLETED|Overall Study||70633
907414|NCT01696968|2193710|P1|COMPLETED|Overall Study||76255
907415|NCT01696968|2193709|P2|STARTED|Overall Study||77445
907416|NCT01696968|2193710|P1|STARTED|Overall Study||77456
907423|NCT01696929|2193741|P1|NOT COMPLETED|Overall Study||1
907424|NCT01696929|2193741|P1|COMPLETED|Overall Study||5
907425|NCT01696929|2193741|P1|STARTED|Overall Study||6
907426|NCT01696773|2193748|P2|NOT COMPLETED|Day 28, Second Intervention||0
907427|NCT01696773|2193749|P1|NOT COMPLETED|Day 28, Second Intervention||0
907428|NCT01696773|2193748|P2|COMPLETED|Day 28, Second Intervention||6
907429|NCT01696773|2193749|P1|COMPLETED|Day 28, Second Intervention||5
907430|NCT01696773|2193748|P2|STARTED|Day 28, Second Intervention||6
907431|NCT01696773|2193749|P1|STARTED|Day 28, Second Intervention||5
907432|NCT01696773|2193748|P2|NOT COMPLETED|Days 15-27, Washout||0
907433|NCT01696773|2193749|P1|NOT COMPLETED|Days 15-27, Washout||1
907434|NCT01696773|2193748|P2|COMPLETED|Days 15-27, Washout||6
907435|NCT01696773|2193749|P1|COMPLETED|Days 15-27, Washout||5
907436|NCT01696773|2193748|P2|STARTED|Days 15-27, Washout||6
907437|NCT01696773|2193749|P1|STARTED|Days 15-27, Washout||6
907438|NCT01696773|2193748|P2|NOT COMPLETED|Day 14, First Intervention||0
907439|NCT01696773|2193749|P1|NOT COMPLETED|Day 14, First Intervention||0
907440|NCT01696773|2193748|P2|COMPLETED|Day 14, First Intervention||6
907441|NCT01696773|2193749|P1|COMPLETED|Day 14, First Intervention||6
907442|NCT01696773|2193748|P2|STARTED|Day 14, First Intervention||6
907443|NCT01696773|2193749|P1|STARTED|Day 14, First Intervention||6
907444|NCT01696773|2193748|P2|NOT COMPLETED|Days 1-13, Washout||0
907445|NCT01696773|2193749|P1|NOT COMPLETED|Days 1-13, Washout||0
907446|NCT01696773|2193748|P2|COMPLETED|Days 1-13, Washout||6
907447|NCT01696773|2193749|P1|COMPLETED|Days 1-13, Washout||6
907448|NCT01696773|2193748|P2|STARTED|Days 1-13, Washout||6
907449|NCT01696773|2193749|P1|STARTED|Days 1-13, Washout||6
907450|NCT01696760|2193757|P2|NOT COMPLETED|Overall Study||0
907451|NCT01696760|2193758|P1|NOT COMPLETED|Overall Study||0
907452|NCT01696760|2193757|P2|COMPLETED|Overall Study||3
907453|NCT01696760|2193758|P1|COMPLETED|Overall Study||9
907454|NCT01696760|2193757|P2|STARTED|Overall Study||3
907455|NCT01696760|2193758|P1|STARTED|Overall Study||9
907456|NCT01696695|2193776|P1|NOT COMPLETED|Overall Study||882
907457|NCT01696695|2193776|P1|COMPLETED|Overall Study||0
907458|NCT01696695|2193776|P1|STARTED|Overall Study||882
907459|NCT01696643|2193788|P2|NOT COMPLETED|Overall Study||535
907460|NCT01696643|2193789|P1|NOT COMPLETED|Overall Study||529
907461|NCT01696643|2193788|P2|COMPLETED|Overall Study||169
907462|NCT01696643|2193789|P1|COMPLETED|Overall Study||174
907463|NCT01696643|2193788|P2|Received at Least 1 Dose of Study Drug|Overall Study|2 participants randomized to placebo took CB-5945. Their results are included in the CB-5945 group.|702
907464|NCT01696643|2193789|P1|Received at Least 1 Dose of Study Drug|Overall Study||701
907465|NCT01696643|2193788|P2|STARTED|Overall Study||704
907466|NCT01696643|2193789|P1|STARTED|Overall Study||703
907467|NCT01696357|2193806|P2|NOT COMPLETED|Overall Study||1
907468|NCT01696357|2193807|P1|NOT COMPLETED|Overall Study||2
907469|NCT01696357|2193806|P2|COMPLETED|Overall Study||41
907470|NCT01696357|2193807|P1|COMPLETED|Overall Study||40
907471|NCT01696357|2193806|P2|STARTED|Overall Study||42
907472|NCT01696357|2193807|P1|STARTED|Overall Study||42
907473|NCT01696214|2193817|P4|NOT COMPLETED|Overall Study||0
907474|NCT01696214|2193818|P3|NOT COMPLETED|Overall Study||0
907475|NCT01696214|2193819|P2|NOT COMPLETED|Overall Study||1
907476|NCT01696214|2193820|P1|NOT COMPLETED|Overall Study||0
907477|NCT01696214|2193817|P4|COMPLETED|Overall Study||5
907478|NCT01696214|2193818|P3|COMPLETED|Overall Study||5
907479|NCT01696214|2193819|P2|COMPLETED|Overall Study||4
907480|NCT01696214|2193820|P1|COMPLETED|Overall Study||5
907481|NCT01696214|2193817|P4|STARTED|Overall Study||5
907482|NCT01696214|2193818|P3|STARTED|Overall Study||5
907483|NCT01696214|2193819|P2|STARTED|Overall Study||5
907484|NCT01696214|2193820|P1|STARTED|Overall Study||5
907485|NCT01696188|2193832|P2|NOT COMPLETED|Overall Study||1
907486|NCT01696188|2193833|P1|NOT COMPLETED|Overall Study||1
907487|NCT01696188|2193832|P2|COMPLETED|Overall Study||42
907488|NCT01696188|2193833|P1|COMPLETED|Overall Study||40
907489|NCT01696188|2193832|P2|STARTED|Overall Study||43
907490|NCT01696188|2193833|P1|STARTED|Overall Study||41
907491|NCT01696084|2193847|P2|NOT COMPLETED|Overall Study||146
907492|NCT01696084|2193848|P1|NOT COMPLETED|Overall Study||131
907493|NCT01696084|2193847|P2|COMPLETED|Overall Study||10
907494|NCT01696084|2193848|P1|COMPLETED|Overall Study||22
907495|NCT01696084|2193847|P2|STARTED|Overall Study||156
907496|NCT01696084|2193848|P1|STARTED|Overall Study||153
907497|NCT01696071|2193864|P2|NOT COMPLETED|Treatment Period 2: 4 Weeks||0
907498|NCT01696071|2193865|P1|NOT COMPLETED|Treatment Period 2: 4 Weeks||1
907499|NCT01696071|2193864|P2|COMPLETED|Treatment Period 2: 4 Weeks||47
907500|NCT01696071|2193865|P1|COMPLETED|Treatment Period 2: 4 Weeks||50
907501|NCT01696071|2193864|P2|STARTED|Treatment Period 2: 4 Weeks||47
907502|NCT01696071|2193865|P1|STARTED|Treatment Period 2: 4 Weeks||51
907503|NCT01696071|2193864|P2|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
907504|NCT01696071|2193865|P1|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
907505|NCT01696071|2193864|P2|COMPLETED|Treatment Period 1: 4 Weeks||47
907506|NCT01696071|2193865|P1|COMPLETED|Treatment Period 1: 4 Weeks||51
907507|NCT01696071|2193864|P2|STARTED|Treatment Period 1: 4 Weeks||47
907508|NCT01696071|2193865|P1|STARTED|Treatment Period 1: 4 Weeks||51
907509|NCT01696058|2193893|P2|NOT COMPLETED|Overall Study||31
907510|NCT01696058|2193894|P1|NOT COMPLETED|Overall Study||43
907511|NCT01696058|2193893|P2|COMPLETED|Overall Study||538
907512|NCT01696058|2193894|P1|COMPLETED|Overall Study||523
907513|NCT01696058|2193893|P2|STARTED|Overall Study||569
907514|NCT01696058|2193894|P1|STARTED|Overall Study||566
907515|NCT01696045|2193922|P2|NOT COMPLETED|Overall Study||7
907516|NCT01696045|2193923|P1|NOT COMPLETED|Overall Study||3
907517|NCT01696045|2193922|P2|COMPLETED|Overall Study||1
907518|NCT01696045|2193923|P1|COMPLETED|Overall Study||1
907519|NCT01696045|2193922|P2|STARTED|Overall Study||8
907520|NCT01696045|2193923|P1|STARTED|Overall Study||4
907521|NCT01695772|2193939|P1|NOT COMPLETED|Overall Study||38
907522|NCT01695772|2193939|P1|COMPLETED|Overall Study||12
907523|NCT01695772|2193939|P1|STARTED|Overall Study||50
907524|NCT01695746|2193951|P1|NOT COMPLETED|Overall Study||12
907525|NCT01695746|2193951|P1|COMPLETED|Overall Study||96
907526|NCT01695746|2193951|P1|STARTED|Overall Study||108
907527|NCT01695668|2193967|P2|NOT COMPLETED|Overall Study||17
907528|NCT01695668|2193968|P1|NOT COMPLETED|Overall Study||15
907529|NCT01695668|2193967|P2|COMPLETED|Overall Study||20
907530|NCT01695668|2193968|P1|COMPLETED|Overall Study||23
907531|NCT01695668|2193967|P2|STARTED|Overall Study||37
907532|NCT01695668|2193968|P1|STARTED|Overall Study||38
907533|NCT01695369|2193974|P1|NOT COMPLETED|Overall Study||0
907534|NCT01695369|2193974|P1|COMPLETED|Overall Study||61
907535|NCT01695369|2193974|P1|STARTED|Overall Study||61
907536|NCT01695330|2193980|P2|NOT COMPLETED|Overall Study||0
907537|NCT01695330|2193981|P1|NOT COMPLETED|Overall Study||47
907538|NCT01695330|2193980|P2|COMPLETED|Overall Study||0
907539|NCT01695330|2193981|P1|COMPLETED|Overall Study||5
907540|NCT01695330|2193980|P2|STARTED|Overall Study||0
907541|NCT01695330|2193981|P1|STARTED|Overall Study||52
907542|NCT01695304|2193987|P2|NOT COMPLETED|Overall Study||0
907543|NCT01695304|2193988|P1|NOT COMPLETED|Overall Study||0
907544|NCT01695304|2193987|P2|COMPLETED|Overall Study|3 deaths & 2 drop out in the intervention group, contributed some information over the 26 weeks|120
907545|NCT01695304|2193988|P1|COMPLETED|Overall Study|2 deaths & 1 drop out in the intervention group, contributed some information over the 26 weeks|120
907546|NCT01695304|2193987|P2|STARTED|Overall Study||120
907547|NCT01695304|2193988|P1|STARTED|Overall Study||120
907568|NCT01695044|2194094|P1|NOT COMPLETED|Overall Study||102
907569|NCT01695044|2194094|P1|COMPLETED|Overall Study||17
907570|NCT01695044|2194094|P1|STARTED|Overall Study||119
907571|NCT01694771|2194106|P2|NOT COMPLETED|Overall Study||40
907572|NCT01694771|2194107|P1|NOT COMPLETED|Overall Study||40
907573|NCT01694771|2194106|P2|COMPLETED|Overall Study||525
907574|NCT01694771|2194107|P1|COMPLETED|Overall Study||527
907575|NCT01694771|2194106|P2|STARTED|Overall Study||565
907576|NCT01694771|2194107|P1|STARTED|Overall Study||567
907577|NCT01694706|2194131|P3|NOT COMPLETED|Overall Study||0
907578|NCT01694706|2194132|P2|NOT COMPLETED|Overall Study||1
907579|NCT01694706|2194133|P1|NOT COMPLETED|Overall Study||1
907580|NCT01694706|2194131|P3|COMPLETED|Overall Study||5
907581|NCT01694706|2194132|P2|COMPLETED|Overall Study||4
907582|NCT01694706|2194133|P1|COMPLETED|Overall Study||4
907583|NCT01694706|2194131|P3|Received Faldaprevir Fed|Overall Study||5
907584|NCT01694706|2194132|P2|Received Faldaprevir Fed|Overall Study||5
907585|NCT01694706|2194133|P1|Received Faldaprevir Fed|Overall Study||4
907586|NCT01694706|2194131|P3|Received Faldaprevir +OMP|Overall Study||5
907587|NCT01694706|2194132|P2|Received Faldaprevir +OMP|Overall Study||5
907588|NCT01694706|2194133|P1|Received Faldaprevir +OMP|Overall Study||5
907589|NCT01694706|2194131|P3|Received Faldaprevir|Overall Study||5
907590|NCT01694706|2194132|P2|Received Faldaprevir|Overall Study||5
907591|NCT01694706|2194133|P1|Received Faldaprevir|Overall Study||5
907592|NCT01694706|2194131|P3|STARTED|Overall Study||5
907593|NCT01694706|2194132|P2|STARTED|Overall Study||5
907594|NCT01694706|2194133|P1|STARTED|Overall Study||5
907595|NCT01694667|2194150|P2|NOT COMPLETED|Overall Study||0
907596|NCT01694667|2194151|P1|NOT COMPLETED|Overall Study||0
907597|NCT01694667|2194150|P2|COMPLETED|Overall Study||28
907598|NCT01694667|2194151|P1|COMPLETED|Overall Study||29
907599|NCT01694667|2194150|P2|STARTED|Overall Study||28
907600|NCT01694667|2194151|P1|STARTED|Overall Study||29
907601|NCT01694641|2194169|P2|NOT COMPLETED|Overall Study||10
907602|NCT01694641|2194170|P1|NOT COMPLETED|Overall Study||12
907603|NCT01694641|2194169|P2|COMPLETED|Overall Study||71
907604|NCT01694641|2194170|P1|COMPLETED|Overall Study||68
907605|NCT01694641|2194169|P2|STARTED|Overall Study||81
907606|NCT01694641|2194170|P1|STARTED|Overall Study||80
907607|NCT01694420|2194176|P1|NOT COMPLETED|Overall Study||3
907608|NCT01694420|2194176|P1|COMPLETED|Overall Study||30
907609|NCT01694420|2194176|P1|STARTED|Overall Study||33
907610|NCT01694199|2194187|P2|NOT COMPLETED|Overall Study||0
907611|NCT01694199|2194188|P1|NOT COMPLETED|Overall Study||0
907612|NCT01694199|2194187|P2|COMPLETED|Overall Study||68
907613|NCT01694199|2194188|P1|COMPLETED|Overall Study||71
907614|NCT01694199|2194187|P2|STARTED|Overall Study||68
907615|NCT01694199|2194188|P1|STARTED|Overall Study||71
907616|NCT01694108|2194204|P2|NOT COMPLETED|Overall Study||0
907617|NCT01694108|2194205|P1|NOT COMPLETED|Overall Study||0
907618|NCT01694108|2194204|P2|COMPLETED|Overall Study|100% follow-up|2133
907619|NCT01694108|2194205|P1|COMPLETED|Overall Study|100% follow-up|2129
907620|NCT01694108|2194204|P2|STARTED|Overall Study||2133
907621|NCT01694108|2194205|P1|STARTED|Overall Study||2129
907622|NCT01693900|2194261|P2|NOT COMPLETED|Overall Study||0
907623|NCT01693900|2194262|P1|NOT COMPLETED|Overall Study||0
907624|NCT01693900|2194261|P2|COMPLETED|Overall Study||25
907625|NCT01693900|2194262|P1|COMPLETED|Overall Study||25
907626|NCT01693900|2194261|P2|STARTED|Overall Study||25
907627|NCT01693900|2194262|P1|STARTED|Overall Study||25
907634|NCT01693484|2194283|P1|NOT COMPLETED|Overall Study||13
907635|NCT01693484|2194283|P1|COMPLETED|Overall Study|Study closed by PI|0
907636|NCT01693484|2194283|P1|STARTED|Overall Study||13
907637|NCT01693367|2194289|P2|NOT COMPLETED|Overall Study||2
907638|NCT01693367|2194290|P1|NOT COMPLETED|Overall Study||1
907639|NCT01693367|2194289|P2|COMPLETED|Overall Study||1
907640|NCT01693367|2194290|P1|COMPLETED|Overall Study||1
907641|NCT01693367|2194289|P2|STARTED|Overall Study||3
907642|NCT01693367|2194290|P1|STARTED|Overall Study||2
907643|NCT01693185|2194308|P2|NOT COMPLETED|Overall Study||6
907644|NCT01693185|2194309|P1|NOT COMPLETED|Overall Study||0
907645|NCT01693185|2194308|P2|COMPLETED|Overall Study||27
907646|NCT01693185|2194309|P1|COMPLETED|Overall Study||27
907647|NCT01693185|2194308|P2|STARTED|Overall Study||33
907648|NCT01693185|2194309|P1|STARTED|Overall Study||27
907649|NCT01693029|2194327|P2|NOT COMPLETED|Overall Study||57
907650|NCT01693029|2194328|P1|NOT COMPLETED|Overall Study||44
907651|NCT01693029|2194327|P2|COMPLETED|Overall Study||161
907652|NCT01693029|2194328|P1|COMPLETED|Overall Study||173
907653|NCT01693029|2194327|P2|STARTED|Overall Study||218
907654|NCT01693029|2194328|P1|STARTED|Overall Study||217
907655|NCT01692951|2194344|P4|NOT COMPLETED|Overall Study||0
907656|NCT01692951|2194345|P3|NOT COMPLETED|Overall Study||0
907657|NCT01692951|2194346|P2|NOT COMPLETED|Overall Study||0
907658|NCT01692951|2194347|P1|NOT COMPLETED|Overall Study||0
907659|NCT01692951|2194344|P4|COMPLETED|Overall Study||54
907660|NCT01692951|2194345|P3|COMPLETED|Overall Study||18
907661|NCT01692951|2194346|P2|COMPLETED|Overall Study||111
907662|NCT01692951|2194347|P1|COMPLETED|Overall Study||37
907663|NCT01692951|2194344|P4|STARTED|Overall Study||54
907664|NCT01692951|2194345|P3|STARTED|Overall Study||18
907665|NCT01692951|2194346|P2|STARTED|Overall Study||111
907666|NCT01692951|2194347|P1|STARTED|Overall Study||37
907667|NCT01692938|2194359|P2|NOT COMPLETED|Overall Study||4
907668|NCT01692938|2194360|P1|NOT COMPLETED|Overall Study||4
907669|NCT01692938|2194359|P2|COMPLETED|Overall Study||12
907670|NCT01692938|2194360|P1|COMPLETED|Overall Study||12
907671|NCT01692938|2194359|P2|STARTED|Overall Study||16
907672|NCT01692938|2194360|P1|STARTED|Overall Study||16
907673|NCT01692782|2194371|P3|NOT COMPLETED|Overall Study||10
907674|NCT01692782|2194372|P2|NOT COMPLETED|Overall Study||56
907675|NCT01692782|2194373|P1|NOT COMPLETED|Overall Study||20
907676|NCT01692782|2194371|P3|COMPLETED|Overall Study||100
907677|NCT01692782|2194372|P2|COMPLETED|Overall Study||59
907678|NCT01692782|2194373|P1|COMPLETED|Overall Study||96
907679|NCT01692782|2194371|P3|STARTED|Overall Study||110
907680|NCT01692782|2194372|P2|STARTED|Overall Study||115
907681|NCT01692782|2194373|P1|STARTED|Overall Study||116
907685|NCT01692626|2194401|P2|NOT COMPLETED|Overall Study||6
907686|NCT01692626|2194402|P1|NOT COMPLETED|Overall Study||4
907687|NCT01692626|2194401|P2|COMPLETED|Overall Study||1
907688|NCT01692626|2194402|P1|COMPLETED|Overall Study||2
907689|NCT01692626|2194401|P2|STARTED|Overall Study||7
907690|NCT01692626|2194402|P1|STARTED|Overall Study||6
907691|NCT01692340|2194410|P3|NOT COMPLETED|Overall Study||0
907692|NCT01692340|2194411|P2|NOT COMPLETED|Overall Study||0
907693|NCT01692340|2194412|P1|NOT COMPLETED|Overall Study||0
907694|NCT01692340|2194410|P3|COMPLETED|Overall Study||0
907695|NCT01692340|2194411|P2|COMPLETED|Overall Study||4
907696|NCT01692340|2194412|P1|COMPLETED|Overall Study||8
907697|NCT01692340|2194410|P3|STARTED|Overall Study||0
907698|NCT01692340|2194411|P2|STARTED|Overall Study||4
907699|NCT01692340|2194412|P1|STARTED|Overall Study||8
907700|NCT01692301|2194431|P2|NOT COMPLETED|Overall Study||42
907701|NCT01692301|2194432|P1|NOT COMPLETED|Overall Study||45
907702|NCT01692301|2194431|P2|COMPLETED|Overall Study||183
907703|NCT01692301|2194432|P1|COMPLETED|Overall Study||184
907704|NCT01692301|2194431|P2|STARTED|Overall Study||225
907705|NCT01692301|2194432|P1|STARTED|Overall Study|"Started indicates patients in randomized, full analysis and safety set"|229
907706|NCT01691885|2194458|P2|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
907707|NCT01691885|2194459|P1|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
907708|NCT01691885|2194458|P2|COMPLETED|Treatment Period 2 (7-14 Days)||21
907709|NCT01691885|2194459|P1|COMPLETED|Treatment Period 2 (7-14 Days)||21
907710|NCT01691885|2194458|P2|STARTED|Treatment Period 2 (7-14 Days)||21
907711|NCT01691885|2194459|P1|STARTED|Treatment Period 2 (7-14 Days)||21
907712|NCT01691885|2194458|P2|NOT COMPLETED|Washout Period (7-9 Days)||1
907713|NCT01691885|2194459|P1|NOT COMPLETED|Washout Period (7-9 Days)||0
907714|NCT01691885|2194458|P2|COMPLETED|Washout Period (7-9 Days)||21
907715|NCT01691885|2194459|P1|COMPLETED|Washout Period (7-9 Days)||21
907716|NCT01691885|2194458|P2|STARTED|Washout Period (7-9 Days)||22
907717|NCT01691885|2194459|P1|STARTED|Washout Period (7-9 Days)||21
907718|NCT01691885|2194458|P2|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
907719|NCT01691885|2194459|P1|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
907720|NCT01691885|2194458|P2|COMPLETED|Treatment Period 1(7-14 Days)||22
907721|NCT01691885|2194459|P1|COMPLETED|Treatment Period 1(7-14 Days)||21
907722|NCT01691885|2194458|P2|STARTED|Treatment Period 1(7-14 Days)||23
907723|NCT01691885|2194459|P1|STARTED|Treatment Period 1(7-14 Days)||22
907724|NCT01691794|2194468|P3|NOT COMPLETED|Overall Study||3
907725|NCT01691794|2194469|P2|NOT COMPLETED|Overall Study||3
907726|NCT01691794|2194470|P1|NOT COMPLETED|Overall Study||0
907727|NCT01691794|2194468|P3|COMPLETED|Overall Study|Completed Phase 1 (to Week 24)|20
907728|NCT01691794|2194469|P2|COMPLETED|Overall Study|Completed Phase 1 (to Week 24)|30
907729|NCT01691794|2194470|P1|COMPLETED|Overall Study|Completed Phase 1 (to Week 24)|3
907730|NCT01691794|2194468|P3|STARTED|Overall Study||23
907731|NCT01691794|2194469|P2|STARTED|Overall Study||33
907732|NCT01691794|2194470|P1|STARTED|Overall Study||3
907733|NCT01691781|2194486|P2|NOT COMPLETED|Overall Study||7
907734|NCT01691781|2194487|P1|NOT COMPLETED|Overall Study||7
907735|NCT01691781|2194486|P2|COMPLETED|Overall Study||15
907736|NCT01691781|2194487|P1|COMPLETED|Overall Study||12
907737|NCT01691781|2194486|P2|STARTED|Overall Study||22
907738|NCT01691781|2194487|P1|STARTED|Overall Study||19
907739|NCT01691690|2194499|P2|NOT COMPLETED|Overall Study||4
907740|NCT01691690|2194500|P1|NOT COMPLETED|Overall Study||7
907741|NCT01691690|2194499|P2|COMPLETED|Overall Study||121
907742|NCT01691690|2194500|P1|COMPLETED|Overall Study||118
907743|NCT01691690|2194499|P2|STARTED|Overall Study||125
907744|NCT01691690|2194500|P1|STARTED|Overall Study||125
907745|NCT01691612|2194510|P1|NOT COMPLETED|Overall Study||7
907746|NCT01691612|2194510|P1|COMPLETED|Overall Study||7
907747|NCT01691612|2194510|P1|Second Visit (Bronchoscopy)|Overall Study||7
907748|NCT01691612|2194510|P1|First Visit (Allergen Challenge)|Overall Study||8
907749|NCT01691612|2194510|P1|STARTED|Overall Study||14
907750|NCT01691560|2194521|P4|NOT COMPLETED|Overall Study||0
907751|NCT01691560|2194522|P3|NOT COMPLETED|Overall Study||0
907752|NCT01691560|2194523|P2|NOT COMPLETED|Overall Study||0
907753|NCT01691560|2194524|P1|NOT COMPLETED|Overall Study||0
907754|NCT01691560|2194521|P4|COMPLETED|Overall Study||33
907755|NCT01691560|2194522|P3|COMPLETED|Overall Study||34
907756|NCT01691560|2194523|P2|COMPLETED|Overall Study||33
907757|NCT01691560|2194524|P1|COMPLETED|Overall Study||34
907758|NCT01691560|2194521|P4|STARTED|Overall Study||33
907759|NCT01691560|2194522|P3|STARTED|Overall Study||34
907760|NCT01691560|2194523|P2|STARTED|Overall Study||33
907761|NCT01691560|2194524|P1|STARTED|Overall Study||34
907762|NCT01691534|2194561|P7|NOT COMPLETED|Overall Study||1
907763|NCT01691534|2194562|P6|NOT COMPLETED|Overall Study||1
907764|NCT01691534|2194563|P5|NOT COMPLETED|Overall Study||0
907765|NCT01691534|2194564|P4|NOT COMPLETED|Overall Study||1
907766|NCT01691534|2194565|P3|NOT COMPLETED|Overall Study||1
907767|NCT01691534|2194566|P2|NOT COMPLETED|Overall Study||1
907768|NCT01691534|2194567|P1|NOT COMPLETED|Overall Study||0
907769|NCT01691534|2194561|P7|COMPLETED|Overall Study||14
907770|NCT01691534|2194562|P6|COMPLETED|Overall Study||14
907771|NCT01691534|2194563|P5|COMPLETED|Overall Study||15
907772|NCT01691534|2194564|P4|COMPLETED|Overall Study||14
907773|NCT01691534|2194565|P3|COMPLETED|Overall Study||14
907774|NCT01691534|2194566|P2|COMPLETED|Overall Study||14
907775|NCT01691534|2194567|P1|COMPLETED|Overall Study||15
907776|NCT01691534|2194561|P7|STARTED|Overall Study||15
907777|NCT01691534|2194562|P6|STARTED|Overall Study||15
907778|NCT01691534|2194563|P5|STARTED|Overall Study||15
907779|NCT01691534|2194564|P4|STARTED|Overall Study||15
907780|NCT01691534|2194565|P3|STARTED|Overall Study||15
907781|NCT01691534|2194566|P2|STARTED|Overall Study||15
907782|NCT01691534|2194567|P1|STARTED|Overall Study||15
907783|NCT01691521|2194621|P3|NOT COMPLETED|Overall Study||9
907784|NCT01691521|2194622|P2|NOT COMPLETED|Overall Study||16
907785|NCT01691521|2194623|P1|NOT COMPLETED|Overall Study||12
907786|NCT01691521|2194621|P3|COMPLETED|Overall Study||185
907787|NCT01691521|2194622|P2|COMPLETED|Overall Study||175
907788|NCT01691521|2194623|P1|COMPLETED|Overall Study||179
907789|NCT01691521|2194621|P3|STARTED|Overall Study||194
907790|NCT01691521|2194622|P2|STARTED|Overall Study||191
907791|NCT01691521|2194623|P1|STARTED|Overall Study||191
907792|NCT01691508|2194645|P2|NOT COMPLETED|Overall Study||3
907793|NCT01691508|2194646|P1|NOT COMPLETED|Overall Study||4
907794|NCT01691508|2194645|P2|COMPLETED|Overall Study||66
907795|NCT01691508|2194646|P1|COMPLETED|Overall Study||62
907796|NCT01691508|2194645|P2|STARTED|Overall Study||69
907797|NCT01691508|2194646|P1|STARTED|Overall Study||66
907798|NCT01691482|2194660|P2|NOT COMPLETED|Treatment Period 2||2
907799|NCT01691482|2194661|P1|NOT COMPLETED|Treatment Period 2||1
907800|NCT01691482|2194660|P2|COMPLETED|Treatment Period 2||26
907801|NCT01691482|2194661|P1|COMPLETED|Treatment Period 2||27
907802|NCT01691482|2194660|P2|STARTED|Treatment Period 2||28
907803|NCT01691482|2194661|P1|STARTED|Treatment Period 2||28
907804|NCT01691482|2194660|P2|NOT COMPLETED|Treatment Period 1||0
907805|NCT01691482|2194661|P1|NOT COMPLETED|Treatment Period 1||0
907806|NCT01691482|2194660|P2|COMPLETED|Treatment Period 1||28
907807|NCT01691482|2194661|P1|COMPLETED|Treatment Period 1||28
907808|NCT01691482|2194660|P2|STARTED|Treatment Period 1||28
907809|NCT01691482|2194661|P1|STARTED|Treatment Period 1||28
907810|NCT01691339|2194681|P4|NOT COMPLETED|Overall Study||0
907811|NCT01691339|2194682|P3|NOT COMPLETED|Overall Study||0
907812|NCT01691339|2194683|P2|NOT COMPLETED|Overall Study||0
907813|NCT01691339|2194684|P1|NOT COMPLETED|Overall Study||0
907814|NCT01691339|2194681|P4|COMPLETED|Overall Study||49
907815|NCT01691339|2194682|P3|COMPLETED|Overall Study||51
907816|NCT01691339|2194683|P2|COMPLETED|Overall Study||50
907817|NCT01691339|2194684|P1|COMPLETED|Overall Study||50
907818|NCT01691339|2194681|P4|STARTED|Overall Study||49
907819|NCT01691339|2194682|P3|STARTED|Overall Study||51
907820|NCT01691339|2194683|P2|STARTED|Overall Study||50
907821|NCT01691339|2194684|P1|STARTED|Overall Study||50
907822|NCT01691326|2194712|P2|NOT COMPLETED|Overall Study||0
907823|NCT01691326|2194713|P1|NOT COMPLETED|Overall Study||0
907824|NCT01691326|2194712|P2|COMPLETED|Overall Study||30
907825|NCT01691326|2194713|P1|COMPLETED|Overall Study||30
907826|NCT01691326|2194712|P2|STARTED|Overall Study||30
907827|NCT01691326|2194713|P1|STARTED|Overall Study||30
907828|NCT01691313|2194731|P4|NOT COMPLETED|Overall Study||0
907829|NCT01691313|2194732|P3|NOT COMPLETED|Overall Study||0
907830|NCT01691313|2194733|P2|NOT COMPLETED|Overall Study||0
907831|NCT01691313|2194734|P1|NOT COMPLETED|Overall Study||0
907832|NCT01691313|2194731|P4|COMPLETED|Overall Study||25
907833|NCT01691313|2194732|P3|COMPLETED|Overall Study||25
907834|NCT01691313|2194733|P2|COMPLETED|Overall Study||32
907835|NCT01691313|2194734|P1|COMPLETED|Overall Study||22
907836|NCT01691313|2194731|P4|STARTED|Overall Study||25
907837|NCT01691313|2194732|P3|STARTED|Overall Study||25
907838|NCT01691313|2194733|P2|STARTED|Overall Study||32
907839|NCT01691313|2194734|P1|STARTED|Overall Study||22
907840|NCT01691248|2194750|P2|NOT COMPLETED|Overall Study||114
907841|NCT01691248|2194751|P1|NOT COMPLETED|Overall Study||111
907842|NCT01691248|2194750|P2|COMPLETED|Overall Study||192
907843|NCT01691248|2194751|P1|COMPLETED|Overall Study||194
907844|NCT01691248|2194750|P2|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
907845|NCT01691248|2194751|P1|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
907846|NCT01691248|2194750|P2|Treated|Overall Study|Received at least 1 dose of study drug|299
907847|NCT01691248|2194751|P1|Treated|Overall Study|Received at least 1 dose of study drug|301
907848|NCT01691248|2194750|P2|STARTED|Overall Study|Randomized|306
907849|NCT01691248|2194751|P1|STARTED|Overall Study|Randomized|305
907850|NCT01691092|2194761|P1|NOT COMPLETED|Overall Study||41
907851|NCT01691092|2194761|P1|COMPLETED|Overall Study||38
907852|NCT01691092|2194761|P1|STARTED|Overall Study||79
907853|NCT01691014|2194769|P4|NOT COMPLETED|Overall Study||5
907854|NCT01691014|2194770|P3|NOT COMPLETED|Overall Study||11
907855|NCT01691014|2194771|P2|NOT COMPLETED|Overall Study||15
907856|NCT01691014|2194772|P1|NOT COMPLETED|Overall Study||3
907857|NCT01691014|2194769|P4|COMPLETED|Overall Study||4
907858|NCT01691014|2194770|P3|COMPLETED|Overall Study||25
907859|NCT01691014|2194771|P2|COMPLETED|Overall Study||11
907860|NCT01691014|2194772|P1|COMPLETED|Overall Study||5
907861|NCT01691014|2194769|P4|STARTED|Overall Study||9
907862|NCT01691014|2194770|P3|STARTED|Overall Study||36
907863|NCT01691014|2194771|P2|STARTED|Overall Study||26
907864|NCT01691014|2194772|P1|STARTED|Overall Study||8
907865|NCT01690923|2194814|P2|NOT COMPLETED|Overall Study||1
907866|NCT01690923|2194815|P1|NOT COMPLETED|Overall Study||0
907867|NCT01690923|2194814|P2|COMPLETED|Overall Study||10
907868|NCT01690923|2194815|P1|COMPLETED|Overall Study||10
907869|NCT01690923|2194814|P2|STARTED|Overall Study|1 participant was withdrawn and excluded due to poor fit with the pillows mask|11
907870|NCT01690923|2194815|P1|STARTED|Overall Study||10
907871|NCT01690663|2194824|P4|NOT COMPLETED|Overall Study||4
907872|NCT01690663|2194825|P3|NOT COMPLETED|Overall Study||3
907873|NCT01690663|2194826|P2|NOT COMPLETED|Overall Study||3
907874|NCT01690663|2194827|P1|NOT COMPLETED|Overall Study||3
907875|NCT01690663|2194824|P4|COMPLETED|Overall Study||20
907876|NCT01690663|2194825|P3|COMPLETED|Overall Study||19
907877|NCT01690663|2194826|P2|COMPLETED|Overall Study||17
907878|NCT01690663|2194827|P1|COMPLETED|Overall Study||20
907879|NCT01690663|2194824|P4|STARTED|Overall Study||24
907880|NCT01690663|2194825|P3|STARTED|Overall Study||22
907881|NCT01690663|2194826|P2|STARTED|Overall Study||20
907882|NCT01690663|2194827|P1|STARTED|Overall Study||23
907883|NCT01690546|2194841|P1|NOT COMPLETED|Overall Study||9
907884|NCT01690546|2194841|P1|COMPLETED|Overall Study||26
907885|NCT01690546|2194841|P1|Extended Release Injectable NTX|Overall Study||27
907886|NCT01690546|2194841|P1|STARTED|Overall Study||35
907887|NCT01690299|2194857|P6|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||30
907888|NCT01690299|2194858|P5|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||33
907889|NCT01690299|2194859|P4|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||26
907890|NCT01690299|2194860|P3|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
907891|NCT01690299|2194861|P2|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
907892|NCT01690299|2194862|P1|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
907893|NCT01690299|2194857|P6|COMPLETED|Apremilast Extension Phase (Weeks16-104)||50
907894|NCT01690299|2194858|P5|COMPLETED|Apremilast Extension Phase (Weeks16-104)||41
907895|NCT01690299|2194859|P4|COMPLETED|Apremilast Extension Phase (Weeks16-104)||47
907896|NCT01690299|2194860|P3|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
907897|NCT01690299|2194861|P2|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
907898|NCT01690299|2194862|P1|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
907899|NCT01690299|2194857|P6|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|79
907900|NCT01690299|2194858|P5|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|74
907901|NCT01690299|2194859|P4|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|73
907902|NCT01690299|2194860|P3|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
907903|NCT01690299|2194861|P2|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
907904|NCT01690299|2194862|P1|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
907905|NCT01690299|2194857|P6|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|80
907906|NCT01690299|2194858|P5|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|74
907907|NCT01690299|2194859|P4|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|73
907908|NCT01690299|2194860|P3|STARTED|Apremilast Extension Phase (Weeks16-104)||0
907909|NCT01690299|2194861|P2|STARTED|Apremilast Extension Phase (Weeks16-104)||0
907910|NCT01690299|2194862|P1|STARTED|Apremilast Extension Phase (Weeks16-104)||0
907911|NCT01690299|2194857|P6|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
907912|NCT01690299|2194858|P5|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
907913|NCT01690299|2194859|P4|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
907914|NCT01690299|2194860|P3|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||2
907915|NCT01690299|2194861|P2|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||6
907916|NCT01690299|2194862|P1|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||9
907917|NCT01690299|2194857|P6|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
907918|NCT01690299|2194858|P5|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
907919|NCT01690299|2194859|P4|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
907920|NCT01690299|2194860|P3|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||81
907921|NCT01690299|2194861|P2|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||77
907922|NCT01690299|2194862|P1|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||75
907923|NCT01690299|2194857|P6|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
907924|NCT01690299|2194858|P5|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
907925|NCT01690299|2194859|P4|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
907926|NCT01690299|2194860|P3|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
907927|NCT01690299|2194861|P2|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
907928|NCT01690299|2194862|P1|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|84
907929|NCT01690299|2194857|P6|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
907930|NCT01690299|2194858|P5|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
907931|NCT01690299|2194859|P4|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
907932|NCT01690299|2194860|P3|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
907933|NCT01690299|2194861|P2|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
907934|NCT01690299|2194862|P1|STARTED|Placebo-controlled Phase (Weeks 0-16)||84
907935|NCT01690273|2194907|P3|NOT COMPLETED|Overall Study||0
907936|NCT01690273|2194908|P2|NOT COMPLETED|Overall Study||0
907937|NCT01690273|2194909|P1|NOT COMPLETED|Overall Study||0
907938|NCT01690273|2194907|P3|COMPLETED|Overall Study||20
907939|NCT01690273|2194908|P2|COMPLETED|Overall Study||17
907940|NCT01690273|2194909|P1|COMPLETED|Overall Study||18
907941|NCT01690273|2194907|P3|STARTED|Overall Study||20
907942|NCT01690273|2194908|P2|STARTED|Overall Study||17
907943|NCT01690273|2194909|P1|STARTED|Overall Study||18
907944|NCT01690117|2194961|P2|NOT COMPLETED|Overall Study||14
907945|NCT01690117|2194962|P1|NOT COMPLETED|Overall Study||16
907946|NCT01690117|2194961|P2|COMPLETED|Overall Study||31
907947|NCT01690117|2194962|P1|COMPLETED|Overall Study||31
907948|NCT01690117|2194961|P2|Post-Measurement|Overall Study||40
907949|NCT01690117|2194962|P1|Post-Measurement|Overall Study||41
907950|NCT01690117|2194961|P2|STARTED|Overall Study||45
907951|NCT01690117|2194962|P1|STARTED|Overall Study||47
907952|NCT01690052|2194998|P2|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
907953|NCT01690052|2194999|P1|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
907954|NCT01690052|2194998|P2|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
907955|NCT01690052|2194999|P1|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
907956|NCT01690052|2194998|P2|STARTED|SECOND INTERVENTION: 4 WEEKS||6
907957|NCT01690052|2194999|P1|STARTED|SECOND INTERVENTION: 4 WEEKS||6
907958|NCT01690052|2194998|P2|NOT COMPLETED|Washout Period of 1 Week||0
907959|NCT01690052|2194999|P1|NOT COMPLETED|Washout Period of 1 Week||0
907960|NCT01690052|2194998|P2|COMPLETED|Washout Period of 1 Week||6
907961|NCT01690052|2194999|P1|COMPLETED|Washout Period of 1 Week||6
907962|NCT01690052|2194998|P2|STARTED|Washout Period of 1 Week||6
907963|NCT01690052|2194999|P1|STARTED|Washout Period of 1 Week||6
907964|NCT01690052|2194998|P2|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||2
907965|NCT01690052|2194999|P1|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||1
907966|NCT01690052|2194998|P2|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
907967|NCT01690052|2194999|P1|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
907968|NCT01690052|2194998|P2|STARTED|FIRST INTERVENTION: 4 WEEKS||8
907969|NCT01690052|2194999|P1|STARTED|FIRST INTERVENTION: 4 WEEKS||7
907970|NCT01690000|2195007|P2|NOT COMPLETED|Overall Study||6
907971|NCT01690000|2195008|P1|NOT COMPLETED|Overall Study||3
907972|NCT01690000|2195007|P2|COMPLETED|Overall Study||35
907973|NCT01690000|2195008|P1|COMPLETED|Overall Study||37
907974|NCT01690000|2195007|P2|STARTED|Overall Study||41
907975|NCT01690000|2195008|P1|STARTED|Overall Study||40
907976|NCT01689857|2195016|P2|NOT COMPLETED|Overall Study||2
907977|NCT01689857|2195017|P1|NOT COMPLETED|Overall Study||5
907978|NCT01689857|2195016|P2|COMPLETED|Overall Study||18
907979|NCT01689857|2195017|P1|COMPLETED|Overall Study||15
907980|NCT01689857|2195016|P2|STARTED|Overall Study||20
907981|NCT01689857|2195017|P1|STARTED|Overall Study||20
907982|NCT01689779|2195025|P2|NOT COMPLETED|Overall Study||0
907983|NCT01689779|2195026|P1|NOT COMPLETED|Overall Study||0
907984|NCT01689779|2195025|P2|COMPLETED|Overall Study||32
907985|NCT01689779|2195026|P1|COMPLETED|Overall Study||28
907986|NCT01689779|2195025|P2|STARTED|Overall Study||32
907987|NCT01689779|2195026|P1|STARTED|Overall Study||28
907988|NCT01689649|2195042|P1|NOT COMPLETED|Overall Study||22
907989|NCT01689649|2195042|P1|COMPLETED|Overall Study||117
907990|NCT01689649|2195042|P1|STARTED|Overall Study||139
907991|NCT01689532|2195054|P2|NOT COMPLETED|Overall Study||9
907992|NCT01689532|2195055|P1|NOT COMPLETED|Overall Study||14
907993|NCT01689532|2195054|P2|COMPLETED|Overall Study||52
907994|NCT01689532|2195055|P1|COMPLETED|Overall Study||47
907995|NCT01689532|2195054|P2|STARTED|Overall Study||61
907996|NCT01689532|2195055|P1|STARTED|Overall Study||61
907997|NCT01689519|2195119|P2|NOT COMPLETED|Overall Study||138
907998|NCT01689519|2195120|P1|NOT COMPLETED|Overall Study||166
907999|NCT01689519|2195119|P2|COMPLETED|Overall Study||109
908000|NCT01689519|2195120|P1|COMPLETED|Overall Study||82
908001|NCT01689519|2195119|P2|Received Treatment|Overall Study||246
908002|NCT01689519|2195120|P1|Received Treatment|Overall Study||247
908003|NCT01689519|2195119|P2|STARTED|Overall Study||247
908004|NCT01689519|2195120|P1|STARTED|Overall Study||248
908005|NCT01689441|2195136|P2|NOT COMPLETED|Overall Study||0
908006|NCT01689441|2195137|P1|NOT COMPLETED|Overall Study||0
908007|NCT01689441|2195136|P2|COMPLETED|Overall Study||31
908008|NCT01689441|2195137|P1|COMPLETED|Overall Study||36
908009|NCT01689441|2195136|P2|STARTED|Overall Study||31
908010|NCT01689441|2195137|P1|STARTED|Overall Study||36
908011|NCT01689363|2195147|P8|NOT COMPLETED|Overall Study||0
908012|NCT01689363|2195148|P7|NOT COMPLETED|Overall Study||0
908013|NCT01689363|2195149|P6|NOT COMPLETED|Overall Study||0
908014|NCT01689363|2195150|P5|NOT COMPLETED|Overall Study||0
908015|NCT01689363|2195151|P4|NOT COMPLETED|Overall Study||0
908016|NCT01689363|2195152|P3|NOT COMPLETED|Overall Study||0
908017|NCT01689363|2195153|P2|NOT COMPLETED|Overall Study||1
908018|NCT01689363|2195154|P1|NOT COMPLETED|Overall Study||0
908019|NCT01689363|2195147|P8|COMPLETED|Overall Study||32
908020|NCT01689363|2195148|P7|COMPLETED|Overall Study||32
908021|NCT01689363|2195149|P6|COMPLETED|Overall Study||31
908022|NCT01689363|2195150|P5|COMPLETED|Overall Study||31
908023|NCT01689363|2195151|P4|COMPLETED|Overall Study||31
908024|NCT01689363|2195152|P3|COMPLETED|Overall Study||32
908025|NCT01689363|2195153|P2|COMPLETED|Overall Study||31
908026|NCT01689363|2195154|P1|COMPLETED|Overall Study||32
908027|NCT01689363|2195147|P8|STARTED|Overall Study||32
908028|NCT01689363|2195148|P7|STARTED|Overall Study||32
908029|NCT01689363|2195149|P6|STARTED|Overall Study||31
908030|NCT01689363|2195150|P5|STARTED|Overall Study||31
908031|NCT01689363|2195151|P4|STARTED|Overall Study||31
908032|NCT01689363|2195152|P3|STARTED|Overall Study||32
908033|NCT01689363|2195153|P2|STARTED|Overall Study||32
908034|NCT01689363|2195154|P1|STARTED|Overall Study||32
908035|NCT01689350|2195200|P2|NOT COMPLETED|Overall Study||0
908036|NCT01689350|2195201|P1|NOT COMPLETED|Overall Study||0
908037|NCT01689350|2195200|P2|COMPLETED|Overall Study||45
908038|NCT01689350|2195201|P1|COMPLETED|Overall Study||47
908039|NCT01689350|2195200|P2|STARTED|Overall Study||45
908040|NCT01689350|2195201|P1|STARTED|Overall Study||47
908041|NCT01689337|2195209|P1|NOT COMPLETED|Overall Study||1
908042|NCT01689337|2195209|P1|COMPLETED|Overall Study||0
908043|NCT01689337|2195209|P1|STARTED|Overall Study||1
908044|NCT01689324|2195224|P1|NOT COMPLETED|Overall Study||0
908045|NCT01689324|2195224|P1|COMPLETED|Overall Study||43
908046|NCT01689324|2195224|P1|STARTED|Overall Study||43
908047|NCT01689207|2195248|P11|NOT COMPLETED|Overall Study||0
908048|NCT01689207|2195249|P10|NOT COMPLETED|Overall Study||0
908049|NCT01689207|2195250|P9|NOT COMPLETED|Overall Study||1
908050|NCT01689207|2195251|P8|NOT COMPLETED|Overall Study||0
908051|NCT01689207|2195252|P7|NOT COMPLETED|Overall Study||0
908052|NCT01689207|2195253|P6|NOT COMPLETED|Overall Study||1
908053|NCT01689207|2195254|P5|NOT COMPLETED|Overall Study||2
908054|NCT01689207|2195255|P4|NOT COMPLETED|Overall Study||0
908055|NCT01689207|2195256|P3|NOT COMPLETED|Overall Study||0
908056|NCT01689207|2195257|P2|NOT COMPLETED|Overall Study||1
908057|NCT01689207|2195258|P1|NOT COMPLETED|Overall Study||0
908058|NCT01689207|2195248|P11|COMPLETED|Overall Study|Subjects completed study|8
908059|NCT01689207|2195249|P10|COMPLETED|Overall Study|Subjects completed study|10
908060|NCT01689207|2195250|P9|COMPLETED|Overall Study|Subjects completed study|5
908061|NCT01689207|2195251|P8|COMPLETED|Overall Study|Subjects completed study|10
908062|NCT01689207|2195252|P7|COMPLETED|Overall Study|Subjects completed study|10
908063|NCT01689207|2195253|P6|COMPLETED|Overall Study|Subjects completed study|7
908064|NCT01689207|2195254|P5|COMPLETED|Overall Study|Subjects completed study|2
908065|NCT01689207|2195255|P4|COMPLETED|Overall Study|Subjects completed study|8
908066|NCT01689207|2195256|P3|COMPLETED|Overall Study|Subjects completed study|16
908067|NCT01689207|2195257|P2|COMPLETED|Overall Study|Subjects completed study|7
908068|NCT01689207|2195258|P1|COMPLETED|Overall Study|Subjects completed study|4
908069|NCT01689207|2195248|P11|STARTED|Overall Study|Subjects randomised|8
908070|NCT01689207|2195249|P10|STARTED|Overall Study|Subjects randomised|10
908071|NCT01689207|2195250|P9|STARTED|Overall Study|Subjects randomised|6
908072|NCT01689207|2195251|P8|STARTED|Overall Study|Subjects randomised|10
908073|NCT01689207|2195252|P7|STARTED|Overall Study|Subjects randomised|10
908074|NCT01689207|2195253|P6|STARTED|Overall Study|Subjects randomised|8
908075|NCT01689207|2195254|P5|STARTED|Overall Study|Subjects randomised|4
908076|NCT01689207|2195255|P4|STARTED|Overall Study|Subjects randomised|8
908077|NCT01689207|2195256|P3|STARTED|Overall Study|Subjects randomised|16
908078|NCT01689207|2195257|P2|STARTED|Overall Study|Subjects randomised|8
908079|NCT01689207|2195258|P1|STARTED|Overall Study|Subjects randomised|4
908080|NCT01689155|2195354|P1|NOT COMPLETED|Overall Study||0
908081|NCT01689155|2195354|P1|COMPLETED|Overall Study||116
908082|NCT01689155|2195354|P1|STARTED|Overall Study||116
908089|NCT01688882|2195391|P2|NOT COMPLETED|Overall Study||1
908090|NCT01688882|2195392|P1|NOT COMPLETED|Overall Study||3
908091|NCT01688882|2195391|P2|COMPLETED|Overall Study|The one patient that discontinued was already switched to open-label QGE031 treatment.|6
908092|NCT01688882|2195392|P1|COMPLETED|Overall Study||10
908093|NCT01688882|2195391|P2|Safety Follow-up|Overall Study||5
908094|NCT01688882|2195392|P1|Safety Follow-up|Overall Study||11
908095|NCT01688882|2195391|P2|STARTED|Overall Study|4 patients who completed 12 weeks of placebo changed to open-label QGE031 treatment.|7
908096|NCT01688882|2195392|P1|STARTED|Overall Study||13
908097|NCT01688830|2195427|P21|NOT COMPLETED|Overall Study||0
908098|NCT01688830|2195428|P20|NOT COMPLETED|Overall Study||0
908099|NCT01688830|2195429|P19|NOT COMPLETED|Overall Study||0
908100|NCT01688830|2195430|P18|NOT COMPLETED|Overall Study||0
908101|NCT01688830|2195431|P17|NOT COMPLETED|Overall Study||0
908102|NCT01688830|2195432|P16|NOT COMPLETED|Overall Study||0
908103|NCT01688830|2195433|P15|NOT COMPLETED|Overall Study||0
908104|NCT01688830|2195434|P14|NOT COMPLETED|Overall Study||0
908105|NCT01688830|2195435|P13|NOT COMPLETED|Overall Study||0
908106|NCT01688830|2195436|P12|NOT COMPLETED|Overall Study||0
908107|NCT01688830|2195437|P11|NOT COMPLETED|Overall Study||1
908108|NCT01688830|2195438|P10|NOT COMPLETED|Overall Study||0
908109|NCT01688830|2195439|P9|NOT COMPLETED|Overall Study||0
908110|NCT01688830|2195440|P8|NOT COMPLETED|Overall Study||0
908111|NCT01688830|2195441|P7|NOT COMPLETED|Overall Study||0
908112|NCT01688830|2195442|P6|NOT COMPLETED|Overall Study||0
908113|NCT01688830|2195443|P5|NOT COMPLETED|Overall Study||0
908114|NCT01688830|2195444|P4|NOT COMPLETED|Overall Study||0
908115|NCT01688830|2195445|P3|NOT COMPLETED|Overall Study||0
908116|NCT01688830|2195446|P2|NOT COMPLETED|Overall Study||0
908117|NCT01688830|2195447|P1|NOT COMPLETED|Overall Study||0
908118|NCT01688830|2195427|P21|COMPLETED|Overall Study||9
908119|NCT01688830|2195428|P20|COMPLETED|Overall Study||3
908120|NCT01688830|2195429|P19|COMPLETED|Overall Study||8
908121|NCT01688830|2195430|P18|COMPLETED|Overall Study||9
908122|NCT01688830|2195431|P17|COMPLETED|Overall Study||9
908123|NCT01688830|2195432|P16|COMPLETED|Overall Study||9
908124|NCT01688830|2195433|P15|COMPLETED|Overall Study||6
908125|NCT01688830|2195434|P14|COMPLETED|Overall Study||6
908126|NCT01688830|2195435|P13|COMPLETED|Overall Study||6
908127|NCT01688830|2195436|P12|COMPLETED|Overall Study||6
908128|NCT01688830|2195437|P11|COMPLETED|Overall Study||5
908129|NCT01688830|2195438|P10|COMPLETED|Overall Study||6
908130|NCT01688830|2195439|P9|COMPLETED|Overall Study||6
908131|NCT01688830|2195440|P8|COMPLETED|Overall Study||6
908132|NCT01688830|2195441|P7|COMPLETED|Overall Study||12
908133|NCT01688830|2195442|P6|COMPLETED|Overall Study||6
908134|NCT01688830|2195443|P5|COMPLETED|Overall Study||5
908135|NCT01688830|2195444|P4|COMPLETED|Overall Study||6
908136|NCT01688830|2195445|P3|COMPLETED|Overall Study||6
908137|NCT01688830|2195446|P2|COMPLETED|Overall Study||6
908138|NCT01688830|2195447|P1|COMPLETED|Overall Study||21
908139|NCT01688830|2195427|P21|STARTED|Overall Study||9
908140|NCT01688830|2195428|P20|STARTED|Overall Study||3
908141|NCT01688830|2195429|P19|STARTED|Overall Study||8
908142|NCT01688830|2195430|P18|STARTED|Overall Study||9
908143|NCT01688830|2195431|P17|STARTED|Overall Study||9
908144|NCT01688830|2195432|P16|STARTED|Overall Study||9
908145|NCT01688830|2195433|P15|STARTED|Overall Study||6
908146|NCT01688830|2195434|P14|STARTED|Overall Study||6
908147|NCT01688830|2195435|P13|STARTED|Overall Study||6
908148|NCT01688830|2195436|P12|STARTED|Overall Study||6
908149|NCT01688830|2195437|P11|STARTED|Overall Study||6
908150|NCT01688830|2195438|P10|STARTED|Overall Study||6
908151|NCT01688830|2195439|P9|STARTED|Overall Study||6
908152|NCT01688830|2195440|P8|STARTED|Overall Study||6
908153|NCT01688830|2195441|P7|STARTED|Overall Study||12
908154|NCT01688830|2195442|P6|STARTED|Overall Study||6
908155|NCT01688830|2195443|P5|STARTED|Overall Study||5
908156|NCT01688830|2195444|P4|STARTED|Overall Study||6
908157|NCT01688830|2195445|P3|STARTED|Overall Study||6
908158|NCT01688830|2195446|P2|STARTED|Overall Study||6
908159|NCT01688830|2195447|P1|STARTED|Overall Study||21
908160|NCT01688726|2195593|P2|NOT COMPLETED|Overall Study||1
908161|NCT01688726|2195594|P1|NOT COMPLETED|Overall Study||1
908162|NCT01688726|2195593|P2|COMPLETED|Overall Study||44
908163|NCT01688726|2195594|P1|COMPLETED|Overall Study||45
908164|NCT01688726|2195593|P2|STARTED|Overall Study||45
908165|NCT01688726|2195594|P1|STARTED|Overall Study||46
908166|NCT01688635|2195606|P2|NOT COMPLETED|Period 4||0
908167|NCT01688635|2195607|P1|NOT COMPLETED|Period 4||0
908168|NCT01688635|2195606|P2|COMPLETED|Period 4||42
908169|NCT01688635|2195607|P1|COMPLETED|Period 4||40
908170|NCT01688635|2195606|P2|STARTED|Period 4||42
908171|NCT01688635|2195607|P1|STARTED|Period 4||40
908172|NCT01688635|2195606|P2|NOT COMPLETED|Washout 3||0
908173|NCT01688635|2195607|P1|NOT COMPLETED|Washout 3||1
908174|NCT01688635|2195606|P2|COMPLETED|Washout 3||42
908175|NCT01688635|2195607|P1|COMPLETED|Washout 3||40
908176|NCT01688635|2195606|P2|STARTED|Washout 3||42
908177|NCT01688635|2195607|P1|STARTED|Washout 3||41
908178|NCT01688635|2195606|P2|NOT COMPLETED|Period 3||0
908179|NCT01688635|2195607|P1|NOT COMPLETED|Period 3||0
908180|NCT01688635|2195606|P2|COMPLETED|Period 3||42
908181|NCT01688635|2195607|P1|COMPLETED|Period 3||41
908182|NCT01688635|2195606|P2|STARTED|Period 3||42
908183|NCT01688635|2195607|P1|STARTED|Period 3||41
908184|NCT01688635|2195606|P2|NOT COMPLETED|Washout 2||2
908185|NCT01688635|2195607|P1|NOT COMPLETED|Washout 2||3
908186|NCT01688635|2195606|P2|COMPLETED|Washout 2||42
908187|NCT01688635|2195607|P1|COMPLETED|Washout 2||41
908188|NCT01688635|2195606|P2|STARTED|Washout 2||44
908189|NCT01688635|2195607|P1|STARTED|Washout 2||44
908190|NCT01688635|2195606|P2|NOT COMPLETED|Period 2||0
908191|NCT01688635|2195607|P1|NOT COMPLETED|Period 2||0
908192|NCT01688635|2195606|P2|COMPLETED|Period 2||44
908193|NCT01688635|2195607|P1|COMPLETED|Period 2||44
908194|NCT01688635|2195606|P2|STARTED|Period 2||44
908195|NCT01688635|2195607|P1|STARTED|Period 2||44
908196|NCT01688635|2195606|P2|NOT COMPLETED|Washout 1||2
908197|NCT01688635|2195607|P1|NOT COMPLETED|Washout 1||1
908198|NCT01688635|2195606|P2|COMPLETED|Washout 1||44
908199|NCT01688635|2195607|P1|COMPLETED|Washout 1||44
908200|NCT01688635|2195606|P2|STARTED|Washout 1||46
908201|NCT01688635|2195607|P1|STARTED|Washout 1||45
908202|NCT01688635|2195606|P2|NOT COMPLETED|Period 1||0
908203|NCT01688635|2195607|P1|NOT COMPLETED|Period 1||0
908204|NCT01688635|2195606|P2|COMPLETED|Period 1||46
908205|NCT01688635|2195607|P1|COMPLETED|Period 1||45
908206|NCT01688635|2195606|P2|Received at Least 1 Dose of Study Drug|Period 1||46
908207|NCT01688635|2195607|P1|Received at Least 1 Dose of Study Drug|Period 1||45
908208|NCT01688635|2195606|P2|STARTED|Period 1||46
908209|NCT01688635|2195607|P1|STARTED|Period 1||45
908210|NCT01688609|2195619|P1|NOT COMPLETED|Overall Study||0
908211|NCT01688609|2195619|P1|COMPLETED|Overall Study||18
908212|NCT01688609|2195619|P1|STARTED|Overall Study||18
908213|NCT01688336|2195627|P1|NOT COMPLETED|Overall Study||0
908214|NCT01688336|2195627|P1|COMPLETED|Overall Study||9
908215|NCT01688336|2195627|P1|STARTED|Overall Study||9
908216|NCT01688310|2195639|P2|NOT COMPLETED|Overall Study||0
908217|NCT01688310|2195640|P1|NOT COMPLETED|Overall Study||0
908218|NCT01688310|2195639|P2|COMPLETED|Overall Study||100
908219|NCT01688310|2195640|P1|COMPLETED|Overall Study||100
908220|NCT01688310|2195639|P2|STARTED|Overall Study||100
908221|NCT01688310|2195640|P1|STARTED|Overall Study||100
908228|NCT01688050|2195689|P1|NOT COMPLETED|Overall Study||50
908229|NCT01688050|2195689|P1|COMPLETED|Overall Study||0
908230|NCT01688050|2195689|P1|30 Days|Overall Study||50
908231|NCT01688050|2195689|P1|STARTED|Overall Study||50
908232|NCT01687790|2195695|P1|NOT COMPLETED|Overall Study||0
908233|NCT01687790|2195695|P1|COMPLETED|Overall Study||60
908234|NCT01687790|2195695|P1|STARTED|Overall Study||60
908235|NCT01687478|2195702|P2|NOT COMPLETED|Overall Study||39
908236|NCT01687478|2195703|P1|NOT COMPLETED|Overall Study||32
908237|NCT01687478|2195702|P2|COMPLETED|Overall Study||49
908238|NCT01687478|2195703|P1|COMPLETED|Overall Study||56
908239|NCT01687478|2195702|P2|Safety Analysis Set|Overall Study||87
908240|NCT01687478|2195703|P1|Safety Analysis Set|Overall Study||88
908241|NCT01687478|2195702|P2|STARTED|Overall Study||88
908242|NCT01687478|2195703|P1|STARTED|Overall Study||88
908243|NCT01687283|2195727|P2|NOT COMPLETED|Overall Study||27
908244|NCT01687283|2195728|P1|NOT COMPLETED|Overall Study||35
908245|NCT01687283|2195727|P2|COMPLETED|Overall Study||130
908246|NCT01687283|2195728|P1|COMPLETED|Overall Study||123
908247|NCT01687283|2195727|P2|STARTED|Overall Study||157
908248|NCT01687283|2195728|P1|STARTED|Overall Study||158
908249|NCT01687270|2195751|P1|NOT COMPLETED|Overall Study||12
908250|NCT01687270|2195751|P1|COMPLETED|Overall Study||28
908251|NCT01687270|2195751|P1|STARTED|Overall Study||40
908252|NCT01687257|2195762|P3|NOT COMPLETED|Overall Study||6
908253|NCT01687257|2195763|P2|NOT COMPLETED|Overall Study||4
908254|NCT01687257|2195764|P1|NOT COMPLETED|Overall Study||8
908255|NCT01687257|2195762|P3|COMPLETED|Overall Study||15
908256|NCT01687257|2195763|P2|COMPLETED|Overall Study||0
908257|NCT01687257|2195764|P1|COMPLETED|Overall Study||17
908258|NCT01687257|2195762|P3|STARTED|Overall Study||21
908259|NCT01687257|2195763|P2|STARTED|Overall Study||4
908260|NCT01687257|2195764|P1|STARTED|Overall Study||25
908261|NCT01687244|2195792|P2|NOT COMPLETED|Overall Study||0
908262|NCT01687244|2195793|P1|NOT COMPLETED|Overall Study||0
908263|NCT01687244|2195792|P2|COMPLETED|Overall Study||19
908264|NCT01687244|2195793|P1|COMPLETED|Overall Study||21
908265|NCT01687244|2195792|P2|STARTED|Overall Study||19
908266|NCT01687244|2195793|P1|STARTED|Overall Study||21
908267|NCT01687218|2195829|P6|NOT COMPLETED|Overall Study||0
908268|NCT01687218|2195830|P5|NOT COMPLETED|Overall Study||1
908269|NCT01687218|2195831|P4|NOT COMPLETED|Overall Study||2
908270|NCT01687218|2195832|P3|NOT COMPLETED|Overall Study||1
908271|NCT01687218|2195833|P2|NOT COMPLETED|Overall Study||3
908272|NCT01687218|2195834|P1|NOT COMPLETED|Overall Study||3
908273|NCT01687218|2195829|P6|COMPLETED|Overall Study||32
908274|NCT01687218|2195830|P5|COMPLETED|Overall Study||32
908275|NCT01687218|2195831|P4|COMPLETED|Overall Study||32
908276|NCT01687218|2195832|P3|COMPLETED|Overall Study||30
908277|NCT01687218|2195833|P2|COMPLETED|Overall Study||29
908278|NCT01687218|2195834|P1|COMPLETED|Overall Study||30
908279|NCT01687218|2195829|P6|STARTED|Overall Study||32
908280|NCT01687218|2195830|P5|STARTED|Overall Study||33
908281|NCT01687218|2195831|P4|STARTED|Overall Study||34
908282|NCT01687218|2195832|P3|STARTED|Overall Study||31
908283|NCT01687218|2195833|P2|STARTED|Overall Study||32
908284|NCT01687218|2195834|P1|STARTED|Overall Study||33
908285|NCT01687114|2195854|P1|NOT COMPLETED|Overall Study||0
908286|NCT01687114|2195854|P1|COMPLETED|Overall Study||5
908287|NCT01687114|2195854|P1|STARTED|Overall Study||5
908288|NCT01687101|2195858|P1|NOT COMPLETED|Overall Study||7
908289|NCT01687101|2195858|P1|COMPLETED|Overall Study||25
908290|NCT01687101|2195858|P1|STARTED|Overall Study||32
908291|NCT01687088|2195864|P2|NOT COMPLETED|Overall Study||0
908292|NCT01687088|2195865|P1|NOT COMPLETED|Overall Study||0
908293|NCT01687088|2195864|P2|COMPLETED|Overall Study||50
908294|NCT01687088|2195865|P1|COMPLETED|Overall Study||50
908295|NCT01687088|2195864|P2|STARTED|Overall Study||50
908296|NCT01687088|2195865|P1|STARTED|Overall Study||50
908297|NCT01687036|2195871|P1|NOT COMPLETED|Overall Study||0
908298|NCT01687036|2195871|P1|COMPLETED|Overall Study||10
908299|NCT01687036|2195871|P1|STARTED|Overall Study||10
908300|NCT01686932|2195885|P2|NOT COMPLETED|Period 2||0
908301|NCT01686932|2195886|P1|NOT COMPLETED|Period 2||0
908302|NCT01686932|2195885|P2|COMPLETED|Period 2||25
908303|NCT01686932|2195886|P1|COMPLETED|Period 2||24
908304|NCT01686932|2195885|P2|STARTED|Period 2||25
908305|NCT01686932|2195886|P1|STARTED|Period 2||24
908306|NCT01686932|2195885|P2|NOT COMPLETED|Period 1||1
908307|NCT01686932|2195886|P1|NOT COMPLETED|Period 1||1
908308|NCT01686932|2195885|P2|COMPLETED|Period 1||25
908309|NCT01686932|2195886|P1|COMPLETED|Period 1||24
908310|NCT01686932|2195885|P2|STARTED|Period 1||26
908311|NCT01686932|2195886|P1|STARTED|Period 1||25
908312|NCT01686828|2195916|P4|NOT COMPLETED|Overall Study||0
908313|NCT01686828|2195917|P3|NOT COMPLETED|Overall Study||1
908314|NCT01686828|2195918|P2|NOT COMPLETED|Overall Study||1
908315|NCT01686828|2195919|P1|NOT COMPLETED|Overall Study||1
908316|NCT01686828|2195916|P4|COMPLETED|Overall Study||13
908317|NCT01686828|2195917|P3|COMPLETED|Overall Study||12
908318|NCT01686828|2195918|P2|COMPLETED|Overall Study||13
908319|NCT01686828|2195919|P1|COMPLETED|Overall Study||12
908320|NCT01686828|2195916|P4|STARTED|Overall Study||13
908321|NCT01686828|2195917|P3|STARTED|Overall Study||13
908322|NCT01686828|2195918|P2|STARTED|Overall Study||14
908323|NCT01686828|2195919|P1|STARTED|Overall Study||13
908324|NCT01686646|2195941|P4|NOT COMPLETED|Overall Study||0
908325|NCT01686646|2195942|P3|NOT COMPLETED|Overall Study||0
908326|NCT01686646|2195943|P2|NOT COMPLETED|Overall Study||0
908327|NCT01686646|2195944|P1|NOT COMPLETED|Overall Study||0
908328|NCT01686646|2195941|P4|COMPLETED|Overall Study||75
908329|NCT01686646|2195942|P3|COMPLETED|Overall Study||75
908330|NCT01686646|2195943|P2|COMPLETED|Overall Study||45
908331|NCT01686646|2195944|P1|COMPLETED|Overall Study||45
908332|NCT01686646|2195941|P4|Safety Population|Overall Study||75
908333|NCT01686646|2195942|P3|Safety Population|Overall Study||74
908334|NCT01686646|2195943|P2|Safety Population|Overall Study||45
908335|NCT01686646|2195944|P1|Safety Population|Overall Study|One subject randomized to Paracetamol+Caffeine (500/65) group but received 1000/130 combination.|46
908336|NCT01686646|2195941|P4|Intent to Treat Population|Overall Study||75
908337|NCT01686646|2195942|P3|Intent to Treat Population|Overall Study||75
908338|NCT01686646|2195943|P2|Intent to Treat Population|Overall Study||45
908339|NCT01686646|2195944|P1|Intent to Treat Population|Overall Study||45
908340|NCT01686646|2195941|P4|STARTED|Overall Study||75
908341|NCT01686646|2195942|P3|STARTED|Overall Study||75
908342|NCT01686646|2195943|P2|STARTED|Overall Study||45
908343|NCT01686646|2195944|P1|STARTED|Overall Study||45
908344|NCT01686633|2195993|P3|NOT COMPLETED|Overall Study||25
908345|NCT01686633|2195994|P2|NOT COMPLETED|Overall Study||32
908346|NCT01686633|2195995|P1|NOT COMPLETED|Overall Study||51
908347|NCT01686633|2195993|P3|COMPLETED|Overall Study||321
908348|NCT01686633|2195994|P2|COMPLETED|Overall Study||314
908349|NCT01686633|2195995|P1|COMPLETED|Overall Study||296
908350|NCT01686633|2195993|P3|STARTED|Overall Study||346
908351|NCT01686633|2195994|P2|STARTED|Overall Study||346
908352|NCT01686633|2195995|P1|STARTED|Overall Study||347
908353|NCT01686568|2196020|P2|NOT COMPLETED|Sub-Study||2
908354|NCT01686568|2196021|P1|NOT COMPLETED|Sub-Study||2
908355|NCT01686568|2196020|P2|COMPLETED|Sub-Study||9
908356|NCT01686568|2196021|P1|COMPLETED|Sub-Study||12
908357|NCT01686568|2196020|P2|STARTED|Sub-Study||11
908358|NCT01686568|2196021|P1|STARTED|Sub-Study||14
908359|NCT01686568|2196020|P2|NOT COMPLETED|Main Study||4
908360|NCT01686568|2196021|P1|NOT COMPLETED|Main Study||2
908361|NCT01686568|2196020|P2|COMPLETED|Main Study||11
908362|NCT01686568|2196021|P1|COMPLETED|Main Study||14
908363|NCT01686568|2196020|P2|STARTED|Main Study||15
908364|NCT01686568|2196021|P1|STARTED|Main Study||16
908365|NCT01686503|2196047|P4|NOT COMPLETED|Overall Study||1
908366|NCT01686503|2196048|P3|NOT COMPLETED|Overall Study||2
908367|NCT01686503|2196049|P2|NOT COMPLETED|Overall Study||3
908368|NCT01686503|2196050|P1|NOT COMPLETED|Overall Study||1
908369|NCT01686503|2196047|P4|COMPLETED|Overall Study||32
908370|NCT01686503|2196048|P3|COMPLETED|Overall Study||64
908371|NCT01686503|2196049|P2|COMPLETED|Overall Study||63
908372|NCT01686503|2196050|P1|COMPLETED|Overall Study||65
908373|NCT01686503|2196047|P4|STARTED|Overall Study||33
908374|NCT01686503|2196048|P3|STARTED|Overall Study||66
908375|NCT01686503|2196049|P2|STARTED|Overall Study||66
908376|NCT01686503|2196050|P1|STARTED|Overall Study||66
908377|NCT01686451|2196066|P2|NOT COMPLETED|Overall Study||0
908378|NCT01686451|2196067|P1|NOT COMPLETED|Overall Study||0
908379|NCT01686451|2196066|P2|COMPLETED|Overall Study||27
908380|NCT01686451|2196067|P1|COMPLETED|Overall Study||33
908381|NCT01686451|2196066|P2|STARTED|Overall Study||27
908382|NCT01686451|2196067|P1|STARTED|Overall Study||33
908383|NCT01685996|2196097|P2|NOT COMPLETED|Overall Study||13
908384|NCT01685996|2196098|P1|NOT COMPLETED|Overall Study||16
908385|NCT01685996|2196097|P2|COMPLETED|Overall Study||27
908386|NCT01685996|2196098|P1|COMPLETED|Overall Study||18
908387|NCT01685996|2196097|P2|STARTED|Overall Study||40
908388|NCT01685996|2196098|P1|STARTED|Overall Study||34
908389|NCT01685983|2196106|P1|NOT COMPLETED|Overall Study||82
908390|NCT01685983|2196106|P1|COMPLETED|Overall Study||0
908391|NCT01685983|2196106|P1|STARTED|Overall Study||82
908392|NCT01685801|2196120|P4|NOT COMPLETED|Open-label Period (8 Weeks)||0
908393|NCT01685801|2196121|P3|NOT COMPLETED|Open-label Period (8 Weeks)||0
908394|NCT01685801|2196122|P2|NOT COMPLETED|Open-label Period (8 Weeks)||0
908395|NCT01685801|2196123|P1|NOT COMPLETED|Open-label Period (8 Weeks)||0
908396|NCT01685801|2196120|P4|COMPLETED|Open-label Period (8 Weeks)||4
908397|NCT01685801|2196121|P3|COMPLETED|Open-label Period (8 Weeks)||7
908398|NCT01685801|2196122|P2|COMPLETED|Open-label Period (8 Weeks)||5
908399|NCT01685801|2196123|P1|COMPLETED|Open-label Period (8 Weeks)||5
908400|NCT01685801|2196120|P4|STARTED|Open-label Period (8 Weeks)||4
908401|NCT01685801|2196121|P3|STARTED|Open-label Period (8 Weeks)||7
908402|NCT01685801|2196122|P2|STARTED|Open-label Period (8 Weeks)||5
908403|NCT01685801|2196123|P1|STARTED|Open-label Period (8 Weeks)||5
908404|NCT01685801|2196120|P4|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
908405|NCT01685801|2196121|P3|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
908406|NCT01685801|2196122|P2|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
908407|NCT01685801|2196123|P1|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
908408|NCT01685801|2196120|P4|COMPLETED|Washout Period 2 (4 Weeks)||4
908409|NCT01685801|2196121|P3|COMPLETED|Washout Period 2 (4 Weeks)||7
908410|NCT01685801|2196122|P2|COMPLETED|Washout Period 2 (4 Weeks)||5
908411|NCT01685801|2196123|P1|COMPLETED|Washout Period 2 (4 Weeks)||5
908412|NCT01685801|2196120|P4|STARTED|Washout Period 2 (4 Weeks)||4
908413|NCT01685801|2196121|P3|STARTED|Washout Period 2 (4 Weeks)||7
908414|NCT01685801|2196122|P2|STARTED|Washout Period 2 (4 Weeks)||5
908415|NCT01685801|2196123|P1|STARTED|Washout Period 2 (4 Weeks)||5
908416|NCT01685801|2196120|P4|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
908417|NCT01685801|2196121|P3|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
908418|NCT01685801|2196122|P2|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
908419|NCT01685801|2196123|P1|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
908420|NCT01685801|2196120|P4|COMPLETED|Cycle 2 Period 2 (2 Weeks)||4
908421|NCT01685801|2196121|P3|COMPLETED|Cycle 2 Period 2 (2 Weeks)||7
908422|NCT01685801|2196122|P2|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
908423|NCT01685801|2196123|P1|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
908424|NCT01685801|2196120|P4|STARTED|Cycle 2 Period 2 (2 Weeks)||5
908425|NCT01685801|2196121|P3|STARTED|Cycle 2 Period 2 (2 Weeks)||7
908426|NCT01685801|2196122|P2|STARTED|Cycle 2 Period 2 (2 Weeks)||6
908427|NCT01685801|2196123|P1|STARTED|Cycle 2 Period 2 (2 Weeks)||5
908428|NCT01685801|2196120|P4|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
908429|NCT01685801|2196121|P3|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
908430|NCT01685801|2196122|P2|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
908431|NCT01685801|2196123|P1|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
908432|NCT01685801|2196120|P4|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
908433|NCT01685801|2196121|P3|COMPLETED|Cycle 2 Period 1 (2 Weeks)||7
908434|NCT01685801|2196122|P2|COMPLETED|Cycle 2 Period 1 (2 Weeks)||6
908435|NCT01685801|2196123|P1|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
908436|NCT01685801|2196120|P4|STARTED|Cycle 2 Period 1 (2 Weeks)||5
908437|NCT01685801|2196121|P3|STARTED|Cycle 2 Period 1 (2 Weeks)||7
908438|NCT01685801|2196122|P2|STARTED|Cycle 2 Period 1 (2 Weeks)||6
908439|NCT01685801|2196123|P1|STARTED|Cycle 2 Period 1 (2 Weeks)||5
908440|NCT01685801|2196120|P4|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
908441|NCT01685801|2196121|P3|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
908442|NCT01685801|2196122|P2|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
908443|NCT01685801|2196123|P1|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
908444|NCT01685801|2196120|P4|COMPLETED|Washout Period 1 (4 Weeks)||5
908445|NCT01685801|2196121|P3|COMPLETED|Washout Period 1 (4 Weeks)||7
908446|NCT01685801|2196122|P2|COMPLETED|Washout Period 1 (4 Weeks)||6
908447|NCT01685801|2196123|P1|COMPLETED|Washout Period 1 (4 Weeks)||5
908448|NCT01685801|2196120|P4|STARTED|Washout Period 1 (4 Weeks)||5
908449|NCT01685801|2196121|P3|STARTED|Washout Period 1 (4 Weeks)||7
908450|NCT01685801|2196122|P2|STARTED|Washout Period 1 (4 Weeks)||6
908451|NCT01685801|2196123|P1|STARTED|Washout Period 1 (4 Weeks)||5
908452|NCT01685801|2196120|P4|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||1
908453|NCT01685801|2196121|P3|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
908454|NCT01685801|2196122|P2|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
908455|NCT01685801|2196123|P1|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
908456|NCT01685801|2196120|P4|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
908457|NCT01685801|2196121|P3|COMPLETED|Cycle 1 Period 2 (2 Weeks)||7
908458|NCT01685801|2196122|P2|COMPLETED|Cycle 1 Period 2 (2 Weeks)||6
908459|NCT01685801|2196123|P1|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
908460|NCT01685801|2196120|P4|STARTED|Cycle 1 Period 2 (2 Weeks)||6
908461|NCT01685801|2196121|P3|STARTED|Cycle 1 Period 2 (2 Weeks)||7
908462|NCT01685801|2196122|P2|STARTED|Cycle 1 Period 2 (2 Weeks)||6
908463|NCT01685801|2196123|P1|STARTED|Cycle 1 Period 2 (2 Weeks)||5
908464|NCT01685801|2196120|P4|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
908465|NCT01685801|2196121|P3|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
908466|NCT01685801|2196122|P2|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
908467|NCT01685801|2196123|P1|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
908468|NCT01685801|2196120|P4|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
908469|NCT01685801|2196121|P3|COMPLETED|Cycle 1 Period 1 (2 Weeks)||7
908470|NCT01685801|2196122|P2|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
908471|NCT01685801|2196123|P1|COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
908472|NCT01685801|2196120|P4|STARTED|Cycle 1 Period 1 (2 Weeks)||6
908473|NCT01685801|2196121|P3|STARTED|Cycle 1 Period 1 (2 Weeks)||7
908474|NCT01685801|2196122|P2|STARTED|Cycle 1 Period 1 (2 Weeks)||6
908475|NCT01685801|2196123|P1|STARTED|Cycle 1 Period 1 (2 Weeks)||5
908476|NCT01685684|2196145|P3|NOT COMPLETED|Double-blind Maintenance Phase||96
908477|NCT01685684|2196146|P2|NOT COMPLETED|Double-blind Maintenance Phase||71
908478|NCT01685684|2196147|P1|NOT COMPLETED|Double-blind Maintenance Phase||0
908479|NCT01685684|2196145|P3|COMPLETED|Double-blind Maintenance Phase||100
908480|NCT01685684|2196146|P2|COMPLETED|Double-blind Maintenance Phase||122
908481|NCT01685684|2196147|P1|COMPLETED|Double-blind Maintenance Phase||0
908482|NCT01685684|2196145|P3|STARTED|Double-blind Maintenance Phase||196
908483|NCT01685684|2196146|P2|STARTED|Double-blind Maintenance Phase||193
908484|NCT01685684|2196147|P1|STARTED|Double-blind Maintenance Phase||0
908485|NCT01685684|2196145|P3|NOT COMPLETED|Titration Phase||0
908486|NCT01685684|2196146|P2|NOT COMPLETED|Titration Phase||0
908487|NCT01685684|2196147|P1|NOT COMPLETED|Titration Phase||351
908488|NCT01685684|2196145|P3|COMPLETED|Titration Phase||0
908489|NCT01685684|2196146|P2|COMPLETED|Titration Phase||0
908490|NCT01685684|2196147|P1|COMPLETED|Titration Phase||389
908491|NCT01685684|2196145|P3|STARTED|Titration Phase||0
908492|NCT01685684|2196146|P2|STARTED|Titration Phase||0
908493|NCT01685684|2196147|P1|STARTED|Titration Phase||740
908494|NCT01685606|2196171|P1|NOT COMPLETED|Overall Study||1
908495|NCT01685606|2196171|P1|COMPLETED|Overall Study||5
908496|NCT01685606|2196171|P1|STARTED|Overall Study||6
908497|NCT01685567|2196176|P1|NOT COMPLETED|Overall Study||0
908498|NCT01685567|2196176|P1|COMPLETED|Overall Study||219
908499|NCT01685567|2196176|P1|STARTED|Overall Study||219
908500|NCT01685437|2196184|P1|NOT COMPLETED|Overall Study||31
908501|NCT01685437|2196184|P1|COMPLETED|Overall Study||158
908502|NCT01685437|2196184|P1|STARTED|Overall Study||189
908503|NCT01685320|2196198|P2|NOT COMPLETED|Overall Study||0
908504|NCT01685320|2196199|P1|NOT COMPLETED|Overall Study||0
908505|NCT01685320|2196198|P2|COMPLETED|Overall Study||15
908506|NCT01685320|2196199|P1|COMPLETED|Overall Study||15
908507|NCT01685320|2196198|P2|STARTED|Overall Study||15
908508|NCT01685320|2196199|P1|STARTED|Overall Study||15
908515|NCT01685216|2196264|P1|NOT COMPLETED|Overall Study||1
908516|NCT01685216|2196264|P1|COMPLETED|Overall Study||6
908517|NCT01685216|2196264|P1|STARTED|Overall Study||7
908518|NCT01685203|2196281|P7|NOT COMPLETED|Overall Study||0
908519|NCT01685203|2196282|P6|NOT COMPLETED|Overall Study||3
908520|NCT01685203|2196283|P5|NOT COMPLETED|Overall Study||0
908521|NCT01685203|2196284|P4|NOT COMPLETED|Overall Study||1
908522|NCT01685203|2196285|P3|NOT COMPLETED|Overall Study||0
908523|NCT01685203|2196286|P2|NOT COMPLETED|Overall Study||3
908524|NCT01685203|2196287|P1|NOT COMPLETED|Overall Study||4
908525|NCT01685203|2196281|P7|COMPLETED|Overall Study||52
908526|NCT01685203|2196282|P6|COMPLETED|Overall Study||44
908527|NCT01685203|2196283|P5|COMPLETED|Overall Study||49
908528|NCT01685203|2196284|P4|COMPLETED|Overall Study||41
908529|NCT01685203|2196285|P3|COMPLETED|Overall Study||40
908530|NCT01685203|2196286|P2|COMPLETED|Overall Study||39
908531|NCT01685203|2196287|P1|COMPLETED|Overall Study||40
908532|NCT01685203|2196281|P7|Completed Study Drug|Overall Study||52
908533|NCT01685203|2196282|P6|Completed Study Drug|Overall Study||43
908534|NCT01685203|2196283|P5|Completed Study Drug|Overall Study||49
908535|NCT01685203|2196284|P4|Completed Study Drug|Overall Study||42
908536|NCT01685203|2196285|P3|Completed Study Drug|Overall Study||39
908537|NCT01685203|2196286|P2|Completed Study Drug|Overall Study||40
908538|NCT01685203|2196287|P1|Completed Study Drug|Overall Study||42
908539|NCT01685203|2196281|P7|STARTED|Overall Study||52
908540|NCT01685203|2196282|P6|STARTED|Overall Study||47
908541|NCT01685203|2196283|P5|STARTED|Overall Study||49
908542|NCT01685203|2196284|P4|STARTED|Overall Study||42
908543|NCT01685203|2196285|P3|STARTED|Overall Study||40
908544|NCT01685203|2196286|P2|STARTED|Overall Study||42
908545|NCT01685203|2196287|P1|STARTED|Overall Study||44
908546|NCT01685060|2196331|P1|NOT COMPLETED|Overall Study||140
908547|NCT01685060|2196331|P1|COMPLETED|Overall Study||0
908548|NCT01685060|2196331|P1|Discontinued From Study|Overall Study||35
908549|NCT01685060|2196331|P1|Entered Survival Follow up|Overall Study||98
908550|NCT01685060|2196331|P1|Entered Post-treatment Efficacy f/u|Overall Study||7
908551|NCT01685060|2196331|P1|STARTED|Overall Study||140
908552|NCT01684930|2196348|P2|NOT COMPLETED|Overall Study||1
908553|NCT01684930|2196349|P1|NOT COMPLETED|Overall Study||3
908554|NCT01684930|2196348|P2|COMPLETED|Overall Study||13
908555|NCT01684930|2196349|P1|COMPLETED|Overall Study||9
908556|NCT01684930|2196348|P2|STARTED|Overall Study||14
908557|NCT01684930|2196349|P1|STARTED|Overall Study||12
908558|NCT01684878|2196369|P4|NOT COMPLETED|Part 2: Randomized Phase||78
908559|NCT01684878|2196370|P3|NOT COMPLETED|Part 2: Randomized Phase||78
908560|NCT01684878|2196371|P2|NOT COMPLETED|Part 2: Randomized Phase||0
908561|NCT01684878|2196372|P1|NOT COMPLETED|Part 2: Randomized Phase||0
908562|NCT01684878|2196369|P4|COMPLETED|Part 2: Randomized Phase||0
908563|NCT01684878|2196370|P3|COMPLETED|Part 2: Randomized Phase||0
908564|NCT01684878|2196371|P2|COMPLETED|Part 2: Randomized Phase||0
908565|NCT01684878|2196372|P1|COMPLETED|Part 2: Randomized Phase||0
908566|NCT01684878|2196369|P4|Participants Mis-randomized|Part 2: Randomized Phase||0
908567|NCT01684878|2196370|P3|Participants Mis-randomized|Part 2: Randomized Phase||2
908568|NCT01684878|2196371|P2|Participants Mis-randomized|Part 2: Randomized Phase||0
908569|NCT01684878|2196372|P1|Participants Mis-randomized|Part 2: Randomized Phase||0
908570|NCT01684878|2196369|P4|Participants Randomized But Not Treated|Part 2: Randomized Phase||2
908571|NCT01684878|2196370|P3|Participants Randomized But Not Treated|Part 2: Randomized Phase||1
908572|NCT01684878|2196371|P2|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
908573|NCT01684878|2196372|P1|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
908574|NCT01684878|2196369|P4|STARTED|Part 2: Randomized Phase||78
908575|NCT01684878|2196370|P3|STARTED|Part 2: Randomized Phase||78
908576|NCT01684878|2196371|P2|STARTED|Part 2: Randomized Phase||0
908577|NCT01684878|2196372|P1|STARTED|Part 2: Randomized Phase||0
908578|NCT01684878|2196369|P4|NOT COMPLETED|Part 1: Safety Run in Phase||0
908579|NCT01684878|2196370|P3|NOT COMPLETED|Part 1: Safety Run in Phase||0
908580|NCT01684878|2196371|P2|NOT COMPLETED|Part 1: Safety Run in Phase||23
908581|NCT01684878|2196372|P1|NOT COMPLETED|Part 1: Safety Run in Phase||16
908582|NCT01684878|2196369|P4|COMPLETED|Part 1: Safety Run in Phase||0
908583|NCT01684878|2196370|P3|COMPLETED|Part 1: Safety Run in Phase||0
908584|NCT01684878|2196371|P2|COMPLETED|Part 1: Safety Run in Phase||5
908585|NCT01684878|2196372|P1|COMPLETED|Part 1: Safety Run in Phase||6
908586|NCT01684878|2196369|P4|STARTED|Part 1: Safety Run in Phase||0
908587|NCT01684878|2196370|P3|STARTED|Part 1: Safety Run in Phase||0
908588|NCT01684878|2196371|P2|STARTED|Part 1: Safety Run in Phase||28
908589|NCT01684878|2196372|P1|STARTED|Part 1: Safety Run in Phase||22
908590|NCT01684839|2196396|P1|NOT COMPLETED|Overall Study||0
908591|NCT01684839|2196396|P1|COMPLETED|Overall Study||9
908592|NCT01684839|2196396|P1|STARTED|Overall Study||9
908593|NCT01684826|2196400|P1|NOT COMPLETED|Overall Study||10
908594|NCT01684826|2196400|P1|COMPLETED|Overall Study||39
908595|NCT01684826|2196400|P1|Collected Dose and Image Information|Overall Study||39
908596|NCT01684826|2196400|P1|STARTED|Overall Study||49
908597|NCT01684748|2196408|P2|NOT COMPLETED|Second Intervention - 8 Weeks||0
908598|NCT01684748|2196409|P1|NOT COMPLETED|Second Intervention - 8 Weeks||0
908599|NCT01684748|2196408|P2|COMPLETED|Second Intervention - 8 Weeks||8
908600|NCT01684748|2196409|P1|COMPLETED|Second Intervention - 8 Weeks||8
908601|NCT01684748|2196408|P2|STARTED|Second Intervention - 8 Weeks||8
908602|NCT01684748|2196409|P1|STARTED|Second Intervention - 8 Weeks||8
908603|NCT01684748|2196408|P2|NOT COMPLETED|First Intervention - 8 Weeks||2
908604|NCT01684748|2196409|P1|NOT COMPLETED|First Intervention - 8 Weeks||2
908605|NCT01684748|2196408|P2|COMPLETED|First Intervention - 8 Weeks||8
908606|NCT01684748|2196409|P1|COMPLETED|First Intervention - 8 Weeks||8
908607|NCT01684748|2196408|P2|STARTED|First Intervention - 8 Weeks||10
908608|NCT01684748|2196409|P1|STARTED|First Intervention - 8 Weeks||10
908609|NCT01684566|2196417|P2|NOT COMPLETED|Overall Study||7
908610|NCT01684566|2196418|P1|NOT COMPLETED|Overall Study||16
908611|NCT01684566|2196417|P2|COMPLETED|Overall Study||49
908612|NCT01684566|2196418|P1|COMPLETED|Overall Study||44
908613|NCT01684566|2196417|P2|Treated (ITT)|Overall Study||52
908614|NCT01684566|2196418|P1|Treated (ITT)|Overall Study||57
908615|NCT01684566|2196417|P2|STARTED|Overall Study||56
908616|NCT01684566|2196418|P1|STARTED|Overall Study||60
908617|NCT01684436|2196440|P1|NOT COMPLETED|Overall Study||1
908618|NCT01684436|2196440|P1|COMPLETED|Overall Study||29
908619|NCT01684436|2196440|P1|STARTED|Overall Study||30
908620|NCT01684423|2196454|P5|NOT COMPLETED|Overall Study||0
908621|NCT01684423|2196455|P4|NOT COMPLETED|Overall Study||0
908622|NCT01684423|2196456|P3|NOT COMPLETED|Overall Study||1
908623|NCT01684423|2196457|P2|NOT COMPLETED|Overall Study||0
908624|NCT01684423|2196458|P1|NOT COMPLETED|Overall Study||0
908625|NCT01684423|2196454|P5|COMPLETED|Overall Study||7
908626|NCT01684423|2196455|P4|COMPLETED|Overall Study||19
908627|NCT01684423|2196456|P3|COMPLETED|Overall Study||12
908628|NCT01684423|2196457|P2|COMPLETED|Overall Study||13
908629|NCT01684423|2196458|P1|COMPLETED|Overall Study||11
908630|NCT01684423|2196454|P5|STARTED|Overall Study||7
908631|NCT01684423|2196455|P4|STARTED|Overall Study||19
908632|NCT01684423|2196456|P3|STARTED|Overall Study||13
908633|NCT01684423|2196457|P2|STARTED|Overall Study||13
908634|NCT01684423|2196458|P1|STARTED|Overall Study||11
908635|NCT01684410|2196495|P3|NOT COMPLETED|Overall Study||0
908636|NCT01684410|2196496|P2|NOT COMPLETED|Overall Study||0
908637|NCT01684410|2196497|P1|NOT COMPLETED|Overall Study||0
908638|NCT01684410|2196495|P3|COMPLETED|Overall Study||10
908639|NCT01684410|2196496|P2|COMPLETED|Overall Study||10
908640|NCT01684410|2196497|P1|COMPLETED|Overall Study||10
908641|NCT01684410|2196495|P3|STARTED|Overall Study||10
908642|NCT01684410|2196496|P2|STARTED|Overall Study||10
908643|NCT01684410|2196497|P1|STARTED|Overall Study||10
908660|NCT01684046|2196592|P2|NOT COMPLETED|Period 2, Second 30 Days||0
908661|NCT01684046|2196593|P1|NOT COMPLETED|Period 2, Second 30 Days||0
908662|NCT01684046|2196592|P2|COMPLETED|Period 2, Second 30 Days||93
908663|NCT01684046|2196593|P1|COMPLETED|Period 2, Second 30 Days||97
908664|NCT01684046|2196592|P2|STARTED|Period 2, Second 30 Days||93
908665|NCT01684046|2196593|P1|STARTED|Period 2, Second 30 Days||97
908666|NCT01684046|2196592|P2|NOT COMPLETED|Period 1, First 30 Days||2
908667|NCT01684046|2196593|P1|NOT COMPLETED|Period 1, First 30 Days||0
908668|NCT01684046|2196592|P2|COMPLETED|Period 1, First 30 Days||93
908669|NCT01684046|2196593|P1|COMPLETED|Period 1, First 30 Days||97
908670|NCT01684046|2196592|P2|STARTED|Period 1, First 30 Days||95
908671|NCT01684046|2196593|P1|STARTED|Period 1, First 30 Days||97
908672|NCT01684033|2196599|P2|NOT COMPLETED|Period 2, Second 30 Days||0
908673|NCT01684033|2196600|P1|NOT COMPLETED|Period 2, Second 30 Days||1
908674|NCT01684033|2196599|P2|COMPLETED|Period 2, Second 30 Days||98
908675|NCT01684033|2196600|P1|COMPLETED|Period 2, Second 30 Days||94
908676|NCT01684033|2196599|P2|STARTED|Period 2, Second 30 Days||98
908677|NCT01684033|2196600|P1|STARTED|Period 2, Second 30 Days||95
908678|NCT01684033|2196599|P2|NOT COMPLETED|Period 1, First 30 Days||1
908679|NCT01684033|2196600|P1|NOT COMPLETED|Period 1, First 30 Days||4
908680|NCT01684033|2196599|P2|COMPLETED|Period 1, First 30 Days||98
908681|NCT01684033|2196600|P1|COMPLETED|Period 1, First 30 Days||95
908682|NCT01684033|2196599|P2|STARTED|Period 1, First 30 Days||99
908683|NCT01684033|2196600|P1|STARTED|Period 1, First 30 Days||99
908684|NCT01684007|2196610|P2|NOT COMPLETED|Overall Study||0
908685|NCT01684007|2196611|P1|NOT COMPLETED|Overall Study||0
908686|NCT01684007|2196610|P2|COMPLETED|Overall Study||50
908687|NCT01684007|2196611|P1|COMPLETED|Overall Study||53
908688|NCT01684007|2196610|P2|STARTED|Overall Study||50
908689|NCT01684007|2196611|P1|STARTED|Overall Study||53
908690|NCT01683838|2196621|P2|NOT COMPLETED|Overall Study||12
908691|NCT01683838|2196622|P1|NOT COMPLETED|Overall Study||26
908692|NCT01683838|2196621|P2|COMPLETED|Overall Study||88
908693|NCT01683838|2196622|P1|COMPLETED|Overall Study||78
908694|NCT01683838|2196621|P2|Efficacy Population|Overall Study||93
908695|NCT01683838|2196622|P1|Efficacy Population|Overall Study||89
908696|NCT01683838|2196621|P2|Safety Population|Overall Study||100
908697|NCT01683838|2196622|P1|Safety Population|Overall Study||103
908698|NCT01683838|2196621|P2|Intent to Treat (ITT) Population|Overall Study||100
908699|NCT01683838|2196622|P1|Intent to Treat (ITT) Population|Overall Study||103
908700|NCT01683838|2196621|P2|STARTED|Overall Study||100
908701|NCT01683838|2196622|P1|STARTED|Overall Study||104
908702|NCT01683812|2196644|P1|NOT COMPLETED|Overall Study||0
908703|NCT01683812|2196644|P1|COMPLETED|Overall Study||23
908704|NCT01683812|2196644|P1|STARTED|Overall Study||23
908705|NCT01683630|2196651|P2|NOT COMPLETED|Overall Study||0
908706|NCT01683630|2196652|P1|NOT COMPLETED|Overall Study||0
908707|NCT01683630|2196651|P2|COMPLETED|Overall Study||445
908708|NCT01683630|2196652|P1|COMPLETED|Overall Study||1404
908709|NCT01683630|2196651|P2|STARTED|Overall Study||445
908710|NCT01683630|2196652|P1|STARTED|Overall Study||1404
908711|NCT01683604|2196662|P1|NOT COMPLETED|Overall Study||5
908712|NCT01683604|2196662|P1|COMPLETED|Overall Study||32
908713|NCT01683604|2196662|P1|STARTED|Overall Study||37
908714|NCT01683526|2196827|P2|NOT COMPLETED|Overall Study||0
908715|NCT01683526|2196828|P1|NOT COMPLETED|Overall Study||0
908716|NCT01683526|2196827|P2|COMPLETED|Overall Study||57
908717|NCT01683526|2196828|P1|COMPLETED|Overall Study||60
908718|NCT01683526|2196827|P2|STARTED|Overall Study||57
908719|NCT01683526|2196828|P1|STARTED|Overall Study||60
908720|NCT01683409|2196847|P5|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||3
908721|NCT01683409|2196848|P4|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
908722|NCT01683409|2196849|P3|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||1
908723|NCT01683409|2196850|P2|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
908724|NCT01683409|2196851|P1|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
908725|NCT01683409|2196847|P5|COMPLETED|Washout Period 2 (Weeks 29-32)||9
908726|NCT01683409|2196848|P4|COMPLETED|Washout Period 2 (Weeks 29-32)||6
908727|NCT01683409|2196849|P3|COMPLETED|Washout Period 2 (Weeks 29-32)||7
908728|NCT01683409|2196850|P2|COMPLETED|Washout Period 2 (Weeks 29-32)||6
908729|NCT01683409|2196851|P1|COMPLETED|Washout Period 2 (Weeks 29-32)||6
908730|NCT01683409|2196847|P5|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 8 participants.|12
908731|NCT01683409|2196848|P4|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 16 participants.|6
908732|NCT01683409|2196849|P3|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 17 participants.|8
908733|NCT01683409|2196850|P2|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 11 participants.|6
908734|NCT01683409|2196851|P1|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 18 participants.|6
908735|NCT01683409|2196847|P5|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
908736|NCT01683409|2196848|P4|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||2
908737|NCT01683409|2196849|P3|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||1
908738|NCT01683409|2196850|P2|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||4
908739|NCT01683409|2196851|P1|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
908740|NCT01683409|2196847|P5|COMPLETED|Washout Period 1 (Weeks 25-28)||20
908741|NCT01683409|2196848|P4|COMPLETED|Washout Period 1 (Weeks 25-28)||22
908742|NCT01683409|2196849|P3|COMPLETED|Washout Period 1 (Weeks 25-28)||25
908743|NCT01683409|2196850|P2|COMPLETED|Washout Period 1 (Weeks 25-28)||17
908744|NCT01683409|2196851|P1|COMPLETED|Washout Period 1 (Weeks 25-28)||24
908745|NCT01683409|2196847|P5|STARTED|Washout Period 1 (Weeks 25-28)||23
908746|NCT01683409|2196848|P4|STARTED|Washout Period 1 (Weeks 25-28)||24
908747|NCT01683409|2196849|P3|STARTED|Washout Period 1 (Weeks 25-28)||26
908748|NCT01683409|2196850|P2|STARTED|Washout Period 1 (Weeks 25-28)||21
908749|NCT01683409|2196851|P1|STARTED|Washout Period 1 (Weeks 25-28)||27
908750|NCT01683409|2196847|P5|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
908751|NCT01683409|2196848|P4|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
908752|NCT01683409|2196849|P3|NOT COMPLETED|Treatment Period (Weeks 1-24)||1
908753|NCT01683409|2196850|P2|NOT COMPLETED|Treatment Period (Weeks 1-24)||4
908754|NCT01683409|2196851|P1|NOT COMPLETED|Treatment Period (Weeks 1-24)||0
908755|NCT01683409|2196847|P5|COMPLETED|Treatment Period (Weeks 1-24)||23
908756|NCT01683409|2196848|P4|COMPLETED|Treatment Period (Weeks 1-24)||24
908757|NCT01683409|2196849|P3|COMPLETED|Treatment Period (Weeks 1-24)||26
908758|NCT01683409|2196850|P2|COMPLETED|Treatment Period (Weeks 1-24)||21
908759|NCT01683409|2196851|P1|COMPLETED|Treatment Period (Weeks 1-24)||27
908760|NCT01683409|2196847|P5|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
908761|NCT01683409|2196848|P4|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
908762|NCT01683409|2196849|P3|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
908763|NCT01683409|2196850|P2|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
908764|NCT01683409|2196851|P1|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||27
908765|NCT01683409|2196847|P5|STARTED|Treatment Period (Weeks 1-24)||25
908766|NCT01683409|2196848|P4|STARTED|Treatment Period (Weeks 1-24)||26
908767|NCT01683409|2196849|P3|STARTED|Treatment Period (Weeks 1-24)||27
908768|NCT01683409|2196850|P2|STARTED|Treatment Period (Weeks 1-24)||25
908769|NCT01683409|2196851|P1|STARTED|Treatment Period (Weeks 1-24)||27
908770|NCT01683383|2196894|P2|NOT COMPLETED|Overall Study||0
908771|NCT01683383|2196895|P1|NOT COMPLETED|Overall Study||1
908772|NCT01683383|2196894|P2|COMPLETED|Overall Study||51
908773|NCT01683383|2196895|P1|COMPLETED|Overall Study||49
908774|NCT01683383|2196894|P2|Transported and Treated|Overall Study||51
908775|NCT01683383|2196895|P1|Transported and Treated|Overall Study||49
908776|NCT01683383|2196894|P2|STARTED|Overall Study||51
908777|NCT01683383|2196895|P1|STARTED|Overall Study||50
908778|NCT01683266|2196911|P2|NOT COMPLETED|Overall Study||50
908779|NCT01683266|2196912|P1|NOT COMPLETED|Overall Study||55
908780|NCT01683266|2196911|P2|COMPLETED|Overall Study||225
908781|NCT01683266|2196912|P1|COMPLETED|Overall Study||219
908782|NCT01683266|2196911|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
908783|NCT01683266|2196912|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
908784|NCT01683266|2196911|P2|STARTED|Overall Study||275
908785|NCT01683266|2196912|P1|STARTED|Overall Study||274
908786|NCT01683058|2196940|P1|NOT COMPLETED|Overall Study||29
908787|NCT01683058|2196940|P1|COMPLETED|Overall Study||45
908788|NCT01683058|2196940|P1|STARTED|Overall Study||74
908798|NCT01682954|2196983|P2|NOT COMPLETED|Overall Study||5
908799|NCT01682954|2196984|P1|NOT COMPLETED|Overall Study||5
908800|NCT01682954|2196983|P2|COMPLETED|Overall Study||33
908801|NCT01682954|2196984|P1|COMPLETED|Overall Study||35
908802|NCT01682954|2196983|P2|STARTED|Overall Study||38
908803|NCT01682954|2196984|P1|STARTED|Overall Study||40
908804|NCT01682876|2196996|P4|NOT COMPLETED|Overall Study||19
908805|NCT01682876|2196997|P3|NOT COMPLETED|Overall Study||11
908806|NCT01682876|2196998|P2|NOT COMPLETED|Overall Study||20
908807|NCT01682876|2196999|P1|NOT COMPLETED|Overall Study||21
908808|NCT01682876|2196996|P4|COMPLETED|Overall Study||157
908809|NCT01682876|2196997|P3|COMPLETED|Overall Study||169
908810|NCT01682876|2196998|P2|COMPLETED|Overall Study||163
908811|NCT01682876|2196999|P1|COMPLETED|Overall Study||155
908812|NCT01682876|2196996|P4|STARTED|Overall Study||176
908813|NCT01682876|2196997|P3|STARTED|Overall Study||180
908814|NCT01682876|2196998|P2|STARTED|Overall Study||183
908815|NCT01682876|2196999|P1|STARTED|Overall Study||176
908816|NCT01682863|2197045|P3|NOT COMPLETED|Overall Study||24
908817|NCT01682863|2197046|P2|NOT COMPLETED|Overall Study||17
908818|NCT01682863|2197047|P1|NOT COMPLETED|Overall Study||27
908819|NCT01682863|2197045|P3|COMPLETED|Overall Study||183
908820|NCT01682863|2197046|P2|COMPLETED|Overall Study||187
908821|NCT01682863|2197047|P1|COMPLETED|Overall Study||177
908822|NCT01682863|2197045|P3|Randomized Set|Overall Study|1 randomized patient was not treated; experienced an AE prior to receiving any study drug|207
908823|NCT01682863|2197046|P2|Randomized Set|Overall Study||204
908824|NCT01682863|2197047|P1|Randomized Set|Overall Study||204
908825|NCT01682863|2197045|P3|Full Analysis Set (FAS)|Overall Study||206
908826|NCT01682863|2197046|P2|Full Analysis Set (FAS)|Overall Study||204
908827|NCT01682863|2197047|P1|Full Analysis Set (FAS)|Overall Study|included all randomized patients who received at least one dose of study medication|204
908828|NCT01682863|2197045|P3|Safety Set|Overall Study||206
908829|NCT01682863|2197046|P2|Safety Set|Overall Study||204
908830|NCT01682863|2197047|P1|Safety Set|Overall Study||204
908831|NCT01682863|2197045|P3|STARTED|Overall Study||207
908832|NCT01682863|2197046|P2|STARTED|Overall Study||204
908833|NCT01682863|2197047|P1|STARTED|Overall Study||204
908834|NCT01682837|2197076|P1|NOT COMPLETED|Fourth Intervention (4 Weeks)||0
908835|NCT01682837|2197076|P1|COMPLETED|Fourth Intervention (4 Weeks)||30
908836|NCT01682837|2197076|P1|Received Placebo|Fourth Intervention (4 Weeks)||7
908837|NCT01682837|2197076|P1|Received KCl|Fourth Intervention (4 Weeks)||8
908838|NCT01682837|2197076|P1|Received KCit|Fourth Intervention (4 Weeks)||9
908839|NCT01682837|2197076|P1|Received KMgCit|Fourth Intervention (4 Weeks)||6
908840|NCT01682837|2197076|P1|STARTED|Fourth Intervention (4 Weeks)||30
908841|NCT01682837|2197076|P1|NOT COMPLETED|Third Intervention (4 Weeks)||0
908842|NCT01682837|2197076|P1|COMPLETED|Third Intervention (4 Weeks)||30
908843|NCT01682837|2197076|P1|Received Placebo|Third Intervention (4 Weeks)||7
908844|NCT01682837|2197076|P1|Received KCl|Third Intervention (4 Weeks)||7
908845|NCT01682837|2197076|P1|Received KCit|Third Intervention (4 Weeks)||7
908846|NCT01682837|2197076|P1|Received KMgCit|Third Intervention (4 Weeks)||9
908847|NCT01682837|2197076|P1|STARTED|Third Intervention (4 Weeks)||30
908848|NCT01682837|2197076|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
908849|NCT01682837|2197076|P1|COMPLETED|Second Intervention (4 Weeks)||30
908850|NCT01682837|2197076|P1|Received Placebo|Second Intervention (4 Weeks)||9
908851|NCT01682837|2197076|P1|Received KCl|Second Intervention (4 Weeks)||8
908852|NCT01682837|2197076|P1|Received KCit|Second Intervention (4 Weeks)||6
908853|NCT01682837|2197076|P1|Received KMgCit|Second Intervention (4 Weeks)||7
908854|NCT01682837|2197076|P1|STARTED|Second Intervention (4 Weeks)||30
908855|NCT01682837|2197076|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
908856|NCT01682837|2197076|P1|COMPLETED|First Intervention (4 Weeks)||30
908857|NCT01682837|2197076|P1|Received Placebo|First Intervention (4 Weeks)||7
908858|NCT01682837|2197076|P1|Received KCl|First Intervention (4 Weeks)||7
908859|NCT01682837|2197076|P1|Received KCit|First Intervention (4 Weeks)||8
908860|NCT01682837|2197076|P1|Received KMgCit|First Intervention (4 Weeks)||8
908861|NCT01682837|2197076|P1|STARTED|First Intervention (4 Weeks)||30
908862|NCT01682837|2197076|P1|NOT COMPLETED|Baseline||5
908863|NCT01682837|2197076|P1|COMPLETED|Baseline||30
908864|NCT01682837|2197076|P1|STARTED|Baseline||35
908865|NCT01682759|2197120|P2|NOT COMPLETED|Overall Study||70
908866|NCT01682759|2197121|P1|NOT COMPLETED|Overall Study||69
908867|NCT01682759|2197120|P2|COMPLETED|Overall Study||305
908868|NCT01682759|2197121|P1|COMPLETED|Overall Study||307
908869|NCT01682759|2197120|P2|Treated|Overall Study||375
908870|NCT01682759|2197121|P1|Treated|Overall Study||375
908871|NCT01682759|2197120|P2|STARTED|Overall Study||375
908872|NCT01682759|2197121|P1|STARTED|Overall Study||376
908873|NCT01682720|2197145|P4|NOT COMPLETED|Overall Study||39
908874|NCT01682720|2197146|P3|NOT COMPLETED|Overall Study||7
908875|NCT01682720|2197147|P2|NOT COMPLETED|Overall Study||5
908876|NCT01682720|2197148|P1|NOT COMPLETED|Overall Study||85
908877|NCT01682720|2197145|P4|COMPLETED|Overall Study||211
908878|NCT01682720|2197146|P3|COMPLETED|Overall Study||5
908879|NCT01682720|2197147|P2|COMPLETED|Overall Study||69
908880|NCT01682720|2197148|P1|COMPLETED|Overall Study||0
908881|NCT01682720|2197145|P4|Included in Full Analysis Set|Overall Study||250
908882|NCT01682720|2197146|P3|Included in Full Analysis Set|Overall Study||11
908883|NCT01682720|2197147|P2|Included in Full Analysis Set|Overall Study||73
908884|NCT01682720|2197148|P1|Included in Full Analysis Set|Overall Study||0
908885|NCT01682720|2197145|P4|STARTED|Overall Study||250
908886|NCT01682720|2197146|P3|STARTED|Overall Study||12
908887|NCT01682720|2197147|P2|STARTED|Overall Study||74
908888|NCT01682720|2197148|P1|STARTED|Overall Study||85
908889|NCT01682681|2197165|P1|NOT COMPLETED|Overall Study||332
908890|NCT01682681|2197165|P1|COMPLETED|Overall Study||902
908891|NCT01682681|2197165|P1|Treated|Overall Study|2 Participants were not compliant with eligibility criteria|1232
908892|NCT01682681|2197165|P1|STARTED|Overall Study||1234
908893|NCT01682642|2197175|P2|NOT COMPLETED|Overall Study||1
908894|NCT01682642|2197176|P1|NOT COMPLETED|Overall Study||0
908895|NCT01682642|2197175|P2|COMPLETED|Overall Study||58
908896|NCT01682642|2197176|P1|COMPLETED|Overall Study||61
908897|NCT01682642|2197175|P2|STARTED|Overall Study||59
908898|NCT01682642|2197176|P1|STARTED|Overall Study||61
908899|NCT01682603|2197194|P1|NOT COMPLETED|Overall Study||3
908900|NCT01682603|2197194|P1|COMPLETED|Overall Study||34
908901|NCT01682603|2197194|P1|STARTED|Overall Study||37
908902|NCT01682538|2197208|P1|NOT COMPLETED|Overall Study||0
908903|NCT01682538|2197208|P1|COMPLETED|Overall Study||12
908904|NCT01682538|2197208|P1|STARTED|Overall Study||12
908905|NCT01682460|2197236|P1|NOT COMPLETED|Overall Study||4
908906|NCT01682460|2197236|P1|COMPLETED|Overall Study||11
908907|NCT01682460|2197236|P1|STARTED|Overall Study||15
908908|NCT01682135|2197254|P3|NOT COMPLETED|Overall Study||0
908909|NCT01682135|2197255|P2|NOT COMPLETED|Overall Study||0
908910|NCT01682135|2197256|P1|NOT COMPLETED|Overall Study||0
908911|NCT01682135|2197254|P3|COMPLETED|Overall Study||12
908912|NCT01682135|2197255|P2|COMPLETED|Overall Study||10
908913|NCT01682135|2197256|P1|COMPLETED|Overall Study||6
908914|NCT01682135|2197254|P3|Received at Least 1 Dose of Study Drug|Overall Study||12
908915|NCT01682135|2197255|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
908916|NCT01682135|2197256|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
908917|NCT01682135|2197254|P3|STARTED|Overall Study||12
908918|NCT01682135|2197255|P2|STARTED|Overall Study||10
908919|NCT01682135|2197256|P1|STARTED|Overall Study||6
908923|NCT01682031|2197300|P2|NOT COMPLETED|Overall Study||5
908924|NCT01682031|2197301|P1|NOT COMPLETED|Overall Study||1
908925|NCT01682031|2197300|P2|COMPLETED|Overall Study||5
908926|NCT01682031|2197301|P1|COMPLETED|Overall Study||7
908927|NCT01682031|2197300|P2|STARTED|Overall Study||10
908928|NCT01682031|2197301|P1|STARTED|Overall Study||8
908929|NCT01681849|2197324|P3|NOT COMPLETED|Overall Study||39
908930|NCT01681849|2197325|P2|NOT COMPLETED|Overall Study||7
908931|NCT01681849|2197326|P1|NOT COMPLETED|Overall Study||8
908932|NCT01681849|2197324|P3|COMPLETED|Overall Study||17
908933|NCT01681849|2197325|P2|COMPLETED|Overall Study||6
908934|NCT01681849|2197326|P1|COMPLETED|Overall Study||7
908935|NCT01681849|2197324|P3|STARTED|Overall Study||56
908936|NCT01681849|2197325|P2|STARTED|Overall Study||13
908937|NCT01681849|2197326|P1|STARTED|Overall Study||15
908938|NCT01681628|2197337|P2|NOT COMPLETED|19 Months Follow-up||43
908939|NCT01681628|2197338|P1|NOT COMPLETED|19 Months Follow-up||62
908940|NCT01681628|2197337|P2|COMPLETED|19 Months Follow-up||64
908941|NCT01681628|2197338|P1|COMPLETED|19 Months Follow-up||52
908942|NCT01681628|2197337|P2|STARTED|19 Months Follow-up||107
908943|NCT01681628|2197338|P1|STARTED|19 Months Follow-up||114
908944|NCT01681628|2197337|P2|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||15
908945|NCT01681628|2197338|P1|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||0
908946|NCT01681628|2197337|P2|COMPLETED|Time 2 to Time 3 (One Week Later).||107
908947|NCT01681628|2197338|P1|COMPLETED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
908948|NCT01681628|2197337|P2|STARTED|Time 2 to Time 3 (One Week Later).||122
908949|NCT01681628|2197338|P1|STARTED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
908950|NCT01681628|2197337|P2|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||6
908951|NCT01681628|2197338|P1|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||14
908952|NCT01681628|2197337|P2|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||122
908953|NCT01681628|2197338|P1|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||114
908954|NCT01681628|2197337|P2|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
908955|NCT01681628|2197338|P1|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
908956|NCT01681576|2197351|P2|NOT COMPLETED|Period 2||1
908957|NCT01681576|2197352|P1|NOT COMPLETED|Period 2||4
908958|NCT01681576|2197351|P2|COMPLETED|Period 2||35
908959|NCT01681576|2197352|P1|COMPLETED|Period 2||30
908960|NCT01681576|2197351|P2|STARTED|Period 2|Period 2: LCZ696 400mg|36
908961|NCT01681576|2197352|P1|STARTED|Period 2|Period 2: Valsartan 320mg|34
908962|NCT01681576|2197351|P2|NOT COMPLETED|Period 1||0
908963|NCT01681576|2197352|P1|NOT COMPLETED|Period 1||2
908964|NCT01681576|2197351|P2|COMPLETED|Period 1||36
908965|NCT01681576|2197352|P1|COMPLETED|Period 1||34
908966|NCT01681576|2197351|P2|STARTED|Period 1||36
908967|NCT01681576|2197352|P1|STARTED|Period 1||36
908968|NCT01681511|2197368|P2|NOT COMPLETED|Overall Study||14
908969|NCT01681511|2197369|P1|NOT COMPLETED|Overall Study||18
908970|NCT01681511|2197368|P2|COMPLETED|Overall Study||35
908971|NCT01681511|2197369|P1|COMPLETED|Overall Study||28
908972|NCT01681511|2197368|P2|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the TIC arm of this population.|14
908973|NCT01681511|2197369|P1|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the Lubri-Sil arm of this population.|16
908974|NCT01681511|2197368|P2|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the TIC treatment after randomization.|46
908975|NCT01681511|2197369|P1|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the Lubri-Sil treatment after randomization.|45
908976|NCT01681511|2197368|P2|STARTED|Overall Study|All randomized subjects in the TIC arm.|49
908977|NCT01681511|2197369|P1|STARTED|Overall Study|All randomized subjects in the Lubri-Sil arm.|46
908978|NCT01681472|2197387|P4|NOT COMPLETED|Overall Study||0
908979|NCT01681472|2197388|P3|NOT COMPLETED|Overall Study||0
908980|NCT01681472|2197389|P2|NOT COMPLETED|Overall Study||1
908981|NCT01681472|2197390|P1|NOT COMPLETED|Overall Study||0
908982|NCT01681472|2197387|P4|COMPLETED|Overall Study||8
908983|NCT01681472|2197388|P3|COMPLETED|Overall Study||8
908984|NCT01681472|2197389|P2|COMPLETED|Overall Study||7
908985|NCT01681472|2197390|P1|COMPLETED|Overall Study||8
908986|NCT01681472|2197387|P4|STARTED|Overall Study||8
908987|NCT01681472|2197388|P3|STARTED|Overall Study||8
908988|NCT01681472|2197389|P2|STARTED|Overall Study||8
908989|NCT01681472|2197390|P1|STARTED|Overall Study||8
908990|NCT01681368|2197400|P1|NOT COMPLETED|Overall Study||2
908991|NCT01681368|2197400|P1|COMPLETED|Overall Study||9
908992|NCT01681368|2197400|P1|STARTED|Overall Study||11
908993|NCT01681277|2197417|P5|NOT COMPLETED|Overall Study||0
908994|NCT01681277|2197418|P4|NOT COMPLETED|Overall Study||0
908995|NCT01681277|2197419|P3|NOT COMPLETED|Overall Study||0
908996|NCT01681277|2197420|P2|NOT COMPLETED|Overall Study||0
908997|NCT01681277|2197421|P1|NOT COMPLETED|Overall Study||1
908998|NCT01681277|2197417|P5|COMPLETED|Overall Study||9
908999|NCT01681277|2197418|P4|COMPLETED|Overall Study||9
909000|NCT01681277|2197419|P3|COMPLETED|Overall Study||9
909001|NCT01681277|2197420|P2|COMPLETED|Overall Study||9
909002|NCT01681277|2197421|P1|COMPLETED|Overall Study||11
909003|NCT01681277|2197417|P5|STARTED|Overall Study||9
909004|NCT01681277|2197418|P4|STARTED|Overall Study||9
909005|NCT01681277|2197419|P3|STARTED|Overall Study||9
909006|NCT01681277|2197420|P2|STARTED|Overall Study||9
909007|NCT01681277|2197421|P1|STARTED|Overall Study||12
909008|NCT01681212|2197462|P1|NOT COMPLETED|Overall Study||6
909009|NCT01681212|2197462|P1|COMPLETED|Overall Study|Completed=patients who received treatment; not completed=patients who did not receive treatment|15
909010|NCT01681212|2197462|P1|Received Treatment|Overall Study||15
909011|NCT01681212|2197462|P1|STARTED|Overall Study|Enrolled|21
909012|NCT01681121|2197470|P2|NOT COMPLETED|Overall Study||11
909013|NCT01681121|2197471|P1|NOT COMPLETED|Overall Study||8
909014|NCT01681121|2197470|P2|COMPLETED|Overall Study||38
909015|NCT01681121|2197471|P1|COMPLETED|Overall Study||36
909016|NCT01681121|2197470|P2|STARTED|Overall Study||49
909017|NCT01681121|2197471|P1|STARTED|Overall Study||44
909018|NCT01681095|2197479|P2|NOT COMPLETED|Overall Study||0
909019|NCT01681095|2197480|P1|NOT COMPLETED|Overall Study||0
909020|NCT01681095|2197479|P2|COMPLETED|Overall Study||55
909021|NCT01681095|2197480|P1|COMPLETED|Overall Study||55
909022|NCT01681095|2197479|P2|STARTED|Overall Study||55
909023|NCT01681095|2197480|P1|STARTED|Overall Study||55
909024|NCT01681069|2197520|P2|NOT COMPLETED|Overall Study||7
909025|NCT01681069|2197521|P1|NOT COMPLETED|Overall Study||5
909026|NCT01681069|2197520|P2|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|53
909027|NCT01681069|2197521|P1|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|55
909028|NCT01681069|2197520|P2|Full Analysis Set (FAS)|Overall Study||60
909029|NCT01681069|2197521|P1|Full Analysis Set (FAS)|Overall Study||57
909030|NCT01681069|2197520|P2|STARTED|Overall Study||60
909031|NCT01681069|2197521|P1|STARTED|Overall Study||60
909032|NCT01681004|2197533|P2|NOT COMPLETED|Study Completion||8
909033|NCT01681004|2197534|P1|NOT COMPLETED|Study Completion||12
909034|NCT01681004|2197533|P2|COMPLETED|Study Completion||36
909035|NCT01681004|2197534|P1|COMPLETED|Study Completion||89
909036|NCT01681004|2197533|P2|STARTED|Study Completion||44
909037|NCT01681004|2197534|P1|STARTED|Study Completion||101
909038|NCT01681004|2197533|P2|NOT COMPLETED|Primary Endpoint: 6 Months||2
909039|NCT01681004|2197534|P1|NOT COMPLETED|Primary Endpoint: 6 Months||1
909040|NCT01681004|2197533|P2|COMPLETED|Primary Endpoint: 6 Months||44
909041|NCT01681004|2197534|P1|COMPLETED|Primary Endpoint: 6 Months||101
909042|NCT01681004|2197533|P2|Crossover to Surgical Treatment|Primary Endpoint: 6 Months|Crossover to surgical treatment allowed per study protocol after the 6-month visit was complete.|39
909043|NCT01681004|2197534|P1|Crossover to Surgical Treatment|Primary Endpoint: 6 Months||0
909044|NCT01681004|2197533|P2|STARTED|Primary Endpoint: 6 Months||46
909045|NCT01681004|2197534|P1|STARTED|Primary Endpoint: 6 Months||102
909046|NCT01680991|2197591|P3|NOT COMPLETED|Overall Study||4
909047|NCT01680991|2197592|P2|NOT COMPLETED|Overall Study||19
909048|NCT01680991|2197593|P1|NOT COMPLETED|Overall Study||8
909049|NCT01680991|2197591|P3|COMPLETED|Overall Study||9
909050|NCT01680991|2197592|P2|COMPLETED|Overall Study||4
909051|NCT01680991|2197593|P1|COMPLETED|Overall Study||4
909052|NCT01680991|2197591|P3|STARTED|Overall Study||13
909053|NCT01680991|2197592|P2|STARTED|Overall Study||23
909054|NCT01680991|2197593|P1|STARTED|Overall Study||12
909055|NCT01680900|2197654|P2|NOT COMPLETED|Overall Study||1
909056|NCT01680900|2197655|P1|NOT COMPLETED|Overall Study||4
909057|NCT01680900|2197654|P2|COMPLETED|Overall Study||11
909058|NCT01680900|2197655|P1|COMPLETED|Overall Study||20
909059|NCT01680900|2197654|P2|STARTED|Overall Study||12
909060|NCT01680900|2197655|P1|STARTED|Overall Study||24
909061|NCT01680861|2197673|P2|NOT COMPLETED|First 12 Months Post-transplant||0
909062|NCT01680861|2197674|P1|NOT COMPLETED|First 12 Months Post-transplant||0
909063|NCT01680861|2197673|P2|COMPLETED|First 12 Months Post-transplant||15
909064|NCT01680861|2197674|P1|COMPLETED|First 12 Months Post-transplant||15
909065|NCT01680861|2197673|P2|STARTED|First 12 Months Post-transplant||15
909066|NCT01680861|2197674|P1|STARTED|First 12 Months Post-transplant||15
909067|NCT01680861|2197673|P2|NOT COMPLETED|Early Post-transplant Period||1
909068|NCT01680861|2197674|P1|NOT COMPLETED|Early Post-transplant Period||1
909069|NCT01680861|2197673|P2|COMPLETED|Early Post-transplant Period||15
909070|NCT01680861|2197674|P1|COMPLETED|Early Post-transplant Period||15
909071|NCT01680861|2197673|P2|STARTED|Early Post-transplant Period|One patient developed immediate DGF (delayed graft function) and was therefore ineligible.|16
909072|NCT01680861|2197674|P1|STARTED|Early Post-transplant Period|One patient didn't produce sufficient urine during first 24hr post-transplant (ineligible).|16
909073|NCT01680848|2197692|P1|NOT COMPLETED|Overall Study||93
909074|NCT01680848|2197692|P1|COMPLETED|Overall Study||189
909075|NCT01680848|2197692|P1|STARTED|Overall Study||282
909082|NCT01680666|2197707|P2|NOT COMPLETED|Overall Study||0
909083|NCT01680666|2197708|P1|NOT COMPLETED|Overall Study||0
909084|NCT01680666|2197707|P2|COMPLETED|Overall Study||66
909085|NCT01680666|2197708|P1|COMPLETED|Overall Study||84
909086|NCT01680666|2197707|P2|STARTED|Overall Study||66
909087|NCT01680666|2197708|P1|STARTED|Overall Study||84
909088|NCT01680549|2197716|P2|NOT COMPLETED|Overall Study||8
909089|NCT01680549|2197717|P1|NOT COMPLETED|Overall Study||5
909090|NCT01680549|2197716|P2|COMPLETED|Overall Study||17
909091|NCT01680549|2197717|P1|COMPLETED|Overall Study||20
909092|NCT01680549|2197716|P2|STARTED|Overall Study||25
909093|NCT01680549|2197717|P1|STARTED|Overall Study||25
909094|NCT01680497|2197729|P1|NOT COMPLETED|Overall Study||2
909095|NCT01680497|2197729|P1|COMPLETED|Overall Study||68
909096|NCT01680497|2197729|P1|STARTED|Overall Study||70
909097|NCT01680458|2197739|P1|NOT COMPLETED|Overall Study||3
909098|NCT01680458|2197739|P1|COMPLETED|Overall Study||27
909099|NCT01680458|2197739|P1|STARTED|Overall Study||30
909100|NCT01680341|2197750|P2|NOT COMPLETED|Overall Study||17
909101|NCT01680341|2197751|P1|NOT COMPLETED|Overall Study||21
909102|NCT01680341|2197750|P2|COMPLETED|Overall Study||119
909103|NCT01680341|2197751|P1|COMPLETED|Overall Study||115
909104|NCT01680341|2197750|P2|Exposed|Overall Study|Two (2) subjects withdrew consent prior to exposure to trial product.|134
909105|NCT01680341|2197751|P1|Exposed|Overall Study|One (1) subject withdrew consent prior to exposure to trial product.|135
909106|NCT01680341|2197750|P2|STARTED|Overall Study||136
909107|NCT01680341|2197751|P1|STARTED|Overall Study||136
909108|NCT01680328|2197771|P1|NOT COMPLETED|Overall Study||2
909109|NCT01680328|2197771|P1|COMPLETED|Overall Study||80
909110|NCT01680328|2197771|P1|Subjects Missing Injections|Overall Study|One missed the [1600 μL, 450 μL/s; thighs]; one missed the [400 μL, 300 μL/s; abdomen]|2
909111|NCT01680328|2197771|P1|STARTED|Overall Study||82
909112|NCT01680172|2197809|P2|NOT COMPLETED|Overall Study||0
909113|NCT01680172|2197810|P1|NOT COMPLETED|Overall Study||0
909114|NCT01680172|2197809|P2|COMPLETED|Overall Study||2
909115|NCT01680172|2197810|P1|COMPLETED|Overall Study||3
909116|NCT01680172|2197809|P2|STARTED|Overall Study||2
909117|NCT01680172|2197810|P1|STARTED|Overall Study||3
909118|NCT01680159|2197822|P1|NOT COMPLETED|Increased Dose Period||8
909119|NCT01680159|2197822|P1|COMPLETED|Increased Dose Period||43
909120|NCT01680159|2197822|P1|STARTED|Increased Dose Period||51
909121|NCT01680159|2197822|P1|NOT COMPLETED|Screening Period||7
909122|NCT01680159|2197822|P1|COMPLETED|Screening Period||39
909123|NCT01680159|2197822|P1|STARTED|Screening Period||46
909124|NCT01680016|2197849|P4|NOT COMPLETED|Overall Study||5
909125|NCT01680016|2197850|P3|NOT COMPLETED|Overall Study||5
909126|NCT01680016|2197851|P2|NOT COMPLETED|Overall Study||8
909127|NCT01680016|2197852|P1|NOT COMPLETED|Overall Study||6
909128|NCT01680016|2197849|P4|COMPLETED|Overall Study||195
909129|NCT01680016|2197850|P3|COMPLETED|Overall Study||196
909130|NCT01680016|2197851|P2|COMPLETED|Overall Study||114
909131|NCT01680016|2197852|P1|COMPLETED|Overall Study||115
909132|NCT01680016|2197849|P4|STARTED|Overall Study||200
909133|NCT01680016|2197850|P3|STARTED|Overall Study||201
909134|NCT01680016|2197851|P2|STARTED|Overall Study||122
909135|NCT01680016|2197852|P1|STARTED|Overall Study||121
909136|NCT01679613|2197914|P4|NOT COMPLETED|Overall Study||2
909137|NCT01679613|2197915|P3|NOT COMPLETED|Overall Study||2
909138|NCT01679613|2197916|P2|NOT COMPLETED|Overall Study||1
909139|NCT01679613|2197917|P1|NOT COMPLETED|Overall Study||0
909140|NCT01679613|2197914|P4|COMPLETED|Overall Study||11
909141|NCT01679613|2197915|P3|COMPLETED|Overall Study||11
909142|NCT01679613|2197916|P2|COMPLETED|Overall Study||3
909143|NCT01679613|2197917|P1|COMPLETED|Overall Study||4
909144|NCT01679613|2197914|P4|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
909145|NCT01679613|2197915|P3|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
909146|NCT01679613|2197916|P2|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
909147|NCT01679613|2197917|P1|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
909148|NCT01679613|2197914|P4|Received Nintedanib (Main)|Overall Study||11
909149|NCT01679613|2197915|P3|Received Nintedanib (Main)|Overall Study||13
909150|NCT01679613|2197916|P2|Received Nintedanib (Main)|Overall Study||0
909151|NCT01679613|2197917|P1|Received Nintedanib (Main)|Overall Study||0
909152|NCT01679613|2197914|P4|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
909153|NCT01679613|2197915|P3|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
909154|NCT01679613|2197916|P2|Received Nintedanib+Ketoconazole (Pilot)|Overall Study|One subject received only ketoconazole not nintedanib|4
909155|NCT01679613|2197917|P1|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||4
909156|NCT01679613|2197914|P4|Received Nintedanib (Pilot)|Overall Study||0
909157|NCT01679613|2197915|P3|Received Nintedanib (Pilot)|Overall Study||0
909158|NCT01679613|2197916|P2|Received Nintedanib (Pilot)|Overall Study||3
909159|NCT01679613|2197917|P1|Received Nintedanib (Pilot)|Overall Study||4
909160|NCT01679613|2197914|P4|STARTED|Overall Study||13
909161|NCT01679613|2197915|P3|STARTED|Overall Study||13
909162|NCT01679613|2197916|P2|STARTED|Overall Study||4
909163|NCT01679613|2197917|P1|STARTED|Overall Study||4
909164|NCT01679600|2197930|P2|NOT COMPLETED|Overall Study||0
909165|NCT01679600|2197931|P1|NOT COMPLETED|Overall Study||0
909166|NCT01679600|2197930|P2|COMPLETED|Overall Study||7
909167|NCT01679600|2197931|P1|COMPLETED|Overall Study||7
909168|NCT01679600|2197930|P2|STARTED|Overall Study||7
909169|NCT01679600|2197931|P1|STARTED|Overall Study||7
909170|NCT01679314|2197939|P2|NOT COMPLETED|Overall Study||0
909171|NCT01679314|2197940|P1|NOT COMPLETED|Overall Study||2
909172|NCT01679314|2197939|P2|COMPLETED|Overall Study||28
909173|NCT01679314|2197940|P1|COMPLETED|Overall Study||24
909174|NCT01679314|2197939|P2|STARTED|Overall Study||28
909175|NCT01679314|2197940|P1|STARTED|Overall Study||26
909176|NCT01679236|2197960|P2|NOT COMPLETED|Overall Study||15
909177|NCT01679236|2197961|P1|NOT COMPLETED|Overall Study||15
909178|NCT01679236|2197960|P2|COMPLETED|Overall Study||10
909179|NCT01679236|2197961|P1|COMPLETED|Overall Study||15
909180|NCT01679236|2197960|P2|STARTED|Overall Study||25
909181|NCT01679236|2197961|P1|STARTED|Overall Study||30
909182|NCT01679197|2197967|P1|NOT COMPLETED|Overall Study||4
909183|NCT01679197|2197967|P1|COMPLETED|Overall Study||19
909184|NCT01679197|2197967|P1|STARTED|Overall Study||23
909185|NCT01679028|2197986|P6|NOT COMPLETED|Overall Study||0
909186|NCT01679028|2197987|P5|NOT COMPLETED|Overall Study||0
909187|NCT01679028|2197988|P4|NOT COMPLETED|Overall Study||0
909188|NCT01679028|2197989|P3|NOT COMPLETED|Overall Study||0
909189|NCT01679028|2197990|P2|NOT COMPLETED|Overall Study||0
909190|NCT01679028|2197991|P1|NOT COMPLETED|Overall Study||0
909191|NCT01679028|2197986|P6|COMPLETED|Overall Study||6
909192|NCT01679028|2197987|P5|COMPLETED|Overall Study||2
909193|NCT01679028|2197988|P4|COMPLETED|Overall Study||4
909194|NCT01679028|2197989|P3|COMPLETED|Overall Study||2
909195|NCT01679028|2197990|P2|COMPLETED|Overall Study||4
909196|NCT01679028|2197991|P1|COMPLETED|Overall Study||2
909197|NCT01679028|2197986|P6|STARTED|Overall Study||6
909198|NCT01679028|2197987|P5|STARTED|Overall Study||2
909199|NCT01679028|2197988|P4|STARTED|Overall Study||4
909200|NCT01679028|2197989|P3|STARTED|Overall Study||2
909201|NCT01679028|2197990|P2|STARTED|Overall Study||4
909202|NCT01679028|2197991|P1|STARTED|Overall Study||2
909203|NCT01679002|2198008|P3|NOT COMPLETED|Overall Study||0
909204|NCT01679002|2198009|P2|NOT COMPLETED|Overall Study||1
909205|NCT01679002|2198010|P1|NOT COMPLETED|Overall Study||1
909206|NCT01679002|2198008|P3|COMPLETED|Overall Study||4
909207|NCT01679002|2198009|P2|COMPLETED|Overall Study||3
909208|NCT01679002|2198010|P1|COMPLETED|Overall Study||3
909209|NCT01679002|2198008|P3|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
909210|NCT01679002|2198009|P2|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
909211|NCT01679002|2198010|P1|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||3
909212|NCT01679002|2198008|P3|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
909213|NCT01679002|2198009|P2|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
909214|NCT01679002|2198010|P1|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
909215|NCT01679002|2198008|P3|BIA 2-093 900 mg Once-daily Period|Overall Study||4
909216|NCT01679002|2198009|P2|BIA 2-093 900 mg Once-daily Period|Overall Study||3
909217|NCT01679002|2198010|P1|BIA 2-093 900 mg Once-daily Period|Overall Study||4
909218|NCT01679002|2198008|P3|STARTED|Overall Study||4
909219|NCT01679002|2198009|P2|STARTED|Overall Study||4
909220|NCT01679002|2198010|P1|STARTED|Overall Study||4
909221|NCT01678976|2198026|P2|NOT COMPLETED|Second Period||0
909222|NCT01678976|2198027|P1|NOT COMPLETED|Second Period||0
909223|NCT01678976|2198026|P2|COMPLETED|Second Period||6
909224|NCT01678976|2198027|P1|COMPLETED|Second Period||6
909225|NCT01678976|2198026|P2|STARTED|Second Period||6
909226|NCT01678976|2198027|P1|STARTED|Second Period||6
909227|NCT01678976|2198026|P2|NOT COMPLETED|First Period||1
909228|NCT01678976|2198027|P1|NOT COMPLETED|First Period||0
909229|NCT01678976|2198026|P2|COMPLETED|First Period||6
909230|NCT01678976|2198027|P1|COMPLETED|First Period||6
909231|NCT01678976|2198026|P2|STARTED|First Period||7
909232|NCT01678976|2198027|P1|STARTED|First Period||6
909233|NCT01678911|2198037|P2|NOT COMPLETED|Second Intervention||0
909234|NCT01678911|2198038|P1|NOT COMPLETED|Second Intervention||2
909235|NCT01678911|2198037|P2|COMPLETED|Second Intervention||1
909236|NCT01678911|2198038|P1|COMPLETED|Second Intervention||2
909237|NCT01678911|2198037|P2|STARTED|Second Intervention||1
909238|NCT01678911|2198038|P1|STARTED|Second Intervention||4
909239|NCT01678911|2198037|P2|NOT COMPLETED|First Intervention||0
909240|NCT01678911|2198038|P1|NOT COMPLETED|First Intervention||0
909241|NCT01678911|2198037|P2|COMPLETED|First Intervention||1
909242|NCT01678911|2198038|P1|COMPLETED|First Intervention||4
909243|NCT01678911|2198037|P2|Cross Over|First Intervention||1
909244|NCT01678911|2198038|P1|Cross Over|First Intervention||4
909245|NCT01678911|2198037|P2|STARTED|First Intervention||1
909246|NCT01678911|2198038|P1|STARTED|First Intervention||4
909247|NCT01678885|2198054|P5|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||17
909248|NCT01678885|2198055|P4|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
909249|NCT01678885|2198056|P3|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
909250|NCT01678885|2198057|P2|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
909251|NCT01678885|2198058|P1|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
909252|NCT01678885|2198054|P5|COMPLETED|Phase II; 8 Week Low Calorie Diet||70
909253|NCT01678885|2198055|P4|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
909254|NCT01678885|2198056|P3|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
909255|NCT01678885|2198057|P2|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
909256|NCT01678885|2198058|P1|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
909257|NCT01678885|2198054|P5|STARTED|Phase II; 8 Week Low Calorie Diet||87
909258|NCT01678885|2198055|P4|STARTED|Phase II; 8 Week Low Calorie Diet||0
909259|NCT01678885|2198056|P3|STARTED|Phase II; 8 Week Low Calorie Diet||0
909260|NCT01678885|2198057|P2|STARTED|Phase II; 8 Week Low Calorie Diet||0
909261|NCT01678885|2198058|P1|STARTED|Phase II; 8 Week Low Calorie Diet||0
909262|NCT01678885|2198054|P5|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
909263|NCT01678885|2198055|P4|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
909264|NCT01678885|2198056|P3|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||1
909265|NCT01678885|2198057|P2|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
909266|NCT01678885|2198058|P1|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
909267|NCT01678885|2198054|P5|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
909268|NCT01678885|2198055|P4|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||21
909269|NCT01678885|2198056|P3|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
909270|NCT01678885|2198057|P2|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||15
909271|NCT01678885|2198058|P1|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
909272|NCT01678885|2198054|P5|STARTED|Phase I; 2 Wks Duration, Both Sub-study||0
909273|NCT01678885|2198055|P4|STARTED|Phase I; 2 Wks Duration, Both Sub-study||24
909274|NCT01678885|2198056|P3|STARTED|Phase I; 2 Wks Duration, Both Sub-study||23
909275|NCT01678885|2198057|P2|STARTED|Phase I; 2 Wks Duration, Both Sub-study||18
909276|NCT01678885|2198058|P1|STARTED|Phase I; 2 Wks Duration, Both Sub-study||22
909277|NCT01678846|2198068|P2|NOT COMPLETED|Overall Study||0
909278|NCT01678846|2198069|P1|NOT COMPLETED|Overall Study||0
909279|NCT01678846|2198068|P2|COMPLETED|Overall Study||1899
909280|NCT01678846|2198069|P1|COMPLETED|Overall Study||1921
909281|NCT01678846|2198068|P2|STARTED|Overall Study||1899
909282|NCT01678846|2198069|P1|STARTED|Overall Study|Whole school implementation. Started and completed shows number of students in the end-line survey.|1921
909283|NCT01678820|2198084|P3|NOT COMPLETED|Overall Study||57
909284|NCT01678820|2198085|P2|NOT COMPLETED|Overall Study||63
909285|NCT01678820|2198086|P1|NOT COMPLETED|Overall Study||62
909286|NCT01678820|2198084|P3|COMPLETED|Overall Study||43
909287|NCT01678820|2198085|P2|COMPLETED|Overall Study||36
909288|NCT01678820|2198086|P1|COMPLETED|Overall Study||38
909289|NCT01678820|2198084|P3|Treated With Double-blind Study Drug|Overall Study||98
909290|NCT01678820|2198085|P2|Treated With Double-blind Study Drug|Overall Study||97
909291|NCT01678820|2198086|P1|Treated With Double-blind Study Drug|Overall Study||100
909292|NCT01678820|2198084|P3|STARTED|Overall Study||100
909293|NCT01678820|2198085|P2|STARTED|Overall Study||99
909294|NCT01678820|2198086|P1|STARTED|Overall Study||100
909295|NCT01678807|2198131|P3|NOT COMPLETED|Overall Study||0
909296|NCT01678807|2198132|P2|NOT COMPLETED|Overall Study||5
909297|NCT01678807|2198133|P1|NOT COMPLETED|Overall Study||4
909298|NCT01678807|2198131|P3|COMPLETED|Overall Study||65
909299|NCT01678807|2198132|P2|COMPLETED|Overall Study||60
909300|NCT01678807|2198133|P1|COMPLETED|Overall Study||61
909301|NCT01678807|2198131|P3|STARTED|Overall Study||65
909302|NCT01678807|2198132|P2|STARTED|Overall Study||65
909303|NCT01678807|2198133|P1|STARTED|Overall Study||65
909304|NCT01678313|2198146|P2|NOT COMPLETED|Prostate Biopsy at 3 Months||12
909305|NCT01678313|2198147|P1|NOT COMPLETED|Prostate Biopsy at 3 Months||11
909306|NCT01678313|2198146|P2|COMPLETED|Prostate Biopsy at 3 Months||37
909307|NCT01678313|2198147|P1|COMPLETED|Prostate Biopsy at 3 Months||45
909308|NCT01678313|2198146|P2|STARTED|Prostate Biopsy at 3 Months||49
909309|NCT01678313|2198147|P1|STARTED|Prostate Biopsy at 3 Months||56
909310|NCT01678313|2198146|P2|NOT COMPLETED|PSA >4 ng/dL at 3 Months||9
909311|NCT01678313|2198147|P1|NOT COMPLETED|PSA >4 ng/dL at 3 Months||8
909312|NCT01678313|2198146|P2|COMPLETED|PSA >4 ng/dL at 3 Months||49
909313|NCT01678313|2198147|P1|COMPLETED|PSA >4 ng/dL at 3 Months||56
909314|NCT01678313|2198146|P2|STARTED|PSA >4 ng/dL at 3 Months||58
909315|NCT01678313|2198147|P1|STARTED|PSA >4 ng/dL at 3 Months||64
909316|NCT01678313|2198146|P2|NOT COMPLETED|Completed the 3-month Therapy||12
909317|NCT01678313|2198147|P1|NOT COMPLETED|Completed the 3-month Therapy||6
909318|NCT01678313|2198146|P2|COMPLETED|Completed the 3-month Therapy||58
909319|NCT01678313|2198147|P1|COMPLETED|Completed the 3-month Therapy||64
909320|NCT01678313|2198146|P2|STARTED|Completed the 3-month Therapy||70
909321|NCT01678313|2198147|P1|STARTED|Completed the 3-month Therapy||70
909322|NCT01678196|2198165|P2|NOT COMPLETED|Overall Study||0
909323|NCT01678196|2198166|P1|NOT COMPLETED|Overall Study||0
909324|NCT01678196|2198165|P2|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|32
909325|NCT01678196|2198166|P1|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|34
909326|NCT01678196|2198165|P2|STARTED|Overall Study||32
909327|NCT01678196|2198166|P1|STARTED|Overall Study||34
909328|NCT01678131|2198181|P3|NOT COMPLETED|Overall Study||2
909329|NCT01678131|2198182|P2|NOT COMPLETED|Overall Study||1
909330|NCT01678131|2198183|P1|NOT COMPLETED|Overall Study||0
909331|NCT01678131|2198181|P3|COMPLETED|Overall Study||9
909332|NCT01678131|2198182|P2|COMPLETED|Overall Study||9
909333|NCT01678131|2198183|P1|COMPLETED|Overall Study||10
909334|NCT01678131|2198181|P3|STARTED|Overall Study||11
909335|NCT01678131|2198182|P2|STARTED|Overall Study||10
909336|NCT01678131|2198183|P1|STARTED|Overall Study||10
909337|NCT01677988|2198191|P1|NOT COMPLETED|Overall Study||2
909338|NCT01677988|2198191|P1|COMPLETED|Overall Study||1
909339|NCT01677988|2198191|P1|STARTED|Overall Study||3
909340|NCT01677936|2198204|P2|NOT COMPLETED|Overall Study||5
909341|NCT01677936|2198205|P1|NOT COMPLETED|Overall Study||9
909342|NCT01677936|2198204|P2|COMPLETED|Overall Study|Full analysis dataset completers|15
909343|NCT01677936|2198205|P1|COMPLETED|Overall Study|Full analysis dataset completers|22
909344|NCT01677936|2198204|P2|STARTED|Overall Study|20 randomized to snacks; 1 excluded due to lack of post-baseline evaluation; 19 = full dataset|20
909345|NCT01677936|2198205|P1|STARTED|Overall Study|31 randomized to raisins; 4 excluded due to lack of post-baseline evaluation; 27 = full dataset|31
909346|NCT01677910|2198216|P3|NOT COMPLETED|Overall Study||8
909347|NCT01677910|2198217|P2|NOT COMPLETED|Overall Study||3
909348|NCT01677910|2198218|P1|NOT COMPLETED|Overall Study||7
909349|NCT01677910|2198216|P3|COMPLETED|Overall Study||38
909350|NCT01677910|2198217|P2|COMPLETED|Overall Study||42
909351|NCT01677910|2198218|P1|COMPLETED|Overall Study||38
909352|NCT01677910|2198216|P3|STARTED|Overall Study||46
909353|NCT01677910|2198217|P2|STARTED|Overall Study||45
909354|NCT01677910|2198218|P1|STARTED|Overall Study||45
909355|NCT01677858|2198243|P5|NOT COMPLETED|Overall Study||85
909356|NCT01677858|2198244|P4|NOT COMPLETED|Overall Study||6
909357|NCT01677858|2198245|P3|NOT COMPLETED|Overall Study||14
909358|NCT01677858|2198246|P2|NOT COMPLETED|Overall Study||2
909359|NCT01677858|2198247|P1|NOT COMPLETED|Overall Study||3
909360|NCT01677858|2198243|P5|COMPLETED|Overall Study|Completed indicates participants ongoing in study|4
909361|NCT01677858|2198244|P4|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
909362|NCT01677858|2198245|P3|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
909363|NCT01677858|2198246|P2|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
909364|NCT01677858|2198247|P1|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
909365|NCT01677858|2198243|P5|STARTED|Overall Study||89
909366|NCT01677858|2198244|P4|STARTED|Overall Study||6
909367|NCT01677858|2198245|P3|STARTED|Overall Study||15
909368|NCT01677858|2198246|P2|STARTED|Overall Study||3
909369|NCT01677858|2198247|P1|STARTED|Overall Study||3
909370|NCT01677767|2198320|P1|NOT COMPLETED|Overall Study||22
909371|NCT01677767|2198320|P1|COMPLETED|Overall Study||102
909372|NCT01677767|2198320|P1|STARTED|Overall Study||124
909373|NCT01677624|2198334|P1|NOT COMPLETED|Overall Study||1
909374|NCT01677624|2198334|P1|COMPLETED|Overall Study||27
909375|NCT01677624|2198334|P1|STARTED|Overall Study||28
909376|NCT01677507|2198339|P2|NOT COMPLETED|Second Assigment||5
909377|NCT01677507|2198340|P1|NOT COMPLETED|Second Assigment||3
909378|NCT01677507|2198339|P2|COMPLETED|Second Assigment||51
909379|NCT01677507|2198340|P1|COMPLETED|Second Assigment||60
909380|NCT01677507|2198339|P2|STARTED|Second Assigment||56
909381|NCT01677507|2198340|P1|STARTED|Second Assigment||63
909382|NCT01677507|2198339|P2|NOT COMPLETED|Initial Assignment||2
909383|NCT01677507|2198340|P1|NOT COMPLETED|Initial Assignment||0
909384|NCT01677507|2198339|P2|COMPLETED|Initial Assignment||56
909385|NCT01677507|2198340|P1|COMPLETED|Initial Assignment||63
909386|NCT01677507|2198339|P2|STARTED|Initial Assignment||58
909387|NCT01677507|2198340|P1|STARTED|Initial Assignment||63
909388|NCT01677299|2198354|P4|NOT COMPLETED|Overall Study||1
909389|NCT01677299|2198355|P3|NOT COMPLETED|Overall Study||1
909390|NCT01677299|2198356|P2|NOT COMPLETED|Overall Study||3
909391|NCT01677299|2198357|P1|NOT COMPLETED|Overall Study||0
909392|NCT01677299|2198354|P4|COMPLETED|Overall Study||5
909393|NCT01677299|2198355|P3|COMPLETED|Overall Study||5
909394|NCT01677299|2198356|P2|COMPLETED|Overall Study||3
909395|NCT01677299|2198357|P1|COMPLETED|Overall Study||6
909396|NCT01677299|2198354|P4|STARTED|Overall Study||6
909397|NCT01677299|2198355|P3|STARTED|Overall Study||6
909398|NCT01677299|2198356|P2|STARTED|Overall Study||6
909399|NCT01677299|2198357|P1|STARTED|Overall Study||6
909400|NCT01677286|2198379|P1|NOT COMPLETED|Overall Study||11
909401|NCT01677286|2198379|P1|COMPLETED|Overall Study||14
909402|NCT01677286|2198379|P1|STARTED|Overall Study||25
909403|NCT01677195|2198389|P3|NOT COMPLETED|Overall Study||30
909404|NCT01677195|2198390|P2|NOT COMPLETED|Overall Study||32
909405|NCT01677195|2198391|P1|NOT COMPLETED|Overall Study||29
909406|NCT01677195|2198389|P3|COMPLETED|Overall Study||50
909407|NCT01677195|2198390|P2|COMPLETED|Overall Study||51
909408|NCT01677195|2198391|P1|COMPLETED|Overall Study||42
909409|NCT01677195|2198389|P3|STARTED|Overall Study||80
909410|NCT01677195|2198390|P2|STARTED|Overall Study||83
909411|NCT01677195|2198391|P1|STARTED|Overall Study||71
909412|NCT01677182|2198402|P3|NOT COMPLETED|Overall Study||39
909413|NCT01677182|2198403|P2|NOT COMPLETED|Overall Study||28
909414|NCT01677182|2198404|P1|NOT COMPLETED|Overall Study||34
909415|NCT01677182|2198402|P3|COMPLETED|Overall Study||143
909416|NCT01677182|2198403|P2|COMPLETED|Overall Study||141
909417|NCT01677182|2198404|P1|COMPLETED|Overall Study||150
909418|NCT01677182|2198402|P3|STARTED|Overall Study||182
909419|NCT01677182|2198403|P2|STARTED|Overall Study||169
909420|NCT01677182|2198404|P1|STARTED|Overall Study||184
909421|NCT01676961|2198436|P1|NOT COMPLETED|Overall Study||5
909422|NCT01676961|2198436|P1|COMPLETED|Overall Study||0
909423|NCT01676961|2198436|P1|STARTED|Overall Study||5
909424|NCT01676896|2198444|P3|NOT COMPLETED|Overall Study||19
909425|NCT01676896|2198445|P2|NOT COMPLETED|Overall Study||7
909426|NCT01676896|2198446|P1|NOT COMPLETED|Overall Study||12
909427|NCT01676896|2198444|P3|COMPLETED|Overall Study||81
909428|NCT01676896|2198445|P2|COMPLETED|Overall Study||89
909429|NCT01676896|2198446|P1|COMPLETED|Overall Study||84
909430|NCT01676896|2198444|P3|STARTED|Overall Study||100
909431|NCT01676896|2198445|P2|STARTED|Overall Study||96
909432|NCT01676896|2198446|P1|STARTED|Overall Study||96
909433|NCT01676714|2198541|P1|NOT COMPLETED|Overall Study||0
909434|NCT01676714|2198541|P1|COMPLETED|Overall Study||10
909435|NCT01676714|2198541|P1|STARTED|Overall Study||10
909436|NCT01676532|2198548|P1|NOT COMPLETED|Overall Study||0
909437|NCT01676532|2198548|P1|COMPLETED|Overall Study||127
909438|NCT01676532|2198548|P1|STARTED|Overall Study||127
909439|NCT01676415|2198559|P2|NOT COMPLETED|Overall Study||0
909440|NCT01676415|2198560|P1|NOT COMPLETED|Overall Study||0
909441|NCT01676415|2198559|P2|COMPLETED|Overall Study||5
909442|NCT01676415|2198560|P1|COMPLETED|Overall Study||4
909443|NCT01676415|2198559|P2|STARTED|Overall Study||5
909444|NCT01676415|2198560|P1|STARTED|Overall Study||4
909445|NCT01676298|2198580|P8|NOT COMPLETED|Overall Study||0
909446|NCT01676298|2198581|P7|NOT COMPLETED|Overall Study||0
909447|NCT01676298|2198582|P6|NOT COMPLETED|Overall Study||0
909448|NCT01676298|2198583|P5|NOT COMPLETED|Overall Study||0
909449|NCT01676298|2198584|P4|NOT COMPLETED|Overall Study||0
909450|NCT01676298|2198585|P3|NOT COMPLETED|Overall Study||0
909451|NCT01676298|2198586|P2|NOT COMPLETED|Overall Study||0
909452|NCT01676298|2198587|P1|NOT COMPLETED|Overall Study||0
909453|NCT01676298|2198580|P8|COMPLETED|Overall Study||1
909454|NCT01676298|2198581|P7|COMPLETED|Overall Study||1
909455|NCT01676298|2198582|P6|COMPLETED|Overall Study||1
909456|NCT01676298|2198583|P5|COMPLETED|Overall Study||1
909457|NCT01676298|2198584|P4|COMPLETED|Overall Study||1
909458|NCT01676298|2198585|P3|COMPLETED|Overall Study||1
909459|NCT01676298|2198586|P2|COMPLETED|Overall Study||1
909460|NCT01676298|2198587|P1|COMPLETED|Overall Study||1
909461|NCT01676298|2198580|P8|Participated in All Tests|Overall Study||1
909462|NCT01676298|2198581|P7|Participated in All Tests|Overall Study||1
909463|NCT01676298|2198582|P6|Participated in All Tests|Overall Study||1
909464|NCT01676298|2198583|P5|Participated in All Tests|Overall Study||1
909465|NCT01676298|2198584|P4|Participated in All Tests|Overall Study||1
909466|NCT01676298|2198585|P3|Participated in All Tests|Overall Study||1
909467|NCT01676298|2198586|P2|Participated in All Tests|Overall Study||1
909468|NCT01676298|2198587|P1|Participated in All Tests|Overall Study||1
909469|NCT01676298|2198580|P8|All Genotypes Confirmed With Reference|Overall Study||1
909470|NCT01676298|2198581|P7|All Genotypes Confirmed With Reference|Overall Study||1
909471|NCT01676298|2198582|P6|All Genotypes Confirmed With Reference|Overall Study||1
909472|NCT01676298|2198583|P5|All Genotypes Confirmed With Reference|Overall Study||1
909473|NCT01676298|2198584|P4|All Genotypes Confirmed With Reference|Overall Study||1
909474|NCT01676298|2198585|P3|All Genotypes Confirmed With Reference|Overall Study||1
909475|NCT01676298|2198586|P2|All Genotypes Confirmed With Reference|Overall Study||1
909476|NCT01676298|2198587|P1|All Genotypes Confirmed With Reference|Overall Study||1
909477|NCT01676298|2198580|P8|STARTED|Overall Study||1
909478|NCT01676298|2198581|P7|STARTED|Overall Study||1
909479|NCT01676298|2198582|P6|STARTED|Overall Study||1
909480|NCT01676298|2198583|P5|STARTED|Overall Study||1
909481|NCT01676298|2198584|P4|STARTED|Overall Study||1
909482|NCT01676298|2198585|P3|STARTED|Overall Study||1
909483|NCT01676298|2198586|P2|STARTED|Overall Study||1
909484|NCT01676298|2198587|P1|STARTED|Overall Study||1
909485|NCT01676220|2198607|P2|NOT COMPLETED|Overall Study||125
909486|NCT01676220|2198608|P1|NOT COMPLETED|Overall Study||102
909487|NCT01676220|2198607|P2|COMPLETED|Overall Study||314
909488|NCT01676220|2198608|P1|COMPLETED|Overall Study||337
909489|NCT01676220|2198607|P2|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post­baseline data|430
909490|NCT01676220|2198608|P1|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post­baseline data|432
909491|NCT01676220|2198607|P2|Treated|Overall Study||438
909492|NCT01676220|2198608|P1|Treated|Overall Study||435
909493|NCT01676220|2198607|P2|STARTED|Overall Study||439
909494|NCT01676220|2198608|P1|STARTED|Overall Study||439
909495|NCT01676012|2198638|P1|NOT COMPLETED|Overall Study||3
909496|NCT01676012|2198638|P1|COMPLETED|Overall Study||29
909497|NCT01676012|2198638|P1|STARTED|Overall Study||32
909498|NCT01675830|2198642|P1|NOT COMPLETED|Overall Study||0
909499|NCT01675830|2198642|P1|COMPLETED|Overall Study||10
909500|NCT01675830|2198642|P1|STARTED|Overall Study||10
909501|NCT01675661|2198649|P2|NOT COMPLETED|Overall Study||46
909502|NCT01675661|2198650|P1|NOT COMPLETED|Overall Study||40
909503|NCT01675661|2198649|P2|COMPLETED|Overall Study||103
909504|NCT01675661|2198650|P1|COMPLETED|Overall Study||113
909505|NCT01675661|2198649|P2|STARTED|Overall Study||149
909506|NCT01675661|2198650|P1|STARTED|Overall Study||153
909507|NCT01675544|2198662|P1|NOT COMPLETED|Overall Study||2
909508|NCT01675544|2198662|P1|COMPLETED|Overall Study||44
909509|NCT01675544|2198662|P1|STARTED|Overall Study||46
909510|NCT01675531|2198667|P1|NOT COMPLETED|Overall Study||25
909511|NCT01675531|2198667|P1|COMPLETED|Overall Study||41
909512|NCT01675531|2198667|P1|STARTED|Overall Study||66
909513|NCT01675492|2198674|P1|NOT COMPLETED|Overall Study||42
909514|NCT01675492|2198674|P1|COMPLETED|Overall Study||42
909515|NCT01675492|2198674|P1|STARTED|Overall Study||84
909516|NCT01675453|2198681|P2|NOT COMPLETED|Overall Study||0
909517|NCT01675453|2198682|P1|NOT COMPLETED|Overall Study||0
909518|NCT01675453|2198681|P2|COMPLETED|Overall Study||20
909519|NCT01675453|2198682|P1|COMPLETED|Overall Study||20
909520|NCT01675453|2198681|P2|STARTED|Overall Study||20
909521|NCT01675453|2198682|P1|STARTED|Overall Study||20
909522|NCT01675427|2198688|P1|NOT COMPLETED|Overall Study||34
909523|NCT01675427|2198688|P1|COMPLETED|Overall Study||4732
909524|NCT01675427|2198688|P1|STARTED|Overall Study||4766
909525|NCT01675167|2198975|P3|NOT COMPLETED|Double-blind Treatment Phase||110
909526|NCT01675167|2198976|P2|NOT COMPLETED|Double-blind Treatment Phase||48
909527|NCT01675167|2198977|P1|NOT COMPLETED|Double-blind Treatment Phase||0
909528|NCT01675167|2198975|P3|COMPLETED|Double-blind Treatment Phase||147
909529|NCT01675167|2198976|P2|COMPLETED|Double-blind Treatment Phase||206
909530|NCT01675167|2198977|P1|COMPLETED|Double-blind Treatment Phase||0
909531|NCT01675167|2198975|P3|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|257
909532|NCT01675167|2198976|P2|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|254
909533|NCT01675167|2198977|P1|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
909534|NCT01675167|2198975|P3|NOT COMPLETED|Open-label Titration Phase||0
909535|NCT01675167|2198976|P2|NOT COMPLETED|Open-label Titration Phase||0
909536|NCT01675167|2198977|P1|NOT COMPLETED|Open-label Titration Phase||304
909537|NCT01675167|2198975|P3|COMPLETED|Open-label Titration Phase||0
909538|NCT01675167|2198976|P2|COMPLETED|Open-label Titration Phase||0
909539|NCT01675167|2198977|P1|COMPLETED|Open-label Titration Phase||511
909540|NCT01675167|2198975|P3|STARTED|Open-label Titration Phase||0
909541|NCT01675167|2198976|P2|STARTED|Open-label Titration Phase||0
909542|NCT01675167|2198977|P1|STARTED|Open-label Titration Phase||815
909543|NCT01675141|2198999|P1|NOT COMPLETED|Overall Study||11
909544|NCT01675141|2198999|P1|COMPLETED|Overall Study||0
909545|NCT01675141|2198999|P1|STARTED|Overall Study||11
909546|NCT01675128|2199012|P3|NOT COMPLETED|Overall Study||1
909547|NCT01675128|2199013|P2|NOT COMPLETED|Overall Study||2
909548|NCT01675128|2199014|P1|NOT COMPLETED|Overall Study||2
909549|NCT01675128|2199012|P3|COMPLETED|Overall Study||9
909550|NCT01675128|2199013|P2|COMPLETED|Overall Study||8
909551|NCT01675128|2199014|P1|COMPLETED|Overall Study||2
909552|NCT01675128|2199012|P3|STARTED|Overall Study||10
909553|NCT01675128|2199013|P2|STARTED|Overall Study||10
909554|NCT01675128|2199014|P1|STARTED|Overall Study||4
909555|NCT01675063|2199036|P1|NOT COMPLETED|Overall Study||0
909556|NCT01675063|2199036|P1|COMPLETED|Overall Study||77
909557|NCT01675063|2199036|P1|STARTED|Overall Study||77
909558|NCT01675050|2199042|P2|NOT COMPLETED|Second Period Treatment||0
909559|NCT01675050|2199043|P1|NOT COMPLETED|Second Period Treatment||0
909560|NCT01675050|2199042|P2|COMPLETED|Second Period Treatment||2
909561|NCT01675050|2199043|P1|COMPLETED|Second Period Treatment||1
909562|NCT01675050|2199042|P2|STARTED|Second Period Treatment||2
909563|NCT01675050|2199043|P1|STARTED|Second Period Treatment||1
909564|NCT01675050|2199042|P2|NOT COMPLETED|Wash Out Period||0
909565|NCT01675050|2199043|P1|NOT COMPLETED|Wash Out Period||0
909566|NCT01675050|2199042|P2|COMPLETED|Wash Out Period||2
909567|NCT01675050|2199043|P1|COMPLETED|Wash Out Period||1
909568|NCT01675050|2199042|P2|STARTED|Wash Out Period||2
909569|NCT01675050|2199043|P1|STARTED|Wash Out Period||1
909570|NCT01675050|2199042|P2|NOT COMPLETED|Period One Treatment||0
909571|NCT01675050|2199043|P1|NOT COMPLETED|Period One Treatment||1
909572|NCT01675050|2199042|P2|COMPLETED|Period One Treatment||2
909573|NCT01675050|2199043|P1|COMPLETED|Period One Treatment||1
909574|NCT01675050|2199042|P2|STARTED|Period One Treatment||2
909575|NCT01675050|2199043|P1|STARTED|Period One Treatment||2
909576|NCT01675011|2199053|P2|NOT COMPLETED|Overall Study||1
909577|NCT01675011|2199054|P1|NOT COMPLETED|Overall Study||3
909578|NCT01675011|2199053|P2|COMPLETED|Overall Study||0
909579|NCT01675011|2199054|P1|COMPLETED|Overall Study||0
909580|NCT01675011|2199053|P2|STARTED|Overall Study||1
909581|NCT01675011|2199054|P1|STARTED|Overall Study||3
909582|NCT01674725|2199062|P2|NOT COMPLETED|Overall Study||1
909583|NCT01674725|2199063|P1|NOT COMPLETED|Overall Study||3
909584|NCT01674725|2199062|P2|COMPLETED|Overall Study||94
909585|NCT01674725|2199063|P1|COMPLETED|Overall Study||89
909586|NCT01674725|2199062|P2|STARTED|Overall Study||95
909587|NCT01674725|2199063|P1|STARTED|Overall Study||92
909588|NCT01674712|2199082|P5|NOT COMPLETED|Overall Study||11
909589|NCT01674712|2199083|P4|NOT COMPLETED|Overall Study||8
909590|NCT01674712|2199084|P3|NOT COMPLETED|Overall Study||9
909591|NCT01674712|2199085|P2|NOT COMPLETED|Overall Study||9
909592|NCT01674712|2199086|P1|NOT COMPLETED|Overall Study||10
909593|NCT01674712|2199082|P5|COMPLETED|Overall Study||102
909594|NCT01674712|2199083|P4|COMPLETED|Overall Study||108
909595|NCT01674712|2199084|P3|COMPLETED|Overall Study||106
909596|NCT01674712|2199085|P2|COMPLETED|Overall Study||108
909597|NCT01674712|2199086|P1|COMPLETED|Overall Study||104
909598|NCT01674712|2199082|P5|Safety Subject Sample|Overall Study||112
909599|NCT01674712|2199083|P4|Safety Subject Sample|Overall Study||115
909600|NCT01674712|2199084|P3|Safety Subject Sample|Overall Study||113
909601|NCT01674712|2199085|P2|Safety Subject Sample|Overall Study||117
909602|NCT01674712|2199086|P1|Safety Subject Sample|Overall Study||111
909603|NCT01674712|2199082|P5|Full Analysis Subject Sample|Overall Study||111
909604|NCT01674712|2199083|P4|Full Analysis Subject Sample|Overall Study||112
909605|NCT01674712|2199084|P3|Full Analysis Subject Sample|Overall Study||110
909606|NCT01674712|2199085|P2|Full Analysis Subject Sample|Overall Study||114
909607|NCT01674712|2199086|P1|Full Analysis Subject Sample|Overall Study||109
909608|NCT01674712|2199082|P5|STARTED|Overall Study||113
909609|NCT01674712|2199083|P4|STARTED|Overall Study||116
909610|NCT01674712|2199084|P3|STARTED|Overall Study||115
909611|NCT01674712|2199085|P2|STARTED|Overall Study||117
909612|NCT01674712|2199086|P1|STARTED|Overall Study||114
909613|NCT01674647|2199110|P2|NOT COMPLETED|30-day Safety Follow-up Period||41
909614|NCT01674647|2199111|P1|NOT COMPLETED|30-day Safety Follow-up Period||58
909615|NCT01674647|2199110|P2|COMPLETED|30-day Safety Follow-up Period||446
909616|NCT01674647|2199111|P1|COMPLETED|30-day Safety Follow-up Period||924
909617|NCT01674647|2199110|P2|STARTED|30-day Safety Follow-up Period||487
909618|NCT01674647|2199111|P1|STARTED|30-day Safety Follow-up Period||982
909619|NCT01674647|2199110|P2|NOT COMPLETED|Treatment Period||102
909620|NCT01674647|2199111|P1|NOT COMPLETED|Treatment Period||156
909621|NCT01674647|2199110|P2|COMPLETED|Treatment Period||400
909622|NCT01674647|2199111|P1|COMPLETED|Treatment Period||846
909623|NCT01674647|2199110|P2|Subjects Received Treatment|Treatment Period||499
909624|NCT01674647|2199111|P1|Subjects Received Treatment|Treatment Period||988
909625|NCT01674647|2199110|P2|STARTED|Treatment Period||502
909626|NCT01674647|2199111|P1|STARTED|Treatment Period||1002
909627|NCT01674634|2199137|P1|NOT COMPLETED|Overall Study||6
909628|NCT01674634|2199137|P1|COMPLETED|Overall Study||709
909629|NCT01674634|2199137|P1|STARTED|Overall Study||715
909630|NCT01674621|2199157|P5|NOT COMPLETED|Overall Study||6
909631|NCT01674621|2199158|P4|NOT COMPLETED|Overall Study||7
909632|NCT01674621|2199159|P3|NOT COMPLETED|Overall Study||8
909633|NCT01674621|2199160|P2|NOT COMPLETED|Overall Study||5
909634|NCT01674621|2199161|P1|NOT COMPLETED|Overall Study||6
909635|NCT01674621|2199157|P5|COMPLETED|Overall Study||45
909636|NCT01674621|2199158|P4|COMPLETED|Overall Study||41
909637|NCT01674621|2199159|P3|COMPLETED|Overall Study||43
909638|NCT01674621|2199160|P2|COMPLETED|Overall Study||45
909639|NCT01674621|2199161|P1|COMPLETED|Overall Study||44
909640|NCT01674621|2199157|P5|STARTED|Overall Study||51
909641|NCT01674621|2199158|P4|STARTED|Overall Study||48
909642|NCT01674621|2199159|P3|STARTED|Overall Study||51
909643|NCT01674621|2199160|P2|STARTED|Overall Study||50
909644|NCT01674621|2199161|P1|STARTED|Overall Study||50
909645|NCT01674062|2199185|P2|NOT COMPLETED|Overall Study||29
909646|NCT01674062|2199186|P1|NOT COMPLETED|Overall Study||66
909647|NCT01674062|2199185|P2|COMPLETED|Overall Study||0
909648|NCT01674062|2199186|P1|COMPLETED|Overall Study||0
909649|NCT01674062|2199185|P2|STARTED|Overall Study||29
909650|NCT01674062|2199186|P1|STARTED|Overall Study||66
909651|NCT01674010|2199201|P3|NOT COMPLETED|Randomization Phase 2||61
909652|NCT01674010|2199202|P2|NOT COMPLETED|Randomization Phase 2||62
909653|NCT01674010|2199203|P1|NOT COMPLETED|Randomization Phase 2||0
909654|NCT01674010|2199201|P3|COMPLETED|Randomization Phase 2||3
909655|NCT01674010|2199202|P2|COMPLETED|Randomization Phase 2||3
909656|NCT01674010|2199203|P1|COMPLETED|Randomization Phase 2||0
909657|NCT01674010|2199201|P3|STARTED|Randomization Phase 2||64
909658|NCT01674010|2199202|P2|STARTED|Randomization Phase 2||65
909659|NCT01674010|2199203|P1|STARTED|Randomization Phase 2||0
909660|NCT01674010|2199201|P3|NOT COMPLETED|Open Treatment Phase 1||0
909661|NCT01674010|2199202|P2|NOT COMPLETED|Open Treatment Phase 1||0
909662|NCT01674010|2199203|P1|NOT COMPLETED|Open Treatment Phase 1||180
909663|NCT01674010|2199201|P3|COMPLETED|Open Treatment Phase 1||0
909664|NCT01674010|2199202|P2|COMPLETED|Open Treatment Phase 1||0
909665|NCT01674010|2199203|P1|COMPLETED|Open Treatment Phase 1||129
909666|NCT01674010|2199201|P3|STARTED|Open Treatment Phase 1||0
909667|NCT01674010|2199202|P2|STARTED|Open Treatment Phase 1||0
909668|NCT01674010|2199203|P1|STARTED|Open Treatment Phase 1||309
909669|NCT01673984|2199222|P2|NOT COMPLETED|Overall Study||6
909670|NCT01673984|2199223|P1|NOT COMPLETED|Overall Study||10
909671|NCT01673984|2199222|P2|COMPLETED|Overall Study||1
909672|NCT01673984|2199223|P1|COMPLETED|Overall Study||4
909673|NCT01673984|2199222|P2|STARTED|Overall Study||7
909674|NCT01673984|2199223|P1|STARTED|Overall Study||14
909675|NCT01673919|2199241|P1|NOT COMPLETED|Overall Study||0
909676|NCT01673919|2199241|P1|COMPLETED|Overall Study||7
909677|NCT01673919|2199241|P1|STARTED|Overall Study||7
909678|NCT01673867|2199265|P2|NOT COMPLETED|Treatment||268
909679|NCT01673867|2199266|P1|NOT COMPLETED|Treatment||244
909680|NCT01673867|2199265|P2|COMPLETED|Treatment||0
909681|NCT01673867|2199266|P1|COMPLETED|Treatment||43
909682|NCT01673867|2199265|P2|STARTED|Treatment||268
909683|NCT01673867|2199266|P1|STARTED|Treatment||287
909684|NCT01673867|2199265|P2|NOT COMPLETED|Randomization||22
909685|NCT01673867|2199266|P1|NOT COMPLETED|Randomization||5
909686|NCT01673867|2199265|P2|COMPLETED|Randomization||268
909687|NCT01673867|2199266|P1|COMPLETED|Randomization||287
909688|NCT01673867|2199265|P2|STARTED|Randomization||290
909689|NCT01673867|2199266|P1|STARTED|Randomization||292
909690|NCT01673854|2199292|P1|NOT COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||19
909691|NCT01673854|2199292|P1|COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||0
909692|NCT01673854|2199292|P1|STARTED|Vem 2 Phase (Vemurafenib Retreatment)||19
909693|NCT01673854|2199292|P1|NOT COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||27
909694|NCT01673854|2199292|P1|COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||19
909695|NCT01673854|2199292|P1|STARTED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||46
909696|NCT01673854|2199292|P1|NOT COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||0
909697|NCT01673854|2199292|P1|COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||46
909698|NCT01673854|2199292|P1|STARTED|Vem 1 Phase (Vemurafenib, 960 mg)||46
909699|NCT01673828|2199302|P2|NOT COMPLETED|Overall Study||0
909700|NCT01673828|2199303|P1|NOT COMPLETED|Overall Study||0
909701|NCT01673828|2199302|P2|COMPLETED|Overall Study||6
909702|NCT01673828|2199303|P1|COMPLETED|Overall Study||7
909703|NCT01673828|2199302|P2|STARTED|Overall Study||6
909704|NCT01673828|2199303|P1|STARTED|Overall Study||7
909705|NCT01673802|2199309|P1|NOT COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||0
909706|NCT01673802|2199309|P1|COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||10
909707|NCT01673802|2199309|P1|STARTED|Gadoxetate Double Dose 0.050 mmol/kg||10
909708|NCT01673802|2199309|P1|NOT COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||0
909709|NCT01673802|2199309|P1|COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||8
909710|NCT01673802|2199309|P1|STARTED|Gadoxetate Standard Dose 0.025 mmol/kg||8
909711|NCT01673698|2199315|P2|NOT COMPLETED|Overall Study||13
909712|NCT01673698|2199316|P1|NOT COMPLETED|Overall Study||51
909713|NCT01673698|2199315|P2|COMPLETED|Overall Study||126
909714|NCT01673698|2199316|P1|COMPLETED|Overall Study||136
909715|NCT01673698|2199315|P2|STARTED|Overall Study||139
909716|NCT01673698|2199316|P1|STARTED|Overall Study||187
909717|NCT01673620|2199326|P2|NOT COMPLETED|Overall Study||0
909718|NCT01673620|2199327|P1|NOT COMPLETED|Overall Study||1
909719|NCT01673620|2199326|P2|COMPLETED|Overall Study||22
909720|NCT01673620|2199327|P1|COMPLETED|Overall Study||46
909721|NCT01673620|2199326|P2|STARTED|Overall Study||22
909722|NCT01673620|2199327|P1|STARTED|Overall Study||47
909723|NCT01673594|2199337|P2|NOT COMPLETED|Overall Study||6
909724|NCT01673594|2199338|P1|NOT COMPLETED|Overall Study||6
909725|NCT01673594|2199337|P2|COMPLETED|Overall Study||13
909726|NCT01673594|2199338|P1|COMPLETED|Overall Study||12
909727|NCT01673594|2199337|P2|STARTED|Overall Study||19
909728|NCT01673594|2199338|P1|STARTED|Overall Study||18
909729|NCT01673568|2199348|P2|NOT COMPLETED|Overall Study||0
909730|NCT01673568|2199349|P1|NOT COMPLETED|Overall Study||0
909731|NCT01673568|2199348|P2|COMPLETED|Overall Study||28
909732|NCT01673568|2199349|P1|COMPLETED|Overall Study||28
909733|NCT01673568|2199348|P2|STARTED|Overall Study||28
909734|NCT01673568|2199349|P1|STARTED|Overall Study||28
909735|NCT01673490|2199357|P1|NOT COMPLETED|Overall Study||7
909736|NCT01673490|2199357|P1|COMPLETED|Overall Study||52
909737|NCT01673490|2199357|P1|STARTED|Overall Study||59
909738|NCT01673425|2199370|P1|NOT COMPLETED|Overall Study||1
909739|NCT01673425|2199370|P1|COMPLETED|Overall Study||4
909740|NCT01673425|2199370|P1|STARTED|Overall Study||5
909741|NCT01673347|2199374|P1|NOT COMPLETED|Overall Study||7
909742|NCT01673347|2199374|P1|COMPLETED|Overall Study||17
909743|NCT01673347|2199374|P1|STARTED|Overall Study||24
909744|NCT01673282|2199383|P2|NOT COMPLETED|Overall Study||26
909745|NCT01673282|2199384|P1|NOT COMPLETED|Overall Study||33
909746|NCT01673282|2199383|P2|COMPLETED|Overall Study||132
909747|NCT01673282|2199384|P1|COMPLETED|Overall Study||120
909748|NCT01673282|2199383|P2|STARTED|Overall Study||158
909749|NCT01673282|2199384|P1|STARTED|Overall Study||153
909750|NCT01673256|2199390|P1|NOT COMPLETED|Overall Study||0
909751|NCT01673256|2199390|P1|COMPLETED|Overall Study||90
909752|NCT01673256|2199390|P1|STARTED|Overall Study||90
909753|NCT01673191|2199396|P2|NOT COMPLETED|Overall Study||0
909754|NCT01673191|2199397|P1|NOT COMPLETED|Overall Study||0
909755|NCT01673191|2199396|P2|COMPLETED|Overall Study||11
909756|NCT01673191|2199397|P1|COMPLETED|Overall Study||26
909757|NCT01673191|2199396|P2|STARTED|Overall Study||11
909758|NCT01673191|2199397|P1|STARTED|Overall Study||26
909759|NCT01673178|2199420|P5|NOT COMPLETED|Overall Study||2
909760|NCT01673178|2199421|P4|NOT COMPLETED|Overall Study||8
909761|NCT01673178|2199422|P3|NOT COMPLETED|Overall Study||3
909762|NCT01673178|2199423|P2|NOT COMPLETED|Overall Study||2
909763|NCT01673178|2199424|P1|NOT COMPLETED|Overall Study||3
909764|NCT01673178|2199420|P5|COMPLETED|Overall Study||19
909765|NCT01673178|2199421|P4|COMPLETED|Overall Study||14
909766|NCT01673178|2199422|P3|COMPLETED|Overall Study||18
909767|NCT01673178|2199423|P2|COMPLETED|Overall Study||19
909768|NCT01673178|2199424|P1|COMPLETED|Overall Study||19
909769|NCT01673178|2199420|P5|STARTED|Overall Study||21
909770|NCT01673178|2199421|P4|STARTED|Overall Study||22
909771|NCT01673178|2199422|P3|STARTED|Overall Study||21
909772|NCT01673178|2199423|P2|STARTED|Overall Study||21
909773|NCT01673178|2199424|P1|STARTED|Overall Study||22
909774|NCT01673126|2199663|P2|NOT COMPLETED|Overall Study||3
909775|NCT01673126|2199664|P1|NOT COMPLETED|Overall Study||4
909776|NCT01673126|2199663|P2|COMPLETED|Overall Study||23
909777|NCT01673126|2199664|P1|COMPLETED|Overall Study||32
909778|NCT01673126|2199663|P2|STARTED|Overall Study|First stimulation (20 minutes) Washout (2days) Second stimulation (20 minutes)|26
909779|NCT01673126|2199664|P1|STARTED|Overall Study|First stimulation (20 minutes) Washout (2 days) Second stimulation (20 minutes)|36
909780|NCT01673113|2199672|P2|NOT COMPLETED|Overall Study||0
909781|NCT01673113|2199673|P1|NOT COMPLETED|Overall Study||0
909782|NCT01673113|2199672|P2|COMPLETED|Overall Study||11
909783|NCT01673113|2199673|P1|COMPLETED|Overall Study||11
909784|NCT01673113|2199672|P2|STARTED|Overall Study||11
909785|NCT01673113|2199673|P1|STARTED|Overall Study||11
909786|NCT01673009|2199680|P1|NOT COMPLETED|Overall Study||13
909787|NCT01673009|2199680|P1|COMPLETED|Overall Study||23
909788|NCT01673009|2199680|P1|STARTED|Overall Study||36
909789|NCT01672996|2199692|P3|NOT COMPLETED|Overall Study||0
909790|NCT01672996|2199693|P2|NOT COMPLETED|Overall Study||0
909791|NCT01672996|2199694|P1|NOT COMPLETED|Overall Study||0
909792|NCT01672996|2199692|P3|COMPLETED|Overall Study||6
909793|NCT01672996|2199693|P2|COMPLETED|Overall Study||30
909794|NCT01672996|2199694|P1|COMPLETED|Overall Study||30
909795|NCT01672996|2199692|P3|STARTED|Overall Study||6
909796|NCT01672996|2199693|P2|STARTED|Overall Study||30
909797|NCT01672996|2199694|P1|STARTED|Overall Study||30
909798|NCT01672983|2199730|P6|NOT COMPLETED|Overall Study||0
909799|NCT01672983|2199731|P5|NOT COMPLETED|Overall Study||0
909800|NCT01672983|2199732|P4|NOT COMPLETED|Overall Study||0
909801|NCT01672983|2199733|P3|NOT COMPLETED|Overall Study||0
909802|NCT01672983|2199734|P2|NOT COMPLETED|Overall Study||0
909803|NCT01672983|2199735|P1|NOT COMPLETED|Overall Study||0
909804|NCT01672983|2199730|P6|COMPLETED|Overall Study||18
909805|NCT01672983|2199731|P5|COMPLETED|Overall Study||19
909806|NCT01672983|2199732|P4|COMPLETED|Overall Study||18
909807|NCT01672983|2199733|P3|COMPLETED|Overall Study||19
909808|NCT01672983|2199734|P2|COMPLETED|Overall Study||18
909809|NCT01672983|2199735|P1|COMPLETED|Overall Study||18
909810|NCT01672983|2199730|P6|Completed Study Drug|Overall Study||17
909811|NCT01672983|2199731|P5|Completed Study Drug|Overall Study||12
909812|NCT01672983|2199732|P4|Completed Study Drug|Overall Study||18
909813|NCT01672983|2199733|P3|Completed Study Drug|Overall Study||18
909814|NCT01672983|2199734|P2|Completed Study Drug|Overall Study||17
909815|NCT01672983|2199735|P1|Completed Study Drug|Overall Study||18
909816|NCT01672983|2199730|P6|STARTED|Overall Study||18
909817|NCT01672983|2199731|P5|STARTED|Overall Study||19
909818|NCT01672983|2199732|P4|STARTED|Overall Study||18
909819|NCT01672983|2199733|P3|STARTED|Overall Study||19
909820|NCT01672983|2199734|P2|STARTED|Overall Study||18
909821|NCT01672983|2199735|P1|STARTED|Overall Study||18
909822|NCT01672970|2199765|P1|NOT COMPLETED|Overall Study||47
909823|NCT01672970|2199765|P1|COMPLETED|Overall Study||244
909824|NCT01672970|2199765|P1|Treated|Overall Study||290
909825|NCT01672970|2199765|P1|STARTED|Overall Study||291
909826|NCT01672957|2199801|P1|NOT COMPLETED|Overall Study||55
909827|NCT01672957|2199801|P1|COMPLETED|Overall Study||73
909828|NCT01672957|2199801|P1|Intent-to-treat (ITT) Population|Overall Study|All enrolled participants who had no major protocol violation.|123
909829|NCT01672957|2199801|P1|STARTED|Overall Study||128
909830|NCT01672827|2199814|P1|NOT COMPLETED|Overall Study||0
909831|NCT01672827|2199814|P1|COMPLETED|Overall Study||276
909832|NCT01672827|2199814|P1|STARTED|Overall Study||276
909833|NCT01672788|2199820|P4|NOT COMPLETED|Treatment Period 4 (3 Days)||0
909834|NCT01672788|2199821|P3|NOT COMPLETED|Treatment Period 4 (3 Days)||0
909835|NCT01672788|2199822|P2|NOT COMPLETED|Treatment Period 4 (3 Days)||0
909836|NCT01672788|2199823|P1|NOT COMPLETED|Treatment Period 4 (3 Days)||0
909837|NCT01672788|2199820|P4|COMPLETED|Treatment Period 4 (3 Days)||8
909838|NCT01672788|2199821|P3|COMPLETED|Treatment Period 4 (3 Days)||9
909839|NCT01672788|2199822|P2|COMPLETED|Treatment Period 4 (3 Days)||9
909840|NCT01672788|2199823|P1|COMPLETED|Treatment Period 4 (3 Days)||9
909841|NCT01672788|2199820|P4|STARTED|Treatment Period 4 (3 Days)||8
909842|NCT01672788|2199821|P3|STARTED|Treatment Period 4 (3 Days)||9
909843|NCT01672788|2199822|P2|STARTED|Treatment Period 4 (3 Days)||9
909844|NCT01672788|2199823|P1|STARTED|Treatment Period 4 (3 Days)||9
909845|NCT01672788|2199820|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
909846|NCT01672788|2199821|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
909847|NCT01672788|2199822|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
909848|NCT01672788|2199823|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
909849|NCT01672788|2199820|P4|COMPLETED|Washout Period 3 (7 Days)||8
909850|NCT01672788|2199821|P3|COMPLETED|Washout Period 3 (7 Days)||9
909851|NCT01672788|2199822|P2|COMPLETED|Washout Period 3 (7 Days)||9
909852|NCT01672788|2199823|P1|COMPLETED|Washout Period 3 (7 Days)||9
909853|NCT01672788|2199820|P4|STARTED|Washout Period 3 (7 Days)||8
909854|NCT01672788|2199821|P3|STARTED|Washout Period 3 (7 Days)||9
909855|NCT01672788|2199822|P2|STARTED|Washout Period 3 (7 Days)||9
909856|NCT01672788|2199823|P1|STARTED|Washout Period 3 (7 Days)||9
909857|NCT01672788|2199820|P4|NOT COMPLETED|Treatment Period 3 (3 Days)||0
909858|NCT01672788|2199821|P3|NOT COMPLETED|Treatment Period 3 (3 Days)||0
909859|NCT01672788|2199822|P2|NOT COMPLETED|Treatment Period 3 (3 Days)||0
909860|NCT01672788|2199823|P1|NOT COMPLETED|Treatment Period 3 (3 Days)||0
909861|NCT01672788|2199820|P4|COMPLETED|Treatment Period 3 (3 Days)||8
909862|NCT01672788|2199821|P3|COMPLETED|Treatment Period 3 (3 Days)||9
909863|NCT01672788|2199822|P2|COMPLETED|Treatment Period 3 (3 Days)||9
909864|NCT01672788|2199823|P1|COMPLETED|Treatment Period 3 (3 Days)||9
909865|NCT01672788|2199820|P4|STARTED|Treatment Period 3 (3 Days)||8
909866|NCT01672788|2199821|P3|STARTED|Treatment Period 3 (3 Days)||9
909867|NCT01672788|2199822|P2|STARTED|Treatment Period 3 (3 Days)||9
909868|NCT01672788|2199823|P1|STARTED|Treatment Period 3 (3 Days)||9
909869|NCT01672788|2199820|P4|NOT COMPLETED|Washout Period 2 (7 Days)||1
909870|NCT01672788|2199821|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
909871|NCT01672788|2199822|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
909872|NCT01672788|2199823|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
909873|NCT01672788|2199820|P4|COMPLETED|Washout Period 2 (7 Days)||8
909874|NCT01672788|2199821|P3|COMPLETED|Washout Period 2 (7 Days)||9
909875|NCT01672788|2199822|P2|COMPLETED|Washout Period 2 (7 Days)||9
909876|NCT01672788|2199823|P1|COMPLETED|Washout Period 2 (7 Days)||9
909877|NCT01672788|2199820|P4|STARTED|Washout Period 2 (7 Days)||9
909878|NCT01672788|2199821|P3|STARTED|Washout Period 2 (7 Days)||9
909879|NCT01672788|2199822|P2|STARTED|Washout Period 2 (7 Days)||9
909880|NCT01672788|2199823|P1|STARTED|Washout Period 2 (7 Days)||9
909881|NCT01672788|2199820|P4|NOT COMPLETED|Treatment Period 2 (3 Days)||0
909882|NCT01672788|2199821|P3|NOT COMPLETED|Treatment Period 2 (3 Days)||0
909883|NCT01672788|2199822|P2|NOT COMPLETED|Treatment Period 2 (3 Days)||0
909884|NCT01672788|2199823|P1|NOT COMPLETED|Treatment Period 2 (3 Days)||0
909885|NCT01672788|2199820|P4|COMPLETED|Treatment Period 2 (3 Days)||9
909886|NCT01672788|2199821|P3|COMPLETED|Treatment Period 2 (3 Days)||9
909887|NCT01672788|2199822|P2|COMPLETED|Treatment Period 2 (3 Days)||9
909888|NCT01672788|2199823|P1|COMPLETED|Treatment Period 2 (3 Days)||9
909889|NCT01672788|2199820|P4|STARTED|Treatment Period 2 (3 Days)||9
909890|NCT01672788|2199821|P3|STARTED|Treatment Period 2 (3 Days)||9
909891|NCT01672788|2199822|P2|STARTED|Treatment Period 2 (3 Days)||9
909892|NCT01672788|2199823|P1|STARTED|Treatment Period 2 (3 Days)||9
909893|NCT01672788|2199820|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
909894|NCT01672788|2199821|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
909895|NCT01672788|2199822|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
909896|NCT01672788|2199823|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
909897|NCT01672788|2199820|P4|COMPLETED|Washout Period 1 (7 Days)||9
909898|NCT01672788|2199821|P3|COMPLETED|Washout Period 1 (7 Days)||9
909899|NCT01672788|2199822|P2|COMPLETED|Washout Period 1 (7 Days)||9
909900|NCT01672788|2199823|P1|COMPLETED|Washout Period 1 (7 Days)||9
909901|NCT01672788|2199820|P4|STARTED|Washout Period 1 (7 Days)||9
909902|NCT01672788|2199821|P3|STARTED|Washout Period 1 (7 Days)||9
909903|NCT01672788|2199822|P2|STARTED|Washout Period 1 (7 Days)||9
909904|NCT01672788|2199823|P1|STARTED|Washout Period 1 (7 Days)||9
909905|NCT01672788|2199820|P4|NOT COMPLETED|Treatment Period 1 (3 Days)||0
909906|NCT01672788|2199821|P3|NOT COMPLETED|Treatment Period 1 (3 Days)||0
909907|NCT01672788|2199822|P2|NOT COMPLETED|Treatment Period 1 (3 Days)||0
909908|NCT01672788|2199823|P1|NOT COMPLETED|Treatment Period 1 (3 Days)||0
909909|NCT01672788|2199820|P4|COMPLETED|Treatment Period 1 (3 Days)||9
909910|NCT01672788|2199821|P3|COMPLETED|Treatment Period 1 (3 Days)||9
909911|NCT01672788|2199822|P2|COMPLETED|Treatment Period 1 (3 Days)||9
909912|NCT01672788|2199823|P1|COMPLETED|Treatment Period 1 (3 Days)||9
909913|NCT01672788|2199820|P4|STARTED|Treatment Period 1 (3 Days)||9
909914|NCT01672788|2199821|P3|STARTED|Treatment Period 1 (3 Days)||9
909915|NCT01672788|2199822|P2|STARTED|Treatment Period 1 (3 Days)||9
909916|NCT01672788|2199823|P1|STARTED|Treatment Period 1 (3 Days)||9
909917|NCT01672723|2199853|P2|NOT COMPLETED|Second Intervention||0
909918|NCT01672723|2199854|P1|NOT COMPLETED|Second Intervention||0
909919|NCT01672723|2199853|P2|COMPLETED|Second Intervention||15
909920|NCT01672723|2199854|P1|COMPLETED|Second Intervention||16
909921|NCT01672723|2199853|P2|STARTED|Second Intervention||15
909922|NCT01672723|2199854|P1|STARTED|Second Intervention||16
909923|NCT01672723|2199853|P2|NOT COMPLETED|Washout Period of 10 Days||0
909924|NCT01672723|2199854|P1|NOT COMPLETED|Washout Period of 10 Days||0
909925|NCT01672723|2199853|P2|COMPLETED|Washout Period of 10 Days||15
909926|NCT01672723|2199854|P1|COMPLETED|Washout Period of 10 Days||16
909927|NCT01672723|2199853|P2|STARTED|Washout Period of 10 Days||15
909928|NCT01672723|2199854|P1|STARTED|Washout Period of 10 Days||16
909929|NCT01672723|2199853|P2|NOT COMPLETED|First Intervention||0
909930|NCT01672723|2199854|P1|NOT COMPLETED|First Intervention||3
909931|NCT01672723|2199853|P2|COMPLETED|First Intervention||15
909932|NCT01672723|2199854|P1|COMPLETED|First Intervention||16
909933|NCT01672723|2199853|P2|STARTED|First Intervention||15
909934|NCT01672723|2199854|P1|STARTED|First Intervention||19
909935|NCT01672658|2199866|P2|NOT COMPLETED|Overall Study||1
909936|NCT01672658|2199867|P1|NOT COMPLETED|Overall Study||0
909937|NCT01672658|2199866|P2|COMPLETED|Overall Study||14
909938|NCT01672658|2199867|P1|COMPLETED|Overall Study||16
909939|NCT01672658|2199866|P2|STARTED|Overall Study||15
909940|NCT01672658|2199867|P1|STARTED|Overall Study||16
909941|NCT01672294|2199891|P4|NOT COMPLETED|Overall Study||13
909942|NCT01672294|2199892|P3|NOT COMPLETED|Overall Study||11
909943|NCT01672294|2199893|P2|NOT COMPLETED|Overall Study||21
909944|NCT01672294|2199894|P1|NOT COMPLETED|Overall Study||6
909945|NCT01672294|2199891|P4|COMPLETED|Overall Study||59
909946|NCT01672294|2199892|P3|COMPLETED|Overall Study||61
909947|NCT01672294|2199893|P2|COMPLETED|Overall Study||50
909948|NCT01672294|2199894|P1|COMPLETED|Overall Study||65
909949|NCT01672294|2199891|P4|STARTED|Overall Study||72
909950|NCT01672294|2199892|P3|STARTED|Overall Study||72
909951|NCT01672294|2199893|P2|STARTED|Overall Study||71
909952|NCT01672294|2199894|P1|STARTED|Overall Study||71
909953|NCT01671839|2199916|P1|NOT COMPLETED|Overall Study||5
909954|NCT01671839|2199916|P1|COMPLETED|Overall Study||50
909955|NCT01671839|2199916|P1|STARTED|Overall Study||55
909956|NCT01671748|2199927|P2|NOT COMPLETED|12 Week Treatment Phase||0
909957|NCT01671748|2199928|P1|NOT COMPLETED|12 Week Treatment Phase||0
909958|NCT01671748|2199927|P2|COMPLETED|12 Week Treatment Phase||17
909959|NCT01671748|2199928|P1|COMPLETED|12 Week Treatment Phase||19
909960|NCT01671748|2199927|P2|STARTED|12 Week Treatment Phase||17
909961|NCT01671748|2199928|P1|STARTED|12 Week Treatment Phase||19
909962|NCT01671748|2199927|P2|NOT COMPLETED|4 Week run-in Phase||0
909963|NCT01671748|2199928|P1|NOT COMPLETED|4 Week run-in Phase||11
909964|NCT01671748|2199927|P2|COMPLETED|4 Week run-in Phase||0
909965|NCT01671748|2199928|P1|COMPLETED|4 Week run-in Phase||36
909966|NCT01671748|2199927|P2|STARTED|4 Week run-in Phase||0
909967|NCT01671748|2199928|P1|STARTED|4 Week run-in Phase||47
909968|NCT01671605|2199948|P2|NOT COMPLETED|Overall Study||0
909969|NCT01671605|2199949|P1|NOT COMPLETED|Overall Study||0
909970|NCT01671605|2199948|P2|COMPLETED|Overall Study||31
909971|NCT01671605|2199949|P1|COMPLETED|Overall Study||72
909972|NCT01671605|2199948|P2|STARTED|Overall Study||31
909973|NCT01671605|2199949|P1|STARTED|Overall Study||72
909974|NCT01671488|2199955|P1|NOT COMPLETED|Overall Study||1
909975|NCT01671488|2199955|P1|COMPLETED|Overall Study||10
909976|NCT01671488|2199955|P1|STARTED|Overall Study||11
909977|NCT01671293|2199963|P2|NOT COMPLETED|Overall Study||2
909978|NCT01671293|2199964|P1|NOT COMPLETED|Overall Study||3
909979|NCT01671293|2199963|P2|COMPLETED|Overall Study||32
909980|NCT01671293|2199964|P1|COMPLETED|Overall Study||33
909981|NCT01671293|2199963|P2|STARTED|Overall Study||34
909982|NCT01671293|2199964|P1|STARTED|Overall Study||36
909983|NCT01671280|2199970|P1|NOT COMPLETED|Overall Study||2
909984|NCT01671280|2199970|P1|COMPLETED|Overall Study||401
909985|NCT01671280|2199970|P1|STARTED|Overall Study|The number is enrollment.|403
909986|NCT01671111|2199976|P1|NOT COMPLETED|Overall Study||30
909987|NCT01671111|2199976|P1|COMPLETED|Overall Study||0
909988|NCT01671111|2199976|P1|STARTED|Overall Study||30
909989|NCT01671059|2199986|P1|NOT COMPLETED|Overall Study||5
909990|NCT01671059|2199986|P1|COMPLETED|Overall Study||75
909991|NCT01671059|2199986|P1|STARTED|Overall Study||80
909992|NCT01670825|2200011|P2|NOT COMPLETED|Overall Study||0
909993|NCT01670825|2200012|P1|NOT COMPLETED|Overall Study||0
909994|NCT01670825|2200011|P2|COMPLETED|Overall Study||39
909995|NCT01670825|2200012|P1|COMPLETED|Overall Study||42
909996|NCT01670825|2200011|P2|STARTED|Overall Study||39
909997|NCT01670825|2200012|P1|STARTED|Overall Study||42
909998|NCT01670721|2200078|P1|NOT COMPLETED|Overall Study||53
909999|NCT01670721|2200078|P1|COMPLETED|Overall Study|81 participants with DP and 41 with adverse events were considered as completed.|122
910000|NCT01670721|2200078|P1|STARTED|Overall Study||175
910001|NCT01670656|2200090|P5|NOT COMPLETED|Overall Study||11
910002|NCT01670656|2200091|P4|NOT COMPLETED|Overall Study||6
910003|NCT01670656|2200092|P3|NOT COMPLETED|Overall Study||8
910004|NCT01670656|2200093|P2|NOT COMPLETED|Overall Study||7
910005|NCT01670656|2200094|P1|NOT COMPLETED|Overall Study||3
910006|NCT01670656|2200090|P5|COMPLETED|Overall Study||79
910007|NCT01670656|2200091|P4|COMPLETED|Overall Study||79
910008|NCT01670656|2200092|P3|COMPLETED|Overall Study||79
910009|NCT01670656|2200093|P2|COMPLETED|Overall Study||84
910010|NCT01670656|2200094|P1|COMPLETED|Overall Study||83
910011|NCT01670656|2200090|P5|Treated|Overall Study||90
910012|NCT01670656|2200091|P4|Treated|Overall Study||85
910013|NCT01670656|2200092|P3|Treated|Overall Study||86
910014|NCT01670656|2200093|P2|Treated|Overall Study||91
910015|NCT01670656|2200094|P1|Treated|Overall Study||86
910016|NCT01670656|2200090|P5|STARTED|Overall Study||90
910017|NCT01670656|2200091|P4|STARTED|Overall Study||85
910018|NCT01670656|2200092|P3|STARTED|Overall Study||87
910019|NCT01670656|2200093|P2|STARTED|Overall Study||91
910020|NCT01670656|2200094|P1|STARTED|Overall Study||86
910021|NCT01670526|2200123|P2|NOT COMPLETED|Overall Study||6
910022|NCT01670526|2200124|P1|NOT COMPLETED|Overall Study||12
910023|NCT01670526|2200123|P2|COMPLETED|Overall Study||39
910024|NCT01670526|2200124|P1|COMPLETED|Overall Study||37
910025|NCT01670526|2200123|P2|STARTED|Overall Study||45
910026|NCT01670526|2200124|P1|STARTED|Overall Study||49
910027|NCT01670487|2200138|P2|NOT COMPLETED|Overall Study||0
910028|NCT01670487|2200139|P1|NOT COMPLETED|Overall Study||0
910029|NCT01670487|2200138|P2|COMPLETED|Overall Study||150
910030|NCT01670487|2200139|P1|COMPLETED|Overall Study||150
910031|NCT01670487|2200138|P2|STARTED|Overall Study||150
910032|NCT01670487|2200139|P1|STARTED|Overall Study||150
910033|NCT01670279|2200148|P4|NOT COMPLETED|Overall Study||1
910034|NCT01670279|2200149|P3|NOT COMPLETED|Overall Study||0
910035|NCT01670279|2200150|P2|NOT COMPLETED|Overall Study||2
910036|NCT01670279|2200151|P1|NOT COMPLETED|Overall Study||0
910037|NCT01670279|2200148|P4|COMPLETED|Overall Study||4
910038|NCT01670279|2200149|P3|COMPLETED|Overall Study||0
910039|NCT01670279|2200150|P2|COMPLETED|Overall Study||5
910040|NCT01670279|2200151|P1|COMPLETED|Overall Study||6
910041|NCT01670279|2200148|P4|STARTED|Overall Study||5
910042|NCT01670279|2200149|P3|STARTED|Overall Study||0
910043|NCT01670279|2200150|P2|STARTED|Overall Study||7
910044|NCT01670279|2200151|P1|STARTED|Overall Study||6
910045|NCT01670201|2200186|P1|NOT COMPLETED|Overall Study||0
910046|NCT01670201|2200186|P1|COMPLETED|Overall Study||8
910047|NCT01670201|2200186|P1|STARTED|Overall Study||8
910048|NCT01670045|2200191|P1|NOT COMPLETED|Overall Study||16
910049|NCT01670045|2200191|P1|COMPLETED|Overall Study||27
910050|NCT01670045|2200191|P1|STARTED|Overall Study||43
910051|NCT01670019|2200209|P2|NOT COMPLETED|Overall Study||0
910052|NCT01670019|2200210|P1|NOT COMPLETED|Overall Study||9
910053|NCT01670019|2200209|P2|COMPLETED|Overall Study||23
910054|NCT01670019|2200210|P1|COMPLETED|Overall Study||14
910055|NCT01670019|2200209|P2|STARTED|Overall Study||23
910056|NCT01670019|2200210|P1|STARTED|Overall Study||23
910057|NCT01669902|2200224|P1|NOT COMPLETED|Overall Study||29
910058|NCT01669902|2200224|P1|COMPLETED|Overall Study||78
910059|NCT01669902|2200224|P1|STARTED|Overall Study||107
910060|NCT01669863|2200251|P1|NOT COMPLETED|Overall Study||0
910061|NCT01669863|2200251|P1|COMPLETED|Overall Study||6
910062|NCT01669863|2200251|P1|STARTED|Overall Study||6
910063|NCT01669811|2200259|P2|NOT COMPLETED|Overall Study||11
910064|NCT01669811|2200260|P1|NOT COMPLETED|Overall Study||3
910065|NCT01669811|2200259|P2|COMPLETED|Overall Study||131
910066|NCT01669811|2200260|P1|COMPLETED|Overall Study||142
910067|NCT01669811|2200259|P2|STARTED|Overall Study||142
910068|NCT01669811|2200260|P1|STARTED|Overall Study||145
910069|NCT01669785|2200281|P3|NOT COMPLETED|Overall Study||0
910070|NCT01669785|2200282|P2|NOT COMPLETED|Overall Study||0
910071|NCT01669785|2200283|P1|NOT COMPLETED|Overall Study||0
910072|NCT01669785|2200281|P3|COMPLETED|Overall Study||46
910073|NCT01669785|2200282|P2|COMPLETED|Overall Study||48
910074|NCT01669785|2200283|P1|COMPLETED|Overall Study||45
910075|NCT01669785|2200281|P3|STARTED|Overall Study||46
910076|NCT01669785|2200282|P2|STARTED|Overall Study||48
910077|NCT01669785|2200283|P1|STARTED|Overall Study||45
910078|NCT01669720|2200320|P2|NOT COMPLETED|Overall Study||0
910079|NCT01669720|2200321|P1|NOT COMPLETED|Overall Study||0
910080|NCT01669720|2200320|P2|COMPLETED|Overall Study||3
910081|NCT01669720|2200321|P1|COMPLETED|Overall Study||7
910082|NCT01669720|2200320|P2|STARTED|Overall Study||3
910083|NCT01669720|2200321|P1|STARTED|Overall Study||7
910084|NCT01669629|2200327|P2|NOT COMPLETED|Period 2||0
910085|NCT01669629|2200328|P1|NOT COMPLETED|Period 2||0
910086|NCT01669629|2200327|P2|COMPLETED|Period 2||89
910087|NCT01669629|2200328|P1|COMPLETED|Period 2||91
910088|NCT01669629|2200327|P2|STARTED|Period 2||89
910089|NCT01669629|2200328|P1|STARTED|Period 2||91
910090|NCT01669629|2200327|P2|NOT COMPLETED|Period 1||2
910091|NCT01669629|2200328|P1|NOT COMPLETED|Period 1||1
910092|NCT01669629|2200327|P2|COMPLETED|Period 1||89
910093|NCT01669629|2200328|P1|COMPLETED|Period 1||91
910094|NCT01669629|2200327|P2|STARTED|Period 1||91
910095|NCT01669629|2200328|P1|STARTED|Period 1||92
910096|NCT01669603|2200344|P2|NOT COMPLETED|Overall Study||38
910097|NCT01669603|2200345|P1|NOT COMPLETED|Overall Study||37
910098|NCT01669603|2200344|P2|COMPLETED|Overall Study||57
910099|NCT01669603|2200345|P1|COMPLETED|Overall Study||58
910100|NCT01669603|2200344|P2|STARTED|Overall Study||95
910101|NCT01669603|2200345|P1|STARTED|Overall Study||95
910102|NCT01669577|2200351|P1|NOT COMPLETED|Overall Study||134
910103|NCT01669577|2200351|P1|COMPLETED|Overall Study|complete case analysis (data missing completely at random)|200
910104|NCT01669577|2200351|P1|STARTED|Overall Study|calculated ISS<16, no informed consent, not enough data(complete case analysis), were excluded|334
910105|NCT01669174|2200357|P2|NOT COMPLETED|Overall Study||6
910106|NCT01669174|2200358|P1|NOT COMPLETED|Overall Study||6
910107|NCT01669174|2200357|P2|COMPLETED|Overall Study||28
910108|NCT01669174|2200358|P1|COMPLETED|Overall Study||27
910109|NCT01669174|2200357|P2|STARTED|Overall Study||34
910110|NCT01669174|2200358|P1|STARTED|Overall Study||33
910111|NCT01669148|2200369|P1|NOT COMPLETED|Overall Study||70
910112|NCT01669148|2200369|P1|COMPLETED|Overall Study||426
910113|NCT01669148|2200369|P1|STARTED|Overall Study||496
910114|NCT01669122|2200374|P1|NOT COMPLETED|Period IV||0
910115|NCT01669122|2200374|P1|COMPLETED|Period IV||37
910116|NCT01669122|2200374|P1|STARTED|Period IV|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=9, Reference Lozenge=9|37
910117|NCT01669122|2200374|P1|NOT COMPLETED|Period III||0
910118|NCT01669122|2200374|P1|COMPLETED|Period III||37
910119|NCT01669122|2200374|P1|STARTED|Period III|Participants who received Lozenge A=10, Lozenge B=8, Lozenge C=10, Reference Lozenge=9|37
910120|NCT01669122|2200374|P1|NOT COMPLETED|Washout Period III||0
910121|NCT01669122|2200374|P1|COMPLETED|Washout Period III||37
910122|NCT01669122|2200374|P1|STARTED|Washout Period III||37
910123|NCT01669122|2200374|P1|NOT COMPLETED|Washout Period II||2
910124|NCT01669122|2200374|P1|COMPLETED|Washout Period II||37
910125|NCT01669122|2200374|P1|STARTED|Washout Period II||39
910126|NCT01669122|2200374|P1|NOT COMPLETED|Period II||0
910127|NCT01669122|2200374|P1|COMPLETED|Period II||39
910128|NCT01669122|2200374|P1|STARTED|Period II|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|39
910129|NCT01669122|2200374|P1|NOT COMPLETED|Washout Period I||0
910130|NCT01669122|2200374|P1|COMPLETED|Washout Period I||39
910131|NCT01669122|2200374|P1|STARTED|Washout Period I||39
910132|NCT01669122|2200374|P1|NOT COMPLETED|Period I||1
910133|NCT01669122|2200374|P1|COMPLETED|Period I||39
910134|NCT01669122|2200374|P1|Safety Population|Period I||39
910135|NCT01669122|2200374|P1|STARTED|Period I|Participants who received Lozenge A=10, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|40
910136|NCT01668836|2200408|P4|NOT COMPLETED|Overall Study||0
910137|NCT01668836|2200409|P3|NOT COMPLETED|Overall Study||0
910138|NCT01668836|2200410|P2|NOT COMPLETED|Overall Study||0
910139|NCT01668836|2200411|P1|NOT COMPLETED|Overall Study||0
910140|NCT01668836|2200408|P4|COMPLETED|Overall Study||12
910141|NCT01668836|2200409|P3|COMPLETED|Overall Study||12
910142|NCT01668836|2200410|P2|COMPLETED|Overall Study||12
910143|NCT01668836|2200411|P1|COMPLETED|Overall Study||12
910144|NCT01668836|2200408|P4|STARTED|Overall Study||12
910145|NCT01668836|2200409|P3|STARTED|Overall Study||12
910146|NCT01668836|2200410|P2|STARTED|Overall Study||12
910147|NCT01668836|2200411|P1|STARTED|Overall Study||12
910148|NCT01668797|2200467|P4|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||96
910149|NCT01668797|2200468|P3|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||83
910150|NCT01668797|2200469|P2|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
910151|NCT01668797|2200470|P1|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
910152|NCT01668797|2200467|P4|COMPLETED|Phase C (Double-Blind Maintenance Phase)||9
910153|NCT01668797|2200468|P3|COMPLETED|Phase C (Double-Blind Maintenance Phase)||14
910154|NCT01668797|2200469|P2|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
910155|NCT01668797|2200470|P1|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
910156|NCT01668797|2200467|P4|STARTED|Phase C (Double-Blind Maintenance Phase)||105
910157|NCT01668797|2200468|P3|STARTED|Phase C (Double-Blind Maintenance Phase)|N= 202 rolled over from Phase B|97
910158|NCT01668797|2200469|P2|STARTED|Phase C (Double-Blind Maintenance Phase)||0
910159|NCT01668797|2200470|P1|STARTED|Phase C (Double-Blind Maintenance Phase)||0
910160|NCT01668797|2200467|P4|NOT COMPLETED|Phase B (Stabilization Phase)||0
910161|NCT01668797|2200468|P3|NOT COMPLETED|Phase B (Stabilization Phase)||0
910162|NCT01668797|2200469|P2|NOT COMPLETED|Phase B (Stabilization Phase)||262
910163|NCT01668797|2200470|P1|NOT COMPLETED|Phase B (Stabilization Phase)||0
910164|NCT01668797|2200467|P4|COMPLETED|Phase B (Stabilization Phase)||0
910165|NCT01668797|2200468|P3|COMPLETED|Phase B (Stabilization Phase)||0
910166|NCT01668797|2200469|P2|COMPLETED|Phase B (Stabilization Phase)||202
910167|NCT01668797|2200470|P1|COMPLETED|Phase B (Stabilization Phase)||0
910168|NCT01668797|2200467|P4|STARTED|Phase B (Stabilization Phase)||0
910169|NCT01668797|2200468|P3|STARTED|Phase B (Stabilization Phase)||0
910170|NCT01668797|2200469|P2|STARTED|Phase B (Stabilization Phase)|N= 464; 346 rolled over from Phase A and 118 entered directly into Phase B|464
910171|NCT01668797|2200470|P1|STARTED|Phase B (Stabilization Phase)||0
910172|NCT01668797|2200467|P4|NOT COMPLETED|Phase A (Conversion Phase)||0
910173|NCT01668797|2200468|P3|NOT COMPLETED|Phase A (Conversion Phase)||0
910174|NCT01668797|2200469|P2|NOT COMPLETED|Phase A (Conversion Phase)||0
910175|NCT01668797|2200470|P1|NOT COMPLETED|Phase A (Conversion Phase)||60
910176|NCT01668797|2200467|P4|COMPLETED|Phase A (Conversion Phase)||0
910177|NCT01668797|2200468|P3|COMPLETED|Phase A (Conversion Phase)||0
910178|NCT01668797|2200469|P2|COMPLETED|Phase A (Conversion Phase)||0
910179|NCT01668797|2200470|P1|COMPLETED|Phase A (Conversion Phase)||346
910180|NCT01668797|2200467|P4|STARTED|Phase A (Conversion Phase)||0
910181|NCT01668797|2200468|P3|STARTED|Phase A (Conversion Phase)||0
910182|NCT01668797|2200469|P2|STARTED|Phase A (Conversion Phase)||0
910183|NCT01668797|2200470|P1|STARTED|Phase A (Conversion Phase)||406
910196|NCT01668667|2200564|P4|NOT COMPLETED|Overall Study||23
910197|NCT01668667|2200565|P3|NOT COMPLETED|Overall Study||31
910198|NCT01668667|2200566|P2|NOT COMPLETED|Overall Study||26
910199|NCT01668667|2200567|P1|NOT COMPLETED|Overall Study||31
910200|NCT01668667|2200564|P4|COMPLETED|Overall Study||102
910201|NCT01668667|2200565|P3|COMPLETED|Overall Study||94
910202|NCT01668667|2200566|P2|COMPLETED|Overall Study||99
910203|NCT01668667|2200567|P1|COMPLETED|Overall Study||95
910204|NCT01668667|2200564|P4|STARTED|Overall Study||125
910205|NCT01668667|2200565|P3|STARTED|Overall Study||125
910206|NCT01668667|2200566|P2|STARTED|Overall Study||125
910207|NCT01668667|2200567|P1|STARTED|Overall Study||126
910208|NCT01668654|2200589|P1|NOT COMPLETED|Overall Study||4
910209|NCT01668654|2200589|P1|COMPLETED|Overall Study||0
910210|NCT01668654|2200589|P1|STARTED|Overall Study||4
910211|NCT01668628|2200632|P3|NOT COMPLETED|Overall Study||0
910212|NCT01668628|2200633|P2|NOT COMPLETED|Overall Study||0
910213|NCT01668628|2200634|P1|NOT COMPLETED|Overall Study||2
910214|NCT01668628|2200632|P3|COMPLETED|Overall Study||367
910215|NCT01668628|2200633|P2|COMPLETED|Overall Study||359
910216|NCT01668628|2200634|P1|COMPLETED|Overall Study||347
910217|NCT01668628|2200632|P3|STARTED|Overall Study|2 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|367
910218|NCT01668628|2200633|P2|STARTED|Overall Study||359
910219|NCT01668628|2200634|P1|STARTED|Overall Study|5 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|349
910220|NCT01668589|2200650|P4|NOT COMPLETED|Overall Study||35
910221|NCT01668589|2200651|P3|NOT COMPLETED|Overall Study||35
910222|NCT01668589|2200652|P2|NOT COMPLETED|Overall Study||58
910223|NCT01668589|2200653|P1|NOT COMPLETED|Overall Study||139
910224|NCT01668589|2200650|P4|COMPLETED|Overall Study||266
910225|NCT01668589|2200651|P3|COMPLETED|Overall Study||265
910226|NCT01668589|2200652|P2|COMPLETED|Overall Study||242
910227|NCT01668589|2200653|P1|COMPLETED|Overall Study||461
910228|NCT01668589|2200650|P4|Received Denosumab|Overall Study||301
910229|NCT01668589|2200651|P3|Received Denosumab|Overall Study||300
910230|NCT01668589|2200652|P2|Received Denosumab|Overall Study||300
910231|NCT01668589|2200653|P1|Received Denosumab|Overall Study||599
910232|NCT01668589|2200650|P4|STARTED|Overall Study||301
910233|NCT01668589|2200651|P3|STARTED|Overall Study||300
910234|NCT01668589|2200652|P2|STARTED|Overall Study||300
910235|NCT01668589|2200653|P1|STARTED|Overall Study||600
910236|NCT01668173|2200691|P1|NOT COMPLETED|Overall Study||7
910237|NCT01668173|2200691|P1|COMPLETED|Overall Study||0
910238|NCT01668173|2200691|P1|STARTED|Overall Study||7
910239|NCT01668030|2200695|P2|NOT COMPLETED|Overall Study||0
910240|NCT01668030|2200696|P1|NOT COMPLETED|Overall Study||0
910241|NCT01668030|2200695|P2|COMPLETED|Overall Study||10
910242|NCT01668030|2200696|P1|COMPLETED|Overall Study||10
910243|NCT01668030|2200695|P2|STARTED|Overall Study||10
910244|NCT01668030|2200696|P1|STARTED|Overall Study||10
910245|NCT01668017|2200706|P5|NOT COMPLETED|Overall Study||0
910246|NCT01668017|2200707|P4|NOT COMPLETED|Overall Study||0
910247|NCT01668017|2200708|P3|NOT COMPLETED|Overall Study||0
910248|NCT01668017|2200709|P2|NOT COMPLETED|Overall Study||0
910249|NCT01668017|2200710|P1|NOT COMPLETED|Overall Study||0
910250|NCT01668017|2200706|P5|COMPLETED|Overall Study||2
910251|NCT01668017|2200707|P4|COMPLETED|Overall Study||5
910252|NCT01668017|2200708|P3|COMPLETED|Overall Study||6
910253|NCT01668017|2200709|P2|COMPLETED|Overall Study||9
910254|NCT01668017|2200710|P1|COMPLETED|Overall Study||4
910255|NCT01668017|2200706|P5|STARTED|Overall Study||2
910256|NCT01668017|2200707|P4|STARTED|Overall Study||5
910257|NCT01668017|2200708|P3|STARTED|Overall Study||6
910258|NCT01668017|2200709|P2|STARTED|Overall Study||9
910259|NCT01668017|2200710|P1|STARTED|Overall Study||4
910260|NCT01668004|2200817|P1|NOT COMPLETED|Overall Study||25
910261|NCT01668004|2200817|P1|COMPLETED|Overall Study||76
910262|NCT01668004|2200817|P1|Treated|Overall Study||101
910263|NCT01668004|2200817|P1|STARTED|Overall Study||101
910264|NCT01667978|2200830|P2|NOT COMPLETED|Overall Study||0
910265|NCT01667978|2200831|P1|NOT COMPLETED|Overall Study||2
910266|NCT01667978|2200830|P2|COMPLETED|Overall Study||17
910267|NCT01667978|2200831|P1|COMPLETED|Overall Study||16
910268|NCT01667978|2200830|P2|STARTED|Overall Study||17
910269|NCT01667978|2200831|P1|STARTED|Overall Study||18
910270|NCT01667926|2200839|P3|NOT COMPLETED|Overall Study||11
910271|NCT01667926|2200840|P2|NOT COMPLETED|Overall Study||4
910272|NCT01667926|2200841|P1|NOT COMPLETED|Overall Study||5
910273|NCT01667926|2200839|P3|COMPLETED|Overall Study|Participants in the screen fail group were not randomized in the study.|0
910274|NCT01667926|2200840|P2|COMPLETED|Overall Study||9
910275|NCT01667926|2200841|P1|COMPLETED|Overall Study||8
910276|NCT01667926|2200839|P3|STARTED|Overall Study||11
910277|NCT01667926|2200840|P2|STARTED|Overall Study||13
910278|NCT01667926|2200841|P1|STARTED|Overall Study||13
910279|NCT01667900|2200854|P20|NOT COMPLETED|Part B||0
910280|NCT01667900|2200855|P19|NOT COMPLETED|Part B||0
910281|NCT01667900|2200856|P18|NOT COMPLETED|Part B||0
910282|NCT01667900|2200857|P17|NOT COMPLETED|Part B||1
910283|NCT01667900|2200858|P16|NOT COMPLETED|Part B||0
910284|NCT01667900|2200859|P15|NOT COMPLETED|Part B||0
910285|NCT01667900|2200860|P14|NOT COMPLETED|Part B||0
910286|NCT01667900|2200861|P13|NOT COMPLETED|Part B||0
910287|NCT01667900|2200862|P12|NOT COMPLETED|Part B||0
910288|NCT01667900|2200863|P11|NOT COMPLETED|Part B||0
910289|NCT01667900|2200864|P10|NOT COMPLETED|Part B||0
910290|NCT01667900|2200865|P9|NOT COMPLETED|Part B||0
910291|NCT01667900|2200866|P8|NOT COMPLETED|Part B||0
910292|NCT01667900|2200867|P7|NOT COMPLETED|Part B||0
910293|NCT01667900|2200868|P6|NOT COMPLETED|Part B||0
910294|NCT01667900|2200869|P5|NOT COMPLETED|Part B||0
910295|NCT01667900|2200870|P4|NOT COMPLETED|Part B||0
910296|NCT01667900|2200871|P3|NOT COMPLETED|Part B||0
910297|NCT01667900|2200872|P2|NOT COMPLETED|Part B||0
910298|NCT01667900|2200873|P1|NOT COMPLETED|Part B||0
910299|NCT01667900|2200854|P20|COMPLETED|Part B||10
910300|NCT01667900|2200855|P19|COMPLETED|Part B||10
910301|NCT01667900|2200856|P18|COMPLETED|Part B||11
910302|NCT01667900|2200857|P17|COMPLETED|Part B||10
910303|NCT01667900|2200858|P16|COMPLETED|Part B||0
910304|NCT01667900|2200859|P15|COMPLETED|Part B||0
910305|NCT01667900|2200860|P14|COMPLETED|Part B||0
910306|NCT01667900|2200861|P13|COMPLETED|Part B||0
910307|NCT01667900|2200862|P12|COMPLETED|Part B||0
910308|NCT01667900|2200863|P11|COMPLETED|Part B||0
910309|NCT01667900|2200864|P10|COMPLETED|Part B||0
910310|NCT01667900|2200865|P9|COMPLETED|Part B||0
910311|NCT01667900|2200866|P8|COMPLETED|Part B||0
910312|NCT01667900|2200867|P7|COMPLETED|Part B||0
910313|NCT01667900|2200868|P6|COMPLETED|Part B||0
910314|NCT01667900|2200869|P5|COMPLETED|Part B||0
910315|NCT01667900|2200870|P4|COMPLETED|Part B||0
910316|NCT01667900|2200871|P3|COMPLETED|Part B||0
910317|NCT01667900|2200872|P2|COMPLETED|Part B||0
910318|NCT01667900|2200873|P1|COMPLETED|Part B||0
910319|NCT01667900|2200854|P20|STARTED|Part B||10
910320|NCT01667900|2200855|P19|STARTED|Part B||10
910321|NCT01667900|2200856|P18|STARTED|Part B||11
910322|NCT01667900|2200857|P17|STARTED|Part B||11
910323|NCT01667900|2200858|P16|STARTED|Part B|Part A participants did not participate in Part B.|0
910324|NCT01667900|2200859|P15|STARTED|Part B|Part A participants did not participate in Part B.|0
910325|NCT01667900|2200860|P14|STARTED|Part B|Part A participants did not participate in Part B.|0
910326|NCT01667900|2200861|P13|STARTED|Part B|Part A participants did not participate in Part B.|0
910327|NCT01667900|2200862|P12|STARTED|Part B|Part A participants did not participate in Part B.|0
910416|NCT01667900|2200871|P3|NOT COMPLETED|Part A, Washout 2||0
910328|NCT01667900|2200863|P11|STARTED|Part B|Part A participants did not participate in Part B.|0
910329|NCT01667900|2200864|P10|STARTED|Part B|Part A participants did not participate in Part B.|0
910330|NCT01667900|2200865|P9|STARTED|Part B|Part A participants did not participate in Part B.|0
910331|NCT01667900|2200866|P8|STARTED|Part B|Part A participants did not participate in Part B.|0
910332|NCT01667900|2200867|P7|STARTED|Part B|Part A participants did not participate in Part B.|0
910333|NCT01667900|2200868|P6|STARTED|Part B|Part A participants did not participate in Part B.|0
910334|NCT01667900|2200869|P5|STARTED|Part B|Part A participants did not participate in Part B.|0
910335|NCT01667900|2200870|P4|STARTED|Part B|Part A participants did not participate in Part B.|0
910336|NCT01667900|2200871|P3|STARTED|Part B|Part A participants did not participate in Part B.|0
910337|NCT01667900|2200872|P2|STARTED|Part B|Part A participants did not participate in Part B.|0
910338|NCT01667900|2200873|P1|STARTED|Part B|Part A participants did not participate in Part B.|0
910339|NCT01667900|2200854|P20|NOT COMPLETED|Part A, Period 3||0
910340|NCT01667900|2200855|P19|NOT COMPLETED|Part A, Period 3||0
910341|NCT01667900|2200856|P18|NOT COMPLETED|Part A, Period 3||0
910342|NCT01667900|2200857|P17|NOT COMPLETED|Part A, Period 3||0
910343|NCT01667900|2200858|P16|NOT COMPLETED|Part A, Period 3||0
910344|NCT01667900|2200859|P15|NOT COMPLETED|Part A, Period 3||0
910345|NCT01667900|2200860|P14|NOT COMPLETED|Part A, Period 3||0
910346|NCT01667900|2200861|P13|NOT COMPLETED|Part A, Period 3||0
910347|NCT01667900|2200862|P12|NOT COMPLETED|Part A, Period 3||0
910348|NCT01667900|2200863|P11|NOT COMPLETED|Part A, Period 3||0
910349|NCT01667900|2200864|P10|NOT COMPLETED|Part A, Period 3||0
910350|NCT01667900|2200865|P9|NOT COMPLETED|Part A, Period 3||0
910351|NCT01667900|2200866|P8|NOT COMPLETED|Part A, Period 3||0
910352|NCT01667900|2200867|P7|NOT COMPLETED|Part A, Period 3||0
910353|NCT01667900|2200868|P6|NOT COMPLETED|Part A, Period 3||0
910354|NCT01667900|2200869|P5|NOT COMPLETED|Part A, Period 3||0
910355|NCT01667900|2200870|P4|NOT COMPLETED|Part A, Period 3||0
910356|NCT01667900|2200871|P3|NOT COMPLETED|Part A, Period 3||0
910357|NCT01667900|2200872|P2|NOT COMPLETED|Part A, Period 3||0
910358|NCT01667900|2200873|P1|NOT COMPLETED|Part A, Period 3||0
910359|NCT01667900|2200854|P20|COMPLETED|Part A, Period 3||0
910360|NCT01667900|2200855|P19|COMPLETED|Part A, Period 3||0
910361|NCT01667900|2200856|P18|COMPLETED|Part A, Period 3||0
910362|NCT01667900|2200857|P17|COMPLETED|Part A, Period 3||0
910363|NCT01667900|2200858|P16|COMPLETED|Part A, Period 3||1
910364|NCT01667900|2200859|P15|COMPLETED|Part A, Period 3||1
910365|NCT01667900|2200860|P14|COMPLETED|Part A, Period 3||1
910366|NCT01667900|2200861|P13|COMPLETED|Part A, Period 3||1
910367|NCT01667900|2200862|P12|COMPLETED|Part A, Period 3||1
910368|NCT01667900|2200863|P11|COMPLETED|Part A, Period 3||1
910369|NCT01667900|2200864|P10|COMPLETED|Part A, Period 3||1
910370|NCT01667900|2200865|P9|COMPLETED|Part A, Period 3||1
910371|NCT01667900|2200866|P8|COMPLETED|Part A, Period 3||1
910372|NCT01667900|2200867|P7|COMPLETED|Part A, Period 3||1
910373|NCT01667900|2200868|P6|COMPLETED|Part A, Period 3||1
910374|NCT01667900|2200869|P5|COMPLETED|Part A, Period 3||1
910375|NCT01667900|2200870|P4|COMPLETED|Part A, Period 3||1
910376|NCT01667900|2200871|P3|COMPLETED|Part A, Period 3||1
910377|NCT01667900|2200872|P2|COMPLETED|Part A, Period 3||1
910378|NCT01667900|2200873|P1|COMPLETED|Part A, Period 3||1
910379|NCT01667900|2200854|P20|STARTED|Part A, Period 3||0
910380|NCT01667900|2200855|P19|STARTED|Part A, Period 3||0
910381|NCT01667900|2200856|P18|STARTED|Part A, Period 3||0
910382|NCT01667900|2200857|P17|STARTED|Part A, Period 3||0
910383|NCT01667900|2200858|P16|STARTED|Part A, Period 3||1
910384|NCT01667900|2200859|P15|STARTED|Part A, Period 3||1
910385|NCT01667900|2200860|P14|STARTED|Part A, Period 3||1
910386|NCT01667900|2200861|P13|STARTED|Part A, Period 3||1
910387|NCT01667900|2200862|P12|STARTED|Part A, Period 3||1
910388|NCT01667900|2200863|P11|STARTED|Part A, Period 3||1
910389|NCT01667900|2200864|P10|STARTED|Part A, Period 3||1
910390|NCT01667900|2200865|P9|STARTED|Part A, Period 3||1
910391|NCT01667900|2200866|P8|STARTED|Part A, Period 3||1
910392|NCT01667900|2200867|P7|STARTED|Part A, Period 3||1
910393|NCT01667900|2200868|P6|STARTED|Part A, Period 3||1
910394|NCT01667900|2200869|P5|STARTED|Part A, Period 3||1
910395|NCT01667900|2200870|P4|STARTED|Part A, Period 3||1
910396|NCT01667900|2200871|P3|STARTED|Part A, Period 3||1
910397|NCT01667900|2200872|P2|STARTED|Part A, Period 3||1
910398|NCT01667900|2200873|P1|STARTED|Part A, Period 3||1
910399|NCT01667900|2200854|P20|NOT COMPLETED|Part A, Washout 2||0
910400|NCT01667900|2200855|P19|NOT COMPLETED|Part A, Washout 2||0
910401|NCT01667900|2200856|P18|NOT COMPLETED|Part A, Washout 2||0
910402|NCT01667900|2200857|P17|NOT COMPLETED|Part A, Washout 2||0
910403|NCT01667900|2200858|P16|NOT COMPLETED|Part A, Washout 2||0
910404|NCT01667900|2200859|P15|NOT COMPLETED|Part A, Washout 2||0
910405|NCT01667900|2200860|P14|NOT COMPLETED|Part A, Washout 2||0
910406|NCT01667900|2200861|P13|NOT COMPLETED|Part A, Washout 2||0
910407|NCT01667900|2200862|P12|NOT COMPLETED|Part A, Washout 2||0
910408|NCT01667900|2200863|P11|NOT COMPLETED|Part A, Washout 2||0
910409|NCT01667900|2200864|P10|NOT COMPLETED|Part A, Washout 2||0
910410|NCT01667900|2200865|P9|NOT COMPLETED|Part A, Washout 2||0
910411|NCT01667900|2200866|P8|NOT COMPLETED|Part A, Washout 2||0
910412|NCT01667900|2200867|P7|NOT COMPLETED|Part A, Washout 2||0
910413|NCT01667900|2200868|P6|NOT COMPLETED|Part A, Washout 2||0
910414|NCT01667900|2200869|P5|NOT COMPLETED|Part A, Washout 2||0
910415|NCT01667900|2200870|P4|NOT COMPLETED|Part A, Washout 2||0
910417|NCT01667900|2200872|P2|NOT COMPLETED|Part A, Washout 2||0
910418|NCT01667900|2200873|P1|NOT COMPLETED|Part A, Washout 2||0
910419|NCT01667900|2200854|P20|COMPLETED|Part A, Washout 2||0
910420|NCT01667900|2200855|P19|COMPLETED|Part A, Washout 2||0
910421|NCT01667900|2200856|P18|COMPLETED|Part A, Washout 2||0
910422|NCT01667900|2200857|P17|COMPLETED|Part A, Washout 2||0
910423|NCT01667900|2200858|P16|COMPLETED|Part A, Washout 2||1
910424|NCT01667900|2200859|P15|COMPLETED|Part A, Washout 2||1
910425|NCT01667900|2200860|P14|COMPLETED|Part A, Washout 2||1
910426|NCT01667900|2200861|P13|COMPLETED|Part A, Washout 2||1
910427|NCT01667900|2200862|P12|COMPLETED|Part A, Washout 2||1
910428|NCT01667900|2200863|P11|COMPLETED|Part A, Washout 2||1
910429|NCT01667900|2200864|P10|COMPLETED|Part A, Washout 2||1
910430|NCT01667900|2200865|P9|COMPLETED|Part A, Washout 2||1
910431|NCT01667900|2200866|P8|COMPLETED|Part A, Washout 2||1
910432|NCT01667900|2200867|P7|COMPLETED|Part A, Washout 2||1
910433|NCT01667900|2200868|P6|COMPLETED|Part A, Washout 2||1
910434|NCT01667900|2200869|P5|COMPLETED|Part A, Washout 2||1
910435|NCT01667900|2200870|P4|COMPLETED|Part A, Washout 2||1
910436|NCT01667900|2200871|P3|COMPLETED|Part A, Washout 2||1
910437|NCT01667900|2200872|P2|COMPLETED|Part A, Washout 2||1
910438|NCT01667900|2200873|P1|COMPLETED|Part A, Washout 2||1
910439|NCT01667900|2200854|P20|STARTED|Part A, Washout 2||0
910440|NCT01667900|2200855|P19|STARTED|Part A, Washout 2||0
910441|NCT01667900|2200856|P18|STARTED|Part A, Washout 2||0
910442|NCT01667900|2200857|P17|STARTED|Part A, Washout 2||0
910443|NCT01667900|2200858|P16|STARTED|Part A, Washout 2||1
910444|NCT01667900|2200859|P15|STARTED|Part A, Washout 2||1
910445|NCT01667900|2200860|P14|STARTED|Part A, Washout 2||1
910446|NCT01667900|2200861|P13|STARTED|Part A, Washout 2||1
910447|NCT01667900|2200862|P12|STARTED|Part A, Washout 2||1
910448|NCT01667900|2200863|P11|STARTED|Part A, Washout 2||1
910449|NCT01667900|2200864|P10|STARTED|Part A, Washout 2||1
910450|NCT01667900|2200865|P9|STARTED|Part A, Washout 2||1
910451|NCT01667900|2200866|P8|STARTED|Part A, Washout 2||1
910452|NCT01667900|2200867|P7|STARTED|Part A, Washout 2||1
910453|NCT01667900|2200868|P6|STARTED|Part A, Washout 2||1
910454|NCT01667900|2200869|P5|STARTED|Part A, Washout 2||1
910455|NCT01667900|2200870|P4|STARTED|Part A, Washout 2||1
910456|NCT01667900|2200871|P3|STARTED|Part A, Washout 2||1
910457|NCT01667900|2200872|P2|STARTED|Part A, Washout 2||1
910458|NCT01667900|2200873|P1|STARTED|Part A, Washout 2||1
910459|NCT01667900|2200854|P20|NOT COMPLETED|Part A, Period 2||0
910460|NCT01667900|2200855|P19|NOT COMPLETED|Part A, Period 2||0
910461|NCT01667900|2200856|P18|NOT COMPLETED|Part A, Period 2||0
910462|NCT01667900|2200857|P17|NOT COMPLETED|Part A, Period 2||0
910463|NCT01667900|2200858|P16|NOT COMPLETED|Part A, Period 2||0
910464|NCT01667900|2200859|P15|NOT COMPLETED|Part A, Period 2||0
910465|NCT01667900|2200860|P14|NOT COMPLETED|Part A, Period 2||0
910466|NCT01667900|2200861|P13|NOT COMPLETED|Part A, Period 2||0
910467|NCT01667900|2200862|P12|NOT COMPLETED|Part A, Period 2||0
910468|NCT01667900|2200863|P11|NOT COMPLETED|Part A, Period 2||0
910469|NCT01667900|2200864|P10|NOT COMPLETED|Part A, Period 2||0
910470|NCT01667900|2200865|P9|NOT COMPLETED|Part A, Period 2||0
910471|NCT01667900|2200866|P8|NOT COMPLETED|Part A, Period 2||0
910472|NCT01667900|2200867|P7|NOT COMPLETED|Part A, Period 2||0
910473|NCT01667900|2200868|P6|NOT COMPLETED|Part A, Period 2||0
910474|NCT01667900|2200869|P5|NOT COMPLETED|Part A, Period 2||0
910475|NCT01667900|2200870|P4|NOT COMPLETED|Part A, Period 2||0
910476|NCT01667900|2200871|P3|NOT COMPLETED|Part A, Period 2||0
910477|NCT01667900|2200872|P2|NOT COMPLETED|Part A, Period 2||0
910478|NCT01667900|2200873|P1|NOT COMPLETED|Part A, Period 2||0
910479|NCT01667900|2200854|P20|COMPLETED|Part A, Period 2||0
910480|NCT01667900|2200855|P19|COMPLETED|Part A, Period 2||0
910481|NCT01667900|2200856|P18|COMPLETED|Part A, Period 2||0
910482|NCT01667900|2200857|P17|COMPLETED|Part A, Period 2||0
910483|NCT01667900|2200858|P16|COMPLETED|Part A, Period 2||1
910484|NCT01667900|2200859|P15|COMPLETED|Part A, Period 2||1
910485|NCT01667900|2200860|P14|COMPLETED|Part A, Period 2||1
910486|NCT01667900|2200861|P13|COMPLETED|Part A, Period 2||1
910487|NCT01667900|2200862|P12|COMPLETED|Part A, Period 2||1
910488|NCT01667900|2200863|P11|COMPLETED|Part A, Period 2||1
910489|NCT01667900|2200864|P10|COMPLETED|Part A, Period 2||1
910490|NCT01667900|2200865|P9|COMPLETED|Part A, Period 2||1
910491|NCT01667900|2200866|P8|COMPLETED|Part A, Period 2||1
910492|NCT01667900|2200867|P7|COMPLETED|Part A, Period 2||1
910493|NCT01667900|2200868|P6|COMPLETED|Part A, Period 2||1
910494|NCT01667900|2200869|P5|COMPLETED|Part A, Period 2||1
910495|NCT01667900|2200870|P4|COMPLETED|Part A, Period 2||1
910496|NCT01667900|2200871|P3|COMPLETED|Part A, Period 2||1
910497|NCT01667900|2200872|P2|COMPLETED|Part A, Period 2||1
910498|NCT01667900|2200873|P1|COMPLETED|Part A, Period 2||1
910499|NCT01667900|2200854|P20|STARTED|Part A, Period 2||0
910500|NCT01667900|2200855|P19|STARTED|Part A, Period 2||0
910501|NCT01667900|2200856|P18|STARTED|Part A, Period 2||0
910502|NCT01667900|2200857|P17|STARTED|Part A, Period 2||0
910503|NCT01667900|2200858|P16|STARTED|Part A, Period 2||1
910504|NCT01667900|2200859|P15|STARTED|Part A, Period 2||1
910505|NCT01667900|2200860|P14|STARTED|Part A, Period 2||1
910506|NCT01667900|2200861|P13|STARTED|Part A, Period 2||1
910507|NCT01667900|2200862|P12|STARTED|Part A, Period 2||1
910508|NCT01667900|2200863|P11|STARTED|Part A, Period 2||1
910509|NCT01667900|2200864|P10|STARTED|Part A, Period 2||1
910510|NCT01667900|2200865|P9|STARTED|Part A, Period 2||1
910511|NCT01667900|2200866|P8|STARTED|Part A, Period 2||1
910512|NCT01667900|2200867|P7|STARTED|Part A, Period 2||1
910513|NCT01667900|2200868|P6|STARTED|Part A, Period 2||1
910514|NCT01667900|2200869|P5|STARTED|Part A, Period 2||1
910515|NCT01667900|2200870|P4|STARTED|Part A, Period 2||1
910516|NCT01667900|2200871|P3|STARTED|Part A, Period 2||1
910517|NCT01667900|2200872|P2|STARTED|Part A, Period 2||1
910518|NCT01667900|2200873|P1|STARTED|Part A, Period 2||1
910519|NCT01667900|2200854|P20|NOT COMPLETED|Part A, Washout 1||0
910520|NCT01667900|2200855|P19|NOT COMPLETED|Part A, Washout 1||0
910521|NCT01667900|2200856|P18|NOT COMPLETED|Part A, Washout 1||0
910522|NCT01667900|2200857|P17|NOT COMPLETED|Part A, Washout 1||0
910523|NCT01667900|2200858|P16|NOT COMPLETED|Part A, Washout 1||0
910524|NCT01667900|2200859|P15|NOT COMPLETED|Part A, Washout 1||0
910525|NCT01667900|2200860|P14|NOT COMPLETED|Part A, Washout 1||0
910526|NCT01667900|2200861|P13|NOT COMPLETED|Part A, Washout 1||0
910527|NCT01667900|2200862|P12|NOT COMPLETED|Part A, Washout 1||0
910528|NCT01667900|2200863|P11|NOT COMPLETED|Part A, Washout 1||0
910529|NCT01667900|2200864|P10|NOT COMPLETED|Part A, Washout 1||0
910530|NCT01667900|2200865|P9|NOT COMPLETED|Part A, Washout 1||0
910531|NCT01667900|2200866|P8|NOT COMPLETED|Part A, Washout 1||0
910532|NCT01667900|2200867|P7|NOT COMPLETED|Part A, Washout 1||0
910533|NCT01667900|2200868|P6|NOT COMPLETED|Part A, Washout 1||0
910534|NCT01667900|2200869|P5|NOT COMPLETED|Part A, Washout 1||0
910535|NCT01667900|2200870|P4|NOT COMPLETED|Part A, Washout 1||0
910536|NCT01667900|2200871|P3|NOT COMPLETED|Part A, Washout 1||0
910537|NCT01667900|2200872|P2|NOT COMPLETED|Part A, Washout 1||0
910538|NCT01667900|2200873|P1|NOT COMPLETED|Part A, Washout 1||0
910539|NCT01667900|2200854|P20|COMPLETED|Part A, Washout 1||0
910540|NCT01667900|2200855|P19|COMPLETED|Part A, Washout 1||0
910541|NCT01667900|2200856|P18|COMPLETED|Part A, Washout 1||0
910542|NCT01667900|2200857|P17|COMPLETED|Part A, Washout 1||0
910543|NCT01667900|2200858|P16|COMPLETED|Part A, Washout 1||1
910544|NCT01667900|2200859|P15|COMPLETED|Part A, Washout 1||1
910545|NCT01667900|2200860|P14|COMPLETED|Part A, Washout 1||1
910546|NCT01667900|2200861|P13|COMPLETED|Part A, Washout 1||1
910547|NCT01667900|2200862|P12|COMPLETED|Part A, Washout 1||1
910548|NCT01667900|2200863|P11|COMPLETED|Part A, Washout 1||1
910549|NCT01667900|2200864|P10|COMPLETED|Part A, Washout 1||1
910550|NCT01667900|2200865|P9|COMPLETED|Part A, Washout 1||1
910551|NCT01667900|2200866|P8|COMPLETED|Part A, Washout 1||1
910552|NCT01667900|2200867|P7|COMPLETED|Part A, Washout 1||1
910553|NCT01667900|2200868|P6|COMPLETED|Part A, Washout 1||1
910554|NCT01667900|2200869|P5|COMPLETED|Part A, Washout 1||1
910555|NCT01667900|2200870|P4|COMPLETED|Part A, Washout 1||1
910556|NCT01667900|2200871|P3|COMPLETED|Part A, Washout 1||1
910557|NCT01667900|2200872|P2|COMPLETED|Part A, Washout 1||1
910558|NCT01667900|2200873|P1|COMPLETED|Part A, Washout 1||1
910559|NCT01667900|2200854|P20|STARTED|Part A, Washout 1||0
910560|NCT01667900|2200855|P19|STARTED|Part A, Washout 1||0
910561|NCT01667900|2200856|P18|STARTED|Part A, Washout 1||0
910562|NCT01667900|2200857|P17|STARTED|Part A, Washout 1||0
910563|NCT01667900|2200858|P16|STARTED|Part A, Washout 1||1
910564|NCT01667900|2200859|P15|STARTED|Part A, Washout 1||1
910565|NCT01667900|2200860|P14|STARTED|Part A, Washout 1||1
910566|NCT01667900|2200861|P13|STARTED|Part A, Washout 1||1
910567|NCT01667900|2200862|P12|STARTED|Part A, Washout 1||1
910568|NCT01667900|2200863|P11|STARTED|Part A, Washout 1||1
910569|NCT01667900|2200864|P10|STARTED|Part A, Washout 1||1
910570|NCT01667900|2200865|P9|STARTED|Part A, Washout 1||1
910571|NCT01667900|2200866|P8|STARTED|Part A, Washout 1||1
910572|NCT01667900|2200867|P7|STARTED|Part A, Washout 1||1
910573|NCT01667900|2200868|P6|STARTED|Part A, Washout 1||1
910574|NCT01667900|2200869|P5|STARTED|Part A, Washout 1||1
910575|NCT01667900|2200870|P4|STARTED|Part A, Washout 1||1
910576|NCT01667900|2200871|P3|STARTED|Part A, Washout 1||1
910577|NCT01667900|2200872|P2|STARTED|Part A, Washout 1||1
910578|NCT01667900|2200873|P1|STARTED|Part A, Washout 1||1
910579|NCT01667900|2200854|P20|NOT COMPLETED|Part A, Period 1||0
910580|NCT01667900|2200855|P19|NOT COMPLETED|Part A, Period 1||0
910581|NCT01667900|2200856|P18|NOT COMPLETED|Part A, Period 1||0
910582|NCT01667900|2200857|P17|NOT COMPLETED|Part A, Period 1||0
910583|NCT01667900|2200858|P16|NOT COMPLETED|Part A, Period 1||0
910584|NCT01667900|2200859|P15|NOT COMPLETED|Part A, Period 1||0
910585|NCT01667900|2200860|P14|NOT COMPLETED|Part A, Period 1||0
910586|NCT01667900|2200861|P13|NOT COMPLETED|Part A, Period 1||0
910587|NCT01667900|2200862|P12|NOT COMPLETED|Part A, Period 1||0
910588|NCT01667900|2200863|P11|NOT COMPLETED|Part A, Period 1||0
910589|NCT01667900|2200864|P10|NOT COMPLETED|Part A, Period 1||0
910590|NCT01667900|2200865|P9|NOT COMPLETED|Part A, Period 1||0
910591|NCT01667900|2200866|P8|NOT COMPLETED|Part A, Period 1||0
910592|NCT01667900|2200867|P7|NOT COMPLETED|Part A, Period 1||0
910593|NCT01667900|2200868|P6|NOT COMPLETED|Part A, Period 1||0
910594|NCT01667900|2200869|P5|NOT COMPLETED|Part A, Period 1||0
910595|NCT01667900|2200870|P4|NOT COMPLETED|Part A, Period 1||0
910596|NCT01667900|2200871|P3|NOT COMPLETED|Part A, Period 1||0
910597|NCT01667900|2200872|P2|NOT COMPLETED|Part A, Period 1||0
910598|NCT01667900|2200873|P1|NOT COMPLETED|Part A, Period 1||0
910599|NCT01667900|2200854|P20|COMPLETED|Part A, Period 1||0
910600|NCT01667900|2200855|P19|COMPLETED|Part A, Period 1||0
910601|NCT01667900|2200856|P18|COMPLETED|Part A, Period 1||0
910602|NCT01667900|2200857|P17|COMPLETED|Part A, Period 1||0
910603|NCT01667900|2200858|P16|COMPLETED|Part A, Period 1||1
910604|NCT01667900|2200859|P15|COMPLETED|Part A, Period 1||1
910605|NCT01667900|2200860|P14|COMPLETED|Part A, Period 1||1
910606|NCT01667900|2200861|P13|COMPLETED|Part A, Period 1||1
910607|NCT01667900|2200862|P12|COMPLETED|Part A, Period 1||1
910608|NCT01667900|2200863|P11|COMPLETED|Part A, Period 1||1
910609|NCT01667900|2200864|P10|COMPLETED|Part A, Period 1||1
910610|NCT01667900|2200865|P9|COMPLETED|Part A, Period 1||1
910611|NCT01667900|2200866|P8|COMPLETED|Part A, Period 1||1
910612|NCT01667900|2200867|P7|COMPLETED|Part A, Period 1||1
910613|NCT01667900|2200868|P6|COMPLETED|Part A, Period 1||1
910614|NCT01667900|2200869|P5|COMPLETED|Part A, Period 1||1
910615|NCT01667900|2200870|P4|COMPLETED|Part A, Period 1||1
910616|NCT01667900|2200871|P3|COMPLETED|Part A, Period 1||1
910617|NCT01667900|2200872|P2|COMPLETED|Part A, Period 1||1
910618|NCT01667900|2200873|P1|COMPLETED|Part A, Period 1||1
910619|NCT01667900|2200854|P20|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
910620|NCT01667900|2200855|P19|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
910621|NCT01667900|2200856|P18|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
910622|NCT01667900|2200857|P17|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
910623|NCT01667900|2200858|P16|STARTED|Part A, Period 1||1
910624|NCT01667900|2200859|P15|STARTED|Part A, Period 1||1
910625|NCT01667900|2200860|P14|STARTED|Part A, Period 1||1
910626|NCT01667900|2200861|P13|STARTED|Part A, Period 1||1
910627|NCT01667900|2200862|P12|STARTED|Part A, Period 1||1
910628|NCT01667900|2200863|P11|STARTED|Part A, Period 1||1
910629|NCT01667900|2200864|P10|STARTED|Part A, Period 1||1
910630|NCT01667900|2200865|P9|STARTED|Part A, Period 1||1
910631|NCT01667900|2200866|P8|STARTED|Part A, Period 1||1
910632|NCT01667900|2200867|P7|STARTED|Part A, Period 1||1
910633|NCT01667900|2200868|P6|STARTED|Part A, Period 1||1
910634|NCT01667900|2200869|P5|STARTED|Part A, Period 1||1
910635|NCT01667900|2200870|P4|STARTED|Part A, Period 1||1
910636|NCT01667900|2200871|P3|STARTED|Part A, Period 1||1
910637|NCT01667900|2200872|P2|STARTED|Part A, Period 1||1
910638|NCT01667900|2200873|P1|STARTED|Part A, Period 1||1
910639|NCT01667848|2200913|P2|NOT COMPLETED|Overall Study||0
910640|NCT01667848|2200914|P1|NOT COMPLETED|Overall Study||0
910641|NCT01667848|2200913|P2|COMPLETED|Overall Study||81
910642|NCT01667848|2200914|P1|COMPLETED|Overall Study||67
910643|NCT01667848|2200913|P2|STARTED|Overall Study||81
910644|NCT01667848|2200914|P1|STARTED|Overall Study||67
910645|NCT01667796|2200924|P2|NOT COMPLETED|Overall Study||1
910646|NCT01667796|2200925|P1|NOT COMPLETED|Overall Study||3
910647|NCT01667796|2200924|P2|COMPLETED|Overall Study||29
910648|NCT01667796|2200925|P1|COMPLETED|Overall Study||24
910649|NCT01667796|2200924|P2|STARTED|Overall Study||30
910650|NCT01667796|2200925|P1|STARTED|Overall Study||27
910651|NCT01667731|2200936|P5|NOT COMPLETED|Overall Study||28
910652|NCT01667731|2200937|P4|NOT COMPLETED|Overall Study||2
910653|NCT01667731|2200938|P3|NOT COMPLETED|Overall Study||2
910654|NCT01667731|2200939|P2|NOT COMPLETED|Overall Study||16
910655|NCT01667731|2200940|P1|NOT COMPLETED|Overall Study||5
910656|NCT01667731|2200936|P5|COMPLETED|Overall Study||87
910657|NCT01667731|2200937|P4|COMPLETED|Overall Study||15
910658|NCT01667731|2200938|P3|COMPLETED|Overall Study||22
910659|NCT01667731|2200939|P2|COMPLETED|Overall Study||26
910660|NCT01667731|2200940|P1|COMPLETED|Overall Study||21
910661|NCT01667731|2200936|P5|STARTED|Overall Study||115
910662|NCT01667731|2200937|P4|STARTED|Overall Study||17
910663|NCT01667731|2200938|P3|STARTED|Overall Study||24
910664|NCT01667731|2200939|P2|STARTED|Overall Study||42
910665|NCT01667731|2200940|P1|STARTED|Overall Study||26
910666|NCT01667679|2200995|P2|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
910667|NCT01667679|2200996|P1|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
910668|NCT01667679|2200995|P2|COMPLETED|Treatment Period 2 (<=12 Weeks)||85
910669|NCT01667679|2200996|P1|COMPLETED|Treatment Period 2 (<=12 Weeks)||100
910670|NCT01667679|2200995|P2|STARTED|Treatment Period 2 (<=12 Weeks)||107
910671|NCT01667679|2200996|P1|STARTED|Treatment Period 2 (<=12 Weeks)||122
910672|NCT01667679|2200995|P2|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||30
910673|NCT01667679|2200996|P1|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||16
910674|NCT01667679|2200995|P2|COMPLETED|Treatment Period 1 (<=12 Weeks)||107
910675|NCT01667679|2200996|P1|COMPLETED|Treatment Period 1 (<=12 Weeks)||122
910676|NCT01667679|2200995|P2|STARTED|Treatment Period 1 (<=12 Weeks)||137
910677|NCT01667679|2200996|P1|STARTED|Treatment Period 1 (<=12 Weeks)||138
910678|NCT01667536|2201054|P1|NOT COMPLETED|Overall Study||0
910679|NCT01667536|2201054|P1|COMPLETED|Overall Study|105 subjects comprised the safety popn, defined as all subjects who received an MIP-1404 injection.|105
910680|NCT01667536|2201054|P1|STARTED|Overall Study||105
910681|NCT01667471|2201065|P1|NOT COMPLETED|Overall Study||0
910682|NCT01667471|2201065|P1|COMPLETED|Overall Study||7
910683|NCT01667471|2201065|P1|STARTED|Overall Study||7
910684|NCT01667432|2201081|P1|NOT COMPLETED|Overall Study||57
910685|NCT01667432|2201081|P1|COMPLETED|Overall Study||84
910686|NCT01667432|2201081|P1|STARTED|Overall Study||141
910687|NCT01667224|2201088|P2|NOT COMPLETED|Overall Study||2
910688|NCT01667224|2201089|P1|NOT COMPLETED|Overall Study||4
910689|NCT01667224|2201088|P2|COMPLETED|Overall Study||38
910690|NCT01667224|2201089|P1|COMPLETED|Overall Study||36
910691|NCT01667224|2201088|P2|STARTED|Overall Study||40
910692|NCT01667224|2201089|P1|STARTED|Overall Study||40
910693|NCT01667107|2201103|P2|NOT COMPLETED|Overall Study||7
910694|NCT01667107|2201104|P1|NOT COMPLETED|Overall Study||4
910695|NCT01667107|2201103|P2|COMPLETED|Overall Study||11
910696|NCT01667107|2201104|P1|COMPLETED|Overall Study||4
910697|NCT01667107|2201103|P2|STARTED|Overall Study||18
910698|NCT01667107|2201104|P1|STARTED|Overall Study||8
910699|NCT01666951|2201122|P2|NOT COMPLETED|Overall Study||1
910700|NCT01666951|2201123|P1|NOT COMPLETED|Overall Study||1
910701|NCT01666951|2201122|P2|COMPLETED|Overall Study||17
910702|NCT01666951|2201123|P1|COMPLETED|Overall Study||17
910703|NCT01666951|2201122|P2|STARTED|Overall Study||18
910704|NCT01666951|2201123|P1|STARTED|Overall Study||18
910705|NCT01666912|2201161|P2|NOT COMPLETED|Overall Study||11
910706|NCT01666912|2201162|P1|NOT COMPLETED|Overall Study||21
910707|NCT01666912|2201161|P2|COMPLETED|Overall Study||37
910708|NCT01666912|2201162|P1|COMPLETED|Overall Study||27
910709|NCT01666912|2201161|P2|STARTED|Overall Study||48
910710|NCT01666912|2201162|P1|STARTED|Overall Study||48
910711|NCT01666782|2201174|P2|NOT COMPLETED|Overall Study||1
910712|NCT01666782|2201175|P1|NOT COMPLETED|Overall Study||4
910713|NCT01666782|2201174|P2|COMPLETED|Overall Study||50
910714|NCT01666782|2201175|P1|COMPLETED|Overall Study||50
910715|NCT01666782|2201174|P2|STARTED|Overall Study||51
910716|NCT01666782|2201175|P1|STARTED|Overall Study||54
910717|NCT01666210|2201193|P2|NOT COMPLETED|Overall Study||1
910718|NCT01666210|2201194|P1|NOT COMPLETED|Overall Study||2
910719|NCT01666210|2201193|P2|COMPLETED|Overall Study||29
910720|NCT01666210|2201194|P1|COMPLETED|Overall Study||28
910721|NCT01666210|2201193|P2|STARTED|Overall Study||30
910722|NCT01666210|2201194|P1|STARTED|Overall Study||30
910723|NCT01666197|2201206|P2|NOT COMPLETED|Overall Study||0
910724|NCT01666197|2201207|P1|NOT COMPLETED|Overall Study||0
910725|NCT01666197|2201206|P2|COMPLETED|Overall Study||50
910726|NCT01666197|2201207|P1|COMPLETED|Overall Study||50
910727|NCT01666197|2201206|P2|STARTED|Overall Study||50
910728|NCT01666197|2201207|P1|STARTED|Overall Study||50
910729|NCT01666119|2201213|P1|NOT COMPLETED|Overall Study||52
910730|NCT01666119|2201213|P1|COMPLETED|Overall Study||197
910731|NCT01666119|2201213|P1|STARTED|Overall Study||249
910732|NCT01666002|2201220|P2|NOT COMPLETED|Overall Study||0
910733|NCT01666002|2201221|P1|NOT COMPLETED|Overall Study||5
910734|NCT01666002|2201220|P2|COMPLETED|Overall Study||10
910735|NCT01666002|2201221|P1|COMPLETED|Overall Study||12
910736|NCT01666002|2201220|P2|STARTED|Overall Study||10
910737|NCT01666002|2201221|P1|STARTED|Overall Study||17
910738|NCT01665950|2201232|P3|NOT COMPLETED|Overall Study||1
910739|NCT01665950|2201233|P2|NOT COMPLETED|Overall Study||0
910740|NCT01665950|2201234|P1|NOT COMPLETED|Overall Study||1
910741|NCT01665950|2201232|P3|COMPLETED|Overall Study||1
910742|NCT01665950|2201233|P2|COMPLETED|Overall Study||0
910743|NCT01665950|2201234|P1|COMPLETED|Overall Study||1
910744|NCT01665950|2201232|P3|STARTED|Overall Study||2
910745|NCT01665950|2201233|P2|STARTED|Overall Study||0
910746|NCT01665950|2201234|P1|STARTED|Overall Study||2
910747|NCT01665911|2201242|P1|NOT COMPLETED|Overall Study||6
910748|NCT01665911|2201242|P1|COMPLETED|Overall Study||22
910749|NCT01665911|2201242|P1|3.0 mg Sodium Fluoride in 200 ml Milk|Overall Study||22
910750|NCT01665911|2201242|P1|3.0 mg Sodium Fluoride in 100 ml Milk|Overall Study||22
910751|NCT01665911|2201242|P1|1.5 mg Sodium Fluoride in 200 ml Milk|Overall Study||25
910752|NCT01665911|2201242|P1|1.5 mg Sodium Fluoride in 100 ml Milk|Overall Study||23
910753|NCT01665911|2201242|P1|0 mg Fluoride in 200 ml Milk|Overall Study||22
910754|NCT01665911|2201242|P1|STARTED|Overall Study||28
910755|NCT01665807|2201251|P3|NOT COMPLETED|Overall Study||1
910756|NCT01665807|2201252|P2|NOT COMPLETED|Overall Study||0
910757|NCT01665807|2201253|P1|NOT COMPLETED|Overall Study||2
910758|NCT01665807|2201251|P3|COMPLETED|Overall Study||401
910759|NCT01665807|2201252|P2|COMPLETED|Overall Study||58
910760|NCT01665807|2201253|P1|COMPLETED|Overall Study||409
910761|NCT01665807|2201251|P3|STARTED|Overall Study||402
910762|NCT01665807|2201252|P2|STARTED|Overall Study||58
910763|NCT01665807|2201253|P1|STARTED|Overall Study||411
910767|NCT01665508|2201284|P1|NOT COMPLETED|Overall Study||5
910768|NCT01665508|2201284|P1|COMPLETED|Overall Study||7
910769|NCT01665508|2201284|P1|STARTED|Overall Study||12
910770|NCT01665170|2201302|P2|NOT COMPLETED|Overall Study||0
910771|NCT01665170|2201303|P1|NOT COMPLETED|Overall Study||0
910772|NCT01665170|2201302|P2|COMPLETED|Overall Study||30
910773|NCT01665170|2201303|P1|COMPLETED|Overall Study|Last TSST/ last patient out|30
910774|NCT01665170|2201302|P2|After TSST|Overall Study||30
910775|NCT01665170|2201303|P1|After TSST|Overall Study||30
910776|NCT01665170|2201302|P2|During TSST|Overall Study||30
910777|NCT01665170|2201303|P1|During TSST|Overall Study||30
910778|NCT01665170|2201302|P2|Bevore TSST|Overall Study||30
910779|NCT01665170|2201303|P1|Bevore TSST|Overall Study||30
910780|NCT01665170|2201302|P2|STARTED|Overall Study||30
910781|NCT01665170|2201303|P1|STARTED|Overall Study|First patient in|30
910782|NCT01665157|2201354|P3|NOT COMPLETED|Overall Study||0
910783|NCT01665157|2201355|P2|NOT COMPLETED|Overall Study||0
910784|NCT01665157|2201356|P1|NOT COMPLETED|Overall Study||0
910785|NCT01665157|2201354|P3|COMPLETED|Overall Study||60
910786|NCT01665157|2201355|P2|COMPLETED|Overall Study||60
910787|NCT01665157|2201356|P1|COMPLETED|Overall Study||60
910788|NCT01665157|2201354|P3|STARTED|Overall Study||60
910789|NCT01665157|2201355|P2|STARTED|Overall Study||60
910790|NCT01665157|2201356|P1|STARTED|Overall Study||60
910791|NCT01665053|2201384|P2|NOT COMPLETED|Overall Study||15
910792|NCT01665053|2201385|P1|NOT COMPLETED|Overall Study||32
910793|NCT01665053|2201384|P2|COMPLETED|Overall Study||831
910794|NCT01665053|2201385|P1|COMPLETED|Overall Study||806
910795|NCT01665053|2201384|P2|Death With No 12-month Clinical FU|Overall Study||9
910796|NCT01665053|2201385|P1|Death With No 12-month Clinical FU|Overall Study||9
910797|NCT01665053|2201384|P2|No 12-Month F/U|Overall Study||15
910798|NCT01665053|2201385|P1|No 12-Month F/U|Overall Study||32
910799|NCT01665053|2201384|P2|Completed 12-Month Clinical F/U|Overall Study||822
910800|NCT01665053|2201385|P1|Completed 12-Month Clinical F/U|Overall Study||797
910801|NCT01665053|2201384|P2|STARTED|Overall Study||846
910802|NCT01665053|2201385|P1|STARTED|Overall Study||838
910803|NCT01664975|2201425|P2|NOT COMPLETED|Overall Study||3
910804|NCT01664975|2201426|P1|NOT COMPLETED|Overall Study||5
910805|NCT01664975|2201425|P2|COMPLETED|Overall Study||51
910806|NCT01664975|2201426|P1|COMPLETED|Overall Study||52
910807|NCT01664975|2201425|P2|STARTED|Overall Study||54
910808|NCT01664975|2201426|P1|STARTED|Overall Study||57
910809|NCT01664949|2201434|P2|NOT COMPLETED|Overall Study||25
910810|NCT01664949|2201435|P1|NOT COMPLETED|Overall Study||24
910811|NCT01664949|2201434|P2|COMPLETED|Overall Study||211
910812|NCT01664949|2201435|P1|COMPLETED|Overall Study||200
910813|NCT01664949|2201434|P2|STARTED|Overall Study||236
910814|NCT01664949|2201435|P1|STARTED|Overall Study||224
910815|NCT01664923|2201451|P2|NOT COMPLETED|Overall Study||158
910816|NCT01664923|2201452|P1|NOT COMPLETED|Overall Study||93
910817|NCT01664923|2201451|P2|COMPLETED|Overall Study|Indicates participants continuing to receive treatment as of 09 February 2015.|40
910818|NCT01664923|2201452|P1|COMPLETED|Overall Study|Indicates participants continuing to receive treatment as of 09 February 2015.|105
910819|NCT01664923|2201451|P2|Received Study Treatment|Overall Study||198
910820|NCT01664923|2201452|P1|Received Study Treatment|Overall Study||197
910821|NCT01664923|2201451|P2|STARTED|Overall Study||198
910822|NCT01664923|2201452|P1|STARTED|Overall Study||198
910823|NCT01664806|2201472|P2|NOT COMPLETED|Overall Study||0
910824|NCT01664806|2201473|P1|NOT COMPLETED|Overall Study||0
910825|NCT01664806|2201472|P2|COMPLETED|Overall Study||20
910826|NCT01664806|2201473|P1|COMPLETED|Overall Study||20
910827|NCT01664806|2201472|P2|STARTED|Overall Study||20
910828|NCT01664806|2201473|P1|STARTED|Overall Study||20
910829|NCT01664793|2201483|P2|NOT COMPLETED|Overall Study||0
910830|NCT01664793|2201484|P1|NOT COMPLETED|Overall Study||0
910831|NCT01664793|2201483|P2|COMPLETED|Overall Study||38626
910832|NCT01664793|2201484|P1|COMPLETED|Overall Study||49039
910833|NCT01664793|2201483|P2|STARTED|Overall Study||38626
910834|NCT01664793|2201484|P1|STARTED|Overall Study||49039
910835|NCT01664624|2201496|P4|NOT COMPLETED|Overall Study||0
910836|NCT01664624|2201497|P3|NOT COMPLETED|Overall Study||0
910837|NCT01664624|2201498|P2|NOT COMPLETED|Overall Study||1
910838|NCT01664624|2201499|P1|NOT COMPLETED|Overall Study||0
910839|NCT01664624|2201496|P4|COMPLETED|Overall Study||9
910840|NCT01664624|2201497|P3|COMPLETED|Overall Study||10
910841|NCT01664624|2201498|P2|COMPLETED|Overall Study||10
910842|NCT01664624|2201499|P1|COMPLETED|Overall Study||10
910843|NCT01664624|2201496|P4|STARTED|Overall Study||9
910844|NCT01664624|2201497|P3|STARTED|Overall Study||10
910845|NCT01664624|2201498|P2|STARTED|Overall Study||11
910846|NCT01664624|2201499|P1|STARTED|Overall Study||10
910847|NCT01664559|2201531|P2|NOT COMPLETED|Overall Study||0
910848|NCT01664559|2201532|P1|NOT COMPLETED|Overall Study||0
910849|NCT01664559|2201531|P2|COMPLETED|Overall Study||33
910850|NCT01664559|2201532|P1|COMPLETED|Overall Study||34
910851|NCT01664559|2201531|P2|STARTED|Overall Study||33
910852|NCT01664559|2201532|P1|STARTED|Overall Study||34
910853|NCT01664533|2201546|P1|NOT COMPLETED|Overall Study||57
910854|NCT01664533|2201546|P1|COMPLETED|Overall Study||0
910855|NCT01664533|2201546|P1|STARTED|Overall Study||57
910856|NCT01664494|2201554|P1|NOT COMPLETED|Overall Study||193
910857|NCT01664494|2201554|P1|COMPLETED|Overall Study||370
910858|NCT01664494|2201554|P1|STARTED|Overall Study||563
910859|NCT01664247|2201561|P2|NOT COMPLETED|Overall Study||41
910860|NCT01664247|2201562|P1|NOT COMPLETED|Overall Study||14
910861|NCT01664247|2201561|P2|COMPLETED|Overall Study||131
910862|NCT01664247|2201562|P1|COMPLETED|Overall Study||160
910863|NCT01664247|2201561|P2|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|170
910864|NCT01664247|2201562|P1|Exposed|Overall Study|1 subject was randomised in error and withdrew before exposure to the drug|173
910865|NCT01664247|2201561|P2|STARTED|Overall Study||172
910866|NCT01664247|2201562|P1|STARTED|Overall Study||174
910867|NCT01664117|2201584|P1|NOT COMPLETED|Overall Study||0
910868|NCT01664117|2201584|P1|COMPLETED|Overall Study||209
910869|NCT01664117|2201584|P1|STARTED|Overall Study||209
910870|NCT01664104|2201639|P1|NOT COMPLETED|Overall Study||16
910871|NCT01664104|2201639|P1|COMPLETED|Overall Study||120
910872|NCT01664104|2201639|P1|STARTED|Overall Study||136
910873|NCT01664052|2201708|P2|NOT COMPLETED|Phase 2||4
910874|NCT01664052|2201709|P1|NOT COMPLETED|Phase 2||0
910875|NCT01664052|2201708|P2|COMPLETED|Phase 2||31
910876|NCT01664052|2201709|P1|COMPLETED|Phase 2||0
910877|NCT01664052|2201708|P2|Repeat HSG and Hysterectomy at 90 Days|Phase 2||10
910878|NCT01664052|2201709|P1|Repeat HSG and Hysterectomy at 90 Days|Phase 2||0
910879|NCT01664052|2201708|P2|Repeat HSG and Hysterectomy at 60 Days|Phase 2||10
910880|NCT01664052|2201709|P1|Repeat HSG and Hysterectomy at 60 Days|Phase 2||0
910881|NCT01664052|2201708|P2|Repeat HSG and Hysterectomy at 30 Days|Phase 2||10
910882|NCT01664052|2201709|P1|Repeat HSG and Hysterectomy at 30 Days|Phase 2||0
910883|NCT01664052|2201708|P2|HSG 1 Hour Post Placement|Phase 2||31
910884|NCT01664052|2201709|P1|HSG 1 Hour Post Placement|Phase 2||0
910885|NCT01664052|2201708|P2|Insert Placed|Phase 2||31
910886|NCT01664052|2201709|P1|Insert Placed|Phase 2||0
910887|NCT01664052|2201708|P2|STARTED|Phase 2||35
910888|NCT01664052|2201709|P1|STARTED|Phase 2|Screened and enrolled|0
910889|NCT01664052|2201708|P2|NOT COMPLETED|Phase 1||0
910890|NCT01664052|2201709|P1|NOT COMPLETED|Phase 1||7
910891|NCT01664052|2201708|P2|COMPLETED|Phase 1||0
910892|NCT01664052|2201709|P1|COMPLETED|Phase 1||24
910893|NCT01664052|2201708|P2|Repeat HSG and Hysterectomy at 90 Days|Phase 1||0
910894|NCT01664052|2201709|P1|Repeat HSG and Hysterectomy at 90 Days|Phase 1||7
910895|NCT01664052|2201708|P2|Repeat HSG and Hysterectomy at 60 Days|Phase 1||0
910896|NCT01664052|2201709|P1|Repeat HSG and Hysterectomy at 60 Days|Phase 1||8
910897|NCT01664052|2201708|P2|Repeat HSG and Hysterectomy at 30 Days|Phase 1||0
910898|NCT01664052|2201709|P1|Repeat HSG and Hysterectomy at 30 Days|Phase 1||9
910899|NCT01664052|2201708|P2|HSG 1 Hour Post Placement|Phase 1||0
910900|NCT01664052|2201709|P1|HSG 1 Hour Post Placement|Phase 1||24
910901|NCT01664052|2201708|P2|Insert Placed in at Least One Tube|Phase 1||0
910902|NCT01664052|2201709|P1|Insert Placed in at Least One Tube|Phase 1||25
910903|NCT01664052|2201708|P2|STARTED|Phase 1||0
910904|NCT01664052|2201709|P1|STARTED|Phase 1|Screening and enrollment|31
910905|NCT01664039|2201727|P2|NOT COMPLETED|Overall Study||9
910906|NCT01664039|2201728|P1|NOT COMPLETED|Overall Study||6
910907|NCT01664039|2201727|P2|COMPLETED|Overall Study||43
910908|NCT01664039|2201728|P1|COMPLETED|Overall Study||46
910909|NCT01664039|2201727|P2|STARTED|Overall Study||52
910910|NCT01664039|2201728|P1|STARTED|Overall Study||52
910911|NCT01663987|2201750|P2|NOT COMPLETED|Overall Study||6
910912|NCT01663987|2201751|P1|NOT COMPLETED|Overall Study||13
910913|NCT01663987|2201750|P2|COMPLETED|Overall Study||34
910914|NCT01663987|2201751|P1|COMPLETED|Overall Study||26
910915|NCT01663987|2201750|P2|STARTED|Overall Study||40
910916|NCT01663987|2201751|P1|STARTED|Overall Study||39
910917|NCT01663922|2201777|P2|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
910918|NCT01663922|2201778|P1|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
910919|NCT01663922|2201777|P2|COMPLETED|Third Intervention (14 Days or 5 Days)||9
910920|NCT01663922|2201778|P1|COMPLETED|Third Intervention (14 Days or 5 Days)||8
910921|NCT01663922|2201777|P2|STARTED|Third Intervention (14 Days or 5 Days)||9
910922|NCT01663922|2201778|P1|STARTED|Third Intervention (14 Days or 5 Days)||8
910923|NCT01663922|2201777|P2|NOT COMPLETED|Washout (7 Days)||0
910924|NCT01663922|2201778|P1|NOT COMPLETED|Washout (7 Days)||0
910925|NCT01663922|2201777|P2|COMPLETED|Washout (7 Days)||9
910926|NCT01663922|2201778|P1|COMPLETED|Washout (7 Days)||8
910927|NCT01663922|2201777|P2|STARTED|Washout (7 Days)||9
910928|NCT01663922|2201778|P1|STARTED|Washout (7 Days)||8
910929|NCT01663922|2201777|P2|NOT COMPLETED|Second Intervention (14 Days)||0
910930|NCT01663922|2201778|P1|NOT COMPLETED|Second Intervention (14 Days)||0
910931|NCT01663922|2201777|P2|COMPLETED|Second Intervention (14 Days)||9
910932|NCT01663922|2201778|P1|COMPLETED|Second Intervention (14 Days)||8
910933|NCT01663922|2201777|P2|STARTED|Second Intervention (14 Days)||9
910934|NCT01663922|2201778|P1|STARTED|Second Intervention (14 Days)||8
910935|NCT01663922|2201777|P2|NOT COMPLETED|Washout (7 Days)||0
910936|NCT01663922|2201778|P1|NOT COMPLETED|Washout (7 Days)||0
910937|NCT01663922|2201777|P2|COMPLETED|Washout (7 Days)||9
910938|NCT01663922|2201778|P1|COMPLETED|Washout (7 Days)||8
910939|NCT01663922|2201777|P2|STARTED|Washout (7 Days)||9
910940|NCT01663922|2201778|P1|STARTED|Washout (7 Days)||8
910941|NCT01663922|2201777|P2|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
910942|NCT01663922|2201778|P1|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
910943|NCT01663922|2201777|P2|COMPLETED|First Intervention (14 Days or 5 Days)||9
910944|NCT01663922|2201778|P1|COMPLETED|First Intervention (14 Days or 5 Days)||8
910945|NCT01663922|2201777|P2|STARTED|First Intervention (14 Days or 5 Days)||9
910946|NCT01663922|2201778|P1|STARTED|First Intervention (14 Days or 5 Days)||8
910947|NCT01663779|2201785|P2|NOT COMPLETED|Overall Study||0
910948|NCT01663779|2201786|P1|NOT COMPLETED|Overall Study||0
910949|NCT01663779|2201785|P2|COMPLETED|Overall Study||23
910950|NCT01663779|2201786|P1|COMPLETED|Overall Study||27
910951|NCT01663779|2201785|P2|STARTED|Overall Study||23
910952|NCT01663779|2201786|P1|STARTED|Overall Study||27
910953|NCT01663727|2201794|P2|NOT COMPLETED|Overall Study||239
910954|NCT01663727|2201795|P1|NOT COMPLETED|Overall Study||242
910955|NCT01663727|2201794|P2|COMPLETED|Overall Study||0
910956|NCT01663727|2201795|P1|COMPLETED|Overall Study||0
910957|NCT01663727|2201794|P2|STARTED|Overall Study||239
910958|NCT01663727|2201795|P1|STARTED|Overall Study||242
910959|NCT01663714|2201823|P1|NOT COMPLETED|Long-Term Follow-Up||6
910960|NCT01663714|2201823|P1|COMPLETED|Long-Term Follow-Up||16
910961|NCT01663714|2201823|P1|STARTED|Long-Term Follow-Up|22 of the30 participants withdrawing from Study BEX104514 enrolled in the LTFU study.|22
910962|NCT01663714|2201823|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||30
910963|NCT01663714|2201823|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
910964|NCT01663714|2201823|P1|STARTED|Dosimetric and Therapeutic Treatment||30
910965|NCT01663532|2201852|P2|NOT COMPLETED|Overall Study||107
910966|NCT01663532|2201853|P1|NOT COMPLETED|Overall Study||74
910967|NCT01663532|2201852|P2|COMPLETED|Overall Study||65
910968|NCT01663532|2201853|P1|COMPLETED|Overall Study||94
910969|NCT01663532|2201852|P2|STARTED|Overall Study||172
910970|NCT01663532|2201853|P1|STARTED|Overall Study||168
910971|NCT01663506|2201871|P1|NOT COMPLETED|Overall Study||8
910972|NCT01663506|2201871|P1|COMPLETED|Overall Study||15
910973|NCT01663506|2201871|P1|STARTED|Overall Study||23
910974|NCT01663363|2201900|P1|NOT COMPLETED|Overall Study||0
910975|NCT01663363|2201900|P1|COMPLETED|Overall Study|334 Eyes were treated among 170 participants|170
910976|NCT01663363|2201900|P1|STARTED|Overall Study|334 Eyes were treated among 170 participants|170
910977|NCT01663285|2201905|P1|NOT COMPLETED|Overall Study||0
910978|NCT01663285|2201905|P1|COMPLETED|Overall Study||1
910979|NCT01663285|2201905|P1|STARTED|Overall Study||1
910980|NCT01663233|2201913|P2|NOT COMPLETED|Overall Study||7
910981|NCT01663233|2201914|P1|NOT COMPLETED|Overall Study||4
910982|NCT01663233|2201913|P2|COMPLETED|Overall Study||129
910983|NCT01663233|2201914|P1|COMPLETED|Overall Study||126
910984|NCT01663233|2201913|P2|STARTED|Overall Study||136
910985|NCT01663233|2201914|P1|STARTED|Overall Study||130
910986|NCT01663103|2201938|P2|NOT COMPLETED|Overall Study||2
910987|NCT01663103|2201939|P1|NOT COMPLETED|Overall Study||3
910988|NCT01663103|2201938|P2|COMPLETED|Overall Study||19
910989|NCT01663103|2201939|P1|COMPLETED|Overall Study||18
910990|NCT01663103|2201938|P2|STARTED|Overall Study||21
910991|NCT01663103|2201939|P1|STARTED|Overall Study||21
910992|NCT01663012|2201955|P1|NOT COMPLETED|Overall Study||0
910993|NCT01663012|2201955|P1|COMPLETED|Overall Study||20
910994|NCT01663012|2201955|P1|STARTED|Overall Study||20
910995|NCT01662999|2201967|P6|NOT COMPLETED|Period 3||0
910996|NCT01662999|2201968|P5|NOT COMPLETED|Period 3||0
910997|NCT01662999|2201969|P4|NOT COMPLETED|Period 3||0
910998|NCT01662999|2201970|P3|NOT COMPLETED|Period 3||0
910999|NCT01662999|2201971|P2|NOT COMPLETED|Period 3||1
911000|NCT01662999|2201972|P1|NOT COMPLETED|Period 3||0
911001|NCT01662999|2201967|P6|COMPLETED|Period 3||7
911002|NCT01662999|2201968|P5|COMPLETED|Period 3||7
911003|NCT01662999|2201969|P4|COMPLETED|Period 3||7
911004|NCT01662999|2201970|P3|COMPLETED|Period 3||7
911005|NCT01662999|2201971|P2|COMPLETED|Period 3|Participant did not provide 36, 48, or 60 hour samples in this period for Treatment B.|6
911006|NCT01662999|2201972|P1|COMPLETED|Period 3||7
911007|NCT01662999|2201967|P6|STARTED|Period 3||7
911008|NCT01662999|2201968|P5|STARTED|Period 3||7
911009|NCT01662999|2201969|P4|STARTED|Period 3||7
911010|NCT01662999|2201970|P3|STARTED|Period 3||7
911011|NCT01662999|2201971|P2|STARTED|Period 3||7
911012|NCT01662999|2201972|P1|STARTED|Period 3||7
911013|NCT01662999|2201967|P6|NOT COMPLETED|Period 2||0
911014|NCT01662999|2201968|P5|NOT COMPLETED|Period 2||0
911015|NCT01662999|2201969|P4|NOT COMPLETED|Period 2||0
911016|NCT01662999|2201970|P3|NOT COMPLETED|Period 2||0
911017|NCT01662999|2201971|P2|NOT COMPLETED|Period 2||0
911018|NCT01662999|2201972|P1|NOT COMPLETED|Period 2||0
911019|NCT01662999|2201967|P6|COMPLETED|Period 2||7
911020|NCT01662999|2201968|P5|COMPLETED|Period 2||7
911021|NCT01662999|2201969|P4|COMPLETED|Period 2||7
911022|NCT01662999|2201970|P3|COMPLETED|Period 2||7
911023|NCT01662999|2201971|P2|COMPLETED|Period 2||7
911024|NCT01662999|2201972|P1|COMPLETED|Period 2||7
911025|NCT01662999|2201967|P6|STARTED|Period 2||7
911026|NCT01662999|2201968|P5|STARTED|Period 2||7
911027|NCT01662999|2201969|P4|STARTED|Period 2||7
911028|NCT01662999|2201970|P3|STARTED|Period 2||7
911029|NCT01662999|2201971|P2|STARTED|Period 2||7
911030|NCT01662999|2201972|P1|STARTED|Period 2||7
911031|NCT01662999|2201967|P6|NOT COMPLETED|Period 1||0
911032|NCT01662999|2201968|P5|NOT COMPLETED|Period 1||0
911033|NCT01662999|2201969|P4|NOT COMPLETED|Period 1||0
911034|NCT01662999|2201970|P3|NOT COMPLETED|Period 1||0
911035|NCT01662999|2201971|P2|NOT COMPLETED|Period 1||0
911036|NCT01662999|2201972|P1|NOT COMPLETED|Period 1||0
911037|NCT01662999|2201967|P6|COMPLETED|Period 1||7
911038|NCT01662999|2201968|P5|COMPLETED|Period 1||7
911039|NCT01662999|2201969|P4|COMPLETED|Period 1||7
911040|NCT01662999|2201970|P3|COMPLETED|Period 1||7
911041|NCT01662999|2201971|P2|COMPLETED|Period 1||7
911042|NCT01662999|2201972|P1|COMPLETED|Period 1||7
911043|NCT01662999|2201967|P6|STARTED|Period 1||7
911044|NCT01662999|2201968|P5|STARTED|Period 1||7
911045|NCT01662999|2201969|P4|STARTED|Period 1||7
911046|NCT01662999|2201970|P3|STARTED|Period 1||7
911047|NCT01662999|2201971|P2|STARTED|Period 1||7
911048|NCT01662999|2201972|P1|STARTED|Period 1||7
911049|NCT01662986|2202043|P2|NOT COMPLETED|Overall Study||13
911050|NCT01662986|2202044|P1|NOT COMPLETED|Overall Study||18
911051|NCT01662986|2202043|P2|COMPLETED|Overall Study||26
911052|NCT01662986|2202044|P1|COMPLETED|Overall Study||22
911053|NCT01662986|2202043|P2|STARTED|Overall Study||39
911054|NCT01662986|2202044|P1|STARTED|Overall Study||40
911055|NCT01662908|2202076|P2|NOT COMPLETED|Overall Study||5
911056|NCT01662908|2202077|P1|NOT COMPLETED|Overall Study||6
911057|NCT01662908|2202076|P2|COMPLETED|Overall Study||23
911058|NCT01662908|2202077|P1|COMPLETED|Overall Study||50
911059|NCT01662908|2202076|P2|STARTED|Overall Study||28
911060|NCT01662908|2202077|P1|STARTED|Overall Study||56
911061|NCT01662882|2202094|P3|NOT COMPLETED|Overall Study||0
911062|NCT01662882|2202095|P2|NOT COMPLETED|Overall Study||0
911063|NCT01662882|2202096|P1|NOT COMPLETED|Overall Study||0
911064|NCT01662882|2202094|P3|COMPLETED|Overall Study||15
911065|NCT01662882|2202095|P2|COMPLETED|Overall Study||18
911066|NCT01662882|2202096|P1|COMPLETED|Overall Study||15
911067|NCT01662882|2202094|P3|STARTED|Overall Study||15
911068|NCT01662882|2202095|P2|STARTED|Overall Study||18
911069|NCT01662882|2202096|P1|STARTED|Overall Study||15
911070|NCT01662856|2202109|P2|NOT COMPLETED|Primary Part II||2
911071|NCT01662856|2202110|P1|NOT COMPLETED|Primary Part II||10
911072|NCT01662856|2202109|P2|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|55
911073|NCT01662856|2202110|P1|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|99
911074|NCT01662856|2202109|P2|Completed Study up to Week 6|Primary Part II||56
911075|NCT01662856|2202110|P1|Completed Study up to Week 6|Primary Part II||106
911076|NCT01662856|2202109|P2|STARTED|Primary Part II||57
911077|NCT01662856|2202110|P1|STARTED|Primary Part II||109
911078|NCT01662856|2202109|P2|NOT COMPLETED|Part I + Part II (Overall Study)||2
911079|NCT01662856|2202110|P1|NOT COMPLETED|Part I + Part II (Overall Study)||16
911080|NCT01662856|2202109|P2|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|55
911081|NCT01662856|2202110|P1|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|152
911082|NCT01662856|2202109|P2|Completed Study up to Week 6|Part I + Part II (Overall Study)||56
911083|NCT01662856|2202110|P1|Completed Study up to Week 6|Part I + Part II (Overall Study)||164
911084|NCT01662856|2202109|P2|STARTED|Part I + Part II (Overall Study)||57
911085|NCT01662856|2202110|P1|STARTED|Part I + Part II (Overall Study)||168
911086|NCT01662791|2202124|P2|NOT COMPLETED|Part 2 - Interventional||0
911087|NCT01662791|2202125|P1|NOT COMPLETED|Part 2 - Interventional||0
911088|NCT01662791|2202124|P2|COMPLETED|Part 2 - Interventional||0
911089|NCT01662791|2202125|P1|COMPLETED|Part 2 - Interventional||8
911090|NCT01662791|2202124|P2|STARTED|Part 2 - Interventional|The Control Group did not take part in the second part of the study.|0
911091|NCT01662791|2202125|P1|STARTED|Part 2 - Interventional||8
911092|NCT01662791|2202124|P2|NOT COMPLETED|Part 1 - Observational||0
911093|NCT01662791|2202125|P1|NOT COMPLETED|Part 1 - Observational||0
911094|NCT01662791|2202124|P2|COMPLETED|Part 1 - Observational||41
911095|NCT01662791|2202125|P1|COMPLETED|Part 1 - Observational||8
911096|NCT01662791|2202124|P2|STARTED|Part 1 - Observational||41
911097|NCT01662791|2202125|P1|STARTED|Part 1 - Observational||8
911098|NCT01662765|2202149|P2|NOT COMPLETED|Overall Study||2
911099|NCT01662765|2202150|P1|NOT COMPLETED|Overall Study||1
911100|NCT01662765|2202149|P2|COMPLETED|Overall Study||40
911101|NCT01662765|2202150|P1|COMPLETED|Overall Study||41
911102|NCT01662765|2202149|P2|STARTED|Overall Study||42
911103|NCT01662765|2202150|P1|STARTED|Overall Study||42
911104|NCT01662648|2202164|P2|NOT COMPLETED|Overall Study||178
911105|NCT01662648|2202165|P1|NOT COMPLETED|Overall Study||147
911106|NCT01662648|2202164|P2|COMPLETED|Overall Study||419
911107|NCT01662648|2202165|P1|COMPLETED|Overall Study||373
911108|NCT01662648|2202164|P2|STARTED|Overall Study||597
911109|NCT01662648|2202165|P1|STARTED|Overall Study||520
911110|NCT01662635|2202187|P1|NOT COMPLETED|Overall Study||30
911111|NCT01662635|2202187|P1|COMPLETED|Overall Study||200
911112|NCT01662635|2202187|P1|STARTED|Overall Study||230
911113|NCT01662583|2202196|P3|NOT COMPLETED|Overall Study||0
911114|NCT01662583|2202197|P2|NOT COMPLETED|Overall Study||0
911115|NCT01662583|2202198|P1|NOT COMPLETED|Overall Study||0
911116|NCT01662583|2202196|P3|COMPLETED|Overall Study||219
911117|NCT01662583|2202197|P2|COMPLETED|Overall Study||225
911118|NCT01662583|2202198|P1|COMPLETED|Overall Study||216
911119|NCT01662583|2202196|P3|STARTED|Overall Study||219
911120|NCT01662583|2202197|P2|STARTED|Overall Study||225
911121|NCT01662583|2202198|P1|STARTED|Overall Study||216
911122|NCT01662531|2202211|P1|NOT COMPLETED|Overall Study||0
911123|NCT01662531|2202211|P1|COMPLETED|Overall Study||27
911124|NCT01662531|2202211|P1|STARTED|Overall Study||27
911125|NCT01662492|2202238|P3|NOT COMPLETED|Overall Study||6
911126|NCT01662492|2202239|P2|NOT COMPLETED|Overall Study||1
911127|NCT01662492|2202240|P1|NOT COMPLETED|Overall Study||3
911128|NCT01662492|2202238|P3|COMPLETED|Overall Study||31
911129|NCT01662492|2202239|P2|COMPLETED|Overall Study||42
911130|NCT01662492|2202240|P1|COMPLETED|Overall Study||42
911131|NCT01662492|2202238|P3|STARTED|Overall Study||37
911132|NCT01662492|2202239|P2|STARTED|Overall Study||43
911133|NCT01662492|2202240|P1|STARTED|Overall Study||45
911146|NCT01662362|2202315|P1|NOT COMPLETED|Overall Study||38
911147|NCT01662362|2202315|P1|COMPLETED|Overall Study||25
911148|NCT01662362|2202315|P1|STARTED|Overall Study||63
911149|NCT01662310|2202320|P5|NOT COMPLETED|Open-Label Extension Phase||10
911150|NCT01662310|2202321|P4|NOT COMPLETED|Open-Label Extension Phase||11
911151|NCT01662310|2202322|P3|NOT COMPLETED|Open-Label Extension Phase||0
911152|NCT01662310|2202323|P2|NOT COMPLETED|Open-Label Extension Phase||0
911153|NCT01662310|2202324|P1|NOT COMPLETED|Open-Label Extension Phase||0
911154|NCT01662310|2202320|P5|COMPLETED|Open-Label Extension Phase||49
911155|NCT01662310|2202321|P4|COMPLETED|Open-Label Extension Phase||36
911156|NCT01662310|2202322|P3|COMPLETED|Open-Label Extension Phase||0
911157|NCT01662310|2202323|P2|COMPLETED|Open-Label Extension Phase||0
911158|NCT01662310|2202324|P1|COMPLETED|Open-Label Extension Phase||0
911159|NCT01662310|2202320|P5|STARTED|Open-Label Extension Phase||59
911160|NCT01662310|2202321|P4|STARTED|Open-Label Extension Phase||47
911161|NCT01662310|2202322|P3|STARTED|Open-Label Extension Phase||0
911162|NCT01662310|2202323|P2|STARTED|Open-Label Extension Phase||0
911163|NCT01662310|2202324|P1|STARTED|Open-Label Extension Phase||0
911164|NCT01662310|2202320|P5|NOT COMPLETED|Double-Blind Phase||0
911165|NCT01662310|2202321|P4|NOT COMPLETED|Double-Blind Phase||0
911166|NCT01662310|2202322|P3|NOT COMPLETED|Double-Blind Phase||5
911167|NCT01662310|2202323|P2|NOT COMPLETED|Double-Blind Phase||15
911168|NCT01662310|2202324|P1|NOT COMPLETED|Double-Blind Phase||0
911169|NCT01662310|2202320|P5|COMPLETED|Double-Blind Phase||0
911170|NCT01662310|2202321|P4|COMPLETED|Double-Blind Phase||0
911171|NCT01662310|2202322|P3|COMPLETED|Double-Blind Phase||66
911172|NCT01662310|2202323|P2|COMPLETED|Double-Blind Phase||50
911173|NCT01662310|2202324|P1|COMPLETED|Double-Blind Phase||0
911174|NCT01662310|2202320|P5|Treated|Double-Blind Phase||0
911175|NCT01662310|2202321|P4|Treated|Double-Blind Phase||0
911176|NCT01662310|2202322|P3|Treated|Double-Blind Phase||71
911177|NCT01662310|2202323|P2|Treated|Double-Blind Phase||64
911178|NCT01662310|2202324|P1|Treated|Double-Blind Phase||0
911179|NCT01662310|2202320|P5|STARTED|Double-Blind Phase||0
911180|NCT01662310|2202321|P4|STARTED|Double-Blind Phase||0
911181|NCT01662310|2202322|P3|STARTED|Double-Blind Phase||71
911182|NCT01662310|2202323|P2|STARTED|Double-Blind Phase||65
911183|NCT01662310|2202324|P1|STARTED|Double-Blind Phase||0
911184|NCT01662310|2202320|P5|NOT COMPLETED|Run-In or Stabilization Phase||0
911185|NCT01662310|2202321|P4|NOT COMPLETED|Run-In or Stabilization Phase||0
911186|NCT01662310|2202322|P3|NOT COMPLETED|Run-In or Stabilization Phase||0
911187|NCT01662310|2202323|P2|NOT COMPLETED|Run-In or Stabilization Phase||0
911188|NCT01662310|2202324|P1|NOT COMPLETED|Run-In or Stabilization Phase||65
911189|NCT01662310|2202320|P5|COMPLETED|Run-In or Stabilization Phase||0
911190|NCT01662310|2202321|P4|COMPLETED|Run-In or Stabilization Phase||0
911191|NCT01662310|2202322|P3|COMPLETED|Run-In or Stabilization Phase||0
911192|NCT01662310|2202323|P2|COMPLETED|Run-In or Stabilization Phase||0
911193|NCT01662310|2202324|P1|COMPLETED|Run-In or Stabilization Phase||136
911194|NCT01662310|2202320|P5|STARTED|Run-In or Stabilization Phase||0
911195|NCT01662310|2202321|P4|STARTED|Run-In or Stabilization Phase||0
911196|NCT01662310|2202322|P3|STARTED|Run-In or Stabilization Phase||0
911197|NCT01662310|2202323|P2|STARTED|Run-In or Stabilization Phase||0
911198|NCT01662310|2202324|P1|STARTED|Run-In or Stabilization Phase||201
911199|NCT01662115|2202359|P3|NOT COMPLETED|Overall Study||0
911200|NCT01662115|2202360|P2|NOT COMPLETED|Overall Study||0
911201|NCT01662115|2202361|P1|NOT COMPLETED|Overall Study||0
911202|NCT01662115|2202359|P3|COMPLETED|Overall Study||0
911203|NCT01662115|2202360|P2|COMPLETED|Overall Study||2
911204|NCT01662115|2202361|P1|COMPLETED|Overall Study||2
911205|NCT01662115|2202359|P3|STARTED|Overall Study||0
911206|NCT01662115|2202360|P2|STARTED|Overall Study||2
911207|NCT01662115|2202361|P1|STARTED|Overall Study||2
911208|NCT01662102|2202380|P2|NOT COMPLETED|Overall Study||0
911209|NCT01662102|2202381|P1|NOT COMPLETED|Overall Study||1
911210|NCT01662102|2202380|P2|COMPLETED|Overall Study||0
911211|NCT01662102|2202381|P1|COMPLETED|Overall Study||0
911212|NCT01662102|2202380|P2|STARTED|Overall Study||0
911213|NCT01662102|2202381|P1|STARTED|Overall Study||1
911214|NCT01662063|2202389|P3|NOT COMPLETED|Overall Study||1
911215|NCT01662063|2202390|P2|NOT COMPLETED|Overall Study||29
911216|NCT01662063|2202391|P1|NOT COMPLETED|Overall Study||5
911217|NCT01662063|2202389|P3|COMPLETED|Overall Study||0
911218|NCT01662063|2202390|P2|COMPLETED|Overall Study||144
911219|NCT01662063|2202391|P1|COMPLETED|Overall Study||39
911220|NCT01662063|2202389|P3|STARTED|Overall Study||1
911221|NCT01662063|2202390|P2|STARTED|Overall Study||173
911222|NCT01662063|2202391|P1|STARTED|Overall Study||44
911223|NCT01662024|2202470|P1|NOT COMPLETED|Overall Study||5
911224|NCT01662024|2202470|P1|COMPLETED|Overall Study||15
911225|NCT01662024|2202470|P1|STARTED|Overall Study||20
911226|NCT01661972|2202482|P2|NOT COMPLETED|Overall Study||4
911227|NCT01661972|2202483|P1|NOT COMPLETED|Overall Study||2
911228|NCT01661972|2202482|P2|COMPLETED|Overall Study||46
911229|NCT01661972|2202483|P1|COMPLETED|Overall Study||11
911230|NCT01661972|2202482|P2|STARTED|Overall Study||50
911231|NCT01661972|2202483|P1|STARTED|Overall Study||13
911232|NCT01661933|2202493|P1|NOT COMPLETED|High-dose Gluten Challenge||2
911233|NCT01661933|2202493|P1|COMPLETED|High-dose Gluten Challenge||8
911234|NCT01661933|2202493|P1|STARTED|High-dose Gluten Challenge|2 of 10 available after post-GC-1g did not enroll for reasons unrelated to gluten.|10
911235|NCT01661933|2202493|P1|NOT COMPLETED|Low-dose Gluten Challenge||2
911236|NCT01661933|2202493|P1|COMPLETED|Low-dose Gluten Challenge|Two had challenge interrupted for 1-2 weeks. All completed challenge.|10
911237|NCT01661933|2202493|P1|STARTED|Low-dose Gluten Challenge|One was symptomatically intolerant to gluten >25 mg. One had active CeD pre- & post-micro-challenge|12
911238|NCT01661933|2202493|P1|NOT COMPLETED|Gluten Micro-challenge||0
911239|NCT01661933|2202493|P1|COMPLETED|Gluten Micro-challenge|Two gluten intolerant participants did not proceed to the low-dose challenge.|12
911240|NCT01661933|2202493|P1|STARTED|Gluten Micro-challenge|All 12 enrolled completed hookworm inoculation and gluten micro-challenge.|12
911241|NCT01661881|2202500|P1|NOT COMPLETED|Overall Study||0
911242|NCT01661881|2202500|P1|COMPLETED|Overall Study||23
911243|NCT01661881|2202500|P1|STARTED|Overall Study||23
911244|NCT01661790|2202508|P2|NOT COMPLETED|Overall Study||2
911245|NCT01661790|2202509|P1|NOT COMPLETED|Overall Study||0
911246|NCT01661790|2202508|P2|COMPLETED|Overall Study||34
911247|NCT01661790|2202509|P1|COMPLETED|Overall Study||36
911248|NCT01661790|2202508|P2|STARTED|Overall Study||36
911249|NCT01661790|2202509|P1|STARTED|Overall Study||36
911250|NCT01661621|2202517|P2|NOT COMPLETED|Overall Study||0
911251|NCT01661621|2202518|P1|NOT COMPLETED|Overall Study||0
911252|NCT01661621|2202517|P2|COMPLETED|Overall Study||279
911253|NCT01661621|2202518|P1|COMPLETED|Overall Study||116
911254|NCT01661621|2202517|P2|STARTED|Overall Study||279
911255|NCT01661621|2202518|P1|STARTED|Overall Study||116
911256|NCT01661270|2202540|P2|NOT COMPLETED|Overall Study||0
911257|NCT01661270|2202541|P1|NOT COMPLETED|Overall Study||0
911258|NCT01661270|2202540|P2|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|223
911259|NCT01661270|2202541|P1|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|109
911260|NCT01661270|2202540|P2|Other Reasons|Overall Study||2
911261|NCT01661270|2202541|P1|Other Reasons|Overall Study||0
911262|NCT01661270|2202540|P2|Participant’s Request|Overall Study|Met EOT criteria|48
911263|NCT01661270|2202541|P1|Participant’s Request|Overall Study|Met EOT criteria|15
911264|NCT01661270|2202540|P2|Physician Decision|Overall Study|Met EOT criteria|8
911265|NCT01661270|2202541|P1|Physician Decision|Overall Study|Met EOT criteria|1
911266|NCT01661270|2202540|P2|Disease Progression|Overall Study|Met EOT criteria|118
911267|NCT01661270|2202541|P1|Disease Progression|Overall Study|Met EOT criteria|67
911268|NCT01661270|2202540|P2|Adverse Event|Overall Study|Met EOT criteria|47
911269|NCT01661270|2202541|P1|Adverse Event|Overall Study|Met end of treatment (EOT) criteria.|26
911270|NCT01661270|2202540|P2|STARTED|Overall Study||223
911271|NCT01661270|2202541|P1|STARTED|Overall Study||109
911272|NCT01661205|2202552|P1|NOT COMPLETED|Overall Study||2
911273|NCT01661205|2202552|P1|COMPLETED|Overall Study||24
911274|NCT01661205|2202552|P1|STARTED|Overall Study||26
911275|NCT01661179|2202563|P1|NOT COMPLETED|Overall Study||6
911276|NCT01661179|2202563|P1|COMPLETED|Overall Study||8
911277|NCT01661179|2202563|P1|STARTED|Overall Study||14
911278|NCT01661140|2202567|P3|NOT COMPLETED|Double-Blind Period||50
911279|NCT01661140|2202568|P2|NOT COMPLETED|Double-Blind Period||41
911280|NCT01661140|2202569|P1|NOT COMPLETED|Double-Blind Period||0
911281|NCT01661140|2202567|P3|COMPLETED|Double-Blind Period||86
911282|NCT01661140|2202568|P2|COMPLETED|Double-Blind Period||95
911283|NCT01661140|2202569|P1|COMPLETED|Double-Blind Period||0
911284|NCT01661140|2202567|P3|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
911285|NCT01661140|2202568|P2|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
911286|NCT01661140|2202569|P1|STARTED|Double-Blind Period|Those with a good/moderate disease response in the initial phase were randomized to the MTX arms.|0
911287|NCT01661140|2202567|P3|NOT COMPLETED|Open-Label Period||0
911288|NCT01661140|2202568|P2|NOT COMPLETED|Open-Label Period||0
911289|NCT01661140|2202569|P1|NOT COMPLETED|Open-Label Period||76
911290|NCT01661140|2202567|P3|COMPLETED|Open-Label Period||0
911291|NCT01661140|2202568|P2|COMPLETED|Open-Label Period||0
911292|NCT01661140|2202569|P1|COMPLETED|Open-Label Period||351
911293|NCT01661140|2202567|P3|STARTED|Open-Label Period||0
911294|NCT01661140|2202568|P2|STARTED|Open-Label Period||0
911295|NCT01661140|2202569|P1|STARTED|Open-Label Period|All participants entered the study in the initial phase for 24 weeks of open label treatment.|427
911296|NCT01661114|2202610|P1|NOT COMPLETED|Overall Study||0
911297|NCT01661114|2202610|P1|COMPLETED|Overall Study||39
911298|NCT01661114|2202610|P1|STARTED|Overall Study||39
911299|NCT01661062|2202615|P1|NOT COMPLETED|Overall Study||5
911300|NCT01661062|2202615|P1|COMPLETED|Overall Study||18
911301|NCT01661062|2202615|P1|STARTED|Overall Study||23
911302|NCT01660906|2202620|P1|NOT COMPLETED|Overall Study||3
911303|NCT01660906|2202620|P1|COMPLETED|Overall Study||36
911304|NCT01660906|2202620|P1|STARTED|Overall Study||39
911305|NCT01660893|2202632|P3|NOT COMPLETED|Overall Study||0
911306|NCT01660893|2202633|P2|NOT COMPLETED|Overall Study||0
911307|NCT01660893|2202634|P1|NOT COMPLETED|Overall Study||0
911308|NCT01660893|2202632|P3|COMPLETED|Overall Study||6
911309|NCT01660893|2202633|P2|COMPLETED|Overall Study||10
911310|NCT01660893|2202634|P1|COMPLETED|Overall Study||10
911311|NCT01660893|2202632|P3|STARTED|Overall Study||6
911312|NCT01660893|2202633|P2|STARTED|Overall Study||10
911313|NCT01660893|2202634|P1|STARTED|Overall Study||10
911314|NCT01660815|2202681|P1|NOT COMPLETED|Overall Study||0
911315|NCT01660815|2202681|P1|COMPLETED|Overall Study||7
911316|NCT01660815|2202681|P1|STARTED|Overall Study||7
911317|NCT01660802|2202688|P2|NOT COMPLETED|Overall Study||11
911318|NCT01660802|2202689|P1|NOT COMPLETED|Overall Study||4
911319|NCT01660802|2202688|P2|COMPLETED|Overall Study||121
911320|NCT01660802|2202689|P1|COMPLETED|Overall Study||126
911321|NCT01660802|2202688|P2|STARTED|Overall Study||132
911322|NCT01660802|2202689|P1|STARTED|Overall Study||130
911323|NCT01660763|2202703|P2|NOT COMPLETED|Overall Study||61
911324|NCT01660763|2202704|P1|NOT COMPLETED|Overall Study||100
911325|NCT01660763|2202703|P2|COMPLETED|Overall Study||43
911326|NCT01660763|2202704|P1|COMPLETED|Overall Study||215
911327|NCT01660763|2202703|P2|STARTED|Overall Study||104
911328|NCT01660763|2202704|P1|STARTED|Overall Study||315
911329|NCT01660737|2202710|P1|NOT COMPLETED|Overall Study||0
911330|NCT01660737|2202710|P1|COMPLETED|Overall Study||123
911331|NCT01660737|2202710|P1|STARTED|Overall Study||123
911332|NCT01660698|2202727|P2|NOT COMPLETED|Overall Study||0
911333|NCT01660698|2202728|P1|NOT COMPLETED|Overall Study||0
911334|NCT01660698|2202727|P2|COMPLETED|Overall Study||10
911335|NCT01660698|2202728|P1|COMPLETED|Overall Study||10
911336|NCT01660698|2202727|P2|STARTED|Overall Study||10
911337|NCT01660698|2202728|P1|STARTED|Overall Study||10
911338|NCT01660672|2202738|P1|NOT COMPLETED|Overall Study||0
911339|NCT01660672|2202738|P1|COMPLETED|Overall Study||7
911340|NCT01660672|2202738|P1|STARTED|Overall Study||7
911341|NCT01660334|2202749|P1|NOT COMPLETED|Overall Study||1
911342|NCT01660334|2202749|P1|COMPLETED|Overall Study||12
911343|NCT01660334|2202749|P1|STARTED|Overall Study||13
911344|NCT01660321|2202754|P1|NOT COMPLETED|Overall Study||0
911345|NCT01660321|2202754|P1|COMPLETED|Overall Study||26
911346|NCT01660321|2202754|P1|STARTED|Overall Study||26
911347|NCT01660230|2202778|P12|NOT COMPLETED|Overall Study||0
911348|NCT01660230|2202779|P11|NOT COMPLETED|Overall Study||0
911349|NCT01660230|2202780|P10|NOT COMPLETED|Overall Study||0
911350|NCT01660230|2202781|P9|NOT COMPLETED|Overall Study||0
911351|NCT01660230|2202782|P8|NOT COMPLETED|Overall Study||0
911352|NCT01660230|2202783|P7|NOT COMPLETED|Overall Study||0
911353|NCT01660230|2202784|P6|NOT COMPLETED|Overall Study||0
911354|NCT01660230|2202785|P5|NOT COMPLETED|Overall Study||0
911355|NCT01660230|2202786|P4|NOT COMPLETED|Overall Study||0
911356|NCT01660230|2202787|P3|NOT COMPLETED|Overall Study||0
911357|NCT01660230|2202788|P2|NOT COMPLETED|Overall Study||0
911358|NCT01660230|2202789|P1|NOT COMPLETED|Overall Study||0
911359|NCT01660230|2202778|P12|COMPLETED|Overall Study||14
911360|NCT01660230|2202779|P11|COMPLETED|Overall Study||6
911361|NCT01660230|2202780|P10|COMPLETED|Overall Study||6
911362|NCT01660230|2202781|P9|COMPLETED|Overall Study||6
911363|NCT01660230|2202782|P8|COMPLETED|Overall Study||6
911364|NCT01660230|2202783|P7|COMPLETED|Overall Study||4
911365|NCT01660230|2202784|P6|COMPLETED|Overall Study||2
911366|NCT01660230|2202785|P5|COMPLETED|Overall Study||4
911367|NCT01660230|2202786|P4|COMPLETED|Overall Study||4
911368|NCT01660230|2202787|P3|COMPLETED|Overall Study||4
911369|NCT01660230|2202788|P2|COMPLETED|Overall Study||4
911370|NCT01660230|2202789|P1|COMPLETED|Overall Study||4
911371|NCT01660230|2202778|P12|STARTED|Overall Study||14
911372|NCT01660230|2202779|P11|STARTED|Overall Study||6
911373|NCT01660230|2202780|P10|STARTED|Overall Study||6
911374|NCT01660230|2202781|P9|STARTED|Overall Study||6
911375|NCT01660230|2202782|P8|STARTED|Overall Study||6
911376|NCT01660230|2202783|P7|STARTED|Overall Study||4
911377|NCT01660230|2202784|P6|STARTED|Overall Study||2
911378|NCT01660230|2202785|P5|STARTED|Overall Study||4
911379|NCT01660230|2202786|P4|STARTED|Overall Study||4
911380|NCT01660230|2202787|P3|STARTED|Overall Study||4
911381|NCT01660230|2202788|P2|STARTED|Overall Study||4
911382|NCT01660230|2202789|P1|STARTED|Overall Study||4
911383|NCT01660191|2202961|P3|NOT COMPLETED|End of Treatment||1
911384|NCT01660191|2202962|P2|NOT COMPLETED|End of Treatment||6
911385|NCT01660191|2202963|P1|NOT COMPLETED|End of Treatment||1
911386|NCT01660191|2202961|P3|COMPLETED|End of Treatment||43
911387|NCT01660191|2202962|P2|COMPLETED|End of Treatment||39
911388|NCT01660191|2202963|P1|COMPLETED|End of Treatment||44
911389|NCT01660191|2202961|P3|STARTED|End of Treatment||44
911390|NCT01660191|2202962|P2|STARTED|End of Treatment||45
911391|NCT01660191|2202963|P1|STARTED|End of Treatment||45
911392|NCT01660191|2202961|P3|NOT COMPLETED|Randomization||0
911393|NCT01660191|2202962|P2|NOT COMPLETED|Randomization||0
911394|NCT01660191|2202963|P1|NOT COMPLETED|Randomization||0
911395|NCT01660191|2202961|P3|COMPLETED|Randomization||44
911396|NCT01660191|2202962|P2|COMPLETED|Randomization||45
911397|NCT01660191|2202963|P1|COMPLETED|Randomization||45
911398|NCT01660191|2202961|P3|STARTED|Randomization||44
911399|NCT01660191|2202962|P2|STARTED|Randomization||45
911400|NCT01660191|2202963|P1|STARTED|Randomization||45
911401|NCT01660191|2202961|P3|NOT COMPLETED|Enrollment and Washout||0
911402|NCT01660191|2202962|P2|NOT COMPLETED|Enrollment and Washout||0
911403|NCT01660191|2202963|P1|NOT COMPLETED|Enrollment and Washout||0
911404|NCT01660191|2202961|P3|COMPLETED|Enrollment and Washout||44
911405|NCT01660191|2202962|P2|COMPLETED|Enrollment and Washout||45
911406|NCT01660191|2202963|P1|COMPLETED|Enrollment and Washout||45
911407|NCT01660191|2202961|P3|STARTED|Enrollment and Washout||44
911408|NCT01660191|2202962|P2|STARTED|Enrollment and Washout||45
911409|NCT01660191|2202963|P1|STARTED|Enrollment and Washout||45
911410|NCT01659021|2202988|P2|NOT COMPLETED|Overall Study||37
911411|NCT01659021|2202989|P1|NOT COMPLETED|Overall Study||88
911412|NCT01659021|2202988|P2|COMPLETED|Overall Study||50
911413|NCT01659021|2202989|P1|COMPLETED|Overall Study||86
911414|NCT01659021|2202988|P2|Randomized and Treated|Overall Study||86
911415|NCT01659021|2202989|P1|Randomized and Treated|Overall Study||173
911416|NCT01659021|2202988|P2|STARTED|Overall Study||87
911417|NCT01659021|2202989|P1|STARTED|Overall Study||174
911418|NCT01658943|2203007|P2|NOT COMPLETED|Overall Study||67
911419|NCT01658943|2203008|P1|NOT COMPLETED|Overall Study||70
911420|NCT01658943|2203007|P2|COMPLETED|Overall Study||0
911421|NCT01658943|2203008|P1|COMPLETED|Overall Study||0
911422|NCT01658943|2203007|P2|Eligible and Began Protocol Therapy|Overall Study||58
911423|NCT01658943|2203008|P1|Eligible and Began Protocol Therapy|Overall Study||62
911424|NCT01658943|2203007|P2|Eligible|Overall Study||58
911425|NCT01658943|2203008|P1|Eligible|Overall Study||63
911426|NCT01658943|2203007|P2|STARTED|Overall Study||67
911427|NCT01658943|2203008|P1|STARTED|Overall Study||70
911428|NCT01658904|2203023|P3|NOT COMPLETED|Overall Study||0
911429|NCT01658904|2203024|P2|NOT COMPLETED|Overall Study||0
911430|NCT01658904|2203025|P1|NOT COMPLETED|Overall Study||2
911431|NCT01658904|2203023|P3|COMPLETED|Overall Study||0
911432|NCT01658904|2203024|P2|COMPLETED|Overall Study||0
911433|NCT01658904|2203025|P1|COMPLETED|Overall Study||1
911434|NCT01658904|2203023|P3|STARTED|Overall Study||0
911435|NCT01658904|2203024|P2|STARTED|Overall Study||0
911436|NCT01658904|2203025|P1|STARTED|Overall Study||3
911437|NCT01660022|2203048|P6|NOT COMPLETED|Second Sequence (42 Days)||0
911438|NCT01660022|2203049|P5|NOT COMPLETED|Second Sequence (42 Days)||0
911439|NCT01660022|2203050|P4|NOT COMPLETED|Second Sequence (42 Days)||0
911440|NCT01660022|2203051|P3|NOT COMPLETED|Second Sequence (42 Days)||0
911441|NCT01660022|2203052|P2|NOT COMPLETED|Second Sequence (42 Days)||0
911442|NCT01660022|2203053|P1|NOT COMPLETED|Second Sequence (42 Days)||0
911443|NCT01660022|2203048|P6|COMPLETED|Second Sequence (42 Days)||16
911444|NCT01660022|2203049|P5|COMPLETED|Second Sequence (42 Days)||6
911445|NCT01660022|2203050|P4|COMPLETED|Second Sequence (42 Days)||7
911446|NCT01660022|2203051|P3|COMPLETED|Second Sequence (42 Days)||8
911447|NCT01660022|2203052|P2|COMPLETED|Second Sequence (42 Days)||7
911448|NCT01660022|2203053|P1|COMPLETED|Second Sequence (42 Days)||8
911449|NCT01660022|2203048|P6|STARTED|Second Sequence (42 Days)||16
911450|NCT01660022|2203049|P5|STARTED|Second Sequence (42 Days)||6
911451|NCT01660022|2203050|P4|STARTED|Second Sequence (42 Days)||7
911452|NCT01660022|2203051|P3|STARTED|Second Sequence (42 Days)||8
911453|NCT01660022|2203052|P2|STARTED|Second Sequence (42 Days)||7
911454|NCT01660022|2203053|P1|STARTED|Second Sequence (42 Days)||8
911455|NCT01660022|2203048|P6|NOT COMPLETED|First Sequence (7 Days)||4
911456|NCT01660022|2203049|P5|NOT COMPLETED|First Sequence (7 Days)||1
911457|NCT01660022|2203050|P4|NOT COMPLETED|First Sequence (7 Days)||1
911458|NCT01660022|2203051|P3|NOT COMPLETED|First Sequence (7 Days)||0
911459|NCT01660022|2203052|P2|NOT COMPLETED|First Sequence (7 Days)||1
911460|NCT01660022|2203053|P1|NOT COMPLETED|First Sequence (7 Days)||0
911461|NCT01660022|2203048|P6|COMPLETED|First Sequence (7 Days)||16
911462|NCT01660022|2203049|P5|COMPLETED|First Sequence (7 Days)||6
911463|NCT01660022|2203050|P4|COMPLETED|First Sequence (7 Days)||7
911464|NCT01660022|2203051|P3|COMPLETED|First Sequence (7 Days)||8
911465|NCT01660022|2203052|P2|COMPLETED|First Sequence (7 Days)||7
911466|NCT01660022|2203053|P1|COMPLETED|First Sequence (7 Days)||8
911467|NCT01660022|2203048|P6|STARTED|First Sequence (7 Days)||20
911468|NCT01660022|2203049|P5|STARTED|First Sequence (7 Days)||7
911469|NCT01660022|2203050|P4|STARTED|First Sequence (7 Days)||8
911470|NCT01660022|2203051|P3|STARTED|First Sequence (7 Days)||8
911471|NCT01660022|2203052|P2|STARTED|First Sequence (7 Days)||8
911472|NCT01660022|2203053|P1|STARTED|First Sequence (7 Days)||8
911473|NCT01659996|2203112|P3|NOT COMPLETED|Overall Study||11
911474|NCT01659996|2203113|P2|NOT COMPLETED|Overall Study||7
911475|NCT01659996|2203114|P1|NOT COMPLETED|Overall Study||8
911476|NCT01659996|2203112|P3|COMPLETED|Overall Study||461
911477|NCT01659996|2203113|P2|COMPLETED|Overall Study||388
911478|NCT01659996|2203114|P1|COMPLETED|Overall Study||413
911479|NCT01659996|2203112|P3|STARTED|Overall Study||472
911480|NCT01659996|2203113|P2|STARTED|Overall Study||395
911481|NCT01659996|2203114|P1|STARTED|Overall Study||421
911482|NCT01659853|2203146|P2|NOT COMPLETED|Treatment Period 2||0
911483|NCT01659853|2203147|P1|NOT COMPLETED|Treatment Period 2||0
911484|NCT01659853|2203146|P2|COMPLETED|Treatment Period 2||35
911485|NCT01659853|2203147|P1|COMPLETED|Treatment Period 2||33
911486|NCT01659853|2203146|P2|STARTED|Treatment Period 2||35
911487|NCT01659853|2203147|P1|STARTED|Treatment Period 2||33
911488|NCT01659853|2203146|P2|NOT COMPLETED|Washout , 3 to 7 Days||0
911489|NCT01659853|2203147|P1|NOT COMPLETED|Washout , 3 to 7 Days||2
911490|NCT01659853|2203146|P2|COMPLETED|Washout , 3 to 7 Days||35
911491|NCT01659853|2203147|P1|COMPLETED|Washout , 3 to 7 Days||33
911492|NCT01659853|2203146|P2|STARTED|Washout , 3 to 7 Days||35
911493|NCT01659853|2203147|P1|STARTED|Washout , 3 to 7 Days||35
911494|NCT01659853|2203146|P2|NOT COMPLETED|Treatment Period 1||0
911495|NCT01659853|2203147|P1|NOT COMPLETED|Treatment Period 1||0
911496|NCT01659853|2203146|P2|COMPLETED|Treatment Period 1||35
911497|NCT01659853|2203147|P1|COMPLETED|Treatment Period 1||35
911498|NCT01659853|2203146|P2|STARTED|Treatment Period 1||35
911499|NCT01659853|2203147|P1|STARTED|Treatment Period 1||35
911500|NCT01659736|2203157|P2|NOT COMPLETED|3-month Follow-up||1
911501|NCT01659736|2203158|P1|NOT COMPLETED|3-month Follow-up||0
911502|NCT01659736|2203157|P2|COMPLETED|3-month Follow-up||9
911503|NCT01659736|2203158|P1|COMPLETED|3-month Follow-up||9
911504|NCT01659736|2203157|P2|STARTED|3-month Follow-up||10
911505|NCT01659736|2203158|P1|STARTED|3-month Follow-up||9
911506|NCT01659736|2203157|P2|NOT COMPLETED|Treatment Period||2
911507|NCT01659736|2203158|P1|NOT COMPLETED|Treatment Period||5
911508|NCT01659736|2203157|P2|COMPLETED|Treatment Period||10
911509|NCT01659736|2203158|P1|COMPLETED|Treatment Period|n = 10, but data from one completer was excluded from all analyses due to protocol violation.|9
911510|NCT01659736|2203157|P2|STARTED|Treatment Period||12
911511|NCT01659736|2203158|P1|STARTED|Treatment Period||14
911512|NCT01659567|2203172|P1|NOT COMPLETED|Overall Study||123
911513|NCT01659567|2203172|P1|COMPLETED|Overall Study||393
911514|NCT01659567|2203172|P1|STARTED|Overall Study||516
911515|NCT01659554|2203189|P1|NOT COMPLETED|Overall Study||4
911516|NCT01659554|2203189|P1|COMPLETED|Overall Study||0
911517|NCT01659554|2203189|P1|STARTED|Overall Study|4 subjects enrolled; 4 subjects treated and 4 did not complete protocol schema|4
911518|NCT01659320|2203196|P1|NOT COMPLETED|Overall Study||3
911519|NCT01659320|2203196|P1|COMPLETED|Overall Study||13
911520|NCT01659320|2203196|P1|STARTED|Overall Study||16
911521|NCT01659268|2203202|P2|NOT COMPLETED|Overall Study||0
911522|NCT01659268|2203203|P1|NOT COMPLETED|Overall Study||0
911523|NCT01659268|2203202|P2|COMPLETED|Overall Study||8
911524|NCT01659268|2203203|P1|COMPLETED|Overall Study||9
911525|NCT01659268|2203202|P2|STARTED|Overall Study||8
911526|NCT01659268|2203203|P1|STARTED|Overall Study||9
911527|NCT01659125|2203215|P1|NOT COMPLETED|Overall Study||14
911528|NCT01659125|2203215|P1|COMPLETED|Overall Study||12
911529|NCT01659125|2203215|P1|Completed 6-month Follow-up|Overall Study||12
911530|NCT01659125|2203215|P1|Completed 3-month Follow-up|Overall Study||16
911531|NCT01659125|2203215|P1|Completed the Posttreatment Assessment|Overall Study||17
911532|NCT01659125|2203215|P1|Initiated Treatment|Overall Study||24
911533|NCT01659125|2203215|P1|STARTED|Overall Study||26
911534|NCT01658839|2203220|P1|NOT COMPLETED|Overall Study||0
911535|NCT01658839|2203220|P1|COMPLETED|Overall Study||25
911536|NCT01658839|2203220|P1|STARTED|Overall Study||25
911542|NCT01658735|2203240|P3|NOT COMPLETED|Overall Study||4
911543|NCT01658735|2203241|P2|NOT COMPLETED|Overall Study||7
911544|NCT01658735|2203242|P1|NOT COMPLETED|Overall Study||5
911545|NCT01658735|2203240|P3|COMPLETED|Overall Study||34
911546|NCT01658735|2203241|P2|COMPLETED|Overall Study||29
911547|NCT01658735|2203242|P1|COMPLETED|Overall Study||34
911548|NCT01658735|2203240|P3|STARTED|Overall Study||38
911549|NCT01658735|2203241|P2|STARTED|Overall Study||36
911550|NCT01658735|2203242|P1|STARTED|Overall Study||39
911551|NCT01658657|2203273|P2|NOT COMPLETED|Overall Study||3
911552|NCT01658657|2203274|P1|NOT COMPLETED|Overall Study||3
911553|NCT01658657|2203273|P2|COMPLETED|Overall Study||7
911554|NCT01658657|2203274|P1|COMPLETED|Overall Study||4
911555|NCT01658657|2203273|P2|STARTED|Overall Study||10
911556|NCT01658657|2203274|P1|STARTED|Overall Study||7
911557|NCT01658579|2203284|P4|NOT COMPLETED|Treatment Period B||1
911558|NCT01658579|2203285|P3|NOT COMPLETED|Treatment Period B||0
911559|NCT01658579|2203286|P2|NOT COMPLETED|Treatment Period B||0
911560|NCT01658579|2203287|P1|NOT COMPLETED|Treatment Period B||0
911561|NCT01658579|2203284|P4|COMPLETED|Treatment Period B||12
911562|NCT01658579|2203285|P3|COMPLETED|Treatment Period B||14
911563|NCT01658579|2203286|P2|COMPLETED|Treatment Period B||15
911564|NCT01658579|2203287|P1|COMPLETED|Treatment Period B||14
911565|NCT01658579|2203284|P4|STARTED|Treatment Period B||13
911566|NCT01658579|2203285|P3|STARTED|Treatment Period B||14
911567|NCT01658579|2203286|P2|STARTED|Treatment Period B||15
911568|NCT01658579|2203287|P1|STARTED|Treatment Period B||14
911569|NCT01658579|2203284|P4|NOT COMPLETED|Treatment Period A||1
911570|NCT01658579|2203285|P3|NOT COMPLETED|Treatment Period A||1
911571|NCT01658579|2203286|P2|NOT COMPLETED|Treatment Period A||0
911572|NCT01658579|2203287|P1|NOT COMPLETED|Treatment Period A||1
911573|NCT01658579|2203284|P4|COMPLETED|Treatment Period A||13
911574|NCT01658579|2203285|P3|COMPLETED|Treatment Period A||14
911575|NCT01658579|2203286|P2|COMPLETED|Treatment Period A||15
911576|NCT01658579|2203287|P1|COMPLETED|Treatment Period A||14
911577|NCT01658579|2203284|P4|STARTED|Treatment Period A||14
911578|NCT01658579|2203285|P3|STARTED|Treatment Period A||15
911579|NCT01658579|2203286|P2|STARTED|Treatment Period A||15
911580|NCT01658579|2203287|P1|STARTED|Treatment Period A||15
911581|NCT01658514|2203315|P3|NOT COMPLETED|Overall Study||2
911582|NCT01658514|2203316|P2|NOT COMPLETED|Overall Study||0
911583|NCT01658514|2203317|P1|NOT COMPLETED|Overall Study||1
911584|NCT01658514|2203315|P3|COMPLETED|Overall Study||12
911585|NCT01658514|2203316|P2|COMPLETED|Overall Study||11
911586|NCT01658514|2203317|P1|COMPLETED|Overall Study||13
911587|NCT01658514|2203315|P3|Completed - Severe RI Cohort Only|Overall Study||3
911588|NCT01658514|2203316|P2|Completed - Severe RI Cohort Only|Overall Study||2
911589|NCT01658514|2203317|P1|Completed - Severe RI Cohort Only|Overall Study||3
911590|NCT01658514|2203315|P3|Started - Severe RI Cohort Only|Overall Study||3
911591|NCT01658514|2203316|P2|Started - Severe RI Cohort Only|Overall Study||2
911592|NCT01658514|2203317|P1|Started - Severe RI Cohort Only|Overall Study||3
911593|NCT01658514|2203315|P3|Completed - Moderate RI Cohort Only|Overall Study||2
911594|NCT01658514|2203316|P2|Completed - Moderate RI Cohort Only|Overall Study||4
911595|NCT01658514|2203317|P1|Completed - Moderate RI Cohort Only|Overall Study||3
911596|NCT01658514|2203315|P3|Started - Moderate RI Cohort Only|Overall Study||4
911597|NCT01658514|2203316|P2|Started - Moderate RI Cohort Only|Overall Study||4
911598|NCT01658514|2203317|P1|Started - Moderate RI Cohort Only|Overall Study||4
911599|NCT01658514|2203315|P3|Completed - Mild RI Cohort Only|Overall Study||4
911600|NCT01658514|2203316|P2|Completed - Mild RI Cohort Only|Overall Study||3
911601|NCT01658514|2203317|P1|Completed - Mild RI Cohort Only|Overall Study||4
911602|NCT01658514|2203315|P3|Started - Mild RI Cohort Only|Overall Study||4
911603|NCT01658514|2203316|P2|Started - Mild RI Cohort Only|Overall Study||3
911604|NCT01658514|2203317|P1|Started - Mild RI Cohort Only|Overall Study||4
911605|NCT01658514|2203315|P3|Completed - Normal RF Cohort Only|Overall Study||3
911606|NCT01658514|2203316|P2|Completed - Normal RF Cohort Only|Overall Study||2
911607|NCT01658514|2203317|P1|Completed - Normal RF Cohort Only|Overall Study||3
911608|NCT01658514|2203315|P3|Started - Normal RF Cohort Only|Overall Study||3
911609|NCT01658514|2203316|P2|Started - Normal RF Cohort Only|Overall Study||2
911610|NCT01658514|2203317|P1|Started - Normal RF Cohort Only|Overall Study||3
911611|NCT01658514|2203315|P3|Completed Treatment C|Overall Study||12
911612|NCT01658514|2203316|P2|Completed Treatment C|Overall Study||11
911613|NCT01658514|2203317|P1|Completed Treatment C|Overall Study||13
911614|NCT01658514|2203315|P3|Completed Treatment B|Overall Study||14
911615|NCT01658514|2203316|P2|Completed Treatment B|Overall Study||11
911616|NCT01658514|2203317|P1|Completed Treatment B|Overall Study||13
911617|NCT01658514|2203315|P3|Completed Treatment A|Overall Study||12
911618|NCT01658514|2203316|P2|Completed Treatment A|Overall Study||11
911619|NCT01658514|2203317|P1|Completed Treatment A|Overall Study||14
911620|NCT01658514|2203315|P3|STARTED|Overall Study||14
911621|NCT01658514|2203316|P2|STARTED|Overall Study||11
911622|NCT01658514|2203317|P1|STARTED|Overall Study||14
911623|NCT01658436|2203328|P2|NOT COMPLETED|Overall Study||11
911624|NCT01658436|2203329|P1|NOT COMPLETED|Overall Study||20
911625|NCT01658436|2203328|P2|COMPLETED|Overall Study||0
911626|NCT01658436|2203329|P1|COMPLETED|Overall Study||0
911627|NCT01658436|2203328|P2|STARTED|Overall Study||11
911628|NCT01658436|2203329|P1|STARTED|Overall Study||20
911629|NCT01658072|2203338|P2|NOT COMPLETED|Overall Study||2
911630|NCT01658072|2203339|P1|NOT COMPLETED|Overall Study||4
911631|NCT01658072|2203338|P2|COMPLETED|Overall Study||43
911632|NCT01658072|2203339|P1|COMPLETED|Overall Study||41
911633|NCT01658072|2203338|P2|STARTED|Overall Study||45
911634|NCT01658072|2203339|P1|STARTED|Overall Study||45
911635|NCT01658020|2203347|P2|NOT COMPLETED|Overall Study||9
911636|NCT01658020|2203348|P1|NOT COMPLETED|Overall Study||8
911637|NCT01658020|2203347|P2|COMPLETED|Overall Study||158
911638|NCT01658020|2203348|P1|COMPLETED|Overall Study||167
911639|NCT01658020|2203347|P2|STARTED|Overall Study||167
911640|NCT01658020|2203348|P1|STARTED|Overall Study||175
911641|NCT01657903|2203364|P1|NOT COMPLETED|Overall Study||2
911642|NCT01657903|2203364|P1|COMPLETED|Overall Study||54
911643|NCT01657903|2203364|P1|Received NaF/KNO3 Toothpaste 2|Overall Study||55
911644|NCT01657903|2203364|P1|Received NaF/KNO3 Toothpaste 3|Overall Study||54
911645|NCT01657903|2203364|P1|Received NaF/KNO3 Toothpaste 1|Overall Study|One participant withdrew consent in study period 3|55
911646|NCT01657903|2203364|P1|Received Placebo (No NaF/KNO3)Toothpaste|Overall Study|One participant was lost to follow up in study period 1|56
911647|NCT01657903|2203364|P1|STARTED|Overall Study||56
911648|NCT01657877|2203386|P1|NOT COMPLETED|Overall Study||14
911649|NCT01657877|2203386|P1|COMPLETED|Overall Study||65
911650|NCT01657877|2203386|P1|Received 1500ppm Fluoride as SMFP+0% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and 1 withdrawal of consent and AE in P3|71
911651|NCT01657877|2203386|P1|Received 0ppm Fluoride+ 0% CSP|Overall Study|Discontinuation: 1 in P4 due to other reasons|69
911652|NCT01657877|2203386|P1|Received 0ppm Fluoride+ 5% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and P2 each and 1 withdrawal of consent in P1.|71
911653|NCT01657877|2203386|P1|Received 1500ppm Fluoride as SMFP+5% CSP|Overall Study|Discontinuations:2 withdrawal of consent in period (P) 1; 1 AE in P2;1 protocol violation in P3 & P4|75
911654|NCT01657877|2203386|P1|Received 500ppm Fluoride as SMFP+ 0% CSP|Overall Study|Discontinuations: 1 due to other reason in P2 and 1 protocol violation in P4|70
911655|NCT01657877|2203386|P1|STARTED|Overall Study||79
911656|NCT01657461|2203405|P2|NOT COMPLETED|Overall Study||20
911657|NCT01657461|2203406|P1|NOT COMPLETED|Overall Study||10
911658|NCT01657461|2203405|P2|COMPLETED|Overall Study||78
911659|NCT01657461|2203406|P1|COMPLETED|Overall Study||88
911660|NCT01657461|2203405|P2|STARTED|Overall Study||98
911661|NCT01657461|2203406|P1|STARTED|Overall Study||98
911662|NCT01657370|2203436|P6|NOT COMPLETED|Overall Study||4
911663|NCT01657370|2203437|P5|NOT COMPLETED|Overall Study||7
911664|NCT01657370|2203438|P4|NOT COMPLETED|Overall Study||5
911665|NCT01657370|2203439|P3|NOT COMPLETED|Overall Study||7
911666|NCT01657370|2203440|P2|NOT COMPLETED|Overall Study||4
911667|NCT01657370|2203441|P1|NOT COMPLETED|Overall Study||6
911668|NCT01657370|2203436|P6|COMPLETED|Overall Study||27
911669|NCT01657370|2203437|P5|COMPLETED|Overall Study||27
911670|NCT01657370|2203438|P4|COMPLETED|Overall Study||28
911671|NCT01657370|2203439|P3|COMPLETED|Overall Study||25
911672|NCT01657370|2203440|P2|COMPLETED|Overall Study||28
911673|NCT01657370|2203441|P1|COMPLETED|Overall Study||27
911674|NCT01657370|2203436|P6|STARTED|Overall Study||31
911675|NCT01657370|2203437|P5|STARTED|Overall Study||34
911676|NCT01657370|2203438|P4|STARTED|Overall Study||33
911677|NCT01657370|2203439|P3|STARTED|Overall Study||32
911678|NCT01657370|2203440|P2|STARTED|Overall Study||32
911679|NCT01657370|2203441|P1|STARTED|Overall Study||33
911680|NCT01657292|2203523|P1|NOT COMPLETED|Overall Study||10
911681|NCT01657292|2203523|P1|COMPLETED|Overall Study||51
911682|NCT01657292|2203523|P1|STARTED|Overall Study||61
911683|NCT01657032|2203532|P2|NOT COMPLETED|Overall Study||7
911684|NCT01657032|2203533|P1|NOT COMPLETED|Overall Study||0
911685|NCT01657032|2203532|P2|COMPLETED|Overall Study||37
911686|NCT01657032|2203533|P1|COMPLETED|Overall Study||44
911687|NCT01657032|2203532|P2|STARTED|Overall Study||44
911688|NCT01657032|2203533|P1|STARTED|Overall Study||44
911689|NCT01657019|2203559|P1|NOT COMPLETED|Overall Study||235
911690|NCT01657019|2203559|P1|COMPLETED|Overall Study||369
911691|NCT01657019|2203559|P1|STARTED|Overall Study||604
911692|NCT01656967|2203573|P2|NOT COMPLETED|Overall Study||2
911693|NCT01656967|2203574|P1|NOT COMPLETED|Overall Study||4
911694|NCT01656967|2203573|P2|COMPLETED|Overall Study||31
911695|NCT01656967|2203574|P1|COMPLETED|Overall Study||29
911696|NCT01656967|2203573|P2|ETT Insertion|Overall Study||31
911697|NCT01656967|2203574|P1|ETT Insertion|Overall Study||29
911698|NCT01656967|2203573|P2|SGA Placement|Overall Study||33
911699|NCT01656967|2203574|P1|SGA Placement|Overall Study||32
911700|NCT01656967|2203573|P2|STARTED|Overall Study||33
911701|NCT01656967|2203574|P1|STARTED|Overall Study||33
911702|NCT01656889|2203596|P2|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||9
911703|NCT01656889|2203597|P1|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||4
911704|NCT01656889|2203596|P2|COMPLETED|Post Treatment Follow-Up, 3 Months||204
911705|NCT01656889|2203597|P1|COMPLETED|Post Treatment Follow-Up, 3 Months||206
911706|NCT01656889|2203596|P2|STARTED|Post Treatment Follow-Up, 3 Months||213
911707|NCT01656889|2203597|P1|STARTED|Post Treatment Follow-Up, 3 Months||210
911708|NCT01656889|2203596|P2|NOT COMPLETED|Treatment Period, 12 Weeks||11
911709|NCT01656889|2203597|P1|NOT COMPLETED|Treatment Period, 12 Weeks||12
911710|NCT01656889|2203596|P2|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|214
911711|NCT01656889|2203597|P1|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|210
911712|NCT01656889|2203596|P2|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|225
911713|NCT01656889|2203597|P1|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|222
911714|NCT01656850|2203617|P2|NOT COMPLETED|Second Intervention (3 Months)||0
911715|NCT01656850|2203618|P1|NOT COMPLETED|Second Intervention (3 Months)||0
911716|NCT01656850|2203617|P2|COMPLETED|Second Intervention (3 Months)||16
911717|NCT01656850|2203618|P1|COMPLETED|Second Intervention (3 Months)||17
911718|NCT01656850|2203617|P2|STARTED|Second Intervention (3 Months)||16
911719|NCT01656850|2203618|P1|STARTED|Second Intervention (3 Months)||17
911720|NCT01656850|2203617|P2|NOT COMPLETED|Washout (2 Weeks)||0
911721|NCT01656850|2203618|P1|NOT COMPLETED|Washout (2 Weeks)||0
911722|NCT01656850|2203617|P2|COMPLETED|Washout (2 Weeks)||16
911723|NCT01656850|2203618|P1|COMPLETED|Washout (2 Weeks)||17
911724|NCT01656850|2203617|P2|STARTED|Washout (2 Weeks)||16
911725|NCT01656850|2203618|P1|STARTED|Washout (2 Weeks)||17
911726|NCT01656850|2203617|P2|NOT COMPLETED|First Intervention (3 Months)||4
911727|NCT01656850|2203618|P1|NOT COMPLETED|First Intervention (3 Months)||3
911728|NCT01656850|2203617|P2|COMPLETED|First Intervention (3 Months)||16
911729|NCT01656850|2203618|P1|COMPLETED|First Intervention (3 Months)||17
911730|NCT01656850|2203617|P2|STARTED|First Intervention (3 Months)||20
911731|NCT01656850|2203618|P1|STARTED|First Intervention (3 Months)||20
911732|NCT01656772|2203698|P2|NOT COMPLETED|Overall Study||0
911733|NCT01656772|2203699|P1|NOT COMPLETED|Overall Study||0
911734|NCT01656772|2203698|P2|COMPLETED|Overall Study||77
911735|NCT01656772|2203699|P1|COMPLETED|Overall Study||43
911736|NCT01656772|2203698|P2|STARTED|Overall Study||77
911737|NCT01656772|2203699|P1|STARTED|Overall Study||43
911738|NCT01656759|2203709|P2|NOT COMPLETED|Overall Study||3
911739|NCT01656759|2203710|P1|NOT COMPLETED|Overall Study||2
911740|NCT01656759|2203709|P2|COMPLETED|Overall Study||22
911741|NCT01656759|2203710|P1|COMPLETED|Overall Study||25
911742|NCT01656759|2203709|P2|STARTED|Overall Study||25
911743|NCT01656759|2203710|P1|STARTED|Overall Study||27
911744|NCT01656486|2203722|P1|NOT COMPLETED|Overall Study||0
911745|NCT01656486|2203722|P1|COMPLETED|Overall Study||1
911746|NCT01656486|2203722|P1|STARTED|Overall Study||1
911747|NCT01656460|2203726|P4|NOT COMPLETED|Overall Study||0
911748|NCT01656460|2203727|P3|NOT COMPLETED|Overall Study||0
911749|NCT01656460|2203728|P2|NOT COMPLETED|Overall Study||0
911750|NCT01656460|2203729|P1|NOT COMPLETED|Overall Study||0
911751|NCT01656460|2203726|P4|COMPLETED|Overall Study||3
911752|NCT01656460|2203727|P3|COMPLETED|Overall Study||3
911753|NCT01656460|2203728|P2|COMPLETED|Overall Study||3
911754|NCT01656460|2203729|P1|COMPLETED|Overall Study||3
911755|NCT01656460|2203726|P4|STARTED|Overall Study||3
911756|NCT01656460|2203727|P3|STARTED|Overall Study||3
911757|NCT01656460|2203728|P2|STARTED|Overall Study||3
911758|NCT01656460|2203729|P1|STARTED|Overall Study||3
911759|NCT01656434|2203741|P2|NOT COMPLETED|Overall Study||580
911760|NCT01656434|2203742|P1|NOT COMPLETED|Overall Study||2401
911761|NCT01656434|2203741|P2|COMPLETED|Overall Study||40
911762|NCT01656434|2203742|P1|COMPLETED|Overall Study||152
911763|NCT01656434|2203741|P2|Treated|Overall Study||604
911764|NCT01656434|2203742|P1|Treated|Overall Study|One treated participant had incomplete data and was not included in the Safety Analyses.|2466
911765|NCT01656434|2203741|P2|STARTED|Overall Study||620
911766|NCT01656434|2203742|P1|STARTED|Overall Study||2553
911767|NCT01656408|2203768|P10|NOT COMPLETED|Overall Study||3
911768|NCT01656408|2203769|P9|NOT COMPLETED|Overall Study||2
911769|NCT01656408|2203770|P8|NOT COMPLETED|Overall Study||1
911770|NCT01656408|2203771|P7|NOT COMPLETED|Overall Study||1
911771|NCT01656408|2203772|P6|NOT COMPLETED|Overall Study||2
911772|NCT01656408|2203773|P5|NOT COMPLETED|Overall Study||1
911773|NCT01656408|2203774|P4|NOT COMPLETED|Overall Study||0
911774|NCT01656408|2203775|P3|NOT COMPLETED|Overall Study||2
911775|NCT01656408|2203776|P2|NOT COMPLETED|Overall Study||0
911776|NCT01656408|2203777|P1|NOT COMPLETED|Overall Study||1
911777|NCT01656408|2203768|P10|COMPLETED|Overall Study||15
911778|NCT01656408|2203769|P9|COMPLETED|Overall Study||16
911779|NCT01656408|2203770|P8|COMPLETED|Overall Study||7
911780|NCT01656408|2203771|P7|COMPLETED|Overall Study||9
911781|NCT01656408|2203772|P6|COMPLETED|Overall Study||7
911782|NCT01656408|2203773|P5|COMPLETED|Overall Study||8
911783|NCT01656408|2203774|P4|COMPLETED|Overall Study||7
911784|NCT01656408|2203775|P3|COMPLETED|Overall Study||6
911785|NCT01656408|2203776|P2|COMPLETED|Overall Study||8
911786|NCT01656408|2203777|P1|COMPLETED|Overall Study||7
911787|NCT01656408|2203768|P10|STARTED|Overall Study||18
911788|NCT01656408|2203769|P9|STARTED|Overall Study||18
911789|NCT01656408|2203770|P8|STARTED|Overall Study||8
911790|NCT01656408|2203771|P7|STARTED|Overall Study||10
911791|NCT01656408|2203772|P6|STARTED|Overall Study||9
911792|NCT01656408|2203773|P5|STARTED|Overall Study||9
911793|NCT01656408|2203774|P4|STARTED|Overall Study||7
911794|NCT01656408|2203775|P3|STARTED|Overall Study||8
911795|NCT01656408|2203776|P2|STARTED|Overall Study||8
911796|NCT01656408|2203777|P1|STARTED|Overall Study||8
911797|NCT01656304|2203966|P1|NOT COMPLETED|Overall Study||1
911798|NCT01656304|2203966|P1|COMPLETED|Overall Study||15
911799|NCT01656304|2203966|P1|STARTED|Overall Study||16
911800|NCT01656252|2203972|P1|NOT COMPLETED|Phase II||0
911801|NCT01656252|2203972|P1|COMPLETED|Phase II||0
911802|NCT01656252|2203972|P1|STARTED|Phase II||0
911803|NCT01656252|2203972|P1|NOT COMPLETED|Phase I||0
911804|NCT01656252|2203972|P1|COMPLETED|Phase I||14
911805|NCT01656252|2203972|P1|STARTED|Phase I||14
911806|NCT01656161|2204004|P1|NOT COMPLETED|Overall Study||7
911807|NCT01656161|2204004|P1|COMPLETED|Overall Study|Per protocol analysis set|113
911808|NCT01656161|2204004|P1|Received Triptorelin at Day 169|Overall Study||115
911809|NCT01656161|2204004|P1|Received Triptorelin at Day 1|Overall Study|Safety analysis set|120
911810|NCT01656161|2204004|P1|STARTED|Overall Study|Intention to treat analysis set|120
911811|NCT01656031|2204018|P1|NOT COMPLETED|Overall Study||0
911812|NCT01656031|2204018|P1|COMPLETED|Overall Study||39
911813|NCT01656031|2204018|P1|STARTED|Overall Study||39
911814|NCT01655498|2204022|P1|NOT COMPLETED|Overall Study||5
911815|NCT01655498|2204022|P1|COMPLETED|Overall Study||56
911816|NCT01655498|2204022|P1|STARTED|Overall Study||61
911817|NCT01655381|2204029|P1|NOT COMPLETED|Overall Study||3
911818|NCT01655381|2204029|P1|COMPLETED|Overall Study||12
911819|NCT01655381|2204029|P1|STARTED|Overall Study||15
911820|NCT01655329|2204049|P1|NOT COMPLETED|Overall Study||0
911821|NCT01655329|2204049|P1|COMPLETED|Overall Study||10
911822|NCT01655329|2204049|P1|STARTED|Overall Study|The same 10 radiologists are interpreting images in both arms.|10
911823|NCT01655043|2204065|P1|NOT COMPLETED|Overall Study||0
911824|NCT01655043|2204065|P1|COMPLETED|Overall Study||20
911825|NCT01655043|2204065|P1|STARTED|Overall Study||20
911826|NCT01654887|2204071|P2|NOT COMPLETED|Overall Study||0
911827|NCT01654887|2204072|P1|NOT COMPLETED|Overall Study||0
911828|NCT01654887|2204071|P2|COMPLETED|Overall Study||88
911829|NCT01654887|2204072|P1|COMPLETED|Overall Study||103
911830|NCT01654887|2204071|P2|STARTED|Overall Study||88
911831|NCT01654887|2204072|P1|STARTED|Overall Study||103
911832|NCT01654861|2204088|P1|NOT COMPLETED|Overall Study||0
911833|NCT01654861|2204088|P1|COMPLETED|Overall Study||3
911834|NCT01654861|2204088|P1|STARTED|Overall Study||3
911835|NCT01654796|2204096|P3|NOT COMPLETED|Overall Study||1
911836|NCT01654796|2204097|P2|NOT COMPLETED|Overall Study||3
911837|NCT01654796|2204098|P1|NOT COMPLETED|Overall Study||1
911838|NCT01654796|2204096|P3|COMPLETED|Overall Study||28
911839|NCT01654796|2204097|P2|COMPLETED|Overall Study||26
911840|NCT01654796|2204098|P1|COMPLETED|Overall Study||25
911841|NCT01654796|2204096|P3|STARTED|Overall Study||29
911842|NCT01654796|2204097|P2|STARTED|Overall Study||29
911843|NCT01654796|2204098|P1|STARTED|Overall Study||26
911844|NCT01654666|2204110|P3|NOT COMPLETED|Overall Study||14
911845|NCT01654666|2204111|P2|NOT COMPLETED|Overall Study||13
911846|NCT01654666|2204112|P1|NOT COMPLETED|Overall Study||15
911847|NCT01654666|2204110|P3|COMPLETED|Overall Study||49
911848|NCT01654666|2204111|P2|COMPLETED|Overall Study||50
911849|NCT01654666|2204112|P1|COMPLETED|Overall Study||48
911850|NCT01654666|2204110|P3|Primary Analysis|Overall Study||54
911851|NCT01654666|2204111|P2|Primary Analysis|Overall Study||56
911852|NCT01654666|2204112|P1|Primary Analysis|Overall Study||52
911853|NCT01654666|2204110|P3|STARTED|Overall Study||63
911854|NCT01654666|2204111|P2|STARTED|Overall Study||63
911855|NCT01654666|2204112|P1|STARTED|Overall Study||63
911856|NCT01654601|2204137|P2|NOT COMPLETED|2nd Administration||1
911857|NCT01654601|2204138|P1|NOT COMPLETED|2nd Administration||1
911858|NCT01654601|2204137|P2|COMPLETED|2nd Administration||11
911859|NCT01654601|2204138|P1|COMPLETED|2nd Administration||11
911860|NCT01654601|2204137|P2|STARTED|2nd Administration||12
911861|NCT01654601|2204138|P1|STARTED|2nd Administration||12
911862|NCT01654601|2204137|P2|NOT COMPLETED|1st Administration||2
911863|NCT01654601|2204138|P1|NOT COMPLETED|1st Administration||2
911864|NCT01654601|2204137|P2|COMPLETED|1st Administration||12
911865|NCT01654601|2204138|P1|COMPLETED|1st Administration||12
911866|NCT01654601|2204137|P2|STARTED|1st Administration||14
911867|NCT01654601|2204138|P1|STARTED|1st Administration||14
911868|NCT01654549|2204152|P2|NOT COMPLETED|Overall Study||1
911869|NCT01654549|2204153|P1|NOT COMPLETED|Overall Study||0
911870|NCT01654549|2204152|P2|COMPLETED|Overall Study||19
911871|NCT01654549|2204153|P1|COMPLETED|Overall Study||20
911872|NCT01654549|2204152|P2|STARTED|Overall Study||20
911873|NCT01654549|2204153|P1|STARTED|Overall Study||20
911874|NCT01654536|2204165|P2|NOT COMPLETED|Overall Study||38
911875|NCT01654536|2204166|P1|NOT COMPLETED|Overall Study||44
911876|NCT01654536|2204165|P2|COMPLETED|Overall Study||331
911877|NCT01654536|2204166|P1|COMPLETED|Overall Study||324
911878|NCT01654536|2204165|P2|STARTED|Overall Study||369
911879|NCT01654536|2204166|P1|STARTED|Overall Study||368
911880|NCT01654523|2204202|P1|NOT COMPLETED|Overall Study||1
911881|NCT01654523|2204202|P1|COMPLETED|Overall Study||19
911882|NCT01654523|2204202|P1|STARTED|Overall Study||20
911883|NCT01654302|2204208|P2|NOT COMPLETED|Second Intervention (Day 7)||1
911884|NCT01654302|2204209|P1|NOT COMPLETED|Second Intervention (Day 7)||1
911885|NCT01654302|2204208|P2|COMPLETED|Second Intervention (Day 7)||19
911886|NCT01654302|2204209|P1|COMPLETED|Second Intervention (Day 7)||19
911887|NCT01654302|2204208|P2|STARTED|Second Intervention (Day 7)||20
911888|NCT01654302|2204209|P1|STARTED|Second Intervention (Day 7)||20
911889|NCT01654302|2204208|P2|NOT COMPLETED|First Intervention (Day 1)||0
911890|NCT01654302|2204209|P1|NOT COMPLETED|First Intervention (Day 1)||0
911891|NCT01654302|2204208|P2|COMPLETED|First Intervention (Day 1)||20
911892|NCT01654302|2204209|P1|COMPLETED|First Intervention (Day 1)||20
911893|NCT01654302|2204208|P2|STARTED|First Intervention (Day 1)||20
911894|NCT01654302|2204209|P1|STARTED|First Intervention (Day 1)||20
911895|NCT01654276|2204215|P1|NOT COMPLETED|Overall Study||6
911896|NCT01654276|2204215|P1|COMPLETED|Overall Study||18
911897|NCT01654276|2204215|P1|Visit 4 (6months)|Overall Study||18
911898|NCT01654276|2204215|P1|Visit 3 (4 Months)|Overall Study||18
911899|NCT01654276|2204215|P1|Visit 2 (2 Months)|Overall Study||19
911900|NCT01654276|2204215|P1|STARTED|Overall Study||24
911901|NCT01654263|2204239|P6|NOT COMPLETED|Overall Study||1
911902|NCT01654263|2204240|P5|NOT COMPLETED|Overall Study||1
911903|NCT01654263|2204241|P4|NOT COMPLETED|Overall Study||1
911904|NCT01654263|2204242|P3|NOT COMPLETED|Overall Study||2
911905|NCT01654263|2204243|P2|NOT COMPLETED|Overall Study||0
911906|NCT01654263|2204244|P1|NOT COMPLETED|Overall Study||0
911907|NCT01654263|2204239|P6|COMPLETED|Overall Study||148
911908|NCT01654263|2204240|P5|COMPLETED|Overall Study||139
911909|NCT01654263|2204241|P4|COMPLETED|Overall Study||144
911910|NCT01654263|2204242|P3|COMPLETED|Overall Study||137
911911|NCT01654263|2204243|P2|COMPLETED|Overall Study||147
911912|NCT01654263|2204244|P1|COMPLETED|Overall Study||164
911913|NCT01654263|2204239|P6|STARTED|Overall Study||149
911914|NCT01654263|2204240|P5|STARTED|Overall Study||140
911915|NCT01654263|2204241|P4|STARTED|Overall Study||145
911916|NCT01654263|2204242|P3|STARTED|Overall Study||139
911917|NCT01654263|2204243|P2|STARTED|Overall Study||147
911918|NCT01654263|2204244|P1|STARTED|Overall Study||164
911919|NCT01654250|2204269|P2|NOT COMPLETED|Overall Study||0
911920|NCT01654250|2204270|P1|NOT COMPLETED|Overall Study||1
911921|NCT01654250|2204269|P2|COMPLETED|Overall Study||42
911922|NCT01654250|2204270|P1|COMPLETED|Overall Study||43
911923|NCT01654250|2204269|P2|STARTED|Overall Study||42
911924|NCT01654250|2204270|P1|STARTED|Overall Study||44
911925|NCT01654224|2204287|P2|NOT COMPLETED|Overall Study||12
911926|NCT01654224|2204288|P1|NOT COMPLETED|Overall Study||6
911927|NCT01654224|2204287|P2|COMPLETED|Overall Study||98
911928|NCT01654224|2204288|P1|COMPLETED|Overall Study||89
911929|NCT01654224|2204287|P2|STARTED|Overall Study||110
911930|NCT01654224|2204288|P1|STARTED|Overall Study||95
911931|NCT01654107|2204300|P2|NOT COMPLETED|Overall Study||8
911932|NCT01654107|2204301|P1|NOT COMPLETED|Overall Study||3
911933|NCT01654107|2204300|P2|COMPLETED|Overall Study||22
911934|NCT01654107|2204301|P1|COMPLETED|Overall Study||25
911935|NCT01654107|2204300|P2|STARTED|Overall Study||30
911936|NCT01654107|2204301|P1|STARTED|Overall Study||28
911937|NCT01653964|2204307|P1|NOT COMPLETED|Overall Study||0
911938|NCT01653964|2204307|P1|COMPLETED|Overall Study||82
911939|NCT01653964|2204307|P1|STARTED|Overall Study||82
911940|NCT01653782|2204314|P3|NOT COMPLETED|Overall Study||6
911941|NCT01653782|2204315|P2|NOT COMPLETED|Overall Study||18
911942|NCT01653782|2204316|P1|NOT COMPLETED|Overall Study||16
911943|NCT01653782|2204314|P3|COMPLETED|Overall Study||46
911944|NCT01653782|2204315|P2|COMPLETED|Overall Study||37
911945|NCT01653782|2204316|P1|COMPLETED|Overall Study||36
911946|NCT01653782|2204314|P3|STARTED|Overall Study||52
911947|NCT01653782|2204315|P2|STARTED|Overall Study||55
911948|NCT01653782|2204316|P1|STARTED|Overall Study||52
911949|NCT01653743|2204326|P2|NOT COMPLETED|Overall Study||0
911950|NCT01653743|2204327|P1|NOT COMPLETED|Overall Study||4
911951|NCT01653743|2204326|P2|COMPLETED|Overall Study||27
911952|NCT01653743|2204327|P1|COMPLETED|Overall Study||50
911953|NCT01653743|2204326|P2|STARTED|Overall Study||27
911954|NCT01653743|2204327|P1|STARTED|Overall Study||54
911955|NCT01653509|2204343|P2|NOT COMPLETED|Overall Study||0
911956|NCT01653509|2204344|P1|NOT COMPLETED|Overall Study||0
911957|NCT01653509|2204343|P2|COMPLETED|Overall Study||13
911958|NCT01653509|2204344|P1|COMPLETED|Overall Study||12
911959|NCT01653509|2204343|P2|STARTED|Overall Study||13
911960|NCT01653509|2204344|P1|STARTED|Overall Study||12
911961|NCT01653418|2204362|P1|NOT COMPLETED|Overall Study||0
911962|NCT01653418|2204362|P1|COMPLETED|Overall Study||10
911963|NCT01653418|2204362|P1|STARTED|Overall Study||10
911964|NCT01653262|2204374|P1|NOT COMPLETED|Overall Study||3
911965|NCT01653262|2204374|P1|COMPLETED|Overall Study||26
911966|NCT01653262|2204374|P1|STARTED|Overall Study||29
911967|NCT01653158|2204387|P8|NOT COMPLETED|Overall Study||15
911968|NCT01653158|2204388|P7|NOT COMPLETED|Overall Study||2
911969|NCT01653158|2204389|P6|NOT COMPLETED|Overall Study||1
911970|NCT01653158|2204390|P5|NOT COMPLETED|Overall Study||1
911971|NCT01653158|2204391|P4|NOT COMPLETED|Overall Study||2
911972|NCT01653158|2204392|P3|NOT COMPLETED|Overall Study||0
911973|NCT01653158|2204393|P2|NOT COMPLETED|Overall Study||0
911974|NCT01653158|2204394|P1|NOT COMPLETED|Overall Study||1
911975|NCT01653158|2204387|P8|COMPLETED|Overall Study||4
911976|NCT01653158|2204388|P7|COMPLETED|Overall Study||7
911977|NCT01653158|2204389|P6|COMPLETED|Overall Study||2
911978|NCT01653158|2204390|P5|COMPLETED|Overall Study||2
911979|NCT01653158|2204391|P4|COMPLETED|Overall Study||1
911980|NCT01653158|2204392|P3|COMPLETED|Overall Study||3
911981|NCT01653158|2204393|P2|COMPLETED|Overall Study||3
911982|NCT01653158|2204394|P1|COMPLETED|Overall Study||2
911983|NCT01653158|2204387|P8|STARTED|Overall Study|Six (6) and 13 participants were enrolled in dose escalation and expansion cohorts, respectively.|19
911984|NCT01653158|2204388|P7|STARTED|Overall Study||9
911985|NCT01653158|2204389|P6|STARTED|Overall Study||3
911986|NCT01653158|2204390|P5|STARTED|Overall Study||3
911987|NCT01653158|2204391|P4|STARTED|Overall Study||3
911988|NCT01653158|2204392|P3|STARTED|Overall Study||3
911989|NCT01653158|2204393|P2|STARTED|Overall Study||3
911990|NCT01653158|2204394|P1|STARTED|Overall Study||3
911991|NCT01653132|2204666|P2|NOT COMPLETED|Second Intervention||0
911992|NCT01653132|2204667|P1|NOT COMPLETED|Second Intervention||0
911993|NCT01653132|2204666|P2|COMPLETED|Second Intervention||5
911994|NCT01653132|2204667|P1|COMPLETED|Second Intervention||4
911995|NCT01653132|2204666|P2|STARTED|Second Intervention||5
911996|NCT01653132|2204667|P1|STARTED|Second Intervention||4
911997|NCT01653132|2204666|P2|NOT COMPLETED|Washout 1-2 Months||0
911998|NCT01653132|2204667|P1|NOT COMPLETED|Washout 1-2 Months||0
911999|NCT01653132|2204666|P2|COMPLETED|Washout 1-2 Months||5
912000|NCT01653132|2204667|P1|COMPLETED|Washout 1-2 Months||4
912001|NCT01653132|2204666|P2|STARTED|Washout 1-2 Months||5
912002|NCT01653132|2204667|P1|STARTED|Washout 1-2 Months||4
912003|NCT01653132|2204666|P2|NOT COMPLETED|First Intervention||0
912004|NCT01653132|2204667|P1|NOT COMPLETED|First Intervention||1
912005|NCT01653132|2204666|P2|COMPLETED|First Intervention||5
912006|NCT01653132|2204667|P1|COMPLETED|First Intervention|one dropped out: wanted to start anticholinergic drug for tremor that could affect saliva volume|4
912007|NCT01653132|2204666|P2|STARTED|First Intervention||5
912008|NCT01653132|2204667|P1|STARTED|First Intervention||5
912009|NCT01653028|2204686|P5|NOT COMPLETED|Overall Study||0
912010|NCT01653028|2204687|P4|NOT COMPLETED|Overall Study||0
912011|NCT01653028|2204688|P3|NOT COMPLETED|Overall Study||0
912012|NCT01653028|2204689|P2|NOT COMPLETED|Overall Study||0
912013|NCT01653028|2204690|P1|NOT COMPLETED|Overall Study||0
912014|NCT01653028|2204686|P5|COMPLETED|Overall Study||29
912015|NCT01653028|2204687|P4|COMPLETED|Overall Study||10
912016|NCT01653028|2204688|P3|COMPLETED|Overall Study||11
912017|NCT01653028|2204689|P2|COMPLETED|Overall Study||10
912018|NCT01653028|2204690|P1|COMPLETED|Overall Study||12
912019|NCT01653028|2204686|P5|STARTED|Overall Study||29
912020|NCT01653028|2204687|P4|STARTED|Overall Study||10
912021|NCT01653028|2204688|P3|STARTED|Overall Study||11
912022|NCT01653028|2204689|P2|STARTED|Overall Study||10
912023|NCT01653028|2204690|P1|STARTED|Overall Study||12
912024|NCT01652885|2204717|P1|NOT COMPLETED|Overall Study||1
912025|NCT01652885|2204717|P1|COMPLETED|Overall Study||22
912026|NCT01652885|2204717|P1|STARTED|Overall Study||23
912027|NCT01652729|2204745|P3|NOT COMPLETED|Overall Study||14
912028|NCT01652729|2204746|P2|NOT COMPLETED|Overall Study||13
912029|NCT01652729|2204747|P1|NOT COMPLETED|Overall Study||27
912030|NCT01652729|2204745|P3|COMPLETED|Overall Study||47
912031|NCT01652729|2204746|P2|COMPLETED|Overall Study||109
912032|NCT01652729|2204747|P1|COMPLETED|Overall Study|The double-enrolled subject’s reasons for withdrawal were LTFU and PV. Only PV is shown below.|155
912033|NCT01652729|2204745|P3|Meal Test Evaluable|Overall Study||15
912034|NCT01652729|2204746|P2|Meal Test Evaluable|Overall Study||31
912035|NCT01652729|2204747|P1|Meal Test Evaluable|Overall Study|ITT subjects who ate >=75% of meal and did not miss 2-hour postprandial glucose measures at V3 and 8|44
912036|NCT01652729|2204745|P3|Meal Test Subjects|Overall Study||20
912037|NCT01652729|2204746|P2|Meal Test Subjects|Overall Study||41
912038|NCT01652729|2204747|P1|Meal Test Subjects|Overall Study||60
912039|NCT01652729|2204745|P3|Evaluable|Overall Study||43
912040|NCT01652729|2204746|P2|Evaluable|Overall Study||91
912041|NCT01652729|2204747|P1|Evaluable|Overall Study|Subjects who completed study procedures to Week 24 or beyond and had adequate study drug exposure|143
912042|NCT01652729|2204745|P3|Treated|Overall Study||61
912043|NCT01652729|2204746|P2|Treated|Overall Study||122
912044|NCT01652729|2204747|P1|Treated|Overall Study|All subjects who received at least one dose of study medication even if not randomized.|181
912045|NCT01652729|2204745|P3|Modified Intent-to-Treat|Overall Study||61
912046|NCT01652729|2204746|P2|Modified Intent-to-Treat|Overall Study||122
912047|NCT01652729|2204747|P1|Modified Intent-to-Treat|Overall Study|All randomized subjects who received at least one dose of study drug.|181
912048|NCT01652729|2204745|P3|STARTED|Overall Study||61
912049|NCT01652729|2204746|P2|STARTED|Overall Study||122
912050|NCT01652729|2204747|P1|STARTED|Overall Study|One subject was enrolled twice at different sites. He was randomized to exenatide at both sites.|182
912051|NCT01652716|2204769|P2|NOT COMPLETED|Overall Study||46
912052|NCT01652716|2204770|P1|NOT COMPLETED|Overall Study||56
912053|NCT01652716|2204769|P2|COMPLETED|Overall Study|* completed study|102
912054|NCT01652716|2204770|P1|COMPLETED|Overall Study|* completed study|173
912055|NCT01652716|2204769|P2|Completed 28-week|Overall Study||118
912056|NCT01652716|2204770|P1|Completed 28-week|Overall Study||197
912057|NCT01652716|2204769|P2|STARTED|Overall Study|Two subjects in the exenatide BID group withdrew from the study before receiving study drug.|148
912058|NCT01652716|2204770|P1|STARTED|Overall Study||229
912059|NCT01652703|2204790|P6|NOT COMPLETED|Overall Study||2
912060|NCT01652703|2204791|P5|NOT COMPLETED|Overall Study||1
912061|NCT01652703|2204792|P4|NOT COMPLETED|Overall Study||2
912062|NCT01652703|2204793|P3|NOT COMPLETED|Overall Study||3
912063|NCT01652703|2204794|P2|NOT COMPLETED|Overall Study||1
912064|NCT01652703|2204795|P1|NOT COMPLETED|Overall Study||0
912065|NCT01652703|2204790|P6|COMPLETED|Overall Study||51
912066|NCT01652703|2204791|P5|COMPLETED|Overall Study||51
912067|NCT01652703|2204792|P4|COMPLETED|Overall Study||50
912068|NCT01652703|2204793|P3|COMPLETED|Overall Study||47
912069|NCT01652703|2204794|P2|COMPLETED|Overall Study||50
912070|NCT01652703|2204795|P1|COMPLETED|Overall Study||52
912071|NCT01652703|2204790|P6|Received Treatment|Overall Study||53
912072|NCT01652703|2204791|P5|Received Treatment|Overall Study||51
912073|NCT01652703|2204792|P4|Received Treatment|Overall Study||52
912074|NCT01652703|2204793|P3|Received Treatment|Overall Study||49
912075|NCT01652703|2204794|P2|Received Treatment|Overall Study||50
912076|NCT01652703|2204795|P1|Received Treatment|Overall Study||52
912077|NCT01652703|2204790|P6|STARTED|Overall Study||53
912078|NCT01652703|2204791|P5|STARTED|Overall Study||52
912079|NCT01652703|2204792|P4|STARTED|Overall Study||52
912080|NCT01652703|2204793|P3|STARTED|Overall Study||50
912081|NCT01652703|2204794|P2|STARTED|Overall Study||51
912082|NCT01652703|2204795|P1|STARTED|Overall Study||52
912083|NCT01652690|2204853|P2|NOT COMPLETED|Overall Study||21
912084|NCT01652690|2204854|P1|NOT COMPLETED|Overall Study||35
912085|NCT01652690|2204853|P2|COMPLETED|Overall Study||279
912086|NCT01652690|2204854|P1|COMPLETED|Overall Study||265
912087|NCT01652690|2204853|P2|STARTED|Overall Study||300
912088|NCT01652690|2204854|P1|STARTED|Overall Study||300
912089|NCT01652664|2204888|P2|NOT COMPLETED|Overall Study||1
912090|NCT01652664|2204889|P1|NOT COMPLETED|Overall Study||6
912091|NCT01652664|2204888|P2|COMPLETED|Overall Study||74
912092|NCT01652664|2204889|P1|COMPLETED|Overall Study||71
912093|NCT01652664|2204888|P2|STARTED|Overall Study||75
912094|NCT01652664|2204889|P1|STARTED|Overall Study||77
912095|NCT01652573|2204898|P2|NOT COMPLETED|Overall Study||1
912096|NCT01652573|2204899|P1|NOT COMPLETED|Overall Study||0
912097|NCT01652573|2204898|P2|COMPLETED|Overall Study||10
912098|NCT01652573|2204899|P1|COMPLETED|Overall Study||10
912099|NCT01652573|2204898|P2|STARTED|Overall Study||11
912100|NCT01652573|2204899|P1|STARTED|Overall Study||10
912101|NCT01652495|2204941|P2|NOT COMPLETED|Overall Study||2
912102|NCT01652495|2204942|P1|NOT COMPLETED|Overall Study||2
912103|NCT01652495|2204941|P2|COMPLETED|Overall Study||20
912104|NCT01652495|2204942|P1|COMPLETED|Overall Study||20
912105|NCT01652495|2204941|P2|STARTED|Overall Study||22
912106|NCT01652495|2204942|P1|STARTED|Overall Study||22
912107|NCT01652287|2204954|P2|NOT COMPLETED|Overall Study||0
912108|NCT01652287|2204955|P1|NOT COMPLETED|Overall Study||2
912109|NCT01652287|2204954|P2|COMPLETED|Overall Study||31
912110|NCT01652287|2204955|P1|COMPLETED|Overall Study|• Did not receive allocated intervention (withdrew consent) (n=2)|29
912111|NCT01652287|2204954|P2|STARTED|Overall Study||31
912112|NCT01652287|2204955|P1|STARTED|Overall Study||31
912113|NCT01652001|2204963|P2|NOT COMPLETED|Overall Study||6
912114|NCT01652001|2204964|P1|NOT COMPLETED|Overall Study||9
912115|NCT01652001|2204963|P2|COMPLETED|Overall Study||79
912116|NCT01652001|2204964|P1|COMPLETED|Overall Study||91
912117|NCT01652001|2204963|P2|STARTED|Overall Study||85
912118|NCT01652001|2204964|P1|STARTED|Overall Study||100
912119|NCT01651949|2204975|P3|NOT COMPLETED|Overall Study||31
912120|NCT01651949|2204976|P2|NOT COMPLETED|Overall Study||86
912121|NCT01651949|2204977|P1|NOT COMPLETED|Overall Study||53
912122|NCT01651949|2204975|P3|COMPLETED|Overall Study||282
912123|NCT01651949|2204976|P2|COMPLETED|Overall Study||1015
912124|NCT01651949|2204977|P1|COMPLETED|Overall Study||1053
912125|NCT01651949|2204975|P3|Vaccination 3|Overall Study||291
912126|NCT01651949|2204976|P2|Vaccination 3|Overall Study||1037
912127|NCT01651949|2204977|P1|Vaccination 3|Overall Study||1067
912128|NCT01651949|2204975|P3|Vaccination 2|Overall Study||298
912129|NCT01651949|2204976|P2|Vaccination 2|Overall Study||1069
912130|NCT01651949|2204977|P1|Vaccination 2|Overall Study||1089
912131|NCT01651949|2204975|P3|Vaccination 1|Overall Study||313
912132|NCT01651949|2204976|P2|Vaccination 1|Overall Study||1099
912133|NCT01651949|2204977|P1|Vaccination 1|Overall Study||1103
912134|NCT01651949|2204975|P3|STARTED|Overall Study||313
912135|NCT01651949|2204976|P2|STARTED|Overall Study||1101
912136|NCT01651949|2204977|P1|STARTED|Overall Study||1106
912137|NCT01651936|2204997|P3|NOT COMPLETED|Extension Study||14
912138|NCT01651936|2204998|P2|NOT COMPLETED|Extension Study||0
912139|NCT01651936|2204999|P1|NOT COMPLETED|Extension Study||0
912140|NCT01651936|2204997|P3|COMPLETED|Extension Study||0
912141|NCT01651936|2204998|P2|COMPLETED|Extension Study||0
912142|NCT01651936|2204999|P1|COMPLETED|Extension Study||0
912143|NCT01651936|2204997|P3|STARTED|Extension Study|Includes completers and early escapees from the Base Study|14
912144|NCT01651936|2204998|P2|STARTED|Extension Study||0
912145|NCT01651936|2204999|P1|STARTED|Extension Study||0
912146|NCT01651936|2204997|P3|NOT COMPLETED|Base Study||0
912147|NCT01651936|2204998|P2|NOT COMPLETED|Base Study||25
912148|NCT01651936|2204999|P1|NOT COMPLETED|Base Study||27
912149|NCT01651936|2204997|P3|COMPLETED|Base Study||0
912150|NCT01651936|2204998|P2|COMPLETED|Base Study||1
912151|NCT01651936|2204999|P1|COMPLETED|Base Study||3
912152|NCT01651936|2204997|P3|STARTED|Base Study||0
912153|NCT01651936|2204998|P2|STARTED|Base Study||26
912154|NCT01651936|2204999|P1|STARTED|Base Study||30
912155|NCT01651780|2205022|P2|NOT COMPLETED|Overall Study||10
912156|NCT01651780|2205023|P1|NOT COMPLETED|Overall Study||11
912157|NCT01651780|2205022|P2|COMPLETED|Overall Study||388
912158|NCT01651780|2205023|P1|COMPLETED|Overall Study||394
912159|NCT01651780|2205022|P2|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|0
912160|NCT01651780|2205023|P1|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|65
912161|NCT01651780|2205022|P2|Received at Least 1 Dose of Study Drug|Overall Study||394
912162|NCT01651780|2205023|P1|Received at Least 1 Dose of Study Drug|Overall Study|All but 1 participant in the bivalirudin group (withdrew consent) comprised the ITT population.|393
912163|NCT01651780|2205022|P2|Intent-To-Treat (ITT) Population|Overall Study||398
912164|NCT01651780|2205023|P1|Intent-To-Treat (ITT) Population|Overall Study||404
912165|NCT01651780|2205022|P2|STARTED|Overall Study||398
912166|NCT01651780|2205023|P1|STARTED|Overall Study||405
912167|NCT01651351|2205055|P2|NOT COMPLETED|Overall Study||0
912168|NCT01651351|2205056|P1|NOT COMPLETED|Overall Study||0
912169|NCT01651351|2205055|P2|COMPLETED|Overall Study||15
912170|NCT01651351|2205056|P1|COMPLETED|Overall Study||15
912171|NCT01651351|2205055|P2|STARTED|Overall Study||15
912172|NCT01651351|2205056|P1|STARTED|Overall Study||15
912173|NCT01651260|2205073|P1|NOT COMPLETED|Overall Study||3
912174|NCT01651260|2205073|P1|COMPLETED|Overall Study||62
912175|NCT01651260|2205073|P1|STARTED|Overall Study||65
912176|NCT01651208|2205080|P2|NOT COMPLETED|Overall Study||16
912177|NCT01651208|2205081|P1|NOT COMPLETED|Overall Study||14
912178|NCT01651208|2205080|P2|COMPLETED|Overall Study|16 subjects had no pharmacy claims data to analyze primary outcome|209
912179|NCT01651208|2205081|P1|COMPLETED|Overall Study|14 patients had no pharmacy claims data to analyze primary outcome|213
912180|NCT01651208|2205080|P2|STARTED|Overall Study||225
912181|NCT01651208|2205081|P1|STARTED|Overall Study||227
912182|NCT01651104|2205089|P1|NOT COMPLETED|Overall Study||0
912183|NCT01651104|2205089|P1|COMPLETED|Overall Study||63
912184|NCT01651104|2205089|P1|STARTED|Overall Study||63
912185|NCT01651000|2205098|P2|NOT COMPLETED|Overall Study||28
912186|NCT01651000|2205099|P1|NOT COMPLETED|Overall Study||10
912187|NCT01651000|2205098|P2|COMPLETED|Overall Study||113
912188|NCT01651000|2205099|P1|COMPLETED|Overall Study||62
912189|NCT01651000|2205098|P2|Entered Extension Study|Overall Study||93
912190|NCT01651000|2205099|P1|Entered Extension Study|Overall Study||50
912191|NCT01651000|2205098|P2|STARTED|Overall Study||141
912192|NCT01651000|2205099|P1|STARTED|Overall Study||72
912193|NCT01650831|2205111|P1|NOT COMPLETED|Overall Study||1
912194|NCT01650831|2205111|P1|COMPLETED|Overall Study||112
912195|NCT01650831|2205111|P1|STARTED|Overall Study||113
912196|NCT01650805|2205121|P2|NOT COMPLETED|Overall Study||0
912197|NCT01650805|2205122|P1|NOT COMPLETED|Overall Study||1
912198|NCT01650805|2205121|P2|COMPLETED|Overall Study||152
912199|NCT01650805|2205122|P1|COMPLETED|Overall Study|Completed means patient initiated and discontinued study treatment.|154
912200|NCT01650805|2205121|P2|STARTED|Overall Study||152
912201|NCT01650805|2205122|P1|STARTED|Overall Study|Started means patient has been randomized.|155
912202|NCT01650779|2205132|P1|NOT COMPLETED|Overall Study||1
912203|NCT01650779|2205132|P1|COMPLETED|Overall Study||14
912204|NCT01650779|2205132|P1|STARTED|Overall Study||15
912205|NCT01650519|2205141|P2|NOT COMPLETED|Overall Study||0
912206|NCT01650519|2205142|P1|NOT COMPLETED|Overall Study||1
912207|NCT01650519|2205141|P2|COMPLETED|Overall Study||31
912208|NCT01650519|2205142|P1|COMPLETED|Overall Study||19
912209|NCT01650519|2205141|P2|STARTED|Overall Study||31
912210|NCT01650519|2205142|P1|STARTED|Overall Study||20
912211|NCT01650350|2205160|P1|NOT COMPLETED|Overall Study||0
912212|NCT01650350|2205160|P1|COMPLETED|Overall Study||7
912213|NCT01650350|2205160|P1|STARTED|Overall Study||7
912214|NCT01650324|2205169|P5|NOT COMPLETED|Overall Study||0
912215|NCT01650324|2205170|P4|NOT COMPLETED|Overall Study||0
912216|NCT01650324|2205171|P3|NOT COMPLETED|Overall Study||0
912217|NCT01650324|2205172|P2|NOT COMPLETED|Overall Study||0
912218|NCT01650324|2205173|P1|NOT COMPLETED|Overall Study||0
912219|NCT01650324|2205169|P5|COMPLETED|Overall Study||6
912220|NCT01650324|2205170|P4|COMPLETED|Overall Study||6
912221|NCT01650324|2205171|P3|COMPLETED|Overall Study||6
912222|NCT01650324|2205172|P2|COMPLETED|Overall Study||6
912223|NCT01650324|2205173|P1|COMPLETED|Overall Study||8
912224|NCT01650324|2205169|P5|STARTED|Overall Study||6
912225|NCT01650324|2205170|P4|STARTED|Overall Study||6
912226|NCT01650324|2205171|P3|STARTED|Overall Study||6
912227|NCT01650324|2205172|P2|STARTED|Overall Study||6
912228|NCT01650324|2205173|P1|STARTED|Overall Study||8
912229|NCT01650285|2205202|P1|NOT COMPLETED|Overall Study||1
912230|NCT01650285|2205202|P1|COMPLETED|Overall Study||4
912231|NCT01650285|2205202|P1|STARTED|Overall Study||5
912232|NCT01650246|2205206|P1|NOT COMPLETED|Overall Study||143
912233|NCT01650246|2205206|P1|COMPLETED|Overall Study||0
912234|NCT01650246|2205206|P1|STARTED|Overall Study||143
912241|NCT01649804|2205246|P1|NOT COMPLETED|Overall Study||8
912242|NCT01649804|2205246|P1|COMPLETED|Overall Study||4
912243|NCT01649804|2205246|P1|STARTED|Overall Study||12
912244|NCT01649791|2205258|P1|NOT COMPLETED|Overall Study||3
912245|NCT01649791|2205258|P1|COMPLETED|Overall Study||5
912246|NCT01649791|2205258|P1|STARTED|Overall Study||8
912247|NCT01649557|2205268|P3|NOT COMPLETED|Overall Study||9
912248|NCT01649557|2205269|P2|NOT COMPLETED|Overall Study||14
912249|NCT01649557|2205270|P1|NOT COMPLETED|Overall Study||44
912250|NCT01649557|2205268|P3|COMPLETED|Overall Study||15
912251|NCT01649557|2205269|P2|COMPLETED|Overall Study||27
912252|NCT01649557|2205270|P1|COMPLETED|Overall Study||135
912253|NCT01649557|2205268|P3|52-week Enrollers|Overall Study||2
912254|NCT01649557|2205269|P2|52-week Enrollers|Overall Study||6
912255|NCT01649557|2205270|P1|52-week Enrollers|Overall Study||20
912256|NCT01649557|2205268|P3|6-week Enrollers|Overall Study||22
912257|NCT01649557|2205269|P2|6-week Enrollers|Overall Study||35
912258|NCT01649557|2205270|P1|6-week Enrollers|Overall Study||159
912259|NCT01649557|2205268|P3|STARTED|Overall Study||24
912260|NCT01649557|2205269|P2|STARTED|Overall Study||41
912261|NCT01649557|2205270|P1|STARTED|Overall Study||179
912262|NCT01649505|2205307|P2|NOT COMPLETED|Overall Study||1
912263|NCT01649505|2205308|P1|NOT COMPLETED|Overall Study||1
912264|NCT01649505|2205307|P2|COMPLETED|Overall Study||0
912265|NCT01649505|2205308|P1|COMPLETED|Overall Study||0
912266|NCT01649505|2205307|P2|STARTED|Overall Study||1
912267|NCT01649505|2205308|P1|STARTED|Overall Study||1
912268|NCT01649362|2205316|P2|NOT COMPLETED|Overall Study||14
912269|NCT01649362|2205317|P1|NOT COMPLETED|Overall Study||1
912270|NCT01649362|2205316|P2|COMPLETED|Overall Study||40
912271|NCT01649362|2205317|P1|COMPLETED|Overall Study||46
912272|NCT01649362|2205316|P2|STARTED|Overall Study||54
912273|NCT01649362|2205317|P1|STARTED|Overall Study||47
912274|NCT01649297|2205332|P5|NOT COMPLETED|Overall Study||4
912275|NCT01649297|2205333|P4|NOT COMPLETED|Overall Study||19
912276|NCT01649297|2205334|P3|NOT COMPLETED|Overall Study||17
912277|NCT01649297|2205335|P2|NOT COMPLETED|Overall Study||13
912278|NCT01649297|2205336|P1|NOT COMPLETED|Overall Study||14
912279|NCT01649297|2205332|P5|COMPLETED|Overall Study||103
912280|NCT01649297|2205333|P4|COMPLETED|Overall Study||201
912281|NCT01649297|2205334|P3|COMPLETED|Overall Study||202
912282|NCT01649297|2205335|P2|COMPLETED|Overall Study||205
912283|NCT01649297|2205336|P1|COMPLETED|Overall Study||205
912284|NCT01649297|2205332|P5|STARTED|Overall Study|randomised|107
912285|NCT01649297|2205333|P4|STARTED|Overall Study|randomised|220
912286|NCT01649297|2205334|P3|STARTED|Overall Study|randomised|219
912287|NCT01649297|2205335|P2|STARTED|Overall Study|randomised|218
912288|NCT01649297|2205336|P1|STARTED|Overall Study|randomised|219
912289|NCT01649232|2205355|P2|NOT COMPLETED|Overall Study||0
912290|NCT01649232|2205356|P1|NOT COMPLETED|Overall Study||2
912291|NCT01649232|2205355|P2|COMPLETED|Overall Study||30
912292|NCT01649232|2205356|P1|COMPLETED|Overall Study|technical problems or excessive artifacts, two data sets were excluded from further analysis.|28
912293|NCT01649232|2205355|P2|STARTED|Overall Study||30
912294|NCT01649232|2205356|P1|STARTED|Overall Study||30
912295|NCT01649180|2205376|P1|NOT COMPLETED|Overall Study||0
912296|NCT01649180|2205376|P1|COMPLETED|Overall Study||3
912297|NCT01649180|2205376|P1|STARTED|Overall Study||3
912298|NCT01648920|2205384|P1|NOT COMPLETED|Overall Study||0
912299|NCT01648920|2205384|P1|COMPLETED|Overall Study||50
912300|NCT01648920|2205384|P1|STARTED|Overall Study||50
912301|NCT01648790|2205408|P5|NOT COMPLETED|Treatment 5||0
912302|NCT01648790|2205409|P4|NOT COMPLETED|Treatment 5||0
912303|NCT01648790|2205410|P3|NOT COMPLETED|Treatment 5||0
912304|NCT01648790|2205411|P2|NOT COMPLETED|Treatment 5||0
912305|NCT01648790|2205412|P1|NOT COMPLETED|Treatment 5||0
912306|NCT01648790|2205408|P5|COMPLETED|Treatment 5||4
912307|NCT01648790|2205409|P4|COMPLETED|Treatment 5||3
912308|NCT01648790|2205410|P3|COMPLETED|Treatment 5||4
912309|NCT01648790|2205411|P2|COMPLETED|Treatment 5||4
912310|NCT01648790|2205412|P1|COMPLETED|Treatment 5||4
912311|NCT01648790|2205408|P5|STARTED|Treatment 5||4
912312|NCT01648790|2205409|P4|STARTED|Treatment 5||3
912313|NCT01648790|2205410|P3|STARTED|Treatment 5||4
912314|NCT01648790|2205411|P2|STARTED|Treatment 5||4
912315|NCT01648790|2205412|P1|STARTED|Treatment 5||4
912316|NCT01648790|2205408|P5|NOT COMPLETED|Treatment 4||0
912317|NCT01648790|2205409|P4|NOT COMPLETED|Treatment 4||0
912318|NCT01648790|2205410|P3|NOT COMPLETED|Treatment 4||0
912319|NCT01648790|2205411|P2|NOT COMPLETED|Treatment 4||0
912320|NCT01648790|2205412|P1|NOT COMPLETED|Treatment 4||0
912321|NCT01648790|2205408|P5|COMPLETED|Treatment 4||4
912322|NCT01648790|2205409|P4|COMPLETED|Treatment 4||3
912323|NCT01648790|2205410|P3|COMPLETED|Treatment 4||4
912324|NCT01648790|2205411|P2|COMPLETED|Treatment 4||4
912325|NCT01648790|2205412|P1|COMPLETED|Treatment 4||4
912326|NCT01648790|2205408|P5|STARTED|Treatment 4||4
912327|NCT01648790|2205409|P4|STARTED|Treatment 4||3
912328|NCT01648790|2205410|P3|STARTED|Treatment 4||4
912329|NCT01648790|2205411|P2|STARTED|Treatment 4||4
912330|NCT01648790|2205412|P1|STARTED|Treatment 4||4
912331|NCT01648790|2205408|P5|NOT COMPLETED|Treatment 3||0
912332|NCT01648790|2205409|P4|NOT COMPLETED|Treatment 3||1
912333|NCT01648790|2205410|P3|NOT COMPLETED|Treatment 3||0
912334|NCT01648790|2205411|P2|NOT COMPLETED|Treatment 3||0
912335|NCT01648790|2205412|P1|NOT COMPLETED|Treatment 3||0
912336|NCT01648790|2205408|P5|COMPLETED|Treatment 3||4
912337|NCT01648790|2205409|P4|COMPLETED|Treatment 3||3
912338|NCT01648790|2205410|P3|COMPLETED|Treatment 3||4
912339|NCT01648790|2205411|P2|COMPLETED|Treatment 3||4
912340|NCT01648790|2205412|P1|COMPLETED|Treatment 3||4
912341|NCT01648790|2205408|P5|STARTED|Treatment 3||4
912342|NCT01648790|2205409|P4|STARTED|Treatment 3|Withdrew consent prior to dosing on this treatment day.|4
912343|NCT01648790|2205410|P3|STARTED|Treatment 3||4
912344|NCT01648790|2205411|P2|STARTED|Treatment 3||4
912345|NCT01648790|2205412|P1|STARTED|Treatment 3||4
912346|NCT01648790|2205408|P5|NOT COMPLETED|Treatment 2||0
912347|NCT01648790|2205409|P4|NOT COMPLETED|Treatment 2||0
912348|NCT01648790|2205410|P3|NOT COMPLETED|Treatment 2||0
912349|NCT01648790|2205411|P2|NOT COMPLETED|Treatment 2||0
912350|NCT01648790|2205412|P1|NOT COMPLETED|Treatment 2||0
912351|NCT01648790|2205408|P5|COMPLETED|Treatment 2||4
912352|NCT01648790|2205409|P4|COMPLETED|Treatment 2||4
912353|NCT01648790|2205410|P3|COMPLETED|Treatment 2||4
912354|NCT01648790|2205411|P2|COMPLETED|Treatment 2||4
912355|NCT01648790|2205412|P1|COMPLETED|Treatment 2||4
912356|NCT01648790|2205408|P5|STARTED|Treatment 2||4
912357|NCT01648790|2205409|P4|STARTED|Treatment 2||4
912358|NCT01648790|2205410|P3|STARTED|Treatment 2||4
912359|NCT01648790|2205411|P2|STARTED|Treatment 2||4
912360|NCT01648790|2205412|P1|STARTED|Treatment 2||4
912361|NCT01648790|2205408|P5|NOT COMPLETED|Treatment 1||0
912362|NCT01648790|2205409|P4|NOT COMPLETED|Treatment 1||0
912363|NCT01648790|2205410|P3|NOT COMPLETED|Treatment 1||0
912364|NCT01648790|2205411|P2|NOT COMPLETED|Treatment 1||0
912365|NCT01648790|2205412|P1|NOT COMPLETED|Treatment 1||0
912366|NCT01648790|2205408|P5|COMPLETED|Treatment 1||4
912367|NCT01648790|2205409|P4|COMPLETED|Treatment 1||4
912368|NCT01648790|2205410|P3|COMPLETED|Treatment 1||4
912369|NCT01648790|2205411|P2|COMPLETED|Treatment 1||4
912370|NCT01648790|2205412|P1|COMPLETED|Treatment 1||4
912371|NCT01648790|2205408|P5|Received at Least 1 Dose of Study Drug|Treatment 1||4
912372|NCT01648790|2205409|P4|Received at Least 1 Dose of Study Drug|Treatment 1||4
912373|NCT01648790|2205410|P3|Received at Least 1 Dose of Study Drug|Treatment 1||4
912374|NCT01648790|2205411|P2|Received at Least 1 Dose of Study Drug|Treatment 1||4
912375|NCT01648790|2205412|P1|Received at Least 1 Dose of Study Drug|Treatment 1||4
912376|NCT01648790|2205408|P5|STARTED|Treatment 1||4
912377|NCT01648790|2205409|P4|STARTED|Treatment 1||4
912378|NCT01648790|2205410|P3|STARTED|Treatment 1||4
912379|NCT01648790|2205411|P2|STARTED|Treatment 1||4
912380|NCT01648790|2205412|P1|STARTED|Treatment 1||4
912381|NCT01648699|2205433|P1|NOT COMPLETED|Overall Study||5
912382|NCT01648699|2205433|P1|COMPLETED|Overall Study||15
912383|NCT01648699|2205433|P1|STARTED|Overall Study||20
912384|NCT01648582|2205462|P3|NOT COMPLETED|Overall Study||32
912385|NCT01648582|2205463|P2|NOT COMPLETED|Overall Study||38
912386|NCT01648582|2205464|P1|NOT COMPLETED|Overall Study||32
912387|NCT01648582|2205462|P3|COMPLETED|Overall Study||227
912388|NCT01648582|2205463|P2|COMPLETED|Overall Study||219
912389|NCT01648582|2205464|P1|COMPLETED|Overall Study||226
912390|NCT01648582|2205462|P3|Modified Intent-to-Treat Population|Overall Study||250
912391|NCT01648582|2205463|P2|Modified Intent-to-Treat Population|Overall Study||252
912392|NCT01648582|2205464|P1|Modified Intent-to-Treat Population|Overall Study||253
912393|NCT01648582|2205462|P3|Received at Least One Dose of Study Drug|Overall Study||259
912394|NCT01648582|2205463|P2|Received at Least One Dose of Study Drug|Overall Study||257
912395|NCT01648582|2205464|P1|Received at Least One Dose of Study Drug|Overall Study||258
912396|NCT01648582|2205462|P3|STARTED|Overall Study||259
912397|NCT01648582|2205463|P2|STARTED|Overall Study||257
912398|NCT01648582|2205464|P1|STARTED|Overall Study||258
912399|NCT01648530|2205533|P1|NOT COMPLETED|Overall Study||10874
912400|NCT01648530|2205533|P1|COMPLETED|Overall Study||5915
912401|NCT01648530|2205533|P1|STARTED|Overall Study||16789
912402|NCT01648491|2205539|P1|NOT COMPLETED|Overall Study||0
912403|NCT01648491|2205539|P1|COMPLETED|Overall Study||1
912404|NCT01648491|2205539|P1|STARTED|Overall Study||1
912405|NCT01648452|2205546|P1|NOT COMPLETED|Overall Study||0
912406|NCT01648452|2205546|P1|COMPLETED|Overall Study|One participant was explanted due to an adverse event. Remainder kept implant at study completion.|5
912407|NCT01648452|2205546|P1|STARTED|Overall Study||5
912408|NCT01648140|2205568|P4|NOT COMPLETED|Overall Study||2
912409|NCT01648140|2205569|P3|NOT COMPLETED|Overall Study||8
912410|NCT01648140|2205570|P2|NOT COMPLETED|Overall Study||12
912411|NCT01648140|2205571|P1|NOT COMPLETED|Overall Study||12
912412|NCT01648140|2205568|P4|COMPLETED|Overall Study||11
912413|NCT01648140|2205569|P3|COMPLETED|Overall Study||9
912414|NCT01648140|2205570|P2|COMPLETED|Overall Study||28
912415|NCT01648140|2205571|P1|COMPLETED|Overall Study||29
912416|NCT01648140|2205568|P4|STARTED|Overall Study||13
912417|NCT01648140|2205569|P3|STARTED|Overall Study||17
912418|NCT01648140|2205570|P2|STARTED|Overall Study||40
912419|NCT01648140|2205571|P1|STARTED|Overall Study||41
912420|NCT01648101|2205736|P3|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
912421|NCT01648101|2205737|P2|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
912422|NCT01648101|2205738|P1|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
912423|NCT01648101|2205736|P3|COMPLETED|Taper/Follow-up Phase (4 Weeks)||3
912424|NCT01648101|2205737|P2|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
912425|NCT01648101|2205738|P1|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
912426|NCT01648101|2205736|P3|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|3
912427|NCT01648101|2205737|P2|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|2
912428|NCT01648101|2205738|P1|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|1
912429|NCT01648101|2205736|P3|NOT COMPLETED|Transition Phase (4 Weeks)||4
912430|NCT01648101|2205737|P2|NOT COMPLETED|Transition Phase (4 Weeks)||5
912431|NCT01648101|2205738|P1|NOT COMPLETED|Transition Phase (4 Weeks)||5
912432|NCT01648101|2205736|P3|COMPLETED|Transition Phase (4 Weeks)||5
912433|NCT01648101|2205737|P2|COMPLETED|Transition Phase (4 Weeks)||13
912434|NCT01648101|2205738|P1|COMPLETED|Transition Phase (4 Weeks)||12
912435|NCT01648101|2205736|P3|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|9
912436|NCT01648101|2205737|P2|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|18
912437|NCT01648101|2205738|P1|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|17
912438|NCT01648101|2205736|P3|NOT COMPLETED|Maintenance Phase (12 Weeks)||6
912439|NCT01648101|2205737|P2|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
912440|NCT01648101|2205738|P1|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
912441|NCT01648101|2205736|P3|COMPLETED|Maintenance Phase (12 Weeks)||12
912442|NCT01648101|2205737|P2|COMPLETED|Maintenance Phase (12 Weeks)||20
912443|NCT01648101|2205738|P1|COMPLETED|Maintenance Phase (12 Weeks)||20
912444|NCT01648101|2205736|P3|STARTED|Maintenance Phase (12 Weeks)||18
912445|NCT01648101|2205737|P2|STARTED|Maintenance Phase (12 Weeks)||23
912446|NCT01648101|2205738|P1|STARTED|Maintenance Phase (12 Weeks)||23
912447|NCT01648101|2205736|P3|NOT COMPLETED|Titration Phase (4 Weeks)||6
912448|NCT01648101|2205737|P2|NOT COMPLETED|Titration Phase (4 Weeks)||3
912449|NCT01648101|2205738|P1|NOT COMPLETED|Titration Phase (4 Weeks)||2
912450|NCT01648101|2205736|P3|COMPLETED|Titration Phase (4 Weeks)||18
912451|NCT01648101|2205737|P2|COMPLETED|Titration Phase (4 Weeks)||23
912452|NCT01648101|2205738|P1|COMPLETED|Titration Phase (4 Weeks)||23
912453|NCT01648101|2205736|P3|STARTED|Titration Phase (4 Weeks)||24
912454|NCT01648101|2205737|P2|STARTED|Titration Phase (4 Weeks)||26
912455|NCT01648101|2205738|P1|STARTED|Titration Phase (4 Weeks)||25
912456|NCT01647945|2205790|P4|NOT COMPLETED|Overall Study||1
912457|NCT01647945|2205791|P3|NOT COMPLETED|Overall Study||2
912458|NCT01647945|2205792|P2|NOT COMPLETED|Overall Study||0
912459|NCT01647945|2205793|P1|NOT COMPLETED|Overall Study||0
912460|NCT01647945|2205790|P4|COMPLETED|Overall Study||5
912461|NCT01647945|2205791|P3|COMPLETED|Overall Study||3
912462|NCT01647945|2205792|P2|COMPLETED|Overall Study||6
912463|NCT01647945|2205793|P1|COMPLETED|Overall Study||6
912464|NCT01647945|2205790|P4|STARTED|Overall Study||6
912465|NCT01647945|2205791|P3|STARTED|Overall Study||5
912466|NCT01647945|2205792|P2|STARTED|Overall Study||6
912467|NCT01647945|2205793|P1|STARTED|Overall Study||6
912468|NCT01647737|2205813|P2|NOT COMPLETED|Overall Study||5
912469|NCT01647737|2205814|P1|NOT COMPLETED|Overall Study||4
912470|NCT01647737|2205813|P2|COMPLETED|Overall Study||25
912471|NCT01647737|2205814|P1|COMPLETED|Overall Study||26
912472|NCT01647737|2205813|P2|STARTED|Overall Study||30
912473|NCT01647737|2205814|P1|STARTED|Overall Study||30
912474|NCT01647711|2205825|P5|NOT COMPLETED|Overall Study||6
912475|NCT01647711|2205826|P4|NOT COMPLETED|Overall Study||11
912476|NCT01647711|2205827|P3|NOT COMPLETED|Overall Study||9
912477|NCT01647711|2205828|P2|NOT COMPLETED|Overall Study||3
912478|NCT01647711|2205829|P1|NOT COMPLETED|Overall Study||6
912479|NCT01647711|2205825|P5|COMPLETED|Overall Study||0
912480|NCT01647711|2205826|P4|COMPLETED|Overall Study||0
912481|NCT01647711|2205827|P3|COMPLETED|Overall Study||0
912482|NCT01647711|2205828|P2|COMPLETED|Overall Study||0
912483|NCT01647711|2205829|P1|COMPLETED|Overall Study||0
912484|NCT01647711|2205825|P5|STARTED|Overall Study||6
912485|NCT01647711|2205826|P4|STARTED|Overall Study||11
912486|NCT01647711|2205827|P3|STARTED|Overall Study||9
912487|NCT01647711|2205828|P2|STARTED|Overall Study||3
912488|NCT01647711|2205829|P1|STARTED|Overall Study||6
912489|NCT01647542|2205857|P3|NOT COMPLETED|Overall Study||72
912490|NCT01647542|2205858|P2|NOT COMPLETED|Overall Study||73
912491|NCT01647542|2205859|P1|NOT COMPLETED|Overall Study||76
912492|NCT01647542|2205857|P3|COMPLETED|Overall Study||59
912493|NCT01647542|2205858|P2|COMPLETED|Overall Study||58
912494|NCT01647542|2205859|P1|COMPLETED|Overall Study||55
912495|NCT01647542|2205857|P3|STARTED|Overall Study||131
912496|NCT01647542|2205858|P2|STARTED|Overall Study||131
912497|NCT01647542|2205859|P1|STARTED|Overall Study||131
912498|NCT01647464|2205876|P1|NOT COMPLETED|Overall Study||0
912499|NCT01647464|2205876|P1|COMPLETED|Overall Study||10
912500|NCT01647464|2205876|P1|STARTED|Overall Study||10
912501|NCT01647438|2205882|P2|NOT COMPLETED|Overall Study||0
912502|NCT01647438|2205883|P1|NOT COMPLETED|Overall Study||0
912503|NCT01647438|2205882|P2|COMPLETED|Overall Study||31
912504|NCT01647438|2205883|P1|COMPLETED|Overall Study||32
912505|NCT01647438|2205882|P2|STARTED|Overall Study||31
912506|NCT01647438|2205883|P1|STARTED|Overall Study||32
912507|NCT01647217|2205893|P2|NOT COMPLETED|Overall Study||1
912508|NCT01647217|2205894|P1|NOT COMPLETED|Overall Study||1
912509|NCT01647217|2205893|P2|COMPLETED|Overall Study||8
912510|NCT01647217|2205894|P1|COMPLETED|Overall Study||7
912511|NCT01647217|2205893|P2|STARTED|Overall Study||9
912512|NCT01647217|2205894|P1|STARTED|Overall Study||8
912513|NCT01646827|2205904|P2|NOT COMPLETED|Overall Study||5
912514|NCT01646827|2205905|P1|NOT COMPLETED|Overall Study||2
912515|NCT01646827|2205904|P2|COMPLETED|Overall Study||14
912516|NCT01646827|2205905|P1|COMPLETED|Overall Study||16
912517|NCT01646827|2205904|P2|STARTED|Overall Study||19
912518|NCT01646827|2205905|P1|STARTED|Overall Study||18
912519|NCT01646814|2205935|P2|NOT COMPLETED|Overall Study||6
912520|NCT01646814|2205936|P1|NOT COMPLETED|Overall Study||11
912521|NCT01646814|2205935|P2|COMPLETED|Overall Study||120
912522|NCT01646814|2205936|P1|COMPLETED|Overall Study||110
912523|NCT01646814|2205935|P2|STARTED|Overall Study||126
912524|NCT01646814|2205936|P1|STARTED|Overall Study||121
912528|NCT01646671|2205954|P3|NOT COMPLETED|Overall Study||0
912529|NCT01646671|2205955|P2|NOT COMPLETED|Overall Study||0
912530|NCT01646671|2205956|P1|NOT COMPLETED|Overall Study||0
912531|NCT01646671|2205954|P3|COMPLETED|Overall Study||21
912532|NCT01646671|2205955|P2|COMPLETED|Overall Study||11
912533|NCT01646671|2205956|P1|COMPLETED|Overall Study||3
912534|NCT01646671|2205954|P3|STARTED|Overall Study||21
912535|NCT01646671|2205955|P2|STARTED|Overall Study||11
912536|NCT01646671|2205956|P1|STARTED|Overall Study||3
912537|NCT01646398|2205992|P2|NOT COMPLETED|Overall Study||0
912538|NCT01646398|2205993|P1|NOT COMPLETED|Overall Study||1
912539|NCT01646398|2205992|P2|COMPLETED|Overall Study||382
912540|NCT01646398|2205993|P1|COMPLETED|Overall Study||381
912541|NCT01646398|2205992|P2|STARTED|Overall Study||382
912542|NCT01646398|2205993|P1|STARTED|Overall Study||382
912543|NCT01646385|2206009|P2|NOT COMPLETED|Overall Study||871
912544|NCT01646385|2206010|P1|NOT COMPLETED|Overall Study||838
912545|NCT01646385|2206009|P2|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|1993
912546|NCT01646385|2206010|P1|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|2691
912547|NCT01646385|2206009|P2|STARTED|Overall Study||2864
912548|NCT01646385|2206010|P1|STARTED|Overall Study||3529
912549|NCT01646320|2206043|P2|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||7
912550|NCT01646320|2206044|P1|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||6
912551|NCT01646320|2206043|P2|COMPLETED|Long-term Period (Weeks 24 to 52)||140
912552|NCT01646320|2206044|P1|COMPLETED|Long-term Period (Weeks 24 to 52)||141
912553|NCT01646320|2206043|P2|STARTED|Long-term Period (Weeks 24 to 52)||147
912554|NCT01646320|2206044|P1|STARTED|Long-term Period (Weeks 24 to 52)||147
912555|NCT01646320|2206043|P2|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||7
912556|NCT01646320|2206044|P1|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||12
912557|NCT01646320|2206043|P2|COMPLETED|Short-term Period (Day 1 to Week 24)||153
912558|NCT01646320|2206044|P1|COMPLETED|Short-term Period (Day 1 to Week 24)||148
912559|NCT01646320|2206043|P2|STARTED|Short-term Period (Day 1 to Week 24)||160
912560|NCT01646320|2206044|P1|STARTED|Short-term Period (Day 1 to Week 24)||160
912561|NCT01646268|2206060|P2|NOT COMPLETED|Overall Study||16
912562|NCT01646268|2206061|P1|NOT COMPLETED|Overall Study||11
912563|NCT01646268|2206060|P2|COMPLETED|Overall Study||107
912564|NCT01646268|2206061|P1|COMPLETED|Overall Study||113
912565|NCT01646268|2206060|P2|STARTED|Overall Study||123
912566|NCT01646268|2206061|P1|STARTED|Overall Study||124
912567|NCT01646255|2206075|P2|NOT COMPLETED|Overall Study||14
912568|NCT01646255|2206076|P1|NOT COMPLETED|Overall Study||21
912569|NCT01646255|2206075|P2|COMPLETED|Overall Study||160
912570|NCT01646255|2206076|P1|COMPLETED|Overall Study||151
912571|NCT01646255|2206075|P2|STARTED|Overall Study||174
912572|NCT01646255|2206076|P1|STARTED|Overall Study||172
912597|NCT01646151|2206191|P1|NOT COMPLETED|Overall Study||170
912598|NCT01646151|2206191|P1|COMPLETED|Overall Study||2410
912599|NCT01646151|2206191|P1|STARTED|Overall Study||2580
912600|NCT01646138|2206207|P5|NOT COMPLETED|Overall Study||2
912601|NCT01646138|2206208|P4|NOT COMPLETED|Overall Study||0
912602|NCT01646138|2206209|P3|NOT COMPLETED|Overall Study||0
912603|NCT01646138|2206210|P2|NOT COMPLETED|Overall Study||0
912604|NCT01646138|2206211|P1|NOT COMPLETED|Overall Study||0
912605|NCT01646138|2206207|P5|COMPLETED|Overall Study||13
912606|NCT01646138|2206208|P4|COMPLETED|Overall Study||19
912607|NCT01646138|2206209|P3|COMPLETED|Overall Study||5
912608|NCT01646138|2206210|P2|COMPLETED|Overall Study||4
912609|NCT01646138|2206211|P1|COMPLETED|Overall Study||5
912610|NCT01646138|2206207|P5|STARTED|Overall Study||15
912611|NCT01646138|2206208|P4|STARTED|Overall Study||19
912612|NCT01646138|2206209|P3|STARTED|Overall Study||5
912613|NCT01646138|2206210|P2|STARTED|Overall Study||4
912614|NCT01646138|2206211|P1|STARTED|Overall Study||5
912615|NCT01646125|2206225|P2|NOT COMPLETED|Overall Study||28
912616|NCT01646125|2206226|P1|NOT COMPLETED|Overall Study||31
912617|NCT01646125|2206225|P2|COMPLETED|Overall Study||0
912618|NCT01646125|2206226|P1|COMPLETED|Overall Study||0
912619|NCT01646125|2206225|P2|STARTED|Overall Study||28
912620|NCT01646125|2206226|P1|STARTED|Overall Study||31
912621|NCT01646073|2206251|P2|NOT COMPLETED|Period B (12 Weeks)||13
912622|NCT01646073|2206252|P1|NOT COMPLETED|Period B (12 Weeks)||1
912623|NCT01646073|2206251|P2|COMPLETED|Period B (12 Weeks)||320
912624|NCT01646073|2206252|P1|COMPLETED|Period B (12 Weeks)||84
912625|NCT01646073|2206251|P2|STARTED|Period B (12 Weeks)||333
912626|NCT01646073|2206252|P1|STARTED|Period B (12 Weeks)||85
912627|NCT01646073|2206251|P2|NOT COMPLETED|Period A (12 Weeks)||5
912628|NCT01646073|2206252|P1|NOT COMPLETED|Period A (12 Weeks)||2
912629|NCT01646073|2206251|P2|COMPLETED|Period A (12 Weeks)||333
912630|NCT01646073|2206252|P1|COMPLETED|Period A (12 Weeks)||85
912631|NCT01646073|2206251|P2|STARTED|Period A (12 Weeks)||338
912632|NCT01646073|2206252|P1|STARTED|Period A (12 Weeks)||87
912633|NCT01646021|2206293|P2|NOT COMPLETED|Overall Study||78
912634|NCT01646021|2206294|P1|NOT COMPLETED|Overall Study||66
912635|NCT01646021|2206293|P2|COMPLETED|Overall Study||63
912636|NCT01646021|2206294|P1|COMPLETED|Overall Study||73
912637|NCT01646021|2206293|P2|Received Treatment|Overall Study||139
912638|NCT01646021|2206294|P1|Received Treatment|Overall Study||139
912639|NCT01646021|2206293|P2|STARTED|Overall Study||141
912640|NCT01646021|2206294|P1|STARTED|Overall Study||139
912641|NCT01645735|2206327|P2|NOT COMPLETED|Overall Study||1
912642|NCT01645735|2206328|P1|NOT COMPLETED|Overall Study||4
912643|NCT01645735|2206327|P2|COMPLETED|Overall Study||16
912644|NCT01645735|2206328|P1|COMPLETED|Overall Study||28
912645|NCT01645735|2206327|P2|STARTED|Overall Study||17
912646|NCT01645735|2206328|P1|STARTED|Overall Study||32
912647|NCT01645709|2206342|P2|NOT COMPLETED|Overall Study||0
912648|NCT01645709|2206343|P1|NOT COMPLETED|Overall Study||0
912649|NCT01645709|2206342|P2|COMPLETED|Overall Study|Study was terminated; not made unblind|0
912650|NCT01645709|2206343|P1|COMPLETED|Overall Study|Study was terminated; not made unblind|0
912651|NCT01645709|2206342|P2|STARTED|Overall Study|Study was terminated; not made unblind|0
912652|NCT01645709|2206343|P1|STARTED|Overall Study|Study was terminated; not made unblind|0
912653|NCT01645280|2206370|P5|NOT COMPLETED|Overall Study||8
912654|NCT01645280|2206371|P4|NOT COMPLETED|Overall Study||6
912655|NCT01645280|2206372|P3|NOT COMPLETED|Overall Study||6
912656|NCT01645280|2206373|P2|NOT COMPLETED|Overall Study||3
912657|NCT01645280|2206374|P1|NOT COMPLETED|Overall Study||6
912658|NCT01645280|2206370|P5|COMPLETED|Overall Study||47
912659|NCT01645280|2206371|P4|COMPLETED|Overall Study||48
912660|NCT01645280|2206372|P3|COMPLETED|Overall Study||49
912661|NCT01645280|2206373|P2|COMPLETED|Overall Study||51
912662|NCT01645280|2206374|P1|COMPLETED|Overall Study||49
912663|NCT01645280|2206370|P5|STARTED|Overall Study||55
912664|NCT01645280|2206371|P4|STARTED|Overall Study||54
912665|NCT01645280|2206372|P3|STARTED|Overall Study||55
912666|NCT01645280|2206373|P2|STARTED|Overall Study||54
912667|NCT01645280|2206374|P1|STARTED|Overall Study|16 participants in placebo group early escaped to receive Ustekinmab; included in safety population.|55
912668|NCT01645176|2206402|P1|NOT COMPLETED|Overall Study||5
912669|NCT01645176|2206402|P1|COMPLETED|Overall Study||16
912670|NCT01645176|2206402|P1|STARTED|Overall Study||21
912671|NCT01645111|2206406|P1|NOT COMPLETED|Overall Study||15
912672|NCT01645111|2206406|P1|COMPLETED|Overall Study||35
912673|NCT01645111|2206406|P1|STARTED|Overall Study||50
912674|NCT01645098|2206412|P2|NOT COMPLETED|Overall Study||0
912675|NCT01645098|2206413|P1|NOT COMPLETED|Overall Study||0
912676|NCT01645098|2206412|P2|COMPLETED|Overall Study||29
912677|NCT01645098|2206413|P1|COMPLETED|Overall Study||24
912678|NCT01645098|2206412|P2|STARTED|Overall Study||29
912679|NCT01645098|2206413|P1|STARTED|Overall Study||24
912680|NCT01645059|2206427|P1|NOT COMPLETED|Overall Study||0
912681|NCT01645059|2206427|P1|COMPLETED|Overall Study||129
912682|NCT01645059|2206427|P1|STARTED|Overall Study||129
912683|NCT01644734|2206445|P1|NOT COMPLETED|Overall Study||266
912684|NCT01644734|2206445|P1|COMPLETED|Overall Study||1016
912685|NCT01644734|2206445|P1|STARTED|Overall Study|Patients with documentation of treatment.|1282
912686|NCT01644695|2206450|P1|NOT COMPLETED|Overall Study||0
912687|NCT01644695|2206450|P1|COMPLETED|Overall Study||85
912688|NCT01644695|2206450|P1|STARTED|Overall Study||85
912689|NCT01644643|2206459|P4|NOT COMPLETED|Overall Study||10
912690|NCT01644643|2206460|P3|NOT COMPLETED|Overall Study||5
912691|NCT01644643|2206461|P2|NOT COMPLETED|Overall Study||0
912692|NCT01644643|2206462|P1|NOT COMPLETED|Overall Study||2
912693|NCT01644643|2206459|P4|COMPLETED|Overall Study||143
912694|NCT01644643|2206460|P3|COMPLETED|Overall Study||148
912695|NCT01644643|2206461|P2|COMPLETED|Overall Study||12
912696|NCT01644643|2206462|P1|COMPLETED|Overall Study||13
912697|NCT01644643|2206459|P4|STARTED|Overall Study||153
912698|NCT01644643|2206460|P3|STARTED|Overall Study||153
912699|NCT01644643|2206461|P2|STARTED|Overall Study||12
912700|NCT01644643|2206462|P1|STARTED|Overall Study||15
912701|NCT01644617|2206627|P3|NOT COMPLETED|Overall Study||7
912702|NCT01644617|2206628|P2|NOT COMPLETED|Overall Study||5
912703|NCT01644617|2206629|P1|NOT COMPLETED|Overall Study||6
912704|NCT01644617|2206627|P3|COMPLETED|Overall Study||34
912705|NCT01644617|2206628|P2|COMPLETED|Overall Study||36
912706|NCT01644617|2206629|P1|COMPLETED|Overall Study||36
912707|NCT01644617|2206627|P3|STARTED|Overall Study||41
912708|NCT01644617|2206628|P2|STARTED|Overall Study||41
912709|NCT01644617|2206629|P1|STARTED|Overall Study||42
912710|NCT01644500|2206682|P3|NOT COMPLETED|Overall Study||18
912711|NCT01644500|2206683|P2|NOT COMPLETED|Overall Study||28
912712|NCT01644500|2206684|P1|NOT COMPLETED|Overall Study||24
912713|NCT01644500|2206682|P3|COMPLETED|Overall Study||253
912714|NCT01644500|2206683|P2|COMPLETED|Overall Study||240
912715|NCT01644500|2206684|P1|COMPLETED|Overall Study||244
912716|NCT01644500|2206682|P3|Modified Intent-to-treat Population|Overall Study||268
912717|NCT01644500|2206683|P2|Modified Intent-to-treat Population|Overall Study||259
912718|NCT01644500|2206684|P1|Modified Intent-to-treat Population|Overall Study||263
912719|NCT01644500|2206682|P3|Received at Least One Dose of Study Drug|Overall Study||269
912720|NCT01644500|2206683|P2|Received at Least One Dose of Study Drug|Overall Study||268
912721|NCT01644500|2206684|P1|Received at Least One Dose of Study Drug|Overall Study||268
912722|NCT01644500|2206682|P3|STARTED|Overall Study||271
912723|NCT01644500|2206683|P2|STARTED|Overall Study||268
912724|NCT01644500|2206684|P1|STARTED|Overall Study||268
912725|NCT01644474|2206754|P2|NOT COMPLETED|Overall Study||8
912726|NCT01644474|2206755|P1|NOT COMPLETED|Overall Study||7
912727|NCT01644474|2206754|P2|COMPLETED|Overall Study||44
912728|NCT01644474|2206755|P1|COMPLETED|Overall Study||44
912729|NCT01644474|2206754|P2|Treated|Overall Study||52
912730|NCT01644474|2206755|P1|Treated|Overall Study||51
912731|NCT01644474|2206754|P2|STARTED|Overall Study|Randomized|52
912732|NCT01644474|2206755|P1|STARTED|Overall Study|Randomized|51
912733|NCT01644396|2206795|P1|NOT COMPLETED|Overall Study||0
912734|NCT01644396|2206795|P1|COMPLETED|Overall Study||50
912735|NCT01644396|2206795|P1|STARTED|Overall Study||50
912736|NCT01644331|2206839|P2|NOT COMPLETED|Overall Study||10
912737|NCT01644331|2206840|P1|NOT COMPLETED|Overall Study||11
912738|NCT01644331|2206839|P2|COMPLETED|Overall Study||118
912739|NCT01644331|2206840|P1|COMPLETED|Overall Study||118
912740|NCT01644331|2206839|P2|STARTED|Overall Study||128
912741|NCT01644331|2206840|P1|STARTED|Overall Study||129
912742|NCT01644292|2206872|P1|NOT COMPLETED|Overall Study||0
912743|NCT01644292|2206872|P1|COMPLETED|Overall Study||2
912744|NCT01644292|2206872|P1|STARTED|Overall Study||2
912745|NCT01644240|2206879|P3|NOT COMPLETED|Overall Study||0
912746|NCT01644240|2206880|P2|NOT COMPLETED|Overall Study||0
912747|NCT01644240|2206881|P1|NOT COMPLETED|Overall Study||0
912748|NCT01644240|2206879|P3|COMPLETED|Overall Study||6
912749|NCT01644240|2206880|P2|COMPLETED|Overall Study||4
912750|NCT01644240|2206881|P1|COMPLETED|Overall Study||6
912751|NCT01644240|2206879|P3|STARTED|Overall Study||6
912752|NCT01644240|2206880|P2|STARTED|Overall Study||4
912753|NCT01644240|2206881|P1|STARTED|Overall Study||6
912754|NCT01644188|2206939|P2|NOT COMPLETED|Overall Study||75
912755|NCT01644188|2206940|P1|NOT COMPLETED|Overall Study||122
912756|NCT01644188|2206939|P2|COMPLETED|Overall Study||166
912757|NCT01644188|2206940|P1|COMPLETED|Overall Study||357
912758|NCT01644188|2206939|P2|Treated|Overall Study||241
912759|NCT01644188|2206940|P1|Treated|Overall Study||479
912760|NCT01644188|2206939|P2|STARTED|Overall Study|Randomized|241
912761|NCT01644188|2206940|P1|STARTED|Overall Study|Randomized|479
912762|NCT01644175|2206998|P2|NOT COMPLETED|Overall Study||53
912763|NCT01644175|2206999|P1|NOT COMPLETED|Overall Study||32
912764|NCT01644175|2206998|P2|COMPLETED|Overall Study||156
912765|NCT01644175|2206999|P1|COMPLETED|Overall Study||75
912766|NCT01644175|2206998|P2|Treated|Overall Study||207
912767|NCT01644175|2206999|P1|Treated|Overall Study||107
912768|NCT01644175|2206998|P2|STARTED|Overall Study|Randomized|209
912769|NCT01644175|2206999|P1|STARTED|Overall Study|Randomized|107
912770|NCT01644058|2207049|P1|NOT COMPLETED|Overall Study||0
912771|NCT01644058|2207049|P1|COMPLETED|Overall Study||18
912772|NCT01644058|2207049|P1|STARTED|Overall Study||18
912773|NCT01643928|2207059|P5|NOT COMPLETED|Overall Study||2
912774|NCT01643928|2207060|P4|NOT COMPLETED|Overall Study||3
912775|NCT01643928|2207061|P3|NOT COMPLETED|Overall Study||3
912776|NCT01643928|2207062|P2|NOT COMPLETED|Overall Study||2
912777|NCT01643928|2207063|P1|NOT COMPLETED|Overall Study||10
912778|NCT01643928|2207059|P5|COMPLETED|Overall Study||28
912779|NCT01643928|2207060|P4|COMPLETED|Overall Study||27
912780|NCT01643928|2207061|P3|COMPLETED|Overall Study||30
912781|NCT01643928|2207062|P2|COMPLETED|Overall Study||30
912782|NCT01643928|2207063|P1|COMPLETED|Overall Study||48
912783|NCT01643928|2207059|P5|STARTED|Overall Study||30
912784|NCT01643928|2207060|P4|STARTED|Overall Study||30
912785|NCT01643928|2207061|P3|STARTED|Overall Study||33
912786|NCT01643928|2207062|P2|STARTED|Overall Study||32
912787|NCT01643928|2207063|P1|STARTED|Overall Study||58
912788|NCT01643902|2207348|P1|NOT COMPLETED|Overall Study||0
912789|NCT01643902|2207348|P1|COMPLETED|Overall Study||20
912790|NCT01643902|2207348|P1|STARTED|Overall Study||20
912791|NCT01643876|2207353|P1|NOT COMPLETED|Overall Study||0
912792|NCT01643876|2207353|P1|COMPLETED|Overall Study||48
912793|NCT01643876|2207353|P1|STARTED|Overall Study||48
912794|NCT01643798|2207358|P2|NOT COMPLETED|Pretreatment 2 and Stimulation||0
912795|NCT01643798|2207359|P1|NOT COMPLETED|Pretreatment 2 and Stimulation||0
912796|NCT01643798|2207358|P2|COMPLETED|Pretreatment 2 and Stimulation||8
912797|NCT01643798|2207359|P1|COMPLETED|Pretreatment 2 and Stimulation||6
912798|NCT01643798|2207358|P2|STARTED|Pretreatment 2 and Stimulation||8
912799|NCT01643798|2207359|P1|STARTED|Pretreatment 2 and Stimulation||6
912800|NCT01643798|2207358|P2|NOT COMPLETED|Pretreatment 1 and Stimulation||0
912801|NCT01643798|2207359|P1|NOT COMPLETED|Pretreatment 1 and Stimulation||1
912802|NCT01643798|2207358|P2|COMPLETED|Pretreatment 1 and Stimulation||8
912803|NCT01643798|2207359|P1|COMPLETED|Pretreatment 1 and Stimulation||6
912804|NCT01643798|2207358|P2|STARTED|Pretreatment 1 and Stimulation||8
912805|NCT01643798|2207359|P1|STARTED|Pretreatment 1 and Stimulation||7
912806|NCT01643668|2207370|P1|NOT COMPLETED|Overall Study||1
912807|NCT01643668|2207370|P1|COMPLETED|Overall Study||33
912808|NCT01643668|2207370|P1|STARTED|Overall Study||34
912809|NCT01643616|2207384|P2|NOT COMPLETED|Overall Study||0
912810|NCT01643616|2207385|P1|NOT COMPLETED|Overall Study||0
912811|NCT01643616|2207384|P2|COMPLETED|Overall Study||125
912812|NCT01643616|2207385|P1|COMPLETED|Overall Study||125
912813|NCT01643616|2207384|P2|STARTED|Overall Study||125
912814|NCT01643616|2207385|P1|STARTED|Overall Study||125
912815|NCT01643525|2207395|P1|NOT COMPLETED|Overall Study||0
912816|NCT01643525|2207395|P1|COMPLETED|Overall Study||29
912817|NCT01643525|2207395|P1|STARTED|Overall Study||29
912818|NCT01643213|2207401|P2|NOT COMPLETED|Overall Study||0
912819|NCT01643213|2207402|P1|NOT COMPLETED|Overall Study||1
912820|NCT01643213|2207401|P2|COMPLETED|Overall Study||14
912821|NCT01643213|2207402|P1|COMPLETED|Overall Study||12
912822|NCT01643213|2207401|P2|STARTED|Overall Study||14
912823|NCT01643213|2207402|P1|STARTED|Overall Study||13
912824|NCT01643044|2207410|P2|NOT COMPLETED|Overall Study||5
912825|NCT01643044|2207411|P1|NOT COMPLETED|Overall Study||4
912826|NCT01643044|2207410|P2|COMPLETED|Overall Study||19
912827|NCT01643044|2207411|P1|COMPLETED|Overall Study||20
912828|NCT01643044|2207410|P2|STARTED|Overall Study||24
912829|NCT01643044|2207411|P1|STARTED|Overall Study||24
912830|NCT01642914|2207420|P3|NOT COMPLETED|Overall Study||40
912831|NCT01642914|2207421|P2|NOT COMPLETED|Overall Study||32
912832|NCT01642914|2207422|P1|NOT COMPLETED|Overall Study||46
912833|NCT01642914|2207420|P3|COMPLETED|Overall Study||120
912834|NCT01642914|2207421|P2|COMPLETED|Overall Study||122
912835|NCT01642914|2207422|P1|COMPLETED|Overall Study||127
912836|NCT01642914|2207420|P3|STARTED|Overall Study||160
912837|NCT01642914|2207421|P2|STARTED|Overall Study||154
912838|NCT01642914|2207422|P1|STARTED|Overall Study||173
912839|NCT01642732|2207497|P1|NOT COMPLETED|Overall Study||1
912840|NCT01642732|2207497|P1|COMPLETED|Overall Study||0
912841|NCT01642732|2207497|P1|STARTED|Overall Study||1
912842|NCT01642615|2207502|P3|NOT COMPLETED|Double Blind Maintenance Phase||6
912843|NCT01642615|2207503|P2|NOT COMPLETED|Double Blind Maintenance Phase||7
912844|NCT01642615|2207504|P1|NOT COMPLETED|Double Blind Maintenance Phase||0
912845|NCT01642615|2207502|P3|COMPLETED|Double Blind Maintenance Phase||20
912846|NCT01642615|2207503|P2|COMPLETED|Double Blind Maintenance Phase||18
912847|NCT01642615|2207504|P1|COMPLETED|Double Blind Maintenance Phase||0
912848|NCT01642615|2207502|P3|STARTED|Double Blind Maintenance Phase||26
912849|NCT01642615|2207503|P2|STARTED|Double Blind Maintenance Phase||25
912850|NCT01642615|2207504|P1|STARTED|Double Blind Maintenance Phase||0
912851|NCT01642615|2207502|P3|NOT COMPLETED|Open Label Maintenance Phase||0
912852|NCT01642615|2207503|P2|NOT COMPLETED|Open Label Maintenance Phase||0
912853|NCT01642615|2207504|P1|NOT COMPLETED|Open Label Maintenance Phase||5
912854|NCT01642615|2207502|P3|COMPLETED|Open Label Maintenance Phase||0
912855|NCT01642615|2207503|P2|COMPLETED|Open Label Maintenance Phase||0
912856|NCT01642615|2207504|P1|COMPLETED|Open Label Maintenance Phase||58
912949|NCT01642485|2207545|P3|NOT COMPLETED|Period 1, Day 3||0
912857|NCT01642615|2207502|P3|Safety Analysis Set|Open Label Maintenance Phase||0
912858|NCT01642615|2207503|P2|Safety Analysis Set|Open Label Maintenance Phase||0
912859|NCT01642615|2207504|P1|Safety Analysis Set|Open Label Maintenance Phase||62
912860|NCT01642615|2207502|P3|STARTED|Open Label Maintenance Phase||0
912861|NCT01642615|2207503|P2|STARTED|Open Label Maintenance Phase||0
912862|NCT01642615|2207504|P1|STARTED|Open Label Maintenance Phase||63
912863|NCT01642602|2207518|P1|NOT COMPLETED|Overall Study||2
912864|NCT01642602|2207518|P1|COMPLETED|Overall Study||102
912865|NCT01642602|2207518|P1|STARTED|Overall Study||104
912866|NCT01642589|2207525|P2|NOT COMPLETED|Overall Study||1
912867|NCT01642589|2207526|P1|NOT COMPLETED|Overall Study||1
912868|NCT01642589|2207525|P2|COMPLETED|Overall Study||99
912869|NCT01642589|2207526|P1|COMPLETED|Overall Study||199
912870|NCT01642589|2207525|P2|STARTED|Overall Study||100
912871|NCT01642589|2207526|P1|STARTED|Overall Study||200
912872|NCT01642485|2207540|P8|NOT COMPLETED|Period 2, Day 3||0
912873|NCT01642485|2207541|P7|NOT COMPLETED|Period 2, Day 3||0
912874|NCT01642485|2207542|P6|NOT COMPLETED|Period 2, Day 3||0
912875|NCT01642485|2207543|P5|NOT COMPLETED|Period 2, Day 3||0
912876|NCT01642485|2207544|P4|NOT COMPLETED|Period 2, Day 3||0
912877|NCT01642485|2207545|P3|NOT COMPLETED|Period 2, Day 3||0
912878|NCT01642485|2207546|P2|NOT COMPLETED|Period 2, Day 3||0
912879|NCT01642485|2207547|P1|NOT COMPLETED|Period 2, Day 3||0
912880|NCT01642485|2207540|P8|COMPLETED|Period 2, Day 3||4
912881|NCT01642485|2207541|P7|COMPLETED|Period 2, Day 3||4
912882|NCT01642485|2207542|P6|COMPLETED|Period 2, Day 3||4
912883|NCT01642485|2207543|P5|COMPLETED|Period 2, Day 3||4
912884|NCT01642485|2207544|P4|COMPLETED|Period 2, Day 3||4
912885|NCT01642485|2207545|P3|COMPLETED|Period 2, Day 3||4
912886|NCT01642485|2207546|P2|COMPLETED|Period 2, Day 3||4
912887|NCT01642485|2207547|P1|COMPLETED|Period 2, Day 3||4
912888|NCT01642485|2207540|P8|STARTED|Period 2, Day 3||4
912889|NCT01642485|2207541|P7|STARTED|Period 2, Day 3||4
912890|NCT01642485|2207542|P6|STARTED|Period 2, Day 3||4
912891|NCT01642485|2207543|P5|STARTED|Period 2, Day 3||4
912892|NCT01642485|2207544|P4|STARTED|Period 2, Day 3||4
912893|NCT01642485|2207545|P3|STARTED|Period 2, Day 3||4
912894|NCT01642485|2207546|P2|STARTED|Period 2, Day 3||4
912895|NCT01642485|2207547|P1|STARTED|Period 2, Day 3||4
912896|NCT01642485|2207540|P8|NOT COMPLETED|Period 2, Day 2||0
912897|NCT01642485|2207541|P7|NOT COMPLETED|Period 2, Day 2||0
912898|NCT01642485|2207542|P6|NOT COMPLETED|Period 2, Day 2||0
912899|NCT01642485|2207543|P5|NOT COMPLETED|Period 2, Day 2||0
912900|NCT01642485|2207544|P4|NOT COMPLETED|Period 2, Day 2||0
912901|NCT01642485|2207545|P3|NOT COMPLETED|Period 2, Day 2||0
912902|NCT01642485|2207546|P2|NOT COMPLETED|Period 2, Day 2||0
912903|NCT01642485|2207547|P1|NOT COMPLETED|Period 2, Day 2||0
912904|NCT01642485|2207540|P8|COMPLETED|Period 2, Day 2||4
912905|NCT01642485|2207541|P7|COMPLETED|Period 2, Day 2||4
912906|NCT01642485|2207542|P6|COMPLETED|Period 2, Day 2||4
912907|NCT01642485|2207543|P5|COMPLETED|Period 2, Day 2||4
912908|NCT01642485|2207544|P4|COMPLETED|Period 2, Day 2||4
912909|NCT01642485|2207545|P3|COMPLETED|Period 2, Day 2||4
912910|NCT01642485|2207546|P2|COMPLETED|Period 2, Day 2||4
912911|NCT01642485|2207547|P1|COMPLETED|Period 2, Day 2||4
912912|NCT01642485|2207540|P8|STARTED|Period 2, Day 2||4
912913|NCT01642485|2207541|P7|STARTED|Period 2, Day 2||4
912914|NCT01642485|2207542|P6|STARTED|Period 2, Day 2||4
912915|NCT01642485|2207543|P5|STARTED|Period 2, Day 2||4
912916|NCT01642485|2207544|P4|STARTED|Period 2, Day 2||4
912917|NCT01642485|2207545|P3|STARTED|Period 2, Day 2||4
912918|NCT01642485|2207546|P2|STARTED|Period 2, Day 2||4
912919|NCT01642485|2207547|P1|STARTED|Period 2, Day 2||4
912920|NCT01642485|2207540|P8|NOT COMPLETED|Period 2, Day 1||0
912921|NCT01642485|2207541|P7|NOT COMPLETED|Period 2, Day 1||0
912922|NCT01642485|2207542|P6|NOT COMPLETED|Period 2, Day 1||0
912923|NCT01642485|2207543|P5|NOT COMPLETED|Period 2, Day 1||0
912924|NCT01642485|2207544|P4|NOT COMPLETED|Period 2, Day 1||0
912925|NCT01642485|2207545|P3|NOT COMPLETED|Period 2, Day 1||0
912926|NCT01642485|2207546|P2|NOT COMPLETED|Period 2, Day 1||0
912927|NCT01642485|2207547|P1|NOT COMPLETED|Period 2, Day 1||0
912928|NCT01642485|2207540|P8|COMPLETED|Period 2, Day 1||4
912929|NCT01642485|2207541|P7|COMPLETED|Period 2, Day 1||4
912930|NCT01642485|2207542|P6|COMPLETED|Period 2, Day 1||4
912931|NCT01642485|2207543|P5|COMPLETED|Period 2, Day 1||4
912932|NCT01642485|2207544|P4|COMPLETED|Period 2, Day 1||4
912933|NCT01642485|2207545|P3|COMPLETED|Period 2, Day 1||4
912934|NCT01642485|2207546|P2|COMPLETED|Period 2, Day 1||4
912935|NCT01642485|2207547|P1|COMPLETED|Period 2, Day 1||4
912936|NCT01642485|2207540|P8|STARTED|Period 2, Day 1||4
912937|NCT01642485|2207541|P7|STARTED|Period 2, Day 1||4
912938|NCT01642485|2207542|P6|STARTED|Period 2, Day 1||4
912939|NCT01642485|2207543|P5|STARTED|Period 2, Day 1||4
912940|NCT01642485|2207544|P4|STARTED|Period 2, Day 1||4
912941|NCT01642485|2207545|P3|STARTED|Period 2, Day 1||4
912942|NCT01642485|2207546|P2|STARTED|Period 2, Day 1||4
912943|NCT01642485|2207547|P1|STARTED|Period 2, Day 1||4
912944|NCT01642485|2207540|P8|NOT COMPLETED|Period 1, Day 3||0
912945|NCT01642485|2207541|P7|NOT COMPLETED|Period 1, Day 3||0
912946|NCT01642485|2207542|P6|NOT COMPLETED|Period 1, Day 3||0
912947|NCT01642485|2207543|P5|NOT COMPLETED|Period 1, Day 3||0
912948|NCT01642485|2207544|P4|NOT COMPLETED|Period 1, Day 3||0
912950|NCT01642485|2207546|P2|NOT COMPLETED|Period 1, Day 3||0
912951|NCT01642485|2207547|P1|NOT COMPLETED|Period 1, Day 3||0
912952|NCT01642485|2207540|P8|COMPLETED|Period 1, Day 3||4
912953|NCT01642485|2207541|P7|COMPLETED|Period 1, Day 3||4
912954|NCT01642485|2207542|P6|COMPLETED|Period 1, Day 3||4
912955|NCT01642485|2207543|P5|COMPLETED|Period 1, Day 3||4
912956|NCT01642485|2207544|P4|COMPLETED|Period 1, Day 3||4
912957|NCT01642485|2207545|P3|COMPLETED|Period 1, Day 3||4
912958|NCT01642485|2207546|P2|COMPLETED|Period 1, Day 3||4
912959|NCT01642485|2207547|P1|COMPLETED|Period 1, Day 3||4
912960|NCT01642485|2207540|P8|STARTED|Period 1, Day 3||4
912961|NCT01642485|2207541|P7|STARTED|Period 1, Day 3||4
912962|NCT01642485|2207542|P6|STARTED|Period 1, Day 3||4
912963|NCT01642485|2207543|P5|STARTED|Period 1, Day 3||4
912964|NCT01642485|2207544|P4|STARTED|Period 1, Day 3||4
912965|NCT01642485|2207545|P3|STARTED|Period 1, Day 3||4
912966|NCT01642485|2207546|P2|STARTED|Period 1, Day 3||4
912967|NCT01642485|2207547|P1|STARTED|Period 1, Day 3||4
912968|NCT01642485|2207540|P8|NOT COMPLETED|Period 1, Day 2||0
912969|NCT01642485|2207541|P7|NOT COMPLETED|Period 1, Day 2||0
912970|NCT01642485|2207542|P6|NOT COMPLETED|Period 1, Day 2||0
912971|NCT01642485|2207543|P5|NOT COMPLETED|Period 1, Day 2||0
912972|NCT01642485|2207544|P4|NOT COMPLETED|Period 1, Day 2||0
912973|NCT01642485|2207545|P3|NOT COMPLETED|Period 1, Day 2||0
912974|NCT01642485|2207546|P2|NOT COMPLETED|Period 1, Day 2||0
912975|NCT01642485|2207547|P1|NOT COMPLETED|Period 1, Day 2||0
912976|NCT01642485|2207540|P8|COMPLETED|Period 1, Day 2||4
912977|NCT01642485|2207541|P7|COMPLETED|Period 1, Day 2||4
912978|NCT01642485|2207542|P6|COMPLETED|Period 1, Day 2||4
912979|NCT01642485|2207543|P5|COMPLETED|Period 1, Day 2||4
912980|NCT01642485|2207544|P4|COMPLETED|Period 1, Day 2||4
912981|NCT01642485|2207545|P3|COMPLETED|Period 1, Day 2||4
912982|NCT01642485|2207546|P2|COMPLETED|Period 1, Day 2||4
912983|NCT01642485|2207547|P1|COMPLETED|Period 1, Day 2||4
912984|NCT01642485|2207540|P8|STARTED|Period 1, Day 2||4
912985|NCT01642485|2207541|P7|STARTED|Period 1, Day 2||4
912986|NCT01642485|2207542|P6|STARTED|Period 1, Day 2||4
912987|NCT01642485|2207543|P5|STARTED|Period 1, Day 2||4
912988|NCT01642485|2207544|P4|STARTED|Period 1, Day 2||4
912989|NCT01642485|2207545|P3|STARTED|Period 1, Day 2||4
912990|NCT01642485|2207546|P2|STARTED|Period 1, Day 2||4
912991|NCT01642485|2207547|P1|STARTED|Period 1, Day 2||4
912992|NCT01642485|2207540|P8|NOT COMPLETED|Period 1, Day 1||0
912993|NCT01642485|2207541|P7|NOT COMPLETED|Period 1, Day 1||0
912994|NCT01642485|2207542|P6|NOT COMPLETED|Period 1, Day 1||0
912995|NCT01642485|2207543|P5|NOT COMPLETED|Period 1, Day 1||0
912996|NCT01642485|2207544|P4|NOT COMPLETED|Period 1, Day 1||0
912997|NCT01642485|2207545|P3|NOT COMPLETED|Period 1, Day 1||0
912998|NCT01642485|2207546|P2|NOT COMPLETED|Period 1, Day 1||0
912999|NCT01642485|2207547|P1|NOT COMPLETED|Period 1, Day 1||0
913000|NCT01642485|2207540|P8|COMPLETED|Period 1, Day 1||4
913001|NCT01642485|2207541|P7|COMPLETED|Period 1, Day 1||4
913002|NCT01642485|2207542|P6|COMPLETED|Period 1, Day 1||4
913003|NCT01642485|2207543|P5|COMPLETED|Period 1, Day 1||4
913004|NCT01642485|2207544|P4|COMPLETED|Period 1, Day 1||4
913005|NCT01642485|2207545|P3|COMPLETED|Period 1, Day 1||4
913006|NCT01642485|2207546|P2|COMPLETED|Period 1, Day 1||4
913007|NCT01642485|2207547|P1|COMPLETED|Period 1, Day 1||4
913008|NCT01642485|2207540|P8|STARTED|Period 1, Day 1||4
913009|NCT01642485|2207541|P7|STARTED|Period 1, Day 1||4
913010|NCT01642485|2207542|P6|STARTED|Period 1, Day 1||4
913011|NCT01642485|2207543|P5|STARTED|Period 1, Day 1||4
913012|NCT01642485|2207544|P4|STARTED|Period 1, Day 1||4
913013|NCT01642485|2207545|P3|STARTED|Period 1, Day 1||4
913014|NCT01642485|2207546|P2|STARTED|Period 1, Day 1||4
913015|NCT01642485|2207547|P1|STARTED|Period 1, Day 1|crossover so all subjects had this treatment|4
913016|NCT01642407|2207565|P1|NOT COMPLETED|Overall Study||2
913017|NCT01642407|2207565|P1|COMPLETED|Overall Study||4
913018|NCT01642407|2207565|P1|STARTED|Overall Study||6
913019|NCT01642277|2207609|P2|NOT COMPLETED|Overall Study||0
913020|NCT01642277|2207610|P1|NOT COMPLETED|Overall Study||24
913021|NCT01642277|2207609|P2|COMPLETED|Overall Study||60
913022|NCT01642277|2207610|P1|COMPLETED|Overall Study||50
913023|NCT01642277|2207609|P2|STARTED|Overall Study||60
913024|NCT01642277|2207610|P1|STARTED|Overall Study||74
913025|NCT01642238|2207619|P2|NOT COMPLETED|Second Intervention (1 Day)||0
913026|NCT01642238|2207620|P1|NOT COMPLETED|Second Intervention (1 Day)||0
913027|NCT01642238|2207619|P2|COMPLETED|Second Intervention (1 Day)||8
913028|NCT01642238|2207620|P1|COMPLETED|Second Intervention (1 Day)||7
913029|NCT01642238|2207619|P2|STARTED|Second Intervention (1 Day)||8
913030|NCT01642238|2207620|P1|STARTED|Second Intervention (1 Day)||7
913031|NCT01642238|2207619|P2|NOT COMPLETED|Washout (1-2 Weeks)||0
913032|NCT01642238|2207620|P1|NOT COMPLETED|Washout (1-2 Weeks)||0
913033|NCT01642238|2207619|P2|COMPLETED|Washout (1-2 Weeks)||8
913034|NCT01642238|2207620|P1|COMPLETED|Washout (1-2 Weeks)||7
913035|NCT01642238|2207619|P2|STARTED|Washout (1-2 Weeks)||8
913036|NCT01642238|2207620|P1|STARTED|Washout (1-2 Weeks)||7
913037|NCT01642238|2207619|P2|NOT COMPLETED|First Intervention (1 Day)||0
913038|NCT01642238|2207620|P1|NOT COMPLETED|First Intervention (1 Day)||0
913039|NCT01642238|2207619|P2|COMPLETED|First Intervention (1 Day)||8
913040|NCT01642238|2207620|P1|COMPLETED|First Intervention (1 Day)||7
913041|NCT01642238|2207619|P2|STARTED|First Intervention (1 Day)||8
913042|NCT01642238|2207620|P1|STARTED|First Intervention (1 Day)||7
913043|NCT01642212|2207642|P5|NOT COMPLETED|Open-label Extension||8
913044|NCT01642212|2207643|P4|NOT COMPLETED|Open-label Extension||10
913045|NCT01642212|2207644|P3|NOT COMPLETED|Open-label Extension||0
913046|NCT01642212|2207645|P2|NOT COMPLETED|Open-label Extension||0
913047|NCT01642212|2207646|P1|NOT COMPLETED|Open-label Extension||0
913048|NCT01642212|2207642|P5|COMPLETED|Open-label Extension||37
913049|NCT01642212|2207643|P4|COMPLETED|Open-label Extension||27
913050|NCT01642212|2207644|P3|COMPLETED|Open-label Extension||0
913051|NCT01642212|2207645|P2|COMPLETED|Open-label Extension||0
913052|NCT01642212|2207646|P1|COMPLETED|Open-label Extension||0
913053|NCT01642212|2207642|P5|STARTED|Open-label Extension|Four participants completed double-blind treatment but did not enter the open-label extension.|45
913054|NCT01642212|2207643|P4|STARTED|Open-label Extension|Two participants completed double-blind treatment but did not enter the open-label extension.|37
913055|NCT01642212|2207644|P3|STARTED|Open-label Extension||0
913056|NCT01642212|2207645|P2|STARTED|Open-label Extension||0
913057|NCT01642212|2207646|P1|STARTED|Open-label Extension||0
913058|NCT01642212|2207642|P5|NOT COMPLETED|Double-blind Treatment||0
913059|NCT01642212|2207643|P4|NOT COMPLETED|Double-blind Treatment||0
913060|NCT01642212|2207644|P3|NOT COMPLETED|Double-blind Treatment||2
913061|NCT01642212|2207645|P2|NOT COMPLETED|Double-blind Treatment||3
913062|NCT01642212|2207646|P1|NOT COMPLETED|Double-blind Treatment||0
913063|NCT01642212|2207642|P5|COMPLETED|Double-blind Treatment||0
913064|NCT01642212|2207643|P4|COMPLETED|Double-blind Treatment||0
913065|NCT01642212|2207644|P3|COMPLETED|Double-blind Treatment||49
913066|NCT01642212|2207645|P2|COMPLETED|Double-blind Treatment||39
913067|NCT01642212|2207646|P1|COMPLETED|Double-blind Treatment||0
913068|NCT01642212|2207642|P5|STARTED|Double-blind Treatment||0
913069|NCT01642212|2207643|P4|STARTED|Double-blind Treatment||0
913070|NCT01642212|2207644|P3|STARTED|Double-blind Treatment||51
913071|NCT01642212|2207645|P2|STARTED|Double-blind Treatment||42
913072|NCT01642212|2207646|P1|STARTED|Double-blind Treatment||0
913073|NCT01642212|2207642|P5|NOT COMPLETED|Single-blind Baseline||0
913074|NCT01642212|2207643|P4|NOT COMPLETED|Single-blind Baseline||0
913075|NCT01642212|2207644|P3|NOT COMPLETED|Single-blind Baseline||0
913076|NCT01642212|2207645|P2|NOT COMPLETED|Single-blind Baseline||0
913077|NCT01642212|2207646|P1|NOT COMPLETED|Single-blind Baseline||26
913078|NCT01642212|2207642|P5|COMPLETED|Single-blind Baseline||0
913079|NCT01642212|2207643|P4|COMPLETED|Single-blind Baseline||0
913080|NCT01642212|2207644|P3|COMPLETED|Single-blind Baseline||0
913081|NCT01642212|2207645|P2|COMPLETED|Single-blind Baseline||0
913082|NCT01642212|2207646|P1|COMPLETED|Single-blind Baseline||93
913083|NCT01642212|2207642|P5|STARTED|Single-blind Baseline||0
913084|NCT01642212|2207643|P4|STARTED|Single-blind Baseline||0
913085|NCT01642212|2207644|P3|STARTED|Single-blind Baseline||0
913086|NCT01642212|2207645|P2|STARTED|Single-blind Baseline||0
913087|NCT01642212|2207646|P1|STARTED|Single-blind Baseline||119
913088|NCT01642147|2207696|P2|NOT COMPLETED|Overall Study||0
913089|NCT01642147|2207697|P1|NOT COMPLETED|Overall Study||0
913090|NCT01642147|2207696|P2|COMPLETED|Overall Study||30
913091|NCT01642147|2207697|P1|COMPLETED|Overall Study||30
913092|NCT01642147|2207696|P2|STARTED|Overall Study||30
913093|NCT01642147|2207697|P1|STARTED|Overall Study||30
913094|NCT01642082|2207725|P1|NOT COMPLETED|Overall Study||0
913095|NCT01642082|2207725|P1|COMPLETED|Overall Study||28
913096|NCT01642082|2207725|P1|STARTED|Overall Study||28
913097|NCT01642004|2207735|P2|NOT COMPLETED|Treatment||127
913098|NCT01642004|2207736|P1|NOT COMPLETED|Treatment||110
913099|NCT01642004|2207735|P2|COMPLETED|Treatment||2
913100|NCT01642004|2207736|P1|COMPLETED|Treatment||21
913101|NCT01642004|2207735|P2|STARTED|Treatment||129
913102|NCT01642004|2207736|P1|STARTED|Treatment||131
913103|NCT01642004|2207735|P2|NOT COMPLETED|Randomization||8
913104|NCT01642004|2207736|P1|NOT COMPLETED|Randomization||4
913105|NCT01642004|2207735|P2|COMPLETED|Randomization||129
913106|NCT01642004|2207736|P1|COMPLETED|Randomization||131
913107|NCT01642004|2207735|P2|STARTED|Randomization||137
913108|NCT01642004|2207736|P1|STARTED|Randomization||135
913109|NCT01641991|2207770|P4|NOT COMPLETED|Overall Study||16
913110|NCT01641991|2207771|P3|NOT COMPLETED|Overall Study||17
913111|NCT01641991|2207772|P2|NOT COMPLETED|Overall Study||8
913112|NCT01641991|2207773|P1|NOT COMPLETED|Overall Study||9
913113|NCT01641991|2207770|P4|COMPLETED|Overall Study||66
913114|NCT01641991|2207771|P3|COMPLETED|Overall Study||65
913115|NCT01641991|2207772|P2|COMPLETED|Overall Study||74
913116|NCT01641991|2207773|P1|COMPLETED|Overall Study||73
913117|NCT01641991|2207770|P4|STARTED|Overall Study||82
913118|NCT01641991|2207771|P3|STARTED|Overall Study||82
913119|NCT01641991|2207772|P2|STARTED|Overall Study||82
913120|NCT01641991|2207773|P1|STARTED|Overall Study||82
913121|NCT01641978|2207849|P1|NOT COMPLETED|Overall Study||0
913122|NCT01641978|2207849|P1|COMPLETED|Overall Study||125
913123|NCT01641978|2207849|P1|STARTED|Overall Study||125
913124|NCT01641952|2207857|P1|NOT COMPLETED|Overall Study||34
913125|NCT01641952|2207857|P1|COMPLETED|Overall Study||471
913126|NCT01641952|2207857|P1|Treated|Overall Study||504
913127|NCT01641952|2207857|P1|STARTED|Overall Study||505
913128|NCT01641939|2207873|P3|NOT COMPLETED|Overall Study||70
913129|NCT01641939|2207874|P2|NOT COMPLETED|Overall Study||228
913130|NCT01641939|2207875|P1|NOT COMPLETED|Overall Study||117
913131|NCT01641939|2207873|P3|COMPLETED|Overall Study||0
913132|NCT01641939|2207874|P2|COMPLETED|Overall Study||0
913133|NCT01641939|2207875|P1|COMPLETED|Overall Study||0
913134|NCT01641939|2207873|P3|Stage 2|Overall Study||0
913135|NCT01641939|2207874|P2|Stage 2|Overall Study||153
913136|NCT01641939|2207875|P1|Stage 2|Overall Study||80
913137|NCT01641939|2207873|P3|Stage 1|Overall Study||70
913138|NCT01641939|2207874|P2|Stage 1|Overall Study||75
913139|NCT01641939|2207875|P1|Stage 1|Overall Study||37
913140|NCT01641939|2207873|P3|STARTED|Overall Study||70
913141|NCT01641939|2207874|P2|STARTED|Overall Study||228
913142|NCT01641939|2207875|P1|STARTED|Overall Study||117
913143|NCT01641926|2207918|P4|NOT COMPLETED|Overall Study||4
913144|NCT01641926|2207919|P3|NOT COMPLETED|Overall Study||11
913145|NCT01641926|2207920|P2|NOT COMPLETED|Overall Study||15
913146|NCT01641926|2207921|P1|NOT COMPLETED|Overall Study||28
913147|NCT01641926|2207918|P4|COMPLETED|Overall Study||53
913148|NCT01641926|2207919|P3|COMPLETED|Overall Study||46
913149|NCT01641926|2207920|P2|COMPLETED|Overall Study||130
913150|NCT01641926|2207921|P1|COMPLETED|Overall Study||115
913151|NCT01641926|2207918|P4|Treated (All Participants as Treated)|Overall Study||57
913152|NCT01641926|2207919|P3|Treated (All Participants as Treated)|Overall Study||56
913153|NCT01641926|2207920|P2|Treated (All Participants as Treated)|Overall Study||144
913154|NCT01641926|2207921|P1|Treated (All Participants as Treated)|Overall Study||142
913155|NCT01641926|2207918|P4|STARTED|Overall Study||57
913156|NCT01641926|2207919|P3|STARTED|Overall Study||57
913157|NCT01641926|2207920|P2|STARTED|Overall Study||145
913158|NCT01641926|2207921|P1|STARTED|Overall Study||143
913159|NCT01641900|2207949|P2|NOT COMPLETED|Overall Study||2
913160|NCT01641900|2207950|P1|NOT COMPLETED|Overall Study||2
913161|NCT01641900|2207949|P2|COMPLETED|Overall Study||29
913162|NCT01641900|2207950|P1|COMPLETED|Overall Study||26
913163|NCT01641900|2207949|P2|Completed Drug Intervention|Overall Study||29
913164|NCT01641900|2207950|P1|Completed Drug Intervention|Overall Study|n=1,assigned to drug intervention first, completed the session and dropped out of the study.|26
913165|NCT01641900|2207949|P2|Completed Placebo Intervention|Overall Study|n=2,both assigned to placebo intervention first, completed the session and dropped out of the study.|29
913166|NCT01641900|2207950|P1|Completed Placebo Intervention|Overall Study|n=1,assigned to placebo intervention first, completed the session and dropped out of the study.|27
913167|NCT01641900|2207949|P2|STARTED|Overall Study||31
913168|NCT01641900|2207950|P1|STARTED|Overall Study||28
913169|NCT01641861|2207962|P2|NOT COMPLETED|Overall Study||25
913170|NCT01641861|2207963|P1|NOT COMPLETED|Overall Study||35
913171|NCT01641861|2207962|P2|COMPLETED|Overall Study||217
913172|NCT01641861|2207963|P1|COMPLETED|Overall Study||211
913173|NCT01641861|2207962|P2|STARTED|Overall Study||242
913174|NCT01641861|2207963|P1|STARTED|Overall Study||246
913175|NCT01641835|2207977|P1|NOT COMPLETED|Overall Study||0
913176|NCT01641835|2207977|P1|COMPLETED|Overall Study||303
913177|NCT01641835|2207977|P1|STARTED|Overall Study||303
913178|NCT01641822|2207984|P3|NOT COMPLETED|Comparative Phase||10
913179|NCT01641822|2207985|P2|NOT COMPLETED|Comparative Phase||6
913180|NCT01641822|2207986|P1|NOT COMPLETED|Comparative Phase||0
913181|NCT01641822|2207984|P3|COMPLETED|Comparative Phase||37
913182|NCT01641822|2207985|P2|COMPLETED|Comparative Phase||37
913183|NCT01641822|2207986|P1|COMPLETED|Comparative Phase||0
913184|NCT01641822|2207984|P3|Received Randomized Study Drug Treatment|Comparative Phase||46
913185|NCT01641822|2207985|P2|Received Randomized Study Drug Treatment|Comparative Phase||42
913186|NCT01641822|2207986|P1|Received Randomized Study Drug Treatment|Comparative Phase||0
913187|NCT01641822|2207984|P3|STARTED|Comparative Phase||47
913188|NCT01641822|2207985|P2|STARTED|Comparative Phase||43
913189|NCT01641822|2207986|P1|STARTED|Comparative Phase|Participants continuing into the Comparative Phase were randomized to the AZLI or Placebo group.|0
913190|NCT01641822|2207984|P3|NOT COMPLETED|Run-in Phase||0
913191|NCT01641822|2207985|P2|NOT COMPLETED|Run-in Phase||0
913192|NCT01641822|2207986|P1|NOT COMPLETED|Run-in Phase||14
913193|NCT01641822|2207984|P3|COMPLETED|Run-in Phase||0
913194|NCT01641822|2207985|P2|COMPLETED|Run-in Phase||0
913195|NCT01641822|2207986|P1|COMPLETED|Run-in Phase|3 participants who completed the TIS Run-In Phase did not continue to the Comparative Phase.|93
913196|NCT01641822|2207984|P3|STARTED|Run-in Phase||0
913197|NCT01641822|2207985|P2|STARTED|Run-in Phase||0
913198|NCT01641822|2207986|P1|STARTED|Run-in Phase||107
913199|NCT01641692|2208003|P8|NOT COMPLETED|Washout Period 3 or Follow-up||0
913200|NCT01641692|2208004|P7|NOT COMPLETED|Washout Period 3 or Follow-up||1
913201|NCT01641692|2208005|P6|NOT COMPLETED|Washout Period 3 or Follow-up||2
913202|NCT01641692|2208006|P5|NOT COMPLETED|Washout Period 3 or Follow-up||0
913203|NCT01641692|2208007|P4|NOT COMPLETED|Washout Period 3 or Follow-up||1
913204|NCT01641692|2208008|P3|NOT COMPLETED|Washout Period 3 or Follow-up||1
913205|NCT01641692|2208009|P2|NOT COMPLETED|Washout Period 3 or Follow-up||0
913206|NCT01641692|2208010|P1|NOT COMPLETED|Washout Period 3 or Follow-up||1
913207|NCT01641692|2208003|P8|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|38
913208|NCT01641692|2208004|P7|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
913209|NCT01641692|2208005|P6|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|37
913210|NCT01641692|2208006|P5|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|40
913211|NCT01641692|2208007|P4|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|41
913212|NCT01641692|2208008|P3|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|36
913213|NCT01641692|2208009|P2|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
913214|NCT01641692|2208010|P1|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|42
913215|NCT01641692|2208003|P8|STARTED|Washout Period 3 or Follow-up||38
913216|NCT01641692|2208004|P7|STARTED|Washout Period 3 or Follow-up||33
913217|NCT01641692|2208005|P6|STARTED|Washout Period 3 or Follow-up||39
913218|NCT01641692|2208006|P5|STARTED|Washout Period 3 or Follow-up||40
913219|NCT01641692|2208007|P4|STARTED|Washout Period 3 or Follow-up||42
913220|NCT01641692|2208008|P3|STARTED|Washout Period 3 or Follow-up||37
913221|NCT01641692|2208009|P2|STARTED|Washout Period 3 or Follow-up||32
913222|NCT01641692|2208010|P1|STARTED|Washout Period 3 or Follow-up||43
913223|NCT01641692|2208003|P8|NOT COMPLETED|Treatment Period 3||0
913224|NCT01641692|2208004|P7|NOT COMPLETED|Treatment Period 3||2
913225|NCT01641692|2208005|P6|NOT COMPLETED|Treatment Period 3||0
913226|NCT01641692|2208006|P5|NOT COMPLETED|Treatment Period 3||0
913227|NCT01641692|2208007|P4|NOT COMPLETED|Treatment Period 3||0
913228|NCT01641692|2208008|P3|NOT COMPLETED|Treatment Period 3||1
913229|NCT01641692|2208009|P2|NOT COMPLETED|Treatment Period 3||1
913230|NCT01641692|2208010|P1|NOT COMPLETED|Treatment Period 3||0
913231|NCT01641692|2208003|P8|COMPLETED|Treatment Period 3||38
913232|NCT01641692|2208004|P7|COMPLETED|Treatment Period 3||33
913233|NCT01641692|2208005|P6|COMPLETED|Treatment Period 3||39
913234|NCT01641692|2208006|P5|COMPLETED|Treatment Period 3||40
913235|NCT01641692|2208007|P4|COMPLETED|Treatment Period 3||42
913236|NCT01641692|2208008|P3|COMPLETED|Treatment Period 3||37
913237|NCT01641692|2208009|P2|COMPLETED|Treatment Period 3||32
913238|NCT01641692|2208010|P1|COMPLETED|Treatment Period 3||43
913239|NCT01641692|2208003|P8|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
913240|NCT01641692|2208004|P7|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|35
913241|NCT01641692|2208005|P6|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|39
913242|NCT01641692|2208006|P5|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|40
913243|NCT01641692|2208007|P4|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|42
913244|NCT01641692|2208008|P3|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
913245|NCT01641692|2208009|P2|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|33
913246|NCT01641692|2208010|P1|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|43
913247|NCT01641692|2208003|P8|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
913248|NCT01641692|2208004|P7|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
913249|NCT01641692|2208005|P6|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
913250|NCT01641692|2208006|P5|NOT COMPLETED|Washout Period 2 (12-14 Days)||3
913251|NCT01641692|2208007|P4|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
913252|NCT01641692|2208008|P3|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
913253|NCT01641692|2208009|P2|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
913254|NCT01641692|2208010|P1|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
913255|NCT01641692|2208003|P8|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
913256|NCT01641692|2208004|P7|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
913257|NCT01641692|2208005|P6|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
913258|NCT01641692|2208006|P5|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
913259|NCT01641692|2208007|P4|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|41
913260|NCT01641692|2208008|P3|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
913261|NCT01641692|2208009|P2|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|46
913262|NCT01641692|2208010|P1|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|30
913263|NCT01641692|2208003|P8|STARTED|Washout Period 2 (12-14 Days)||35
913264|NCT01641692|2208004|P7|STARTED|Washout Period 2 (12-14 Days)||43
913265|NCT01641692|2208005|P6|STARTED|Washout Period 2 (12-14 Days)||43
913266|NCT01641692|2208006|P5|STARTED|Washout Period 2 (12-14 Days)||37
913267|NCT01641692|2208007|P4|STARTED|Washout Period 2 (12-14 Days)||41
913268|NCT01641692|2208008|P3|STARTED|Washout Period 2 (12-14 Days)||40
913269|NCT01641692|2208009|P2|STARTED|Washout Period 2 (12-14 Days)||46
913270|NCT01641692|2208010|P1|STARTED|Washout Period 2 (12-14 Days)||30
913271|NCT01641692|2208003|P8|NOT COMPLETED|Treatment Period 2||1
913272|NCT01641692|2208004|P7|NOT COMPLETED|Treatment Period 2||0
913273|NCT01641692|2208005|P6|NOT COMPLETED|Treatment Period 2||2
913274|NCT01641692|2208006|P5|NOT COMPLETED|Treatment Period 2||0
913275|NCT01641692|2208007|P4|NOT COMPLETED|Treatment Period 2||0
913276|NCT01641692|2208008|P3|NOT COMPLETED|Treatment Period 2||0
913277|NCT01641692|2208009|P2|NOT COMPLETED|Treatment Period 2||0
913278|NCT01641692|2208010|P1|NOT COMPLETED|Treatment Period 2||3
913279|NCT01641692|2208003|P8|COMPLETED|Treatment Period 2||35
913280|NCT01641692|2208004|P7|COMPLETED|Treatment Period 2||43
913281|NCT01641692|2208005|P6|COMPLETED|Treatment Period 2||43
913282|NCT01641692|2208006|P5|COMPLETED|Treatment Period 2||37
913283|NCT01641692|2208007|P4|COMPLETED|Treatment Period 2||41
913284|NCT01641692|2208008|P3|COMPLETED|Treatment Period 2||40
913285|NCT01641692|2208009|P2|COMPLETED|Treatment Period 2||46
913286|NCT01641692|2208010|P1|COMPLETED|Treatment Period 2||30
913287|NCT01641692|2208003|P8|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|36
913288|NCT01641692|2208004|P7|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|43
913289|NCT01641692|2208005|P6|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|45
913290|NCT01641692|2208006|P5|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|37
913291|NCT01641692|2208007|P4|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|41
913292|NCT01641692|2208008|P3|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|40
913293|NCT01641692|2208009|P2|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|46
913294|NCT01641692|2208010|P1|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|33
913295|NCT01641692|2208003|P8|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
913296|NCT01641692|2208004|P7|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
913297|NCT01641692|2208005|P6|NOT COMPLETED|Washout Period 1 (12-14 Days)||0
913298|NCT01641692|2208006|P5|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
913299|NCT01641692|2208007|P4|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
913300|NCT01641692|2208008|P3|NOT COMPLETED|Washout Period 1 (12-14 Days)||3
913301|NCT01641692|2208009|P2|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
913302|NCT01641692|2208010|P1|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
913303|NCT01641692|2208003|P8|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
913304|NCT01641692|2208004|P7|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
913305|NCT01641692|2208005|P6|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|37
913306|NCT01641692|2208006|P5|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|35
913307|NCT01641692|2208007|P4|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
913308|NCT01641692|2208008|P3|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
913309|NCT01641692|2208009|P2|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|44
913310|NCT01641692|2208010|P1|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
913311|NCT01641692|2208003|P8|STARTED|Washout Period 1 (12-14 Days)||48
913312|NCT01641692|2208004|P7|STARTED|Washout Period 1 (12-14 Days)||38
913313|NCT01641692|2208005|P6|STARTED|Washout Period 1 (12-14 Days)||37
913314|NCT01641692|2208006|P5|STARTED|Washout Period 1 (12-14 Days)||39
913315|NCT01641692|2208007|P4|STARTED|Washout Period 1 (12-14 Days)||41
913316|NCT01641692|2208008|P3|STARTED|Washout Period 1 (12-14 Days)||50
913317|NCT01641692|2208009|P2|STARTED|Washout Period 1 (12-14 Days)||45
913318|NCT01641692|2208010|P1|STARTED|Washout Period 1 (12-14 Days)||40
913319|NCT01641692|2208003|P8|NOT COMPLETED|Treatment Period 1||3
913320|NCT01641692|2208004|P7|NOT COMPLETED|Treatment Period 1||0
913321|NCT01641692|2208005|P6|NOT COMPLETED|Treatment Period 1||2
913322|NCT01641692|2208006|P5|NOT COMPLETED|Treatment Period 1||4
913323|NCT01641692|2208007|P4|NOT COMPLETED|Treatment Period 1||0
913324|NCT01641692|2208008|P3|NOT COMPLETED|Treatment Period 1||1
913325|NCT01641692|2208009|P2|NOT COMPLETED|Treatment Period 1||0
913326|NCT01641692|2208010|P1|NOT COMPLETED|Treatment Period 1||2
913327|NCT01641692|2208003|P8|COMPLETED|Treatment Period 1||48
913328|NCT01641692|2208004|P7|COMPLETED|Treatment Period 1||38
913329|NCT01641692|2208005|P6|COMPLETED|Treatment Period 1||37
913330|NCT01641692|2208006|P5|COMPLETED|Treatment Period 1||39
913331|NCT01641692|2208007|P4|COMPLETED|Treatment Period 1||41
913332|NCT01641692|2208008|P3|COMPLETED|Treatment Period 1||50
913333|NCT01641692|2208009|P2|COMPLETED|Treatment Period 1||45
913334|NCT01641692|2208010|P1|COMPLETED|Treatment Period 1||40
913335|NCT01641692|2208003|P8|STARTED|Treatment Period 1||51
913336|NCT01641692|2208004|P7|STARTED|Treatment Period 1||38
913337|NCT01641692|2208005|P6|STARTED|Treatment Period 1||39
913338|NCT01641692|2208006|P5|STARTED|Treatment Period 1||43
913339|NCT01641692|2208007|P4|STARTED|Treatment Period 1||41
913340|NCT01641692|2208008|P3|STARTED|Treatment Period 1||51
913341|NCT01641692|2208009|P2|STARTED|Treatment Period 1||45
913342|NCT01641692|2208010|P1|STARTED|Treatment Period 1||42
913343|NCT01641653|2208199|P2|NOT COMPLETED|Overall Study||0
913344|NCT01641653|2208200|P1|NOT COMPLETED|Overall Study||0
913345|NCT01641653|2208199|P2|COMPLETED|Overall Study||30
913346|NCT01641653|2208200|P1|COMPLETED|Overall Study||30
913347|NCT01641653|2208199|P2|STARTED|Overall Study||30
913348|NCT01641653|2208200|P1|STARTED|Overall Study||30
913349|NCT01641640|2208210|P1|NOT COMPLETED|Overall Study||36
913350|NCT01641640|2208210|P1|COMPLETED|Overall Study||292
913351|NCT01641640|2208210|P1|Enrolled and Treated|Overall Study||327
913352|NCT01641640|2208210|P1|STARTED|Overall Study||328
913359|NCT01641237|2208228|P4|NOT COMPLETED|Period IV||0
913360|NCT01641237|2208229|P3|NOT COMPLETED|Period IV||0
913361|NCT01641237|2208230|P2|NOT COMPLETED|Period IV||0
913362|NCT01641237|2208231|P1|NOT COMPLETED|Period IV||0
913363|NCT01641237|2208228|P4|COMPLETED|Period IV||15
913364|NCT01641237|2208229|P3|COMPLETED|Period IV||15
913365|NCT01641237|2208230|P2|COMPLETED|Period IV||15
913366|NCT01641237|2208231|P1|COMPLETED|Period IV||15
913367|NCT01641237|2208228|P4|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
913368|NCT01641237|2208229|P3|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
913369|NCT01641237|2208230|P2|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
913370|NCT01641237|2208231|P1|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
913371|NCT01641237|2208228|P4|NOT COMPLETED|Period III||0
913372|NCT01641237|2208229|P3|NOT COMPLETED|Period III||0
913373|NCT01641237|2208230|P2|NOT COMPLETED|Period III||0
913374|NCT01641237|2208231|P1|NOT COMPLETED|Period III||1
913375|NCT01641237|2208228|P4|COMPLETED|Period III||16
913376|NCT01641237|2208229|P3|COMPLETED|Period III||15
913377|NCT01641237|2208230|P2|COMPLETED|Period III||14
913378|NCT01641237|2208231|P1|COMPLETED|Period III||15
913379|NCT01641237|2208228|P4|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
913380|NCT01641237|2208229|P3|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|15
913381|NCT01641237|2208230|P2|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
913382|NCT01641237|2208231|P1|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
913383|NCT01641237|2208228|P4|NOT COMPLETED|Period II||0
913384|NCT01641237|2208229|P3|NOT COMPLETED|Period II||0
913385|NCT01641237|2208230|P2|NOT COMPLETED|Period II||0
913386|NCT01641237|2208231|P1|NOT COMPLETED|Period II||1
913387|NCT01641237|2208228|P4|COMPLETED|Period II||15
913388|NCT01641237|2208229|P3|COMPLETED|Period II||16
913389|NCT01641237|2208230|P2|COMPLETED|Period II||16
913390|NCT01641237|2208231|P1|COMPLETED|Period II||14
913391|NCT01641237|2208228|P4|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
913392|NCT01641237|2208229|P3|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
913393|NCT01641237|2208230|P2|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
913394|NCT01641237|2208231|P1|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
913395|NCT01641237|2208228|P4|NOT COMPLETED|Period I||0
913396|NCT01641237|2208229|P3|NOT COMPLETED|Period I||0
913397|NCT01641237|2208230|P2|NOT COMPLETED|Period I||0
913398|NCT01641237|2208231|P1|NOT COMPLETED|Period I||0
913399|NCT01641237|2208228|P4|COMPLETED|Period I||15
913400|NCT01641237|2208229|P3|COMPLETED|Period I||15
913401|NCT01641237|2208230|P2|COMPLETED|Period I||16
913402|NCT01641237|2208231|P1|COMPLETED|Period I||16
913403|NCT01641237|2208228|P4|STARTED|Period I||15
913404|NCT01641237|2208229|P3|STARTED|Period I||15
913405|NCT01641237|2208230|P2|STARTED|Period I||16
913406|NCT01641237|2208231|P1|STARTED|Period I||16
913407|NCT01641159|2208255|P2|NOT COMPLETED|Overall Study||2
913408|NCT01641159|2208256|P1|NOT COMPLETED|Overall Study||2
913409|NCT01641159|2208255|P2|COMPLETED|Overall Study||25
913410|NCT01641159|2208256|P1|COMPLETED|Overall Study||33
913411|NCT01641159|2208255|P2|STARTED|Overall Study||27
913412|NCT01641159|2208256|P1|STARTED|Overall Study||35
913413|NCT01641133|2208267|P3|NOT COMPLETED|Overall Study||8
913414|NCT01641133|2208268|P2|NOT COMPLETED|Overall Study||9
913415|NCT01641133|2208269|P1|NOT COMPLETED|Overall Study||10
913416|NCT01641133|2208267|P3|COMPLETED|Overall Study||90
913417|NCT01641133|2208268|P2|COMPLETED|Overall Study||90
913418|NCT01641133|2208269|P1|COMPLETED|Overall Study||87
913419|NCT01641133|2208267|P3|STARTED|Overall Study||98
913420|NCT01641133|2208268|P2|STARTED|Overall Study||99
913421|NCT01641133|2208269|P1|STARTED|Overall Study||97
913422|NCT01641120|2208307|P1|NOT COMPLETED|30 Gauge Needle Weeks 2 and 3||0
913423|NCT01641120|2208307|P1|COMPLETED|30 Gauge Needle Weeks 2 and 3||20
913424|NCT01641120|2208307|P1|STARTED|30 Gauge Needle Weeks 2 and 3||20
913425|NCT01641120|2208307|P1|NOT COMPLETED|25 Gauge Needle Weeks 1, 4, 5||0
913426|NCT01641120|2208307|P1|COMPLETED|25 Gauge Needle Weeks 1, 4, 5||20
913427|NCT01641120|2208307|P1|STARTED|25 Gauge Needle Weeks 1, 4, 5||20
913428|NCT01641081|2208319|P10|NOT COMPLETED|Period 5||0
913429|NCT01641081|2208320|P9|NOT COMPLETED|Period 5||0
913430|NCT01641081|2208321|P8|NOT COMPLETED|Period 5||0
913431|NCT01641081|2208322|P7|NOT COMPLETED|Period 5||0
913432|NCT01641081|2208323|P6|NOT COMPLETED|Period 5||0
913433|NCT01641081|2208324|P5|NOT COMPLETED|Period 5||0
913434|NCT01641081|2208325|P4|NOT COMPLETED|Period 5||0
913435|NCT01641081|2208326|P3|NOT COMPLETED|Period 5||2
913436|NCT01641081|2208327|P2|NOT COMPLETED|Period 5||0
913437|NCT01641081|2208328|P1|NOT COMPLETED|Period 5||0
913438|NCT01641081|2208319|P10|COMPLETED|Period 5||14
913439|NCT01641081|2208320|P9|COMPLETED|Period 5||14
913440|NCT01641081|2208321|P8|COMPLETED|Period 5||14
913441|NCT01641081|2208322|P7|COMPLETED|Period 5||16
913442|NCT01641081|2208323|P6|COMPLETED|Period 5||18
913443|NCT01641081|2208324|P5|COMPLETED|Period 5||16
913444|NCT01641081|2208325|P4|COMPLETED|Period 5||20
913445|NCT01641081|2208326|P3|COMPLETED|Period 5||12
913446|NCT01641081|2208327|P2|COMPLETED|Period 5||17
913447|NCT01641081|2208328|P1|COMPLETED|Period 5||16
913448|NCT01641081|2208319|P10|STARTED|Period 5||14
913449|NCT01641081|2208320|P9|STARTED|Period 5||14
913450|NCT01641081|2208321|P8|STARTED|Period 5||14
913451|NCT01641081|2208322|P7|STARTED|Period 5||16
913452|NCT01641081|2208323|P6|STARTED|Period 5||18
913453|NCT01641081|2208324|P5|STARTED|Period 5||16
913454|NCT01641081|2208325|P4|STARTED|Period 5||20
913455|NCT01641081|2208326|P3|STARTED|Period 5||14
913456|NCT01641081|2208327|P2|STARTED|Period 5||17
913457|NCT01641081|2208328|P1|STARTED|Period 5||16
913458|NCT01641081|2208319|P10|NOT COMPLETED|Period 4||0
913459|NCT01641081|2208320|P9|NOT COMPLETED|Period 4||0
913460|NCT01641081|2208321|P8|NOT COMPLETED|Period 4||0
913461|NCT01641081|2208322|P7|NOT COMPLETED|Period 4||0
913462|NCT01641081|2208323|P6|NOT COMPLETED|Period 4||0
913463|NCT01641081|2208324|P5|NOT COMPLETED|Period 4||0
913464|NCT01641081|2208325|P4|NOT COMPLETED|Period 4||1
913465|NCT01641081|2208326|P3|NOT COMPLETED|Period 4||0
913466|NCT01641081|2208327|P2|NOT COMPLETED|Period 4||1
913467|NCT01641081|2208328|P1|NOT COMPLETED|Period 4||0
913468|NCT01641081|2208319|P10|COMPLETED|Period 4||14
913469|NCT01641081|2208320|P9|COMPLETED|Period 4||14
913470|NCT01641081|2208321|P8|COMPLETED|Period 4||14
913471|NCT01641081|2208322|P7|COMPLETED|Period 4||16
913472|NCT01641081|2208323|P6|COMPLETED|Period 4||18
913473|NCT01641081|2208324|P5|COMPLETED|Period 4||16
913474|NCT01641081|2208325|P4|COMPLETED|Period 4||20
913475|NCT01641081|2208326|P3|COMPLETED|Period 4||14
913476|NCT01641081|2208327|P2|COMPLETED|Period 4||17
913477|NCT01641081|2208328|P1|COMPLETED|Period 4||16
913478|NCT01641081|2208319|P10|STARTED|Period 4||14
913479|NCT01641081|2208320|P9|STARTED|Period 4||14
913480|NCT01641081|2208321|P8|STARTED|Period 4||14
913481|NCT01641081|2208322|P7|STARTED|Period 4||16
913482|NCT01641081|2208323|P6|STARTED|Period 4||18
913483|NCT01641081|2208324|P5|STARTED|Period 4||16
913484|NCT01641081|2208325|P4|STARTED|Period 4||21
913485|NCT01641081|2208326|P3|STARTED|Period 4||14
913486|NCT01641081|2208327|P2|STARTED|Period 4||18
913487|NCT01641081|2208328|P1|STARTED|Period 4||16
913488|NCT01641081|2208319|P10|NOT COMPLETED|Period 3||0
913489|NCT01641081|2208320|P9|NOT COMPLETED|Period 3||1
913490|NCT01641081|2208321|P8|NOT COMPLETED|Period 3||0
913491|NCT01641081|2208322|P7|NOT COMPLETED|Period 3||0
913492|NCT01641081|2208323|P6|NOT COMPLETED|Period 3||0
913493|NCT01641081|2208324|P5|NOT COMPLETED|Period 3||0
913494|NCT01641081|2208325|P4|NOT COMPLETED|Period 3||0
913495|NCT01641081|2208326|P3|NOT COMPLETED|Period 3||1
913496|NCT01641081|2208327|P2|NOT COMPLETED|Period 3||0
913497|NCT01641081|2208328|P1|NOT COMPLETED|Period 3||0
913498|NCT01641081|2208319|P10|COMPLETED|Period 3||14
913499|NCT01641081|2208320|P9|COMPLETED|Period 3||14
913500|NCT01641081|2208321|P8|COMPLETED|Period 3||14
913501|NCT01641081|2208322|P7|COMPLETED|Period 3||16
913502|NCT01641081|2208323|P6|COMPLETED|Period 3||18
913503|NCT01641081|2208324|P5|COMPLETED|Period 3||16
913504|NCT01641081|2208325|P4|COMPLETED|Period 3||21
913505|NCT01641081|2208326|P3|COMPLETED|Period 3||14
913506|NCT01641081|2208327|P2|COMPLETED|Period 3||18
913507|NCT01641081|2208328|P1|COMPLETED|Period 3||16
913508|NCT01641081|2208319|P10|STARTED|Period 3||14
913509|NCT01641081|2208320|P9|STARTED|Period 3||15
913510|NCT01641081|2208321|P8|STARTED|Period 3||14
913511|NCT01641081|2208322|P7|STARTED|Period 3||16
913512|NCT01641081|2208323|P6|STARTED|Period 3||18
913513|NCT01641081|2208324|P5|STARTED|Period 3||16
913514|NCT01641081|2208325|P4|STARTED|Period 3||21
913515|NCT01641081|2208326|P3|STARTED|Period 3||15
913516|NCT01641081|2208327|P2|STARTED|Period 3||18
913517|NCT01641081|2208328|P1|STARTED|Period 3||16
913518|NCT01641081|2208319|P10|NOT COMPLETED|Period 2||0
913519|NCT01641081|2208320|P9|NOT COMPLETED|Period 2||0
913520|NCT01641081|2208321|P8|NOT COMPLETED|Period 2||0
913521|NCT01641081|2208322|P7|NOT COMPLETED|Period 2||2
913522|NCT01641081|2208323|P6|NOT COMPLETED|Period 2||1
913523|NCT01641081|2208324|P5|NOT COMPLETED|Period 2||0
913524|NCT01641081|2208325|P4|NOT COMPLETED|Period 2||1
913525|NCT01641081|2208326|P3|NOT COMPLETED|Period 2||0
913526|NCT01641081|2208327|P2|NOT COMPLETED|Period 2||0
913527|NCT01641081|2208328|P1|NOT COMPLETED|Period 2||1
913528|NCT01641081|2208319|P10|COMPLETED|Period 2||14
913529|NCT01641081|2208320|P9|COMPLETED|Period 2||15
913530|NCT01641081|2208321|P8|COMPLETED|Period 2||14
913531|NCT01641081|2208322|P7|COMPLETED|Period 2||16
913532|NCT01641081|2208323|P6|COMPLETED|Period 2||18
913533|NCT01641081|2208324|P5|COMPLETED|Period 2||16
913534|NCT01641081|2208325|P4|COMPLETED|Period 2||21
913535|NCT01641081|2208326|P3|COMPLETED|Period 2||15
913536|NCT01641081|2208327|P2|COMPLETED|Period 2||18
913537|NCT01641081|2208328|P1|COMPLETED|Period 2||16
913538|NCT01641081|2208319|P10|STARTED|Period 2||14
913539|NCT01641081|2208320|P9|STARTED|Period 2||15
913540|NCT01641081|2208321|P8|STARTED|Period 2||14
913541|NCT01641081|2208322|P7|STARTED|Period 2||18
913542|NCT01641081|2208323|P6|STARTED|Period 2||19
913543|NCT01641081|2208324|P5|STARTED|Period 2||16
913544|NCT01641081|2208325|P4|STARTED|Period 2||22
913545|NCT01641081|2208326|P3|STARTED|Period 2||15
913546|NCT01641081|2208327|P2|STARTED|Period 2||18
913547|NCT01641081|2208328|P1|STARTED|Period 2||17
913548|NCT01641081|2208319|P10|NOT COMPLETED|Period 1||0
913549|NCT01641081|2208320|P9|NOT COMPLETED|Period 1||0
913550|NCT01641081|2208321|P8|NOT COMPLETED|Period 1||3
913551|NCT01641081|2208322|P7|NOT COMPLETED|Period 1||1
913552|NCT01641081|2208323|P6|NOT COMPLETED|Period 1||0
913553|NCT01641081|2208324|P5|NOT COMPLETED|Period 1||1
913554|NCT01641081|2208325|P4|NOT COMPLETED|Period 1||0
913555|NCT01641081|2208326|P3|NOT COMPLETED|Period 1||0
913556|NCT01641081|2208327|P2|NOT COMPLETED|Period 1||0
913557|NCT01641081|2208328|P1|NOT COMPLETED|Period 1||1
913558|NCT01641081|2208319|P10|COMPLETED|Period 1||14
913559|NCT01641081|2208320|P9|COMPLETED|Period 1||15
913560|NCT01641081|2208321|P8|COMPLETED|Period 1||14
913561|NCT01641081|2208322|P7|COMPLETED|Period 1||18
913562|NCT01641081|2208323|P6|COMPLETED|Period 1||19
913563|NCT01641081|2208324|P5|COMPLETED|Period 1||16
913564|NCT01641081|2208325|P4|COMPLETED|Period 1||22
913565|NCT01641081|2208326|P3|COMPLETED|Period 1||15
913566|NCT01641081|2208327|P2|COMPLETED|Period 1||18
913567|NCT01641081|2208328|P1|COMPLETED|Period 1||17
913568|NCT01641081|2208319|P10|STARTED|Period 1||14
913569|NCT01641081|2208320|P9|STARTED|Period 1||15
913570|NCT01641081|2208321|P8|STARTED|Period 1||17
913571|NCT01641081|2208322|P7|STARTED|Period 1||19
913572|NCT01641081|2208323|P6|STARTED|Period 1||19
913573|NCT01641081|2208324|P5|STARTED|Period 1||17
913574|NCT01641081|2208325|P4|STARTED|Period 1||22
913575|NCT01641081|2208326|P3|STARTED|Period 1||15
913576|NCT01641081|2208327|P2|STARTED|Period 1||18
913577|NCT01641081|2208328|P1|STARTED|Period 1||18
913578|NCT01640964|2208348|P3|NOT COMPLETED|Overall Study||3
913579|NCT01640964|2208349|P2|NOT COMPLETED|Overall Study||1
913580|NCT01640964|2208350|P1|NOT COMPLETED|Overall Study||1
913581|NCT01640964|2208348|P3|COMPLETED|Overall Study||3
913582|NCT01640964|2208349|P2|COMPLETED|Overall Study||19
913583|NCT01640964|2208350|P1|COMPLETED|Overall Study||19
913584|NCT01640964|2208348|P3|STARTED|Overall Study||6
913585|NCT01640964|2208349|P2|STARTED|Overall Study||20
913586|NCT01640964|2208350|P1|STARTED|Overall Study||20
913587|NCT01640925|2208367|P2|NOT COMPLETED|Overall Study||11
913588|NCT01640925|2208368|P1|NOT COMPLETED|Overall Study||14
913589|NCT01640925|2208367|P2|COMPLETED|Overall Study||164
913590|NCT01640925|2208368|P1|COMPLETED|Overall Study||161
913591|NCT01640925|2208367|P2|STARTED|Overall Study||175
913592|NCT01640925|2208368|P1|STARTED|Overall Study||175
913593|NCT01640548|2208374|P1|NOT COMPLETED|Overall Study||0
913594|NCT01640548|2208374|P1|COMPLETED|Overall Study||309
913595|NCT01640548|2208374|P1|STARTED|Overall Study||309
913596|NCT01640353|2208388|P1|NOT COMPLETED|Overall Study||45
913597|NCT01640353|2208388|P1|COMPLETED|Overall Study||149
913598|NCT01640353|2208388|P1|Month 18|Overall Study||150
913599|NCT01640353|2208388|P1|Month 12|Overall Study||160
913600|NCT01640353|2208388|P1|Month 6|Overall Study||168
913601|NCT01640353|2208388|P1|Month 3|Overall Study||169
913602|NCT01640353|2208388|P1|Month 1|Overall Study||171
913603|NCT01640353|2208388|P1|Treated|Overall Study||172
913604|NCT01640353|2208388|P1|STARTED|Overall Study||194
913605|NCT01640340|2208400|P2|NOT COMPLETED|Overall Study||0
913606|NCT01640340|2208401|P1|NOT COMPLETED|Overall Study||0
913607|NCT01640340|2208400|P2|COMPLETED|Overall Study||20
913608|NCT01640340|2208401|P1|COMPLETED|Overall Study||20
913609|NCT01640340|2208400|P2|Overall Complete Response Rate|Overall Study||20
913610|NCT01640340|2208401|P1|Overall Complete Response Rate|Overall Study||20
913611|NCT01640340|2208400|P2|STARTED|Overall Study||20
913612|NCT01640340|2208401|P1|STARTED|Overall Study||20
913613|NCT01640327|2208421|P2|NOT COMPLETED|Overall Study||0
913614|NCT01640327|2208422|P1|NOT COMPLETED|Overall Study||0
913615|NCT01640327|2208421|P2|COMPLETED|Overall Study||63
913616|NCT01640327|2208422|P1|COMPLETED|Overall Study||63
913617|NCT01640327|2208421|P2|STARTED|Overall Study||63
913618|NCT01640327|2208422|P1|STARTED|Overall Study||63
913619|NCT01640314|2208436|P2|NOT COMPLETED|Overall Study||1
913620|NCT01640314|2208437|P1|NOT COMPLETED|Overall Study||0
913621|NCT01640314|2208436|P2|COMPLETED|Overall Study||62
913622|NCT01640314|2208437|P1|COMPLETED|Overall Study||63
913623|NCT01640314|2208436|P2|STARTED|Overall Study||63
913624|NCT01640314|2208437|P1|STARTED|Overall Study||63
913625|NCT01640197|2208453|P2|NOT COMPLETED|Overall Study||0
913626|NCT01640197|2208454|P1|NOT COMPLETED|Overall Study||0
913627|NCT01640197|2208453|P2|COMPLETED|Overall Study||30
913628|NCT01640197|2208454|P1|COMPLETED|Overall Study||30
913629|NCT01640197|2208453|P2|STARTED|Overall Study||30
913630|NCT01640197|2208454|P1|STARTED|Overall Study||30
913631|NCT01640184|2208475|P3|NOT COMPLETED|Overall Study||2
913632|NCT01640184|2208476|P2|NOT COMPLETED|Overall Study||2
913633|NCT01640184|2208477|P1|NOT COMPLETED|Overall Study||8
913634|NCT01640184|2208475|P3|COMPLETED|Overall Study||20
913635|NCT01640184|2208476|P2|COMPLETED|Overall Study||21
913636|NCT01640184|2208477|P1|COMPLETED|Overall Study||26
913637|NCT01640184|2208475|P3|STARTED|Overall Study||22
913638|NCT01640184|2208476|P2|STARTED|Overall Study||23
913639|NCT01640184|2208477|P1|STARTED|Overall Study||34
913640|NCT01640171|2208499|P1|NOT COMPLETED|Overall Study||0
913641|NCT01640171|2208499|P1|COMPLETED|Overall Study||57
913642|NCT01640171|2208499|P1|STARTED|Overall Study||57
913643|NCT01640054|2208506|P1|NOT COMPLETED|Overall Study||6
913644|NCT01640054|2208506|P1|COMPLETED|Overall Study|Number of patients on treatment when the study was stopped.|109
913645|NCT01640054|2208506|P1|Did Not Receive Treatment|Overall Study||0
913646|NCT01640054|2208506|P1|STARTED|Overall Study|Patients who received treatment|115
913647|NCT01639833|2208516|P2|NOT COMPLETED|Overall Study||4
913648|NCT01639833|2208517|P1|NOT COMPLETED|Overall Study||6
913649|NCT01639833|2208516|P2|COMPLETED|Overall Study||41
913650|NCT01639833|2208517|P1|COMPLETED|Overall Study||39
913651|NCT01639833|2208516|P2|STARTED|Overall Study||45
913652|NCT01639833|2208517|P1|STARTED|Overall Study||45
913653|NCT01639755|2208525|P1|NOT COMPLETED|Overall Study||19
913654|NCT01639755|2208525|P1|COMPLETED|Overall Study||0
913655|NCT01639755|2208525|P1|STARTED|Overall Study||19
913656|NCT01639742|2208533|P1|NOT COMPLETED|Overall Study||18
913657|NCT01639742|2208533|P1|COMPLETED|Overall Study||0
913658|NCT01639742|2208533|P1|STARTED|Overall Study||18
913659|NCT01639729|2208541|P6|NOT COMPLETED|Overall Study||0
913660|NCT01639729|2208542|P5|NOT COMPLETED|Overall Study||0
913661|NCT01639729|2208543|P4|NOT COMPLETED|Overall Study||1
913662|NCT01639729|2208544|P3|NOT COMPLETED|Overall Study||1
913663|NCT01639729|2208545|P2|NOT COMPLETED|Overall Study||0
913664|NCT01639729|2208546|P1|NOT COMPLETED|Overall Study||1
913665|NCT01639729|2208541|P6|COMPLETED|Overall Study||4
913666|NCT01639729|2208542|P5|COMPLETED|Overall Study||4
913667|NCT01639729|2208543|P4|COMPLETED|Overall Study||4
913668|NCT01639729|2208544|P3|COMPLETED|Overall Study||3
913669|NCT01639729|2208545|P2|COMPLETED|Overall Study||4
913670|NCT01639729|2208546|P1|COMPLETED|Overall Study||3
913671|NCT01639729|2208541|P6|STARTED|Overall Study||4
913672|NCT01639729|2208542|P5|STARTED|Overall Study||4
913673|NCT01639729|2208543|P4|STARTED|Overall Study||5
913674|NCT01639729|2208544|P3|STARTED|Overall Study||4
913675|NCT01639729|2208545|P2|STARTED|Overall Study||4
913676|NCT01639729|2208546|P1|STARTED|Overall Study||4
913677|NCT01639703|2208568|P1|NOT COMPLETED|Overall Study||12
913678|NCT01639703|2208568|P1|COMPLETED|Overall Study||84
913679|NCT01639703|2208568|P1|STARTED|Overall Study||96
913680|NCT01639560|2208611|P2|NOT COMPLETED|Overall Study||29
913681|NCT01639560|2208612|P1|NOT COMPLETED|Overall Study||19
913682|NCT01639560|2208611|P2|COMPLETED|Overall Study||19
913683|NCT01639560|2208612|P1|COMPLETED|Overall Study||26
913684|NCT01639560|2208611|P2|End of Treatment|Overall Study||20
913685|NCT01639560|2208612|P1|End of Treatment|Overall Study||28
913686|NCT01639560|2208611|P2|STARTED|Overall Study||48
913687|NCT01639560|2208612|P1|STARTED|Overall Study||45
913688|NCT01639469|2208626|P2|NOT COMPLETED|Overall Study||3
913689|NCT01639469|2208627|P1|NOT COMPLETED|Overall Study||5
913690|NCT01639469|2208626|P2|COMPLETED|Overall Study||77
913691|NCT01639469|2208627|P1|COMPLETED|Overall Study||84
913692|NCT01639469|2208626|P2|STARTED|Overall Study||80
913693|NCT01639469|2208627|P1|STARTED|Overall Study||89
913700|NCT01639352|2208652|P1|NOT COMPLETED|Overall Study||0
913701|NCT01639352|2208652|P1|COMPLETED|Overall Study||20
913702|NCT01639352|2208652|P1|STARTED|Overall Study||20
913703|NCT01639222|2208661|P1|NOT COMPLETED|Overall Study||0
913704|NCT01639222|2208661|P1|COMPLETED|Overall Study||55
913705|NCT01639222|2208661|P1|STARTED|Overall Study||55
913706|NCT01639157|2208671|P2|NOT COMPLETED|Overall Study||0
913707|NCT01639157|2208672|P1|NOT COMPLETED|Overall Study||0
913708|NCT01639157|2208671|P2|COMPLETED|Overall Study||5
913709|NCT01639157|2208672|P1|COMPLETED|Overall Study||4
913710|NCT01639157|2208671|P2|STARTED|Overall Study||5
913711|NCT01639157|2208672|P1|STARTED|Overall Study||4
913712|NCT01639144|2208732|P2|NOT COMPLETED|Overall Study||5
913713|NCT01639144|2208733|P1|NOT COMPLETED|Overall Study||10
913714|NCT01639144|2208732|P2|COMPLETED|Overall Study||250
913715|NCT01639144|2208733|P1|COMPLETED|Overall Study||250
913716|NCT01639144|2208732|P2|STARTED|Overall Study||255
913717|NCT01639144|2208733|P1|STARTED|Overall Study||260
913726|NCT01638559|2208786|P1|NOT COMPLETED|Overall Study||0
913727|NCT01638559|2208786|P1|COMPLETED|Overall Study|Completion through the time of the primary endpoint.|88
913728|NCT01638559|2208786|P1|STARTED|Overall Study||88
913729|NCT01638507|2208790|P1|NOT COMPLETED|Overall Study||6
913730|NCT01638507|2208790|P1|COMPLETED|Overall Study||224
913731|NCT01638507|2208790|P1|STARTED|Overall Study||230
913732|NCT01638468|2208803|P1|NOT COMPLETED|Overall Study||0
913733|NCT01638468|2208803|P1|COMPLETED|Overall Study||7
913734|NCT01638468|2208803|P1|STARTED|Overall Study||7
913735|NCT01638312|2208819|P2|NOT COMPLETED|Overall Study||0
913736|NCT01638312|2208820|P1|NOT COMPLETED|Overall Study||0
913737|NCT01638312|2208819|P2|COMPLETED|Overall Study||30
913738|NCT01638312|2208820|P1|COMPLETED|Overall Study||20
913739|NCT01638312|2208819|P2|STARTED|Overall Study||30
913740|NCT01638312|2208820|P1|STARTED|Overall Study||20
913741|NCT01638000|2208828|P2|NOT COMPLETED|Overall Study||71
913742|NCT01638000|2208829|P1|NOT COMPLETED|Overall Study||60
913743|NCT01638000|2208828|P2|COMPLETED|Overall Study||873
913744|NCT01638000|2208829|P1|COMPLETED|Overall Study||883
913745|NCT01638000|2208828|P2|Received at Least 1 Double-Blind Dose|Overall Study||934
913746|NCT01638000|2208829|P1|Received at Least 1 Double-Blind Dose|Overall Study||936
913747|NCT01638000|2208828|P2|STARTED|Overall Study||944
913748|NCT01638000|2208829|P1|STARTED|Overall Study||943
913749|NCT01637961|2208927|P1|NOT COMPLETED|Overall Study||2
913750|NCT01637961|2208927|P1|COMPLETED|Overall Study|Eligible and treated patients.|21
913751|NCT01637961|2208927|P1|STARTED|Overall Study||23
913752|NCT01637935|2208935|P2|NOT COMPLETED|Overall Study||0
913753|NCT01637935|2208936|P1|NOT COMPLETED|Overall Study||0
913754|NCT01637935|2208935|P2|COMPLETED|Overall Study||158918
913755|NCT01637935|2208936|P1|COMPLETED|Overall Study||34181
913756|NCT01637935|2208935|P2|STARTED|Overall Study||158918
913757|NCT01637935|2208936|P1|STARTED|Overall Study||34181
913758|NCT01637922|2208952|P2|NOT COMPLETED|Overall Study||5
913759|NCT01637922|2208953|P1|NOT COMPLETED|Overall Study||2
913760|NCT01637922|2208952|P2|COMPLETED|Overall Study||14
913761|NCT01637922|2208953|P1|COMPLETED|Overall Study||13
913762|NCT01637922|2208952|P2|STARTED|Overall Study||19
913763|NCT01637922|2208953|P1|STARTED|Overall Study||15
913764|NCT01637584|2208978|P2|NOT COMPLETED|Overall Study||3
913765|NCT01637584|2208979|P1|NOT COMPLETED|Overall Study||1
913766|NCT01637584|2208978|P2|COMPLETED|Overall Study||17
913767|NCT01637584|2208979|P1|COMPLETED|Overall Study||19
913768|NCT01637584|2208978|P2|STARTED|Overall Study||20
913769|NCT01637584|2208979|P1|STARTED|Overall Study||20
913770|NCT01637272|2208986|P1|NOT COMPLETED|Overall Study||20
913771|NCT01637272|2208986|P1|COMPLETED|Overall Study||23
913772|NCT01637272|2208986|P1|Completed Core But Did no Enter Ext..|Overall Study||4
913773|NCT01637272|2208986|P1|Entered Extension Phase|Overall Study||27
913774|NCT01637272|2208986|P1|Completed Core Phase (sc + LAR)|Overall Study||31
913775|NCT01637272|2208986|P1|Completed sc Phase|Overall Study||33
913776|NCT01637272|2208986|P1|STARTED|Overall Study||43
913777|NCT01637246|2209048|P1|NOT COMPLETED|Overall Study||2139
913778|NCT01637246|2209048|P1|COMPLETED|Overall Study||2246
913779|NCT01637246|2209048|P1|STARTED|Overall Study||4385
913780|NCT01637090|2209056|P1|NOT COMPLETED|Overall Study||3
913781|NCT01637090|2209056|P1|COMPLETED|Overall Study||0
913782|NCT01637090|2209056|P1|STARTED|Overall Study||3
913783|NCT01636986|2209066|P2|NOT COMPLETED|Overall Study||2
913784|NCT01636986|2209067|P1|NOT COMPLETED|Overall Study||0
913785|NCT01636986|2209066|P2|COMPLETED|Overall Study||30
913786|NCT01636986|2209067|P1|COMPLETED|Overall Study||30
913787|NCT01636986|2209066|P2|STARTED|Overall Study||32
913788|NCT01636986|2209067|P1|STARTED|Overall Study||30
913789|NCT01636960|2209073|P1|NOT COMPLETED|Maintenance Phase||7
913790|NCT01636960|2209073|P1|COMPLETED|Maintenance Phase||0
913791|NCT01636960|2209073|P1|STARTED|Maintenance Phase||7
913792|NCT01636960|2209073|P1|NOT COMPLETED|Induction Phase||2
913793|NCT01636960|2209073|P1|COMPLETED|Induction Phase|Participants continuing into Maintenance Phase|7
913794|NCT01636960|2209073|P1|STARTED|Induction Phase||9
913795|NCT01636947|2209081|P2|NOT COMPLETED|Overall Study||11
913796|NCT01636947|2209082|P1|NOT COMPLETED|Overall Study||12
913797|NCT01636947|2209081|P2|COMPLETED|Overall Study||239
913798|NCT01636947|2209082|P1|COMPLETED|Overall Study||232
913799|NCT01636947|2209081|P2|Treated|Overall Study||248
913800|NCT01636947|2209082|P1|Treated|Overall Study||242
913801|NCT01636947|2209081|P2|STARTED|Overall Study||250
913802|NCT01636947|2209082|P1|STARTED|Overall Study||244
913803|NCT01636778|2209102|P3|NOT COMPLETED|Follow-up Period After Part 2||4
913804|NCT01636778|2209103|P2|NOT COMPLETED|Follow-up Period After Part 2||0
913805|NCT01636778|2209104|P1|NOT COMPLETED|Follow-up Period After Part 2||0
913806|NCT01636778|2209102|P3|COMPLETED|Follow-up Period After Part 2||37
913807|NCT01636778|2209103|P2|COMPLETED|Follow-up Period After Part 2||0
913808|NCT01636778|2209104|P1|COMPLETED|Follow-up Period After Part 2||0
913809|NCT01636778|2209102|P3|STARTED|Follow-up Period After Part 2||41
913810|NCT01636778|2209103|P2|STARTED|Follow-up Period After Part 2||0
913811|NCT01636778|2209104|P1|STARTED|Follow-up Period After Part 2||0
913812|NCT01636778|2209102|P3|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
913813|NCT01636778|2209103|P2|NOT COMPLETED|Antiviral Treatment Period (Part 2)||10
913814|NCT01636778|2209104|P1|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
913815|NCT01636778|2209102|P3|COMPLETED|Antiviral Treatment Period (Part 2)||0
913816|NCT01636778|2209103|P2|COMPLETED|Antiviral Treatment Period (Part 2)||31
913817|NCT01636778|2209104|P1|COMPLETED|Antiviral Treatment Period (Part 2)||0
913818|NCT01636778|2209102|P3|STARTED|Antiviral Treatment Period (Part 2)||0
913819|NCT01636778|2209103|P2|STARTED|Antiviral Treatment Period (Part 2)||41
913820|NCT01636778|2209104|P1|STARTED|Antiviral Treatment Period (Part 2)||0
913821|NCT01636778|2209102|P3|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
913822|NCT01636778|2209103|P2|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
913823|NCT01636778|2209104|P1|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||4
913824|NCT01636778|2209102|P3|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
913825|NCT01636778|2209103|P2|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
913826|NCT01636778|2209104|P1|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||41
913827|NCT01636778|2209102|P3|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
913828|NCT01636778|2209103|P2|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
913829|NCT01636778|2209104|P1|STARTED|Pre-Antiviral Treatment Period (Part 1)||45
913830|NCT01636765|2209167|P1|NOT COMPLETED|Overall Study||0
913831|NCT01636765|2209167|P1|COMPLETED|Overall Study||104
913832|NCT01636765|2209167|P1|STARTED|Overall Study||104
913833|NCT01636713|2209175|P3|NOT COMPLETED|Overall Study||23
913834|NCT01636713|2209176|P2|NOT COMPLETED|Overall Study||28
913835|NCT01636713|2209177|P1|NOT COMPLETED|Overall Study||32
913836|NCT01636713|2209175|P3|COMPLETED|Overall Study||170
913837|NCT01636713|2209176|P2|COMPLETED|Overall Study||166
913838|NCT01636713|2209177|P1|COMPLETED|Overall Study||161
913839|NCT01636713|2209175|P3|STARTED|Overall Study||193
913840|NCT01636713|2209176|P2|STARTED|Overall Study||194
913841|NCT01636713|2209177|P1|STARTED|Overall Study||193
913842|NCT01636661|2209193|P2|NOT COMPLETED|Overall Study||0
913843|NCT01636661|2209194|P1|NOT COMPLETED|Overall Study||0
913844|NCT01636661|2209193|P2|COMPLETED|Overall Study||6
913845|NCT01636661|2209194|P1|COMPLETED|Overall Study||5
913846|NCT01636661|2209193|P2|STARTED|Overall Study||6
913847|NCT01636661|2209194|P1|STARTED|Overall Study||5
913848|NCT01636466|2209204|P2|NOT COMPLETED|Overall Study||0
913849|NCT01636466|2209205|P1|NOT COMPLETED|Overall Study||1
913850|NCT01636466|2209204|P2|COMPLETED|Overall Study||0
913851|NCT01636466|2209205|P1|COMPLETED|Overall Study||0
913852|NCT01636466|2209204|P2|STARTED|Overall Study||0
913853|NCT01636466|2209205|P1|STARTED|Overall Study||1
913854|NCT01636414|2209214|P3|NOT COMPLETED|Overall Study||9
913855|NCT01636414|2209215|P2|NOT COMPLETED|Overall Study||6
913856|NCT01636414|2209216|P1|NOT COMPLETED|Overall Study||3
913857|NCT01636414|2209214|P3|COMPLETED|Overall Study||65
913858|NCT01636414|2209215|P2|COMPLETED|Overall Study||60
913859|NCT01636414|2209216|P1|COMPLETED|Overall Study||61
913860|NCT01636414|2209214|P3|STARTED|Overall Study||74
913861|NCT01636414|2209215|P2|STARTED|Overall Study||66
913862|NCT01636414|2209216|P1|STARTED|Overall Study||64
913863|NCT01636362|2209227|P1|NOT COMPLETED|Overall Study||8
913864|NCT01636362|2209227|P1|COMPLETED|Overall Study||37
913865|NCT01636362|2209227|P1|STARTED|Overall Study||45
913866|NCT01636258|2209235|P2|NOT COMPLETED|Overall Study||0
913867|NCT01636258|2209236|P1|NOT COMPLETED|Overall Study||1
913868|NCT01636258|2209235|P2|COMPLETED|Overall Study||14
913869|NCT01636258|2209236|P1|COMPLETED|Overall Study||12
913870|NCT01636258|2209235|P2|STARTED|Overall Study||14
913871|NCT01636258|2209236|P1|STARTED|Overall Study||13
913872|NCT01636206|2209252|P2|NOT COMPLETED|Overall Study||51
913873|NCT01636206|2209253|P1|NOT COMPLETED|Overall Study||19
913874|NCT01636206|2209252|P2|COMPLETED|Overall Study||170
913875|NCT01636206|2209253|P1|COMPLETED|Overall Study||92
913876|NCT01636206|2209252|P2|STARTED|Overall Study||221
913877|NCT01636206|2209253|P1|STARTED|Overall Study||111
913878|NCT01636102|2209261|P2|NOT COMPLETED|Overall Study||0
913879|NCT01636102|2209262|P1|NOT COMPLETED|Overall Study||0
913880|NCT01636102|2209261|P2|COMPLETED|Overall Study||63
913881|NCT01636102|2209262|P1|COMPLETED|Overall Study||63
913882|NCT01636102|2209261|P2|STARTED|Overall Study||63
913883|NCT01636102|2209262|P1|STARTED|Overall Study||63
913884|NCT01636076|2209276|P2|NOT COMPLETED|Overall Study||25
913885|NCT01636076|2209277|P1|NOT COMPLETED|Overall Study||17
913886|NCT01636076|2209276|P2|COMPLETED|Overall Study||288
913887|NCT01636076|2209277|P1|COMPLETED|Overall Study||299
913888|NCT01636076|2209276|P2|STARTED|Overall Study||313
913889|NCT01636076|2209277|P1|STARTED|Overall Study||316
913890|NCT01636063|2209339|P2|NOT COMPLETED|Overall Study||0
913891|NCT01636063|2209340|P1|NOT COMPLETED|Overall Study||0
913892|NCT01636063|2209339|P2|COMPLETED|Overall Study||21
913893|NCT01636063|2209340|P1|COMPLETED|Overall Study||21
913894|NCT01636063|2209339|P2|STARTED|Overall Study||21
913895|NCT01636063|2209340|P1|STARTED|Overall Study||21
913896|NCT01635933|2209348|P2|NOT COMPLETED|Overall Study||8
913897|NCT01635933|2209349|P1|NOT COMPLETED|Overall Study||2
913898|NCT01635933|2209348|P2|COMPLETED|Overall Study||177
913899|NCT01635933|2209349|P1|COMPLETED|Overall Study||176
913900|NCT01635933|2209348|P2|STARTED|Overall Study||185
913901|NCT01635933|2209349|P1|STARTED|Overall Study||178
913902|NCT01635920|2209361|P2|NOT COMPLETED|Overall Study||1
913903|NCT01635920|2209362|P1|NOT COMPLETED|Overall Study||3
913904|NCT01635920|2209361|P2|COMPLETED|Overall Study||125
913905|NCT01635920|2209362|P1|COMPLETED|Overall Study||122
913906|NCT01635920|2209361|P2|STARTED|Overall Study||126
913907|NCT01635920|2209362|P1|STARTED|Overall Study||125
913908|NCT01635881|2209370|P1|NOT COMPLETED|Overall Study||0
913909|NCT01635881|2209370|P1|COMPLETED|Overall Study||60
913910|NCT01635881|2209370|P1|STARTED|Overall Study||60
913911|NCT01635855|2209375|P1|NOT COMPLETED|Overall Study||4
913912|NCT01635855|2209375|P1|COMPLETED|Overall Study||113
913913|NCT01635855|2209375|P1|STARTED|Overall Study||117
913914|NCT01635764|2209384|P1|NOT COMPLETED|Overall Study||273
913915|NCT01635764|2209384|P1|COMPLETED|Overall Study||235
913916|NCT01635764|2209384|P1|STARTED|Overall Study||508
913917|NCT01635504|2209412|P1|NOT COMPLETED|Overall Study||0
913918|NCT01635504|2209412|P1|COMPLETED|Overall Study||5
913919|NCT01635504|2209412|P1|STARTED|Overall Study||5
913920|NCT01635439|2209419|P2|NOT COMPLETED|Overall Study||0
913921|NCT01635439|2209420|P1|NOT COMPLETED|Overall Study||0
913922|NCT01635439|2209419|P2|COMPLETED|Overall Study||100
913923|NCT01635439|2209420|P1|COMPLETED|Overall Study||100
913924|NCT01635439|2209419|P2|STARTED|Overall Study||100
913925|NCT01635439|2209420|P1|STARTED|Overall Study||100
913926|NCT01635244|2209437|P3|NOT COMPLETED|Overall Study||2
913927|NCT01635244|2209438|P2|NOT COMPLETED|Overall Study||1
913928|NCT01635244|2209439|P1|NOT COMPLETED|Overall Study||1
913929|NCT01635244|2209437|P3|COMPLETED|Overall Study||18
913930|NCT01635244|2209438|P2|COMPLETED|Overall Study||21
913931|NCT01635244|2209439|P1|COMPLETED|Overall Study||17
913932|NCT01635244|2209437|P3|STARTED|Overall Study||20
913933|NCT01635244|2209438|P2|STARTED|Overall Study||22
913934|NCT01635244|2209439|P1|STARTED|Overall Study||18
913935|NCT01635218|2209450|P3|NOT COMPLETED|Overall Study||6
913936|NCT01635218|2209451|P2|NOT COMPLETED|Overall Study||7
913937|NCT01635218|2209452|P1|NOT COMPLETED|Overall Study||3
913938|NCT01635218|2209450|P3|COMPLETED|Overall Study||37
913939|NCT01635218|2209451|P2|COMPLETED|Overall Study||39
913940|NCT01635218|2209452|P1|COMPLETED|Overall Study||41
913941|NCT01635218|2209450|P3|STARTED|Overall Study||43
913942|NCT01635218|2209451|P2|STARTED|Overall Study||46
913943|NCT01635218|2209452|P1|STARTED|Overall Study||44
913944|NCT01635062|2209474|P2|NOT COMPLETED|Overall Study||0
913945|NCT01635062|2209475|P1|NOT COMPLETED|Overall Study||0
913946|NCT01635062|2209474|P2|COMPLETED|Overall Study||9
913947|NCT01635062|2209475|P1|COMPLETED|Overall Study||9
913948|NCT01635062|2209474|P2|Post-Randomization Sodium Loaded|Overall Study||9
913949|NCT01635062|2209475|P1|Post-Randomization Sodium Loaded|Overall Study||9
913950|NCT01635062|2209474|P2|Post-randomization Sodium Restriction|Overall Study||9
913951|NCT01635062|2209475|P1|Post-randomization Sodium Restriction|Overall Study||9
913952|NCT01635062|2209474|P2|Sodium Loading Baseline Visit|Overall Study||9
913953|NCT01635062|2209475|P1|Sodium Loading Baseline Visit|Overall Study||9
913954|NCT01635062|2209474|P2|Sodium Restriction Baseline Visit|Overall Study||9
913955|NCT01635062|2209475|P1|Sodium Restriction Baseline Visit|Overall Study||9
913956|NCT01635062|2209474|P2|STARTED|Overall Study||9
913957|NCT01635062|2209475|P1|STARTED|Overall Study||9
913958|NCT01634854|2209487|P2|NOT COMPLETED|Overall Study||7
913959|NCT01634854|2209488|P1|NOT COMPLETED|Overall Study||2
913960|NCT01634854|2209487|P2|COMPLETED|Overall Study||59
913961|NCT01634854|2209488|P1|COMPLETED|Overall Study||62
913962|NCT01634854|2209487|P2|STARTED|Overall Study||66
913963|NCT01634854|2209488|P1|STARTED|Overall Study||64
913964|NCT01634659|2209508|P2|NOT COMPLETED|Period 2 - Second 8 Days of Wear||0
913965|NCT01634659|2209509|P1|NOT COMPLETED|Period 2 - Second 8 Days of Wear||3
913966|NCT01634659|2209508|P2|COMPLETED|Period 2 - Second 8 Days of Wear||158
913967|NCT01634659|2209509|P1|COMPLETED|Period 2 - Second 8 Days of Wear||152
913968|NCT01634659|2209508|P2|STARTED|Period 2 - Second 8 Days of Wear||158
913969|NCT01634659|2209509|P1|STARTED|Period 2 - Second 8 Days of Wear||155
913970|NCT01634659|2209508|P2|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
913971|NCT01634659|2209509|P1|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
913972|NCT01634659|2209508|P2|COMPLETED|Period 1 - First 8 Days of Wear||158
913973|NCT01634659|2209509|P1|COMPLETED|Period 1 - First 8 Days of Wear||155
913974|NCT01634659|2209508|P2|STARTED|Period 1 - First 8 Days of Wear||158
913975|NCT01634659|2209509|P1|STARTED|Period 1 - First 8 Days of Wear||155
913976|NCT01634620|2209519|P1|NOT COMPLETED|Overall Study||0
913977|NCT01634620|2209519|P1|COMPLETED|Overall Study||200
913978|NCT01634620|2209519|P1|STARTED|Overall Study||200
913979|NCT01634555|2209539|P1|NOT COMPLETED|Overall Study||17
913980|NCT01634555|2209539|P1|COMPLETED|Overall Study|Completed the required treatment and assessment.|12
913981|NCT01634555|2209539|P1|Drug-Drug Interaction (DDI) Population|Overall Study|Completed the required treatment in Cycle 1, Day 1 and Cycle 2, Day 1.|25
913982|NCT01634555|2209539|P1|Received at Least 1 Dose of Study Drug|Overall Study||29
913983|NCT01634555|2209539|P1|STARTED|Overall Study||29
913984|NCT01634360|2209549|P2|NOT COMPLETED|Overall Study||136
913985|NCT01634360|2209550|P1|NOT COMPLETED|Overall Study||49
913986|NCT01634360|2209549|P2|COMPLETED|Overall Study||0
913987|NCT01634360|2209550|P1|COMPLETED|Overall Study||0
913988|NCT01634360|2209549|P2|STARTED|Overall Study||136
913989|NCT01634360|2209550|P1|STARTED|Overall Study||49
913990|NCT01634256|2209562|P2|NOT COMPLETED|Overall Study||8
913991|NCT01634256|2209563|P1|NOT COMPLETED|Overall Study||4
913992|NCT01634256|2209562|P2|COMPLETED|Overall Study||22
913993|NCT01634256|2209563|P1|COMPLETED|Overall Study||26
913994|NCT01634256|2209562|P2|STARTED|Overall Study||30
913995|NCT01634256|2209563|P1|STARTED|Overall Study||30
913996|NCT01634243|2209579|P2|NOT COMPLETED|Overall Study||5
913997|NCT01634243|2209580|P1|NOT COMPLETED|Overall Study||6
913998|NCT01634243|2209579|P2|COMPLETED|Overall Study||38
913999|NCT01634243|2209580|P1|COMPLETED|Overall Study||15
914000|NCT01634243|2209579|P2|STARTED|Overall Study||43
914001|NCT01634243|2209580|P1|STARTED|Overall Study||21
914002|NCT01634165|2209606|P4|NOT COMPLETED|Period 4||0
914003|NCT01634165|2209607|P3|NOT COMPLETED|Period 4||0
914004|NCT01634165|2209608|P2|NOT COMPLETED|Period 4||0
914005|NCT01634165|2209609|P1|NOT COMPLETED|Period 4||0
914006|NCT01634165|2209606|P4|COMPLETED|Period 4||6
914007|NCT01634165|2209607|P3|COMPLETED|Period 4||6
914008|NCT01634165|2209608|P2|COMPLETED|Period 4||5
914009|NCT01634165|2209609|P1|COMPLETED|Period 4||6
914010|NCT01634165|2209606|P4|STARTED|Period 4||6
914011|NCT01634165|2209607|P3|STARTED|Period 4||6
914012|NCT01634165|2209608|P2|STARTED|Period 4||5
914013|NCT01634165|2209609|P1|STARTED|Period 4||6
914014|NCT01634165|2209606|P4|NOT COMPLETED|Period 3||0
914015|NCT01634165|2209607|P3|NOT COMPLETED|Period 3||0
914016|NCT01634165|2209608|P2|NOT COMPLETED|Period 3||0
914017|NCT01634165|2209609|P1|NOT COMPLETED|Period 3||0
914018|NCT01634165|2209606|P4|COMPLETED|Period 3||6
914019|NCT01634165|2209607|P3|COMPLETED|Period 3||6
914020|NCT01634165|2209608|P2|COMPLETED|Period 3||5
914021|NCT01634165|2209609|P1|COMPLETED|Period 3||6
914022|NCT01634165|2209606|P4|STARTED|Period 3||6
914023|NCT01634165|2209607|P3|STARTED|Period 3||6
914024|NCT01634165|2209608|P2|STARTED|Period 3||5
914025|NCT01634165|2209609|P1|STARTED|Period 3||6
914026|NCT01634165|2209606|P4|NOT COMPLETED|Period 2||0
914027|NCT01634165|2209607|P3|NOT COMPLETED|Period 2||0
914028|NCT01634165|2209608|P2|NOT COMPLETED|Period 2||1
914029|NCT01634165|2209609|P1|NOT COMPLETED|Period 2||0
914030|NCT01634165|2209606|P4|COMPLETED|Period 2||6
914031|NCT01634165|2209607|P3|COMPLETED|Period 2||6
914032|NCT01634165|2209608|P2|COMPLETED|Period 2||5
914033|NCT01634165|2209609|P1|COMPLETED|Period 2||6
914034|NCT01634165|2209606|P4|STARTED|Period 2||6
914035|NCT01634165|2209607|P3|STARTED|Period 2||6
914036|NCT01634165|2209608|P2|STARTED|Period 2||6
914037|NCT01634165|2209609|P1|STARTED|Period 2||6
914038|NCT01634165|2209606|P4|NOT COMPLETED|Period 1||0
914039|NCT01634165|2209607|P3|NOT COMPLETED|Period 1||0
914040|NCT01634165|2209608|P2|NOT COMPLETED|Period 1||0
914041|NCT01634165|2209609|P1|NOT COMPLETED|Period 1||0
914042|NCT01634165|2209606|P4|COMPLETED|Period 1||6
914043|NCT01634165|2209607|P3|COMPLETED|Period 1||6
914044|NCT01634165|2209608|P2|COMPLETED|Period 1||6
914045|NCT01634165|2209609|P1|COMPLETED|Period 1||6
914046|NCT01634165|2209606|P4|Received at Least 1 Dose of Study Drug|Period 1||6
914047|NCT01634165|2209607|P3|Received at Least 1 Dose of Study Drug|Period 1||6
914048|NCT01634165|2209608|P2|Received at Least 1 Dose of Study Drug|Period 1||6
914049|NCT01634165|2209609|P1|Received at Least 1 Dose of Study Drug|Period 1||6
914050|NCT01634165|2209606|P4|STARTED|Period 1||6
914051|NCT01634165|2209607|P3|STARTED|Period 1||6
914052|NCT01634165|2209608|P2|STARTED|Period 1||6
914053|NCT01634165|2209609|P1|STARTED|Period 1||6
914054|NCT01634152|2209642|P3|NOT COMPLETED|Overall Study||4
914055|NCT01634152|2209643|P2|NOT COMPLETED|Overall Study||1
914056|NCT01634152|2209644|P1|NOT COMPLETED|Overall Study||4
914057|NCT01634152|2209642|P3|COMPLETED|Overall Study||126
914058|NCT01634152|2209643|P2|COMPLETED|Overall Study||136
914059|NCT01634152|2209644|P1|COMPLETED|Overall Study||130
914060|NCT01634152|2209642|P3|STARTED|Overall Study||130
914061|NCT01634152|2209643|P2|STARTED|Overall Study||137
914062|NCT01634152|2209644|P1|STARTED|Overall Study||134
914063|NCT01634139|2209727|P3|NOT COMPLETED|Overall Study||5
914064|NCT01634139|2209728|P2|NOT COMPLETED|Overall Study||6
914065|NCT01634139|2209729|P1|NOT COMPLETED|Overall Study||10
914066|NCT01634139|2209727|P3|COMPLETED|Overall Study||130
914067|NCT01634139|2209728|P2|COMPLETED|Overall Study||130
914068|NCT01634139|2209729|P1|COMPLETED|Overall Study||122
914069|NCT01634139|2209727|P3|STARTED|Overall Study||135
914070|NCT01634139|2209728|P2|STARTED|Overall Study||136
914071|NCT01634139|2209729|P1|STARTED|Overall Study||132
914072|NCT01634113|2209830|P3|NOT COMPLETED|Overall Study||1
914073|NCT01634113|2209831|P2|NOT COMPLETED|Overall Study||0
914074|NCT01634113|2209832|P1|NOT COMPLETED|Overall Study||0
914075|NCT01634113|2209830|P3|COMPLETED|Overall Study||31
914076|NCT01634113|2209831|P2|COMPLETED|Overall Study||36
914077|NCT01634113|2209832|P1|COMPLETED|Overall Study||34
914078|NCT01634113|2209830|P3|STARTED|Overall Study||32
914079|NCT01634113|2209831|P2|STARTED|Overall Study||36
914080|NCT01634113|2209832|P1|STARTED|Overall Study||34
914081|NCT01634100|2209876|P6|NOT COMPLETED|Overall Study||0
914082|NCT01634100|2209877|P5|NOT COMPLETED|Overall Study||0
914083|NCT01634100|2209878|P4|NOT COMPLETED|Overall Study||0
914084|NCT01634100|2209879|P3|NOT COMPLETED|Overall Study||1
914085|NCT01634100|2209880|P2|NOT COMPLETED|Overall Study||0
914086|NCT01634100|2209881|P1|NOT COMPLETED|Overall Study||1
914087|NCT01634100|2209876|P6|COMPLETED|Overall Study||3
914088|NCT01634100|2209877|P5|COMPLETED|Overall Study||3
914089|NCT01634100|2209878|P4|COMPLETED|Overall Study||3
914090|NCT01634100|2209879|P3|COMPLETED|Overall Study||2
914091|NCT01634100|2209880|P2|COMPLETED|Overall Study||3
914092|NCT01634100|2209881|P1|COMPLETED|Overall Study||2
914093|NCT01634100|2209876|P6|Received Empa + Probenecid|Overall Study||3
914094|NCT01634100|2209877|P5|Received Empa + Probenecid|Overall Study||3
914095|NCT01634100|2209878|P4|Received Empa + Probenecid|Overall Study||3
914096|NCT01634100|2209879|P3|Received Empa + Probenecid|Overall Study||2
914097|NCT01634100|2209880|P2|Received Empa + Probenecid|Overall Study||3
914098|NCT01634100|2209881|P1|Received Empa + Probenecid|Overall Study||2
914099|NCT01634100|2209876|P6|Received Empa + Rifampicin|Overall Study||3
914100|NCT01634100|2209877|P5|Received Empa + Rifampicin|Overall Study||3
914101|NCT01634100|2209878|P4|Received Empa + Rifampicin|Overall Study||3
914102|NCT01634100|2209879|P3|Received Empa + Rifampicin|Overall Study||3
914103|NCT01634100|2209880|P2|Received Empa + Rifampicin|Overall Study||3
914104|NCT01634100|2209881|P1|Received Empa + Rifampicin|Overall Study||3
914105|NCT01634100|2209876|P6|Received Empa Alone|Overall Study||3
914106|NCT01634100|2209877|P5|Received Empa Alone|Overall Study||3
914107|NCT01634100|2209878|P4|Received Empa Alone|Overall Study||3
914108|NCT01634100|2209879|P3|Received Empa Alone|Overall Study||3
914109|NCT01634100|2209880|P2|Received Empa Alone|Overall Study||3
914110|NCT01634100|2209881|P1|Received Empa Alone|Overall Study||3
914111|NCT01634100|2209876|P6|STARTED|Overall Study||3
914112|NCT01634100|2209877|P5|STARTED|Overall Study||3
914113|NCT01634100|2209878|P4|STARTED|Overall Study||3
914114|NCT01634100|2209879|P3|STARTED|Overall Study||3
914115|NCT01634100|2209880|P2|STARTED|Overall Study||3
914116|NCT01634100|2209881|P1|STARTED|Overall Study||3
914117|NCT01633944|2209897|P3|NOT COMPLETED|Double-blind Treatment Phase||58
914118|NCT01633944|2209898|P2|NOT COMPLETED|Double-blind Treatment Phase||54
914119|NCT01633944|2209899|P1|NOT COMPLETED|Double-blind Treatment Phase||0
914120|NCT01633944|2209897|P3|COMPLETED|Double-blind Treatment Phase||174
914121|NCT01633944|2209898|P2|COMPLETED|Double-blind Treatment Phase||176
914122|NCT01633944|2209899|P1|COMPLETED|Double-blind Treatment Phase||0
914123|NCT01633944|2209897|P3|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|232
914124|NCT01633944|2209898|P2|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|230
914125|NCT01633944|2209899|P1|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
914126|NCT01633944|2209897|P3|NOT COMPLETED|Open-label Titration Phase||0
914127|NCT01633944|2209898|P2|NOT COMPLETED|Open-label Titration Phase||0
914128|NCT01633944|2209899|P1|NOT COMPLETED|Open-label Titration Phase||290
914129|NCT01633944|2209897|P3|COMPLETED|Open-label Titration Phase||0
914130|NCT01633944|2209898|P2|COMPLETED|Open-label Titration Phase||0
914131|NCT01633944|2209899|P1|COMPLETED|Open-label Titration Phase||462
914132|NCT01633944|2209897|P3|STARTED|Open-label Titration Phase||0
914133|NCT01633944|2209898|P2|STARTED|Open-label Titration Phase||0
914134|NCT01633944|2209899|P1|STARTED|Open-label Titration Phase||752
914135|NCT01633892|2209919|P1|NOT COMPLETED|Overall Study||0
914136|NCT01633892|2209919|P1|COMPLETED|Overall Study||5
914137|NCT01633892|2209919|P1|STARTED|Overall Study||5
914138|NCT01633853|2209929|P2|NOT COMPLETED|Overall Study||0
914139|NCT01633853|2209930|P1|NOT COMPLETED|Overall Study||0
914140|NCT01633853|2209929|P2|COMPLETED|Overall Study||100
914141|NCT01633853|2209930|P1|COMPLETED|Overall Study||104
914142|NCT01633853|2209929|P2|STARTED|Overall Study||100
914143|NCT01633853|2209930|P1|STARTED|Overall Study||104
914144|NCT01633827|2209944|P2|NOT COMPLETED|Second Intervention||0
914145|NCT01633827|2209945|P1|NOT COMPLETED|Second Intervention||0
914146|NCT01633827|2209944|P2|COMPLETED|Second Intervention||11
914147|NCT01633827|2209945|P1|COMPLETED|Second Intervention||11
914148|NCT01633827|2209944|P2|STARTED|Second Intervention||11
914149|NCT01633827|2209945|P1|STARTED|Second Intervention||11
914150|NCT01633827|2209944|P2|NOT COMPLETED|Washout Period||0
914151|NCT01633827|2209945|P1|NOT COMPLETED|Washout Period||0
914152|NCT01633827|2209944|P2|COMPLETED|Washout Period||11
914153|NCT01633827|2209945|P1|COMPLETED|Washout Period||11
914154|NCT01633827|2209944|P2|STARTED|Washout Period||11
914155|NCT01633827|2209945|P1|STARTED|Washout Period||11
914156|NCT01633827|2209944|P2|NOT COMPLETED|First Intervention||0
914157|NCT01633827|2209945|P1|NOT COMPLETED|First Intervention||0
914158|NCT01633827|2209944|P2|COMPLETED|First Intervention||11
914159|NCT01633827|2209945|P1|COMPLETED|First Intervention||11
914160|NCT01633827|2209944|P2|STARTED|First Intervention||11
914161|NCT01633827|2209945|P1|STARTED|First Intervention||11
914162|NCT01633814|2209958|P1|NOT COMPLETED|Overall Study||0
914163|NCT01633814|2209958|P1|COMPLETED|Overall Study||4
914164|NCT01633814|2209958|P1|STARTED|Overall Study||4
914165|NCT01633788|2209967|P4|NOT COMPLETED|Overall Study||13
914166|NCT01633788|2209968|P3|NOT COMPLETED|Overall Study||10
914167|NCT01633788|2209969|P2|NOT COMPLETED|Overall Study||8
914168|NCT01633788|2209970|P1|NOT COMPLETED|Overall Study||7
914169|NCT01633788|2209967|P4|COMPLETED|Overall Study||45
914170|NCT01633788|2209968|P3|COMPLETED|Overall Study||49
914171|NCT01633788|2209969|P2|COMPLETED|Overall Study||50
914172|NCT01633788|2209970|P1|COMPLETED|Overall Study||50
914173|NCT01633788|2209967|P4|STARTED|Overall Study||58
914174|NCT01633788|2209968|P3|STARTED|Overall Study||59
914175|NCT01633788|2209969|P2|STARTED|Overall Study||58
914176|NCT01633788|2209970|P1|STARTED|Overall Study||57
914177|NCT01633320|2209990|P2|NOT COMPLETED|Overall Study||0
914178|NCT01633320|2209991|P1|NOT COMPLETED|Overall Study||0
914179|NCT01633320|2209990|P2|COMPLETED|Overall Study||68
914180|NCT01633320|2209991|P1|COMPLETED|Overall Study||132
914181|NCT01633320|2209990|P2|STARTED|Overall Study||68
914182|NCT01633320|2209991|P1|STARTED|Overall Study||132
914183|NCT01632995|2209999|P1|NOT COMPLETED|Main Study Follow-up Period||120
914184|NCT01632995|2209999|P1|COMPLETED|Main Study Follow-up Period||437
914185|NCT01632995|2209999|P1|STARTED|Main Study Follow-up Period||557
914186|NCT01632995|2209999|P1|NOT COMPLETED|Pre-screening to Enrollment Period||512
914187|NCT01632995|2209999|P1|COMPLETED|Pre-screening to Enrollment Period||557
914188|NCT01632995|2209999|P1|STARTED|Pre-screening to Enrollment Period||1069
914189|NCT01632904|2210014|P2|NOT COMPLETED|Overall Study||6
914190|NCT01632904|2210015|P1|NOT COMPLETED|Overall Study||7
914191|NCT01632904|2210014|P2|COMPLETED|Overall Study|Patients still in the study as of 27MAR2014, including those who crossed over to ruxolitinib|50
914192|NCT01632904|2210015|P1|COMPLETED|Overall Study|Patients still in the study as of data cutoff, 27MAR2014.|47
914193|NCT01632904|2210014|P2|STARTED|Overall Study||56
914194|NCT01632904|2210015|P1|STARTED|Overall Study||54
914195|NCT01632878|2210025|P1|NOT COMPLETED|Treatment||158
914196|NCT01632878|2210025|P1|COMPLETED|Treatment||1105
914197|NCT01632878|2210025|P1|STARTED|Treatment||1263
914198|NCT01632878|2210025|P1|NOT COMPLETED|Screening||268
914199|NCT01632878|2210025|P1|COMPLETED|Screening||1263
914200|NCT01632878|2210025|P1|STARTED|Screening||1531
914201|NCT01632800|2210029|P1|NOT COMPLETED|Overall Study||1
914202|NCT01632800|2210029|P1|COMPLETED|Overall Study||25
914203|NCT01632800|2210029|P1|STARTED|Overall Study||26
914204|NCT01632735|2210035|P2|NOT COMPLETED|Overall Study||3
914205|NCT01632735|2210036|P1|NOT COMPLETED|Overall Study||4
914206|NCT01632735|2210035|P2|COMPLETED|Overall Study||37
914207|NCT01632735|2210036|P1|COMPLETED|Overall Study||36
914208|NCT01632735|2210035|P2|STARTED|Overall Study||40
914209|NCT01632735|2210036|P1|STARTED|Overall Study||40
914210|NCT01632709|2210052|P4|NOT COMPLETED|Overall Study||1
914211|NCT01632709|2210053|P3|NOT COMPLETED|Overall Study||0
914212|NCT01632709|2210054|P2|NOT COMPLETED|Overall Study||1
914213|NCT01632709|2210055|P1|NOT COMPLETED|Overall Study||2
914214|NCT01632709|2210052|P4|COMPLETED|Overall Study||3
914215|NCT01632709|2210053|P3|COMPLETED|Overall Study||5
914216|NCT01632709|2210054|P2|COMPLETED|Overall Study||2
914217|NCT01632709|2210055|P1|COMPLETED|Overall Study||2
914218|NCT01632709|2210052|P4|Completed Visit 2 (Received Injection)|Overall Study||3
914219|NCT01632709|2210053|P3|Completed Visit 2 (Received Injection)|Overall Study||5
914220|NCT01632709|2210054|P2|Completed Visit 2 (Received Injection)|Overall Study||2
914221|NCT01632709|2210055|P1|Completed Visit 2 (Received Injection)|Overall Study||4
914222|NCT01632709|2210052|P4|STARTED|Overall Study||4
914223|NCT01632709|2210053|P3|STARTED|Overall Study||5
914224|NCT01632709|2210054|P2|STARTED|Overall Study||3
914225|NCT01632709|2210055|P1|STARTED|Overall Study||4
914226|NCT01632683|2210081|P2|NOT COMPLETED|Overall Study||0
914227|NCT01632683|2210082|P1|NOT COMPLETED|Overall Study||0
914228|NCT01632683|2210081|P2|COMPLETED|Overall Study||552
914229|NCT01632683|2210082|P1|COMPLETED|Overall Study||548
914230|NCT01632683|2210081|P2|STARTED|Overall Study||552
914231|NCT01632683|2210082|P1|STARTED|Overall Study||548
914232|NCT01632423|2210088|P1|NOT COMPLETED|Overall Study||246
914233|NCT01632423|2210088|P1|COMPLETED|Overall Study||10091
914234|NCT01632423|2210088|P1|STARTED|Overall Study||10337
914235|NCT01632267|2210096|P1|NOT COMPLETED|Overall Study||7
914236|NCT01632267|2210096|P1|COMPLETED|Overall Study||97
914237|NCT01632267|2210096|P1|STARTED|Overall Study||104
914238|NCT01632215|2210102|P2|NOT COMPLETED|Overall Study||1
914239|NCT01632215|2210103|P1|NOT COMPLETED|Overall Study||2
914240|NCT01632215|2210102|P2|COMPLETED|Overall Study||19
914241|NCT01632215|2210103|P1|COMPLETED|Overall Study||18
914242|NCT01632215|2210102|P2|STARTED|Overall Study||20
914243|NCT01632215|2210103|P1|STARTED|Overall Study||20
914244|NCT01632150|2210109|P1|NOT COMPLETED|Overall Study||40
914245|NCT01632150|2210109|P1|COMPLETED|Overall Study|Completed=still receiving treatment|0
914246|NCT01632150|2210109|P1|Received Cyclophosphamide|Overall Study||11
914247|NCT01632150|2210109|P1|STARTED|Overall Study||40
914248|NCT01632020|2210118|P2|NOT COMPLETED|Overall Study||0
914249|NCT01632020|2210119|P1|NOT COMPLETED|Overall Study||2
914250|NCT01632020|2210118|P2|COMPLETED|Overall Study||3
914251|NCT01632020|2210119|P1|COMPLETED|Overall Study||2
914252|NCT01632020|2210118|P2|STARTED|Overall Study||3
914253|NCT01632020|2210119|P1|STARTED|Overall Study||4
914254|NCT01631929|2210129|P2|NOT COMPLETED|Overall Study||0
914255|NCT01631929|2210130|P1|NOT COMPLETED|Overall Study||0
914256|NCT01631929|2210129|P2|COMPLETED|Overall Study||6
914257|NCT01631929|2210130|P1|COMPLETED|Overall Study||6
914258|NCT01631929|2210129|P2|STARTED|Overall Study||6
914259|NCT01631929|2210130|P1|STARTED|Overall Study||6
914260|NCT01631864|2210138|P2|NOT COMPLETED|Overall Study||4
914261|NCT01631864|2210139|P1|NOT COMPLETED|Overall Study||2
914262|NCT01631864|2210138|P2|COMPLETED|Overall Study||44
914263|NCT01631864|2210139|P1|COMPLETED|Overall Study||48
914264|NCT01631864|2210138|P2|STARTED|Overall Study||48
914265|NCT01631864|2210139|P1|STARTED|Overall Study||50
914266|NCT01631825|2210151|P1|NOT COMPLETED|Overall Study||65
914267|NCT01631825|2210151|P1|COMPLETED|Overall Study||256
914268|NCT01631825|2210151|P1|STARTED|Overall Study||321
914269|NCT01631812|2210171|P1|NOT COMPLETED|Overall Study||37
914270|NCT01631812|2210171|P1|COMPLETED|Overall Study||93
914271|NCT01631812|2210171|P1|STARTED|Overall Study||130
914272|NCT01631682|2210183|P4|NOT COMPLETED|Overall Study||2
914273|NCT01631682|2210184|P3|NOT COMPLETED|Overall Study||31
914274|NCT01631682|2210185|P2|NOT COMPLETED|Overall Study||45
914275|NCT01631682|2210186|P1|NOT COMPLETED|Overall Study||31
914276|NCT01631682|2210183|P4|COMPLETED|Overall Study||5
914277|NCT01631682|2210184|P3|COMPLETED|Overall Study||13
914278|NCT01631682|2210185|P2|COMPLETED|Overall Study||21
914279|NCT01631682|2210186|P1|COMPLETED|Overall Study||24
914280|NCT01631682|2210183|P4|STARTED|Overall Study||7
914281|NCT01631682|2210184|P3|STARTED|Overall Study||44
914282|NCT01631682|2210185|P2|STARTED|Overall Study||66
914283|NCT01631682|2210186|P1|STARTED|Overall Study||55
914284|NCT01631630|2210198|P2|NOT COMPLETED|Overall Study||0
914285|NCT01631630|2210199|P1|NOT COMPLETED|Overall Study||3
914286|NCT01631630|2210198|P2|COMPLETED|Overall Study||8
914287|NCT01631630|2210199|P1|COMPLETED|Overall Study||5
914288|NCT01631630|2210198|P2|STARTED|Overall Study||8
914289|NCT01631630|2210199|P1|STARTED|Overall Study||8
914290|NCT01631435|2210309|P1|NOT COMPLETED|Overall Study||9
914291|NCT01631435|2210309|P1|COMPLETED|Overall Study||66
914292|NCT01631435|2210309|P1|STARTED|Overall Study||75
914293|NCT01631331|2210314|P1|NOT COMPLETED|Overall Study||4
914294|NCT01631331|2210314|P1|COMPLETED|Overall Study||11
914295|NCT01631331|2210314|P1|STARTED|Overall Study||15
914296|NCT01631227|2210323|P2|NOT COMPLETED|Overall Study||22
914297|NCT01631227|2210324|P1|NOT COMPLETED|Overall Study||30
914298|NCT01631227|2210323|P2|COMPLETED|Overall Study||310
914299|NCT01631227|2210324|P1|COMPLETED|Overall Study||303
914300|NCT01631227|2210323|P2|Full Analysis Set Population|Overall Study|1 patient not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|331
914301|NCT01631227|2210324|P1|Full Analysis Set Population|Overall Study|2 patients not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|330
914302|NCT01631227|2210323|P2|Safety Subject Sample|Overall Study||332
914303|NCT01631227|2210324|P1|Safety Subject Sample|Overall Study|1 patient was randomized by mistake and never received study medication.|332
914304|NCT01631227|2210323|P2|STARTED|Overall Study||332
914305|NCT01631227|2210324|P1|STARTED|Overall Study||333
914306|NCT01631149|2210332|P2|NOT COMPLETED|Overall Study||0
914307|NCT01631149|2210333|P1|NOT COMPLETED|Overall Study||0
914308|NCT01631149|2210332|P2|COMPLETED|Overall Study||12
914309|NCT01631149|2210333|P1|COMPLETED|Overall Study||12
914310|NCT01631149|2210332|P2|STARTED|Overall Study||12
914311|NCT01631149|2210333|P1|STARTED|Overall Study||12
914312|NCT01631110|2210349|P2|NOT COMPLETED|Overall Study||0
914313|NCT01631110|2210350|P1|NOT COMPLETED|Overall Study||0
914314|NCT01631110|2210349|P2|COMPLETED|Overall Study||55
914315|NCT01631110|2210350|P1|COMPLETED|Overall Study||55
914316|NCT01631110|2210349|P2|STARTED|Overall Study||55
914317|NCT01631110|2210350|P1|STARTED|Overall Study||55
914318|NCT01631071|2210364|P2|NOT COMPLETED|Overall Study||0
914319|NCT01631071|2210365|P1|NOT COMPLETED|Overall Study||0
914320|NCT01631071|2210364|P2|COMPLETED|Overall Study||55
914321|NCT01631071|2210365|P1|COMPLETED|Overall Study||55
914322|NCT01631071|2210364|P2|STARTED|Overall Study||55
914323|NCT01631071|2210365|P1|STARTED|Overall Study||55
914324|NCT01630694|2210379|P2|NOT COMPLETED|Overall Study||0
914325|NCT01630694|2210380|P1|NOT COMPLETED|Overall Study||0
914326|NCT01630694|2210379|P2|COMPLETED|Overall Study||16
914327|NCT01630694|2210380|P1|COMPLETED|Overall Study||12
914328|NCT01630694|2210379|P2|STARTED|Overall Study||16
914329|NCT01630694|2210380|P1|STARTED|Overall Study||12
914330|NCT01630135|2210390|P2|NOT COMPLETED|Overall Study||2
914331|NCT01630135|2210391|P1|NOT COMPLETED|Overall Study||0
914332|NCT01630135|2210390|P2|COMPLETED|Overall Study||128
914333|NCT01630135|2210391|P1|COMPLETED|Overall Study||131
914334|NCT01630135|2210390|P2|STARTED|Overall Study||130
914335|NCT01630135|2210391|P1|STARTED|Overall Study||131
914336|NCT01630109|2210430|P3|NOT COMPLETED|Overall Study||0
914337|NCT01630109|2210431|P2|NOT COMPLETED|Overall Study||0
914338|NCT01630109|2210432|P1|NOT COMPLETED|Overall Study||0
914339|NCT01630109|2210430|P3|COMPLETED|Overall Study||3
914340|NCT01630109|2210431|P2|COMPLETED|Overall Study||1
914341|NCT01630109|2210432|P1|COMPLETED|Overall Study||1
914342|NCT01630109|2210430|P3|STARTED|Overall Study||3
914343|NCT01630109|2210431|P2|STARTED|Overall Study||1
914344|NCT01630109|2210432|P1|STARTED|Overall Study||1
914345|NCT01629823|2210455|P3|NOT COMPLETED|Washout Period||0
914346|NCT01629823|2210456|P2|NOT COMPLETED|Washout Period||6
914347|NCT01629823|2210457|P1|NOT COMPLETED|Washout Period||3
914348|NCT01629823|2210455|P3|COMPLETED|Washout Period||50
914349|NCT01629823|2210456|P2|COMPLETED|Washout Period||51
914350|NCT01629823|2210457|P1|COMPLETED|Washout Period||51
914351|NCT01629823|2210455|P3|STARTED|Washout Period||50
914352|NCT01629823|2210456|P2|STARTED|Washout Period||57
914353|NCT01629823|2210457|P1|STARTED|Washout Period||54
914354|NCT01629823|2210455|P3|NOT COMPLETED|Trial Period||10
914355|NCT01629823|2210456|P2|NOT COMPLETED|Trial Period||13
914356|NCT01629823|2210457|P1|NOT COMPLETED|Trial Period||13
914357|NCT01629823|2210455|P3|COMPLETED|Trial Period||49
914358|NCT01629823|2210456|P2|COMPLETED|Trial Period||56
914359|NCT01629823|2210457|P1|COMPLETED|Trial Period||53
914360|NCT01629823|2210455|P3|STARTED|Trial Period||59
914361|NCT01629823|2210456|P2|STARTED|Trial Period||69
914362|NCT01629823|2210457|P1|STARTED|Trial Period||66
914363|NCT01629797|2210465|P1|NOT COMPLETED|Overall Study||18
914364|NCT01629797|2210465|P1|COMPLETED|Overall Study||82
914365|NCT01629797|2210465|P1|STARTED|Overall Study||100
914366|NCT01629784|2210472|P1|NOT COMPLETED|Overall Study||6
914367|NCT01629784|2210472|P1|COMPLETED|Overall Study||25
914368|NCT01629784|2210472|P1|STARTED|Overall Study||31
914369|NCT01629771|2210481|P2|NOT COMPLETED|Overall Study||0
914370|NCT01629771|2210482|P1|NOT COMPLETED|Overall Study||0
914371|NCT01629771|2210481|P2|COMPLETED|Overall Study||36
914372|NCT01629771|2210482|P1|COMPLETED|Overall Study||36
914373|NCT01629771|2210481|P2|STARTED|Overall Study||36
914374|NCT01629771|2210482|P1|STARTED|Overall Study||36
914375|NCT01629706|2210492|P1|NOT COMPLETED|Phase 2 Habitual||10
914376|NCT01629706|2210492|P1|COMPLETED|Phase 2 Habitual||48
914377|NCT01629706|2210492|P1|STARTED|Phase 2 Habitual|Phase 2 enrolled 48 new participants, plus 10 participants from Phase 1|58
914378|NCT01629706|2210492|P1|NOT COMPLETED|Phase 1 PureVision||9
914379|NCT01629706|2210492|P1|COMPLETED|Phase 1 PureVision||35
914380|NCT01629706|2210492|P1|STARTED|Phase 1 PureVision||44
914381|NCT01629693|2210520|P2|NOT COMPLETED|Overall Study||10
914382|NCT01629693|2210521|P1|NOT COMPLETED|Overall Study||5
914383|NCT01629693|2210520|P2|COMPLETED|Overall Study||178
914384|NCT01629693|2210521|P1|COMPLETED|Overall Study||188
914385|NCT01629693|2210520|P2|STARTED|Overall Study||188
914386|NCT01629693|2210521|P1|STARTED|Overall Study||193
914387|NCT01629667|2210530|P3|NOT COMPLETED|Overall Study||45
914388|NCT01629667|2210531|P2|NOT COMPLETED|Overall Study||41
914389|NCT01629667|2210532|P1|NOT COMPLETED|Overall Study||47
914390|NCT01629667|2210530|P3|COMPLETED|Overall Study||14
914391|NCT01629667|2210531|P2|COMPLETED|Overall Study||17
914392|NCT01629667|2210532|P1|COMPLETED|Overall Study||12
914393|NCT01629667|2210530|P3|Randomized and Treated|Overall Study||59
914394|NCT01629667|2210531|P2|Randomized and Treated|Overall Study||57
914395|NCT01629667|2210532|P1|Randomized and Treated|Overall Study||57
914396|NCT01629667|2210530|P3|STARTED|Overall Study||59
914397|NCT01629667|2210531|P2|STARTED|Overall Study||58
914398|NCT01629667|2210532|P1|STARTED|Overall Study||59
914399|NCT01629589|2210616|P2|NOT COMPLETED|Overall Study||7
914400|NCT01629589|2210617|P1|NOT COMPLETED|Overall Study||8
914401|NCT01629589|2210616|P2|COMPLETED|Overall Study||204
914402|NCT01629589|2210617|P1|COMPLETED|Overall Study|A participant received the Boostrix vaccine. Study data reported for the Boostrix vaccine group.|204
914403|NCT01629589|2210616|P2|STARTED|Overall Study||211
914404|NCT01629589|2210617|P1|STARTED|Overall Study||212
914405|NCT01629290|2210633|P1|NOT COMPLETED|Overall Study||0
914406|NCT01629290|2210633|P1|COMPLETED|Overall Study||15
914407|NCT01629290|2210633|P1|STARTED|Overall Study||15
914408|NCT01629134|2210643|P1|NOT COMPLETED|Overall Study||0
914409|NCT01629134|2210643|P1|COMPLETED|Overall Study||62
914410|NCT01629134|2210643|P1|STARTED|Overall Study||62
914411|NCT01628965|2210656|P1|NOT COMPLETED|Overall Study||49
914412|NCT01628965|2210656|P1|COMPLETED|Overall Study||94
914413|NCT01628965|2210656|P1|STARTED|Overall Study||143
914414|NCT01628926|2210665|P3|NOT COMPLETED|Overall Study||17
914415|NCT01628926|2210666|P2|NOT COMPLETED|Overall Study||23
914416|NCT01628926|2210667|P1|NOT COMPLETED|Overall Study||26
914417|NCT01628926|2210665|P3|COMPLETED|Overall Study||68
914418|NCT01628926|2210666|P2|COMPLETED|Overall Study||144
914419|NCT01628926|2210667|P1|COMPLETED|Overall Study||142
914420|NCT01628926|2210665|P3|STARTED|Overall Study||85
914421|NCT01628926|2210666|P2|STARTED|Overall Study||167
914422|NCT01628926|2210667|P1|STARTED|Overall Study||168
914423|NCT01628913|2210716|P2|NOT COMPLETED|Overall Study||31
914424|NCT01628913|2210717|P1|NOT COMPLETED|Overall Study||31
914425|NCT01628913|2210716|P2|COMPLETED|Overall Study||0
914426|NCT01628913|2210717|P1|COMPLETED|Overall Study||0
914427|NCT01628913|2210716|P2|STARTED|Overall Study||31
914428|NCT01628913|2210717|P1|STARTED|Overall Study||31
914429|NCT01628848|2210731|P2|NOT COMPLETED|Overall Study||14
914430|NCT01628848|2210732|P1|NOT COMPLETED|Overall Study||12
914431|NCT01628848|2210731|P2|COMPLETED|Overall Study||73
914432|NCT01628848|2210732|P1|COMPLETED|Overall Study||75
914433|NCT01628848|2210731|P2|STARTED|Overall Study||87
914434|NCT01628848|2210732|P1|STARTED|Overall Study||87
914435|NCT01628692|2210766|P6|NOT COMPLETED|Overall Study||9
914436|NCT01628692|2210767|P5|NOT COMPLETED|Overall Study||4
914437|NCT01628692|2210768|P4|NOT COMPLETED|Overall Study||1
914438|NCT01628692|2210769|P3|NOT COMPLETED|Overall Study||8
914439|NCT01628692|2210770|P2|NOT COMPLETED|Overall Study||6
914440|NCT01628692|2210771|P1|NOT COMPLETED|Overall Study||7
914441|NCT01628692|2210766|P6|COMPLETED|Overall Study||0
914442|NCT01628692|2210767|P5|COMPLETED|Overall Study||8
914443|NCT01628692|2210768|P4|COMPLETED|Overall Study||19
914444|NCT01628692|2210769|P3|COMPLETED|Overall Study||43
914445|NCT01628692|2210770|P2|COMPLETED|Overall Study||17
914446|NCT01628692|2210771|P1|COMPLETED|Overall Study||46
914447|NCT01628692|2210766|P6|STARTED|Overall Study||9
914448|NCT01628692|2210767|P5|STARTED|Overall Study||12
914449|NCT01628692|2210768|P4|STARTED|Overall Study||20
914450|NCT01628692|2210769|P3|STARTED|Overall Study||51
914451|NCT01628692|2210770|P2|STARTED|Overall Study||23
914452|NCT01628692|2210771|P1|STARTED|Overall Study||53
914453|NCT01628614|2210815|P1|NOT COMPLETED|Overall Study||1775
914454|NCT01628614|2210815|P1|COMPLETED|Overall Study||3037
914455|NCT01628614|2210815|P1|STARTED|Overall Study||4812
914456|NCT01628601|2210821|P1|NOT COMPLETED|Overall Study||41
914457|NCT01628601|2210821|P1|COMPLETED|Overall Study||351
914458|NCT01628601|2210821|P1|STARTED|Overall Study||392
914459|NCT01628588|2210829|P1|NOT COMPLETED|Overall Study||16
914460|NCT01628588|2210829|P1|COMPLETED|Overall Study||838
914461|NCT01628588|2210829|P1|STARTED|Overall Study||854
914462|NCT01628510|2210839|P2|NOT COMPLETED|Overall Study||5
914463|NCT01628510|2210840|P1|NOT COMPLETED|Overall Study||3
914464|NCT01628510|2210839|P2|COMPLETED|Overall Study||44
914465|NCT01628510|2210840|P1|COMPLETED|Overall Study||48
914466|NCT01628510|2210839|P2|STARTED|Overall Study||49
914467|NCT01628510|2210840|P1|STARTED|Overall Study||51
914468|NCT01628367|2210848|P2|NOT COMPLETED|Overall Study||0
914469|NCT01628367|2210849|P1|NOT COMPLETED|Overall Study||1
914470|NCT01628367|2210848|P2|COMPLETED|Overall Study||16
914471|NCT01628367|2210849|P1|COMPLETED|Overall Study||15
914472|NCT01628367|2210848|P2|STARTED|Overall Study||16
914473|NCT01628367|2210849|P1|STARTED|Overall Study||16
914474|NCT01628250|2210861|P2|NOT COMPLETED|Overall Study||0
914475|NCT01628250|2210862|P1|NOT COMPLETED|Overall Study||0
914476|NCT01628250|2210861|P2|COMPLETED|Overall Study||50
914477|NCT01628250|2210862|P1|COMPLETED|Overall Study||49
914478|NCT01628250|2210861|P2|STARTED|Overall Study||50
914479|NCT01628250|2210862|P1|STARTED|Overall Study||49
914480|NCT01628042|2210872|P4|NOT COMPLETED|Overall Study||0
914481|NCT01628042|2210873|P3|NOT COMPLETED|Overall Study||0
914482|NCT01628042|2210874|P2|NOT COMPLETED|Overall Study||0
914483|NCT01628042|2210875|P1|NOT COMPLETED|Overall Study||0
914484|NCT01628042|2210872|P4|COMPLETED|Overall Study||8
914485|NCT01628042|2210873|P3|COMPLETED|Overall Study||8
914486|NCT01628042|2210874|P2|COMPLETED|Overall Study||8
914487|NCT01628042|2210875|P1|COMPLETED|Overall Study||8
914488|NCT01628042|2210872|P4|STARTED|Overall Study||8
914489|NCT01628042|2210873|P3|STARTED|Overall Study||8
914490|NCT01628042|2210874|P2|STARTED|Overall Study||8
914491|NCT01628042|2210875|P1|STARTED|Overall Study||8
914492|NCT01627860|2210895|P2|NOT COMPLETED|Overall Study||6
914493|NCT01627860|2210896|P1|NOT COMPLETED|Overall Study||12
914494|NCT01627860|2210895|P2|COMPLETED|Overall Study||14
914495|NCT01627860|2210896|P1|COMPLETED|Overall Study||23
914496|NCT01627860|2210895|P2|STARTED|Overall Study||20
914497|NCT01627860|2210896|P1|STARTED|Overall Study||35
914498|NCT01627782|2210910|P4|NOT COMPLETED|Overall Study||6
914499|NCT01627782|2210911|P3|NOT COMPLETED|Overall Study||15
914500|NCT01627782|2210912|P2|NOT COMPLETED|Overall Study||6
914501|NCT01627782|2210913|P1|NOT COMPLETED|Overall Study||16
914502|NCT01627782|2210910|P4|COMPLETED|Overall Study||11
914503|NCT01627782|2210911|P3|COMPLETED|Overall Study||1
914504|NCT01627782|2210912|P2|COMPLETED|Overall Study||12
914505|NCT01627782|2210913|P1|COMPLETED|Overall Study||1
914506|NCT01627782|2210910|P4|Treated|Overall Study||17
914507|NCT01627782|2210911|P3|Treated|Overall Study||16
914508|NCT01627782|2210912|P2|Treated|Overall Study||18
914509|NCT01627782|2210913|P1|Treated|Overall Study||16
914510|NCT01627782|2210910|P4|STARTED|Overall Study||17
914511|NCT01627782|2210911|P3|STARTED|Overall Study||16
914512|NCT01627782|2210912|P2|STARTED|Overall Study||18
914513|NCT01627782|2210913|P1|STARTED|Overall Study||17
914514|NCT01627561|2210971|P2|NOT COMPLETED|Overall Study||3
914515|NCT01627561|2210972|P1|NOT COMPLETED|Overall Study||0
914516|NCT01627561|2210971|P2|COMPLETED|Overall Study||71
914517|NCT01627561|2210972|P1|COMPLETED|Overall Study||74
914518|NCT01627561|2210971|P2|STARTED|Overall Study||74
914519|NCT01627561|2210972|P1|STARTED|Overall Study||74
914520|NCT01627340|2211020|P2|NOT COMPLETED|Overall Study||4
914521|NCT01627340|2211021|P1|NOT COMPLETED|Overall Study||12
914522|NCT01627340|2211020|P2|COMPLETED|Overall Study||254
914523|NCT01627340|2211021|P1|COMPLETED|Overall Study||404
914524|NCT01627340|2211020|P2|STARTED|Overall Study||258
914525|NCT01627340|2211021|P1|STARTED|Overall Study||416
914526|NCT01627327|2211039|P2|NOT COMPLETED|Overall Study||39
914527|NCT01627327|2211040|P1|NOT COMPLETED|Overall Study||19
914528|NCT01627327|2211039|P2|COMPLETED|Overall Study||274
914529|NCT01627327|2211040|P1|COMPLETED|Overall Study||291
914530|NCT01627327|2211039|P2|STARTED|Overall Study||313
914531|NCT01627327|2211040|P1|STARTED|Overall Study||310
914532|NCT01627249|2211053|P3|NOT COMPLETED|Overall Study||12
914533|NCT01627249|2211054|P2|NOT COMPLETED|Overall Study||12
914534|NCT01627249|2211055|P1|NOT COMPLETED|Overall Study||16
914535|NCT01627249|2211053|P3|COMPLETED|Overall Study||206
914536|NCT01627249|2211054|P2|COMPLETED|Overall Study||206
914537|NCT01627249|2211055|P1|COMPLETED|Overall Study||208
914538|NCT01627249|2211053|P3|STARTED|Overall Study||218
914539|NCT01627249|2211054|P2|STARTED|Overall Study||218
914540|NCT01627249|2211055|P1|STARTED|Overall Study||224
914541|NCT01627002|2211092|P9|NOT COMPLETED|Overall Study||0
914542|NCT01627002|2211093|P8|NOT COMPLETED|Overall Study||0
914543|NCT01627002|2211094|P7|NOT COMPLETED|Overall Study||0
914544|NCT01627002|2211095|P6|NOT COMPLETED|Overall Study||0
914545|NCT01627002|2211096|P5|NOT COMPLETED|Overall Study||0
914546|NCT01627002|2211097|P4|NOT COMPLETED|Overall Study||0
914547|NCT01627002|2211098|P3|NOT COMPLETED|Overall Study||0
914548|NCT01627002|2211099|P2|NOT COMPLETED|Overall Study||0
914549|NCT01627002|2211100|P1|NOT COMPLETED|Overall Study||0
914550|NCT01627002|2211092|P9|COMPLETED|Overall Study||7
914551|NCT01627002|2211093|P8|COMPLETED|Overall Study||5
914552|NCT01627002|2211094|P7|COMPLETED|Overall Study||10
914553|NCT01627002|2211095|P6|COMPLETED|Overall Study||9
914554|NCT01627002|2211096|P5|COMPLETED|Overall Study||2
914555|NCT01627002|2211097|P4|COMPLETED|Overall Study||4
914556|NCT01627002|2211098|P3|COMPLETED|Overall Study||4
914557|NCT01627002|2211099|P2|COMPLETED|Overall Study||4
914558|NCT01627002|2211100|P1|COMPLETED|Overall Study||4
914559|NCT01627002|2211092|P9|STARTED|Overall Study||7
914560|NCT01627002|2211093|P8|STARTED|Overall Study||5
914561|NCT01627002|2211094|P7|STARTED|Overall Study||10
914562|NCT01627002|2211095|P6|STARTED|Overall Study||9
914563|NCT01627002|2211096|P5|STARTED|Overall Study||2
914564|NCT01627002|2211097|P4|STARTED|Overall Study||4
914565|NCT01627002|2211098|P3|STARTED|Overall Study||4
914566|NCT01627002|2211099|P2|STARTED|Overall Study||4
914567|NCT01627002|2211100|P1|STARTED|Overall Study||4
914568|NCT01626820|2211153|P2|NOT COMPLETED|Overall Study||0
914569|NCT01626820|2211154|P1|NOT COMPLETED|Overall Study||0
914570|NCT01626820|2211153|P2|COMPLETED|Overall Study||57
914571|NCT01626820|2211154|P1|COMPLETED|Overall Study||56
914572|NCT01626820|2211153|P2|STARTED|Overall Study||57
914573|NCT01626820|2211154|P1|STARTED|Overall Study||56
914574|NCT01626690|2211176|P2|NOT COMPLETED|Overall Study||0
914575|NCT01626690|2211177|P1|NOT COMPLETED|Overall Study||2
914576|NCT01626690|2211176|P2|COMPLETED|Overall Study||51
914577|NCT01626690|2211177|P1|COMPLETED|Overall Study||47
914578|NCT01626690|2211176|P2|STARTED|Overall Study||51
914579|NCT01626690|2211177|P1|STARTED|Overall Study||49
914580|NCT01626456|2211199|P2|NOT COMPLETED|Overall Study||117
914581|NCT01626456|2211200|P1|NOT COMPLETED|Overall Study||35
914582|NCT01626456|2211199|P2|COMPLETED|Overall Study||251
914583|NCT01626456|2211200|P1|COMPLETED|Overall Study||75
914584|NCT01626456|2211199|P2|STARTED|Overall Study||368
914585|NCT01626456|2211200|P1|STARTED|Overall Study||110
914586|NCT01626391|2211230|P2|NOT COMPLETED|Overall Study||0
914587|NCT01626391|2211231|P1|NOT COMPLETED|Overall Study||2
914588|NCT01626391|2211230|P2|COMPLETED|Overall Study||4
914589|NCT01626391|2211231|P1|COMPLETED|Overall Study||3
914590|NCT01626391|2211230|P2|STARTED|Overall Study||4
914591|NCT01626391|2211231|P1|STARTED|Overall Study||5
914592|NCT01626118|2211241|P4|NOT COMPLETED|Overall Study||3
914593|NCT01626118|2211242|P3|NOT COMPLETED|Overall Study||2
914594|NCT01626118|2211243|P2|NOT COMPLETED|Overall Study||2
914595|NCT01626118|2211244|P1|NOT COMPLETED|Overall Study||2
914596|NCT01626118|2211241|P4|COMPLETED|Overall Study||91
914597|NCT01626118|2211242|P3|COMPLETED|Overall Study||90
914598|NCT01626118|2211243|P2|COMPLETED|Overall Study||91
914599|NCT01626118|2211244|P1|COMPLETED|Overall Study||92
914600|NCT01626118|2211241|P4|STARTED|Overall Study||94
914601|NCT01626118|2211242|P3|STARTED|Overall Study||92
914602|NCT01626118|2211243|P2|STARTED|Overall Study||93
914603|NCT01626118|2211244|P1|STARTED|Overall Study||94
914604|NCT01626092|2211282|P1|NOT COMPLETED|Overall Study||0
914605|NCT01626092|2211282|P1|COMPLETED|Overall Study||3
914606|NCT01626092|2211282|P1|STARTED|Overall Study||3
914607|NCT01625910|2211290|P2|NOT COMPLETED|Overall Study||4
914608|NCT01625910|2211291|P1|NOT COMPLETED|Overall Study||3
914609|NCT01625910|2211290|P2|COMPLETED|Overall Study||33
914610|NCT01625910|2211291|P1|COMPLETED|Overall Study||32
914611|NCT01625910|2211290|P2|STARTED|Overall Study||37
914612|NCT01625910|2211291|P1|STARTED|Overall Study||35
914613|NCT01625845|2211301|P2|NOT COMPLETED|Overall Study||3
914614|NCT01625845|2211302|P1|NOT COMPLETED|Overall Study||5
914615|NCT01625845|2211301|P2|COMPLETED|Overall Study||3
914616|NCT01625845|2211302|P1|COMPLETED|Overall Study||5
914617|NCT01625845|2211301|P2|STARTED|Overall Study||6
914618|NCT01625845|2211302|P1|STARTED|Overall Study||10
914619|NCT01625689|2211322|P2|NOT COMPLETED|Overall Study||1
914620|NCT01625689|2211323|P1|NOT COMPLETED|Overall Study||2
914621|NCT01625689|2211322|P2|COMPLETED|Overall Study||149
914622|NCT01625689|2211323|P1|COMPLETED|Overall Study||148
914623|NCT01625689|2211322|P2|STARTED|Overall Study||150
914624|NCT01625689|2211323|P1|STARTED|Overall Study||150
914625|NCT01625507|2211333|P1|NOT COMPLETED|Overall Study||10
914626|NCT01625507|2211333|P1|COMPLETED|Overall Study||63
914627|NCT01625507|2211333|P1|STARTED|Overall Study||73
914628|NCT01625455|2211348|P2|NOT COMPLETED|Overall Study||0
914629|NCT01625455|2211349|P1|NOT COMPLETED|Overall Study||0
914630|NCT01625455|2211348|P2|COMPLETED|Overall Study||3
914631|NCT01625455|2211349|P1|COMPLETED|Overall Study||2
914632|NCT01625455|2211348|P2|STARTED|Overall Study||3
914633|NCT01625455|2211349|P1|STARTED|Overall Study||2
914634|NCT01625377|2211359|P2|NOT COMPLETED|Overall Study||22
914635|NCT01625377|2211360|P1|NOT COMPLETED|Overall Study||7
914636|NCT01625377|2211359|P2|COMPLETED|Overall Study||71
914637|NCT01625377|2211360|P1|COMPLETED|Overall Study||88
914638|NCT01625377|2211359|P2|Intent to Treat Population|Overall Study||90
914639|NCT01625377|2211360|P1|Intent to Treat Population|Overall Study||93
914640|NCT01625377|2211359|P2|Safety Set of Population|Overall Study||90
914641|NCT01625377|2211360|P1|Safety Set of Population|Overall Study||94
914642|NCT01625377|2211359|P2|STARTED|Overall Study||93
914643|NCT01625377|2211360|P1|STARTED|Overall Study|"Started indicates randomized patients."|95
914644|NCT01625338|2211393|P3|NOT COMPLETED|Overall Study||39
914645|NCT01625338|2211394|P2|NOT COMPLETED|Overall Study||44
914646|NCT01625338|2211395|P1|NOT COMPLETED|Overall Study||32
914647|NCT01625338|2211393|P3|COMPLETED|Overall Study||181
914648|NCT01625338|2211394|P2|COMPLETED|Overall Study||156
914649|NCT01625338|2211395|P1|COMPLETED|Overall Study||82
914650|NCT01625338|2211393|P3|STARTED|Overall Study||220
914651|NCT01625338|2211394|P2|STARTED|Overall Study||200
914652|NCT01625338|2211395|P1|STARTED|Overall Study||114
914653|NCT01625221|2211415|P1|NOT COMPLETED|Overall Study||7
914654|NCT01625221|2211415|P1|COMPLETED|Overall Study||28
914655|NCT01625221|2211415|P1|STARTED|Overall Study||35
914662|NCT01625169|2211435|P1|NOT COMPLETED|Overall Study||0
914663|NCT01625169|2211435|P1|COMPLETED|Overall Study||9
914664|NCT01625169|2211435|P1|STARTED|Overall Study||9
914665|NCT01625091|2211450|P2|NOT COMPLETED|Post-intervention||2
914666|NCT01625091|2211451|P1|NOT COMPLETED|Post-intervention||4
914667|NCT01625091|2211450|P2|COMPLETED|Post-intervention||85
914668|NCT01625091|2211451|P1|COMPLETED|Post-intervention||81
914669|NCT01625091|2211450|P2|7 Months|Post-intervention||85
914670|NCT01625091|2211451|P1|7 Months|Post-intervention||81
914671|NCT01625091|2211450|P2|STARTED|Post-intervention||87
914672|NCT01625091|2211451|P1|STARTED|Post-intervention||85
914673|NCT01625091|2211450|P2|NOT COMPLETED|Intervention||11
914674|NCT01625091|2211451|P1|NOT COMPLETED|Intervention||11
914675|NCT01625091|2211450|P2|COMPLETED|Intervention||87
914676|NCT01625091|2211451|P1|COMPLETED|Intervention||85
914677|NCT01625091|2211450|P2|4 Months|Intervention||87
914678|NCT01625091|2211451|P1|4 Months|Intervention||85
914679|NCT01625091|2211450|P2|2 Months|Intervention||93
914680|NCT01625091|2211451|P1|2 Months|Intervention||90
914681|NCT01625091|2211450|P2|STARTED|Intervention||98
914682|NCT01625091|2211451|P1|STARTED|Intervention||96
914683|NCT01624948|2211465|P2|NOT COMPLETED|Overall Study||0
914684|NCT01624948|2211466|P1|NOT COMPLETED|Overall Study||0
914685|NCT01624948|2211465|P2|COMPLETED|Overall Study||20
914686|NCT01624948|2211466|P1|COMPLETED|Overall Study||20
914687|NCT01624948|2211465|P2|STARTED|Overall Study||20
914688|NCT01624948|2211466|P1|STARTED|Overall Study||20
914689|NCT01624740|2211484|P2|NOT COMPLETED|Second Intervention (3-4 Days)||0
914690|NCT01624740|2211485|P1|NOT COMPLETED|Second Intervention (3-4 Days)||1
914691|NCT01624740|2211484|P2|COMPLETED|Second Intervention (3-4 Days)||9
914692|NCT01624740|2211485|P1|COMPLETED|Second Intervention (3-4 Days)||8
914693|NCT01624740|2211484|P2|STARTED|Second Intervention (3-4 Days)||9
914694|NCT01624740|2211485|P1|STARTED|Second Intervention (3-4 Days)||9
914695|NCT01624740|2211484|P2|NOT COMPLETED|Washout (1 Hour)||0
914696|NCT01624740|2211485|P1|NOT COMPLETED|Washout (1 Hour)||0
914697|NCT01624740|2211484|P2|COMPLETED|Washout (1 Hour)||9
914698|NCT01624740|2211485|P1|COMPLETED|Washout (1 Hour)||9
914699|NCT01624740|2211484|P2|STARTED|Washout (1 Hour)||9
914700|NCT01624740|2211485|P1|STARTED|Washout (1 Hour)||9
914701|NCT01624740|2211484|P2|NOT COMPLETED|First Intervention (3-4 Days)||0
914702|NCT01624740|2211485|P1|NOT COMPLETED|First Intervention (3-4 Days)||0
914703|NCT01624740|2211484|P2|COMPLETED|First Intervention (3-4 Days)||9
914704|NCT01624740|2211485|P1|COMPLETED|First Intervention (3-4 Days)||9
914705|NCT01624740|2211484|P2|STARTED|First Intervention (3-4 Days)||9
914706|NCT01624740|2211485|P1|STARTED|First Intervention (3-4 Days)||9
914707|NCT01624467|2211492|P1|NOT COMPLETED|Overall Study||31
914708|NCT01624467|2211492|P1|COMPLETED|Overall Study||44
914709|NCT01624467|2211492|P1|Received at Least One Dose of Study Drug|Overall Study||75
914710|NCT01624467|2211492|P1|STARTED|Overall Study||75
914711|NCT01624363|2211505|P1|NOT COMPLETED|Overall Study||0
914712|NCT01624363|2211505|P1|COMPLETED|Overall Study||341
914713|NCT01624363|2211505|P1|STARTED|Overall Study||341
914714|NCT01624350|2211509|P1|NOT COMPLETED|Overall Study||25
914715|NCT01624350|2211509|P1|COMPLETED|Overall Study||75
914716|NCT01624350|2211509|P1|STARTED|Overall Study||100
914717|NCT01624259|2211531|P2|NOT COMPLETED|Overall Study||31
914718|NCT01624259|2211532|P1|NOT COMPLETED|Overall Study||30
914719|NCT01624259|2211531|P2|COMPLETED|Overall Study|Completed the study on study treatment|269
914720|NCT01624259|2211532|P1|COMPLETED|Overall Study|Completed the study on study treatment|269
914721|NCT01624259|2211531|P2|Received at Least One Dose of Study Drug|Overall Study||300
914722|NCT01624259|2211532|P1|Received at Least One Dose of Study Drug|Overall Study||299
914723|NCT01624259|2211531|P2|STARTED|Overall Study||300
914724|NCT01624259|2211532|P1|STARTED|Overall Study||299
914736|NCT01624168|2211601|P3|NOT COMPLETED|Overall Study||6
914737|NCT01624168|2211602|P2|NOT COMPLETED|Overall Study||12
914738|NCT01624168|2211603|P1|NOT COMPLETED|Overall Study||4
914739|NCT01624168|2211601|P3|COMPLETED|Overall Study||22
914740|NCT01624168|2211602|P2|COMPLETED|Overall Study||16
914741|NCT01624168|2211603|P1|COMPLETED|Overall Study||15
914742|NCT01624168|2211601|P3|STARTED|Overall Study||28
914743|NCT01624168|2211602|P2|STARTED|Overall Study||28
914744|NCT01624168|2211603|P1|STARTED|Overall Study||19
914745|NCT01623869|2211626|P1|NOT COMPLETED|Overall Study||0
914746|NCT01623869|2211626|P1|COMPLETED|Overall Study||16
914747|NCT01623869|2211626|P1|STARTED|Overall Study||16
914748|NCT01623830|2211634|P2|NOT COMPLETED|Overall Study||9
914749|NCT01623830|2211635|P1|NOT COMPLETED|Overall Study||7
914750|NCT01623830|2211634|P2|COMPLETED|Overall Study||35
914751|NCT01623830|2211635|P1|COMPLETED|Overall Study||38
914752|NCT01623830|2211634|P2|STARTED|Overall Study||44
914753|NCT01623830|2211635|P1|STARTED|Overall Study||45
914754|NCT01623479|2211649|P1|NOT COMPLETED|Overall Study||0
914755|NCT01623479|2211649|P1|COMPLETED|Overall Study||585
914756|NCT01623479|2211649|P1|STARTED|Overall Study||585
914757|NCT01623466|2211657|P2|NOT COMPLETED|Overall Study||0
914758|NCT01623466|2211658|P1|NOT COMPLETED|Overall Study||1
914759|NCT01623466|2211657|P2|COMPLETED|Overall Study||18
914760|NCT01623466|2211658|P1|COMPLETED|Overall Study||17
914761|NCT01623466|2211657|P2|STARTED|Overall Study||18
914762|NCT01623466|2211658|P1|STARTED|Overall Study||18
914763|NCT01623323|2211672|P1|NOT COMPLETED|Overall Study||104
914764|NCT01623323|2211672|P1|COMPLETED|Overall Study||601
914765|NCT01623323|2211672|P1|STARTED|Overall Study||705
914766|NCT01623271|2211676|P1|NOT COMPLETED|Overall Study||2
914767|NCT01623271|2211676|P1|COMPLETED|Overall Study||3
914768|NCT01623271|2211676|P1|STARTED|Overall Study||5
914769|NCT01623154|2211680|P1|NOT COMPLETED|Overall Study||4
914770|NCT01623154|2211680|P1|COMPLETED|Overall Study||95
914771|NCT01623154|2211680|P1|Available for Analysis|Overall Study||95
914772|NCT01623154|2211680|P1|STARTED|Overall Study||99
914773|NCT01623115|2211688|P2|NOT COMPLETED|Overall Study||77
914774|NCT01623115|2211689|P1|NOT COMPLETED|Overall Study||33
914775|NCT01623115|2211688|P2|COMPLETED|Overall Study||246
914776|NCT01623115|2211689|P1|COMPLETED|Overall Study||130
914777|NCT01623115|2211688|P2|Treated|Overall Study||322
914778|NCT01623115|2211689|P1|Treated|Overall Study||163
914779|NCT01623115|2211688|P2|STARTED|Overall Study|Randomized|323
914780|NCT01623115|2211689|P1|STARTED|Overall Study|Randomized|163
914781|NCT01623050|2211749|P1|NOT COMPLETED|Overall Study||9
914782|NCT01623050|2211749|P1|COMPLETED|Overall Study||27
914783|NCT01623050|2211749|P1|Treated|Overall Study||34
914784|NCT01623050|2211749|P1|STARTED|Overall Study||36
914785|NCT01622673|2211763|P6|NOT COMPLETED|Treatment Period 5||0
914786|NCT01622673|2211764|P5|NOT COMPLETED|Treatment Period 5||0
914787|NCT01622673|2211765|P4|NOT COMPLETED|Treatment Period 5||0
914788|NCT01622673|2211766|P3|NOT COMPLETED|Treatment Period 5||0
914789|NCT01622673|2211767|P2|NOT COMPLETED|Treatment Period 5||0
914790|NCT01622673|2211768|P1|NOT COMPLETED|Treatment Period 5||0
914791|NCT01622673|2211763|P6|COMPLETED|Treatment Period 5||4
914792|NCT01622673|2211764|P5|COMPLETED|Treatment Period 5||4
914793|NCT01622673|2211765|P4|COMPLETED|Treatment Period 5||4
914794|NCT01622673|2211766|P3|COMPLETED|Treatment Period 5||4
914795|NCT01622673|2211767|P2|COMPLETED|Treatment Period 5||3
914796|NCT01622673|2211768|P1|COMPLETED|Treatment Period 5||4
914797|NCT01622673|2211763|P6|STARTED|Treatment Period 5||4
914798|NCT01622673|2211764|P5|STARTED|Treatment Period 5||4
914799|NCT01622673|2211765|P4|STARTED|Treatment Period 5||4
914800|NCT01622673|2211766|P3|STARTED|Treatment Period 5||4
914801|NCT01622673|2211767|P2|STARTED|Treatment Period 5||3
914802|NCT01622673|2211768|P1|STARTED|Treatment Period 5||4
914803|NCT01622673|2211763|P6|NOT COMPLETED|Treatment Period 4||0
914804|NCT01622673|2211764|P5|NOT COMPLETED|Treatment Period 4||0
914805|NCT01622673|2211765|P4|NOT COMPLETED|Treatment Period 4||0
914806|NCT01622673|2211766|P3|NOT COMPLETED|Treatment Period 4||0
914807|NCT01622673|2211767|P2|NOT COMPLETED|Treatment Period 4||0
914808|NCT01622673|2211768|P1|NOT COMPLETED|Treatment Period 4||0
914809|NCT01622673|2211763|P6|COMPLETED|Treatment Period 4||4
914810|NCT01622673|2211764|P5|COMPLETED|Treatment Period 4||4
914811|NCT01622673|2211765|P4|COMPLETED|Treatment Period 4||4
914812|NCT01622673|2211766|P3|COMPLETED|Treatment Period 4||4
914813|NCT01622673|2211767|P2|COMPLETED|Treatment Period 4||3
914814|NCT01622673|2211768|P1|COMPLETED|Treatment Period 4||4
914815|NCT01622673|2211763|P6|STARTED|Treatment Period 4||4
914816|NCT01622673|2211764|P5|STARTED|Treatment Period 4||4
914817|NCT01622673|2211765|P4|STARTED|Treatment Period 4||4
914818|NCT01622673|2211766|P3|STARTED|Treatment Period 4||4
914819|NCT01622673|2211767|P2|STARTED|Treatment Period 4||3
914820|NCT01622673|2211768|P1|STARTED|Treatment Period 4||4
914821|NCT01622673|2211763|P6|NOT COMPLETED|Treatment Period 3||0
914822|NCT01622673|2211764|P5|NOT COMPLETED|Treatment Period 3||0
914823|NCT01622673|2211765|P4|NOT COMPLETED|Treatment Period 3||0
914824|NCT01622673|2211766|P3|NOT COMPLETED|Treatment Period 3||0
914825|NCT01622673|2211767|P2|NOT COMPLETED|Treatment Period 3||1
914826|NCT01622673|2211768|P1|NOT COMPLETED|Treatment Period 3||0
914827|NCT01622673|2211763|P6|COMPLETED|Treatment Period 3||4
914828|NCT01622673|2211764|P5|COMPLETED|Treatment Period 3||4
914829|NCT01622673|2211765|P4|COMPLETED|Treatment Period 3||4
914830|NCT01622673|2211766|P3|COMPLETED|Treatment Period 3||4
914831|NCT01622673|2211767|P2|COMPLETED|Treatment Period 3||3
914832|NCT01622673|2211768|P1|COMPLETED|Treatment Period 3||4
914833|NCT01622673|2211763|P6|STARTED|Treatment Period 3||4
914834|NCT01622673|2211764|P5|STARTED|Treatment Period 3||4
914835|NCT01622673|2211765|P4|STARTED|Treatment Period 3||4
914836|NCT01622673|2211766|P3|STARTED|Treatment Period 3||4
914837|NCT01622673|2211767|P2|STARTED|Treatment Period 3||4
914838|NCT01622673|2211768|P1|STARTED|Treatment Period 3||4
914839|NCT01622673|2211763|P6|NOT COMPLETED|Treatment Period 2||0
914840|NCT01622673|2211764|P5|NOT COMPLETED|Treatment Period 2||0
914841|NCT01622673|2211765|P4|NOT COMPLETED|Treatment Period 2||1
914842|NCT01622673|2211766|P3|NOT COMPLETED|Treatment Period 2||0
914843|NCT01622673|2211767|P2|NOT COMPLETED|Treatment Period 2||0
914844|NCT01622673|2211768|P1|NOT COMPLETED|Treatment Period 2||0
914845|NCT01622673|2211763|P6|COMPLETED|Treatment Period 2||4
914846|NCT01622673|2211764|P5|COMPLETED|Treatment Period 2||4
914847|NCT01622673|2211765|P4|COMPLETED|Treatment Period 2||4
914848|NCT01622673|2211766|P3|COMPLETED|Treatment Period 2||4
914849|NCT01622673|2211767|P2|COMPLETED|Treatment Period 2||4
914850|NCT01622673|2211768|P1|COMPLETED|Treatment Period 2||4
914851|NCT01622673|2211763|P6|STARTED|Treatment Period 2||4
914852|NCT01622673|2211764|P5|STARTED|Treatment Period 2||4
914853|NCT01622673|2211765|P4|STARTED|Treatment Period 2||5
914854|NCT01622673|2211766|P3|STARTED|Treatment Period 2||4
914855|NCT01622673|2211767|P2|STARTED|Treatment Period 2||4
914856|NCT01622673|2211768|P1|STARTED|Treatment Period 2||4
914857|NCT01622673|2211763|P6|NOT COMPLETED|Treatment Period 1||0
914858|NCT01622673|2211764|P5|NOT COMPLETED|Treatment Period 1||0
914859|NCT01622673|2211765|P4|NOT COMPLETED|Treatment Period 1||1
914860|NCT01622673|2211766|P3|NOT COMPLETED|Treatment Period 1||0
914861|NCT01622673|2211767|P2|NOT COMPLETED|Treatment Period 1||1
914862|NCT01622673|2211768|P1|NOT COMPLETED|Treatment Period 1||0
914863|NCT01622673|2211763|P6|COMPLETED|Treatment Period 1||4
914864|NCT01622673|2211764|P5|COMPLETED|Treatment Period 1||4
914865|NCT01622673|2211765|P4|COMPLETED|Treatment Period 1||5
914866|NCT01622673|2211766|P3|COMPLETED|Treatment Period 1||4
914867|NCT01622673|2211767|P2|COMPLETED|Treatment Period 1||4
914868|NCT01622673|2211768|P1|COMPLETED|Treatment Period 1||4
914869|NCT01622673|2211763|P6|STARTED|Treatment Period 1||4
914870|NCT01622673|2211764|P5|STARTED|Treatment Period 1||4
914871|NCT01622673|2211765|P4|STARTED|Treatment Period 1||6
914872|NCT01622673|2211766|P3|STARTED|Treatment Period 1||4
914873|NCT01622673|2211767|P2|STARTED|Treatment Period 1||5
914874|NCT01622673|2211768|P1|STARTED|Treatment Period 1||4
914875|NCT01622660|2211803|P1|NOT COMPLETED|Overall Study||1
914876|NCT01622660|2211803|P1|COMPLETED|Overall Study||1
914877|NCT01622660|2211803|P1|STARTED|Overall Study||2
914878|NCT01622296|2211807|P2|NOT COMPLETED|Second Intervention||0
914879|NCT01622296|2211808|P1|NOT COMPLETED|Second Intervention||0
914880|NCT01622296|2211807|P2|COMPLETED|Second Intervention||10
914881|NCT01622296|2211808|P1|COMPLETED|Second Intervention||10
914882|NCT01622296|2211807|P2|STARTED|Second Intervention||10
914883|NCT01622296|2211808|P1|STARTED|Second Intervention||10
914884|NCT01622296|2211807|P2|NOT COMPLETED|Washout Period of at Least 1 Week||0
914885|NCT01622296|2211808|P1|NOT COMPLETED|Washout Period of at Least 1 Week||0
914886|NCT01622296|2211807|P2|COMPLETED|Washout Period of at Least 1 Week||10
914887|NCT01622296|2211808|P1|COMPLETED|Washout Period of at Least 1 Week||10
914888|NCT01622296|2211807|P2|STARTED|Washout Period of at Least 1 Week||10
914889|NCT01622296|2211808|P1|STARTED|Washout Period of at Least 1 Week||10
914890|NCT01622296|2211807|P2|NOT COMPLETED|First Intervention||0
914891|NCT01622296|2211808|P1|NOT COMPLETED|First Intervention||0
914892|NCT01622296|2211807|P2|COMPLETED|First Intervention||10
914893|NCT01622296|2211808|P1|COMPLETED|First Intervention||10
914894|NCT01622296|2211807|P2|STARTED|First Intervention||10
914895|NCT01622296|2211808|P1|STARTED|First Intervention||10
914896|NCT01622257|2211816|P3|NOT COMPLETED|Overall Study||0
914897|NCT01622257|2211817|P2|NOT COMPLETED|Overall Study||0
914898|NCT01622257|2211818|P1|NOT COMPLETED|Overall Study||0
914899|NCT01622257|2211816|P3|COMPLETED|Overall Study||66
914900|NCT01622257|2211817|P2|COMPLETED|Overall Study||66
914901|NCT01622257|2211818|P1|COMPLETED|Overall Study||66
914902|NCT01622257|2211816|P3|STARTED|Overall Study||66
914903|NCT01622257|2211817|P2|STARTED|Overall Study||66
914904|NCT01622257|2211818|P1|STARTED|Overall Study||66
914905|NCT01622231|2211838|P1|NOT COMPLETED|Overall Study||2
914906|NCT01622231|2211838|P1|COMPLETED|Overall Study||59
914907|NCT01622231|2211838|P1|STARTED|Overall Study||61
914926|NCT01621776|2211984|P3|NOT COMPLETED|Overall Study||0
914927|NCT01621776|2211985|P2|NOT COMPLETED|Overall Study||0
914928|NCT01621776|2211986|P1|NOT COMPLETED|Overall Study||0
914929|NCT01621776|2211984|P3|COMPLETED|Overall Study||18
914930|NCT01621776|2211985|P2|COMPLETED|Overall Study||40
914931|NCT01621776|2211986|P1|COMPLETED|Overall Study||41
914932|NCT01621776|2211984|P3|STARTED|Overall Study||18
914933|NCT01621776|2211985|P2|STARTED|Overall Study||40
914934|NCT01621776|2211986|P1|STARTED|Overall Study||41
914935|NCT01621672|2212002|P2|NOT COMPLETED|Overall Study||0
914936|NCT01621672|2212003|P1|NOT COMPLETED|Overall Study||0
914937|NCT01621672|2212002|P2|COMPLETED|Overall Study||17
914938|NCT01621672|2212003|P1|COMPLETED|Overall Study||25
914939|NCT01621672|2212002|P2|STARTED|Overall Study||17
914940|NCT01621672|2212003|P1|STARTED|Overall Study||25
914941|NCT01621633|2212013|P4|NOT COMPLETED|Overall Study||0
914942|NCT01621633|2212014|P3|NOT COMPLETED|Overall Study||0
914943|NCT01621633|2212015|P2|NOT COMPLETED|Overall Study||0
914944|NCT01621633|2212016|P1|NOT COMPLETED|Overall Study||0
914945|NCT01621633|2212013|P4|COMPLETED|Overall Study||8
914946|NCT01621633|2212014|P3|COMPLETED|Overall Study||8
914947|NCT01621633|2212015|P2|COMPLETED|Overall Study||8
914948|NCT01621633|2212016|P1|COMPLETED|Overall Study||8
914949|NCT01621633|2212013|P4|STARTED|Overall Study||8
914950|NCT01621633|2212014|P3|STARTED|Overall Study||8
914951|NCT01621633|2212015|P2|STARTED|Overall Study||8
914952|NCT01621633|2212016|P1|STARTED|Overall Study||8
914953|NCT01621477|2212038|P1|NOT COMPLETED|Overall Study||0
914954|NCT01621477|2212038|P1|COMPLETED|Overall Study||17
914955|NCT01621477|2212038|P1|STARTED|Overall Study||17
914956|NCT01621191|2212048|P1|NOT COMPLETED|Overall Study||25
914957|NCT01621191|2212048|P1|COMPLETED|Overall Study||124
914958|NCT01621191|2212048|P1|Had at Least 1 Post-Baseline Observation|Overall Study||148
914959|NCT01621191|2212048|P1|Received at Least 1 Dose of Study Drug|Overall Study||149
914960|NCT01621191|2212048|P1|STARTED|Overall Study||149
914961|NCT01621178|2212062|P3|NOT COMPLETED|Overall Study||31
914962|NCT01621178|2212063|P2|NOT COMPLETED|Overall Study||22
914963|NCT01621178|2212064|P1|NOT COMPLETED|Overall Study||15
914964|NCT01621178|2212062|P3|COMPLETED|Overall Study||162
914965|NCT01621178|2212063|P2|COMPLETED|Overall Study||168
914966|NCT01621178|2212064|P1|COMPLETED|Overall Study||179
914967|NCT01621178|2212062|P3|Received at Least One Dose of Study Drug|Overall Study||192
914968|NCT01621178|2212063|P2|Received at Least One Dose of Study Drug|Overall Study||190
914969|NCT01621178|2212064|P1|Received at Least One Dose of Study Drug|Overall Study||194
914970|NCT01621178|2212062|P3|STARTED|Overall Study||193
914971|NCT01621178|2212063|P2|STARTED|Overall Study||190
914972|NCT01621178|2212064|P1|STARTED|Overall Study||194
914973|NCT01621126|2212111|P1|NOT COMPLETED|Overall Study||6
914974|NCT01621126|2212111|P1|COMPLETED|Overall Study||34
914975|NCT01621126|2212111|P1|STARTED|Overall Study||40
914976|NCT01621009|2212119|P4|NOT COMPLETED|Overall Study||53
914977|NCT01621009|2212120|P3|NOT COMPLETED|Overall Study||63
914978|NCT01621009|2212121|P2|NOT COMPLETED|Overall Study||51
914979|NCT01621009|2212122|P1|NOT COMPLETED|Overall Study||43
914980|NCT01621009|2212119|P4|COMPLETED|Overall Study||60
914981|NCT01621009|2212120|P3|COMPLETED|Overall Study||58
914982|NCT01621009|2212121|P2|COMPLETED|Overall Study||65
914983|NCT01621009|2212122|P1|COMPLETED|Overall Study||70
914984|NCT01621009|2212119|P4|STARTED|Overall Study||113
914985|NCT01621009|2212120|P3|STARTED|Overall Study||121
914986|NCT01621009|2212121|P2|STARTED|Overall Study||116
914987|NCT01621009|2212122|P1|STARTED|Overall Study||113
914988|NCT01620489|2212132|P2|NOT COMPLETED|Overall Study||34
914989|NCT01620489|2212133|P1|NOT COMPLETED|Overall Study||35
914990|NCT01620489|2212132|P2|COMPLETED|Overall Study|2 subjects did not take trial product|105
914991|NCT01620489|2212133|P1|COMPLETED|Overall Study||105
914992|NCT01620489|2212132|P2|Exposed|Overall Study|2 subjects did not take trial product|137
914993|NCT01620489|2212133|P1|Exposed|Overall Study||140
914994|NCT01620489|2212132|P2|STARTED|Overall Study||139
914995|NCT01620489|2212133|P1|STARTED|Overall Study||140
914996|NCT01620255|2212154|P5|NOT COMPLETED|Overall Study||6
914997|NCT01620255|2212155|P4|NOT COMPLETED|Overall Study||3
914998|NCT01620255|2212156|P3|NOT COMPLETED|Overall Study||2
914999|NCT01620255|2212157|P2|NOT COMPLETED|Overall Study||6
915000|NCT01620255|2212158|P1|NOT COMPLETED|Overall Study||4
915001|NCT01620255|2212154|P5|COMPLETED|Overall Study||64
915002|NCT01620255|2212155|P4|COMPLETED|Overall Study||70
915003|NCT01620255|2212156|P3|COMPLETED|Overall Study||68
915004|NCT01620255|2212157|P2|COMPLETED|Overall Study||65
915005|NCT01620255|2212158|P1|COMPLETED|Overall Study||69
915006|NCT01620255|2212154|P5|Treated|Overall Study||70
915007|NCT01620255|2212155|P4|Treated|Overall Study||73
915008|NCT01620255|2212156|P3|Treated|Overall Study||70
915009|NCT01620255|2212157|P2|Treated|Overall Study||71
915010|NCT01620255|2212158|P1|Treated|Overall Study||73
915011|NCT01620255|2212154|P5|STARTED|Overall Study||70
915012|NCT01620255|2212155|P4|STARTED|Overall Study||73
915013|NCT01620255|2212156|P3|STARTED|Overall Study||70
915014|NCT01620255|2212157|P2|STARTED|Overall Study||71
915015|NCT01620255|2212158|P1|STARTED|Overall Study||73
915016|NCT01620177|2212235|P1|NOT COMPLETED|Overall Study||79
915017|NCT01620177|2212235|P1|COMPLETED|Overall Study||19
915018|NCT01620177|2212235|P1|STARTED|Overall Study||98
915019|NCT01620138|2212260|P2|NOT COMPLETED|Overall Study||0
915020|NCT01620138|2212261|P1|NOT COMPLETED|Overall Study||6
915021|NCT01620138|2212260|P2|COMPLETED|Overall Study||9
915022|NCT01620138|2212261|P1|COMPLETED|Overall Study||6
915023|NCT01620138|2212260|P2|STARTED|Overall Study||9
915024|NCT01620138|2212261|P1|STARTED|Overall Study||12
915025|NCT01620086|2212269|P3|NOT COMPLETED|Overall Study||0
915026|NCT01620086|2212270|P2|NOT COMPLETED|Overall Study||7
915027|NCT01620086|2212271|P1|NOT COMPLETED|Overall Study||5
915028|NCT01620086|2212269|P3|COMPLETED|Overall Study||2
915029|NCT01620086|2212270|P2|COMPLETED|Overall Study||4
915030|NCT01620086|2212271|P1|COMPLETED|Overall Study||8
915031|NCT01620086|2212269|P3|STARTED|Overall Study||2
915032|NCT01620086|2212270|P2|STARTED|Overall Study||11
915033|NCT01620086|2212271|P1|STARTED|Overall Study||13
915034|NCT01620060|2212290|P1|NOT COMPLETED|Overall Study||15
915035|NCT01620060|2212290|P1|COMPLETED|Overall Study||90
915036|NCT01620060|2212290|P1|STARTED|Overall Study||105
915037|NCT01620047|2212299|P3|NOT COMPLETED|Overall Study||0
915038|NCT01620047|2212300|P2|NOT COMPLETED|Overall Study||0
915039|NCT01620047|2212301|P1|NOT COMPLETED|Overall Study||0
915040|NCT01620047|2212299|P3|COMPLETED|Overall Study||20
915041|NCT01620047|2212300|P2|COMPLETED|Overall Study||20
915042|NCT01620047|2212301|P1|COMPLETED|Overall Study||20
915043|NCT01620047|2212299|P3|STARTED|Overall Study||20
915044|NCT01620047|2212300|P2|STARTED|Overall Study||20
915045|NCT01620047|2212301|P1|STARTED|Overall Study||20
915046|NCT01619878|2212309|P1|NOT COMPLETED|Follow-up at 12 Months of Age||3
915047|NCT01619878|2212309|P1|COMPLETED|Follow-up at 12 Months of Age||17
915048|NCT01619878|2212309|P1|STARTED|Follow-up at 12 Months of Age||20
915049|NCT01619878|2212309|P1|NOT COMPLETED|6 Week Follow-up Phase||1
915050|NCT01619878|2212309|P1|COMPLETED|6 Week Follow-up Phase||19
915051|NCT01619878|2212309|P1|STARTED|6 Week Follow-up Phase||20
915052|NCT01619800|2212323|P2|NOT COMPLETED|Overall Study||0
915053|NCT01619800|2212324|P1|NOT COMPLETED|Overall Study||2
915054|NCT01619800|2212323|P2|COMPLETED|Overall Study||0
915055|NCT01619800|2212324|P1|COMPLETED|Overall Study||0
915056|NCT01619800|2212323|P2|STARTED|Overall Study||0
915057|NCT01619800|2212324|P1|STARTED|Overall Study||2
915058|NCT01619787|2212332|P1|NOT COMPLETED|Overall Study||5
915059|NCT01619787|2212332|P1|COMPLETED|Overall Study||212
915060|NCT01619787|2212332|P1|STARTED|Overall Study||217
915061|NCT01619774|2212341|P1|NOT COMPLETED|Overall Study||0
915062|NCT01619774|2212341|P1|COMPLETED|Overall Study||23
915063|NCT01619774|2212341|P1|STARTED|Overall Study||23
915064|NCT01619579|2212349|P2|NOT COMPLETED|Overall Study||3
915065|NCT01619579|2212350|P1|NOT COMPLETED|Overall Study||0
915066|NCT01619579|2212349|P2|COMPLETED|Overall Study||14
915067|NCT01619579|2212350|P1|COMPLETED|Overall Study||5
915068|NCT01619579|2212349|P2|STARTED|Overall Study||17
915069|NCT01619579|2212350|P1|STARTED|Overall Study||5
915070|NCT01619059|2212362|P2|NOT COMPLETED|Long-Term (LT) Treatment Period||9
915071|NCT01619059|2212363|P1|NOT COMPLETED|Long-Term (LT) Treatment Period||8
915072|NCT01619059|2212362|P2|COMPLETED|Long-Term (LT) Treatment Period||133
915073|NCT01619059|2212363|P1|COMPLETED|Long-Term (LT) Treatment Period||147
915074|NCT01619059|2212362|P2|STARTED|Long-Term (LT) Treatment Period||142
915075|NCT01619059|2212363|P1|STARTED|Long-Term (LT) Treatment Period||155
915076|NCT01619059|2212362|P2|NOT COMPLETED|Short-Term (ST) Treatment Period||11
915077|NCT01619059|2212363|P1|NOT COMPLETED|Short-Term (ST) Treatment Period||6
915078|NCT01619059|2212362|P2|COMPLETED|Short-Term (ST) Treatment Period||142
915079|NCT01619059|2212363|P1|COMPLETED|Short-Term (ST) Treatment Period||156
915080|NCT01619059|2212362|P2|STARTED|Short-Term (ST) Treatment Period||153
915081|NCT01619059|2212363|P1|STARTED|Short-Term (ST) Treatment Period||162
915082|NCT01618968|2212379|P4|NOT COMPLETED|Overall Study||1
915083|NCT01618968|2212380|P3|NOT COMPLETED|Overall Study||0
915084|NCT01618968|2212381|P2|NOT COMPLETED|Overall Study||0
915085|NCT01618968|2212382|P1|NOT COMPLETED|Overall Study||1
915086|NCT01618968|2212379|P4|COMPLETED|Overall Study||11
915087|NCT01618968|2212380|P3|COMPLETED|Overall Study||12
915088|NCT01618968|2212381|P2|COMPLETED|Overall Study||12
915089|NCT01618968|2212382|P1|COMPLETED|Overall Study||12
915090|NCT01618968|2212379|P4|Received Treatment C|Overall Study||11
915091|NCT01618968|2212380|P3|Received Treatment C|Overall Study||12
915092|NCT01618968|2212381|P2|Received Treatment C|Overall Study||12
915093|NCT01618968|2212382|P1|Received Treatment C|Overall Study||12
915094|NCT01618968|2212379|P4|Received Treatment B|Overall Study||12
915095|NCT01618968|2212380|P3|Received Treatment B|Overall Study||12
915096|NCT01618968|2212381|P2|Received Treatment B|Overall Study||12
915097|NCT01618968|2212382|P1|Received Treatment B|Overall Study||13
915098|NCT01618968|2212379|P4|Received Treatment A|Overall Study||11
915099|NCT01618968|2212380|P3|Received Treatment A|Overall Study||12
915100|NCT01618968|2212381|P2|Received Treatment A|Overall Study||12
915101|NCT01618968|2212382|P1|Received Treatment A|Overall Study||12
915102|NCT01618968|2212379|P4|STARTED|Overall Study||12
915103|NCT01618968|2212380|P3|STARTED|Overall Study||12
915104|NCT01618968|2212381|P2|STARTED|Overall Study||12
915105|NCT01618968|2212382|P1|STARTED|Overall Study||13
915106|NCT01618955|2212401|P4|NOT COMPLETED|Overall Study||0
915107|NCT01618955|2212402|P3|NOT COMPLETED|Overall Study||0
915108|NCT01618955|2212403|P2|NOT COMPLETED|Overall Study||0
915109|NCT01618955|2212404|P1|NOT COMPLETED|Overall Study||0
915110|NCT01618955|2212401|P4|COMPLETED|Overall Study||20
915111|NCT01618955|2212402|P3|COMPLETED|Overall Study||31
915112|NCT01618955|2212403|P2|COMPLETED|Overall Study||30
915113|NCT01618955|2212404|P1|COMPLETED|Overall Study||20
915114|NCT01618955|2212401|P4|STARTED|Overall Study||20
915115|NCT01618955|2212402|P3|STARTED|Overall Study||31
915116|NCT01618955|2212403|P2|STARTED|Overall Study||30
915117|NCT01618955|2212404|P1|STARTED|Overall Study||20
915118|NCT01618942|2212428|P2|NOT COMPLETED|Overall Study||0
915119|NCT01618942|2212429|P1|NOT COMPLETED|Overall Study||0
915120|NCT01618942|2212428|P2|COMPLETED|Overall Study||50
915121|NCT01618942|2212429|P1|COMPLETED|Overall Study||50
915122|NCT01618942|2212428|P2|STARTED|Overall Study||50
915123|NCT01618942|2212429|P1|STARTED|Overall Study||50
915124|NCT01618864|2212449|P1|NOT COMPLETED|Overall Study||4
915125|NCT01618864|2212449|P1|COMPLETED|Overall Study|Completed 4 weeks and 8 weeks of treatment|19
915126|NCT01618864|2212449|P1|Completed 2 Weeks|Overall Study||19
915127|NCT01618864|2212449|P1|STARTED|Overall Study||23
915128|NCT01618838|2212458|P1|NOT COMPLETED|Overall Study||4
915129|NCT01618838|2212458|P1|COMPLETED|Overall Study||0
915130|NCT01618838|2212458|P1|STARTED|Overall Study||4
915131|NCT01618708|2212464|P2|NOT COMPLETED|Overall Study||46
915132|NCT01618708|2212465|P1|NOT COMPLETED|Overall Study||44
915133|NCT01618708|2212464|P2|COMPLETED|Overall Study||136
915134|NCT01618708|2212465|P1|COMPLETED|Overall Study||131
915135|NCT01618708|2212464|P2|Treated|Overall Study||180
915136|NCT01618708|2212465|P1|Treated|Overall Study||172
915137|NCT01618708|2212464|P2|STARTED|Overall Study||182
915138|NCT01618708|2212465|P1|STARTED|Overall Study||175
915139|NCT01618669|2212479|P2|NOT COMPLETED|Overall Study||23
915140|NCT01618669|2212480|P1|NOT COMPLETED|Overall Study||34
915141|NCT01618669|2212479|P2|COMPLETED|Overall Study||546
915142|NCT01618669|2212480|P1|COMPLETED|Overall Study||544
915143|NCT01618669|2212479|P2|Received Treatment|Overall Study||567
915144|NCT01618669|2212480|P1|Received Treatment|Overall Study||575
915145|NCT01618669|2212479|P2|STARTED|Overall Study||569
915146|NCT01618669|2212480|P1|STARTED|Overall Study||578
915147|NCT01618422|2212526|P2|NOT COMPLETED|Overall Study||0
915148|NCT01618422|2212527|P1|NOT COMPLETED|Overall Study||0
915149|NCT01618422|2212526|P2|COMPLETED|Overall Study||111
915150|NCT01618422|2212527|P1|COMPLETED|Overall Study||114
915151|NCT01618422|2212526|P2|STARTED|Overall Study||111
915152|NCT01618422|2212527|P1|STARTED|Overall Study||114
915153|NCT01618266|2212533|P1|NOT COMPLETED|Overall Study||96
915154|NCT01618266|2212533|P1|COMPLETED|Overall Study||279
915155|NCT01618266|2212533|P1|STARTED|Overall Study||375
915156|NCT01618240|2212548|P1|NOT COMPLETED|Overall Study||0
915157|NCT01618240|2212548|P1|COMPLETED|Overall Study||30
915158|NCT01618240|2212548|P1|STARTED|Overall Study||30
915159|NCT01618227|2212555|P2|NOT COMPLETED|Overall Study||2
915160|NCT01618227|2212556|P1|NOT COMPLETED|Overall Study||0
915161|NCT01618227|2212555|P2|COMPLETED|Overall Study||0
915162|NCT01618227|2212556|P1|COMPLETED|Overall Study||2
915163|NCT01618227|2212555|P2|STARTED|Overall Study||2
915164|NCT01618227|2212556|P1|STARTED|Overall Study||2
915165|NCT01618214|2212570|P2|NOT COMPLETED|Overall Study||13
915166|NCT01618214|2212571|P1|NOT COMPLETED|Overall Study||10
915167|NCT01618214|2212570|P2|COMPLETED|Overall Study||159
915168|NCT01618214|2212571|P1|COMPLETED|Overall Study||162
915169|NCT01618214|2212570|P2|Exposed|Overall Study||172
915170|NCT01618214|2212571|P1|Exposed|Overall Study||172
915171|NCT01618214|2212570|P2|STARTED|Overall Study||172
915172|NCT01618214|2212571|P1|STARTED|Overall Study||172
915181|NCT01618019|2212608|P2|NOT COMPLETED|Overall Study||14
915182|NCT01618019|2212609|P1|NOT COMPLETED|Overall Study||14
915183|NCT01618019|2212608|P2|COMPLETED|Overall Study||40
915184|NCT01618019|2212609|P1|COMPLETED|Overall Study||41
915185|NCT01618019|2212608|P2|STARTED|Overall Study||54
915186|NCT01618019|2212609|P1|STARTED|Overall Study||55
915187|NCT01617681|2212633|P5|NOT COMPLETED|Period 2 Open Label||6
915188|NCT01617681|2212634|P4|NOT COMPLETED|Period 2 Open Label||0
915189|NCT01617681|2212635|P3|NOT COMPLETED|Period 2 Open Label||0
915190|NCT01617681|2212636|P2|NOT COMPLETED|Period 2 Open Label||0
915191|NCT01617681|2212637|P1|NOT COMPLETED|Period 2 Open Label||0
915192|NCT01617681|2212633|P5|COMPLETED|Period 2 Open Label||114
915193|NCT01617681|2212634|P4|COMPLETED|Period 2 Open Label||0
915194|NCT01617681|2212635|P3|COMPLETED|Period 2 Open Label||0
915195|NCT01617681|2212636|P2|COMPLETED|Period 2 Open Label||0
915196|NCT01617681|2212637|P1|COMPLETED|Period 2 Open Label||0
915197|NCT01617681|2212633|P5|STARTED|Period 2 Open Label||120
915198|NCT01617681|2212634|P4|STARTED|Period 2 Open Label||0
915199|NCT01617681|2212635|P3|STARTED|Period 2 Open Label||0
915200|NCT01617681|2212636|P2|STARTED|Period 2 Open Label||0
915201|NCT01617681|2212637|P1|STARTED|Period 2 Open Label||0
915202|NCT01617681|2212633|P5|NOT COMPLETED|Period 1 Double Blind||0
915203|NCT01617681|2212634|P4|NOT COMPLETED|Period 1 Double Blind||2
915204|NCT01617681|2212635|P3|NOT COMPLETED|Period 1 Double Blind||1
915205|NCT01617681|2212636|P2|NOT COMPLETED|Period 1 Double Blind||1
915206|NCT01617681|2212637|P1|NOT COMPLETED|Period 1 Double Blind||3
915207|NCT01617681|2212633|P5|COMPLETED|Period 1 Double Blind||0
915208|NCT01617681|2212634|P4|COMPLETED|Period 1 Double Blind||29
915209|NCT01617681|2212635|P3|COMPLETED|Period 1 Double Blind||32
915210|NCT01617681|2212636|P2|COMPLETED|Period 1 Double Blind||30
915211|NCT01617681|2212637|P1|COMPLETED|Period 1 Double Blind||29
915212|NCT01617681|2212633|P5|Full Analysis Set (FAS)|Period 1 Double Blind||0
915213|NCT01617681|2212634|P4|Full Analysis Set (FAS)|Period 1 Double Blind||31
915214|NCT01617681|2212635|P3|Full Analysis Set (FAS)|Period 1 Double Blind||33
915215|NCT01617681|2212636|P2|Full Analysis Set (FAS)|Period 1 Double Blind||31
915216|NCT01617681|2212637|P1|Full Analysis Set (FAS)|Period 1 Double Blind||31
915217|NCT01617681|2212633|P5|STARTED|Period 1 Double Blind||0
915218|NCT01617681|2212634|P4|STARTED|Period 1 Double Blind||31
915219|NCT01617681|2212635|P3|STARTED|Period 1 Double Blind||33
915220|NCT01617681|2212636|P2|STARTED|Period 1 Double Blind||31
915221|NCT01617681|2212637|P1|STARTED|Period 1 Double Blind||32
915222|NCT01617668|2212658|P4|NOT COMPLETED|Overall Study||15
915223|NCT01617668|2212659|P3|NOT COMPLETED|Overall Study||23
915224|NCT01617668|2212660|P2|NOT COMPLETED|Overall Study||9
915225|NCT01617668|2212661|P1|NOT COMPLETED|Overall Study||13
915226|NCT01617668|2212658|P4|COMPLETED|Overall Study||38
915227|NCT01617668|2212659|P3|COMPLETED|Overall Study||32
915228|NCT01617668|2212660|P2|COMPLETED|Overall Study||41
915229|NCT01617668|2212661|P1|COMPLETED|Overall Study||38
915230|NCT01617668|2212658|P4|Randomized Patients|Overall Study||55
915231|NCT01617668|2212659|P3|Randomized Patients|Overall Study||55
915232|NCT01617668|2212660|P2|Randomized Patients|Overall Study||54
915233|NCT01617668|2212661|P1|Randomized Patients|Overall Study||51
915234|NCT01617668|2212658|P4|STARTED|Overall Study|55 patients were randomized and only 53 received study treatment.|53
915235|NCT01617668|2212659|P3|STARTED|Overall Study||55
915236|NCT01617668|2212660|P2|STARTED|Overall Study|54 patients were randomized and only 50 received study treatment.|50
915237|NCT01617668|2212661|P1|STARTED|Overall Study||51
915238|NCT01617655|2212702|P2|NOT COMPLETED|Overall Study||29
915239|NCT01617655|2212703|P1|NOT COMPLETED|Overall Study||9
915240|NCT01617655|2212702|P2|COMPLETED|Overall Study||43
915241|NCT01617655|2212703|P1|COMPLETED|Overall Study||26
915242|NCT01617655|2212702|P2|Treated|Overall Study||72
915243|NCT01617655|2212703|P1|Treated|Overall Study||35
915244|NCT01617655|2212702|P2|STARTED|Overall Study|Randomized|72
915245|NCT01617655|2212703|P1|STARTED|Overall Study|Randomized|35
915246|NCT01617603|2212766|P3|NOT COMPLETED|Overall Study||1
915247|NCT01617603|2212767|P2|NOT COMPLETED|Overall Study||2
915248|NCT01617603|2212768|P1|NOT COMPLETED|Overall Study||3
915249|NCT01617603|2212766|P3|COMPLETED|Overall Study||20
915250|NCT01617603|2212767|P2|COMPLETED|Overall Study||19
915251|NCT01617603|2212768|P1|COMPLETED|Overall Study||17
915252|NCT01617603|2212766|P3|STARTED|Overall Study||21
915253|NCT01617603|2212767|P2|STARTED|Overall Study||21
915254|NCT01617603|2212768|P1|STARTED|Overall Study||20
915255|NCT01617577|2212778|P2|NOT COMPLETED|Overall Study||0
915256|NCT01617577|2212779|P1|NOT COMPLETED|Overall Study||0
915257|NCT01617577|2212778|P2|COMPLETED|Overall Study||3
915258|NCT01617577|2212779|P1|COMPLETED|Overall Study||5
915259|NCT01617577|2212778|P2|STARTED|Overall Study||3
915260|NCT01617577|2212779|P1|STARTED|Overall Study||5
915261|NCT01617447|2212788|P2|NOT COMPLETED|Overall Study||3
915262|NCT01617447|2212789|P1|NOT COMPLETED|Overall Study||0
915263|NCT01617447|2212788|P2|COMPLETED|Overall Study||42
915264|NCT01617447|2212789|P1|COMPLETED|Overall Study||47
915265|NCT01617447|2212788|P2|STARTED|Overall Study||45
915266|NCT01617447|2212789|P1|STARTED|Overall Study||47
915267|NCT01617434|2212797|P2|NOT COMPLETED|Overall Study||51
915268|NCT01617434|2212798|P1|NOT COMPLETED|Overall Study||35
915269|NCT01617434|2212797|P2|COMPLETED|Overall Study||174
915270|NCT01617434|2212798|P1|COMPLETED|Overall Study||191
915271|NCT01617434|2212797|P2|Exposed|Overall Study||225
915272|NCT01617434|2212798|P1|Exposed|Overall Study||225
915273|NCT01617434|2212797|P2|STARTED|Overall Study||225
915274|NCT01617434|2212798|P1|STARTED|Overall Study||226
915275|NCT01617369|2212820|P1|NOT COMPLETED|Overall Study||0
915276|NCT01617369|2212820|P1|COMPLETED|Overall Study||12
915277|NCT01617369|2212820|P1|STARTED|Overall Study||12
915278|NCT01617187|2212830|P4|NOT COMPLETED|Treatment Through Study Completion||10
915279|NCT01617187|2212831|P3|NOT COMPLETED|Treatment Through Study Completion||5
915280|NCT01617187|2212832|P2|NOT COMPLETED|Treatment Through Study Completion||11
915281|NCT01617187|2212833|P1|NOT COMPLETED|Treatment Through Study Completion||11
915282|NCT01617187|2212830|P4|COMPLETED|Treatment Through Study Completion||91
915283|NCT01617187|2212831|P3|COMPLETED|Treatment Through Study Completion||41
915284|NCT01617187|2212832|P2|COMPLETED|Treatment Through Study Completion||102
915285|NCT01617187|2212833|P1|COMPLETED|Treatment Through Study Completion|Excludes the participant who did not receive study drug but completed study in database|86
915286|NCT01617187|2212830|P4|STARTED|Treatment Through Study Completion|Treated|101
915287|NCT01617187|2212831|P3|STARTED|Treatment Through Study Completion|Treated|46
915288|NCT01617187|2212832|P2|STARTED|Treatment Through Study Completion|Treated|113
915289|NCT01617187|2212833|P1|STARTED|Treatment Through Study Completion|Treated|97
915290|NCT01617187|2212830|P4|NOT COMPLETED|Randomization Through Start Treatment||2
915291|NCT01617187|2212831|P3|NOT COMPLETED|Randomization Through Start Treatment||0
915292|NCT01617187|2212832|P2|NOT COMPLETED|Randomization Through Start Treatment||0
915293|NCT01617187|2212833|P1|NOT COMPLETED|Randomization Through Start Treatment||1
915294|NCT01617187|2212830|P4|COMPLETED|Randomization Through Start Treatment||101
915295|NCT01617187|2212831|P3|COMPLETED|Randomization Through Start Treatment||46
915296|NCT01617187|2212832|P2|COMPLETED|Randomization Through Start Treatment||113
915297|NCT01617187|2212833|P1|COMPLETED|Randomization Through Start Treatment||97
915298|NCT01617187|2212830|P4|STARTED|Randomization Through Start Treatment|Randomized|103
915299|NCT01617187|2212831|P3|STARTED|Randomization Through Start Treatment|Randomized|46
915300|NCT01617187|2212832|P2|STARTED|Randomization Through Start Treatment|Randomized|113
915301|NCT01617187|2212833|P1|STARTED|Randomization Through Start Treatment|Randomized|98
915302|NCT01617070|2212903|P1|NOT COMPLETED|BH4 and LNAA (4 Weeks)||1
915303|NCT01617070|2212903|P1|COMPLETED|BH4 and LNAA (4 Weeks)||9
915304|NCT01617070|2212903|P1|STARTED|BH4 and LNAA (4 Weeks)||10
915305|NCT01617070|2212903|P1|NOT COMPLETED|BH4 Therapy (4 Weeks)||0
915306|NCT01617070|2212903|P1|COMPLETED|BH4 Therapy (4 Weeks)||10
915307|NCT01617070|2212903|P1|STARTED|BH4 Therapy (4 Weeks)||10
915308|NCT01617070|2212903|P1|NOT COMPLETED|Washout (4 Weeks)||0
915309|NCT01617070|2212903|P1|COMPLETED|Washout (4 Weeks)||10
915310|NCT01617070|2212903|P1|STARTED|Washout (4 Weeks)||10
915311|NCT01617070|2212903|P1|NOT COMPLETED|LNAA (4 Weeks)||0
915312|NCT01617070|2212903|P1|COMPLETED|LNAA (4 Weeks)||10
915313|NCT01617070|2212903|P1|STARTED|LNAA (4 Weeks)||10
915314|NCT01617005|2212921|P1|NOT COMPLETED|Overall Study||2
915315|NCT01617005|2212921|P1|COMPLETED|Overall Study||48
915316|NCT01617005|2212921|P1|STARTED|Overall Study||50
915317|NCT01616953|2212930|P2|NOT COMPLETED|Overall Study||0
915318|NCT01616953|2212931|P1|NOT COMPLETED|Overall Study||2
915319|NCT01616953|2212930|P2|COMPLETED|Overall Study||8
915320|NCT01616953|2212931|P1|COMPLETED|Overall Study||8
915321|NCT01616953|2212930|P2|6 Months Post-loading|Overall Study||8
915322|NCT01616953|2212931|P1|6 Months Post-loading|Overall Study||8
915323|NCT01616953|2212930|P2|Implant Uncovery|Overall Study||8
915324|NCT01616953|2212931|P1|Implant Uncovery|Overall Study||8
915325|NCT01616953|2212930|P2|Implant Placement Surgery|Overall Study||8
915326|NCT01616953|2212931|P1|Implant Placement Surgery|Overall Study||9
915327|NCT01616953|2212930|P2|STARTED|Overall Study||8
915328|NCT01616953|2212931|P1|STARTED|Overall Study||10
915329|NCT01616771|2212939|P1|NOT COMPLETED|Smaller Sized GVL for 5 Sec||4
915330|NCT01616771|2212939|P1|COMPLETED|Smaller Sized GVL for 5 Sec||19
915331|NCT01616771|2212939|P1|STARTED|Smaller Sized GVL for 5 Sec|Four of 23 patients could not be evaluated by smaller sized GVL, because there was no smaller one.|23
915332|NCT01616771|2212939|P1|NOT COMPLETED|GVL Selected by Weight for 5 Sec||0
915333|NCT01616771|2212939|P1|COMPLETED|GVL Selected by Weight for 5 Sec||23
915334|NCT01616771|2212939|P1|STARTED|GVL Selected by Weight for 5 Sec||23
915335|NCT01616771|2212939|P1|NOT COMPLETED|Macintosh Laryngoscopy for 5 Sec||0
915336|NCT01616771|2212939|P1|COMPLETED|Macintosh Laryngoscopy for 5 Sec||23
915337|NCT01616771|2212939|P1|STARTED|Macintosh Laryngoscopy for 5 Sec||23
915338|NCT01616576|2212950|P2|NOT COMPLETED|Overall Study||0
915339|NCT01616576|2212951|P1|NOT COMPLETED|Overall Study||0
915340|NCT01616576|2212950|P2|COMPLETED|Overall Study||18
915341|NCT01616576|2212951|P1|COMPLETED|Overall Study||18
915342|NCT01616576|2212950|P2|STARTED|Overall Study||18
915343|NCT01616576|2212951|P1|STARTED|Overall Study||18
915344|NCT01616459|2212964|P4|NOT COMPLETED|Overall Study||8
915345|NCT01616459|2212965|P3|NOT COMPLETED|Overall Study||10
915346|NCT01616459|2212966|P2|NOT COMPLETED|Overall Study||17
915347|NCT01616459|2212967|P1|NOT COMPLETED|Overall Study||4
915348|NCT01616459|2212964|P4|COMPLETED|Overall Study||233
915349|NCT01616459|2212965|P3|COMPLETED|Overall Study||220
915350|NCT01616459|2212966|P2|COMPLETED|Overall Study||223
915351|NCT01616459|2212967|P1|COMPLETED|Overall Study||236
915352|NCT01616459|2212964|P4|STARTED|Overall Study||241
915353|NCT01616459|2212965|P3|STARTED|Overall Study||230
915354|NCT01616459|2212966|P2|STARTED|Overall Study||240
915355|NCT01616459|2212967|P1|STARTED|Overall Study||240
915356|NCT01616173|2213056|P3|NOT COMPLETED|Overall Study||0
915357|NCT01616173|2213057|P2|NOT COMPLETED|Overall Study||2
915358|NCT01616173|2213058|P1|NOT COMPLETED|Overall Study||0
915359|NCT01616173|2213056|P3|COMPLETED|Overall Study||27
915360|NCT01616173|2213057|P2|COMPLETED|Overall Study||24
915361|NCT01616173|2213058|P1|COMPLETED|Overall Study||27
915362|NCT01616173|2213056|P3|STARTED|Overall Study||27
915363|NCT01616173|2213057|P2|STARTED|Overall Study||26
915364|NCT01616173|2213058|P1|STARTED|Overall Study||27
915365|NCT01616056|2213072|P1|NOT COMPLETED|Overall Study||1
915366|NCT01616056|2213072|P1|COMPLETED|Overall Study||19
915367|NCT01616056|2213072|P1|STARTED|Overall Study||20
915368|NCT01615939|2213086|P2|NOT COMPLETED|Overall Study||0
915369|NCT01615939|2213087|P1|NOT COMPLETED|Overall Study||5
915370|NCT01615939|2213086|P2|COMPLETED|Overall Study||4
915371|NCT01615939|2213087|P1|COMPLETED|Overall Study||8
915372|NCT01615939|2213086|P2|STARTED|Overall Study||4
915373|NCT01615939|2213087|P1|STARTED|Overall Study||13
915374|NCT01615822|2213100|P3|NOT COMPLETED|Period 2||2
915375|NCT01615822|2213101|P2|NOT COMPLETED|Period 2||1
915376|NCT01615822|2213102|P1|NOT COMPLETED|Period 2||0
915377|NCT01615822|2213100|P3|COMPLETED|Period 2||4
915378|NCT01615822|2213101|P2|COMPLETED|Period 2||8
915379|NCT01615822|2213102|P1|COMPLETED|Period 2||7
915380|NCT01615822|2213100|P3|STARTED|Period 2||6
915381|NCT01615822|2213101|P2|STARTED|Period 2||9
915382|NCT01615822|2213102|P1|STARTED|Period 2||7
915383|NCT01615822|2213100|P3|NOT COMPLETED|Period 1||0
915384|NCT01615822|2213101|P2|NOT COMPLETED|Period 1||2
915385|NCT01615822|2213102|P1|NOT COMPLETED|Period 1||1
915386|NCT01615822|2213100|P3|COMPLETED|Period 1||6
915387|NCT01615822|2213101|P2|COMPLETED|Period 1||9
915388|NCT01615822|2213102|P1|COMPLETED|Period 1||7
915389|NCT01615822|2213100|P3|STARTED|Period 1||6
915390|NCT01615822|2213101|P2|STARTED|Period 1||11
915391|NCT01615822|2213102|P1|STARTED|Period 1||8
915392|NCT01615809|2213119|P1|NOT COMPLETED|Overall Study||10
915393|NCT01615809|2213119|P1|COMPLETED|Overall Study||22
915394|NCT01615809|2213119|P1|STARTED|Overall Study|basal visit|32
915401|NCT01615328|2213148|P2|NOT COMPLETED|Overall Study||5
915402|NCT01615328|2213149|P1|NOT COMPLETED|Overall Study||3
915403|NCT01615328|2213148|P2|COMPLETED|Overall Study||38
915404|NCT01615328|2213149|P1|COMPLETED|Overall Study||39
915405|NCT01615328|2213148|P2|STARTED|Overall Study||43
915406|NCT01615328|2213149|P1|STARTED|Overall Study||42
915407|NCT01615263|2213161|P2|NOT COMPLETED|Overall Study||2
915408|NCT01615263|2213162|P1|NOT COMPLETED|Overall Study||0
915409|NCT01615263|2213161|P2|COMPLETED|Overall Study||18
915410|NCT01615263|2213162|P1|COMPLETED|Overall Study||20
915411|NCT01615263|2213161|P2|STARTED|Overall Study||20
915412|NCT01615263|2213162|P1|STARTED|Overall Study||20
915413|NCT01615198|2213176|P2|NOT COMPLETED|Overall Study||19
915414|NCT01615198|2213177|P1|NOT COMPLETED|Overall Study||24
915415|NCT01615198|2213176|P2|COMPLETED|Overall Study||273
915416|NCT01615198|2213177|P1|COMPLETED|Overall Study||272
915417|NCT01615198|2213176|P2|ABPM Dipper Status Subset|Overall Study||84
915418|NCT01615198|2213177|P1|ABPM Dipper Status Subset|Overall Study||82
915419|NCT01615198|2213176|P2|Safety Set|Overall Study||292
915420|NCT01615198|2213177|P1|Safety Set|Overall Study||296
915421|NCT01615198|2213176|P2|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||157
915422|NCT01615198|2213177|P1|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||154
915423|NCT01615198|2213176|P2|Full Analysis Set|Overall Study||292
915424|NCT01615198|2213177|P1|Full Analysis Set|Overall Study||296
915425|NCT01615198|2213176|P2|STARTED|Overall Study||292
915426|NCT01615198|2213177|P1|STARTED|Overall Study||296
915427|NCT01615029|2213210|P5|NOT COMPLETED|Overall Study||32
915428|NCT01615029|2213211|P4|NOT COMPLETED|Overall Study||3
915429|NCT01615029|2213212|P3|NOT COMPLETED|Overall Study||4
915430|NCT01615029|2213213|P2|NOT COMPLETED|Overall Study||3
915431|NCT01615029|2213214|P1|NOT COMPLETED|Overall Study||3
915432|NCT01615029|2213210|P5|COMPLETED|Overall Study||0
915433|NCT01615029|2213211|P4|COMPLETED|Overall Study||0
915434|NCT01615029|2213212|P3|COMPLETED|Overall Study||0
915435|NCT01615029|2213213|P2|COMPLETED|Overall Study||0
915436|NCT01615029|2213214|P1|COMPLETED|Overall Study||0
915437|NCT01615029|2213210|P5|STARTED|Overall Study||32
915438|NCT01615029|2213211|P4|STARTED|Overall Study||3
915439|NCT01615029|2213212|P3|STARTED|Overall Study||4
915440|NCT01615029|2213213|P2|STARTED|Overall Study||3
915441|NCT01615029|2213214|P1|STARTED|Overall Study||3
915442|NCT01614886|2213237|P2|NOT COMPLETED|Overall Study||26
915443|NCT01614886|2213238|P1|NOT COMPLETED|Overall Study||20
915444|NCT01614886|2213237|P2|COMPLETED|Overall Study||83
915445|NCT01614886|2213238|P1|COMPLETED|Overall Study||87
915446|NCT01614886|2213237|P2|Full Analysis Set (FAS)|Overall Study||105
915447|NCT01614886|2213238|P1|Full Analysis Set (FAS)|Overall Study||104
915448|NCT01614886|2213237|P2|Safety Population (SAF)|Overall Study||108
915449|NCT01614886|2213238|P1|Safety Population (SAF)|Overall Study||107
915450|NCT01614886|2213237|P2|STARTED|Overall Study||109
915451|NCT01614886|2213238|P1|STARTED|Overall Study||107
915452|NCT01614795|2213256|P4|NOT COMPLETED|Overall Study||12
915453|NCT01614795|2213257|P3|NOT COMPLETED|Overall Study||11
915454|NCT01614795|2213258|P2|NOT COMPLETED|Overall Study||12
915455|NCT01614795|2213259|P1|NOT COMPLETED|Overall Study||11
915456|NCT01614795|2213256|P4|COMPLETED|Overall Study||0
915457|NCT01614795|2213257|P3|COMPLETED|Overall Study||0
915458|NCT01614795|2213258|P2|COMPLETED|Overall Study||0
915459|NCT01614795|2213259|P1|COMPLETED|Overall Study||0
915460|NCT01614795|2213256|P4|STARTED|Overall Study||12
915461|NCT01614795|2213257|P3|STARTED|Overall Study||11
915462|NCT01614795|2213258|P2|STARTED|Overall Study||12
915463|NCT01614795|2213259|P1|STARTED|Overall Study||11
915464|NCT01614769|2213269|P6|NOT COMPLETED|Period 3||0
915465|NCT01614769|2213270|P5|NOT COMPLETED|Period 3||0
915466|NCT01614769|2213271|P4|NOT COMPLETED|Period 3||0
915467|NCT01614769|2213272|P3|NOT COMPLETED|Period 3||1
915468|NCT01614769|2213273|P2|NOT COMPLETED|Period 3||0
915469|NCT01614769|2213274|P1|NOT COMPLETED|Period 3||0
915470|NCT01614769|2213269|P6|COMPLETED|Period 3||1
915471|NCT01614769|2213270|P5|COMPLETED|Period 3||1
915472|NCT01614769|2213271|P4|COMPLETED|Period 3||0
915473|NCT01614769|2213272|P3|COMPLETED|Period 3||1
915474|NCT01614769|2213273|P2|COMPLETED|Period 3||1
915475|NCT01614769|2213274|P1|COMPLETED|Period 3||1
915476|NCT01614769|2213269|P6|STARTED|Period 3||1
915477|NCT01614769|2213270|P5|STARTED|Period 3||1
915478|NCT01614769|2213271|P4|STARTED|Period 3||0
915479|NCT01614769|2213272|P3|STARTED|Period 3||2
915480|NCT01614769|2213273|P2|STARTED|Period 3||1
915481|NCT01614769|2213274|P1|STARTED|Period 3||1
915482|NCT01614769|2213269|P6|NOT COMPLETED|7-Day Washout||0
915483|NCT01614769|2213270|P5|NOT COMPLETED|7-Day Washout||0
915484|NCT01614769|2213271|P4|NOT COMPLETED|7-Day Washout||0
915485|NCT01614769|2213272|P3|NOT COMPLETED|7-Day Washout||0
915486|NCT01614769|2213273|P2|NOT COMPLETED|7-Day Washout||0
915487|NCT01614769|2213274|P1|NOT COMPLETED|7-Day Washout||0
915488|NCT01614769|2213269|P6|COMPLETED|7-Day Washout||1
915489|NCT01614769|2213270|P5|COMPLETED|7-Day Washout||1
915490|NCT01614769|2213271|P4|COMPLETED|7-Day Washout||0
915491|NCT01614769|2213272|P3|COMPLETED|7-Day Washout||2
915492|NCT01614769|2213273|P2|COMPLETED|7-Day Washout||1
915493|NCT01614769|2213274|P1|COMPLETED|7-Day Washout||1
915494|NCT01614769|2213269|P6|STARTED|7-Day Washout||1
915495|NCT01614769|2213270|P5|STARTED|7-Day Washout||1
915496|NCT01614769|2213271|P4|STARTED|7-Day Washout||0
915497|NCT01614769|2213272|P3|STARTED|7-Day Washout||2
915498|NCT01614769|2213273|P2|STARTED|7-Day Washout||1
915499|NCT01614769|2213274|P1|STARTED|7-Day Washout||1
915500|NCT01614769|2213269|P6|NOT COMPLETED|Period 2||0
915501|NCT01614769|2213270|P5|NOT COMPLETED|Period 2||0
915502|NCT01614769|2213271|P4|NOT COMPLETED|Period 2||0
915503|NCT01614769|2213272|P3|NOT COMPLETED|Period 2||0
915504|NCT01614769|2213273|P2|NOT COMPLETED|Period 2||0
915505|NCT01614769|2213274|P1|NOT COMPLETED|Period 2||0
915506|NCT01614769|2213269|P6|COMPLETED|Period 2||1
915507|NCT01614769|2213270|P5|COMPLETED|Period 2||1
915508|NCT01614769|2213271|P4|COMPLETED|Period 2||0
915509|NCT01614769|2213272|P3|COMPLETED|Period 2||2
915510|NCT01614769|2213273|P2|COMPLETED|Period 2||1
915511|NCT01614769|2213274|P1|COMPLETED|Period 2||1
915512|NCT01614769|2213269|P6|STARTED|Period 2||1
915513|NCT01614769|2213270|P5|STARTED|Period 2||1
915514|NCT01614769|2213271|P4|STARTED|Period 2||0
915515|NCT01614769|2213272|P3|STARTED|Period 2||2
915516|NCT01614769|2213273|P2|STARTED|Period 2||1
915517|NCT01614769|2213274|P1|STARTED|Period 2||1
915518|NCT01614769|2213269|P6|NOT COMPLETED|7-Day Washout||0
915519|NCT01614769|2213270|P5|NOT COMPLETED|7-Day Washout||0
915520|NCT01614769|2213271|P4|NOT COMPLETED|7-Day Washout||0
915521|NCT01614769|2213272|P3|NOT COMPLETED|7-Day Washout||0
915522|NCT01614769|2213273|P2|NOT COMPLETED|7-Day Washout||0
915523|NCT01614769|2213274|P1|NOT COMPLETED|7-Day Washout||0
915524|NCT01614769|2213269|P6|COMPLETED|7-Day Washout||1
915525|NCT01614769|2213270|P5|COMPLETED|7-Day Washout||1
915526|NCT01614769|2213271|P4|COMPLETED|7-Day Washout||0
915527|NCT01614769|2213272|P3|COMPLETED|7-Day Washout||2
915528|NCT01614769|2213273|P2|COMPLETED|7-Day Washout||1
915529|NCT01614769|2213274|P1|COMPLETED|7-Day Washout||1
915530|NCT01614769|2213269|P6|STARTED|7-Day Washout||1
915531|NCT01614769|2213270|P5|STARTED|7-Day Washout||1
915532|NCT01614769|2213271|P4|STARTED|7-Day Washout||0
915533|NCT01614769|2213272|P3|STARTED|7-Day Washout||2
915534|NCT01614769|2213273|P2|STARTED|7-Day Washout||1
915535|NCT01614769|2213274|P1|STARTED|7-Day Washout||1
915536|NCT01614769|2213269|P6|NOT COMPLETED|Period 1||1
915537|NCT01614769|2213270|P5|NOT COMPLETED|Period 1||0
915538|NCT01614769|2213271|P4|NOT COMPLETED|Period 1||2
915539|NCT01614769|2213272|P3|NOT COMPLETED|Period 1||0
915540|NCT01614769|2213273|P2|NOT COMPLETED|Period 1||0
915541|NCT01614769|2213274|P1|NOT COMPLETED|Period 1||1
915542|NCT01614769|2213269|P6|COMPLETED|Period 1||1
915543|NCT01614769|2213270|P5|COMPLETED|Period 1||1
915544|NCT01614769|2213271|P4|COMPLETED|Period 1||0
915545|NCT01614769|2213272|P3|COMPLETED|Period 1||2
915546|NCT01614769|2213273|P2|COMPLETED|Period 1||1
915547|NCT01614769|2213274|P1|COMPLETED|Period 1||1
915548|NCT01614769|2213269|P6|STARTED|Period 1||2
915549|NCT01614769|2213270|P5|STARTED|Period 1||1
915550|NCT01614769|2213271|P4|STARTED|Period 1||2
915551|NCT01614769|2213272|P3|STARTED|Period 1||2
915552|NCT01614769|2213273|P2|STARTED|Period 1||1
915553|NCT01614769|2213274|P1|STARTED|Period 1||2
915554|NCT01614613|2213288|P1|NOT COMPLETED|Overall Study||0
915555|NCT01614613|2213288|P1|COMPLETED|Overall Study||146
915556|NCT01614613|2213288|P1|STARTED|Overall Study||146
915557|NCT01614600|2213296|P1|NOT COMPLETED|Overall Study||4
915558|NCT01614600|2213296|P1|COMPLETED|Overall Study||84
915559|NCT01614600|2213296|P1|STARTED|Overall Study||88
915560|NCT01614574|2213300|P1|NOT COMPLETED|Overall Study||0
915561|NCT01614574|2213300|P1|COMPLETED|Overall Study||6
915562|NCT01614574|2213300|P1|STARTED|Overall Study||6
915563|NCT01614509|2213316|P2|NOT COMPLETED|Overall Study||3
915564|NCT01614509|2213317|P1|NOT COMPLETED|Overall Study||1
915565|NCT01614509|2213316|P2|COMPLETED|Overall Study||18
915566|NCT01614509|2213317|P1|COMPLETED|Overall Study||23
915567|NCT01614509|2213316|P2|STARTED|Overall Study||21
915568|NCT01614509|2213317|P1|STARTED|Overall Study||24
915569|NCT01614470|2213327|P3|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
915570|NCT01614470|2213328|P2|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
915571|NCT01614470|2213329|P1|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
915572|NCT01614470|2213327|P3|COMPLETED|Part 2: Open-label Period (16 Weeks)||36
915573|NCT01614470|2213328|P2|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
915574|NCT01614470|2213329|P1|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
915575|NCT01614470|2213327|P3|STARTED|Part 2: Open-label Period (16 Weeks)||36
915576|NCT01614470|2213328|P2|STARTED|Part 2: Open-label Period (16 Weeks)||0
915577|NCT01614470|2213329|P1|STARTED|Part 2: Open-label Period (16 Weeks)||0
915578|NCT01614470|2213327|P3|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
915579|NCT01614470|2213328|P2|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
915580|NCT01614470|2213329|P1|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
915581|NCT01614470|2213327|P3|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
915582|NCT01614470|2213328|P2|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
915583|NCT01614470|2213329|P1|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
915584|NCT01614470|2213327|P3|STARTED|Part 1: Treatment Period 2 (8 Weeks)||0
915585|NCT01614470|2213328|P2|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
915586|NCT01614470|2213329|P1|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
915587|NCT01614470|2213327|P3|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
915588|NCT01614470|2213328|P2|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
915589|NCT01614470|2213329|P1|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
915590|NCT01614470|2213327|P3|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
915591|NCT01614470|2213328|P2|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
915592|NCT01614470|2213329|P1|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
915593|NCT01614470|2213327|P3|STARTED|Part 1: Washout Period (4 to 8 Weeks)||0
915594|NCT01614470|2213328|P2|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
915595|NCT01614470|2213329|P1|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
915596|NCT01614470|2213327|P3|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
915597|NCT01614470|2213328|P2|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||1
915598|NCT01614470|2213329|P1|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||2
915599|NCT01614470|2213327|P3|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
915600|NCT01614470|2213328|P2|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
915601|NCT01614470|2213329|P1|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
915602|NCT01614470|2213327|P3|STARTED|Part 1: Treatment Period 1 (8 Weeks)||0
915603|NCT01614470|2213328|P2|STARTED|Part 1: Treatment Period 1 (8 Weeks)||19
915604|NCT01614470|2213329|P1|STARTED|Part 1: Treatment Period 1 (8 Weeks)||20
915605|NCT01614457|2213351|P2|NOT COMPLETED|Overall Study||0
915606|NCT01614457|2213352|P1|NOT COMPLETED|Overall Study||2
915607|NCT01614457|2213351|P2|COMPLETED|Overall Study||35
915608|NCT01614457|2213352|P1|COMPLETED|Overall Study||32
915609|NCT01614457|2213351|P2|STARTED|Overall Study||35
915610|NCT01614457|2213352|P1|STARTED|Overall Study||34
915611|NCT01614249|2213370|P2|NOT COMPLETED|Overall Study||23
915612|NCT01614249|2213371|P1|NOT COMPLETED|Overall Study||11
915613|NCT01614249|2213370|P2|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|86
915614|NCT01614249|2213371|P1|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|96
915615|NCT01614249|2213370|P2|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|86
915616|NCT01614249|2213371|P1|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|96
915617|NCT01614249|2213370|P2|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|92
915618|NCT01614249|2213371|P1|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|98
915619|NCT01614249|2213370|P2|STARTED|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|109
915620|NCT01614249|2213371|P1|STARTED|Overall Study|Participants received every two-weeks supply and monitored regularly on cell-phone and face-to-face.|107
915624|NCT01613599|2213382|P1|NOT COMPLETED|Overall Study||97
915625|NCT01613599|2213382|P1|COMPLETED|Overall Study||0
915626|NCT01613599|2213382|P1|STARTED|Overall Study||97
915627|NCT01613417|2213397|P2|NOT COMPLETED|Second Injection||0
915628|NCT01613417|2213398|P1|NOT COMPLETED|Second Injection||0
915629|NCT01613417|2213397|P2|COMPLETED|Second Injection||109
915630|NCT01613417|2213398|P1|COMPLETED|Second Injection||100
915631|NCT01613417|2213397|P2|STARTED|Second Injection||109
915632|NCT01613417|2213398|P1|STARTED|Second Injection||100
915633|NCT01613417|2213397|P2|NOT COMPLETED|Washout (no Second Injection/MRI)||7
915634|NCT01613417|2213398|P1|NOT COMPLETED|Washout (no Second Injection/MRI)||13
915635|NCT01613417|2213397|P2|COMPLETED|Washout (no Second Injection/MRI)||109
915636|NCT01613417|2213398|P1|COMPLETED|Washout (no Second Injection/MRI)||100
915637|NCT01613417|2213397|P2|STARTED|Washout (no Second Injection/MRI)||116
915638|NCT01613417|2213398|P1|STARTED|Washout (no Second Injection/MRI)||113
915639|NCT01613417|2213397|P2|NOT COMPLETED|First Injection||0
915640|NCT01613417|2213398|P1|NOT COMPLETED|First Injection||0
915641|NCT01613417|2213397|P2|COMPLETED|First Injection||116
915642|NCT01613417|2213398|P1|COMPLETED|First Injection||113
915643|NCT01613417|2213397|P2|STARTED|First Injection||116
915644|NCT01613417|2213398|P1|STARTED|First Injection||113
915645|NCT01613378|2213435|P1|NOT COMPLETED|Overall Study||39
915646|NCT01613378|2213435|P1|COMPLETED|Overall Study||161
915647|NCT01613378|2213435|P1|STARTED|Overall Study||200
915648|NCT01613339|2213453|P2|NOT COMPLETED|Overall Study||1
915649|NCT01613339|2213454|P1|NOT COMPLETED|Overall Study||3
915650|NCT01613339|2213453|P2|COMPLETED|Overall Study||21
915651|NCT01613339|2213454|P1|COMPLETED|Overall Study||21
915652|NCT01613339|2213453|P2|STARTED|Overall Study||22
915653|NCT01613339|2213454|P1|STARTED|Overall Study||24
915654|NCT01613326|2213465|P2|NOT COMPLETED|Overall Study||14
915655|NCT01613326|2213466|P1|NOT COMPLETED|Overall Study||13
915656|NCT01613326|2213465|P2|COMPLETED|Overall Study||316
915657|NCT01613326|2213466|P1|COMPLETED|Overall Study||314
915658|NCT01613326|2213465|P2|STARTED|Overall Study||330
915659|NCT01613326|2213466|P1|STARTED|Overall Study||327
915660|NCT01613313|2213500|P4|NOT COMPLETED|Overall Study||0
915661|NCT01613313|2213501|P3|NOT COMPLETED|Overall Study||0
915662|NCT01613313|2213502|P2|NOT COMPLETED|Overall Study||0
915663|NCT01613313|2213503|P1|NOT COMPLETED|Overall Study||0
915664|NCT01613313|2213500|P4|COMPLETED|Overall Study||4
915665|NCT01613313|2213501|P3|COMPLETED|Overall Study||4
915666|NCT01613313|2213502|P2|COMPLETED|Overall Study||4
915667|NCT01613313|2213503|P1|COMPLETED|Overall Study||2
915668|NCT01613313|2213500|P4|STARTED|Overall Study||4
915669|NCT01613313|2213501|P3|STARTED|Overall Study||4
915670|NCT01613313|2213502|P2|STARTED|Overall Study||4
915671|NCT01613313|2213503|P1|STARTED|Overall Study||2
915672|NCT01613248|2213523|P6|NOT COMPLETED|Overall Study||38
915673|NCT01613248|2213524|P5|NOT COMPLETED|Overall Study||35
915674|NCT01613248|2213525|P4|NOT COMPLETED|Overall Study||38
915675|NCT01613248|2213526|P3|NOT COMPLETED|Overall Study||33
915676|NCT01613248|2213527|P2|NOT COMPLETED|Overall Study||34
915677|NCT01613248|2213528|P1|NOT COMPLETED|Overall Study||29
915678|NCT01613248|2213523|P6|COMPLETED|Overall Study||102
915679|NCT01613248|2213524|P5|COMPLETED|Overall Study||104
915680|NCT01613248|2213525|P4|COMPLETED|Overall Study||101
915681|NCT01613248|2213526|P3|COMPLETED|Overall Study||106
915682|NCT01613248|2213527|P2|COMPLETED|Overall Study||104
915683|NCT01613248|2213528|P1|COMPLETED|Overall Study||110
915684|NCT01613248|2213523|P6|STARTED|Overall Study||140
915685|NCT01613248|2213524|P5|STARTED|Overall Study||139
915686|NCT01613248|2213525|P4|STARTED|Overall Study||139
915687|NCT01613248|2213526|P3|STARTED|Overall Study||139
915688|NCT01613248|2213527|P2|STARTED|Overall Study||138
915689|NCT01613248|2213528|P1|STARTED|Overall Study||139
915690|NCT01613131|2213628|P2|NOT COMPLETED|Overall Study||5
915691|NCT01613131|2213629|P1|NOT COMPLETED|Overall Study||3
915692|NCT01613131|2213628|P2|COMPLETED|Overall Study||13
915693|NCT01613131|2213629|P1|COMPLETED|Overall Study||17
915694|NCT01613131|2213628|P2|STARTED|Overall Study||18
915695|NCT01613131|2213629|P1|STARTED|Overall Study||20
915696|NCT01613027|2213657|P1|NOT COMPLETED|Overall Study||8
915697|NCT01613027|2213657|P1|COMPLETED|Overall Study||127
915698|NCT01613027|2213657|P1|STARTED|Overall Study||135
915699|NCT01613014|2213678|P2|NOT COMPLETED|Overall Study||12
915700|NCT01613014|2213679|P1|NOT COMPLETED|Overall Study||18
915701|NCT01613014|2213678|P2|COMPLETED|Overall Study||63
915702|NCT01613014|2213679|P1|COMPLETED|Overall Study||57
915703|NCT01613014|2213678|P2|STARTED|Overall Study||75
915704|NCT01613014|2213679|P1|STARTED|Overall Study||75
915705|NCT01612858|2213687|P2|NOT COMPLETED|Overall Study||1
915706|NCT01612858|2213688|P1|NOT COMPLETED|Overall Study||5
915707|NCT01612858|2213687|P2|COMPLETED|Overall Study||3
915708|NCT01612858|2213688|P1|COMPLETED|Overall Study||11
915709|NCT01612858|2213687|P2|STARTED|Overall Study||4
915710|NCT01612858|2213688|P1|STARTED|Overall Study||16
915714|NCT01612702|2213725|P2|NOT COMPLETED|Overall Study||11
915715|NCT01612702|2213726|P1|NOT COMPLETED|Overall Study||11
915716|NCT01612702|2213725|P2|COMPLETED|Overall Study||134
915717|NCT01612702|2213726|P1|COMPLETED|Overall Study||135
915718|NCT01612702|2213725|P2|STARTED|Overall Study||145
915719|NCT01612702|2213726|P1|STARTED|Overall Study||146
915720|NCT01612676|2213740|P4|NOT COMPLETED|Overall Study||3
915721|NCT01612676|2213741|P3|NOT COMPLETED|Overall Study||1
915722|NCT01612676|2213742|P2|NOT COMPLETED|Overall Study||4
915723|NCT01612676|2213743|P1|NOT COMPLETED|Overall Study||2
915724|NCT01612676|2213740|P4|COMPLETED|Overall Study||10
915725|NCT01612676|2213741|P3|COMPLETED|Overall Study||4
915726|NCT01612676|2213742|P2|COMPLETED|Overall Study||3
915727|NCT01612676|2213743|P1|COMPLETED|Overall Study||4
915728|NCT01612676|2213740|P4|Dosed|Overall Study||13
915729|NCT01612676|2213741|P3|Dosed|Overall Study||5
915730|NCT01612676|2213742|P2|Dosed|Overall Study||7
915731|NCT01612676|2213743|P1|Dosed|Overall Study||5
915732|NCT01612676|2213740|P4|STARTED|Overall Study||13
915733|NCT01612676|2213741|P3|STARTED|Overall Study||5
915734|NCT01612676|2213742|P2|STARTED|Overall Study||7
915735|NCT01612676|2213743|P1|STARTED|Overall Study||6
915736|NCT01612494|2213801|P2|NOT COMPLETED|Overall Study||0
915737|NCT01612494|2213802|P1|NOT COMPLETED|Overall Study||0
915738|NCT01612494|2213801|P2|COMPLETED|Overall Study||23
915739|NCT01612494|2213802|P1|COMPLETED|Overall Study||21
915740|NCT01612494|2213801|P2|STARTED|Overall Study||23
915741|NCT01612494|2213802|P1|STARTED|Overall Study||21
915742|NCT01612221|2213810|P2|NOT COMPLETED|Overall Study||0
915743|NCT01612221|2213811|P1|NOT COMPLETED|Overall Study||0
915744|NCT01612221|2213810|P2|COMPLETED|Overall Study||50
915745|NCT01612221|2213811|P1|COMPLETED|Overall Study||50
915746|NCT01612221|2213810|P2|STARTED|Overall Study||50
915747|NCT01612221|2213811|P1|STARTED|Overall Study||50
915748|NCT01612156|2213821|P2|NOT COMPLETED|Overall Study||0
915749|NCT01612156|2213822|P1|NOT COMPLETED|Overall Study||2
915750|NCT01612156|2213821|P2|COMPLETED|Overall Study||48
915751|NCT01612156|2213822|P1|COMPLETED|Overall Study|Contraindication to urodynamics (urinary tract infection) diagnosed after randomization|40
915752|NCT01612156|2213821|P2|STARTED|Overall Study||48
915753|NCT01612156|2213822|P1|STARTED|Overall Study||42
915754|NCT01612000|2213834|P4|NOT COMPLETED|Overall Study||10
915755|NCT01612000|2213835|P3|NOT COMPLETED|Overall Study||7
915756|NCT01612000|2213836|P2|NOT COMPLETED|Overall Study||5
915757|NCT01612000|2213837|P1|NOT COMPLETED|Overall Study||9
915758|NCT01612000|2213834|P4|COMPLETED|Overall Study||76
915759|NCT01612000|2213835|P3|COMPLETED|Overall Study||78
915760|NCT01612000|2213836|P2|COMPLETED|Overall Study||81
915761|NCT01612000|2213837|P1|COMPLETED|Overall Study||75
915762|NCT01612000|2213834|P4|STARTED|Overall Study||86
915763|NCT01612000|2213835|P3|STARTED|Overall Study||85
915764|NCT01612000|2213836|P2|STARTED|Overall Study||86
915765|NCT01612000|2213837|P1|STARTED|Overall Study||84
915766|NCT01611974|2213862|P3|NOT COMPLETED|Overall Study||16
915767|NCT01611974|2213863|P2|NOT COMPLETED|Overall Study||15
915768|NCT01611974|2213864|P1|NOT COMPLETED|Overall Study||15
915769|NCT01611974|2213862|P3|COMPLETED|Overall Study||24
915770|NCT01611974|2213863|P2|COMPLETED|Overall Study||25
915771|NCT01611974|2213864|P1|COMPLETED|Overall Study||25
915772|NCT01611974|2213862|P3|STARTED|Overall Study||40
915773|NCT01611974|2213863|P2|STARTED|Overall Study||40
915774|NCT01611974|2213864|P1|STARTED|Overall Study||40
915775|NCT01611948|2213901|P2|NOT COMPLETED|Overall Study||12
915776|NCT01611948|2213902|P1|NOT COMPLETED|Overall Study||14
915777|NCT01611948|2213901|P2|COMPLETED|Overall Study||26
915778|NCT01611948|2213902|P1|COMPLETED|Overall Study||18
915779|NCT01611948|2213901|P2|STARTED|Overall Study||38
915780|NCT01611948|2213902|P1|STARTED|Overall Study||32
915781|NCT01611883|2213910|P2|NOT COMPLETED|Overall Study||1
915782|NCT01611883|2213911|P1|NOT COMPLETED|Overall Study||1
915783|NCT01611883|2213910|P2|COMPLETED|Overall Study||76
915784|NCT01611883|2213911|P1|COMPLETED|Overall Study||74
915785|NCT01611883|2213910|P2|STARTED|Overall Study||77
915786|NCT01611883|2213911|P1|STARTED|Overall Study||75
915787|NCT01611857|2213937|P2|NOT COMPLETED|Overall Study||2
915788|NCT01611857|2213938|P1|NOT COMPLETED|Overall Study||0
915789|NCT01611857|2213937|P2|COMPLETED|Overall Study||32
915790|NCT01611857|2213938|P1|COMPLETED|Overall Study||15
915791|NCT01611857|2213937|P2|Tivantinib 360 mg|Overall Study|Two participants withdrew prior to receiving drug.|32
915792|NCT01611857|2213938|P1|Tivantinib 360 mg|Overall Study||7
915793|NCT01611857|2213937|P2|Tivantinib 240 mg|Overall Study||0
915794|NCT01611857|2213938|P1|Tivantinib 240 mg|Overall Study||3
915795|NCT01611857|2213937|P2|Tivantinib 120 mg|Overall Study||0
915796|NCT01611857|2213938|P1|Tivantinib 120 mg|Overall Study||5
915797|NCT01611857|2213937|P2|STARTED|Overall Study||34
915798|NCT01611857|2213938|P1|STARTED|Overall Study|Three dose levels of tivantinib (120 mg, 240 mg, and 360 mg) were evaluated to determine the MTD.|15
915817|NCT01611779|2213967|P1|NOT COMPLETED|Overall Study||0
915818|NCT01611779|2213967|P1|COMPLETED|Overall Study||5
915819|NCT01611779|2213967|P1|STARTED|Overall Study||5
915820|NCT01611662|2213976|P1|NOT COMPLETED|Overall Study||1
915821|NCT01611662|2213976|P1|COMPLETED|Overall Study||31
915822|NCT01611662|2213976|P1|STARTED|Overall Study||32
915823|NCT01611571|2213983|P3|NOT COMPLETED|Overall Study||1
915824|NCT01611571|2213984|P2|NOT COMPLETED|Overall Study||0
915825|NCT01611571|2213985|P1|NOT COMPLETED|Overall Study||1
915826|NCT01611571|2213983|P3|COMPLETED|Overall Study||9
915827|NCT01611571|2213984|P2|COMPLETED|Overall Study||10
915828|NCT01611571|2213985|P1|COMPLETED|Overall Study||10
915829|NCT01611571|2213983|P3|STARTED|Overall Study||10
915830|NCT01611571|2213984|P2|STARTED|Overall Study||10
915831|NCT01611571|2213985|P1|STARTED|Overall Study||11
915832|NCT01611558|2214005|P1|NOT COMPLETED|Maintenance Phase||2
915833|NCT01611558|2214005|P1|COMPLETED|Maintenance Phase||0
915834|NCT01611558|2214005|P1|STARTED|Maintenance Phase||2
915835|NCT01611558|2214005|P1|NOT COMPLETED|Induction Phase||38
915836|NCT01611558|2214005|P1|COMPLETED|Induction Phase||2
915837|NCT01611558|2214005|P1|STARTED|Induction Phase||40
915838|NCT01610791|2214011|P1|NOT COMPLETED|Overall Study||21
915839|NCT01610791|2214011|P1|COMPLETED|Overall Study||100
915840|NCT01610791|2214011|P1|STARTED|Overall Study||121
915841|NCT01610713|2214034|P2|NOT COMPLETED|Overall Study||1
915842|NCT01610713|2214035|P1|NOT COMPLETED|Overall Study||6
915843|NCT01610713|2214034|P2|COMPLETED|Overall Study||76
915844|NCT01610713|2214035|P1|COMPLETED|Overall Study||71
915845|NCT01610713|2214034|P2|STARTED|Overall Study||77
915846|NCT01610713|2214035|P1|STARTED|Overall Study||77
915847|NCT01610700|2214093|P2|NOT COMPLETED|Overall Study||3
915848|NCT01610700|2214094|P1|NOT COMPLETED|Overall Study||3
915849|NCT01610700|2214093|P2|COMPLETED|Overall Study||77
915850|NCT01610700|2214094|P1|COMPLETED|Overall Study||77
915851|NCT01610700|2214093|P2|STARTED|Overall Study||80
915852|NCT01610700|2214094|P1|STARTED|Overall Study||80
915853|NCT01610687|2214148|P1|NOT COMPLETED|Overall Study||67
915854|NCT01610687|2214148|P1|COMPLETED|Overall Study||70
915855|NCT01610687|2214148|P1|STARTED|Overall Study||137
915856|NCT01610596|2214161|P2|NOT COMPLETED|Overall Study||1
915857|NCT01610596|2214162|P1|NOT COMPLETED|Overall Study||0
915858|NCT01610596|2214161|P2|COMPLETED|Overall Study||35
915859|NCT01610596|2214162|P1|COMPLETED|Overall Study||36
915860|NCT01610596|2214161|P2|STARTED|Overall Study||36
915861|NCT01610596|2214162|P1|STARTED|Overall Study||36
915862|NCT01610570|2214178|P4|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
915863|NCT01610570|2214179|P3|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
915864|NCT01610570|2214180|P2|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
915865|NCT01610570|2214181|P1|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
915866|NCT01610570|2214178|P4|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
915867|NCT01610570|2214179|P3|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
915868|NCT01610570|2214180|P2|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
915869|NCT01610570|2214181|P1|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
915870|NCT01610570|2214178|P4|STARTED|Ph II >/= 12 mo. & </=17yrs||0
915871|NCT01610570|2214179|P3|STARTED|Ph II >/= 12 mo. & </=17yrs||0
915872|NCT01610570|2214180|P2|STARTED|Ph II >/= 12 mo. & </=17yrs||0
915873|NCT01610570|2214181|P1|STARTED|Ph II >/= 12 mo. & </=17yrs||0
915874|NCT01610570|2214178|P4|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
915875|NCT01610570|2214179|P3|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
915876|NCT01610570|2214180|P2|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
915877|NCT01610570|2214181|P1|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
915878|NCT01610570|2214178|P4|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||6
915879|NCT01610570|2214179|P3|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
915880|NCT01610570|2214180|P2|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
915881|NCT01610570|2214181|P1|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
915882|NCT01610570|2214178|P4|STARTED|Ph II >/= 18yrs of Age at Enrollment||6
915883|NCT01610570|2214179|P3|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
915884|NCT01610570|2214180|P2|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
915885|NCT01610570|2214181|P1|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
915886|NCT01610570|2214178|P4|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
915887|NCT01610570|2214179|P3|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
915888|NCT01610570|2214180|P2|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
915889|NCT01610570|2214181|P1|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
915890|NCT01610570|2214178|P4|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
915891|NCT01610570|2214179|P3|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
915892|NCT01610570|2214180|P2|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||2
915893|NCT01610570|2214181|P1|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
915894|NCT01610570|2214178|P4|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
915895|NCT01610570|2214179|P3|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
915896|NCT01610570|2214180|P2|STARTED|Ph I >/= 12 mo. Children & Adolescents||2
915897|NCT01610570|2214181|P1|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
915898|NCT01610557|2214220|P5|NOT COMPLETED|Post-36-Week Extension Phase||3
915899|NCT01610557|2214221|P4|NOT COMPLETED|Post-36-Week Extension Phase||0
915900|NCT01610557|2214222|P3|NOT COMPLETED|Post-36-Week Extension Phase||0
915901|NCT01610557|2214223|P2|NOT COMPLETED|Post-36-Week Extension Phase||0
915902|NCT01610557|2214224|P1|NOT COMPLETED|Post-36-Week Extension Phase||0
915903|NCT01610557|2214220|P5|COMPLETED|Post-36-Week Extension Phase|2 bilateral participants withdrew before their first post-36-week extension visit|52
915904|NCT01610557|2214221|P4|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
915905|NCT01610557|2214222|P3|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
915906|NCT01610557|2214223|P2|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
915907|NCT01610557|2214224|P1|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
915908|NCT01610557|2214220|P5|STARTED|Post-36-Week Extension Phase||55
915909|NCT01610557|2214221|P4|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
915910|NCT01610557|2214222|P3|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
915911|NCT01610557|2214223|P2|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
915912|NCT01610557|2214224|P1|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
915913|NCT01610557|2214220|P5|NOT COMPLETED|36-Week Randomized Crossover Phase||0
915914|NCT01610557|2214221|P4|NOT COMPLETED|36-Week Randomized Crossover Phase||0
915915|NCT01610557|2214222|P3|NOT COMPLETED|36-Week Randomized Crossover Phase||0
915916|NCT01610557|2214223|P2|NOT COMPLETED|36-Week Randomized Crossover Phase||1
915917|NCT01610557|2214224|P1|NOT COMPLETED|36-Week Randomized Crossover Phase||0
915918|NCT01610557|2214220|P5|COMPLETED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
915919|NCT01610557|2214221|P4|COMPLETED|36-Week Randomized Crossover Phase||13
915920|NCT01610557|2214222|P3|COMPLETED|36-Week Randomized Crossover Phase||14
915921|NCT01610557|2214223|P2|COMPLETED|36-Week Randomized Crossover Phase|Unilateral participant unable to return for visits after Wk 4 due to recovery from an adverse event|12
915922|NCT01610557|2214224|P1|COMPLETED|36-Week Randomized Crossover Phase||16
915923|NCT01610557|2214220|P5|STARTED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
915924|NCT01610557|2214221|P4|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 4: 11 unilateral and 2 bilateral (left eye assigned to Grp 2)|13
916011|NCT01609582|2214411|P1|COMPLETED|Overall Study||0
915925|NCT01610557|2214222|P3|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 3: 13 unilateral and 1 bilateral (left eye assigned to Grp 1)|14
915926|NCT01610557|2214223|P2|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 2: 12 unilateral and 1 bilateral (left eye assigned to Grp 4)|13
915927|NCT01610557|2214224|P1|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 1: 14 unilateral and 2 bilateral (left eye assigned to Grp 3)|16
915931|NCT01610453|2214244|P1|NOT COMPLETED|Overall Study||0
915932|NCT01610453|2214244|P1|COMPLETED|Overall Study||150
915933|NCT01610453|2214244|P1|STARTED|Overall Study||150
915934|NCT01610297|2214249|P1|NOT COMPLETED|Overall Study||1
915935|NCT01610297|2214249|P1|COMPLETED|Overall Study||26
915936|NCT01610297|2214249|P1|STARTED|Overall Study||27
915937|NCT01610167|2214260|P3|NOT COMPLETED|Overall Study||2
915938|NCT01610167|2214261|P2|NOT COMPLETED|Overall Study||0
915939|NCT01610167|2214262|P1|NOT COMPLETED|Overall Study||0
915940|NCT01610167|2214260|P3|COMPLETED|Overall Study||48
915941|NCT01610167|2214261|P2|COMPLETED|Overall Study||49
915942|NCT01610167|2214262|P1|COMPLETED|Overall Study||52
915943|NCT01610167|2214260|P3|STARTED|Overall Study||50
915944|NCT01610167|2214261|P2|STARTED|Overall Study||49
915945|NCT01610167|2214262|P1|STARTED|Overall Study||52
915946|NCT01610154|2214282|P1|NOT COMPLETED|Overall Study||1
915947|NCT01610154|2214282|P1|COMPLETED|Overall Study||84
915948|NCT01610154|2214282|P1|STARTED|Overall Study||85
915949|NCT01610076|2214299|P2|NOT COMPLETED|Overall Study||5
915950|NCT01610076|2214300|P1|NOT COMPLETED|Overall Study||3
915951|NCT01610076|2214299|P2|COMPLETED|Overall Study||100
915952|NCT01610076|2214300|P1|COMPLETED|Overall Study||100
915953|NCT01610076|2214299|P2|STARTED|Overall Study||105
915954|NCT01610076|2214300|P1|STARTED|Overall Study||103
915955|NCT01610063|2214311|P2|NOT COMPLETED|Overall Study||20
915956|NCT01610063|2214312|P1|NOT COMPLETED|Overall Study||42
915957|NCT01610063|2214311|P2|COMPLETED|Overall Study||93
915958|NCT01610063|2214312|P1|COMPLETED|Overall Study||72
915959|NCT01610063|2214311|P2|Completed 8-week|Overall Study||93
915960|NCT01610063|2214312|P1|Completed 8-week|Overall Study||72
915961|NCT01610063|2214311|P2|Completed 4-week|Overall Study||98
915962|NCT01610063|2214312|P1|Completed 4-week|Overall Study||86
915963|NCT01610063|2214311|P2|Completed 2-week|Overall Study||105
915964|NCT01610063|2214312|P1|Completed 2-week|Overall Study||97
915965|NCT01610063|2214311|P2|Baseline|Overall Study||113
915966|NCT01610063|2214312|P1|Baseline|Overall Study||114
915967|NCT01610063|2214311|P2|STARTED|Overall Study||113
915968|NCT01610063|2214312|P1|STARTED|Overall Study||114
915969|NCT01610037|2214335|P3|NOT COMPLETED|Treatment and Follow up Period||26
915970|NCT01610037|2214336|P2|NOT COMPLETED|Treatment and Follow up Period||28
915971|NCT01610037|2214337|P1|NOT COMPLETED|Treatment and Follow up Period||25
915972|NCT01610037|2214335|P3|COMPLETED|Treatment and Follow up Period||378
915973|NCT01610037|2214336|P2|COMPLETED|Treatment and Follow up Period||377
915974|NCT01610037|2214337|P1|COMPLETED|Treatment and Follow up Period||382
915975|NCT01610037|2214335|P3|STARTED|Treatment and Follow up Period||404
915976|NCT01610037|2214336|P2|STARTED|Treatment and Follow up Period||405
915977|NCT01610037|2214337|P1|STARTED|Treatment and Follow up Period||407
915978|NCT01610037|2214335|P3|NOT COMPLETED|All Patients||84
915979|NCT01610037|2214336|P2|NOT COMPLETED|All Patients||51
915980|NCT01610037|2214337|P1|NOT COMPLETED|All Patients||59
915981|NCT01610037|2214335|P3|COMPLETED|All Patients||320
915982|NCT01610037|2214336|P2|COMPLETED|All Patients||354
915983|NCT01610037|2214337|P1|COMPLETED|All Patients||348
915984|NCT01610037|2214335|P3|Full Analysis Set (FAS)|All Patients||403
915985|NCT01610037|2214336|P2|Full Analysis Set (FAS)|All Patients||405
915986|NCT01610037|2214337|P1|Full Analysis Set (FAS)|All Patients||407
915987|NCT01610037|2214335|P3|Randomized Set (RAN)|All Patients||404
915988|NCT01610037|2214336|P2|Randomized Set (RAN)|All Patients||405
915989|NCT01610037|2214337|P1|Randomized Set (RAN)|All Patients||407
915990|NCT01610037|2214335|P3|STARTED|All Patients||404
915991|NCT01610037|2214336|P2|STARTED|All Patients||405
915992|NCT01610037|2214337|P1|STARTED|All Patients||407
915993|NCT01610011|2214380|P2|NOT COMPLETED|Overall Study||0
915994|NCT01610011|2214381|P1|NOT COMPLETED|Overall Study||10
915995|NCT01610011|2214380|P2|COMPLETED|Overall Study||2
915996|NCT01610011|2214381|P1|COMPLETED|Overall Study||9
915997|NCT01610011|2214380|P2|STARTED|Overall Study||2
915998|NCT01610011|2214381|P1|STARTED|Overall Study||19
915999|NCT01609790|2214390|P3|NOT COMPLETED|Overall Study||8
916000|NCT01609790|2214391|P2|NOT COMPLETED|Overall Study||7
916001|NCT01609790|2214392|P1|NOT COMPLETED|Overall Study||1
916002|NCT01609790|2214390|P3|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|57
916003|NCT01609790|2214391|P2|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
916004|NCT01609790|2214392|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|6
916005|NCT01609790|2214390|P3|STARTED|Overall Study||65
916006|NCT01609790|2214391|P2|STARTED|Overall Study||65
916007|NCT01609790|2214392|P1|STARTED|Overall Study||7
916008|NCT01609582|2214410|P2|NOT COMPLETED|Overall Study||1604
916009|NCT01609582|2214411|P1|NOT COMPLETED|Overall Study||1603
916010|NCT01609582|2214410|P2|COMPLETED|Overall Study||0
916012|NCT01609582|2214410|P2|Treated|Overall Study||1601
916013|NCT01609582|2214411|P1|Treated|Overall Study||1603
916014|NCT01609582|2214410|P2|STARTED|Overall Study||1604
916015|NCT01609582|2214411|P1|STARTED|Overall Study||1603
916016|NCT01609543|2214419|P1|NOT COMPLETED|Overall Study||42
916017|NCT01609543|2214419|P1|COMPLETED|Overall Study||20
916018|NCT01609543|2214419|P1|STARTED|Overall Study||62
916019|NCT01609478|2214428|P3|NOT COMPLETED|Overall Study||9
916020|NCT01609478|2214429|P2|NOT COMPLETED|Overall Study||2
916021|NCT01609478|2214430|P1|NOT COMPLETED|Overall Study||7
916022|NCT01609478|2214428|P3|COMPLETED|Overall Study||107
916023|NCT01609478|2214429|P2|COMPLETED|Overall Study||106
916024|NCT01609478|2214430|P1|COMPLETED|Overall Study||104
916025|NCT01609478|2214428|P3|Full Analysis Set (FAS)|Overall Study||115
916026|NCT01609478|2214429|P2|Full Analysis Set (FAS)|Overall Study||108
916027|NCT01609478|2214430|P1|Full Analysis Set (FAS)|Overall Study||110
916028|NCT01609478|2214428|P3|STARTED|Overall Study||116
916029|NCT01609478|2214429|P2|STARTED|Overall Study||108
916030|NCT01609478|2214430|P1|STARTED|Overall Study||111
916031|NCT01609257|2214496|P2|NOT COMPLETED|Overall Study||8
916032|NCT01609257|2214497|P1|NOT COMPLETED|Overall Study||6
916033|NCT01609257|2214496|P2|COMPLETED|Overall Study||57
916034|NCT01609257|2214497|P1|COMPLETED|Overall Study||61
916035|NCT01609257|2214496|P2|Received Challenge Product|Overall Study||53
916036|NCT01609257|2214497|P1|Received Challenge Product|Overall Study||56
916037|NCT01609257|2214496|P2|Received 2 Doses|Overall Study||64
916038|NCT01609257|2214497|P1|Received 2 Doses|Overall Study||63
916039|NCT01609257|2214496|P2|STARTED|Overall Study||65
916040|NCT01609257|2214497|P1|STARTED|Overall Study||67
916041|NCT01609062|2214569|P2|NOT COMPLETED|Extension Phase||10
916042|NCT01609062|2214570|P1|NOT COMPLETED|Extension Phase||15
916043|NCT01609062|2214569|P2|COMPLETED|Extension Phase|EAP = Expanded Access Program|0
916044|NCT01609062|2214570|P1|COMPLETED|Extension Phase||0
916045|NCT01609062|2214569|P2|STARTED|Extension Phase||10
916046|NCT01609062|2214570|P1|STARTED|Extension Phase||15
916047|NCT01609062|2214569|P2|NOT COMPLETED|Primary Phase||0
916048|NCT01609062|2214570|P1|NOT COMPLETED|Primary Phase||0
916049|NCT01609062|2214569|P2|COMPLETED|Primary Phase||10
916050|NCT01609062|2214570|P1|COMPLETED|Primary Phase||15
916051|NCT01609062|2214569|P2|STARTED|Primary Phase||10
916052|NCT01609062|2214570|P1|STARTED|Primary Phase||15
916053|NCT01609023|2214613|P1|NOT COMPLETED|Overall Study||33
916054|NCT01609023|2214613|P1|COMPLETED|Overall Study||34
916055|NCT01609023|2214613|P1|STARTED|Overall Study||67
916056|NCT01609010|2214625|P2|NOT COMPLETED|Overall Study||37
916057|NCT01609010|2214626|P1|NOT COMPLETED|Overall Study||43
916058|NCT01609010|2214625|P2|COMPLETED|Overall Study||120
916059|NCT01609010|2214626|P1|COMPLETED|Overall Study||113
916060|NCT01609010|2214625|P2|Entering Cycle 2|Overall Study||124
916061|NCT01609010|2214626|P1|Entering Cycle 2|Overall Study||120
916062|NCT01609010|2214625|P2|STARTED|Overall Study||157
916063|NCT01609010|2214626|P1|STARTED|Overall Study||156
916064|NCT01608971|2214652|P2|NOT COMPLETED|Overall Study||0
916065|NCT01608971|2214653|P1|NOT COMPLETED|Overall Study||0
916066|NCT01608971|2214652|P2|COMPLETED|Overall Study||15
916067|NCT01608971|2214653|P1|COMPLETED|Overall Study||15
916068|NCT01608971|2214652|P2|STARTED|Overall Study||15
916069|NCT01608971|2214653|P1|STARTED|Overall Study||15
916070|NCT01608815|2214668|P3|NOT COMPLETED|Overall Study||0
916071|NCT01608815|2214669|P2|NOT COMPLETED|Overall Study||0
916072|NCT01608815|2214670|P1|NOT COMPLETED|Overall Study||0
916073|NCT01608815|2214668|P3|COMPLETED|Overall Study||5
916074|NCT01608815|2214669|P2|COMPLETED|Overall Study||7
916075|NCT01608815|2214670|P1|COMPLETED|Overall Study||188
916076|NCT01608815|2214668|P3|STARTED|Overall Study||5
916077|NCT01608815|2214669|P2|STARTED|Overall Study||7
916078|NCT01608815|2214670|P1|STARTED|Overall Study||188
916079|NCT01608724|2214687|P1|NOT COMPLETED|Overall Study||243
916080|NCT01608724|2214687|P1|COMPLETED|Overall Study||1180
916081|NCT01608724|2214687|P1|Treated|Overall Study||1361
916082|NCT01608724|2214687|P1|STARTED|Overall Study|One patient was excluded because the Informed Consent Form was destroyed by site staff by mistake.|1423
916083|NCT01608672|2214694|P1|NOT COMPLETED|Overall Study||0
916084|NCT01608672|2214694|P1|COMPLETED|Overall Study||207
916085|NCT01608672|2214694|P1|STARTED|Overall Study||207
916086|NCT01608659|2214700|P1|NOT COMPLETED|Overall Study||16
916087|NCT01608659|2214700|P1|COMPLETED|Overall Study||94
916088|NCT01608659|2214700|P1|STARTED|Overall Study||110
916089|NCT01608490|2214708|P2|NOT COMPLETED|Overall Study||0
916090|NCT01608490|2214709|P1|NOT COMPLETED|Overall Study||0
916091|NCT01608490|2214708|P2|COMPLETED|Overall Study||157
916092|NCT01608490|2214709|P1|COMPLETED|Overall Study||158
916093|NCT01608490|2214708|P2|STARTED|Overall Study||157
916094|NCT01608490|2214709|P1|STARTED|Overall Study||158
916095|NCT01608321|2214719|P2|NOT COMPLETED|Overall Study||0
916096|NCT01608321|2214720|P1|NOT COMPLETED|Overall Study||1
916097|NCT01608321|2214719|P2|COMPLETED|Overall Study||4
916098|NCT01608321|2214720|P1|COMPLETED|Overall Study||12
916099|NCT01608321|2214719|P2|STARTED|Overall Study||4
916100|NCT01608321|2214720|P1|STARTED|Overall Study||13
916101|NCT01608308|2214728|P2|NOT COMPLETED|Overall Study||2
916102|NCT01608308|2214729|P1|NOT COMPLETED|Overall Study||0
916103|NCT01608308|2214728|P2|COMPLETED|Overall Study||29
916104|NCT01608308|2214729|P1|COMPLETED|Overall Study||31
916105|NCT01608308|2214728|P2|STARTED|Overall Study||31
916106|NCT01608308|2214729|P1|STARTED|Overall Study||31
916107|NCT01608295|2214753|P2|NOT COMPLETED|Overall Study||5
916108|NCT01608295|2214754|P1|NOT COMPLETED|Overall Study||6
916109|NCT01608295|2214753|P2|COMPLETED|Overall Study||25
916110|NCT01608295|2214754|P1|COMPLETED|Overall Study||20
916111|NCT01608295|2214753|P2|STARTED|Overall Study||30
916112|NCT01608295|2214754|P1|STARTED|Overall Study||26
916113|NCT01608100|2214764|P1|NOT COMPLETED|Overall Study||0
916114|NCT01608100|2214764|P1|COMPLETED|Overall Study||1101
916115|NCT01608100|2214764|P1|STARTED|Overall Study||1101
916116|NCT01607853|2214788|P1|NOT COMPLETED|Overall Study||0
916117|NCT01607853|2214788|P1|COMPLETED|Overall Study||24
916118|NCT01607853|2214788|P1|STARTED|Overall Study||24
916119|NCT01607645|2214897|P2|NOT COMPLETED|Overall Study||0
916120|NCT01607645|2214898|P1|NOT COMPLETED|Overall Study||0
916121|NCT01607645|2214897|P2|COMPLETED|Overall Study||3
916122|NCT01607645|2214898|P1|COMPLETED|Overall Study||4
916123|NCT01607645|2214897|P2|STARTED|Overall Study||3
916124|NCT01607645|2214898|P1|STARTED|Overall Study||4
916125|NCT01607593|2214928|P1|NOT COMPLETED|Overall Study||93
916126|NCT01607593|2214928|P1|COMPLETED|Overall Study||29
916127|NCT01607593|2214928|P1|STARTED|Overall Study||122
916128|NCT01607476|2214937|P3|NOT COMPLETED|Overall Study||3
916129|NCT01607476|2214938|P2|NOT COMPLETED|Overall Study||0
916130|NCT01607476|2214939|P1|NOT COMPLETED|Overall Study||1
916131|NCT01607476|2214937|P3|COMPLETED|Overall Study||30
916132|NCT01607476|2214938|P2|COMPLETED|Overall Study||30
916133|NCT01607476|2214939|P1|COMPLETED|Overall Study||24
916134|NCT01607476|2214937|P3|STARTED|Overall Study||33
916135|NCT01607476|2214938|P2|STARTED|Overall Study||30
916136|NCT01607476|2214939|P1|STARTED|Overall Study||25
916137|NCT01607450|2214957|P7|NOT COMPLETED|Overall Study||0
916138|NCT01607450|2214958|P6|NOT COMPLETED|Overall Study||0
916139|NCT01607450|2214959|P5|NOT COMPLETED|Overall Study||0
916140|NCT01607450|2214960|P4|NOT COMPLETED|Overall Study||0
916141|NCT01607450|2214961|P3|NOT COMPLETED|Overall Study||0
916142|NCT01607450|2214962|P2|NOT COMPLETED|Overall Study||0
916143|NCT01607450|2214963|P1|NOT COMPLETED|Overall Study||0
916144|NCT01607450|2214957|P7|COMPLETED|Overall Study||0
916145|NCT01607450|2214958|P6|COMPLETED|Overall Study||0
916146|NCT01607450|2214959|P5|COMPLETED|Overall Study||1
916147|NCT01607450|2214960|P4|COMPLETED|Overall Study||11
916148|NCT01607450|2214961|P3|COMPLETED|Overall Study||7
916149|NCT01607450|2214962|P2|COMPLETED|Overall Study||8
916150|NCT01607450|2214963|P1|COMPLETED|Overall Study||6
916151|NCT01607450|2214957|P7|STARTED|Overall Study||0
916152|NCT01607450|2214958|P6|STARTED|Overall Study||0
916153|NCT01607450|2214959|P5|STARTED|Overall Study||1
916154|NCT01607450|2214960|P4|STARTED|Overall Study||11
916155|NCT01607450|2214961|P3|STARTED|Overall Study||7
916156|NCT01607450|2214962|P2|STARTED|Overall Study||8
916157|NCT01607450|2214963|P1|STARTED|Overall Study||6
916158|NCT01607411|2215007|P4|NOT COMPLETED|Period IV||0
916159|NCT01607411|2215008|P3|NOT COMPLETED|Period IV||0
916160|NCT01607411|2215009|P2|NOT COMPLETED|Period IV||0
916161|NCT01607411|2215010|P1|NOT COMPLETED|Period IV||0
916162|NCT01607411|2215007|P4|COMPLETED|Period IV||14
916163|NCT01607411|2215008|P3|COMPLETED|Period IV||14
916164|NCT01607411|2215009|P2|COMPLETED|Period IV||14
916165|NCT01607411|2215010|P1|COMPLETED|Period IV||13
916166|NCT01607411|2215007|P4|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
916167|NCT01607411|2215008|P3|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
916168|NCT01607411|2215009|P2|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
916169|NCT01607411|2215010|P1|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|13
916170|NCT01607411|2215007|P4|NOT COMPLETED|Period III||0
916171|NCT01607411|2215008|P3|NOT COMPLETED|Period III||0
916172|NCT01607411|2215009|P2|NOT COMPLETED|Period III||0
916173|NCT01607411|2215010|P1|NOT COMPLETED|Period III||0
916174|NCT01607411|2215007|P4|COMPLETED|Period III||13
916175|NCT01607411|2215008|P3|COMPLETED|Period III||14
916176|NCT01607411|2215009|P2|COMPLETED|Period III||14
916177|NCT01607411|2215010|P1|COMPLETED|Period III||14
916178|NCT01607411|2215007|P4|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|13
916179|NCT01607411|2215008|P3|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
916180|NCT01607411|2215009|P2|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
916181|NCT01607411|2215010|P1|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
916182|NCT01607411|2215007|P4|NOT COMPLETED|Period II||0
916183|NCT01607411|2215008|P3|NOT COMPLETED|Period II||0
916184|NCT01607411|2215009|P2|NOT COMPLETED|Period II||0
916185|NCT01607411|2215010|P1|NOT COMPLETED|Period II||0
916186|NCT01607411|2215007|P4|COMPLETED|Period II||14
916187|NCT01607411|2215008|P3|COMPLETED|Period II||13
916188|NCT01607411|2215009|P2|COMPLETED|Period II||14
916189|NCT01607411|2215010|P1|COMPLETED|Period II||14
916190|NCT01607411|2215007|P4|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
916191|NCT01607411|2215008|P3|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|13
916192|NCT01607411|2215009|P2|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
916193|NCT01607411|2215010|P1|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
916194|NCT01607411|2215007|P4|NOT COMPLETED|Period I||0
916195|NCT01607411|2215008|P3|NOT COMPLETED|Period I||0
916196|NCT01607411|2215009|P2|NOT COMPLETED|Period I||0
916197|NCT01607411|2215010|P1|NOT COMPLETED|Period I||0
916198|NCT01607411|2215007|P4|COMPLETED|Period I||14
916199|NCT01607411|2215008|P3|COMPLETED|Period I||14
916200|NCT01607411|2215009|P2|COMPLETED|Period I||13
916201|NCT01607411|2215010|P1|COMPLETED|Period I||14
916202|NCT01607411|2215007|P4|STARTED|Period I||14
916203|NCT01607411|2215008|P3|STARTED|Period I||14
916204|NCT01607411|2215009|P2|STARTED|Period I||13
916205|NCT01607411|2215010|P1|STARTED|Period I||14
916206|NCT01607398|2215033|P2|NOT COMPLETED|Overall Study||2
916207|NCT01607398|2215034|P1|NOT COMPLETED|Overall Study||2
916208|NCT01607398|2215033|P2|COMPLETED|Overall Study||26
916209|NCT01607398|2215034|P1|COMPLETED|Overall Study||26
916210|NCT01607398|2215033|P2|STARTED|Overall Study||28
916211|NCT01607398|2215034|P1|STARTED|Overall Study||28
916215|NCT01607320|2215094|P2|NOT COMPLETED|Overall Study||0
916216|NCT01607320|2215095|P1|NOT COMPLETED|Overall Study||0
916217|NCT01607320|2215094|P2|COMPLETED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
916218|NCT01607320|2215095|P1|COMPLETED|Overall Study|The study was randomized between the 2 treatments and was never unblinded,so unknown.|0
916219|NCT01607320|2215094|P2|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
916220|NCT01607320|2215095|P1|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
916221|NCT01607203|2215101|P2|NOT COMPLETED|Overall Study||0
916222|NCT01607203|2215102|P1|NOT COMPLETED|Overall Study||0
916223|NCT01607203|2215101|P2|COMPLETED|Overall Study||61
916224|NCT01607203|2215102|P1|COMPLETED|Overall Study||59
916225|NCT01607203|2215101|P2|STARTED|Overall Study||61
916226|NCT01607203|2215102|P1|STARTED|Overall Study||59
916227|NCT01607112|2215114|P2|NOT COMPLETED|Overall Study||0
916228|NCT01607112|2215115|P1|NOT COMPLETED|Overall Study||0
916229|NCT01607112|2215114|P2|COMPLETED|Overall Study||59
916230|NCT01607112|2215115|P1|COMPLETED|Overall Study||60
916231|NCT01607112|2215114|P2|STARTED|Overall Study||59
916232|NCT01607112|2215115|P1|STARTED|Overall Study||60
916233|NCT01606800|2215151|P2|NOT COMPLETED|Overall Study||2
916234|NCT01606800|2215152|P1|NOT COMPLETED|Overall Study||5
916235|NCT01606800|2215151|P2|COMPLETED|Overall Study||21
916236|NCT01606800|2215152|P1|COMPLETED|Overall Study||17
916237|NCT01606800|2215151|P2|Treated|Overall Study||23
916238|NCT01606800|2215152|P1|Treated|Overall Study||22
916239|NCT01606800|2215151|P2|STARTED|Overall Study||23
916240|NCT01606800|2215152|P1|STARTED|Overall Study||22
916241|NCT01606748|2215160|P2|NOT COMPLETED|Overall Study||0
916242|NCT01606748|2215161|P1|NOT COMPLETED|Overall Study||3
916243|NCT01606748|2215160|P2|COMPLETED|Overall Study||17
916244|NCT01606748|2215161|P1|COMPLETED|Overall Study||15
916245|NCT01606748|2215160|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
916246|NCT01606748|2215161|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
916247|NCT01606748|2215160|P2|STARTED|Overall Study||17
916248|NCT01606748|2215161|P1|STARTED|Overall Study||18
916249|NCT01606735|2215192|P3|NOT COMPLETED|Overall Study||0
916250|NCT01606735|2215193|P2|NOT COMPLETED|Overall Study||0
916251|NCT01606735|2215194|P1|NOT COMPLETED|Overall Study||0
916252|NCT01606735|2215192|P3|COMPLETED|Overall Study||58
916253|NCT01606735|2215193|P2|COMPLETED|Overall Study||56
916254|NCT01606735|2215194|P1|COMPLETED|Overall Study||58
916255|NCT01606735|2215192|P3|STARTED|Overall Study||58
916256|NCT01606735|2215193|P2|STARTED|Overall Study||56
916257|NCT01606735|2215194|P1|STARTED|Overall Study||58
916258|NCT01606670|2215202|P1|NOT COMPLETED|Overall Study||16
916259|NCT01606670|2215202|P1|COMPLETED|Overall Study||77
916260|NCT01606670|2215202|P1|Full Analysis Set|Overall Study||70
916261|NCT01606670|2215202|P1|Safety Set|Overall Study||93
916262|NCT01606670|2215202|P1|STARTED|Overall Study||93
916263|NCT01606319|2215212|P2|NOT COMPLETED|Overall Study||40
916264|NCT01606319|2215213|P1|NOT COMPLETED|Overall Study||34
916265|NCT01606319|2215212|P2|COMPLETED|Overall Study||110
916266|NCT01606319|2215213|P1|COMPLETED|Overall Study||116
916267|NCT01606319|2215212|P2|STARTED|Overall Study||150
916268|NCT01606319|2215213|P1|STARTED|Overall Study||150
916269|NCT01606306|2215231|P6|NOT COMPLETED|Overall Study||11
916270|NCT01606306|2215232|P5|NOT COMPLETED|Overall Study||11
916271|NCT01606306|2215233|P4|NOT COMPLETED|Overall Study||13
916272|NCT01606306|2215234|P3|NOT COMPLETED|Overall Study||14
916273|NCT01606306|2215235|P2|NOT COMPLETED|Overall Study||10
916274|NCT01606306|2215236|P1|NOT COMPLETED|Overall Study||15
916275|NCT01606306|2215231|P6|COMPLETED|Overall Study||36
916276|NCT01606306|2215232|P5|COMPLETED|Overall Study||41
916277|NCT01606306|2215233|P4|COMPLETED|Overall Study||38
916278|NCT01606306|2215234|P3|COMPLETED|Overall Study||37
916279|NCT01606306|2215235|P2|COMPLETED|Overall Study||39
916280|NCT01606306|2215236|P1|COMPLETED|Overall Study||35
916281|NCT01606306|2215231|P6|Completed Third Treatment Period|Overall Study||36
916282|NCT01606306|2215232|P5|Completed Third Treatment Period|Overall Study||41
916283|NCT01606306|2215233|P4|Completed Third Treatment Period|Overall Study||38
916284|NCT01606306|2215234|P3|Completed Third Treatment Period|Overall Study||37
916285|NCT01606306|2215235|P2|Completed Third Treatment Period|Overall Study||39
916286|NCT01606306|2215236|P1|Completed Third Treatment Period|Overall Study||35
916287|NCT01606306|2215231|P6|Completed Second Treatment Period|Overall Study||41
916288|NCT01606306|2215232|P5|Completed Second Treatment Period|Overall Study||46
916289|NCT01606306|2215233|P4|Completed Second Treatment Period|Overall Study||44
916290|NCT01606306|2215234|P3|Completed Second Treatment Period|Overall Study||43
916291|NCT01606306|2215235|P2|Completed Second Treatment Period|Overall Study||38
916292|NCT01606306|2215236|P1|Completed Second Treatment Period|Overall Study||41
916293|NCT01606306|2215231|P6|Completed First Treatment Period|Overall Study||44
916294|NCT01606306|2215232|P5|Completed First Treatment Period|Overall Study||47
916295|NCT01606306|2215233|P4|Completed First Treatment Period|Overall Study||45
916296|NCT01606306|2215234|P3|Completed First Treatment Period|Overall Study||47
916297|NCT01606306|2215235|P2|Completed First Treatment Period|Overall Study||47
916298|NCT01606306|2215236|P1|Completed First Treatment Period|Overall Study||43
916299|NCT01606306|2215231|P6|STARTED|Overall Study||47
916300|NCT01606306|2215232|P5|STARTED|Overall Study||52
916301|NCT01606306|2215233|P4|STARTED|Overall Study||51
916302|NCT01606306|2215234|P3|STARTED|Overall Study||51
916303|NCT01606306|2215235|P2|STARTED|Overall Study||49
916304|NCT01606306|2215236|P1|STARTED|Overall Study||50
916305|NCT01606254|2215246|P4|NOT COMPLETED|Overall Study||3
916306|NCT01606254|2215247|P3|NOT COMPLETED|Overall Study||0
916307|NCT01606254|2215248|P2|NOT COMPLETED|Overall Study||4
916308|NCT01606254|2215249|P1|NOT COMPLETED|Overall Study||2
916309|NCT01606254|2215246|P4|COMPLETED|Overall Study||11
916310|NCT01606254|2215247|P3|COMPLETED|Overall Study||14
916311|NCT01606254|2215248|P2|COMPLETED|Overall Study||10
916312|NCT01606254|2215249|P1|COMPLETED|Overall Study||12
916313|NCT01606254|2215246|P4|STARTED|Overall Study||14
916314|NCT01606254|2215247|P3|STARTED|Overall Study||14
916315|NCT01606254|2215248|P2|STARTED|Overall Study||14
916316|NCT01606254|2215249|P1|STARTED|Overall Study||14
916317|NCT01606228|2215331|P1|NOT COMPLETED|Overall Study||29
916318|NCT01606228|2215331|P1|COMPLETED|Overall Study||159
916319|NCT01606228|2215331|P1|STARTED|Overall Study||188
916320|NCT01606202|2215348|P2|NOT COMPLETED|Overall Study||3
916321|NCT01606202|2215349|P1|NOT COMPLETED|Overall Study||7
916322|NCT01606202|2215348|P2|COMPLETED|Overall Study||57
916323|NCT01606202|2215349|P1|COMPLETED|Overall Study||49
916324|NCT01606202|2215348|P2|STARTED|Overall Study||60
916325|NCT01606202|2215349|P1|STARTED|Overall Study||56
916326|NCT01606189|2215381|P6|NOT COMPLETED|Third Intenvention (14-20 Days)||1
916327|NCT01606189|2215382|P5|NOT COMPLETED|Third Intenvention (14-20 Days)||0
916328|NCT01606189|2215383|P4|NOT COMPLETED|Third Intenvention (14-20 Days)||0
916329|NCT01606189|2215384|P3|NOT COMPLETED|Third Intenvention (14-20 Days)||0
916330|NCT01606189|2215385|P2|NOT COMPLETED|Third Intenvention (14-20 Days)||0
916331|NCT01606189|2215386|P1|NOT COMPLETED|Third Intenvention (14-20 Days)||0
916332|NCT01606189|2215381|P6|COMPLETED|Third Intenvention (14-20 Days)||6
916333|NCT01606189|2215382|P5|COMPLETED|Third Intenvention (14-20 Days)||8
916334|NCT01606189|2215383|P4|COMPLETED|Third Intenvention (14-20 Days)||8
916335|NCT01606189|2215384|P3|COMPLETED|Third Intenvention (14-20 Days)||8
916336|NCT01606189|2215385|P2|COMPLETED|Third Intenvention (14-20 Days)||8
916337|NCT01606189|2215386|P1|COMPLETED|Third Intenvention (14-20 Days)||8
916338|NCT01606189|2215381|P6|STARTED|Third Intenvention (14-20 Days)||7
916339|NCT01606189|2215382|P5|STARTED|Third Intenvention (14-20 Days)||8
916340|NCT01606189|2215383|P4|STARTED|Third Intenvention (14-20 Days)||8
916341|NCT01606189|2215384|P3|STARTED|Third Intenvention (14-20 Days)||8
916342|NCT01606189|2215385|P2|STARTED|Third Intenvention (14-20 Days)||8
916343|NCT01606189|2215386|P1|STARTED|Third Intenvention (14-20 Days)||8
916344|NCT01606189|2215381|P6|NOT COMPLETED|Second Intenvention (14-20 Days)||1
916345|NCT01606189|2215382|P5|NOT COMPLETED|Second Intenvention (14-20 Days)||0
916346|NCT01606189|2215383|P4|NOT COMPLETED|Second Intenvention (14-20 Days)||0
916347|NCT01606189|2215384|P3|NOT COMPLETED|Second Intenvention (14-20 Days)||0
916348|NCT01606189|2215385|P2|NOT COMPLETED|Second Intenvention (14-20 Days)||0
916349|NCT01606189|2215386|P1|NOT COMPLETED|Second Intenvention (14-20 Days)||0
916350|NCT01606189|2215381|P6|COMPLETED|Second Intenvention (14-20 Days)||7
916351|NCT01606189|2215382|P5|COMPLETED|Second Intenvention (14-20 Days)||8
916352|NCT01606189|2215383|P4|COMPLETED|Second Intenvention (14-20 Days)||8
916353|NCT01606189|2215384|P3|COMPLETED|Second Intenvention (14-20 Days)||8
916354|NCT01606189|2215385|P2|COMPLETED|Second Intenvention (14-20 Days)||8
916355|NCT01606189|2215386|P1|COMPLETED|Second Intenvention (14-20 Days)||8
916356|NCT01606189|2215381|P6|STARTED|Second Intenvention (14-20 Days)||8
916357|NCT01606189|2215382|P5|STARTED|Second Intenvention (14-20 Days)||8
916358|NCT01606189|2215383|P4|STARTED|Second Intenvention (14-20 Days)||8
916359|NCT01606189|2215384|P3|STARTED|Second Intenvention (14-20 Days)||8
916360|NCT01606189|2215385|P2|STARTED|Second Intenvention (14-20 Days)||8
916361|NCT01606189|2215386|P1|STARTED|Second Intenvention (14-20 Days)||8
916362|NCT01606189|2215381|P6|NOT COMPLETED|First Intenvention (14-20 Days)||0
916363|NCT01606189|2215382|P5|NOT COMPLETED|First Intenvention (14-20 Days)||0
916364|NCT01606189|2215383|P4|NOT COMPLETED|First Intenvention (14-20 Days)||0
916365|NCT01606189|2215384|P3|NOT COMPLETED|First Intenvention (14-20 Days)||0
916366|NCT01606189|2215385|P2|NOT COMPLETED|First Intenvention (14-20 Days)||0
916367|NCT01606189|2215386|P1|NOT COMPLETED|First Intenvention (14-20 Days)||0
916368|NCT01606189|2215381|P6|COMPLETED|First Intenvention (14-20 Days)||8
916369|NCT01606189|2215382|P5|COMPLETED|First Intenvention (14-20 Days)||8
916370|NCT01606189|2215383|P4|COMPLETED|First Intenvention (14-20 Days)||8
916371|NCT01606189|2215384|P3|COMPLETED|First Intenvention (14-20 Days)||8
916372|NCT01606189|2215385|P2|COMPLETED|First Intenvention (14-20 Days)||8
916373|NCT01606189|2215386|P1|COMPLETED|First Intenvention (14-20 Days)||8
916374|NCT01606189|2215381|P6|STARTED|First Intenvention (14-20 Days)||8
916375|NCT01606189|2215382|P5|STARTED|First Intenvention (14-20 Days)||8
916376|NCT01606189|2215383|P4|STARTED|First Intenvention (14-20 Days)||8
916377|NCT01606189|2215384|P3|STARTED|First Intenvention (14-20 Days)||8
916378|NCT01606189|2215385|P2|STARTED|First Intenvention (14-20 Days)||8
916379|NCT01606189|2215386|P1|STARTED|First Intenvention (14-20 Days)||8
916380|NCT01606176|2215420|P2|NOT COMPLETED|Overall Study||3
916381|NCT01606176|2215421|P1|NOT COMPLETED|Overall Study||4
916382|NCT01606176|2215420|P2|COMPLETED|Overall Study||31
916383|NCT01606176|2215421|P1|COMPLETED|Overall Study||32
916384|NCT01606176|2215420|P2|STARTED|Overall Study||34
916385|NCT01606176|2215421|P1|STARTED|Overall Study||36
916386|NCT01606150|2215457|P2|NOT COMPLETED|Overall Study||0
916387|NCT01606150|2215458|P1|NOT COMPLETED|Overall Study||0
916388|NCT01606150|2215457|P2|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
916389|NCT01606150|2215458|P1|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
916390|NCT01606150|2215457|P2|STARTED|Overall Study||0
916391|NCT01606150|2215458|P1|STARTED|Overall Study||0
916392|NCT01606137|2215466|P1|NOT COMPLETED|Overall Study||262
916393|NCT01606137|2215466|P1|COMPLETED|Overall Study||245
916394|NCT01606137|2215466|P1|STARTED|Overall Study||507
916401|NCT01606007|2215500|P3|NOT COMPLETED|Overall Study||10
916402|NCT01606007|2215501|P2|NOT COMPLETED|Overall Study||19
916403|NCT01606007|2215502|P1|NOT COMPLETED|Overall Study||15
916404|NCT01606007|2215500|P3|COMPLETED|Overall Study||169
916405|NCT01606007|2215501|P2|COMPLETED|Overall Study||160
916406|NCT01606007|2215502|P1|COMPLETED|Overall Study||161
916407|NCT01606007|2215500|P3|STARTED|Overall Study||179
916408|NCT01606007|2215501|P2|STARTED|Overall Study||179
916409|NCT01606007|2215502|P1|STARTED|Overall Study||176
916410|NCT01605942|2215524|P2|NOT COMPLETED|Overall Study||0
916411|NCT01605942|2215525|P1|NOT COMPLETED|Overall Study||0
916412|NCT01605942|2215524|P2|COMPLETED|Overall Study||2
916413|NCT01605942|2215525|P1|COMPLETED|Overall Study||6
916414|NCT01605942|2215524|P2|STARTED|Overall Study||2
916415|NCT01605942|2215525|P1|STARTED|Overall Study||6
916416|NCT01605916|2215537|P5|NOT COMPLETED|Overall Study||6
916417|NCT01605916|2215538|P4|NOT COMPLETED|Overall Study||6
916418|NCT01605916|2215539|P3|NOT COMPLETED|Overall Study||3
916419|NCT01605916|2215540|P2|NOT COMPLETED|Overall Study||4
916420|NCT01605916|2215541|P1|NOT COMPLETED|Overall Study||4
916421|NCT01605916|2215537|P5|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
916422|NCT01605916|2215538|P4|COMPLETED|Overall Study||0
916423|NCT01605916|2215539|P3|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
916424|NCT01605916|2215540|P2|COMPLETED|Overall Study||0
916425|NCT01605916|2215541|P1|COMPLETED|Overall Study||0
916426|NCT01605916|2215537|P5|STARTED|Overall Study||7
916427|NCT01605916|2215538|P4|STARTED|Overall Study||6
916428|NCT01605916|2215539|P3|STARTED|Overall Study||4
916429|NCT01605916|2215540|P2|STARTED|Overall Study||4
916430|NCT01605916|2215541|P1|STARTED|Overall Study||4
916431|NCT01605877|2215614|P1|NOT COMPLETED|Overall Study||1
916432|NCT01605877|2215614|P1|COMPLETED|Overall Study||63
916433|NCT01605877|2215614|P1|STARTED|Overall Study||64
916434|NCT01605825|2215678|P2|NOT COMPLETED|Overall Study||3
916435|NCT01605825|2215679|P1|NOT COMPLETED|Overall Study||10
916436|NCT01605825|2215678|P2|COMPLETED|Overall Study||25
916437|NCT01605825|2215679|P1|COMPLETED|Overall Study||45
916438|NCT01605825|2215678|P2|STARTED|Overall Study||28
916439|NCT01605825|2215679|P1|STARTED|Overall Study||55
916440|NCT01605799|2215687|P2|NOT COMPLETED|Overall Study||1
916441|NCT01605799|2215688|P1|NOT COMPLETED|Overall Study||2
916442|NCT01605799|2215687|P2|COMPLETED|Overall Study||15
916443|NCT01605799|2215688|P1|COMPLETED|Overall Study||15
916444|NCT01605799|2215687|P2|STARTED|Overall Study||16
916445|NCT01605799|2215688|P1|STARTED|Overall Study||17
916446|NCT01605669|2215696|P1|NOT COMPLETED|Overall Study||0
916447|NCT01605669|2215696|P1|COMPLETED|Overall Study||50
916448|NCT01605669|2215696|P1|STARTED|Overall Study||50
916449|NCT01605617|2215703|P2|NOT COMPLETED|Second Intervention||0
916450|NCT01605617|2215704|P1|NOT COMPLETED|Second Intervention||0
916451|NCT01605617|2215703|P2|COMPLETED|Second Intervention||0
916452|NCT01605617|2215704|P1|COMPLETED|Second Intervention||0
916453|NCT01605617|2215703|P2|STARTED|Second Intervention||0
916454|NCT01605617|2215704|P1|STARTED|Second Intervention||0
916455|NCT01605617|2215703|P2|NOT COMPLETED|Washout Period of 4 Weeks||1
916456|NCT01605617|2215704|P1|NOT COMPLETED|Washout Period of 4 Weeks||2
916457|NCT01605617|2215703|P2|COMPLETED|Washout Period of 4 Weeks||0
916458|NCT01605617|2215704|P1|COMPLETED|Washout Period of 4 Weeks||0
916459|NCT01605617|2215703|P2|STARTED|Washout Period of 4 Weeks||1
916460|NCT01605617|2215704|P1|STARTED|Washout Period of 4 Weeks||2
916461|NCT01605617|2215703|P2|NOT COMPLETED|First Intervention||1
916462|NCT01605617|2215704|P1|NOT COMPLETED|First Intervention||0
916463|NCT01605617|2215703|P2|COMPLETED|First Intervention||1
916464|NCT01605617|2215704|P1|COMPLETED|First Intervention||2
916465|NCT01605617|2215703|P2|STARTED|First Intervention||2
916466|NCT01605617|2215704|P1|STARTED|First Intervention||2
916467|NCT01605552|2215724|P2|NOT COMPLETED|Overall Study||2
916468|NCT01605552|2215725|P1|NOT COMPLETED|Overall Study||6
916469|NCT01605552|2215724|P2|COMPLETED|Overall Study||14
916470|NCT01605552|2215725|P1|COMPLETED|Overall Study|4 dropped out before the first BtB visit; it is unlikely that the treatment was the cause of dropout|7
916471|NCT01605552|2215724|P2|STARTED|Overall Study||16
916472|NCT01605552|2215725|P1|STARTED|Overall Study||13
916473|NCT01605539|2215739|P3|NOT COMPLETED|Overall Study||0
916474|NCT01605539|2215740|P2|NOT COMPLETED|Overall Study||1
916475|NCT01605539|2215741|P1|NOT COMPLETED|Overall Study||0
916476|NCT01605539|2215739|P3|COMPLETED|Overall Study||4
916477|NCT01605539|2215740|P2|COMPLETED|Overall Study||2
916478|NCT01605539|2215741|P1|COMPLETED|Overall Study||3
916479|NCT01605539|2215739|P3|STARTED|Overall Study||4
916480|NCT01605539|2215740|P2|STARTED|Overall Study||3
916481|NCT01605539|2215741|P1|STARTED|Overall Study||3
916482|NCT01605461|2215763|P1|NOT COMPLETED|Overall Study||4
916483|NCT01605461|2215763|P1|COMPLETED|Overall Study||8
916484|NCT01605461|2215763|P1|STARTED|Overall Study||12
916485|NCT01605370|2215774|P2|NOT COMPLETED|Overall Study||0
916486|NCT01605370|2215775|P1|NOT COMPLETED|Overall Study||1
916487|NCT01605370|2215774|P2|COMPLETED|Overall Study||0
916488|NCT01605370|2215775|P1|COMPLETED|Overall Study||0
916489|NCT01605370|2215774|P2|STARTED|Overall Study||0
916490|NCT01605370|2215775|P1|STARTED|Overall Study||1
916491|NCT01605292|2215783|P2|NOT COMPLETED|Overall Study||0
916492|NCT01605292|2215784|P1|NOT COMPLETED|Overall Study||0
916493|NCT01605292|2215783|P2|COMPLETED|Overall Study||347
916494|NCT01605292|2215784|P1|COMPLETED|Overall Study||351
916495|NCT01605292|2215783|P2|STARTED|Overall Study||347
916496|NCT01605292|2215784|P1|STARTED|Overall Study||351
916497|NCT01604941|2215810|P6|NOT COMPLETED|Overall Study||7
916498|NCT01604941|2215811|P5|NOT COMPLETED|Overall Study||1
916499|NCT01604941|2215812|P4|NOT COMPLETED|Overall Study||3
916500|NCT01604941|2215813|P3|NOT COMPLETED|Overall Study||3
916501|NCT01604941|2215814|P2|NOT COMPLETED|Overall Study||4
916502|NCT01604941|2215815|P1|NOT COMPLETED|Overall Study||11
916503|NCT01604941|2215810|P6|COMPLETED|Overall Study||0
916504|NCT01604941|2215811|P5|COMPLETED|Overall Study||3
916505|NCT01604941|2215812|P4|COMPLETED|Overall Study||0
916506|NCT01604941|2215813|P3|COMPLETED|Overall Study||0
916507|NCT01604941|2215814|P2|COMPLETED|Overall Study||0
916508|NCT01604941|2215815|P1|COMPLETED|Overall Study||0
916509|NCT01604941|2215810|P6|STARTED|Overall Study||7
916510|NCT01604941|2215811|P5|STARTED|Overall Study||4
916511|NCT01604941|2215812|P4|STARTED|Overall Study||3
916512|NCT01604941|2215813|P3|STARTED|Overall Study||3
916513|NCT01604941|2215814|P2|STARTED|Overall Study||4
916514|NCT01604941|2215815|P1|STARTED|Overall Study||11
916515|NCT01604850|2215843|P2|NOT COMPLETED|Overall Study||30
916516|NCT01604850|2215844|P1|NOT COMPLETED|Overall Study||52
916517|NCT01604850|2215843|P2|COMPLETED|Overall Study||69
916518|NCT01604850|2215844|P1|COMPLETED|Overall Study||51
916519|NCT01604850|2215843|P2|Enrolled and Treated|Overall Study||98
916520|NCT01604850|2215844|P1|Enrolled and Treated|Overall Study||103
916521|NCT01604850|2215843|P2|STARTED|Overall Study||99
916522|NCT01604850|2215844|P1|STARTED|Overall Study||103
916523|NCT01604772|2215860|P1|NOT COMPLETED|Overall Study||0
916524|NCT01604772|2215860|P1|COMPLETED|Overall Study||16
916525|NCT01604772|2215860|P1|STARTED|Overall Study||16
916526|NCT01604278|2215868|P2|NOT COMPLETED|Overall Study||13
916527|NCT01604278|2215869|P1|NOT COMPLETED|Overall Study||14
916528|NCT01604278|2215868|P2|COMPLETED|Overall Study||210
916529|NCT01604278|2215869|P1|COMPLETED|Overall Study||212
916530|NCT01604278|2215868|P2|Full Analysis Set|Overall Study|Three randomized participants excluded: 2 who did not receive study drug; 1 with a major deviation.|220
916531|NCT01604278|2215869|P1|Full Analysis Set|Overall Study||226
916532|NCT01604278|2215868|P2|Safety Set|Overall Study|Two randomized participants who did not receive study drug were excluded from this set.|221
916533|NCT01604278|2215869|P1|Safety Set|Overall Study||226
916534|NCT01604278|2215868|P2|STARTED|Overall Study||223
916535|NCT01604278|2215869|P1|STARTED|Overall Study||226
916536|NCT01604265|2215895|P2|NOT COMPLETED|Overall Study||0
916537|NCT01604265|2215896|P1|NOT COMPLETED|Overall Study||2
916538|NCT01604265|2215895|P2|COMPLETED|Overall Study||32
916539|NCT01604265|2215896|P1|COMPLETED|Overall Study||32
916540|NCT01604265|2215895|P2|STARTED|Overall Study||32
916541|NCT01604265|2215896|P1|STARTED|Overall Study||34
916542|NCT01604122|2215932|P2|NOT COMPLETED|Overall Study||0
916543|NCT01604122|2215933|P1|NOT COMPLETED|Overall Study||0
916544|NCT01604122|2215932|P2|COMPLETED|Overall Study||32
916545|NCT01604122|2215933|P1|COMPLETED|Overall Study||60
916546|NCT01604122|2215932|P2|STARTED|Overall Study||32
916547|NCT01604122|2215933|P1|STARTED|Overall Study||60
916548|NCT01604109|2215980|P2|NOT COMPLETED|Overall Study||34
916549|NCT01604109|2215981|P1|NOT COMPLETED|Overall Study||33
916550|NCT01604109|2215980|P2|COMPLETED|Overall Study||112
916551|NCT01604109|2215981|P1|COMPLETED|Overall Study||117
916552|NCT01604109|2215980|P2|STARTED|Overall Study||146
916553|NCT01604109|2215981|P1|STARTED|Overall Study||150
916554|NCT01603940|2215989|P2|NOT COMPLETED|Overall Study||0
916555|NCT01603940|2215990|P1|NOT COMPLETED|Overall Study||0
916556|NCT01603940|2215989|P2|COMPLETED|Overall Study||14
916557|NCT01603940|2215990|P1|COMPLETED|Overall Study||16
916558|NCT01603940|2215989|P2|STARTED|Overall Study||14
916559|NCT01603940|2215990|P1|STARTED|Overall Study||16
916560|NCT01603875|2216007|P3|NOT COMPLETED|Overall Study||9
916561|NCT01603875|2216008|P2|NOT COMPLETED|Overall Study||8
916562|NCT01603875|2216009|P1|NOT COMPLETED|Overall Study||7
916563|NCT01603875|2216007|P3|COMPLETED|Overall Study||26
916564|NCT01603875|2216008|P2|COMPLETED|Overall Study||27
916565|NCT01603875|2216009|P1|COMPLETED|Overall Study||28
916566|NCT01603875|2216007|P3|STARTED|Overall Study||35
916567|NCT01603875|2216008|P2|STARTED|Overall Study||35
916568|NCT01603875|2216009|P1|STARTED|Overall Study||35
916569|NCT01603459|2216029|P1|NOT COMPLETED|Overall Study||18
916570|NCT01603459|2216029|P1|COMPLETED|Overall Study||137
916571|NCT01603459|2216029|P1|STARTED|Overall Study||155
916572|NCT01603420|2216151|P2|NOT COMPLETED|Overall Study||0
916573|NCT01603420|2216152|P1|NOT COMPLETED|Overall Study||0
916574|NCT01603420|2216151|P2|COMPLETED|Overall Study||1
916575|NCT01603420|2216152|P1|COMPLETED|Overall Study||1
916576|NCT01603420|2216151|P2|STARTED|Overall Study||1
916577|NCT01603420|2216152|P1|STARTED|Overall Study||1
916578|NCT01603394|2216180|P1|NOT COMPLETED|Overall Study||1
916579|NCT01603394|2216180|P1|COMPLETED|Overall Study||8
916580|NCT01603394|2216180|P1|STARTED|Overall Study||9
916581|NCT01603277|2216197|P2|NOT COMPLETED|Overall Study||18
916582|NCT01603277|2216198|P1|NOT COMPLETED|Overall Study||14
916583|NCT01603277|2216197|P2|COMPLETED|Overall Study||64
916584|NCT01603277|2216198|P1|COMPLETED|Overall Study||64
916585|NCT01603277|2216197|P2|STARTED|Overall Study||82
916586|NCT01603277|2216198|P1|STARTED|Overall Study||78
916587|NCT01603121|2216204|P2|NOT COMPLETED|Second Intervention, 10 Hours||0
916588|NCT01603121|2216205|P1|NOT COMPLETED|Second Intervention, 10 Hours||1
916589|NCT01603121|2216204|P2|COMPLETED|Second Intervention, 10 Hours||0
916590|NCT01603121|2216205|P1|COMPLETED|Second Intervention, 10 Hours||0
916591|NCT01603121|2216204|P2|STARTED|Second Intervention, 10 Hours||0
916592|NCT01603121|2216205|P1|STARTED|Second Intervention, 10 Hours||1
916593|NCT01603121|2216204|P2|NOT COMPLETED|First Intervention, 10 Hours||0
916594|NCT01603121|2216205|P1|NOT COMPLETED|First Intervention, 10 Hours||0
916595|NCT01603121|2216204|P2|COMPLETED|First Intervention, 10 Hours||0
916596|NCT01603121|2216205|P1|COMPLETED|First Intervention, 10 Hours||1
916597|NCT01603121|2216204|P2|STARTED|First Intervention, 10 Hours||0
916598|NCT01603121|2216205|P1|STARTED|First Intervention, 10 Hours||1
916599|NCT01603082|2216217|P2|NOT COMPLETED|Overall Study||1
916600|NCT01603082|2216218|P1|NOT COMPLETED|Overall Study||2
916601|NCT01603082|2216217|P2|COMPLETED|Overall Study|Completed the study|48
916602|NCT01603082|2216218|P1|COMPLETED|Overall Study|Completed the study.|49
916603|NCT01603082|2216217|P2|STARTED|Overall Study|Randomized|49
916604|NCT01603082|2216218|P1|STARTED|Overall Study|Randomized|51
916605|NCT01603056|2216228|P2|NOT COMPLETED|Overall Study||14
916606|NCT01603056|2216229|P1|NOT COMPLETED|Overall Study||34
916607|NCT01603056|2216228|P2|COMPLETED|Overall Study||190
916608|NCT01603056|2216229|P1|COMPLETED|Overall Study||379
916609|NCT01603056|2216228|P2|STARTED|Overall Study||204
916610|NCT01603056|2216229|P1|STARTED|Overall Study||413
916611|NCT01603043|2216259|P2|NOT COMPLETED|Overall Study||3
916612|NCT01603043|2216260|P1|NOT COMPLETED|Overall Study||7
916613|NCT01603043|2216259|P2|COMPLETED|Overall Study||0
916614|NCT01603043|2216260|P1|COMPLETED|Overall Study||0
916615|NCT01603043|2216259|P2|STARTED|Overall Study||3
916616|NCT01603043|2216260|P1|STARTED|Overall Study||7
916617|NCT01602965|2216272|P2|NOT COMPLETED|Overall Study||2
916618|NCT01602965|2216273|P1|NOT COMPLETED|Overall Study||4
916619|NCT01602965|2216272|P2|COMPLETED|Overall Study||18
916620|NCT01602965|2216273|P1|COMPLETED|Overall Study||16
916621|NCT01602965|2216272|P2|STARTED|Overall Study||20
916622|NCT01602965|2216273|P1|STARTED|Overall Study||20
916623|NCT01602744|2216281|P2|NOT COMPLETED|Overall Study||23
916624|NCT01602744|2216282|P1|NOT COMPLETED|Overall Study||30
916625|NCT01602744|2216281|P2|COMPLETED|Overall Study||160
916626|NCT01602744|2216282|P1|COMPLETED|Overall Study||146
916627|NCT01602744|2216281|P2|STARTED|Overall Study||183
916628|NCT01602744|2216282|P1|STARTED|Overall Study||176
916629|NCT01602731|2216298|P1|NOT COMPLETED|Overall Study||30
916630|NCT01602731|2216298|P1|COMPLETED|Overall Study||15
916631|NCT01602731|2216298|P1|Poor Medication Adherence|Overall Study|24 out of 35 patients who completed 1-month pill counts had medication adherence <88%.|24
916632|NCT01602731|2216298|P1|Cognitive Impairment|Overall Study|After repeat cognitive testing, additional 1 patient had no cognitive impairment and did not proceed|44
916633|NCT01602731|2216298|P1|STARTED|Overall Study||45
916634|NCT01602562|2216306|P2|NOT COMPLETED|Overall Study||3
916635|NCT01602562|2216307|P1|NOT COMPLETED|Overall Study||5
916636|NCT01602562|2216306|P2|COMPLETED|Overall Study||16
916637|NCT01602562|2216307|P1|COMPLETED|Overall Study||16
916638|NCT01602562|2216306|P2|STARTED|Overall Study||19
916639|NCT01602562|2216307|P1|STARTED|Overall Study||21
916640|NCT01602549|2216343|P2|NOT COMPLETED|Overall Study||1
916641|NCT01602549|2216344|P1|NOT COMPLETED|Overall Study||1
916642|NCT01602549|2216343|P2|COMPLETED|Overall Study||37
916643|NCT01602549|2216344|P1|COMPLETED|Overall Study||18
916644|NCT01602549|2216343|P2|STARTED|Overall Study||38
916645|NCT01602549|2216344|P1|STARTED|Overall Study||19
916646|NCT01602510|2216423|P3|NOT COMPLETED|Randomized Phase||73
916647|NCT01602510|2216424|P2|NOT COMPLETED|Randomized Phase||74
916648|NCT01602510|2216425|P1|NOT COMPLETED|Randomized Phase||0
916649|NCT01602510|2216423|P3|COMPLETED|Randomized Phase||58
916650|NCT01602510|2216424|P2|COMPLETED|Randomized Phase||59
916651|NCT01602510|2216425|P1|COMPLETED|Randomized Phase||0
916652|NCT01602510|2216423|P3|STARTED|Randomized Phase||131
916653|NCT01602510|2216424|P2|STARTED|Randomized Phase||133
916654|NCT01602510|2216425|P1|STARTED|Randomized Phase||0
916655|NCT01602510|2216423|P3|NOT COMPLETED|Open Label Phase||0
916656|NCT01602510|2216424|P2|NOT COMPLETED|Open Label Phase||0
916657|NCT01602510|2216425|P1|NOT COMPLETED|Open Label Phase||303
916658|NCT01602510|2216423|P3|COMPLETED|Open Label Phase||0
916659|NCT01602510|2216424|P2|COMPLETED|Open Label Phase||0
916660|NCT01602510|2216425|P1|COMPLETED|Open Label Phase||117
916661|NCT01602510|2216423|P3|STARTED|Open Label Phase||0
916662|NCT01602510|2216424|P2|STARTED|Open Label Phase||0
916663|NCT01602510|2216425|P1|STARTED|Open Label Phase||420
916664|NCT01602484|2216451|P2|NOT COMPLETED|Overall Study||1
916665|NCT01602484|2216452|P1|NOT COMPLETED|Overall Study||0
916666|NCT01602484|2216451|P2|COMPLETED|Overall Study||24
916667|NCT01602484|2216452|P1|COMPLETED|Overall Study||25
916668|NCT01602484|2216451|P2|STARTED|Overall Study||25
916669|NCT01602484|2216452|P1|STARTED|Overall Study||25
916670|NCT01602471|2216464|P1|NOT COMPLETED|Overall Study||0
916671|NCT01602471|2216464|P1|COMPLETED|Overall Study||4
916672|NCT01602471|2216464|P1|STARTED|Overall Study||4
916673|NCT01602380|2216470|P2|NOT COMPLETED|Overall Study||101
916674|NCT01602380|2216471|P1|NOT COMPLETED|Overall Study||93
916675|NCT01602380|2216470|P2|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|131
916676|NCT01602380|2216471|P1|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|137
916677|NCT01602380|2216470|P2|STARTED|Overall Study||232
916678|NCT01602380|2216471|P1|STARTED|Overall Study||230
916679|NCT01602341|2216495|P2|NOT COMPLETED|Overall Study||1
916680|NCT01602341|2216496|P1|NOT COMPLETED|Overall Study||0
916681|NCT01602341|2216495|P2|COMPLETED|Overall Study||41
916682|NCT01602341|2216496|P1|COMPLETED|Overall Study||44
916683|NCT01602341|2216495|P2|STARTED|Overall Study||42
916684|NCT01602341|2216496|P1|STARTED|Overall Study||44
916685|NCT01602198|2216532|P2|NOT COMPLETED|Overall Study||0
916686|NCT01602198|2216533|P1|NOT COMPLETED|Overall Study||0
916687|NCT01602198|2216532|P2|COMPLETED|Overall Study||1
916688|NCT01602198|2216533|P1|COMPLETED|Overall Study||0
916689|NCT01602198|2216532|P2|STARTED|Overall Study||1
916690|NCT01602198|2216533|P1|STARTED|Overall Study||0
916694|NCT01601977|2216543|P1|NOT COMPLETED|Overall Study||0
916695|NCT01601977|2216543|P1|COMPLETED|Overall Study||10
916696|NCT01601977|2216543|P1|STARTED|Overall Study|5 patients consented for study participation but did not attend for study assessments.|10
916697|NCT01601821|2216563|P2|NOT COMPLETED|Overall Study||29
916698|NCT01601821|2216564|P1|NOT COMPLETED|Overall Study||29
916699|NCT01601821|2216563|P2|COMPLETED|Overall Study||91
916700|NCT01601821|2216564|P1|COMPLETED|Overall Study||96
916701|NCT01601821|2216563|P2|STARTED|Overall Study||120
916702|NCT01601821|2216564|P1|STARTED|Overall Study||125
916703|NCT01601782|2216594|P1|NOT COMPLETED|Overall Study||0
916704|NCT01601782|2216594|P1|COMPLETED|Overall Study||16
916705|NCT01601782|2216594|P1|STARTED|Overall Study||16
916706|NCT01601704|2216600|P2|NOT COMPLETED|Overall Study||4
916707|NCT01601704|2216601|P1|NOT COMPLETED|Overall Study||1
916708|NCT01601704|2216600|P2|COMPLETED|Overall Study||4450
916709|NCT01601704|2216601|P1|COMPLETED|Overall Study||4455
916710|NCT01601704|2216600|P2|Treated|Overall Study||4450
916711|NCT01601704|2216601|P1|Treated|Overall Study||4455
916712|NCT01601704|2216600|P2|STARTED|Overall Study||4454
916713|NCT01601704|2216601|P1|STARTED|Overall Study||4456
916714|NCT01601691|2216615|P1|NOT COMPLETED|Overall Study||0
916715|NCT01601691|2216615|P1|COMPLETED|Overall Study||10
916716|NCT01601691|2216615|P1|STARTED|Overall Study||10
916717|NCT01601470|2216619|P1|NOT COMPLETED|Period 3 - LCZ696+Sildenafil||0
916718|NCT01601470|2216619|P1|COMPLETED|Period 3 - LCZ696+Sildenafil||27
916719|NCT01601470|2216619|P1|Safety Set|Period 3 - LCZ696+Sildenafil||27
916720|NCT01601470|2216619|P1|PK Analysis Set|Period 3 - LCZ696+Sildenafil||27
916721|NCT01601470|2216619|P1|STARTED|Period 3 - LCZ696+Sildenafil||27
916722|NCT01601470|2216619|P1|NOT COMPLETED|Period 2 - LCZ696||1
916723|NCT01601470|2216619|P1|COMPLETED|Period 2 - LCZ696||27
916724|NCT01601470|2216619|P1|Safety Set|Period 2 - LCZ696||27
916725|NCT01601470|2216619|P1|PK Analysis Set|Period 2 - LCZ696||27
916726|NCT01601470|2216619|P1|STARTED|Period 2 - LCZ696||28
916727|NCT01601470|2216619|P1|NOT COMPLETED|Period 1 - Sildenafil||0
916728|NCT01601470|2216619|P1|COMPLETED|Period 1 - Sildenafil||28
916729|NCT01601470|2216619|P1|Safety Set|Period 1 - Sildenafil||28
916730|NCT01601470|2216619|P1|PK Analysis Set|Period 1 - Sildenafil||28
916731|NCT01601470|2216619|P1|STARTED|Period 1 - Sildenafil||28
916732|NCT01601236|2216640|P6|NOT COMPLETED|Overall Study||1
916733|NCT01601236|2216641|P5|NOT COMPLETED|Overall Study||3
916734|NCT01601236|2216642|P4|NOT COMPLETED|Overall Study||2
916735|NCT01601236|2216643|P3|NOT COMPLETED|Overall Study||6
916736|NCT01601236|2216644|P2|NOT COMPLETED|Overall Study||1
916737|NCT01601236|2216645|P1|NOT COMPLETED|Overall Study||5
916738|NCT01601236|2216640|P6|COMPLETED|Overall Study||0
916739|NCT01601236|2216641|P5|COMPLETED|Overall Study||0
916740|NCT01601236|2216642|P4|COMPLETED|Overall Study||4
916741|NCT01601236|2216643|P3|COMPLETED|Overall Study||8
916742|NCT01601236|2216644|P2|COMPLETED|Overall Study||2
916743|NCT01601236|2216645|P1|COMPLETED|Overall Study||2
916744|NCT01601236|2216640|P6|STARTED|Overall Study||1
916745|NCT01601236|2216641|P5|STARTED|Overall Study||3
916746|NCT01601236|2216642|P4|STARTED|Overall Study||6
916747|NCT01601236|2216643|P3|STARTED|Overall Study||14
916748|NCT01601236|2216644|P2|STARTED|Overall Study||3
916749|NCT01601236|2216645|P1|STARTED|Overall Study||7
916750|NCT01601132|2216681|P1|NOT COMPLETED|Overall Study||2
916751|NCT01601132|2216681|P1|COMPLETED|Overall Study||28
916752|NCT01601132|2216681|P1|STARTED|Overall Study||30
916753|NCT01600950|2216698|P2|NOT COMPLETED|Period 2||0
916754|NCT01600950|2216699|P1|NOT COMPLETED|Period 2||0
916755|NCT01600950|2216698|P2|COMPLETED|Period 2||10
916756|NCT01600950|2216699|P1|COMPLETED|Period 2||10
916757|NCT01600950|2216698|P2|STARTED|Period 2||10
916758|NCT01600950|2216699|P1|STARTED|Period 2||10
916759|NCT01600950|2216698|P2|NOT COMPLETED|Period 1||0
916760|NCT01600950|2216699|P1|NOT COMPLETED|Period 1||0
916761|NCT01600950|2216698|P2|COMPLETED|Period 1||10
916762|NCT01600950|2216699|P1|COMPLETED|Period 1||10
916763|NCT01600950|2216698|P2|STARTED|Period 1||10
916764|NCT01600950|2216699|P1|STARTED|Period 1||10
916765|NCT01600885|2216715|P2|NOT COMPLETED|Second Period||0
916766|NCT01600885|2216716|P1|NOT COMPLETED|Second Period||0
916767|NCT01600885|2216715|P2|COMPLETED|Second Period||8
916768|NCT01600885|2216716|P1|COMPLETED|Second Period||8
916769|NCT01600885|2216715|P2|STARTED|Second Period||8
916770|NCT01600885|2216716|P1|STARTED|Second Period||8
916771|NCT01600885|2216715|P2|NOT COMPLETED|Wash Out Period||0
916772|NCT01600885|2216716|P1|NOT COMPLETED|Wash Out Period||0
916773|NCT01600885|2216715|P2|COMPLETED|Wash Out Period||8
916774|NCT01600885|2216716|P1|COMPLETED|Wash Out Period||8
916775|NCT01600885|2216715|P2|STARTED|Wash Out Period||8
916776|NCT01600885|2216716|P1|STARTED|Wash Out Period||8
916777|NCT01600885|2216715|P2|NOT COMPLETED|First Period||1
916778|NCT01600885|2216716|P1|NOT COMPLETED|First Period||2
916779|NCT01600885|2216715|P2|COMPLETED|First Period||8
916780|NCT01600885|2216716|P1|COMPLETED|First Period||8
916781|NCT01600885|2216715|P2|STARTED|First Period||9
916782|NCT01600885|2216716|P1|STARTED|First Period||10
916783|NCT01600729|2216726|P1|NOT COMPLETED|Overall Study||1
916784|NCT01600729|2216726|P1|COMPLETED|Overall Study||65
916785|NCT01600729|2216726|P1|STARTED|Overall Study||66
916792|NCT01600703|2216750|P2|NOT COMPLETED|Second Intervention||0
916793|NCT01600703|2216751|P1|NOT COMPLETED|Second Intervention||0
916794|NCT01600703|2216750|P2|COMPLETED|Second Intervention||8
916795|NCT01600703|2216751|P1|COMPLETED|Second Intervention||7
916796|NCT01600703|2216750|P2|STARTED|Second Intervention||8
916797|NCT01600703|2216751|P1|STARTED|Second Intervention||7
916798|NCT01600703|2216750|P2|NOT COMPLETED|First Intervention||0
916799|NCT01600703|2216751|P1|NOT COMPLETED|First Intervention||0
916800|NCT01600703|2216750|P2|COMPLETED|First Intervention||8
916801|NCT01600703|2216751|P1|COMPLETED|First Intervention||7
916802|NCT01600703|2216750|P2|STARTED|First Intervention||8
916803|NCT01600703|2216751|P1|STARTED|First Intervention||7
916804|NCT01600677|2216761|P2|NOT COMPLETED|Overall Study||0
916805|NCT01600677|2216762|P1|NOT COMPLETED|Overall Study||0
916806|NCT01600677|2216761|P2|COMPLETED|Overall Study||4
916807|NCT01600677|2216762|P1|COMPLETED|Overall Study||7
916808|NCT01600677|2216761|P2|STARTED|Overall Study||4
916809|NCT01600677|2216762|P1|STARTED|Overall Study||7
916810|NCT01600495|2216774|P2|NOT COMPLETED|Overall Study||0
916811|NCT01600495|2216775|P1|NOT COMPLETED|Overall Study||0
916812|NCT01600495|2216774|P2|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
916813|NCT01600495|2216775|P1|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
916814|NCT01600495|2216774|P2|STARTED|Overall Study|We start with the prediction of collecting 20 control patients|23
916815|NCT01600495|2216775|P1|STARTED|Overall Study|We start with the prediction of collecting 20 patients in the treated group|23
916816|NCT01600482|2216789|P2|NOT COMPLETED|Overall Study||0
916817|NCT01600482|2216790|P1|NOT COMPLETED|Overall Study||0
916818|NCT01600482|2216789|P2|COMPLETED|Overall Study||59
916819|NCT01600482|2216790|P1|COMPLETED|Overall Study|Last 26 patients allocated to CELT ACD|148
916820|NCT01600482|2216789|P2|STARTED|Overall Study|Last 26 patients allocated to CELT ACD|59
916821|NCT01600482|2216790|P1|STARTED|Overall Study||148
916822|NCT01600326|2216810|P2|NOT COMPLETED|Overall Study||1
916823|NCT01600326|2216811|P1|NOT COMPLETED|Overall Study||1
916824|NCT01600326|2216810|P2|COMPLETED|Overall Study||14
916825|NCT01600326|2216811|P1|COMPLETED|Overall Study||14
916826|NCT01600326|2216810|P2|Primary Outcome Measure Data Collection|Overall Study||15
916827|NCT01600326|2216811|P1|Primary Outcome Measure Data Collection|Overall Study||15
916828|NCT01600326|2216810|P2|STARTED|Overall Study||15
916829|NCT01600326|2216811|P1|STARTED|Overall Study||15
916830|NCT01600287|2216821|P2|NOT COMPLETED|Overall Study||0
916831|NCT01600287|2216822|P1|NOT COMPLETED|Overall Study||0
916832|NCT01600287|2216821|P2|COMPLETED|Overall Study||20
916833|NCT01600287|2216822|P1|COMPLETED|Overall Study||20
916834|NCT01600287|2216821|P2|STARTED|Overall Study||20
916835|NCT01600287|2216822|P1|STARTED|Overall Study||20
916836|NCT01600222|2216862|P1|NOT COMPLETED|Overall Study||2
916837|NCT01600222|2216862|P1|COMPLETED|Overall Study||35
916838|NCT01600222|2216862|P1|STARTED|Overall Study||37
916839|NCT01600092|2216887|P2|NOT COMPLETED|Overall Study||16
916840|NCT01600092|2216888|P1|NOT COMPLETED|Overall Study||18
916841|NCT01600092|2216887|P2|COMPLETED|Overall Study||491
916842|NCT01600092|2216888|P1|COMPLETED|Overall Study||495
916843|NCT01600092|2216887|P2|Received All 3 Vaccinations|Overall Study||494
916844|NCT01600092|2216888|P1|Received All 3 Vaccinations|Overall Study||500
916845|NCT01600092|2216887|P2|Received at Least 1 Vaccination|Overall Study||504
916846|NCT01600092|2216888|P1|Received at Least 1 Vaccination|Overall Study|1 participant received RotaTeq™ existing formulation as their first vaccination|510
916847|NCT01600092|2216887|P2|STARTED|Overall Study||507
916848|NCT01600092|2216888|P1|STARTED|Overall Study||513
916849|NCT01600053|2216902|P1|NOT COMPLETED|Overall Study||11
916850|NCT01600053|2216902|P1|COMPLETED|Overall Study||0
916851|NCT01600053|2216902|P1|STARTED|Overall Study||11
916852|NCT01600014|2216907|P2|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||0
916853|NCT01600014|2216908|P1|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||3
916854|NCT01600014|2216907|P2|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||20
916855|NCT01600014|2216908|P1|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||39
916856|NCT01600014|2216907|P2|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||20
916857|NCT01600014|2216908|P1|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||42
916858|NCT01600014|2216907|P2|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||10
916859|NCT01600014|2216908|P1|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||12
916860|NCT01600014|2216907|P2|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||39
916861|NCT01600014|2216908|P1|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||80
916862|NCT01600014|2216907|P2|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||49
916863|NCT01600014|2216908|P1|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||92
916864|NCT01600014|2216907|P2|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||0
916865|NCT01600014|2216908|P1|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||288
916866|NCT01600014|2216907|P2|COMPLETED|1. Cycle & Observation Period D1 to W52||0
916867|NCT01600014|2216908|P1|COMPLETED|1. Cycle & Observation Period D1 to W52||162
916868|NCT01600014|2216907|P2|STARTED|1. Cycle & Observation Period D1 to W52||0
916869|NCT01600014|2216908|P1|STARTED|1. Cycle & Observation Period D1 to W52|Subjects completing W52 without having been administered a 2nd cycle are counted as completers.|450
916870|NCT01599832|2216926|P1|NOT COMPLETED|Overall Study||0
916871|NCT01599832|2216926|P1|COMPLETED|Overall Study||20
916872|NCT01599832|2216926|P1|STARTED|Overall Study||20
916873|NCT01599806|2216936|P2|NOT COMPLETED|Overall Study||41
916874|NCT01599806|2216937|P1|NOT COMPLETED|Overall Study||43
916875|NCT01599806|2216936|P2|COMPLETED|Overall Study||476
916876|NCT01599806|2216937|P1|COMPLETED|Overall Study||473
916877|NCT01599806|2216936|P2|STARTED|Overall Study||517
916878|NCT01599806|2216937|P1|STARTED|Overall Study||516
916879|NCT01599741|2217061|P1|NOT COMPLETED|Overall Study||3
916880|NCT01599741|2217061|P1|COMPLETED|Overall Study||48
916881|NCT01599741|2217061|P1|Collected Dose and Image Information|Overall Study||48
916882|NCT01599741|2217061|P1|STARTED|Overall Study||51
916883|NCT01599650|2217070|P3|NOT COMPLETED|Overall Study||27
916884|NCT01599650|2217071|P2|NOT COMPLETED|Overall Study||26
916885|NCT01599650|2217072|P1|NOT COMPLETED|Overall Study||22
916886|NCT01599650|2217070|P3|COMPLETED|Overall Study||65
916887|NCT01599650|2217071|P2|COMPLETED|Overall Study||154
916888|NCT01599650|2217072|P1|COMPLETED|Overall Study||161
916889|NCT01599650|2217070|P3|Completed 6 Mos|Overall Study||80
916890|NCT01599650|2217071|P2|Completed 6 Mos|Overall Study||170
916891|NCT01599650|2217072|P1|Completed 6 Mos|Overall Study||174
916892|NCT01599650|2217070|P3|STARTED|Overall Study||92
916893|NCT01599650|2217071|P2|STARTED|Overall Study||180
916894|NCT01599650|2217072|P1|STARTED|Overall Study||183
916895|NCT01599637|2217111|P3|NOT COMPLETED|Overall Study||0
916896|NCT01599637|2217112|P2|NOT COMPLETED|Overall Study||2
916897|NCT01599637|2217113|P1|NOT COMPLETED|Overall Study||1
916898|NCT01599637|2217111|P3|COMPLETED|Overall Study||10
916899|NCT01599637|2217112|P2|COMPLETED|Overall Study||8
916900|NCT01599637|2217113|P1|COMPLETED|Overall Study||19
916901|NCT01599637|2217111|P3|STARTED|Overall Study||10
916902|NCT01599637|2217112|P2|STARTED|Overall Study||10
916903|NCT01599637|2217113|P1|STARTED|Overall Study|" started indicates randomized safety, pharmacodynamics and pharmocokinetics set"|20
916904|NCT01599585|2217160|P2|NOT COMPLETED|Overall Study||17
916905|NCT01599585|2217161|P1|NOT COMPLETED|Overall Study||22
916906|NCT01599585|2217160|P2|COMPLETED|Overall Study||42
916907|NCT01599585|2217161|P1|COMPLETED|Overall Study||40
916908|NCT01599585|2217160|P2|STARTED|Overall Study||59
916909|NCT01599585|2217161|P1|STARTED|Overall Study||62
916910|NCT01599325|2217199|P1|NOT COMPLETED|Overall Study||57
916911|NCT01599325|2217199|P1|COMPLETED|Overall Study|Participants still on study treatment at time of study closure|15
916912|NCT01599325|2217199|P1|Pharmacokinetic (PK) Population|Overall Study|Includes all participants with evaluable azacitidine plasma PK profiles.|12
916913|NCT01599325|2217199|P1|Intent to Treat (ITT) Population|Overall Study|Includes all participants who were enrolled into the study|72
916914|NCT01599325|2217199|P1|STARTED|Overall Study||72
916915|NCT01599234|2217221|P2|NOT COMPLETED|Overall Study||15
916916|NCT01599234|2217222|P1|NOT COMPLETED|Overall Study||17
916917|NCT01599234|2217221|P2|COMPLETED|Overall Study||155
916918|NCT01599234|2217222|P1|COMPLETED|Overall Study||150
916919|NCT01599234|2217221|P2|STARTED|Overall Study||170
916920|NCT01599234|2217222|P1|STARTED|Overall Study||167
916921|NCT01599104|2217247|P3|NOT COMPLETED|Overall Study||26
916922|NCT01599104|2217248|P2|NOT COMPLETED|Overall Study||14
916923|NCT01599104|2217249|P1|NOT COMPLETED|Overall Study||16
916924|NCT01599104|2217247|P3|COMPLETED|Overall Study||363
916925|NCT01599104|2217248|P2|COMPLETED|Overall Study||371
916926|NCT01599104|2217249|P1|COMPLETED|Overall Study||371
916927|NCT01599104|2217247|P3|STARTED|Overall Study||389
916928|NCT01599104|2217248|P2|STARTED|Overall Study||385
916929|NCT01599104|2217249|P1|STARTED|Overall Study||387
916930|NCT01598987|2217287|P1|NOT COMPLETED|Baseline to 24 Month||8
916931|NCT01598987|2217287|P1|COMPLETED|Baseline to 24 Month||48
916932|NCT01598987|2217287|P1|STARTED|Baseline to 24 Month||56
916933|NCT01598987|2217287|P1|NOT COMPLETED|Baseline to Month 12||6
916934|NCT01598987|2217287|P1|COMPLETED|Baseline to Month 12||50
916935|NCT01598987|2217287|P1|STARTED|Baseline to Month 12||56
916936|NCT01598779|2217321|P1|NOT COMPLETED|Overall Study||0
916937|NCT01598779|2217321|P1|COMPLETED|Overall Study||150
916938|NCT01598779|2217321|P1|STARTED|Overall Study||150
916939|NCT01598740|2217327|P2|NOT COMPLETED|Period 2||0
916940|NCT01598740|2217328|P1|NOT COMPLETED|Period 2||1
916941|NCT01598740|2217327|P2|COMPLETED|Period 2||9
916942|NCT01598740|2217328|P1|COMPLETED|Period 2||7
916943|NCT01598740|2217327|P2|STARTED|Period 2||9
916944|NCT01598740|2217328|P1|STARTED|Period 2|1 subject discontinued during the washout period prior to starting treatment period 2.|8
916945|NCT01598740|2217327|P2|NOT COMPLETED|Period 1||0
916946|NCT01598740|2217328|P1|NOT COMPLETED|Period 1||0
916947|NCT01598740|2217327|P2|COMPLETED|Period 1||9
916948|NCT01598740|2217328|P1|COMPLETED|Period 1||9
916949|NCT01598740|2217327|P2|STARTED|Period 1||9
916950|NCT01598740|2217328|P1|STARTED|Period 1||9
916951|NCT01598610|2217336|P1|NOT COMPLETED|Overall Study||1
916952|NCT01598610|2217336|P1|COMPLETED|Overall Study||219
916953|NCT01598610|2217336|P1|STARTED|Overall Study||220
916954|NCT01598545|2217345|P1|NOT COMPLETED|Overall Study||0
916955|NCT01598545|2217345|P1|COMPLETED|Overall Study||20
916956|NCT01598545|2217345|P1|STARTED|Overall Study||20
916957|NCT01598532|2217353|P1|NOT COMPLETED|Overall Study||11
916958|NCT01598532|2217353|P1|COMPLETED|Overall Study||11
916959|NCT01598532|2217353|P1|STARTED|Overall Study||22
916960|NCT01598506|2217362|P1|NOT COMPLETED|Overall Study||2
916961|NCT01598506|2217362|P1|COMPLETED|Overall Study||20
916962|NCT01598506|2217362|P1|STARTED|Overall Study||22
916963|NCT01598428|2217368|P1|NOT COMPLETED|Overall Study||0
916964|NCT01598428|2217368|P1|COMPLETED|Overall Study||20
916965|NCT01598428|2217368|P1|STARTED|Overall Study||20
916966|NCT01598350|2217377|P1|NOT COMPLETED|Overall Study||0
916967|NCT01598350|2217377|P1|COMPLETED|Overall Study||6
916968|NCT01598350|2217377|P1|STARTED|Overall Study||6
916969|NCT01598207|2217383|P2|NOT COMPLETED|Overall Study||0
916970|NCT01598207|2217384|P1|NOT COMPLETED|Overall Study||1
916971|NCT01598207|2217383|P2|COMPLETED|Overall Study||6
916972|NCT01598207|2217384|P1|COMPLETED|Overall Study||6
916973|NCT01598207|2217383|P2|STARTED|Overall Study||6
916974|NCT01598207|2217384|P1|STARTED|Overall Study||7
916975|NCT01598129|2217402|P1|NOT COMPLETED|Overall Study||9
916976|NCT01598129|2217402|P1|COMPLETED|Overall Study||3
916977|NCT01598129|2217402|P1|STARTED|Overall Study||12
916978|NCT01598064|2217413|P2|NOT COMPLETED|Overall Study||0
916979|NCT01598064|2217414|P1|NOT COMPLETED|Overall Study||0
916980|NCT01598064|2217413|P2|COMPLETED|Overall Study||24
916981|NCT01598064|2217414|P1|COMPLETED|Overall Study||25
916982|NCT01598064|2217413|P2|STARTED|Overall Study||24
916983|NCT01598064|2217414|P1|STARTED|Overall Study||25
916984|NCT01597908|2217424|P2|NOT COMPLETED|Overall Study||352
916985|NCT01597908|2217425|P1|NOT COMPLETED|Overall Study||352
916986|NCT01597908|2217424|P2|COMPLETED|Overall Study||0
916987|NCT01597908|2217425|P1|COMPLETED|Overall Study||0
916988|NCT01597908|2217424|P2|Ongoing|Overall Study||202
916989|NCT01597908|2217425|P1|Ongoing|Overall Study||236
916990|NCT01597908|2217424|P2|STARTED|Overall Study||352
916991|NCT01597908|2217425|P1|STARTED|Overall Study||352
916992|NCT01597843|2217440|P3|NOT COMPLETED|Overall Study||0
916993|NCT01597843|2217441|P2|NOT COMPLETED|Overall Study||0
916994|NCT01597843|2217442|P1|NOT COMPLETED|Overall Study||0
916995|NCT01597843|2217440|P3|COMPLETED|Overall Study||81
916996|NCT01597843|2217441|P2|COMPLETED|Overall Study||122
916997|NCT01597843|2217442|P1|COMPLETED|Overall Study||79
916998|NCT01597843|2217440|P3|Survey 3 Responses|Overall Study||76
916999|NCT01597843|2217441|P2|Survey 3 Responses|Overall Study||56
917000|NCT01597843|2217442|P1|Survey 3 Responses|Overall Study||65
917001|NCT01597843|2217440|P3|Survey 2 Responses|Overall Study||58
917002|NCT01597843|2217441|P2|Survey 2 Responses|Overall Study||42
917003|NCT01597843|2217442|P1|Survey 2 Responses|Overall Study||52
917004|NCT01597843|2217440|P3|Survey 1 Responses|Overall Study||59
917005|NCT01597843|2217441|P2|Survey 1 Responses|Overall Study||71
917006|NCT01597843|2217442|P1|Survey 1 Responses|Overall Study||45
917007|NCT01597843|2217440|P3|STARTED|Overall Study||81
917008|NCT01597843|2217441|P2|STARTED|Overall Study||122
917009|NCT01597843|2217442|P1|STARTED|Overall Study||79
917016|NCT01597635|2217462|P3|NOT COMPLETED|Part B||4
917017|NCT01597635|2217463|P2|NOT COMPLETED|Part B||6
917018|NCT01597635|2217464|P1|NOT COMPLETED|Part B||0
917019|NCT01597635|2217462|P3|COMPLETED|Part B||15
917020|NCT01597635|2217463|P2|COMPLETED|Part B||14
917021|NCT01597635|2217464|P1|COMPLETED|Part B||0
917022|NCT01597635|2217462|P3|STARTED|Part B||19
917023|NCT01597635|2217463|P2|STARTED|Part B||20
917024|NCT01597635|2217464|P1|STARTED|Part B||0
917025|NCT01597635|2217462|P3|NOT COMPLETED|Part A||0
917026|NCT01597635|2217463|P2|NOT COMPLETED|Part A||0
917027|NCT01597635|2217464|P1|NOT COMPLETED|Part A||3
917028|NCT01597635|2217462|P3|COMPLETED|Part A||0
917029|NCT01597635|2217463|P2|COMPLETED|Part A||0
917030|NCT01597635|2217464|P1|COMPLETED|Part A||2
917031|NCT01597635|2217462|P3|STARTED|Part A||0
917032|NCT01597635|2217463|P2|STARTED|Part A||0
917033|NCT01597635|2217464|P1|STARTED|Part A||5
917034|NCT01597596|2217529|P2|NOT COMPLETED|Overall Study||1
917035|NCT01597596|2217530|P1|NOT COMPLETED|Overall Study||1
917036|NCT01597596|2217529|P2|COMPLETED|Overall Study||2
917037|NCT01597596|2217530|P1|COMPLETED|Overall Study||0
917038|NCT01597596|2217529|P2|STARTED|Overall Study||3
917039|NCT01597596|2217530|P1|STARTED|Overall Study||1
917040|NCT01597492|2217544|P2|NOT COMPLETED|Overall Study||4
917041|NCT01597492|2217545|P1|NOT COMPLETED|Overall Study||6
917042|NCT01597492|2217544|P2|COMPLETED|Overall Study||41
917043|NCT01597492|2217545|P1|COMPLETED|Overall Study||28
917044|NCT01597492|2217544|P2|STARTED|Overall Study||45
917045|NCT01597492|2217545|P1|STARTED|Overall Study||34
917046|NCT01597479|2217553|P2|NOT COMPLETED|Overall Study||0
917047|NCT01597479|2217554|P1|NOT COMPLETED|Overall Study||2
917048|NCT01597479|2217553|P2|COMPLETED|Overall Study||26
917049|NCT01597479|2217554|P1|COMPLETED|Overall Study||24
917050|NCT01597479|2217553|P2|STARTED|Overall Study||26
917051|NCT01597479|2217554|P1|STARTED|Overall Study||26
917052|NCT01597440|2217563|P2|NOT COMPLETED|Overall Study||0
917053|NCT01597440|2217564|P1|NOT COMPLETED|Overall Study||0
917054|NCT01597440|2217563|P2|COMPLETED|Overall Study||0
917055|NCT01597440|2217564|P1|COMPLETED|Overall Study||1
917056|NCT01597440|2217563|P2|STARTED|Overall Study||0
917057|NCT01597440|2217564|P1|STARTED|Overall Study||1
917058|NCT01597245|2217576|P13|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||12
917059|NCT01597245|2217577|P12|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||19
917060|NCT01597245|2217578|P11|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||22
917061|NCT01597245|2217579|P10|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||118
917062|NCT01597245|2217580|P9|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||20
917063|NCT01597245|2217581|P8|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||3
917064|NCT01597245|2217582|P7|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||37
917065|NCT01597245|2217583|P6|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||89
917066|NCT01597245|2217584|P5|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||159
917067|NCT01597245|2217585|P4|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
917068|NCT01597245|2217586|P3|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
917069|NCT01597245|2217587|P2|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
917070|NCT01597245|2217588|P1|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
917071|NCT01597245|2217576|P13|COMPLETED|Maintenance Period (Week 12 to Week 60)||37
917072|NCT01597245|2217577|P12|COMPLETED|Maintenance Period (Week 12 to Week 60)||56
917073|NCT01597245|2217578|P11|COMPLETED|Maintenance Period (Week 12 to Week 60)||178
917074|NCT01597245|2217579|P10|COMPLETED|Maintenance Period (Week 12 to Week 60)||14
917075|NCT01597245|2217580|P9|COMPLETED|Maintenance Period (Week 12 to Week 60)||135
917076|NCT01597245|2217581|P8|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
917077|NCT01597245|2217582|P7|COMPLETED|Maintenance Period (Week 12 to Week 60)||150
917078|NCT01597245|2217583|P6|COMPLETED|Maintenance Period (Week 12 to Week 60)||92
917079|NCT01597245|2217584|P5|COMPLETED|Maintenance Period (Week 12 to Week 60)||17
917080|NCT01597245|2217585|P4|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
917081|NCT01597245|2217586|P3|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
917082|NCT01597245|2217587|P2|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
917083|NCT01597245|2217588|P1|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
917084|NCT01597245|2217576|P13|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||49
917085|NCT01597245|2217577|P12|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||75
917086|NCT01597245|2217578|P11|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||200
917087|NCT01597245|2217579|P10|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||132
917088|NCT01597245|2217580|P9|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||155
917089|NCT01597245|2217581|P8|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||3
917090|NCT01597245|2217582|P7|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||187
917091|NCT01597245|2217583|P6|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||181
917092|NCT01597245|2217584|P5|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||176
917093|NCT01597245|2217585|P4|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
917094|NCT01597245|2217586|P3|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
917095|NCT01597245|2217587|P2|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
917096|NCT01597245|2217588|P1|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
917097|NCT01597245|2217576|P13|STARTED|Maintenance Period (Week 12 to Week 60)||49
917098|NCT01597245|2217577|P12|STARTED|Maintenance Period (Week 12 to Week 60)||75
917099|NCT01597245|2217578|P11|STARTED|Maintenance Period (Week 12 to Week 60)||200
917100|NCT01597245|2217579|P10|STARTED|Maintenance Period (Week 12 to Week 60)||132
917101|NCT01597245|2217580|P9|STARTED|Maintenance Period (Week 12 to Week 60)||155
917102|NCT01597245|2217581|P8|STARTED|Maintenance Period (Week 12 to Week 60)||3
917103|NCT01597245|2217582|P7|STARTED|Maintenance Period (Week 12 to Week 60)||187
917104|NCT01597245|2217583|P6|STARTED|Maintenance Period (Week 12 to Week 60)||181
917105|NCT01597245|2217584|P5|STARTED|Maintenance Period (Week 12 to Week 60)||176
917106|NCT01597245|2217585|P4|STARTED|Maintenance Period (Week 12 to Week 60)||0
917107|NCT01597245|2217586|P3|STARTED|Maintenance Period (Week 12 to Week 60)||0
917108|NCT01597245|2217587|P2|STARTED|Maintenance Period (Week 12 to Week 60)||0
917109|NCT01597245|2217588|P1|STARTED|Maintenance Period (Week 12 to Week 60)||0
917110|NCT01597245|2217576|P13|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
917111|NCT01597245|2217577|P12|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
917112|NCT01597245|2217578|P11|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
917113|NCT01597245|2217579|P10|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
917114|NCT01597245|2217580|P9|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
917115|NCT01597245|2217581|P8|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
917116|NCT01597245|2217582|P7|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
917117|NCT01597245|2217583|P6|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
917118|NCT01597245|2217584|P5|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
917119|NCT01597245|2217585|P4|NOT COMPLETED|Induction Period (Week 0 - Week 12)||9
917120|NCT01597245|2217586|P3|NOT COMPLETED|Induction Period (Week 0 - Week 12)||19
917121|NCT01597245|2217587|P2|NOT COMPLETED|Induction Period (Week 0 - Week 12)||25
917122|NCT01597245|2217588|P1|NOT COMPLETED|Induction Period (Week 0 - Week 12)||10
917123|NCT01597245|2217576|P13|COMPLETED|Induction Period (Week 0 - Week 12)||0
917124|NCT01597245|2217577|P12|COMPLETED|Induction Period (Week 0 - Week 12)||0
917125|NCT01597245|2217578|P11|COMPLETED|Induction Period (Week 0 - Week 12)||0
917126|NCT01597245|2217579|P10|COMPLETED|Induction Period (Week 0 - Week 12)||0
917127|NCT01597245|2217580|P9|COMPLETED|Induction Period (Week 0 - Week 12)||0
917128|NCT01597245|2217581|P8|COMPLETED|Induction Period (Week 0 - Week 12)||0
917129|NCT01597245|2217582|P7|COMPLETED|Induction Period (Week 0 - Week 12)||0
917130|NCT01597245|2217583|P6|COMPLETED|Induction Period (Week 0 - Week 12)||0
917131|NCT01597245|2217584|P5|COMPLETED|Induction Period (Week 0 - Week 12)||0
917132|NCT01597245|2217585|P4|COMPLETED|Induction Period (Week 0 - Week 12)|2 participants discontinued after IND completion and prior to randomizing into maintenance period.|342
917133|NCT01597245|2217586|P3|COMPLETED|Induction Period (Week 0 - Week 12)||328
917134|NCT01597245|2217587|P2|COMPLETED|Induction Period (Week 0 - Week 12)|1 participant randomized to maintenance period but did not receive a dose in the maintenance period.|333
917135|NCT01597245|2217588|P1|COMPLETED|Induction Period (Week 0 - Week 12)||158
917136|NCT01597245|2217576|P13|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
917137|NCT01597245|2217577|P12|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
917138|NCT01597245|2217578|P11|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
917139|NCT01597245|2217579|P10|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
917140|NCT01597245|2217580|P9|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
917141|NCT01597245|2217581|P8|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
917142|NCT01597245|2217582|P7|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
917143|NCT01597245|2217583|P6|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
917144|NCT01597245|2217584|P5|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
917145|NCT01597245|2217585|P4|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||350
917146|NCT01597245|2217586|P3|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||347
917147|NCT01597245|2217587|P2|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||357
917148|NCT01597245|2217588|P1|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||167
917149|NCT01597245|2217576|P13|STARTED|Induction Period (Week 0 - Week 12)||0
917150|NCT01597245|2217577|P12|STARTED|Induction Period (Week 0 - Week 12)||0
917151|NCT01597245|2217578|P11|STARTED|Induction Period (Week 0 - Week 12)||0
917152|NCT01597245|2217579|P10|STARTED|Induction Period (Week 0 - Week 12)||0
917153|NCT01597245|2217580|P9|STARTED|Induction Period (Week 0 - Week 12)||0
917154|NCT01597245|2217581|P8|STARTED|Induction Period (Week 0 - Week 12)||0
917155|NCT01597245|2217582|P7|STARTED|Induction Period (Week 0 - Week 12)||0
917156|NCT01597245|2217583|P6|STARTED|Induction Period (Week 0 - Week 12)||0
917157|NCT01597245|2217584|P5|STARTED|Induction Period (Week 0 - Week 12)||0
917158|NCT01597245|2217585|P4|STARTED|Induction Period (Week 0 - Week 12)||351
917159|NCT01597245|2217586|P3|STARTED|Induction Period (Week 0 - Week 12)||347
917160|NCT01597245|2217587|P2|STARTED|Induction Period (Week 0 - Week 12)||358
917161|NCT01597245|2217588|P1|STARTED|Induction Period (Week 0 - Week 12)||168
917162|NCT01597141|2217673|P2|NOT COMPLETED|Overall Study||0
917163|NCT01597141|2217674|P1|NOT COMPLETED|Overall Study||0
917164|NCT01597141|2217673|P2|COMPLETED|Overall Study||50
917165|NCT01597141|2217674|P1|COMPLETED|Overall Study||50
917166|NCT01597141|2217673|P2|STARTED|Overall Study||50
917167|NCT01597141|2217674|P1|STARTED|Overall Study||50
917168|NCT01597128|2217684|P2|NOT COMPLETED|Overall Study||0
917169|NCT01597128|2217685|P1|NOT COMPLETED|Overall Study||0
917170|NCT01597128|2217684|P2|COMPLETED|Overall Study||17
917171|NCT01597128|2217685|P1|COMPLETED|Overall Study||18
917172|NCT01597128|2217684|P2|STARTED|Overall Study||17
917173|NCT01597128|2217685|P1|STARTED|Overall Study||18
917174|NCT01597050|2217711|P2|NOT COMPLETED|Overall Study||0
917175|NCT01597050|2217712|P1|NOT COMPLETED|Overall Study||1
917176|NCT01597050|2217711|P2|COMPLETED|Overall Study||18
917177|NCT01597050|2217712|P1|COMPLETED|Overall Study||35
917178|NCT01597050|2217711|P2|STARTED|Overall Study||18
917179|NCT01597050|2217712|P1|STARTED|Overall Study||36
917180|NCT01596972|2217720|P2|NOT COMPLETED|Overall Study||14
917181|NCT01596972|2217721|P1|NOT COMPLETED|Overall Study||1
917182|NCT01596972|2217720|P2|COMPLETED|Overall Study||12
917183|NCT01596972|2217721|P1|COMPLETED|Overall Study||24
917184|NCT01596972|2217720|P2|STARTED|Overall Study||26
917185|NCT01596972|2217721|P1|STARTED|Overall Study||25
917186|NCT01596842|2217733|P2|NOT COMPLETED|Overall Study||0
917187|NCT01596842|2217734|P1|NOT COMPLETED|Overall Study||2
917188|NCT01596842|2217733|P2|COMPLETED|Overall Study||7
917189|NCT01596842|2217734|P1|COMPLETED|Overall Study||8
917190|NCT01596842|2217733|P2|STARTED|Overall Study||7
917191|NCT01596842|2217734|P1|STARTED|Overall Study||10
917192|NCT01596582|2217744|P2|NOT COMPLETED|Overall Study||7
917193|NCT01596582|2217745|P1|NOT COMPLETED|Overall Study||4
917194|NCT01596582|2217744|P2|COMPLETED|Overall Study||173
917195|NCT01596582|2217745|P1|COMPLETED|Overall Study||168
917196|NCT01596582|2217744|P2|STARTED|Overall Study||180
917197|NCT01596582|2217745|P1|STARTED|Overall Study||172
917198|NCT01596504|2217772|P3|NOT COMPLETED|Overall Study||1
917199|NCT01596504|2217773|P2|NOT COMPLETED|Overall Study||3
917200|NCT01596504|2217774|P1|NOT COMPLETED|Overall Study||2
917201|NCT01596504|2217772|P3|COMPLETED|Overall Study||46
917202|NCT01596504|2217773|P2|COMPLETED|Overall Study||44
917203|NCT01596504|2217774|P1|COMPLETED|Overall Study||46
917204|NCT01596504|2217772|P3|STARTED|Overall Study||47
917205|NCT01596504|2217773|P2|STARTED|Overall Study||47
917206|NCT01596504|2217774|P1|STARTED|Overall Study||48
917207|NCT01596231|2217832|P2|NOT COMPLETED|Overall Study||0
917208|NCT01596231|2217833|P1|NOT COMPLETED|Overall Study||0
917209|NCT01596231|2217832|P2|COMPLETED|Overall Study||10
917210|NCT01596231|2217833|P1|COMPLETED|Overall Study||10
917211|NCT01596231|2217832|P2|STARTED|Overall Study||10
917212|NCT01596231|2217833|P1|STARTED|Overall Study||10
917213|NCT01596088|2217839|P1|NOT COMPLETED|Overall Study||0
917214|NCT01596088|2217839|P1|COMPLETED|Overall Study||2
917215|NCT01596088|2217839|P1|STARTED|Overall Study||2
917216|NCT01596062|2217846|P3|NOT COMPLETED|Overall Study||3
917217|NCT01596062|2217847|P2|NOT COMPLETED|Overall Study||0
917218|NCT01596062|2217848|P1|NOT COMPLETED|Overall Study||1
917219|NCT01596062|2217846|P3|COMPLETED|Overall Study||4
917220|NCT01596062|2217847|P2|COMPLETED|Overall Study||6
917221|NCT01596062|2217848|P1|COMPLETED|Overall Study||2
917222|NCT01596062|2217846|P3|STARTED|Overall Study||7
917223|NCT01596062|2217847|P2|STARTED|Overall Study||6
917224|NCT01596062|2217848|P1|STARTED|Overall Study||3
917225|NCT01595854|2217885|P5|NOT COMPLETED|Overall Study||0
917226|NCT01595854|2217886|P4|NOT COMPLETED|Overall Study||0
917227|NCT01595854|2217887|P3|NOT COMPLETED|Overall Study||0
917228|NCT01595854|2217888|P2|NOT COMPLETED|Overall Study||0
917229|NCT01595854|2217889|P1|NOT COMPLETED|Overall Study||0
917230|NCT01595854|2217885|P5|COMPLETED|Overall Study||12
917231|NCT01595854|2217886|P4|COMPLETED|Overall Study||4
917232|NCT01595854|2217887|P3|COMPLETED|Overall Study||8
917233|NCT01595854|2217888|P2|COMPLETED|Overall Study||4
917234|NCT01595854|2217889|P1|COMPLETED|Overall Study||8
917235|NCT01595854|2217885|P5|STARTED|Overall Study||12
917236|NCT01595854|2217886|P4|STARTED|Overall Study||4
917237|NCT01595854|2217887|P3|STARTED|Overall Study||8
917238|NCT01595854|2217888|P2|STARTED|Overall Study||4
917239|NCT01595854|2217889|P1|STARTED|Overall Study||8
917240|NCT01595438|2217911|P2|NOT COMPLETED|Overall Study||41
917241|NCT01595438|2217912|P1|NOT COMPLETED|Overall Study||43
917242|NCT01595438|2217911|P2|COMPLETED|Overall Study||476
917243|NCT01595438|2217912|P1|COMPLETED|Overall Study||473
917244|NCT01595438|2217911|P2|STARTED|Overall Study||517
917245|NCT01595438|2217912|P1|STARTED|Overall Study||516
917246|NCT01595386|2218038|P2|NOT COMPLETED|Overall Study||0
917247|NCT01595386|2218039|P1|NOT COMPLETED|Overall Study||0
917248|NCT01595386|2218038|P2|COMPLETED|Overall Study||19
917249|NCT01595386|2218039|P1|COMPLETED|Overall Study||21
917250|NCT01595386|2218038|P2|STARTED|Overall Study||19
917251|NCT01595386|2218039|P1|STARTED|Overall Study||21
917252|NCT01595282|2218067|P2|NOT COMPLETED|Overall Study||0
917253|NCT01595282|2218068|P1|NOT COMPLETED|Overall Study||0
917254|NCT01595282|2218067|P2|COMPLETED|Overall Study||47
917255|NCT01595282|2218068|P1|COMPLETED|Overall Study||47
917256|NCT01595282|2218067|P2|STARTED|Overall Study||47
917257|NCT01595282|2218068|P1|STARTED|Overall Study||47
917258|NCT01594970|2218081|P3|NOT COMPLETED|Overall Study||66
917259|NCT01594970|2218082|P2|NOT COMPLETED|Overall Study||82
917260|NCT01594970|2218083|P1|NOT COMPLETED|Overall Study||75
917261|NCT01594970|2218081|P3|COMPLETED|Overall Study||191
917262|NCT01594970|2218082|P2|COMPLETED|Overall Study||166
917263|NCT01594970|2218083|P1|COMPLETED|Overall Study||220
917264|NCT01594970|2218081|P3|STARTED|Overall Study||257
917265|NCT01594970|2218082|P2|STARTED|Overall Study||248
917266|NCT01594970|2218083|P1|STARTED|Overall Study||295
917267|NCT01594762|2218102|P2|NOT COMPLETED|Overall Study||10
917268|NCT01594762|2218103|P1|NOT COMPLETED|Overall Study||11
917269|NCT01594762|2218102|P2|COMPLETED|Overall Study||93
917270|NCT01594762|2218103|P1|COMPLETED|Overall Study||86
917271|NCT01594762|2218102|P2|STARTED|Overall Study||103
917272|NCT01594762|2218103|P1|STARTED|Overall Study||97
917273|NCT01594749|2218115|P2|NOT COMPLETED|Overall Study||18
917274|NCT01594749|2218116|P1|NOT COMPLETED|Overall Study||22
917275|NCT01594749|2218115|P2|COMPLETED|Overall Study||490
917276|NCT01594749|2218116|P1|COMPLETED|Overall Study||485
917277|NCT01594749|2218115|P2|Treated|Overall Study||498
917278|NCT01594749|2218116|P1|Treated|Overall Study||503
917279|NCT01594749|2218115|P2|STARTED|Overall Study||508
917280|NCT01594749|2218116|P1|STARTED|Overall Study||507
917281|NCT01594515|2218142|P10|NOT COMPLETED|Overall Study||0
917282|NCT01594515|2218143|P9|NOT COMPLETED|Overall Study||0
917283|NCT01594515|2218144|P8|NOT COMPLETED|Overall Study||0
917284|NCT01594515|2218145|P7|NOT COMPLETED|Overall Study||0
917285|NCT01594515|2218146|P6|NOT COMPLETED|Overall Study||0
917286|NCT01594515|2218147|P5|NOT COMPLETED|Overall Study||0
917287|NCT01594515|2218148|P4|NOT COMPLETED|Overall Study||0
917288|NCT01594515|2218149|P3|NOT COMPLETED|Overall Study||0
917289|NCT01594515|2218150|P2|NOT COMPLETED|Overall Study||0
917290|NCT01594515|2218151|P1|NOT COMPLETED|Overall Study||0
917291|NCT01594515|2218142|P10|COMPLETED|Overall Study||16
917292|NCT01594515|2218143|P9|COMPLETED|Overall Study||6
917293|NCT01594515|2218144|P8|COMPLETED|Overall Study||6
917294|NCT01594515|2218145|P7|COMPLETED|Overall Study||6
917295|NCT01594515|2218146|P6|COMPLETED|Overall Study||6
917296|NCT01594515|2218147|P5|COMPLETED|Overall Study||6
917297|NCT01594515|2218148|P4|COMPLETED|Overall Study||6
917298|NCT01594515|2218149|P3|COMPLETED|Overall Study||6
917299|NCT01594515|2218150|P2|COMPLETED|Overall Study||6
917300|NCT01594515|2218151|P1|COMPLETED|Overall Study||6
917301|NCT01594515|2218142|P10|STARTED|Overall Study||16
917302|NCT01594515|2218143|P9|STARTED|Overall Study||6
917303|NCT01594515|2218144|P8|STARTED|Overall Study||6
917304|NCT01594515|2218145|P7|STARTED|Overall Study||6
917305|NCT01594515|2218146|P6|STARTED|Overall Study||6
917306|NCT01594515|2218147|P5|STARTED|Overall Study||6
917307|NCT01594515|2218148|P4|STARTED|Overall Study||6
917308|NCT01594515|2218149|P3|STARTED|Overall Study||6
917309|NCT01594515|2218150|P2|STARTED|Overall Study||6
917310|NCT01594515|2218151|P1|STARTED|Overall Study||6
917311|NCT01594424|2218241|P1|NOT COMPLETED|Overall Study||2
917312|NCT01594424|2218241|P1|COMPLETED|Overall Study||8
917313|NCT01594424|2218241|P1|STARTED|Overall Study||10
917314|NCT01594411|2218245|P1|NOT COMPLETED|Overall Study||2
917315|NCT01594411|2218245|P1|COMPLETED|Overall Study||249
917316|NCT01594411|2218245|P1|STARTED|Overall Study||251
917323|NCT01593215|2218263|P2|NOT COMPLETED|Overall Study||0
917324|NCT01593215|2218264|P1|NOT COMPLETED|Overall Study||1
917325|NCT01593215|2218263|P2|COMPLETED|Overall Study||25
917326|NCT01593215|2218264|P1|COMPLETED|Overall Study||24
917327|NCT01593215|2218263|P2|STARTED|Overall Study||25
917328|NCT01593215|2218264|P1|STARTED|Overall Study||25
917329|NCT01594294|2218272|P2|NOT COMPLETED|Overall Study||4
917330|NCT01594294|2218273|P1|NOT COMPLETED|Overall Study||3
917331|NCT01594294|2218272|P2|COMPLETED|Overall Study||36
917332|NCT01594294|2218273|P1|COMPLETED|Overall Study||36
917333|NCT01594294|2218272|P2|STARTED|Overall Study||40
917334|NCT01594294|2218273|P1|STARTED|Overall Study||39
917335|NCT01594125|2218292|P5|NOT COMPLETED|Overall Study||7
917336|NCT01594125|2218293|P4|NOT COMPLETED|Overall Study||4
917337|NCT01594125|2218294|P3|NOT COMPLETED|Overall Study||3
917338|NCT01594125|2218295|P2|NOT COMPLETED|Overall Study||12
917339|NCT01594125|2218296|P1|NOT COMPLETED|Overall Study||4
917340|NCT01594125|2218292|P5|COMPLETED|Overall Study||0
917341|NCT01594125|2218293|P4|COMPLETED|Overall Study||0
917342|NCT01594125|2218294|P3|COMPLETED|Overall Study||0
917343|NCT01594125|2218295|P2|COMPLETED|Overall Study||0
917344|NCT01594125|2218296|P1|COMPLETED|Overall Study||0
917345|NCT01594125|2218292|P5|STARTED|Overall Study||7
917346|NCT01594125|2218293|P4|STARTED|Overall Study||4
917347|NCT01594125|2218294|P3|STARTED|Overall Study||3
917348|NCT01594125|2218295|P2|STARTED|Overall Study||12
917349|NCT01594125|2218296|P1|STARTED|Overall Study||4
917350|NCT01593852|2218330|P2|NOT COMPLETED|Overall Study||0
917351|NCT01593852|2218331|P1|NOT COMPLETED|Overall Study||0
917352|NCT01593852|2218330|P2|COMPLETED|Overall Study||68
917353|NCT01593852|2218331|P1|COMPLETED|Overall Study||68
917354|NCT01593852|2218330|P2|STARTED|Overall Study||68
917355|NCT01593852|2218331|P1|STARTED|Overall Study||68
917356|NCT01593787|2218356|P3|NOT COMPLETED|Overall Study||0
917357|NCT01593787|2218357|P2|NOT COMPLETED|Overall Study||0
917358|NCT01593787|2218358|P1|NOT COMPLETED|Overall Study||1
917359|NCT01593787|2218356|P3|COMPLETED|Overall Study||18
917360|NCT01593787|2218357|P2|COMPLETED|Overall Study||8
917361|NCT01593787|2218358|P1|COMPLETED|Overall Study||5
917362|NCT01593787|2218356|P3|STARTED|Overall Study||18
917363|NCT01593787|2218357|P2|STARTED|Overall Study||8
917364|NCT01593787|2218358|P1|STARTED|Overall Study||6
917365|NCT01593722|2218398|P2|NOT COMPLETED|Overall Study||0
917366|NCT01593722|2218399|P1|NOT COMPLETED|Overall Study||0
917367|NCT01593722|2218398|P2|COMPLETED|Overall Study||6
917368|NCT01593722|2218399|P1|COMPLETED|Overall Study||6
917369|NCT01593722|2218398|P2|STARTED|Overall Study||6
917370|NCT01593722|2218399|P1|STARTED|Overall Study||6
917371|NCT01593670|2218413|P1|NOT COMPLETED|Overall Study||0
917372|NCT01593670|2218413|P1|COMPLETED|Overall Study||9
917373|NCT01593670|2218413|P1|STARTED|Overall Study||9
917374|NCT01593592|2218423|P2|NOT COMPLETED|Overall Study||0
917375|NCT01593592|2218424|P1|NOT COMPLETED|Overall Study||0
917376|NCT01593592|2218423|P2|COMPLETED|Overall Study||35
917377|NCT01593592|2218424|P1|COMPLETED|Overall Study||35
917378|NCT01593592|2218423|P2|STARTED|Overall Study||35
917379|NCT01593592|2218424|P1|STARTED|Overall Study||35
917380|NCT01592864|2218436|P2|NOT COMPLETED|Overall Study||1
917381|NCT01592864|2218437|P1|NOT COMPLETED|Overall Study||0
917382|NCT01592864|2218436|P2|COMPLETED|Overall Study||57
917383|NCT01592864|2218437|P1|COMPLETED|Overall Study||60
917384|NCT01592864|2218436|P2|STARTED|Overall Study||58
917385|NCT01592864|2218437|P1|STARTED|Overall Study||60
917386|NCT01592851|2218451|P2|NOT COMPLETED|Overall Study||0
917387|NCT01592851|2218452|P1|NOT COMPLETED|Overall Study||0
917388|NCT01592851|2218451|P2|COMPLETED|Overall Study||57
917389|NCT01592851|2218452|P1|COMPLETED|Overall Study||56
917390|NCT01592851|2218451|P2|STARTED|Overall Study||57
917391|NCT01592851|2218452|P1|STARTED|Overall Study||56
917392|NCT01592786|2218468|P1|NOT COMPLETED|Overall Study||138
917393|NCT01592786|2218468|P1|COMPLETED|Overall Study||765
917394|NCT01592786|2218468|P1|STARTED|Overall Study|Participants in the Safety Population are being presented.|903
917395|NCT01592773|2218472|P1|NOT COMPLETED|Overall Study||666
917396|NCT01592773|2218472|P1|COMPLETED|Overall Study||81
917397|NCT01592773|2218472|P1|STARTED|Overall Study|All enrolled patients received at least 1 dose of investigational product (Safety Population).|747
917398|NCT01592760|2218479|P3|NOT COMPLETED|24-hour Follow-Up||2
917399|NCT01592760|2218480|P2|NOT COMPLETED|24-hour Follow-Up||3
917400|NCT01592760|2218481|P1|NOT COMPLETED|24-hour Follow-Up||4
917401|NCT01592760|2218479|P3|COMPLETED|24-hour Follow-Up||43
917402|NCT01592760|2218480|P2|COMPLETED|24-hour Follow-Up||87
917403|NCT01592760|2218481|P1|COMPLETED|24-hour Follow-Up||86
917404|NCT01592760|2218479|P3|STARTED|24-hour Follow-Up||45
917405|NCT01592760|2218480|P2|STARTED|24-hour Follow-Up||90
917406|NCT01592760|2218481|P1|STARTED|24-hour Follow-Up||90
917407|NCT01592760|2218479|P3|NOT COMPLETED|Perioperative to Discharge||0
917408|NCT01592760|2218480|P2|NOT COMPLETED|Perioperative to Discharge||0
917409|NCT01592760|2218481|P1|NOT COMPLETED|Perioperative to Discharge||0
917410|NCT01592760|2218479|P3|COMPLETED|Perioperative to Discharge||45
917411|NCT01592760|2218480|P2|COMPLETED|Perioperative to Discharge||90
917412|NCT01592760|2218481|P1|COMPLETED|Perioperative to Discharge||90
917413|NCT01592760|2218479|P3|STARTED|Perioperative to Discharge||45
917414|NCT01592760|2218480|P2|STARTED|Perioperative to Discharge||90
917415|NCT01592760|2218481|P1|STARTED|Perioperative to Discharge||90
917416|NCT01592708|2218524|P2|NOT COMPLETED|Overall Study||0
917417|NCT01592708|2218525|P1|NOT COMPLETED|Overall Study||3
917418|NCT01592708|2218524|P2|COMPLETED|Overall Study||137
917419|NCT01592708|2218525|P1|COMPLETED|Overall Study||93
917420|NCT01592708|2218524|P2|STARTED|Overall Study||137
917421|NCT01592708|2218525|P1|STARTED|Overall Study||96
917422|NCT01592695|2218541|P2|NOT COMPLETED|Overall Study||4
917423|NCT01592695|2218542|P1|NOT COMPLETED|Overall Study||8
917424|NCT01592695|2218541|P2|COMPLETED|Overall Study||28
917425|NCT01592695|2218542|P1|COMPLETED|Overall Study||23
917426|NCT01592695|2218541|P2|STARTED|Overall Study||32
917427|NCT01592695|2218542|P1|STARTED|Overall Study||31
917428|NCT01592435|2218560|P1|NOT COMPLETED|Overall Study||0
917429|NCT01592435|2218560|P1|COMPLETED|Overall Study||76
917430|NCT01592435|2218560|P1|STARTED|Overall Study||76
917431|NCT01592396|2218568|P2|NOT COMPLETED|Overall Study||0
917432|NCT01592396|2218569|P1|NOT COMPLETED|Overall Study||0
917433|NCT01592396|2218568|P2|COMPLETED|Overall Study||10
917434|NCT01592396|2218569|P1|COMPLETED|Overall Study||10
917435|NCT01592396|2218568|P2|STARTED|Overall Study||10
917436|NCT01592396|2218569|P1|STARTED|Overall Study||10
917437|NCT01592344|2218586|P2|NOT COMPLETED|Overall Study||5
917438|NCT01592344|2218587|P1|NOT COMPLETED|Overall Study||4
917439|NCT01592344|2218586|P2|COMPLETED|Overall Study||44
917440|NCT01592344|2218587|P1|COMPLETED|Overall Study||41
917441|NCT01592344|2218586|P2|STARTED|Overall Study||49
917442|NCT01592344|2218587|P1|STARTED|Overall Study||45
917443|NCT01592292|2218601|P4|NOT COMPLETED|Overall Study||1
917444|NCT01592292|2218602|P3|NOT COMPLETED|Overall Study||3
917445|NCT01592292|2218603|P2|NOT COMPLETED|Overall Study||5
917446|NCT01592292|2218604|P1|NOT COMPLETED|Overall Study||6
917447|NCT01592292|2218601|P4|COMPLETED|Overall Study||10
917448|NCT01592292|2218602|P3|COMPLETED|Overall Study||10
917449|NCT01592292|2218603|P2|COMPLETED|Overall Study||15
917450|NCT01592292|2218604|P1|COMPLETED|Overall Study|Participants who completed 12 months visit.|40
917451|NCT01592292|2218601|P4|Standard Population Set (SPS)|Overall Study||7
917452|NCT01592292|2218602|P3|Standard Population Set (SPS)|Overall Study||7
917453|NCT01592292|2218603|P2|Standard Population Set (SPS)|Overall Study||10
917454|NCT01592292|2218604|P1|Standard Population Set (SPS)|Overall Study|Excluding participants with change of administration drug or suspension of drug administration.|31
917455|NCT01592292|2218601|P4|Intention to Treat (ITT) Set|Overall Study||8
917456|NCT01592292|2218602|P3|Intention to Treat (ITT) Set|Overall Study||10
917457|NCT01592292|2218603|P2|Intention to Treat (ITT) Set|Overall Study||13
917458|NCT01592292|2218604|P1|Intention to Treat (ITT) Set|Overall Study|Excluding primary effect evaluation omission.|34
917459|NCT01592292|2218601|P4|STARTED|Overall Study||11
917460|NCT01592292|2218602|P3|STARTED|Overall Study||13
917461|NCT01592292|2218603|P2|STARTED|Overall Study||20
917462|NCT01592292|2218604|P1|STARTED|Overall Study||46
917463|NCT01592071|2218636|P1|NOT COMPLETED|Overall Study||0
917464|NCT01592071|2218636|P1|COMPLETED|Overall Study||120
917465|NCT01592071|2218636|P1|STARTED|Overall Study||120
917466|NCT01592045|2218649|P2|NOT COMPLETED|Overall Study||2
917467|NCT01592045|2218650|P1|NOT COMPLETED|Overall Study||5
917468|NCT01592045|2218649|P2|COMPLETED|Overall Study||12
917469|NCT01592045|2218650|P1|COMPLETED|Overall Study||9
917470|NCT01592045|2218649|P2|Completed Course 5|Overall Study||12
917471|NCT01592045|2218650|P1|Completed Course 5|Overall Study||9
917472|NCT01592045|2218649|P2|Completed Course 4|Overall Study||12
917473|NCT01592045|2218650|P1|Completed Course 4|Overall Study||11
917474|NCT01592045|2218649|P2|Completed Course 3|Overall Study||13
917475|NCT01592045|2218650|P1|Completed Course 3|Overall Study||11
917476|NCT01592045|2218649|P2|Completed Course 2|Overall Study||13
917477|NCT01592045|2218650|P1|Completed Course 2|Overall Study||13
917478|NCT01592045|2218649|P2|Completed Course 1|Overall Study||14
917479|NCT01592045|2218650|P1|Completed Course 1|Overall Study||13
917480|NCT01592045|2218649|P2|STARTED|Overall Study||14
917481|NCT01592045|2218650|P1|STARTED|Overall Study||14
917482|NCT01592006|2218658|P1|NOT COMPLETED|Overall Study||0
917483|NCT01592006|2218658|P1|COMPLETED|Overall Study||3
917484|NCT01592006|2218658|P1|STARTED|Overall Study||3
917485|NCT01591954|2218663|P1|NOT COMPLETED|Overall Study||0
917486|NCT01591954|2218663|P1|COMPLETED|Overall Study||1
917487|NCT01591954|2218663|P1|STARTED|Overall Study||1
917488|NCT01591863|2218668|P1|NOT COMPLETED|Overall Study||14
917489|NCT01591863|2218668|P1|COMPLETED|Overall Study||24
917490|NCT01591863|2218668|P1|STARTED|Overall Study||38
917491|NCT01591837|2218680|P2|NOT COMPLETED|Overall Study||0
917492|NCT01591837|2218681|P1|NOT COMPLETED|Overall Study||0
917493|NCT01591837|2218680|P2|COMPLETED|Overall Study||60
917494|NCT01591837|2218681|P1|COMPLETED|Overall Study||60
917495|NCT01591837|2218680|P2|STARTED|Overall Study||60
917496|NCT01591837|2218681|P1|STARTED|Overall Study||60
917497|NCT01591681|2218695|P1|NOT COMPLETED|Overall Study||4
917498|NCT01591681|2218695|P1|COMPLETED|Overall Study||45
917499|NCT01591681|2218695|P1|STARTED|Overall Study||49
917500|NCT01591616|2218721|P1|NOT COMPLETED|Overall Study||1
917501|NCT01591616|2218721|P1|COMPLETED|Overall Study||15
917502|NCT01591616|2218721|P1|STARTED|Overall Study||16
917503|NCT01591499|2218862|P4|NOT COMPLETED|Second Intervention (up to 24 Days)||3
917504|NCT01591499|2218863|P3|NOT COMPLETED|Second Intervention (up to 24 Days)||3
917505|NCT01591499|2218864|P2|NOT COMPLETED|Second Intervention (up to 24 Days)||3
917506|NCT01591499|2218865|P1|NOT COMPLETED|Second Intervention (up to 24 Days)||6
917507|NCT01591499|2218862|P4|COMPLETED|Second Intervention (up to 24 Days)||34
917508|NCT01591499|2218863|P3|COMPLETED|Second Intervention (up to 24 Days)||28
917509|NCT01591499|2218864|P2|COMPLETED|Second Intervention (up to 24 Days)||34
917510|NCT01591499|2218865|P1|COMPLETED|Second Intervention (up to 24 Days)||27
917511|NCT01591499|2218862|P4|STARTED|Second Intervention (up to 24 Days)||37
917512|NCT01591499|2218863|P3|STARTED|Second Intervention (up to 24 Days)||31
917513|NCT01591499|2218864|P2|STARTED|Second Intervention (up to 24 Days)||37
917514|NCT01591499|2218865|P1|STARTED|Second Intervention (up to 24 Days)||33
917515|NCT01591499|2218862|P4|NOT COMPLETED|First Intervention (up to 24 Days)||0
917516|NCT01591499|2218863|P3|NOT COMPLETED|First Intervention (up to 24 Days)||0
917517|NCT01591499|2218864|P2|NOT COMPLETED|First Intervention (up to 24 Days)||0
917518|NCT01591499|2218865|P1|NOT COMPLETED|First Intervention (up to 24 Days)||0
917519|NCT01591499|2218862|P4|COMPLETED|First Intervention (up to 24 Days)||37
917520|NCT01591499|2218863|P3|COMPLETED|First Intervention (up to 24 Days)||31
917521|NCT01591499|2218864|P2|COMPLETED|First Intervention (up to 24 Days)||37
917522|NCT01591499|2218865|P1|COMPLETED|First Intervention (up to 24 Days)||33
917523|NCT01591499|2218862|P4|STARTED|First Intervention (up to 24 Days)||37
917524|NCT01591499|2218863|P3|STARTED|First Intervention (up to 24 Days)||31
917525|NCT01591499|2218864|P2|STARTED|First Intervention (up to 24 Days)||37
917526|NCT01591499|2218865|P1|STARTED|First Intervention (up to 24 Days)||33
917527|NCT01591499|2218862|P4|NOT COMPLETED|Baseline Visit||2
917528|NCT01591499|2218863|P3|NOT COMPLETED|Baseline Visit||0
917529|NCT01591499|2218864|P2|NOT COMPLETED|Baseline Visit||2
917530|NCT01591499|2218865|P1|NOT COMPLETED|Baseline Visit||0
917531|NCT01591499|2218862|P4|COMPLETED|Baseline Visit||37
917532|NCT01591499|2218863|P3|COMPLETED|Baseline Visit||31
917533|NCT01591499|2218864|P2|COMPLETED|Baseline Visit||37
917534|NCT01591499|2218865|P1|COMPLETED|Baseline Visit||33
917535|NCT01591499|2218862|P4|STARTED|Baseline Visit||39
917536|NCT01591499|2218863|P3|STARTED|Baseline Visit||31
917537|NCT01591499|2218864|P2|STARTED|Baseline Visit||39
917538|NCT01591499|2218865|P1|STARTED|Baseline Visit||33
917539|NCT01591460|2218931|P1|NOT COMPLETED|Overall Study||26
917540|NCT01591460|2218931|P1|COMPLETED|Overall Study|The number who completed PEG-IFN, as scheduled according to response-guided treatment, is presented.|139
917541|NCT01591460|2218931|P1|STARTED|Overall Study|Those with elevated (Week 12) or detectable (Week 24) virus discontinued due to the Futility Rule.|165
917542|NCT01591408|2219013|P2|NOT COMPLETED|Overall Study||8
917543|NCT01591408|2219014|P1|NOT COMPLETED|Overall Study||12
917544|NCT01591408|2219013|P2|COMPLETED|Overall Study||24
917545|NCT01591408|2219014|P1|COMPLETED|Overall Study||24
917546|NCT01591408|2219013|P2|STARTED|Overall Study||32
917547|NCT01591408|2219014|P1|STARTED|Overall Study||36
917548|NCT01591382|2219022|P2|NOT COMPLETED|Overall Study||2
917549|NCT01591382|2219023|P1|NOT COMPLETED|Overall Study||3
917550|NCT01591382|2219022|P2|COMPLETED|Overall Study||30
917551|NCT01591382|2219023|P1|COMPLETED|Overall Study||29
917552|NCT01591382|2219022|P2|STARTED|Overall Study||32
917553|NCT01591382|2219023|P1|STARTED|Overall Study||32
917554|NCT01591317|2219040|P3|NOT COMPLETED|Overall Study||0
917555|NCT01591317|2219041|P2|NOT COMPLETED|Overall Study||0
917556|NCT01591317|2219042|P1|NOT COMPLETED|Overall Study||0
917557|NCT01591317|2219040|P3|COMPLETED|Overall Study||10
917558|NCT01591317|2219041|P2|COMPLETED|Overall Study||10
917559|NCT01591317|2219042|P1|COMPLETED|Overall Study||10
917560|NCT01591317|2219040|P3|STARTED|Overall Study||10
917561|NCT01591317|2219041|P2|STARTED|Overall Study||10
917562|NCT01591317|2219042|P1|STARTED|Overall Study||10
917563|NCT01591044|2219071|P3|NOT COMPLETED|Overall Study||4
917564|NCT01591044|2219072|P2|NOT COMPLETED|Overall Study||9
917565|NCT01591044|2219073|P1|NOT COMPLETED|Overall Study||7
917566|NCT01591044|2219071|P3|COMPLETED|Overall Study||96
917567|NCT01591044|2219072|P2|COMPLETED|Overall Study||91
917568|NCT01591044|2219073|P1|COMPLETED|Overall Study||94
917569|NCT01591044|2219071|P3|STARTED|Overall Study||100
917570|NCT01591044|2219072|P2|STARTED|Overall Study||100
917571|NCT01591044|2219073|P1|STARTED|Overall Study||101
917572|NCT01591018|2219083|P2|NOT COMPLETED|Overall Study||0
917573|NCT01591018|2219084|P1|NOT COMPLETED|Overall Study||0
917574|NCT01591018|2219083|P2|COMPLETED|Overall Study||60
917575|NCT01591018|2219084|P1|COMPLETED|Overall Study||60
917576|NCT01591018|2219083|P2|STARTED|Overall Study||60
917577|NCT01591018|2219084|P1|STARTED|Overall Study||60
917578|NCT01591005|2219098|P4|NOT COMPLETED|Overall Study||0
917579|NCT01591005|2219099|P3|NOT COMPLETED|Overall Study||0
917580|NCT01591005|2219100|P2|NOT COMPLETED|Overall Study||0
917581|NCT01591005|2219101|P1|NOT COMPLETED|Overall Study||0
917582|NCT01591005|2219098|P4|COMPLETED|Overall Study||68
917583|NCT01591005|2219099|P3|COMPLETED|Overall Study||68
917584|NCT01591005|2219100|P2|COMPLETED|Overall Study||53
917585|NCT01591005|2219101|P1|COMPLETED|Overall Study||53
917586|NCT01591005|2219098|P4|STARTED|Overall Study||68
917587|NCT01591005|2219099|P3|STARTED|Overall Study||68
917588|NCT01591005|2219100|P2|STARTED|Overall Study||53
917589|NCT01591005|2219101|P1|STARTED|Overall Study||53
917590|NCT01590979|2219137|P2|NOT COMPLETED|Overall Study||0
917591|NCT01590979|2219138|P1|NOT COMPLETED|Overall Study||0
917592|NCT01590979|2219137|P2|COMPLETED|Overall Study||27
917593|NCT01590979|2219138|P1|COMPLETED|Overall Study||27
917594|NCT01590979|2219137|P2|STARTED|Overall Study||27
917595|NCT01590979|2219138|P1|STARTED|Overall Study||27
917596|NCT01590888|2219147|P3|NOT COMPLETED|Overall Study||1
917597|NCT01590888|2219148|P2|NOT COMPLETED|Overall Study||0
917598|NCT01590888|2219149|P1|NOT COMPLETED|Overall Study||4
917599|NCT01590888|2219147|P3|COMPLETED|Overall Study||34
917600|NCT01590888|2219148|P2|COMPLETED|Overall Study||38
917601|NCT01590888|2219149|P1|COMPLETED|Overall Study||32
917602|NCT01590888|2219147|P3|STARTED|Overall Study||35
917603|NCT01590888|2219148|P2|STARTED|Overall Study||38
917604|NCT01590888|2219149|P1|STARTED|Overall Study||36
917605|NCT01590875|2219195|P2|NOT COMPLETED|Overall Study||0
917606|NCT01590875|2219196|P1|NOT COMPLETED|Overall Study||0
917607|NCT01590875|2219195|P2|COMPLETED|Overall Study||10
917608|NCT01590875|2219196|P1|COMPLETED|Overall Study||10
917609|NCT01590875|2219195|P2|STARTED|Overall Study||10
917610|NCT01590875|2219196|P1|STARTED|Overall Study||10
917611|NCT01590810|2219213|P5|NOT COMPLETED|Overall Study||0
917612|NCT01590810|2219214|P4|NOT COMPLETED|Overall Study||0
917613|NCT01590810|2219215|P3|NOT COMPLETED|Overall Study||1
917614|NCT01590810|2219216|P2|NOT COMPLETED|Overall Study||1
917615|NCT01590810|2219217|P1|NOT COMPLETED|Overall Study||0
917616|NCT01590810|2219213|P5|COMPLETED|Overall Study||2
917617|NCT01590810|2219214|P4|COMPLETED|Overall Study||8
917618|NCT01590810|2219215|P3|COMPLETED|Overall Study||7
917619|NCT01590810|2219216|P2|COMPLETED|Overall Study||7
917620|NCT01590810|2219217|P1|COMPLETED|Overall Study||8
917621|NCT01590810|2219213|P5|STARTED|Overall Study||2
917622|NCT01590810|2219214|P4|STARTED|Overall Study||8
917623|NCT01590810|2219215|P3|STARTED|Overall Study||8
917624|NCT01590810|2219216|P2|STARTED|Overall Study||8
917625|NCT01590810|2219217|P1|STARTED|Overall Study||8
917626|NCT01590797|2219362|P2|NOT COMPLETED|Overall Study||16
917627|NCT01590797|2219363|P1|NOT COMPLETED|Overall Study||17
917628|NCT01590797|2219362|P2|COMPLETED|Overall Study||217
917629|NCT01590797|2219363|P1|COMPLETED|Overall Study||217
917630|NCT01590797|2219362|P2|STARTED|Overall Study||233
917631|NCT01590797|2219363|P1|STARTED|Overall Study||234
917632|NCT01590771|2219379|P2|NOT COMPLETED|Overall Study||39
917633|NCT01590771|2219380|P1|NOT COMPLETED|Overall Study||19
917634|NCT01590771|2219379|P2|COMPLETED|Overall Study||210
917635|NCT01590771|2219380|P1|COMPLETED|Overall Study||230
917636|NCT01590771|2219379|P2|STARTED|Overall Study||249
917637|NCT01590771|2219380|P1|STARTED|Overall Study||249
917638|NCT01590758|2219408|P2|NOT COMPLETED|Overall Study||7
917639|NCT01590758|2219409|P1|NOT COMPLETED|Overall Study||5
917640|NCT01590758|2219408|P2|COMPLETED|Overall Study||97
917641|NCT01590758|2219409|P1|COMPLETED|Overall Study||80
917642|NCT01590758|2219408|P2|STARTED|Overall Study||104
917643|NCT01590758|2219409|P1|STARTED|Overall Study||85
917644|NCT01590563|2219419|P1|NOT COMPLETED|Overall Study||1
917645|NCT01590563|2219419|P1|COMPLETED|Overall Study||14
917646|NCT01590563|2219419|P1|STARTED|Overall Study||15
917647|NCT01590550|2219425|P1|NOT COMPLETED|Overall Study||0
917648|NCT01590550|2219425|P1|COMPLETED|Overall Study||18
917649|NCT01590550|2219425|P1|STARTED|Overall Study||18
917650|NCT01590264|2219431|P1|NOT COMPLETED|Overall Study||0
917651|NCT01590264|2219431|P1|COMPLETED|Overall Study||5
917652|NCT01590264|2219431|P1|STARTED|Overall Study||5
917653|NCT01590238|2219436|P1|NOT COMPLETED|Overall Study||2
917654|NCT01590238|2219436|P1|COMPLETED|Overall Study||13
917655|NCT01590238|2219436|P1|STARTED|Overall Study||15
917656|NCT01590212|2219443|P3|NOT COMPLETED|Overall Study||5
917657|NCT01590212|2219444|P2|NOT COMPLETED|Overall Study||4
917658|NCT01590212|2219445|P1|NOT COMPLETED|Overall Study||3
917659|NCT01590212|2219443|P3|COMPLETED|Overall Study||9
917660|NCT01590212|2219444|P2|COMPLETED|Overall Study||5
917661|NCT01590212|2219445|P1|COMPLETED|Overall Study|Includes 2 contacted who failed contact at post-intervention data collection point|9
917662|NCT01590212|2219443|P3|Post-intervention|Overall Study|failed contact=1|10
917663|NCT01590212|2219444|P2|Post-intervention|Overall Study|failed contact=2; withdrew=1|6
917664|NCT01590212|2219445|P1|Post-intervention|Overall Study|failed contact=3|7
917665|NCT01590212|2219443|P3|Baseline (Pre-intervention)|Overall Study|failed contact=2|12
917666|NCT01590212|2219444|P2|Baseline (Pre-intervention)|Overall Study||9
917667|NCT01590212|2219445|P1|Baseline (Pre-intervention)|Overall Study|withdrew=2|10
917668|NCT01590212|2219443|P3|STARTED|Overall Study||14
917669|NCT01590212|2219444|P2|STARTED|Overall Study||9
917670|NCT01590212|2219445|P1|STARTED|Overall Study||12
917671|NCT01589978|2219462|P1|NOT COMPLETED|Overall Study||0
917672|NCT01589978|2219462|P1|COMPLETED|Overall Study||2681
917673|NCT01589978|2219462|P1|STARTED|Overall Study||2681
917674|NCT01589822|2219489|P3|NOT COMPLETED|Overall Study||1
917675|NCT01589822|2219490|P2|NOT COMPLETED|Overall Study||3
917676|NCT01589822|2219491|P1|NOT COMPLETED|Overall Study||4
917677|NCT01589822|2219489|P3|COMPLETED|Overall Study||40
917678|NCT01589822|2219490|P2|COMPLETED|Overall Study||86
917679|NCT01589822|2219491|P1|COMPLETED|Overall Study||80
917680|NCT01589822|2219489|P3|STARTED|Overall Study||41
917681|NCT01589822|2219490|P2|STARTED|Overall Study||89
917682|NCT01589822|2219491|P1|STARTED|Overall Study||84
917683|NCT01589653|2219510|P2|NOT COMPLETED|Overall Study||11
917684|NCT01589653|2219511|P1|NOT COMPLETED|Overall Study||7
917685|NCT01589653|2219510|P2|COMPLETED|Overall Study||68
917686|NCT01589653|2219511|P1|COMPLETED|Overall Study||69
917687|NCT01589653|2219510|P2|Exposed|Overall Study||78
917688|NCT01589653|2219511|P1|Exposed|Overall Study||76
917689|NCT01589653|2219510|P2|STARTED|Overall Study||79
917690|NCT01589653|2219511|P1|STARTED|Overall Study||76
917691|NCT01589601|2219527|P2|NOT COMPLETED|Overall Study||49
917692|NCT01589601|2219528|P1|NOT COMPLETED|Overall Study||47
917693|NCT01589601|2219527|P2|COMPLETED|Overall Study||26
917694|NCT01589601|2219528|P1|COMPLETED|Overall Study||28
917695|NCT01589601|2219527|P2|STARTED|Overall Study||75
917696|NCT01589601|2219528|P1|STARTED|Overall Study||75
917697|NCT01589510|2219544|P1|NOT COMPLETED|Overall Study||33
917698|NCT01589510|2219544|P1|COMPLETED|Overall Study||386
917699|NCT01589510|2219544|P1|STARTED|Overall Study||419
917700|NCT01589497|2219559|P4|NOT COMPLETED|Overall Study||1
917701|NCT01589497|2219560|P3|NOT COMPLETED|Overall Study||1
917702|NCT01589497|2219561|P2|NOT COMPLETED|Overall Study||1
917703|NCT01589497|2219562|P1|NOT COMPLETED|Overall Study||1
917704|NCT01589497|2219559|P4|COMPLETED|Overall Study||17
917705|NCT01589497|2219560|P3|COMPLETED|Overall Study||15
917706|NCT01589497|2219561|P2|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|16
917707|NCT01589497|2219562|P1|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|17
917708|NCT01589497|2219559|P4|STARTED|Overall Study||18
917709|NCT01589497|2219560|P3|STARTED|Overall Study||16
917710|NCT01589497|2219561|P2|STARTED|Overall Study||17
917711|NCT01589497|2219562|P1|STARTED|Overall Study||18
917712|NCT01589484|2219595|P1|NOT COMPLETED|Overall Study||4
917713|NCT01589484|2219595|P1|COMPLETED|Overall Study||100
917714|NCT01589484|2219595|P1|STARTED|Overall Study||104
917715|NCT01589445|2219600|P1|NOT COMPLETED|002 (Metformin)-3 Months||9
917716|NCT01589445|2219600|P1|COMPLETED|002 (Metformin)-3 Months|61 patients completed the drug 002.9 patients dropped out.|61
917717|NCT01589445|2219600|P1|STARTED|002 (Metformin)-3 Months|70 patients participated for trial of drug 002.|70
917718|NCT01589445|2219600|P1|NOT COMPLETED|001 (Pioglitazone) -3 Months||7
917719|NCT01589445|2219600|P1|COMPLETED|001 (Pioglitazone) -3 Months|dropped out 7 patients|70
917720|NCT01589445|2219600|P1|STARTED|001 (Pioglitazone) -3 Months||77
917721|NCT01589237|2219620|P4|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
917722|NCT01589237|2219621|P3|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
917723|NCT01589237|2219622|P2|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||6
917724|NCT01589237|2219623|P1|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||5
917725|NCT01589237|2219620|P4|COMPLETED|Part B (Planned for 78 Week-terminated)||0
917726|NCT01589237|2219621|P3|COMPLETED|Part B (Planned for 78 Week-terminated)||0
917727|NCT01589237|2219622|P2|COMPLETED|Part B (Planned for 78 Week-terminated)||0
917728|NCT01589237|2219623|P1|COMPLETED|Part B (Planned for 78 Week-terminated)||0
917729|NCT01589237|2219620|P4|STARTED|Part B (Planned for 78 Week-terminated)||4
917730|NCT01589237|2219621|P3|STARTED|Part B (Planned for 78 Week-terminated)||4
917731|NCT01589237|2219622|P2|STARTED|Part B (Planned for 78 Week-terminated)||6
917732|NCT01589237|2219623|P1|STARTED|Part B (Planned for 78 Week-terminated)||5
917733|NCT01589237|2219620|P4|NOT COMPLETED|Part A (52 Weeks)||0
917734|NCT01589237|2219621|P3|NOT COMPLETED|Part A (52 Weeks)||2
917735|NCT01589237|2219622|P2|NOT COMPLETED|Part A (52 Weeks)||3
917736|NCT01589237|2219623|P1|NOT COMPLETED|Part A (52 Weeks)||2
917737|NCT01589237|2219620|P4|COMPLETED|Part A (52 Weeks)||5
917738|NCT01589237|2219621|P3|COMPLETED|Part A (52 Weeks)||8
917739|NCT01589237|2219622|P2|COMPLETED|Part A (52 Weeks)||9
917740|NCT01589237|2219623|P1|COMPLETED|Part A (52 Weeks)||9
917741|NCT01589237|2219620|P4|STARTED|Part A (52 Weeks)||5
917742|NCT01589237|2219621|P3|STARTED|Part A (52 Weeks)||10
917743|NCT01589237|2219622|P2|STARTED|Part A (52 Weeks)||12
917744|NCT01589237|2219623|P1|STARTED|Part A (52 Weeks)|"Started = Full analysis set/safety set"|11
917745|NCT01588951|2219672|P3|NOT COMPLETED|Overall Study||1
917746|NCT01588951|2219673|P2|NOT COMPLETED|Overall Study||0
917747|NCT01588951|2219674|P1|NOT COMPLETED|Overall Study||0
917748|NCT01588951|2219672|P3|COMPLETED|Overall Study||5
917749|NCT01588951|2219673|P2|COMPLETED|Overall Study||2
917750|NCT01588951|2219674|P1|COMPLETED|Overall Study||2
917751|NCT01588951|2219672|P3|STARTED|Overall Study||6
917752|NCT01588951|2219673|P2|STARTED|Overall Study||2
917753|NCT01588951|2219674|P1|STARTED|Overall Study||2
917754|NCT01588561|2219682|P2|NOT COMPLETED|Overall Study||0
917755|NCT01588561|2219683|P1|NOT COMPLETED|Overall Study||0
917756|NCT01588561|2219682|P2|COMPLETED|Overall Study||1
917757|NCT01588561|2219683|P1|COMPLETED|Overall Study||14
917758|NCT01588561|2219682|P2|Second Injection (Visit 2)|Overall Study||1
917759|NCT01588561|2219683|P1|Second Injection (Visit 2)|Overall Study||14
917760|NCT01588561|2219682|P2|Rest Period|Overall Study||1
917761|NCT01588561|2219683|P1|Rest Period|Overall Study||14
917762|NCT01588561|2219682|P2|First Injection (Visit 1)|Overall Study||1
917763|NCT01588561|2219683|P1|First Injection (Visit 1)|Overall Study||14
917764|NCT01588561|2219682|P2|STARTED|Overall Study||1
917765|NCT01588561|2219683|P1|STARTED|Overall Study||14
917766|NCT01588548|2219700|P6|NOT COMPLETED|Overall Study||6
917767|NCT01588548|2219701|P5|NOT COMPLETED|Overall Study||6
917768|NCT01588548|2219702|P4|NOT COMPLETED|Overall Study||7
917769|NCT01588548|2219703|P3|NOT COMPLETED|Overall Study||6
917770|NCT01588548|2219704|P2|NOT COMPLETED|Overall Study||7
917771|NCT01588548|2219705|P1|NOT COMPLETED|Overall Study||3
917772|NCT01588548|2219700|P6|COMPLETED|Overall Study||0
917773|NCT01588548|2219701|P5|COMPLETED|Overall Study||0
917774|NCT01588548|2219702|P4|COMPLETED|Overall Study||0
917775|NCT01588548|2219703|P3|COMPLETED|Overall Study||0
917776|NCT01588548|2219704|P2|COMPLETED|Overall Study||0
917777|NCT01588548|2219705|P1|COMPLETED|Overall Study||0
917778|NCT01588548|2219700|P6|Cycle 1 Day 21|Overall Study||3
917779|NCT01588548|2219701|P5|Cycle 1 Day 21|Overall Study||3
917780|NCT01588548|2219702|P4|Cycle 1 Day 21|Overall Study||5
917781|NCT01588548|2219703|P3|Cycle 1 Day 21|Overall Study||2
917782|NCT01588548|2219704|P2|Cycle 1 Day 21|Overall Study||5
917783|NCT01588548|2219705|P1|Cycle 1 Day 21|Overall Study||3
917784|NCT01588548|2219700|P6|STARTED|Overall Study||6
917785|NCT01588548|2219701|P5|STARTED|Overall Study||6
917786|NCT01588548|2219702|P4|STARTED|Overall Study||7
917787|NCT01588548|2219703|P3|STARTED|Overall Study||6
917788|NCT01588548|2219704|P2|STARTED|Overall Study||7
917789|NCT01588548|2219705|P1|STARTED|Overall Study||3
917790|NCT01588496|2219722|P3|NOT COMPLETED|Overall Study||0
917791|NCT01588496|2219723|P2|NOT COMPLETED|Overall Study||1
917792|NCT01588496|2219724|P1|NOT COMPLETED|Overall Study||0
917793|NCT01588496|2219722|P3|COMPLETED|Overall Study||33
917794|NCT01588496|2219723|P2|COMPLETED|Overall Study||16
917795|NCT01588496|2219724|P1|COMPLETED|Overall Study||8
917796|NCT01588496|2219722|P3|Received Treatment|Overall Study||33
917797|NCT01588496|2219723|P2|Received Treatment|Overall Study||16
917798|NCT01588496|2219724|P1|Received Treatment|Overall Study||8
917799|NCT01588496|2219722|P3|STARTED|Overall Study||33
917800|NCT01588496|2219723|P2|STARTED|Overall Study||17
917801|NCT01588496|2219724|P1|STARTED|Overall Study||8
917802|NCT01588444|2219751|P2|NOT COMPLETED|Overall Study||0
917803|NCT01588444|2219752|P1|NOT COMPLETED|Overall Study||0
917804|NCT01588444|2219751|P2|COMPLETED|Overall Study||20
917805|NCT01588444|2219752|P1|COMPLETED|Overall Study||20
917806|NCT01588444|2219751|P2|STARTED|Overall Study||20
917807|NCT01588444|2219752|P1|STARTED|Overall Study||20
917808|NCT01588418|2219758|P2|NOT COMPLETED|Overall Study||0
917809|NCT01588418|2219759|P1|NOT COMPLETED|Overall Study||0
917810|NCT01588418|2219758|P2|COMPLETED|Overall Study||4
917811|NCT01588418|2219759|P1|COMPLETED|Overall Study||11
917812|NCT01588418|2219758|P2|STARTED|Overall Study||4
917813|NCT01588418|2219759|P1|STARTED|Overall Study||11
917814|NCT01588405|2219763|P1|NOT COMPLETED|Overall Study||2
917815|NCT01588405|2219763|P1|COMPLETED|Overall Study||31
917816|NCT01588405|2219763|P1|STARTED|Overall Study||33
917817|NCT01588353|2219790|P3|NOT COMPLETED|Step3||2
917818|NCT01588353|2219791|P2|NOT COMPLETED|Step3||0
917819|NCT01588353|2219792|P1|NOT COMPLETED|Step3||0
917820|NCT01588353|2219790|P3|COMPLETED|Step3||23
917821|NCT01588353|2219791|P2|COMPLETED|Step3||0
917822|NCT01588353|2219792|P1|COMPLETED|Step3||0
917823|NCT01588353|2219790|P3|STARTED|Step3||25
917824|NCT01588353|2219791|P2|STARTED|Step3||0
917825|NCT01588353|2219792|P1|STARTED|Step3||0
917826|NCT01588353|2219790|P3|NOT COMPLETED|Step2||0
917827|NCT01588353|2219791|P2|NOT COMPLETED|Step2||1
917828|NCT01588353|2219792|P1|NOT COMPLETED|Step2||0
917829|NCT01588353|2219790|P3|COMPLETED|Step2||0
917830|NCT01588353|2219791|P2|COMPLETED|Step2||70
917831|NCT01588353|2219792|P1|COMPLETED|Step2||0
917832|NCT01588353|2219790|P3|STARTED|Step2||0
917833|NCT01588353|2219791|P2|STARTED|Step2||71
917834|NCT01588353|2219792|P1|STARTED|Step2||0
917835|NCT01588353|2219790|P3|NOT COMPLETED|Step1||0
917836|NCT01588353|2219791|P2|NOT COMPLETED|Step1||0
917837|NCT01588353|2219792|P1|NOT COMPLETED|Step1||0
917838|NCT01588353|2219790|P3|COMPLETED|Step1||0
917839|NCT01588353|2219791|P2|COMPLETED|Step1||0
917840|NCT01588353|2219792|P1|COMPLETED|Step1||6
917841|NCT01588353|2219790|P3|STARTED|Step1||0
917842|NCT01588353|2219791|P2|STARTED|Step1||0
917843|NCT01588353|2219792|P1|STARTED|Step1||6
917844|NCT01588158|2219810|P2|NOT COMPLETED|Overall Study||0
917845|NCT01588158|2219811|P1|NOT COMPLETED|Overall Study||0
917846|NCT01588158|2219810|P2|COMPLETED|Overall Study||3
917847|NCT01588158|2219811|P1|COMPLETED|Overall Study||4
917848|NCT01588158|2219810|P2|STARTED|Overall Study||3
917849|NCT01588158|2219811|P1|STARTED|Overall Study||4
917850|NCT01588106|2219835|P2|NOT COMPLETED|Overall Study||4
917851|NCT01588106|2219836|P1|NOT COMPLETED|Overall Study||5
917852|NCT01588106|2219835|P2|COMPLETED|Overall Study||72
917853|NCT01588106|2219836|P1|COMPLETED|Overall Study||73
917854|NCT01588106|2219835|P2|STARTED|Overall Study||76
917855|NCT01588106|2219836|P1|STARTED|Overall Study||78
917856|NCT01587989|2219844|P3|NOT COMPLETED|Randomized Study Treatment||1
917857|NCT01587989|2219845|P2|NOT COMPLETED|Randomized Study Treatment||2
917858|NCT01587989|2219846|P1|NOT COMPLETED|Randomized Study Treatment||0
917859|NCT01587989|2219844|P3|COMPLETED|Randomized Study Treatment||32
917860|NCT01587989|2219845|P2|COMPLETED|Randomized Study Treatment||30
917861|NCT01587989|2219846|P1|COMPLETED|Randomized Study Treatment||0
917862|NCT01587989|2219844|P3|STARTED|Randomized Study Treatment||33
917863|NCT01587989|2219845|P2|STARTED|Randomized Study Treatment||32
917864|NCT01587989|2219846|P1|STARTED|Randomized Study Treatment||0
917865|NCT01587989|2219844|P3|NOT COMPLETED|12-Week Open-Label Run-In Period||0
917866|NCT01587989|2219845|P2|NOT COMPLETED|12-Week Open-Label Run-In Period||0
917867|NCT01587989|2219846|P1|NOT COMPLETED|12-Week Open-Label Run-In Period||12
917868|NCT01587989|2219844|P3|COMPLETED|12-Week Open-Label Run-In Period||0
917869|NCT01587989|2219845|P2|COMPLETED|12-Week Open-Label Run-In Period||0
917870|NCT01587989|2219846|P1|COMPLETED|12-Week Open-Label Run-In Period||65
917871|NCT01587989|2219844|P3|STARTED|12-Week Open-Label Run-In Period||0
917872|NCT01587989|2219845|P2|STARTED|12-Week Open-Label Run-In Period||0
917873|NCT01587989|2219846|P1|STARTED|12-Week Open-Label Run-In Period||77
917874|NCT01587963|2219870|P2|NOT COMPLETED|Overall Study||0
917875|NCT01587963|2219871|P1|NOT COMPLETED|Overall Study||1
917876|NCT01587963|2219870|P2|COMPLETED|Overall Study||4
917877|NCT01587963|2219871|P1|COMPLETED|Overall Study||6
917878|NCT01587963|2219870|P2|STARTED|Overall Study||4
917879|NCT01587963|2219871|P1|STARTED|Overall Study||7
917880|NCT01587950|2219877|P1|NOT COMPLETED|Period 3||0
917881|NCT01587950|2219877|P1|COMPLETED|Period 3||12
917882|NCT01587950|2219877|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 3||5
917883|NCT01587950|2219877|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 3||3
917884|NCT01587950|2219877|P1|Received 5% KNO3 Solution (2 Minutes)|Period 3||3
917885|NCT01587950|2219877|P1|Received 5% KNO3 Solution (5 Minutes)|Period 3||5
917886|NCT01587950|2219877|P1|Received Sterile Water (5 Minutes)|Period 3||5
917887|NCT01587950|2219877|P1|Received 5% KNO3 Solution (10 Minutes)|Period 3||4
917888|NCT01587950|2219877|P1|Received Sterile Water (2 Minutes)|Period 3||2
917889|NCT01587950|2219877|P1|Received Sterile Water (10 Minutes)|Period 3||5
917890|NCT01587950|2219877|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 3||4
917891|NCT01587950|2219877|P1|STARTED|Period 3||12
917892|NCT01587950|2219877|P1|NOT COMPLETED|Washout 2||0
917893|NCT01587950|2219877|P1|COMPLETED|Washout 2||12
917894|NCT01587950|2219877|P1|STARTED|Washout 2||12
917895|NCT01587950|2219877|P1|NOT COMPLETED|Period 2||0
917896|NCT01587950|2219877|P1|COMPLETED|Period 2||12
917897|NCT01587950|2219877|P1|Received 5% KNO3 Solution (5 Minutes)|Period 2||2
917898|NCT01587950|2219877|P1|Received Sterile Water (10 Minutes)|Period 2||2
917899|NCT01587950|2219877|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 2||4
917900|NCT01587950|2219877|P1|Received Sterile Water (5 Minutes)|Period 2||2
917901|NCT01587950|2219877|P1|Received 5% KNO3 Solution (2 Minutes)|Period 2||6
917902|NCT01587950|2219877|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 2||6
917903|NCT01587950|2219877|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 2||2
917904|NCT01587950|2219877|P1|Received 5% KNO3 Solution (10 Minutes)|Period 2||4
917905|NCT01587950|2219877|P1|Received Sterile Water (2 Minutes)|Period 2||8
917906|NCT01587950|2219877|P1|STARTED|Period 2||12
917907|NCT01587950|2219877|P1|NOT COMPLETED|Washout 1||0
917908|NCT01587950|2219877|P1|COMPLETED|Washout 1||12
917909|NCT01587950|2219877|P1|STARTED|Washout 1||12
917910|NCT01587950|2219877|P1|NOT COMPLETED|Period 1||0
917911|NCT01587950|2219877|P1|COMPLETED|Period 1||12
917912|NCT01587950|2219877|P1|Received Sterile Water (5 Minutes)|Period 1||5
917913|NCT01587950|2219877|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 1||5
917914|NCT01587950|2219877|P1|Received Sterile Water (10 Minutes)|Period 1||5
917915|NCT01587950|2219877|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 1||3
917916|NCT01587950|2219877|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 1||4
917917|NCT01587950|2219877|P1|Received 5% KNO3 Solution (10 Minutes)|Period 1||4
917918|NCT01587950|2219877|P1|Received Sterile Water (2 Minutes)|Period 1||2
917919|NCT01587950|2219877|P1|Received 5% KNO3 Solution (2 Minutes)|Period 1||3
917920|NCT01587950|2219877|P1|Received 5% KNO3 Solution (5 Minutes)|Period 1||5
917921|NCT01587950|2219877|P1|STARTED|Period 1||12
917922|NCT01587924|2219911|P4|NOT COMPLETED|Overall Study||1
917923|NCT01587924|2219912|P3|NOT COMPLETED|Overall Study||4
917924|NCT01587924|2219913|P2|NOT COMPLETED|Overall Study||4
917925|NCT01587924|2219914|P1|NOT COMPLETED|Overall Study||4
917926|NCT01587924|2219911|P4|COMPLETED|Overall Study||19
917927|NCT01587924|2219912|P3|COMPLETED|Overall Study||17
917928|NCT01587924|2219913|P2|COMPLETED|Overall Study||17
917929|NCT01587924|2219914|P1|COMPLETED|Overall Study||17
917930|NCT01587924|2219911|P4|STARTED|Overall Study||20
917931|NCT01587924|2219912|P3|STARTED|Overall Study||21
917932|NCT01587924|2219913|P2|STARTED|Overall Study||21
917933|NCT01587924|2219914|P1|STARTED|Overall Study||21
917934|NCT01587885|2220011|P2|NOT COMPLETED|Treatment Period 2||0
917935|NCT01587885|2220012|P1|NOT COMPLETED|Treatment Period 2||0
917936|NCT01587885|2220011|P2|COMPLETED|Treatment Period 2||19
917937|NCT01587885|2220012|P1|COMPLETED|Treatment Period 2||26
917938|NCT01587885|2220011|P2|STARTED|Treatment Period 2||19
917939|NCT01587885|2220012|P1|STARTED|Treatment Period 2||26
917940|NCT01587885|2220011|P2|NOT COMPLETED|Treatment Period 1||3
917941|NCT01587885|2220012|P1|NOT COMPLETED|Treatment Period 1||0
917942|NCT01587885|2220011|P2|COMPLETED|Treatment Period 1||19
917943|NCT01587885|2220012|P1|COMPLETED|Treatment Period 1||26
917944|NCT01587885|2220011|P2|STARTED|Treatment Period 1||22
917945|NCT01587885|2220012|P1|STARTED|Treatment Period 1||26
917946|NCT01587651|2220028|P3|NOT COMPLETED|Overall Study||1
917947|NCT01587651|2220029|P2|NOT COMPLETED|Overall Study||3
917948|NCT01587651|2220030|P1|NOT COMPLETED|Overall Study||0
917949|NCT01587651|2220028|P3|COMPLETED|Overall Study||34
917950|NCT01587651|2220029|P2|COMPLETED|Overall Study||38
917951|NCT01587651|2220030|P1|COMPLETED|Overall Study||34
917952|NCT01587651|2220028|P3|STARTED|Overall Study||35
917953|NCT01587651|2220029|P2|STARTED|Overall Study||41
917954|NCT01587651|2220030|P1|STARTED|Overall Study||34
917955|NCT01587118|2220057|P1|NOT COMPLETED|Overall Study||7
917956|NCT01587118|2220057|P1|COMPLETED|Overall Study||11
917957|NCT01587118|2220057|P1|STARTED|Overall Study|31 signed consent and 18 were deemed eligible and initiated treatment with adjunctive asenapine.|18
917958|NCT01587105|2220064|P2|NOT COMPLETED|Overall Study||43
917959|NCT01587105|2220065|P1|NOT COMPLETED|Overall Study||6
917960|NCT01587105|2220064|P2|COMPLETED|Overall Study||138
917961|NCT01587105|2220065|P1|COMPLETED|Overall Study||144
917962|NCT01587105|2220064|P2|STARTED|Overall Study||181
917963|NCT01587105|2220065|P1|STARTED|Overall Study||150
917964|NCT01587079|2220081|P1|NOT COMPLETED|Overall Study||39
917965|NCT01587079|2220081|P1|COMPLETED|Overall Study||120
917966|NCT01587079|2220081|P1|STARTED|Overall Study||159
917967|NCT01587027|2220205|P2|NOT COMPLETED|Discharge (1 Day)||0
917968|NCT01587027|2220206|P1|NOT COMPLETED|Discharge (1 Day)||0
917969|NCT01587027|2220205|P2|COMPLETED|Discharge (1 Day)||8
917970|NCT01587027|2220206|P1|COMPLETED|Discharge (1 Day)||8
917971|NCT01587027|2220205|P2|STARTED|Discharge (1 Day)||8
917972|NCT01587027|2220206|P1|STARTED|Discharge (1 Day)||8
917973|NCT01587027|2220205|P2|NOT COMPLETED|Third Intervention (1 Day)||0
917974|NCT01587027|2220206|P1|NOT COMPLETED|Third Intervention (1 Day)||0
917975|NCT01587027|2220205|P2|COMPLETED|Third Intervention (1 Day)||8
917976|NCT01587027|2220206|P1|COMPLETED|Third Intervention (1 Day)||8
917977|NCT01587027|2220205|P2|STARTED|Third Intervention (1 Day)||8
917978|NCT01587027|2220206|P1|STARTED|Third Intervention (1 Day)||8
917979|NCT01587027|2220205|P2|NOT COMPLETED|Washout (1 Day)||0
917980|NCT01587027|2220206|P1|NOT COMPLETED|Washout (1 Day)||0
917981|NCT01587027|2220205|P2|COMPLETED|Washout (1 Day)||8
917982|NCT01587027|2220206|P1|COMPLETED|Washout (1 Day)||8
917983|NCT01587027|2220205|P2|STARTED|Washout (1 Day)||8
917984|NCT01587027|2220206|P1|STARTED|Washout (1 Day)||8
917985|NCT01587027|2220205|P2|NOT COMPLETED|Second Intervention (1 Day)||0
917986|NCT01587027|2220206|P1|NOT COMPLETED|Second Intervention (1 Day)||0
917987|NCT01587027|2220205|P2|COMPLETED|Second Intervention (1 Day)||8
917988|NCT01587027|2220206|P1|COMPLETED|Second Intervention (1 Day)||8
917989|NCT01587027|2220205|P2|STARTED|Second Intervention (1 Day)||8
917990|NCT01587027|2220206|P1|STARTED|Second Intervention (1 Day)||8
917991|NCT01587027|2220205|P2|NOT COMPLETED|Washout (1 Day)||0
917992|NCT01587027|2220206|P1|NOT COMPLETED|Washout (1 Day)||0
917993|NCT01587027|2220205|P2|COMPLETED|Washout (1 Day)||8
917994|NCT01587027|2220206|P1|COMPLETED|Washout (1 Day)||8
917995|NCT01587027|2220205|P2|STARTED|Washout (1 Day)||8
917996|NCT01587027|2220206|P1|STARTED|Washout (1 Day)||8
917997|NCT01587027|2220205|P2|NOT COMPLETED|First Intervention (1 Day)||0
917998|NCT01587027|2220206|P1|NOT COMPLETED|First Intervention (1 Day)||0
917999|NCT01587027|2220205|P2|COMPLETED|First Intervention (1 Day)||8
918000|NCT01587027|2220206|P1|COMPLETED|First Intervention (1 Day)||8
918001|NCT01587027|2220205|P2|STARTED|First Intervention (1 Day)||8
918002|NCT01587027|2220206|P1|STARTED|First Intervention (1 Day)||8
918003|NCT01587014|2220212|P1|NOT COMPLETED|Overall Study||2
918004|NCT01587014|2220212|P1|COMPLETED|Overall Study||24
918005|NCT01587014|2220212|P1|STARTED|Overall Study||26
918006|NCT01587001|2220219|P2|NOT COMPLETED|Overall Study||1
918007|NCT01587001|2220220|P1|NOT COMPLETED|Overall Study||6
918008|NCT01587001|2220219|P2|COMPLETED|Overall Study||2
918009|NCT01587001|2220220|P1|COMPLETED|Overall Study||8
918010|NCT01587001|2220219|P2|STARTED|Overall Study||3
918011|NCT01587001|2220220|P1|STARTED|Overall Study||14
918012|NCT01586975|2220231|P3|NOT COMPLETED|Overall Study||0
918013|NCT01586975|2220232|P2|NOT COMPLETED|Overall Study||0
918014|NCT01586975|2220233|P1|NOT COMPLETED|Overall Study||0
918015|NCT01586975|2220231|P3|COMPLETED|Overall Study||46
918016|NCT01586975|2220232|P2|COMPLETED|Overall Study||32
918017|NCT01586975|2220233|P1|COMPLETED|Overall Study||15
918018|NCT01586975|2220231|P3|STARTED|Overall Study||46
918019|NCT01586975|2220232|P2|STARTED|Overall Study||32
918020|NCT01586975|2220233|P1|STARTED|Overall Study||15
918021|NCT01586962|2220241|P1|NOT COMPLETED|Overall Study||0
918022|NCT01586962|2220241|P1|COMPLETED|Overall Study||56
918023|NCT01586962|2220241|P1|STARTED|Overall Study||56
918024|NCT01586897|2220249|P2|NOT COMPLETED|Overall Study||0
918025|NCT01586897|2220250|P1|NOT COMPLETED|Overall Study||0
918026|NCT01586897|2220249|P2|COMPLETED|Overall Study||26
918027|NCT01586897|2220250|P1|COMPLETED|Overall Study||26
918028|NCT01586897|2220249|P2|STARTED|Overall Study||26
918029|NCT01586897|2220250|P1|STARTED|Overall Study||26
918030|NCT01586819|2220268|P2|NOT COMPLETED|Overall Study||0
918031|NCT01586819|2220269|P1|NOT COMPLETED|Overall Study||1
918032|NCT01586819|2220268|P2|COMPLETED|Overall Study||14
918033|NCT01586819|2220269|P1|COMPLETED|Overall Study||11
918034|NCT01586819|2220268|P2|STARTED|Overall Study||14
918035|NCT01586819|2220269|P1|STARTED|Overall Study||12
918036|NCT01586806|2220280|P3|NOT COMPLETED|Overall Study||2
918037|NCT01586806|2220281|P2|NOT COMPLETED|Overall Study||4
918038|NCT01586806|2220282|P1|NOT COMPLETED|Overall Study||3
918039|NCT01586806|2220280|P3|COMPLETED|Overall Study||63
918040|NCT01586806|2220281|P2|COMPLETED|Overall Study||61
918041|NCT01586806|2220282|P1|COMPLETED|Overall Study||62
918042|NCT01586806|2220280|P3|STARTED|Overall Study||65
918043|NCT01586806|2220281|P2|STARTED|Overall Study||65
918044|NCT01586806|2220282|P1|STARTED|Overall Study||65
918045|NCT01586364|2220302|P1|NOT COMPLETED|Overall Study||117
918046|NCT01586364|2220302|P1|COMPLETED|Overall Study||184
918047|NCT01586364|2220302|P1|STARTED|Overall Study||301
918048|NCT01586338|2220355|P1|NOT COMPLETED|Overall Study||8
918049|NCT01586338|2220355|P1|COMPLETED|Overall Study||229
918050|NCT01586338|2220355|P1|STARTED|Overall Study||237
918051|NCT01586312|2220367|P2|NOT COMPLETED|Overall Study||0
918052|NCT01586312|2220368|P1|NOT COMPLETED|Overall Study||0
918053|NCT01586312|2220367|P2|COMPLETED|Overall Study||15
918054|NCT01586312|2220368|P1|COMPLETED|Overall Study||15
918055|NCT01586312|2220367|P2|STARTED|Overall Study||15
918056|NCT01586312|2220368|P1|STARTED|Overall Study||15
918057|NCT01586195|2220378|P1|NOT COMPLETED|Overall Study||26
918058|NCT01586195|2220378|P1|COMPLETED|Overall Study||5
918059|NCT01586195|2220378|P1|STARTED|Overall Study||31
918060|NCT01586026|2220389|P3|NOT COMPLETED|Overall Study||0
918061|NCT01586026|2220390|P2|NOT COMPLETED|Overall Study||0
918062|NCT01586026|2220391|P1|NOT COMPLETED|Overall Study||0
918063|NCT01586026|2220389|P3|COMPLETED|Overall Study||271
918064|NCT01586026|2220390|P2|COMPLETED|Overall Study||414
918065|NCT01586026|2220391|P1|COMPLETED|Overall Study||350
918066|NCT01586026|2220389|P3|STARTED|Overall Study||271
918067|NCT01586026|2220390|P2|STARTED|Overall Study||414
918068|NCT01586026|2220391|P1|STARTED|Overall Study||350
918069|NCT01585987|2220401|P2|NOT COMPLETED|Treated||49
918070|NCT01585987|2220402|P1|NOT COMPLETED|Treated||54
918071|NCT01585987|2220401|P2|COMPLETED|Treated||2
918072|NCT01585987|2220402|P1|COMPLETED|Treated||3
918073|NCT01585987|2220401|P2|STARTED|Treated||51
918074|NCT01585987|2220402|P1|STARTED|Treated||57
918075|NCT01585987|2220401|P2|NOT COMPLETED|Randomized||6
918076|NCT01585987|2220402|P1|NOT COMPLETED|Randomized||0
918077|NCT01585987|2220401|P2|COMPLETED|Randomized||51
918078|NCT01585987|2220402|P1|COMPLETED|Randomized||57
918079|NCT01585987|2220401|P2|STARTED|Randomized||57
918080|NCT01585987|2220402|P1|STARTED|Randomized||57
918081|NCT01585961|2220417|P1|NOT COMPLETED|Overall Study||33
918082|NCT01585961|2220417|P1|COMPLETED|Overall Study||478
918083|NCT01585961|2220417|P1|Safety|Overall Study|Patients ablated with study catheter|508
918084|NCT01585961|2220417|P1|STARTED|Overall Study||511
918085|NCT01585779|2220434|P2|NOT COMPLETED|Overall Study||7
918086|NCT01585779|2220435|P1|NOT COMPLETED|Overall Study||10
918087|NCT01585779|2220434|P2|COMPLETED|Overall Study||21
918088|NCT01585779|2220435|P1|COMPLETED|Overall Study||26
918089|NCT01585779|2220434|P2|STARTED|Overall Study||28
918090|NCT01585779|2220435|P1|STARTED|Overall Study||36
918091|NCT01585597|2220489|P1|NOT COMPLETED|Overall Study||0
918092|NCT01585597|2220489|P1|COMPLETED|Overall Study||20
918093|NCT01585597|2220489|P1|STARTED|Overall Study||20
918094|NCT01585584|2220494|P1|NOT COMPLETED|Overall Study||4
918095|NCT01585584|2220494|P1|COMPLETED|Overall Study||6
918096|NCT01585584|2220494|P1|STARTED|Overall Study||10
918097|NCT01585558|2220501|P3|NOT COMPLETED|Overall Study||15
918098|NCT01585558|2220502|P2|NOT COMPLETED|Overall Study||12
918099|NCT01585558|2220503|P1|NOT COMPLETED|Overall Study||13
918100|NCT01585558|2220501|P3|COMPLETED|Overall Study||34
918101|NCT01585558|2220502|P2|COMPLETED|Overall Study||57
918102|NCT01585558|2220503|P1|COMPLETED|Overall Study||49
918103|NCT01585558|2220501|P3|STARTED|Overall Study||49
918104|NCT01585558|2220502|P2|STARTED|Overall Study||69
918105|NCT01585558|2220503|P1|STARTED|Overall Study||62
918106|NCT01585441|2220684|P2|NOT COMPLETED|Overall Study||0
918107|NCT01585441|2220685|P1|NOT COMPLETED|Overall Study||0
918108|NCT01585441|2220684|P2|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
918109|NCT01585441|2220685|P1|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
918110|NCT01585441|2220684|P2|Final Study Safety Visit|Overall Study|A final study visit was not required for the placebo participant who completed the study at Month 3.|2
918111|NCT01585441|2220685|P1|Final Study Safety Visit|Overall Study||3
918112|NCT01585441|2220684|P2|Received Finasteride at Month 3|Overall Study||2
918113|NCT01585441|2220685|P1|Received Finasteride at Month 3|Overall Study||2
918114|NCT01585441|2220684|P2|Month 3|Overall Study||3
918115|NCT01585441|2220685|P1|Month 3|Overall Study|One participant was not evaluated at Month 3 but at the final visit due to study terminating early.|2
918116|NCT01585441|2220684|P2|STARTED|Overall Study||3
918117|NCT01585441|2220685|P1|STARTED|Overall Study||3
918118|NCT01585428|2220737|P2|NOT COMPLETED|Overall Study||0
918119|NCT01585428|2220738|P1|NOT COMPLETED|Overall Study||1
918120|NCT01585428|2220737|P2|COMPLETED|Overall Study||11
918121|NCT01585428|2220738|P1|COMPLETED|Overall Study||17
918122|NCT01585428|2220737|P2|STARTED|Overall Study||11
918123|NCT01585428|2220738|P1|STARTED|Overall Study||18
918124|NCT01585324|2220746|P1|NOT COMPLETED|Overall Study||0
918125|NCT01585324|2220746|P1|COMPLETED|Overall Study||30
918126|NCT01585324|2220746|P1|STARTED|Overall Study||30
918127|NCT01585272|2220762|P1|NOT COMPLETED|Overall Study||39
918128|NCT01585272|2220762|P1|COMPLETED|Overall Study||82
918129|NCT01585272|2220762|P1|Exelon Patch 10 cm2|Overall Study||96
918130|NCT01585272|2220762|P1|Exelon Patch 5 cm2|Overall Study||114
918131|NCT01585272|2220762|P1|Safety Set|Overall Study|Subjects received 3 mg bid Exelon caps for more than 4 weeks & used at least 1 dose of Exelon patch.|102
918132|NCT01585272|2220762|P1|STARTED|Overall Study||121
918133|NCT01585246|2220775|P5|NOT COMPLETED|Overall Study||2
918134|NCT01585246|2220776|P4|NOT COMPLETED|Overall Study||4
918135|NCT01585246|2220777|P3|NOT COMPLETED|Overall Study||4
918136|NCT01585246|2220778|P2|NOT COMPLETED|Overall Study||1
918137|NCT01585246|2220779|P1|NOT COMPLETED|Overall Study||0
918138|NCT01585246|2220775|P5|COMPLETED|Overall Study||9
918139|NCT01585246|2220776|P4|COMPLETED|Overall Study||6
918140|NCT01585246|2220777|P3|COMPLETED|Overall Study||16
918141|NCT01585246|2220778|P2|COMPLETED|Overall Study||3
918142|NCT01585246|2220779|P1|COMPLETED|Overall Study||3
918143|NCT01585246|2220775|P5|STARTED|Overall Study||11
918144|NCT01585246|2220776|P4|STARTED|Overall Study||10
918145|NCT01585246|2220777|P3|STARTED|Overall Study||20
918146|NCT01585246|2220778|P2|STARTED|Overall Study||4
918147|NCT01585246|2220779|P1|STARTED|Overall Study||3
918148|NCT01585038|2220796|P2|NOT COMPLETED|Overall Study||2
918149|NCT01585038|2220797|P1|NOT COMPLETED|Overall Study||2
918150|NCT01585038|2220796|P2|COMPLETED|Overall Study||18
918151|NCT01585038|2220797|P1|COMPLETED|Overall Study||18
918152|NCT01585038|2220796|P2|STARTED|Overall Study||20
918153|NCT01585038|2220797|P1|STARTED|Overall Study||20
918154|NCT01584843|2220813|P6|NOT COMPLETED|Second Treatment Period||1
918155|NCT01584843|2220814|P5|NOT COMPLETED|Second Treatment Period||0
918156|NCT01584843|2220815|P4|NOT COMPLETED|Second Treatment Period||0
918157|NCT01584843|2220816|P3|NOT COMPLETED|Second Treatment Period||0
918158|NCT01584843|2220817|P2|NOT COMPLETED|Second Treatment Period||0
918159|NCT01584843|2220818|P1|NOT COMPLETED|Second Treatment Period||0
918160|NCT01584843|2220813|P6|COMPLETED|Second Treatment Period||0
918161|NCT01584843|2220814|P5|COMPLETED|Second Treatment Period||3
918162|NCT01584843|2220815|P4|COMPLETED|Second Treatment Period||6
918163|NCT01584843|2220816|P3|COMPLETED|Second Treatment Period||2
918164|NCT01584843|2220817|P2|COMPLETED|Second Treatment Period||1
918165|NCT01584843|2220818|P1|COMPLETED|Second Treatment Period||2
918166|NCT01584843|2220813|P6|STARTED|Second Treatment Period||1
918167|NCT01584843|2220814|P5|STARTED|Second Treatment Period||3
918168|NCT01584843|2220815|P4|STARTED|Second Treatment Period||6
918169|NCT01584843|2220816|P3|STARTED|Second Treatment Period||2
918170|NCT01584843|2220817|P2|STARTED|Second Treatment Period||1
918171|NCT01584843|2220818|P1|STARTED|Second Treatment Period||2
918172|NCT01584843|2220813|P6|NOT COMPLETED|First Treatment Period||2
918173|NCT01584843|2220814|P5|NOT COMPLETED|First Treatment Period||0
918174|NCT01584843|2220815|P4|NOT COMPLETED|First Treatment Period||0
918175|NCT01584843|2220816|P3|NOT COMPLETED|First Treatment Period||1
918176|NCT01584843|2220817|P2|NOT COMPLETED|First Treatment Period||0
918177|NCT01584843|2220818|P1|NOT COMPLETED|First Treatment Period||0
918178|NCT01584843|2220813|P6|COMPLETED|First Treatment Period||9
918179|NCT01584843|2220814|P5|COMPLETED|First Treatment Period||10
918180|NCT01584843|2220815|P4|COMPLETED|First Treatment Period||10
918181|NCT01584843|2220816|P3|COMPLETED|First Treatment Period||2
918182|NCT01584843|2220817|P2|COMPLETED|First Treatment Period||4
918183|NCT01584843|2220818|P1|COMPLETED|First Treatment Period||3
918184|NCT01584843|2220813|P6|STARTED|First Treatment Period||11
918185|NCT01584843|2220814|P5|STARTED|First Treatment Period||10
918186|NCT01584843|2220815|P4|STARTED|First Treatment Period||10
918187|NCT01584843|2220816|P3|STARTED|First Treatment Period||3
918188|NCT01584843|2220817|P2|STARTED|First Treatment Period||4
918189|NCT01584843|2220818|P1|STARTED|First Treatment Period||3
918190|NCT01584648|2220929|P2|NOT COMPLETED|Overall Study||212
918191|NCT01584648|2220930|P1|NOT COMPLETED|Overall Study||211
918192|NCT01584648|2220929|P2|COMPLETED|Overall Study||0
918193|NCT01584648|2220930|P1|COMPLETED|Overall Study||0
918194|NCT01584648|2220929|P2|Ongoing|Overall Study||147
918195|NCT01584648|2220930|P1|Ongoing|Overall Study||154
918196|NCT01584648|2220929|P2|STARTED|Overall Study||212
918197|NCT01584648|2220930|P1|STARTED|Overall Study||211
918198|NCT01584544|2220973|P5|NOT COMPLETED|Overall Study||0
918199|NCT01584544|2220974|P4|NOT COMPLETED|Overall Study||0
918200|NCT01584544|2220975|P3|NOT COMPLETED|Overall Study||0
918201|NCT01584544|2220976|P2|NOT COMPLETED|Overall Study||0
918202|NCT01584544|2220977|P1|NOT COMPLETED|Overall Study||0
918203|NCT01584544|2220973|P5|COMPLETED|Overall Study||6
918204|NCT01584544|2220974|P4|COMPLETED|Overall Study||3
918205|NCT01584544|2220975|P3|COMPLETED|Overall Study||6
918206|NCT01584544|2220976|P2|COMPLETED|Overall Study||6
918207|NCT01584544|2220977|P1|COMPLETED|Overall Study||3
918208|NCT01584544|2220973|P5|STARTED|Overall Study||6
918209|NCT01584544|2220974|P4|STARTED|Overall Study||3
918210|NCT01584544|2220975|P3|STARTED|Overall Study||6
918211|NCT01584544|2220976|P2|STARTED|Overall Study||6
918212|NCT01584544|2220977|P1|STARTED|Overall Study||3
918213|NCT01584518|2220991|P2|NOT COMPLETED|Overall Study||0
918214|NCT01584518|2220992|P1|NOT COMPLETED|Overall Study||0
918215|NCT01584518|2220991|P2|COMPLETED|Overall Study||25
918216|NCT01584518|2220992|P1|COMPLETED|Overall Study||25
918217|NCT01584518|2220991|P2|STARTED|Overall Study||25
918218|NCT01584518|2220992|P1|STARTED|Overall Study||25
918219|NCT01584479|2221002|P4|NOT COMPLETED|Overall Study||0
918220|NCT01584479|2221003|P3|NOT COMPLETED|Overall Study||0
918221|NCT01584479|2221004|P2|NOT COMPLETED|Overall Study||0
918222|NCT01584479|2221005|P1|NOT COMPLETED|Overall Study||0
918223|NCT01584479|2221002|P4|COMPLETED|Overall Study||1847
918224|NCT01584479|2221003|P3|COMPLETED|Overall Study||852
918225|NCT01584479|2221004|P2|COMPLETED|Overall Study||1686
918226|NCT01584479|2221005|P1|COMPLETED|Overall Study||732
918227|NCT01584479|2221002|P4|STARTED|Overall Study||1847
918228|NCT01584479|2221003|P3|STARTED|Overall Study||852
918229|NCT01584479|2221004|P2|STARTED|Overall Study||1686
918230|NCT01584479|2221005|P1|STARTED|Overall Study||732
918231|NCT01584388|2221015|P1|NOT COMPLETED|Overall Study||0
918232|NCT01584388|2221015|P1|COMPLETED|Overall Study||30
918233|NCT01584388|2221015|P1|STARTED|Overall Study||30
918234|NCT01584232|2221035|P2|NOT COMPLETED|Overall Study||3
918235|NCT01584232|2221036|P1|NOT COMPLETED|Overall Study||8
918236|NCT01584232|2221035|P2|COMPLETED|Overall Study||177
918237|NCT01584232|2221036|P1|COMPLETED|Overall Study||173
918238|NCT01584232|2221035|P2|Received at Least 1 Dose of Study Drug|Overall Study||180
918239|NCT01584232|2221036|P1|Received at Least 1 Dose of Study Drug|Overall Study||181
918240|NCT01584232|2221035|P2|STARTED|Overall Study||180
918241|NCT01584232|2221036|P1|STARTED|Overall Study||181
918242|NCT01583894|2221052|P1|NOT COMPLETED|Overall Study||15
918243|NCT01583894|2221052|P1|COMPLETED|Overall Study||813
918244|NCT01583894|2221052|P1|STARTED|Overall Study||828
918245|NCT01583647|2221056|P2|NOT COMPLETED|Overall Study||0
918246|NCT01583647|2221057|P1|NOT COMPLETED|Overall Study||0
918247|NCT01583647|2221056|P2|COMPLETED|Overall Study||0
918248|NCT01583647|2221057|P1|COMPLETED|Overall Study||10
918249|NCT01583647|2221056|P2|STARTED|Overall Study|Study terminated prior to Panel B being conducted.|0
918250|NCT01583647|2221057|P1|STARTED|Overall Study||10
918251|NCT01583543|2221069|P1|NOT COMPLETED|Overall Study||0
918252|NCT01583543|2221069|P1|COMPLETED|Overall Study||12
918253|NCT01583543|2221069|P1|STARTED|Overall Study||12
918254|NCT01583530|2221082|P6|NOT COMPLETED|Overall Study||3
918255|NCT01583530|2221083|P5|NOT COMPLETED|Overall Study||5
918256|NCT01583530|2221084|P4|NOT COMPLETED|Overall Study||1
918257|NCT01583530|2221085|P3|NOT COMPLETED|Overall Study||0
918258|NCT01583530|2221086|P2|NOT COMPLETED|Overall Study||3
918259|NCT01583530|2221087|P1|NOT COMPLETED|Overall Study||0
918260|NCT01583530|2221082|P6|COMPLETED|Overall Study||17
918261|NCT01583530|2221083|P5|COMPLETED|Overall Study||15
918262|NCT01583530|2221084|P4|COMPLETED|Overall Study||18
918263|NCT01583530|2221085|P3|COMPLETED|Overall Study||20
918264|NCT01583530|2221086|P2|COMPLETED|Overall Study||17
918265|NCT01583530|2221087|P1|COMPLETED|Overall Study||19
918266|NCT01583530|2221082|P6|STARTED|Overall Study||20
918267|NCT01583530|2221083|P5|STARTED|Overall Study||20
918268|NCT01583530|2221084|P4|STARTED|Overall Study||19
918269|NCT01583530|2221085|P3|STARTED|Overall Study||20
918270|NCT01583530|2221086|P2|STARTED|Overall Study||20
918271|NCT01583530|2221087|P1|STARTED|Overall Study||19
918272|NCT01583452|2221133|P2|NOT COMPLETED|Overall Study||0
918273|NCT01583452|2221134|P1|NOT COMPLETED|Overall Study||0
918274|NCT01583452|2221133|P2|COMPLETED|Overall Study||20
918275|NCT01583452|2221134|P1|COMPLETED|Overall Study||21
918276|NCT01583452|2221133|P2|STARTED|Overall Study||20
918277|NCT01583452|2221134|P1|STARTED|Overall Study||21
918278|NCT01583374|2221149|P3|NOT COMPLETED|Overall Study||25
918279|NCT01583374|2221150|P2|NOT COMPLETED|Overall Study||16
918280|NCT01583374|2221151|P1|NOT COMPLETED|Overall Study||19
918281|NCT01583374|2221149|P3|COMPLETED|Overall Study|Completed = those who completed the Placebo-controlled Treatment Phase – Weeks 0 to 24|138
918282|NCT01583374|2221150|P2|COMPLETED|Overall Study|Completed = those who completed the Placebo-controlled Treatment Phase – Weeks 0 to 24|147
918283|NCT01583374|2221151|P1|COMPLETED|Overall Study|Completed = those who completed the Placebo-controlled Treatment Phase – Weeks 0 to 24|145
918284|NCT01583374|2221149|P3|Early Escape at Week 16|Overall Study|One participant who escaped early did not complete Week 24|49
918285|NCT01583374|2221150|P2|Early Escape at Week 16|Overall Study||49
918286|NCT01583374|2221151|P1|Early Escape at Week 16|Overall Study|One participant who escaped early did not complete Week 24|51
918287|NCT01583374|2221149|P3|Completed Week 16|Overall Study||144
918288|NCT01583374|2221150|P2|Completed Week 16|Overall Study||151
918289|NCT01583374|2221151|P1|Completed Week 16|Overall Study||150
918290|NCT01583374|2221149|P3|Received Treatment|Overall Study||163
918291|NCT01583374|2221150|P2|Received Treatment|Overall Study||163
918292|NCT01583374|2221151|P1|Received Treatment|Overall Study||164
918293|NCT01583374|2221149|P3|STARTED|Overall Study||163
918294|NCT01583374|2221150|P2|STARTED|Overall Study||163
918295|NCT01583374|2221151|P1|STARTED|Overall Study||164
918296|NCT01583218|2221163|P2|NOT COMPLETED|Overall Study||283
918297|NCT01583218|2221164|P1|NOT COMPLETED|Overall Study||289
918298|NCT01583218|2221163|P2|COMPLETED|Overall Study||3471
918299|NCT01583218|2221164|P1|COMPLETED|Overall Study||3470
918300|NCT01583218|2221163|P2|STARTED|Overall Study||3754
918301|NCT01583218|2221164|P1|STARTED|Overall Study||3759
918302|NCT01583101|2221184|P2|NOT COMPLETED|Overall Study||0
918303|NCT01583101|2221185|P1|NOT COMPLETED|Overall Study||0
918304|NCT01583101|2221184|P2|COMPLETED|Overall Study||1161
918305|NCT01583101|2221185|P1|COMPLETED|Overall Study||1076
918306|NCT01583101|2221184|P2|STARTED|Overall Study||1161
918307|NCT01583101|2221185|P1|STARTED|Overall Study||1076
918308|NCT01582971|2221193|P2|NOT COMPLETED|Overall Study||37
918309|NCT01582971|2221194|P1|NOT COMPLETED|Overall Study||39
918310|NCT01582971|2221193|P2|COMPLETED|Overall Study||91
918311|NCT01582971|2221194|P1|COMPLETED|Overall Study||89
918312|NCT01582971|2221193|P2|STARTED|Overall Study||128
918313|NCT01582971|2221194|P1|STARTED|Overall Study||128
918314|NCT01582945|2221212|P1|NOT COMPLETED|Overall Study||2
918315|NCT01582945|2221212|P1|COMPLETED|Overall Study||12
918316|NCT01582945|2221212|P1|STARTED|Overall Study||14
918317|NCT01582880|2221216|P1|NOT COMPLETED|Overall Study||0
918318|NCT01582880|2221216|P1|COMPLETED|Overall Study||1
918319|NCT01582880|2221216|P1|STARTED|Overall Study||1
918320|NCT01582854|2221226|P2|NOT COMPLETED|Overall Study||34
918321|NCT01582854|2221227|P1|NOT COMPLETED|Overall Study||36
918322|NCT01582854|2221226|P2|COMPLETED|Overall Study||221
918323|NCT01582854|2221227|P1|COMPLETED|Overall Study||212
918324|NCT01582854|2221226|P2|STARTED|Overall Study||255
918325|NCT01582854|2221227|P1|STARTED|Overall Study||248
918326|NCT01582789|2221255|P2|NOT COMPLETED|Second Intervention (14 Days)||0
918327|NCT01582789|2221256|P1|NOT COMPLETED|Second Intervention (14 Days)||1
918328|NCT01582789|2221255|P2|COMPLETED|Second Intervention (14 Days)||27
918329|NCT01582789|2221256|P1|COMPLETED|Second Intervention (14 Days)||33
918330|NCT01582789|2221255|P2|STARTED|Second Intervention (14 Days)||27
918331|NCT01582789|2221256|P1|STARTED|Second Intervention (14 Days)||34
918332|NCT01582789|2221255|P2|NOT COMPLETED|First Intervention (14 Days)||0
918333|NCT01582789|2221256|P1|NOT COMPLETED|First Intervention (14 Days)||0
918334|NCT01582789|2221255|P2|COMPLETED|First Intervention (14 Days)||27
918335|NCT01582789|2221256|P1|COMPLETED|First Intervention (14 Days)||34
918336|NCT01582789|2221255|P2|STARTED|First Intervention (14 Days)||27
918337|NCT01582789|2221256|P1|STARTED|First Intervention (14 Days)||34
918338|NCT01582490|2221274|P2|NOT COMPLETED|Overall Study||1
918339|NCT01582490|2221275|P1|NOT COMPLETED|Overall Study||1
918340|NCT01582490|2221274|P2|COMPLETED|Overall Study||9
918341|NCT01582490|2221275|P1|COMPLETED|Overall Study||8
918342|NCT01582490|2221274|P2|STARTED|Overall Study||10
918343|NCT01582490|2221275|P1|STARTED|Overall Study||9
918344|NCT01582477|2221297|P2|NOT COMPLETED|Overall Study||0
918345|NCT01582477|2221298|P1|NOT COMPLETED|Overall Study||0
918346|NCT01582477|2221297|P2|COMPLETED|Overall Study||12
918347|NCT01582477|2221298|P1|COMPLETED|Overall Study||12
918348|NCT01582477|2221297|P2|STARTED|Overall Study||12
918349|NCT01582477|2221298|P1|STARTED|Overall Study||12
918350|NCT01582308|2221314|P10|NOT COMPLETED|Period 5||0
918351|NCT01582308|2221315|P9|NOT COMPLETED|Period 5||0
918352|NCT01582308|2221316|P8|NOT COMPLETED|Period 5||0
918353|NCT01582308|2221317|P7|NOT COMPLETED|Period 5||0
918354|NCT01582308|2221318|P6|NOT COMPLETED|Period 5||0
918355|NCT01582308|2221319|P5|NOT COMPLETED|Period 5||0
918356|NCT01582308|2221320|P4|NOT COMPLETED|Period 5||0
918357|NCT01582308|2221321|P3|NOT COMPLETED|Period 5||0
918358|NCT01582308|2221322|P2|NOT COMPLETED|Period 5||0
918359|NCT01582308|2221323|P1|NOT COMPLETED|Period 5||0
918360|NCT01582308|2221314|P10|COMPLETED|Period 5||1
918361|NCT01582308|2221315|P9|COMPLETED|Period 5||2
918362|NCT01582308|2221316|P8|COMPLETED|Period 5||2
918363|NCT01582308|2221317|P7|COMPLETED|Period 5||2
918364|NCT01582308|2221318|P6|COMPLETED|Period 5||1
918365|NCT01582308|2221319|P5|COMPLETED|Period 5||2
918366|NCT01582308|2221320|P4|COMPLETED|Period 5||2
918367|NCT01582308|2221321|P3|COMPLETED|Period 5||2
918368|NCT01582308|2221322|P2|COMPLETED|Period 5||2
918369|NCT01582308|2221323|P1|COMPLETED|Period 5||1
918370|NCT01582308|2221314|P10|STARTED|Period 5||1
918371|NCT01582308|2221315|P9|STARTED|Period 5||2
918372|NCT01582308|2221316|P8|STARTED|Period 5||2
918373|NCT01582308|2221317|P7|STARTED|Period 5||2
918374|NCT01582308|2221318|P6|STARTED|Period 5||1
918375|NCT01582308|2221319|P5|STARTED|Period 5||2
918376|NCT01582308|2221320|P4|STARTED|Period 5||2
918377|NCT01582308|2221321|P3|STARTED|Period 5||2
918378|NCT01582308|2221322|P2|STARTED|Period 5||2
918379|NCT01582308|2221323|P1|STARTED|Period 5||1
918380|NCT01582308|2221314|P10|NOT COMPLETED|10-day Washout Following Period 4||0
918381|NCT01582308|2221315|P9|NOT COMPLETED|10-day Washout Following Period 4||0
918382|NCT01582308|2221316|P8|NOT COMPLETED|10-day Washout Following Period 4||0
918383|NCT01582308|2221317|P7|NOT COMPLETED|10-day Washout Following Period 4||0
918384|NCT01582308|2221318|P6|NOT COMPLETED|10-day Washout Following Period 4||0
918385|NCT01582308|2221319|P5|NOT COMPLETED|10-day Washout Following Period 4||0
918386|NCT01582308|2221320|P4|NOT COMPLETED|10-day Washout Following Period 4||0
918387|NCT01582308|2221321|P3|NOT COMPLETED|10-day Washout Following Period 4||0
918388|NCT01582308|2221322|P2|NOT COMPLETED|10-day Washout Following Period 4||0
918389|NCT01582308|2221323|P1|NOT COMPLETED|10-day Washout Following Period 4||0
918390|NCT01582308|2221314|P10|COMPLETED|10-day Washout Following Period 4||1
918391|NCT01582308|2221315|P9|COMPLETED|10-day Washout Following Period 4||2
918392|NCT01582308|2221316|P8|COMPLETED|10-day Washout Following Period 4||2
918393|NCT01582308|2221317|P7|COMPLETED|10-day Washout Following Period 4||2
918394|NCT01582308|2221318|P6|COMPLETED|10-day Washout Following Period 4||1
918395|NCT01582308|2221319|P5|COMPLETED|10-day Washout Following Period 4||2
918396|NCT01582308|2221320|P4|COMPLETED|10-day Washout Following Period 4||2
918397|NCT01582308|2221321|P3|COMPLETED|10-day Washout Following Period 4||2
918398|NCT01582308|2221322|P2|COMPLETED|10-day Washout Following Period 4||2
918399|NCT01582308|2221323|P1|COMPLETED|10-day Washout Following Period 4||1
918400|NCT01582308|2221314|P10|STARTED|10-day Washout Following Period 4||1
918401|NCT01582308|2221315|P9|STARTED|10-day Washout Following Period 4||2
918402|NCT01582308|2221316|P8|STARTED|10-day Washout Following Period 4||2
918403|NCT01582308|2221317|P7|STARTED|10-day Washout Following Period 4||2
918404|NCT01582308|2221318|P6|STARTED|10-day Washout Following Period 4||1
918405|NCT01582308|2221319|P5|STARTED|10-day Washout Following Period 4||2
918406|NCT01582308|2221320|P4|STARTED|10-day Washout Following Period 4||2
918407|NCT01582308|2221321|P3|STARTED|10-day Washout Following Period 4||2
918408|NCT01582308|2221322|P2|STARTED|10-day Washout Following Period 4||2
918409|NCT01582308|2221323|P1|STARTED|10-day Washout Following Period 4||1
918410|NCT01582308|2221314|P10|NOT COMPLETED|Period 4||1
918411|NCT01582308|2221315|P9|NOT COMPLETED|Period 4||0
918412|NCT01582308|2221316|P8|NOT COMPLETED|Period 4||0
918413|NCT01582308|2221317|P7|NOT COMPLETED|Period 4||0
918414|NCT01582308|2221318|P6|NOT COMPLETED|Period 4||1
918415|NCT01582308|2221319|P5|NOT COMPLETED|Period 4||0
918416|NCT01582308|2221320|P4|NOT COMPLETED|Period 4||0
918417|NCT01582308|2221321|P3|NOT COMPLETED|Period 4||0
918418|NCT01582308|2221322|P2|NOT COMPLETED|Period 4||0
918419|NCT01582308|2221323|P1|NOT COMPLETED|Period 4||1
918420|NCT01582308|2221314|P10|COMPLETED|Period 4||1
918421|NCT01582308|2221315|P9|COMPLETED|Period 4||2
918422|NCT01582308|2221316|P8|COMPLETED|Period 4||2
918423|NCT01582308|2221317|P7|COMPLETED|Period 4||2
918424|NCT01582308|2221318|P6|COMPLETED|Period 4||1
918425|NCT01582308|2221319|P5|COMPLETED|Period 4||2
918426|NCT01582308|2221320|P4|COMPLETED|Period 4||2
918427|NCT01582308|2221321|P3|COMPLETED|Period 4||2
918428|NCT01582308|2221322|P2|COMPLETED|Period 4||2
918429|NCT01582308|2221323|P1|COMPLETED|Period 4||1
918430|NCT01582308|2221314|P10|STARTED|Period 4||2
918431|NCT01582308|2221315|P9|STARTED|Period 4||2
918432|NCT01582308|2221316|P8|STARTED|Period 4||2
918433|NCT01582308|2221317|P7|STARTED|Period 4||2
918434|NCT01582308|2221318|P6|STARTED|Period 4||2
918435|NCT01582308|2221319|P5|STARTED|Period 4||2
918436|NCT01582308|2221320|P4|STARTED|Period 4||2
918437|NCT01582308|2221321|P3|STARTED|Period 4||2
918438|NCT01582308|2221322|P2|STARTED|Period 4||2
918439|NCT01582308|2221323|P1|STARTED|Period 4||2
918440|NCT01582308|2221314|P10|NOT COMPLETED|10-day Washout Following Period 3||0
918441|NCT01582308|2221315|P9|NOT COMPLETED|10-day Washout Following Period 3||0
918442|NCT01582308|2221316|P8|NOT COMPLETED|10-day Washout Following Period 3||0
918443|NCT01582308|2221317|P7|NOT COMPLETED|10-day Washout Following Period 3||0
918444|NCT01582308|2221318|P6|NOT COMPLETED|10-day Washout Following Period 3||0
918445|NCT01582308|2221319|P5|NOT COMPLETED|10-day Washout Following Period 3||0
918446|NCT01582308|2221320|P4|NOT COMPLETED|10-day Washout Following Period 3||0
918447|NCT01582308|2221321|P3|NOT COMPLETED|10-day Washout Following Period 3||0
918448|NCT01582308|2221322|P2|NOT COMPLETED|10-day Washout Following Period 3||0
918449|NCT01582308|2221323|P1|NOT COMPLETED|10-day Washout Following Period 3||0
918450|NCT01582308|2221314|P10|COMPLETED|10-day Washout Following Period 3||2
918451|NCT01582308|2221315|P9|COMPLETED|10-day Washout Following Period 3||2
918452|NCT01582308|2221316|P8|COMPLETED|10-day Washout Following Period 3||2
918453|NCT01582308|2221317|P7|COMPLETED|10-day Washout Following Period 3||2
918454|NCT01582308|2221318|P6|COMPLETED|10-day Washout Following Period 3||2
918455|NCT01582308|2221319|P5|COMPLETED|10-day Washout Following Period 3||2
918456|NCT01582308|2221320|P4|COMPLETED|10-day Washout Following Period 3||2
918457|NCT01582308|2221321|P3|COMPLETED|10-day Washout Following Period 3||2
918458|NCT01582308|2221322|P2|COMPLETED|10-day Washout Following Period 3||2
918459|NCT01582308|2221323|P1|COMPLETED|10-day Washout Following Period 3||2
918460|NCT01582308|2221314|P10|STARTED|10-day Washout Following Period 3||2
918461|NCT01582308|2221315|P9|STARTED|10-day Washout Following Period 3||2
918462|NCT01582308|2221316|P8|STARTED|10-day Washout Following Period 3||2
918463|NCT01582308|2221317|P7|STARTED|10-day Washout Following Period 3||2
918464|NCT01582308|2221318|P6|STARTED|10-day Washout Following Period 3||2
918465|NCT01582308|2221319|P5|STARTED|10-day Washout Following Period 3||2
918466|NCT01582308|2221320|P4|STARTED|10-day Washout Following Period 3||2
918467|NCT01582308|2221321|P3|STARTED|10-day Washout Following Period 3||2
918468|NCT01582308|2221322|P2|STARTED|10-day Washout Following Period 3||2
918469|NCT01582308|2221323|P1|STARTED|10-day Washout Following Period 3||2
918470|NCT01582308|2221314|P10|NOT COMPLETED|Period 3||0
918471|NCT01582308|2221315|P9|NOT COMPLETED|Period 3||0
918472|NCT01582308|2221316|P8|NOT COMPLETED|Period 3||0
918473|NCT01582308|2221317|P7|NOT COMPLETED|Period 3||0
918474|NCT01582308|2221318|P6|NOT COMPLETED|Period 3||0
918475|NCT01582308|2221319|P5|NOT COMPLETED|Period 3||0
918476|NCT01582308|2221320|P4|NOT COMPLETED|Period 3||0
918477|NCT01582308|2221321|P3|NOT COMPLETED|Period 3||0
918478|NCT01582308|2221322|P2|NOT COMPLETED|Period 3||0
918479|NCT01582308|2221323|P1|NOT COMPLETED|Period 3||0
918480|NCT01582308|2221314|P10|COMPLETED|Period 3||2
918481|NCT01582308|2221315|P9|COMPLETED|Period 3||2
918482|NCT01582308|2221316|P8|COMPLETED|Period 3||2
918483|NCT01582308|2221317|P7|COMPLETED|Period 3||2
918484|NCT01582308|2221318|P6|COMPLETED|Period 3||2
918485|NCT01582308|2221319|P5|COMPLETED|Period 3||2
918486|NCT01582308|2221320|P4|COMPLETED|Period 3||2
918487|NCT01582308|2221321|P3|COMPLETED|Period 3||2
918488|NCT01582308|2221322|P2|COMPLETED|Period 3||2
918489|NCT01582308|2221323|P1|COMPLETED|Period 3||2
918490|NCT01582308|2221314|P10|STARTED|Period 3||2
918491|NCT01582308|2221315|P9|STARTED|Period 3||2
918492|NCT01582308|2221316|P8|STARTED|Period 3||2
918493|NCT01582308|2221317|P7|STARTED|Period 3||2
918494|NCT01582308|2221318|P6|STARTED|Period 3||2
918495|NCT01582308|2221319|P5|STARTED|Period 3||2
918496|NCT01582308|2221320|P4|STARTED|Period 3||2
918497|NCT01582308|2221321|P3|STARTED|Period 3||2
918498|NCT01582308|2221322|P2|STARTED|Period 3||2
918499|NCT01582308|2221323|P1|STARTED|Period 3||2
918500|NCT01582308|2221314|P10|NOT COMPLETED|10-day Washout Following Period 2||0
918501|NCT01582308|2221315|P9|NOT COMPLETED|10-day Washout Following Period 2||0
918502|NCT01582308|2221316|P8|NOT COMPLETED|10-day Washout Following Period 2||0
918503|NCT01582308|2221317|P7|NOT COMPLETED|10-day Washout Following Period 2||0
918504|NCT01582308|2221318|P6|NOT COMPLETED|10-day Washout Following Period 2||0
918505|NCT01582308|2221319|P5|NOT COMPLETED|10-day Washout Following Period 2||0
918506|NCT01582308|2221320|P4|NOT COMPLETED|10-day Washout Following Period 2||0
918507|NCT01582308|2221321|P3|NOT COMPLETED|10-day Washout Following Period 2||0
918508|NCT01582308|2221322|P2|NOT COMPLETED|10-day Washout Following Period 2||0
918509|NCT01582308|2221323|P1|NOT COMPLETED|10-day Washout Following Period 2||0
918510|NCT01582308|2221314|P10|COMPLETED|10-day Washout Following Period 2||2
918511|NCT01582308|2221315|P9|COMPLETED|10-day Washout Following Period 2||2
918512|NCT01582308|2221316|P8|COMPLETED|10-day Washout Following Period 2||2
918513|NCT01582308|2221317|P7|COMPLETED|10-day Washout Following Period 2||2
918514|NCT01582308|2221318|P6|COMPLETED|10-day Washout Following Period 2||2
918515|NCT01582308|2221319|P5|COMPLETED|10-day Washout Following Period 2||2
918516|NCT01582308|2221320|P4|COMPLETED|10-day Washout Following Period 2||2
918517|NCT01582308|2221321|P3|COMPLETED|10-day Washout Following Period 2||2
918518|NCT01582308|2221322|P2|COMPLETED|10-day Washout Following Period 2||2
918519|NCT01582308|2221323|P1|COMPLETED|10-day Washout Following Period 2||2
918520|NCT01582308|2221314|P10|STARTED|10-day Washout Following Period 2||2
918521|NCT01582308|2221315|P9|STARTED|10-day Washout Following Period 2||2
918522|NCT01582308|2221316|P8|STARTED|10-day Washout Following Period 2||2
918523|NCT01582308|2221317|P7|STARTED|10-day Washout Following Period 2||2
918524|NCT01582308|2221318|P6|STARTED|10-day Washout Following Period 2||2
918525|NCT01582308|2221319|P5|STARTED|10-day Washout Following Period 2||2
918526|NCT01582308|2221320|P4|STARTED|10-day Washout Following Period 2||2
918527|NCT01582308|2221321|P3|STARTED|10-day Washout Following Period 2||2
918528|NCT01582308|2221322|P2|STARTED|10-day Washout Following Period 2||2
918529|NCT01582308|2221323|P1|STARTED|10-day Washout Following Period 2||2
918530|NCT01582308|2221314|P10|NOT COMPLETED|Period 2||0
918531|NCT01582308|2221315|P9|NOT COMPLETED|Period 2||0
918532|NCT01582308|2221316|P8|NOT COMPLETED|Period 2||0
918533|NCT01582308|2221317|P7|NOT COMPLETED|Period 2||0
918534|NCT01582308|2221318|P6|NOT COMPLETED|Period 2||0
918535|NCT01582308|2221319|P5|NOT COMPLETED|Period 2||0
918536|NCT01582308|2221320|P4|NOT COMPLETED|Period 2||0
918537|NCT01582308|2221321|P3|NOT COMPLETED|Period 2||0
918538|NCT01582308|2221322|P2|NOT COMPLETED|Period 2||0
918539|NCT01582308|2221323|P1|NOT COMPLETED|Period 2||0
918540|NCT01582308|2221314|P10|COMPLETED|Period 2||2
918541|NCT01582308|2221315|P9|COMPLETED|Period 2||2
918542|NCT01582308|2221316|P8|COMPLETED|Period 2||2
918543|NCT01582308|2221317|P7|COMPLETED|Period 2||2
918544|NCT01582308|2221318|P6|COMPLETED|Period 2||2
918545|NCT01582308|2221319|P5|COMPLETED|Period 2||2
918546|NCT01582308|2221320|P4|COMPLETED|Period 2||2
918547|NCT01582308|2221321|P3|COMPLETED|Period 2||2
918548|NCT01582308|2221322|P2|COMPLETED|Period 2||2
918549|NCT01582308|2221323|P1|COMPLETED|Period 2||2
918550|NCT01582308|2221314|P10|STARTED|Period 2||2
918551|NCT01582308|2221315|P9|STARTED|Period 2||2
918552|NCT01582308|2221316|P8|STARTED|Period 2||2
918553|NCT01582308|2221317|P7|STARTED|Period 2||2
918554|NCT01582308|2221318|P6|STARTED|Period 2||2
918555|NCT01582308|2221319|P5|STARTED|Period 2||2
918556|NCT01582308|2221320|P4|STARTED|Period 2||2
918557|NCT01582308|2221321|P3|STARTED|Period 2||2
918558|NCT01582308|2221322|P2|STARTED|Period 2||2
918559|NCT01582308|2221323|P1|STARTED|Period 2||2
918560|NCT01582308|2221314|P10|NOT COMPLETED|10-day Washout Following Period 1||0
918561|NCT01582308|2221315|P9|NOT COMPLETED|10-day Washout Following Period 1||0
918562|NCT01582308|2221316|P8|NOT COMPLETED|10-day Washout Following Period 1||0
918563|NCT01582308|2221317|P7|NOT COMPLETED|10-day Washout Following Period 1||0
918564|NCT01582308|2221318|P6|NOT COMPLETED|10-day Washout Following Period 1||0
918565|NCT01582308|2221319|P5|NOT COMPLETED|10-day Washout Following Period 1||1
918566|NCT01582308|2221320|P4|NOT COMPLETED|10-day Washout Following Period 1||0
918567|NCT01582308|2221321|P3|NOT COMPLETED|10-day Washout Following Period 1||0
918568|NCT01582308|2221322|P2|NOT COMPLETED|10-day Washout Following Period 1||0
918569|NCT01582308|2221323|P1|NOT COMPLETED|10-day Washout Following Period 1||0
918570|NCT01582308|2221314|P10|COMPLETED|10-day Washout Following Period 1||2
918571|NCT01582308|2221315|P9|COMPLETED|10-day Washout Following Period 1||2
918572|NCT01582308|2221316|P8|COMPLETED|10-day Washout Following Period 1||2
918573|NCT01582308|2221317|P7|COMPLETED|10-day Washout Following Period 1||2
918574|NCT01582308|2221318|P6|COMPLETED|10-day Washout Following Period 1||2
918575|NCT01582308|2221319|P5|COMPLETED|10-day Washout Following Period 1||2
918576|NCT01582308|2221320|P4|COMPLETED|10-day Washout Following Period 1||2
918577|NCT01582308|2221321|P3|COMPLETED|10-day Washout Following Period 1||2
918578|NCT01582308|2221322|P2|COMPLETED|10-day Washout Following Period 1||2
918579|NCT01582308|2221323|P1|COMPLETED|10-day Washout Following Period 1||2
918580|NCT01582308|2221314|P10|STARTED|10-day Washout Following Period 1||2
918581|NCT01582308|2221315|P9|STARTED|10-day Washout Following Period 1||2
918582|NCT01582308|2221316|P8|STARTED|10-day Washout Following Period 1||2
918583|NCT01582308|2221317|P7|STARTED|10-day Washout Following Period 1||2
918584|NCT01582308|2221318|P6|STARTED|10-day Washout Following Period 1||2
918585|NCT01582308|2221319|P5|STARTED|10-day Washout Following Period 1||3
918586|NCT01582308|2221320|P4|STARTED|10-day Washout Following Period 1||2
918587|NCT01582308|2221321|P3|STARTED|10-day Washout Following Period 1||2
918588|NCT01582308|2221322|P2|STARTED|10-day Washout Following Period 1||2
918589|NCT01582308|2221323|P1|STARTED|10-day Washout Following Period 1||2
918590|NCT01582308|2221314|P10|NOT COMPLETED|Period 1||0
918591|NCT01582308|2221315|P9|NOT COMPLETED|Period 1||0
918592|NCT01582308|2221316|P8|NOT COMPLETED|Period 1||0
918593|NCT01582308|2221317|P7|NOT COMPLETED|Period 1||1
918594|NCT01582308|2221318|P6|NOT COMPLETED|Period 1||0
918595|NCT01582308|2221319|P5|NOT COMPLETED|Period 1||0
918596|NCT01582308|2221320|P4|NOT COMPLETED|Period 1||0
918597|NCT01582308|2221321|P3|NOT COMPLETED|Period 1||0
918598|NCT01582308|2221322|P2|NOT COMPLETED|Period 1||0
918599|NCT01582308|2221323|P1|NOT COMPLETED|Period 1||0
918600|NCT01582308|2221314|P10|COMPLETED|Period 1||2
918601|NCT01582308|2221315|P9|COMPLETED|Period 1||2
918602|NCT01582308|2221316|P8|COMPLETED|Period 1||2
918603|NCT01582308|2221317|P7|COMPLETED|Period 1||2
918604|NCT01582308|2221318|P6|COMPLETED|Period 1||2
918605|NCT01582308|2221319|P5|COMPLETED|Period 1||3
918606|NCT01582308|2221320|P4|COMPLETED|Period 1||2
918607|NCT01582308|2221321|P3|COMPLETED|Period 1||2
918608|NCT01582308|2221322|P2|COMPLETED|Period 1||2
918609|NCT01582308|2221323|P1|COMPLETED|Period 1||2
918610|NCT01582308|2221314|P10|STARTED|Period 1||2
918611|NCT01582308|2221315|P9|STARTED|Period 1||2
918612|NCT01582308|2221316|P8|STARTED|Period 1||2
918613|NCT01582308|2221317|P7|STARTED|Period 1|Includes replacement for a participant who discontinued during period 1|3
918614|NCT01582308|2221318|P6|STARTED|Period 1||2
918615|NCT01582308|2221319|P5|STARTED|Period 1|Includes replacement for a participant who discontinued after period 1|3
918616|NCT01582308|2221320|P4|STARTED|Period 1||2
918617|NCT01582308|2221321|P3|STARTED|Period 1||2
918618|NCT01582308|2221322|P2|STARTED|Period 1||2
918619|NCT01582308|2221323|P1|STARTED|Period 1||2
918620|NCT01582282|2221351|P3|NOT COMPLETED|Overall Study||0
918621|NCT01582282|2221352|P2|NOT COMPLETED|Overall Study||2
918622|NCT01582282|2221353|P1|NOT COMPLETED|Overall Study||2
918623|NCT01582282|2221351|P3|COMPLETED|Overall Study||8
918624|NCT01582282|2221352|P2|COMPLETED|Overall Study||12
918625|NCT01582282|2221353|P1|COMPLETED|Overall Study||13
918626|NCT01582282|2221351|P3|STARTED|Overall Study||8
918627|NCT01582282|2221352|P2|STARTED|Overall Study||14
918628|NCT01582282|2221353|P1|STARTED|Overall Study||15
918629|NCT01582243|2221376|P1|NOT COMPLETED|Overall Study||3
918630|NCT01582243|2221376|P1|COMPLETED|Overall Study||37
918631|NCT01582243|2221376|P1|STARTED|Overall Study||40
918632|NCT01582178|2221387|P2|NOT COMPLETED|Overall Study||5
918633|NCT01582178|2221388|P1|NOT COMPLETED|Overall Study||6
918634|NCT01582178|2221387|P2|COMPLETED|Overall Study||101
918635|NCT01582178|2221388|P1|COMPLETED|Overall Study||100
918636|NCT01582178|2221387|P2|STARTED|Overall Study||106
918637|NCT01582178|2221388|P1|STARTED|Overall Study||106
918638|NCT01582139|2221396|P2|NOT COMPLETED|Overall Study||0
918639|NCT01582139|2221397|P1|NOT COMPLETED|Overall Study||0
918640|NCT01582139|2221396|P2|COMPLETED|Overall Study||6
918641|NCT01582139|2221397|P1|COMPLETED|Overall Study||6
918642|NCT01582139|2221396|P2|STARTED|Overall Study||6
918643|NCT01582139|2221397|P1|STARTED|Overall Study||6
918644|NCT01582100|2221409|P1|NOT COMPLETED|Overall Study||2
918645|NCT01582100|2221409|P1|COMPLETED|Overall Study||0
918646|NCT01582100|2221409|P1|STARTED|Overall Study||2
918647|NCT01582009|2221413|P1|NOT COMPLETED|Overall Study||2
918648|NCT01582009|2221413|P1|COMPLETED|Overall Study||24
918649|NCT01582009|2221413|P1|STARTED|Overall Study||26
918650|NCT01581931|2221421|P2|NOT COMPLETED|Second Period||0
918651|NCT01581931|2221422|P1|NOT COMPLETED|Second Period||0
918652|NCT01581931|2221421|P2|COMPLETED|Second Period||15
918653|NCT01581931|2221422|P1|COMPLETED|Second Period||16
918654|NCT01581931|2221421|P2|STARTED|Second Period||15
918655|NCT01581931|2221422|P1|STARTED|Second Period||16
918656|NCT01581931|2221421|P2|NOT COMPLETED|Washout||1
918657|NCT01581931|2221422|P1|NOT COMPLETED|Washout||0
918658|NCT01581931|2221421|P2|COMPLETED|Washout||15
918659|NCT01581931|2221422|P1|COMPLETED|Washout||16
918660|NCT01581931|2221421|P2|STARTED|Washout||16
918661|NCT01581931|2221422|P1|STARTED|Washout||16
918662|NCT01581931|2221421|P2|NOT COMPLETED|First Period||0
918663|NCT01581931|2221422|P1|NOT COMPLETED|First Period||0
918664|NCT01581931|2221421|P2|COMPLETED|First Period||16
918665|NCT01581931|2221422|P1|COMPLETED|First Period||16
918666|NCT01581931|2221421|P2|STARTED|First Period||16
918667|NCT01581931|2221422|P1|STARTED|First Period||16
918668|NCT01581684|2221446|P10|NOT COMPLETED|Overall Study||0
918669|NCT01581684|2221447|P9|NOT COMPLETED|Overall Study||1
918670|NCT01581684|2221448|P8|NOT COMPLETED|Overall Study||0
918671|NCT01581684|2221449|P7|NOT COMPLETED|Overall Study||0
918672|NCT01581684|2221450|P6|NOT COMPLETED|Overall Study||0
918673|NCT01581684|2221451|P5|NOT COMPLETED|Overall Study||0
918674|NCT01581684|2221452|P4|NOT COMPLETED|Overall Study||0
918675|NCT01581684|2221453|P3|NOT COMPLETED|Overall Study||0
918676|NCT01581684|2221454|P2|NOT COMPLETED|Overall Study||0
918677|NCT01581684|2221455|P1|NOT COMPLETED|Overall Study||0
918678|NCT01581684|2221446|P10|COMPLETED|Overall Study||5
918679|NCT01581684|2221447|P9|COMPLETED|Overall Study||0
918680|NCT01581684|2221448|P8|COMPLETED|Overall Study||6
918681|NCT01581684|2221449|P7|COMPLETED|Overall Study||6
918682|NCT01581684|2221450|P6|COMPLETED|Overall Study||6
918683|NCT01581684|2221451|P5|COMPLETED|Overall Study||6
918684|NCT01581684|2221452|P4|COMPLETED|Overall Study||6
918685|NCT01581684|2221453|P3|COMPLETED|Overall Study||6
918686|NCT01581684|2221454|P2|COMPLETED|Overall Study||6
918687|NCT01581684|2221455|P1|COMPLETED|Overall Study||14
918688|NCT01581684|2221446|P10|STARTED|Overall Study||5
918689|NCT01581684|2221447|P9|STARTED|Overall Study||1
918690|NCT01581684|2221448|P8|STARTED|Overall Study||6
918691|NCT01581684|2221449|P7|STARTED|Overall Study||6
918692|NCT01581684|2221450|P6|STARTED|Overall Study||6
918693|NCT01581684|2221451|P5|STARTED|Overall Study||6
918694|NCT01581684|2221452|P4|STARTED|Overall Study||6
918695|NCT01581684|2221453|P3|STARTED|Overall Study||6
918696|NCT01581684|2221454|P2|STARTED|Overall Study||6
918697|NCT01581684|2221455|P1|STARTED|Overall Study||14
918698|NCT01581658|2221530|P4|NOT COMPLETED|Overall Study||0
918699|NCT01581658|2221531|P3|NOT COMPLETED|Overall Study||0
918700|NCT01581658|2221532|P2|NOT COMPLETED|Overall Study||0
918701|NCT01581658|2221533|P1|NOT COMPLETED|Overall Study||0
918702|NCT01581658|2221530|P4|COMPLETED|Overall Study||8
918703|NCT01581658|2221531|P3|COMPLETED|Overall Study||8
918704|NCT01581658|2221532|P2|COMPLETED|Overall Study||8
918705|NCT01581658|2221533|P1|COMPLETED|Overall Study||8
918706|NCT01581658|2221530|P4|STARTED|Overall Study||8
918707|NCT01581658|2221531|P3|STARTED|Overall Study||8
918708|NCT01581658|2221532|P2|STARTED|Overall Study||8
918709|NCT01581658|2221533|P1|STARTED|Overall Study||8
918710|NCT01581619|2221551|P1|NOT COMPLETED|Overall Study||2
918711|NCT01581619|2221551|P1|COMPLETED|Overall Study||52
918712|NCT01581619|2221551|P1|STARTED|Overall Study||54
918713|NCT01581541|2221559|P11|NOT COMPLETED|Overall Study||0
918714|NCT01581541|2221560|P10|NOT COMPLETED|Overall Study||0
918715|NCT01581541|2221561|P9|NOT COMPLETED|Overall Study||0
918716|NCT01581541|2221562|P8|NOT COMPLETED|Overall Study||0
918717|NCT01581541|2221563|P7|NOT COMPLETED|Overall Study||0
918718|NCT01581541|2221564|P6|NOT COMPLETED|Overall Study||0
918719|NCT01581541|2221565|P5|NOT COMPLETED|Overall Study||0
918720|NCT01581541|2221566|P4|NOT COMPLETED|Overall Study||0
918721|NCT01581541|2221567|P3|NOT COMPLETED|Overall Study||0
918722|NCT01581541|2221568|P2|NOT COMPLETED|Overall Study||0
918723|NCT01581541|2221569|P1|NOT COMPLETED|Overall Study||0
918724|NCT01581541|2221559|P11|COMPLETED|Overall Study||1
918725|NCT01581541|2221560|P10|COMPLETED|Overall Study||3
918726|NCT01581541|2221561|P9|COMPLETED|Overall Study||1
918727|NCT01581541|2221562|P8|COMPLETED|Overall Study||2
918728|NCT01581541|2221563|P7|COMPLETED|Overall Study||1
918729|NCT01581541|2221564|P6|COMPLETED|Overall Study||3
918730|NCT01581541|2221565|P5|COMPLETED|Overall Study||2
918731|NCT01581541|2221566|P4|COMPLETED|Overall Study||1
918732|NCT01581541|2221567|P3|COMPLETED|Overall Study||1
918733|NCT01581541|2221568|P2|COMPLETED|Overall Study||1
918734|NCT01581541|2221569|P1|COMPLETED|Overall Study||1
918735|NCT01581541|2221559|P11|STARTED|Overall Study||1
918736|NCT01581541|2221560|P10|STARTED|Overall Study||3
918737|NCT01581541|2221561|P9|STARTED|Overall Study||1
918738|NCT01581541|2221562|P8|STARTED|Overall Study||2
918739|NCT01581541|2221563|P7|STARTED|Overall Study||1
918740|NCT01581541|2221564|P6|STARTED|Overall Study||3
918741|NCT01581541|2221565|P5|STARTED|Overall Study||2
918742|NCT01581541|2221566|P4|STARTED|Overall Study||1
918743|NCT01581541|2221567|P3|STARTED|Overall Study||1
918744|NCT01581541|2221568|P2|STARTED|Overall Study||1
918745|NCT01581541|2221569|P1|STARTED|Overall Study||1
918746|NCT01581437|2221693|P1|NOT COMPLETED|Overall Study||0
918747|NCT01581437|2221693|P1|COMPLETED|Overall Study||78
918748|NCT01581437|2221693|P1|STARTED|Overall Study||78
918749|NCT01581307|2221704|P1|NOT COMPLETED|Overall Study||1
918750|NCT01581307|2221704|P1|COMPLETED|Overall Study||8
918751|NCT01581307|2221704|P1|STARTED|Overall Study||9
918752|NCT01581281|2221713|P3|NOT COMPLETED|Overall Study||12
918753|NCT01581281|2221714|P2|NOT COMPLETED|Overall Study||6
918754|NCT01581281|2221715|P1|NOT COMPLETED|Overall Study||15
918755|NCT01581281|2221713|P3|COMPLETED|Overall Study||132
918756|NCT01581281|2221714|P2|COMPLETED|Overall Study||66
918757|NCT01581281|2221715|P1|COMPLETED|Overall Study||130
918758|NCT01581281|2221713|P3|STARTED|Overall Study||144
918759|NCT01581281|2221714|P2|STARTED|Overall Study||72
918760|NCT01581281|2221715|P1|STARTED|Overall Study||145
918761|NCT01581021|2221737|P2|NOT COMPLETED|Overall Study||11
918762|NCT01581021|2221738|P1|NOT COMPLETED|Overall Study||10
918763|NCT01581021|2221737|P2|COMPLETED|Overall Study||18
918764|NCT01581021|2221738|P1|COMPLETED|Overall Study||19
918765|NCT01581021|2221737|P2|STARTED|Overall Study||29
918766|NCT01581021|2221738|P1|STARTED|Overall Study||29
918767|NCT01581008|2221752|P2|NOT COMPLETED|Overall Study||6
918768|NCT01581008|2221753|P1|NOT COMPLETED|Overall Study||1
918769|NCT01581008|2221752|P2|COMPLETED|Overall Study||7
918770|NCT01581008|2221753|P1|COMPLETED|Overall Study||16
918771|NCT01581008|2221752|P2|STARTED|Overall Study||13
918772|NCT01581008|2221753|P1|STARTED|Overall Study||17
918773|NCT01580995|2221764|P2|NOT COMPLETED|Overall Study||2
918774|NCT01580995|2221765|P1|NOT COMPLETED|Overall Study||2
918775|NCT01580995|2221764|P2|COMPLETED|Overall Study||7
918776|NCT01580995|2221765|P1|COMPLETED|Overall Study||8
918777|NCT01580995|2221764|P2|STARTED|Overall Study||9
918778|NCT01580995|2221765|P1|STARTED|Overall Study||10
918779|NCT01580904|2221773|P2|NOT COMPLETED|Overall Study||7
918780|NCT01580904|2221774|P1|NOT COMPLETED|Overall Study||4
918781|NCT01580904|2221773|P2|COMPLETED|Overall Study||42
918782|NCT01580904|2221774|P1|COMPLETED|Overall Study||47
918783|NCT01580904|2221773|P2|STARTED|Overall Study||49
918784|NCT01580904|2221774|P1|STARTED|Overall Study||51
918785|NCT01580618|2221788|P2|NOT COMPLETED|Overall Study||0
918786|NCT01580618|2221789|P1|NOT COMPLETED|Overall Study||1
918787|NCT01580618|2221788|P2|COMPLETED|Overall Study||12
918788|NCT01580618|2221789|P1|COMPLETED|Overall Study|One patient was switched from the normal saline to TNKase arm at attending physician request.|7
918789|NCT01580618|2221788|P2|STARTED|Overall Study||12
918790|NCT01580618|2221789|P1|STARTED|Overall Study||8
918791|NCT01580592|2221805|P3|NOT COMPLETED|Overall Study||0
918792|NCT01580592|2221806|P2|NOT COMPLETED|Overall Study||0
918793|NCT01580592|2221807|P1|NOT COMPLETED|Overall Study||0
918794|NCT01580592|2221805|P3|COMPLETED|Overall Study||12
918795|NCT01580592|2221806|P2|COMPLETED|Overall Study||9
918796|NCT01580592|2221807|P1|COMPLETED|Overall Study||10
918797|NCT01580592|2221805|P3|STARTED|Overall Study||12
918798|NCT01580592|2221806|P2|STARTED|Overall Study||9
918799|NCT01580592|2221807|P1|STARTED|Overall Study||10
918800|NCT01580488|2221818|P1|NOT COMPLETED|Overall Study||1
918801|NCT01580488|2221818|P1|COMPLETED|Overall Study||23
918802|NCT01580488|2221818|P1|STARTED|Overall Study||24
918803|NCT01580423|2221862|P2|NOT COMPLETED|Second Intervention||0
918804|NCT01580423|2221863|P1|NOT COMPLETED|Second Intervention||0
918805|NCT01580423|2221862|P2|COMPLETED|Second Intervention||8
918806|NCT01580423|2221863|P1|COMPLETED|Second Intervention||8
918807|NCT01580423|2221862|P2|STARTED|Second Intervention||8
918808|NCT01580423|2221863|P1|STARTED|Second Intervention||8
918809|NCT01580423|2221862|P2|NOT COMPLETED|First Intervention||0
918810|NCT01580423|2221863|P1|NOT COMPLETED|First Intervention||0
918811|NCT01580423|2221862|P2|COMPLETED|First Intervention||8
918812|NCT01580423|2221863|P1|COMPLETED|First Intervention||8
918813|NCT01580423|2221862|P2|STARTED|First Intervention||8
918814|NCT01580423|2221863|P1|STARTED|First Intervention||8
918815|NCT01580306|2221877|P4|NOT COMPLETED|Overall Study||0
918816|NCT01580306|2221878|P3|NOT COMPLETED|Overall Study||0
918817|NCT01580306|2221879|P2|NOT COMPLETED|Overall Study||0
918818|NCT01580306|2221880|P1|NOT COMPLETED|Overall Study||0
918819|NCT01580306|2221877|P4|COMPLETED|Overall Study||8
918820|NCT01580306|2221878|P3|COMPLETED|Overall Study||8
918821|NCT01580306|2221879|P2|COMPLETED|Overall Study||8
918822|NCT01580306|2221880|P1|COMPLETED|Overall Study||8
918823|NCT01580306|2221877|P4|STARTED|Overall Study||8
918824|NCT01580306|2221878|P3|STARTED|Overall Study||8
918825|NCT01580306|2221879|P2|STARTED|Overall Study||8
918826|NCT01580306|2221880|P1|STARTED|Overall Study||8
918827|NCT01580098|2221904|P3|NOT COMPLETED|Overall Study||3
918828|NCT01580098|2221905|P2|NOT COMPLETED|Overall Study||13
918829|NCT01580098|2221906|P1|NOT COMPLETED|Overall Study||15
918830|NCT01580098|2221904|P3|COMPLETED|Overall Study|Due to high age and bad health conditions no patients finished (nursing)|0
918831|NCT01580098|2221905|P2|COMPLETED|Overall Study||101
918832|NCT01580098|2221906|P1|COMPLETED|Overall Study||61
918833|NCT01580098|2221904|P3|STARTED|Overall Study||3
918834|NCT01580098|2221905|P2|STARTED|Overall Study||114
918835|NCT01580098|2221906|P1|STARTED|Overall Study||76
918836|NCT01580072|2221929|P3|NOT COMPLETED|Overall Study||0
918837|NCT01580072|2221930|P2|NOT COMPLETED|Overall Study||9
918838|NCT01580072|2221931|P1|NOT COMPLETED|Overall Study||12
918839|NCT01580072|2221929|P3|COMPLETED|Overall Study||0
918840|NCT01580072|2221930|P2|COMPLETED|Overall Study||28
918841|NCT01580072|2221931|P1|COMPLETED|Overall Study||16
918842|NCT01580072|2221929|P3|STARTED|Overall Study||0
918843|NCT01580072|2221930|P2|STARTED|Overall Study||37
918844|NCT01580072|2221931|P1|STARTED|Overall Study||28
918845|NCT01580020|2221959|P4|NOT COMPLETED|Overall Study||2
918846|NCT01580020|2221960|P3|NOT COMPLETED|Overall Study||4
918847|NCT01580020|2221961|P2|NOT COMPLETED|Overall Study||7
918848|NCT01580020|2221962|P1|NOT COMPLETED|Overall Study||1
918849|NCT01580020|2221959|P4|COMPLETED|Overall Study||20
918850|NCT01580020|2221960|P3|COMPLETED|Overall Study||57
918851|NCT01580020|2221961|P2|COMPLETED|Overall Study||33
918852|NCT01580020|2221962|P1|COMPLETED|Overall Study||51
918853|NCT01580020|2221959|P4|STARTED|Overall Study||22
918854|NCT01580020|2221960|P3|STARTED|Overall Study||61
918855|NCT01580020|2221961|P2|STARTED|Overall Study||40
918856|NCT01580020|2221962|P1|STARTED|Overall Study||52
918857|NCT01579916|2222006|P2|NOT COMPLETED|Overall Study||2
918858|NCT01579916|2222007|P1|NOT COMPLETED|Overall Study||8
918859|NCT01579916|2222006|P2|COMPLETED|Overall Study||59
918860|NCT01579916|2222007|P1|COMPLETED|Overall Study||234
918861|NCT01579916|2222006|P2|STARTED|Overall Study||61
918862|NCT01579916|2222007|P1|STARTED|Overall Study||242
918863|NCT01578850|2222035|P3|NOT COMPLETED|Period 2||14
918864|NCT01578850|2222036|P2|NOT COMPLETED|Period 2||13
918865|NCT01578850|2222037|P1|NOT COMPLETED|Period 2||0
918866|NCT01578850|2222035|P3|COMPLETED|Period 2||162
918867|NCT01578850|2222036|P2|COMPLETED|Period 2||154
918868|NCT01578850|2222037|P1|COMPLETED|Period 2||0
918869|NCT01578850|2222035|P3|STARTED|Period 2|One participants in PBO did not receive treatment.|176
918870|NCT01578850|2222036|P2|STARTED|Period 2|Two participants in ETN did not receive treatment.|167
918871|NCT01578850|2222037|P1|STARTED|Period 2||0
918872|NCT01578850|2222035|P3|NOT COMPLETED|Period 1||0
918873|NCT01578850|2222036|P2|NOT COMPLETED|Period 1||0
918874|NCT01578850|2222037|P1|NOT COMPLETED|Period 1||37
918875|NCT01578850|2222035|P3|COMPLETED|Period 1||0
918876|NCT01578850|2222036|P2|COMPLETED|Period 1||0
918877|NCT01578850|2222037|P1|COMPLETED|Period 1||452
918878|NCT01578850|2222035|P3|STARTED|Period 1||0
918879|NCT01578850|2222036|P2|STARTED|Period 1||0
918880|NCT01578850|2222037|P1|STARTED|Period 1|491 participants were enrolled in open-label treatment but 2 did not receive study medication.|489
918881|NCT01579747|2222089|P2|NOT COMPLETED|Overall Study||0
918882|NCT01579747|2222090|P1|NOT COMPLETED|Overall Study||0
918883|NCT01579747|2222089|P2|COMPLETED|Overall Study||12
918884|NCT01579747|2222090|P1|COMPLETED|Overall Study||12
918885|NCT01579747|2222089|P2|STARTED|Overall Study||12
918886|NCT01579747|2222090|P1|STARTED|Overall Study||12
918887|NCT01579669|2222100|P2|NOT COMPLETED|Overall Study||0
918888|NCT01579669|2222101|P1|NOT COMPLETED|Overall Study||36
918889|NCT01579669|2222100|P2|COMPLETED|Overall Study||41
918890|NCT01579669|2222101|P1|COMPLETED|Overall Study||134
918891|NCT01579669|2222100|P2|STARTED|Overall Study||41
918892|NCT01579669|2222101|P1|STARTED|Overall Study||170
918893|NCT01579578|2222113|P2|NOT COMPLETED|Overall Study||12
918894|NCT01579578|2222114|P1|NOT COMPLETED|Overall Study||13
918895|NCT01579578|2222113|P2|COMPLETED|Overall Study||0
918896|NCT01579578|2222114|P1|COMPLETED|Overall Study||0
918897|NCT01579578|2222113|P2|Ongoing|Overall Study||0
918898|NCT01579578|2222114|P1|Ongoing|Overall Study||3
918899|NCT01579578|2222113|P2|STARTED|Overall Study||12
918900|NCT01579578|2222114|P1|STARTED|Overall Study||13
918901|NCT01579565|2222126|P2|NOT COMPLETED|Treated||3
918902|NCT01579565|2222127|P1|NOT COMPLETED|Treated||2
918903|NCT01579565|2222126|P2|COMPLETED|Treated||201
918904|NCT01579565|2222127|P1|COMPLETED|Treated||200
918905|NCT01579565|2222126|P2|STARTED|Treated||204
918906|NCT01579565|2222127|P1|STARTED|Treated||202
918907|NCT01579565|2222126|P2|NOT COMPLETED|Randomized||5
918908|NCT01579565|2222127|P1|NOT COMPLETED|Randomized||5
918909|NCT01579565|2222126|P2|COMPLETED|Randomized||204
918910|NCT01579565|2222127|P1|COMPLETED|Randomized||202
918911|NCT01579565|2222126|P2|STARTED|Randomized||209
918912|NCT01579565|2222127|P1|STARTED|Randomized||207
918913|NCT01579474|2222161|P6|NOT COMPLETED|Overall Study||1
918914|NCT01579474|2222162|P5|NOT COMPLETED|Overall Study||1
918915|NCT01579474|2222163|P4|NOT COMPLETED|Overall Study||0
918916|NCT01579474|2222164|P3|NOT COMPLETED|Overall Study||2
918917|NCT01579474|2222165|P2|NOT COMPLETED|Overall Study||13
918918|NCT01579474|2222166|P1|NOT COMPLETED|Overall Study||3
918919|NCT01579474|2222161|P6|COMPLETED|Overall Study||1
918920|NCT01579474|2222162|P5|COMPLETED|Overall Study||9
918921|NCT01579474|2222163|P4|COMPLETED|Overall Study||3
918922|NCT01579474|2222164|P3|COMPLETED|Overall Study||27
918923|NCT01579474|2222165|P2|COMPLETED|Overall Study||30
918924|NCT01579474|2222166|P1|COMPLETED|Overall Study||41
918925|NCT01579474|2222161|P6|STARTED|Overall Study||2
918926|NCT01579474|2222162|P5|STARTED|Overall Study||10
918927|NCT01579474|2222163|P4|STARTED|Overall Study||3
918928|NCT01579474|2222164|P3|STARTED|Overall Study||29
918929|NCT01579474|2222165|P2|STARTED|Overall Study||43
918930|NCT01579474|2222166|P1|STARTED|Overall Study||44
918931|NCT01579305|2222242|P2|NOT COMPLETED|Overall Study||27
918932|NCT01579305|2222243|P1|NOT COMPLETED|Overall Study||21
918933|NCT01579305|2222242|P2|COMPLETED|Overall Study||115
918934|NCT01579305|2222243|P1|COMPLETED|Overall Study||118
918935|NCT01579305|2222242|P2|Continued After Treatment|Overall Study||141
918936|NCT01579305|2222243|P1|Continued After Treatment|Overall Study||139
918937|NCT01579305|2222242|P2|Discontinued Before Treatment|Overall Study||1
918938|NCT01579305|2222243|P1|Discontinued Before Treatment|Overall Study||0
918939|NCT01579305|2222242|P2|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|142
918940|NCT01579305|2222243|P1|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|139
918941|NCT01579084|2222259|P10|NOT COMPLETED|Overall Study||0
918942|NCT01579084|2222260|P9|NOT COMPLETED|Overall Study||0
918943|NCT01579084|2222261|P8|NOT COMPLETED|Overall Study||0
918944|NCT01579084|2222262|P7|NOT COMPLETED|Overall Study||0
918945|NCT01579084|2222263|P6|NOT COMPLETED|Overall Study||0
918946|NCT01579084|2222264|P5|NOT COMPLETED|Overall Study||0
918947|NCT01579084|2222265|P4|NOT COMPLETED|Overall Study||0
918948|NCT01579084|2222266|P3|NOT COMPLETED|Overall Study||0
918949|NCT01579084|2222267|P2|NOT COMPLETED|Overall Study||0
918950|NCT01579084|2222268|P1|NOT COMPLETED|Overall Study||0
918951|NCT01579084|2222259|P10|COMPLETED|Overall Study||4
918952|NCT01579084|2222260|P9|COMPLETED|Overall Study||4
918953|NCT01579084|2222261|P8|COMPLETED|Overall Study||4
918954|NCT01579084|2222262|P7|COMPLETED|Overall Study||4
918955|NCT01579084|2222263|P6|COMPLETED|Overall Study||8
918956|NCT01579084|2222264|P5|COMPLETED|Overall Study||8
918957|NCT01579084|2222265|P4|COMPLETED|Overall Study||8
918958|NCT01579084|2222266|P3|COMPLETED|Overall Study||8
918959|NCT01579084|2222267|P2|COMPLETED|Overall Study||8
918960|NCT01579084|2222268|P1|COMPLETED|Overall Study||8
918961|NCT01579084|2222259|P10|STARTED|Overall Study||4
918962|NCT01579084|2222260|P9|STARTED|Overall Study||4
918963|NCT01579084|2222261|P8|STARTED|Overall Study||4
918964|NCT01579084|2222262|P7|STARTED|Overall Study||4
918965|NCT01579084|2222263|P6|STARTED|Overall Study||8
918966|NCT01579084|2222264|P5|STARTED|Overall Study||8
918967|NCT01579084|2222265|P4|STARTED|Overall Study||8
918968|NCT01579084|2222266|P3|STARTED|Overall Study||8
918969|NCT01579084|2222267|P2|STARTED|Overall Study||8
918970|NCT01579084|2222268|P1|STARTED|Overall Study||8
918971|NCT01579045|2222296|P1|NOT COMPLETED|Overall Study||0
918972|NCT01579045|2222296|P1|COMPLETED|Overall Study||24
918973|NCT01579045|2222296|P1|STARTED|Overall Study||24
918974|NCT01579006|2222313|P1|NOT COMPLETED|Overall Study||33
918975|NCT01579006|2222313|P1|COMPLETED|Overall Study||151
918976|NCT01579006|2222313|P1|STARTED|Overall Study||184
918977|NCT01578993|2222352|P1|NOT COMPLETED|Overall Study||0
918978|NCT01578993|2222352|P1|COMPLETED|Overall Study||101
918979|NCT01578993|2222352|P1|STARTED|Overall Study||101
918980|NCT01578980|2222356|P1|NOT COMPLETED|Overall Study||0
918981|NCT01578980|2222356|P1|COMPLETED|Overall Study||20
918982|NCT01578980|2222356|P1|STARTED|Overall Study||20
918983|NCT01578785|2222363|P2|NOT COMPLETED|Overall Study||119
918984|NCT01578785|2222364|P1|NOT COMPLETED|Overall Study||59
918985|NCT01578785|2222363|P2|COMPLETED|Overall Study||0
918986|NCT01578785|2222364|P1|COMPLETED|Overall Study||0
918987|NCT01578785|2222363|P2|STARTED|Overall Study||119
918988|NCT01578785|2222364|P1|STARTED|Overall Study||59
918989|NCT01578772|2222376|P1|NOT COMPLETED|Overall Study||0
918990|NCT01578772|2222376|P1|COMPLETED|Overall Study||17
918991|NCT01578772|2222376|P1|STARTED|Overall Study||17
918992|NCT01578707|2222385|P2|NOT COMPLETED|Overall Study||0
918993|NCT01578707|2222386|P1|NOT COMPLETED|Overall Study||0
918994|NCT01578707|2222385|P2|COMPLETED|Overall Study||195
918995|NCT01578707|2222386|P1|COMPLETED|Overall Study||196
918996|NCT01578707|2222385|P2|STARTED|Overall Study||195
918997|NCT01578707|2222386|P1|STARTED|Overall Study||196
918998|NCT01578330|2222394|P1|NOT COMPLETED|Overall Study||7
918999|NCT01578330|2222394|P1|COMPLETED|Overall Study||35
919000|NCT01578330|2222394|P1|Per Protocol Population|Overall Study||35
919001|NCT01578330|2222394|P1|STARTED|Overall Study||42
919002|NCT01578239|2222403|P2|NOT COMPLETED|Overall Study||25
919003|NCT01578239|2222404|P1|NOT COMPLETED|Overall Study||22
919004|NCT01578239|2222403|P2|COMPLETED|Overall Study||88
919005|NCT01578239|2222404|P1|COMPLETED|Overall Study||94
919006|NCT01578239|2222403|P2|STARTED|Overall Study||113
919007|NCT01578239|2222404|P1|STARTED|Overall Study||116
919008|NCT01578187|2222410|P1|NOT COMPLETED|Usability Phase||1
919009|NCT01578187|2222410|P1|COMPLETED|Usability Phase||47
919010|NCT01578187|2222410|P1|STARTED|Usability Phase||48
919011|NCT01578187|2222410|P1|NOT COMPLETED|Label Comprehension Phase||0
919012|NCT01578187|2222410|P1|COMPLETED|Label Comprehension Phase||63
919013|NCT01578187|2222410|P1|STARTED|Label Comprehension Phase||63
919014|NCT01578044|2222418|P2|NOT COMPLETED|Overall Study||0
919015|NCT01578044|2222419|P1|NOT COMPLETED|Overall Study||0
919016|NCT01578044|2222418|P2|COMPLETED|Overall Study||6
919017|NCT01578044|2222419|P1|COMPLETED|Overall Study||6
919018|NCT01578044|2222418|P2|STARTED|Overall Study||6
919019|NCT01578044|2222419|P1|STARTED|Overall Study||6
919020|NCT01578031|2222429|P4|NOT COMPLETED|Overall Study||0
919021|NCT01578031|2222430|P3|NOT COMPLETED|Overall Study||0
919022|NCT01578031|2222431|P2|NOT COMPLETED|Overall Study||34
919023|NCT01578031|2222432|P1|NOT COMPLETED|Overall Study||62
919024|NCT01578031|2222429|P4|COMPLETED|Overall Study|Only baseline data collected|30
919025|NCT01578031|2222430|P3|COMPLETED|Overall Study|Only baseline data collected|12
919026|NCT01578031|2222431|P2|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|35
919027|NCT01578031|2222432|P1|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|67
919028|NCT01578031|2222429|P4|STARTED|Overall Study||30
919029|NCT01578031|2222430|P3|STARTED|Overall Study||12
919030|NCT01578031|2222431|P2|STARTED|Overall Study||69
919031|NCT01578031|2222432|P1|STARTED|Overall Study||129
919032|NCT01577966|2222440|P1|NOT COMPLETED|Overall Study||0
919033|NCT01577966|2222440|P1|COMPLETED|Overall Study||9
919034|NCT01577966|2222440|P1|STARTED|Overall Study||9
919035|NCT01577758|2222444|P8|NOT COMPLETED|mCRC Expansion Phase||25
919036|NCT01577758|2222445|P7|NOT COMPLETED|mCRC Expansion Phase||0
919037|NCT01577758|2222446|P6|NOT COMPLETED|mCRC Expansion Phase||0
919038|NCT01577758|2222447|P5|NOT COMPLETED|mCRC Expansion Phase||0
919039|NCT01577758|2222448|P4|NOT COMPLETED|mCRC Expansion Phase||0
919040|NCT01577758|2222449|P3|NOT COMPLETED|mCRC Expansion Phase||0
919041|NCT01577758|2222450|P2|NOT COMPLETED|mCRC Expansion Phase||0
919042|NCT01577758|2222451|P1|NOT COMPLETED|mCRC Expansion Phase||0
919043|NCT01577758|2222444|P8|COMPLETED|mCRC Expansion Phase||0
919044|NCT01577758|2222445|P7|COMPLETED|mCRC Expansion Phase||0
919045|NCT01577758|2222446|P6|COMPLETED|mCRC Expansion Phase||0
919046|NCT01577758|2222447|P5|COMPLETED|mCRC Expansion Phase||0
919047|NCT01577758|2222448|P4|COMPLETED|mCRC Expansion Phase||0
919048|NCT01577758|2222449|P3|COMPLETED|mCRC Expansion Phase||0
919049|NCT01577758|2222450|P2|COMPLETED|mCRC Expansion Phase||0
919050|NCT01577758|2222451|P1|COMPLETED|mCRC Expansion Phase||0
919051|NCT01577758|2222444|P8|STARTED|mCRC Expansion Phase||25
919052|NCT01577758|2222445|P7|STARTED|mCRC Expansion Phase||0
919053|NCT01577758|2222446|P6|STARTED|mCRC Expansion Phase||0
919054|NCT01577758|2222447|P5|STARTED|mCRC Expansion Phase||0
919055|NCT01577758|2222448|P4|STARTED|mCRC Expansion Phase||0
919056|NCT01577758|2222449|P3|STARTED|mCRC Expansion Phase||0
919057|NCT01577758|2222450|P2|STARTED|mCRC Expansion Phase||0
919058|NCT01577758|2222451|P1|STARTED|mCRC Expansion Phase||0
919059|NCT01577758|2222444|P8|NOT COMPLETED|Dose Escalation Phase||0
919060|NCT01577758|2222445|P7|NOT COMPLETED|Dose Escalation Phase||1
919061|NCT01577758|2222446|P6|NOT COMPLETED|Dose Escalation Phase||4
919062|NCT01577758|2222447|P5|NOT COMPLETED|Dose Escalation Phase||6
919063|NCT01577758|2222448|P4|NOT COMPLETED|Dose Escalation Phase||2
919064|NCT01577758|2222449|P3|NOT COMPLETED|Dose Escalation Phase||2
919065|NCT01577758|2222450|P2|NOT COMPLETED|Dose Escalation Phase||2
919066|NCT01577758|2222451|P1|NOT COMPLETED|Dose Escalation Phase||2
919067|NCT01577758|2222444|P8|COMPLETED|Dose Escalation Phase||0
919068|NCT01577758|2222445|P7|COMPLETED|Dose Escalation Phase||0
919069|NCT01577758|2222446|P6|COMPLETED|Dose Escalation Phase||0
919070|NCT01577758|2222447|P5|COMPLETED|Dose Escalation Phase||0
919071|NCT01577758|2222448|P4|COMPLETED|Dose Escalation Phase||0
919072|NCT01577758|2222449|P3|COMPLETED|Dose Escalation Phase||0
919073|NCT01577758|2222450|P2|COMPLETED|Dose Escalation Phase||0
919074|NCT01577758|2222451|P1|COMPLETED|Dose Escalation Phase||0
919075|NCT01577758|2222444|P8|STARTED|Dose Escalation Phase||0
919076|NCT01577758|2222445|P7|STARTED|Dose Escalation Phase||1
919077|NCT01577758|2222446|P6|STARTED|Dose Escalation Phase||4
919078|NCT01577758|2222447|P5|STARTED|Dose Escalation Phase||6
919079|NCT01577758|2222448|P4|STARTED|Dose Escalation Phase||2
919080|NCT01577758|2222449|P3|STARTED|Dose Escalation Phase||2
919081|NCT01577758|2222450|P2|STARTED|Dose Escalation Phase||2
919082|NCT01577758|2222451|P1|STARTED|Dose Escalation Phase||2
919083|NCT01577745|2222490|P6|NOT COMPLETED|Overall Study||4
919084|NCT01577745|2222491|P5|NOT COMPLETED|Overall Study||5
919085|NCT01577745|2222492|P4|NOT COMPLETED|Overall Study||6
919086|NCT01577745|2222493|P3|NOT COMPLETED|Overall Study||2
919087|NCT01577745|2222494|P2|NOT COMPLETED|Overall Study||3
919088|NCT01577745|2222495|P1|NOT COMPLETED|Overall Study||3
919089|NCT01577745|2222490|P6|COMPLETED|Overall Study||1
919090|NCT01577745|2222491|P5|COMPLETED|Overall Study||0
919091|NCT01577745|2222492|P4|COMPLETED|Overall Study||0
919092|NCT01577745|2222493|P3|COMPLETED|Overall Study||1
919093|NCT01577745|2222494|P2|COMPLETED|Overall Study||0
919094|NCT01577745|2222495|P1|COMPLETED|Overall Study||0
919095|NCT01577745|2222490|P6|STARTED|Overall Study||5
919096|NCT01577745|2222491|P5|STARTED|Overall Study||5
919097|NCT01577745|2222492|P4|STARTED|Overall Study||6
919098|NCT01577745|2222493|P3|STARTED|Overall Study||3
919099|NCT01577745|2222494|P2|STARTED|Overall Study||3
919100|NCT01577745|2222495|P1|STARTED|Overall Study||3
919101|NCT01577732|2222612|P1|NOT COMPLETED|Overall Study||0
919102|NCT01577732|2222612|P1|COMPLETED|Overall Study||300
919103|NCT01577732|2222612|P1|STARTED|Overall Study||300
919104|NCT01577706|2222619|P3|NOT COMPLETED|Third Intervention (1 Day)||0
919105|NCT01577706|2222620|P2|NOT COMPLETED|Third Intervention (1 Day)||0
919106|NCT01577706|2222621|P1|NOT COMPLETED|Third Intervention (1 Day)||0
919107|NCT01577706|2222619|P3|COMPLETED|Third Intervention (1 Day)||3
919108|NCT01577706|2222620|P2|COMPLETED|Third Intervention (1 Day)||1
919109|NCT01577706|2222621|P1|COMPLETED|Third Intervention (1 Day)||3
919110|NCT01577706|2222619|P3|STARTED|Third Intervention (1 Day)||3
919111|NCT01577706|2222620|P2|STARTED|Third Intervention (1 Day)||1
919112|NCT01577706|2222621|P1|STARTED|Third Intervention (1 Day)||3
919113|NCT01577706|2222619|P3|NOT COMPLETED|Washout (at Least 1 Week)||0
919114|NCT01577706|2222620|P2|NOT COMPLETED|Washout (at Least 1 Week)||0
919115|NCT01577706|2222621|P1|NOT COMPLETED|Washout (at Least 1 Week)||0
919116|NCT01577706|2222619|P3|COMPLETED|Washout (at Least 1 Week)||3
919117|NCT01577706|2222620|P2|COMPLETED|Washout (at Least 1 Week)||1
919118|NCT01577706|2222621|P1|COMPLETED|Washout (at Least 1 Week)||3
919119|NCT01577706|2222619|P3|STARTED|Washout (at Least 1 Week)||3
919120|NCT01577706|2222620|P2|STARTED|Washout (at Least 1 Week)||1
919121|NCT01577706|2222621|P1|STARTED|Washout (at Least 1 Week)||3
919122|NCT01577706|2222619|P3|NOT COMPLETED|Second Intervention (1 Day)||0
919123|NCT01577706|2222620|P2|NOT COMPLETED|Second Intervention (1 Day)||0
919124|NCT01577706|2222621|P1|NOT COMPLETED|Second Intervention (1 Day)||0
919125|NCT01577706|2222619|P3|COMPLETED|Second Intervention (1 Day)||3
919126|NCT01577706|2222620|P2|COMPLETED|Second Intervention (1 Day)||1
919127|NCT01577706|2222621|P1|COMPLETED|Second Intervention (1 Day)||3
919128|NCT01577706|2222619|P3|STARTED|Second Intervention (1 Day)||3
919129|NCT01577706|2222620|P2|STARTED|Second Intervention (1 Day)||1
919130|NCT01577706|2222621|P1|STARTED|Second Intervention (1 Day)||3
919131|NCT01577706|2222619|P3|NOT COMPLETED|Washout (at Least 1 Week)||0
919132|NCT01577706|2222620|P2|NOT COMPLETED|Washout (at Least 1 Week)||0
919133|NCT01577706|2222621|P1|NOT COMPLETED|Washout (at Least 1 Week)||0
919134|NCT01577706|2222619|P3|COMPLETED|Washout (at Least 1 Week)||3
919135|NCT01577706|2222620|P2|COMPLETED|Washout (at Least 1 Week)||1
919136|NCT01577706|2222621|P1|COMPLETED|Washout (at Least 1 Week)||3
919137|NCT01577706|2222619|P3|STARTED|Washout (at Least 1 Week)||3
919138|NCT01577706|2222620|P2|STARTED|Washout (at Least 1 Week)||1
919139|NCT01577706|2222621|P1|STARTED|Washout (at Least 1 Week)||3
919140|NCT01577706|2222619|P3|NOT COMPLETED|First Intervention (1 Day)||0
919141|NCT01577706|2222620|P2|NOT COMPLETED|First Intervention (1 Day)||0
919142|NCT01577706|2222621|P1|NOT COMPLETED|First Intervention (1 Day)||0
919143|NCT01577706|2222619|P3|COMPLETED|First Intervention (1 Day)||3
919144|NCT01577706|2222620|P2|COMPLETED|First Intervention (1 Day)||1
919145|NCT01577706|2222621|P1|COMPLETED|First Intervention (1 Day)||3
919146|NCT01577706|2222619|P3|STARTED|First Intervention (1 Day)||3
919147|NCT01577706|2222620|P2|STARTED|First Intervention (1 Day)||1
919148|NCT01577706|2222621|P1|STARTED|First Intervention (1 Day)||3
919149|NCT01577628|2222649|P3|NOT COMPLETED|Overall Study||2
919150|NCT01577628|2222650|P2|NOT COMPLETED|Overall Study||0
919151|NCT01577628|2222651|P1|NOT COMPLETED|Overall Study||0
919152|NCT01577628|2222649|P3|COMPLETED|Overall Study||0
919153|NCT01577628|2222650|P2|COMPLETED|Overall Study||0
919154|NCT01577628|2222651|P1|COMPLETED|Overall Study||0
919155|NCT01577628|2222649|P3|STARTED|Overall Study||2
919156|NCT01577628|2222650|P2|STARTED|Overall Study||0
919157|NCT01577628|2222651|P1|STARTED|Overall Study||0
919158|NCT01577381|2222679|P4|NOT COMPLETED|Overall Study||2
919159|NCT01577381|2222680|P3|NOT COMPLETED|Overall Study||3
919160|NCT01577381|2222681|P2|NOT COMPLETED|Overall Study||3
919161|NCT01577381|2222682|P1|NOT COMPLETED|Overall Study||2
919162|NCT01577381|2222679|P4|COMPLETED|Overall Study||0
919163|NCT01577381|2222680|P3|COMPLETED|Overall Study||0
919164|NCT01577381|2222681|P2|COMPLETED|Overall Study||0
919165|NCT01577381|2222682|P1|COMPLETED|Overall Study||0
919166|NCT01577381|2222679|P4|STARTED|Overall Study||2
919167|NCT01577381|2222680|P3|STARTED|Overall Study||3
919168|NCT01577381|2222681|P2|STARTED|Overall Study||3
919169|NCT01577381|2222682|P1|STARTED|Overall Study||2
919170|NCT01577329|2222813|P2|NOT COMPLETED|Overall Study||0
919171|NCT01577329|2222814|P1|NOT COMPLETED|Overall Study||3
919172|NCT01577329|2222813|P2|COMPLETED|Overall Study||22
919173|NCT01577329|2222814|P1|COMPLETED|Overall Study||16
919174|NCT01577329|2222813|P2|STARTED|Overall Study||22
919175|NCT01577329|2222814|P1|STARTED|Overall Study||19
919176|NCT01577186|2222820|P1|NOT COMPLETED|Overall Study||130
919177|NCT01577186|2222820|P1|COMPLETED|Overall Study||350
919178|NCT01577186|2222820|P1|STARTED|Overall Study||480
919179|NCT01577160|2222828|P1|NOT COMPLETED|Overall Study||98
919180|NCT01577160|2222828|P1|COMPLETED|Overall Study||255
919181|NCT01577160|2222828|P1|STARTED|Overall Study||353
919182|NCT01577108|2222838|P2|NOT COMPLETED|Overall Study||6
919183|NCT01577108|2222839|P1|NOT COMPLETED|Overall Study||5
919184|NCT01577108|2222838|P2|COMPLETED|Overall Study||50
919185|NCT01577108|2222839|P1|COMPLETED|Overall Study||49
919186|NCT01577108|2222838|P2|STARTED|Overall Study||56
919187|NCT01577108|2222839|P1|STARTED|Overall Study||54
919188|NCT01576952|2222847|P2|NOT COMPLETED|Overall Study||55
919189|NCT01576952|2222848|P1|NOT COMPLETED|Overall Study||41
919190|NCT01576952|2222847|P2|COMPLETED|Overall Study||33
919191|NCT01576952|2222848|P1|COMPLETED|Overall Study||139
919192|NCT01576952|2222847|P2|mITT Population|Overall Study||85
919193|NCT01576952|2222848|P1|mITT Population|Overall Study||168
919194|NCT01576952|2222847|P2|Safety Population|Overall Study||85
919195|NCT01576952|2222848|P1|Safety Population|Overall Study||169
919196|NCT01576952|2222847|P2|STARTED|Overall Study||88
919197|NCT01576952|2222848|P1|STARTED|Overall Study||180
919198|NCT01576939|2222854|P1|NOT COMPLETED|Overall Study||0
919199|NCT01576939|2222854|P1|COMPLETED|Overall Study||30
919200|NCT01576939|2222854|P1|STARTED|Overall Study||30
919201|NCT01576809|2222862|P1|NOT COMPLETED|Overall Study||0
919202|NCT01576809|2222862|P1|COMPLETED|Overall Study||51
919203|NCT01576809|2222862|P1|STARTED|Overall Study||51
919204|NCT01576718|2222874|P7|NOT COMPLETED|Treatment Period||30
919205|NCT01576718|2222875|P6|NOT COMPLETED|Treatment Period||48
919206|NCT01576718|2222876|P5|NOT COMPLETED|Treatment Period||27
919207|NCT01576718|2222877|P4|NOT COMPLETED|Treatment Period||31
919208|NCT01576718|2222878|P3|NOT COMPLETED|Treatment Period||20
919209|NCT01576718|2222879|P2|NOT COMPLETED|Treatment Period||25
919210|NCT01576718|2222880|P1|NOT COMPLETED|Treatment Period||0
919211|NCT01576718|2222874|P7|COMPLETED|Treatment Period||77
919212|NCT01576718|2222875|P6|COMPLETED|Treatment Period||58
919213|NCT01576718|2222876|P5|COMPLETED|Treatment Period||80
919214|NCT01576718|2222877|P4|COMPLETED|Treatment Period||75
919215|NCT01576718|2222878|P3|COMPLETED|Treatment Period||87
919216|NCT01576718|2222879|P2|COMPLETED|Treatment Period||82
919217|NCT01576718|2222880|P1|COMPLETED|Treatment Period||0
919218|NCT01576718|2222874|P7|Efficacy Population (Full Analysis Set)|Treatment Period||103
919219|NCT01576718|2222875|P6|Efficacy Population (Full Analysis Set)|Treatment Period||105
919220|NCT01576718|2222876|P5|Efficacy Population (Full Analysis Set)|Treatment Period||107
919221|NCT01576718|2222877|P4|Efficacy Population (Full Analysis Set)|Treatment Period||102
919222|NCT01576718|2222878|P3|Efficacy Population (Full Analysis Set)|Treatment Period||106
919223|NCT01576718|2222879|P2|Efficacy Population (Full Analysis Set)|Treatment Period||107
919224|NCT01576718|2222880|P1|Efficacy Population (Full Analysis Set)|Treatment Period||0
919225|NCT01576718|2222874|P7|Safety Population|Treatment Period||106
919226|NCT01576718|2222875|P6|Safety Population|Treatment Period||106
919227|NCT01576718|2222876|P5|Safety Population|Treatment Period||107
919228|NCT01576718|2222877|P4|Safety Population|Treatment Period||106
919229|NCT01576718|2222878|P3|Safety Population|Treatment Period||107
919230|NCT01576718|2222879|P2|Safety Population|Treatment Period||107
919231|NCT01576718|2222880|P1|Safety Population|Treatment Period||0
919232|NCT01576718|2222874|P7|STARTED|Treatment Period||107
919233|NCT01576718|2222875|P6|STARTED|Treatment Period||106
919234|NCT01576718|2222876|P5|STARTED|Treatment Period||107
919235|NCT01576718|2222877|P4|STARTED|Treatment Period||106
919236|NCT01576718|2222878|P3|STARTED|Treatment Period||107
919237|NCT01576718|2222879|P2|STARTED|Treatment Period||107
919238|NCT01576718|2222880|P1|STARTED|Treatment Period||0
919239|NCT01576718|2222874|P7|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
919240|NCT01576718|2222875|P6|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
919241|NCT01576718|2222876|P5|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
919242|NCT01576718|2222877|P4|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
919243|NCT01576718|2222878|P3|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
919244|NCT01576718|2222879|P2|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
919245|NCT01576718|2222880|P1|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||249
919246|NCT01576718|2222874|P7|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
919247|NCT01576718|2222875|P6|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
919248|NCT01576718|2222876|P5|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
919249|NCT01576718|2222877|P4|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
919250|NCT01576718|2222878|P3|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
919251|NCT01576718|2222879|P2|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
919252|NCT01576718|2222880|P1|COMPLETED|Pre-Assignment Period (Run-In Placebo)|Participants randomized into the Treatment Period|640
919253|NCT01576718|2222874|P7|STARTED|Pre-Assignment Period (Run-In Placebo)||0
919254|NCT01576718|2222875|P6|STARTED|Pre-Assignment Period (Run-In Placebo)||0
919255|NCT01576718|2222876|P5|STARTED|Pre-Assignment Period (Run-In Placebo)||0
919256|NCT01576718|2222877|P4|STARTED|Pre-Assignment Period (Run-In Placebo)||0
919257|NCT01576718|2222878|P3|STARTED|Pre-Assignment Period (Run-In Placebo)||0
919258|NCT01576718|2222879|P2|STARTED|Pre-Assignment Period (Run-In Placebo)||0
919259|NCT01576718|2222880|P1|STARTED|Pre-Assignment Period (Run-In Placebo)||889
919260|NCT01576471|2222974|P2|NOT COMPLETED|Overall Study||9
919261|NCT01576471|2222975|P1|NOT COMPLETED|Overall Study||8
919262|NCT01576471|2222974|P2|COMPLETED|Overall Study||116
919263|NCT01576471|2222975|P1|COMPLETED|Overall Study||117
919264|NCT01576471|2222974|P2|STARTED|Overall Study||125
919265|NCT01576471|2222975|P1|STARTED|Overall Study||125
919266|NCT01576367|2222981|P1|NOT COMPLETED|Overall Study||3
919267|NCT01576367|2222981|P1|COMPLETED|Overall Study||14
919268|NCT01576367|2222981|P1|STARTED|Overall Study||17
919269|NCT01576341|2222989|P1|NOT COMPLETED|Overall Study||93
919270|NCT01576341|2222989|P1|COMPLETED|Overall Study||324
919271|NCT01576341|2222989|P1|STARTED|Overall Study||417
919272|NCT01576159|2223000|P4|NOT COMPLETED|Overall Study||1
919273|NCT01576159|2223001|P3|NOT COMPLETED|Overall Study||1
919274|NCT01576159|2223002|P2|NOT COMPLETED|Overall Study||1
919275|NCT01576159|2223003|P1|NOT COMPLETED|Overall Study||1
919276|NCT01576159|2223000|P4|COMPLETED|Overall Study||11
919277|NCT01576159|2223001|P3|COMPLETED|Overall Study||11
919278|NCT01576159|2223002|P2|COMPLETED|Overall Study||11
919279|NCT01576159|2223003|P1|COMPLETED|Overall Study||11
919280|NCT01576159|2223000|P4|STARTED|Overall Study||12
919281|NCT01576159|2223001|P3|STARTED|Overall Study||12
919282|NCT01576159|2223002|P2|STARTED|Overall Study||12
919283|NCT01576159|2223003|P1|STARTED|Overall Study||12
919284|NCT01576146|2223021|P1|NOT COMPLETED|Extension Period 2||17
919285|NCT01576146|2223021|P1|COMPLETED|Extension Period 2||0
919286|NCT01576146|2223021|P1|STARTED|Extension Period 2|Three participants who completed Extension Period 1 did not enroll in Period 2|17
919287|NCT01576146|2223021|P1|NOT COMPLETED|Extension Period 1||10
919288|NCT01576146|2223021|P1|COMPLETED|Extension Period 1||20
919289|NCT01576146|2223021|P1|STARTED|Extension Period 1||30
919290|NCT01576120|2223030|P2|NOT COMPLETED|Overall Study||0
919291|NCT01576120|2223031|P1|NOT COMPLETED|Overall Study||0
919292|NCT01576120|2223030|P2|COMPLETED|Overall Study||19
919293|NCT01576120|2223031|P1|COMPLETED|Overall Study||21
919294|NCT01576120|2223030|P2|STARTED|Overall Study||19
919295|NCT01576120|2223031|P1|STARTED|Overall Study||21
919302|NCT01576042|2223054|P2|NOT COMPLETED|Overall Study||0
919303|NCT01576042|2223055|P1|NOT COMPLETED|Overall Study||2
919304|NCT01576042|2223054|P2|COMPLETED|Overall Study||14
919305|NCT01576042|2223055|P1|COMPLETED|Overall Study||11
919306|NCT01576042|2223054|P2|Switched to the Other Arm|Overall Study||1
919307|NCT01576042|2223055|P1|Switched to the Other Arm|Overall Study||5
919308|NCT01576042|2223054|P2|STARTED|Overall Study||14
919309|NCT01576042|2223055|P1|STARTED|Overall Study||13
919310|NCT01575912|2223078|P3|NOT COMPLETED|Overall Study||0
919311|NCT01575912|2223079|P2|NOT COMPLETED|Overall Study||0
919312|NCT01575912|2223080|P1|NOT COMPLETED|Overall Study||0
919313|NCT01575912|2223078|P3|COMPLETED|Overall Study||30
919314|NCT01575912|2223079|P2|COMPLETED|Overall Study||32
919315|NCT01575912|2223080|P1|COMPLETED|Overall Study||30
919316|NCT01575912|2223078|P3|STARTED|Overall Study||30
919317|NCT01575912|2223079|P2|STARTED|Overall Study||32
919318|NCT01575912|2223080|P1|STARTED|Overall Study||30
919319|NCT01575899|2223091|P3|NOT COMPLETED|Overall Study||2
919320|NCT01575899|2223092|P2|NOT COMPLETED|Overall Study||5
919321|NCT01575899|2223093|P1|NOT COMPLETED|Overall Study||5
919322|NCT01575899|2223091|P3|COMPLETED|Overall Study||60
919323|NCT01575899|2223092|P2|COMPLETED|Overall Study||68
919324|NCT01575899|2223093|P1|COMPLETED|Overall Study||68
919325|NCT01575899|2223091|P3|STARTED|Overall Study|Included patients still with Hp infection after previous therapy without levofloxacin and Augmentin.|62
919326|NCT01575899|2223092|P2|STARTED|Overall Study||73
919327|NCT01575899|2223093|P1|STARTED|Overall Study||73
919328|NCT01575769|2223103|P1|NOT COMPLETED|Overall Study||41
919329|NCT01575769|2223103|P1|COMPLETED|Overall Study||0
919330|NCT01575769|2223103|P1|STARTED|Overall Study||41
919331|NCT01575756|2223129|P2|NOT COMPLETED|Treatment Period 2||0
919332|NCT01575756|2223130|P1|NOT COMPLETED|Treatment Period 2||0
919333|NCT01575756|2223129|P2|COMPLETED|Treatment Period 2||11
919334|NCT01575756|2223130|P1|COMPLETED|Treatment Period 2||11
919335|NCT01575756|2223129|P2|STARTED|Treatment Period 2||11
919336|NCT01575756|2223130|P1|STARTED|Treatment Period 2||11
919337|NCT01575756|2223129|P2|NOT COMPLETED|Treatment Period 1||0
919338|NCT01575756|2223130|P1|NOT COMPLETED|Treatment Period 1||0
919339|NCT01575756|2223129|P2|COMPLETED|Treatment Period 1||11
919340|NCT01575756|2223130|P1|COMPLETED|Treatment Period 1||11
919341|NCT01575756|2223129|P2|STARTED|Treatment Period 1||11
919342|NCT01575756|2223130|P1|STARTED|Treatment Period 1||11
919343|NCT01575561|2223146|P1|NOT COMPLETED|Overall Study||39
919344|NCT01575561|2223146|P1|COMPLETED|Overall Study||338
919345|NCT01575561|2223146|P1|STARTED|Overall Study||377
919346|NCT01575522|2223158|P1|NOT COMPLETED|Overall Study||0
919347|NCT01575522|2223158|P1|COMPLETED|Overall Study||22
919348|NCT01575522|2223158|P1|STARTED|Overall Study||22
919349|NCT01575197|2223169|P3|NOT COMPLETED|Overall Study||6
919350|NCT01575197|2223170|P2|NOT COMPLETED|Overall Study||9
919351|NCT01575197|2223171|P1|NOT COMPLETED|Overall Study||3
919352|NCT01575197|2223169|P3|COMPLETED|Overall Study||146
919353|NCT01575197|2223170|P2|COMPLETED|Overall Study||143
919354|NCT01575197|2223171|P1|COMPLETED|Overall Study||149
919355|NCT01575197|2223169|P3|STARTED|Overall Study||152
919356|NCT01575197|2223170|P2|STARTED|Overall Study||152
919357|NCT01575197|2223171|P1|STARTED|Overall Study||152
919358|NCT01575080|2223184|P1|NOT COMPLETED|Overall Study||0
919359|NCT01575080|2223184|P1|COMPLETED|Overall Study||102
919360|NCT01575080|2223184|P1|STARTED|Overall Study||102
919361|NCT01575054|2223193|P2|NOT COMPLETED|Overall Study||26
919362|NCT01575054|2223194|P1|NOT COMPLETED|Overall Study||29
919363|NCT01575054|2223193|P2|COMPLETED|Overall Study||209
919364|NCT01575054|2223194|P1|COMPLETED|Overall Study||204
919365|NCT01575054|2223193|P2|STARTED|Overall Study||235
919366|NCT01575054|2223194|P1|STARTED|Overall Study||233
919367|NCT01575028|2223210|P2|NOT COMPLETED|Overall Study||1
919368|NCT01575028|2223211|P1|NOT COMPLETED|Overall Study||0
919369|NCT01575028|2223210|P2|COMPLETED|Overall Study||0
919370|NCT01575028|2223211|P1|COMPLETED|Overall Study||2
919371|NCT01575028|2223210|P2|STARTED|Overall Study||1
919372|NCT01575028|2223211|P1|STARTED|Overall Study||2
919373|NCT01574703|2223221|P4|NOT COMPLETED|Overall Study||114
919374|NCT01574703|2223222|P3|NOT COMPLETED|Overall Study||105
919375|NCT01574703|2223223|P2|NOT COMPLETED|Overall Study||112
919376|NCT01574703|2223224|P1|NOT COMPLETED|Overall Study||125
919377|NCT01574703|2223221|P4|COMPLETED|Overall Study||1007
919378|NCT01574703|2223222|P3|COMPLETED|Overall Study||1011
919379|NCT01574703|2223223|P2|COMPLETED|Overall Study||1054
919380|NCT01574703|2223224|P1|COMPLETED|Overall Study||1067
919381|NCT01574703|2223221|P4|STARTED|Overall Study||1121
919382|NCT01574703|2223222|P3|STARTED|Overall Study||1116
919383|NCT01574703|2223223|P2|STARTED|Overall Study||1166
919384|NCT01574703|2223224|P1|STARTED|Overall Study||1192
919385|NCT01574651|2223268|P2|NOT COMPLETED|Overall Study||52
919386|NCT01574651|2223269|P1|NOT COMPLETED|Overall Study||61
919387|NCT01574651|2223268|P2|COMPLETED|Overall Study||406
919388|NCT01574651|2223269|P1|COMPLETED|Overall Study||415
919389|NCT01574651|2223268|P2|Per Protocol Set (PPS)|Overall Study||374
919390|NCT01574651|2223269|P1|Per Protocol Set (PPS)|Overall Study||373
919391|NCT01574651|2223268|P2|Full Analysis Set (FAS)|Overall Study||458
919392|NCT01574651|2223269|P1|Full Analysis Set (FAS)|Overall Study||476
919393|NCT01574651|2223268|P2|STARTED|Overall Study||458
919394|NCT01574651|2223269|P1|STARTED|Overall Study||476
919395|NCT01574612|2223291|P1|NOT COMPLETED|Overall Study||8
919396|NCT01574612|2223291|P1|COMPLETED|Overall Study||46
919397|NCT01574612|2223291|P1|STARTED|Overall Study|patients who were identified as having the appropriate medical history of herpes labialis|54
919398|NCT01574326|2223297|P2|NOT COMPLETED|Overall Study||19
919399|NCT01574326|2223298|P1|NOT COMPLETED|Overall Study||16
919400|NCT01574326|2223297|P2|COMPLETED|Overall Study||31
919401|NCT01574326|2223298|P1|COMPLETED|Overall Study||35
919402|NCT01574326|2223297|P2|Treated|Overall Study||49
919403|NCT01574326|2223298|P1|Treated|Overall Study||51
919404|NCT01574326|2223297|P2|STARTED|Overall Study||50
919405|NCT01574326|2223298|P1|STARTED|Overall Study||51
919406|NCT01574248|2223311|P2|NOT COMPLETED|Overall Study||0
919407|NCT01574248|2223312|P1|NOT COMPLETED|Overall Study||3
919408|NCT01574248|2223311|P2|COMPLETED|Overall Study||18
919409|NCT01574248|2223312|P1|COMPLETED|Overall Study||12
919410|NCT01574248|2223311|P2|STARTED|Overall Study||18
919411|NCT01574248|2223312|P1|STARTED|Overall Study||15
919412|NCT01574183|2223332|P2|NOT COMPLETED|Overall Study||18
919413|NCT01574183|2223333|P1|NOT COMPLETED|Overall Study||27
919414|NCT01574183|2223332|P2|COMPLETED|Overall Study||17
919415|NCT01574183|2223333|P1|COMPLETED|Overall Study||14
919416|NCT01574183|2223332|P2|STARTED|Overall Study||35
919417|NCT01574183|2223333|P1|STARTED|Overall Study||41
919418|NCT01574105|2223345|P2|NOT COMPLETED|Overall Study||0
919419|NCT01574105|2223346|P1|NOT COMPLETED|Overall Study||0
919420|NCT01574105|2223345|P2|COMPLETED|Overall Study||37
919421|NCT01574105|2223346|P1|COMPLETED|Overall Study||29
919422|NCT01574105|2223345|P2|STARTED|Overall Study||37
919423|NCT01574105|2223346|P1|STARTED|Overall Study||29
919424|NCT01574079|2223356|P2|NOT COMPLETED|Overall Study||2
919425|NCT01574079|2223357|P1|NOT COMPLETED|Overall Study||1
919426|NCT01574079|2223356|P2|COMPLETED|Overall Study||13
919427|NCT01574079|2223357|P1|COMPLETED|Overall Study||17
919428|NCT01574079|2223356|P2|STARTED|Overall Study||15
919429|NCT01574079|2223357|P1|STARTED|Overall Study||18
919430|NCT01573910|2223369|P2|NOT COMPLETED|Overall Study||17
919431|NCT01573910|2223370|P1|NOT COMPLETED|Overall Study||20
919432|NCT01573910|2223369|P2|COMPLETED|Overall Study||476
919433|NCT01573910|2223370|P1|COMPLETED|Overall Study||469
919434|NCT01573910|2223369|P2|STARTED|Overall Study||493
919435|NCT01573910|2223370|P1|STARTED|Overall Study||489
919436|NCT01573767|2223382|P4|NOT COMPLETED|Overall Study||24
919437|NCT01573767|2223383|P3|NOT COMPLETED|Overall Study||14
919438|NCT01573767|2223384|P2|NOT COMPLETED|Overall Study||21
919439|NCT01573767|2223385|P1|NOT COMPLETED|Overall Study||22
919440|NCT01573767|2223382|P4|COMPLETED|Overall Study||90
919441|NCT01573767|2223383|P3|COMPLETED|Overall Study||99
919442|NCT01573767|2223384|P2|COMPLETED|Overall Study||93
919443|NCT01573767|2223385|P1|COMPLETED|Overall Study||93
919444|NCT01573767|2223382|P4|STARTED|Overall Study||114
919445|NCT01573767|2223383|P3|STARTED|Overall Study||113
919446|NCT01573767|2223384|P2|STARTED|Overall Study||114
919447|NCT01573767|2223385|P1|STARTED|Overall Study||115
919448|NCT01573624|2223419|P7|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
919449|NCT01573624|2223420|P6|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
919450|NCT01573624|2223421|P5|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||2
919451|NCT01573624|2223422|P4|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
919452|NCT01573624|2223423|P3|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
919453|NCT01573624|2223424|P2|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
919454|NCT01573624|2223425|P1|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
919455|NCT01573624|2223419|P7|COMPLETED|Period 6 : Follow-up Period (7 Days)||48
919456|NCT01573624|2223420|P6|COMPLETED|Period 6 : Follow-up Period (7 Days)||38
919457|NCT01573624|2223421|P5|COMPLETED|Period 6 : Follow-up Period (7 Days)||49
919458|NCT01573624|2223422|P4|COMPLETED|Period 6 : Follow-up Period (7 Days)||53
919459|NCT01573624|2223423|P3|COMPLETED|Period 6 : Follow-up Period (7 Days)||43
919460|NCT01573624|2223424|P2|COMPLETED|Period 6 : Follow-up Period (7 Days)||47
919461|NCT01573624|2223425|P1|COMPLETED|Period 6 : Follow-up Period (7 Days)||45
919462|NCT01573624|2223419|P7|STARTED|Period 6 : Follow-up Period (7 Days)||48
919463|NCT01573624|2223420|P6|STARTED|Period 6 : Follow-up Period (7 Days)||39
919464|NCT01573624|2223421|P5|STARTED|Period 6 : Follow-up Period (7 Days)||51
919465|NCT01573624|2223422|P4|STARTED|Period 6 : Follow-up Period (7 Days)||53
919466|NCT01573624|2223423|P3|STARTED|Period 6 : Follow-up Period (7 Days)||43
919467|NCT01573624|2223424|P2|STARTED|Period 6 : Follow-up Period (7 Days)||47
919468|NCT01573624|2223425|P1|STARTED|Period 6 : Follow-up Period (7 Days)||46
919469|NCT01573624|2223419|P7|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||4
919470|NCT01573624|2223420|P6|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||2
919471|NCT01573624|2223421|P5|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
919472|NCT01573624|2223422|P4|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
919473|NCT01573624|2223423|P3|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
919474|NCT01573624|2223424|P2|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
919475|NCT01573624|2223425|P1|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||3
919476|NCT01573624|2223419|P7|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||48
919477|NCT01573624|2223420|P6|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||39
919478|NCT01573624|2223421|P5|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||51
919479|NCT01573624|2223422|P4|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||53
919480|NCT01573624|2223423|P3|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||43
919481|NCT01573624|2223424|P2|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||47
919482|NCT01573624|2223425|P1|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||46
919483|NCT01573624|2223419|P7|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
919484|NCT01573624|2223420|P6|STARTED|Period 5 : Treatment Period 3 (14 Days)||41
919485|NCT01573624|2223421|P5|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
919486|NCT01573624|2223422|P4|STARTED|Period 5 : Treatment Period 3 (14 Days)||53
919487|NCT01573624|2223423|P3|STARTED|Period 5 : Treatment Period 3 (14 Days)||43
919488|NCT01573624|2223424|P2|STARTED|Period 5 : Treatment Period 3 (14 Days)||48
919489|NCT01573624|2223425|P1|STARTED|Period 5 : Treatment Period 3 (14 Days)||49
919490|NCT01573624|2223419|P7|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||3
919491|NCT01573624|2223420|P6|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
919492|NCT01573624|2223421|P5|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
919493|NCT01573624|2223422|P4|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
919494|NCT01573624|2223423|P3|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
919495|NCT01573624|2223424|P2|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||4
919496|NCT01573624|2223425|P1|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
919497|NCT01573624|2223419|P7|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
919498|NCT01573624|2223420|P6|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||41
919499|NCT01573624|2223421|P5|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
919500|NCT01573624|2223422|P4|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||53
919501|NCT01573624|2223423|P3|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||43
919502|NCT01573624|2223424|P2|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||48
919503|NCT01573624|2223425|P1|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||49
919504|NCT01573624|2223419|P7|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
919505|NCT01573624|2223420|P6|STARTED|Period 4 : Washout Period 2 (12-14 Days)||43
919506|NCT01573624|2223421|P5|STARTED|Period 4 : Washout Period 2 (12-14 Days)||53
919507|NCT01573624|2223422|P4|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
919508|NCT01573624|2223423|P3|STARTED|Period 4 : Washout Period 2 (12-14 Days)||45
919509|NCT01573624|2223424|P2|STARTED|Period 4 : Washout Period 2 (12-14 Days)||52
919510|NCT01573624|2223425|P1|STARTED|Period 4 : Washout Period 2 (12-14 Days)||50
919511|NCT01573624|2223419|P7|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||0
919512|NCT01573624|2223420|P6|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||5
919513|NCT01573624|2223421|P5|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
919514|NCT01573624|2223422|P4|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||1
919515|NCT01573624|2223423|P3|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
919516|NCT01573624|2223424|P2|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||6
919517|NCT01573624|2223425|P1|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||7
919518|NCT01573624|2223419|P7|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
919519|NCT01573624|2223420|P6|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||43
919520|NCT01573624|2223421|P5|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||53
919521|NCT01573624|2223422|P4|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
919522|NCT01573624|2223423|P3|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||45
919523|NCT01573624|2223424|P2|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||52
919524|NCT01573624|2223425|P1|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||50
919525|NCT01573624|2223419|P7|STARTED|Period 3 : Treatment Period 2 (14 Days)||55
919526|NCT01573624|2223420|P6|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
919527|NCT01573624|2223421|P5|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
919528|NCT01573624|2223422|P4|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
919529|NCT01573624|2223423|P3|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
919530|NCT01573624|2223424|P2|STARTED|Period 3 : Treatment Period 2 (14 Days)||58
919531|NCT01573624|2223425|P1|STARTED|Period 3 : Treatment Period 2 (14 Days)||57
919532|NCT01573624|2223419|P7|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||2
919533|NCT01573624|2223420|P6|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
919534|NCT01573624|2223421|P5|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||0
919535|NCT01573624|2223422|P4|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||5
919536|NCT01573624|2223423|P3|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
919537|NCT01573624|2223424|P2|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
919538|NCT01573624|2223425|P1|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
919539|NCT01573624|2223419|P7|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||55
919540|NCT01573624|2223420|P6|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
919541|NCT01573624|2223421|P5|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
919542|NCT01573624|2223422|P4|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
919543|NCT01573624|2223423|P3|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
919544|NCT01573624|2223424|P2|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||58
919545|NCT01573624|2223425|P1|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||57
919546|NCT01573624|2223419|P7|STARTED|Period 2 : Washout Period 1 (12-14 Days)||57
919547|NCT01573624|2223420|P6|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
919548|NCT01573624|2223421|P5|STARTED|Period 2 : Washout Period 1 (12-14 Days)||56
919549|NCT01573624|2223422|P4|STARTED|Period 2 : Washout Period 1 (12-14 Days)||61
919550|NCT01573624|2223423|P3|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
919551|NCT01573624|2223424|P2|STARTED|Period 2 : Washout Period 1 (12-14 Days)||59
919552|NCT01573624|2223425|P1|STARTED|Period 2 : Washout Period 1 (12-14 Days)||58
919553|NCT01573624|2223419|P7|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
919554|NCT01573624|2223420|P6|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||4
919555|NCT01573624|2223421|P5|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
919556|NCT01573624|2223422|P4|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
919557|NCT01573624|2223423|P3|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||9
919558|NCT01573624|2223424|P2|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||3
919559|NCT01573624|2223425|P1|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||6
919560|NCT01573624|2223419|P7|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||57
919561|NCT01573624|2223420|P6|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
919562|NCT01573624|2223421|P5|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||56
919563|NCT01573624|2223422|P4|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||61
919564|NCT01573624|2223423|P3|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
919565|NCT01573624|2223424|P2|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||59
919566|NCT01573624|2223425|P1|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||58
919567|NCT01573624|2223419|P7|STARTED|Period 1 : Treatment Period 1 (14 Days)||59
919568|NCT01573624|2223420|P6|STARTED|Period 1 : Treatment Period 1 (14 Days)||55
919569|NCT01573624|2223421|P5|STARTED|Period 1 : Treatment Period 1 (14 Days)||58
919570|NCT01573624|2223422|P4|STARTED|Period 1 : Treatment Period 1 (14 Days)||63
919571|NCT01573624|2223423|P3|STARTED|Period 1 : Treatment Period 1 (14 Days)||60
919572|NCT01573624|2223424|P2|STARTED|Period 1 : Treatment Period 1 (14 Days)||62
919573|NCT01573624|2223425|P1|STARTED|Period 1 : Treatment Period 1 (14 Days)||64
919574|NCT01573325|2223472|P1|NOT COMPLETED|Overall Study||0
919575|NCT01573325|2223472|P1|COMPLETED|Overall Study||50
919576|NCT01573325|2223472|P1|STARTED|Overall Study||50
919577|NCT01573260|2223479|P2|NOT COMPLETED|Overall Study||0
919578|NCT01573260|2223480|P1|NOT COMPLETED|Overall Study||0
919579|NCT01573260|2223479|P2|COMPLETED|Overall Study||15
919580|NCT01573260|2223480|P1|COMPLETED|Overall Study||18
919581|NCT01573260|2223479|P2|STARTED|Overall Study||15
919582|NCT01573260|2223480|P1|STARTED|Overall Study||18
919583|NCT01573000|2223514|P2|NOT COMPLETED|Long-Term Follow-Up||1
919584|NCT01573000|2223515|P1|NOT COMPLETED|Long-Term Follow-Up||3
919585|NCT01573000|2223514|P2|COMPLETED|Long-Term Follow-Up|One participant who received crossover treatment was lost to follow up.|4
919586|NCT01573000|2223515|P1|COMPLETED|Long-Term Follow-Up||11
919587|NCT01573000|2223514|P2|STARTED|Long-Term Follow-Up|5 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|5
919588|NCT01573000|2223515|P1|STARTED|Long-Term Follow-Up|14 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|14
919589|NCT01573000|2223514|P2|NOT COMPLETED|Crossover Phase||18
919590|NCT01573000|2223515|P1|NOT COMPLETED|Crossover Phase||0
919591|NCT01573000|2223514|P2|COMPLETED|Crossover Phase|This participant completed 2 years of follow up and enrolled in BEX104526.|1
919592|NCT01573000|2223515|P1|COMPLETED|Crossover Phase||0
919593|NCT01573000|2223514|P2|STARTED|Crossover Phase|19 of 36 par. randomized to receive Unlabeled TST crossed over to receive TST and Iodine I 131 TST.|19
919594|NCT01573000|2223515|P1|STARTED|Crossover Phase||0
919595|NCT01573000|2223514|P2|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
919596|NCT01573000|2223515|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
919597|NCT01573000|2223514|P2|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|1
919598|NCT01573000|2223515|P1|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|7
919599|NCT01573000|2223514|P2|STARTED|Dosimetric and Therapeutic Treatment||36
919600|NCT01573000|2223515|P1|STARTED|Dosimetric and Therapeutic Treatment||42
919601|NCT01572948|2223611|P2|NOT COMPLETED|Overall Study||1
919602|NCT01572948|2223612|P1|NOT COMPLETED|Overall Study||1
919603|NCT01572948|2223611|P2|COMPLETED|Overall Study||15
919604|NCT01572948|2223612|P1|COMPLETED|Overall Study||10
919605|NCT01572948|2223611|P2|STARTED|Overall Study||16
919606|NCT01572948|2223612|P1|STARTED|Overall Study||11
919607|NCT01572792|2223633|P5|NOT COMPLETED|Extension Study||32
919608|NCT01572792|2223634|P4|NOT COMPLETED|Extension Study||29
919609|NCT01572792|2223635|P3|NOT COMPLETED|Extension Study||26
919610|NCT01572792|2223636|P2|NOT COMPLETED|Extension Study||29
919611|NCT01572792|2223637|P1|NOT COMPLETED|Extension Study||25
919612|NCT01572792|2223633|P5|COMPLETED|Extension Study||160
919613|NCT01572792|2223634|P4|COMPLETED|Extension Study||165
919614|NCT01572792|2223635|P3|COMPLETED|Extension Study||179
919615|NCT01572792|2223636|P2|COMPLETED|Extension Study||155
919616|NCT01572792|2223637|P1|COMPLETED|Extension Study||121
919617|NCT01572792|2223633|P5|STARTED|Extension Study||192
919618|NCT01572792|2223634|P4|STARTED|Extension Study||194
919619|NCT01572792|2223635|P3|STARTED|Extension Study||205
919620|NCT01572792|2223636|P2|STARTED|Extension Study||184
919621|NCT01572792|2223637|P1|STARTED|Extension Study||146
919622|NCT01572792|2223633|P5|NOT COMPLETED|Lead-in Study||69
919623|NCT01572792|2223634|P4|NOT COMPLETED|Lead-in Study||72
919624|NCT01572792|2223635|P3|NOT COMPLETED|Lead-in Study||62
919625|NCT01572792|2223636|P2|NOT COMPLETED|Lead-in Study||66
919626|NCT01572792|2223637|P1|NOT COMPLETED|Lead-in Study||101
919627|NCT01572792|2223633|P5|COMPLETED|Lead-in Study||270
919628|NCT01572792|2223634|P4|COMPLETED|Lead-in Study||268
919629|NCT01572792|2223635|P3|COMPLETED|Lead-in Study||276
919630|NCT01572792|2223636|P2|COMPLETED|Lead-in Study||272
919631|NCT01572792|2223637|P1|COMPLETED|Lead-in Study||236
919632|NCT01572792|2223633|P5|STARTED|Lead-in Study||339
919633|NCT01572792|2223634|P4|STARTED|Lead-in Study||340
919634|NCT01572792|2223635|P3|STARTED|Lead-in Study||338
919635|NCT01572792|2223636|P2|STARTED|Lead-in Study||338
919636|NCT01572792|2223637|P1|STARTED|Lead-in Study||337
919637|NCT01572740|2223686|P2|NOT COMPLETED|Overall Study||5
919638|NCT01572740|2223687|P1|NOT COMPLETED|Overall Study||6
919639|NCT01572740|2223686|P2|COMPLETED|Overall Study||125
919640|NCT01572740|2223687|P1|COMPLETED|Overall Study||121
919641|NCT01572740|2223686|P2|STARTED|Overall Study||130
919642|NCT01572740|2223687|P1|STARTED|Overall Study||127
919643|NCT01572727|2223717|P2|NOT COMPLETED|Overall Study||209
919644|NCT01572727|2223718|P1|NOT COMPLETED|Overall Study||207
919645|NCT01572727|2223717|P2|COMPLETED|Overall Study||0
919646|NCT01572727|2223718|P1|COMPLETED|Overall Study||0
919647|NCT01572727|2223717|P2|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|201
919648|NCT01572727|2223718|P1|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|202
919649|NCT01572727|2223717|P2|STARTED|Overall Study||209
919650|NCT01572727|2223718|P1|STARTED|Overall Study||207
919651|NCT01572675|2223740|P2|NOT COMPLETED|Overall Study||223
919652|NCT01572675|2223741|P1|NOT COMPLETED|Overall Study||237
919653|NCT01572675|2223740|P2|COMPLETED|Overall Study||56
919654|NCT01572675|2223741|P1|COMPLETED|Overall Study||31
919655|NCT01572675|2223740|P2|STARTED|Overall Study||279
919656|NCT01572675|2223741|P1|STARTED|Overall Study||268
919663|NCT01572207|2223849|P2|NOT COMPLETED|Overall Study||3
919664|NCT01572207|2223850|P1|NOT COMPLETED|Overall Study||2
919665|NCT01572207|2223849|P2|COMPLETED|Overall Study||13
919666|NCT01572207|2223850|P1|COMPLETED|Overall Study||12
919667|NCT01572207|2223849|P2|STARTED|Overall Study||16
919668|NCT01572207|2223850|P1|STARTED|Overall Study||14
919669|NCT01571557|2223860|P1|NOT COMPLETED|Overall Study||0
919670|NCT01571557|2223860|P1|COMPLETED|Overall Study||573
919671|NCT01571557|2223860|P1|STARTED|Overall Study||573
919672|NCT01571453|2223869|P2|NOT COMPLETED|Overall Study||62
919673|NCT01571453|2223870|P1|NOT COMPLETED|Overall Study||38
919674|NCT01571453|2223869|P2|COMPLETED|Overall Study||164
919675|NCT01571453|2223870|P1|COMPLETED|Overall Study||173
919676|NCT01571453|2223869|P2|STARTED|Overall Study||226
919677|NCT01571453|2223870|P1|STARTED|Overall Study||211
919678|NCT01571362|2223886|P3|NOT COMPLETED|Double-Blind Treatment Period||39
919679|NCT01571362|2223887|P2|NOT COMPLETED|Double-Blind Treatment Period||53
919680|NCT01571362|2223888|P1|NOT COMPLETED|Double-Blind Treatment Period||0
919681|NCT01571362|2223886|P3|COMPLETED|Double-Blind Treatment Period||107
919682|NCT01571362|2223887|P2|COMPLETED|Double-Blind Treatment Period||81
919683|NCT01571362|2223888|P1|COMPLETED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
919684|NCT01571362|2223886|P3|STARTED|Double-Blind Treatment Period||146
919685|NCT01571362|2223887|P2|STARTED|Double-Blind Treatment Period||134
919686|NCT01571362|2223888|P1|STARTED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
919687|NCT01571362|2223886|P3|NOT COMPLETED|Open-Label Conversion + Titration Period||0
919688|NCT01571362|2223887|P2|NOT COMPLETED|Open-Label Conversion + Titration Period||0
919689|NCT01571362|2223888|P1|NOT COMPLETED|Open-Label Conversion + Titration Period||129
919690|NCT01571362|2223886|P3|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
919691|NCT01571362|2223887|P2|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
919692|NCT01571362|2223888|P1|COMPLETED|Open-Label Conversion + Titration Period||281
919693|NCT01571362|2223886|P3|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
919694|NCT01571362|2223887|P2|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
919695|NCT01571362|2223888|P1|STARTED|Open-Label Conversion + Titration Period||410
919696|NCT01571232|2224060|P2|NOT COMPLETED|Overall Study||1
919697|NCT01571232|2224061|P1|NOT COMPLETED|Overall Study||1
919698|NCT01571232|2224060|P2|COMPLETED|Overall Study||9
919699|NCT01571232|2224061|P1|COMPLETED|Overall Study||9
919700|NCT01571232|2224060|P2|STARTED|Overall Study||10
919701|NCT01571232|2224061|P1|STARTED|Overall Study||10
919702|NCT01570751|2224073|P2|NOT COMPLETED|Period B (16 Weeks)||1
919703|NCT01570751|2224074|P1|NOT COMPLETED|Period B (16 Weeks)||1
919704|NCT01570751|2224073|P2|COMPLETED|Period B (16 Weeks)||66
919705|NCT01570751|2224074|P1|COMPLETED|Period B (16 Weeks)||69
919706|NCT01570751|2224073|P2|Exposed|Period B (16 Weeks)||67
919707|NCT01570751|2224074|P1|Exposed|Period B (16 Weeks)||70
919708|NCT01570751|2224073|P2|STARTED|Period B (16 Weeks)||67
919709|NCT01570751|2224074|P1|STARTED|Period B (16 Weeks)||70
919710|NCT01570751|2224073|P2|NOT COMPLETED|Period A (16 Weeks)||5
919711|NCT01570751|2224074|P1|NOT COMPLETED|Period A (16 Weeks)||3
919712|NCT01570751|2224073|P2|COMPLETED|Period A (16 Weeks)||67
919713|NCT01570751|2224074|P1|COMPLETED|Period A (16 Weeks)||70
919714|NCT01570751|2224073|P2|Exposed|Period A (16 Weeks)||72
919715|NCT01570751|2224074|P1|Exposed|Period A (16 Weeks)||73
919716|NCT01570751|2224073|P2|STARTED|Period A (16 Weeks)||72
919717|NCT01570751|2224074|P1|STARTED|Period A (16 Weeks)||73
919718|NCT01570686|2224092|P2|NOT COMPLETED|Overall Study||16
919719|NCT01570686|2224093|P1|NOT COMPLETED|Overall Study||22
919720|NCT01570686|2224092|P2|COMPLETED|Overall Study||278
919721|NCT01570686|2224093|P1|COMPLETED|Overall Study||274
919722|NCT01570686|2224092|P2|Safety and Full Analysis Set (FAS)|Overall Study||294
919723|NCT01570686|2224093|P1|Safety and Full Analysis Set (FAS)|Overall Study|One patient was mis-randomized and never received study drug. Hence not included in Safety or FAS.|295
919724|NCT01570686|2224092|P2|STARTED|Overall Study||294
919725|NCT01570686|2224093|P1|STARTED|Overall Study||296
919726|NCT01570634|2224119|P1|NOT COMPLETED|Overall Study||0
919727|NCT01570634|2224119|P1|COMPLETED|Overall Study||2
919728|NCT01570634|2224119|P1|STARTED|Overall Study||2
919729|NCT01570309|2224129|P2|NOT COMPLETED|Overall Study||3
919730|NCT01570309|2224130|P1|NOT COMPLETED|Overall Study||3
919731|NCT01570309|2224129|P2|COMPLETED|Overall Study||45
919732|NCT01570309|2224130|P1|COMPLETED|Overall Study||45
919733|NCT01570309|2224129|P2|STARTED|Overall Study||48
919734|NCT01570309|2224130|P1|STARTED|Overall Study||48
919735|NCT01570244|2224144|P1|NOT COMPLETED|Microgynon+Faldaprevir||1
919736|NCT01570244|2224144|P1|COMPLETED|Microgynon+Faldaprevir||15
919737|NCT01570244|2224144|P1|STARTED|Microgynon+Faldaprevir||16
919738|NCT01570244|2224144|P1|NOT COMPLETED|Microgynon||0
919739|NCT01570244|2224144|P1|COMPLETED|Microgynon||16
919740|NCT01570244|2224144|P1|STARTED|Microgynon||16
919747|NCT01569841|2224205|P2|NOT COMPLETED|Period B (6 Weeks)||0
919748|NCT01569841|2224206|P1|NOT COMPLETED|Period B (6 Weeks)||0
919749|NCT01569841|2224205|P2|COMPLETED|Period B (6 Weeks)||11
919750|NCT01569841|2224206|P1|COMPLETED|Period B (6 Weeks)||12
919751|NCT01569841|2224205|P2|Exposed|Period B (6 Weeks)||11
919752|NCT01569841|2224206|P1|Exposed|Period B (6 Weeks)||12
919753|NCT01569841|2224205|P2|STARTED|Period B (6 Weeks)||11
919754|NCT01569841|2224206|P1|STARTED|Period B (6 Weeks)||12
919755|NCT01569841|2224205|P2|NOT COMPLETED|Period A (6 Weeks)||1
919756|NCT01569841|2224206|P1|NOT COMPLETED|Period A (6 Weeks)||0
919757|NCT01569841|2224205|P2|COMPLETED|Period A (6 Weeks)||11
919758|NCT01569841|2224206|P1|COMPLETED|Period A (6 Weeks)||12
919759|NCT01569841|2224205|P2|Exposed|Period A (6 Weeks)||12
919760|NCT01569841|2224206|P1|Exposed|Period A (6 Weeks)||12
919761|NCT01569841|2224205|P2|STARTED|Period A (6 Weeks)||12
919762|NCT01569841|2224206|P1|STARTED|Period A (6 Weeks)||12
919763|NCT01569828|2224224|P2|NOT COMPLETED|Overall Study||0
919764|NCT01569828|2224225|P1|NOT COMPLETED|Overall Study||0
919765|NCT01569828|2224224|P2|COMPLETED|Overall Study||6
919766|NCT01569828|2224225|P1|COMPLETED|Overall Study||6
919767|NCT01569828|2224224|P2|STARTED|Overall Study||6
919768|NCT01569828|2224225|P1|STARTED|Overall Study||6
919769|NCT01569815|2224247|P4|NOT COMPLETED|Overall Study||0
919770|NCT01569815|2224248|P3|NOT COMPLETED|Overall Study||0
919771|NCT01569815|2224249|P2|NOT COMPLETED|Overall Study||0
919772|NCT01569815|2224250|P1|NOT COMPLETED|Overall Study||0
919773|NCT01569815|2224247|P4|COMPLETED|Overall Study||8
919774|NCT01569815|2224248|P3|COMPLETED|Overall Study||8
919775|NCT01569815|2224249|P2|COMPLETED|Overall Study||8
919776|NCT01569815|2224250|P1|COMPLETED|Overall Study||8
919777|NCT01569815|2224247|P4|STARTED|Overall Study||8
919778|NCT01569815|2224248|P3|STARTED|Overall Study||8
919779|NCT01569815|2224249|P2|STARTED|Overall Study||8
919780|NCT01569815|2224250|P1|STARTED|Overall Study||8
919781|NCT01569763|2224295|P2|NOT COMPLETED|Overall Study||7
919782|NCT01569763|2224296|P1|NOT COMPLETED|Overall Study||3
919783|NCT01569763|2224295|P2|COMPLETED|Overall Study|Completed 12 Months of Follow-up|44
919784|NCT01569763|2224296|P1|COMPLETED|Overall Study|Completed 12 Months of Follow-up|99
919785|NCT01569763|2224295|P2|Treated|Overall Study||51
919786|NCT01569763|2224296|P1|Treated|Overall Study||102
919787|NCT01569763|2224295|P2|STARTED|Overall Study||51
919788|NCT01569763|2224296|P1|STARTED|Overall Study||102
919789|NCT01569568|2224308|P2|NOT COMPLETED|Overall Study||2
919790|NCT01569568|2224309|P1|NOT COMPLETED|Overall Study||0
919791|NCT01569568|2224308|P2|COMPLETED|Overall Study||27
919792|NCT01569568|2224309|P1|COMPLETED|Overall Study||20
919793|NCT01569568|2224308|P2|STARTED|Overall Study||29
919794|NCT01569568|2224309|P1|STARTED|Overall Study||20
919795|NCT01569529|2224323|P2|NOT COMPLETED|Overall Study||0
919796|NCT01569529|2224324|P1|NOT COMPLETED|Overall Study||0
919797|NCT01569529|2224323|P2|COMPLETED|Overall Study||394
919798|NCT01569529|2224324|P1|COMPLETED|Overall Study||2676
919799|NCT01569529|2224323|P2|STARTED|Overall Study||394
919800|NCT01569529|2224324|P1|STARTED|Overall Study||2676
919801|NCT01569464|2224332|P2|NOT COMPLETED|Overall Study||5
919802|NCT01569464|2224333|P1|NOT COMPLETED|Overall Study||10
919803|NCT01569464|2224332|P2|COMPLETED|Overall Study||44
919804|NCT01569464|2224333|P1|COMPLETED|Overall Study||91
919805|NCT01569464|2224332|P2|STARTED|Overall Study||49
919806|NCT01569464|2224333|P1|STARTED|Overall Study||101
919807|NCT01569438|2224371|P2|NOT COMPLETED|Overall Study||9
919808|NCT01569438|2224372|P1|NOT COMPLETED|Overall Study||2
919809|NCT01569438|2224371|P2|COMPLETED|Overall Study||27
919810|NCT01569438|2224372|P1|COMPLETED|Overall Study||36
919811|NCT01569438|2224371|P2|STARTED|Overall Study||36
919812|NCT01569438|2224372|P1|STARTED|Overall Study||38
919813|NCT01569152|2224386|P3|NOT COMPLETED|Safety Extension, Period 3||55
919814|NCT01569152|2224387|P2|NOT COMPLETED|Safety Extension, Period 3||0
919815|NCT01569152|2224388|P1|NOT COMPLETED|Safety Extension, Period 3||0
919816|NCT01569152|2224386|P3|COMPLETED|Safety Extension, Period 3||0
919817|NCT01569152|2224387|P2|COMPLETED|Safety Extension, Period 3||0
919818|NCT01569152|2224388|P1|COMPLETED|Safety Extension, Period 3||0
919819|NCT01569152|2224386|P3|STARTED|Safety Extension, Period 3|Includes 29 completers and 26 early escapees from Base Study Phase IIa|55
919820|NCT01569152|2224387|P2|STARTED|Safety Extension, Period 3||0
919821|NCT01569152|2224388|P1|STARTED|Safety Extension, Period 3||0
919822|NCT01569152|2224386|P3|NOT COMPLETED|Phase IIa, Period 1||0
919823|NCT01569152|2224387|P2|NOT COMPLETED|Phase IIa, Period 1||32
919824|NCT01569152|2224388|P1|NOT COMPLETED|Phase IIa, Period 1||21
919825|NCT01569152|2224386|P3|COMPLETED|Phase IIa, Period 1||0
919826|NCT01569152|2224387|P2|COMPLETED|Phase IIa, Period 1||9
919827|NCT01569152|2224388|P1|COMPLETED|Phase IIa, Period 1||20
919828|NCT01569152|2224386|P3|STARTED|Phase IIa, Period 1||0
919829|NCT01569152|2224387|P2|STARTED|Phase IIa, Period 1||41
919830|NCT01569152|2224388|P1|STARTED|Phase IIa, Period 1||41
919831|NCT01569126|2224451|P6|NOT COMPLETED|Overall Study||0
919832|NCT01569126|2224452|P5|NOT COMPLETED|Overall Study||0
919833|NCT01569126|2224453|P4|NOT COMPLETED|Overall Study||0
919834|NCT01569126|2224454|P3|NOT COMPLETED|Overall Study||0
919835|NCT01569126|2224455|P2|NOT COMPLETED|Overall Study||0
919836|NCT01569126|2224456|P1|NOT COMPLETED|Overall Study||0
919837|NCT01569126|2224451|P6|COMPLETED|Overall Study||12
919838|NCT01569126|2224452|P5|COMPLETED|Overall Study||12
919839|NCT01569126|2224453|P4|COMPLETED|Overall Study||8
919840|NCT01569126|2224454|P3|COMPLETED|Overall Study||8
919841|NCT01569126|2224455|P2|COMPLETED|Overall Study||8
919842|NCT01569126|2224456|P1|COMPLETED|Overall Study||8
919843|NCT01569126|2224451|P6|Received at Least 1 Dose of Study Drug|Overall Study||12
919844|NCT01569126|2224452|P5|Received at Least 1 Dose of Study Drug|Overall Study||12
919845|NCT01569126|2224453|P4|Received at Least 1 Dose of Study Drug|Overall Study||8
919846|NCT01569126|2224454|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
919847|NCT01569126|2224455|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
919848|NCT01569126|2224456|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
919849|NCT01569126|2224451|P6|STARTED|Overall Study||12
919850|NCT01569126|2224452|P5|STARTED|Overall Study||12
919851|NCT01569126|2224453|P4|STARTED|Overall Study||8
919852|NCT01569126|2224454|P3|STARTED|Overall Study||8
919853|NCT01569126|2224455|P2|STARTED|Overall Study||8
919854|NCT01569126|2224456|P1|STARTED|Overall Study||8
919855|NCT01569087|2224494|P3|NOT COMPLETED|Overall Study||1
919856|NCT01569087|2224495|P2|NOT COMPLETED|Overall Study||0
919857|NCT01569087|2224496|P1|NOT COMPLETED|Overall Study||1
919858|NCT01569087|2224494|P3|COMPLETED|Overall Study||18
919859|NCT01569087|2224495|P2|COMPLETED|Overall Study||20
919860|NCT01569087|2224496|P1|COMPLETED|Overall Study||20
919861|NCT01569087|2224494|P3|STARTED|Overall Study||19
919862|NCT01569087|2224495|P2|STARTED|Overall Study||20
919863|NCT01569087|2224496|P1|STARTED|Overall Study||21
919864|NCT01569074|2224524|P5|NOT COMPLETED|Overall Study||8
919865|NCT01569074|2224525|P4|NOT COMPLETED|Overall Study||8
919866|NCT01569074|2224526|P3|NOT COMPLETED|Overall Study||12
919867|NCT01569074|2224527|P2|NOT COMPLETED|Overall Study||9
919868|NCT01569074|2224528|P1|NOT COMPLETED|Overall Study||7
919869|NCT01569074|2224524|P5|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
919870|NCT01569074|2224525|P4|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
919871|NCT01569074|2224526|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|21
919872|NCT01569074|2224527|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
919873|NCT01569074|2224528|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
919874|NCT01569074|2224524|P5|Randomised But Did Not Receive Treatment|Overall Study||0
919875|NCT01569074|2224525|P4|Randomised But Did Not Receive Treatment|Overall Study||0
919876|NCT01569074|2224526|P3|Randomised But Did Not Receive Treatment|Overall Study||0
919877|NCT01569074|2224527|P2|Randomised But Did Not Receive Treatment|Overall Study||0
919878|NCT01569074|2224528|P1|Randomised But Did Not Receive Treatment|Overall Study||0
919879|NCT01569074|2224524|P5|STARTED|Overall Study|Patients who received treatment|33
919880|NCT01569074|2224525|P4|STARTED|Overall Study|Patients who received treatment|33
919881|NCT01569074|2224526|P3|STARTED|Overall Study|Patients who received treatment|33
919882|NCT01569074|2224527|P2|STARTED|Overall Study|Patients who received treatment|33
919883|NCT01569074|2224528|P1|STARTED|Overall Study|Patients who received treatment|31
919884|NCT01568905|2224587|P3|NOT COMPLETED|Overall Study||0
919885|NCT01568905|2224588|P2|NOT COMPLETED|Overall Study||0
919886|NCT01568905|2224589|P1|NOT COMPLETED|Overall Study||1
919887|NCT01568905|2224587|P3|COMPLETED|Overall Study||12
919888|NCT01568905|2224588|P2|COMPLETED|Overall Study||11
919889|NCT01568905|2224589|P1|COMPLETED|Overall Study||12
919890|NCT01568905|2224587|P3|STARTED|Overall Study||12
919891|NCT01568905|2224588|P2|STARTED|Overall Study||11
919892|NCT01568905|2224589|P1|STARTED|Overall Study||13
919893|NCT01568892|2224608|P2|NOT COMPLETED|Open-label Phase||16
919894|NCT01568892|2224609|P1|NOT COMPLETED|Open-label Phase||13
919895|NCT01568892|2224608|P2|COMPLETED|Open-label Phase||0
919896|NCT01568892|2224609|P1|COMPLETED|Open-label Phase||0
919897|NCT01568892|2224608|P2|Ongoing|Open-label Phase||15
919898|NCT01568892|2224609|P1|Ongoing|Open-label Phase||12
919899|NCT01568892|2224608|P2|STARTED|Open-label Phase||16
919900|NCT01568892|2224609|P1|STARTED|Open-label Phase|One participant completing the DB Phase withdrew on Day 8 and did not enter the Open-label Phase.|13
919901|NCT01568892|2224608|P2|NOT COMPLETED|Double-blind Phase||0
919902|NCT01568892|2224609|P1|NOT COMPLETED|Double-blind Phase||0
919903|NCT01568892|2224608|P2|COMPLETED|Double-blind Phase||16
919904|NCT01568892|2224609|P1|COMPLETED|Double-blind Phase||14
919905|NCT01568892|2224608|P2|STARTED|Double-blind Phase||16
919906|NCT01568892|2224609|P1|STARTED|Double-blind Phase||14
919907|NCT01568866|2224647|P2|NOT COMPLETED|Overall Study||264
919908|NCT01568866|2224648|P1|NOT COMPLETED|Overall Study||360
919909|NCT01568866|2224647|P2|COMPLETED|Overall Study|Indicates participants still receiving treatment|200
919910|NCT01568866|2224648|P1|COMPLETED|Overall Study|Indicates participants still receiving treatment|105
919911|NCT01568866|2224647|P2|Received Treatment|Overall Study||463
919912|NCT01568866|2224648|P1|Received Treatment|Overall Study||456
919913|NCT01568866|2224647|P2|STARTED|Overall Study||464
919914|NCT01568866|2224648|P1|STARTED|Overall Study||465
919915|NCT01568827|2224670|P2|NOT COMPLETED|Intervention 2 (5 Days)||0
919916|NCT01568827|2224671|P1|NOT COMPLETED|Intervention 2 (5 Days)||0
919917|NCT01568827|2224670|P2|COMPLETED|Intervention 2 (5 Days)||5
919918|NCT01568827|2224671|P1|COMPLETED|Intervention 2 (5 Days)||5
919919|NCT01568827|2224670|P2|STARTED|Intervention 2 (5 Days)||5
919920|NCT01568827|2224671|P1|STARTED|Intervention 2 (5 Days)||5
919921|NCT01568827|2224670|P2|NOT COMPLETED|Washout (2 Days)||0
919922|NCT01568827|2224671|P1|NOT COMPLETED|Washout (2 Days)||0
919923|NCT01568827|2224670|P2|COMPLETED|Washout (2 Days)||5
919924|NCT01568827|2224671|P1|COMPLETED|Washout (2 Days)||5
919925|NCT01568827|2224670|P2|STARTED|Washout (2 Days)||5
919926|NCT01568827|2224671|P1|STARTED|Washout (2 Days)||5
919927|NCT01568827|2224670|P2|NOT COMPLETED|First Intervention (6 Days)||0
919928|NCT01568827|2224671|P1|NOT COMPLETED|First Intervention (6 Days)||0
919929|NCT01568827|2224670|P2|COMPLETED|First Intervention (6 Days)||5
919930|NCT01568827|2224671|P1|COMPLETED|First Intervention (6 Days)||5
919931|NCT01568827|2224670|P2|STARTED|First Intervention (6 Days)||5
919932|NCT01568827|2224671|P1|STARTED|First Intervention (6 Days)||5
919933|NCT01568593|2224679|P2|NOT COMPLETED|Overall Study||3
919934|NCT01568593|2224680|P1|NOT COMPLETED|Overall Study||7
919935|NCT01568593|2224679|P2|COMPLETED|Overall Study||42
919936|NCT01568593|2224680|P1|COMPLETED|Overall Study||41
919937|NCT01568593|2224679|P2|STARTED|Overall Study||45
919938|NCT01568593|2224680|P1|STARTED|Overall Study||48
919939|NCT01568424|2224686|P1|NOT COMPLETED|Overall Study||0
919940|NCT01568424|2224686|P1|COMPLETED|Overall Study||25
919941|NCT01568424|2224686|P1|STARTED|Overall Study||25
919942|NCT01568112|2224700|P4|NOT COMPLETED|Overall Study||12
919943|NCT01568112|2224701|P3|NOT COMPLETED|Overall Study||7
919944|NCT01568112|2224702|P2|NOT COMPLETED|Overall Study||8
919945|NCT01568112|2224703|P1|NOT COMPLETED|Overall Study||5
919946|NCT01568112|2224700|P4|COMPLETED|Overall Study||30
919947|NCT01568112|2224701|P3|COMPLETED|Overall Study||36
919948|NCT01568112|2224702|P2|COMPLETED|Overall Study||36
919949|NCT01568112|2224703|P1|COMPLETED|Overall Study||39
919950|NCT01568112|2224700|P4|STARTED|Overall Study||42
919951|NCT01568112|2224701|P3|STARTED|Overall Study||43
919952|NCT01568112|2224702|P2|STARTED|Overall Study||44
919953|NCT01568112|2224703|P1|STARTED|Overall Study||44
919954|NCT01568073|2224826|P5|NOT COMPLETED|Overall Study||9
919955|NCT01568073|2224827|P4|NOT COMPLETED|Overall Study||11
919956|NCT01568073|2224828|P3|NOT COMPLETED|Overall Study||12
919957|NCT01568073|2224829|P2|NOT COMPLETED|Overall Study||15
919958|NCT01568073|2224830|P1|NOT COMPLETED|Overall Study||11
919959|NCT01568073|2224826|P5|COMPLETED|Overall Study||107
919960|NCT01568073|2224827|P4|COMPLETED|Overall Study||108
919961|NCT01568073|2224828|P3|COMPLETED|Overall Study||110
919962|NCT01568073|2224829|P2|COMPLETED|Overall Study||107
919963|NCT01568073|2224830|P1|COMPLETED|Overall Study||110
919964|NCT01568073|2224826|P5|STARTED|Overall Study||116
919965|NCT01568073|2224827|P4|STARTED|Overall Study||119
919966|NCT01568073|2224828|P3|STARTED|Overall Study||122
919967|NCT01568073|2224829|P2|STARTED|Overall Study||122
919968|NCT01568073|2224830|P1|STARTED|Overall Study||121
919969|NCT01568047|2224861|P4|NOT COMPLETED|Overall Study||1
919970|NCT01568047|2224862|P3|NOT COMPLETED|Overall Study||1
919971|NCT01568047|2224863|P2|NOT COMPLETED|Overall Study||1
919972|NCT01568047|2224864|P1|NOT COMPLETED|Overall Study||1
919973|NCT01568047|2224861|P4|COMPLETED|Overall Study||9
919974|NCT01568047|2224862|P3|COMPLETED|Overall Study||9
919975|NCT01568047|2224863|P2|COMPLETED|Overall Study||9
919976|NCT01568047|2224864|P1|COMPLETED|Overall Study||9
919977|NCT01568047|2224861|P4|STARTED|Overall Study||10
919978|NCT01568047|2224862|P3|STARTED|Overall Study||10
919979|NCT01568047|2224863|P2|STARTED|Overall Study||10
919980|NCT01568047|2224864|P1|STARTED|Overall Study||10
919981|NCT01568034|2224882|P4|NOT COMPLETED|Overall Study||0
919982|NCT01568034|2224883|P3|NOT COMPLETED|Overall Study||0
919983|NCT01568034|2224884|P2|NOT COMPLETED|Overall Study||0
919984|NCT01568034|2224885|P1|NOT COMPLETED|Overall Study||1
919985|NCT01568034|2224882|P4|COMPLETED|Overall Study||3
919986|NCT01568034|2224883|P3|COMPLETED|Overall Study||3
919987|NCT01568034|2224884|P2|COMPLETED|Overall Study||2
919988|NCT01568034|2224885|P1|COMPLETED|Overall Study||1
919989|NCT01568034|2224882|P4|Placebo|Overall Study||3
919990|NCT01568034|2224883|P3|Placebo|Overall Study||3
919991|NCT01568034|2224884|P2|Placebo|Overall Study||2
919992|NCT01568034|2224885|P1|Placebo|Overall Study||1
919993|NCT01568034|2224882|P4|100 mg BIA 9-1067|Overall Study||3
919994|NCT01568034|2224883|P3|100 mg BIA 9-1067|Overall Study||3
919995|NCT01568034|2224884|P2|100 mg BIA 9-1067|Overall Study||2
919996|NCT01568034|2224885|P1|100 mg BIA 9-1067|Overall Study||2
919997|NCT01568034|2224882|P4|50 mg BIA 9-1067|Overall Study||3
919998|NCT01568034|2224883|P3|50 mg BIA 9-1067|Overall Study||3
919999|NCT01568034|2224884|P2|50 mg BIA 9-1067|Overall Study||2
920000|NCT01568034|2224885|P1|50 mg BIA 9-1067|Overall Study||2
920001|NCT01568034|2224882|P4|25 mg BIA 9-1067|Overall Study||3
920002|NCT01568034|2224883|P3|25 mg BIA 9-1067|Overall Study||3
920003|NCT01568034|2224884|P2|25 mg BIA 9-1067|Overall Study||2
920004|NCT01568034|2224885|P1|25 mg BIA 9-1067|Overall Study||2
920005|NCT01568034|2224882|P4|STARTED|Overall Study||3
920006|NCT01568034|2224883|P3|STARTED|Overall Study||3
920007|NCT01568034|2224884|P2|STARTED|Overall Study||2
920008|NCT01568034|2224885|P1|STARTED|Overall Study||2
920009|NCT01568021|2224903|P1|NOT COMPLETED|Overall Study||16
920010|NCT01568021|2224903|P1|COMPLETED|Overall Study||83
920011|NCT01568021|2224903|P1|STARTED|Overall Study||99
920012|NCT01568008|2224909|P1|NOT COMPLETED|Overall Study||234
920013|NCT01568008|2224909|P1|COMPLETED|Overall Study||699
920014|NCT01568008|2224909|P1|STARTED|Overall Study||933
920015|NCT01567943|2224920|P3|NOT COMPLETED|Overall Study||0
920016|NCT01567943|2224921|P2|NOT COMPLETED|Overall Study||10
920017|NCT01567943|2224922|P1|NOT COMPLETED|Overall Study||14
920018|NCT01567943|2224920|P3|COMPLETED|Overall Study||44
920019|NCT01567943|2224921|P2|COMPLETED|Overall Study||29
920020|NCT01567943|2224922|P1|COMPLETED|Overall Study||26
920021|NCT01567943|2224920|P3|STARTED|Overall Study||44
920022|NCT01567943|2224921|P2|STARTED|Overall Study||39
920023|NCT01567943|2224922|P1|STARTED|Overall Study||40
920024|NCT01567852|2224932|P2|NOT COMPLETED|Overall Study||7
920025|NCT01567852|2224933|P1|NOT COMPLETED|Overall Study||4
920026|NCT01567852|2224932|P2|COMPLETED|Overall Study||5
920027|NCT01567852|2224933|P1|COMPLETED|Overall Study||4
920028|NCT01567852|2224932|P2|STARTED|Overall Study||12
920029|NCT01567852|2224933|P1|STARTED|Overall Study||8
920030|NCT01567839|2224941|P1|NOT COMPLETED|Overall Study||0
920031|NCT01567839|2224941|P1|COMPLETED|Overall Study||60
920032|NCT01567839|2224941|P1|STARTED|Overall Study||60
920033|NCT01567826|2224951|P2|NOT COMPLETED|Overall Study||2
920034|NCT01567826|2224952|P1|NOT COMPLETED|Overall Study||3
920035|NCT01567826|2224951|P2|COMPLETED|Overall Study||42
920036|NCT01567826|2224952|P1|COMPLETED|Overall Study||40
920037|NCT01567826|2224951|P2|STARTED|Overall Study||44
920038|NCT01567826|2224952|P1|STARTED|Overall Study||43
920039|NCT01567371|2224976|P1|NOT COMPLETED|Overall Study||0
920040|NCT01567371|2224976|P1|COMPLETED|Overall Study||30
920041|NCT01567371|2224976|P1|STARTED|Overall Study||30
920042|NCT01567163|2224981|P1|NOT COMPLETED|Overall Study||4
920043|NCT01567163|2224981|P1|COMPLETED|Overall Study||18
920044|NCT01567163|2224981|P1|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1, Day 1 and Cycle 2, Day 1 treatment with required assessments.|18
920045|NCT01567163|2224981|P1|Received at Least 1 Dose of Study Drug|Overall Study||22
920046|NCT01567163|2224981|P1|STARTED|Overall Study||22
920047|NCT01567150|2224993|P2|NOT COMPLETED|Overall Study||2
920048|NCT01567150|2224994|P1|NOT COMPLETED|Overall Study||2
920049|NCT01567150|2224993|P2|COMPLETED|Overall Study||16
920050|NCT01567150|2224994|P1|COMPLETED|Overall Study||19
920051|NCT01567150|2224993|P2|STARTED|Overall Study||18
920052|NCT01567150|2224994|P1|STARTED|Overall Study||21
920053|NCT01567020|2225006|P4|NOT COMPLETED|Overall Study||1
920054|NCT01567020|2225007|P3|NOT COMPLETED|Overall Study||2
920055|NCT01567020|2225008|P2|NOT COMPLETED|Overall Study||5
920056|NCT01567020|2225009|P1|NOT COMPLETED|Overall Study||7
920057|NCT01567020|2225006|P4|COMPLETED|Overall Study||10
920058|NCT01567020|2225007|P3|COMPLETED|Overall Study||18
920059|NCT01567020|2225008|P2|COMPLETED|Overall Study||41
920060|NCT01567020|2225009|P1|COMPLETED|Overall Study||21
920061|NCT01567020|2225006|P4|STARTED|Overall Study||11
920062|NCT01567020|2225007|P3|STARTED|Overall Study||20
920063|NCT01567020|2225008|P2|STARTED|Overall Study||46
920064|NCT01567020|2225009|P1|STARTED|Overall Study||28
920065|NCT01566981|2225021|P2|NOT COMPLETED|Overall Study||8
920066|NCT01566981|2225022|P1|NOT COMPLETED|Overall Study||5
920067|NCT01566981|2225021|P2|COMPLETED|Overall Study||54
920068|NCT01566981|2225022|P1|COMPLETED|Overall Study||53
920069|NCT01566981|2225021|P2|STARTED|Overall Study||62
920070|NCT01566981|2225022|P1|STARTED|Overall Study||58
920071|NCT01566838|2225034|P2|NOT COMPLETED|Overall Study||0
920072|NCT01566838|2225035|P1|NOT COMPLETED|Overall Study||3
920073|NCT01566838|2225034|P2|COMPLETED|Overall Study||42
920074|NCT01566838|2225035|P1|COMPLETED|Overall Study||38
920075|NCT01566838|2225034|P2|STARTED|Overall Study||42
920076|NCT01566838|2225035|P1|STARTED|Overall Study||41
920077|NCT01566721|2225053|P2|NOT COMPLETED|Overall Study||710
920078|NCT01566721|2225054|P1|NOT COMPLETED|Overall Study||1867
920079|NCT01566721|2225053|P2|COMPLETED|Overall Study||0
920080|NCT01566721|2225054|P1|COMPLETED|Overall Study||0
920081|NCT01566721|2225053|P2|Received Treatment|Overall Study||709
920082|NCT01566721|2225054|P1|Received Treatment|Overall Study||1864
920083|NCT01566721|2225053|P2|STARTED|Overall Study||710
920084|NCT01566721|2225054|P1|STARTED|Overall Study||1867
920085|NCT01566630|2225079|P2|NOT COMPLETED|Overall Study||0
920086|NCT01566630|2225080|P1|NOT COMPLETED|Overall Study||0
920087|NCT01566630|2225079|P2|COMPLETED|Overall Study||1
920088|NCT01566630|2225080|P1|COMPLETED|Overall Study||2
920089|NCT01566630|2225079|P2|STARTED|Overall Study||1
920090|NCT01566630|2225080|P1|STARTED|Overall Study||2
920091|NCT01566604|2225136|P2|NOT COMPLETED|Overall Study||11
920092|NCT01566604|2225137|P1|NOT COMPLETED|Overall Study||24
920093|NCT01566604|2225136|P2|COMPLETED|Overall Study||143
920094|NCT01566604|2225137|P1|COMPLETED|Overall Study||282
920095|NCT01566604|2225136|P2|FAS, Serial Spirometry Subgroup|Overall Study||58
920096|NCT01566604|2225137|P1|FAS, Serial Spirometry Subgroup|Overall Study||134
920097|NCT01566604|2225136|P2|Full Analysis Set (FAS)|Overall Study||154
920098|NCT01566604|2225137|P1|Full Analysis Set (FAS)|Overall Study||305
920099|NCT01566604|2225136|P2|Safety Set|Overall Study||154
920100|NCT01566604|2225137|P1|Safety Set|Overall Study||305
920101|NCT01566604|2225136|P2|STARTED|Overall Study||154
920102|NCT01566604|2225137|P1|STARTED|Overall Study||306
920103|NCT01566539|2225171|P9|NOT COMPLETED|Within Subject Group||0
920104|NCT01566539|2225172|P8|NOT COMPLETED|Within Subject Group||0
920105|NCT01566539|2225173|P7|NOT COMPLETED|Within Subject Group||0
920106|NCT01566539|2225174|P6|NOT COMPLETED|Within Subject Group||0
920107|NCT01566539|2225175|P5|NOT COMPLETED|Within Subject Group||0
920108|NCT01566539|2225176|P4|NOT COMPLETED|Within Subject Group||3
920109|NCT01566539|2225177|P3|NOT COMPLETED|Within Subject Group||0
920110|NCT01566539|2225178|P2|NOT COMPLETED|Within Subject Group||0
920111|NCT01566539|2225179|P1|NOT COMPLETED|Within Subject Group||0
920112|NCT01566539|2225171|P9|COMPLETED|Within Subject Group||0
920113|NCT01566539|2225172|P8|COMPLETED|Within Subject Group||0
920114|NCT01566539|2225173|P7|COMPLETED|Within Subject Group||0
920115|NCT01566539|2225174|P6|COMPLETED|Within Subject Group||0
920116|NCT01566539|2225175|P5|COMPLETED|Within Subject Group||0
920117|NCT01566539|2225176|P4|COMPLETED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|153
920118|NCT01566539|2225177|P3|COMPLETED|Within Subject Group||0
920119|NCT01566539|2225178|P2|COMPLETED|Within Subject Group||0
920120|NCT01566539|2225179|P1|COMPLETED|Within Subject Group||0
920121|NCT01566539|2225171|P9|STARTED|Within Subject Group||0
920122|NCT01566539|2225172|P8|STARTED|Within Subject Group||0
920123|NCT01566539|2225173|P7|STARTED|Within Subject Group||0
920124|NCT01566539|2225174|P6|STARTED|Within Subject Group||0
920125|NCT01566539|2225175|P5|STARTED|Within Subject Group||0
920126|NCT01566539|2225176|P4|STARTED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|156
920127|NCT01566539|2225177|P3|STARTED|Within Subject Group||0
920128|NCT01566539|2225178|P2|STARTED|Within Subject Group||0
920129|NCT01566539|2225179|P1|STARTED|Within Subject Group||0
920130|NCT01566539|2225171|P9|NOT COMPLETED|Main Study Period||0
920131|NCT01566539|2225172|P8|NOT COMPLETED|Main Study Period||0
920132|NCT01566539|2225173|P7|NOT COMPLETED|Main Study Period||0
920133|NCT01566539|2225174|P6|NOT COMPLETED|Main Study Period||3
920134|NCT01566539|2225175|P5|NOT COMPLETED|Main Study Period||0
920135|NCT01566539|2225176|P4|NOT COMPLETED|Main Study Period||0
920136|NCT01566539|2225177|P3|NOT COMPLETED|Main Study Period||0
920137|NCT01566539|2225178|P2|NOT COMPLETED|Main Study Period||0
920138|NCT01566539|2225179|P1|NOT COMPLETED|Main Study Period||1
920139|NCT01566539|2225171|P9|COMPLETED|Main Study Period||1
920140|NCT01566539|2225172|P8|COMPLETED|Main Study Period||30
920141|NCT01566539|2225173|P7|COMPLETED|Main Study Period||30
920142|NCT01566539|2225174|P6|COMPLETED|Main Study Period||40
920143|NCT01566539|2225175|P5|COMPLETED|Main Study Period||40
920144|NCT01566539|2225176|P4|COMPLETED|Main Study Period||0
920145|NCT01566539|2225177|P3|COMPLETED|Main Study Period||104
920146|NCT01566539|2225178|P2|COMPLETED|Main Study Period||100
920147|NCT01566539|2225179|P1|COMPLETED|Main Study Period||100
920148|NCT01566539|2225171|P9|STARTED|Main Study Period||1
920149|NCT01566539|2225172|P8|STARTED|Main Study Period||30
920150|NCT01566539|2225173|P7|STARTED|Main Study Period||30
920151|NCT01566539|2225174|P6|STARTED|Main Study Period||43
920152|NCT01566539|2225175|P5|STARTED|Main Study Period||40
920153|NCT01566539|2225176|P4|STARTED|Main Study Period||0
920154|NCT01566539|2225177|P3|STARTED|Main Study Period||104
920155|NCT01566539|2225178|P2|STARTED|Main Study Period||100
920156|NCT01566539|2225179|P1|STARTED|Main Study Period||101
920157|NCT01566526|2225232|P1|NOT COMPLETED|Overall Study||0
920158|NCT01566526|2225232|P1|COMPLETED|Overall Study||26
920159|NCT01566526|2225232|P1|STARTED|Overall Study||26
920160|NCT01566500|2225242|P1|NOT COMPLETED|Overall Study||0
920161|NCT01566500|2225242|P1|COMPLETED|Overall Study||140
920162|NCT01566500|2225242|P1|STARTED|Overall Study||140
920163|NCT01566461|2225248|P2|NOT COMPLETED|IN.PACT SFA II Phase||5
920164|NCT01566461|2225249|P1|NOT COMPLETED|IN.PACT SFA II Phase||12
920165|NCT01566461|2225248|P2|COMPLETED|IN.PACT SFA II Phase||55
920166|NCT01566461|2225249|P1|COMPLETED|IN.PACT SFA II Phase||109
920167|NCT01566461|2225248|P2|STARTED|IN.PACT SFA II Phase||60
920168|NCT01566461|2225249|P1|STARTED|IN.PACT SFA II Phase||121
920169|NCT01566461|2225248|P2|NOT COMPLETED|IN.PACT SFA I Phase||2
920170|NCT01566461|2225249|P1|NOT COMPLETED|IN.PACT SFA I Phase||11
920171|NCT01566461|2225248|P2|COMPLETED|IN.PACT SFA I Phase||49
920172|NCT01566461|2225249|P1|COMPLETED|IN.PACT SFA I Phase||88
920173|NCT01566461|2225248|P2|STARTED|IN.PACT SFA I Phase||51
920174|NCT01566461|2225249|P1|STARTED|IN.PACT SFA I Phase||99
920175|NCT01566435|2225293|P1|NOT COMPLETED|ACF Definitive Chemoradiation-cetuximab||0
920176|NCT01566435|2225293|P1|COMPLETED|ACF Definitive Chemoradiation-cetuximab||2
920177|NCT01566435|2225293|P1|STARTED|ACF Definitive Chemoradiation-cetuximab||2
920178|NCT01566435|2225293|P1|NOT COMPLETED|ACF Definitive Chemoradiation-cisplatin||1
920179|NCT01566435|2225293|P1|COMPLETED|ACF Definitive Chemoradiation-cisplatin||27
920180|NCT01566435|2225293|P1|STARTED|ACF Definitive Chemoradiation-cisplatin||28
920181|NCT01566435|2225293|P1|NOT COMPLETED|ACF Induction Therapy||0
920182|NCT01566435|2225293|P1|COMPLETED|ACF Induction Therapy||30
920183|NCT01566435|2225293|P1|STARTED|ACF Induction Therapy||30
920184|NCT01566409|2225309|P2|NOT COMPLETED|Overall Study||5
920185|NCT01566409|2225310|P1|NOT COMPLETED|Overall Study||2
920186|NCT01566409|2225309|P2|COMPLETED|Overall Study||48
920187|NCT01566409|2225310|P1|COMPLETED|Overall Study||47
920188|NCT01566409|2225309|P2|STARTED|Overall Study||53
920189|NCT01566409|2225310|P1|STARTED|Overall Study||49
920190|NCT01566370|2225318|P2|NOT COMPLETED|Overall Study||1
920191|NCT01566370|2225319|P1|NOT COMPLETED|Overall Study||2
920192|NCT01566370|2225318|P2|COMPLETED|Overall Study||0
920193|NCT01566370|2225319|P1|COMPLETED|Overall Study||0
920194|NCT01566370|2225318|P2|STARTED|Overall Study||1
920195|NCT01566370|2225319|P1|STARTED|Overall Study||2
920196|NCT01566331|2225345|P2|NOT COMPLETED|Overall Study||0
920197|NCT01566331|2225346|P1|NOT COMPLETED|Overall Study||0
920198|NCT01566331|2225345|P2|COMPLETED|Overall Study||40
920199|NCT01566331|2225346|P1|COMPLETED|Overall Study||40
920200|NCT01566331|2225345|P2|STARTED|Overall Study||40
920201|NCT01566331|2225346|P1|STARTED|Overall Study||40
920202|NCT01566162|2225352|P1|NOT COMPLETED|Overall Study||36
920203|NCT01566162|2225352|P1|COMPLETED|Overall Study||155
920204|NCT01566162|2225352|P1|STARTED|Overall Study||191
920205|NCT01566149|2225366|P2|NOT COMPLETED|Overall Study||2
920206|NCT01566149|2225367|P1|NOT COMPLETED|Overall Study||3
920207|NCT01566149|2225366|P2|COMPLETED|Overall Study||23
920208|NCT01566149|2225367|P1|COMPLETED|Overall Study||21
920209|NCT01566149|2225366|P2|STARTED|Overall Study||25
920210|NCT01566149|2225367|P1|STARTED|Overall Study||24
920211|NCT01566084|2225383|P2|NOT COMPLETED|Overall Study||0
920212|NCT01566084|2225384|P1|NOT COMPLETED|Overall Study||0
920213|NCT01566084|2225383|P2|COMPLETED|Overall Study||10
920214|NCT01566084|2225384|P1|COMPLETED|Overall Study||7
920215|NCT01566084|2225383|P2|STARTED|Overall Study||10
920216|NCT01566084|2225384|P1|STARTED|Overall Study||7
920217|NCT01565993|2225400|P2|NOT COMPLETED|Overall Study||3
920218|NCT01565993|2225401|P1|NOT COMPLETED|Overall Study||0
920219|NCT01565993|2225400|P2|COMPLETED|Overall Study||39
920220|NCT01565993|2225401|P1|COMPLETED|Overall Study|A total of 105 polypectomies were performed on 98 patients|66
920221|NCT01565993|2225400|P2|STARTED|Overall Study|3 patients were excluded for failing to meet the inclusion criteria|42
920222|NCT01565993|2225401|P1|STARTED|Overall Study||66
920223|NCT01565980|2225409|P2|NOT COMPLETED|Overall Study||4
920224|NCT01565980|2225410|P1|NOT COMPLETED|Overall Study||4
920225|NCT01565980|2225409|P2|COMPLETED|Overall Study||16
920226|NCT01565980|2225410|P1|COMPLETED|Overall Study||16
920319|NCT01565551|2225645|P1|Clinical/Demographics|Overall Study||586
920227|NCT01565980|2225409|P2|STARTED|Overall Study|Three patients had started the intervention protocol at the time of study withdrawal.|20
920228|NCT01565980|2225410|P1|STARTED|Overall Study||20
920229|NCT01565902|2225432|P4|NOT COMPLETED|Overall Study||0
920230|NCT01565902|2225433|P3|NOT COMPLETED|Overall Study||0
920231|NCT01565902|2225434|P2|NOT COMPLETED|Overall Study||0
920232|NCT01565902|2225435|P1|NOT COMPLETED|Overall Study||0
920233|NCT01565902|2225432|P4|COMPLETED|Overall Study||16
920234|NCT01565902|2225433|P3|COMPLETED|Overall Study||8
920235|NCT01565902|2225434|P2|COMPLETED|Overall Study||8
920236|NCT01565902|2225435|P1|COMPLETED|Overall Study||8
920237|NCT01565902|2225432|P4|STARTED|Overall Study||16
920238|NCT01565902|2225433|P3|STARTED|Overall Study||8
920239|NCT01565902|2225434|P2|STARTED|Overall Study||8
920240|NCT01565902|2225435|P1|STARTED|Overall Study||8
920241|NCT01565889|2225469|P6|NOT COMPLETED|Part B||4
920242|NCT01565889|2225470|P5|NOT COMPLETED|Part B||0
920243|NCT01565889|2225471|P4|NOT COMPLETED|Part B||0
920244|NCT01565889|2225472|P3|NOT COMPLETED|Part B||0
920245|NCT01565889|2225473|P2|NOT COMPLETED|Part B||0
920246|NCT01565889|2225474|P1|NOT COMPLETED|Part B||0
920247|NCT01565889|2225469|P6|COMPLETED|Part B||19
920248|NCT01565889|2225470|P5|COMPLETED|Part B||0
920249|NCT01565889|2225471|P4|COMPLETED|Part B||0
920250|NCT01565889|2225472|P3|COMPLETED|Part B||0
920251|NCT01565889|2225473|P2|COMPLETED|Part B||0
920252|NCT01565889|2225474|P1|COMPLETED|Part B||0
920253|NCT01565889|2225469|P6|STARTED|Part B|9 participants in this group transferred from a Part A cohort, and 14 participants joined the study.|23
920254|NCT01565889|2225470|P5|STARTED|Part B||0
920255|NCT01565889|2225471|P4|STARTED|Part B||0
920256|NCT01565889|2225472|P3|STARTED|Part B||0
920257|NCT01565889|2225473|P2|STARTED|Part B||0
920258|NCT01565889|2225474|P1|STARTED|Part B||0
920259|NCT01565889|2225469|P6|NOT COMPLETED|Part A||0
920260|NCT01565889|2225470|P5|NOT COMPLETED|Part A||0
920261|NCT01565889|2225471|P4|NOT COMPLETED|Part A||0
920262|NCT01565889|2225472|P3|NOT COMPLETED|Part A||0
920263|NCT01565889|2225473|P2|NOT COMPLETED|Part A||0
920264|NCT01565889|2225474|P1|NOT COMPLETED|Part A||1
920265|NCT01565889|2225469|P6|COMPLETED|Part A||0
920266|NCT01565889|2225470|P5|COMPLETED|Part A|1 participant from this group continued in the Part B: SOF+PEG+RBV group.|7
920267|NCT01565889|2225471|P4|COMPLETED|Part A|2 participants from this group continued in the Part B: SOF+PEG+RBV group.|7
920268|NCT01565889|2225472|P3|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|8
920269|NCT01565889|2225473|P2|COMPLETED|Part A|No participants from this group continued in the Part B: SOF+PEG+RBV group.|4
920270|NCT01565889|2225474|P1|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|11
920271|NCT01565889|2225469|P6|STARTED|Part A||0
920272|NCT01565889|2225470|P5|STARTED|Part A||7
920273|NCT01565889|2225471|P4|STARTED|Part A||7
920274|NCT01565889|2225472|P3|STARTED|Part A||8
920275|NCT01565889|2225473|P2|STARTED|Part A||4
920276|NCT01565889|2225474|P1|STARTED|Part A||12
920277|NCT01565850|2225505|P2|NOT COMPLETED|Overall Study||8
920278|NCT01565850|2225506|P1|NOT COMPLETED|Overall Study||20
920279|NCT01565850|2225505|P2|COMPLETED|Overall Study||42
920280|NCT01565850|2225506|P1|COMPLETED|Overall Study||83
920281|NCT01565850|2225505|P2|STARTED|Overall Study||50
920282|NCT01565850|2225506|P1|STARTED|Overall Study||103
920283|NCT01565707|2225526|P4|NOT COMPLETED|Overall Study||5
920284|NCT01565707|2225527|P3|NOT COMPLETED|Overall Study||3
920285|NCT01565707|2225528|P2|NOT COMPLETED|Overall Study||8
920286|NCT01565707|2225529|P1|NOT COMPLETED|Overall Study||9
920287|NCT01565707|2225526|P4|COMPLETED|Overall Study||17
920288|NCT01565707|2225527|P3|COMPLETED|Overall Study||16
920289|NCT01565707|2225528|P2|COMPLETED|Overall Study||65
920290|NCT01565707|2225529|P1|COMPLETED|Overall Study||66
920291|NCT01565707|2225526|P4|Treated|Overall Study||22
920292|NCT01565707|2225527|P3|Treated|Overall Study||19
920293|NCT01565707|2225528|P2|Treated|Overall Study||73
920294|NCT01565707|2225529|P1|Treated|Overall Study||73
920295|NCT01565707|2225526|P4|STARTED|Overall Study||22
920296|NCT01565707|2225527|P3|STARTED|Overall Study||19
920297|NCT01565707|2225528|P2|STARTED|Overall Study||73
920298|NCT01565707|2225529|P1|STARTED|Overall Study||75
920299|NCT01565616|2225620|P1|NOT COMPLETED|Overall Study||0
920300|NCT01565616|2225620|P1|COMPLETED|Overall Study||22
920301|NCT01565616|2225620|P1|STARTED|Overall Study||22
920302|NCT01565564|2225633|P2|NOT COMPLETED|Overall Study||1
920303|NCT01565564|2225634|P1|NOT COMPLETED|Overall Study||5
920304|NCT01565564|2225633|P2|COMPLETED|Overall Study||361
920305|NCT01565564|2225634|P1|COMPLETED|Overall Study||339
920306|NCT01565564|2225633|P2|STARTED|Overall Study||362
920307|NCT01565564|2225634|P1|STARTED|Overall Study||344
920308|NCT01565551|2225644|P2|NOT COMPLETED|Overall Study||0
920309|NCT01565551|2225645|P1|NOT COMPLETED|Overall Study||0
920310|NCT01565551|2225644|P2|COMPLETED|Overall Study||51
920311|NCT01565551|2225645|P1|COMPLETED|Overall Study||586
920312|NCT01565551|2225644|P2|6-Month Outcomes|Overall Study||30
920313|NCT01565551|2225645|P1|6-Month Outcomes|Overall Study||412
920314|NCT01565551|2225644|P2|Neuroimaging|Overall Study||25
920315|NCT01565551|2225645|P1|Neuroimaging|Overall Study||233
920316|NCT01565551|2225644|P2|Biospecimens/Biomarkers|Overall Study||22
920317|NCT01565551|2225645|P1|Biospecimens/Biomarkers|Overall Study||479
920318|NCT01565551|2225644|P2|Clinical/Demographics|Overall Study||51
920320|NCT01565551|2225644|P2|STARTED|Overall Study||51
920321|NCT01565551|2225645|P1|STARTED|Overall Study||586
920322|NCT01565538|2225653|P2|NOT COMPLETED|Overall Study||0
920323|NCT01565538|2225654|P1|NOT COMPLETED|Overall Study||0
920324|NCT01565538|2225653|P2|COMPLETED|Overall Study||62
920325|NCT01565538|2225654|P1|COMPLETED|Overall Study||61
920326|NCT01565538|2225653|P2|STARTED|Overall Study||62
920327|NCT01565538|2225654|P1|STARTED|Overall Study||61
920328|NCT01565382|2225664|P2|NOT COMPLETED|Overall Study||0
920329|NCT01565382|2225665|P1|NOT COMPLETED|Overall Study||0
920330|NCT01565382|2225664|P2|COMPLETED|Overall Study||7
920331|NCT01565382|2225665|P1|COMPLETED|Overall Study||40
920332|NCT01565382|2225664|P2|STARTED|Overall Study||7
920333|NCT01565382|2225665|P1|STARTED|Overall Study||40
920334|NCT01565369|2225670|P1|NOT COMPLETED|Overall Study||0
920335|NCT01565369|2225670|P1|COMPLETED|Overall Study||35
920336|NCT01565369|2225670|P1|STARTED|Overall Study||35
920337|NCT01565356|2225676|P1|NOT COMPLETED|Overall Study||0
920338|NCT01565356|2225676|P1|COMPLETED|Overall Study||41
920339|NCT01565356|2225676|P1|STARTED|Overall Study||41
920340|NCT01565343|2225684|P3|NOT COMPLETED|Overall Study||0
920341|NCT01565343|2225685|P2|NOT COMPLETED|Overall Study||0
920342|NCT01565343|2225686|P1|NOT COMPLETED|Overall Study||1
920343|NCT01565343|2225684|P3|COMPLETED|Overall Study||10
920344|NCT01565343|2225685|P2|COMPLETED|Overall Study||4
920345|NCT01565343|2225686|P1|COMPLETED|Overall Study||10
920346|NCT01565343|2225684|P3|STARTED|Overall Study||10
920347|NCT01565343|2225685|P2|STARTED|Overall Study||4
920348|NCT01565343|2225686|P1|STARTED|Overall Study||11
920349|NCT01565330|2225697|P4|NOT COMPLETED|Overall Study||0
920350|NCT01565330|2225698|P3|NOT COMPLETED|Overall Study||0
920351|NCT01565330|2225699|P2|NOT COMPLETED|Overall Study||0
920352|NCT01565330|2225700|P1|NOT COMPLETED|Overall Study||0
920353|NCT01565330|2225697|P4|COMPLETED|Overall Study||7
920354|NCT01565330|2225698|P3|COMPLETED|Overall Study||4
920355|NCT01565330|2225699|P2|COMPLETED|Overall Study||4
920356|NCT01565330|2225700|P1|COMPLETED|Overall Study||5
920357|NCT01565330|2225697|P4|STARTED|Overall Study||7
920358|NCT01565330|2225698|P3|STARTED|Overall Study||4
920359|NCT01565330|2225699|P2|STARTED|Overall Study||4
920360|NCT01565330|2225700|P1|STARTED|Overall Study||5
920361|NCT01565291|2225716|P2|NOT COMPLETED|Overall Study||0
920362|NCT01565291|2225717|P1|NOT COMPLETED|Overall Study||1
920363|NCT01565291|2225716|P2|COMPLETED|Overall Study||16
920364|NCT01565291|2225717|P1|COMPLETED|Overall Study||15
920365|NCT01565291|2225716|P2|STARTED|Overall Study||16
920366|NCT01565291|2225717|P1|STARTED|Overall Study||16
920367|NCT01565148|2225729|P4|NOT COMPLETED|Overall Study||13
920368|NCT01565148|2225730|P3|NOT COMPLETED|Overall Study||7
920369|NCT01565148|2225731|P2|NOT COMPLETED|Overall Study||15
920370|NCT01565148|2225732|P1|NOT COMPLETED|Overall Study||15
920371|NCT01565148|2225729|P4|COMPLETED|Overall Study||32
920372|NCT01565148|2225730|P3|COMPLETED|Overall Study||40
920373|NCT01565148|2225731|P2|COMPLETED|Overall Study||31
920374|NCT01565148|2225732|P1|COMPLETED|Overall Study||32
920375|NCT01565148|2225729|P4|STARTED|Overall Study||45
920376|NCT01565148|2225730|P3|STARTED|Overall Study||47
920377|NCT01565148|2225731|P2|STARTED|Overall Study||46
920378|NCT01565148|2225732|P1|STARTED|Overall Study||47
920379|NCT01565083|2225768|P2|NOT COMPLETED|Overall Study||39
920380|NCT01565083|2225769|P1|NOT COMPLETED|Overall Study||33
920381|NCT01565083|2225768|P2|COMPLETED|Overall Study||68
920382|NCT01565083|2225769|P1|COMPLETED|Overall Study||73
920383|NCT01565083|2225768|P2|STARTED|Overall Study||107
920384|NCT01565083|2225769|P1|STARTED|Overall Study||106
920385|NCT01564953|2225795|P1|NOT COMPLETED|Overall Study||0
920386|NCT01564953|2225795|P1|COMPLETED|Overall Study||143
920387|NCT01564953|2225795|P1|STARTED|Overall Study||143
920388|NCT01564862|2225806|P3|NOT COMPLETED|Overall Study||30
920389|NCT01564862|2225807|P2|NOT COMPLETED|Overall Study||34
920390|NCT01564862|2225808|P1|NOT COMPLETED|Overall Study||30
920391|NCT01564862|2225806|P3|COMPLETED|Overall Study||164
920392|NCT01564862|2225807|P2|COMPLETED|Overall Study||176
920393|NCT01564862|2225808|P1|COMPLETED|Overall Study||168
920394|NCT01564862|2225806|P3|Received Treatment|Overall Study||191
920395|NCT01564862|2225807|P2|Received Treatment|Overall Study||207
920396|NCT01564862|2225808|P1|Received Treatment|Overall Study||196
920397|NCT01564862|2225806|P3|STARTED|Overall Study||194
920398|NCT01564862|2225807|P2|STARTED|Overall Study||210
920399|NCT01564862|2225808|P1|STARTED|Overall Study||198
920400|NCT01564758|2225857|P1|NOT COMPLETED|Overall Study||14
920401|NCT01564758|2225857|P1|COMPLETED|Overall Study||85
920402|NCT01564758|2225857|P1|STARTED|Overall Study||99
920403|NCT01564732|2225864|P2|NOT COMPLETED|Overall Study||5
920404|NCT01564732|2225865|P1|NOT COMPLETED|Overall Study||6
920405|NCT01564732|2225864|P2|COMPLETED|Overall Study||0
920406|NCT01564732|2225865|P1|COMPLETED|Overall Study||0
920407|NCT01564732|2225864|P2|STARTED|Overall Study||5
920408|NCT01564732|2225865|P1|STARTED|Overall Study||6
920409|NCT01564706|2225881|P1|NOT COMPLETED|Overall Study||0
920410|NCT01564706|2225881|P1|COMPLETED|Overall Study||9
920411|NCT01564706|2225881|P1|STARTED|Overall Study||9
920412|NCT01564693|2225888|P3|NOT COMPLETED|Overall Study||0
920413|NCT01564693|2225889|P2|NOT COMPLETED|Overall Study||0
920414|NCT01564693|2225890|P1|NOT COMPLETED|Overall Study||0
920415|NCT01564693|2225888|P3|COMPLETED|Overall Study||2
920416|NCT01564693|2225889|P2|COMPLETED|Overall Study||4
920417|NCT01564693|2225890|P1|COMPLETED|Overall Study||9
920418|NCT01564693|2225888|P3|STARTED|Overall Study|Only 2 patients were found necessary to give statistical relevance to the patients' results.|2
920419|NCT01564693|2225889|P2|STARTED|Overall Study||4
920420|NCT01564693|2225890|P1|STARTED|Overall Study|Originally we planned to study 4 patients. We expanded to 9 to improve consistency of the results.|9
920421|NCT01564537|2225900|P2|NOT COMPLETED|Overall Study||6
920422|NCT01564537|2225901|P1|NOT COMPLETED|Overall Study||6
920423|NCT01564537|2225900|P2|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|356
920424|NCT01564537|2225901|P1|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|354
920425|NCT01564537|2225900|P2|Safety Population: Received Study Drug|Overall Study||360
920426|NCT01564537|2225901|P1|Safety Population: Received Study Drug|Overall Study||360
920427|NCT01564537|2225900|P2|STARTED|Overall Study||362
920428|NCT01564537|2225901|P1|STARTED|Overall Study||360
920429|NCT01564459|2225924|P3|NOT COMPLETED|Double-blind Treatment||1
920430|NCT01564459|2225925|P2|NOT COMPLETED|Double-blind Treatment||0
920431|NCT01564459|2225926|P1|NOT COMPLETED|Double-blind Treatment||0
920432|NCT01564459|2225924|P3|COMPLETED|Double-blind Treatment||82
920433|NCT01564459|2225925|P2|COMPLETED|Double-blind Treatment||87
920434|NCT01564459|2225926|P1|COMPLETED|Double-blind Treatment||0
920435|NCT01564459|2225924|P3|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|83
920436|NCT01564459|2225925|P2|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|87
920437|NCT01564459|2225926|P1|STARTED|Double-blind Treatment||0
920438|NCT01564459|2225924|P3|NOT COMPLETED|Run-In||0
920439|NCT01564459|2225925|P2|NOT COMPLETED|Run-In||0
920440|NCT01564459|2225926|P1|NOT COMPLETED|Run-In||12
920441|NCT01564459|2225924|P3|COMPLETED|Run-In||83
920442|NCT01564459|2225925|P2|COMPLETED|Run-In||87
920443|NCT01564459|2225926|P1|COMPLETED|Run-In||0
920444|NCT01564459|2225924|P3|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|83
920445|NCT01564459|2225925|P2|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|87
920446|NCT01564459|2225926|P1|STARTED|Run-In||12
920447|NCT01564407|2225950|P5|NOT COMPLETED|Overall Study||0
920448|NCT01564407|2225951|P4|NOT COMPLETED|Overall Study||1
920449|NCT01564407|2225952|P3|NOT COMPLETED|Overall Study||0
920450|NCT01564407|2225953|P2|NOT COMPLETED|Overall Study||2
920451|NCT01564407|2225954|P1|NOT COMPLETED|Overall Study||0
920452|NCT01564407|2225950|P5|COMPLETED|Overall Study||0
920453|NCT01564407|2225951|P4|COMPLETED|Overall Study||1
920454|NCT01564407|2225952|P3|COMPLETED|Overall Study||4
920455|NCT01564407|2225953|P2|COMPLETED|Overall Study||3
920456|NCT01564407|2225954|P1|COMPLETED|Overall Study||4
920457|NCT01564407|2225950|P5|STARTED|Overall Study||0
920458|NCT01564407|2225951|P4|STARTED|Overall Study||2
920459|NCT01564407|2225952|P3|STARTED|Overall Study||4
920460|NCT01564407|2225953|P2|STARTED|Overall Study||5
920461|NCT01564407|2225954|P1|STARTED|Overall Study||4
920462|NCT01564394|2225995|P2|NOT COMPLETED|Overall Study||10
920463|NCT01564394|2225996|P1|NOT COMPLETED|Overall Study||6
920464|NCT01564394|2225995|P2|COMPLETED|Overall Study|Prostate cancer survivors n=13, family n=7.|20
920465|NCT01564394|2225996|P1|COMPLETED|Overall Study|Prostate cancer survivors n=16, family n=8.|24
920466|NCT01564394|2225995|P2|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
920467|NCT01564394|2225996|P1|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
920468|NCT01563978|2226010|P2|NOT COMPLETED|Overall Study||2
920469|NCT01563978|2226011|P1|NOT COMPLETED|Overall Study||4
920470|NCT01563978|2226010|P2|COMPLETED|Overall Study||65
920471|NCT01563978|2226011|P1|COMPLETED|Overall Study||64
920472|NCT01563978|2226010|P2|Randomised But Did Not Receive Treatment|Overall Study||0
920473|NCT01563978|2226011|P1|Randomised But Did Not Receive Treatment|Overall Study||0
920474|NCT01563978|2226010|P2|STARTED|Overall Study|Patients who received treatment.|67
920475|NCT01563978|2226011|P1|STARTED|Overall Study|Patients who received treatment.|68
920476|NCT01563536|2226037|P2|NOT COMPLETED|Overall Study||2
920477|NCT01563536|2226038|P1|NOT COMPLETED|Overall Study||1
920478|NCT01563536|2226037|P2|COMPLETED|Overall Study||4
920479|NCT01563536|2226038|P1|COMPLETED|Overall Study||5
920480|NCT01563536|2226037|P2|STARTED|Overall Study||6
920481|NCT01563536|2226038|P1|STARTED|Overall Study||6
920482|NCT01563406|2226070|P4|NOT COMPLETED|Overall Study||0
920483|NCT01563406|2226071|P3|NOT COMPLETED|Overall Study||0
920484|NCT01563406|2226072|P2|NOT COMPLETED|Overall Study||0
920485|NCT01563406|2226073|P1|NOT COMPLETED|Overall Study||0
920486|NCT01563406|2226070|P4|COMPLETED|Overall Study|112 hubs|29
920487|NCT01563406|2226071|P3|COMPLETED|Overall Study|101 hubs|30
920488|NCT01563406|2226072|P2|COMPLETED|Overall Study|102 hubs|30
920489|NCT01563406|2226073|P1|COMPLETED|Overall Study|194 hubs|60
920490|NCT01563406|2226070|P4|STARTED|Overall Study|112 hubs|29
920491|NCT01563406|2226071|P3|STARTED|Overall Study|101 hubs|30
920492|NCT01563406|2226072|P2|STARTED|Overall Study|102 hubs|30
920493|NCT01563406|2226073|P1|STARTED|Overall Study|194 hubs|60
920494|NCT01563198|2226091|P1|NOT COMPLETED|After Training||0
920495|NCT01563198|2226091|P1|COMPLETED|After Training||47979
920496|NCT01563198|2226091|P1|STARTED|After Training||47979
920497|NCT01563198|2226091|P1|NOT COMPLETED|Baseline||0
920498|NCT01563198|2226091|P1|COMPLETED|Baseline||49733
920499|NCT01563198|2226091|P1|STARTED|Baseline||49733
920500|NCT01563185|2226097|P1|NOT COMPLETED|Overall Study||2
920501|NCT01563185|2226097|P1|COMPLETED|Overall Study||10
920502|NCT01563185|2226097|P1|STARTED|Overall Study||12
920503|NCT01563172|2226111|P1|NOT COMPLETED|Overall Study||13
920504|NCT01563172|2226111|P1|COMPLETED|Overall Study||52
920505|NCT01563172|2226111|P1|Control Dentifrice|Overall Study||60
920506|NCT01563172|2226111|P1|Experimental Dentifrice 1.5g/ 45 Sec|Overall Study||58
920507|NCT01563172|2226111|P1|Experimental Dentifrice 1.5g/ 2min|Overall Study||58
920508|NCT01563172|2226111|P1|Experimental Dentifrice 0.5g/45 Sec|Overall Study||59
920509|NCT01563172|2226111|P1|Experimental Dentifrice 0.5g/2 Min|Overall Study||59
920510|NCT01563172|2226111|P1|STARTED|Overall Study||65
920511|NCT01563081|2226140|P2|NOT COMPLETED|Overall Study||0
920512|NCT01563081|2226141|P1|NOT COMPLETED|Overall Study||0
920513|NCT01563081|2226140|P2|COMPLETED|Overall Study||30
920514|NCT01563081|2226141|P1|COMPLETED|Overall Study||30
920515|NCT01563081|2226140|P2|STARTED|Overall Study||30
920516|NCT01563081|2226141|P1|STARTED|Overall Study||30
920517|NCT01563055|2226154|P1|NOT COMPLETED|Overall Study||0
920518|NCT01563055|2226154|P1|COMPLETED|Overall Study||10
920519|NCT01563055|2226154|P1|STARTED|Overall Study||10
920520|NCT01563029|2226217|P5|NOT COMPLETED|Overall Study||29
920521|NCT01563029|2226218|P4|NOT COMPLETED|Overall Study||33
920522|NCT01563029|2226219|P3|NOT COMPLETED|Overall Study||33
920523|NCT01563029|2226220|P2|NOT COMPLETED|Overall Study||24
920524|NCT01563029|2226221|P1|NOT COMPLETED|Overall Study||53
920525|NCT01563029|2226217|P5|COMPLETED|Overall Study||89
920526|NCT01563029|2226218|P4|COMPLETED|Overall Study||85
920527|NCT01563029|2226219|P3|COMPLETED|Overall Study||87
920528|NCT01563029|2226220|P2|COMPLETED|Overall Study||94
920529|NCT01563029|2226221|P1|COMPLETED|Overall Study||66
920530|NCT01563029|2226217|P5|STARTED|Overall Study||118
920531|NCT01563029|2226218|P4|STARTED|Overall Study||118
920532|NCT01563029|2226219|P3|STARTED|Overall Study||120
920533|NCT01563029|2226220|P2|STARTED|Overall Study||118
920534|NCT01563029|2226221|P1|STARTED|Overall Study||119
920535|NCT01563003|2226271|P2|NOT COMPLETED|Overall Study||0
920536|NCT01563003|2226272|P1|NOT COMPLETED|Overall Study||0
920537|NCT01563003|2226271|P2|COMPLETED|Overall Study||15
920538|NCT01563003|2226272|P1|COMPLETED|Overall Study||16
920539|NCT01563003|2226271|P2|STARTED|Overall Study||15
920540|NCT01563003|2226272|P1|STARTED|Overall Study||16
920541|NCT01562886|2226282|P1|NOT COMPLETED|Overall Study||1
920542|NCT01562886|2226282|P1|COMPLETED|Overall Study||13
920543|NCT01562886|2226282|P1|STARTED|Overall Study||14
920544|NCT01562873|2226287|P2|NOT COMPLETED|Overall Study||0
920545|NCT01562873|2226288|P1|NOT COMPLETED|Overall Study||21
920546|NCT01562873|2226287|P2|COMPLETED|Overall Study||0
920547|NCT01562873|2226288|P1|COMPLETED|Overall Study||0
920548|NCT01562873|2226287|P2|STARTED|Overall Study|The observed number of objective responses in Cohort A was not sufficient for Cohort B to open.|0
920549|NCT01562873|2226288|P1|STARTED|Overall Study||21
920550|NCT01562756|2226295|P1|NOT COMPLETED|Overall Study||0
920551|NCT01562756|2226295|P1|COMPLETED|Overall Study||6
920552|NCT01562756|2226295|P1|STARTED|Overall Study||6
920553|NCT01562743|2226300|P1|NOT COMPLETED|Overall Study||52
920554|NCT01562743|2226300|P1|COMPLETED|Overall Study||133
920555|NCT01562743|2226300|P1|STARTED|Overall Study||185
920556|NCT01562678|2226312|P2|NOT COMPLETED|Overall Study||2
920557|NCT01562678|2226313|P1|NOT COMPLETED|Overall Study||6
920558|NCT01562678|2226312|P2|COMPLETED|Overall Study||12
920559|NCT01562678|2226313|P1|COMPLETED|Overall Study||8
920560|NCT01562678|2226312|P2|STARTED|Overall Study||14
920561|NCT01562678|2226313|P1|STARTED|Overall Study||14
920562|NCT01562613|2226319|P1|NOT COMPLETED|Overall Study||4
920563|NCT01562613|2226319|P1|COMPLETED|Overall Study||529
920564|NCT01562613|2226319|P1|STARTED|Overall Study||533
920565|NCT01562548|2226329|P4|NOT COMPLETED|Overall Study||0
920566|NCT01562548|2226330|P3|NOT COMPLETED|Overall Study||1
920567|NCT01562548|2226331|P2|NOT COMPLETED|Overall Study||0
920568|NCT01562548|2226332|P1|NOT COMPLETED|Overall Study||0
920569|NCT01562548|2226329|P4|COMPLETED|Overall Study||14
920570|NCT01562548|2226330|P3|COMPLETED|Overall Study||24
920571|NCT01562548|2226331|P2|COMPLETED|Overall Study||15
920572|NCT01562548|2226332|P1|COMPLETED|Overall Study||25
920573|NCT01562548|2226329|P4|STARTED|Overall Study||14
920574|NCT01562548|2226330|P3|STARTED|Overall Study||25
920575|NCT01562548|2226331|P2|STARTED|Overall Study||15
920576|NCT01562548|2226332|P1|STARTED|Overall Study||25
920577|NCT01562327|2226382|P1|NOT COMPLETED|Overall Study||8
920578|NCT01562327|2226382|P1|COMPLETED|Overall Study||42
920579|NCT01562327|2226382|P1|STARTED|Overall Study||50
920580|NCT01562314|2226412|P2|NOT COMPLETED|Overall Study||8
920581|NCT01562314|2226413|P1|NOT COMPLETED|Overall Study||13
920582|NCT01562314|2226412|P2|COMPLETED|Overall Study||23
920583|NCT01562314|2226413|P1|COMPLETED|Overall Study||16
920584|NCT01562314|2226412|P2|STARTED|Overall Study||31
920585|NCT01562314|2226413|P1|STARTED|Overall Study||29
920586|NCT01562275|2226500|P13|NOT COMPLETED|Stage 2||5
920587|NCT01562275|2226501|P12|NOT COMPLETED|Stage 2||14
920588|NCT01562275|2226502|P11|NOT COMPLETED|Stage 2||0
920589|NCT01562275|2226503|P10|NOT COMPLETED|Stage 2||0
920590|NCT01562275|2226504|P9|NOT COMPLETED|Stage 2||0
920591|NCT01562275|2226505|P8|NOT COMPLETED|Stage 2||0
920592|NCT01562275|2226506|P7|NOT COMPLETED|Stage 2||0
920593|NCT01562275|2226507|P6|NOT COMPLETED|Stage 2||0
920594|NCT01562275|2226508|P5|NOT COMPLETED|Stage 2||0
920595|NCT01562275|2226509|P4|NOT COMPLETED|Stage 2||0
920596|NCT01562275|2226510|P3|NOT COMPLETED|Stage 2||0
920597|NCT01562275|2226511|P2|NOT COMPLETED|Stage 2||0
920598|NCT01562275|2226512|P1|NOT COMPLETED|Stage 2||0
920599|NCT01562275|2226500|P13|COMPLETED|Stage 2||0
920600|NCT01562275|2226501|P12|COMPLETED|Stage 2||0
920601|NCT01562275|2226502|P11|COMPLETED|Stage 2||0
920602|NCT01562275|2226503|P10|COMPLETED|Stage 2||0
920603|NCT01562275|2226504|P9|COMPLETED|Stage 2||0
920604|NCT01562275|2226505|P8|COMPLETED|Stage 2||0
920605|NCT01562275|2226506|P7|COMPLETED|Stage 2||0
920606|NCT01562275|2226507|P6|COMPLETED|Stage 2||0
920607|NCT01562275|2226508|P5|COMPLETED|Stage 2||0
920608|NCT01562275|2226509|P4|COMPLETED|Stage 2||0
920609|NCT01562275|2226510|P3|COMPLETED|Stage 2||0
920610|NCT01562275|2226511|P2|COMPLETED|Stage 2||0
920611|NCT01562275|2226512|P1|COMPLETED|Stage 2||0
920612|NCT01562275|2226500|P13|STARTED|Stage 2||5
920613|NCT01562275|2226501|P12|STARTED|Stage 2||14
920614|NCT01562275|2226502|P11|STARTED|Stage 2||0
920615|NCT01562275|2226503|P10|STARTED|Stage 2||0
920616|NCT01562275|2226504|P9|STARTED|Stage 2||0
920617|NCT01562275|2226505|P8|STARTED|Stage 2||0
920618|NCT01562275|2226506|P7|STARTED|Stage 2||0
920619|NCT01562275|2226507|P6|STARTED|Stage 2||0
920620|NCT01562275|2226508|P5|STARTED|Stage 2||0
920621|NCT01562275|2226509|P4|STARTED|Stage 2||0
920622|NCT01562275|2226510|P3|STARTED|Stage 2||0
920623|NCT01562275|2226511|P2|STARTED|Stage 2||0
920624|NCT01562275|2226512|P1|STARTED|Stage 2||0
920625|NCT01562275|2226500|P13|NOT COMPLETED|Stage 1||0
920626|NCT01562275|2226501|P12|NOT COMPLETED|Stage 1||0
920627|NCT01562275|2226502|P11|NOT COMPLETED|Stage 1||3
920628|NCT01562275|2226503|P10|NOT COMPLETED|Stage 1||7
920629|NCT01562275|2226504|P9|NOT COMPLETED|Stage 1||3
920630|NCT01562275|2226505|P8|NOT COMPLETED|Stage 1||7
920631|NCT01562275|2226506|P7|NOT COMPLETED|Stage 1||3
920632|NCT01562275|2226507|P6|NOT COMPLETED|Stage 1||4
920633|NCT01562275|2226508|P5|NOT COMPLETED|Stage 1||4
920634|NCT01562275|2226509|P4|NOT COMPLETED|Stage 1||4
920635|NCT01562275|2226510|P3|NOT COMPLETED|Stage 1||3
920636|NCT01562275|2226511|P2|NOT COMPLETED|Stage 1||7
920637|NCT01562275|2226512|P1|NOT COMPLETED|Stage 1||3
920638|NCT01562275|2226500|P13|COMPLETED|Stage 1||0
920639|NCT01562275|2226501|P12|COMPLETED|Stage 1||0
920640|NCT01562275|2226502|P11|COMPLETED|Stage 1||0
920641|NCT01562275|2226503|P10|COMPLETED|Stage 1||0
920642|NCT01562275|2226504|P9|COMPLETED|Stage 1||0
920643|NCT01562275|2226505|P8|COMPLETED|Stage 1||0
920644|NCT01562275|2226506|P7|COMPLETED|Stage 1||0
920645|NCT01562275|2226507|P6|COMPLETED|Stage 1||0
920646|NCT01562275|2226508|P5|COMPLETED|Stage 1||0
920647|NCT01562275|2226509|P4|COMPLETED|Stage 1||0
920648|NCT01562275|2226510|P3|COMPLETED|Stage 1||0
920649|NCT01562275|2226511|P2|COMPLETED|Stage 1||0
920650|NCT01562275|2226512|P1|COMPLETED|Stage 1||0
920651|NCT01562275|2226500|P13|STARTED|Stage 1||0
920652|NCT01562275|2226501|P12|STARTED|Stage 1||0
920653|NCT01562275|2226502|P11|STARTED|Stage 1||3
920654|NCT01562275|2226503|P10|STARTED|Stage 1||7
920655|NCT01562275|2226504|P9|STARTED|Stage 1||3
920656|NCT01562275|2226505|P8|STARTED|Stage 1||7
920657|NCT01562275|2226506|P7|STARTED|Stage 1||3
920658|NCT01562275|2226507|P6|STARTED|Stage 1||4
920659|NCT01562275|2226508|P5|STARTED|Stage 1||4
920660|NCT01562275|2226509|P4|STARTED|Stage 1||4
920661|NCT01562275|2226510|P3|STARTED|Stage 1||3
920662|NCT01562275|2226511|P2|STARTED|Stage 1||7
920663|NCT01562275|2226512|P1|STARTED|Stage 1||3
920664|NCT01562132|2226644|P2|NOT COMPLETED|Overall Study||0
920665|NCT01562132|2226645|P1|NOT COMPLETED|Overall Study||0
920666|NCT01562132|2226644|P2|COMPLETED|Overall Study||3
920667|NCT01562132|2226645|P1|COMPLETED|Overall Study||3
920668|NCT01562132|2226644|P2|STARTED|Overall Study||3
920669|NCT01562132|2226645|P1|STARTED|Overall Study||3
920670|NCT01561898|2226655|P4|NOT COMPLETED|Overall Study||20
920671|NCT01561898|2226656|P3|NOT COMPLETED|Overall Study||44
920672|NCT01561898|2226657|P2|NOT COMPLETED|Overall Study||41
920673|NCT01561898|2226658|P1|NOT COMPLETED|Overall Study||2
920674|NCT01561898|2226655|P4|COMPLETED|Overall Study||12
920675|NCT01561898|2226656|P3|COMPLETED|Overall Study||53
920676|NCT01561898|2226657|P2|COMPLETED|Overall Study||51
920677|NCT01561898|2226658|P1|COMPLETED|Overall Study||5
920678|NCT01561898|2226655|P4|STARTED|Overall Study||32
920679|NCT01561898|2226656|P3|STARTED|Overall Study||97
920680|NCT01561898|2226657|P2|STARTED|Overall Study||92
920681|NCT01561898|2226658|P1|STARTED|Overall Study||7
920682|NCT01561716|2226676|P6|NOT COMPLETED|Overall Study||0
920683|NCT01561716|2226677|P5|NOT COMPLETED|Overall Study||0
920684|NCT01561716|2226678|P4|NOT COMPLETED|Overall Study||0
920685|NCT01561716|2226679|P3|NOT COMPLETED|Overall Study||0
920686|NCT01561716|2226680|P2|NOT COMPLETED|Overall Study||0
920687|NCT01561716|2226681|P1|NOT COMPLETED|Overall Study||0
920688|NCT01561716|2226676|P6|COMPLETED|Overall Study||5
920689|NCT01561716|2226677|P5|COMPLETED|Overall Study||5
920690|NCT01561716|2226678|P4|COMPLETED|Overall Study||5
920691|NCT01561716|2226679|P3|COMPLETED|Overall Study||5
920692|NCT01561716|2226680|P2|COMPLETED|Overall Study||5
920693|NCT01561716|2226681|P1|COMPLETED|Overall Study||5
920694|NCT01561716|2226676|P6|STARTED|Overall Study||5
920695|NCT01561716|2226677|P5|STARTED|Overall Study||5
920696|NCT01561716|2226678|P4|STARTED|Overall Study||5
920697|NCT01561716|2226679|P3|STARTED|Overall Study||5
920698|NCT01561716|2226680|P2|STARTED|Overall Study||5
920699|NCT01561716|2226681|P1|STARTED|Overall Study||5
920700|NCT01561703|2226697|P2|NOT COMPLETED|Overall Study||6
920701|NCT01561703|2226698|P1|NOT COMPLETED|Overall Study||8
920702|NCT01561703|2226697|P2|COMPLETED|Overall Study||24
920703|NCT01561703|2226698|P1|COMPLETED|Overall Study||20
920704|NCT01561703|2226697|P2|STARTED|Overall Study||30
920705|NCT01561703|2226698|P1|STARTED|Overall Study||28
920706|NCT01561560|2226704|P2|NOT COMPLETED|Second Two Weeks of Wear||1
920707|NCT01561560|2226705|P1|NOT COMPLETED|Second Two Weeks of Wear||0
920708|NCT01561560|2226704|P2|COMPLETED|Second Two Weeks of Wear||58
920709|NCT01561560|2226705|P1|COMPLETED|Second Two Weeks of Wear||60
920710|NCT01561560|2226704|P2|STARTED|Second Two Weeks of Wear||59
920711|NCT01561560|2226705|P1|STARTED|Second Two Weeks of Wear||60
920712|NCT01561560|2226704|P2|NOT COMPLETED|First Two Weeks of Wear||2
920713|NCT01561560|2226705|P1|NOT COMPLETED|First Two Weeks of Wear||0
920714|NCT01561560|2226704|P2|COMPLETED|First Two Weeks of Wear||59
920715|NCT01561560|2226705|P1|COMPLETED|First Two Weeks of Wear||60
920716|NCT01561560|2226704|P2|STARTED|First Two Weeks of Wear||61
920717|NCT01561560|2226705|P1|STARTED|First Two Weeks of Wear||60
920718|NCT01561469|2226713|P2|NOT COMPLETED|Overall Study||0
920719|NCT01561469|2226714|P1|NOT COMPLETED|Overall Study||0
920720|NCT01561469|2226713|P2|COMPLETED|Overall Study||87
920721|NCT01561469|2226714|P1|COMPLETED|Overall Study||101
920722|NCT01561469|2226713|P2|STARTED|Overall Study||87
920723|NCT01561469|2226714|P1|STARTED|Overall Study||101
920724|NCT01561313|2226734|P2|NOT COMPLETED|Overall Study||0
920725|NCT01561313|2226735|P1|NOT COMPLETED|Overall Study||2
920726|NCT01561313|2226734|P2|COMPLETED|Overall Study||31
920727|NCT01561313|2226735|P1|COMPLETED|Overall Study||31
920728|NCT01561313|2226734|P2|STARTED|Overall Study||31
920729|NCT01561313|2226735|P1|STARTED|Overall Study||33
920730|NCT01561300|2226753|P2|NOT COMPLETED|Second Intervention||0
920731|NCT01561300|2226754|P1|NOT COMPLETED|Second Intervention||0
920732|NCT01561300|2226753|P2|COMPLETED|Second Intervention||15
920733|NCT01561300|2226754|P1|COMPLETED|Second Intervention||14
920734|NCT01561300|2226753|P2|STARTED|Second Intervention||15
920735|NCT01561300|2226754|P1|STARTED|Second Intervention||14
920736|NCT01561300|2226753|P2|NOT COMPLETED|Washout on Placebo||0
920737|NCT01561300|2226754|P1|NOT COMPLETED|Washout on Placebo||0
920738|NCT01561300|2226753|P2|COMPLETED|Washout on Placebo||15
920739|NCT01561300|2226754|P1|COMPLETED|Washout on Placebo||14
920740|NCT01561300|2226753|P2|STARTED|Washout on Placebo||15
920741|NCT01561300|2226754|P1|STARTED|Washout on Placebo||14
920742|NCT01561300|2226753|P2|NOT COMPLETED|First Intervention||0
920743|NCT01561300|2226754|P1|NOT COMPLETED|First Intervention||0
920744|NCT01561300|2226753|P2|COMPLETED|First Intervention||15
920745|NCT01561300|2226754|P1|COMPLETED|First Intervention||14
920746|NCT01561300|2226753|P2|STARTED|First Intervention||15
920747|NCT01561300|2226754|P1|STARTED|First Intervention||14
920748|NCT01561300|2226753|P2|NOT COMPLETED|Run in on Placebo||0
920749|NCT01561300|2226754|P1|NOT COMPLETED|Run in on Placebo||1
920750|NCT01561300|2226753|P2|COMPLETED|Run in on Placebo||15
920751|NCT01561300|2226754|P1|COMPLETED|Run in on Placebo||14
920752|NCT01561300|2226753|P2|STARTED|Run in on Placebo||15
920753|NCT01561300|2226754|P1|STARTED|Run in on Placebo||15
920754|NCT01561079|2226765|P1|NOT COMPLETED|Overall Study||78
920755|NCT01561079|2226765|P1|COMPLETED|Overall Study||49
920756|NCT01561079|2226765|P1|STARTED|Overall Study||127
920757|NCT01560988|2226808|P2|NOT COMPLETED|Second Intervention (Six Weeks)||2
920758|NCT01560988|2226809|P1|NOT COMPLETED|Second Intervention (Six Weeks)||2
920759|NCT01560988|2226808|P2|COMPLETED|Second Intervention (Six Weeks)||22
920760|NCT01560988|2226809|P1|COMPLETED|Second Intervention (Six Weeks)||18
920761|NCT01560988|2226808|P2|STARTED|Second Intervention (Six Weeks)||24
920762|NCT01560988|2226809|P1|STARTED|Second Intervention (Six Weeks)||20
920763|NCT01560988|2226808|P2|NOT COMPLETED|Washout (Six Weeks)||2
920764|NCT01560988|2226809|P1|NOT COMPLETED|Washout (Six Weeks)||2
920765|NCT01560988|2226808|P2|COMPLETED|Washout (Six Weeks)||24
920766|NCT01560988|2226809|P1|COMPLETED|Washout (Six Weeks)||20
920767|NCT01560988|2226808|P2|STARTED|Washout (Six Weeks)||26
920768|NCT01560988|2226809|P1|STARTED|Washout (Six Weeks)||22
920769|NCT01560988|2226808|P2|NOT COMPLETED|First Intervention (Six Weeks)||4
920770|NCT01560988|2226809|P1|NOT COMPLETED|First Intervention (Six Weeks)||10
920771|NCT01560988|2226808|P2|COMPLETED|First Intervention (Six Weeks)||26
920772|NCT01560988|2226809|P1|COMPLETED|First Intervention (Six Weeks)||22
920773|NCT01560988|2226808|P2|STARTED|First Intervention (Six Weeks)||30
920774|NCT01560988|2226809|P1|STARTED|First Intervention (Six Weeks)||32
920775|NCT01560975|2226827|P1|NOT COMPLETED|Overall Study||0
920776|NCT01560975|2226827|P1|COMPLETED|Overall Study||10
920777|NCT01560975|2226827|P1|STARTED|Overall Study||10
920778|NCT01560819|2226842|P2|NOT COMPLETED|Overall Study||0
920779|NCT01560819|2226843|P1|NOT COMPLETED|Overall Study||1
920780|NCT01560819|2226842|P2|COMPLETED|Overall Study||10
920781|NCT01560819|2226843|P1|COMPLETED|Overall Study||9
920782|NCT01560819|2226842|P2|STARTED|Overall Study||10
920783|NCT01560819|2226843|P1|STARTED|Overall Study||10
920784|NCT01560507|2226850|P3|NOT COMPLETED|Overall Study||2
920785|NCT01560507|2226851|P2|NOT COMPLETED|Overall Study||2
920786|NCT01560507|2226852|P1|NOT COMPLETED|Overall Study||4
920787|NCT01560507|2226850|P3|COMPLETED|Overall Study||0
920788|NCT01560507|2226851|P2|COMPLETED|Overall Study||0
920789|NCT01560507|2226852|P1|COMPLETED|Overall Study||1
920790|NCT01560507|2226850|P3|STARTED|Overall Study||2
920791|NCT01560507|2226851|P2|STARTED|Overall Study||2
920792|NCT01560507|2226852|P1|STARTED|Overall Study||5
920793|NCT01560429|2226865|P2|NOT COMPLETED|Overall Study||6
920794|NCT01560429|2226866|P1|NOT COMPLETED|Overall Study||3
920795|NCT01560429|2226865|P2|COMPLETED|Overall Study||20
920796|NCT01560429|2226866|P1|COMPLETED|Overall Study||23
920797|NCT01560429|2226865|P2|STARTED|Overall Study||26
920798|NCT01560429|2226866|P1|STARTED|Overall Study||26
920799|NCT01560403|2226876|P2|NOT COMPLETED|Overall Study||1
920800|NCT01560403|2226877|P1|NOT COMPLETED|Overall Study||0
920801|NCT01560403|2226876|P2|COMPLETED|Overall Study||8
920802|NCT01560403|2226877|P1|COMPLETED|Overall Study||5
920803|NCT01560403|2226876|P2|STARTED|Overall Study||9
920804|NCT01560403|2226877|P1|STARTED|Overall Study||5
920805|NCT01560260|2226883|P1|NOT COMPLETED|Overall Study||0
920806|NCT01560260|2226883|P1|COMPLETED|Overall Study||20
920807|NCT01560260|2226883|P1|STARTED|Overall Study||20
920808|NCT01560234|2226895|P8|NOT COMPLETED|Overall Study||2
920809|NCT01560234|2226896|P7|NOT COMPLETED|Overall Study||0
920810|NCT01560234|2226897|P6|NOT COMPLETED|Overall Study||2
920811|NCT01560234|2226898|P5|NOT COMPLETED|Overall Study||0
920812|NCT01560234|2226899|P4|NOT COMPLETED|Overall Study||0
920813|NCT01560234|2226900|P3|NOT COMPLETED|Overall Study||1
920814|NCT01560234|2226901|P2|NOT COMPLETED|Overall Study||0
920815|NCT01560234|2226902|P1|NOT COMPLETED|Overall Study||3
920816|NCT01560234|2226895|P8|COMPLETED|Overall Study||6
920817|NCT01560234|2226896|P7|COMPLETED|Overall Study||4
920818|NCT01560234|2226897|P6|COMPLETED|Overall Study||2
920819|NCT01560234|2226898|P5|COMPLETED|Overall Study||4
920820|NCT01560234|2226899|P4|COMPLETED|Overall Study||3
920821|NCT01560234|2226900|P3|COMPLETED|Overall Study||3
920822|NCT01560234|2226901|P2|COMPLETED|Overall Study||4
920823|NCT01560234|2226902|P1|COMPLETED|Overall Study||13
920824|NCT01560234|2226895|P8|STARTED|Overall Study||8
920825|NCT01560234|2226896|P7|STARTED|Overall Study||4
920826|NCT01560234|2226897|P6|STARTED|Overall Study||4
920827|NCT01560234|2226898|P5|STARTED|Overall Study||4
920828|NCT01560234|2226899|P4|STARTED|Overall Study||3
920829|NCT01560234|2226900|P3|STARTED|Overall Study||4
920830|NCT01560234|2226901|P2|STARTED|Overall Study||4
920831|NCT01560234|2226902|P1|STARTED|Overall Study||16
920832|NCT01560143|2226976|P1|NOT COMPLETED|Overall Study||0
920833|NCT01560143|2226976|P1|COMPLETED|Overall Study||12
920834|NCT01560143|2226976|P1|STARTED|Overall Study||12
920835|NCT01559935|2226980|P1|NOT COMPLETED|Maintenance Phase||54
920836|NCT01559935|2226980|P1|COMPLETED|Maintenance Phase||0
920837|NCT01559935|2226980|P1|STARTED|Maintenance Phase||54
920838|NCT01559935|2226980|P1|NOT COMPLETED|BiRD Phase||4
920839|NCT01559935|2226980|P1|COMPLETED|BiRD Phase||54
920840|NCT01559935|2226980|P1|STARTED|BiRD Phase||58
920841|NCT01559935|2226980|P1|NOT COMPLETED|Car Phase||14
920842|NCT01559935|2226980|P1|COMPLETED|Car Phase||58
920843|NCT01559935|2226980|P1|STARTED|Car Phase||72
920844|NCT01559922|2226990|P2|NOT COMPLETED|Overall Study||10
920845|NCT01559922|2226991|P1|NOT COMPLETED|Overall Study||4
920846|NCT01559922|2226990|P2|COMPLETED|Overall Study||87
920847|NCT01559922|2226991|P1|COMPLETED|Overall Study||46
920848|NCT01559922|2226990|P2|STARTED|Overall Study||97
920849|NCT01559922|2226991|P1|STARTED|Overall Study||50
920850|NCT01559857|2226999|P2|NOT COMPLETED|Overall Study||0
920851|NCT01559857|2227000|P1|NOT COMPLETED|Overall Study||0
920852|NCT01559857|2226999|P2|COMPLETED|Overall Study||18
920853|NCT01559857|2227000|P1|COMPLETED|Overall Study||19
920854|NCT01559857|2226999|P2|STARTED|Overall Study||18
920855|NCT01559857|2227000|P1|STARTED|Overall Study||19
920856|NCT01559844|2227016|P1|NOT COMPLETED|Overall Study||25
920857|NCT01559844|2227016|P1|COMPLETED|Overall Study||36
920858|NCT01559844|2227016|P1|STARTED|Overall Study||61
920859|NCT01559675|2227029|P2|NOT COMPLETED|Overall Study||14
920860|NCT01559675|2227030|P1|NOT COMPLETED|Overall Study||15
920861|NCT01559675|2227029|P2|COMPLETED|Overall Study||49
920862|NCT01559675|2227030|P1|COMPLETED|Overall Study||43
920863|NCT01559675|2227029|P2|STARTED|Overall Study||63
920864|NCT01559675|2227030|P1|STARTED|Overall Study||58
920865|NCT01559649|2227038|P2|NOT COMPLETED|Overall Study||6
920866|NCT01559649|2227039|P1|NOT COMPLETED|Overall Study||19
920867|NCT01559649|2227038|P2|COMPLETED|Overall Study||9
920868|NCT01559649|2227039|P1|COMPLETED|Overall Study|Screening not completed in 11, VFSS not completed in 2, 6 excluded from analysis. N=250 analyzed|250
920869|NCT01559649|2227038|P2|STARTED|Overall Study|Started with 10 nurses. As an RN dropped out due to scheduling, etc, RN replaced with another RN|15
920870|NCT01559649|2227039|P1|STARTED|Overall Study||269
920871|NCT01559506|2227052|P2|NOT COMPLETED|Overall Study||3
920872|NCT01559506|2227053|P1|NOT COMPLETED|Overall Study||0
920873|NCT01559506|2227052|P2|COMPLETED|Overall Study||18
920874|NCT01559506|2227053|P1|COMPLETED|Overall Study||20
920875|NCT01559506|2227052|P2|STARTED|Overall Study||21
920876|NCT01559506|2227053|P1|STARTED|Overall Study||20
920877|NCT01559454|2227061|P2|NOT COMPLETED|Overall Study||6
920878|NCT01559454|2227062|P1|NOT COMPLETED|Overall Study||3
920879|NCT01559454|2227061|P2|COMPLETED|Overall Study||4
920880|NCT01559454|2227062|P1|COMPLETED|Overall Study||6
920881|NCT01559454|2227061|P2|STARTED|Overall Study||10
920882|NCT01559454|2227062|P1|STARTED|Overall Study||9
920883|NCT01559311|2227081|P3|NOT COMPLETED|Overall Study||8
920884|NCT01559311|2227082|P2|NOT COMPLETED|Overall Study||6
920885|NCT01559311|2227083|P1|NOT COMPLETED|Overall Study||3
920886|NCT01559311|2227081|P3|COMPLETED|Overall Study|12-Month|26
920887|NCT01559311|2227082|P2|COMPLETED|Overall Study|12-Month|28
920888|NCT01559311|2227083|P1|COMPLETED|Overall Study|12-Month|27
920889|NCT01559311|2227081|P3|6-Month|Overall Study||28
920890|NCT01559311|2227082|P2|6-Month|Overall Study||33
920891|NCT01559311|2227083|P1|6-Month|Overall Study||27
920892|NCT01559311|2227081|P3|3-Month|Overall Study||29
920893|NCT01559311|2227082|P2|3-Month|Overall Study||34
920894|NCT01559311|2227083|P1|3-Month|Overall Study||27
920895|NCT01559311|2227081|P3|1-Month|Overall Study||29
920896|NCT01559311|2227082|P2|1-Month|Overall Study||34
920897|NCT01559311|2227083|P1|1-Month|Overall Study||27
920898|NCT01559311|2227081|P3|Implant|Overall Study||32
920899|NCT01559311|2227082|P2|Implant|Overall Study||34
920900|NCT01559311|2227083|P1|Implant|Overall Study||28
920901|NCT01559311|2227081|P3|STARTED|Overall Study|Enrollment & Baseline|34
920902|NCT01559311|2227082|P2|STARTED|Overall Study|Enrollment & Baseline|34
920903|NCT01559311|2227083|P1|STARTED|Overall Study|Enrollment & Baseline|30
920904|NCT01559116|2227094|P1|NOT COMPLETED|Overall Study||26
920905|NCT01559116|2227094|P1|COMPLETED|Overall Study|Completed all 4 treatment periods|193
920906|NCT01559116|2227094|P1|STARTED|Overall Study|Randomised|219
920907|NCT01559064|2227165|P3|NOT COMPLETED|Overall Study||2
920908|NCT01559064|2227166|P2|NOT COMPLETED|Overall Study||1
920909|NCT01559064|2227167|P1|NOT COMPLETED|Overall Study||1
920910|NCT01559064|2227165|P3|COMPLETED|Overall Study||57
920911|NCT01559064|2227166|P2|COMPLETED|Overall Study||39
920912|NCT01559064|2227167|P1|COMPLETED|Overall Study||15
920913|NCT01559064|2227165|P3|STARTED|Overall Study||59
920914|NCT01559064|2227166|P2|STARTED|Overall Study||40
920915|NCT01559064|2227167|P1|STARTED|Overall Study||16
920916|NCT01559012|2227177|P2|NOT COMPLETED|Overall Study||1
920917|NCT01559012|2227178|P1|NOT COMPLETED|Overall Study||0
920918|NCT01559012|2227177|P2|COMPLETED|Overall Study|Patient N. 2 withdrew from study for alleged side effects at day 1 of placebo cycle.|6
920919|NCT01559012|2227178|P1|COMPLETED|Overall Study||6
920920|NCT01559012|2227177|P2|STARTED|Overall Study|1 more patient added to randomization list to reach the pre-assignment number of treated patients|7
920921|NCT01559012|2227178|P1|STARTED|Overall Study||6
920922|NCT01558791|2227203|P2|NOT COMPLETED|Overall Study||0
920923|NCT01558791|2227204|P1|NOT COMPLETED|Overall Study||0
920924|NCT01558791|2227203|P2|COMPLETED|Overall Study||629
920925|NCT01558791|2227204|P1|COMPLETED|Overall Study||607
920926|NCT01558791|2227203|P2|STARTED|Overall Study||629
920927|NCT01558791|2227204|P1|STARTED|Overall Study||607
920928|NCT01558739|2227214|P1|NOT COMPLETED|Overall Study||17
920929|NCT01558739|2227214|P1|COMPLETED|Overall Study||31
920930|NCT01558739|2227214|P1|STARTED|Overall Study||48
920931|NCT01558700|2227228|P2|NOT COMPLETED|Overall Study||0
920932|NCT01558700|2227229|P1|NOT COMPLETED|Overall Study||0
920933|NCT01558700|2227228|P2|COMPLETED|Overall Study||21
920934|NCT01558700|2227229|P1|COMPLETED|Overall Study||19
920935|NCT01558700|2227228|P2|STARTED|Overall Study||21
920936|NCT01558700|2227229|P1|STARTED|Overall Study||19
920937|NCT01558674|2227239|P2|NOT COMPLETED|Part 2||0
920938|NCT01558674|2227240|P1|NOT COMPLETED|Part 2||0
920939|NCT01558674|2227239|P2|COMPLETED|Part 2||0
920940|NCT01558674|2227240|P1|COMPLETED|Part 2||0
920941|NCT01558674|2227239|P2|STARTED|Part 2||0
920942|NCT01558674|2227240|P1|STARTED|Part 2||0
920943|NCT01558674|2227239|P2|NOT COMPLETED|Part 1||0
920944|NCT01558674|2227240|P1|NOT COMPLETED|Part 1||11
920945|NCT01558674|2227239|P2|COMPLETED|Part 1||0
920946|NCT01558674|2227240|P1|COMPLETED|Part 1||0
920947|NCT01558674|2227239|P2|STARTED|Part 1||0
920948|NCT01558674|2227240|P1|STARTED|Part 1||11
920949|NCT01558596|2227286|P2|NOT COMPLETED|Overall Study||1
920950|NCT01558596|2227287|P1|NOT COMPLETED|Overall Study||3
920951|NCT01558596|2227286|P2|COMPLETED|Overall Study||100
920952|NCT01558596|2227287|P1|COMPLETED|Overall Study||101
920953|NCT01558596|2227286|P2|STARTED|Overall Study||101
920954|NCT01558596|2227287|P1|STARTED|Overall Study||104
920955|NCT01558492|2227293|P1|NOT COMPLETED|Overall Study||0
920956|NCT01558492|2227293|P1|COMPLETED|Overall Study||3
920957|NCT01558492|2227293|P1|STARTED|Overall Study||3
920958|NCT01558297|2227302|P3|NOT COMPLETED|Overall Study||1
920959|NCT01558297|2227303|P2|NOT COMPLETED|Overall Study||2
920960|NCT01558297|2227304|P1|NOT COMPLETED|Overall Study||2
920961|NCT01558297|2227302|P3|COMPLETED|Overall Study||29
920962|NCT01558297|2227303|P2|COMPLETED|Overall Study||27
920963|NCT01558297|2227304|P1|COMPLETED|Overall Study||28
920964|NCT01558297|2227302|P3|STARTED|Overall Study||30
920965|NCT01558297|2227303|P2|STARTED|Overall Study||29
920966|NCT01558297|2227304|P1|STARTED|Overall Study||30
920967|NCT01558271|2227321|P3|NOT COMPLETED|Overall Study||17
920968|NCT01558271|2227322|P2|NOT COMPLETED|Overall Study||11
920969|NCT01558271|2227323|P1|NOT COMPLETED|Overall Study||18
920970|NCT01558271|2227321|P3|COMPLETED|Overall Study||124
920971|NCT01558271|2227322|P2|COMPLETED|Overall Study||59
920972|NCT01558271|2227323|P1|COMPLETED|Overall Study||263
920973|NCT01558271|2227321|P3|Completed 26 Weeks|Overall Study||128
920974|NCT01558271|2227322|P2|Completed 26 Weeks|Overall Study||63
920975|NCT01558271|2227323|P1|Completed 26 Weeks|Overall Study||271
920976|NCT01558271|2227321|P3|Received at Least 1 Dose of Study Drug|Overall Study||137
920977|NCT01558271|2227322|P2|Received at Least 1 Dose of Study Drug|Overall Study||70
920978|NCT01558271|2227323|P1|Received at Least 1 Dose of Study Drug|Overall Study||280
920979|NCT01558271|2227321|P3|STARTED|Overall Study||141
920980|NCT01558271|2227322|P2|STARTED|Overall Study||70
920981|NCT01558271|2227323|P1|STARTED|Overall Study||281
920982|NCT01558128|2227385|P1|NOT COMPLETED|Overall Study||0
920983|NCT01558128|2227385|P1|COMPLETED|Overall Study||1
920984|NCT01558128|2227385|P1|STARTED|Overall Study||1
920985|NCT01558089|2227389|P1|NOT COMPLETED|Overall Study||13
920986|NCT01558089|2227389|P1|COMPLETED|Overall Study||63
920987|NCT01558089|2227389|P1|STARTED|Overall Study||76
920988|NCT01557959|2227400|P1|NOT COMPLETED|Overall Study||0
920989|NCT01557959|2227400|P1|COMPLETED|Overall Study||45
920990|NCT01557959|2227400|P1|STARTED|Overall Study||45
920991|NCT01557946|2227406|P2|NOT COMPLETED|Overall Study||0
920992|NCT01557946|2227407|P1|NOT COMPLETED|Overall Study||3
920993|NCT01557946|2227406|P2|COMPLETED|Overall Study|2 subjects with unusable imaging data.|12
920994|NCT01557946|2227407|P1|COMPLETED|Overall Study|20 consented and scanned - 1 subject's data not used due to ongoing neurological condition.|17
920995|NCT01557946|2227406|P2|STARTED|Overall Study||12
920996|NCT01557946|2227407|P1|STARTED|Overall Study||20
920997|NCT01557920|2227413|P2|NOT COMPLETED|Overall Study||3
920998|NCT01557920|2227414|P1|NOT COMPLETED|Overall Study||3
920999|NCT01557920|2227413|P2|COMPLETED|Overall Study||6
921000|NCT01557920|2227414|P1|COMPLETED|Overall Study||6
921001|NCT01557920|2227413|P2|STARTED|Overall Study||9
921002|NCT01557920|2227414|P1|STARTED|Overall Study||9
921003|NCT01557894|2227449|P2|NOT COMPLETED|Overall Study||5
921004|NCT01557894|2227450|P1|NOT COMPLETED|Overall Study||3
921005|NCT01557894|2227449|P2|COMPLETED|Overall Study||33
921006|NCT01557894|2227450|P1|COMPLETED|Overall Study||35
921007|NCT01557894|2227449|P2|STARTED|Overall Study||38
921008|NCT01557894|2227450|P1|STARTED|Overall Study||38
921009|NCT01557868|2227466|P2|NOT COMPLETED|Overall Study||30
921010|NCT01557868|2227467|P1|NOT COMPLETED|Overall Study||27
921011|NCT01557868|2227466|P2|COMPLETED|Overall Study||65
921012|NCT01557868|2227467|P1|COMPLETED|Overall Study||76
921013|NCT01557868|2227466|P2|STARTED|Overall Study||95
921014|NCT01557868|2227467|P1|STARTED|Overall Study||103
921015|NCT01557842|2227477|P2|NOT COMPLETED|Overall Study||6
921016|NCT01557842|2227478|P1|NOT COMPLETED|Overall Study||9
921017|NCT01557842|2227477|P2|COMPLETED|Overall Study||0
921018|NCT01557842|2227478|P1|COMPLETED|Overall Study||0
921019|NCT01557842|2227477|P2|STARTED|Overall Study||6
921020|NCT01557842|2227478|P1|STARTED|Overall Study||9
921021|NCT01557699|2227489|P3|NOT COMPLETED|Overall Study||0
921022|NCT01557699|2227490|P2|NOT COMPLETED|Overall Study||0
921023|NCT01557699|2227491|P1|NOT COMPLETED|Overall Study||0
921024|NCT01557699|2227489|P3|COMPLETED|Overall Study||20
921025|NCT01557699|2227490|P2|COMPLETED|Overall Study||20
921026|NCT01557699|2227491|P1|COMPLETED|Overall Study||20
921027|NCT01557699|2227489|P3|STARTED|Overall Study||20
921028|NCT01557699|2227490|P2|STARTED|Overall Study||20
921029|NCT01557699|2227491|P1|STARTED|Overall Study||20
921030|NCT01557595|2227523|P1|NOT COMPLETED|Overall Study||8
921031|NCT01557595|2227523|P1|COMPLETED|Overall Study||14
921032|NCT01557595|2227523|P1|STARTED|Overall Study||22
921033|NCT01557582|2227527|P1|NOT COMPLETED|Overall Study||6
921034|NCT01557582|2227527|P1|COMPLETED|Overall Study||97
921035|NCT01557582|2227527|P1|STARTED|Overall Study||103
921036|NCT01557569|2227535|P2|NOT COMPLETED|Overall Study||7
921037|NCT01557569|2227536|P1|NOT COMPLETED|Overall Study||5
921038|NCT01557569|2227535|P2|COMPLETED|Overall Study||0
921039|NCT01557569|2227536|P1|COMPLETED|Overall Study||1
921040|NCT01557569|2227535|P2|Completed 2-wk Residential Stay|Overall Study||1
921041|NCT01557569|2227536|P1|Completed 2-wk Residential Stay|Overall Study||3
921042|NCT01557569|2227535|P2|STARTED|Overall Study|Those who received at least one dose of medication|7
921043|NCT01557569|2227536|P1|STARTED|Overall Study|Those who received at least one dose of medication|6
921044|NCT01557504|2227544|P2|NOT COMPLETED|Overall Study||0
921045|NCT01557504|2227545|P1|NOT COMPLETED|Overall Study||1
921046|NCT01557504|2227544|P2|COMPLETED|Overall Study||12
921047|NCT01557504|2227545|P1|COMPLETED|Overall Study||12
921048|NCT01557504|2227544|P2|STARTED|Overall Study||12
921049|NCT01557504|2227545|P1|STARTED|Overall Study||13
921050|NCT01557348|2227570|P2|NOT COMPLETED|Overall Study||90
921051|NCT01557348|2227571|P1|NOT COMPLETED|Overall Study||80
921052|NCT01557348|2227570|P2|COMPLETED|Overall Study||417
921053|NCT01557348|2227571|P1|COMPLETED|Overall Study||524
921054|NCT01557348|2227570|P2|Safety Population|Overall Study||507
921055|NCT01557348|2227571|P1|Safety Population|Overall Study||604
921056|NCT01557348|2227570|P2|STARTED|Overall Study||507
921057|NCT01557348|2227571|P1|STARTED|Overall Study||604
921058|NCT01557322|2227613|P2|NOT COMPLETED|Overall Study||0
921059|NCT01557322|2227614|P1|NOT COMPLETED|Overall Study||0
921060|NCT01557322|2227613|P2|COMPLETED|Overall Study||1543
921061|NCT01557322|2227614|P1|COMPLETED|Overall Study||211
921062|NCT01557322|2227613|P2|STARTED|Overall Study||1543
921063|NCT01557322|2227614|P1|STARTED|Overall Study||211
921064|NCT01557283|2227688|P1|NOT COMPLETED|Overall Study||44
921065|NCT01557283|2227688|P1|COMPLETED|Overall Study||96
921066|NCT01557283|2227688|P1|STARTED|Overall Study||140
921075|NCT01556997|2227716|P3|NOT COMPLETED|Overall Study||32
921076|NCT01556997|2227717|P2|NOT COMPLETED|Overall Study||28
921077|NCT01556997|2227718|P1|NOT COMPLETED|Overall Study||26
921078|NCT01556997|2227716|P3|COMPLETED|Overall Study||246
921079|NCT01556997|2227717|P2|COMPLETED|Overall Study||252
921080|NCT01556997|2227718|P1|COMPLETED|Overall Study||253
921081|NCT01556997|2227716|P3|STARTED|Overall Study||278
921082|NCT01556997|2227717|P2|STARTED|Overall Study||280
921083|NCT01556997|2227718|P1|STARTED|Overall Study||279
921084|NCT01556932|2227729|P2|NOT COMPLETED|Second Treament||0
921085|NCT01556932|2227730|P1|NOT COMPLETED|Second Treament||0
921086|NCT01556932|2227729|P2|COMPLETED|Second Treament||8
921087|NCT01556932|2227730|P1|COMPLETED|Second Treament||12
921088|NCT01556932|2227729|P2|Recieved|Second Treament||8
921089|NCT01556932|2227730|P1|Recieved|Second Treament||12
921090|NCT01556932|2227729|P2|STARTED|Second Treament||8
921091|NCT01556932|2227730|P1|STARTED|Second Treament||12
921092|NCT01556932|2227729|P2|NOT COMPLETED|Time Point 60 Minutes||1
921093|NCT01556932|2227730|P1|NOT COMPLETED|Time Point 60 Minutes||1
921094|NCT01556932|2227729|P2|COMPLETED|Time Point 60 Minutes||8
921095|NCT01556932|2227730|P1|COMPLETED|Time Point 60 Minutes||12
921096|NCT01556932|2227729|P2|Recieved|Time Point 60 Minutes||8
921097|NCT01556932|2227730|P1|Recieved|Time Point 60 Minutes||12
921098|NCT01556932|2227729|P2|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|9
921099|NCT01556932|2227730|P1|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|13
921100|NCT01556932|2227729|P2|NOT COMPLETED|Baseline First Treatment||0
921101|NCT01556932|2227730|P1|NOT COMPLETED|Baseline First Treatment||0
921102|NCT01556932|2227729|P2|COMPLETED|Baseline First Treatment||9
921103|NCT01556932|2227730|P1|COMPLETED|Baseline First Treatment||13
921104|NCT01556932|2227729|P2|Recieved|Baseline First Treatment||9
921105|NCT01556932|2227730|P1|Recieved|Baseline First Treatment||13
921106|NCT01556932|2227729|P2|STARTED|Baseline First Treatment||9
921107|NCT01556932|2227730|P1|STARTED|Baseline First Treatment||13
921108|NCT01556906|2227735|P1|NOT COMPLETED|Overall Study||0
921109|NCT01556906|2227735|P1|COMPLETED|Overall Study||6
921110|NCT01556906|2227735|P1|STARTED|Overall Study||6
921111|NCT01556763|2227756|P3|NOT COMPLETED|Overall Study||0
921112|NCT01556763|2227757|P2|NOT COMPLETED|Overall Study||1
921113|NCT01556763|2227758|P1|NOT COMPLETED|Overall Study||0
921114|NCT01556763|2227756|P3|COMPLETED|Overall Study||8
921115|NCT01556763|2227757|P2|COMPLETED|Overall Study||8
921116|NCT01556763|2227758|P1|COMPLETED|Overall Study||4
921117|NCT01556763|2227756|P3|STARTED|Overall Study||8
921118|NCT01556763|2227757|P2|STARTED|Overall Study||9
921119|NCT01556763|2227758|P1|STARTED|Overall Study||4
921120|NCT01556724|2227796|P2|NOT COMPLETED|Overall Study||0
921121|NCT01556724|2227797|P1|NOT COMPLETED|Overall Study||0
921122|NCT01556724|2227796|P2|COMPLETED|Overall Study||15
921123|NCT01556724|2227797|P1|COMPLETED|Overall Study||15
921124|NCT01556724|2227796|P2|STARTED|Overall Study||15
921125|NCT01556724|2227797|P1|STARTED|Overall Study||15
921126|NCT01556633|2227805|P2|NOT COMPLETED|Overall Study||0
921127|NCT01556633|2227806|P1|NOT COMPLETED|Overall Study||0
921128|NCT01556633|2227805|P2|COMPLETED|Overall Study||6
921129|NCT01556633|2227806|P1|COMPLETED|Overall Study||10
921130|NCT01556633|2227805|P2|STARTED|Overall Study||6
921131|NCT01556633|2227806|P1|STARTED|Overall Study||10
921132|NCT01556594|2227831|P3|NOT COMPLETED|Overall Study||0
921133|NCT01556594|2227832|P2|NOT COMPLETED|Overall Study||0
921134|NCT01556594|2227833|P1|NOT COMPLETED|Overall Study||0
921135|NCT01556594|2227831|P3|COMPLETED|Overall Study||6
921136|NCT01556594|2227832|P2|COMPLETED|Overall Study||2
921137|NCT01556594|2227833|P1|COMPLETED|Overall Study||10
921138|NCT01556594|2227831|P3|STARTED|Overall Study||6
921139|NCT01556594|2227832|P2|STARTED|Overall Study||2
921140|NCT01556594|2227833|P1|STARTED|Overall Study||10
921141|NCT01556451|2227851|P1|NOT COMPLETED|Overall Study||0
921142|NCT01556451|2227851|P1|COMPLETED|Overall Study||180
921143|NCT01556451|2227851|P1|STARTED|Overall Study||180
921144|NCT01556204|2227860|P2|NOT COMPLETED|Overall Study||0
921145|NCT01556204|2227861|P1|NOT COMPLETED|Overall Study||0
921146|NCT01556204|2227860|P2|COMPLETED|Overall Study||38
921147|NCT01556204|2227861|P1|COMPLETED|Overall Study||35
921148|NCT01556204|2227860|P2|STARTED|Overall Study||38
921149|NCT01556204|2227861|P1|STARTED|Overall Study||35
921150|NCT01556165|2227871|P2|NOT COMPLETED|Overall Study||7
921151|NCT01556165|2227872|P1|NOT COMPLETED|Overall Study||12
921152|NCT01556165|2227871|P2|COMPLETED|Overall Study||58
921153|NCT01556165|2227872|P1|COMPLETED|Overall Study||53
921154|NCT01556165|2227871|P2|STARTED|Overall Study||65
921155|NCT01556165|2227872|P1|STARTED|Overall Study||65
921156|NCT01556061|2227886|P2|NOT COMPLETED|Overall Study||0
921157|NCT01556061|2227887|P1|NOT COMPLETED|Overall Study||0
921158|NCT01556061|2227886|P2|COMPLETED|Overall Study||25
921159|NCT01556061|2227887|P1|COMPLETED|Overall Study||25
921160|NCT01556061|2227886|P2|STARTED|Overall Study||25
921161|NCT01556061|2227887|P1|STARTED|Overall Study||25
921162|NCT01555983|2227897|P6|NOT COMPLETED|Overall Study||1
921163|NCT01555983|2227898|P5|NOT COMPLETED|Overall Study||1
921164|NCT01555983|2227899|P4|NOT COMPLETED|Overall Study||0
921165|NCT01555983|2227900|P3|NOT COMPLETED|Overall Study||0
921166|NCT01555983|2227901|P2|NOT COMPLETED|Overall Study||0
921167|NCT01555983|2227902|P1|NOT COMPLETED|Overall Study||1
921168|NCT01555983|2227897|P6|COMPLETED|Overall Study|One subject completed the 6.7%THC session, then dropped out.|6
921169|NCT01555983|2227898|P5|COMPLETED|Overall Study|One subject complete 6.7%THC and placebo sessions, then dropped out|4
921170|NCT01555983|2227899|P4|COMPLETED|Overall Study||7
921171|NCT01555983|2227900|P3|COMPLETED|Overall Study||7
921172|NCT01555983|2227901|P2|COMPLETED|Overall Study||7
921173|NCT01555983|2227902|P1|COMPLETED|Overall Study|One subject only finished the placebo session, then dropped out of study|8
921174|NCT01555983|2227897|P6|STARTED|Overall Study||7
921175|NCT01555983|2227898|P5|STARTED|Overall Study||5
921176|NCT01555983|2227899|P4|STARTED|Overall Study||7
921177|NCT01555983|2227900|P3|STARTED|Overall Study||7
921178|NCT01555983|2227901|P2|STARTED|Overall Study||7
921179|NCT01555983|2227902|P1|STARTED|Overall Study||9
921180|NCT01555931|2227912|P2|NOT COMPLETED|Overall Study||5
921181|NCT01555931|2227913|P1|NOT COMPLETED|Overall Study||2
921182|NCT01555931|2227912|P2|COMPLETED|Overall Study||13
921183|NCT01555931|2227913|P1|COMPLETED|Overall Study||15
921184|NCT01555931|2227912|P2|STARTED|Overall Study||18
921185|NCT01555931|2227913|P1|STARTED|Overall Study||17
921186|NCT01555567|2227925|P4|NOT COMPLETED|Return to Activity||1
921187|NCT01555567|2227926|P3|NOT COMPLETED|Return to Activity||0
921188|NCT01555567|2227927|P2|NOT COMPLETED|Return to Activity||2
921189|NCT01555567|2227928|P1|NOT COMPLETED|Return to Activity||1
921190|NCT01555567|2227925|P4|COMPLETED|Return to Activity||8
921191|NCT01555567|2227926|P3|COMPLETED|Return to Activity||8
921192|NCT01555567|2227927|P2|COMPLETED|Return to Activity||10
921193|NCT01555567|2227928|P1|COMPLETED|Return to Activity||10
921194|NCT01555567|2227925|P4|STARTED|Return to Activity||9
921195|NCT01555567|2227926|P3|STARTED|Return to Activity||8
921196|NCT01555567|2227927|P2|STARTED|Return to Activity||12
921197|NCT01555567|2227928|P1|STARTED|Return to Activity||11
921198|NCT01555567|2227925|P4|NOT COMPLETED|12 Week||0
921199|NCT01555567|2227926|P3|NOT COMPLETED|12 Week||1
921200|NCT01555567|2227927|P2|NOT COMPLETED|12 Week||1
921201|NCT01555567|2227928|P1|NOT COMPLETED|12 Week||1
921202|NCT01555567|2227925|P4|COMPLETED|12 Week||9
921203|NCT01555567|2227926|P3|COMPLETED|12 Week||8
921204|NCT01555567|2227927|P2|COMPLETED|12 Week||12
921205|NCT01555567|2227928|P1|COMPLETED|12 Week||11
921206|NCT01555567|2227925|P4|STARTED|12 Week||9
921207|NCT01555567|2227926|P3|STARTED|12 Week||9
921208|NCT01555567|2227927|P2|STARTED|12 Week||13
921209|NCT01555567|2227928|P1|STARTED|12 Week||12
921210|NCT01555463|2227944|P2|NOT COMPLETED|Follow up||45
921211|NCT01555463|2227945|P1|NOT COMPLETED|Follow up||38
921212|NCT01555463|2227944|P2|COMPLETED|Follow up||394
921213|NCT01555463|2227945|P1|COMPLETED|Follow up||409
921214|NCT01555463|2227944|P2|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|439
921215|NCT01555463|2227945|P1|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|447
921216|NCT01555463|2227944|P2|NOT COMPLETED|Treatment||79
921217|NCT01555463|2227945|P1|NOT COMPLETED|Treatment||64
921218|NCT01555463|2227944|P2|COMPLETED|Treatment||399
921219|NCT01555463|2227945|P1|COMPLETED|Treatment||419
921220|NCT01555463|2227944|P2|STARTED|Treatment||478
921221|NCT01555463|2227945|P1|STARTED|Treatment||483
921222|NCT01555164|2227987|P2|NOT COMPLETED|Overall Study||35
921223|NCT01555164|2227988|P1|NOT COMPLETED|Overall Study||40
921224|NCT01555164|2227987|P2|COMPLETED|Overall Study||185
921225|NCT01555164|2227988|P1|COMPLETED|Overall Study||182
921226|NCT01555164|2227987|P2|STARTED|Overall Study||220
921227|NCT01555164|2227988|P1|STARTED|Overall Study||222
921228|NCT01555151|2228002|P4|NOT COMPLETED|Overall Study||10
921229|NCT01555151|2228003|P3|NOT COMPLETED|Overall Study||6
921230|NCT01555151|2228004|P2|NOT COMPLETED|Overall Study||8
921231|NCT01555151|2228005|P1|NOT COMPLETED|Overall Study||13
921232|NCT01555151|2228002|P4|COMPLETED|Overall Study||176
921233|NCT01555151|2228003|P3|COMPLETED|Overall Study||178
921234|NCT01555151|2228004|P2|COMPLETED|Overall Study||173
921235|NCT01555151|2228005|P1|COMPLETED|Overall Study||175
921236|NCT01555151|2228002|P4|Safety Set (SAF)|Overall Study||186
921237|NCT01555151|2228003|P3|Safety Set (SAF)|Overall Study||183
921238|NCT01555151|2228004|P2|Safety Set (SAF)|Overall Study||180
921239|NCT01555151|2228005|P1|Safety Set (SAF)|Overall Study||186
921240|NCT01555151|2228002|P4|STARTED|Overall Study||186
921241|NCT01555151|2228003|P3|STARTED|Overall Study||184
921242|NCT01555151|2228004|P2|STARTED|Overall Study||181
921243|NCT01555151|2228005|P1|STARTED|Overall Study||188
921244|NCT01555138|2228058|P2|NOT COMPLETED|Overall Study||38
921245|NCT01555138|2228059|P1|NOT COMPLETED|Overall Study||47
921246|NCT01555138|2228058|P2|COMPLETED|Overall Study||250
921247|NCT01555138|2228059|P1|COMPLETED|Overall Study||246
921248|NCT01555138|2228058|P2|STARTED|Overall Study||288
921249|NCT01555138|2228059|P1|STARTED|Overall Study||293
921250|NCT01555073|2228089|P4|NOT COMPLETED|Overall Study||5
921251|NCT01555073|2228090|P3|NOT COMPLETED|Overall Study||0
921252|NCT01555073|2228091|P2|NOT COMPLETED|Overall Study||2
921253|NCT01555073|2228092|P1|NOT COMPLETED|Overall Study||1
921254|NCT01555073|2228089|P4|COMPLETED|Overall Study||1
921255|NCT01555073|2228090|P3|COMPLETED|Overall Study||7
921256|NCT01555073|2228091|P2|COMPLETED|Overall Study||1
921257|NCT01555073|2228092|P1|COMPLETED|Overall Study||6
921258|NCT01555073|2228089|P4|STARTED|Overall Study||6
921259|NCT01555073|2228090|P3|STARTED|Overall Study||7
921260|NCT01555073|2228091|P2|STARTED|Overall Study||3
921261|NCT01555073|2228092|P1|STARTED|Overall Study||7
921262|NCT01554982|2228106|P1|NOT COMPLETED|Overall Study||43
921263|NCT01554982|2228106|P1|COMPLETED|Overall Study||125
921264|NCT01554982|2228106|P1|Received Drug|Overall Study||166
921265|NCT01554982|2228106|P1|STARTED|Overall Study||168
921266|NCT01554904|2228119|P1|NOT COMPLETED|Overall Study||4
921267|NCT01554904|2228119|P1|COMPLETED|Overall Study||14
921268|NCT01554904|2228119|P1|Home Sleep Study 2|Overall Study||14
921269|NCT01554904|2228119|P1|Complete 6 Weeks of Facial Training|Overall Study|3 subjects withdrew during training|14
921270|NCT01554904|2228119|P1|Start 6 Weeks of Facial Training|Overall Study|1 participant was found to have obstructive sleep apnea on the home sleep study #1|17
921271|NCT01554904|2228119|P1|Home Sleep Study 1|Overall Study|After informed consent signed.|18
921272|NCT01554904|2228119|P1|STARTED|Overall Study||18
921273|NCT01554891|2228127|P3|NOT COMPLETED|Overall Study||2
921274|NCT01554891|2228128|P2|NOT COMPLETED|Overall Study||5
921275|NCT01554891|2228129|P1|NOT COMPLETED|Overall Study||7
921276|NCT01554891|2228127|P3|COMPLETED|Overall Study||55
921277|NCT01554891|2228128|P2|COMPLETED|Overall Study||115
921278|NCT01554891|2228129|P1|COMPLETED|Overall Study||98
921279|NCT01554891|2228127|P3|STARTED|Overall Study||57
921280|NCT01554891|2228128|P2|STARTED|Overall Study||120
921281|NCT01554891|2228129|P1|STARTED|Overall Study||105
921282|NCT01554579|2228139|P2|NOT COMPLETED|Overall Study||27
921283|NCT01554579|2228140|P1|NOT COMPLETED|Overall Study||10
921284|NCT01554579|2228139|P2|COMPLETED|Overall Study||58
921285|NCT01554579|2228140|P1|COMPLETED|Overall Study||76
921286|NCT01554579|2228139|P2|STARTED|Overall Study||85
921287|NCT01554579|2228140|P1|STARTED|Overall Study||86
921288|NCT01554241|2228154|P4|NOT COMPLETED|Overall Study||1
921289|NCT01554241|2228155|P3|NOT COMPLETED|Overall Study||4
921290|NCT01554241|2228156|P2|NOT COMPLETED|Overall Study||1
921291|NCT01554241|2228157|P1|NOT COMPLETED|Overall Study||3
921292|NCT01554241|2228154|P4|COMPLETED|Overall Study||13
921293|NCT01554241|2228155|P3|COMPLETED|Overall Study||20
921294|NCT01554241|2228156|P2|COMPLETED|Overall Study||19
921295|NCT01554241|2228157|P1|COMPLETED|Overall Study||20
921296|NCT01554241|2228154|P4|STARTED|Overall Study||14
921297|NCT01554241|2228155|P3|STARTED|Overall Study||24
921298|NCT01554241|2228156|P2|STARTED|Overall Study||20
921299|NCT01554241|2228157|P1|STARTED|Overall Study||23
921300|NCT01554176|2228173|P5|NOT COMPLETED|Run-out Phase||0
921301|NCT01554176|2228174|P4|NOT COMPLETED|Run-out Phase||1
921302|NCT01554176|2228175|P3|NOT COMPLETED|Run-out Phase||0
921303|NCT01554176|2228176|P2|NOT COMPLETED|Run-out Phase||0
921304|NCT01554176|2228177|P1|NOT COMPLETED|Run-out Phase||0
921305|NCT01554176|2228173|P5|COMPLETED|Run-out Phase||59
921306|NCT01554176|2228174|P4|COMPLETED|Run-out Phase||27
921307|NCT01554176|2228175|P3|COMPLETED|Run-out Phase||29
921308|NCT01554176|2228176|P2|COMPLETED|Run-out Phase||0
921309|NCT01554176|2228177|P1|COMPLETED|Run-out Phase||0
921310|NCT01554176|2228173|P5|Treated|Run-out Phase||59
921311|NCT01554176|2228174|P4|Treated|Run-out Phase||28
921312|NCT01554176|2228175|P3|Treated|Run-out Phase||29
921313|NCT01554176|2228176|P2|Treated|Run-out Phase||0
921314|NCT01554176|2228177|P1|Treated|Run-out Phase||0
921315|NCT01554176|2228173|P5|STARTED|Run-out Phase||59
921316|NCT01554176|2228174|P4|STARTED|Run-out Phase||28
921317|NCT01554176|2228175|P3|STARTED|Run-out Phase||29
921318|NCT01554176|2228176|P2|STARTED|Run-out Phase||0
921319|NCT01554176|2228177|P1|STARTED|Run-out Phase||0
921320|NCT01554176|2228173|P5|NOT COMPLETED|Treatment Phase||0
921321|NCT01554176|2228174|P4|NOT COMPLETED|Treatment Phase||0
921322|NCT01554176|2228175|P3|NOT COMPLETED|Treatment Phase||0
921323|NCT01554176|2228176|P2|NOT COMPLETED|Treatment Phase||5
921324|NCT01554176|2228177|P1|NOT COMPLETED|Treatment Phase||8
921325|NCT01554176|2228173|P5|COMPLETED|Treatment Phase||0
921326|NCT01554176|2228174|P4|COMPLETED|Treatment Phase||0
921327|NCT01554176|2228175|P3|COMPLETED|Treatment Phase||0
921328|NCT01554176|2228176|P2|COMPLETED|Treatment Phase||59
921329|NCT01554176|2228177|P1|COMPLETED|Treatment Phase||57
921330|NCT01554176|2228173|P5|Treated|Treatment Phase||0
921331|NCT01554176|2228174|P4|Treated|Treatment Phase||0
921332|NCT01554176|2228175|P3|Treated|Treatment Phase||0
921333|NCT01554176|2228176|P2|Treated|Treatment Phase||64
921334|NCT01554176|2228177|P1|Treated|Treatment Phase||64
921335|NCT01554176|2228173|P5|STARTED|Treatment Phase||0
921336|NCT01554176|2228174|P4|STARTED|Treatment Phase||0
921337|NCT01554176|2228175|P3|STARTED|Treatment Phase||0
921338|NCT01554176|2228176|P2|STARTED|Treatment Phase||64
921339|NCT01554176|2228177|P1|STARTED|Treatment Phase||65
921340|NCT01554163|2228204|P2|NOT COMPLETED|Overall Study||10
921341|NCT01554163|2228205|P1|NOT COMPLETED|Overall Study||8
921342|NCT01554163|2228204|P2|COMPLETED|Overall Study||109
921343|NCT01554163|2228205|P1|COMPLETED|Overall Study||112
921344|NCT01554163|2228204|P2|Number Treated|Overall Study||119
921345|NCT01554163|2228205|P1|Number Treated|Overall Study||119
921346|NCT01554163|2228204|P2|STARTED|Overall Study||119
921347|NCT01554163|2228205|P1|STARTED|Overall Study||120
921348|NCT01553851|2228223|P1|NOT COMPLETED|Overall Study||3
921349|NCT01553851|2228223|P1|COMPLETED|Overall Study||17
921350|NCT01553851|2228223|P1|STARTED|Overall Study||20
921351|NCT01552772|2228235|P1|NOT COMPLETED|Overall Study||4
921352|NCT01552772|2228235|P1|COMPLETED|Overall Study|Participants who completed the Day 28 visit were defined as completers for the trial.|56
921353|NCT01552772|2228235|P1|STARTED|Overall Study||60
921354|NCT01552694|2228251|P2|NOT COMPLETED|Overall Study||2
921355|NCT01552694|2228252|P1|NOT COMPLETED|Overall Study||0
921356|NCT01552694|2228251|P2|COMPLETED|Overall Study||18
921357|NCT01552694|2228252|P1|COMPLETED|Overall Study||18
921358|NCT01552694|2228251|P2|STARTED|Overall Study||20
921359|NCT01552694|2228252|P1|STARTED|Overall Study||18
921360|NCT01552681|2228264|P2|NOT COMPLETED|Overall Study||1
921361|NCT01552681|2228265|P1|NOT COMPLETED|Overall Study||5
921362|NCT01552681|2228264|P2|COMPLETED|Overall Study||18
921363|NCT01552681|2228265|P1|COMPLETED|Overall Study||28
921364|NCT01552681|2228264|P2|STARTED|Overall Study||19
921365|NCT01552681|2228265|P1|STARTED|Overall Study||33
921366|NCT01553708|2228315|P2|NOT COMPLETED|Overall Study||0
921367|NCT01553708|2228316|P1|NOT COMPLETED|Overall Study||0
921368|NCT01553708|2228315|P2|COMPLETED|Overall Study||17
921369|NCT01553708|2228316|P1|COMPLETED|Overall Study||17
921370|NCT01553708|2228315|P2|STARTED|Overall Study||17
921371|NCT01553708|2228316|P1|STARTED|Overall Study||17
921372|NCT01553539|2228322|P1|NOT COMPLETED|Overall Study||0
921373|NCT01553539|2228322|P1|COMPLETED|Overall Study||20
921374|NCT01553539|2228322|P1|STARTED|Overall Study||20
921375|NCT01553318|2228329|P2|NOT COMPLETED|Overall Study||2
921376|NCT01553318|2228330|P1|NOT COMPLETED|Overall Study||3
921377|NCT01553318|2228329|P2|COMPLETED|Overall Study||25
921378|NCT01553318|2228330|P1|COMPLETED|Overall Study||21
921379|NCT01553318|2228329|P2|STARTED|Overall Study||27
921380|NCT01553318|2228330|P1|STARTED|Overall Study||24
921381|NCT01553292|2228342|P1|NOT COMPLETED|Overall Study||0
921382|NCT01553292|2228342|P1|COMPLETED|Overall Study||21
921383|NCT01553292|2228342|P1|STARTED|Overall Study||21
921384|NCT01553240|2228358|P1|NOT COMPLETED|Overall Study||0
921385|NCT01553240|2228358|P1|COMPLETED|Overall Study||0
921386|NCT01553240|2228358|P1|STARTED|Overall Study||0
921387|NCT01552954|2228365|P2|NOT COMPLETED|Overall Study||6
921388|NCT01552954|2228366|P1|NOT COMPLETED|Overall Study||5
921389|NCT01552954|2228365|P2|COMPLETED|Overall Study||119
921390|NCT01552954|2228366|P1|COMPLETED|Overall Study||126
921391|NCT01552954|2228365|P2|STARTED|Overall Study||125
921392|NCT01552954|2228366|P1|STARTED|Overall Study|A total of 13 patients were withdrawn from 269 patients. The remained 256 patients were randomized.|131
921393|NCT01552928|2228382|P4|NOT COMPLETED|Period 4||0
921394|NCT01552928|2228383|P3|NOT COMPLETED|Period 4||0
921395|NCT01552928|2228384|P2|NOT COMPLETED|Period 4||0
921396|NCT01552928|2228385|P1|NOT COMPLETED|Period 4||0
921397|NCT01552928|2228382|P4|COMPLETED|Period 4||16
921398|NCT01552928|2228383|P3|COMPLETED|Period 4||14
921399|NCT01552928|2228384|P2|COMPLETED|Period 4||15
921400|NCT01552928|2228385|P1|COMPLETED|Period 4||14
921401|NCT01552928|2228382|P4|STARTED|Period 4||16
921402|NCT01552928|2228383|P3|STARTED|Period 4||14
921403|NCT01552928|2228384|P2|STARTED|Period 4||15
921404|NCT01552928|2228385|P1|STARTED|Period 4||14
921405|NCT01552928|2228382|P4|NOT COMPLETED|Period 3||0
921406|NCT01552928|2228383|P3|NOT COMPLETED|Period 3||1
921407|NCT01552928|2228384|P2|NOT COMPLETED|Period 3||0
921408|NCT01552928|2228385|P1|NOT COMPLETED|Period 3||0
921409|NCT01552928|2228382|P4|COMPLETED|Period 3||16
921410|NCT01552928|2228383|P3|COMPLETED|Period 3||14
921411|NCT01552928|2228384|P2|COMPLETED|Period 3||15
921412|NCT01552928|2228385|P1|COMPLETED|Period 3||14
921413|NCT01552928|2228382|P4|STARTED|Period 3||16
921414|NCT01552928|2228383|P3|STARTED|Period 3||15
921415|NCT01552928|2228384|P2|STARTED|Period 3||15
921416|NCT01552928|2228385|P1|STARTED|Period 3||14
921417|NCT01552928|2228382|P4|NOT COMPLETED|Period 2||0
921418|NCT01552928|2228383|P3|NOT COMPLETED|Period 2||0
921419|NCT01552928|2228384|P2|NOT COMPLETED|Period 2||0
921420|NCT01552928|2228385|P1|NOT COMPLETED|Period 2||0
921421|NCT01552928|2228382|P4|COMPLETED|Period 2||16
921422|NCT01552928|2228383|P3|COMPLETED|Period 2||15
921423|NCT01552928|2228384|P2|COMPLETED|Period 2||15
921424|NCT01552928|2228385|P1|COMPLETED|Period 2||14
921425|NCT01552928|2228382|P4|STARTED|Period 2||16
921426|NCT01552928|2228383|P3|STARTED|Period 2||15
921427|NCT01552928|2228384|P2|STARTED|Period 2||15
921428|NCT01552928|2228385|P1|STARTED|Period 2||14
921429|NCT01552928|2228382|P4|NOT COMPLETED|Period 1||0
921430|NCT01552928|2228383|P3|NOT COMPLETED|Period 1||0
921431|NCT01552928|2228384|P2|NOT COMPLETED|Period 1||0
921432|NCT01552928|2228385|P1|NOT COMPLETED|Period 1||0
921433|NCT01552928|2228382|P4|COMPLETED|Period 1||16
921434|NCT01552928|2228383|P3|COMPLETED|Period 1||15
921435|NCT01552928|2228384|P2|COMPLETED|Period 1||15
921436|NCT01552928|2228385|P1|COMPLETED|Period 1||14
921437|NCT01552928|2228382|P4|STARTED|Period 1||16
921438|NCT01552928|2228383|P3|STARTED|Period 1||15
921439|NCT01552928|2228384|P2|STARTED|Period 1||15
921440|NCT01552928|2228385|P1|STARTED|Period 1||14
921441|NCT01552915|2228432|P3|NOT COMPLETED|Overall Study||27
921442|NCT01552915|2228433|P2|NOT COMPLETED|Overall Study||29
921443|NCT01552915|2228434|P1|NOT COMPLETED|Overall Study||23
921444|NCT01552915|2228432|P3|COMPLETED|Overall Study||157
921445|NCT01552915|2228433|P2|COMPLETED|Overall Study||155
921446|NCT01552915|2228434|P1|COMPLETED|Overall Study||68
921447|NCT01552915|2228432|P3|STARTED|Overall Study|This population is from the Safety Set. One randomized subject was not dosed and was excluded.|184
921448|NCT01552915|2228433|P2|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|184
921449|NCT01552915|2228434|P1|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|91
921450|NCT01552902|2228457|P3|NOT COMPLETED|Overall Study||33
921451|NCT01552902|2228458|P2|NOT COMPLETED|Overall Study||37
921452|NCT01552902|2228459|P1|NOT COMPLETED|Overall Study||13
921453|NCT01552902|2228457|P3|COMPLETED|Overall Study||186
921454|NCT01552902|2228458|P2|COMPLETED|Overall Study||181
921455|NCT01552902|2228459|P1|COMPLETED|Overall Study||97
921456|NCT01552902|2228457|P3|STARTED|Overall Study||219
921457|NCT01552902|2228458|P2|STARTED|Overall Study||218
921458|NCT01552902|2228459|P1|STARTED|Overall Study||110
921459|NCT01552889|2228481|P2|NOT COMPLETED|Overall Study||5
921460|NCT01552889|2228482|P1|NOT COMPLETED|Overall Study||11
921461|NCT01552889|2228481|P2|COMPLETED|Overall Study||95
921462|NCT01552889|2228482|P1|COMPLETED|Overall Study||90
921463|NCT01552889|2228481|P2|STARTED|Overall Study||100
921464|NCT01552889|2228482|P1|STARTED|Overall Study||101
921465|NCT01552876|2228492|P2|NOT COMPLETED|Overall Study||0
921466|NCT01552876|2228493|P1|NOT COMPLETED|Overall Study||0
921467|NCT01552876|2228492|P2|COMPLETED|Overall Study||20
921468|NCT01552876|2228493|P1|COMPLETED|Overall Study||20
921469|NCT01552876|2228492|P2|STARTED|Overall Study||20
921470|NCT01552876|2228493|P1|STARTED|Overall Study||20
921471|NCT01552603|2228509|P1|NOT COMPLETED|Overall Study||1
921472|NCT01552603|2228509|P1|COMPLETED|Overall Study||13
921473|NCT01552603|2228509|P1|STARTED|Overall Study||14
921474|NCT01552343|2228516|P2|NOT COMPLETED|Overall Study||0
921475|NCT01552343|2228517|P1|NOT COMPLETED|Overall Study||0
921476|NCT01552343|2228516|P2|COMPLETED|Overall Study||27
921477|NCT01552343|2228517|P1|COMPLETED|Overall Study||29
921478|NCT01552343|2228516|P2|STARTED|Overall Study||27
921479|NCT01552343|2228517|P1|STARTED|Overall Study||29
921480|NCT01552057|2228540|P2|NOT COMPLETED|Overall Study||48
921481|NCT01552057|2228541|P1|NOT COMPLETED|Overall Study||30
921482|NCT01552057|2228540|P2|COMPLETED|Overall Study||149
921483|NCT01552057|2228541|P1|COMPLETED|Overall Study||166
921484|NCT01552057|2228540|P2|Received at Least 1 Dose of Study Drug|Overall Study||196
921485|NCT01552057|2228541|P1|Received at Least 1 Dose of Study Drug|Overall Study||194
921486|NCT01552057|2228540|P2|STARTED|Overall Study||197
921487|NCT01552057|2228541|P1|STARTED|Overall Study||196
921488|NCT01551979|2228575|P2|NOT COMPLETED|Overall Study||2
921489|NCT01551979|2228576|P1|NOT COMPLETED|Overall Study||2
921490|NCT01551979|2228575|P2|COMPLETED|Overall Study||6
921491|NCT01551979|2228576|P1|COMPLETED|Overall Study||7
921492|NCT01551979|2228575|P2|1 Week Post Treatment|Overall Study||7
921493|NCT01551979|2228576|P1|1 Week Post Treatment|Overall Study||9
921494|NCT01551979|2228575|P2|Last Day of Treatment (After 5 Days of t|Overall Study||8
921495|NCT01551979|2228576|P1|Last Day of Treatment (After 5 Days of t|Overall Study||9
921496|NCT01551979|2228575|P2|STARTED|Overall Study||8
921497|NCT01551979|2228576|P1|STARTED|Overall Study||9
921498|NCT01551888|2228592|P2|NOT COMPLETED|Period 2||0
921499|NCT01551888|2228593|P1|NOT COMPLETED|Period 2||0
921500|NCT01551888|2228592|P2|COMPLETED|Period 2||12
921501|NCT01551888|2228593|P1|COMPLETED|Period 2||12
921502|NCT01551888|2228592|P2|STARTED|Period 2||12
921503|NCT01551888|2228593|P1|STARTED|Period 2||12
921504|NCT01551888|2228592|P2|NOT COMPLETED|Period 1||0
921505|NCT01551888|2228593|P1|NOT COMPLETED|Period 1||0
921506|NCT01551888|2228592|P2|COMPLETED|Period 1||12
921507|NCT01551888|2228593|P1|COMPLETED|Period 1||12
921508|NCT01551888|2228592|P2|STARTED|Period 1||12
921509|NCT01551888|2228593|P1|STARTED|Period 1||12
921510|NCT01551758|2228607|P2|NOT COMPLETED|Overall Study||105
921511|NCT01551758|2228608|P1|NOT COMPLETED|Overall Study||94
921512|NCT01551758|2228607|P2|COMPLETED|Overall Study||1291
921513|NCT01551758|2228608|P1|COMPLETED|Overall Study||1309
921514|NCT01551758|2228607|P2|STARTED|Overall Study||1396
921515|NCT01551758|2228608|P1|STARTED|Overall Study||1403
921516|NCT01551693|2228648|P2|NOT COMPLETED|Overall Study||2
921517|NCT01551693|2228649|P1|NOT COMPLETED|Overall Study||1
921518|NCT01551693|2228648|P2|COMPLETED|Overall Study||0
921519|NCT01551693|2228649|P1|COMPLETED|Overall Study||0
921520|NCT01551693|2228648|P2|STARTED|Overall Study||2
921521|NCT01551693|2228649|P1|STARTED|Overall Study||1
921522|NCT01551355|2228665|P6|NOT COMPLETED|Overall Study||6
921523|NCT01551355|2228666|P5|NOT COMPLETED|Overall Study||9
921524|NCT01551355|2228667|P4|NOT COMPLETED|Overall Study||24
921525|NCT01551355|2228668|P3|NOT COMPLETED|Overall Study||34
921526|NCT01551355|2228669|P2|NOT COMPLETED|Overall Study||49
921527|NCT01551355|2228670|P1|NOT COMPLETED|Overall Study||51
921528|NCT01551355|2228665|P6|COMPLETED|Overall Study||65
921529|NCT01551355|2228666|P5|COMPLETED|Overall Study||55
921530|NCT01551355|2228667|P4|COMPLETED|Overall Study||411
921531|NCT01551355|2228668|P3|COMPLETED|Overall Study||459
921532|NCT01551355|2228669|P2|COMPLETED|Overall Study||545
921533|NCT01551355|2228670|P1|COMPLETED|Overall Study||571
921534|NCT01551355|2228665|P6|STARTED|Overall Study||71
921535|NCT01551355|2228666|P5|STARTED|Overall Study||64
921536|NCT01551355|2228667|P4|STARTED|Overall Study||435
921537|NCT01551355|2228668|P3|STARTED|Overall Study||493
921538|NCT01551355|2228669|P2|STARTED|Overall Study||594
921539|NCT01551355|2228670|P1|STARTED|Overall Study||622
921540|NCT01551303|2228684|P2|NOT COMPLETED|Overall Study||7
921541|NCT01551303|2228685|P1|NOT COMPLETED|Overall Study||4
921542|NCT01551303|2228684|P2|COMPLETED|Overall Study||15
921543|NCT01551303|2228685|P1|COMPLETED|Overall Study||21
921544|NCT01551303|2228684|P2|STARTED|Overall Study||22
921545|NCT01551303|2228685|P1|STARTED|Overall Study||25
921546|NCT01551199|2228691|P1|NOT COMPLETED|Overall Study||5
921547|NCT01551199|2228691|P1|COMPLETED|Overall Study||2
921548|NCT01551199|2228691|P1|STARTED|Overall Study||7
921549|NCT01551173|2228699|P2|NOT COMPLETED|Overall Study||32
921550|NCT01551173|2228700|P1|NOT COMPLETED|Overall Study||28
921551|NCT01551173|2228699|P2|COMPLETED|Overall Study||186
921552|NCT01551173|2228700|P1|COMPLETED|Overall Study||190
921553|NCT01551173|2228699|P2|Full Analysis Set (FAS)|Overall Study||214
921554|NCT01551173|2228700|P1|Full Analysis Set (FAS)|Overall Study|Patients took at least 1 dose of study drug & had at least 1 post-randomization efficacy parameter|210
921555|NCT01551173|2228699|P2|STARTED|Overall Study||218
921556|NCT01551173|2228700|P1|STARTED|Overall Study|"Started indicates randomized"|218
921557|NCT01551095|2228711|P1|NOT COMPLETED|Overall Study||0
921558|NCT01551095|2228711|P1|COMPLETED|Overall Study||7
921559|NCT01551095|2228711|P1|STARTED|Overall Study||7
921560|NCT01551082|2228716|P1|NOT COMPLETED|Overall Study||0
921561|NCT01551082|2228716|P1|COMPLETED|Overall Study||12
921562|NCT01551082|2228716|P1|STARTED|Overall Study||12
921563|NCT01551056|2228722|P2|NOT COMPLETED|Overall Study||0
921564|NCT01551056|2228723|P1|NOT COMPLETED|Overall Study||2
921565|NCT01551056|2228722|P2|COMPLETED|Overall Study||45
921566|NCT01551056|2228723|P1|COMPLETED|Overall Study||44
921567|NCT01551056|2228722|P2|STARTED|Overall Study||45
921568|NCT01551056|2228723|P1|STARTED|Overall Study||46
921569|NCT01550965|2228777|P1|NOT COMPLETED|Overall Study||110
921570|NCT01550965|2228777|P1|COMPLETED|Overall Study||353
921571|NCT01550965|2228777|P1|STARTED|Overall Study||463
921572|NCT01550952|2228796|P1|NOT COMPLETED|Overall Study||0
921573|NCT01550952|2228796|P1|COMPLETED|Overall Study||10
921574|NCT01550952|2228796|P1|STARTED|Overall Study||10
921575|NCT01550809|2228806|P2|NOT COMPLETED|Overall Study||0
921576|NCT01550809|2228807|P1|NOT COMPLETED|Overall Study||0
921577|NCT01550809|2228806|P2|COMPLETED|Overall Study||6
921578|NCT01550809|2228807|P1|COMPLETED|Overall Study||6
921579|NCT01550809|2228806|P2|STARTED|Overall Study|Six patients started with the iBolus, the others with the tBolus, according to a crossover design.|6
921580|NCT01550809|2228807|P1|STARTED|Overall Study|Six patients started with the tBolus, the others with the iBolus, according to a crossover design.|6
921581|NCT01550744|2228817|P3|NOT COMPLETED|Double-Blind||67
921582|NCT01550744|2228818|P2|NOT COMPLETED|Double-Blind||17
921583|NCT01550744|2228819|P1|NOT COMPLETED|Double-Blind||0
921584|NCT01550744|2228817|P3|COMPLETED|Double-Blind||235
921585|NCT01550744|2228818|P2|COMPLETED|Double-Blind||59
921586|NCT01550744|2228819|P1|COMPLETED|Double-Blind||0
921587|NCT01550744|2228817|P3|STARTED|Double-Blind||302
921588|NCT01550744|2228818|P2|STARTED|Double-Blind||76
921589|NCT01550744|2228819|P1|STARTED|Double-Blind||0
921590|NCT01550744|2228817|P3|NOT COMPLETED|Open-Label||0
921591|NCT01550744|2228818|P2|NOT COMPLETED|Open-Label||0
921592|NCT01550744|2228819|P1|NOT COMPLETED|Open-Label||100
921593|NCT01550744|2228817|P3|COMPLETED|Open-Label||0
921594|NCT01550744|2228818|P2|COMPLETED|Open-Label||0
921595|NCT01550744|2228819|P1|COMPLETED|Open-Label||378
921596|NCT01550744|2228817|P3|STARTED|Open-Label||0
921597|NCT01550744|2228818|P2|STARTED|Open-Label||0
921598|NCT01550744|2228819|P1|STARTED|Open-Label||478
921599|NCT01550705|2228832|P1|NOT COMPLETED|Overall Study||1
921600|NCT01550705|2228832|P1|COMPLETED|Overall Study||10
921601|NCT01550705|2228832|P1|STARTED|Overall Study||11
921602|NCT01550549|2228837|P1|NOT COMPLETED|Overall Study||0
921603|NCT01550549|2228837|P1|COMPLETED|Overall Study||151
921604|NCT01550549|2228837|P1|STARTED|Overall Study||151
921605|NCT01550302|2228851|P2|NOT COMPLETED|Overall Study||0
921606|NCT01550302|2228852|P1|NOT COMPLETED|Overall Study||0
921607|NCT01550302|2228851|P2|COMPLETED|Overall Study||5
921608|NCT01550302|2228852|P1|COMPLETED|Overall Study||5
921609|NCT01550302|2228851|P2|STARTED|Overall Study||5
921610|NCT01550302|2228852|P1|STARTED|Overall Study||5
921611|NCT01550289|2228872|P2|NOT COMPLETED|Overall Study||4
921612|NCT01550289|2228873|P1|NOT COMPLETED|Overall Study||13
921613|NCT01550289|2228872|P2|COMPLETED|Overall Study||57
921614|NCT01550289|2228873|P1|COMPLETED|Overall Study||115
921615|NCT01550289|2228872|P2|STARTED|Overall Study||61
921616|NCT01550289|2228873|P1|STARTED|Overall Study||128
921617|NCT01549977|2228905|P2|NOT COMPLETED|Overall Study||0
921618|NCT01549977|2228906|P1|NOT COMPLETED|Overall Study||0
921619|NCT01549977|2228905|P2|COMPLETED|Overall Study||0
921620|NCT01549977|2228906|P1|COMPLETED|Overall Study||1
921621|NCT01549977|2228905|P2|STARTED|Overall Study||0
921622|NCT01549977|2228906|P1|STARTED|Overall Study||1
921623|NCT01549964|2228924|P4|NOT COMPLETED|80-Week Extension Period||137
921624|NCT01549964|2228925|P3|NOT COMPLETED|80-Week Extension Period||140
921625|NCT01549964|2228926|P2|NOT COMPLETED|80-Week Extension Period||138
921626|NCT01549964|2228927|P1|NOT COMPLETED|80-Week Extension Period||66
921627|NCT01549964|2228924|P4|COMPLETED|80-Week Extension Period||0
921628|NCT01549964|2228925|P3|COMPLETED|80-Week Extension Period||0
921629|NCT01549964|2228926|P2|COMPLETED|80-Week Extension Period||0
921630|NCT01549964|2228927|P1|COMPLETED|80-Week Extension Period||0
921631|NCT01549964|2228924|P4|STARTED|80-Week Extension Period||137
921632|NCT01549964|2228925|P3|STARTED|80-Week Extension Period||140
921633|NCT01549964|2228926|P2|STARTED|80-Week Extension Period||138
921634|NCT01549964|2228927|P1|STARTED|80-Week Extension Period||66
921635|NCT01549964|2228924|P4|NOT COMPLETED|24-Week Treatment Period||121
921636|NCT01549964|2228925|P3|NOT COMPLETED|24-Week Treatment Period||116
921637|NCT01549964|2228926|P2|NOT COMPLETED|24-Week Treatment Period||111
921638|NCT01549964|2228927|P1|NOT COMPLETED|24-Week Treatment Period||61
921639|NCT01549964|2228924|P4|COMPLETED|24-Week Treatment Period||140
921640|NCT01549964|2228925|P3|COMPLETED|24-Week Treatment Period||147
921641|NCT01549964|2228926|P2|COMPLETED|24-Week Treatment Period||149
921642|NCT01549964|2228927|P1|COMPLETED|24-Week Treatment Period||71
921643|NCT01549964|2228924|P4|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
921644|NCT01549964|2228925|P3|Safety Analysis Set=Received Treatment|24-Week Treatment Period||263
921645|NCT01549964|2228926|P2|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
921646|NCT01549964|2228927|P1|Safety Analysis Set=Received Treatment|24-Week Treatment Period||132
921647|NCT01549964|2228924|P4|STARTED|24-Week Treatment Period||261
921648|NCT01549964|2228925|P3|STARTED|24-Week Treatment Period||263
921649|NCT01549964|2228926|P2|STARTED|24-Week Treatment Period||260
921650|NCT01549964|2228927|P1|STARTED|24-Week Treatment Period||132
921651|NCT01549951|2228945|P1|NOT COMPLETED|Overall Study||50
921652|NCT01549951|2228945|P1|COMPLETED|Overall Study||0
921653|NCT01549951|2228945|P1|Primary Reason Off Study Treatment|Overall Study||50
921654|NCT01549951|2228945|P1|STARTED|Overall Study||50
921655|NCT01549925|2228963|P2|NOT COMPLETED|Overall Study||0
921656|NCT01549925|2228964|P1|NOT COMPLETED|Overall Study||0
921657|NCT01549925|2228963|P2|COMPLETED|Overall Study||25
921658|NCT01549925|2228964|P1|COMPLETED|Overall Study||25
921659|NCT01549925|2228963|P2|STARTED|Overall Study||25
921660|NCT01549925|2228964|P1|STARTED|Overall Study||25
921661|NCT01549873|2228972|P2|NOT COMPLETED|Overall Study||1
921662|NCT01549873|2228973|P1|NOT COMPLETED|Overall Study||0
921663|NCT01549873|2228972|P2|COMPLETED|Overall Study||14
921664|NCT01549873|2228973|P1|COMPLETED|Overall Study||15
921665|NCT01549873|2228972|P2|STARTED|Overall Study||15
921666|NCT01549873|2228973|P1|STARTED|Overall Study||15
921667|NCT01549860|2228985|P2|NOT COMPLETED|Overall Study||1
921668|NCT01549860|2228986|P1|NOT COMPLETED|Overall Study||2
921669|NCT01549860|2228985|P2|COMPLETED|Overall Study||40
921670|NCT01549860|2228986|P1|COMPLETED|Overall Study||38
921671|NCT01549860|2228985|P2|STARTED|Overall Study||41
921672|NCT01549860|2228986|P1|STARTED|Overall Study||40
921673|NCT01549613|2228998|P2|NOT COMPLETED|Overall Study||11
921674|NCT01549613|2228999|P1|NOT COMPLETED|Overall Study||11
921675|NCT01549613|2228998|P2|COMPLETED|Overall Study||39
921676|NCT01549613|2228999|P1|COMPLETED|Overall Study||39
921677|NCT01549613|2228998|P2|STARTED|Overall Study||50
921678|NCT01549613|2228999|P1|STARTED|Overall Study||50
921679|NCT01549405|2229007|P2|NOT COMPLETED|Overall Study||0
921680|NCT01549405|2229008|P1|NOT COMPLETED|Overall Study||0
921681|NCT01549405|2229007|P2|COMPLETED|Overall Study||20
921682|NCT01549405|2229008|P1|COMPLETED|Overall Study||20
921683|NCT01549405|2229007|P2|STARTED|Overall Study||20
921684|NCT01549405|2229008|P1|STARTED|Overall Study||20
921685|NCT01549392|2229018|P2|NOT COMPLETED|Overall Study||0
921686|NCT01549392|2229019|P1|NOT COMPLETED|Overall Study||1
921687|NCT01549392|2229018|P2|COMPLETED|Overall Study||0
921688|NCT01549392|2229019|P1|COMPLETED|Overall Study||2
921689|NCT01549392|2229018|P2|STARTED|Overall Study||0
921690|NCT01549392|2229019|P1|STARTED|Overall Study||3
921691|NCT01549340|2229025|P1|NOT COMPLETED|Overall Study||8405
921692|NCT01549340|2229025|P1|COMPLETED|Overall Study|Completed 5 years of AIT|385
921693|NCT01549340|2229025|P1|Started AIT|Overall Study||3182
921694|NCT01549340|2229025|P1|STARTED|Overall Study|Advised to receive AIT|8790
921695|NCT01549275|2229038|P2|NOT COMPLETED|Overall Study||0
921696|NCT01549275|2229039|P1|NOT COMPLETED|Overall Study||1
921697|NCT01549275|2229038|P2|COMPLETED|Overall Study||29
921698|NCT01549275|2229039|P1|COMPLETED|Overall Study||75
921699|NCT01549275|2229038|P2|STARTED|Overall Study||29
921700|NCT01549275|2229039|P1|STARTED|Overall Study||76
921701|NCT01549223|2229051|P2|NOT COMPLETED|Overall Study||0
921702|NCT01549223|2229052|P1|NOT COMPLETED|Overall Study||0
921703|NCT01549223|2229051|P2|COMPLETED|Overall Study||30
921704|NCT01549223|2229052|P1|COMPLETED|Overall Study||30
921705|NCT01549223|2229051|P2|STARTED|Overall Study||30
921706|NCT01549223|2229052|P1|STARTED|Overall Study||30
921707|NCT01549041|2229062|P2|NOT COMPLETED|Overall Study||8
921708|NCT01549041|2229063|P1|NOT COMPLETED|Overall Study||2
921709|NCT01549041|2229062|P2|COMPLETED|Overall Study||10
921710|NCT01549041|2229063|P1|COMPLETED|Overall Study||10
921711|NCT01549041|2229062|P2|STARTED|Overall Study||18
921712|NCT01549041|2229063|P1|STARTED|Overall Study||12
921713|NCT01549002|2229073|P2|NOT COMPLETED|Overall Study||4
921714|NCT01549002|2229074|P1|NOT COMPLETED|Overall Study||0
921715|NCT01549002|2229073|P2|COMPLETED|Overall Study||6
921716|NCT01549002|2229074|P1|COMPLETED|Overall Study||10
921717|NCT01549002|2229073|P2|STARTED|Overall Study||10
921718|NCT01549002|2229074|P1|STARTED|Overall Study||10
921719|NCT01548885|2229080|P1|NOT COMPLETED|Overall Study||0
921720|NCT01548885|2229080|P1|COMPLETED|Overall Study||146
921721|NCT01548885|2229080|P1|STARTED|Overall Study||146
921722|NCT01548833|2229085|P1|NOT COMPLETED|Overall Study||0
921723|NCT01548833|2229085|P1|COMPLETED|Overall Study||39
921724|NCT01548833|2229085|P1|STARTED|Overall Study||39
921725|NCT01548742|2229095|P2|NOT COMPLETED|Overall Study||4
921726|NCT01548742|2229096|P1|NOT COMPLETED|Overall Study||13
921727|NCT01548742|2229095|P2|COMPLETED|Overall Study||54
921728|NCT01548742|2229096|P1|COMPLETED|Overall Study||45
921729|NCT01548742|2229095|P2|STARTED|Overall Study||58
921730|NCT01548742|2229096|P1|STARTED|Overall Study||58
921731|NCT01548638|2229110|P1|NOT COMPLETED|Overall Study||4
921732|NCT01548638|2229110|P1|COMPLETED|Overall Study||9
921733|NCT01548638|2229110|P1|STARTED|Overall Study||13
921734|NCT01548573|2229117|P1|NOT COMPLETED|Overall Study||5
921735|NCT01548573|2229117|P1|COMPLETED|Overall Study||14
921736|NCT01548573|2229117|P1|STARTED|Overall Study||19
921737|NCT01548417|2229126|P2|NOT COMPLETED|Overall Study||2
921738|NCT01548417|2229127|P1|NOT COMPLETED|Overall Study||0
921739|NCT01548417|2229126|P2|COMPLETED|Overall Study||26
921740|NCT01548417|2229127|P1|COMPLETED|Overall Study||28
921741|NCT01548417|2229126|P2|STARTED|Overall Study||28
921742|NCT01548417|2229127|P1|STARTED|Overall Study||28
921743|NCT01548287|2229139|P5|NOT COMPLETED|Randomized Period||0
921744|NCT01548287|2229140|P4|NOT COMPLETED|Randomized Period||0
921745|NCT01548287|2229141|P3|NOT COMPLETED|Randomized Period||7
921746|NCT01548287|2229142|P2|NOT COMPLETED|Randomized Period||2
921747|NCT01548287|2229143|P1|NOT COMPLETED|Randomized Period||0
921748|NCT01548287|2229139|P5|COMPLETED|Randomized Period||0
921749|NCT01548287|2229140|P4|COMPLETED|Randomized Period||20
921750|NCT01548287|2229141|P3|COMPLETED|Randomized Period||13
921751|NCT01548287|2229142|P2|COMPLETED|Randomized Period||20
921752|NCT01548287|2229143|P1|COMPLETED|Randomized Period||19
921753|NCT01548287|2229139|P5|STARTED|Randomized Period||0
921754|NCT01548287|2229140|P4|STARTED|Randomized Period||20
921755|NCT01548287|2229141|P3|STARTED|Randomized Period||20
921756|NCT01548287|2229142|P2|STARTED|Randomized Period||22
921757|NCT01548287|2229143|P1|STARTED|Randomized Period||19
921758|NCT01548287|2229139|P5|NOT COMPLETED|Screening||83
921759|NCT01548287|2229140|P4|NOT COMPLETED|Screening||0
921760|NCT01548287|2229141|P3|NOT COMPLETED|Screening||0
921761|NCT01548287|2229142|P2|NOT COMPLETED|Screening||0
921762|NCT01548287|2229143|P1|NOT COMPLETED|Screening||0
921763|NCT01548287|2229139|P5|COMPLETED|Screening||0
921764|NCT01548287|2229140|P4|COMPLETED|Screening||20
921765|NCT01548287|2229141|P3|COMPLETED|Screening||20
921766|NCT01548287|2229142|P2|COMPLETED|Screening||22
921767|NCT01548287|2229143|P1|COMPLETED|Screening||19
921768|NCT01548287|2229139|P5|STARTED|Screening||83
921769|NCT01548287|2229140|P4|STARTED|Screening||20
921770|NCT01548287|2229141|P3|STARTED|Screening||20
921771|NCT01548287|2229142|P2|STARTED|Screening||22
921772|NCT01548287|2229143|P1|STARTED|Screening||19
921773|NCT01547806|2229173|P1|NOT COMPLETED|Overall Study||0
921774|NCT01547806|2229173|P1|COMPLETED|Overall Study||49
921775|NCT01547806|2229173|P1|STARTED|Overall Study||49
921776|NCT01547728|2229189|P1|NOT COMPLETED|Overall Study||41
921777|NCT01547728|2229189|P1|COMPLETED|Overall Study||1
921778|NCT01547728|2229189|P1|STARTED|Overall Study||42
921779|NCT01547715|2229196|P3|NOT COMPLETED|Overall Study||0
921780|NCT01547715|2229197|P2|NOT COMPLETED|Overall Study||0
921781|NCT01547715|2229198|P1|NOT COMPLETED|Overall Study||0
921782|NCT01547715|2229196|P3|COMPLETED|Overall Study||60
921783|NCT01547715|2229197|P2|COMPLETED|Overall Study||60
921784|NCT01547715|2229198|P1|COMPLETED|Overall Study||60
921785|NCT01547715|2229196|P3|STARTED|Overall Study||60
921786|NCT01547715|2229197|P2|STARTED|Overall Study||60
921787|NCT01547715|2229198|P1|STARTED|Overall Study||60
921788|NCT01547598|2229298|P2|NOT COMPLETED|Overall Study||5
921789|NCT01547598|2229299|P1|NOT COMPLETED|Overall Study||6
921790|NCT01547598|2229298|P2|COMPLETED|Overall Study||63
921791|NCT01547598|2229299|P1|COMPLETED|Overall Study||61
921792|NCT01547598|2229298|P2|STARTED|Overall Study||68
921793|NCT01547598|2229299|P1|STARTED|Overall Study||67
921800|NCT01547286|2229377|P1|NOT COMPLETED|Overall Study||2
921801|NCT01547286|2229377|P1|COMPLETED|Overall Study||5
921802|NCT01547286|2229377|P1|STARTED|Overall Study||7
921803|NCT01547247|2229384|P2|NOT COMPLETED|Overall Study||6
921804|NCT01547247|2229385|P1|NOT COMPLETED|Overall Study||6
921805|NCT01547247|2229384|P2|COMPLETED|Overall Study||98
921806|NCT01547247|2229385|P1|COMPLETED|Overall Study||98
921807|NCT01547247|2229384|P2|STARTED|Overall Study||104
921808|NCT01547247|2229385|P1|STARTED|Overall Study||104
921809|NCT01547130|2229395|P2|NOT COMPLETED|Overall Study||5
921810|NCT01547130|2229396|P1|NOT COMPLETED|Overall Study||9
921811|NCT01547130|2229395|P2|COMPLETED|Overall Study||68
921812|NCT01547130|2229396|P1|COMPLETED|Overall Study||65
921813|NCT01547130|2229395|P2|STARTED|Overall Study||73
921814|NCT01547130|2229396|P1|STARTED|Overall Study||74
921815|NCT01546922|2229410|P2|NOT COMPLETED|Second Period of 10 Weeks||3
921816|NCT01546922|2229411|P1|NOT COMPLETED|Second Period of 10 Weeks||3
921817|NCT01546922|2229410|P2|COMPLETED|Second Period of 10 Weeks||25
921818|NCT01546922|2229411|P1|COMPLETED|Second Period of 10 Weeks||22
921819|NCT01546922|2229410|P2|STARTED|Second Period of 10 Weeks||28
921820|NCT01546922|2229411|P1|STARTED|Second Period of 10 Weeks||25
921821|NCT01546922|2229410|P2|NOT COMPLETED|First Period of 10 Weeks||2
921822|NCT01546922|2229411|P1|NOT COMPLETED|First Period of 10 Weeks||5
921823|NCT01546922|2229410|P2|COMPLETED|First Period of 10 Weeks||28
921824|NCT01546922|2229411|P1|COMPLETED|First Period of 10 Weeks||25
921825|NCT01546922|2229410|P2|STARTED|First Period of 10 Weeks||30
921826|NCT01546922|2229411|P1|STARTED|First Period of 10 Weeks||30
921827|NCT01546883|2229417|P1|NOT COMPLETED|Overall Study||12
921828|NCT01546883|2229417|P1|COMPLETED|Overall Study||2
921829|NCT01546883|2229417|P1|STARTED|Overall Study||14
921830|NCT01546688|2229423|P2|NOT COMPLETED|Overall Study||5
921831|NCT01546688|2229424|P1|NOT COMPLETED|Overall Study||3
921832|NCT01546688|2229423|P2|COMPLETED|Overall Study||28
921833|NCT01546688|2229424|P1|COMPLETED|Overall Study||15
921834|NCT01546688|2229423|P2|STARTED|Overall Study||33
921835|NCT01546688|2229424|P1|STARTED|Overall Study||18
921836|NCT01546675|2229438|P2|NOT COMPLETED|Overall Study||0
921837|NCT01546675|2229439|P1|NOT COMPLETED|Overall Study||0
921838|NCT01546675|2229438|P2|COMPLETED|Overall Study||1
921839|NCT01546675|2229439|P1|COMPLETED|Overall Study||1
921840|NCT01546675|2229438|P2|STARTED|Overall Study||1
921841|NCT01546675|2229439|P1|STARTED|Overall Study||1
921842|NCT01546649|2229456|P2|NOT COMPLETED|Overall Study||9
921843|NCT01546649|2229457|P1|NOT COMPLETED|Overall Study||8
921844|NCT01546649|2229456|P2|COMPLETED|Overall Study||75
921845|NCT01546649|2229457|P1|COMPLETED|Overall Study||75
921846|NCT01546649|2229456|P2|STARTED|Overall Study||84
921847|NCT01546649|2229457|P1|STARTED|Overall Study||83
921848|NCT01546636|2229479|P2|NOT COMPLETED|Overall Study||0
921849|NCT01546636|2229480|P1|NOT COMPLETED|Overall Study||0
921850|NCT01546636|2229479|P2|COMPLETED|Overall Study||34
921851|NCT01546636|2229480|P1|COMPLETED|Overall Study||36
921852|NCT01546636|2229479|P2|STARTED|Overall Study||34
921853|NCT01546636|2229480|P1|STARTED|Overall Study||36
921854|NCT01546623|2229492|P2|NOT COMPLETED|Overall Study||6
921855|NCT01546623|2229493|P1|NOT COMPLETED|Overall Study||6
921856|NCT01546623|2229492|P2|COMPLETED|Overall Study||74
921857|NCT01546623|2229493|P1|COMPLETED|Overall Study||76
921858|NCT01546623|2229492|P2|Received Study Drug|Overall Study||79
921859|NCT01546623|2229493|P1|Received Study Drug|Overall Study||81
921860|NCT01546623|2229492|P2|STARTED|Overall Study||80
921861|NCT01546623|2229493|P1|STARTED|Overall Study||82
921862|NCT01545388|2229522|P3|NOT COMPLETED|Overall Study||8
921863|NCT01545388|2229523|P2|NOT COMPLETED|Overall Study||11
921864|NCT01545388|2229524|P1|NOT COMPLETED|Overall Study||8
921865|NCT01545388|2229522|P3|COMPLETED|Overall Study||58
921866|NCT01545388|2229523|P2|COMPLETED|Overall Study||122
921867|NCT01545388|2229524|P1|COMPLETED|Overall Study||130
921868|NCT01545388|2229522|P3|STARTED|Overall Study||66
921869|NCT01545388|2229523|P2|STARTED|Overall Study||133
921870|NCT01545388|2229524|P1|STARTED|Overall Study||138
921871|NCT01545375|2229543|P2|NOT COMPLETED|Overall Study||90
921872|NCT01545375|2229544|P1|NOT COMPLETED|Overall Study||97
921873|NCT01545375|2229543|P2|COMPLETED|Overall Study||813
921874|NCT01545375|2229544|P1|COMPLETED|Overall Study||803
921875|NCT01545375|2229543|P2|STARTED|Overall Study||903
921876|NCT01545375|2229544|P1|STARTED|Overall Study||900
921877|NCT01546519|2229596|P4|NOT COMPLETED|Overall Study||6
921878|NCT01546519|2229597|P3|NOT COMPLETED|Overall Study||8
921879|NCT01546519|2229598|P2|NOT COMPLETED|Overall Study||8
921880|NCT01546519|2229599|P1|NOT COMPLETED|Overall Study||9
921881|NCT01546519|2229596|P4|COMPLETED|Overall Study||0
921882|NCT01546519|2229597|P3|COMPLETED|Overall Study||0
921883|NCT01546519|2229598|P2|COMPLETED|Overall Study||0
921884|NCT01546519|2229599|P1|COMPLETED|Overall Study||0
921885|NCT01546519|2229596|P4|Safety-Evaluable Participants|Overall Study||6
921886|NCT01546519|2229597|P3|Safety-Evaluable Participants|Overall Study||8
921887|NCT01546519|2229598|P2|Safety-Evaluable Participants|Overall Study||8
921888|NCT01546519|2229599|P1|Safety-Evaluable Participants|Overall Study||9
921889|NCT01546519|2229596|P4|STARTED|Overall Study||6
921890|NCT01546519|2229597|P3|STARTED|Overall Study||8
921891|NCT01546519|2229598|P2|STARTED|Overall Study||8
921892|NCT01546519|2229599|P1|STARTED|Overall Study||9
921893|NCT01546454|2229641|P1|NOT COMPLETED|Estrogen/Progesterone Replacement Cycle||0
921894|NCT01546454|2229641|P1|COMPLETED|Estrogen/Progesterone Replacement Cycle||4
921895|NCT01546454|2229641|P1|STARTED|Estrogen/Progesterone Replacement Cycle||4
921896|NCT01546454|2229641|P1|NOT COMPLETED|Eligard Treatment||0
921897|NCT01546454|2229641|P1|COMPLETED|Eligard Treatment||4
921898|NCT01546454|2229641|P1|STARTED|Eligard Treatment||4
921899|NCT01546454|2229641|P1|NOT COMPLETED|Oral Contraceptive Cycle||0
921900|NCT01546454|2229641|P1|COMPLETED|Oral Contraceptive Cycle||4
921901|NCT01546454|2229641|P1|STARTED|Oral Contraceptive Cycle||4
921902|NCT01546454|2229641|P1|NOT COMPLETED|Natural Menstrual Cycle||0
921903|NCT01546454|2229641|P1|COMPLETED|Natural Menstrual Cycle||4
921904|NCT01546454|2229641|P1|STARTED|Natural Menstrual Cycle||4
921905|NCT01546402|2229649|P2|NOT COMPLETED|Overall Study||0
921906|NCT01546402|2229650|P1|NOT COMPLETED|Overall Study||0
921907|NCT01546402|2229649|P2|COMPLETED|Overall Study||10
921908|NCT01546402|2229650|P1|COMPLETED|Overall Study||10
921909|NCT01546402|2229649|P2|STARTED|Overall Study||10
921910|NCT01546402|2229650|P1|STARTED|Overall Study||10
921911|NCT01546285|2229658|P1|NOT COMPLETED|Overall Study||0
921912|NCT01546285|2229658|P1|COMPLETED|Overall Study||66
921913|NCT01546285|2229658|P1|STARTED|Overall Study||66
921914|NCT01546207|2229664|P1|NOT COMPLETED|Overall Study||1
921915|NCT01546207|2229664|P1|COMPLETED|Overall Study||3
921916|NCT01546207|2229664|P1|STARTED|Overall Study||4
921917|NCT01546194|2229670|P2|NOT COMPLETED|Overall Study||35
921918|NCT01546194|2229671|P1|NOT COMPLETED|Overall Study||36
921919|NCT01546194|2229670|P2|COMPLETED|Overall Study||65
921920|NCT01546194|2229671|P1|COMPLETED|Overall Study||64
921921|NCT01546194|2229670|P2|STARTED|Overall Study||100
921922|NCT01546194|2229671|P1|STARTED|Overall Study||100
921923|NCT01546155|2229677|P1|NOT COMPLETED|Overall Study||3
921924|NCT01546155|2229677|P1|COMPLETED|Overall Study||8
921925|NCT01546155|2229677|P1|STARTED|Overall Study||11
921926|NCT01546142|2229683|P2|NOT COMPLETED|Overall Study||34
921927|NCT01546142|2229684|P1|NOT COMPLETED|Overall Study||44
921928|NCT01546142|2229683|P2|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|224
921929|NCT01546142|2229684|P1|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|214
921930|NCT01546142|2229683|P2|Received Treatment|Overall Study||257
921931|NCT01546142|2229684|P1|Received Treatment|Overall Study||257
921932|NCT01546142|2229683|P2|STARTED|Overall Study||258
921933|NCT01546142|2229684|P1|STARTED|Overall Study||258
921934|NCT01545843|2229699|P3|NOT COMPLETED|Overall Study||4
921935|NCT01545843|2229700|P2|NOT COMPLETED|Overall Study||7
921936|NCT01545843|2229701|P1|NOT COMPLETED|Overall Study||3
921937|NCT01545843|2229699|P3|COMPLETED|Overall Study||21
921938|NCT01545843|2229700|P2|COMPLETED|Overall Study||17
921939|NCT01545843|2229701|P1|COMPLETED|Overall Study||16
921940|NCT01545843|2229699|P3|STARTED|Overall Study||25
921941|NCT01545843|2229700|P2|STARTED|Overall Study||24
921942|NCT01545843|2229701|P1|STARTED|Overall Study||19
921943|NCT01545765|2229712|P1|NOT COMPLETED|Overall Study||0
921944|NCT01545765|2229712|P1|COMPLETED|Overall Study||31
921945|NCT01545765|2229712|P1|STARTED|Overall Study||31
921946|NCT01545700|2229729|P6|NOT COMPLETED|Overall Study||0
921947|NCT01545700|2229730|P5|NOT COMPLETED|Overall Study||1
921948|NCT01545700|2229731|P4|NOT COMPLETED|Overall Study||0
921949|NCT01545700|2229732|P3|NOT COMPLETED|Overall Study||2
921950|NCT01545700|2229733|P2|NOT COMPLETED|Overall Study||1
921951|NCT01545700|2229734|P1|NOT COMPLETED|Overall Study||1
921952|NCT01545700|2229729|P6|COMPLETED|Overall Study||33
921953|NCT01545700|2229730|P5|COMPLETED|Overall Study||32
921954|NCT01545700|2229731|P4|COMPLETED|Overall Study||34
921955|NCT01545700|2229732|P3|COMPLETED|Overall Study||31
921956|NCT01545700|2229733|P2|COMPLETED|Overall Study||32
921957|NCT01545700|2229734|P1|COMPLETED|Overall Study||33
921958|NCT01545700|2229729|P6|STARTED|Overall Study||33
921959|NCT01545700|2229730|P5|STARTED|Overall Study||33
921960|NCT01545700|2229731|P4|STARTED|Overall Study||34
921961|NCT01545700|2229732|P3|STARTED|Overall Study||33
921962|NCT01545700|2229733|P2|STARTED|Overall Study||33
921963|NCT01545700|2229734|P1|STARTED|Overall Study||34
921964|NCT01545518|2229768|P1|NOT COMPLETED|Overall Study||0
921965|NCT01545518|2229768|P1|COMPLETED|Overall Study||20
921966|NCT01545518|2229768|P1|STARTED|Overall Study||20
921967|NCT01545336|2229774|P2|NOT COMPLETED|Overall Study||0
921968|NCT01545336|2229775|P1|NOT COMPLETED|Overall Study||0
921969|NCT01545336|2229774|P2|COMPLETED|Overall Study||6
921970|NCT01545336|2229775|P1|COMPLETED|Overall Study||12
921971|NCT01545336|2229774|P2|STARTED|Overall Study||6
921972|NCT01545336|2229775|P1|STARTED|Overall Study||12
921973|NCT01545232|2229787|P2|NOT COMPLETED|Overall Study||0
921974|NCT01545232|2229788|P1|NOT COMPLETED|Overall Study||0
921975|NCT01545232|2229787|P2|COMPLETED|Overall Study||342
921976|NCT01545232|2229788|P1|COMPLETED|Overall Study||338
921977|NCT01545232|2229787|P2|STARTED|Overall Study||342
921978|NCT01545232|2229788|P1|STARTED|Overall Study||338
921979|NCT01545193|2229818|P2|NOT COMPLETED|Overall Study||1
921980|NCT01545193|2229819|P1|NOT COMPLETED|Overall Study||0
921981|NCT01545193|2229818|P2|COMPLETED|Overall Study||149
921982|NCT01545193|2229819|P1|COMPLETED|Overall Study||150
921983|NCT01545193|2229818|P2|STARTED|Overall Study||150
921984|NCT01545193|2229819|P1|STARTED|Overall Study||150
921985|NCT01544998|2229831|P2|NOT COMPLETED|Second Intervention (3 Hours)||0
921986|NCT01544998|2229832|P1|NOT COMPLETED|Second Intervention (3 Hours)||0
921987|NCT01544998|2229831|P2|COMPLETED|Second Intervention (3 Hours)||15
921988|NCT01544998|2229832|P1|COMPLETED|Second Intervention (3 Hours)||26
921989|NCT01544998|2229831|P2|STARTED|Second Intervention (3 Hours)||15
921990|NCT01544998|2229832|P1|STARTED|Second Intervention (3 Hours)||26
921991|NCT01544998|2229831|P2|NOT COMPLETED|Washout (1 Week)||0
921992|NCT01544998|2229832|P1|NOT COMPLETED|Washout (1 Week)||0
921993|NCT01544998|2229831|P2|COMPLETED|Washout (1 Week)||15
921994|NCT01544998|2229832|P1|COMPLETED|Washout (1 Week)||26
921995|NCT01544998|2229831|P2|STARTED|Washout (1 Week)||15
921996|NCT01544998|2229832|P1|STARTED|Washout (1 Week)||26
921997|NCT01544998|2229831|P2|NOT COMPLETED|First Intervention (3 Hours)||0
921998|NCT01544998|2229832|P1|NOT COMPLETED|First Intervention (3 Hours)||0
921999|NCT01544998|2229831|P2|COMPLETED|First Intervention (3 Hours)||15
922000|NCT01544998|2229832|P1|COMPLETED|First Intervention (3 Hours)||26
922001|NCT01544998|2229831|P2|STARTED|First Intervention (3 Hours)||15
922002|NCT01544998|2229832|P1|STARTED|First Intervention (3 Hours)||26
922003|NCT01544920|2229844|P2|NOT COMPLETED|Overall Study||23
922004|NCT01544920|2229845|P1|NOT COMPLETED|Overall Study||19
922005|NCT01544920|2229844|P2|COMPLETED|Overall Study||346
922006|NCT01544920|2229845|P1|COMPLETED|Overall Study||349
922007|NCT01544920|2229844|P2|STARTED|Overall Study||369
922008|NCT01544920|2229845|P1|STARTED|Overall Study||368
922009|NCT01544582|2229856|P4|NOT COMPLETED|Analysis Population||39
922010|NCT01544582|2229857|P3|NOT COMPLETED|Analysis Population||102
922011|NCT01544582|2229858|P2|NOT COMPLETED|Analysis Population||118
922012|NCT01544582|2229859|P1|NOT COMPLETED|Analysis Population||0
922013|NCT01544582|2229856|P4|COMPLETED|Analysis Population||35
922014|NCT01544582|2229857|P3|COMPLETED|Analysis Population||205
922015|NCT01544582|2229858|P2|COMPLETED|Analysis Population||180
922016|NCT01544582|2229859|P1|COMPLETED|Analysis Population||0
922017|NCT01544582|2229856|P4|STARTED|Analysis Population||74
922018|NCT01544582|2229857|P3|STARTED|Analysis Population||307
922019|NCT01544582|2229858|P2|STARTED|Analysis Population||298
922020|NCT01544582|2229859|P1|STARTED|Analysis Population|Analysis Population was grouped into Boceprevir+PR, Telaprevir+PR, or PR Alone|0
922021|NCT01544582|2229856|P4|NOT COMPLETED|Screening/Eligibility||0
922022|NCT01544582|2229857|P3|NOT COMPLETED|Screening/Eligibility||0
922023|NCT01544582|2229858|P2|NOT COMPLETED|Screening/Eligibility||0
922024|NCT01544582|2229859|P1|NOT COMPLETED|Screening/Eligibility||34
922025|NCT01544582|2229856|P4|COMPLETED|Screening/Eligibility||0
922026|NCT01544582|2229857|P3|COMPLETED|Screening/Eligibility||0
922027|NCT01544582|2229858|P2|COMPLETED|Screening/Eligibility||0
922028|NCT01544582|2229859|P1|COMPLETED|Screening/Eligibility|Completed means met criteria for Analysis Population|679
922029|NCT01544582|2229856|P4|Analysis Population|Screening/Eligibility||0
922030|NCT01544582|2229857|P3|Analysis Population|Screening/Eligibility||0
922031|NCT01544582|2229858|P2|Analysis Population|Screening/Eligibility||0
922032|NCT01544582|2229859|P1|Analysis Population|Screening/Eligibility||679
922033|NCT01544582|2229856|P4|STARTED|Screening/Eligibility||0
922034|NCT01544582|2229857|P3|STARTED|Screening/Eligibility||0
922035|NCT01544582|2229858|P2|STARTED|Screening/Eligibility||0
922036|NCT01544582|2229859|P1|STARTED|Screening/Eligibility||713
922037|NCT01544478|2229917|P1|NOT COMPLETED|Overall Study||118
922038|NCT01544478|2229917|P1|COMPLETED|Overall Study||912
922039|NCT01544478|2229917|P1|Vaccination 3|Overall Study||1019
922040|NCT01544478|2229917|P1|Vaccination 2|Overall Study||1026
922041|NCT01544478|2229917|P1|Vaccination 1|Overall Study||1030
922042|NCT01544478|2229917|P1|STARTED|Overall Study||1030
922043|NCT01544361|2229926|P5|NOT COMPLETED|Overall Study||0
922044|NCT01544361|2229927|P4|NOT COMPLETED|Overall Study||0
922045|NCT01544361|2229928|P3|NOT COMPLETED|Overall Study||0
922046|NCT01544361|2229929|P2|NOT COMPLETED|Overall Study||0
922047|NCT01544361|2229930|P1|NOT COMPLETED|Overall Study||0
922048|NCT01544361|2229926|P5|COMPLETED|Overall Study||6
922049|NCT01544361|2229927|P4|COMPLETED|Overall Study||6
922050|NCT01544361|2229928|P3|COMPLETED|Overall Study||6
922051|NCT01544361|2229929|P2|COMPLETED|Overall Study||6
922052|NCT01544361|2229930|P1|COMPLETED|Overall Study||8
922053|NCT01544361|2229926|P5|STARTED|Overall Study||6
922054|NCT01544361|2229927|P4|STARTED|Overall Study||6
922055|NCT01544361|2229928|P3|STARTED|Overall Study||6
922056|NCT01544361|2229929|P2|STARTED|Overall Study||6
922057|NCT01544361|2229930|P1|STARTED|Overall Study||8
922058|NCT01544348|2229960|P8|NOT COMPLETED|Overall Study||0
922059|NCT01544348|2229961|P7|NOT COMPLETED|Overall Study||2
922060|NCT01544348|2229962|P6|NOT COMPLETED|Overall Study||3
922061|NCT01544348|2229963|P5|NOT COMPLETED|Overall Study||1
922062|NCT01544348|2229964|P4|NOT COMPLETED|Overall Study||0
922063|NCT01544348|2229965|P3|NOT COMPLETED|Overall Study||0
922064|NCT01544348|2229966|P2|NOT COMPLETED|Overall Study||0
922065|NCT01544348|2229967|P1|NOT COMPLETED|Overall Study||2
922066|NCT01544348|2229960|P8|COMPLETED|Overall Study||8
922067|NCT01544348|2229961|P7|COMPLETED|Overall Study||12
922068|NCT01544348|2229962|P6|COMPLETED|Overall Study||16
922069|NCT01544348|2229963|P5|COMPLETED|Overall Study||15
922070|NCT01544348|2229964|P4|COMPLETED|Overall Study||3
922071|NCT01544348|2229965|P3|COMPLETED|Overall Study||3
922072|NCT01544348|2229966|P2|COMPLETED|Overall Study||6
922073|NCT01544348|2229967|P1|COMPLETED|Overall Study||15
922074|NCT01544348|2229960|P8|Treated|Overall Study||8
922075|NCT01544348|2229961|P7|Treated|Overall Study||14
922076|NCT01544348|2229962|P6|Treated|Overall Study||18
922077|NCT01544348|2229963|P5|Treated|Overall Study||15
922078|NCT01544348|2229964|P4|Treated|Overall Study||3
922079|NCT01544348|2229965|P3|Treated|Overall Study||3
922080|NCT01544348|2229966|P2|Treated|Overall Study||6
922081|NCT01544348|2229967|P1|Treated|Overall Study||17
922082|NCT01544348|2229960|P8|STARTED|Overall Study||8
922083|NCT01544348|2229961|P7|STARTED|Overall Study||14
922084|NCT01544348|2229962|P6|STARTED|Overall Study||19
922085|NCT01544348|2229963|P5|STARTED|Overall Study||16
922086|NCT01544348|2229964|P4|STARTED|Overall Study||3
922087|NCT01544348|2229965|P3|STARTED|Overall Study||3
922088|NCT01544348|2229966|P2|STARTED|Overall Study||6
922089|NCT01544348|2229967|P1|STARTED|Overall Study||17
922090|NCT01544309|2230009|P2|NOT COMPLETED|Overall Study||11
922091|NCT01544309|2230010|P1|NOT COMPLETED|Overall Study||20
922092|NCT01544309|2230009|P2|COMPLETED|Overall Study||514
922093|NCT01544309|2230010|P1|COMPLETED|Overall Study||504
922094|NCT01544309|2230009|P2|STARTED|Overall Study||525
922095|NCT01544309|2230010|P1|STARTED|Overall Study||524
922106|NCT01544166|2230077|P1|NOT COMPLETED|Overall Study||0
922107|NCT01544166|2230077|P1|COMPLETED|Overall Study||44
922108|NCT01544166|2230077|P1|STARTED|Overall Study||44
922109|NCT01544153|2230142|P4|NOT COMPLETED|Overall Study||0
922110|NCT01544153|2230143|P3|NOT COMPLETED|Overall Study||1
922111|NCT01544153|2230144|P2|NOT COMPLETED|Overall Study||1
922112|NCT01544153|2230145|P1|NOT COMPLETED|Overall Study||0
922113|NCT01544153|2230142|P4|COMPLETED|Overall Study||1317
922114|NCT01544153|2230143|P3|COMPLETED|Overall Study||1313
922115|NCT01544153|2230144|P2|COMPLETED|Overall Study||1323
922116|NCT01544153|2230145|P1|COMPLETED|Overall Study||1337
922117|NCT01544153|2230142|P4|STARTED|Overall Study||1317
922118|NCT01544153|2230143|P3|STARTED|Overall Study||1314
922119|NCT01544153|2230144|P2|STARTED|Overall Study||1324
922120|NCT01544153|2230145|P1|STARTED|Overall Study||1337
922121|NCT01544114|2230162|P3|NOT COMPLETED|Overall Study||5
922122|NCT01544114|2230163|P2|NOT COMPLETED|Overall Study||4
922123|NCT01544114|2230164|P1|NOT COMPLETED|Overall Study||1
922124|NCT01544114|2230162|P3|COMPLETED|Overall Study|completed study and received 6 months of study drug|17
922125|NCT01544114|2230163|P2|COMPLETED|Overall Study|completed study and received 6 months of study drug|16
922126|NCT01544114|2230164|P1|COMPLETED|Overall Study|completed study and received 6 months of study drug|3
922127|NCT01544114|2230162|P3|STARTED|Overall Study||22
922128|NCT01544114|2230163|P2|STARTED|Overall Study||20
922129|NCT01544114|2230164|P1|STARTED|Overall Study||4
922130|NCT01544062|2230195|P2|NOT COMPLETED|Overall Study||0
922131|NCT01544062|2230196|P1|NOT COMPLETED|Overall Study||0
922132|NCT01544062|2230195|P2|COMPLETED|Overall Study||35
922133|NCT01544062|2230196|P1|COMPLETED|Overall Study||33
922134|NCT01544062|2230195|P2|STARTED|Overall Study||35
922135|NCT01544062|2230196|P1|STARTED|Overall Study||33
922136|NCT01544023|2230242|P1|NOT COMPLETED|Overall Study||0
922137|NCT01544023|2230242|P1|COMPLETED|Overall Study||207
922138|NCT01544023|2230242|P1|STARTED|Overall Study|retrospective|207
922139|NCT01543958|2230247|P1|NOT COMPLETED|Overall Study||4
922140|NCT01543958|2230247|P1|COMPLETED|Overall Study||36
922141|NCT01543958|2230247|P1|STARTED|Overall Study||40
922142|NCT01543828|2230302|P2|NOT COMPLETED|Treatment 2||0
922143|NCT01543828|2230303|P1|NOT COMPLETED|Treatment 2||1
922144|NCT01543828|2230302|P2|COMPLETED|Treatment 2||19
922145|NCT01543828|2230303|P1|COMPLETED|Treatment 2||19
922146|NCT01543828|2230302|P2|STARTED|Treatment 2|1 participant completed treatment 1, had an adverse event, and did not receive treatment 2.|19
922147|NCT01543828|2230303|P1|STARTED|Treatment 2||20
922148|NCT01543828|2230302|P2|NOT COMPLETED|Treatment 1||0
922149|NCT01543828|2230303|P1|NOT COMPLETED|Treatment 1||0
922150|NCT01543828|2230302|P2|COMPLETED|Treatment 1||20
922151|NCT01543828|2230303|P1|COMPLETED|Treatment 1||20
922152|NCT01543828|2230302|P2|STARTED|Treatment 1||20
922153|NCT01543828|2230303|P1|STARTED|Treatment 1||20
922154|NCT01543685|2230316|P5|NOT COMPLETED|Overall Study||4
922155|NCT01543685|2230317|P4|NOT COMPLETED|Overall Study||0
922156|NCT01543685|2230318|P3|NOT COMPLETED|Overall Study||2
922157|NCT01543685|2230319|P2|NOT COMPLETED|Overall Study||3
922158|NCT01543685|2230320|P1|NOT COMPLETED|Overall Study||3
922159|NCT01543685|2230316|P5|COMPLETED|Overall Study||90
922160|NCT01543685|2230317|P4|COMPLETED|Overall Study||93
922161|NCT01543685|2230318|P3|COMPLETED|Overall Study||89
922162|NCT01543685|2230319|P2|COMPLETED|Overall Study||88
922163|NCT01543685|2230320|P1|COMPLETED|Overall Study||90
922164|NCT01543685|2230316|P5|STARTED|Overall Study||94
922165|NCT01543685|2230317|P4|STARTED|Overall Study||93
922166|NCT01543685|2230318|P3|STARTED|Overall Study||91
922167|NCT01543685|2230319|P2|STARTED|Overall Study||91
922168|NCT01543685|2230320|P1|STARTED|Overall Study||93
922169|NCT01543607|2230367|P1|NOT COMPLETED|Overall Study||0
922170|NCT01543607|2230367|P1|COMPLETED|Overall Study||1
922171|NCT01543607|2230367|P1|STARTED|Overall Study||1
922172|NCT01543581|2230373|P2|NOT COMPLETED|Overall Study||0
922173|NCT01543581|2230374|P1|NOT COMPLETED|Overall Study||0
922174|NCT01543581|2230373|P2|COMPLETED|Overall Study||0
922175|NCT01543581|2230374|P1|COMPLETED|Overall Study||1
922176|NCT01543581|2230373|P2|STARTED|Overall Study||0
922177|NCT01543581|2230374|P1|STARTED|Overall Study||1
922178|NCT01543568|2230380|P1|NOT COMPLETED|Overall Study||1
922179|NCT01543568|2230380|P1|COMPLETED|Overall Study||45
922180|NCT01543568|2230380|P1|STARTED|Overall Study||46
922181|NCT01543503|2230392|P2|NOT COMPLETED|Overall Study||87
922182|NCT01543503|2230393|P1|NOT COMPLETED|Overall Study||76
922183|NCT01543503|2230392|P2|COMPLETED|Overall Study||711
922184|NCT01543503|2230393|P1|COMPLETED|Overall Study||350
922185|NCT01543503|2230392|P2|STARTED|Overall Study||798
922186|NCT01543503|2230393|P1|STARTED|Overall Study||426
922187|NCT01543204|2230437|P1|NOT COMPLETED|Overall Study||8
922188|NCT01543204|2230437|P1|COMPLETED|Overall Study||56
922189|NCT01543204|2230437|P1|STARTED|Overall Study||64
922190|NCT01543178|2230484|P3|NOT COMPLETED|Double-blind Period||37
922191|NCT01543178|2230485|P2|NOT COMPLETED|Double-blind Period||44
922192|NCT01543178|2230486|P1|NOT COMPLETED|Double-blind Period||0
922193|NCT01543178|2230484|P3|COMPLETED|Double-blind Period|283 completed 1st double-blind retreatment and 271 completed 2nd double-blind retreatment.|271
922194|NCT01543178|2230485|P2|COMPLETED|Double-blind Period|295 completed 1st double-blind retreatment and 284 completed 2nd double-blind retreatment.|284
922195|NCT01543178|2230486|P1|COMPLETED|Double-blind Period||0
922196|NCT01543178|2230484|P3|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 308 randomized to placebo.|308
922197|NCT01543178|2230485|P2|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 328 randomized to rifaximin.|328
922198|NCT01543178|2230486|P1|STARTED|Double-blind Period|The open-label rifaximin arm/group is not applicable to the double-blind period.|0
922199|NCT01543178|2230484|P3|NOT COMPLETED|Open-label Period||0
922200|NCT01543178|2230485|P2|NOT COMPLETED|Open-label Period||0
922201|NCT01543178|2230486|P1|NOT COMPLETED|Open-label Period||1947
922202|NCT01543178|2230484|P3|COMPLETED|Open-label Period||0
922203|NCT01543178|2230485|P2|COMPLETED|Open-label Period||0
922204|NCT01543178|2230486|P1|COMPLETED|Open-label Period||636
922205|NCT01543178|2230484|P3|STARTED|Open-label Period|The double-blind placebo arm/group is not applicable to the open-label period.|0
922206|NCT01543178|2230485|P2|STARTED|Open-label Period|The double-blind rifaximin arm/group is not applicable to the open-label period.|0
922207|NCT01543178|2230486|P1|STARTED|Open-label Period|2583 subjects entered the open-label period, but 4 received no rifaximin; 2579 received rifaximin.|2583
922208|NCT01543074|2230497|P4|NOT COMPLETED|Overall Study||0
922209|NCT01543074|2230498|P3|NOT COMPLETED|Overall Study||0
922210|NCT01543074|2230499|P2|NOT COMPLETED|Overall Study||0
922211|NCT01543074|2230500|P1|NOT COMPLETED|Overall Study||0
922212|NCT01543074|2230497|P4|COMPLETED|Overall Study||6
922213|NCT01543074|2230498|P3|COMPLETED|Overall Study||5
922214|NCT01543074|2230499|P2|COMPLETED|Overall Study||7
922215|NCT01543074|2230500|P1|COMPLETED|Overall Study||5
922216|NCT01543074|2230497|P4|STARTED|Overall Study||6
922217|NCT01543074|2230498|P3|STARTED|Overall Study||5
922218|NCT01543074|2230499|P2|STARTED|Overall Study||7
922219|NCT01543074|2230500|P1|STARTED|Overall Study||5
922220|NCT01542957|2230516|P2|NOT COMPLETED|12-month Follow-up||13
922221|NCT01542957|2230517|P1|NOT COMPLETED|12-month Follow-up||16
922222|NCT01542957|2230516|P2|COMPLETED|12-month Follow-up||40
922223|NCT01542957|2230517|P1|COMPLETED|12-month Follow-up||37
922224|NCT01542957|2230516|P2|STARTED|12-month Follow-up||53
922225|NCT01542957|2230517|P1|STARTED|12-month Follow-up||53
922226|NCT01542957|2230516|P2|NOT COMPLETED|3-month Follow-up||8
922227|NCT01542957|2230517|P1|NOT COMPLETED|3-month Follow-up||3
922228|NCT01542957|2230516|P2|COMPLETED|3-month Follow-up||45
922229|NCT01542957|2230517|P1|COMPLETED|3-month Follow-up||50
922230|NCT01542957|2230516|P2|STARTED|3-month Follow-up||53
922231|NCT01542957|2230517|P1|STARTED|3-month Follow-up||53
922232|NCT01542957|2230516|P2|NOT COMPLETED|End of Therapy||10
922233|NCT01542957|2230517|P1|NOT COMPLETED|End of Therapy||12
922234|NCT01542957|2230516|P2|COMPLETED|End of Therapy||53
922235|NCT01542957|2230517|P1|COMPLETED|End of Therapy||53
922236|NCT01542957|2230516|P2|STARTED|End of Therapy||63
922237|NCT01542957|2230517|P1|STARTED|End of Therapy||65
922238|NCT01542788|2230529|P2|NOT COMPLETED|Overall Study||71
922239|NCT01542788|2230530|P1|NOT COMPLETED|Overall Study||55
922240|NCT01542788|2230529|P2|COMPLETED|Overall Study||0
922241|NCT01542788|2230530|P1|COMPLETED|Overall Study||154
922242|NCT01542788|2230529|P2|Randomized and Treated|Overall Study||71
922243|NCT01542788|2230530|P1|Randomized and Treated|Overall Study||207
922244|NCT01542788|2230529|P2|STARTED|Overall Study||71
922245|NCT01542788|2230530|P1|STARTED|Overall Study||209
922246|NCT01542684|2230546|P1|NOT COMPLETED|Overall Study||0
922247|NCT01542684|2230546|P1|COMPLETED|Overall Study||8
922248|NCT01542684|2230546|P1|STARTED|Overall Study||8
922249|NCT01542645|2230552|P2|NOT COMPLETED|Overall Study||3
922250|NCT01542645|2230553|P1|NOT COMPLETED|Overall Study||5
922251|NCT01542645|2230552|P2|COMPLETED|Overall Study||79
922252|NCT01542645|2230553|P1|COMPLETED|Overall Study||77
922253|NCT01542645|2230552|P2|STARTED|Overall Study||82
922254|NCT01542645|2230553|P1|STARTED|Overall Study||82
922255|NCT01542632|2230569|P6|NOT COMPLETED|Overall Study||0
922256|NCT01542632|2230570|P5|NOT COMPLETED|Overall Study||4
922257|NCT01542632|2230571|P4|NOT COMPLETED|Overall Study||2
922258|NCT01542632|2230572|P3|NOT COMPLETED|Overall Study||1
922259|NCT01542632|2230573|P2|NOT COMPLETED|Overall Study||1
922260|NCT01542632|2230574|P1|NOT COMPLETED|Overall Study||0
922261|NCT01542632|2230569|P6|COMPLETED|Overall Study||24
922262|NCT01542632|2230570|P5|COMPLETED|Overall Study||17
922263|NCT01542632|2230571|P4|COMPLETED|Overall Study||19
922264|NCT01542632|2230572|P3|COMPLETED|Overall Study||23
922265|NCT01542632|2230573|P2|COMPLETED|Overall Study||24
922266|NCT01542632|2230574|P1|COMPLETED|Overall Study||25
922267|NCT01542632|2230569|P6|STARTED|Overall Study||24
922268|NCT01542632|2230570|P5|STARTED|Overall Study||21
922269|NCT01542632|2230571|P4|STARTED|Overall Study||21
922270|NCT01542632|2230572|P3|STARTED|Overall Study||24
922271|NCT01542632|2230573|P2|STARTED|Overall Study||25
922272|NCT01542632|2230574|P1|STARTED|Overall Study||25
922279|NCT01542528|2230629|P2|NOT COMPLETED|Overall Study||7
922280|NCT01542528|2230630|P1|NOT COMPLETED|Overall Study||12
922281|NCT01542528|2230629|P2|COMPLETED|Overall Study||49
922282|NCT01542528|2230630|P1|COMPLETED|Overall Study||49
922283|NCT01542528|2230629|P2|STARTED|Overall Study||56
922284|NCT01542528|2230630|P1|STARTED|Overall Study||61
922285|NCT01542502|2230638|P2|NOT COMPLETED|Overall Study||0
922286|NCT01542502|2230639|P1|NOT COMPLETED|Overall Study||0
922287|NCT01542502|2230638|P2|COMPLETED|Overall Study||6
922288|NCT01542502|2230639|P1|COMPLETED|Overall Study||6
922289|NCT01542502|2230638|P2|STARTED|Overall Study||6
922290|NCT01542502|2230639|P1|STARTED|Overall Study||6
922291|NCT01542372|2230647|P2|NOT COMPLETED|Overall Study||0
922292|NCT01542372|2230648|P1|NOT COMPLETED|Overall Study||0
922293|NCT01542372|2230647|P2|COMPLETED|Overall Study||11
922294|NCT01542372|2230648|P1|COMPLETED|Overall Study||11
922295|NCT01542372|2230647|P2|STARTED|Overall Study||11
922296|NCT01542372|2230648|P1|STARTED|Overall Study||11
922297|NCT01542307|2230663|P2|NOT COMPLETED|Overall Study||0
922298|NCT01542307|2230664|P1|NOT COMPLETED|Overall Study||0
922299|NCT01542307|2230663|P2|COMPLETED|Overall Study||22
922300|NCT01542307|2230664|P1|COMPLETED|Overall Study||22
922301|NCT01542307|2230663|P2|STARTED|Overall Study|Each subject inhaled Medical Air for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
922302|NCT01542307|2230664|P1|STARTED|Overall Study|Each subject inhaled Oxygen for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
922303|NCT01542255|2230684|P1|NOT COMPLETED|Overall Study||0
922304|NCT01542255|2230684|P1|COMPLETED|Overall Study||7
922305|NCT01542255|2230684|P1|Analyzed for Time to Progression|Overall Study||7
922306|NCT01542255|2230684|P1|STARTED|Overall Study||7
922307|NCT01542125|2230690|P2|NOT COMPLETED|Overall Study||0
922308|NCT01542125|2230691|P1|NOT COMPLETED|Overall Study||0
922309|NCT01542125|2230690|P2|COMPLETED|Overall Study||141
922310|NCT01542125|2230691|P1|COMPLETED|Overall Study||140
922311|NCT01542125|2230690|P2|STARTED|Overall Study||141
922312|NCT01542125|2230691|P1|STARTED|Overall Study||140
922313|NCT01542034|2230699|P2|NOT COMPLETED|Overall Study||23
922314|NCT01542034|2230700|P1|NOT COMPLETED|Overall Study||30
922315|NCT01542034|2230699|P2|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|227
922316|NCT01542034|2230700|P1|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|226
922317|NCT01542034|2230699|P2|Received Treatment|Overall Study||249
922318|NCT01542034|2230700|P1|Received Treatment|Overall Study||256
922319|NCT01542034|2230699|P2|STARTED|Overall Study||250
922320|NCT01542034|2230700|P1|STARTED|Overall Study||256
922321|NCT01541969|2230714|P2|NOT COMPLETED|Open Label Extension (12-36 Weeks)||13
922322|NCT01541969|2230715|P1|NOT COMPLETED|Open Label Extension (12-36 Weeks)||11
922323|NCT01541969|2230714|P2|COMPLETED|Open Label Extension (12-36 Weeks)||35
922324|NCT01541969|2230715|P1|COMPLETED|Open Label Extension (12-36 Weeks)||33
922325|NCT01541969|2230714|P2|STARTED|Open Label Extension (12-36 Weeks)||48
922326|NCT01541969|2230715|P1|STARTED|Open Label Extension (12-36 Weeks)||44
922327|NCT01541969|2230714|P2|NOT COMPLETED|Double-blind (0-12 Weeks)||2
922328|NCT01541969|2230715|P1|NOT COMPLETED|Double-blind (0-12 Weeks)||6
922329|NCT01541969|2230714|P2|COMPLETED|Double-blind (0-12 Weeks)||48
922330|NCT01541969|2230715|P1|COMPLETED|Double-blind (0-12 Weeks)||44
922331|NCT01541969|2230714|P2|STARTED|Double-blind (0-12 Weeks)||50
922332|NCT01541969|2230715|P1|STARTED|Double-blind (0-12 Weeks)||50
922333|NCT01541930|2230731|P1|NOT COMPLETED|Overall Study||1
922334|NCT01541930|2230731|P1|COMPLETED|Overall Study||20
922335|NCT01541930|2230731|P1|STARTED|Overall Study||21
922336|NCT01541917|2230753|P2|NOT COMPLETED|Overall Study||9
922337|NCT01541917|2230754|P1|NOT COMPLETED|Overall Study||15
922338|NCT01541917|2230753|P2|COMPLETED|Overall Study||136
922339|NCT01541917|2230754|P1|COMPLETED|Overall Study||129
922340|NCT01541917|2230753|P2|STARTED|Overall Study||145
922341|NCT01541917|2230754|P1|STARTED|Overall Study||144
922342|NCT01541865|2230770|P1|NOT COMPLETED|Overall Study||22
922343|NCT01541865|2230770|P1|COMPLETED|Overall Study||124
922344|NCT01541865|2230770|P1|STARTED|Overall Study||146
922345|NCT01541826|2230788|P3|NOT COMPLETED|Overall Study||0
922346|NCT01541826|2230789|P2|NOT COMPLETED|Overall Study||3
922347|NCT01541826|2230790|P1|NOT COMPLETED|Overall Study||4
922348|NCT01541826|2230788|P3|COMPLETED|Overall Study||6
922349|NCT01541826|2230789|P2|COMPLETED|Overall Study||25
922350|NCT01541826|2230790|P1|COMPLETED|Overall Study||24
922351|NCT01541826|2230788|P3|STARTED|Overall Study||6
922352|NCT01541826|2230789|P2|STARTED|Overall Study||28
922353|NCT01541826|2230790|P1|STARTED|Overall Study||28
922354|NCT01541735|2230859|P2|NOT COMPLETED|Overall Study||0
922355|NCT01541735|2230860|P1|NOT COMPLETED|Overall Study||0
922356|NCT01541735|2230859|P2|COMPLETED|Overall Study||7
922357|NCT01541735|2230860|P1|COMPLETED|Overall Study||7
922358|NCT01541735|2230859|P2|STARTED|Overall Study||7
922359|NCT01541735|2230860|P1|STARTED|Overall Study||7
922360|NCT01541644|2230872|P1|NOT COMPLETED|Overall Study||3
922361|NCT01541644|2230872|P1|COMPLETED|Overall Study||24
922362|NCT01541644|2230872|P1|STARTED|Overall Study||27
922363|NCT01541553|2230878|P2|NOT COMPLETED|Overall Study||14
922364|NCT01541553|2230879|P1|NOT COMPLETED|Overall Study||12
922365|NCT01541553|2230878|P2|COMPLETED|Overall Study||148
922366|NCT01541553|2230879|P1|COMPLETED|Overall Study||155
922367|NCT01541553|2230878|P2|STARTED|Overall Study||162
922368|NCT01541553|2230879|P1|STARTED|Overall Study||167
922369|NCT01541397|2230891|P2|NOT COMPLETED|Overall Study||2
922370|NCT01541397|2230892|P1|NOT COMPLETED|Overall Study||4
922371|NCT01541397|2230891|P2|COMPLETED|Overall Study||0
922372|NCT01541397|2230892|P1|COMPLETED|Overall Study||0
922373|NCT01541397|2230891|P2|STARTED|Overall Study||2
922374|NCT01541397|2230892|P1|STARTED|Overall Study||4
922375|NCT01541384|2230907|P3|NOT COMPLETED|Overall Study||2
922376|NCT01541384|2230908|P2|NOT COMPLETED|Overall Study||1
922377|NCT01541384|2230909|P1|NOT COMPLETED|Overall Study||0
922378|NCT01541384|2230907|P3|COMPLETED|Overall Study||38
922379|NCT01541384|2230908|P2|COMPLETED|Overall Study||39
922380|NCT01541384|2230909|P1|COMPLETED|Overall Study||40
922381|NCT01541384|2230907|P3|STARTED|Overall Study||40
922382|NCT01541384|2230908|P2|STARTED|Overall Study||40
922383|NCT01541384|2230909|P1|STARTED|Overall Study||40
922384|NCT01541371|2230917|P1|NOT COMPLETED|Overall Study||77
922385|NCT01541371|2230917|P1|COMPLETED|Overall Study||326
922386|NCT01541371|2230917|P1|Full Analysis Set|Overall Study||394
922387|NCT01541371|2230917|P1|STARTED|Overall Study||403
922388|NCT01541358|2230940|P1|NOT COMPLETED|Overall Study||0
922389|NCT01541358|2230940|P1|COMPLETED|Overall Study||2
922390|NCT01541358|2230940|P1|STARTED|Overall Study||2
922391|NCT01541254|2230946|P1|NOT COMPLETED|Overall Study||6
922392|NCT01541254|2230946|P1|COMPLETED|Overall Study||30
922393|NCT01541254|2230946|P1|STARTED|Overall Study||36
922394|NCT01540981|2230953|P2|NOT COMPLETED|Overall Study||0
922395|NCT01540981|2230954|P1|NOT COMPLETED|Overall Study||1
922396|NCT01540981|2230953|P2|COMPLETED|Overall Study||6
922397|NCT01540981|2230954|P1|COMPLETED|Overall Study||5
922398|NCT01540981|2230953|P2|STARTED|Overall Study||6
922399|NCT01540981|2230954|P1|STARTED|Overall Study||6
922400|NCT01540851|2230964|P2|NOT COMPLETED|Overall Study||18
922401|NCT01540851|2230965|P1|NOT COMPLETED|Overall Study||21
922402|NCT01540851|2230964|P2|COMPLETED|Overall Study||136
922403|NCT01540851|2230965|P1|COMPLETED|Overall Study||133
922404|NCT01540851|2230964|P2|STARTED|Overall Study||154
922405|NCT01540851|2230965|P1|STARTED|Overall Study||154
922406|NCT01540825|2230986|P11|NOT COMPLETED|Overall Study||0
922407|NCT01540825|2230987|P10|NOT COMPLETED|Overall Study||0
922408|NCT01540825|2230988|P9|NOT COMPLETED|Overall Study||0
922409|NCT01540825|2230989|P8|NOT COMPLETED|Overall Study||0
922410|NCT01540825|2230990|P7|NOT COMPLETED|Overall Study||0
922411|NCT01540825|2230991|P6|NOT COMPLETED|Overall Study||0
922412|NCT01540825|2230992|P5|NOT COMPLETED|Overall Study||0
922413|NCT01540825|2230993|P4|NOT COMPLETED|Overall Study||0
922414|NCT01540825|2230994|P3|NOT COMPLETED|Overall Study||0
922415|NCT01540825|2230995|P2|NOT COMPLETED|Overall Study||0
922416|NCT01540825|2230996|P1|NOT COMPLETED|Overall Study||0
922417|NCT01540825|2230986|P11|COMPLETED|Overall Study||6
922418|NCT01540825|2230987|P10|COMPLETED|Overall Study||6
922419|NCT01540825|2230988|P9|COMPLETED|Overall Study||6
922420|NCT01540825|2230989|P8|COMPLETED|Overall Study||6
922421|NCT01540825|2230990|P7|COMPLETED|Overall Study||6
922422|NCT01540825|2230991|P6|COMPLETED|Overall Study||6
922423|NCT01540825|2230992|P5|COMPLETED|Overall Study||6
922424|NCT01540825|2230993|P4|COMPLETED|Overall Study||6
922425|NCT01540825|2230994|P3|COMPLETED|Overall Study||6
922426|NCT01540825|2230995|P2|COMPLETED|Overall Study||6
922427|NCT01540825|2230996|P1|COMPLETED|Overall Study||20
922428|NCT01540825|2230986|P11|STARTED|Overall Study||6
922429|NCT01540825|2230987|P10|STARTED|Overall Study||6
922430|NCT01540825|2230988|P9|STARTED|Overall Study||6
922431|NCT01540825|2230989|P8|STARTED|Overall Study||6
922432|NCT01540825|2230990|P7|STARTED|Overall Study||6
922433|NCT01540825|2230991|P6|STARTED|Overall Study||6
922434|NCT01540825|2230992|P5|STARTED|Overall Study||6
922435|NCT01540825|2230993|P4|STARTED|Overall Study||6
922436|NCT01540825|2230994|P3|STARTED|Overall Study||6
922437|NCT01540825|2230995|P2|STARTED|Overall Study||6
922438|NCT01540825|2230996|P1|STARTED|Overall Study||20
922439|NCT01540773|2231092|P2|NOT COMPLETED|Second Intervention||0
922440|NCT01540773|2231093|P1|NOT COMPLETED|Second Intervention||0
922441|NCT01540773|2231092|P2|COMPLETED|Second Intervention||8
922442|NCT01540773|2231093|P1|COMPLETED|Second Intervention||8
922443|NCT01540773|2231092|P2|STARTED|Second Intervention||8
922444|NCT01540773|2231093|P1|STARTED|Second Intervention||8
922445|NCT01540773|2231092|P2|NOT COMPLETED|Wash Out Period of 1 Week||0
922446|NCT01540773|2231093|P1|NOT COMPLETED|Wash Out Period of 1 Week||0
922447|NCT01540773|2231092|P2|COMPLETED|Wash Out Period of 1 Week||8
922448|NCT01540773|2231093|P1|COMPLETED|Wash Out Period of 1 Week||8
922449|NCT01540773|2231092|P2|STARTED|Wash Out Period of 1 Week||8
922450|NCT01540773|2231093|P1|STARTED|Wash Out Period of 1 Week||8
922451|NCT01540773|2231092|P2|NOT COMPLETED|First Intervention||0
922452|NCT01540773|2231093|P1|NOT COMPLETED|First Intervention||0
922453|NCT01540773|2231092|P2|COMPLETED|First Intervention||8
922454|NCT01540773|2231093|P1|COMPLETED|First Intervention||8
922455|NCT01540773|2231092|P2|STARTED|First Intervention||8
922456|NCT01540773|2231093|P1|STARTED|First Intervention||8
922457|NCT01540487|2231105|P2|NOT COMPLETED|Overall Study||0
922458|NCT01540487|2231106|P1|NOT COMPLETED|Overall Study||1
922459|NCT01540487|2231105|P2|COMPLETED|Overall Study||24
922460|NCT01540487|2231106|P1|COMPLETED|Overall Study||23
922461|NCT01540487|2231105|P2|STARTED|Overall Study||24
922462|NCT01540487|2231106|P1|STARTED|Overall Study||24
922463|NCT01540370|2231140|P1|NOT COMPLETED|Overall Study||2
922464|NCT01540370|2231140|P1|COMPLETED|Overall Study||100
922465|NCT01540370|2231140|P1|STARTED|Overall Study||102
922466|NCT01540266|2231151|P6|NOT COMPLETED|Overall Study||0
922467|NCT01540266|2231152|P5|NOT COMPLETED|Overall Study||0
922468|NCT01540266|2231153|P4|NOT COMPLETED|Overall Study||0
922469|NCT01540266|2231154|P3|NOT COMPLETED|Overall Study||1
922470|NCT01540266|2231155|P2|NOT COMPLETED|Overall Study||1
922471|NCT01540266|2231156|P1|NOT COMPLETED|Overall Study||6
922472|NCT01540266|2231151|P6|COMPLETED|Overall Study||19
922473|NCT01540266|2231152|P5|COMPLETED|Overall Study||20
922474|NCT01540266|2231153|P4|COMPLETED|Overall Study||38
922475|NCT01540266|2231154|P3|COMPLETED|Overall Study||59
922476|NCT01540266|2231155|P2|COMPLETED|Overall Study||41
922477|NCT01540266|2231156|P1|COMPLETED|Overall Study||57
922478|NCT01540266|2231151|P6|STARTED|Overall Study||19
922479|NCT01540266|2231152|P5|STARTED|Overall Study||20
922480|NCT01540266|2231153|P4|STARTED|Overall Study||38
922481|NCT01540266|2231154|P3|STARTED|Overall Study||60
922482|NCT01540266|2231155|P2|STARTED|Overall Study||42
922483|NCT01540266|2231156|P1|STARTED|Overall Study||63
922484|NCT01540162|2231172|P2|NOT COMPLETED|Overall Study||0
922485|NCT01540162|2231173|P1|NOT COMPLETED|Overall Study||0
922486|NCT01540162|2231172|P2|COMPLETED|Overall Study||32
922487|NCT01540162|2231173|P1|COMPLETED|Overall Study||30
922488|NCT01540162|2231172|P2|STARTED|Overall Study||32
922489|NCT01540162|2231173|P1|STARTED|Overall Study||30
922490|NCT01540045|2231183|P1|NOT COMPLETED|Overall Study||0
922491|NCT01540045|2231183|P1|COMPLETED|Overall Study||40
922492|NCT01540045|2231183|P1|STARTED|Overall Study||40
922493|NCT01539980|2231222|P1|NOT COMPLETED|Overall Study||0
922494|NCT01539980|2231222|P1|COMPLETED|Overall Study||30
922495|NCT01539980|2231222|P1|STARTED|Overall Study||30
922496|NCT01539811|2231232|P2|NOT COMPLETED|Overall Study||0
922497|NCT01539811|2231233|P1|NOT COMPLETED|Overall Study||0
922498|NCT01539811|2231232|P2|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
922499|NCT01539811|2231233|P1|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
922500|NCT01539811|2231232|P2|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
922501|NCT01539811|2231233|P1|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
922516|NCT01539642|2231252|P2|NOT COMPLETED|Overall Study||31
922517|NCT01539642|2231253|P1|NOT COMPLETED|Overall Study||36
922518|NCT01539642|2231252|P2|COMPLETED|Overall Study||27
922519|NCT01539642|2231253|P1|COMPLETED|Overall Study||78
922520|NCT01539642|2231252|P2|STARTED|Overall Study||58
922521|NCT01539642|2231253|P1|STARTED|Overall Study||114
922522|NCT01539590|2231261|P2|NOT COMPLETED|Overall Study||0
922523|NCT01539590|2231262|P1|NOT COMPLETED|Overall Study||3
922524|NCT01539590|2231261|P2|COMPLETED|Overall Study||2
922525|NCT01539590|2231262|P1|COMPLETED|Overall Study||0
922526|NCT01539590|2231261|P2|Complete Study Treatment|Overall Study||2
922527|NCT01539590|2231262|P1|Complete Study Treatment|Overall Study||1
922528|NCT01539590|2231261|P2|STARTED|Overall Study||2
922529|NCT01539590|2231262|P1|STARTED|Overall Study||3
922530|NCT01539538|2231270|P2|NOT COMPLETED|Overall Study||44
922531|NCT01539538|2231271|P1|NOT COMPLETED|Overall Study||31
922532|NCT01539538|2231270|P2|COMPLETED|Overall Study||136
922533|NCT01539538|2231271|P1|COMPLETED|Overall Study||146
922534|NCT01539538|2231270|P2|STARTED|Overall Study||180
922535|NCT01539538|2231271|P1|STARTED|Overall Study||177
922536|NCT01539525|2231280|P3|NOT COMPLETED|Overall Study||17
922537|NCT01539525|2231281|P2|NOT COMPLETED|Overall Study||16
922538|NCT01539525|2231282|P1|NOT COMPLETED|Overall Study||20
922539|NCT01539525|2231280|P3|COMPLETED|Overall Study||134
922540|NCT01539525|2231281|P2|COMPLETED|Overall Study||127
922541|NCT01539525|2231282|P1|COMPLETED|Overall Study||125
922542|NCT01539525|2231280|P3|STARTED|Overall Study||151
922543|NCT01539525|2231281|P2|STARTED|Overall Study||143
922544|NCT01539525|2231282|P1|STARTED|Overall Study||145
922545|NCT01539512|2231301|P2|NOT COMPLETED|Overall Study||13
922546|NCT01539512|2231302|P1|NOT COMPLETED|Overall Study||23
922547|NCT01539512|2231301|P2|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|97
922548|NCT01539512|2231302|P1|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|87
922549|NCT01539512|2231301|P2|STARTED|Overall Study||110
922550|NCT01539512|2231302|P1|STARTED|Overall Study||110
922551|NCT01539317|2231318|P2|NOT COMPLETED|Overall Study||0
922552|NCT01539317|2231319|P1|NOT COMPLETED|Overall Study||1
922553|NCT01539317|2231318|P2|COMPLETED|Overall Study||25
922554|NCT01539317|2231319|P1|COMPLETED|Overall Study||24
922555|NCT01539317|2231318|P2|STARTED|Overall Study||25
922556|NCT01539317|2231319|P1|STARTED|Overall Study||25
922557|NCT01539135|2231336|P2|NOT COMPLETED|Overall Study||0
922558|NCT01539135|2231337|P1|NOT COMPLETED|Overall Study||0
922559|NCT01539135|2231336|P2|COMPLETED|Overall Study||37
922560|NCT01539135|2231337|P1|COMPLETED|Overall Study||43
922561|NCT01539135|2231336|P2|STARTED|Overall Study||37
922562|NCT01539135|2231337|P1|STARTED|Overall Study||43
922563|NCT01539083|2231349|P3|NOT COMPLETED|After Randomization (TP and VTP)||11
922564|NCT01539083|2231350|P2|NOT COMPLETED|After Randomization (TP and VTP)||13
922565|NCT01539083|2231351|P1|NOT COMPLETED|After Randomization (TP and VTP)||0
922566|NCT01539083|2231349|P3|COMPLETED|After Randomization (TP and VTP)||92
922567|NCT01539083|2231350|P2|COMPLETED|After Randomization (TP and VTP)||87
922568|NCT01539083|2231351|P1|COMPLETED|After Randomization (TP and VTP)||0
922569|NCT01539083|2231349|P3|Safety Population|After Randomization (TP and VTP)||103
922570|NCT01539083|2231350|P2|Safety Population|After Randomization (TP and VTP)|One participant was randomized but not treated. Hence, was not included in safety population.|99
922571|NCT01539083|2231351|P1|Safety Population|After Randomization (TP and VTP)||0
922572|NCT01539083|2231349|P3|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidated treatment.|103
922573|NCT01539083|2231350|P2|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidated treatment.|100
922574|NCT01539083|2231351|P1|STARTED|After Randomization (TP and VTP)||0
922575|NCT01539083|2231349|P3|NOT COMPLETED|Before Randomization (VCD Induction)||0
922576|NCT01539083|2231350|P2|NOT COMPLETED|Before Randomization (VCD Induction)||0
922577|NCT01539083|2231351|P1|NOT COMPLETED|Before Randomization (VCD Induction)||53
922578|NCT01539083|2231349|P3|COMPLETED|Before Randomization (VCD Induction)||0
922579|NCT01539083|2231350|P2|COMPLETED|Before Randomization (VCD Induction)||0
922580|NCT01539083|2231351|P1|COMPLETED|Before Randomization (VCD Induction)||203
922581|NCT01539083|2231349|P3|Treated|Before Randomization (VCD Induction)||0
922582|NCT01539083|2231350|P2|Treated|Before Randomization (VCD Induction)||0
922583|NCT01539083|2231351|P1|Treated|Before Randomization (VCD Induction)||254
922584|NCT01539083|2231349|P3|STARTED|Before Randomization (VCD Induction)||0
922585|NCT01539083|2231350|P2|STARTED|Before Randomization (VCD Induction)||0
922586|NCT01539083|2231351|P1|STARTED|Before Randomization (VCD Induction)||256
922587|NCT01539070|2231374|P2|NOT COMPLETED|Overall Study||39
922588|NCT01539070|2231375|P1|NOT COMPLETED|Overall Study||59
922589|NCT01539070|2231374|P2|COMPLETED|Overall Study||99
922590|NCT01539070|2231375|P1|COMPLETED|Overall Study||109
922591|NCT01539070|2231374|P2|STARTED|Overall Study||138
922592|NCT01539070|2231375|P1|STARTED|Overall Study||168
922593|NCT01538862|2231387|P1|NOT COMPLETED|Overall Study||0
922594|NCT01538862|2231387|P1|COMPLETED|Overall Study||7
922595|NCT01538862|2231387|P1|STARTED|Overall Study||7
922596|NCT01538472|2231393|P1|NOT COMPLETED|Overall Study||4
922597|NCT01538472|2231393|P1|COMPLETED|Overall Study||36
922598|NCT01538472|2231393|P1|STARTED|Overall Study||40
922599|NCT01537900|2231398|P1|NOT COMPLETED|Overall Study||0
922600|NCT01537900|2231398|P1|COMPLETED|Overall Study||4
922601|NCT01537900|2231398|P1|STARTED|Overall Study||4
922602|NCT01537835|2231412|P3|NOT COMPLETED|Overall Study||0
922603|NCT01537835|2231413|P2|NOT COMPLETED|Overall Study||0
922604|NCT01537835|2231414|P1|NOT COMPLETED|Overall Study||0
922605|NCT01537835|2231412|P3|COMPLETED|Overall Study||35
922606|NCT01537835|2231413|P2|COMPLETED|Overall Study||37
922607|NCT01537835|2231414|P1|COMPLETED|Overall Study||37
922608|NCT01537835|2231412|P3|STARTED|Overall Study||35
922609|NCT01537835|2231413|P2|STARTED|Overall Study||37
922610|NCT01537835|2231414|P1|STARTED|Overall Study||37
922611|NCT01537783|2231427|P2|NOT COMPLETED|Overall Study||2
922612|NCT01537783|2231428|P1|NOT COMPLETED|Overall Study||11
922613|NCT01537783|2231427|P2|COMPLETED|Overall Study||23
922614|NCT01537783|2231428|P1|COMPLETED|Overall Study||14
922615|NCT01537783|2231427|P2|STARTED|Overall Study||25
922616|NCT01537783|2231428|P1|STARTED|Overall Study||25
922617|NCT01537666|2231438|P4|NOT COMPLETED|Overall Study||0
922618|NCT01537666|2231439|P3|NOT COMPLETED|Overall Study||0
922619|NCT01537666|2231440|P2|NOT COMPLETED|Overall Study||0
922620|NCT01537666|2231441|P1|NOT COMPLETED|Overall Study||0
922621|NCT01537666|2231438|P4|COMPLETED|Overall Study|1 patient withdrew after a 32 mg dose and was replaced by a patient who only received an 80 mg dose.|7
922622|NCT01537666|2231439|P3|COMPLETED|Overall Study||6
922623|NCT01537666|2231440|P2|COMPLETED|Overall Study||6
922624|NCT01537666|2231441|P1|COMPLETED|Overall Study||6
922625|NCT01537666|2231438|P4|STARTED|Overall Study|5 of 7 patients received a 32 mg dose of AeroVanc followed by a dose of 80 mg at least 1 week later.|7
922626|NCT01537666|2231439|P3|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
922627|NCT01537666|2231440|P2|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
922628|NCT01537666|2231441|P1|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
922629|NCT01537549|2231479|P1|NOT COMPLETED|Overall Study||3
922630|NCT01537549|2231479|P1|COMPLETED|Overall Study||8
922631|NCT01537549|2231479|P1|STARTED|Overall Study||11
922632|NCT01537432|2231487|P2|NOT COMPLETED|Overall Study||2
922633|NCT01537432|2231488|P1|NOT COMPLETED|Overall Study||6
922634|NCT01537432|2231487|P2|COMPLETED|Overall Study||10
922635|NCT01537432|2231488|P1|COMPLETED|Overall Study||18
922636|NCT01537432|2231487|P2|STARTED|Overall Study||12
922637|NCT01537432|2231488|P1|STARTED|Overall Study||24
922638|NCT01537367|2231499|P3|NOT COMPLETED|Overall Study||0
922639|NCT01537367|2231500|P2|NOT COMPLETED|Overall Study||0
922640|NCT01537367|2231501|P1|NOT COMPLETED|Overall Study||0
922641|NCT01537367|2231499|P3|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|613
922642|NCT01537367|2231500|P2|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|610
922643|NCT01537367|2231501|P1|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|615
922644|NCT01537367|2231499|P3|STARTED|Overall Study||613
922645|NCT01537367|2231500|P2|STARTED|Overall Study||610
922646|NCT01537367|2231501|P1|STARTED|Overall Study||615
922647|NCT01537315|2231517|P2|NOT COMPLETED|Overall Study||0
922648|NCT01537315|2231518|P1|NOT COMPLETED|Overall Study||0
922649|NCT01537315|2231517|P2|COMPLETED|Overall Study||7
922650|NCT01537315|2231518|P1|COMPLETED|Overall Study||1
922651|NCT01537315|2231517|P2|STARTED|Overall Study||7
922652|NCT01537315|2231518|P1|STARTED|Overall Study||1
922653|NCT01537302|2231524|P1|NOT COMPLETED|Overall Study||2
922654|NCT01537302|2231524|P1|COMPLETED|Overall Study||199
922655|NCT01537302|2231524|P1|STARTED|Overall Study||201
922656|NCT01537198|2231531|P1|NOT COMPLETED|Overall Study||154
922657|NCT01537198|2231531|P1|COMPLETED|Overall Study||463
922658|NCT01537198|2231531|P1|STARTED|Overall Study||617
922659|NCT01537185|2231539|P4|NOT COMPLETED|Overall Study||2
922660|NCT01537185|2231540|P3|NOT COMPLETED|Overall Study||6
922661|NCT01537185|2231541|P2|NOT COMPLETED|Overall Study||6
922662|NCT01537185|2231542|P1|NOT COMPLETED|Overall Study||3
922663|NCT01537185|2231539|P4|COMPLETED|Overall Study||8
922664|NCT01537185|2231540|P3|COMPLETED|Overall Study||4
922665|NCT01537185|2231541|P2|COMPLETED|Overall Study||6
922666|NCT01537185|2231542|P1|COMPLETED|Overall Study||7
922667|NCT01537185|2231539|P4|STARTED|Overall Study||10
922668|NCT01537185|2231540|P3|STARTED|Overall Study||10
922669|NCT01537185|2231541|P2|STARTED|Overall Study||12
922670|NCT01537185|2231542|P1|STARTED|Overall Study||10
922671|NCT01537133|2231560|P4|NOT COMPLETED|Overall Study||0
922672|NCT01537133|2231561|P3|NOT COMPLETED|Overall Study||0
922673|NCT01537133|2231562|P2|NOT COMPLETED|Overall Study||0
922674|NCT01537133|2231563|P1|NOT COMPLETED|Overall Study||3
922675|NCT01537133|2231560|P4|COMPLETED|Overall Study||21
922676|NCT01537133|2231561|P3|COMPLETED|Overall Study||21
922677|NCT01537133|2231562|P2|COMPLETED|Overall Study||14
922678|NCT01537133|2231563|P1|COMPLETED|Overall Study||25
922679|NCT01537133|2231560|P4|STARTED|Overall Study||21
922680|NCT01537133|2231561|P3|STARTED|Overall Study||21
922681|NCT01537133|2231562|P2|STARTED|Overall Study||14
922682|NCT01537133|2231563|P1|STARTED|Overall Study||28
922683|NCT01537120|2231579|P1|NOT COMPLETED|12 Weeks Vildagliptin||0
922684|NCT01537120|2231579|P1|COMPLETED|12 Weeks Vildagliptin||23
922685|NCT01537120|2231579|P1|STARTED|12 Weeks Vildagliptin||23
922686|NCT01537120|2231579|P1|NOT COMPLETED|3 Weeks Placebo||1
922687|NCT01537120|2231579|P1|COMPLETED|3 Weeks Placebo||23
922688|NCT01537120|2231579|P1|STARTED|3 Weeks Placebo||24
922689|NCT01537120|2231579|P1|NOT COMPLETED|8 Weeks Washout||1
922690|NCT01537120|2231579|P1|COMPLETED|8 Weeks Washout||24
922691|NCT01537120|2231579|P1|STARTED|8 Weeks Washout||25
922692|NCT01537120|2231579|P1|NOT COMPLETED|Enrolled||0
922693|NCT01537120|2231579|P1|COMPLETED|Enrolled||25
922694|NCT01537120|2231579|P1|STARTED|Enrolled||25
922695|NCT01537081|2231592|P3|NOT COMPLETED|Overall Study||16
922696|NCT01537081|2231593|P2|NOT COMPLETED|Overall Study||38
922697|NCT01537081|2231594|P1|NOT COMPLETED|Overall Study||39
922698|NCT01537081|2231592|P3|COMPLETED|Overall Study||547
922699|NCT01537081|2231593|P2|COMPLETED|Overall Study||1086
922700|NCT01537081|2231594|P1|COMPLETED|Overall Study||1084
922701|NCT01537081|2231592|P3|Modified Intent to Treat Population|Overall Study||556
922702|NCT01537081|2231593|P2|Modified Intent to Treat Population|Overall Study||1109
922703|NCT01537081|2231594|P1|Modified Intent to Treat Population|Overall Study||1106
922704|NCT01537081|2231592|P3|Safety Population|Overall Study||561
922705|NCT01537081|2231593|P2|Safety Population|Overall Study||1122
922706|NCT01537081|2231594|P1|Safety Population|Overall Study||1122
922707|NCT01537081|2231592|P3|STARTED|Overall Study||563
922708|NCT01537081|2231593|P2|STARTED|Overall Study||1124
922709|NCT01537081|2231594|P1|STARTED|Overall Study||1123
922710|NCT01537068|2231607|P2|NOT COMPLETED|Overall Study||3
922711|NCT01537068|2231608|P1|NOT COMPLETED|Overall Study||4
922712|NCT01537068|2231607|P2|COMPLETED|Overall Study||26
922713|NCT01537068|2231608|P1|COMPLETED|Overall Study||26
922714|NCT01537068|2231607|P2|STARTED|Overall Study||29
922715|NCT01537068|2231608|P1|STARTED|Overall Study||30
922716|NCT01537042|2231620|P2|NOT COMPLETED|Overall Study||5
922717|NCT01537042|2231621|P1|NOT COMPLETED|Overall Study||0
922718|NCT01537042|2231620|P2|COMPLETED|Overall Study||15
922719|NCT01537042|2231621|P1|COMPLETED|Overall Study||10
922720|NCT01537042|2231620|P2|STARTED|Overall Study||20
922721|NCT01537042|2231621|P1|STARTED|Overall Study||10
922722|NCT01536951|2231659|P9|NOT COMPLETED|Third Intervention||0
922723|NCT01536951|2231660|P8|NOT COMPLETED|Third Intervention||0
922724|NCT01536951|2231661|P7|NOT COMPLETED|Third Intervention||0
922725|NCT01536951|2231662|P6|NOT COMPLETED|Third Intervention||0
922726|NCT01536951|2231663|P5|NOT COMPLETED|Third Intervention||0
922727|NCT01536951|2231664|P4|NOT COMPLETED|Third Intervention||0
922728|NCT01536951|2231665|P3|NOT COMPLETED|Third Intervention||0
922729|NCT01536951|2231666|P2|NOT COMPLETED|Third Intervention||0
922730|NCT01536951|2231667|P1|NOT COMPLETED|Third Intervention||0
922731|NCT01536951|2231659|P9|COMPLETED|Third Intervention||9
922732|NCT01536951|2231660|P8|COMPLETED|Third Intervention||8
922733|NCT01536951|2231661|P7|COMPLETED|Third Intervention||9
922734|NCT01536951|2231662|P6|COMPLETED|Third Intervention||9
922735|NCT01536951|2231663|P5|COMPLETED|Third Intervention||9
922736|NCT01536951|2231664|P4|COMPLETED|Third Intervention||8
922737|NCT01536951|2231665|P3|COMPLETED|Third Intervention||2
922738|NCT01536951|2231666|P2|COMPLETED|Third Intervention||3
922739|NCT01536951|2231667|P1|COMPLETED|Third Intervention||3
922740|NCT01536951|2231659|P9|STARTED|Third Intervention||9
922741|NCT01536951|2231660|P8|STARTED|Third Intervention||8
922742|NCT01536951|2231661|P7|STARTED|Third Intervention||9
922743|NCT01536951|2231662|P6|STARTED|Third Intervention||9
922744|NCT01536951|2231663|P5|STARTED|Third Intervention||9
922745|NCT01536951|2231664|P4|STARTED|Third Intervention||8
922746|NCT01536951|2231665|P3|STARTED|Third Intervention||2
922747|NCT01536951|2231666|P2|STARTED|Third Intervention||3
922748|NCT01536951|2231667|P1|STARTED|Third Intervention||3
922749|NCT01536951|2231659|P9|NOT COMPLETED|Second Intervention and Washout Period 2||0
922750|NCT01536951|2231660|P8|NOT COMPLETED|Second Intervention and Washout Period 2||1
922751|NCT01536951|2231661|P7|NOT COMPLETED|Second Intervention and Washout Period 2||0
922752|NCT01536951|2231662|P6|NOT COMPLETED|Second Intervention and Washout Period 2||0
922753|NCT01536951|2231663|P5|NOT COMPLETED|Second Intervention and Washout Period 2||0
922754|NCT01536951|2231664|P4|NOT COMPLETED|Second Intervention and Washout Period 2||0
922755|NCT01536951|2231665|P3|NOT COMPLETED|Second Intervention and Washout Period 2||0
922756|NCT01536951|2231666|P2|NOT COMPLETED|Second Intervention and Washout Period 2||0
922757|NCT01536951|2231667|P1|NOT COMPLETED|Second Intervention and Washout Period 2||0
922758|NCT01536951|2231659|P9|COMPLETED|Second Intervention and Washout Period 2||9
922759|NCT01536951|2231660|P8|COMPLETED|Second Intervention and Washout Period 2||8
922760|NCT01536951|2231661|P7|COMPLETED|Second Intervention and Washout Period 2||9
922761|NCT01536951|2231662|P6|COMPLETED|Second Intervention and Washout Period 2||9
922762|NCT01536951|2231663|P5|COMPLETED|Second Intervention and Washout Period 2||9
922763|NCT01536951|2231664|P4|COMPLETED|Second Intervention and Washout Period 2||8
922764|NCT01536951|2231665|P3|COMPLETED|Second Intervention and Washout Period 2||2
922765|NCT01536951|2231666|P2|COMPLETED|Second Intervention and Washout Period 2||3
922766|NCT01536951|2231667|P1|COMPLETED|Second Intervention and Washout Period 2||3
922767|NCT01536951|2231659|P9|STARTED|Second Intervention and Washout Period 2||9
922768|NCT01536951|2231660|P8|STARTED|Second Intervention and Washout Period 2||9
922769|NCT01536951|2231661|P7|STARTED|Second Intervention and Washout Period 2||9
922770|NCT01536951|2231662|P6|STARTED|Second Intervention and Washout Period 2||9
922771|NCT01536951|2231663|P5|STARTED|Second Intervention and Washout Period 2||9
922772|NCT01536951|2231664|P4|STARTED|Second Intervention and Washout Period 2||8
922773|NCT01536951|2231665|P3|STARTED|Second Intervention and Washout Period 2||2
922774|NCT01536951|2231666|P2|STARTED|Second Intervention and Washout Period 2||3
922775|NCT01536951|2231667|P1|STARTED|Second Intervention and Washout Period 2||3
922776|NCT01536951|2231659|P9|NOT COMPLETED|First Intervention and Washout Period 1||0
922777|NCT01536951|2231660|P8|NOT COMPLETED|First Intervention and Washout Period 1||0
922778|NCT01536951|2231661|P7|NOT COMPLETED|First Intervention and Washout Period 1||0
922779|NCT01536951|2231662|P6|NOT COMPLETED|First Intervention and Washout Period 1||0
922780|NCT01536951|2231663|P5|NOT COMPLETED|First Intervention and Washout Period 1||0
922781|NCT01536951|2231664|P4|NOT COMPLETED|First Intervention and Washout Period 1||0
922782|NCT01536951|2231665|P3|NOT COMPLETED|First Intervention and Washout Period 1||1
922783|NCT01536951|2231666|P2|NOT COMPLETED|First Intervention and Washout Period 1||0
922784|NCT01536951|2231667|P1|NOT COMPLETED|First Intervention and Washout Period 1||0
922785|NCT01536951|2231659|P9|COMPLETED|First Intervention and Washout Period 1||9
922786|NCT01536951|2231660|P8|COMPLETED|First Intervention and Washout Period 1||9
922787|NCT01536951|2231661|P7|COMPLETED|First Intervention and Washout Period 1||9
922788|NCT01536951|2231662|P6|COMPLETED|First Intervention and Washout Period 1||9
922789|NCT01536951|2231663|P5|COMPLETED|First Intervention and Washout Period 1||9
922790|NCT01536951|2231664|P4|COMPLETED|First Intervention and Washout Period 1||8
922791|NCT01536951|2231665|P3|COMPLETED|First Intervention and Washout Period 1||2
922792|NCT01536951|2231666|P2|COMPLETED|First Intervention and Washout Period 1||3
922793|NCT01536951|2231667|P1|COMPLETED|First Intervention and Washout Period 1||3
922794|NCT01536951|2231659|P9|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
922795|NCT01536951|2231660|P8|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
922796|NCT01536951|2231661|P7|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
922797|NCT01536951|2231662|P6|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
922798|NCT01536951|2231663|P5|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
922799|NCT01536951|2231664|P4|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||8
922800|NCT01536951|2231665|P3|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
922801|NCT01536951|2231666|P2|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
922802|NCT01536951|2231667|P1|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1|Across all reporting groups, study drug is LY3009104, moxifloxacin, or placebo.|3
922803|NCT01536951|2231659|P9|STARTED|First Intervention and Washout Period 1||9
922804|NCT01536951|2231660|P8|STARTED|First Intervention and Washout Period 1||9
922805|NCT01536951|2231661|P7|STARTED|First Intervention and Washout Period 1||9
922806|NCT01536951|2231662|P6|STARTED|First Intervention and Washout Period 1||9
922807|NCT01536951|2231663|P5|STARTED|First Intervention and Washout Period 1||9
922808|NCT01536951|2231664|P4|STARTED|First Intervention and Washout Period 1||8
922809|NCT01536951|2231665|P3|STARTED|First Intervention and Washout Period 1||3
922810|NCT01536951|2231666|P2|STARTED|First Intervention and Washout Period 1||3
922811|NCT01536951|2231667|P1|STARTED|First Intervention and Washout Period 1||3
922812|NCT01536938|2231697|P3|NOT COMPLETED|Overall Study||8
922813|NCT01536938|2231698|P2|NOT COMPLETED|Overall Study||7
922814|NCT01536938|2231699|P1|NOT COMPLETED|Overall Study||6
922815|NCT01536938|2231697|P3|COMPLETED|Overall Study||93
922816|NCT01536938|2231698|P2|COMPLETED|Overall Study||94
922817|NCT01536938|2231699|P1|COMPLETED|Overall Study||94
922818|NCT01536938|2231697|P3|STARTED|Overall Study||101
922819|NCT01536938|2231698|P2|STARTED|Overall Study||101
922820|NCT01536938|2231699|P1|STARTED|Overall Study||100
922821|NCT01536886|2231711|P4|NOT COMPLETED|Overall Study||3
922822|NCT01536886|2231712|P3|NOT COMPLETED|Overall Study||2
922823|NCT01536886|2231713|P2|NOT COMPLETED|Overall Study||8
922824|NCT01536886|2231714|P1|NOT COMPLETED|Overall Study||5
922825|NCT01536886|2231711|P4|COMPLETED|Overall Study||48
922826|NCT01536886|2231712|P3|COMPLETED|Overall Study||47
922827|NCT01536886|2231713|P2|COMPLETED|Overall Study||127
922828|NCT01536886|2231714|P1|COMPLETED|Overall Study||136
922829|NCT01536886|2231711|P4|STARTED|Overall Study||51
922830|NCT01536886|2231712|P3|STARTED|Overall Study||49
922831|NCT01536886|2231713|P2|STARTED|Overall Study||135
922832|NCT01536886|2231714|P1|STARTED|Overall Study||141
922833|NCT01536860|2231724|P3|NOT COMPLETED|Third Intervention (1 Day)||0
922834|NCT01536860|2231725|P2|NOT COMPLETED|Third Intervention (1 Day)||0
922835|NCT01536860|2231726|P1|NOT COMPLETED|Third Intervention (1 Day)||0
922836|NCT01536860|2231724|P3|COMPLETED|Third Intervention (1 Day)||4
922837|NCT01536860|2231725|P2|COMPLETED|Third Intervention (1 Day)||4
922838|NCT01536860|2231726|P1|COMPLETED|Third Intervention (1 Day)||3
922839|NCT01536860|2231724|P3|STARTED|Third Intervention (1 Day)||4
922840|NCT01536860|2231725|P2|STARTED|Third Intervention (1 Day)||4
922841|NCT01536860|2231726|P1|STARTED|Third Intervention (1 Day)||3
922842|NCT01536860|2231724|P3|NOT COMPLETED|Washout Period (3 Days)||0
922843|NCT01536860|2231725|P2|NOT COMPLETED|Washout Period (3 Days)||0
922844|NCT01536860|2231726|P1|NOT COMPLETED|Washout Period (3 Days)||1
922845|NCT01536860|2231724|P3|COMPLETED|Washout Period (3 Days)||4
922846|NCT01536860|2231725|P2|COMPLETED|Washout Period (3 Days)||4
922847|NCT01536860|2231726|P1|COMPLETED|Washout Period (3 Days)||3
922848|NCT01536860|2231724|P3|STARTED|Washout Period (3 Days)||4
922849|NCT01536860|2231725|P2|STARTED|Washout Period (3 Days)||4
922850|NCT01536860|2231726|P1|STARTED|Washout Period (3 Days)||4
922851|NCT01536860|2231724|P3|NOT COMPLETED|Second Intervention (1 Day)||0
922852|NCT01536860|2231725|P2|NOT COMPLETED|Second Intervention (1 Day)||0
922853|NCT01536860|2231726|P1|NOT COMPLETED|Second Intervention (1 Day)||0
922854|NCT01536860|2231724|P3|COMPLETED|Second Intervention (1 Day)||4
922855|NCT01536860|2231725|P2|COMPLETED|Second Intervention (1 Day)||4
922856|NCT01536860|2231726|P1|COMPLETED|Second Intervention (1 Day)||4
922857|NCT01536860|2231724|P3|STARTED|Second Intervention (1 Day)||4
922858|NCT01536860|2231725|P2|STARTED|Second Intervention (1 Day)||4
922859|NCT01536860|2231726|P1|STARTED|Second Intervention (1 Day)||4
922860|NCT01536860|2231724|P3|NOT COMPLETED|Washout Period (3 Days)||0
922861|NCT01536860|2231725|P2|NOT COMPLETED|Washout Period (3 Days)||0
922862|NCT01536860|2231726|P1|NOT COMPLETED|Washout Period (3 Days)||0
922863|NCT01536860|2231724|P3|COMPLETED|Washout Period (3 Days)||4
922864|NCT01536860|2231725|P2|COMPLETED|Washout Period (3 Days)||4
922865|NCT01536860|2231726|P1|COMPLETED|Washout Period (3 Days)||4
922866|NCT01536860|2231724|P3|STARTED|Washout Period (3 Days)||4
922867|NCT01536860|2231725|P2|STARTED|Washout Period (3 Days)||4
922868|NCT01536860|2231726|P1|STARTED|Washout Period (3 Days)||4
922869|NCT01536860|2231724|P3|NOT COMPLETED|First Intervention (1 Day)||0
922870|NCT01536860|2231725|P2|NOT COMPLETED|First Intervention (1 Day)||0
922871|NCT01536860|2231726|P1|NOT COMPLETED|First Intervention (1 Day)||0
922872|NCT01536860|2231724|P3|COMPLETED|First Intervention (1 Day)||4
922873|NCT01536860|2231725|P2|COMPLETED|First Intervention (1 Day)||4
922874|NCT01536860|2231726|P1|COMPLETED|First Intervention (1 Day)||4
922875|NCT01536860|2231724|P3|STARTED|First Intervention (1 Day)||4
922876|NCT01536860|2231725|P2|STARTED|First Intervention (1 Day)||4
922877|NCT01536860|2231726|P1|STARTED|First Intervention (1 Day)||4
922878|NCT01536704|2231734|P4|NOT COMPLETED|Period 4||0
922879|NCT01536704|2231735|P3|NOT COMPLETED|Period 4||0
922880|NCT01536704|2231736|P2|NOT COMPLETED|Period 4||0
922881|NCT01536704|2231737|P1|NOT COMPLETED|Period 4||0
922882|NCT01536704|2231734|P4|COMPLETED|Period 4||10
922883|NCT01536704|2231735|P3|COMPLETED|Period 4||10
922884|NCT01536704|2231736|P2|COMPLETED|Period 4||11
922885|NCT01536704|2231737|P1|COMPLETED|Period 4||12
922886|NCT01536704|2231734|P4|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
922887|NCT01536704|2231735|P3|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
922888|NCT01536704|2231736|P2|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
922889|NCT01536704|2231737|P1|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|12
922890|NCT01536704|2231734|P4|NOT COMPLETED|Washout Period 3||0
922891|NCT01536704|2231735|P3|NOT COMPLETED|Washout Period 3||1
922892|NCT01536704|2231736|P2|NOT COMPLETED|Washout Period 3||0
922893|NCT01536704|2231737|P1|NOT COMPLETED|Washout Period 3||0
922894|NCT01536704|2231734|P4|COMPLETED|Washout Period 3||10
922895|NCT01536704|2231735|P3|COMPLETED|Washout Period 3||11
922896|NCT01536704|2231736|P2|COMPLETED|Washout Period 3||12
922897|NCT01536704|2231737|P1|COMPLETED|Washout Period 3||10
922898|NCT01536704|2231734|P4|STARTED|Washout Period 3||10
922899|NCT01536704|2231735|P3|STARTED|Washout Period 3||12
922900|NCT01536704|2231736|P2|STARTED|Washout Period 3||12
922901|NCT01536704|2231737|P1|STARTED|Washout Period 3||10
922902|NCT01536704|2231734|P4|NOT COMPLETED|Period 3||1
922903|NCT01536704|2231735|P3|NOT COMPLETED|Period 3||0
922904|NCT01536704|2231736|P2|NOT COMPLETED|Period 3||0
922905|NCT01536704|2231737|P1|NOT COMPLETED|Period 3||0
922906|NCT01536704|2231734|P4|COMPLETED|Period 3||10
922907|NCT01536704|2231735|P3|COMPLETED|Period 3||12
922908|NCT01536704|2231736|P2|COMPLETED|Period 3||12
922909|NCT01536704|2231737|P1|COMPLETED|Period 3||10
922910|NCT01536704|2231734|P4|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|11
922911|NCT01536704|2231735|P3|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
922912|NCT01536704|2231736|P2|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
922913|NCT01536704|2231737|P1|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|10
922914|NCT01536704|2231734|P4|NOT COMPLETED|Washout Period 2||1
922915|NCT01536704|2231735|P3|NOT COMPLETED|Washout Period 2||0
922916|NCT01536704|2231736|P2|NOT COMPLETED|Washout Period 2||0
922917|NCT01536704|2231737|P1|NOT COMPLETED|Washout Period 2||1
922918|NCT01536704|2231734|P4|COMPLETED|Washout Period 2||12
922919|NCT01536704|2231735|P3|COMPLETED|Washout Period 2||10
922920|NCT01536704|2231736|P2|COMPLETED|Washout Period 2||11
922921|NCT01536704|2231737|P1|COMPLETED|Washout Period 2||12
922922|NCT01536704|2231734|P4|STARTED|Washout Period 2||13
922923|NCT01536704|2231735|P3|STARTED|Washout Period 2||10
922924|NCT01536704|2231736|P2|STARTED|Washout Period 2||11
922925|NCT01536704|2231737|P1|STARTED|Washout Period 2||13
922926|NCT01536704|2231734|P4|NOT COMPLETED|Period 2||0
922927|NCT01536704|2231735|P3|NOT COMPLETED|Period 2||0
922928|NCT01536704|2231736|P2|NOT COMPLETED|Period 2||0
922929|NCT01536704|2231737|P1|NOT COMPLETED|Period 2||0
922930|NCT01536704|2231734|P4|COMPLETED|Period 2||13
922931|NCT01536704|2231735|P3|COMPLETED|Period 2||10
922932|NCT01536704|2231736|P2|COMPLETED|Period 2||11
922933|NCT01536704|2231737|P1|COMPLETED|Period 2||13
922934|NCT01536704|2231734|P4|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
922935|NCT01536704|2231735|P3|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|10
922936|NCT01536704|2231736|P2|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
922937|NCT01536704|2231737|P1|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
922938|NCT01536704|2231734|P4|NOT COMPLETED|Washout Period 1||0
922939|NCT01536704|2231735|P3|NOT COMPLETED|Washout Period 1||0
922940|NCT01536704|2231736|P2|NOT COMPLETED|Washout Period 1||2
922941|NCT01536704|2231737|P1|NOT COMPLETED|Washout Period 1||1
922942|NCT01536704|2231734|P4|COMPLETED|Washout Period 1||13
922943|NCT01536704|2231735|P3|COMPLETED|Washout Period 1||13
922944|NCT01536704|2231736|P2|COMPLETED|Washout Period 1||10
922945|NCT01536704|2231737|P1|COMPLETED|Washout Period 1||11
922946|NCT01536704|2231734|P4|STARTED|Washout Period 1||13
922947|NCT01536704|2231735|P3|STARTED|Washout Period 1||13
922948|NCT01536704|2231736|P2|STARTED|Washout Period 1||12
922949|NCT01536704|2231737|P1|STARTED|Washout Period 1||12
922950|NCT01536704|2231734|P4|NOT COMPLETED|Period 1||0
922951|NCT01536704|2231735|P3|NOT COMPLETED|Period 1||0
922952|NCT01536704|2231736|P2|NOT COMPLETED|Period 1||0
922953|NCT01536704|2231737|P1|NOT COMPLETED|Period 1||0
922954|NCT01536704|2231734|P4|COMPLETED|Period 1||13
922955|NCT01536704|2231735|P3|COMPLETED|Period 1||13
922956|NCT01536704|2231736|P2|COMPLETED|Period 1||12
922957|NCT01536704|2231737|P1|COMPLETED|Period 1||12
922958|NCT01536704|2231734|P4|STARTED|Period 1||13
922959|NCT01536704|2231735|P3|STARTED|Period 1||13
922960|NCT01536704|2231736|P2|STARTED|Period 1||12
922961|NCT01536704|2231737|P1|STARTED|Period 1||12
922962|NCT01536587|2231767|P1|NOT COMPLETED|Overall Study||2
922963|NCT01536587|2231767|P1|COMPLETED|Overall Study||30
922964|NCT01536587|2231767|P1|STARTED|Overall Study||32
922965|NCT01536574|2231806|P2|NOT COMPLETED|Overall Study||7
922966|NCT01536574|2231807|P1|NOT COMPLETED|Overall Study||6
922967|NCT01536574|2231806|P2|COMPLETED|Overall Study||126
922968|NCT01536574|2231807|P1|COMPLETED|Overall Study||156
922969|NCT01536574|2231806|P2|STARTED|Overall Study||133
922970|NCT01536574|2231807|P1|STARTED|Overall Study||162
922971|NCT01536561|2231825|P1|NOT COMPLETED|Long-Term Follow-Up||0
922972|NCT01536561|2231825|P1|COMPLETED|Long-Term Follow-Up||13
922973|NCT01536561|2231825|P1|STARTED|Long-Term Follow-Up||13
922974|NCT01536561|2231825|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||59
922975|NCT01536561|2231825|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
922976|NCT01536561|2231825|P1|STARTED|Dosimetric and Therapeutic Treatment||59
922977|NCT01536496|2231865|P2|NOT COMPLETED|Overall Study||1
922978|NCT01536496|2231866|P1|NOT COMPLETED|Overall Study||2
922979|NCT01536496|2231865|P2|COMPLETED|Overall Study||56
922980|NCT01536496|2231866|P1|COMPLETED|Overall Study||55
922981|NCT01536496|2231865|P2|STARTED|Overall Study||57
922982|NCT01536496|2231866|P1|STARTED|Overall Study||57
922983|NCT01536418|2231902|P2|NOT COMPLETED|Overall Study||66
922984|NCT01536418|2231903|P1|NOT COMPLETED|Overall Study||69
922985|NCT01536418|2231902|P2|COMPLETED|Overall Study||60
922986|NCT01536418|2231903|P1|COMPLETED|Overall Study||58
922987|NCT01536418|2231902|P2|STARTED|Overall Study||126
922988|NCT01536418|2231903|P1|STARTED|Overall Study||127
922989|NCT01536405|2231923|P2|NOT COMPLETED|Visit 4 to Extended Study Follow-up||23
922990|NCT01536405|2231924|P1|NOT COMPLETED|Visit 4 to Extended Study Follow-up||20
922991|NCT01536405|2231923|P2|COMPLETED|Visit 4 to Extended Study Follow-up||595
922992|NCT01536405|2231924|P1|COMPLETED|Visit 4 to Extended Study Follow-up||595
922993|NCT01536405|2231923|P2|STARTED|Visit 4 to Extended Study Follow-up||618
922994|NCT01536405|2231924|P1|STARTED|Visit 4 to Extended Study Follow-up||615
922995|NCT01536405|2231923|P2|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||16
922996|NCT01536405|2231924|P1|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||20
922997|NCT01536405|2231923|P2|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||618
922998|NCT01536405|2231924|P1|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||615
922999|NCT01536405|2231923|P2|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||632
923000|NCT01536405|2231924|P1|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||634
923001|NCT01536405|2231923|P2|STARTED|Visit 3 (Vaccination 2) to Visit 4||634
923002|NCT01536405|2231924|P1|STARTED|Visit 3 (Vaccination 2) to Visit 4||635
923003|NCT01536405|2231923|P2|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||28
923004|NCT01536405|2231924|P1|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||31
923005|NCT01536405|2231923|P2|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||634
923006|NCT01536405|2231924|P1|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||635
923007|NCT01536405|2231923|P2|STARTED|Visit 2 to Visit 3 (Vaccination 2)||662
923008|NCT01536405|2231924|P1|STARTED|Visit 2 to Visit 3 (Vaccination 2)||666
923009|NCT01536405|2231923|P2|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||40
923010|NCT01536405|2231924|P1|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||32
923011|NCT01536405|2231923|P2|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||662
923012|NCT01536405|2231924|P1|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||666
923013|NCT01536405|2231923|P2|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||702
923014|NCT01536405|2231924|P1|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||698
923015|NCT01536405|2231923|P2|STARTED|Visit 1 (Vaccination 1) to Visit 2||702
923016|NCT01536405|2231924|P1|STARTED|Visit 1 (Vaccination 1) to Visit 2||698
923017|NCT01536405|2231923|P2|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||4
923018|NCT01536405|2231924|P1|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||8
923019|NCT01536405|2231923|P2|COMPLETED|Randomization to Visit 1 (Vaccination 1)||702
923020|NCT01536405|2231924|P1|COMPLETED|Randomization to Visit 1 (Vaccination 1)||698
923021|NCT01536405|2231923|P2|STARTED|Randomization to Visit 1 (Vaccination 1)||706
923022|NCT01536405|2231924|P1|STARTED|Randomization to Visit 1 (Vaccination 1)||706
923023|NCT01536379|2231962|P2|NOT COMPLETED|Overall Study||3
923024|NCT01536379|2231963|P1|NOT COMPLETED|Overall Study||2
923025|NCT01536379|2231962|P2|COMPLETED|Overall Study||9
923026|NCT01536379|2231963|P1|COMPLETED|Overall Study||11
923027|NCT01536379|2231962|P2|STARTED|Overall Study||12
923028|NCT01536379|2231963|P1|STARTED|Overall Study||13
923029|NCT01536366|2232039|P2|NOT COMPLETED|Overall Study||4
923030|NCT01536366|2232040|P1|NOT COMPLETED|Overall Study||13
923031|NCT01536366|2232039|P2|COMPLETED|Overall Study||9
923032|NCT01536366|2232040|P1|COMPLETED|Overall Study||1
923033|NCT01536366|2232039|P2|Follow-up|Overall Study||9
923034|NCT01536366|2232040|P1|Follow-up|Overall Study||13
923035|NCT01536366|2232039|P2|Repaglinide|Overall Study||13
923036|NCT01536366|2232040|P1|Repaglinide|Overall Study||14
923037|NCT01536366|2232039|P2|BIA 9-1067 + Repaglinide|Overall Study||10
923038|NCT01536366|2232040|P1|BIA 9-1067 + Repaglinide|Overall Study||14
923039|NCT01536366|2232039|P2|STARTED|Overall Study||13
923040|NCT01536366|2232040|P1|STARTED|Overall Study||14
923041|NCT01536262|2232055|P3|NOT COMPLETED|Overall Study||2
923042|NCT01536262|2232056|P2|NOT COMPLETED|Overall Study||2
923043|NCT01536262|2232057|P1|NOT COMPLETED|Overall Study||8
923044|NCT01536262|2232055|P3|COMPLETED|Overall Study||39
923045|NCT01536262|2232056|P2|COMPLETED|Overall Study||38
923046|NCT01536262|2232057|P1|COMPLETED|Overall Study||33
923047|NCT01536262|2232055|P3|STARTED|Overall Study||41
923048|NCT01536262|2232056|P2|STARTED|Overall Study||40
923049|NCT01536262|2232057|P1|STARTED|Overall Study||41
923056|NCT01536184|2232084|P2|NOT COMPLETED|Overall Study||0
923057|NCT01536184|2232085|P1|NOT COMPLETED|Overall Study||0
923058|NCT01536184|2232084|P2|COMPLETED|Overall Study||4
923059|NCT01536184|2232085|P1|COMPLETED|Overall Study||8
923060|NCT01536184|2232084|P2|STARTED|Overall Study||4
923061|NCT01536184|2232085|P1|STARTED|Overall Study||8
923062|NCT01536171|2232099|P1|NOT COMPLETED|Overall Study||1
923063|NCT01536171|2232099|P1|COMPLETED|Overall Study||21
923064|NCT01536171|2232099|P1|STARTED|Overall Study||22
923065|NCT01536145|2232104|P11|NOT COMPLETED|Overall Study||10
923066|NCT01536145|2232105|P10|NOT COMPLETED|Overall Study||6
923067|NCT01536145|2232106|P9|NOT COMPLETED|Overall Study||3
923068|NCT01536145|2232107|P8|NOT COMPLETED|Overall Study||4
923069|NCT01536145|2232108|P7|NOT COMPLETED|Overall Study||2
923070|NCT01536145|2232109|P6|NOT COMPLETED|Overall Study||3
923071|NCT01536145|2232110|P5|NOT COMPLETED|Overall Study||2
923072|NCT01536145|2232111|P4|NOT COMPLETED|Overall Study||2
923073|NCT01536145|2232112|P3|NOT COMPLETED|Overall Study||2
923074|NCT01536145|2232113|P2|NOT COMPLETED|Overall Study||4
923075|NCT01536145|2232114|P1|NOT COMPLETED|Overall Study||3
923076|NCT01536145|2232104|P11|COMPLETED|Overall Study||0
923077|NCT01536145|2232105|P10|COMPLETED|Overall Study||1
923078|NCT01536145|2232106|P9|COMPLETED|Overall Study||0
923079|NCT01536145|2232107|P8|COMPLETED|Overall Study||0
923080|NCT01536145|2232108|P7|COMPLETED|Overall Study||1
923081|NCT01536145|2232109|P6|COMPLETED|Overall Study||0
923082|NCT01536145|2232110|P5|COMPLETED|Overall Study||2
923083|NCT01536145|2232111|P4|COMPLETED|Overall Study||1
923084|NCT01536145|2232112|P3|COMPLETED|Overall Study||1
923085|NCT01536145|2232113|P2|COMPLETED|Overall Study||0
923086|NCT01536145|2232114|P1|COMPLETED|Overall Study||0
923087|NCT01536145|2232104|P11|STARTED|Overall Study||10
923088|NCT01536145|2232105|P10|STARTED|Overall Study||7
923089|NCT01536145|2232106|P9|STARTED|Overall Study||3
923090|NCT01536145|2232107|P8|STARTED|Overall Study||4
923091|NCT01536145|2232108|P7|STARTED|Overall Study||3
923092|NCT01536145|2232109|P6|STARTED|Overall Study||3
923093|NCT01536145|2232110|P5|STARTED|Overall Study||4
923094|NCT01536145|2232111|P4|STARTED|Overall Study||3
923095|NCT01536145|2232112|P3|STARTED|Overall Study||3
923096|NCT01536145|2232113|P2|STARTED|Overall Study||4
923097|NCT01536145|2232114|P1|STARTED|Overall Study||3
923098|NCT01536119|2232221|P2|NOT COMPLETED|Overall Study||14
923099|NCT01536119|2232222|P1|NOT COMPLETED|Overall Study||17
923100|NCT01536119|2232221|P2|COMPLETED|Overall Study|105 mothers + 95 fathers = 200 participants 2 mothers + 12 fathers = 14 did not complete the study|200
923101|NCT01536119|2232222|P1|COMPLETED|Overall Study|104 Mothers + 93 fathers = 197 participants 3 mothers + 14 fathers = 17 did not complete the study|197
923102|NCT01536119|2232221|P2|STARTED|Overall Study|(107*2=214) (107 mothers and 107 fathers)|214
923103|NCT01536119|2232222|P1|STARTED|Overall Study|(107*2= 214) (107 mothers and 107 fathers)|214
923104|NCT01536093|2232248|P2|NOT COMPLETED|Overall Study||3
923105|NCT01536093|2232249|P1|NOT COMPLETED|Overall Study||3
923106|NCT01536093|2232248|P2|COMPLETED|Overall Study||21
923107|NCT01536093|2232249|P1|COMPLETED|Overall Study||21
923108|NCT01536093|2232248|P2|STARTED|Overall Study||24
923109|NCT01536093|2232249|P1|STARTED|Overall Study||24
923110|NCT01536067|2232265|P1|NOT COMPLETED|Overall Study||1
923111|NCT01536067|2232265|P1|COMPLETED|Overall Study||2
923112|NCT01536067|2232265|P1|STARTED|Overall Study||3
923113|NCT01536015|2232278|P2|NOT COMPLETED|Overall Study||10
923114|NCT01536015|2232279|P1|NOT COMPLETED|Overall Study||8
923115|NCT01536015|2232278|P2|COMPLETED|Overall Study||3
923116|NCT01536015|2232279|P1|COMPLETED|Overall Study||4
923117|NCT01536015|2232278|P2|STARTED|Overall Study||13
923118|NCT01536015|2232279|P1|STARTED|Overall Study||12
923119|NCT01535976|2232297|P2|NOT COMPLETED|Overall Study||1
923120|NCT01535976|2232298|P1|NOT COMPLETED|Overall Study||1
923121|NCT01535976|2232297|P2|COMPLETED|Overall Study||26
923122|NCT01535976|2232298|P1|COMPLETED|Overall Study||26
923123|NCT01535976|2232297|P2|STARTED|Overall Study||27
923124|NCT01535976|2232298|P1|STARTED|Overall Study||27
923125|NCT01535807|2232306|P2|NOT COMPLETED|Overall Study||2
923126|NCT01535807|2232307|P1|NOT COMPLETED|Overall Study||2
923127|NCT01535807|2232306|P2|COMPLETED|Overall Study||20
923128|NCT01535807|2232307|P1|COMPLETED|Overall Study||20
923129|NCT01535807|2232306|P2|STARTED|Overall Study||22
923130|NCT01535807|2232307|P1|STARTED|Overall Study||22
923131|NCT01535729|2232313|P1|NOT COMPLETED|Overall Study||416
923132|NCT01535729|2232313|P1|COMPLETED|Overall Study||49
923133|NCT01535729|2232313|P1|Treated|Overall Study||385
923134|NCT01535729|2232313|P1|STARTED|Overall Study||465
923135|NCT01535664|2232340|P1|NOT COMPLETED|Overall Study||0
923136|NCT01535664|2232340|P1|COMPLETED|Overall Study||20
923137|NCT01535664|2232340|P1|STARTED|Overall Study||20
923138|NCT01535638|2232354|P6|NOT COMPLETED|Treatment 3 (Single Dose)||0
923139|NCT01535638|2232355|P5|NOT COMPLETED|Treatment 3 (Single Dose)||0
923140|NCT01535638|2232356|P4|NOT COMPLETED|Treatment 3 (Single Dose)||1
923141|NCT01535638|2232357|P3|NOT COMPLETED|Treatment 3 (Single Dose)||0
923142|NCT01535638|2232358|P2|NOT COMPLETED|Treatment 3 (Single Dose)||0
923143|NCT01535638|2232359|P1|NOT COMPLETED|Treatment 3 (Single Dose)||0
923144|NCT01535638|2232354|P6|COMPLETED|Treatment 3 (Single Dose)||2
923145|NCT01535638|2232355|P5|COMPLETED|Treatment 3 (Single Dose)||3
923146|NCT01535638|2232356|P4|COMPLETED|Treatment 3 (Single Dose)||2
923147|NCT01535638|2232357|P3|COMPLETED|Treatment 3 (Single Dose)||3
923148|NCT01535638|2232358|P2|COMPLETED|Treatment 3 (Single Dose)||3
923149|NCT01535638|2232359|P1|COMPLETED|Treatment 3 (Single Dose)||3
923150|NCT01535638|2232354|P6|STARTED|Treatment 3 (Single Dose)||2
923151|NCT01535638|2232355|P5|STARTED|Treatment 3 (Single Dose)||3
923152|NCT01535638|2232356|P4|STARTED|Treatment 3 (Single Dose)||3
923153|NCT01535638|2232357|P3|STARTED|Treatment 3 (Single Dose)||3
923154|NCT01535638|2232358|P2|STARTED|Treatment 3 (Single Dose)||3
923155|NCT01535638|2232359|P1|STARTED|Treatment 3 (Single Dose)||3
923156|NCT01535638|2232354|P6|NOT COMPLETED|Treatment 2 (Single Dose)||0
923157|NCT01535638|2232355|P5|NOT COMPLETED|Treatment 2 (Single Dose)||0
923158|NCT01535638|2232356|P4|NOT COMPLETED|Treatment 2 (Single Dose)||0
923159|NCT01535638|2232357|P3|NOT COMPLETED|Treatment 2 (Single Dose)||0
923160|NCT01535638|2232358|P2|NOT COMPLETED|Treatment 2 (Single Dose)||0
923161|NCT01535638|2232359|P1|NOT COMPLETED|Treatment 2 (Single Dose)||0
923162|NCT01535638|2232354|P6|COMPLETED|Treatment 2 (Single Dose)||2
923163|NCT01535638|2232355|P5|COMPLETED|Treatment 2 (Single Dose)||3
923164|NCT01535638|2232356|P4|COMPLETED|Treatment 2 (Single Dose)||3
923165|NCT01535638|2232357|P3|COMPLETED|Treatment 2 (Single Dose)||3
923166|NCT01535638|2232358|P2|COMPLETED|Treatment 2 (Single Dose)||3
923167|NCT01535638|2232359|P1|COMPLETED|Treatment 2 (Single Dose)||3
923168|NCT01535638|2232354|P6|STARTED|Treatment 2 (Single Dose)||2
923169|NCT01535638|2232355|P5|STARTED|Treatment 2 (Single Dose)||3
923170|NCT01535638|2232356|P4|STARTED|Treatment 2 (Single Dose)||3
923171|NCT01535638|2232357|P3|STARTED|Treatment 2 (Single Dose)||3
923172|NCT01535638|2232358|P2|STARTED|Treatment 2 (Single Dose)||3
923173|NCT01535638|2232359|P1|STARTED|Treatment 2 (Single Dose)||3
923174|NCT01535638|2232354|P6|NOT COMPLETED|Treatment 1 (Single Dose)||1
923175|NCT01535638|2232355|P5|NOT COMPLETED|Treatment 1 (Single Dose)||0
923176|NCT01535638|2232356|P4|NOT COMPLETED|Treatment 1 (Single Dose)||0
923177|NCT01535638|2232357|P3|NOT COMPLETED|Treatment 1 (Single Dose)||0
923178|NCT01535638|2232358|P2|NOT COMPLETED|Treatment 1 (Single Dose)||0
923179|NCT01535638|2232359|P1|NOT COMPLETED|Treatment 1 (Single Dose)||0
923180|NCT01535638|2232354|P6|COMPLETED|Treatment 1 (Single Dose)||2
923181|NCT01535638|2232355|P5|COMPLETED|Treatment 1 (Single Dose)||3
923182|NCT01535638|2232356|P4|COMPLETED|Treatment 1 (Single Dose)||3
923183|NCT01535638|2232357|P3|COMPLETED|Treatment 1 (Single Dose)||3
923184|NCT01535638|2232358|P2|COMPLETED|Treatment 1 (Single Dose)||3
923185|NCT01535638|2232359|P1|COMPLETED|Treatment 1 (Single Dose)||3
923186|NCT01535638|2232354|P6|STARTED|Treatment 1 (Single Dose)||3
923187|NCT01535638|2232355|P5|STARTED|Treatment 1 (Single Dose)||3
923188|NCT01535638|2232356|P4|STARTED|Treatment 1 (Single Dose)||3
923189|NCT01535638|2232357|P3|STARTED|Treatment 1 (Single Dose)||3
923190|NCT01535638|2232358|P2|STARTED|Treatment 1 (Single Dose)||3
923191|NCT01535638|2232359|P1|STARTED|Treatment 1 (Single Dose)||3
923192|NCT01535599|2232373|P2|NOT COMPLETED|Overall Study||96
923193|NCT01535599|2232374|P1|NOT COMPLETED|Overall Study||50
923194|NCT01535599|2232373|P2|COMPLETED|Overall Study||250
923195|NCT01535599|2232374|P1|COMPLETED|Overall Study||297
923196|NCT01535599|2232373|P2|STARTED|Overall Study||346
923197|NCT01535599|2232374|P1|STARTED|Overall Study||347
923198|NCT01535560|2232386|P2|NOT COMPLETED|Overall Study||96
923199|NCT01535560|2232387|P1|NOT COMPLETED|Overall Study||37
923200|NCT01535560|2232386|P2|COMPLETED|Overall Study||179
923201|NCT01535560|2232387|P1|COMPLETED|Overall Study||237
923202|NCT01535560|2232386|P2|STARTED|Overall Study||275
923203|NCT01535560|2232387|P1|STARTED|Overall Study||274
923204|NCT01535365|2232399|P2|NOT COMPLETED|Overall Study||0
923205|NCT01535365|2232400|P1|NOT COMPLETED|Overall Study||0
923206|NCT01535365|2232399|P2|COMPLETED|Overall Study||29
923207|NCT01535365|2232400|P1|COMPLETED|Overall Study||31
923208|NCT01535365|2232399|P2|STARTED|Overall Study||29
923209|NCT01535365|2232400|P1|STARTED|Overall Study||31
923210|NCT01535326|2232411|P3|NOT COMPLETED|Overall Study||0
923211|NCT01535326|2232412|P2|NOT COMPLETED|Overall Study||0
923212|NCT01535326|2232413|P1|NOT COMPLETED|Overall Study||0
923213|NCT01535326|2232411|P3|COMPLETED|Overall Study||90
923214|NCT01535326|2232412|P2|COMPLETED|Overall Study||90
923215|NCT01535326|2232413|P1|COMPLETED|Overall Study||90
923216|NCT01535326|2232411|P3|STARTED|Overall Study||90
923217|NCT01535326|2232412|P2|STARTED|Overall Study||90
923218|NCT01535326|2232413|P1|STARTED|Overall Study||90
923219|NCT01535261|2232430|P1|NOT COMPLETED|Overall Study||50
923220|NCT01535261|2232430|P1|COMPLETED|Overall Study||307
923221|NCT01535261|2232430|P1|STARTED|Overall Study||357
923222|NCT01535235|2232443|P2|NOT COMPLETED|Overall Study||0
923223|NCT01535235|2232444|P1|NOT COMPLETED|Overall Study||1
923224|NCT01535235|2232443|P2|COMPLETED|Overall Study||15
923225|NCT01535235|2232444|P1|COMPLETED|Overall Study||15
923226|NCT01535235|2232443|P2|STARTED|Overall Study||15
923227|NCT01535235|2232444|P1|STARTED|Overall Study||16
923228|NCT01535222|2232458|P6|NOT COMPLETED|Overall Study||0
923229|NCT01535222|2232459|P5|NOT COMPLETED|Overall Study||0
923230|NCT01535222|2232460|P4|NOT COMPLETED|Overall Study||0
923231|NCT01535222|2232461|P3|NOT COMPLETED|Overall Study||1
923232|NCT01535222|2232462|P2|NOT COMPLETED|Overall Study||0
923233|NCT01535222|2232463|P1|NOT COMPLETED|Overall Study||0
923234|NCT01535222|2232458|P6|COMPLETED|Overall Study||8
923235|NCT01535222|2232459|P5|COMPLETED|Overall Study||6
923236|NCT01535222|2232460|P4|COMPLETED|Overall Study||6
923237|NCT01535222|2232461|P3|COMPLETED|Overall Study||6
923238|NCT01535222|2232462|P2|COMPLETED|Overall Study||3
923239|NCT01535222|2232463|P1|COMPLETED|Overall Study||3
923240|NCT01535222|2232458|P6|STARTED|Overall Study||8
923241|NCT01535222|2232459|P5|STARTED|Overall Study||6
923242|NCT01535222|2232460|P4|STARTED|Overall Study||6
923243|NCT01535222|2232461|P3|STARTED|Overall Study|Patient randomized but did not meet inclusion/exclusion criteria and did not receive study drug|7
923244|NCT01535222|2232462|P2|STARTED|Overall Study||3
923245|NCT01535222|2232463|P1|STARTED|Overall Study||3
923246|NCT01535118|2232483|P1|NOT COMPLETED|Overall Study||0
923247|NCT01535118|2232483|P1|COMPLETED|Overall Study||2765
923248|NCT01535118|2232483|P1|STARTED|Overall Study||2765
923249|NCT01535040|2232494|P2|NOT COMPLETED|Overall Study||21
923250|NCT01535040|2232495|P1|NOT COMPLETED|Overall Study||30
923251|NCT01535040|2232494|P2|COMPLETED|Overall Study||44
923252|NCT01535040|2232495|P1|COMPLETED|Overall Study||35
923253|NCT01535040|2232494|P2|STARTED|Overall Study||65
923254|NCT01535040|2232495|P1|STARTED|Overall Study||65
923261|NCT01534962|2232536|P4|NOT COMPLETED|Overall Study||32
923262|NCT01534962|2232537|P3|NOT COMPLETED|Overall Study||24
923263|NCT01534962|2232538|P2|NOT COMPLETED|Overall Study||26
923264|NCT01534962|2232539|P1|NOT COMPLETED|Overall Study||37
923265|NCT01534962|2232536|P4|COMPLETED|Overall Study||24
923266|NCT01534962|2232537|P3|COMPLETED|Overall Study||34
923267|NCT01534962|2232538|P2|COMPLETED|Overall Study||34
923268|NCT01534962|2232539|P1|COMPLETED|Overall Study||30
923269|NCT01534962|2232536|P4|STARTED|Overall Study||56
923270|NCT01534962|2232537|P3|STARTED|Overall Study||58
923271|NCT01534962|2232538|P2|STARTED|Overall Study||60
923272|NCT01534962|2232539|P1|STARTED|Overall Study||67
923273|NCT01534910|2232571|P2|NOT COMPLETED|Overall Study||4
923274|NCT01534910|2232572|P1|NOT COMPLETED|Overall Study||4
923275|NCT01534910|2232571|P2|COMPLETED|Overall Study||28
923276|NCT01534910|2232572|P1|COMPLETED|Overall Study||29
923277|NCT01534910|2232571|P2|STARTED|Overall Study||32
923278|NCT01534910|2232572|P1|STARTED|Overall Study||33
923279|NCT01534897|2232580|P1|NOT COMPLETED|Overall Study||0
923280|NCT01534897|2232580|P1|COMPLETED|Overall Study||10
923281|NCT01534897|2232580|P1|Day 37 Iodine-131 Treatment|Overall Study||6
923282|NCT01534897|2232580|P1|Day 25 Iodine-131 Scan|Overall Study||10
923283|NCT01534897|2232580|P1|STARTED|Overall Study||10
923284|NCT01534689|2232588|P1|NOT COMPLETED|Overall Study||0
923285|NCT01534689|2232588|P1|COMPLETED|Overall Study||105
923286|NCT01534689|2232588|P1|STARTED|Overall Study||105
923287|NCT01534676|2232596|P2|NOT COMPLETED|Overall Study||1
923288|NCT01534676|2232597|P1|NOT COMPLETED|Overall Study||2
923289|NCT01534676|2232596|P2|COMPLETED|Overall Study||0
923290|NCT01534676|2232597|P1|COMPLETED|Overall Study||0
923291|NCT01534676|2232596|P2|STARTED|Overall Study||1
923292|NCT01534676|2232597|P1|STARTED|Overall Study||2
923293|NCT01534637|2232603|P1|NOT COMPLETED|Overall Study||9
923294|NCT01534637|2232603|P1|COMPLETED|Overall Study||13
923295|NCT01534637|2232603|P1|STARTED|Overall Study||22
923296|NCT01534533|2232613|P4|NOT COMPLETED|Overall Study||4
923297|NCT01534533|2232614|P3|NOT COMPLETED|Overall Study||8
923298|NCT01534533|2232615|P2|NOT COMPLETED|Overall Study||3
923299|NCT01534533|2232616|P1|NOT COMPLETED|Overall Study||8
923300|NCT01534533|2232613|P4|COMPLETED|Overall Study||44
923301|NCT01534533|2232614|P3|COMPLETED|Overall Study||40
923302|NCT01534533|2232615|P2|COMPLETED|Overall Study||45
923303|NCT01534533|2232616|P1|COMPLETED|Overall Study||40
923304|NCT01534533|2232613|P4|STARTED|Overall Study||48
923305|NCT01534533|2232614|P3|STARTED|Overall Study||48
923306|NCT01534533|2232615|P2|STARTED|Overall Study||48
923307|NCT01534533|2232616|P1|STARTED|Overall Study||48
923308|NCT01534520|2232644|P2|NOT COMPLETED|Overall Study||1
923309|NCT01534520|2232645|P1|NOT COMPLETED|Overall Study||0
923310|NCT01534520|2232644|P2|COMPLETED|Overall Study|1 subject withdrew consent at time of uterine sound attempt due to intolerable pain|28
923311|NCT01534520|2232645|P1|COMPLETED|Overall Study||30
923312|NCT01534520|2232644|P2|STARTED|Overall Study||29
923313|NCT01534520|2232645|P1|STARTED|Overall Study||30
923314|NCT01534351|2232660|P3|NOT COMPLETED|Overall Study||0
923315|NCT01534351|2232661|P2|NOT COMPLETED|Overall Study||0
923316|NCT01534351|2232662|P1|NOT COMPLETED|Overall Study||1
923317|NCT01534351|2232660|P3|COMPLETED|Overall Study||0
923318|NCT01534351|2232661|P2|COMPLETED|Overall Study||0
923319|NCT01534351|2232662|P1|COMPLETED|Overall Study||0
923320|NCT01534351|2232660|P3|STARTED|Overall Study||0
923321|NCT01534351|2232661|P2|STARTED|Overall Study||0
923322|NCT01534351|2232662|P1|STARTED|Overall Study||1
923323|NCT01534208|2232681|P2|NOT COMPLETED|Overall Study||49
923324|NCT01534208|2232682|P1|NOT COMPLETED|Overall Study||57
923325|NCT01534208|2232681|P2|COMPLETED|Overall Study||234
923326|NCT01534208|2232682|P1|COMPLETED|Overall Study||159
923327|NCT01534208|2232681|P2|STARTED|Overall Study||283
923328|NCT01534208|2232682|P1|STARTED|Overall Study||216
923329|NCT01534182|2232700|P2|NOT COMPLETED|Overall Study||10
923330|NCT01534182|2232701|P1|NOT COMPLETED|Overall Study||12
923331|NCT01534182|2232700|P2|COMPLETED|Overall Study||58
923332|NCT01534182|2232701|P1|COMPLETED|Overall Study||218
923333|NCT01534182|2232700|P2|Full Analysis Set|Overall Study||62
923334|NCT01534182|2232701|P1|Full Analysis Set|Overall Study||229
923335|NCT01534182|2232700|P2|Safety Set|Overall Study||64
923336|NCT01534182|2232701|P1|Safety Set|Overall Study||230
923337|NCT01534182|2232700|P2|STARTED|Overall Study||68
923338|NCT01534182|2232701|P1|STARTED|Overall Study||230
923339|NCT01534143|2232716|P1|NOT COMPLETED|Overall Study||0
923340|NCT01534143|2232716|P1|COMPLETED|Overall Study||1
923341|NCT01534143|2232716|P1|STARTED|Overall Study||1
923342|NCT01534078|2232732|P1|NOT COMPLETED|Overall Study||2
923343|NCT01534078|2232732|P1|COMPLETED|Overall Study||32
923344|NCT01534078|2232732|P1|STARTED|Overall Study||34
923345|NCT01533974|2232741|P2|NOT COMPLETED|Overall Study||50
923346|NCT01533974|2232742|P1|NOT COMPLETED|Overall Study||51
923347|NCT01533974|2232741|P2|COMPLETED|Overall Study||176
923348|NCT01533974|2232742|P1|COMPLETED|Overall Study||173
923349|NCT01533974|2232741|P2|STARTED|Overall Study||226
923350|NCT01533974|2232742|P1|STARTED|Overall Study||224
923351|NCT01533935|2232748|P5|NOT COMPLETED|Overall Study||8
923352|NCT01533935|2232749|P4|NOT COMPLETED|Overall Study||7
923353|NCT01533935|2232750|P3|NOT COMPLETED|Overall Study||8
923354|NCT01533935|2232751|P2|NOT COMPLETED|Overall Study||13
923355|NCT01533935|2232752|P1|NOT COMPLETED|Overall Study||6
923356|NCT01533935|2232748|P5|COMPLETED|Overall Study|All treatment periods|50
923357|NCT01533935|2232749|P4|COMPLETED|Overall Study|All treatment periods|52
923358|NCT01533935|2232750|P3|COMPLETED|Overall Study|All treatment periods|50
923359|NCT01533935|2232751|P2|COMPLETED|Overall Study|All treatment periods|45
923360|NCT01533935|2232752|P1|COMPLETED|Overall Study|All treatment periods|52
923361|NCT01533935|2232748|P5|Received Tio+Olo 5/5|Overall Study||55
923362|NCT01533935|2232749|P4|Received Tio+Olo 5/5|Overall Study||54
923363|NCT01533935|2232750|P3|Received Tio+Olo 5/5|Overall Study|One patient received Tio+Olo 5/5 instead of Tio+Olo 2.5/5 by mistake.|1
923364|NCT01533935|2232751|P2|Received Tio+Olo 5/5|Overall Study||58
923365|NCT01533935|2232752|P1|Received Tio+Olo 5/5|Overall Study||56
923366|NCT01533935|2232748|P5|Received Tio+Olo 2.5/5|Overall Study||56
923367|NCT01533935|2232749|P4|Received Tio+Olo 2.5/5|Overall Study||56
923368|NCT01533935|2232750|P3|Received Tio+Olo 2.5/5|Overall Study||49
923369|NCT01533935|2232751|P2|Received Tio+Olo 2.5/5|Overall Study||0
923370|NCT01533935|2232752|P1|Received Tio+Olo 2.5/5|Overall Study||58
923371|NCT01533935|2232748|P5|Received Tio 5|Overall Study||52
923372|NCT01533935|2232749|P4|Received Tio 5|Overall Study||0
923373|NCT01533935|2232750|P3|Received Tio 5|Overall Study||58
923374|NCT01533935|2232751|P2|Received Tio 5|Overall Study||54
923375|NCT01533935|2232752|P1|Received Tio 5|Overall Study||54
923376|NCT01533935|2232748|P5|Received Olo 5|Overall Study||0
923377|NCT01533935|2232749|P4|Received Olo 5|Overall Study||59
923378|NCT01533935|2232750|P3|Received Olo 5|Overall Study||55
923379|NCT01533935|2232751|P2|Received Olo 5|Overall Study||52
923380|NCT01533935|2232752|P1|Received Olo 5|Overall Study||52
923381|NCT01533935|2232748|P5|Received Placebo|Overall Study||58
923382|NCT01533935|2232749|P4|Received Placebo|Overall Study||57
923383|NCT01533935|2232750|P3|Received Placebo|Overall Study||52
923384|NCT01533935|2232751|P2|Received Placebo|Overall Study||47
923385|NCT01533935|2232752|P1|Received Placebo|Overall Study||0
923386|NCT01533935|2232748|P5|STARTED|Overall Study||58
923387|NCT01533935|2232749|P4|STARTED|Overall Study||59
923388|NCT01533935|2232750|P3|STARTED|Overall Study||58
923389|NCT01533935|2232751|P2|STARTED|Overall Study||58
923390|NCT01533935|2232752|P1|STARTED|Overall Study||58
923391|NCT01533922|2232779|P5|NOT COMPLETED|Overall Study||6
923392|NCT01533922|2232780|P4|NOT COMPLETED|Overall Study||5
923393|NCT01533922|2232781|P3|NOT COMPLETED|Overall Study||10
923394|NCT01533922|2232782|P2|NOT COMPLETED|Overall Study||12
923395|NCT01533922|2232783|P1|NOT COMPLETED|Overall Study||10
923396|NCT01533922|2232779|P5|COMPLETED|Overall Study|Completed all treatment arms|53
923397|NCT01533922|2232780|P4|COMPLETED|Overall Study|Completed all treatment arms|53
923398|NCT01533922|2232781|P3|COMPLETED|Overall Study|Completed all treatment arms|50
923399|NCT01533922|2232782|P2|COMPLETED|Overall Study|Completed all treatment arms|47
923400|NCT01533922|2232783|P1|COMPLETED|Overall Study|Completed all treatment arms|49
923401|NCT01533922|2232779|P5|Received Tio+Olo 5/5|Overall Study||56
923402|NCT01533922|2232780|P4|Received Tio+Olo 5/5|Overall Study||53
923403|NCT01533922|2232781|P3|Received Tio+Olo 5/5|Overall Study||0
923404|NCT01533922|2232782|P2|Received Tio+Olo 5/5|Overall Study||59
923405|NCT01533922|2232783|P1|Received Tio+Olo 5/5|Overall Study||58
923406|NCT01533922|2232779|P5|Received Tio+Olo 2.5/5|Overall Study||56
923407|NCT01533922|2232780|P4|Received Tio+Olo 2.5/5|Overall Study||55
923408|NCT01533922|2232781|P3|Received Tio+Olo 2.5/5|Overall Study||52
923409|NCT01533922|2232782|P2|Received Tio+Olo 2.5/5|Overall Study||0
923410|NCT01533922|2232783|P1|Received Tio+Olo 2.5/5|Overall Study||59
923411|NCT01533922|2232779|P5|Received Tio 5|Overall Study||54
923412|NCT01533922|2232780|P4|Received Tio 5|Overall Study|One patient received Tio 5 instead of Olo 5 by mistake.|1
923413|NCT01533922|2232781|P3|Received Tio 5|Overall Study||59
923414|NCT01533922|2232782|P2|Received Tio 5|Overall Study||58
923415|NCT01533922|2232783|P1|Received Tio 5|Overall Study||54
923416|NCT01533922|2232779|P5|Received Olo 5|Overall Study||0
923417|NCT01533922|2232780|P4|Received Olo 5|Overall Study||57
923418|NCT01533922|2232781|P3|Received Olo 5|Overall Study||57
923419|NCT01533922|2232782|P2|Received Olo 5|Overall Study||52
923420|NCT01533922|2232783|P1|Received Olo 5|Overall Study||51
923421|NCT01533922|2232779|P5|Received Placebo|Overall Study||59
923422|NCT01533922|2232780|P4|Received Placebo|Overall Study||57
923423|NCT01533922|2232781|P3|Received Placebo|Overall Study||57
923424|NCT01533922|2232782|P2|Received Placebo|Overall Study||49
923425|NCT01533922|2232783|P1|Received Placebo|Overall Study||0
923426|NCT01533922|2232779|P5|STARTED|Overall Study||59
923427|NCT01533922|2232780|P4|STARTED|Overall Study||58
923428|NCT01533922|2232781|P3|STARTED|Overall Study||60
923429|NCT01533922|2232782|P2|STARTED|Overall Study||59
923430|NCT01533922|2232783|P1|STARTED|Overall Study||59
923431|NCT01533753|2232812|P2|NOT COMPLETED|Overall Study||0
923432|NCT01533753|2232813|P1|NOT COMPLETED|Overall Study||0
923433|NCT01533753|2232812|P2|COMPLETED|Overall Study||3
923434|NCT01533753|2232813|P1|COMPLETED|Overall Study||2
923435|NCT01533753|2232812|P2|STARTED|Overall Study||3
923436|NCT01533753|2232813|P1|STARTED|Overall Study||2
923437|NCT01533597|2232827|P2|NOT COMPLETED|Overall Study||10
923438|NCT01533597|2232828|P1|NOT COMPLETED|Overall Study||6
923439|NCT01533597|2232827|P2|COMPLETED|Overall Study||25
923440|NCT01533597|2232828|P1|COMPLETED|Overall Study||29
923441|NCT01533597|2232827|P2|STARTED|Overall Study||35
923442|NCT01533597|2232828|P1|STARTED|Overall Study||35
923443|NCT01533493|2232846|P2|NOT COMPLETED|Overall Study||3
923444|NCT01533493|2232847|P1|NOT COMPLETED|Overall Study||5
923445|NCT01533493|2232846|P2|COMPLETED|Overall Study||11
923446|NCT01533493|2232847|P1|COMPLETED|Overall Study||7
923447|NCT01533493|2232846|P2|STARTED|Overall Study||14
923448|NCT01533493|2232847|P1|STARTED|Overall Study||12
923449|NCT01533428|2232855|P2|NOT COMPLETED|Overall Study||8
923450|NCT01533428|2232856|P1|NOT COMPLETED|Overall Study||9
923451|NCT01533428|2232855|P2|COMPLETED|Overall Study||175
923452|NCT01533428|2232856|P1|COMPLETED|Overall Study||177
923453|NCT01533428|2232855|P2|STARTED|Overall Study||183
923454|NCT01533428|2232856|P1|STARTED|Overall Study||186
923455|NCT01533259|2232896|P1|NOT COMPLETED|Overall Study||0
923456|NCT01533259|2232896|P1|COMPLETED|Overall Study||48
923457|NCT01533259|2232896|P1|STARTED|Overall Study||48
923458|NCT01533246|2232902|P1|NOT COMPLETED|Overall Study||2
923459|NCT01533246|2232902|P1|COMPLETED|Overall Study||15
923460|NCT01533246|2232902|P1|STARTED|Overall Study||17
923461|NCT01533181|2232913|P2|NOT COMPLETED|Overall Study||1
923462|NCT01533181|2232914|P1|NOT COMPLETED|Overall Study||1
923463|NCT01533181|2232913|P2|COMPLETED|Overall Study||28
923464|NCT01533181|2232914|P1|COMPLETED|Overall Study||14
923465|NCT01533181|2232913|P2|STARTED|Overall Study||29
923466|NCT01533181|2232914|P1|STARTED|Overall Study||15
923467|NCT01533116|2232930|P4|NOT COMPLETED|Overall Study||0
923468|NCT01533116|2232931|P3|NOT COMPLETED|Overall Study||1
923469|NCT01533116|2232932|P2|NOT COMPLETED|Overall Study||1
923470|NCT01533116|2232933|P1|NOT COMPLETED|Overall Study||2
923471|NCT01533116|2232930|P4|COMPLETED|Overall Study||12
923472|NCT01533116|2232931|P3|COMPLETED|Overall Study||12
923473|NCT01533116|2232932|P2|COMPLETED|Overall Study||12
923474|NCT01533116|2232933|P1|COMPLETED|Overall Study||12
923475|NCT01533116|2232930|P4|STARTED|Overall Study||12
923476|NCT01533116|2232931|P3|STARTED|Overall Study||13
923477|NCT01533116|2232932|P2|STARTED|Overall Study||13
923478|NCT01533116|2232933|P1|STARTED|Overall Study||14
923479|NCT01533077|2232963|P4|NOT COMPLETED|Overall Study||0
923480|NCT01533077|2232964|P3|NOT COMPLETED|Overall Study||0
923481|NCT01533077|2232965|P2|NOT COMPLETED|Overall Study||1
923482|NCT01533077|2232966|P1|NOT COMPLETED|Overall Study||1
923483|NCT01533077|2232963|P4|COMPLETED|Overall Study||4
923484|NCT01533077|2232964|P3|COMPLETED|Overall Study||4
923485|NCT01533077|2232965|P2|COMPLETED|Overall Study||4
923486|NCT01533077|2232966|P1|COMPLETED|Overall Study||4
923487|NCT01533077|2232963|P4|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
923488|NCT01533077|2232964|P3|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
923489|NCT01533077|2232965|P2|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
923490|NCT01533077|2232966|P1|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
923491|NCT01533077|2232963|P4|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
923492|NCT01533077|2232964|P3|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
923493|NCT01533077|2232965|P2|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
923494|NCT01533077|2232966|P1|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
923495|NCT01533077|2232963|P4|Sinemet® 100/25|Overall Study||4
923496|NCT01533077|2232964|P3|Sinemet® 100/25|Overall Study||4
923497|NCT01533077|2232965|P2|Sinemet® 100/25|Overall Study||5
923498|NCT01533077|2232966|P1|Sinemet® 100/25|Overall Study||4
923499|NCT01533077|2232963|P4|BIA 9-1067 50 mg|Overall Study||4
923500|NCT01533077|2232964|P3|BIA 9-1067 50 mg|Overall Study||4
923501|NCT01533077|2232965|P2|BIA 9-1067 50 mg|Overall Study||5
923502|NCT01533077|2232966|P1|BIA 9-1067 50 mg|Overall Study||5
923503|NCT01533077|2232963|P4|STARTED|Overall Study||4
923504|NCT01533077|2232964|P3|STARTED|Overall Study||4
923505|NCT01533077|2232965|P2|STARTED|Overall Study||5
923506|NCT01533077|2232966|P1|STARTED|Overall Study||5
923507|NCT01533038|2233022|P2|NOT COMPLETED|Overall Study||1
923508|NCT01533038|2233023|P1|NOT COMPLETED|Overall Study||0
923509|NCT01533038|2233022|P2|COMPLETED|Overall Study||34
923510|NCT01533038|2233023|P1|COMPLETED|Overall Study||45
923511|NCT01533038|2233022|P2|STARTED|Overall Study||35
923512|NCT01533038|2233023|P1|STARTED|Overall Study||45
923513|NCT01532999|2233031|P2|NOT COMPLETED|Overall Study||18
923514|NCT01532999|2233032|P1|NOT COMPLETED|Overall Study||31
923515|NCT01532999|2233031|P2|COMPLETED|Overall Study||77
923516|NCT01532999|2233032|P1|COMPLETED|Overall Study||65
923517|NCT01532999|2233031|P2|STARTED|Overall Study||95
923518|NCT01532999|2233032|P1|STARTED|Overall Study||96
923519|NCT01532973|2233063|P10|NOT COMPLETED|Part 3||0
923520|NCT01532973|2233064|P9|NOT COMPLETED|Part 3||0
923521|NCT01532973|2233065|P8|NOT COMPLETED|Part 3||0
923522|NCT01532973|2233066|P7|NOT COMPLETED|Part 3||0
923523|NCT01532973|2233067|P6|NOT COMPLETED|Part 3||0
923524|NCT01532973|2233068|P5|NOT COMPLETED|Part 3||0
923525|NCT01532973|2233069|P4|NOT COMPLETED|Part 3||0
923526|NCT01532973|2233070|P3|NOT COMPLETED|Part 3||0
923527|NCT01532973|2233071|P2|NOT COMPLETED|Part 3||0
923528|NCT01532973|2233072|P1|NOT COMPLETED|Part 3||0
923529|NCT01532973|2233063|P10|COMPLETED|Part 3||6
923530|NCT01532973|2233064|P9|COMPLETED|Part 3||6
923531|NCT01532973|2233065|P8|COMPLETED|Part 3||0
923532|NCT01532973|2233066|P7|COMPLETED|Part 3||0
923533|NCT01532973|2233067|P6|COMPLETED|Part 3||0
923534|NCT01532973|2233068|P5|COMPLETED|Part 3||0
923535|NCT01532973|2233069|P4|COMPLETED|Part 3||0
923536|NCT01532973|2233070|P3|COMPLETED|Part 3||0
923537|NCT01532973|2233071|P2|COMPLETED|Part 3||0
923538|NCT01532973|2233072|P1|COMPLETED|Part 3||0
923539|NCT01532973|2233063|P10|STARTED|Part 3||6
923540|NCT01532973|2233064|P9|STARTED|Part 3||6
923541|NCT01532973|2233065|P8|STARTED|Part 3||0
923542|NCT01532973|2233066|P7|STARTED|Part 3||0
923543|NCT01532973|2233067|P6|STARTED|Part 3||0
923544|NCT01532973|2233068|P5|STARTED|Part 3||0
923545|NCT01532973|2233069|P4|STARTED|Part 3||0
923546|NCT01532973|2233070|P3|STARTED|Part 3||0
923547|NCT01532973|2233071|P2|STARTED|Part 3||0
923548|NCT01532973|2233072|P1|STARTED|Part 3||0
923549|NCT01532973|2233063|P10|NOT COMPLETED|Part 2||0
923550|NCT01532973|2233064|P9|NOT COMPLETED|Part 2||0
923551|NCT01532973|2233065|P8|NOT COMPLETED|Part 2||0
923552|NCT01532973|2233066|P7|NOT COMPLETED|Part 2||0
923553|NCT01532973|2233067|P6|NOT COMPLETED|Part 2||0
923554|NCT01532973|2233068|P5|NOT COMPLETED|Part 2||0
923555|NCT01532973|2233069|P4|NOT COMPLETED|Part 2||0
923556|NCT01532973|2233070|P3|NOT COMPLETED|Part 2||0
923557|NCT01532973|2233071|P2|NOT COMPLETED|Part 2||0
923558|NCT01532973|2233072|P1|NOT COMPLETED|Part 2||0
923559|NCT01532973|2233063|P10|COMPLETED|Part 2||0
923560|NCT01532973|2233064|P9|COMPLETED|Part 2||0
923561|NCT01532973|2233065|P8|COMPLETED|Part 2||0
923562|NCT01532973|2233066|P7|COMPLETED|Part 2||6
923563|NCT01532973|2233067|P6|COMPLETED|Part 2||6
923564|NCT01532973|2233068|P5|COMPLETED|Part 2||6
923565|NCT01532973|2233069|P4|COMPLETED|Part 2||0
923566|NCT01532973|2233070|P3|COMPLETED|Part 2||0
923567|NCT01532973|2233071|P2|COMPLETED|Part 2||0
923568|NCT01532973|2233072|P1|COMPLETED|Part 2||0
923569|NCT01532973|2233063|P10|STARTED|Part 2||0
923570|NCT01532973|2233064|P9|STARTED|Part 2||0
923571|NCT01532973|2233065|P8|STARTED|Part 2|Planned panel not performed. No participants were enrolled.|0
923572|NCT01532973|2233066|P7|STARTED|Part 2||6
923573|NCT01532973|2233067|P6|STARTED|Part 2||6
923574|NCT01532973|2233068|P5|STARTED|Part 2||6
923575|NCT01532973|2233069|P4|STARTED|Part 2||0
923576|NCT01532973|2233070|P3|STARTED|Part 2||0
923577|NCT01532973|2233071|P2|STARTED|Part 2||0
923578|NCT01532973|2233072|P1|STARTED|Part 2||0
923579|NCT01532973|2233063|P10|NOT COMPLETED|Part 1||0
923580|NCT01532973|2233064|P9|NOT COMPLETED|Part 1||0
923581|NCT01532973|2233065|P8|NOT COMPLETED|Part 1||0
923582|NCT01532973|2233066|P7|NOT COMPLETED|Part 1||0
923583|NCT01532973|2233067|P6|NOT COMPLETED|Part 1||0
923584|NCT01532973|2233068|P5|NOT COMPLETED|Part 1||0
923585|NCT01532973|2233069|P4|NOT COMPLETED|Part 1||0
923586|NCT01532973|2233070|P3|NOT COMPLETED|Part 1||0
923587|NCT01532973|2233071|P2|NOT COMPLETED|Part 1||0
923588|NCT01532973|2233072|P1|NOT COMPLETED|Part 1||0
923589|NCT01532973|2233063|P10|COMPLETED|Part 1||0
923590|NCT01532973|2233064|P9|COMPLETED|Part 1||0
923591|NCT01532973|2233065|P8|COMPLETED|Part 1||0
923592|NCT01532973|2233066|P7|COMPLETED|Part 1||0
923593|NCT01532973|2233067|P6|COMPLETED|Part 1||0
923594|NCT01532973|2233068|P5|COMPLETED|Part 1||0
923595|NCT01532973|2233069|P4|COMPLETED|Part 1||0
923596|NCT01532973|2233070|P3|COMPLETED|Part 1||6
923597|NCT01532973|2233071|P2|COMPLETED|Part 1||6
923598|NCT01532973|2233072|P1|COMPLETED|Part 1||6
923599|NCT01532973|2233063|P10|STARTED|Part 1||0
923600|NCT01532973|2233064|P9|STARTED|Part 1||0
923601|NCT01532973|2233065|P8|STARTED|Part 1||0
923602|NCT01532973|2233066|P7|STARTED|Part 1||0
923603|NCT01532973|2233067|P6|STARTED|Part 1||0
923604|NCT01532973|2233068|P5|STARTED|Part 1||0
923605|NCT01532973|2233069|P4|STARTED|Part 1|Planned panel not performed. No participants were enrolled.|0
923606|NCT01532973|2233070|P3|STARTED|Part 1||6
923607|NCT01532973|2233071|P2|STARTED|Part 1||6
923608|NCT01532973|2233072|P1|STARTED|Part 1||6
923609|NCT01532934|2233114|P2|NOT COMPLETED|Overall Study||13
923610|NCT01532934|2233115|P1|NOT COMPLETED|Overall Study||14
923611|NCT01532934|2233114|P2|COMPLETED|Overall Study||39
923612|NCT01532934|2233115|P1|COMPLETED|Overall Study||39
923613|NCT01532934|2233114|P2|STARTED|Overall Study||52
923614|NCT01532934|2233115|P1|STARTED|Overall Study||53
923615|NCT01532869|2233127|P2|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||3
923700|NCT01532128|2233281|P2|STARTED|Overall Study||8
923616|NCT01532869|2233128|P1|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||7
923617|NCT01532869|2233127|P2|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|27
923618|NCT01532869|2233128|P1|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|24
923619|NCT01532869|2233127|P2|STARTED|Open-label Period (Week 48 to Week 96)||30
923620|NCT01532869|2233128|P1|STARTED|Open-label Period (Week 48 to Week 96)|Two participants did not start the open label extension period.|31
923621|NCT01532869|2233127|P2|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||13
923622|NCT01532869|2233128|P1|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||11
923623|NCT01532869|2233127|P2|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|30
923624|NCT01532869|2233128|P1|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|33
923625|NCT01532869|2233127|P2|STARTED|Blinded-Treatment Period (Up to Week 48)||43
923626|NCT01532869|2233128|P1|STARTED|Blinded-Treatment Period (Up to Week 48)||44
923627|NCT01532869|2233127|P2|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
923628|NCT01532869|2233128|P1|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
923629|NCT01532869|2233127|P2|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|35
923630|NCT01532869|2233128|P1|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|36
923631|NCT01532869|2233127|P2|STARTED|Blinded-Treatment Period (Up to Week 24)||43
923632|NCT01532869|2233128|P1|STARTED|Blinded-Treatment Period (Up to Week 24)||44
923633|NCT01532635|2233165|P1|NOT COMPLETED|Overall Study||0
923634|NCT01532635|2233165|P1|COMPLETED|Overall Study||4
923635|NCT01532635|2233165|P1|STARTED|Overall Study||4
923636|NCT01532570|2233181|P4|NOT COMPLETED|Overall Study||0
923637|NCT01532570|2233182|P3|NOT COMPLETED|Overall Study||0
923638|NCT01532570|2233183|P2|NOT COMPLETED|Overall Study||1
923639|NCT01532570|2233184|P1|NOT COMPLETED|Overall Study||1
923640|NCT01532570|2233181|P4|COMPLETED|Overall Study||4
923641|NCT01532570|2233182|P3|COMPLETED|Overall Study||1
923642|NCT01532570|2233183|P2|COMPLETED|Overall Study||1
923643|NCT01532570|2233184|P1|COMPLETED|Overall Study||10
923644|NCT01532570|2233181|P4|STARTED|Overall Study||4
923645|NCT01532570|2233182|P3|STARTED|Overall Study||1
923646|NCT01532570|2233183|P2|STARTED|Overall Study||2
923647|NCT01532570|2233184|P1|STARTED|Overall Study||11
923648|NCT01532453|2233217|P2|NOT COMPLETED|Overall Study||70
923649|NCT01532453|2233218|P1|NOT COMPLETED|Overall Study||27
923650|NCT01532453|2233217|P2|COMPLETED|Overall Study||90
923651|NCT01532453|2233218|P1|COMPLETED|Overall Study||54
923652|NCT01532453|2233217|P2|STARTED|Overall Study||160
923653|NCT01532453|2233218|P1|STARTED|Overall Study||81
923654|NCT01532414|2233229|P3|NOT COMPLETED|Overall Study||3
923655|NCT01532414|2233230|P2|NOT COMPLETED|Overall Study||2
923656|NCT01532414|2233231|P1|NOT COMPLETED|Overall Study||7
923657|NCT01532414|2233229|P3|COMPLETED|Overall Study||35
923658|NCT01532414|2233230|P2|COMPLETED|Overall Study||19
923659|NCT01532414|2233231|P1|COMPLETED|Overall Study||85
923660|NCT01532414|2233229|P3|STARTED|Overall Study||38
923661|NCT01532414|2233230|P2|STARTED|Overall Study|Up-titrated at 6 weeks from a starting dose of 12.5 mg due to morning testosterone <300 ng/dL|21
923662|NCT01532414|2233231|P1|STARTED|Overall Study||92
923663|NCT01532362|2233241|P2|NOT COMPLETED|Overall Study||0
923664|NCT01532362|2233242|P1|NOT COMPLETED|Overall Study||0
923665|NCT01532362|2233241|P2|COMPLETED|Overall Study||0
923666|NCT01532362|2233242|P1|COMPLETED|Overall Study||1
923667|NCT01532362|2233241|P2|STARTED|Overall Study||0
923668|NCT01532362|2233242|P1|STARTED|Overall Study||1
923669|NCT01532349|2233250|P2|NOT COMPLETED|Overall Study||5
923670|NCT01532349|2233251|P1|NOT COMPLETED|Overall Study||2
923671|NCT01532349|2233250|P2|COMPLETED|Overall Study||12
923672|NCT01532349|2233251|P1|COMPLETED|Overall Study||15
923673|NCT01532349|2233250|P2|STARTED|Overall Study||17
923674|NCT01532349|2233251|P1|STARTED|Overall Study||17
923675|NCT01532141|2233260|P3|NOT COMPLETED|Overall Study||0
923676|NCT01532141|2233261|P2|NOT COMPLETED|Overall Study||0
923677|NCT01532141|2233262|P1|NOT COMPLETED|Overall Study||1
923678|NCT01532141|2233260|P3|COMPLETED|Overall Study||8
923679|NCT01532141|2233261|P2|COMPLETED|Overall Study||8
923680|NCT01532141|2233262|P1|COMPLETED|Overall Study||8
923681|NCT01532141|2233260|P3|Period 3|Overall Study||8
923682|NCT01532141|2233261|P2|Period 3|Overall Study||8
923683|NCT01532141|2233262|P1|Period 3|Overall Study||8
923684|NCT01532141|2233260|P3|Period 2|Overall Study||8
923685|NCT01532141|2233261|P2|Period 2|Overall Study||8
923686|NCT01532141|2233262|P1|Period 2|Overall Study||8
923687|NCT01532141|2233260|P3|Period 1|Overall Study||8
923688|NCT01532141|2233261|P2|Period 1|Overall Study||8
923689|NCT01532141|2233262|P1|Period 1|Overall Study||9
923690|NCT01532141|2233260|P3|STARTED|Overall Study||8
923691|NCT01532141|2233261|P2|STARTED|Overall Study||8
923692|NCT01532141|2233262|P1|STARTED|Overall Study||9
923693|NCT01532128|2233280|P3|NOT COMPLETED|Overall Study||0
923694|NCT01532128|2233281|P2|NOT COMPLETED|Overall Study||0
923695|NCT01532128|2233282|P1|NOT COMPLETED|Overall Study||0
923696|NCT01532128|2233280|P3|COMPLETED|Overall Study||8
923697|NCT01532128|2233281|P2|COMPLETED|Overall Study||8
923698|NCT01532128|2233282|P1|COMPLETED|Overall Study||8
923699|NCT01532128|2233280|P3|STARTED|Overall Study||8
923701|NCT01532128|2233282|P1|STARTED|Overall Study||8
923702|NCT01531998|2233297|P1|NOT COMPLETED|Overall Study||3
923703|NCT01531998|2233297|P1|COMPLETED|Overall Study||8
923704|NCT01531998|2233297|P1|STARTED|Overall Study||11
923705|NCT01531725|2233302|P1|NOT COMPLETED|Overall Study||5
923706|NCT01531725|2233302|P1|COMPLETED|Overall Study||197
923707|NCT01531725|2233302|P1|STARTED|Overall Study|5 patients with protocol violation were excluded.|202
923708|NCT01531387|2233309|P2|NOT COMPLETED|Overall Study||11
923709|NCT01531387|2233310|P1|NOT COMPLETED|Overall Study||11
923710|NCT01531387|2233309|P2|COMPLETED|Overall Study||0
923711|NCT01531387|2233310|P1|COMPLETED|Overall Study||0
923712|NCT01531387|2233309|P2|STARTED|Overall Study||11
923713|NCT01531387|2233310|P1|STARTED|Overall Study||11
923723|NCT01531335|2233393|P2|NOT COMPLETED|Overall Study||0
923724|NCT01531335|2233394|P1|NOT COMPLETED|Overall Study||0
923725|NCT01531335|2233393|P2|COMPLETED|Overall Study||40
923726|NCT01531335|2233394|P1|COMPLETED|Overall Study||40
923727|NCT01531335|2233393|P2|STARTED|Overall Study||40
923728|NCT01531335|2233394|P1|STARTED|Overall Study||40
923729|NCT01531205|2233402|P1|NOT COMPLETED|Overall Study||1
923730|NCT01531205|2233402|P1|COMPLETED|Overall Study||1
923731|NCT01531205|2233402|P1|STARTED|Overall Study||2
923732|NCT01530997|2233411|P1|NOT COMPLETED|Overall Study||2
923733|NCT01530997|2233411|P1|COMPLETED|Overall Study||43
923734|NCT01530997|2233411|P1|STARTED|Overall Study||45
923735|NCT01530880|2233431|P1|NOT COMPLETED|Overall Study||0
923736|NCT01530880|2233431|P1|COMPLETED|Overall Study||35
923737|NCT01530880|2233431|P1|STARTED|Overall Study||35
923738|NCT01530477|2233445|P3|NOT COMPLETED|Overall Study||0
923739|NCT01530477|2233446|P2|NOT COMPLETED|Overall Study||0
923740|NCT01530477|2233447|P1|NOT COMPLETED|Overall Study||0
923741|NCT01530477|2233445|P3|COMPLETED|Overall Study|53 subjects completed the imaging in both the Skeletal and Body Composition cohorts.|53
923742|NCT01530477|2233446|P2|COMPLETED|Overall Study|12 subjects completed imaging in the Body Composition cohort only.|12
923743|NCT01530477|2233447|P1|COMPLETED|Overall Study|17 subjects completed imaging in the Skeletal cohort only.|17
923744|NCT01530477|2233445|P3|STARTED|Overall Study|53 subjects consented to both the Skeletal and body Composition cohorts.|53
923745|NCT01530477|2233446|P2|STARTED|Overall Study|12 subjects consented to the Body Composition cohort only.|12
923746|NCT01530477|2233447|P1|STARTED|Overall Study|17 subjects consented to the Skeletal cohort only.|17
923747|NCT01530464|2233455|P2|NOT COMPLETED|Washout (24h)||1
923748|NCT01530464|2233456|P1|NOT COMPLETED|Washout (24h)||0
923749|NCT01530464|2233455|P2|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|7
923750|NCT01530464|2233456|P1|COMPLETED|Washout (24h)||9
923751|NCT01530464|2233455|P2|STARTED|Washout (24h)||8
923752|NCT01530464|2233456|P1|STARTED|Washout (24h)||9
923753|NCT01530464|2233455|P2|NOT COMPLETED|Third Intervention (24h)||0
923754|NCT01530464|2233456|P1|NOT COMPLETED|Third Intervention (24h)||0
923755|NCT01530464|2233455|P2|COMPLETED|Third Intervention (24h)||8
923756|NCT01530464|2233456|P1|COMPLETED|Third Intervention (24h)||9
923757|NCT01530464|2233455|P2|STARTED|Third Intervention (24h)||8
923758|NCT01530464|2233456|P1|STARTED|Third Intervention (24h)||9
923759|NCT01530464|2233455|P2|NOT COMPLETED|Washout (24h)||0
923760|NCT01530464|2233456|P1|NOT COMPLETED|Washout (24h)||1
923761|NCT01530464|2233455|P2|COMPLETED|Washout (24h)||8
923762|NCT01530464|2233456|P1|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|9
923763|NCT01530464|2233455|P2|STARTED|Washout (24h)||8
923764|NCT01530464|2233456|P1|STARTED|Washout (24h)||10
923765|NCT01530464|2233455|P2|NOT COMPLETED|Second Intervention (24h)||0
923766|NCT01530464|2233456|P1|NOT COMPLETED|Second Intervention (24h)||0
923767|NCT01530464|2233455|P2|COMPLETED|Second Intervention (24h)||8
923768|NCT01530464|2233456|P1|COMPLETED|Second Intervention (24h)||10
923769|NCT01530464|2233455|P2|STARTED|Second Intervention (24h)||8
923770|NCT01530464|2233456|P1|STARTED|Second Intervention (24h)||10
923771|NCT01530464|2233455|P2|NOT COMPLETED|Washout (24h)||0
923772|NCT01530464|2233456|P1|NOT COMPLETED|Washout (24h)||0
923773|NCT01530464|2233455|P2|COMPLETED|Washout (24h)||8
923774|NCT01530464|2233456|P1|COMPLETED|Washout (24h)||10
923775|NCT01530464|2233455|P2|STARTED|Washout (24h)||8
923776|NCT01530464|2233456|P1|STARTED|Washout (24h)||10
923777|NCT01530464|2233455|P2|NOT COMPLETED|First Intervention (24h)||0
923778|NCT01530464|2233456|P1|NOT COMPLETED|First Intervention (24h)||0
923779|NCT01530464|2233455|P2|COMPLETED|First Intervention (24h)||8
923780|NCT01530464|2233456|P1|COMPLETED|First Intervention (24h)||10
923781|NCT01530464|2233455|P2|STARTED|First Intervention (24h)||8
923782|NCT01530464|2233456|P1|STARTED|First Intervention (24h)||10
923783|NCT01530399|2233489|P6|NOT COMPLETED|Overall Study||1
923784|NCT01530399|2233490|P5|NOT COMPLETED|Overall Study||0
923785|NCT01530399|2233491|P4|NOT COMPLETED|Overall Study||0
923786|NCT01530399|2233492|P3|NOT COMPLETED|Overall Study||1
923787|NCT01530399|2233493|P2|NOT COMPLETED|Overall Study||2
923788|NCT01530399|2233494|P1|NOT COMPLETED|Overall Study||1
923789|NCT01530399|2233489|P6|COMPLETED|Overall Study||6
923790|NCT01530399|2233490|P5|COMPLETED|Overall Study||6
923791|NCT01530399|2233491|P4|COMPLETED|Overall Study||10
923792|NCT01530399|2233492|P3|COMPLETED|Overall Study||7
923793|NCT01530399|2233493|P2|COMPLETED|Overall Study||8
923794|NCT01530399|2233494|P1|COMPLETED|Overall Study||7
923795|NCT01530399|2233489|P6|STARTED|Overall Study||7
923796|NCT01530399|2233490|P5|STARTED|Overall Study||6
923797|NCT01530399|2233491|P4|STARTED|Overall Study||10
923798|NCT01530399|2233492|P3|STARTED|Overall Study||8
923799|NCT01530399|2233493|P2|STARTED|Overall Study||10
923800|NCT01530399|2233494|P1|STARTED|Overall Study||8
923801|NCT01530334|2233508|P1|NOT COMPLETED|Overall Study||51
923802|NCT01530334|2233508|P1|COMPLETED|Overall Study||10
923803|NCT01530334|2233508|P1|STARTED|Overall Study||61
923804|NCT01530243|2233521|P4|NOT COMPLETED|Overall Study||2
923805|NCT01530243|2233522|P3|NOT COMPLETED|Overall Study||3
923806|NCT01530243|2233523|P2|NOT COMPLETED|Overall Study||3
923807|NCT01530243|2233524|P1|NOT COMPLETED|Overall Study||2
923808|NCT01530243|2233521|P4|COMPLETED|Overall Study||24
923809|NCT01530243|2233522|P3|COMPLETED|Overall Study||23
923810|NCT01530243|2233523|P2|COMPLETED|Overall Study||23
923811|NCT01530243|2233524|P1|COMPLETED|Overall Study||24
923812|NCT01530243|2233521|P4|STARTED|Overall Study||26
923813|NCT01530243|2233522|P3|STARTED|Overall Study||26
923814|NCT01530243|2233523|P2|STARTED|Overall Study||26
923815|NCT01530243|2233524|P1|STARTED|Overall Study||26
923816|NCT01530087|2233542|P1|NOT COMPLETED|Overall Study||2
923817|NCT01530087|2233542|P1|COMPLETED|Overall Study||1
923818|NCT01530087|2233542|P1|STARTED|Overall Study||3
923819|NCT01529827|2233547|P1|NOT COMPLETED|Overall Study||0
923820|NCT01529827|2233547|P1|COMPLETED|Overall Study||94
923821|NCT01529827|2233547|P1|STARTED|Overall Study||94
923822|NCT01529645|2233564|P10|NOT COMPLETED|Overall Study||0
923823|NCT01529645|2233565|P9|NOT COMPLETED|Overall Study||1
923824|NCT01529645|2233566|P8|NOT COMPLETED|Overall Study||0
923825|NCT01529645|2233567|P7|NOT COMPLETED|Overall Study||2
923826|NCT01529645|2233568|P6|NOT COMPLETED|Overall Study||1
923827|NCT01529645|2233569|P5|NOT COMPLETED|Overall Study||2
923828|NCT01529645|2233570|P4|NOT COMPLETED|Overall Study||2
923829|NCT01529645|2233571|P3|NOT COMPLETED|Overall Study||2
923830|NCT01529645|2233572|P2|NOT COMPLETED|Overall Study||1
923831|NCT01529645|2233573|P1|NOT COMPLETED|Overall Study||2
923832|NCT01529645|2233564|P10|COMPLETED|Overall Study||42
923833|NCT01529645|2233565|P9|COMPLETED|Overall Study||41
923834|NCT01529645|2233566|P8|COMPLETED|Overall Study||42
923835|NCT01529645|2233567|P7|COMPLETED|Overall Study||40
923836|NCT01529645|2233568|P6|COMPLETED|Overall Study||41
923837|NCT01529645|2233569|P5|COMPLETED|Overall Study||40
923838|NCT01529645|2233570|P4|COMPLETED|Overall Study||40
923839|NCT01529645|2233571|P3|COMPLETED|Overall Study||40
923840|NCT01529645|2233572|P2|COMPLETED|Overall Study||41
923841|NCT01529645|2233573|P1|COMPLETED|Overall Study||40
923842|NCT01529645|2233564|P10|STARTED|Overall Study||42
923843|NCT01529645|2233565|P9|STARTED|Overall Study||42
923844|NCT01529645|2233566|P8|STARTED|Overall Study||42
923845|NCT01529645|2233567|P7|STARTED|Overall Study||42
923846|NCT01529645|2233568|P6|STARTED|Overall Study||42
923847|NCT01529645|2233569|P5|STARTED|Overall Study||42
923848|NCT01529645|2233570|P4|STARTED|Overall Study||42
923849|NCT01529645|2233571|P3|STARTED|Overall Study||42
923850|NCT01529645|2233572|P2|STARTED|Overall Study||42
923851|NCT01529645|2233573|P1|STARTED|Overall Study||42
923852|NCT01529632|2233671|P2|NOT COMPLETED|Overall Study||3
923853|NCT01529632|2233672|P1|NOT COMPLETED|Overall Study||3
923854|NCT01529632|2233671|P2|COMPLETED|Overall Study||100
923855|NCT01529632|2233672|P1|COMPLETED|Overall Study||87
923856|NCT01529632|2233671|P2|STARTED|Overall Study||103
923857|NCT01529632|2233672|P1|STARTED|Overall Study||90
923858|NCT01529515|2233692|P4|NOT COMPLETED|DOUBLE BLIND PHASE||12
923859|NCT01529515|2233693|P3|NOT COMPLETED|DOUBLE BLIND PHASE||23
923860|NCT01529515|2233694|P2|NOT COMPLETED|DOUBLE BLIND PHASE||0
923861|NCT01529515|2233695|P1|NOT COMPLETED|DOUBLE BLIND PHASE||0
923862|NCT01529515|2233692|P4|COMPLETED|DOUBLE BLIND PHASE||148
923863|NCT01529515|2233693|P3|COMPLETED|DOUBLE BLIND PHASE||122
923864|NCT01529515|2233694|P2|COMPLETED|DOUBLE BLIND PHASE||0
923865|NCT01529515|2233695|P1|COMPLETED|DOUBLE BLIND PHASE||0
923866|NCT01529515|2233692|P4|STARTED|DOUBLE BLIND PHASE||160
923867|NCT01529515|2233693|P3|STARTED|DOUBLE BLIND PHASE||145
923868|NCT01529515|2233694|P2|STARTED|DOUBLE BLIND PHASE||0
923869|NCT01529515|2233695|P1|STARTED|DOUBLE BLIND PHASE||0
923870|NCT01529515|2233692|P4|NOT COMPLETED|MAINTENANCE PHASE||0
923871|NCT01529515|2233693|P3|NOT COMPLETED|MAINTENANCE PHASE||0
923872|NCT01529515|2233694|P2|NOT COMPLETED|MAINTENANCE PHASE||74
923873|NCT01529515|2233695|P1|NOT COMPLETED|MAINTENANCE PHASE||0
923874|NCT01529515|2233692|P4|COMPLETED|MAINTENANCE PHASE||0
923875|NCT01529515|2233693|P3|COMPLETED|MAINTENANCE PHASE||0
923876|NCT01529515|2233694|P2|COMPLETED|MAINTENANCE PHASE||305
923877|NCT01529515|2233695|P1|COMPLETED|MAINTENANCE PHASE||0
923878|NCT01529515|2233692|P4|STARTED|MAINTENANCE PHASE||0
923879|NCT01529515|2233693|P3|STARTED|MAINTENANCE PHASE||0
923880|NCT01529515|2233694|P2|STARTED|MAINTENANCE PHASE||379
923881|NCT01529515|2233695|P1|STARTED|MAINTENANCE PHASE||0
923882|NCT01529515|2233692|P4|NOT COMPLETED|TRANSITION PHASE||0
923883|NCT01529515|2233693|P3|NOT COMPLETED|TRANSITION PHASE||0
923884|NCT01529515|2233694|P2|NOT COMPLETED|TRANSITION PHASE||0
923885|NCT01529515|2233695|P1|NOT COMPLETED|TRANSITION PHASE||127
923886|NCT01529515|2233692|P4|COMPLETED|TRANSITION PHASE||0
923887|NCT01529515|2233693|P3|COMPLETED|TRANSITION PHASE||0
923888|NCT01529515|2233694|P2|COMPLETED|TRANSITION PHASE||0
923889|NCT01529515|2233695|P1|COMPLETED|TRANSITION PHASE||379
923890|NCT01529515|2233692|P4|STARTED|TRANSITION PHASE||0
923891|NCT01529515|2233693|P3|STARTED|TRANSITION PHASE||0
923892|NCT01529515|2233694|P2|STARTED|TRANSITION PHASE||0
923893|NCT01529515|2233695|P1|STARTED|TRANSITION PHASE||506
923894|NCT01529502|2233714|P6|NOT COMPLETED|Overall Study||0
923895|NCT01529502|2233715|P5|NOT COMPLETED|Overall Study||0
923896|NCT01529502|2233716|P4|NOT COMPLETED|Overall Study||2
923897|NCT01529502|2233717|P3|NOT COMPLETED|Overall Study||0
923898|NCT01529502|2233718|P2|NOT COMPLETED|Overall Study||0
923899|NCT01529502|2233719|P1|NOT COMPLETED|Overall Study||0
923900|NCT01529502|2233714|P6|COMPLETED|Overall Study||2
923901|NCT01529502|2233715|P5|COMPLETED|Overall Study||2
923902|NCT01529502|2233716|P4|COMPLETED|Overall Study||1
923903|NCT01529502|2233717|P3|COMPLETED|Overall Study||2
923904|NCT01529502|2233718|P2|COMPLETED|Overall Study||3
923905|NCT01529502|2233719|P1|COMPLETED|Overall Study||2
923906|NCT01529502|2233714|P6|STARTED|Overall Study||2
923907|NCT01529502|2233715|P5|STARTED|Overall Study||2
923908|NCT01529502|2233716|P4|STARTED|Overall Study||3
923909|NCT01529502|2233717|P3|STARTED|Overall Study||2
923910|NCT01529502|2233718|P2|STARTED|Overall Study||3
923911|NCT01529502|2233719|P1|STARTED|Overall Study||2
923912|NCT01529450|2233732|P2|NOT COMPLETED|Overall Study||2
923913|NCT01529450|2233733|P1|NOT COMPLETED|Overall Study||0
923914|NCT01529450|2233732|P2|COMPLETED|Overall Study||6
923915|NCT01529450|2233733|P1|COMPLETED|Overall Study||3
923916|NCT01529450|2233732|P2|STARTED|Overall Study||8
923917|NCT01529450|2233733|P1|STARTED|Overall Study||3
923918|NCT01529385|2233742|P2|NOT COMPLETED|Overall Study||1
923919|NCT01529385|2233743|P1|NOT COMPLETED|Overall Study||2
923920|NCT01529385|2233742|P2|COMPLETED|Overall Study||39
923921|NCT01529385|2233743|P1|COMPLETED|Overall Study||38
923922|NCT01529385|2233742|P2|Received Intervention|Overall Study||40
923923|NCT01529385|2233743|P1|Received Intervention|Overall Study|1 participant failed to show up to treatment allocation visit and was subsequently lost to follow up|39
923924|NCT01529385|2233742|P2|STARTED|Overall Study||40
923925|NCT01529385|2233743|P1|STARTED|Overall Study||40
923926|NCT01529268|2233769|P2|NOT COMPLETED|Overall Study||3
923927|NCT01529268|2233770|P1|NOT COMPLETED|Overall Study||12
923928|NCT01529268|2233769|P2|COMPLETED|Overall Study||78
923929|NCT01529268|2233770|P1|COMPLETED|Overall Study||76
923930|NCT01529268|2233769|P2|Completed 52-week Biopsy|Overall Study||75
923931|NCT01529268|2233770|P1|Completed 52-week Biopsy|Overall Study||71
923932|NCT01529268|2233769|P2|STARTED|Overall Study||81
923933|NCT01529268|2233770|P1|STARTED|Overall Study||88
923934|NCT01529203|2233824|P1|NOT COMPLETED|Overall Study||3
923935|NCT01529203|2233824|P1|COMPLETED|Overall Study||57
923936|NCT01529203|2233824|P1|STARTED|Overall Study||60
923937|NCT01529112|2233832|P2|NOT COMPLETED|Overall Study||41
923938|NCT01529112|2233833|P1|NOT COMPLETED|Overall Study||69
923939|NCT01529112|2233832|P2|COMPLETED|Overall Study|Discontinued treatment-continued follow-up=5 (data cut-off date 21 January 2014)|5
923940|NCT01529112|2233833|P1|COMPLETED|Overall Study|On treatment=2, Discontinued treatment-continued follow-up=18 (data cut-off date 21 January 2014)|20
923941|NCT01529112|2233832|P2|STARTED|Overall Study||46
923942|NCT01529112|2233833|P1|STARTED|Overall Study||89
923943|NCT01528969|2233860|P2|NOT COMPLETED|Overall Study||0
923944|NCT01528969|2233861|P1|NOT COMPLETED|Overall Study||2
923945|NCT01528969|2233860|P2|COMPLETED|Overall Study||38
923946|NCT01528969|2233861|P1|COMPLETED|Overall Study||35
923947|NCT01528969|2233860|P2|STARTED|Overall Study||38
923948|NCT01528969|2233861|P1|STARTED|Overall Study||37
923949|NCT01528891|2233869|P2|NOT COMPLETED|Overall Study||0
923950|NCT01528891|2233870|P1|NOT COMPLETED|Overall Study||0
923951|NCT01528891|2233869|P2|COMPLETED|Overall Study||200
923952|NCT01528891|2233870|P1|COMPLETED|Overall Study||200
923953|NCT01528891|2233869|P2|STARTED|Overall Study||200
923954|NCT01528891|2233870|P1|STARTED|Overall Study||200
923955|NCT01528735|2233884|P2|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||0
923956|NCT01528735|2233885|P1|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||1
923957|NCT01528735|2233884|P2|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||12
923958|NCT01528735|2233885|P1|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||10
923959|NCT01528735|2233884|P2|STARTED|Treatment Period 2: Faldap/PegIFN/RBV|One patient was treated with only PegIFN/RBV, as faldaprevir was discontinued due to adverse events|12
923960|NCT01528735|2233885|P1|STARTED|Treatment Period 2: Faldap/PegIFN/RBV||11
923961|NCT01528735|2233884|P2|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
923962|NCT01528735|2233885|P1|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
923963|NCT01528735|2233884|P2|COMPLETED|Treatment Period 1: Faldap/Del/RBV||12
923964|NCT01528735|2233885|P1|COMPLETED|Treatment Period 1: Faldap/Del/RBV||11
923965|NCT01528735|2233884|P2|STARTED|Treatment Period 1: Faldap/Del/RBV||13
923966|NCT01528735|2233885|P1|STARTED|Treatment Period 1: Faldap/Del/RBV||12
923967|NCT01528696|2233987|P2|NOT COMPLETED|Overall Study||19
923968|NCT01528696|2233988|P1|NOT COMPLETED|Overall Study||18
923969|NCT01528696|2233987|P2|COMPLETED|Overall Study||0
923970|NCT01528696|2233988|P1|COMPLETED|Overall Study||0
923971|NCT01528696|2233987|P2|Hospital Stay (2-5 Days)|Overall Study||19
923972|NCT01528696|2233988|P1|Hospital Stay (2-5 Days)|Overall Study||18
923973|NCT01528696|2233987|P2|STARTED|Overall Study||19
923974|NCT01528696|2233988|P1|STARTED|Overall Study||18
923975|NCT01528605|2234004|P6|NOT COMPLETED|Overall Study||0
923976|NCT01528605|2234005|P5|NOT COMPLETED|Overall Study||0
923977|NCT01528605|2234006|P4|NOT COMPLETED|Overall Study||1
923978|NCT01528605|2234007|P3|NOT COMPLETED|Overall Study||1
923979|NCT01528605|2234008|P2|NOT COMPLETED|Overall Study||0
923980|NCT01528605|2234009|P1|NOT COMPLETED|Overall Study||2
923981|NCT01528605|2234004|P6|COMPLETED|Overall Study||28
923982|NCT01528605|2234005|P5|COMPLETED|Overall Study||28
923983|NCT01528605|2234006|P4|COMPLETED|Overall Study||27
923984|NCT01528605|2234007|P3|COMPLETED|Overall Study||27
923985|NCT01528605|2234008|P2|COMPLETED|Overall Study||28
923986|NCT01528605|2234009|P1|COMPLETED|Overall Study||26
923987|NCT01528605|2234004|P6|STARTED|Overall Study||28
923988|NCT01528605|2234005|P5|STARTED|Overall Study||28
923989|NCT01528605|2234006|P4|STARTED|Overall Study||28
923990|NCT01528605|2234007|P3|STARTED|Overall Study||28
923991|NCT01528605|2234008|P2|STARTED|Overall Study||28
923992|NCT01528605|2234009|P1|STARTED|Overall Study||28
923996|NCT01528345|2234039|P2|NOT COMPLETED|Overall Study||50
923997|NCT01528345|2234040|P1|NOT COMPLETED|Overall Study||47
923998|NCT01528345|2234039|P2|COMPLETED|Overall Study||0
923999|NCT01528345|2234040|P1|COMPLETED|Overall Study||0
924000|NCT01528345|2234039|P2|STARTED|Overall Study||50
924001|NCT01528345|2234040|P1|STARTED|Overall Study||47
924002|NCT01528332|2234058|P2|NOT COMPLETED|Overall Study||2
924003|NCT01528332|2234059|P1|NOT COMPLETED|Overall Study||4
924004|NCT01528332|2234058|P2|COMPLETED|Overall Study||84
924005|NCT01528332|2234059|P1|COMPLETED|Overall Study||81
924006|NCT01528332|2234058|P2|STARTED|Overall Study||86
924007|NCT01528332|2234059|P1|STARTED|Overall Study||85
924008|NCT01528319|2234065|P1|NOT COMPLETED|Overall Study||1
924009|NCT01528319|2234065|P1|COMPLETED|Overall Study||23
924010|NCT01528319|2234065|P1|12 Weeks After Surgery|Overall Study||24
924011|NCT01528319|2234065|P1|STARTED|Overall Study||24
924012|NCT01528293|2234076|P2|NOT COMPLETED|Overall Study||0
924013|NCT01528293|2234077|P1|NOT COMPLETED|Overall Study||1
924014|NCT01528293|2234076|P2|COMPLETED|Overall Study||1
924015|NCT01528293|2234077|P1|COMPLETED|Overall Study||0
924016|NCT01528293|2234076|P2|STARTED|Overall Study||1
924017|NCT01528293|2234077|P1|STARTED|Overall Study||1
924018|NCT01528215|2234091|P2|NOT COMPLETED|Overall Study||1
924019|NCT01528215|2234092|P1|NOT COMPLETED|Overall Study||4
924020|NCT01528215|2234091|P2|COMPLETED|Overall Study||60
924021|NCT01528215|2234092|P1|COMPLETED|Overall Study||55
924022|NCT01528215|2234091|P2|STARTED|Overall Study||61
924023|NCT01528215|2234092|P1|STARTED|Overall Study||59
924024|NCT01528150|2234098|P1|NOT COMPLETED|Overall Study||44
924025|NCT01528150|2234098|P1|COMPLETED|Overall Study||422
924026|NCT01528150|2234098|P1|STARTED|Overall Study||466
924027|NCT01527942|2234104|P2|NOT COMPLETED|Overall Study||0
924028|NCT01527942|2234105|P1|NOT COMPLETED|Overall Study||0
924029|NCT01527942|2234104|P2|COMPLETED|Overall Study||18
924030|NCT01527942|2234105|P1|COMPLETED|Overall Study||16
924031|NCT01527942|2234104|P2|STARTED|Overall Study||18
924032|NCT01527942|2234105|P1|STARTED|Overall Study||16
924033|NCT01527513|2234117|P2|NOT COMPLETED|Eligible for 1-Year Open Label Period||17
924034|NCT01527513|2234118|P1|NOT COMPLETED|Eligible for 1-Year Open Label Period||0
924035|NCT01527513|2234117|P2|COMPLETED|Eligible for 1-Year Open Label Period||95
924036|NCT01527513|2234118|P1|COMPLETED|Eligible for 1-Year Open Label Period||0
924037|NCT01527513|2234117|P2|STARTED|Eligible for 1-Year Open Label Period|Participants that were eligible to participate in for 1-Year Open Label Period - Part II|112
924038|NCT01527513|2234118|P1|STARTED|Eligible for 1-Year Open Label Period||0
924039|NCT01527513|2234117|P2|NOT COMPLETED|Double Blind Period (DB) - Part I||8
924040|NCT01527513|2234118|P1|NOT COMPLETED|Double Blind Period (DB) - Part I||3
924041|NCT01527513|2234117|P2|COMPLETED|Double Blind Period (DB) - Part I||75
924042|NCT01527513|2234118|P1|COMPLETED|Double Blind Period (DB) - Part I||37
924043|NCT01527513|2234117|P2|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||66
924044|NCT01527513|2234118|P1|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||36
924045|NCT01527513|2234117|P2|Efficacy PP Population|Double Blind Period (DB) - Part I||67
924046|NCT01527513|2234118|P1|Efficacy PP Population|Double Blind Period (DB) - Part I||37
924047|NCT01527513|2234117|P2|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||75
924048|NCT01527513|2234118|P1|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||37
924049|NCT01527513|2234117|P2|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||75
924050|NCT01527513|2234118|P1|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||37
924051|NCT01527513|2234117|P2|Entered Maintenance Period|Double Blind Period (DB) - Part I||76
924052|NCT01527513|2234118|P1|Entered Maintenance Period|Double Blind Period (DB) - Part I||40
924053|NCT01527513|2234117|P2|Safety Population|Double Blind Period (DB) - Part I||83
924054|NCT01527513|2234118|P1|Safety Population|Double Blind Period (DB) - Part I||40
924055|NCT01527513|2234117|P2|Randomized|Double Blind Period (DB) - Part I||83
924056|NCT01527513|2234118|P1|Randomized|Double Blind Period (DB) - Part I||40
924057|NCT01527513|2234117|P2|STARTED|Double Blind Period (DB) - Part I||83
924058|NCT01527513|2234118|P1|STARTED|Double Blind Period (DB) - Part I||40
924059|NCT01527487|2234130|P2|NOT COMPLETED|Overall Study||7
924060|NCT01527487|2234131|P1|NOT COMPLETED|Overall Study||8
924061|NCT01527487|2234130|P2|COMPLETED|Overall Study||15
924062|NCT01527487|2234131|P1|COMPLETED|Overall Study|Patients who completed 6 cycles plus surgery.|46
924063|NCT01527487|2234130|P2|STARTED|Overall Study||22
924064|NCT01527487|2234131|P1|STARTED|Overall Study|Includes 10 patients from safety lead-in.|54
924065|NCT01527370|2234143|P1|NOT COMPLETED|Overall Study||6
924066|NCT01527370|2234143|P1|COMPLETED|Overall Study||244
924067|NCT01527370|2234143|P1|STARTED|Overall Study||250
924068|NCT01527162|2234149|P2|NOT COMPLETED|Overall Study||0
924069|NCT01527162|2234150|P1|NOT COMPLETED|Overall Study||0
924070|NCT01527162|2234149|P2|COMPLETED|Overall Study||5
924071|NCT01527162|2234150|P1|COMPLETED|Overall Study||6
924072|NCT01527162|2234149|P2|STARTED|Overall Study||5
924073|NCT01527162|2234150|P1|STARTED|Overall Study||6
924074|NCT01527006|2234162|P2|NOT COMPLETED|Extension Phase||8
924075|NCT01527006|2234163|P1|NOT COMPLETED|Extension Phase||6
924076|NCT01527006|2234162|P2|COMPLETED|Extension Phase||14
924077|NCT01527006|2234163|P1|COMPLETED|Extension Phase||13
924078|NCT01527006|2234162|P2|STARTED|Extension Phase||22
924079|NCT01527006|2234163|P1|STARTED|Extension Phase|Of the 20 subjects who completed the Core Study, 19 subjects continued into the Extension Phase.|19
924080|NCT01527006|2234162|P2|NOT COMPLETED|Core Study||6
924081|NCT01527006|2234163|P1|NOT COMPLETED|Core Study||2
924082|NCT01527006|2234162|P2|COMPLETED|Core Study||22
924083|NCT01527006|2234163|P1|COMPLETED|Core Study||20
924084|NCT01527006|2234162|P2|STARTED|Core Study||28
924085|NCT01527006|2234163|P1|STARTED|Core Study||22
924086|NCT01526902|2234213|P2|NOT COMPLETED|Overall Study||0
924087|NCT01526902|2234214|P1|NOT COMPLETED|Overall Study||0
924088|NCT01526902|2234213|P2|COMPLETED|Overall Study||24
924089|NCT01526902|2234214|P1|COMPLETED|Overall Study||25
924090|NCT01526902|2234213|P2|STARTED|Overall Study||24
924091|NCT01526902|2234214|P1|STARTED|Overall Study||25
924092|NCT01526785|2234230|P1|NOT COMPLETED|Overall Study||13
924093|NCT01526785|2234230|P1|COMPLETED|Overall Study||100
924094|NCT01526785|2234230|P1|STARTED|Overall Study||113
924095|NCT01526733|2234240|P2|NOT COMPLETED|Phase 2||0
924096|NCT01526733|2234241|P1|NOT COMPLETED|Phase 2||0
924097|NCT01526733|2234240|P2|COMPLETED|Phase 2||12
924098|NCT01526733|2234241|P1|COMPLETED|Phase 2||10
924099|NCT01526733|2234240|P2|STARTED|Phase 2||12
924100|NCT01526733|2234241|P1|STARTED|Phase 2||10
924101|NCT01526733|2234240|P2|NOT COMPLETED|Washout Period of 5 to 21 Days||0
924102|NCT01526733|2234241|P1|NOT COMPLETED|Washout Period of 5 to 21 Days||0
924103|NCT01526733|2234240|P2|COMPLETED|Washout Period of 5 to 21 Days||12
924104|NCT01526733|2234241|P1|COMPLETED|Washout Period of 5 to 21 Days||10
924105|NCT01526733|2234240|P2|STARTED|Washout Period of 5 to 21 Days||12
924106|NCT01526733|2234241|P1|STARTED|Washout Period of 5 to 21 Days||10
924107|NCT01526733|2234240|P2|NOT COMPLETED|Phase 1||1
924108|NCT01526733|2234241|P1|NOT COMPLETED|Phase 1||2
924109|NCT01526733|2234240|P2|COMPLETED|Phase 1||12
924110|NCT01526733|2234241|P1|COMPLETED|Phase 1||10
924111|NCT01526733|2234240|P2|Received at Least 1 Dose of Study Drug|Phase 1||13
924112|NCT01526733|2234241|P1|Received at Least 1 Dose of Study Drug|Phase 1||12
924113|NCT01526733|2234240|P2|STARTED|Phase 1|One participant discontinued after receiving insulin-sham and before receiving insulin-rHuPH20.|13
924114|NCT01526733|2234241|P1|STARTED|Phase 1||12
924115|NCT01526629|2234259|P1|NOT COMPLETED|Overall Study||46
924116|NCT01526629|2234259|P1|COMPLETED|Overall Study||308
924117|NCT01526629|2234259|P1|STARTED|Overall Study||354
924118|NCT01526551|2234263|P1|NOT COMPLETED|Overall Study||424
924119|NCT01526551|2234263|P1|COMPLETED|Overall Study||511
924120|NCT01526551|2234263|P1|STARTED|Overall Study||935
924121|NCT01526538|2234270|P2|NOT COMPLETED|Overall Study||4
924122|NCT01526538|2234271|P1|NOT COMPLETED|Overall Study||9
924123|NCT01526538|2234270|P2|COMPLETED|Overall Study||18
924124|NCT01526538|2234271|P1|COMPLETED|Overall Study||21
924125|NCT01526538|2234270|P2|STARTED|Overall Study||22
924126|NCT01526538|2234271|P1|STARTED|Overall Study||30
924127|NCT01526343|2234281|P1|NOT COMPLETED|Overall Study||0
924128|NCT01526343|2234281|P1|COMPLETED|Overall Study||47
924129|NCT01526343|2234281|P1|STARTED|Overall Study||47
924130|NCT01526213|2234292|P6|NOT COMPLETED|Period 3 (5 Days)||0
924131|NCT01526213|2234293|P5|NOT COMPLETED|Period 3 (5 Days)||0
924132|NCT01526213|2234294|P4|NOT COMPLETED|Period 3 (5 Days)||0
924133|NCT01526213|2234295|P3|NOT COMPLETED|Period 3 (5 Days)||0
924134|NCT01526213|2234296|P2|NOT COMPLETED|Period 3 (5 Days)||0
924135|NCT01526213|2234297|P1|NOT COMPLETED|Period 3 (5 Days)||0
924136|NCT01526213|2234292|P6|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
924137|NCT01526213|2234293|P5|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
924138|NCT01526213|2234294|P4|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
924139|NCT01526213|2234295|P3|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
924140|NCT01526213|2234296|P2|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
924141|NCT01526213|2234297|P1|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
924142|NCT01526213|2234292|P6|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
924143|NCT01526213|2234293|P5|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
924144|NCT01526213|2234294|P4|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
924145|NCT01526213|2234295|P3|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
924146|NCT01526213|2234296|P2|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
924147|NCT01526213|2234297|P1|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
924148|NCT01526213|2234292|P6|NOT COMPLETED|Washout 2 (10 Days)||0
924149|NCT01526213|2234293|P5|NOT COMPLETED|Washout 2 (10 Days)||0
924150|NCT01526213|2234294|P4|NOT COMPLETED|Washout 2 (10 Days)||0
924151|NCT01526213|2234295|P3|NOT COMPLETED|Washout 2 (10 Days)||0
924152|NCT01526213|2234296|P2|NOT COMPLETED|Washout 2 (10 Days)||0
924153|NCT01526213|2234297|P1|NOT COMPLETED|Washout 2 (10 Days)||0
924154|NCT01526213|2234292|P6|COMPLETED|Washout 2 (10 Days)||3
924155|NCT01526213|2234293|P5|COMPLETED|Washout 2 (10 Days)||3
924156|NCT01526213|2234294|P4|COMPLETED|Washout 2 (10 Days)||3
924157|NCT01526213|2234295|P3|COMPLETED|Washout 2 (10 Days)||3
924158|NCT01526213|2234296|P2|COMPLETED|Washout 2 (10 Days)||3
924159|NCT01526213|2234297|P1|COMPLETED|Washout 2 (10 Days)||3
924160|NCT01526213|2234292|P6|STARTED|Washout 2 (10 Days)||3
924161|NCT01526213|2234293|P5|STARTED|Washout 2 (10 Days)||3
924162|NCT01526213|2234294|P4|STARTED|Washout 2 (10 Days)||3
924163|NCT01526213|2234295|P3|STARTED|Washout 2 (10 Days)||3
924164|NCT01526213|2234296|P2|STARTED|Washout 2 (10 Days)||3
924165|NCT01526213|2234297|P1|STARTED|Washout 2 (10 Days)||3
924166|NCT01526213|2234292|P6|NOT COMPLETED|Period 2 (5 Days)||0
924167|NCT01526213|2234293|P5|NOT COMPLETED|Period 2 (5 Days)||0
924168|NCT01526213|2234294|P4|NOT COMPLETED|Period 2 (5 Days)||0
924169|NCT01526213|2234295|P3|NOT COMPLETED|Period 2 (5 Days)||0
924170|NCT01526213|2234296|P2|NOT COMPLETED|Period 2 (5 Days)||0
924171|NCT01526213|2234297|P1|NOT COMPLETED|Period 2 (5 Days)||0
924172|NCT01526213|2234292|P6|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
924173|NCT01526213|2234293|P5|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
924174|NCT01526213|2234294|P4|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
924175|NCT01526213|2234295|P3|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
924176|NCT01526213|2234296|P2|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
924177|NCT01526213|2234297|P1|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
924178|NCT01526213|2234292|P6|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
924179|NCT01526213|2234293|P5|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
924180|NCT01526213|2234294|P4|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
924181|NCT01526213|2234295|P3|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
924182|NCT01526213|2234296|P2|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
924183|NCT01526213|2234297|P1|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
924184|NCT01526213|2234292|P6|NOT COMPLETED|Washout 1 (10 Days)||0
924185|NCT01526213|2234293|P5|NOT COMPLETED|Washout 1 (10 Days)||0
924186|NCT01526213|2234294|P4|NOT COMPLETED|Washout 1 (10 Days)||0
924187|NCT01526213|2234295|P3|NOT COMPLETED|Washout 1 (10 Days)||0
924188|NCT01526213|2234296|P2|NOT COMPLETED|Washout 1 (10 Days)||0
924189|NCT01526213|2234297|P1|NOT COMPLETED|Washout 1 (10 Days)||0
924190|NCT01526213|2234292|P6|COMPLETED|Washout 1 (10 Days)||3
924191|NCT01526213|2234293|P5|COMPLETED|Washout 1 (10 Days)||3
924192|NCT01526213|2234294|P4|COMPLETED|Washout 1 (10 Days)||3
924193|NCT01526213|2234295|P3|COMPLETED|Washout 1 (10 Days)||3
924194|NCT01526213|2234296|P2|COMPLETED|Washout 1 (10 Days)||3
924195|NCT01526213|2234297|P1|COMPLETED|Washout 1 (10 Days)||3
924196|NCT01526213|2234292|P6|STARTED|Washout 1 (10 Days)||3
924197|NCT01526213|2234293|P5|STARTED|Washout 1 (10 Days)||3
924198|NCT01526213|2234294|P4|STARTED|Washout 1 (10 Days)||3
924199|NCT01526213|2234295|P3|STARTED|Washout 1 (10 Days)||3
924200|NCT01526213|2234296|P2|STARTED|Washout 1 (10 Days)||3
924201|NCT01526213|2234297|P1|STARTED|Washout 1 (10 Days)||3
924202|NCT01526213|2234292|P6|NOT COMPLETED|Period 1 (5 Days)||0
924203|NCT01526213|2234293|P5|NOT COMPLETED|Period 1 (5 Days)||0
924204|NCT01526213|2234294|P4|NOT COMPLETED|Period 1 (5 Days)||0
924205|NCT01526213|2234295|P3|NOT COMPLETED|Period 1 (5 Days)||0
924206|NCT01526213|2234296|P2|NOT COMPLETED|Period 1 (5 Days)||0
924207|NCT01526213|2234297|P1|NOT COMPLETED|Period 1 (5 Days)||0
924208|NCT01526213|2234292|P6|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
924209|NCT01526213|2234293|P5|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
924210|NCT01526213|2234294|P4|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
924211|NCT01526213|2234295|P3|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
924212|NCT01526213|2234296|P2|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
924213|NCT01526213|2234297|P1|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
924301|NCT01525407|2234601|P1|COMPLETED|Overall Study||38
924214|NCT01526213|2234292|P6|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to (and completed) one of six sequences.|3
924215|NCT01526213|2234293|P5|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
924216|NCT01526213|2234294|P4|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
924217|NCT01526213|2234295|P3|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
924218|NCT01526213|2234296|P2|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
924219|NCT01526213|2234297|P1|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
924220|NCT01526148|2234310|P2|NOT COMPLETED|Overall Study||13
924221|NCT01526148|2234311|P1|NOT COMPLETED|Overall Study||14
924222|NCT01526148|2234310|P2|COMPLETED|Overall Study||11
924223|NCT01526148|2234311|P1|COMPLETED|Overall Study||4
924224|NCT01526148|2234310|P2|STARTED|Overall Study||24
924225|NCT01526148|2234311|P1|STARTED|Overall Study||18
924226|NCT01525927|2234321|P1|NOT COMPLETED|Overall Study||0
924227|NCT01525927|2234321|P1|COMPLETED|Overall Study||0
924228|NCT01525927|2234321|P1|STARTED|Overall Study||0
924229|NCT01525849|2234328|P2|NOT COMPLETED|Overall Study||16
924230|NCT01525849|2234329|P1|NOT COMPLETED|Overall Study||5
924231|NCT01525849|2234328|P2|COMPLETED|Overall Study||59
924232|NCT01525849|2234329|P1|COMPLETED|Overall Study||71
924233|NCT01525849|2234328|P2|6-Months|Overall Study||60
924234|NCT01525849|2234329|P1|6-Months|Overall Study||73
924235|NCT01525849|2234328|P2|Treated|Overall Study|14 withdrew before treatment: 8 didn't want FESS, 1 too busy, 2 medical issues, 3 excl. criteria.|61
924236|NCT01525849|2234329|P1|Treated|Overall Study|2 withdrew before treatment: 1 didn't want balloon dilation, 1 unrelated medical issue.|74
924237|NCT01525849|2234328|P2|STARTED|Overall Study||75
924238|NCT01525849|2234329|P1|STARTED|Overall Study||76
924239|NCT01525745|2234345|P2|NOT COMPLETED|Overall Study||1
924240|NCT01525745|2234346|P1|NOT COMPLETED|Overall Study||1
924241|NCT01525745|2234345|P2|COMPLETED|Overall Study||1
924242|NCT01525745|2234346|P1|COMPLETED|Overall Study||3
924243|NCT01525745|2234345|P2|STARTED|Overall Study||2
924244|NCT01525745|2234346|P1|STARTED|Overall Study||4
924245|NCT01525667|2234363|P3|NOT COMPLETED|Overall Study||0
924246|NCT01525667|2234364|P2|NOT COMPLETED|Overall Study||0
924247|NCT01525667|2234365|P1|NOT COMPLETED|Overall Study||0
924248|NCT01525667|2234363|P3|COMPLETED|Overall Study||7
924249|NCT01525667|2234364|P2|COMPLETED|Overall Study||6
924250|NCT01525667|2234365|P1|COMPLETED|Overall Study||7
924251|NCT01525667|2234363|P3|STARTED|Overall Study||7
924252|NCT01525667|2234364|P2|STARTED|Overall Study||6
924253|NCT01525667|2234365|P1|STARTED|Overall Study||7
924254|NCT01525641|2234385|P1|NOT COMPLETED|Overall Study||180
924255|NCT01525641|2234385|P1|COMPLETED|Overall Study||435
924256|NCT01525641|2234385|P1|STARTED|Overall Study||615
924257|NCT01525628|2234399|P5|NOT COMPLETED|Overall Study||3
924258|NCT01525628|2234400|P4|NOT COMPLETED|Overall Study||4
924259|NCT01525628|2234401|P3|NOT COMPLETED|Overall Study||5
924260|NCT01525628|2234402|P2|NOT COMPLETED|Overall Study||5
924261|NCT01525628|2234403|P1|NOT COMPLETED|Overall Study||2
924262|NCT01525628|2234399|P5|COMPLETED|Overall Study||4
924263|NCT01525628|2234400|P4|COMPLETED|Overall Study||10
924264|NCT01525628|2234401|P3|COMPLETED|Overall Study||11
924265|NCT01525628|2234402|P2|COMPLETED|Overall Study||14
924266|NCT01525628|2234403|P1|COMPLETED|Overall Study||14
924267|NCT01525628|2234399|P5|STARTED|Overall Study||7
924268|NCT01525628|2234400|P4|STARTED|Overall Study||14
924269|NCT01525628|2234401|P3|STARTED|Overall Study||16
924270|NCT01525628|2234402|P2|STARTED|Overall Study||19
924271|NCT01525628|2234403|P1|STARTED|Overall Study||16
924272|NCT01525615|2234470|P3|NOT COMPLETED|Overall Study||6
924273|NCT01525615|2234471|P2|NOT COMPLETED|Overall Study||7
924274|NCT01525615|2234472|P1|NOT COMPLETED|Overall Study||14
924275|NCT01525615|2234470|P3|COMPLETED|Overall Study||133
924276|NCT01525615|2234471|P2|COMPLETED|Overall Study||126
924277|NCT01525615|2234472|P1|COMPLETED|Overall Study||118
924278|NCT01525615|2234470|P3|STARTED|Overall Study||139
924279|NCT01525615|2234471|P2|STARTED|Overall Study||133
924280|NCT01525615|2234472|P1|STARTED|Overall Study||132
924281|NCT01525563|2234516|P1|NOT COMPLETED|Overall Study||212
924282|NCT01525563|2234516|P1|COMPLETED|Overall Study|6 Months Follow-up|788
924283|NCT01525563|2234516|P1|3 Months Follow-up|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|838
924284|NCT01525563|2234516|P1|End of Treatment|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|910
924285|NCT01525563|2234516|P1|STARTED|Overall Study||1000
924286|NCT01525550|2234528|P2|NOT COMPLETED|Overall Study||45
924287|NCT01525550|2234529|P1|NOT COMPLETED|Overall Study||61
924288|NCT01525550|2234528|P2|COMPLETED|Overall Study||0
924289|NCT01525550|2234529|P1|COMPLETED|Overall Study||0
924290|NCT01525550|2234528|P2|STARTED|Overall Study||45
924291|NCT01525550|2234529|P1|STARTED|Overall Study||61
924292|NCT01525420|2234591|P2|NOT COMPLETED|Overall Study||24
924293|NCT01525420|2234592|P1|NOT COMPLETED|Overall Study||16
924294|NCT01525420|2234591|P2|COMPLETED|Overall Study||38
924295|NCT01525420|2234592|P1|COMPLETED|Overall Study||43
924296|NCT01525420|2234591|P2|STARTED|Overall Study||62
924297|NCT01525420|2234592|P1|STARTED|Overall Study||59
924298|NCT01525407|2234600|P2|NOT COMPLETED|Overall Study||4
924299|NCT01525407|2234601|P1|NOT COMPLETED|Overall Study||3
924300|NCT01525407|2234600|P2|COMPLETED|Overall Study||38
924302|NCT01525407|2234600|P2|STARTED|Overall Study||42
924303|NCT01525407|2234601|P1|STARTED|Overall Study||41
924304|NCT01525238|2234618|P3|NOT COMPLETED|Overall Study||0
924305|NCT01525238|2234619|P2|NOT COMPLETED|Overall Study||0
924306|NCT01525238|2234620|P1|NOT COMPLETED|Overall Study||1
924307|NCT01525238|2234618|P3|COMPLETED|Overall Study||8
924308|NCT01525238|2234619|P2|COMPLETED|Overall Study||8
924309|NCT01525238|2234620|P1|COMPLETED|Overall Study||7
924310|NCT01525238|2234618|P3|STARTED|Overall Study||8
924311|NCT01525238|2234619|P2|STARTED|Overall Study||8
924312|NCT01525238|2234620|P1|STARTED|Overall Study||8
924313|NCT01525225|2234685|P1|NOT COMPLETED|Treated||0
924314|NCT01525225|2234685|P1|COMPLETED|Treated||2
924315|NCT01525225|2234685|P1|STARTED|Treated||2
924316|NCT01525225|2234685|P1|NOT COMPLETED|Enrollment||2
924317|NCT01525225|2234685|P1|COMPLETED|Enrollment||2
924318|NCT01525225|2234685|P1|STARTED|Enrollment||4
924319|NCT01525173|2234692|P2|NOT COMPLETED|Overall Study||5
924320|NCT01525173|2234693|P1|NOT COMPLETED|Overall Study||7
924321|NCT01525173|2234692|P2|COMPLETED|Overall Study||62
924322|NCT01525173|2234693|P1|COMPLETED|Overall Study||63
924323|NCT01525173|2234692|P2|STARTED|Overall Study||67
924324|NCT01525173|2234693|P1|STARTED|Overall Study||70
924325|NCT01524913|2234702|P3|NOT COMPLETED|Overall Study||0
924326|NCT01524913|2234703|P2|NOT COMPLETED|Overall Study||0
924327|NCT01524913|2234704|P1|NOT COMPLETED|Overall Study||4
924328|NCT01524913|2234702|P3|COMPLETED|Overall Study||31
924329|NCT01524913|2234703|P2|COMPLETED|Overall Study||36
924330|NCT01524913|2234704|P1|COMPLETED|Overall Study||31
924331|NCT01524913|2234702|P3|STARTED|Overall Study||31
924332|NCT01524913|2234703|P2|STARTED|Overall Study||36
924333|NCT01524913|2234704|P1|STARTED|Overall Study||35
924334|NCT01524900|2234726|P5|NOT COMPLETED|Overall Study||0
924335|NCT01524900|2234727|P4|NOT COMPLETED|Overall Study||1
924336|NCT01524900|2234728|P3|NOT COMPLETED|Overall Study||1
924337|NCT01524900|2234729|P2|NOT COMPLETED|Overall Study||14
924338|NCT01524900|2234730|P1|NOT COMPLETED|Overall Study||6
924339|NCT01524900|2234726|P5|COMPLETED|Overall Study||40
924340|NCT01524900|2234727|P4|COMPLETED|Overall Study||21
924341|NCT01524900|2234728|P3|COMPLETED|Overall Study||29
924342|NCT01524900|2234729|P2|COMPLETED|Overall Study||232
924343|NCT01524900|2234730|P1|COMPLETED|Overall Study||43
924344|NCT01524900|2234726|P5|STARTED|Overall Study||40
924345|NCT01524900|2234727|P4|STARTED|Overall Study||22
924346|NCT01524900|2234728|P3|STARTED|Overall Study||30
924347|NCT01524900|2234729|P2|STARTED|Overall Study||246
924348|NCT01524900|2234730|P1|STARTED|Overall Study||49
924349|NCT01524887|2234775|P3|NOT COMPLETED|Overall Study||86
924350|NCT01524887|2234776|P2|NOT COMPLETED|Overall Study||90
924351|NCT01524887|2234777|P1|NOT COMPLETED|Overall Study||85
924352|NCT01524887|2234775|P3|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
924353|NCT01524887|2234776|P2|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
924354|NCT01524887|2234777|P1|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
924355|NCT01524887|2234775|P3|Received Treatment|Overall Study||83
924356|NCT01524887|2234776|P2|Received Treatment|Overall Study||85
924357|NCT01524887|2234777|P1|Received Treatment|Overall Study||83
924358|NCT01524887|2234775|P3|STARTED|Overall Study||86
924359|NCT01524887|2234776|P2|STARTED|Overall Study||90
924360|NCT01524887|2234777|P1|STARTED|Overall Study||85
924361|NCT01524796|2234821|P1|NOT COMPLETED|Overall Study||28
924362|NCT01524796|2234821|P1|COMPLETED|Overall Study||100
924363|NCT01524796|2234821|P1|STARTED|Overall Study||128
924364|NCT01524783|2234836|P2|NOT COMPLETED|Randomized and Treated||84
924365|NCT01524783|2234837|P1|NOT COMPLETED|Randomized and Treated||155
924366|NCT01524783|2234836|P2|COMPLETED|Randomized and Treated|Completed = Patients with ongoing treatment at the time of data cut-off of 28-Nov-2014.|13
924367|NCT01524783|2234837|P1|COMPLETED|Randomized and Treated|Completed = Patients with ongoing treatment at the time of data cut-off of 28-Nov-2014.|48
924368|NCT01524783|2234836|P2|STARTED|Randomized and Treated||97
924369|NCT01524783|2234837|P1|STARTED|Randomized and Treated||203
924370|NCT01524783|2234836|P2|NOT COMPLETED|Randomized But Not Treated||0
924371|NCT01524783|2234837|P1|NOT COMPLETED|Randomized But Not Treated||2
924372|NCT01524783|2234836|P2|COMPLETED|Randomized But Not Treated|Completed = Participants randomized and treated with study drug|97
924373|NCT01524783|2234837|P1|COMPLETED|Randomized But Not Treated|Completed = Participants randomized and treated with study drug|203
924374|NCT01524783|2234836|P2|STARTED|Randomized But Not Treated||97
924375|NCT01524783|2234837|P1|STARTED|Randomized But Not Treated||205
924376|NCT01524770|2234859|P2|NOT COMPLETED|Second Intervention||0
924377|NCT01524770|2234860|P1|NOT COMPLETED|Second Intervention||0
924378|NCT01524770|2234859|P2|COMPLETED|Second Intervention||23
924379|NCT01524770|2234860|P1|COMPLETED|Second Intervention||23
924380|NCT01524770|2234859|P2|STARTED|Second Intervention||23
924381|NCT01524770|2234860|P1|STARTED|Second Intervention||23
924382|NCT01524770|2234859|P2|NOT COMPLETED|Washout Period of at Least 28 Days||0
924383|NCT01524770|2234860|P1|NOT COMPLETED|Washout Period of at Least 28 Days||0
924384|NCT01524770|2234859|P2|COMPLETED|Washout Period of at Least 28 Days||23
924385|NCT01524770|2234860|P1|COMPLETED|Washout Period of at Least 28 Days||23
924386|NCT01524770|2234859|P2|STARTED|Washout Period of at Least 28 Days||23
924387|NCT01524770|2234860|P1|STARTED|Washout Period of at Least 28 Days||23
924388|NCT01524770|2234859|P2|NOT COMPLETED|First Intervention||1
924389|NCT01524770|2234860|P1|NOT COMPLETED|First Intervention||3
924390|NCT01524770|2234859|P2|COMPLETED|First Intervention||23
924391|NCT01524770|2234860|P1|COMPLETED|First Intervention||23
924392|NCT01524770|2234859|P2|Received at Least 1 Dose of Study Drug|First Intervention||24
924393|NCT01524770|2234860|P1|Received at Least 1 Dose of Study Drug|First Intervention||26
924394|NCT01524770|2234859|P2|STARTED|First Intervention||24
924395|NCT01524770|2234860|P1|STARTED|First Intervention||26
924396|NCT01524627|2234872|P2|NOT COMPLETED|Overall Study||2
924397|NCT01524627|2234873|P1|NOT COMPLETED|Overall Study||1
924398|NCT01524627|2234872|P2|COMPLETED|Overall Study||19
924399|NCT01524627|2234873|P1|COMPLETED|Overall Study||21
924400|NCT01524627|2234872|P2|STARTED|Overall Study||21
924401|NCT01524627|2234873|P1|STARTED|Overall Study||22
924402|NCT01524302|2234881|P2|NOT COMPLETED|Overall Study||0
924403|NCT01524302|2234882|P1|NOT COMPLETED|Overall Study||0
924404|NCT01524302|2234881|P2|COMPLETED|Overall Study||6
924405|NCT01524302|2234882|P1|COMPLETED|Overall Study||6
924406|NCT01524302|2234881|P2|STARTED|Overall Study||6
924407|NCT01524302|2234882|P1|STARTED|Overall Study||6
924408|NCT01524198|2234900|P2|NOT COMPLETED|Overall Study||16
924409|NCT01524198|2234901|P1|NOT COMPLETED|Overall Study||23
924410|NCT01524198|2234900|P2|COMPLETED|Overall Study||458
924411|NCT01524198|2234901|P1|COMPLETED|Overall Study||448
924412|NCT01524198|2234900|P2|STARTED|Overall Study||474
924413|NCT01524198|2234901|P1|STARTED|Overall Study||471
924414|NCT01523964|2234913|P4|NOT COMPLETED|Overall Study||0
924415|NCT01523964|2234914|P3|NOT COMPLETED|Overall Study||0
924416|NCT01523964|2234915|P2|NOT COMPLETED|Overall Study||0
924417|NCT01523964|2234916|P1|NOT COMPLETED|Overall Study||0
924418|NCT01523964|2234913|P4|COMPLETED|Overall Study||15
924419|NCT01523964|2234914|P3|COMPLETED|Overall Study||16
924420|NCT01523964|2234915|P2|COMPLETED|Overall Study||30
924421|NCT01523964|2234916|P1|COMPLETED|Overall Study||31
924422|NCT01523964|2234913|P4|STARTED|Overall Study||15
924423|NCT01523964|2234914|P3|STARTED|Overall Study||16
924424|NCT01523964|2234915|P2|STARTED|Overall Study||30
924425|NCT01523964|2234916|P1|STARTED|Overall Study||31
924426|NCT01523899|2234928|P2|NOT COMPLETED|Overall Study||0
924427|NCT01523899|2234929|P1|NOT COMPLETED|Overall Study||0
924428|NCT01523899|2234928|P2|COMPLETED|Overall Study||126
924429|NCT01523899|2234929|P1|COMPLETED|Overall Study||126
924430|NCT01523899|2234928|P2|STARTED|Overall Study||126
924431|NCT01523899|2234929|P1|STARTED|Overall Study||126
924432|NCT01523886|2234941|P2|NOT COMPLETED|Overall Study||1
924433|NCT01523886|2234942|P1|NOT COMPLETED|Overall Study||0
924434|NCT01523886|2234941|P2|COMPLETED|Overall Study||23
924435|NCT01523886|2234942|P1|COMPLETED|Overall Study||25
924436|NCT01523886|2234941|P2|STARTED|Overall Study||24
924437|NCT01523886|2234942|P1|STARTED|Overall Study||25
924438|NCT01523873|2234948|P1|NOT COMPLETED|Overall Study||422
924439|NCT01523873|2234948|P1|COMPLETED|Overall Study||35499
924440|NCT01523873|2234948|P1|Administered With Dotarem|Overall Study||35474
924441|NCT01523873|2234948|P1|STARTED|Overall Study||35921
924442|NCT01523756|2234955|P2|NOT COMPLETED|Test Period 2||1
924443|NCT01523756|2234956|P1|NOT COMPLETED|Test Period 2||0
924444|NCT01523756|2234955|P2|COMPLETED|Test Period 2||7
924445|NCT01523756|2234956|P1|COMPLETED|Test Period 2||10
924446|NCT01523756|2234955|P2|STARTED|Test Period 2||8
924447|NCT01523756|2234956|P1|STARTED|Test Period 2||10
924448|NCT01523756|2234955|P2|NOT COMPLETED|Test Period 1||0
924449|NCT01523756|2234956|P1|NOT COMPLETED|Test Period 1||1
924450|NCT01523756|2234955|P2|COMPLETED|Test Period 1||8
924451|NCT01523756|2234956|P1|COMPLETED|Test Period 1||10
924452|NCT01523756|2234955|P2|STARTED|Test Period 1||8
924453|NCT01523756|2234956|P1|STARTED|Test Period 1||11
924454|NCT01523756|2234955|P2|NOT COMPLETED|Baseline Period||1
924455|NCT01523756|2234956|P1|NOT COMPLETED|Baseline Period||0
924456|NCT01523756|2234955|P2|COMPLETED|Baseline Period||8
924457|NCT01523756|2234956|P1|COMPLETED|Baseline Period||11
924458|NCT01523756|2234955|P2|STARTED|Baseline Period||9
924459|NCT01523756|2234956|P1|STARTED|Baseline Period||11
924460|NCT01523743|2234964|P2|NOT COMPLETED|Period 2||2
924461|NCT01523743|2234965|P1|NOT COMPLETED|Period 2||1
924462|NCT01523743|2234964|P2|COMPLETED|Period 2||58
924463|NCT01523743|2234965|P1|COMPLETED|Period 2||52
924464|NCT01523743|2234964|P2|STARTED|Period 2||60
924465|NCT01523743|2234965|P1|STARTED|Period 2||53
924466|NCT01523743|2234964|P2|NOT COMPLETED|Period 1||2
924467|NCT01523743|2234965|P1|NOT COMPLETED|Period 1||10
924468|NCT01523743|2234964|P2|COMPLETED|Period 1||60
924469|NCT01523743|2234965|P1|COMPLETED|Period 1||53
924470|NCT01523743|2234964|P2|STARTED|Period 1||62
924471|NCT01523743|2234965|P1|STARTED|Period 1||63
924472|NCT01523613|2234974|P3|NOT COMPLETED|Overall Study||12
924473|NCT01523613|2234975|P2|NOT COMPLETED|Overall Study||5
924474|NCT01523613|2234976|P1|NOT COMPLETED|Overall Study||7
924475|NCT01523613|2234974|P3|COMPLETED|Overall Study|- 42 paired restorations (21R and 21F)|21
924476|NCT01523613|2234975|P2|COMPLETED|Overall Study|- 25 single restorations (25F)|25
924477|NCT01523613|2234976|P1|COMPLETED|Overall Study|- 23 single restorations (23R)|23
924478|NCT01523613|2234974|P3|STARTED|Overall Study|- 66 paired restorations (33R + 33F)|33
924479|NCT01523613|2234975|P2|STARTED|Overall Study|- 30 single restorations (30 F)|30
924480|NCT01523613|2234976|P1|STARTED|Overall Study|- 30 single restorations (30 R)|30
924481|NCT01523587|2234988|P2|NOT COMPLETED|Overall Study||54
924482|NCT01523587|2234989|P1|NOT COMPLETED|Overall Study||87
924483|NCT01523587|2234988|P2|COMPLETED|Overall Study|Pts that withdrew due to PD (RECIST 1.1), PD (non RECIST1.1) and ongoing were considered Completed.|280
924484|NCT01523587|2234989|P1|COMPLETED|Overall Study|Pts that withdrew due to PD (RECIST 1.1), PD (non RECIST1.1) and ongoing were considered Completed.|248
924485|NCT01523587|2234988|P2|STARTED|Overall Study||334
924486|NCT01523587|2234989|P1|STARTED|Overall Study||335
924487|NCT01523457|2235009|P2|NOT COMPLETED|Overall Study||2
924488|NCT01523457|2235010|P1|NOT COMPLETED|Overall Study||7
924489|NCT01523457|2235009|P2|COMPLETED|Overall Study||29
924490|NCT01523457|2235010|P1|COMPLETED|Overall Study||37
924491|NCT01523457|2235009|P2|STARTED|Overall Study||31
924492|NCT01523457|2235010|P1|STARTED|Overall Study||44
924493|NCT01523392|2235028|P2|NOT COMPLETED|Treatment Period 2||0
924494|NCT01523392|2235029|P1|NOT COMPLETED|Treatment Period 2||0
924495|NCT01523392|2235028|P2|COMPLETED|Treatment Period 2||14
924496|NCT01523392|2235029|P1|COMPLETED|Treatment Period 2||17
924497|NCT01523392|2235028|P2|STARTED|Treatment Period 2||14
924498|NCT01523392|2235029|P1|STARTED|Treatment Period 2||17
924499|NCT01523392|2235028|P2|NOT COMPLETED|Washout Period - 10 to 14 Days||0
924500|NCT01523392|2235029|P1|NOT COMPLETED|Washout Period - 10 to 14 Days||1
924501|NCT01523392|2235028|P2|COMPLETED|Washout Period - 10 to 14 Days||14
924502|NCT01523392|2235029|P1|COMPLETED|Washout Period - 10 to 14 Days||17
924503|NCT01523392|2235028|P2|STARTED|Washout Period - 10 to 14 Days||14
924504|NCT01523392|2235029|P1|STARTED|Washout Period - 10 to 14 Days|1 patient did not complete 7-9 days of Period 1 treatment but continued in the Washout and Period 2|18
924505|NCT01523392|2235028|P2|NOT COMPLETED|Treatment Period 1||0
924506|NCT01523392|2235029|P1|NOT COMPLETED|Treatment Period 1||3
924507|NCT01523392|2235028|P2|COMPLETED|Treatment Period 1||14
924508|NCT01523392|2235029|P1|COMPLETED|Treatment Period 1||17
924509|NCT01523392|2235028|P2|STARTED|Treatment Period 1||14
924510|NCT01523392|2235029|P1|STARTED|Treatment Period 1||20
924511|NCT01523366|2235045|P2|NOT COMPLETED|Treatment Period 2||0
924512|NCT01523366|2235046|P1|NOT COMPLETED|Treatment Period 2||1
924513|NCT01523366|2235045|P2|COMPLETED|Treatment Period 2||20
924514|NCT01523366|2235046|P1|COMPLETED|Treatment Period 2||18
924515|NCT01523366|2235045|P2|STARTED|Treatment Period 2||20
924516|NCT01523366|2235046|P1|STARTED|Treatment Period 2||19
924517|NCT01523366|2235045|P2|NOT COMPLETED|Washout Period - 10-14 Days||0
924518|NCT01523366|2235046|P1|NOT COMPLETED|Washout Period - 10-14 Days||0
924519|NCT01523366|2235045|P2|COMPLETED|Washout Period - 10-14 Days||20
924520|NCT01523366|2235046|P1|COMPLETED|Washout Period - 10-14 Days||19
924521|NCT01523366|2235045|P2|STARTED|Washout Period - 10-14 Days||20
924522|NCT01523366|2235046|P1|STARTED|Washout Period - 10-14 Days||19
924523|NCT01523366|2235045|P2|NOT COMPLETED|Treatment Period 1||0
924524|NCT01523366|2235046|P1|NOT COMPLETED|Treatment Period 1||1
924525|NCT01523366|2235045|P2|COMPLETED|Treatment Period 1||20
924526|NCT01523366|2235046|P1|COMPLETED|Treatment Period 1||19
924527|NCT01523366|2235045|P2|STARTED|Treatment Period 1||20
924528|NCT01523366|2235046|P1|STARTED|Treatment Period 1||20
924529|NCT01523301|2235062|P2|NOT COMPLETED|Overall Study||32
924530|NCT01523301|2235063|P1|NOT COMPLETED|Overall Study||35
924531|NCT01523301|2235062|P2|COMPLETED|Overall Study||164
924532|NCT01523301|2235063|P1|COMPLETED|Overall Study||149
924533|NCT01523301|2235062|P2|STARTED|Overall Study||196
924534|NCT01523301|2235063|P1|STARTED|Overall Study||184
924535|NCT01522976|2235084|P3|NOT COMPLETED|Overall Study||93
924536|NCT01522976|2235085|P2|NOT COMPLETED|Overall Study||92
924537|NCT01522976|2235086|P1|NOT COMPLETED|Overall Study||97
924538|NCT01522976|2235084|P3|COMPLETED|Overall Study||0
924539|NCT01522976|2235085|P2|COMPLETED|Overall Study||0
924540|NCT01522976|2235086|P1|COMPLETED|Overall Study||0
924541|NCT01522976|2235084|P3|STARTED|Overall Study||93
924542|NCT01522976|2235085|P2|STARTED|Overall Study||92
924543|NCT01522976|2235086|P1|STARTED|Overall Study||97
924544|NCT01522963|2235110|P4|NOT COMPLETED|Overall Study||6
924545|NCT01522963|2235111|P3|NOT COMPLETED|Overall Study||3
924546|NCT01522963|2235112|P2|NOT COMPLETED|Overall Study||3
924547|NCT01522963|2235113|P1|NOT COMPLETED|Overall Study||2
924548|NCT01522963|2235110|P4|COMPLETED|Overall Study||18
924549|NCT01522963|2235111|P3|COMPLETED|Overall Study||22
924550|NCT01522963|2235112|P2|COMPLETED|Overall Study||22
924551|NCT01522963|2235113|P1|COMPLETED|Overall Study||22
924552|NCT01522963|2235110|P4|STARTED|Overall Study||24
924553|NCT01522963|2235111|P3|STARTED|Overall Study||25
924554|NCT01522963|2235112|P2|STARTED|Overall Study||25
924555|NCT01522963|2235113|P1|STARTED|Overall Study||24
924556|NCT01522937|2235125|P1|NOT COMPLETED|Overall Study||0
924557|NCT01522937|2235125|P1|COMPLETED|Overall Study||146
924558|NCT01522937|2235125|P1|STARTED|Overall Study||146
924559|NCT01522924|2235135|P2|NOT COMPLETED|Overall Study||0
924560|NCT01522924|2235136|P1|NOT COMPLETED|Overall Study||0
924561|NCT01522924|2235135|P2|COMPLETED|Overall Study|There were 52 dental students who completed the second survey after the lecture.|52
924562|NCT01522924|2235136|P1|COMPLETED|Overall Study|There were 42 dental students who completed the second survey after the intervention.|42
924563|NCT01522924|2235135|P2|STARTED|Overall Study|There were 52 dental students in the control group.|52
924564|NCT01522924|2235136|P1|STARTED|Overall Study|There were 42 dental students in the intervention group.|42
924565|NCT01522703|2235156|P2|NOT COMPLETED|Overall Study||6
924566|NCT01522703|2235157|P1|NOT COMPLETED|Overall Study||5
924567|NCT01522703|2235156|P2|COMPLETED|Overall Study||20
924568|NCT01522703|2235157|P1|COMPLETED|Overall Study||20
924569|NCT01522703|2235156|P2|STARTED|Overall Study||26
924570|NCT01522703|2235157|P1|STARTED|Overall Study||25
924571|NCT01522456|2235163|P1|NOT COMPLETED|Overall Study||8
924572|NCT01522456|2235163|P1|COMPLETED|Overall Study||65
924573|NCT01522456|2235163|P1|STARTED|Overall Study||73
924574|NCT01522339|2235224|P1|NOT COMPLETED|Overall Study||0
924575|NCT01522339|2235224|P1|COMPLETED|Overall Study||15
924576|NCT01522339|2235224|P1|STARTED|Overall Study||15
924577|NCT01522235|2235231|P2|NOT COMPLETED|Overall Study||1
924578|NCT01522235|2235232|P1|NOT COMPLETED|Overall Study||1
924579|NCT01522235|2235231|P2|COMPLETED|Overall Study||2
924580|NCT01522235|2235232|P1|COMPLETED|Overall Study||2
924581|NCT01522235|2235231|P2|Randomized|Overall Study||3
924582|NCT01522235|2235232|P1|Randomized|Overall Study||2
924583|NCT01522235|2235231|P2|STARTED|Overall Study||3
924584|NCT01522235|2235232|P1|STARTED|Overall Study||3
924585|NCT01522131|2235250|P2|NOT COMPLETED|Overall Study||0
924586|NCT01522131|2235251|P1|NOT COMPLETED|Overall Study||2
924587|NCT01522131|2235250|P2|COMPLETED|Overall Study||17
924588|NCT01522131|2235251|P1|COMPLETED|Overall Study||14
924589|NCT01522131|2235250|P2|STARTED|Overall Study||17
924590|NCT01522131|2235251|P1|STARTED|Overall Study||16
924591|NCT01521923|2235263|P4|NOT COMPLETED|Overall Study||13
924592|NCT01521923|2235264|P3|NOT COMPLETED|Overall Study||15
924593|NCT01521923|2235265|P2|NOT COMPLETED|Overall Study||9
924594|NCT01521923|2235266|P1|NOT COMPLETED|Overall Study||7
924595|NCT01521923|2235263|P4|COMPLETED|Overall Study||70
924596|NCT01521923|2235264|P3|COMPLETED|Overall Study||112
924597|NCT01521923|2235265|P2|COMPLETED|Overall Study||72
924598|NCT01521923|2235266|P1|COMPLETED|Overall Study||59
924599|NCT01521923|2235263|P4|STARTED|Overall Study||83
924600|NCT01521923|2235264|P3|STARTED|Overall Study||127
924601|NCT01521923|2235265|P2|STARTED|Overall Study||81
924602|NCT01521923|2235266|P1|STARTED|Overall Study||66
924603|NCT01521897|2235386|P1|NOT COMPLETED|Overall Study||23
924604|NCT01521897|2235386|P1|COMPLETED|Overall Study||1120
924605|NCT01521897|2235386|P1|STARTED|Overall Study||1143
924606|NCT01521884|2235398|P1|NOT COMPLETED|Overall Study||27
924607|NCT01521884|2235398|P1|COMPLETED|Overall Study||35
924608|NCT01521884|2235398|P1|STARTED|Overall Study||62
924609|NCT01521871|2235417|P2|NOT COMPLETED|Overall Study||0
924610|NCT01521871|2235418|P1|NOT COMPLETED|Overall Study||0
924611|NCT01521871|2235417|P2|COMPLETED|Overall Study||32
924612|NCT01521871|2235418|P1|COMPLETED|Overall Study||32
924613|NCT01521871|2235417|P2|STARTED|Overall Study||32
924614|NCT01521871|2235418|P1|STARTED|Overall Study||32
924615|NCT01521845|2235458|P2|NOT COMPLETED|Overall Study||5
924616|NCT01521845|2235459|P1|NOT COMPLETED|Overall Study||9
924617|NCT01521845|2235458|P2|COMPLETED|Overall Study||47
924618|NCT01521845|2235459|P1|COMPLETED|Overall Study||43
924619|NCT01521845|2235458|P2|STARTED|Overall Study||52
924620|NCT01521845|2235459|P1|STARTED|Overall Study||52
924621|NCT01521780|2235469|P3|NOT COMPLETED|Overall Study||0
924622|NCT01521780|2235470|P2|NOT COMPLETED|Overall Study||0
924623|NCT01521780|2235471|P1|NOT COMPLETED|Overall Study||0
924624|NCT01521780|2235469|P3|COMPLETED|Overall Study||2
924625|NCT01521780|2235470|P2|COMPLETED|Overall Study||1
924626|NCT01521780|2235471|P1|COMPLETED|Overall Study||9
924627|NCT01521780|2235469|P3|STARTED|Overall Study||2
924628|NCT01521780|2235470|P2|STARTED|Overall Study||1
924629|NCT01521780|2235471|P1|STARTED|Overall Study||9
924630|NCT01521559|2235495|P2|NOT COMPLETED|Overall Study||18
924631|NCT01521559|2235496|P1|NOT COMPLETED|Overall Study||15
924632|NCT01521559|2235495|P2|COMPLETED|Overall Study||73
924633|NCT01521559|2235496|P1|COMPLETED|Overall Study||77
924634|NCT01521559|2235495|P2|Completed Week 52|Overall Study||73
924635|NCT01521559|2235496|P1|Completed Week 52|Overall Study||77
924636|NCT01521559|2235495|P2|Completed Week 24|Overall Study||85
924637|NCT01521559|2235496|P1|Completed Week 24|Overall Study||83
924638|NCT01521559|2235495|P2|STARTED|Overall Study||91
924639|NCT01521559|2235496|P1|STARTED|Overall Study||92
924640|NCT01521546|2235510|P2|NOT COMPLETED|Overall Study||0
924641|NCT01521546|2235511|P1|NOT COMPLETED|Overall Study||2
924642|NCT01521546|2235510|P2|COMPLETED|Overall Study||20
924643|NCT01521546|2235511|P1|COMPLETED|Overall Study||20
924644|NCT01521546|2235510|P2|STARTED|Overall Study||20
924645|NCT01521546|2235511|P1|STARTED|Overall Study||22
924646|NCT01521507|2235519|P2|NOT COMPLETED|Stage 2: Observational Design||2
924647|NCT01521507|2235520|P1|NOT COMPLETED|Stage 2: Observational Design||4
924648|NCT01521507|2235519|P2|COMPLETED|Stage 2: Observational Design||92
924649|NCT01521507|2235520|P1|COMPLETED|Stage 2: Observational Design||94
924650|NCT01521507|2235519|P2|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||1
924651|NCT01521507|2235520|P1|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||2
924652|NCT01521507|2235519|P2|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||9
924653|NCT01521507|2235520|P1|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||11
924654|NCT01521507|2235519|P2|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||82
924655|NCT01521507|2235520|P1|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||81
924656|NCT01521507|2235519|P2|Received Crossover LipiFlow Tx|Stage 2: Observational Design||93
924657|NCT01521507|2235520|P1|Received Crossover LipiFlow Tx|Stage 2: Observational Design||0
924658|NCT01521507|2235519|P2|STARTED|Stage 2: Observational Design||94
924659|NCT01521507|2235520|P1|STARTED|Stage 2: Observational Design||98
924660|NCT01521507|2235519|P2|NOT COMPLETED|Stage 1: Randomized Design||5
924661|NCT01521507|2235520|P1|NOT COMPLETED|Stage 1: Randomized Design||3
924662|NCT01521507|2235519|P2|COMPLETED|Stage 1: Randomized Design||94
924663|NCT01521507|2235520|P1|COMPLETED|Stage 1: Randomized Design||98
924664|NCT01521507|2235519|P2|Received Initial Treatment (Tx)|Stage 1: Randomized Design||98
924665|NCT01521507|2235520|P1|Received Initial Treatment (Tx)|Stage 1: Randomized Design||99
924666|NCT01521507|2235519|P2|STARTED|Stage 1: Randomized Design||99
924667|NCT01521507|2235520|P1|STARTED|Stage 1: Randomized Design||101
924668|NCT01521364|2235537|P1|NOT COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||1
924669|NCT01521364|2235537|P1|COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||5
924670|NCT01521364|2235537|P1|STARTED|Linezolid + 500mg Claritromycin (wk 4&5)||6
924671|NCT01521364|2235537|P1|NOT COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||1
924672|NCT01521364|2235537|P1|COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||6
924673|NCT01521364|2235537|P1|STARTED|Linezolid + 250mg Claritromycin (wk 2&3)||7
924674|NCT01521364|2235537|P1|NOT COMPLETED|Linezolid Without Clarithromycin (1 wk)||0
924675|NCT01521364|2235537|P1|COMPLETED|Linezolid Without Clarithromycin (1 wk)||7
924676|NCT01521364|2235537|P1|STARTED|Linezolid Without Clarithromycin (1 wk)||7
924677|NCT01521260|2235550|P2|NOT COMPLETED|Overall Study||0
924678|NCT01521260|2235551|P1|NOT COMPLETED|Overall Study||0
924679|NCT01521260|2235550|P2|COMPLETED|Overall Study||15
924680|NCT01521260|2235551|P1|COMPLETED|Overall Study||15
924681|NCT01521260|2235550|P2|STARTED|Overall Study||15
924682|NCT01521260|2235551|P1|STARTED|Overall Study||15
924683|NCT01521143|2235561|P4|NOT COMPLETED|Overall Study||7
924684|NCT01521143|2235562|P3|NOT COMPLETED|Overall Study||8
924685|NCT01521143|2235563|P2|NOT COMPLETED|Overall Study||26
924686|NCT01521143|2235564|P1|NOT COMPLETED|Overall Study||29
924687|NCT01521143|2235561|P4|COMPLETED|Overall Study||0
924688|NCT01521143|2235562|P3|COMPLETED|Overall Study||0
924689|NCT01521143|2235563|P2|COMPLETED|Overall Study||10
924690|NCT01521143|2235564|P1|COMPLETED|Overall Study||11
924691|NCT01521143|2235561|P4|Received Treatment|Overall Study||4
924692|NCT01521143|2235562|P3|Received Treatment|Overall Study||3
924693|NCT01521143|2235563|P2|Received Treatment|Overall Study||20
924694|NCT01521143|2235564|P1|Received Treatment|Overall Study||20
924695|NCT01521143|2235561|P4|STARTED|Overall Study||7
924696|NCT01521143|2235562|P3|STARTED|Overall Study||8
924697|NCT01521143|2235563|P2|STARTED|Overall Study||36
924698|NCT01521143|2235564|P1|STARTED|Overall Study||40
924699|NCT01521026|2235596|P2|NOT COMPLETED|Overall Study||3
924700|NCT01521026|2235597|P1|NOT COMPLETED|Overall Study||15
924701|NCT01521026|2235596|P2|COMPLETED|Overall Study||28
924702|NCT01521026|2235597|P1|COMPLETED|Overall Study||23
924703|NCT01521026|2235596|P2|STARTED|Overall Study||31
924704|NCT01521026|2235597|P1|STARTED|Overall Study||38
924705|NCT01520987|2235613|P8|NOT COMPLETED|Overall Study||0
924706|NCT01520987|2235614|P7|NOT COMPLETED|Overall Study||0
924707|NCT01520987|2235615|P6|NOT COMPLETED|Overall Study||1
924708|NCT01520987|2235616|P5|NOT COMPLETED|Overall Study||0
924709|NCT01520987|2235617|P4|NOT COMPLETED|Overall Study||0
924710|NCT01520987|2235618|P3|NOT COMPLETED|Overall Study||0
924711|NCT01520987|2235619|P2|NOT COMPLETED|Overall Study||0
924712|NCT01520987|2235620|P1|NOT COMPLETED|Overall Study||1
924713|NCT01520987|2235613|P8|COMPLETED|Overall Study||14
924714|NCT01520987|2235614|P7|COMPLETED|Overall Study||12
924715|NCT01520987|2235615|P6|COMPLETED|Overall Study||13
924716|NCT01520987|2235616|P5|COMPLETED|Overall Study||14
924717|NCT01520987|2235617|P4|COMPLETED|Overall Study||15
924718|NCT01520987|2235618|P3|COMPLETED|Overall Study||11
924719|NCT01520987|2235619|P2|COMPLETED|Overall Study||12
924720|NCT01520987|2235620|P1|COMPLETED|Overall Study||12
924721|NCT01520987|2235613|P8|Dosed|Overall Study||14
924722|NCT01520987|2235614|P7|Dosed|Overall Study||12
924723|NCT01520987|2235615|P6|Dosed|Overall Study||14
924724|NCT01520987|2235616|P5|Dosed|Overall Study||14
924725|NCT01520987|2235617|P4|Dosed|Overall Study||15
924726|NCT01520987|2235618|P3|Dosed|Overall Study||11
924727|NCT01520987|2235619|P2|Dosed|Overall Study||12
924728|NCT01520987|2235620|P1|Dosed|Overall Study||13
924729|NCT01520987|2235613|P8|STARTED|Overall Study||14
924730|NCT01520987|2235614|P7|STARTED|Overall Study||12
924731|NCT01520987|2235615|P6|STARTED|Overall Study||14
924732|NCT01520987|2235616|P5|STARTED|Overall Study||14
924733|NCT01520987|2235617|P4|STARTED|Overall Study||15
924734|NCT01520987|2235618|P3|STARTED|Overall Study||11
924735|NCT01520987|2235619|P2|STARTED|Overall Study||12
924736|NCT01520987|2235620|P1|STARTED|Overall Study||13
924737|NCT01520922|2235680|P2|NOT COMPLETED|Survival Follow-up||0
924738|NCT01520922|2235681|P1|NOT COMPLETED|Survival Follow-up||1
924739|NCT01520922|2235680|P2|COMPLETED|Survival Follow-up||40
924740|NCT01520922|2235681|P1|COMPLETED|Survival Follow-up||20
924741|NCT01520922|2235680|P2|STARTED|Survival Follow-up||40
924742|NCT01520922|2235681|P1|STARTED|Survival Follow-up||21
924743|NCT01520922|2235680|P2|NOT COMPLETED|Follow up||1
924744|NCT01520922|2235681|P1|NOT COMPLETED|Follow up||0
924745|NCT01520922|2235680|P2|COMPLETED|Follow up||44
924746|NCT01520922|2235681|P1|COMPLETED|Follow up||44
924747|NCT01520922|2235680|P2|STARTED|Follow up||45
924748|NCT01520922|2235681|P1|STARTED|Follow up||44
924749|NCT01520922|2235680|P2|NOT COMPLETED|Treatment Phase||8
924750|NCT01520922|2235681|P1|NOT COMPLETED|Treatment Phase||5
924751|NCT01520922|2235680|P2|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|45
924752|NCT01520922|2235681|P1|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|39
924753|NCT01520922|2235680|P2|STARTED|Treatment Phase||53
924754|NCT01520922|2235681|P1|STARTED|Treatment Phase||44
924755|NCT01520909|2235743|P3|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||7
924756|NCT01520909|2235744|P2|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
924757|NCT01520909|2235745|P1|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
924758|NCT01520909|2235743|P3|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||80
924759|NCT01520909|2235744|P2|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
924760|NCT01520909|2235745|P1|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
924761|NCT01520909|2235743|P3|STARTED|Part 2 (Open-Label Period)-Eltrombopag|Two participants that completed Part 1 did not start Part 2 because of lack of efficacy.|87
924762|NCT01520909|2235744|P2|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
924763|NCT01520909|2235745|P1|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
924764|NCT01520909|2235743|P3|NOT COMPLETED|Part 1 (Randomized Period)||0
924765|NCT01520909|2235744|P2|NOT COMPLETED|Part 1 (Randomized Period)||2
924766|NCT01520909|2235745|P1|NOT COMPLETED|Part 1 (Randomized Period)||1
924767|NCT01520909|2235743|P3|COMPLETED|Part 1 (Randomized Period)||0
924768|NCT01520909|2235744|P2|COMPLETED|Part 1 (Randomized Period)||61
924769|NCT01520909|2235745|P1|COMPLETED|Part 1 (Randomized Period)||28
924770|NCT01520909|2235743|P3|STARTED|Part 1 (Randomized Period)||0
924771|NCT01520909|2235744|P2|STARTED|Part 1 (Randomized Period)||63
924772|NCT01520909|2235745|P1|STARTED|Part 1 (Randomized Period)||29
924773|NCT01520727|2235816|P9|NOT COMPLETED|Overall Study||0
924774|NCT01520727|2235817|P8|NOT COMPLETED|Overall Study||0
924775|NCT01520727|2235818|P7|NOT COMPLETED|Overall Study||0
924776|NCT01520727|2235819|P6|NOT COMPLETED|Overall Study||0
924777|NCT01520727|2235820|P5|NOT COMPLETED|Overall Study||0
924778|NCT01520727|2235821|P4|NOT COMPLETED|Overall Study||0
924779|NCT01520727|2235822|P3|NOT COMPLETED|Overall Study||0
924780|NCT01520727|2235823|P2|NOT COMPLETED|Overall Study||0
924781|NCT01520727|2235824|P1|NOT COMPLETED|Overall Study||0
924782|NCT01520727|2235816|P9|COMPLETED|Overall Study||16
924783|NCT01520727|2235817|P8|COMPLETED|Overall Study||6
924784|NCT01520727|2235818|P7|COMPLETED|Overall Study||6
924785|NCT01520727|2235819|P6|COMPLETED|Overall Study||6
924786|NCT01520727|2235820|P5|COMPLETED|Overall Study||6
924787|NCT01520727|2235821|P4|COMPLETED|Overall Study||6
924788|NCT01520727|2235822|P3|COMPLETED|Overall Study||6
924789|NCT01520727|2235823|P2|COMPLETED|Overall Study||6
924790|NCT01520727|2235824|P1|COMPLETED|Overall Study||6
924791|NCT01520727|2235816|P9|STARTED|Overall Study||16
924792|NCT01520727|2235817|P8|STARTED|Overall Study||6
924793|NCT01520727|2235818|P7|STARTED|Overall Study||6
924794|NCT01520727|2235819|P6|STARTED|Overall Study||6
924795|NCT01520727|2235820|P5|STARTED|Overall Study||6
924796|NCT01520727|2235821|P4|STARTED|Overall Study||6
924797|NCT01520727|2235822|P3|STARTED|Overall Study||6
924798|NCT01520727|2235823|P2|STARTED|Overall Study||6
924799|NCT01520727|2235824|P1|STARTED|Overall Study||6
924800|NCT01520714|2235862|P2|NOT COMPLETED|Overall Study||6
924801|NCT01520714|2235863|P1|NOT COMPLETED|Overall Study||0
924802|NCT01520714|2235862|P2|COMPLETED|Overall Study||5
924803|NCT01520714|2235863|P1|COMPLETED|Overall Study||0
924804|NCT01520714|2235862|P2|STARTED|Overall Study||11
924805|NCT01520714|2235863|P1|STARTED|Overall Study||0
924806|NCT01520558|2235872|P3|NOT COMPLETED|Overall Study||3
924807|NCT01520558|2235873|P2|NOT COMPLETED|Overall Study||2
924808|NCT01520558|2235874|P1|NOT COMPLETED|Overall Study||2
924809|NCT01520558|2235872|P3|COMPLETED|Overall Study||3
924810|NCT01520558|2235873|P2|COMPLETED|Overall Study||1
924811|NCT01520558|2235874|P1|COMPLETED|Overall Study||1
924812|NCT01520558|2235872|P3|STARTED|Overall Study||6
924813|NCT01520558|2235873|P2|STARTED|Overall Study||3
924814|NCT01520558|2235874|P1|STARTED|Overall Study||3
924815|NCT01520532|2235882|P1|NOT COMPLETED|Overall Study||0
924816|NCT01520532|2235882|P1|COMPLETED|Overall Study||60
924817|NCT01520532|2235882|P1|STARTED|Overall Study|Subjects who underwent an ablation and had post-procedure MRI|60
924818|NCT01520506|2235888|P1|NOT COMPLETED|Overall Study||6
924819|NCT01520506|2235888|P1|COMPLETED|Overall Study||44
924820|NCT01520506|2235888|P1|STARTED|Overall Study||50
924821|NCT01520454|2235898|P4|NOT COMPLETED|Overall Study||0
924822|NCT01520454|2235899|P3|NOT COMPLETED|Overall Study||0
924823|NCT01520454|2235900|P2|NOT COMPLETED|Overall Study||0
924824|NCT01520454|2235901|P1|NOT COMPLETED|Overall Study||0
924825|NCT01520454|2235898|P4|COMPLETED|Overall Study||6
924826|NCT01520454|2235899|P3|COMPLETED|Overall Study||5
924827|NCT01520454|2235900|P2|COMPLETED|Overall Study||6
924828|NCT01520454|2235901|P1|COMPLETED|Overall Study||9
924829|NCT01520454|2235898|P4|STARTED|Overall Study||6
924830|NCT01520454|2235899|P3|STARTED|Overall Study||5
924831|NCT01520454|2235900|P2|STARTED|Overall Study||6
924832|NCT01520454|2235901|P1|STARTED|Overall Study||9
924833|NCT01520402|2235939|P1|NOT COMPLETED|Overall Study||5
924834|NCT01520402|2235939|P1|COMPLETED|Overall Study||30
924835|NCT01520402|2235939|P1|STARTED|Overall Study||35
924836|NCT01519960|2235953|P3|NOT COMPLETED|Overall Study||10
924837|NCT01519960|2235954|P2|NOT COMPLETED|Overall Study||50
924838|NCT01519960|2235955|P1|NOT COMPLETED|Overall Study||101
924839|NCT01519960|2235953|P3|COMPLETED|Overall Study||0
924840|NCT01519960|2235954|P2|COMPLETED|Overall Study||0
924841|NCT01519960|2235955|P1|COMPLETED|Overall Study||0
924842|NCT01519960|2235953|P3|Completed FU Week 24|Overall Study||10
924843|NCT01519960|2235954|P2|Completed FU Week 24|Overall Study||15
924844|NCT01519960|2235955|P1|Completed FU Week 24|Overall Study||101
924845|NCT01519960|2235953|P3|Completed Follow-Up (FU) Week 12|Overall Study||10
924846|NCT01519960|2235954|P2|Completed Follow-Up (FU) Week 12|Overall Study||26
924847|NCT01519960|2235955|P1|Completed Follow-Up (FU) Week 12|Overall Study||101
924848|NCT01519960|2235953|P3|Completed Week 48|Overall Study||10
924849|NCT01519960|2235954|P2|Completed Week 48|Overall Study||47
924850|NCT01519960|2235955|P1|Completed Week 48|Overall Study||99
924851|NCT01519960|2235953|P3|STARTED|Overall Study||10
924852|NCT01519960|2235954|P2|STARTED|Overall Study||50
924853|NCT01519960|2235955|P1|STARTED|Overall Study||101
924854|NCT01519934|2236061|P1|NOT COMPLETED|Overall Study||3
924855|NCT01519934|2236061|P1|COMPLETED|Overall Study||45
924856|NCT01519934|2236061|P1|STARTED|Overall Study||48
924857|NCT01519921|2236070|P2|NOT COMPLETED|Overall Study||15
924858|NCT01519921|2236071|P1|NOT COMPLETED|Overall Study||21
924859|NCT01519921|2236070|P2|COMPLETED|Overall Study||49
924860|NCT01519921|2236071|P1|COMPLETED|Overall Study||65
924861|NCT01519921|2236070|P2|STARTED|Overall Study||64
924862|NCT01519921|2236071|P1|STARTED|Overall Study||86
924863|NCT01519882|2236095|P2|NOT COMPLETED|Overall Study||0
924864|NCT01519882|2236096|P1|NOT COMPLETED|Overall Study||0
924865|NCT01519882|2236095|P2|COMPLETED|Overall Study||0
924866|NCT01519882|2236096|P1|COMPLETED|Overall Study||1
924867|NCT01519882|2236095|P2|STARTED|Overall Study||0
924868|NCT01519882|2236096|P1|STARTED|Overall Study||1
924869|NCT01519817|2236120|P4|NOT COMPLETED|Overall Study||1
924870|NCT01519817|2236121|P3|NOT COMPLETED|Overall Study||0
924871|NCT01519817|2236122|P2|NOT COMPLETED|Overall Study||0
924872|NCT01519817|2236123|P1|NOT COMPLETED|Overall Study||1
924873|NCT01519817|2236120|P4|COMPLETED|Overall Study||10
924874|NCT01519817|2236121|P3|COMPLETED|Overall Study||16
924875|NCT01519817|2236122|P2|COMPLETED|Overall Study||3
924876|NCT01519817|2236123|P1|COMPLETED|Overall Study||3
924877|NCT01519817|2236120|P4|STARTED|Overall Study||11
924878|NCT01519817|2236121|P3|STARTED|Overall Study||16
924879|NCT01519817|2236122|P2|STARTED|Overall Study||3
924880|NCT01519817|2236123|P1|STARTED|Overall Study||4
924881|NCT01519791|2236163|P2|NOT COMPLETED|Overall Study||368
924882|NCT01519791|2236164|P1|NOT COMPLETED|Overall Study||152
924883|NCT01519791|2236163|P2|COMPLETED|Overall Study||292
924884|NCT01519791|2236164|P1|COMPLETED|Overall Study||67
924885|NCT01519791|2236163|P2|Completed Week 52|Overall Study||500
924886|NCT01519791|2236164|P1|Completed Week 52|Overall Study||143
924887|NCT01519791|2236163|P2|STARTED|Overall Study||660
924888|NCT01519791|2236164|P1|STARTED|Overall Study||219
924889|NCT01519778|2236228|P1|NOT COMPLETED|Overall Study||14
924890|NCT01519778|2236228|P1|COMPLETED|Overall Study||186
924891|NCT01519778|2236228|P1|STARTED|Overall Study||200
924892|NCT01519765|2236234|P2|NOT COMPLETED|Overall Study||2
924893|NCT01519765|2236235|P1|NOT COMPLETED|Overall Study||3
924894|NCT01519765|2236234|P2|COMPLETED|Overall Study||34
924895|NCT01519765|2236235|P1|COMPLETED|Overall Study||34
924896|NCT01519765|2236234|P2|STARTED|Overall Study||36
924897|NCT01519765|2236235|P1|STARTED|Overall Study||37
924898|NCT01519713|2236284|P3|NOT COMPLETED|Overall Study||0
924899|NCT01519713|2236285|P2|NOT COMPLETED|Overall Study||0
924900|NCT01519713|2236286|P1|NOT COMPLETED|Overall Study||0
924901|NCT01519713|2236284|P3|COMPLETED|Overall Study||4
924902|NCT01519713|2236285|P2|COMPLETED|Overall Study||2
924903|NCT01519713|2236286|P1|COMPLETED|Overall Study||194
924904|NCT01519713|2236284|P3|STARTED|Overall Study||4
924905|NCT01519713|2236285|P2|STARTED|Overall Study||2
924906|NCT01519713|2236286|P1|STARTED|Overall Study||194
924907|NCT01519700|2236313|P4|NOT COMPLETED|Overall Study||7
924908|NCT01519700|2236314|P3|NOT COMPLETED|Overall Study||7
924909|NCT01519700|2236315|P2|NOT COMPLETED|Overall Study||6
924910|NCT01519700|2236316|P1|NOT COMPLETED|Overall Study||9
924911|NCT01519700|2236313|P4|COMPLETED|Overall Study||47
924912|NCT01519700|2236314|P3|COMPLETED|Overall Study||48
924913|NCT01519700|2236315|P2|COMPLETED|Overall Study||49
924914|NCT01519700|2236316|P1|COMPLETED|Overall Study||45
924915|NCT01519700|2236313|P4|Treated Cycle 6 Neupogen|Overall Study||49
924916|NCT01519700|2236314|P3|Treated Cycle 6 Neupogen|Overall Study||0
924917|NCT01519700|2236315|P2|Treated Cycle 6 Neupogen|Overall Study||49
924918|NCT01519700|2236316|P1|Treated Cycle 6 Neupogen|Overall Study||0
924919|NCT01519700|2236313|P4|Treated Cycle 6 EP2006|Overall Study||0
924920|NCT01519700|2236314|P3|Treated Cycle 6 EP2006|Overall Study||48
924921|NCT01519700|2236315|P2|Treated Cycle 6 EP2006|Overall Study||0
924922|NCT01519700|2236316|P1|Treated Cycle 6 EP2006|Overall Study||45
924923|NCT01519700|2236313|P4|Treated Cycle 5 Neupogen|Overall Study||50
924924|NCT01519700|2236314|P3|Treated Cycle 5 Neupogen|Overall Study||48
924925|NCT01519700|2236315|P2|Treated Cycle 5 Neupogen|Overall Study||0
924926|NCT01519700|2236316|P1|Treated Cycle 5 Neupogen|Overall Study||0
924927|NCT01519700|2236313|P4|Treated Cycle 5 EP2006|Overall Study||0
924928|NCT01519700|2236314|P3|Treated Cycle 5 EP2006|Overall Study||0
924929|NCT01519700|2236315|P2|Treated Cycle 5 EP2006|Overall Study||49
924930|NCT01519700|2236316|P1|Treated Cycle 5 EP2006|Overall Study||46
924931|NCT01519700|2236313|P4|Treated Cycle 4 Neupogen|Overall Study||50
924932|NCT01519700|2236314|P3|Treated Cycle 4 Neupogen|Overall Study||0
924933|NCT01519700|2236315|P2|Treated Cycle 4 Neupogen|Overall Study||51
924934|NCT01519700|2236316|P1|Treated Cycle 4 Neupogen|Overall Study||0
924935|NCT01519700|2236313|P4|Treated Cycle 4 EP2006|Overall Study||0
924936|NCT01519700|2236314|P3|Treated Cycle 4 EP2006|Overall Study||50
924937|NCT01519700|2236315|P2|Treated Cycle 4 EP2006|Overall Study||0
924938|NCT01519700|2236316|P1|Treated Cycle 4 EP2006|Overall Study||51
924939|NCT01519700|2236313|P4|Treated Cycle 3 Neupogen|Overall Study||51
924940|NCT01519700|2236314|P3|Treated Cycle 3 Neupogen|Overall Study||54
924941|NCT01519700|2236315|P2|Treated Cycle 3 Neupogen|Overall Study||0
924942|NCT01519700|2236316|P1|Treated Cycle 3 Neupogen|Overall Study||0
924943|NCT01519700|2236313|P4|Treated Cycle 3 EP2006|Overall Study||0
924944|NCT01519700|2236314|P3|Treated Cycle 3 EP2006|Overall Study||0
924945|NCT01519700|2236315|P2|Treated Cycle 3 EP2006|Overall Study||51
924946|NCT01519700|2236316|P1|Treated Cycle 3 EP2006|Overall Study||51
924947|NCT01519700|2236313|P4|Treated Cycle 2 Neupogen|Overall Study||51
924948|NCT01519700|2236314|P3|Treated Cycle 2 Neupogen|Overall Study||0
924949|NCT01519700|2236315|P2|Treated Cycle 2 Neupogen|Overall Study||52
924950|NCT01519700|2236316|P1|Treated Cycle 2 Neupogen|Overall Study||0
924951|NCT01519700|2236313|P4|Treated Cycle 2 EP2006|Overall Study||0
924952|NCT01519700|2236314|P3|Treated Cycle 2 EP2006|Overall Study||55
924953|NCT01519700|2236315|P2|Treated Cycle 2 EP2006|Overall Study||0
924954|NCT01519700|2236316|P1|Treated Cycle 2 EP2006|Overall Study||52
924955|NCT01519700|2236313|P4|Treated Cycle 1 Neupogen|Overall Study||52
924956|NCT01519700|2236314|P3|Treated Cycle 1 Neupogen|Overall Study||55
924957|NCT01519700|2236315|P2|Treated Cycle 1 Neupogen|Overall Study||0
924958|NCT01519700|2236316|P1|Treated Cycle 1 Neupogen|Overall Study||0
924959|NCT01519700|2236313|P4|Treated Cycle 1 EP2006|Overall Study||0
924960|NCT01519700|2236314|P3|Treated Cycle 1 EP2006|Overall Study||0
924961|NCT01519700|2236315|P2|Treated Cycle 1 EP2006|Overall Study||54
924962|NCT01519700|2236316|P1|Treated Cycle 1 EP2006|Overall Study||53
924963|NCT01519700|2236313|P4|STARTED|Overall Study||54
924964|NCT01519700|2236314|P3|STARTED|Overall Study||55
924965|NCT01519700|2236315|P2|STARTED|Overall Study||55
924966|NCT01519700|2236316|P1|STARTED|Overall Study||54
924967|NCT01519674|2236351|P3|NOT COMPLETED|Overall Study||12
924968|NCT01519674|2236352|P2|NOT COMPLETED|Overall Study||13
924969|NCT01519674|2236353|P1|NOT COMPLETED|Overall Study||21
924970|NCT01519674|2236351|P3|COMPLETED|Overall Study||181
924971|NCT01519674|2236352|P2|COMPLETED|Overall Study||182
924972|NCT01519674|2236353|P1|COMPLETED|Overall Study||173
924973|NCT01519674|2236351|P3|Exposed|Overall Study||190
924974|NCT01519674|2236352|P2|Exposed|Overall Study||193
924975|NCT01519674|2236353|P1|Exposed|Overall Study||192
924976|NCT01519674|2236351|P3|STARTED|Overall Study||193
924977|NCT01519674|2236352|P2|STARTED|Overall Study||195
924978|NCT01519674|2236353|P1|STARTED|Overall Study||194
924979|NCT01519661|2236391|P1|NOT COMPLETED|Overall Study||61
924980|NCT01519661|2236391|P1|COMPLETED|Overall Study||96
924981|NCT01519661|2236391|P1|STARTED|Overall Study||157
924982|NCT01519648|2236408|P2|NOT COMPLETED|Overall Study||0
924983|NCT01519648|2236409|P1|NOT COMPLETED|Overall Study||0
924984|NCT01519648|2236408|P2|COMPLETED|Overall Study||306
924985|NCT01519648|2236409|P1|COMPLETED|Overall Study||502
924986|NCT01519648|2236408|P2|STARTED|Overall Study||306
924987|NCT01519648|2236409|P1|STARTED|Overall Study||502
924988|NCT01519518|2236417|P2|NOT COMPLETED|Overall Study||10
924989|NCT01519518|2236418|P1|NOT COMPLETED|Overall Study||7
924990|NCT01519518|2236417|P2|COMPLETED|Overall Study||905
924991|NCT01519518|2236418|P1|COMPLETED|Overall Study||907
924992|NCT01519518|2236417|P2|STARTED|Overall Study||915
924993|NCT01519518|2236418|P1|STARTED|Overall Study||914
924994|NCT01519466|2236432|P2|NOT COMPLETED|Overall Study||0
924995|NCT01519466|2236433|P1|NOT COMPLETED|Overall Study||0
924996|NCT01519466|2236432|P2|COMPLETED|Overall Study||16
924997|NCT01519466|2236433|P1|COMPLETED|Overall Study||33
924998|NCT01519466|2236432|P2|STARTED|Overall Study||16
924999|NCT01519466|2236433|P1|STARTED|Overall Study||33
925000|NCT01519427|2236443|P1|NOT COMPLETED|Overall Study||2
925001|NCT01519427|2236443|P1|COMPLETED|Overall Study||0
925002|NCT01519427|2236443|P1|STARTED|Overall Study||2
925003|NCT01519323|2236450|P2|NOT COMPLETED|Overall Study||3
925004|NCT01519323|2236451|P1|NOT COMPLETED|Overall Study||3
925005|NCT01519323|2236450|P2|COMPLETED|Overall Study||0
925006|NCT01519323|2236451|P1|COMPLETED|Overall Study||0
925007|NCT01519323|2236450|P2|STARTED|Overall Study||3
925008|NCT01519323|2236451|P1|STARTED|Overall Study||3
925009|NCT01519284|2236467|P5|NOT COMPLETED|Overall Study||0
925010|NCT01519284|2236468|P4|NOT COMPLETED|Overall Study||0
925011|NCT01519284|2236469|P3|NOT COMPLETED|Overall Study||2
925012|NCT01519284|2236470|P2|NOT COMPLETED|Overall Study||0
925013|NCT01519284|2236471|P1|NOT COMPLETED|Overall Study||0
925014|NCT01519284|2236467|P5|COMPLETED|Overall Study||16
925015|NCT01519284|2236468|P4|COMPLETED|Overall Study||16
925016|NCT01519284|2236469|P3|COMPLETED|Overall Study||16
925017|NCT01519284|2236470|P2|COMPLETED|Overall Study||16
925018|NCT01519284|2236471|P1|COMPLETED|Overall Study||16
925019|NCT01519284|2236467|P5|STARTED|Overall Study||16
925020|NCT01519284|2236468|P4|STARTED|Overall Study||16
925021|NCT01519284|2236469|P3|STARTED|Overall Study||18
925022|NCT01519284|2236470|P2|STARTED|Overall Study||16
925023|NCT01519284|2236471|P1|STARTED|Overall Study||16
925024|NCT01519271|2236500|P2|NOT COMPLETED|Phase 2||0
925025|NCT01519271|2236501|P1|NOT COMPLETED|Phase 2||0
925026|NCT01519271|2236500|P2|COMPLETED|Phase 2||14
925027|NCT01519271|2236501|P1|COMPLETED|Phase 2||12
925028|NCT01519271|2236500|P2|STARTED|Phase 2||14
925029|NCT01519271|2236501|P1|STARTED|Phase 2|2 participants discontinued after Phase 1|12
925030|NCT01519271|2236500|P2|NOT COMPLETED|Phase 1||1
925031|NCT01519271|2236501|P1|NOT COMPLETED|Phase 1||0
925032|NCT01519271|2236500|P2|COMPLETED|Phase 1|1 participant discontinued participation in the middle of phase 1.|13
925033|NCT01519271|2236501|P1|COMPLETED|Phase 1||14
925034|NCT01519271|2236500|P2|STARTED|Phase 1||14
925035|NCT01519271|2236501|P1|STARTED|Phase 1||14
925036|NCT01519245|2236511|P2|NOT COMPLETED|Overall Study||2
925037|NCT01519245|2236512|P1|NOT COMPLETED|Overall Study||1
925038|NCT01519245|2236511|P2|COMPLETED|Overall Study||18
925039|NCT01519245|2236512|P1|COMPLETED|Overall Study||23
925040|NCT01519245|2236511|P2|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|2
925041|NCT01519245|2236512|P1|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|6
925042|NCT01519245|2236511|P2|Received Pre-pump IV TXA|Overall Study|All patients meeting inclusion criteria received appropriate dosing, as per protocol.|18
925043|NCT01519245|2236512|P1|Received Pre-pump IV TXA|Overall Study|Two patients included in in the final analysis did not receive pre-pump IV TXA.|21
925044|NCT01519245|2236511|P2|STARTED|Overall Study||20
925045|NCT01519245|2236512|P1|STARTED|Overall Study||24
925046|NCT01519206|2236524|P1|NOT COMPLETED|Overall Study||5
925047|NCT01519206|2236524|P1|COMPLETED|Overall Study||27
925048|NCT01519206|2236524|P1|STARTED|Overall Study||32
925049|NCT01519167|2236538|P2|NOT COMPLETED|Overall Study||8
925050|NCT01519167|2236539|P1|NOT COMPLETED|Overall Study||0
925051|NCT01519167|2236538|P2|COMPLETED|Overall Study||81
925052|NCT01519167|2236539|P1|COMPLETED|Overall Study||1
925053|NCT01519167|2236538|P2|STARTED|Overall Study||89
925054|NCT01519167|2236539|P1|STARTED|Overall Study||1
925055|NCT01519089|2236565|P2|NOT COMPLETED|Overall Study||15
925056|NCT01519089|2236566|P1|NOT COMPLETED|Overall Study||7
925057|NCT01519089|2236565|P2|COMPLETED|Overall Study||33
925058|NCT01519089|2236566|P1|COMPLETED|Overall Study||40
925059|NCT01519089|2236565|P2|Received Treatment|Overall Study||47
925060|NCT01519089|2236566|P1|Received Treatment|Overall Study||47
925061|NCT01519089|2236565|P2|STARTED|Overall Study||48
925062|NCT01519089|2236566|P1|STARTED|Overall Study||47
925063|NCT01518946|2236687|P3|NOT COMPLETED|Randomized Phase (Second Intervention)||0
925064|NCT01518946|2236688|P2|NOT COMPLETED|Randomized Phase (Second Intervention)||0
925065|NCT01518946|2236689|P1|NOT COMPLETED|Randomized Phase (Second Intervention)||0
925066|NCT01518946|2236687|P3|COMPLETED|Randomized Phase (Second Intervention)||10
925067|NCT01518946|2236688|P2|COMPLETED|Randomized Phase (Second Intervention)||9
925068|NCT01518946|2236689|P1|COMPLETED|Randomized Phase (Second Intervention)||0
925069|NCT01518946|2236687|P3|STARTED|Randomized Phase (Second Intervention)||10
925070|NCT01518946|2236688|P2|STARTED|Randomized Phase (Second Intervention)||9
925071|NCT01518946|2236689|P1|STARTED|Randomized Phase (Second Intervention)||0
925072|NCT01518946|2236687|P3|NOT COMPLETED|Randomized Phase (First Intervention)||0
925073|NCT01518946|2236688|P2|NOT COMPLETED|Randomized Phase (First Intervention)||1
925074|NCT01518946|2236689|P1|NOT COMPLETED|Randomized Phase (First Intervention)||0
925075|NCT01518946|2236687|P3|COMPLETED|Randomized Phase (First Intervention)||10
925076|NCT01518946|2236688|P2|COMPLETED|Randomized Phase (First Intervention)||9
925077|NCT01518946|2236689|P1|COMPLETED|Randomized Phase (First Intervention)||0
925078|NCT01518946|2236687|P3|STARTED|Randomized Phase (First Intervention)||10
925079|NCT01518946|2236688|P2|STARTED|Randomized Phase (First Intervention)||10
925080|NCT01518946|2236689|P1|STARTED|Randomized Phase (First Intervention)||0
925081|NCT01518946|2236687|P3|NOT COMPLETED|Open-label Phase||0
925082|NCT01518946|2236688|P2|NOT COMPLETED|Open-label Phase||0
925083|NCT01518946|2236689|P1|NOT COMPLETED|Open-label Phase||4
925084|NCT01518946|2236687|P3|COMPLETED|Open-label Phase||0
925085|NCT01518946|2236688|P2|COMPLETED|Open-label Phase||0
925086|NCT01518946|2236689|P1|COMPLETED|Open-label Phase||20
925087|NCT01518946|2236687|P3|STARTED|Open-label Phase||0
925088|NCT01518946|2236688|P2|STARTED|Open-label Phase||0
925089|NCT01518946|2236689|P1|STARTED|Open-label Phase||24
925090|NCT01518530|2236696|P1|NOT COMPLETED|Post-Treatment Follow-up||0
925091|NCT01518530|2236696|P1|COMPLETED|Post-Treatment Follow-up||9
925092|NCT01518530|2236696|P1|STARTED|Post-Treatment Follow-up||9
925093|NCT01518530|2236696|P1|NOT COMPLETED|Active Treatment Period||1
925094|NCT01518530|2236696|P1|COMPLETED|Active Treatment Period||9
925095|NCT01518530|2236696|P1|STARTED|Active Treatment Period||10
925096|NCT01518322|2236700|P1|NOT COMPLETED|Overall Study||13
925097|NCT01518322|2236700|P1|COMPLETED|Overall Study||222
925098|NCT01518322|2236700|P1|STARTED|Overall Study||235
925099|NCT01518270|2236713|P1|NOT COMPLETED|Overall Study||0
925100|NCT01518270|2236713|P1|COMPLETED|Overall Study||179
925101|NCT01518270|2236713|P1|STARTED|Overall Study||179
925102|NCT01518257|2236721|P2|NOT COMPLETED|Overall Study||0
925103|NCT01518257|2236722|P1|NOT COMPLETED|Overall Study||2
925104|NCT01518257|2236721|P2|COMPLETED|Overall Study||60
925105|NCT01518257|2236722|P1|COMPLETED|Overall Study||59
925106|NCT01518257|2236721|P2|STARTED|Overall Study||60
925107|NCT01518257|2236722|P1|STARTED|Overall Study||61
925108|NCT01518244|2236744|P1|NOT COMPLETED|Overall Study||3
925109|NCT01518244|2236744|P1|COMPLETED|Overall Study||47
925110|NCT01518244|2236744|P1|STARTED|Overall Study||50
925111|NCT01518192|2236752|P3|NOT COMPLETED|Overall Study||35
925112|NCT01518192|2236753|P2|NOT COMPLETED|Overall Study||26
925113|NCT01518192|2236754|P1|NOT COMPLETED|Overall Study||29
925114|NCT01518192|2236752|P3|COMPLETED|Overall Study||224
925115|NCT01518192|2236753|P2|COMPLETED|Overall Study||114
925116|NCT01518192|2236754|P1|COMPLETED|Overall Study||116
925117|NCT01518192|2236752|P3|STARTED|Overall Study||259
925118|NCT01518192|2236753|P2|STARTED|Overall Study||140
925119|NCT01518192|2236754|P1|STARTED|Overall Study||145
925120|NCT01518153|2236775|P3|NOT COMPLETED|Donor Lymphocyte Infusion||1
925121|NCT01518153|2236776|P2|NOT COMPLETED|Donor Lymphocyte Infusion||2
925122|NCT01518153|2236777|P1|NOT COMPLETED|Donor Lymphocyte Infusion||0
925123|NCT01518153|2236775|P3|COMPLETED|Donor Lymphocyte Infusion||3
925124|NCT01518153|2236776|P2|COMPLETED|Donor Lymphocyte Infusion||1
925125|NCT01518153|2236777|P1|COMPLETED|Donor Lymphocyte Infusion||0
925126|NCT01518153|2236775|P3|STARTED|Donor Lymphocyte Infusion||4
925127|NCT01518153|2236776|P2|STARTED|Donor Lymphocyte Infusion||3
925128|NCT01518153|2236777|P1|STARTED|Donor Lymphocyte Infusion||0
925129|NCT01518153|2236775|P3|NOT COMPLETED|Stem Cell Transplant||0
925130|NCT01518153|2236776|P2|NOT COMPLETED|Stem Cell Transplant||0
925131|NCT01518153|2236777|P1|NOT COMPLETED|Stem Cell Transplant||9
925132|NCT01518153|2236775|P3|COMPLETED|Stem Cell Transplant||0
925133|NCT01518153|2236776|P2|COMPLETED|Stem Cell Transplant||0
925134|NCT01518153|2236777|P1|COMPLETED|Stem Cell Transplant||7
925135|NCT01518153|2236775|P3|STARTED|Stem Cell Transplant||0
925136|NCT01518153|2236776|P2|STARTED|Stem Cell Transplant||0
925137|NCT01518153|2236777|P1|STARTED|Stem Cell Transplant||16
925138|NCT01517984|2236788|P4|NOT COMPLETED|Overall Study||1
925139|NCT01517984|2236789|P3|NOT COMPLETED|Overall Study||4
925140|NCT01517984|2236790|P2|NOT COMPLETED|Overall Study||23
925141|NCT01517984|2236791|P1|NOT COMPLETED|Overall Study||5
925142|NCT01517984|2236788|P4|COMPLETED|Overall Study||6
925143|NCT01517984|2236789|P3|COMPLETED|Overall Study||10
925144|NCT01517984|2236790|P2|COMPLETED|Overall Study||3
925145|NCT01517984|2236791|P1|COMPLETED|Overall Study||0
925146|NCT01517984|2236788|P4|STARTED|Overall Study||7
925147|NCT01517984|2236789|P3|STARTED|Overall Study||14
925148|NCT01517984|2236790|P2|STARTED|Overall Study||26
925149|NCT01517984|2236791|P1|STARTED|Overall Study||5
925150|NCT01517893|2236817|P2|NOT COMPLETED|Overall Study||1
925151|NCT01517893|2236818|P1|NOT COMPLETED|Overall Study||2
925152|NCT01517893|2236817|P2|COMPLETED|Overall Study||6
925153|NCT01517893|2236818|P1|COMPLETED|Overall Study||6
925154|NCT01517893|2236817|P2|STARTED|Overall Study||7
925155|NCT01517893|2236818|P1|STARTED|Overall Study||8
925156|NCT01517750|2236828|P4|NOT COMPLETED|Overall Study||1
925157|NCT01517750|2236829|P3|NOT COMPLETED|Overall Study||4
925158|NCT01517750|2236830|P2|NOT COMPLETED|Overall Study||2
925159|NCT01517750|2236831|P1|NOT COMPLETED|Overall Study||1
925160|NCT01517750|2236828|P4|COMPLETED|Overall Study||18
925161|NCT01517750|2236829|P3|COMPLETED|Overall Study||17
925162|NCT01517750|2236830|P2|COMPLETED|Overall Study||17
925163|NCT01517750|2236831|P1|COMPLETED|Overall Study||20
925164|NCT01517750|2236828|P4|STARTED|Overall Study||19
925165|NCT01517750|2236829|P3|STARTED|Overall Study||21
925166|NCT01517750|2236830|P2|STARTED|Overall Study||19
925167|NCT01517750|2236831|P1|STARTED|Overall Study||21
925168|NCT01517529|2236861|P1|NOT COMPLETED|Overall Study||0
925169|NCT01517529|2236861|P1|COMPLETED|Overall Study||10
925170|NCT01517529|2236861|P1|STARTED|Overall Study||10
925171|NCT01517412|2236868|P2|NOT COMPLETED|Overall Study||24
925172|NCT01517412|2236869|P1|NOT COMPLETED|Overall Study||36
925173|NCT01517412|2236868|P2|COMPLETED|Overall Study||202
925174|NCT01517412|2236869|P1|COMPLETED|Overall Study||189
925175|NCT01517412|2236868|P2|STARTED|Overall Study||226
925176|NCT01517412|2236869|P1|STARTED|Overall Study||225
925177|NCT01517373|2236898|P6|NOT COMPLETED|Treatment Period||7
925178|NCT01517373|2236899|P5|NOT COMPLETED|Treatment Period||6
925179|NCT01517373|2236900|P4|NOT COMPLETED|Treatment Period||7
925180|NCT01517373|2236901|P3|NOT COMPLETED|Treatment Period||6
925181|NCT01517373|2236902|P2|NOT COMPLETED|Treatment Period||4
925182|NCT01517373|2236903|P1|NOT COMPLETED|Treatment Period||0
925183|NCT01517373|2236898|P6|COMPLETED|Treatment Period||54
925184|NCT01517373|2236899|P5|COMPLETED|Treatment Period||55
925185|NCT01517373|2236900|P4|COMPLETED|Treatment Period||54
925186|NCT01517373|2236901|P3|COMPLETED|Treatment Period||54
925187|NCT01517373|2236902|P2|COMPLETED|Treatment Period||57
925188|NCT01517373|2236903|P1|COMPLETED|Treatment Period||0
925189|NCT01517373|2236898|P6|STARTED|Treatment Period||61
925190|NCT01517373|2236899|P5|STARTED|Treatment Period||61
925191|NCT01517373|2236900|P4|STARTED|Treatment Period||61
925192|NCT01517373|2236901|P3|STARTED|Treatment Period||60
925193|NCT01517373|2236902|P2|STARTED|Treatment Period||61
925194|NCT01517373|2236903|P1|STARTED|Treatment Period||0
925195|NCT01517373|2236898|P6|NOT COMPLETED|Run-in Period||0
925196|NCT01517373|2236899|P5|NOT COMPLETED|Run-in Period||0
925197|NCT01517373|2236900|P4|NOT COMPLETED|Run-in Period||0
925198|NCT01517373|2236901|P3|NOT COMPLETED|Run-in Period||0
925199|NCT01517373|2236902|P2|NOT COMPLETED|Run-in Period||0
925200|NCT01517373|2236903|P1|NOT COMPLETED|Run-in Period||57
925201|NCT01517373|2236898|P6|COMPLETED|Run-in Period||0
925202|NCT01517373|2236899|P5|COMPLETED|Run-in Period||0
925203|NCT01517373|2236900|P4|COMPLETED|Run-in Period||0
925204|NCT01517373|2236901|P3|COMPLETED|Run-in Period||0
925205|NCT01517373|2236902|P2|COMPLETED|Run-in Period||0
925206|NCT01517373|2236903|P1|COMPLETED|Run-in Period||304
925207|NCT01517373|2236898|P6|STARTED|Run-in Period||0
925208|NCT01517373|2236899|P5|STARTED|Run-in Period||0
925209|NCT01517373|2236900|P4|STARTED|Run-in Period||0
925210|NCT01517373|2236901|P3|STARTED|Run-in Period||0
925211|NCT01517373|2236902|P2|STARTED|Run-in Period||0
925212|NCT01517373|2236903|P1|STARTED|Run-in Period||361
925213|NCT01517295|2236973|P2|NOT COMPLETED|Overall Study||0
925214|NCT01517295|2236974|P1|NOT COMPLETED|Overall Study||1
925215|NCT01517295|2236973|P2|COMPLETED|Overall Study||14
925216|NCT01517295|2236974|P1|COMPLETED|Overall Study||15
925217|NCT01517295|2236973|P2|STARTED|Overall Study||14
925218|NCT01517295|2236974|P1|STARTED|Overall Study||16
925219|NCT01517282|2236988|P4|NOT COMPLETED|Overall Study||1
925220|NCT01517282|2236989|P3|NOT COMPLETED|Overall Study||1
925221|NCT01517282|2236990|P2|NOT COMPLETED|Overall Study||1
925222|NCT01517282|2236991|P1|NOT COMPLETED|Overall Study||1
925223|NCT01517282|2236988|P4|COMPLETED|Overall Study||5
925224|NCT01517282|2236989|P3|COMPLETED|Overall Study||8
925225|NCT01517282|2236990|P2|COMPLETED|Overall Study||7
925226|NCT01517282|2236991|P1|COMPLETED|Overall Study||8
925227|NCT01517282|2236988|P4|STARTED|Overall Study||6
925228|NCT01517282|2236989|P3|STARTED|Overall Study|1 patient completed the trial, but received only 4 doses of medication and 2 MRIs due to pregnancy|9
925229|NCT01517282|2236990|P2|STARTED|Overall Study||8
925230|NCT01517282|2236991|P1|STARTED|Overall Study|One patient was randomized but did not receive study medication based on the investigator's decision|9
925231|NCT01517178|2237025|P2|NOT COMPLETED|Period 2||2
925232|NCT01517178|2237026|P1|NOT COMPLETED|Period 2||6
925233|NCT01517178|2237025|P2|COMPLETED|Period 2||4
925234|NCT01517178|2237026|P1|COMPLETED|Period 2||5
925235|NCT01517178|2237025|P2|STARTED|Period 2||6
925236|NCT01517178|2237026|P1|STARTED|Period 2|One subject discontinued during run-in and did not start period 2.|11
925237|NCT01517178|2237025|P2|NOT COMPLETED|Period 1||5
925238|NCT01517178|2237026|P1|NOT COMPLETED|Period 1||4
925239|NCT01517178|2237025|P2|COMPLETED|Period 1||6
925240|NCT01517178|2237026|P1|COMPLETED|Period 1||12
925241|NCT01517178|2237025|P2|STARTED|Period 1||11
925242|NCT01517178|2237026|P1|STARTED|Period 1|One subject (who discontinued due to an adverse event) actually used New ostomy base plate.|16
925243|NCT01517074|2237032|P1|NOT COMPLETED|Overall Study||0
925244|NCT01517074|2237032|P1|COMPLETED|Overall Study||5
925245|NCT01517074|2237032|P1|STARTED|Overall Study||5
925246|NCT01516970|2237045|P2|NOT COMPLETED|Overall Study||21
925247|NCT01516970|2237046|P1|NOT COMPLETED|Overall Study||18
925248|NCT01516970|2237045|P2|COMPLETED|Overall Study||132
925249|NCT01516970|2237046|P1|COMPLETED|Overall Study||141
925250|NCT01516970|2237045|P2|STARTED|Overall Study||153
925251|NCT01516970|2237046|P1|STARTED|Overall Study||159
925252|NCT01516892|2237058|P1|NOT COMPLETED|Overall Study||343
925253|NCT01516892|2237058|P1|COMPLETED|Overall Study||373
925254|NCT01516892|2237058|P1|STARTED|Overall Study||716
925255|NCT01516879|2237066|P2|NOT COMPLETED|Overall Study||34
925256|NCT01516879|2237067|P1|NOT COMPLETED|Overall Study||16
925257|NCT01516879|2237066|P2|COMPLETED|Overall Study||568
925258|NCT01516879|2237067|P1|COMPLETED|Overall Study||287
925259|NCT01516879|2237066|P2|Received Treatment|Overall Study||599
925260|NCT01516879|2237067|P1|Received Treatment|Overall Study||302
925261|NCT01516879|2237066|P2|STARTED|Overall Study||602
925262|NCT01516879|2237067|P1|STARTED|Overall Study||303
925263|NCT01516749|2237101|P1|NOT COMPLETED|Follow-up Off Therapy||1
925264|NCT01516749|2237101|P1|COMPLETED|Follow-up Off Therapy||4
925265|NCT01516749|2237101|P1|STARTED|Follow-up Off Therapy||5
925266|NCT01516749|2237101|P1|NOT COMPLETED|Active Therapy||1
925267|NCT01516749|2237101|P1|COMPLETED|Active Therapy||5
925268|NCT01516749|2237101|P1|STARTED|Active Therapy||6
925269|NCT01516736|2237110|P2|NOT COMPLETED|Overall Study||13
925270|NCT01516736|2237111|P1|NOT COMPLETED|Overall Study||20
925271|NCT01516736|2237110|P2|COMPLETED|Overall Study||140
925272|NCT01516736|2237111|P1|COMPLETED|Overall Study||135
925273|NCT01516736|2237110|P2|STARTED|Overall Study||153
925274|NCT01516736|2237111|P1|STARTED|Overall Study||155
925275|NCT01516632|2237133|P2|NOT COMPLETED|Overall Study||15
925276|NCT01516632|2237134|P1|NOT COMPLETED|Overall Study||24
925277|NCT01516632|2237133|P2|COMPLETED|Overall Study||48
925278|NCT01516632|2237134|P1|COMPLETED|Overall Study||77
925279|NCT01516632|2237133|P2|STARTED|Overall Study||63
925280|NCT01516632|2237134|P1|STARTED|Overall Study||101
925281|NCT01516437|2237148|P4|NOT COMPLETED|Overall Study||1
925282|NCT01516437|2237149|P3|NOT COMPLETED|Overall Study||1
925283|NCT01516437|2237150|P2|NOT COMPLETED|Overall Study||0
925284|NCT01516437|2237151|P1|NOT COMPLETED|Overall Study||0
925285|NCT01516437|2237148|P4|COMPLETED|Overall Study||6
925286|NCT01516437|2237149|P3|COMPLETED|Overall Study||14
925287|NCT01516437|2237150|P2|COMPLETED|Overall Study||24
925288|NCT01516437|2237151|P1|COMPLETED|Overall Study||24
925289|NCT01516437|2237148|P4|STARTED|Overall Study||7
925290|NCT01516437|2237149|P3|STARTED|Overall Study||15
925291|NCT01516437|2237150|P2|STARTED|Overall Study||24
925292|NCT01516437|2237151|P1|STARTED|Overall Study||24
925293|NCT01516268|2237207|P2|NOT COMPLETED|Overall Study||0
925294|NCT01516268|2237208|P1|NOT COMPLETED|Overall Study||0
925295|NCT01516268|2237207|P2|COMPLETED|Overall Study||25
925296|NCT01516268|2237208|P1|COMPLETED|Overall Study||25
925297|NCT01516268|2237207|P2|STARTED|Overall Study||25
925298|NCT01516268|2237208|P1|STARTED|Overall Study||25
925299|NCT01516034|2237214|P1|NOT COMPLETED|Overall Study||8
925300|NCT01516034|2237214|P1|COMPLETED|Overall Study||0
925301|NCT01516034|2237214|P1|STARTED|Overall Study||8
925302|NCT01516008|2237221|P3|NOT COMPLETED|Overall Study||18
925303|NCT01516008|2237222|P2|NOT COMPLETED|Overall Study||16
925304|NCT01516008|2237223|P1|NOT COMPLETED|Overall Study||45
925305|NCT01516008|2237221|P3|COMPLETED|Overall Study||99
925306|NCT01516008|2237222|P2|COMPLETED|Overall Study||105
925307|NCT01516008|2237223|P1|COMPLETED|Overall Study||69
925308|NCT01516008|2237221|P3|STARTED|Overall Study||117
925309|NCT01516008|2237222|P2|STARTED|Overall Study||121
925310|NCT01516008|2237223|P1|STARTED|Overall Study||114
925311|NCT01515956|2237255|P1|NOT COMPLETED|Overall Study||0
925312|NCT01515956|2237255|P1|COMPLETED|Overall Study||15
925313|NCT01515956|2237255|P1|STARTED|Overall Study||15
925314|NCT01515943|2237264|P3|NOT COMPLETED|Overall Study||13
925315|NCT01515943|2237265|P2|NOT COMPLETED|Overall Study||16
925316|NCT01515943|2237266|P1|NOT COMPLETED|Overall Study||6
925317|NCT01515943|2237264|P3|COMPLETED|Overall Study||31
925318|NCT01515943|2237265|P2|COMPLETED|Overall Study||69
925319|NCT01515943|2237266|P1|COMPLETED|Overall Study||69
925320|NCT01515943|2237264|P3|STARTED|Overall Study||44
925321|NCT01515943|2237265|P2|STARTED|Overall Study||85
925322|NCT01515943|2237266|P1|STARTED|Overall Study||75
925323|NCT01515891|2237312|P1|NOT COMPLETED|Overall Study||0
925324|NCT01515891|2237312|P1|COMPLETED|Overall Study||4
925325|NCT01515891|2237312|P1|STARTED|Overall Study||4
925326|NCT01515865|2237319|P3|NOT COMPLETED|Part C (Randomized)||0
925327|NCT01515865|2237320|P2|NOT COMPLETED|Part C (Randomized)||0
925328|NCT01515865|2237321|P1|NOT COMPLETED|Part C (Randomized)||0
925329|NCT01515865|2237319|P3|COMPLETED|Part C (Randomized)||34
925330|NCT01515865|2237320|P2|COMPLETED|Part C (Randomized)||33
925331|NCT01515865|2237321|P1|COMPLETED|Part C (Randomized)||0
925332|NCT01515865|2237319|P3|STARTED|Part C (Randomized)||34
925333|NCT01515865|2237320|P2|STARTED|Part C (Randomized)|A total of two subjects from Part B did not meet the criteria required to be enrolled into Part C.|33
925334|NCT01515865|2237321|P1|STARTED|Part C (Randomized)||0
925335|NCT01515865|2237319|P3|NOT COMPLETED|Part B (Open-label)||0
925336|NCT01515865|2237320|P2|NOT COMPLETED|Part B (Open-label)||0
925337|NCT01515865|2237321|P1|NOT COMPLETED|Part B (Open-label)||2
925338|NCT01515865|2237319|P3|COMPLETED|Part B (Open-label)||0
925339|NCT01515865|2237320|P2|COMPLETED|Part B (Open-label)||0
925340|NCT01515865|2237321|P1|COMPLETED|Part B (Open-label)||69
925341|NCT01515865|2237319|P3|STARTED|Part B (Open-label)||0
925342|NCT01515865|2237320|P2|STARTED|Part B (Open-label)||0
925343|NCT01515865|2237321|P1|STARTED|Part B (Open-label)|Twenty-four subjects from Part A did not meet the criteria required to be enrolled into Part B.|71
925344|NCT01515865|2237319|P3|NOT COMPLETED|Part A (Open-label)||0
925345|NCT01515865|2237320|P2|NOT COMPLETED|Part A (Open-label)||0
925346|NCT01515865|2237321|P1|NOT COMPLETED|Part A (Open-label)||3
925347|NCT01515865|2237319|P3|COMPLETED|Part A (Open-label)||0
925348|NCT01515865|2237320|P2|COMPLETED|Part A (Open-label)||0
925349|NCT01515865|2237321|P1|COMPLETED|Part A (Open-label)||95
925350|NCT01515865|2237319|P3|STARTED|Part A (Open-label)||0
925351|NCT01515865|2237320|P2|STARTED|Part A (Open-label)||0
925352|NCT01515865|2237321|P1|STARTED|Part A (Open-label)||98
925353|NCT01515696|2237331|P2|NOT COMPLETED|Overall Study||10
925354|NCT01515696|2237332|P1|NOT COMPLETED|Overall Study||8
925355|NCT01515696|2237331|P2|COMPLETED|Overall Study||39
925356|NCT01515696|2237332|P1|COMPLETED|Overall Study||39
925357|NCT01515696|2237331|P2|STARTED|Overall Study||49
925358|NCT01515696|2237332|P1|STARTED|Overall Study||47
925359|NCT01515657|2237342|P3|NOT COMPLETED|Third Intervention||0
925360|NCT01515657|2237343|P2|NOT COMPLETED|Third Intervention||0
925361|NCT01515657|2237344|P1|NOT COMPLETED|Third Intervention||1
925362|NCT01515657|2237342|P3|COMPLETED|Third Intervention||13
925363|NCT01515657|2237343|P2|COMPLETED|Third Intervention||11
925364|NCT01515657|2237344|P1|COMPLETED|Third Intervention||13
925365|NCT01515657|2237342|P3|STARTED|Third Intervention||13
925366|NCT01515657|2237343|P2|STARTED|Third Intervention||11
925367|NCT01515657|2237344|P1|STARTED|Third Intervention||14
925368|NCT01515657|2237342|P3|NOT COMPLETED|Second Intervention||0
925369|NCT01515657|2237343|P2|NOT COMPLETED|Second Intervention||1
925370|NCT01515657|2237344|P1|NOT COMPLETED|Second Intervention||0
925371|NCT01515657|2237342|P3|COMPLETED|Second Intervention||13
925372|NCT01515657|2237343|P2|COMPLETED|Second Intervention||11
925373|NCT01515657|2237344|P1|COMPLETED|Second Intervention||14
925374|NCT01515657|2237342|P3|STARTED|Second Intervention||13
925375|NCT01515657|2237343|P2|STARTED|Second Intervention||12
925376|NCT01515657|2237344|P1|STARTED|Second Intervention||14
925377|NCT01515657|2237342|P3|NOT COMPLETED|First Intervention||0
925378|NCT01515657|2237343|P2|NOT COMPLETED|First Intervention||1
925379|NCT01515657|2237344|P1|NOT COMPLETED|First Intervention||0
925380|NCT01515657|2237342|P3|COMPLETED|First Intervention||13
925381|NCT01515657|2237343|P2|COMPLETED|First Intervention||12
925382|NCT01515657|2237344|P1|COMPLETED|First Intervention||14
925383|NCT01515657|2237342|P3|STARTED|First Intervention||13
925384|NCT01515657|2237343|P2|STARTED|First Intervention||13
925385|NCT01515657|2237344|P1|STARTED|First Intervention||14
925386|NCT01515566|2237354|P2|NOT COMPLETED|Overall Study||0
925387|NCT01515566|2237355|P1|NOT COMPLETED|Overall Study||0
925388|NCT01515566|2237354|P2|COMPLETED|Overall Study||10
925389|NCT01515566|2237355|P1|COMPLETED|Overall Study||10
925390|NCT01515566|2237354|P2|STARTED|Overall Study||10
925391|NCT01515566|2237355|P1|STARTED|Overall Study||10
925392|NCT01515540|2237367|P2|NOT COMPLETED|Overall Study||3
925393|NCT01515540|2237368|P1|NOT COMPLETED|Overall Study||5
925394|NCT01515540|2237367|P2|COMPLETED|Overall Study||15
925395|NCT01515540|2237368|P1|COMPLETED|Overall Study||15
925396|NCT01515540|2237367|P2|STARTED|Overall Study||18
925397|NCT01515540|2237368|P1|STARTED|Overall Study||20
925398|NCT01515488|2237376|P2|NOT COMPLETED|Overall Study||0
925399|NCT01515488|2237377|P1|NOT COMPLETED|Overall Study||0
925400|NCT01515488|2237376|P2|COMPLETED|Overall Study||200
925401|NCT01515488|2237377|P1|COMPLETED|Overall Study||200
925402|NCT01515488|2237376|P2|STARTED|Overall Study||200
925403|NCT01515488|2237377|P1|STARTED|Overall Study||200
925404|NCT01515423|2237389|P3|NOT COMPLETED|DOUBLE BLIND||92
925405|NCT01515423|2237390|P2|NOT COMPLETED|DOUBLE BLIND||82
925406|NCT01515423|2237391|P1|NOT COMPLETED|DOUBLE BLIND||0
925407|NCT01515423|2237389|P3|COMPLETED|DOUBLE BLIND||420
925408|NCT01515423|2237390|P2|COMPLETED|DOUBLE BLIND||422
925409|NCT01515423|2237391|P1|COMPLETED|DOUBLE BLIND||0
925410|NCT01515423|2237389|P3|STARTED|DOUBLE BLIND||512
925411|NCT01515423|2237390|P2|STARTED|DOUBLE BLIND||504
925412|NCT01515423|2237391|P1|STARTED|DOUBLE BLIND||0
925413|NCT01515423|2237389|P3|NOT COMPLETED|Open Label Phase||0
925414|NCT01515423|2237390|P2|NOT COMPLETED|Open Label Phase||0
925415|NCT01515423|2237391|P1|NOT COMPLETED|Open Label Phase||413
925416|NCT01515423|2237389|P3|COMPLETED|Open Label Phase||0
925417|NCT01515423|2237390|P2|COMPLETED|Open Label Phase||0
925418|NCT01515423|2237391|P1|COMPLETED|Open Label Phase||1016
925419|NCT01515423|2237389|P3|STARTED|Open Label Phase||0
925420|NCT01515423|2237390|P2|STARTED|Open Label Phase||0
925421|NCT01515423|2237391|P1|STARTED|Open Label Phase||1429
925422|NCT01515410|2237410|P2|NOT COMPLETED|Overall Study||0
925423|NCT01515410|2237411|P1|NOT COMPLETED|Overall Study||0
925424|NCT01515410|2237410|P2|COMPLETED|Overall Study||15
925425|NCT01515410|2237411|P1|COMPLETED|Overall Study||19
925426|NCT01515410|2237410|P2|STARTED|Overall Study||15
925427|NCT01515410|2237411|P1|STARTED|Overall Study||19
925428|NCT01515345|2237419|P2|NOT COMPLETED|Overall Study||0
925429|NCT01515345|2237420|P1|NOT COMPLETED|Overall Study||1
925430|NCT01515345|2237419|P2|COMPLETED|Overall Study||343
925431|NCT01515345|2237420|P1|COMPLETED|Overall Study||664
925432|NCT01515345|2237419|P2|STARTED|Overall Study||343
925433|NCT01515345|2237420|P1|STARTED|Overall Study||665
925434|NCT01515306|2237432|P2|NOT COMPLETED|Overall Study||14
925435|NCT01515306|2237433|P1|NOT COMPLETED|Overall Study||12
925436|NCT01515306|2237432|P2|COMPLETED|Overall Study||2
925437|NCT01515306|2237433|P1|COMPLETED|Overall Study|Completed the required treatment in Cycle 1 Day 1 and Cycle 2 Day 1 and assessment.|12
925438|NCT01515306|2237432|P2|Drug-Drug Interaction Population|Overall Study|Drug-drug interaction was only assessed in Part A.|0
925439|NCT01515306|2237433|P1|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1 Day 1 and Cycle 2 Day 1 treatment.|21
925440|NCT01515306|2237432|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
925441|NCT01515306|2237433|P1|Received at Least 1 Dose of Study Drug|Overall Study||24
925442|NCT01515306|2237432|P2|STARTED|Overall Study||16
925443|NCT01515306|2237433|P1|STARTED|Overall Study||24
925456|NCT01515072|2237469|P2|NOT COMPLETED|Overall Study||0
925457|NCT01515072|2237470|P1|NOT COMPLETED|Overall Study||0
925458|NCT01515072|2237469|P2|COMPLETED|Overall Study|There were 513 total organs transplanted and 235 kidneys transplanted in the RIPC group|155
925459|NCT01515072|2237470|P1|COMPLETED|Overall Study|There were 566 total organs transplanted and 248 kidneys transplanted in the No RIPC group.|166
925460|NCT01515072|2237469|P2|STARTED|Overall Study||155
925461|NCT01515072|2237470|P1|STARTED|Overall Study||166
925462|NCT01515046|2237510|P1|NOT COMPLETED|Overall Study||0
925463|NCT01515046|2237510|P1|COMPLETED|Overall Study||1
925464|NCT01515046|2237510|P1|STARTED|Overall Study||1
925465|NCT01514864|2237520|P2|NOT COMPLETED|Overall Study||5
925466|NCT01514864|2237521|P1|NOT COMPLETED|Overall Study||9
925467|NCT01514864|2237520|P2|COMPLETED|Overall Study||0
925468|NCT01514864|2237521|P1|COMPLETED|Overall Study|Study was terminated; no patients completed study treatment|0
925469|NCT01514864|2237520|P2|STARTED|Overall Study||5
925470|NCT01514864|2237521|P1|STARTED|Overall Study||9
925471|NCT01514786|2237539|P2|NOT COMPLETED|Overall Study||0
925472|NCT01514786|2237540|P1|NOT COMPLETED|Overall Study||0
925473|NCT01514786|2237539|P2|COMPLETED|Overall Study||284
925474|NCT01514786|2237540|P1|COMPLETED|Overall Study||286
925475|NCT01514786|2237539|P2|STARTED|Overall Study||284
925476|NCT01514786|2237540|P1|STARTED|Overall Study||286
925480|NCT01514734|2237553|P1|NOT COMPLETED|Overall Study||0
925481|NCT01514734|2237553|P1|COMPLETED|Overall Study||9
925482|NCT01514734|2237553|P1|STARTED|Overall Study||9
925483|NCT01514630|2237557|P1|NOT COMPLETED|Overall Study||3
925484|NCT01514630|2237557|P1|COMPLETED|Overall Study||11
925485|NCT01514630|2237557|P1|STARTED|Overall Study||14
925486|NCT01514513|2237563|P2|NOT COMPLETED|Overall Study||1
925487|NCT01514513|2237564|P1|NOT COMPLETED|Overall Study||1
925488|NCT01514513|2237563|P2|COMPLETED|Overall Study||20
925489|NCT01514513|2237564|P1|COMPLETED|Overall Study||20
925490|NCT01514513|2237563|P2|STARTED|Overall Study||21
925491|NCT01514513|2237564|P1|STARTED|Overall Study||21
925492|NCT01514461|2237575|P3|NOT COMPLETED|Overall Study||4
925493|NCT01514461|2237576|P2|NOT COMPLETED|Overall Study||3
925494|NCT01514461|2237577|P1|NOT COMPLETED|Overall Study||5
925495|NCT01514461|2237575|P3|COMPLETED|Overall Study||11
925496|NCT01514461|2237576|P2|COMPLETED|Overall Study||12
925497|NCT01514461|2237577|P1|COMPLETED|Overall Study||10
925498|NCT01514461|2237575|P3|STARTED|Overall Study||15
925499|NCT01514461|2237576|P2|STARTED|Overall Study||15
925500|NCT01514461|2237577|P1|STARTED|Overall Study||15
925501|NCT01514448|2237616|P2|NOT COMPLETED|Overall Study||8
925502|NCT01514448|2237617|P1|NOT COMPLETED|Overall Study||12
925503|NCT01514448|2237616|P2|COMPLETED|Overall Study||5
925504|NCT01514448|2237617|P1|COMPLETED|Overall Study||4
925505|NCT01514448|2237616|P2|Full Analysis Set (FAS)|Overall Study||13
925506|NCT01514448|2237617|P1|Full Analysis Set (FAS)|Overall Study||12
925507|NCT01514448|2237616|P2|STARTED|Overall Study||13
925508|NCT01514448|2237617|P1|STARTED|Overall Study||16
925509|NCT01514422|2237632|P1|NOT COMPLETED|Overall Study||1
925510|NCT01514422|2237632|P1|COMPLETED|Overall Study||19
925511|NCT01514422|2237632|P1|STARTED|Overall Study||20
925512|NCT01514318|2237638|P1|NOT COMPLETED|Overall Study||0
925513|NCT01514318|2237638|P1|COMPLETED|Overall Study||8
925514|NCT01514318|2237638|P1|STARTED|Overall Study||8
925515|NCT01514292|2237644|P1|NOT COMPLETED|Overall Study||0
925516|NCT01514292|2237644|P1|COMPLETED|Overall Study||72
925517|NCT01514292|2237644|P1|STARTED|Overall Study||72
925518|NCT01514240|2237650|P2|NOT COMPLETED|Overall Study||11
925519|NCT01514240|2237651|P1|NOT COMPLETED|Overall Study||6
925520|NCT01514240|2237650|P2|COMPLETED|Overall Study||45
925521|NCT01514240|2237651|P1|COMPLETED|Overall Study||50
925522|NCT01514240|2237650|P2|STARTED|Overall Study||56
925523|NCT01514240|2237651|P1|STARTED|Overall Study||56
925524|NCT01514162|2237725|P1|NOT COMPLETED|Overall Study||85
925525|NCT01514162|2237725|P1|COMPLETED|Overall Study||160
925526|NCT01514162|2237725|P1|STARTED|Overall Study||245
925527|NCT01514149|2237736|P5|NOT COMPLETED|Overall Study||1
925528|NCT01514149|2237737|P4|NOT COMPLETED|Overall Study||1
925529|NCT01514149|2237738|P3|NOT COMPLETED|Overall Study||3
925530|NCT01514149|2237739|P2|NOT COMPLETED|Overall Study||1
925531|NCT01514149|2237740|P1|NOT COMPLETED|Overall Study||3
925532|NCT01514149|2237736|P5|COMPLETED|Overall Study||14
925533|NCT01514149|2237737|P4|COMPLETED|Overall Study||13
925534|NCT01514149|2237738|P3|COMPLETED|Overall Study||11
925535|NCT01514149|2237739|P2|COMPLETED|Overall Study||14
925536|NCT01514149|2237740|P1|COMPLETED|Overall Study||12
925537|NCT01514149|2237736|P5|STARTED|Overall Study||15
925538|NCT01514149|2237737|P4|STARTED|Overall Study||14
925539|NCT01514149|2237738|P3|STARTED|Overall Study||14
925540|NCT01514149|2237739|P2|STARTED|Overall Study||15
925541|NCT01514149|2237740|P1|STARTED|Overall Study||15
925542|NCT01514136|2237764|P8|NOT COMPLETED|Test Period; Test D*||0
925543|NCT01514136|2237765|P7|NOT COMPLETED|Test Period; Test D*||0
925544|NCT01514136|2237766|P6|NOT COMPLETED|Test Period; Test D*||0
925545|NCT01514136|2237767|P5|NOT COMPLETED|Test Period; Test D*||0
925546|NCT01514136|2237768|P4|NOT COMPLETED|Test Period; Test D*||0
925547|NCT01514136|2237769|P3|NOT COMPLETED|Test Period; Test D*||0
925548|NCT01514136|2237770|P2|NOT COMPLETED|Test Period; Test D*||0
925549|NCT01514136|2237771|P1|NOT COMPLETED|Test Period; Test D*||0
925550|NCT01514136|2237764|P8|COMPLETED|Test Period; Test D*||23
925551|NCT01514136|2237765|P7|COMPLETED|Test Period; Test D*||0
925552|NCT01514136|2237766|P6|COMPLETED|Test Period; Test D*||0
925553|NCT01514136|2237767|P5|COMPLETED|Test Period; Test D*||0
925554|NCT01514136|2237768|P4|COMPLETED|Test Period; Test D*||0
925555|NCT01514136|2237769|P3|COMPLETED|Test Period; Test D*||0
925556|NCT01514136|2237770|P2|COMPLETED|Test Period; Test D*||0
925557|NCT01514136|2237771|P1|COMPLETED|Test Period; Test D*||0
925558|NCT01514136|2237764|P8|STARTED|Test Period; Test D*||23
925559|NCT01514136|2237765|P7|STARTED|Test Period; Test D*||0
925560|NCT01514136|2237766|P6|STARTED|Test Period; Test D*||0
925561|NCT01514136|2237767|P5|STARTED|Test Period; Test D*||0
925562|NCT01514136|2237768|P4|STARTED|Test Period; Test D*||0
925563|NCT01514136|2237769|P3|STARTED|Test Period; Test D*||0
925564|NCT01514136|2237770|P2|STARTED|Test Period; Test D*||0
925565|NCT01514136|2237771|P1|STARTED|Test Period; Test D*||0
925566|NCT01514136|2237764|P8|NOT COMPLETED|Test Period 2; Test C*||0
925567|NCT01514136|2237765|P7|NOT COMPLETED|Test Period 2; Test C*||3
925568|NCT01514136|2237766|P6|NOT COMPLETED|Test Period 2; Test C*||0
925569|NCT01514136|2237767|P5|NOT COMPLETED|Test Period 2; Test C*||0
925570|NCT01514136|2237768|P4|NOT COMPLETED|Test Period 2; Test C*||0
925571|NCT01514136|2237769|P3|NOT COMPLETED|Test Period 2; Test C*||0
925572|NCT01514136|2237770|P2|NOT COMPLETED|Test Period 2; Test C*||0
925573|NCT01514136|2237771|P1|NOT COMPLETED|Test Period 2; Test C*||0
925574|NCT01514136|2237764|P8|COMPLETED|Test Period 2; Test C*||0
925575|NCT01514136|2237765|P7|COMPLETED|Test Period 2; Test C*||23
925576|NCT01514136|2237766|P6|COMPLETED|Test Period 2; Test C*||0
925577|NCT01514136|2237767|P5|COMPLETED|Test Period 2; Test C*||0
925578|NCT01514136|2237768|P4|COMPLETED|Test Period 2; Test C*||0
925579|NCT01514136|2237769|P3|COMPLETED|Test Period 2; Test C*||0
925580|NCT01514136|2237770|P2|COMPLETED|Test Period 2; Test C*||0
925581|NCT01514136|2237771|P1|COMPLETED|Test Period 2; Test C*||0
925582|NCT01514136|2237764|P8|STARTED|Test Period 2; Test C*||0
925583|NCT01514136|2237765|P7|STARTED|Test Period 2; Test C*||26
925584|NCT01514136|2237766|P6|STARTED|Test Period 2; Test C*||0
925585|NCT01514136|2237767|P5|STARTED|Test Period 2; Test C*||0
925586|NCT01514136|2237768|P4|STARTED|Test Period 2; Test C*||0
925587|NCT01514136|2237769|P3|STARTED|Test Period 2; Test C*||0
925588|NCT01514136|2237770|P2|STARTED|Test Period 2; Test C*||0
925589|NCT01514136|2237771|P1|STARTED|Test Period 2; Test C*||0
925590|NCT01514136|2237764|P8|NOT COMPLETED|Test Period 2; Test B*||0
925591|NCT01514136|2237765|P7|NOT COMPLETED|Test Period 2; Test B*||0
925592|NCT01514136|2237766|P6|NOT COMPLETED|Test Period 2; Test B*||2
925593|NCT01514136|2237767|P5|NOT COMPLETED|Test Period 2; Test B*||0
925594|NCT01514136|2237768|P4|NOT COMPLETED|Test Period 2; Test B*||0
925595|NCT01514136|2237769|P3|NOT COMPLETED|Test Period 2; Test B*||0
925596|NCT01514136|2237770|P2|NOT COMPLETED|Test Period 2; Test B*||0
925597|NCT01514136|2237771|P1|NOT COMPLETED|Test Period 2; Test B*||0
925598|NCT01514136|2237764|P8|COMPLETED|Test Period 2; Test B*||0
925599|NCT01514136|2237765|P7|COMPLETED|Test Period 2; Test B*||0
925600|NCT01514136|2237766|P6|COMPLETED|Test Period 2; Test B*||26
925601|NCT01514136|2237767|P5|COMPLETED|Test Period 2; Test B*||0
925602|NCT01514136|2237768|P4|COMPLETED|Test Period 2; Test B*||0
925603|NCT01514136|2237769|P3|COMPLETED|Test Period 2; Test B*||0
925604|NCT01514136|2237770|P2|COMPLETED|Test Period 2; Test B*||0
925605|NCT01514136|2237771|P1|COMPLETED|Test Period 2; Test B*||0
925606|NCT01514136|2237764|P8|STARTED|Test Period 2; Test B*||0
925607|NCT01514136|2237765|P7|STARTED|Test Period 2; Test B*||0
925608|NCT01514136|2237766|P6|STARTED|Test Period 2; Test B*|Two subjects did not test test A*, but had a break and continued again on Test B*|28
925609|NCT01514136|2237767|P5|STARTED|Test Period 2; Test B*||0
925610|NCT01514136|2237768|P4|STARTED|Test Period 2; Test B*||0
925611|NCT01514136|2237769|P3|STARTED|Test Period 2; Test B*||0
925612|NCT01514136|2237770|P2|STARTED|Test Period 2; Test B*||0
925613|NCT01514136|2237771|P1|STARTED|Test Period 2; Test B*||0
925614|NCT01514136|2237764|P8|NOT COMPLETED|Test Period 2; Test A*||0
925615|NCT01514136|2237765|P7|NOT COMPLETED|Test Period 2; Test A*||0
925616|NCT01514136|2237766|P6|NOT COMPLETED|Test Period 2; Test A*||0
925617|NCT01514136|2237767|P5|NOT COMPLETED|Test Period 2; Test A*||2
925618|NCT01514136|2237768|P4|NOT COMPLETED|Test Period 2; Test A*||0
925619|NCT01514136|2237769|P3|NOT COMPLETED|Test Period 2; Test A*||0
925620|NCT01514136|2237770|P2|NOT COMPLETED|Test Period 2; Test A*||0
925621|NCT01514136|2237771|P1|NOT COMPLETED|Test Period 2; Test A*||0
925622|NCT01514136|2237764|P8|COMPLETED|Test Period 2; Test A*||0
925623|NCT01514136|2237765|P7|COMPLETED|Test Period 2; Test A*||0
925624|NCT01514136|2237766|P6|COMPLETED|Test Period 2; Test A*||0
925625|NCT01514136|2237767|P5|COMPLETED|Test Period 2; Test A*||26
925626|NCT01514136|2237768|P4|COMPLETED|Test Period 2; Test A*||0
925627|NCT01514136|2237769|P3|COMPLETED|Test Period 2; Test A*||0
925628|NCT01514136|2237770|P2|COMPLETED|Test Period 2; Test A*||0
925629|NCT01514136|2237771|P1|COMPLETED|Test Period 2; Test A*||0
925630|NCT01514136|2237764|P8|STARTED|Test Period 2; Test A*||0
925631|NCT01514136|2237765|P7|STARTED|Test Period 2; Test A*||0
925632|NCT01514136|2237766|P6|STARTED|Test Period 2; Test A*||0
925633|NCT01514136|2237767|P5|STARTED|Test Period 2; Test A*|4 new subjects were included in the investigation|28
925634|NCT01514136|2237768|P4|STARTED|Test Period 2; Test A*||0
925635|NCT01514136|2237769|P3|STARTED|Test Period 2; Test A*||0
925636|NCT01514136|2237770|P2|STARTED|Test Period 2; Test A*||0
925637|NCT01514136|2237771|P1|STARTED|Test Period 2; Test A*||0
925638|NCT01514136|2237764|P8|NOT COMPLETED|Test Period 1; Test D||0
925639|NCT01514136|2237765|P7|NOT COMPLETED|Test Period 1; Test D||0
925640|NCT01514136|2237766|P6|NOT COMPLETED|Test Period 1; Test D||0
925641|NCT01514136|2237767|P5|NOT COMPLETED|Test Period 1; Test D||0
925642|NCT01514136|2237768|P4|NOT COMPLETED|Test Period 1; Test D||2
925643|NCT01514136|2237769|P3|NOT COMPLETED|Test Period 1; Test D||0
925644|NCT01514136|2237770|P2|NOT COMPLETED|Test Period 1; Test D||0
925645|NCT01514136|2237771|P1|NOT COMPLETED|Test Period 1; Test D||0
925646|NCT01514136|2237764|P8|COMPLETED|Test Period 1; Test D||0
925647|NCT01514136|2237765|P7|COMPLETED|Test Period 1; Test D||0
925648|NCT01514136|2237766|P6|COMPLETED|Test Period 1; Test D||0
925649|NCT01514136|2237767|P5|COMPLETED|Test Period 1; Test D||0
925650|NCT01514136|2237768|P4|COMPLETED|Test Period 1; Test D||24
925651|NCT01514136|2237769|P3|COMPLETED|Test Period 1; Test D||0
925652|NCT01514136|2237770|P2|COMPLETED|Test Period 1; Test D||0
925653|NCT01514136|2237771|P1|COMPLETED|Test Period 1; Test D||0
925654|NCT01514136|2237764|P8|STARTED|Test Period 1; Test D||0
925655|NCT01514136|2237765|P7|STARTED|Test Period 1; Test D||0
925656|NCT01514136|2237766|P6|STARTED|Test Period 1; Test D||0
925657|NCT01514136|2237767|P5|STARTED|Test Period 1; Test D||0
925658|NCT01514136|2237768|P4|STARTED|Test Period 1; Test D|The two subject that were on holiday after test A re-entered the investigation|26
925659|NCT01514136|2237769|P3|STARTED|Test Period 1; Test D||0
925660|NCT01514136|2237770|P2|STARTED|Test Period 1; Test D||0
925661|NCT01514136|2237771|P1|STARTED|Test Period 1; Test D||0
925662|NCT01514136|2237764|P8|NOT COMPLETED|Test Period 1; Test C||0
925663|NCT01514136|2237765|P7|NOT COMPLETED|Test Period 1; Test C||0
925664|NCT01514136|2237766|P6|NOT COMPLETED|Test Period 1; Test C||0
925665|NCT01514136|2237767|P5|NOT COMPLETED|Test Period 1; Test C||0
925666|NCT01514136|2237768|P4|NOT COMPLETED|Test Period 1; Test C||0
925667|NCT01514136|2237769|P3|NOT COMPLETED|Test Period 1; Test C||0
925668|NCT01514136|2237770|P2|NOT COMPLETED|Test Period 1; Test C||0
925669|NCT01514136|2237771|P1|NOT COMPLETED|Test Period 1; Test C||0
925670|NCT01514136|2237764|P8|COMPLETED|Test Period 1; Test C||0
925671|NCT01514136|2237765|P7|COMPLETED|Test Period 1; Test C||0
925672|NCT01514136|2237766|P6|COMPLETED|Test Period 1; Test C||0
925673|NCT01514136|2237767|P5|COMPLETED|Test Period 1; Test C||0
925674|NCT01514136|2237768|P4|COMPLETED|Test Period 1; Test C||0
925675|NCT01514136|2237769|P3|COMPLETED|Test Period 1; Test C||24
925676|NCT01514136|2237770|P2|COMPLETED|Test Period 1; Test C||0
925677|NCT01514136|2237771|P1|COMPLETED|Test Period 1; Test C||0
925678|NCT01514136|2237764|P8|STARTED|Test Period 1; Test C||0
925679|NCT01514136|2237765|P7|STARTED|Test Period 1; Test C||0
925680|NCT01514136|2237766|P6|STARTED|Test Period 1; Test C||0
925681|NCT01514136|2237767|P5|STARTED|Test Period 1; Test C||0
925682|NCT01514136|2237768|P4|STARTED|Test Period 1; Test C||0
925683|NCT01514136|2237769|P3|STARTED|Test Period 1; Test C|1 new subject was included in the investigation|24
925684|NCT01514136|2237770|P2|STARTED|Test Period 1; Test C||0
925685|NCT01514136|2237771|P1|STARTED|Test Period 1; Test C||0
925686|NCT01514136|2237764|P8|NOT COMPLETED|Test Period 1; Test B||0
925687|NCT01514136|2237765|P7|NOT COMPLETED|Test Period 1; Test B||0
925688|NCT01514136|2237766|P6|NOT COMPLETED|Test Period 1; Test B||0
925689|NCT01514136|2237767|P5|NOT COMPLETED|Test Period 1; Test B||0
925690|NCT01514136|2237768|P4|NOT COMPLETED|Test Period 1; Test B||0
925691|NCT01514136|2237769|P3|NOT COMPLETED|Test Period 1; Test B||0
925692|NCT01514136|2237770|P2|NOT COMPLETED|Test Period 1; Test B||1
925693|NCT01514136|2237771|P1|NOT COMPLETED|Test Period 1; Test B||0
925694|NCT01514136|2237764|P8|COMPLETED|Test Period 1; Test B||0
925695|NCT01514136|2237765|P7|COMPLETED|Test Period 1; Test B||0
925696|NCT01514136|2237766|P6|COMPLETED|Test Period 1; Test B||0
925697|NCT01514136|2237767|P5|COMPLETED|Test Period 1; Test B||0
925698|NCT01514136|2237768|P4|COMPLETED|Test Period 1; Test B||0
925699|NCT01514136|2237769|P3|COMPLETED|Test Period 1; Test B||0
925700|NCT01514136|2237770|P2|COMPLETED|Test Period 1; Test B||23
925701|NCT01514136|2237771|P1|COMPLETED|Test Period 1; Test B||0
925702|NCT01514136|2237764|P8|STARTED|Test Period 1; Test B||0
925703|NCT01514136|2237765|P7|STARTED|Test Period 1; Test B||0
925704|NCT01514136|2237766|P6|STARTED|Test Period 1; Test B||0
925705|NCT01514136|2237767|P5|STARTED|Test Period 1; Test B||0
925706|NCT01514136|2237768|P4|STARTED|Test Period 1; Test B||0
925707|NCT01514136|2237769|P3|STARTED|Test Period 1; Test B||0
925708|NCT01514136|2237770|P2|STARTED|Test Period 1; Test B|2 new subjects were entered the investigation|24
925709|NCT01514136|2237771|P1|STARTED|Test Period 1; Test B||0
925710|NCT01514136|2237764|P8|NOT COMPLETED|Test Period 1; Test A||0
925711|NCT01514136|2237765|P7|NOT COMPLETED|Test Period 1; Test A||0
925712|NCT01514136|2237766|P6|NOT COMPLETED|Test Period 1; Test A||0
925713|NCT01514136|2237767|P5|NOT COMPLETED|Test Period 1; Test A||0
925714|NCT01514136|2237768|P4|NOT COMPLETED|Test Period 1; Test A||0
925715|NCT01514136|2237769|P3|NOT COMPLETED|Test Period 1; Test A||0
925716|NCT01514136|2237770|P2|NOT COMPLETED|Test Period 1; Test A||0
925717|NCT01514136|2237771|P1|NOT COMPLETED|Test Period 1; Test A||3
925718|NCT01514136|2237764|P8|COMPLETED|Test Period 1; Test A||0
925719|NCT01514136|2237765|P7|COMPLETED|Test Period 1; Test A||0
925720|NCT01514136|2237766|P6|COMPLETED|Test Period 1; Test A||0
925721|NCT01514136|2237767|P5|COMPLETED|Test Period 1; Test A||0
925722|NCT01514136|2237768|P4|COMPLETED|Test Period 1; Test A||0
925723|NCT01514136|2237769|P3|COMPLETED|Test Period 1; Test A||0
925724|NCT01514136|2237770|P2|COMPLETED|Test Period 1; Test A||0
925725|NCT01514136|2237771|P1|COMPLETED|Test Period 1; Test A||22
925726|NCT01514136|2237764|P8|STARTED|Test Period 1; Test A||0
925727|NCT01514136|2237765|P7|STARTED|Test Period 1; Test A||0
925728|NCT01514136|2237766|P6|STARTED|Test Period 1; Test A||0
925729|NCT01514136|2237767|P5|STARTED|Test Period 1; Test A||0
925730|NCT01514136|2237768|P4|STARTED|Test Period 1; Test A||0
925731|NCT01514136|2237769|P3|STARTED|Test Period 1; Test A||0
925732|NCT01514136|2237770|P2|STARTED|Test Period 1; Test A||0
925733|NCT01514136|2237771|P1|STARTED|Test Period 1; Test A|26 subjects tested Test A|25
925734|NCT01513902|2237800|P3|NOT COMPLETED|Overall Study||0
925735|NCT01513902|2237801|P2|NOT COMPLETED|Overall Study||0
925736|NCT01513902|2237802|P1|NOT COMPLETED|Overall Study||0
925737|NCT01513902|2237800|P3|COMPLETED|Overall Study||9
925738|NCT01513902|2237801|P2|COMPLETED|Overall Study||9
925739|NCT01513902|2237802|P1|COMPLETED|Overall Study||8
925740|NCT01513902|2237800|P3|STARTED|Overall Study||9
925741|NCT01513902|2237801|P2|STARTED|Overall Study||9
925742|NCT01513902|2237802|P1|STARTED|Overall Study||8
925743|NCT01513590|2237839|P2|NOT COMPLETED|Overall Study||13
925744|NCT01513590|2237840|P1|NOT COMPLETED|Overall Study||10
925745|NCT01513590|2237839|P2|COMPLETED|Overall Study||184
925746|NCT01513590|2237840|P1|COMPLETED|Overall Study||187
925747|NCT01513590|2237839|P2|Exposed|Overall Study|"Two (2) subjects were withdrawn prior to exposure due to withdrawal of consent"|195
925748|NCT01513590|2237840|P1|Exposed|Overall Study|One (1) subject was withdrawn prior to exposure due to “non fulfilment of inclusion criteria”|196
925749|NCT01513590|2237839|P2|STARTED|Overall Study||197
925750|NCT01513590|2237840|P1|STARTED|Overall Study||197
925751|NCT01513473|2237860|P2|NOT COMPLETED|Extension Trial (26 Weeks)||6
925752|NCT01513473|2237861|P1|NOT COMPLETED|Extension Trial (26 Weeks)||1
925753|NCT01513473|2237860|P2|COMPLETED|Extension Trial (26 Weeks)||122
925754|NCT01513473|2237861|P1|COMPLETED|Extension Trial (26 Weeks)||151
925755|NCT01513473|2237860|P2|STARTED|Extension Trial (26 Weeks)|37 subjects did not consent to participate in the extension trial.|128
925756|NCT01513473|2237861|P1|STARTED|Extension Trial (26 Weeks)|18 subjects did not consent to participate in the extension trial.|152
925757|NCT01513473|2237860|P2|NOT COMPLETED|Main Trial (26 Weeks)||11
925758|NCT01513473|2237861|P1|NOT COMPLETED|Main Trial (26 Weeks)||4
925759|NCT01513473|2237860|P2|COMPLETED|Main Trial (26 Weeks)||165
925760|NCT01513473|2237861|P1|COMPLETED|Main Trial (26 Weeks)||170
925761|NCT01513473|2237860|P2|Exposed|Main Trial (26 Weeks)||175
925762|NCT01513473|2237861|P1|Exposed|Main Trial (26 Weeks)||174
925763|NCT01513473|2237860|P2|STARTED|Main Trial (26 Weeks)|1 subject was randomised but withdrew before the drug exposure.|176
925764|NCT01513473|2237861|P1|STARTED|Main Trial (26 Weeks)||174
925765|NCT01513460|2237888|P3|NOT COMPLETED|Overall Study||56
925766|NCT01513460|2237889|P2|NOT COMPLETED|Overall Study||32
925767|NCT01513460|2237890|P1|NOT COMPLETED|Overall Study||29
925768|NCT01513460|2237888|P3|COMPLETED|Overall Study||201
925769|NCT01513460|2237889|P2|COMPLETED|Overall Study||226
925770|NCT01513460|2237890|P1|COMPLETED|Overall Study||229
925771|NCT01513460|2237888|P3|Per-protocol Set|Overall Study||166
925772|NCT01513460|2237889|P2|Per-protocol Set|Overall Study||186
925773|NCT01513460|2237890|P1|Per-protocol Set|Overall Study||196
925774|NCT01513460|2237888|P3|Full Analysis Set|Overall Study||257
925775|NCT01513460|2237889|P2|Full Analysis Set|Overall Study||258
925776|NCT01513460|2237890|P1|Full Analysis Set|Overall Study||257
925777|NCT01513460|2237888|P3|STARTED|Overall Study||257
925778|NCT01513460|2237889|P2|STARTED|Overall Study||258
925779|NCT01513460|2237890|P1|STARTED|Overall Study||258
925780|NCT01513447|2237916|P2|NOT COMPLETED|Overall Study||0
925781|NCT01513447|2237917|P1|NOT COMPLETED|Overall Study||0
925782|NCT01513447|2237916|P2|COMPLETED|Overall Study||5
925783|NCT01513447|2237917|P1|COMPLETED|Overall Study||3
925784|NCT01513447|2237916|P2|STARTED|Overall Study||5
925785|NCT01513447|2237917|P1|STARTED|Overall Study||3
925786|NCT01513330|2237925|P2|NOT COMPLETED|Standard Care First,||4
925787|NCT01513330|2237926|P1|NOT COMPLETED|Standard Care First,||4
925788|NCT01513330|2237925|P2|COMPLETED|Standard Care First,||52
925789|NCT01513330|2237926|P1|COMPLETED|Standard Care First,||56
925790|NCT01513330|2237925|P2|STARTED|Standard Care First,||56
925791|NCT01513330|2237926|P1|STARTED|Standard Care First,||60
925792|NCT01513330|2237925|P2|NOT COMPLETED|SenSura Mio First,||2
925793|NCT01513330|2237926|P1|NOT COMPLETED|SenSura Mio First,||4
925794|NCT01513330|2237925|P2|COMPLETED|SenSura Mio First,||56
925795|NCT01513330|2237926|P1|COMPLETED|SenSura Mio First,||60
925796|NCT01513330|2237925|P2|STARTED|SenSura Mio First,||58
925797|NCT01513330|2237926|P1|STARTED|SenSura Mio First,||64
925798|NCT01513317|2237934|P2|NOT COMPLETED|Overall Study||24
925799|NCT01513317|2237935|P1|NOT COMPLETED|Overall Study||34
925800|NCT01513317|2237934|P2|COMPLETED|Overall Study||2
925801|NCT01513317|2237935|P1|COMPLETED|Overall Study||16
925802|NCT01513317|2237934|P2|STARTED|Overall Study||26
925803|NCT01513317|2237935|P1|STARTED|Overall Study||50
925804|NCT01513291|2237953|P5|NOT COMPLETED|Run-out Period||0
925805|NCT01513291|2237954|P4|NOT COMPLETED|Run-out Period||2
925806|NCT01513291|2237955|P3|NOT COMPLETED|Run-out Period||0
925807|NCT01513291|2237956|P2|NOT COMPLETED|Run-out Period||0
925808|NCT01513291|2237957|P1|NOT COMPLETED|Run-out Period||0
925809|NCT01513291|2237953|P5|COMPLETED|Run-out Period||101
925810|NCT01513291|2237954|P4|COMPLETED|Run-out Period||45
925811|NCT01513291|2237955|P3|COMPLETED|Run-out Period||50
925812|NCT01513291|2237956|P2|COMPLETED|Run-out Period||0
925813|NCT01513291|2237957|P1|COMPLETED|Run-out Period||0
925814|NCT01513291|2237953|P5|STARTED|Run-out Period|These participants were completers from the Treatment Period: Placebo group|101
925815|NCT01513291|2237954|P4|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|47
925816|NCT01513291|2237955|P3|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|50
925817|NCT01513291|2237956|P2|STARTED|Run-out Period||0
925818|NCT01513291|2237957|P1|STARTED|Run-out Period||0
925819|NCT01513291|2237953|P5|NOT COMPLETED|Treatment Period||0
925820|NCT01513291|2237954|P4|NOT COMPLETED|Treatment Period||0
925821|NCT01513291|2237955|P3|NOT COMPLETED|Treatment Period||0
925822|NCT01513291|2237956|P2|NOT COMPLETED|Treatment Period||16
925823|NCT01513291|2237957|P1|NOT COMPLETED|Treatment Period||23
925824|NCT01513291|2237953|P5|COMPLETED|Treatment Period||0
925825|NCT01513291|2237954|P4|COMPLETED|Treatment Period||0
925826|NCT01513291|2237955|P3|COMPLETED|Treatment Period||0
925827|NCT01513291|2237956|P2|COMPLETED|Treatment Period||101
925828|NCT01513291|2237957|P1|COMPLETED|Treatment Period||97
925829|NCT01513291|2237953|P5|Treated|Treatment Period||0
925830|NCT01513291|2237954|P4|Treated|Treatment Period||0
925831|NCT01513291|2237955|P3|Treated|Treatment Period||0
925832|NCT01513291|2237956|P2|Treated|Treatment Period||115
925833|NCT01513291|2237957|P1|Treated|Treatment Period||120
925834|NCT01513291|2237953|P5|STARTED|Treatment Period||0
925835|NCT01513291|2237954|P4|STARTED|Treatment Period||0
925836|NCT01513291|2237955|P3|STARTED|Treatment Period||0
925837|NCT01513291|2237956|P2|STARTED|Treatment Period||117
925838|NCT01513291|2237957|P1|STARTED|Treatment Period||120
925839|NCT01513239|2237985|P3|NOT COMPLETED|Overall Study||88
925840|NCT01513239|2237986|P2|NOT COMPLETED|Overall Study||70
925841|NCT01513239|2237987|P1|NOT COMPLETED|Overall Study||75
925842|NCT01513239|2237985|P3|COMPLETED|Overall Study||311
925843|NCT01513239|2237986|P2|COMPLETED|Overall Study||337
925844|NCT01513239|2237987|P1|COMPLETED|Overall Study||322
925845|NCT01513239|2237985|P3|All Participants as Treated|Overall Study|Treatment actually received|381
925846|NCT01513239|2237986|P2|All Participants as Treated|Overall Study|Treatment actually received|396
925847|NCT01513239|2237987|P1|All Participants as Treated|Overall Study|One participant randomized to receive MK-3415A (MK-3415 plus MK-6072) received only MK-3415|390
925848|NCT01513239|2237985|P3|Treated|Overall Study|Treated participants|381
925849|NCT01513239|2237986|P2|Treated|Overall Study|Treated participants|396
925850|NCT01513239|2237987|P1|Treated|Overall Study|Treated participants|391
925851|NCT01513239|2237985|P3|STARTED|Overall Study|Randomized participants|399
925852|NCT01513239|2237986|P2|STARTED|Overall Study|Randomized participants|407
925853|NCT01513239|2237987|P1|STARTED|Overall Study|Randomized participants|397
925854|NCT01513148|2238037|P2|NOT COMPLETED|Overall Study||2
925855|NCT01513148|2238038|P1|NOT COMPLETED|Overall Study||2
925856|NCT01513148|2238037|P2|COMPLETED|Overall Study||14
925857|NCT01513148|2238038|P1|COMPLETED|Overall Study||14
925858|NCT01513148|2238037|P2|STARTED|Overall Study||16
925859|NCT01513148|2238038|P1|STARTED|Overall Study||16
925860|NCT01513122|2238086|P2|NOT COMPLETED|Overall Study||3
925861|NCT01513122|2238087|P1|NOT COMPLETED|Overall Study||11
925862|NCT01513122|2238086|P2|COMPLETED|Overall Study||105
925863|NCT01513122|2238087|P1|COMPLETED|Overall Study||91
925864|NCT01513122|2238086|P2|STARTED|Overall Study||108
925865|NCT01513122|2238087|P1|STARTED|Overall Study||102
925866|NCT01512979|2238105|P2|NOT COMPLETED|Overall Study||22
925867|NCT01512979|2238106|P1|NOT COMPLETED|Overall Study||19
925868|NCT01512979|2238105|P2|COMPLETED|Overall Study||135
925869|NCT01512979|2238106|P1|COMPLETED|Overall Study||140
925870|NCT01512979|2238105|P2|STARTED|Overall Study|Randomised and treated|157
925871|NCT01512979|2238106|P1|STARTED|Overall Study|Randomised and treated|159
925872|NCT01512849|2238126|P4|NOT COMPLETED|Crossover Period 2||0
925873|NCT01512849|2238127|P3|NOT COMPLETED|Crossover Period 2||0
925874|NCT01512849|2238128|P2|NOT COMPLETED|Crossover Period 2||0
925875|NCT01512849|2238129|P1|NOT COMPLETED|Crossover Period 2||0
925876|NCT01512849|2238126|P4|COMPLETED|Crossover Period 2||6
925877|NCT01512849|2238127|P3|COMPLETED|Crossover Period 2||6
925878|NCT01512849|2238128|P2|COMPLETED|Crossover Period 2||6
925879|NCT01512849|2238129|P1|COMPLETED|Crossover Period 2||6
925880|NCT01512849|2238126|P4|STARTED|Crossover Period 2||6
925881|NCT01512849|2238127|P3|STARTED|Crossover Period 2||6
925882|NCT01512849|2238128|P2|STARTED|Crossover Period 2||6
925883|NCT01512849|2238129|P1|STARTED|Crossover Period 2||6
925884|NCT01512849|2238126|P4|NOT COMPLETED|Crossover Period 1||0
925885|NCT01512849|2238127|P3|NOT COMPLETED|Crossover Period 1||0
925886|NCT01512849|2238128|P2|NOT COMPLETED|Crossover Period 1||0
925887|NCT01512849|2238129|P1|NOT COMPLETED|Crossover Period 1||0
925888|NCT01512849|2238126|P4|COMPLETED|Crossover Period 1||6
925889|NCT01512849|2238127|P3|COMPLETED|Crossover Period 1||6
925890|NCT01512849|2238128|P2|COMPLETED|Crossover Period 1||6
925891|NCT01512849|2238129|P1|COMPLETED|Crossover Period 1||6
925892|NCT01512849|2238126|P4|STARTED|Crossover Period 1||6
925893|NCT01512849|2238127|P3|STARTED|Crossover Period 1||6
925894|NCT01512849|2238128|P2|STARTED|Crossover Period 1||6
925895|NCT01512849|2238129|P1|STARTED|Crossover Period 1||6
925896|NCT01512745|2238153|P2|NOT COMPLETED|Overall Study||20
925897|NCT01512745|2238154|P1|NOT COMPLETED|Overall Study||40
925898|NCT01512745|2238153|P2|COMPLETED|Overall Study||71
925899|NCT01512745|2238154|P1|COMPLETED|Overall Study||136
925900|NCT01512745|2238153|P2|STARTED|Overall Study||91
925901|NCT01512745|2238154|P1|STARTED|Overall Study||176
925902|NCT01512368|2238168|P1|NOT COMPLETED|Overall Study||3
925903|NCT01512368|2238168|P1|COMPLETED|Overall Study||60
925904|NCT01512368|2238168|P1|STARTED|Overall Study||63
925905|NCT01512225|2238179|P2|NOT COMPLETED|Overall Study||0
925906|NCT01512225|2238180|P1|NOT COMPLETED|Overall Study||0
925907|NCT01512225|2238179|P2|COMPLETED|Overall Study||45
925908|NCT01512225|2238180|P1|COMPLETED|Overall Study||45
925909|NCT01512225|2238179|P2|Provided Day 14 Volume|Overall Study||40
925910|NCT01512225|2238180|P1|Provided Day 14 Volume|Overall Study||45
925911|NCT01512225|2238179|P2|STARTED|Overall Study||45
925912|NCT01512225|2238180|P1|STARTED|Overall Study||45
925913|NCT01512160|2238204|P4|NOT COMPLETED|Overall Study||1
925914|NCT01512160|2238205|P3|NOT COMPLETED|Overall Study||0
925915|NCT01512160|2238206|P2|NOT COMPLETED|Overall Study||0
925916|NCT01512160|2238207|P1|NOT COMPLETED|Overall Study||2
925917|NCT01512160|2238204|P4|COMPLETED|Overall Study||22
925918|NCT01512160|2238205|P3|COMPLETED|Overall Study||22
925919|NCT01512160|2238206|P2|COMPLETED|Overall Study||23
925920|NCT01512160|2238207|P1|COMPLETED|Overall Study||20
925921|NCT01512160|2238204|P4|STARTED|Overall Study||23
925922|NCT01512160|2238205|P3|STARTED|Overall Study||22
925923|NCT01512160|2238206|P2|STARTED|Overall Study||23
925924|NCT01512160|2238207|P1|STARTED|Overall Study||22
925925|NCT01512108|2238299|P2|NOT COMPLETED|Overall Study||9
925926|NCT01512108|2238300|P1|NOT COMPLETED|Overall Study||22
925927|NCT01512108|2238299|P2|COMPLETED|Overall Study||111
925928|NCT01512108|2238300|P1|COMPLETED|Overall Study||221
925929|NCT01512108|2238299|P2|Exposed|Overall Study||120
925930|NCT01512108|2238300|P1|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|240
925931|NCT01512108|2238299|P2|STARTED|Overall Study||120
925932|NCT01512108|2238300|P1|STARTED|Overall Study||243
925933|NCT01511978|2238314|P2|NOT COMPLETED|Overall Study||0
925934|NCT01511978|2238315|P1|NOT COMPLETED|Overall Study||0
925935|NCT01511978|2238314|P2|COMPLETED|Overall Study||18
925936|NCT01511978|2238315|P1|COMPLETED|Overall Study||14
925937|NCT01511978|2238314|P2|STARTED|Overall Study||18
925938|NCT01511978|2238315|P1|STARTED|Overall Study||14
925939|NCT01511939|2238326|P3|NOT COMPLETED|Overall Study||0
925940|NCT01511939|2238327|P2|NOT COMPLETED|Overall Study||1
925941|NCT01511939|2238328|P1|NOT COMPLETED|Overall Study||2
925942|NCT01511939|2238326|P3|COMPLETED|Overall Study||8
925943|NCT01511939|2238327|P2|COMPLETED|Overall Study||4
925944|NCT01511939|2238328|P1|COMPLETED|Overall Study||7
925945|NCT01511939|2238326|P3|STARTED|Overall Study||8
925946|NCT01511939|2238327|P2|STARTED|Overall Study|Includes one patient who was also taking aspirin.|5
925947|NCT01511939|2238328|P1|STARTED|Overall Study|Includes 1 subject who was also taking aspirin.|9
925948|NCT01511809|2238347|P2|NOT COMPLETED|Overall Study||7
925949|NCT01511809|2238348|P1|NOT COMPLETED|Overall Study||7
925950|NCT01511809|2238347|P2|COMPLETED|Overall Study||52
925951|NCT01511809|2238348|P1|COMPLETED|Overall Study||51
925952|NCT01511809|2238347|P2|STARTED|Overall Study||59
925953|NCT01511809|2238348|P1|STARTED|Overall Study||58
925954|NCT01511536|2238357|P3|NOT COMPLETED|Phase 2||9
925955|NCT01511536|2238358|P2|NOT COMPLETED|Phase 2||0
925956|NCT01511536|2238359|P1|NOT COMPLETED|Phase 2||0
925957|NCT01511536|2238357|P3|COMPLETED|Phase 2|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|18
925958|NCT01511536|2238358|P2|COMPLETED|Phase 2||0
925959|NCT01511536|2238359|P1|COMPLETED|Phase 2||0
925960|NCT01511536|2238357|P3|STARTED|Phase 2||27
925961|NCT01511536|2238358|P2|STARTED|Phase 2||0
925962|NCT01511536|2238359|P1|STARTED|Phase 2||0
925963|NCT01511536|2238357|P3|NOT COMPLETED|Phase 1||0
925964|NCT01511536|2238358|P2|NOT COMPLETED|Phase 1||1
925965|NCT01511536|2238359|P1|NOT COMPLETED|Phase 1||0
925966|NCT01511536|2238357|P3|COMPLETED|Phase 1||0
925967|NCT01511536|2238358|P2|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|6
925968|NCT01511536|2238359|P1|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|3
925969|NCT01511536|2238357|P3|STARTED|Phase 1|Phase 1 and phase 2 are separate populations.|0
925970|NCT01511536|2238358|P2|STARTED|Phase 1||7
925971|NCT01511536|2238359|P1|STARTED|Phase 1||3
925972|NCT01511445|2238381|P2|NOT COMPLETED|Overall Study||4
925973|NCT01511445|2238382|P1|NOT COMPLETED|Overall Study||5
925974|NCT01511445|2238381|P2|COMPLETED|Overall Study|Data analysis was completed in February, 2016|47
925975|NCT01511445|2238382|P1|COMPLETED|Overall Study|Data analysis was completed in February, 2016|48
925976|NCT01511445|2238381|P2|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|47
925977|NCT01511445|2238382|P1|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|48
925978|NCT01511445|2238381|P2|Primary Completion October, 2014|Overall Study|3 protocol violations. 1 lost to follow-up.|47
925979|NCT01511445|2238382|P1|Primary Completion October, 2014|Overall Study|1 was excluded Bechterew's disease. 1 protocol violation. 3 were lost to follow-up.|48
925980|NCT01511445|2238381|P2|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|51
925981|NCT01511445|2238382|P1|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|53
925982|NCT01511445|2238381|P2|STARTED|Overall Study|Patient enrollment started in December, 2011.|51
925983|NCT01511445|2238382|P1|STARTED|Overall Study|Patient enrollment started in December, 2011.|53
925984|NCT01511315|2238390|P1|NOT COMPLETED|Overall Study||4
925985|NCT01511315|2238390|P1|COMPLETED|Overall Study||32
925986|NCT01511315|2238390|P1|STARTED|Overall Study||36
925987|NCT01511107|2238402|P2|NOT COMPLETED|Overall Study||41
925988|NCT01511107|2238403|P1|NOT COMPLETED|Overall Study||22
925989|NCT01511107|2238402|P2|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|219
925990|NCT01511107|2238403|P1|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|238
925991|NCT01511107|2238402|P2|STARTED|Overall Study|Randomized to the treatment group.|260
925992|NCT01511107|2238403|P1|STARTED|Overall Study|Randomized to the treatment group.|260
925993|NCT01511016|2238453|P2|NOT COMPLETED|Overall Study||2
925994|NCT01511016|2238454|P1|NOT COMPLETED|Overall Study||2
925995|NCT01511016|2238453|P2|COMPLETED|Overall Study||7
925996|NCT01511016|2238454|P1|COMPLETED|Overall Study||6
925997|NCT01511016|2238453|P2|STARTED|Overall Study||9
925998|NCT01511016|2238454|P1|STARTED|Overall Study||8
925999|NCT01510912|2238470|P1|NOT COMPLETED|Overall Study||242
926000|NCT01510912|2238470|P1|COMPLETED|Overall Study||360
926001|NCT01510912|2238470|P1|STARTED|Overall Study||602
926002|NCT01510834|2238476|P1|NOT COMPLETED|Overall Study||33
926003|NCT01510834|2238476|P1|COMPLETED|Overall Study||57
926004|NCT01510834|2238476|P1|STARTED|Overall Study||90
926005|NCT01510769|2238486|P3|NOT COMPLETED|Overall Study||22
926006|NCT01510769|2238487|P2|NOT COMPLETED|Overall Study||25
926007|NCT01510769|2238488|P1|NOT COMPLETED|Overall Study||27
926008|NCT01510769|2238486|P3|COMPLETED|Overall Study||87
926009|NCT01510769|2238487|P2|COMPLETED|Overall Study||84
926010|NCT01510769|2238488|P1|COMPLETED|Overall Study||79
926011|NCT01510769|2238486|P3|STARTED|Overall Study||109
926012|NCT01510769|2238487|P2|STARTED|Overall Study||109
926013|NCT01510769|2238488|P1|STARTED|Overall Study||106
926014|NCT01510756|2238505|P1|NOT COMPLETED|Overall Study||4
926015|NCT01510756|2238505|P1|COMPLETED|Overall Study||0
926016|NCT01510756|2238505|P1|STARTED|Overall Study||4
926017|NCT01510717|2238513|P2|NOT COMPLETED|Overall Study||5
926018|NCT01510717|2238514|P1|NOT COMPLETED|Overall Study||2
926019|NCT01510717|2238513|P2|COMPLETED|Overall Study||160
926020|NCT01510717|2238514|P1|COMPLETED|Overall Study||153
926021|NCT01510717|2238513|P2|STARTED|Overall Study||165
926022|NCT01510717|2238514|P1|STARTED|Overall Study||155
926023|NCT01510704|2238542|P4|NOT COMPLETED|Overall Study||0
926024|NCT01510704|2238543|P3|NOT COMPLETED|Overall Study||0
926025|NCT01510704|2238544|P2|NOT COMPLETED|Overall Study||0
926026|NCT01510704|2238545|P1|NOT COMPLETED|Overall Study||0
926027|NCT01510704|2238542|P4|COMPLETED|Overall Study||53
926028|NCT01510704|2238543|P3|COMPLETED|Overall Study||50
926029|NCT01510704|2238544|P2|COMPLETED|Overall Study||58
926030|NCT01510704|2238545|P1|COMPLETED|Overall Study||54
926031|NCT01510704|2238542|P4|STARTED|Overall Study||53
926032|NCT01510704|2238543|P3|STARTED|Overall Study||50
926033|NCT01510704|2238544|P2|STARTED|Overall Study||58
926034|NCT01510704|2238545|P1|STARTED|Overall Study||54
926035|NCT01510652|2238557|P2|NOT COMPLETED|Overall Study||67
926036|NCT01510652|2238558|P1|NOT COMPLETED|Overall Study||92
926037|NCT01510652|2238557|P2|COMPLETED|Overall Study||288
926038|NCT01510652|2238558|P1|COMPLETED|Overall Study||627
926039|NCT01510652|2238557|P2|Baseline|Overall Study||348
926040|NCT01510652|2238558|P1|Baseline|Overall Study||718
926041|NCT01510652|2238557|P2|STARTED|Overall Study||355
926042|NCT01510652|2238558|P1|STARTED|Overall Study||719
926043|NCT01510457|2238570|P2|NOT COMPLETED|Overall Study||3
926044|NCT01510457|2238571|P1|NOT COMPLETED|Overall Study||5
926045|NCT01510457|2238570|P2|COMPLETED|Overall Study||26
926046|NCT01510457|2238571|P1|COMPLETED|Overall Study||12
926047|NCT01510457|2238570|P2|STARTED|Overall Study||29
926048|NCT01510457|2238571|P1|STARTED|Overall Study||17
926049|NCT01510379|2238591|P2|NOT COMPLETED|Overall Study||0
926050|NCT01510379|2238592|P1|NOT COMPLETED|Overall Study||0
926051|NCT01510379|2238591|P2|COMPLETED|Overall Study||51
926052|NCT01510379|2238592|P1|COMPLETED|Overall Study||49
926053|NCT01510379|2238591|P2|STARTED|Overall Study||51
926054|NCT01510379|2238592|P1|STARTED|Overall Study||49
926055|NCT01510327|2238600|P1|NOT COMPLETED|Overall Study||0
926056|NCT01510327|2238600|P1|COMPLETED|Overall Study||22
926057|NCT01510327|2238600|P1|STARTED|Overall Study||22
926058|NCT01510158|2238634|P3|NOT COMPLETED|Overall Study||50
926059|NCT01510158|2238635|P2|NOT COMPLETED|Overall Study||53
926060|NCT01510158|2238636|P1|NOT COMPLETED|Overall Study||51
926061|NCT01510158|2238634|P3|COMPLETED|Overall Study||152
926062|NCT01510158|2238635|P2|COMPLETED|Overall Study||150
926063|NCT01510158|2238636|P1|COMPLETED|Overall Study||151
926064|NCT01510158|2238634|P3|STARTED|Overall Study||202
926065|NCT01510158|2238635|P2|STARTED|Overall Study||203
926066|NCT01510158|2238636|P1|STARTED|Overall Study||202
926067|NCT01510145|2238650|P1|NOT COMPLETED|Overall Study||18
926068|NCT01510145|2238650|P1|COMPLETED|Overall Study||173
926069|NCT01510145|2238650|P1|STARTED|Overall Study||191
926070|NCT01509807|2238657|P2|NOT COMPLETED|Overall Study||1
926071|NCT01509807|2238658|P1|NOT COMPLETED|Overall Study||1
926072|NCT01509807|2238657|P2|COMPLETED|Overall Study||16
926073|NCT01509807|2238658|P1|COMPLETED|Overall Study||15
926074|NCT01509807|2238657|P2|STARTED|Overall Study||17
926075|NCT01509807|2238658|P1|STARTED|Overall Study||16
926076|NCT01509664|2238684|P2|NOT COMPLETED|Overall Study||21
926077|NCT01509664|2238685|P1|NOT COMPLETED|Overall Study||15
926078|NCT01509664|2238684|P2|COMPLETED|Overall Study||28
926079|NCT01509664|2238685|P1|COMPLETED|Overall Study||34
926080|NCT01509664|2238684|P2|T3 Follow-up|Overall Study||33
926081|NCT01509664|2238685|P1|T3 Follow-up|Overall Study||40
926082|NCT01509664|2238684|P2|T2 Follow-up|Overall Study||38
926083|NCT01509664|2238685|P1|T2 Follow-up|Overall Study||45
926084|NCT01509664|2238684|P2|STARTED|Overall Study||49
926085|NCT01509664|2238685|P1|STARTED|Overall Study||49
926086|NCT01509638|2238693|P2|NOT COMPLETED|Overall Study||2
926087|NCT01509638|2238694|P1|NOT COMPLETED|Overall Study||3
926088|NCT01509638|2238693|P2|COMPLETED|Overall Study||24
926089|NCT01509638|2238694|P1|COMPLETED|Overall Study||20
926090|NCT01509638|2238693|P2|STARTED|Overall Study||26
926091|NCT01509638|2238694|P1|STARTED|Overall Study||23
926092|NCT01509625|2238718|P1|NOT COMPLETED|Overall Study||9
926093|NCT01509625|2238718|P1|COMPLETED|Overall Study||263
926094|NCT01509625|2238718|P1|STARTED|Overall Study||272
926095|NCT01509586|2238736|P2|NOT COMPLETED|Overall Study||0
926096|NCT01509586|2238737|P1|NOT COMPLETED|Overall Study||0
926097|NCT01509586|2238736|P2|COMPLETED|Overall Study|final intent to treat sample|610
926098|NCT01509586|2238737|P1|COMPLETED|Overall Study|final intent to treat sample|626
926099|NCT01509586|2238736|P2|Week 58 (Month 12)|Overall Study||499
926100|NCT01509586|2238737|P1|Week 58 (Month 12)|Overall Study||492
926101|NCT01509586|2238736|P2|Week 46|Overall Study||494
926102|NCT01509586|2238737|P1|Week 46|Overall Study||483
926103|NCT01509586|2238736|P2|Week 32 (Month 6)|Overall Study||523
926104|NCT01509586|2238737|P1|Week 32 (Month 6)|Overall Study||504
926105|NCT01509586|2238736|P2|Week18|Overall Study||555
926106|NCT01509586|2238737|P1|Week18|Overall Study||529
926107|NCT01509586|2238736|P2|Week 14|Overall Study||566
926108|NCT01509586|2238737|P1|Week 14|Overall Study||528
926109|NCT01509586|2238736|P2|Week 10|Overall Study||574
926110|NCT01509586|2238737|P1|Week 10|Overall Study||537
926111|NCT01509586|2238736|P2|Week 6|Overall Study||585
926112|NCT01509586|2238737|P1|Week 6|Overall Study||551
926113|NCT01509586|2238736|P2|Week 3|Overall Study||585
926114|NCT01509586|2238737|P1|Week 3|Overall Study||574
926115|NCT01509586|2238736|P2|STARTED|Overall Study|Week 0|610
926116|NCT01509586|2238737|P1|STARTED|Overall Study|Week 0|626
926117|NCT01509105|2238743|P1|NOT COMPLETED|Overall Study||0
926118|NCT01509105|2238743|P1|COMPLETED|Overall Study||649
926119|NCT01509105|2238743|P1|STARTED|Overall Study||649
926120|NCT01509079|2238760|P2|NOT COMPLETED|Overall Study||3
926121|NCT01509079|2238761|P1|NOT COMPLETED|Overall Study||0
926122|NCT01509079|2238760|P2|COMPLETED|Overall Study||56
926123|NCT01509079|2238761|P1|COMPLETED|Overall Study||57
926124|NCT01509079|2238760|P2|STARTED|Overall Study||59
926125|NCT01509079|2238761|P1|STARTED|Overall Study||57
926126|NCT01509053|2238777|P1|NOT COMPLETED|Aripiprazole IM Depot Extension Phase(C)||3
926127|NCT01509053|2238777|P1|COMPLETED|Aripiprazole IM Depot Extension Phase(C)||0
926128|NCT01509053|2238777|P1|STARTED|Aripiprazole IM Depot Extension Phase(C)||3
926129|NCT01509053|2238777|P1|NOT COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||16
926130|NCT01509053|2238777|P1|COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||3
926131|NCT01509053|2238777|P1|STARTED|Aripiprazole IM Depot Treatment Phase(B)|Includes 8 patients from Phase A + 11 patients who entered directly into Phase B.|19
926132|NCT01509053|2238777|P1|NOT COMPLETED|Oral Aripirazole (Phase A)||11
926133|NCT01509053|2238777|P1|COMPLETED|Oral Aripirazole (Phase A)||8
926134|NCT01509053|2238777|P1|STARTED|Oral Aripirazole (Phase A)||19
926135|NCT01509040|2238791|P3|NOT COMPLETED|Overall Study||0
926136|NCT01509040|2238792|P2|NOT COMPLETED|Overall Study||1
926137|NCT01509040|2238793|P1|NOT COMPLETED|Overall Study||0
926138|NCT01509040|2238791|P3|COMPLETED|Overall Study||0
926139|NCT01509040|2238792|P2|COMPLETED|Overall Study||1
926140|NCT01509040|2238793|P1|COMPLETED|Overall Study||0
926141|NCT01509040|2238791|P3|STARTED|Overall Study||0
926142|NCT01509040|2238792|P2|STARTED|Overall Study||2
926143|NCT01509040|2238793|P1|STARTED|Overall Study||0
926144|NCT01508936|2238839|P2|NOT COMPLETED|Overall Study||79
926145|NCT01508936|2238840|P1|NOT COMPLETED|Overall Study||23
926146|NCT01508936|2238839|P2|COMPLETED|Overall Study||330
926147|NCT01508936|2238840|P1|COMPLETED|Overall Study||79
926148|NCT01508936|2238839|P2|FEV1 Subpopulation Analysis Set|Overall Study||346
926149|NCT01508936|2238840|P1|FEV1 Subpopulation Analysis Set|Overall Study||91
926150|NCT01508936|2238839|P2|Full Analysis Set|Overall Study||395
926151|NCT01508936|2238840|P1|Full Analysis Set|Overall Study||97
926152|NCT01508936|2238839|P2|Safety Analysis Set|Overall Study||395
926153|NCT01508936|2238840|P1|Safety Analysis Set|Overall Study||97
926154|NCT01508936|2238839|P2|Randomized, Not Treated|Overall Study||3
926155|NCT01508936|2238840|P1|Randomized, Not Treated|Overall Study||1
926156|NCT01508936|2238839|P2|Randomized|Overall Study||398
926157|NCT01508936|2238840|P1|Randomized|Overall Study||98
926158|NCT01508936|2238839|P2|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|11
926159|NCT01508936|2238840|P1|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|4
926160|NCT01508936|2238839|P2|STARTED|Overall Study||409
926161|NCT01508936|2238840|P1|STARTED|Overall Study||102
926186|NCT01508832|2238906|P2|NOT COMPLETED|Overall Study||0
926187|NCT01508832|2238907|P1|NOT COMPLETED|Overall Study||0
926188|NCT01508832|2238906|P2|COMPLETED|Overall Study||6
926189|NCT01508832|2238907|P1|COMPLETED|Overall Study||6
926190|NCT01508832|2238906|P2|STARTED|Overall Study||6
926191|NCT01508832|2238907|P1|STARTED|Overall Study||6
926192|NCT01508702|2238915|P2|NOT COMPLETED|Overall Study||13
926193|NCT01508702|2238916|P1|NOT COMPLETED|Overall Study||23
926194|NCT01508702|2238915|P2|COMPLETED|Overall Study||94
926195|NCT01508702|2238916|P1|COMPLETED|Overall Study||84
926196|NCT01508702|2238915|P2|STARTED|Overall Study||107
926197|NCT01508702|2238916|P1|STARTED|Overall Study||107
926198|NCT01508676|2238924|P2|NOT COMPLETED|Phase II (2 Weeks)||1
926199|NCT01508676|2238925|P1|NOT COMPLETED|Phase II (2 Weeks)||1
926200|NCT01508676|2238924|P2|COMPLETED|Phase II (2 Weeks)||13
926201|NCT01508676|2238925|P1|COMPLETED|Phase II (2 Weeks)||15
926202|NCT01508676|2238924|P2|STARTED|Phase II (2 Weeks)||14
926203|NCT01508676|2238925|P1|STARTED|Phase II (2 Weeks)||16
926204|NCT01508676|2238924|P2|NOT COMPLETED|Washout Period (1 Week)||0
926205|NCT01508676|2238925|P1|NOT COMPLETED|Washout Period (1 Week)||0
926206|NCT01508676|2238924|P2|COMPLETED|Washout Period (1 Week)||14
926207|NCT01508676|2238925|P1|COMPLETED|Washout Period (1 Week)||16
926208|NCT01508676|2238924|P2|STARTED|Washout Period (1 Week)||14
926209|NCT01508676|2238925|P1|STARTED|Washout Period (1 Week)||16
926210|NCT01508676|2238924|P2|NOT COMPLETED|Phase I (2 Weeks)||3
926211|NCT01508676|2238925|P1|NOT COMPLETED|Phase I (2 Weeks)||2
926212|NCT01508676|2238924|P2|COMPLETED|Phase I (2 Weeks)||14
926213|NCT01508676|2238925|P1|COMPLETED|Phase I (2 Weeks)||16
926214|NCT01508676|2238924|P2|STARTED|Phase I (2 Weeks)||17
926215|NCT01508676|2238925|P1|STARTED|Phase I (2 Weeks)||18
926216|NCT01508455|2238935|P1|NOT COMPLETED|Overall Study||0
926217|NCT01508455|2238935|P1|COMPLETED|Overall Study||6
926218|NCT01508455|2238935|P1|STARTED|Overall Study||6
926219|NCT01508325|2238946|P2|NOT COMPLETED|Overall Study||21
926220|NCT01508325|2238947|P1|NOT COMPLETED|Overall Study||18
926221|NCT01508325|2238946|P2|COMPLETED|Overall Study||72
926222|NCT01508325|2238947|P1|COMPLETED|Overall Study||75
926223|NCT01508325|2238946|P2|STARTED|Overall Study||93
926224|NCT01508325|2238947|P1|STARTED|Overall Study||93
926225|NCT01508169|2238977|P2|NOT COMPLETED|Overall Study||2
926226|NCT01508169|2238978|P1|NOT COMPLETED|Overall Study||3
926227|NCT01508169|2238977|P2|COMPLETED|Overall Study||45
926228|NCT01508169|2238978|P1|COMPLETED|Overall Study||44
926229|NCT01508169|2238977|P2|STARTED|Overall Study||47
926230|NCT01508169|2238978|P1|STARTED|Overall Study||47
926231|NCT01508130|2238992|P2|NOT COMPLETED|Overall Study||69
926232|NCT01508130|2238993|P1|NOT COMPLETED|Overall Study||227
926233|NCT01508130|2238992|P2|COMPLETED|Overall Study||73
926234|NCT01508130|2238993|P1|COMPLETED|Overall Study||266
926235|NCT01508130|2238992|P2|mTRT|Overall Study||142
926236|NCT01508130|2238993|P1|mTRT|Overall Study||493
926237|NCT01508130|2238992|P2|STARTED|Overall Study||142
926238|NCT01508130|2238993|P1|STARTED|Overall Study||493
926239|NCT01508117|2239035|P1|NOT COMPLETED|Overall Study||0
926240|NCT01508117|2239035|P1|COMPLETED|Overall Study||1
926241|NCT01508117|2239035|P1|STARTED|Overall Study||1
926242|NCT01508052|2239041|P2|NOT COMPLETED|Overall Study||0
926243|NCT01508052|2239042|P1|NOT COMPLETED|Overall Study||0
926244|NCT01508052|2239041|P2|COMPLETED|Overall Study||20
926245|NCT01508052|2239042|P1|COMPLETED|Overall Study||20
926246|NCT01508052|2239041|P2|STARTED|Overall Study||20
926247|NCT01508052|2239042|P1|STARTED|Overall Study||20
926248|NCT01508013|2239050|P2|NOT COMPLETED|Overall Study||23
926249|NCT01508013|2239051|P1|NOT COMPLETED|Overall Study||32
926250|NCT01508013|2239050|P2|COMPLETED|Overall Study||206
926251|NCT01508013|2239051|P1|COMPLETED|Overall Study||182
926252|NCT01508013|2239050|P2|STARTED|Overall Study||229
926253|NCT01508013|2239051|P1|STARTED|Overall Study||214
926257|NCT01507831|2239104|P2|NOT COMPLETED|Overall Study||440
926258|NCT01507831|2239105|P1|NOT COMPLETED|Overall Study||193
926259|NCT01507831|2239104|P2|COMPLETED|Overall Study||1113
926260|NCT01507831|2239105|P1|COMPLETED|Overall Study||595
926261|NCT01507831|2239104|P2|Treated|Overall Study||1550
926262|NCT01507831|2239105|P1|Treated|Overall Study||788
926263|NCT01507831|2239104|P2|STARTED|Overall Study|Randomized|1553
926264|NCT01507831|2239105|P1|STARTED|Overall Study|Randomized|788
926265|NCT01507662|2239175|P2|NOT COMPLETED|Overall Study||831
926266|NCT01507662|2239176|P1|NOT COMPLETED|Overall Study||816
926267|NCT01507662|2239175|P2|COMPLETED|Overall Study||3020
926268|NCT01507662|2239176|P1|COMPLETED|Overall Study||3082
926269|NCT01507662|2239175|P2|STARTED|Overall Study||3851
926270|NCT01507662|2239176|P1|STARTED|Overall Study||3898
926271|NCT01507493|2239184|P2|NOT COMPLETED|Overall Study||0
926272|NCT01507493|2239185|P1|NOT COMPLETED|Overall Study||0
926273|NCT01507493|2239184|P2|COMPLETED|Overall Study||178
926274|NCT01507493|2239185|P1|COMPLETED|Overall Study||22
926275|NCT01507493|2239184|P2|STARTED|Overall Study||178
926276|NCT01507493|2239185|P1|STARTED|Overall Study||22
926277|NCT01507246|2239201|P2|NOT COMPLETED|Overall Study||1
926278|NCT01507246|2239202|P1|NOT COMPLETED|Overall Study||2
926279|NCT01507246|2239201|P2|COMPLETED|Overall Study||21
926280|NCT01507246|2239202|P1|COMPLETED|Overall Study||18
926281|NCT01507246|2239201|P2|STARTED|Overall Study||22
926282|NCT01507246|2239202|P1|STARTED|Overall Study||20
926283|NCT01507233|2239216|P2|NOT COMPLETED|Overall Study||0
926284|NCT01507233|2239217|P1|NOT COMPLETED|Overall Study||0
926285|NCT01507233|2239216|P2|COMPLETED|Overall Study||0
926286|NCT01507233|2239217|P1|COMPLETED|Overall Study||5
926287|NCT01507233|2239216|P2|STARTED|Overall Study||0
926288|NCT01507233|2239217|P1|STARTED|Overall Study||5
926289|NCT01507220|2239229|P2|NOT COMPLETED|Overall Study||0
926290|NCT01507220|2239230|P1|NOT COMPLETED|Overall Study||0
926291|NCT01507220|2239229|P2|COMPLETED|Overall Study||0
926292|NCT01507220|2239230|P1|COMPLETED|Overall Study||2
926293|NCT01507220|2239229|P2|STARTED|Overall Study||0
926294|NCT01507220|2239230|P1|STARTED|Overall Study||2
926295|NCT01507181|2239244|P2|NOT COMPLETED|Overall Study||0
926296|NCT01507181|2239245|P1|NOT COMPLETED|Overall Study||0
926297|NCT01507181|2239244|P2|COMPLETED|Overall Study||12
926298|NCT01507181|2239245|P1|COMPLETED|Overall Study||12
926299|NCT01507181|2239244|P2|STARTED|Overall Study||12
926300|NCT01507181|2239245|P1|STARTED|Overall Study||12
926301|NCT01507155|2239265|P2|NOT COMPLETED|Overall Study||0
926302|NCT01507155|2239266|P1|NOT COMPLETED|Overall Study||0
926303|NCT01507155|2239265|P2|COMPLETED|Overall Study||60
926304|NCT01507155|2239266|P1|COMPLETED|Overall Study||625
926305|NCT01507155|2239265|P2|STARTED|Overall Study||60
926306|NCT01507155|2239266|P1|STARTED|Overall Study||625
926307|NCT01507103|2239275|P3|NOT COMPLETED|Overall Study||0
926308|NCT01507103|2239276|P2|NOT COMPLETED|Overall Study||0
926309|NCT01507103|2239277|P1|NOT COMPLETED|Overall Study||0
926310|NCT01507103|2239275|P3|COMPLETED|Overall Study||42
926311|NCT01507103|2239276|P2|COMPLETED|Overall Study||41
926312|NCT01507103|2239277|P1|COMPLETED|Overall Study||41
926313|NCT01507103|2239275|P3|STARTED|Overall Study||42
926314|NCT01507103|2239276|P2|STARTED|Overall Study||41
926315|NCT01507103|2239277|P1|STARTED|Overall Study||41
926316|NCT01507090|2239300|P1|NOT COMPLETED|Overall Study||18
926317|NCT01507090|2239300|P1|COMPLETED|Overall Study||624
926318|NCT01507090|2239300|P1|STARTED|Overall Study||642
926319|NCT01507051|2239339|P4|NOT COMPLETED|Overall Study||7
926320|NCT01507051|2239340|P3|NOT COMPLETED|Overall Study||1
926321|NCT01507051|2239341|P2|NOT COMPLETED|Overall Study||3
926322|NCT01507051|2239342|P1|NOT COMPLETED|Overall Study||2
926323|NCT01507051|2239339|P4|COMPLETED|Overall Study||0
926324|NCT01507051|2239340|P3|COMPLETED|Overall Study||28
926325|NCT01507051|2239341|P2|COMPLETED|Overall Study||28
926326|NCT01507051|2239342|P1|COMPLETED|Overall Study||27
926327|NCT01507051|2239339|P4|Received Placebo or Rivaroxaban|Overall Study||0
926328|NCT01507051|2239340|P3|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG3|28
926329|NCT01507051|2239341|P2|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG2 and in RG4|28
926330|NCT01507051|2239342|P1|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG1 and in RG4 (RG = Reporting Group for Safety Data)|28
926331|NCT01507051|2239339|P4|Warfarin run-in Phase|Overall Study|Safety Population: in RG4|7
926332|NCT01507051|2239340|P3|Warfarin run-in Phase|Overall Study||0
926333|NCT01507051|2239341|P2|Warfarin run-in Phase|Overall Study||28
926334|NCT01507051|2239342|P1|Warfarin run-in Phase|Overall Study||28
926335|NCT01507051|2239339|P4|STARTED|Overall Study||7
926336|NCT01507051|2239340|P3|STARTED|Overall Study||29
926337|NCT01507051|2239341|P2|STARTED|Overall Study||31
926338|NCT01507051|2239342|P1|STARTED|Overall Study||29
926339|NCT01506960|2239460|P1|NOT COMPLETED|Overall Study||47
926340|NCT01506960|2239460|P1|COMPLETED|Overall Study||17
926341|NCT01506960|2239460|P1|STARTED|Overall Study||64
926342|NCT01506947|2239466|P1|NOT COMPLETED|Overall Study||16
926343|NCT01506947|2239466|P1|COMPLETED|Overall Study||49
926344|NCT01506947|2239466|P1|STARTED|Overall Study||65
926345|NCT01506908|2239484|P2|NOT COMPLETED|Overall Study||0
926346|NCT01506908|2239485|P1|NOT COMPLETED|Overall Study||1
926347|NCT01506908|2239484|P2|COMPLETED|Overall Study||161
926348|NCT01506908|2239485|P1|COMPLETED|Overall Study||161
926349|NCT01506908|2239484|P2|STARTED|Overall Study||161
926350|NCT01506908|2239485|P1|STARTED|Overall Study||162
926351|NCT01506882|2239503|P2|NOT COMPLETED|Overall Study||7
926352|NCT01506882|2239504|P1|NOT COMPLETED|Overall Study||22
926353|NCT01506882|2239503|P2|COMPLETED|Overall Study||3
926354|NCT01506882|2239504|P1|COMPLETED|Overall Study||39
926355|NCT01506882|2239503|P2|STARTED|Overall Study||10
926356|NCT01506882|2239504|P1|STARTED|Overall Study||61
926357|NCT01506726|2239518|P2|NOT COMPLETED|Overall Study||2
926358|NCT01506726|2239519|P1|NOT COMPLETED|Overall Study||1
926359|NCT01506726|2239518|P2|COMPLETED|Overall Study||3
926360|NCT01506726|2239519|P1|COMPLETED|Overall Study||5
926361|NCT01506726|2239518|P2|STARTED|Overall Study||5
926362|NCT01506726|2239519|P1|STARTED|Overall Study||6
926363|NCT01506596|2239559|P1|NOT COMPLETED|Overall Study||1
926364|NCT01506596|2239559|P1|COMPLETED|Overall Study|One enrolled patient had ineligible pathology after starting treatment; was removed from treatment.|41
926365|NCT01506596|2239559|P1|STARTED|Overall Study||42
926366|NCT01506362|2239567|P1|NOT COMPLETED|Overall Study||6
926367|NCT01506362|2239567|P1|COMPLETED|Overall Study||16
926368|NCT01506362|2239567|P1|STARTED|Overall Study||22
926369|NCT01506323|2239573|P2|NOT COMPLETED|Overall Study||13
926370|NCT01506323|2239574|P1|NOT COMPLETED|Overall Study||24
926371|NCT01506323|2239573|P2|COMPLETED|Overall Study||71
926372|NCT01506323|2239574|P1|COMPLETED|Overall Study||65
926373|NCT01506323|2239573|P2|Post-treatment Completed CAPS|Overall Study||72
926374|NCT01506323|2239574|P1|Post-treatment Completed CAPS|Overall Study||68
926375|NCT01506323|2239573|P2|Post-treatment Completers|Overall Study||72
926376|NCT01506323|2239574|P1|Post-treatment Completers|Overall Study||69
926377|NCT01506323|2239573|P2|STARTED|Overall Study||84
926378|NCT01506323|2239574|P1|STARTED|Overall Study||89
926379|NCT01506193|2239603|P3|NOT COMPLETED|Overall Study||14
926380|NCT01506193|2239604|P2|NOT COMPLETED|Overall Study||4
926381|NCT01506193|2239605|P1|NOT COMPLETED|Overall Study||14
926382|NCT01506193|2239603|P3|COMPLETED|Overall Study||168
926383|NCT01506193|2239604|P2|COMPLETED|Overall Study||179
926384|NCT01506193|2239605|P1|COMPLETED|Overall Study||337
926385|NCT01506193|2239603|P3|STARTED|Overall Study||182
926386|NCT01506193|2239604|P2|STARTED|Overall Study||183
926387|NCT01506193|2239605|P1|STARTED|Overall Study||351
926388|NCT01505881|2239638|P2|NOT COMPLETED|Overall Study||1
926389|NCT01505881|2239639|P1|NOT COMPLETED|Overall Study||4
926390|NCT01505881|2239638|P2|COMPLETED|Overall Study||58
926391|NCT01505881|2239639|P1|COMPLETED|Overall Study||95
926392|NCT01505881|2239638|P2|STARTED|Overall Study||59
926393|NCT01505881|2239639|P1|STARTED|Overall Study||99
926394|NCT01505764|2239653|P2|NOT COMPLETED|Overall Study||1
926395|NCT01505764|2239654|P1|NOT COMPLETED|Overall Study||3
926396|NCT01505764|2239653|P2|COMPLETED|Overall Study||2
926397|NCT01505764|2239654|P1|COMPLETED|Overall Study||3
926398|NCT01505764|2239653|P2|STARTED|Overall Study||3
926399|NCT01505764|2239654|P1|STARTED|Overall Study||6
926400|NCT01505647|2239662|P2|NOT COMPLETED|Day 43 Through Day 182 Follow-up||3
926401|NCT01505647|2239663|P1|NOT COMPLETED|Day 43 Through Day 182 Follow-up||1
926402|NCT01505647|2239662|P2|COMPLETED|Day 43 Through Day 182 Follow-up||163
926403|NCT01505647|2239663|P1|COMPLETED|Day 43 Through Day 182 Follow-up||328
926404|NCT01505647|2239662|P2|STARTED|Day 43 Through Day 182 Follow-up||166
926405|NCT01505647|2239663|P1|STARTED|Day 43 Through Day 182 Follow-up||329
926406|NCT01505647|2239662|P2|NOT COMPLETED|Day 1 Through Day 42 Follow-up||0
926407|NCT01505647|2239663|P1|NOT COMPLETED|Day 1 Through Day 42 Follow-up||3
926408|NCT01505647|2239662|P2|COMPLETED|Day 1 Through Day 42 Follow-up||166
926409|NCT01505647|2239663|P1|COMPLETED|Day 1 Through Day 42 Follow-up||329
926410|NCT01505647|2239662|P2|Vaccinated|Day 1 Through Day 42 Follow-up||166
926411|NCT01505647|2239663|P1|Vaccinated|Day 1 Through Day 42 Follow-up||331
926412|NCT01505647|2239662|P2|STARTED|Day 1 Through Day 42 Follow-up||166
926413|NCT01505647|2239663|P1|STARTED|Day 1 Through Day 42 Follow-up||332
926414|NCT01505608|2239679|P2|NOT COMPLETED|Phase II||2
926415|NCT01505608|2239680|P1|NOT COMPLETED|Phase II||2
926416|NCT01505608|2239679|P2|COMPLETED|Phase II||2
926417|NCT01505608|2239680|P1|COMPLETED|Phase II||0
926418|NCT01505608|2239679|P2|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|4
926419|NCT01505608|2239680|P1|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|2
926420|NCT01505608|2239679|P2|NOT COMPLETED|Phase I||6
926421|NCT01505608|2239680|P1|NOT COMPLETED|Phase I||0
926422|NCT01505608|2239679|P2|COMPLETED|Phase I||2
926423|NCT01505608|2239680|P1|COMPLETED|Phase I||0
926424|NCT01505608|2239679|P2|STARTED|Phase I||8
926425|NCT01505608|2239680|P1|STARTED|Phase I|Randomization to Arm A began in Phase 2. All patients in Phase I were enrolled to receive TPI 287.|0
926426|NCT01505465|2239698|P2|NOT COMPLETED|Overall Study||7
926427|NCT01505465|2239699|P1|NOT COMPLETED|Overall Study||6
926428|NCT01505465|2239698|P2|COMPLETED|Overall Study||18
926429|NCT01505465|2239699|P1|COMPLETED|Overall Study||19
926430|NCT01505465|2239698|P2|STARTED|Overall Study||25
926431|NCT01505465|2239699|P1|STARTED|Overall Study||25
926432|NCT01505387|2239715|P2|NOT COMPLETED|Overall Study||1
926433|NCT01505387|2239716|P1|NOT COMPLETED|Overall Study||2
926434|NCT01505387|2239715|P2|COMPLETED|Overall Study||24
926435|NCT01505387|2239716|P1|COMPLETED|Overall Study|1 subject not included in intention to treat population as violated inclusion criteria|23
926436|NCT01505387|2239715|P2|Treated|Overall Study||24
926437|NCT01505387|2239716|P1|Treated|Overall Study||24
926438|NCT01505387|2239715|P2|STARTED|Overall Study||25
926439|NCT01505387|2239716|P1|STARTED|Overall Study||25
926440|NCT01505374|2239722|P2|NOT COMPLETED|Overall Study||0
926441|NCT01505374|2239723|P1|NOT COMPLETED|Overall Study||1
926442|NCT01505374|2239722|P2|COMPLETED|Overall Study||30
926443|NCT01505374|2239723|P1|COMPLETED|Overall Study||29
926444|NCT01505374|2239722|P2|STARTED|Overall Study||30
926445|NCT01505374|2239723|P1|STARTED|Overall Study||30
926446|NCT01505114|2239741|P4|NOT COMPLETED|Overall Study||23
926447|NCT01505114|2239742|P3|NOT COMPLETED|Overall Study||18
926448|NCT01505114|2239743|P2|NOT COMPLETED|Overall Study||13
926449|NCT01505114|2239744|P1|NOT COMPLETED|Overall Study||25
926450|NCT01505114|2239741|P4|COMPLETED|Overall Study||128
926451|NCT01505114|2239742|P3|COMPLETED|Overall Study||129
926452|NCT01505114|2239743|P2|COMPLETED|Overall Study||135
926453|NCT01505114|2239744|P1|COMPLETED|Overall Study||123
926454|NCT01505114|2239741|P4|STARTED|Overall Study||151
926455|NCT01505114|2239742|P3|STARTED|Overall Study||147
926456|NCT01505114|2239743|P2|STARTED|Overall Study||148
926457|NCT01505114|2239744|P1|STARTED|Overall Study||148
926458|NCT01504997|2239754|P1|NOT COMPLETED|Overall Study||0
926459|NCT01504997|2239754|P1|COMPLETED|Overall Study||18
926460|NCT01504997|2239754|P1|STARTED|Overall Study||18
926461|NCT01504971|2239758|P1|NOT COMPLETED|Overall Study||13
926462|NCT01504971|2239758|P1|COMPLETED|Overall Study||82
926463|NCT01504971|2239758|P1|STARTED|Overall Study||95
926464|NCT01504958|2239769|P3|NOT COMPLETED|Overall Study||0
926465|NCT01504958|2239770|P2|NOT COMPLETED|Overall Study||0
926466|NCT01504958|2239771|P1|NOT COMPLETED|Overall Study||0
926467|NCT01504958|2239769|P3|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
926468|NCT01504958|2239770|P2|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
926469|NCT01504958|2239771|P1|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|10
926470|NCT01504958|2239769|P3|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
926471|NCT01504958|2239770|P2|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
926472|NCT01504958|2239771|P1|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|10
926473|NCT01504867|2239787|P2|NOT COMPLETED|Overall Study||3
926474|NCT01504867|2239788|P1|NOT COMPLETED|Overall Study||7
926475|NCT01504867|2239787|P2|COMPLETED|Overall Study||195
926476|NCT01504867|2239788|P1|COMPLETED|Overall Study||195
926477|NCT01504867|2239787|P2|STARTED|Overall Study||198
926478|NCT01504867|2239788|P1|STARTED|Overall Study||202
926479|NCT01504854|2239808|P2|NOT COMPLETED|Overall Study||7
926480|NCT01504854|2239809|P1|NOT COMPLETED|Overall Study||8
926481|NCT01504854|2239808|P2|COMPLETED|Overall Study||48
926482|NCT01504854|2239809|P1|COMPLETED|Overall Study||56
926483|NCT01504854|2239808|P2|STARTED|Overall Study||55
926484|NCT01504854|2239809|P1|STARTED|Overall Study||64
926485|NCT01503749|2239826|P3|NOT COMPLETED|Overall Study||0
926486|NCT01503749|2239827|P2|NOT COMPLETED|Overall Study||0
926487|NCT01503749|2239828|P1|NOT COMPLETED|Overall Study||0
926488|NCT01503749|2239826|P3|COMPLETED|Overall Study||3
926489|NCT01503749|2239827|P2|COMPLETED|Overall Study||3
926490|NCT01503749|2239828|P1|COMPLETED|Overall Study||3
926491|NCT01503749|2239826|P3|STARTED|Overall Study||3
926492|NCT01503749|2239827|P2|STARTED|Overall Study||3
926493|NCT01503749|2239828|P1|STARTED|Overall Study||3
926494|NCT01503021|2239841|P2|NOT COMPLETED|Overall Study||26
926495|NCT01503021|2239842|P1|NOT COMPLETED|Overall Study||27
926496|NCT01503021|2239841|P2|COMPLETED|Overall Study||332
926497|NCT01503021|2239842|P1|COMPLETED|Overall Study||333
926498|NCT01503021|2239841|P2|Completed Treatment|Overall Study|One patient completed the treatment period but discontinued prior to completing the follow-up visit.|333
926499|NCT01503021|2239842|P1|Completed Treatment|Overall Study||333
926500|NCT01503021|2239841|P2|Dosed|Overall Study||352
926501|NCT01503021|2239842|P1|Dosed|Overall Study||351
926502|NCT01503021|2239841|P2|STARTED|Overall Study||358
926503|NCT01503021|2239842|P1|STARTED|Overall Study||360
926504|NCT01502787|2239889|P2|NOT COMPLETED|Overall Study||0
926505|NCT01502787|2239890|P1|NOT COMPLETED|Overall Study||0
926506|NCT01502787|2239889|P2|COMPLETED|Overall Study||10
926507|NCT01502787|2239890|P1|COMPLETED|Overall Study||11
926508|NCT01502787|2239889|P2|STARTED|Overall Study||10
926509|NCT01502787|2239890|P1|STARTED|Overall Study||11
926510|NCT01502761|2239900|P4|NOT COMPLETED|Overall Study||0
926511|NCT01502761|2239901|P3|NOT COMPLETED|Overall Study||0
926512|NCT01502761|2239902|P2|NOT COMPLETED|Overall Study||0
926513|NCT01502761|2239903|P1|NOT COMPLETED|Overall Study||0
926514|NCT01502761|2239900|P4|COMPLETED|Overall Study||0
926515|NCT01502761|2239901|P3|COMPLETED|Overall Study||0
926516|NCT01502761|2239902|P2|COMPLETED|Overall Study||0
926517|NCT01502761|2239903|P1|COMPLETED|Overall Study||4
926518|NCT01502761|2239900|P4|STARTED|Overall Study||0
926519|NCT01502761|2239901|P3|STARTED|Overall Study||0
926520|NCT01502761|2239902|P2|STARTED|Overall Study||0
926521|NCT01502761|2239903|P1|STARTED|Overall Study||4
926522|NCT01502709|2239919|P2|NOT COMPLETED|Overall Study||0
926523|NCT01502709|2239920|P1|NOT COMPLETED|Overall Study||4
926524|NCT01502709|2239919|P2|COMPLETED|Overall Study||0
926525|NCT01502709|2239920|P1|COMPLETED|Overall Study||1
926526|NCT01502709|2239919|P2|STARTED|Overall Study||0
926527|NCT01502709|2239920|P1|STARTED|Overall Study||5
926528|NCT01502644|2239933|P4|NOT COMPLETED|Assigned to NA Groups||8
926529|NCT01502644|2239934|P3|NOT COMPLETED|Assigned to NA Groups||3
926530|NCT01502644|2239935|P2|NOT COMPLETED|Assigned to NA Groups||6
926531|NCT01502644|2239936|P1|NOT COMPLETED|Assigned to NA Groups||0
926532|NCT01502644|2239933|P4|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
926533|NCT01502644|2239934|P3|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|7
926534|NCT01502644|2239935|P2|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
926535|NCT01502644|2239936|P1|COMPLETED|Assigned to NA Groups||0
926536|NCT01502644|2239933|P4|STARTED|Assigned to NA Groups||32
926537|NCT01502644|2239934|P3|STARTED|Assigned to NA Groups||10
926538|NCT01502644|2239935|P2|STARTED|Assigned to NA Groups||30
926539|NCT01502644|2239936|P1|STARTED|Assigned to NA Groups||0
926540|NCT01502644|2239933|P4|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
926541|NCT01502644|2239934|P3|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
926542|NCT01502644|2239935|P2|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
926543|NCT01502644|2239936|P1|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||9
926544|NCT01502644|2239933|P4|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
926545|NCT01502644|2239934|P3|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
926546|NCT01502644|2239935|P2|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
926547|NCT01502644|2239936|P1|COMPLETED|Enrolled at Visit 1 After Pre-screening|Participants who completed Visit 1 were assigned to 1 of the 3 NA groups for remainder of the trial|72
926548|NCT01502644|2239933|P4|STARTED|Enrolled at Visit 1 After Pre-screening||0
926549|NCT01502644|2239934|P3|STARTED|Enrolled at Visit 1 After Pre-screening||0
926550|NCT01502644|2239935|P2|STARTED|Enrolled at Visit 1 After Pre-screening||0
926551|NCT01502644|2239936|P1|STARTED|Enrolled at Visit 1 After Pre-screening||81
926552|NCT01502423|2239946|P2|NOT COMPLETED|Overall Study||1
926553|NCT01502423|2239947|P1|NOT COMPLETED|Overall Study||0
926554|NCT01502423|2239946|P2|COMPLETED|Overall Study||29
926555|NCT01502423|2239947|P1|COMPLETED|Overall Study||31
926556|NCT01502423|2239946|P2|STARTED|Overall Study||30
926557|NCT01502423|2239947|P1|STARTED|Overall Study||31
926558|NCT01502410|2239969|P4|NOT COMPLETED|Overall Study||0
926559|NCT01502410|2239970|P3|NOT COMPLETED|Overall Study||0
926560|NCT01502410|2239971|P2|NOT COMPLETED|Overall Study||10
926561|NCT01502410|2239972|P1|NOT COMPLETED|Overall Study||10
926562|NCT01502410|2239969|P4|COMPLETED|Overall Study||0
926563|NCT01502410|2239970|P3|COMPLETED|Overall Study||0
926564|NCT01502410|2239971|P2|COMPLETED|Overall Study||0
926565|NCT01502410|2239972|P1|COMPLETED|Overall Study||0
926566|NCT01502410|2239969|P4|STARTED|Overall Study||0
926567|NCT01502410|2239970|P3|STARTED|Overall Study||0
926568|NCT01502410|2239971|P2|STARTED|Overall Study||10
926569|NCT01502410|2239972|P1|STARTED|Overall Study||10
926570|NCT01502371|2239985|P5|NOT COMPLETED|Overall Study||52
926571|NCT01502371|2239986|P4|NOT COMPLETED|Overall Study||37
926572|NCT01502371|2239987|P3|NOT COMPLETED|Overall Study||25
926573|NCT01502371|2239988|P2|NOT COMPLETED|Overall Study||32
926574|NCT01502371|2239989|P1|NOT COMPLETED|Overall Study||41
926575|NCT01502371|2239985|P5|COMPLETED|Overall Study||60
926576|NCT01502371|2239986|P4|COMPLETED|Overall Study||88
926577|NCT01502371|2239987|P3|COMPLETED|Overall Study||83
926578|NCT01502371|2239988|P2|COMPLETED|Overall Study||81
926579|NCT01502371|2239989|P1|COMPLETED|Overall Study||79
926580|NCT01502371|2239985|P5|STARTED|Overall Study||112
926581|NCT01502371|2239986|P4|STARTED|Overall Study||125
926582|NCT01502371|2239987|P3|STARTED|Overall Study||108
926583|NCT01502371|2239988|P2|STARTED|Overall Study||113
926584|NCT01502371|2239989|P1|STARTED|Overall Study||120
926585|NCT01502332|2240014|P2|NOT COMPLETED|Overall Study||0
926586|NCT01502332|2240015|P1|NOT COMPLETED|Overall Study||0
926587|NCT01502332|2240014|P2|COMPLETED|Overall Study||163
926588|NCT01502332|2240015|P1|COMPLETED|Overall Study||157
926589|NCT01502332|2240014|P2|STARTED|Overall Study||163
926590|NCT01502332|2240015|P1|STARTED|Overall Study||157
926591|NCT01502228|2240029|P1|NOT COMPLETED|Overall Study||1
926592|NCT01502228|2240029|P1|COMPLETED|Overall Study||13
926593|NCT01502228|2240029|P1|STARTED|Overall Study||14
926594|NCT01502033|2240034|P1|NOT COMPLETED|Overall Study||3
926595|NCT01502033|2240034|P1|COMPLETED|Overall Study|Milestone (10 participants) met|7
926596|NCT01502033|2240034|P1|STARTED|Overall Study|Milestone (10 participants) met.|10
926597|NCT01501162|2240042|P2|NOT COMPLETED|Overall Study||5
926598|NCT01501162|2240043|P1|NOT COMPLETED|Overall Study||8
926599|NCT01501162|2240042|P2|COMPLETED|Overall Study||60
926600|NCT01501162|2240043|P1|COMPLETED|Overall Study||57
926601|NCT01501162|2240042|P2|STARTED|Overall Study||65
926602|NCT01501162|2240043|P1|STARTED|Overall Study||65
926603|NCT01501110|2240053|P2|NOT COMPLETED|Overall Study||1
926604|NCT01501110|2240054|P1|NOT COMPLETED|Overall Study||0
926605|NCT01501110|2240053|P2|COMPLETED|Overall Study||33
926606|NCT01501110|2240054|P1|COMPLETED|Overall Study||34
926607|NCT01501110|2240053|P2|STARTED|Overall Study||34
926608|NCT01501110|2240054|P1|STARTED|Overall Study||34
926609|NCT01500772|2240060|P1|NOT COMPLETED|Overall Study||6
926610|NCT01500772|2240060|P1|COMPLETED|Overall Study||0
926611|NCT01500772|2240060|P1|STARTED|Overall Study||6
926612|NCT01500746|2240069|P2|NOT COMPLETED|Overall Study||0
926613|NCT01500746|2240070|P1|NOT COMPLETED|Overall Study||0
926614|NCT01500746|2240069|P2|COMPLETED|Overall Study||4
926615|NCT01500746|2240070|P1|COMPLETED|Overall Study||4
926616|NCT01500746|2240069|P2|STARTED|Overall Study||4
926617|NCT01500746|2240070|P1|STARTED|Overall Study||4
926618|NCT01500720|2240078|P2|NOT COMPLETED|Overall Study||9
926619|NCT01500720|2240079|P1|NOT COMPLETED|Overall Study||5
926620|NCT01500720|2240078|P2|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|80
926621|NCT01500720|2240079|P1|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|85
926622|NCT01500720|2240078|P2|Treated|Overall Study||88
926623|NCT01500720|2240079|P1|Treated|Overall Study||89
926624|NCT01500720|2240078|P2|STARTED|Overall Study|Randomized|89
926625|NCT01500720|2240079|P1|STARTED|Overall Study|Randomized|90
926626|NCT01500694|2240093|P2|NOT COMPLETED|Overall Study||29
926627|NCT01500694|2240094|P1|NOT COMPLETED|Overall Study||52
926628|NCT01500694|2240093|P2|COMPLETED|Overall Study||54
926629|NCT01500694|2240094|P1|COMPLETED|Overall Study||79
926630|NCT01500694|2240093|P2|STARTED|Overall Study|Participants who received treatment were reported as Started.|83
926631|NCT01500694|2240094|P1|STARTED|Overall Study||131
926632|NCT01500629|2240120|P2|NOT COMPLETED|Period 2 (Single Dose)||0
926633|NCT01500629|2240121|P1|NOT COMPLETED|Period 2 (Single Dose)||0
926634|NCT01500629|2240120|P2|COMPLETED|Period 2 (Single Dose)||10
926635|NCT01500629|2240121|P1|COMPLETED|Period 2 (Single Dose)||10
926636|NCT01500629|2240120|P2|STARTED|Period 2 (Single Dose)||10
926637|NCT01500629|2240121|P1|STARTED|Period 2 (Single Dose)||10
926638|NCT01500629|2240120|P2|NOT COMPLETED|Washout Period of 14 to 30 Days||0
926639|NCT01500629|2240121|P1|NOT COMPLETED|Washout Period of 14 to 30 Days||1
926640|NCT01500629|2240120|P2|COMPLETED|Washout Period of 14 to 30 Days||10
926641|NCT01500629|2240121|P1|COMPLETED|Washout Period of 14 to 30 Days||10
926642|NCT01500629|2240120|P2|STARTED|Washout Period of 14 to 30 Days||10
926643|NCT01500629|2240121|P1|STARTED|Washout Period of 14 to 30 Days||11
926644|NCT01500629|2240120|P2|NOT COMPLETED|Period 1 (Single Dose)||0
926645|NCT01500629|2240121|P1|NOT COMPLETED|Period 1 (Single Dose)||0
926646|NCT01500629|2240120|P2|COMPLETED|Period 1 (Single Dose)||10
926647|NCT01500629|2240121|P1|COMPLETED|Period 1 (Single Dose)||11
926648|NCT01500629|2240120|P2|STARTED|Period 1 (Single Dose)||10
926649|NCT01500629|2240121|P1|STARTED|Period 1 (Single Dose)||11
926650|NCT01500434|2240205|P1|NOT COMPLETED|Overall Study||7
926651|NCT01500434|2240205|P1|COMPLETED|Overall Study||95
926652|NCT01500434|2240205|P1|STARTED|Overall Study||102
926653|NCT01500382|2240238|P4|NOT COMPLETED|Treatment Period 2||0
926654|NCT01500382|2240239|P3|NOT COMPLETED|Treatment Period 2||0
926655|NCT01500382|2240240|P2|NOT COMPLETED|Treatment Period 2||0
926656|NCT01500382|2240241|P1|NOT COMPLETED|Treatment Period 2||0
926657|NCT01500382|2240238|P4|COMPLETED|Treatment Period 2||1
926658|NCT01500382|2240239|P3|COMPLETED|Treatment Period 2||0
926659|NCT01500382|2240240|P2|COMPLETED|Treatment Period 2||1
926660|NCT01500382|2240241|P1|COMPLETED|Treatment Period 2||1
926661|NCT01500382|2240238|P4|STARTED|Treatment Period 2||1
926662|NCT01500382|2240239|P3|STARTED|Treatment Period 2||0
926663|NCT01500382|2240240|P2|STARTED|Treatment Period 2||1
926664|NCT01500382|2240241|P1|STARTED|Treatment Period 2||1
926665|NCT01500382|2240238|P4|NOT COMPLETED|Washout Period||0
926666|NCT01500382|2240239|P3|NOT COMPLETED|Washout Period||1
926667|NCT01500382|2240240|P2|NOT COMPLETED|Washout Period||0
926668|NCT01500382|2240241|P1|NOT COMPLETED|Washout Period||0
926669|NCT01500382|2240238|P4|COMPLETED|Washout Period||1
926670|NCT01500382|2240239|P3|COMPLETED|Washout Period||0
926671|NCT01500382|2240240|P2|COMPLETED|Washout Period||1
926672|NCT01500382|2240241|P1|COMPLETED|Washout Period||1
926673|NCT01500382|2240238|P4|STARTED|Washout Period||1
926674|NCT01500382|2240239|P3|STARTED|Washout Period||1
926675|NCT01500382|2240240|P2|STARTED|Washout Period||1
926676|NCT01500382|2240241|P1|STARTED|Washout Period||1
926677|NCT01500382|2240238|P4|NOT COMPLETED|Treatment Period 1||0
926678|NCT01500382|2240239|P3|NOT COMPLETED|Treatment Period 1||0
926679|NCT01500382|2240240|P2|NOT COMPLETED|Treatment Period 1||0
926680|NCT01500382|2240241|P1|NOT COMPLETED|Treatment Period 1||0
926681|NCT01500382|2240238|P4|COMPLETED|Treatment Period 1||1
926682|NCT01500382|2240239|P3|COMPLETED|Treatment Period 1||1
926683|NCT01500382|2240240|P2|COMPLETED|Treatment Period 1||1
926684|NCT01500382|2240241|P1|COMPLETED|Treatment Period 1||1
926685|NCT01500382|2240238|P4|STARTED|Treatment Period 1||1
926686|NCT01500382|2240239|P3|STARTED|Treatment Period 1||1
926687|NCT01500382|2240240|P2|STARTED|Treatment Period 1||1
926688|NCT01500382|2240241|P1|STARTED|Treatment Period 1||1
926689|NCT01500317|2240266|P3|NOT COMPLETED|Overall Study||0
926690|NCT01500317|2240267|P2|NOT COMPLETED|Overall Study||2
926691|NCT01500317|2240268|P1|NOT COMPLETED|Overall Study||3
926692|NCT01500317|2240266|P3|COMPLETED|Overall Study||13
926693|NCT01500317|2240267|P2|COMPLETED|Overall Study||10
926694|NCT01500317|2240268|P1|COMPLETED|Overall Study||10
926695|NCT01500317|2240266|P3|STARTED|Overall Study||13
926696|NCT01500317|2240267|P2|STARTED|Overall Study||12
926697|NCT01500317|2240268|P1|STARTED|Overall Study||13
926698|NCT01500278|2240290|P2|NOT COMPLETED|Week 13 - Week 104||126
926699|NCT01500278|2240291|P1|NOT COMPLETED|Week 13 - Week 104||139
926700|NCT01500278|2240290|P2|COMPLETED|Week 13 - Week 104||302
926701|NCT01500278|2240291|P1|COMPLETED|Week 13 - Week 104||287
926702|NCT01500278|2240290|P2|STARTED|Week 13 - Week 104||428
926703|NCT01500278|2240291|P1|STARTED|Week 13 - Week 104||426
926704|NCT01500278|2240290|P2|NOT COMPLETED|Week 0 - Week 12||30
926705|NCT01500278|2240291|P1|NOT COMPLETED|Week 0 - Week 12||31
926706|NCT01500278|2240290|P2|COMPLETED|Week 0 - Week 12||428
926707|NCT01500278|2240291|P1|COMPLETED|Week 0 - Week 12||426
926708|NCT01500278|2240290|P2|STARTED|Week 0 - Week 12||458
926709|NCT01500278|2240291|P1|STARTED|Week 0 - Week 12||457
926710|NCT01500252|2240315|P2|NOT COMPLETED|Overall Study||6
926711|NCT01500252|2240316|P1|NOT COMPLETED|Overall Study||9
926712|NCT01500252|2240315|P2|COMPLETED|Overall Study|2 participant deceased by 5 years; no further deaths between 5 & 10 years for a total of 2 deaths|11
926713|NCT01500252|2240316|P1|COMPLETED|Overall Study|2 participants died within 5 years; 2 participants died between 5 & 10 years for a total of 4 deaths|12
926714|NCT01500252|2240315|P2|Ten Years|Overall Study||11
926715|NCT01500252|2240316|P1|Ten Years|Overall Study||12
926716|NCT01500252|2240315|P2|Five Years|Overall Study||13
926717|NCT01500252|2240316|P1|Five Years|Overall Study||17
926718|NCT01500252|2240315|P2|One Years|Overall Study||16
926719|NCT01500252|2240316|P1|One Years|Overall Study||20
926720|NCT01500252|2240315|P2|STARTED|Overall Study||17
926721|NCT01500252|2240316|P1|STARTED|Overall Study||21
926722|NCT01500226|2240342|P2|NOT COMPLETED|Overall Study||494
926723|NCT01500226|2240343|P1|NOT COMPLETED|Overall Study||499
926724|NCT01500226|2240342|P2|COMPLETED|Overall Study||191
926725|NCT01500226|2240343|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|185
926726|NCT01500226|2240342|P2|STARTED|Overall Study||685
926727|NCT01500226|2240343|P1|STARTED|Overall Study|Number of randomized patients|684
926728|NCT01500213|2240355|P2|NOT COMPLETED|Overall Study||224
926729|NCT01500213|2240356|P1|NOT COMPLETED|Overall Study||217
926730|NCT01500213|2240355|P2|COMPLETED|Overall Study||53
926731|NCT01500213|2240356|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|61
926732|NCT01500213|2240355|P2|STARTED|Overall Study||277
926733|NCT01500213|2240356|P1|STARTED|Overall Study|Number of randomized patients|278
926734|NCT01500135|2240368|P2|NOT COMPLETED|Overall Study||11
926735|NCT01500135|2240369|P1|NOT COMPLETED|Overall Study||17
926736|NCT01500135|2240368|P2|COMPLETED|Overall Study||39
926737|NCT01500135|2240369|P1|COMPLETED|Overall Study||83
926738|NCT01500135|2240368|P2|STARTED|Overall Study||50
926739|NCT01500135|2240369|P1|STARTED|Overall Study||100
926740|NCT01500109|2240382|P3|NOT COMPLETED|Overall Study||0
926741|NCT01500109|2240383|P2|NOT COMPLETED|Overall Study||0
926742|NCT01500109|2240384|P1|NOT COMPLETED|Overall Study||0
926743|NCT01500109|2240382|P3|COMPLETED|Overall Study||16
926744|NCT01500109|2240383|P2|COMPLETED|Overall Study||14
926745|NCT01500109|2240384|P1|COMPLETED|Overall Study||15
926746|NCT01500109|2240382|P3|STARTED|Overall Study||16
926747|NCT01500109|2240383|P2|STARTED|Overall Study||14
926748|NCT01500109|2240384|P1|STARTED|Overall Study||15
926749|NCT01500083|2240394|P2|NOT COMPLETED|Overall Study||43
926750|NCT01500083|2240395|P1|NOT COMPLETED|Overall Study||12
926751|NCT01500083|2240394|P2|COMPLETED|Overall Study||31
926752|NCT01500083|2240395|P1|COMPLETED|Overall Study||4
926753|NCT01500083|2240394|P2|STARTED|Overall Study||74
926754|NCT01500083|2240395|P1|STARTED|Overall Study||16
926755|NCT01500031|2240401|P1|NOT COMPLETED|Overall Study||5
926756|NCT01500031|2240401|P1|COMPLETED|Overall Study||87
926757|NCT01500031|2240401|P1|STARTED|Overall Study||92
926758|NCT01499862|2240416|P1|NOT COMPLETED|Overall Study||0
926759|NCT01499862|2240416|P1|COMPLETED|Overall Study||3
926760|NCT01499862|2240416|P1|STARTED|Overall Study||3
926761|NCT01499849|2240436|P2|NOT COMPLETED|Overall Study||226
926762|NCT01499849|2240437|P1|NOT COMPLETED|Overall Study||224
926763|NCT01499849|2240436|P2|COMPLETED|Overall Study||40
926764|NCT01499849|2240437|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|42
926765|NCT01499849|2240436|P2|STARTED|Overall Study||266
926766|NCT01499849|2240437|P1|STARTED|Overall Study|Number of randomized patients|266
926767|NCT01499810|2240447|P1|NOT COMPLETED|Overall Study||12
926768|NCT01499810|2240447|P1|COMPLETED|Overall Study||41
926769|NCT01499810|2240447|P1|STARTED|Overall Study||53
926770|NCT01499667|2240497|P3|NOT COMPLETED|Overall Study||10
926771|NCT01499667|2240498|P2|NOT COMPLETED|Overall Study||11
926772|NCT01499667|2240499|P1|NOT COMPLETED|Overall Study||9
926773|NCT01499667|2240497|P3|COMPLETED|Overall Study||40
926774|NCT01499667|2240498|P2|COMPLETED|Overall Study||31
926775|NCT01499667|2240499|P1|COMPLETED|Overall Study||41
926776|NCT01499667|2240497|P3|Modified Full Analysis Set|Overall Study||39
926777|NCT01499667|2240498|P2|Modified Full Analysis Set|Overall Study||29
926778|NCT01499667|2240499|P1|Modified Full Analysis Set|Overall Study|mFAS included all FAS patients who completed 8 wks of fingolimod treatment with MRI scan|41
926779|NCT01499667|2240497|P3|Full Analysis Set (FAS)|Overall Study||50
926780|NCT01499667|2240498|P2|Full Analysis Set (FAS)|Overall Study||42
926781|NCT01499667|2240499|P1|Full Analysis Set (FAS)|Overall Study|One randomized patient did not receive natalizumub at screening, which was a requirement for FAS.|49
926782|NCT01499667|2240497|P3|STARTED|Overall Study||50
926783|NCT01499667|2240498|P2|STARTED|Overall Study||42
926784|NCT01499667|2240499|P1|STARTED|Overall Study|Started” indicates randomized as well as safety population.|50
926785|NCT01499654|2240528|P1|NOT COMPLETED|Overall Study||0
926786|NCT01499654|2240528|P1|COMPLETED|Overall Study||64
926787|NCT01499654|2240528|P1|STARTED|Overall Study||64
926788|NCT01499576|2240547|P1|NOT COMPLETED|Overall Study||21
926789|NCT01499576|2240547|P1|COMPLETED|Overall Study||105
926790|NCT01499576|2240547|P1|STARTED|Overall Study||126
926791|NCT01499498|2240553|P1|NOT COMPLETED|Overall Study||0
926792|NCT01499498|2240553|P1|COMPLETED|Overall Study||13
926793|NCT01499498|2240553|P1|STARTED|Overall Study||13
926794|NCT01499355|2240561|P4|NOT COMPLETED|Double-Blind Period||23
926795|NCT01499355|2240562|P3|NOT COMPLETED|Double-Blind Period||25
926796|NCT01499355|2240563|P2|NOT COMPLETED|Double-Blind Period||23
926797|NCT01499355|2240564|P1|NOT COMPLETED|Double-Blind Period||0
926798|NCT01499355|2240561|P4|COMPLETED|Double-Blind Period||39
926799|NCT01499355|2240562|P3|COMPLETED|Double-Blind Period||38
926800|NCT01499355|2240563|P2|COMPLETED|Double-Blind Period||40
926801|NCT01499355|2240564|P1|COMPLETED|Double-Blind Period||0
926802|NCT01499355|2240561|P4|STARTED|Double-Blind Period||62
926803|NCT01499355|2240562|P3|STARTED|Double-Blind Period||63
926804|NCT01499355|2240563|P2|STARTED|Double-Blind Period||63
926805|NCT01499355|2240564|P1|STARTED|Double-Blind Period||0
926806|NCT01499355|2240561|P4|NOT COMPLETED|Run-In Period||0
926807|NCT01499355|2240562|P3|NOT COMPLETED|Run-In Period||0
926808|NCT01499355|2240563|P2|NOT COMPLETED|Run-In Period||0
926809|NCT01499355|2240564|P1|NOT COMPLETED|Run-In Period||31
926810|NCT01499355|2240561|P4|COMPLETED|Run-In Period||0
926811|NCT01499355|2240562|P3|COMPLETED|Run-In Period||0
926812|NCT01499355|2240563|P2|COMPLETED|Run-In Period||0
926813|NCT01499355|2240564|P1|COMPLETED|Run-In Period||245
926814|NCT01499355|2240561|P4|STARTED|Run-In Period||0
926815|NCT01499355|2240562|P3|STARTED|Run-In Period||0
926816|NCT01499355|2240563|P2|STARTED|Run-In Period||0
926817|NCT01499355|2240564|P1|STARTED|Run-In Period||276
926818|NCT01499303|2240597|P2|NOT COMPLETED|Overall Study||7
926819|NCT01499303|2240598|P1|NOT COMPLETED|Overall Study||3
926820|NCT01499303|2240597|P2|COMPLETED|Overall Study||40
926821|NCT01499303|2240598|P1|COMPLETED|Overall Study||18
926822|NCT01499303|2240597|P2|STARTED|Overall Study||47
926823|NCT01499303|2240598|P1|STARTED|Overall Study||21
926824|NCT01499290|2240606|P2|NOT COMPLETED|Overall Study||35
926825|NCT01499290|2240607|P1|NOT COMPLETED|Overall Study||55
926826|NCT01499290|2240606|P2|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|494
926827|NCT01499290|2240607|P1|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|474
926828|NCT01499290|2240606|P2|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
926829|NCT01499290|2240607|P1|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
926830|NCT01499277|2240657|P2|NOT COMPLETED|Overall Study||32
926831|NCT01499277|2240658|P1|NOT COMPLETED|Overall Study||47
926832|NCT01499277|2240657|P2|COMPLETED|Overall Study||223
926833|NCT01499277|2240658|P1|COMPLETED|Overall Study||459
926834|NCT01499277|2240657|P2|STARTED|Overall Study||255
926835|NCT01499277|2240658|P1|STARTED|Overall Study||506
926836|NCT01499199|2240680|P1|NOT COMPLETED|Overall Study||2
926837|NCT01499199|2240680|P1|COMPLETED|Overall Study||11
926838|NCT01499199|2240680|P1|STARTED|Overall Study||13
926839|NCT01499173|2240699|P1|NOT COMPLETED|Overall Study||37
926840|NCT01499173|2240699|P1|COMPLETED|Overall Study||64
926841|NCT01499173|2240699|P1|STARTED|Overall Study||101
926842|NCT01499147|2240711|P2|NOT COMPLETED|Overall Study||5
926843|NCT01499147|2240712|P1|NOT COMPLETED|Overall Study||15
926844|NCT01499147|2240711|P2|COMPLETED|Overall Study||12
926845|NCT01499147|2240712|P1|COMPLETED|Overall Study||18
926846|NCT01499147|2240711|P2|STARTED|Overall Study||17
926847|NCT01499147|2240712|P1|STARTED|Overall Study||33
926848|NCT01499134|2240727|P2|NOT COMPLETED|Overall Study||1
926849|NCT01499134|2240728|P1|NOT COMPLETED|Overall Study||0
926850|NCT01499134|2240727|P2|COMPLETED|Overall Study||7
926851|NCT01499134|2240728|P1|COMPLETED|Overall Study||9
926852|NCT01499134|2240727|P2|STARTED|Overall Study||8
926853|NCT01499134|2240728|P1|STARTED|Overall Study||9
926854|NCT01499095|2240750|P2|NOT COMPLETED|Overall Study||93
926855|NCT01499095|2240751|P1|NOT COMPLETED|Overall Study||89
926856|NCT01499095|2240750|P2|COMPLETED|Overall Study||314
926857|NCT01499095|2240751|P1|COMPLETED|Overall Study||315
926858|NCT01499095|2240750|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|405
926859|NCT01499095|2240751|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|403
926860|NCT01499095|2240750|P2|Participated in Substudy|Overall Study||0
926861|NCT01499095|2240751|P1|Participated in Substudy|Overall Study|45 participants received adaptable dosing regimen and 44 participants received fixed dosing regimen|89
926862|NCT01499095|2240750|P2|Treated|Overall Study||406
926863|NCT01499095|2240751|P1|Treated|Overall Study||403
926864|NCT01499095|2240750|P2|STARTED|Overall Study||407
926865|NCT01499095|2240751|P1|STARTED|Overall Study||404
926866|NCT01499082|2240781|P2|NOT COMPLETED|Overall Study||48
926867|NCT01499082|2240782|P1|NOT COMPLETED|Overall Study||45
926868|NCT01499082|2240781|P2|COMPLETED|Overall Study||355
926869|NCT01499082|2240782|P1|COMPLETED|Overall Study||359
926870|NCT01499082|2240781|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|400
926871|NCT01499082|2240782|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|404
926872|NCT01499082|2240781|P2|Participated in Substudy|Overall Study||0
926873|NCT01499082|2240782|P1|Participated in Substudy|Overall Study|56 participants received adaptable dosing regimen and 53 participants received fixed dosing regimen|109
926874|NCT01499082|2240781|P2|Treated|Overall Study||402
926875|NCT01499082|2240782|P1|Treated|Overall Study||404
926876|NCT01499082|2240781|P2|STARTED|Overall Study||403
926877|NCT01499082|2240782|P1|STARTED|Overall Study||404
926878|NCT01498822|2240812|P2|NOT COMPLETED|Overall Study||56
926879|NCT01498822|2240813|P1|NOT COMPLETED|Overall Study||54
926880|NCT01498822|2240812|P2|COMPLETED|Overall Study||122
926881|NCT01498822|2240813|P1|COMPLETED|Overall Study||121
926882|NCT01498822|2240812|P2|STARTED|Overall Study||178
926883|NCT01498822|2240813|P1|STARTED|Overall Study||175
926884|NCT01498744|2240827|P2|NOT COMPLETED|Overall Study||0
926885|NCT01498744|2240828|P1|NOT COMPLETED|Overall Study||0
926886|NCT01498744|2240827|P2|COMPLETED|Overall Study||31
926887|NCT01498744|2240828|P1|COMPLETED|Overall Study||22
926888|NCT01498744|2240827|P2|STARTED|Overall Study||31
926889|NCT01498744|2240828|P1|STARTED|Overall Study||22
926890|NCT01498692|2240840|P1|NOT COMPLETED|Overall Study||8
926891|NCT01498692|2240840|P1|COMPLETED|Overall Study||86
926892|NCT01498692|2240840|P1|STARTED|Overall Study||94
926893|NCT01498679|2240871|P2|NOT COMPLETED|Overall Study||22
926894|NCT01498679|2240872|P1|NOT COMPLETED|Overall Study||89
926895|NCT01498679|2240871|P2|COMPLETED|Overall Study||131
926896|NCT01498679|2240872|P1|COMPLETED|Overall Study||65
926897|NCT01498679|2240871|P2|STARTED|Overall Study||153
926898|NCT01498679|2240872|P1|STARTED|Overall Study||154
926899|NCT01498653|2240888|P2|NOT COMPLETED|Overall Study||35
926900|NCT01498653|2240889|P1|NOT COMPLETED|Overall Study||19
926901|NCT01498653|2240888|P2|COMPLETED|Overall Study||119
926902|NCT01498653|2240889|P1|COMPLETED|Overall Study||136
926903|NCT01498653|2240888|P2|STARTED|Overall Study||154
926904|NCT01498653|2240889|P1|STARTED|Overall Study||155
926905|NCT01498640|2240903|P1|NOT COMPLETED|Overall Study||5
926906|NCT01498640|2240903|P1|COMPLETED|Overall Study||47
926907|NCT01498640|2240903|P1|STARTED|Overall Study||52
926908|NCT01498601|2240919|P2|NOT COMPLETED|Overall Study||0
926909|NCT01498601|2240920|P1|NOT COMPLETED|Overall Study||0
926910|NCT01498601|2240919|P2|COMPLETED|Overall Study||32
926911|NCT01498601|2240920|P1|COMPLETED|Overall Study||51
926912|NCT01498601|2240919|P2|STARTED|Overall Study||32
926913|NCT01498601|2240920|P1|STARTED|Overall Study||51
926914|NCT01498588|2240926|P1|NOT COMPLETED|Overall Study||0
926915|NCT01498588|2240926|P1|COMPLETED|Overall Study||7
926916|NCT01498588|2240926|P1|STARTED|Overall Study||7
926917|NCT01498575|2240933|P2|NOT COMPLETED|On the Road Driving Assessment (ODA)||24
926918|NCT01498575|2240934|P1|NOT COMPLETED|On the Road Driving Assessment (ODA)||42
926919|NCT01498575|2240933|P2|COMPLETED|On the Road Driving Assessment (ODA)||65
926920|NCT01498575|2240934|P1|COMPLETED|On the Road Driving Assessment (ODA)||86
926921|NCT01498575|2240933|P2|STARTED|On the Road Driving Assessment (ODA)||89
926922|NCT01498575|2240934|P1|STARTED|On the Road Driving Assessment (ODA)||128
926923|NCT01498575|2240933|P2|NOT COMPLETED|Overall Sample||14
926924|NCT01498575|2240934|P1|NOT COMPLETED|Overall Sample||60
926925|NCT01498575|2240933|P2|COMPLETED|Overall Sample||400
926926|NCT01498575|2240934|P1|COMPLETED|Overall Sample||550
926927|NCT01498575|2240933|P2|STARTED|Overall Sample||414
926928|NCT01498575|2240934|P1|STARTED|Overall Sample||610
926929|NCT01498549|2240940|P1|NOT COMPLETED|Overall Study||4
926930|NCT01498549|2240940|P1|COMPLETED|Overall Study||35
926931|NCT01498549|2240940|P1|Sugar Pill 0 mg|Overall Study||36
926932|NCT01498549|2240940|P1|Atomoxetine 80 mg|Overall Study||37
926933|NCT01498549|2240940|P1|Atomoxetine 40 mg|Overall Study||39
926934|NCT01498549|2240940|P1|STARTED|Overall Study||39
926935|NCT01498458|2240951|P1|NOT COMPLETED|Overall Study||7
926936|NCT01498458|2240951|P1|COMPLETED|Overall Study|only 1 patient was in the study at the end. 7 left due to Adverse Events or Investigators Decision.|1
926937|NCT01498458|2240951|P1|STARTED|Overall Study|9 patients took part in the study of which 8 received pazopanib.|8
926938|NCT01498419|2240964|P4|NOT COMPLETED|Overall Study||19
926939|NCT01498419|2240965|P3|NOT COMPLETED|Overall Study||18
926940|NCT01498419|2240966|P2|NOT COMPLETED|Overall Study||23
926941|NCT01498419|2240967|P1|NOT COMPLETED|Overall Study||18
926942|NCT01498419|2240964|P4|COMPLETED|Overall Study||7
926943|NCT01498419|2240965|P3|COMPLETED|Overall Study||41
926944|NCT01498419|2240966|P2|COMPLETED|Overall Study||39
926945|NCT01498419|2240967|P1|COMPLETED|Overall Study||42
926946|NCT01498419|2240964|P4|STARTED|Overall Study||26
926947|NCT01498419|2240965|P3|STARTED|Overall Study||59
926948|NCT01498419|2240966|P2|STARTED|Overall Study||62
926949|NCT01498419|2240967|P1|STARTED|Overall Study||60
926950|NCT01498185|2241006|P5|NOT COMPLETED|Overall Study||3
926951|NCT01498185|2241007|P4|NOT COMPLETED|Overall Study||3
926952|NCT01498185|2241008|P3|NOT COMPLETED|Overall Study||0
926953|NCT01498185|2241009|P2|NOT COMPLETED|Overall Study||1
926954|NCT01498185|2241010|P1|NOT COMPLETED|Overall Study||1
926955|NCT01498185|2241006|P5|COMPLETED|Overall Study||12
926956|NCT01498185|2241007|P4|COMPLETED|Overall Study||11
926957|NCT01498185|2241008|P3|COMPLETED|Overall Study||15
926958|NCT01498185|2241009|P2|COMPLETED|Overall Study||12
926959|NCT01498185|2241010|P1|COMPLETED|Overall Study||12
926960|NCT01498185|2241006|P5|STARTED|Overall Study||15
926961|NCT01498185|2241007|P4|STARTED|Overall Study||14
926962|NCT01498185|2241008|P3|STARTED|Overall Study||15
926963|NCT01498185|2241009|P2|STARTED|Overall Study||13
926964|NCT01498185|2241010|P1|STARTED|Overall Study||13
926965|NCT01498120|2241050|P1|NOT COMPLETED|Overall Study||13
926966|NCT01498120|2241050|P1|COMPLETED|Overall Study||1
926967|NCT01498120|2241050|P1|STARTED|Overall Study||14
926968|NCT01498068|2241057|P2|NOT COMPLETED|Overall Study||1
926969|NCT01498068|2241058|P1|NOT COMPLETED|Overall Study||1
926970|NCT01498068|2241057|P2|COMPLETED|Overall Study||19
926971|NCT01498068|2241058|P1|COMPLETED|Overall Study||15
926972|NCT01498068|2241057|P2|STARTED|Overall Study||20
926973|NCT01498068|2241058|P1|STARTED|Overall Study||16
926974|NCT01497938|2241076|P2|NOT COMPLETED|Overall Study||2
926975|NCT01497938|2241077|P1|NOT COMPLETED|Overall Study||5
926976|NCT01497938|2241076|P2|COMPLETED|Overall Study||124
926977|NCT01497938|2241077|P1|COMPLETED|Overall Study||116
926978|NCT01497938|2241076|P2|STARTED|Overall Study||126
926979|NCT01497938|2241077|P1|STARTED|Overall Study||121
926980|NCT01497899|2241089|P4|NOT COMPLETED|Open-Label Extension Phase||5
926981|NCT01497899|2241090|P3|NOT COMPLETED|Open-Label Extension Phase||9
926982|NCT01497899|2241091|P2|NOT COMPLETED|Open-Label Extension Phase||7
926983|NCT01497899|2241092|P1|NOT COMPLETED|Open-Label Extension Phase||19
926984|NCT01497899|2241089|P4|COMPLETED|Open-Label Extension Phase||33
926985|NCT01497899|2241090|P3|COMPLETED|Open-Label Extension Phase||61
926986|NCT01497899|2241091|P2|COMPLETED|Open-Label Extension Phase||46
926987|NCT01497899|2241092|P1|COMPLETED|Open-Label Extension Phase||86
927078|NCT01496352|2241321|P2|STARTED|Overall Study||6
926988|NCT01497899|2241089|P4|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|38
926989|NCT01497899|2241090|P3|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|70
926990|NCT01497899|2241091|P2|STARTED|Open-Label Extension Phase||53
926991|NCT01497899|2241092|P1|STARTED|Open-Label Extension Phase|2 participants completed the Double-Blind Phase, but did not continue in the Open-Label Extension.|105
926992|NCT01497899|2241089|P4|NOT COMPLETED|Double-Blind Phase||0
926993|NCT01497899|2241090|P3|NOT COMPLETED|Double-Blind Phase||0
926994|NCT01497899|2241091|P2|NOT COMPLETED|Double-Blind Phase||5
926995|NCT01497899|2241092|P1|NOT COMPLETED|Double-Blind Phase||6
926996|NCT01497899|2241089|P4|COMPLETED|Double-Blind Phase||0
926997|NCT01497899|2241090|P3|COMPLETED|Double-Blind Phase||0
926998|NCT01497899|2241091|P2|COMPLETED|Double-Blind Phase||53
926999|NCT01497899|2241092|P1|COMPLETED|Double-Blind Phase||107
927000|NCT01497899|2241089|P4|STARTED|Double-Blind Phase||0
927001|NCT01497899|2241090|P3|STARTED|Double-Blind Phase||0
927002|NCT01497899|2241091|P2|STARTED|Double-Blind Phase||58
927003|NCT01497899|2241092|P1|STARTED|Double-Blind Phase||113
927004|NCT01497756|2241105|P1|NOT COMPLETED|Overall Study||0
927005|NCT01497756|2241105|P1|COMPLETED|Overall Study||10
927006|NCT01497756|2241105|P1|STARTED|Overall Study||10
927007|NCT01497665|2241110|P1|NOT COMPLETED|Overall Study||0
927008|NCT01497665|2241110|P1|COMPLETED|Overall Study||16
927009|NCT01497665|2241110|P1|Completed Effifcacy Assessment|Overall Study|Number of patients who completed efficacy assessment with CNS lesions per Overall RECIST 1.1.|10
927010|NCT01497665|2241110|P1|STARTED|Overall Study||16
927011|NCT01497366|2241120|P2|NOT COMPLETED|Overall Study||88
927012|NCT01497366|2241121|P1|NOT COMPLETED|Overall Study||39
927013|NCT01497366|2241120|P2|COMPLETED|Overall Study||176
927014|NCT01497366|2241121|P1|COMPLETED|Overall Study||224
927015|NCT01497366|2241120|P2|Randomized But Not Treated|Overall Study||21
927016|NCT01497366|2241121|P1|Randomized But Not Treated|Overall Study||7
927017|NCT01497366|2241120|P2|STARTED|Overall Study||264
927018|NCT01497366|2241121|P1|STARTED|Overall Study||263
927019|NCT01497275|2241139|P1|NOT COMPLETED|Overall Study||2
927020|NCT01497275|2241139|P1|COMPLETED|Overall Study||3
927021|NCT01497275|2241139|P1|STARTED|Overall Study||5
927022|NCT01497262|2241146|P1|NOT COMPLETED|Overall Study||11
927023|NCT01497262|2241146|P1|COMPLETED|Overall Study||151
927024|NCT01497262|2241146|P1|STARTED|Overall Study||162
927025|NCT01497197|2241153|P2|NOT COMPLETED|Overall Study||15
927026|NCT01497197|2241154|P1|NOT COMPLETED|Overall Study||17
927027|NCT01497197|2241153|P2|COMPLETED|Overall Study||70
927028|NCT01497197|2241154|P1|COMPLETED|Overall Study||72
927029|NCT01497197|2241153|P2|STARTED|Overall Study||85
927030|NCT01497197|2241154|P1|STARTED|Overall Study||89
927031|NCT01497171|2241182|P2|NOT COMPLETED|Overall Study||0
927032|NCT01497171|2241183|P1|NOT COMPLETED|Overall Study||0
927033|NCT01497171|2241182|P2|COMPLETED|Overall Study||3
927034|NCT01497171|2241183|P1|COMPLETED|Overall Study||2
927035|NCT01497171|2241182|P2|STARTED|Overall Study||3
927036|NCT01497171|2241183|P1|STARTED|Overall Study||2
927049|NCT01496807|2241207|P1|NOT COMPLETED|Overall Study||30
927050|NCT01496807|2241207|P1|COMPLETED|Overall Study||1
927051|NCT01496807|2241207|P1|STARTED|Overall Study||31
927052|NCT01496469|2241219|P2|NOT COMPLETED|Overall Study||8
927053|NCT01496469|2241220|P1|NOT COMPLETED|Overall Study||10
927054|NCT01496469|2241219|P2|COMPLETED|Overall Study||53
927055|NCT01496469|2241220|P1|COMPLETED|Overall Study||50
927056|NCT01496469|2241219|P2|STARTED|Overall Study||61
927057|NCT01496469|2241220|P1|STARTED|Overall Study||60
927058|NCT01496456|2241230|P1|NOT COMPLETED|Overall Study||8
927059|NCT01496456|2241230|P1|COMPLETED|Overall Study||9
927060|NCT01496456|2241230|P1|3-yr Final Recall|Overall Study||9
927061|NCT01496456|2241230|P1|2-yr Recall|Overall Study||10
927062|NCT01496456|2241230|P1|1-yr Recall|Overall Study||12
927063|NCT01496456|2241230|P1|Baseline|Overall Study|Baseline group started with 16 patients.|16
927064|NCT01496456|2241230|P1|STARTED|Overall Study||17
927065|NCT01496430|2241243|P3|NOT COMPLETED|Overall Study||10
927066|NCT01496430|2241244|P2|NOT COMPLETED|Overall Study||5
927067|NCT01496430|2241245|P1|NOT COMPLETED|Overall Study||6
927068|NCT01496430|2241243|P3|COMPLETED|Overall Study||25
927069|NCT01496430|2241244|P2|COMPLETED|Overall Study||30
927070|NCT01496430|2241245|P1|COMPLETED|Overall Study||29
927071|NCT01496430|2241243|P3|STARTED|Overall Study||35
927072|NCT01496430|2241244|P2|STARTED|Overall Study||35
927073|NCT01496430|2241245|P1|STARTED|Overall Study||35
927074|NCT01496352|2241321|P2|NOT COMPLETED|Overall Study||0
927075|NCT01496352|2241322|P1|NOT COMPLETED|Overall Study||0
927076|NCT01496352|2241321|P2|COMPLETED|Overall Study||6
927077|NCT01496352|2241322|P1|COMPLETED|Overall Study||24
927079|NCT01496352|2241322|P1|STARTED|Overall Study||24
927080|NCT01496313|2241340|P2|NOT COMPLETED|Overall Study||15
927081|NCT01496313|2241341|P1|NOT COMPLETED|Overall Study||5
927082|NCT01496313|2241340|P2|COMPLETED|Overall Study||26
927083|NCT01496313|2241341|P1|COMPLETED|Overall Study||35
927084|NCT01496313|2241340|P2|STARTED|Overall Study||41
927085|NCT01496313|2241341|P1|STARTED|Overall Study||40
927086|NCT01496287|2241357|P1|NOT COMPLETED|Overall Study||6
927087|NCT01496287|2241357|P1|COMPLETED|Overall Study||64
927088|NCT01496287|2241357|P1|STARTED|Overall Study||70
927089|NCT01496274|2241367|P2|NOT COMPLETED|Overall Study||5
927090|NCT01496274|2241368|P1|NOT COMPLETED|Overall Study||3
927091|NCT01496274|2241367|P2|COMPLETED|Overall Study||18
927092|NCT01496274|2241368|P1|COMPLETED|Overall Study||37
927093|NCT01496274|2241367|P2|STARTED|Overall Study||23
927094|NCT01496274|2241368|P1|STARTED|Overall Study||40
927095|NCT01496248|2241400|P1|NOT COMPLETED|Overall Study||10
927096|NCT01496248|2241400|P1|COMPLETED|Overall Study||25
927097|NCT01496248|2241400|P1|STARTED|Overall Study||35
927098|NCT01496183|2241413|P2|NOT COMPLETED|Overall Study||2
927099|NCT01496183|2241414|P1|NOT COMPLETED|Overall Study||3
927100|NCT01496183|2241413|P2|COMPLETED|Overall Study||13
927101|NCT01496183|2241414|P1|COMPLETED|Overall Study||6
927102|NCT01496183|2241413|P2|STARTED|Overall Study||15
927103|NCT01496183|2241414|P1|STARTED|Overall Study||9
927128|NCT01495975|2241463|P2|NOT COMPLETED|Overall Study||0
927129|NCT01495975|2241464|P1|NOT COMPLETED|Overall Study||1
927130|NCT01495975|2241463|P2|COMPLETED|Overall Study||14
927131|NCT01495975|2241464|P1|COMPLETED|Overall Study||14
927132|NCT01495975|2241463|P2|STARTED|Overall Study||14
927133|NCT01495975|2241464|P1|STARTED|Overall Study||15
927134|NCT01495923|2241472|P2|NOT COMPLETED|Overall Study||0
927135|NCT01495923|2241473|P1|NOT COMPLETED|Overall Study||0
927136|NCT01495923|2241472|P2|COMPLETED|Overall Study||72
927137|NCT01495923|2241473|P1|COMPLETED|Overall Study||73
927138|NCT01495923|2241472|P2|STARTED|Overall Study||72
927139|NCT01495923|2241473|P1|STARTED|Overall Study||73
927140|NCT01495858|2241506|P3|NOT COMPLETED|Overall Study||0
927141|NCT01495858|2241507|P2|NOT COMPLETED|Overall Study||0
927142|NCT01495858|2241508|P1|NOT COMPLETED|Overall Study||0
927143|NCT01495858|2241506|P3|COMPLETED|Overall Study||54
927144|NCT01495858|2241507|P2|COMPLETED|Overall Study||106
927145|NCT01495858|2241508|P1|COMPLETED|Overall Study||107
927146|NCT01495858|2241506|P3|STARTED|Overall Study||54
927147|NCT01495858|2241507|P2|STARTED|Overall Study||106
927148|NCT01495858|2241508|P1|STARTED|Overall Study||107
927149|NCT01495793|2241588|P1|NOT COMPLETED|Overall Study||2
927150|NCT01495793|2241588|P1|COMPLETED|Overall Study||22
927151|NCT01495793|2241588|P1|STARTED|Overall Study||24
927152|NCT01495702|2241601|P2|NOT COMPLETED|Extension Phase||0
927153|NCT01495702|2241602|P1|NOT COMPLETED|Extension Phase||0
927154|NCT01495702|2241601|P2|COMPLETED|Extension Phase||2
927155|NCT01495702|2241602|P1|COMPLETED|Extension Phase||26
927156|NCT01495702|2241601|P2|STARTED|Extension Phase||2
927157|NCT01495702|2241602|P1|STARTED|Extension Phase||26
927158|NCT01495702|2241601|P2|NOT COMPLETED|Randomized Phase||28
927159|NCT01495702|2241602|P1|NOT COMPLETED|Randomized Phase||26
927160|NCT01495702|2241601|P2|COMPLETED|Randomized Phase||119
927161|NCT01495702|2241602|P1|COMPLETED|Randomized Phase||266
927162|NCT01495702|2241601|P2|STARTED|Randomized Phase||147
927163|NCT01495702|2241602|P1|STARTED|Randomized Phase||292
927164|NCT01495689|2241617|P2|NOT COMPLETED|Overall Study||7
927165|NCT01495689|2241618|P1|NOT COMPLETED|Overall Study||10
927166|NCT01495689|2241617|P2|COMPLETED|Overall Study||16
927167|NCT01495689|2241618|P1|COMPLETED|Overall Study||16
927168|NCT01495689|2241617|P2|STARTED|Overall Study||23
927169|NCT01495689|2241618|P1|STARTED|Overall Study||26
927170|NCT01495585|2241627|P3|NOT COMPLETED|Overall Study||0
927171|NCT01495585|2241628|P2|NOT COMPLETED|Overall Study||0
927172|NCT01495585|2241629|P1|NOT COMPLETED|Overall Study||0
927173|NCT01495585|2241627|P3|COMPLETED|Overall Study||4
927174|NCT01495585|2241628|P2|COMPLETED|Overall Study||6
927175|NCT01495585|2241629|P1|COMPLETED|Overall Study||4
927176|NCT01495585|2241627|P3|Open Label Lonafarnib 200 mg|Overall Study||0
927177|NCT01495585|2241628|P2|Open Label Lonafarnib 200 mg|Overall Study||0
927178|NCT01495585|2241629|P1|Open Label Lonafarnib 200 mg|Overall Study||2
927179|NCT01495585|2241627|P3|STARTED|Overall Study||4
927180|NCT01495585|2241628|P2|STARTED|Overall Study||6
927181|NCT01495585|2241629|P1|STARTED|Overall Study||4
927182|NCT01495572|2241642|P2|NOT COMPLETED|Overall Study||0
927183|NCT01495572|2241643|P1|NOT COMPLETED|Overall Study||0
927184|NCT01495572|2241642|P2|COMPLETED|Overall Study||5
927185|NCT01495572|2241643|P1|COMPLETED|Overall Study||0
927186|NCT01495572|2241642|P2|STARTED|Overall Study||5
927187|NCT01495572|2241643|P1|STARTED|Overall Study||0
927188|NCT01495481|2241651|P1|NOT COMPLETED|Dexmedetomidine||0
927189|NCT01495481|2241651|P1|COMPLETED|Dexmedetomidine||22
927190|NCT01495481|2241651|P1|STARTED|Dexmedetomidine||22
927191|NCT01495481|2241651|P1|NOT COMPLETED|Washout||0
927192|NCT01495481|2241651|P1|COMPLETED|Washout||22
927193|NCT01495481|2241651|P1|STARTED|Washout||22
927194|NCT01495481|2241651|P1|NOT COMPLETED|Adenosine||0
927195|NCT01495481|2241651|P1|COMPLETED|Adenosine||22
927196|NCT01495481|2241651|P1|STARTED|Adenosine|Patients first received adenosine and then dexmedetomidine.|22
927197|NCT01495286|2241663|P1|NOT COMPLETED|Overall Study||0
927198|NCT01495286|2241663|P1|COMPLETED|Overall Study||30
927199|NCT01495286|2241663|P1|STARTED|Overall Study||30
927200|NCT01495000|2241673|P2|NOT COMPLETED|Overall Study||12
927201|NCT01495000|2241674|P1|NOT COMPLETED|Overall Study||13
927202|NCT01495000|2241673|P2|COMPLETED|Overall Study||114
927203|NCT01495000|2241674|P1|COMPLETED|Overall Study||111
927204|NCT01495000|2241673|P2|STARTED|Overall Study||126
927205|NCT01495000|2241674|P1|STARTED|Overall Study||124
927206|NCT01494987|2241716|P2|NOT COMPLETED|Overall Study||28
927207|NCT01494987|2241717|P1|NOT COMPLETED|Overall Study||28
927208|NCT01494987|2241716|P2|COMPLETED|Overall Study||187
927209|NCT01494987|2241717|P1|COMPLETED|Overall Study||188
927210|NCT01494987|2241716|P2|STARTED|Overall Study||215
927211|NCT01494987|2241717|P1|STARTED|Overall Study||216
927212|NCT01494818|2241731|P2|NOT COMPLETED|Overall Study||2
927213|NCT01494818|2241732|P1|NOT COMPLETED|Overall Study||2
927214|NCT01494818|2241731|P2|COMPLETED|Overall Study||37
927215|NCT01494818|2241732|P1|COMPLETED|Overall Study||37
927216|NCT01494818|2241731|P2|STARTED|Overall Study||39
927217|NCT01494818|2241732|P1|STARTED|Overall Study||39
927218|NCT01494753|2241754|P2|NOT COMPLETED|Day42-Day84||0
927219|NCT01494753|2241755|P1|NOT COMPLETED|Day42-Day84||0
927220|NCT01494753|2241754|P2|COMPLETED|Day42-Day84||15
927221|NCT01494753|2241755|P1|COMPLETED|Day42-Day84||15
927222|NCT01494753|2241754|P2|STARTED|Day42-Day84||15
927223|NCT01494753|2241755|P1|STARTED|Day42-Day84||15
927224|NCT01494753|2241754|P2|NOT COMPLETED|Day0-Day42||0
927225|NCT01494753|2241755|P1|NOT COMPLETED|Day0-Day42||0
927226|NCT01494753|2241754|P2|COMPLETED|Day0-Day42||15
927227|NCT01494753|2241755|P1|COMPLETED|Day0-Day42||15
927228|NCT01494753|2241754|P2|STARTED|Day0-Day42||15
927229|NCT01494753|2241755|P1|STARTED|Day0-Day42||15
927230|NCT01494649|2241763|P2|NOT COMPLETED|Overall Study||1
927231|NCT01494649|2241764|P1|NOT COMPLETED|Overall Study||0
927232|NCT01494649|2241763|P2|COMPLETED|Overall Study||58
927233|NCT01494649|2241764|P1|COMPLETED|Overall Study||59
927234|NCT01494649|2241763|P2|STARTED|Overall Study||59
927235|NCT01494649|2241764|P1|STARTED|Overall Study||59
927236|NCT01494610|2241780|P2|NOT COMPLETED|Period 4||0
927237|NCT01494610|2241781|P1|NOT COMPLETED|Period 4||1
927238|NCT01494610|2241780|P2|COMPLETED|Period 4||28
927239|NCT01494610|2241781|P1|COMPLETED|Period 4||27
927240|NCT01494610|2241780|P2|STARTED|Period 4||28
927241|NCT01494610|2241781|P1|STARTED|Period 4||28
927242|NCT01494610|2241780|P2|NOT COMPLETED|Period 3||0
927243|NCT01494610|2241781|P1|NOT COMPLETED|Period 3||2
927244|NCT01494610|2241780|P2|COMPLETED|Period 3||28
927245|NCT01494610|2241781|P1|COMPLETED|Period 3||28
927246|NCT01494610|2241780|P2|STARTED|Period 3||28
927247|NCT01494610|2241781|P1|STARTED|Period 3||30
927248|NCT01494610|2241780|P2|NOT COMPLETED|Period 2||0
927249|NCT01494610|2241781|P1|NOT COMPLETED|Period 2||0
927250|NCT01494610|2241780|P2|COMPLETED|Period 2||28
927251|NCT01494610|2241781|P1|COMPLETED|Period 2||30
927252|NCT01494610|2241780|P2|STARTED|Period 2||28
927253|NCT01494610|2241781|P1|STARTED|Period 2||30
927254|NCT01494610|2241780|P2|NOT COMPLETED|Period 1||1
927255|NCT01494610|2241781|P1|NOT COMPLETED|Period 1||1
927256|NCT01494610|2241780|P2|COMPLETED|Period 1||28
927257|NCT01494610|2241781|P1|COMPLETED|Period 1||30
927258|NCT01494610|2241780|P2|STARTED|Period 1||29
927259|NCT01494610|2241781|P1|STARTED|Period 1||31
927260|NCT01494584|2241849|P1|NOT COMPLETED|Overall Study||1
927261|NCT01494584|2241849|P1|COMPLETED|Overall Study||4
927262|NCT01494584|2241849|P1|STARTED|Overall Study||5
927263|NCT01494545|2241938|P1|NOT COMPLETED|Overall Study||10
927264|NCT01494545|2241938|P1|COMPLETED|Overall Study||92
927265|NCT01494545|2241938|P1|STARTED|Overall Study||102
927266|NCT01494532|2241981|P6|NOT COMPLETED|Overall Study||0
927267|NCT01494532|2241982|P5|NOT COMPLETED|Overall Study||12
927268|NCT01494532|2241983|P4|NOT COMPLETED|Overall Study||15
927269|NCT01494532|2241984|P3|NOT COMPLETED|Overall Study||17
927270|NCT01494532|2241985|P2|NOT COMPLETED|Overall Study||4
927271|NCT01494532|2241986|P1|NOT COMPLETED|Overall Study||10
927272|NCT01494532|2241981|P6|COMPLETED|Overall Study||25
927273|NCT01494532|2241982|P5|COMPLETED|Overall Study||64
927274|NCT01494532|2241983|P4|COMPLETED|Overall Study||60
927275|NCT01494532|2241984|P3|COMPLETED|Overall Study||59
927276|NCT01494532|2241985|P2|COMPLETED|Overall Study||21
927277|NCT01494532|2241986|P1|COMPLETED|Overall Study||65
927278|NCT01494532|2241981|P6|STARTED|Overall Study||25
927279|NCT01494532|2241982|P5|STARTED|Overall Study||76
927280|NCT01494532|2241983|P4|STARTED|Overall Study||75
927281|NCT01494532|2241984|P3|STARTED|Overall Study||76
927282|NCT01494532|2241985|P2|STARTED|Overall Study||25
927283|NCT01494532|2241986|P1|STARTED|Overall Study||75
927284|NCT01494506|2242141|P3|NOT COMPLETED|Overall Study||103
927285|NCT01494506|2242142|P2|NOT COMPLETED|Overall Study||143
927286|NCT01494506|2242143|P1|NOT COMPLETED|Overall Study||148
927287|NCT01494506|2242141|P3|COMPLETED|Overall Study||14
927288|NCT01494506|2242142|P2|COMPLETED|Overall Study||6
927289|NCT01494506|2242143|P1|COMPLETED|Overall Study|Completed = Subjects remaining on treatment at the time of the primary analysis data cut off.|3
927290|NCT01494506|2242141|P3|Treated Population|Overall Study|2 randomized Arm C patients did not receive study drug. 1 patient each in A and B received Arm C.|117
927291|NCT01494506|2242142|P2|Treated Population|Overall Study||134
927292|NCT01494506|2242143|P1|Treated Population|Overall Study|Treated population: Patients who received at least 1 dose of study drug.|147
927293|NCT01494506|2242141|P3|STARTED|Overall Study||117
927294|NCT01494506|2242142|P2|STARTED|Overall Study||149
927295|NCT01494506|2242143|P1|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|151
927296|NCT01494467|2242180|P2|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
927297|NCT01494467|2242181|P1|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
927298|NCT01494467|2242180|P2|COMPLETED|Part C Safety Follow up (4 Weeks)||159
927299|NCT01494467|2242181|P1|COMPLETED|Part C Safety Follow up (4 Weeks)||353
927300|NCT01494467|2242180|P2|STARTED|Part C Safety Follow up (4 Weeks)||159
927301|NCT01494467|2242181|P1|STARTED|Part C Safety Follow up (4 Weeks)||353
927302|NCT01494467|2242180|P2|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||49
927303|NCT01494467|2242181|P1|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||75
927304|NCT01494467|2242180|P2|COMPLETED|Part B Long Term Active Control 40 Weeks||159
927305|NCT01494467|2242181|P1|COMPLETED|Part B Long Term Active Control 40 Weeks||353
927306|NCT01494467|2242180|P2|STARTED|Part B Long Term Active Control 40 Weeks||208
927307|NCT01494467|2242181|P1|STARTED|Part B Long Term Active Control 40 Weeks|429 completed Part A. Subsequently, one subject discontinued so only 428 entered Part B|428
927308|NCT01494467|2242180|P2|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||21
927309|NCT01494467|2242181|P1|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||30
927310|NCT01494467|2242180|P2|COMPLETED|Part A Vehicle Control (12 Weeks)||208
927311|NCT01494467|2242181|P1|COMPLETED|Part A Vehicle Control (12 Weeks)||429
927312|NCT01494467|2242180|P2|STARTED|Part A Vehicle Control (12 Weeks)||229
927313|NCT01494467|2242181|P1|STARTED|Part A Vehicle Control (12 Weeks)||459
927314|NCT01493180|2242199|P2|NOT COMPLETED|Overall Study||2
927315|NCT01493180|2242200|P1|NOT COMPLETED|Overall Study||3
927316|NCT01493180|2242199|P2|COMPLETED|Overall Study||49
927317|NCT01493180|2242200|P1|COMPLETED|Overall Study||48
927318|NCT01493180|2242199|P2|STARTED|Overall Study||51
927319|NCT01493180|2242200|P1|STARTED|Overall Study||51
927320|NCT01494350|2242206|P1|NOT COMPLETED|Overall Study||1
927321|NCT01494350|2242206|P1|COMPLETED|Overall Study||49
927322|NCT01494350|2242206|P1|STARTED|Overall Study||50
927323|NCT01494298|2242216|P2|NOT COMPLETED|Overall Study||8
927324|NCT01494298|2242217|P1|NOT COMPLETED|Overall Study||2
927325|NCT01494298|2242216|P2|COMPLETED|Overall Study||47
927326|NCT01494298|2242217|P1|COMPLETED|Overall Study||54
927327|NCT01494298|2242216|P2|STARTED|Overall Study||55
927328|NCT01494298|2242217|P1|STARTED|Overall Study||56
927329|NCT01493947|2242229|P2|NOT COMPLETED|Period B Extension Period||32
927330|NCT01493947|2242230|P1|NOT COMPLETED|Period B Extension Period||33
927331|NCT01493947|2242229|P2|COMPLETED|Period B Extension Period||326
927332|NCT01493947|2242230|P1|COMPLETED|Period B Extension Period||366
927333|NCT01493947|2242229|P2|STARTED|Period B Extension Period|358 / 456 subjects were eligible to enter in Period B (i.e IGA =0 or 1 at end of Period A).|358
927334|NCT01493947|2242230|P1|STARTED|Period B Extension Period|Only 399 /446 subjects were eligible to enter in Period B (i.e IGA=0 or1 at end of Period A).|399
927335|NCT01493947|2242229|P2|NOT COMPLETED|Period A Efficacy and Safety Data||28
927336|NCT01493947|2242230|P1|NOT COMPLETED|Period A Efficacy and Safety Data||32
927337|NCT01493947|2242229|P2|COMPLETED|Period A Efficacy and Safety Data||456
927338|NCT01493947|2242230|P1|COMPLETED|Period A Efficacy and Safety Data||446
927339|NCT01493947|2242229|P2|STARTED|Period A Efficacy and Safety Data||484
927340|NCT01493947|2242230|P1|STARTED|Period A Efficacy and Safety Data||478
927341|NCT01493687|2242242|P2|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||1
927342|NCT01493687|2242243|P1|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
927343|NCT01493687|2242242|P2|COMPLETED|Part C Safety Follow up (4 Weeks)||174
927344|NCT01493687|2242243|P1|COMPLETED|Part C Safety Follow up (4 Weeks)||350
927345|NCT01493687|2242242|P2|STARTED|Part C Safety Follow up (4 Weeks)||175
927346|NCT01493687|2242243|P1|STARTED|Part C Safety Follow up (4 Weeks)|351 completed Part B. Then 1 discontinued (subject request) prior to Part C.|350
927347|NCT01493687|2242242|P2|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||35
927523|NCT01491035|2242846|P2|NOT COMPLETED|Overall Study||0
927348|NCT01493687|2242243|P1|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||61
927349|NCT01493687|2242242|P2|COMPLETED|Part B Long Term Active Control 40 Weeks||175
927350|NCT01493687|2242243|P1|COMPLETED|Part B Long Term Active Control 40 Weeks||351
927351|NCT01493687|2242242|P2|STARTED|Part B Long Term Active Control 40 Weeks||210
927352|NCT01493687|2242243|P1|STARTED|Part B Long Term Active Control 40 Weeks|414 completed Part A. Then 2 discontinued (lack of efficacy, subject request) prior to Part B.|412
927353|NCT01493687|2242242|P2|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||22
927354|NCT01493687|2242243|P1|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||37
927355|NCT01493687|2242242|P2|COMPLETED|Part A Vehicle Control (12 Weeks)||210
927356|NCT01493687|2242243|P1|COMPLETED|Part A Vehicle Control (12 Weeks)||414
927357|NCT01493687|2242242|P2|STARTED|Part A Vehicle Control (12 Weeks)||232
927358|NCT01493687|2242243|P1|STARTED|Part A Vehicle Control (12 Weeks)||451
927359|NCT01493557|2242262|P3|NOT COMPLETED|Adding the Second Strategy||0
927360|NCT01493557|2242263|P2|NOT COMPLETED|Adding the Second Strategy||4
927361|NCT01493557|2242264|P1|NOT COMPLETED|Adding the Second Strategy||2
927362|NCT01493557|2242262|P3|COMPLETED|Adding the Second Strategy||0
927363|NCT01493557|2242263|P2|COMPLETED|Adding the Second Strategy||11
927364|NCT01493557|2242264|P1|COMPLETED|Adding the Second Strategy||12
927365|NCT01493557|2242262|P3|STARTED|Adding the Second Strategy||0
927366|NCT01493557|2242263|P2|STARTED|Adding the Second Strategy||15
927367|NCT01493557|2242264|P1|STARTED|Adding the Second Strategy||14
927368|NCT01493557|2242262|P3|NOT COMPLETED|Randomized to Management Strategies||0
927369|NCT01493557|2242263|P2|NOT COMPLETED|Randomized to Management Strategies||11
927370|NCT01493557|2242264|P1|NOT COMPLETED|Randomized to Management Strategies||15
927371|NCT01493557|2242262|P3|COMPLETED|Randomized to Management Strategies||0
927372|NCT01493557|2242263|P2|COMPLETED|Randomized to Management Strategies||47
927373|NCT01493557|2242264|P1|COMPLETED|Randomized to Management Strategies||44
927374|NCT01493557|2242262|P3|STARTED|Randomized to Management Strategies||0
927375|NCT01493557|2242263|P2|STARTED|Randomized to Management Strategies||58
927376|NCT01493557|2242264|P1|STARTED|Randomized to Management Strategies||59
927377|NCT01493557|2242262|P3|NOT COMPLETED|Not Randomized to Management Strategies||134
927378|NCT01493557|2242263|P2|NOT COMPLETED|Not Randomized to Management Strategies||0
927379|NCT01493557|2242264|P1|NOT COMPLETED|Not Randomized to Management Strategies||0
927380|NCT01493557|2242262|P3|COMPLETED|Not Randomized to Management Strategies||816
927381|NCT01493557|2242263|P2|COMPLETED|Not Randomized to Management Strategies||0
927382|NCT01493557|2242264|P1|COMPLETED|Not Randomized to Management Strategies||0
927383|NCT01493557|2242262|P3|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies|26 patients completed (GIS resolved ) and 4 patients completed (GIS not resolved ) the trial.|48
927384|NCT01493557|2242263|P2|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
927385|NCT01493557|2242264|P1|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
927386|NCT01493557|2242262|P3|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies|32 patients completed the trial.|48
927387|NCT01493557|2242263|P2|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
927388|NCT01493557|2242264|P1|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
927389|NCT01493557|2242262|P3|Without Experiencing GIS|Not Randomized to Management Strategies|754 patients completed the trial.|854
927390|NCT01493557|2242263|P2|Without Experiencing GIS|Not Randomized to Management Strategies||0
927391|NCT01493557|2242264|P1|Without Experiencing GIS|Not Randomized to Management Strategies||0
927392|NCT01493557|2242262|P3|STARTED|Not Randomized to Management Strategies||950
927393|NCT01493557|2242263|P2|STARTED|Not Randomized to Management Strategies||0
927394|NCT01493557|2242264|P1|STARTED|Not Randomized to Management Strategies||0
927395|NCT01493531|2242292|P3|NOT COMPLETED|Overall Study||48
927396|NCT01493531|2242293|P2|NOT COMPLETED|Overall Study||50
927397|NCT01493531|2242294|P1|NOT COMPLETED|Overall Study||41
927398|NCT01493531|2242292|P3|COMPLETED|Overall Study||158
927399|NCT01493531|2242293|P2|COMPLETED|Overall Study||150
927400|NCT01493531|2242294|P1|COMPLETED|Overall Study||163
927401|NCT01493531|2242292|P3|STARTED|Overall Study||206
927402|NCT01493531|2242293|P2|STARTED|Overall Study||200
927403|NCT01493531|2242294|P1|STARTED|Overall Study||204
927404|NCT01493427|2242308|P1|NOT COMPLETED|Overall Study||20
927405|NCT01493427|2242308|P1|COMPLETED|Overall Study||179
927406|NCT01493427|2242308|P1|STARTED|Overall Study||199
927407|NCT01493167|2242313|P1|NOT COMPLETED|Overall Study||0
927408|NCT01493167|2242313|P1|COMPLETED|Overall Study||97
927409|NCT01493167|2242313|P1|STARTED|Overall Study||97
927410|NCT01493089|2242319|P2|NOT COMPLETED|Overall Study||3
927411|NCT01493089|2242320|P1|NOT COMPLETED|Overall Study||3
927412|NCT01493089|2242319|P2|COMPLETED|Overall Study||114
927413|NCT01493089|2242320|P1|COMPLETED|Overall Study||119
927414|NCT01493089|2242319|P2|STARTED|Overall Study||117
927415|NCT01493089|2242320|P1|STARTED|Overall Study||122
927416|NCT01492439|2242338|P2|NOT COMPLETED|Overall Study||9
927417|NCT01492439|2242339|P1|NOT COMPLETED|Overall Study||4
927418|NCT01492439|2242338|P2|COMPLETED|Overall Study||9
927419|NCT01492439|2242339|P1|COMPLETED|Overall Study||15
927420|NCT01492439|2242338|P2|Post-intervention|Overall Study||13
927421|NCT01492439|2242339|P1|Post-intervention|Overall Study||18
927422|NCT01492439|2242338|P2|STARTED|Overall Study||18
927423|NCT01492439|2242339|P1|STARTED|Overall Study||19
927424|NCT01492426|2242387|P2|NOT COMPLETED|Follow-Up||10
927425|NCT01492426|2242388|P1|NOT COMPLETED|Follow-Up||25
927426|NCT01492426|2242387|P2|COMPLETED|Follow-Up||181
927427|NCT01492426|2242388|P1|COMPLETED|Follow-Up||359
927428|NCT01492426|2242387|P2|STARTED|Follow-Up|This total number includes 160 who completed treatment plus 31 who rejoined for follow-up.|191
927429|NCT01492426|2242388|P1|STARTED|Follow-Up|This total number includes 319 who completed treatment plus 65 who rejoined for follow-up.|384
927430|NCT01492426|2242387|P2|NOT COMPLETED|Treatment||40
927431|NCT01492426|2242388|P1|NOT COMPLETED|Treatment||83
927432|NCT01492426|2242387|P2|COMPLETED|Treatment||160
927433|NCT01492426|2242388|P1|COMPLETED|Treatment||319
927434|NCT01492426|2242387|P2|STARTED|Treatment||200
927435|NCT01492426|2242388|P1|STARTED|Treatment||402
927436|NCT01492400|2242406|P2|NOT COMPLETED|Overall Study||16
927437|NCT01492400|2242407|P1|NOT COMPLETED|Overall Study||16
927438|NCT01492400|2242406|P2|COMPLETED|Overall Study||166
927439|NCT01492400|2242407|P1|COMPLETED|Overall Study||165
927440|NCT01492400|2242406|P2|STARTED|Overall Study||182
927441|NCT01492400|2242407|P1|STARTED|Overall Study||181
927442|NCT01492088|2242420|P3|NOT COMPLETED|Overall Study||13
927443|NCT01492088|2242421|P2|NOT COMPLETED|Overall Study||14
927444|NCT01492088|2242422|P1|NOT COMPLETED|Overall Study||3
927445|NCT01492088|2242420|P3|COMPLETED|Overall Study||4
927446|NCT01492088|2242421|P2|COMPLETED|Overall Study||2
927447|NCT01492088|2242422|P1|COMPLETED|Overall Study||0
927448|NCT01492088|2242420|P3|STARTED|Overall Study||17
927449|NCT01492088|2242421|P2|STARTED|Overall Study||16
927450|NCT01492088|2242422|P1|STARTED|Overall Study||3
927451|NCT01491984|2242482|P2|NOT COMPLETED|Overall Study||1
927452|NCT01491984|2242483|P1|NOT COMPLETED|Overall Study||2
927453|NCT01491984|2242482|P2|COMPLETED|Overall Study||44
927454|NCT01491984|2242483|P1|COMPLETED|Overall Study||47
927455|NCT01491984|2242482|P2|STARTED|Overall Study||45
927456|NCT01491984|2242483|P1|STARTED|Overall Study||49
927457|NCT01491919|2242492|P3|NOT COMPLETED|Overall Study||1
927458|NCT01491919|2242493|P2|NOT COMPLETED|Overall Study||2
927459|NCT01491919|2242494|P1|NOT COMPLETED|Overall Study||1
927460|NCT01491919|2242492|P3|COMPLETED|Overall Study||2
927461|NCT01491919|2242493|P2|COMPLETED|Overall Study||8
927462|NCT01491919|2242494|P1|COMPLETED|Overall Study||12
927463|NCT01491919|2242492|P3|STARTED|Overall Study||3
927464|NCT01491919|2242493|P2|STARTED|Overall Study||10
927465|NCT01491919|2242494|P1|STARTED|Overall Study||13
927466|NCT01491802|2242540|P2|NOT COMPLETED|Overall Study||2
927467|NCT01491802|2242541|P1|NOT COMPLETED|Overall Study||1
927468|NCT01491802|2242540|P2|COMPLETED|Overall Study||6
927469|NCT01491802|2242541|P1|COMPLETED|Overall Study||8
927470|NCT01491802|2242540|P2|STARTED|Overall Study||8
927471|NCT01491802|2242541|P1|STARTED|Overall Study||9
927472|NCT01491737|2242568|P2|NOT COMPLETED|Overall Study||50
927473|NCT01491737|2242569|P1|NOT COMPLETED|Overall Study||49
927474|NCT01491737|2242568|P2|COMPLETED|Overall Study||79
927475|NCT01491737|2242569|P1|COMPLETED|Overall Study||80
927476|NCT01491737|2242568|P2|STARTED|Overall Study||129
927477|NCT01491737|2242569|P1|STARTED|Overall Study||129
927478|NCT01491672|2242592|P3|NOT COMPLETED|Overall Study||11
927479|NCT01491672|2242593|P2|NOT COMPLETED|Overall Study||60
927480|NCT01491672|2242594|P1|NOT COMPLETED|Overall Study||56
927481|NCT01491672|2242592|P3|COMPLETED|Overall Study||3
927482|NCT01491672|2242593|P2|COMPLETED|Overall Study||2
927483|NCT01491672|2242594|P1|COMPLETED|Overall Study||2
927484|NCT01491672|2242592|P3|Safety Set|Overall Study||14
927485|NCT01491672|2242593|P2|Safety Set|Overall Study||61
927486|NCT01491672|2242594|P1|Safety Set|Overall Study||58
927487|NCT01491672|2242592|P3|STARTED|Overall Study||14
927488|NCT01491672|2242593|P2|STARTED|Overall Study|1 participant died prior to treatment initiation.|62
927489|NCT01491672|2242594|P1|STARTED|Overall Study||58
927490|NCT01491633|2242619|P1|NOT COMPLETED|Overall Study||5
927491|NCT01491633|2242619|P1|COMPLETED|Overall Study||0
927492|NCT01491633|2242619|P1|STARTED|Overall Study||5
927493|NCT01491607|2242631|P1|NOT COMPLETED|Overall Study||10
927494|NCT01491607|2242631|P1|COMPLETED|Overall Study||190
927495|NCT01491607|2242631|P1|STARTED|Overall Study||200
927496|NCT01491490|2242729|P2|NOT COMPLETED|Overall Study||0
927497|NCT01491490|2242730|P1|NOT COMPLETED|Overall Study||0
927498|NCT01491490|2242729|P2|COMPLETED|Overall Study||1
927499|NCT01491490|2242730|P1|COMPLETED|Overall Study||1
927500|NCT01491490|2242729|P2|STARTED|Overall Study||1
927501|NCT01491490|2242730|P1|STARTED|Overall Study||1
927502|NCT01491113|2242741|P5|NOT COMPLETED|Overall Study||0
927503|NCT01491113|2242742|P4|NOT COMPLETED|Overall Study||0
927504|NCT01491113|2242743|P3|NOT COMPLETED|Overall Study||0
927505|NCT01491113|2242744|P2|NOT COMPLETED|Overall Study||0
927506|NCT01491113|2242745|P1|NOT COMPLETED|Overall Study||0
927507|NCT01491113|2242741|P5|COMPLETED|Overall Study||6
927508|NCT01491113|2242742|P4|COMPLETED|Overall Study||6
927509|NCT01491113|2242743|P3|COMPLETED|Overall Study||6
927510|NCT01491113|2242744|P2|COMPLETED|Overall Study||6
927511|NCT01491113|2242745|P1|COMPLETED|Overall Study||6
927512|NCT01491113|2242741|P5|STARTED|Overall Study||6
927513|NCT01491113|2242742|P4|STARTED|Overall Study||6
927514|NCT01491113|2242743|P3|STARTED|Overall Study||6
927515|NCT01491113|2242744|P2|STARTED|Overall Study||6
927516|NCT01491113|2242745|P1|STARTED|Overall Study||6
927517|NCT01491035|2242840|P8|NOT COMPLETED|Overall Study||0
927518|NCT01491035|2242841|P7|NOT COMPLETED|Overall Study||0
927519|NCT01491035|2242842|P6|NOT COMPLETED|Overall Study||0
927520|NCT01491035|2242843|P5|NOT COMPLETED|Overall Study||1
927521|NCT01491035|2242844|P4|NOT COMPLETED|Overall Study||0
927522|NCT01491035|2242845|P3|NOT COMPLETED|Overall Study||0
927524|NCT01491035|2242847|P1|NOT COMPLETED|Overall Study||0
927525|NCT01491035|2242840|P8|COMPLETED|Overall Study||6
927526|NCT01491035|2242841|P7|COMPLETED|Overall Study||6
927527|NCT01491035|2242842|P6|COMPLETED|Overall Study||6
927528|NCT01491035|2242843|P5|COMPLETED|Overall Study||5
927529|NCT01491035|2242844|P4|COMPLETED|Overall Study||6
927530|NCT01491035|2242845|P3|COMPLETED|Overall Study||6
927531|NCT01491035|2242846|P2|COMPLETED|Overall Study||6
927532|NCT01491035|2242847|P1|COMPLETED|Overall Study||6
927533|NCT01491035|2242840|P8|STARTED|Overall Study||6
927534|NCT01491035|2242841|P7|STARTED|Overall Study||6
927535|NCT01491035|2242842|P6|STARTED|Overall Study||6
927536|NCT01491035|2242843|P5|STARTED|Overall Study||6
927537|NCT01491035|2242844|P4|STARTED|Overall Study||6
927538|NCT01491035|2242845|P3|STARTED|Overall Study||6
927539|NCT01491035|2242846|P2|STARTED|Overall Study||6
927540|NCT01491035|2242847|P1|STARTED|Overall Study||6
927541|NCT01491022|2242915|P2|NOT COMPLETED|Intervention 2||0
927542|NCT01491022|2242916|P1|NOT COMPLETED|Intervention 2||1
927543|NCT01491022|2242915|P2|COMPLETED|Intervention 2||11
927544|NCT01491022|2242916|P1|COMPLETED|Intervention 2||8
927545|NCT01491022|2242915|P2|STARTED|Intervention 2||11
927546|NCT01491022|2242916|P1|STARTED|Intervention 2||9
927547|NCT01491022|2242915|P2|NOT COMPLETED|2 Week Washout||0
927548|NCT01491022|2242916|P1|NOT COMPLETED|2 Week Washout||0
927549|NCT01491022|2242915|P2|COMPLETED|2 Week Washout||11
927550|NCT01491022|2242916|P1|COMPLETED|2 Week Washout||9
927551|NCT01491022|2242915|P2|STARTED|2 Week Washout||11
927552|NCT01491022|2242916|P1|STARTED|2 Week Washout||9
927553|NCT01491022|2242915|P2|NOT COMPLETED|Intervention 1||1
927554|NCT01491022|2242916|P1|NOT COMPLETED|Intervention 1||1
927555|NCT01491022|2242915|P2|COMPLETED|Intervention 1||11
927556|NCT01491022|2242916|P1|COMPLETED|Intervention 1||9
927557|NCT01491022|2242915|P2|STARTED|Intervention 1||12
927558|NCT01491022|2242916|P1|STARTED|Intervention 1||10
927559|NCT01490931|2242932|P1|NOT COMPLETED|Overall Study||0
927560|NCT01490931|2242932|P1|COMPLETED|Overall Study||25
927561|NCT01490931|2242932|P1|STARTED|Overall Study||25
927562|NCT01490866|2242948|P1|NOT COMPLETED|Axitinib Maintenance Therapy||49
927563|NCT01490866|2242948|P1|COMPLETED|Axitinib Maintenance Therapy|No protocol defined endpoint to Axitinib maintenance treatment.|0
927564|NCT01490866|2242948|P1|STARTED|Axitinib Maintenance Therapy||49
927565|NCT01490866|2242948|P1|NOT COMPLETED|FOLFOX/Bevacizumab Treatment||21
927566|NCT01490866|2242948|P1|COMPLETED|FOLFOX/Bevacizumab Treatment||49
927567|NCT01490866|2242948|P1|STARTED|FOLFOX/Bevacizumab Treatment||70
927568|NCT01490840|2242959|P2|NOT COMPLETED|Phase 2||6
927569|NCT01490840|2242960|P1|NOT COMPLETED|Phase 2||6
927570|NCT01490840|2242959|P2|COMPLETED|Phase 2||68
927571|NCT01490840|2242960|P1|COMPLETED|Phase 2||75
927572|NCT01490840|2242959|P2|STARTED|Phase 2|4 participants discontinued between phase 1 and phase 2|74
927573|NCT01490840|2242960|P1|STARTED|Phase 2|3 participants discontinued between phase 1 and phase 2|81
927574|NCT01490840|2242959|P2|NOT COMPLETED|Phase 1||6
927575|NCT01490840|2242960|P1|NOT COMPLETED|Phase 1||10
927576|NCT01490840|2242959|P2|COMPLETED|Phase 1||78
927577|NCT01490840|2242960|P1|COMPLETED|Phase 1||84
927578|NCT01490840|2242959|P2|Modified Full Analysis Set|Phase 1||83
927579|NCT01490840|2242960|P1|Modified Full Analysis Set|Phase 1||56
927580|NCT01490840|2242959|P2|STARTED|Phase 1||84
927581|NCT01490840|2242960|P1|STARTED|Phase 1||94
927582|NCT01490697|2242984|P2|NOT COMPLETED|Overall Study||2
927583|NCT01490697|2242985|P1|NOT COMPLETED|Overall Study||1
927584|NCT01490697|2242984|P2|COMPLETED|Overall Study||16
927585|NCT01490697|2242985|P1|COMPLETED|Overall Study||15
927586|NCT01490697|2242984|P2|STARTED|Overall Study||18
927587|NCT01490697|2242985|P1|STARTED|Overall Study||16
927588|NCT01490632|2242998|P20|NOT COMPLETED|Part D: Re-Treatment Period||7
927589|NCT01490632|2242999|P19|NOT COMPLETED|Part D: Re-Treatment Period||7
927590|NCT01490632|2243000|P18|NOT COMPLETED|Part D: Re-Treatment Period||5
927591|NCT01490632|2243001|P17|NOT COMPLETED|Part D: Re-Treatment Period||0
927592|NCT01490632|2243002|P16|NOT COMPLETED|Part D: Re-Treatment Period||0
927593|NCT01490632|2243003|P15|NOT COMPLETED|Part D: Re-Treatment Period||0
927594|NCT01490632|2243004|P14|NOT COMPLETED|Part D: Re-Treatment Period||0
927595|NCT01490632|2243005|P13|NOT COMPLETED|Part D: Re-Treatment Period||0
927596|NCT01490632|2243006|P12|NOT COMPLETED|Part D: Re-Treatment Period||0
927597|NCT01490632|2243007|P11|NOT COMPLETED|Part D: Re-Treatment Period||0
927598|NCT01490632|2243008|P10|NOT COMPLETED|Part D: Re-Treatment Period||0
927599|NCT01490632|2243009|P9|NOT COMPLETED|Part D: Re-Treatment Period||0
927600|NCT01490632|2243010|P8|NOT COMPLETED|Part D: Re-Treatment Period||0
927601|NCT01490632|2243011|P7|NOT COMPLETED|Part D: Re-Treatment Period||0
927602|NCT01490632|2243012|P6|NOT COMPLETED|Part D: Re-Treatment Period||0
927603|NCT01490632|2243013|P5|NOT COMPLETED|Part D: Re-Treatment Period||0
927604|NCT01490632|2243014|P4|NOT COMPLETED|Part D: Re-Treatment Period||0
927605|NCT01490632|2243015|P3|NOT COMPLETED|Part D: Re-Treatment Period||0
927606|NCT01490632|2243016|P2|NOT COMPLETED|Part D: Re-Treatment Period||0
927607|NCT01490632|2243017|P1|NOT COMPLETED|Part D: Re-Treatment Period||0
927608|NCT01490632|2242998|P20|COMPLETED|Part D: Re-Treatment Period||30
927609|NCT01490632|2242999|P19|COMPLETED|Part D: Re-Treatment Period||12
927610|NCT01490632|2243000|P18|COMPLETED|Part D: Re-Treatment Period||8
927611|NCT01490632|2243001|P17|COMPLETED|Part D: Re-Treatment Period||3
927612|NCT01490632|2243002|P16|COMPLETED|Part D: Re-Treatment Period||0
927613|NCT01490632|2243003|P15|COMPLETED|Part D: Re-Treatment Period||0
927614|NCT01490632|2243004|P14|COMPLETED|Part D: Re-Treatment Period||0
927615|NCT01490632|2243005|P13|COMPLETED|Part D: Re-Treatment Period||0
927616|NCT01490632|2243006|P12|COMPLETED|Part D: Re-Treatment Period||0
927617|NCT01490632|2243007|P11|COMPLETED|Part D: Re-Treatment Period||0
927618|NCT01490632|2243008|P10|COMPLETED|Part D: Re-Treatment Period||0
927619|NCT01490632|2243009|P9|COMPLETED|Part D: Re-Treatment Period||0
927620|NCT01490632|2243010|P8|COMPLETED|Part D: Re-Treatment Period||0
927621|NCT01490632|2243011|P7|COMPLETED|Part D: Re-Treatment Period||0
927622|NCT01490632|2243012|P6|COMPLETED|Part D: Re-Treatment Period||0
927623|NCT01490632|2243013|P5|COMPLETED|Part D: Re-Treatment Period||0
927624|NCT01490632|2243014|P4|COMPLETED|Part D: Re-Treatment Period||0
927625|NCT01490632|2243015|P3|COMPLETED|Part D: Re-Treatment Period||0
927626|NCT01490632|2243016|P2|COMPLETED|Part D: Re-Treatment Period||0
927627|NCT01490632|2243017|P1|COMPLETED|Part D: Re-Treatment Period||0
927628|NCT01490632|2242998|P20|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 10 mg.|37
927629|NCT01490632|2242999|P19|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 8 mg.|19
927630|NCT01490632|2243000|P18|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 4 mg.|13
927631|NCT01490632|2243001|P17|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 2 mg.|3
927632|NCT01490632|2243002|P16|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|0
927633|NCT01490632|2243003|P15|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|0
927634|NCT01490632|2243004|P14|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|0
927635|NCT01490632|2243005|P13|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|0
927636|NCT01490632|2243006|P12|STARTED|Part D: Re-Treatment Period||0
927637|NCT01490632|2243007|P11|STARTED|Part D: Re-Treatment Period||0
927638|NCT01490632|2243008|P10|STARTED|Part D: Re-Treatment Period||0
927639|NCT01490632|2243009|P9|STARTED|Part D: Re-Treatment Period||0
927640|NCT01490632|2243010|P8|STARTED|Part D: Re-Treatment Period||0
927641|NCT01490632|2243011|P7|STARTED|Part D: Re-Treatment Period||0
927642|NCT01490632|2243012|P6|STARTED|Part D: Re-Treatment Period||0
927643|NCT01490632|2243013|P5|STARTED|Part D: Re-Treatment Period||0
927644|NCT01490632|2243014|P4|STARTED|Part D: Re-Treatment Period||0
927645|NCT01490632|2243015|P3|STARTED|Part D: Re-Treatment Period||0
927646|NCT01490632|2243016|P2|STARTED|Part D: Re-Treatment Period||0
927647|NCT01490632|2243017|P1|STARTED|Part D: Re-Treatment Period||0
927648|NCT01490632|2242998|P20|NOT COMPLETED|Part C: Washout or Step-Down Period||0
927649|NCT01490632|2242999|P19|NOT COMPLETED|Part C: Washout or Step-Down Period||0
927650|NCT01490632|2243000|P18|NOT COMPLETED|Part C: Washout or Step-Down Period||0
927651|NCT01490632|2243001|P17|NOT COMPLETED|Part C: Washout or Step-Down Period||0
927652|NCT01490632|2243002|P16|NOT COMPLETED|Part C: Washout or Step-Down Period||37
927653|NCT01490632|2243003|P15|NOT COMPLETED|Part C: Washout or Step-Down Period||18
927654|NCT01490632|2243004|P14|NOT COMPLETED|Part C: Washout or Step-Down Period||10
927655|NCT01490632|2243005|P13|NOT COMPLETED|Part C: Washout or Step-Down Period||5
927656|NCT01490632|2243006|P12|NOT COMPLETED|Part C: Washout or Step-Down Period||0
927657|NCT01490632|2243007|P11|NOT COMPLETED|Part C: Washout or Step-Down Period||0
927658|NCT01490632|2243008|P10|NOT COMPLETED|Part C: Washout or Step-Down Period||0
927659|NCT01490632|2243009|P9|NOT COMPLETED|Part C: Washout or Step-Down Period||0
927660|NCT01490632|2243010|P8|NOT COMPLETED|Part C: Washout or Step-Down Period||0
927661|NCT01490632|2243011|P7|NOT COMPLETED|Part C: Washout or Step-Down Period||0
927662|NCT01490632|2243012|P6|NOT COMPLETED|Part C: Washout or Step-Down Period||0
927663|NCT01490632|2243013|P5|NOT COMPLETED|Part C: Washout or Step-Down Period||0
927664|NCT01490632|2243014|P4|NOT COMPLETED|Part C: Washout or Step-Down Period||0
927665|NCT01490632|2243015|P3|NOT COMPLETED|Part C: Washout or Step-Down Period||0
927666|NCT01490632|2243016|P2|NOT COMPLETED|Part C: Washout or Step-Down Period||0
927667|NCT01490632|2243017|P1|NOT COMPLETED|Part C: Washout or Step-Down Period||0
927668|NCT01490632|2242998|P20|COMPLETED|Part C: Washout or Step-Down Period||0
927669|NCT01490632|2242999|P19|COMPLETED|Part C: Washout or Step-Down Period||0
927670|NCT01490632|2243000|P18|COMPLETED|Part C: Washout or Step-Down Period||0
927671|NCT01490632|2243001|P17|COMPLETED|Part C: Washout or Step-Down Period||0
927672|NCT01490632|2243002|P16|COMPLETED|Part C: Washout or Step-Down Period||18
927673|NCT01490632|2243003|P15|COMPLETED|Part C: Washout or Step-Down Period||37
927674|NCT01490632|2243004|P14|COMPLETED|Part C: Washout or Step-Down Period||6
927675|NCT01490632|2243005|P13|COMPLETED|Part C: Washout or Step-Down Period||10
927676|NCT01490632|2243006|P12|COMPLETED|Part C: Washout or Step-Down Period||0
927677|NCT01490632|2243007|P11|COMPLETED|Part C: Washout or Step-Down Period||0
927678|NCT01490632|2243008|P10|COMPLETED|Part C: Washout or Step-Down Period||0
927679|NCT01490632|2243009|P9|COMPLETED|Part C: Washout or Step-Down Period||0
927680|NCT01490632|2243010|P8|COMPLETED|Part C: Washout or Step-Down Period||0
927681|NCT01490632|2243011|P7|COMPLETED|Part C: Washout or Step-Down Period||0
927682|NCT01490632|2243012|P6|COMPLETED|Part C: Washout or Step-Down Period||0
927683|NCT01490632|2243013|P5|COMPLETED|Part C: Washout or Step-Down Period||0
927684|NCT01490632|2243014|P4|COMPLETED|Part C: Washout or Step-Down Period||0
927685|NCT01490632|2243015|P3|COMPLETED|Part C: Washout or Step-Down Period||0
927686|NCT01490632|2243016|P2|COMPLETED|Part C: Washout or Step-Down Period||0
927687|NCT01490632|2243017|P1|COMPLETED|Part C: Washout or Step-Down Period||0
927688|NCT01490632|2242998|P20|STARTED|Part C: Washout or Step-Down Period||0
927689|NCT01490632|2242999|P19|STARTED|Part C: Washout or Step-Down Period||0
927690|NCT01490632|2243000|P18|STARTED|Part C: Washout or Step-Down Period||0
927691|NCT01490632|2243001|P17|STARTED|Part C: Washout or Step-Down Period||0
927692|NCT01490632|2243002|P16|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|55
927693|NCT01490632|2243003|P15|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|55
927694|NCT01490632|2243004|P14|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|16
927695|NCT01490632|2243005|P13|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|15
927696|NCT01490632|2243006|P12|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to Placebo remained on Placebo.|0
927697|NCT01490632|2243007|P11|STARTED|Part C: Washout or Step-Down Period|Part A 10 mg non-responders were discontinued from the study.|0
927698|NCT01490632|2243008|P10|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|0
927699|NCT01490632|2243009|P9|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|0
927700|NCT01490632|2243010|P8|STARTED|Part C: Washout or Step-Down Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|0
927701|NCT01490632|2243011|P7|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|0
927702|NCT01490632|2243012|P6|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|0
927703|NCT01490632|2243013|P5|STARTED|Part C: Washout or Step-Down Period|One participant completed Part B but discontinued without receiving a Part C treatment assignment.|0
927704|NCT01490632|2243014|P4|STARTED|Part C: Washout or Step-Down Period||0
927705|NCT01490632|2243015|P3|STARTED|Part C: Washout or Step-Down Period||0
927706|NCT01490632|2243016|P2|STARTED|Part C: Washout or Step-Down Period||0
927707|NCT01490632|2243017|P1|STARTED|Part C: Washout or Step-Down Period||0
927708|NCT01490632|2242998|P20|NOT COMPLETED|Part B: Extension or Step-Up Period||0
927709|NCT01490632|2242999|P19|NOT COMPLETED|Part B: Extension or Step-Up Period||0
927710|NCT01490632|2243000|P18|NOT COMPLETED|Part B: Extension or Step-Up Period||0
927711|NCT01490632|2243001|P17|NOT COMPLETED|Part B: Extension or Step-Up Period||0
927712|NCT01490632|2243002|P16|NOT COMPLETED|Part B: Extension or Step-Up Period||0
927713|NCT01490632|2243003|P15|NOT COMPLETED|Part B: Extension or Step-Up Period||0
927714|NCT01490632|2243004|P14|NOT COMPLETED|Part B: Extension or Step-Up Period||0
927715|NCT01490632|2243005|P13|NOT COMPLETED|Part B: Extension or Step-Up Period||0
927716|NCT01490632|2243006|P12|NOT COMPLETED|Part B: Extension or Step-Up Period||8
927717|NCT01490632|2243007|P11|NOT COMPLETED|Part B: Extension or Step-Up Period||21
927718|NCT01490632|2243008|P10|NOT COMPLETED|Part B: Extension or Step-Up Period||25
927719|NCT01490632|2243009|P9|NOT COMPLETED|Part B: Extension or Step-Up Period||10
927720|NCT01490632|2243010|P8|NOT COMPLETED|Part B: Extension or Step-Up Period||6
927721|NCT01490632|2243011|P7|NOT COMPLETED|Part B: Extension or Step-Up Period||13
927722|NCT01490632|2243012|P6|NOT COMPLETED|Part B: Extension or Step-Up Period||4
927723|NCT01490632|2243013|P5|NOT COMPLETED|Part B: Extension or Step-Up Period||0
927724|NCT01490632|2243014|P4|NOT COMPLETED|Part B: Extension or Step-Up Period||0
927725|NCT01490632|2243015|P3|NOT COMPLETED|Part B: Extension or Step-Up Period||0
927726|NCT01490632|2243016|P2|NOT COMPLETED|Part B: Extension or Step-Up Period||0
927727|NCT01490632|2243017|P1|NOT COMPLETED|Part B: Extension or Step-Up Period||0
927728|NCT01490632|2242998|P20|COMPLETED|Part B: Extension or Step-Up Period||0
927729|NCT01490632|2242999|P19|COMPLETED|Part B: Extension or Step-Up Period||0
927730|NCT01490632|2243000|P18|COMPLETED|Part B: Extension or Step-Up Period||0
927731|NCT01490632|2243001|P17|COMPLETED|Part B: Extension or Step-Up Period||0
927732|NCT01490632|2243002|P16|COMPLETED|Part B: Extension or Step-Up Period||0
927733|NCT01490632|2243003|P15|COMPLETED|Part B: Extension or Step-Up Period||0
927734|NCT01490632|2243004|P14|COMPLETED|Part B: Extension or Step-Up Period||0
927735|NCT01490632|2243005|P13|COMPLETED|Part B: Extension or Step-Up Period||0
927736|NCT01490632|2243006|P12|COMPLETED|Part B: Extension or Step-Up Period||0
927737|NCT01490632|2243007|P11|COMPLETED|Part B: Extension or Step-Up Period||22
927738|NCT01490632|2243008|P10|COMPLETED|Part B: Extension or Step-Up Period||25
927739|NCT01490632|2243009|P9|COMPLETED|Part B: Extension or Step-Up Period||6
927740|NCT01490632|2243010|P8|COMPLETED|Part B: Extension or Step-Up Period||13
927741|NCT01490632|2243011|P7|COMPLETED|Part B: Extension or Step-Up Period||51
927742|NCT01490632|2243012|P6|COMPLETED|Part B: Extension or Step-Up Period||25
927743|NCT01490632|2243013|P5|COMPLETED|Part B: Extension or Step-Up Period||0
927744|NCT01490632|2243014|P4|COMPLETED|Part B: Extension or Step-Up Period||0
927745|NCT01490632|2243015|P3|COMPLETED|Part B: Extension or Step-Up Period||0
927746|NCT01490632|2243016|P2|COMPLETED|Part B: Extension or Step-Up Period||0
927747|NCT01490632|2243017|P1|COMPLETED|Part B: Extension or Step-Up Period||0
927748|NCT01490632|2242998|P20|STARTED|Part B: Extension or Step-Up Period||0
927749|NCT01490632|2242999|P19|STARTED|Part B: Extension or Step-Up Period||0
927750|NCT01490632|2243000|P18|STARTED|Part B: Extension or Step-Up Period||0
927751|NCT01490632|2243001|P17|STARTED|Part B: Extension or Step-Up Period||0
927752|NCT01490632|2243002|P16|STARTED|Part B: Extension or Step-Up Period||0
927753|NCT01490632|2243003|P15|STARTED|Part B: Extension or Step-Up Period||0
927754|NCT01490632|2243004|P14|STARTED|Part B: Extension or Step-Up Period||0
927755|NCT01490632|2243005|P13|STARTED|Part B: Extension or Step-Up Period||0
927756|NCT01490632|2243006|P12|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to Placebo remained on Placebo.|8
927757|NCT01490632|2243007|P11|STARTED|Part B: Extension or Step-Up Period|Part A 10 mg non-responders were discontinued from the study.|43
927758|NCT01490632|2243008|P10|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|50
927759|NCT01490632|2243009|P9|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|16
927760|NCT01490632|2243010|P8|STARTED|Part B: Extension or Step-Up Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|19
927761|NCT01490632|2243011|P7|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|64
927762|NCT01490632|2243012|P6|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|29
927763|NCT01490632|2243013|P5|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
927764|NCT01490632|2243014|P4|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
927765|NCT01490632|2243015|P3|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
927766|NCT01490632|2243016|P2|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
927767|NCT01490632|2243017|P1|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
927768|NCT01490632|2242998|P20|NOT COMPLETED|Part A: Initial Treatment Period||0
927769|NCT01490632|2242999|P19|NOT COMPLETED|Part A: Initial Treatment Period||0
927770|NCT01490632|2243000|P18|NOT COMPLETED|Part A: Initial Treatment Period||0
927771|NCT01490632|2243001|P17|NOT COMPLETED|Part A: Initial Treatment Period||0
927772|NCT01490632|2243002|P16|NOT COMPLETED|Part A: Initial Treatment Period||0
927773|NCT01490632|2243003|P15|NOT COMPLETED|Part A: Initial Treatment Period||0
927774|NCT01490632|2243004|P14|NOT COMPLETED|Part A: Initial Treatment Period||0
927775|NCT01490632|2243005|P13|NOT COMPLETED|Part A: Initial Treatment Period||0
927776|NCT01490632|2243006|P12|NOT COMPLETED|Part A: Initial Treatment Period||0
927777|NCT01490632|2243007|P11|NOT COMPLETED|Part A: Initial Treatment Period||0
927778|NCT01490632|2243008|P10|NOT COMPLETED|Part A: Initial Treatment Period||0
927779|NCT01490632|2243009|P9|NOT COMPLETED|Part A: Initial Treatment Period||0
927780|NCT01490632|2243010|P8|NOT COMPLETED|Part A: Initial Treatment Period||0
927781|NCT01490632|2243011|P7|NOT COMPLETED|Part A: Initial Treatment Period||0
927782|NCT01490632|2243012|P6|NOT COMPLETED|Part A: Initial Treatment Period||0
927783|NCT01490632|2243013|P5|NOT COMPLETED|Part A: Initial Treatment Period||17
927784|NCT01490632|2243014|P4|NOT COMPLETED|Part A: Initial Treatment Period||9
927785|NCT01490632|2243015|P3|NOT COMPLETED|Part A: Initial Treatment Period||5
927786|NCT01490632|2243016|P2|NOT COMPLETED|Part A: Initial Treatment Period||4
927787|NCT01490632|2243017|P1|NOT COMPLETED|Part A: Initial Treatment Period||7
927788|NCT01490632|2242998|P20|COMPLETED|Part A: Initial Treatment Period||0
927789|NCT01490632|2242999|P19|COMPLETED|Part A: Initial Treatment Period||0
927790|NCT01490632|2243000|P18|COMPLETED|Part A: Initial Treatment Period||0
927791|NCT01490632|2243001|P17|COMPLETED|Part A: Initial Treatment Period||0
927792|NCT01490632|2243002|P16|COMPLETED|Part A: Initial Treatment Period||0
927793|NCT01490632|2243003|P15|COMPLETED|Part A: Initial Treatment Period||0
927794|NCT01490632|2243004|P14|COMPLETED|Part A: Initial Treatment Period||0
927795|NCT01490632|2243005|P13|COMPLETED|Part A: Initial Treatment Period||0
927796|NCT01490632|2243006|P12|COMPLETED|Part A: Initial Treatment Period||0
927797|NCT01490632|2243007|P11|COMPLETED|Part A: Initial Treatment Period||0
927798|NCT01490632|2243008|P10|COMPLETED|Part A: Initial Treatment Period||0
927799|NCT01490632|2243009|P9|COMPLETED|Part A: Initial Treatment Period||0
927800|NCT01490632|2243010|P8|COMPLETED|Part A: Initial Treatment Period||0
927801|NCT01490632|2243011|P7|COMPLETED|Part A: Initial Treatment Period||0
927802|NCT01490632|2243012|P6|COMPLETED|Part A: Initial Treatment Period||0
927803|NCT01490632|2243013|P5|COMPLETED|Part A: Initial Treatment Period|Includes participants who completed Part A, but discontinued per protocol using Part A PASI score.|52
927804|NCT01490632|2243014|P4|COMPLETED|Part A: Initial Treatment Period||55
927805|NCT01490632|2243015|P3|COMPLETED|Part A: Initial Treatment Period||67
927806|NCT01490632|2243016|P2|COMPLETED|Part A: Initial Treatment Period||28
927807|NCT01490632|2243017|P1|COMPLETED|Part A: Initial Treatment Period||27
927808|NCT01490632|2242998|P20|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
927809|NCT01490632|2242999|P19|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
927810|NCT01490632|2243000|P18|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
927811|NCT01490632|2243001|P17|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
927812|NCT01490632|2243002|P16|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
927813|NCT01490632|2243003|P15|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
927814|NCT01490632|2243004|P14|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
927815|NCT01490632|2243005|P13|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
927816|NCT01490632|2243006|P12|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
927817|NCT01490632|2243007|P11|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
927818|NCT01490632|2243008|P10|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
927819|NCT01490632|2243009|P9|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
927820|NCT01490632|2243010|P8|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
927821|NCT01490632|2243011|P7|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
927822|NCT01490632|2243012|P6|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
927823|NCT01490632|2243013|P5|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||69
927824|NCT01490632|2243014|P4|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||64
927825|NCT01490632|2243015|P3|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||72
927826|NCT01490632|2243016|P2|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||32
927827|NCT01490632|2243017|P1|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||34
927828|NCT01490632|2242998|P20|STARTED|Part A: Initial Treatment Period||0
927829|NCT01490632|2242999|P19|STARTED|Part A: Initial Treatment Period||0
927830|NCT01490632|2243000|P18|STARTED|Part A: Initial Treatment Period||0
927831|NCT01490632|2243001|P17|STARTED|Part A: Initial Treatment Period||0
927832|NCT01490632|2243002|P16|STARTED|Part A: Initial Treatment Period||0
927833|NCT01490632|2243003|P15|STARTED|Part A: Initial Treatment Period||0
927834|NCT01490632|2243004|P14|STARTED|Part A: Initial Treatment Period||0
927835|NCT01490632|2243005|P13|STARTED|Part A: Initial Treatment Period||0
927836|NCT01490632|2243006|P12|STARTED|Part A: Initial Treatment Period||0
927837|NCT01490632|2243007|P11|STARTED|Part A: Initial Treatment Period||0
927838|NCT01490632|2243008|P10|STARTED|Part A: Initial Treatment Period||0
927839|NCT01490632|2243009|P9|STARTED|Part A: Initial Treatment Period||0
927840|NCT01490632|2243010|P8|STARTED|Part A: Initial Treatment Period||0
927841|NCT01490632|2243011|P7|STARTED|Part A: Initial Treatment Period||0
927842|NCT01490632|2243012|P6|STARTED|Part A: Initial Treatment Period||0
927843|NCT01490632|2243013|P5|STARTED|Part A: Initial Treatment Period||69
927844|NCT01490632|2243014|P4|STARTED|Part A: Initial Treatment Period||64
927845|NCT01490632|2243015|P3|STARTED|Part A: Initial Treatment Period||72
927846|NCT01490632|2243016|P2|STARTED|Part A: Initial Treatment Period||32
927847|NCT01490632|2243017|P1|STARTED|Part A: Initial Treatment Period||34
927848|NCT01490294|2243149|P4|NOT COMPLETED|Overall Study||1
927849|NCT01490294|2243150|P3|NOT COMPLETED|Overall Study||1
927850|NCT01490294|2243151|P2|NOT COMPLETED|Overall Study||0
927851|NCT01490294|2243152|P1|NOT COMPLETED|Overall Study||5
927852|NCT01490294|2243149|P4|COMPLETED|Overall Study||54
927853|NCT01490294|2243150|P3|COMPLETED|Overall Study||58
927854|NCT01490294|2243151|P2|COMPLETED|Overall Study||60
927855|NCT01490294|2243152|P1|COMPLETED|Overall Study||53
927856|NCT01490294|2243149|P4|Participant Received Treatment|Overall Study||54
927857|NCT01490294|2243150|P3|Participant Received Treatment|Overall Study||58
927858|NCT01490294|2243151|P2|Participant Received Treatment|Overall Study||60
927859|NCT01490294|2243152|P1|Participant Received Treatment|Overall Study||54
927860|NCT01490294|2243149|P4|STARTED|Overall Study||55
927861|NCT01490294|2243150|P3|STARTED|Overall Study||59
927862|NCT01490294|2243151|P2|STARTED|Overall Study||60
927863|NCT01490294|2243152|P1|STARTED|Overall Study||58
927864|NCT01490190|2243386|P1|NOT COMPLETED|Overall Study||48
927865|NCT01490190|2243386|P1|COMPLETED|Overall Study||204
927866|NCT01490190|2243386|P1|STARTED|Overall Study||252
927867|NCT01490151|2243407|P1|NOT COMPLETED|Overall Study||0
927868|NCT01490151|2243407|P1|COMPLETED|Overall Study||22
927869|NCT01490151|2243407|P1|STARTED|Overall Study||22
927870|NCT01490125|2243413|P6|NOT COMPLETED|Period III||0
927871|NCT01490125|2243414|P5|NOT COMPLETED|Period III||1
927872|NCT01490125|2243415|P4|NOT COMPLETED|Period III||2
927873|NCT01490125|2243416|P3|NOT COMPLETED|Period III||0
927874|NCT01490125|2243417|P2|NOT COMPLETED|Period III||1
927875|NCT01490125|2243418|P1|NOT COMPLETED|Period III||3
927876|NCT01490125|2243413|P6|COMPLETED|Period III||35
927877|NCT01490125|2243414|P5|COMPLETED|Period III||31
927878|NCT01490125|2243415|P4|COMPLETED|Period III||28
927879|NCT01490125|2243416|P3|COMPLETED|Period III||34
927880|NCT01490125|2243417|P2|COMPLETED|Period III||32
927881|NCT01490125|2243418|P1|COMPLETED|Period III||31
927882|NCT01490125|2243413|P6|STARTED|Period III||35
927883|NCT01490125|2243414|P5|STARTED|Period III||32
927884|NCT01490125|2243415|P4|STARTED|Period III||30
927885|NCT01490125|2243416|P3|STARTED|Period III||34
927886|NCT01490125|2243417|P2|STARTED|Period III||33
927887|NCT01490125|2243418|P1|STARTED|Period III||34
927888|NCT01490125|2243413|P6|NOT COMPLETED|Period II||2
927889|NCT01490125|2243414|P5|NOT COMPLETED|Period II||4
927890|NCT01490125|2243415|P4|NOT COMPLETED|Period II||3
927891|NCT01490125|2243416|P3|NOT COMPLETED|Period II||3
927892|NCT01490125|2243417|P2|NOT COMPLETED|Period II||4
927893|NCT01490125|2243418|P1|NOT COMPLETED|Period II||3
927894|NCT01490125|2243413|P6|COMPLETED|Period II||35
927895|NCT01490125|2243414|P5|COMPLETED|Period II||32
927896|NCT01490125|2243415|P4|COMPLETED|Period II||30
927897|NCT01490125|2243416|P3|COMPLETED|Period II||34
927898|NCT01490125|2243417|P2|COMPLETED|Period II||33
927899|NCT01490125|2243418|P1|COMPLETED|Period II||34
927900|NCT01490125|2243413|P6|STARTED|Period II||37
927901|NCT01490125|2243414|P5|STARTED|Period II||36
927902|NCT01490125|2243415|P4|STARTED|Period II||33
927903|NCT01490125|2243416|P3|STARTED|Period II||37
927904|NCT01490125|2243417|P2|STARTED|Period II||37
927905|NCT01490125|2243418|P1|STARTED|Period II||37
927906|NCT01490125|2243413|P6|NOT COMPLETED|Period I||5
927907|NCT01490125|2243414|P5|NOT COMPLETED|Period I||4
927908|NCT01490125|2243415|P4|NOT COMPLETED|Period I||5
927909|NCT01490125|2243416|P3|NOT COMPLETED|Period I||4
927910|NCT01490125|2243417|P2|NOT COMPLETED|Period I||5
927911|NCT01490125|2243418|P1|NOT COMPLETED|Period I||6
927912|NCT01490125|2243413|P6|COMPLETED|Period I||37
927913|NCT01490125|2243414|P5|COMPLETED|Period I||36
927914|NCT01490125|2243415|P4|COMPLETED|Period I||33
927915|NCT01490125|2243416|P3|COMPLETED|Period I||37
927916|NCT01490125|2243417|P2|COMPLETED|Period I||37
927917|NCT01490125|2243418|P1|COMPLETED|Period I||37
927918|NCT01490125|2243413|P6|STARTED|Period I||42
927919|NCT01490125|2243414|P5|STARTED|Period I||40
927920|NCT01490125|2243415|P4|STARTED|Period I||38
927921|NCT01490125|2243416|P3|STARTED|Period I||41
927922|NCT01490125|2243417|P2|STARTED|Period I||42
927923|NCT01490125|2243418|P1|STARTED|Period I||43
927924|NCT01490086|2243446|P5|NOT COMPLETED|Overall Study||11
927925|NCT01490086|2243447|P4|NOT COMPLETED|Overall Study||7
927926|NCT01490086|2243448|P3|NOT COMPLETED|Overall Study||7
927927|NCT01490086|2243449|P2|NOT COMPLETED|Overall Study||15
927928|NCT01490086|2243450|P1|NOT COMPLETED|Overall Study||8
927929|NCT01490086|2243446|P5|COMPLETED|Overall Study||28
927930|NCT01490086|2243447|P4|COMPLETED|Overall Study||13
927931|NCT01490086|2243448|P3|COMPLETED|Overall Study||51
927932|NCT01490086|2243449|P2|COMPLETED|Overall Study||44
927933|NCT01490086|2243450|P1|COMPLETED|Overall Study||50
927934|NCT01490086|2243446|P5|STARTED|Overall Study||39
927935|NCT01490086|2243447|P4|STARTED|Overall Study||20
927936|NCT01490086|2243448|P3|STARTED|Overall Study||58
927937|NCT01490086|2243449|P2|STARTED|Overall Study||59
927938|NCT01490086|2243450|P1|STARTED|Overall Study||58
927939|NCT01490060|2243484|P4|NOT COMPLETED|Cycle 2||0
927940|NCT01490060|2243485|P3|NOT COMPLETED|Cycle 2||1
927941|NCT01490060|2243486|P2|NOT COMPLETED|Cycle 2||1
927942|NCT01490060|2243487|P1|NOT COMPLETED|Cycle 2||2
927943|NCT01490060|2243484|P4|COMPLETED|Cycle 2||8
927944|NCT01490060|2243485|P3|COMPLETED|Cycle 2||8
927945|NCT01490060|2243486|P2|COMPLETED|Cycle 2||11
927946|NCT01490060|2243487|P1|COMPLETED|Cycle 2||9
927947|NCT01490060|2243484|P4|STARTED|Cycle 2||8
927948|NCT01490060|2243485|P3|STARTED|Cycle 2||9
927949|NCT01490060|2243486|P2|STARTED|Cycle 2||12
927950|NCT01490060|2243487|P1|STARTED|Cycle 2||11
927951|NCT01490060|2243484|P4|NOT COMPLETED|Cycle 1||3
927952|NCT01490060|2243485|P3|NOT COMPLETED|Cycle 1||3
927953|NCT01490060|2243486|P2|NOT COMPLETED|Cycle 1||1
927954|NCT01490060|2243487|P1|NOT COMPLETED|Cycle 1||0
927955|NCT01490060|2243484|P4|COMPLETED|Cycle 1||8
927956|NCT01490060|2243485|P3|COMPLETED|Cycle 1||9
927957|NCT01490060|2243486|P2|COMPLETED|Cycle 1||12
927958|NCT01490060|2243487|P1|COMPLETED|Cycle 1||11
927959|NCT01490060|2243484|P4|STARTED|Cycle 1||11
927960|NCT01490060|2243485|P3|STARTED|Cycle 1||12
927961|NCT01490060|2243486|P2|STARTED|Cycle 1||13
927962|NCT01490060|2243487|P1|STARTED|Cycle 1||11
927963|NCT01489956|2243497|P3|NOT COMPLETED|Overall Study||1
927964|NCT01489956|2243498|P2|NOT COMPLETED|Overall Study||0
927965|NCT01489956|2243499|P1|NOT COMPLETED|Overall Study||1
927966|NCT01489956|2243497|P3|COMPLETED|Overall Study||5
927967|NCT01489956|2243498|P2|COMPLETED|Overall Study||0
927968|NCT01489956|2243499|P1|COMPLETED|Overall Study||12
927969|NCT01489956|2243497|P3|STARTED|Overall Study|These 6 subjects had Immucothel alone since Montanide was not needed for the 10 participants dosed.|6
927970|NCT01489956|2243498|P2|STARTED|Overall Study|Nine of the 10 participants receiving Immucothel alone had a response, so Montanide was not used.|0
927971|NCT01489956|2243499|P1|STARTED|Overall Study|Ten of the 13 participants were considered evaluable.|13
927972|NCT01489891|2243536|P2|NOT COMPLETED|Overall Study||0
927973|NCT01489891|2243537|P1|NOT COMPLETED|Overall Study||1
927974|NCT01489891|2243536|P2|COMPLETED|Overall Study||60
927975|NCT01489891|2243537|P1|COMPLETED|Overall Study||59
927976|NCT01489891|2243536|P2|STARTED|Overall Study||60
927977|NCT01489891|2243537|P1|STARTED|Overall Study||60
927978|NCT01489826|2243558|P9|NOT COMPLETED|Overall Study||0
927979|NCT01489826|2243559|P8|NOT COMPLETED|Overall Study||0
927980|NCT01489826|2243560|P7|NOT COMPLETED|Overall Study||0
927981|NCT01489826|2243561|P6|NOT COMPLETED|Overall Study||0
927982|NCT01489826|2243562|P5|NOT COMPLETED|Overall Study||0
927983|NCT01489826|2243563|P4|NOT COMPLETED|Overall Study||0
927984|NCT01489826|2243564|P3|NOT COMPLETED|Overall Study||0
927985|NCT01489826|2243565|P2|NOT COMPLETED|Overall Study||0
927986|NCT01489826|2243566|P1|NOT COMPLETED|Overall Study||0
927987|NCT01489826|2243558|P9|COMPLETED|Overall Study||6
927988|NCT01489826|2243559|P8|COMPLETED|Overall Study||3
927989|NCT01489826|2243560|P7|COMPLETED|Overall Study||9
927990|NCT01489826|2243561|P6|COMPLETED|Overall Study||3
927991|NCT01489826|2243562|P5|COMPLETED|Overall Study||3
927992|NCT01489826|2243563|P4|COMPLETED|Overall Study||7
927993|NCT01489826|2243564|P3|COMPLETED|Overall Study||3
927994|NCT01489826|2243565|P2|COMPLETED|Overall Study||3
927995|NCT01489826|2243566|P1|COMPLETED|Overall Study||3
927996|NCT01489826|2243558|P9|STARTED|Overall Study||6
927997|NCT01489826|2243559|P8|STARTED|Overall Study||3
927998|NCT01489826|2243560|P7|STARTED|Overall Study||9
927999|NCT01489826|2243561|P6|STARTED|Overall Study||3
928000|NCT01489826|2243562|P5|STARTED|Overall Study||3
928001|NCT01489826|2243563|P4|STARTED|Overall Study||7
928002|NCT01489826|2243564|P3|STARTED|Overall Study||3
928003|NCT01489826|2243565|P2|STARTED|Overall Study||3
928004|NCT01489826|2243566|P1|STARTED|Overall Study||3
928005|NCT01489670|2243663|P1|NOT COMPLETED|Overall Study||53
928006|NCT01489670|2243663|P1|COMPLETED|Overall Study||334
928007|NCT01489670|2243663|P1|STARTED|Overall Study||387
928008|NCT01489527|2243675|P2|NOT COMPLETED|Overall Study||26
928009|NCT01489527|2243676|P1|NOT COMPLETED|Overall Study||22
928010|NCT01489527|2243675|P2|COMPLETED|Overall Study||175
928011|NCT01489527|2243676|P1|COMPLETED|Overall Study||183
928012|NCT01489527|2243675|P2|STARTED|Overall Study||201
928013|NCT01489527|2243676|P1|STARTED|Overall Study||205
928014|NCT01489358|2243693|P3|NOT COMPLETED|Overall Study||2
928015|NCT01489358|2243694|P2|NOT COMPLETED|Overall Study||0
928016|NCT01489358|2243695|P1|NOT COMPLETED|Overall Study||0
928017|NCT01489358|2243693|P3|COMPLETED|Overall Study||8
928018|NCT01489358|2243694|P2|COMPLETED|Overall Study||10
928019|NCT01489358|2243695|P1|COMPLETED|Overall Study||5
928020|NCT01489358|2243693|P3|STARTED|Overall Study||10
928021|NCT01489358|2243694|P2|STARTED|Overall Study||10
928022|NCT01489358|2243695|P1|STARTED|Overall Study||5
928023|NCT01489254|2243745|P4|NOT COMPLETED|Open-label Extension Part||58
928024|NCT01489254|2243746|P3|NOT COMPLETED|Open-label Extension Part||0
928025|NCT01489254|2243747|P2|NOT COMPLETED|Open-label Extension Part||0
928026|NCT01489254|2243748|P1|NOT COMPLETED|Open-label Extension Part||0
928027|NCT01489254|2243745|P4|COMPLETED|Open-label Extension Part||670
928028|NCT01489254|2243746|P3|COMPLETED|Open-label Extension Part||0
928029|NCT01489254|2243747|P2|COMPLETED|Open-label Extension Part||0
928030|NCT01489254|2243748|P1|COMPLETED|Open-label Extension Part||0
928031|NCT01489254|2243745|P4|STARTED|Open-label Extension Part|735 completed the DB part, 729 were eligible to continue in the OL part, 1 opted not to continue|728
928032|NCT01489254|2243746|P3|STARTED|Open-label Extension Part||0
928033|NCT01489254|2243747|P2|STARTED|Open-label Extension Part||0
928034|NCT01489254|2243748|P1|STARTED|Open-label Extension Part||0
928035|NCT01489254|2243745|P4|NOT COMPLETED|Double-blind Part||0
928036|NCT01489254|2243746|P3|NOT COMPLETED|Double-blind Part||3
928037|NCT01489254|2243747|P2|NOT COMPLETED|Double-blind Part||33
928038|NCT01489254|2243748|P1|NOT COMPLETED|Double-blind Part||25
928039|NCT01489254|2243745|P4|COMPLETED|Double-blind Part||0
928040|NCT01489254|2243746|P3|COMPLETED|Double-blind Part||81
928041|NCT01489254|2243747|P2|COMPLETED|Double-blind Part||324
928042|NCT01489254|2243748|P1|COMPLETED|Double-blind Part||330
928043|NCT01489254|2243745|P4|STARTED|Double-blind Part||0
928044|NCT01489254|2243746|P3|STARTED|Double-blind Part||84
928045|NCT01489254|2243747|P2|STARTED|Double-blind Part||357
928046|NCT01489254|2243748|P1|STARTED|Double-blind Part||355
928047|NCT01489189|2243759|P2|NOT COMPLETED|Overall Study||35
928048|NCT01489189|2243760|P1|NOT COMPLETED|Overall Study||31
928049|NCT01489189|2243759|P2|COMPLETED|Overall Study|Number of Eyes|168
928050|NCT01489189|2243760|P1|COMPLETED|Overall Study|Number of Eyes|160
928051|NCT01489189|2243759|P2|STARTED|Overall Study|Number of Eyes|203
928052|NCT01489189|2243760|P1|STARTED|Overall Study|Number of Eyes|191
928059|NCT01488877|2243875|P3|NOT COMPLETED|Re-randomization||0
928060|NCT01488877|2243876|P2|NOT COMPLETED|Re-randomization||0
928061|NCT01488877|2243877|P1|NOT COMPLETED|Re-randomization||0
928062|NCT01488877|2243875|P3|COMPLETED|Re-randomization||3
928063|NCT01488877|2243876|P2|COMPLETED|Re-randomization||0
928064|NCT01488877|2243877|P1|COMPLETED|Re-randomization||0
928065|NCT01488877|2243875|P3|STARTED|Re-randomization|Three participants were re-randomized from PF-03882845 3 mg arm.|3
928066|NCT01488877|2243876|P2|STARTED|Re-randomization||0
928067|NCT01488877|2243877|P1|STARTED|Re-randomization||0
928068|NCT01488877|2243875|P3|NOT COMPLETED|Initial Randomization||0
928069|NCT01488877|2243876|P2|NOT COMPLETED|Initial Randomization||0
928070|NCT01488877|2243877|P1|NOT COMPLETED|Initial Randomization||0
928071|NCT01488877|2243875|P3|COMPLETED|Initial Randomization||0
928072|NCT01488877|2243876|P2|COMPLETED|Initial Randomization||5
928073|NCT01488877|2243877|P1|COMPLETED|Initial Randomization||1
928074|NCT01488877|2243875|P3|STARTED|Initial Randomization||0
928075|NCT01488877|2243876|P2|STARTED|Initial Randomization||5
928076|NCT01488877|2243877|P1|STARTED|Initial Randomization||1
928077|NCT01488578|2243892|P1|NOT COMPLETED|Overall Study||1836
928078|NCT01488578|2243892|P1|COMPLETED|Overall Study||9321
928079|NCT01488578|2243892|P1|STARTED|Overall Study||11157
928080|NCT01488487|2243926|P1|NOT COMPLETED|Overall Study||9
928081|NCT01488487|2243926|P1|COMPLETED|Overall Study||15
928082|NCT01488487|2243926|P1|Received Treatment|Overall Study||24
928083|NCT01488487|2243926|P1|STARTED|Overall Study||24
928084|NCT01488448|2243935|P2|NOT COMPLETED|Overall Study||17
928085|NCT01488448|2243936|P1|NOT COMPLETED|Overall Study||20
928086|NCT01488448|2243935|P2|COMPLETED|Overall Study||97
928087|NCT01488448|2243936|P1|COMPLETED|Overall Study||93
928088|NCT01488448|2243935|P2|STARTED|Overall Study||114
928089|NCT01488448|2243936|P1|STARTED|Overall Study||113
928090|NCT01488409|2243960|P2|NOT COMPLETED|Overall Study||4
928091|NCT01488409|2243961|P1|NOT COMPLETED|Overall Study||4
928092|NCT01488409|2243960|P2|COMPLETED|Overall Study||15
928093|NCT01488409|2243961|P1|COMPLETED|Overall Study||16
928094|NCT01488409|2243960|P2|STARTED|Overall Study||19
928095|NCT01488409|2243961|P1|STARTED|Overall Study||20
928096|NCT01488370|2243978|P3|NOT COMPLETED|Overall Study||1
928097|NCT01488370|2243979|P2|NOT COMPLETED|Overall Study||1
928098|NCT01488370|2243980|P1|NOT COMPLETED|Overall Study||0
928099|NCT01488370|2243978|P3|COMPLETED|Overall Study||19
928100|NCT01488370|2243979|P2|COMPLETED|Overall Study||22
928101|NCT01488370|2243980|P1|COMPLETED|Overall Study||22
928102|NCT01488370|2243978|P3|STARTED|Overall Study||20
928103|NCT01488370|2243979|P2|STARTED|Overall Study||23
928104|NCT01488370|2243980|P1|STARTED|Overall Study||22
928105|NCT01488188|2244002|P2|NOT COMPLETED|Overall Study||0
928106|NCT01488188|2244003|P1|NOT COMPLETED|Overall Study||0
928107|NCT01488188|2244002|P2|COMPLETED|Overall Study||20
928108|NCT01488188|2244003|P1|COMPLETED|Overall Study||20
928109|NCT01488188|2244002|P2|STARTED|Overall Study||20
928110|NCT01488188|2244003|P1|STARTED|Overall Study||20
928111|NCT01488097|2244015|P1|NOT COMPLETED|Long-term Treatment (Beyond Week 104)||6
928112|NCT01488097|2244015|P1|COMPLETED|Long-term Treatment (Beyond Week 104)|This period is ongoing.|2
928113|NCT01488097|2244015|P1|STARTED|Long-term Treatment (Beyond Week 104)||8
928114|NCT01488097|2244015|P1|NOT COMPLETED|Long-term Treatment (up to Week 104)||0
928115|NCT01488097|2244015|P1|COMPLETED|Long-term Treatment (up to Week 104)||8
928116|NCT01488097|2244015|P1|STARTED|Long-term Treatment (up to Week 104)||8
928117|NCT01488071|2244027|P2|NOT COMPLETED|Overall Study||63
928118|NCT01488071|2244028|P1|NOT COMPLETED|Overall Study||53
928119|NCT01488071|2244027|P2|COMPLETED|Overall Study||179
928120|NCT01488071|2244028|P1|COMPLETED|Overall Study||200
928121|NCT01488071|2244027|P2|STARTED|Overall Study|APTS|242
928122|NCT01488071|2244028|P1|STARTED|Overall Study|all-patients-treated set (APTS)|253
928123|NCT01488019|2244062|P2|NOT COMPLETED|Overall Study||304
928124|NCT01488019|2244063|P1|NOT COMPLETED|Overall Study||247
928125|NCT01488019|2244062|P2|COMPLETED|Overall Study||226
928126|NCT01488019|2244063|P1|COMPLETED|Overall Study||294
928127|NCT01488019|2244062|P2|STARTED|Overall Study||530
928128|NCT01488019|2244063|P1|STARTED|Overall Study||541
928129|NCT01487954|2244097|P2|NOT COMPLETED|Overall Study||0
928130|NCT01487954|2244098|P1|NOT COMPLETED|Overall Study||0
928131|NCT01487954|2244097|P2|COMPLETED|Overall Study||16
928132|NCT01487954|2244098|P1|COMPLETED|Overall Study||29
928133|NCT01487954|2244097|P2|Safety lead-in|Overall Study|Only the first 10 patients in the alkaline group were analyzed, as that was the experimental group.|0
928134|NCT01487954|2244098|P1|Safety lead-in|Overall Study||10
928135|NCT01487954|2244097|P2|STARTED|Overall Study||16
928136|NCT01487954|2244098|P1|STARTED|Overall Study||29
928137|NCT01487863|2244108|P2|NOT COMPLETED|Overall Study||19
928138|NCT01487863|2244109|P1|NOT COMPLETED|Overall Study||19
928139|NCT01487863|2244108|P2|COMPLETED|Overall Study||15
928140|NCT01487863|2244109|P1|COMPLETED|Overall Study||16
928141|NCT01487863|2244108|P2|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||34
928142|NCT01487863|2244109|P1|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||35
928143|NCT01487863|2244108|P2|Subjects Randomized (Efficacy Analysis)|Overall Study||34
928144|NCT01487863|2244109|P1|Subjects Randomized (Efficacy Analysis)|Overall Study||35
928145|NCT01487863|2244108|P2|STARTED|Overall Study||34
928146|NCT01487863|2244109|P1|STARTED|Overall Study||35
928147|NCT01487668|2244117|P2|NOT COMPLETED|Overall Study||17
928148|NCT01487668|2244118|P1|NOT COMPLETED|Overall Study||25
928149|NCT01487668|2244117|P2|COMPLETED|Overall Study||124
928150|NCT01487668|2244118|P1|COMPLETED|Overall Study||121
928151|NCT01487668|2244117|P2|STARTED|Overall Study||141
928152|NCT01487668|2244118|P1|STARTED|Overall Study||146
928153|NCT01487577|2244126|P1|NOT COMPLETED|Overall Study||1
928154|NCT01487577|2244126|P1|COMPLETED|Overall Study|One participant became ineligible after signing consent, but before receiving protocol therapy.|18
928155|NCT01487577|2244126|P1|STARTED|Overall Study||19
928156|NCT01487525|2244140|P2|NOT COMPLETED|Overall Study||1
928157|NCT01487525|2244141|P1|NOT COMPLETED|Overall Study||0
928158|NCT01487525|2244140|P2|COMPLETED|Overall Study||19
928159|NCT01487525|2244141|P1|COMPLETED|Overall Study||22
928160|NCT01487525|2244140|P2|STARTED|Overall Study||20
928161|NCT01487525|2244141|P1|STARTED|Overall Study||22
928162|NCT01487499|2244151|P1|NOT COMPLETED|Overall Study||0
928163|NCT01487499|2244151|P1|COMPLETED|Overall Study||4
928164|NCT01487499|2244151|P1|STARTED|Overall Study||4
928165|NCT01486966|2244159|P2|NOT COMPLETED|Overall Study||2
928166|NCT01486966|2244160|P1|NOT COMPLETED|Overall Study||0
928167|NCT01486966|2244159|P2|COMPLETED|Overall Study||27
928168|NCT01486966|2244160|P1|COMPLETED|Overall Study||29
928169|NCT01486966|2244159|P2|STARTED|Overall Study||29
928170|NCT01486966|2244160|P1|STARTED|Overall Study||29
928171|NCT01486927|2244184|P1|NOT COMPLETED|Overall Study||13
928172|NCT01486927|2244184|P1|COMPLETED|Overall Study||161
928173|NCT01486927|2244184|P1|STARTED|Overall Study||174
928174|NCT01486758|2244217|P2|NOT COMPLETED|Overall Study||1
928175|NCT01486758|2244218|P1|NOT COMPLETED|Overall Study||0
928176|NCT01486758|2244217|P2|COMPLETED|Overall Study||19
928177|NCT01486758|2244218|P1|COMPLETED|Overall Study||20
928178|NCT01486758|2244217|P2|STARTED|Overall Study||20
928179|NCT01486758|2244218|P1|STARTED|Overall Study||20
928180|NCT01486615|2244242|P4|NOT COMPLETED|Overall Study||2
928181|NCT01486615|2244243|P3|NOT COMPLETED|Overall Study||2
928182|NCT01486615|2244244|P2|NOT COMPLETED|Overall Study||1
928183|NCT01486615|2244245|P1|NOT COMPLETED|Overall Study||0
928184|NCT01486615|2244242|P4|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
928185|NCT01486615|2244243|P3|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
928186|NCT01486615|2244244|P2|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|19
928187|NCT01486615|2244245|P1|COMPLETED|Overall Study||20
928188|NCT01486615|2244242|P4|STARTED|Overall Study||20
928189|NCT01486615|2244243|P3|STARTED|Overall Study||20
928190|NCT01486615|2244244|P2|STARTED|Overall Study||20
928191|NCT01486615|2244245|P1|STARTED|Overall Study||20
928192|NCT01486446|2244285|P2|NOT COMPLETED|Overall Study||0
928193|NCT01486446|2244286|P1|NOT COMPLETED|Overall Study||1
928194|NCT01486446|2244285|P2|COMPLETED|Overall Study||1
928195|NCT01486446|2244286|P1|COMPLETED|Overall Study||6
928196|NCT01486446|2244285|P2|STARTED|Overall Study||1
928197|NCT01486446|2244286|P1|STARTED|Overall Study||7
928198|NCT01486238|2244308|P2|NOT COMPLETED|Overall Study||6
928199|NCT01486238|2244309|P1|NOT COMPLETED|Overall Study||2
928200|NCT01486238|2244308|P2|COMPLETED|Overall Study||43
928201|NCT01486238|2244309|P1|COMPLETED|Overall Study||21
928202|NCT01486238|2244308|P2|STARTED|Overall Study||49
928203|NCT01486238|2244309|P1|STARTED|Overall Study||23
928204|NCT01486199|2244317|P2|NOT COMPLETED|Study Day at t= 2 Years||0
928205|NCT01486199|2244318|P1|NOT COMPLETED|Study Day at t= 2 Years||0
928206|NCT01486199|2244317|P2|COMPLETED|Study Day at t= 2 Years||0
928207|NCT01486199|2244318|P1|COMPLETED|Study Day at t= 2 Years||9
928208|NCT01486199|2244317|P2|STARTED|Study Day at t= 2 Years||0
928209|NCT01486199|2244318|P1|STARTED|Study Day at t= 2 Years||9
928210|NCT01486199|2244317|P2|NOT COMPLETED|Two Year Period Between Study Days||0
928211|NCT01486199|2244318|P1|NOT COMPLETED|Two Year Period Between Study Days||1
928212|NCT01486199|2244317|P2|COMPLETED|Two Year Period Between Study Days||0
928213|NCT01486199|2244318|P1|COMPLETED|Two Year Period Between Study Days||9
928214|NCT01486199|2244317|P2|STARTED|Two Year Period Between Study Days||0
928215|NCT01486199|2244318|P1|STARTED|Two Year Period Between Study Days||10
928216|NCT01486199|2244317|P2|NOT COMPLETED|Baseline Study Day||1
928217|NCT01486199|2244318|P1|NOT COMPLETED|Baseline Study Day||0
928218|NCT01486199|2244317|P2|COMPLETED|Baseline Study Day||9
928219|NCT01486199|2244318|P1|COMPLETED|Baseline Study Day||10
928220|NCT01486199|2244317|P2|STARTED|Baseline Study Day||10
928221|NCT01486199|2244318|P1|STARTED|Baseline Study Day||10
928222|NCT01486043|2244330|P1|NOT COMPLETED|Overall Study||2
928223|NCT01486043|2244330|P1|COMPLETED|Overall Study|Study terminated due to insufficient recruitment|2
928224|NCT01486043|2244330|P1|STARTED|Overall Study||4
928225|NCT01485991|2244338|P2|NOT COMPLETED|Overall Study||36
928226|NCT01485991|2244339|P1|NOT COMPLETED|Overall Study||32
928227|NCT01485991|2244338|P2|COMPLETED|Overall Study||350
928228|NCT01485991|2244339|P1|COMPLETED|Overall Study||353
928229|NCT01485991|2244338|P2|Treated|Overall Study||384
928230|NCT01485991|2244339|P1|Treated|Overall Study||379
928231|NCT01485991|2244338|P2|STARTED|Overall Study||386
928232|NCT01485991|2244339|P1|STARTED|Overall Study||385
928233|NCT01485887|2244349|P1|NOT COMPLETED|Overall Study||12
928234|NCT01485887|2244349|P1|COMPLETED|Overall Study||38
928235|NCT01485887|2244349|P1|STARTED|Overall Study||50
928254|NCT01485640|2244383|P1|NOT COMPLETED|Overall Study||122
928255|NCT01485640|2244383|P1|COMPLETED|Overall Study||40
928256|NCT01485640|2244383|P1|STARTED|Overall Study||162
928257|NCT01485536|2244388|P1|NOT COMPLETED|Overall Study||4
928258|NCT01485536|2244388|P1|COMPLETED|Overall Study||17
928259|NCT01485536|2244388|P1|STARTED|Overall Study||21
928260|NCT01485380|2244393|P1|NOT COMPLETED|Overall Study||3
928261|NCT01485380|2244393|P1|COMPLETED|Overall Study||17
928262|NCT01485380|2244393|P1|STARTED|Overall Study||20
928263|NCT01485354|2244397|P1|NOT COMPLETED|Overall Study||5
928264|NCT01485354|2244397|P1|COMPLETED|Overall Study||12
928265|NCT01485354|2244397|P1|STARTED|Overall Study||17
928266|NCT01485172|2244411|P6|NOT COMPLETED|Overall Study||4
928267|NCT01485172|2244412|P5|NOT COMPLETED|Overall Study||5
928268|NCT01485172|2244413|P4|NOT COMPLETED|Overall Study||8
928269|NCT01485172|2244414|P3|NOT COMPLETED|Overall Study||7
928270|NCT01485172|2244415|P2|NOT COMPLETED|Overall Study||1
928271|NCT01485172|2244416|P1|NOT COMPLETED|Overall Study||7
928272|NCT01485172|2244411|P6|COMPLETED|Overall Study||9
928273|NCT01485172|2244412|P5|COMPLETED|Overall Study||34
928274|NCT01485172|2244413|P4|COMPLETED|Overall Study||32
928275|NCT01485172|2244414|P3|COMPLETED|Overall Study||34
928276|NCT01485172|2244415|P2|COMPLETED|Overall Study||12
928277|NCT01485172|2244416|P1|COMPLETED|Overall Study||33
928278|NCT01485172|2244411|P6|STARTED|Overall Study||13
928279|NCT01485172|2244412|P5|STARTED|Overall Study||39
928280|NCT01485172|2244413|P4|STARTED|Overall Study||40
928281|NCT01485172|2244414|P3|STARTED|Overall Study||41
928282|NCT01485172|2244415|P2|STARTED|Overall Study||13
928283|NCT01485172|2244416|P1|STARTED|Overall Study||40
928284|NCT01485094|2244493|P3|NOT COMPLETED|Overall Study||1
928285|NCT01485094|2244494|P2|NOT COMPLETED|Overall Study||2
928286|NCT01485094|2244495|P1|NOT COMPLETED|Overall Study||3
928287|NCT01485094|2244493|P3|COMPLETED|Overall Study||18
928288|NCT01485094|2244494|P2|COMPLETED|Overall Study||18
928289|NCT01485094|2244495|P1|COMPLETED|Overall Study||17
928290|NCT01485094|2244493|P3|STARTED|Overall Study||19
928291|NCT01485094|2244494|P2|STARTED|Overall Study||20
928292|NCT01485094|2244495|P1|STARTED|Overall Study||20
928293|NCT01484977|2244536|P1|NOT COMPLETED|Overall Study||27
928294|NCT01484977|2244536|P1|COMPLETED|Overall Study||93
928295|NCT01484977|2244536|P1|STARTED|Overall Study||120
928296|NCT01484951|2244540|P1|NOT COMPLETED|Overall Study||5
928297|NCT01484951|2244540|P1|COMPLETED|Overall Study||69
928298|NCT01484951|2244540|P1|STARTED|Overall Study||74
928299|NCT01484938|2244545|P1|NOT COMPLETED|Overall Study||4
928300|NCT01484938|2244545|P1|COMPLETED|Overall Study||171
928301|NCT01484938|2244545|P1|STARTED|Overall Study||175
928302|NCT01484912|2244552|P2|NOT COMPLETED|Overall Study||1
928303|NCT01484912|2244553|P1|NOT COMPLETED|Overall Study||1
928304|NCT01484912|2244552|P2|COMPLETED|Overall Study||39
928305|NCT01484912|2244553|P1|COMPLETED|Overall Study||38
928306|NCT01484912|2244552|P2|STARTED|Overall Study||40
928307|NCT01484912|2244553|P1|STARTED|Overall Study||39
928308|NCT01484873|2244563|P1|NOT COMPLETED|Overall Study||2
928309|NCT01484873|2244563|P1|COMPLETED|Overall Study||8
928310|NCT01484873|2244563|P1|STARTED|Overall Study||10
928311|NCT01484834|2244575|P4|NOT COMPLETED|Overall Study||4
928312|NCT01484834|2244576|P3|NOT COMPLETED|Overall Study||1
928313|NCT01484834|2244577|P2|NOT COMPLETED|Overall Study||8
928314|NCT01484834|2244578|P1|NOT COMPLETED|Overall Study||5
928315|NCT01484834|2244575|P4|COMPLETED|Overall Study||20
928316|NCT01484834|2244576|P3|COMPLETED|Overall Study||38
928317|NCT01484834|2244577|P2|COMPLETED|Overall Study||54
928318|NCT01484834|2244578|P1|COMPLETED|Overall Study||60
928319|NCT01484834|2244575|P4|STARTED|Overall Study||24
928320|NCT01484834|2244576|P3|STARTED|Overall Study||39
928321|NCT01484834|2244577|P2|STARTED|Overall Study||62
928322|NCT01484834|2244578|P1|STARTED|Overall Study||65
928323|NCT01484652|2244606|P2|NOT COMPLETED|Overall Study||21
928324|NCT01484652|2244607|P1|NOT COMPLETED|Overall Study||15
928325|NCT01484652|2244606|P2|COMPLETED|Overall Study||142
928326|NCT01484652|2244607|P1|COMPLETED|Overall Study||151
928327|NCT01484652|2244606|P2|STARTED|Overall Study||163
928328|NCT01484652|2244607|P1|STARTED|Overall Study||166
928329|NCT01484561|2244615|P2|NOT COMPLETED|Overall Study||6
928330|NCT01484561|2244616|P1|NOT COMPLETED|Overall Study||9
928331|NCT01484561|2244615|P2|COMPLETED|Overall Study||45
928332|NCT01484561|2244616|P1|COMPLETED|Overall Study||88
928333|NCT01484561|2244615|P2|STARTED|Overall Study||51
928334|NCT01484561|2244616|P1|STARTED|Overall Study||97
928335|NCT01484496|2244706|P4|NOT COMPLETED|Period 2||22
928336|NCT01484496|2244707|P3|NOT COMPLETED|Period 2||15
928337|NCT01484496|2244708|P2|NOT COMPLETED|Period 2||0
928338|NCT01484496|2244709|P1|NOT COMPLETED|Period 2||0
928339|NCT01484496|2244706|P4|COMPLETED|Period 2||434
928340|NCT01484496|2244707|P3|COMPLETED|Period 2||191
928341|NCT01484496|2244708|P2|COMPLETED|Period 2||0
928342|NCT01484496|2244709|P1|COMPLETED|Period 2||0
928343|NCT01484496|2244706|P4|STARTED|Period 2||456
928344|NCT01484496|2244707|P3|STARTED|Period 2||206
928345|NCT01484496|2244708|P2|STARTED|Period 2||0
928346|NCT01484496|2244709|P1|STARTED|Period 2||0
928347|NCT01484496|2244706|P4|NOT COMPLETED|Period 1||0
928348|NCT01484496|2244707|P3|NOT COMPLETED|Period 1||0
928349|NCT01484496|2244708|P2|NOT COMPLETED|Period 1||93
928350|NCT01484496|2244709|P1|NOT COMPLETED|Period 1||66
928351|NCT01484496|2244706|P4|COMPLETED|Period 1||0
928352|NCT01484496|2244707|P3|COMPLETED|Period 1||0
928353|NCT01484496|2244708|P2|COMPLETED|Period 1||463
928354|NCT01484496|2244709|P1|COMPLETED|Period 1||214
928355|NCT01484496|2244706|P4|STARTED|Period 1||0
928356|NCT01484496|2244707|P3|STARTED|Period 1||0
928357|NCT01484496|2244708|P2|STARTED|Period 1||556
928358|NCT01484496|2244709|P1|STARTED|Period 1||280
928359|NCT01484314|2244721|P1|NOT COMPLETED|Overall Study||0
928360|NCT01484314|2244721|P1|COMPLETED|Overall Study||1
928361|NCT01484314|2244721|P1|STARTED|Overall Study||1
928362|NCT01484197|2244727|P4|NOT COMPLETED|Treatment Period 4||0
928363|NCT01484197|2244728|P3|NOT COMPLETED|Treatment Period 4||0
928364|NCT01484197|2244729|P2|NOT COMPLETED|Treatment Period 4||0
928365|NCT01484197|2244730|P1|NOT COMPLETED|Treatment Period 4||0
928366|NCT01484197|2244727|P4|COMPLETED|Treatment Period 4||6
928367|NCT01484197|2244728|P3|COMPLETED|Treatment Period 4||9
928368|NCT01484197|2244729|P2|COMPLETED|Treatment Period 4||8
928369|NCT01484197|2244730|P1|COMPLETED|Treatment Period 4||7
928370|NCT01484197|2244727|P4|STARTED|Treatment Period 4|2 patients completed Period 3 but did not enter Period 4 due to a Protocol deviation and an AE.|6
928371|NCT01484197|2244728|P3|STARTED|Treatment Period 4||9
928372|NCT01484197|2244729|P2|STARTED|Treatment Period 4||8
928373|NCT01484197|2244730|P1|STARTED|Treatment Period 4||7
928374|NCT01484197|2244727|P4|NOT COMPLETED|Treatment Period 3||0
928375|NCT01484197|2244728|P3|NOT COMPLETED|Treatment Period 3||0
928376|NCT01484197|2244729|P2|NOT COMPLETED|Treatment Period 3||0
928377|NCT01484197|2244730|P1|NOT COMPLETED|Treatment Period 3||0
928378|NCT01484197|2244727|P4|COMPLETED|Treatment Period 3||8
928379|NCT01484197|2244728|P3|COMPLETED|Treatment Period 3||9
928380|NCT01484197|2244729|P2|COMPLETED|Treatment Period 3||8
928381|NCT01484197|2244730|P1|COMPLETED|Treatment Period 3||7
928382|NCT01484197|2244727|P4|STARTED|Treatment Period 3||8
928383|NCT01484197|2244728|P3|STARTED|Treatment Period 3||9
928384|NCT01484197|2244729|P2|STARTED|Treatment Period 3||8
928385|NCT01484197|2244730|P1|STARTED|Treatment Period 3||7
928386|NCT01484197|2244727|P4|NOT COMPLETED|Treatment Period 2||1
928387|NCT01484197|2244728|P3|NOT COMPLETED|Treatment Period 2||0
928388|NCT01484197|2244729|P2|NOT COMPLETED|Treatment Period 2||0
928389|NCT01484197|2244730|P1|NOT COMPLETED|Treatment Period 2||0
928390|NCT01484197|2244727|P4|COMPLETED|Treatment Period 2||8
928391|NCT01484197|2244728|P3|COMPLETED|Treatment Period 2||9
928392|NCT01484197|2244729|P2|COMPLETED|Treatment Period 2||8
928393|NCT01484197|2244730|P1|COMPLETED|Treatment Period 2||7
928394|NCT01484197|2244727|P4|STARTED|Treatment Period 2||9
928395|NCT01484197|2244728|P3|STARTED|Treatment Period 2||9
928396|NCT01484197|2244729|P2|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to an Adverse event (AE).|8
928397|NCT01484197|2244730|P1|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to a Protocol deviation.|7
928398|NCT01484197|2244727|P4|NOT COMPLETED|Treatment Period 1||0
928399|NCT01484197|2244728|P3|NOT COMPLETED|Treatment Period 1||0
928400|NCT01484197|2244729|P2|NOT COMPLETED|Treatment Period 1||0
928401|NCT01484197|2244730|P1|NOT COMPLETED|Treatment Period 1||1
928402|NCT01484197|2244727|P4|COMPLETED|Treatment Period 1||9
928403|NCT01484197|2244728|P3|COMPLETED|Treatment Period 1||9
928404|NCT01484197|2244729|P2|COMPLETED|Treatment Period 1||9
928405|NCT01484197|2244730|P1|COMPLETED|Treatment Period 1||8
928406|NCT01484197|2244727|P4|STARTED|Treatment Period 1||9
928407|NCT01484197|2244728|P3|STARTED|Treatment Period 1||9
928408|NCT01484197|2244729|P2|STARTED|Treatment Period 1||9
928409|NCT01484197|2244730|P1|STARTED|Treatment Period 1||9
928410|NCT01484132|2244813|P1|NOT COMPLETED|Overall Study||22
928411|NCT01484132|2244813|P1|COMPLETED|Overall Study|91 subjects had at least one pre-treatment and at least one post-treatment urine sample.|91
928412|NCT01484132|2244813|P1|Pre-treatment Urine Sample|Overall Study|Urine samples were collected twice pre-treatment. 101 subjects completed at least one urine sample.|101
928413|NCT01484132|2244813|P1|STARTED|Overall Study||113
928414|NCT01484054|2244821|P2|NOT COMPLETED|Period 2||0
928415|NCT01484054|2244822|P1|NOT COMPLETED|Period 2||0
928416|NCT01484054|2244821|P2|COMPLETED|Period 2||49
928417|NCT01484054|2244822|P1|COMPLETED|Period 2||50
928418|NCT01484054|2244821|P2|STARTED|Period 2||49
928419|NCT01484054|2244822|P1|STARTED|Period 2||50
928420|NCT01484054|2244821|P2|NOT COMPLETED|Period 1||1
928421|NCT01484054|2244822|P1|NOT COMPLETED|Period 1||0
928422|NCT01484054|2244821|P2|COMPLETED|Period 1||49
928423|NCT01484054|2244822|P1|COMPLETED|Period 1||50
928424|NCT01484054|2244821|P2|STARTED|Period 1||50
928425|NCT01484054|2244822|P1|STARTED|Period 1||50
928426|NCT01484041|2244832|P1|NOT COMPLETED|Overall Study||0
928427|NCT01484041|2244832|P1|COMPLETED|Overall Study||12
928428|NCT01484041|2244832|P1|STARTED|Overall Study||12
928429|NCT01484028|2244840|P4|NOT COMPLETED|Period 2||0
928430|NCT01484028|2244841|P3|NOT COMPLETED|Period 2||0
928431|NCT01484028|2244842|P2|NOT COMPLETED|Period 2||0
928432|NCT01484028|2244843|P1|NOT COMPLETED|Period 2||0
928433|NCT01484028|2244840|P4|COMPLETED|Period 2||66
928434|NCT01484028|2244841|P3|COMPLETED|Period 2||64
928435|NCT01484028|2244842|P2|COMPLETED|Period 2||67
928436|NCT01484028|2244843|P1|COMPLETED|Period 2||66
928437|NCT01484028|2244840|P4|STARTED|Period 2||66
928438|NCT01484028|2244841|P3|STARTED|Period 2||64
928439|NCT01484028|2244842|P2|STARTED|Period 2||67
928440|NCT01484028|2244843|P1|STARTED|Period 2||66
928441|NCT01484028|2244840|P4|NOT COMPLETED|Period 1||1
928442|NCT01484028|2244841|P3|NOT COMPLETED|Period 1||0
928443|NCT01484028|2244842|P2|NOT COMPLETED|Period 1||3
928444|NCT01484028|2244843|P1|NOT COMPLETED|Period 1||0
928445|NCT01484028|2244840|P4|COMPLETED|Period 1||66
928446|NCT01484028|2244841|P3|COMPLETED|Period 1||64
928447|NCT01484028|2244842|P2|COMPLETED|Period 1||67
928448|NCT01484028|2244843|P1|COMPLETED|Period 1||66
928449|NCT01484028|2244840|P4|STARTED|Period 1||67
928450|NCT01484028|2244841|P3|STARTED|Period 1||64
928451|NCT01484028|2244842|P2|STARTED|Period 1||70
928452|NCT01484028|2244843|P1|STARTED|Period 1||66
928453|NCT01483963|2244858|P5|NOT COMPLETED|Overall Study||0
928454|NCT01483963|2244859|P4|NOT COMPLETED|Overall Study||0
928455|NCT01483963|2244860|P3|NOT COMPLETED|Overall Study||0
928456|NCT01483963|2244861|P2|NOT COMPLETED|Overall Study||0
928457|NCT01483963|2244862|P1|NOT COMPLETED|Overall Study||0
928458|NCT01483963|2244858|P5|COMPLETED|Overall Study||10
928459|NCT01483963|2244859|P4|COMPLETED|Overall Study||10
928460|NCT01483963|2244860|P3|COMPLETED|Overall Study||10
928461|NCT01483963|2244861|P2|COMPLETED|Overall Study||10
928462|NCT01483963|2244862|P1|COMPLETED|Overall Study||10
928463|NCT01483963|2244858|P5|STARTED|Overall Study||10
928464|NCT01483963|2244859|P4|STARTED|Overall Study||10
928465|NCT01483963|2244860|P3|STARTED|Overall Study||10
928466|NCT01483963|2244861|P2|STARTED|Overall Study||10
928467|NCT01483963|2244862|P1|STARTED|Overall Study||10
928468|NCT01483937|2244936|P2|NOT COMPLETED|Overall Study||3
928469|NCT01483937|2244937|P1|NOT COMPLETED|Overall Study||4
928470|NCT01483937|2244936|P2|COMPLETED|Overall Study||14
928471|NCT01483937|2244937|P1|COMPLETED|Overall Study||11
928472|NCT01483937|2244936|P2|STARTED|Overall Study||17
928473|NCT01483937|2244937|P1|STARTED|Overall Study||15
928474|NCT01483924|2244964|P5|NOT COMPLETED|Overall Study||2
928475|NCT01483924|2244965|P4|NOT COMPLETED|Overall Study||4
928476|NCT01483924|2244966|P3|NOT COMPLETED|Overall Study||1
928477|NCT01483924|2244967|P2|NOT COMPLETED|Overall Study||0
928478|NCT01483924|2244968|P1|NOT COMPLETED|Overall Study||2
928479|NCT01483924|2244964|P5|COMPLETED|Overall Study||10
928480|NCT01483924|2244965|P4|COMPLETED|Overall Study||8
928481|NCT01483924|2244966|P3|COMPLETED|Overall Study||11
928482|NCT01483924|2244967|P2|COMPLETED|Overall Study||12
928483|NCT01483924|2244968|P1|COMPLETED|Overall Study||10
928484|NCT01483924|2244964|P5|STARTED|Overall Study||12
928485|NCT01483924|2244965|P4|STARTED|Overall Study||12
928486|NCT01483924|2244966|P3|STARTED|Overall Study||12
928487|NCT01483924|2244967|P2|STARTED|Overall Study||12
928488|NCT01483924|2244968|P1|STARTED|Overall Study||12
928489|NCT01483820|2245016|P1|NOT COMPLETED|Overall Study||8
928490|NCT01483820|2245016|P1|COMPLETED|Overall Study||0
928491|NCT01483820|2245016|P1|STARTED|Overall Study||8
928492|NCT01483651|2245025|P6|NOT COMPLETED|Overall Study||1
928493|NCT01483651|2245026|P5|NOT COMPLETED|Overall Study||0
928494|NCT01483651|2245027|P4|NOT COMPLETED|Overall Study||0
928495|NCT01483651|2245028|P3|NOT COMPLETED|Overall Study||1
928496|NCT01483651|2245029|P2|NOT COMPLETED|Overall Study||1
928497|NCT01483651|2245030|P1|NOT COMPLETED|Overall Study||0
928498|NCT01483651|2245025|P6|COMPLETED|Overall Study||1
928499|NCT01483651|2245026|P5|COMPLETED|Overall Study||2
928500|NCT01483651|2245027|P4|COMPLETED|Overall Study||1
928501|NCT01483651|2245028|P3|COMPLETED|Overall Study||1
928502|NCT01483651|2245029|P2|COMPLETED|Overall Study||2
928503|NCT01483651|2245030|P1|COMPLETED|Overall Study||1
928504|NCT01483651|2245025|P6|STARTED|Overall Study||2
928505|NCT01483651|2245026|P5|STARTED|Overall Study||2
928506|NCT01483651|2245027|P4|STARTED|Overall Study||1
928507|NCT01483651|2245028|P3|STARTED|Overall Study||2
928508|NCT01483651|2245029|P2|STARTED|Overall Study||3
928509|NCT01483651|2245030|P1|STARTED|Overall Study||1
928510|NCT01483625|2245040|P2|NOT COMPLETED|Overall Study||2
928511|NCT01483625|2245041|P1|NOT COMPLETED|Overall Study||4
928512|NCT01483625|2245040|P2|COMPLETED|Overall Study||66
928513|NCT01483625|2245041|P1|COMPLETED|Overall Study||68
928514|NCT01483625|2245040|P2|STARTED|Overall Study||68
928515|NCT01483625|2245041|P1|STARTED|Overall Study||72
928516|NCT01483599|2245064|P14|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||7
928517|NCT01483599|2245065|P13|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||3
928518|NCT01483599|2245066|P12|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||1
928519|NCT01483599|2245067|P11|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
928520|NCT01483599|2245068|P10|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||4
928521|NCT01483599|2245069|P9|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||9
928522|NCT01483599|2245070|P8|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
928523|NCT01483599|2245071|P7|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
928524|NCT01483599|2245072|P6|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
928525|NCT01483599|2245073|P5|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
928526|NCT01483599|2245074|P4|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
928527|NCT01483599|2245075|P3|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
928528|NCT01483599|2245076|P2|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
928529|NCT01483599|2245077|P1|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
928530|NCT01483599|2245064|P14|COMPLETED|After Controlled Period(Week 16-Week 40)||32
928531|NCT01483599|2245065|P13|COMPLETED|After Controlled Period(Week 16-Week 40)||35
928532|NCT01483599|2245066|P12|COMPLETED|After Controlled Period(Week 16-Week 40)||39
928533|NCT01483599|2245067|P11|COMPLETED|After Controlled Period(Week 16-Week 40)||37
928534|NCT01483599|2245068|P10|COMPLETED|After Controlled Period(Week 16-Week 40)||37
928535|NCT01483599|2245069|P9|COMPLETED|After Controlled Period(Week 16-Week 40)||29
928536|NCT01483599|2245070|P8|COMPLETED|After Controlled Period(Week 16-Week 40)||37
928537|NCT01483599|2245071|P7|COMPLETED|After Controlled Period(Week 16-Week 40)||0
928538|NCT01483599|2245072|P6|COMPLETED|After Controlled Period(Week 16-Week 40)||0
928539|NCT01483599|2245073|P5|COMPLETED|After Controlled Period(Week 16-Week 40)||0
928540|NCT01483599|2245074|P4|COMPLETED|After Controlled Period(Week 16-Week 40)||0
928541|NCT01483599|2245075|P3|COMPLETED|After Controlled Period(Week 16-Week 40)||0
928542|NCT01483599|2245076|P2|COMPLETED|After Controlled Period(Week 16-Week 40)||0
928543|NCT01483599|2245077|P1|COMPLETED|After Controlled Period(Week 16-Week 40)||0
928544|NCT01483599|2245064|P14|STARTED|After Controlled Period(Week 16-Week 40)||39
928545|NCT01483599|2245065|P13|STARTED|After Controlled Period(Week 16-Week 40)||38
928546|NCT01483599|2245066|P12|STARTED|After Controlled Period(Week 16-Week 40)||40
928547|NCT01483599|2245067|P11|STARTED|After Controlled Period(Week 16-Week 40)||39
928548|NCT01483599|2245068|P10|STARTED|After Controlled Period(Week 16-Week 40)||41
928549|NCT01483599|2245069|P9|STARTED|After Controlled Period(Week 16-Week 40)||38
928550|NCT01483599|2245070|P8|STARTED|After Controlled Period(Week 16-Week 40)||39
928551|NCT01483599|2245071|P7|STARTED|After Controlled Period(Week 16-Week 40)||0
928552|NCT01483599|2245072|P6|STARTED|After Controlled Period(Week 16-Week 40)||0
928553|NCT01483599|2245073|P5|STARTED|After Controlled Period(Week 16-Week 40)||0
928554|NCT01483599|2245074|P4|STARTED|After Controlled Period(Week 16-Week 40)||0
928555|NCT01483599|2245075|P3|STARTED|After Controlled Period(Week 16-Week 40)||0
928556|NCT01483599|2245076|P2|STARTED|After Controlled Period(Week 16-Week 40)||0
928557|NCT01483599|2245077|P1|STARTED|After Controlled Period(Week 16-Week 40)||0
928558|NCT01483599|2245064|P14|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
928559|NCT01483599|2245065|P13|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
928560|NCT01483599|2245066|P12|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
928561|NCT01483599|2245067|P11|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
928562|NCT01483599|2245068|P10|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
928563|NCT01483599|2245069|P9|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
928564|NCT01483599|2245070|P8|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
928565|NCT01483599|2245071|P7|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
928566|NCT01483599|2245072|P6|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
928567|NCT01483599|2245073|P5|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||2
928568|NCT01483599|2245074|P4|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
928569|NCT01483599|2245075|P3|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
928570|NCT01483599|2245076|P2|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
928571|NCT01483599|2245077|P1|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
928572|NCT01483599|2245064|P14|COMPLETED|Controlled Period (CP) (up to Week 16)||0
928573|NCT01483599|2245065|P13|COMPLETED|Controlled Period (CP) (up to Week 16)||0
928574|NCT01483599|2245066|P12|COMPLETED|Controlled Period (CP) (up to Week 16)||0
928575|NCT01483599|2245067|P11|COMPLETED|Controlled Period (CP) (up to Week 16)||0
928576|NCT01483599|2245068|P10|COMPLETED|Controlled Period (CP) (up to Week 16)||0
928577|NCT01483599|2245069|P9|COMPLETED|Controlled Period (CP) (up to Week 16)||0
928578|NCT01483599|2245070|P8|COMPLETED|Controlled Period (CP) (up to Week 16)||0
928579|NCT01483599|2245071|P7|COMPLETED|Controlled Period (CP) (up to Week 16)||39
928580|NCT01483599|2245072|P6|COMPLETED|Controlled Period (CP) (up to Week 16)||38
928581|NCT01483599|2245073|P5|COMPLETED|Controlled Period (CP) (up to Week 16)||40
928582|NCT01483599|2245074|P4|COMPLETED|Controlled Period (CP) (up to Week 16)||39
928583|NCT01483599|2245075|P3|COMPLETED|Controlled Period (CP) (up to Week 16)||41
928584|NCT01483599|2245076|P2|COMPLETED|Controlled Period (CP) (up to Week 16)||38
928585|NCT01483599|2245077|P1|COMPLETED|Controlled Period (CP) (up to Week 16)||39
928586|NCT01483599|2245064|P14|Treated|Controlled Period (CP) (up to Week 16)||0
928587|NCT01483599|2245065|P13|Treated|Controlled Period (CP) (up to Week 16)||0
928588|NCT01483599|2245066|P12|Treated|Controlled Period (CP) (up to Week 16)||0
928589|NCT01483599|2245067|P11|Treated|Controlled Period (CP) (up to Week 16)||0
928590|NCT01483599|2245068|P10|Treated|Controlled Period (CP) (up to Week 16)||0
928591|NCT01483599|2245069|P9|Treated|Controlled Period (CP) (up to Week 16)||0
928592|NCT01483599|2245070|P8|Treated|Controlled Period (CP) (up to Week 16)||0
928593|NCT01483599|2245071|P7|Treated|Controlled Period (CP) (up to Week 16)||43
928594|NCT01483599|2245072|P6|Treated|Controlled Period (CP) (up to Week 16)||41
928595|NCT01483599|2245073|P5|Treated|Controlled Period (CP) (up to Week 16)||42
928596|NCT01483599|2245074|P4|Treated|Controlled Period (CP) (up to Week 16)||42
928597|NCT01483599|2245075|P3|Treated|Controlled Period (CP) (up to Week 16)||41
928598|NCT01483599|2245076|P2|Treated|Controlled Period (CP) (up to Week 16)||41
928599|NCT01483599|2245077|P1|Treated|Controlled Period (CP) (up to Week 16)||42
928600|NCT01483599|2245064|P14|STARTED|Controlled Period (CP) (up to Week 16)||0
928601|NCT01483599|2245065|P13|STARTED|Controlled Period (CP) (up to Week 16)||0
928602|NCT01483599|2245066|P12|STARTED|Controlled Period (CP) (up to Week 16)||0
928603|NCT01483599|2245067|P11|STARTED|Controlled Period (CP) (up to Week 16)||0
928604|NCT01483599|2245068|P10|STARTED|Controlled Period (CP) (up to Week 16)||0
928605|NCT01483599|2245069|P9|STARTED|Controlled Period (CP) (up to Week 16)||0
928606|NCT01483599|2245070|P8|STARTED|Controlled Period (CP) (up to Week 16)||0
928607|NCT01483599|2245071|P7|STARTED|Controlled Period (CP) (up to Week 16)||43
928608|NCT01483599|2245072|P6|STARTED|Controlled Period (CP) (up to Week 16)||42
928609|NCT01483599|2245073|P5|STARTED|Controlled Period (CP) (up to Week 16)||42
928610|NCT01483599|2245074|P4|STARTED|Controlled Period (CP) (up to Week 16)||42
928611|NCT01483599|2245075|P3|STARTED|Controlled Period (CP) (up to Week 16)||41
928612|NCT01483599|2245076|P2|STARTED|Controlled Period (CP) (up to Week 16)||41
928613|NCT01483599|2245077|P1|STARTED|Controlled Period (CP) (up to Week 16)||42
928614|NCT01483378|2245126|P2|NOT COMPLETED|Overall Study||0
928615|NCT01483378|2245127|P1|NOT COMPLETED|Overall Study||0
928616|NCT01483378|2245126|P2|COMPLETED|Overall Study||66
928617|NCT01483378|2245127|P1|COMPLETED|Overall Study||100
928618|NCT01483378|2245126|P2|STARTED|Overall Study||66
928619|NCT01483378|2245127|P1|STARTED|Overall Study||100
928620|NCT01483352|2245133|P1|NOT COMPLETED|Overall Study||0
928621|NCT01483352|2245133|P1|COMPLETED|Overall Study||12
928622|NCT01483352|2245133|P1|STARTED|Overall Study||12
928623|NCT01483209|2245152|P1|NOT COMPLETED|Overall Study||1
928624|NCT01483209|2245152|P1|COMPLETED|Overall Study||1
928625|NCT01483209|2245152|P1|STARTED|Overall Study||2
928626|NCT01483183|2245167|P10|NOT COMPLETED|Overall Study||1
928627|NCT01483183|2245168|P9|NOT COMPLETED|Overall Study||0
928628|NCT01483183|2245169|P8|NOT COMPLETED|Overall Study||0
928629|NCT01483183|2245170|P7|NOT COMPLETED|Overall Study||2
928630|NCT01483183|2245171|P6|NOT COMPLETED|Overall Study||0
928631|NCT01483183|2245172|P5|NOT COMPLETED|Overall Study||0
928632|NCT01483183|2245173|P4|NOT COMPLETED|Overall Study||0
928633|NCT01483183|2245174|P3|NOT COMPLETED|Overall Study||0
928634|NCT01483183|2245175|P2|NOT COMPLETED|Overall Study||0
928635|NCT01483183|2245176|P1|NOT COMPLETED|Overall Study||0
928636|NCT01483183|2245167|P10|COMPLETED|Overall Study||4
928637|NCT01483183|2245168|P9|COMPLETED|Overall Study||4
928638|NCT01483183|2245169|P8|COMPLETED|Overall Study||4
928639|NCT01483183|2245170|P7|COMPLETED|Overall Study||4
928640|NCT01483183|2245171|P6|COMPLETED|Overall Study||4
928641|NCT01483183|2245172|P5|COMPLETED|Overall Study||4
928642|NCT01483183|2245173|P4|COMPLETED|Overall Study||3
928643|NCT01483183|2245174|P3|COMPLETED|Overall Study||5
928644|NCT01483183|2245175|P2|COMPLETED|Overall Study||1
928645|NCT01483183|2245176|P1|COMPLETED|Overall Study||4
928646|NCT01483183|2245167|P10|STARTED|Overall Study||5
928647|NCT01483183|2245168|P9|STARTED|Overall Study||4
928648|NCT01483183|2245169|P8|STARTED|Overall Study||4
928649|NCT01483183|2245170|P7|STARTED|Overall Study||6
928650|NCT01483183|2245171|P6|STARTED|Overall Study||4
928651|NCT01483183|2245172|P5|STARTED|Overall Study||4
928652|NCT01483183|2245173|P4|STARTED|Overall Study||3
928653|NCT01483183|2245174|P3|STARTED|Overall Study||5
928654|NCT01483183|2245175|P2|STARTED|Overall Study||1
928655|NCT01483183|2245176|P1|STARTED|Overall Study||4
928656|NCT01483118|2245246|P2|NOT COMPLETED|Overall Study||16
928657|NCT01483118|2245247|P1|NOT COMPLETED|Overall Study||12
928658|NCT01483118|2245246|P2|COMPLETED|Overall Study||6
928659|NCT01483118|2245247|P1|COMPLETED|Overall Study||11
928660|NCT01483118|2245246|P2|Completed 3 Months|Overall Study||11
928661|NCT01483118|2245247|P1|Completed 3 Months|Overall Study||15
928662|NCT01483118|2245246|P2|STARTED|Overall Study||22
928663|NCT01483118|2245247|P1|STARTED|Overall Study||23
928664|NCT01482910|2245259|P2|NOT COMPLETED|Overall Study||9
928665|NCT01482910|2245260|P1|NOT COMPLETED|Overall Study||15
928666|NCT01482910|2245259|P2|COMPLETED|Overall Study||67
928667|NCT01482910|2245260|P1|COMPLETED|Overall Study||213
928668|NCT01482910|2245259|P2|Completed Week 28|Overall Study||71
928669|NCT01482910|2245260|P1|Completed Week 28|Overall Study||216
928670|NCT01482910|2245259|P2|STARTED|Overall Study||76
928671|NCT01482910|2245260|P1|STARTED|Overall Study||228
928672|NCT01482884|2245272|P2|NOT COMPLETED|Overall Study||18
928673|NCT01482884|2245273|P1|NOT COMPLETED|Overall Study||13
928674|NCT01482884|2245272|P2|COMPLETED|Overall Study||37
928675|NCT01482884|2245273|P1|COMPLETED|Overall Study||43
928676|NCT01482884|2245272|P2|STARTED|Overall Study||55
928677|NCT01482884|2245273|P1|STARTED|Overall Study|One participant did not receive study treatment|56
928678|NCT01482819|2245299|P1|NOT COMPLETED|Overall Study||2
928679|NCT01482819|2245299|P1|COMPLETED|Overall Study||19
928680|NCT01482819|2245299|P1|STARTED|Overall Study||21
928681|NCT01482767|2245319|P2|NOT COMPLETED|Overall Study||49
928682|NCT01482767|2245320|P1|NOT COMPLETED|Overall Study||54
928683|NCT01482767|2245319|P2|COMPLETED|Overall Study||78
928684|NCT01482767|2245320|P1|COMPLETED|Overall Study||81
928685|NCT01482767|2245319|P2|STARTED|Overall Study||127
928686|NCT01482767|2245320|P1|STARTED|Overall Study||135
928687|NCT01482429|2245342|P2|NOT COMPLETED|Protocol||0
928688|NCT01482429|2245343|P1|NOT COMPLETED|Protocol||275
928689|NCT01482429|2245342|P2|COMPLETED|Protocol||0
928690|NCT01482429|2245343|P1|COMPLETED|Protocol||139
928691|NCT01482429|2245342|P2|STARTED|Protocol||0
928692|NCT01482429|2245343|P1|STARTED|Protocol||414
928693|NCT01482429|2245342|P2|NOT COMPLETED|Care Usual||173
928694|NCT01482429|2245343|P1|NOT COMPLETED|Care Usual||0
928695|NCT01482429|2245342|P2|COMPLETED|Care Usual||96
928696|NCT01482429|2245343|P1|COMPLETED|Care Usual||0
928697|NCT01482429|2245342|P2|STARTED|Care Usual||269
928698|NCT01482429|2245343|P1|STARTED|Care Usual||0
928699|NCT01482325|2245351|P1|NOT COMPLETED|Overall Study||0
928700|NCT01482325|2245351|P1|COMPLETED|Overall Study||31
928701|NCT01482325|2245351|P1|STARTED|Overall Study||31
928702|NCT01482312|2245355|P3|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
928703|NCT01482312|2245356|P2|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
928704|NCT01482312|2245357|P1|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
928705|NCT01482312|2245355|P3|COMPLETED|Period 3, 90 Minutes of Wear||9
928706|NCT01482312|2245356|P2|COMPLETED|Period 3, 90 Minutes of Wear||9
928707|NCT01482312|2245357|P1|COMPLETED|Period 3, 90 Minutes of Wear||8
928708|NCT01482312|2245355|P3|STARTED|Period 3, 90 Minutes of Wear||9
928709|NCT01482312|2245356|P2|STARTED|Period 3, 90 Minutes of Wear||9
928710|NCT01482312|2245357|P1|STARTED|Period 3, 90 Minutes of Wear||8
928711|NCT01482312|2245355|P3|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
928712|NCT01482312|2245356|P2|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
928713|NCT01482312|2245357|P1|NOT COMPLETED|Period 2, 90 Minutes of Wear||1
928714|NCT01482312|2245355|P3|COMPLETED|Period 2, 90 Minutes of Wear||9
928715|NCT01482312|2245356|P2|COMPLETED|Period 2, 90 Minutes of Wear||9
928716|NCT01482312|2245357|P1|COMPLETED|Period 2, 90 Minutes of Wear||8
928717|NCT01482312|2245355|P3|STARTED|Period 2, 90 Minutes of Wear|One participant discontinued between Period 1 and Period 2|9
928718|NCT01482312|2245356|P2|STARTED|Period 2, 90 Minutes of Wear||9
928719|NCT01482312|2245357|P1|STARTED|Period 2, 90 Minutes of Wear||9
928720|NCT01482312|2245355|P3|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
928721|NCT01482312|2245356|P2|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
928722|NCT01482312|2245357|P1|NOT COMPLETED|Period 1, 90 Minutes of Wear||1
928723|NCT01482312|2245355|P3|COMPLETED|Period 1, 90 Minutes of Wear||10
928724|NCT01482312|2245356|P2|COMPLETED|Period 1, 90 Minutes of Wear||9
928725|NCT01482312|2245357|P1|COMPLETED|Period 1, 90 Minutes of Wear||9
928726|NCT01482312|2245355|P3|STARTED|Period 1, 90 Minutes of Wear||10
928727|NCT01482312|2245356|P2|STARTED|Period 1, 90 Minutes of Wear||9
928728|NCT01482312|2245357|P1|STARTED|Period 1, 90 Minutes of Wear||10
928729|NCT01482221|2245371|P3|NOT COMPLETED|Overall Study||23
928730|NCT01482221|2245372|P2|NOT COMPLETED|Overall Study||20
928731|NCT01482221|2245373|P1|NOT COMPLETED|Overall Study||21
928732|NCT01482221|2245371|P3|COMPLETED|Overall Study||77
928733|NCT01482221|2245372|P2|COMPLETED|Overall Study||81
928734|NCT01482221|2245373|P1|COMPLETED|Overall Study||80
928735|NCT01482221|2245371|P3|STARTED|Overall Study||100
928736|NCT01482221|2245372|P2|STARTED|Overall Study||101
928737|NCT01482221|2245373|P1|STARTED|Overall Study||101
928738|NCT01482091|2245416|P2|NOT COMPLETED|Overall Study||0
928739|NCT01482091|2245417|P1|NOT COMPLETED|Overall Study||0
928740|NCT01482091|2245416|P2|COMPLETED|Overall Study||24
928741|NCT01482091|2245417|P1|COMPLETED|Overall Study||25
928742|NCT01482091|2245416|P2|STARTED|Overall Study||24
928743|NCT01482091|2245417|P1|STARTED|Overall Study||25
928744|NCT01482065|2245449|P2|NOT COMPLETED|Overall Study||1
928745|NCT01482065|2245450|P1|NOT COMPLETED|Overall Study||0
928746|NCT01482065|2245449|P2|COMPLETED|Overall Study||4
928747|NCT01482065|2245450|P1|COMPLETED|Overall Study||4
928748|NCT01482065|2245449|P2|STARTED|Overall Study||5
928749|NCT01482065|2245450|P1|STARTED|Overall Study||4
928750|NCT01481935|2245464|P2|NOT COMPLETED|Overall Study||0
928751|NCT01481935|2245465|P1|NOT COMPLETED|Overall Study||0
928752|NCT01481935|2245464|P2|COMPLETED|Overall Study||93
928753|NCT01481935|2245465|P1|COMPLETED|Overall Study||97
928754|NCT01481935|2245464|P2|STARTED|Overall Study||93
928755|NCT01481935|2245465|P1|STARTED|Overall Study||97
928756|NCT01481896|2245471|P1|NOT COMPLETED|Overall Study||12
928757|NCT01481896|2245471|P1|COMPLETED|Overall Study|The 114 participants includes 5 participants with bilateral hip replacements for a total of 119 THAs|114
928758|NCT01481896|2245471|P1|Min 4.75 yr Follow-up, Revised or Dead|Overall Study|114 participants with 119 THAs had at least 4.75 year follow-up or were known revised or deceased|114
928759|NCT01481896|2245471|P1|STARTED|Overall Study|The 126 participants includes 5 participants with bilateral hip replacements for a total of 131 THAs|126
928760|NCT01481740|2245487|P2|NOT COMPLETED|Overall Study||7
928761|NCT01481740|2245488|P1|NOT COMPLETED|Overall Study||11
928762|NCT01481740|2245487|P2|COMPLETED|Overall Study||81
928763|NCT01481740|2245488|P1|COMPLETED|Overall Study||79
928764|NCT01481740|2245487|P2|STARTED|Overall Study||88
928765|NCT01481740|2245488|P1|STARTED|Overall Study||90
928766|NCT01481558|2245506|P2|NOT COMPLETED|Overall Study||0
928767|NCT01481558|2245507|P1|NOT COMPLETED|Overall Study||0
928768|NCT01481558|2245506|P2|COMPLETED|Overall Study||20
928769|NCT01481558|2245507|P1|COMPLETED|Overall Study||20
928770|NCT01481558|2245506|P2|STARTED|Overall Study||20
928771|NCT01481558|2245507|P1|STARTED|Overall Study||20
928772|NCT01481376|2245513|P1|NOT COMPLETED|Overall Study||31
928773|NCT01481376|2245513|P1|COMPLETED|Overall Study||169
928774|NCT01481376|2245513|P1|STARTED|Overall Study||200
928775|NCT01481324|2245524|P3|NOT COMPLETED|Overall Study||2
928776|NCT01481324|2245525|P2|NOT COMPLETED|Overall Study||2
928777|NCT01481324|2245526|P1|NOT COMPLETED|Overall Study||0
928778|NCT01481324|2245524|P3|COMPLETED|Overall Study||20
928779|NCT01481324|2245525|P2|COMPLETED|Overall Study||22
928780|NCT01481324|2245526|P1|COMPLETED|Overall Study||21
928781|NCT01481324|2245524|P3|Month 3-Wear Rate Data|Overall Study||6
928782|NCT01481324|2245525|P2|Month 3-Wear Rate Data|Overall Study||11
928783|NCT01481324|2245526|P1|Month 3-Wear Rate Data|Overall Study||7
928784|NCT01481324|2245524|P3|Month 2-Wear Rate Data|Overall Study||7
928785|NCT01481324|2245525|P2|Month 2-Wear Rate Data|Overall Study||13
928786|NCT01481324|2245526|P1|Month 2-Wear Rate Data|Overall Study||9
928787|NCT01481324|2245524|P3|Month 1-Wear Rate Data|Overall Study||8
928788|NCT01481324|2245525|P2|Month 1-Wear Rate Data|Overall Study||16
928789|NCT01481324|2245526|P1|Month 1-Wear Rate Data|Overall Study||15
928790|NCT01481324|2245524|P3|STARTED|Overall Study||22
928791|NCT01481324|2245525|P2|STARTED|Overall Study||24
928792|NCT01481324|2245526|P1|STARTED|Overall Study||21
928793|NCT01481129|2245534|P1|NOT COMPLETED|Overall Study||0
928794|NCT01481129|2245534|P1|COMPLETED|Overall Study||22
928795|NCT01481129|2245534|P1|STARTED|Overall Study||22
928796|NCT01481116|2245545|P3|NOT COMPLETED|Overall Study||813
928797|NCT01481116|2245546|P2|NOT COMPLETED|Overall Study||817
928798|NCT01481116|2245547|P1|NOT COMPLETED|Overall Study||824
928799|NCT01481116|2245545|P3|COMPLETED|Overall Study||0
928800|NCT01481116|2245546|P2|COMPLETED|Overall Study||0
928801|NCT01481116|2245547|P1|COMPLETED|Overall Study||0
928802|NCT01481116|2245545|P3|Treated|Overall Study||813
928803|NCT01481116|2245546|P2|Treated|Overall Study||816
928804|NCT01481116|2245547|P1|Treated|Overall Study||822
928805|NCT01481116|2245545|P3|STARTED|Overall Study||813
928806|NCT01481116|2245546|P2|STARTED|Overall Study||817
928807|NCT01481116|2245547|P1|STARTED|Overall Study||824
928808|NCT01480674|2245573|P1|NOT COMPLETED|Overall Study||35
928809|NCT01480674|2245573|P1|COMPLETED|Overall Study||125
928810|NCT01480674|2245573|P1|Analysed Set|Overall Study||128
928811|NCT01480674|2245573|P1|Safety Set|Overall Study||154
928812|NCT01480674|2245573|P1|STARTED|Overall Study||160
928813|NCT01480596|2245587|P2|NOT COMPLETED|Overall Study||2
928814|NCT01480596|2245588|P1|NOT COMPLETED|Overall Study||5
928815|NCT01480596|2245587|P2|COMPLETED|Overall Study||16
928816|NCT01480596|2245588|P1|COMPLETED|Overall Study||17
928817|NCT01480596|2245587|P2|STARTED|Overall Study||18
928818|NCT01480596|2245588|P1|STARTED|Overall Study||22
928819|NCT01480297|2245630|P1|NOT COMPLETED|Overall Study||0
928820|NCT01480297|2245630|P1|COMPLETED|Overall Study||8
928821|NCT01480297|2245630|P1|STARTED|Overall Study||8
928822|NCT01480284|2245636|P2|NOT COMPLETED|Overall Study||0
928823|NCT01480284|2245637|P1|NOT COMPLETED|Overall Study||8
928824|NCT01480284|2245636|P2|COMPLETED|Overall Study||56
928825|NCT01480284|2245637|P1|COMPLETED|Overall Study||102
928826|NCT01480284|2245636|P2|STARTED|Overall Study||56
928827|NCT01480284|2245637|P1|STARTED|Overall Study||110
928828|NCT01480232|2245669|P4|NOT COMPLETED|Overall Study||19
928829|NCT01480232|2245670|P3|NOT COMPLETED|Overall Study||17
928830|NCT01480232|2245671|P2|NOT COMPLETED|Overall Study||22
928831|NCT01480232|2245672|P1|NOT COMPLETED|Overall Study||18
928832|NCT01480232|2245669|P4|COMPLETED|Overall Study||22
928833|NCT01480232|2245670|P3|COMPLETED|Overall Study||21
928834|NCT01480232|2245671|P2|COMPLETED|Overall Study||19
928835|NCT01480232|2245672|P1|COMPLETED|Overall Study||22
928836|NCT01480232|2245669|P4|STARTED|Overall Study||41
928837|NCT01480232|2245670|P3|STARTED|Overall Study||38
928838|NCT01480232|2245671|P2|STARTED|Overall Study||41
928839|NCT01480232|2245672|P1|STARTED|Overall Study||40
928840|NCT01480219|2245700|P2|NOT COMPLETED|Overall Study||0
928841|NCT01480219|2245701|P1|NOT COMPLETED|Overall Study||0
928842|NCT01480219|2245700|P2|COMPLETED|Overall Study||142
928843|NCT01480219|2245701|P1|COMPLETED|Overall Study||325
928844|NCT01480219|2245700|P2|STARTED|Overall Study||142
928845|NCT01480219|2245701|P1|STARTED|Overall Study||325
928846|NCT01480089|2245709|P2|NOT COMPLETED|Overall Study||0
928847|NCT01480089|2245710|P1|NOT COMPLETED|Overall Study||0
928848|NCT01480089|2245709|P2|COMPLETED|Overall Study||30
928849|NCT01480089|2245710|P1|COMPLETED|Overall Study||25
928850|NCT01480089|2245709|P2|STARTED|Overall Study||30
928851|NCT01480089|2245710|P1|STARTED|Overall Study||25
928852|NCT01480076|2245720|P1|NOT COMPLETED|Overall Study||290
928853|NCT01480076|2245720|P1|COMPLETED|Overall Study||611
928854|NCT01480076|2245720|P1|Intent to Treat Population|Overall Study|Received ≥1 dose of study drug & provided ≥1 efficacy assessment at Baseline & the 3-month visit.|835
928855|NCT01480076|2245720|P1|STARTED|Overall Study|enrolled and started run-in treatment|901
928856|NCT01479868|2245839|P1|NOT COMPLETED|Overall Study||9
928857|NCT01479868|2245839|P1|COMPLETED|Overall Study||97
928858|NCT01479868|2245839|P1|STARTED|Overall Study|Restricted to subject who received at least one dose of treatment (TMC435/RBV/PegIFN).|106
928859|NCT01479777|2245854|P1|NOT COMPLETED|Overall Study||2
928860|NCT01479777|2245854|P1|COMPLETED|Overall Study||10
928861|NCT01479777|2245854|P1|STARTED|Overall Study||12
928862|NCT01479764|2245866|P2|NOT COMPLETED|Treated||2
928863|NCT01479764|2245867|P1|NOT COMPLETED|Treated||0
928864|NCT01479764|2245866|P2|COMPLETED|Treated||75
928865|NCT01479764|2245867|P1|COMPLETED|Treated||74
928866|NCT01479764|2245866|P2|STARTED|Treated||77
928867|NCT01479764|2245867|P1|STARTED|Treated||74
928868|NCT01479764|2245866|P2|NOT COMPLETED|Randomized||1
928869|NCT01479764|2245867|P1|NOT COMPLETED|Randomized||2
928870|NCT01479764|2245866|P2|COMPLETED|Randomized|1 randomized participant did not receive study drug|77
928871|NCT01479764|2245867|P1|COMPLETED|Randomized|2 randomized participants did not receive study drug|74
928872|NCT01479764|2245866|P2|STARTED|Randomized||78
928873|NCT01479764|2245867|P1|STARTED|Randomized||76
928874|NCT01479725|2245877|P2|NOT COMPLETED|Overall Study||1
928875|NCT01479725|2245878|P1|NOT COMPLETED|Overall Study||2
928876|NCT01479725|2245877|P2|COMPLETED|Overall Study||1
928877|NCT01479725|2245878|P1|COMPLETED|Overall Study||4
928878|NCT01479725|2245877|P2|STARTED|Overall Study||2
928879|NCT01479725|2245878|P1|STARTED|Overall Study||6
928880|NCT01479621|2245890|P7|NOT COMPLETED|Treatment Period||20
928881|NCT01479621|2245891|P6|NOT COMPLETED|Treatment Period||41
928882|NCT01479621|2245892|P5|NOT COMPLETED|Treatment Period||21
928883|NCT01479621|2245893|P4|NOT COMPLETED|Treatment Period||12
928884|NCT01479621|2245894|P3|NOT COMPLETED|Treatment Period||21
928885|NCT01479621|2245895|P2|NOT COMPLETED|Treatment Period||24
928886|NCT01479621|2245896|P1|NOT COMPLETED|Treatment Period||0
928887|NCT01479621|2245890|P7|COMPLETED|Treatment Period||84
928888|NCT01479621|2245891|P6|COMPLETED|Treatment Period||63
928889|NCT01479621|2245892|P5|COMPLETED|Treatment Period||82
928890|NCT01479621|2245893|P4|COMPLETED|Treatment Period||92
928891|NCT01479621|2245894|P3|COMPLETED|Treatment Period||83
928892|NCT01479621|2245895|P2|COMPLETED|Treatment Period||79
928893|NCT01479621|2245896|P1|COMPLETED|Treatment Period||0
928894|NCT01479621|2245890|P7|Full Analysis Set|Treatment Period||102
928895|NCT01479621|2245891|P6|Full Analysis Set|Treatment Period||102
928896|NCT01479621|2245892|P5|Full Analysis Set|Treatment Period||102
928897|NCT01479621|2245893|P4|Full Analysis Set|Treatment Period||102
928898|NCT01479621|2245894|P3|Full Analysis Set|Treatment Period||101
928899|NCT01479621|2245895|P2|Full Analysis Set|Treatment Period||102
928900|NCT01479621|2245896|P1|Full Analysis Set|Treatment Period||0
928901|NCT01479621|2245890|P7|Safety Population|Treatment Period||104
928902|NCT01479621|2245891|P6|Safety Population|Treatment Period||104
928903|NCT01479621|2245892|P5|Safety Population|Treatment Period||103
928904|NCT01479621|2245893|P4|Safety Population|Treatment Period||104
928905|NCT01479621|2245894|P3|Safety Population|Treatment Period||104
928906|NCT01479621|2245895|P2|Safety Population|Treatment Period||103
928907|NCT01479621|2245896|P1|Safety Population|Treatment Period||0
928908|NCT01479621|2245890|P7|STARTED|Treatment Period||104
928909|NCT01479621|2245891|P6|STARTED|Treatment Period||104
928910|NCT01479621|2245892|P5|STARTED|Treatment Period||103
928911|NCT01479621|2245893|P4|STARTED|Treatment Period||104
928912|NCT01479621|2245894|P3|STARTED|Treatment Period||104
928913|NCT01479621|2245895|P2|STARTED|Treatment Period||103
928914|NCT01479621|2245896|P1|STARTED|Treatment Period||0
928915|NCT01479621|2245890|P7|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
928916|NCT01479621|2245891|P6|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
928917|NCT01479621|2245892|P5|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
928918|NCT01479621|2245893|P4|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
928919|NCT01479621|2245894|P3|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
928920|NCT01479621|2245895|P2|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
928921|NCT01479621|2245896|P1|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||287
928922|NCT01479621|2245890|P7|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
928923|NCT01479621|2245891|P6|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
928924|NCT01479621|2245892|P5|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
928925|NCT01479621|2245893|P4|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
928926|NCT01479621|2245894|P3|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
928927|NCT01479621|2245895|P2|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
928928|NCT01479621|2245896|P1|COMPLETED|Pre-Assignment Period (Run-In Placebo)||622
928929|NCT01479621|2245890|P7|STARTED|Pre-Assignment Period (Run-In Placebo)||0
928930|NCT01479621|2245891|P6|STARTED|Pre-Assignment Period (Run-In Placebo)||0
928931|NCT01479621|2245892|P5|STARTED|Pre-Assignment Period (Run-In Placebo)||0
928932|NCT01479621|2245893|P4|STARTED|Pre-Assignment Period (Run-In Placebo)||0
928933|NCT01479621|2245894|P3|STARTED|Pre-Assignment Period (Run-In Placebo)||0
928934|NCT01479621|2245895|P2|STARTED|Pre-Assignment Period (Run-In Placebo)||0
928935|NCT01479621|2245896|P1|STARTED|Pre-Assignment Period (Run-In Placebo)||909
928936|NCT01479595|2245984|P2|NOT COMPLETED|Overall Study||2
928937|NCT01479595|2245985|P1|NOT COMPLETED|Overall Study||2
928938|NCT01479595|2245984|P2|COMPLETED|Overall Study||19
928939|NCT01479595|2245985|P1|COMPLETED|Overall Study||42
928940|NCT01479595|2245984|P2|Per Protocol Analysis Set|Overall Study||20
928941|NCT01479595|2245985|P1|Per Protocol Analysis Set|Overall Study||41
928942|NCT01479595|2245984|P2|PK Analysis Set|Overall Study||0
928943|NCT01479595|2245985|P1|PK Analysis Set|Overall Study||42
928944|NCT01479595|2245984|P2|STARTED|Overall Study||21
928945|NCT01479595|2245985|P1|STARTED|Overall Study||44
928946|NCT01479543|2246012|P5|NOT COMPLETED|Overall Study||1
928947|NCT01479543|2246013|P4|NOT COMPLETED|Overall Study||0
928948|NCT01479543|2246014|P3|NOT COMPLETED|Overall Study||1
928949|NCT01479543|2246015|P2|NOT COMPLETED|Overall Study||0
928950|NCT01479543|2246016|P1|NOT COMPLETED|Overall Study||1
928951|NCT01479543|2246012|P5|COMPLETED|Overall Study||20
928952|NCT01479543|2246013|P4|COMPLETED|Overall Study||20
928953|NCT01479543|2246014|P3|COMPLETED|Overall Study||20
928954|NCT01479543|2246015|P2|COMPLETED|Overall Study||20
928955|NCT01479543|2246016|P1|COMPLETED|Overall Study||20
928956|NCT01479543|2246012|P5|STARTED|Overall Study||21
928957|NCT01479543|2246013|P4|STARTED|Overall Study||20
928958|NCT01479543|2246014|P3|STARTED|Overall Study||21
928959|NCT01479543|2246015|P2|STARTED|Overall Study||20
928960|NCT01479543|2246016|P1|STARTED|Overall Study||21
928961|NCT01479530|2246030|P2|NOT COMPLETED|Overall Study||12
928962|NCT01479530|2246031|P1|NOT COMPLETED|Overall Study||10
928963|NCT01479530|2246030|P2|COMPLETED|Overall Study||151
928964|NCT01479530|2246031|P1|COMPLETED|Overall Study||148
928965|NCT01479530|2246030|P2|STARTED|Overall Study||163
928966|NCT01479530|2246031|P1|STARTED|Overall Study||158
928967|NCT01479517|2246046|P3|NOT COMPLETED|Overall Study||0
928968|NCT01479517|2246047|P2|NOT COMPLETED|Overall Study||0
928969|NCT01479517|2246048|P1|NOT COMPLETED|Overall Study||0
928970|NCT01479517|2246046|P3|COMPLETED|Overall Study||10
928971|NCT01479517|2246047|P2|COMPLETED|Overall Study||10
928972|NCT01479517|2246048|P1|COMPLETED|Overall Study||10
928973|NCT01479517|2246046|P3|STARTED|Overall Study||10
928974|NCT01479517|2246047|P2|STARTED|Overall Study||10
928975|NCT01479517|2246048|P1|STARTED|Overall Study||10
928976|NCT01479374|2246068|P3|NOT COMPLETED|Overall Study||5
928977|NCT01479374|2246069|P2|NOT COMPLETED|Overall Study||8
928978|NCT01479374|2246070|P1|NOT COMPLETED|Overall Study||3
928979|NCT01479374|2246068|P3|COMPLETED|Overall Study||63
928980|NCT01479374|2246069|P2|COMPLETED|Overall Study||60
928981|NCT01479374|2246070|P1|COMPLETED|Overall Study||63
928982|NCT01479374|2246068|P3|STARTED|Overall Study||68
928983|NCT01479374|2246069|P2|STARTED|Overall Study||68
928984|NCT01479374|2246070|P1|STARTED|Overall Study||66
928985|NCT01479127|2246096|P1|NOT COMPLETED|Overall Study||3
928986|NCT01479127|2246096|P1|COMPLETED|Overall Study||5
928987|NCT01479127|2246096|P1|Started LCIG|Overall Study||6
928988|NCT01479127|2246096|P1|STARTED|Overall Study|started oral study drug (full safety sample)|8
928989|NCT01479010|2246130|P1|NOT COMPLETED|Overall Study||1
928990|NCT01479010|2246130|P1|COMPLETED|Overall Study||1
928991|NCT01479010|2246130|P1|STARTED|Overall Study||2
928992|NCT01478971|2246135|P1|NOT COMPLETED|Peginesatide Treatment Period||14
928993|NCT01478971|2246135|P1|COMPLETED|Peginesatide Treatment Period||143
928994|NCT01478971|2246135|P1|STARTED|Peginesatide Treatment Period|2 participants terminated the study before transitioning to peginesatide for unknown reasons|157
928995|NCT01478971|2246135|P1|NOT COMPLETED|Standard of Care Period||25
928996|NCT01478971|2246135|P1|COMPLETED|Standard of Care Period||159
928997|NCT01478971|2246135|P1|Received Treatment|Standard of Care Period||178
928998|NCT01478971|2246135|P1|STARTED|Standard of Care Period||184
928999|NCT01478958|2246152|P3|NOT COMPLETED|Overall Study||3
929000|NCT01478958|2246153|P2|NOT COMPLETED|Overall Study||2
929001|NCT01478958|2246154|P1|NOT COMPLETED|Overall Study||2
929002|NCT01478958|2246152|P3|COMPLETED|Overall Study||66
929003|NCT01478958|2246153|P2|COMPLETED|Overall Study||64
929004|NCT01478958|2246154|P1|COMPLETED|Overall Study||65
929005|NCT01478958|2246152|P3|STARTED|Overall Study||69
929006|NCT01478958|2246153|P2|STARTED|Overall Study||66
929007|NCT01478958|2246154|P1|STARTED|Overall Study||67
929008|NCT01478828|2246162|P1|NOT COMPLETED|Overall Study||1
929009|NCT01478828|2246162|P1|COMPLETED|Overall Study||1
929010|NCT01478828|2246162|P1|STARTED|Overall Study||2
929011|NCT01478620|2246167|P1|NOT COMPLETED|Overall Study||6
929012|NCT01478620|2246167|P1|COMPLETED|Overall Study||119
929013|NCT01478620|2246167|P1|STARTED|Overall Study||125
929014|NCT01478594|2246173|P2|NOT COMPLETED|Overall Study||28
929015|NCT01478594|2246174|P1|NOT COMPLETED|Overall Study||65
929016|NCT01478594|2246173|P2|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|60
929017|NCT01478594|2246174|P1|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|112
929018|NCT01478594|2246173|P2|Treated|Overall Study||87
929019|NCT01478594|2246174|P1|Treated|Overall Study||177
929020|NCT01478594|2246173|P2|STARTED|Overall Study||88
929021|NCT01478594|2246174|P1|STARTED|Overall Study||177
929022|NCT01478373|2246246|P1|NOT COMPLETED|Survival Phase||38
929023|NCT01478373|2246246|P1|COMPLETED|Survival Phase||0
929024|NCT01478373|2246246|P1|STARTED|Survival Phase||38
929025|NCT01478373|2246246|P1|NOT COMPLETED|Treatment Phase||1
929026|NCT01478373|2246246|P1|COMPLETED|Treatment Phase||38
929027|NCT01478373|2246246|P1|STARTED|Treatment Phase||39
929028|NCT01478360|2246259|P2|NOT COMPLETED|Overall Study||3
929029|NCT01478360|2246260|P1|NOT COMPLETED|Overall Study||2
929030|NCT01478360|2246259|P2|COMPLETED|Overall Study||12
929031|NCT01478360|2246260|P1|COMPLETED|Overall Study||29
929032|NCT01478360|2246259|P2|PK (Pharmacokinetics) Analysis Set|Overall Study||0
929033|NCT01478360|2246260|P1|PK (Pharmacokinetics) Analysis Set|Overall Study|Serum samples were collected during the study and analyzed only for the AIN457 group|31
929034|NCT01478360|2246259|P2|PD (Pharmacodynamic) Analysis Set|Overall Study||15
929035|NCT01478360|2246260|P1|PD (Pharmacodynamic) Analysis Set|Overall Study||31
929036|NCT01478360|2246259|P2|STARTED|Overall Study||15
929037|NCT01478360|2246260|P1|STARTED|Overall Study||31
929038|NCT01478347|2246266|P1|NOT COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||8
929039|NCT01478347|2246266|P1|COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||4
929040|NCT01478347|2246266|P1|STARTED|Visit 4-Visit 7 (Day 151-331) - Part II||12
929041|NCT01478347|2246266|P1|NOT COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||1
929042|NCT01478347|2246266|P1|COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||17
929043|NCT01478347|2246266|P1|STARTED|Visit 1-Visit 3 (Day 0-91) - Part I||18
929044|NCT01478256|2246273|P2|NOT COMPLETED|Overall Study||0
929045|NCT01478256|2246274|P1|NOT COMPLETED|Overall Study||0
929046|NCT01478256|2246273|P2|COMPLETED|Overall Study||15
929047|NCT01478256|2246274|P1|COMPLETED|Overall Study||15
929048|NCT01478256|2246273|P2|STARTED|Overall Study||15
929049|NCT01478256|2246274|P1|STARTED|Overall Study||15
929050|NCT01478113|2246284|P2|NOT COMPLETED|Overall Study||1
929051|NCT01478113|2246285|P1|NOT COMPLETED|Overall Study||1
929052|NCT01478113|2246284|P2|COMPLETED|Overall Study||1
929053|NCT01478113|2246285|P1|COMPLETED|Overall Study||1
929054|NCT01478113|2246284|P2|STARTED|Overall Study||2
929055|NCT01478113|2246285|P1|STARTED|Overall Study||2
929056|NCT01478087|2246303|P1|NOT COMPLETED|Overall Study||1
929057|NCT01478087|2246303|P1|COMPLETED|Overall Study||2
929058|NCT01478087|2246303|P1|STARTED|Overall Study||3
929059|NCT01478048|2246310|P2|NOT COMPLETED|Overall Study||68
929060|NCT01478048|2246311|P1|NOT COMPLETED|Overall Study||63
929061|NCT01478048|2246310|P2|COMPLETED|Overall Study|completed=treatment on-going|7
929062|NCT01478048|2246311|P1|COMPLETED|Overall Study|completed=treatment on-going|14
929063|NCT01478048|2246310|P2|Received Treatment|Overall Study||75
929064|NCT01478048|2246311|P1|Received Treatment|Overall Study||75
929065|NCT01478048|2246310|P2|STARTED|Overall Study||75
929066|NCT01478048|2246311|P1|STARTED|Overall Study||77
929067|NCT01478009|2246329|P2|NOT COMPLETED|Overall Study||1
929068|NCT01478009|2246330|P1|NOT COMPLETED|Overall Study||1
929069|NCT01478009|2246329|P2|COMPLETED|Overall Study||49
929070|NCT01478009|2246330|P1|COMPLETED|Overall Study||49
929071|NCT01478009|2246329|P2|STARTED|Overall Study||50
929072|NCT01478009|2246330|P1|STARTED|Overall Study||50
929073|NCT01477892|2246340|P2|NOT COMPLETED|Overall Study||2
929074|NCT01477892|2246341|P1|NOT COMPLETED|Overall Study||0
929075|NCT01477892|2246340|P2|COMPLETED|Overall Study||5
929076|NCT01477892|2246341|P1|COMPLETED|Overall Study||7
929077|NCT01477892|2246340|P2|STARTED|Overall Study||7
929078|NCT01477892|2246341|P1|STARTED|Overall Study||7
929079|NCT01477853|2246352|P3|NOT COMPLETED|Phase B||11
929080|NCT01477853|2246353|P2|NOT COMPLETED|Phase B||11
929081|NCT01477853|2246354|P1|NOT COMPLETED|Phase B||12
929082|NCT01477853|2246352|P3|COMPLETED|Phase B||0
929083|NCT01477853|2246353|P2|COMPLETED|Phase B||0
929084|NCT01477853|2246354|P1|COMPLETED|Phase B||0
929085|NCT01477853|2246352|P3|STARTED|Phase B||11
929086|NCT01477853|2246353|P2|STARTED|Phase B||11
929087|NCT01477853|2246354|P1|STARTED|Phase B||12
929088|NCT01477853|2246352|P3|NOT COMPLETED|Phase A||44
929089|NCT01477853|2246353|P2|NOT COMPLETED|Phase A||45
929090|NCT01477853|2246354|P1|NOT COMPLETED|Phase A||43
929091|NCT01477853|2246352|P3|COMPLETED|Phase A||11
929092|NCT01477853|2246353|P2|COMPLETED|Phase A||11
929093|NCT01477853|2246354|P1|COMPLETED|Phase A||12
929094|NCT01477853|2246352|P3|STARTED|Phase A||55
929095|NCT01477853|2246353|P2|STARTED|Phase A||56
929096|NCT01477853|2246354|P1|STARTED|Phase A||55
929097|NCT01477762|2246396|P4|NOT COMPLETED|Overall Study||2
929098|NCT01477762|2246397|P3|NOT COMPLETED|Overall Study||4
929099|NCT01477762|2246398|P2|NOT COMPLETED|Overall Study||13
929100|NCT01477762|2246399|P1|NOT COMPLETED|Overall Study||9
929101|NCT01477762|2246396|P4|COMPLETED|Overall Study||11
929102|NCT01477762|2246397|P3|COMPLETED|Overall Study||16
929103|NCT01477762|2246398|P2|COMPLETED|Overall Study||20
929104|NCT01477762|2246399|P1|COMPLETED|Overall Study||16
929105|NCT01477762|2246396|P4|STARTED|Overall Study||13
929106|NCT01477762|2246397|P3|STARTED|Overall Study||20
929107|NCT01477762|2246398|P2|STARTED|Overall Study||33
929108|NCT01477762|2246399|P1|STARTED|Overall Study||25
929109|NCT01477749|2246421|P1|NOT COMPLETED|Overall Study||4
929110|NCT01477749|2246421|P1|COMPLETED|Overall Study||43
929111|NCT01477749|2246421|P1|STARTED|Overall Study||47
929112|NCT01477710|2246428|P1|NOT COMPLETED|Overall Study||0
929113|NCT01477710|2246428|P1|COMPLETED|Overall Study||30
929114|NCT01477710|2246428|P1|STARTED|Overall Study||30
929115|NCT01477567|2246443|P7|NOT COMPLETED|Overall Study||0
929116|NCT01477567|2246444|P6|NOT COMPLETED|Overall Study||0
929117|NCT01477567|2246445|P5|NOT COMPLETED|Overall Study||0
929118|NCT01477567|2246446|P4|NOT COMPLETED|Overall Study||0
929119|NCT01477567|2246447|P3|NOT COMPLETED|Overall Study||0
929120|NCT01477567|2246448|P2|NOT COMPLETED|Overall Study||0
929121|NCT01477567|2246449|P1|NOT COMPLETED|Overall Study||0
929122|NCT01477567|2246443|P7|COMPLETED|Overall Study||6
929123|NCT01477567|2246444|P6|COMPLETED|Overall Study||5
929124|NCT01477567|2246445|P5|COMPLETED|Overall Study||6
929125|NCT01477567|2246446|P4|COMPLETED|Overall Study||6
929126|NCT01477567|2246447|P3|COMPLETED|Overall Study||6
929127|NCT01477567|2246448|P2|COMPLETED|Overall Study||6
929128|NCT01477567|2246449|P1|COMPLETED|Overall Study||5
929129|NCT01477567|2246443|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
929130|NCT01477567|2246444|P6|Received at Least 1 Dose of Study Drug|Overall Study||5
929131|NCT01477567|2246445|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
929132|NCT01477567|2246446|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
929133|NCT01477567|2246447|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
929134|NCT01477567|2246448|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
929135|NCT01477567|2246449|P1|Received at Least 1 Dose of Study Drug|Overall Study||5
929136|NCT01477567|2246443|P7|STARTED|Overall Study||6
929137|NCT01477567|2246444|P6|STARTED|Overall Study||5
929138|NCT01477567|2246445|P5|STARTED|Overall Study||6
929139|NCT01477567|2246446|P4|STARTED|Overall Study||6
929140|NCT01477567|2246447|P3|STARTED|Overall Study||6
929141|NCT01477567|2246448|P2|STARTED|Overall Study||6
929142|NCT01477567|2246449|P1|STARTED|Overall Study||5
929143|NCT01477463|2246505|P2|NOT COMPLETED|Overall Study||0
929144|NCT01477463|2246506|P1|NOT COMPLETED|Overall Study||0
929145|NCT01477463|2246505|P2|COMPLETED|Overall Study||6
929146|NCT01477463|2246506|P1|COMPLETED|Overall Study||18
929147|NCT01477463|2246505|P2|STARTED|Overall Study||6
929148|NCT01477463|2246506|P1|STARTED|Overall Study||18
929149|NCT01477450|2246519|P3|NOT COMPLETED|Overall Study||0
929150|NCT01477450|2246520|P2|NOT COMPLETED|Overall Study||0
929151|NCT01477450|2246521|P1|NOT COMPLETED|Overall Study||0
929152|NCT01477450|2246519|P3|COMPLETED|Overall Study||10
929153|NCT01477450|2246520|P2|COMPLETED|Overall Study||10
929154|NCT01477450|2246521|P1|COMPLETED|Overall Study||10
929155|NCT01477450|2246519|P3|STARTED|Overall Study||10
929156|NCT01477450|2246520|P2|STARTED|Overall Study||10
929157|NCT01477450|2246521|P1|STARTED|Overall Study||10
929158|NCT01477333|2246529|P1|NOT COMPLETED|Overall Study||3
929159|NCT01477333|2246529|P1|COMPLETED|Overall Study||15
929160|NCT01477333|2246529|P1|STARTED|Overall Study||18
929161|NCT01476748|2246548|P3|NOT COMPLETED|Overall Study||0
929162|NCT01476748|2246549|P2|NOT COMPLETED|Overall Study||0
929163|NCT01476748|2246550|P1|NOT COMPLETED|Overall Study||0
929164|NCT01476748|2246548|P3|COMPLETED|Overall Study||5
929165|NCT01476748|2246549|P2|COMPLETED|Overall Study||5
929166|NCT01476748|2246550|P1|COMPLETED|Overall Study||5
929167|NCT01476748|2246548|P3|STARTED|Overall Study||5
929168|NCT01476748|2246549|P2|STARTED|Overall Study||5
929169|NCT01476748|2246550|P1|STARTED|Overall Study||5
929170|NCT01476722|2246561|P1|NOT COMPLETED|Overall Study||1
929171|NCT01476722|2246561|P1|COMPLETED|Overall Study||124
929172|NCT01476722|2246561|P1|STARTED|Overall Study||125
929173|NCT01476696|2246568|P3|NOT COMPLETED|Overall Study||0
929174|NCT01476696|2246569|P2|NOT COMPLETED|Overall Study||1
929175|NCT01476696|2246570|P1|NOT COMPLETED|Overall Study||3
929176|NCT01476696|2246568|P3|COMPLETED|Overall Study||9
929177|NCT01476696|2246569|P2|COMPLETED|Overall Study||8
929178|NCT01476696|2246570|P1|COMPLETED|Overall Study||12
929179|NCT01476696|2246568|P3|Received at Least 1 Dose of Study Drug|Overall Study||9
929180|NCT01476696|2246569|P2|Received at Least 1 Dose of Study Drug|Overall Study||9
929181|NCT01476696|2246570|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
929182|NCT01476696|2246568|P3|STARTED|Overall Study||9
929183|NCT01476696|2246569|P2|STARTED|Overall Study||9
929184|NCT01476696|2246570|P1|STARTED|Overall Study||15
929185|NCT01476475|2246586|P2|NOT COMPLETED|Overall Study||3
929186|NCT01476475|2246587|P1|NOT COMPLETED|Overall Study||11
929187|NCT01476475|2246586|P2|COMPLETED|Overall Study||159
929188|NCT01476475|2246587|P1|COMPLETED|Overall Study||150
929189|NCT01476475|2246586|P2|STARTED|Overall Study||162
929190|NCT01476475|2246587|P1|STARTED|Overall Study||161
929191|NCT01476345|2246619|P2|NOT COMPLETED|Period 4||0
929192|NCT01476345|2246620|P1|NOT COMPLETED|Period 4||0
929193|NCT01476345|2246619|P2|COMPLETED|Period 4||39
929194|NCT01476345|2246620|P1|COMPLETED|Period 4||39
929195|NCT01476345|2246619|P2|STARTED|Period 4||39
929196|NCT01476345|2246620|P1|STARTED|Period 4||39
929197|NCT01476345|2246619|P2|NOT COMPLETED|Period 3||0
929198|NCT01476345|2246620|P1|NOT COMPLETED|Period 3||0
929199|NCT01476345|2246619|P2|COMPLETED|Period 3||39
929200|NCT01476345|2246620|P1|COMPLETED|Period 3||39
929201|NCT01476345|2246619|P2|STARTED|Period 3||39
929202|NCT01476345|2246620|P1|STARTED|Period 3||39
929203|NCT01476345|2246619|P2|NOT COMPLETED|Period 2||0
929204|NCT01476345|2246620|P1|NOT COMPLETED|Period 2||0
929205|NCT01476345|2246619|P2|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
929206|NCT01476345|2246620|P1|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
929207|NCT01476345|2246619|P2|STARTED|Period 2||40
929208|NCT01476345|2246620|P1|STARTED|Period 2||40
929209|NCT01476345|2246619|P2|NOT COMPLETED|Period 1||0
929210|NCT01476345|2246620|P1|NOT COMPLETED|Period 1||0
929211|NCT01476345|2246619|P2|COMPLETED|Period 1||40
929212|NCT01476345|2246620|P1|COMPLETED|Period 1||40
929213|NCT01476345|2246619|P2|Received at Least 1 Dose of Study Drug|Period 1||40
929214|NCT01476345|2246620|P1|Received at Least 1 Dose of Study Drug|Period 1||40
929215|NCT01476345|2246619|P2|STARTED|Period 1||40
929216|NCT01476345|2246620|P1|STARTED|Period 1||40
929217|NCT01476202|2246635|P3|NOT COMPLETED|Overall Study||0
929218|NCT01476202|2246636|P2|NOT COMPLETED|Overall Study||0
929219|NCT01476202|2246637|P1|NOT COMPLETED|Overall Study||0
929220|NCT01476202|2246635|P3|COMPLETED|Overall Study||40
929221|NCT01476202|2246636|P2|COMPLETED|Overall Study||40
929222|NCT01476202|2246637|P1|COMPLETED|Overall Study||40
929223|NCT01476202|2246635|P3|STARTED|Overall Study||40
929224|NCT01476202|2246636|P2|STARTED|Overall Study||40
929225|NCT01476202|2246637|P1|STARTED|Overall Study||40
929226|NCT01475955|2246653|P5|NOT COMPLETED|Overall Study||0
929227|NCT01475955|2246654|P4|NOT COMPLETED|Overall Study||0
929228|NCT01475955|2246655|P3|NOT COMPLETED|Overall Study||3
929229|NCT01475955|2246656|P2|NOT COMPLETED|Overall Study||0
929230|NCT01475955|2246657|P1|NOT COMPLETED|Overall Study||1
929231|NCT01475955|2246653|P5|COMPLETED|Overall Study||46
929232|NCT01475955|2246654|P4|COMPLETED|Overall Study||46
929233|NCT01475955|2246655|P3|COMPLETED|Overall Study||44
929234|NCT01475955|2246656|P2|COMPLETED|Overall Study||48
929235|NCT01475955|2246657|P1|COMPLETED|Overall Study||47
929236|NCT01475955|2246653|P5|STARTED|Overall Study||46
929237|NCT01475955|2246654|P4|STARTED|Overall Study||46
929238|NCT01475955|2246655|P3|STARTED|Overall Study||47
929239|NCT01475955|2246656|P2|STARTED|Overall Study||48
929240|NCT01475955|2246657|P1|STARTED|Overall Study||48
929241|NCT01475851|2247016|P2|NOT COMPLETED|Overall Study||0
929242|NCT01475851|2247017|P1|NOT COMPLETED|Overall Study||1
929243|NCT01475851|2247016|P2|COMPLETED|Overall Study||21
929244|NCT01475851|2247017|P1|COMPLETED|Overall Study||12
929245|NCT01475851|2247016|P2|STARTED|Overall Study||21
929246|NCT01475851|2247017|P1|STARTED|Overall Study||13
929247|NCT01475838|2247045|P2|NOT COMPLETED|Extension Phase||0
929248|NCT01475838|2247046|P1|NOT COMPLETED|Extension Phase||1
929249|NCT01475838|2247045|P2|COMPLETED|Extension Phase||20
929250|NCT01475838|2247046|P1|COMPLETED|Extension Phase||41
929251|NCT01475838|2247045|P2|STARTED|Extension Phase||20
929252|NCT01475838|2247046|P1|STARTED|Extension Phase||42
929253|NCT01475838|2247045|P2|NOT COMPLETED|Randomized Phase||36
929254|NCT01475838|2247046|P1|NOT COMPLETED|Randomized Phase||30
929255|NCT01475838|2247045|P2|COMPLETED|Randomized Phase||109
929256|NCT01475838|2247046|P1|COMPLETED|Randomized Phase||263
929257|NCT01475838|2247045|P2|STARTED|Randomized Phase||145
929258|NCT01475838|2247046|P1|STARTED|Randomized Phase||293
929259|NCT01475734|2247061|P2|NOT COMPLETED|Overall Study||1
929260|NCT01475734|2247062|P1|NOT COMPLETED|Overall Study||2
929261|NCT01475734|2247061|P2|COMPLETED|Overall Study||21
929262|NCT01475734|2247062|P1|COMPLETED|Overall Study||20
929263|NCT01475734|2247061|P2|STARTED|Overall Study||22
929264|NCT01475734|2247062|P1|STARTED|Overall Study||22
929265|NCT01475721|2247090|P2|NOT COMPLETED|Overall Study||14
929266|NCT01475721|2247091|P1|NOT COMPLETED|Overall Study||11
929267|NCT01475721|2247090|P2|COMPLETED|Overall Study||5831
929268|NCT01475721|2247091|P1|COMPLETED|Overall Study||5823
929269|NCT01475721|2247090|P2|STARTED|Overall Study||5845
929270|NCT01475721|2247091|P1|STARTED|Overall Study||5834
929271|NCT01475487|2247107|P2|NOT COMPLETED|Overall Study||1
929272|NCT01475487|2247108|P1|NOT COMPLETED|Overall Study||2
929273|NCT01475487|2247107|P2|COMPLETED|Overall Study||24
929274|NCT01475487|2247108|P1|COMPLETED|Overall Study||23
929275|NCT01475487|2247107|P2|STARTED|Overall Study||25
929276|NCT01475487|2247108|P1|STARTED|Overall Study||25
929277|NCT01475474|2247120|P1|NOT COMPLETED|Return to Baseline Period - 4 Weeks||2
929278|NCT01475474|2247120|P1|COMPLETED|Return to Baseline Period - 4 Weeks||71
929279|NCT01475474|2247120|P1|STARTED|Return to Baseline Period - 4 Weeks||73
929280|NCT01475474|2247120|P1|NOT COMPLETED|Treatment Period - 12 Weeks||18
929281|NCT01475474|2247120|P1|COMPLETED|Treatment Period - 12 Weeks||73
929282|NCT01475474|2247120|P1|STARTED|Treatment Period - 12 Weeks||91
929283|NCT01475474|2247120|P1|NOT COMPLETED|Baseline Period - 4 Weeks||6
929284|NCT01475474|2247120|P1|COMPLETED|Baseline Period - 4 Weeks||91
929285|NCT01475474|2247120|P1|STARTED|Baseline Period - 4 Weeks||97
929286|NCT01475461|2247131|P7|NOT COMPLETED|Treatment Period||2
929287|NCT01475461|2247132|P6|NOT COMPLETED|Treatment Period||5
929288|NCT01475461|2247133|P5|NOT COMPLETED|Treatment Period||4
929289|NCT01475461|2247134|P4|NOT COMPLETED|Treatment Period||8
929290|NCT01475461|2247135|P3|NOT COMPLETED|Treatment Period||4
929291|NCT01475461|2247136|P2|NOT COMPLETED|Treatment Period||9
929292|NCT01475461|2247137|P1|NOT COMPLETED|Treatment Period||0
929293|NCT01475461|2247131|P7|COMPLETED|Treatment Period||53
929294|NCT01475461|2247132|P6|COMPLETED|Treatment Period||51
929295|NCT01475461|2247133|P5|COMPLETED|Treatment Period||52
929296|NCT01475461|2247134|P4|COMPLETED|Treatment Period||46
929297|NCT01475461|2247135|P3|COMPLETED|Treatment Period||53
929298|NCT01475461|2247136|P2|COMPLETED|Treatment Period||48
929299|NCT01475461|2247137|P1|COMPLETED|Treatment Period||0
929300|NCT01475461|2247131|P7|STARTED|Treatment Period||55
929301|NCT01475461|2247132|P6|STARTED|Treatment Period||56
929302|NCT01475461|2247133|P5|STARTED|Treatment Period||56
929303|NCT01475461|2247134|P4|STARTED|Treatment Period||54
929304|NCT01475461|2247135|P3|STARTED|Treatment Period||57
929305|NCT01475461|2247136|P2|STARTED|Treatment Period||57
929306|NCT01475461|2247137|P1|STARTED|Treatment Period||0
929307|NCT01475461|2247131|P7|NOT COMPLETED|Run-in Period||0
929308|NCT01475461|2247132|P6|NOT COMPLETED|Run-in Period||0
929309|NCT01475461|2247133|P5|NOT COMPLETED|Run-in Period||0
929310|NCT01475461|2247134|P4|NOT COMPLETED|Run-in Period||0
929311|NCT01475461|2247135|P3|NOT COMPLETED|Run-in Period||0
929312|NCT01475461|2247136|P2|NOT COMPLETED|Run-in Period||0
929313|NCT01475461|2247137|P1|NOT COMPLETED|Run-in Period||41
929314|NCT01475461|2247131|P7|COMPLETED|Run-in Period||0
929315|NCT01475461|2247132|P6|COMPLETED|Run-in Period||0
929316|NCT01475461|2247133|P5|COMPLETED|Run-in Period||0
929317|NCT01475461|2247134|P4|COMPLETED|Run-in Period||0
929318|NCT01475461|2247135|P3|COMPLETED|Run-in Period||0
929319|NCT01475461|2247136|P2|COMPLETED|Run-in Period||0
929320|NCT01475461|2247137|P1|COMPLETED|Run-in Period||335
929321|NCT01475461|2247131|P7|STARTED|Run-in Period||0
929322|NCT01475461|2247132|P6|STARTED|Run-in Period||0
929323|NCT01475461|2247133|P5|STARTED|Run-in Period||0
929324|NCT01475461|2247134|P4|STARTED|Run-in Period||0
929325|NCT01475461|2247135|P3|STARTED|Run-in Period||0
929326|NCT01475461|2247136|P2|STARTED|Run-in Period||0
929327|NCT01475461|2247137|P1|STARTED|Run-in Period||376
929328|NCT01475305|2247217|P2|NOT COMPLETED|Overall Study||0
929329|NCT01475305|2247218|P1|NOT COMPLETED|Overall Study||0
929330|NCT01475305|2247217|P2|COMPLETED|Overall Study||3
929331|NCT01475305|2247218|P1|COMPLETED|Overall Study||4
929332|NCT01475305|2247217|P2|End of Quarantine, Day 15|Overall Study||3
929333|NCT01475305|2247218|P1|End of Quarantine, Day 15|Overall Study||4
929334|NCT01475305|2247217|P2|STARTED|Overall Study||3
929335|NCT01475305|2247218|P1|STARTED|Overall Study||4
929336|NCT01475253|2247261|P4|NOT COMPLETED|Open Label Extension||0
929337|NCT01475253|2247262|P3|NOT COMPLETED|Open Label Extension||0
929338|NCT01475253|2247263|P2|NOT COMPLETED|Open Label Extension||0
929339|NCT01475253|2247264|P1|NOT COMPLETED|Open Label Extension||0
929340|NCT01475253|2247261|P4|COMPLETED|Open Label Extension||56
929341|NCT01475253|2247262|P3|COMPLETED|Open Label Extension||0
929342|NCT01475253|2247263|P2|COMPLETED|Open Label Extension||0
929343|NCT01475253|2247264|P1|COMPLETED|Open Label Extension||0
929344|NCT01475253|2247261|P4|STARTED|Open Label Extension||56
929345|NCT01475253|2247262|P3|STARTED|Open Label Extension||0
929346|NCT01475253|2247263|P2|STARTED|Open Label Extension||0
929347|NCT01475253|2247264|P1|STARTED|Open Label Extension||0
929348|NCT01475253|2247261|P4|NOT COMPLETED|Randomized, Blinded Study||0
929349|NCT01475253|2247262|P3|NOT COMPLETED|Randomized, Blinded Study||0
929350|NCT01475253|2247263|P2|NOT COMPLETED|Randomized, Blinded Study||1
929351|NCT01475253|2247264|P1|NOT COMPLETED|Randomized, Blinded Study||2
929352|NCT01475253|2247261|P4|COMPLETED|Randomized, Blinded Study||0
929353|NCT01475253|2247262|P3|COMPLETED|Randomized, Blinded Study||11
929354|NCT01475253|2247263|P2|COMPLETED|Randomized, Blinded Study||45
929355|NCT01475253|2247264|P1|COMPLETED|Randomized, Blinded Study||45
929356|NCT01475253|2247261|P4|STARTED|Randomized, Blinded Study||0
929357|NCT01475253|2247262|P3|STARTED|Randomized, Blinded Study||11
929358|NCT01475253|2247263|P2|STARTED|Randomized, Blinded Study||46
929359|NCT01475253|2247264|P1|STARTED|Randomized, Blinded Study||47
929360|NCT01475214|2247293|P3|NOT COMPLETED|Overall Study||2
929361|NCT01475214|2247294|P2|NOT COMPLETED|Overall Study||4
929362|NCT01475214|2247295|P1|NOT COMPLETED|Overall Study||5
929363|NCT01475214|2247293|P3|COMPLETED|Overall Study||79
929364|NCT01475214|2247294|P2|COMPLETED|Overall Study||75
929365|NCT01475214|2247295|P1|COMPLETED|Overall Study||79
929366|NCT01475214|2247293|P3|STARTED|Overall Study||81
929367|NCT01475214|2247294|P2|STARTED|Overall Study||79
929368|NCT01475214|2247295|P1|STARTED|Overall Study||84
929369|NCT01475175|2247306|P1|NOT COMPLETED|Overall Study||0
929370|NCT01475175|2247306|P1|COMPLETED|Overall Study||12
929371|NCT01475175|2247306|P1|STARTED|Overall Study||12
929372|NCT01475097|2247320|P2|NOT COMPLETED|Overall Study||1
929373|NCT01475097|2247321|P1|NOT COMPLETED|Overall Study||1
929374|NCT01475097|2247320|P2|COMPLETED|Overall Study||126
929375|NCT01475097|2247321|P1|COMPLETED|Overall Study||127
929376|NCT01475097|2247320|P2|STARTED|Overall Study||127
929377|NCT01475097|2247321|P1|STARTED|Overall Study||128
929378|NCT01475071|2247329|P1|NOT COMPLETED|Overall Study||8
929379|NCT01475071|2247329|P1|COMPLETED|Overall Study||92
929380|NCT01475071|2247329|P1|STARTED|Overall Study||100
929381|NCT01474993|2247339|P2|NOT COMPLETED|Overall Study||3
929382|NCT01474993|2247340|P1|NOT COMPLETED|Overall Study||1
929383|NCT01474993|2247339|P2|COMPLETED|Overall Study||26
929384|NCT01474993|2247340|P1|COMPLETED|Overall Study||14
929385|NCT01474993|2247339|P2|STARTED|Overall Study||29
929386|NCT01474993|2247340|P1|STARTED|Overall Study||15
929387|NCT01474915|2247366|P2|NOT COMPLETED|Overall Study||10
929388|NCT01474915|2247367|P1|NOT COMPLETED|Overall Study||10
929389|NCT01474915|2247366|P2|COMPLETED|Overall Study||51
929390|NCT01474915|2247367|P1|COMPLETED|Overall Study||50
929391|NCT01474915|2247366|P2|STARTED|Overall Study||61
929392|NCT01474915|2247367|P1|STARTED|Overall Study||60
929393|NCT01474876|2247378|P3|NOT COMPLETED|Overall Study||0
929394|NCT01474876|2247379|P2|NOT COMPLETED|Overall Study||23
929395|NCT01474876|2247380|P1|NOT COMPLETED|Overall Study||66
929396|NCT01474876|2247378|P3|COMPLETED|Overall Study||1
929397|NCT01474876|2247379|P2|COMPLETED|Overall Study||128
929398|NCT01474876|2247380|P1|COMPLETED|Overall Study||337
929399|NCT01474876|2247378|P3|STARTED|Overall Study||1
929400|NCT01474876|2247379|P2|STARTED|Overall Study||151
929401|NCT01474876|2247380|P1|STARTED|Overall Study||403
929402|NCT01474863|2247414|P3|NOT COMPLETED|Overall Study||0
929403|NCT01474863|2247415|P2|NOT COMPLETED|Overall Study||0
929404|NCT01474863|2247416|P1|NOT COMPLETED|Overall Study||0
929405|NCT01474863|2247414|P3|COMPLETED|Overall Study||24
929406|NCT01474863|2247415|P2|COMPLETED|Overall Study||22
929407|NCT01474863|2247416|P1|COMPLETED|Overall Study||26
929408|NCT01474863|2247414|P3|STARTED|Overall Study||24
929409|NCT01474863|2247415|P2|STARTED|Overall Study||22
929410|NCT01474863|2247416|P1|STARTED|Overall Study||26
929411|NCT01474772|2247426|P2|NOT COMPLETED|Follow-up||1
929412|NCT01474772|2247427|P1|NOT COMPLETED|Follow-up||0
929413|NCT01474772|2247426|P2|COMPLETED|Follow-up||86
929414|NCT01474772|2247427|P1|COMPLETED|Follow-up||77
929415|NCT01474772|2247426|P2|STARTED|Follow-up||87
929416|NCT01474772|2247427|P1|STARTED|Follow-up||77
929417|NCT01474772|2247426|P2|NOT COMPLETED|Period 2||10
929418|NCT01474772|2247427|P1|NOT COMPLETED|Period 2||9
929419|NCT01474772|2247426|P2|COMPLETED|Period 2||87
929420|NCT01474772|2247427|P1|COMPLETED|Period 2||77
929421|NCT01474772|2247426|P2|STARTED|Period 2||97
929422|NCT01474772|2247427|P1|STARTED|Period 2||86
929423|NCT01474772|2247426|P2|NOT COMPLETED|Washout||2
929424|NCT01474772|2247427|P1|NOT COMPLETED|Washout||3
929425|NCT01474772|2247426|P2|COMPLETED|Washout||97
929426|NCT01474772|2247427|P1|COMPLETED|Washout||86
929427|NCT01474772|2247426|P2|STARTED|Washout||99
929428|NCT01474772|2247427|P1|STARTED|Washout||89
929429|NCT01474772|2247426|P2|NOT COMPLETED|Period 1||3
929430|NCT01474772|2247427|P1|NOT COMPLETED|Period 1||12
929431|NCT01474772|2247426|P2|COMPLETED|Period 1||99
929432|NCT01474772|2247427|P1|COMPLETED|Period 1||89
929433|NCT01474772|2247426|P2|STARTED|Period 1|STARTED=treated|102
929434|NCT01474772|2247427|P1|STARTED|Period 1|STARTED=treated. In Period 1 a participant discontinued due to an AE and later died due to the AE.|101
929435|NCT01474746|2247477|P2|NOT COMPLETED|Overall Study||2
929436|NCT01474746|2247478|P1|NOT COMPLETED|Overall Study||3
929437|NCT01474746|2247477|P2|COMPLETED|Overall Study||25
929438|NCT01474746|2247478|P1|COMPLETED|Overall Study||27
929439|NCT01474746|2247477|P2|STARTED|Overall Study||27
929440|NCT01474746|2247478|P1|STARTED|Overall Study||30
929441|NCT01474681|2247542|P4|NOT COMPLETED|Overall Study||6
929442|NCT01474681|2247543|P3|NOT COMPLETED|Overall Study||2
929443|NCT01474681|2247544|P2|NOT COMPLETED|Overall Study||3
929444|NCT01474681|2247545|P1|NOT COMPLETED|Overall Study||0
929445|NCT01474681|2247542|P4|COMPLETED|Overall Study||9
929446|NCT01474681|2247543|P3|COMPLETED|Overall Study||1
929447|NCT01474681|2247544|P2|COMPLETED|Overall Study||5
929448|NCT01474681|2247545|P1|COMPLETED|Overall Study||1
929449|NCT01474681|2247542|P4|STARTED|Overall Study||15
929450|NCT01474681|2247543|P3|STARTED|Overall Study||3
929451|NCT01474681|2247544|P2|STARTED|Overall Study||8
929452|NCT01474681|2247545|P1|STARTED|Overall Study||1
929453|NCT01474590|2247589|P2|NOT COMPLETED|Overall Study||17
929454|NCT01474590|2247590|P1|NOT COMPLETED|Overall Study||28
929455|NCT01474590|2247589|P2|COMPLETED|Overall Study||116
929456|NCT01474590|2247590|P1|COMPLETED|Overall Study||105
929457|NCT01474590|2247589|P2|STARTED|Overall Study||133
929458|NCT01474590|2247590|P1|STARTED|Overall Study||133
929459|NCT01474551|2247596|P1|NOT COMPLETED|Overall Study||1
929460|NCT01474551|2247596|P1|COMPLETED|Overall Study||1
929461|NCT01474551|2247596|P1|STARTED|Overall Study||2
929462|NCT01474538|2247602|P2|NOT COMPLETED|Treatment Period 2||2
929463|NCT01474538|2247603|P1|NOT COMPLETED|Treatment Period 2||6
929464|NCT01474538|2247602|P2|COMPLETED|Treatment Period 2||56
929465|NCT01474538|2247603|P1|COMPLETED|Treatment Period 2||51
929466|NCT01474538|2247602|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2||58
929467|NCT01474538|2247603|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2||57
929468|NCT01474538|2247602|P2|STARTED|Treatment Period 2||58
929469|NCT01474538|2247603|P1|STARTED|Treatment Period 2||57
929470|NCT01474538|2247602|P2|NOT COMPLETED|Treatment Period 1||4
929471|NCT01474538|2247603|P1|NOT COMPLETED|Treatment Period 1||3
929472|NCT01474538|2247602|P2|COMPLETED|Treatment Period 1||58
929473|NCT01474538|2247603|P1|COMPLETED|Treatment Period 1||57
929474|NCT01474538|2247602|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||62
929475|NCT01474538|2247603|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||60
929476|NCT01474538|2247602|P2|STARTED|Treatment Period 1||62
929477|NCT01474538|2247603|P1|STARTED|Treatment Period 1||60
929478|NCT01474512|2247620|P10|NOT COMPLETED|Maintenance Period||18
929479|NCT01474512|2247621|P9|NOT COMPLETED|Maintenance Period||16
929480|NCT01474512|2247622|P8|NOT COMPLETED|Maintenance Period||41
929481|NCT01474512|2247623|P7|NOT COMPLETED|Maintenance Period||10
929482|NCT01474512|2247624|P6|NOT COMPLETED|Maintenance Period||52
929483|NCT01474512|2247625|P5|NOT COMPLETED|Maintenance Period||119
929484|NCT01474512|2247626|P4|NOT COMPLETED|Maintenance Period||202
929485|NCT01474512|2247627|P3|NOT COMPLETED|Maintenance Period||0
929486|NCT01474512|2247628|P2|NOT COMPLETED|Maintenance Period||0
929487|NCT01474512|2247629|P1|NOT COMPLETED|Maintenance Period||0
929488|NCT01474512|2247620|P10|COMPLETED|Maintenance Period||44
929489|NCT01474512|2247621|P9|COMPLETED|Maintenance Period||62
929490|NCT01474512|2247622|P8|COMPLETED|Maintenance Period||350
929491|NCT01474512|2247623|P7|COMPLETED|Maintenance Period||6
929492|NCT01474512|2247624|P6|COMPLETED|Maintenance Period||177
929493|NCT01474512|2247625|P5|COMPLETED|Maintenance Period||108
929494|NCT01474512|2247626|P4|COMPLETED|Maintenance Period||24
929495|NCT01474512|2247627|P3|COMPLETED|Maintenance Period||0
929496|NCT01474512|2247628|P2|COMPLETED|Maintenance Period||0
929497|NCT01474512|2247629|P1|COMPLETED|Maintenance Period||0
929498|NCT01474512|2247620|P10|Received Study Drug|Maintenance Period||62
929499|NCT01474512|2247621|P9|Received Study Drug|Maintenance Period||78
929500|NCT01474512|2247622|P8|Received Study Drug|Maintenance Period||391
929501|NCT01474512|2247623|P7|Received Study Drug|Maintenance Period||16
929502|NCT01474512|2247624|P6|Received Study Drug|Maintenance Period||229
929503|NCT01474512|2247625|P5|Received Study Drug|Maintenance Period||227
929504|NCT01474512|2247626|P4|Received Study Drug|Maintenance Period||226
929505|NCT01474512|2247627|P3|Received Study Drug|Maintenance Period||0
929506|NCT01474512|2247628|P2|Received Study Drug|Maintenance Period||0
929507|NCT01474512|2247629|P1|Received Study Drug|Maintenance Period||0
929508|NCT01474512|2247620|P10|STARTED|Maintenance Period||62
929509|NCT01474512|2247621|P9|STARTED|Maintenance Period||78
929510|NCT01474512|2247622|P8|STARTED|Maintenance Period||391
929511|NCT01474512|2247623|P7|STARTED|Maintenance Period||16
929512|NCT01474512|2247624|P6|STARTED|Maintenance Period||229
929513|NCT01474512|2247625|P5|STARTED|Maintenance Period|One participant withdrew end of Induction but re-randomized and treated with maintenance dose ixe.|227
929514|NCT01474512|2247626|P4|STARTED|Maintenance Period||226
929515|NCT01474512|2247627|P3|STARTED|Maintenance Period||0
929516|NCT01474512|2247628|P2|STARTED|Maintenance Period||0
929517|NCT01474512|2247629|P1|STARTED|Maintenance Period||0
929518|NCT01474512|2247620|P10|NOT COMPLETED|Induction Period||0
929519|NCT01474512|2247621|P9|NOT COMPLETED|Induction Period||0
929520|NCT01474512|2247622|P8|NOT COMPLETED|Induction Period||0
929521|NCT01474512|2247623|P7|NOT COMPLETED|Induction Period||0
929522|NCT01474512|2247624|P6|NOT COMPLETED|Induction Period||0
929523|NCT01474512|2247625|P5|NOT COMPLETED|Induction Period||0
929524|NCT01474512|2247626|P4|NOT COMPLETED|Induction Period||0
929525|NCT01474512|2247627|P3|NOT COMPLETED|Induction Period||18
929526|NCT01474512|2247628|P2|NOT COMPLETED|Induction Period||24
929527|NCT01474512|2247629|P1|NOT COMPLETED|Induction Period||24
929528|NCT01474512|2247620|P10|COMPLETED|Induction Period||0
929529|NCT01474512|2247621|P9|COMPLETED|Induction Period||0
929530|NCT01474512|2247622|P8|COMPLETED|Induction Period||0
929531|NCT01474512|2247623|P7|COMPLETED|Induction Period||0
929532|NCT01474512|2247624|P6|COMPLETED|Induction Period||0
929533|NCT01474512|2247625|P5|COMPLETED|Induction Period||0
929534|NCT01474512|2247626|P4|COMPLETED|Induction Period||0
929535|NCT01474512|2247627|P3|COMPLETED|Induction Period||415
929536|NCT01474512|2247628|P2|COMPLETED|Induction Period||408
929537|NCT01474512|2247629|P1|COMPLETED|Induction Period||407
929538|NCT01474512|2247620|P10|Received Study Drug|Induction Period||0
929539|NCT01474512|2247621|P9|Received Study Drug|Induction Period||0
929540|NCT01474512|2247622|P8|Received Study Drug|Induction Period||0
929541|NCT01474512|2247623|P7|Received Study Drug|Induction Period||0
929542|NCT01474512|2247624|P6|Received Study Drug|Induction Period||0
929543|NCT01474512|2247625|P5|Received Study Drug|Induction Period||0
929544|NCT01474512|2247626|P4|Received Study Drug|Induction Period||0
929545|NCT01474512|2247627|P3|Received Study Drug|Induction Period||433
929546|NCT01474512|2247628|P2|Received Study Drug|Induction Period||432
929547|NCT01474512|2247629|P1|Received Study Drug|Induction Period||431
929548|NCT01474512|2247620|P10|STARTED|Induction Period||0
929549|NCT01474512|2247621|P9|STARTED|Induction Period||0
929550|NCT01474512|2247622|P8|STARTED|Induction Period||0
929551|NCT01474512|2247623|P7|STARTED|Induction Period||0
929552|NCT01474512|2247624|P6|STARTED|Induction Period||0
929553|NCT01474512|2247625|P5|STARTED|Induction Period||0
929554|NCT01474512|2247626|P4|STARTED|Induction Period||0
929555|NCT01474512|2247627|P3|STARTED|Induction Period||433
929556|NCT01474512|2247628|P2|STARTED|Induction Period||432
929557|NCT01474512|2247629|P1|STARTED|Induction Period||431
929558|NCT01474434|2247698|P4|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
929559|NCT01474434|2247699|P3|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
929560|NCT01474434|2247700|P2|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
929561|NCT01474434|2247701|P1|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
929562|NCT01474434|2247698|P4|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||11
929563|NCT01474434|2247699|P3|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||10
929564|NCT01474434|2247700|P2|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||9
929565|NCT01474434|2247701|P1|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||7
929566|NCT01474434|2247698|P4|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||11
929567|NCT01474434|2247699|P3|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||10
929568|NCT01474434|2247700|P2|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||9
929569|NCT01474434|2247701|P1|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||7
929570|NCT01474434|2247698|P4|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||2
929571|NCT01474434|2247699|P3|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
929572|NCT01474434|2247700|P2|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||0
929573|NCT01474434|2247701|P1|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
929574|NCT01474434|2247698|P4|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||11
929575|NCT01474434|2247699|P3|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||10
929576|NCT01474434|2247700|P2|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||9
929577|NCT01474434|2247701|P1|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||7
929578|NCT01474434|2247698|P4|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||13
929579|NCT01474434|2247699|P3|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||11
929580|NCT01474434|2247700|P2|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||9
929581|NCT01474434|2247701|P1|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||8
929582|NCT01474317|2247743|P1|NOT COMPLETED|Overall Study||2
929583|NCT01474317|2247743|P1|COMPLETED|Overall Study||224
929584|NCT01474317|2247743|P1|STARTED|Overall Study||226
929585|NCT01474291|2247752|P1|NOT COMPLETED|Overall Study||220
929586|NCT01474291|2247752|P1|COMPLETED|Overall Study||383
929587|NCT01474291|2247752|P1|Evaluable for Efficacy|Overall Study|Received tocilizumab infusion and met all inclusion/exclusion criteria|577
929588|NCT01474291|2247752|P1|STARTED|Overall Study||603
929589|NCT01474239|2247796|P2|NOT COMPLETED|Overall Study||32
929590|NCT01474239|2247797|P1|NOT COMPLETED|Overall Study||59
929591|NCT01474239|2247796|P2|COMPLETED|Overall Study||0
929592|NCT01474239|2247797|P1|COMPLETED|Overall Study||0
929593|NCT01474239|2247796|P2|STARTED|Overall Study||32
929594|NCT01474239|2247797|P1|STARTED|Overall Study||59
929595|NCT01474213|2247835|P2|NOT COMPLETED|Overall Study||0
929596|NCT01474213|2247836|P1|NOT COMPLETED|Overall Study||0
929597|NCT01474213|2247835|P2|COMPLETED|Overall Study||20
929598|NCT01474213|2247836|P1|COMPLETED|Overall Study||20
929599|NCT01474213|2247835|P2|STARTED|Overall Study||20
929600|NCT01474213|2247836|P1|STARTED|Overall Study||20
929601|NCT01474200|2247860|P2|NOT COMPLETED|Overall Study||30
929602|NCT01474200|2247861|P1|NOT COMPLETED|Overall Study||29
929603|NCT01474200|2247860|P2|COMPLETED|Overall Study||84
929604|NCT01474200|2247861|P1|COMPLETED|Overall Study||81
929605|NCT01474200|2247860|P2|STARTED|Overall Study||114
929606|NCT01474200|2247861|P1|STARTED|Overall Study||110
929607|NCT01474122|2247914|P3|NOT COMPLETED|Period 2: Week 16 to End of Study||15
929608|NCT01474122|2247915|P2|NOT COMPLETED|Period 2: Week 16 to End of Study||13
929609|NCT01474122|2247916|P1|NOT COMPLETED|Period 2: Week 16 to End of Study||17
929610|NCT01474122|2247914|P3|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
929611|NCT01474122|2247915|P2|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
929612|NCT01474122|2247916|P1|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|70
929613|NCT01474122|2247914|P3|STARTED|Period 2: Week 16 to End of Study||88
929614|NCT01474122|2247915|P2|STARTED|Period 2: Week 16 to End of Study||86
929615|NCT01474122|2247916|P1|STARTED|Period 2: Week 16 to End of Study||87
929616|NCT01474122|2247914|P3|NOT COMPLETED|Period 1: Baseline to Week 16||1
929617|NCT01474122|2247915|P2|NOT COMPLETED|Period 1: Baseline to Week 16||2
929618|NCT01474122|2247916|P1|NOT COMPLETED|Period 1: Baseline to Week 16||1
929619|NCT01474122|2247914|P3|COMPLETED|Period 1: Baseline to Week 16||88
929620|NCT01474122|2247915|P2|COMPLETED|Period 1: Baseline to Week 16||86
929621|NCT01474122|2247916|P1|COMPLETED|Period 1: Baseline to Week 16||87
929622|NCT01474122|2247914|P3|STARTED|Period 1: Baseline to Week 16||89
929623|NCT01474122|2247915|P2|STARTED|Period 1: Baseline to Week 16|One patient was randomised but did not receive study treatment|88
929624|NCT01474122|2247916|P1|STARTED|Period 1: Baseline to Week 16||88
929625|NCT01474109|2247942|P3|NOT COMPLETED|Period 2: Week 16 to End of Study||12
929626|NCT01474109|2247943|P2|NOT COMPLETED|Period 2: Week 16 to End of Study||18
929627|NCT01474109|2247944|P1|NOT COMPLETED|Period 2: Week 16 to End of Study||18
929628|NCT01474109|2247942|P3|COMPLETED|Period 2: Week 16 to End of Study||83
929629|NCT01474109|2247943|P2|COMPLETED|Period 2: Week 16 to End of Study||73
929630|NCT01474109|2247944|P1|COMPLETED|Period 2: Week 16 to End of Study||70
929631|NCT01474109|2247942|P3|STARTED|Period 2: Week 16 to End of Study||95
929632|NCT01474109|2247943|P2|STARTED|Period 2: Week 16 to End of Study||91
929633|NCT01474109|2247944|P1|STARTED|Period 2: Week 16 to End of Study||88
929634|NCT01474109|2247942|P3|NOT COMPLETED|Period 1: Baseline to Week 16||2
929635|NCT01474109|2247943|P2|NOT COMPLETED|Period 1: Baseline to Week 16||6
929636|NCT01474109|2247944|P1|NOT COMPLETED|Period 1: Baseline to Week 16||7
929637|NCT01474109|2247942|P3|COMPLETED|Period 1: Baseline to Week 16||95
929638|NCT01474109|2247943|P2|COMPLETED|Period 1: Baseline to Week 16||91
929639|NCT01474109|2247944|P1|COMPLETED|Period 1: Baseline to Week 16||88
929640|NCT01474109|2247942|P3|STARTED|Period 1: Baseline to Week 16||97
929641|NCT01474109|2247943|P2|STARTED|Period 1: Baseline to Week 16||97
929642|NCT01474109|2247944|P1|STARTED|Period 1: Baseline to Week 16||95
929643|NCT01473992|2247969|P3|NOT COMPLETED|Overall Study||0
929644|NCT01473992|2247970|P2|NOT COMPLETED|Overall Study||0
929645|NCT01473992|2247971|P1|NOT COMPLETED|Overall Study||0
929646|NCT01473992|2247969|P3|COMPLETED|Overall Study||5
929647|NCT01473992|2247970|P2|COMPLETED|Overall Study||10
929648|NCT01473992|2247971|P1|COMPLETED|Overall Study||10
929649|NCT01473992|2247969|P3|STARTED|Overall Study||5
929650|NCT01473992|2247970|P2|STARTED|Overall Study||10
929651|NCT01473992|2247971|P1|STARTED|Overall Study||10
929652|NCT01473953|2247991|P5|NOT COMPLETED|Overall Study||0
929653|NCT01473953|2247992|P4|NOT COMPLETED|Overall Study||0
929654|NCT01473953|2247993|P3|NOT COMPLETED|Overall Study||0
929655|NCT01473953|2247994|P2|NOT COMPLETED|Overall Study||0
929656|NCT01473953|2247995|P1|NOT COMPLETED|Overall Study||1
929657|NCT01473953|2247991|P5|COMPLETED|Overall Study||8
929658|NCT01473953|2247992|P4|COMPLETED|Overall Study||5
929659|NCT01473953|2247993|P3|COMPLETED|Overall Study||6
929660|NCT01473953|2247994|P2|COMPLETED|Overall Study||6
929661|NCT01473953|2247995|P1|COMPLETED|Overall Study||5
929662|NCT01473953|2247991|P5|STARTED|Overall Study||8
929663|NCT01473953|2247992|P4|STARTED|Overall Study||5
929664|NCT01473953|2247993|P3|STARTED|Overall Study||6
929665|NCT01473953|2247994|P2|STARTED|Overall Study||6
929666|NCT01473953|2247995|P1|STARTED|Overall Study||6
929667|NCT01473836|2248037|P1|NOT COMPLETED|Overall Study||6
929668|NCT01473836|2248037|P1|COMPLETED|Overall Study||32
929669|NCT01473836|2248037|P1|STARTED|Overall Study||38
929670|NCT01473758|2248048|P4|NOT COMPLETED|Cycle 2||0
929671|NCT01473758|2248049|P3|NOT COMPLETED|Cycle 2||5
929672|NCT01473758|2248050|P2|NOT COMPLETED|Cycle 2||0
929673|NCT01473758|2248051|P1|NOT COMPLETED|Cycle 2||0
929674|NCT01473758|2248048|P4|COMPLETED|Cycle 2||4
929675|NCT01473758|2248049|P3|COMPLETED|Cycle 2||5
929676|NCT01473758|2248050|P2|COMPLETED|Cycle 2||0
929677|NCT01473758|2248051|P1|COMPLETED|Cycle 2||0
929678|NCT01473758|2248048|P4|STARTED|Cycle 2||4
929679|NCT01473758|2248049|P3|STARTED|Cycle 2||10
929680|NCT01473758|2248050|P2|STARTED|Cycle 2||0
929681|NCT01473758|2248051|P1|STARTED|Cycle 2||0
929682|NCT01473758|2248048|P4|NOT COMPLETED|Cycle 1||0
929683|NCT01473758|2248049|P3|NOT COMPLETED|Cycle 1||0
929684|NCT01473758|2248050|P2|NOT COMPLETED|Cycle 1||3
929685|NCT01473758|2248051|P1|NOT COMPLETED|Cycle 1||11
929686|NCT01473758|2248048|P4|COMPLETED|Cycle 1||0
929687|NCT01473758|2248049|P3|COMPLETED|Cycle 1||0
929688|NCT01473758|2248050|P2|COMPLETED|Cycle 1||40
929689|NCT01473758|2248051|P1|COMPLETED|Cycle 1||27
929690|NCT01473758|2248048|P4|STARTED|Cycle 1||0
929691|NCT01473758|2248049|P3|STARTED|Cycle 1||0
929692|NCT01473758|2248050|P2|STARTED|Cycle 1||43
929693|NCT01473758|2248051|P1|STARTED|Cycle 1||38
929694|NCT01473745|2248175|P2|NOT COMPLETED|Overall Study||0
929695|NCT01473745|2248176|P1|NOT COMPLETED|Overall Study||0
929696|NCT01473745|2248175|P2|COMPLETED|Overall Study||24
929697|NCT01473745|2248176|P1|COMPLETED|Overall Study||24
929698|NCT01473745|2248175|P2|STARTED|Overall Study||24
929699|NCT01473745|2248176|P1|STARTED|Overall Study||24
929700|NCT01473602|2248188|P2|NOT COMPLETED|Overall Study||8
929701|NCT01473602|2248189|P1|NOT COMPLETED|Overall Study||8
929702|NCT01473602|2248188|P2|COMPLETED|Overall Study||13
929703|NCT01473602|2248189|P1|COMPLETED|Overall Study||10
929704|NCT01473602|2248188|P2|Completed 12 Months|Overall Study||13
929705|NCT01473602|2248189|P1|Completed 12 Months|Overall Study||10
929706|NCT01473602|2248188|P2|Completed 6 Months|Overall Study||15
929707|NCT01473602|2248189|P1|Completed 6 Months|Overall Study||12
929708|NCT01473602|2248188|P2|Received at Least 1 Dose of Study Drug|Overall Study||20
929802|NCT01472562|2248498|P1|COMPLETED|Maintenance Phase (Week 49 to PD)||4
929709|NCT01473602|2248189|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
929710|NCT01473602|2248188|P2|STARTED|Overall Study||21
929711|NCT01473602|2248189|P1|STARTED|Overall Study||18
929712|NCT01473589|2248225|P2|NOT COMPLETED|Overall Study||16
929713|NCT01473589|2248226|P1|NOT COMPLETED|Overall Study||11
929714|NCT01473589|2248225|P2|COMPLETED|Overall Study||46
929715|NCT01473589|2248226|P1|COMPLETED|Overall Study||49
929716|NCT01473589|2248225|P2|Completed 12 Months|Overall Study||48
929717|NCT01473589|2248226|P1|Completed 12 Months|Overall Study||49
929718|NCT01473589|2248225|P2|Completed 6 Months|Overall Study||54
929719|NCT01473589|2248226|P1|Completed 6 Months|Overall Study||51
929720|NCT01473589|2248225|P2|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|61
929721|NCT01473589|2248226|P1|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|60
929722|NCT01473589|2248225|P2|STARTED|Overall Study||62
929723|NCT01473589|2248226|P1|STARTED|Overall Study||60
929724|NCT01473563|2248260|P1|NOT COMPLETED|Overall Study||1
929725|NCT01473563|2248260|P1|COMPLETED|Overall Study||51
929726|NCT01473563|2248260|P1|Received at Least 1 Dose of Study Drug|Overall Study||52
929727|NCT01473563|2248260|P1|STARTED|Overall Study||52
929728|NCT01473524|2248282|P3|NOT COMPLETED|Overall Study||3
929729|NCT01473524|2248283|P2|NOT COMPLETED|Overall Study||9
929730|NCT01473524|2248284|P1|NOT COMPLETED|Overall Study||7
929731|NCT01473524|2248282|P3|COMPLETED|Overall Study||70
929732|NCT01473524|2248283|P2|COMPLETED|Overall Study||64
929733|NCT01473524|2248284|P1|COMPLETED|Overall Study||64
929734|NCT01473524|2248282|P3|STARTED|Overall Study||73
929735|NCT01473524|2248283|P2|STARTED|Overall Study||73
929736|NCT01473524|2248284|P1|STARTED|Overall Study||71
929737|NCT01473394|2248317|P2|NOT COMPLETED|Overall Study||43
929738|NCT01473394|2248318|P1|NOT COMPLETED|Overall Study||45
929739|NCT01473394|2248317|P2|COMPLETED|Overall Study||212
929740|NCT01473394|2248318|P1|COMPLETED|Overall Study||208
929741|NCT01473394|2248317|P2|STARTED|Overall Study||255
929742|NCT01473394|2248318|P1|STARTED|Overall Study||253
929743|NCT01473381|2248332|P4|NOT COMPLETED|Overall Study||89
929744|NCT01473381|2248333|P3|NOT COMPLETED|Overall Study||102
929745|NCT01473381|2248334|P2|NOT COMPLETED|Overall Study||93
929746|NCT01473381|2248335|P1|NOT COMPLETED|Overall Study||80
929747|NCT01473381|2248332|P4|COMPLETED|Overall Study||200
929748|NCT01473381|2248333|P3|COMPLETED|Overall Study||189
929749|NCT01473381|2248334|P2|COMPLETED|Overall Study||199
929750|NCT01473381|2248335|P1|COMPLETED|Overall Study||210
929751|NCT01473381|2248332|P4|Safety Population|Overall Study||282
929752|NCT01473381|2248333|P3|Safety Population|Overall Study||287
929753|NCT01473381|2248334|P2|Safety Population|Overall Study||288
929754|NCT01473381|2248335|P1|Safety Population|Overall Study||281
929755|NCT01473381|2248332|P4|STARTED|Overall Study||289
929756|NCT01473381|2248333|P3|STARTED|Overall Study||291
929757|NCT01473381|2248334|P2|STARTED|Overall Study||292
929758|NCT01473381|2248335|P1|STARTED|Overall Study||290
929759|NCT01473368|2248357|P4|NOT COMPLETED|Overall Study||0
929760|NCT01473368|2248358|P3|NOT COMPLETED|Overall Study||3
929761|NCT01473368|2248359|P2|NOT COMPLETED|Overall Study||0
929762|NCT01473368|2248360|P1|NOT COMPLETED|Overall Study||1
929763|NCT01473368|2248357|P4|COMPLETED|Overall Study||12
929764|NCT01473368|2248358|P3|COMPLETED|Overall Study||12
929765|NCT01473368|2248359|P2|COMPLETED|Overall Study||12
929766|NCT01473368|2248360|P1|COMPLETED|Overall Study||13
929767|NCT01473368|2248357|P4|STARTED|Overall Study||12
929768|NCT01473368|2248358|P3|STARTED|Overall Study||15
929769|NCT01473368|2248359|P2|STARTED|Overall Study||12
929770|NCT01473368|2248360|P1|STARTED|Overall Study||14
929771|NCT01473160|2248397|P1|NOT COMPLETED|Overall Study||0
929772|NCT01473160|2248397|P1|COMPLETED|Overall Study||9
929773|NCT01473160|2248397|P1|STARTED|Overall Study||9
929774|NCT01472939|2248419|P4|NOT COMPLETED|Overall Study||20
929775|NCT01472939|2248420|P3|NOT COMPLETED|Overall Study||11
929776|NCT01472939|2248421|P2|NOT COMPLETED|Overall Study||14
929777|NCT01472939|2248422|P1|NOT COMPLETED|Overall Study||20
929778|NCT01472939|2248419|P4|COMPLETED|Overall Study||99
929779|NCT01472939|2248420|P3|COMPLETED|Overall Study||108
929780|NCT01472939|2248421|P2|COMPLETED|Overall Study||105
929781|NCT01472939|2248422|P1|COMPLETED|Overall Study||103
929782|NCT01472939|2248419|P4|STARTED|Overall Study||119
929783|NCT01472939|2248420|P3|STARTED|Overall Study||119
929784|NCT01472939|2248421|P2|STARTED|Overall Study||119
929785|NCT01472939|2248422|P1|STARTED|Overall Study||123
929786|NCT01472874|2248449|P1|NOT COMPLETED|Overall Study||0
929787|NCT01472874|2248449|P1|COMPLETED|Overall Study||8
929788|NCT01472874|2248449|P1|STARTED|Overall Study||8
929789|NCT01472835|2248466|P2|NOT COMPLETED|Overall Study||0
929790|NCT01472835|2248467|P1|NOT COMPLETED|Overall Study||2
929791|NCT01472835|2248466|P2|COMPLETED|Overall Study||36
929792|NCT01472835|2248467|P1|COMPLETED|Overall Study||35
929793|NCT01472835|2248466|P2|STARTED|Overall Study||36
929794|NCT01472835|2248467|P1|STARTED|Overall Study||37
929795|NCT01472822|2248483|P2|NOT COMPLETED|Overall Study||2
929796|NCT01472822|2248484|P1|NOT COMPLETED|Overall Study||2
929797|NCT01472822|2248483|P2|COMPLETED|Overall Study||28
929798|NCT01472822|2248484|P1|COMPLETED|Overall Study||28
929799|NCT01472822|2248483|P2|STARTED|Overall Study||30
929800|NCT01472822|2248484|P1|STARTED|Overall Study||30
929801|NCT01472562|2248498|P1|NOT COMPLETED|Maintenance Phase (Week 49 to PD)||23
929803|NCT01472562|2248498|P1|STARTED|Maintenance Phase (Week 49 to PD)||27
929804|NCT01472562|2248498|P1|NOT COMPLETED|Induction Phase (Week 1- 48)||11
929805|NCT01472562|2248498|P1|COMPLETED|Induction Phase (Week 1- 48)||27
929806|NCT01472562|2248498|P1|STARTED|Induction Phase (Week 1- 48)||38
929807|NCT01472432|2248505|P2|NOT COMPLETED|Overall Study||0
929808|NCT01472432|2248506|P1|NOT COMPLETED|Overall Study||0
929809|NCT01472432|2248505|P2|COMPLETED|Overall Study||53
929810|NCT01472432|2248506|P1|COMPLETED|Overall Study||53
929811|NCT01472432|2248505|P2|Ulcer Reduction|Overall Study||33
929812|NCT01472432|2248506|P1|Ulcer Reduction|Overall Study||13
929813|NCT01472432|2248505|P2|STARTED|Overall Study||53
929814|NCT01472432|2248506|P1|STARTED|Overall Study||53
929815|NCT01472380|2248522|P1|NOT COMPLETED|Efavirenz and FFA||0
929816|NCT01472380|2248522|P1|COMPLETED|Efavirenz and FFA||28
929817|NCT01472380|2248522|P1|STARTED|Efavirenz and FFA||28
929818|NCT01472380|2248522|P1|NOT COMPLETED|1 Day Period Between Dosing||1
929819|NCT01472380|2248522|P1|COMPLETED|1 Day Period Between Dosing||28
929820|NCT01472380|2248522|P1|STARTED|1 Day Period Between Dosing||29
929821|NCT01472380|2248522|P1|NOT COMPLETED|Fenofibric Acid (FFA) Alone||0
929822|NCT01472380|2248522|P1|COMPLETED|Fenofibric Acid (FFA) Alone||29
929823|NCT01472380|2248522|P1|STARTED|Fenofibric Acid (FFA) Alone||29
929824|NCT01472380|2248522|P1|NOT COMPLETED|Efavirenz Alone||1
929825|NCT01472380|2248522|P1|COMPLETED|Efavirenz Alone||29
929826|NCT01472380|2248522|P1|STARTED|Efavirenz Alone||30
929827|NCT01472341|2248533|P1|NOT COMPLETED|Overall Study||272
929828|NCT01472341|2248533|P1|COMPLETED|Overall Study||235
929829|NCT01472341|2248533|P1|STARTED|Overall Study||507
929830|NCT01472289|2248539|P1|NOT COMPLETED|Overall Study||2
929831|NCT01472289|2248539|P1|COMPLETED|Overall Study||15
929832|NCT01472289|2248539|P1|STARTED|Overall Study||17
929833|NCT01472185|2248551|P2|NOT COMPLETED|Overall Study||34
929834|NCT01472185|2248552|P1|NOT COMPLETED|Overall Study||34
929835|NCT01472185|2248551|P2|COMPLETED|Overall Study||199
929836|NCT01472185|2248552|P1|COMPLETED|Overall Study||198
929837|NCT01472185|2248551|P2|STARTED|Overall Study||233
929838|NCT01472185|2248552|P1|STARTED|Overall Study||232
929839|NCT01471782|2248572|P6|NOT COMPLETED|Overall Study||41
929840|NCT01471782|2248573|P5|NOT COMPLETED|Overall Study||26
929841|NCT01471782|2248574|P4|NOT COMPLETED|Overall Study||5
929842|NCT01471782|2248575|P3|NOT COMPLETED|Overall Study||5
929843|NCT01471782|2248576|P2|NOT COMPLETED|Overall Study||6
929844|NCT01471782|2248577|P1|NOT COMPLETED|Overall Study||5
929845|NCT01471782|2248572|P6|COMPLETED|Overall Study|Completed 5 cycles|3
929846|NCT01471782|2248573|P5|COMPLETED|Overall Study|Completed 5 cycles|0
929847|NCT01471782|2248574|P4|COMPLETED|Overall Study|Completed 5 cycles|1
929848|NCT01471782|2248575|P3|COMPLETED|Overall Study|Completed 5 cycles|0
929849|NCT01471782|2248576|P2|COMPLETED|Overall Study|Completed 5 cycles|1
929850|NCT01471782|2248577|P1|COMPLETED|Overall Study|Completed 5 cycles|0
929851|NCT01471782|2248572|P6|STARTED|Overall Study||44
929852|NCT01471782|2248573|P5|STARTED|Overall Study||26
929853|NCT01471782|2248574|P4|STARTED|Overall Study||6
929854|NCT01471782|2248575|P3|STARTED|Overall Study||5
929855|NCT01471782|2248576|P2|STARTED|Overall Study||7
929856|NCT01471782|2248577|P1|STARTED|Overall Study||5
929857|NCT01471691|2248631|P2|NOT COMPLETED|Overall Study||1
929858|NCT01471691|2248632|P1|NOT COMPLETED|Overall Study||0
929859|NCT01471691|2248631|P2|COMPLETED|Overall Study||5
929860|NCT01471691|2248632|P1|COMPLETED|Overall Study||8
929861|NCT01471691|2248631|P2|STARTED|Overall Study||6
929862|NCT01471691|2248632|P1|STARTED|Overall Study||8
929863|NCT01471639|2248638|P1|NOT COMPLETED|Overall Study||0
929864|NCT01471639|2248638|P1|COMPLETED|Overall Study||37
929865|NCT01471639|2248638|P1|STARTED|Overall Study||37
929866|NCT01471626|2248643|P1|NOT COMPLETED|Overall Study||0
929867|NCT01471626|2248643|P1|COMPLETED|Overall Study||21
929868|NCT01471626|2248643|P1|STARTED|Overall Study||21
929869|NCT01471574|2248651|P4|NOT COMPLETED|Follow-up Period||3
929870|NCT01471574|2248652|P3|NOT COMPLETED|Follow-up Period||7
929871|NCT01471574|2248653|P2|NOT COMPLETED|Follow-up Period||2
929872|NCT01471574|2248654|P1|NOT COMPLETED|Follow-up Period||7
929873|NCT01471574|2248651|P4|COMPLETED|Follow-up Period||21
929874|NCT01471574|2248652|P3|COMPLETED|Follow-up Period||95
929875|NCT01471574|2248653|P2|COMPLETED|Follow-up Period||32
929876|NCT01471574|2248654|P1|COMPLETED|Follow-up Period||114
929877|NCT01471574|2248651|P4|STARTED|Follow-up Period||24
929878|NCT01471574|2248652|P3|STARTED|Follow-up Period||102
929879|NCT01471574|2248653|P2|STARTED|Follow-up Period||34
929880|NCT01471574|2248654|P1|STARTED|Follow-up Period||121
929881|NCT01471574|2248651|P4|NOT COMPLETED|Treatment Period||3
929882|NCT01471574|2248652|P3|NOT COMPLETED|Treatment Period||24
929883|NCT01471574|2248653|P2|NOT COMPLETED|Treatment Period||10
929884|NCT01471574|2248654|P1|NOT COMPLETED|Treatment Period||31
929885|NCT01471574|2248651|P4|COMPLETED|Treatment Period||21
929886|NCT01471574|2248652|P3|COMPLETED|Treatment Period||82
929887|NCT01471574|2248653|P2|COMPLETED|Treatment Period||29
929888|NCT01471574|2248654|P1|COMPLETED|Treatment Period||101
929889|NCT01471574|2248651|P4|STARTED|Treatment Period||24
929890|NCT01471574|2248652|P3|STARTED|Treatment Period||106
929891|NCT01471574|2248653|P2|STARTED|Treatment Period||39
929892|NCT01471574|2248654|P1|STARTED|Treatment Period||132
929893|NCT01471379|2248686|P3|NOT COMPLETED|Overall Study||0
929894|NCT01471379|2248687|P2|NOT COMPLETED|Overall Study||1
929895|NCT01471379|2248688|P1|NOT COMPLETED|Overall Study||1
929896|NCT01471379|2248686|P3|COMPLETED|Overall Study||0
929897|NCT01471379|2248687|P2|COMPLETED|Overall Study||0
929898|NCT01471379|2248688|P1|COMPLETED|Overall Study||0
929899|NCT01471379|2248686|P3|STARTED|Overall Study||0
929900|NCT01471379|2248687|P2|STARTED|Overall Study||1
929901|NCT01471379|2248688|P1|STARTED|Overall Study||1
929902|NCT01471353|2248708|P1|NOT COMPLETED|Overall Study||3
929903|NCT01471353|2248708|P1|COMPLETED|Overall Study||39
929904|NCT01471353|2248708|P1|STARTED|Overall Study||42
929905|NCT01471197|2248716|P2|NOT COMPLETED|Overall Study||2
929906|NCT01471197|2248717|P1|NOT COMPLETED|Overall Study||6
929907|NCT01471197|2248716|P2|COMPLETED|Overall Study||0
929908|NCT01471197|2248717|P1|COMPLETED|Overall Study||0
929909|NCT01471197|2248716|P2|STARTED|Overall Study||2
929910|NCT01471197|2248717|P1|STARTED|Overall Study||6
929911|NCT01471171|2248727|P2|NOT COMPLETED|Treatment Period 2||0
929912|NCT01471171|2248728|P1|NOT COMPLETED|Treatment Period 2||1
929913|NCT01471171|2248727|P2|COMPLETED|Treatment Period 2||54
929914|NCT01471171|2248728|P1|COMPLETED|Treatment Period 2||52
929915|NCT01471171|2248727|P2|STARTED|Treatment Period 2||54
929916|NCT01471171|2248728|P1|STARTED|Treatment Period 2||53
929917|NCT01471171|2248727|P2|NOT COMPLETED|Treatment Period 1||1
929918|NCT01471171|2248728|P1|NOT COMPLETED|Treatment Period 1||4
929919|NCT01471171|2248727|P2|COMPLETED|Treatment Period 1||54
929920|NCT01471171|2248728|P1|COMPLETED|Treatment Period 1||53
929921|NCT01471171|2248727|P2|STARTED|Treatment Period 1||55
929922|NCT01471171|2248728|P1|STARTED|Treatment Period 1||57
929923|NCT01471041|2248738|P1|NOT COMPLETED|Overall Study||7
929924|NCT01471041|2248738|P1|COMPLETED|Overall Study||47
929925|NCT01471041|2248738|P1|STARTED|Overall Study||54
929926|NCT01471015|2248746|P3|NOT COMPLETED|Overall Study||1
929927|NCT01471015|2248747|P2|NOT COMPLETED|Overall Study||1
929928|NCT01471015|2248748|P1|NOT COMPLETED|Overall Study||0
929929|NCT01471015|2248746|P3|COMPLETED|Overall Study||9
929930|NCT01471015|2248747|P2|COMPLETED|Overall Study||9
929931|NCT01471015|2248748|P1|COMPLETED|Overall Study||10
929932|NCT01471015|2248746|P3|STARTED|Overall Study||10
929933|NCT01471015|2248747|P2|STARTED|Overall Study||10
929934|NCT01471015|2248748|P1|STARTED|Overall Study||10
929935|NCT01470859|2248762|P2|NOT COMPLETED|Overall Study||0
929936|NCT01470859|2248763|P1|NOT COMPLETED|Overall Study||1
929937|NCT01470859|2248762|P2|COMPLETED|Overall Study||15
929938|NCT01470859|2248763|P1|COMPLETED|Overall Study||14
929939|NCT01470859|2248762|P2|STARTED|Overall Study||15
929940|NCT01470859|2248763|P1|STARTED|Overall Study||15
929941|NCT01470651|2248779|P2|NOT COMPLETED|Overall Study||3
929942|NCT01470651|2248780|P1|NOT COMPLETED|Overall Study||7
929943|NCT01470651|2248779|P2|COMPLETED|Overall Study||10
929944|NCT01470651|2248780|P1|COMPLETED|Overall Study||6
929945|NCT01470651|2248779|P2|STARTED|Overall Study||13
929946|NCT01470651|2248780|P1|STARTED|Overall Study||13
929947|NCT01470469|2248790|P2|NOT COMPLETED|Overall Study||24
929948|NCT01470469|2248791|P1|NOT COMPLETED|Overall Study||10
929949|NCT01470469|2248790|P2|COMPLETED|Overall Study||38
929950|NCT01470469|2248791|P1|COMPLETED|Overall Study||11
929951|NCT01470469|2248790|P2|STARTED|Overall Study||62
929952|NCT01470469|2248791|P1|STARTED|Overall Study||21
929953|NCT01470417|2248811|P2|NOT COMPLETED|Overall Study||2
929954|NCT01470417|2248812|P1|NOT COMPLETED|Overall Study||0
929955|NCT01470417|2248811|P2|COMPLETED|Overall Study||5
929956|NCT01470417|2248812|P1|COMPLETED|Overall Study||3
929957|NCT01470417|2248811|P2|STARTED|Overall Study||7
929958|NCT01470417|2248812|P1|STARTED|Overall Study||3
929959|NCT01470248|2248824|P1|NOT COMPLETED|Overall Study||1
929960|NCT01470248|2248824|P1|COMPLETED|Overall Study||19
929961|NCT01470248|2248824|P1|STARTED|Overall Study||20
929962|NCT01470196|2248831|P1|NOT COMPLETED|Overall Study||0
929963|NCT01470196|2248831|P1|COMPLETED|Overall Study||31
929964|NCT01470196|2248831|P1|STARTED|Overall Study||31
929965|NCT01470170|2248844|P5|NOT COMPLETED|Overall Study||0
929966|NCT01470170|2248845|P4|NOT COMPLETED|Overall Study||0
929967|NCT01470170|2248846|P3|NOT COMPLETED|Overall Study||0
929968|NCT01470170|2248847|P2|NOT COMPLETED|Overall Study||0
929969|NCT01470170|2248848|P1|NOT COMPLETED|Overall Study||0
929970|NCT01470170|2248844|P5|COMPLETED|Overall Study||34
929971|NCT01470170|2248845|P4|COMPLETED|Overall Study||36
929972|NCT01470170|2248846|P3|COMPLETED|Overall Study||34
929973|NCT01470170|2248847|P2|COMPLETED|Overall Study||35
929974|NCT01470170|2248848|P1|COMPLETED|Overall Study||34
929975|NCT01470170|2248844|P5|STARTED|Overall Study||34
929976|NCT01470170|2248845|P4|STARTED|Overall Study||36
929977|NCT01470170|2248846|P3|STARTED|Overall Study||34
929978|NCT01470170|2248847|P2|STARTED|Overall Study||35
929979|NCT01470170|2248848|P1|STARTED|Overall Study||34
929980|NCT01470144|2248880|P1|NOT COMPLETED|Overall Study||10
929981|NCT01470144|2248880|P1|COMPLETED|Overall Study|"Completed corresponds to subjects switching to commercial EFI upon market approval/reimbursement"|31
929982|NCT01470144|2248880|P1|STARTED|Overall Study||41
929983|NCT01470118|2248888|P3|NOT COMPLETED|Overall Study||2
929984|NCT01470118|2248889|P2|NOT COMPLETED|Overall Study||5
929985|NCT01470118|2248890|P1|NOT COMPLETED|Overall Study||5
929986|NCT01470118|2248888|P3|COMPLETED|Overall Study||39
929987|NCT01470118|2248889|P2|COMPLETED|Overall Study||38
929988|NCT01470118|2248890|P1|COMPLETED|Overall Study||38
929989|NCT01470118|2248888|P3|STARTED|Overall Study||41
929990|NCT01470118|2248889|P2|STARTED|Overall Study||43
929991|NCT01470118|2248890|P1|STARTED|Overall Study||43
929992|NCT01470001|2248921|P2|NOT COMPLETED|Overall Study||2
929993|NCT01470001|2248922|P1|NOT COMPLETED|Overall Study||5
929994|NCT01470001|2248921|P2|COMPLETED|Overall Study||58
929995|NCT01470001|2248922|P1|COMPLETED|Overall Study||53
929996|NCT01470001|2248921|P2|STARTED|Overall Study||60
929997|NCT01470001|2248922|P1|STARTED|Overall Study||58
929998|NCT01469819|2248932|P1|NOT COMPLETED|Overall Study||8
929999|NCT01469819|2248932|P1|COMPLETED|Overall Study||29
930000|NCT01469819|2248932|P1|STARTED|Overall Study||37
930001|NCT01469767|2248942|P1|NOT COMPLETED|Overall Study||0
930002|NCT01469767|2248942|P1|COMPLETED|Overall Study||10
930003|NCT01469767|2248942|P1|STARTED|Overall Study||10
930004|NCT01469715|2248950|P1|NOT COMPLETED|Overall Study||0
930005|NCT01469715|2248950|P1|COMPLETED|Overall Study||16
930006|NCT01469715|2248950|P1|STARTED|Overall Study||16
930007|NCT01469637|2248956|P2|NOT COMPLETED|Second Intervention||0
930008|NCT01469637|2248957|P1|NOT COMPLETED|Second Intervention||1
930009|NCT01469637|2248956|P2|COMPLETED|Second Intervention||21
930010|NCT01469637|2248957|P1|COMPLETED|Second Intervention||21
930011|NCT01469637|2248956|P2|STARTED|Second Intervention||21
930012|NCT01469637|2248957|P1|STARTED|Second Intervention||22
930013|NCT01469637|2248956|P2|NOT COMPLETED|First Intervention||1
930014|NCT01469637|2248957|P1|NOT COMPLETED|First Intervention||0
930015|NCT01469637|2248956|P2|COMPLETED|First Intervention||21
930016|NCT01469637|2248957|P1|COMPLETED|First Intervention||22
930017|NCT01469637|2248956|P2|STARTED|First Intervention||22
930018|NCT01469637|2248957|P1|STARTED|First Intervention||22
930019|NCT01469546|2248965|P1|NOT COMPLETED|Dose Escalation to 10 mg||0
930020|NCT01469546|2248965|P1|COMPLETED|Dose Escalation to 10 mg||19
930021|NCT01469546|2248965|P1|STARTED|Dose Escalation to 10 mg||19
930022|NCT01469546|2248965|P1|NOT COMPLETED|Received 5 mg Dose||23
930023|NCT01469546|2248965|P1|COMPLETED|Received 5 mg Dose||19
930024|NCT01469546|2248965|P1|Completed First Cycle|Received 5 mg Dose||30
930025|NCT01469546|2248965|P1|STARTED|Received 5 mg Dose||42
930026|NCT01469364|2248972|P1|NOT COMPLETED|Overall Study||2
930027|NCT01469364|2248972|P1|COMPLETED|Overall Study||28
930028|NCT01469364|2248972|P1|STARTED|Overall Study||30
930029|NCT01469234|2248990|P3|NOT COMPLETED|Overall Study||0
930030|NCT01469234|2248991|P2|NOT COMPLETED|Overall Study||0
930031|NCT01469234|2248992|P1|NOT COMPLETED|Overall Study||0
930032|NCT01469234|2248990|P3|COMPLETED|Overall Study||85
930033|NCT01469234|2248991|P2|COMPLETED|Overall Study||85
930034|NCT01469234|2248992|P1|COMPLETED|Overall Study||85
930035|NCT01469234|2248990|P3|STARTED|Overall Study||85
930036|NCT01469234|2248991|P2|STARTED|Overall Study||85
930037|NCT01469234|2248992|P1|STARTED|Overall Study||85
930038|NCT01469182|2249023|P2|NOT COMPLETED|Overall Study||6
930039|NCT01469182|2249024|P1|NOT COMPLETED|Overall Study||35
930040|NCT01469182|2249023|P2|COMPLETED|Overall Study||298
930041|NCT01469182|2249024|P1|COMPLETED|Overall Study||575
930042|NCT01469182|2249023|P2|Treated|Overall Study||304
930043|NCT01469182|2249024|P1|Treated|Overall Study||609
930044|NCT01469182|2249023|P2|STARTED|Overall Study||304
930045|NCT01469182|2249024|P1|STARTED|Overall Study||610
930046|NCT01469065|2249051|P5|NOT COMPLETED|Overall Study||1
930047|NCT01469065|2249052|P4|NOT COMPLETED|Overall Study||0
930048|NCT01469065|2249053|P3|NOT COMPLETED|Overall Study||0
930049|NCT01469065|2249054|P2|NOT COMPLETED|Overall Study||1
930050|NCT01469065|2249055|P1|NOT COMPLETED|Overall Study||0
930051|NCT01469065|2249051|P5|COMPLETED|Overall Study||16
930052|NCT01469065|2249052|P4|COMPLETED|Overall Study||16
930053|NCT01469065|2249053|P3|COMPLETED|Overall Study||16
930054|NCT01469065|2249054|P2|COMPLETED|Overall Study||16
930055|NCT01469065|2249055|P1|COMPLETED|Overall Study||16
930056|NCT01469065|2249051|P5|STARTED|Overall Study||17
930057|NCT01469065|2249052|P4|STARTED|Overall Study||16
930058|NCT01469065|2249053|P3|STARTED|Overall Study||16
930059|NCT01469065|2249054|P2|STARTED|Overall Study||17
930060|NCT01469065|2249055|P1|STARTED|Overall Study||16
930061|NCT01469052|2249151|P6|NOT COMPLETED|Overall Study||6
930062|NCT01469052|2249152|P5|NOT COMPLETED|Overall Study||8
930063|NCT01469052|2249153|P4|NOT COMPLETED|Overall Study||5
930064|NCT01469052|2249154|P3|NOT COMPLETED|Overall Study||6
930065|NCT01469052|2249155|P2|NOT COMPLETED|Overall Study||4
930066|NCT01469052|2249156|P1|NOT COMPLETED|Overall Study||6
930067|NCT01469052|2249151|P6|COMPLETED|Overall Study||0
930068|NCT01469052|2249152|P5|COMPLETED|Overall Study||0
930069|NCT01469052|2249153|P4|COMPLETED|Overall Study||1
930070|NCT01469052|2249154|P3|COMPLETED|Overall Study||0
930071|NCT01469052|2249155|P2|COMPLETED|Overall Study||0
930072|NCT01469052|2249156|P1|COMPLETED|Overall Study||0
930073|NCT01469052|2249151|P6|STARTED|Overall Study||6
930074|NCT01469052|2249152|P5|STARTED|Overall Study||8
930075|NCT01469052|2249153|P4|STARTED|Overall Study||6
930076|NCT01469052|2249154|P3|STARTED|Overall Study||6
930077|NCT01469052|2249155|P2|STARTED|Overall Study||4
930078|NCT01469052|2249156|P1|STARTED|Overall Study||6
930079|NCT01469039|2249203|P3|NOT COMPLETED|Overall Study||113
930080|NCT01469039|2249204|P2|NOT COMPLETED|Overall Study||73
930081|NCT01469039|2249205|P1|NOT COMPLETED|Overall Study||77
930082|NCT01469039|2249203|P3|COMPLETED|Overall Study||95
930083|NCT01469039|2249204|P2|COMPLETED|Overall Study||135
930084|NCT01469039|2249205|P1|COMPLETED|Overall Study||130
930085|NCT01469039|2249203|P3|STARTED|Overall Study||208
930086|NCT01469039|2249204|P2|STARTED|Overall Study||208
930087|NCT01469039|2249205|P1|STARTED|Overall Study||207
930088|NCT01469000|2249218|P2|NOT COMPLETED|Overall Study||9
930089|NCT01469000|2249219|P1|NOT COMPLETED|Overall Study||33
930090|NCT01469000|2249218|P2|COMPLETED|Overall Study||57
930091|NCT01469000|2249219|P1|COMPLETED|Overall Study||96
930092|NCT01469000|2249218|P2|Received at Least 1 Dose of Study Drug|Overall Study||65
930093|NCT01469000|2249219|P1|Received at Least 1 Dose of Study Drug|Overall Study||126
930094|NCT01469000|2249218|P2|STARTED|Overall Study||66
930095|NCT01469000|2249219|P1|STARTED|Overall Study||129
930102|NCT01468818|2249252|P1|NOT COMPLETED|Overall Study||2
930103|NCT01468818|2249252|P1|COMPLETED|Overall Study||16
930104|NCT01468818|2249252|P1|STARTED|Overall Study||18
930105|NCT01468675|2249259|P2|NOT COMPLETED|Overall Study||1372
930106|NCT01468675|2249260|P1|NOT COMPLETED|Overall Study||1000
930107|NCT01468675|2249259|P2|COMPLETED|Overall Study||2004
930108|NCT01468675|2249260|P1|COMPLETED|Overall Study||1699
930109|NCT01468675|2249259|P2|STARTED|Overall Study||3376
930110|NCT01468675|2249260|P1|STARTED|Overall Study||2699
930111|NCT01468584|2249266|P1|NOT COMPLETED|Overall Study||0
930112|NCT01468584|2249266|P1|COMPLETED|Overall Study||10
930113|NCT01468584|2249266|P1|STARTED|Overall Study||10
930114|NCT01468558|2249270|P1|NOT COMPLETED|Overall Study||2
930115|NCT01468558|2249270|P1|COMPLETED|Overall Study||22
930116|NCT01468558|2249270|P1|STARTED|Overall Study||24
930117|NCT01468350|2249285|P4|NOT COMPLETED|(PART B) Day 1, Day 15||0
930118|NCT01468350|2249286|P3|NOT COMPLETED|(PART B) Day 1, Day 15||0
930119|NCT01468350|2249287|P2|NOT COMPLETED|(PART B) Day 1, Day 15||0
930120|NCT01468350|2249288|P1|NOT COMPLETED|(PART B) Day 1, Day 15||0
930121|NCT01468350|2249285|P4|COMPLETED|(PART B) Day 1, Day 15||12
930122|NCT01468350|2249286|P3|COMPLETED|(PART B) Day 1, Day 15||12
930123|NCT01468350|2249287|P2|COMPLETED|(PART B) Day 1, Day 15||0
930124|NCT01468350|2249288|P1|COMPLETED|(PART B) Day 1, Day 15||0
930125|NCT01468350|2249285|P4|STARTED|(PART B) Day 1, Day 15||12
930126|NCT01468350|2249286|P3|STARTED|(PART B) Day 1, Day 15||12
930127|NCT01468350|2249287|P2|STARTED|(PART B) Day 1, Day 15||0
930128|NCT01468350|2249288|P1|STARTED|(PART B) Day 1, Day 15||0
930129|NCT01468350|2249285|P4|NOT COMPLETED|(PART A) Day 1, Day 3||0
930130|NCT01468350|2249286|P3|NOT COMPLETED|(PART A) Day 1, Day 3||0
930131|NCT01468350|2249287|P2|NOT COMPLETED|(PART A) Day 1, Day 3||0
930132|NCT01468350|2249288|P1|NOT COMPLETED|(PART A) Day 1, Day 3||0
930133|NCT01468350|2249285|P4|COMPLETED|(PART A) Day 1, Day 3||0
930134|NCT01468350|2249286|P3|COMPLETED|(PART A) Day 1, Day 3||0
930135|NCT01468350|2249287|P2|COMPLETED|(PART A) Day 1, Day 3||5
930136|NCT01468350|2249288|P1|COMPLETED|(PART A) Day 1, Day 3||6
930137|NCT01468350|2249285|P4|STARTED|(PART A) Day 1, Day 3||0
930138|NCT01468350|2249286|P3|STARTED|(PART A) Day 1, Day 3||0
930139|NCT01468350|2249287|P2|STARTED|(PART A) Day 1, Day 3||5
930140|NCT01468350|2249288|P1|STARTED|(PART A) Day 1, Day 3||6
930141|NCT01468337|2249298|P1|NOT COMPLETED|Overall Study||0
930142|NCT01468337|2249298|P1|COMPLETED|Overall Study||5
930143|NCT01468337|2249298|P1|Week 48|Overall Study|Two participants did not have a Week 48 visit but completed the study.|3
930144|NCT01468337|2249298|P1|Received Interferon Gamma-1b After Wk 8|Overall Study|Two participants had 2 Interferon gamma-1b dosing cycles after Wk 8|4
930145|NCT01468337|2249298|P1|Received Interferon Gamma-1b at Week 4|Overall Study|One participant received additional Interferon gamma-1b dosing at Week 4 and after Week 8|2
930146|NCT01468337|2249298|P1|Week 2|Overall Study||5
930147|NCT01468337|2249298|P1|STARTED|Overall Study||5
930148|NCT01468311|2249310|P1|NOT COMPLETED|Overall Study||2
930149|NCT01468311|2249310|P1|COMPLETED|Overall Study||4
930150|NCT01468311|2249310|P1|STARTED|Overall Study||6
930151|NCT01468233|2249322|P6|NOT COMPLETED|Treatment Period 2||23
930152|NCT01468233|2249323|P5|NOT COMPLETED|Treatment Period 2||28
930153|NCT01468233|2249324|P4|NOT COMPLETED|Treatment Period 2||28
930154|NCT01468233|2249325|P3|NOT COMPLETED|Treatment Period 2||111
930155|NCT01468233|2249326|P2|NOT COMPLETED|Treatment Period 2||0
930156|NCT01468233|2249327|P1|NOT COMPLETED|Treatment Period 2||0
930157|NCT01468233|2249322|P6|COMPLETED|Treatment Period 2||28
930158|NCT01468233|2249323|P5|COMPLETED|Treatment Period 2||25
930159|NCT01468233|2249324|P4|COMPLETED|Treatment Period 2||23
930160|NCT01468233|2249325|P3|COMPLETED|Treatment Period 2||40
930161|NCT01468233|2249326|P2|COMPLETED|Treatment Period 2||0
930162|NCT01468233|2249327|P1|COMPLETED|Treatment Period 2||0
930163|NCT01468233|2249322|P6|STARTED|Treatment Period 2||51
930164|NCT01468233|2249323|P5|STARTED|Treatment Period 2||53
930165|NCT01468233|2249324|P4|STARTED|Treatment Period 2||51
930166|NCT01468233|2249325|P3|STARTED|Treatment Period 2||151
930167|NCT01468233|2249326|P2|STARTED|Treatment Period 2||0
930168|NCT01468233|2249327|P1|STARTED|Treatment Period 2||0
930169|NCT01468233|2249322|P6|NOT COMPLETED|Treatment Period 1||0
930170|NCT01468233|2249323|P5|NOT COMPLETED|Treatment Period 1||0
930171|NCT01468233|2249324|P4|NOT COMPLETED|Treatment Period 1||0
930172|NCT01468233|2249325|P3|NOT COMPLETED|Treatment Period 1||0
930173|NCT01468233|2249326|P2|NOT COMPLETED|Treatment Period 1||8
930174|NCT01468233|2249327|P1|NOT COMPLETED|Treatment Period 1||12
930175|NCT01468233|2249322|P6|COMPLETED|Treatment Period 1||0
930176|NCT01468233|2249323|P5|COMPLETED|Treatment Period 1||0
930177|NCT01468233|2249324|P4|COMPLETED|Treatment Period 1||0
930178|NCT01468233|2249325|P3|COMPLETED|Treatment Period 1||0
930179|NCT01468233|2249326|P2|COMPLETED|Treatment Period 1||155
930180|NCT01468233|2249327|P1|COMPLETED|Treatment Period 1||151
930181|NCT01468233|2249322|P6|STARTED|Treatment Period 1||0
930182|NCT01468233|2249323|P5|STARTED|Treatment Period 1||0
930183|NCT01468233|2249324|P4|STARTED|Treatment Period 1||0
930184|NCT01468233|2249325|P3|STARTED|Treatment Period 1||0
930185|NCT01468233|2249326|P2|STARTED|Treatment Period 1||163
930186|NCT01468233|2249327|P1|STARTED|Treatment Period 1||163
930187|NCT01468207|2249349|P6|NOT COMPLETED|Treatment Period 2||20
930188|NCT01468207|2249350|P5|NOT COMPLETED|Treatment Period 2||21
930189|NCT01468207|2249351|P4|NOT COMPLETED|Treatment Period 2||27
930190|NCT01468207|2249352|P3|NOT COMPLETED|Treatment Period 2||52
930191|NCT01468207|2249353|P2|NOT COMPLETED|Treatment Period 2||0
930192|NCT01468207|2249354|P1|NOT COMPLETED|Treatment Period 2||0
930193|NCT01468207|2249349|P6|COMPLETED|Treatment Period 2||28
930194|NCT01468207|2249350|P5|COMPLETED|Treatment Period 2||27
930195|NCT01468207|2249351|P4|COMPLETED|Treatment Period 2||22
930196|NCT01468207|2249352|P3|COMPLETED|Treatment Period 2||93
930197|NCT01468207|2249353|P2|COMPLETED|Treatment Period 2||0
930198|NCT01468207|2249354|P1|COMPLETED|Treatment Period 2||0
930199|NCT01468207|2249349|P6|STARTED|Treatment Period 2||48
930200|NCT01468207|2249350|P5|STARTED|Treatment Period 2||48
930201|NCT01468207|2249351|P4|STARTED|Treatment Period 2||49
930202|NCT01468207|2249352|P3|STARTED|Treatment Period 2||145
930203|NCT01468207|2249353|P2|STARTED|Treatment Period 2||0
930204|NCT01468207|2249354|P1|STARTED|Treatment Period 2||0
930205|NCT01468207|2249349|P6|NOT COMPLETED|Treatment Period 1||0
930206|NCT01468207|2249350|P5|NOT COMPLETED|Treatment Period 1||0
930207|NCT01468207|2249351|P4|NOT COMPLETED|Treatment Period 1||0
930208|NCT01468207|2249352|P3|NOT COMPLETED|Treatment Period 1||0
930209|NCT01468207|2249353|P2|NOT COMPLETED|Treatment Period 1||8
930210|NCT01468207|2249354|P1|NOT COMPLETED|Treatment Period 1||9
930211|NCT01468207|2249349|P6|COMPLETED|Treatment Period 1||0
930212|NCT01468207|2249350|P5|COMPLETED|Treatment Period 1||0
930213|NCT01468207|2249351|P4|COMPLETED|Treatment Period 1||0
930214|NCT01468207|2249352|P3|COMPLETED|Treatment Period 1||0
930215|NCT01468207|2249353|P2|COMPLETED|Treatment Period 1||145
930216|NCT01468207|2249354|P1|COMPLETED|Treatment Period 1||145
930217|NCT01468207|2249349|P6|Received Study Drug|Treatment Period 1||0
930218|NCT01468207|2249350|P5|Received Study Drug|Treatment Period 1||0
930219|NCT01468207|2249351|P4|Received Study Drug|Treatment Period 1||0
930220|NCT01468207|2249352|P3|Received Study Drug|Treatment Period 1||0
930221|NCT01468207|2249353|P2|Received Study Drug|Treatment Period 1||153
930222|NCT01468207|2249354|P1|Received Study Drug|Treatment Period 1||152
930223|NCT01468207|2249349|P6|STARTED|Treatment Period 1||0
930224|NCT01468207|2249350|P5|STARTED|Treatment Period 1||0
930225|NCT01468207|2249351|P4|STARTED|Treatment Period 1||0
930226|NCT01468207|2249352|P3|STARTED|Treatment Period 1||0
930227|NCT01468207|2249353|P2|STARTED|Treatment Period 1||153
930228|NCT01468207|2249354|P1|STARTED|Treatment Period 1||154
930229|NCT01468181|2249379|P5|NOT COMPLETED|Overall Study||5
930230|NCT01468181|2249380|P4|NOT COMPLETED|Overall Study||3
930231|NCT01468181|2249381|P3|NOT COMPLETED|Overall Study||8
930232|NCT01468181|2249382|P2|NOT COMPLETED|Overall Study||2
930233|NCT01468181|2249383|P1|NOT COMPLETED|Overall Study||10
930234|NCT01468181|2249379|P5|COMPLETED|Overall Study||66
930235|NCT01468181|2249380|P4|COMPLETED|Overall Study||63
930236|NCT01468181|2249381|P3|COMPLETED|Overall Study||57
930237|NCT01468181|2249382|P2|COMPLETED|Overall Study||59
930238|NCT01468181|2249383|P1|COMPLETED|Overall Study||121
930239|NCT01468181|2249379|P5|Received at Least 1 Dose of Study Drug|Overall Study||71
930240|NCT01468181|2249380|P4|Received at Least 1 Dose of Study Drug|Overall Study||66
930241|NCT01468181|2249381|P3|Received at Least 1 Dose of Study Drug|Overall Study||65
930242|NCT01468181|2249382|P2|Received at Least 1 Dose of Study Drug|Overall Study||61
930243|NCT01468181|2249383|P1|Received at Least 1 Dose of Study Drug|Overall Study||131
930244|NCT01468181|2249379|P5|STARTED|Overall Study||71
930245|NCT01468181|2249380|P4|STARTED|Overall Study||66
930246|NCT01468181|2249381|P3|STARTED|Overall Study||65
930247|NCT01468181|2249382|P2|STARTED|Overall Study||61
930248|NCT01468181|2249383|P1|STARTED|Overall Study||131
930249|NCT01468077|2249432|P2|NOT COMPLETED|Overall Study||3
930250|NCT01468077|2249433|P1|NOT COMPLETED|Overall Study||4
930251|NCT01468077|2249432|P2|COMPLETED|Overall Study||22
930252|NCT01468077|2249433|P1|COMPLETED|Overall Study||18
930253|NCT01468077|2249432|P2|STARTED|Overall Study||25
930254|NCT01468077|2249433|P1|STARTED|Overall Study||22
930255|NCT01468012|2249472|P3|NOT COMPLETED|Overall Study||4
930256|NCT01468012|2249473|P2|NOT COMPLETED|Overall Study||1
930257|NCT01468012|2249474|P1|NOT COMPLETED|Overall Study||2
930258|NCT01468012|2249472|P3|COMPLETED|Overall Study||0
930259|NCT01468012|2249473|P2|COMPLETED|Overall Study||9
930260|NCT01468012|2249474|P1|COMPLETED|Overall Study||7
930261|NCT01468012|2249472|P3|STARTED|Overall Study||4
930262|NCT01468012|2249473|P2|STARTED|Overall Study||10
930263|NCT01468012|2249474|P1|STARTED|Overall Study||9
930264|NCT01467960|2249486|P6|NOT COMPLETED|Overall Study||30
930265|NCT01467960|2249487|P5|NOT COMPLETED|Overall Study||30
930266|NCT01467960|2249488|P4|NOT COMPLETED|Overall Study||30
930267|NCT01467960|2249489|P3|NOT COMPLETED|Overall Study||0
930268|NCT01467960|2249490|P2|NOT COMPLETED|Overall Study||0
930269|NCT01467960|2249491|P1|NOT COMPLETED|Overall Study||0
930270|NCT01467960|2249486|P6|COMPLETED|Overall Study||0
930271|NCT01467960|2249487|P5|COMPLETED|Overall Study||0
930272|NCT01467960|2249488|P4|COMPLETED|Overall Study||0
930273|NCT01467960|2249489|P3|COMPLETED|Overall Study||30
930274|NCT01467960|2249490|P2|COMPLETED|Overall Study||30
930275|NCT01467960|2249491|P1|COMPLETED|Overall Study||30
930276|NCT01467960|2249486|P6|STARTED|Overall Study||30
930277|NCT01467960|2249487|P5|STARTED|Overall Study||30
930278|NCT01467960|2249488|P4|STARTED|Overall Study||30
930279|NCT01467960|2249489|P3|STARTED|Overall Study||30
930280|NCT01467960|2249490|P2|STARTED|Overall Study||30
930281|NCT01467960|2249491|P1|STARTED|Overall Study||30
930282|NCT01467947|2249505|P1|NOT COMPLETED|Overall Study||0
930283|NCT01467947|2249505|P1|COMPLETED|Overall Study||46
930284|NCT01467947|2249505|P1|STARTED|Overall Study||46
930285|NCT01467934|2249513|P3|NOT COMPLETED|Overall Study||0
930286|NCT01467934|2249514|P2|NOT COMPLETED|Overall Study||0
930287|NCT01467934|2249515|P1|NOT COMPLETED|Overall Study||0
930288|NCT01467934|2249513|P3|COMPLETED|Overall Study||110
930289|NCT01467934|2249514|P2|COMPLETED|Overall Study||212
930290|NCT01467934|2249515|P1|COMPLETED|Overall Study||208
930291|NCT01467934|2249513|P3|STARTED|Overall Study||110
930292|NCT01467934|2249514|P2|STARTED|Overall Study||212
930293|NCT01467934|2249515|P1|STARTED|Overall Study||208
930294|NCT01467882|2249523|P1|NOT COMPLETED|Overall Study||0
930295|NCT01467882|2249523|P1|COMPLETED|Overall Study||44
930296|NCT01467882|2249523|P1|STARTED|Overall Study||44
930297|NCT01467713|2249550|P4|NOT COMPLETED|Overall Study||109
930298|NCT01467713|2249551|P3|NOT COMPLETED|Overall Study||102
930299|NCT01467713|2249552|P2|NOT COMPLETED|Overall Study||104
930300|NCT01467713|2249553|P1|NOT COMPLETED|Overall Study||102
930301|NCT01467713|2249550|P4|COMPLETED|Overall Study||45
930302|NCT01467713|2249551|P3|COMPLETED|Overall Study||58
930303|NCT01467713|2249552|P2|COMPLETED|Overall Study||60
930304|NCT01467713|2249553|P1|COMPLETED|Overall Study||62
930305|NCT01467713|2249550|P4|Safety Analysis Set: Received Treatment|Overall Study||154
930306|NCT01467713|2249551|P3|Safety Analysis Set: Received Treatment|Overall Study||159
930307|NCT01467713|2249552|P2|Safety Analysis Set: Received Treatment|Overall Study||164
930308|NCT01467713|2249553|P1|Safety Analysis Set: Received Treatment|Overall Study||163
930309|NCT01467713|2249550|P4|STARTED|Overall Study||154
930310|NCT01467713|2249551|P3|STARTED|Overall Study||160
930311|NCT01467713|2249552|P2|STARTED|Overall Study||164
930312|NCT01467713|2249553|P1|STARTED|Overall Study||164
930313|NCT01467700|2249607|P4|NOT COMPLETED|Overall Study||27
930314|NCT01467700|2249608|P3|NOT COMPLETED|Overall Study||27
930315|NCT01467700|2249609|P2|NOT COMPLETED|Overall Study||28
930316|NCT01467700|2249610|P1|NOT COMPLETED|Overall Study||29
930317|NCT01467700|2249607|P4|COMPLETED|Overall Study||96
930318|NCT01467700|2249608|P3|COMPLETED|Overall Study||97
930319|NCT01467700|2249609|P2|COMPLETED|Overall Study||100
930320|NCT01467700|2249610|P1|COMPLETED|Overall Study||86
930321|NCT01467700|2249607|P4|Safety Set - Received Treatment|Overall Study||123
930322|NCT01467700|2249608|P3|Safety Set - Received Treatment|Overall Study||124
930323|NCT01467700|2249609|P2|Safety Set - Received Treatment|Overall Study||127
930324|NCT01467700|2249610|P1|Safety Set - Received Treatment|Overall Study||115
930325|NCT01467700|2249607|P4|STARTED|Overall Study||123
930326|NCT01467700|2249608|P3|STARTED|Overall Study||124
930327|NCT01467700|2249609|P2|STARTED|Overall Study||128
930328|NCT01467700|2249610|P1|STARTED|Overall Study||115
930329|NCT01467661|2249652|P1|NOT COMPLETED|Overall Study||21
930330|NCT01467661|2249652|P1|COMPLETED|Overall Study|Completed study SPD422-309 (NCT01467661)|32
930331|NCT01467661|2249652|P1|Started Post Marketing Trial|Overall Study||33
930332|NCT01467661|2249652|P1|Started SPD422-309 (NCT01467661)|Overall Study||41
930333|NCT01467661|2249652|P1|Completed SPD422-308 (NCT01214915)|Overall Study||42
930334|NCT01467661|2249652|P1|STARTED|Overall Study|Started Study SPD422-308 (NCT01214915)|53
930335|NCT01467583|2249672|P3|NOT COMPLETED|Overall Study||2
930336|NCT01467583|2249673|P2|NOT COMPLETED|Overall Study||1
930337|NCT01467583|2249674|P1|NOT COMPLETED|Overall Study||2
930338|NCT01467583|2249672|P3|COMPLETED|Overall Study||10
930339|NCT01467583|2249673|P2|COMPLETED|Overall Study|Death unrelated to study drug on day #3. Data to that point is included in the results|3
930340|NCT01467583|2249674|P1|COMPLETED|Overall Study|Both patients completed > 1 dose and so their data was included in the results.|14
930341|NCT01467583|2249672|P3|STARTED|Overall Study||12
930342|NCT01467583|2249673|P2|STARTED|Overall Study||4
930343|NCT01467583|2249674|P1|STARTED|Overall Study||16
930344|NCT01467570|2249687|P2|NOT COMPLETED|Overall Study||9
930345|NCT01467570|2249688|P1|NOT COMPLETED|Overall Study||8
930346|NCT01467570|2249687|P2|COMPLETED|Overall Study||63
930347|NCT01467570|2249688|P1|COMPLETED|Overall Study||67
930348|NCT01467570|2249687|P2|STARTED|Overall Study||72
930349|NCT01467570|2249688|P1|STARTED|Overall Study||75
930350|NCT01467557|2249714|P2|NOT COMPLETED|Overall Study||107
930351|NCT01467557|2249715|P1|NOT COMPLETED|Overall Study||99
930352|NCT01467557|2249714|P2|COMPLETED|Overall Study||463
930353|NCT01467557|2249715|P1|COMPLETED|Overall Study||502
930354|NCT01467557|2249714|P2|12 Month Survey Completed|Overall Study||463
930355|NCT01467557|2249715|P1|12 Month Survey Completed|Overall Study||502
930356|NCT01467557|2249714|P2|4 Month Survey Completed|Overall Study||493
930357|NCT01467557|2249715|P1|4 Month Survey Completed|Overall Study||533
930358|NCT01467557|2249714|P2|2 Week Survey Completed|Overall Study||522
930359|NCT01467557|2249715|P1|2 Week Survey Completed|Overall Study||551
930360|NCT01467557|2249714|P2|STARTED|Overall Study||570
930361|NCT01467557|2249715|P1|STARTED|Overall Study||601
930362|NCT01467505|2249725|P2|NOT COMPLETED|Overall Study||3
930363|NCT01467505|2249726|P1|NOT COMPLETED|Overall Study||33
930364|NCT01467505|2249725|P2|COMPLETED|Overall Study||7
930365|NCT01467505|2249726|P1|COMPLETED|Overall Study||18
930366|NCT01467505|2249725|P2|STARTED|Overall Study||10
930367|NCT01467505|2249726|P1|STARTED|Overall Study||51
930368|NCT01467492|2249758|P2|NOT COMPLETED|Overall Study||13
930369|NCT01467492|2249759|P1|NOT COMPLETED|Overall Study||22
930370|NCT01467492|2249758|P2|COMPLETED|Overall Study||25
930371|NCT01467492|2249759|P1|COMPLETED|Overall Study||61
930372|NCT01467492|2249758|P2|STARTED|Overall Study||38
930373|NCT01467492|2249759|P1|STARTED|Overall Study||83
930374|NCT01467479|2249783|P3|NOT COMPLETED|Overall Study||16
930375|NCT01467479|2249784|P2|NOT COMPLETED|Overall Study||17
930376|NCT01467479|2249785|P1|NOT COMPLETED|Overall Study||9
930377|NCT01467479|2249783|P3|COMPLETED|Overall Study||45
930378|NCT01467479|2249784|P2|COMPLETED|Overall Study||52
930379|NCT01467479|2249785|P1|COMPLETED|Overall Study||46
930380|NCT01467479|2249783|P3|Treated|Overall Study||59
930381|NCT01467479|2249784|P2|Treated|Overall Study||69
930382|NCT01467479|2249785|P1|Treated|Overall Study||54
930383|NCT01467479|2249783|P3|STARTED|Overall Study||61
930384|NCT01467479|2249784|P2|STARTED|Overall Study||69
930385|NCT01467479|2249785|P1|STARTED|Overall Study||55
930386|NCT01467076|2249815|P3|NOT COMPLETED|Overall Study||0
930387|NCT01467076|2249816|P2|NOT COMPLETED|Overall Study||0
930388|NCT01467076|2249817|P1|NOT COMPLETED|Overall Study||1
930389|NCT01467076|2249815|P3|COMPLETED|Overall Study||2
930390|NCT01467076|2249816|P2|COMPLETED|Overall Study||2
930391|NCT01467076|2249817|P1|COMPLETED|Overall Study||2
930392|NCT01467076|2249815|P3|STARTED|Overall Study||2
930393|NCT01467076|2249816|P2|STARTED|Overall Study||2
930394|NCT01467076|2249817|P1|STARTED|Overall Study||3
930395|NCT01467037|2249827|P1|NOT COMPLETED|Overall Study||0
930396|NCT01467037|2249827|P1|COMPLETED|Overall Study||374
930397|NCT01467037|2249827|P1|STARTED|Overall Study||374
930398|NCT01466881|2249834|P1|NOT COMPLETED|Overall Study||40
930399|NCT01466881|2249834|P1|COMPLETED|Overall Study||2
930400|NCT01466881|2249834|P1|Eligible and Treated|Overall Study||37
930401|NCT01466881|2249834|P1|STARTED|Overall Study||42
930402|NCT01466790|2249851|P8|NOT COMPLETED|Overall Study||1
930403|NCT01466790|2249852|P7|NOT COMPLETED|Overall Study||1
930404|NCT01466790|2249853|P6|NOT COMPLETED|Overall Study||0
930405|NCT01466790|2249854|P5|NOT COMPLETED|Overall Study||3
930406|NCT01466790|2249855|P4|NOT COMPLETED|Overall Study||0
930407|NCT01466790|2249856|P3|NOT COMPLETED|Overall Study||0
930408|NCT01466790|2249857|P2|NOT COMPLETED|Overall Study||1
930409|NCT01466790|2249858|P1|NOT COMPLETED|Overall Study||4
930410|NCT01466790|2249851|P8|COMPLETED|Overall Study||13
930411|NCT01466790|2249852|P7|COMPLETED|Overall Study||26
930412|NCT01466790|2249853|P6|COMPLETED|Overall Study||16
930413|NCT01466790|2249854|P5|COMPLETED|Overall Study||27
930414|NCT01466790|2249855|P4|COMPLETED|Overall Study||14
930415|NCT01466790|2249856|P3|COMPLETED|Overall Study||27
930416|NCT01466790|2249857|P2|COMPLETED|Overall Study||14
930417|NCT01466790|2249858|P1|COMPLETED|Overall Study||20
930418|NCT01466790|2249851|P8|STARTED|Overall Study||14
930419|NCT01466790|2249852|P7|STARTED|Overall Study||27
930420|NCT01466790|2249853|P6|STARTED|Overall Study||16
930421|NCT01466790|2249854|P5|STARTED|Overall Study||30
930422|NCT01466790|2249855|P4|STARTED|Overall Study||14
930423|NCT01466790|2249856|P3|STARTED|Overall Study||27
930424|NCT01466790|2249857|P2|STARTED|Overall Study||15
930425|NCT01466790|2249858|P1|STARTED|Overall Study|Not including 1 participant who was randomized to this group, but never received treatment.|24
930426|NCT01466764|2249922|P2|NOT COMPLETED|Overall Study||0
930427|NCT01466764|2249923|P1|NOT COMPLETED|Overall Study||0
930428|NCT01466764|2249922|P2|COMPLETED|Overall Study||5
930429|NCT01466764|2249923|P1|COMPLETED|Overall Study||5
930430|NCT01466764|2249922|P2|STARTED|Overall Study||5
930431|NCT01466764|2249923|P1|STARTED|Overall Study||5
930432|NCT01466673|2249943|P2|NOT COMPLETED|Overall Study||6
930433|NCT01466673|2249944|P1|NOT COMPLETED|Overall Study||7
930434|NCT01466673|2249943|P2|COMPLETED|Overall Study||95
930435|NCT01466673|2249944|P1|COMPLETED|Overall Study||93
930436|NCT01466673|2249943|P2|STARTED|Overall Study||101
930437|NCT01466673|2249944|P1|STARTED|Overall Study||100
930438|NCT01466660|2249970|P2|NOT COMPLETED|Overall Study||151
930439|NCT01466660|2249971|P1|NOT COMPLETED|Overall Study||146
930440|NCT01466660|2249970|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date, 08 April 2016|8
930441|NCT01466660|2249971|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date, 08 April 2016|14
930442|NCT01466660|2249970|P2|STARTED|Overall Study||159
930443|NCT01466660|2249971|P1|STARTED|Overall Study||160
930444|NCT01466595|2249997|P2|NOT COMPLETED|Overall Study||1
930445|NCT01466595|2249998|P1|NOT COMPLETED|Overall Study||0
930446|NCT01466595|2249997|P2|COMPLETED|Overall Study||23
930447|NCT01466595|2249998|P1|COMPLETED|Overall Study||49
930448|NCT01466595|2249997|P2|STARTED|Overall Study||24
930449|NCT01466595|2249998|P1|STARTED|Overall Study||49
930450|NCT01466491|2250092|P4|NOT COMPLETED|Overall Study||0
930451|NCT01466491|2250093|P3|NOT COMPLETED|Overall Study||3
930452|NCT01466491|2250094|P2|NOT COMPLETED|Overall Study||3
930453|NCT01466491|2250095|P1|NOT COMPLETED|Overall Study||0
930454|NCT01466491|2250092|P4|COMPLETED|Overall Study||83
930455|NCT01466491|2250093|P3|COMPLETED|Overall Study||80
930456|NCT01466491|2250094|P2|COMPLETED|Overall Study||80
930457|NCT01466491|2250095|P1|COMPLETED|Overall Study||83
930458|NCT01466491|2250092|P4|STARTED|Overall Study||83
930459|NCT01466491|2250093|P3|STARTED|Overall Study||83
930460|NCT01466491|2250094|P2|STARTED|Overall Study||83
930461|NCT01466491|2250095|P1|STARTED|Overall Study||83
930480|NCT01466361|2250162|P4|NOT COMPLETED|Overall Study||0
930481|NCT01466361|2250163|P3|NOT COMPLETED|Overall Study||0
930482|NCT01466361|2250164|P2|NOT COMPLETED|Overall Study||0
930483|NCT01466361|2250165|P1|NOT COMPLETED|Overall Study||0
930484|NCT01466361|2250162|P4|COMPLETED|Overall Study||41
930485|NCT01466361|2250163|P3|COMPLETED|Overall Study||60
930486|NCT01466361|2250164|P2|COMPLETED|Overall Study||34
930487|NCT01466361|2250165|P1|COMPLETED|Overall Study||52
930488|NCT01466361|2250162|P4|STARTED|Overall Study||41
930489|NCT01466361|2250163|P3|STARTED|Overall Study||60
930490|NCT01466361|2250164|P2|STARTED|Overall Study||34
930491|NCT01466361|2250165|P1|STARTED|Overall Study||52
930492|NCT01466348|2250181|P2|NOT COMPLETED|Period II - Second Intervention||0
930493|NCT01466348|2250182|P1|NOT COMPLETED|Period II - Second Intervention||0
930494|NCT01466348|2250181|P2|COMPLETED|Period II - Second Intervention||36
930495|NCT01466348|2250182|P1|COMPLETED|Period II - Second Intervention||35
930496|NCT01466348|2250181|P2|STARTED|Period II - Second Intervention||36
930497|NCT01466348|2250182|P1|STARTED|Period II - Second Intervention||35
930498|NCT01466348|2250181|P2|NOT COMPLETED|Period I - First Intervention||1
930499|NCT01466348|2250182|P1|NOT COMPLETED|Period I - First Intervention||0
930500|NCT01466348|2250181|P2|COMPLETED|Period I - First Intervention||35
930501|NCT01466348|2250182|P1|COMPLETED|Period I - First Intervention||36
930502|NCT01466348|2250181|P2|Intent To Treat (ITT) Population|Period I - First Intervention|1 participant withdrew prior receiving the treatment|35
930503|NCT01466348|2250182|P1|Intent To Treat (ITT) Population|Period I - First Intervention||36
930504|NCT01466348|2250181|P2|STARTED|Period I - First Intervention||36
930505|NCT01466348|2250182|P1|STARTED|Period I - First Intervention||36
930506|NCT01466270|2250210|P2|NOT COMPLETED|Overall Study||6
930507|NCT01466270|2250211|P1|NOT COMPLETED|Overall Study||12
930508|NCT01466270|2250210|P2|COMPLETED|Overall Study||25
930509|NCT01466270|2250211|P1|COMPLETED|Overall Study||19
930510|NCT01466270|2250210|P2|STARTED|Overall Study||31
930511|NCT01466270|2250211|P1|STARTED|Overall Study||31
930512|NCT01466192|2250223|P1|NOT COMPLETED|Overall Study||4
930513|NCT01466192|2250223|P1|COMPLETED|Overall Study||104
930514|NCT01466192|2250223|P1|STARTED|Overall Study||108
930515|NCT01466179|2250227|P1|NOT COMPLETED|Overall Study||179
930516|NCT01466179|2250227|P1|COMPLETED|Overall Study|Completed 5 cycles of treatment; Data as of the time of the data cut-off date (10 October 2013).|10
930517|NCT01466179|2250227|P1|STARTED|Overall Study|Participants enrolled during the first 3 stages of the study|189
930518|NCT01466153|2250250|P3|NOT COMPLETED|Overall Study||25
930519|NCT01466153|2250251|P2|NOT COMPLETED|Overall Study||24
930520|NCT01466153|2250252|P1|NOT COMPLETED|Overall Study||29
930521|NCT01466153|2250250|P3|COMPLETED|Overall Study||36
930522|NCT01466153|2250251|P2|COMPLETED|Overall Study||12
930523|NCT01466153|2250252|P1|COMPLETED|Overall Study||33
930524|NCT01466153|2250250|P3|STARTED|Overall Study||61
930525|NCT01466153|2250251|P2|STARTED|Overall Study||36
930526|NCT01466153|2250252|P1|STARTED|Overall Study||62
930527|NCT01466127|2250293|P2|NOT COMPLETED|Overall Study||16
930528|NCT01466127|2250294|P1|NOT COMPLETED|Overall Study||14
930529|NCT01466127|2250293|P2|COMPLETED|Overall Study||14
930530|NCT01466127|2250294|P1|COMPLETED|Overall Study||16
930531|NCT01466127|2250293|P2|STARTED|Overall Study||30
930532|NCT01466127|2250294|P1|STARTED|Overall Study||30
930533|NCT01466075|2250300|P1|NOT COMPLETED|Overall Study||0
930534|NCT01466075|2250300|P1|COMPLETED|Overall Study||207
930535|NCT01466075|2250300|P1|STARTED|Overall Study||207
930536|NCT01466062|2250307|P1|NOT COMPLETED|Overall Study||2
930537|NCT01466062|2250307|P1|COMPLETED|Overall Study||26
930538|NCT01466062|2250307|P1|STARTED|Overall Study||28
930545|NCT01465958|2250341|P2|NOT COMPLETED|Subcutaneous (SC) Phase||1
930546|NCT01465958|2250342|P1|NOT COMPLETED|Subcutaneous (SC) Phase||0
930547|NCT01465958|2250341|P2|COMPLETED|Subcutaneous (SC) Phase||10
930548|NCT01465958|2250342|P1|COMPLETED|Subcutaneous (SC) Phase||0
930549|NCT01465958|2250341|P2|STARTED|Subcutaneous (SC) Phase|Eleven subjects completed the IV phase and entered the SC phase.|11
930550|NCT01465958|2250342|P1|STARTED|Subcutaneous (SC) Phase|After completing the intravenous (IV) phase, subjects entered the subcutaneous (SC) phase.|0
930551|NCT01465958|2250341|P2|NOT COMPLETED|Intravenous (IV) Phase||0
930552|NCT01465958|2250342|P1|NOT COMPLETED|Intravenous (IV) Phase||0
930553|NCT01465958|2250341|P2|COMPLETED|Intravenous (IV) Phase||0
930554|NCT01465958|2250342|P1|COMPLETED|Intravenous (IV) Phase||11
930555|NCT01465958|2250341|P2|STARTED|Intravenous (IV) Phase||0
930556|NCT01465958|2250342|P1|STARTED|Intravenous (IV) Phase|One subject entered the IV phase directly.|11
930557|NCT01465958|2250341|P2|NOT COMPLETED|Run-in Phase||0
930558|NCT01465958|2250342|P1|NOT COMPLETED|Run-in Phase||1
930559|NCT01465958|2250341|P2|COMPLETED|Run-in Phase||0
930560|NCT01465958|2250342|P1|COMPLETED|Run-in Phase||10
930561|NCT01465958|2250341|P2|STARTED|Run-in Phase||0
930562|NCT01465958|2250342|P1|STARTED|Run-in Phase||11
930563|NCT01465802|2250355|P5|NOT COMPLETED|Overall Study||12
930564|NCT01465802|2250356|P4|NOT COMPLETED|Overall Study||29
930565|NCT01465802|2250357|P3|NOT COMPLETED|Overall Study||0
930566|NCT01465802|2250358|P2|NOT COMPLETED|Overall Study||24
930567|NCT01465802|2250359|P1|NOT COMPLETED|Overall Study||33
930568|NCT01465802|2250355|P5|COMPLETED|Overall Study||13
930569|NCT01465802|2250356|P4|COMPLETED|Overall Study||38
930570|NCT01465802|2250357|P3|COMPLETED|Overall Study||7
930571|NCT01465802|2250358|P2|COMPLETED|Overall Study||42
930572|NCT01465802|2250359|P1|COMPLETED|Overall Study||33
930573|NCT01465802|2250355|P5|STARTED|Overall Study||25
930574|NCT01465802|2250356|P4|STARTED|Overall Study|An additional 5 participants were enrolled in Cohort II but not treated.|67
930575|NCT01465802|2250357|P3|STARTED|Overall Study||7
930576|NCT01465802|2250358|P2|STARTED|Overall Study||66
930577|NCT01465802|2250359|P1|STARTED|Overall Study||66
930578|NCT01465763|2250411|P3|NOT COMPLETED|Overall Study||4
930579|NCT01465763|2250412|P2|NOT COMPLETED|Overall Study||1
930580|NCT01465763|2250413|P1|NOT COMPLETED|Overall Study||31
930581|NCT01465763|2250411|P3|COMPLETED|Overall Study||118
930582|NCT01465763|2250412|P2|COMPLETED|Overall Study||15
930583|NCT01465763|2250413|P1|COMPLETED|Overall Study||445
930584|NCT01465763|2250411|P3|STARTED|Overall Study||122
930585|NCT01465763|2250412|P2|STARTED|Overall Study||16
930586|NCT01465763|2250413|P1|STARTED|Overall Study||476
930587|NCT01465412|2250442|P4|NOT COMPLETED|Overall Study||0
930588|NCT01465412|2250443|P3|NOT COMPLETED|Overall Study||0
930589|NCT01465412|2250444|P2|NOT COMPLETED|Overall Study||0
930590|NCT01465412|2250445|P1|NOT COMPLETED|Overall Study||0
930591|NCT01465412|2250442|P4|COMPLETED|Overall Study||9
930592|NCT01465412|2250443|P3|COMPLETED|Overall Study||9
930593|NCT01465412|2250444|P2|COMPLETED|Overall Study||12
930594|NCT01465412|2250445|P1|COMPLETED|Overall Study||12
930595|NCT01465412|2250442|P4|STARTED|Overall Study||9
930596|NCT01465412|2250443|P3|STARTED|Overall Study||9
930597|NCT01465412|2250444|P2|STARTED|Overall Study||12
930598|NCT01465412|2250445|P1|STARTED|Overall Study||12
930599|NCT01465386|2250483|P1|NOT COMPLETED|Overall Study||4
930600|NCT01465386|2250483|P1|COMPLETED|Overall Study||2
930601|NCT01465386|2250483|P1|STARTED|Overall Study||6
930602|NCT01465347|2250487|P2|NOT COMPLETED|Overall Study||3
930603|NCT01465347|2250488|P1|NOT COMPLETED|Overall Study||1
930604|NCT01465347|2250487|P2|COMPLETED|Overall Study||53
930605|NCT01465347|2250488|P1|COMPLETED|Overall Study||2
930606|NCT01465347|2250487|P2|STARTED|Overall Study||56
930607|NCT01465347|2250488|P1|STARTED|Overall Study||3
930608|NCT01465230|2250498|P1|NOT COMPLETED|Overall Study||2
930609|NCT01465230|2250498|P1|COMPLETED|Overall Study||0
930610|NCT01465230|2250498|P1|STARTED|Overall Study||2
930611|NCT01465178|2250504|P2|NOT COMPLETED|Overall Study||0
930612|NCT01465178|2250505|P1|NOT COMPLETED|Overall Study||1
930613|NCT01465178|2250504|P2|COMPLETED|Overall Study||31
930614|NCT01465178|2250505|P1|COMPLETED|Overall Study||30
930615|NCT01465178|2250504|P2|STARTED|Overall Study||31
930616|NCT01465178|2250505|P1|STARTED|Overall Study||31
930617|NCT01465048|2250516|P3|NOT COMPLETED|Overall Study||0
930618|NCT01465048|2250517|P2|NOT COMPLETED|Overall Study||0
930619|NCT01465048|2250518|P1|NOT COMPLETED|Overall Study||0
930620|NCT01465048|2250516|P3|COMPLETED|Overall Study||6
930621|NCT01465048|2250517|P2|COMPLETED|Overall Study||6
930622|NCT01465048|2250518|P1|COMPLETED|Overall Study||6
930623|NCT01465048|2250516|P3|STARTED|Overall Study||6
930624|NCT01465048|2250517|P2|STARTED|Overall Study||6
930625|NCT01465048|2250518|P1|STARTED|Overall Study||6
930626|NCT01465022|2250529|P3|NOT COMPLETED|Overall Study||70
930627|NCT01465022|2250530|P2|NOT COMPLETED|Overall Study||23
930628|NCT01465022|2250531|P1|NOT COMPLETED|Overall Study||23
930629|NCT01465022|2250529|P3|COMPLETED|Overall Study||0
930630|NCT01465022|2250530|P2|COMPLETED|Overall Study||40
930631|NCT01465022|2250531|P1|COMPLETED|Overall Study||41
930632|NCT01465022|2250529|P3|STARTED|Overall Study||70
930633|NCT01465022|2250530|P2|STARTED|Overall Study||63
930634|NCT01465022|2250531|P1|STARTED|Overall Study||64
930635|NCT01464996|2250545|P1|NOT COMPLETED|Overall Study||0
930636|NCT01464996|2250545|P1|COMPLETED|Overall Study||24
930637|NCT01464996|2250545|P1|OptiBond FL|Overall Study||24
930638|NCT01464996|2250545|P1|OptiBond XTR|Overall Study||23
930639|NCT01464996|2250545|P1|STARTED|Overall Study||24
930640|NCT01464931|2250565|P2|NOT COMPLETED|Overall Study||0
930641|NCT01464931|2250566|P1|NOT COMPLETED|Overall Study||1
930642|NCT01464931|2250565|P2|COMPLETED|Overall Study||16
930643|NCT01464931|2250566|P1|COMPLETED|Overall Study||15
930644|NCT01464931|2250565|P2|STARTED|Overall Study||16
930645|NCT01464931|2250566|P1|STARTED|Overall Study||16
930646|NCT01464879|2250603|P1|NOT COMPLETED|Overall Study||2
930647|NCT01464879|2250603|P1|COMPLETED|Overall Study||18
930648|NCT01464879|2250603|P1|Applicator Application (3.75 mL)|Overall Study||18
930649|NCT01464879|2250603|P1|Applicator Application (2.50 mL)|Overall Study|One subject discontinued due to physician's decision.|18
930650|NCT01464879|2250603|P1|Applicator Application (1.25 mL)|Overall Study|One subject discontinued due to non-compliance.|19
930651|NCT01464879|2250603|P1|Washout Period|Overall Study||20
930652|NCT01464879|2250603|P1|Hand Application (2.50 mL)|Overall Study||20
930653|NCT01464879|2250603|P1|STARTED|Overall Study||20
930654|NCT01464840|2250640|P3|NOT COMPLETED|Overall Study||0
930655|NCT01464840|2250641|P2|NOT COMPLETED|Overall Study||0
930656|NCT01464840|2250642|P1|NOT COMPLETED|Overall Study||0
930657|NCT01464840|2250640|P3|COMPLETED|Overall Study||10
930658|NCT01464840|2250641|P2|COMPLETED|Overall Study||10
930659|NCT01464840|2250642|P1|COMPLETED|Overall Study||10
930660|NCT01464840|2250640|P3|STARTED|Overall Study||10
930661|NCT01464840|2250641|P2|STARTED|Overall Study||10
930662|NCT01464840|2250642|P1|STARTED|Overall Study||10
930663|NCT01464827|2250664|P14|NOT COMPLETED|Overall Study||3
930664|NCT01464827|2250665|P13|NOT COMPLETED|Overall Study||2
930665|NCT01464827|2250666|P12|NOT COMPLETED|Overall Study||2
930666|NCT01464827|2250667|P11|NOT COMPLETED|Overall Study||2
930667|NCT01464827|2250668|P10|NOT COMPLETED|Overall Study||3
930668|NCT01464827|2250669|P9|NOT COMPLETED|Overall Study||3
930669|NCT01464827|2250670|P8|NOT COMPLETED|Overall Study||3
930670|NCT01464827|2250671|P7|NOT COMPLETED|Overall Study||4
930671|NCT01464827|2250672|P6|NOT COMPLETED|Overall Study||1
930672|NCT01464827|2250673|P5|NOT COMPLETED|Overall Study||8
930673|NCT01464827|2250674|P4|NOT COMPLETED|Overall Study||4
930674|NCT01464827|2250675|P3|NOT COMPLETED|Overall Study||0
930675|NCT01464827|2250676|P2|NOT COMPLETED|Overall Study||7
930676|NCT01464827|2250677|P1|NOT COMPLETED|Overall Study||3
930677|NCT01464827|2250664|P14|COMPLETED|Overall Study||19
930678|NCT01464827|2250665|P13|COMPLETED|Overall Study||21
930679|NCT01464827|2250666|P12|COMPLETED|Overall Study||21
930680|NCT01464827|2250667|P11|COMPLETED|Overall Study||21
930681|NCT01464827|2250668|P10|COMPLETED|Overall Study||44
930682|NCT01464827|2250669|P9|COMPLETED|Overall Study||37
930683|NCT01464827|2250670|P8|COMPLETED|Overall Study||37
930684|NCT01464827|2250671|P7|COMPLETED|Overall Study||37
930685|NCT01464827|2250672|P6|COMPLETED|Overall Study||38
930686|NCT01464827|2250673|P5|COMPLETED|Overall Study||72
930687|NCT01464827|2250674|P4|COMPLETED|Overall Study||36
930688|NCT01464827|2250675|P3|COMPLETED|Overall Study||39
930689|NCT01464827|2250676|P2|COMPLETED|Overall Study||36
930690|NCT01464827|2250677|P1|COMPLETED|Overall Study||77
930691|NCT01464827|2250664|P14|Treated|Overall Study||20
930692|NCT01464827|2250665|P13|Treated|Overall Study||23
930693|NCT01464827|2250666|P12|Treated|Overall Study||22
930694|NCT01464827|2250667|P11|Treated|Overall Study||23
930695|NCT01464827|2250668|P10|Treated|Overall Study||45
930696|NCT01464827|2250669|P9|Treated|Overall Study||40
930697|NCT01464827|2250670|P8|Treated|Overall Study||40
930698|NCT01464827|2250671|P7|Treated|Overall Study||40
930699|NCT01464827|2250672|P6|Treated|Overall Study||39
930700|NCT01464827|2250673|P5|Treated|Overall Study||79
930701|NCT01464827|2250674|P4|Treated|Overall Study||40
930702|NCT01464827|2250675|P3|Treated|Overall Study||39
930703|NCT01464827|2250676|P2|Treated|Overall Study||41
930704|NCT01464827|2250677|P1|Treated|Overall Study||80
930705|NCT01464827|2250664|P14|STARTED|Overall Study||22
930706|NCT01464827|2250665|P13|STARTED|Overall Study||23
930707|NCT01464827|2250666|P12|STARTED|Overall Study||23
930708|NCT01464827|2250667|P11|STARTED|Overall Study||23
930709|NCT01464827|2250668|P10|STARTED|Overall Study||47
930710|NCT01464827|2250669|P9|STARTED|Overall Study||40
930711|NCT01464827|2250670|P8|STARTED|Overall Study||40
930712|NCT01464827|2250671|P7|STARTED|Overall Study||41
930713|NCT01464827|2250672|P6|STARTED|Overall Study||39
930714|NCT01464827|2250673|P5|STARTED|Overall Study||80
930715|NCT01464827|2250674|P4|STARTED|Overall Study||40
930716|NCT01464827|2250675|P3|STARTED|Overall Study||39
930717|NCT01464827|2250676|P2|STARTED|Overall Study||43
930718|NCT01464827|2250677|P1|STARTED|Overall Study||80
930719|NCT01464788|2250724|P3|NOT COMPLETED|Overall Study||0
930720|NCT01464788|2250725|P2|NOT COMPLETED|Overall Study||2
930721|NCT01464788|2250726|P1|NOT COMPLETED|Overall Study||0
930722|NCT01464788|2250724|P3|COMPLETED|Overall Study||29
930723|NCT01464788|2250725|P2|COMPLETED|Overall Study||29
930724|NCT01464788|2250726|P1|COMPLETED|Overall Study||30
930725|NCT01464788|2250724|P3|STARTED|Overall Study||29
930726|NCT01464788|2250725|P2|STARTED|Overall Study||31
930727|NCT01464788|2250726|P1|STARTED|Overall Study||30
930728|NCT01464619|2250739|P2|NOT COMPLETED|Overall Study||4
930729|NCT01464619|2250740|P1|NOT COMPLETED|Overall Study||3
930730|NCT01464619|2250739|P2|COMPLETED|Overall Study||25
930731|NCT01464619|2250740|P1|COMPLETED|Overall Study||29
930732|NCT01464619|2250739|P2|STARTED|Overall Study||29
930733|NCT01464619|2250740|P1|STARTED|Overall Study||32
930734|NCT01464424|2250760|P2|NOT COMPLETED|Period 2, Second 6 Weeks||0
930735|NCT01464424|2250761|P1|NOT COMPLETED|Period 2, Second 6 Weeks||0
930736|NCT01464424|2250760|P2|COMPLETED|Period 2, Second 6 Weeks||41
930737|NCT01464424|2250761|P1|COMPLETED|Period 2, Second 6 Weeks||42
930738|NCT01464424|2250760|P2|STARTED|Period 2, Second 6 Weeks||41
930739|NCT01464424|2250761|P1|STARTED|Period 2, Second 6 Weeks||42
930740|NCT01464424|2250760|P2|NOT COMPLETED|Period 1, First 6 Weeks||1
930741|NCT01464424|2250761|P1|NOT COMPLETED|Period 1, First 6 Weeks||0
930742|NCT01464424|2250760|P2|COMPLETED|Period 1, First 6 Weeks||41
930743|NCT01464424|2250761|P1|COMPLETED|Period 1, First 6 Weeks||42
930744|NCT01464424|2250760|P2|STARTED|Period 1, First 6 Weeks||42
930745|NCT01464424|2250761|P1|STARTED|Period 1, First 6 Weeks||42
930746|NCT01464359|2250769|P1|NOT COMPLETED|Overall Study||0
930747|NCT01464359|2250769|P1|COMPLETED|Overall Study||3
930748|NCT01464359|2250769|P1|STARTED|Overall Study||3
930749|NCT01464307|2250783|P2|NOT COMPLETED|Open-Label Extension Period||0
930750|NCT01464307|2250784|P1|NOT COMPLETED|Open-Label Extension Period||51
930751|NCT01464307|2250783|P2|COMPLETED|Open-Label Extension Period||0
930752|NCT01464307|2250784|P1|COMPLETED|Open-Label Extension Period||218
930753|NCT01464307|2250783|P2|Treated|Open-Label Extension Period||0
930754|NCT01464307|2250784|P1|Treated|Open-Label Extension Period||269
930755|NCT01464307|2250783|P2|STARTED|Open-Label Extension Period||0
930756|NCT01464307|2250784|P1|STARTED|Open-Label Extension Period||269
930757|NCT01464307|2250783|P2|NOT COMPLETED|Main Period||5
930758|NCT01464307|2250784|P1|NOT COMPLETED|Main Period||15
930759|NCT01464307|2250783|P2|COMPLETED|Main Period||140
930760|NCT01464307|2250784|P1|COMPLETED|Main Period||129
930761|NCT01464307|2250783|P2|Treated|Main Period||145
930762|NCT01464307|2250784|P1|Treated|Main Period||144
930763|NCT01464307|2250783|P2|STARTED|Main Period||145
930764|NCT01464307|2250784|P1|STARTED|Main Period||144
930765|NCT01464255|2250799|P2|NOT COMPLETED|Overall Study||1
930766|NCT01464255|2250800|P1|NOT COMPLETED|Overall Study||0
930767|NCT01464255|2250799|P2|COMPLETED|Overall Study||24
930768|NCT01464255|2250800|P1|COMPLETED|Overall Study||25
930769|NCT01464255|2250799|P2|STARTED|Overall Study||25
930770|NCT01464255|2250800|P1|STARTED|Overall Study||25
930771|NCT01464229|2250825|P2|NOT COMPLETED|Overall Study||2
930772|NCT01464229|2250826|P1|NOT COMPLETED|Overall Study||5
930773|NCT01464229|2250825|P2|COMPLETED|Overall Study||8
930774|NCT01464229|2250826|P1|COMPLETED|Overall Study||5
930775|NCT01464229|2250825|P2|STARTED|Overall Study||10
930776|NCT01464229|2250826|P1|STARTED|Overall Study||10
930777|NCT01464190|2250834|P2|NOT COMPLETED|Overall Study||41
930778|NCT01464190|2250835|P1|NOT COMPLETED|Overall Study||69
930779|NCT01464190|2250834|P2|COMPLETED|Overall Study||227
930780|NCT01464190|2250835|P1|COMPLETED|Overall Study||322
930781|NCT01464190|2250834|P2|STARTED|Overall Study||268
930782|NCT01464190|2250835|P1|STARTED|Overall Study||391
930783|NCT01464021|2250845|P1|NOT COMPLETED|Overall Study||26
930784|NCT01464021|2250845|P1|COMPLETED|Overall Study||0
930785|NCT01464021|2250845|P1|STARTED|Overall Study||26
930786|NCT01463982|2250861|P4|NOT COMPLETED|Overall Study||0
930787|NCT01463982|2250862|P3|NOT COMPLETED|Overall Study||2
930788|NCT01463982|2250863|P2|NOT COMPLETED|Overall Study||1
930789|NCT01463982|2250864|P1|NOT COMPLETED|Overall Study||0
930790|NCT01463982|2250861|P4|COMPLETED|Overall Study||6
930791|NCT01463982|2250862|P3|COMPLETED|Overall Study||2
930792|NCT01463982|2250863|P2|COMPLETED|Overall Study||7
930793|NCT01463982|2250864|P1|COMPLETED|Overall Study||3
930794|NCT01463982|2250861|P4|STARTED|Overall Study||6
930795|NCT01463982|2250862|P3|STARTED|Overall Study||4
930796|NCT01463982|2250863|P2|STARTED|Overall Study||8
930797|NCT01463982|2250864|P1|STARTED|Overall Study||3
930798|NCT01463878|2250880|P2|NOT COMPLETED|Overall Study||2
930799|NCT01463878|2250881|P1|NOT COMPLETED|Overall Study||2
930800|NCT01463878|2250880|P2|COMPLETED|Overall Study||7
930801|NCT01463878|2250881|P1|COMPLETED|Overall Study||7
930802|NCT01463878|2250880|P2|STARTED|Overall Study||9
930803|NCT01463878|2250881|P1|STARTED|Overall Study||9
930804|NCT01463696|2250895|P8|NOT COMPLETED|Overall Study||4
930805|NCT01463696|2250896|P7|NOT COMPLETED|Overall Study||10
930806|NCT01463696|2250897|P6|NOT COMPLETED|Overall Study||3
930807|NCT01463696|2250898|P5|NOT COMPLETED|Overall Study||1
930808|NCT01463696|2250899|P4|NOT COMPLETED|Overall Study||4
930809|NCT01463696|2250900|P3|NOT COMPLETED|Overall Study||1
930810|NCT01463696|2250901|P2|NOT COMPLETED|Overall Study||2
930811|NCT01463696|2250902|P1|NOT COMPLETED|Overall Study||0
930812|NCT01463696|2250895|P8|COMPLETED|Overall Study||2
930813|NCT01463696|2250896|P7|COMPLETED|Overall Study||6
930814|NCT01463696|2250897|P6|COMPLETED|Overall Study||3
930815|NCT01463696|2250898|P5|COMPLETED|Overall Study||2
930816|NCT01463696|2250899|P4|COMPLETED|Overall Study||3
930817|NCT01463696|2250900|P3|COMPLETED|Overall Study||2
930818|NCT01463696|2250901|P2|COMPLETED|Overall Study||4
930819|NCT01463696|2250902|P1|COMPLETED|Overall Study||1
930820|NCT01463696|2250895|P8|Treated|Overall Study||6
930821|NCT01463696|2250896|P7|Treated|Overall Study||15
930822|NCT01463696|2250897|P6|Treated|Overall Study||6
930823|NCT01463696|2250898|P5|Treated|Overall Study||3
930824|NCT01463696|2250899|P4|Treated|Overall Study||7
930825|NCT01463696|2250900|P3|Treated|Overall Study||3
930826|NCT01463696|2250901|P2|Treated|Overall Study||6
930827|NCT01463696|2250902|P1|Treated|Overall Study||1
930828|NCT01463696|2250895|P8|STARTED|Overall Study||6
930829|NCT01463696|2250896|P7|STARTED|Overall Study||16
930830|NCT01463696|2250897|P6|STARTED|Overall Study||6
930831|NCT01463696|2250898|P5|STARTED|Overall Study||3
930832|NCT01463696|2250899|P4|STARTED|Overall Study||7
930833|NCT01463696|2250900|P3|STARTED|Overall Study||3
930834|NCT01463696|2250901|P2|STARTED|Overall Study||6
930835|NCT01463696|2250902|P1|STARTED|Overall Study||1
930836|NCT01463683|2250955|P3|NOT COMPLETED|Overall Study||11
930837|NCT01463683|2250956|P2|NOT COMPLETED|Overall Study||31
930838|NCT01463683|2250957|P1|NOT COMPLETED|Overall Study||19
930839|NCT01463683|2250955|P3|COMPLETED|Overall Study||93
930840|NCT01463683|2250956|P2|COMPLETED|Overall Study||278
930841|NCT01463683|2250957|P1|COMPLETED|Overall Study||290
930842|NCT01463683|2250955|P3|Received Vaccination 3 (Month 6)|Overall Study||93
930843|NCT01463683|2250956|P2|Received Vaccination 3 (Month 6)|Overall Study||281
930844|NCT01463683|2250957|P1|Received Vaccination 3 (Month 6)|Overall Study||290
930845|NCT01463683|2250955|P3|Received Vaccination 2 (Month 1)|Overall Study||103
930846|NCT01463683|2250956|P2|Received Vaccination 2 (Month 1)|Overall Study||300
930847|NCT01463683|2250957|P1|Received Vaccination 2 (Month 1)|Overall Study||302
930848|NCT01463683|2250955|P3|Received Vaccination 1 (Day 1)|Overall Study||104
930849|NCT01463683|2250956|P2|Received Vaccination 1 (Day 1)|Overall Study||308
930850|NCT01463683|2250957|P1|Received Vaccination 1 (Day 1)|Overall Study||309
930851|NCT01463683|2250955|P3|STARTED|Overall Study||104
930852|NCT01463683|2250956|P2|STARTED|Overall Study||309
930853|NCT01463683|2250957|P1|STARTED|Overall Study||309
930860|NCT01463384|2250979|P1|NOT COMPLETED|Overall Study||0
930861|NCT01463384|2250979|P1|COMPLETED|Overall Study||13
930862|NCT01463384|2250979|P1|STARTED|Overall Study||13
930863|NCT01463293|2250994|P3|NOT COMPLETED|Overall Study||12
930864|NCT01463293|2250995|P2|NOT COMPLETED|Overall Study||16
930865|NCT01463293|2250996|P1|NOT COMPLETED|Overall Study||6
930866|NCT01463293|2250994|P3|COMPLETED|Overall Study||59
930867|NCT01463293|2250995|P2|COMPLETED|Overall Study||63
930868|NCT01463293|2250996|P1|COMPLETED|Overall Study||68
930869|NCT01463293|2250994|P3|STARTED|Overall Study||71
930870|NCT01463293|2250995|P2|STARTED|Overall Study||79
930871|NCT01463293|2250996|P1|STARTED|Overall Study||74
930872|NCT01463111|2251004|P1|NOT COMPLETED|Overall Study||9
930873|NCT01463111|2251004|P1|COMPLETED|Overall Study||17
930874|NCT01463111|2251004|P1|STARTED|Overall Study||26
930875|NCT01463033|2251014|P2|NOT COMPLETED|Overall Study||6
930876|NCT01463033|2251015|P1|NOT COMPLETED|Overall Study||7
930877|NCT01463033|2251014|P2|COMPLETED|Overall Study|2 deaths, 4 lost to follow up|54
930878|NCT01463033|2251015|P1|COMPLETED|Overall Study|3 deaths, 4 lost to follow up|59
930879|NCT01463033|2251014|P2|STARTED|Overall Study||60
930880|NCT01463033|2251015|P1|STARTED|Overall Study||66
930881|NCT01463007|2251022|P1|NOT COMPLETED|Overall Study||1
930882|NCT01463007|2251022|P1|COMPLETED|Overall Study||40
930883|NCT01463007|2251022|P1|STARTED|Overall Study||41
930884|NCT01462942|2251033|P5|NOT COMPLETED|Overall Study||45
930885|NCT01462942|2251034|P4|NOT COMPLETED|Overall Study||50
930886|NCT01462942|2251035|P3|NOT COMPLETED|Overall Study||40
930887|NCT01462942|2251036|P2|NOT COMPLETED|Overall Study||34
930888|NCT01462942|2251037|P1|NOT COMPLETED|Overall Study||34
930889|NCT01462942|2251033|P5|COMPLETED|Overall Study||339
930890|NCT01462942|2251034|P4|COMPLETED|Overall Study||335
930891|NCT01462942|2251035|P3|COMPLETED|Overall Study||341
930892|NCT01462942|2251036|P2|COMPLETED|Overall Study||351
930893|NCT01462942|2251037|P1|COMPLETED|Overall Study||160
930894|NCT01462942|2251033|P5|STARTED|Overall Study||384
930895|NCT01462942|2251034|P4|STARTED|Overall Study||385
930896|NCT01462942|2251035|P3|STARTED|Overall Study||381
930897|NCT01462942|2251036|P2|STARTED|Overall Study||385
930898|NCT01462942|2251037|P1|STARTED|Overall Study||194
930899|NCT01462929|2251067|P3|NOT COMPLETED|Overall Study||5
930900|NCT01462929|2251068|P2|NOT COMPLETED|Overall Study||4
930901|NCT01462929|2251069|P1|NOT COMPLETED|Overall Study||5
930902|NCT01462929|2251067|P3|COMPLETED|Overall Study||80
930903|NCT01462929|2251068|P2|COMPLETED|Overall Study||154
930904|NCT01462929|2251069|P1|COMPLETED|Overall Study||166
930905|NCT01462929|2251067|P3|STARTED|Overall Study||85
930906|NCT01462929|2251068|P2|STARTED|Overall Study||158
930907|NCT01462929|2251069|P1|STARTED|Overall Study||171
930908|NCT01462877|2251080|P1|NOT COMPLETED|Overall Study||71
930909|NCT01462877|2251080|P1|COMPLETED|Overall Study||435
930910|NCT01462877|2251080|P1|Per-protocol Set|Overall Study||364
930911|NCT01462877|2251080|P1|Full Analysis Set|Overall Study||468
930912|NCT01462877|2251080|P1|Safety Set|Overall Study||492
930913|NCT01462877|2251080|P1|STARTED|Overall Study||506
930914|NCT01462812|2251096|P2|NOT COMPLETED|Overall Study||1
930915|NCT01462812|2251097|P1|NOT COMPLETED|Overall Study||0
930916|NCT01462812|2251096|P2|COMPLETED|Overall Study||111
930917|NCT01462812|2251097|P1|COMPLETED|Overall Study||111
930918|NCT01462812|2251096|P2|STARTED|Overall Study||112
930919|NCT01462812|2251097|P1|STARTED|Overall Study||111
930920|NCT01462773|2251103|P1|NOT COMPLETED|Overall Study||0
930921|NCT01462773|2251103|P1|COMPLETED|Overall Study||16
930922|NCT01462773|2251103|P1|STARTED|Overall Study||16
930923|NCT01462695|2251110|P2|NOT COMPLETED|Overall Study||13
930924|NCT01462695|2251111|P1|NOT COMPLETED|Overall Study||17
930925|NCT01462695|2251110|P2|COMPLETED|Overall Study||0
930926|NCT01462695|2251111|P1|COMPLETED|Overall Study||0
930927|NCT01462695|2251110|P2|STARTED|Overall Study||13
930928|NCT01462695|2251111|P1|STARTED|Overall Study||17
930929|NCT01462435|2251121|P4|NOT COMPLETED|Overall Study||5
930930|NCT01462435|2251122|P3|NOT COMPLETED|Overall Study||1
930931|NCT01462435|2251123|P2|NOT COMPLETED|Overall Study||0
930932|NCT01462435|2251124|P1|NOT COMPLETED|Overall Study||1
930933|NCT01462435|2251121|P4|COMPLETED|Overall Study||101
930934|NCT01462435|2251122|P3|COMPLETED|Overall Study||106
930935|NCT01462435|2251123|P2|COMPLETED|Overall Study||109
930936|NCT01462435|2251124|P1|COMPLETED|Overall Study||105
930937|NCT01462435|2251121|P4|STARTED|Overall Study||106
930938|NCT01462435|2251122|P3|STARTED|Overall Study||107
930939|NCT01462435|2251123|P2|STARTED|Overall Study||109
930940|NCT01462435|2251124|P1|STARTED|Overall Study||106
930941|NCT01462370|2251162|P2|NOT COMPLETED|Overall Study||5
930942|NCT01462370|2251163|P1|NOT COMPLETED|Overall Study||1
930943|NCT01462370|2251162|P2|COMPLETED|Overall Study||65
930944|NCT01462370|2251163|P1|COMPLETED|Overall Study||68
930945|NCT01462370|2251162|P2|STARTED|Overall Study||70
930946|NCT01462370|2251163|P1|STARTED|Overall Study||69
930947|NCT01462357|2251198|P3|NOT COMPLETED|Month 36||0
930948|NCT01462357|2251199|P2|NOT COMPLETED|Month 36||0
930949|NCT01462357|2251200|P1|NOT COMPLETED|Month 36||0
930950|NCT01462357|2251198|P3|COMPLETED|Month 36||346
930951|NCT01462357|2251199|P2|COMPLETED|Month 36||339
930952|NCT01462357|2251200|P1|COMPLETED|Month 36||351
930953|NCT01462357|2251198|P3|STARTED|Month 36||346
930954|NCT01462357|2251199|P2|STARTED|Month 36||339
930955|NCT01462357|2251200|P1|STARTED|Month 36||351
930956|NCT01462357|2251198|P3|NOT COMPLETED|Month 24||9
930957|NCT01462357|2251199|P2|NOT COMPLETED|Month 24||14
930958|NCT01462357|2251200|P1|NOT COMPLETED|Month 24||4
930959|NCT01462357|2251198|P3|COMPLETED|Month 24||349
930960|NCT01462357|2251199|P2|COMPLETED|Month 24||344
930961|NCT01462357|2251200|P1|COMPLETED|Month 24||355
930962|NCT01462357|2251198|P3|STARTED|Month 24||358
930963|NCT01462357|2251199|P2|STARTED|Month 24||358
930964|NCT01462357|2251200|P1|STARTED|Month 24||359
930965|NCT01462357|2251198|P3|NOT COMPLETED|Month 18||9
930966|NCT01462357|2251199|P2|NOT COMPLETED|Month 18||11
930967|NCT01462357|2251200|P1|NOT COMPLETED|Month 18||3
930968|NCT01462357|2251198|P3|COMPLETED|Month 18||349
930969|NCT01462357|2251199|P2|COMPLETED|Month 18||347
930970|NCT01462357|2251200|P1|COMPLETED|Month 18||356
930971|NCT01462357|2251198|P3|STARTED|Month 18||358
930972|NCT01462357|2251199|P2|STARTED|Month 18||358
930973|NCT01462357|2251200|P1|STARTED|Month 18||359
930974|NCT01462357|2251198|P3|NOT COMPLETED|Month 12||8
930975|NCT01462357|2251199|P2|NOT COMPLETED|Month 12||10
930976|NCT01462357|2251200|P1|NOT COMPLETED|Month 12||3
930977|NCT01462357|2251198|P3|COMPLETED|Month 12||350
930978|NCT01462357|2251199|P2|COMPLETED|Month 12||348
930979|NCT01462357|2251200|P1|COMPLETED|Month 12||356
930980|NCT01462357|2251198|P3|STARTED|Month 12||358
930981|NCT01462357|2251199|P2|STARTED|Month 12||358
930982|NCT01462357|2251200|P1|STARTED|Month 12||359
930983|NCT01462357|2251198|P3|NOT COMPLETED|Month 7||6
930984|NCT01462357|2251199|P2|NOT COMPLETED|Month 7||5
930985|NCT01462357|2251200|P1|NOT COMPLETED|Month 7||1
930986|NCT01462357|2251198|P3|COMPLETED|Month 7||352
930987|NCT01462357|2251199|P2|COMPLETED|Month 7||353
930988|NCT01462357|2251200|P1|COMPLETED|Month 7||358
930989|NCT01462357|2251198|P3|STARTED|Month 7||358
930990|NCT01462357|2251199|P2|STARTED|Month 7||358
930991|NCT01462357|2251200|P1|STARTED|Month 7||359
930992|NCT01462344|2251273|P2|NOT COMPLETED|Overall Study||350
930993|NCT01462344|2251274|P1|NOT COMPLETED|Overall Study||383
930994|NCT01462344|2251273|P2|COMPLETED|Overall Study||2751
930995|NCT01462344|2251274|P1|COMPLETED|Overall Study||2724
930996|NCT01462344|2251273|P2|STARTED|Overall Study||3101
930997|NCT01462344|2251274|P1|STARTED|Overall Study||3107
930998|NCT01462318|2251296|P3|NOT COMPLETED|Extension Phase||45
930999|NCT01462318|2251297|P2|NOT COMPLETED|Extension Phase||0
931000|NCT01462318|2251298|P1|NOT COMPLETED|Extension Phase||0
931001|NCT01462318|2251296|P3|COMPLETED|Extension Phase||70
931002|NCT01462318|2251297|P2|COMPLETED|Extension Phase||0
931003|NCT01462318|2251298|P1|COMPLETED|Extension Phase||0
931004|NCT01462318|2251296|P3|STARTED|Extension Phase|10 participants from the Main Study did not enter the Extension Phase.|115
931005|NCT01462318|2251297|P2|STARTED|Extension Phase|20 participants from the TP-DI Study entered the Extension Phase|0
931006|NCT01462318|2251298|P1|STARTED|Extension Phase|95 participants from the Main Study entered the Extension Phase|0
931007|NCT01462318|2251296|P3|NOT COMPLETED|Main Study / TP-DI Study||0
931008|NCT01462318|2251297|P2|NOT COMPLETED|Main Study / TP-DI Study||0
931009|NCT01462318|2251298|P1|NOT COMPLETED|Main Study / TP-DI Study||8
931010|NCT01462318|2251296|P3|COMPLETED|Main Study / TP-DI Study||0
931011|NCT01462318|2251297|P2|COMPLETED|Main Study / TP-DI Study||20
931012|NCT01462318|2251298|P1|COMPLETED|Main Study / TP-DI Study||105
931013|NCT01462318|2251296|P3|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
931014|NCT01462318|2251297|P2|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
931015|NCT01462318|2251298|P1|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||26
931016|NCT01462318|2251296|P3|STARTED|Main Study / TP-DI Study||0
931017|NCT01462318|2251297|P2|STARTED|Main Study / TP-DI Study||20
931018|NCT01462318|2251298|P1|STARTED|Main Study / TP-DI Study||113
931019|NCT01462279|2251315|P1|NOT COMPLETED|Overall Study||3
931020|NCT01462279|2251315|P1|COMPLETED|Overall Study||17
931021|NCT01462279|2251315|P1|STARTED|Overall Study||20
931022|NCT01462266|2251321|P2|NOT COMPLETED|Overall Study||27
931023|NCT01462266|2251322|P1|NOT COMPLETED|Overall Study||35
931024|NCT01462266|2251321|P2|COMPLETED|Overall Study||303
931025|NCT01462266|2251322|P1|COMPLETED|Overall Study||295
931026|NCT01462266|2251321|P2|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
931027|NCT01462266|2251322|P1|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
931028|NCT01462266|2251321|P2|STARTED|Overall Study||330
931029|NCT01462266|2251322|P1|STARTED|Overall Study||330
931030|NCT01462227|2251338|P4|NOT COMPLETED|Second Assignment||0
931031|NCT01462227|2251339|P3|NOT COMPLETED|Second Assignment||1
931032|NCT01462227|2251340|P2|NOT COMPLETED|Second Assignment||1
931033|NCT01462227|2251341|P1|NOT COMPLETED|Second Assignment||1
931034|NCT01462227|2251338|P4|COMPLETED|Second Assignment||5
931035|NCT01462227|2251339|P3|COMPLETED|Second Assignment||5
931036|NCT01462227|2251340|P2|COMPLETED|Second Assignment||1
931037|NCT01462227|2251341|P1|COMPLETED|Second Assignment||3
931038|NCT01462227|2251338|P4|STARTED|Second Assignment||5
931039|NCT01462227|2251339|P3|STARTED|Second Assignment||6
931040|NCT01462227|2251340|P2|STARTED|Second Assignment||2
931041|NCT01462227|2251341|P1|STARTED|Second Assignment||4
931042|NCT01462227|2251338|P4|NOT COMPLETED|First Assignment||0
931043|NCT01462227|2251339|P3|NOT COMPLETED|First Assignment||0
931044|NCT01462227|2251340|P2|NOT COMPLETED|First Assignment||0
931045|NCT01462227|2251341|P1|NOT COMPLETED|First Assignment||0
931046|NCT01462227|2251338|P4|COMPLETED|First Assignment||5
931047|NCT01462227|2251339|P3|COMPLETED|First Assignment||6
931048|NCT01462227|2251340|P2|COMPLETED|First Assignment||2
931049|NCT01462227|2251341|P1|COMPLETED|First Assignment||4
931050|NCT01462227|2251338|P4|STARTED|First Assignment||5
931051|NCT01462227|2251339|P3|STARTED|First Assignment||6
931052|NCT01462227|2251340|P2|STARTED|First Assignment||2
931053|NCT01462227|2251341|P1|STARTED|First Assignment||4
931054|NCT01462162|2251359|P1|NOT COMPLETED|Overall Study||12
931055|NCT01462162|2251359|P1|COMPLETED|Overall Study||108
931056|NCT01462162|2251359|P1|STARTED|Overall Study||120
931057|NCT01462084|2251384|P2|NOT COMPLETED|Overall Study||1
931058|NCT01462084|2251385|P1|NOT COMPLETED|Overall Study||2
931059|NCT01462084|2251384|P2|COMPLETED|Overall Study||9
931060|NCT01462084|2251385|P1|COMPLETED|Overall Study||9
931061|NCT01462084|2251384|P2|Included for Analysis|Overall Study||9
931062|NCT01462084|2251385|P1|Included for Analysis|Overall Study||9
931063|NCT01462084|2251384|P2|STARTED|Overall Study||10
931064|NCT01462084|2251385|P1|STARTED|Overall Study||11
931065|NCT01462045|2251396|P3|NOT COMPLETED|Overall Study||0
931066|NCT01462045|2251397|P2|NOT COMPLETED|Overall Study||1
931067|NCT01462045|2251398|P1|NOT COMPLETED|Overall Study||0
931068|NCT01462045|2251396|P3|COMPLETED|Overall Study||7
931069|NCT01462045|2251397|P2|COMPLETED|Overall Study||10
931070|NCT01462045|2251398|P1|COMPLETED|Overall Study||11
931071|NCT01462045|2251396|P3|STARTED|Overall Study||7
931072|NCT01462045|2251397|P2|STARTED|Overall Study||11
931073|NCT01462045|2251398|P1|STARTED|Overall Study||11
931074|NCT01461993|2251412|P3|NOT COMPLETED|Overall Study||64
931075|NCT01461993|2251413|P2|NOT COMPLETED|Overall Study||157
931076|NCT01461993|2251414|P1|NOT COMPLETED|Overall Study||151
931077|NCT01461993|2251412|P3|COMPLETED|Overall Study||438
931078|NCT01461993|2251413|P2|COMPLETED|Overall Study||841
931079|NCT01461993|2251414|P1|COMPLETED|Overall Study||848
931080|NCT01461993|2251412|P3|STARTED|Overall Study||502
931081|NCT01461993|2251413|P2|STARTED|Overall Study||998
931082|NCT01461993|2251414|P1|STARTED|Overall Study||999
931083|NCT01461980|2251439|P3|NOT COMPLETED|Overall Study||165
931084|NCT01461980|2251440|P2|NOT COMPLETED|Overall Study||145
931085|NCT01461980|2251441|P1|NOT COMPLETED|Overall Study||166
931086|NCT01461980|2251439|P3|COMPLETED|Overall Study||717
931087|NCT01461980|2251440|P2|COMPLETED|Overall Study||733
931088|NCT01461980|2251441|P1|COMPLETED|Overall Study||722
931089|NCT01461980|2251439|P3|Vaccination 3|Overall Study||748
931090|NCT01461980|2251440|P2|Vaccination 3|Overall Study||777
931091|NCT01461980|2251441|P1|Vaccination 3|Overall Study||757
931092|NCT01461980|2251439|P3|Vaccination 2|Overall Study||799
931093|NCT01461980|2251440|P2|Vaccination 2|Overall Study||819
931094|NCT01461980|2251441|P1|Vaccination 2|Overall Study||802
931095|NCT01461980|2251439|P3|Vaccination 1|Overall Study||875
931096|NCT01461980|2251440|P2|Vaccination 1|Overall Study||870
931097|NCT01461980|2251441|P1|Vaccination 1|Overall Study||884
931098|NCT01461980|2251439|P3|STARTED|Overall Study||882
931099|NCT01461980|2251440|P2|STARTED|Overall Study||878
931100|NCT01461980|2251441|P1|STARTED|Overall Study||888
931101|NCT01461811|2251473|P2|NOT COMPLETED|Overall Study||3
931102|NCT01461811|2251474|P1|NOT COMPLETED|Overall Study||4
931103|NCT01461811|2251473|P2|COMPLETED|Overall Study||46
931104|NCT01461811|2251474|P1|COMPLETED|Overall Study||91
931105|NCT01461811|2251473|P2|STARTED|Overall Study||49
931106|NCT01461811|2251474|P1|STARTED|Overall Study||95
931107|NCT01461733|2251504|P2|NOT COMPLETED|Overall Study||4
931108|NCT01461733|2251505|P1|NOT COMPLETED|Overall Study||4
931109|NCT01461733|2251504|P2|COMPLETED|Overall Study||8
931110|NCT01461733|2251505|P1|COMPLETED|Overall Study||8
931111|NCT01461733|2251504|P2|STARTED|Overall Study||12
931112|NCT01461733|2251505|P1|STARTED|Overall Study||12
931113|NCT01461707|2251513|P2|NOT COMPLETED|Overall Study||0
931114|NCT01461707|2251514|P1|NOT COMPLETED|Overall Study||1
931115|NCT01461707|2251513|P2|COMPLETED|Overall Study||15
931116|NCT01461707|2251514|P1|COMPLETED|Overall Study||14
931117|NCT01461707|2251513|P2|STARTED|Overall Study||15
931118|NCT01461707|2251514|P1|STARTED|Overall Study||15
931119|NCT01461655|2251522|P1|NOT COMPLETED|Overall Study||0
931120|NCT01461655|2251522|P1|COMPLETED|Overall Study||40
931121|NCT01461655|2251522|P1|STARTED|Overall Study||40
931122|NCT01461551|2251542|P3|NOT COMPLETED|Overall Study||2
931123|NCT01461551|2251543|P2|NOT COMPLETED|Overall Study||1
931124|NCT01461551|2251544|P1|NOT COMPLETED|Overall Study||2
931125|NCT01461551|2251542|P3|COMPLETED|Overall Study||33
931126|NCT01461551|2251543|P2|COMPLETED|Overall Study||34
931127|NCT01461551|2251544|P1|COMPLETED|Overall Study||33
931128|NCT01461551|2251542|P3|STARTED|Overall Study||35
931129|NCT01461551|2251543|P2|STARTED|Overall Study||35
931130|NCT01461551|2251544|P1|STARTED|Overall Study||35
931131|NCT01461538|2251555|P3|NOT COMPLETED|Overall Study||2
931132|NCT01461538|2251556|P2|NOT COMPLETED|Overall Study||8
931133|NCT01461538|2251557|P1|NOT COMPLETED|Overall Study||18
931134|NCT01461538|2251555|P3|COMPLETED|Overall Study||7
931135|NCT01461538|2251556|P2|COMPLETED|Overall Study||20
931136|NCT01461538|2251557|P1|COMPLETED|Overall Study||28
931137|NCT01461538|2251555|P3|STARTED|Overall Study||9
931138|NCT01461538|2251556|P2|STARTED|Overall Study||28
931139|NCT01461538|2251557|P1|STARTED|Overall Study||46
931140|NCT01461473|2251595|P2|NOT COMPLETED|Overall Study||4
931141|NCT01461473|2251596|P1|NOT COMPLETED|Overall Study||5
931142|NCT01461473|2251595|P2|COMPLETED|Overall Study||55
931143|NCT01461473|2251596|P1|COMPLETED|Overall Study||67
931144|NCT01461473|2251595|P2|STARTED|Overall Study||59
931145|NCT01461473|2251596|P1|STARTED|Overall Study||72
931146|NCT01461369|2251615|P3|NOT COMPLETED|Overall Study||17
931147|NCT01461369|2251616|P2|NOT COMPLETED|Overall Study||17
931148|NCT01461369|2251617|P1|NOT COMPLETED|Overall Study||13
931149|NCT01461369|2251615|P3|COMPLETED|Overall Study||86
931150|NCT01461369|2251616|P2|COMPLETED|Overall Study||81
931151|NCT01461369|2251617|P1|COMPLETED|Overall Study||91
931152|NCT01461369|2251615|P3|STARTED|Overall Study||103
931153|NCT01461369|2251616|P2|STARTED|Overall Study||98
931154|NCT01461369|2251617|P1|STARTED|Overall Study||104
931155|NCT01461096|2251642|P2|NOT COMPLETED|Overall Study||61
931156|NCT01461096|2251643|P1|NOT COMPLETED|Overall Study||62
931157|NCT01461096|2251642|P2|COMPLETED|Overall Study||226
931158|NCT01461096|2251643|P1|COMPLETED|Overall Study||226
931159|NCT01461096|2251642|P2|Did Not Start Treatment|Overall Study|Randomized but never started treatment and was discontinued from the study|1
931160|NCT01461096|2251643|P1|Did Not Start Treatment|Overall Study||0
931161|NCT01461096|2251642|P2|STARTED|Overall Study||287
931162|NCT01461096|2251643|P1|STARTED|Overall Study||288
931163|NCT01461057|2251659|P2|NOT COMPLETED|Overall Study||15
931164|NCT01461057|2251660|P1|NOT COMPLETED|Overall Study||15
931165|NCT01461057|2251659|P2|COMPLETED|Overall Study||0
931166|NCT01461057|2251660|P1|COMPLETED|Overall Study||0
931167|NCT01461057|2251659|P2|STARTED|Overall Study||15
931168|NCT01461057|2251660|P1|STARTED|Overall Study||15
931169|NCT01461044|2251670|P2|NOT COMPLETED|Overall Study||40
931170|NCT01461044|2251671|P1|NOT COMPLETED|Overall Study||70
931171|NCT01461044|2251670|P2|COMPLETED|Overall Study||37
931172|NCT01461044|2251671|P1|COMPLETED|Overall Study||80
931173|NCT01461044|2251670|P2|Participants Alive at Inclusion|Overall Study||58
931174|NCT01461044|2251671|P1|Participants Alive at Inclusion|Overall Study||127
931175|NCT01461044|2251670|P2|STARTED|Overall Study||77
931176|NCT01461044|2251671|P1|STARTED|Overall Study||150
931177|NCT01460940|2251744|P1|NOT COMPLETED|Overall Study||0
931178|NCT01460940|2251744|P1|COMPLETED|Overall Study||24
931179|NCT01460940|2251744|P1|STARTED|Overall Study||24
931180|NCT01460927|2251750|P1|NOT COMPLETED|Overall Study||0
931181|NCT01460927|2251750|P1|COMPLETED|Overall Study||25
931182|NCT01460927|2251750|P1|STARTED|Overall Study||25
931183|NCT01460732|2251758|P1|NOT COMPLETED|Overall Study||0
931184|NCT01460732|2251758|P1|COMPLETED|Overall Study||81
931185|NCT01460732|2251758|P1|STARTED|Overall Study||81
931186|NCT01460628|2251771|P1|NOT COMPLETED|Overall Study||5
931187|NCT01460628|2251771|P1|COMPLETED|Overall Study||20
931188|NCT01460628|2251771|P1|STARTED|Overall Study||25
931189|NCT01460446|2251783|P2|NOT COMPLETED|Overall Study||20
931190|NCT01460446|2251784|P1|NOT COMPLETED|Overall Study||5
931191|NCT01460446|2251783|P2|COMPLETED|Overall Study||93
931192|NCT01460446|2251784|P1|COMPLETED|Overall Study||100
931193|NCT01460446|2251783|P2|STARTED|Overall Study||113
931194|NCT01460446|2251784|P1|STARTED|Overall Study||105
931195|NCT01460342|2251813|P2|NOT COMPLETED|Overall Study||14
931196|NCT01460342|2251814|P1|NOT COMPLETED|Overall Study||11
931197|NCT01460342|2251813|P2|COMPLETED|Overall Study||292
931198|NCT01460342|2251814|P1|COMPLETED|Overall Study||293
931199|NCT01460342|2251813|P2|Received at Least 1 Dose of Study Drug|Overall Study||306
931200|NCT01460342|2251814|P1|Received at Least 1 Dose of Study Drug|Overall Study||304
931201|NCT01460342|2251813|P2|STARTED|Overall Study||306
931202|NCT01460342|2251814|P1|STARTED|Overall Study||304
931203|NCT01460303|2251836|P2|NOT COMPLETED|Overall Study||0
931204|NCT01460303|2251837|P1|NOT COMPLETED|Overall Study||0
931205|NCT01460303|2251836|P2|COMPLETED|Overall Study||24
931206|NCT01460303|2251837|P1|COMPLETED|Overall Study||25
931207|NCT01460303|2251836|P2|STARTED|Overall Study||24
931208|NCT01460303|2251837|P1|STARTED|Overall Study||25
931209|NCT01460290|2251845|P1|NOT COMPLETED|Overall Study||4
931210|NCT01460290|2251845|P1|COMPLETED|Overall Study||11
931211|NCT01460290|2251845|P1|STARTED|Overall Study||15
931212|NCT01459913|2251869|P4|NOT COMPLETED|Overall Study||33
931213|NCT01459913|2251870|P3|NOT COMPLETED|Overall Study||13
931214|NCT01459913|2251871|P2|NOT COMPLETED|Overall Study||20
931215|NCT01459913|2251872|P1|NOT COMPLETED|Overall Study||41
931216|NCT01459913|2251869|P4|COMPLETED|Overall Study||29
931217|NCT01459913|2251870|P3|COMPLETED|Overall Study||6
931218|NCT01459913|2251871|P2|COMPLETED|Overall Study||32
931219|NCT01459913|2251872|P1|COMPLETED|Overall Study||65
931220|NCT01459913|2251869|P4|STARTED|Overall Study||62
931221|NCT01459913|2251870|P3|STARTED|Overall Study||19
931222|NCT01459913|2251871|P2|STARTED|Overall Study||52
931223|NCT01459913|2251872|P1|STARTED|Overall Study||106
931224|NCT01459796|2251903|P2|NOT COMPLETED|Overall Study||126
931225|NCT01459796|2251904|P1|NOT COMPLETED|Overall Study||94
931226|NCT01459796|2251903|P2|COMPLETED|Overall Study||0
931227|NCT01459796|2251904|P1|COMPLETED|Overall Study||0
931228|NCT01459796|2251903|P2|STARTED|Overall Study||126
931229|NCT01459796|2251904|P1|STARTED|Overall Study||94
931230|NCT01459783|2251922|P2|NOT COMPLETED|6 Months to 12 Months||30
931231|NCT01459783|2251923|P1|NOT COMPLETED|6 Months to 12 Months||19
931232|NCT01459783|2251922|P2|COMPLETED|6 Months to 12 Months||23
931233|NCT01459783|2251923|P1|COMPLETED|6 Months to 12 Months||20
931234|NCT01459783|2251922|P2|STARTED|6 Months to 12 Months||53
931235|NCT01459783|2251923|P1|STARTED|6 Months to 12 Months||39
931236|NCT01459783|2251922|P2|NOT COMPLETED|Baseline to 6 Months||20
931237|NCT01459783|2251923|P1|NOT COMPLETED|Baseline to 6 Months||32
931238|NCT01459783|2251922|P2|COMPLETED|Baseline to 6 Months||53
931239|NCT01459783|2251923|P1|COMPLETED|Baseline to 6 Months||39
931240|NCT01459783|2251922|P2|STARTED|Baseline to 6 Months||73
931241|NCT01459783|2251923|P1|STARTED|Baseline to 6 Months||71
931242|NCT01459705|2251934|P3|NOT COMPLETED|Overall Study||7
931243|NCT01459705|2251935|P2|NOT COMPLETED|Overall Study||24
931244|NCT01459705|2251936|P1|NOT COMPLETED|Overall Study||22
931245|NCT01459705|2251934|P3|COMPLETED|Overall Study||47
931246|NCT01459705|2251935|P2|COMPLETED|Overall Study||30
931247|NCT01459705|2251936|P1|COMPLETED|Overall Study||32
931248|NCT01459705|2251934|P3|STARTED|Overall Study||54
931249|NCT01459705|2251935|P2|STARTED|Overall Study||54
931250|NCT01459705|2251936|P1|STARTED|Overall Study||54
931251|NCT01459653|2251954|P1|NOT COMPLETED|Overall Study||668
931252|NCT01459653|2251954|P1|COMPLETED|Overall Study||828
931253|NCT01459653|2251954|P1|STARTED|Overall Study||1496
931254|NCT01459588|2252104|P4|NOT COMPLETED|Overall Study||1
931255|NCT01459588|2252105|P3|NOT COMPLETED|Overall Study||1
931256|NCT01459588|2252106|P2|NOT COMPLETED|Overall Study||2
931257|NCT01459588|2252107|P1|NOT COMPLETED|Overall Study||1
931258|NCT01459588|2252104|P4|COMPLETED|Overall Study||55
931259|NCT01459588|2252105|P3|COMPLETED|Overall Study||102
931260|NCT01459588|2252106|P2|COMPLETED|Overall Study||49
931261|NCT01459588|2252107|P1|COMPLETED|Overall Study||104
931262|NCT01459588|2252104|P4|STARTED|Overall Study||56
931263|NCT01459588|2252105|P3|STARTED|Overall Study||103
931264|NCT01459588|2252106|P2|STARTED|Overall Study||51
931265|NCT01459588|2252107|P1|STARTED|Overall Study||105
931266|NCT01459068|2252135|P2|NOT COMPLETED|Overall Study||34
931267|NCT01459068|2252136|P1|NOT COMPLETED|Overall Study||39
931268|NCT01459068|2252135|P2|COMPLETED|Overall Study||148
931269|NCT01459068|2252136|P1|COMPLETED|Overall Study||126
931270|NCT01459068|2252135|P2|STARTED|Overall Study||182
931271|NCT01459068|2252136|P1|STARTED|Overall Study||165
931272|NCT01459016|2252152|P1|NOT COMPLETED|Overall Study||15
931273|NCT01459016|2252152|P1|COMPLETED|Overall Study||41
931274|NCT01459016|2252152|P1|STARTED|Overall Study||56
931275|NCT01458951|2252169|P3|NOT COMPLETED|Overall Study||15
931276|NCT01458951|2252170|P2|NOT COMPLETED|Overall Study||1
931277|NCT01458951|2252171|P1|NOT COMPLETED|Overall Study||32
931278|NCT01458951|2252169|P3|COMPLETED|Overall Study||97
931279|NCT01458951|2252170|P2|COMPLETED|Overall Study||5
931280|NCT01458951|2252171|P1|COMPLETED|Overall Study||397
931281|NCT01458951|2252169|P3|STARTED|Overall Study||112
931282|NCT01458951|2252170|P2|STARTED|Overall Study||6
931283|NCT01458951|2252171|P1|STARTED|Overall Study||429
931284|NCT01458639|2252196|P1|NOT COMPLETED|Overall Study||6
931285|NCT01458639|2252196|P1|COMPLETED|Overall Study||12
931286|NCT01458639|2252196|P1|STARTED|Overall Study||18
931287|NCT01458587|2252208|P2|NOT COMPLETED|Overall Study||0
931288|NCT01458587|2252209|P1|NOT COMPLETED|Overall Study||1
931289|NCT01458587|2252208|P2|COMPLETED|Overall Study||35
931290|NCT01458587|2252209|P1|COMPLETED|Overall Study||34
931291|NCT01458587|2252208|P2|STARTED|Overall Study||35
931292|NCT01458587|2252209|P1|STARTED|Overall Study||35
931293|NCT01458574|2252372|P3|NOT COMPLETED|Overall Study||145
931294|NCT01458574|2252373|P2|NOT COMPLETED|Overall Study||71
931295|NCT01458574|2252374|P1|NOT COMPLETED|Overall Study||87
931296|NCT01458574|2252372|P3|COMPLETED|Overall Study||53
931297|NCT01458574|2252373|P2|COMPLETED|Overall Study||126
931298|NCT01458574|2252374|P1|COMPLETED|Overall Study||111
931299|NCT01458574|2252372|P3|Treated|Overall Study||198
931300|NCT01458574|2252373|P2|Treated|Overall Study||196
931301|NCT01458574|2252374|P1|Treated|Overall Study||198
931302|NCT01458574|2252372|P3|STARTED|Overall Study||198
931303|NCT01458574|2252373|P2|STARTED|Overall Study||197
931304|NCT01458574|2252374|P1|STARTED|Overall Study||198
931305|NCT01458561|2252459|P2|NOT COMPLETED|Overall Study||0
931306|NCT01458561|2252460|P1|NOT COMPLETED|Overall Study||0
931307|NCT01458561|2252459|P2|COMPLETED|Overall Study||1
931308|NCT01458561|2252460|P1|COMPLETED|Overall Study||0
931309|NCT01458561|2252459|P2|STARTED|Overall Study||1
931310|NCT01458561|2252460|P1|STARTED|Overall Study||0
931311|NCT01458535|2252504|P6|NOT COMPLETED|Overall Study||4
931312|NCT01458535|2252505|P5|NOT COMPLETED|Overall Study||4
931313|NCT01458535|2252506|P4|NOT COMPLETED|Overall Study||4
931314|NCT01458535|2252507|P3|NOT COMPLETED|Overall Study||2
931315|NCT01458535|2252508|P2|NOT COMPLETED|Overall Study||2
931316|NCT01458535|2252509|P1|NOT COMPLETED|Overall Study||0
931317|NCT01458535|2252504|P6|COMPLETED|Overall Study||7
931318|NCT01458535|2252505|P5|COMPLETED|Overall Study||6
931319|NCT01458535|2252506|P4|COMPLETED|Overall Study||6
931320|NCT01458535|2252507|P3|COMPLETED|Overall Study||8
931321|NCT01458535|2252508|P2|COMPLETED|Overall Study||8
931322|NCT01458535|2252509|P1|COMPLETED|Overall Study||10
931323|NCT01458535|2252504|P6|STARTED|Overall Study||11
931324|NCT01458535|2252505|P5|STARTED|Overall Study||10
931325|NCT01458535|2252506|P4|STARTED|Overall Study||10
931326|NCT01458535|2252507|P3|STARTED|Overall Study||10
931327|NCT01458535|2252508|P2|STARTED|Overall Study||10
931328|NCT01458535|2252509|P1|STARTED|Overall Study||10
931329|NCT01458392|2252562|P3|NOT COMPLETED|Overall Study||31
931330|NCT01458392|2252563|P2|NOT COMPLETED|Overall Study||13
931331|NCT01458392|2252564|P1|NOT COMPLETED|Overall Study||2
931332|NCT01458392|2252562|P3|COMPLETED|Overall Study||0
931333|NCT01458392|2252563|P2|COMPLETED|Overall Study||0
931334|NCT01458392|2252564|P1|COMPLETED|Overall Study||0
931335|NCT01458392|2252562|P3|STARTED|Overall Study||31
931336|NCT01458392|2252563|P2|STARTED|Overall Study||13
931337|NCT01458392|2252564|P1|STARTED|Overall Study||2
931338|NCT01458288|2252584|P1|NOT COMPLETED|Overall Study||0
931339|NCT01458288|2252584|P1|COMPLETED|Overall Study||12
931340|NCT01458288|2252584|P1|STARTED|Overall Study||12
931341|NCT01458275|2252592|P3|NOT COMPLETED|Overall Study||9
931342|NCT01458275|2252593|P2|NOT COMPLETED|Overall Study||13
931343|NCT01458275|2252594|P1|NOT COMPLETED|Overall Study||14
931344|NCT01458275|2252592|P3|COMPLETED|Overall Study||273
931345|NCT01458275|2252593|P2|COMPLETED|Overall Study||269
931346|NCT01458275|2252594|P1|COMPLETED|Overall Study||269
931347|NCT01458275|2252592|P3|STARTED|Overall Study||282
931348|NCT01458275|2252593|P2|STARTED|Overall Study||282
931349|NCT01458275|2252594|P1|STARTED|Overall Study||283
931350|NCT01458249|2252636|P1|NOT COMPLETED|Overall Study||8
931351|NCT01458249|2252636|P1|COMPLETED|Overall Study||44
931352|NCT01458249|2252636|P1|Participants Treated|Overall Study||51
931353|NCT01458249|2252636|P1|STARTED|Overall Study||52
931354|NCT01458210|2252655|P1|NOT COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||3
931355|NCT01458210|2252655|P1|COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||15
931356|NCT01458210|2252655|P1|STARTED|Ortho-Cyclen + Dulaglutide (Period 2)|1 participant received Ortho-Cyclen, discontinued due to Adverse Event before receiving Dulaglutide.|18
931357|NCT01458210|2252655|P1|NOT COMPLETED|Ortho-Cyclen Alone (Period 1)||4
931358|NCT01458210|2252655|P1|COMPLETED|Ortho-Cyclen Alone (Period 1)||18
931359|NCT01458210|2252655|P1|STARTED|Ortho-Cyclen Alone (Period 1)||22
931360|NCT01458210|2252655|P1|NOT COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||0
931361|NCT01458210|2252655|P1|COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||22
931362|NCT01458210|2252655|P1|Received at Least One Dose of Study Drug|Lead-in (1st Course of Ortho-Cyclen)||22
931363|NCT01458210|2252655|P1|STARTED|Lead-in (1st Course of Ortho-Cyclen)||22
931364|NCT01458171|2252672|P1|NOT COMPLETED|Overall Study||1
931365|NCT01458171|2252672|P1|COMPLETED|Overall Study||22
931366|NCT01458171|2252672|P1|STARTED|Overall Study||23
931367|NCT01458106|2252695|P2|NOT COMPLETED|Overall Study||1
931368|NCT01458106|2252696|P1|NOT COMPLETED|Overall Study||3
931369|NCT01458106|2252695|P2|COMPLETED|Overall Study||34
931370|NCT01458106|2252696|P1|COMPLETED|Overall Study||33
931371|NCT01458106|2252695|P2|Non-PK Subgroup|Overall Study||0
931372|NCT01458106|2252696|P1|Non-PK Subgroup|Overall Study||11
931373|NCT01458106|2252695|P2|PK Subgroup|Overall Study||35
931374|NCT01458106|2252696|P1|PK Subgroup|Overall Study||25
931375|NCT01458106|2252695|P2|STARTED|Overall Study||35
931376|NCT01458106|2252696|P1|STARTED|Overall Study||36
931377|NCT01457950|2252773|P4|NOT COMPLETED|Open-Label Phase||2
931378|NCT01457950|2252774|P3|NOT COMPLETED|Open-Label Phase||2
931379|NCT01457950|2252775|P2|NOT COMPLETED|Open-Label Phase||0
931380|NCT01457950|2252776|P1|NOT COMPLETED|Open-Label Phase||0
931381|NCT01457950|2252773|P4|COMPLETED|Open-Label Phase||61
931382|NCT01457950|2252774|P3|COMPLETED|Open-Label Phase||58
931383|NCT01457950|2252775|P2|COMPLETED|Open-Label Phase||0
931384|NCT01457950|2252776|P1|COMPLETED|Open-Label Phase||0
931385|NCT01457950|2252773|P4|STARTED|Open-Label Phase||63
931386|NCT01457950|2252774|P3|STARTED|Open-Label Phase||60
931387|NCT01457950|2252775|P2|STARTED|Open-Label Phase||0
931388|NCT01457950|2252776|P1|STARTED|Open-Label Phase||0
931389|NCT01457950|2252773|P4|NOT COMPLETED|Double-Blind Phase||0
931390|NCT01457950|2252774|P3|NOT COMPLETED|Double-Blind Phase||0
931391|NCT01457950|2252775|P2|NOT COMPLETED|Double-Blind Phase||3
931392|NCT01457950|2252776|P1|NOT COMPLETED|Double-Blind Phase||9
931393|NCT01457950|2252773|P4|COMPLETED|Double-Blind Phase||0
931394|NCT01457950|2252774|P3|COMPLETED|Double-Blind Phase||0
931395|NCT01457950|2252775|P2|COMPLETED|Double-Blind Phase|“Completed” refers to par. that did not have a withdraw reason at the 6 month visit.|63
931396|NCT01457950|2252776|P1|COMPLETED|Double-Blind Phase|“Completed” refers to par. that did not have a withdraw reason at the 6 month visit.|60
931397|NCT01457950|2252773|P4|Completed the 6 Month Assessment|Double-Blind Phase||0
931398|NCT01457950|2252774|P3|Completed the 6 Month Assessment|Double-Blind Phase||0
931399|NCT01457950|2252775|P2|Completed the 6 Month Assessment|Double-Blind Phase|“Completed 6 month assessment” refers to par. that completed at least one 6 month assessment.|64
931400|NCT01457950|2252776|P1|Completed the 6 Month Assessment|Double-Blind Phase|“Completed 6 month assessment” refers to par. that completed at least one 6 month assessment.|62
931401|NCT01457950|2252773|P4|STARTED|Double-Blind Phase||0
931402|NCT01457950|2252774|P3|STARTED|Double-Blind Phase||0
931403|NCT01457950|2252775|P2|STARTED|Double-Blind Phase||66
931404|NCT01457950|2252776|P1|STARTED|Double-Blind Phase||69
931405|NCT01457885|2252850|P1|NOT COMPLETED|Overall Study||0
931406|NCT01457885|2252850|P1|COMPLETED|Overall Study||74
931407|NCT01457885|2252850|P1|STARTED|Overall Study||74
931408|NCT01457846|2252858|P2|NOT COMPLETED|Overall Study||30
931409|NCT01457846|2252859|P1|NOT COMPLETED|Overall Study||41
931410|NCT01457846|2252858|P2|COMPLETED|Overall Study||0
931411|NCT01457846|2252859|P1|COMPLETED|Overall Study||0
931412|NCT01457846|2252858|P2|Ongoing Treatment at Data Cut-off|Overall Study||1
931413|NCT01457846|2252859|P1|Ongoing Treatment at Data Cut-off|Overall Study||1
931414|NCT01457846|2252858|P2|Did Not Receive Treatment|Overall Study||3
931415|NCT01457846|2252859|P1|Did Not Receive Treatment|Overall Study||1
931416|NCT01457846|2252858|P2|Received Treatment|Overall Study||27
931417|NCT01457846|2252859|P1|Received Treatment|Overall Study||40
931418|NCT01457846|2252858|P2|STARTED|Overall Study||30
931419|NCT01457846|2252859|P1|STARTED|Overall Study||41
931420|NCT01457703|2252875|P2|NOT COMPLETED|Overall Study||11
931421|NCT01457703|2252876|P1|NOT COMPLETED|Overall Study||6
931422|NCT01457703|2252875|P2|COMPLETED|Overall Study||22
931423|NCT01457703|2252876|P1|COMPLETED|Overall Study||23
931424|NCT01457703|2252875|P2|STARTED|Overall Study||33
931425|NCT01457703|2252876|P1|STARTED|Overall Study||29
931426|NCT01457521|2252892|P2|NOT COMPLETED|Overall Study||10
931427|NCT01457521|2252893|P1|NOT COMPLETED|Overall Study||12
931428|NCT01457521|2252892|P2|COMPLETED|Overall Study||117
931429|NCT01457521|2252893|P1|COMPLETED|Overall Study||111
931430|NCT01457521|2252892|P2|STARTED|Overall Study||127
931431|NCT01457521|2252893|P1|STARTED|Overall Study||123
931432|NCT01457430|2252899|P1|NOT COMPLETED|Overall Study||0
931433|NCT01457430|2252899|P1|COMPLETED|Overall Study||19
931434|NCT01457430|2252899|P1|STARTED|Overall Study||19
931435|NCT01457417|2252911|P5|NOT COMPLETED|Overall Study||0
931436|NCT01457417|2252912|P4|NOT COMPLETED|Overall Study||0
931437|NCT01457417|2252913|P3|NOT COMPLETED|Overall Study||0
931438|NCT01457417|2252914|P2|NOT COMPLETED|Overall Study||0
931439|NCT01457417|2252915|P1|NOT COMPLETED|Overall Study||0
931440|NCT01457417|2252911|P5|COMPLETED|Overall Study||19
931441|NCT01457417|2252912|P4|COMPLETED|Overall Study||3
931442|NCT01457417|2252913|P3|COMPLETED|Overall Study||4
931443|NCT01457417|2252914|P2|COMPLETED|Overall Study||3
931444|NCT01457417|2252915|P1|COMPLETED|Overall Study||3
931445|NCT01457417|2252911|P5|STARTED|Overall Study||19
931446|NCT01457417|2252912|P4|STARTED|Overall Study||3
931447|NCT01457417|2252913|P3|STARTED|Overall Study||4
931448|NCT01457417|2252914|P2|STARTED|Overall Study||3
931449|NCT01457417|2252915|P1|STARTED|Overall Study||3
931450|NCT01457339|2252973|P2|NOT COMPLETED|Period 6 (250 mg)||1
931451|NCT01457339|2252974|P1|NOT COMPLETED|Period 6 (250 mg)||1
931452|NCT01457339|2252973|P2|COMPLETED|Period 6 (250 mg)||21
931453|NCT01457339|2252974|P1|COMPLETED|Period 6 (250 mg)||6
931454|NCT01457339|2252973|P2|STARTED|Period 6 (250 mg)||22
931455|NCT01457339|2252974|P1|STARTED|Period 6 (250 mg)||7
931456|NCT01457339|2252973|P2|NOT COMPLETED|Period 5 (200 mg)||1
931457|NCT01457339|2252974|P1|NOT COMPLETED|Period 5 (200 mg)||0
931458|NCT01457339|2252973|P2|COMPLETED|Period 5 (200 mg)||22
931459|NCT01457339|2252974|P1|COMPLETED|Period 5 (200 mg)||7
931460|NCT01457339|2252973|P2|STARTED|Period 5 (200 mg)||23
931461|NCT01457339|2252974|P1|STARTED|Period 5 (200 mg)||7
931462|NCT01457339|2252973|P2|NOT COMPLETED|Period 4 (150 mg)||0
931463|NCT01457339|2252974|P1|NOT COMPLETED|Period 4 (150 mg)||0
931464|NCT01457339|2252973|P2|COMPLETED|Period 4 (150 mg)||23
931465|NCT01457339|2252974|P1|COMPLETED|Period 4 (150 mg)||7
931466|NCT01457339|2252973|P2|STARTED|Period 4 (150 mg)||23
931467|NCT01457339|2252974|P1|STARTED|Period 4 (150 mg)||7
931468|NCT01457339|2252973|P2|NOT COMPLETED|Period 3 (100 mg)||1
931469|NCT01457339|2252974|P1|NOT COMPLETED|Period 3 (100 mg)||0
931470|NCT01457339|2252973|P2|COMPLETED|Period 3 (100 mg)||23
931471|NCT01457339|2252974|P1|COMPLETED|Period 3 (100 mg)||7
931472|NCT01457339|2252973|P2|STARTED|Period 3 (100 mg)||24
931473|NCT01457339|2252974|P1|STARTED|Period 3 (100 mg)||7
931474|NCT01457339|2252973|P2|NOT COMPLETED|Period 2 (70 mg)||0
931475|NCT01457339|2252974|P1|NOT COMPLETED|Period 2 (70 mg)||0
931476|NCT01457339|2252973|P2|COMPLETED|Period 2 (70 mg)||24
931477|NCT01457339|2252974|P1|COMPLETED|Period 2 (70 mg)||7
931478|NCT01457339|2252973|P2|STARTED|Period 2 (70 mg)||24
931479|NCT01457339|2252974|P1|STARTED|Period 2 (70 mg)||7
931480|NCT01457339|2252973|P2|NOT COMPLETED|Period 1 (50 mg)||0
931481|NCT01457339|2252974|P1|NOT COMPLETED|Period 1 (50 mg)||0
931482|NCT01457339|2252973|P2|COMPLETED|Period 1 (50 mg)||24
931483|NCT01457339|2252974|P1|COMPLETED|Period 1 (50 mg)||7
931484|NCT01457339|2252973|P2|STARTED|Period 1 (50 mg)||24
931485|NCT01457339|2252974|P1|STARTED|Period 1 (50 mg)||7
931486|NCT01457053|2253140|P2|NOT COMPLETED|Overall Study||1
931487|NCT01457053|2253141|P1|NOT COMPLETED|Overall Study||1
931488|NCT01457053|2253140|P2|COMPLETED|Overall Study||1
931489|NCT01457053|2253141|P1|COMPLETED|Overall Study||1
931490|NCT01457053|2253140|P2|STARTED|Overall Study||2
931491|NCT01457053|2253141|P1|STARTED|Overall Study||2
931492|NCT01457014|2253147|P4|NOT COMPLETED|Fourth Night||0
931493|NCT01457014|2253148|P3|NOT COMPLETED|Fourth Night||0
931494|NCT01457014|2253149|P2|NOT COMPLETED|Fourth Night||0
931495|NCT01457014|2253150|P1|NOT COMPLETED|Fourth Night||0
931496|NCT01457014|2253147|P4|COMPLETED|Fourth Night||11
931497|NCT01457014|2253148|P3|COMPLETED|Fourth Night||12
931498|NCT01457014|2253149|P2|COMPLETED|Fourth Night||11
931499|NCT01457014|2253150|P1|COMPLETED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
931500|NCT01457014|2253147|P4|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
931501|NCT01457014|2253148|P3|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
931502|NCT01457014|2253149|P2|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
931503|NCT01457014|2253150|P1|STARTED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
931504|NCT01457014|2253147|P4|NOT COMPLETED|Third Night||0
931505|NCT01457014|2253148|P3|NOT COMPLETED|Third Night||0
931506|NCT01457014|2253149|P2|NOT COMPLETED|Third Night||0
931507|NCT01457014|2253150|P1|NOT COMPLETED|Third Night||0
931508|NCT01457014|2253147|P4|COMPLETED|Third Night||12
931509|NCT01457014|2253148|P3|COMPLETED|Third Night||11
931510|NCT01457014|2253149|P2|COMPLETED|Third Night||11
931511|NCT01457014|2253150|P1|COMPLETED|Third Night|The Diagnostic PSG was only completed on the First night|0
931512|NCT01457014|2253147|P4|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
931513|NCT01457014|2253148|P3|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
931514|NCT01457014|2253149|P2|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
931515|NCT01457014|2253150|P1|STARTED|Third Night|The Diagnostic PSG was only completed on the First night|0
931516|NCT01457014|2253147|P4|NOT COMPLETED|Second Night||0
931517|NCT01457014|2253148|P3|NOT COMPLETED|Second Night||0
931518|NCT01457014|2253149|P2|NOT COMPLETED|Second Night||0
931519|NCT01457014|2253150|P1|NOT COMPLETED|Second Night||0
931520|NCT01457014|2253147|P4|COMPLETED|Second Night||11
931521|NCT01457014|2253148|P3|COMPLETED|Second Night||11
931522|NCT01457014|2253149|P2|COMPLETED|Second Night||12
931523|NCT01457014|2253150|P1|COMPLETED|Second Night|The Diagnostic PSG was only completed on the First night|0
931524|NCT01457014|2253147|P4|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
931525|NCT01457014|2253148|P3|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
931526|NCT01457014|2253149|P2|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
931527|NCT01457014|2253150|P1|STARTED|Second Night|The Diagnostic PSG was only completed on the First night|0
931528|NCT01457014|2253147|P4|NOT COMPLETED|First Night||0
931529|NCT01457014|2253148|P3|NOT COMPLETED|First Night||0
931530|NCT01457014|2253149|P2|NOT COMPLETED|First Night||0
931531|NCT01457014|2253150|P1|NOT COMPLETED|First Night||40
931532|NCT01457014|2253147|P4|COMPLETED|First Night||0
931533|NCT01457014|2253148|P3|COMPLETED|First Night||0
931534|NCT01457014|2253149|P2|COMPLETED|First Night||0
931535|NCT01457014|2253150|P1|COMPLETED|First Night||34
931536|NCT01457014|2253147|P4|STARTED|First Night||0
931537|NCT01457014|2253148|P3|STARTED|First Night||0
931538|NCT01457014|2253149|P2|STARTED|First Night||0
931539|NCT01457014|2253150|P1|STARTED|First Night||74
931540|NCT01456962|2253167|P2|NOT COMPLETED|Overall Study||1
931541|NCT01456962|2253168|P1|NOT COMPLETED|Overall Study||2
931542|NCT01456962|2253167|P2|COMPLETED|Overall Study||19
931543|NCT01456962|2253168|P1|COMPLETED|Overall Study||14
931544|NCT01456962|2253167|P2|STARTED|Overall Study||20
931545|NCT01456962|2253168|P1|STARTED|Overall Study||16
931546|NCT01456936|2253178|P4|NOT COMPLETED|Overall Study||483
931547|NCT01456936|2253179|P3|NOT COMPLETED|Overall Study||481
931548|NCT01456936|2253180|P2|NOT COMPLETED|Overall Study||448
931549|NCT01456936|2253181|P1|NOT COMPLETED|Overall Study||439
931550|NCT01456936|2253178|P4|COMPLETED|Overall Study||1552
931551|NCT01456936|2253179|P3|COMPLETED|Overall Study||1557
931552|NCT01456936|2253180|P2|COMPLETED|Overall Study||1586
931553|NCT01456936|2253181|P1|COMPLETED|Overall Study||1598
931554|NCT01456936|2253178|P4|Randomized and Treated|Overall Study||2014
931555|NCT01456936|2253179|P3|Randomized and Treated|Overall Study||2022
931556|NCT01456936|2253180|P2|Randomized and Treated|Overall Study||2006
931557|NCT01456936|2253181|P1|Randomized and Treated|Overall Study||2016
931558|NCT01456936|2253178|P4|STARTED|Overall Study||2035
931559|NCT01456936|2253179|P3|STARTED|Overall Study||2038
931560|NCT01456936|2253180|P2|STARTED|Overall Study||2034
931561|NCT01456936|2253181|P1|STARTED|Overall Study||2037
931562|NCT01456780|2253290|P3|NOT COMPLETED|Overall Study||0
931563|NCT01456780|2253291|P2|NOT COMPLETED|Overall Study||3
931564|NCT01456780|2253292|P1|NOT COMPLETED|Overall Study||3
931565|NCT01456780|2253290|P3|COMPLETED|Overall Study||20
931566|NCT01456780|2253291|P2|COMPLETED|Overall Study||17
931567|NCT01456780|2253292|P1|COMPLETED|Overall Study||17
931568|NCT01456780|2253290|P3|STARTED|Overall Study||20
931569|NCT01456780|2253291|P2|STARTED|Overall Study||20
931570|NCT01456780|2253292|P1|STARTED|Overall Study||20
931571|NCT01456299|2253312|P3|NOT COMPLETED|Overall Study||1
931572|NCT01456299|2253313|P2|NOT COMPLETED|Overall Study||1
931573|NCT01456299|2253314|P1|NOT COMPLETED|Overall Study||0
931574|NCT01456299|2253312|P3|COMPLETED|Overall Study||33
931575|NCT01456299|2253313|P2|COMPLETED|Overall Study||33
931576|NCT01456299|2253314|P1|COMPLETED|Overall Study||34
931577|NCT01456299|2253312|P3|STARTED|Overall Study||34
931578|NCT01456299|2253313|P2|STARTED|Overall Study||34
931579|NCT01456299|2253314|P1|STARTED|Overall Study||34
931580|NCT01456195|2253325|P3|NOT COMPLETED|Overall Study||14
931581|NCT01456195|2253326|P2|NOT COMPLETED|Overall Study||10
931582|NCT01456195|2253327|P1|NOT COMPLETED|Overall Study||11
931583|NCT01456195|2253325|P3|COMPLETED|Overall Study||127
931584|NCT01456195|2253326|P2|COMPLETED|Overall Study||127
931585|NCT01456195|2253327|P1|COMPLETED|Overall Study||132
931586|NCT01456195|2253325|P3|STARTED|Overall Study||141
931587|NCT01456195|2253326|P2|STARTED|Overall Study||137
931588|NCT01456195|2253327|P1|STARTED|Overall Study||143
931589|NCT01456169|2253347|P3|NOT COMPLETED|Overall Study||12
931590|NCT01456169|2253348|P2|NOT COMPLETED|Overall Study||5
931591|NCT01456169|2253349|P1|NOT COMPLETED|Overall Study||10
931592|NCT01456169|2253347|P3|COMPLETED|Overall Study||123
931593|NCT01456169|2253348|P2|COMPLETED|Overall Study||122
931594|NCT01456169|2253349|P1|COMPLETED|Overall Study||123
931595|NCT01456169|2253347|P3|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|135
931596|NCT01456169|2253348|P2|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|127
931597|NCT01456169|2253349|P1|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|133
931598|NCT01456143|2253400|P1|NOT COMPLETED|Overall Study||0
931599|NCT01456143|2253400|P1|COMPLETED|Overall Study||33
931600|NCT01456143|2253400|P1|STARTED|Overall Study||33
931601|NCT01456130|2253409|P1|NOT COMPLETED|Overall Study||10
931602|NCT01456130|2253409|P1|COMPLETED|Overall Study||57
931603|NCT01456130|2253409|P1|STARTED|Overall Study||67
931604|NCT01456052|2253419|P3|NOT COMPLETED|Overall Study||5
931605|NCT01456052|2253420|P2|NOT COMPLETED|Overall Study||5
931606|NCT01456052|2253421|P1|NOT COMPLETED|Overall Study||2
931607|NCT01456052|2253419|P3|COMPLETED|Overall Study||19
931608|NCT01456052|2253420|P2|COMPLETED|Overall Study||20
931609|NCT01456052|2253421|P1|COMPLETED|Overall Study||8
931610|NCT01456052|2253419|P3|STARTED|Overall Study||24
931611|NCT01456052|2253420|P2|STARTED|Overall Study|One subject did not receive any study drug. That subject is not included in the safety population.|25
931612|NCT01456052|2253421|P1|STARTED|Overall Study||10
931613|NCT01456039|2253441|P3|NOT COMPLETED|Phase 2 (Second Step)||33
931614|NCT01456039|2253442|P2|NOT COMPLETED|Phase 2 (Second Step)||0
931615|NCT01456039|2253443|P1|NOT COMPLETED|Phase 2 (Second Step)||0
931616|NCT01456039|2253441|P3|COMPLETED|Phase 2 (Second Step)||7
931617|NCT01456039|2253442|P2|COMPLETED|Phase 2 (Second Step)||0
931618|NCT01456039|2253443|P1|COMPLETED|Phase 2 (Second Step)||0
931619|NCT01456039|2253441|P3|STARTED|Phase 2 (Second Step)||40
931620|NCT01456039|2253442|P2|STARTED|Phase 2 (Second Step)||0
931621|NCT01456039|2253443|P1|STARTED|Phase 2 (Second Step)||0
931622|NCT01456039|2253441|P3|NOT COMPLETED|Phase 1 (First Step)||0
931623|NCT01456039|2253442|P2|NOT COMPLETED|Phase 1 (First Step)||7
931624|NCT01456039|2253443|P1|NOT COMPLETED|Phase 1 (First Step)||2
931625|NCT01456039|2253441|P3|COMPLETED|Phase 1 (First Step)||0
931626|NCT01456039|2253442|P2|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
931627|NCT01456039|2253443|P1|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
931628|NCT01456039|2253441|P3|STARTED|Phase 1 (First Step)||0
931629|NCT01456039|2253442|P2|STARTED|Phase 1 (First Step)||8
931630|NCT01456039|2253443|P1|STARTED|Phase 1 (First Step)||3
931631|NCT01456000|2253515|P2|NOT COMPLETED|Overall Study||3
931632|NCT01456000|2253516|P1|NOT COMPLETED|Overall Study||8
931633|NCT01456000|2253515|P2|COMPLETED|Overall Study||172
931634|NCT01456000|2253516|P1|COMPLETED|Overall Study||170
931635|NCT01456000|2253515|P2|STARTED|Overall Study||175
931636|NCT01456000|2253516|P1|STARTED|Overall Study||178
931637|NCT01455545|2253522|P2|NOT COMPLETED|Overall Study||0
931638|NCT01455545|2253523|P1|NOT COMPLETED|Overall Study||0
931639|NCT01455545|2253522|P2|COMPLETED|Overall Study||45
931640|NCT01455545|2253523|P1|COMPLETED|Overall Study||55
931641|NCT01455545|2253522|P2|STARTED|Overall Study||45
931642|NCT01455545|2253523|P1|STARTED|Overall Study||55
931649|NCT01455428|2253586|P2|NOT COMPLETED|Overall Study||18
931650|NCT01455428|2253587|P1|NOT COMPLETED|Overall Study||14
931651|NCT01455428|2253586|P2|COMPLETED|Overall Study||92
931652|NCT01455428|2253587|P1|COMPLETED|Overall Study||98
931653|NCT01455428|2253586|P2|Treated|Overall Study||109
931654|NCT01455428|2253587|P1|Treated|Overall Study||111
931655|NCT01455428|2253586|P2|STARTED|Overall Study||110
931656|NCT01455428|2253587|P1|STARTED|Overall Study||112
931657|NCT01455415|2253643|P2|NOT COMPLETED|Follow-up||2
931658|NCT01455415|2253644|P1|NOT COMPLETED|Follow-up||3
931659|NCT01455415|2253643|P2|COMPLETED|Follow-up||104
931660|NCT01455415|2253644|P1|COMPLETED|Follow-up||111
931661|NCT01455415|2253643|P2|STARTED|Follow-up||106
931662|NCT01455415|2253644|P1|STARTED|Follow-up||114
931663|NCT01455415|2253643|P2|NOT COMPLETED|Period 2||10
931664|NCT01455415|2253644|P1|NOT COMPLETED|Period 2||13
931665|NCT01455415|2253643|P2|COMPLETED|Period 2||106
931666|NCT01455415|2253644|P1|COMPLETED|Period 2||114
931667|NCT01455415|2253643|P2|STARTED|Period 2||116
931668|NCT01455415|2253644|P1|STARTED|Period 2||127
931669|NCT01455415|2253643|P2|NOT COMPLETED|Washout||7
931670|NCT01455415|2253644|P1|NOT COMPLETED|Washout||8
931671|NCT01455415|2253643|P2|COMPLETED|Washout||116
931672|NCT01455415|2253644|P1|COMPLETED|Washout||127
931673|NCT01455415|2253643|P2|STARTED|Washout||123
931674|NCT01455415|2253644|P1|STARTED|Washout||135
931675|NCT01455415|2253643|P2|NOT COMPLETED|Period 1||24
931676|NCT01455415|2253644|P1|NOT COMPLETED|Period 1||19
931677|NCT01455415|2253643|P2|COMPLETED|Period 1||123
931678|NCT01455415|2253644|P1|COMPLETED|Period 1||135
931679|NCT01455415|2253643|P2|STARTED|Period 1|Started=Treated|147
931680|NCT01455415|2253644|P1|STARTED|Period 1|Started=Treated|154
931681|NCT01455220|2253694|P1|NOT COMPLETED|Overall Study||30
931682|NCT01455220|2253694|P1|COMPLETED|Overall Study||15
931683|NCT01455220|2253694|P1|STARTED|Overall Study||45
931684|NCT01455194|2253704|P4|NOT COMPLETED|Overall Study||28
931685|NCT01455194|2253705|P3|NOT COMPLETED|Overall Study||30
931686|NCT01455194|2253706|P2|NOT COMPLETED|Overall Study||31
931687|NCT01455194|2253707|P1|NOT COMPLETED|Overall Study||153
931688|NCT01455194|2253704|P4|COMPLETED|Overall Study||97
931689|NCT01455194|2253705|P3|COMPLETED|Overall Study||92
931690|NCT01455194|2253706|P2|COMPLETED|Overall Study||89
931691|NCT01455194|2253707|P1|COMPLETED|Overall Study||0
931692|NCT01455194|2253704|P4|STARTED|Overall Study||125
931693|NCT01455194|2253705|P3|STARTED|Overall Study||122
931694|NCT01455194|2253706|P2|STARTED|Overall Study||120
931695|NCT01455194|2253707|P1|STARTED|Overall Study||153
931696|NCT01455181|2253756|P1|NOT COMPLETED|Overall Study||0
931697|NCT01455181|2253756|P1|COMPLETED|Overall Study||24
931698|NCT01455181|2253756|P1|STARTED|Overall Study||24
931699|NCT01455064|2253764|P1|NOT COMPLETED|Overall Study||1
931700|NCT01455064|2253764|P1|COMPLETED|Overall Study||30
931701|NCT01455064|2253764|P1|STARTED|Overall Study||31
931702|NCT01455012|2253770|P2|NOT COMPLETED|Overall Study||4
931703|NCT01455012|2253771|P1|NOT COMPLETED|Overall Study||11
931704|NCT01455012|2253770|P2|COMPLETED|Overall Study||36
931705|NCT01455012|2253771|P1|COMPLETED|Overall Study||30
931706|NCT01455012|2253770|P2|STARTED|Overall Study||40
931707|NCT01455012|2253771|P1|STARTED|Overall Study||41
931708|NCT01454947|2253811|P8|NOT COMPLETED|Overall Study||5
931709|NCT01454947|2253812|P7|NOT COMPLETED|Overall Study||1
931710|NCT01454947|2253813|P6|NOT COMPLETED|Overall Study||3
931711|NCT01454947|2253814|P5|NOT COMPLETED|Overall Study||1
931712|NCT01454947|2253815|P4|NOT COMPLETED|Overall Study||1
931713|NCT01454947|2253816|P3|NOT COMPLETED|Overall Study||3
931714|NCT01454947|2253817|P2|NOT COMPLETED|Overall Study||4
931715|NCT01454947|2253818|P1|NOT COMPLETED|Overall Study||3
931716|NCT01454947|2253811|P8|COMPLETED|Overall Study||23
931717|NCT01454947|2253812|P7|COMPLETED|Overall Study||26
931718|NCT01454947|2253813|P6|COMPLETED|Overall Study||32
931719|NCT01454947|2253814|P5|COMPLETED|Overall Study||33
931720|NCT01454947|2253815|P4|COMPLETED|Overall Study||19
931721|NCT01454947|2253816|P3|COMPLETED|Overall Study||32
931722|NCT01454947|2253817|P2|COMPLETED|Overall Study||38
931723|NCT01454947|2253818|P1|COMPLETED|Overall Study||24
931724|NCT01454947|2253811|P8|STARTED|Overall Study||28
931725|NCT01454947|2253812|P7|STARTED|Overall Study||27
931726|NCT01454947|2253813|P6|STARTED|Overall Study||35
931727|NCT01454947|2253814|P5|STARTED|Overall Study||34
931728|NCT01454947|2253815|P4|STARTED|Overall Study||20
931729|NCT01454947|2253816|P3|STARTED|Overall Study||35
931730|NCT01454947|2253817|P2|STARTED|Overall Study||42
931731|NCT01454947|2253818|P1|STARTED|Overall Study||27
931732|NCT01454934|2253838|P2|NOT COMPLETED|Overall Study||270
931733|NCT01454934|2253839|P1|NOT COMPLETED|Overall Study||270
931734|NCT01454934|2253838|P2|COMPLETED|Overall Study||0
931735|NCT01454934|2253839|P1|COMPLETED|Overall Study||0
931736|NCT01454934|2253838|P2|STARTED|Overall Study||270
931737|NCT01454934|2253839|P1|STARTED|Overall Study||270
931738|NCT01454830|2253851|P2|NOT COMPLETED|Overall Study||27
931739|NCT01454830|2253852|P1|NOT COMPLETED|Overall Study||31
931740|NCT01454830|2253851|P2|COMPLETED|Overall Study||30
931741|NCT01454830|2253852|P1|COMPLETED|Overall Study||30
931742|NCT01454830|2253851|P2|STARTED|Overall Study||57
931743|NCT01454830|2253852|P1|STARTED|Overall Study||61
931744|NCT01454791|2253872|P2|NOT COMPLETED|Overall Study||0
931745|NCT01454791|2253873|P1|NOT COMPLETED|Overall Study||0
931746|NCT01454791|2253872|P2|COMPLETED|Overall Study|20 subjects started with placebo, then switched to Diclofenac|20
931747|NCT01454791|2253873|P1|COMPLETED|Overall Study|20 subjects started with Diclofenac, then switched to placebo|20
931748|NCT01454791|2253872|P2|STARTED|Overall Study||20
931749|NCT01454791|2253873|P1|STARTED|Overall Study||20
931750|NCT01454778|2253883|P1|NOT COMPLETED|Overall Study||3
931751|NCT01454778|2253883|P1|COMPLETED|Overall Study||47
931752|NCT01454778|2253883|P1|STARTED|Overall Study||50
931753|NCT01454726|2253894|P2|NOT COMPLETED|Overall Study||1
931754|NCT01454726|2253895|P1|NOT COMPLETED|Overall Study||0
931755|NCT01454726|2253894|P2|COMPLETED|Overall Study||10
931756|NCT01454726|2253895|P1|COMPLETED|Overall Study||16
931757|NCT01454726|2253894|P2|STARTED|Overall Study||11
931758|NCT01454726|2253895|P1|STARTED|Overall Study||16
931759|NCT01454583|2253904|P3|NOT COMPLETED|3rd Year||297
931760|NCT01454583|2253905|P2|NOT COMPLETED|3rd Year||512
931761|NCT01454583|2253906|P1|NOT COMPLETED|3rd Year||1959
931762|NCT01454583|2253904|P3|COMPLETED|3rd Year||285
931763|NCT01454583|2253905|P2|COMPLETED|3rd Year||470
931764|NCT01454583|2253906|P1|COMPLETED|3rd Year||1832
931765|NCT01454583|2253904|P3|STARTED|3rd Year||582
931766|NCT01454583|2253905|P2|STARTED|3rd Year||982
931767|NCT01454583|2253906|P1|STARTED|3rd Year||3791
931768|NCT01454583|2253904|P3|NOT COMPLETED|2nd Year||737
931769|NCT01454583|2253905|P2|NOT COMPLETED|2nd Year||1049
931770|NCT01454583|2253906|P1|NOT COMPLETED|2nd Year||3965
931771|NCT01454583|2253904|P3|COMPLETED|2nd Year||1376
931772|NCT01454583|2253905|P2|COMPLETED|2nd Year||1647
931773|NCT01454583|2253906|P1|COMPLETED|2nd Year||6212
931774|NCT01454583|2253904|P3|STARTED|2nd Year||2113
931775|NCT01454583|2253905|P2|STARTED|2nd Year||2696
931776|NCT01454583|2253906|P1|STARTED|2nd Year||10177
931777|NCT01454583|2253904|P3|NOT COMPLETED|1st Year||180
931778|NCT01454583|2253905|P2|NOT COMPLETED|1st Year||318
931779|NCT01454583|2253906|P1|NOT COMPLETED|1st Year||1057
931780|NCT01454583|2253904|P3|COMPLETED|1st Year||1933
931781|NCT01454583|2253905|P2|COMPLETED|1st Year||2378
931782|NCT01454583|2253906|P1|COMPLETED|1st Year||9120
931783|NCT01454583|2253904|P3|STARTED|1st Year||2113
931784|NCT01454583|2253905|P2|STARTED|1st Year||2696
931785|NCT01454583|2253906|P1|STARTED|1st Year|From initially 15337 pat. 351 withdrawed from the registry, 14986 pat. were assigned to the groups.|10177
931786|NCT01454531|2253974|P1|NOT COMPLETED|Overall Study||23
931787|NCT01454531|2253974|P1|COMPLETED|Overall Study||173
931788|NCT01454531|2253974|P1|Subjects Treated|Overall Study||192
931789|NCT01454531|2253974|P1|STARTED|Overall Study||196
931790|NCT01454505|2253986|P4|NOT COMPLETED|Overall Study||0
931791|NCT01454505|2253987|P3|NOT COMPLETED|Overall Study||0
931792|NCT01454505|2253988|P2|NOT COMPLETED|Overall Study||0
931793|NCT01454505|2253989|P1|NOT COMPLETED|Overall Study||0
931794|NCT01454505|2253986|P4|COMPLETED|Overall Study||20
931795|NCT01454505|2253987|P3|COMPLETED|Overall Study||40
931796|NCT01454505|2253988|P2|COMPLETED|Overall Study||15
931797|NCT01454505|2253989|P1|COMPLETED|Overall Study||35
931798|NCT01454505|2253986|P4|STARTED|Overall Study||20
931799|NCT01454505|2253987|P3|STARTED|Overall Study||40
931800|NCT01454505|2253988|P2|STARTED|Overall Study||15
931801|NCT01454505|2253989|P1|STARTED|Overall Study||35
931802|NCT01454414|2254003|P2|NOT COMPLETED|Overall Study||16
931803|NCT01454414|2254004|P1|NOT COMPLETED|Overall Study||13
931804|NCT01454414|2254003|P2|COMPLETED|Overall Study||64
931805|NCT01454414|2254004|P1|COMPLETED|Overall Study||66
931806|NCT01454414|2254003|P2|Baseline: Subjects That Sent Uniforms|Overall Study||66
931807|NCT01454414|2254004|P1|Baseline: Subjects That Sent Uniforms|Overall Study||67
931808|NCT01454414|2254003|P2|STARTED|Overall Study||80
931809|NCT01454414|2254004|P1|STARTED|Overall Study||79
931810|NCT01454401|2254010|P1|NOT COMPLETED|Overall Study||5
931811|NCT01454401|2254010|P1|COMPLETED|Overall Study|Per Protocol (PP)|39
931812|NCT01454401|2254010|P1|STARTED|Overall Study|ITT|44
931813|NCT01454258|2254015|P1|NOT COMPLETED|Overall Study||997
931814|NCT01454258|2254015|P1|COMPLETED|Overall Study||9103
931815|NCT01454258|2254015|P1|STARTED|Overall Study||10100
931816|NCT01454063|2254023|P2|NOT COMPLETED|Treated||0
931817|NCT01454063|2254024|P1|NOT COMPLETED|Treated||2
931818|NCT01454063|2254023|P2|COMPLETED|Treated||201
931819|NCT01454063|2254024|P1|COMPLETED|Treated||199
931820|NCT01454063|2254023|P2|STARTED|Treated||201
931821|NCT01454063|2254024|P1|STARTED|Treated||201
931822|NCT01454063|2254023|P2|NOT COMPLETED|Randomized||2
931823|NCT01454063|2254024|P1|NOT COMPLETED|Randomized||1
931824|NCT01454063|2254023|P2|COMPLETED|Randomized||201
931825|NCT01454063|2254024|P1|COMPLETED|Randomized||201
931826|NCT01454063|2254023|P2|STARTED|Randomized||203
931827|NCT01454063|2254024|P1|STARTED|Randomized||202
931828|NCT01453998|2254045|P3|NOT COMPLETED|After Protocol Amendment 2.||0
931829|NCT01453998|2254046|P2|NOT COMPLETED|After Protocol Amendment 2.||0
931830|NCT01453998|2254047|P1|NOT COMPLETED|After Protocol Amendment 2.||1
931831|NCT01453998|2254045|P3|COMPLETED|After Protocol Amendment 2.||183
931832|NCT01453998|2254046|P2|COMPLETED|After Protocol Amendment 2.||99
931833|NCT01453998|2254047|P1|COMPLETED|After Protocol Amendment 2.||102
931834|NCT01453998|2254045|P3|STARTED|After Protocol Amendment 2.||183
931835|NCT01453998|2254046|P2|STARTED|After Protocol Amendment 2.||99
931836|NCT01453998|2254047|P1|STARTED|After Protocol Amendment 2.||103
931837|NCT01453998|2254045|P3|NOT COMPLETED|Before Protocol Amendment 2||0
931838|NCT01453998|2254046|P2|NOT COMPLETED|Before Protocol Amendment 2||0
931839|NCT01453998|2254047|P1|NOT COMPLETED|Before Protocol Amendment 2||0
931840|NCT01453998|2254045|P3|COMPLETED|Before Protocol Amendment 2||99
931841|NCT01453998|2254046|P2|COMPLETED|Before Protocol Amendment 2||88
931842|NCT01453998|2254047|P1|COMPLETED|Before Protocol Amendment 2||85
931843|NCT01453998|2254045|P3|STARTED|Before Protocol Amendment 2||99
931844|NCT01453998|2254046|P2|STARTED|Before Protocol Amendment 2||88
931845|NCT01453998|2254047|P1|STARTED|Before Protocol Amendment 2||85
931846|NCT01453946|2254112|P1|NOT COMPLETED|Overall Study||9
931847|NCT01453946|2254112|P1|COMPLETED|Overall Study||41
931848|NCT01453946|2254112|P1|STARTED|Overall Study||50
931849|NCT01453894|2254120|P2|NOT COMPLETED|Overall Study||0
931850|NCT01453894|2254121|P1|NOT COMPLETED|Overall Study||0
931851|NCT01453894|2254120|P2|COMPLETED|Overall Study||225
931852|NCT01453894|2254121|P1|COMPLETED|Overall Study||225
931853|NCT01453894|2254120|P2|STARTED|Overall Study||225
931854|NCT01453894|2254121|P1|STARTED|Overall Study||225
931855|NCT01453855|2254129|P2|NOT COMPLETED|Overall Study||14
931856|NCT01453855|2254130|P1|NOT COMPLETED|Overall Study||10
931857|NCT01453855|2254129|P2|COMPLETED|Overall Study||408
931858|NCT01453855|2254130|P1|COMPLETED|Overall Study||432
931859|NCT01453855|2254129|P2|STARTED|Overall Study||422
931860|NCT01453855|2254130|P1|STARTED|Overall Study||442
931861|NCT01453725|2254138|P2|NOT COMPLETED|Overall Study||11
931862|NCT01453725|2254139|P1|NOT COMPLETED|Overall Study||13
931863|NCT01453725|2254138|P2|COMPLETED|Overall Study||89
931864|NCT01453725|2254139|P1|COMPLETED|Overall Study||85
931865|NCT01453725|2254138|P2|STARTED|Overall Study||100
931866|NCT01453725|2254139|P1|STARTED|Overall Study||98
931867|NCT01453595|2254162|P3|NOT COMPLETED|Overall Study||2
931868|NCT01453595|2254163|P2|NOT COMPLETED|Overall Study||1
931869|NCT01453595|2254164|P1|NOT COMPLETED|Overall Study||2
931870|NCT01453595|2254162|P3|COMPLETED|Overall Study||0
931871|NCT01453595|2254163|P2|COMPLETED|Overall Study||5
931872|NCT01453595|2254164|P1|COMPLETED|Overall Study||0
931873|NCT01453595|2254162|P3|STARTED|Overall Study||2
931874|NCT01453595|2254163|P2|STARTED|Overall Study||6
931875|NCT01453595|2254164|P1|STARTED|Overall Study||2
931876|NCT01453569|2254173|P3|NOT COMPLETED|Overall Study||7
931877|NCT01453569|2254174|P2|NOT COMPLETED|Overall Study||14
931878|NCT01453569|2254175|P1|NOT COMPLETED|Overall Study||11
931879|NCT01453569|2254173|P3|COMPLETED|Overall Study||78
931880|NCT01453569|2254174|P2|COMPLETED|Overall Study||70
931881|NCT01453569|2254175|P1|COMPLETED|Overall Study||75
931882|NCT01453569|2254173|P3|STARTED|Overall Study||85
931883|NCT01453569|2254174|P2|STARTED|Overall Study||84
931884|NCT01453569|2254175|P1|STARTED|Overall Study||86
931885|NCT01453413|2254192|P1|NOT COMPLETED|Overall Study||0
931886|NCT01453413|2254192|P1|COMPLETED|Overall Study||297
931887|NCT01453413|2254192|P1|STARTED|Overall Study||297
931888|NCT01453387|2254199|P2|NOT COMPLETED|Overall Study||0
931889|NCT01453387|2254200|P1|NOT COMPLETED|Overall Study||0
931890|NCT01453387|2254199|P2|COMPLETED|Overall Study||7
931891|NCT01453387|2254200|P1|COMPLETED|Overall Study||21
931892|NCT01453387|2254199|P2|STARTED|Overall Study||7
931893|NCT01453387|2254200|P1|STARTED|Overall Study||21
931894|NCT01453374|2254283|P1|NOT COMPLETED|Overall Study||18
931895|NCT01453374|2254283|P1|COMPLETED|Overall Study|Defined as receiving 7 injections and 2 follow-up visits.|9
931896|NCT01453374|2254283|P1|STARTED|Overall Study||27
931906|NCT01453296|2254320|P2|NOT COMPLETED|Treatment Period 2||0
931907|NCT01453296|2254321|P1|NOT COMPLETED|Treatment Period 2||2
931908|NCT01453296|2254320|P2|COMPLETED|Treatment Period 2||13
931909|NCT01453296|2254321|P1|COMPLETED|Treatment Period 2||11
931910|NCT01453296|2254320|P2|STARTED|Treatment Period 2||13
931911|NCT01453296|2254321|P1|STARTED|Treatment Period 2||13
931912|NCT01453296|2254320|P2|NOT COMPLETED|Washout Period||0
931913|NCT01453296|2254321|P1|NOT COMPLETED|Washout Period||0
931914|NCT01453296|2254320|P2|COMPLETED|Washout Period||13
931915|NCT01453296|2254321|P1|COMPLETED|Washout Period||13
931916|NCT01453296|2254320|P2|STARTED|Washout Period||13
931917|NCT01453296|2254321|P1|STARTED|Washout Period||13
931918|NCT01453296|2254320|P2|NOT COMPLETED|Treatment Period 1||1
931919|NCT01453296|2254321|P1|NOT COMPLETED|Treatment Period 1||1
931920|NCT01453296|2254320|P2|COMPLETED|Treatment Period 1||13
931921|NCT01453296|2254321|P1|COMPLETED|Treatment Period 1||13
931922|NCT01453296|2254320|P2|STARTED|Treatment Period 1||14
931923|NCT01453296|2254321|P1|STARTED|Treatment Period 1||14
931924|NCT01453166|2254388|P3|NOT COMPLETED|Overall Study||1
931925|NCT01453166|2254389|P2|NOT COMPLETED|Overall Study||2
931926|NCT01453166|2254390|P1|NOT COMPLETED|Overall Study||2
931927|NCT01453166|2254388|P3|COMPLETED|Overall Study||38
931928|NCT01453166|2254389|P2|COMPLETED|Overall Study||39
931929|NCT01453166|2254390|P1|COMPLETED|Overall Study||40
931930|NCT01453166|2254388|P3|STARTED|Overall Study||39
931931|NCT01453166|2254389|P2|STARTED|Overall Study||41
931932|NCT01453166|2254390|P1|STARTED|Overall Study||42
931933|NCT01453075|2254412|P2|NOT COMPLETED|Overall Study||1
931934|NCT01453075|2254413|P1|NOT COMPLETED|Overall Study||5
931935|NCT01453075|2254412|P2|COMPLETED|Overall Study||14
931936|NCT01453075|2254413|P1|COMPLETED|Overall Study||11
931937|NCT01453075|2254412|P2|STARTED|Overall Study||15
931938|NCT01453075|2254413|P1|STARTED|Overall Study||16
931939|NCT01453049|2254421|P2|NOT COMPLETED|Overall Study||42
931940|NCT01453049|2254422|P1|NOT COMPLETED|Overall Study||41
931941|NCT01453049|2254421|P2|COMPLETED|Overall Study||2
931942|NCT01453049|2254422|P1|COMPLETED|Overall Study||1
931943|NCT01453049|2254421|P2|STARTED|Overall Study||44
931944|NCT01453049|2254422|P1|STARTED|Overall Study||42
931945|NCT01453036|2254495|P3|NOT COMPLETED|Overall Study||31
931946|NCT01453036|2254496|P2|NOT COMPLETED|Overall Study||115
931947|NCT01453036|2254497|P1|NOT COMPLETED|Overall Study||26
931948|NCT01453036|2254495|P3|COMPLETED|Overall Study||277
931949|NCT01453036|2254496|P2|COMPLETED|Overall Study||193
931950|NCT01453036|2254497|P1|COMPLETED|Overall Study||282
931951|NCT01453036|2254495|P3|STARTED|Overall Study||308
931952|NCT01453036|2254496|P2|STARTED|Overall Study||308
931953|NCT01453036|2254497|P1|STARTED|Overall Study||308
931954|NCT01453023|2254505|P2|NOT COMPLETED|Treatment Period 2||1
931955|NCT01453023|2254506|P1|NOT COMPLETED|Treatment Period 2||0
931956|NCT01453023|2254505|P2|COMPLETED|Treatment Period 2||11
931957|NCT01453023|2254506|P1|COMPLETED|Treatment Period 2||12
931958|NCT01453023|2254505|P2|STARTED|Treatment Period 2||12
931959|NCT01453023|2254506|P1|STARTED|Treatment Period 2||12
931960|NCT01453023|2254505|P2|NOT COMPLETED|Washout Period||0
931961|NCT01453023|2254506|P1|NOT COMPLETED|Washout Period||0
931962|NCT01453023|2254505|P2|COMPLETED|Washout Period||12
931963|NCT01453023|2254506|P1|COMPLETED|Washout Period||12
931964|NCT01453023|2254505|P2|STARTED|Washout Period||12
931965|NCT01453023|2254506|P1|STARTED|Washout Period||12
931966|NCT01453023|2254505|P2|NOT COMPLETED|Treatment Period (TP) 1||1
931967|NCT01453023|2254506|P1|NOT COMPLETED|Treatment Period (TP) 1||1
931968|NCT01453023|2254505|P2|COMPLETED|Treatment Period (TP) 1||12
931969|NCT01453023|2254506|P1|COMPLETED|Treatment Period (TP) 1||12
931970|NCT01453023|2254505|P2|STARTED|Treatment Period (TP) 1||13
931971|NCT01453023|2254506|P1|STARTED|Treatment Period (TP) 1||13
931972|NCT01452854|2254574|P1|NOT COMPLETED|Overall Study||0
931973|NCT01452854|2254574|P1|COMPLETED|Overall Study||2
931974|NCT01452854|2254574|P1|STARTED|Overall Study||2
931993|NCT01452425|2254589|P1|NOT COMPLETED|Overall Study||0
931994|NCT01452425|2254589|P1|COMPLETED|Overall Study||10
931995|NCT01452425|2254589|P1|STARTED|Overall Study||10
931996|NCT01452347|2254596|P2|NOT COMPLETED|Overall Study||7
931997|NCT01452347|2254597|P1|NOT COMPLETED|Overall Study||17
931998|NCT01452347|2254596|P2|COMPLETED|Overall Study||77
931999|NCT01452347|2254597|P1|COMPLETED|Overall Study||151
932000|NCT01452347|2254596|P2|STARTED|Overall Study||84
932001|NCT01452347|2254597|P1|STARTED|Overall Study||168
932002|NCT01452269|2254615|P2|NOT COMPLETED|Overall Study||5
932003|NCT01452269|2254616|P1|NOT COMPLETED|Overall Study||1
932004|NCT01452269|2254615|P2|COMPLETED|Overall Study||51
932005|NCT01452269|2254616|P1|COMPLETED|Overall Study||47
932006|NCT01452269|2254615|P2|STARTED|Overall Study||56
932007|NCT01452269|2254616|P1|STARTED|Overall Study||48
932008|NCT01452152|2254629|P3|NOT COMPLETED|Overall Study||4
932009|NCT01452152|2254630|P2|NOT COMPLETED|Overall Study||0
932010|NCT01452152|2254631|P1|NOT COMPLETED|Overall Study||5
932011|NCT01452152|2254629|P3|COMPLETED|Overall Study||0
932012|NCT01452152|2254630|P2|COMPLETED|Overall Study||0
932013|NCT01452152|2254631|P1|COMPLETED|Overall Study||0
932014|NCT01452152|2254629|P3|STARTED|Overall Study||4
932015|NCT01452152|2254630|P2|STARTED|Overall Study||0
932016|NCT01452152|2254631|P1|STARTED|Overall Study||5
932017|NCT01452126|2254639|P1|NOT COMPLETED|Overall Study||0
932018|NCT01452126|2254639|P1|COMPLETED|Overall Study||49
932019|NCT01452126|2254639|P1|STARTED|Overall Study||49
932020|NCT01451983|2254651|P4|NOT COMPLETED|Overall Study||0
932021|NCT01451983|2254652|P3|NOT COMPLETED|Overall Study||0
932022|NCT01451983|2254653|P2|NOT COMPLETED|Overall Study||0
932023|NCT01451983|2254654|P1|NOT COMPLETED|Overall Study||0
932024|NCT01451983|2254651|P4|COMPLETED|Overall Study||24
932025|NCT01451983|2254652|P3|COMPLETED|Overall Study||61
932026|NCT01451983|2254653|P2|COMPLETED|Overall Study||27
932027|NCT01451983|2254654|P1|COMPLETED|Overall Study||26
932028|NCT01451983|2254651|P4|STARTED|Overall Study||24
932029|NCT01451983|2254652|P3|STARTED|Overall Study||61
932030|NCT01451983|2254653|P2|STARTED|Overall Study||27
932031|NCT01451983|2254654|P1|STARTED|Overall Study||26
932032|NCT01451931|2254667|P3|NOT COMPLETED|Overall Study||43
932033|NCT01451931|2254668|P2|NOT COMPLETED|Overall Study||58
932034|NCT01451931|2254669|P1|NOT COMPLETED|Overall Study||33
932035|NCT01451931|2254667|P3|COMPLETED|Overall Study||923
932036|NCT01451931|2254668|P2|COMPLETED|Overall Study||843
932037|NCT01451931|2254669|P1|COMPLETED|Overall Study||876
932038|NCT01451931|2254667|P3|6-month Follow up|Overall Study||923
932039|NCT01451931|2254668|P2|6-month Follow up|Overall Study||843
932040|NCT01451931|2254669|P1|6-month Follow up|Overall Study||876
932041|NCT01451931|2254667|P3|Baseline Data Collection|Overall Study||958
932042|NCT01451931|2254668|P2|Baseline Data Collection|Overall Study||893
932043|NCT01451931|2254669|P1|Baseline Data Collection|Overall Study||908
932044|NCT01451931|2254667|P3|STARTED|Overall Study||966
932045|NCT01451931|2254668|P2|STARTED|Overall Study||901
932046|NCT01451931|2254669|P1|STARTED|Overall Study||909
932047|NCT01451814|2254691|P2|NOT COMPLETED|Overall Study||5
932048|NCT01451814|2254692|P1|NOT COMPLETED|Overall Study||6
932049|NCT01451814|2254691|P2|COMPLETED|Overall Study||26
932050|NCT01451814|2254692|P1|COMPLETED|Overall Study||29
932051|NCT01451814|2254691|P2|Attended a Session|Overall Study||31
932052|NCT01451814|2254692|P1|Attended a Session|Overall Study||35
932053|NCT01451814|2254691|P2|STARTED|Overall Study||31
932054|NCT01451814|2254692|P1|STARTED|Overall Study||35
932055|NCT01451775|2254702|P6|NOT COMPLETED|Overall Study||0
932056|NCT01451775|2254703|P5|NOT COMPLETED|Overall Study||0
932057|NCT01451775|2254704|P4|NOT COMPLETED|Overall Study||0
932058|NCT01451775|2254705|P3|NOT COMPLETED|Overall Study||0
932059|NCT01451775|2254706|P2|NOT COMPLETED|Overall Study||0
932060|NCT01451775|2254707|P1|NOT COMPLETED|Overall Study||0
932061|NCT01451775|2254702|P6|COMPLETED|Overall Study||3
932062|NCT01451775|2254703|P5|COMPLETED|Overall Study||3
932063|NCT01451775|2254704|P4|COMPLETED|Overall Study||3
932064|NCT01451775|2254705|P3|COMPLETED|Overall Study||3
932065|NCT01451775|2254706|P2|COMPLETED|Overall Study||3
932066|NCT01451775|2254707|P1|COMPLETED|Overall Study||3
932067|NCT01451775|2254702|P6|STARTED|Overall Study||3
932068|NCT01451775|2254703|P5|STARTED|Overall Study||3
932069|NCT01451775|2254704|P4|STARTED|Overall Study||3
932070|NCT01451775|2254705|P3|STARTED|Overall Study||3
932071|NCT01451775|2254706|P2|STARTED|Overall Study||3
932072|NCT01451775|2254707|P1|STARTED|Overall Study||3
932073|NCT01451762|2254724|P3|NOT COMPLETED|Overall Study||6
932074|NCT01451762|2254725|P2|NOT COMPLETED|Overall Study||6
932075|NCT01451762|2254726|P1|NOT COMPLETED|Overall Study||3
932076|NCT01451762|2254724|P3|COMPLETED|Overall Study||24
932077|NCT01451762|2254725|P2|COMPLETED|Overall Study||24
932078|NCT01451762|2254726|P1|COMPLETED|Overall Study||27
932079|NCT01451762|2254724|P3|STARTED|Overall Study||30
932080|NCT01451762|2254725|P2|STARTED|Overall Study||30
932081|NCT01451762|2254726|P1|STARTED|Overall Study||30
932082|NCT01451749|2254736|P2|NOT COMPLETED|Overall Study||14
932083|NCT01451749|2254737|P1|NOT COMPLETED|Overall Study||32
932084|NCT01451749|2254736|P2|COMPLETED|Overall Study||94
932085|NCT01451749|2254737|P1|COMPLETED|Overall Study||184
932086|NCT01451749|2254736|P2|STARTED|Overall Study||108
932087|NCT01451749|2254737|P1|STARTED|Overall Study||216
932088|NCT01451723|2254749|P2|NOT COMPLETED|Overall Study||5
932089|NCT01451723|2254750|P1|NOT COMPLETED|Overall Study||6
932090|NCT01451723|2254749|P2|COMPLETED|Overall Study||0
932091|NCT01451723|2254750|P1|COMPLETED|Overall Study||0
932092|NCT01451723|2254749|P2|STARTED|Overall Study||5
932093|NCT01451723|2254750|P1|STARTED|Overall Study||6
932094|NCT01451645|2254760|P2|NOT COMPLETED|Overall Study||8
932095|NCT01451645|2254761|P1|NOT COMPLETED|Overall Study||9
932096|NCT01451645|2254760|P2|COMPLETED|Overall Study||33
932097|NCT01451645|2254761|P1|COMPLETED|Overall Study||32
932098|NCT01451645|2254760|P2|STARTED|Overall Study||41
932099|NCT01451645|2254761|P1|STARTED|Overall Study||41
932100|NCT01451632|2254775|P10|NOT COMPLETED|Overall Study||0
932101|NCT01451632|2254776|P9|NOT COMPLETED|Overall Study||0
932102|NCT01451632|2254777|P8|NOT COMPLETED|Overall Study||0
932103|NCT01451632|2254778|P7|NOT COMPLETED|Overall Study||0
932104|NCT01451632|2254779|P6|NOT COMPLETED|Overall Study||0
932105|NCT01451632|2254780|P5|NOT COMPLETED|Overall Study||0
932106|NCT01451632|2254781|P4|NOT COMPLETED|Overall Study||0
932107|NCT01451632|2254782|P3|NOT COMPLETED|Overall Study||0
932108|NCT01451632|2254783|P2|NOT COMPLETED|Overall Study||0
932109|NCT01451632|2254784|P1|NOT COMPLETED|Overall Study||0
932110|NCT01451632|2254775|P10|COMPLETED|Overall Study||4
932111|NCT01451632|2254776|P9|COMPLETED|Overall Study||4
932112|NCT01451632|2254777|P8|COMPLETED|Overall Study||6
932113|NCT01451632|2254778|P7|COMPLETED|Overall Study||8
932114|NCT01451632|2254779|P6|COMPLETED|Overall Study||4
932115|NCT01451632|2254780|P5|COMPLETED|Overall Study||4
932116|NCT01451632|2254781|P4|COMPLETED|Overall Study||3
932117|NCT01451632|2254782|P3|COMPLETED|Overall Study||3
932118|NCT01451632|2254783|P2|COMPLETED|Overall Study||4
932119|NCT01451632|2254784|P1|COMPLETED|Overall Study||8
932120|NCT01451632|2254775|P10|STARTED|Overall Study||4
932121|NCT01451632|2254776|P9|STARTED|Overall Study||4
932122|NCT01451632|2254777|P8|STARTED|Overall Study||6
932123|NCT01451632|2254778|P7|STARTED|Overall Study||8
932124|NCT01451632|2254779|P6|STARTED|Overall Study||4
932125|NCT01451632|2254780|P5|STARTED|Overall Study||4
932126|NCT01451632|2254781|P4|STARTED|Overall Study||3
932127|NCT01451632|2254782|P3|STARTED|Overall Study||3
932128|NCT01451632|2254783|P2|STARTED|Overall Study||4
932129|NCT01451632|2254784|P1|STARTED|Overall Study||8
932130|NCT01451554|2254832|P2|NOT COMPLETED|Overall Study||9
932131|NCT01451554|2254833|P1|NOT COMPLETED|Overall Study||14
932132|NCT01451554|2254832|P2|COMPLETED|Overall Study||23
932133|NCT01451554|2254833|P1|COMPLETED|Overall Study||19
932134|NCT01451554|2254832|P2|STARTED|Overall Study||32
932135|NCT01451554|2254833|P1|STARTED|Overall Study||33
932136|NCT01451541|2254844|P3|NOT COMPLETED|Overall Study||27
932137|NCT01451541|2254845|P2|NOT COMPLETED|Overall Study||25
932138|NCT01451541|2254846|P1|NOT COMPLETED|Overall Study||36
932139|NCT01451541|2254844|P3|COMPLETED|Overall Study||254
932140|NCT01451541|2254845|P2|COMPLETED|Overall Study||257
932141|NCT01451541|2254846|P1|COMPLETED|Overall Study||247
932142|NCT01451541|2254844|P3|STARTED|Overall Study|283 randomized. ITT = 281 (2 subjects discontinued prior to study medication).|281
932143|NCT01451541|2254845|P2|STARTED|Overall Study||282
932144|NCT01451541|2254846|P1|STARTED|Overall Study||283
932145|NCT01451437|2254895|P9|NOT COMPLETED|Overall Study||4
932146|NCT01451437|2254896|P8|NOT COMPLETED|Overall Study||3
932147|NCT01451437|2254897|P7|NOT COMPLETED|Overall Study||6
932148|NCT01451437|2254898|P6|NOT COMPLETED|Overall Study||3
932149|NCT01451437|2254899|P5|NOT COMPLETED|Overall Study||4
932150|NCT01451437|2254900|P4|NOT COMPLETED|Overall Study||1
932151|NCT01451437|2254901|P3|NOT COMPLETED|Overall Study||3
932152|NCT01451437|2254902|P2|NOT COMPLETED|Overall Study||1
932153|NCT01451437|2254903|P1|NOT COMPLETED|Overall Study||1
932154|NCT01451437|2254895|P9|COMPLETED|Overall Study||0
932155|NCT01451437|2254896|P8|COMPLETED|Overall Study||0
932156|NCT01451437|2254897|P7|COMPLETED|Overall Study||0
932157|NCT01451437|2254898|P6|COMPLETED|Overall Study||0
932158|NCT01451437|2254899|P5|COMPLETED|Overall Study||0
932159|NCT01451437|2254900|P4|COMPLETED|Overall Study||0
932160|NCT01451437|2254901|P3|COMPLETED|Overall Study||0
932161|NCT01451437|2254902|P2|COMPLETED|Overall Study||0
932162|NCT01451437|2254903|P1|COMPLETED|Overall Study||0
932163|NCT01451437|2254895|P9|STARTED|Overall Study||4
932164|NCT01451437|2254896|P8|STARTED|Overall Study||3
932165|NCT01451437|2254897|P7|STARTED|Overall Study||6
932166|NCT01451437|2254898|P6|STARTED|Overall Study||3
932167|NCT01451437|2254899|P5|STARTED|Overall Study||4
932168|NCT01451437|2254900|P4|STARTED|Overall Study||1
932169|NCT01451437|2254901|P3|STARTED|Overall Study||3
932170|NCT01451437|2254902|P2|STARTED|Overall Study||1
932171|NCT01451437|2254903|P1|STARTED|Overall Study||1
932172|NCT01451424|2255035|P4|NOT COMPLETED|Overall Study||5
932173|NCT01451424|2255036|P3|NOT COMPLETED|Overall Study||1
932174|NCT01451424|2255037|P2|NOT COMPLETED|Overall Study||2
932175|NCT01451424|2255038|P1|NOT COMPLETED|Overall Study||1
932176|NCT01451424|2255035|P4|COMPLETED|Overall Study||5
932177|NCT01451424|2255036|P3|COMPLETED|Overall Study||11
932178|NCT01451424|2255037|P2|COMPLETED|Overall Study||7
932179|NCT01451424|2255038|P1|COMPLETED|Overall Study||8
932180|NCT01451424|2255035|P4|STARTED|Overall Study||10
932181|NCT01451424|2255036|P3|STARTED|Overall Study||12
932182|NCT01451424|2255037|P2|STARTED|Overall Study||9
932183|NCT01451424|2255038|P1|STARTED|Overall Study||9
932184|NCT01451411|2255071|P2|NOT COMPLETED|Overall Study||0
932185|NCT01451411|2255072|P1|NOT COMPLETED|Overall Study||0
932186|NCT01451411|2255071|P2|COMPLETED|Overall Study||1
932187|NCT01451411|2255072|P1|COMPLETED|Overall Study||3
932188|NCT01451411|2255071|P2|STARTED|Overall Study||1
932189|NCT01451411|2255072|P1|STARTED|Overall Study||3
932190|NCT01451398|2255096|P2|NOT COMPLETED|Overall Study||37
932191|NCT01451398|2255097|P1|NOT COMPLETED|Overall Study||27
932192|NCT01451398|2255096|P2|COMPLETED|Overall Study||139
932193|NCT01451398|2255097|P1|COMPLETED|Overall Study||150
932194|NCT01451398|2255096|P2|STARTED|Overall Study||176
932195|NCT01451398|2255097|P1|STARTED|Overall Study||177
932196|NCT01451203|2255131|P2|NOT COMPLETED|Post-treatment Period||34
932197|NCT01451203|2255132|P1|NOT COMPLETED|Post-treatment Period||14
932198|NCT01451203|2255131|P2|COMPLETED|Post-treatment Period||74
932199|NCT01451203|2255132|P1|COMPLETED|Post-treatment Period||57
932200|NCT01451203|2255131|P2|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|28
932201|NCT01451203|2255132|P1|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|12
932202|NCT01451203|2255131|P2|STARTED|Post-treatment Period|Three participants received rescue treatment and did not enter this period.|108
932203|NCT01451203|2255132|P1|STARTED|Post-treatment Period|Two participants received rescue treatment and did not enter this period.|71
932204|NCT01451203|2255131|P2|NOT COMPLETED|Double-blind Treatment Period||50
932205|NCT01451203|2255132|P1|NOT COMPLETED|Double-blind Treatment Period||85
932206|NCT01451203|2255131|P2|COMPLETED|Double-blind Treatment Period||111
932207|NCT01451203|2255132|P1|COMPLETED|Double-blind Treatment Period||73
932208|NCT01451203|2255131|P2|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|36
932209|NCT01451203|2255132|P1|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|70
932210|NCT01451203|2255131|P2|Received Treatment|Double-blind Treatment Period||159
932211|NCT01451203|2255132|P1|Received Treatment|Double-blind Treatment Period||157
932212|NCT01451203|2255131|P2|STARTED|Double-blind Treatment Period||161
932213|NCT01451203|2255132|P1|STARTED|Double-blind Treatment Period||158
932214|NCT01450813|2255150|P4|NOT COMPLETED|Overall Study||3
932215|NCT01450813|2255151|P3|NOT COMPLETED|Overall Study||0
932216|NCT01450813|2255152|P2|NOT COMPLETED|Overall Study||1
932217|NCT01450813|2255153|P1|NOT COMPLETED|Overall Study||1
932218|NCT01450813|2255150|P4|COMPLETED|Overall Study||17
932219|NCT01450813|2255151|P3|COMPLETED|Overall Study||20
932220|NCT01450813|2255152|P2|COMPLETED|Overall Study||19
932221|NCT01450813|2255153|P1|COMPLETED|Overall Study||19
932222|NCT01450813|2255150|P4|STARTED|Overall Study||20
932223|NCT01450813|2255151|P3|STARTED|Overall Study||20
932224|NCT01450813|2255152|P2|STARTED|Overall Study||20
932225|NCT01450813|2255153|P1|STARTED|Overall Study||20
932226|NCT01450800|2255167|P2|NOT COMPLETED|Overall Study||3
932227|NCT01450800|2255168|P1|NOT COMPLETED|Overall Study||1
932228|NCT01450800|2255167|P2|COMPLETED|Overall Study||78
932229|NCT01450800|2255168|P1|COMPLETED|Overall Study||81
932230|NCT01450800|2255167|P2|STARTED|Overall Study|81 participants were randomized to placebo|81
932231|NCT01450800|2255168|P1|STARTED|Overall Study|82 participants were randomized to nitrofurantoin|82
932232|NCT01450787|2255184|P2|NOT COMPLETED|Overall Study||0
932233|NCT01450787|2255185|P1|NOT COMPLETED|Overall Study||0
932234|NCT01450787|2255184|P2|COMPLETED|Overall Study||25
932235|NCT01450787|2255185|P1|COMPLETED|Overall Study||38
932236|NCT01450787|2255184|P2|STARTED|Overall Study||25
932237|NCT01450787|2255185|P1|STARTED|Overall Study||38
932238|NCT01450761|2255203|P2|NOT COMPLETED|Treatment With Blinded Study Therapy||466
932239|NCT01450761|2255204|P1|NOT COMPLETED|Treatment With Blinded Study Therapy||464
932240|NCT01450761|2255203|P2|COMPLETED|Treatment With Blinded Study Therapy||10
932241|NCT01450761|2255204|P1|COMPLETED|Treatment With Blinded Study Therapy||14
932242|NCT01450761|2255203|P2|STARTED|Treatment With Blinded Study Therapy||476
932243|NCT01450761|2255204|P1|STARTED|Treatment With Blinded Study Therapy||478
932244|NCT01450761|2255203|P2|NOT COMPLETED|Lead-in Chemotherapy||85
932245|NCT01450761|2255204|P1|NOT COMPLETED|Lead-in Chemotherapy||84
932246|NCT01450761|2255203|P2|COMPLETED|Lead-in Chemotherapy||476
932247|NCT01450761|2255204|P1|COMPLETED|Lead-in Chemotherapy||478
932248|NCT01450761|2255203|P2|STARTED|Lead-in Chemotherapy||561
932249|NCT01450761|2255204|P1|STARTED|Lead-in Chemotherapy||562
932250|NCT01450761|2255203|P2|NOT COMPLETED|Randomization||5
932251|NCT01450761|2255204|P1|NOT COMPLETED|Randomization||4
932252|NCT01450761|2255203|P2|COMPLETED|Randomization||561
932253|NCT01450761|2255204|P1|COMPLETED|Randomization||562
932254|NCT01450761|2255203|P2|STARTED|Randomization||566
932255|NCT01450761|2255204|P1|STARTED|Randomization||566
932256|NCT01450696|2255216|P2|NOT COMPLETED|Overall Study||148
932257|NCT01450696|2255217|P1|NOT COMPLETED|Overall Study||148
932258|NCT01450696|2255216|P2|COMPLETED|Overall Study||0
932259|NCT01450696|2255217|P1|COMPLETED|Overall Study||0
932260|NCT01450696|2255216|P2|Treated (Safety Population)|Overall Study||147
932261|NCT01450696|2255217|P1|Treated (Safety Population)|Overall Study||147
932262|NCT01450696|2255216|P2|STARTED|Overall Study||148
932263|NCT01450696|2255217|P1|STARTED|Overall Study||148
932264|NCT01450683|2255239|P1|NOT COMPLETED|Overall Study||2
932265|NCT01450683|2255239|P1|COMPLETED|Overall Study||2
932266|NCT01450683|2255239|P1|STARTED|Overall Study||4
932267|NCT01450631|2255245|P2|NOT COMPLETED|Overall Study||4
932268|NCT01450631|2255246|P1|NOT COMPLETED|Overall Study||3
932269|NCT01450631|2255245|P2|COMPLETED|Overall Study||42
932270|NCT01450631|2255246|P1|COMPLETED|Overall Study||43
932271|NCT01450631|2255245|P2|STARTED|Overall Study||46
932272|NCT01450631|2255246|P1|STARTED|Overall Study||46
932273|NCT01450397|2255254|P1|NOT COMPLETED|Overall Study||0
932274|NCT01450397|2255254|P1|COMPLETED|Overall Study||5
932275|NCT01450397|2255254|P1|STARTED|Overall Study||5
932276|NCT01450319|2255258|P1|NOT COMPLETED|Overall Study||0
932277|NCT01450319|2255258|P1|COMPLETED|Overall Study||70
932278|NCT01450319|2255258|P1|STARTED|Overall Study||70
932279|NCT01450306|2255271|P2|NOT COMPLETED|Overall Study||0
932280|NCT01450306|2255272|P1|NOT COMPLETED|Overall Study||0
932281|NCT01450306|2255271|P2|COMPLETED|Overall Study||10
932282|NCT01450306|2255272|P1|COMPLETED|Overall Study||10
932283|NCT01450306|2255271|P2|STARTED|Overall Study||10
932284|NCT01450306|2255272|P1|STARTED|Overall Study||10
932285|NCT01450189|2255285|P3|NOT COMPLETED|Overall Study||0
932286|NCT01450189|2255286|P2|NOT COMPLETED|Overall Study||0
932287|NCT01450189|2255287|P1|NOT COMPLETED|Overall Study||0
932288|NCT01450189|2255285|P3|COMPLETED|Overall Study||19
932289|NCT01450189|2255286|P2|COMPLETED|Overall Study||18
932290|NCT01450189|2255287|P1|COMPLETED|Overall Study||9
932291|NCT01450189|2255285|P3|STARTED|Overall Study||19
932292|NCT01450189|2255286|P2|STARTED|Overall Study||18
932293|NCT01450189|2255287|P1|STARTED|Overall Study||9
932294|NCT01450007|2255377|P3|NOT COMPLETED|Overall Study||3
932295|NCT01450007|2255378|P2|NOT COMPLETED|Overall Study||5
932296|NCT01450007|2255379|P1|NOT COMPLETED|Overall Study||2
932297|NCT01450007|2255377|P3|COMPLETED|Overall Study||41
932298|NCT01450007|2255378|P2|COMPLETED|Overall Study||37
932299|NCT01450007|2255379|P1|COMPLETED|Overall Study||42
932300|NCT01450007|2255377|P3|STARTED|Overall Study||44
932301|NCT01450007|2255378|P2|STARTED|Overall Study||42
932302|NCT01450007|2255379|P1|STARTED|Overall Study||44
932303|NCT01449955|2255398|P2|NOT COMPLETED|Overall Study||2
932304|NCT01449955|2255399|P1|NOT COMPLETED|Overall Study||1
932305|NCT01449955|2255398|P2|COMPLETED|Overall Study||24
932306|NCT01449955|2255399|P1|COMPLETED|Overall Study||27
932307|NCT01449955|2255398|P2|STARTED|Overall Study||26
932308|NCT01449955|2255399|P1|STARTED|Overall Study||28
932317|NCT01449812|2255447|P3|NOT COMPLETED|Overall Study||1
932318|NCT01449812|2255448|P2|NOT COMPLETED|Overall Study||0
932319|NCT01449812|2255449|P1|NOT COMPLETED|Overall Study||2
932320|NCT01449812|2255447|P3|COMPLETED|Overall Study||279
932321|NCT01449812|2255448|P2|COMPLETED|Overall Study||273
932322|NCT01449812|2255449|P1|COMPLETED|Overall Study||270
932323|NCT01449812|2255447|P3|STARTED|Overall Study||280
932324|NCT01449812|2255448|P2|STARTED|Overall Study||273
932325|NCT01449812|2255449|P1|STARTED|Overall Study||272
932326|NCT01449747|2255543|P2|NOT COMPLETED|Overall Study||0
932327|NCT01449747|2255544|P1|NOT COMPLETED|Overall Study||0
932328|NCT01449747|2255543|P2|COMPLETED|Overall Study||12
932329|NCT01449747|2255544|P1|COMPLETED|Overall Study||12
932330|NCT01449747|2255543|P2|STARTED|Overall Study||12
932331|NCT01449747|2255544|P1|STARTED|Overall Study||12
932332|NCT01449734|2255558|P1|NOT COMPLETED|Overall Study||0
932333|NCT01449734|2255558|P1|COMPLETED|Overall Study||215
932334|NCT01449734|2255558|P1|STARTED|Overall Study||215
932335|NCT01449721|2255564|P2|NOT COMPLETED|Overall Study||2
932336|NCT01449721|2255565|P1|NOT COMPLETED|Overall Study||0
932337|NCT01449721|2255564|P2|COMPLETED|Overall Study||28
932338|NCT01449721|2255565|P1|COMPLETED|Overall Study||112
932339|NCT01449721|2255564|P2|STARTED|Overall Study||30
932340|NCT01449721|2255565|P1|STARTED|Overall Study||112
932341|NCT01449708|2255577|P2|NOT COMPLETED|Overall Study||3
932342|NCT01449708|2255578|P1|NOT COMPLETED|Overall Study||2
932343|NCT01449708|2255577|P2|COMPLETED|Overall Study||60
932344|NCT01449708|2255578|P1|COMPLETED|Overall Study||59
932345|NCT01449708|2255577|P2|STARTED|Overall Study||63
932346|NCT01449708|2255578|P1|STARTED|Overall Study||61
932347|NCT01449682|2255589|P2|NOT COMPLETED|Overall Study||1
932348|NCT01449682|2255590|P1|NOT COMPLETED|Overall Study||1
932349|NCT01449682|2255589|P2|COMPLETED|Overall Study||4
932350|NCT01449682|2255590|P1|COMPLETED|Overall Study||4
932351|NCT01449682|2255589|P2|STARTED|Overall Study||5
932352|NCT01449682|2255590|P1|STARTED|Overall Study||5
932353|NCT01449539|2255602|P1|NOT COMPLETED|Overall Study||4
932354|NCT01449539|2255602|P1|COMPLETED|Overall Study||4
932355|NCT01449539|2255602|P1|STARTED|Overall Study||8
932356|NCT01449526|2255608|P2|NOT COMPLETED|Overall Study||6
932357|NCT01449526|2255609|P1|NOT COMPLETED|Overall Study||2
932358|NCT01449526|2255608|P2|COMPLETED|Overall Study||77
932359|NCT01449526|2255609|P1|COMPLETED|Overall Study||81
932360|NCT01449526|2255608|P2|STARTED|Overall Study||83
932361|NCT01449526|2255609|P1|STARTED|Overall Study||83
932362|NCT01449513|2255619|P2|NOT COMPLETED|Overall Study||0
932363|NCT01449513|2255620|P1|NOT COMPLETED|Overall Study||0
932364|NCT01449513|2255619|P2|COMPLETED|Overall Study||8
932365|NCT01449513|2255620|P1|COMPLETED|Overall Study||16
932366|NCT01449513|2255619|P2|STARTED|Overall Study||8
932367|NCT01449513|2255620|P1|STARTED|Overall Study||16
932368|NCT01449461|2255678|P6|NOT COMPLETED|Overall Study||15
932369|NCT01449461|2255679|P5|NOT COMPLETED|Overall Study||48
932370|NCT01449461|2255680|P4|NOT COMPLETED|Overall Study||32
932371|NCT01449461|2255681|P3|NOT COMPLETED|Overall Study||18
932372|NCT01449461|2255682|P2|NOT COMPLETED|Overall Study||18
932373|NCT01449461|2255683|P1|NOT COMPLETED|Overall Study||6
932374|NCT01449461|2255678|P6|COMPLETED|Overall Study||0
932375|NCT01449461|2255679|P5|COMPLETED|Overall Study||0
932376|NCT01449461|2255680|P4|COMPLETED|Overall Study||0
932377|NCT01449461|2255681|P3|COMPLETED|Overall Study||0
932378|NCT01449461|2255682|P2|COMPLETED|Overall Study||0
932379|NCT01449461|2255683|P1|COMPLETED|Overall Study||0
932380|NCT01449461|2255678|P6|STARTED|Overall Study||15
932381|NCT01449461|2255679|P5|STARTED|Overall Study||48
932382|NCT01449461|2255680|P4|STARTED|Overall Study||32
932383|NCT01449461|2255681|P3|STARTED|Overall Study||18
932384|NCT01449461|2255682|P2|STARTED|Overall Study||18
932385|NCT01449461|2255683|P1|STARTED|Overall Study||6
932386|NCT01449370|2255820|P25|NOT COMPLETED|Overall Study||8
932387|NCT01449370|2255821|P24|NOT COMPLETED|Overall Study||10
932388|NCT01449370|2255822|P23|NOT COMPLETED|Overall Study||4
932389|NCT01449370|2255823|P22|NOT COMPLETED|Overall Study||4
932390|NCT01449370|2255824|P21|NOT COMPLETED|Overall Study||6
932391|NCT01449370|2255825|P20|NOT COMPLETED|Overall Study||3
932392|NCT01449370|2255826|P19|NOT COMPLETED|Overall Study||3
932393|NCT01449370|2255827|P18|NOT COMPLETED|Overall Study||3
932394|NCT01449370|2255828|P17|NOT COMPLETED|Overall Study||7
932395|NCT01449370|2255829|P16|NOT COMPLETED|Overall Study||3
932396|NCT01449370|2255830|P15|NOT COMPLETED|Overall Study||3
932397|NCT01449370|2255831|P14|NOT COMPLETED|Overall Study||11
932398|NCT01449370|2255832|P13|NOT COMPLETED|Overall Study||3
932399|NCT01449370|2255833|P12|NOT COMPLETED|Overall Study||3
932400|NCT01449370|2255834|P11|NOT COMPLETED|Overall Study||3
932401|NCT01449370|2255835|P10|NOT COMPLETED|Overall Study||3
932402|NCT01449370|2255836|P9|NOT COMPLETED|Overall Study||12
932403|NCT01449370|2255837|P8|NOT COMPLETED|Overall Study||3
932404|NCT01449370|2255838|P7|NOT COMPLETED|Overall Study||3
932405|NCT01449370|2255839|P6|NOT COMPLETED|Overall Study||3
932406|NCT01449370|2255840|P5|NOT COMPLETED|Overall Study||3
932407|NCT01449370|2255841|P4|NOT COMPLETED|Overall Study||4
932408|NCT01449370|2255842|P3|NOT COMPLETED|Overall Study||8
932409|NCT01449370|2255843|P2|NOT COMPLETED|Overall Study||6
932410|NCT01449370|2255844|P1|NOT COMPLETED|Overall Study||6
932411|NCT01449370|2255820|P25|COMPLETED|Overall Study||0
932412|NCT01449370|2255821|P24|COMPLETED|Overall Study||0
932413|NCT01449370|2255822|P23|COMPLETED|Overall Study||0
932414|NCT01449370|2255823|P22|COMPLETED|Overall Study||0
932415|NCT01449370|2255824|P21|COMPLETED|Overall Study||0
932416|NCT01449370|2255825|P20|COMPLETED|Overall Study||0
932417|NCT01449370|2255826|P19|COMPLETED|Overall Study||0
932418|NCT01449370|2255827|P18|COMPLETED|Overall Study||0
932419|NCT01449370|2255828|P17|COMPLETED|Overall Study||0
932420|NCT01449370|2255829|P16|COMPLETED|Overall Study||0
932421|NCT01449370|2255830|P15|COMPLETED|Overall Study||0
932422|NCT01449370|2255831|P14|COMPLETED|Overall Study||0
932423|NCT01449370|2255832|P13|COMPLETED|Overall Study||0
932424|NCT01449370|2255833|P12|COMPLETED|Overall Study||0
932425|NCT01449370|2255834|P11|COMPLETED|Overall Study||0
932426|NCT01449370|2255835|P10|COMPLETED|Overall Study||0
932427|NCT01449370|2255836|P9|COMPLETED|Overall Study||0
932428|NCT01449370|2255837|P8|COMPLETED|Overall Study||0
932429|NCT01449370|2255838|P7|COMPLETED|Overall Study||0
932430|NCT01449370|2255839|P6|COMPLETED|Overall Study||0
932431|NCT01449370|2255840|P5|COMPLETED|Overall Study||0
932432|NCT01449370|2255841|P4|COMPLETED|Overall Study||0
932433|NCT01449370|2255842|P3|COMPLETED|Overall Study||0
932434|NCT01449370|2255843|P2|COMPLETED|Overall Study||0
932435|NCT01449370|2255844|P1|COMPLETED|Overall Study||0
932436|NCT01449370|2255820|P25|STARTED|Overall Study||8
932437|NCT01449370|2255821|P24|STARTED|Overall Study||10
932438|NCT01449370|2255822|P23|STARTED|Overall Study||4
932439|NCT01449370|2255823|P22|STARTED|Overall Study||4
932440|NCT01449370|2255824|P21|STARTED|Overall Study||6
932441|NCT01449370|2255825|P20|STARTED|Overall Study||3
932442|NCT01449370|2255826|P19|STARTED|Overall Study||3
932443|NCT01449370|2255827|P18|STARTED|Overall Study||3
932444|NCT01449370|2255828|P17|STARTED|Overall Study||7
932445|NCT01449370|2255829|P16|STARTED|Overall Study||3
932446|NCT01449370|2255830|P15|STARTED|Overall Study||3
932447|NCT01449370|2255831|P14|STARTED|Overall Study||11
932448|NCT01449370|2255832|P13|STARTED|Overall Study||3
932449|NCT01449370|2255833|P12|STARTED|Overall Study||3
932450|NCT01449370|2255834|P11|STARTED|Overall Study||3
932451|NCT01449370|2255835|P10|STARTED|Overall Study||3
932452|NCT01449370|2255836|P9|STARTED|Overall Study||12
932453|NCT01449370|2255837|P8|STARTED|Overall Study||3
932454|NCT01449370|2255838|P7|STARTED|Overall Study||3
932455|NCT01449370|2255839|P6|STARTED|Overall Study||3
932456|NCT01449370|2255840|P5|STARTED|Overall Study||3
932457|NCT01449370|2255841|P4|STARTED|Overall Study||4
932458|NCT01449370|2255842|P3|STARTED|Overall Study||8
932459|NCT01449370|2255843|P2|STARTED|Overall Study||6
932460|NCT01449370|2255844|P1|STARTED|Overall Study||6
932461|NCT01449305|2256217|P1|NOT COMPLETED|Overall Study||2
932462|NCT01449305|2256217|P1|COMPLETED|Overall Study||42
932463|NCT01449305|2256217|P1|STARTED|Overall Study||44
932464|NCT01449279|2256222|P1|NOT COMPLETED|Overall Study||7
932465|NCT01449279|2256222|P1|COMPLETED|Overall Study||15
932466|NCT01449279|2256222|P1|STARTED|Overall Study||22
932467|NCT01449266|2256233|P1|NOT COMPLETED|Overall Study||0
932468|NCT01449266|2256233|P1|COMPLETED|Overall Study||10
932469|NCT01449266|2256233|P1|STARTED|Overall Study||10
932470|NCT01449240|2256240|P1|NOT COMPLETED|Overall Study||0
932471|NCT01449240|2256240|P1|COMPLETED|Overall Study||10
932472|NCT01449240|2256240|P1|STARTED|Overall Study||10
932473|NCT01449006|2256247|P2|NOT COMPLETED|Overall Study||0
932474|NCT01449006|2256248|P1|NOT COMPLETED|Overall Study||3
932475|NCT01449006|2256247|P2|COMPLETED|Overall Study||9
932476|NCT01449006|2256248|P1|COMPLETED|Overall Study||5
932477|NCT01449006|2256247|P2|STARTED|Overall Study||9
932478|NCT01449006|2256248|P1|STARTED|Overall Study||8
932479|NCT01448850|2256262|P2|NOT COMPLETED|Overall Study||40
932480|NCT01448850|2256263|P1|NOT COMPLETED|Overall Study||34
932481|NCT01448850|2256262|P2|COMPLETED|Overall Study||120
932482|NCT01448850|2256263|P1|COMPLETED|Overall Study||130
932483|NCT01448850|2256262|P2|STARTED|Overall Study||160
932484|NCT01448850|2256263|P1|STARTED|Overall Study||164
932485|NCT01448707|2256288|P2|NOT COMPLETED|Overall Study||18
932486|NCT01448707|2256289|P1|NOT COMPLETED|Overall Study||18
932487|NCT01448707|2256288|P2|COMPLETED|Overall Study||118
932488|NCT01448707|2256289|P1|COMPLETED|Overall Study||119
932489|NCT01448707|2256288|P2|STARTED|Overall Study||136
932490|NCT01448707|2256289|P1|STARTED|Overall Study||137
932491|NCT01448616|2256310|P4|NOT COMPLETED|Study Drug (Treatment Phase)||4
932492|NCT01448616|2256311|P3|NOT COMPLETED|Study Drug (Treatment Phase)||4
932493|NCT01448616|2256312|P2|NOT COMPLETED|Study Drug (Treatment Phase)||2
932494|NCT01448616|2256313|P1|NOT COMPLETED|Study Drug (Treatment Phase)||0
932495|NCT01448616|2256310|P4|COMPLETED|Study Drug (Treatment Phase)||9
932496|NCT01448616|2256311|P3|COMPLETED|Study Drug (Treatment Phase)||23
932497|NCT01448616|2256312|P2|COMPLETED|Study Drug (Treatment Phase)||22
932498|NCT01448616|2256313|P1|COMPLETED|Study Drug (Treatment Phase)||0
932499|NCT01448616|2256310|P4|STARTED|Study Drug (Treatment Phase)||13
932500|NCT01448616|2256311|P3|STARTED|Study Drug (Treatment Phase)||27
932501|NCT01448616|2256312|P2|STARTED|Study Drug (Treatment Phase)||24
932502|NCT01448616|2256313|P1|STARTED|Study Drug (Treatment Phase)|All qualifying participants from this group moved to treatment group.|0
932503|NCT01448616|2256310|P4|NOT COMPLETED|Lead-In (Observational Phase)||0
932504|NCT01448616|2256311|P3|NOT COMPLETED|Lead-In (Observational Phase)||0
932505|NCT01448616|2256312|P2|NOT COMPLETED|Lead-In (Observational Phase)||0
932506|NCT01448616|2256313|P1|NOT COMPLETED|Lead-In (Observational Phase)||9
932507|NCT01448616|2256310|P4|COMPLETED|Lead-In (Observational Phase)||0
932508|NCT01448616|2256311|P3|COMPLETED|Lead-In (Observational Phase)||0
932509|NCT01448616|2256312|P2|COMPLETED|Lead-In (Observational Phase)|completed >90% of sample collection to qualify for randomization for next phase|0
932510|NCT01448616|2256313|P1|COMPLETED|Lead-In (Observational Phase)|Participants who swabbed >90% completed this phase and were randomized to treatment 2:2:1.|64
932511|NCT01448616|2256310|P4|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
932512|NCT01448616|2256311|P3|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
932513|NCT01448616|2256312|P2|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
932514|NCT01448616|2256313|P1|STARTED|Lead-In (Observational Phase)||73
932515|NCT01448525|2256333|P2|NOT COMPLETED|Overall Study||2
932516|NCT01448525|2256334|P1|NOT COMPLETED|Overall Study||1
932517|NCT01448525|2256333|P2|COMPLETED|Overall Study||42
932518|NCT01448525|2256334|P1|COMPLETED|Overall Study||43
932519|NCT01448525|2256333|P2|STARTED|Overall Study||44
932520|NCT01448525|2256334|P1|STARTED|Overall Study||44
932521|NCT01448486|2256344|P2|NOT COMPLETED|Overall Study||0
932522|NCT01448486|2256345|P1|NOT COMPLETED|Overall Study||0
932523|NCT01448486|2256344|P2|COMPLETED|Overall Study||3
932524|NCT01448486|2256345|P1|COMPLETED|Overall Study||3
932525|NCT01448486|2256344|P2|STARTED|Overall Study||3
932526|NCT01448486|2256345|P1|STARTED|Overall Study||3
932527|NCT01448356|2256353|P1|NOT COMPLETED|Overall Study||0
932528|NCT01448356|2256353|P1|COMPLETED|Overall Study|cross-over|10
932529|NCT01448356|2256353|P1|STARTED|Overall Study||10
932530|NCT01448213|2256360|P2|NOT COMPLETED|Overall Study||22
932531|NCT01448213|2256361|P1|NOT COMPLETED|Overall Study||17
932532|NCT01448213|2256360|P2|COMPLETED|Overall Study||112
932533|NCT01448213|2256361|P1|COMPLETED|Overall Study||113
932534|NCT01448213|2256360|P2|STARTED|Overall Study||134
932535|NCT01448213|2256361|P1|STARTED|Overall Study||130
932536|NCT01448057|2256371|P2|NOT COMPLETED|Overall Study||4
932537|NCT01448057|2256372|P1|NOT COMPLETED|Overall Study||8
932538|NCT01448057|2256371|P2|COMPLETED|Overall Study||167
932539|NCT01448057|2256372|P1|COMPLETED|Overall Study||162
932540|NCT01448057|2256371|P2|STARTED|Overall Study||171
932541|NCT01448057|2256372|P1|STARTED|Overall Study||170
932542|NCT01448044|2256382|P2|NOT COMPLETED|Follow Up Period||14
932543|NCT01448044|2256383|P1|NOT COMPLETED|Follow Up Period||12
932544|NCT01448044|2256382|P2|COMPLETED|Follow Up Period||26
932545|NCT01448044|2256383|P1|COMPLETED|Follow Up Period||65
932546|NCT01448044|2256382|P2|STARTED|Follow Up Period|Out of 42 participants who entered the treatment period, 40 continued in the follow-up period.|40
932547|NCT01448044|2256383|P1|STARTED|Follow Up Period|Out of 82 participants who entered the treatment period, 77 continued in the follow-up period.|77
932548|NCT01448044|2256382|P2|NOT COMPLETED|Treatment Period||16
932549|NCT01448044|2256383|P1|NOT COMPLETED|Treatment Period||23
932550|NCT01448044|2256382|P2|COMPLETED|Treatment Period||26
932551|NCT01448044|2256383|P1|COMPLETED|Treatment Period||59
932552|NCT01448044|2256382|P2|STARTED|Treatment Period||42
932553|NCT01448044|2256383|P1|STARTED|Treatment Period||82
932554|NCT01447927|2256399|P2|NOT COMPLETED|Overall Study||3
932555|NCT01447927|2256400|P1|NOT COMPLETED|Overall Study||5
932556|NCT01447927|2256399|P2|COMPLETED|Overall Study||33
932557|NCT01447927|2256400|P1|COMPLETED|Overall Study||33
932558|NCT01447927|2256399|P2|STARTED|Overall Study||36
932559|NCT01447927|2256400|P1|STARTED|Overall Study||38
932560|NCT01447914|2256408|P1|NOT COMPLETED|Overall Study||0
932561|NCT01447914|2256408|P1|COMPLETED|Overall Study||16
932562|NCT01447914|2256408|P1|STARTED|Overall Study||16
932563|NCT01447849|2256417|P4|NOT COMPLETED|Second Intervention||0
932564|NCT01447849|2256418|P3|NOT COMPLETED|Second Intervention||0
932565|NCT01447849|2256419|P2|NOT COMPLETED|Second Intervention||0
932566|NCT01447849|2256420|P1|NOT COMPLETED|Second Intervention||0
932567|NCT01447849|2256417|P4|COMPLETED|Second Intervention||10
932568|NCT01447849|2256418|P3|COMPLETED|Second Intervention||10
932569|NCT01447849|2256419|P2|COMPLETED|Second Intervention||10
932570|NCT01447849|2256420|P1|COMPLETED|Second Intervention||10
932571|NCT01447849|2256417|P4|STARTED|Second Intervention||10
932572|NCT01447849|2256418|P3|STARTED|Second Intervention||10
932573|NCT01447849|2256419|P2|STARTED|Second Intervention||10
932574|NCT01447849|2256420|P1|STARTED|Second Intervention||10
932575|NCT01447849|2256417|P4|NOT COMPLETED|Washout Period for 1 Week||0
932576|NCT01447849|2256418|P3|NOT COMPLETED|Washout Period for 1 Week||0
932577|NCT01447849|2256419|P2|NOT COMPLETED|Washout Period for 1 Week||0
932578|NCT01447849|2256420|P1|NOT COMPLETED|Washout Period for 1 Week||0
932579|NCT01447849|2256417|P4|COMPLETED|Washout Period for 1 Week||10
932580|NCT01447849|2256418|P3|COMPLETED|Washout Period for 1 Week||10
932581|NCT01447849|2256419|P2|COMPLETED|Washout Period for 1 Week||10
932582|NCT01447849|2256420|P1|COMPLETED|Washout Period for 1 Week||10
932583|NCT01447849|2256417|P4|STARTED|Washout Period for 1 Week||10
932584|NCT01447849|2256418|P3|STARTED|Washout Period for 1 Week||10
932585|NCT01447849|2256419|P2|STARTED|Washout Period for 1 Week||10
932586|NCT01447849|2256420|P1|STARTED|Washout Period for 1 Week||10
932587|NCT01447849|2256417|P4|NOT COMPLETED|First Intervention||0
932588|NCT01447849|2256418|P3|NOT COMPLETED|First Intervention||0
932589|NCT01447849|2256419|P2|NOT COMPLETED|First Intervention||0
932590|NCT01447849|2256420|P1|NOT COMPLETED|First Intervention||0
932591|NCT01447849|2256417|P4|COMPLETED|First Intervention||10
932592|NCT01447849|2256418|P3|COMPLETED|First Intervention||10
932593|NCT01447849|2256419|P2|COMPLETED|First Intervention||10
932594|NCT01447849|2256420|P1|COMPLETED|First Intervention||10
932595|NCT01447849|2256417|P4|STARTED|First Intervention||10
932596|NCT01447849|2256418|P3|STARTED|First Intervention||10
932597|NCT01447849|2256419|P2|STARTED|First Intervention||10
932598|NCT01447849|2256420|P1|STARTED|First Intervention||10
932599|NCT01447719|2256430|P1|NOT COMPLETED|Overall Study||93
932600|NCT01447719|2256430|P1|COMPLETED|Overall Study||59
932601|NCT01447719|2256430|P1|Deceased <2 Years After AV-45 Scan|Overall Study||66
932602|NCT01447719|2256430|P1|Valid AV-45 Scan Acquired|Overall Study||147
932603|NCT01447719|2256430|P1|STARTED|Overall Study||152
932604|NCT01447706|2256443|P2|NOT COMPLETED|Overall Study||3
932605|NCT01447706|2256444|P1|NOT COMPLETED|Overall Study||0
932606|NCT01447706|2256443|P2|COMPLETED|Overall Study||80
932607|NCT01447706|2256444|P1|COMPLETED|Overall Study||140
932608|NCT01447706|2256443|P2|STARTED|Overall Study|3 patients enrolled but not dosed|83
932609|NCT01447706|2256444|P1|STARTED|Overall Study||140
932610|NCT01447576|2256456|P1|NOT COMPLETED|Overall Study||476
932611|NCT01447576|2256456|P1|COMPLETED|Overall Study||560
932612|NCT01447576|2256456|P1|STARTED|Overall Study||1036
932613|NCT01447511|2256467|P5|NOT COMPLETED|Rifampin Period||0
932614|NCT01447511|2256468|P4|NOT COMPLETED|Rifampin Period||1
932615|NCT01447511|2256469|P3|NOT COMPLETED|Rifampin Period||0
932616|NCT01447511|2256470|P2|NOT COMPLETED|Rifampin Period||0
932617|NCT01447511|2256471|P1|NOT COMPLETED|Rifampin Period||0
932618|NCT01447511|2256467|P5|COMPLETED|Rifampin Period||4
932619|NCT01447511|2256468|P4|COMPLETED|Rifampin Period||2
932620|NCT01447511|2256469|P3|COMPLETED|Rifampin Period||8
932621|NCT01447511|2256470|P2|COMPLETED|Rifampin Period||5
932622|NCT01447511|2256471|P1|COMPLETED|Rifampin Period||8
932623|NCT01447511|2256467|P5|STARTED|Rifampin Period||4
932624|NCT01447511|2256468|P4|STARTED|Rifampin Period||3
932625|NCT01447511|2256469|P3|STARTED|Rifampin Period||8
932626|NCT01447511|2256470|P2|STARTED|Rifampin Period||5
932627|NCT01447511|2256471|P1|STARTED|Rifampin Period||8
932628|NCT01447511|2256467|P5|NOT COMPLETED|Fluconazole Period||0
932629|NCT01447511|2256468|P4|NOT COMPLETED|Fluconazole Period||0
932630|NCT01447511|2256469|P3|NOT COMPLETED|Fluconazole Period||1
932631|NCT01447511|2256470|P2|NOT COMPLETED|Fluconazole Period||0
932632|NCT01447511|2256471|P1|NOT COMPLETED|Fluconazole Period||0
932633|NCT01447511|2256467|P5|COMPLETED|Fluconazole Period||4
932634|NCT01447511|2256468|P4|COMPLETED|Fluconazole Period||3
932635|NCT01447511|2256469|P3|COMPLETED|Fluconazole Period||8
932636|NCT01447511|2256470|P2|COMPLETED|Fluconazole Period||0
932637|NCT01447511|2256471|P1|COMPLETED|Fluconazole Period||8
932638|NCT01447511|2256467|P5|STARTED|Fluconazole Period||4
932639|NCT01447511|2256468|P4|STARTED|Fluconazole Period||3
932640|NCT01447511|2256469|P3|STARTED|Fluconazole Period||9
932641|NCT01447511|2256470|P2|STARTED|Fluconazole Period||0
932642|NCT01447511|2256471|P1|STARTED|Fluconazole Period||8
932643|NCT01447511|2256467|P5|NOT COMPLETED|Control Period||0
932644|NCT01447511|2256468|P4|NOT COMPLETED|Control Period||0
932645|NCT01447511|2256469|P3|NOT COMPLETED|Control Period||0
932646|NCT01447511|2256470|P2|NOT COMPLETED|Control Period||0
932647|NCT01447511|2256471|P1|NOT COMPLETED|Control Period||0
932648|NCT01447511|2256467|P5|COMPLETED|Control Period||4
932649|NCT01447511|2256468|P4|COMPLETED|Control Period||3
932650|NCT01447511|2256469|P3|COMPLETED|Control Period||9
932651|NCT01447511|2256470|P2|COMPLETED|Control Period||5
932652|NCT01447511|2256471|P1|COMPLETED|Control Period||8
932653|NCT01447511|2256467|P5|STARTED|Control Period||4
932654|NCT01447511|2256468|P4|STARTED|Control Period||3
932655|NCT01447511|2256469|P3|STARTED|Control Period||9
932656|NCT01447511|2256470|P2|STARTED|Control Period||5
932657|NCT01447511|2256471|P1|STARTED|Control Period||8
932658|NCT01447446|2256489|P6|NOT COMPLETED|Overall Study||32
932659|NCT01447446|2256490|P5|NOT COMPLETED|Overall Study||211
932660|NCT01447446|2256491|P4|NOT COMPLETED|Overall Study||33
932661|NCT01447446|2256492|P3|NOT COMPLETED|Overall Study||100
932662|NCT01447446|2256493|P2|NOT COMPLETED|Overall Study||165
932663|NCT01447446|2256494|P1|NOT COMPLETED|Overall Study||722
932664|NCT01447446|2256489|P6|COMPLETED|Overall Study||54
932665|NCT01447446|2256490|P5|COMPLETED|Overall Study||610
932666|NCT01447446|2256491|P4|COMPLETED|Overall Study||60
932667|NCT01447446|2256492|P3|COMPLETED|Overall Study||192
932668|NCT01447446|2256493|P2|COMPLETED|Overall Study|Insuff.=Insufficient VR= Virological response TRT.=Treatment SVR= Sustained Virological Response|331
932669|NCT01447446|2256494|P1|COMPLETED|Overall Study|Completed means the participants who completed the 24- weeks of follow-up period.|1590
932670|NCT01447446|2256489|P6|STARTED|Overall Study||86
932671|NCT01447446|2256490|P5|STARTED|Overall Study||821
932672|NCT01447446|2256491|P4|STARTED|Overall Study||93
932673|NCT01447446|2256492|P3|STARTED|Overall Study||292
932674|NCT01447446|2256493|P2|STARTED|Overall Study||496
932675|NCT01447446|2256494|P1|STARTED|Overall Study|Started means participants who started treatment and included in core population.|2312
932676|NCT01447433|2256584|P2|NOT COMPLETED|Overall Study||6
932677|NCT01447433|2256585|P1|NOT COMPLETED|Overall Study||4
932678|NCT01447433|2256584|P2|COMPLETED|Overall Study||21
932679|NCT01447433|2256585|P1|COMPLETED|Overall Study||22
932680|NCT01447433|2256584|P2|STARTED|Overall Study||27
932681|NCT01447433|2256585|P1|STARTED|Overall Study||26
932682|NCT01447420|2256612|P3|NOT COMPLETED|Overall Study||10
932683|NCT01447420|2256613|P2|NOT COMPLETED|Overall Study||27
932684|NCT01447420|2256614|P1|NOT COMPLETED|Overall Study||10
932685|NCT01447420|2256612|P3|COMPLETED|Overall Study||8
932686|NCT01447420|2256613|P2|COMPLETED|Overall Study||45
932687|NCT01447420|2256614|P1|COMPLETED|Overall Study||29
932688|NCT01447420|2256612|P3|STARTED|Overall Study||18
932689|NCT01447420|2256613|P2|STARTED|Overall Study||72
932690|NCT01447420|2256614|P1|STARTED|Overall Study||39
932691|NCT01447225|2256634|P10|NOT COMPLETED|Overall Study||0
932692|NCT01447225|2256635|P9|NOT COMPLETED|Overall Study||0
932693|NCT01447225|2256636|P8|NOT COMPLETED|Overall Study||0
932694|NCT01447225|2256637|P7|NOT COMPLETED|Overall Study||0
932695|NCT01447225|2256638|P6|NOT COMPLETED|Overall Study||0
932696|NCT01447225|2256639|P5|NOT COMPLETED|Overall Study||0
932697|NCT01447225|2256640|P4|NOT COMPLETED|Overall Study||0
932698|NCT01447225|2256641|P3|NOT COMPLETED|Overall Study||0
932699|NCT01447225|2256642|P2|NOT COMPLETED|Overall Study||0
932700|NCT01447225|2256643|P1|NOT COMPLETED|Overall Study||0
932701|NCT01447225|2256634|P10|COMPLETED|Overall Study||4
932702|NCT01447225|2256635|P9|COMPLETED|Overall Study||3
932703|NCT01447225|2256636|P8|COMPLETED|Overall Study||4
932704|NCT01447225|2256637|P7|COMPLETED|Overall Study||7
932705|NCT01447225|2256638|P6|COMPLETED|Overall Study||3
932706|NCT01447225|2256639|P5|COMPLETED|Overall Study||3
932707|NCT01447225|2256640|P4|COMPLETED|Overall Study||3
932708|NCT01447225|2256641|P3|COMPLETED|Overall Study||5
932709|NCT01447225|2256642|P2|COMPLETED|Overall Study||8
932710|NCT01447225|2256643|P1|COMPLETED|Overall Study||3
932711|NCT01447225|2256634|P10|STARTED|Overall Study||4
932712|NCT01447225|2256635|P9|STARTED|Overall Study||3
932713|NCT01447225|2256636|P8|STARTED|Overall Study||4
932714|NCT01447225|2256637|P7|STARTED|Overall Study||7
932715|NCT01447225|2256638|P6|STARTED|Overall Study||3
932716|NCT01447225|2256639|P5|STARTED|Overall Study||3
932717|NCT01447225|2256640|P4|STARTED|Overall Study||3
932718|NCT01447225|2256641|P3|STARTED|Overall Study||5
932719|NCT01447225|2256642|P2|STARTED|Overall Study||8
932720|NCT01447225|2256643|P1|STARTED|Overall Study||3
932721|NCT01447121|2256713|P1|NOT COMPLETED|Overall Study||0
932722|NCT01447121|2256713|P1|COMPLETED|Overall Study||118
932723|NCT01447121|2256713|P1|STARTED|Overall Study||118
932724|NCT01447017|2256720|P2|NOT COMPLETED|Overall Study||10
932725|NCT01447017|2256721|P1|NOT COMPLETED|Overall Study||10
932726|NCT01447017|2256720|P2|COMPLETED|Overall Study|In safety analysis: 24. In efficacy analyses: 24 in full analysis set, and 22 in per-protocol set.|14
932727|NCT01447017|2256721|P1|COMPLETED|Overall Study|In safety analysis: 42. In efficacy analyses: 40 in full analysis set, and 39 in per-protocol set.|35
932728|NCT01447017|2256720|P2|Performed Visit 2|Overall Study||24
932729|NCT01447017|2256721|P1|Performed Visit 2|Overall Study||43
932730|NCT01447017|2256720|P2|STARTED|Overall Study||24
932731|NCT01447017|2256721|P1|STARTED|Overall Study||45
932732|NCT01446796|2256727|P2|NOT COMPLETED|Overall Study||0
932733|NCT01446796|2256728|P1|NOT COMPLETED|Overall Study||1
932734|NCT01446796|2256727|P2|COMPLETED|Overall Study|Study terminated early|0
932735|NCT01446796|2256728|P1|COMPLETED|Overall Study|"Study terminated early
One subject of three withdrew prior to randomization and did not start"|2
932736|NCT01446796|2256727|P2|STARTED|Overall Study||0
932737|NCT01446796|2256728|P1|STARTED|Overall Study||3
932738|NCT01446705|2256742|P2|NOT COMPLETED|Overall Study||0
932739|NCT01446705|2256743|P1|NOT COMPLETED|Overall Study||0
932740|NCT01446705|2256742|P2|COMPLETED|Overall Study||6627
932741|NCT01446705|2256743|P1|COMPLETED|Overall Study||50446
932742|NCT01446705|2256742|P2|STARTED|Overall Study||6627
932743|NCT01446705|2256743|P1|STARTED|Overall Study||50446
932744|NCT01446419|2256753|P2|NOT COMPLETED|Overall Study||1
932745|NCT01446419|2256754|P1|NOT COMPLETED|Overall Study||5
932746|NCT01446419|2256753|P2|COMPLETED|Overall Study||77
932747|NCT01446419|2256754|P1|COMPLETED|Overall Study||142
932748|NCT01446419|2256753|P2|12 Month Follow-up|Overall Study||77
932749|NCT01446419|2256754|P1|12 Month Follow-up|Overall Study||142
932750|NCT01446419|2256753|P2|6 Month Follow-up|Overall Study||77
932751|NCT01446419|2256754|P1|6 Month Follow-up|Overall Study||144
932752|NCT01446419|2256753|P2|3 Month Follow-up|Overall Study||77
932753|NCT01446419|2256754|P1|3 Month Follow-up|Overall Study||146
932754|NCT01446419|2256753|P2|STARTED|Overall Study||78
932755|NCT01446419|2256754|P1|STARTED|Overall Study||147
932756|NCT01446289|2256768|P4|NOT COMPLETED|Overall Study||0
932757|NCT01446289|2256769|P3|NOT COMPLETED|Overall Study||1
932758|NCT01446289|2256770|P2|NOT COMPLETED|Overall Study||0
932759|NCT01446289|2256771|P1|NOT COMPLETED|Overall Study||1
932760|NCT01446289|2256768|P4|COMPLETED|Overall Study||35
932761|NCT01446289|2256769|P3|COMPLETED|Overall Study||50
932762|NCT01446289|2256770|P2|COMPLETED|Overall Study||35
932763|NCT01446289|2256771|P1|COMPLETED|Overall Study||50
932764|NCT01446289|2256768|P4|STARTED|Overall Study||35
932765|NCT01446289|2256769|P3|STARTED|Overall Study||51
932766|NCT01446289|2256770|P2|STARTED|Overall Study||35
932767|NCT01446289|2256771|P1|STARTED|Overall Study||51
932768|NCT01446250|2256799|P4|NOT COMPLETED|Follow-up||6
932769|NCT01446250|2256800|P3|NOT COMPLETED|Follow-up||0
932770|NCT01446250|2256801|P2|NOT COMPLETED|Follow-up||0
932771|NCT01446250|2256802|P1|NOT COMPLETED|Follow-up||0
932772|NCT01446250|2256799|P4|COMPLETED|Follow-up||0
932773|NCT01446250|2256800|P3|COMPLETED|Follow-up||0
932774|NCT01446250|2256801|P2|COMPLETED|Follow-up||0
932775|NCT01446250|2256802|P1|COMPLETED|Follow-up||0
932776|NCT01446250|2256799|P4|STARTED|Follow-up||6
932777|NCT01446250|2256800|P3|STARTED|Follow-up||0
932778|NCT01446250|2256801|P2|STARTED|Follow-up||0
932779|NCT01446250|2256802|P1|STARTED|Follow-up||0
932780|NCT01446250|2256799|P4|NOT COMPLETED|Treatment Period 2||0
932781|NCT01446250|2256800|P3|NOT COMPLETED|Treatment Period 2||0
932782|NCT01446250|2256801|P2|NOT COMPLETED|Treatment Period 2||1
932783|NCT01446250|2256802|P1|NOT COMPLETED|Treatment Period 2||0
932784|NCT01446250|2256799|P4|COMPLETED|Treatment Period 2||0
932785|NCT01446250|2256800|P3|COMPLETED|Treatment Period 2||0
932786|NCT01446250|2256801|P2|COMPLETED|Treatment Period 2||6
932787|NCT01446250|2256802|P1|COMPLETED|Treatment Period 2||0
932788|NCT01446250|2256799|P4|STARTED|Treatment Period 2||0
932789|NCT01446250|2256800|P3|STARTED|Treatment Period 2||0
932790|NCT01446250|2256801|P2|STARTED|Treatment Period 2||7
932791|NCT01446250|2256802|P1|STARTED|Treatment Period 2||0
932792|NCT01446250|2256799|P4|NOT COMPLETED|Clinical Hold||0
932793|NCT01446250|2256800|P3|NOT COMPLETED|Clinical Hold||0
932794|NCT01446250|2256801|P2|NOT COMPLETED|Clinical Hold||0
932795|NCT01446250|2256802|P1|NOT COMPLETED|Clinical Hold||0
932796|NCT01446250|2256799|P4|COMPLETED|Clinical Hold||0
932797|NCT01446250|2256800|P3|COMPLETED|Clinical Hold||5
932798|NCT01446250|2256801|P2|COMPLETED|Clinical Hold||2
932799|NCT01446250|2256802|P1|COMPLETED|Clinical Hold||0
932800|NCT01446250|2256799|P4|STARTED|Clinical Hold||0
932801|NCT01446250|2256800|P3|STARTED|Clinical Hold||5
932802|NCT01446250|2256801|P2|STARTED|Clinical Hold||2
932803|NCT01446250|2256802|P1|STARTED|Clinical Hold||0
932804|NCT01446250|2256799|P4|NOT COMPLETED|Treatment Period 1||0
932805|NCT01446250|2256800|P3|NOT COMPLETED|Treatment Period 1||0
932806|NCT01446250|2256801|P2|NOT COMPLETED|Treatment Period 1||1
932807|NCT01446250|2256802|P1|NOT COMPLETED|Treatment Period 1||0
932808|NCT01446250|2256799|P4|COMPLETED|Treatment Period 1||0
932809|NCT01446250|2256800|P3|COMPLETED|Treatment Period 1||0
932810|NCT01446250|2256801|P2|COMPLETED|Treatment Period 1||2
932811|NCT01446250|2256802|P1|COMPLETED|Treatment Period 1||5
932812|NCT01446250|2256799|P4|STARTED|Treatment Period 1||0
932813|NCT01446250|2256800|P3|STARTED|Treatment Period 1||0
932814|NCT01446250|2256801|P2|STARTED|Treatment Period 1||3
932815|NCT01446250|2256802|P1|STARTED|Treatment Period 1||5
932816|NCT01446237|2256814|P1|NOT COMPLETED|Overall Study||10
932817|NCT01446237|2256814|P1|COMPLETED|Overall Study||115
932818|NCT01446237|2256814|P1|STARTED|Overall Study||125
932819|NCT01446003|2256822|P2|NOT COMPLETED|Period 2||0
932820|NCT01446003|2256823|P1|NOT COMPLETED|Period 2||1
932821|NCT01446003|2256822|P2|COMPLETED|Period 2||15
932822|NCT01446003|2256823|P1|COMPLETED|Period 2||13
932823|NCT01446003|2256822|P2|STARTED|Period 2||15
932824|NCT01446003|2256823|P1|STARTED|Period 2||14
932825|NCT01446003|2256822|P2|NOT COMPLETED|Period 1||0
932826|NCT01446003|2256823|P1|NOT COMPLETED|Period 1||2
932827|NCT01446003|2256822|P2|COMPLETED|Period 1||15
932828|NCT01446003|2256823|P1|COMPLETED|Period 1||14
932829|NCT01446003|2256822|P2|STARTED|Period 1||15
932830|NCT01446003|2256823|P1|STARTED|Period 1||16
932831|NCT01445951|2256844|P3|NOT COMPLETED|Overall Study||19
932832|NCT01445951|2256845|P2|NOT COMPLETED|Overall Study||36
932833|NCT01445951|2256846|P1|NOT COMPLETED|Overall Study||44
932834|NCT01445951|2256844|P3|COMPLETED|Overall Study||151
932835|NCT01445951|2256845|P2|COMPLETED|Overall Study||138
932836|NCT01445951|2256846|P1|COMPLETED|Overall Study||130
932837|NCT01445951|2256844|P3|STARTED|Overall Study||170
932838|NCT01445951|2256845|P2|STARTED|Overall Study||174
932839|NCT01445951|2256846|P1|STARTED|Overall Study||174
932840|NCT01445873|2256884|P1|NOT COMPLETED|Overall Study||0
932841|NCT01445873|2256884|P1|COMPLETED|Overall Study||36
932842|NCT01445873|2256884|P1|STARTED|Overall Study||36
932843|NCT01445847|2256914|P2|NOT COMPLETED|Overall Study||14
932844|NCT01445847|2256915|P1|NOT COMPLETED|Overall Study||14
932845|NCT01445847|2256914|P2|COMPLETED|Overall Study||36
932846|NCT01445847|2256915|P1|COMPLETED|Overall Study||36
932847|NCT01445847|2256914|P2|STARTED|Overall Study||50
932848|NCT01445847|2256915|P1|STARTED|Overall Study||50
932849|NCT01445769|2256921|P1|NOT COMPLETED|Overall Study||8
932850|NCT01445769|2256921|P1|COMPLETED|Overall Study||37
932851|NCT01445769|2256921|P1|STARTED|Overall Study||45
932852|NCT01445678|2256941|P2|NOT COMPLETED|Overall Study||21
932853|NCT01445678|2256942|P1|NOT COMPLETED|Overall Study||30
932854|NCT01445678|2256941|P2|COMPLETED|Overall Study||476
932855|NCT01445678|2256942|P1|COMPLETED|Overall Study||452
932856|NCT01445678|2256941|P2|STARTED|Overall Study||497
932857|NCT01445678|2256942|P1|STARTED|Overall Study||482
932858|NCT01445652|2256960|P2|NOT COMPLETED|Overall Study||3
932859|NCT01445652|2256961|P1|NOT COMPLETED|Overall Study||10
932860|NCT01445652|2256960|P2|COMPLETED|Overall Study||50
932861|NCT01445652|2256961|P1|COMPLETED|Overall Study||47
932862|NCT01445652|2256960|P2|STARTED|Overall Study||53
932863|NCT01445652|2256961|P1|STARTED|Overall Study||57
932864|NCT01445626|2256969|P1|NOT COMPLETED|Overall Study||0
932865|NCT01445626|2256969|P1|COMPLETED|Overall Study||87
932866|NCT01445626|2256969|P1|STARTED|Overall Study||87
932867|NCT01445613|2256979|P1|NOT COMPLETED|1-year Follow-up||77
932868|NCT01445613|2256979|P1|COMPLETED|1-year Follow-up||1088
932869|NCT01445613|2256979|P1|STARTED|1-year Follow-up||1165
932870|NCT01445613|2256979|P1|NOT COMPLETED|30-day Follow-up||35
932871|NCT01445613|2256979|P1|COMPLETED|30-day Follow-up||1165
932872|NCT01445613|2256979|P1|STARTED|30-day Follow-up||1200
932873|NCT01445548|2256997|P1|NOT COMPLETED|Overall Study||1
932874|NCT01445548|2256997|P1|COMPLETED|Overall Study||5
932875|NCT01445548|2256997|P1|STARTED|Overall Study||6
932876|NCT01445028|2257020|P2|NOT COMPLETED|Overall Study||3
932877|NCT01445028|2257021|P1|NOT COMPLETED|Overall Study||0
932878|NCT01445028|2257020|P2|COMPLETED|Overall Study||51
932879|NCT01445028|2257021|P1|COMPLETED|Overall Study||58
932880|NCT01445028|2257020|P2|STARTED|Overall Study||54
932881|NCT01445028|2257021|P1|STARTED|Overall Study||58
932882|NCT01444924|2257029|P2|NOT COMPLETED|Overall Study||0
932883|NCT01444924|2257030|P1|NOT COMPLETED|Overall Study||0
932884|NCT01444924|2257029|P2|COMPLETED|Overall Study||33
932885|NCT01444924|2257030|P1|COMPLETED|Overall Study||31
932886|NCT01444924|2257029|P2|STARTED|Overall Study||33
932887|NCT01444924|2257030|P1|STARTED|Overall Study||31
932888|NCT01444911|2257038|P2|NOT COMPLETED|Overall Study||0
932889|NCT01444911|2257039|P1|NOT COMPLETED|Overall Study||8
932890|NCT01444911|2257038|P2|COMPLETED|Overall Study||13
932891|NCT01444911|2257039|P1|COMPLETED|Overall Study||8
932892|NCT01444911|2257038|P2|STARTED|Overall Study||13
932893|NCT01444911|2257039|P1|STARTED|Overall Study||16
932894|NCT01444898|2257051|P1|NOT COMPLETED|Overall Study||1
932895|NCT01444898|2257051|P1|COMPLETED|Overall Study||9
932896|NCT01444898|2257051|P1|STARTED|Overall Study||10
932897|NCT01444781|2257066|P3|NOT COMPLETED|Overall Study||3
932898|NCT01444781|2257067|P2|NOT COMPLETED|Overall Study||4
932899|NCT01444781|2257068|P1|NOT COMPLETED|Overall Study||3
932900|NCT01444781|2257066|P3|COMPLETED|Overall Study||272
932901|NCT01444781|2257067|P2|COMPLETED|Overall Study||411
932902|NCT01444781|2257068|P1|COMPLETED|Overall Study||413
932903|NCT01444781|2257066|P3|STARTED|Overall Study||275
932904|NCT01444781|2257067|P2|STARTED|Overall Study||415
932905|NCT01444781|2257068|P1|STARTED|Overall Study||416
932906|NCT01444651|2257108|P2|NOT COMPLETED|Overall Study||9
932907|NCT01444651|2257109|P1|NOT COMPLETED|Overall Study||11
932908|NCT01444651|2257108|P2|COMPLETED|Overall Study||28
932909|NCT01444651|2257109|P1|COMPLETED|Overall Study||25
932910|NCT01444651|2257108|P2|STARTED|Overall Study||37
932911|NCT01444651|2257109|P1|STARTED|Overall Study||36
932912|NCT01444456|2257125|P1|NOT COMPLETED|Overall Study||285
932913|NCT01444456|2257125|P1|COMPLETED|Overall Study|Defined as 4 weeks after last dose of ESA or chemotherapy or 13 weeks after enrolment|977
932914|NCT01444456|2257125|P1|Received Darbepoetin Alfa|Overall Study||1134
932915|NCT01444456|2257125|P1|Received Darbepoetin Alfa or Other ESA|Overall Study||1158
932916|NCT01444456|2257125|P1|STARTED|Overall Study||1262
932917|NCT01444430|2257136|P2|NOT COMPLETED|Overall Study||81
932918|NCT01444430|2257137|P1|NOT COMPLETED|Overall Study||61
932919|NCT01444430|2257136|P2|COMPLETED|Overall Study||5766
932920|NCT01444430|2257137|P1|COMPLETED|Overall Study||5785
932921|NCT01444430|2257136|P2|STARTED|Overall Study||5847
932922|NCT01444430|2257137|P1|STARTED|Overall Study||5846
932923|NCT01444417|2257159|P2|NOT COMPLETED|Overall Study||1
932924|NCT01444417|2257160|P1|NOT COMPLETED|Overall Study||2
932925|NCT01444417|2257159|P2|COMPLETED|Overall Study||41
932926|NCT01444417|2257160|P1|COMPLETED|Overall Study||18
932927|NCT01444417|2257159|P2|Received Treatment|Overall Study||42
932928|NCT01444417|2257160|P1|Received Treatment|Overall Study||19
932929|NCT01444417|2257159|P2|STARTED|Overall Study||42
932930|NCT01444417|2257160|P1|STARTED|Overall Study||20
932931|NCT01444391|2257176|P1|NOT COMPLETED|Overall Study||1
932932|NCT01444391|2257176|P1|COMPLETED|Overall Study||41
932933|NCT01444391|2257176|P1|STARTED|Overall Study||42
932934|NCT01444378|2257184|P1|NOT COMPLETED|Overall Study||17
932935|NCT01444378|2257184|P1|COMPLETED|Overall Study||124
932936|NCT01444378|2257184|P1|STARTED|Overall Study|A total of 141 patients were enrolled into MOMENTUM|141
932937|NCT01444300|2257296|P2|NOT COMPLETED|Overall Study||0
932938|NCT01444300|2257297|P1|NOT COMPLETED|Overall Study||4
932939|NCT01444300|2257296|P2|COMPLETED|Overall Study||12
932940|NCT01444300|2257297|P1|COMPLETED|Overall Study||8
932941|NCT01444300|2257296|P2|STARTED|Overall Study||12
932942|NCT01444300|2257297|P1|STARTED|Overall Study||12
932943|NCT01444287|2257307|P1|NOT COMPLETED|Period 4||0
932944|NCT01444287|2257307|P1|COMPLETED|Period 4||22
932945|NCT01444287|2257307|P1|STARTED|Period 4||22
932946|NCT01444287|2257307|P1|NOT COMPLETED|Period 3||0
932947|NCT01444287|2257307|P1|COMPLETED|Period 3||22
932948|NCT01444287|2257307|P1|STARTED|Period 3||22
932949|NCT01444287|2257307|P1|NOT COMPLETED|Period 2||0
932950|NCT01444287|2257307|P1|COMPLETED|Period 2||22
932951|NCT01444287|2257307|P1|STARTED|Period 2||22
932952|NCT01444287|2257307|P1|NOT COMPLETED|Period 1||0
932953|NCT01444287|2257307|P1|COMPLETED|Period 1||22
932954|NCT01444287|2257307|P1|STARTED|Period 1||22
932955|NCT01444092|2257329|P1|NOT COMPLETED|Overall Study||17
932956|NCT01444092|2257329|P1|COMPLETED|Overall Study||91
932957|NCT01444092|2257329|P1|INFORMED CONSENT OBTAINED|Overall Study||108
932958|NCT01444092|2257329|P1|STARTED|Overall Study||108
932959|NCT01443923|2257337|P2|NOT COMPLETED|Overall Study||0
932960|NCT01443923|2257338|P1|NOT COMPLETED|Overall Study||1
932961|NCT01443923|2257337|P2|COMPLETED|Overall Study||1
932962|NCT01443923|2257338|P1|COMPLETED|Overall Study||2
932963|NCT01443923|2257337|P2|STARTED|Overall Study||1
932964|NCT01443923|2257338|P1|STARTED|Overall Study||3
932965|NCT01443858|2257355|P3|NOT COMPLETED|Overall Study||7
932966|NCT01443858|2257356|P2|NOT COMPLETED|Overall Study||13
932967|NCT01443858|2257357|P1|NOT COMPLETED|Overall Study||15
932968|NCT01443858|2257355|P3|COMPLETED|Overall Study||18
932969|NCT01443858|2257356|P2|COMPLETED|Overall Study||12
932970|NCT01443858|2257357|P1|COMPLETED|Overall Study||10
932971|NCT01443858|2257355|P3|STARTED|Overall Study||25
932972|NCT01443858|2257356|P2|STARTED|Overall Study||25
932973|NCT01443858|2257357|P1|STARTED|Overall Study||25
932974|NCT01443845|2257379|P2|NOT COMPLETED|Overall Study||337
932975|NCT01443845|2257380|P1|NOT COMPLETED|Overall Study||254
932976|NCT01443845|2257379|P2|COMPLETED|Overall Study||841
932977|NCT01443845|2257380|P1|COMPLETED|Overall Study||922
932978|NCT01443845|2257379|P2|STARTED|Overall Study||1178
932979|NCT01443845|2257380|P1|STARTED|Overall Study||1176
932980|NCT01443494|2257392|P1|NOT COMPLETED|Overall Study||0
932981|NCT01443494|2257392|P1|COMPLETED|Overall Study||19
932982|NCT01443494|2257392|P1|STARTED|Overall Study||19
932983|NCT01443403|2257401|P4|NOT COMPLETED|Overall Study||9
932984|NCT01443403|2257402|P3|NOT COMPLETED|Overall Study||7
932985|NCT01443403|2257403|P2|NOT COMPLETED|Overall Study||6
932986|NCT01443403|2257404|P1|NOT COMPLETED|Overall Study||6
932987|NCT01443403|2257401|P4|COMPLETED|Overall Study||52
932988|NCT01443403|2257402|P3|COMPLETED|Overall Study||54
932989|NCT01443403|2257403|P2|COMPLETED|Overall Study||55
932990|NCT01443403|2257404|P1|COMPLETED|Overall Study||55
932991|NCT01443403|2257401|P4|Received Treatment|Overall Study||61
932992|NCT01443403|2257402|P3|Received Treatment|Overall Study||60
932993|NCT01443403|2257403|P2|Received Treatment|Overall Study||61
932994|NCT01443403|2257404|P1|Received Treatment|Overall Study||61
932995|NCT01443403|2257401|P4|STARTED|Overall Study||61
932996|NCT01443403|2257402|P3|STARTED|Overall Study||61
932997|NCT01443403|2257403|P2|STARTED|Overall Study||61
932998|NCT01443403|2257404|P1|STARTED|Overall Study||61
932999|NCT01443364|2257551|P1|NOT COMPLETED|Overall Study||41
933000|NCT01443364|2257551|P1|COMPLETED|Overall Study||91
933001|NCT01443364|2257551|P1|STARTED|Overall Study||132
933002|NCT01443130|2257680|P6|NOT COMPLETED|Overall Study||34
933003|NCT01443130|2257681|P5|NOT COMPLETED|Overall Study||44
933004|NCT01443130|2257682|P4|NOT COMPLETED|Overall Study||39
933005|NCT01443130|2257683|P3|NOT COMPLETED|Overall Study||77
933006|NCT01443130|2257684|P2|NOT COMPLETED|Overall Study||69
933007|NCT01443130|2257685|P1|NOT COMPLETED|Overall Study||68
933008|NCT01443130|2257680|P6|COMPLETED|Overall Study||225
933009|NCT01443130|2257681|P5|COMPLETED|Overall Study||230
933010|NCT01443130|2257682|P4|COMPLETED|Overall Study||231
933011|NCT01443130|2257683|P3|COMPLETED|Overall Study||223
933012|NCT01443130|2257684|P2|COMPLETED|Overall Study||231
933013|NCT01443130|2257685|P1|COMPLETED|Overall Study||232
933014|NCT01443130|2257680|P6|STARTED|Overall Study||259
933015|NCT01443130|2257681|P5|STARTED|Overall Study||274
933016|NCT01443130|2257682|P4|STARTED|Overall Study||270
933017|NCT01443130|2257683|P3|STARTED|Overall Study||300
933018|NCT01443130|2257684|P2|STARTED|Overall Study||300
933019|NCT01443130|2257685|P1|STARTED|Overall Study||300
933020|NCT01443078|2257735|P1|NOT COMPLETED|Overall Study||29
933021|NCT01443078|2257735|P1|COMPLETED|Overall Study||13
933022|NCT01443078|2257735|P1|STARTED|Overall Study||42
933023|NCT01443026|2257741|P2|NOT COMPLETED|Overall Study||5
933024|NCT01443026|2257742|P1|NOT COMPLETED|Overall Study||3
933025|NCT01443026|2257741|P2|COMPLETED|Overall Study||32
933026|NCT01443026|2257742|P1|COMPLETED|Overall Study||26
933027|NCT01443026|2257741|P2|STARTED|Overall Study||37
933028|NCT01443026|2257742|P1|STARTED|Overall Study||29
933029|NCT01442844|2257750|P2|NOT COMPLETED|Overall Study||0
933030|NCT01442844|2257751|P1|NOT COMPLETED|Overall Study||0
933031|NCT01442844|2257750|P2|COMPLETED|Overall Study||2
933032|NCT01442844|2257751|P1|COMPLETED|Overall Study||1
933033|NCT01442844|2257750|P2|STARTED|Overall Study||2
933034|NCT01442844|2257751|P1|STARTED|Overall Study||1
933035|NCT01442779|2257757|P1|NOT COMPLETED|Overall Study||7
933036|NCT01442779|2257757|P1|COMPLETED|Overall Study||11
933037|NCT01442779|2257757|P1|STARTED|Overall Study||18
933038|NCT01442688|2257765|P2|NOT COMPLETED|Second Intervention||0
933039|NCT01442688|2257766|P1|NOT COMPLETED|Second Intervention||1
933040|NCT01442688|2257765|P2|COMPLETED|Second Intervention||31
933041|NCT01442688|2257766|P1|COMPLETED|Second Intervention||28
933042|NCT01442688|2257765|P2|STARTED|Second Intervention||31
933043|NCT01442688|2257766|P1|STARTED|Second Intervention||29
933044|NCT01442688|2257765|P2|NOT COMPLETED|First Intervention||0
933045|NCT01442688|2257766|P1|NOT COMPLETED|First Intervention||2
933046|NCT01442688|2257765|P2|COMPLETED|First Intervention||31
933047|NCT01442688|2257766|P1|COMPLETED|First Intervention||29
933048|NCT01442688|2257765|P2|STARTED|First Intervention||31
933049|NCT01442688|2257766|P1|STARTED|First Intervention||31
933050|NCT01442675|2257774|P1|NOT COMPLETED|Overall Study||12
933051|NCT01442675|2257774|P1|COMPLETED|Overall Study||822
933052|NCT01442675|2257774|P1|Per-Protocol Analysis Set|Overall Study|The Per-Protocol Analysis Set are subjects with no pre-defined protocol deviations.|781
933053|NCT01442675|2257774|P1|Safety Analysis Set|Overall Study|Safety Analysis Set are subjects who received study vaccine and for whom safety data were available.|831
933054|NCT01442675|2257774|P1|STARTED|Overall Study||834
933055|NCT01442493|2257786|P2|NOT COMPLETED|Overall Study||2
933056|NCT01442493|2257787|P1|NOT COMPLETED|Overall Study||3
933057|NCT01442493|2257786|P2|COMPLETED|Overall Study||149
933058|NCT01442493|2257787|P1|COMPLETED|Overall Study||146
933059|NCT01442493|2257786|P2|STARTED|Overall Study||151
933060|NCT01442493|2257787|P1|STARTED|Overall Study||149
933061|NCT01442376|2257808|P3|NOT COMPLETED|Overall Study||5
933062|NCT01442376|2257809|P2|NOT COMPLETED|Overall Study||9
933063|NCT01442376|2257810|P1|NOT COMPLETED|Overall Study||3
933064|NCT01442376|2257808|P3|COMPLETED|Overall Study||159
933065|NCT01442376|2257809|P2|COMPLETED|Overall Study||160
933066|NCT01442376|2257810|P1|COMPLETED|Overall Study||166
933067|NCT01442376|2257808|P3|STARTED|Overall Study|Randomized patients|164
933068|NCT01442376|2257809|P2|STARTED|Overall Study|Randomized patients|169
933069|NCT01442376|2257810|P1|STARTED|Overall Study|Randomized patients|169
933070|NCT01442181|2257823|P2|NOT COMPLETED|Overall Study||3
933071|NCT01442181|2257824|P1|NOT COMPLETED|Overall Study||4
933072|NCT01442181|2257823|P2|COMPLETED|Overall Study||8
933073|NCT01442181|2257824|P1|COMPLETED|Overall Study||10
933074|NCT01442181|2257823|P2|STARTED|Overall Study||11
933075|NCT01442181|2257824|P1|STARTED|Overall Study||14
933076|NCT01442155|2257848|P1|NOT COMPLETED|Overall Study||65
933077|NCT01442155|2257848|P1|COMPLETED|Overall Study||9
933078|NCT01442155|2257848|P1|STARTED|Overall Study||74
933079|NCT01442129|2257855|P2|NOT COMPLETED|Overall Study||0
933080|NCT01442129|2257856|P1|NOT COMPLETED|Overall Study||0
933081|NCT01442129|2257855|P2|COMPLETED|Overall Study||10
933082|NCT01442129|2257856|P1|COMPLETED|Overall Study|Treatment withheld from 1 patient randomized before results of screening PRA known|20
933083|NCT01442129|2257855|P2|STARTED|Overall Study||10
933084|NCT01442129|2257856|P1|STARTED|Overall Study||20
933085|NCT01442103|2257864|P1|NOT COMPLETED|Overall Study||2
933086|NCT01442103|2257864|P1|COMPLETED|Overall Study||8
933087|NCT01442103|2257864|P1|STARTED|Overall Study||10
933088|NCT01442064|2257874|P6|NOT COMPLETED|Overall Study||99
933089|NCT01442064|2257875|P5|NOT COMPLETED|Overall Study||106
933090|NCT01442064|2257876|P4|NOT COMPLETED|Overall Study||98
933091|NCT01442064|2257877|P3|NOT COMPLETED|Overall Study||104
933092|NCT01442064|2257878|P2|NOT COMPLETED|Overall Study||101
933093|NCT01442064|2257879|P1|NOT COMPLETED|Overall Study||97
933094|NCT01442064|2257874|P6|COMPLETED|Overall Study||0
933095|NCT01442064|2257875|P5|COMPLETED|Overall Study||1
933096|NCT01442064|2257876|P4|COMPLETED|Overall Study||0
933097|NCT01442064|2257877|P3|COMPLETED|Overall Study||0
933098|NCT01442064|2257878|P2|COMPLETED|Overall Study||2
933099|NCT01442064|2257879|P1|COMPLETED|Overall Study||0
933100|NCT01442064|2257874|P6|Received Study Drug in Extension Study|Overall Study||81
933101|NCT01442064|2257875|P5|Received Study Drug in Extension Study|Overall Study||89
933102|NCT01442064|2257876|P4|Received Study Drug in Extension Study|Overall Study||70
933103|NCT01442064|2257877|P3|Received Study Drug in Extension Study|Overall Study||60
933104|NCT01442064|2257878|P2|Received Study Drug in Extension Study|Overall Study||70
933105|NCT01442064|2257879|P1|Received Study Drug in Extension Study|Overall Study||61
933106|NCT01442064|2257874|P6|Ranibizumab-Treated Subjects|Overall Study||99
933107|NCT01442064|2257875|P5|Ranibizumab-Treated Subjects|Overall Study||107
933108|NCT01442064|2257876|P4|Ranibizumab-Treated Subjects|Overall Study||96
933109|NCT01442064|2257877|P3|Ranibizumab-Treated Subjects|Overall Study||104
933110|NCT01442064|2257878|P2|Ranibizumab-Treated Subjects|Overall Study||103
933111|NCT01442064|2257879|P1|Ranibizumab-Treated Subjects|Overall Study|Includes participants who received Ranibizumab in either the initial studies or the extension study.|93
933112|NCT01442064|2257874|P6|STARTED|Overall Study||99
933113|NCT01442064|2257875|P5|STARTED|Overall Study||107
933114|NCT01442064|2257876|P4|STARTED|Overall Study||98
933115|NCT01442064|2257877|P3|STARTED|Overall Study||104
933116|NCT01442064|2257878|P2|STARTED|Overall Study||103
933117|NCT01442064|2257879|P1|STARTED|Overall Study||97
933118|NCT01442038|2257916|P2|NOT COMPLETED|Overall Study||279
933119|NCT01442038|2257917|P1|NOT COMPLETED|Overall Study||303
933120|NCT01442038|2257916|P2|COMPLETED|Overall Study||1040
933121|NCT01442038|2257917|P1|COMPLETED|Overall Study||1029
933122|NCT01442038|2257916|P2|STARTED|Overall Study||1319
933123|NCT01442038|2257917|P1|STARTED|Overall Study||1332
933124|NCT01441973|2257931|P2|NOT COMPLETED|Overall Study||5
933125|NCT01441973|2257932|P1|NOT COMPLETED|Overall Study||8
933126|NCT01441973|2257931|P2|COMPLETED|Overall Study|Still receiving treatment|11
933127|NCT01441973|2257932|P1|COMPLETED|Overall Study|Still receiving treatment|7
933128|NCT01441973|2257931|P2|STARTED|Overall Study||16
933129|NCT01441973|2257932|P1|STARTED|Overall Study||15
933130|NCT01441960|2257946|P2|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
933131|NCT01441960|2257947|P1|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
933132|NCT01441960|2257946|P2|COMPLETED|Second Neuromuscular Blocking Agent||13
933133|NCT01441960|2257947|P1|COMPLETED|Second Neuromuscular Blocking Agent||18
933134|NCT01441960|2257946|P2|STARTED|Second Neuromuscular Blocking Agent||13
933135|NCT01441960|2257947|P1|STARTED|Second Neuromuscular Blocking Agent||18
933136|NCT01441960|2257946|P2|NOT COMPLETED|First Neuromuscular Blocking Agent:||6
933137|NCT01441960|2257947|P1|NOT COMPLETED|First Neuromuscular Blocking Agent:||8
933138|NCT01441960|2257946|P2|COMPLETED|First Neuromuscular Blocking Agent:||13
933139|NCT01441960|2257947|P1|COMPLETED|First Neuromuscular Blocking Agent:||18
933140|NCT01441960|2257946|P2|STARTED|First Neuromuscular Blocking Agent:||19
933141|NCT01441960|2257947|P1|STARTED|First Neuromuscular Blocking Agent:||26
933142|NCT01441843|2257959|P2|NOT COMPLETED|Overall Study||5
933143|NCT01441843|2257960|P1|NOT COMPLETED|Overall Study||12
933144|NCT01441843|2257959|P2|COMPLETED|Overall Study||195
933145|NCT01441843|2257960|P1|COMPLETED|Overall Study||188
933146|NCT01441843|2257959|P2|STARTED|Overall Study||200
933147|NCT01441843|2257960|P1|STARTED|Overall Study||200
933148|NCT01441765|2257968|P2|NOT COMPLETED|Overall Study||0
933149|NCT01441765|2257969|P1|NOT COMPLETED|Overall Study||1
933150|NCT01441765|2257968|P2|COMPLETED|Overall Study|not opened|0
933151|NCT01441765|2257969|P1|COMPLETED|Overall Study||10
933152|NCT01441765|2257968|P2|STARTED|Overall Study|not opened|0
933153|NCT01441765|2257969|P1|STARTED|Overall Study||11
933154|NCT01441596|2257986|P3|NOT COMPLETED|Overall Study||4
933155|NCT01441596|2257987|P2|NOT COMPLETED|Overall Study||3
933156|NCT01441596|2257988|P1|NOT COMPLETED|Overall Study||4
933157|NCT01441596|2257986|P3|COMPLETED|Overall Study||39
933158|NCT01441596|2257987|P2|COMPLETED|Overall Study||35
933159|NCT01441596|2257988|P1|COMPLETED|Overall Study||36
933160|NCT01441596|2257986|P3|STARTED|Overall Study||43
933161|NCT01441596|2257987|P2|STARTED|Overall Study||38
933162|NCT01441596|2257988|P1|STARTED|Overall Study||40
933163|NCT01441570|2258004|P2|NOT COMPLETED|Overall Study||0
933164|NCT01441570|2258005|P1|NOT COMPLETED|Overall Study||0
933165|NCT01441570|2258004|P2|COMPLETED|Overall Study||5
933166|NCT01441570|2258005|P1|COMPLETED|Overall Study||6
933167|NCT01441570|2258004|P2|STARTED|Overall Study||5
933168|NCT01441570|2258005|P1|STARTED|Overall Study||6
933169|NCT01441466|2258015|P2|NOT COMPLETED|Overall Study||0
933170|NCT01441466|2258016|P1|NOT COMPLETED|Overall Study||0
933171|NCT01441466|2258015|P2|COMPLETED|Overall Study||11
933172|NCT01441466|2258016|P1|COMPLETED|Overall Study||37
933173|NCT01441466|2258015|P2|STARTED|Overall Study||11
933174|NCT01441466|2258016|P1|STARTED|Overall Study||37
933175|NCT01441440|2258035|P3|NOT COMPLETED|Overall Study||22
933176|NCT01441440|2258036|P2|NOT COMPLETED|Overall Study||23
933177|NCT01441440|2258037|P1|NOT COMPLETED|Overall Study||17
933178|NCT01441440|2258035|P3|COMPLETED|Overall Study||158
933179|NCT01441440|2258036|P2|COMPLETED|Overall Study||151
933180|NCT01441440|2258037|P1|COMPLETED|Overall Study||166
933181|NCT01441440|2258035|P3|STARTED|Overall Study|Safety analysis set|180
933182|NCT01441440|2258036|P2|STARTED|Overall Study|Safety analysis set|174
933183|NCT01441440|2258037|P1|STARTED|Overall Study|Safety analysis set|183
933184|NCT01441414|2258060|P1|NOT COMPLETED|Overall Study||15
933185|NCT01441414|2258060|P1|COMPLETED|Overall Study||3
933186|NCT01441414|2258060|P1|STARTED|Overall Study||18
933187|NCT01441401|2258085|P1|NOT COMPLETED|Overall Study||0
933188|NCT01441401|2258085|P1|COMPLETED|Overall Study|Number of participants whose survey form was collected was presented.|82
933189|NCT01441401|2258085|P1|STARTED|Overall Study||82
933190|NCT01441245|2258113|P2|NOT COMPLETED|Overall Study||0
933191|NCT01441245|2258114|P1|NOT COMPLETED|Overall Study||0
933192|NCT01441245|2258113|P2|COMPLETED|Overall Study||27
933193|NCT01441245|2258114|P1|COMPLETED|Overall Study||30
933194|NCT01441245|2258113|P2|STARTED|Overall Study||27
933195|NCT01441245|2258114|P1|STARTED|Overall Study||30
933196|NCT01441180|2258139|P3|NOT COMPLETED|Overall Study||3
933197|NCT01441180|2258140|P2|NOT COMPLETED|Overall Study||1
933198|NCT01441180|2258141|P1|NOT COMPLETED|Overall Study||1
933199|NCT01441180|2258139|P3|COMPLETED|Overall Study||22
933200|NCT01441180|2258140|P2|COMPLETED|Overall Study||24
933201|NCT01441180|2258141|P1|COMPLETED|Overall Study||9
933202|NCT01441180|2258139|P3|STARTED|Overall Study||25
933203|NCT01441180|2258140|P2|STARTED|Overall Study||25
933204|NCT01441180|2258141|P1|STARTED|Overall Study||10
933205|NCT01441102|2258152|P1|NOT COMPLETED|Overall Study||3
933206|NCT01441102|2258152|P1|COMPLETED|Overall Study||4
933207|NCT01441102|2258152|P1|STARTED|Overall Study|Two participants withdrew prior to Month 6; therefore, two additional participants were enrolled.|7
933208|NCT01441076|2258172|P1|NOT COMPLETED|Overall Study||2
933209|NCT01441076|2258172|P1|COMPLETED|Overall Study||4
933210|NCT01441076|2258172|P1|STARTED|Overall Study||6
933211|NCT01440972|2258192|P2|NOT COMPLETED|Overall Study||2
933212|NCT01440972|2258193|P1|NOT COMPLETED|Overall Study||3
933213|NCT01440972|2258192|P2|COMPLETED|Overall Study||19
933214|NCT01440972|2258193|P1|COMPLETED|Overall Study||21
933215|NCT01440972|2258192|P2|STARTED|Overall Study||21
933216|NCT01440972|2258193|P1|STARTED|Overall Study||24
933217|NCT01440959|2258207|P1|NOT COMPLETED|Overall Study||0
933218|NCT01440959|2258207|P1|COMPLETED|Overall Study||30
933219|NCT01440959|2258207|P1|STARTED|Overall Study||30
933220|NCT01440946|2258217|P2|NOT COMPLETED|Overall Study||1
933221|NCT01440946|2258218|P1|NOT COMPLETED|Overall Study||2
933222|NCT01440946|2258217|P2|COMPLETED|Overall Study||14
933223|NCT01440946|2258218|P1|COMPLETED|Overall Study||13
933224|NCT01440946|2258217|P2|STARTED|Overall Study||15
933225|NCT01440946|2258218|P1|STARTED|Overall Study||15
933226|NCT01440881|2258257|P2|NOT COMPLETED|Overall Study||1
933227|NCT01440881|2258258|P1|NOT COMPLETED|Overall Study||0
933228|NCT01440881|2258257|P2|COMPLETED|Overall Study||14
933229|NCT01440881|2258258|P1|COMPLETED|Overall Study||14
933230|NCT01440881|2258257|P2|STARTED|Overall Study||15
933231|NCT01440881|2258258|P1|STARTED|Overall Study||14
933232|NCT01440764|2258272|P7|NOT COMPLETED|Test Day 3||0
933233|NCT01440764|2258273|P6|NOT COMPLETED|Test Day 3||0
933234|NCT01440764|2258274|P5|NOT COMPLETED|Test Day 3||0
933235|NCT01440764|2258275|P4|NOT COMPLETED|Test Day 3||0
933236|NCT01440764|2258276|P3|NOT COMPLETED|Test Day 3||0
933237|NCT01440764|2258277|P2|NOT COMPLETED|Test Day 3||0
933238|NCT01440764|2258278|P1|NOT COMPLETED|Test Day 3||0
933239|NCT01440764|2258272|P7|COMPLETED|Test Day 3||3
933240|NCT01440764|2258273|P6|COMPLETED|Test Day 3||5
933241|NCT01440764|2258274|P5|COMPLETED|Test Day 3||3
933242|NCT01440764|2258275|P4|COMPLETED|Test Day 3||1
933243|NCT01440764|2258276|P3|COMPLETED|Test Day 3||6
933244|NCT01440764|2258277|P2|COMPLETED|Test Day 3||2
933245|NCT01440764|2258278|P1|COMPLETED|Test Day 3||3
933246|NCT01440764|2258272|P7|STARTED|Test Day 3||3
933247|NCT01440764|2258273|P6|STARTED|Test Day 3||5
933248|NCT01440764|2258274|P5|STARTED|Test Day 3||3
933249|NCT01440764|2258275|P4|STARTED|Test Day 3||1
933250|NCT01440764|2258276|P3|STARTED|Test Day 3||6
933251|NCT01440764|2258277|P2|STARTED|Test Day 3||2
933252|NCT01440764|2258278|P1|STARTED|Test Day 3||3
933253|NCT01440764|2258272|P7|NOT COMPLETED|Test Day 2||0
933254|NCT01440764|2258273|P6|NOT COMPLETED|Test Day 2||0
933255|NCT01440764|2258274|P5|NOT COMPLETED|Test Day 2||0
933256|NCT01440764|2258275|P4|NOT COMPLETED|Test Day 2||0
933257|NCT01440764|2258276|P3|NOT COMPLETED|Test Day 2||0
933258|NCT01440764|2258277|P2|NOT COMPLETED|Test Day 2||0
933259|NCT01440764|2258278|P1|NOT COMPLETED|Test Day 2||0
933260|NCT01440764|2258272|P7|COMPLETED|Test Day 2||3
933261|NCT01440764|2258273|P6|COMPLETED|Test Day 2||5
933262|NCT01440764|2258274|P5|COMPLETED|Test Day 2||3
933263|NCT01440764|2258275|P4|COMPLETED|Test Day 2||1
933264|NCT01440764|2258276|P3|COMPLETED|Test Day 2||6
933265|NCT01440764|2258277|P2|COMPLETED|Test Day 2||2
933266|NCT01440764|2258278|P1|COMPLETED|Test Day 2||3
933267|NCT01440764|2258272|P7|STARTED|Test Day 2||3
933268|NCT01440764|2258273|P6|STARTED|Test Day 2||5
933269|NCT01440764|2258274|P5|STARTED|Test Day 2||3
933270|NCT01440764|2258275|P4|STARTED|Test Day 2||1
933271|NCT01440764|2258276|P3|STARTED|Test Day 2||6
933272|NCT01440764|2258277|P2|STARTED|Test Day 2||2
933273|NCT01440764|2258278|P1|STARTED|Test Day 2|Following Test Day 1, 1 subject withdrew from the study before beginning Test Day 2.|3
933274|NCT01440764|2258272|P7|NOT COMPLETED|Test Day 1||0
933275|NCT01440764|2258273|P6|NOT COMPLETED|Test Day 1||0
933276|NCT01440764|2258274|P5|NOT COMPLETED|Test Day 1||0
933277|NCT01440764|2258275|P4|NOT COMPLETED|Test Day 1||0
933278|NCT01440764|2258276|P3|NOT COMPLETED|Test Day 1||0
933279|NCT01440764|2258277|P2|NOT COMPLETED|Test Day 1||0
933280|NCT01440764|2258278|P1|NOT COMPLETED|Test Day 1||0
933281|NCT01440764|2258272|P7|COMPLETED|Test Day 1||3
933282|NCT01440764|2258273|P6|COMPLETED|Test Day 1||5
933283|NCT01440764|2258274|P5|COMPLETED|Test Day 1||3
933284|NCT01440764|2258275|P4|COMPLETED|Test Day 1||1
933285|NCT01440764|2258276|P3|COMPLETED|Test Day 1||6
933286|NCT01440764|2258277|P2|COMPLETED|Test Day 1||2
933287|NCT01440764|2258278|P1|COMPLETED|Test Day 1||4
933288|NCT01440764|2258272|P7|STARTED|Test Day 1||3
933289|NCT01440764|2258273|P6|STARTED|Test Day 1||5
933290|NCT01440764|2258274|P5|STARTED|Test Day 1||3
933291|NCT01440764|2258275|P4|STARTED|Test Day 1||1
933292|NCT01440764|2258276|P3|STARTED|Test Day 1||6
933293|NCT01440764|2258277|P2|STARTED|Test Day 1||2
933294|NCT01440764|2258278|P1|STARTED|Test Day 1||4
933295|NCT01440647|2258299|P2|NOT COMPLETED|Overall Study||3
933296|NCT01440647|2258300|P1|NOT COMPLETED|Overall Study||2
933297|NCT01440647|2258299|P2|COMPLETED|Overall Study||15
933298|NCT01440647|2258300|P1|COMPLETED|Overall Study||14
933299|NCT01440647|2258299|P2|STARTED|Overall Study||18
933300|NCT01440647|2258300|P1|STARTED|Overall Study||16
933301|NCT01440634|2258310|P2|NOT COMPLETED|Randomization Phase||10
933302|NCT01440634|2258311|P1|NOT COMPLETED|Randomization Phase||6
933303|NCT01440634|2258310|P2|COMPLETED|Randomization Phase||14
933304|NCT01440634|2258311|P1|COMPLETED|Randomization Phase||24
933305|NCT01440634|2258310|P2|STARTED|Randomization Phase||24
933306|NCT01440634|2258311|P1|STARTED|Randomization Phase||30
933307|NCT01440634|2258310|P2|NOT COMPLETED|Cross Sectional Phase||0
933308|NCT01440634|2258311|P1|NOT COMPLETED|Cross Sectional Phase||0
933309|NCT01440634|2258310|P2|COMPLETED|Cross Sectional Phase||347
933310|NCT01440634|2258311|P1|COMPLETED|Cross Sectional Phase||0
933311|NCT01440634|2258310|P2|STARTED|Cross Sectional Phase||347
933312|NCT01440634|2258311|P1|STARTED|Cross Sectional Phase||0
933313|NCT01440595|2258319|P3|NOT COMPLETED|Overall Study||1
933314|NCT01440595|2258320|P2|NOT COMPLETED|Overall Study||3
933315|NCT01440595|2258321|P1|NOT COMPLETED|Overall Study||1
933316|NCT01440595|2258319|P3|COMPLETED|Overall Study||0
933317|NCT01440595|2258320|P2|COMPLETED|Overall Study||0
933318|NCT01440595|2258321|P1|COMPLETED|Overall Study||0
933319|NCT01440595|2258319|P3|STARTED|Overall Study||1
933320|NCT01440595|2258320|P2|STARTED|Overall Study||3
933321|NCT01440595|2258321|P1|STARTED|Overall Study||1
933322|NCT01440569|2258341|P2|NOT COMPLETED|Open-Label Rollover Phase||6
933323|NCT01440569|2258342|P1|NOT COMPLETED|Open-Label Rollover Phase||47
933324|NCT01440569|2258341|P2|COMPLETED|Open-Label Rollover Phase||7
933325|NCT01440569|2258342|P1|COMPLETED|Open-Label Rollover Phase||204
933326|NCT01440569|2258341|P2|STARTED|Open-Label Rollover Phase|1 participant who completed the Main Study did not enroll into the Rollover Phase.|13
933327|NCT01440569|2258342|P1|STARTED|Open-Label Rollover Phase|9 participants who completed the Main Study did not enroll into the Rollover Phase.|251
933328|NCT01440569|2258341|P2|NOT COMPLETED|Main Study||4
933329|NCT01440569|2258342|P1|NOT COMPLETED|Main Study||36
933330|NCT01440569|2258341|P2|COMPLETED|Main Study||14
933331|NCT01440569|2258342|P1|COMPLETED|Main Study||260
933332|NCT01440569|2258341|P2|Enrolled and Treated|Main Study||18
933333|NCT01440569|2258342|P1|Enrolled and Treated|Main Study||295
933334|NCT01440569|2258341|P2|STARTED|Main Study||18
933335|NCT01440569|2258342|P1|STARTED|Main Study||296
933336|NCT01440543|2258364|P4|NOT COMPLETED|Overall Study||6
933337|NCT01440543|2258365|P3|NOT COMPLETED|Overall Study||2
933338|NCT01440543|2258366|P2|NOT COMPLETED|Overall Study||4
933339|NCT01440543|2258367|P1|NOT COMPLETED|Overall Study||4
933340|NCT01440543|2258364|P4|COMPLETED|Overall Study||101
933341|NCT01440543|2258365|P3|COMPLETED|Overall Study||100
933342|NCT01440543|2258366|P2|COMPLETED|Overall Study||101
933343|NCT01440543|2258367|P1|COMPLETED|Overall Study||102
933344|NCT01440543|2258364|P4|STARTED|Overall Study||107
933345|NCT01440543|2258365|P3|STARTED|Overall Study||102
933346|NCT01440543|2258366|P2|STARTED|Overall Study||105
933347|NCT01440543|2258367|P1|STARTED|Overall Study||106
933348|NCT01440517|2258377|P1|NOT COMPLETED|Overall Study||1
933349|NCT01440517|2258377|P1|COMPLETED|Overall Study||4
933350|NCT01440517|2258377|P1|STARTED|Overall Study||5
933351|NCT01440387|2258384|P2|NOT COMPLETED|Overall Study||0
933352|NCT01440387|2258385|P1|NOT COMPLETED|Overall Study||0
933353|NCT01440387|2258384|P2|COMPLETED|Overall Study||56
933354|NCT01440387|2258385|P1|COMPLETED|Overall Study||56
933355|NCT01440387|2258384|P2|STARTED|Overall Study||56
933356|NCT01440387|2258385|P1|STARTED|Overall Study||56
933357|NCT01440374|2258408|P4|NOT COMPLETED|Part 3: Extension||32
933358|NCT01440374|2258409|P3|NOT COMPLETED|Part 3: Extension||0
933359|NCT01440374|2258410|P2|NOT COMPLETED|Part 3: Extension||0
933360|NCT01440374|2258411|P1|NOT COMPLETED|Part 3: Extension||0
933361|NCT01440374|2258408|P4|COMPLETED|Part 3: Extension||27
933362|NCT01440374|2258409|P3|COMPLETED|Part 3: Extension||0
933363|NCT01440374|2258410|P2|COMPLETED|Part 3: Extension||0
933364|NCT01440374|2258411|P1|COMPLETED|Part 3: Extension||0
933365|NCT01440374|2258408|P4|STARTED|Part 3: Extension||59
933366|NCT01440374|2258409|P3|STARTED|Part 3: Extension||0
933367|NCT01440374|2258410|P2|STARTED|Part 3: Extension||0
933368|NCT01440374|2258411|P1|STARTED|Part 3: Extension||0
933369|NCT01440374|2258408|P4|NOT COMPLETED|Part 2; Double-blind Phase||0
933370|NCT01440374|2258409|P3|NOT COMPLETED|Part 2; Double-blind Phase||55
933371|NCT01440374|2258410|P2|NOT COMPLETED|Part 2; Double-blind Phase||20
933372|NCT01440374|2258411|P1|NOT COMPLETED|Part 2; Double-blind Phase||0
933373|NCT01440374|2258408|P4|COMPLETED|Part 2; Double-blind Phase||0
933374|NCT01440374|2258409|P3|COMPLETED|Part 2; Double-blind Phase||43
933375|NCT01440374|2258410|P2|COMPLETED|Part 2; Double-blind Phase||27
933376|NCT01440374|2258411|P1|COMPLETED|Part 2; Double-blind Phase||0
933377|NCT01440374|2258408|P4|STARTED|Part 2; Double-blind Phase||0
933378|NCT01440374|2258409|P3|STARTED|Part 2; Double-blind Phase||98
933379|NCT01440374|2258410|P2|STARTED|Part 2; Double-blind Phase||47
933380|NCT01440374|2258411|P1|STARTED|Part 2; Double-blind Phase||0
933381|NCT01440374|2258408|P4|NOT COMPLETED|Part 1: Open-label Phase||0
933382|NCT01440374|2258409|P3|NOT COMPLETED|Part 1: Open-label Phase||0
933383|NCT01440374|2258410|P2|NOT COMPLETED|Part 1: Open-label Phase||0
933384|NCT01440374|2258411|P1|NOT COMPLETED|Part 1: Open-label Phase||6
933385|NCT01440374|2258408|P4|COMPLETED|Part 1: Open-label Phase||0
933386|NCT01440374|2258409|P3|COMPLETED|Part 1: Open-label Phase||0
933387|NCT01440374|2258410|P2|COMPLETED|Part 1: Open-label Phase||0
933388|NCT01440374|2258411|P1|COMPLETED|Part 1: Open-label Phase||11
933389|NCT01440374|2258408|P4|STARTED|Part 1: Open-label Phase||0
933390|NCT01440374|2258409|P3|STARTED|Part 1: Open-label Phase||0
933391|NCT01440374|2258410|P2|STARTED|Part 1: Open-label Phase||0
933392|NCT01440374|2258411|P1|STARTED|Part 1: Open-label Phase||17
933393|NCT01440322|2258446|P2|NOT COMPLETED|Overall Study||1
933394|NCT01440322|2258447|P1|NOT COMPLETED|Overall Study||7
933395|NCT01440322|2258446|P2|COMPLETED|Overall Study||49
933396|NCT01440322|2258447|P1|COMPLETED|Overall Study||90
933397|NCT01440322|2258446|P2|STARTED|Overall Study||50
933398|NCT01440322|2258447|P1|STARTED|Overall Study||97
933399|NCT01440283|2258469|P1|NOT COMPLETED|Overall Study||10
933400|NCT01440283|2258469|P1|COMPLETED|Overall Study||4
933401|NCT01440283|2258469|P1|STARTED|Overall Study||14
933402|NCT01440101|2258484|P3|NOT COMPLETED|Overall Study||1
933403|NCT01440101|2258485|P2|NOT COMPLETED|Overall Study||4
933404|NCT01440101|2258486|P1|NOT COMPLETED|Overall Study||2
933405|NCT01440101|2258484|P3|COMPLETED|Overall Study||46
933406|NCT01440101|2258485|P2|COMPLETED|Overall Study||43
933407|NCT01440101|2258486|P1|COMPLETED|Overall Study||10
933408|NCT01440101|2258484|P3|STARTED|Overall Study||47
933409|NCT01440101|2258485|P2|STARTED|Overall Study||47
933410|NCT01440101|2258486|P1|STARTED|Overall Study||12
933411|NCT01440049|2258519|P1|NOT COMPLETED|Overall Study||5
933412|NCT01440049|2258519|P1|COMPLETED|Overall Study||155
933413|NCT01440049|2258519|P1|STARTED|Overall Study||160
933414|NCT01439971|2258551|P5|NOT COMPLETED|Overall Study||1
933415|NCT01439971|2258552|P4|NOT COMPLETED|Overall Study||0
933416|NCT01439971|2258553|P3|NOT COMPLETED|Overall Study||2
933417|NCT01439971|2258554|P2|NOT COMPLETED|Overall Study||1
933418|NCT01439971|2258555|P1|NOT COMPLETED|Overall Study||0
933419|NCT01439971|2258551|P5|COMPLETED|Overall Study||6
933420|NCT01439971|2258552|P4|COMPLETED|Overall Study||6
933421|NCT01439971|2258553|P3|COMPLETED|Overall Study||6
933422|NCT01439971|2258554|P2|COMPLETED|Overall Study||6
933423|NCT01439971|2258555|P1|COMPLETED|Overall Study||1
933424|NCT01439971|2258551|P5|Received Treatment|Overall Study||6
933425|NCT01439971|2258552|P4|Received Treatment|Overall Study||6
933426|NCT01439971|2258553|P3|Received Treatment|Overall Study||6
933427|NCT01439971|2258554|P2|Received Treatment|Overall Study||6
933428|NCT01439971|2258555|P1|Received Treatment|Overall Study||1
933429|NCT01439971|2258551|P5|STARTED|Overall Study||7
933430|NCT01439971|2258552|P4|STARTED|Overall Study||6
933431|NCT01439971|2258553|P3|STARTED|Overall Study||8
933432|NCT01439971|2258554|P2|STARTED|Overall Study||7
933433|NCT01439971|2258555|P1|STARTED|Overall Study||1
933434|NCT01439945|2258735|P4|NOT COMPLETED|Optional Continuation Phase||0
933435|NCT01439945|2258736|P3|NOT COMPLETED|Optional Continuation Phase||0
933436|NCT01439945|2258737|P2|NOT COMPLETED|Optional Continuation Phase||0
933437|NCT01439945|2258738|P1|NOT COMPLETED|Optional Continuation Phase||0
933438|NCT01439945|2258735|P4|COMPLETED|Optional Continuation Phase||0
933439|NCT01439945|2258736|P3|COMPLETED|Optional Continuation Phase||0
933440|NCT01439945|2258737|P2|COMPLETED|Optional Continuation Phase||44
933441|NCT01439945|2258738|P1|COMPLETED|Optional Continuation Phase||72
933442|NCT01439945|2258735|P4|STARTED|Optional Continuation Phase||0
933443|NCT01439945|2258736|P3|STARTED|Optional Continuation Phase||0
933444|NCT01439945|2258737|P2|STARTED|Optional Continuation Phase||44
933445|NCT01439945|2258738|P1|STARTED|Optional Continuation Phase||72
933446|NCT01439945|2258735|P4|NOT COMPLETED|Double-Blind Treatment Phase||2
933447|NCT01439945|2258736|P3|NOT COMPLETED|Double-Blind Treatment Phase||3
933448|NCT01439945|2258737|P2|NOT COMPLETED|Double-Blind Treatment Phase||5
933449|NCT01439945|2258738|P1|NOT COMPLETED|Double-Blind Treatment Phase||4
933450|NCT01439945|2258735|P4|COMPLETED|Double-Blind Treatment Phase||46
933451|NCT01439945|2258736|P3|COMPLETED|Double-Blind Treatment Phase||45
933452|NCT01439945|2258737|P2|COMPLETED|Double-Blind Treatment Phase||91
933453|NCT01439945|2258738|P1|COMPLETED|Double-Blind Treatment Phase||93
933454|NCT01439945|2258735|P4|STARTED|Double-Blind Treatment Phase||48
933455|NCT01439945|2258736|P3|STARTED|Double-Blind Treatment Phase||48
933456|NCT01439945|2258737|P2|STARTED|Double-Blind Treatment Phase||96
933457|NCT01439945|2258738|P1|STARTED|Double-Blind Treatment Phase||97
933458|NCT01439867|2258763|P2|NOT COMPLETED|Overall Study||8
933459|NCT01439867|2258764|P1|NOT COMPLETED|Overall Study||6
933460|NCT01439867|2258763|P2|COMPLETED|Overall Study||2
933461|NCT01439867|2258764|P1|COMPLETED|Overall Study||2
933462|NCT01439867|2258763|P2|Received Treatment|Overall Study||10
933463|NCT01439867|2258764|P1|Received Treatment|Overall Study||7
933464|NCT01439867|2258763|P2|STARTED|Overall Study||10
933465|NCT01439867|2258764|P1|STARTED|Overall Study||8
933466|NCT01439724|2258805|P2|NOT COMPLETED|Overall Study||8
933467|NCT01439724|2258806|P1|NOT COMPLETED|Overall Study||9
933468|NCT01439724|2258805|P2|COMPLETED|Overall Study||39
933469|NCT01439724|2258806|P1|COMPLETED|Overall Study||38
933470|NCT01439724|2258805|P2|STARTED|Overall Study||47
933471|NCT01439724|2258806|P1|STARTED|Overall Study||47
933472|NCT01439672|2258812|P1|NOT COMPLETED|Overall Study||24
933473|NCT01439672|2258812|P1|COMPLETED|Overall Study||11
933474|NCT01439672|2258812|P1|STARTED|Overall Study||35
933481|NCT01439282|2258869|P2|NOT COMPLETED|Overall Study||1
933482|NCT01439282|2258870|P1|NOT COMPLETED|Overall Study||8
933483|NCT01439282|2258869|P2|COMPLETED|Overall Study||9
933484|NCT01439282|2258870|P1|COMPLETED|Overall Study||59
933485|NCT01439282|2258869|P2|STARTED|Overall Study||10
933486|NCT01439282|2258870|P1|STARTED|Overall Study||67
933487|NCT01439204|2258880|P2|NOT COMPLETED|Overall Study||3
933488|NCT01439204|2258881|P1|NOT COMPLETED|Overall Study||4
933489|NCT01439204|2258880|P2|COMPLETED|Overall Study||33
933490|NCT01439204|2258881|P1|COMPLETED|Overall Study||32
933491|NCT01439204|2258880|P2|STARTED|Overall Study||36
933492|NCT01439204|2258881|P1|STARTED|Overall Study||36
933499|NCT01439126|2258930|P2|NOT COMPLETED|Overall Study||42
933500|NCT01439126|2258931|P1|NOT COMPLETED|Overall Study||31
933501|NCT01439126|2258930|P2|COMPLETED|Overall Study||25
933502|NCT01439126|2258931|P1|COMPLETED|Overall Study||37
933503|NCT01439126|2258930|P2|STARTED|Overall Study||67
933504|NCT01439126|2258931|P1|STARTED|Overall Study||68
933505|NCT01439074|2258953|P2|NOT COMPLETED|Overall Study||13
933506|NCT01439074|2258954|P1|NOT COMPLETED|Overall Study||9
933507|NCT01439074|2258953|P2|COMPLETED|Overall Study||74
933508|NCT01439074|2258954|P1|COMPLETED|Overall Study||66
933509|NCT01439074|2258953|P2|STARTED|Overall Study||87
933510|NCT01439074|2258954|P1|STARTED|Overall Study||75
933511|NCT01438996|2258969|P3|NOT COMPLETED|Overall Study||0
933512|NCT01438996|2258970|P2|NOT COMPLETED|Overall Study||1
933513|NCT01438996|2258971|P1|NOT COMPLETED|Overall Study||4
933514|NCT01438996|2258969|P3|COMPLETED|Overall Study||20
933515|NCT01438996|2258970|P2|COMPLETED|Overall Study||12
933516|NCT01438996|2258971|P1|COMPLETED|Overall Study||14
933517|NCT01438996|2258969|P3|STARTED|Overall Study||20
933518|NCT01438996|2258970|P2|STARTED|Overall Study||13
933519|NCT01438996|2258971|P1|STARTED|Overall Study||18
933520|NCT01438814|2259005|P2|NOT COMPLETED|Overall Study||14
933521|NCT01438814|2259006|P1|NOT COMPLETED|Overall Study||14
933522|NCT01438814|2259005|P2|COMPLETED|Overall Study||331
933523|NCT01438814|2259006|P1|COMPLETED|Overall Study||330
933524|NCT01438814|2259005|P2|STARTED|Overall Study||345
933525|NCT01438814|2259006|P1|STARTED|Overall Study||344
933526|NCT01438710|2259036|P2|NOT COMPLETED|Second Week of Treatment||0
933527|NCT01438710|2259037|P1|NOT COMPLETED|Second Week of Treatment||1
933528|NCT01438710|2259036|P2|COMPLETED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
933529|NCT01438710|2259037|P1|COMPLETED|Second Week of Treatment||40
933530|NCT01438710|2259036|P2|STARTED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
933531|NCT01438710|2259037|P1|STARTED|Second Week of Treatment|Patients completing the first week will continue on LCP-Tacro treatment during the second week.|41
933532|NCT01438710|2259036|P2|NOT COMPLETED|First Week of Treatment||3
933533|NCT01438710|2259037|P1|NOT COMPLETED|First Week of Treatment||0
933534|NCT01438710|2259036|P2|COMPLETED|First Week of Treatment||41
933535|NCT01438710|2259037|P1|COMPLETED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
933536|NCT01438710|2259036|P2|STARTED|First Week of Treatment||44
933537|NCT01438710|2259037|P1|STARTED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
933538|NCT01438541|2259042|P1|NOT COMPLETED|Overall Study||7
933539|NCT01438541|2259042|P1|COMPLETED|Overall Study||22
933540|NCT01438541|2259042|P1|STARTED|Overall Study||29
933541|NCT01438489|2259051|P3|NOT COMPLETED|Overall Study||19
933542|NCT01438489|2259052|P2|NOT COMPLETED|Overall Study||16
933543|NCT01438489|2259053|P1|NOT COMPLETED|Overall Study||26
933544|NCT01438489|2259051|P3|COMPLETED|Overall Study||85
933545|NCT01438489|2259052|P2|COMPLETED|Overall Study||84
933546|NCT01438489|2259053|P1|COMPLETED|Overall Study||77
933547|NCT01438489|2259051|P3|STARTED|Overall Study||104
933548|NCT01438489|2259052|P2|STARTED|Overall Study||100
933549|NCT01438489|2259053|P1|STARTED|Overall Study||103
933550|NCT01438424|2259096|P1|NOT COMPLETED|Overall Study||417
933551|NCT01438424|2259096|P1|COMPLETED|Overall Study|Completed treatment|634
933552|NCT01438424|2259096|P1|STARTED|Overall Study|Received treatment|1051
933553|NCT01438307|2259134|P2|NOT COMPLETED|Overall Study||1
933554|NCT01438307|2259135|P1|NOT COMPLETED|Overall Study||1
933555|NCT01438307|2259134|P2|COMPLETED|Overall Study||13
933556|NCT01438307|2259135|P1|COMPLETED|Overall Study||13
933557|NCT01438307|2259134|P2|STARTED|Overall Study||14
933558|NCT01438307|2259135|P1|STARTED|Overall Study||14
933559|NCT01438294|2259149|P2|NOT COMPLETED|Overall Study||7
933560|NCT01438294|2259150|P1|NOT COMPLETED|Overall Study||3
933561|NCT01438294|2259149|P2|COMPLETED|Overall Study||13
933562|NCT01438294|2259150|P1|COMPLETED|Overall Study||13
933563|NCT01438294|2259149|P2|STARTED|Overall Study||20
933564|NCT01438294|2259150|P1|STARTED|Overall Study||16
933565|NCT01438229|2259160|P1|NOT COMPLETED|Overall Study||3
933566|NCT01438229|2259160|P1|COMPLETED|Overall Study||44
933567|NCT01438229|2259160|P1|Underwent Procedure|Overall Study||46
933568|NCT01438229|2259160|P1|Excluded Due to Renal Artery Anatomy|Overall Study||1
933569|NCT01438229|2259160|P1|STARTED|Overall Study||47
933570|NCT01438177|2259193|P1|NOT COMPLETED|Overall Study||2
933571|NCT01438177|2259193|P1|COMPLETED|Overall Study|Patients who were off due to disease progression|9
933572|NCT01438177|2259193|P1|STARTED|Overall Study||11
933573|NCT01438151|2259199|P1|NOT COMPLETED|Overall Study||8
933574|NCT01438151|2259199|P1|COMPLETED|Overall Study||3
933575|NCT01438151|2259199|P1|STARTED|Overall Study||11
933576|NCT01438060|2259205|P2|NOT COMPLETED|On Study Beyond Week 140||8
933577|NCT01438060|2259206|P1|NOT COMPLETED|On Study Beyond Week 140||0
933578|NCT01438060|2259205|P2|COMPLETED|On Study Beyond Week 140||1
933579|NCT01438060|2259206|P1|COMPLETED|On Study Beyond Week 140||0
933580|NCT01438060|2259205|P2|STARTED|On Study Beyond Week 140|9 participants in France who showed improvement at Week 140 continued treatment beyond 140 weeks|9
933581|NCT01438060|2259206|P1|STARTED|On Study Beyond Week 140||0
933582|NCT01438060|2259205|P2|NOT COMPLETED|Extension Phase: Week 10 to Week 130||56
933583|NCT01438060|2259206|P1|NOT COMPLETED|Extension Phase: Week 10 to Week 130||58
933584|NCT01438060|2259205|P2|COMPLETED|Extension Phase: Week 10 to Week 130||25
933585|NCT01438060|2259206|P1|COMPLETED|Extension Phase: Week 10 to Week 130||22
933586|NCT01438060|2259205|P2|STARTED|Extension Phase: Week 10 to Week 130|Of the 88 participants, who completed Acute Phase, 81 opted to enter 130-week extension phase|81
933587|NCT01438060|2259206|P1|STARTED|Extension Phase: Week 10 to Week 130|80 out of the 84 participants entered extension phase. All were treated with open-label aripiprazole|80
933588|NCT01438060|2259205|P2|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
933589|NCT01438060|2259206|P1|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
933590|NCT01438060|2259205|P2|COMPLETED|Acute Phase: Double-blind, 10 Weeks||88
933591|NCT01438060|2259206|P1|COMPLETED|Acute Phase: Double-blind, 10 Weeks||84
933592|NCT01438060|2259205|P2|STARTED|Acute Phase: Double-blind, 10 Weeks||106
933593|NCT01438060|2259206|P1|STARTED|Acute Phase: Double-blind, 10 Weeks||102
933594|NCT01437995|2259287|P3|NOT COMPLETED|Overall Study||20
933595|NCT01437995|2259288|P2|NOT COMPLETED|Overall Study||18
933596|NCT01437995|2259289|P1|NOT COMPLETED|Overall Study||11
933597|NCT01437995|2259287|P3|COMPLETED|Overall Study||135
933598|NCT01437995|2259288|P2|COMPLETED|Overall Study||131
933599|NCT01437995|2259289|P1|COMPLETED|Overall Study||140
933600|NCT01437995|2259287|P3|Included in Treatment Failure Analysis|Overall Study||151
933601|NCT01437995|2259288|P2|Included in Treatment Failure Analysis|Overall Study||146
933602|NCT01437995|2259289|P1|Included in Treatment Failure Analysis|Overall Study||150
933603|NCT01437995|2259287|P3|STARTED|Overall Study||155
933604|NCT01437995|2259288|P2|STARTED|Overall Study||149
933605|NCT01437995|2259289|P1|STARTED|Overall Study||151
933606|NCT01437943|2259311|P2|NOT COMPLETED|Overall Study||2
933607|NCT01437943|2259312|P1|NOT COMPLETED|Overall Study||7
933608|NCT01437943|2259311|P2|COMPLETED|Overall Study||1
933609|NCT01437943|2259312|P1|COMPLETED|Overall Study||0
933610|NCT01437943|2259311|P2|STARTED|Overall Study||3
933611|NCT01437943|2259312|P1|STARTED|Overall Study||7
933612|NCT01437878|2259320|P2|NOT COMPLETED|Overall Study||0
933613|NCT01437878|2259321|P1|NOT COMPLETED|Overall Study||1
933614|NCT01437878|2259320|P2|COMPLETED|Overall Study||1
933615|NCT01437878|2259321|P1|COMPLETED|Overall Study||0
933616|NCT01437878|2259320|P2|STARTED|Overall Study||1
933617|NCT01437878|2259321|P1|STARTED|Overall Study|Patient discontinued the study prior to initiation of study treatment|1
933618|NCT01437540|2259363|P2|NOT COMPLETED|Overall Study||65
933619|NCT01437540|2259364|P1|NOT COMPLETED|Overall Study||127
933620|NCT01437540|2259363|P2|COMPLETED|Overall Study||133
933621|NCT01437540|2259364|P1|COMPLETED|Overall Study||265
933622|NCT01437540|2259363|P2|STARTED|Overall Study||198
933623|NCT01437540|2259364|P1|STARTED|Overall Study||392
933624|NCT01437501|2259378|P2|NOT COMPLETED|Overall Study||11
933625|NCT01437501|2259379|P1|NOT COMPLETED|Overall Study||13
933626|NCT01437501|2259378|P2|COMPLETED|Overall Study||132
933627|NCT01437501|2259379|P1|COMPLETED|Overall Study||135
933628|NCT01437501|2259378|P2|STARTED|Overall Study||143
933629|NCT01437501|2259379|P1|STARTED|Overall Study||148
933630|NCT01437488|2259385|P1|NOT COMPLETED|Overall Study||0
933631|NCT01437488|2259385|P1|COMPLETED|Overall Study||14
933632|NCT01437488|2259385|P1|STARTED|Overall Study||14
933633|NCT01437423|2259391|P1|NOT COMPLETED|Overall Study||15
933634|NCT01437423|2259391|P1|COMPLETED|Overall Study||647
933635|NCT01437423|2259391|P1|STARTED|Overall Study||662
933636|NCT01437397|2259403|P5|NOT COMPLETED|Overall Study||101
933637|NCT01437397|2259404|P4|NOT COMPLETED|Overall Study||69
933638|NCT01437397|2259405|P3|NOT COMPLETED|Overall Study||72
933639|NCT01437397|2259406|P2|NOT COMPLETED|Overall Study||62
933640|NCT01437397|2259407|P1|NOT COMPLETED|Overall Study||66
933641|NCT01437397|2259403|P5|COMPLETED|Overall Study||236
933642|NCT01437397|2259404|P4|COMPLETED|Overall Study||270
933643|NCT01437397|2259405|P3|COMPLETED|Overall Study||268
933644|NCT01437397|2259406|P2|COMPLETED|Overall Study||276
933645|NCT01437397|2259407|P1|COMPLETED|Overall Study||272
933646|NCT01437397|2259403|P5|STARTED|Overall Study||337
933647|NCT01437397|2259404|P4|STARTED|Overall Study||339
933648|NCT01437397|2259405|P3|STARTED|Overall Study||340
933649|NCT01437397|2259406|P2|STARTED|Overall Study||338
933650|NCT01437397|2259407|P1|STARTED|Overall Study||338
933651|NCT01437319|2259434|P3|NOT COMPLETED|Phase II||37
933652|NCT01437319|2259435|P2|NOT COMPLETED|Phase II||44
933653|NCT01437319|2259436|P1|NOT COMPLETED|Phase II||0
933654|NCT01437319|2259434|P3|COMPLETED|Phase II||75
933655|NCT01437319|2259435|P2|COMPLETED|Phase II||71
933656|NCT01437319|2259436|P1|COMPLETED|Phase II||0
933657|NCT01437319|2259434|P3|STARTED|Phase II||112
933658|NCT01437319|2259435|P2|STARTED|Phase II||115
933659|NCT01437319|2259436|P1|STARTED|Phase II||0
933660|NCT01437319|2259434|P3|NOT COMPLETED|Phase I||0
933661|NCT01437319|2259435|P2|NOT COMPLETED|Phase I||0
933662|NCT01437319|2259436|P1|NOT COMPLETED|Phase I||55
933663|NCT01437319|2259434|P3|COMPLETED|Phase I||0
933664|NCT01437319|2259435|P2|COMPLETED|Phase I||0
933665|NCT01437319|2259436|P1|COMPLETED|Phase I||227
933666|NCT01437319|2259434|P3|STARTED|Phase I||0
933667|NCT01437319|2259435|P2|STARTED|Phase I||0
933668|NCT01437319|2259436|P1|STARTED|Phase I||282
933669|NCT01437267|2259451|P6|NOT COMPLETED|Overall Study||0
933670|NCT01437267|2259452|P5|NOT COMPLETED|Overall Study||0
933671|NCT01437267|2259453|P4|NOT COMPLETED|Overall Study||1
933672|NCT01437267|2259454|P3|NOT COMPLETED|Overall Study||0
933673|NCT01437267|2259455|P2|NOT COMPLETED|Overall Study||1
933674|NCT01437267|2259456|P1|NOT COMPLETED|Overall Study||0
933675|NCT01437267|2259451|P6|COMPLETED|Overall Study||20
933676|NCT01437267|2259452|P5|COMPLETED|Overall Study||20
933677|NCT01437267|2259453|P4|COMPLETED|Overall Study||19
933678|NCT01437267|2259454|P3|COMPLETED|Overall Study||20
933679|NCT01437267|2259455|P2|COMPLETED|Overall Study||19
933680|NCT01437267|2259456|P1|COMPLETED|Overall Study||20
933681|NCT01437267|2259451|P6|STARTED|Overall Study||20
933682|NCT01437267|2259452|P5|STARTED|Overall Study||20
933683|NCT01437267|2259453|P4|STARTED|Overall Study||20
933684|NCT01437267|2259454|P3|STARTED|Overall Study||20
933685|NCT01437267|2259455|P2|STARTED|Overall Study||20
933686|NCT01437267|2259456|P1|STARTED|Overall Study||20
933687|NCT01437124|2259494|P1|NOT COMPLETED|Overall Study||0
933688|NCT01437124|2259494|P1|COMPLETED|Overall Study||83
933689|NCT01437124|2259494|P1|STARTED|Overall Study||83
933690|NCT01437111|2259499|P1|NOT COMPLETED|Overall Study||18
933691|NCT01437111|2259499|P1|COMPLETED|Overall Study||182
933692|NCT01437111|2259499|P1|Treated Participants|Overall Study||198
933693|NCT01437111|2259499|P1|STARTED|Overall Study||200
933702|NCT01436799|2259567|P2|NOT COMPLETED|Overall Study||0
933703|NCT01436799|2259568|P1|NOT COMPLETED|Overall Study||0
933704|NCT01436799|2259567|P2|COMPLETED|Overall Study||20
933705|NCT01436799|2259568|P1|COMPLETED|Overall Study||20
933706|NCT01436799|2259567|P2|STARTED|Overall Study||20
933707|NCT01436799|2259568|P1|STARTED|Overall Study||20
933708|NCT01436643|2259577|P4|NOT COMPLETED|Core Phase (16 Weeks)||0
933709|NCT01436643|2259578|P3|NOT COMPLETED|Core Phase (16 Weeks)||3
933710|NCT01436643|2259579|P2|NOT COMPLETED|Core Phase (16 Weeks)||4
933711|NCT01436643|2259580|P1|NOT COMPLETED|Core Phase (16 Weeks)||1
933712|NCT01436643|2259577|P4|COMPLETED|Core Phase (16 Weeks)||0
933713|NCT01436643|2259578|P3|COMPLETED|Core Phase (16 Weeks)||17
933714|NCT01436643|2259579|P2|COMPLETED|Core Phase (16 Weeks)||11
933715|NCT01436643|2259580|P1|COMPLETED|Core Phase (16 Weeks)||16
933716|NCT01436643|2259577|P4|STARTED|Core Phase (16 Weeks)||0
933717|NCT01436643|2259578|P3|STARTED|Core Phase (16 Weeks)||20
933718|NCT01436643|2259579|P2|STARTED|Core Phase (16 Weeks)||15
933719|NCT01436643|2259580|P1|STARTED|Core Phase (16 Weeks)||17
933720|NCT01436643|2259577|P4|NOT COMPLETED|2-week Pre-treatment||10
933721|NCT01436643|2259578|P3|NOT COMPLETED|2-week Pre-treatment||0
933722|NCT01436643|2259579|P2|NOT COMPLETED|2-week Pre-treatment||0
933723|NCT01436643|2259580|P1|NOT COMPLETED|2-week Pre-treatment||0
933724|NCT01436643|2259577|P4|COMPLETED|2-week Pre-treatment||44
933725|NCT01436643|2259578|P3|COMPLETED|2-week Pre-treatment||0
933726|NCT01436643|2259579|P2|COMPLETED|2-week Pre-treatment||0
933727|NCT01436643|2259580|P1|COMPLETED|2-week Pre-treatment||0
933728|NCT01436643|2259577|P4|STARTED|2-week Pre-treatment||54
933729|NCT01436643|2259578|P3|STARTED|2-week Pre-treatment||0
933730|NCT01436643|2259579|P2|STARTED|2-week Pre-treatment||0
933731|NCT01436643|2259580|P1|STARTED|2-week Pre-treatment||0
933732|NCT01436526|2259592|P2|NOT COMPLETED|Period 2||0
933733|NCT01436526|2259593|P1|NOT COMPLETED|Period 2||0
933734|NCT01436526|2259592|P2|COMPLETED|Period 2||13
933735|NCT01436526|2259593|P1|COMPLETED|Period 2||13
933736|NCT01436526|2259592|P2|Participants Received Treatment|Period 2||13
933737|NCT01436526|2259593|P1|Participants Received Treatment|Period 2||13
933738|NCT01436526|2259592|P2|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
933739|NCT01436526|2259593|P1|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
933740|NCT01436526|2259592|P2|NOT COMPLETED|Period 1||0
933741|NCT01436526|2259593|P1|NOT COMPLETED|Period 1||0
933742|NCT01436526|2259592|P2|COMPLETED|Period 1||14
933743|NCT01436526|2259593|P1|COMPLETED|Period 1||14
933744|NCT01436526|2259592|P2|Participants Received Treatment|Period 1||14
933745|NCT01436526|2259593|P1|Participants Received Treatment|Period 1||14
933746|NCT01436526|2259592|P2|STARTED|Period 1||14
933747|NCT01436526|2259593|P1|STARTED|Period 1||14
933748|NCT01436500|2259615|P5|NOT COMPLETED|Overall Study||4
933749|NCT01436500|2259616|P4|NOT COMPLETED|Overall Study||1
933750|NCT01436500|2259617|P3|NOT COMPLETED|Overall Study||5
933751|NCT01436500|2259618|P2|NOT COMPLETED|Overall Study||3
933752|NCT01436500|2259619|P1|NOT COMPLETED|Overall Study||3
933753|NCT01436500|2259615|P5|COMPLETED|Overall Study||9
933754|NCT01436500|2259616|P4|COMPLETED|Overall Study||5
933755|NCT01436500|2259617|P3|COMPLETED|Overall Study||7
933756|NCT01436500|2259618|P2|COMPLETED|Overall Study||9
933757|NCT01436500|2259619|P1|COMPLETED|Overall Study||9
933758|NCT01436500|2259615|P5|STARTED|Overall Study||13
933759|NCT01436500|2259616|P4|STARTED|Overall Study||6
933760|NCT01436500|2259617|P3|STARTED|Overall Study||12
933761|NCT01436500|2259618|P2|STARTED|Overall Study||12
933762|NCT01436500|2259619|P1|STARTED|Overall Study||12
933763|NCT01436435|2259652|P1|NOT COMPLETED|Overall Study||64
933764|NCT01436435|2259652|P1|COMPLETED|Overall Study||177
933765|NCT01436435|2259652|P1|STARTED|Overall Study||241
933766|NCT01436370|2259669|P8|NOT COMPLETED|Overall Study||0
933767|NCT01436370|2259670|P7|NOT COMPLETED|Overall Study||0
933768|NCT01436370|2259671|P6|NOT COMPLETED|Overall Study||0
933769|NCT01436370|2259672|P5|NOT COMPLETED|Overall Study||1
933770|NCT01436370|2259673|P4|NOT COMPLETED|Overall Study||0
933771|NCT01436370|2259674|P3|NOT COMPLETED|Overall Study||0
933772|NCT01436370|2259675|P2|NOT COMPLETED|Overall Study||0
933773|NCT01436370|2259676|P1|NOT COMPLETED|Overall Study||0
933774|NCT01436370|2259669|P8|COMPLETED|Overall Study||16
933775|NCT01436370|2259670|P7|COMPLETED|Overall Study||16
933776|NCT01436370|2259671|P6|COMPLETED|Overall Study||19
933777|NCT01436370|2259672|P5|COMPLETED|Overall Study||18
933778|NCT01436370|2259673|P4|COMPLETED|Overall Study||10
933779|NCT01436370|2259674|P3|COMPLETED|Overall Study||10
933780|NCT01436370|2259675|P2|COMPLETED|Overall Study||6
933781|NCT01436370|2259676|P1|COMPLETED|Overall Study||6
933782|NCT01436370|2259669|P8|STARTED|Overall Study||16
933783|NCT01436370|2259670|P7|STARTED|Overall Study||16
933784|NCT01436370|2259671|P6|STARTED|Overall Study||19
933785|NCT01436370|2259672|P5|STARTED|Overall Study||19
933786|NCT01436370|2259673|P4|STARTED|Overall Study||10
933787|NCT01436370|2259674|P3|STARTED|Overall Study||10
933788|NCT01436370|2259675|P2|STARTED|Overall Study||6
933789|NCT01436370|2259676|P1|STARTED|Overall Study||6
933790|NCT01436305|2259757|P3|NOT COMPLETED|Overall Study||0
933791|NCT01436305|2259758|P2|NOT COMPLETED|Overall Study||4
933792|NCT01436305|2259759|P1|NOT COMPLETED|Overall Study||2
933793|NCT01436305|2259757|P3|COMPLETED|Overall Study||7
933794|NCT01436305|2259758|P2|COMPLETED|Overall Study||2
933795|NCT01436305|2259759|P1|COMPLETED|Overall Study||4
933796|NCT01436305|2259757|P3|STARTED|Overall Study||7
933797|NCT01436305|2259758|P2|STARTED|Overall Study||6
933798|NCT01436305|2259759|P1|STARTED|Overall Study||6
933799|NCT01436279|2259856|P2|NOT COMPLETED|Overall Study||0
933800|NCT01436279|2259857|P1|NOT COMPLETED|Overall Study||0
933801|NCT01436279|2259856|P2|COMPLETED|Overall Study||20
933802|NCT01436279|2259857|P1|COMPLETED|Overall Study||30
933803|NCT01436279|2259856|P2|STARTED|Overall Study||20
933804|NCT01436279|2259857|P1|STARTED|Overall Study||30
933805|NCT01436266|2259879|P2|NOT COMPLETED|Overall Study||0
933806|NCT01436266|2259880|P1|NOT COMPLETED|Overall Study||0
933807|NCT01436266|2259879|P2|COMPLETED|Overall Study||1
933808|NCT01436266|2259880|P1|COMPLETED|Overall Study||1
933809|NCT01436266|2259879|P2|STARTED|Overall Study||1
933810|NCT01436266|2259880|P1|STARTED|Overall Study||1
933811|NCT01436253|2259886|P1|NOT COMPLETED|Overall Study||299
933812|NCT01436253|2259886|P1|COMPLETED|Overall Study||1897
933813|NCT01436253|2259886|P1|STARTED|Overall Study||2196
933814|NCT01436201|2259891|P1|NOT COMPLETED|Overall Study||4
933815|NCT01436201|2259891|P1|COMPLETED|Overall Study||20
933816|NCT01436201|2259891|P1|Received at Least 1 Dose of Study Drug|Overall Study||24
933817|NCT01436201|2259891|P1|STARTED|Overall Study||24
933818|NCT01436175|2259901|P1|NOT COMPLETED|Overall Study||1270
933819|NCT01436175|2259901|P1|COMPLETED|Overall Study||300
933820|NCT01436175|2259901|P1|STARTED|Overall Study||1570
933821|NCT01436162|2259928|P3|NOT COMPLETED|Randomized Phase||25
933822|NCT01436162|2259929|P2|NOT COMPLETED|Randomized Phase||31
933823|NCT01436162|2259930|P1|NOT COMPLETED|Randomized Phase||44
933824|NCT01436162|2259928|P3|COMPLETED|Randomized Phase||189
933825|NCT01436162|2259929|P2|COMPLETED|Randomized Phase||181
933826|NCT01436162|2259930|P1|COMPLETED|Randomized Phase||353
933827|NCT01436162|2259928|P3|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|214
933828|NCT01436162|2259929|P2|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|212
933829|NCT01436162|2259930|P1|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|397
933830|NCT01436162|2259928|P3|NOT COMPLETED|Single-blind Lead-in Phase||0
933831|NCT01436162|2259929|P2|NOT COMPLETED|Single-blind Lead-in Phase||0
933832|NCT01436162|2259930|P1|NOT COMPLETED|Single-blind Lead-in Phase||282
933833|NCT01436162|2259928|P3|COMPLETED|Single-blind Lead-in Phase||0
933834|NCT01436162|2259929|P2|COMPLETED|Single-blind Lead-in Phase||0
933835|NCT01436162|2259930|P1|COMPLETED|Single-blind Lead-in Phase||823
933836|NCT01436162|2259928|P3|STARTED|Single-blind Lead-in Phase||0
933837|NCT01436162|2259929|P2|STARTED|Single-blind Lead-in Phase||0
933838|NCT01436162|2259930|P1|STARTED|Single-blind Lead-in Phase|Ten subjects were enrolled but not dosed.|1105
933839|NCT01436149|2259964|P3|NOT COMPLETED|Randomized Phase||42
933840|NCT01436149|2259965|P2|NOT COMPLETED|Randomized Phase||38
933841|NCT01436149|2259966|P1|NOT COMPLETED|Randomized Phase||77
933842|NCT01436149|2259964|P3|COMPLETED|Randomized Phase|1 subject completed the study without a Visit 14 MADRS and was not included in the completers set.|160
933843|NCT01436149|2259965|P2|COMPLETED|Randomized Phase||164
933844|NCT01436149|2259966|P1|COMPLETED|Randomized Phase||415
933845|NCT01436149|2259964|P3|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
933846|NCT01436149|2259965|P2|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
933847|NCT01436149|2259966|P1|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|492
933848|NCT01436149|2259964|P3|NOT COMPLETED|Antidepressant Lead-in Phase||0
933849|NCT01436149|2259965|P2|NOT COMPLETED|Antidepressant Lead-in Phase||0
933850|NCT01436149|2259966|P1|NOT COMPLETED|Antidepressant Lead-in Phase||366
933851|NCT01436149|2259964|P3|COMPLETED|Antidepressant Lead-in Phase||0
933852|NCT01436149|2259965|P2|COMPLETED|Antidepressant Lead-in Phase||0
933853|NCT01436149|2259966|P1|COMPLETED|Antidepressant Lead-in Phase||896
933854|NCT01436149|2259964|P3|STARTED|Antidepressant Lead-in Phase||0
933855|NCT01436149|2259965|P2|STARTED|Antidepressant Lead-in Phase||0
933856|NCT01436149|2259966|P1|STARTED|Antidepressant Lead-in Phase|Twenty-three subjects were enrolled but not dosed.|1262
933857|NCT01436110|2259997|P3|NOT COMPLETED|Overall Study||23
933858|NCT01436110|2259998|P2|NOT COMPLETED|Overall Study||26
933859|NCT01436110|2259999|P1|NOT COMPLETED|Overall Study||39
933860|NCT01436110|2259997|P3|COMPLETED|Overall Study||95
933861|NCT01436110|2259998|P2|COMPLETED|Overall Study||91
933862|NCT01436110|2259999|P1|COMPLETED|Overall Study||77
933863|NCT01436110|2259997|P3|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
933864|NCT01436110|2259998|P2|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|117
933865|NCT01436110|2259999|P1|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
933866|NCT01436110|2259997|P3|STARTED|Overall Study|These participants were randomized to trial medication.|118
933867|NCT01436110|2259998|P2|STARTED|Overall Study|These participants were randomized to trial medication.|117
933868|NCT01436110|2259999|P1|STARTED|Overall Study|These participants were randomized to trial medication.|116
933869|NCT01436084|2260022|P1|NOT COMPLETED|Overall Study||4
933870|NCT01436084|2260022|P1|COMPLETED|Overall Study||0
933871|NCT01436084|2260022|P1|STARTED|Overall Study||4
933872|NCT01436071|2260028|P2|NOT COMPLETED|Overall Study||14
933873|NCT01436071|2260029|P1|NOT COMPLETED|Overall Study||26
933874|NCT01436071|2260028|P2|COMPLETED|Overall Study||110
933875|NCT01436071|2260029|P1|COMPLETED|Overall Study||98
933876|NCT01436071|2260028|P2|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
933877|NCT01436071|2260029|P1|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
933878|NCT01436071|2260028|P2|STARTED|Overall Study|These participants were randomized to trial medication.|124
933879|NCT01436071|2260029|P1|STARTED|Overall Study|These participants were randomized to trial medication.|124
933880|NCT01436045|2260045|P2|NOT COMPLETED|Overall Study||0
933881|NCT01436045|2260046|P1|NOT COMPLETED|Overall Study||0
933882|NCT01436045|2260045|P2|COMPLETED|Overall Study||6
933883|NCT01436045|2260046|P1|COMPLETED|Overall Study||6
933884|NCT01436045|2260045|P2|STARTED|Overall Study||6
933885|NCT01436045|2260046|P1|STARTED|Overall Study||6
933886|NCT01436006|2260057|P1|NOT COMPLETED|Overall Study||37
933887|NCT01436006|2260057|P1|COMPLETED|Overall Study||6663
933888|NCT01436006|2260057|P1|STARTED|Overall Study||6700
933889|NCT01435928|2260071|P3|NOT COMPLETED|Double Blind Phase - 28 Weeks||121
933890|NCT01435928|2260072|P2|NOT COMPLETED|Double Blind Phase - 28 Weeks||116
933891|NCT01435928|2260073|P1|NOT COMPLETED|Double Blind Phase - 28 Weeks||0
933892|NCT01435928|2260071|P3|COMPLETED|Double Blind Phase - 28 Weeks||20
933893|NCT01435928|2260072|P2|COMPLETED|Double Blind Phase - 28 Weeks||28
933894|NCT01435928|2260073|P1|COMPLETED|Double Blind Phase - 28 Weeks||0
933895|NCT01435928|2260071|P3|STARTED|Double Blind Phase - 28 Weeks||141
933896|NCT01435928|2260072|P2|STARTED|Double Blind Phase - 28 Weeks||144
933897|NCT01435928|2260073|P1|STARTED|Double Blind Phase - 28 Weeks||0
933898|NCT01435928|2260071|P3|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
933899|NCT01435928|2260072|P2|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
933900|NCT01435928|2260073|P1|NOT COMPLETED|Open Label Phase - up to 24 Weeks||389
933901|NCT01435928|2260071|P3|COMPLETED|Open Label Phase - up to 24 Weeks||0
933902|NCT01435928|2260072|P2|COMPLETED|Open Label Phase - up to 24 Weeks||0
933903|NCT01435928|2260073|P1|COMPLETED|Open Label Phase - up to 24 Weeks||287
933904|NCT01435928|2260071|P3|STARTED|Open Label Phase - up to 24 Weeks||0
933905|NCT01435928|2260072|P2|STARTED|Open Label Phase - up to 24 Weeks||0
933906|NCT01435928|2260073|P1|STARTED|Open Label Phase - up to 24 Weeks||676
933907|NCT01435798|2260100|P1|NOT COMPLETED|Overall Study||1
933908|NCT01435798|2260100|P1|COMPLETED|Overall Study|Crossover design|25
933909|NCT01435798|2260100|P1|100% MTD|Overall Study||25
933910|NCT01435798|2260100|P1|50% MTD|Overall Study||25
933911|NCT01435798|2260100|P1|25% MTD|Overall Study||26
933912|NCT01435798|2260100|P1|0% MTD|Overall Study||25
933913|NCT01435798|2260100|P1|STARTED|Overall Study|Crossover design|26
933914|NCT01435759|2260119|P6|NOT COMPLETED|Double-blind Phase||9
933915|NCT01435759|2260120|P5|NOT COMPLETED|Double-blind Phase||9
933916|NCT01435759|2260121|P4|NOT COMPLETED|Double-blind Phase||9
933917|NCT01435759|2260122|P3|NOT COMPLETED|Double-blind Phase||7
933918|NCT01435759|2260123|P2|NOT COMPLETED|Double-blind Phase||7
933919|NCT01435759|2260124|P1|NOT COMPLETED|Double-blind Phase||66
933920|NCT01435759|2260119|P6|COMPLETED|Double-blind Phase||71
933921|NCT01435759|2260120|P5|COMPLETED|Double-blind Phase||69
933922|NCT01435759|2260121|P4|COMPLETED|Double-blind Phase||69
933923|NCT01435759|2260122|P3|COMPLETED|Double-blind Phase||71
933924|NCT01435759|2260123|P2|COMPLETED|Double-blind Phase||71
933925|NCT01435759|2260124|P1|COMPLETED|Double-blind Phase||397
933926|NCT01435759|2260119|P6|STARTED|Double-blind Phase||80
933927|NCT01435759|2260120|P5|STARTED|Double-blind Phase||78
933928|NCT01435759|2260121|P4|STARTED|Double-blind Phase|Two subjects were not dosed.|78
933929|NCT01435759|2260122|P3|STARTED|Double-blind Phase|One subject was not dosed.|78
933930|NCT01435759|2260123|P2|STARTED|Double-blind Phase||78
933931|NCT01435759|2260124|P1|STARTED|Double-blind Phase|These subjects were not included in the Safety Dose Response Evaluable Set or Safety Analysis Set.|463
933932|NCT01435759|2260119|P6|NOT COMPLETED|Antidepressant Lead-in Phase||0
933933|NCT01435759|2260120|P5|NOT COMPLETED|Antidepressant Lead-in Phase||0
933934|NCT01435759|2260121|P4|NOT COMPLETED|Antidepressant Lead-in Phase||0
933935|NCT01435759|2260122|P3|NOT COMPLETED|Antidepressant Lead-in Phase||0
933936|NCT01435759|2260123|P2|NOT COMPLETED|Antidepressant Lead-in Phase||0
933937|NCT01435759|2260124|P1|NOT COMPLETED|Antidepressant Lead-in Phase||342
933938|NCT01435759|2260119|P6|COMPLETED|Antidepressant Lead-in Phase||0
933939|NCT01435759|2260120|P5|COMPLETED|Antidepressant Lead-in Phase||0
933940|NCT01435759|2260121|P4|COMPLETED|Antidepressant Lead-in Phase||0
933941|NCT01435759|2260122|P3|COMPLETED|Antidepressant Lead-in Phase||0
933942|NCT01435759|2260123|P2|COMPLETED|Antidepressant Lead-in Phase||0
933943|NCT01435759|2260124|P1|COMPLETED|Antidepressant Lead-in Phase||855
933944|NCT01435759|2260119|P6|STARTED|Antidepressant Lead-in Phase||0
933945|NCT01435759|2260120|P5|STARTED|Antidepressant Lead-in Phase||0
933946|NCT01435759|2260121|P4|STARTED|Antidepressant Lead-in Phase||0
933947|NCT01435759|2260122|P3|STARTED|Antidepressant Lead-in Phase||0
933948|NCT01435759|2260123|P2|STARTED|Antidepressant Lead-in Phase||0
933949|NCT01435759|2260124|P1|STARTED|Antidepressant Lead-in Phase|Of these 1197 subjects, 19 subjects were not dosed.|1197
933950|NCT01435655|2260151|P1|NOT COMPLETED|Overall Study||3
933951|NCT01435655|2260151|P1|COMPLETED|Overall Study||7
933952|NCT01435655|2260151|P1|STARTED|Overall Study||10
933953|NCT01435577|2260165|P2|NOT COMPLETED|Overall Study||52
933954|NCT01435577|2260166|P1|NOT COMPLETED|Overall Study||17
933955|NCT01435577|2260165|P2|COMPLETED|Overall Study||13
933956|NCT01435577|2260166|P1|COMPLETED|Overall Study||47
933957|NCT01435577|2260165|P2|STARTED|Overall Study||65
933958|NCT01435577|2260166|P1|STARTED|Overall Study||64
933959|NCT01435460|2260216|P2|NOT COMPLETED|Overall Study||6
933960|NCT01435460|2260217|P1|NOT COMPLETED|Overall Study||11
933961|NCT01435460|2260216|P2|COMPLETED|Overall Study||143
933962|NCT01435460|2260217|P1|COMPLETED|Overall Study||140
933963|NCT01435460|2260216|P2|STARTED|Overall Study||149
933964|NCT01435460|2260217|P1|STARTED|Overall Study||151
933965|NCT01435265|2260231|P2|NOT COMPLETED|Overall Study||1
933966|NCT01435265|2260232|P1|NOT COMPLETED|Overall Study||0
933967|NCT01435265|2260231|P2|COMPLETED|Overall Study||3
933968|NCT01435265|2260232|P1|COMPLETED|Overall Study||3
933969|NCT01435265|2260231|P2|STARTED|Overall Study||4
933970|NCT01435265|2260232|P1|STARTED|Overall Study||3
933974|NCT01435122|2260246|P1|NOT COMPLETED|Overall Study||8
933975|NCT01435122|2260246|P1|COMPLETED|Overall Study||22
933976|NCT01435122|2260246|P1|STARTED|Overall Study||30
933977|NCT01435031|2260255|P1|NOT COMPLETED|ITT at 2 Years||9
933978|NCT01435031|2260255|P1|COMPLETED|ITT at 2 Years||194
933979|NCT01435031|2260255|P1|STARTED|ITT at 2 Years||203
933980|NCT01435031|2260255|P1|NOT COMPLETED|ITT at 1 Year||8
933981|NCT01435031|2260255|P1|COMPLETED|ITT at 1 Year||203
933982|NCT01435031|2260255|P1|STARTED|ITT at 1 Year||211
933983|NCT01435031|2260255|P1|NOT COMPLETED|ITT at 6 Months||5
933984|NCT01435031|2260255|P1|COMPLETED|ITT at 6 Months||211
933985|NCT01435031|2260255|P1|STARTED|ITT at 6 Months||216
933986|NCT01435031|2260255|P1|NOT COMPLETED|ITT at 1 Month||6
933987|NCT01435031|2260255|P1|COMPLETED|ITT at 1 Month||216
933988|NCT01435031|2260255|P1|STARTED|ITT at 1 Month|ITT population|222
933989|NCT01434823|2260335|P2|NOT COMPLETED|Overall Study||7
933990|NCT01434823|2260336|P1|NOT COMPLETED|Overall Study||4
933991|NCT01434823|2260335|P2|COMPLETED|Overall Study||778
933992|NCT01434823|2260336|P1|COMPLETED|Overall Study||820
933993|NCT01434823|2260335|P2|STARTED|Overall Study||785
933994|NCT01434823|2260336|P1|STARTED|Overall Study||824
933995|NCT01434693|2260354|P4|NOT COMPLETED|Overall Study||1
933996|NCT01434693|2260355|P3|NOT COMPLETED|Overall Study||1
933997|NCT01434693|2260356|P2|NOT COMPLETED|Overall Study||0
933998|NCT01434693|2260357|P1|NOT COMPLETED|Overall Study||3
933999|NCT01434693|2260354|P4|COMPLETED|Overall Study||8
934000|NCT01434693|2260355|P3|COMPLETED|Overall Study||8
934001|NCT01434693|2260356|P2|COMPLETED|Overall Study||9
934002|NCT01434693|2260357|P1|COMPLETED|Overall Study||6
934003|NCT01434693|2260354|P4|STARTED|Overall Study||9
934004|NCT01434693|2260355|P3|STARTED|Overall Study||9
934005|NCT01434693|2260356|P2|STARTED|Overall Study||9
934006|NCT01434693|2260357|P1|STARTED|Overall Study||9
934007|NCT01434680|2260371|P4|NOT COMPLETED|Overall Study||0
934008|NCT01434680|2260372|P3|NOT COMPLETED|Overall Study||2
934009|NCT01434680|2260373|P2|NOT COMPLETED|Overall Study||2
934010|NCT01434680|2260374|P1|NOT COMPLETED|Overall Study||3
934011|NCT01434680|2260371|P4|COMPLETED|Overall Study||119
934012|NCT01434680|2260372|P3|COMPLETED|Overall Study||304
934013|NCT01434680|2260373|P2|COMPLETED|Overall Study||266
934014|NCT01434680|2260374|P1|COMPLETED|Overall Study||296
934015|NCT01434680|2260371|P4|STARTED|Overall Study||119
934016|NCT01434680|2260372|P3|STARTED|Overall Study||306
934017|NCT01434680|2260373|P2|STARTED|Overall Study||268
934018|NCT01434680|2260374|P1|STARTED|Overall Study||299
934019|NCT01434654|2260391|P2|NOT COMPLETED|Overall Study||0
934020|NCT01434654|2260392|P1|NOT COMPLETED|Overall Study||2
934021|NCT01434654|2260391|P2|COMPLETED|Overall Study||12
934022|NCT01434654|2260392|P1|COMPLETED|Overall Study||5
934023|NCT01434654|2260391|P2|STARTED|Overall Study||12
934024|NCT01434654|2260392|P1|STARTED|Overall Study||7
934025|NCT01434641|2260404|P1|NOT COMPLETED|Overall Study||0
934026|NCT01434641|2260404|P1|COMPLETED|Overall Study||102
934027|NCT01434641|2260404|P1|STARTED|Overall Study||102
934028|NCT01434511|2260409|P1|NOT COMPLETED|Overall Study||0
934029|NCT01434511|2260409|P1|COMPLETED|Overall Study||1
934030|NCT01434511|2260409|P1|STARTED|Overall Study||1
934031|NCT01434342|2260428|P2|NOT COMPLETED|Overall Study||17
934032|NCT01434342|2260429|P1|NOT COMPLETED|Overall Study||48
934033|NCT01434342|2260428|P2|COMPLETED|Overall Study||31
934034|NCT01434342|2260429|P1|COMPLETED|Overall Study||50
934035|NCT01434342|2260428|P2|STARTED|Overall Study||48
934036|NCT01434342|2260429|P1|STARTED|Overall Study||98
934037|NCT01434186|2260439|P2|NOT COMPLETED|Overall Study||0
934038|NCT01434186|2260440|P1|NOT COMPLETED|Overall Study||0
934039|NCT01434186|2260439|P2|COMPLETED|Overall Study||4
934040|NCT01434186|2260440|P1|COMPLETED|Overall Study||2
934041|NCT01434186|2260439|P2|STARTED|Overall Study||4
934042|NCT01434186|2260440|P1|STARTED|Overall Study||2
934043|NCT01434121|2260449|P3|NOT COMPLETED|Overall Study||0
934044|NCT01434121|2260450|P2|NOT COMPLETED|Overall Study||0
934045|NCT01434121|2260451|P1|NOT COMPLETED|Overall Study||0
934046|NCT01434121|2260449|P3|COMPLETED|Overall Study||8
934047|NCT01434121|2260450|P2|COMPLETED|Overall Study||8
934048|NCT01434121|2260451|P1|COMPLETED|Overall Study||8
934049|NCT01434121|2260449|P3|STARTED|Overall Study||8
934050|NCT01434121|2260450|P2|STARTED|Overall Study||8
934051|NCT01434121|2260451|P1|STARTED|Overall Study||8
934052|NCT01434030|2260459|P1|NOT COMPLETED|Overall Study||1
934053|NCT01434030|2260459|P1|COMPLETED|Overall Study||56
934054|NCT01434030|2260459|P1|STARTED|Overall Study||57
934055|NCT01433913|2260466|P2|NOT COMPLETED|Overall Study||0
934056|NCT01433913|2260467|P1|NOT COMPLETED|Overall Study||1
934057|NCT01433913|2260466|P2|COMPLETED|Overall Study||10
934058|NCT01433913|2260467|P1|COMPLETED|Overall Study||9
934059|NCT01433913|2260466|P2|STARTED|Overall Study||10
934060|NCT01433913|2260467|P1|STARTED|Overall Study||10
934061|NCT01433731|2260477|P4|NOT COMPLETED|Overall Study||0
934062|NCT01433731|2260478|P3|NOT COMPLETED|Overall Study||0
934063|NCT01433731|2260479|P2|NOT COMPLETED|Overall Study||0
934064|NCT01433731|2260480|P1|NOT COMPLETED|Overall Study||0
934065|NCT01433731|2260477|P4|COMPLETED|Overall Study||5
934066|NCT01433731|2260478|P3|COMPLETED|Overall Study||5
934067|NCT01433731|2260479|P2|COMPLETED|Overall Study||5
934068|NCT01433731|2260480|P1|COMPLETED|Overall Study||3
934069|NCT01433731|2260477|P4|STARTED|Overall Study||5
934070|NCT01433731|2260478|P3|STARTED|Overall Study||5
934071|NCT01433731|2260479|P2|STARTED|Overall Study||5
934072|NCT01433731|2260480|P1|STARTED|Overall Study||3
934073|NCT01433549|2260488|P2|NOT COMPLETED|Phase 2: Second Study Product||1
934074|NCT01433549|2260489|P1|NOT COMPLETED|Phase 2: Second Study Product||0
934075|NCT01433549|2260488|P2|COMPLETED|Phase 2: Second Study Product||12
934076|NCT01433549|2260489|P1|COMPLETED|Phase 2: Second Study Product||12
934077|NCT01433549|2260488|P2|STARTED|Phase 2: Second Study Product||13
934078|NCT01433549|2260489|P1|STARTED|Phase 2: Second Study Product||12
934079|NCT01433549|2260488|P2|NOT COMPLETED|Phase 1: First Study Product||0
934080|NCT01433549|2260489|P1|NOT COMPLETED|Phase 1: First Study Product||0
934081|NCT01433549|2260488|P2|COMPLETED|Phase 1: First Study Product||13
934082|NCT01433549|2260489|P1|COMPLETED|Phase 1: First Study Product||12
934083|NCT01433549|2260488|P2|STARTED|Phase 1: First Study Product||13
934084|NCT01433549|2260489|P1|STARTED|Phase 1: First Study Product||12
934085|NCT01433471|2260499|P2|NOT COMPLETED|Overall Study||1
934086|NCT01433471|2260500|P1|NOT COMPLETED|Overall Study||0
934087|NCT01433471|2260499|P2|COMPLETED|Overall Study||1
934088|NCT01433471|2260500|P1|COMPLETED|Overall Study||2
934089|NCT01433471|2260499|P2|STARTED|Overall Study||2
934090|NCT01433471|2260500|P1|STARTED|Overall Study||2
934091|NCT01433354|2260516|P1|NOT COMPLETED|Overall Study||119
934092|NCT01433354|2260516|P1|COMPLETED|Overall Study||0
934093|NCT01433354|2260516|P1|STARTED|Overall Study|120 enrolled of which 119 were administered drug|119
934094|NCT01433263|2260532|P2|NOT COMPLETED|Overall Study||12
934095|NCT01433263|2260533|P1|NOT COMPLETED|Overall Study||19
934096|NCT01433263|2260532|P2|COMPLETED|Overall Study||16
934097|NCT01433263|2260533|P1|COMPLETED|Overall Study||10
934098|NCT01433263|2260532|P2|STARTED|Overall Study||28
934099|NCT01433263|2260533|P1|STARTED|Overall Study||29
934100|NCT01433250|2260562|P2|NOT COMPLETED|Overall Study||3
934101|NCT01433250|2260563|P1|NOT COMPLETED|Overall Study||3
934102|NCT01433250|2260562|P2|COMPLETED|Overall Study||14
934103|NCT01433250|2260563|P1|COMPLETED|Overall Study||19
934104|NCT01433250|2260562|P2|STARTED|Overall Study||17
934105|NCT01433250|2260563|P1|STARTED|Overall Study||22
934106|NCT01433172|2260582|P3|NOT COMPLETED|Overall Study||1
934107|NCT01433172|2260583|P2|NOT COMPLETED|Overall Study||3
934108|NCT01433172|2260584|P1|NOT COMPLETED|Overall Study||0
934109|NCT01433172|2260582|P3|COMPLETED|Overall Study||32
934110|NCT01433172|2260583|P2|COMPLETED|Overall Study||34
934111|NCT01433172|2260584|P1|COMPLETED|Overall Study||3
934112|NCT01433172|2260582|P3|STARTED|Overall Study||33
934113|NCT01433172|2260583|P2|STARTED|Overall Study||37
934114|NCT01433172|2260584|P1|STARTED|Overall Study||3
934115|NCT01433159|2260596|P2|NOT COMPLETED|Overall Study||1
934116|NCT01433159|2260597|P1|NOT COMPLETED|Overall Study||2
934117|NCT01433159|2260596|P2|COMPLETED|Overall Study||9
934118|NCT01433159|2260597|P1|COMPLETED|Overall Study||7
934119|NCT01433159|2260596|P2|STARTED|Overall Study||10
934120|NCT01433159|2260597|P1|STARTED|Overall Study||9
934121|NCT01433107|2260605|P2|NOT COMPLETED|Overall Study||17
934122|NCT01433107|2260606|P1|NOT COMPLETED|Overall Study||27
934123|NCT01433107|2260605|P2|COMPLETED|Overall Study||128
934124|NCT01433107|2260606|P1|COMPLETED|Overall Study||118
934125|NCT01433107|2260605|P2|STARTED|Overall Study||145
934126|NCT01433107|2260606|P1|STARTED|Overall Study||145
934127|NCT01433081|2260618|P2|NOT COMPLETED|Overall Study||2
934128|NCT01433081|2260619|P1|NOT COMPLETED|Overall Study||2
934129|NCT01433081|2260618|P2|COMPLETED|Overall Study||23
934130|NCT01433081|2260619|P1|COMPLETED|Overall Study||23
934131|NCT01433081|2260618|P2|STARTED|Overall Study||25
934132|NCT01433081|2260619|P1|STARTED|Overall Study||25
934133|NCT01433055|2260629|P2|NOT COMPLETED|Overall Study||0
934134|NCT01433055|2260630|P1|NOT COMPLETED|Overall Study||2
934135|NCT01433055|2260629|P2|COMPLETED|Overall Study||23
934136|NCT01433055|2260630|P1|COMPLETED|Overall Study||27
934137|NCT01433055|2260629|P2|STARTED|Overall Study||23
934138|NCT01433055|2260630|P1|STARTED|Overall Study||29
934139|NCT01433042|2260644|P1|NOT COMPLETED|Overall Study||1
934140|NCT01433042|2260644|P1|COMPLETED|Overall Study||224
934141|NCT01433042|2260644|P1|STARTED|Overall Study||225
934142|NCT01433016|2260648|P1|NOT COMPLETED|Overall Study||0
934143|NCT01433016|2260648|P1|COMPLETED|Overall Study||20
934144|NCT01433016|2260648|P1|STARTED|Overall Study||20
934145|NCT01432938|2260652|P2|NOT COMPLETED|Second Intervention||0
934146|NCT01432938|2260653|P1|NOT COMPLETED|Second Intervention||1
934147|NCT01432938|2260652|P2|COMPLETED|Second Intervention||14
934148|NCT01432938|2260653|P1|COMPLETED|Second Intervention||11
934149|NCT01432938|2260652|P2|STARTED|Second Intervention||14
934150|NCT01432938|2260653|P1|STARTED|Second Intervention||12
934151|NCT01432938|2260652|P2|NOT COMPLETED|Washout Period of at Least 24 Days||0
934152|NCT01432938|2260653|P1|NOT COMPLETED|Washout Period of at Least 24 Days||0
934153|NCT01432938|2260652|P2|COMPLETED|Washout Period of at Least 24 Days||14
934154|NCT01432938|2260653|P1|COMPLETED|Washout Period of at Least 24 Days||12
934155|NCT01432938|2260652|P2|STARTED|Washout Period of at Least 24 Days||14
934156|NCT01432938|2260653|P1|STARTED|Washout Period of at Least 24 Days||12
934157|NCT01432938|2260652|P2|NOT COMPLETED|First Intervention||0
934158|NCT01432938|2260653|P1|NOT COMPLETED|First Intervention||2
934159|NCT01432938|2260652|P2|COMPLETED|First Intervention||14
934160|NCT01432938|2260653|P1|COMPLETED|First Intervention||12
934161|NCT01432938|2260652|P2|Received at Least 1 Dose of Study Drug|First Intervention||14
934162|NCT01432938|2260653|P1|Received at Least 1 Dose of Study Drug|First Intervention||14
934163|NCT01432938|2260652|P2|STARTED|First Intervention||14
934164|NCT01432938|2260653|P1|STARTED|First Intervention||14
934165|NCT01432886|2260670|P2|NOT COMPLETED|Overall Study||0
934166|NCT01432886|2260671|P1|NOT COMPLETED|Overall Study||0
934167|NCT01432886|2260670|P2|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
934168|NCT01432886|2260671|P1|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
934169|NCT01432886|2260670|P2|STARTED|Overall Study||6
934170|NCT01432886|2260671|P1|STARTED|Overall Study||6
934171|NCT01432756|2260683|P4|NOT COMPLETED|Overall Study||1
934172|NCT01432756|2260684|P3|NOT COMPLETED|Overall Study||2
934173|NCT01432756|2260685|P2|NOT COMPLETED|Overall Study||0
934174|NCT01432756|2260686|P1|NOT COMPLETED|Overall Study||1
934175|NCT01432756|2260683|P4|COMPLETED|Overall Study||33
934176|NCT01432756|2260684|P3|COMPLETED|Overall Study||30
934177|NCT01432756|2260685|P2|COMPLETED|Overall Study||34
934178|NCT01432756|2260686|P1|COMPLETED|Overall Study||31
934179|NCT01432756|2260683|P4|STARTED|Overall Study||34
934180|NCT01432756|2260684|P3|STARTED|Overall Study||32
934181|NCT01432756|2260685|P2|STARTED|Overall Study||34
934182|NCT01432756|2260686|P1|STARTED|Overall Study||32
934183|NCT01432626|2260694|P1|NOT COMPLETED|Overall Study||7
934184|NCT01432626|2260694|P1|COMPLETED|Overall Study|Completed both images|3
934185|NCT01432626|2260694|P1|STARTED|Overall Study||10
934186|NCT01432600|2260701|P3|NOT COMPLETED|Overall Study||1
934187|NCT01432600|2260702|P2|NOT COMPLETED|Overall Study||1
934188|NCT01432600|2260703|P1|NOT COMPLETED|Overall Study||0
934189|NCT01432600|2260701|P3|COMPLETED|Overall Study||33
934190|NCT01432600|2260702|P2|COMPLETED|Overall Study||35
934191|NCT01432600|2260703|P1|COMPLETED|Overall Study||10
934192|NCT01432600|2260701|P3|STARTED|Overall Study||34
934193|NCT01432600|2260702|P2|STARTED|Overall Study||36
934194|NCT01432600|2260703|P1|STARTED|Overall Study||10
934195|NCT01432574|2260719|P1|NOT COMPLETED|Overall Study||3
934196|NCT01432574|2260719|P1|COMPLETED|Overall Study||147
934197|NCT01432574|2260719|P1|STARTED|Overall Study||150
934198|NCT01432561|2260725|P1|NOT COMPLETED|Overall Study||0
934199|NCT01432561|2260725|P1|COMPLETED|Overall Study||8
934200|NCT01432561|2260725|P1|STARTED|Overall Study||8
934201|NCT01432535|2260734|P3|NOT COMPLETED|Overall Study||0
934202|NCT01432535|2260735|P2|NOT COMPLETED|Overall Study||0
934203|NCT01432535|2260736|P1|NOT COMPLETED|Overall Study||0
934204|NCT01432535|2260734|P3|COMPLETED|Overall Study||6
934205|NCT01432535|2260735|P2|COMPLETED|Overall Study||7
934206|NCT01432535|2260736|P1|COMPLETED|Overall Study||12
934207|NCT01432535|2260734|P3|STARTED|Overall Study||6
934208|NCT01432535|2260735|P2|STARTED|Overall Study|One participant later determined ineligible is not included in baseline/efficacy analyses.|7
934209|NCT01432535|2260736|P1|STARTED|Overall Study||12
934210|NCT01432457|2260765|P3|NOT COMPLETED|Overall Study||59
934211|NCT01432457|2260766|P2|NOT COMPLETED|Overall Study||48
934212|NCT01432457|2260767|P1|NOT COMPLETED|Overall Study||37
934213|NCT01432457|2260765|P3|COMPLETED|Overall Study||253
934214|NCT01432457|2260766|P2|COMPLETED|Overall Study||258
934215|NCT01432457|2260767|P1|COMPLETED|Overall Study||269
934216|NCT01432457|2260765|P3|STARTED|Overall Study||312
934217|NCT01432457|2260766|P2|STARTED|Overall Study||306
934218|NCT01432457|2260767|P1|STARTED|Overall Study||306
934219|NCT01432444|2260796|P3|NOT COMPLETED|Extension Phase||192
934220|NCT01432444|2260797|P2|NOT COMPLETED|Extension Phase||0
934221|NCT01432444|2260798|P1|NOT COMPLETED|Extension Phase||0
934222|NCT01432444|2260796|P3|COMPLETED|Extension Phase||0
934223|NCT01432444|2260797|P2|COMPLETED|Extension Phase||0
934224|NCT01432444|2260798|P1|COMPLETED|Extension Phase||0
934225|NCT01432444|2260796|P3|STARTED|Extension Phase||192
934226|NCT01432444|2260797|P2|STARTED|Extension Phase||0
934227|NCT01432444|2260798|P1|STARTED|Extension Phase||0
934228|NCT01432444|2260796|P3|NOT COMPLETED|Treatment Phase||0
934229|NCT01432444|2260797|P2|NOT COMPLETED|Treatment Phase||140
934230|NCT01432444|2260798|P1|NOT COMPLETED|Treatment Phase||0
934231|NCT01432444|2260796|P3|COMPLETED|Treatment Phase||0
934232|NCT01432444|2260797|P2|COMPLETED|Treatment Phase||293
934233|NCT01432444|2260798|P1|COMPLETED|Treatment Phase||0
934234|NCT01432444|2260796|P3|STARTED|Treatment Phase||0
934235|NCT01432444|2260797|P2|STARTED|Treatment Phase||433
934236|NCT01432444|2260798|P1|STARTED|Treatment Phase||0
934237|NCT01432444|2260796|P3|NOT COMPLETED|Tolerability/Cross-titration Phase||0
934238|NCT01432444|2260797|P2|NOT COMPLETED|Tolerability/Cross-titration Phase||0
934239|NCT01432444|2260798|P1|NOT COMPLETED|Tolerability/Cross-titration Phase||60
934240|NCT01432444|2260796|P3|COMPLETED|Tolerability/Cross-titration Phase||0
934241|NCT01432444|2260797|P2|COMPLETED|Tolerability/Cross-titration Phase||0
934242|NCT01432444|2260798|P1|COMPLETED|Tolerability/Cross-titration Phase||265
934243|NCT01432444|2260796|P3|STARTED|Tolerability/Cross-titration Phase||0
934244|NCT01432444|2260797|P2|STARTED|Tolerability/Cross-titration Phase||0
934245|NCT01432444|2260798|P1|STARTED|Tolerability/Cross-titration Phase||325
934246|NCT01432405|2260810|P2|NOT COMPLETED|Overall Study||2
934247|NCT01432405|2260811|P1|NOT COMPLETED|Overall Study||1
934248|NCT01432405|2260810|P2|COMPLETED|Overall Study||10
934249|NCT01432405|2260811|P1|COMPLETED|Overall Study||11
934250|NCT01432405|2260810|P2|STARTED|Overall Study||12
934251|NCT01432405|2260811|P1|STARTED|Overall Study||12
934252|NCT01432379|2260819|P1|NOT COMPLETED|Overall Study||385
934253|NCT01432379|2260819|P1|COMPLETED|Overall Study||783
934254|NCT01432379|2260819|P1|STARTED|Overall Study||1168
934255|NCT01432366|2260824|P1|NOT COMPLETED|Overall Study||68
934256|NCT01432366|2260824|P1|COMPLETED|Overall Study||392
934257|NCT01432366|2260824|P1|STARTED|Overall Study||460
934258|NCT01432327|2260846|P4|NOT COMPLETED|Posttest 1 Year||23
934259|NCT01432327|2260847|P3|NOT COMPLETED|Posttest 1 Year||20
934260|NCT01432327|2260848|P2|NOT COMPLETED|Posttest 1 Year||28
934261|NCT01432327|2260849|P1|NOT COMPLETED|Posttest 1 Year||24
934262|NCT01432327|2260846|P4|COMPLETED|Posttest 1 Year||31
934263|NCT01432327|2260847|P3|COMPLETED|Posttest 1 Year||30
934264|NCT01432327|2260848|P2|COMPLETED|Posttest 1 Year||27
934265|NCT01432327|2260849|P1|COMPLETED|Posttest 1 Year||28
934266|NCT01432327|2260846|P4|STARTED|Posttest 1 Year||54
934267|NCT01432327|2260847|P3|STARTED|Posttest 1 Year||50
934268|NCT01432327|2260848|P2|STARTED|Posttest 1 Year||55
934269|NCT01432327|2260849|P1|STARTED|Posttest 1 Year||52
934270|NCT01432327|2260846|P4|NOT COMPLETED|Posttest 6 Months||2
934271|NCT01432327|2260847|P3|NOT COMPLETED|Posttest 6 Months||5
934272|NCT01432327|2260848|P2|NOT COMPLETED|Posttest 6 Months||0
934273|NCT01432327|2260849|P1|NOT COMPLETED|Posttest 6 Months||0
934274|NCT01432327|2260846|P4|COMPLETED|Posttest 6 Months||54
934275|NCT01432327|2260847|P3|COMPLETED|Posttest 6 Months||50
934276|NCT01432327|2260848|P2|COMPLETED|Posttest 6 Months||55
934277|NCT01432327|2260849|P1|COMPLETED|Posttest 6 Months||52
934278|NCT01432327|2260846|P4|STARTED|Posttest 6 Months||56
934279|NCT01432327|2260847|P3|STARTED|Posttest 6 Months||55
934280|NCT01432327|2260848|P2|STARTED|Posttest 6 Months||55
934281|NCT01432327|2260849|P1|STARTED|Posttest 6 Months||52
934282|NCT01432327|2260846|P4|NOT COMPLETED|Posttest 3 Months||1
934283|NCT01432327|2260847|P3|NOT COMPLETED|Posttest 3 Months||2
934284|NCT01432327|2260848|P2|NOT COMPLETED|Posttest 3 Months||2
934285|NCT01432327|2260849|P1|NOT COMPLETED|Posttest 3 Months||4
934286|NCT01432327|2260846|P4|COMPLETED|Posttest 3 Months||56
934287|NCT01432327|2260847|P3|COMPLETED|Posttest 3 Months||55
934288|NCT01432327|2260848|P2|COMPLETED|Posttest 3 Months||55
934289|NCT01432327|2260849|P1|COMPLETED|Posttest 3 Months||52
934290|NCT01432327|2260846|P4|STARTED|Posttest 3 Months||57
934291|NCT01432327|2260847|P3|STARTED|Posttest 3 Months||57
934292|NCT01432327|2260848|P2|STARTED|Posttest 3 Months||57
934293|NCT01432327|2260849|P1|STARTED|Posttest 3 Months||56
934294|NCT01432327|2260846|P4|NOT COMPLETED|Baseline||0
934295|NCT01432327|2260847|P3|NOT COMPLETED|Baseline||0
934296|NCT01432327|2260848|P2|NOT COMPLETED|Baseline||0
934297|NCT01432327|2260849|P1|NOT COMPLETED|Baseline||0
934298|NCT01432327|2260846|P4|COMPLETED|Baseline||57
934299|NCT01432327|2260847|P3|COMPLETED|Baseline||57
934300|NCT01432327|2260848|P2|COMPLETED|Baseline||57
934301|NCT01432327|2260849|P1|COMPLETED|Baseline||56
934302|NCT01432327|2260846|P4|STARTED|Baseline||57
934303|NCT01432327|2260847|P3|STARTED|Baseline||57
934304|NCT01432327|2260848|P2|STARTED|Baseline||57
934305|NCT01432327|2260849|P1|STARTED|Baseline||56
934306|NCT01432275|2260859|P2|NOT COMPLETED|ADC With Calculator (10 Days)||2
934307|NCT01432275|2260860|P1|NOT COMPLETED|ADC With Calculator (10 Days)||3
934308|NCT01432275|2260859|P2|COMPLETED|ADC With Calculator (10 Days)||79
934309|NCT01432275|2260860|P1|COMPLETED|ADC With Calculator (10 Days)||85
934310|NCT01432275|2260859|P2|STARTED|ADC With Calculator (10 Days)||81
934311|NCT01432275|2260860|P1|STARTED|ADC With Calculator (10 Days)||88
934312|NCT01432275|2260859|P2|NOT COMPLETED|Second BG Meter System (7 Days)||3
934313|NCT01432275|2260860|P1|NOT COMPLETED|Second BG Meter System (7 Days)||2
934314|NCT01432275|2260859|P2|COMPLETED|Second BG Meter System (7 Days)||81
934315|NCT01432275|2260860|P1|COMPLETED|Second BG Meter System (7 Days)||88
934316|NCT01432275|2260859|P2|STARTED|Second BG Meter System (7 Days)||84
934317|NCT01432275|2260860|P1|STARTED|Second BG Meter System (7 Days)||90
934318|NCT01432275|2260859|P2|NOT COMPLETED|First BG Meter System (7 Days)||3
934319|NCT01432275|2260860|P1|NOT COMPLETED|First BG Meter System (7 Days)||0
934320|NCT01432275|2260859|P2|COMPLETED|First BG Meter System (7 Days)||84
934321|NCT01432275|2260860|P1|COMPLETED|First BG Meter System (7 Days)||90
934322|NCT01432275|2260859|P2|STARTED|First BG Meter System (7 Days)||87
934323|NCT01432275|2260860|P1|STARTED|First BG Meter System (7 Days)||90
934324|NCT01432262|2260869|P2|NOT COMPLETED|Overall Study||1
934325|NCT01432262|2260870|P1|NOT COMPLETED|Overall Study||2
934326|NCT01432262|2260869|P2|COMPLETED|Overall Study||161
934327|NCT01432262|2260870|P1|COMPLETED|Overall Study||160
934328|NCT01432262|2260869|P2|Vaccinated|Overall Study||161
934329|NCT01432262|2260870|P1|Vaccinated|Overall Study||162
934330|NCT01432262|2260869|P2|STARTED|Overall Study||162
934331|NCT01432262|2260870|P1|STARTED|Overall Study||162
934332|NCT01432236|2260888|P2|NOT COMPLETED|Overall Study||18
934333|NCT01432236|2260889|P1|NOT COMPLETED|Overall Study||26
934334|NCT01432236|2260888|P2|COMPLETED|Overall Study||79
934335|NCT01432236|2260889|P1|COMPLETED|Overall Study||70
934336|NCT01432236|2260888|P2|STARTED|Overall Study||97
934337|NCT01432236|2260889|P1|STARTED|Overall Study||96
934338|NCT01432015|2260936|P2|NOT COMPLETED|Overall Study||0
934339|NCT01432015|2260937|P1|NOT COMPLETED|Overall Study||0
934340|NCT01432015|2260936|P2|COMPLETED|Overall Study||10
934341|NCT01432015|2260937|P1|COMPLETED|Overall Study||10
934342|NCT01432015|2260936|P2|STARTED|Overall Study||10
934343|NCT01432015|2260937|P1|STARTED|Overall Study||10
934344|NCT01431989|2260945|P2|NOT COMPLETED|Period 2||0
934345|NCT01431989|2260946|P1|NOT COMPLETED|Period 2||0
934346|NCT01431989|2260945|P2|COMPLETED|Period 2||14
934347|NCT01431989|2260946|P1|COMPLETED|Period 2||14
934348|NCT01431989|2260945|P2|STARTED|Period 2||14
934349|NCT01431989|2260946|P1|STARTED|Period 2||14
934350|NCT01431989|2260945|P2|NOT COMPLETED|14-Day Washout Period||0
934351|NCT01431989|2260946|P1|NOT COMPLETED|14-Day Washout Period||0
934352|NCT01431989|2260945|P2|COMPLETED|14-Day Washout Period||14
934353|NCT01431989|2260946|P1|COMPLETED|14-Day Washout Period||14
934354|NCT01431989|2260945|P2|STARTED|14-Day Washout Period||14
934355|NCT01431989|2260946|P1|STARTED|14-Day Washout Period||14
934356|NCT01431989|2260945|P2|NOT COMPLETED|Period 1||0
934357|NCT01431989|2260946|P1|NOT COMPLETED|Period 1||0
934358|NCT01431989|2260945|P2|COMPLETED|Period 1||14
934359|NCT01431989|2260946|P1|COMPLETED|Period 1||14
934360|NCT01431989|2260945|P2|STARTED|Period 1||14
934361|NCT01431989|2260946|P1|STARTED|Period 1||14
934362|NCT01431976|2260964|P1|NOT COMPLETED|Overall Study||14
934363|NCT01431976|2260964|P1|COMPLETED|Overall Study||6
934364|NCT01431976|2260964|P1|STARTED|Overall Study||20
934365|NCT01431963|2260975|P1|NOT COMPLETED|Overall Study||35
934366|NCT01431963|2260975|P1|COMPLETED|Overall Study||32
934367|NCT01431963|2260975|P1|Complete ExP (gt= 24 Weeks)|Overall Study|(>=24 weeks); gt= abbreviation for greater than or equal to|19
934368|NCT01431963|2260975|P1|Begin Extension Phase (ExP; gt= 24weeks)|Overall Study|Only Japanese participants in ExP,lamotrigine monotherapy was available in Korea. (>=24weeks)|19
934369|NCT01431963|2260975|P1|Complete MP (24 Weeks)|Overall Study||42
934370|NCT01431963|2260975|P1|Begin Maintenance Phase (MP; 24 Weeks)|Overall Study||52
934371|NCT01431963|2260975|P1|Complete EP (6 Weeks)|Overall Study||52
934372|NCT01431963|2260975|P1|Received Treatment|Overall Study||65
934373|NCT01431963|2260975|P1|Begin Escalation Phase (EP; 6 Weeks)|Overall Study||67
934374|NCT01431963|2260975|P1|STARTED|Overall Study||67
934375|NCT01431950|2260983|P2|NOT COMPLETED|Overall Study||15
934376|NCT01431950|2260984|P1|NOT COMPLETED|Overall Study||19
934377|NCT01431950|2260983|P2|COMPLETED|Overall Study||104
934378|NCT01431950|2260984|P1|COMPLETED|Overall Study||100
934379|NCT01431950|2260983|P2|STARTED|Overall Study||119
934380|NCT01431950|2260984|P1|STARTED|Overall Study||119
934381|NCT01431846|2261001|P3|NOT COMPLETED|Overall Study||0
934382|NCT01431846|2261002|P2|NOT COMPLETED|Overall Study||0
934383|NCT01431846|2261003|P1|NOT COMPLETED|Overall Study||0
934384|NCT01431846|2261001|P3|COMPLETED|Overall Study||8
934385|NCT01431846|2261002|P2|COMPLETED|Overall Study||3
934386|NCT01431846|2261003|P1|COMPLETED|Overall Study||8
934387|NCT01431846|2261001|P3|STARTED|Overall Study||8
934388|NCT01431846|2261002|P2|STARTED|Overall Study||3
934389|NCT01431846|2261003|P1|STARTED|Overall Study||8
934390|NCT01431755|2261011|P1|NOT COMPLETED|Overall Study||5
934391|NCT01431755|2261011|P1|COMPLETED|Overall Study||49
934392|NCT01431755|2261011|P1|STARTED|Overall Study||54
934393|NCT01431716|2261022|P1|NOT COMPLETED|Overall Study||1
934394|NCT01431716|2261022|P1|COMPLETED|Overall Study||41
934395|NCT01431716|2261022|P1|STARTED|Overall Study||42
934396|NCT01431703|2261039|P1|NOT COMPLETED|Overall Study||0
934397|NCT01431703|2261039|P1|COMPLETED|Overall Study||326
934398|NCT01431703|2261039|P1|STARTED|Overall Study||326
934399|NCT01431521|2261047|P4|NOT COMPLETED|Overall Study||0
934400|NCT01431521|2261048|P3|NOT COMPLETED|Overall Study||1
934401|NCT01431521|2261049|P2|NOT COMPLETED|Overall Study||0
934402|NCT01431521|2261050|P1|NOT COMPLETED|Overall Study||0
934403|NCT01431521|2261047|P4|COMPLETED|Overall Study||5
934404|NCT01431521|2261048|P3|COMPLETED|Overall Study||10
934405|NCT01431521|2261049|P2|COMPLETED|Overall Study||5
934406|NCT01431521|2261050|P1|COMPLETED|Overall Study||10
934407|NCT01431521|2261047|P4|Treated|Overall Study||5
934408|NCT01431521|2261048|P3|Treated|Overall Study||10
934409|NCT01431521|2261049|P2|Treated|Overall Study||5
934410|NCT01431521|2261050|P1|Treated|Overall Study||10
934411|NCT01431521|2261047|P4|STARTED|Overall Study||5
934412|NCT01431521|2261048|P3|STARTED|Overall Study||11
934413|NCT01431521|2261049|P2|STARTED|Overall Study||5
934414|NCT01431521|2261050|P1|STARTED|Overall Study||10
934415|NCT01431508|2261071|P1|NOT COMPLETED|Overall Study||2
934416|NCT01431508|2261071|P1|COMPLETED|Overall Study||13
934417|NCT01431508|2261071|P1|STARTED|Overall Study||15
934418|NCT01431391|2261077|P2|NOT COMPLETED|Overall Study||4
934419|NCT01431391|2261078|P1|NOT COMPLETED|Overall Study||8
934420|NCT01431391|2261077|P2|COMPLETED|Overall Study||30
934421|NCT01431391|2261078|P1|COMPLETED|Overall Study||26
934422|NCT01431391|2261077|P2|Received ≥1 Leaukapheresis|Overall Study||34
934423|NCT01431391|2261078|P1|Received ≥1 Leaukapheresis|Overall Study||34
934424|NCT01431391|2261077|P2|STARTED|Overall Study||34
934425|NCT01431391|2261078|P1|STARTED|Overall Study||34
934426|NCT01431339|2261088|P2|NOT COMPLETED|Overall Study||35
934427|NCT01431339|2261089|P1|NOT COMPLETED|Overall Study||39
934428|NCT01431339|2261088|P2|COMPLETED|Overall Study||333
934429|NCT01431339|2261089|P1|COMPLETED|Overall Study||332
934430|NCT01431339|2261088|P2|Safety Population|Overall Study||367
934431|NCT01431339|2261089|P1|Safety Population|Overall Study||368
934432|NCT01431339|2261088|P2|STARTED|Overall Study||368
934433|NCT01431339|2261089|P1|STARTED|Overall Study||371
934434|NCT01431300|2261104|P3|NOT COMPLETED|Overall Study||0
934435|NCT01431300|2261105|P2|NOT COMPLETED|Overall Study||0
934436|NCT01431300|2261106|P1|NOT COMPLETED|Overall Study||1
934437|NCT01431300|2261104|P3|COMPLETED|Overall Study||10
934438|NCT01431300|2261105|P2|COMPLETED|Overall Study||10
934439|NCT01431300|2261106|P1|COMPLETED|Overall Study||10
934440|NCT01431300|2261104|P3|STARTED|Overall Study||10
934441|NCT01431300|2261105|P2|STARTED|Overall Study||10
934442|NCT01431300|2261106|P1|STARTED|Overall Study|One subject with indeterminate pregnancy test, subject declined to proceed|11
934443|NCT01431287|2261122|P5|NOT COMPLETED|Overall Study||77
934444|NCT01431287|2261123|P4|NOT COMPLETED|Overall Study||63
934445|NCT01431287|2261124|P3|NOT COMPLETED|Overall Study||97
934446|NCT01431287|2261125|P2|NOT COMPLETED|Overall Study||98
934447|NCT01431287|2261126|P1|NOT COMPLETED|Overall Study||98
934448|NCT01431287|2261122|P5|COMPLETED|Overall Study||430
934449|NCT01431287|2261123|P4|COMPLETED|Overall Study||445
934450|NCT01431287|2261124|P3|COMPLETED|Overall Study||410
934451|NCT01431287|2261125|P2|COMPLETED|Overall Study||409
934452|NCT01431287|2261126|P1|COMPLETED|Overall Study||412
934453|NCT01431287|2261122|P5|STARTED|Overall Study||507
934454|NCT01431287|2261123|P4|STARTED|Overall Study||508
934455|NCT01431287|2261124|P3|STARTED|Overall Study||507
934456|NCT01431287|2261125|P2|STARTED|Overall Study||507
934457|NCT01431287|2261126|P1|STARTED|Overall Study|started are actually the randomized|510
934458|NCT01431274|2261288|P5|NOT COMPLETED|Overall Study||56
934459|NCT01431274|2261289|P4|NOT COMPLETED|Overall Study||60
934460|NCT01431274|2261290|P3|NOT COMPLETED|Overall Study||72
934461|NCT01431274|2261291|P2|NOT COMPLETED|Overall Study||77
934462|NCT01431274|2261292|P1|NOT COMPLETED|Overall Study||97
934463|NCT01431274|2261288|P5|COMPLETED|Overall Study||466
934464|NCT01431274|2261289|P4|COMPLETED|Overall Study||462
934465|NCT01431274|2261290|P3|COMPLETED|Overall Study||455
934466|NCT01431274|2261291|P2|COMPLETED|Overall Study||448
934467|NCT01431274|2261292|P1|COMPLETED|Overall Study||431
934468|NCT01431274|2261288|P5|STARTED|Overall Study||522
934469|NCT01431274|2261289|P4|STARTED|Overall Study||522
934470|NCT01431274|2261290|P3|STARTED|Overall Study||527
934471|NCT01431274|2261291|P2|STARTED|Overall Study||525
934472|NCT01431274|2261292|P1|STARTED|Overall Study||528
934473|NCT01431170|2261451|P2|NOT COMPLETED|Overall Study||1
934474|NCT01431170|2261452|P1|NOT COMPLETED|Overall Study||3
934475|NCT01431170|2261451|P2|COMPLETED|Overall Study||11
934476|NCT01431170|2261452|P1|COMPLETED|Overall Study||9
934477|NCT01431170|2261451|P2|STARTED|Overall Study||12
934478|NCT01431170|2261452|P1|STARTED|Overall Study||12
934479|NCT01431144|2261470|P2|NOT COMPLETED|Overall Study||0
934480|NCT01431144|2261471|P1|NOT COMPLETED|Overall Study||2
934481|NCT01431144|2261470|P2|COMPLETED|Overall Study||14
934482|NCT01431144|2261471|P1|COMPLETED|Overall Study||11
934483|NCT01431144|2261470|P2|STARTED|Overall Study||14
934484|NCT01431144|2261471|P1|STARTED|Overall Study||13
934485|NCT01431131|2261479|P2|NOT COMPLETED|Overall Study||0
934486|NCT01431131|2261480|P1|NOT COMPLETED|Overall Study||0
934487|NCT01431131|2261479|P2|COMPLETED|Overall Study||12
934488|NCT01431131|2261480|P1|COMPLETED|Overall Study||12
934489|NCT01431131|2261479|P2|STARTED|Overall Study||12
934490|NCT01431131|2261480|P1|STARTED|Overall Study||12
934491|NCT01431079|2261490|P2|NOT COMPLETED|Overall Study||39
934492|NCT01431079|2261491|P1|NOT COMPLETED|Overall Study||35
934493|NCT01431079|2261490|P2|COMPLETED|Overall Study||6
934494|NCT01431079|2261491|P1|COMPLETED|Overall Study||10
934495|NCT01431079|2261490|P2|Post-test|Overall Study||45
934496|NCT01431079|2261491|P1|Post-test|Overall Study||45
934497|NCT01431079|2261490|P2|STARTED|Overall Study||45
934498|NCT01431079|2261491|P1|STARTED|Overall Study||45
934499|NCT01431014|2261545|P2|NOT COMPLETED|Overall Study||9
934500|NCT01431014|2261546|P1|NOT COMPLETED|Overall Study||3
934501|NCT01431014|2261545|P2|COMPLETED|Overall Study||25
934502|NCT01431014|2261546|P1|COMPLETED|Overall Study||31
934503|NCT01431014|2261545|P2|STARTED|Overall Study||34
934504|NCT01431014|2261546|P1|STARTED|Overall Study||34
934505|NCT01430819|2261554|P2|NOT COMPLETED|Overall Study||0
934506|NCT01430819|2261555|P1|NOT COMPLETED|Overall Study||0
934507|NCT01430819|2261554|P2|COMPLETED|Overall Study||150
934508|NCT01430819|2261555|P1|COMPLETED|Overall Study||150
934509|NCT01430819|2261554|P2|STARTED|Overall Study||150
934510|NCT01430819|2261555|P1|STARTED|Overall Study||150
934511|NCT01430754|2261570|P2|NOT COMPLETED|Randomized Phase||0
934512|NCT01430754|2261571|P1|NOT COMPLETED|Randomized Phase||0
934513|NCT01430754|2261570|P2|COMPLETED|Randomized Phase||10
934514|NCT01430754|2261571|P1|COMPLETED|Randomized Phase||10
934515|NCT01430754|2261570|P2|STARTED|Randomized Phase||10
934516|NCT01430754|2261571|P1|STARTED|Randomized Phase||10
934517|NCT01430754|2261570|P2|NOT COMPLETED|Run-In Phase||0
934518|NCT01430754|2261571|P1|NOT COMPLETED|Run-In Phase||37
934519|NCT01430754|2261570|P2|COMPLETED|Run-In Phase||0
934520|NCT01430754|2261571|P1|COMPLETED|Run-In Phase|Defined as the number of patients who entered the randomized-withdrawal phase|20
934521|NCT01430754|2261570|P2|Entrained - After Run-In Phase|Run-In Phase||0
934522|NCT01430754|2261571|P1|Entrained - After Run-In Phase|Run-In Phase||24
934523|NCT01430754|2261570|P2|STARTED|Run-In Phase|During the run-in phase, participants were treated with tasimelteon only.|0
934524|NCT01430754|2261571|P1|STARTED|Run-In Phase||57
934525|NCT01430741|2261593|P4|NOT COMPLETED|Overall Study||0
934526|NCT01430741|2261594|P3|NOT COMPLETED|Overall Study||10
934527|NCT01430741|2261595|P2|NOT COMPLETED|Overall Study||0
934528|NCT01430741|2261596|P1|NOT COMPLETED|Overall Study||0
934529|NCT01430741|2261593|P4|COMPLETED|Overall Study||81
934530|NCT01430741|2261594|P3|COMPLETED|Overall Study||37
934531|NCT01430741|2261595|P2|COMPLETED|Overall Study||87
934532|NCT01430741|2261596|P1|COMPLETED|Overall Study||22
934533|NCT01430741|2261593|P4|STARTED|Overall Study||81
934534|NCT01430741|2261594|P3|STARTED|Overall Study||47
934535|NCT01430741|2261595|P2|STARTED|Overall Study||87
934536|NCT01430741|2261596|P1|STARTED|Overall Study||22
934537|NCT01430624|2261629|P3|NOT COMPLETED|Overall Study||29
934538|NCT01430624|2261630|P2|NOT COMPLETED|Overall Study||34
934539|NCT01430624|2261631|P1|NOT COMPLETED|Overall Study||28
934540|NCT01430624|2261629|P3|COMPLETED|Overall Study|Completed one or more follow-ups|52
934541|NCT01430624|2261630|P2|COMPLETED|Overall Study|Completed one or more follow-ups|48
934542|NCT01430624|2261631|P1|COMPLETED|Overall Study|Completed one or more follow-ups|54
934543|NCT01430624|2261629|P3|Eligible Baseline Completes|Overall Study||79
934544|NCT01430624|2261630|P2|Eligible Baseline Completes|Overall Study||77
934545|NCT01430624|2261631|P1|Eligible Baseline Completes|Overall Study||77
934546|NCT01430624|2261629|P3|STARTED|Overall Study||81
934547|NCT01430624|2261630|P2|STARTED|Overall Study||82
934548|NCT01430624|2261631|P1|STARTED|Overall Study|Initial potential eligible screened enrolled|82
934549|NCT01430611|2261662|P2|NOT COMPLETED|Overall Study||15
934550|NCT01430611|2261663|P1|NOT COMPLETED|Overall Study||17
934551|NCT01430611|2261662|P2|COMPLETED|Overall Study||318
934552|NCT01430611|2261663|P1|COMPLETED|Overall Study||315
934553|NCT01430611|2261662|P2|STARTED|Overall Study||333
934554|NCT01430611|2261663|P1|STARTED|Overall Study||332
934555|NCT01430585|2261681|P1|NOT COMPLETED|Overall Study||14
934556|NCT01430585|2261681|P1|COMPLETED|Overall Study||0
934557|NCT01430585|2261681|P1|STARTED|Overall Study||14
934558|NCT01430468|2261716|P2|NOT COMPLETED|Overall Study||2
934559|NCT01430468|2261717|P1|NOT COMPLETED|Overall Study||3
934560|NCT01430468|2261716|P2|COMPLETED|Overall Study||16
934561|NCT01430468|2261717|P1|COMPLETED|Overall Study||15
934562|NCT01430468|2261716|P2|STARTED|Overall Study||18
934563|NCT01430468|2261717|P1|STARTED|Overall Study||18
934564|NCT01430403|2261726|P3|NOT COMPLETED|Overall Study||8
934565|NCT01430403|2261727|P2|NOT COMPLETED|Overall Study||9
934566|NCT01430403|2261728|P1|NOT COMPLETED|Overall Study||17
934567|NCT01430403|2261726|P3|COMPLETED|Overall Study||81
934568|NCT01430403|2261727|P2|COMPLETED|Overall Study||121
934569|NCT01430403|2261728|P1|COMPLETED|Overall Study||242
934570|NCT01430403|2261726|P3|STARTED|Overall Study|Intent-to-treat|89
934571|NCT01430403|2261727|P2|STARTED|Overall Study|Intent-to-treat|130
934572|NCT01430403|2261728|P1|STARTED|Overall Study|Intent-to-treat|259
934573|NCT01430325|2261781|P4|NOT COMPLETED|Overall Study||0
934574|NCT01430325|2261782|P3|NOT COMPLETED|Overall Study||0
934575|NCT01430325|2261783|P2|NOT COMPLETED|Overall Study||0
934576|NCT01430325|2261784|P1|NOT COMPLETED|Overall Study||0
934577|NCT01430325|2261781|P4|COMPLETED|Overall Study||12
934578|NCT01430325|2261782|P3|COMPLETED|Overall Study||8
934579|NCT01430325|2261783|P2|COMPLETED|Overall Study||12
934580|NCT01430325|2261784|P1|COMPLETED|Overall Study||10
934581|NCT01430325|2261781|P4|STARTED|Overall Study||12
934582|NCT01430325|2261782|P3|STARTED|Overall Study||8
934583|NCT01430325|2261783|P2|STARTED|Overall Study||12
934584|NCT01430325|2261784|P1|STARTED|Overall Study||10
934585|NCT01430182|2261804|P2|NOT COMPLETED|Overall Study||0
934586|NCT01430182|2261805|P1|NOT COMPLETED|Overall Study||0
934587|NCT01430182|2261804|P2|COMPLETED|Overall Study||8
934588|NCT01430182|2261805|P1|COMPLETED|Overall Study||9
934589|NCT01430182|2261804|P2|STARTED|Overall Study||8
934590|NCT01430182|2261805|P1|STARTED|Overall Study||9
934591|NCT01430169|2261811|P1|NOT COMPLETED|Overall Study||0
934592|NCT01430169|2261811|P1|COMPLETED|Overall Study||20
934593|NCT01430169|2261811|P1|STARTED|Overall Study||20
934594|NCT01430130|2261826|P1|NOT COMPLETED|Overall Study||2
934595|NCT01430130|2261826|P1|COMPLETED|Overall Study||10
934596|NCT01430130|2261826|P1|STARTED|Overall Study||12
934597|NCT01430104|2261832|P1|NOT COMPLETED|28-Day Teriparatide Treatment Period||1
934598|NCT01430104|2261832|P1|COMPLETED|28-Day Teriparatide Treatment Period||28
934599|NCT01430104|2261832|P1|Received at Least 1 Dose of Teriparatide|28-Day Teriparatide Treatment Period||29
934600|NCT01430104|2261832|P1|STARTED|28-Day Teriparatide Treatment Period|1 participant withdrew from the study after completing the 14-day Lead-in Period.|29
934601|NCT01430104|2261832|P1|NOT COMPLETED|14-Day Lead-In Period||0
934602|NCT01430104|2261832|P1|COMPLETED|14-Day Lead-In Period||30
934603|NCT01430104|2261832|P1|STARTED|14-Day Lead-In Period||30
934604|NCT01430091|2261844|P1|NOT COMPLETED|Overall Study||0
934605|NCT01430091|2261844|P1|COMPLETED|Overall Study||18
934606|NCT01430091|2261844|P1|STARTED|Overall Study||18
934607|NCT01429623|2261868|P2|NOT COMPLETED|Overall Study||59
934608|NCT01429623|2261869|P1|NOT COMPLETED|Overall Study||51
934609|NCT01429623|2261868|P2|COMPLETED|Overall Study||48
934610|NCT01429623|2261869|P1|COMPLETED|Overall Study||51
934611|NCT01429623|2261868|P2|Converted to Alzheimer's|Overall Study|21 of 103|21
934612|NCT01429623|2261869|P1|Converted to Alzheimer's|Overall Study|14 of 99|14
934613|NCT01429623|2261868|P2|STARTED|Overall Study|107 allocated, 4 lacked post baseline data|107
934614|NCT01429623|2261869|P1|STARTED|Overall Study|103 allocated, 1 withdrew consent prior to first dose, 4 lacked post baseline data|102
934615|NCT01429584|2261883|P2|NOT COMPLETED|Overall Study||1
934616|NCT01429584|2261884|P1|NOT COMPLETED|Overall Study||1
934617|NCT01429584|2261883|P2|COMPLETED|Overall Study||14
934618|NCT01429584|2261884|P1|COMPLETED|Overall Study||14
934619|NCT01429584|2261883|P2|STARTED|Overall Study||15
934620|NCT01429584|2261884|P1|STARTED|Overall Study||15
934621|NCT01429532|2261897|P3|NOT COMPLETED|Overall Study||0
934622|NCT01429532|2261898|P2|NOT COMPLETED|Overall Study||0
934623|NCT01429532|2261899|P1|NOT COMPLETED|Overall Study||0
934624|NCT01429532|2261897|P3|COMPLETED|Overall Study||40
934625|NCT01429532|2261898|P2|COMPLETED|Overall Study||40
934626|NCT01429532|2261899|P1|COMPLETED|Overall Study||40
934627|NCT01429532|2261897|P3|STARTED|Overall Study||40
934628|NCT01429532|2261898|P2|STARTED|Overall Study||40
934629|NCT01429532|2261899|P1|STARTED|Overall Study||40
934630|NCT01429441|2261915|P2|NOT COMPLETED|Overall Study||23
934631|NCT01429441|2261916|P1|NOT COMPLETED|Overall Study||38
934632|NCT01429441|2261915|P2|COMPLETED|Overall Study||51
934633|NCT01429441|2261916|P1|COMPLETED|Overall Study||108
934634|NCT01429441|2261915|P2|STARTED|Overall Study||74
934635|NCT01429441|2261916|P1|STARTED|Overall Study||146
934636|NCT01429259|2261924|P1|NOT COMPLETED|Overall Study||0
934637|NCT01429259|2261924|P1|COMPLETED|Overall Study||30
934638|NCT01429259|2261924|P1|STARTED|Overall Study||30
934639|NCT01429077|2261931|P2|NOT COMPLETED|Overall Study||3
934640|NCT01429077|2261932|P1|NOT COMPLETED|Overall Study||0
934641|NCT01429077|2261931|P2|COMPLETED|Overall Study||14
934642|NCT01429077|2261932|P1|COMPLETED|Overall Study||19
934643|NCT01429077|2261931|P2|Completed 6-week Intervention|Overall Study||17
934644|NCT01429077|2261932|P1|Completed 6-week Intervention|Overall Study||19
934645|NCT01429077|2261931|P2|STARTED|Overall Study||17
934646|NCT01429077|2261932|P1|STARTED|Overall Study||19
934647|NCT01429064|2261942|P4|NOT COMPLETED|Overall Study||0
934648|NCT01429064|2261943|P3|NOT COMPLETED|Overall Study||0
934649|NCT01429064|2261944|P2|NOT COMPLETED|Overall Study||0
934650|NCT01429064|2261945|P1|NOT COMPLETED|Overall Study||0
934651|NCT01429064|2261942|P4|COMPLETED|Overall Study||16
934652|NCT01429064|2261943|P3|COMPLETED|Overall Study||19
934653|NCT01429064|2261944|P2|COMPLETED|Overall Study||22
934654|NCT01429064|2261945|P1|COMPLETED|Overall Study||19
934655|NCT01429064|2261942|P4|STARTED|Overall Study||16
934656|NCT01429064|2261943|P3|STARTED|Overall Study||19
934657|NCT01429064|2261944|P2|STARTED|Overall Study||22
934658|NCT01429064|2261945|P1|STARTED|Overall Study||19
934659|NCT01429051|2261955|P1|NOT COMPLETED|Tolerability Phase||15
934660|NCT01429051|2261955|P1|COMPLETED|Tolerability Phase||16
934661|NCT01429051|2261955|P1|STARTED|Tolerability Phase|Participants entered directly from the Titration or Efficacy Phase|31
934662|NCT01429051|2261955|P1|NOT COMPLETED|Efficacy Phase||2
934663|NCT01429051|2261955|P1|COMPLETED|Efficacy Phase||13
934664|NCT01429051|2261955|P1|STARTED|Efficacy Phase|Participants titrated to 200 or 400 μg INFS in Titration Phase|15
934665|NCT01429051|2261955|P1|NOT COMPLETED|Titration Phase||12
934666|NCT01429051|2261955|P1|COMPLETED|Titration Phase||33
934667|NCT01429051|2261955|P1|STARTED|Titration Phase||45
934668|NCT01428882|2261978|P2|NOT COMPLETED|Overall Study||10
934669|NCT01428882|2261979|P1|NOT COMPLETED|Overall Study||6
934670|NCT01428882|2261978|P2|COMPLETED|Overall Study||58
934671|NCT01428882|2261979|P1|COMPLETED|Overall Study||61
934672|NCT01428882|2261978|P2|STARTED|Overall Study||68
934673|NCT01428882|2261979|P1|STARTED|Overall Study||67
934674|NCT01428765|2261991|P1|NOT COMPLETED|Overall Study||0
934675|NCT01428765|2261991|P1|COMPLETED|Overall Study||1063
934676|NCT01428765|2261991|P1|STARTED|Overall Study||1063
934677|NCT01428713|2262002|P2|NOT COMPLETED|Overall Study||5
934678|NCT01428713|2262003|P1|NOT COMPLETED|Overall Study||3
934679|NCT01428713|2262002|P2|COMPLETED|Overall Study||3
934680|NCT01428713|2262003|P1|COMPLETED|Overall Study||6
934681|NCT01428713|2262002|P2|STARTED|Overall Study||8
934682|NCT01428713|2262003|P1|STARTED|Overall Study||9
934683|NCT01428661|2262012|P3|NOT COMPLETED|Open Label Extension||320
934684|NCT01428661|2262013|P2|NOT COMPLETED|Open Label Extension||0
934685|NCT01428661|2262014|P1|NOT COMPLETED|Open Label Extension||0
934686|NCT01428661|2262012|P3|COMPLETED|Open Label Extension||19
934687|NCT01428661|2262013|P2|COMPLETED|Open Label Extension|Does not apply.|0
934688|NCT01428661|2262014|P1|COMPLETED|Open Label Extension|Does not apply.|0
934689|NCT01428661|2262012|P3|STARTED|Open Label Extension||339
934690|NCT01428661|2262013|P2|STARTED|Open Label Extension|Does not apply.|0
934691|NCT01428661|2262014|P1|STARTED|Open Label Extension|Does not apply.|0
934692|NCT01428661|2262012|P3|NOT COMPLETED|Double-Masked Phase||0
934693|NCT01428661|2262013|P2|NOT COMPLETED|Double-Masked Phase||49
934694|NCT01428661|2262014|P1|NOT COMPLETED|Double-Masked Phase||57
934695|NCT01428661|2262012|P3|COMPLETED|Double-Masked Phase|Does not apply.|0
934696|NCT01428661|2262013|P2|COMPLETED|Double-Masked Phase||204
934697|NCT01428661|2262014|P1|COMPLETED|Double-Masked Phase||197
934698|NCT01428661|2262012|P3|STARTED|Double-Masked Phase|Does not apply.|0
934699|NCT01428661|2262013|P2|STARTED|Double-Masked Phase||253
934700|NCT01428661|2262014|P1|STARTED|Double-Masked Phase||254
934701|NCT01428583|2262022|P1|NOT COMPLETED|Overall Study||237
934702|NCT01428583|2262022|P1|COMPLETED|Overall Study||158
934703|NCT01428583|2262022|P1|STARTED|Overall Study||395
934704|NCT01428336|2262046|P2|NOT COMPLETED|Overall Study||0
934705|NCT01428336|2262047|P1|NOT COMPLETED|Overall Study||0
934706|NCT01428336|2262046|P2|COMPLETED|Overall Study||12
934707|NCT01428336|2262047|P1|COMPLETED|Overall Study||10
934708|NCT01428336|2262046|P2|STARTED|Overall Study||12
934709|NCT01428336|2262047|P1|STARTED|Overall Study||10
934710|NCT01428258|2262059|P2|NOT COMPLETED|Intervention 2||0
934711|NCT01428258|2262060|P1|NOT COMPLETED|Intervention 2||0
934712|NCT01428258|2262059|P2|COMPLETED|Intervention 2||15
934713|NCT01428258|2262060|P1|COMPLETED|Intervention 2||15
934714|NCT01428258|2262059|P2|STARTED|Intervention 2||15
934715|NCT01428258|2262060|P1|STARTED|Intervention 2||15
934716|NCT01428258|2262059|P2|NOT COMPLETED|Intervention 1||0
934717|NCT01428258|2262060|P1|NOT COMPLETED|Intervention 1||2
934718|NCT01428258|2262059|P2|COMPLETED|Intervention 1||15
934719|NCT01428258|2262060|P1|COMPLETED|Intervention 1||15
934720|NCT01428258|2262059|P2|STARTED|Intervention 1||15
934721|NCT01428258|2262060|P1|STARTED|Intervention 1||17
934722|NCT01428219|2262078|P1|NOT COMPLETED|Overall Study||0
934723|NCT01428219|2262078|P1|COMPLETED|Overall Study||25
934724|NCT01428219|2262078|P1|STARTED|Overall Study||25
934725|NCT01428128|2262082|P1|NOT COMPLETED|Overall Study||17
934726|NCT01428128|2262082|P1|COMPLETED|Overall Study||33
934727|NCT01428128|2262082|P1|STARTED|Overall Study||50
934728|NCT01428115|2262086|P1|NOT COMPLETED|Overall Study||21
934729|NCT01428115|2262086|P1|COMPLETED|Overall Study||62
934730|NCT01428115|2262086|P1|STARTED|Overall Study||83
934731|NCT01428076|2262101|P2|NOT COMPLETED|Overall Study||1
934732|NCT01428076|2262102|P1|NOT COMPLETED|Overall Study||0
934733|NCT01428076|2262101|P2|COMPLETED|Overall Study||11
934734|NCT01428076|2262102|P1|COMPLETED|Overall Study||9
934735|NCT01428076|2262101|P2|STARTED|Overall Study||12
934736|NCT01428076|2262102|P1|STARTED|Overall Study||9
934737|NCT01428063|2262113|P3|NOT COMPLETED|Overall Study||1
934738|NCT01428063|2262114|P2|NOT COMPLETED|Overall Study||10
934739|NCT01428063|2262115|P1|NOT COMPLETED|Overall Study||10
934740|NCT01428063|2262113|P3|COMPLETED|Overall Study||5
934741|NCT01428063|2262114|P2|COMPLETED|Overall Study||112
934742|NCT01428063|2262115|P1|COMPLETED|Overall Study||89
934743|NCT01428063|2262113|P3|STARTED|Overall Study||6
934744|NCT01428063|2262114|P2|STARTED|Overall Study||122
934745|NCT01428063|2262115|P1|STARTED|Overall Study||99
934746|NCT01427933|2262186|P2|NOT COMPLETED|Overall Study||13
934747|NCT01427933|2262187|P1|NOT COMPLETED|Overall Study||8
934748|NCT01427933|2262186|P2|COMPLETED|Overall Study||57
934749|NCT01427933|2262187|P1|COMPLETED|Overall Study||63
934750|NCT01427933|2262186|P2|Received at Least 1 Dose of Study Drug|Overall Study||65
934751|NCT01427933|2262187|P1|Received at Least 1 Dose of Study Drug|Overall Study||69
934752|NCT01427933|2262186|P2|STARTED|Overall Study||70
934753|NCT01427933|2262187|P1|STARTED|Overall Study||71
934754|NCT01427920|2262207|P2|NOT COMPLETED|Overall Study||17
934755|NCT01427920|2262208|P1|NOT COMPLETED|Overall Study||9
934756|NCT01427920|2262207|P2|COMPLETED|Overall Study||157
934757|NCT01427920|2262208|P1|COMPLETED|Overall Study||165
934758|NCT01427920|2262207|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|173
934759|NCT01427920|2262208|P1|Exposed|Overall Study||174
934760|NCT01427920|2262207|P2|STARTED|Overall Study||174
934761|NCT01427920|2262208|P1|STARTED|Overall Study||174
934762|NCT01427907|2262228|P2|NOT COMPLETED|Overall Study||4
934763|NCT01427907|2262229|P1|NOT COMPLETED|Overall Study||3
934764|NCT01427907|2262228|P2|COMPLETED|Overall Study|Completed study|14
934765|NCT01427907|2262229|P1|COMPLETED|Overall Study|Completed study|17
934766|NCT01427907|2262228|P2|STARTED|Overall Study|Randomized|18
934767|NCT01427907|2262229|P1|STARTED|Overall Study|Randomized|20
934768|NCT01427881|2262235|P1|NOT COMPLETED|Overall Study||0
934769|NCT01427881|2262235|P1|COMPLETED|Overall Study||43
934770|NCT01427881|2262235|P1|STARTED|Overall Study||43
934771|NCT01427803|2262250|P2|NOT COMPLETED|Overall Study||26
934772|NCT01427803|2262251|P1|NOT COMPLETED|Overall Study||63
934773|NCT01427803|2262250|P2|COMPLETED|Overall Study|130 participants interviewed. Remaining subjects continued in trial to collect safety information.|226
934774|NCT01427803|2262251|P1|COMPLETED|Overall Study||463
934775|NCT01427803|2262250|P2|Took Product|Overall Study|Those who took at least one dose of investigational product as logged in e diary & 1 on Health Log.|237
934776|NCT01427803|2262251|P1|Took Product|Overall Study|Those who took at least one dose of investigational product. Only 502 qualified for data analysis.|508
934777|NCT01427803|2262250|P2|Baseline Assessment|Overall Study|only interviewed participants were assessed|130
934778|NCT01427803|2262251|P1|Baseline Assessment|Overall Study||516
934779|NCT01427803|2262250|P2|Purchased Product|Overall Study||252
934780|NCT01427803|2262251|P1|Purchased Product|Overall Study|Only 516 participants used e-diary|525
934781|NCT01427803|2262250|P2|STARTED|Overall Study||252
934782|NCT01427803|2262251|P1|STARTED|Overall Study||526
934783|NCT01427751|2262265|P2|NOT COMPLETED|Overall Study||14
934784|NCT01427751|2262266|P1|NOT COMPLETED|Overall Study||42
934785|NCT01427751|2262265|P2|COMPLETED|Overall Study||139
934786|NCT01427751|2262266|P1|COMPLETED|Overall Study||112
934787|NCT01427751|2262265|P2|STARTED|Overall Study||153
934788|NCT01427751|2262266|P1|STARTED|Overall Study||154
934789|NCT01427738|2262286|P2|NOT COMPLETED|Overall Study||21
934790|NCT01427738|2262287|P1|NOT COMPLETED|Overall Study||19
934791|NCT01427738|2262286|P2|COMPLETED|Overall Study||90
934792|NCT01427738|2262287|P1|COMPLETED|Overall Study||91
934793|NCT01427738|2262286|P2|STARTED|Overall Study||111
934794|NCT01427738|2262287|P1|STARTED|Overall Study||110
934795|NCT01427517|2262308|P3|NOT COMPLETED|Overall Study||0
934796|NCT01427517|2262309|P2|NOT COMPLETED|Overall Study||0
934797|NCT01427517|2262310|P1|NOT COMPLETED|Overall Study||0
934798|NCT01427517|2262308|P3|COMPLETED|Overall Study||3
934799|NCT01427517|2262309|P2|COMPLETED|Overall Study||3
934800|NCT01427517|2262310|P1|COMPLETED|Overall Study||3
934801|NCT01427517|2262308|P3|STARTED|Overall Study||3
934802|NCT01427517|2262309|P2|STARTED|Overall Study||3
934803|NCT01427517|2262310|P1|STARTED|Overall Study||3
934804|NCT01427504|2262324|P6|NOT COMPLETED|Overall Study||2
934805|NCT01427504|2262325|P5|NOT COMPLETED|Overall Study||1
934806|NCT01427504|2262326|P4|NOT COMPLETED|Overall Study||1
934807|NCT01427504|2262327|P3|NOT COMPLETED|Overall Study||1
934808|NCT01427504|2262328|P2|NOT COMPLETED|Overall Study||1
934809|NCT01427504|2262329|P1|NOT COMPLETED|Overall Study||0
934810|NCT01427504|2262324|P6|COMPLETED|Overall Study||4
934811|NCT01427504|2262325|P5|COMPLETED|Overall Study||2
934812|NCT01427504|2262326|P4|COMPLETED|Overall Study||5
934813|NCT01427504|2262327|P3|COMPLETED|Overall Study||3
934814|NCT01427504|2262328|P2|COMPLETED|Overall Study||2
934815|NCT01427504|2262329|P1|COMPLETED|Overall Study||4
934816|NCT01427504|2262324|P6|Received Combination|Overall Study||6
934817|NCT01427504|2262325|P5|Received Combination|Overall Study||3
934818|NCT01427504|2262326|P4|Received Combination|Overall Study||6
934819|NCT01427504|2262327|P3|Received Combination|Overall Study||3
934820|NCT01427504|2262328|P2|Received Combination|Overall Study||3
934821|NCT01427504|2262329|P1|Received Combination|Overall Study||4
934822|NCT01427504|2262324|P6|Received Etravirine|Overall Study||4
934823|NCT01427504|2262325|P5|Received Etravirine|Overall Study||2
934824|NCT01427504|2262326|P4|Received Etravirine|Overall Study||6
934825|NCT01427504|2262327|P3|Received Etravirine|Overall Study||4
934826|NCT01427504|2262328|P2|Received Etravirine|Overall Study||2
934827|NCT01427504|2262329|P1|Received Etravirine|Overall Study||4
934828|NCT01427504|2262324|P6|Received Boceprevir|Overall Study||4
934829|NCT01427504|2262325|P5|Received Boceprevir|Overall Study||2
934830|NCT01427504|2262326|P4|Received Boceprevir|Overall Study||5
934831|NCT01427504|2262327|P3|Received Boceprevir|Overall Study||3
934832|NCT01427504|2262328|P2|Received Boceprevir|Overall Study||3
934833|NCT01427504|2262329|P1|Received Boceprevir|Overall Study||4
934834|NCT01427504|2262324|P6|STARTED|Overall Study||6
934835|NCT01427504|2262325|P5|STARTED|Overall Study||3
934836|NCT01427504|2262326|P4|STARTED|Overall Study||6
934837|NCT01427504|2262327|P3|STARTED|Overall Study||4
934838|NCT01427504|2262328|P2|STARTED|Overall Study||3
934839|NCT01427504|2262329|P1|STARTED|Overall Study||4
934840|NCT01427309|2262350|P4|NOT COMPLETED|Overall Study||376
934841|NCT01427309|2262351|P3|NOT COMPLETED|Overall Study||361
934842|NCT01427309|2262352|P2|NOT COMPLETED|Overall Study||407
934843|NCT01427309|2262353|P1|NOT COMPLETED|Overall Study||372
934844|NCT01427309|2262350|P4|COMPLETED|Overall Study||8373
934845|NCT01427309|2262351|P3|COMPLETED|Overall Study||8376
934846|NCT01427309|2262352|P2|COMPLETED|Overall Study||6837
934847|NCT01427309|2262353|P1|COMPLETED|Overall Study||6881
934848|NCT01427309|2262350|P4|STARTED|Overall Study||8749
934849|NCT01427309|2262351|P3|STARTED|Overall Study||8737
934850|NCT01427309|2262352|P2|STARTED|Overall Study||7244
934851|NCT01427309|2262353|P1|STARTED|Overall Study||7253
934852|NCT01426958|2262391|P1|NOT COMPLETED|Overall Study||2
934853|NCT01426958|2262391|P1|COMPLETED|Overall Study||22
934854|NCT01426958|2262391|P1|STARTED|Overall Study||24
934855|NCT01426867|2262408|P3|NOT COMPLETED|Overall Study||0
934856|NCT01426867|2262409|P2|NOT COMPLETED|Overall Study||0
934857|NCT01426867|2262410|P1|NOT COMPLETED|Overall Study||0
934858|NCT01426867|2262408|P3|COMPLETED|Overall Study||34
934859|NCT01426867|2262409|P2|COMPLETED|Overall Study||34
934860|NCT01426867|2262410|P1|COMPLETED|Overall Study||33
934861|NCT01426867|2262408|P3|STARTED|Overall Study||34
934862|NCT01426867|2262409|P2|STARTED|Overall Study||34
934863|NCT01426867|2262410|P1|STARTED|Overall Study||33
934864|NCT01426854|2262420|P2|NOT COMPLETED|Overall Study||31
934865|NCT01426854|2262421|P1|NOT COMPLETED|Overall Study||12
934866|NCT01426854|2262420|P2|COMPLETED|Overall Study||98
934867|NCT01426854|2262421|P1|COMPLETED|Overall Study||119
934868|NCT01426854|2262420|P2|STARTED|Overall Study||129
934869|NCT01426854|2262421|P1|STARTED|Overall Study||131
934870|NCT01426789|2262431|P6|NOT COMPLETED|Part 2||0
934871|NCT01426789|2262432|P5|NOT COMPLETED|Part 2||8
934872|NCT01426789|2262433|P4|NOT COMPLETED|Part 2||1
934873|NCT01426789|2262434|P3|NOT COMPLETED|Part 2||15
934874|NCT01426789|2262435|P2|NOT COMPLETED|Part 2||0
934875|NCT01426789|2262436|P1|NOT COMPLETED|Part 2||0
934876|NCT01426789|2262431|P6|COMPLETED|Part 2||1
934877|NCT01426789|2262432|P5|COMPLETED|Part 2||19
934878|NCT01426789|2262433|P4|COMPLETED|Part 2||12
934879|NCT01426789|2262434|P3|COMPLETED|Part 2||34
934880|NCT01426789|2262435|P2|COMPLETED|Part 2||0
934881|NCT01426789|2262436|P1|COMPLETED|Part 2||0
934882|NCT01426789|2262431|P6|STARTED|Part 2||1
934883|NCT01426789|2262432|P5|STARTED|Part 2||27
934884|NCT01426789|2262433|P4|STARTED|Part 2||13
934885|NCT01426789|2262434|P3|STARTED|Part 2||49
934886|NCT01426789|2262435|P2|STARTED|Part 2||0
934887|NCT01426789|2262436|P1|STARTED|Part 2||0
934888|NCT01426789|2262431|P6|NOT COMPLETED|Part 1||0
934889|NCT01426789|2262432|P5|NOT COMPLETED|Part 1||0
934890|NCT01426789|2262433|P4|NOT COMPLETED|Part 1||0
934891|NCT01426789|2262434|P3|NOT COMPLETED|Part 1||0
934892|NCT01426789|2262435|P2|NOT COMPLETED|Part 1||4
934893|NCT01426789|2262436|P1|NOT COMPLETED|Part 1||6
934894|NCT01426789|2262431|P6|COMPLETED|Part 1||0
934895|NCT01426789|2262432|P5|COMPLETED|Part 1||0
934896|NCT01426789|2262433|P4|COMPLETED|Part 1||0
934897|NCT01426789|2262434|P3|COMPLETED|Part 1||0
934898|NCT01426789|2262435|P2|COMPLETED|Part 1||28
934899|NCT01426789|2262436|P1|COMPLETED|Part 1||62
934900|NCT01426789|2262431|P6|STARTED|Part 1||0
934901|NCT01426789|2262432|P5|STARTED|Part 1||0
934902|NCT01426789|2262433|P4|STARTED|Part 1||0
934903|NCT01426789|2262434|P3|STARTED|Part 1||0
934904|NCT01426789|2262435|P2|STARTED|Part 1||32
934905|NCT01426789|2262436|P1|STARTED|Part 1||68
934906|NCT01426763|2262452|P2|NOT COMPLETED|Overall Study||0
934907|NCT01426763|2262453|P1|NOT COMPLETED|Overall Study||0
934908|NCT01426763|2262452|P2|COMPLETED|Overall Study||6
934909|NCT01426763|2262453|P1|COMPLETED|Overall Study||6
934910|NCT01426763|2262452|P2|STARTED|Overall Study||6
934911|NCT01426763|2262453|P1|STARTED|Overall Study||6
934912|NCT01426555|2262461|P2|NOT COMPLETED|Overall Study||15
934913|NCT01426555|2262462|P1|NOT COMPLETED|Overall Study||18
934914|NCT01426555|2262461|P2|COMPLETED|Overall Study||20
934915|NCT01426555|2262462|P1|COMPLETED|Overall Study||17
934916|NCT01426555|2262461|P2|STARTED|Overall Study||35
934917|NCT01426555|2262462|P1|STARTED|Overall Study||35
934918|NCT01426516|2262472|P2|NOT COMPLETED|Overall Study||0
934919|NCT01426516|2262473|P1|NOT COMPLETED|Overall Study||0
934920|NCT01426516|2262472|P2|COMPLETED|Overall Study||17
934921|NCT01426516|2262473|P1|COMPLETED|Overall Study||12
934922|NCT01426516|2262472|P2|STARTED|Overall Study||17
934923|NCT01426516|2262473|P1|STARTED|Overall Study||12
934924|NCT01426438|2262481|P2|NOT COMPLETED|Overall Study||10
934925|NCT01426438|2262482|P1|NOT COMPLETED|Overall Study||15
934926|NCT01426438|2262481|P2|COMPLETED|Overall Study||39
934927|NCT01426438|2262482|P1|COMPLETED|Overall Study||35
934928|NCT01426438|2262481|P2|STARTED|Overall Study||49
934929|NCT01426438|2262482|P1|STARTED|Overall Study||50
934930|NCT01426425|2262514|P1|NOT COMPLETED|Overall Study||175
934931|NCT01426425|2262514|P1|COMPLETED|Overall Study|The pre-specified modified intent-to-treat analysis set was used for the primary objectives.|397
934932|NCT01426425|2262514|P1|Intent to Treat|Overall Study|Met all inclusion and no exclusion criteria.|399
934933|NCT01426425|2262514|P1|EP Study|Overall Study|EP study used to assess inclusion and exclusion criteria.|550
934934|NCT01426425|2262514|P1|STARTED|Overall Study||572
934935|NCT01426373|2262520|P1|NOT COMPLETED|Overall Study||34
934936|NCT01426373|2262520|P1|COMPLETED|Overall Study|Completed the last follow-up visit 12 months after last treatment|131
934937|NCT01426373|2262520|P1|STARTED|Overall Study||165
934938|NCT01426360|2262538|P2|NOT COMPLETED|Overall Study||0
934939|NCT01426360|2262539|P1|NOT COMPLETED|Overall Study||0
934940|NCT01426360|2262538|P2|COMPLETED|Overall Study||41
934941|NCT01426360|2262539|P1|COMPLETED|Overall Study||38
934942|NCT01426360|2262538|P2|STARTED|Overall Study||41
934943|NCT01426360|2262539|P1|STARTED|Overall Study||38
934944|NCT01426347|2262553|P2|NOT COMPLETED|Overall Study||3
934945|NCT01426347|2262554|P1|NOT COMPLETED|Overall Study||7
934946|NCT01426347|2262553|P2|COMPLETED|Overall Study||39
934947|NCT01426347|2262554|P1|COMPLETED|Overall Study||34
934948|NCT01426347|2262553|P2|STARTED|Overall Study||42
934949|NCT01426347|2262554|P1|STARTED|Overall Study||41
934950|NCT01426269|2262562|P3|NOT COMPLETED|Period 2: 40 Weeks||47
934951|NCT01426269|2262563|P2|NOT COMPLETED|Period 2: 40 Weeks||38
934952|NCT01426269|2262564|P1|NOT COMPLETED|Period 2: 40 Weeks||0
934953|NCT01426269|2262562|P3|COMPLETED|Period 2: 40 Weeks||18
934954|NCT01426269|2262563|P2|COMPLETED|Period 2: 40 Weeks||27
934955|NCT01426269|2262564|P1|COMPLETED|Period 2: 40 Weeks||0
934956|NCT01426269|2262562|P3|STARTED|Period 2: 40 Weeks||65
934957|NCT01426269|2262563|P2|STARTED|Period 2: 40 Weeks||65
934958|NCT01426269|2262564|P1|STARTED|Period 2: 40 Weeks||0
934959|NCT01426269|2262562|P3|NOT COMPLETED|Eligibility for Period 2, Randomization||0
934960|NCT01426269|2262563|P2|NOT COMPLETED|Eligibility for Period 2, Randomization||0
934961|NCT01426269|2262564|P1|NOT COMPLETED|Eligibility for Period 2, Randomization||50
934962|NCT01426269|2262562|P3|COMPLETED|Eligibility for Period 2, Randomization||0
934963|NCT01426269|2262563|P2|COMPLETED|Eligibility for Period 2, Randomization||0
934964|NCT01426269|2262564|P1|COMPLETED|Eligibility for Period 2, Randomization||130
934965|NCT01426269|2262562|P3|STARTED|Eligibility for Period 2, Randomization||0
934966|NCT01426269|2262563|P2|STARTED|Eligibility for Period 2, Randomization||0
934967|NCT01426269|2262564|P1|STARTED|Eligibility for Period 2, Randomization||180
934968|NCT01426269|2262562|P3|NOT COMPLETED|Period 1: 12 Weeks||0
934969|NCT01426269|2262563|P2|NOT COMPLETED|Period 1: 12 Weeks||0
934970|NCT01426269|2262564|P1|NOT COMPLETED|Period 1: 12 Weeks||55
934971|NCT01426269|2262562|P3|COMPLETED|Period 1: 12 Weeks||0
934972|NCT01426269|2262563|P2|COMPLETED|Period 1: 12 Weeks||0
934973|NCT01426269|2262564|P1|COMPLETED|Period 1: 12 Weeks||180
934974|NCT01426269|2262562|P3|STARTED|Period 1: 12 Weeks||0
934975|NCT01426269|2262563|P2|STARTED|Period 1: 12 Weeks||0
934976|NCT01426269|2262564|P1|STARTED|Period 1: 12 Weeks||235
934977|NCT01426230|2262591|P2|NOT COMPLETED|Overall Study||27
934978|NCT01426230|2262592|P1|NOT COMPLETED|Overall Study||31
934979|NCT01426230|2262591|P2|COMPLETED|Overall Study||84
934980|NCT01426230|2262592|P1|COMPLETED|Overall Study||55
934981|NCT01426230|2262591|P2|STARTED|Overall Study||111
934982|NCT01426230|2262592|P1|STARTED|Overall Study|90 patients were enrolled, but only 86 received study treatment.|86
934983|NCT01426113|2262599|P2|NOT COMPLETED|Overall Study||2
934984|NCT01426113|2262600|P1|NOT COMPLETED|Overall Study||1
934985|NCT01426113|2262599|P2|COMPLETED|Overall Study||1
934986|NCT01426113|2262600|P1|COMPLETED|Overall Study||2
934987|NCT01426113|2262599|P2|STARTED|Overall Study||3
934988|NCT01426113|2262600|P1|STARTED|Overall Study||3
934989|NCT01425879|2262606|P1|NOT COMPLETED|Overall Study||0
934990|NCT01425879|2262606|P1|COMPLETED|Overall Study||8
934991|NCT01425879|2262606|P1|STARTED|Overall Study||8
934992|NCT01425853|2262615|P2|NOT COMPLETED|Overall Study||77
934993|NCT01425853|2262616|P1|NOT COMPLETED|Overall Study||64
934994|NCT01425853|2262615|P2|COMPLETED|Overall Study||225
934995|NCT01425853|2262616|P1|COMPLETED|Overall Study||240
934996|NCT01425853|2262615|P2|Per Protocol (PP)|Overall Study||258
934997|NCT01425853|2262616|P1|Per Protocol (PP)|Overall Study||264
934998|NCT01425853|2262615|P2|Safety Population|Overall Study||299
934999|NCT01425853|2262616|P1|Safety Population|Overall Study||304
935000|NCT01425853|2262615|P2|STARTED|Overall Study||302
935001|NCT01425853|2262616|P1|STARTED|Overall Study||304
935002|NCT01425814|2262646|P6|NOT COMPLETED|Period 5||1
935003|NCT01425814|2262647|P5|NOT COMPLETED|Period 5||0
935004|NCT01425814|2262648|P4|NOT COMPLETED|Period 5||0
935005|NCT01425814|2262649|P3|NOT COMPLETED|Period 5||1
935006|NCT01425814|2262650|P2|NOT COMPLETED|Period 5||0
935007|NCT01425814|2262651|P1|NOT COMPLETED|Period 5||0
935008|NCT01425814|2262646|P6|COMPLETED|Period 5||11
935009|NCT01425814|2262647|P5|COMPLETED|Period 5||12
935010|NCT01425814|2262648|P4|COMPLETED|Period 5||10
935011|NCT01425814|2262649|P3|COMPLETED|Period 5||10
935012|NCT01425814|2262650|P2|COMPLETED|Period 5||9
935013|NCT01425814|2262651|P1|COMPLETED|Period 5||11
935014|NCT01425814|2262646|P6|STARTED|Period 5||12
935015|NCT01425814|2262647|P5|STARTED|Period 5||12
935016|NCT01425814|2262648|P4|STARTED|Period 5||10
935017|NCT01425814|2262649|P3|STARTED|Period 5||11
935018|NCT01425814|2262650|P2|STARTED|Period 5||9
935019|NCT01425814|2262651|P1|STARTED|Period 5||11
935020|NCT01425814|2262646|P6|NOT COMPLETED|Period 4||0
935021|NCT01425814|2262647|P5|NOT COMPLETED|Period 4||0
935022|NCT01425814|2262648|P4|NOT COMPLETED|Period 4||0
935023|NCT01425814|2262649|P3|NOT COMPLETED|Period 4||1
935024|NCT01425814|2262650|P2|NOT COMPLETED|Period 4||0
935025|NCT01425814|2262651|P1|NOT COMPLETED|Period 4||1
935026|NCT01425814|2262646|P6|COMPLETED|Period 4||12
935027|NCT01425814|2262647|P5|COMPLETED|Period 4||12
935028|NCT01425814|2262648|P4|COMPLETED|Period 4||10
935029|NCT01425814|2262649|P3|COMPLETED|Period 4||11
935030|NCT01425814|2262650|P2|COMPLETED|Period 4||9
935031|NCT01425814|2262651|P1|COMPLETED|Period 4||11
935032|NCT01425814|2262646|P6|STARTED|Period 4||12
935033|NCT01425814|2262647|P5|STARTED|Period 4||12
935034|NCT01425814|2262648|P4|STARTED|Period 4||10
935035|NCT01425814|2262649|P3|STARTED|Period 4||12
935036|NCT01425814|2262650|P2|STARTED|Period 4||9
935037|NCT01425814|2262651|P1|STARTED|Period 4||12
935038|NCT01425814|2262646|P6|NOT COMPLETED|Period 3||1
935039|NCT01425814|2262647|P5|NOT COMPLETED|Period 3||0
935040|NCT01425814|2262648|P4|NOT COMPLETED|Period 3||0
935041|NCT01425814|2262649|P3|NOT COMPLETED|Period 3||0
935042|NCT01425814|2262650|P2|NOT COMPLETED|Period 3||0
935043|NCT01425814|2262651|P1|NOT COMPLETED|Period 3||0
935044|NCT01425814|2262646|P6|COMPLETED|Period 3||12
935045|NCT01425814|2262647|P5|COMPLETED|Period 3||12
935046|NCT01425814|2262648|P4|COMPLETED|Period 3||10
935047|NCT01425814|2262649|P3|COMPLETED|Period 3||12
935048|NCT01425814|2262650|P2|COMPLETED|Period 3||9
935049|NCT01425814|2262651|P1|COMPLETED|Period 3||12
935050|NCT01425814|2262646|P6|STARTED|Period 3||13
935051|NCT01425814|2262647|P5|STARTED|Period 3||12
935052|NCT01425814|2262648|P4|STARTED|Period 3||10
935053|NCT01425814|2262649|P3|STARTED|Period 3||12
935054|NCT01425814|2262650|P2|STARTED|Period 3||9
935055|NCT01425814|2262651|P1|STARTED|Period 3||12
935056|NCT01425814|2262646|P6|NOT COMPLETED|Period 2||0
935057|NCT01425814|2262647|P5|NOT COMPLETED|Period 2||0
935058|NCT01425814|2262648|P4|NOT COMPLETED|Period 2||0
935059|NCT01425814|2262649|P3|NOT COMPLETED|Period 2||0
935060|NCT01425814|2262650|P2|NOT COMPLETED|Period 2||1
935061|NCT01425814|2262651|P1|NOT COMPLETED|Period 2||0
935062|NCT01425814|2262646|P6|COMPLETED|Period 2||13
935063|NCT01425814|2262647|P5|COMPLETED|Period 2||12
935064|NCT01425814|2262648|P4|COMPLETED|Period 2||10
935065|NCT01425814|2262649|P3|COMPLETED|Period 2||12
935066|NCT01425814|2262650|P2|COMPLETED|Period 2||9
935067|NCT01425814|2262651|P1|COMPLETED|Period 2||12
935068|NCT01425814|2262646|P6|STARTED|Period 2||13
935069|NCT01425814|2262647|P5|STARTED|Period 2||12
935070|NCT01425814|2262648|P4|STARTED|Period 2||10
935071|NCT01425814|2262649|P3|STARTED|Period 2||12
935072|NCT01425814|2262650|P2|STARTED|Period 2||10
935073|NCT01425814|2262651|P1|STARTED|Period 2||12
935074|NCT01425814|2262646|P6|NOT COMPLETED|Period 1||0
935075|NCT01425814|2262647|P5|NOT COMPLETED|Period 1||0
935076|NCT01425814|2262648|P4|NOT COMPLETED|Period 1||0
935077|NCT01425814|2262649|P3|NOT COMPLETED|Period 1||0
935078|NCT01425814|2262650|P2|NOT COMPLETED|Period 1||1
935079|NCT01425814|2262651|P1|NOT COMPLETED|Period 1||0
935080|NCT01425814|2262646|P6|COMPLETED|Period 1||13
935081|NCT01425814|2262647|P5|COMPLETED|Period 1||12
935082|NCT01425814|2262648|P4|COMPLETED|Period 1||10
935083|NCT01425814|2262649|P3|COMPLETED|Period 1||12
935084|NCT01425814|2262650|P2|COMPLETED|Period 1||10
935085|NCT01425814|2262651|P1|COMPLETED|Period 1||12
935086|NCT01425814|2262646|P6|STARTED|Period 1||13
935087|NCT01425814|2262647|P5|STARTED|Period 1||12
935088|NCT01425814|2262648|P4|STARTED|Period 1||10
935089|NCT01425814|2262649|P3|STARTED|Period 1||12
935090|NCT01425814|2262650|P2|STARTED|Period 1||11
935091|NCT01425814|2262651|P1|STARTED|Period 1||12
935092|NCT01425749|2262745|P2|NOT COMPLETED|Overall Study||1
935093|NCT01425749|2262746|P1|NOT COMPLETED|Overall Study||0
935094|NCT01425749|2262745|P2|COMPLETED|Overall Study||11
935095|NCT01425749|2262746|P1|COMPLETED|Overall Study||13
935096|NCT01425749|2262745|P2|STARTED|Overall Study||12
935097|NCT01425749|2262746|P1|STARTED|Overall Study||13
935098|NCT01425632|2262764|P3|NOT COMPLETED|Overall Study||4
935099|NCT01425632|2262765|P2|NOT COMPLETED|Overall Study||1
935100|NCT01425632|2262766|P1|NOT COMPLETED|Overall Study||1
935101|NCT01425632|2262764|P3|COMPLETED|Overall Study||159
935102|NCT01425632|2262765|P2|COMPLETED|Overall Study||165
935103|NCT01425632|2262766|P1|COMPLETED|Overall Study||160
935104|NCT01425632|2262764|P3|STARTED|Overall Study||163
935105|NCT01425632|2262765|P2|STARTED|Overall Study||166
935106|NCT01425632|2262766|P1|STARTED|Overall Study||161
935107|NCT01425528|2262776|P2|NOT COMPLETED|Overall Study||1
935108|NCT01425528|2262777|P1|NOT COMPLETED|Overall Study||1
935109|NCT01425528|2262776|P2|COMPLETED|Overall Study||5
935110|NCT01425528|2262777|P1|COMPLETED|Overall Study||5
935111|NCT01425528|2262776|P2|STARTED|Overall Study||6
935112|NCT01425528|2262777|P1|STARTED|Overall Study||6
935113|NCT01425463|2262785|P2|NOT COMPLETED|Overall Study||24
935114|NCT01425463|2262786|P1|NOT COMPLETED|Overall Study||24
935115|NCT01425463|2262785|P2|COMPLETED|Overall Study||102
935116|NCT01425463|2262786|P1|COMPLETED|Overall Study||106
935117|NCT01425463|2262785|P2|Full Analysis Set|Overall Study||116
935118|NCT01425463|2262786|P1|Full Analysis Set|Overall Study||122
935119|NCT01425463|2262785|P2|Safety Set|Overall Study||122
935120|NCT01425463|2262786|P1|Safety Set|Overall Study||126
935121|NCT01425463|2262785|P2|STARTED|Overall Study||126
935122|NCT01425463|2262786|P1|STARTED|Overall Study||130
935123|NCT01425359|2262802|P2|NOT COMPLETED|Overall Study||22
935124|NCT01425359|2262803|P1|NOT COMPLETED|Overall Study||19
935125|NCT01425359|2262802|P2|COMPLETED|Overall Study||451
935126|NCT01425359|2262803|P1|COMPLETED|Overall Study||457
935127|NCT01425359|2262802|P2|STARTED|Overall Study||473
935128|NCT01425359|2262803|P1|STARTED|Overall Study||476
935129|NCT01425307|2262821|P2|NOT COMPLETED|Overall Study||19
935130|NCT01425307|2262822|P1|NOT COMPLETED|Overall Study||19
935131|NCT01425307|2262821|P2|COMPLETED|Overall Study|Treatment Phase: 41; 6-Month Follow-up:59|41
935132|NCT01425307|2262822|P1|COMPLETED|Overall Study|Treatment Phase: 42; 6-Month Follow up: 58|42
935133|NCT01425307|2262821|P2|STARTED|Overall Study|Randomized Sample: 60; Intention-to Treat Sample:60|60
935134|NCT01425307|2262822|P1|STARTED|Overall Study|Randomized Sample: 61; Intention-to Treat Sample:61|61
935135|NCT01425268|2262834|P2|NOT COMPLETED|Overall Study||0
935136|NCT01425268|2262835|P1|NOT COMPLETED|Overall Study||8
935137|NCT01425268|2262834|P2|COMPLETED|Overall Study||52
935138|NCT01425268|2262835|P1|COMPLETED|Overall Study||98
935139|NCT01425268|2262834|P2|STARTED|Overall Study|52 Subjects Randomized to Saline Arm / 52 Subjects Treated (Implanted)|52
935140|NCT01425268|2262835|P1|STARTED|Overall Study|106 Subjects Randomized to AeroForm Arm / 98 Subjects Treated (Implanted)|106
935141|NCT01425229|2262843|P1|NOT COMPLETED|Bosentan During Clarithromycin||0
935142|NCT01425229|2262843|P1|COMPLETED|Bosentan During Clarithromycin||16
935143|NCT01425229|2262843|P1|STARTED|Bosentan During Clarithromycin||16
935144|NCT01425229|2262843|P1|NOT COMPLETED|Bosentan Steady-state||0
935145|NCT01425229|2262843|P1|COMPLETED|Bosentan Steady-state||16
935146|NCT01425229|2262843|P1|STARTED|Bosentan Steady-state||16
935147|NCT01425229|2262843|P1|NOT COMPLETED|Bosentan Single Dose||0
935148|NCT01425229|2262843|P1|COMPLETED|Bosentan Single Dose||16
935149|NCT01425229|2262843|P1|STARTED|Bosentan Single Dose||16
935150|NCT01425203|2262856|P3|NOT COMPLETED|Follow-up Phase||0
935151|NCT01425203|2262857|P2|NOT COMPLETED|Follow-up Phase||0
935152|NCT01425203|2262858|P1|NOT COMPLETED|Follow-up Phase||0
935153|NCT01425203|2262856|P3|COMPLETED|Follow-up Phase||27
935154|NCT01425203|2262857|P2|COMPLETED|Follow-up Phase||49
935155|NCT01425203|2262858|P1|COMPLETED|Follow-up Phase||153
935156|NCT01425203|2262856|P3|STARTED|Follow-up Phase|All participants treated in crossover arm entered follow-up.|27
935157|NCT01425203|2262857|P2|STARTED|Follow-up Phase|27 starting treatment in PBO+PR Control arm switched to Crossover arm and 2 did not enter follow-up|49
935158|NCT01425203|2262858|P1|STARTED|Follow-up Phase|6 participants who started treatment in RGT BOC + PR arm did not enter follow-up.|153
935159|NCT01425203|2262856|P3|NOT COMPLETED|Crossover Phase||6
935160|NCT01425203|2262857|P2|NOT COMPLETED|Crossover Phase||0
935161|NCT01425203|2262858|P1|NOT COMPLETED|Crossover Phase||0
935162|NCT01425203|2262856|P3|COMPLETED|Crossover Phase||21
935163|NCT01425203|2262857|P2|COMPLETED|Crossover Phase||0
935164|NCT01425203|2262858|P1|COMPLETED|Crossover Phase||0
935165|NCT01425203|2262856|P3|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|27
935166|NCT01425203|2262857|P2|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
935167|NCT01425203|2262858|P1|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
935168|NCT01425203|2262856|P3|NOT COMPLETED|Treatment Phase||0
935169|NCT01425203|2262857|P2|NOT COMPLETED|Treatment Phase||37
935170|NCT01425203|2262858|P1|NOT COMPLETED|Treatment Phase||27
935171|NCT01425203|2262856|P3|COMPLETED|Treatment Phase||0
935172|NCT01425203|2262857|P2|COMPLETED|Treatment Phase||42
935173|NCT01425203|2262858|P1|COMPLETED|Treatment Phase||132
935174|NCT01425203|2262856|P3|Treated (FAS)|Treatment Phase||0
935175|NCT01425203|2262857|P2|Treated (FAS)|Treatment Phase||78
935176|NCT01425203|2262858|P1|Treated (FAS)|Treatment Phase||159
935177|NCT01425203|2262856|P3|STARTED|Treatment Phase||0
935178|NCT01425203|2262857|P2|STARTED|Treatment Phase||79
935179|NCT01425203|2262858|P1|STARTED|Treatment Phase||159
935180|NCT01425190|2262875|P3|NOT COMPLETED|Overall Study||0
935181|NCT01425190|2262876|P2|NOT COMPLETED|Overall Study||0
935182|NCT01425190|2262877|P1|NOT COMPLETED|Overall Study||1
935183|NCT01425190|2262875|P3|COMPLETED|Overall Study||0
935184|NCT01425190|2262876|P2|COMPLETED|Overall Study||0
935185|NCT01425190|2262877|P1|COMPLETED|Overall Study||15
935186|NCT01425190|2262875|P3|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 3.|0
935187|NCT01425190|2262876|P2|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 2.|0
935188|NCT01425190|2262877|P1|STARTED|Overall Study||16
935189|NCT01424943|2262896|P2|NOT COMPLETED|Overall Study||1
935190|NCT01424943|2262897|P1|NOT COMPLETED|Overall Study||13
935191|NCT01424943|2262896|P2|COMPLETED|Overall Study||23
935192|NCT01424943|2262897|P1|COMPLETED|Overall Study||12
935193|NCT01424943|2262896|P2|STARTED|Overall Study||24
935194|NCT01424943|2262897|P1|STARTED|Overall Study||25
935195|NCT01424930|2262913|P2|NOT COMPLETED|Overall Study||14
935196|NCT01424930|2262914|P1|NOT COMPLETED|Overall Study||4
935197|NCT01424930|2262913|P2|COMPLETED|Overall Study||4
935198|NCT01424930|2262914|P1|COMPLETED|Overall Study||3
935199|NCT01424930|2262913|P2|Completed Food Safety Evaluation|Overall Study||18
935200|NCT01424930|2262914|P1|Completed Food Safety Evaluation|Overall Study||6
935201|NCT01424930|2262913|P2|STARTED|Overall Study||18
935202|NCT01424930|2262914|P1|STARTED|Overall Study||7
935203|NCT01424813|2262928|P2|NOT COMPLETED|Overall Study||2
935204|NCT01424813|2262929|P1|NOT COMPLETED|Overall Study||5
935205|NCT01424813|2262928|P2|COMPLETED|Overall Study||77
935206|NCT01424813|2262929|P1|COMPLETED|Overall Study||74
935207|NCT01424813|2262928|P2|Treated|Overall Study|Safety set and full analysis set|78
935208|NCT01424813|2262929|P1|Treated|Overall Study|Safety set and full analysis set|79
935209|NCT01424813|2262928|P2|STARTED|Overall Study||79
935210|NCT01424813|2262929|P1|STARTED|Overall Study||79
935211|NCT01424644|2262949|P2|NOT COMPLETED|Overall Study||27
935212|NCT01424644|2262950|P1|NOT COMPLETED|Overall Study||33
935213|NCT01424644|2262949|P2|COMPLETED|Overall Study||372
935214|NCT01424644|2262950|P1|COMPLETED|Overall Study||369
935215|NCT01424644|2262949|P2|STARTED|Overall Study||399
935216|NCT01424644|2262950|P1|STARTED|Overall Study||402
935217|NCT01423617|2262966|P2|NOT COMPLETED|Overall Study||1
935218|NCT01423617|2262967|P1|NOT COMPLETED|Overall Study||0
935219|NCT01423617|2262966|P2|COMPLETED|Overall Study||45
935220|NCT01423617|2262967|P1|COMPLETED|Overall Study||46
935221|NCT01423617|2262966|P2|STARTED|Overall Study||46
935222|NCT01423617|2262967|P1|STARTED|Overall Study||46
935223|NCT01424501|2262987|P6|NOT COMPLETED|Overall Study||0
935224|NCT01424501|2262988|P5|NOT COMPLETED|Overall Study||0
935225|NCT01424501|2262989|P4|NOT COMPLETED|Overall Study||0
935226|NCT01424501|2262990|P3|NOT COMPLETED|Overall Study||2
935227|NCT01424501|2262991|P2|NOT COMPLETED|Overall Study||1
935228|NCT01424501|2262992|P1|NOT COMPLETED|Overall Study||1
935229|NCT01424501|2262987|P6|COMPLETED|Overall Study||40
935230|NCT01424501|2262988|P5|COMPLETED|Overall Study||40
935231|NCT01424501|2262989|P4|COMPLETED|Overall Study||25
935232|NCT01424501|2262990|P3|COMPLETED|Overall Study||22
935233|NCT01424501|2262991|P2|COMPLETED|Overall Study||5
935234|NCT01424501|2262992|P1|COMPLETED|Overall Study||6
935235|NCT01424501|2262987|P6|STARTED|Overall Study||40
935236|NCT01424501|2262988|P5|STARTED|Overall Study||40
935237|NCT01424501|2262989|P4|STARTED|Overall Study||25
935238|NCT01424501|2262990|P3|STARTED|Overall Study||24
935239|NCT01424501|2262991|P2|STARTED|Overall Study||6
935240|NCT01424501|2262992|P1|STARTED|Overall Study||7
935241|NCT01424306|2263156|P6|NOT COMPLETED|Overall Study||0
935242|NCT01424306|2263157|P5|NOT COMPLETED|Overall Study||1
935243|NCT01424306|2263158|P4|NOT COMPLETED|Overall Study||0
935244|NCT01424306|2263159|P3|NOT COMPLETED|Overall Study||0
935245|NCT01424306|2263160|P2|NOT COMPLETED|Overall Study||0
935246|NCT01424306|2263161|P1|NOT COMPLETED|Overall Study||0
935247|NCT01424306|2263156|P6|COMPLETED|Overall Study||6
935248|NCT01424306|2263157|P5|COMPLETED|Overall Study||4
935249|NCT01424306|2263158|P4|COMPLETED|Overall Study||3
935250|NCT01424306|2263159|P3|COMPLETED|Overall Study||3
935251|NCT01424306|2263160|P2|COMPLETED|Overall Study||4
935252|NCT01424306|2263161|P1|COMPLETED|Overall Study||4
935253|NCT01424306|2263156|P6|STARTED|Overall Study||6
935254|NCT01424306|2263157|P5|STARTED|Overall Study||5
935255|NCT01424306|2263158|P4|STARTED|Overall Study||3
935256|NCT01424306|2263159|P3|STARTED|Overall Study||3
935257|NCT01424306|2263160|P2|STARTED|Overall Study||4
935258|NCT01424306|2263161|P1|STARTED|Overall Study||4
935259|NCT01424228|2263210|P2|NOT COMPLETED|Overall Study||47
935260|NCT01424228|2263211|P1|NOT COMPLETED|Overall Study||56
935261|NCT01424228|2263210|P2|COMPLETED|Overall Study||135
935262|NCT01424228|2263211|P1|COMPLETED|Overall Study||126
935263|NCT01424228|2263210|P2|STARTED|Overall Study||182
935264|NCT01424228|2263211|P1|STARTED|Overall Study||182
935265|NCT01424189|2263251|P2|NOT COMPLETED|Overall Study||6
935266|NCT01424189|2263252|P1|NOT COMPLETED|Overall Study||13
935267|NCT01424189|2263251|P2|COMPLETED|Overall Study||182
935268|NCT01424189|2263252|P1|COMPLETED|Overall Study||373
935269|NCT01424189|2263251|P2|STARTED|Overall Study||188
935270|NCT01424189|2263252|P1|STARTED|Overall Study||386
935271|NCT01424072|2263267|P3|NOT COMPLETED|Overall Study||0
935272|NCT01424072|2263268|P2|NOT COMPLETED|Overall Study||0
935273|NCT01424072|2263269|P1|NOT COMPLETED|Overall Study||0
935274|NCT01424072|2263267|P3|COMPLETED|Overall Study||22
935275|NCT01424072|2263268|P2|COMPLETED|Overall Study||26
935276|NCT01424072|2263269|P1|COMPLETED|Overall Study||27
935277|NCT01424072|2263267|P3|STARTED|Overall Study||22
935278|NCT01424072|2263268|P2|STARTED|Overall Study||26
935279|NCT01424072|2263269|P1|STARTED|Overall Study||27
935280|NCT01424033|2263286|P1|NOT COMPLETED|Overall Study||5
935281|NCT01424033|2263286|P1|COMPLETED|Overall Study||0
935282|NCT01424033|2263286|P1|STARTED|Overall Study||5
935283|NCT01423916|2263293|P3|NOT COMPLETED|Overall Study||7
935284|NCT01423916|2263294|P2|NOT COMPLETED|Overall Study||20
935285|NCT01423916|2263295|P1|NOT COMPLETED|Overall Study||11
935286|NCT01423916|2263293|P3|COMPLETED|Overall Study||64
935287|NCT01423916|2263294|P2|COMPLETED|Overall Study||53
935288|NCT01423916|2263295|P1|COMPLETED|Overall Study||63
935289|NCT01423916|2263293|P3|STARTED|Overall Study||71
935290|NCT01423916|2263294|P2|STARTED|Overall Study||73
935291|NCT01423916|2263295|P1|STARTED|Overall Study||74
935292|NCT01423773|2263349|P2|NOT COMPLETED|Period 2, 2 Days||0
935293|NCT01423773|2263350|P1|NOT COMPLETED|Period 2, 2 Days||0
935294|NCT01423773|2263349|P2|COMPLETED|Period 2, 2 Days||10
935295|NCT01423773|2263350|P1|COMPLETED|Period 2, 2 Days||10
935296|NCT01423773|2263349|P2|STARTED|Period 2, 2 Days||10
935297|NCT01423773|2263350|P1|STARTED|Period 2, 2 Days||10
935298|NCT01423773|2263349|P2|NOT COMPLETED|Period One, 2 Days||0
935299|NCT01423773|2263350|P1|NOT COMPLETED|Period One, 2 Days||0
935300|NCT01423773|2263349|P2|COMPLETED|Period One, 2 Days||10
935301|NCT01423773|2263350|P1|COMPLETED|Period One, 2 Days||10
935302|NCT01423773|2263349|P2|STARTED|Period One, 2 Days||10
935303|NCT01423773|2263350|P1|STARTED|Period One, 2 Days||10
935304|NCT01423760|2263358|P2|NOT COMPLETED|Overall Study||0
935305|NCT01423760|2263359|P1|NOT COMPLETED|Overall Study||0
935306|NCT01423760|2263358|P2|COMPLETED|Overall Study||13
935307|NCT01423760|2263359|P1|COMPLETED|Overall Study||14
935308|NCT01423760|2263358|P2|Safety Analysis Set|Overall Study||8
935309|NCT01423760|2263359|P1|Safety Analysis Set|Overall Study||12
935310|NCT01423760|2263358|P2|Number of Non-treatment Subjects|Overall Study||5
935311|NCT01423760|2263359|P1|Number of Non-treatment Subjects|Overall Study||2
935312|NCT01423760|2263358|P2|Number of Tecemotide Subjects|Overall Study||8
935313|NCT01423760|2263359|P1|Number of Tecemotide Subjects|Overall Study||12
935314|NCT01423760|2263358|P2|STARTED|Overall Study||13
935315|NCT01423760|2263359|P1|STARTED|Overall Study||14
935316|NCT01423604|2263370|P2|NOT COMPLETED|Randomized||63
935317|NCT01423604|2263371|P1|NOT COMPLETED|Randomized||63
935318|NCT01423604|2263370|P2|COMPLETED|Randomized||0
935413|NCT01422850|2263515|P1|Week 9 - Second Treatment|Overall Study||20
935319|NCT01423604|2263371|P1|COMPLETED|Randomized|As of 07August2015, 1 subject was receiving treatment in the randomized portion.|1
935320|NCT01423604|2263370|P2|STARTED|Randomized||63
935321|NCT01423604|2263371|P1|STARTED|Randomized||64
935322|NCT01423604|2263370|P2|NOT COMPLETED|Safety Run-In||0
935323|NCT01423604|2263371|P1|NOT COMPLETED|Safety Run-In||9
935324|NCT01423604|2263370|P2|COMPLETED|Safety Run-In||0
935325|NCT01423604|2263371|P1|COMPLETED|Safety Run-In||0
935326|NCT01423604|2263370|P2|STARTED|Safety Run-In||0
935327|NCT01423604|2263371|P1|STARTED|Safety Run-In||9
935331|NCT01423162|2263399|P2|NOT COMPLETED|Overall Study||0
935332|NCT01423162|2263400|P1|NOT COMPLETED|Overall Study||0
935333|NCT01423162|2263399|P2|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|9
935334|NCT01423162|2263400|P1|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|11
935335|NCT01423162|2263399|P2|STARTED|Overall Study||9
935336|NCT01423162|2263400|P1|STARTED|Overall Study||11
935337|NCT01423084|2263408|P2|NOT COMPLETED|Overall Study||4
935338|NCT01423084|2263409|P1|NOT COMPLETED|Overall Study||2
935339|NCT01423084|2263408|P2|COMPLETED|Overall Study||170
935340|NCT01423084|2263409|P1|COMPLETED|Overall Study||168
935341|NCT01423084|2263408|P2|STARTED|Overall Study||174
935342|NCT01423084|2263409|P1|STARTED|Overall Study||170
935343|NCT01422915|2263439|P1|NOT COMPLETED|Overall Study||1
935344|NCT01422915|2263439|P1|COMPLETED|Overall Study||3
935345|NCT01422915|2263439|P1|STARTED|Overall Study|1 subject with abnormal liver chemistries removed during the first period.|4
935346|NCT01422889|2263444|P1|NOT COMPLETED|Overall Study||9
935347|NCT01422889|2263444|P1|COMPLETED|Overall Study|9 subjects did not receive a study stent therefore 1111 subjects were eligible for follow up.|1111
935348|NCT01422889|2263444|P1|STARTED|Overall Study||1120
935349|NCT01422876|2263459|P10|NOT COMPLETED|Week 52||17
935350|NCT01422876|2263460|P9|NOT COMPLETED|Week 52||21
935351|NCT01422876|2263461|P8|NOT COMPLETED|Week 52||23
935352|NCT01422876|2263462|P7|NOT COMPLETED|Week 52||16
935353|NCT01422876|2263463|P6|NOT COMPLETED|Week 52||17
935354|NCT01422876|2263464|P5|NOT COMPLETED|Week 52||15
935355|NCT01422876|2263465|P4|NOT COMPLETED|Week 52||18
935356|NCT01422876|2263466|P3|NOT COMPLETED|Week 52||13
935357|NCT01422876|2263467|P2|NOT COMPLETED|Week 52||10
935358|NCT01422876|2263468|P1|NOT COMPLETED|Week 52||12
935359|NCT01422876|2263459|P10|COMPLETED|Week 52||118
935360|NCT01422876|2263460|P9|COMPLETED|Week 52||113
935361|NCT01422876|2263461|P8|COMPLETED|Week 52||112
935362|NCT01422876|2263462|P7|COMPLETED|Week 52||120
935363|NCT01422876|2263463|P6|COMPLETED|Week 52||120
935364|NCT01422876|2263464|P5|COMPLETED|Week 52||117
935365|NCT01422876|2263465|P4|COMPLETED|Week 52||122
935366|NCT01422876|2263466|P3|COMPLETED|Week 52||128
935367|NCT01422876|2263467|P2|COMPLETED|Week 52||126
935368|NCT01422876|2263468|P1|COMPLETED|Week 52||125
935369|NCT01422876|2263459|P10|STARTED|Week 52||135
935370|NCT01422876|2263460|P9|STARTED|Week 52||134
935371|NCT01422876|2263461|P8|STARTED|Week 52||135
935372|NCT01422876|2263462|P7|STARTED|Week 52||136
935373|NCT01422876|2263463|P6|STARTED|Week 52||137
935374|NCT01422876|2263464|P5|STARTED|Week 52||132
935375|NCT01422876|2263465|P4|STARTED|Week 52||140
935376|NCT01422876|2263466|P3|STARTED|Week 52||141
935377|NCT01422876|2263467|P2|STARTED|Week 52||136
935378|NCT01422876|2263468|P1|STARTED|Week 52||137
935379|NCT01422876|2263459|P10|NOT COMPLETED|Week 24||10
935380|NCT01422876|2263460|P9|NOT COMPLETED|Week 24||6
935381|NCT01422876|2263461|P8|NOT COMPLETED|Week 24||7
935382|NCT01422876|2263462|P7|NOT COMPLETED|Week 24||6
935383|NCT01422876|2263463|P6|NOT COMPLETED|Week 24||6
935384|NCT01422876|2263464|P5|NOT COMPLETED|Week 24||7
935385|NCT01422876|2263465|P4|NOT COMPLETED|Week 24||8
935386|NCT01422876|2263466|P3|NOT COMPLETED|Week 24||5
935387|NCT01422876|2263467|P2|NOT COMPLETED|Week 24||3
935388|NCT01422876|2263468|P1|NOT COMPLETED|Week 24||6
935389|NCT01422876|2263459|P10|COMPLETED|Week 24||125
935390|NCT01422876|2263460|P9|COMPLETED|Week 24||128
935391|NCT01422876|2263461|P8|COMPLETED|Week 24||128
935392|NCT01422876|2263462|P7|COMPLETED|Week 24||130
935393|NCT01422876|2263463|P6|COMPLETED|Week 24||131
935394|NCT01422876|2263464|P5|COMPLETED|Week 24||125
935395|NCT01422876|2263465|P4|COMPLETED|Week 24||132
935396|NCT01422876|2263466|P3|COMPLETED|Week 24||136
935397|NCT01422876|2263467|P2|COMPLETED|Week 24||133
935398|NCT01422876|2263468|P1|COMPLETED|Week 24||131
935399|NCT01422876|2263459|P10|STARTED|Week 24||135
935400|NCT01422876|2263460|P9|STARTED|Week 24||134
935401|NCT01422876|2263461|P8|STARTED|Week 24||135
935402|NCT01422876|2263462|P7|STARTED|Week 24||136
935403|NCT01422876|2263463|P6|STARTED|Week 24||137
935404|NCT01422876|2263464|P5|STARTED|Week 24||132
935405|NCT01422876|2263465|P4|STARTED|Week 24||140
935406|NCT01422876|2263466|P3|STARTED|Week 24||141
935407|NCT01422876|2263467|P2|STARTED|Week 24||136
935408|NCT01422876|2263468|P1|STARTED|Week 24||137
935409|NCT01422850|2263515|P1|NOT COMPLETED|Overall Study||3
935410|NCT01422850|2263515|P1|COMPLETED|Overall Study||18
935411|NCT01422850|2263515|P1|Week 15|Overall Study|One patient withdrawn by PI due to increased PSA. Started bicalutamide treatment.|18
935412|NCT01422850|2263515|P1|Week 14 - Third Treatment|Overall Study|One patient withdrawn by PI and referred to external radiotherapy due to progressive disease.|19
935414|NCT01422850|2263515|P1|Week 5|Overall Study|One patient withdrawn by PI due to progressive disease|20
935415|NCT01422850|2263515|P1|Week 4 - First Treatment|Overall Study||21
935416|NCT01422850|2263515|P1|STARTED|Overall Study||21
935417|NCT01422824|2263521|P1|NOT COMPLETED|Overall Study||38
935418|NCT01422824|2263521|P1|COMPLETED|Overall Study||147
935419|NCT01422824|2263521|P1|Treated|Overall Study||184
935420|NCT01422824|2263521|P1|STARTED|Overall Study||185
935421|NCT01422720|2263526|P1|NOT COMPLETED|Overall Study||22
935422|NCT01422720|2263526|P1|COMPLETED|Overall Study||50
935423|NCT01422720|2263526|P1|Per-Protocol Set (PPS)|Overall Study||55
935424|NCT01422720|2263526|P1|Full Analysis Set (FAS)|Overall Study||71
935425|NCT01422720|2263526|P1|Safety Set|Overall Study||72
935426|NCT01422720|2263526|P1|STARTED|Overall Study||72
935427|NCT01422538|2263537|P3|NOT COMPLETED|Overall Study||2
935428|NCT01422538|2263538|P2|NOT COMPLETED|Overall Study||2
935429|NCT01422538|2263539|P1|NOT COMPLETED|Overall Study||0
935430|NCT01422538|2263537|P3|COMPLETED|Overall Study||8
935431|NCT01422538|2263538|P2|COMPLETED|Overall Study||8
935432|NCT01422538|2263539|P1|COMPLETED|Overall Study||10
935433|NCT01422538|2263537|P3|STARTED|Overall Study||10
935434|NCT01422538|2263538|P2|STARTED|Overall Study||10
935435|NCT01422538|2263539|P1|STARTED|Overall Study||10
935436|NCT01422434|2263564|P3|NOT COMPLETED|Overall Study||6
935437|NCT01422434|2263565|P2|NOT COMPLETED|Overall Study||5
935438|NCT01422434|2263566|P1|NOT COMPLETED|Overall Study||11
935439|NCT01422434|2263564|P3|COMPLETED|Overall Study||217
935440|NCT01422434|2263565|P2|COMPLETED|Overall Study||221
935441|NCT01422434|2263566|P1|COMPLETED|Overall Study||216
935442|NCT01422434|2263564|P3|STARTED|Overall Study||223
935443|NCT01422434|2263565|P2|STARTED|Overall Study||226
935444|NCT01422434|2263566|P1|STARTED|Overall Study||227
935448|NCT01422382|2263612|P1|NOT COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||1
935449|NCT01422382|2263612|P1|COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||27
935450|NCT01422382|2263612|P1|STARTED|NK-104 4mg QD and Diltiazem 240 mg QD||28
935451|NCT01422382|2263612|P1|NOT COMPLETED|Diltiazem 240 mg QD||0
935452|NCT01422382|2263612|P1|COMPLETED|Diltiazem 240 mg QD||28
935453|NCT01422382|2263612|P1|STARTED|Diltiazem 240 mg QD||28
935454|NCT01422382|2263612|P1|NOT COMPLETED|NK-104 4mg Once Daily (QD)||0
935455|NCT01422382|2263612|P1|COMPLETED|NK-104 4mg Once Daily (QD)||28
935456|NCT01422382|2263612|P1|STARTED|NK-104 4mg Once Daily (QD)||28
935457|NCT01422369|2263617|P1|NOT COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||1
935458|NCT01422369|2263617|P1|COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||27
935459|NCT01422369|2263617|P1|STARTED|NK-104 4mg QD & Prezista 800mg/100mg QD||28
935460|NCT01422369|2263617|P1|NOT COMPLETED|Prezista 800mg/100mg QD||0
935461|NCT01422369|2263617|P1|COMPLETED|Prezista 800mg/100mg QD||28
935462|NCT01422369|2263617|P1|STARTED|Prezista 800mg/100mg QD||28
935463|NCT01422369|2263617|P1|NOT COMPLETED|NK-104 4mg QD||0
935464|NCT01422369|2263617|P1|COMPLETED|NK-104 4mg QD||28
935465|NCT01422369|2263617|P1|STARTED|NK-104 4mg QD||28
935466|NCT01422356|2263622|P1|NOT COMPLETED|Overall Study||31
935467|NCT01422356|2263622|P1|COMPLETED|Overall Study||169
935468|NCT01422356|2263622|P1|STARTED|Overall Study||200
935469|NCT01422304|2263628|P2|NOT COMPLETED|Overall Study||37
935470|NCT01422304|2263629|P1|NOT COMPLETED|Overall Study||24
935471|NCT01422304|2263628|P2|COMPLETED|Overall Study||563
935472|NCT01422304|2263629|P1|COMPLETED|Overall Study||574
935473|NCT01422304|2263628|P2|Treated|Overall Study|1 given sugammadex; thus All Participants as Treated (APaT) Ns are 596 Sugammadex, 588 Usual Care|589
935474|NCT01422304|2263629|P1|Treated|Overall Study||595
935475|NCT01422304|2263628|P2|STARTED|Overall Study|Randomized|600
935476|NCT01422304|2263629|P1|STARTED|Overall Study|Randomized|598
935477|NCT01422239|2263661|P2|NOT COMPLETED|Overall Study||3
935478|NCT01422239|2263662|P1|NOT COMPLETED|Overall Study||4
935479|NCT01422239|2263661|P2|COMPLETED|Overall Study||3
935480|NCT01422239|2263662|P1|COMPLETED|Overall Study||10
935481|NCT01422239|2263661|P2|STARTED|Overall Study||6
935482|NCT01422239|2263662|P1|STARTED|Overall Study||14
935483|NCT01422226|2263674|P2|NOT COMPLETED|Overall Study||0
935484|NCT01422226|2263675|P1|NOT COMPLETED|Overall Study||0
935485|NCT01422226|2263674|P2|COMPLETED|Overall Study||2
935486|NCT01422226|2263675|P1|COMPLETED|Overall Study||1
935487|NCT01422226|2263674|P2|STARTED|Overall Study||2
935488|NCT01422226|2263675|P1|STARTED|Overall Study||1
935489|NCT01422213|2263684|P3|NOT COMPLETED|Overall Study||29
935490|NCT01422213|2263685|P2|NOT COMPLETED|Overall Study||22
935491|NCT01422213|2263686|P1|NOT COMPLETED|Overall Study||33
935492|NCT01422213|2263684|P3|COMPLETED|Overall Study||178
935493|NCT01422213|2263685|P2|COMPLETED|Overall Study||173
935494|NCT01422213|2263686|P1|COMPLETED|Overall Study||163
935495|NCT01422213|2263684|P3|STARTED|Overall Study||207
935496|NCT01422213|2263685|P2|STARTED|Overall Study||195
935497|NCT01422213|2263686|P1|STARTED|Overall Study||196
935498|NCT01422187|2263747|P3|NOT COMPLETED|Overall Study||0
935499|NCT01422187|2263748|P2|NOT COMPLETED|Overall Study||1
935500|NCT01422187|2263749|P1|NOT COMPLETED|Overall Study||1
935501|NCT01422187|2263747|P3|COMPLETED|Overall Study||2
935502|NCT01422187|2263748|P2|COMPLETED|Overall Study||8
935503|NCT01422187|2263749|P1|COMPLETED|Overall Study||7
935504|NCT01422187|2263747|P3|STARTED|Overall Study||2
935505|NCT01422187|2263748|P2|STARTED|Overall Study||9
935506|NCT01422187|2263749|P1|STARTED|Overall Study||8
935507|NCT01422070|2263768|P2|NOT COMPLETED|Overall Study||0
935508|NCT01422070|2263769|P1|NOT COMPLETED|Overall Study||0
935509|NCT01422070|2263768|P2|COMPLETED|Overall Study||803
935510|NCT01422070|2263769|P1|COMPLETED|Overall Study||5031
935511|NCT01422070|2263768|P2|STARTED|Overall Study|Number of patients admitted to 27 intensive care units.|803
935512|NCT01422070|2263769|P1|STARTED|Overall Study|Number of patients admitted to 140 intensive care units|5031
935513|NCT01421719|2263780|P1|NOT COMPLETED|Overall Study||4
935514|NCT01421719|2263780|P1|COMPLETED|Overall Study||16
935515|NCT01421719|2263780|P1|STARTED|Overall Study||20
935516|NCT01421667|2263789|P4|NOT COMPLETED|Overall Study||1
935517|NCT01421667|2263790|P3|NOT COMPLETED|Overall Study||2
935518|NCT01421667|2263791|P2|NOT COMPLETED|Overall Study||2
935519|NCT01421667|2263792|P1|NOT COMPLETED|Overall Study||0
935520|NCT01421667|2263789|P4|COMPLETED|Overall Study|Completed per protocol due to death [7] or study termination by sponsor [8]|15
935521|NCT01421667|2263790|P3|COMPLETED|Overall Study|Completed per protocol due to death [33] or study termination by sponsor [18]|51
935522|NCT01421667|2263791|P2|COMPLETED|Overall Study|Completed per protocol due to death [45] or study termination by sponsor [21]|66
935523|NCT01421667|2263792|P1|COMPLETED|Overall Study|Completed per protocol due to death [24] or study termination by sponsor [11]|35
935524|NCT01421667|2263789|P4|STARTED|Overall Study||16
935525|NCT01421667|2263790|P3|STARTED|Overall Study||53
935526|NCT01421667|2263791|P2|STARTED|Overall Study||68
935527|NCT01421667|2263792|P1|STARTED|Overall Study||35
935528|NCT01421654|2263844|P2|NOT COMPLETED|Overall Study||0
935529|NCT01421654|2263845|P1|NOT COMPLETED|Overall Study||0
935530|NCT01421654|2263844|P2|COMPLETED|Overall Study|10 subjects completed study, but 1 subject was found to not meet IEC at the end; data was not used.|9
935531|NCT01421654|2263845|P1|COMPLETED|Overall Study||11
935532|NCT01421654|2263844|P2|STARTED|Overall Study||9
935533|NCT01421654|2263845|P1|STARTED|Overall Study||11
935534|NCT01421641|2263853|P2|NOT COMPLETED|Overall Study||2
935535|NCT01421641|2263854|P1|NOT COMPLETED|Overall Study||2
935536|NCT01421641|2263853|P2|COMPLETED|Overall Study||35
935537|NCT01421641|2263854|P1|COMPLETED|Overall Study||35
935538|NCT01421641|2263853|P2|STARTED|Overall Study||37
935539|NCT01421641|2263854|P1|STARTED|Overall Study||37
935540|NCT01421589|2263864|P1|NOT COMPLETED|Overall Study||0
935541|NCT01421589|2263864|P1|COMPLETED|Overall Study||15
935542|NCT01421589|2263864|P1|STARTED|Overall Study||15
935543|NCT01421511|2263876|P2|NOT COMPLETED|Overall Study||28
935544|NCT01421511|2263877|P1|NOT COMPLETED|Overall Study||19
935545|NCT01421511|2263876|P2|COMPLETED|Overall Study||306
935546|NCT01421511|2263877|P1|COMPLETED|Overall Study||313
935547|NCT01421511|2263876|P2|STARTED|Overall Study||334
935548|NCT01421511|2263877|P1|STARTED|Overall Study||332
935549|NCT01421498|2263899|P2|NOT COMPLETED|Overall Study||11
935550|NCT01421498|2263900|P1|NOT COMPLETED|Overall Study||12
935551|NCT01421498|2263899|P2|COMPLETED|Overall Study||284
935552|NCT01421498|2263900|P1|COMPLETED|Overall Study||281
935553|NCT01421498|2263899|P2|STARTED|Overall Study||295
935554|NCT01421498|2263900|P1|STARTED|Overall Study||293
935555|NCT01421472|2263912|P4|NOT COMPLETED|Overall Study||0
935556|NCT01421472|2263913|P3|NOT COMPLETED|Overall Study||0
935557|NCT01421472|2263914|P2|NOT COMPLETED|Overall Study||0
935558|NCT01421472|2263915|P1|NOT COMPLETED|Overall Study||0
935559|NCT01421472|2263912|P4|COMPLETED|Overall Study||32
935560|NCT01421472|2263913|P3|COMPLETED|Overall Study||64
935561|NCT01421472|2263914|P2|COMPLETED|Overall Study||33
935562|NCT01421472|2263915|P1|COMPLETED|Overall Study||67
935563|NCT01421472|2263912|P4|STARTED|Overall Study||32
935564|NCT01421472|2263913|P3|STARTED|Overall Study||64
935565|NCT01421472|2263914|P2|STARTED|Overall Study||33
935566|NCT01421472|2263915|P1|STARTED|Overall Study||67
935567|NCT01421459|2263927|P2|NOT COMPLETED|Overall Study||52
935568|NCT01421459|2263928|P1|NOT COMPLETED|Overall Study||45
935569|NCT01421459|2263927|P2|COMPLETED|Overall Study||328
935570|NCT01421459|2263928|P1|COMPLETED|Overall Study||334
935571|NCT01421459|2263927|P2|Received at Least 1 Dose of Study Drug|Overall Study||380
935572|NCT01421459|2263928|P1|Received at Least 1 Dose of Study Drug|Overall Study||376
935573|NCT01421459|2263927|P2|STARTED|Overall Study||380
935574|NCT01421459|2263928|P1|STARTED|Overall Study||379
935575|NCT01421355|2263962|P1|NOT COMPLETED|Overall Study||6
935576|NCT01421355|2263962|P1|COMPLETED|Overall Study||15
935577|NCT01421355|2263962|P1|STARTED|Overall Study||21
935578|NCT01421303|2263966|P1|NOT COMPLETED|Overall Study||22
935579|NCT01421303|2263966|P1|COMPLETED|Overall Study||58
935580|NCT01421303|2263966|P1|STARTED|Overall Study||80
935581|NCT01421277|2263993|P2|NOT COMPLETED|Overall Study||92
935582|NCT01421277|2263994|P1|NOT COMPLETED|Overall Study||0
935583|NCT01421277|2263993|P2|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|99
935584|NCT01421277|2263994|P1|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|25
935585|NCT01421277|2263993|P2|STARTED|Overall Study||191
935586|NCT01421277|2263994|P1|STARTED|Overall Study||25
935587|NCT01421147|2264006|P2|NOT COMPLETED|Extension Period||11
935588|NCT01421147|2264007|P1|NOT COMPLETED|Extension Period||8
935589|NCT01421147|2264006|P2|COMPLETED|Extension Period||245
935590|NCT01421147|2264007|P1|COMPLETED|Extension Period||245
935591|NCT01421147|2264006|P2|STARTED|Extension Period||256
935592|NCT01421147|2264007|P1|STARTED|Extension Period||253
935593|NCT01421147|2264006|P2|NOT COMPLETED|Treatment Period||11
935594|NCT01421147|2264007|P1|NOT COMPLETED|Treatment Period||16
935595|NCT01421147|2264006|P2|COMPLETED|Treatment Period||256
935596|NCT01421147|2264007|P1|COMPLETED|Treatment Period||253
935597|NCT01421147|2264006|P2|Received at Least 1 Dose of Study Drug|Treatment Period||267
935598|NCT01421147|2264007|P1|Received at Least 1 Dose of Study Drug|Treatment Period||268
935599|NCT01421147|2264006|P2|STARTED|Treatment Period||267
935600|NCT01421147|2264007|P1|STARTED|Treatment Period||269
935601|NCT01421134|2264039|P2|NOT COMPLETED|Overall Study||15
935602|NCT01421134|2264040|P1|NOT COMPLETED|Overall Study||7
935603|NCT01421134|2264039|P2|COMPLETED|Overall Study||87
935604|NCT01421134|2264040|P1|COMPLETED|Overall Study||102
935605|NCT01421134|2264039|P2|STARTED|Overall Study||102
935606|NCT01421134|2264040|P1|STARTED|Overall Study||109
935613|NCT01420848|2264078|P3|NOT COMPLETED|Overall Study||0
935614|NCT01420848|2264079|P2|NOT COMPLETED|Overall Study||0
935615|NCT01420848|2264080|P1|NOT COMPLETED|Overall Study||0
935616|NCT01420848|2264078|P3|COMPLETED|Overall Study||22
935617|NCT01420848|2264079|P2|COMPLETED|Overall Study||25
935618|NCT01420848|2264080|P1|COMPLETED|Overall Study||24
935619|NCT01420848|2264078|P3|STARTED|Overall Study||22
935620|NCT01420848|2264079|P2|STARTED|Overall Study||25
935621|NCT01420848|2264080|P1|STARTED|Overall Study||24
935622|NCT01420289|2264093|P2|NOT COMPLETED|Overall Study||0
935623|NCT01420289|2264094|P1|NOT COMPLETED|Overall Study||0
935624|NCT01420289|2264093|P2|COMPLETED|Overall Study||16
935625|NCT01420289|2264094|P1|COMPLETED|Overall Study||18
935626|NCT01420289|2264093|P2|STARTED|Overall Study||16
935627|NCT01420289|2264094|P1|STARTED|Overall Study||18
935628|NCT01420146|2264106|P1|NOT COMPLETED|Overall Study||0
935629|NCT01420146|2264106|P1|COMPLETED|Overall Study||20
935630|NCT01420146|2264106|P1|STARTED|Overall Study||20
935631|NCT01420081|2264119|P9|NOT COMPLETED|Overall Study||3
935632|NCT01420081|2264120|P8|NOT COMPLETED|Overall Study||3
935633|NCT01420081|2264121|P7|NOT COMPLETED|Overall Study||3
935634|NCT01420081|2264122|P6|NOT COMPLETED|Overall Study||20
935635|NCT01420081|2264123|P5|NOT COMPLETED|Overall Study||20
935636|NCT01420081|2264124|P4|NOT COMPLETED|Overall Study||3
935637|NCT01420081|2264125|P3|NOT COMPLETED|Overall Study||11
935638|NCT01420081|2264126|P2|NOT COMPLETED|Overall Study||1
935639|NCT01420081|2264127|P1|NOT COMPLETED|Overall Study||3
935640|NCT01420081|2264119|P9|COMPLETED|Overall Study||0
935641|NCT01420081|2264120|P8|COMPLETED|Overall Study||0
935642|NCT01420081|2264121|P7|COMPLETED|Overall Study||0
935643|NCT01420081|2264122|P6|COMPLETED|Overall Study||0
935644|NCT01420081|2264123|P5|COMPLETED|Overall Study||0
935645|NCT01420081|2264124|P4|COMPLETED|Overall Study||0
935646|NCT01420081|2264125|P3|COMPLETED|Overall Study||0
935647|NCT01420081|2264126|P2|COMPLETED|Overall Study||0
935648|NCT01420081|2264127|P1|COMPLETED|Overall Study||0
935649|NCT01420081|2264119|P9|STARTED|Overall Study||3
935650|NCT01420081|2264120|P8|STARTED|Overall Study||3
935651|NCT01420081|2264121|P7|STARTED|Overall Study||3
935652|NCT01420081|2264122|P6|STARTED|Overall Study||20
935653|NCT01420081|2264123|P5|STARTED|Overall Study||20
935654|NCT01420081|2264124|P4|STARTED|Overall Study||3
935655|NCT01420081|2264125|P3|STARTED|Overall Study||11
935656|NCT01420081|2264126|P2|STARTED|Overall Study||1
935657|NCT01420081|2264127|P1|STARTED|Overall Study||3
935658|NCT01419977|2264208|P2|NOT COMPLETED|Overall Study||0
935659|NCT01419977|2264209|P1|NOT COMPLETED|Overall Study||0
935660|NCT01419977|2264208|P2|COMPLETED|Overall Study||13
935661|NCT01419977|2264209|P1|COMPLETED|Overall Study||16
935662|NCT01419977|2264208|P2|STARTED|Overall Study||13
935663|NCT01419977|2264209|P1|STARTED|Overall Study||16
935664|NCT01419795|2264223|P2|NOT COMPLETED|Overall Study||0
935665|NCT01419795|2264224|P1|NOT COMPLETED|Overall Study||0
935666|NCT01419795|2264223|P2|COMPLETED|Overall Study||0
935667|NCT01419795|2264224|P1|COMPLETED|Overall Study||3
935668|NCT01419795|2264223|P2|STARTED|Overall Study||0
935669|NCT01419795|2264224|P1|STARTED|Overall Study||3
935670|NCT01419769|2264246|P1|NOT COMPLETED|Overall Study||4
935671|NCT01419769|2264246|P1|COMPLETED|Overall Study||29
935672|NCT01419769|2264246|P1|STARTED|Overall Study||33
935673|NCT01419639|2264259|P1|NOT COMPLETED|Overall Study||1
935674|NCT01419639|2264259|P1|COMPLETED|Overall Study||9
935675|NCT01419639|2264259|P1|STARTED|Overall Study||10
935676|NCT01419314|2264267|P2|NOT COMPLETED|Follow-up at Week 6 of the Trial||2
935677|NCT01419314|2264268|P1|NOT COMPLETED|Follow-up at Week 6 of the Trial||1
935678|NCT01419314|2264267|P2|COMPLETED|Follow-up at Week 6 of the Trial||19
935679|NCT01419314|2264268|P1|COMPLETED|Follow-up at Week 6 of the Trial|2 people who missed the first follow-up, returned for the final follow-up at week 6 (n=18).|16
935680|NCT01419314|2264267|P2|STARTED|Follow-up at Week 6 of the Trial|2 participants did not return for their final follow-up|21
935681|NCT01419314|2264268|P1|STARTED|Follow-up at Week 6 of the Trial||17
935682|NCT01419314|2264267|P2|NOT COMPLETED|Follow-up at Week 3 of the Trial||1
935683|NCT01419314|2264268|P1|NOT COMPLETED|Follow-up at Week 3 of the Trial||6
935684|NCT01419314|2264267|P2|COMPLETED|Follow-up at Week 3 of the Trial||21
935685|NCT01419314|2264268|P1|COMPLETED|Follow-up at Week 3 of the Trial||17
935686|NCT01419314|2264267|P2|STARTED|Follow-up at Week 3 of the Trial|one participant failed to return for the 3 week follow-up|22
935687|NCT01419314|2264268|P1|STARTED|Follow-up at Week 3 of the Trial|3 participants discontinued the trial, 3 failed to return for additional follow-ups.|23
935688|NCT01419314|2264267|P2|NOT COMPLETED|Start of Study||0
935689|NCT01419314|2264268|P1|NOT COMPLETED|Start of Study||0
935690|NCT01419314|2264267|P2|COMPLETED|Start of Study||22
935691|NCT01419314|2264268|P1|COMPLETED|Start of Study||23
935692|NCT01419314|2264267|P2|STARTED|Start of Study|No comfort issues reported.|22
935693|NCT01419314|2264268|P1|STARTED|Start of Study|minor comfort issues were reported within the first 2 weeks of the trial|23
935694|NCT01419275|2264288|P1|NOT COMPLETED|Overall Study||0
935695|NCT01419275|2264288|P1|COMPLETED|Overall Study||126
935696|NCT01419275|2264288|P1|STARTED|Overall Study||126
935697|NCT01419249|2264294|P2|NOT COMPLETED|Overall Study||0
935698|NCT01419249|2264295|P1|NOT COMPLETED|Overall Study||0
935699|NCT01419249|2264294|P2|COMPLETED|Overall Study||140
935700|NCT01419249|2264295|P1|COMPLETED|Overall Study||318
935701|NCT01419249|2264294|P2|STARTED|Overall Study||140
935702|NCT01419249|2264295|P1|STARTED|Overall Study||318
935703|NCT01419236|2264309|P2|NOT COMPLETED|Overall Study||5
935704|NCT01419236|2264310|P1|NOT COMPLETED|Overall Study||5
935705|NCT01419236|2264309|P2|COMPLETED|Overall Study||35
935706|NCT01419236|2264310|P1|COMPLETED|Overall Study||31
935707|NCT01419236|2264309|P2|Received at Least 1 Dose of Study Drug|Overall Study||39
935708|NCT01419236|2264310|P1|Received at Least 1 Dose of Study Drug|Overall Study||35
935709|NCT01419236|2264309|P2|STARTED|Overall Study||40
935710|NCT01419236|2264310|P1|STARTED|Overall Study||36
935711|NCT01419197|2264334|P2|NOT COMPLETED|Overall Study||198
935712|NCT01419197|2264335|P1|NOT COMPLETED|Overall Study||404
935713|NCT01419197|2264334|P2|COMPLETED|Overall Study||0
935714|NCT01419197|2264335|P1|COMPLETED|Overall Study||0
935715|NCT01419197|2264334|P2|Switched to Trastuzumab Emtansine|Overall Study||94
935716|NCT01419197|2264335|P1|Switched to Trastuzumab Emtansine|Overall Study||0
935717|NCT01419197|2264334|P2|STARTED|Overall Study||198
935718|NCT01419197|2264335|P1|STARTED|Overall Study||404
935719|NCT01419184|2264360|P2|NOT COMPLETED|Overall Study||15
935720|NCT01419184|2264361|P1|NOT COMPLETED|Overall Study||10
935721|NCT01419184|2264360|P2|COMPLETED|Overall Study|13 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|106
935722|NCT01419184|2264361|P1|COMPLETED|Overall Study|6 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|118
935723|NCT01419184|2264360|P2|Received at Least 1 Dose of Study Drug|Overall Study||106
935724|NCT01419184|2264361|P1|Received at Least 1 Dose of Study Drug|Overall Study||118
935725|NCT01419184|2264360|P2|STARTED|Overall Study||121
935726|NCT01419184|2264361|P1|STARTED|Overall Study||128
935727|NCT01419171|2264377|P1|NOT COMPLETED|Overall Study||0
935728|NCT01419171|2264377|P1|COMPLETED|Overall Study||328
935729|NCT01419171|2264377|P1|STARTED|Overall Study||328
935730|NCT01419028|2264394|P1|NOT COMPLETED|Overall Study||0
935731|NCT01419028|2264394|P1|COMPLETED|Overall Study||48
935732|NCT01419028|2264394|P1|STARTED|Overall Study||48
935733|NCT01418937|2264399|P1|NOT COMPLETED|Overall Study||8
935734|NCT01418937|2264399|P1|COMPLETED|Overall Study||156
935735|NCT01418937|2264399|P1|STARTED|Overall Study||164
935736|NCT01418703|2264408|P4|NOT COMPLETED|Overall Study||0
935737|NCT01418703|2264409|P3|NOT COMPLETED|Overall Study||0
935738|NCT01418703|2264410|P2|NOT COMPLETED|Overall Study||0
935739|NCT01418703|2264411|P1|NOT COMPLETED|Overall Study||0
935740|NCT01418703|2264408|P4|COMPLETED|Overall Study||6
935741|NCT01418703|2264409|P3|COMPLETED|Overall Study||6
935742|NCT01418703|2264410|P2|COMPLETED|Overall Study||13
935743|NCT01418703|2264411|P1|COMPLETED|Overall Study||13
935744|NCT01418703|2264408|P4|STARTED|Overall Study||6
935745|NCT01418703|2264409|P3|STARTED|Overall Study||6
935746|NCT01418703|2264410|P2|STARTED|Overall Study||13
935747|NCT01418703|2264411|P1|STARTED|Overall Study||13
935748|NCT01418482|2264422|P1|NOT COMPLETED|Overall Study||0
935749|NCT01418482|2264422|P1|COMPLETED|Overall Study||15
935750|NCT01418482|2264422|P1|STARTED|Overall Study||15
935751|NCT01418365|2264430|P2|NOT COMPLETED|Second Intervention||1
935752|NCT01418365|2264431|P1|NOT COMPLETED|Second Intervention||0
935753|NCT01418365|2264430|P2|COMPLETED|Second Intervention||13
935754|NCT01418365|2264431|P1|COMPLETED|Second Intervention||14
935755|NCT01418365|2264430|P2|STARTED|Second Intervention||14
935756|NCT01418365|2264431|P1|STARTED|Second Intervention||14
935757|NCT01418365|2264430|P2|NOT COMPLETED|First Intervention||1
935758|NCT01418365|2264431|P1|NOT COMPLETED|First Intervention||1
935759|NCT01418365|2264430|P2|COMPLETED|First Intervention||14
935760|NCT01418365|2264431|P1|COMPLETED|First Intervention||14
935761|NCT01418365|2264430|P2|STARTED|First Intervention||15
935762|NCT01418365|2264431|P1|STARTED|First Intervention||15
935763|NCT01418209|2264442|P3|NOT COMPLETED|Overall Study||4
935764|NCT01418209|2264443|P2|NOT COMPLETED|Overall Study||3
935765|NCT01418209|2264444|P1|NOT COMPLETED|Overall Study||2
935766|NCT01418209|2264442|P3|COMPLETED|Overall Study||142
935767|NCT01418209|2264443|P2|COMPLETED|Overall Study||93
935768|NCT01418209|2264444|P1|COMPLETED|Overall Study||95
935769|NCT01418209|2264442|P3|STARTED|Overall Study||146
935770|NCT01418209|2264443|P2|STARTED|Overall Study||96
935771|NCT01418209|2264444|P1|STARTED|Overall Study||97
935772|NCT01418001|2264473|P1|NOT COMPLETED|Overall Study||0
935773|NCT01418001|2264473|P1|COMPLETED|Overall Study||5
935774|NCT01418001|2264473|P1|STARTED|Overall Study||5
935775|NCT01417936|2264477|P1|NOT COMPLETED|Overall Study||0
935776|NCT01417936|2264477|P1|COMPLETED|Overall Study||26
935777|NCT01417936|2264477|P1|STARTED|Overall Study||26
935778|NCT01417481|2264498|P2|NOT COMPLETED|Second Period (8 Weeks)||0
935779|NCT01417481|2264499|P1|NOT COMPLETED|Second Period (8 Weeks)||0
935780|NCT01417481|2264498|P2|COMPLETED|Second Period (8 Weeks)||5
935781|NCT01417481|2264499|P1|COMPLETED|Second Period (8 Weeks)||8
935782|NCT01417481|2264498|P2|STARTED|Second Period (8 Weeks)||5
935783|NCT01417481|2264499|P1|STARTED|Second Period (8 Weeks)||8
935784|NCT01417481|2264498|P2|NOT COMPLETED|Washout (2 Weeks)||0
935785|NCT01417481|2264499|P1|NOT COMPLETED|Washout (2 Weeks)||0
935786|NCT01417481|2264498|P2|COMPLETED|Washout (2 Weeks)||5
935787|NCT01417481|2264499|P1|COMPLETED|Washout (2 Weeks)||8
935788|NCT01417481|2264498|P2|STARTED|Washout (2 Weeks)||5
935789|NCT01417481|2264499|P1|STARTED|Washout (2 Weeks)||8
935790|NCT01417481|2264498|P2|NOT COMPLETED|First Intervention (8 Weeks)||2
935791|NCT01417481|2264499|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
935792|NCT01417481|2264498|P2|COMPLETED|First Intervention (8 Weeks)||5
935793|NCT01417481|2264499|P1|COMPLETED|First Intervention (8 Weeks)||8
935794|NCT01417481|2264498|P2|STARTED|First Intervention (8 Weeks)||7
935795|NCT01417481|2264499|P1|STARTED|First Intervention (8 Weeks)||8
935796|NCT01417455|2264531|P8|NOT COMPLETED|Overall Study||0
935797|NCT01417455|2264532|P7|NOT COMPLETED|Overall Study||0
935798|NCT01417455|2264533|P6|NOT COMPLETED|Overall Study||0
935799|NCT01417455|2264534|P5|NOT COMPLETED|Overall Study||0
935800|NCT01417455|2264535|P4|NOT COMPLETED|Overall Study||0
935801|NCT01417455|2264536|P3|NOT COMPLETED|Overall Study||0
935802|NCT01417455|2264537|P2|NOT COMPLETED|Overall Study||0
935803|NCT01417455|2264538|P1|NOT COMPLETED|Overall Study||0
935804|NCT01417455|2264531|P8|COMPLETED|Overall Study||25
935805|NCT01417455|2264532|P7|COMPLETED|Overall Study||13
935806|NCT01417455|2264533|P6|COMPLETED|Overall Study||13
935807|NCT01417455|2264534|P5|COMPLETED|Overall Study||30
935808|NCT01417455|2264535|P4|COMPLETED|Overall Study||17
935809|NCT01417455|2264536|P3|COMPLETED|Overall Study||17
935810|NCT01417455|2264537|P2|COMPLETED|Overall Study||16
935811|NCT01417455|2264538|P1|COMPLETED|Overall Study||16
935812|NCT01417455|2264531|P8|STARTED|Overall Study||25
935813|NCT01417455|2264532|P7|STARTED|Overall Study||13
935814|NCT01417455|2264533|P6|STARTED|Overall Study||13
935815|NCT01417455|2264534|P5|STARTED|Overall Study||30
935816|NCT01417455|2264535|P4|STARTED|Overall Study||17
935817|NCT01417455|2264536|P3|STARTED|Overall Study||17
935818|NCT01417455|2264537|P2|STARTED|Overall Study||16
935819|NCT01417455|2264538|P1|STARTED|Overall Study||16
935820|NCT01417377|2264564|P1|NOT COMPLETED|Overall Study||13
935821|NCT01417377|2264564|P1|COMPLETED|Overall Study||9
935822|NCT01417377|2264564|P1|Treated|Overall Study||21
935823|NCT01417377|2264564|P1|STARTED|Overall Study||22
935824|NCT01417195|2264573|P2|NOT COMPLETED|Overall Study||1
935825|NCT01417195|2264574|P1|NOT COMPLETED|Overall Study||3
935826|NCT01417195|2264573|P2|COMPLETED|Overall Study||61
935827|NCT01417195|2264574|P1|COMPLETED|Overall Study||57
935828|NCT01417195|2264573|P2|STARTED|Overall Study||62
935829|NCT01417195|2264574|P1|STARTED|Overall Study||60
935830|NCT01417156|2264590|P1|NOT COMPLETED|Overall Study||14
935831|NCT01417156|2264590|P1|COMPLETED|Overall Study||6
935832|NCT01417156|2264590|P1|STARTED|Overall Study||20
935833|NCT01417104|2264600|P2|NOT COMPLETED|Overall Study||2
935834|NCT01417104|2264601|P1|NOT COMPLETED|Overall Study||6
935835|NCT01417104|2264600|P2|COMPLETED|Overall Study||35
935836|NCT01417104|2264601|P1|COMPLETED|Overall Study||28
935837|NCT01417104|2264600|P2|STARTED|Overall Study||37
935838|NCT01417104|2264601|P1|STARTED|Overall Study||34
935839|NCT01417078|2264611|P1|NOT COMPLETED|Overall Study||1
935840|NCT01417078|2264611|P1|COMPLETED|Overall Study||30
935841|NCT01417078|2264611|P1|STARTED|Overall Study||31
935842|NCT01417026|2264623|P2|NOT COMPLETED|Overall Study||0
935843|NCT01417026|2264624|P1|NOT COMPLETED|Overall Study||2
935844|NCT01417026|2264623|P2|COMPLETED|Overall Study||13
935845|NCT01417026|2264624|P1|COMPLETED|Overall Study||14
935846|NCT01417026|2264623|P2|STARTED|Overall Study||13
935847|NCT01417026|2264624|P1|STARTED|Overall Study||16
935848|NCT01416610|2264634|P1|NOT COMPLETED|Overall Study||43
935849|NCT01416610|2264634|P1|COMPLETED|Overall Study||45
935850|NCT01416610|2264634|P1|Completed Follow-up|Overall Study||45
935851|NCT01416610|2264634|P1|Completed Treatment|Overall Study||47
935852|NCT01416610|2264634|P1|Per Protocol|Overall Study||83
935853|NCT01416610|2264634|P1|Safety Population|Overall Study||86
935854|NCT01416610|2264634|P1|Intention to Treat|Overall Study||88
935855|NCT01416610|2264634|P1|STARTED|Overall Study||88
935865|NCT01416571|2264688|P1|NOT COMPLETED|Overall Study||2
935866|NCT01416571|2264688|P1|COMPLETED|Overall Study|Number of subjects completed at Day 385.|76
935867|NCT01416571|2264688|P1|STARTED|Overall Study||78
935868|NCT01416272|2264715|P1|NOT COMPLETED|Overall Study||4
935869|NCT01416272|2264715|P1|COMPLETED|Overall Study||8
935870|NCT01416272|2264715|P1|STARTED|Overall Study||12
935871|NCT01416181|2264723|P2|NOT COMPLETED|Part 2||286
935872|NCT01416181|2264724|P1|NOT COMPLETED|Part 2||271
935873|NCT01416181|2264723|P2|COMPLETED|Part 2||6
935874|NCT01416181|2264724|P1|COMPLETED|Part 2||3
935875|NCT01416181|2264723|P2|Completed Treatment for > 96 Weeks|Part 2||0
935876|NCT01416181|2264724|P1|Completed Treatment for > 96 Weeks|Part 2||1
935877|NCT01416181|2264723|P2|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|0
935878|NCT01416181|2264724|P1|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|1
935879|NCT01416181|2264723|P2|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|111
935880|NCT01416181|2264724|P1|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|98
935881|NCT01416181|2264723|P2|STARTED|Part 2||292
935882|NCT01416181|2264724|P1|STARTED|Part 2||274
935883|NCT01416181|2264723|P2|NOT COMPLETED|Part 1||114
935884|NCT01416181|2264724|P1|NOT COMPLETED|Part 1||137
935885|NCT01416181|2264723|P2|COMPLETED|Part 1|Completed Study through Week 108|326
935886|NCT01416181|2264724|P1|COMPLETED|Part 1|Completed Study through Week 108|312
935887|NCT01416181|2264723|P2|Withdrew Prior to Dosing|Part 1||1
935888|NCT01416181|2264724|P1|Withdrew Prior to Dosing|Part 1||0
935889|NCT01416181|2264723|P2|STARTED|Part 1||440
935890|NCT01416181|2264724|P1|STARTED|Part 1||449
935891|NCT01416155|2264786|P1|NOT COMPLETED|Overall Study||58
935892|NCT01416155|2264786|P1|COMPLETED|Overall Study||39
935893|NCT01416155|2264786|P1|STARTED|Overall Study||97
935894|NCT01416142|2264793|P3|NOT COMPLETED|PureVision2 HD||1
935895|NCT01416142|2264794|P2|NOT COMPLETED|PureVision2 HD||0
935896|NCT01416142|2264795|P1|NOT COMPLETED|PureVision2 HD||0
935897|NCT01416142|2264793|P3|COMPLETED|PureVision2 HD||62
935898|NCT01416142|2264794|P2|COMPLETED|PureVision2 HD||0
935899|NCT01416142|2264795|P1|COMPLETED|PureVision2 HD||0
935900|NCT01416142|2264793|P3|STARTED|PureVision2 HD||63
935901|NCT01416142|2264794|P2|STARTED|PureVision2 HD||0
935902|NCT01416142|2264795|P1|STARTED|PureVision2 HD||0
935903|NCT01416142|2264793|P3|NOT COMPLETED|Cross Over at Movie Intermission||0
935904|NCT01416142|2264794|P2|NOT COMPLETED|Cross Over at Movie Intermission||0
935905|NCT01416142|2264795|P1|NOT COMPLETED|Cross Over at Movie Intermission||0
935906|NCT01416142|2264793|P3|COMPLETED|Cross Over at Movie Intermission||0
935907|NCT01416142|2264794|P2|COMPLETED|Cross Over at Movie Intermission||31
935908|NCT01416142|2264795|P1|COMPLETED|Cross Over at Movie Intermission||32
935909|NCT01416142|2264793|P3|STARTED|Cross Over at Movie Intermission||0
935910|NCT01416142|2264794|P2|STARTED|Cross Over at Movie Intermission||31
935911|NCT01416142|2264795|P1|STARTED|Cross Over at Movie Intermission||32
935912|NCT01416129|2264806|P2|NOT COMPLETED|Experimental Condition: Brimless||0
935913|NCT01416129|2264807|P1|NOT COMPLETED|Experimental Condition: Brimless||0
935914|NCT01416129|2264806|P2|COMPLETED|Experimental Condition: Brimless||5
935915|NCT01416129|2264807|P1|COMPLETED|Experimental Condition: Brimless||5
935916|NCT01416129|2264806|P2|STARTED|Experimental Condition: Brimless||5
935917|NCT01416129|2264807|P1|STARTED|Experimental Condition: Brimless||5
935918|NCT01416129|2264806|P2|NOT COMPLETED|Control Condition: Ischial Containment||0
935919|NCT01416129|2264807|P1|NOT COMPLETED|Control Condition: Ischial Containment||0
935920|NCT01416129|2264806|P2|COMPLETED|Control Condition: Ischial Containment||5
935921|NCT01416129|2264807|P1|COMPLETED|Control Condition: Ischial Containment||5
935922|NCT01416129|2264806|P2|STARTED|Control Condition: Ischial Containment||5
935923|NCT01416129|2264807|P1|STARTED|Control Condition: Ischial Containment||5
935924|NCT01416025|2264815|P2|NOT COMPLETED|Overall Study||0
935925|NCT01416025|2264816|P1|NOT COMPLETED|Overall Study||0
935926|NCT01416025|2264815|P2|COMPLETED|Overall Study||15
935927|NCT01416025|2264816|P1|COMPLETED|Overall Study||14
935928|NCT01416025|2264815|P2|STARTED|Overall Study||15
935929|NCT01416025|2264816|P1|STARTED|Overall Study||14
935930|NCT01415986|2264822|P1|NOT COMPLETED|Overall Study||1
935931|NCT01415986|2264822|P1|COMPLETED|Overall Study|Study terminated|0
935932|NCT01415986|2264822|P1|STARTED|Overall Study||1
935933|NCT01415960|2264827|P1|NOT COMPLETED|Overall Study||12
935934|NCT01415960|2264827|P1|COMPLETED|Overall Study|Patients completed Study (151) Per protocol Patients (146)|151
935935|NCT01415960|2264827|P1|PK Subgroup|Overall Study||30
935936|NCT01415960|2264827|P1|ITT|Overall Study||161
935937|NCT01415960|2264827|P1|STARTED|Overall Study||163
935938|NCT01415921|2264839|P2|NOT COMPLETED|Overall Study||3
935939|NCT01415921|2264840|P1|NOT COMPLETED|Overall Study||3
935940|NCT01415921|2264839|P2|COMPLETED|Overall Study||14
935941|NCT01415921|2264840|P1|COMPLETED|Overall Study||13
935942|NCT01415921|2264839|P2|STARTED|Overall Study||17
935943|NCT01415921|2264840|P1|STARTED|Overall Study||16
935944|NCT01415908|2264850|P2|NOT COMPLETED|Overall Study||0
935945|NCT01415908|2264851|P1|NOT COMPLETED|Overall Study||1
935946|NCT01415908|2264850|P2|COMPLETED|Overall Study||4
935947|NCT01415908|2264851|P1|COMPLETED|Overall Study||10
935948|NCT01415908|2264850|P2|STARTED|Overall Study||4
935949|NCT01415908|2264851|P1|STARTED|Overall Study||11
935950|NCT01415583|2264879|P2|NOT COMPLETED|Overall Study||0
935951|NCT01415583|2264880|P1|NOT COMPLETED|Overall Study||0
935952|NCT01415583|2264879|P2|COMPLETED|Overall Study||157
935953|NCT01415583|2264880|P1|COMPLETED|Overall Study||157
935954|NCT01415583|2264879|P2|STARTED|Overall Study||157
935955|NCT01415583|2264880|P1|STARTED|Overall Study||157
935956|NCT01415531|2264888|P2|NOT COMPLETED|Overall Study||37
935957|NCT01415531|2264889|P1|NOT COMPLETED|Overall Study||25
935958|NCT01415531|2264888|P2|COMPLETED|Overall Study||390
935959|NCT01415531|2264889|P1|COMPLETED|Overall Study||189
935960|NCT01415531|2264888|P2|STARTED|Overall Study||427
935961|NCT01415531|2264889|P1|STARTED|Overall Study||214
935962|NCT01415518|2264899|P2|NOT COMPLETED|Overall Study||31
935963|NCT01415518|2264900|P1|NOT COMPLETED|Overall Study||16
935964|NCT01415518|2264899|P2|COMPLETED|Overall Study||261
935965|NCT01415518|2264900|P1|COMPLETED|Overall Study||276
935966|NCT01415518|2264899|P2|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 292 patients. Safety analysis used 292-3=289 patients.|289
935967|NCT01415518|2264900|P1|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 290 patients. Safety analysis used 290+3=293 patients.|290
935968|NCT01415518|2264899|P2|Patients Who Received Study Treatment|Overall Study||292
935969|NCT01415518|2264900|P1|Patients Who Received Study Treatment|Overall Study||290
935970|NCT01415518|2264899|P2|STARTED|Overall Study||292
935971|NCT01415518|2264900|P1|STARTED|Overall Study||292
935972|NCT01415453|2264952|P1|NOT COMPLETED|Overall Study||0
935973|NCT01415453|2264952|P1|COMPLETED|Overall Study||1
935974|NCT01415453|2264952|P1|Imaging Study|Overall Study||1
935975|NCT01415453|2264952|P1|STARTED|Overall Study||1
935976|NCT01415427|2264960|P4|NOT COMPLETED|Overall Study||56
935977|NCT01415427|2264961|P3|NOT COMPLETED|Overall Study||58
935978|NCT01415427|2264962|P2|NOT COMPLETED|Overall Study||29
935979|NCT01415427|2264963|P1|NOT COMPLETED|Overall Study||29
935980|NCT01415427|2264960|P4|COMPLETED|Overall Study||0
935981|NCT01415427|2264961|P3|COMPLETED|Overall Study||1
935982|NCT01415427|2264962|P2|COMPLETED|Overall Study||0
935983|NCT01415427|2264963|P1|COMPLETED|Overall Study||0
935984|NCT01415427|2264960|P4|STARTED|Overall Study||56
935985|NCT01415427|2264961|P3|STARTED|Overall Study||59
935986|NCT01415427|2264962|P2|STARTED|Overall Study||29
935987|NCT01415427|2264963|P1|STARTED|Overall Study||29
935988|NCT01415401|2265000|P1|NOT COMPLETED|Overall Study||7
935989|NCT01415401|2265000|P1|COMPLETED|Overall Study||47
935990|NCT01415401|2265000|P1|STARTED|Overall Study||54
935991|NCT01415349|2265005|P2|NOT COMPLETED|Treatment Period 2||0
935992|NCT01415349|2265006|P1|NOT COMPLETED|Treatment Period 2||0
935993|NCT01415349|2265005|P2|COMPLETED|Treatment Period 2||19
935994|NCT01415349|2265006|P1|COMPLETED|Treatment Period 2||21
935995|NCT01415349|2265005|P2|STARTED|Treatment Period 2||19
935996|NCT01415349|2265006|P1|STARTED|Treatment Period 2||21
935997|NCT01415349|2265005|P2|NOT COMPLETED|Treatment Period 1||2
935998|NCT01415349|2265006|P1|NOT COMPLETED|Treatment Period 1||0
935999|NCT01415349|2265005|P2|COMPLETED|Treatment Period 1||19
936000|NCT01415349|2265006|P1|COMPLETED|Treatment Period 1||21
936001|NCT01415349|2265005|P2|STARTED|Treatment Period 1||21
936002|NCT01415349|2265006|P1|STARTED|Treatment Period 1||21
936006|NCT01414855|2265018|P1|NOT COMPLETED|Overall Study||13
936007|NCT01414855|2265018|P1|COMPLETED|Overall Study|Completed=Completed treatment.|87
936008|NCT01414855|2265018|P1|STARTED|Overall Study||100
936009|NCT01414634|2265034|P8|NOT COMPLETED|Overall Study||0
936010|NCT01414634|2265035|P7|NOT COMPLETED|Overall Study||0
936011|NCT01414634|2265036|P6|NOT COMPLETED|Overall Study||0
936012|NCT01414634|2265037|P5|NOT COMPLETED|Overall Study||0
936013|NCT01414634|2265038|P4|NOT COMPLETED|Overall Study||0
936014|NCT01414634|2265039|P3|NOT COMPLETED|Overall Study||0
936015|NCT01414634|2265040|P2|NOT COMPLETED|Overall Study||0
936016|NCT01414634|2265041|P1|NOT COMPLETED|Overall Study||0
936017|NCT01414634|2265034|P8|COMPLETED|Overall Study||1
936018|NCT01414634|2265035|P7|COMPLETED|Overall Study||1
936019|NCT01414634|2265036|P6|COMPLETED|Overall Study||2
936020|NCT01414634|2265037|P5|COMPLETED|Overall Study||1
936021|NCT01414634|2265038|P4|COMPLETED|Overall Study||1
936022|NCT01414634|2265039|P3|COMPLETED|Overall Study||1
936023|NCT01414634|2265040|P2|COMPLETED|Overall Study||1
936024|NCT01414634|2265041|P1|COMPLETED|Overall Study||1
936025|NCT01414634|2265034|P8|STARTED|Overall Study||1
936026|NCT01414634|2265035|P7|STARTED|Overall Study||1
936027|NCT01414634|2265036|P6|STARTED|Overall Study||2
936028|NCT01414634|2265037|P5|STARTED|Overall Study||1
936029|NCT01414634|2265038|P4|STARTED|Overall Study||1
936030|NCT01414634|2265039|P3|STARTED|Overall Study||1
936031|NCT01414634|2265040|P2|STARTED|Overall Study||1
936032|NCT01414634|2265041|P1|STARTED|Overall Study||1
936033|NCT01414413|2265054|P2|NOT COMPLETED|Overall Study||0
936034|NCT01414413|2265055|P1|NOT COMPLETED|Overall Study||0
936035|NCT01414413|2265054|P2|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8466
936036|NCT01414413|2265055|P1|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8194
936037|NCT01414413|2265054|P2|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8466
936038|NCT01414413|2265055|P1|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8194
936039|NCT01412983|2265067|P2|NOT COMPLETED|2nd Period||0
936040|NCT01412983|2265068|P1|NOT COMPLETED|2nd Period||0
936041|NCT01412983|2265067|P2|COMPLETED|2nd Period||46
936042|NCT01412983|2265068|P1|COMPLETED|2nd Period||50
936043|NCT01412983|2265067|P2|STARTED|2nd Period||46
936044|NCT01412983|2265068|P1|STARTED|2nd Period||50
936045|NCT01412983|2265067|P2|NOT COMPLETED|1st Period||4
936046|NCT01412983|2265068|P1|NOT COMPLETED|1st Period||0
936047|NCT01412983|2265067|P2|COMPLETED|1st Period||46
936048|NCT01412983|2265068|P1|COMPLETED|1st Period||50
936049|NCT01412983|2265067|P2|STARTED|1st Period||50
936050|NCT01412983|2265068|P1|STARTED|1st Period||50
936051|NCT01414244|2265078|P2|NOT COMPLETED|Overall Study||0
936052|NCT01414244|2265079|P1|NOT COMPLETED|Overall Study||0
936053|NCT01414244|2265078|P2|COMPLETED|Overall Study||52
936054|NCT01414244|2265079|P1|COMPLETED|Overall Study||54
936055|NCT01414244|2265078|P2|STARTED|Overall Study||52
936056|NCT01414244|2265079|P1|STARTED|Overall Study||54
936057|NCT01414205|2265093|P2|NOT COMPLETED|Overall Study||7
936058|NCT01414205|2265094|P1|NOT COMPLETED|Overall Study||7
936059|NCT01414205|2265093|P2|COMPLETED|Overall Study||32
936060|NCT01414205|2265094|P1|COMPLETED|Overall Study||34
936061|NCT01414205|2265093|P2|Received Study Drug|Overall Study||38
936062|NCT01414205|2265094|P1|Received Study Drug|Overall Study||40
936063|NCT01414205|2265093|P2|STARTED|Overall Study||39
936064|NCT01414205|2265094|P1|STARTED|Overall Study||41
936065|NCT01414192|2265130|P4|NOT COMPLETED|Overall Study||0
936066|NCT01414192|2265131|P3|NOT COMPLETED|Overall Study||0
936067|NCT01414192|2265132|P2|NOT COMPLETED|Overall Study||0
936068|NCT01414192|2265133|P1|NOT COMPLETED|Overall Study||0
936069|NCT01414192|2265130|P4|COMPLETED|Overall Study||1726
936070|NCT01414192|2265131|P3|COMPLETED|Overall Study||424
936071|NCT01414192|2265132|P2|COMPLETED|Overall Study||575
936072|NCT01414192|2265133|P1|COMPLETED|Overall Study||490
936073|NCT01414192|2265130|P4|STARTED|Overall Study||1726
936074|NCT01414192|2265131|P3|STARTED|Overall Study||424
936075|NCT01414192|2265132|P2|STARTED|Overall Study||575
936076|NCT01414192|2265133|P1|STARTED|Overall Study||490
936077|NCT01414166|2265163|P2|NOT COMPLETED|Overall Study||83
936078|NCT01414166|2265164|P1|NOT COMPLETED|Overall Study||91
936079|NCT01414166|2265163|P2|COMPLETED|Overall Study||39
936080|NCT01414166|2265164|P1|COMPLETED|Overall Study||31
936081|NCT01414166|2265163|P2|Treated|Overall Study||121
936082|NCT01414166|2265164|P1|Treated|Overall Study||120
936083|NCT01414166|2265163|P2|STARTED|Overall Study||122
936084|NCT01414166|2265164|P1|STARTED|Overall Study||122
936085|NCT01414153|2265190|P4|NOT COMPLETED|Overall Study||4
936086|NCT01414153|2265191|P3|NOT COMPLETED|Overall Study||4
936087|NCT01414153|2265192|P2|NOT COMPLETED|Overall Study||2
936088|NCT01414153|2265193|P1|NOT COMPLETED|Overall Study||8
936089|NCT01414153|2265190|P4|COMPLETED|Overall Study||37
936090|NCT01414153|2265191|P3|COMPLETED|Overall Study||35
936091|NCT01414153|2265192|P2|COMPLETED|Overall Study||38
936092|NCT01414153|2265193|P1|COMPLETED|Overall Study||30
936093|NCT01414153|2265190|P4|STARTED|Overall Study||41
936094|NCT01414153|2265191|P3|STARTED|Overall Study||39
936095|NCT01414153|2265192|P2|STARTED|Overall Study||40
936096|NCT01414153|2265193|P1|STARTED|Overall Study||38
936097|NCT01414114|2265227|P1|NOT COMPLETED|Overall Study||5
936098|NCT01414114|2265227|P1|COMPLETED|Overall Study|Completed 12-week treatment period|32
936099|NCT01414114|2265227|P1|STARTED|Overall Study||37
936100|NCT01414036|2265247|P2|NOT COMPLETED|Completed 3 Month Survey||5
936101|NCT01414036|2265248|P1|NOT COMPLETED|Completed 3 Month Survey||9
936102|NCT01414036|2265247|P2|COMPLETED|Completed 3 Month Survey||19
936103|NCT01414036|2265248|P1|COMPLETED|Completed 3 Month Survey||14
936104|NCT01414036|2265247|P2|STARTED|Completed 3 Month Survey||24
936105|NCT01414036|2265248|P1|STARTED|Completed 3 Month Survey||23
936106|NCT01414036|2265247|P2|NOT COMPLETED|Received Allocated Intervention||13
936107|NCT01414036|2265248|P1|NOT COMPLETED|Received Allocated Intervention||0
936108|NCT01414036|2265247|P2|COMPLETED|Received Allocated Intervention||11
936109|NCT01414036|2265248|P1|COMPLETED|Received Allocated Intervention||23
936110|NCT01414036|2265247|P2|STARTED|Received Allocated Intervention||24
936111|NCT01414036|2265248|P1|STARTED|Received Allocated Intervention||23
936112|NCT01414010|2265262|P4|NOT COMPLETED|Overall Study||0
936113|NCT01414010|2265263|P3|NOT COMPLETED|Overall Study||0
936114|NCT01414010|2265264|P2|NOT COMPLETED|Overall Study||0
936115|NCT01414010|2265265|P1|NOT COMPLETED|Overall Study||2
936116|NCT01414010|2265262|P4|COMPLETED|Overall Study||8
936117|NCT01414010|2265263|P3|COMPLETED|Overall Study||8
936118|NCT01414010|2265264|P2|COMPLETED|Overall Study||8
936119|NCT01414010|2265265|P1|COMPLETED|Overall Study||6
936120|NCT01414010|2265262|P4|STARTED|Overall Study||8
936121|NCT01414010|2265263|P3|STARTED|Overall Study||8
936122|NCT01414010|2265264|P2|STARTED|Overall Study||8
936123|NCT01414010|2265265|P1|STARTED|Overall Study||8
936124|NCT01413958|2265283|P2|NOT COMPLETED|Overall Study||1
936125|NCT01413958|2265284|P1|NOT COMPLETED|Overall Study||0
936126|NCT01413958|2265283|P2|COMPLETED|Overall Study||286
936127|NCT01413958|2265284|P1|COMPLETED|Overall Study||288
936128|NCT01413958|2265283|P2|STARTED|Overall Study||287
936129|NCT01413958|2265284|P1|STARTED|Overall Study||288
936130|NCT01413750|2265319|P4|NOT COMPLETED|Overall Study||0
936131|NCT01413750|2265320|P3|NOT COMPLETED|Overall Study||0
936132|NCT01413750|2265321|P2|NOT COMPLETED|Overall Study||0
936133|NCT01413750|2265322|P1|NOT COMPLETED|Overall Study||0
936134|NCT01413750|2265319|P4|COMPLETED|Overall Study||7
936135|NCT01413750|2265320|P3|COMPLETED|Overall Study||4
936136|NCT01413750|2265321|P2|COMPLETED|Overall Study||6
936137|NCT01413750|2265322|P1|COMPLETED|Overall Study||6
936138|NCT01413750|2265319|P4|STARTED|Overall Study||7
936139|NCT01413750|2265320|P3|STARTED|Overall Study||4
936140|NCT01413750|2265321|P2|STARTED|Overall Study||6
936141|NCT01413750|2265322|P1|STARTED|Overall Study||6
936142|NCT01413542|2265335|P4|NOT COMPLETED|Overall Study||1
936143|NCT01413542|2265336|P3|NOT COMPLETED|Overall Study||3
936144|NCT01413542|2265337|P2|NOT COMPLETED|Overall Study||0
936145|NCT01413542|2265338|P1|NOT COMPLETED|Overall Study||1
936146|NCT01413542|2265335|P4|COMPLETED|Overall Study||7
936147|NCT01413542|2265336|P3|COMPLETED|Overall Study||6
936148|NCT01413542|2265337|P2|COMPLETED|Overall Study||6
936149|NCT01413542|2265338|P1|COMPLETED|Overall Study||5
936150|NCT01413542|2265335|P4|STARTED|Overall Study||8
936151|NCT01413542|2265336|P3|STARTED|Overall Study||9
936152|NCT01413542|2265337|P2|STARTED|Overall Study||6
936153|NCT01413542|2265338|P1|STARTED|Overall Study||6
936154|NCT01413516|2265353|P2|NOT COMPLETED|Overall Study||0
936155|NCT01413516|2265354|P1|NOT COMPLETED|Overall Study||0
936156|NCT01413516|2265353|P2|COMPLETED|Overall Study||9
936157|NCT01413516|2265354|P1|COMPLETED|Overall Study||8
936158|NCT01413516|2265353|P2|STARTED|Overall Study||9
936159|NCT01413516|2265354|P1|STARTED|Overall Study||8
936160|NCT01413360|2265360|P1|NOT COMPLETED|Overall Study||3
936161|NCT01413360|2265360|P1|COMPLETED|Overall Study||7
936162|NCT01413360|2265360|P1|STARTED|Overall Study||10
936163|NCT01413204|2265368|P3|NOT COMPLETED|Overall Study||19
936164|NCT01413204|2265369|P2|NOT COMPLETED|Overall Study||6
936165|NCT01413204|2265370|P1|NOT COMPLETED|Overall Study||6
936166|NCT01413204|2265368|P3|COMPLETED|Overall Study||74
936167|NCT01413204|2265369|P2|COMPLETED|Overall Study||83
936168|NCT01413204|2265370|P1|COMPLETED|Overall Study||84
936169|NCT01413204|2265368|P3|STARTED|Overall Study||93
936170|NCT01413204|2265369|P2|STARTED|Overall Study||89
936171|NCT01413204|2265370|P1|STARTED|Overall Study||90
936172|NCT01413191|2265378|P1|NOT COMPLETED|Overall Study||11
936173|NCT01413191|2265378|P1|COMPLETED|Overall Study||7
936174|NCT01413191|2265378|P1|STARTED|Overall Study||18
936175|NCT01412957|2265384|P2|NOT COMPLETED|Overall Study||157
936176|NCT01412957|2265385|P1|NOT COMPLETED|Overall Study||149
936177|NCT01412957|2265384|P2|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|31
936178|NCT01412957|2265385|P1|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|40
936179|NCT01412957|2265384|P2|STARTED|Overall Study||188
936180|NCT01412957|2265385|P1|STARTED|Overall Study||189
936181|NCT01412944|2265407|P6|NOT COMPLETED|Follow-up||0
936182|NCT01412944|2265408|P5|NOT COMPLETED|Follow-up||0
936183|NCT01412944|2265409|P4|NOT COMPLETED|Follow-up||0
936184|NCT01412944|2265410|P3|NOT COMPLETED|Follow-up||0
936185|NCT01412944|2265411|P2|NOT COMPLETED|Follow-up||0
936186|NCT01412944|2265412|P1|NOT COMPLETED|Follow-up||0
936187|NCT01412944|2265407|P6|COMPLETED|Follow-up||0
936188|NCT01412944|2265408|P5|COMPLETED|Follow-up||2
936189|NCT01412944|2265409|P4|COMPLETED|Follow-up||1
936190|NCT01412944|2265410|P3|COMPLETED|Follow-up||2
936191|NCT01412944|2265411|P2|COMPLETED|Follow-up||0
936192|NCT01412944|2265412|P1|COMPLETED|Follow-up||0
936193|NCT01412944|2265407|P6|STARTED|Follow-up||0
936194|NCT01412944|2265408|P5|STARTED|Follow-up||2
936195|NCT01412944|2265409|P4|STARTED|Follow-up||1
936196|NCT01412944|2265410|P3|STARTED|Follow-up||2
936197|NCT01412944|2265411|P2|STARTED|Follow-up||0
936198|NCT01412944|2265412|P1|STARTED|Follow-up||0
936199|NCT01412944|2265407|P6|NOT COMPLETED|Entire: IV + Maintenance||0
936200|NCT01412944|2265408|P5|NOT COMPLETED|Entire: IV + Maintenance||0
936201|NCT01412944|2265409|P4|NOT COMPLETED|Entire: IV + Maintenance||0
936202|NCT01412944|2265410|P3|NOT COMPLETED|Entire: IV + Maintenance||0
936203|NCT01412944|2265411|P2|NOT COMPLETED|Entire: IV + Maintenance||5
936204|NCT01412944|2265412|P1|NOT COMPLETED|Entire: IV + Maintenance||2
936205|NCT01412944|2265407|P6|COMPLETED|Entire: IV + Maintenance||0
936206|NCT01412944|2265408|P5|COMPLETED|Entire: IV + Maintenance||0
936207|NCT01412944|2265409|P4|COMPLETED|Entire: IV + Maintenance||0
936208|NCT01412944|2265410|P3|COMPLETED|Entire: IV + Maintenance||0
936209|NCT01412944|2265411|P2|COMPLETED|Entire: IV + Maintenance||17
936210|NCT01412944|2265412|P1|COMPLETED|Entire: IV + Maintenance||19
936211|NCT01412944|2265407|P6|STARTED|Entire: IV + Maintenance||0
936212|NCT01412944|2265408|P5|STARTED|Entire: IV + Maintenance||0
936213|NCT01412944|2265409|P4|STARTED|Entire: IV + Maintenance||0
936214|NCT01412944|2265410|P3|STARTED|Entire: IV + Maintenance||0
936215|NCT01412944|2265411|P2|STARTED|Entire: IV + Maintenance||22
936216|NCT01412944|2265412|P1|STARTED|Entire: IV + Maintenance||21
936217|NCT01412944|2265407|P6|NOT COMPLETED|Entire: IV + Maintenance||2
936218|NCT01412944|2265408|P5|NOT COMPLETED|Entire: IV + Maintenance||3
936219|NCT01412944|2265409|P4|NOT COMPLETED|Entire: IV + Maintenance||1
936220|NCT01412944|2265410|P3|NOT COMPLETED|Entire: IV + Maintenance||1
936221|NCT01412944|2265411|P2|NOT COMPLETED|Entire: IV + Maintenance||0
936222|NCT01412944|2265412|P1|NOT COMPLETED|Entire: IV + Maintenance||0
936223|NCT01412944|2265407|P6|COMPLETED|Entire: IV + Maintenance||6
936224|NCT01412944|2265408|P5|COMPLETED|Entire: IV + Maintenance||11
936225|NCT01412944|2265409|P4|COMPLETED|Entire: IV + Maintenance||5
936226|NCT01412944|2265410|P3|COMPLETED|Entire: IV + Maintenance||14
936227|NCT01412944|2265411|P2|COMPLETED|Entire: IV + Maintenance||0
936228|NCT01412944|2265412|P1|COMPLETED|Entire: IV + Maintenance||0
936229|NCT01412944|2265407|P6|STARTED|Entire: IV + Maintenance||8
936230|NCT01412944|2265408|P5|STARTED|Entire: IV + Maintenance||14
936231|NCT01412944|2265409|P4|STARTED|Entire: IV + Maintenance||6
936232|NCT01412944|2265410|P3|STARTED|Entire: IV + Maintenance||15
936233|NCT01412944|2265411|P2|STARTED|Entire: IV + Maintenance||0
936234|NCT01412944|2265412|P1|STARTED|Entire: IV + Maintenance||0
936235|NCT01412944|2265407|P6|NOT COMPLETED|IV: Per CAIN457A2307||0
936236|NCT01412944|2265408|P5|NOT COMPLETED|IV: Per CAIN457A2307||0
936237|NCT01412944|2265409|P4|NOT COMPLETED|IV: Per CAIN457A2307||0
936238|NCT01412944|2265410|P3|NOT COMPLETED|IV: Per CAIN457A2307||0
936239|NCT01412944|2265411|P2|NOT COMPLETED|IV: Per CAIN457A2307||2
936240|NCT01412944|2265412|P1|NOT COMPLETED|IV: Per CAIN457A2307||1
936241|NCT01412944|2265407|P6|COMPLETED|IV: Per CAIN457A2307||0
936242|NCT01412944|2265408|P5|COMPLETED|IV: Per CAIN457A2307||0
936243|NCT01412944|2265409|P4|COMPLETED|IV: Per CAIN457A2307||0
936244|NCT01412944|2265410|P3|COMPLETED|IV: Per CAIN457A2307||0
936245|NCT01412944|2265411|P2|COMPLETED|IV: Per CAIN457A2307||20
936246|NCT01412944|2265412|P1|COMPLETED|IV: Per CAIN457A2307||20
936247|NCT01412944|2265407|P6|STARTED|IV: Per CAIN457A2307||0
936248|NCT01412944|2265408|P5|STARTED|IV: Per CAIN457A2307||0
936249|NCT01412944|2265409|P4|STARTED|IV: Per CAIN457A2307||0
936250|NCT01412944|2265410|P3|STARTED|IV: Per CAIN457A2307||0
936251|NCT01412944|2265411|P2|STARTED|IV: Per CAIN457A2307||22
936252|NCT01412944|2265412|P1|STARTED|IV: Per CAIN457A2307||21
936253|NCT01412944|2265407|P6|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||2
936254|NCT01412944|2265408|P5|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
936255|NCT01412944|2265409|P4|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
936256|NCT01412944|2265410|P3|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||1
936257|NCT01412944|2265411|P2|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
936258|NCT01412944|2265412|P1|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
936259|NCT01412944|2265407|P6|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
936260|NCT01412944|2265408|P5|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
936261|NCT01412944|2265409|P4|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
936262|NCT01412944|2265410|P3|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
936263|NCT01412944|2265411|P2|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
936264|NCT01412944|2265412|P1|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
936265|NCT01412944|2265407|P6|STARTED|IV: Per Previous CAIN457A2304 Treatment||8
936266|NCT01412944|2265408|P5|STARTED|IV: Per Previous CAIN457A2304 Treatment||14
936267|NCT01412944|2265409|P4|STARTED|IV: Per Previous CAIN457A2304 Treatment||6
936268|NCT01412944|2265410|P3|STARTED|IV: Per Previous CAIN457A2304 Treatment||15
936269|NCT01412944|2265411|P2|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
936270|NCT01412944|2265412|P1|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
936271|NCT01412918|2265448|P2|NOT COMPLETED|Overall Study||0
936272|NCT01412918|2265449|P1|NOT COMPLETED|Overall Study||0
936273|NCT01412918|2265448|P2|COMPLETED|Overall Study||1
936274|NCT01412918|2265449|P1|COMPLETED|Overall Study||20
936275|NCT01412918|2265448|P2|STARTED|Overall Study||1
936276|NCT01412918|2265449|P1|STARTED|Overall Study||20
936277|NCT01412879|2265458|P3|NOT COMPLETED|Consolidation Therapy||0
936278|NCT01412879|2265459|P2|NOT COMPLETED|Consolidation Therapy||0
936279|NCT01412879|2265460|P1|NOT COMPLETED|Consolidation Therapy||0
936280|NCT01412879|2265458|P3|COMPLETED|Consolidation Therapy||26
936281|NCT01412879|2265459|P2|COMPLETED|Consolidation Therapy||0
936282|NCT01412879|2265460|P1|COMPLETED|Consolidation Therapy||0
936283|NCT01412879|2265458|P3|STARTED|Consolidation Therapy|Only eligible patients who are able to have stem cell harvested receive consolidation therapy.|26
936284|NCT01412879|2265459|P2|STARTED|Consolidation Therapy||0
936285|NCT01412879|2265460|P1|STARTED|Consolidation Therapy||0
936286|NCT01412879|2265458|P3|NOT COMPLETED|Initial Registration (Induction Therapy)||0
936287|NCT01412879|2265459|P2|NOT COMPLETED|Initial Registration (Induction Therapy)||8
936288|NCT01412879|2265460|P1|NOT COMPLETED|Initial Registration (Induction Therapy)||13
936289|NCT01412879|2265458|P3|COMPLETED|Initial Registration (Induction Therapy)||0
936290|NCT01412879|2265459|P2|COMPLETED|Initial Registration (Induction Therapy)||27
936291|NCT01412879|2265460|P1|COMPLETED|Initial Registration (Induction Therapy)||5
936292|NCT01412879|2265458|P3|Treatment Started|Initial Registration (Induction Therapy)||0
936293|NCT01412879|2265459|P2|Treatment Started|Initial Registration (Induction Therapy)||35
936294|NCT01412879|2265460|P1|Treatment Started|Initial Registration (Induction Therapy)||17
936295|NCT01412879|2265458|P3|STARTED|Initial Registration (Induction Therapy)||0
936296|NCT01412879|2265459|P2|STARTED|Initial Registration (Induction Therapy)||35
936297|NCT01412879|2265460|P1|STARTED|Initial Registration (Induction Therapy)||18
936298|NCT01412801|2265480|P6|NOT COMPLETED|Overall Study||3
936299|NCT01412801|2265481|P5|NOT COMPLETED|Overall Study||3
936300|NCT01412801|2265482|P4|NOT COMPLETED|Overall Study||4
936301|NCT01412801|2265483|P3|NOT COMPLETED|Overall Study||7
936302|NCT01412801|2265484|P2|NOT COMPLETED|Overall Study||5
936303|NCT01412801|2265485|P1|NOT COMPLETED|Overall Study||4
936304|NCT01412801|2265480|P6|COMPLETED|Overall Study||84
936305|NCT01412801|2265481|P5|COMPLETED|Overall Study||85
936306|NCT01412801|2265482|P4|COMPLETED|Overall Study||87
936307|NCT01412801|2265483|P3|COMPLETED|Overall Study||83
936308|NCT01412801|2265484|P2|COMPLETED|Overall Study||84
936309|NCT01412801|2265485|P1|COMPLETED|Overall Study||87
936310|NCT01412801|2265480|P6|STARTED|Overall Study||87
936311|NCT01412801|2265481|P5|STARTED|Overall Study||88
936312|NCT01412801|2265482|P4|STARTED|Overall Study||91
936313|NCT01412801|2265483|P3|STARTED|Overall Study||90
936314|NCT01412801|2265484|P2|STARTED|Overall Study||89
936315|NCT01412801|2265485|P1|STARTED|Overall Study||91
936316|NCT01412541|2265524|P2|NOT COMPLETED|Overall Study||20
936317|NCT01412541|2265525|P1|NOT COMPLETED|Overall Study||36
936318|NCT01412541|2265524|P2|COMPLETED|Overall Study||140
936319|NCT01412541|2265525|P1|COMPLETED|Overall Study||280
936320|NCT01412541|2265524|P2|STARTED|Overall Study||160
936321|NCT01412541|2265525|P1|STARTED|Overall Study||316
936322|NCT01412424|2265633|P1|NOT COMPLETED|Extension Treatment Period||6
936323|NCT01412424|2265633|P1|COMPLETED|Extension Treatment Period||82
936324|NCT01412424|2265633|P1|STARTED|Extension Treatment Period|86% of participants who completed the core period voluntarily entered the optional extension period.|88
936325|NCT01412424|2265633|P1|NOT COMPLETED|Core Treatment Period||53
936326|NCT01412424|2265633|P1|COMPLETED|Core Treatment Period||102
936327|NCT01412424|2265633|P1|STARTED|Core Treatment Period||155
936328|NCT01412333|2265651|P2|NOT COMPLETED|Overall Study||57
936329|NCT01412333|2265652|P1|NOT COMPLETED|Overall Study||98
936330|NCT01412333|2265651|P2|COMPLETED|Overall Study||360
936331|NCT01412333|2265652|P1|COMPLETED|Overall Study||320
936332|NCT01412333|2265651|P2|STARTED|Overall Study||417
936333|NCT01412333|2265652|P1|STARTED|Overall Study||418
936334|NCT01412281|2265687|P4|NOT COMPLETED|Overall Study||0
936335|NCT01412281|2265688|P3|NOT COMPLETED|Overall Study||0
936336|NCT01412281|2265689|P2|NOT COMPLETED|Overall Study||0
936337|NCT01412281|2265690|P1|NOT COMPLETED|Overall Study||0
936338|NCT01412281|2265687|P4|COMPLETED|Overall Study||110
936339|NCT01412281|2265688|P3|COMPLETED|Overall Study||110
936340|NCT01412281|2265689|P2|COMPLETED|Overall Study||110
936341|NCT01412281|2265690|P1|COMPLETED|Overall Study||110
936342|NCT01412281|2265687|P4|STARTED|Overall Study||110
936343|NCT01412281|2265688|P3|STARTED|Overall Study||110
936344|NCT01412281|2265689|P2|STARTED|Overall Study||110
936345|NCT01412281|2265690|P1|STARTED|Overall Study||110
936346|NCT01412229|2265712|P1|NOT COMPLETED|Overall Study||1
936347|NCT01412229|2265712|P1|COMPLETED|Overall Study||38
936348|NCT01412229|2265712|P1|STARTED|Overall Study||39
936349|NCT01412164|2265724|P1|NOT COMPLETED|Overall Study||18
936350|NCT01412164|2265724|P1|COMPLETED|Overall Study||712
936351|NCT01412164|2265724|P1|STARTED|Overall Study||730
936352|NCT01412151|2265728|P1|NOT COMPLETED|Week 306 - 310 - Washout Period||2
936353|NCT01412151|2265728|P1|COMPLETED|Week 306 - 310 - Washout Period||3
936354|NCT01412151|2265728|P1|STARTED|Week 306 - 310 - Washout Period||5
936355|NCT01412151|2265728|P1|NOT COMPLETED|Week 0 - 306 - Treatment Period||5
936356|NCT01412151|2265728|P1|COMPLETED|Week 0 - 306 - Treatment Period||5
936357|NCT01412151|2265728|P1|STARTED|Week 0 - 306 - Treatment Period||10
936358|NCT01412086|2265732|P1|NOT COMPLETED|Overall Study||0
936359|NCT01412086|2265732|P1|COMPLETED|Overall Study||112
936360|NCT01412086|2265732|P1|STARTED|Overall Study||112
936361|NCT01411891|2265739|P2|NOT COMPLETED|Overall Study||2
936362|NCT01411891|2265740|P1|NOT COMPLETED|Overall Study||3
936363|NCT01411891|2265739|P2|COMPLETED|Overall Study||48
936364|NCT01411891|2265740|P1|COMPLETED|Overall Study||47
936365|NCT01411891|2265739|P2|STARTED|Overall Study||50
936366|NCT01411891|2265740|P1|STARTED|Overall Study||50
936379|NCT01411696|2265792|P1|NOT COMPLETED|Overall Study||0
936380|NCT01411696|2265792|P1|COMPLETED|Overall Study||289
936381|NCT01411696|2265792|P1|STARTED|Overall Study||289
936382|NCT01411592|2265801|P2|NOT COMPLETED|Overall Study||0
936383|NCT01411592|2265802|P1|NOT COMPLETED|Overall Study||0
936384|NCT01411592|2265801|P2|COMPLETED|Overall Study||16
936385|NCT01411592|2265802|P1|COMPLETED|Overall Study||14
936386|NCT01411592|2265801|P2|5-Year Time Frame|Overall Study||16
936387|NCT01411592|2265802|P1|5-Year Time Frame|Overall Study||14
936388|NCT01411592|2265801|P2|STARTED|Overall Study||16
936389|NCT01411592|2265802|P1|STARTED|Overall Study||14
936390|NCT01411501|2265814|P4|NOT COMPLETED|Overall Study||7
936391|NCT01411501|2265815|P3|NOT COMPLETED|Overall Study||6
936392|NCT01411501|2265816|P2|NOT COMPLETED|Overall Study||6
936393|NCT01411501|2265817|P1|NOT COMPLETED|Overall Study||10
936394|NCT01411501|2265814|P4|COMPLETED|Overall Study||163
936395|NCT01411501|2265815|P3|COMPLETED|Overall Study||159
936396|NCT01411501|2265816|P2|COMPLETED|Overall Study||166
936397|NCT01411501|2265817|P1|COMPLETED|Overall Study||158
936398|NCT01411501|2265814|P4|STARTED|Overall Study||170
936399|NCT01411501|2265815|P3|STARTED|Overall Study||165
936400|NCT01411501|2265816|P2|STARTED|Overall Study||172
936401|NCT01411501|2265817|P1|STARTED|Overall Study||168
936402|NCT01411488|2265849|P2|NOT COMPLETED|Overall Study||5
936403|NCT01411488|2265850|P1|NOT COMPLETED|Overall Study||6
936404|NCT01411488|2265849|P2|COMPLETED|Overall Study||38
936405|NCT01411488|2265850|P1|COMPLETED|Overall Study||41
936406|NCT01411488|2265849|P2|STARTED|Overall Study||43
936407|NCT01411488|2265850|P1|STARTED|Overall Study||47
936408|NCT01411228|2265859|P3|NOT COMPLETED|Overall Study||1
936409|NCT01411228|2265860|P2|NOT COMPLETED|Overall Study||0
936410|NCT01411228|2265861|P1|NOT COMPLETED|Overall Study||1
936411|NCT01411228|2265859|P3|COMPLETED|Overall Study||4
936412|NCT01411228|2265860|P2|COMPLETED|Overall Study||5
936413|NCT01411228|2265861|P1|COMPLETED|Overall Study||4
936414|NCT01411228|2265859|P3|STARTED|Overall Study||5
936415|NCT01411228|2265860|P2|STARTED|Overall Study||5
936416|NCT01411228|2265861|P1|STARTED|Overall Study||5
936417|NCT01411215|2265883|P2|NOT COMPLETED|Overall Study||84
936418|NCT01411215|2265884|P1|NOT COMPLETED|Overall Study||66
936419|NCT01411215|2265883|P2|COMPLETED|Overall Study||7
936420|NCT01411215|2265884|P1|COMPLETED|Overall Study||3
936421|NCT01411215|2265883|P2|Treated|Overall Study|1 participant was considered as screen failure and therefore not treated.|90
936422|NCT01411215|2265884|P1|Treated|Overall Study||69
936423|NCT01411215|2265883|P2|STARTED|Overall Study||91
936424|NCT01411215|2265884|P1|STARTED|Overall Study||69
936425|NCT01411137|2265917|P1|NOT COMPLETED|Part 3: Open-Label Extension||0
936426|NCT01411137|2265917|P1|COMPLETED|Part 3: Open-Label Extension||12
936427|NCT01411137|2265917|P1|STARTED|Part 3: Open-Label Extension|Two sites with 11 completers of Part 2 did not participate in Part 3. Two subjects lost contact.|12
936428|NCT01411137|2265917|P1|NOT COMPLETED|Part 2: Open-Label Extension||7
936429|NCT01411137|2265917|P1|COMPLETED|Part 2: Open-Label Extension||25
936430|NCT01411137|2265917|P1|STARTED|Part 2: Open-Label Extension|1 subject who completed Part 1 did not elect to continue into Part 2.|32
936431|NCT01411137|2265917|P1|NOT COMPLETED|Part 1: Dose Conversion||10
936432|NCT01411137|2265917|P1|COMPLETED|Part 1: Dose Conversion||33
936433|NCT01411137|2265917|P1|STARTED|Part 1: Dose Conversion||43
936434|NCT01410773|2265936|P1|NOT COMPLETED|Overall Study||0
936435|NCT01410773|2265936|P1|COMPLETED|Overall Study||110
936436|NCT01410773|2265936|P1|STARTED|Overall Study||110
936437|NCT01410604|2265943|P2|NOT COMPLETED|Overall Study||2
936438|NCT01410604|2265944|P1|NOT COMPLETED|Overall Study||3
936439|NCT01410604|2265943|P2|COMPLETED|Overall Study||14
936440|NCT01410604|2265944|P1|COMPLETED|Overall Study||12
936441|NCT01410604|2265943|P2|STARTED|Overall Study||16
936442|NCT01410604|2265944|P1|STARTED|Overall Study||15
936443|NCT01410565|2265966|P3|NOT COMPLETED|Double Blind Phase||0
936444|NCT01410565|2265967|P2|NOT COMPLETED|Double Blind Phase||15
936445|NCT01410565|2265968|P1|NOT COMPLETED|Double Blind Phase||13
936446|NCT01410565|2265966|P3|COMPLETED|Double Blind Phase||0
936447|NCT01410565|2265967|P2|COMPLETED|Double Blind Phase||0
936448|NCT01410565|2265968|P1|COMPLETED|Double Blind Phase||0
936449|NCT01410565|2265966|P3|STARTED|Double Blind Phase||0
936450|NCT01410565|2265967|P2|STARTED|Double Blind Phase||15
936451|NCT01410565|2265968|P1|STARTED|Double Blind Phase|All 66 patients received one dose of Apaziquone in the open label phase.|13
936452|NCT01410565|2265966|P3|NOT COMPLETED|Open Label Phase Apaziquone||8
936453|NCT01410565|2265967|P2|NOT COMPLETED|Open Label Phase Apaziquone||0
936454|NCT01410565|2265968|P1|NOT COMPLETED|Open Label Phase Apaziquone||0
936455|NCT01410565|2265966|P3|COMPLETED|Open Label Phase Apaziquone||58
936456|NCT01410565|2265967|P2|COMPLETED|Open Label Phase Apaziquone||0
936457|NCT01410565|2265968|P1|COMPLETED|Open Label Phase Apaziquone||0
936458|NCT01410565|2265966|P3|STARTED|Open Label Phase Apaziquone||66
936459|NCT01410565|2265967|P2|STARTED|Open Label Phase Apaziquone||0
936460|NCT01410565|2265968|P1|STARTED|Open Label Phase Apaziquone||0
936461|NCT01410474|2265980|P2|NOT COMPLETED|Overall Study||1
936462|NCT01410474|2265981|P1|NOT COMPLETED|Overall Study||0
936463|NCT01410474|2265980|P2|COMPLETED|Overall Study||167
936464|NCT01410474|2265981|P1|COMPLETED|Overall Study||173
936465|NCT01410474|2265980|P2|STARTED|Overall Study||168
936466|NCT01410474|2265981|P1|STARTED|Overall Study||173
936467|NCT01410448|2266004|P2|NOT COMPLETED|Overall Study||35
936468|NCT01410448|2266005|P1|NOT COMPLETED|Overall Study||12
936469|NCT01410448|2266004|P2|COMPLETED|Overall Study||155
936470|NCT01410448|2266005|P1|COMPLETED|Overall Study||181
936471|NCT01410448|2266004|P2|Modified ITT Analysis Set|Overall Study||149
936472|NCT01410448|2266005|P1|Modified ITT Analysis Set|Overall Study||161
936473|NCT01410448|2266004|P2|Intent-to Treat (ITT) Analysis Set|Overall Study||190
936474|NCT01410448|2266005|P1|Intent-to Treat (ITT) Analysis Set|Overall Study||193
936475|NCT01410448|2266004|P2|STARTED|Overall Study||190
936476|NCT01410448|2266005|P1|STARTED|Overall Study||193
936483|NCT01410357|2266070|P2|NOT COMPLETED|Overall Study||24
936484|NCT01410357|2266071|P1|NOT COMPLETED|Overall Study||26
936485|NCT01410357|2266070|P2|COMPLETED|Overall Study||76
936486|NCT01410357|2266071|P1|COMPLETED|Overall Study||74
936487|NCT01410357|2266070|P2|STARTED|Overall Study||100
936488|NCT01410357|2266071|P1|STARTED|Overall Study||100
936489|NCT01410240|2266128|P3|NOT COMPLETED|Overall Study||2
936490|NCT01410240|2266129|P2|NOT COMPLETED|Overall Study||1
936491|NCT01410240|2266130|P1|NOT COMPLETED|Overall Study||1
936492|NCT01410240|2266128|P3|COMPLETED|Overall Study||10
936493|NCT01410240|2266129|P2|COMPLETED|Overall Study||52
936494|NCT01410240|2266130|P1|COMPLETED|Overall Study||52
936495|NCT01410240|2266128|P3|STARTED|Overall Study||12
936496|NCT01410240|2266129|P2|STARTED|Overall Study||53
936497|NCT01410240|2266130|P1|STARTED|Overall Study||53
936498|NCT01410227|2266201|P4|NOT COMPLETED|Overall Study||1
936499|NCT01410227|2266202|P3|NOT COMPLETED|Overall Study||2
936500|NCT01410227|2266203|P2|NOT COMPLETED|Overall Study||0
936501|NCT01410227|2266204|P1|NOT COMPLETED|Overall Study||4
936502|NCT01410227|2266201|P4|COMPLETED|Overall Study||5
936503|NCT01410227|2266202|P3|COMPLETED|Overall Study||13
936504|NCT01410227|2266203|P2|COMPLETED|Overall Study||8
936505|NCT01410227|2266204|P1|COMPLETED|Overall Study||4
936506|NCT01410227|2266201|P4|STARTED|Overall Study||6
936507|NCT01410227|2266202|P3|STARTED|Overall Study||15
936508|NCT01410227|2266203|P2|STARTED|Overall Study||8
936509|NCT01410227|2266204|P1|STARTED|Overall Study||8
936510|NCT01410110|2266276|P2|NOT COMPLETED|Overall Study||2
936511|NCT01410110|2266277|P1|NOT COMPLETED|Overall Study||4
936512|NCT01410110|2266276|P2|COMPLETED|Overall Study||22
936513|NCT01410110|2266277|P1|COMPLETED|Overall Study||20
936514|NCT01410110|2266276|P2|6 Month Follow-up|Overall Study||22
936515|NCT01410110|2266277|P1|6 Month Follow-up|Overall Study||20
936516|NCT01410110|2266276|P2|3 Months (End of Intervention)|Overall Study||22
936517|NCT01410110|2266277|P1|3 Months (End of Intervention)|Overall Study||20
936518|NCT01410110|2266276|P2|Randomization|Overall Study||24
936519|NCT01410110|2266277|P1|Randomization|Overall Study||24
936520|NCT01410110|2266276|P2|STARTED|Overall Study||24
936521|NCT01410110|2266277|P1|STARTED|Overall Study||24
936522|NCT01409993|2266301|P4|NOT COMPLETED|Overall Study||5
936523|NCT01409993|2266302|P3|NOT COMPLETED|Overall Study||3
936524|NCT01409993|2266303|P2|NOT COMPLETED|Overall Study||5
936525|NCT01409993|2266304|P1|NOT COMPLETED|Overall Study||4
936526|NCT01409993|2266301|P4|COMPLETED|Overall Study||8
936527|NCT01409993|2266302|P3|COMPLETED|Overall Study||11
936528|NCT01409993|2266303|P2|COMPLETED|Overall Study||21
936529|NCT01409993|2266304|P1|COMPLETED|Overall Study||21
936530|NCT01409993|2266301|P4|STARTED|Overall Study||13
936531|NCT01409993|2266302|P3|STARTED|Overall Study||14
936532|NCT01409993|2266303|P2|STARTED|Overall Study||26
936533|NCT01409993|2266304|P1|STARTED|Overall Study||25
936534|NCT01409837|2266324|P2|NOT COMPLETED|Overall Study||2
936535|NCT01409837|2266325|P1|NOT COMPLETED|Overall Study||3
936536|NCT01409837|2266324|P2|COMPLETED|Overall Study||14
936537|NCT01409837|2266325|P1|COMPLETED|Overall Study||14
936538|NCT01409837|2266324|P2|282nd Week|Overall Study||14
936539|NCT01409837|2266325|P1|282nd Week|Overall Study||14
936540|NCT01409837|2266324|P2|186th Week|Overall Study||14
936541|NCT01409837|2266325|P1|186th Week|Overall Study|Moved away to another location|14
936542|NCT01409837|2266324|P2|138th Week|Overall Study||14
936543|NCT01409837|2266325|P1|138th Week|Overall Study||15
936544|NCT01409837|2266324|P2|114th Week|Overall Study||14
936545|NCT01409837|2266325|P1|114th Week|Overall Study||15
936546|NCT01409837|2266324|P2|102nd Week|Overall Study|Married another wife|14
936547|NCT01409837|2266325|P1|102nd Week|Overall Study||15
936548|NCT01409837|2266324|P2|96th Week|Overall Study||15
936549|NCT01409837|2266325|P1|96th Week|Overall Study||15
936550|NCT01409837|2266324|P2|48th Week|Overall Study||15
936551|NCT01409837|2266325|P1|48th Week|Overall Study|Lost to follow-up|15
936552|NCT01409837|2266324|P2|24th Week|Overall Study|Diagnosed with Lymphocytic Lymphoma and withdrawn|15
936553|NCT01409837|2266325|P1|24th Week|Overall Study||16
936554|NCT01409837|2266324|P2|12th Week|Overall Study||16
936555|NCT01409837|2266325|P1|12th Week|Overall Study|Moved away to another location|16
936556|NCT01409837|2266324|P2|6th Week|Overall Study||16
936557|NCT01409837|2266325|P1|6th Week|Overall Study||17
936558|NCT01409837|2266324|P2|STARTED|Overall Study||16
936559|NCT01409837|2266325|P1|STARTED|Overall Study||17
936560|NCT01409707|2266350|P3|NOT COMPLETED|Overall Study||16
936561|NCT01409707|2266351|P2|NOT COMPLETED|Overall Study||17
936562|NCT01409707|2266352|P1|NOT COMPLETED|Overall Study||5
936563|NCT01409707|2266350|P3|COMPLETED|Overall Study||24
936564|NCT01409707|2266351|P2|COMPLETED|Overall Study||28
936565|NCT01409707|2266352|P1|COMPLETED|Overall Study||36
936566|NCT01409707|2266350|P3|STARTED|Overall Study||40
936567|NCT01409707|2266351|P2|STARTED|Overall Study||45
936568|NCT01409707|2266352|P1|STARTED|Overall Study||41
936569|NCT01409564|2266364|P2|NOT COMPLETED|Overall Study||5
936570|NCT01409564|2266365|P1|NOT COMPLETED|Overall Study||5
936571|NCT01409564|2266364|P2|COMPLETED|Overall Study||18
936572|NCT01409564|2266365|P1|COMPLETED|Overall Study||18
936573|NCT01409564|2266364|P2|STARTED|Overall Study||23
936574|NCT01409564|2266365|P1|STARTED|Overall Study||23
936575|NCT01409434|2266383|P1|NOT COMPLETED|Overall Study||4
936576|NCT01409434|2266383|P1|COMPLETED|Overall Study||40
936577|NCT01409434|2266383|P1|STARTED|Overall Study||44
936578|NCT01409382|2266393|P2|NOT COMPLETED|Overall Study||80
936579|NCT01409382|2266394|P1|NOT COMPLETED|Overall Study||81
936580|NCT01409382|2266393|P2|COMPLETED|Overall Study||160
936581|NCT01409382|2266394|P1|COMPLETED|Overall Study||159
936582|NCT01409382|2266393|P2|STARTED|Overall Study||240
936583|NCT01409382|2266394|P1|STARTED|Overall Study||240
936584|NCT01409291|2266408|P2|NOT COMPLETED|Overall Study||9
936585|NCT01409291|2266409|P1|NOT COMPLETED|Overall Study||7
936586|NCT01409291|2266408|P2|COMPLETED|Overall Study||19
936587|NCT01409291|2266409|P1|COMPLETED|Overall Study||29
936588|NCT01409291|2266408|P2|STARTED|Overall Study||28
936589|NCT01409291|2266409|P1|STARTED|Overall Study||36
936590|NCT01409239|2266419|P2|NOT COMPLETED|Overall Study||0
936591|NCT01409239|2266420|P1|NOT COMPLETED|Overall Study||0
936592|NCT01409239|2266419|P2|COMPLETED|Overall Study||17
936593|NCT01409239|2266420|P1|COMPLETED|Overall Study||16
936594|NCT01409239|2266419|P2|STARTED|Overall Study||17
936595|NCT01409239|2266420|P1|STARTED|Overall Study||16
936596|NCT01409213|2266426|P1|NOT COMPLETED|Overall Study||0
936597|NCT01409213|2266426|P1|COMPLETED|Overall Study||1523
936598|NCT01409213|2266426|P1|STARTED|Overall Study||1523
936605|NCT01408992|2266446|P1|NOT COMPLETED|Overall Study||0
936606|NCT01408992|2266446|P1|COMPLETED|Overall Study||558
936607|NCT01408992|2266446|P1|STARTED|Overall Study||558
936608|NCT01408914|2266461|P3|NOT COMPLETED|Overall Study||13
936609|NCT01408914|2266462|P2|NOT COMPLETED|Overall Study||12
936610|NCT01408914|2266463|P1|NOT COMPLETED|Overall Study||12
936611|NCT01408914|2266461|P3|COMPLETED|Overall Study||47
936612|NCT01408914|2266462|P2|COMPLETED|Overall Study||48
936613|NCT01408914|2266463|P1|COMPLETED|Overall Study||48
936614|NCT01408914|2266461|P3|STARTED|Overall Study||60
936615|NCT01408914|2266462|P2|STARTED|Overall Study||60
936616|NCT01408914|2266463|P1|STARTED|Overall Study||60
936617|NCT01408888|2266477|P2|NOT COMPLETED|Second Intervention||0
936618|NCT01408888|2266478|P1|NOT COMPLETED|Second Intervention||2
936619|NCT01408888|2266477|P2|COMPLETED|Second Intervention||8
936620|NCT01408888|2266478|P1|COMPLETED|Second Intervention||16
936621|NCT01408888|2266477|P2|STARTED|Second Intervention||8
936622|NCT01408888|2266478|P1|STARTED|Second Intervention||18
936623|NCT01408888|2266477|P2|NOT COMPLETED|Washout of at Least 21 Days||0
936624|NCT01408888|2266478|P1|NOT COMPLETED|Washout of at Least 21 Days||0
936625|NCT01408888|2266477|P2|COMPLETED|Washout of at Least 21 Days||8
936626|NCT01408888|2266478|P1|COMPLETED|Washout of at Least 21 Days||18
936627|NCT01408888|2266477|P2|STARTED|Washout of at Least 21 Days||8
936628|NCT01408888|2266478|P1|STARTED|Washout of at Least 21 Days||18
936629|NCT01408888|2266477|P2|NOT COMPLETED|First Intervention||3
936630|NCT01408888|2266478|P1|NOT COMPLETED|First Intervention||0
936631|NCT01408888|2266477|P2|COMPLETED|First Intervention||8
936632|NCT01408888|2266478|P1|COMPLETED|First Intervention||18
936633|NCT01408888|2266477|P2|Received at Least 1 Dose of Drug|First Intervention||11
936634|NCT01408888|2266478|P1|Received at Least 1 Dose of Drug|First Intervention||18
936635|NCT01408888|2266477|P2|STARTED|First Intervention||11
936636|NCT01408888|2266478|P1|STARTED|First Intervention||18
936637|NCT01408862|2266501|P1|NOT COMPLETED|Overall Study||0
936638|NCT01408862|2266501|P1|COMPLETED|Overall Study||20
936639|NCT01408862|2266501|P1|STARTED|Overall Study||20
936640|NCT01408719|2266526|P20|NOT COMPLETED|Fourth Intervention (35 Days)||0
936641|NCT01408719|2266527|P19|NOT COMPLETED|Fourth Intervention (35 Days)||0
936642|NCT01408719|2266528|P18|NOT COMPLETED|Fourth Intervention (35 Days)||0
936643|NCT01408719|2266529|P17|NOT COMPLETED|Fourth Intervention (35 Days)||0
936644|NCT01408719|2266530|P16|NOT COMPLETED|Fourth Intervention (35 Days)||0
936645|NCT01408719|2266531|P15|NOT COMPLETED|Fourth Intervention (35 Days)||0
936646|NCT01408719|2266532|P14|NOT COMPLETED|Fourth Intervention (35 Days)||0
936647|NCT01408719|2266533|P13|NOT COMPLETED|Fourth Intervention (35 Days)||0
936648|NCT01408719|2266534|P12|NOT COMPLETED|Fourth Intervention (35 Days)||0
936649|NCT01408719|2266535|P11|NOT COMPLETED|Fourth Intervention (35 Days)||0
936650|NCT01408719|2266536|P10|NOT COMPLETED|Fourth Intervention (35 Days)||0
936651|NCT01408719|2266537|P9|NOT COMPLETED|Fourth Intervention (35 Days)||0
936652|NCT01408719|2266538|P8|NOT COMPLETED|Fourth Intervention (35 Days)||0
936653|NCT01408719|2266539|P7|NOT COMPLETED|Fourth Intervention (35 Days)||0
936654|NCT01408719|2266540|P6|NOT COMPLETED|Fourth Intervention (35 Days)||0
936655|NCT01408719|2266541|P5|NOT COMPLETED|Fourth Intervention (35 Days)||0
936656|NCT01408719|2266542|P4|NOT COMPLETED|Fourth Intervention (35 Days)||0
936657|NCT01408719|2266543|P3|NOT COMPLETED|Fourth Intervention (35 Days)||0
936658|NCT01408719|2266544|P2|NOT COMPLETED|Fourth Intervention (35 Days)||0
936659|NCT01408719|2266545|P1|NOT COMPLETED|Fourth Intervention (35 Days)||0
936660|NCT01408719|2266526|P20|COMPLETED|Fourth Intervention (35 Days)||1
936661|NCT01408719|2266527|P19|COMPLETED|Fourth Intervention (35 Days)||0
936662|NCT01408719|2266528|P18|COMPLETED|Fourth Intervention (35 Days)||2
936663|NCT01408719|2266529|P17|COMPLETED|Fourth Intervention (35 Days)||2
936664|NCT01408719|2266530|P16|COMPLETED|Fourth Intervention (35 Days)||1
936665|NCT01408719|2266531|P15|COMPLETED|Fourth Intervention (35 Days)||1
936666|NCT01408719|2266532|P14|COMPLETED|Fourth Intervention (35 Days)||3
936667|NCT01408719|2266533|P13|COMPLETED|Fourth Intervention (35 Days)||1
936668|NCT01408719|2266534|P12|COMPLETED|Fourth Intervention (35 Days)||2
936669|NCT01408719|2266535|P11|COMPLETED|Fourth Intervention (35 Days)||2
936670|NCT01408719|2266536|P10|COMPLETED|Fourth Intervention (35 Days)||1
936671|NCT01408719|2266537|P9|COMPLETED|Fourth Intervention (35 Days)||1
936672|NCT01408719|2266538|P8|COMPLETED|Fourth Intervention (35 Days)||2
936673|NCT01408719|2266539|P7|COMPLETED|Fourth Intervention (35 Days)||2
936674|NCT01408719|2266540|P6|COMPLETED|Fourth Intervention (35 Days)||3
936675|NCT01408719|2266541|P5|COMPLETED|Fourth Intervention (35 Days)||3
936676|NCT01408719|2266542|P4|COMPLETED|Fourth Intervention (35 Days)||2
936677|NCT01408719|2266543|P3|COMPLETED|Fourth Intervention (35 Days)||1
936678|NCT01408719|2266544|P2|COMPLETED|Fourth Intervention (35 Days)||3
936679|NCT01408719|2266545|P1|COMPLETED|Fourth Intervention (35 Days)||2
936680|NCT01408719|2266526|P20|STARTED|Fourth Intervention (35 Days)||1
936681|NCT01408719|2266527|P19|STARTED|Fourth Intervention (35 Days)||0
936682|NCT01408719|2266528|P18|STARTED|Fourth Intervention (35 Days)||2
936683|NCT01408719|2266529|P17|STARTED|Fourth Intervention (35 Days)||2
936684|NCT01408719|2266530|P16|STARTED|Fourth Intervention (35 Days)||1
936685|NCT01408719|2266531|P15|STARTED|Fourth Intervention (35 Days)||1
936686|NCT01408719|2266532|P14|STARTED|Fourth Intervention (35 Days)||3
936687|NCT01408719|2266533|P13|STARTED|Fourth Intervention (35 Days)||1
936688|NCT01408719|2266534|P12|STARTED|Fourth Intervention (35 Days)||2
936689|NCT01408719|2266535|P11|STARTED|Fourth Intervention (35 Days)||2
936690|NCT01408719|2266536|P10|STARTED|Fourth Intervention (35 Days)||1
936691|NCT01408719|2266537|P9|STARTED|Fourth Intervention (35 Days)||1
936692|NCT01408719|2266538|P8|STARTED|Fourth Intervention (35 Days)||2
936693|NCT01408719|2266539|P7|STARTED|Fourth Intervention (35 Days)||2
936694|NCT01408719|2266540|P6|STARTED|Fourth Intervention (35 Days)||3
936695|NCT01408719|2266541|P5|STARTED|Fourth Intervention (35 Days)||3
936696|NCT01408719|2266542|P4|STARTED|Fourth Intervention (35 Days)||2
936697|NCT01408719|2266543|P3|STARTED|Fourth Intervention (35 Days)||1
936698|NCT01408719|2266544|P2|STARTED|Fourth Intervention (35 Days)||3
936699|NCT01408719|2266545|P1|STARTED|Fourth Intervention (35 Days)||2
936700|NCT01408719|2266526|P20|NOT COMPLETED|Washout Period (28 Days)||0
936701|NCT01408719|2266527|P19|NOT COMPLETED|Washout Period (28 Days)||0
936702|NCT01408719|2266528|P18|NOT COMPLETED|Washout Period (28 Days)||0
936703|NCT01408719|2266529|P17|NOT COMPLETED|Washout Period (28 Days)||0
936704|NCT01408719|2266530|P16|NOT COMPLETED|Washout Period (28 Days)||0
936705|NCT01408719|2266531|P15|NOT COMPLETED|Washout Period (28 Days)||0
936706|NCT01408719|2266532|P14|NOT COMPLETED|Washout Period (28 Days)||0
936707|NCT01408719|2266533|P13|NOT COMPLETED|Washout Period (28 Days)||0
936708|NCT01408719|2266534|P12|NOT COMPLETED|Washout Period (28 Days)||0
936709|NCT01408719|2266535|P11|NOT COMPLETED|Washout Period (28 Days)||0
936710|NCT01408719|2266536|P10|NOT COMPLETED|Washout Period (28 Days)||0
936711|NCT01408719|2266537|P9|NOT COMPLETED|Washout Period (28 Days)||0
936712|NCT01408719|2266538|P8|NOT COMPLETED|Washout Period (28 Days)||0
936713|NCT01408719|2266539|P7|NOT COMPLETED|Washout Period (28 Days)||0
936714|NCT01408719|2266540|P6|NOT COMPLETED|Washout Period (28 Days)||0
936715|NCT01408719|2266541|P5|NOT COMPLETED|Washout Period (28 Days)||0
936716|NCT01408719|2266542|P4|NOT COMPLETED|Washout Period (28 Days)||0
936717|NCT01408719|2266543|P3|NOT COMPLETED|Washout Period (28 Days)||0
936718|NCT01408719|2266544|P2|NOT COMPLETED|Washout Period (28 Days)||0
936719|NCT01408719|2266545|P1|NOT COMPLETED|Washout Period (28 Days)||0
936720|NCT01408719|2266526|P20|COMPLETED|Washout Period (28 Days)||1
936721|NCT01408719|2266527|P19|COMPLETED|Washout Period (28 Days)||0
936722|NCT01408719|2266528|P18|COMPLETED|Washout Period (28 Days)||2
936723|NCT01408719|2266529|P17|COMPLETED|Washout Period (28 Days)||2
936724|NCT01408719|2266530|P16|COMPLETED|Washout Period (28 Days)||1
936725|NCT01408719|2266531|P15|COMPLETED|Washout Period (28 Days)||1
936726|NCT01408719|2266532|P14|COMPLETED|Washout Period (28 Days)||3
936727|NCT01408719|2266533|P13|COMPLETED|Washout Period (28 Days)||1
936728|NCT01408719|2266534|P12|COMPLETED|Washout Period (28 Days)||2
936729|NCT01408719|2266535|P11|COMPLETED|Washout Period (28 Days)||2
936730|NCT01408719|2266536|P10|COMPLETED|Washout Period (28 Days)||1
936731|NCT01408719|2266537|P9|COMPLETED|Washout Period (28 Days)||1
936732|NCT01408719|2266538|P8|COMPLETED|Washout Period (28 Days)||2
936733|NCT01408719|2266539|P7|COMPLETED|Washout Period (28 Days)||2
936734|NCT01408719|2266540|P6|COMPLETED|Washout Period (28 Days)||3
936735|NCT01408719|2266541|P5|COMPLETED|Washout Period (28 Days)||3
936736|NCT01408719|2266542|P4|COMPLETED|Washout Period (28 Days)||2
936737|NCT01408719|2266543|P3|COMPLETED|Washout Period (28 Days)||1
936738|NCT01408719|2266544|P2|COMPLETED|Washout Period (28 Days)||3
936739|NCT01408719|2266545|P1|COMPLETED|Washout Period (28 Days)||2
936740|NCT01408719|2266526|P20|STARTED|Washout Period (28 Days)||1
936741|NCT01408719|2266527|P19|STARTED|Washout Period (28 Days)||0
936742|NCT01408719|2266528|P18|STARTED|Washout Period (28 Days)||2
936743|NCT01408719|2266529|P17|STARTED|Washout Period (28 Days)||2
936744|NCT01408719|2266530|P16|STARTED|Washout Period (28 Days)||1
936745|NCT01408719|2266531|P15|STARTED|Washout Period (28 Days)||1
936746|NCT01408719|2266532|P14|STARTED|Washout Period (28 Days)||3
936747|NCT01408719|2266533|P13|STARTED|Washout Period (28 Days)||1
936748|NCT01408719|2266534|P12|STARTED|Washout Period (28 Days)||2
936749|NCT01408719|2266535|P11|STARTED|Washout Period (28 Days)||2
936750|NCT01408719|2266536|P10|STARTED|Washout Period (28 Days)||1
936751|NCT01408719|2266537|P9|STARTED|Washout Period (28 Days)||1
936752|NCT01408719|2266538|P8|STARTED|Washout Period (28 Days)||2
936753|NCT01408719|2266539|P7|STARTED|Washout Period (28 Days)||2
936754|NCT01408719|2266540|P6|STARTED|Washout Period (28 Days)||3
936755|NCT01408719|2266541|P5|STARTED|Washout Period (28 Days)||3
936756|NCT01408719|2266542|P4|STARTED|Washout Period (28 Days)||2
936757|NCT01408719|2266543|P3|STARTED|Washout Period (28 Days)||1
936758|NCT01408719|2266544|P2|STARTED|Washout Period (28 Days)||3
936759|NCT01408719|2266545|P1|STARTED|Washout Period (28 Days)||2
936760|NCT01408719|2266526|P20|NOT COMPLETED|Third Intervention (35 Days)||0
936761|NCT01408719|2266527|P19|NOT COMPLETED|Third Intervention (35 Days)||0
936762|NCT01408719|2266528|P18|NOT COMPLETED|Third Intervention (35 Days)||0
936763|NCT01408719|2266529|P17|NOT COMPLETED|Third Intervention (35 Days)||0
936764|NCT01408719|2266530|P16|NOT COMPLETED|Third Intervention (35 Days)||0
936765|NCT01408719|2266531|P15|NOT COMPLETED|Third Intervention (35 Days)||0
936766|NCT01408719|2266532|P14|NOT COMPLETED|Third Intervention (35 Days)||0
936767|NCT01408719|2266533|P13|NOT COMPLETED|Third Intervention (35 Days)||0
936768|NCT01408719|2266534|P12|NOT COMPLETED|Third Intervention (35 Days)||0
936769|NCT01408719|2266535|P11|NOT COMPLETED|Third Intervention (35 Days)||0
936770|NCT01408719|2266536|P10|NOT COMPLETED|Third Intervention (35 Days)||0
936771|NCT01408719|2266537|P9|NOT COMPLETED|Third Intervention (35 Days)||0
936772|NCT01408719|2266538|P8|NOT COMPLETED|Third Intervention (35 Days)||1
936773|NCT01408719|2266539|P7|NOT COMPLETED|Third Intervention (35 Days)||0
936774|NCT01408719|2266540|P6|NOT COMPLETED|Third Intervention (35 Days)||0
936775|NCT01408719|2266541|P5|NOT COMPLETED|Third Intervention (35 Days)||0
936776|NCT01408719|2266542|P4|NOT COMPLETED|Third Intervention (35 Days)||0
936777|NCT01408719|2266543|P3|NOT COMPLETED|Third Intervention (35 Days)||0
936778|NCT01408719|2266544|P2|NOT COMPLETED|Third Intervention (35 Days)||0
936779|NCT01408719|2266545|P1|NOT COMPLETED|Third Intervention (35 Days)||0
936780|NCT01408719|2266526|P20|COMPLETED|Third Intervention (35 Days)||1
936781|NCT01408719|2266527|P19|COMPLETED|Third Intervention (35 Days)||0
936782|NCT01408719|2266528|P18|COMPLETED|Third Intervention (35 Days)||2
936783|NCT01408719|2266529|P17|COMPLETED|Third Intervention (35 Days)||2
936784|NCT01408719|2266530|P16|COMPLETED|Third Intervention (35 Days)||1
936785|NCT01408719|2266531|P15|COMPLETED|Third Intervention (35 Days)||1
936786|NCT01408719|2266532|P14|COMPLETED|Third Intervention (35 Days)||3
936787|NCT01408719|2266533|P13|COMPLETED|Third Intervention (35 Days)||2
936788|NCT01408719|2266534|P12|COMPLETED|Third Intervention (35 Days)||2
936789|NCT01408719|2266535|P11|COMPLETED|Third Intervention (35 Days)||2
936790|NCT01408719|2266536|P10|COMPLETED|Third Intervention (35 Days)||1
936791|NCT01408719|2266537|P9|COMPLETED|Third Intervention (35 Days)||1
936792|NCT01408719|2266538|P8|COMPLETED|Third Intervention (35 Days)||2
936793|NCT01408719|2266539|P7|COMPLETED|Third Intervention (35 Days)||2
936794|NCT01408719|2266540|P6|COMPLETED|Third Intervention (35 Days)||3
936795|NCT01408719|2266541|P5|COMPLETED|Third Intervention (35 Days)||3
936796|NCT01408719|2266542|P4|COMPLETED|Third Intervention (35 Days)||2
936797|NCT01408719|2266543|P3|COMPLETED|Third Intervention (35 Days)||1
936798|NCT01408719|2266544|P2|COMPLETED|Third Intervention (35 Days)||3
936799|NCT01408719|2266545|P1|COMPLETED|Third Intervention (35 Days)||2
936800|NCT01408719|2266526|P20|STARTED|Third Intervention (35 Days)||1
936801|NCT01408719|2266527|P19|STARTED|Third Intervention (35 Days)||0
936802|NCT01408719|2266528|P18|STARTED|Third Intervention (35 Days)||2
936803|NCT01408719|2266529|P17|STARTED|Third Intervention (35 Days)||2
936804|NCT01408719|2266530|P16|STARTED|Third Intervention (35 Days)||1
936805|NCT01408719|2266531|P15|STARTED|Third Intervention (35 Days)||1
936806|NCT01408719|2266532|P14|STARTED|Third Intervention (35 Days)||3
936807|NCT01408719|2266533|P13|STARTED|Third Intervention (35 Days)||2
936808|NCT01408719|2266534|P12|STARTED|Third Intervention (35 Days)||2
936809|NCT01408719|2266535|P11|STARTED|Third Intervention (35 Days)||2
936810|NCT01408719|2266536|P10|STARTED|Third Intervention (35 Days)||1
936811|NCT01408719|2266537|P9|STARTED|Third Intervention (35 Days)||1
936812|NCT01408719|2266538|P8|STARTED|Third Intervention (35 Days)||3
936813|NCT01408719|2266539|P7|STARTED|Third Intervention (35 Days)||2
936814|NCT01408719|2266540|P6|STARTED|Third Intervention (35 Days)||3
936815|NCT01408719|2266541|P5|STARTED|Third Intervention (35 Days)||3
936816|NCT01408719|2266542|P4|STARTED|Third Intervention (35 Days)||2
936817|NCT01408719|2266543|P3|STARTED|Third Intervention (35 Days)||1
936818|NCT01408719|2266544|P2|STARTED|Third Intervention (35 Days)||3
936819|NCT01408719|2266545|P1|STARTED|Third Intervention (35 Days)||2
936820|NCT01408719|2266526|P20|NOT COMPLETED|Washout Period (28 Days)||0
936821|NCT01408719|2266527|P19|NOT COMPLETED|Washout Period (28 Days)||0
936822|NCT01408719|2266528|P18|NOT COMPLETED|Washout Period (28 Days)||0
936823|NCT01408719|2266529|P17|NOT COMPLETED|Washout Period (28 Days)||0
936824|NCT01408719|2266530|P16|NOT COMPLETED|Washout Period (28 Days)||0
936825|NCT01408719|2266531|P15|NOT COMPLETED|Washout Period (28 Days)||0
936826|NCT01408719|2266532|P14|NOT COMPLETED|Washout Period (28 Days)||0
936827|NCT01408719|2266533|P13|NOT COMPLETED|Washout Period (28 Days)||0
936828|NCT01408719|2266534|P12|NOT COMPLETED|Washout Period (28 Days)||0
936829|NCT01408719|2266535|P11|NOT COMPLETED|Washout Period (28 Days)||0
936830|NCT01408719|2266536|P10|NOT COMPLETED|Washout Period (28 Days)||0
936831|NCT01408719|2266537|P9|NOT COMPLETED|Washout Period (28 Days)||0
936832|NCT01408719|2266538|P8|NOT COMPLETED|Washout Period (28 Days)||0
936833|NCT01408719|2266539|P7|NOT COMPLETED|Washout Period (28 Days)||0
936834|NCT01408719|2266540|P6|NOT COMPLETED|Washout Period (28 Days)||0
936835|NCT01408719|2266541|P5|NOT COMPLETED|Washout Period (28 Days)||0
936836|NCT01408719|2266542|P4|NOT COMPLETED|Washout Period (28 Days)||0
936837|NCT01408719|2266543|P3|NOT COMPLETED|Washout Period (28 Days)||0
936838|NCT01408719|2266544|P2|NOT COMPLETED|Washout Period (28 Days)||0
936839|NCT01408719|2266545|P1|NOT COMPLETED|Washout Period (28 Days)||0
936840|NCT01408719|2266526|P20|COMPLETED|Washout Period (28 Days)||1
936841|NCT01408719|2266527|P19|COMPLETED|Washout Period (28 Days)||0
936842|NCT01408719|2266528|P18|COMPLETED|Washout Period (28 Days)||2
936843|NCT01408719|2266529|P17|COMPLETED|Washout Period (28 Days)||2
936844|NCT01408719|2266530|P16|COMPLETED|Washout Period (28 Days)||1
936845|NCT01408719|2266531|P15|COMPLETED|Washout Period (28 Days)||1
936846|NCT01408719|2266532|P14|COMPLETED|Washout Period (28 Days)||3
936847|NCT01408719|2266533|P13|COMPLETED|Washout Period (28 Days)||2
936848|NCT01408719|2266534|P12|COMPLETED|Washout Period (28 Days)||2
936849|NCT01408719|2266535|P11|COMPLETED|Washout Period (28 Days)||2
936850|NCT01408719|2266536|P10|COMPLETED|Washout Period (28 Days)||1
936851|NCT01408719|2266537|P9|COMPLETED|Washout Period (28 Days)||1
936852|NCT01408719|2266538|P8|COMPLETED|Washout Period (28 Days)||3
936853|NCT01408719|2266539|P7|COMPLETED|Washout Period (28 Days)||2
936854|NCT01408719|2266540|P6|COMPLETED|Washout Period (28 Days)||3
936855|NCT01408719|2266541|P5|COMPLETED|Washout Period (28 Days)||3
936856|NCT01408719|2266542|P4|COMPLETED|Washout Period (28 Days)||2
936857|NCT01408719|2266543|P3|COMPLETED|Washout Period (28 Days)||1
936858|NCT01408719|2266544|P2|COMPLETED|Washout Period (28 Days)||3
936859|NCT01408719|2266545|P1|COMPLETED|Washout Period (28 Days)||2
936860|NCT01408719|2266526|P20|STARTED|Washout Period (28 Days)||1
936861|NCT01408719|2266527|P19|STARTED|Washout Period (28 Days)||0
936862|NCT01408719|2266528|P18|STARTED|Washout Period (28 Days)||2
936863|NCT01408719|2266529|P17|STARTED|Washout Period (28 Days)||2
936864|NCT01408719|2266530|P16|STARTED|Washout Period (28 Days)||1
936865|NCT01408719|2266531|P15|STARTED|Washout Period (28 Days)||1
936866|NCT01408719|2266532|P14|STARTED|Washout Period (28 Days)||3
936867|NCT01408719|2266533|P13|STARTED|Washout Period (28 Days)||2
936868|NCT01408719|2266534|P12|STARTED|Washout Period (28 Days)||2
936869|NCT01408719|2266535|P11|STARTED|Washout Period (28 Days)||2
936870|NCT01408719|2266536|P10|STARTED|Washout Period (28 Days)||1
936871|NCT01408719|2266537|P9|STARTED|Washout Period (28 Days)||1
936872|NCT01408719|2266538|P8|STARTED|Washout Period (28 Days)||3
936873|NCT01408719|2266539|P7|STARTED|Washout Period (28 Days)||2
936874|NCT01408719|2266540|P6|STARTED|Washout Period (28 Days)||3
936875|NCT01408719|2266541|P5|STARTED|Washout Period (28 Days)||3
936876|NCT01408719|2266542|P4|STARTED|Washout Period (28 Days)||2
936877|NCT01408719|2266543|P3|STARTED|Washout Period (28 Days)||1
936878|NCT01408719|2266544|P2|STARTED|Washout Period (28 Days)||3
936879|NCT01408719|2266545|P1|STARTED|Washout Period (28 Days)||2
936880|NCT01408719|2266526|P20|NOT COMPLETED|Second Intervention (35 Days)||0
936881|NCT01408719|2266527|P19|NOT COMPLETED|Second Intervention (35 Days)||0
936882|NCT01408719|2266528|P18|NOT COMPLETED|Second Intervention (35 Days)||0
936883|NCT01408719|2266529|P17|NOT COMPLETED|Second Intervention (35 Days)||0
936884|NCT01408719|2266530|P16|NOT COMPLETED|Second Intervention (35 Days)||0
936885|NCT01408719|2266531|P15|NOT COMPLETED|Second Intervention (35 Days)||0
936886|NCT01408719|2266532|P14|NOT COMPLETED|Second Intervention (35 Days)||1
936887|NCT01408719|2266533|P13|NOT COMPLETED|Second Intervention (35 Days)||0
936888|NCT01408719|2266534|P12|NOT COMPLETED|Second Intervention (35 Days)||0
936889|NCT01408719|2266535|P11|NOT COMPLETED|Second Intervention (35 Days)||0
936890|NCT01408719|2266536|P10|NOT COMPLETED|Second Intervention (35 Days)||0
936891|NCT01408719|2266537|P9|NOT COMPLETED|Second Intervention (35 Days)||0
936892|NCT01408719|2266538|P8|NOT COMPLETED|Second Intervention (35 Days)||0
936893|NCT01408719|2266539|P7|NOT COMPLETED|Second Intervention (35 Days)||0
936894|NCT01408719|2266540|P6|NOT COMPLETED|Second Intervention (35 Days)||0
936895|NCT01408719|2266541|P5|NOT COMPLETED|Second Intervention (35 Days)||0
936896|NCT01408719|2266542|P4|NOT COMPLETED|Second Intervention (35 Days)||0
936897|NCT01408719|2266543|P3|NOT COMPLETED|Second Intervention (35 Days)||0
936898|NCT01408719|2266544|P2|NOT COMPLETED|Second Intervention (35 Days)||0
936899|NCT01408719|2266545|P1|NOT COMPLETED|Second Intervention (35 Days)||0
936900|NCT01408719|2266526|P20|COMPLETED|Second Intervention (35 Days)||1
936901|NCT01408719|2266527|P19|COMPLETED|Second Intervention (35 Days)||0
936902|NCT01408719|2266528|P18|COMPLETED|Second Intervention (35 Days)||2
936903|NCT01408719|2266529|P17|COMPLETED|Second Intervention (35 Days)||2
936904|NCT01408719|2266530|P16|COMPLETED|Second Intervention (35 Days)||2
936905|NCT01408719|2266531|P15|COMPLETED|Second Intervention (35 Days)||1
936906|NCT01408719|2266532|P14|COMPLETED|Second Intervention (35 Days)||3
936907|NCT01408719|2266533|P13|COMPLETED|Second Intervention (35 Days)||2
936908|NCT01408719|2266534|P12|COMPLETED|Second Intervention (35 Days)||2
936909|NCT01408719|2266535|P11|COMPLETED|Second Intervention (35 Days)||2
936910|NCT01408719|2266536|P10|COMPLETED|Second Intervention (35 Days)||1
936911|NCT01408719|2266537|P9|COMPLETED|Second Intervention (35 Days)||1
936912|NCT01408719|2266538|P8|COMPLETED|Second Intervention (35 Days)||3
936913|NCT01408719|2266539|P7|COMPLETED|Second Intervention (35 Days)||2
936914|NCT01408719|2266540|P6|COMPLETED|Second Intervention (35 Days)||3
936915|NCT01408719|2266541|P5|COMPLETED|Second Intervention (35 Days)||3
936916|NCT01408719|2266542|P4|COMPLETED|Second Intervention (35 Days)||2
936917|NCT01408719|2266543|P3|COMPLETED|Second Intervention (35 Days)||1
936918|NCT01408719|2266544|P2|COMPLETED|Second Intervention (35 Days)||3
936919|NCT01408719|2266545|P1|COMPLETED|Second Intervention (35 Days)||2
936920|NCT01408719|2266526|P20|STARTED|Second Intervention (35 Days)||1
936921|NCT01408719|2266527|P19|STARTED|Second Intervention (35 Days)||0
936922|NCT01408719|2266528|P18|STARTED|Second Intervention (35 Days)||2
936923|NCT01408719|2266529|P17|STARTED|Second Intervention (35 Days)||2
936924|NCT01408719|2266530|P16|STARTED|Second Intervention (35 Days)||2
936925|NCT01408719|2266531|P15|STARTED|Second Intervention (35 Days)||1
936926|NCT01408719|2266532|P14|STARTED|Second Intervention (35 Days)||4
936927|NCT01408719|2266533|P13|STARTED|Second Intervention (35 Days)||2
936928|NCT01408719|2266534|P12|STARTED|Second Intervention (35 Days)||2
936929|NCT01408719|2266535|P11|STARTED|Second Intervention (35 Days)||2
936930|NCT01408719|2266536|P10|STARTED|Second Intervention (35 Days)||1
936931|NCT01408719|2266537|P9|STARTED|Second Intervention (35 Days)||1
936932|NCT01408719|2266538|P8|STARTED|Second Intervention (35 Days)||3
936933|NCT01408719|2266539|P7|STARTED|Second Intervention (35 Days)||2
936934|NCT01408719|2266540|P6|STARTED|Second Intervention (35 Days)||3
936935|NCT01408719|2266541|P5|STARTED|Second Intervention (35 Days)||3
936936|NCT01408719|2266542|P4|STARTED|Second Intervention (35 Days)||2
936937|NCT01408719|2266543|P3|STARTED|Second Intervention (35 Days)||1
936938|NCT01408719|2266544|P2|STARTED|Second Intervention (35 Days)||3
936939|NCT01408719|2266545|P1|STARTED|Second Intervention (35 Days)||2
936940|NCT01408719|2266526|P20|NOT COMPLETED|Washout Period (28 Days)||0
936941|NCT01408719|2266527|P19|NOT COMPLETED|Washout Period (28 Days)||0
936942|NCT01408719|2266528|P18|NOT COMPLETED|Washout Period (28 Days)||0
936943|NCT01408719|2266529|P17|NOT COMPLETED|Washout Period (28 Days)||0
936944|NCT01408719|2266530|P16|NOT COMPLETED|Washout Period (28 Days)||0
936945|NCT01408719|2266531|P15|NOT COMPLETED|Washout Period (28 Days)||0
936946|NCT01408719|2266532|P14|NOT COMPLETED|Washout Period (28 Days)||0
936947|NCT01408719|2266533|P13|NOT COMPLETED|Washout Period (28 Days)||0
936948|NCT01408719|2266534|P12|NOT COMPLETED|Washout Period (28 Days)||0
936949|NCT01408719|2266535|P11|NOT COMPLETED|Washout Period (28 Days)||0
936950|NCT01408719|2266536|P10|NOT COMPLETED|Washout Period (28 Days)||0
936951|NCT01408719|2266537|P9|NOT COMPLETED|Washout Period (28 Days)||0
936952|NCT01408719|2266538|P8|NOT COMPLETED|Washout Period (28 Days)||0
936953|NCT01408719|2266539|P7|NOT COMPLETED|Washout Period (28 Days)||0
936954|NCT01408719|2266540|P6|NOT COMPLETED|Washout Period (28 Days)||0
936955|NCT01408719|2266541|P5|NOT COMPLETED|Washout Period (28 Days)||0
936956|NCT01408719|2266542|P4|NOT COMPLETED|Washout Period (28 Days)||0
936957|NCT01408719|2266543|P3|NOT COMPLETED|Washout Period (28 Days)||0
936958|NCT01408719|2266544|P2|NOT COMPLETED|Washout Period (28 Days)||0
936959|NCT01408719|2266545|P1|NOT COMPLETED|Washout Period (28 Days)||0
936960|NCT01408719|2266526|P20|COMPLETED|Washout Period (28 Days)||1
936961|NCT01408719|2266527|P19|COMPLETED|Washout Period (28 Days)||0
936962|NCT01408719|2266528|P18|COMPLETED|Washout Period (28 Days)||2
936963|NCT01408719|2266529|P17|COMPLETED|Washout Period (28 Days)||2
936964|NCT01408719|2266530|P16|COMPLETED|Washout Period (28 Days)||2
936965|NCT01408719|2266531|P15|COMPLETED|Washout Period (28 Days)||1
936966|NCT01408719|2266532|P14|COMPLETED|Washout Period (28 Days)||4
936967|NCT01408719|2266533|P13|COMPLETED|Washout Period (28 Days)||2
936968|NCT01408719|2266534|P12|COMPLETED|Washout Period (28 Days)||2
936969|NCT01408719|2266535|P11|COMPLETED|Washout Period (28 Days)||2
936970|NCT01408719|2266536|P10|COMPLETED|Washout Period (28 Days)||1
936971|NCT01408719|2266537|P9|COMPLETED|Washout Period (28 Days)||1
936972|NCT01408719|2266538|P8|COMPLETED|Washout Period (28 Days)||3
936973|NCT01408719|2266539|P7|COMPLETED|Washout Period (28 Days)||2
936974|NCT01408719|2266540|P6|COMPLETED|Washout Period (28 Days)||3
936975|NCT01408719|2266541|P5|COMPLETED|Washout Period (28 Days)||3
936976|NCT01408719|2266542|P4|COMPLETED|Washout Period (28 Days)||2
936977|NCT01408719|2266543|P3|COMPLETED|Washout Period (28 Days)||1
936978|NCT01408719|2266544|P2|COMPLETED|Washout Period (28 Days)||3
936979|NCT01408719|2266545|P1|COMPLETED|Washout Period (28 Days)||2
936980|NCT01408719|2266526|P20|STARTED|Washout Period (28 Days)||1
936981|NCT01408719|2266527|P19|STARTED|Washout Period (28 Days)||0
936982|NCT01408719|2266528|P18|STARTED|Washout Period (28 Days)||2
936983|NCT01408719|2266529|P17|STARTED|Washout Period (28 Days)||2
936984|NCT01408719|2266530|P16|STARTED|Washout Period (28 Days)||2
936985|NCT01408719|2266531|P15|STARTED|Washout Period (28 Days)||1
936986|NCT01408719|2266532|P14|STARTED|Washout Period (28 Days)||4
936987|NCT01408719|2266533|P13|STARTED|Washout Period (28 Days)||2
936988|NCT01408719|2266534|P12|STARTED|Washout Period (28 Days)||2
936989|NCT01408719|2266535|P11|STARTED|Washout Period (28 Days)||2
936990|NCT01408719|2266536|P10|STARTED|Washout Period (28 Days)||1
936991|NCT01408719|2266537|P9|STARTED|Washout Period (28 Days)||1
936992|NCT01408719|2266538|P8|STARTED|Washout Period (28 Days)||3
936993|NCT01408719|2266539|P7|STARTED|Washout Period (28 Days)||2
936994|NCT01408719|2266540|P6|STARTED|Washout Period (28 Days)||3
936995|NCT01408719|2266541|P5|STARTED|Washout Period (28 Days)||3
936996|NCT01408719|2266542|P4|STARTED|Washout Period (28 Days)||2
936997|NCT01408719|2266543|P3|STARTED|Washout Period (28 Days)||1
936998|NCT01408719|2266544|P2|STARTED|Washout Period (28 Days)||3
936999|NCT01408719|2266545|P1|STARTED|Washout Period (28 Days)||2
937000|NCT01408719|2266526|P20|NOT COMPLETED|First Intervention (35 Days)||0
937001|NCT01408719|2266527|P19|NOT COMPLETED|First Intervention (35 Days)||1
937002|NCT01408719|2266528|P18|NOT COMPLETED|First Intervention (35 Days)||0
937003|NCT01408719|2266529|P17|NOT COMPLETED|First Intervention (35 Days)||1
937004|NCT01408719|2266530|P16|NOT COMPLETED|First Intervention (35 Days)||0
937005|NCT01408719|2266531|P15|NOT COMPLETED|First Intervention (35 Days)||0
937006|NCT01408719|2266532|P14|NOT COMPLETED|First Intervention (35 Days)||1
937007|NCT01408719|2266533|P13|NOT COMPLETED|First Intervention (35 Days)||0
937008|NCT01408719|2266534|P12|NOT COMPLETED|First Intervention (35 Days)||0
937009|NCT01408719|2266535|P11|NOT COMPLETED|First Intervention (35 Days)||0
937010|NCT01408719|2266536|P10|NOT COMPLETED|First Intervention (35 Days)||0
937011|NCT01408719|2266537|P9|NOT COMPLETED|First Intervention (35 Days)||1
937012|NCT01408719|2266538|P8|NOT COMPLETED|First Intervention (35 Days)||0
937013|NCT01408719|2266539|P7|NOT COMPLETED|First Intervention (35 Days)||0
937014|NCT01408719|2266540|P6|NOT COMPLETED|First Intervention (35 Days)||0
937015|NCT01408719|2266541|P5|NOT COMPLETED|First Intervention (35 Days)||1
937016|NCT01408719|2266542|P4|NOT COMPLETED|First Intervention (35 Days)||0
937017|NCT01408719|2266543|P3|NOT COMPLETED|First Intervention (35 Days)||1
937018|NCT01408719|2266544|P2|NOT COMPLETED|First Intervention (35 Days)||0
937019|NCT01408719|2266545|P1|NOT COMPLETED|First Intervention (35 Days)||0
937020|NCT01408719|2266526|P20|COMPLETED|First Intervention (35 Days)||1
937021|NCT01408719|2266527|P19|COMPLETED|First Intervention (35 Days)||0
937022|NCT01408719|2266528|P18|COMPLETED|First Intervention (35 Days)||2
937023|NCT01408719|2266529|P17|COMPLETED|First Intervention (35 Days)||2
937024|NCT01408719|2266530|P16|COMPLETED|First Intervention (35 Days)||2
937025|NCT01408719|2266531|P15|COMPLETED|First Intervention (35 Days)||1
937026|NCT01408719|2266532|P14|COMPLETED|First Intervention (35 Days)||4
937027|NCT01408719|2266533|P13|COMPLETED|First Intervention (35 Days)||2
937028|NCT01408719|2266534|P12|COMPLETED|First Intervention (35 Days)||2
937029|NCT01408719|2266535|P11|COMPLETED|First Intervention (35 Days)||2
937030|NCT01408719|2266536|P10|COMPLETED|First Intervention (35 Days)||1
937031|NCT01408719|2266537|P9|COMPLETED|First Intervention (35 Days)||1
937032|NCT01408719|2266538|P8|COMPLETED|First Intervention (35 Days)||3
937033|NCT01408719|2266539|P7|COMPLETED|First Intervention (35 Days)||2
937034|NCT01408719|2266540|P6|COMPLETED|First Intervention (35 Days)||3
937035|NCT01408719|2266541|P5|COMPLETED|First Intervention (35 Days)||3
937036|NCT01408719|2266542|P4|COMPLETED|First Intervention (35 Days)||2
937037|NCT01408719|2266543|P3|COMPLETED|First Intervention (35 Days)||1
937038|NCT01408719|2266544|P2|COMPLETED|First Intervention (35 Days)||3
937039|NCT01408719|2266545|P1|COMPLETED|First Intervention (35 Days)||2
937040|NCT01408719|2266526|P20|STARTED|First Intervention (35 Days)||1
937041|NCT01408719|2266527|P19|STARTED|First Intervention (35 Days)||1
937042|NCT01408719|2266528|P18|STARTED|First Intervention (35 Days)||2
937043|NCT01408719|2266529|P17|STARTED|First Intervention (35 Days)||3
937044|NCT01408719|2266530|P16|STARTED|First Intervention (35 Days)||2
937045|NCT01408719|2266531|P15|STARTED|First Intervention (35 Days)||1
937046|NCT01408719|2266532|P14|STARTED|First Intervention (35 Days)||5
937047|NCT01408719|2266533|P13|STARTED|First Intervention (35 Days)||2
937048|NCT01408719|2266534|P12|STARTED|First Intervention (35 Days)||2
937049|NCT01408719|2266535|P11|STARTED|First Intervention (35 Days)||2
937050|NCT01408719|2266536|P10|STARTED|First Intervention (35 Days)||1
937051|NCT01408719|2266537|P9|STARTED|First Intervention (35 Days)||2
937052|NCT01408719|2266538|P8|STARTED|First Intervention (35 Days)||3
937053|NCT01408719|2266539|P7|STARTED|First Intervention (35 Days)||2
937054|NCT01408719|2266540|P6|STARTED|First Intervention (35 Days)||3
937055|NCT01408719|2266541|P5|STARTED|First Intervention (35 Days)||4
937056|NCT01408719|2266542|P4|STARTED|First Intervention (35 Days)||2
937057|NCT01408719|2266543|P3|STARTED|First Intervention (35 Days)||2
937058|NCT01408719|2266544|P2|STARTED|First Intervention (35 Days)||3
937059|NCT01408719|2266545|P1|STARTED|First Intervention (35 Days)||2
937060|NCT01408706|2266557|P2|NOT COMPLETED|Overall Study||0
937061|NCT01408706|2266558|P1|NOT COMPLETED|Overall Study||1
937062|NCT01408706|2266557|P2|COMPLETED|Overall Study||30
937063|NCT01408706|2266558|P1|COMPLETED|Overall Study||29
937064|NCT01408706|2266557|P2|STARTED|Overall Study||30
937065|NCT01408706|2266558|P1|STARTED|Overall Study||30
937066|NCT01408628|2266568|P1|NOT COMPLETED|Completed 6 Month Follow-Up||14
937067|NCT01408628|2266568|P1|COMPLETED|Completed 6 Month Follow-Up||25
937068|NCT01408628|2266568|P1|STARTED|Completed 6 Month Follow-Up||39
937069|NCT01408628|2266568|P1|NOT COMPLETED|Started Classes/Intervention||0
937070|NCT01408628|2266568|P1|COMPLETED|Started Classes/Intervention||39
937071|NCT01408628|2266568|P1|STARTED|Started Classes/Intervention||39
937072|NCT01408628|2266568|P1|NOT COMPLETED|Consented||12
937073|NCT01408628|2266568|P1|COMPLETED|Consented||39
937074|NCT01408628|2266568|P1|STARTED|Consented||51
937075|NCT01408537|2266574|P1|NOT COMPLETED|Overall Study||8
937076|NCT01408537|2266574|P1|COMPLETED|Overall Study||144
937077|NCT01408537|2266574|P1|STARTED|Overall Study||152
937078|NCT01408485|2266590|P1|NOT COMPLETED|Overall Study||21
937079|NCT01408485|2266590|P1|COMPLETED|Overall Study||179
937080|NCT01408485|2266590|P1|STARTED|Overall Study||200
937081|NCT01408329|2266598|P2|NOT COMPLETED|Overall Study||4
937082|NCT01408329|2266599|P1|NOT COMPLETED|Overall Study||3
937083|NCT01408329|2266598|P2|COMPLETED|Overall Study||11
937084|NCT01408329|2266599|P1|COMPLETED|Overall Study||10
937085|NCT01408329|2266598|P2|STARTED|Overall Study||15
937086|NCT01408329|2266599|P1|STARTED|Overall Study||13
937087|NCT01408303|2266608|P3|NOT COMPLETED|Overall Study||6
937088|NCT01408303|2266609|P2|NOT COMPLETED|Overall Study||12
937089|NCT01408303|2266610|P1|NOT COMPLETED|Overall Study||6
937090|NCT01408303|2266608|P3|COMPLETED|Overall Study||210
937091|NCT01408303|2266609|P2|COMPLETED|Overall Study||204
937092|NCT01408303|2266610|P1|COMPLETED|Overall Study||209
937093|NCT01408303|2266608|P3|STARTED|Overall Study||216
937094|NCT01408303|2266609|P2|STARTED|Overall Study||216
937095|NCT01408303|2266610|P1|STARTED|Overall Study||215
937096|NCT01408277|2266620|P2|NOT COMPLETED|Overall Study||4
937097|NCT01408277|2266621|P1|NOT COMPLETED|Overall Study||8
937098|NCT01408277|2266620|P2|COMPLETED|Overall Study||23
937099|NCT01408277|2266621|P1|COMPLETED|Overall Study||20
937100|NCT01408277|2266620|P2|STARTED|Overall Study||27
937101|NCT01408277|2266621|P1|STARTED|Overall Study||28
937102|NCT01407575|2266629|P2|NOT COMPLETED|Overall Study||1
937103|NCT01407575|2266630|P1|NOT COMPLETED|Overall Study||2
937104|NCT01407575|2266629|P2|COMPLETED|Overall Study||5
937105|NCT01407575|2266630|P1|COMPLETED|Overall Study||5
937106|NCT01407575|2266629|P2|STARTED|Overall Study||6
937107|NCT01407575|2266630|P1|STARTED|Overall Study||7
937108|NCT01407523|2266648|P1|NOT COMPLETED|Overall Study||0
937109|NCT01407523|2266648|P1|COMPLETED|Overall Study||16
937110|NCT01407523|2266648|P1|STARTED|Overall Study||16
937111|NCT01407354|2266658|P2|NOT COMPLETED|Second Intervention||2
937112|NCT01407354|2266659|P1|NOT COMPLETED|Second Intervention||0
937113|NCT01407354|2266658|P2|COMPLETED|Second Intervention||13
937114|NCT01407354|2266659|P1|COMPLETED|Second Intervention||18
937115|NCT01407354|2266658|P2|STARTED|Second Intervention||15
937116|NCT01407354|2266659|P1|STARTED|Second Intervention||18
937117|NCT01407354|2266658|P2|NOT COMPLETED|First Intervention||2
937118|NCT01407354|2266659|P1|NOT COMPLETED|First Intervention||2
937119|NCT01407354|2266658|P2|COMPLETED|First Intervention||15
937120|NCT01407354|2266659|P1|COMPLETED|First Intervention||18
937121|NCT01407354|2266658|P2|STARTED|First Intervention||17
937122|NCT01407354|2266659|P1|STARTED|First Intervention||20
937123|NCT01407276|2266675|P8|NOT COMPLETED|Overall Study||1
937124|NCT01407276|2266676|P7|NOT COMPLETED|Overall Study||0
937125|NCT01407276|2266677|P6|NOT COMPLETED|Overall Study||0
937126|NCT01407276|2266678|P5|NOT COMPLETED|Overall Study||0
937127|NCT01407276|2266679|P4|NOT COMPLETED|Overall Study||0
937128|NCT01407276|2266680|P3|NOT COMPLETED|Overall Study||0
937129|NCT01407276|2266681|P2|NOT COMPLETED|Overall Study||0
937130|NCT01407276|2266682|P1|NOT COMPLETED|Overall Study||0
937131|NCT01407276|2266675|P8|COMPLETED|Overall Study||6
937132|NCT01407276|2266676|P7|COMPLETED|Overall Study||6
937133|NCT01407276|2266677|P6|COMPLETED|Overall Study||6
937134|NCT01407276|2266678|P5|COMPLETED|Overall Study||6
937135|NCT01407276|2266679|P4|COMPLETED|Overall Study||6
937136|NCT01407276|2266680|P3|COMPLETED|Overall Study||6
937137|NCT01407276|2266681|P2|COMPLETED|Overall Study||6
937138|NCT01407276|2266682|P1|COMPLETED|Overall Study||6
937139|NCT01407276|2266675|P8|STARTED|Overall Study||7
937140|NCT01407276|2266676|P7|STARTED|Overall Study||6
937141|NCT01407276|2266677|P6|STARTED|Overall Study||6
937142|NCT01407276|2266678|P5|STARTED|Overall Study||6
937143|NCT01407276|2266679|P4|STARTED|Overall Study||6
937144|NCT01407276|2266680|P3|STARTED|Overall Study||6
937145|NCT01407276|2266681|P2|STARTED|Overall Study||6
937146|NCT01407276|2266682|P1|STARTED|Overall Study||6
937147|NCT01407068|2266806|P1|NOT COMPLETED|Overall Study||0
937148|NCT01407068|2266806|P1|COMPLETED|Overall Study||60
937149|NCT01407068|2266806|P1|STARTED|Overall Study||60
937150|NCT01406990|2266815|P1|NOT COMPLETED|Overall Study||0
937151|NCT01406990|2266815|P1|COMPLETED|Overall Study||15
937152|NCT01406990|2266815|P1|STARTED|Overall Study||15
937153|NCT01406938|2266821|P6|NOT COMPLETED|Follow up||3
937154|NCT01406938|2266822|P5|NOT COMPLETED|Follow up||9
937155|NCT01406938|2266823|P4|NOT COMPLETED|Follow up||3
937156|NCT01406938|2266824|P3|NOT COMPLETED|Follow up||8
937157|NCT01406938|2266825|P2|NOT COMPLETED|Follow up||5
937158|NCT01406938|2266826|P1|NOT COMPLETED|Follow up||8
937159|NCT01406938|2266821|P6|COMPLETED|Follow up||32
937160|NCT01406938|2266822|P5|COMPLETED|Follow up||31
937161|NCT01406938|2266823|P4|COMPLETED|Follow up||36
937162|NCT01406938|2266824|P3|COMPLETED|Follow up||32
937163|NCT01406938|2266825|P2|COMPLETED|Follow up||18
937164|NCT01406938|2266826|P1|COMPLETED|Follow up||18
937165|NCT01406938|2266821|P6|STARTED|Follow up||35
937166|NCT01406938|2266822|P5|STARTED|Follow up||40
937167|NCT01406938|2266823|P4|STARTED|Follow up||39
937168|NCT01406938|2266824|P3|STARTED|Follow up||40
937169|NCT01406938|2266825|P2|STARTED|Follow up||23
937170|NCT01406938|2266826|P1|STARTED|Follow up||26
937171|NCT01406938|2266821|P6|NOT COMPLETED|Maintenance Period||16
937172|NCT01406938|2266822|P5|NOT COMPLETED|Maintenance Period||25
937173|NCT01406938|2266823|P4|NOT COMPLETED|Maintenance Period||18
937174|NCT01406938|2266824|P3|NOT COMPLETED|Maintenance Period||17
937175|NCT01406938|2266825|P2|NOT COMPLETED|Maintenance Period||0
937176|NCT01406938|2266826|P1|NOT COMPLETED|Maintenance Period||0
937177|NCT01406938|2266821|P6|COMPLETED|Maintenance Period||201
937178|NCT01406938|2266822|P5|COMPLETED|Maintenance Period||181
937179|NCT01406938|2266823|P4|COMPLETED|Maintenance Period||199
937180|NCT01406938|2266824|P3|COMPLETED|Maintenance Period||186
937181|NCT01406938|2266825|P2|COMPLETED|Maintenance Period||0
937182|NCT01406938|2266826|P1|COMPLETED|Maintenance Period||0
937183|NCT01406938|2266821|P6|FAS: Patients Assigned Treatment Drug|Maintenance Period||217
937184|NCT01406938|2266822|P5|FAS: Patients Assigned Treatment Drug|Maintenance Period||206
937185|NCT01406938|2266823|P4|FAS: Patients Assigned Treatment Drug|Maintenance Period||216
937186|NCT01406938|2266824|P3|FAS: Patients Assigned Treatment Drug|Maintenance Period||203
937187|NCT01406938|2266825|P2|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
937188|NCT01406938|2266826|P1|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
937189|NCT01406938|2266821|P6|STARTED|Maintenance Period||217
937190|NCT01406938|2266822|P5|STARTED|Maintenance Period||206
937191|NCT01406938|2266823|P4|STARTED|Maintenance Period||217
937192|NCT01406938|2266824|P3|STARTED|Maintenance Period||203
937193|NCT01406938|2266825|P2|STARTED|Maintenance Period||0
937194|NCT01406938|2266826|P1|STARTED|Maintenance Period||0
937195|NCT01406938|2266821|P6|NOT COMPLETED|Induction Period||0
937196|NCT01406938|2266822|P5|NOT COMPLETED|Induction Period||0
937197|NCT01406938|2266823|P4|NOT COMPLETED|Induction Period||0
937198|NCT01406938|2266824|P3|NOT COMPLETED|Induction Period||0
937199|NCT01406938|2266825|P2|NOT COMPLETED|Induction Period||20
937200|NCT01406938|2266826|P1|NOT COMPLETED|Induction Period||18
937201|NCT01406938|2266821|P6|COMPLETED|Induction Period||0
937202|NCT01406938|2266822|P5|COMPLETED|Induction Period||0
937203|NCT01406938|2266823|P4|COMPLETED|Induction Period||0
937204|NCT01406938|2266824|P3|COMPLETED|Induction Period||0
937205|NCT01406938|2266825|P2|COMPLETED|Induction Period||464
937206|NCT01406938|2266826|P1|COMPLETED|Induction Period||464
937207|NCT01406938|2266821|P6|FAS:Patients Assigned Study Treatment|Induction Period||0
937208|NCT01406938|2266822|P5|FAS:Patients Assigned Study Treatment|Induction Period||0
937209|NCT01406938|2266823|P4|FAS:Patients Assigned Study Treatment|Induction Period||0
937210|NCT01406938|2266824|P3|FAS:Patients Assigned Study Treatment|Induction Period||0
937211|NCT01406938|2266825|P2|FAS:Patients Assigned Study Treatment|Induction Period||483
937212|NCT01406938|2266826|P1|FAS:Patients Assigned Study Treatment|Induction Period||482
937213|NCT01406938|2266821|P6|STARTED|Induction Period||0
937214|NCT01406938|2266822|P5|STARTED|Induction Period||0
937215|NCT01406938|2266823|P4|STARTED|Induction Period||0
937216|NCT01406938|2266824|P3|STARTED|Induction Period||0
937217|NCT01406938|2266825|P2|STARTED|Induction Period||484
937218|NCT01406938|2266826|P1|STARTED|Induction Period||482
937219|NCT01406795|2266942|P1|NOT COMPLETED|Overall Study||1
937220|NCT01406795|2266942|P1|COMPLETED|Overall Study||0
937221|NCT01406795|2266942|P1|STARTED|Overall Study||1
937222|NCT01406574|2266956|P4|NOT COMPLETED|Overall Study||4
937223|NCT01406574|2266957|P3|NOT COMPLETED|Overall Study||1
937224|NCT01406574|2266958|P2|NOT COMPLETED|Overall Study||1
937225|NCT01406574|2266959|P1|NOT COMPLETED|Overall Study||1
937226|NCT01406574|2266956|P4|COMPLETED|Overall Study||1
937227|NCT01406574|2266957|P3|COMPLETED|Overall Study||6
937228|NCT01406574|2266958|P2|COMPLETED|Overall Study||3
937229|NCT01406574|2266959|P1|COMPLETED|Overall Study||6
937230|NCT01406574|2266956|P4|STARTED|Overall Study||5
937231|NCT01406574|2266957|P3|STARTED|Overall Study||7
937232|NCT01406574|2266958|P2|STARTED|Overall Study||4
937233|NCT01406574|2266959|P1|STARTED|Overall Study||7
937246|NCT01406015|2266994|P2|NOT COMPLETED|Overall Study||3
937247|NCT01406015|2266995|P1|NOT COMPLETED|Overall Study||3
937248|NCT01406015|2266994|P2|COMPLETED|Overall Study||16
937249|NCT01406015|2266995|P1|COMPLETED|Overall Study||16
937250|NCT01406015|2266994|P2|STARTED|Overall Study||19
937251|NCT01406015|2266995|P1|STARTED|Overall Study||19
937252|NCT01405950|2267011|P4|NOT COMPLETED|Overall Study||0
937253|NCT01405950|2267012|P3|NOT COMPLETED|Overall Study||0
937254|NCT01405950|2267013|P2|NOT COMPLETED|Overall Study||0
937255|NCT01405950|2267014|P1|NOT COMPLETED|Overall Study||1
937256|NCT01405950|2267011|P4|COMPLETED|Overall Study||0
937257|NCT01405950|2267012|P3|COMPLETED|Overall Study||0
937258|NCT01405950|2267013|P2|COMPLETED|Overall Study||2
937259|NCT01405950|2267014|P1|COMPLETED|Overall Study||7
937260|NCT01405950|2267011|P4|STARTED|Overall Study||0
937261|NCT01405950|2267012|P3|STARTED|Overall Study||0
937262|NCT01405950|2267013|P2|STARTED|Overall Study||2
937263|NCT01405950|2267014|P1|STARTED|Overall Study||8
937264|NCT01405937|2267028|P2|NOT COMPLETED|Overall Study||0
937265|NCT01405937|2267029|P1|NOT COMPLETED|Overall Study||0
937266|NCT01405937|2267028|P2|COMPLETED|Overall Study||26
937267|NCT01405937|2267029|P1|COMPLETED|Overall Study||25
937268|NCT01405937|2267028|P2|STARTED|Overall Study||26
937269|NCT01405937|2267029|P1|STARTED|Overall Study||25
937270|NCT01405924|2267049|P1|NOT COMPLETED|Overall Study||10
937271|NCT01405924|2267049|P1|COMPLETED|Overall Study||101
937272|NCT01405924|2267049|P1|STARTED|Overall Study||111
937273|NCT01405898|2267061|P2|NOT COMPLETED|Overall Study||2
937274|NCT01405898|2267062|P1|NOT COMPLETED|Overall Study||2
937275|NCT01405898|2267061|P2|COMPLETED|Overall Study||32
937276|NCT01405898|2267062|P1|COMPLETED|Overall Study||32
937277|NCT01405898|2267061|P2|STARTED|Overall Study||34
937278|NCT01405898|2267062|P1|STARTED|Overall Study||34
937279|NCT01405820|2267086|P6|NOT COMPLETED|Open-Label Treatment Period||2
937280|NCT01405820|2267087|P5|NOT COMPLETED|Open-Label Treatment Period||2
937281|NCT01405820|2267088|P4|NOT COMPLETED|Open-Label Treatment Period||5
937282|NCT01405820|2267089|P3|NOT COMPLETED|Open-Label Treatment Period||3
937283|NCT01405820|2267090|P2|NOT COMPLETED|Open-Label Treatment Period||2
937284|NCT01405820|2267091|P1|NOT COMPLETED|Open-Label Treatment Period||4
937285|NCT01405820|2267086|P6|COMPLETED|Open-Label Treatment Period||30
937286|NCT01405820|2267087|P5|COMPLETED|Open-Label Treatment Period||40
937287|NCT01405820|2267088|P4|COMPLETED|Open-Label Treatment Period||37
937288|NCT01405820|2267089|P3|COMPLETED|Open-Label Treatment Period||39
937289|NCT01405820|2267090|P2|COMPLETED|Open-Label Treatment Period||33
937290|NCT01405820|2267091|P1|COMPLETED|Open-Label Treatment Period||40
937291|NCT01405820|2267086|P6|STARTED|Open-Label Treatment Period||32
937292|NCT01405820|2267087|P5|STARTED|Open-Label Treatment Period||42
937293|NCT01405820|2267088|P4|STARTED|Open-Label Treatment Period||42
937294|NCT01405820|2267089|P3|STARTED|Open-Label Treatment Period||42
937295|NCT01405820|2267090|P2|STARTED|Open-Label Treatment Period||35
937296|NCT01405820|2267091|P1|STARTED|Open-Label Treatment Period|1 participant discontinued randomized period due to an adverse event but entered open-label period.|44
937297|NCT01405820|2267086|P6|NOT COMPLETED|Randomized Treatment Period||37
937298|NCT01405820|2267087|P5|NOT COMPLETED|Randomized Treatment Period||45
937299|NCT01405820|2267088|P4|NOT COMPLETED|Randomized Treatment Period||51
937300|NCT01405820|2267089|P3|NOT COMPLETED|Randomized Treatment Period||43
937301|NCT01405820|2267090|P2|NOT COMPLETED|Randomized Treatment Period||10
937302|NCT01405820|2267091|P1|NOT COMPLETED|Randomized Treatment Period||11
937303|NCT01405820|2267086|P6|COMPLETED|Randomized Treatment Period||1
937304|NCT01405820|2267087|P5|COMPLETED|Randomized Treatment Period||2
937305|NCT01405820|2267088|P4|COMPLETED|Randomized Treatment Period||3
937306|NCT01405820|2267089|P3|COMPLETED|Randomized Treatment Period||9
937307|NCT01405820|2267090|P2|COMPLETED|Randomized Treatment Period||35
937308|NCT01405820|2267091|P1|COMPLETED|Randomized Treatment Period||43
937309|NCT01405820|2267086|P6|Safety Population|Randomized Treatment Period||38
937310|NCT01405820|2267087|P5|Safety Population|Randomized Treatment Period||47
937311|NCT01405820|2267088|P4|Safety Population|Randomized Treatment Period|1 participant did not receive any study medication.|53
937312|NCT01405820|2267089|P3|Safety Population|Randomized Treatment Period||52
937313|NCT01405820|2267090|P2|Safety Population|Randomized Treatment Period||45
937314|NCT01405820|2267091|P1|Safety Population|Randomized Treatment Period||54
937315|NCT01405820|2267086|P6|STARTED|Randomized Treatment Period||38
937316|NCT01405820|2267087|P5|STARTED|Randomized Treatment Period||47
937317|NCT01405820|2267088|P4|STARTED|Randomized Treatment Period||54
937318|NCT01405820|2267089|P3|STARTED|Randomized Treatment Period||52
937319|NCT01405820|2267090|P2|STARTED|Randomized Treatment Period||45
937320|NCT01405820|2267091|P1|STARTED|Randomized Treatment Period||54
937321|NCT01405794|2267111|P1|NOT COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||0
937322|NCT01405794|2267111|P1|COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||12
937323|NCT01405794|2267111|P1|STARTED|Second Dose 32ppm Oral Silver (14 Days)||12
937324|NCT01405794|2267111|P1|NOT COMPLETED|72 hr Washout||0
937325|NCT01405794|2267111|P1|COMPLETED|72 hr Washout||12
937326|NCT01405794|2267111|P1|STARTED|72 hr Washout||12
937327|NCT01405794|2267111|P1|NOT COMPLETED|First Dose Placebo (14 Days)||0
937328|NCT01405794|2267111|P1|COMPLETED|First Dose Placebo (14 Days)||12
937329|NCT01405794|2267111|P1|STARTED|First Dose Placebo (14 Days)||12
937330|NCT01405768|2267187|P2|NOT COMPLETED|Overall Study||0
937331|NCT01405768|2267188|P1|NOT COMPLETED|Overall Study||4
937332|NCT01405768|2267187|P2|COMPLETED|Overall Study||28
937333|NCT01405768|2267188|P1|COMPLETED|Overall Study||24
937334|NCT01405768|2267187|P2|STARTED|Overall Study||28
937335|NCT01405768|2267188|P1|STARTED|Overall Study||28
937336|NCT01405742|2267200|P2|NOT COMPLETED|Overall Study||0
937337|NCT01405742|2267201|P1|NOT COMPLETED|Overall Study||1
937338|NCT01405742|2267200|P2|COMPLETED|Overall Study||2
937339|NCT01405742|2267201|P1|COMPLETED|Overall Study||1
937340|NCT01405742|2267200|P2|STARTED|Overall Study||2
937341|NCT01405742|2267201|P1|STARTED|Overall Study||2
937342|NCT01405560|2267211|P1|NOT COMPLETED|Overall Study||1
937343|NCT01405560|2267211|P1|COMPLETED|Overall Study||41
937344|NCT01405560|2267211|P1|STARTED|Overall Study||42
937345|NCT01405508|2267226|P4|NOT COMPLETED|Overall Study||0
937346|NCT01405508|2267227|P3|NOT COMPLETED|Overall Study||0
937347|NCT01405508|2267228|P2|NOT COMPLETED|Overall Study||1
937348|NCT01405508|2267229|P1|NOT COMPLETED|Overall Study||1
937349|NCT01405508|2267226|P4|COMPLETED|Overall Study||26
937350|NCT01405508|2267227|P3|COMPLETED|Overall Study||27
937351|NCT01405508|2267228|P2|COMPLETED|Overall Study||25
937352|NCT01405508|2267229|P1|COMPLETED|Overall Study||25
937353|NCT01405508|2267226|P4|STARTED|Overall Study||26
937354|NCT01405508|2267227|P3|STARTED|Overall Study||27
937355|NCT01405508|2267228|P2|STARTED|Overall Study||26
937356|NCT01405508|2267229|P1|STARTED|Overall Study||26
937357|NCT01405469|2267247|P1|NOT COMPLETED|Overall Study||0
937358|NCT01405469|2267247|P1|COMPLETED|Overall Study||16
937359|NCT01405469|2267247|P1|STARTED|Overall Study||16
937360|NCT01405313|2267259|P1|NOT COMPLETED|Overall Study||0
937361|NCT01405313|2267259|P1|COMPLETED|Overall Study||21
937362|NCT01405313|2267259|P1|STARTED|Overall Study||21
937363|NCT01405027|2267269|P2|NOT COMPLETED|Overall Study||51
937364|NCT01405027|2267270|P1|NOT COMPLETED|Overall Study||32
937365|NCT01405027|2267269|P2|COMPLETED|Overall Study||62
937366|NCT01405027|2267270|P1|COMPLETED|Overall Study||52
937367|NCT01405027|2267269|P2|STARTED|Overall Study||113
937368|NCT01405027|2267270|P1|STARTED|Overall Study||84
937369|NCT01404988|2267287|P3|NOT COMPLETED|Overall Study||3
937370|NCT01404988|2267288|P2|NOT COMPLETED|Overall Study||4
937371|NCT01404988|2267289|P1|NOT COMPLETED|Overall Study||6
937372|NCT01404988|2267287|P3|COMPLETED|Overall Study||30
937373|NCT01404988|2267288|P2|COMPLETED|Overall Study||29
937374|NCT01404988|2267289|P1|COMPLETED|Overall Study||27
937375|NCT01404988|2267287|P3|STARTED|Overall Study||33
937376|NCT01404988|2267288|P2|STARTED|Overall Study||33
937377|NCT01404988|2267289|P1|STARTED|Overall Study||33
937378|NCT01404936|2267306|P1|NOT COMPLETED|Overall Study||0
937379|NCT01404936|2267306|P1|COMPLETED|Overall Study||30
937380|NCT01404936|2267306|P1|STARTED|Overall Study||30
937381|NCT01404923|2267312|P2|NOT COMPLETED|Overall Study||17
937382|NCT01404923|2267313|P1|NOT COMPLETED|Overall Study||23
937383|NCT01404923|2267312|P2|COMPLETED|Overall Study||197
937384|NCT01404923|2267313|P1|COMPLETED|Overall Study||199
937385|NCT01404923|2267312|P2|STARTED|Overall Study||214
937386|NCT01404923|2267313|P1|STARTED|Overall Study||222
937387|NCT01404832|2267321|P1|NOT COMPLETED|Overall Study||0
937388|NCT01404832|2267321|P1|COMPLETED|Overall Study||21
937389|NCT01404832|2267321|P1|STARTED|Overall Study||21
937390|NCT01404650|2267326|P1|NOT COMPLETED|Overall Study||0
937391|NCT01404650|2267326|P1|COMPLETED|Overall Study||25
937392|NCT01404650|2267326|P1|STARTED|Overall Study|Twenty-five patients received a median of 2 cycles of AUY922.|25
937393|NCT01404611|2267336|P3|NOT COMPLETED|Overall Study||5
937394|NCT01404611|2267337|P2|NOT COMPLETED|Overall Study||19
937395|NCT01404611|2267338|P1|NOT COMPLETED|Overall Study||8
937396|NCT01404611|2267336|P3|COMPLETED|Overall Study||106
937397|NCT01404611|2267337|P2|COMPLETED|Overall Study||89
937398|NCT01404611|2267338|P1|COMPLETED|Overall Study||104
937399|NCT01404611|2267336|P3|STARTED|Overall Study||111
937400|NCT01404611|2267337|P2|STARTED|Overall Study||108
937401|NCT01404611|2267338|P1|STARTED|Overall Study||112
937402|NCT01404572|2267346|P3|NOT COMPLETED|Overall Study||0
937403|NCT01404572|2267347|P2|NOT COMPLETED|Overall Study||0
937404|NCT01404572|2267348|P1|NOT COMPLETED|Overall Study||0
937405|NCT01404572|2267346|P3|COMPLETED|Overall Study||4
937406|NCT01404572|2267347|P2|COMPLETED|Overall Study||4
937407|NCT01404572|2267348|P1|COMPLETED|Overall Study||4
937408|NCT01404572|2267346|P3|STARTED|Overall Study||4
937409|NCT01404572|2267347|P2|STARTED|Overall Study||4
937410|NCT01404572|2267348|P1|STARTED|Overall Study||4
937411|NCT01404559|2267379|P4|NOT COMPLETED|Overall Study||0
937412|NCT01404559|2267380|P3|NOT COMPLETED|Overall Study||0
937413|NCT01404559|2267381|P2|NOT COMPLETED|Overall Study||0
937414|NCT01404559|2267382|P1|NOT COMPLETED|Overall Study||0
937415|NCT01404559|2267379|P4|COMPLETED|Overall Study||14
937416|NCT01404559|2267380|P3|COMPLETED|Overall Study||4
937417|NCT01404559|2267381|P2|COMPLETED|Overall Study||5
937418|NCT01404559|2267382|P1|COMPLETED|Overall Study||5
937419|NCT01404559|2267379|P4|STARTED|Overall Study||14
937420|NCT01404559|2267380|P3|STARTED|Overall Study||4
937421|NCT01404559|2267381|P2|STARTED|Overall Study||5
937422|NCT01404559|2267382|P1|STARTED|Overall Study||5
937423|NCT01404429|2267395|P2|NOT COMPLETED|Overall Study||7
937424|NCT01404429|2267396|P1|NOT COMPLETED|Overall Study||9
937425|NCT01404429|2267395|P2|COMPLETED|Overall Study||46
937426|NCT01404429|2267396|P1|COMPLETED|Overall Study||38
937427|NCT01404429|2267395|P2|STARTED|Overall Study||53
937428|NCT01404429|2267396|P1|STARTED|Overall Study||47
937429|NCT01404260|2267410|P2|NOT COMPLETED|Overall Study||9
937430|NCT01404260|2267411|P1|NOT COMPLETED|Overall Study||3
937431|NCT01404260|2267410|P2|COMPLETED|Overall Study||101
937432|NCT01404260|2267411|P1|COMPLETED|Overall Study||106
937433|NCT01404260|2267410|P2|STARTED|Overall Study||110
937434|NCT01404260|2267411|P1|STARTED|Overall Study||109
937435|NCT01404234|2267417|P1|NOT COMPLETED|Overall Study||2
937436|NCT01404234|2267417|P1|COMPLETED|Overall Study||59
937437|NCT01404234|2267417|P1|STARTED|Overall Study||61
937438|NCT01404208|2267433|P2|NOT COMPLETED|Overall Study||0
937439|NCT01404208|2267434|P1|NOT COMPLETED|Overall Study||3
937440|NCT01404208|2267433|P2|COMPLETED|Overall Study||72
937441|NCT01404208|2267434|P1|COMPLETED|Overall Study||67
937442|NCT01404208|2267433|P2|STARTED|Overall Study||72
937443|NCT01404208|2267434|P1|STARTED|Overall Study||70
937444|NCT01404078|2267444|P2|NOT COMPLETED|Overall Study||20
937445|NCT01404078|2267445|P1|NOT COMPLETED|Overall Study||18
937446|NCT01404078|2267444|P2|COMPLETED|Overall Study||237
937447|NCT01404078|2267445|P1|COMPLETED|Overall Study||243
937448|NCT01404078|2267444|P2|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|257
937449|NCT01404078|2267445|P1|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|261
937450|NCT01404039|2267460|P13|NOT COMPLETED|Overall Study||0
937451|NCT01404039|2267461|P12|NOT COMPLETED|Overall Study||0
937452|NCT01404039|2267462|P11|NOT COMPLETED|Overall Study||1
937453|NCT01404039|2267463|P10|NOT COMPLETED|Overall Study||1
937454|NCT01404039|2267464|P9|NOT COMPLETED|Overall Study||0
937455|NCT01404039|2267465|P8|NOT COMPLETED|Overall Study||0
937456|NCT01404039|2267466|P7|NOT COMPLETED|Overall Study||0
937457|NCT01404039|2267467|P6|NOT COMPLETED|Overall Study||0
937458|NCT01404039|2267468|P5|NOT COMPLETED|Overall Study||0
937459|NCT01404039|2267469|P4|NOT COMPLETED|Overall Study||0
937460|NCT01404039|2267470|P3|NOT COMPLETED|Overall Study||0
937461|NCT01404039|2267471|P2|NOT COMPLETED|Overall Study||0
937462|NCT01404039|2267472|P1|NOT COMPLETED|Overall Study||1
937463|NCT01404039|2267460|P13|COMPLETED|Overall Study||0
937464|NCT01404039|2267461|P12|COMPLETED|Overall Study||0
937465|NCT01404039|2267462|P11|COMPLETED|Overall Study||14
937466|NCT01404039|2267463|P10|COMPLETED|Overall Study||14
937467|NCT01404039|2267464|P9|COMPLETED|Overall Study||15
937468|NCT01404039|2267465|P8|COMPLETED|Overall Study||15
937469|NCT01404039|2267466|P7|COMPLETED|Overall Study||10
937470|NCT01404039|2267467|P6|COMPLETED|Overall Study||10
937471|NCT01404039|2267468|P5|COMPLETED|Overall Study||10
937472|NCT01404039|2267469|P4|COMPLETED|Overall Study||10
937473|NCT01404039|2267470|P3|COMPLETED|Overall Study||5
937474|NCT01404039|2267471|P2|COMPLETED|Overall Study||5
937475|NCT01404039|2267472|P1|COMPLETED|Overall Study||4
937476|NCT01404039|2267460|P13|STARTED|Overall Study||0
937477|NCT01404039|2267461|P12|STARTED|Overall Study||0
937478|NCT01404039|2267462|P11|STARTED|Overall Study||15
937479|NCT01404039|2267463|P10|STARTED|Overall Study||15
937480|NCT01404039|2267464|P9|STARTED|Overall Study||15
937481|NCT01404039|2267465|P8|STARTED|Overall Study||15
937482|NCT01404039|2267466|P7|STARTED|Overall Study||10
937483|NCT01404039|2267467|P6|STARTED|Overall Study||10
937484|NCT01404039|2267468|P5|STARTED|Overall Study||10
937485|NCT01404039|2267469|P4|STARTED|Overall Study||10
937486|NCT01404039|2267470|P3|STARTED|Overall Study||5
937487|NCT01404039|2267471|P2|STARTED|Overall Study||5
937488|NCT01404039|2267472|P1|STARTED|Overall Study||5
937489|NCT01403987|2267499|P3|NOT COMPLETED|Overall Study||18
937490|NCT01403987|2267500|P2|NOT COMPLETED|Overall Study||17
937491|NCT01403987|2267501|P1|NOT COMPLETED|Overall Study||18
937492|NCT01403987|2267499|P3|COMPLETED|Overall Study||50
937493|NCT01403987|2267500|P2|COMPLETED|Overall Study||17
937494|NCT01403987|2267501|P1|COMPLETED|Overall Study||16
937495|NCT01403987|2267499|P3|STARTED|Overall Study||68
937496|NCT01403987|2267500|P2|STARTED|Overall Study||34
937497|NCT01403987|2267501|P1|STARTED|Overall Study||34
937498|NCT01403805|2267517|P2|NOT COMPLETED|Overall Study||7
937499|NCT01403805|2267518|P1|NOT COMPLETED|Overall Study||0
937500|NCT01403805|2267517|P2|COMPLETED|Overall Study||98
937501|NCT01403805|2267518|P1|COMPLETED|Overall Study||94
937502|NCT01403805|2267517|P2|Pneumonia Diagnosis|Overall Study||2
937503|NCT01403805|2267518|P1|Pneumonia Diagnosis|Overall Study||21
937504|NCT01403805|2267517|P2|STARTED|Overall Study||105
937505|NCT01403805|2267518|P1|STARTED|Overall Study||94
937506|NCT01403441|2267530|P1|NOT COMPLETED|Overall Study||0
937507|NCT01403441|2267530|P1|COMPLETED|Overall Study||3
937508|NCT01403441|2267530|P1|STARTED|Overall Study||3
937509|NCT01403376|2267540|P3|NOT COMPLETED|Overall Study||0
937510|NCT01403376|2267541|P2|NOT COMPLETED|Overall Study||0
937511|NCT01403376|2267542|P1|NOT COMPLETED|Overall Study||0
937512|NCT01403376|2267540|P3|COMPLETED|Overall Study||46
937513|NCT01403376|2267541|P2|COMPLETED|Overall Study||41
937514|NCT01403376|2267542|P1|COMPLETED|Overall Study||41
937515|NCT01403376|2267540|P3|STARTED|Overall Study||46
937516|NCT01403376|2267541|P2|STARTED|Overall Study||41
937517|NCT01403376|2267542|P1|STARTED|Overall Study||41
937518|NCT01403194|2267562|P1|NOT COMPLETED|Overall Study||10
937519|NCT01403194|2267562|P1|COMPLETED|Overall Study||1
937520|NCT01403194|2267562|P1|STARTED|Overall Study||11
937521|NCT01403090|2267568|P1|NOT COMPLETED|Overall Study||0
937522|NCT01403090|2267568|P1|COMPLETED|Overall Study||8
937523|NCT01403090|2267568|P1|STARTED|Overall Study||8
937524|NCT01403051|2267574|P2|NOT COMPLETED|Overall Study||6
937525|NCT01403051|2267575|P1|NOT COMPLETED|Overall Study||10
937526|NCT01403051|2267574|P2|COMPLETED|Overall Study||80
937527|NCT01403051|2267575|P1|COMPLETED|Overall Study||71
937528|NCT01403051|2267574|P2|Initiated Study Treatment|Overall Study||86
937529|NCT01403051|2267575|P1|Initiated Study Treatment|Overall Study||81
937530|NCT01403051|2267574|P2|STARTED|Overall Study||86
937531|NCT01403051|2267575|P1|STARTED|Overall Study||81
937532|NCT01402986|2267611|P4|NOT COMPLETED|Overall Study||22
937533|NCT01402986|2267612|P3|NOT COMPLETED|Overall Study||8
937534|NCT01402986|2267613|P2|NOT COMPLETED|Overall Study||15
937535|NCT01402986|2267614|P1|NOT COMPLETED|Overall Study||9
937536|NCT01402986|2267611|P4|COMPLETED|Overall Study||129
937537|NCT01402986|2267612|P3|COMPLETED|Overall Study||67
937538|NCT01402986|2267613|P2|COMPLETED|Overall Study||135
937539|NCT01402986|2267614|P1|COMPLETED|Overall Study||67
937540|NCT01402986|2267611|P4|STARTED|Overall Study||151
937541|NCT01402986|2267612|P3|STARTED|Overall Study||75
937542|NCT01402986|2267613|P2|STARTED|Overall Study||150
937543|NCT01402986|2267614|P1|STARTED|Overall Study||76
937544|NCT01402947|2267749|P2|NOT COMPLETED|Second Intervention||0
937545|NCT01402947|2267750|P1|NOT COMPLETED|Second Intervention||0
937546|NCT01402947|2267749|P2|COMPLETED|Second Intervention||14
937547|NCT01402947|2267750|P1|COMPLETED|Second Intervention||15
937548|NCT01402947|2267749|P2|STARTED|Second Intervention||14
937549|NCT01402947|2267750|P1|STARTED|Second Intervention||15
937550|NCT01402947|2267749|P2|NOT COMPLETED|First Intervention||1
937551|NCT01402947|2267750|P1|NOT COMPLETED|First Intervention||0
937552|NCT01402947|2267749|P2|COMPLETED|First Intervention||14
937553|NCT01402947|2267750|P1|COMPLETED|First Intervention||15
937554|NCT01402947|2267749|P2|STARTED|First Intervention||15
937555|NCT01402947|2267750|P1|STARTED|First Intervention||15
937556|NCT01402869|2267761|P3|NOT COMPLETED|Overall Study||1
937557|NCT01402869|2267762|P2|NOT COMPLETED|Overall Study||0
937558|NCT01402869|2267763|P1|NOT COMPLETED|Overall Study||0
937559|NCT01402869|2267761|P3|COMPLETED|Overall Study||30
937560|NCT01402869|2267762|P2|COMPLETED|Overall Study||30
937561|NCT01402869|2267763|P1|COMPLETED|Overall Study||30
937562|NCT01402869|2267761|P3|STARTED|Overall Study||31
937563|NCT01402869|2267762|P2|STARTED|Overall Study||30
937564|NCT01402869|2267763|P1|STARTED|Overall Study||30
937565|NCT01402817|2267777|P1|NOT COMPLETED|Overall Study||11
937566|NCT01402817|2267777|P1|COMPLETED|Overall Study||8
937567|NCT01402817|2267777|P1|STARTED|Overall Study||19
937568|NCT01402700|2267782|P1|NOT COMPLETED|Overall Study||7
937569|NCT01402700|2267782|P1|COMPLETED|Overall Study||68
937570|NCT01402700|2267782|P1|STARTED|Overall Study||75
937571|NCT01402570|2267786|P1|NOT COMPLETED|Overall Study||1
937572|NCT01402570|2267786|P1|COMPLETED|Overall Study||19
937573|NCT01402570|2267786|P1|STARTED|Overall Study||20
937574|NCT01402427|2267795|P2|NOT COMPLETED|Overall Study||0
937575|NCT01402427|2267796|P1|NOT COMPLETED|Overall Study||0
937576|NCT01402427|2267795|P2|COMPLETED|Overall Study||294
937577|NCT01402427|2267796|P1|COMPLETED|Overall Study||297
937578|NCT01402427|2267795|P2|STARTED|Overall Study||294
937579|NCT01402427|2267796|P1|STARTED|Overall Study||297
937580|NCT01402284|2267814|P1|NOT COMPLETED|Overall Study||15
937581|NCT01402284|2267814|P1|COMPLETED|Overall Study||30
937582|NCT01402284|2267814|P1|STARTED|Overall Study||45
937583|NCT01402141|2267827|P2|NOT COMPLETED|Overall Study||2
937584|NCT01402141|2267828|P1|NOT COMPLETED|Overall Study||1
937585|NCT01402141|2267827|P2|COMPLETED|Overall Study||28
937586|NCT01402141|2267828|P1|COMPLETED|Overall Study||29
937587|NCT01402141|2267827|P2|STARTED|Overall Study||30
937588|NCT01402141|2267828|P1|STARTED|Overall Study||30
937589|NCT01402128|2267850|P2|NOT COMPLETED|Overall Study||0
937590|NCT01402128|2267851|P1|NOT COMPLETED|Overall Study||1
937591|NCT01402128|2267850|P2|COMPLETED|Overall Study||40
937592|NCT01402128|2267851|P1|COMPLETED|Overall Study||39
937593|NCT01402128|2267850|P2|STARTED|Overall Study||40
937594|NCT01402128|2267851|P1|STARTED|Overall Study||40
937595|NCT01402115|2267879|P2|NOT COMPLETED|Overall Study||1
937596|NCT01402115|2267880|P1|NOT COMPLETED|Overall Study||1
937597|NCT01402115|2267879|P2|COMPLETED|Overall Study||29
937598|NCT01402115|2267880|P1|COMPLETED|Overall Study||29
937599|NCT01402115|2267879|P2|STARTED|Overall Study||30
937600|NCT01402115|2267880|P1|STARTED|Overall Study||30
937601|NCT01402102|2267896|P2|NOT COMPLETED|Overall Study||3
937602|NCT01402102|2267897|P1|NOT COMPLETED|Overall Study||2
937603|NCT01402102|2267896|P2|COMPLETED|Overall Study||27
937604|NCT01402102|2267897|P1|COMPLETED|Overall Study||28
937605|NCT01402102|2267896|P2|STARTED|Overall Study||30
937606|NCT01402102|2267897|P1|STARTED|Overall Study||30
937607|NCT01402063|2267917|P2|NOT COMPLETED|Overall Study||3
937608|NCT01402063|2267918|P1|NOT COMPLETED|Overall Study||3
937609|NCT01402063|2267917|P2|COMPLETED|Overall Study||18
937610|NCT01402063|2267918|P1|COMPLETED|Overall Study||39
937611|NCT01402063|2267917|P2|STARTED|Overall Study||21
937612|NCT01402063|2267918|P1|STARTED|Overall Study||42
937613|NCT01401907|2267926|P2|NOT COMPLETED|Overall Study||51
937614|NCT01401907|2267927|P1|NOT COMPLETED|Overall Study||57
937615|NCT01401907|2267926|P2|COMPLETED|Overall Study||124
937616|NCT01401907|2267927|P1|COMPLETED|Overall Study||118
937617|NCT01401907|2267926|P2|12 Week Outcomes|Overall Study||153
937618|NCT01401907|2267927|P1|12 Week Outcomes|Overall Study||148
937619|NCT01401907|2267926|P2|STARTED|Overall Study||175
937620|NCT01401907|2267927|P1|STARTED|Overall Study||175
937621|NCT01401842|2267947|P2|NOT COMPLETED|Overall Study||67
937622|NCT01401842|2267948|P1|NOT COMPLETED|Overall Study||68
937623|NCT01401842|2267947|P2|COMPLETED|Overall Study||217
937624|NCT01401842|2267948|P1|COMPLETED|Overall Study||230
937625|NCT01401842|2267947|P2|STARTED|Overall Study||284
937626|NCT01401842|2267948|P1|STARTED|Overall Study||298
937627|NCT01401647|2267961|P3|NOT COMPLETED|Overall Study||3
937628|NCT01401647|2267962|P2|NOT COMPLETED|Overall Study||8
937629|NCT01401647|2267963|P1|NOT COMPLETED|Overall Study||4
937630|NCT01401647|2267961|P3|COMPLETED|Overall Study||1056
937631|NCT01401647|2267962|P2|COMPLETED|Overall Study||985
937632|NCT01401647|2267963|P1|COMPLETED|Overall Study||968
937633|NCT01401647|2267961|P3|STARTED|Overall Study||1059
937634|NCT01401647|2267962|P2|STARTED|Overall Study||993
937635|NCT01401647|2267963|P1|STARTED|Overall Study||972
937636|NCT01401595|2267976|P2|NOT COMPLETED|Imaging and Treatment (for NE Arm)||0
937637|NCT01401595|2267977|P1|NOT COMPLETED|Imaging and Treatment (for NE Arm)||14
937638|NCT01401595|2267976|P2|COMPLETED|Imaging and Treatment (for NE Arm)||10
937639|NCT01401595|2267977|P1|COMPLETED|Imaging and Treatment (for NE Arm)||18
937640|NCT01401595|2267976|P2|STARTED|Imaging and Treatment (for NE Arm)||10
937641|NCT01401595|2267977|P1|STARTED|Imaging and Treatment (for NE Arm)||32
937642|NCT01401595|2267976|P2|NOT COMPLETED|Recruitment and Screening||2
937643|NCT01401595|2267977|P1|NOT COMPLETED|Recruitment and Screening||43
937644|NCT01401595|2267976|P2|COMPLETED|Recruitment and Screening|10 of the 12 remained eligible/interested after the initial screening visit.|10
937645|NCT01401595|2267977|P1|COMPLETED|Recruitment and Screening|Of the 75, 32 remained interested/eligible after the initial screening period.|32
937646|NCT01401595|2267976|P2|STARTED|Recruitment and Screening|Of 32 calls, 12 control subjects attended an initial screening visit.|12
937647|NCT01401595|2267977|P1|STARTED|Recruitment and Screening|Of 345 calls, 75 potential NES subjects attended the screening visit and provided informed consent.|75
937648|NCT01401582|2267988|P2|NOT COMPLETED|Overall Study||117
937649|NCT01401582|2267989|P1|NOT COMPLETED|Overall Study||110
937650|NCT01401582|2267988|P2|COMPLETED|Overall Study||291
937651|NCT01401582|2267989|P1|COMPLETED|Overall Study||116
937652|NCT01401582|2267988|P2|Baseline Completed|Overall Study||348
937653|NCT01401582|2267989|P1|Baseline Completed|Overall Study||168
937654|NCT01401582|2267988|P2|STARTED|Overall Study||408
937655|NCT01401582|2267989|P1|STARTED|Overall Study||226
937656|NCT01401517|2268008|P3|NOT COMPLETED|Overall Study||3
937657|NCT01401517|2268009|P2|NOT COMPLETED|Overall Study||2
937658|NCT01401517|2268010|P1|NOT COMPLETED|Overall Study||3
937659|NCT01401517|2268008|P3|COMPLETED|Overall Study||15
937660|NCT01401517|2268009|P2|COMPLETED|Overall Study||17
937661|NCT01401517|2268010|P1|COMPLETED|Overall Study||15
937662|NCT01401517|2268008|P3|STARTED|Overall Study||18
937663|NCT01401517|2268009|P2|STARTED|Overall Study||19
937664|NCT01401517|2268010|P1|STARTED|Overall Study||18
937665|NCT01401478|2268018|P1|NOT COMPLETED|Overall Study||31
937666|NCT01401478|2268018|P1|COMPLETED|Overall Study||55
937667|NCT01401478|2268018|P1|STARTED|Overall Study||86
937668|NCT01401465|2268031|P2|NOT COMPLETED|Treatment Period 2||2
937669|NCT01401465|2268032|P1|NOT COMPLETED|Treatment Period 2||0
937670|NCT01401465|2268031|P2|COMPLETED|Treatment Period 2||144
937671|NCT01401465|2268032|P1|COMPLETED|Treatment Period 2||150
937672|NCT01401465|2268031|P2|STARTED|Treatment Period 2||146
937673|NCT01401465|2268032|P1|STARTED|Treatment Period 2||150
937674|NCT01401465|2268031|P2|NOT COMPLETED|Washout||0
937675|NCT01401465|2268032|P1|NOT COMPLETED|Washout||0
937676|NCT01401465|2268031|P2|COMPLETED|Washout||146
937677|NCT01401465|2268032|P1|COMPLETED|Washout||150
937678|NCT01401465|2268031|P2|STARTED|Washout||146
937679|NCT01401465|2268032|P1|STARTED|Washout||150
937680|NCT01401465|2268031|P2|NOT COMPLETED|Treatment Period 1||16
937681|NCT01401465|2268032|P1|NOT COMPLETED|Treatment Period 1||15
937682|NCT01401465|2268031|P2|COMPLETED|Treatment Period 1||146
937683|NCT01401465|2268032|P1|COMPLETED|Treatment Period 1||150
937684|NCT01401465|2268031|P2|STARTED|Treatment Period 1||162
937685|NCT01401465|2268032|P1|STARTED|Treatment Period 1||165
937686|NCT01401452|2268095|P1|NOT COMPLETED|Overall Study||72
937687|NCT01401452|2268095|P1|COMPLETED|Overall Study||174
937688|NCT01401452|2268095|P1|Visit 5 (9 Months)|Overall Study||175
937689|NCT01401452|2268095|P1|Visit 4 (6 Months)|Overall Study||172
937690|NCT01401452|2268095|P1|Visit 3 (3 Months)|Overall Study||217
937691|NCT01401452|2268095|P1|Visit 2 (1 Month)|Overall Study||225
937692|NCT01401452|2268095|P1|Visit 1 (Baseline)|Overall Study||246
937693|NCT01401452|2268095|P1|STARTED|Overall Study||246
937694|NCT01401361|2268107|P1|NOT COMPLETED|Overall Study||28
937695|NCT01401361|2268107|P1|COMPLETED|Overall Study|16 subjects were withdrawn prior to the use of the investigational device|122
937696|NCT01401361|2268107|P1|STARTED|Overall Study||150
937697|NCT01401322|2268113|P1|NOT COMPLETED|Overall Study||2
937698|NCT01401322|2268113|P1|COMPLETED|Overall Study||3
937699|NCT01401322|2268113|P1|STARTED|Overall Study||5
937700|NCT01401283|2268119|P2|NOT COMPLETED|Overall Study||10
937701|NCT01401283|2268120|P1|NOT COMPLETED|Overall Study||10
937702|NCT01401283|2268119|P2|COMPLETED|Overall Study||81
937703|NCT01401283|2268120|P1|COMPLETED|Overall Study||79
937704|NCT01401283|2268119|P2|STARTED|Overall Study||91
937705|NCT01401283|2268120|P1|STARTED|Overall Study||89
937706|NCT01401257|2268132|P4|NOT COMPLETED|Overall Study||2
937707|NCT01401257|2268133|P3|NOT COMPLETED|Overall Study||3
937708|NCT01401257|2268134|P2|NOT COMPLETED|Overall Study||2
937709|NCT01401257|2268135|P1|NOT COMPLETED|Overall Study||0
937710|NCT01401257|2268132|P4|COMPLETED|Overall Study||17
937711|NCT01401257|2268133|P3|COMPLETED|Overall Study||16
937712|NCT01401257|2268134|P2|COMPLETED|Overall Study||19
937713|NCT01401257|2268135|P1|COMPLETED|Overall Study||21
937714|NCT01401257|2268132|P4|STARTED|Overall Study||19
937715|NCT01401257|2268133|P3|STARTED|Overall Study||19
937716|NCT01401257|2268134|P2|STARTED|Overall Study||21
937717|NCT01401257|2268135|P1|STARTED|Overall Study||21
937718|NCT01401166|2268147|P4|NOT COMPLETED|Safety Follow-Up Period||19
937719|NCT01401166|2268148|P3|NOT COMPLETED|Safety Follow-Up Period||17
937720|NCT01401166|2268149|P2|NOT COMPLETED|Safety Follow-Up Period||18
937721|NCT01401166|2268150|P1|NOT COMPLETED|Safety Follow-Up Period||25
937722|NCT01401166|2268147|P4|COMPLETED|Safety Follow-Up Period||100
937723|NCT01401166|2268148|P3|COMPLETED|Safety Follow-Up Period||104
937724|NCT01401166|2268149|P2|COMPLETED|Safety Follow-Up Period||106
937725|NCT01401166|2268150|P1|COMPLETED|Safety Follow-Up Period||99
937726|NCT01401166|2268147|P4|STARTED|Safety Follow-Up Period|All 119 randomized participants entered follow-up regardless of whether they received treatment.|119
937727|NCT01401166|2268148|P3|STARTED|Safety Follow-Up Period|All 121 randomized participants entered follow-up regardless of whether they received treatment.|121
937728|NCT01401166|2268149|P2|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
937729|NCT01401166|2268150|P1|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
937730|NCT01401166|2268147|P4|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||3
937731|NCT01401166|2268148|P3|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||2
937732|NCT01401166|2268149|P2|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||7
937733|NCT01401166|2268150|P1|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||4
937734|NCT01401166|2268147|P4|COMPLETED|Continuation Treatment (Cycles 9 to 18)||102
937735|NCT01401166|2268148|P3|COMPLETED|Continuation Treatment (Cycles 9 to 18)||105
937736|NCT01401166|2268149|P2|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
937737|NCT01401166|2268150|P1|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
937738|NCT01401166|2268147|P4|STARTED|Continuation Treatment (Cycles 9 to 18)||105
937739|NCT01401166|2268148|P3|STARTED|Continuation Treatment (Cycles 9 to 18)||107
937740|NCT01401166|2268149|P2|STARTED|Continuation Treatment (Cycles 9 to 18)||116
937741|NCT01401166|2268150|P1|STARTED|Continuation Treatment (Cycles 9 to 18)||113
937742|NCT01401166|2268147|P4|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||11
937743|NCT01401166|2268148|P3|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||12
937744|NCT01401166|2268149|P2|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||4
937745|NCT01401166|2268150|P1|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||6
937746|NCT01401166|2268147|P4|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||105
937747|NCT01401166|2268148|P3|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||107
937748|NCT01401166|2268149|P2|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||116
937749|NCT01401166|2268150|P1|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||113
937750|NCT01401166|2268147|P4|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||116
937751|NCT01401166|2268148|P3|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
937752|NCT01401166|2268149|P2|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||120
937753|NCT01401166|2268150|P1|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
937754|NCT01401166|2268147|P4|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
937755|NCT01401166|2268148|P3|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
937756|NCT01401166|2268149|P2|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
937757|NCT01401166|2268150|P1|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||3
937758|NCT01401166|2268147|P4|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||116
937759|NCT01401166|2268148|P3|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
937760|NCT01401166|2268149|P2|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||120
937761|NCT01401166|2268150|P1|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
937762|NCT01401166|2268147|P4|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 119 participants were randomized, but 1 did not receive any treatment.|118
937763|NCT01401166|2268148|P3|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 121 participants were randomized who all received study treatment.|121
937764|NCT01401166|2268149|P2|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
937765|NCT01401166|2268150|P1|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
937766|NCT01401153|2268186|P2|NOT COMPLETED|Second Test Day||5
937767|NCT01401153|2268187|P1|NOT COMPLETED|Second Test Day||0
937768|NCT01401153|2268186|P2|COMPLETED|Second Test Day||60
937769|NCT01401153|2268187|P1|COMPLETED|Second Test Day||45
937770|NCT01401153|2268186|P2|STARTED|Second Test Day||65
937771|NCT01401153|2268187|P1|STARTED|Second Test Day||45
937772|NCT01401153|2268186|P2|NOT COMPLETED|First Test Day||10
937773|NCT01401153|2268187|P1|NOT COMPLETED|First Test Day||1
937774|NCT01401153|2268186|P2|COMPLETED|First Test Day||45
937775|NCT01401153|2268187|P1|COMPLETED|First Test Day||65
937776|NCT01401153|2268186|P2|STARTED|First Test Day||55
937777|NCT01401153|2268187|P1|STARTED|First Test Day||66
937778|NCT01401101|2268221|P2|NOT COMPLETED|Overall Study||27
937779|NCT01401101|2268222|P1|NOT COMPLETED|Overall Study||22
937780|NCT01401101|2268221|P2|COMPLETED|Overall Study||171
937781|NCT01401101|2268222|P1|COMPLETED|Overall Study||184
937782|NCT01401101|2268221|P2|STARTED|Overall Study||198
937783|NCT01401101|2268222|P1|STARTED|Overall Study||206
937784|NCT01401062|2268234|P2|NOT COMPLETED|Overall Study||8
937785|NCT01401062|2268235|P1|NOT COMPLETED|Overall Study||11
937786|NCT01401062|2268234|P2|COMPLETED|Overall Study|At time of data entry, these 4 patients are still undergoing follow-up|4
937787|NCT01401062|2268235|P1|COMPLETED|Overall Study||0
937788|NCT01401062|2268234|P2|STARTED|Overall Study||12
937789|NCT01401062|2268235|P1|STARTED|Overall Study||11
937790|NCT01401049|2268243|P2|NOT COMPLETED|Overall Study||0
937791|NCT01401049|2268244|P1|NOT COMPLETED|Overall Study||0
937792|NCT01401049|2268243|P2|COMPLETED|Overall Study||0
937793|NCT01401049|2268244|P1|COMPLETED|Overall Study||0
937794|NCT01401049|2268243|P2|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
937795|NCT01401049|2268244|P1|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
937796|NCT01401023|2268250|P1|NOT COMPLETED|Overall Study||0
937797|NCT01401023|2268250|P1|COMPLETED|Overall Study||10
937798|NCT01401023|2268250|P1|STARTED|Overall Study||10
937799|NCT01401010|2268258|P2|NOT COMPLETED|Overall Study||0
937800|NCT01401010|2268259|P1|NOT COMPLETED|Overall Study||1
937801|NCT01401010|2268258|P2|COMPLETED|Overall Study||6
937802|NCT01401010|2268259|P1|COMPLETED|Overall Study||5
937803|NCT01401010|2268258|P2|STARTED|Overall Study||6
937804|NCT01401010|2268259|P1|STARTED|Overall Study||6
937805|NCT01400958|2268284|P2|NOT COMPLETED|Overall Study||2
937806|NCT01400958|2268285|P1|NOT COMPLETED|Overall Study||1
937807|NCT01400958|2268284|P2|COMPLETED|Overall Study||1
937808|NCT01400958|2268285|P1|COMPLETED|Overall Study||2
937809|NCT01400958|2268284|P2|STARTED|Overall Study||3
937810|NCT01400958|2268285|P1|STARTED|Overall Study||3
937811|NCT01400932|2268295|P2|NOT COMPLETED|Overall Study||15
937812|NCT01400932|2268296|P1|NOT COMPLETED|Overall Study||14
937813|NCT01400932|2268295|P2|COMPLETED|Overall Study||167
937814|NCT01400932|2268296|P1|COMPLETED|Overall Study||164
937815|NCT01400932|2268295|P2|STARTED|Overall Study||182
937816|NCT01400932|2268296|P1|STARTED|Overall Study||178
937817|NCT01400919|2268318|P1|NOT COMPLETED|Overall Study||8
937818|NCT01400919|2268318|P1|COMPLETED|Overall Study||67
937819|NCT01400919|2268318|P1|STARTED|Overall Study||75
937820|NCT01400906|2268322|P6|NOT COMPLETED|Treatment Period 3||0
937821|NCT01400906|2268323|P5|NOT COMPLETED|Treatment Period 3||0
937822|NCT01400906|2268324|P4|NOT COMPLETED|Treatment Period 3||0
937823|NCT01400906|2268325|P3|NOT COMPLETED|Treatment Period 3||0
937824|NCT01400906|2268326|P2|NOT COMPLETED|Treatment Period 3||0
937825|NCT01400906|2268327|P1|NOT COMPLETED|Treatment Period 3||0
937826|NCT01400906|2268322|P6|COMPLETED|Treatment Period 3||5
937827|NCT01400906|2268323|P5|COMPLETED|Treatment Period 3||6
937828|NCT01400906|2268324|P4|COMPLETED|Treatment Period 3||6
937829|NCT01400906|2268325|P3|COMPLETED|Treatment Period 3||6
937830|NCT01400906|2268326|P2|COMPLETED|Treatment Period 3||6
937831|NCT01400906|2268327|P1|COMPLETED|Treatment Period 3||6
937832|NCT01400906|2268322|P6|STARTED|Treatment Period 3||5
937833|NCT01400906|2268323|P5|STARTED|Treatment Period 3||6
937834|NCT01400906|2268324|P4|STARTED|Treatment Period 3||6
937835|NCT01400906|2268325|P3|STARTED|Treatment Period 3||6
937836|NCT01400906|2268326|P2|STARTED|Treatment Period 3||6
937837|NCT01400906|2268327|P1|STARTED|Treatment Period 3||6
937838|NCT01400906|2268322|P6|NOT COMPLETED|Washout Period 2||0
937839|NCT01400906|2268323|P5|NOT COMPLETED|Washout Period 2||0
937840|NCT01400906|2268324|P4|NOT COMPLETED|Washout Period 2||0
937841|NCT01400906|2268325|P3|NOT COMPLETED|Washout Period 2||0
937842|NCT01400906|2268326|P2|NOT COMPLETED|Washout Period 2||0
937843|NCT01400906|2268327|P1|NOT COMPLETED|Washout Period 2||0
937844|NCT01400906|2268322|P6|COMPLETED|Washout Period 2||5
937845|NCT01400906|2268323|P5|COMPLETED|Washout Period 2||6
937846|NCT01400906|2268324|P4|COMPLETED|Washout Period 2||6
937847|NCT01400906|2268325|P3|COMPLETED|Washout Period 2||6
937848|NCT01400906|2268326|P2|COMPLETED|Washout Period 2||6
937849|NCT01400906|2268327|P1|COMPLETED|Washout Period 2||6
937850|NCT01400906|2268322|P6|STARTED|Washout Period 2||5
937851|NCT01400906|2268323|P5|STARTED|Washout Period 2||6
937852|NCT01400906|2268324|P4|STARTED|Washout Period 2||6
937853|NCT01400906|2268325|P3|STARTED|Washout Period 2||6
937854|NCT01400906|2268326|P2|STARTED|Washout Period 2||6
937855|NCT01400906|2268327|P1|STARTED|Washout Period 2||6
937856|NCT01400906|2268322|P6|NOT COMPLETED|Treatment Period 2||0
937857|NCT01400906|2268323|P5|NOT COMPLETED|Treatment Period 2||0
937858|NCT01400906|2268324|P4|NOT COMPLETED|Treatment Period 2||0
937859|NCT01400906|2268325|P3|NOT COMPLETED|Treatment Period 2||0
937860|NCT01400906|2268326|P2|NOT COMPLETED|Treatment Period 2||0
937861|NCT01400906|2268327|P1|NOT COMPLETED|Treatment Period 2||0
937862|NCT01400906|2268322|P6|COMPLETED|Treatment Period 2||5
937863|NCT01400906|2268323|P5|COMPLETED|Treatment Period 2||6
937864|NCT01400906|2268324|P4|COMPLETED|Treatment Period 2||6
937865|NCT01400906|2268325|P3|COMPLETED|Treatment Period 2||6
937866|NCT01400906|2268326|P2|COMPLETED|Treatment Period 2||6
937867|NCT01400906|2268327|P1|COMPLETED|Treatment Period 2||6
937868|NCT01400906|2268322|P6|STARTED|Treatment Period 2||5
937869|NCT01400906|2268323|P5|STARTED|Treatment Period 2||6
937870|NCT01400906|2268324|P4|STARTED|Treatment Period 2||6
937871|NCT01400906|2268325|P3|STARTED|Treatment Period 2||6
937872|NCT01400906|2268326|P2|STARTED|Treatment Period 2||6
937873|NCT01400906|2268327|P1|STARTED|Treatment Period 2||6
937874|NCT01400906|2268322|P6|NOT COMPLETED|Washout Period 1||0
937875|NCT01400906|2268323|P5|NOT COMPLETED|Washout Period 1||0
937876|NCT01400906|2268324|P4|NOT COMPLETED|Washout Period 1||0
937877|NCT01400906|2268325|P3|NOT COMPLETED|Washout Period 1||0
937878|NCT01400906|2268326|P2|NOT COMPLETED|Washout Period 1||0
937879|NCT01400906|2268327|P1|NOT COMPLETED|Washout Period 1||0
937880|NCT01400906|2268322|P6|COMPLETED|Washout Period 1||5
937881|NCT01400906|2268323|P5|COMPLETED|Washout Period 1||6
937882|NCT01400906|2268324|P4|COMPLETED|Washout Period 1||6
937883|NCT01400906|2268325|P3|COMPLETED|Washout Period 1||6
937884|NCT01400906|2268326|P2|COMPLETED|Washout Period 1||6
937885|NCT01400906|2268327|P1|COMPLETED|Washout Period 1||6
937886|NCT01400906|2268322|P6|STARTED|Washout Period 1||5
937887|NCT01400906|2268323|P5|STARTED|Washout Period 1||6
937888|NCT01400906|2268324|P4|STARTED|Washout Period 1||6
937889|NCT01400906|2268325|P3|STARTED|Washout Period 1||6
937890|NCT01400906|2268326|P2|STARTED|Washout Period 1||6
937891|NCT01400906|2268327|P1|STARTED|Washout Period 1||6
937892|NCT01400906|2268322|P6|NOT COMPLETED|Treatment Period 1||0
937893|NCT01400906|2268323|P5|NOT COMPLETED|Treatment Period 1||0
937894|NCT01400906|2268324|P4|NOT COMPLETED|Treatment Period 1||0
937895|NCT01400906|2268325|P3|NOT COMPLETED|Treatment Period 1||0
937896|NCT01400906|2268326|P2|NOT COMPLETED|Treatment Period 1||0
937897|NCT01400906|2268327|P1|NOT COMPLETED|Treatment Period 1||0
937898|NCT01400906|2268322|P6|COMPLETED|Treatment Period 1||5
937899|NCT01400906|2268323|P5|COMPLETED|Treatment Period 1||6
937900|NCT01400906|2268324|P4|COMPLETED|Treatment Period 1||6
937901|NCT01400906|2268325|P3|COMPLETED|Treatment Period 1||6
937902|NCT01400906|2268326|P2|COMPLETED|Treatment Period 1||6
937903|NCT01400906|2268327|P1|COMPLETED|Treatment Period 1||6
937904|NCT01400906|2268322|P6|STARTED|Treatment Period 1||5
937905|NCT01400906|2268323|P5|STARTED|Treatment Period 1||6
937906|NCT01400906|2268324|P4|STARTED|Treatment Period 1||6
937907|NCT01400906|2268325|P3|STARTED|Treatment Period 1||6
937908|NCT01400906|2268326|P2|STARTED|Treatment Period 1||6
937909|NCT01400906|2268327|P1|STARTED|Treatment Period 1||6
937910|NCT01400893|2268361|P2|NOT COMPLETED|Overall Study||27
937911|NCT01400893|2268362|P1|NOT COMPLETED|Overall Study||27
937912|NCT01400893|2268361|P2|COMPLETED|Overall Study||38
937913|NCT01400893|2268362|P1|COMPLETED|Overall Study||42
937914|NCT01400893|2268361|P2|STARTED|Overall Study||65
937915|NCT01400893|2268362|P1|STARTED|Overall Study||69
937916|NCT01400880|2268370|P1|NOT COMPLETED|Overall Study||2
937917|NCT01400880|2268370|P1|COMPLETED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|101
937918|NCT01400880|2268370|P1|STARTED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|103
937919|NCT01400841|2268374|P1|NOT COMPLETED|Extended Study Phase (2 Years)||2
937920|NCT01400841|2268374|P1|COMPLETED|Extended Study Phase (2 Years)||11
937921|NCT01400841|2268374|P1|STARTED|Extended Study Phase (2 Years)|"1 subject refused further participation
1 subject death prior to agreeing to extended follow-up"|13
937922|NCT01400841|2268374|P1|NOT COMPLETED|Initial Study Phase (6 Months)||1
937923|NCT01400841|2268374|P1|COMPLETED|Initial Study Phase (6 Months)||15
937924|NCT01400841|2268374|P1|STARTED|Initial Study Phase (6 Months)|2 of the 18 consented subjects did not receive the device|16
937925|NCT01400698|2268412|P6|NOT COMPLETED|Overall Study||6
937926|NCT01400698|2268413|P5|NOT COMPLETED|Overall Study||7
937927|NCT01400698|2268414|P4|NOT COMPLETED|Overall Study||8
937928|NCT01400698|2268415|P3|NOT COMPLETED|Overall Study||2
937929|NCT01400698|2268416|P2|NOT COMPLETED|Overall Study||11
937930|NCT01400698|2268417|P1|NOT COMPLETED|Overall Study||15
937931|NCT01400698|2268412|P6|COMPLETED|Overall Study||9
937932|NCT01400698|2268413|P5|COMPLETED|Overall Study||7
937933|NCT01400698|2268414|P4|COMPLETED|Overall Study||6
937934|NCT01400698|2268415|P3|COMPLETED|Overall Study||0
937935|NCT01400698|2268416|P2|COMPLETED|Overall Study||12
937936|NCT01400698|2268417|P1|COMPLETED|Overall Study||8
937937|NCT01400698|2268412|P6|STARTED|Overall Study||15
937938|NCT01400698|2268413|P5|STARTED|Overall Study||14
937939|NCT01400698|2268414|P4|STARTED|Overall Study||14
937940|NCT01400698|2268415|P3|STARTED|Overall Study||2
937941|NCT01400698|2268416|P2|STARTED|Overall Study||23
937942|NCT01400698|2268417|P1|STARTED|Overall Study||23
937943|NCT01400516|2268441|P2|NOT COMPLETED|Extension Trial||0
937944|NCT01400516|2268442|P1|NOT COMPLETED|Extension Trial||0
937945|NCT01400516|2268441|P2|COMPLETED|Extension Trial||7
937946|NCT01400516|2268442|P1|COMPLETED|Extension Trial||6
937947|NCT01400516|2268441|P2|STARTED|Extension Trial|Only 7 participants in the Teriparatide arm entered the Extension Trial.|7
937948|NCT01400516|2268442|P1|STARTED|Extension Trial|Only 6 participants in the Control arm entered the Extension Trial.|6
937949|NCT01400516|2268441|P2|NOT COMPLETED|Primary Trial||2
937950|NCT01400516|2268442|P1|NOT COMPLETED|Primary Trial||0
937951|NCT01400516|2268441|P2|COMPLETED|Primary Trial||12
937952|NCT01400516|2268442|P1|COMPLETED|Primary Trial||12
937953|NCT01400516|2268441|P2|STARTED|Primary Trial||14
937954|NCT01400516|2268442|P1|STARTED|Primary Trial||12
937955|NCT01400451|2268455|P3|NOT COMPLETED|Combination Treatment (or Intended)||2
937956|NCT01400451|2268456|P2|NOT COMPLETED|Combination Treatment (or Intended)||4
937957|NCT01400451|2268457|P1|NOT COMPLETED|Combination Treatment (or Intended)||6
937958|NCT01400451|2268455|P3|COMPLETED|Combination Treatment (or Intended)||0
937959|NCT01400451|2268456|P2|COMPLETED|Combination Treatment (or Intended)||0
937960|NCT01400451|2268457|P1|COMPLETED|Combination Treatment (or Intended)||0
937961|NCT01400451|2268455|P3|STARTED|Combination Treatment (or Intended)|Did not start Ipilimumab but remained on vemurafenib alone.|2
937962|NCT01400451|2268456|P2|STARTED|Combination Treatment (or Intended)||4
937963|NCT01400451|2268457|P1|STARTED|Combination Treatment (or Intended)||6
937964|NCT01400451|2268455|P3|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
937965|NCT01400451|2268456|P2|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
937966|NCT01400451|2268457|P1|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
937967|NCT01400451|2268455|P3|COMPLETED|28 Day Lead In With Vemurafenib Alone||2
937968|NCT01400451|2268456|P2|COMPLETED|28 Day Lead In With Vemurafenib Alone||4
937969|NCT01400451|2268457|P1|COMPLETED|28 Day Lead In With Vemurafenib Alone||6
937970|NCT01400451|2268455|P3|STARTED|28 Day Lead In With Vemurafenib Alone||2
937971|NCT01400451|2268456|P2|STARTED|28 Day Lead In With Vemurafenib Alone||4
937972|NCT01400451|2268457|P1|STARTED|28 Day Lead In With Vemurafenib Alone||6
937973|NCT01400425|2268471|P1|NOT COMPLETED|Overall Study||10
937974|NCT01400425|2268471|P1|COMPLETED|Overall Study||229
937975|NCT01400425|2268471|P1|STARTED|Overall Study||239
937976|NCT01400412|2268484|P2|NOT COMPLETED|Overall Study||17
937977|NCT01400412|2268485|P1|NOT COMPLETED|Overall Study||10
937978|NCT01400412|2268484|P2|COMPLETED|Overall Study||115
937979|NCT01400412|2268485|P1|COMPLETED|Overall Study||120
937980|NCT01400412|2268484|P2|STARTED|Overall Study||132
937981|NCT01400412|2268485|P1|STARTED|Overall Study||130
937982|NCT01400243|2268531|P2|NOT COMPLETED|Overall Study||11
937983|NCT01400243|2268532|P1|NOT COMPLETED|Overall Study||8
937984|NCT01400243|2268531|P2|COMPLETED|Overall Study||52
937985|NCT01400243|2268532|P1|COMPLETED|Overall Study||56
937986|NCT01400243|2268531|P2|STARTED|Overall Study||63
937987|NCT01400243|2268532|P1|STARTED|Overall Study||64
937994|NCT01400113|2268564|P2|NOT COMPLETED|Overall Study||1
937995|NCT01400113|2268565|P1|NOT COMPLETED|Overall Study||1
937996|NCT01400113|2268564|P2|COMPLETED|Overall Study||59
937997|NCT01400113|2268565|P1|COMPLETED|Overall Study||59
937998|NCT01400113|2268564|P2|STARTED|Overall Study||60
937999|NCT01400113|2268565|P1|STARTED|Overall Study||60
938000|NCT01399866|2268573|P2|NOT COMPLETED|Overall Study||2
938001|NCT01399866|2268574|P1|NOT COMPLETED|Overall Study||4
938002|NCT01399866|2268573|P2|COMPLETED|Overall Study||28
938003|NCT01399866|2268574|P1|COMPLETED|Overall Study||28
938004|NCT01399866|2268573|P2|STARTED|Overall Study||30
938005|NCT01399866|2268574|P1|STARTED|Overall Study||32
938006|NCT01399788|2268580|P2|NOT COMPLETED|Second Intervention Period||0
938007|NCT01399788|2268581|P1|NOT COMPLETED|Second Intervention Period||0
938008|NCT01399788|2268580|P2|COMPLETED|Second Intervention Period||18
938009|NCT01399788|2268581|P1|COMPLETED|Second Intervention Period||17
938010|NCT01399788|2268580|P2|STARTED|Second Intervention Period||18
938011|NCT01399788|2268581|P1|STARTED|Second Intervention Period||17
938012|NCT01399788|2268580|P2|NOT COMPLETED|Washout Period (at Least 1 Week)||0
938013|NCT01399788|2268581|P1|NOT COMPLETED|Washout Period (at Least 1 Week)||0
938014|NCT01399788|2268580|P2|COMPLETED|Washout Period (at Least 1 Week)||18
938015|NCT01399788|2268581|P1|COMPLETED|Washout Period (at Least 1 Week)||17
938016|NCT01399788|2268580|P2|STARTED|Washout Period (at Least 1 Week)||18
938017|NCT01399788|2268581|P1|STARTED|Washout Period (at Least 1 Week)||17
938018|NCT01399788|2268580|P2|NOT COMPLETED|First Intervention Period||0
938019|NCT01399788|2268581|P1|NOT COMPLETED|First Intervention Period||1
938020|NCT01399788|2268580|P2|COMPLETED|First Intervention Period||18
938021|NCT01399788|2268581|P1|COMPLETED|First Intervention Period||17
938022|NCT01399788|2268580|P2|STARTED|First Intervention Period||18
938023|NCT01399788|2268581|P1|STARTED|First Intervention Period||18
938024|NCT01399723|2268603|P2|NOT COMPLETED|Overall Study||1
938025|NCT01399723|2268604|P1|NOT COMPLETED|Overall Study||0
938026|NCT01399723|2268603|P2|COMPLETED|Overall Study||263
938027|NCT01399723|2268604|P1|COMPLETED|Overall Study||263
938028|NCT01399723|2268603|P2|STARTED|Overall Study||264
938029|NCT01399723|2268604|P1|STARTED|Overall Study||263
938030|NCT01399697|2268617|P3|NOT COMPLETED|Overall Study||4
938031|NCT01399697|2268618|P2|NOT COMPLETED|Overall Study||3
938032|NCT01399697|2268619|P1|NOT COMPLETED|Overall Study||41
938033|NCT01399697|2268617|P3|COMPLETED|Overall Study||78
938034|NCT01399697|2268618|P2|COMPLETED|Overall Study||80
938035|NCT01399697|2268619|P1|COMPLETED|Overall Study||55
938036|NCT01399697|2268617|P3|STARTED|Overall Study||82
938037|NCT01399697|2268618|P2|STARTED|Overall Study||83
938038|NCT01399697|2268619|P1|STARTED|Overall Study||96
938039|NCT01399619|2268646|P4|NOT COMPLETED|Overall Study||17
938040|NCT01399619|2268647|P3|NOT COMPLETED|Overall Study||12
938041|NCT01399619|2268648|P2|NOT COMPLETED|Overall Study||0
938042|NCT01399619|2268649|P1|NOT COMPLETED|Overall Study||25
938043|NCT01399619|2268646|P4|COMPLETED|Overall Study||0
938044|NCT01399619|2268647|P3|COMPLETED|Overall Study||74
938045|NCT01399619|2268648|P2|COMPLETED|Overall Study||84
938046|NCT01399619|2268649|P1|COMPLETED|Overall Study||98
938047|NCT01399619|2268646|P4|STARTED|Overall Study||17
938048|NCT01399619|2268647|P3|STARTED|Overall Study||86
938049|NCT01399619|2268648|P2|STARTED|Overall Study||84
938050|NCT01399619|2268649|P1|STARTED|Overall Study||123
938051|NCT01399593|2268712|P2|NOT COMPLETED|Overall Study||2
938052|NCT01399593|2268713|P1|NOT COMPLETED|Overall Study||3
938053|NCT01399593|2268712|P2|COMPLETED|Overall Study||49
938054|NCT01399593|2268713|P1|COMPLETED|Overall Study||48
938055|NCT01399593|2268712|P2|STARTED|Overall Study||51
938056|NCT01399593|2268713|P1|STARTED|Overall Study||51
938057|NCT01399268|2268721|P2|NOT COMPLETED|Overall Study||0
938058|NCT01399268|2268722|P1|NOT COMPLETED|Overall Study||0
938059|NCT01399268|2268721|P2|COMPLETED|Overall Study||15
938060|NCT01399268|2268722|P1|COMPLETED|Overall Study||15
938061|NCT01399268|2268721|P2|STARTED|Overall Study||15
938062|NCT01399268|2268722|P1|STARTED|Overall Study||15
938063|NCT01399229|2268740|P3|NOT COMPLETED|Overall Study||0
938064|NCT01399229|2268741|P2|NOT COMPLETED|Overall Study||0
938065|NCT01399229|2268742|P1|NOT COMPLETED|Overall Study||0
938066|NCT01399229|2268740|P3|COMPLETED|Overall Study||5
938067|NCT01399229|2268741|P2|COMPLETED|Overall Study||5
938068|NCT01399229|2268742|P1|COMPLETED|Overall Study||20
938069|NCT01399229|2268740|P3|STARTED|Overall Study||5
938070|NCT01399229|2268741|P2|STARTED|Overall Study||5
938071|NCT01399229|2268742|P1|STARTED|Overall Study||20
938072|NCT01399190|2268746|P1|NOT COMPLETED|Overall Study||20
938073|NCT01399190|2268746|P1|COMPLETED|Overall Study||48
938074|NCT01399190|2268746|P1|Evaluable for Primary Endpoint Analysis|Overall Study||60
938075|NCT01399190|2268746|P1|Included in Final Analysis|Overall Study||63
938076|NCT01399190|2268746|P1|STARTED|Overall Study||68
938077|NCT01399125|2268754|P2|NOT COMPLETED|Overall Study||60
938078|NCT01399125|2268755|P1|NOT COMPLETED|Overall Study||51
938079|NCT01399125|2268754|P2|COMPLETED|Overall Study||193
938080|NCT01399125|2268755|P1|COMPLETED|Overall Study||197
938081|NCT01399125|2268754|P2|Per Protocol (PP) Population|Overall Study||188
938082|NCT01399125|2268755|P1|Per Protocol (PP) Population|Overall Study||192
938083|NCT01399125|2268754|P2|STARTED|Overall Study||253
938084|NCT01399125|2268755|P1|STARTED|Overall Study||248
938085|NCT01399099|2268769|P1|NOT COMPLETED|Overall Study||31
938086|NCT01399099|2268769|P1|COMPLETED|Overall Study||36
938087|NCT01399099|2268769|P1|6 Months|Overall Study||47
938088|NCT01399099|2268769|P1|STARTED|Overall Study||67
938089|NCT01399047|2268776|P2|NOT COMPLETED|Overall Study||1
938090|NCT01399047|2268777|P1|NOT COMPLETED|Overall Study||0
938091|NCT01399047|2268776|P2|COMPLETED|Overall Study||8
938092|NCT01399047|2268777|P1|COMPLETED|Overall Study||10
938093|NCT01399047|2268776|P2|STARTED|Overall Study||9
938094|NCT01399047|2268777|P1|STARTED|Overall Study||10
938095|NCT01399008|2268786|P3|NOT COMPLETED|Overall Study||2
938096|NCT01399008|2268787|P2|NOT COMPLETED|Overall Study||5
938097|NCT01399008|2268788|P1|NOT COMPLETED|Overall Study||3
938098|NCT01399008|2268786|P3|COMPLETED|Overall Study||31
938099|NCT01399008|2268787|P2|COMPLETED|Overall Study||27
938100|NCT01399008|2268788|P1|COMPLETED|Overall Study||32
938101|NCT01399008|2268786|P3|STARTED|Overall Study||33
938102|NCT01399008|2268787|P2|STARTED|Overall Study||32
938103|NCT01399008|2268788|P1|STARTED|Overall Study||35
938104|NCT01398982|2268798|P2|NOT COMPLETED|Overall Study||2
938105|NCT01398982|2268799|P1|NOT COMPLETED|Overall Study||6
938106|NCT01398982|2268798|P2|COMPLETED|Overall Study||47
938107|NCT01398982|2268799|P1|COMPLETED|Overall Study||38
938108|NCT01398982|2268798|P2|STARTED|Overall Study||49
938109|NCT01398982|2268799|P1|STARTED|Overall Study||44
938110|NCT01398956|2268805|P1|NOT COMPLETED|Overall Study||10
938111|NCT01398956|2268805|P1|COMPLETED|Overall Study||34
938112|NCT01398956|2268805|P1|STARTED|Overall Study||44
938113|NCT01398943|2268813|P4|NOT COMPLETED|Second Intervention (1 Day)||0
938114|NCT01398943|2268814|P3|NOT COMPLETED|Second Intervention (1 Day)||0
938115|NCT01398943|2268815|P2|NOT COMPLETED|Second Intervention (1 Day)||0
938116|NCT01398943|2268816|P1|NOT COMPLETED|Second Intervention (1 Day)||0
938117|NCT01398943|2268813|P4|COMPLETED|Second Intervention (1 Day)||15
938118|NCT01398943|2268814|P3|COMPLETED|Second Intervention (1 Day)||15
938119|NCT01398943|2268815|P2|COMPLETED|Second Intervention (1 Day)||15
938120|NCT01398943|2268816|P1|COMPLETED|Second Intervention (1 Day)||15
938121|NCT01398943|2268813|P4|STARTED|Second Intervention (1 Day)||15
938122|NCT01398943|2268814|P3|STARTED|Second Intervention (1 Day)||15
938123|NCT01398943|2268815|P2|STARTED|Second Intervention (1 Day)||15
938124|NCT01398943|2268816|P1|STARTED|Second Intervention (1 Day)||15
938125|NCT01398943|2268813|P4|NOT COMPLETED|Washout (2-7 Days)||0
938126|NCT01398943|2268814|P3|NOT COMPLETED|Washout (2-7 Days)||0
938127|NCT01398943|2268815|P2|NOT COMPLETED|Washout (2-7 Days)||0
938128|NCT01398943|2268816|P1|NOT COMPLETED|Washout (2-7 Days)||0
938129|NCT01398943|2268813|P4|COMPLETED|Washout (2-7 Days)||15
938130|NCT01398943|2268814|P3|COMPLETED|Washout (2-7 Days)||15
938131|NCT01398943|2268815|P2|COMPLETED|Washout (2-7 Days)||15
938132|NCT01398943|2268816|P1|COMPLETED|Washout (2-7 Days)||15
938133|NCT01398943|2268813|P4|STARTED|Washout (2-7 Days)||15
938134|NCT01398943|2268814|P3|STARTED|Washout (2-7 Days)||15
938135|NCT01398943|2268815|P2|STARTED|Washout (2-7 Days)||15
938136|NCT01398943|2268816|P1|STARTED|Washout (2-7 Days)||15
938137|NCT01398943|2268813|P4|NOT COMPLETED|First Intervention (1 Day)||0
938138|NCT01398943|2268814|P3|NOT COMPLETED|First Intervention (1 Day)||0
938139|NCT01398943|2268815|P2|NOT COMPLETED|First Intervention (1 Day)||0
938140|NCT01398943|2268816|P1|NOT COMPLETED|First Intervention (1 Day)||0
938141|NCT01398943|2268813|P4|COMPLETED|First Intervention (1 Day)||15
938142|NCT01398943|2268814|P3|COMPLETED|First Intervention (1 Day)||15
938143|NCT01398943|2268815|P2|COMPLETED|First Intervention (1 Day)||15
938144|NCT01398943|2268816|P1|COMPLETED|First Intervention (1 Day)||15
938145|NCT01398943|2268813|P4|STARTED|First Intervention (1 Day)||15
938146|NCT01398943|2268814|P3|STARTED|First Intervention (1 Day)||15
938147|NCT01398943|2268815|P2|STARTED|First Intervention (1 Day)||15
938148|NCT01398943|2268816|P1|STARTED|First Intervention (1 Day)||15
938149|NCT01398852|2268824|P1|NOT COMPLETED|Overall Study||372
938150|NCT01398852|2268824|P1|COMPLETED|Overall Study||0
938151|NCT01398852|2268824|P1|STARTED|Overall Study|Due to termination of the study the exact number of participants enrolled is unknown at this time.|372
938152|NCT01398839|2268830|P2|NOT COMPLETED|Overall Study||0
938153|NCT01398839|2268831|P1|NOT COMPLETED|Overall Study||0
938154|NCT01398839|2268830|P2|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|37
938155|NCT01398839|2268831|P1|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|35
938156|NCT01398839|2268830|P2|STARTED|Overall Study||37
938157|NCT01398839|2268831|P1|STARTED|Overall Study||35
938158|NCT01398787|2268837|P1|NOT COMPLETED|Overall Study||1
938159|NCT01398787|2268837|P1|COMPLETED|Overall Study||197
938160|NCT01398787|2268837|P1|STARTED|Overall Study||198
938161|NCT01398514|2268855|P2|NOT COMPLETED|Overall Study||6
938162|NCT01398514|2268856|P1|NOT COMPLETED|Overall Study||8
938163|NCT01398514|2268855|P2|COMPLETED|Overall Study||20
938164|NCT01398514|2268856|P1|COMPLETED|Overall Study||18
938165|NCT01398514|2268855|P2|STARTED|Overall Study||26
938166|NCT01398514|2268856|P1|STARTED|Overall Study||26
938167|NCT01398475|2268868|P4|NOT COMPLETED|Overall Study||0
938168|NCT01398475|2268869|P3|NOT COMPLETED|Overall Study||0
938169|NCT01398475|2268870|P2|NOT COMPLETED|Overall Study||0
938170|NCT01398475|2268871|P1|NOT COMPLETED|Overall Study||0
938171|NCT01398475|2268868|P4|COMPLETED|Overall Study||4
938172|NCT01398475|2268869|P3|COMPLETED|Overall Study||4
938173|NCT01398475|2268870|P2|COMPLETED|Overall Study||3
938174|NCT01398475|2268871|P1|COMPLETED|Overall Study||4
938175|NCT01398475|2268868|P4|Received Fourth Intervention|Overall Study||4
938176|NCT01398475|2268869|P3|Received Fourth Intervention|Overall Study||4
938177|NCT01398475|2268870|P2|Received Fourth Intervention|Overall Study||3
938178|NCT01398475|2268871|P1|Received Fourth Intervention|Overall Study||4
938179|NCT01398475|2268868|P4|Received Third Intervention|Overall Study||4
938180|NCT01398475|2268869|P3|Received Third Intervention|Overall Study||4
938181|NCT01398475|2268870|P2|Received Third Intervention|Overall Study||3
938182|NCT01398475|2268871|P1|Received Third Intervention|Overall Study||4
938183|NCT01398475|2268868|P4|Received Second Intervention|Overall Study||4
938184|NCT01398475|2268869|P3|Received Second Intervention|Overall Study||4
938185|NCT01398475|2268870|P2|Received Second Intervention|Overall Study||3
938186|NCT01398475|2268871|P1|Received Second Intervention|Overall Study||4
938187|NCT01398475|2268868|P4|Received First Intervention|Overall Study||4
938188|NCT01398475|2268869|P3|Received First Intervention|Overall Study||4
938189|NCT01398475|2268870|P2|Received First Intervention|Overall Study||3
938190|NCT01398475|2268871|P1|Received First Intervention|Overall Study||4
938191|NCT01398475|2268868|P4|STARTED|Overall Study||4
938192|NCT01398475|2268869|P3|STARTED|Overall Study||4
938193|NCT01398475|2268870|P2|STARTED|Overall Study||3
938194|NCT01398475|2268871|P1|STARTED|Overall Study||4
938195|NCT01398410|2268891|P2|NOT COMPLETED|Overall Study||56
938196|NCT01398410|2268892|P1|NOT COMPLETED|Overall Study||58
938197|NCT01398410|2268891|P2|COMPLETED|Overall Study||148
938198|NCT01398410|2268892|P1|COMPLETED|Overall Study||143
938199|NCT01398410|2268891|P2|STARTED|Overall Study||204
938200|NCT01398410|2268892|P1|STARTED|Overall Study|Treated participants (all participants who received at least one dose of rabeprazole).|201
938201|NCT01398176|2268902|P2|NOT COMPLETED|Overall Study||6
938202|NCT01398176|2268903|P1|NOT COMPLETED|Overall Study||3
938203|NCT01398176|2268902|P2|COMPLETED|Overall Study||19
938204|NCT01398176|2268903|P1|COMPLETED|Overall Study||23
938205|NCT01398176|2268902|P2|STARTED|Overall Study||25
938206|NCT01398176|2268903|P1|STARTED|Overall Study||26
938207|NCT01397890|2268911|P2|NOT COMPLETED|Overall Study||31
938208|NCT01397890|2268912|P1|NOT COMPLETED|Overall Study||23
938209|NCT01397890|2268911|P2|COMPLETED|Overall Study||260
938210|NCT01397890|2268912|P1|COMPLETED|Overall Study||264
938211|NCT01397890|2268911|P2|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =291+1-3=289.|287
938212|NCT01397890|2268912|P1|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =287+3-1=289. 3 and 1 pts in respective groups received opposite treatment.|286
938213|NCT01397890|2268911|P2|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|290
938214|NCT01397890|2268912|P1|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|287
938215|NCT01397890|2268911|P2|STARTED|Overall Study||291
938216|NCT01397890|2268912|P1|STARTED|Overall Study||287
938217|NCT01397851|2268966|P2|NOT COMPLETED|Overall Study||46
938218|NCT01397851|2268967|P1|NOT COMPLETED|Overall Study||79
938219|NCT01397851|2268966|P2|COMPLETED|Overall Study||39917
938220|NCT01397851|2268967|P1|COMPLETED|Overall Study||41555
938221|NCT01397851|2268966|P2|STARTED|Overall Study||39963
938222|NCT01397851|2268967|P1|STARTED|Overall Study||41634
938223|NCT01397786|2268982|P3|NOT COMPLETED|Phase B||138
938224|NCT01397786|2268983|P2|NOT COMPLETED|Phase B||95
938225|NCT01397786|2268984|P1|NOT COMPLETED|Phase B||303
938226|NCT01397786|2268982|P3|COMPLETED|Phase B||91
938227|NCT01397786|2268983|P2|COMPLETED|Phase B||109
938228|NCT01397786|2268984|P1|COMPLETED|Phase B||308
938229|NCT01397786|2268982|P3|STARTED|Phase B||229
938230|NCT01397786|2268983|P2|STARTED|Phase B||204
938231|NCT01397786|2268984|P1|STARTED|Phase B||611
938232|NCT01397786|2268982|P3|NOT COMPLETED|Phase A||28
938233|NCT01397786|2268983|P2|NOT COMPLETED|Phase A||0
938234|NCT01397786|2268984|P1|NOT COMPLETED|Phase A||0
938235|NCT01397786|2268982|P3|COMPLETED|Phase A||199
938236|NCT01397786|2268983|P2|COMPLETED|Phase A||0
938237|NCT01397786|2268984|P1|COMPLETED|Phase A||12
938238|NCT01397786|2268982|P3|STARTED|Phase A||227
938239|NCT01397786|2268983|P2|STARTED|Phase A||0
938240|NCT01397786|2268984|P1|STARTED|Phase A|Subjects in NCT01668797 Phase A at IA-related study termination rolled over to NCT01397786 Phase A.|12
938241|NCT01397747|2269050|P1|NOT COMPLETED|Overall Study||1027
938242|NCT01397747|2269050|P1|COMPLETED|Overall Study||9989
938243|NCT01397747|2269050|P1|STARTED|Overall Study||11016
938244|NCT01397617|2269058|P3|NOT COMPLETED|Overall Study||29
938245|NCT01397617|2269059|P2|NOT COMPLETED|Overall Study||23
938246|NCT01397617|2269060|P1|NOT COMPLETED|Overall Study||31
938247|NCT01397617|2269058|P3|COMPLETED|Overall Study||31
938248|NCT01397617|2269059|P2|COMPLETED|Overall Study||30
938249|NCT01397617|2269060|P1|COMPLETED|Overall Study||33
938250|NCT01397617|2269058|P3|STARTED|Overall Study||60
938251|NCT01397617|2269059|P2|STARTED|Overall Study||53
938252|NCT01397617|2269060|P1|STARTED|Overall Study||64
938253|NCT01397591|2269071|P1|NOT COMPLETED|Overall Study||0
938254|NCT01397591|2269071|P1|COMPLETED|Overall Study||2
938255|NCT01397591|2269071|P1|STARTED|Overall Study||2
938256|NCT01397461|2269082|P3|NOT COMPLETED|Overall Study||2
938257|NCT01397461|2269083|P2|NOT COMPLETED|Overall Study||6
938258|NCT01397461|2269084|P1|NOT COMPLETED|Overall Study||2
938259|NCT01397461|2269082|P3|COMPLETED|Overall Study||152
938260|NCT01397461|2269083|P2|COMPLETED|Overall Study||150
938261|NCT01397461|2269084|P1|COMPLETED|Overall Study||153
938262|NCT01397461|2269082|P3|STARTED|Overall Study||154
938263|NCT01397461|2269083|P2|STARTED|Overall Study||156
938264|NCT01397461|2269084|P1|STARTED|Overall Study||155
938265|NCT01397448|2269095|P3|NOT COMPLETED|Overall Study||18
938266|NCT01397448|2269096|P2|NOT COMPLETED|Overall Study||15
938267|NCT01397448|2269097|P1|NOT COMPLETED|Overall Study||18
938268|NCT01397448|2269095|P3|COMPLETED|Overall Study||140
938269|NCT01397448|2269096|P2|COMPLETED|Overall Study||142
938270|NCT01397448|2269097|P1|COMPLETED|Overall Study||138
938271|NCT01397448|2269095|P3|STARTED|Overall Study||158
938272|NCT01397448|2269096|P2|STARTED|Overall Study|158 participants were randomized but 1 participant was not treated with drug.|157
938273|NCT01397448|2269097|P1|STARTED|Overall Study||156
938274|NCT01397409|2269118|P10|NOT COMPLETED|Stage 3||0
938275|NCT01397409|2269119|P9|NOT COMPLETED|Stage 3||0
938276|NCT01397409|2269120|P8|NOT COMPLETED|Stage 3||2
938277|NCT01397409|2269121|P7|NOT COMPLETED|Stage 3||0
938278|NCT01397409|2269122|P6|NOT COMPLETED|Stage 3||0
938279|NCT01397409|2269123|P5|NOT COMPLETED|Stage 3||0
938280|NCT01397409|2269124|P4|NOT COMPLETED|Stage 3||0
938281|NCT01397409|2269125|P3|NOT COMPLETED|Stage 3||0
938282|NCT01397409|2269126|P2|NOT COMPLETED|Stage 3||0
938283|NCT01397409|2269127|P1|NOT COMPLETED|Stage 3||0
938284|NCT01397409|2269118|P10|COMPLETED|Stage 3||16
938285|NCT01397409|2269119|P9|COMPLETED|Stage 3||25
938286|NCT01397409|2269120|P8|COMPLETED|Stage 3||21
938287|NCT01397409|2269121|P7|COMPLETED|Stage 3||0
938288|NCT01397409|2269122|P6|COMPLETED|Stage 3||0
938289|NCT01397409|2269123|P5|COMPLETED|Stage 3||0
938290|NCT01397409|2269124|P4|COMPLETED|Stage 3||0
938291|NCT01397409|2269125|P3|COMPLETED|Stage 3||0
938292|NCT01397409|2269126|P2|COMPLETED|Stage 3||0
938293|NCT01397409|2269127|P1|COMPLETED|Stage 3||0
938294|NCT01397409|2269118|P10|STARTED|Stage 3||16
938295|NCT01397409|2269119|P9|STARTED|Stage 3||25
938296|NCT01397409|2269120|P8|STARTED|Stage 3||23
938297|NCT01397409|2269121|P7|STARTED|Stage 3||0
938298|NCT01397409|2269122|P6|STARTED|Stage 3||0
938299|NCT01397409|2269123|P5|STARTED|Stage 3||0
938300|NCT01397409|2269124|P4|STARTED|Stage 3||0
938301|NCT01397409|2269125|P3|STARTED|Stage 3||0
938302|NCT01397409|2269126|P2|STARTED|Stage 3||0
938303|NCT01397409|2269127|P1|STARTED|Stage 3||0
938304|NCT01397409|2269118|P10|NOT COMPLETED|Stage 2||0
938305|NCT01397409|2269119|P9|NOT COMPLETED|Stage 2||0
938306|NCT01397409|2269120|P8|NOT COMPLETED|Stage 2||0
938307|NCT01397409|2269121|P7|NOT COMPLETED|Stage 2||0
938308|NCT01397409|2269122|P6|NOT COMPLETED|Stage 2||4
938309|NCT01397409|2269123|P5|NOT COMPLETED|Stage 2||8
938310|NCT01397409|2269124|P4|NOT COMPLETED|Stage 2||0
938311|NCT01397409|2269125|P3|NOT COMPLETED|Stage 2||0
938312|NCT01397409|2269126|P2|NOT COMPLETED|Stage 2||0
938313|NCT01397409|2269127|P1|NOT COMPLETED|Stage 2||0
938314|NCT01397409|2269118|P10|COMPLETED|Stage 2||0
938315|NCT01397409|2269119|P9|COMPLETED|Stage 2||0
938316|NCT01397409|2269120|P8|COMPLETED|Stage 2||0
938317|NCT01397409|2269121|P7|COMPLETED|Stage 2||58
938318|NCT01397409|2269122|P6|COMPLETED|Stage 2||54
938319|NCT01397409|2269123|P5|COMPLETED|Stage 2||59
938320|NCT01397409|2269124|P4|COMPLETED|Stage 2||0
938321|NCT01397409|2269125|P3|COMPLETED|Stage 2||0
938322|NCT01397409|2269126|P2|COMPLETED|Stage 2||0
938323|NCT01397409|2269127|P1|COMPLETED|Stage 2||0
938324|NCT01397409|2269118|P10|STARTED|Stage 2||0
938325|NCT01397409|2269119|P9|STARTED|Stage 2||0
938326|NCT01397409|2269120|P8|STARTED|Stage 2||0
938327|NCT01397409|2269121|P7|STARTED|Stage 2||58
938328|NCT01397409|2269122|P6|STARTED|Stage 2||58
938329|NCT01397409|2269123|P5|STARTED|Stage 2||67
938330|NCT01397409|2269124|P4|STARTED|Stage 2||0
938331|NCT01397409|2269125|P3|STARTED|Stage 2||0
938332|NCT01397409|2269126|P2|STARTED|Stage 2||0
938333|NCT01397409|2269127|P1|STARTED|Stage 2||0
938334|NCT01397409|2269118|P10|NOT COMPLETED|Stage 1||0
938335|NCT01397409|2269119|P9|NOT COMPLETED|Stage 1||0
938336|NCT01397409|2269120|P8|NOT COMPLETED|Stage 1||0
938337|NCT01397409|2269121|P7|NOT COMPLETED|Stage 1||0
938338|NCT01397409|2269122|P6|NOT COMPLETED|Stage 1||0
938339|NCT01397409|2269123|P5|NOT COMPLETED|Stage 1||0
938340|NCT01397409|2269124|P4|NOT COMPLETED|Stage 1||0
938341|NCT01397409|2269125|P3|NOT COMPLETED|Stage 1||0
938342|NCT01397409|2269126|P2|NOT COMPLETED|Stage 1||0
938343|NCT01397409|2269127|P1|NOT COMPLETED|Stage 1||0
938344|NCT01397409|2269118|P10|COMPLETED|Stage 1||0
938345|NCT01397409|2269119|P9|COMPLETED|Stage 1||0
938346|NCT01397409|2269120|P8|COMPLETED|Stage 1||0
938347|NCT01397409|2269121|P7|COMPLETED|Stage 1||0
938348|NCT01397409|2269122|P6|COMPLETED|Stage 1||0
938349|NCT01397409|2269123|P5|COMPLETED|Stage 1||0
938350|NCT01397409|2269124|P4|COMPLETED|Stage 1||3
938351|NCT01397409|2269125|P3|COMPLETED|Stage 1||6
938352|NCT01397409|2269126|P2|COMPLETED|Stage 1||6
938353|NCT01397409|2269127|P1|COMPLETED|Stage 1||9
938354|NCT01397409|2269118|P10|STARTED|Stage 1||0
938355|NCT01397409|2269119|P9|STARTED|Stage 1||0
938356|NCT01397409|2269120|P8|STARTED|Stage 1||0
938357|NCT01397409|2269121|P7|STARTED|Stage 1||0
938358|NCT01397409|2269122|P6|STARTED|Stage 1||0
938359|NCT01397409|2269123|P5|STARTED|Stage 1||0
938360|NCT01397409|2269124|P4|STARTED|Stage 1||3
938361|NCT01397409|2269125|P3|STARTED|Stage 1||6
938362|NCT01397409|2269126|P2|STARTED|Stage 1||6
938363|NCT01397409|2269127|P1|STARTED|Stage 1||9
938364|NCT01397253|2269167|P2|NOT COMPLETED|Overall Study||149
938365|NCT01397253|2269168|P1|NOT COMPLETED|Overall Study||126
938366|NCT01397253|2269167|P2|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|243
938367|NCT01397253|2269168|P1|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|317
938368|NCT01397253|2269167|P2|STARTED|Overall Study||392
938369|NCT01397253|2269168|P1|STARTED|Overall Study||443
938370|NCT01397084|2269174|P1|NOT COMPLETED|Overall Study||8
938371|NCT01397084|2269174|P1|COMPLETED|Overall Study||100
938372|NCT01397084|2269174|P1|STARTED|Overall Study||108
938373|NCT01396525|2269181|P1|NOT COMPLETED|Overall Study||26
938374|NCT01396525|2269181|P1|COMPLETED|Overall Study||127
938375|NCT01396525|2269181|P1|STARTED|Overall Study||153
938376|NCT01396512|2269281|P2|NOT COMPLETED|Overall Study||1
938377|NCT01396512|2269282|P1|NOT COMPLETED|Overall Study||0
938378|NCT01396512|2269281|P2|COMPLETED|Overall Study||136
938379|NCT01396512|2269282|P1|COMPLETED|Overall Study||137
938380|NCT01396512|2269281|P2|STARTED|Overall Study||137
938381|NCT01396512|2269282|P1|STARTED|Overall Study||137
938382|NCT01396434|2269297|P3|NOT COMPLETED|Overall Study||0
938383|NCT01396434|2269298|P2|NOT COMPLETED|Overall Study||0
938384|NCT01396434|2269299|P1|NOT COMPLETED|Overall Study||11
938385|NCT01396434|2269297|P3|COMPLETED|Overall Study||14
938386|NCT01396434|2269298|P2|COMPLETED|Overall Study||175
938387|NCT01396434|2269299|P1|COMPLETED|Overall Study||2806
938388|NCT01396434|2269297|P3|STARTED|Overall Study||14
938389|NCT01396434|2269298|P2|STARTED|Overall Study||175
938390|NCT01396434|2269299|P1|STARTED|Overall Study||2817
938391|NCT01396421|2269311|P4|NOT COMPLETED|Overall Study||75
938392|NCT01396421|2269312|P3|NOT COMPLETED|Overall Study||34
938393|NCT01396421|2269313|P2|NOT COMPLETED|Overall Study||58
938394|NCT01396421|2269314|P1|NOT COMPLETED|Overall Study||59
938395|NCT01396421|2269311|P4|COMPLETED|Overall Study||109
938396|NCT01396421|2269312|P3|COMPLETED|Overall Study||56
938397|NCT01396421|2269313|P2|COMPLETED|Overall Study||124
938398|NCT01396421|2269314|P1|COMPLETED|Overall Study||121
938399|NCT01396421|2269311|P4|STARTED|Overall Study||184
938400|NCT01396421|2269312|P3|STARTED|Overall Study||90
938401|NCT01396421|2269313|P2|STARTED|Overall Study||182
938402|NCT01396421|2269314|P1|STARTED|Overall Study||180
938403|NCT01396395|2269386|P2|NOT COMPLETED|Overall Study||27
938404|NCT01396395|2269387|P1|NOT COMPLETED|Overall Study||40
938405|NCT01396395|2269386|P2|COMPLETED|Overall Study||175
938406|NCT01396395|2269387|P1|COMPLETED|Overall Study||160
938407|NCT01396395|2269386|P2|Safety Analysis Set|Overall Study|4 subjects randomized to standard+nicorandil were included in standard as no nicorandil was received|205
938408|NCT01396395|2269387|P1|Safety Analysis Set|Overall Study|1 subject randomized to standard was included in standard+nicorandil as nicorandil was received.|197
938409|NCT01396395|2269386|P2|STARTED|Overall Study||202
938410|NCT01396395|2269387|P1|STARTED|Overall Study||200
938411|NCT01396382|2269422|P1|NOT COMPLETED|Overall Study||0
938412|NCT01396382|2269422|P1|COMPLETED|Overall Study||97
938413|NCT01396382|2269422|P1|STARTED|Overall Study||97
938414|NCT01396265|2269427|P1|NOT COMPLETED|Rifa+Afatinib||1
938415|NCT01396265|2269427|P1|COMPLETED|Rifa+Afatinib||21
938416|NCT01396265|2269427|P1|STARTED|Rifa+Afatinib||22
938417|NCT01396265|2269427|P1|NOT COMPLETED|Washout||0
938418|NCT01396265|2269427|P1|COMPLETED|Washout||22
938419|NCT01396265|2269427|P1|STARTED|Washout||22
938420|NCT01396265|2269427|P1|NOT COMPLETED|Afatinib||0
938421|NCT01396265|2269427|P1|COMPLETED|Afatinib||22
938422|NCT01396265|2269427|P1|STARTED|Afatinib||22
938423|NCT01396239|2269454|P4|NOT COMPLETED|Overall Study||0
938424|NCT01396239|2269455|P3|NOT COMPLETED|Overall Study||0
938425|NCT01396239|2269456|P2|NOT COMPLETED|Overall Study||0
938426|NCT01396239|2269457|P1|NOT COMPLETED|Overall Study||0
938427|NCT01396239|2269454|P4|COMPLETED|Overall Study||2
938428|NCT01396239|2269455|P3|COMPLETED|Overall Study||4
938429|NCT01396239|2269456|P2|COMPLETED|Overall Study||2
938430|NCT01396239|2269457|P1|COMPLETED|Overall Study||4
938431|NCT01396239|2269454|P4|STARTED|Overall Study||2
938432|NCT01396239|2269455|P3|STARTED|Overall Study||4
938433|NCT01396239|2269456|P2|STARTED|Overall Study||2
938434|NCT01396239|2269457|P1|STARTED|Overall Study||4
938435|NCT01396226|2269480|P2|NOT COMPLETED|Overall Study||0
938436|NCT01396226|2269481|P1|NOT COMPLETED|Overall Study||0
938437|NCT01396226|2269480|P2|COMPLETED|Overall Study||6
938438|NCT01396226|2269481|P1|COMPLETED|Overall Study||12
938439|NCT01396226|2269480|P2|Patients Who Completed Treatment|Overall Study||6
938440|NCT01396226|2269481|P1|Patients Who Completed Treatment|Overall Study||12
938441|NCT01396226|2269480|P2|Patients Who Received Treatment|Overall Study||6
938442|NCT01396226|2269481|P1|Patients Who Received Treatment|Overall Study||12
938443|NCT01396226|2269480|P2|STARTED|Overall Study||6
938444|NCT01396226|2269481|P1|STARTED|Overall Study||12
938445|NCT01396187|2269516|P5|NOT COMPLETED|Overall Study||1
938446|NCT01396187|2269517|P4|NOT COMPLETED|Overall Study||0
938447|NCT01396187|2269518|P3|NOT COMPLETED|Overall Study||1
938448|NCT01396187|2269519|P2|NOT COMPLETED|Overall Study||3
938449|NCT01396187|2269520|P1|NOT COMPLETED|Overall Study||1
938450|NCT01396187|2269516|P5|COMPLETED|Overall Study||9
938451|NCT01396187|2269517|P4|COMPLETED|Overall Study||10
938452|NCT01396187|2269518|P3|COMPLETED|Overall Study||9
938453|NCT01396187|2269519|P2|COMPLETED|Overall Study||9
938454|NCT01396187|2269520|P1|COMPLETED|Overall Study||7
938455|NCT01396187|2269516|P5|STARTED|Overall Study||10
938456|NCT01396187|2269517|P4|STARTED|Overall Study||10
938457|NCT01396187|2269518|P3|STARTED|Overall Study||10
938458|NCT01396187|2269519|P2|STARTED|Overall Study||12
938459|NCT01396187|2269520|P1|STARTED|Overall Study||8
938460|NCT01396161|2269620|P7|NOT COMPLETED|Overall Study||1
938461|NCT01396161|2269621|P6|NOT COMPLETED|Overall Study||0
938462|NCT01396161|2269622|P5|NOT COMPLETED|Overall Study||1
938463|NCT01396161|2269623|P4|NOT COMPLETED|Overall Study||0
938464|NCT01396161|2269624|P3|NOT COMPLETED|Overall Study||0
938465|NCT01396161|2269625|P2|NOT COMPLETED|Overall Study||0
938466|NCT01396161|2269626|P1|NOT COMPLETED|Overall Study||0
938467|NCT01396161|2269620|P7|COMPLETED|Overall Study||10
938468|NCT01396161|2269621|P6|COMPLETED|Overall Study||9
938469|NCT01396161|2269622|P5|COMPLETED|Overall Study||8
938470|NCT01396161|2269623|P4|COMPLETED|Overall Study||9
938471|NCT01396161|2269624|P3|COMPLETED|Overall Study||9
938472|NCT01396161|2269625|P2|COMPLETED|Overall Study||5
938473|NCT01396161|2269626|P1|COMPLETED|Overall Study||12
938474|NCT01396161|2269620|P7|STARTED|Overall Study||11
938475|NCT01396161|2269621|P6|STARTED|Overall Study||9
938476|NCT01396161|2269622|P5|STARTED|Overall Study||9
938477|NCT01396161|2269623|P4|STARTED|Overall Study||9
938478|NCT01396161|2269624|P3|STARTED|Overall Study||9
938479|NCT01396161|2269625|P2|STARTED|Overall Study||5
938480|NCT01396161|2269626|P1|STARTED|Overall Study||12
938481|NCT01396083|2269681|P2|NOT COMPLETED|Overall Study||47
938482|NCT01396083|2269682|P1|NOT COMPLETED|Overall Study||11
938483|NCT01396083|2269681|P2|COMPLETED|Overall Study||72
938484|NCT01396083|2269682|P1|COMPLETED|Overall Study||113
938485|NCT01396083|2269681|P2|STARTED|Overall Study||119
938486|NCT01396083|2269682|P1|STARTED|Overall Study||124
938487|NCT01396070|2269706|P1|NOT COMPLETED|Overall Study||19
938488|NCT01396070|2269706|P1|COMPLETED|Overall Study||17
938489|NCT01396070|2269706|P1|STARTED|Overall Study||36
938490|NCT01396057|2269715|P2|NOT COMPLETED|Overall Study||18
938491|NCT01396057|2269716|P1|NOT COMPLETED|Overall Study||11
938492|NCT01396057|2269715|P2|COMPLETED|Overall Study||100
938493|NCT01396057|2269716|P1|COMPLETED|Overall Study||115
938494|NCT01396057|2269715|P2|STARTED|Overall Study||118
938495|NCT01396057|2269716|P1|STARTED|Overall Study||126
938496|NCT01396044|2269742|P2|NOT COMPLETED|Overall Study||0
938497|NCT01396044|2269743|P1|NOT COMPLETED|Overall Study||0
938498|NCT01396044|2269742|P2|COMPLETED|Overall Study||171
938499|NCT01396044|2269743|P1|COMPLETED|Overall Study||125
938500|NCT01396044|2269742|P2|STARTED|Overall Study||171
938501|NCT01396044|2269743|P1|STARTED|Overall Study||125
938502|NCT01396005|2269765|P2|NOT COMPLETED|Overall Study||2
938503|NCT01396005|2269766|P1|NOT COMPLETED|Overall Study||0
938504|NCT01396005|2269765|P2|COMPLETED|Overall Study||9
938505|NCT01396005|2269766|P1|COMPLETED|Overall Study||10
938506|NCT01396005|2269765|P2|STARTED|Overall Study||11
938507|NCT01396005|2269766|P1|STARTED|Overall Study||10
938508|NCT01395966|2269785|P3|NOT COMPLETED|Overall Study||8
938509|NCT01395966|2269786|P2|NOT COMPLETED|Overall Study||19
938510|NCT01395966|2269787|P1|NOT COMPLETED|Overall Study||10
938511|NCT01395966|2269785|P3|COMPLETED|Overall Study||104
938512|NCT01395966|2269786|P2|COMPLETED|Overall Study||91
938513|NCT01395966|2269787|P1|COMPLETED|Overall Study||99
938514|NCT01395966|2269785|P3|STARTED|Overall Study||112
938515|NCT01395966|2269786|P2|STARTED|Overall Study||110
938516|NCT01395966|2269787|P1|STARTED|Overall Study||109
938517|NCT01395914|2269797|P2|NOT COMPLETED|Overall Study||37
938518|NCT01395914|2269798|P1|NOT COMPLETED|Overall Study||72
938519|NCT01395914|2269797|P2|COMPLETED|Overall Study||131
938520|NCT01395914|2269798|P1|COMPLETED|Overall Study||273
938521|NCT01395914|2269797|P2|Safety Population|Overall Study||167
938522|NCT01395914|2269798|P1|Safety Population|Overall Study||343
938523|NCT01395914|2269797|P2|ITT Population|Overall Study||168
938524|NCT01395914|2269798|P1|ITT Population|Overall Study||345
938525|NCT01395914|2269797|P2|STARTED|Overall Study||168
938526|NCT01395914|2269798|P1|STARTED|Overall Study||345
938527|NCT01395901|2269812|P2|NOT COMPLETED|Overall Study||5
938528|NCT01395901|2269813|P1|NOT COMPLETED|Overall Study||10
938529|NCT01395901|2269812|P2|COMPLETED|Overall Study|Treated patients completing the study|329
938530|NCT01395901|2269813|P1|COMPLETED|Overall Study|Treated patients completing the study|326
938531|NCT01395901|2269812|P2|STARTED|Overall Study|Randomized Population|334
938532|NCT01395901|2269813|P1|STARTED|Overall Study|Randomized Population|336
938533|NCT01395888|2269829|P3|NOT COMPLETED|Treatment Period (TP)||17
938534|NCT01395888|2269830|P2|NOT COMPLETED|Treatment Period (TP)||15
938535|NCT01395888|2269831|P1|NOT COMPLETED|Treatment Period (TP)||0
938536|NCT01395888|2269829|P3|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|113
938537|NCT01395888|2269830|P2|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|112
938538|NCT01395888|2269831|P1|COMPLETED|Treatment Period (TP)||0
938628|NCT01394991|2269956|P2|NOT COMPLETED|Overall Study||72
938539|NCT01395888|2269829|P3|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|113
938540|NCT01395888|2269830|P2|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|112
938541|NCT01395888|2269831|P1|Completed the Treatment Period|Treatment Period (TP)||0
938542|NCT01395888|2269829|P3|STARTED|Treatment Period (TP)||130
938543|NCT01395888|2269830|P2|STARTED|Treatment Period (TP)||127
938544|NCT01395888|2269831|P1|STARTED|Treatment Period (TP)||0
938545|NCT01395888|2269829|P3|NOT COMPLETED|2-week Run-in Period||0
938546|NCT01395888|2269830|P2|NOT COMPLETED|2-week Run-in Period||0
938547|NCT01395888|2269831|P1|NOT COMPLETED|2-week Run-in Period||22
938548|NCT01395888|2269829|P3|COMPLETED|2-week Run-in Period||0
938549|NCT01395888|2269830|P2|COMPLETED|2-week Run-in Period||0
938550|NCT01395888|2269831|P1|COMPLETED|2-week Run-in Period||257
938551|NCT01395888|2269829|P3|STARTED|2-week Run-in Period||0
938552|NCT01395888|2269830|P2|STARTED|2-week Run-in Period||0
938553|NCT01395888|2269831|P1|STARTED|2-week Run-in Period||279
938554|NCT01395823|2269839|P2|NOT COMPLETED|Overall Study||9
938555|NCT01395823|2269840|P1|NOT COMPLETED|Overall Study||15
938556|NCT01395823|2269839|P2|COMPLETED|Overall Study||130
938557|NCT01395823|2269840|P1|COMPLETED|Overall Study||122
938558|NCT01395823|2269839|P2|STARTED|Overall Study||139
938559|NCT01395823|2269840|P1|STARTED|Overall Study||137
938560|NCT01395797|2269852|P6|NOT COMPLETED|Overall Study||3
938561|NCT01395797|2269853|P5|NOT COMPLETED|Overall Study||2
938562|NCT01395797|2269854|P4|NOT COMPLETED|Overall Study||2
938563|NCT01395797|2269855|P3|NOT COMPLETED|Overall Study||4
938564|NCT01395797|2269856|P2|NOT COMPLETED|Overall Study||1
938565|NCT01395797|2269857|P1|NOT COMPLETED|Overall Study||3
938566|NCT01395797|2269852|P6|COMPLETED|Overall Study||14
938567|NCT01395797|2269853|P5|COMPLETED|Overall Study||7
938568|NCT01395797|2269854|P4|COMPLETED|Overall Study||13
938569|NCT01395797|2269855|P3|COMPLETED|Overall Study||14
938570|NCT01395797|2269856|P2|COMPLETED|Overall Study||3
938571|NCT01395797|2269857|P1|COMPLETED|Overall Study||16
938572|NCT01395797|2269852|P6|STARTED|Overall Study||17
938573|NCT01395797|2269853|P5|STARTED|Overall Study||9
938574|NCT01395797|2269854|P4|STARTED|Overall Study||15
938575|NCT01395797|2269855|P3|STARTED|Overall Study||18
938576|NCT01395797|2269856|P2|STARTED|Overall Study||4
938577|NCT01395797|2269857|P1|STARTED|Overall Study||19
938578|NCT01395784|2269877|P1|NOT COMPLETED|Overall Study||15
938579|NCT01395784|2269877|P1|COMPLETED|Overall Study||17
938580|NCT01395784|2269877|P1|STARTED|Overall Study||32
938581|NCT01395524|2269885|P3|NOT COMPLETED|Overall Study||17
938582|NCT01395524|2269886|P2|NOT COMPLETED|Overall Study||16
938583|NCT01395524|2269887|P1|NOT COMPLETED|Overall Study||18
938584|NCT01395524|2269885|P3|COMPLETED|Overall Study||89
938585|NCT01395524|2269886|P2|COMPLETED|Overall Study||83
938586|NCT01395524|2269887|P1|COMPLETED|Overall Study||79
938587|NCT01395524|2269885|P3|STARTED|Overall Study||106
938588|NCT01395524|2269886|P2|STARTED|Overall Study||99
938589|NCT01395524|2269887|P1|STARTED|Overall Study||97
938590|NCT01395394|2269910|P3|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
938591|NCT01395394|2269911|P2|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
938592|NCT01395394|2269912|P1|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
938593|NCT01395394|2269910|P3|COMPLETED|Study Visit 2 (Non-responders Only)||0
938594|NCT01395394|2269911|P2|COMPLETED|Study Visit 2 (Non-responders Only)||0
938595|NCT01395394|2269912|P1|COMPLETED|Study Visit 2 (Non-responders Only)||3
938596|NCT01395394|2269910|P3|STARTED|Study Visit 2 (Non-responders Only)||0
938597|NCT01395394|2269911|P2|STARTED|Study Visit 2 (Non-responders Only)||0
938598|NCT01395394|2269912|P1|STARTED|Study Visit 2 (Non-responders Only)||3
938599|NCT01395394|2269910|P3|NOT COMPLETED|Baseline Study Visit||0
938600|NCT01395394|2269911|P2|NOT COMPLETED|Baseline Study Visit||0
938601|NCT01395394|2269912|P1|NOT COMPLETED|Baseline Study Visit||1
938602|NCT01395394|2269910|P3|COMPLETED|Baseline Study Visit||5
938603|NCT01395394|2269911|P2|COMPLETED|Baseline Study Visit||3
938604|NCT01395394|2269912|P1|COMPLETED|Baseline Study Visit||3
938605|NCT01395394|2269910|P3|STARTED|Baseline Study Visit||5
938606|NCT01395394|2269911|P2|STARTED|Baseline Study Visit||3
938607|NCT01395394|2269912|P1|STARTED|Baseline Study Visit||4
938608|NCT01395368|2269923|P1|NOT COMPLETED|Overall Study||16
938609|NCT01395368|2269923|P1|COMPLETED|Overall Study||92
938610|NCT01395368|2269923|P1|STARTED|Overall Study||108
938611|NCT01395277|2269929|P2|NOT COMPLETED|Overall Study||0
938612|NCT01395277|2269930|P1|NOT COMPLETED|Overall Study||0
938613|NCT01395277|2269929|P2|COMPLETED|Overall Study||15
938614|NCT01395277|2269930|P1|COMPLETED|Overall Study||15
938615|NCT01395277|2269929|P2|STARTED|Overall Study||15
938616|NCT01395277|2269930|P1|STARTED|Overall Study||15
938617|NCT01395043|2269938|P1|NOT COMPLETED|Overall Study||0
938618|NCT01395043|2269938|P1|COMPLETED|Overall Study||15
938619|NCT01395043|2269938|P1|STARTED|Overall Study||15
938620|NCT01395017|2269945|P2|NOT COMPLETED|Overall Study||102
938621|NCT01395017|2269946|P1|NOT COMPLETED|Overall Study||100
938622|NCT01395017|2269945|P2|COMPLETED|Overall Study||0
938623|NCT01395017|2269946|P1|COMPLETED|Overall Study||0
938624|NCT01395017|2269945|P2|Treated|Overall Study||101
938625|NCT01395017|2269946|P1|Treated|Overall Study||98
938626|NCT01395017|2269945|P2|STARTED|Overall Study||102
938627|NCT01395017|2269946|P1|STARTED|Overall Study||100
938629|NCT01394991|2269957|P1|NOT COMPLETED|Overall Study||59
938630|NCT01394991|2269956|P2|COMPLETED|Overall Study||190
938631|NCT01394991|2269957|P1|COMPLETED|Overall Study||183
938632|NCT01394991|2269956|P2|STARTED|Overall Study||262
938633|NCT01394991|2269957|P1|STARTED|Overall Study||242
938634|NCT01394978|2269979|P2|NOT COMPLETED|Overall Study||31
938635|NCT01394978|2269980|P1|NOT COMPLETED|Overall Study||21
938636|NCT01394978|2269979|P2|COMPLETED|Overall Study||245
938637|NCT01394978|2269980|P1|COMPLETED|Overall Study||147
938638|NCT01394978|2269979|P2|STARTED|Overall Study||276
938639|NCT01394978|2269980|P1|STARTED|Overall Study||168
938640|NCT01394926|2269986|P1|NOT COMPLETED|Overall Study||0
938641|NCT01394926|2269986|P1|COMPLETED|Overall Study||21
938642|NCT01394926|2269986|P1|STARTED|Overall Study||21
938643|NCT01394718|2269997|P2|NOT COMPLETED|Overall Study||1
938644|NCT01394718|2269998|P1|NOT COMPLETED|Overall Study||2
938645|NCT01394718|2269997|P2|COMPLETED|Overall Study||29
938646|NCT01394718|2269998|P1|COMPLETED|Overall Study||28
938647|NCT01394718|2269997|P2|STARTED|Overall Study||30
938648|NCT01394718|2269998|P1|STARTED|Overall Study||30
938649|NCT01394692|2270012|P2|NOT COMPLETED|Overall Study||0
938650|NCT01394692|2270013|P1|NOT COMPLETED|Overall Study||0
938651|NCT01394692|2270012|P2|COMPLETED|Overall Study||29
938652|NCT01394692|2270013|P1|COMPLETED|Overall Study||29
938653|NCT01394692|2270012|P2|STARTED|Overall Study||29
938654|NCT01394692|2270013|P1|STARTED|Overall Study||29
938655|NCT01394614|2270021|P2|NOT COMPLETED|Overall Study||0
938656|NCT01394614|2270022|P1|NOT COMPLETED|Overall Study||0
938657|NCT01394614|2270021|P2|COMPLETED|Overall Study||16
938658|NCT01394614|2270022|P1|COMPLETED|Overall Study||8
938659|NCT01394614|2270021|P2|STARTED|Overall Study||16
938660|NCT01394614|2270022|P1|STARTED|Overall Study||8
938661|NCT01394510|2270028|P1|NOT COMPLETED|Overall Study||0
938662|NCT01394510|2270028|P1|COMPLETED|Overall Study||13
938663|NCT01394510|2270028|P1|STARTED|Overall Study||13
938664|NCT01394276|2270034|P1|NOT COMPLETED|Overall Study||62
938665|NCT01394276|2270034|P1|COMPLETED|Overall Study||260
938666|NCT01394276|2270034|P1|STARTED|Overall Study||322
938667|NCT01394250|2270058|P2|NOT COMPLETED|Successful IV Placement & Follow-Up||11
938668|NCT01394250|2270059|P1|NOT COMPLETED|Successful IV Placement & Follow-Up||6
938669|NCT01394250|2270058|P2|COMPLETED|Successful IV Placement & Follow-Up||110
938670|NCT01394250|2270059|P1|COMPLETED|Successful IV Placement & Follow-Up||114
938671|NCT01394250|2270058|P2|STARTED|Successful IV Placement & Follow-Up||121
938672|NCT01394250|2270059|P1|STARTED|Successful IV Placement & Follow-Up||120
938673|NCT01394250|2270058|P2|NOT COMPLETED|Randomization and IV Placement Attempt||13
938674|NCT01394250|2270059|P1|NOT COMPLETED|Randomization and IV Placement Attempt||14
938675|NCT01394250|2270058|P2|COMPLETED|Randomization and IV Placement Attempt||121
938676|NCT01394250|2270059|P1|COMPLETED|Randomization and IV Placement Attempt||120
938677|NCT01394250|2270058|P2|STARTED|Randomization and IV Placement Attempt||134
938678|NCT01394250|2270059|P1|STARTED|Randomization and IV Placement Attempt||134
938679|NCT01394185|2270067|P6|NOT COMPLETED|Overall Study||1
938680|NCT01394185|2270068|P5|NOT COMPLETED|Overall Study||4
938681|NCT01394185|2270069|P4|NOT COMPLETED|Overall Study||1
938682|NCT01394185|2270070|P3|NOT COMPLETED|Overall Study||0
938683|NCT01394185|2270071|P2|NOT COMPLETED|Overall Study||0
938684|NCT01394185|2270072|P1|NOT COMPLETED|Overall Study||6
938685|NCT01394185|2270067|P6|COMPLETED|Overall Study||2
938686|NCT01394185|2270068|P5|COMPLETED|Overall Study||2
938687|NCT01394185|2270069|P4|COMPLETED|Overall Study||3
938688|NCT01394185|2270070|P3|COMPLETED|Overall Study||2
938689|NCT01394185|2270071|P2|COMPLETED|Overall Study||2
938690|NCT01394185|2270072|P1|COMPLETED|Overall Study||2
938691|NCT01394185|2270067|P6|STARTED|Overall Study||3
938692|NCT01394185|2270068|P5|STARTED|Overall Study||6
938693|NCT01394185|2270069|P4|STARTED|Overall Study||4
938694|NCT01394185|2270070|P3|STARTED|Overall Study||2
938695|NCT01394185|2270071|P2|STARTED|Overall Study||2
938696|NCT01394185|2270072|P1|STARTED|Overall Study||8
938697|NCT01394159|2270085|P2|NOT COMPLETED|Overall Study||0
938698|NCT01394159|2270086|P1|NOT COMPLETED|Overall Study||0
938699|NCT01394159|2270085|P2|COMPLETED|Overall Study||28
938700|NCT01394159|2270086|P1|COMPLETED|Overall Study||28
938701|NCT01394159|2270085|P2|STARTED|Overall Study||28
938702|NCT01394159|2270086|P1|STARTED|Overall Study||28
938703|NCT01393964|2270099|P3|NOT COMPLETED|Overall Study||9
938704|NCT01393964|2270100|P2|NOT COMPLETED|Overall Study||9
938705|NCT01393964|2270101|P1|NOT COMPLETED|Overall Study||8
938706|NCT01393964|2270099|P3|COMPLETED|Overall Study|Completed=treatment on-going|0
938707|NCT01393964|2270100|P2|COMPLETED|Overall Study|Completed=treatment on-going|0
938708|NCT01393964|2270101|P1|COMPLETED|Overall Study|Completed=treatment on-going|0
938709|NCT01393964|2270099|P3|STARTED|Overall Study||9
938710|NCT01393964|2270100|P2|STARTED|Overall Study||9
938711|NCT01393964|2270101|P1|STARTED|Overall Study||8
938712|NCT01393899|2270142|P3|NOT COMPLETED|Overall Study||23
938713|NCT01393899|2270143|P2|NOT COMPLETED|Overall Study||28
938714|NCT01393899|2270144|P1|NOT COMPLETED|Overall Study||32
938715|NCT01393899|2270142|P3|COMPLETED|Overall Study||38
938716|NCT01393899|2270143|P2|COMPLETED|Overall Study||32
938717|NCT01393899|2270144|P1|COMPLETED|Overall Study||27
938718|NCT01393899|2270142|P3|STARTED|Overall Study||61
938719|NCT01393899|2270143|P2|STARTED|Overall Study||60
938720|NCT01393899|2270144|P1|STARTED|Overall Study||59
938721|NCT01393743|2270198|P3|NOT COMPLETED|Extension Phase||60
938722|NCT01393743|2270199|P2|NOT COMPLETED|Extension Phase||0
938723|NCT01393743|2270200|P1|NOT COMPLETED|Extension Phase||0
938724|NCT01393743|2270198|P3|COMPLETED|Extension Phase||78
938725|NCT01393743|2270199|P2|COMPLETED|Extension Phase||0
938726|NCT01393743|2270200|P1|COMPLETED|Extension Phase||0
938727|NCT01393743|2270198|P3|STARTED|Extension Phase|Continuation into the Extension Phase was optional.|138
938728|NCT01393743|2270199|P2|STARTED|Extension Phase||0
938729|NCT01393743|2270200|P1|STARTED|Extension Phase||0
938730|NCT01393743|2270198|P3|NOT COMPLETED|Core Study||0
938731|NCT01393743|2270199|P2|NOT COMPLETED|Core Study||13
938732|NCT01393743|2270200|P1|NOT COMPLETED|Core Study||10
938733|NCT01393743|2270198|P3|COMPLETED|Core Study||0
938734|NCT01393743|2270199|P2|COMPLETED|Core Study||68
938735|NCT01393743|2270200|P1|COMPLETED|Core Study||72
938736|NCT01393743|2270198|P3|STARTED|Core Study||0
938737|NCT01393743|2270199|P2|STARTED|Core Study|Treated|81
938738|NCT01393743|2270200|P1|STARTED|Core Study|Treated|82
938739|NCT01393730|2270223|P1|NOT COMPLETED|Overall Study||6
938740|NCT01393730|2270223|P1|COMPLETED|Overall Study||34
938741|NCT01393730|2270223|P1|Evaluable AR Mutation|Overall Study||14
938742|NCT01393730|2270223|P1|Evaluable AR Amplification|Overall Study||21
938743|NCT01393730|2270223|P1|Treated|Overall Study||38
938744|NCT01393730|2270223|P1|STARTED|Overall Study||40
938745|NCT01393704|2270237|P2|NOT COMPLETED|Overall Study||0
938746|NCT01393704|2270238|P1|NOT COMPLETED|Overall Study||0
938747|NCT01393704|2270237|P2|COMPLETED|Overall Study||76
938748|NCT01393704|2270238|P1|COMPLETED|Overall Study||76
938749|NCT01393704|2270237|P2|STARTED|Overall Study||76
938750|NCT01393704|2270238|P1|STARTED|Overall Study||76
938751|NCT01393626|2270256|P4|NOT COMPLETED|Overall Study||1
938752|NCT01393626|2270257|P3|NOT COMPLETED|Overall Study||12
938753|NCT01393626|2270258|P2|NOT COMPLETED|Overall Study||12
938754|NCT01393626|2270259|P1|NOT COMPLETED|Overall Study||18
938755|NCT01393626|2270256|P4|COMPLETED|Overall Study||15
938756|NCT01393626|2270257|P3|COMPLETED|Overall Study||74
938757|NCT01393626|2270258|P2|COMPLETED|Overall Study||74
938758|NCT01393626|2270259|P1|COMPLETED|Overall Study||73
938759|NCT01393626|2270256|P4|STARTED|Overall Study||16
938760|NCT01393626|2270257|P3|STARTED|Overall Study||86
938761|NCT01393626|2270258|P2|STARTED|Overall Study||86
938762|NCT01393626|2270259|P1|STARTED|Overall Study||91
938763|NCT01393613|2270339|P4|NOT COMPLETED|Overall Study||66
938764|NCT01393613|2270340|P3|NOT COMPLETED|Overall Study||54
938765|NCT01393613|2270341|P2|NOT COMPLETED|Overall Study||57
938766|NCT01393613|2270342|P1|NOT COMPLETED|Overall Study||39
938767|NCT01393613|2270339|P4|COMPLETED|Overall Study||118
938768|NCT01393613|2270340|P3|COMPLETED|Overall Study||130
938769|NCT01393613|2270341|P2|COMPLETED|Overall Study||129
938770|NCT01393613|2270342|P1|COMPLETED|Overall Study||81
938771|NCT01393613|2270339|P4|STARTED|Overall Study||184
938772|NCT01393613|2270340|P3|STARTED|Overall Study||184
938773|NCT01393613|2270341|P2|STARTED|Overall Study||186
938774|NCT01393613|2270342|P1|STARTED|Overall Study||120
938775|NCT01393600|2270404|P4|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
938776|NCT01393600|2270405|P3|NOT COMPLETED|Follow-up Period (Day 29 to 35)||1
938777|NCT01393600|2270406|P2|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
938778|NCT01393600|2270407|P1|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
938779|NCT01393600|2270404|P4|COMPLETED|Follow-up Period (Day 29 to 35)||8
938780|NCT01393600|2270405|P3|COMPLETED|Follow-up Period (Day 29 to 35)||6
938781|NCT01393600|2270406|P2|COMPLETED|Follow-up Period (Day 29 to 35)||7
938782|NCT01393600|2270407|P1|COMPLETED|Follow-up Period (Day 29 to 35)||9
938783|NCT01393600|2270404|P4|STARTED|Follow-up Period (Day 29 to 35)||8
938784|NCT01393600|2270405|P3|STARTED|Follow-up Period (Day 29 to 35)||7
938785|NCT01393600|2270406|P2|STARTED|Follow-up Period (Day 29 to 35)||7
938786|NCT01393600|2270407|P1|STARTED|Follow-up Period (Day 29 to 35)||9
938787|NCT01393600|2270404|P4|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||1
938788|NCT01393600|2270405|P3|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||2
938789|NCT01393600|2270406|P2|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
938790|NCT01393600|2270407|P1|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
938791|NCT01393600|2270404|P4|COMPLETED|Treatment Period 2 (Day 15 to 28)||8
938792|NCT01393600|2270405|P3|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
938793|NCT01393600|2270406|P2|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
938794|NCT01393600|2270407|P1|COMPLETED|Treatment Period 2 (Day 15 to 28)||9
938795|NCT01393600|2270404|P4|STARTED|Treatment Period 2 (Day 15 to 28)||9
938796|NCT01393600|2270405|P3|STARTED|Treatment Period 2 (Day 15 to 28)||9
938797|NCT01393600|2270406|P2|STARTED|Treatment Period 2 (Day 15 to 28)||7
938798|NCT01393600|2270407|P1|STARTED|Treatment Period 2 (Day 15 to 28)||9
938799|NCT01393600|2270404|P4|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
938800|NCT01393600|2270405|P3|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
938801|NCT01393600|2270406|P2|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
938802|NCT01393600|2270407|P1|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||0
938803|NCT01393600|2270404|P4|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
938804|NCT01393600|2270405|P3|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
938805|NCT01393600|2270406|P2|COMPLETED|Treatment Period 1 (Day 1 to 14)||7
938806|NCT01393600|2270407|P1|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
938807|NCT01393600|2270404|P4|STARTED|Treatment Period 1 (Day 1 to 14)||10
938808|NCT01393600|2270405|P3|STARTED|Treatment Period 1 (Day 1 to 14)||10
938809|NCT01393600|2270406|P2|STARTED|Treatment Period 1 (Day 1 to 14)||8
938810|NCT01393600|2270407|P1|STARTED|Treatment Period 1 (Day 1 to 14)||9
938811|NCT01393444|2270422|P1|NOT COMPLETED|Overall Study||3
938812|NCT01393444|2270422|P1|COMPLETED|Overall Study|2015: Third implanted subject completed the study. This fulfilled the requirements of our grant.|3
938813|NCT01393444|2270422|P1|Sixth (3rd Implanted) Subject|Overall Study|2014: Individual with brachial plexus injury enrolled and was eligible. Implanted in 2015.|1
938814|NCT01393444|2270422|P1|Fifth (2nd Implanted) Subject Enrolled|Overall Study|2013: Individual with ALS enrolled and was eligible. Implanted in 2014.|1
938815|NCT01393444|2270422|P1|Fourth Subject Enrolled|Overall Study|2013: Fourth participant enrolled. Ineligible.|1
938816|NCT01393444|2270422|P1|Third Subject Enrolled|Overall Study|2013: Third participant enrolled. Withdrew due to family commitments.|1
938817|NCT01393444|2270422|P1|Second Subject Enrolled|Overall Study|2012: Second participant enrolled. Ineligible.|1
938818|NCT01393444|2270422|P1|First (1st Implanted) Subject Enrolled|Overall Study|2011: Individual with cervical spinal cord injury enrolled and was eligible. Implanted in 2011.|1
938819|NCT01393444|2270422|P1|STARTED|Overall Study||6
938820|NCT01393132|2270429|P2|NOT COMPLETED|Overall Study||0
938821|NCT01393132|2270430|P1|NOT COMPLETED|Overall Study||0
938822|NCT01393132|2270429|P2|COMPLETED|Overall Study||3
938823|NCT01393132|2270430|P1|COMPLETED|Overall Study||6
938824|NCT01393132|2270429|P2|STARTED|Overall Study||3
938825|NCT01393132|2270430|P1|STARTED|Overall Study||6
938826|NCT01393106|2270442|P1|NOT COMPLETED|Overall Study||5
938827|NCT01393106|2270442|P1|COMPLETED|Overall Study|Completed: Disease Progression/Death|20
938828|NCT01393106|2270442|P1|STARTED|Overall Study||25
938829|NCT01392742|2270459|P1|NOT COMPLETED|Overall Study||201
938830|NCT01392742|2270459|P1|COMPLETED|Overall Study||242
938831|NCT01392742|2270459|P1|STARTED|Overall Study||443
938832|NCT01392703|2270474|P3|NOT COMPLETED|Day 9||0
938833|NCT01392703|2270475|P2|NOT COMPLETED|Day 9||0
938834|NCT01392703|2270476|P1|NOT COMPLETED|Day 9||0
938835|NCT01392703|2270474|P3|COMPLETED|Day 9||25
938836|NCT01392703|2270475|P2|COMPLETED|Day 9||26
938837|NCT01392703|2270476|P1|COMPLETED|Day 9||26
938838|NCT01392703|2270474|P3|STARTED|Day 9||25
938839|NCT01392703|2270475|P2|STARTED|Day 9||26
938840|NCT01392703|2270476|P1|STARTED|Day 9||26
938841|NCT01392703|2270474|P3|NOT COMPLETED|Day 5||0
938842|NCT01392703|2270475|P2|NOT COMPLETED|Day 5||0
938843|NCT01392703|2270476|P1|NOT COMPLETED|Day 5||0
938844|NCT01392703|2270474|P3|COMPLETED|Day 5||26
938845|NCT01392703|2270475|P2|COMPLETED|Day 5||25
938846|NCT01392703|2270476|P1|COMPLETED|Day 5||26
938847|NCT01392703|2270474|P3|STARTED|Day 5||26
938848|NCT01392703|2270475|P2|STARTED|Day 5|1 participant no longer met dosing criteria and dropped out during washout period prior to Day 5.|25
938849|NCT01392703|2270476|P1|STARTED|Day 5||26
938850|NCT01392703|2270474|P3|NOT COMPLETED|Day 1||0
938851|NCT01392703|2270475|P2|NOT COMPLETED|Day 1||0
938852|NCT01392703|2270476|P1|NOT COMPLETED|Day 1||0
938853|NCT01392703|2270474|P3|COMPLETED|Day 1||26
938854|NCT01392703|2270475|P2|COMPLETED|Day 1||26
938855|NCT01392703|2270476|P1|COMPLETED|Day 1||26
938856|NCT01392703|2270474|P3|STARTED|Day 1||26
938857|NCT01392703|2270475|P2|STARTED|Day 1||26
938858|NCT01392703|2270476|P1|STARTED|Day 1||26
938859|NCT01392677|2270505|P2|NOT COMPLETED|Overall Study||8
938860|NCT01392677|2270506|P1|NOT COMPLETED|Overall Study||8
938861|NCT01392677|2270505|P2|COMPLETED|Overall Study||101
938862|NCT01392677|2270506|P1|COMPLETED|Overall Study||101
938863|NCT01392677|2270505|P2|STARTED|Overall Study||109
938864|NCT01392677|2270506|P1|STARTED|Overall Study||109
938873|NCT01392560|2270531|P1|NOT COMPLETED|Overall Study||12
938874|NCT01392560|2270531|P1|COMPLETED|Overall Study||40
938875|NCT01392560|2270531|P1|STARTED|Overall Study||52
938876|NCT01392547|2270537|P1|NOT COMPLETED|Overall Study||8
938877|NCT01392547|2270537|P1|COMPLETED|Overall Study||64
938878|NCT01392547|2270537|P1|STARTED|Overall Study|567 bleeds by 69 subjects, 340 were treated with vatreptacog alfa and 227 with rFVIIa|72
938879|NCT01392495|2270551|P1|NOT COMPLETED|Overall Study||16
938880|NCT01392495|2270551|P1|COMPLETED|Overall Study||1
938881|NCT01392495|2270551|P1|Received 400 mg|Overall Study||13
938882|NCT01392495|2270551|P1|Received 200 mg|Overall Study||4
938883|NCT01392495|2270551|P1|STARTED|Overall Study||17
938884|NCT01392378|2270568|P5|NOT COMPLETED|Toddler Dose||1
938885|NCT01392378|2270569|P4|NOT COMPLETED|Toddler Dose||2
938886|NCT01392378|2270570|P3|NOT COMPLETED|Toddler Dose||0
938887|NCT01392378|2270571|P2|NOT COMPLETED|Toddler Dose||1
938888|NCT01392378|2270572|P1|NOT COMPLETED|Toddler Dose||0
938889|NCT01392378|2270568|P5|COMPLETED|Toddler Dose||208
938890|NCT01392378|2270569|P4|COMPLETED|Toddler Dose||173
938891|NCT01392378|2270570|P3|COMPLETED|Toddler Dose||170
938892|NCT01392378|2270571|P2|COMPLETED|Toddler Dose||172
938893|NCT01392378|2270572|P1|COMPLETED|Toddler Dose||169
938894|NCT01392378|2270568|P5|STARTED|Toddler Dose||209
938895|NCT01392378|2270569|P4|STARTED|Toddler Dose||175
938896|NCT01392378|2270570|P3|STARTED|Toddler Dose||170
938897|NCT01392378|2270571|P2|STARTED|Toddler Dose||173
938898|NCT01392378|2270572|P1|STARTED|Toddler Dose||169
938899|NCT01392378|2270568|P5|NOT COMPLETED|After Infant Series||1
938900|NCT01392378|2270569|P4|NOT COMPLETED|After Infant Series||0
938901|NCT01392378|2270570|P3|NOT COMPLETED|After Infant Series||2
938902|NCT01392378|2270571|P2|NOT COMPLETED|After Infant Series||1
938903|NCT01392378|2270572|P1|NOT COMPLETED|After Infant Series||0
938904|NCT01392378|2270568|P5|COMPLETED|After Infant Series||209
938905|NCT01392378|2270569|P4|COMPLETED|After Infant Series||175
938906|NCT01392378|2270570|P3|COMPLETED|After Infant Series||170
938907|NCT01392378|2270571|P2|COMPLETED|After Infant Series||173
938908|NCT01392378|2270572|P1|COMPLETED|After Infant Series||169
938909|NCT01392378|2270568|P5|STARTED|After Infant Series||210
938910|NCT01392378|2270569|P4|STARTED|After Infant Series||175
938911|NCT01392378|2270570|P3|STARTED|After Infant Series||172
938912|NCT01392378|2270571|P2|STARTED|After Infant Series||174
938913|NCT01392378|2270572|P1|STARTED|After Infant Series||169
938914|NCT01392378|2270568|P5|NOT COMPLETED|Infant Series||0
938915|NCT01392378|2270569|P4|NOT COMPLETED|Infant Series||2
938916|NCT01392378|2270570|P3|NOT COMPLETED|Infant Series||0
938917|NCT01392378|2270571|P2|NOT COMPLETED|Infant Series||2
938918|NCT01392378|2270572|P1|NOT COMPLETED|Infant Series||4
938919|NCT01392378|2270568|P5|COMPLETED|Infant Series||210
938920|NCT01392378|2270569|P4|COMPLETED|Infant Series||175
938921|NCT01392378|2270570|P3|COMPLETED|Infant Series||172
938922|NCT01392378|2270571|P2|COMPLETED|Infant Series||174
938923|NCT01392378|2270572|P1|COMPLETED|Infant Series||169
938924|NCT01392378|2270568|P5|Vaccinated Dose 3|Infant Series||210
938925|NCT01392378|2270569|P4|Vaccinated Dose 3|Infant Series||176
938926|NCT01392378|2270570|P3|Vaccinated Dose 3|Infant Series||172
938927|NCT01392378|2270571|P2|Vaccinated Dose 3|Infant Series||174
938928|NCT01392378|2270572|P1|Vaccinated Dose 3|Infant Series||170
938929|NCT01392378|2270568|P5|Vaccinated Dose 2|Infant Series||210
938930|NCT01392378|2270569|P4|Vaccinated Dose 2|Infant Series||177
938931|NCT01392378|2270570|P3|Vaccinated Dose 2|Infant Series||172
938932|NCT01392378|2270571|P2|Vaccinated Dose 2|Infant Series||174
938933|NCT01392378|2270572|P1|Vaccinated Dose 2|Infant Series||171
938934|NCT01392378|2270568|P5|Vaccinated Dose 1|Infant Series||210
938935|NCT01392378|2270569|P4|Vaccinated Dose 1|Infant Series||177
938936|NCT01392378|2270570|P3|Vaccinated Dose 1|Infant Series||172
938937|NCT01392378|2270571|P2|Vaccinated Dose 1|Infant Series||176
938938|NCT01392378|2270572|P1|Vaccinated Dose 1|Infant Series||173
938939|NCT01392378|2270568|P5|STARTED|Infant Series||210
938940|NCT01392378|2270569|P4|STARTED|Infant Series||177
938941|NCT01392378|2270570|P3|STARTED|Infant Series||172
938942|NCT01392378|2270571|P2|STARTED|Infant Series||176
938943|NCT01392378|2270572|P1|STARTED|Infant Series||173
938944|NCT01392326|2270712|P3|NOT COMPLETED|Overall Study||48
938945|NCT01392326|2270713|P2|NOT COMPLETED|Overall Study||35
938946|NCT01392326|2270714|P1|NOT COMPLETED|Overall Study||47
938947|NCT01392326|2270712|P3|COMPLETED|Overall Study||154
938948|NCT01392326|2270713|P2|COMPLETED|Overall Study||167
938949|NCT01392326|2270714|P1|COMPLETED|Overall Study||155
938950|NCT01392326|2270712|P3|STARTED|Overall Study||202
938951|NCT01392326|2270713|P2|STARTED|Overall Study||202
938952|NCT01392326|2270714|P1|STARTED|Overall Study||202
938953|NCT01392300|2270751|P3|NOT COMPLETED|Open Label Extension (OLEX) Period||51
938954|NCT01392300|2270752|P2|NOT COMPLETED|Open Label Extension (OLEX) Period||0
938955|NCT01392300|2270753|P1|NOT COMPLETED|Open Label Extension (OLEX) Period||0
938956|NCT01392300|2270751|P3|COMPLETED|Open Label Extension (OLEX) Period||248
938957|NCT01392300|2270752|P2|COMPLETED|Open Label Extension (OLEX) Period||0
938958|NCT01392300|2270753|P1|COMPLETED|Open Label Extension (OLEX) Period||0
938959|NCT01392300|2270751|P3|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|299
938960|NCT01392300|2270752|P2|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
938961|NCT01392300|2270753|P1|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
938962|NCT01392300|2270751|P3|NOT COMPLETED|Main Period (MP)||0
938963|NCT01392300|2270752|P2|NOT COMPLETED|Main Period (MP)||7
938964|NCT01392300|2270753|P1|NOT COMPLETED|Main Period (MP)||11
938965|NCT01392300|2270751|P3|COMPLETED|Main Period (MP)||0
938966|NCT01392300|2270752|P2|COMPLETED|Main Period (MP)||100
938967|NCT01392300|2270753|P1|COMPLETED|Main Period (MP)||199
938968|NCT01392300|2270751|P3|STARTED|Main Period (MP)||0
938969|NCT01392300|2270752|P2|STARTED|Main Period (MP)||107
938970|NCT01392300|2270753|P1|STARTED|Main Period (MP)||210
938971|NCT01391325|2270858|P1|NOT COMPLETED|Overall Study||494
938972|NCT01391325|2270858|P1|COMPLETED|Overall Study||1238
938973|NCT01391325|2270858|P1|STARTED|Overall Study||1732
938974|NCT01391312|2270867|P2|NOT COMPLETED|Overall Study||1
938975|NCT01391312|2270868|P1|NOT COMPLETED|Overall Study||2
938976|NCT01391312|2270867|P2|COMPLETED|Overall Study||19
938977|NCT01391312|2270868|P1|COMPLETED|Overall Study||18
938978|NCT01391312|2270867|P2|STARTED|Overall Study||20
938979|NCT01391312|2270868|P1|STARTED|Overall Study||20
938980|NCT01391299|2270881|P3|NOT COMPLETED|Overall Study||2
938981|NCT01391299|2270882|P2|NOT COMPLETED|Overall Study||1
938982|NCT01391299|2270883|P1|NOT COMPLETED|Overall Study||0
938983|NCT01391299|2270881|P3|COMPLETED|Overall Study||56
938984|NCT01391299|2270882|P2|COMPLETED|Overall Study||59
938985|NCT01391299|2270883|P1|COMPLETED|Overall Study||57
938986|NCT01391299|2270881|P3|STARTED|Overall Study||58
938987|NCT01391299|2270882|P2|STARTED|Overall Study||60
938988|NCT01391299|2270883|P1|STARTED|Overall Study||57
938989|NCT01391286|2270905|P2|NOT COMPLETED|Overall Study||0
938990|NCT01391286|2270906|P1|NOT COMPLETED|Overall Study||0
938991|NCT01391286|2270905|P2|COMPLETED|Overall Study||18
938992|NCT01391286|2270906|P1|COMPLETED|Overall Study||18
938993|NCT01391286|2270905|P2|STARTED|Overall Study||18
938994|NCT01391286|2270906|P1|STARTED|Overall Study||18
938995|NCT01391273|2270920|P2|NOT COMPLETED|Overall Study||2
938996|NCT01391273|2270921|P1|NOT COMPLETED|Overall Study||4
938997|NCT01391273|2270920|P2|COMPLETED|Overall Study||83
938998|NCT01391273|2270921|P1|COMPLETED|Overall Study||84
938999|NCT01391273|2270920|P2|STARTED|Overall Study||85
939000|NCT01391273|2270921|P1|STARTED|Overall Study||88
939001|NCT01392170|2270933|P1|NOT COMPLETED|Overall Study||2
939002|NCT01392170|2270933|P1|COMPLETED|Overall Study||0
939003|NCT01392170|2270933|P1|STARTED|Overall Study||2
939004|NCT01392053|2270939|P2|NOT COMPLETED|Overall Study||0
939005|NCT01392053|2270940|P1|NOT COMPLETED|Overall Study||0
939006|NCT01392053|2270939|P2|COMPLETED|Overall Study||23
939007|NCT01392053|2270940|P1|COMPLETED|Overall Study||23
939008|NCT01392053|2270939|P2|STARTED|Overall Study||23
939009|NCT01392053|2270940|P1|STARTED|Overall Study||23
939010|NCT01391858|2270960|P2|NOT COMPLETED|Overall Study||0
939011|NCT01391858|2270961|P1|NOT COMPLETED|Overall Study||2
939012|NCT01391858|2270960|P2|COMPLETED|Overall Study||24
939013|NCT01391858|2270961|P1|COMPLETED|Overall Study||23
939014|NCT01391858|2270960|P2|STARTED|Overall Study||24
939015|NCT01391858|2270961|P1|STARTED|Overall Study||25
939016|NCT01391819|2270981|P1|NOT COMPLETED|Overall Study||402
939017|NCT01391819|2270981|P1|COMPLETED|Overall Study||1714
939018|NCT01391819|2270981|P1|STARTED|Overall Study||2116
939019|NCT01391663|2271012|P4|NOT COMPLETED|Overall Study||0
939020|NCT01391663|2271013|P3|NOT COMPLETED|Overall Study||1
939021|NCT01391663|2271014|P2|NOT COMPLETED|Overall Study||0
939022|NCT01391663|2271015|P1|NOT COMPLETED|Overall Study||0
939023|NCT01391663|2271012|P4|COMPLETED|Overall Study||12
939024|NCT01391663|2271013|P3|COMPLETED|Overall Study||11
939025|NCT01391663|2271014|P2|COMPLETED|Overall Study||12
939026|NCT01391663|2271015|P1|COMPLETED|Overall Study||12
939027|NCT01391663|2271012|P4|STARTED|Overall Study||12
939028|NCT01391663|2271013|P3|STARTED|Overall Study||12
939029|NCT01391663|2271014|P2|STARTED|Overall Study||12
939030|NCT01391663|2271015|P1|STARTED|Overall Study||12
939031|NCT01391611|2271045|P1|NOT COMPLETED|Overall Study||22
939032|NCT01391611|2271045|P1|COMPLETED|Overall Study||3
939033|NCT01391611|2271045|P1|STARTED|Overall Study||25
939034|NCT01391559|2271050|P2|NOT COMPLETED|Second Intervention||0
939035|NCT01391559|2271051|P1|NOT COMPLETED|Second Intervention||0
939036|NCT01391559|2271050|P2|COMPLETED|Second Intervention||10
939037|NCT01391559|2271051|P1|COMPLETED|Second Intervention||10
939038|NCT01391559|2271050|P2|STARTED|Second Intervention||10
939039|NCT01391559|2271051|P1|STARTED|Second Intervention||10
939040|NCT01391559|2271050|P2|NOT COMPLETED|First Intervention||0
939041|NCT01391559|2271051|P1|NOT COMPLETED|First Intervention||0
939042|NCT01391559|2271050|P2|COMPLETED|First Intervention||10
939043|NCT01391559|2271051|P1|COMPLETED|First Intervention||10
939044|NCT01391559|2271050|P2|STARTED|First Intervention||10
939045|NCT01391559|2271051|P1|STARTED|First Intervention||10
939046|NCT01391507|2271061|P4|NOT COMPLETED|Overall Study||7
939047|NCT01391507|2271062|P3|NOT COMPLETED|Overall Study||4
939048|NCT01391507|2271063|P2|NOT COMPLETED|Overall Study||4
939049|NCT01391507|2271064|P1|NOT COMPLETED|Overall Study||4
939050|NCT01391507|2271061|P4|COMPLETED|Overall Study||5
939051|NCT01391507|2271062|P3|COMPLETED|Overall Study||2
939052|NCT01391507|2271063|P2|COMPLETED|Overall Study||4
939053|NCT01391507|2271064|P1|COMPLETED|Overall Study||6
939054|NCT01391507|2271061|P4|STARTED|Overall Study||12
939055|NCT01391507|2271062|P3|STARTED|Overall Study||6
939056|NCT01391507|2271063|P2|STARTED|Overall Study||8
939057|NCT01391507|2271064|P1|STARTED|Overall Study||10
939058|NCT01391468|2271112|P2|NOT COMPLETED|Overall Study||2
939059|NCT01391468|2271113|P1|NOT COMPLETED|Overall Study||6
939060|NCT01391468|2271112|P2|COMPLETED|Overall Study||21
939061|NCT01391468|2271113|P1|COMPLETED|Overall Study||18
939062|NCT01391468|2271112|P2|STARTED|Overall Study||23
939063|NCT01391468|2271113|P1|STARTED|Overall Study||24
939064|NCT01391013|2271127|P2|NOT COMPLETED|Overall Study||0
939065|NCT01391013|2271128|P1|NOT COMPLETED|Overall Study||0
939066|NCT01391013|2271127|P2|COMPLETED|Overall Study||15
939067|NCT01391013|2271128|P1|COMPLETED|Overall Study||15
939068|NCT01391013|2271127|P2|STARTED|Overall Study||15
939069|NCT01391013|2271128|P1|STARTED|Overall Study||15
939070|NCT01391000|2271168|P2|NOT COMPLETED|Overall Study||0
939071|NCT01391000|2271169|P1|NOT COMPLETED|Overall Study||2
939072|NCT01391000|2271168|P2|COMPLETED|Overall Study||35
939073|NCT01391000|2271169|P1|COMPLETED|Overall Study||33
939074|NCT01391000|2271168|P2|STARTED|Overall Study||35
939075|NCT01391000|2271169|P1|STARTED|Overall Study||35
939088|NCT01390909|2271223|P6|NOT COMPLETED|Overall Study||0
939089|NCT01390909|2271224|P5|NOT COMPLETED|Overall Study||0
939090|NCT01390909|2271225|P4|NOT COMPLETED|Overall Study||0
939091|NCT01390909|2271226|P3|NOT COMPLETED|Overall Study||0
939092|NCT01390909|2271227|P2|NOT COMPLETED|Overall Study||0
939093|NCT01390909|2271228|P1|NOT COMPLETED|Overall Study||0
939094|NCT01390909|2271223|P6|COMPLETED|Overall Study||613
939095|NCT01390909|2271224|P5|COMPLETED|Overall Study||613
939096|NCT01390909|2271225|P4|COMPLETED|Overall Study||602
939097|NCT01390909|2271226|P3|COMPLETED|Overall Study||3552
939098|NCT01390909|2271227|P2|COMPLETED|Overall Study||3552
939099|NCT01390909|2271228|P1|COMPLETED|Overall Study||3454
939100|NCT01390909|2271223|P6|Participants in Subgroup|Overall Study||0
939101|NCT01390909|2271224|P5|Participants in Subgroup|Overall Study||602
939102|NCT01390909|2271225|P4|Participants in Subgroup|Overall Study||0
939103|NCT01390909|2271226|P3|Participants in Subgroup|Overall Study||0
939104|NCT01390909|2271227|P2|Participants in Subgroup|Overall Study||3454
939105|NCT01390909|2271228|P1|Participants in Subgroup|Overall Study||0
939106|NCT01390909|2271223|P6|STARTED|Overall Study||613
939107|NCT01390909|2271224|P5|STARTED|Overall Study||613
939108|NCT01390909|2271225|P4|STARTED|Overall Study||602
939109|NCT01390909|2271226|P3|STARTED|Overall Study||3552
939110|NCT01390909|2271227|P2|STARTED|Overall Study||3552
939111|NCT01390909|2271228|P1|STARTED|Overall Study||3454
939112|NCT01390870|2271246|P1|NOT COMPLETED|Overall Study||0
939113|NCT01390870|2271246|P1|COMPLETED|Overall Study||400
939114|NCT01390870|2271246|P1|STARTED|Overall Study||400
939115|NCT01390857|2271250|P1|NOT COMPLETED|Overall Study||10
939116|NCT01390857|2271250|P1|COMPLETED|Overall Study||369
939117|NCT01390857|2271250|P1|STARTED|Overall Study||379
939118|NCT01390844|2271261|P4|NOT COMPLETED|Follow-Up Phase||0
939119|NCT01390844|2271262|P3|NOT COMPLETED|Follow-Up Phase||1
939120|NCT01390844|2271263|P2|NOT COMPLETED|Follow-Up Phase||1
939121|NCT01390844|2271264|P1|NOT COMPLETED|Follow-Up Phase||1
939122|NCT01390844|2271261|P4|COMPLETED|Follow-Up Phase||8
939123|NCT01390844|2271262|P3|COMPLETED|Follow-Up Phase||25
939124|NCT01390844|2271263|P2|COMPLETED|Follow-Up Phase||36
939125|NCT01390844|2271264|P1|COMPLETED|Follow-Up Phase||92
939126|NCT01390844|2271261|P4|STARTED|Follow-Up Phase||8
939127|NCT01390844|2271262|P3|STARTED|Follow-Up Phase||26
939128|NCT01390844|2271263|P2|STARTED|Follow-Up Phase||37
939129|NCT01390844|2271264|P1|STARTED|Follow-Up Phase||93
939130|NCT01390844|2271261|P4|NOT COMPLETED|Treatment Phase||19
939131|NCT01390844|2271262|P3|NOT COMPLETED|Treatment Phase||31
939132|NCT01390844|2271263|P2|NOT COMPLETED|Treatment Phase||28
939133|NCT01390844|2271264|P1|NOT COMPLETED|Treatment Phase||40
939134|NCT01390844|2271261|P4|COMPLETED|Treatment Phase||8
939135|NCT01390844|2271262|P3|COMPLETED|Treatment Phase||26
939136|NCT01390844|2271263|P2|COMPLETED|Treatment Phase||37
939137|NCT01390844|2271264|P1|COMPLETED|Treatment Phase||93
939138|NCT01390844|2271261|P4|Followed Good Clinical Practice (GCP)|Treatment Phase||24
939139|NCT01390844|2271262|P3|Followed Good Clinical Practice (GCP)|Treatment Phase||47
939140|NCT01390844|2271263|P2|Followed Good Clinical Practice (GCP)|Treatment Phase||65
939141|NCT01390844|2271264|P1|Followed Good Clinical Practice (GCP)|Treatment Phase||133
939142|NCT01390844|2271261|P4|STARTED|Treatment Phase||27
939143|NCT01390844|2271262|P3|STARTED|Treatment Phase||57
939144|NCT01390844|2271263|P2|STARTED|Treatment Phase||65
939145|NCT01390844|2271264|P1|STARTED|Treatment Phase||133
939146|NCT01390818|2271305|P15|NOT COMPLETED|Overall Study||0
939147|NCT01390818|2271306|P14|NOT COMPLETED|Overall Study||0
939148|NCT01390818|2271307|P13|NOT COMPLETED|Overall Study||0
939149|NCT01390818|2271308|P12|NOT COMPLETED|Overall Study||0
939150|NCT01390818|2271309|P11|NOT COMPLETED|Overall Study||0
939151|NCT01390818|2271310|P10|NOT COMPLETED|Overall Study||0
939152|NCT01390818|2271311|P9|NOT COMPLETED|Overall Study||0
939153|NCT01390818|2271312|P8|NOT COMPLETED|Overall Study||0
939154|NCT01390818|2271313|P7|NOT COMPLETED|Overall Study||0
939155|NCT01390818|2271314|P6|NOT COMPLETED|Overall Study||0
939156|NCT01390818|2271315|P5|NOT COMPLETED|Overall Study||0
939157|NCT01390818|2271316|P4|NOT COMPLETED|Overall Study||0
939158|NCT01390818|2271317|P3|NOT COMPLETED|Overall Study||0
939159|NCT01390818|2271318|P2|NOT COMPLETED|Overall Study||0
939160|NCT01390818|2271319|P1|NOT COMPLETED|Overall Study||0
939161|NCT01390818|2271305|P15|COMPLETED|Overall Study||15
939162|NCT01390818|2271306|P14|COMPLETED|Overall Study||18
939163|NCT01390818|2271307|P13|COMPLETED|Overall Study||24
939164|NCT01390818|2271308|P12|COMPLETED|Overall Study||26
939165|NCT01390818|2271309|P11|COMPLETED|Overall Study||4
939166|NCT01390818|2271310|P10|COMPLETED|Overall Study||3
939167|NCT01390818|2271311|P9|COMPLETED|Overall Study||3
939168|NCT01390818|2271312|P8|COMPLETED|Overall Study||14
939169|NCT01390818|2271313|P7|COMPLETED|Overall Study||19
939170|NCT01390818|2271314|P6|COMPLETED|Overall Study||3
939171|NCT01390818|2271315|P5|COMPLETED|Overall Study||4
939172|NCT01390818|2271316|P4|COMPLETED|Overall Study||4
939173|NCT01390818|2271317|P3|COMPLETED|Overall Study||3
939174|NCT01390818|2271318|P2|COMPLETED|Overall Study||3
939175|NCT01390818|2271319|P1|COMPLETED|Overall Study||3
939176|NCT01390818|2271305|P15|STARTED|Overall Study||15
939177|NCT01390818|2271306|P14|STARTED|Overall Study||18
939178|NCT01390818|2271307|P13|STARTED|Overall Study||24
939179|NCT01390818|2271308|P12|STARTED|Overall Study||26
939180|NCT01390818|2271309|P11|STARTED|Overall Study||4
939181|NCT01390818|2271310|P10|STARTED|Overall Study||3
939182|NCT01390818|2271311|P9|STARTED|Overall Study||3
939183|NCT01390818|2271312|P8|STARTED|Overall Study||14
939184|NCT01390818|2271313|P7|STARTED|Overall Study||19
939185|NCT01390818|2271314|P6|STARTED|Overall Study||3
939186|NCT01390818|2271315|P5|STARTED|Overall Study||4
939187|NCT01390818|2271316|P4|STARTED|Overall Study||4
939188|NCT01390818|2271317|P3|STARTED|Overall Study||3
939189|NCT01390818|2271318|P2|STARTED|Overall Study||3
939190|NCT01390818|2271319|P1|STARTED|Overall Study||3
939191|NCT01390779|2271591|P1|NOT COMPLETED|Overall Study||1
939192|NCT01390779|2271591|P1|COMPLETED|Overall Study||32
939193|NCT01390779|2271591|P1|STARTED|Overall Study||33
939194|NCT01390649|2271596|P1|NOT COMPLETED|Overall Study||1
939195|NCT01390649|2271596|P1|COMPLETED|Overall Study||56
939196|NCT01390649|2271596|P1|STARTED|Overall Study|Subjects treated with Privigen|57
939197|NCT01390441|2271606|P5|NOT COMPLETED|Extension Period||0
939198|NCT01390441|2271607|P4|NOT COMPLETED|Extension Period||1
939199|NCT01390441|2271608|P3|NOT COMPLETED|Extension Period||0
939200|NCT01390441|2271609|P2|NOT COMPLETED|Extension Period||1
939201|NCT01390441|2271610|P1|NOT COMPLETED|Extension Period||3
939202|NCT01390441|2271606|P5|COMPLETED|Extension Period||3
939203|NCT01390441|2271607|P4|COMPLETED|Extension Period||0
939204|NCT01390441|2271608|P3|COMPLETED|Extension Period||1
939205|NCT01390441|2271609|P2|COMPLETED|Extension Period||12
939206|NCT01390441|2271610|P1|COMPLETED|Extension Period||12
939207|NCT01390441|2271606|P5|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|3
939208|NCT01390441|2271607|P4|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
939209|NCT01390441|2271608|P3|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
939210|NCT01390441|2271609|P2|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|13
939211|NCT01390441|2271610|P1|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|15
939212|NCT01390441|2271606|P5|NOT COMPLETED|Treatment Period||11
939213|NCT01390441|2271607|P4|NOT COMPLETED|Treatment Period||13
939214|NCT01390441|2271608|P3|NOT COMPLETED|Treatment Period||10
939215|NCT01390441|2271609|P2|NOT COMPLETED|Treatment Period||1
939216|NCT01390441|2271610|P1|NOT COMPLETED|Treatment Period||1
939217|NCT01390441|2271606|P5|COMPLETED|Treatment Period||7
939218|NCT01390441|2271607|P4|COMPLETED|Treatment Period||6
939219|NCT01390441|2271608|P3|COMPLETED|Treatment Period||8
939220|NCT01390441|2271609|P2|COMPLETED|Treatment Period||21
939221|NCT01390441|2271610|P1|COMPLETED|Treatment Period||22
939222|NCT01390441|2271606|P5|STARTED|Treatment Period||18
939223|NCT01390441|2271607|P4|STARTED|Treatment Period||19
939224|NCT01390441|2271608|P3|STARTED|Treatment Period||18
939225|NCT01390441|2271609|P2|STARTED|Treatment Period||22
939226|NCT01390441|2271610|P1|STARTED|Treatment Period||23
939227|NCT01390428|2271675|P6|NOT COMPLETED|Overall Study||0
939228|NCT01390428|2271676|P5|NOT COMPLETED|Overall Study||1
939229|NCT01390428|2271677|P4|NOT COMPLETED|Overall Study||0
939230|NCT01390428|2271678|P3|NOT COMPLETED|Overall Study||1
939231|NCT01390428|2271679|P2|NOT COMPLETED|Overall Study||0
939232|NCT01390428|2271680|P1|NOT COMPLETED|Overall Study||0
939233|NCT01390428|2271675|P6|COMPLETED|Overall Study||8
939234|NCT01390428|2271676|P5|COMPLETED|Overall Study||7
939235|NCT01390428|2271677|P4|COMPLETED|Overall Study||9
939236|NCT01390428|2271678|P3|COMPLETED|Overall Study||8
939237|NCT01390428|2271679|P2|COMPLETED|Overall Study||8
939238|NCT01390428|2271680|P1|COMPLETED|Overall Study||8
939239|NCT01390428|2271675|P6|STARTED|Overall Study||8
939240|NCT01390428|2271676|P5|STARTED|Overall Study||8
939241|NCT01390428|2271677|P4|STARTED|Overall Study||9
939242|NCT01390428|2271678|P3|STARTED|Overall Study||9
939243|NCT01390428|2271679|P2|STARTED|Overall Study||8
939244|NCT01390428|2271680|P1|STARTED|Overall Study||8
939245|NCT01390415|2271732|P2|NOT COMPLETED|Overall Study||0
939246|NCT01390415|2271733|P1|NOT COMPLETED|Overall Study||0
939247|NCT01390415|2271732|P2|COMPLETED|Overall Study||37
939248|NCT01390415|2271733|P1|COMPLETED|Overall Study||99
939249|NCT01390415|2271732|P2|STARTED|Overall Study||37
939250|NCT01390415|2271733|P1|STARTED|Overall Study||99
939251|NCT01390402|2271743|P1|NOT COMPLETED|Overall Study||5
939252|NCT01390402|2271743|P1|COMPLETED|Overall Study||1
939253|NCT01390402|2271743|P1|STARTED|Overall Study||6
939260|NCT01390259|2271756|P2|NOT COMPLETED|Overall Study||0
939261|NCT01390259|2271757|P1|NOT COMPLETED|Overall Study||0
939262|NCT01390259|2271756|P2|COMPLETED|Overall Study||6
939263|NCT01390259|2271757|P1|COMPLETED|Overall Study||5
939264|NCT01390259|2271756|P2|STARTED|Overall Study||6
939265|NCT01390259|2271757|P1|STARTED|Overall Study||5
939266|NCT01390233|2271769|P3|NOT COMPLETED|Overall Study||6
939267|NCT01390233|2271770|P2|NOT COMPLETED|Overall Study||2
939268|NCT01390233|2271771|P1|NOT COMPLETED|Overall Study||5
939269|NCT01390233|2271769|P3|COMPLETED|Overall Study||30
939270|NCT01390233|2271770|P2|COMPLETED|Overall Study||29
939271|NCT01390233|2271771|P1|COMPLETED|Overall Study||30
939272|NCT01390233|2271769|P3|STARTED|Overall Study||36
939273|NCT01390233|2271770|P2|STARTED|Overall Study||31
939274|NCT01390233|2271771|P1|STARTED|Overall Study||35
939275|NCT01390181|2271779|P1|NOT COMPLETED|Overall Study||4
939276|NCT01390181|2271779|P1|COMPLETED|Overall Study||0
939277|NCT01390181|2271779|P1|STARTED|Overall Study||4
939278|NCT01390038|2271783|P1|NOT COMPLETED|Overall Study||8
939279|NCT01390038|2271783|P1|COMPLETED|Overall Study||149
939280|NCT01390038|2271783|P1|STARTED|Overall Study||157
939281|NCT01389973|2271793|P1|NOT COMPLETED|Overall Study||20
939282|NCT01389973|2271793|P1|COMPLETED|Overall Study||0
939283|NCT01389973|2271793|P1|STARTED|Overall Study||20
939284|NCT01389882|2271803|P2|NOT COMPLETED|Overall Study||4
939285|NCT01389882|2271804|P1|NOT COMPLETED|Overall Study||1
939286|NCT01389882|2271803|P2|COMPLETED|Overall Study||7
939287|NCT01389882|2271804|P1|COMPLETED|Overall Study||12
939288|NCT01389882|2271803|P2|STARTED|Overall Study||11
939289|NCT01389882|2271804|P1|STARTED|Overall Study||13
939290|NCT01389856|2271834|P2|NOT COMPLETED|Overall Study||0
939291|NCT01389856|2271835|P1|NOT COMPLETED|Overall Study||0
939292|NCT01389856|2271834|P2|COMPLETED|Overall Study||8
939293|NCT01389856|2271835|P1|COMPLETED|Overall Study||13
939294|NCT01389856|2271834|P2|STARTED|Overall Study|Randomized and treated.|8
939295|NCT01389856|2271835|P1|STARTED|Overall Study|Randomized and treated. An additional 2 patients were randomized but not treated.|13
939296|NCT01389817|2271892|P2|NOT COMPLETED|Overall Study||0
939297|NCT01389817|2271893|P1|NOT COMPLETED|Overall Study||4
939298|NCT01389817|2271892|P2|COMPLETED|Overall Study||0
939299|NCT01389817|2271893|P1|COMPLETED|Overall Study||0
939300|NCT01389817|2271892|P2|STARTED|Overall Study||0
939301|NCT01389817|2271893|P1|STARTED|Overall Study||4
939302|NCT01389596|2271902|P3|NOT COMPLETED|Overall Study||10
939303|NCT01389596|2271903|P2|NOT COMPLETED|Overall Study||16
939304|NCT01389596|2271904|P1|NOT COMPLETED|Overall Study||10
939305|NCT01389596|2271902|P3|COMPLETED|Overall Study||84
939306|NCT01389596|2271903|P2|COMPLETED|Overall Study||81
939307|NCT01389596|2271904|P1|COMPLETED|Overall Study||94
939308|NCT01389596|2271902|P3|STARTED|Overall Study||94
939309|NCT01389596|2271903|P2|STARTED|Overall Study||97
939310|NCT01389596|2271904|P1|STARTED|Overall Study||104
939311|NCT01389323|2271963|P1|NOT COMPLETED|Follow-up Period (up to 48 Weeks)||37
939312|NCT01389323|2271963|P1|COMPLETED|Follow-up Period (up to 48 Weeks)||184
939313|NCT01389323|2271963|P1|STARTED|Follow-up Period (up to 48 Weeks)|Out of 246 participants who entered the treatment period, 221 continued in the follow-up period.|221
939314|NCT01389323|2271963|P1|NOT COMPLETED|Treatment Period (up to 48 Weeks)||95
939315|NCT01389323|2271963|P1|COMPLETED|Treatment Period (up to 48 Weeks)||151
939316|NCT01389323|2271963|P1|STARTED|Treatment Period (up to 48 Weeks)||246
939317|NCT01389284|2271986|P3|NOT COMPLETED|Overall Study||0
939318|NCT01389284|2271987|P2|NOT COMPLETED|Overall Study||0
939319|NCT01389284|2271988|P1|NOT COMPLETED|Overall Study||0
939320|NCT01389284|2271986|P3|COMPLETED|Overall Study||60
939321|NCT01389284|2271987|P2|COMPLETED|Overall Study||120
939322|NCT01389284|2271988|P1|COMPLETED|Overall Study||120
939323|NCT01389284|2271986|P3|STARTED|Overall Study||60
939324|NCT01389284|2271987|P2|STARTED|Overall Study||120
939325|NCT01389284|2271988|P1|STARTED|Overall Study||120
939326|NCT01389102|2272026|P6|NOT COMPLETED|Overall Study||8
939327|NCT01389102|2272027|P5|NOT COMPLETED|Overall Study||13
939328|NCT01389102|2272028|P4|NOT COMPLETED|Overall Study||7
939329|NCT01389102|2272029|P3|NOT COMPLETED|Overall Study||19
939330|NCT01389102|2272030|P2|NOT COMPLETED|Overall Study||12
939331|NCT01389102|2272031|P1|NOT COMPLETED|Overall Study||18
939332|NCT01389102|2272026|P6|COMPLETED|Overall Study||68
939333|NCT01389102|2272027|P5|COMPLETED|Overall Study||61
939334|NCT01389102|2272028|P4|COMPLETED|Overall Study||69
939335|NCT01389102|2272029|P3|COMPLETED|Overall Study||58
939336|NCT01389102|2272030|P2|COMPLETED|Overall Study||64
939337|NCT01389102|2272031|P1|COMPLETED|Overall Study||57
939338|NCT01389102|2272026|P6|STARTED|Overall Study||76
939339|NCT01389102|2272027|P5|STARTED|Overall Study||74
939340|NCT01389102|2272028|P4|STARTED|Overall Study||76
939341|NCT01389102|2272029|P3|STARTED|Overall Study||77
939342|NCT01389102|2272030|P2|STARTED|Overall Study||76
939343|NCT01389102|2272031|P1|STARTED|Overall Study||75
939344|NCT01389076|2272051|P1|NOT COMPLETED|Overall Study||0
939345|NCT01389076|2272051|P1|COMPLETED|Overall Study||22
939346|NCT01389076|2272051|P1|STARTED|Overall Study||22
939347|NCT01388946|2272061|P2|NOT COMPLETED|Overall Study||3
939348|NCT01388946|2272062|P1|NOT COMPLETED|Overall Study||6
939349|NCT01388946|2272061|P2|COMPLETED|Overall Study||52
939350|NCT01388946|2272062|P1|COMPLETED|Overall Study||49
939351|NCT01388946|2272061|P2|STARTED|Overall Study||55
939352|NCT01388946|2272062|P1|STARTED|Overall Study||55
939353|NCT01388920|2272097|P3|NOT COMPLETED|Overall Study||0
939354|NCT01388920|2272098|P2|NOT COMPLETED|Overall Study||0
939355|NCT01388920|2272099|P1|NOT COMPLETED|Overall Study||0
939356|NCT01388920|2272097|P3|COMPLETED|Overall Study||0
939357|NCT01388920|2272098|P2|COMPLETED|Overall Study||1
939358|NCT01388920|2272099|P1|COMPLETED|Overall Study||1
939359|NCT01388920|2272097|P3|STARTED|Overall Study||0
939360|NCT01388920|2272098|P2|STARTED|Overall Study||1
939361|NCT01388920|2272099|P1|STARTED|Overall Study||1
939362|NCT01388907|2272109|P2|NOT COMPLETED|Overall Study||0
939363|NCT01388907|2272110|P1|NOT COMPLETED|Overall Study||2
939364|NCT01388907|2272109|P2|COMPLETED|Overall Study||28
939365|NCT01388907|2272110|P1|COMPLETED|Overall Study||31
939366|NCT01388907|2272109|P2|STARTED|Overall Study||28
939367|NCT01388907|2272110|P1|STARTED|Overall Study||33
939368|NCT01388816|2272126|P4|NOT COMPLETED|Overall Study||0
939369|NCT01388816|2272127|P3|NOT COMPLETED|Overall Study||3
939370|NCT01388816|2272128|P2|NOT COMPLETED|Overall Study||4
939371|NCT01388816|2272129|P1|NOT COMPLETED|Overall Study||2
939372|NCT01388816|2272126|P4|COMPLETED|Overall Study||44
939373|NCT01388816|2272127|P3|COMPLETED|Overall Study||41
939374|NCT01388816|2272128|P2|COMPLETED|Overall Study||39
939375|NCT01388816|2272129|P1|COMPLETED|Overall Study||43
939376|NCT01388816|2272126|P4|STARTED|Overall Study||44
939377|NCT01388816|2272127|P3|STARTED|Overall Study||44
939378|NCT01388816|2272128|P2|STARTED|Overall Study||43
939379|NCT01388816|2272129|P1|STARTED|Overall Study||45
939380|NCT01388790|2272158|P1|NOT COMPLETED|Overall Study||8
939381|NCT01388790|2272158|P1|COMPLETED|Overall Study||32
939382|NCT01388790|2272158|P1|STARTED|Overall Study||40
939383|NCT01388647|2272165|P2|NOT COMPLETED|Overall Study||2
939384|NCT01388647|2272166|P1|NOT COMPLETED|Overall Study||1
939385|NCT01388647|2272165|P2|COMPLETED|Overall Study|two subjects ended study treatment due to adverse events|4
939386|NCT01388647|2272166|P1|COMPLETED|Overall Study|one subject ended study treatment due to adverse events|5
939387|NCT01388647|2272165|P2|STARTED|Overall Study||6
939388|NCT01388647|2272166|P1|STARTED|Overall Study||6
939389|NCT01388530|2272177|P1|NOT COMPLETED|Overall Study||5
939390|NCT01388530|2272177|P1|COMPLETED|Overall Study||20
939391|NCT01388530|2272177|P1|STARTED|Overall Study||25
939392|NCT01388491|2272186|P2|NOT COMPLETED|Overall Study||29
939393|NCT01388491|2272187|P1|NOT COMPLETED|Overall Study||34
939394|NCT01388491|2272186|P2|COMPLETED|Overall Study||114
939395|NCT01388491|2272187|P1|COMPLETED|Overall Study||116
939396|NCT01388491|2272186|P2|Per Protocol (PP) Population|Overall Study||121
939397|NCT01388491|2272187|P1|Per Protocol (PP) Population|Overall Study|PP: all data from ITT participants obtained prior to any major protocol violations|125
939398|NCT01388491|2272186|P2|Intent-to-Treat (ITT) Population|Overall Study||136
939399|NCT01388491|2272187|P1|Intent-to-Treat (ITT) Population|Overall Study|ITT:participants in safety population with baseline (BL) + ≥1 post-BL prothrombin fragment 1+2 value|140
939400|NCT01388491|2272186|P2|Safety Population|Overall Study||142
939401|NCT01388491|2272187|P1|Safety Population|Overall Study|Safety: all randomized participants who took 1 or more doses of study drug|145
939402|NCT01388491|2272186|P2|STARTED|Overall Study||143
939403|NCT01388491|2272187|P1|STARTED|Overall Study|number randomized|150
939404|NCT01388361|2272222|P3|NOT COMPLETED|Overall Study||14
939405|NCT01388361|2272223|P2|NOT COMPLETED|Overall Study||12
939406|NCT01388361|2272224|P1|NOT COMPLETED|Overall Study||12
939407|NCT01388361|2272222|P3|COMPLETED|Overall Study||75
939408|NCT01388361|2272223|P2|COMPLETED|Overall Study||76
939409|NCT01388361|2272224|P1|COMPLETED|Overall Study||224
939410|NCT01388361|2272222|P3|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug.|86
939411|NCT01388361|2272223|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|87
939412|NCT01388361|2272224|P1|Exposed|Overall Study|Two subjects withdrew prior to exposure to IDeg during NN1250-3948|234
939413|NCT01388361|2272222|P3|STARTED|Overall Study||89
939414|NCT01388361|2272223|P2|STARTED|Overall Study||88
939415|NCT01388361|2272224|P1|STARTED|Overall Study||236
939416|NCT01388166|2272241|P1|NOT COMPLETED|Overall Study||59
939417|NCT01388166|2272241|P1|COMPLETED|Overall Study||1194
939418|NCT01388166|2272241|P1|STARTED|Overall Study||1253
939419|NCT01387789|2272247|P1|NOT COMPLETED|Overall Study||8
939420|NCT01387789|2272247|P1|COMPLETED|Overall Study||63
939421|NCT01387789|2272247|P1|STARTED|Overall Study||71
939422|NCT01387737|2272261|P2|NOT COMPLETED|Overall Study||74
939423|NCT01387737|2272262|P1|NOT COMPLETED|Overall Study||52
939424|NCT01387737|2272261|P2|COMPLETED|Overall Study||641
939425|NCT01387737|2272262|P1|COMPLETED|Overall Study||532
939426|NCT01387737|2272261|P2|STARTED|Overall Study||715
939427|NCT01387737|2272262|P1|STARTED|Overall Study||584
939428|NCT01387672|2272274|P6|NOT COMPLETED|Overall Study||0
939429|NCT01387672|2272275|P5|NOT COMPLETED|Overall Study||4
939430|NCT01387672|2272276|P4|NOT COMPLETED|Overall Study||4
939431|NCT01387672|2272277|P3|NOT COMPLETED|Overall Study||5
939432|NCT01387672|2272278|P2|NOT COMPLETED|Overall Study||7
939433|NCT01387672|2272279|P1|NOT COMPLETED|Overall Study||7
939434|NCT01387672|2272274|P6|COMPLETED|Overall Study||37
939435|NCT01387672|2272275|P5|COMPLETED|Overall Study||34
939436|NCT01387672|2272276|P4|COMPLETED|Overall Study||35
939437|NCT01387672|2272277|P3|COMPLETED|Overall Study||33
939438|NCT01387672|2272278|P2|COMPLETED|Overall Study||31
939439|NCT01387672|2272279|P1|COMPLETED|Overall Study||32
939440|NCT01387672|2272274|P6|STARTED|Overall Study||37
939441|NCT01387672|2272275|P5|STARTED|Overall Study||38
939442|NCT01387672|2272276|P4|STARTED|Overall Study||39
939443|NCT01387672|2272277|P3|STARTED|Overall Study||38
939444|NCT01387672|2272278|P2|STARTED|Overall Study||38
939445|NCT01387672|2272279|P1|STARTED|Overall Study||39
939446|NCT01387594|2272296|P2|NOT COMPLETED|Overall Study||3
939447|NCT01387594|2272297|P1|NOT COMPLETED|Overall Study||0
939448|NCT01387594|2272296|P2|COMPLETED|Overall Study||36
939449|NCT01387594|2272297|P1|COMPLETED|Overall Study||10
939450|NCT01387594|2272296|P2|STARTED|Overall Study||39
939451|NCT01387594|2272297|P1|STARTED|Overall Study||10
939452|NCT01387581|2272312|P3|NOT COMPLETED|Overall Study||3
939453|NCT01387581|2272313|P2|NOT COMPLETED|Overall Study||6
939454|NCT01387581|2272314|P1|NOT COMPLETED|Overall Study||7
939455|NCT01387581|2272312|P3|COMPLETED|Overall Study||9
939456|NCT01387581|2272313|P2|COMPLETED|Overall Study||101
939457|NCT01387581|2272314|P1|COMPLETED|Overall Study||101
939458|NCT01387581|2272312|P3|STARTED|Overall Study||12
939459|NCT01387581|2272313|P2|STARTED|Overall Study||107
939460|NCT01387581|2272314|P1|STARTED|Overall Study||108
939461|NCT01387542|2272325|P1|NOT COMPLETED|Overall Study||8
939462|NCT01387542|2272325|P1|COMPLETED|Overall Study||32
939463|NCT01387542|2272325|P1|Treated|Overall Study||38
939464|NCT01387542|2272325|P1|STARTED|Overall Study||40
939465|NCT01387464|2272334|P2|NOT COMPLETED|Overall Study||1
939466|NCT01387464|2272335|P1|NOT COMPLETED|Overall Study||1
939467|NCT01387464|2272334|P2|COMPLETED|Overall Study||29
939468|NCT01387464|2272335|P1|COMPLETED|Overall Study||29
939469|NCT01387464|2272334|P2|Per-Protocol Population|Overall Study||29
939470|NCT01387464|2272335|P1|Per-Protocol Population|Overall Study|Safety subjects who completed surgery|29
939471|NCT01387464|2272334|P2|Safety Population|Overall Study||29
939472|NCT01387464|2272335|P1|Safety Population|Overall Study||30
939473|NCT01387464|2272334|P2|STARTED|Overall Study||30
939474|NCT01387464|2272335|P1|STARTED|Overall Study||30
939475|NCT01387347|2272343|P2|NOT COMPLETED|Overall Study||1
939476|NCT01387347|2272344|P1|NOT COMPLETED|Overall Study||2
939477|NCT01387347|2272343|P2|COMPLETED|Overall Study||35
939478|NCT01387347|2272344|P1|COMPLETED|Overall Study||34
939479|NCT01387347|2272343|P2|STARTED|Overall Study||36
939480|NCT01387347|2272344|P1|STARTED|Overall Study||36
939505|NCT01387230|2272391|P3|NOT COMPLETED|Overall Study||13
939506|NCT01387230|2272392|P2|NOT COMPLETED|Overall Study||7
939507|NCT01387230|2272393|P1|NOT COMPLETED|Overall Study||18
939508|NCT01387230|2272391|P3|COMPLETED|Overall Study||56
939509|NCT01387230|2272392|P2|COMPLETED|Overall Study||62
939510|NCT01387230|2272393|P1|COMPLETED|Overall Study||50
939511|NCT01387230|2272391|P3|STARTED|Overall Study||69
939512|NCT01387230|2272392|P2|STARTED|Overall Study||69
939513|NCT01387230|2272393|P1|STARTED|Overall Study||68
939514|NCT01387178|2272409|P2|NOT COMPLETED|Overall Study||0
939515|NCT01387178|2272410|P1|NOT COMPLETED|Overall Study||0
939516|NCT01387178|2272409|P2|COMPLETED|Overall Study||10641
939517|NCT01387178|2272410|P1|COMPLETED|Overall Study||11582
939518|NCT01387178|2272409|P2|STARTED|Overall Study||10641
939519|NCT01387178|2272410|P1|STARTED|Overall Study||11582
939520|NCT01387139|2272422|P2|NOT COMPLETED|Overall Study||0
939521|NCT01387139|2272423|P1|NOT COMPLETED|Overall Study||0
939522|NCT01387139|2272422|P2|COMPLETED|Overall Study||84
939523|NCT01387139|2272423|P1|COMPLETED|Overall Study||99
939524|NCT01387139|2272422|P2|STARTED|Overall Study||84
939525|NCT01387139|2272423|P1|STARTED|Overall Study||99
939526|NCT01387074|2272439|P1|NOT COMPLETED|Overall Study||8
939527|NCT01387074|2272439|P1|COMPLETED|Overall Study||100
939528|NCT01387074|2272439|P1|STARTED|Overall Study||108
939529|NCT01387022|2272452|P2|NOT COMPLETED|Overall Study||4
939530|NCT01387022|2272453|P1|NOT COMPLETED|Overall Study||1
939531|NCT01387022|2272452|P2|COMPLETED|Overall Study||26
939532|NCT01387022|2272453|P1|COMPLETED|Overall Study||28
939533|NCT01387022|2272452|P2|STARTED|Overall Study||30
939534|NCT01387022|2272453|P1|STARTED|Overall Study||29
939535|NCT01386983|2272471|P2|NOT COMPLETED|Overall Study||0
939536|NCT01386983|2272472|P1|NOT COMPLETED|Overall Study||0
939537|NCT01386983|2272471|P2|COMPLETED|Overall Study||68
939538|NCT01386983|2272472|P1|COMPLETED|Overall Study||264
939539|NCT01386983|2272471|P2|STARTED|Overall Study||68
939540|NCT01386983|2272472|P1|STARTED|Overall Study||264
939541|NCT01386944|2272480|P1|NOT COMPLETED|Overall Study||56
939542|NCT01386944|2272480|P1|COMPLETED|Overall Study||46
939543|NCT01386944|2272480|P1|STARTED|Overall Study||102
939544|NCT01386788|2272490|P1|NOT COMPLETED|Overall Study||2
939545|NCT01386788|2272490|P1|COMPLETED|Overall Study||100
939546|NCT01386788|2272490|P1|STARTED|Overall Study||102
939547|NCT01386632|2272497|P2|NOT COMPLETED|Overall Study||4
939548|NCT01386632|2272498|P1|NOT COMPLETED|Overall Study||5
939549|NCT01386632|2272497|P2|COMPLETED|Overall Study||21
939550|NCT01386632|2272498|P1|COMPLETED|Overall Study||20
939551|NCT01386632|2272497|P2|STARTED|Overall Study||25
939552|NCT01386632|2272498|P1|STARTED|Overall Study||25
939553|NCT01386606|2272510|P4|NOT COMPLETED|Overall Study||1
939554|NCT01386606|2272511|P3|NOT COMPLETED|Overall Study||3
939555|NCT01386606|2272512|P2|NOT COMPLETED|Overall Study||4
939556|NCT01386606|2272513|P1|NOT COMPLETED|Overall Study||4
939557|NCT01386606|2272510|P4|COMPLETED|Overall Study||13
939558|NCT01386606|2272511|P3|COMPLETED|Overall Study||13
939559|NCT01386606|2272512|P2|COMPLETED|Overall Study||10
939560|NCT01386606|2272513|P1|COMPLETED|Overall Study||12
939561|NCT01386606|2272510|P4|STARTED|Overall Study||14
939562|NCT01386606|2272511|P3|STARTED|Overall Study||16
939563|NCT01386606|2272512|P2|STARTED|Overall Study||14
939564|NCT01386606|2272513|P1|STARTED|Overall Study||16
939565|NCT01386528|2272541|P1|NOT COMPLETED|Overall Study||0
939566|NCT01386528|2272541|P1|COMPLETED|Overall Study||13
939567|NCT01386528|2272541|P1|STARTED|Overall Study||13
939568|NCT01386125|2272553|P2|NOT COMPLETED|Overall Study||37
939569|NCT01386125|2272554|P1|NOT COMPLETED|Overall Study||25
939570|NCT01386125|2272553|P2|COMPLETED|Overall Study||336
939571|NCT01386125|2272554|P1|COMPLETED|Overall Study||350
939572|NCT01386125|2272553|P2|STARTED|Overall Study||373
939573|NCT01386125|2272554|P1|STARTED|Overall Study||375
939574|NCT01386008|2272562|P1|NOT COMPLETED|Overall Study||20
939575|NCT01386008|2272562|P1|COMPLETED|Overall Study||0
939576|NCT01386008|2272562|P1|STARTED|Overall Study||20
939577|NCT01385995|2272571|P2|NOT COMPLETED|Period 2, 2 Months||0
939578|NCT01385995|2272572|P1|NOT COMPLETED|Period 2, 2 Months||0
939579|NCT01385995|2272571|P2|COMPLETED|Period 2, 2 Months||25
939580|NCT01385995|2272572|P1|COMPLETED|Period 2, 2 Months||24
939581|NCT01385995|2272571|P2|STARTED|Period 2, 2 Months||25
939582|NCT01385995|2272572|P1|STARTED|Period 2, 2 Months||24
939583|NCT01385995|2272571|P2|NOT COMPLETED|Washout Period, 1 Month||0
939584|NCT01385995|2272572|P1|NOT COMPLETED|Washout Period, 1 Month||0
939585|NCT01385995|2272571|P2|COMPLETED|Washout Period, 1 Month||25
939586|NCT01385995|2272572|P1|COMPLETED|Washout Period, 1 Month||24
939587|NCT01385995|2272571|P2|STARTED|Washout Period, 1 Month||25
939588|NCT01385995|2272572|P1|STARTED|Washout Period, 1 Month||24
939589|NCT01385995|2272571|P2|NOT COMPLETED|Period 1, 2 Months||0
939590|NCT01385995|2272572|P1|NOT COMPLETED|Period 1, 2 Months||1
939591|NCT01385995|2272571|P2|COMPLETED|Period 1, 2 Months||25
939592|NCT01385995|2272572|P1|COMPLETED|Period 1, 2 Months||24
939593|NCT01385995|2272571|P2|STARTED|Period 1, 2 Months||25
939594|NCT01385995|2272572|P1|STARTED|Period 1, 2 Months||25
939595|NCT01385748|2272589|P3|NOT COMPLETED|Overall Study||13
939596|NCT01385748|2272590|P2|NOT COMPLETED|Overall Study||14
939597|NCT01385748|2272591|P1|NOT COMPLETED|Overall Study||15
939598|NCT01385748|2272589|P3|COMPLETED|Overall Study||49
939599|NCT01385748|2272590|P2|COMPLETED|Overall Study||51
939600|NCT01385748|2272591|P1|COMPLETED|Overall Study||41
939601|NCT01385748|2272589|P3|STARTED|Overall Study||62
939602|NCT01385748|2272590|P2|STARTED|Overall Study||65
939603|NCT01385748|2272591|P1|STARTED|Overall Study||56
939604|NCT01385696|2272632|P2|NOT COMPLETED|Overall Study||0
939605|NCT01385696|2272633|P1|NOT COMPLETED|Overall Study||0
939606|NCT01385696|2272632|P2|COMPLETED|Overall Study||64
939607|NCT01385696|2272633|P1|COMPLETED|Overall Study||66
939608|NCT01385696|2272632|P2|STARTED|Overall Study|1 patient used Handihaler® once only, Genuair® zero times, & was excluded from the safety population|64
939609|NCT01385696|2272633|P1|STARTED|Overall Study||66
939610|NCT01385644|2272644|P2|NOT COMPLETED|Overall Study||0
939611|NCT01385644|2272645|P1|NOT COMPLETED|Overall Study||0
939612|NCT01385644|2272644|P2|COMPLETED|Overall Study||4
939613|NCT01385644|2272645|P1|COMPLETED|Overall Study||4
939614|NCT01385644|2272644|P2|STARTED|Overall Study||4
939615|NCT01385644|2272645|P1|STARTED|Overall Study||4
939616|NCT01385579|2272659|P2|NOT COMPLETED|Overall Study||0
939617|NCT01385579|2272660|P1|NOT COMPLETED|Overall Study||0
939618|NCT01385579|2272659|P2|COMPLETED|Overall Study||104
939619|NCT01385579|2272660|P1|COMPLETED|Overall Study||98
939620|NCT01385579|2272659|P2|STARTED|Overall Study||104
939621|NCT01385579|2272660|P1|STARTED|Overall Study||98
939622|NCT01385566|2272672|P6|NOT COMPLETED|Overall Study||0
939623|NCT01385566|2272673|P5|NOT COMPLETED|Overall Study||0
939624|NCT01385566|2272674|P4|NOT COMPLETED|Overall Study||1
939625|NCT01385566|2272675|P3|NOT COMPLETED|Overall Study||0
939626|NCT01385566|2272676|P2|NOT COMPLETED|Overall Study||0
939627|NCT01385566|2272677|P1|NOT COMPLETED|Overall Study||1
939628|NCT01385566|2272672|P6|COMPLETED|Overall Study||34
939629|NCT01385566|2272673|P5|COMPLETED|Overall Study||34
939630|NCT01385566|2272674|P4|COMPLETED|Overall Study||34
939631|NCT01385566|2272675|P3|COMPLETED|Overall Study||34
939632|NCT01385566|2272676|P2|COMPLETED|Overall Study||34
939633|NCT01385566|2272677|P1|COMPLETED|Overall Study||51
939634|NCT01385566|2272672|P6|STARTED|Overall Study||34
939635|NCT01385566|2272673|P5|STARTED|Overall Study||34
939636|NCT01385566|2272674|P4|STARTED|Overall Study||35
939637|NCT01385566|2272675|P3|STARTED|Overall Study||34
939638|NCT01385566|2272676|P2|STARTED|Overall Study||34
939639|NCT01385566|2272677|P1|STARTED|Overall Study||52
939640|NCT01385371|2272731|P2|NOT COMPLETED|Overall Study||97
939641|NCT01385371|2272732|P1|NOT COMPLETED|Overall Study||149
939642|NCT01385371|2272731|P2|COMPLETED|Overall Study||652
939643|NCT01385371|2272732|P1|COMPLETED|Overall Study||603
939644|NCT01385371|2272731|P2|STARTED|Overall Study||749
939645|NCT01385371|2272732|P1|STARTED|Overall Study||752
939646|NCT01385293|2272752|P1|NOT COMPLETED|Overall Study||0
939647|NCT01385293|2272752|P1|COMPLETED|Overall Study||30
939648|NCT01385293|2272752|P1|STARTED|Overall Study||30
939649|NCT01385202|2272762|P1|NOT COMPLETED|Overall Study||18
939650|NCT01385202|2272762|P1|COMPLETED|Overall Study||154
939651|NCT01385202|2272762|P1|Undergoing Ablation|Overall Study||160
939652|NCT01385202|2272762|P1|Study Catheter Inserted|Overall Study||161
939653|NCT01385202|2272762|P1|STARTED|Overall Study|Per protocol, enrolled subjects were defined as those who signed inform consent form.|172
939654|NCT01385189|2272774|P5|NOT COMPLETED|Overall Study||2
939655|NCT01385189|2272775|P4|NOT COMPLETED|Overall Study||1
939656|NCT01385189|2272776|P3|NOT COMPLETED|Overall Study||0
939657|NCT01385189|2272777|P2|NOT COMPLETED|Overall Study||1
939658|NCT01385189|2272778|P1|NOT COMPLETED|Overall Study||1
939659|NCT01385189|2272774|P5|COMPLETED|Overall Study||6
939660|NCT01385189|2272775|P4|COMPLETED|Overall Study||3
939661|NCT01385189|2272776|P3|COMPLETED|Overall Study||4
939662|NCT01385189|2272777|P2|COMPLETED|Overall Study||11
939663|NCT01385189|2272778|P1|COMPLETED|Overall Study||11
939664|NCT01385189|2272774|P5|STARTED|Overall Study||8
939665|NCT01385189|2272775|P4|STARTED|Overall Study||4
939666|NCT01385189|2272776|P3|STARTED|Overall Study||4
939667|NCT01385189|2272777|P2|STARTED|Overall Study||12
939668|NCT01385189|2272778|P1|STARTED|Overall Study||12
939669|NCT01385137|2272799|P2|NOT COMPLETED|Evaluable for Primary Endpoint||24
939670|NCT01385137|2272800|P1|NOT COMPLETED|Evaluable for Primary Endpoint||29
939671|NCT01385137|2272799|P2|COMPLETED|Evaluable for Primary Endpoint||107
939672|NCT01385137|2272800|P1|COMPLETED|Evaluable for Primary Endpoint||102
939673|NCT01385137|2272799|P2|STARTED|Evaluable for Primary Endpoint||131
939674|NCT01385137|2272800|P1|STARTED|Evaluable for Primary Endpoint||131
939675|NCT01385137|2272799|P2|NOT COMPLETED|Evaluable at Baseline||4
939676|NCT01385137|2272800|P1|NOT COMPLETED|Evaluable at Baseline||9
939677|NCT01385137|2272799|P2|COMPLETED|Evaluable at Baseline||127
939678|NCT01385137|2272800|P1|COMPLETED|Evaluable at Baseline||122
939679|NCT01385137|2272799|P2|STARTED|Evaluable at Baseline||131
939680|NCT01385137|2272800|P1|STARTED|Evaluable at Baseline||131
939681|NCT01385033|2272816|P6|NOT COMPLETED|Part III||0
939682|NCT01385033|2272817|P5|NOT COMPLETED|Part III||0
939683|NCT01385033|2272818|P4|NOT COMPLETED|Part III||0
939684|NCT01385033|2272819|P3|NOT COMPLETED|Part III||0
939685|NCT01385033|2272820|P2|NOT COMPLETED|Part III||0
939686|NCT01385033|2272821|P1|NOT COMPLETED|Part III||0
939687|NCT01385033|2272816|P6|COMPLETED|Part III||0
939688|NCT01385033|2272817|P5|COMPLETED|Part III||0
939689|NCT01385033|2272818|P4|COMPLETED|Part III||0
939690|NCT01385033|2272819|P3|COMPLETED|Part III||0
939691|NCT01385033|2272820|P2|COMPLETED|Part III||0
939692|NCT01385033|2272821|P1|COMPLETED|Part III||0
939693|NCT01385033|2272816|P6|STARTED|Part III||0
939694|NCT01385033|2272817|P5|STARTED|Part III||0
939695|NCT01385033|2272818|P4|STARTED|Part III||0
939696|NCT01385033|2272819|P3|STARTED|Part III||0
939697|NCT01385033|2272820|P2|STARTED|Part III||0
939698|NCT01385033|2272821|P1|STARTED|Part III||0
939699|NCT01385033|2272816|P6|NOT COMPLETED|Part II||0
939700|NCT01385033|2272817|P5|NOT COMPLETED|Part II||0
939701|NCT01385033|2272818|P4|NOT COMPLETED|Part II||0
939702|NCT01385033|2272819|P3|NOT COMPLETED|Part II||0
939703|NCT01385033|2272820|P2|NOT COMPLETED|Part II||0
939704|NCT01385033|2272821|P1|NOT COMPLETED|Part II||0
939705|NCT01385033|2272816|P6|COMPLETED|Part II||0
939706|NCT01385033|2272817|P5|COMPLETED|Part II||0
939707|NCT01385033|2272818|P4|COMPLETED|Part II||0
939708|NCT01385033|2272819|P3|COMPLETED|Part II||0
939709|NCT01385033|2272820|P2|COMPLETED|Part II||0
939710|NCT01385033|2272821|P1|COMPLETED|Part II||0
939711|NCT01385033|2272816|P6|STARTED|Part II||0
939712|NCT01385033|2272817|P5|STARTED|Part II||0
939713|NCT01385033|2272818|P4|STARTED|Part II||0
939714|NCT01385033|2272819|P3|STARTED|Part II||0
939715|NCT01385033|2272820|P2|STARTED|Part II||0
939716|NCT01385033|2272821|P1|STARTED|Part II||0
939717|NCT01385033|2272816|P6|NOT COMPLETED|Part I||0
939718|NCT01385033|2272817|P5|NOT COMPLETED|Part I||0
939719|NCT01385033|2272818|P4|NOT COMPLETED|Part I||0
939720|NCT01385033|2272819|P3|NOT COMPLETED|Part I||0
939721|NCT01385033|2272820|P2|NOT COMPLETED|Part I||0
939722|NCT01385033|2272821|P1|NOT COMPLETED|Part I||0
939723|NCT01385033|2272816|P6|COMPLETED|Part I||0
939724|NCT01385033|2272817|P5|COMPLETED|Part I||0
939725|NCT01385033|2272818|P4|COMPLETED|Part I||0
939726|NCT01385033|2272819|P3|COMPLETED|Part I||0
939727|NCT01385033|2272820|P2|COMPLETED|Part I||14
939728|NCT01385033|2272821|P1|COMPLETED|Part I||6
939729|NCT01385033|2272816|P6|STARTED|Part I||0
939730|NCT01385033|2272817|P5|STARTED|Part I||0
939731|NCT01385033|2272818|P4|STARTED|Part I||0
939732|NCT01385033|2272819|P3|STARTED|Part I||0
939733|NCT01385033|2272820|P2|STARTED|Part I|These subjects did not participate in Part II or III|14
939734|NCT01385033|2272821|P1|STARTED|Part I|These subjects did not participate in Part II or III|6
939735|NCT01384760|2272830|P2|NOT COMPLETED|Overall Study||6
939736|NCT01384760|2272831|P1|NOT COMPLETED|Overall Study||16
939737|NCT01384760|2272830|P2|COMPLETED|Overall Study||37
939738|NCT01384760|2272831|P1|COMPLETED|Overall Study||45
939739|NCT01384760|2272830|P2|Randomized|Overall Study||43
939740|NCT01384760|2272831|P1|Randomized|Overall Study||61
939741|NCT01384760|2272830|P2|STARTED|Overall Study||43
939742|NCT01384760|2272831|P1|STARTED|Overall Study||61
939743|NCT01384539|2272841|P2|NOT COMPLETED|Overall Study||7
939744|NCT01384539|2272842|P1|NOT COMPLETED|Overall Study||6
939745|NCT01384539|2272841|P2|COMPLETED|Overall Study||57
939746|NCT01384539|2272842|P1|COMPLETED|Overall Study||58
939747|NCT01384539|2272841|P2|STARTED|Overall Study||64
939748|NCT01384539|2272842|P1|STARTED|Overall Study||64
939749|NCT01384292|2272851|P3|NOT COMPLETED|Part B||0
939750|NCT01384292|2272852|P2|NOT COMPLETED|Part B||0
939751|NCT01384292|2272853|P1|NOT COMPLETED|Part B||1
939752|NCT01384292|2272851|P3|COMPLETED|Part B||0
939753|NCT01384292|2272852|P2|COMPLETED|Part B||6
939754|NCT01384292|2272853|P1|COMPLETED|Part B||2
939755|NCT01384292|2272851|P3|STARTED|Part B||0
939756|NCT01384292|2272852|P2|STARTED|Part B||6
939757|NCT01384292|2272853|P1|STARTED|Part B||3
939758|NCT01384292|2272851|P3|NOT COMPLETED|Part A||0
939759|NCT01384292|2272852|P2|NOT COMPLETED|Part A||0
939760|NCT01384292|2272853|P1|NOT COMPLETED|Part A||0
939761|NCT01384292|2272851|P3|COMPLETED|Part A||4
939762|NCT01384292|2272852|P2|COMPLETED|Part A||5
939763|NCT01384292|2272853|P1|COMPLETED|Part A||5
939764|NCT01384292|2272851|P3|STARTED|Part A||4
939765|NCT01384292|2272852|P2|STARTED|Part A||5
939766|NCT01384292|2272853|P1|STARTED|Part A||5
939767|NCT01384019|2272865|P2|NOT COMPLETED|Overall Study||6
939768|NCT01384019|2272866|P1|NOT COMPLETED|Overall Study||10
939769|NCT01384019|2272865|P2|COMPLETED|Overall Study||55
939770|NCT01384019|2272866|P1|COMPLETED|Overall Study||55
939771|NCT01384019|2272865|P2|STARTED|Overall Study||61
939772|NCT01384019|2272866|P1|STARTED|Overall Study||65
939773|NCT01383993|2272875|P3|NOT COMPLETED|Overall Study||1
939774|NCT01383993|2272876|P2|NOT COMPLETED|Overall Study||1
939775|NCT01383993|2272877|P1|NOT COMPLETED|Overall Study||3
939776|NCT01383993|2272875|P3|COMPLETED|Overall Study||1
939777|NCT01383993|2272876|P2|COMPLETED|Overall Study||3
939778|NCT01383993|2272877|P1|COMPLETED|Overall Study||12
939779|NCT01383993|2272875|P3|STARTED|Overall Study||2
939780|NCT01383993|2272876|P2|STARTED|Overall Study||4
939781|NCT01383993|2272877|P1|STARTED|Overall Study||15
939782|NCT01383954|2272924|P1|NOT COMPLETED|Overall Study||14
939783|NCT01383954|2272924|P1|COMPLETED|Overall Study||38
939784|NCT01383954|2272924|P1|Safety Population: Received Treatment|Overall Study||48
939785|NCT01383954|2272924|P1|STARTED|Overall Study||52
939804|NCT01383720|2272976|P1|NOT COMPLETED|Overall Study||0
939805|NCT01383720|2272976|P1|COMPLETED|Overall Study|Study is continuing to 5 years. All patients are still in the study.|11
939806|NCT01383720|2272976|P1|Primary Endpoint (Discharge/7 Days)|Overall Study||11
939807|NCT01383720|2272976|P1|STARTED|Overall Study||11
939808|NCT01383707|2272998|P1|NOT COMPLETED|Overall Study||72
939809|NCT01383707|2272998|P1|COMPLETED|Overall Study||5
939810|NCT01383707|2272998|P1|STARTED|Overall Study||77
939811|NCT01383681|2273007|P1|NOT COMPLETED|Overall Study||46
939812|NCT01383681|2273007|P1|COMPLETED|Overall Study||189
939813|NCT01383681|2273007|P1|STARTED|Overall Study||235
939814|NCT01383616|2273014|P2|NOT COMPLETED|Overall Study||23
939815|NCT01383616|2273015|P1|NOT COMPLETED|Overall Study||17
939816|NCT01383616|2273014|P2|COMPLETED|Overall Study||21
939817|NCT01383616|2273015|P1|COMPLETED|Overall Study||23
939818|NCT01383616|2273014|P2|STARTED|Overall Study||44
939819|NCT01383616|2273015|P1|STARTED|Overall Study||40
939820|NCT01383499|2273038|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
939821|NCT01383499|2273039|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
939822|NCT01383499|2273040|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
939823|NCT01383499|2273041|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
939824|NCT01383499|2273038|P4|COMPLETED|Period 3 (4 Weeks)||25
939825|NCT01383499|2273039|P3|COMPLETED|Period 3 (4 Weeks)||25
939826|NCT01383499|2273040|P2|COMPLETED|Period 3 (4 Weeks)||24
939827|NCT01383499|2273041|P1|COMPLETED|Period 3 (4 Weeks)||26
939828|NCT01383499|2273038|P4|STARTED|Period 3 (4 Weeks)||25
939829|NCT01383499|2273039|P3|STARTED|Period 3 (4 Weeks)||25
939830|NCT01383499|2273040|P2|STARTED|Period 3 (4 Weeks)||24
939831|NCT01383499|2273041|P1|STARTED|Period 3 (4 Weeks)||26
939832|NCT01383499|2273038|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
939833|NCT01383499|2273039|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
939834|NCT01383499|2273040|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
939835|NCT01383499|2273041|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
939836|NCT01383499|2273038|P4|COMPLETED|Period 2 (4 Weeks)||25
939837|NCT01383499|2273039|P3|COMPLETED|Period 2 (4 Weeks)||25
939838|NCT01383499|2273040|P2|COMPLETED|Period 2 (4 Weeks)||24
939839|NCT01383499|2273041|P1|COMPLETED|Period 2 (4 Weeks)||26
939840|NCT01383499|2273038|P4|STARTED|Period 2 (4 Weeks)||25
939841|NCT01383499|2273039|P3|STARTED|Period 2 (4 Weeks)||25
939842|NCT01383499|2273040|P2|STARTED|Period 2 (4 Weeks)||24
939843|NCT01383499|2273041|P1|STARTED|Period 2 (4 Weeks)||26
939844|NCT01383499|2273038|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
939845|NCT01383499|2273039|P3|NOT COMPLETED|Period 1 (4 Weeks)||0
939846|NCT01383499|2273040|P2|NOT COMPLETED|Period 1 (4 Weeks)||0
939847|NCT01383499|2273041|P1|NOT COMPLETED|Period 1 (4 Weeks)||1
939848|NCT01383499|2273038|P4|COMPLETED|Period 1 (4 Weeks)||25
939849|NCT01383499|2273039|P3|COMPLETED|Period 1 (4 Weeks)||25
939850|NCT01383499|2273040|P2|COMPLETED|Period 1 (4 Weeks)||24
939851|NCT01383499|2273041|P1|COMPLETED|Period 1 (4 Weeks)||26
939852|NCT01383499|2273038|P4|STARTED|Period 1 (4 Weeks)||25
939853|NCT01383499|2273039|P3|STARTED|Period 1 (4 Weeks)||25
939854|NCT01383499|2273040|P2|STARTED|Period 1 (4 Weeks)||24
939855|NCT01383499|2273041|P1|STARTED|Period 1 (4 Weeks)||27
939856|NCT01383486|2273091|P1|NOT COMPLETED|Overall Study||18
939857|NCT01383486|2273091|P1|COMPLETED|Overall Study|Took any study medication and gave estimated duration of pain (Selection Evaluation Population)|235
939858|NCT01383486|2273091|P1|Treated|Overall Study|Number of participants who took any study medication (Safety Population)|237
939859|NCT01383486|2273091|P1|STARTED|Overall Study|Number of participants who were provided with investigational products|253
939860|NCT01383447|2273097|P1|NOT COMPLETED|Overall Study||2
939861|NCT01383447|2273097|P1|COMPLETED|Overall Study||0
939862|NCT01383447|2273097|P1|STARTED|Overall Study||2
939863|NCT01383421|2273105|P1|NOT COMPLETED|Overall Study||346
939864|NCT01383421|2273105|P1|COMPLETED|Overall Study||679
939865|NCT01383421|2273105|P1|STARTED|Overall Study|ITT population: all enrolled participants who received at least 1 dose of study drug.|1025
939866|NCT01383356|2273168|P2|NOT COMPLETED|Period 2||0
939867|NCT01383356|2273169|P1|NOT COMPLETED|Period 2||0
939868|NCT01383356|2273168|P2|COMPLETED|Period 2|Completed period 2.|23
939869|NCT01383356|2273169|P1|COMPLETED|Period 2|Completed period 2.|21
939870|NCT01383356|2273168|P2|STARTED|Period 2|Entered and treated.|23
939871|NCT01383356|2273169|P1|STARTED|Period 2|Entered and treated.|21
939872|NCT01383356|2273168|P2|NOT COMPLETED|Washout Period (at Least 35 Days)||0
939873|NCT01383356|2273169|P1|NOT COMPLETED|Washout Period (at Least 35 Days)||0
939874|NCT01383356|2273168|P2|COMPLETED|Washout Period (at Least 35 Days)||23
939875|NCT01383356|2273169|P1|COMPLETED|Washout Period (at Least 35 Days)||21
939876|NCT01383356|2273168|P2|STARTED|Washout Period (at Least 35 Days)||23
939877|NCT01383356|2273169|P1|STARTED|Washout Period (at Least 35 Days)||21
939878|NCT01383356|2273168|P2|NOT COMPLETED|Period 1||6
939879|NCT01383356|2273169|P1|NOT COMPLETED|Period 1||8
939880|NCT01383356|2273168|P2|COMPLETED|Period 1|Completed period 1.|23
939881|NCT01383356|2273169|P1|COMPLETED|Period 1|Completed period 1.|21
939882|NCT01383356|2273168|P2|STARTED|Period 1|Entered and treated.|29
939883|NCT01383356|2273169|P1|STARTED|Period 1|Entered and treated.|29
939884|NCT01383213|2273181|P2|NOT COMPLETED|Overall Study||0
939885|NCT01383213|2273182|P1|NOT COMPLETED|Overall Study||0
939886|NCT01383213|2273181|P2|COMPLETED|Overall Study||41
939887|NCT01383213|2273182|P1|COMPLETED|Overall Study||40
939888|NCT01383213|2273181|P2|STARTED|Overall Study||41
939889|NCT01383213|2273182|P1|STARTED|Overall Study||40
939890|NCT01383200|2273190|P2|NOT COMPLETED|Overall Study||0
939891|NCT01383200|2273191|P1|NOT COMPLETED|Overall Study||0
939892|NCT01383200|2273190|P2|COMPLETED|Overall Study||6
939893|NCT01383200|2273191|P1|COMPLETED|Overall Study||5
939894|NCT01383200|2273190|P2|STARTED|Overall Study||6
939895|NCT01383200|2273191|P1|STARTED|Overall Study||5
939896|NCT01383174|2273199|P2|NOT COMPLETED|6 Month Assessment||1
939897|NCT01383174|2273200|P1|NOT COMPLETED|6 Month Assessment||5
939898|NCT01383174|2273199|P2|COMPLETED|6 Month Assessment|These 73 completed the 6 month assessment and completed the study.|73
939899|NCT01383174|2273200|P1|COMPLETED|6 Month Assessment|These 71 completed the 6 month assessment and completed the study.|71
939900|NCT01383174|2273199|P2|STARTED|6 Month Assessment||74
939901|NCT01383174|2273200|P1|STARTED|6 Month Assessment|All 76 people were contacted at 6 months;1 person returned and 5 did not return to study at 6 months|76
939902|NCT01383174|2273199|P2|NOT COMPLETED|3 Month Assessment||1
939903|NCT01383174|2273200|P1|NOT COMPLETED|3 Month Assessment||6
939904|NCT01383174|2273199|P2|COMPLETED|3 Month Assessment|These 74 completed the 3 month assessment and continued in the study.|74
939905|NCT01383174|2273200|P1|COMPLETED|3 Month Assessment|These 70 completed the 3 month assessment and continued in the study.|70
939906|NCT01383174|2273199|P2|STARTED|3 Month Assessment||75
939907|NCT01383174|2273200|P1|STARTED|3 Month Assessment||76
939908|NCT01383174|2273199|P2|NOT COMPLETED|Baseline Assessment||0
939909|NCT01383174|2273200|P1|NOT COMPLETED|Baseline Assessment||0
939910|NCT01383174|2273199|P2|COMPLETED|Baseline Assessment|These 75 completed the baseline assessment and continued in the study.|75
939911|NCT01383174|2273200|P1|COMPLETED|Baseline Assessment|These 76 completed the baseline assessment and continued in the study.|76
939912|NCT01383174|2273199|P2|STARTED|Baseline Assessment||75
939913|NCT01383174|2273200|P1|STARTED|Baseline Assessment||76
939914|NCT01383096|2273227|P3|NOT COMPLETED|Fifth Intervention (8 Days)||0
939915|NCT01383096|2273228|P2|NOT COMPLETED|Fifth Intervention (8 Days)||0
939916|NCT01383096|2273229|P1|NOT COMPLETED|Fifth Intervention (8 Days)||2
939917|NCT01383096|2273227|P3|COMPLETED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
939918|NCT01383096|2273228|P2|COMPLETED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
939919|NCT01383096|2273229|P1|COMPLETED|Fifth Intervention (8 Days)||11
939920|NCT01383096|2273227|P3|STARTED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
939921|NCT01383096|2273228|P2|STARTED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
939922|NCT01383096|2273229|P1|STARTED|Fifth Intervention (8 Days)||13
939923|NCT01383096|2273227|P3|NOT COMPLETED|Fourth Intervention (8 Days)||0
939924|NCT01383096|2273228|P2|NOT COMPLETED|Fourth Intervention (8 Days)||0
939925|NCT01383096|2273229|P1|NOT COMPLETED|Fourth Intervention (8 Days)||2
939926|NCT01383096|2273227|P3|COMPLETED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
939927|NCT01383096|2273228|P2|COMPLETED|Fourth Intervention (8 Days)||12
939928|NCT01383096|2273229|P1|COMPLETED|Fourth Intervention (8 Days)||13
939929|NCT01383096|2273227|P3|STARTED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
939930|NCT01383096|2273228|P2|STARTED|Fourth Intervention (8 Days)||12
939931|NCT01383096|2273229|P1|STARTED|Fourth Intervention (8 Days)||15
939932|NCT01383096|2273227|P3|NOT COMPLETED|Third Intervention (8 Days)||0
939933|NCT01383096|2273228|P2|NOT COMPLETED|Third Intervention (8 Days)||4
939934|NCT01383096|2273229|P1|NOT COMPLETED|Third Intervention (8 Days)||4
939935|NCT01383096|2273227|P3|COMPLETED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
939936|NCT01383096|2273228|P2|COMPLETED|Third Intervention (8 Days)||12
939937|NCT01383096|2273229|P1|COMPLETED|Third Intervention (8 Days)||15
939938|NCT01383096|2273227|P3|STARTED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
939939|NCT01383096|2273228|P2|STARTED|Third Intervention (8 Days)||16
939940|NCT01383096|2273229|P1|STARTED|Third Intervention (8 Days)||19
939941|NCT01383096|2273227|P3|NOT COMPLETED|Second Intervention (8 Days)||2
939942|NCT01383096|2273228|P2|NOT COMPLETED|Second Intervention (8 Days)||1
939943|NCT01383096|2273229|P1|NOT COMPLETED|Second Intervention (8 Days)||0
939944|NCT01383096|2273227|P3|COMPLETED|Second Intervention (8 Days)||14
939945|NCT01383096|2273228|P2|COMPLETED|Second Intervention (8 Days)||16
939946|NCT01383096|2273229|P1|COMPLETED|Second Intervention (8 Days)||19
939947|NCT01383096|2273227|P3|STARTED|Second Intervention (8 Days)||16
939948|NCT01383096|2273228|P2|STARTED|Second Intervention (8 Days)||17
939949|NCT01383096|2273229|P1|STARTED|Second Intervention (8 Days)||19
939950|NCT01383096|2273227|P3|NOT COMPLETED|First Intervention (8 Days)||0
939951|NCT01383096|2273228|P2|NOT COMPLETED|First Intervention (8 Days)||0
939952|NCT01383096|2273229|P1|NOT COMPLETED|First Intervention (8 Days)||0
939953|NCT01383096|2273227|P3|COMPLETED|First Intervention (8 Days)||16
939954|NCT01383096|2273228|P2|COMPLETED|First Intervention (8 Days)||17
939955|NCT01383096|2273229|P1|COMPLETED|First Intervention (8 Days)||19
939956|NCT01383096|2273227|P3|STARTED|First Intervention (8 Days)||16
939957|NCT01383096|2273228|P2|STARTED|First Intervention (8 Days)||17
939958|NCT01383096|2273229|P1|STARTED|First Intervention (8 Days)||19
939959|NCT01383005|2273277|P2|NOT COMPLETED|Overall Study||0
939960|NCT01383005|2273278|P1|NOT COMPLETED|Overall Study||0
939961|NCT01383005|2273277|P2|COMPLETED|Overall Study||60
939962|NCT01383005|2273278|P1|COMPLETED|Overall Study||34
939963|NCT01383005|2273277|P2|STARTED|Overall Study||60
939964|NCT01383005|2273278|P1|STARTED|Overall Study||34
939965|NCT01382940|2273297|P1|NOT COMPLETED|Overall Study||73
939966|NCT01382940|2273297|P1|COMPLETED|Overall Study||278
939967|NCT01382940|2273297|P1|Received Day 182 Infusion|Overall Study||278
939968|NCT01382940|2273297|P1|Received Day 168 Infusion|Overall Study||290
939969|NCT01382940|2273297|P1|Received Day 15 Infusions|Overall Study||341
939970|NCT01382940|2273297|P1|Received Day 1 Infusion|Overall Study||351
939971|NCT01382940|2273297|P1|STARTED|Overall Study||351
939972|NCT01382901|2273309|P2|NOT COMPLETED|Overall Study||14
939973|NCT01382901|2273310|P1|NOT COMPLETED|Overall Study||17
939974|NCT01382901|2273309|P2|COMPLETED|Overall Study||7
939975|NCT01382901|2273310|P1|COMPLETED|Overall Study||7
939976|NCT01382901|2273309|P2|STARTED|Overall Study||21
939977|NCT01382901|2273310|P1|STARTED|Overall Study||24
939978|NCT01382719|2273320|P4|NOT COMPLETED|Overall Study||33
939979|NCT01382719|2273321|P3|NOT COMPLETED|Overall Study||34
939980|NCT01382719|2273322|P2|NOT COMPLETED|Overall Study||19
939981|NCT01382719|2273323|P1|NOT COMPLETED|Overall Study||18
939982|NCT01382719|2273320|P4|COMPLETED|Overall Study||66
939983|NCT01382719|2273321|P3|COMPLETED|Overall Study||66
939984|NCT01382719|2273322|P2|COMPLETED|Overall Study||81
939985|NCT01382719|2273323|P1|COMPLETED|Overall Study||80
939986|NCT01382719|2273320|P4|Subjects Not Dosed|Overall Study||1
939987|NCT01382719|2273321|P3|Subjects Not Dosed|Overall Study||1
939988|NCT01382719|2273322|P2|Subjects Not Dosed|Overall Study||0
939989|NCT01382719|2273323|P1|Subjects Not Dosed|Overall Study||1
939990|NCT01382719|2273320|P4|STARTED|Overall Study||99
939991|NCT01382719|2273321|P3|STARTED|Overall Study||100
939992|NCT01382719|2273322|P2|STARTED|Overall Study||100
939993|NCT01382719|2273323|P1|STARTED|Overall Study||98
939994|NCT01382446|2273359|P2|NOT COMPLETED|Overall Study||4
939995|NCT01382446|2273360|P1|NOT COMPLETED|Overall Study||3
939996|NCT01382446|2273359|P2|COMPLETED|Overall Study||29
939997|NCT01382446|2273360|P1|COMPLETED|Overall Study||30
939998|NCT01382446|2273359|P2|STARTED|Overall Study||33
939999|NCT01382446|2273360|P1|STARTED|Overall Study||33
940000|NCT01382303|2273368|P2|NOT COMPLETED|Overall Study||17
940001|NCT01382303|2273369|P1|NOT COMPLETED|Overall Study||35
940002|NCT01382303|2273368|P2|COMPLETED|Overall Study||70
940003|NCT01382303|2273369|P1|COMPLETED|Overall Study||52
940004|NCT01382303|2273368|P2|STARTED|Overall Study||87
940005|NCT01382303|2273369|P1|STARTED|Overall Study||87
940006|NCT01382251|2273387|P2|NOT COMPLETED|Overall Study||21
940007|NCT01382251|2273388|P1|NOT COMPLETED|Overall Study||21
940008|NCT01382251|2273387|P2|COMPLETED|Overall Study||102
940009|NCT01382251|2273388|P1|COMPLETED|Overall Study||102
940010|NCT01382251|2273387|P2|STARTED|Overall Study||123
940011|NCT01382251|2273388|P1|STARTED|Overall Study||123
940012|NCT01382225|2273401|P2|NOT COMPLETED|Overall Study||7
940013|NCT01382225|2273402|P1|NOT COMPLETED|Overall Study||14
940014|NCT01382225|2273401|P2|COMPLETED|Overall Study||722
940015|NCT01382225|2273402|P1|COMPLETED|Overall Study||711
940016|NCT01382225|2273401|P2|STARTED|Overall Study||729
940017|NCT01382225|2273402|P1|STARTED|Overall Study||725
940018|NCT01382212|2273424|P1|NOT COMPLETED|Overall Study||2
940019|NCT01382212|2273424|P1|COMPLETED|Overall Study||11
940020|NCT01382212|2273424|P1|STARTED|Overall Study||13
940021|NCT01382186|2273450|P2|NOT COMPLETED|Overall Study||0
940022|NCT01382186|2273451|P1|NOT COMPLETED|Overall Study||1
940023|NCT01382186|2273450|P2|COMPLETED|Overall Study||819
940024|NCT01382186|2273451|P1|COMPLETED|Overall Study||32
940025|NCT01382186|2273450|P2|STARTED|Overall Study||819
940026|NCT01382186|2273451|P1|STARTED|Overall Study||33
940027|NCT01382108|2273467|P2|NOT COMPLETED|Overall Study||0
940028|NCT01382108|2273468|P1|NOT COMPLETED|Overall Study||0
940029|NCT01382108|2273467|P2|COMPLETED|Overall Study||19
940030|NCT01382108|2273468|P1|COMPLETED|Overall Study||20
940031|NCT01382108|2273467|P2|STARTED|Overall Study||19
940032|NCT01382108|2273468|P1|STARTED|Overall Study||20
940033|NCT01381952|2273478|P1|NOT COMPLETED|Overall Study||0
940034|NCT01381952|2273478|P1|COMPLETED|Overall Study||20
940035|NCT01381952|2273478|P1|Collected Dose and Image Information|Overall Study||20
940036|NCT01381952|2273478|P1|STARTED|Overall Study||20
940037|NCT01381926|2273487|P2|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
940038|NCT01381926|2273488|P1|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
940039|NCT01381926|2273487|P2|COMPLETED|Low/High Dose of 2nd Treatment (2months)||4
940040|NCT01381926|2273488|P1|COMPLETED|Low/High Dose of 2nd Treatment (2months)||3
940041|NCT01381926|2273487|P2|STARTED|Low/High Dose of 2nd Treatment (2months)||4
940042|NCT01381926|2273488|P1|STARTED|Low/High Dose of 2nd Treatment (2months)||3
940043|NCT01381926|2273487|P2|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||1
940044|NCT01381926|2273488|P1|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||2
940045|NCT01381926|2273487|P2|COMPLETED|Low/High Dose of 1st Treatment (2months)||4
940046|NCT01381926|2273488|P1|COMPLETED|Low/High Dose of 1st Treatment (2months)||3
940047|NCT01381926|2273487|P2|STARTED|Low/High Dose of 1st Treatment (2months)||5
940048|NCT01381926|2273488|P1|STARTED|Low/High Dose of 1st Treatment (2months)||5
940049|NCT01381900|2273501|P3|NOT COMPLETED|Overall Study||12
940050|NCT01381900|2273502|P2|NOT COMPLETED|Overall Study||9
940051|NCT01381900|2273503|P1|NOT COMPLETED|Overall Study||9
940052|NCT01381900|2273501|P3|COMPLETED|Overall Study||215
940053|NCT01381900|2273502|P2|COMPLETED|Overall Study||214
940054|NCT01381900|2273503|P1|COMPLETED|Overall Study||217
940055|NCT01381900|2273501|P3|STARTED|Overall Study||227
940056|NCT01381900|2273502|P2|STARTED|Overall Study||223
940057|NCT01381900|2273503|P1|STARTED|Overall Study||226
940058|NCT01381679|2273523|P1|NOT COMPLETED|Overall Study||888
940059|NCT01381679|2273523|P1|COMPLETED|Overall Study||794
940060|NCT01381679|2273523|P1|STARTED|Overall Study||1682
940061|NCT01381575|2273538|P3|NOT COMPLETED|Overall Study||7
940062|NCT01381575|2273539|P2|NOT COMPLETED|Overall Study||10
940063|NCT01381575|2273540|P1|NOT COMPLETED|Overall Study||2
940064|NCT01381575|2273538|P3|COMPLETED|Overall Study||408
940065|NCT01381575|2273539|P2|COMPLETED|Overall Study||472
940066|NCT01381575|2273540|P1|COMPLETED|Overall Study||548
940067|NCT01381575|2273538|P3|STARTED|Overall Study||415
940068|NCT01381575|2273539|P2|STARTED|Overall Study||482
940069|NCT01381575|2273540|P1|STARTED|Overall Study||550
940070|NCT01381549|2273597|P3|NOT COMPLETED|Overall Study||1
940071|NCT01381549|2273598|P2|NOT COMPLETED|Overall Study||0
940072|NCT01381549|2273599|P1|NOT COMPLETED|Overall Study||0
940073|NCT01381549|2273597|P3|COMPLETED|Overall Study||5
940074|NCT01381549|2273598|P2|COMPLETED|Overall Study||8
940075|NCT01381549|2273599|P1|COMPLETED|Overall Study||6
940076|NCT01381549|2273597|P3|STARTED|Overall Study||6
940077|NCT01381549|2273598|P2|STARTED|Overall Study||8
940078|NCT01381549|2273599|P1|STARTED|Overall Study||6
940079|NCT01381471|2273694|P1|NOT COMPLETED|Overall Study||0
940080|NCT01381471|2273694|P1|COMPLETED|Overall Study||11060
940081|NCT01381471|2273694|P1|STARTED|Overall Study||11060
940082|NCT01381406|2273701|P2|NOT COMPLETED|Overall Study||0
940083|NCT01381406|2273702|P1|NOT COMPLETED|Overall Study||0
940084|NCT01381406|2273701|P2|COMPLETED|Overall Study||852
940085|NCT01381406|2273702|P1|COMPLETED|Overall Study||2481
940086|NCT01381406|2273701|P2|STARTED|Overall Study||852
940087|NCT01381406|2273702|P1|STARTED|Overall Study||2481
940088|NCT01381120|2273714|P2|NOT COMPLETED|Overall Study||9
940089|NCT01381120|2273715|P1|NOT COMPLETED|Overall Study||11
940090|NCT01381120|2273714|P2|COMPLETED|Overall Study||18
940091|NCT01381120|2273715|P1|COMPLETED|Overall Study||39
940092|NCT01381120|2273714|P2|STARTED|Overall Study||27
940093|NCT01381120|2273715|P1|STARTED|Overall Study||50
940094|NCT01381016|2273725|P2|NOT COMPLETED|Overall Study||6
940095|NCT01381016|2273726|P1|NOT COMPLETED|Overall Study||3
940096|NCT01381016|2273725|P2|COMPLETED|Overall Study||11
940097|NCT01381016|2273726|P1|COMPLETED|Overall Study||10
940098|NCT01381016|2273725|P2|STARTED|Overall Study||17
940099|NCT01381016|2273726|P1|STARTED|Overall Study||13
940100|NCT01380834|2273736|P2|NOT COMPLETED|Overall Study||0
940101|NCT01380834|2273737|P1|NOT COMPLETED|Overall Study||1
940102|NCT01380834|2273736|P2|COMPLETED|Overall Study||42
940103|NCT01380834|2273737|P1|COMPLETED|Overall Study||41
940104|NCT01380834|2273736|P2|STARTED|Overall Study||42
940105|NCT01380834|2273737|P1|STARTED|Overall Study||42
940106|NCT01380782|2273749|P4|NOT COMPLETED|Overall Study||4
940107|NCT01380782|2273750|P3|NOT COMPLETED|Overall Study||11
940108|NCT01380782|2273751|P2|NOT COMPLETED|Overall Study||10
940109|NCT01380782|2273752|P1|NOT COMPLETED|Overall Study||12
940110|NCT01380782|2273749|P4|COMPLETED|Overall Study||0
940111|NCT01380782|2273750|P3|COMPLETED|Overall Study||0
940112|NCT01380782|2273751|P2|COMPLETED|Overall Study||0
940113|NCT01380782|2273752|P1|COMPLETED|Overall Study||0
940114|NCT01380782|2273749|P4|STARTED|Overall Study||4
940115|NCT01380782|2273750|P3|STARTED|Overall Study||11
940116|NCT01380782|2273751|P2|STARTED|Overall Study||10
940117|NCT01380782|2273752|P1|STARTED|Overall Study||12
940118|NCT01380769|2273775|P2|NOT COMPLETED|Overall Study||14
940119|NCT01380769|2273776|P1|NOT COMPLETED|Overall Study||9
940120|NCT01380769|2273775|P2|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|43
940121|NCT01380769|2273776|P1|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|91
940122|NCT01380769|2273775|P2|STARTED|Overall Study||57
940123|NCT01380769|2273776|P1|STARTED|Overall Study||100
940124|NCT01380730|2273792|P8|NOT COMPLETED|Overall Study||0
940125|NCT01380730|2273793|P7|NOT COMPLETED|Overall Study||0
940126|NCT01380730|2273794|P6|NOT COMPLETED|Overall Study||0
940127|NCT01380730|2273795|P5|NOT COMPLETED|Overall Study||1
940128|NCT01380730|2273796|P4|NOT COMPLETED|Overall Study||0
940129|NCT01380730|2273797|P3|NOT COMPLETED|Overall Study||0
940130|NCT01380730|2273798|P2|NOT COMPLETED|Overall Study||0
940131|NCT01380730|2273799|P1|NOT COMPLETED|Overall Study||0
940132|NCT01380730|2273792|P8|COMPLETED|Overall Study||80
940133|NCT01380730|2273793|P7|COMPLETED|Overall Study||79
940134|NCT01380730|2273794|P6|COMPLETED|Overall Study||79
940135|NCT01380730|2273795|P5|COMPLETED|Overall Study||77
940136|NCT01380730|2273796|P4|COMPLETED|Overall Study||79
940137|NCT01380730|2273797|P3|COMPLETED|Overall Study||79
940138|NCT01380730|2273798|P2|COMPLETED|Overall Study||79
940139|NCT01380730|2273799|P1|COMPLETED|Overall Study||78
940140|NCT01380730|2273792|P8|Received Treatment|Overall Study||80
940141|NCT01380730|2273793|P7|Received Treatment|Overall Study||79
940142|NCT01380730|2273794|P6|Received Treatment|Overall Study||79
940143|NCT01380730|2273795|P5|Received Treatment|Overall Study||78
940144|NCT01380730|2273796|P4|Received Treatment|Overall Study||79
940145|NCT01380730|2273797|P3|Received Treatment|Overall Study||79
940146|NCT01380730|2273798|P2|Received Treatment|Overall Study|2 participants did not receive treatment but were followed until the end of study|77
940147|NCT01380730|2273799|P1|Received Treatment|Overall Study||78
940148|NCT01380730|2273792|P8|STARTED|Overall Study||80
940149|NCT01380730|2273793|P7|STARTED|Overall Study||79
940150|NCT01380730|2273794|P6|STARTED|Overall Study||79
940151|NCT01380730|2273795|P5|STARTED|Overall Study||78
940152|NCT01380730|2273796|P4|STARTED|Overall Study||79
940153|NCT01380730|2273797|P3|STARTED|Overall Study||79
940154|NCT01380730|2273798|P2|STARTED|Overall Study||79
940155|NCT01380730|2273799|P1|STARTED|Overall Study||78
940156|NCT01380639|2273859|P2|NOT COMPLETED|Overall Study||4
940157|NCT01380639|2273860|P1|NOT COMPLETED|Overall Study||6
940158|NCT01380639|2273859|P2|COMPLETED|Overall Study||36
940159|NCT01380639|2273860|P1|COMPLETED|Overall Study||36
940160|NCT01380639|2273859|P2|STARTED|Overall Study||40
940161|NCT01380639|2273860|P1|STARTED|Overall Study||42
940162|NCT01380379|2273866|P1|NOT COMPLETED|Overall Study||1
940163|NCT01380379|2273866|P1|COMPLETED|Overall Study||8
940164|NCT01380379|2273866|P1|STARTED|Overall Study||9
940165|NCT01380366|2273871|P1|NOT COMPLETED|Overall Study||0
940166|NCT01380366|2273871|P1|COMPLETED|Overall Study||15
940167|NCT01380366|2273871|P1|STARTED|Overall Study||15
940168|NCT01380327|2273879|P3|NOT COMPLETED|Overall Study||7
940169|NCT01380327|2273880|P2|NOT COMPLETED|Overall Study||3
940170|NCT01380327|2273881|P1|NOT COMPLETED|Overall Study||3
940171|NCT01380327|2273879|P3|COMPLETED|Overall Study||21
940172|NCT01380327|2273880|P2|COMPLETED|Overall Study||28
940173|NCT01380327|2273881|P1|COMPLETED|Overall Study||27
940174|NCT01380327|2273879|P3|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|28
940175|NCT01380327|2273880|P2|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|31
940176|NCT01380327|2273881|P1|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|30
940177|NCT01380197|2273903|P2|NOT COMPLETED|Overall Study||0
940178|NCT01380197|2273904|P1|NOT COMPLETED|Overall Study||0
940179|NCT01380197|2273903|P2|COMPLETED|Overall Study||20
940180|NCT01380197|2273904|P1|COMPLETED|Overall Study||20
940181|NCT01380197|2273903|P2|STARTED|Overall Study||20
940182|NCT01380197|2273904|P1|STARTED|Overall Study||20
940183|NCT01380145|2273912|P1|NOT COMPLETED|Overall Study||4
940184|NCT01380145|2273912|P1|COMPLETED|Overall Study||9
940185|NCT01380145|2273912|P1|STARTED|Overall Study||13
940186|NCT01380093|2273920|P9|NOT COMPLETED|Treatment Phase: Third Intervention||2
940187|NCT01380093|2273921|P8|NOT COMPLETED|Treatment Phase: Third Intervention||0
940188|NCT01380093|2273922|P7|NOT COMPLETED|Treatment Phase: Third Intervention||0
940189|NCT01380093|2273923|P6|NOT COMPLETED|Treatment Phase: Third Intervention||0
940190|NCT01380093|2273924|P5|NOT COMPLETED|Treatment Phase: Third Intervention||0
940191|NCT01380093|2273925|P4|NOT COMPLETED|Treatment Phase: Third Intervention||0
940192|NCT01380093|2273926|P3|NOT COMPLETED|Treatment Phase: Third Intervention||0
940193|NCT01380093|2273927|P2|NOT COMPLETED|Treatment Phase: Third Intervention||0
940194|NCT01380093|2273928|P1|NOT COMPLETED|Treatment Phase: Third Intervention||0
940195|NCT01380093|2273920|P9|COMPLETED|Treatment Phase: Third Intervention||4
940196|NCT01380093|2273921|P8|COMPLETED|Treatment Phase: Third Intervention||6
940197|NCT01380093|2273922|P7|COMPLETED|Treatment Phase: Third Intervention||6
940198|NCT01380093|2273923|P6|COMPLETED|Treatment Phase: Third Intervention||6
940199|NCT01380093|2273924|P5|COMPLETED|Treatment Phase: Third Intervention||6
940200|NCT01380093|2273925|P4|COMPLETED|Treatment Phase: Third Intervention||5
940201|NCT01380093|2273926|P3|COMPLETED|Treatment Phase: Third Intervention||0
940202|NCT01380093|2273927|P2|COMPLETED|Treatment Phase: Third Intervention||0
940203|NCT01380093|2273928|P1|COMPLETED|Treatment Phase: Third Intervention||0
940204|NCT01380093|2273920|P9|STARTED|Treatment Phase: Third Intervention||6
940205|NCT01380093|2273921|P8|STARTED|Treatment Phase: Third Intervention||6
940206|NCT01380093|2273922|P7|STARTED|Treatment Phase: Third Intervention||6
940207|NCT01380093|2273923|P6|STARTED|Treatment Phase: Third Intervention||6
940208|NCT01380093|2273924|P5|STARTED|Treatment Phase: Third Intervention||6
940209|NCT01380093|2273925|P4|STARTED|Treatment Phase: Third Intervention||5
940210|NCT01380093|2273926|P3|STARTED|Treatment Phase: Third Intervention||0
940211|NCT01380093|2273927|P2|STARTED|Treatment Phase: Third Intervention||0
940212|NCT01380093|2273928|P1|STARTED|Treatment Phase: Third Intervention||0
940213|NCT01380093|2273920|P9|NOT COMPLETED|Treatment Phase: Washout Period||0
940214|NCT01380093|2273921|P8|NOT COMPLETED|Treatment Phase: Washout Period||0
940215|NCT01380093|2273922|P7|NOT COMPLETED|Treatment Phase: Washout Period||0
940216|NCT01380093|2273923|P6|NOT COMPLETED|Treatment Phase: Washout Period||0
940217|NCT01380093|2273924|P5|NOT COMPLETED|Treatment Phase: Washout Period||0
940218|NCT01380093|2273925|P4|NOT COMPLETED|Treatment Phase: Washout Period||0
940219|NCT01380093|2273926|P3|NOT COMPLETED|Treatment Phase: Washout Period||0
940220|NCT01380093|2273927|P2|NOT COMPLETED|Treatment Phase: Washout Period||0
940221|NCT01380093|2273928|P1|NOT COMPLETED|Treatment Phase: Washout Period||0
940222|NCT01380093|2273920|P9|COMPLETED|Treatment Phase: Washout Period||6
940223|NCT01380093|2273921|P8|COMPLETED|Treatment Phase: Washout Period||6
940224|NCT01380093|2273922|P7|COMPLETED|Treatment Phase: Washout Period||6
940225|NCT01380093|2273923|P6|COMPLETED|Treatment Phase: Washout Period||6
940226|NCT01380093|2273924|P5|COMPLETED|Treatment Phase: Washout Period||6
940227|NCT01380093|2273925|P4|COMPLETED|Treatment Phase: Washout Period||5
940228|NCT01380093|2273926|P3|COMPLETED|Treatment Phase: Washout Period||0
940229|NCT01380093|2273927|P2|COMPLETED|Treatment Phase: Washout Period||0
940230|NCT01380093|2273928|P1|COMPLETED|Treatment Phase: Washout Period||0
940231|NCT01380093|2273920|P9|STARTED|Treatment Phase: Washout Period||6
940232|NCT01380093|2273921|P8|STARTED|Treatment Phase: Washout Period||6
940233|NCT01380093|2273922|P7|STARTED|Treatment Phase: Washout Period||6
940234|NCT01380093|2273923|P6|STARTED|Treatment Phase: Washout Period||6
940235|NCT01380093|2273924|P5|STARTED|Treatment Phase: Washout Period||6
940236|NCT01380093|2273925|P4|STARTED|Treatment Phase: Washout Period||5
940237|NCT01380093|2273926|P3|STARTED|Treatment Phase: Washout Period||0
940238|NCT01380093|2273927|P2|STARTED|Treatment Phase: Washout Period||0
940239|NCT01380093|2273928|P1|STARTED|Treatment Phase: Washout Period||0
940240|NCT01380093|2273920|P9|NOT COMPLETED|Treatment Phase: Second Intervention||0
940241|NCT01380093|2273921|P8|NOT COMPLETED|Treatment Phase: Second Intervention||0
940242|NCT01380093|2273922|P7|NOT COMPLETED|Treatment Phase: Second Intervention||0
940243|NCT01380093|2273923|P6|NOT COMPLETED|Treatment Phase: Second Intervention||0
940244|NCT01380093|2273924|P5|NOT COMPLETED|Treatment Phase: Second Intervention||0
940245|NCT01380093|2273925|P4|NOT COMPLETED|Treatment Phase: Second Intervention||1
940246|NCT01380093|2273926|P3|NOT COMPLETED|Treatment Phase: Second Intervention||0
940247|NCT01380093|2273927|P2|NOT COMPLETED|Treatment Phase: Second Intervention||0
940248|NCT01380093|2273928|P1|NOT COMPLETED|Treatment Phase: Second Intervention||0
940249|NCT01380093|2273920|P9|COMPLETED|Treatment Phase: Second Intervention||6
940250|NCT01380093|2273921|P8|COMPLETED|Treatment Phase: Second Intervention||6
940251|NCT01380093|2273922|P7|COMPLETED|Treatment Phase: Second Intervention||6
940252|NCT01380093|2273923|P6|COMPLETED|Treatment Phase: Second Intervention||6
940253|NCT01380093|2273924|P5|COMPLETED|Treatment Phase: Second Intervention||6
940254|NCT01380093|2273925|P4|COMPLETED|Treatment Phase: Second Intervention||5
940255|NCT01380093|2273926|P3|COMPLETED|Treatment Phase: Second Intervention||0
940256|NCT01380093|2273927|P2|COMPLETED|Treatment Phase: Second Intervention||0
940257|NCT01380093|2273928|P1|COMPLETED|Treatment Phase: Second Intervention||0
940258|NCT01380093|2273920|P9|STARTED|Treatment Phase: Second Intervention||6
940259|NCT01380093|2273921|P8|STARTED|Treatment Phase: Second Intervention||6
940260|NCT01380093|2273922|P7|STARTED|Treatment Phase: Second Intervention||6
940261|NCT01380093|2273923|P6|STARTED|Treatment Phase: Second Intervention||6
940262|NCT01380093|2273924|P5|STARTED|Treatment Phase: Second Intervention||6
940263|NCT01380093|2273925|P4|STARTED|Treatment Phase: Second Intervention||6
940264|NCT01380093|2273926|P3|STARTED|Treatment Phase: Second Intervention||0
940265|NCT01380093|2273927|P2|STARTED|Treatment Phase: Second Intervention||0
940266|NCT01380093|2273928|P1|STARTED|Treatment Phase: Second Intervention||0
940267|NCT01380093|2273920|P9|NOT COMPLETED|Treatment Phase: Washout Period||0
940268|NCT01380093|2273921|P8|NOT COMPLETED|Treatment Phase: Washout Period||0
940269|NCT01380093|2273922|P7|NOT COMPLETED|Treatment Phase: Washout Period||0
940270|NCT01380093|2273923|P6|NOT COMPLETED|Treatment Phase: Washout Period||0
940271|NCT01380093|2273924|P5|NOT COMPLETED|Treatment Phase: Washout Period||0
940272|NCT01380093|2273925|P4|NOT COMPLETED|Treatment Phase: Washout Period||0
940273|NCT01380093|2273926|P3|NOT COMPLETED|Treatment Phase: Washout Period||0
940274|NCT01380093|2273927|P2|NOT COMPLETED|Treatment Phase: Washout Period||0
940275|NCT01380093|2273928|P1|NOT COMPLETED|Treatment Phase: Washout Period||0
940276|NCT01380093|2273920|P9|COMPLETED|Treatment Phase: Washout Period||6
940277|NCT01380093|2273921|P8|COMPLETED|Treatment Phase: Washout Period||6
940278|NCT01380093|2273922|P7|COMPLETED|Treatment Phase: Washout Period||6
940279|NCT01380093|2273923|P6|COMPLETED|Treatment Phase: Washout Period||6
940280|NCT01380093|2273924|P5|COMPLETED|Treatment Phase: Washout Period||6
940281|NCT01380093|2273925|P4|COMPLETED|Treatment Phase: Washout Period||6
940282|NCT01380093|2273926|P3|COMPLETED|Treatment Phase: Washout Period||0
940283|NCT01380093|2273927|P2|COMPLETED|Treatment Phase: Washout Period||0
940284|NCT01380093|2273928|P1|COMPLETED|Treatment Phase: Washout Period||0
940285|NCT01380093|2273920|P9|STARTED|Treatment Phase: Washout Period||6
940286|NCT01380093|2273921|P8|STARTED|Treatment Phase: Washout Period||6
940287|NCT01380093|2273922|P7|STARTED|Treatment Phase: Washout Period||6
940288|NCT01380093|2273923|P6|STARTED|Treatment Phase: Washout Period||6
940289|NCT01380093|2273924|P5|STARTED|Treatment Phase: Washout Period||6
940290|NCT01380093|2273925|P4|STARTED|Treatment Phase: Washout Period||6
940291|NCT01380093|2273926|P3|STARTED|Treatment Phase: Washout Period||0
940292|NCT01380093|2273927|P2|STARTED|Treatment Phase: Washout Period||0
940293|NCT01380093|2273928|P1|STARTED|Treatment Phase: Washout Period||0
940294|NCT01380093|2273920|P9|NOT COMPLETED|Treatment Phase: First Intervention||0
940295|NCT01380093|2273921|P8|NOT COMPLETED|Treatment Phase: First Intervention||0
940296|NCT01380093|2273922|P7|NOT COMPLETED|Treatment Phase: First Intervention||0
940297|NCT01380093|2273923|P6|NOT COMPLETED|Treatment Phase: First Intervention||0
940298|NCT01380093|2273924|P5|NOT COMPLETED|Treatment Phase: First Intervention||0
940299|NCT01380093|2273925|P4|NOT COMPLETED|Treatment Phase: First Intervention||0
940300|NCT01380093|2273926|P3|NOT COMPLETED|Treatment Phase: First Intervention||0
940301|NCT01380093|2273927|P2|NOT COMPLETED|Treatment Phase: First Intervention||0
940302|NCT01380093|2273928|P1|NOT COMPLETED|Treatment Phase: First Intervention||0
940303|NCT01380093|2273920|P9|COMPLETED|Treatment Phase: First Intervention||6
940304|NCT01380093|2273921|P8|COMPLETED|Treatment Phase: First Intervention||6
940305|NCT01380093|2273922|P7|COMPLETED|Treatment Phase: First Intervention||6
940306|NCT01380093|2273923|P6|COMPLETED|Treatment Phase: First Intervention||6
940307|NCT01380093|2273924|P5|COMPLETED|Treatment Phase: First Intervention||6
940308|NCT01380093|2273925|P4|COMPLETED|Treatment Phase: First Intervention||6
940309|NCT01380093|2273926|P3|COMPLETED|Treatment Phase: First Intervention||0
940310|NCT01380093|2273927|P2|COMPLETED|Treatment Phase: First Intervention||0
940311|NCT01380093|2273928|P1|COMPLETED|Treatment Phase: First Intervention||0
940312|NCT01380093|2273920|P9|STARTED|Treatment Phase: First Intervention||6
940313|NCT01380093|2273921|P8|STARTED|Treatment Phase: First Intervention||6
940314|NCT01380093|2273922|P7|STARTED|Treatment Phase: First Intervention||6
940315|NCT01380093|2273923|P6|STARTED|Treatment Phase: First Intervention||6
940316|NCT01380093|2273924|P5|STARTED|Treatment Phase: First Intervention||6
940317|NCT01380093|2273925|P4|STARTED|Treatment Phase: First Intervention||6
940318|NCT01380093|2273926|P3|STARTED|Treatment Phase: First Intervention||0
940319|NCT01380093|2273927|P2|STARTED|Treatment Phase: First Intervention||0
940320|NCT01380093|2273928|P1|STARTED|Treatment Phase: First Intervention||0
940321|NCT01380093|2273920|P9|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
940322|NCT01380093|2273921|P8|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
940323|NCT01380093|2273922|P7|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
940324|NCT01380093|2273923|P6|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
940325|NCT01380093|2273924|P5|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
940326|NCT01380093|2273925|P4|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
940327|NCT01380093|2273926|P3|NOT COMPLETED|Drug Discrimination Phase: Day 2||13
940328|NCT01380093|2273927|P2|NOT COMPLETED|Drug Discrimination Phase: Day 2||9
940329|NCT01380093|2273928|P1|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
940330|NCT01380093|2273920|P9|COMPLETED|Drug Discrimination Phase: Day 2||0
940331|NCT01380093|2273921|P8|COMPLETED|Drug Discrimination Phase: Day 2||0
940332|NCT01380093|2273922|P7|COMPLETED|Drug Discrimination Phase: Day 2||0
940333|NCT01380093|2273923|P6|COMPLETED|Drug Discrimination Phase: Day 2||0
940334|NCT01380093|2273924|P5|COMPLETED|Drug Discrimination Phase: Day 2||0
940335|NCT01380093|2273925|P4|COMPLETED|Drug Discrimination Phase: Day 2||0
940336|NCT01380093|2273926|P3|COMPLETED|Drug Discrimination Phase: Day 2||16
940337|NCT01380093|2273927|P2|COMPLETED|Drug Discrimination Phase: Day 2||20
940338|NCT01380093|2273928|P1|COMPLETED|Drug Discrimination Phase: Day 2||0
940339|NCT01380093|2273920|P9|STARTED|Drug Discrimination Phase: Day 2||0
940340|NCT01380093|2273921|P8|STARTED|Drug Discrimination Phase: Day 2||0
940341|NCT01380093|2273922|P7|STARTED|Drug Discrimination Phase: Day 2||0
940342|NCT01380093|2273923|P6|STARTED|Drug Discrimination Phase: Day 2||0
940343|NCT01380093|2273924|P5|STARTED|Drug Discrimination Phase: Day 2||0
940344|NCT01380093|2273925|P4|STARTED|Drug Discrimination Phase: Day 2||0
940345|NCT01380093|2273926|P3|STARTED|Drug Discrimination Phase: Day 2||29
940346|NCT01380093|2273927|P2|STARTED|Drug Discrimination Phase: Day 2||29
940347|NCT01380093|2273928|P1|STARTED|Drug Discrimination Phase: Day 2||0
940348|NCT01380093|2273920|P9|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
940349|NCT01380093|2273921|P8|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
940350|NCT01380093|2273922|P7|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
940351|NCT01380093|2273923|P6|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
940352|NCT01380093|2273924|P5|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
940353|NCT01380093|2273925|P4|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
940354|NCT01380093|2273926|P3|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
940355|NCT01380093|2273927|P2|NOT COMPLETED|Drug Discrimination Phase: Day 1||1
940356|NCT01380093|2273928|P1|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
940357|NCT01380093|2273920|P9|COMPLETED|Drug Discrimination Phase: Day 1||0
940358|NCT01380093|2273921|P8|COMPLETED|Drug Discrimination Phase: Day 1||0
940359|NCT01380093|2273922|P7|COMPLETED|Drug Discrimination Phase: Day 1||0
940360|NCT01380093|2273923|P6|COMPLETED|Drug Discrimination Phase: Day 1||0
940361|NCT01380093|2273924|P5|COMPLETED|Drug Discrimination Phase: Day 1||0
940362|NCT01380093|2273925|P4|COMPLETED|Drug Discrimination Phase: Day 1||0
940363|NCT01380093|2273926|P3|COMPLETED|Drug Discrimination Phase: Day 1||29
940364|NCT01380093|2273927|P2|COMPLETED|Drug Discrimination Phase: Day 1||29
940365|NCT01380093|2273928|P1|COMPLETED|Drug Discrimination Phase: Day 1||0
940366|NCT01380093|2273920|P9|STARTED|Drug Discrimination Phase: Day 1||0
940367|NCT01380093|2273921|P8|STARTED|Drug Discrimination Phase: Day 1||0
940368|NCT01380093|2273922|P7|STARTED|Drug Discrimination Phase: Day 1||0
940369|NCT01380093|2273923|P6|STARTED|Drug Discrimination Phase: Day 1||0
940370|NCT01380093|2273924|P5|STARTED|Drug Discrimination Phase: Day 1||0
940371|NCT01380093|2273925|P4|STARTED|Drug Discrimination Phase: Day 1||0
940372|NCT01380093|2273926|P3|STARTED|Drug Discrimination Phase: Day 1||29
940373|NCT01380093|2273927|P2|STARTED|Drug Discrimination Phase: Day 1||30
940374|NCT01380093|2273928|P1|STARTED|Drug Discrimination Phase: Day 1||0
940375|NCT01380093|2273920|P9|NOT COMPLETED|Naloxone Challenge Phase||0
940376|NCT01380093|2273921|P8|NOT COMPLETED|Naloxone Challenge Phase||0
940377|NCT01380093|2273922|P7|NOT COMPLETED|Naloxone Challenge Phase||0
940378|NCT01380093|2273923|P6|NOT COMPLETED|Naloxone Challenge Phase||0
940379|NCT01380093|2273924|P5|NOT COMPLETED|Naloxone Challenge Phase||0
940380|NCT01380093|2273925|P4|NOT COMPLETED|Naloxone Challenge Phase||0
940381|NCT01380093|2273926|P3|NOT COMPLETED|Naloxone Challenge Phase||0
940382|NCT01380093|2273927|P2|NOT COMPLETED|Naloxone Challenge Phase||0
940383|NCT01380093|2273928|P1|NOT COMPLETED|Naloxone Challenge Phase||21
940384|NCT01380093|2273920|P9|COMPLETED|Naloxone Challenge Phase||0
940385|NCT01380093|2273921|P8|COMPLETED|Naloxone Challenge Phase||0
940386|NCT01380093|2273922|P7|COMPLETED|Naloxone Challenge Phase||0
940387|NCT01380093|2273923|P6|COMPLETED|Naloxone Challenge Phase||0
940388|NCT01380093|2273924|P5|COMPLETED|Naloxone Challenge Phase||0
940389|NCT01380093|2273925|P4|COMPLETED|Naloxone Challenge Phase||0
940390|NCT01380093|2273926|P3|COMPLETED|Naloxone Challenge Phase||0
940391|NCT01380093|2273927|P2|COMPLETED|Naloxone Challenge Phase||0
940392|NCT01380093|2273928|P1|COMPLETED|Naloxone Challenge Phase||59
940393|NCT01380093|2273920|P9|TREATED|Naloxone Challenge Phase||0
940394|NCT01380093|2273921|P8|TREATED|Naloxone Challenge Phase||0
940395|NCT01380093|2273922|P7|TREATED|Naloxone Challenge Phase||0
940396|NCT01380093|2273923|P6|TREATED|Naloxone Challenge Phase||0
940397|NCT01380093|2273924|P5|TREATED|Naloxone Challenge Phase||0
940398|NCT01380093|2273925|P4|TREATED|Naloxone Challenge Phase||0
940399|NCT01380093|2273926|P3|TREATED|Naloxone Challenge Phase||0
940400|NCT01380093|2273927|P2|TREATED|Naloxone Challenge Phase||0
940401|NCT01380093|2273928|P1|TREATED|Naloxone Challenge Phase||59
940402|NCT01380093|2273920|P9|STARTED|Naloxone Challenge Phase||0
940403|NCT01380093|2273921|P8|STARTED|Naloxone Challenge Phase||0
940404|NCT01380093|2273922|P7|STARTED|Naloxone Challenge Phase||0
940405|NCT01380093|2273923|P6|STARTED|Naloxone Challenge Phase||0
940406|NCT01380093|2273924|P5|STARTED|Naloxone Challenge Phase||0
940407|NCT01380093|2273925|P4|STARTED|Naloxone Challenge Phase||0
940408|NCT01380093|2273926|P3|STARTED|Naloxone Challenge Phase||0
940409|NCT01380093|2273927|P2|STARTED|Naloxone Challenge Phase||0
940410|NCT01380093|2273928|P1|STARTED|Naloxone Challenge Phase||80
940411|NCT01380080|2274220|P2|NOT COMPLETED|Overall Study||23
940412|NCT01380080|2274221|P1|NOT COMPLETED|Overall Study||33
940413|NCT01380080|2274220|P2|COMPLETED|Overall Study||403
940414|NCT01380080|2274221|P1|COMPLETED|Overall Study||391
940415|NCT01380080|2274220|P2|STARTED|Overall Study||426
940416|NCT01380080|2274221|P1|STARTED|Overall Study||424
940417|NCT01379963|2274237|P1|NOT COMPLETED|Overall Study||0
940418|NCT01379963|2274237|P1|COMPLETED|Overall Study||780
940419|NCT01379963|2274237|P1|STARTED|Overall Study||780
940420|NCT01379937|2274246|P4|NOT COMPLETED|Overall Study||1
940421|NCT01379937|2274247|P3|NOT COMPLETED|Overall Study||2
940422|NCT01379937|2274248|P2|NOT COMPLETED|Overall Study||3
940423|NCT01379937|2274249|P1|NOT COMPLETED|Overall Study||1
940424|NCT01379937|2274246|P4|COMPLETED|Overall Study||103
940425|NCT01379937|2274247|P3|COMPLETED|Overall Study||102
940426|NCT01379937|2274248|P2|COMPLETED|Overall Study||153
940427|NCT01379937|2274249|P1|COMPLETED|Overall Study||155
940428|NCT01379937|2274246|P4|STARTED|Overall Study||104
940429|NCT01379937|2274247|P3|STARTED|Overall Study||104
940430|NCT01379937|2274248|P2|STARTED|Overall Study||156
940431|NCT01379937|2274249|P1|STARTED|Overall Study||156
940432|NCT01379781|2274331|P2|NOT COMPLETED|Overall Study||8
940433|NCT01379781|2274332|P1|NOT COMPLETED|Overall Study||11
940434|NCT01379781|2274331|P2|COMPLETED|Overall Study||19
940435|NCT01379781|2274332|P1|COMPLETED|Overall Study||16
940436|NCT01379781|2274331|P2|STARTED|Overall Study||27
940437|NCT01379781|2274332|P1|STARTED|Overall Study||27
940438|NCT01379768|2274341|P3|NOT COMPLETED|Overall Study||0
940439|NCT01379768|2274342|P2|NOT COMPLETED|Overall Study||1
940440|NCT01379768|2274343|P1|NOT COMPLETED|Overall Study||3
940441|NCT01379768|2274341|P3|COMPLETED|Overall Study||20
940442|NCT01379768|2274342|P2|COMPLETED|Overall Study||21
940443|NCT01379768|2274343|P1|COMPLETED|Overall Study||20
940444|NCT01379768|2274341|P3|STARTED|Overall Study||20
940445|NCT01379768|2274342|P2|STARTED|Overall Study||22
940446|NCT01379768|2274343|P1|STARTED|Overall Study||23
940447|NCT01379703|2274366|P3|NOT COMPLETED|9 Months Through 18 Months||0
940448|NCT01379703|2274367|P2|NOT COMPLETED|9 Months Through 18 Months||230
940449|NCT01379703|2274368|P1|NOT COMPLETED|9 Months Through 18 Months||0
940450|NCT01379703|2274366|P3|COMPLETED|9 Months Through 18 Months||0
940451|NCT01379703|2274367|P2|COMPLETED|9 Months Through 18 Months||854
940452|NCT01379703|2274368|P1|COMPLETED|9 Months Through 18 Months||0
940453|NCT01379703|2274366|P3|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
940454|NCT01379703|2274367|P2|STARTED|9 Months Through 18 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
940455|NCT01379703|2274368|P1|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
940456|NCT01379703|2274366|P3|NOT COMPLETED|Study Start Through 9 Months||143
940457|NCT01379703|2274367|P2|NOT COMPLETED|Study Start Through 9 Months||122
940458|NCT01379703|2274368|P1|NOT COMPLETED|Study Start Through 9 Months||4
940459|NCT01379703|2274366|P3|COMPLETED|Study Start Through 9 Months||873
940460|NCT01379703|2274367|P2|COMPLETED|Study Start Through 9 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
940461|NCT01379703|2274368|P1|COMPLETED|Study Start Through 9 Months||62
940462|NCT01379703|2274366|P3|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir tablet formulation (only) during study (1016/2288)|1016
940463|NCT01379703|2274367|P2|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir capsule formulation (only) during study (1206/2288)|1206
940464|NCT01379703|2274368|P1|STARTED|Study Start Through 9 Months|Participants taking lopinavir/ritonavir tablets/capsules or oral solution during the study (66/2288)|66
940465|NCT01379664|2274431|P2|NOT COMPLETED|Overall Study||0
940466|NCT01379664|2274432|P1|NOT COMPLETED|Overall Study||0
940467|NCT01379664|2274431|P2|COMPLETED|Overall Study||870
940468|NCT01379664|2274432|P1|COMPLETED|Overall Study||714
940469|NCT01379664|2274431|P2|STARTED|Overall Study||870
940470|NCT01379664|2274432|P1|STARTED|Overall Study||714
940471|NCT01379651|2274444|P2|NOT COMPLETED|Overall Study||0
940472|NCT01379651|2274445|P1|NOT COMPLETED|Overall Study||0
940473|NCT01379651|2274444|P2|COMPLETED|Overall Study||10
940474|NCT01379651|2274445|P1|COMPLETED|Overall Study||10
940475|NCT01379651|2274444|P2|STARTED|Overall Study||10
940476|NCT01379651|2274445|P1|STARTED|Overall Study||10
940477|NCT01379625|2274455|P2|NOT COMPLETED|Overall Study||0
940478|NCT01379625|2274456|P1|NOT COMPLETED|Overall Study||0
940479|NCT01379625|2274455|P2|COMPLETED|Overall Study||16
940480|NCT01379625|2274456|P1|COMPLETED|Overall Study||16
940481|NCT01379625|2274455|P2|STARTED|Overall Study||16
940482|NCT01379625|2274456|P1|STARTED|Overall Study||16
940483|NCT01379534|2274468|P2|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||2
940484|NCT01379534|2274469|P1|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||4
940485|NCT01379534|2274468|P2|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
940486|NCT01379534|2274469|P1|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
940487|NCT01379534|2274468|P2|STARTED|Tumor Assessment Follow-up (f/u) Phase||2
940488|NCT01379534|2274469|P1|STARTED|Tumor Assessment Follow-up (f/u) Phase|All participants discontinued the Treatment Phase. Of these, only 6 qualified for f/u tumor assess..|4
940489|NCT01379534|2274468|P2|NOT COMPLETED|Treatment Phase||31
940490|NCT01379534|2274469|P1|NOT COMPLETED|Treatment Phase||22
940491|NCT01379534|2274468|P2|COMPLETED|Treatment Phase||0
940492|NCT01379534|2274469|P1|COMPLETED|Treatment Phase||0
940493|NCT01379534|2274468|P2|STARTED|Treatment Phase||31
940494|NCT01379534|2274469|P1|STARTED|Treatment Phase||22
940495|NCT01379521|2274489|P2|NOT COMPLETED|Post-Treatment Evaluations||21
940496|NCT01379521|2274490|P1|NOT COMPLETED|Post-Treatment Evaluations||25
940497|NCT01379521|2274489|P2|COMPLETED|Post-Treatment Evaluations||0
940498|NCT01379521|2274490|P1|COMPLETED|Post-Treatment Evaluations||0
940499|NCT01379521|2274489|P2|STARTED|Post-Treatment Evaluations||21
940500|NCT01379521|2274490|P1|STARTED|Post-Treatment Evaluations||25
940501|NCT01379521|2274489|P2|NOT COMPLETED|Overall Study -Treatment Period||26
940502|NCT01379521|2274490|P1|NOT COMPLETED|Overall Study -Treatment Period||33
940503|NCT01379521|2274489|P2|COMPLETED|Overall Study -Treatment Period||0
940504|NCT01379521|2274490|P1|COMPLETED|Overall Study -Treatment Period||0
940505|NCT01379521|2274489|P2|STARTED|Overall Study -Treatment Period||26
940506|NCT01379521|2274490|P1|STARTED|Overall Study -Treatment Period||33
940507|NCT01379183|2274510|P2|NOT COMPLETED|Overall Study||0
940508|NCT01379183|2274511|P1|NOT COMPLETED|Overall Study||0
940509|NCT01379183|2274510|P2|COMPLETED|Overall Study||21
940510|NCT01379183|2274511|P1|COMPLETED|Overall Study||19
940511|NCT01379183|2274510|P2|STARTED|Overall Study||21
940512|NCT01379183|2274511|P1|STARTED|Overall Study||19
940513|NCT01378988|2274529|P2|NOT COMPLETED|Overall Study||0
940514|NCT01378988|2274530|P1|NOT COMPLETED|Overall Study||0
940515|NCT01378988|2274529|P2|COMPLETED|Overall Study||3
940516|NCT01378988|2274530|P1|COMPLETED|Overall Study||2
940517|NCT01378988|2274529|P2|STARTED|Overall Study||3
940518|NCT01378988|2274530|P1|STARTED|Overall Study||2
940519|NCT01378975|2274560|P2|NOT COMPLETED|Overall Study||50
940520|NCT01378975|2274561|P1|NOT COMPLETED|Overall Study||86
940521|NCT01378975|2274560|P2|COMPLETED|Overall Study||6
940522|NCT01378975|2274561|P1|COMPLETED|Overall Study||4
940523|NCT01378975|2274560|P2|STARTED|Overall Study||56
940524|NCT01378975|2274561|P1|STARTED|Overall Study||90
940525|NCT01378962|2274587|P1|NOT COMPLETED|Overall Study||17
940526|NCT01378962|2274587|P1|COMPLETED|Overall Study||33
940527|NCT01378962|2274587|P1|STARTED|Overall Study||50
940528|NCT01378520|2274600|P2|NOT COMPLETED|Second Intervention||0
940529|NCT01378520|2274601|P1|NOT COMPLETED|Second Intervention||0
940530|NCT01378520|2274600|P2|COMPLETED|Second Intervention||10
940531|NCT01378520|2274601|P1|COMPLETED|Second Intervention||10
940532|NCT01378520|2274600|P2|STARTED|Second Intervention||10
940533|NCT01378520|2274601|P1|STARTED|Second Intervention||10
940534|NCT01378520|2274600|P2|NOT COMPLETED|First Intervention||0
940535|NCT01378520|2274601|P1|NOT COMPLETED|First Intervention||0
940536|NCT01378520|2274600|P2|COMPLETED|First Intervention||10
940537|NCT01378520|2274601|P1|COMPLETED|First Intervention||10
940538|NCT01378520|2274600|P2|STARTED|First Intervention||10
940539|NCT01378520|2274601|P1|STARTED|First Intervention||10
940540|NCT01378429|2274613|P2|NOT COMPLETED|Overall Study||0
940541|NCT01378429|2274614|P1|NOT COMPLETED|Overall Study||1
940542|NCT01378429|2274613|P2|COMPLETED|Overall Study||47
940543|NCT01378429|2274614|P1|COMPLETED|Overall Study||41
940544|NCT01378429|2274613|P2|STARTED|Overall Study||47
940545|NCT01378429|2274614|P1|STARTED|Overall Study||42
940546|NCT01378416|2274646|P1|NOT COMPLETED|Overall Study||0
940547|NCT01378416|2274646|P1|COMPLETED|Overall Study||16
940548|NCT01378416|2274646|P1|STARTED|Overall Study||16
940549|NCT01378325|2274656|P2|NOT COMPLETED|Overall Study||1
940550|NCT01378325|2274657|P1|NOT COMPLETED|Overall Study||0
940551|NCT01378325|2274656|P2|COMPLETED|Overall Study||39
940552|NCT01378325|2274657|P1|COMPLETED|Overall Study||40
940553|NCT01378325|2274656|P2|STARTED|Overall Study||40
940554|NCT01378325|2274657|P1|STARTED|Overall Study||40
940555|NCT01378221|2274665|P2|NOT COMPLETED|Overall Study||9
940556|NCT01378221|2274666|P1|NOT COMPLETED|Overall Study||7
940557|NCT01378221|2274665|P2|COMPLETED|Overall Study||30
940558|NCT01378221|2274666|P1|COMPLETED|Overall Study||29
940559|NCT01378221|2274665|P2|STARTED|Overall Study||39
940560|NCT01378221|2274666|P1|STARTED|Overall Study||36
940561|NCT01378195|2274674|P2|NOT COMPLETED|Overall Study||18
940562|NCT01378195|2274675|P1|NOT COMPLETED|Overall Study||29
940563|NCT01378195|2274674|P2|COMPLETED|Overall Study||57
940564|NCT01378195|2274675|P1|COMPLETED|Overall Study||46
940565|NCT01378195|2274674|P2|STARTED|Overall Study||75
940566|NCT01378195|2274675|P1|STARTED|Overall Study||75
940567|NCT01378117|2274688|P3|NOT COMPLETED|Overall Study||3
940568|NCT01378117|2274689|P2|NOT COMPLETED|Overall Study||1
940569|NCT01378117|2274690|P1|NOT COMPLETED|Overall Study||4
940570|NCT01378117|2274688|P3|COMPLETED|Overall Study||26
940571|NCT01378117|2274689|P2|COMPLETED|Overall Study||29
940572|NCT01378117|2274690|P1|COMPLETED|Overall Study||27
940573|NCT01378117|2274688|P3|STARTED|Overall Study||29
940574|NCT01378117|2274689|P2|STARTED|Overall Study||30
940575|NCT01378117|2274690|P1|STARTED|Overall Study||31
940576|NCT01378104|2274700|P2|NOT COMPLETED|Overall Study||26
940577|NCT01378104|2274701|P1|NOT COMPLETED|Overall Study||27
940578|NCT01378104|2274700|P2|COMPLETED|Overall Study||60
940579|NCT01378104|2274701|P1|COMPLETED|Overall Study||65
940580|NCT01378104|2274700|P2|STARTED|Overall Study||86
940581|NCT01378104|2274701|P1|STARTED|Overall Study||92
940582|NCT01378065|2274709|P1|NOT COMPLETED|Overall Study||0
940583|NCT01378065|2274709|P1|COMPLETED|Overall Study||30
940584|NCT01378065|2274709|P1|12 Months|Overall Study||30
940585|NCT01378065|2274709|P1|6 Months|Overall Study||30
940586|NCT01378065|2274709|P1|3 Months|Overall Study||30
940587|NCT01378065|2274709|P1|6 Week|Overall Study||30
940588|NCT01378065|2274709|P1|STARTED|Overall Study|31 subjects were enrolled/consented. However, 1 subject was not implanted with a study device.|30
940589|NCT01377636|2274746|P1|NOT COMPLETED|Overall Study||0
940590|NCT01377636|2274746|P1|COMPLETED|Overall Study||20
940591|NCT01377636|2274746|P1|STARTED|Overall Study||20
940592|NCT01377623|2274760|P2|NOT COMPLETED|Overall Study||5
940593|NCT01377623|2274761|P1|NOT COMPLETED|Overall Study||7
940594|NCT01377623|2274760|P2|COMPLETED|Overall Study||28
940595|NCT01377623|2274761|P1|COMPLETED|Overall Study||26
940596|NCT01377623|2274760|P2|STARTED|Overall Study||33
940597|NCT01377623|2274761|P1|STARTED|Overall Study||33
940598|NCT01377584|2274781|P6|NOT COMPLETED|Overall Study||3
940599|NCT01377584|2274782|P5|NOT COMPLETED|Overall Study||3
940600|NCT01377584|2274783|P4|NOT COMPLETED|Overall Study||4
940601|NCT01377584|2274784|P3|NOT COMPLETED|Overall Study||4
940602|NCT01377584|2274785|P2|NOT COMPLETED|Overall Study||3
940603|NCT01377584|2274786|P1|NOT COMPLETED|Overall Study||3
940604|NCT01377584|2274781|P6|COMPLETED|Overall Study||9
940605|NCT01377584|2274782|P5|COMPLETED|Overall Study||9
940606|NCT01377584|2274783|P4|COMPLETED|Overall Study||6
940607|NCT01377584|2274784|P3|COMPLETED|Overall Study||6
940608|NCT01377584|2274785|P2|COMPLETED|Overall Study||5
940609|NCT01377584|2274786|P1|COMPLETED|Overall Study||5
940610|NCT01377584|2274781|P6|STARTED|Overall Study||12
940611|NCT01377584|2274782|P5|STARTED|Overall Study||12
940612|NCT01377584|2274783|P4|STARTED|Overall Study||10
940613|NCT01377584|2274784|P3|STARTED|Overall Study||10
940614|NCT01377584|2274785|P2|STARTED|Overall Study||8
940615|NCT01377584|2274786|P1|STARTED|Overall Study||8
940616|NCT01377480|2274819|P4|NOT COMPLETED|Overall Study||11
940617|NCT01377480|2274820|P3|NOT COMPLETED|Overall Study||10
940618|NCT01377480|2274821|P2|NOT COMPLETED|Overall Study||1
940619|NCT01377480|2274822|P1|NOT COMPLETED|Overall Study||0
940620|NCT01377480|2274819|P4|COMPLETED|Overall Study||19
940621|NCT01377480|2274820|P3|COMPLETED|Overall Study||18
940622|NCT01377480|2274821|P2|COMPLETED|Overall Study||29
940623|NCT01377480|2274822|P1|COMPLETED|Overall Study||32
940624|NCT01377480|2274819|P4|STARTED|Overall Study||30
940625|NCT01377480|2274820|P3|STARTED|Overall Study|2 participants received only POS and were analyzed as part of the posaconazole group|28
940626|NCT01377480|2274821|P2|STARTED|Overall Study||30
940627|NCT01377480|2274822|P1|STARTED|Overall Study|Includes 2 participants randomized to POS + BNZ but who only received POS|32
940628|NCT01377467|2274834|P2|NOT COMPLETED|Overall Study||0
940629|NCT01377467|2274835|P1|NOT COMPLETED|Overall Study||0
940630|NCT01377467|2274834|P2|COMPLETED|Overall Study||44
940631|NCT01377467|2274835|P1|COMPLETED|Overall Study||46
940632|NCT01377467|2274834|P2|STARTED|Overall Study||44
940633|NCT01377467|2274835|P1|STARTED|Overall Study||46
940634|NCT01377441|2274883|P2|NOT COMPLETED|Overall Study||0
940635|NCT01377441|2274884|P1|NOT COMPLETED|Overall Study||0
940636|NCT01377441|2274883|P2|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
940637|NCT01377441|2274884|P1|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
940638|NCT01377441|2274883|P2|STARTED|Overall Study||0
940639|NCT01377441|2274884|P1|STARTED|Overall Study||0
940640|NCT01377402|2274890|P1|NOT COMPLETED|Overall Study||0
940641|NCT01377402|2274890|P1|COMPLETED|Overall Study||982
940642|NCT01377402|2274890|P1|STARTED|Overall Study||982
940643|NCT01377233|2274901|P5|NOT COMPLETED|Double-blind||2
940644|NCT01377233|2274902|P4|NOT COMPLETED|Double-blind||4
940645|NCT01377233|2274903|P3|NOT COMPLETED|Double-blind||2
940646|NCT01377233|2274904|P2|NOT COMPLETED|Double-blind||1
940647|NCT01377233|2274905|P1|NOT COMPLETED|Double-blind||0
940648|NCT01377233|2274901|P5|COMPLETED|Double-blind||8
940649|NCT01377233|2274902|P4|COMPLETED|Double-blind||7
940650|NCT01377233|2274903|P3|COMPLETED|Double-blind||8
940651|NCT01377233|2274904|P2|COMPLETED|Double-blind||10
940652|NCT01377233|2274905|P1|COMPLETED|Double-blind||0
940653|NCT01377233|2274901|P5|STARTED|Double-blind||10
940654|NCT01377233|2274902|P4|STARTED|Double-blind||11
940655|NCT01377233|2274903|P3|STARTED|Double-blind||10
940656|NCT01377233|2274904|P2|STARTED|Double-blind||11
940657|NCT01377233|2274905|P1|STARTED|Double-blind||0
940658|NCT01377233|2274901|P5|NOT COMPLETED|Open-label||0
940659|NCT01377233|2274902|P4|NOT COMPLETED|Open-label||0
940660|NCT01377233|2274903|P3|NOT COMPLETED|Open-label||0
940661|NCT01377233|2274904|P2|NOT COMPLETED|Open-label||0
940662|NCT01377233|2274905|P1|NOT COMPLETED|Open-label||4
940663|NCT01377233|2274901|P5|COMPLETED|Open-label||0
940664|NCT01377233|2274902|P4|COMPLETED|Open-label||0
940665|NCT01377233|2274903|P3|COMPLETED|Open-label||0
940666|NCT01377233|2274904|P2|COMPLETED|Open-label||0
940667|NCT01377233|2274905|P1|COMPLETED|Open-label||42
940668|NCT01377233|2274901|P5|STARTED|Open-label||0
940669|NCT01377233|2274902|P4|STARTED|Open-label||0
940670|NCT01377233|2274903|P3|STARTED|Open-label||0
940671|NCT01377233|2274904|P2|STARTED|Open-label||0
940672|NCT01377233|2274905|P1|STARTED|Open-label||46
940673|NCT01377194|2274932|P3|NOT COMPLETED|Overall Study||46
940674|NCT01377194|2274933|P2|NOT COMPLETED|Overall Study||43
940675|NCT01377194|2274934|P1|NOT COMPLETED|Overall Study||32
940676|NCT01377194|2274932|P3|COMPLETED|Overall Study||142
940677|NCT01377194|2274933|P2|COMPLETED|Overall Study||145
940678|NCT01377194|2274934|P1|COMPLETED|Overall Study||154
940679|NCT01377194|2274932|P3|STARTED|Overall Study||188
940680|NCT01377194|2274933|P2|STARTED|Overall Study||188
940681|NCT01377194|2274934|P1|STARTED|Overall Study||186
940682|NCT01377012|2274948|P3|NOT COMPLETED|Extension Study, Weeks 104-260||68
940683|NCT01377012|2274949|P2|NOT COMPLETED|Extension Study, Weeks 104-260||71
940684|NCT01377012|2274950|P1|NOT COMPLETED|Extension Study, Weeks 104-260||57
940685|NCT01377012|2274948|P3|COMPLETED|Extension Study, Weeks 104-260||0
940686|NCT01377012|2274949|P2|COMPLETED|Extension Study, Weeks 104-260||0
940687|NCT01377012|2274950|P1|COMPLETED|Extension Study, Weeks 104-260||0
940688|NCT01377012|2274948|P3|STARTED|Extension Study, Weeks 104-260||68
940689|NCT01377012|2274949|P2|STARTED|Extension Study, Weeks 104-260||71
940690|NCT01377012|2274950|P1|STARTED|Extension Study, Weeks 104-260||57
940691|NCT01377012|2274948|P3|NOT COMPLETED|Core Study||134
940692|NCT01377012|2274949|P2|NOT COMPLETED|Core Study||132
940693|NCT01377012|2274950|P1|NOT COMPLETED|Core Study||134
940694|NCT01377012|2274948|P3|COMPLETED|Core Study||80
940695|NCT01377012|2274949|P2|COMPLETED|Core Study||81
940696|NCT01377012|2274950|P1|COMPLETED|Core Study||76
940697|NCT01377012|2274948|P3|wk 24 Re-randomized to AIN 150 mg Res|Core Study||34
940698|NCT01377012|2274949|P2|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
940699|NCT01377012|2274950|P1|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
940700|NCT01377012|2274948|P3|wk 24 Re-randomized to AIN 75 mg Res|Core Study|Res= responder|38
940701|NCT01377012|2274949|P2|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
940702|NCT01377012|2274950|P1|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
940703|NCT01377012|2274948|P3|wk16 Re-randomized to AIN 150mg NR|Core Study||53
940704|NCT01377012|2274949|P2|wk16 Re-randomized to AIN 150mg NR|Core Study||0
940705|NCT01377012|2274950|P1|wk16 Re-randomized to AIN 150mg NR|Core Study||0
940706|NCT01377012|2274948|P3|wk16 Re-randomized to AIN 75mg NR|Core Study|NR=Non-responder|56
940707|NCT01377012|2274949|P2|wk16 Re-randomized to AIN 75mg NR|Core Study||0
940708|NCT01377012|2274950|P1|wk16 Re-randomized to AIN 75mg NR|Core Study||0
940709|NCT01377012|2274948|P3|STARTED|Core Study||214
940710|NCT01377012|2274949|P2|STARTED|Core Study||213
940711|NCT01377012|2274950|P1|STARTED|Core Study||210
940712|NCT01376908|2274987|P2|NOT COMPLETED|Overall Study||3
940713|NCT01376908|2274988|P1|NOT COMPLETED|Overall Study||2
940714|NCT01376908|2274987|P2|COMPLETED|Overall Study||26
940715|NCT01376908|2274988|P1|COMPLETED|Overall Study||25
940716|NCT01376908|2274987|P2|STARTED|Overall Study||29
940717|NCT01376908|2274988|P1|STARTED|Overall Study||27
940718|NCT01376804|2275021|P1|NOT COMPLETED|Follow-up Period||0
940719|NCT01376804|2275021|P1|COMPLETED|Follow-up Period||55
940720|NCT01376804|2275021|P1|STARTED|Follow-up Period|6 of the 7 patients who withdrew from treatment continued to the Follow-up Period.|55
940721|NCT01376804|2275021|P1|NOT COMPLETED|Treatment Period||8
940722|NCT01376804|2275021|P1|COMPLETED|Treatment Period||49
940723|NCT01376804|2275021|P1|Received Study Drug|Treatment Period||56
940724|NCT01376804|2275021|P1|STARTED|Treatment Period||57
940725|NCT01376700|2275032|P1|NOT COMPLETED|Overall Study||16
940726|NCT01376700|2275032|P1|COMPLETED|Overall Study||3
940727|NCT01376700|2275032|P1|STARTED|Overall Study||19
940728|NCT01376557|2275053|P5|NOT COMPLETED|Overall Study||7
940729|NCT01376557|2275054|P4|NOT COMPLETED|Overall Study||6
940730|NCT01376557|2275055|P3|NOT COMPLETED|Overall Study||5
940731|NCT01376557|2275056|P2|NOT COMPLETED|Overall Study||6
940732|NCT01376557|2275057|P1|NOT COMPLETED|Overall Study||8
940733|NCT01376557|2275053|P5|COMPLETED|Overall Study||53
940734|NCT01376557|2275054|P4|COMPLETED|Overall Study||54
940735|NCT01376557|2275055|P3|COMPLETED|Overall Study||55
940736|NCT01376557|2275056|P2|COMPLETED|Overall Study||54
940737|NCT01376557|2275057|P1|COMPLETED|Overall Study||51
940738|NCT01376557|2275053|P5|STARTED|Overall Study||60
940739|NCT01376557|2275054|P4|STARTED|Overall Study||60
940740|NCT01376557|2275055|P3|STARTED|Overall Study||60
940741|NCT01376557|2275056|P2|STARTED|Overall Study||60
940742|NCT01376557|2275057|P1|STARTED|Overall Study||59
940743|NCT01376388|2275094|P1|NOT COMPLETED|Overall Study||18
940744|NCT01376388|2275094|P1|COMPLETED|Overall Study||112
940745|NCT01376388|2275094|P1|STARTED|Overall Study||130
940746|NCT01376362|2275109|P1|NOT COMPLETED|Overall Study||0
940747|NCT01376362|2275109|P1|COMPLETED|Overall Study||5
940748|NCT01376362|2275109|P1|STARTED|Overall Study||5
940749|NCT01376349|2275132|P3|NOT COMPLETED|Optional Continuation Phase||0
940750|NCT01376349|2275133|P2|NOT COMPLETED|Optional Continuation Phase||0
940751|NCT01376349|2275134|P1|NOT COMPLETED|Optional Continuation Phase||0
940752|NCT01376349|2275132|P3|COMPLETED|Optional Continuation Phase||94
940753|NCT01376349|2275133|P2|COMPLETED|Optional Continuation Phase||0
940754|NCT01376349|2275134|P1|COMPLETED|Optional Continuation Phase||0
940755|NCT01376349|2275132|P3|STARTED|Optional Continuation Phase|Patients completing Arm III Placebo were offered the option of continuing High Dose DHEA|94
940756|NCT01376349|2275133|P2|STARTED|Optional Continuation Phase||0
940757|NCT01376349|2275134|P1|STARTED|Optional Continuation Phase||0
940758|NCT01376349|2275132|P3|NOT COMPLETED|Raondomized Treatment||29
940759|NCT01376349|2275133|P2|NOT COMPLETED|Raondomized Treatment||35
940760|NCT01376349|2275134|P1|NOT COMPLETED|Raondomized Treatment||24
940761|NCT01376349|2275132|P3|COMPLETED|Raondomized Treatment||118
940762|NCT01376349|2275133|P2|COMPLETED|Raondomized Treatment||114
940763|NCT01376349|2275134|P1|COMPLETED|Raondomized Treatment||123
940764|NCT01376349|2275132|P3|STARTED|Raondomized Treatment||147
940765|NCT01376349|2275133|P2|STARTED|Raondomized Treatment||149
940766|NCT01376349|2275134|P1|STARTED|Raondomized Treatment||147
940767|NCT01376297|2275145|P2|NOT COMPLETED|Overall Study||49
940768|NCT01376297|2275146|P1|NOT COMPLETED|Overall Study||128
940769|NCT01376297|2275145|P2|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|55
940770|NCT01376297|2275146|P1|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|181
940771|NCT01376297|2275145|P2|STARTED|Overall Study|number of randomised patients|104
940772|NCT01376297|2275146|P1|STARTED|Overall Study|number of randomised patients|309
940773|NCT01376245|2275156|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||26
940774|NCT01376245|2275157|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||23
940775|NCT01376245|2275158|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||25
940776|NCT01376245|2275159|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||32
940777|NCT01376245|2275160|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
940778|NCT01376245|2275156|P5|COMPLETED|24-week, Double-blind Treatment Period||134
940779|NCT01376245|2275157|P4|COMPLETED|24-week, Double-blind Treatment Period||138
940780|NCT01376245|2275158|P3|COMPLETED|24-week, Double-blind Treatment Period||135
940781|NCT01376245|2275159|P2|COMPLETED|24-week, Double-blind Treatment Period||130
940782|NCT01376245|2275160|P1|COMPLETED|24-week, Double-blind Treatment Period||0
940783|NCT01376245|2275156|P5|STARTED|24-week, Double-blind Treatment Period||160
940784|NCT01376245|2275157|P4|STARTED|24-week, Double-blind Treatment Period||161
940785|NCT01376245|2275158|P3|STARTED|24-week, Double-blind Treatment Period||160
940786|NCT01376245|2275159|P2|STARTED|24-week, Double-blind Treatment Period||162
940787|NCT01376245|2275160|P1|STARTED|24-week, Double-blind Treatment Period||0
940788|NCT01376245|2275156|P5|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
940789|NCT01376245|2275157|P4|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
940790|NCT01376245|2275158|P3|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
940791|NCT01376245|2275159|P2|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
940792|NCT01376245|2275160|P1|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||101
940793|NCT01376245|2275156|P5|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
940794|NCT01376245|2275157|P4|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
940795|NCT01376245|2275158|P3|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
940796|NCT01376245|2275159|P2|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
940797|NCT01376245|2275160|P1|COMPLETED|2-wk Single-blind Placebo Run-in Period||643
940798|NCT01376245|2275156|P5|STARTED|2-wk Single-blind Placebo Run-in Period||0
940799|NCT01376245|2275157|P4|STARTED|2-wk Single-blind Placebo Run-in Period||0
940800|NCT01376245|2275158|P3|STARTED|2-wk Single-blind Placebo Run-in Period||0
940801|NCT01376245|2275159|P2|STARTED|2-wk Single-blind Placebo Run-in Period||0
940802|NCT01376245|2275160|P1|STARTED|2-wk Single-blind Placebo Run-in Period||744
940803|NCT01376089|2275176|P2|NOT COMPLETED|Overall Study||4
940804|NCT01376089|2275177|P1|NOT COMPLETED|Overall Study||3
940805|NCT01376089|2275176|P2|COMPLETED|Overall Study||144
940806|NCT01376089|2275177|P1|COMPLETED|Overall Study||148
940807|NCT01376089|2275176|P2|STARTED|Overall Study||148
940808|NCT01376089|2275177|P1|STARTED|Overall Study||151
940809|NCT01376050|2275189|P2|NOT COMPLETED|Overall Study||0
940810|NCT01376050|2275190|P1|NOT COMPLETED|Overall Study||0
940811|NCT01376050|2275189|P2|COMPLETED|Overall Study||11
940812|NCT01376050|2275190|P1|COMPLETED|Overall Study||13
940813|NCT01376050|2275189|P2|STARTED|Overall Study||11
940814|NCT01376050|2275190|P1|STARTED|Overall Study||13
940815|NCT01376037|2275200|P2|NOT COMPLETED|Overall Study||2
940816|NCT01376037|2275201|P1|NOT COMPLETED|Overall Study||0
940817|NCT01376037|2275200|P2|COMPLETED|Overall Study||29
940818|NCT01376037|2275201|P1|COMPLETED|Overall Study||31
940819|NCT01376037|2275200|P2|STARTED|Overall Study||31
940820|NCT01376037|2275201|P1|STARTED|Overall Study||31
940821|NCT01375777|2275216|P9|NOT COMPLETED|Overall Study||2
940822|NCT01375777|2275217|P8|NOT COMPLETED|Overall Study||2
940823|NCT01375777|2275218|P7|NOT COMPLETED|Overall Study||2
940824|NCT01375777|2275219|P6|NOT COMPLETED|Overall Study||1
940825|NCT01375777|2275220|P5|NOT COMPLETED|Overall Study||1
940826|NCT01375777|2275221|P4|NOT COMPLETED|Overall Study||0
940827|NCT01375777|2275222|P3|NOT COMPLETED|Overall Study||1
940828|NCT01375777|2275223|P2|NOT COMPLETED|Overall Study||3
940829|NCT01375777|2275224|P1|NOT COMPLETED|Overall Study||2
940830|NCT01375777|2275216|P9|COMPLETED|Overall Study||44
940831|NCT01375777|2275217|P8|COMPLETED|Overall Study||44
940832|NCT01375777|2275218|P7|COMPLETED|Overall Study||44
940833|NCT01375777|2275219|P6|COMPLETED|Overall Study||44
940834|NCT01375777|2275220|P5|COMPLETED|Overall Study||45
940835|NCT01375777|2275221|P4|COMPLETED|Overall Study||45
940836|NCT01375777|2275222|P3|COMPLETED|Overall Study||45
940837|NCT01375777|2275223|P2|COMPLETED|Overall Study||42
940838|NCT01375777|2275224|P1|COMPLETED|Overall Study||44
940839|NCT01375777|2275216|P9|Received Treatment|Overall Study||45
940840|NCT01375777|2275217|P8|Received Treatment|Overall Study||45
940841|NCT01375777|2275218|P7|Received Treatment|Overall Study||45
940842|NCT01375777|2275219|P6|Received Treatment|Overall Study||45
940843|NCT01375777|2275220|P5|Received Treatment|Overall Study||46
940844|NCT01375777|2275221|P4|Received Treatment|Overall Study||45
940845|NCT01375777|2275222|P3|Received Treatment|Overall Study||45
940846|NCT01375777|2275223|P2|Received Treatment|Overall Study||45
940847|NCT01375777|2275224|P1|Received Treatment|Overall Study||45
940848|NCT01375777|2275216|P9|STARTED|Overall Study||46
940849|NCT01375777|2275217|P8|STARTED|Overall Study||46
940850|NCT01375777|2275218|P7|STARTED|Overall Study||46
940851|NCT01375777|2275219|P6|STARTED|Overall Study||45
940852|NCT01375777|2275220|P5|STARTED|Overall Study||46
940853|NCT01375777|2275221|P4|STARTED|Overall Study||45
940854|NCT01375777|2275222|P3|STARTED|Overall Study||46
940855|NCT01375777|2275223|P2|STARTED|Overall Study||45
940856|NCT01375777|2275224|P1|STARTED|Overall Study||46
940857|NCT01375764|2275294|P5|NOT COMPLETED|Overall Study||1
940858|NCT01375764|2275295|P4|NOT COMPLETED|Overall Study||1
940859|NCT01375764|2275296|P3|NOT COMPLETED|Overall Study||0
940860|NCT01375764|2275297|P2|NOT COMPLETED|Overall Study||1
940861|NCT01375764|2275298|P1|NOT COMPLETED|Overall Study||2
940862|NCT01375764|2275294|P5|COMPLETED|Overall Study||31
940863|NCT01375764|2275295|P4|COMPLETED|Overall Study||31
940864|NCT01375764|2275296|P3|COMPLETED|Overall Study||32
940865|NCT01375764|2275297|P2|COMPLETED|Overall Study||30
940866|NCT01375764|2275298|P1|COMPLETED|Overall Study||31
940867|NCT01375764|2275294|P5|Received Treatment|Overall Study||32
940868|NCT01375764|2275295|P4|Received Treatment|Overall Study||31
940869|NCT01375764|2275296|P3|Received Treatment|Overall Study||32
940870|NCT01375764|2275297|P2|Received Treatment|Overall Study||30
940871|NCT01375764|2275298|P1|Received Treatment|Overall Study||32
940872|NCT01375764|2275294|P5|STARTED|Overall Study||32
940873|NCT01375764|2275295|P4|STARTED|Overall Study||32
940874|NCT01375764|2275296|P3|STARTED|Overall Study||32
940875|NCT01375764|2275297|P2|STARTED|Overall Study||31
940876|NCT01375764|2275298|P1|STARTED|Overall Study||33
940877|NCT01375751|2275344|P3|NOT COMPLETED|Overall Study||0
940878|NCT01375751|2275345|P2|NOT COMPLETED|Overall Study||1
940879|NCT01375751|2275346|P1|NOT COMPLETED|Overall Study||0
940880|NCT01375751|2275344|P3|COMPLETED|Overall Study||56
940881|NCT01375751|2275345|P2|COMPLETED|Overall Study||55
940882|NCT01375751|2275346|P1|COMPLETED|Overall Study||56
940883|NCT01375751|2275344|P3|Received Treatment|Overall Study||56
940884|NCT01375751|2275345|P2|Received Treatment|Overall Study||55
940885|NCT01375751|2275346|P1|Received Treatment|Overall Study||56
940886|NCT01375751|2275344|P3|STARTED|Overall Study||56
940887|NCT01375751|2275345|P2|STARTED|Overall Study||56
940888|NCT01375751|2275346|P1|STARTED|Overall Study||56
940889|NCT01375660|2275371|P2|NOT COMPLETED|Overall Study||16
940890|NCT01375660|2275372|P1|NOT COMPLETED|Overall Study||16
940891|NCT01375660|2275371|P2|COMPLETED|Overall Study||87
940892|NCT01375660|2275372|P1|COMPLETED|Overall Study||86
940893|NCT01375660|2275371|P2|STARTED|Overall Study||103
940894|NCT01375660|2275372|P1|STARTED|Overall Study||102
940895|NCT01375608|2275390|P1|NOT COMPLETED|Overall Study||2
940896|NCT01375608|2275390|P1|COMPLETED|Overall Study||8
940897|NCT01375608|2275390|P1|STARTED|Overall Study||10
940898|NCT01375569|2275394|P1|NOT COMPLETED|Overall Study||0
940899|NCT01375569|2275394|P1|COMPLETED|Overall Study||11
940900|NCT01375569|2275394|P1|STARTED|Overall Study||11
940904|NCT01375127|2275412|P6|NOT COMPLETED|Overall Study||0
940905|NCT01375127|2275413|P5|NOT COMPLETED|Overall Study||0
940906|NCT01375127|2275414|P4|NOT COMPLETED|Overall Study||0
940907|NCT01375127|2275415|P3|NOT COMPLETED|Overall Study||0
940908|NCT01375127|2275416|P2|NOT COMPLETED|Overall Study||0
940909|NCT01375127|2275417|P1|NOT COMPLETED|Overall Study||0
940910|NCT01375127|2275412|P6|COMPLETED|Overall Study||3
940911|NCT01375127|2275413|P5|COMPLETED|Overall Study||5
940912|NCT01375127|2275414|P4|COMPLETED|Overall Study||33
940913|NCT01375127|2275415|P3|COMPLETED|Overall Study||40
940914|NCT01375127|2275416|P2|COMPLETED|Overall Study||1
940915|NCT01375127|2275417|P1|COMPLETED|Overall Study||1
940916|NCT01375127|2275412|P6|STARTED|Overall Study||3
940917|NCT01375127|2275413|P5|STARTED|Overall Study||5
940918|NCT01375127|2275414|P4|STARTED|Overall Study||33
940919|NCT01375127|2275415|P3|STARTED|Overall Study||40
940920|NCT01375127|2275416|P2|STARTED|Overall Study||1
940921|NCT01375127|2275417|P1|STARTED|Overall Study||1
940922|NCT01375049|2275449|P1|NOT COMPLETED|Overall Study||50
940923|NCT01375049|2275449|P1|COMPLETED|Overall Study||55
940924|NCT01375049|2275449|P1|STARTED|Overall Study||105
940925|NCT01374971|2275464|P1|NOT COMPLETED|Overall Study||1
940926|NCT01374971|2275464|P1|COMPLETED|Overall Study||11
940927|NCT01374971|2275464|P1|STARTED|Overall Study||12
940928|NCT01374919|2275469|P1|NOT COMPLETED|Overall Study||2
940929|NCT01374919|2275469|P1|COMPLETED|Overall Study||58
940930|NCT01374919|2275469|P1|STARTED|Overall Study||60
940931|NCT01374802|2275474|P1|NOT COMPLETED|Overall Study||0
940932|NCT01374802|2275474|P1|COMPLETED|Overall Study||14
940933|NCT01374802|2275474|P1|STARTED|Overall Study||14
940934|NCT01374568|2275488|P2|NOT COMPLETED|Overall Study||2
940935|NCT01374568|2275489|P1|NOT COMPLETED|Overall Study||0
940936|NCT01374568|2275488|P2|COMPLETED|Overall Study||1
940937|NCT01374568|2275489|P1|COMPLETED|Overall Study||2
940938|NCT01374568|2275488|P2|STARTED|Overall Study||3
940939|NCT01374568|2275489|P1|STARTED|Overall Study||2
940940|NCT01374451|2275499|P2|NOT COMPLETED|Overall Study||0
940941|NCT01374451|2275500|P1|NOT COMPLETED|Overall Study||1
940942|NCT01374451|2275499|P2|COMPLETED|Overall Study||81
940943|NCT01374451|2275500|P1|COMPLETED|Overall Study||78
940944|NCT01374451|2275499|P2|STARTED|Overall Study||81
940945|NCT01374451|2275500|P1|STARTED|Overall Study||79
940946|NCT01374438|2275529|P2|NOT COMPLETED|Overall Study||0
940947|NCT01374438|2275530|P1|NOT COMPLETED|Overall Study||0
940948|NCT01374438|2275529|P2|COMPLETED|Overall Study||13
940949|NCT01374438|2275530|P1|COMPLETED|Overall Study||16
940950|NCT01374438|2275529|P2|STARTED|Overall Study||13
940951|NCT01374438|2275530|P1|STARTED|Overall Study||16
940952|NCT01374425|2275546|P2|NOT COMPLETED|Overall Study||188
940953|NCT01374425|2275547|P1|NOT COMPLETED|Overall Study||188
940954|NCT01374425|2275546|P2|COMPLETED|Overall Study||0
940955|NCT01374425|2275547|P1|COMPLETED|Overall Study||0
940956|NCT01374425|2275546|P2|STARTED|Overall Study||188
940957|NCT01374425|2275547|P1|STARTED|Overall Study||188
940958|NCT01374269|2275627|P2|NOT COMPLETED|Overall Study||5
940959|NCT01374269|2275628|P1|NOT COMPLETED|Overall Study||6
940960|NCT01374269|2275627|P2|COMPLETED|Overall Study||39
940961|NCT01374269|2275628|P1|COMPLETED|Overall Study||40
940962|NCT01374269|2275627|P2|STARTED|Overall Study||44
940963|NCT01374269|2275628|P1|STARTED|Overall Study||46
940964|NCT01374178|2275756|P2|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||0
940965|NCT01374178|2275757|P1|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||2
940966|NCT01374178|2275756|P2|COMPLETED|Period 2 (up to 24 Hours After Dosing)||5
940967|NCT01374178|2275757|P1|COMPLETED|Period 2 (up to 24 Hours After Dosing)||8
940968|NCT01374178|2275756|P2|STARTED|Period 2 (up to 24 Hours After Dosing)||5
940969|NCT01374178|2275757|P1|STARTED|Period 2 (up to 24 Hours After Dosing)||10
940970|NCT01374178|2275756|P2|NOT COMPLETED|Washout Period of at Least 7 Days||0
940971|NCT01374178|2275757|P1|NOT COMPLETED|Washout Period of at Least 7 Days||1
940972|NCT01374178|2275756|P2|COMPLETED|Washout Period of at Least 7 Days||5
940973|NCT01374178|2275757|P1|COMPLETED|Washout Period of at Least 7 Days||10
940974|NCT01374178|2275756|P2|STARTED|Washout Period of at Least 7 Days||5
940975|NCT01374178|2275757|P1|STARTED|Washout Period of at Least 7 Days||11
940976|NCT01374178|2275756|P2|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
940977|NCT01374178|2275757|P1|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
940978|NCT01374178|2275756|P2|COMPLETED|Period 1 (up to 24 Hours After Dosing)||5
940979|NCT01374178|2275757|P1|COMPLETED|Period 1 (up to 24 Hours After Dosing)||11
940980|NCT01374178|2275756|P2|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||5
940981|NCT01374178|2275757|P1|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||11
940982|NCT01374178|2275756|P2|STARTED|Period 1 (up to 24 Hours After Dosing)||5
940983|NCT01374178|2275757|P1|STARTED|Period 1 (up to 24 Hours After Dosing)||11
940984|NCT01374087|2275775|P2|NOT COMPLETED|Overall Study||16
940985|NCT01374087|2275776|P1|NOT COMPLETED|Overall Study||15
940986|NCT01374087|2275775|P2|COMPLETED|Overall Study||0
940987|NCT01374087|2275776|P1|COMPLETED|Overall Study||0
940988|NCT01374087|2275775|P2|STARTED|Overall Study||16
940989|NCT01374087|2275776|P1|STARTED|Overall Study||15
940990|NCT01373918|2275786|P2|NOT COMPLETED|Overall Study||1
940991|NCT01373918|2275787|P1|NOT COMPLETED|Overall Study||0
940992|NCT01373918|2275786|P2|COMPLETED|Overall Study||15
940993|NCT01373918|2275787|P1|COMPLETED|Overall Study||20
940994|NCT01373918|2275786|P2|STARTED|Overall Study||16
940995|NCT01373918|2275787|P1|STARTED|Overall Study||20
940996|NCT01373671|2275799|P1|NOT COMPLETED|Overall Study||92
940997|NCT01373671|2275799|P1|COMPLETED|Overall Study||672
940998|NCT01373671|2275799|P1|STARTED|Overall Study||764
940999|NCT01373450|2275804|P6|NOT COMPLETED|Crossover Period 4||0
941000|NCT01373450|2275805|P5|NOT COMPLETED|Crossover Period 4||0
941001|NCT01373450|2275806|P4|NOT COMPLETED|Crossover Period 4||0
941002|NCT01373450|2275807|P3|NOT COMPLETED|Crossover Period 4||0
941003|NCT01373450|2275808|P2|NOT COMPLETED|Crossover Period 4||0
941004|NCT01373450|2275809|P1|NOT COMPLETED|Crossover Period 4||0
941005|NCT01373450|2275804|P6|COMPLETED|Crossover Period 4||2
941006|NCT01373450|2275805|P5|COMPLETED|Crossover Period 4||2
941007|NCT01373450|2275806|P4|COMPLETED|Crossover Period 4||2
941008|NCT01373450|2275807|P3|COMPLETED|Crossover Period 4||2
941009|NCT01373450|2275808|P2|COMPLETED|Crossover Period 4||2
941010|NCT01373450|2275809|P1|COMPLETED|Crossover Period 4||2
941011|NCT01373450|2275804|P6|STARTED|Crossover Period 4||2
941012|NCT01373450|2275805|P5|STARTED|Crossover Period 4||2
941013|NCT01373450|2275806|P4|STARTED|Crossover Period 4||2
941014|NCT01373450|2275807|P3|STARTED|Crossover Period 4||2
941015|NCT01373450|2275808|P2|STARTED|Crossover Period 4||2
941016|NCT01373450|2275809|P1|STARTED|Crossover Period 4||2
941017|NCT01373450|2275804|P6|NOT COMPLETED|7 Day Wash-out||0
941018|NCT01373450|2275805|P5|NOT COMPLETED|7 Day Wash-out||0
941019|NCT01373450|2275806|P4|NOT COMPLETED|7 Day Wash-out||0
941020|NCT01373450|2275807|P3|NOT COMPLETED|7 Day Wash-out||0
941021|NCT01373450|2275808|P2|NOT COMPLETED|7 Day Wash-out||0
941022|NCT01373450|2275809|P1|NOT COMPLETED|7 Day Wash-out||0
941023|NCT01373450|2275804|P6|COMPLETED|7 Day Wash-out||2
941024|NCT01373450|2275805|P5|COMPLETED|7 Day Wash-out||2
941025|NCT01373450|2275806|P4|COMPLETED|7 Day Wash-out||2
941026|NCT01373450|2275807|P3|COMPLETED|7 Day Wash-out||2
941027|NCT01373450|2275808|P2|COMPLETED|7 Day Wash-out||2
941028|NCT01373450|2275809|P1|COMPLETED|7 Day Wash-out||2
941029|NCT01373450|2275804|P6|STARTED|7 Day Wash-out||2
941030|NCT01373450|2275805|P5|STARTED|7 Day Wash-out||2
941031|NCT01373450|2275806|P4|STARTED|7 Day Wash-out||2
941032|NCT01373450|2275807|P3|STARTED|7 Day Wash-out||2
941033|NCT01373450|2275808|P2|STARTED|7 Day Wash-out||2
941034|NCT01373450|2275809|P1|STARTED|7 Day Wash-out||2
941035|NCT01373450|2275804|P6|NOT COMPLETED|Crossover Period 3||0
941036|NCT01373450|2275805|P5|NOT COMPLETED|Crossover Period 3||0
941037|NCT01373450|2275806|P4|NOT COMPLETED|Crossover Period 3||0
941038|NCT01373450|2275807|P3|NOT COMPLETED|Crossover Period 3||0
941039|NCT01373450|2275808|P2|NOT COMPLETED|Crossover Period 3||0
941040|NCT01373450|2275809|P1|NOT COMPLETED|Crossover Period 3||0
941041|NCT01373450|2275804|P6|COMPLETED|Crossover Period 3||2
941042|NCT01373450|2275805|P5|COMPLETED|Crossover Period 3||2
941043|NCT01373450|2275806|P4|COMPLETED|Crossover Period 3||2
941044|NCT01373450|2275807|P3|COMPLETED|Crossover Period 3||2
941045|NCT01373450|2275808|P2|COMPLETED|Crossover Period 3||2
941046|NCT01373450|2275809|P1|COMPLETED|Crossover Period 3||2
941047|NCT01373450|2275804|P6|STARTED|Crossover Period 3||2
941048|NCT01373450|2275805|P5|STARTED|Crossover Period 3||2
941049|NCT01373450|2275806|P4|STARTED|Crossover Period 3||2
941050|NCT01373450|2275807|P3|STARTED|Crossover Period 3||2
941051|NCT01373450|2275808|P2|STARTED|Crossover Period 3||2
941052|NCT01373450|2275809|P1|STARTED|Crossover Period 3||2
941053|NCT01373450|2275804|P6|NOT COMPLETED|7 Day Wash-out||0
941054|NCT01373450|2275805|P5|NOT COMPLETED|7 Day Wash-out||0
941055|NCT01373450|2275806|P4|NOT COMPLETED|7 Day Wash-out||0
941056|NCT01373450|2275807|P3|NOT COMPLETED|7 Day Wash-out||0
941057|NCT01373450|2275808|P2|NOT COMPLETED|7 Day Wash-out||0
941058|NCT01373450|2275809|P1|NOT COMPLETED|7 Day Wash-out||0
941059|NCT01373450|2275804|P6|COMPLETED|7 Day Wash-out||2
941060|NCT01373450|2275805|P5|COMPLETED|7 Day Wash-out||2
941061|NCT01373450|2275806|P4|COMPLETED|7 Day Wash-out||2
941062|NCT01373450|2275807|P3|COMPLETED|7 Day Wash-out||2
941063|NCT01373450|2275808|P2|COMPLETED|7 Day Wash-out||2
941064|NCT01373450|2275809|P1|COMPLETED|7 Day Wash-out||2
941065|NCT01373450|2275804|P6|STARTED|7 Day Wash-out||2
941066|NCT01373450|2275805|P5|STARTED|7 Day Wash-out||2
941067|NCT01373450|2275806|P4|STARTED|7 Day Wash-out||2
941068|NCT01373450|2275807|P3|STARTED|7 Day Wash-out||2
941069|NCT01373450|2275808|P2|STARTED|7 Day Wash-out||2
941070|NCT01373450|2275809|P1|STARTED|7 Day Wash-out||2
941071|NCT01373450|2275804|P6|NOT COMPLETED|Crossover Period 2||0
941072|NCT01373450|2275805|P5|NOT COMPLETED|Crossover Period 2||0
941073|NCT01373450|2275806|P4|NOT COMPLETED|Crossover Period 2||0
941074|NCT01373450|2275807|P3|NOT COMPLETED|Crossover Period 2||0
941075|NCT01373450|2275808|P2|NOT COMPLETED|Crossover Period 2||0
941076|NCT01373450|2275809|P1|NOT COMPLETED|Crossover Period 2||0
941077|NCT01373450|2275804|P6|COMPLETED|Crossover Period 2||2
941078|NCT01373450|2275805|P5|COMPLETED|Crossover Period 2||2
941079|NCT01373450|2275806|P4|COMPLETED|Crossover Period 2||2
941080|NCT01373450|2275807|P3|COMPLETED|Crossover Period 2||2
941081|NCT01373450|2275808|P2|COMPLETED|Crossover Period 2||2
941082|NCT01373450|2275809|P1|COMPLETED|Crossover Period 2||2
941083|NCT01373450|2275804|P6|STARTED|Crossover Period 2||2
941084|NCT01373450|2275805|P5|STARTED|Crossover Period 2||2
941085|NCT01373450|2275806|P4|STARTED|Crossover Period 2||2
941086|NCT01373450|2275807|P3|STARTED|Crossover Period 2||2
941087|NCT01373450|2275808|P2|STARTED|Crossover Period 2||2
941088|NCT01373450|2275809|P1|STARTED|Crossover Period 2||2
941089|NCT01373450|2275804|P6|NOT COMPLETED|7 Day Wash-out||0
941090|NCT01373450|2275805|P5|NOT COMPLETED|7 Day Wash-out||0
941091|NCT01373450|2275806|P4|NOT COMPLETED|7 Day Wash-out||0
941092|NCT01373450|2275807|P3|NOT COMPLETED|7 Day Wash-out||0
941093|NCT01373450|2275808|P2|NOT COMPLETED|7 Day Wash-out||0
941094|NCT01373450|2275809|P1|NOT COMPLETED|7 Day Wash-out||0
941095|NCT01373450|2275804|P6|COMPLETED|7 Day Wash-out||2
941096|NCT01373450|2275805|P5|COMPLETED|7 Day Wash-out||2
941097|NCT01373450|2275806|P4|COMPLETED|7 Day Wash-out||2
941098|NCT01373450|2275807|P3|COMPLETED|7 Day Wash-out||2
941099|NCT01373450|2275808|P2|COMPLETED|7 Day Wash-out||2
941100|NCT01373450|2275809|P1|COMPLETED|7 Day Wash-out||2
941101|NCT01373450|2275804|P6|STARTED|7 Day Wash-out||2
941102|NCT01373450|2275805|P5|STARTED|7 Day Wash-out||2
941103|NCT01373450|2275806|P4|STARTED|7 Day Wash-out||2
941104|NCT01373450|2275807|P3|STARTED|7 Day Wash-out||2
941105|NCT01373450|2275808|P2|STARTED|7 Day Wash-out||2
941106|NCT01373450|2275809|P1|STARTED|7 Day Wash-out||2
941107|NCT01373450|2275804|P6|NOT COMPLETED|Crossover Period 1||0
941108|NCT01373450|2275805|P5|NOT COMPLETED|Crossover Period 1||0
941109|NCT01373450|2275806|P4|NOT COMPLETED|Crossover Period 1||0
941110|NCT01373450|2275807|P3|NOT COMPLETED|Crossover Period 1||0
941111|NCT01373450|2275808|P2|NOT COMPLETED|Crossover Period 1||0
941112|NCT01373450|2275809|P1|NOT COMPLETED|Crossover Period 1||0
941113|NCT01373450|2275804|P6|COMPLETED|Crossover Period 1||2
941114|NCT01373450|2275805|P5|COMPLETED|Crossover Period 1||2
941115|NCT01373450|2275806|P4|COMPLETED|Crossover Period 1||2
941116|NCT01373450|2275807|P3|COMPLETED|Crossover Period 1||2
941117|NCT01373450|2275808|P2|COMPLETED|Crossover Period 1||2
941118|NCT01373450|2275809|P1|COMPLETED|Crossover Period 1||2
941119|NCT01373450|2275804|P6|STARTED|Crossover Period 1||2
941120|NCT01373450|2275805|P5|STARTED|Crossover Period 1||2
941121|NCT01373450|2275806|P4|STARTED|Crossover Period 1||2
941122|NCT01373450|2275807|P3|STARTED|Crossover Period 1||2
941123|NCT01373450|2275808|P2|STARTED|Crossover Period 1||2
941124|NCT01373450|2275809|P1|STARTED|Crossover Period 1||2
941125|NCT01373346|2275831|P1|NOT COMPLETED|Overall Study||1
941126|NCT01373346|2275831|P1|COMPLETED|Overall Study||14
941127|NCT01373346|2275831|P1|STARTED|Overall Study||15
941128|NCT01373294|2275854|P2|NOT COMPLETED|Overall Study||0
941129|NCT01373294|2275855|P1|NOT COMPLETED|Overall Study||1
941130|NCT01373294|2275854|P2|COMPLETED|Overall Study||2
941131|NCT01373294|2275855|P1|COMPLETED|Overall Study||14
941132|NCT01373294|2275854|P2|STARTED|Overall Study||2
941133|NCT01373294|2275855|P1|STARTED|Overall Study||15
941134|NCT01373281|2275864|P2|NOT COMPLETED|Overall Study||45
941135|NCT01373281|2275865|P1|NOT COMPLETED|Overall Study||79
941136|NCT01373281|2275864|P2|COMPLETED|Overall Study||3379
941137|NCT01373281|2275865|P1|COMPLETED|Overall Study||6772
941138|NCT01373281|2275864|P2|STARTED|Overall Study||3424
941139|NCT01373281|2275865|P1|STARTED|Overall Study||6851
941140|NCT01372995|2275884|P3|NOT COMPLETED|Overall Study||1
941141|NCT01372995|2275885|P2|NOT COMPLETED|Overall Study||1
941142|NCT01372995|2275886|P1|NOT COMPLETED|Overall Study||0
941143|NCT01372995|2275884|P3|COMPLETED|Overall Study|The transferred participant was included in the intent to treat analyses.|10
941144|NCT01372995|2275885|P2|COMPLETED|Overall Study||9
941145|NCT01372995|2275886|P1|COMPLETED|Overall Study||10
941146|NCT01372995|2275884|P3|STARTED|Overall Study|One participant was transferred to comfort care prior to completing the intervention.|11
941147|NCT01372995|2275885|P2|STARTED|Overall Study||10
941148|NCT01372995|2275886|P1|STARTED|Overall Study||10
941149|NCT01372878|2275933|P1|NOT COMPLETED|Overall Study||184
941150|NCT01372878|2275933|P1|COMPLETED|Overall Study||700
941151|NCT01372878|2275933|P1|STARTED|Overall Study||884
941152|NCT01372813|2275938|P1|NOT COMPLETED|Overall Study||0
941153|NCT01372813|2275938|P1|COMPLETED|Overall Study||3
941154|NCT01372813|2275938|P1|STARTED|Overall Study||3
941155|NCT01372748|2275953|P2|NOT COMPLETED|Overall Study||39
941156|NCT01372748|2275954|P1|NOT COMPLETED|Overall Study||23
941157|NCT01372748|2275953|P2|COMPLETED|Overall Study|defined as having vital status|12603
941158|NCT01372748|2275954|P1|COMPLETED|Overall Study|defined as having vital status|11022
941159|NCT01372748|2275953|P2|STARTED|Overall Study||12642
941160|NCT01372748|2275954|P1|STARTED|Overall Study||11045
941161|NCT01372605|2275964|P2|NOT COMPLETED|Overall Study||10
941162|NCT01372605|2275965|P1|NOT COMPLETED|Overall Study||12
941163|NCT01372605|2275964|P2|COMPLETED|Overall Study||145
941164|NCT01372605|2275965|P1|COMPLETED|Overall Study||137
941165|NCT01372605|2275964|P2|STARTED|Overall Study||155
941166|NCT01372605|2275965|P1|STARTED|Overall Study||149
941167|NCT01372501|2275991|P1|NOT COMPLETED|Overall Study||5
941168|NCT01372501|2275991|P1|COMPLETED|Overall Study||14
941169|NCT01372501|2275991|P1|STARTED|Overall Study||19
941170|NCT01372462|2275996|P1|NOT COMPLETED|No Treatment Control||0
941171|NCT01372462|2275996|P1|COMPLETED|No Treatment Control||15
941172|NCT01372462|2275996|P1|STARTED|No Treatment Control||15
941173|NCT01372462|2275996|P1|NOT COMPLETED|Oxygen Nasal Cannula||0
941174|NCT01372462|2275996|P1|COMPLETED|Oxygen Nasal Cannula||15
941175|NCT01372462|2275996|P1|STARTED|Oxygen Nasal Cannula||15
941176|NCT01372462|2275996|P1|NOT COMPLETED|NIOV - Oxygen||0
941177|NCT01372462|2275996|P1|COMPLETED|NIOV - Oxygen||15
941178|NCT01372462|2275996|P1|STARTED|NIOV - Oxygen||15
941179|NCT01372462|2275996|P1|NOT COMPLETED|NIOV - Room Air||0
941180|NCT01372462|2275996|P1|COMPLETED|NIOV - Room Air||15
941181|NCT01372462|2275996|P1|STARTED|NIOV - Room Air||15
941182|NCT01372410|2276014|P8|NOT COMPLETED|Treatment Period 3 (7 Days)||0
941183|NCT01372410|2276015|P7|NOT COMPLETED|Treatment Period 3 (7 Days)||0
941184|NCT01372410|2276016|P6|NOT COMPLETED|Treatment Period 3 (7 Days)||1
941185|NCT01372410|2276017|P5|NOT COMPLETED|Treatment Period 3 (7 Days)||0
941186|NCT01372410|2276018|P4|NOT COMPLETED|Treatment Period 3 (7 Days)||0
941187|NCT01372410|2276019|P3|NOT COMPLETED|Treatment Period 3 (7 Days)||1
941188|NCT01372410|2276020|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||0
941189|NCT01372410|2276021|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
941190|NCT01372410|2276014|P8|COMPLETED|Treatment Period 3 (7 Days)||18
941191|NCT01372410|2276015|P7|COMPLETED|Treatment Period 3 (7 Days)||15
941192|NCT01372410|2276016|P6|COMPLETED|Treatment Period 3 (7 Days)||18
941193|NCT01372410|2276017|P5|COMPLETED|Treatment Period 3 (7 Days)||20
941194|NCT01372410|2276018|P4|COMPLETED|Treatment Period 3 (7 Days)||22
941195|NCT01372410|2276019|P3|COMPLETED|Treatment Period 3 (7 Days)||15
941196|NCT01372410|2276020|P2|COMPLETED|Treatment Period 3 (7 Days)||18
941197|NCT01372410|2276021|P1|COMPLETED|Treatment Period 3 (7 Days)||21
941198|NCT01372410|2276014|P8|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
941199|NCT01372410|2276015|P7|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|15
941200|NCT01372410|2276016|P6|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
941201|NCT01372410|2276017|P5|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|20
941202|NCT01372410|2276018|P4|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
941203|NCT01372410|2276019|P3|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
941204|NCT01372410|2276020|P2|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
941205|NCT01372410|2276021|P1|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
941206|NCT01372410|2276014|P8|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
941207|NCT01372410|2276015|P7|NOT COMPLETED|Washout Period 2 (10-14 Days)||1
941208|NCT01372410|2276016|P6|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
941209|NCT01372410|2276017|P5|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
941210|NCT01372410|2276018|P4|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
941211|NCT01372410|2276019|P3|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
941212|NCT01372410|2276020|P2|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
941213|NCT01372410|2276021|P1|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
941275|NCT01372410|2276019|P3|STARTED|Washout Period 1 (10-14 Days)||19
941214|NCT01372410|2276014|P8|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
941215|NCT01372410|2276015|P7|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
941216|NCT01372410|2276016|P6|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|16
941217|NCT01372410|2276017|P5|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
941218|NCT01372410|2276018|P4|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
941219|NCT01372410|2276019|P3|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|22
941220|NCT01372410|2276020|P2|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
941221|NCT01372410|2276021|P1|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
941222|NCT01372410|2276014|P8|STARTED|Washout Period 2 (10-14 Days)||19
941223|NCT01372410|2276015|P7|STARTED|Washout Period 2 (10-14 Days)||21
941224|NCT01372410|2276016|P6|STARTED|Washout Period 2 (10-14 Days)||16
941225|NCT01372410|2276017|P5|STARTED|Washout Period 2 (10-14 Days)||19
941226|NCT01372410|2276018|P4|STARTED|Washout Period 2 (10-14 Days)||17
941227|NCT01372410|2276019|P3|STARTED|Washout Period 2 (10-14 Days)||22
941228|NCT01372410|2276020|P2|STARTED|Washout Period 2 (10-14 Days)||21
941229|NCT01372410|2276021|P1|STARTED|Washout Period 2 (10-14 Days)||19
941230|NCT01372410|2276014|P8|NOT COMPLETED|Treatment Period 2 (7 Days)||0
941231|NCT01372410|2276015|P7|NOT COMPLETED|Treatment Period 2 (7 Days)||0
941232|NCT01372410|2276016|P6|NOT COMPLETED|Treatment Period 2 (7 Days)||0
941233|NCT01372410|2276017|P5|NOT COMPLETED|Treatment Period 2 (7 Days)||0
941234|NCT01372410|2276018|P4|NOT COMPLETED|Treatment Period 2 (7 Days)||0
941235|NCT01372410|2276019|P3|NOT COMPLETED|Treatment Period 2 (7 Days)||0
941236|NCT01372410|2276020|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||0
941237|NCT01372410|2276021|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
941238|NCT01372410|2276014|P8|COMPLETED|Treatment Period 2 (7 Days)||19
941239|NCT01372410|2276015|P7|COMPLETED|Treatment Period 2 (7 Days)||21
941240|NCT01372410|2276016|P6|COMPLETED|Treatment Period 2 (7 Days)||16
941241|NCT01372410|2276017|P5|COMPLETED|Treatment Period 2 (7 Days)||19
941242|NCT01372410|2276018|P4|COMPLETED|Treatment Period 2 (7 Days)||17
941243|NCT01372410|2276019|P3|COMPLETED|Treatment Period 2 (7 Days)||22
941244|NCT01372410|2276020|P2|COMPLETED|Treatment Period 2 (7 Days)||21
941245|NCT01372410|2276021|P1|COMPLETED|Treatment Period 2 (7 Days)||19
941246|NCT01372410|2276014|P8|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
941247|NCT01372410|2276015|P7|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
941248|NCT01372410|2276016|P6|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
941249|NCT01372410|2276017|P5|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
941250|NCT01372410|2276018|P4|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|17
941251|NCT01372410|2276019|P3|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
941252|NCT01372410|2276020|P2|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
941253|NCT01372410|2276021|P1|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
941254|NCT01372410|2276014|P8|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
941255|NCT01372410|2276015|P7|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
941256|NCT01372410|2276016|P6|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
941257|NCT01372410|2276017|P5|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
941258|NCT01372410|2276018|P4|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
941259|NCT01372410|2276019|P3|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
941260|NCT01372410|2276020|P2|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
941261|NCT01372410|2276021|P1|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
941262|NCT01372410|2276014|P8|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
941263|NCT01372410|2276015|P7|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
941264|NCT01372410|2276016|P6|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
941265|NCT01372410|2276017|P5|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
941266|NCT01372410|2276018|P4|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
941267|NCT01372410|2276019|P3|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
941268|NCT01372410|2276020|P2|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
941269|NCT01372410|2276021|P1|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
941270|NCT01372410|2276014|P8|STARTED|Washout Period 1 (10-14 Days)||19
941271|NCT01372410|2276015|P7|STARTED|Washout Period 1 (10-14 Days)||20
941272|NCT01372410|2276016|P6|STARTED|Washout Period 1 (10-14 Days)||21
941273|NCT01372410|2276017|P5|STARTED|Washout Period 1 (10-14 Days)||19
941274|NCT01372410|2276018|P4|STARTED|Washout Period 1 (10-14 Days)||20
941276|NCT01372410|2276020|P2|STARTED|Washout Period 1 (10-14 Days)||19
941277|NCT01372410|2276021|P1|STARTED|Washout Period 1 (10-14 Days)||19
941278|NCT01372410|2276014|P8|NOT COMPLETED|Treatment Period 1 (7 Days)||0
941279|NCT01372410|2276015|P7|NOT COMPLETED|Treatment Period 1 (7 Days)||2
941280|NCT01372410|2276016|P6|NOT COMPLETED|Treatment Period 1 (7 Days)||0
941281|NCT01372410|2276017|P5|NOT COMPLETED|Treatment Period 1 (7 Days)||2
941282|NCT01372410|2276018|P4|NOT COMPLETED|Treatment Period 1 (7 Days)||0
941283|NCT01372410|2276019|P3|NOT COMPLETED|Treatment Period 1 (7 Days)||0
941284|NCT01372410|2276020|P2|NOT COMPLETED|Treatment Period 1 (7 Days)||2
941285|NCT01372410|2276021|P1|NOT COMPLETED|Treatment Period 1 (7 Days)||1
941286|NCT01372410|2276014|P8|COMPLETED|Treatment Period 1 (7 Days)||19
941287|NCT01372410|2276015|P7|COMPLETED|Treatment Period 1 (7 Days)||20
941288|NCT01372410|2276016|P6|COMPLETED|Treatment Period 1 (7 Days)||21
941289|NCT01372410|2276017|P5|COMPLETED|Treatment Period 1 (7 Days)||19
941290|NCT01372410|2276018|P4|COMPLETED|Treatment Period 1 (7 Days)||20
941291|NCT01372410|2276019|P3|COMPLETED|Treatment Period 1 (7 Days)||19
941292|NCT01372410|2276020|P2|COMPLETED|Treatment Period 1 (7 Days)||19
941293|NCT01372410|2276021|P1|COMPLETED|Treatment Period 1 (7 Days)||19
941294|NCT01372410|2276014|P8|STARTED|Treatment Period 1 (7 Days)||19
941295|NCT01372410|2276015|P7|STARTED|Treatment Period 1 (7 Days)||22
941296|NCT01372410|2276016|P6|STARTED|Treatment Period 1 (7 Days)||21
941297|NCT01372410|2276017|P5|STARTED|Treatment Period 1 (7 Days)||21
941298|NCT01372410|2276018|P4|STARTED|Treatment Period 1 (7 Days)||20
941299|NCT01372410|2276019|P3|STARTED|Treatment Period 1 (7 Days)||19
941300|NCT01372410|2276020|P2|STARTED|Treatment Period 1 (7 Days)||21
941301|NCT01372410|2276021|P1|STARTED|Treatment Period 1 (7 Days)||20
941302|NCT01372384|2276058|P1|NOT COMPLETED|Overall Study||3
941303|NCT01372384|2276058|P1|COMPLETED|Overall Study||3
941304|NCT01372384|2276058|P1|STARTED|Overall Study||6
941305|NCT01372202|2276068|P3|NOT COMPLETED|Overall Study||0
941306|NCT01372202|2276069|P2|NOT COMPLETED|Overall Study||0
941307|NCT01372202|2276070|P1|NOT COMPLETED|Overall Study||0
941308|NCT01372202|2276068|P3|COMPLETED|Overall Study||9
941309|NCT01372202|2276069|P2|COMPLETED|Overall Study||9
941310|NCT01372202|2276070|P1|COMPLETED|Overall Study||13
941311|NCT01372202|2276068|P3|STARTED|Overall Study||9
941312|NCT01372202|2276069|P2|STARTED|Overall Study||9
941313|NCT01372202|2276070|P1|STARTED|Overall Study||13
941314|NCT01372150|2276081|P3|NOT COMPLETED|Overall Study||16
941315|NCT01372150|2276082|P2|NOT COMPLETED|Overall Study||14
941316|NCT01372150|2276083|P1|NOT COMPLETED|Overall Study||13
941317|NCT01372150|2276081|P3|COMPLETED|Overall Study||99
941318|NCT01372150|2276082|P2|COMPLETED|Overall Study||99
941319|NCT01372150|2276083|P1|COMPLETED|Overall Study||99
941320|NCT01372150|2276081|P3|Treated|Overall Study||115
941321|NCT01372150|2276082|P2|Treated|Overall Study||112
941322|NCT01372150|2276083|P1|Treated|Overall Study||112
941323|NCT01372150|2276081|P3|STARTED|Overall Study||115
941324|NCT01372150|2276082|P2|STARTED|Overall Study||113
941325|NCT01372150|2276083|P1|STARTED|Overall Study||112
941326|NCT01371994|2276102|P2|NOT COMPLETED|Overall Study||42
941327|NCT01371994|2276103|P1|NOT COMPLETED|Overall Study||57
941328|NCT01371994|2276102|P2|COMPLETED|Overall Study||278
941329|NCT01371994|2276103|P1|COMPLETED|Overall Study||263
941330|NCT01371994|2276102|P2|Received Treatment|Overall Study||313
941331|NCT01371994|2276103|P1|Received Treatment|Overall Study||310
941332|NCT01371994|2276102|P2|STARTED|Overall Study||320
941333|NCT01371994|2276103|P1|STARTED|Overall Study||320
941334|NCT01371877|2276147|P2|NOT COMPLETED|Overall Study||4
941335|NCT01371877|2276148|P1|NOT COMPLETED|Overall Study||0
941336|NCT01371877|2276147|P2|COMPLETED|Overall Study||17
941337|NCT01371877|2276148|P1|COMPLETED|Overall Study||21
941338|NCT01371877|2276147|P2|STARTED|Overall Study||21
941339|NCT01371877|2276148|P1|STARTED|Overall Study||21
941340|NCT01371851|2276160|P2|NOT COMPLETED|Overall Study||9
941341|NCT01371851|2276161|P1|NOT COMPLETED|Overall Study||8
941342|NCT01371851|2276160|P2|COMPLETED|Overall Study||2
941343|NCT01371851|2276161|P1|COMPLETED|Overall Study||3
941344|NCT01371851|2276160|P2|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
941345|NCT01371851|2276161|P1|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
941346|NCT01371838|2276169|P2|NOT COMPLETED|Overall Study||66
941347|NCT01371838|2276170|P1|NOT COMPLETED|Overall Study||49
941348|NCT01371838|2276169|P2|COMPLETED|Overall Study||317
941349|NCT01371838|2276170|P1|COMPLETED|Overall Study||332
941350|NCT01371838|2276169|P2|STARTED|Overall Study||383
941351|NCT01371838|2276170|P1|STARTED|Overall Study||381
941352|NCT01371825|2276206|P1|NOT COMPLETED|Long-term Treatment Period||0
941353|NCT01371825|2276206|P1|COMPLETED|Long-term Treatment Period|This period is currently ongoing.|6
941354|NCT01371825|2276206|P1|STARTED|Long-term Treatment Period||6
941355|NCT01371825|2276206|P1|NOT COMPLETED|Primary Efficacy Analysis Period||3
941356|NCT01371825|2276206|P1|COMPLETED|Primary Efficacy Analysis Period||6
941357|NCT01371825|2276206|P1|STARTED|Primary Efficacy Analysis Period||9
941358|NCT01371786|2276220|P2|NOT COMPLETED|Overall Study||0
941359|NCT01371786|2276221|P1|NOT COMPLETED|Overall Study||0
941360|NCT01371786|2276220|P2|COMPLETED|Overall Study||7
941361|NCT01371786|2276221|P1|COMPLETED|Overall Study||7
941362|NCT01371786|2276220|P2|STARTED|Overall Study||7
941363|NCT01371786|2276221|P1|STARTED|Overall Study||7
941364|NCT01371747|2276241|P6|NOT COMPLETED|Overall Study||14
941365|NCT01371747|2276242|P5|NOT COMPLETED|Overall Study||7
941366|NCT01371747|2276243|P4|NOT COMPLETED|Overall Study||9
941367|NCT01371747|2276244|P3|NOT COMPLETED|Overall Study||24
941368|NCT01371747|2276245|P2|NOT COMPLETED|Overall Study||23
941369|NCT01371747|2276246|P1|NOT COMPLETED|Overall Study||18
941370|NCT01371747|2276241|P6|COMPLETED|Overall Study||16
941371|NCT01371747|2276242|P5|COMPLETED|Overall Study||21
941372|NCT01371747|2276243|P4|COMPLETED|Overall Study||17
941373|NCT01371747|2276244|P3|COMPLETED|Overall Study||50
941374|NCT01371747|2276245|P2|COMPLETED|Overall Study||51
941375|NCT01371747|2276246|P1|COMPLETED|Overall Study||56
941376|NCT01371747|2276241|P6|STARTED|Overall Study||30
941377|NCT01371747|2276242|P5|STARTED|Overall Study||28
941378|NCT01371747|2276243|P4|STARTED|Overall Study||26
941379|NCT01371747|2276244|P3|STARTED|Overall Study||74
941380|NCT01371747|2276245|P2|STARTED|Overall Study||74
941381|NCT01371747|2276246|P1|STARTED|Overall Study||74
941382|NCT01371734|2276311|P3|NOT COMPLETED|Overall Study||17
941383|NCT01371734|2276312|P2|NOT COMPLETED|Overall Study||19
941384|NCT01371734|2276313|P1|NOT COMPLETED|Overall Study||23
941385|NCT01371734|2276311|P3|COMPLETED|Overall Study||104
941386|NCT01371734|2276312|P2|COMPLETED|Overall Study||103
941387|NCT01371734|2276313|P1|COMPLETED|Overall Study||97
941388|NCT01371734|2276311|P3|STARTED|Overall Study||121
941389|NCT01371734|2276312|P2|STARTED|Overall Study||122
941390|NCT01371734|2276313|P1|STARTED|Overall Study||120
941391|NCT01371721|2276333|P3|NOT COMPLETED|Overall Study||30
941392|NCT01371721|2276334|P2|NOT COMPLETED|Overall Study||24
941393|NCT01371721|2276335|P1|NOT COMPLETED|Overall Study||29
941394|NCT01371721|2276333|P3|COMPLETED|Overall Study||62
941395|NCT01371721|2276334|P2|COMPLETED|Overall Study||65
941396|NCT01371721|2276335|P1|COMPLETED|Overall Study||59
941397|NCT01371721|2276333|P3|Treated|Overall Study||92
941398|NCT01371721|2276334|P2|Treated|Overall Study||89
941399|NCT01371721|2276335|P1|Treated|Overall Study||87
941400|NCT01371721|2276333|P3|STARTED|Overall Study||92
941401|NCT01371721|2276334|P2|STARTED|Overall Study||89
941402|NCT01371721|2276335|P1|STARTED|Overall Study||88
941403|NCT01371708|2276368|P3|NOT COMPLETED|Overall Study||39
941404|NCT01371708|2276369|P2|NOT COMPLETED|Overall Study||30
941405|NCT01371708|2276370|P1|NOT COMPLETED|Overall Study||26
941406|NCT01371708|2276368|P3|COMPLETED|Overall Study||59
941407|NCT01371708|2276369|P2|COMPLETED|Overall Study||63
941408|NCT01371708|2276370|P1|COMPLETED|Overall Study||66
941409|NCT01371708|2276368|P3|Received Treatment|Overall Study||97
941410|NCT01371708|2276369|P2|Received Treatment|Overall Study||93
941411|NCT01371708|2276370|P1|Received Treatment|Overall Study||91
941412|NCT01371708|2276368|P3|STARTED|Overall Study||98
941413|NCT01371708|2276369|P2|STARTED|Overall Study||93
941414|NCT01371708|2276370|P1|STARTED|Overall Study||92
941415|NCT01371643|2276402|P2|NOT COMPLETED|Overall Study||0
941416|NCT01371643|2276403|P1|NOT COMPLETED|Overall Study||3
941417|NCT01371643|2276402|P2|COMPLETED|Overall Study||26
941418|NCT01371643|2276403|P1|COMPLETED|Overall Study||12
941419|NCT01371643|2276402|P2|STARTED|Overall Study||26
941420|NCT01371643|2276403|P1|STARTED|Overall Study||15
941421|NCT01371565|2276413|P1|NOT COMPLETED|Overall Study||3
941422|NCT01371565|2276413|P1|COMPLETED|Overall Study||1
941423|NCT01371565|2276413|P1|STARTED|Overall Study||4
941424|NCT01371552|2276417|P6|NOT COMPLETED|Part 2, One Week||0
941425|NCT01371552|2276418|P5|NOT COMPLETED|Part 2, One Week||0
941426|NCT01371552|2276419|P4|NOT COMPLETED|Part 2, One Week||0
941427|NCT01371552|2276420|P3|NOT COMPLETED|Part 2, One Week||0
941428|NCT01371552|2276421|P2|NOT COMPLETED|Part 2, One Week||0
941429|NCT01371552|2276422|P1|NOT COMPLETED|Part 2, One Week||0
941430|NCT01371552|2276417|P6|COMPLETED|Part 2, One Week||18
941431|NCT01371552|2276418|P5|COMPLETED|Part 2, One Week||15
941432|NCT01371552|2276419|P4|COMPLETED|Part 2, One Week||20
941433|NCT01371552|2276420|P3|COMPLETED|Part 2, One Week||18
941434|NCT01371552|2276421|P2|COMPLETED|Part 2, One Week||17
941435|NCT01371552|2276422|P1|COMPLETED|Part 2, One Week||18
941436|NCT01371552|2276417|P6|STARTED|Part 2, One Week||18
941437|NCT01371552|2276418|P5|STARTED|Part 2, One Week||15
941438|NCT01371552|2276419|P4|STARTED|Part 2, One Week||20
941439|NCT01371552|2276420|P3|STARTED|Part 2, One Week||18
941440|NCT01371552|2276421|P2|STARTED|Part 2, One Week||17
941441|NCT01371552|2276422|P1|STARTED|Part 2, One Week|One participant discontinued between Part 1 and Part 2 due to inconvenience|18
941442|NCT01371552|2276417|P6|NOT COMPLETED|Part 1, Third 3 Days||1
941443|NCT01371552|2276418|P5|NOT COMPLETED|Part 1, Third 3 Days||1
941444|NCT01371552|2276419|P4|NOT COMPLETED|Part 1, Third 3 Days||0
941445|NCT01371552|2276420|P3|NOT COMPLETED|Part 1, Third 3 Days||0
941446|NCT01371552|2276421|P2|NOT COMPLETED|Part 1, Third 3 Days||0
941447|NCT01371552|2276422|P1|NOT COMPLETED|Part 1, Third 3 Days||0
941448|NCT01371552|2276417|P6|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to discomfort, but continued into Part 2.|17
941449|NCT01371552|2276418|P5|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to randomization error, but continued into Part 2.|14
941450|NCT01371552|2276419|P4|COMPLETED|Part 1, Third 3 Days||20
941451|NCT01371552|2276420|P3|COMPLETED|Part 1, Third 3 Days||18
941452|NCT01371552|2276421|P2|COMPLETED|Part 1, Third 3 Days||17
941453|NCT01371552|2276422|P1|COMPLETED|Part 1, Third 3 Days||19
941454|NCT01371552|2276417|P6|STARTED|Part 1, Third 3 Days||18
941455|NCT01371552|2276418|P5|STARTED|Part 1, Third 3 Days||15
941456|NCT01371552|2276419|P4|STARTED|Part 1, Third 3 Days||20
941457|NCT01371552|2276420|P3|STARTED|Part 1, Third 3 Days||18
941458|NCT01371552|2276421|P2|STARTED|Part 1, Third 3 Days||17
941459|NCT01371552|2276422|P1|STARTED|Part 1, Third 3 Days||19
941460|NCT01371552|2276417|P6|NOT COMPLETED|Part 1, Second 3 Days||0
941461|NCT01371552|2276418|P5|NOT COMPLETED|Part 1, Second 3 Days||0
941462|NCT01371552|2276419|P4|NOT COMPLETED|Part 1, Second 3 Days||0
941463|NCT01371552|2276420|P3|NOT COMPLETED|Part 1, Second 3 Days||0
941464|NCT01371552|2276421|P2|NOT COMPLETED|Part 1, Second 3 Days||0
941465|NCT01371552|2276422|P1|NOT COMPLETED|Part 1, Second 3 Days||1
941466|NCT01371552|2276417|P6|COMPLETED|Part 1, Second 3 Days||18
941467|NCT01371552|2276418|P5|COMPLETED|Part 1, Second 3 Days||15
941468|NCT01371552|2276419|P4|COMPLETED|Part 1, Second 3 Days||20
941469|NCT01371552|2276420|P3|COMPLETED|Part 1, Second 3 Days||18
941470|NCT01371552|2276421|P2|COMPLETED|Part 1, Second 3 Days||17
941471|NCT01371552|2276422|P1|COMPLETED|Part 1, Second 3 Days|One subject did not complete period due to discomfort but continued to next, as allowed by protocol|18
941472|NCT01371552|2276417|P6|STARTED|Part 1, Second 3 Days||18
941473|NCT01371552|2276418|P5|STARTED|Part 1, Second 3 Days||15
941474|NCT01371552|2276419|P4|STARTED|Part 1, Second 3 Days||20
941475|NCT01371552|2276420|P3|STARTED|Part 1, Second 3 Days|1 subject discontinued after First 3 days due to positive slit lamp findings unrelated to lens wear|18
941476|NCT01371552|2276421|P2|STARTED|Part 1, Second 3 Days||17
941477|NCT01371552|2276422|P1|STARTED|Part 1, Second 3 Days||19
941478|NCT01371552|2276417|P6|NOT COMPLETED|Part 1, First 3 Days||0
941479|NCT01371552|2276418|P5|NOT COMPLETED|Part 1, First 3 Days||0
941480|NCT01371552|2276419|P4|NOT COMPLETED|Part 1, First 3 Days||0
941481|NCT01371552|2276420|P3|NOT COMPLETED|Part 1, First 3 Days||1
941482|NCT01371552|2276421|P2|NOT COMPLETED|Part 1, First 3 Days||0
941483|NCT01371552|2276422|P1|NOT COMPLETED|Part 1, First 3 Days||0
941484|NCT01371552|2276417|P6|COMPLETED|Part 1, First 3 Days||18
941485|NCT01371552|2276418|P5|COMPLETED|Part 1, First 3 Days||15
941486|NCT01371552|2276419|P4|COMPLETED|Part 1, First 3 Days||20
941487|NCT01371552|2276420|P3|COMPLETED|Part 1, First 3 Days||19
941488|NCT01371552|2276421|P2|COMPLETED|Part 1, First 3 Days||17
941489|NCT01371552|2276422|P1|COMPLETED|Part 1, First 3 Days||19
941490|NCT01371552|2276417|P6|STARTED|Part 1, First 3 Days||18
941491|NCT01371552|2276418|P5|STARTED|Part 1, First 3 Days||15
941492|NCT01371552|2276419|P4|STARTED|Part 1, First 3 Days||20
941493|NCT01371552|2276420|P3|STARTED|Part 1, First 3 Days||20
941494|NCT01371552|2276421|P2|STARTED|Part 1, First 3 Days||17
941495|NCT01371552|2276422|P1|STARTED|Part 1, First 3 Days||19
941496|NCT01371539|2276449|P2|NOT COMPLETED|Period Two: One Week||3
941497|NCT01371539|2276450|P1|NOT COMPLETED|Period Two: One Week||0
941498|NCT01371539|2276449|P2|COMPLETED|Period Two: One Week||47
941499|NCT01371539|2276450|P1|COMPLETED|Period Two: One Week||53
941500|NCT01371539|2276449|P2|STARTED|Period Two: One Week||50
941501|NCT01371539|2276450|P1|STARTED|Period Two: One Week||53
941502|NCT01371539|2276449|P2|NOT COMPLETED|Period One: One Week||1
941503|NCT01371539|2276450|P1|NOT COMPLETED|Period One: One Week||0
941504|NCT01371539|2276449|P2|COMPLETED|Period One: One Week||50
941505|NCT01371539|2276450|P1|COMPLETED|Period One: One Week||53
941506|NCT01371539|2276449|P2|STARTED|Period One: One Week||51
941507|NCT01371539|2276450|P1|STARTED|Period One: One Week||53
941514|NCT01371006|2276471|P2|NOT COMPLETED|Overall Study||0
941515|NCT01371006|2276472|P1|NOT COMPLETED|Overall Study||1
941516|NCT01371006|2276471|P2|COMPLETED|Overall Study||15
941517|NCT01371006|2276472|P1|COMPLETED|Overall Study||13
941518|NCT01371006|2276471|P2|STARTED|Overall Study||15
941519|NCT01371006|2276472|P1|STARTED|Overall Study||14
941520|NCT01370863|2276513|P2|NOT COMPLETED|Overall Study||3
941521|NCT01370863|2276514|P1|NOT COMPLETED|Overall Study||2
941522|NCT01370863|2276513|P2|COMPLETED|Overall Study||30
941523|NCT01370863|2276514|P1|COMPLETED|Overall Study||32
941524|NCT01370863|2276513|P2|STARTED|Overall Study||33
941525|NCT01370863|2276514|P1|STARTED|Overall Study||34
941526|NCT01370837|2276527|P3|NOT COMPLETED|Overall Study||0
941527|NCT01370837|2276528|P2|NOT COMPLETED|Overall Study||0
941528|NCT01370837|2276529|P1|NOT COMPLETED|Overall Study||0
941529|NCT01370837|2276527|P3|COMPLETED|Overall Study||17
941530|NCT01370837|2276528|P2|COMPLETED|Overall Study||12
941531|NCT01370837|2276529|P1|COMPLETED|Overall Study||12
941532|NCT01370837|2276527|P3|STARTED|Overall Study||17
941533|NCT01370837|2276528|P2|STARTED|Overall Study||12
941534|NCT01370837|2276529|P1|STARTED|Overall Study||12
941535|NCT01370733|2276539|P2|NOT COMPLETED|Overall Study||22
941536|NCT01370733|2276540|P1|NOT COMPLETED|Overall Study||17
941537|NCT01370733|2276539|P2|COMPLETED|Overall Study||77
941538|NCT01370733|2276540|P1|COMPLETED|Overall Study||86
941539|NCT01370733|2276539|P2|STARTED|Overall Study||99
941540|NCT01370733|2276540|P1|STARTED|Overall Study||103
941541|NCT01370694|2276562|P1|NOT COMPLETED|Overall Study||6
941542|NCT01370694|2276562|P1|COMPLETED|Overall Study||1
941543|NCT01370694|2276562|P1|STARTED|Overall Study||7
941544|NCT01370655|2276584|P12|NOT COMPLETED|Period 2||0
941545|NCT01370655|2276585|P11|NOT COMPLETED|Period 2||1
941546|NCT01370655|2276586|P10|NOT COMPLETED|Period 2||0
941547|NCT01370655|2276587|P9|NOT COMPLETED|Period 2||2
941548|NCT01370655|2276588|P8|NOT COMPLETED|Period 2||1
941549|NCT01370655|2276589|P7|NOT COMPLETED|Period 2||1
941550|NCT01370655|2276590|P6|NOT COMPLETED|Period 2||0
941551|NCT01370655|2276591|P5|NOT COMPLETED|Period 2||1
941552|NCT01370655|2276592|P4|NOT COMPLETED|Period 2||0
941553|NCT01370655|2276593|P3|NOT COMPLETED|Period 2||2
941554|NCT01370655|2276594|P2|NOT COMPLETED|Period 2||0
941555|NCT01370655|2276595|P1|NOT COMPLETED|Period 2||0
941556|NCT01370655|2276584|P12|COMPLETED|Period 2||3
941557|NCT01370655|2276585|P11|COMPLETED|Period 2||2
941558|NCT01370655|2276586|P10|COMPLETED|Period 2||2
941559|NCT01370655|2276587|P9|COMPLETED|Period 2||1
941560|NCT01370655|2276588|P8|COMPLETED|Period 2||3
941561|NCT01370655|2276589|P7|COMPLETED|Period 2||2
941562|NCT01370655|2276590|P6|COMPLETED|Period 2||4
941563|NCT01370655|2276591|P5|COMPLETED|Period 2||2
941564|NCT01370655|2276592|P4|COMPLETED|Period 2||3
941565|NCT01370655|2276593|P3|COMPLETED|Period 2||1
941566|NCT01370655|2276594|P2|COMPLETED|Period 2||7
941567|NCT01370655|2276595|P1|COMPLETED|Period 2||5
941568|NCT01370655|2276584|P12|STARTED|Period 2||3
941569|NCT01370655|2276585|P11|STARTED|Period 2||3
941570|NCT01370655|2276586|P10|STARTED|Period 2||2
941571|NCT01370655|2276587|P9|STARTED|Period 2||3
941572|NCT01370655|2276588|P8|STARTED|Period 2||4
941573|NCT01370655|2276589|P7|STARTED|Period 2||3
941574|NCT01370655|2276590|P6|STARTED|Period 2||4
941575|NCT01370655|2276591|P5|STARTED|Period 2||3
941576|NCT01370655|2276592|P4|STARTED|Period 2||3
941577|NCT01370655|2276593|P3|STARTED|Period 2||3
941578|NCT01370655|2276594|P2|STARTED|Period 2||7
941579|NCT01370655|2276595|P1|STARTED|Period 2||5
941580|NCT01370655|2276584|P12|NOT COMPLETED|Period 1||0
941581|NCT01370655|2276585|P11|NOT COMPLETED|Period 1||0
941582|NCT01370655|2276586|P10|NOT COMPLETED|Period 1||0
941583|NCT01370655|2276587|P9|NOT COMPLETED|Period 1||0
941584|NCT01370655|2276588|P8|NOT COMPLETED|Period 1||0
941585|NCT01370655|2276589|P7|NOT COMPLETED|Period 1||1
941586|NCT01370655|2276590|P6|NOT COMPLETED|Period 1||0
941587|NCT01370655|2276591|P5|NOT COMPLETED|Period 1||0
941588|NCT01370655|2276592|P4|NOT COMPLETED|Period 1||0
941589|NCT01370655|2276593|P3|NOT COMPLETED|Period 1||0
941590|NCT01370655|2276594|P2|NOT COMPLETED|Period 1||0
941591|NCT01370655|2276595|P1|NOT COMPLETED|Period 1||2
941592|NCT01370655|2276584|P12|COMPLETED|Period 1||3
941593|NCT01370655|2276585|P11|COMPLETED|Period 1||3
941594|NCT01370655|2276586|P10|COMPLETED|Period 1||2
941595|NCT01370655|2276587|P9|COMPLETED|Period 1||3
941596|NCT01370655|2276588|P8|COMPLETED|Period 1||4
941597|NCT01370655|2276589|P7|COMPLETED|Period 1||3
941598|NCT01370655|2276590|P6|COMPLETED|Period 1||4
941599|NCT01370655|2276591|P5|COMPLETED|Period 1||3
941600|NCT01370655|2276592|P4|COMPLETED|Period 1||3
941601|NCT01370655|2276593|P3|COMPLETED|Period 1||3
941602|NCT01370655|2276594|P2|COMPLETED|Period 1||7
941603|NCT01370655|2276595|P1|COMPLETED|Period 1||5
941604|NCT01370655|2276584|P12|STARTED|Period 1||3
941605|NCT01370655|2276585|P11|STARTED|Period 1||3
941606|NCT01370655|2276586|P10|STARTED|Period 1||2
941607|NCT01370655|2276587|P9|STARTED|Period 1||3
941608|NCT01370655|2276588|P8|STARTED|Period 1||4
941609|NCT01370655|2276589|P7|STARTED|Period 1||4
941610|NCT01370655|2276590|P6|STARTED|Period 1||4
941611|NCT01370655|2276591|P5|STARTED|Period 1||3
941612|NCT01370655|2276592|P4|STARTED|Period 1||3
941613|NCT01370655|2276593|P3|STARTED|Period 1||3
941614|NCT01370655|2276594|P2|STARTED|Period 1||7
941615|NCT01370655|2276595|P1|STARTED|Period 1||7
941616|NCT01370642|2276632|P3|NOT COMPLETED|Overall Study||29
941617|NCT01370642|2276633|P2|NOT COMPLETED|Overall Study||6
941618|NCT01370642|2276634|P1|NOT COMPLETED|Overall Study||8
941619|NCT01370642|2276632|P3|COMPLETED|Overall Study||69
941620|NCT01370642|2276633|P2|COMPLETED|Overall Study||92
941621|NCT01370642|2276634|P1|COMPLETED|Overall Study||90
941622|NCT01370642|2276632|P3|FAS Population|Overall Study||98
941623|NCT01370642|2276633|P2|FAS Population|Overall Study||97
941624|NCT01370642|2276634|P1|FAS Population|Overall Study||98
941625|NCT01370642|2276632|P3|STARTED|Overall Study||98
941626|NCT01370642|2276633|P2|STARTED|Overall Study||98
941627|NCT01370642|2276634|P1|STARTED|Overall Study||98
941628|NCT01370616|2276665|P2|NOT COMPLETED|Overall Study||67
941629|NCT01370616|2276666|P1|NOT COMPLETED|Overall Study||62
941630|NCT01370616|2276665|P2|COMPLETED|Overall Study||216
941631|NCT01370616|2276666|P1|COMPLETED|Overall Study||220
941632|NCT01370616|2276665|P2|Treated|Overall Study||275
941633|NCT01370616|2276666|P1|Treated|Overall Study||275
941634|NCT01370616|2276665|P2|STARTED|Overall Study|Participants randomized|283
941635|NCT01370616|2276666|P1|STARTED|Overall Study|Participants randomized|282
941636|NCT01370603|2276690|P2|NOT COMPLETED|Period 2||4
941637|NCT01370603|2276691|P1|NOT COMPLETED|Period 2||3
941638|NCT01370603|2276690|P2|COMPLETED|Period 2||146
941639|NCT01370603|2276691|P1|COMPLETED|Period 2||138
941640|NCT01370603|2276690|P2|STARTED|Period 2||150
941641|NCT01370603|2276691|P1|STARTED|Period 2||141
941642|NCT01370603|2276690|P2|NOT COMPLETED|Crossover Washout||4
941643|NCT01370603|2276691|P1|NOT COMPLETED|Crossover Washout||9
941644|NCT01370603|2276690|P2|COMPLETED|Crossover Washout||150
941645|NCT01370603|2276691|P1|COMPLETED|Crossover Washout||141
941646|NCT01370603|2276690|P2|STARTED|Crossover Washout||154
941647|NCT01370603|2276691|P1|STARTED|Crossover Washout||150
941648|NCT01370603|2276690|P2|NOT COMPLETED|Period 1||10
941649|NCT01370603|2276691|P1|NOT COMPLETED|Period 1||14
941650|NCT01370603|2276690|P2|COMPLETED|Period 1||154
941651|NCT01370603|2276691|P1|COMPLETED|Period 1||150
941652|NCT01370603|2276690|P2|STARTED|Period 1||164
941653|NCT01370603|2276691|P1|STARTED|Period 1||164
941654|NCT01370590|2276709|P2|NOT COMPLETED|Period 2||2
941655|NCT01370590|2276710|P1|NOT COMPLETED|Period 2||1
941656|NCT01370590|2276709|P2|COMPLETED|Period 2||184
941657|NCT01370590|2276710|P1|COMPLETED|Period 2||180
941658|NCT01370590|2276709|P2|STARTED|Period 2||186
941659|NCT01370590|2276710|P1|STARTED|Period 2||181
941660|NCT01370590|2276709|P2|NOT COMPLETED|Crossover Washout Period||6
941661|NCT01370590|2276710|P1|NOT COMPLETED|Crossover Washout Period||6
941662|NCT01370590|2276709|P2|COMPLETED|Crossover Washout Period||186
941663|NCT01370590|2276710|P1|COMPLETED|Crossover Washout Period||181
941664|NCT01370590|2276709|P2|STARTED|Crossover Washout Period||192
941665|NCT01370590|2276710|P1|STARTED|Crossover Washout Period||187
941666|NCT01370590|2276709|P2|NOT COMPLETED|Period 1||11
941667|NCT01370590|2276710|P1|NOT COMPLETED|Period 1||16
941668|NCT01370590|2276709|P2|COMPLETED|Period 1||192
941669|NCT01370590|2276710|P1|COMPLETED|Period 1||187
941670|NCT01370590|2276709|P2|STARTED|Period 1||203
941671|NCT01370590|2276710|P1|STARTED|Period 1||203
941672|NCT01370538|2276728|P2|NOT COMPLETED|Overall Study||19
941673|NCT01370538|2276729|P1|NOT COMPLETED|Overall Study||19
941674|NCT01370538|2276728|P2|COMPLETED|Overall Study||152
941675|NCT01370538|2276729|P1|COMPLETED|Overall Study||151
941676|NCT01370538|2276728|P2|Patients Who Completed Treatment|Overall Study||152
941677|NCT01370538|2276729|P1|Patients Who Completed Treatment|Overall Study||151
941678|NCT01370538|2276728|P2|Patients Who Received Treatment|Overall Study||161
941679|NCT01370538|2276729|P1|Patients Who Received Treatment|Overall Study||165
941680|NCT01370538|2276728|P2|STARTED|Overall Study||171
941681|NCT01370538|2276729|P1|STARTED|Overall Study||170
941682|NCT01370525|2276745|P2|NOT COMPLETED|Overall Study||11
941683|NCT01370525|2276746|P1|NOT COMPLETED|Overall Study||8
941684|NCT01370525|2276745|P2|COMPLETED|Overall Study||158
941685|NCT01370525|2276746|P1|COMPLETED|Overall Study||163
941686|NCT01370525|2276745|P2|Patients Who Completed Treatment|Overall Study||158
941687|NCT01370525|2276746|P1|Patients Who Completed Treatment|Overall Study||163
941688|NCT01370525|2276745|P2|Patients Who Received Treatment|Overall Study||163
941689|NCT01370525|2276746|P1|Patients Who Received Treatment|Overall Study||168
941690|NCT01370525|2276745|P2|STARTED|Overall Study||169
941691|NCT01370525|2276746|P1|STARTED|Overall Study||171
941692|NCT01370460|2276762|P2|NOT COMPLETED|Overall Study||0
941693|NCT01370460|2276763|P1|NOT COMPLETED|Overall Study||0
941694|NCT01370460|2276762|P2|COMPLETED|Overall Study||51
941695|NCT01370460|2276763|P1|COMPLETED|Overall Study||50
941696|NCT01370460|2276762|P2|STARTED|Overall Study||51
941697|NCT01370460|2276763|P1|STARTED|Overall Study||50
941698|NCT01370408|2276770|P1|NOT COMPLETED|Overall Study||9
941699|NCT01370408|2276770|P1|COMPLETED|Overall Study||76
941700|NCT01370408|2276770|P1|STARTED|Overall Study||85
941701|NCT01370369|2276781|P1|NOT COMPLETED|Overall Study||0
941702|NCT01370369|2276781|P1|COMPLETED|Overall Study||20
941703|NCT01370369|2276781|P1|STARTED|Overall Study||20
941704|NCT01370356|2276830|P2|NOT COMPLETED|Overall Study||227
941705|NCT01370356|2276831|P1|NOT COMPLETED|Overall Study||192
941706|NCT01370356|2276830|P2|COMPLETED|Overall Study||515
941707|NCT01370356|2276831|P1|COMPLETED|Overall Study||559
941708|NCT01370356|2276830|P2|STARTED|Overall Study||742
941709|NCT01370356|2276831|P1|STARTED|Overall Study||751
941710|NCT01370265|2276845|P2|NOT COMPLETED|Second Intervention||0
941711|NCT01370265|2276846|P1|NOT COMPLETED|Second Intervention||0
941712|NCT01370265|2276845|P2|COMPLETED|Second Intervention||5
941713|NCT01370265|2276846|P1|COMPLETED|Second Intervention||5
941714|NCT01370265|2276845|P2|STARTED|Second Intervention||5
941715|NCT01370265|2276846|P1|STARTED|Second Intervention||5
941716|NCT01370265|2276845|P2|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
941717|NCT01370265|2276846|P1|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
941718|NCT01370265|2276845|P2|COMPLETED|Washout Period (50-minute Period Decay)||5
941719|NCT01370265|2276846|P1|COMPLETED|Washout Period (50-minute Period Decay)||5
941720|NCT01370265|2276845|P2|STARTED|Washout Period (50-minute Period Decay)||5
941721|NCT01370265|2276846|P1|STARTED|Washout Period (50-minute Period Decay)||5
941722|NCT01370265|2276845|P2|NOT COMPLETED|First Intervention||1
941723|NCT01370265|2276846|P1|NOT COMPLETED|First Intervention||1
941724|NCT01370265|2276845|P2|COMPLETED|First Intervention||5
941725|NCT01370265|2276846|P1|COMPLETED|First Intervention||5
941726|NCT01370265|2276845|P2|STARTED|First Intervention||6
941727|NCT01370265|2276846|P1|STARTED|First Intervention||6
941728|NCT01370265|2276845|P2|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
941729|NCT01370265|2276846|P1|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
941730|NCT01370265|2276845|P2|COMPLETED|Washout Period (50-minute Period Decay)||6
941731|NCT01370265|2276846|P1|COMPLETED|Washout Period (50-minute Period Decay)||6
941732|NCT01370265|2276845|P2|STARTED|Washout Period (50-minute Period Decay)||6
941733|NCT01370265|2276846|P1|STARTED|Washout Period (50-minute Period Decay)||6
941734|NCT01370265|2276845|P2|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
941735|NCT01370265|2276846|P1|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
941736|NCT01370265|2276845|P2|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
941737|NCT01370265|2276846|P1|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
941738|NCT01370265|2276845|P2|STARTED|Resting Myocardial Blood Flow (MBF)||6
941739|NCT01370265|2276846|P1|STARTED|Resting Myocardial Blood Flow (MBF)||6
941740|NCT01370083|2276865|P2|NOT COMPLETED|Overall Study||1
941741|NCT01370083|2276866|P1|NOT COMPLETED|Overall Study||2
941742|NCT01370083|2276865|P2|COMPLETED|Overall Study||6
941743|NCT01370083|2276866|P1|COMPLETED|Overall Study||5
941744|NCT01370083|2276865|P2|STARTED|Overall Study||7
941745|NCT01370083|2276866|P1|STARTED|Overall Study||7
941746|NCT01370005|2276879|P3|NOT COMPLETED|Overall Study||11
941747|NCT01370005|2276880|P2|NOT COMPLETED|Overall Study||11
941748|NCT01370005|2276881|P1|NOT COMPLETED|Overall Study||16
941749|NCT01370005|2276879|P3|COMPLETED|Overall Study||266
941750|NCT01370005|2276880|P2|COMPLETED|Overall Study||265
941751|NCT01370005|2276881|P1|COMPLETED|Overall Study||256
941752|NCT01370005|2276879|P3|STARTED|Overall Study||277
941753|NCT01370005|2276880|P2|STARTED|Overall Study||276
941754|NCT01370005|2276881|P1|STARTED|Overall Study||272
941755|NCT01369888|2276938|P4|NOT COMPLETED|Overall Study||0
941756|NCT01369888|2276939|P3|NOT COMPLETED|Overall Study||0
941757|NCT01369888|2276940|P2|NOT COMPLETED|Overall Study||0
941758|NCT01369888|2276941|P1|NOT COMPLETED|Overall Study||0
941759|NCT01369888|2276938|P4|COMPLETED|Overall Study||0
941760|NCT01369888|2276939|P3|COMPLETED|Overall Study||0
941761|NCT01369888|2276940|P2|COMPLETED|Overall Study||2
941762|NCT01369888|2276941|P1|COMPLETED|Overall Study||1
941763|NCT01369888|2276938|P4|STARTED|Overall Study||0
941764|NCT01369888|2276939|P3|STARTED|Overall Study||0
941765|NCT01369888|2276940|P2|STARTED|Overall Study||2
941766|NCT01369888|2276941|P1|STARTED|Overall Study||1
941767|NCT01369875|2276951|P2|NOT COMPLETED|Overall Study||0
941768|NCT01369875|2276952|P1|NOT COMPLETED|Overall Study||0
941769|NCT01369875|2276951|P2|COMPLETED|Overall Study||1
941770|NCT01369875|2276952|P1|COMPLETED|Overall Study||1
941771|NCT01369875|2276951|P2|STARTED|Overall Study||1
941772|NCT01369875|2276952|P1|STARTED|Overall Study||1
941773|NCT01369849|2276963|P3|NOT COMPLETED|Overall Study||1
941774|NCT01369849|2276964|P2|NOT COMPLETED|Overall Study||1
941775|NCT01369849|2276965|P1|NOT COMPLETED|Overall Study||0
941776|NCT01369849|2276963|P3|COMPLETED|Overall Study||4
941777|NCT01369849|2276964|P2|COMPLETED|Overall Study||3
941778|NCT01369849|2276965|P1|COMPLETED|Overall Study||6
941779|NCT01369849|2276963|P3|STARTED|Overall Study||5
941780|NCT01369849|2276964|P2|STARTED|Overall Study||4
941781|NCT01369849|2276965|P1|STARTED|Overall Study||6
941782|NCT01369784|2276987|P1|NOT COMPLETED|Overall Study||12
941783|NCT01369784|2276987|P1|COMPLETED|Overall Study||146
941784|NCT01369784|2276987|P1|STARTED|Overall Study||158
941785|NCT01369758|2277012|P1|NOT COMPLETED|Overall Study||0
941786|NCT01369758|2277012|P1|COMPLETED|Overall Study||290
941787|NCT01369758|2277012|P1|STARTED|Overall Study||290
941788|NCT01369745|2277022|P5|NOT COMPLETED|Overall Study||18
941789|NCT01369745|2277023|P4|NOT COMPLETED|Overall Study||20
941790|NCT01369745|2277024|P3|NOT COMPLETED|Overall Study||2
941791|NCT01369745|2277025|P2|NOT COMPLETED|Overall Study||13
941792|NCT01369745|2277026|P1|NOT COMPLETED|Overall Study||7
941793|NCT01369745|2277022|P5|COMPLETED|Overall Study||65
941794|NCT01369745|2277023|P4|COMPLETED|Overall Study||64
941795|NCT01369745|2277024|P3|COMPLETED|Overall Study||16
941796|NCT01369745|2277025|P2|COMPLETED|Overall Study||28
941797|NCT01369745|2277026|P1|COMPLETED|Overall Study||25
941798|NCT01369745|2277022|P5|STARTED|Overall Study||83
941799|NCT01369745|2277023|P4|STARTED|Overall Study||84
941800|NCT01369745|2277024|P3|STARTED|Overall Study||18
941801|NCT01369745|2277025|P2|STARTED|Overall Study||41
941802|NCT01369745|2277026|P1|STARTED|Overall Study||32
941803|NCT01369732|2277060|P2|NOT COMPLETED|Overall Study||2
941804|NCT01369732|2277061|P1|NOT COMPLETED|Overall Study||4
941805|NCT01369732|2277060|P2|COMPLETED|Overall Study||31
941806|NCT01369732|2277061|P1|COMPLETED|Overall Study||29
941807|NCT01369732|2277060|P2|STARTED|Overall Study||33
941808|NCT01369732|2277061|P1|STARTED|Overall Study||33
941809|NCT01369706|2277067|P1|NOT COMPLETED|Overall Study||0
941810|NCT01369706|2277067|P1|COMPLETED|Overall Study||388
941811|NCT01369706|2277067|P1|STARTED|Overall Study||388
941812|NCT01369680|2277075|P4|NOT COMPLETED|Overall Study||2
941813|NCT01369680|2277076|P3|NOT COMPLETED|Overall Study||1
941814|NCT01369680|2277077|P2|NOT COMPLETED|Overall Study||0
941815|NCT01369680|2277078|P1|NOT COMPLETED|Overall Study||0
941816|NCT01369680|2277075|P4|COMPLETED|Overall Study||1
941817|NCT01369680|2277076|P3|COMPLETED|Overall Study||2
941818|NCT01369680|2277077|P2|COMPLETED|Overall Study||3
941819|NCT01369680|2277078|P1|COMPLETED|Overall Study||3
941820|NCT01369680|2277075|P4|STARTED|Overall Study||3
941821|NCT01369680|2277076|P3|STARTED|Overall Study||3
941822|NCT01369680|2277077|P2|STARTED|Overall Study||3
941823|NCT01369680|2277078|P1|STARTED|Overall Study||3
941827|NCT01369615|2277105|P2|NOT COMPLETED|Overall Study||2
941828|NCT01369615|2277106|P1|NOT COMPLETED|Overall Study||0
941829|NCT01369615|2277105|P2|COMPLETED|Overall Study||12
941830|NCT01369615|2277106|P1|COMPLETED|Overall Study||9
941831|NCT01369615|2277105|P2|STARTED|Overall Study||14
941832|NCT01369615|2277106|P1|STARTED|Overall Study||9
941833|NCT01369485|2277114|P2|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||40
941834|NCT01369485|2277115|P1|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||33
941835|NCT01369485|2277114|P2|COMPLETED|Open Label Phase (Week 12 to Month 12)||26
941836|NCT01369485|2277115|P1|COMPLETED|Open Label Phase (Week 12 to Month 12)||24
941837|NCT01369485|2277114|P2|STARTED|Open Label Phase (Week 12 to Month 12)||66
941838|NCT01369485|2277115|P1|STARTED|Open Label Phase (Week 12 to Month 12)||57
941839|NCT01369485|2277114|P2|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||17
941840|NCT01369485|2277115|P1|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||23
941841|NCT01369485|2277114|P2|COMPLETED|Randomized Phase (Day 0 to Week 12)||66
941842|NCT01369485|2277115|P1|COMPLETED|Randomized Phase (Day 0 to Week 12)||57
941843|NCT01369485|2277114|P2|STARTED|Randomized Phase (Day 0 to Week 12)||83
941844|NCT01369485|2277115|P1|STARTED|Randomized Phase (Day 0 to Week 12)||80
941845|NCT01369355|2277161|P6|NOT COMPLETED|Overall Study||272
941846|NCT01369355|2277162|P5|NOT COMPLETED|Overall Study||154
941847|NCT01369355|2277163|P4|NOT COMPLETED|Overall Study||30
941848|NCT01369355|2277164|P3|NOT COMPLETED|Overall Study||31
941849|NCT01369355|2277165|P2|NOT COMPLETED|Overall Study||29
941850|NCT01369355|2277166|P1|NOT COMPLETED|Overall Study||31
941851|NCT01369355|2277161|P6|COMPLETED|Overall Study||204
941852|NCT01369355|2277162|P5|COMPLETED|Overall Study||131
941853|NCT01369355|2277163|P4|COMPLETED|Overall Study||93
941854|NCT01369355|2277164|P3|COMPLETED|Overall Study||101
941855|NCT01369355|2277165|P2|COMPLETED|Overall Study||103
941856|NCT01369355|2277166|P1|COMPLETED|Overall Study||102
941857|NCT01369355|2277161|P6|Treated|Overall Study||476
941858|NCT01369355|2277162|P5|Treated|Overall Study||285
941859|NCT01369355|2277163|P4|Treated|Overall Study||123
941860|NCT01369355|2277164|P3|Treated|Overall Study||131
941861|NCT01369355|2277165|P2|Treated|Overall Study||132
941862|NCT01369355|2277166|P1|Treated|Overall Study||133
941863|NCT01369355|2277161|P6|STARTED|Overall Study||476
941864|NCT01369355|2277162|P5|STARTED|Overall Study||285
941865|NCT01369355|2277163|P4|STARTED|Overall Study||123
941866|NCT01369355|2277164|P3|STARTED|Overall Study||132
941867|NCT01369355|2277165|P2|STARTED|Overall Study||132
941868|NCT01369355|2277166|P1|STARTED|Overall Study||133
941887|NCT01369225|2277248|P6|NOT COMPLETED|Overall Study||0
941888|NCT01369225|2277249|P5|NOT COMPLETED|Overall Study||2
941889|NCT01369225|2277250|P4|NOT COMPLETED|Overall Study||2
941890|NCT01369225|2277251|P3|NOT COMPLETED|Overall Study||3
941891|NCT01369225|2277252|P2|NOT COMPLETED|Overall Study||0
941892|NCT01369225|2277253|P1|NOT COMPLETED|Overall Study||2
941893|NCT01369225|2277248|P6|COMPLETED|Overall Study||9
941894|NCT01369225|2277249|P5|COMPLETED|Overall Study||10
941895|NCT01369225|2277250|P4|COMPLETED|Overall Study||8
941896|NCT01369225|2277251|P3|COMPLETED|Overall Study||9
941897|NCT01369225|2277252|P2|COMPLETED|Overall Study||3
941898|NCT01369225|2277253|P1|COMPLETED|Overall Study||4
941899|NCT01369225|2277248|P6|STARTED|Overall Study||9
941900|NCT01369225|2277249|P5|STARTED|Overall Study||12
941901|NCT01369225|2277250|P4|STARTED|Overall Study||10
941902|NCT01369225|2277251|P3|STARTED|Overall Study||12
941903|NCT01369225|2277252|P2|STARTED|Overall Study||3
941904|NCT01369225|2277253|P1|STARTED|Overall Study||6
941905|NCT01369030|2277345|P1|NOT COMPLETED|Overall Study||40
941906|NCT01369030|2277345|P1|COMPLETED|Overall Study||554
941907|NCT01369030|2277345|P1|STARTED|Overall Study||594
941908|NCT01368965|2277351|P1|NOT COMPLETED|Overall Study||12
941909|NCT01368965|2277351|P1|COMPLETED|Overall Study||40
941910|NCT01368965|2277351|P1|Subject Withdrawal Prior to Treatment|Overall Study||2
941911|NCT01368965|2277351|P1|STARTED|Overall Study|Two subjects withdrew consent prior to study treatment. Data analyses are based on 52 subjects.|52
941912|NCT01368900|2277360|P1|NOT COMPLETED|Overall Study||7
941913|NCT01368900|2277360|P1|COMPLETED|Overall Study||61
941914|NCT01368900|2277360|P1|STARTED|Overall Study||68
941915|NCT01368874|2277373|P3|NOT COMPLETED|Overall Study||1
941916|NCT01368874|2277374|P2|NOT COMPLETED|Overall Study||0
941917|NCT01368874|2277375|P1|NOT COMPLETED|Overall Study||3
941918|NCT01368874|2277373|P3|COMPLETED|Overall Study||24
941919|NCT01368874|2277374|P2|COMPLETED|Overall Study||5
941920|NCT01368874|2277375|P1|COMPLETED|Overall Study||31
941921|NCT01368874|2277373|P3|STARTED|Overall Study||25
941922|NCT01368874|2277374|P2|STARTED|Overall Study||5
941923|NCT01368874|2277375|P1|STARTED|Overall Study||34
941924|NCT01368835|2277435|P1|NOT COMPLETED|Overall Study||33
941925|NCT01368835|2277435|P1|COMPLETED|Overall Study||70
941926|NCT01368835|2277435|P1|STARTED|Overall Study|103 Subjects Enrolled|103
941927|NCT01368809|2277444|P2|NOT COMPLETED|Overall Study||0
941928|NCT01368809|2277445|P1|NOT COMPLETED|Overall Study||0
941929|NCT01368809|2277444|P2|COMPLETED|Overall Study||50
941930|NCT01368809|2277445|P1|COMPLETED|Overall Study||50
941931|NCT01368809|2277444|P2|STARTED|Overall Study||50
941932|NCT01368809|2277445|P1|STARTED|Overall Study||50
941933|NCT01368653|2277457|P2|NOT COMPLETED|Overall Study||9
941934|NCT01368653|2277458|P1|NOT COMPLETED|Overall Study||6
941935|NCT01368653|2277457|P2|COMPLETED|Overall Study||37
941936|NCT01368653|2277458|P1|COMPLETED|Overall Study||41
941937|NCT01368653|2277457|P2|Randomized to Advice Only in Phase 2|Overall Study||10
941938|NCT01368653|2277458|P1|Randomized to Advice Only in Phase 2|Overall Study||10
941939|NCT01368653|2277457|P2|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|9
941940|NCT01368653|2277458|P1|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|11
941941|NCT01368653|2277457|P2|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|19
941942|NCT01368653|2277458|P1|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|21
941943|NCT01368653|2277457|P2|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|20
941944|NCT01368653|2277458|P1|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|29
941945|NCT01368653|2277457|P2|Completed 4-week Follow-up|Overall Study||37
941946|NCT01368653|2277458|P1|Completed 4-week Follow-up|Overall Study||44
941947|NCT01368653|2277457|P2|STARTED|Overall Study||46
941948|NCT01368653|2277458|P1|STARTED|Overall Study||47
941949|NCT01368536|2277477|P3|NOT COMPLETED|Overall Study||59
941950|NCT01368536|2277478|P2|NOT COMPLETED|Overall Study||59
941951|NCT01368536|2277479|P1|NOT COMPLETED|Overall Study||51
941952|NCT01368536|2277477|P3|COMPLETED|Overall Study||83
941953|NCT01368536|2277478|P2|COMPLETED|Overall Study||78
941954|NCT01368536|2277479|P1|COMPLETED|Overall Study||87
941955|NCT01368536|2277477|P3|Full Analysis Set|Overall Study|One patient was excluded from efficacy analysis as there was no post baseline data|141
941956|NCT01368536|2277478|P2|Full Analysis Set|Overall Study||137
941957|NCT01368536|2277479|P1|Full Analysis Set|Overall Study||138
941958|NCT01368536|2277477|P3|STARTED|Overall Study||142
941959|NCT01368536|2277478|P2|STARTED|Overall Study||137
941960|NCT01368536|2277479|P1|STARTED|Overall Study||138
941961|NCT01368432|2277502|P2|NOT COMPLETED|Overall Study||1
941962|NCT01368432|2277503|P1|NOT COMPLETED|Overall Study||0
941963|NCT01368432|2277502|P2|COMPLETED|Overall Study||7
941964|NCT01368432|2277503|P1|COMPLETED|Overall Study||6
941965|NCT01368432|2277502|P2|STARTED|Overall Study||8
941966|NCT01368432|2277503|P1|STARTED|Overall Study||6
941967|NCT01368406|2277537|P2|NOT COMPLETED|Overall Study||13
941968|NCT01368406|2277538|P1|NOT COMPLETED|Overall Study||21
941969|NCT01368406|2277537|P2|COMPLETED|Overall Study||66
941970|NCT01368406|2277538|P1|COMPLETED|Overall Study||60
941971|NCT01368406|2277537|P2|STARTED|Overall Study||79
941972|NCT01368406|2277538|P1|STARTED|Overall Study||81
941973|NCT01368276|2277546|P2|NOT COMPLETED|Overall Study||10
941974|NCT01368276|2277547|P1|NOT COMPLETED|Overall Study||1
941975|NCT01368276|2277546|P2|COMPLETED|Overall Study||18
941976|NCT01368276|2277547|P1|COMPLETED|Overall Study||2
941977|NCT01368276|2277546|P2|STARTED|Overall Study||28
941978|NCT01368276|2277547|P1|STARTED|Overall Study||3
941979|NCT01368263|2277560|P3|NOT COMPLETED|Overall Study||0
941980|NCT01368263|2277561|P2|NOT COMPLETED|Overall Study||0
941981|NCT01368263|2277562|P1|NOT COMPLETED|Overall Study||0
941982|NCT01368263|2277560|P3|COMPLETED|Overall Study||1
941983|NCT01368263|2277561|P2|COMPLETED|Overall Study||1
941984|NCT01368263|2277562|P1|COMPLETED|Overall Study||6
941985|NCT01368263|2277560|P3|STARTED|Overall Study||1
941986|NCT01368263|2277561|P2|STARTED|Overall Study||1
941987|NCT01368263|2277562|P1|STARTED|Overall Study||6
941988|NCT01368211|2277584|P2|NOT COMPLETED|Second Platelets Transfusion||2
941989|NCT01368211|2277585|P1|NOT COMPLETED|Second Platelets Transfusion||1
941990|NCT01368211|2277584|P2|COMPLETED|Second Platelets Transfusion||5
941991|NCT01368211|2277585|P1|COMPLETED|Second Platelets Transfusion||7
941992|NCT01368211|2277584|P2|STARTED|Second Platelets Transfusion||7
941993|NCT01368211|2277585|P1|STARTED|Second Platelets Transfusion||8
941994|NCT01368211|2277584|P2|NOT COMPLETED|First Platelets Transfusion||0
941995|NCT01368211|2277585|P1|NOT COMPLETED|First Platelets Transfusion||0
941996|NCT01368211|2277584|P2|COMPLETED|First Platelets Transfusion||7
941997|NCT01368211|2277585|P1|COMPLETED|First Platelets Transfusion||8
941998|NCT01368211|2277584|P2|STARTED|First Platelets Transfusion||7
941999|NCT01368211|2277585|P1|STARTED|First Platelets Transfusion||8
942000|NCT01368185|2277593|P1|NOT COMPLETED|Overall Study||0
942001|NCT01368185|2277593|P1|COMPLETED|Overall Study||1705
942002|NCT01368185|2277593|P1|STARTED|Overall Study||1705
942003|NCT01368081|2277613|P13|NOT COMPLETED|Overall Study||7
942004|NCT01368081|2277614|P12|NOT COMPLETED|Overall Study||3
942005|NCT01368081|2277615|P11|NOT COMPLETED|Overall Study||9
942006|NCT01368081|2277616|P10|NOT COMPLETED|Overall Study||10
942007|NCT01368081|2277617|P9|NOT COMPLETED|Overall Study||8
942008|NCT01368081|2277618|P8|NOT COMPLETED|Overall Study||7
942009|NCT01368081|2277619|P7|NOT COMPLETED|Overall Study||12
942010|NCT01368081|2277620|P6|NOT COMPLETED|Overall Study||10
942011|NCT01368081|2277621|P5|NOT COMPLETED|Overall Study||2
942012|NCT01368081|2277622|P4|NOT COMPLETED|Overall Study||5
942013|NCT01368081|2277623|P3|NOT COMPLETED|Overall Study||4
942014|NCT01368081|2277624|P2|NOT COMPLETED|Overall Study||9
942015|NCT01368081|2277625|P1|NOT COMPLETED|Overall Study||10
942016|NCT01368081|2277613|P13|COMPLETED|Overall Study||63
942017|NCT01368081|2277614|P12|COMPLETED|Overall Study||67
942018|NCT01368081|2277615|P11|COMPLETED|Overall Study||62
942019|NCT01368081|2277616|P10|COMPLETED|Overall Study||58
942020|NCT01368081|2277617|P9|COMPLETED|Overall Study||62
942021|NCT01368081|2277618|P8|COMPLETED|Overall Study||62
942022|NCT01368081|2277619|P7|COMPLETED|Overall Study||124
942023|NCT01368081|2277620|P6|COMPLETED|Overall Study||127
942024|NCT01368081|2277621|P5|COMPLETED|Overall Study||63
942025|NCT01368081|2277622|P4|COMPLETED|Overall Study||63
942026|NCT01368081|2277623|P3|COMPLETED|Overall Study||59
942027|NCT01368081|2277624|P2|COMPLETED|Overall Study||128
942028|NCT01368081|2277625|P1|COMPLETED|Overall Study||126
942029|NCT01368081|2277613|P13|STARTED|Overall Study||70
942030|NCT01368081|2277614|P12|STARTED|Overall Study||70
942031|NCT01368081|2277615|P11|STARTED|Overall Study||71
942032|NCT01368081|2277616|P10|STARTED|Overall Study||68
942033|NCT01368081|2277617|P9|STARTED|Overall Study||70
942034|NCT01368081|2277618|P8|STARTED|Overall Study||69
942035|NCT01368081|2277619|P7|STARTED|Overall Study||136
942036|NCT01368081|2277620|P6|STARTED|Overall Study||137
942037|NCT01368081|2277621|P5|STARTED|Overall Study||65
942038|NCT01368081|2277622|P4|STARTED|Overall Study||68
942039|NCT01368081|2277623|P3|STARTED|Overall Study||63
942040|NCT01368081|2277624|P2|STARTED|Overall Study||137
942041|NCT01368081|2277625|P1|STARTED|Overall Study||136
942042|NCT01368042|2277679|P1|NOT COMPLETED|Overall Study||30
942043|NCT01368042|2277679|P1|COMPLETED|Overall Study||235
942044|NCT01368042|2277679|P1|STARTED|Overall Study||265
942045|NCT01367886|2277699|P1|NOT COMPLETED|Overall Study||7
942046|NCT01367886|2277699|P1|COMPLETED|Overall Study||14
942047|NCT01367886|2277699|P1|STARTED|Overall Study||21
942048|NCT01367860|2277708|P2|NOT COMPLETED|Overall Study||0
942049|NCT01367860|2277709|P1|NOT COMPLETED|Overall Study||0
942050|NCT01367860|2277708|P2|COMPLETED|Overall Study||20
942051|NCT01367860|2277709|P1|COMPLETED|Overall Study||20
942052|NCT01367860|2277708|P2|STARTED|Overall Study||20
942053|NCT01367860|2277709|P1|STARTED|Overall Study||20
942054|NCT01367834|2277749|P2|NOT COMPLETED|Overall Study||3
942055|NCT01367834|2277750|P1|NOT COMPLETED|Overall Study||2
942056|NCT01367834|2277749|P2|COMPLETED|Overall Study||3
942057|NCT01367834|2277750|P1|COMPLETED|Overall Study||9
942058|NCT01367834|2277749|P2|STARTED|Overall Study||6
942059|NCT01367834|2277750|P1|STARTED|Overall Study||11
942060|NCT01367704|2277774|P2|NOT COMPLETED|Overall Study||161
942061|NCT01367704|2277775|P1|NOT COMPLETED|Overall Study||47
942062|NCT01367704|2277774|P2|COMPLETED|Overall Study||847
942063|NCT01367704|2277775|P1|COMPLETED|Overall Study||951
942064|NCT01367704|2277774|P2|STARTED|Overall Study||1008
942065|NCT01367704|2277775|P1|STARTED|Overall Study||998
942066|NCT01367457|2277788|P3|NOT COMPLETED|Overall Study||0
942067|NCT01367457|2277789|P2|NOT COMPLETED|Overall Study||0
942068|NCT01367457|2277790|P1|NOT COMPLETED|Overall Study||188
942069|NCT01367457|2277788|P3|COMPLETED|Overall Study||26
942070|NCT01367457|2277789|P2|COMPLETED|Overall Study||23
942071|NCT01367457|2277790|P1|COMPLETED|Overall Study||5
942072|NCT01367457|2277788|P3|STARTED|Overall Study||26
942073|NCT01367457|2277789|P2|STARTED|Overall Study||23
942074|NCT01367457|2277790|P1|STARTED|Overall Study||193
942075|NCT01367249|2277812|P2|NOT COMPLETED|Overall Study||16
942076|NCT01367249|2277813|P1|NOT COMPLETED|Overall Study||9
942077|NCT01367249|2277812|P2|COMPLETED|Overall Study||202
942078|NCT01367249|2277813|P1|COMPLETED|Overall Study||213
942079|NCT01367249|2277812|P2|STARTED|Overall Study||218
942080|NCT01367249|2277813|P1|STARTED|Overall Study||222
942081|NCT01367158|2277832|P11|NOT COMPLETED|Overall Study||1
942082|NCT01367158|2277833|P10|NOT COMPLETED|Overall Study||0
942083|NCT01367158|2277834|P9|NOT COMPLETED|Overall Study||0
942084|NCT01367158|2277835|P8|NOT COMPLETED|Overall Study||2
942085|NCT01367158|2277836|P7|NOT COMPLETED|Overall Study||0
942086|NCT01367158|2277837|P6|NOT COMPLETED|Overall Study||2
942087|NCT01367158|2277838|P5|NOT COMPLETED|Overall Study||2
942088|NCT01367158|2277839|P4|NOT COMPLETED|Overall Study||1
942089|NCT01367158|2277840|P3|NOT COMPLETED|Overall Study||1
942090|NCT01367158|2277841|P2|NOT COMPLETED|Overall Study||3
942091|NCT01367158|2277842|P1|NOT COMPLETED|Overall Study||0
942092|NCT01367158|2277832|P11|COMPLETED|Overall Study||72
942093|NCT01367158|2277833|P10|COMPLETED|Overall Study||50
942094|NCT01367158|2277834|P9|COMPLETED|Overall Study||23
942095|NCT01367158|2277835|P8|COMPLETED|Overall Study||47
942096|NCT01367158|2277836|P7|COMPLETED|Overall Study||25
942097|NCT01367158|2277837|P6|COMPLETED|Overall Study||46
942098|NCT01367158|2277838|P5|COMPLETED|Overall Study||23
942099|NCT01367158|2277839|P4|COMPLETED|Overall Study||48
942100|NCT01367158|2277840|P3|COMPLETED|Overall Study||23
942101|NCT01367158|2277841|P2|COMPLETED|Overall Study||46
942102|NCT01367158|2277842|P1|COMPLETED|Overall Study||25
942103|NCT01367158|2277832|P11|STARTED|Overall Study||73
942104|NCT01367158|2277833|P10|STARTED|Overall Study||50
942105|NCT01367158|2277834|P9|STARTED|Overall Study||23
942106|NCT01367158|2277835|P8|STARTED|Overall Study||49
942107|NCT01367158|2277836|P7|STARTED|Overall Study||25
942108|NCT01367158|2277837|P6|STARTED|Overall Study||48
942109|NCT01367158|2277838|P5|STARTED|Overall Study||25
942110|NCT01367158|2277839|P4|STARTED|Overall Study||49
942111|NCT01367158|2277840|P3|STARTED|Overall Study||24
942112|NCT01367158|2277841|P2|STARTED|Overall Study||49
942113|NCT01367158|2277842|P1|STARTED|Overall Study||25
942114|NCT01367119|2277986|P2|NOT COMPLETED|Overall Study||1
942115|NCT01367119|2277987|P1|NOT COMPLETED|Overall Study||2
942116|NCT01367119|2277986|P2|COMPLETED|Overall Study||16
942117|NCT01367119|2277987|P1|COMPLETED|Overall Study||19
942118|NCT01367119|2277986|P2|STARTED|Overall Study||17
942119|NCT01367119|2277987|P1|STARTED|Overall Study||21
942120|NCT01367080|2277999|P2|NOT COMPLETED|2nd Administration||0
942121|NCT01367080|2278000|P1|NOT COMPLETED|2nd Administration||0
942122|NCT01367080|2277999|P2|COMPLETED|2nd Administration||6
942123|NCT01367080|2278000|P1|COMPLETED|2nd Administration||6
942124|NCT01367080|2277999|P2|STARTED|2nd Administration||6
942125|NCT01367080|2278000|P1|STARTED|2nd Administration||6
942126|NCT01367080|2277999|P2|NOT COMPLETED|1st Administration||0
942127|NCT01367080|2278000|P1|NOT COMPLETED|1st Administration||0
942128|NCT01367080|2277999|P2|COMPLETED|1st Administration||6
942129|NCT01367080|2278000|P1|COMPLETED|1st Administration||6
942130|NCT01367080|2277999|P2|STARTED|1st Administration||6
942131|NCT01367080|2278000|P1|STARTED|1st Administration||6
942132|NCT01366976|2278014|P2|NOT COMPLETED|Overall Study||0
942133|NCT01366976|2278015|P1|NOT COMPLETED|Overall Study||0
942134|NCT01366976|2278014|P2|COMPLETED|Overall Study||30
942135|NCT01366976|2278015|P1|COMPLETED|Overall Study||30
942136|NCT01366976|2278014|P2|STARTED|Overall Study||30
942137|NCT01366976|2278015|P1|STARTED|Overall Study||30
942138|NCT01366885|2278027|P1|NOT COMPLETED|Overall Study||1
942139|NCT01366885|2278027|P1|COMPLETED|Overall Study|We completed our study when the last child born had reached 36 months of age.|19
942140|NCT01366885|2278027|P1|STARTED|Overall Study|We started recruiting in February 2008 and recruited 20 mothers.|20
942141|NCT01366872|2278032|P1|NOT COMPLETED|Overall Study||0
942142|NCT01366872|2278032|P1|COMPLETED|Overall Study||50
942143|NCT01366872|2278032|P1|STARTED|Overall Study||50
942144|NCT01366846|2278042|P4|NOT COMPLETED|Overall Study||1
942145|NCT01366846|2278043|P3|NOT COMPLETED|Overall Study||1
942146|NCT01366846|2278044|P2|NOT COMPLETED|Overall Study||4
942147|NCT01366846|2278045|P1|NOT COMPLETED|Overall Study||3
942148|NCT01366846|2278042|P4|COMPLETED|Overall Study||45
942149|NCT01366846|2278043|P3|COMPLETED|Overall Study||46
942150|NCT01366846|2278044|P2|COMPLETED|Overall Study||224
942151|NCT01366846|2278045|P1|COMPLETED|Overall Study||232
942152|NCT01366846|2278042|P4|STARTED|Overall Study||46
942153|NCT01366846|2278043|P3|STARTED|Overall Study||47
942154|NCT01366846|2278044|P2|STARTED|Overall Study||228
942155|NCT01366846|2278045|P1|STARTED|Overall Study||235
942156|NCT01366638|2278068|P3|NOT COMPLETED|Overall Study||6
942157|NCT01366638|2278069|P2|NOT COMPLETED|Overall Study||0
942158|NCT01366638|2278070|P1|NOT COMPLETED|Overall Study||1
942159|NCT01366638|2278068|P3|COMPLETED|Overall Study||20
942160|NCT01366638|2278069|P2|COMPLETED|Overall Study||29
942161|NCT01366638|2278070|P1|COMPLETED|Overall Study||23
942162|NCT01366638|2278068|P3|STARTED|Overall Study||26
942163|NCT01366638|2278069|P2|STARTED|Overall Study||29
942164|NCT01366638|2278070|P1|STARTED|Overall Study||24
942165|NCT01366534|2278107|P3|NOT COMPLETED|Overall Study||0
942166|NCT01366534|2278108|P2|NOT COMPLETED|Overall Study||2
942167|NCT01366534|2278109|P1|NOT COMPLETED|Overall Study||2
942168|NCT01366534|2278107|P3|COMPLETED|Overall Study||12
942169|NCT01366534|2278108|P2|COMPLETED|Overall Study||25
942170|NCT01366534|2278109|P1|COMPLETED|Overall Study||26
942171|NCT01366534|2278107|P3|STARTED|Overall Study||12
942172|NCT01366534|2278108|P2|STARTED|Overall Study||27
942173|NCT01366534|2278109|P1|STARTED|Overall Study||28
942174|NCT01366521|2278159|P4|NOT COMPLETED|Overall Study||0
942175|NCT01366521|2278160|P3|NOT COMPLETED|Overall Study||2
942176|NCT01366521|2278161|P2|NOT COMPLETED|Overall Study||1
942177|NCT01366521|2278162|P1|NOT COMPLETED|Overall Study||1
942178|NCT01366521|2278159|P4|COMPLETED|Overall Study||11
942179|NCT01366521|2278160|P3|COMPLETED|Overall Study||21
942180|NCT01366521|2278161|P2|COMPLETED|Overall Study||14
942181|NCT01366521|2278162|P1|COMPLETED|Overall Study||20
942182|NCT01366521|2278159|P4|STARTED|Overall Study||11
942183|NCT01366521|2278160|P3|STARTED|Overall Study||23
942184|NCT01366521|2278161|P2|STARTED|Overall Study||15
942185|NCT01366521|2278162|P1|STARTED|Overall Study||21
942186|NCT01366443|2278237|P1|NOT COMPLETED|Overall Study||3
942187|NCT01366443|2278237|P1|COMPLETED|Overall Study||285
942188|NCT01366443|2278237|P1|STARTED|Overall Study||288
942189|NCT01366417|2278242|P1|NOT COMPLETED|Overall Study||18
942190|NCT01366417|2278242|P1|COMPLETED|Overall Study|25 subjects included in the analysis|25
942191|NCT01366417|2278242|P1|Excluded From Analysis|Overall Study|3 subjects did not have qualifying Treatment Day microbial counts and were excluded from analysis|3
942192|NCT01366417|2278242|P1|Discontinued Prior to Treatment|Overall Study|5 eligible subjects were not treated because enrollment target of 25 was met and enrollment closed.|5
942193|NCT01366417|2278242|P1|Completed the Study|Overall Study|treatment baseline microbial counts not available until after treatment; subjects not evaluable|28
942194|NCT01366417|2278242|P1|Completed Treatment Visit|Overall Study|28 subjects were treated with ChloraPrep and 70% Isopropyl Alcohol (single topical treatment)|28
942195|NCT01366417|2278242|P1|Completed Screen Visit|Overall Study|33 subjects had qualifying screening bacterial counts and were eligible for the Treatment Visit|33
942196|NCT01366417|2278242|P1|Signed Informed Consent|Overall Study|Microbial samples were taken from 43 subjects for screening baseline.|43
942197|NCT01366417|2278242|P1|STARTED|Overall Study||43
942198|NCT01366209|2278251|P2|NOT COMPLETED|Overall Study||36
942199|NCT01366209|2278252|P1|NOT COMPLETED|Overall Study||35
942200|NCT01366209|2278251|P2|COMPLETED|Overall Study||241
942201|NCT01366209|2278252|P1|COMPLETED|Overall Study|Participants completing study assessment at Week 52 were completers, even if treatment was withdrawn|243
942202|NCT01366209|2278251|P2|STARTED|Overall Study||277
942203|NCT01366209|2278252|P1|STARTED|Overall Study||278
942204|NCT01366196|2278260|P2|NOT COMPLETED|Overall Study||0
942205|NCT01366196|2278261|P1|NOT COMPLETED|Overall Study||0
942206|NCT01366196|2278260|P2|COMPLETED|Overall Study||43
942207|NCT01366196|2278261|P1|COMPLETED|Overall Study||43
942208|NCT01366196|2278260|P2|STARTED|Overall Study||43
942209|NCT01366196|2278261|P1|STARTED|Overall Study||43
942210|NCT01366092|2278269|P1|NOT COMPLETED|Overall Study||4
942211|NCT01366092|2278269|P1|COMPLETED|Overall Study||31
942212|NCT01366092|2278269|P1|STARTED|Overall Study||35
942213|NCT01365910|2278278|P1|NOT COMPLETED|Overall Study||30
942214|NCT01365910|2278278|P1|COMPLETED|Overall Study||0
942215|NCT01365910|2278278|P1|STARTED|Overall Study||30
942216|NCT01365845|2278285|P3|NOT COMPLETED|Treatment Phase||0
942217|NCT01365845|2278286|P2|NOT COMPLETED|Treatment Phase||0
942218|NCT01365845|2278287|P1|NOT COMPLETED|Treatment Phase||0
942219|NCT01365845|2278285|P3|COMPLETED|Treatment Phase||18
942220|NCT01365845|2278286|P2|COMPLETED|Treatment Phase||0
942221|NCT01365845|2278287|P1|COMPLETED|Treatment Phase||0
942222|NCT01365845|2278285|P3|STARTED|Treatment Phase||18
942223|NCT01365845|2278286|P2|STARTED|Treatment Phase||0
942224|NCT01365845|2278287|P1|STARTED|Treatment Phase||0
942225|NCT01365845|2278285|P3|NOT COMPLETED|Induction Phase||0
942226|NCT01365845|2278286|P2|NOT COMPLETED|Induction Phase||0
942227|NCT01365845|2278287|P1|NOT COMPLETED|Induction Phase||0
942228|NCT01365845|2278285|P3|COMPLETED|Induction Phase||0
942229|NCT01365845|2278286|P2|COMPLETED|Induction Phase||0
942230|NCT01365845|2278287|P1|COMPLETED|Induction Phase||18
942231|NCT01365845|2278285|P3|STARTED|Induction Phase||0
942232|NCT01365845|2278286|P2|STARTED|Induction Phase||0
942233|NCT01365845|2278287|P1|STARTED|Induction Phase||18
942234|NCT01365819|2278294|P2|NOT COMPLETED|Overall Study||13
942235|NCT01365819|2278295|P1|NOT COMPLETED|Overall Study||13
942236|NCT01365819|2278294|P2|COMPLETED|Overall Study||14
942237|NCT01365819|2278295|P1|COMPLETED|Overall Study||12
942238|NCT01365819|2278294|P2|STARTED|Overall Study||27
942239|NCT01365819|2278295|P1|STARTED|Overall Study||25
942240|NCT01365650|2278301|P1|NOT COMPLETED|Treatment C||0
942241|NCT01365650|2278301|P1|COMPLETED|Treatment C||24
942242|NCT01365650|2278301|P1|STARTED|Treatment C||24
942243|NCT01365650|2278301|P1|NOT COMPLETED|Treatment B||0
942244|NCT01365650|2278301|P1|COMPLETED|Treatment B||24
942245|NCT01365650|2278301|P1|STARTED|Treatment B||24
942246|NCT01365650|2278301|P1|NOT COMPLETED|Treatment A||0
942247|NCT01365650|2278301|P1|COMPLETED|Treatment A||24
942248|NCT01365650|2278301|P1|STARTED|Treatment A||24
942249|NCT01365624|2278326|P2|NOT COMPLETED|Overall Study||0
942250|NCT01365624|2278327|P1|NOT COMPLETED|Overall Study||0
942251|NCT01365624|2278326|P2|COMPLETED|Overall Study||15
942252|NCT01365624|2278327|P1|COMPLETED|Overall Study||15
942253|NCT01365624|2278326|P2|STARTED|Overall Study||15
942254|NCT01365624|2278327|P1|STARTED|Overall Study||15
942255|NCT01365611|2278343|P1|NOT COMPLETED|Overall Study||0
942256|NCT01365611|2278343|P1|COMPLETED|Overall Study||36
942257|NCT01365611|2278343|P1|STARTED|Overall Study||36
942258|NCT01365585|2278359|P1|NOT COMPLETED|Overall Study||0
942259|NCT01365585|2278359|P1|COMPLETED|Overall Study||227
942260|NCT01365585|2278359|P1|STARTED|Overall Study||227
942261|NCT01365546|2278373|P1|NOT COMPLETED|Overall Study||11
942262|NCT01365546|2278373|P1|COMPLETED|Overall Study||30
942263|NCT01365546|2278373|P1|STARTED|Overall Study|in this study 41 patients were screened but only 30 patients completed the study.|41
942264|NCT01365507|2278383|P2|NOT COMPLETED|Overall Study||9
942265|NCT01365507|2278384|P1|NOT COMPLETED|Overall Study||9
942266|NCT01365507|2278383|P2|COMPLETED|Overall Study||131
942267|NCT01365507|2278384|P1|COMPLETED|Overall Study||127
942268|NCT01365507|2278383|P2|Exposed|Overall Study||140
942269|NCT01365507|2278384|P1|Exposed|Overall Study|Two subjects withdrew before exposure to trial drug|134
942270|NCT01365507|2278383|P2|STARTED|Overall Study||140
942271|NCT01365507|2278384|P1|STARTED|Overall Study||136
942272|NCT01365494|2278400|P2|NOT COMPLETED|Overall Study||3
942273|NCT01365494|2278401|P1|NOT COMPLETED|Overall Study||2
942274|NCT01365494|2278400|P2|COMPLETED|Overall Study||121
942275|NCT01365494|2278401|P1|COMPLETED|Overall Study||124
942276|NCT01365494|2278400|P2|STARTED|Overall Study||124
942277|NCT01365494|2278401|P1|STARTED|Overall Study||126
942278|NCT01365481|2278417|P4|NOT COMPLETED|Overall Study||7
942279|NCT01365481|2278418|P3|NOT COMPLETED|Overall Study||4
942280|NCT01365481|2278419|P2|NOT COMPLETED|Overall Study||15
942281|NCT01365481|2278420|P1|NOT COMPLETED|Overall Study||7
942282|NCT01365481|2278417|P4|COMPLETED|Overall Study||50
942283|NCT01365481|2278418|P3|COMPLETED|Overall Study||14
942284|NCT01365481|2278419|P2|COMPLETED|Overall Study||37
942285|NCT01365481|2278420|P1|COMPLETED|Overall Study||16
942286|NCT01365481|2278417|P4|STARTED|Overall Study||57
942287|NCT01365481|2278418|P3|STARTED|Overall Study||18
942288|NCT01365481|2278419|P2|STARTED|Overall Study||52
942289|NCT01365481|2278420|P1|STARTED|Overall Study||23
942290|NCT01365468|2278440|P2|NOT COMPLETED|Overall Study||0
942291|NCT01365468|2278441|P1|NOT COMPLETED|Overall Study||4
942292|NCT01365468|2278440|P2|COMPLETED|Overall Study||5
942293|NCT01365468|2278441|P1|COMPLETED|Overall Study||0
942294|NCT01365468|2278440|P2|STARTED|Overall Study||5
942295|NCT01365468|2278441|P1|STARTED|Overall Study||4
942296|NCT01365455|2278456|P5|NOT COMPLETED|Follow-up Period||0
942297|NCT01365455|2278457|P4|NOT COMPLETED|Follow-up Period||0
942298|NCT01365455|2278458|P3|NOT COMPLETED|Follow-up Period||0
942299|NCT01365455|2278459|P2|NOT COMPLETED|Follow-up Period||0
942300|NCT01365455|2278460|P1|NOT COMPLETED|Follow-up Period||0
942301|NCT01365455|2278456|P5|COMPLETED|Follow-up Period||0
942302|NCT01365455|2278457|P4|COMPLETED|Follow-up Period||0
942303|NCT01365455|2278458|P3|COMPLETED|Follow-up Period||18
942304|NCT01365455|2278459|P2|COMPLETED|Follow-up Period||47
942305|NCT01365455|2278460|P1|COMPLETED|Follow-up Period||58
942306|NCT01365455|2278456|P5|STARTED|Follow-up Period||0
942307|NCT01365455|2278457|P4|STARTED|Follow-up Period||0
942308|NCT01365455|2278458|P3|STARTED|Follow-up Period||18
942309|NCT01365455|2278459|P2|STARTED|Follow-up Period||47
942310|NCT01365455|2278460|P1|STARTED|Follow-up Period||58
942311|NCT01365455|2278456|P5|NOT COMPLETED|Maintenance Period||13
942312|NCT01365455|2278457|P4|NOT COMPLETED|Maintenance Period||9
942313|NCT01365455|2278458|P3|NOT COMPLETED|Maintenance Period||3
942314|NCT01365455|2278459|P2|NOT COMPLETED|Maintenance Period||23
942315|NCT01365455|2278460|P1|NOT COMPLETED|Maintenance Period||29
942316|NCT01365455|2278456|P5|COMPLETED|Maintenance Period||92
942317|NCT01365455|2278457|P4|COMPLETED|Maintenance Period||100
942318|NCT01365455|2278458|P3|COMPLETED|Maintenance Period||15
942319|NCT01365455|2278459|P2|COMPLETED|Maintenance Period||215
942320|NCT01365455|2278460|P1|COMPLETED|Maintenance Period||201
942321|NCT01365455|2278456|P5|STARTED|Maintenance Period||105
942322|NCT01365455|2278457|P4|STARTED|Maintenance Period||109
942323|NCT01365455|2278458|P3|STARTED|Maintenance Period||18
942324|NCT01365455|2278459|P2|STARTED|Maintenance Period||238
942325|NCT01365455|2278460|P1|STARTED|Maintenance Period||230
942326|NCT01365455|2278456|P5|NOT COMPLETED|Induction Period||0
942327|NCT01365455|2278457|P4|NOT COMPLETED|Induction Period||0
942328|NCT01365455|2278458|P3|NOT COMPLETED|Induction Period||16
942329|NCT01365455|2278459|P2|NOT COMPLETED|Induction Period||7
942330|NCT01365455|2278460|P1|NOT COMPLETED|Induction Period||15
942331|NCT01365455|2278456|P5|COMPLETED|Induction Period||0
942332|NCT01365455|2278457|P4|COMPLETED|Induction Period||0
942333|NCT01365455|2278458|P3|COMPLETED|Induction Period||232
942334|NCT01365455|2278459|P2|COMPLETED|Induction Period||238
942335|NCT01365455|2278460|P1|COMPLETED|Induction Period||230
942336|NCT01365455|2278456|P5|STARTED|Induction Period||0
942337|NCT01365455|2278457|P4|STARTED|Induction Period||0
942338|NCT01365455|2278458|P3|STARTED|Induction Period||248
942339|NCT01365455|2278459|P2|STARTED|Induction Period||245
942340|NCT01365455|2278460|P1|STARTED|Induction Period||245
942341|NCT01365273|2278550|P2|NOT COMPLETED|Overall Study||1
942342|NCT01365273|2278551|P1|NOT COMPLETED|Overall Study||2
942343|NCT01365273|2278550|P2|COMPLETED|Overall Study||20
942344|NCT01365273|2278551|P1|COMPLETED|Overall Study||20
942345|NCT01365273|2278550|P2|Compl. Pts, Not Evaluable for Pain.|Overall Study||4
942346|NCT01365273|2278551|P1|Compl. Pts, Not Evaluable for Pain.|Overall Study||2
942347|NCT01365273|2278550|P2|STARTED|Overall Study||21
942348|NCT01365273|2278551|P1|STARTED|Overall Study||22
942349|NCT01365130|2278561|P1|NOT COMPLETED|Overall Study||2
942350|NCT01365130|2278561|P1|COMPLETED|Overall Study||13
942351|NCT01365130|2278561|P1|STARTED|Overall Study|15 patients were enrolled to the study but only 13 went on to begin treatment|15
942352|NCT01365091|2278569|P4|NOT COMPLETED|Period 2||0
942353|NCT01365091|2278570|P3|NOT COMPLETED|Period 2||1
942354|NCT01365091|2278571|P2|NOT COMPLETED|Period 2||0
942355|NCT01365091|2278572|P1|NOT COMPLETED|Period 2||1
942356|NCT01365091|2278569|P4|COMPLETED|Period 2||25
942357|NCT01365091|2278570|P3|COMPLETED|Period 2||24
942358|NCT01365091|2278571|P2|COMPLETED|Period 2||26
942359|NCT01365091|2278572|P1|COMPLETED|Period 2||25
942360|NCT01365091|2278569|P4|STARTED|Period 2||25
942361|NCT01365091|2278570|P3|STARTED|Period 2||25
942362|NCT01365091|2278571|P2|STARTED|Period 2||26
942363|NCT01365091|2278572|P1|STARTED|Period 2||26
942364|NCT01365091|2278569|P4|NOT COMPLETED|Period 1||3
942365|NCT01365091|2278570|P3|NOT COMPLETED|Period 1||3
942366|NCT01365091|2278571|P2|NOT COMPLETED|Period 1||2
942367|NCT01365091|2278572|P1|NOT COMPLETED|Period 1||2
942368|NCT01365091|2278569|P4|COMPLETED|Period 1||25
942369|NCT01365091|2278570|P3|COMPLETED|Period 1||25
942370|NCT01365091|2278571|P2|COMPLETED|Period 1||26
942371|NCT01365091|2278572|P1|COMPLETED|Period 1||26
942372|NCT01365091|2278569|P4|STARTED|Period 1||28
942373|NCT01365091|2278570|P3|STARTED|Period 1||28
942374|NCT01365091|2278571|P2|STARTED|Period 1||28
942375|NCT01365091|2278572|P1|STARTED|Period 1||28
942376|NCT01365052|2278600|P2|NOT COMPLETED|Overall Study||4
942377|NCT01365052|2278601|P1|NOT COMPLETED|Overall Study||4
942378|NCT01365052|2278600|P2|COMPLETED|Overall Study||105
942379|NCT01365052|2278601|P1|COMPLETED|Overall Study||213
942380|NCT01365052|2278600|P2|STARTED|Overall Study||109
942381|NCT01365052|2278601|P1|STARTED|Overall Study||217
942382|NCT01365039|2278617|P2|NOT COMPLETED|Overall Study||0
942383|NCT01365039|2278618|P1|NOT COMPLETED|Overall Study||1
942384|NCT01365039|2278617|P2|COMPLETED|Overall Study||87
942385|NCT01365039|2278618|P1|COMPLETED|Overall Study||85
942386|NCT01365039|2278617|P2|STARTED|Overall Study||87
942387|NCT01365039|2278618|P1|STARTED|Overall Study||86
942388|NCT01364922|2278629|P3|NOT COMPLETED|Double-Blind (DB) Period||5
942389|NCT01364922|2278630|P2|NOT COMPLETED|Double-Blind (DB) Period||5
942390|NCT01364922|2278631|P1|NOT COMPLETED|Double-Blind (DB) Period||0
942391|NCT01364922|2278629|P3|COMPLETED|Double-Blind (DB) Period||42
942392|NCT01364922|2278630|P2|COMPLETED|Double-Blind (DB) Period||94
942393|NCT01364922|2278631|P1|COMPLETED|Double-Blind (DB) Period||0
942394|NCT01364922|2278629|P3|STARTED|Double-Blind (DB) Period||47
942395|NCT01364922|2278630|P2|STARTED|Double-Blind (DB) Period||99
942396|NCT01364922|2278631|P1|STARTED|Double-Blind (DB) Period||0
942397|NCT01364922|2278629|P3|NOT COMPLETED|Open-label (OL) Period||0
942398|NCT01364922|2278630|P2|NOT COMPLETED|Open-label (OL) Period||0
942399|NCT01364922|2278631|P1|NOT COMPLETED|Open-label (OL) Period||22
942400|NCT01364922|2278629|P3|COMPLETED|Open-label (OL) Period||0
942401|NCT01364922|2278630|P2|COMPLETED|Open-label (OL) Period||0
942402|NCT01364922|2278631|P1|COMPLETED|Open-label (OL) Period||146
942403|NCT01364922|2278629|P3|STARTED|Open-label (OL) Period||0
942404|NCT01364922|2278630|P2|STARTED|Open-label (OL) Period||0
942405|NCT01364922|2278631|P1|STARTED|Open-label (OL) Period||168
942406|NCT01364896|2278642|P1|NOT COMPLETED|Overall Study||0
942407|NCT01364896|2278642|P1|COMPLETED|Overall Study||46
942408|NCT01364896|2278642|P1|STARTED|Overall Study||46
942409|NCT01364740|2278650|P1|NOT COMPLETED|Overall Study||0
942410|NCT01364740|2278650|P1|COMPLETED|Overall Study||10
942411|NCT01364740|2278650|P1|STARTED|Overall Study||10
942412|NCT01364727|2278658|P1|NOT COMPLETED|Overall Study||2
942413|NCT01364727|2278658|P1|COMPLETED|Overall Study||33
942414|NCT01364727|2278658|P1|STARTED|Overall Study||35
942415|NCT01364649|2278666|P2|NOT COMPLETED|Overall Study||43
942416|NCT01364649|2278667|P1|NOT COMPLETED|Overall Study||56
942417|NCT01364649|2278666|P2|COMPLETED|Overall Study||179
942418|NCT01364649|2278667|P1|COMPLETED|Overall Study||169
942419|NCT01364649|2278666|P2|STARTED|Overall Study||222
942420|NCT01364649|2278667|P1|STARTED|Overall Study||225
942421|NCT01364558|2278677|P3|NOT COMPLETED|Dose Three||0
942422|NCT01364558|2278678|P2|NOT COMPLETED|Dose Three||0
942423|NCT01364558|2278679|P1|NOT COMPLETED|Dose Three||0
942424|NCT01364558|2278677|P3|COMPLETED|Dose Three||8
942425|NCT01364558|2278678|P2|COMPLETED|Dose Three||8
942426|NCT01364558|2278679|P1|COMPLETED|Dose Three||8
942427|NCT01364558|2278677|P3|STARTED|Dose Three||8
942428|NCT01364558|2278678|P2|STARTED|Dose Three||8
942429|NCT01364558|2278679|P1|STARTED|Dose Three||8
942430|NCT01364558|2278677|P3|NOT COMPLETED|Dose Two||0
942431|NCT01364558|2278678|P2|NOT COMPLETED|Dose Two||0
942432|NCT01364558|2278679|P1|NOT COMPLETED|Dose Two||0
942433|NCT01364558|2278677|P3|COMPLETED|Dose Two||8
942434|NCT01364558|2278678|P2|COMPLETED|Dose Two||8
942435|NCT01364558|2278679|P1|COMPLETED|Dose Two||8
942436|NCT01364558|2278677|P3|STARTED|Dose Two||8
942437|NCT01364558|2278678|P2|STARTED|Dose Two||8
942438|NCT01364558|2278679|P1|STARTED|Dose Two||8
942439|NCT01364558|2278677|P3|NOT COMPLETED|Dose One||0
942440|NCT01364558|2278678|P2|NOT COMPLETED|Dose One||0
942441|NCT01364558|2278679|P1|NOT COMPLETED|Dose One||0
942442|NCT01364558|2278677|P3|COMPLETED|Dose One||8
942443|NCT01364558|2278678|P2|COMPLETED|Dose One||8
942444|NCT01364558|2278679|P1|COMPLETED|Dose One||8
942445|NCT01364558|2278677|P3|STARTED|Dose One||8
942446|NCT01364558|2278678|P2|STARTED|Dose One||8
942447|NCT01364558|2278679|P1|STARTED|Dose One||8
942448|NCT01364428|2278689|P2|NOT COMPLETED|Overall Study||15
942449|NCT01364428|2278690|P1|NOT COMPLETED|Overall Study||20
942450|NCT01364428|2278689|P2|COMPLETED|Overall Study||172
942451|NCT01364428|2278690|P1|COMPLETED|Overall Study||166
942452|NCT01364428|2278689|P2|Exposed|Overall Study||187
942453|NCT01364428|2278690|P1|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|184
942454|NCT01364428|2278689|P2|STARTED|Overall Study||187
942455|NCT01364428|2278690|P1|STARTED|Overall Study||186
942456|NCT01364389|2278707|P3|NOT COMPLETED|Overall Study||1
942457|NCT01364389|2278708|P2|NOT COMPLETED|Overall Study||1
942458|NCT01364389|2278709|P1|NOT COMPLETED|Overall Study||2
942459|NCT01364389|2278707|P3|COMPLETED|Overall Study||4
942460|NCT01364389|2278708|P2|COMPLETED|Overall Study||5
942461|NCT01364389|2278709|P1|COMPLETED|Overall Study||3
942462|NCT01364389|2278707|P3|Pharmacodynamic (PD) Analysis Set|Overall Study|One patient excluded: did not receive study drug; received placebo caps. and infusion only in error.|4
942463|NCT01364389|2278708|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||6
942464|NCT01364389|2278709|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||5
942465|NCT01364389|2278707|P3|STARTED|Overall Study||5
942466|NCT01364389|2278708|P2|STARTED|Overall Study||6
942467|NCT01364389|2278709|P1|STARTED|Overall Study||5
942468|NCT01364298|2278728|P2|NOT COMPLETED|Overall Study||23
942469|NCT01364298|2278729|P1|NOT COMPLETED|Overall Study||14
942470|NCT01364298|2278728|P2|COMPLETED|Overall Study||154
942471|NCT01364298|2278729|P1|COMPLETED|Overall Study||162
942472|NCT01364298|2278728|P2|Treated|Overall Study||174
942473|NCT01364298|2278729|P1|Treated|Overall Study||174
942474|NCT01364298|2278728|P2|STARTED|Overall Study||177
942475|NCT01364298|2278729|P1|STARTED|Overall Study||176
942476|NCT01364259|2278753|P2|NOT COMPLETED|Overall Study||0
942477|NCT01364259|2278754|P1|NOT COMPLETED|Overall Study||0
942478|NCT01364259|2278753|P2|COMPLETED|Overall Study||8
942479|NCT01364259|2278754|P1|COMPLETED|Overall Study||9
942480|NCT01364259|2278753|P2|STARTED|Overall Study||8
942481|NCT01364259|2278754|P1|STARTED|Overall Study||9
942482|NCT01364207|2278762|P2|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
942483|NCT01364207|2278763|P1|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
942484|NCT01364207|2278762|P2|COMPLETED|Second Visit (~1.5-2 Hours)||54
942485|NCT01364207|2278763|P1|COMPLETED|Second Visit (~1.5-2 Hours)||52
942486|NCT01364207|2278762|P2|STARTED|Second Visit (~1.5-2 Hours)||54
942487|NCT01364207|2278763|P1|STARTED|Second Visit (~1.5-2 Hours)||52
942488|NCT01364207|2278762|P2|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||4
942489|NCT01364207|2278763|P1|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||2
942490|NCT01364207|2278762|P2|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||54
942491|NCT01364207|2278763|P1|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||52
942492|NCT01364207|2278762|P2|STARTED|Time Between Visits (2 Days to 4 Weeks)||58
942493|NCT01364207|2278763|P1|STARTED|Time Between Visits (2 Days to 4 Weeks)||54
942494|NCT01364207|2278762|P2|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
942495|NCT01364207|2278763|P1|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
942496|NCT01364207|2278762|P2|COMPLETED|First Visit (~1.5-2 Hours)||58
942497|NCT01364207|2278763|P1|COMPLETED|First Visit (~1.5-2 Hours)||54
942498|NCT01364207|2278762|P2|STARTED|First Visit (~1.5-2 Hours)||58
942499|NCT01364207|2278763|P1|STARTED|First Visit (~1.5-2 Hours)||54
942500|NCT01363986|2278771|P1|NOT COMPLETED|Overall Study||1
942501|NCT01363986|2278771|P1|COMPLETED|Overall Study||2
942502|NCT01363986|2278771|P1|STARTED|Overall Study||3
942503|NCT01363908|2278781|P2|NOT COMPLETED|Chronic Dosing (CD) Phase||6
942504|NCT01363908|2278782|P1|NOT COMPLETED|Chronic Dosing (CD) Phase||10
942505|NCT01363908|2278781|P2|COMPLETED|Chronic Dosing (CD) Phase||10
942506|NCT01363908|2278782|P1|COMPLETED|Chronic Dosing (CD) Phase||3
942507|NCT01363908|2278781|P2|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|16
942508|NCT01363908|2278782|P1|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|13
942509|NCT01363908|2278781|P2|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
942510|NCT01363908|2278782|P1|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
942511|NCT01363908|2278781|P2|COMPLETED|Pharmacokinetic (PK) Phase||8
942512|NCT01363908|2278782|P1|COMPLETED|Pharmacokinetic (PK) Phase||8
942513|NCT01363908|2278781|P2|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
942514|NCT01363908|2278782|P1|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
942515|NCT01363908|2278781|P2|NOT COMPLETED|Screening/Enrollment||0
942516|NCT01363908|2278782|P1|NOT COMPLETED|Screening/Enrollment||1
942517|NCT01363908|2278781|P2|COMPLETED|Screening/Enrollment||16
942518|NCT01363908|2278782|P1|COMPLETED|Screening/Enrollment|One participant did not receive investigational product.|13
942519|NCT01363908|2278781|P2|STARTED|Screening/Enrollment||16
942520|NCT01363908|2278782|P1|STARTED|Screening/Enrollment||14
942521|NCT01363843|2278812|P1|NOT COMPLETED|Overall Study||1
942522|NCT01363843|2278812|P1|COMPLETED|Overall Study|39 enrolled, 36 completed 8 cycles of mFOLFOX6, 35 completed chemo-radiation, 38 underwent surgery.|38
942523|NCT01363843|2278812|P1|STARTED|Overall Study||39
942524|NCT01363765|2278818|P2|NOT COMPLETED|Overall Study||4731
942525|NCT01363765|2278819|P1|NOT COMPLETED|Overall Study||5800
942526|NCT01363765|2278818|P2|COMPLETED|Overall Study|Samples contributing to observation arm. Excluded were duplicates, non-residents, missing age.|11705
942527|NCT01363765|2278819|P1|COMPLETED|Overall Study|Excluded were duplicates, non-residents, missing age, unavailability of system (smears done instead)|12522
942528|NCT01363765|2278818|P2|STARTED|Overall Study|This is number of participants enrolled, each with one sample considered in baseline arm.|16436
942529|NCT01363765|2278819|P1|STARTED|Overall Study|This is number of participants enrolled, each with one sample submitted to Xpert in intervention arm|18322
942530|NCT01363713|2278831|P1|NOT COMPLETED|Overall Study||6
942531|NCT01363713|2278831|P1|COMPLETED|Overall Study|Analysed (n=130)|124
942532|NCT01363713|2278831|P1|ALLOCATED|Overall Study||130
942533|NCT01363713|2278831|P1|STARTED|Overall Study|Assessed for eligibility|130
942534|NCT01363700|2278840|P5|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
942535|NCT01363700|2278841|P4|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
942536|NCT01363700|2278842|P3|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
942537|NCT01363700|2278843|P2|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
942538|NCT01363700|2278844|P1|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
942539|NCT01363700|2278840|P5|COMPLETED|Epinastine vs Olopatadine Period2||43
942540|NCT01363700|2278841|P4|COMPLETED|Epinastine vs Olopatadine Period2||43
942541|NCT01363700|2278842|P3|COMPLETED|Epinastine vs Olopatadine Period2||0
942542|NCT01363700|2278843|P2|COMPLETED|Epinastine vs Olopatadine Period2||0
942543|NCT01363700|2278844|P1|COMPLETED|Epinastine vs Olopatadine Period2||0
942544|NCT01363700|2278840|P5|STARTED|Epinastine vs Olopatadine Period2||43
942545|NCT01363700|2278841|P4|STARTED|Epinastine vs Olopatadine Period2||43
942546|NCT01363700|2278842|P3|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
942547|NCT01363700|2278843|P2|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
942548|NCT01363700|2278844|P1|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
942549|NCT01363700|2278840|P5|NOT COMPLETED|Epinastine vs Placebo Period1||0
942550|NCT01363700|2278841|P4|NOT COMPLETED|Epinastine vs Placebo Period1||0
942551|NCT01363700|2278842|P3|NOT COMPLETED|Epinastine vs Placebo Period1||0
942552|NCT01363700|2278843|P2|NOT COMPLETED|Epinastine vs Placebo Period1||1
942553|NCT01363700|2278844|P1|NOT COMPLETED|Epinastine vs Placebo Period1||0
942554|NCT01363700|2278840|P5|COMPLETED|Epinastine vs Placebo Period1||0
942555|NCT01363700|2278841|P4|COMPLETED|Epinastine vs Placebo Period1||0
942556|NCT01363700|2278842|P3|COMPLETED|Epinastine vs Placebo Period1||22
942557|NCT01363700|2278843|P2|COMPLETED|Epinastine vs Placebo Period1||21
942558|NCT01363700|2278844|P1|COMPLETED|Epinastine vs Placebo Period1||43
942559|NCT01363700|2278840|P5|STARTED|Epinastine vs Placebo Period1|No Allocation|0
942560|NCT01363700|2278841|P4|STARTED|Epinastine vs Placebo Period1|No Allocation|0
942561|NCT01363700|2278842|P3|STARTED|Epinastine vs Placebo Period1||22
942562|NCT01363700|2278843|P2|STARTED|Epinastine vs Placebo Period1||22
942563|NCT01363700|2278844|P1|STARTED|Epinastine vs Placebo Period1||43
942564|NCT01363661|2278863|P2|NOT COMPLETED|Overall Study||4
942565|NCT01363661|2278864|P1|NOT COMPLETED|Overall Study||14
942566|NCT01363661|2278863|P2|COMPLETED|Overall Study||28
942567|NCT01363661|2278864|P1|COMPLETED|Overall Study||18
942568|NCT01363661|2278863|P2|STARTED|Overall Study||32
942569|NCT01363661|2278864|P1|STARTED|Overall Study||32
942570|NCT01363492|2278880|P1|NOT COMPLETED|Overall Study||0
942571|NCT01363492|2278880|P1|COMPLETED|Overall Study||14
942572|NCT01363492|2278880|P1|STARTED|Overall Study||14
942579|NCT01363440|2278905|P3|NOT COMPLETED|Overall Study||27
942580|NCT01363440|2278906|P2|NOT COMPLETED|Overall Study||31
942581|NCT01363440|2278907|P1|NOT COMPLETED|Overall Study||23
942582|NCT01363440|2278905|P3|COMPLETED|Overall Study|Completed Week 100|127
942583|NCT01363440|2278906|P2|COMPLETED|Overall Study|Completed Week 100|125
942584|NCT01363440|2278907|P1|COMPLETED|Overall Study|Completed Week 100|133
942585|NCT01363440|2278905|P3|Completed Week 100|Overall Study||127
942586|NCT01363440|2278906|P2|Completed Week 100|Overall Study||125
942587|NCT01363440|2278907|P1|Completed Week 100|Overall Study||133
942588|NCT01363440|2278905|P3|Completed Week 52|Overall Study||144
942589|NCT01363440|2278906|P2|Completed Week 52|Overall Study||146
942590|NCT01363440|2278907|P1|Completed Week 52|Overall Study||145
942591|NCT01363440|2278905|P3|Participants Received Treatment|Overall Study|safety analysis set (SAF)|152
942592|NCT01363440|2278906|P2|Participants Received Treatment|Overall Study|safety analysis set (SAF)|155
942593|NCT01363440|2278907|P1|Participants Received Treatment|Overall Study|safety analysis set (SAF)|154
942594|NCT01363440|2278905|P3|STARTED|Overall Study|randomized|154
942595|NCT01363440|2278906|P2|STARTED|Overall Study|randomized|156
942596|NCT01363440|2278907|P1|STARTED|Overall Study|randomized|156
942597|NCT01363401|2278938|P2|NOT COMPLETED|Overall Study||4
942598|NCT01363401|2278939|P1|NOT COMPLETED|Overall Study||2
942599|NCT01363401|2278938|P2|COMPLETED|Overall Study||27
942600|NCT01363401|2278939|P1|COMPLETED|Overall Study||39
942601|NCT01363401|2278938|P2|STARTED|Overall Study||31
942602|NCT01363401|2278939|P1|STARTED|Overall Study|"Including 8 subjects of Phase 1 safety assessment. (Called Modified ITT in this clinical trials)"|41
942603|NCT01363349|2278953|P2|NOT COMPLETED|Overall Study||70
942604|NCT01363349|2278954|P1|NOT COMPLETED|Overall Study||67
942605|NCT01363349|2278953|P2|COMPLETED|Overall Study||66
942606|NCT01363349|2278954|P1|COMPLETED|Overall Study||66
942607|NCT01363349|2278953|P2|Randomized|Overall Study||136
942608|NCT01363349|2278954|P1|Randomized|Overall Study||133
942609|NCT01363349|2278953|P2|STARTED|Overall Study||136
942610|NCT01363349|2278954|P1|STARTED|Overall Study||133
942611|NCT01363297|2278965|P5|NOT COMPLETED|Overall Study||31
942612|NCT01363297|2278966|P4|NOT COMPLETED|Overall Study||10
942613|NCT01363297|2278967|P3|NOT COMPLETED|Overall Study||6
942614|NCT01363297|2278968|P2|NOT COMPLETED|Overall Study||6
942615|NCT01363297|2278969|P1|NOT COMPLETED|Overall Study||3
942616|NCT01363297|2278965|P5|COMPLETED|Overall Study||4
942617|NCT01363297|2278966|P4|COMPLETED|Overall Study||3
942618|NCT01363297|2278967|P3|COMPLETED|Overall Study||3
942619|NCT01363297|2278968|P2|COMPLETED|Overall Study||6
942620|NCT01363297|2278969|P1|COMPLETED|Overall Study||0
942621|NCT01363297|2278965|P5|STARTED|Overall Study||35
942622|NCT01363297|2278966|P4|STARTED|Overall Study||13
942623|NCT01363297|2278967|P3|STARTED|Overall Study||9
942624|NCT01363297|2278968|P2|STARTED|Overall Study||12
942625|NCT01363297|2278969|P1|STARTED|Overall Study||3
942626|NCT01363076|2279061|P2|NOT COMPLETED|Overall Study||1
942627|NCT01363076|2279062|P1|NOT COMPLETED|Overall Study||0
942628|NCT01363076|2279061|P2|COMPLETED|Overall Study||12
942629|NCT01363076|2279062|P1|COMPLETED|Overall Study||7
942630|NCT01363076|2279061|P2|STARTED|Overall Study||13
942631|NCT01363076|2279062|P1|STARTED|Overall Study||7
942632|NCT01363050|2279080|P1|NOT COMPLETED|Overall Study||0
942633|NCT01363050|2279080|P1|COMPLETED|Overall Study||15
942634|NCT01363050|2279080|P1|STARTED|Overall Study||15
942635|NCT01363011|2279094|P2|NOT COMPLETED|Extension Phase||8
942636|NCT01363011|2279095|P1|NOT COMPLETED|Extension Phase||5
942637|NCT01363011|2279094|P2|COMPLETED|Extension Phase||41
942638|NCT01363011|2279095|P1|COMPLETED|Extension Phase||13
942639|NCT01363011|2279094|P2|STARTED|Extension Phase|15 participants who completed the main study did not enroll into the extension phase.|49
942640|NCT01363011|2279095|P1|STARTED|Extension Phase|11 participants who completed the main study did not enroll into the extension phase.|18
942641|NCT01363011|2279094|P2|NOT COMPLETED|Main Study||9
942642|NCT01363011|2279095|P1|NOT COMPLETED|Main Study||4
942643|NCT01363011|2279094|P2|COMPLETED|Main Study||64
942644|NCT01363011|2279095|P1|COMPLETED|Main Study||29
942645|NCT01363011|2279094|P2|STARTED|Main Study||73
942646|NCT01363011|2279095|P1|STARTED|Main Study||33
942647|NCT01362946|2279135|P2|NOT COMPLETED|Second Behavior Modification Block||0
942648|NCT01362946|2279136|P1|NOT COMPLETED|Second Behavior Modification Block||0
942649|NCT01362946|2279135|P2|COMPLETED|Second Behavior Modification Block||24
942650|NCT01362946|2279136|P1|COMPLETED|Second Behavior Modification Block||23
942651|NCT01362946|2279135|P2|STARTED|Second Behavior Modification Block||24
942652|NCT01362946|2279136|P1|STARTED|Second Behavior Modification Block|1 participant withdrew after last but before this treatment period - illness unrelated to study.|23
942653|NCT01362946|2279135|P2|NOT COMPLETED|First Behavior Modification Block||0
942654|NCT01362946|2279136|P1|NOT COMPLETED|First Behavior Modification Block||0
942655|NCT01362946|2279135|P2|COMPLETED|First Behavior Modification Block||24
942656|NCT01362946|2279136|P1|COMPLETED|First Behavior Modification Block||24
942657|NCT01362946|2279135|P2|STARTED|First Behavior Modification Block||24
942658|NCT01362946|2279136|P1|STARTED|First Behavior Modification Block||24
942659|NCT01362907|2279169|P2|NOT COMPLETED|Period 2, One Week||0
942660|NCT01362907|2279170|P1|NOT COMPLETED|Period 2, One Week||0
942661|NCT01362907|2279169|P2|COMPLETED|Period 2, One Week||20
942662|NCT01362907|2279170|P1|COMPLETED|Period 2, One Week||20
942663|NCT01362907|2279169|P2|STARTED|Period 2, One Week||20
942664|NCT01362907|2279170|P1|STARTED|Period 2, One Week||20
942665|NCT01362907|2279169|P2|NOT COMPLETED|Period 1, One Week||0
942666|NCT01362907|2279170|P1|NOT COMPLETED|Period 1, One Week||0
942667|NCT01362907|2279169|P2|COMPLETED|Period 1, One Week||20
942668|NCT01362907|2279170|P1|COMPLETED|Period 1, One Week||20
942669|NCT01362907|2279169|P2|STARTED|Period 1, One Week||20
942670|NCT01362907|2279170|P1|STARTED|Period 1, One Week||20
942671|NCT01362894|2279184|P2|NOT COMPLETED|Period Two, 1 Week||0
942672|NCT01362894|2279185|P1|NOT COMPLETED|Period Two, 1 Week||0
942673|NCT01362894|2279184|P2|COMPLETED|Period Two, 1 Week||115
942674|NCT01362894|2279185|P1|COMPLETED|Period Two, 1 Week||118
942675|NCT01362894|2279184|P2|STARTED|Period Two, 1 Week|Three participants discontinued between Periods 1 and 2 due to unacceptable vision.|115
942676|NCT01362894|2279185|P1|STARTED|Period Two, 1 Week|Two participants discontinued between Periods 1 and 2 due to discomfort (1) and poor fit (1).|118
942677|NCT01362894|2279184|P2|NOT COMPLETED|Period One, 1 Week||0
942678|NCT01362894|2279185|P1|NOT COMPLETED|Period One, 1 Week||0
942679|NCT01362894|2279184|P2|COMPLETED|Period One, 1 Week||117
942680|NCT01362894|2279185|P1|COMPLETED|Period One, 1 Week||119
942681|NCT01362894|2279184|P2|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|117
942682|NCT01362894|2279185|P1|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|119
942683|NCT01362686|2279202|P3|NOT COMPLETED|Overall Study||10
942684|NCT01362686|2279203|P2|NOT COMPLETED|Overall Study||12
942685|NCT01362686|2279204|P1|NOT COMPLETED|Overall Study||8
942686|NCT01362686|2279202|P3|COMPLETED|Overall Study||53
942687|NCT01362686|2279203|P2|COMPLETED|Overall Study||54
942688|NCT01362686|2279204|P1|COMPLETED|Overall Study||59
942689|NCT01362686|2279202|P3|STARTED|Overall Study||63
942690|NCT01362686|2279203|P2|STARTED|Overall Study||66
942691|NCT01362686|2279204|P1|STARTED|Overall Study||67
942692|NCT01362608|2279220|P2|NOT COMPLETED|Overall Study||8
942693|NCT01362608|2279221|P1|NOT COMPLETED|Overall Study||4
942694|NCT01362608|2279220|P2|COMPLETED|Overall Study||61
942695|NCT01362608|2279221|P1|COMPLETED|Overall Study||63
942696|NCT01362608|2279220|P2|STARTED|Overall Study||69
942697|NCT01362608|2279221|P1|STARTED|Overall Study||67
942698|NCT01362530|2279259|P2|NOT COMPLETED|Optional Extension (Cycles 2-6)||0
942699|NCT01362530|2279260|P1|NOT COMPLETED|Optional Extension (Cycles 2-6)||125
942700|NCT01362530|2279259|P2|COMPLETED|Optional Extension (Cycles 2-6)||0
942701|NCT01362530|2279260|P1|COMPLETED|Optional Extension (Cycles 2-6)||46
942702|NCT01362530|2279259|P2|STARTED|Optional Extension (Cycles 2-6)||0
942703|NCT01362530|2279260|P1|STARTED|Optional Extension (Cycles 2-6)||171
942704|NCT01362530|2279259|P2|NOT COMPLETED|Base Study (Cycle 1)||3
942705|NCT01362530|2279260|P1|NOT COMPLETED|Base Study (Cycle 1)||5
942706|NCT01362530|2279259|P2|COMPLETED|Base Study (Cycle 1)||149
942707|NCT01362530|2279260|P1|COMPLETED|Base Study (Cycle 1)||150
942708|NCT01362530|2279259|P2|Received Study Treatment|Base Study (Cycle 1)||150
942709|NCT01362530|2279260|P1|Received Study Treatment|Base Study (Cycle 1)||152
942710|NCT01362530|2279259|P2|STARTED|Base Study (Cycle 1)||152
942711|NCT01362530|2279260|P1|STARTED|Base Study (Cycle 1)||155
942712|NCT01362517|2279273|P1|NOT COMPLETED|Overall Study||2
942713|NCT01362517|2279273|P1|COMPLETED|Overall Study||129
942714|NCT01362517|2279273|P1|STARTED|Overall Study||131
942715|NCT01362491|2279284|P3|NOT COMPLETED|Overall Study||0
942716|NCT01362491|2279285|P2|NOT COMPLETED|Overall Study||0
942717|NCT01362491|2279286|P1|NOT COMPLETED|Overall Study||1
942718|NCT01362491|2279284|P3|COMPLETED|Overall Study||46
942719|NCT01362491|2279285|P2|COMPLETED|Overall Study||89
942720|NCT01362491|2279286|P1|COMPLETED|Overall Study||90
942721|NCT01362491|2279284|P3|STARTED|Overall Study||46
942722|NCT01362491|2279285|P2|STARTED|Overall Study||89
942723|NCT01362491|2279286|P1|STARTED|Overall Study||91
942724|NCT01362439|2279334|P1|NOT COMPLETED|Overall Study||15
942725|NCT01362439|2279334|P1|COMPLETED|Overall Study||118
942726|NCT01362439|2279334|P1|STARTED|Overall Study||133
942727|NCT01362348|2279349|P1|NOT COMPLETED|Overall Study||14
942728|NCT01362348|2279349|P1|COMPLETED|Overall Study||5
942729|NCT01362348|2279349|P1|STARTED|Overall Study||19
942730|NCT01362296|2279368|P4|NOT COMPLETED|Crossover Phase||2
942731|NCT01362296|2279369|P3|NOT COMPLETED|Crossover Phase||23
942732|NCT01362296|2279370|P2|NOT COMPLETED|Crossover Phase||0
942733|NCT01362296|2279371|P1|NOT COMPLETED|Crossover Phase||0
942734|NCT01362296|2279368|P4|COMPLETED|Crossover Phase||0
942735|NCT01362296|2279369|P3|COMPLETED|Crossover Phase||0
942736|NCT01362296|2279370|P2|COMPLETED|Crossover Phase||0
942737|NCT01362296|2279371|P1|COMPLETED|Crossover Phase||0
942738|NCT01362296|2279368|P4|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|2
942739|NCT01362296|2279369|P3|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|23
942740|NCT01362296|2279370|P2|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
942741|NCT01362296|2279371|P1|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
942742|NCT01362296|2279368|P4|NOT COMPLETED|Randomized Phase (RP)||0
942743|NCT01362296|2279369|P3|NOT COMPLETED|Randomized Phase (RP)||0
942744|NCT01362296|2279370|P2|NOT COMPLETED|Randomized Phase (RP)||43
942745|NCT01362296|2279371|P1|NOT COMPLETED|Randomized Phase (RP)||87
942746|NCT01362296|2279368|P4|COMPLETED|Randomized Phase (RP)||0
942747|NCT01362296|2279369|P3|COMPLETED|Randomized Phase (RP)||0
942748|NCT01362296|2279370|P2|COMPLETED|Randomized Phase (RP)||0
942749|NCT01362296|2279371|P1|COMPLETED|Randomized Phase (RP)||0
942750|NCT01362296|2279368|P4|STARTED|Randomized Phase (RP)||0
942751|NCT01362296|2279369|P3|STARTED|Randomized Phase (RP)||0
942752|NCT01362296|2279370|P2|STARTED|Randomized Phase (RP)||43
942753|NCT01362296|2279371|P1|STARTED|Randomized Phase (RP)||87
942754|NCT01362244|2279419|P2|NOT COMPLETED|Overall Study||32
942755|NCT01362244|2279420|P1|NOT COMPLETED|Overall Study||32
942756|NCT01362244|2279419|P2|COMPLETED|Overall Study||19
942757|NCT01362244|2279420|P1|COMPLETED|Overall Study||22
942758|NCT01362244|2279419|P2|STARTED|Overall Study||51
942759|NCT01362244|2279420|P1|STARTED|Overall Study||54
942760|NCT01362205|2279493|P2|NOT COMPLETED|Overall Study||0
942761|NCT01362205|2279494|P1|NOT COMPLETED|Overall Study||0
942762|NCT01362205|2279493|P2|COMPLETED|Overall Study||27
942763|NCT01362205|2279494|P1|COMPLETED|Overall Study||22
942764|NCT01362205|2279493|P2|STARTED|Overall Study||27
942765|NCT01362205|2279494|P1|STARTED|Overall Study||22
942766|NCT01362192|2279520|P1|NOT COMPLETED|Overall Study||4
942767|NCT01362192|2279520|P1|COMPLETED|Overall Study||16
942768|NCT01362192|2279520|P1|STARTED|Overall Study||20
942777|NCT01362062|2279557|P2|NOT COMPLETED|Overall Study||0
942778|NCT01362062|2279558|P1|NOT COMPLETED|Overall Study||26
942779|NCT01362062|2279557|P2|COMPLETED|Overall Study||62
942780|NCT01362062|2279558|P1|COMPLETED|Overall Study||22
942781|NCT01362062|2279557|P2|STARTED|Overall Study||62
942782|NCT01362062|2279558|P1|STARTED|Overall Study||48
942783|NCT01362049|2279579|P4|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
942784|NCT01362049|2279580|P3|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||2
942785|NCT01362049|2279581|P2|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
942786|NCT01362049|2279582|P1|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||5
942787|NCT01362049|2279579|P4|COMPLETED|Follow-Up at 52 Weeks (12 Months)||21
942788|NCT01362049|2279580|P3|COMPLETED|Follow-Up at 52 Weeks (12 Months)||28
942789|NCT01362049|2279581|P2|COMPLETED|Follow-Up at 52 Weeks (12 Months)||13
942790|NCT01362049|2279582|P1|COMPLETED|Follow-Up at 52 Weeks (12 Months)||18
942791|NCT01362049|2279579|P4|STARTED|Follow-Up at 52 Weeks (12 Months)||24
942792|NCT01362049|2279580|P3|STARTED|Follow-Up at 52 Weeks (12 Months)||30
942793|NCT01362049|2279581|P2|STARTED|Follow-Up at 52 Weeks (12 Months)||16
942794|NCT01362049|2279582|P1|STARTED|Follow-Up at 52 Weeks (12 Months)||23
942795|NCT01362049|2279579|P4|NOT COMPLETED|Follow-Up at 7 Weeks||1
942796|NCT01362049|2279580|P3|NOT COMPLETED|Follow-Up at 7 Weeks||2
942797|NCT01362049|2279581|P2|NOT COMPLETED|Follow-Up at 7 Weeks||3
942798|NCT01362049|2279582|P1|NOT COMPLETED|Follow-Up at 7 Weeks||3
942799|NCT01362049|2279579|P4|COMPLETED|Follow-Up at 7 Weeks||24
942800|NCT01362049|2279580|P3|COMPLETED|Follow-Up at 7 Weeks||30
942801|NCT01362049|2279581|P2|COMPLETED|Follow-Up at 7 Weeks||16
942802|NCT01362049|2279582|P1|COMPLETED|Follow-Up at 7 Weeks||23
942803|NCT01362049|2279579|P4|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||25
942804|NCT01362049|2279580|P3|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||32
942805|NCT01362049|2279581|P2|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||18
942806|NCT01362049|2279582|P1|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||26
942807|NCT01362049|2279579|P4|STARTED|Follow-Up at 7 Weeks||25
942808|NCT01362049|2279580|P3|STARTED|Follow-Up at 7 Weeks||32
942809|NCT01362049|2279581|P2|STARTED|Follow-Up at 7 Weeks||19
942810|NCT01362049|2279582|P1|STARTED|Follow-Up at 7 Weeks||26
942811|NCT01361867|2279620|P1|NOT COMPLETED|Overall Study||0
942812|NCT01361867|2279620|P1|COMPLETED|Overall Study||15
942813|NCT01361867|2279620|P1|STARTED|Overall Study||15
942814|NCT01361854|2279625|P2|NOT COMPLETED|Second Intervention||0
942815|NCT01361854|2279626|P1|NOT COMPLETED|Second Intervention||0
942816|NCT01361854|2279625|P2|COMPLETED|Second Intervention||48
942817|NCT01361854|2279626|P1|COMPLETED|Second Intervention||47
942818|NCT01361854|2279625|P2|STARTED|Second Intervention||48
942819|NCT01361854|2279626|P1|STARTED|Second Intervention||47
942820|NCT01361854|2279625|P2|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
942821|NCT01361854|2279626|P1|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
942822|NCT01361854|2279625|P2|COMPLETED|Wash-out, Maximum 2 Weeks||48
942823|NCT01361854|2279626|P1|COMPLETED|Wash-out, Maximum 2 Weeks||47
942824|NCT01361854|2279625|P2|STARTED|Wash-out, Maximum 2 Weeks||48
942825|NCT01361854|2279626|P1|STARTED|Wash-out, Maximum 2 Weeks||47
942826|NCT01361854|2279625|P2|NOT COMPLETED|Day 1||3
942827|NCT01361854|2279626|P1|NOT COMPLETED|Day 1||4
942828|NCT01361854|2279625|P2|COMPLETED|Day 1||48
942829|NCT01361854|2279626|P1|COMPLETED|Day 1||47
942830|NCT01361854|2279625|P2|STARTED|Day 1||51
942831|NCT01361854|2279626|P1|STARTED|Day 1||51
942832|NCT01361633|2279634|P2|NOT COMPLETED|Overall Study||3
942833|NCT01361633|2279635|P1|NOT COMPLETED|Overall Study||6
942834|NCT01361633|2279634|P2|COMPLETED|Overall Study||23
942835|NCT01361633|2279635|P1|COMPLETED|Overall Study||19
942836|NCT01361633|2279634|P2|STARTED|Overall Study||26
942837|NCT01361633|2279635|P1|STARTED|Overall Study||25
942838|NCT01361620|2279641|P1|NOT COMPLETED|Overall Study||0
942839|NCT01361620|2279641|P1|COMPLETED|Overall Study||132
942840|NCT01361620|2279641|P1|STARTED|Overall Study||132
942841|NCT01361594|2279647|P2|NOT COMPLETED|Overall Study||2
942842|NCT01361594|2279648|P1|NOT COMPLETED|Overall Study||1
942843|NCT01361594|2279647|P2|COMPLETED|Overall Study||151
942844|NCT01361594|2279648|P1|COMPLETED|Overall Study||151
942845|NCT01361594|2279647|P2|STARTED|Overall Study||153
942846|NCT01361594|2279648|P1|STARTED|Overall Study||152
942847|NCT01361568|2279662|P6|NOT COMPLETED|Overall Study||2
942848|NCT01361568|2279663|P5|NOT COMPLETED|Overall Study||1
942849|NCT01361568|2279664|P4|NOT COMPLETED|Overall Study||0
942850|NCT01361568|2279665|P3|NOT COMPLETED|Overall Study||0
942851|NCT01361568|2279666|P2|NOT COMPLETED|Overall Study||1
942852|NCT01361568|2279667|P1|NOT COMPLETED|Overall Study||2
942853|NCT01361568|2279662|P6|COMPLETED|Overall Study||11
942854|NCT01361568|2279663|P5|COMPLETED|Overall Study||6
942855|NCT01361568|2279664|P4|COMPLETED|Overall Study||21
942856|NCT01361568|2279665|P3|COMPLETED|Overall Study||20
942857|NCT01361568|2279666|P2|COMPLETED|Overall Study||70
942858|NCT01361568|2279667|P1|COMPLETED|Overall Study||69
942859|NCT01361568|2279662|P6|STARTED|Overall Study||13
942860|NCT01361568|2279663|P5|STARTED|Overall Study||7
942861|NCT01361568|2279664|P4|STARTED|Overall Study||21
942862|NCT01361568|2279665|P3|STARTED|Overall Study||20
942863|NCT01361568|2279666|P2|STARTED|Overall Study||71
942864|NCT01361568|2279667|P1|STARTED|Overall Study||71
942865|NCT01361464|2279697|P1|NOT COMPLETED|Overall Study||3
942866|NCT01361464|2279697|P1|COMPLETED|Overall Study||18
942867|NCT01361464|2279697|P1|STARTED|Overall Study||21
942868|NCT01361308|2279706|P2|NOT COMPLETED|Overall Study||30
942869|NCT01361308|2279707|P1|NOT COMPLETED|Overall Study||35
942870|NCT01361308|2279706|P2|COMPLETED|Overall Study||278
942871|NCT01361308|2279707|P1|COMPLETED|Overall Study||271
942872|NCT01361308|2279706|P2|STARTED|Overall Study||308
942873|NCT01361308|2279707|P1|STARTED|Overall Study||306
942874|NCT01361178|2279749|P2|NOT COMPLETED|Overall Study||0
942875|NCT01361178|2279750|P1|NOT COMPLETED|Overall Study||13
942876|NCT01361178|2279749|P2|COMPLETED|Overall Study||11
942877|NCT01361178|2279750|P1|COMPLETED|Overall Study||109
942878|NCT01361178|2279749|P2|STARTED|Overall Study||11
942879|NCT01361178|2279750|P1|STARTED|Overall Study||122
942880|NCT01361126|2279758|P2|NOT COMPLETED|Overall Study||2
942881|NCT01361126|2279759|P1|NOT COMPLETED|Overall Study||0
942882|NCT01361126|2279758|P2|COMPLETED|Overall Study||2
942883|NCT01361126|2279759|P1|COMPLETED|Overall Study||13
942884|NCT01361126|2279758|P2|STARTED|Overall Study||4
942885|NCT01361126|2279759|P1|STARTED|Overall Study||13
942886|NCT01361113|2279774|P1|NOT COMPLETED|Overall Study||0
942887|NCT01361113|2279774|P1|COMPLETED|Overall Study||21
942888|NCT01361113|2279774|P1|STARTED|Overall Study||21
942889|NCT01361048|2279782|P3|NOT COMPLETED|Overall Study||1
942890|NCT01361048|2279783|P2|NOT COMPLETED|Overall Study||0
942891|NCT01361048|2279784|P1|NOT COMPLETED|Overall Study||0
942892|NCT01361048|2279782|P3|COMPLETED|Overall Study||9
942893|NCT01361048|2279783|P2|COMPLETED|Overall Study||10
942894|NCT01361048|2279784|P1|COMPLETED|Overall Study||20
942895|NCT01361048|2279782|P3|STARTED|Overall Study||10
942896|NCT01361048|2279783|P2|STARTED|Overall Study||10
942897|NCT01361048|2279784|P1|STARTED|Overall Study||20
942898|NCT01361009|2279792|P1|NOT COMPLETED|Overall Study||116
942899|NCT01361009|2279792|P1|COMPLETED|Overall Study||1901
942900|NCT01361009|2279792|P1|STARTED|Overall Study||2017
942901|NCT01360996|2279802|P3|NOT COMPLETED|Overall Study||2
942902|NCT01360996|2279803|P2|NOT COMPLETED|Overall Study||3
942903|NCT01360996|2279804|P1|NOT COMPLETED|Overall Study||6
942904|NCT01360996|2279802|P3|COMPLETED|Overall Study||21
942905|NCT01360996|2279803|P2|COMPLETED|Overall Study||18
942906|NCT01360996|2279804|P1|COMPLETED|Overall Study||14
942907|NCT01360996|2279802|P3|STARTED|Overall Study||23
942908|NCT01360996|2279803|P2|STARTED|Overall Study||21
942909|NCT01360996|2279804|P1|STARTED|Overall Study||20
942910|NCT01360840|2279826|P3|NOT COMPLETED|Overall Study||9
942911|NCT01360840|2279827|P2|NOT COMPLETED|Overall Study||10
942912|NCT01360840|2279828|P1|NOT COMPLETED|Overall Study||10
942913|NCT01360840|2279826|P3|COMPLETED|Overall Study||51
942914|NCT01360840|2279827|P2|COMPLETED|Overall Study||50
942915|NCT01360840|2279828|P1|COMPLETED|Overall Study||50
942916|NCT01360840|2279826|P3|STARTED|Overall Study||60
942917|NCT01360840|2279827|P2|STARTED|Overall Study||60
942918|NCT01360840|2279828|P1|STARTED|Overall Study||60
942919|NCT01360645|2279880|P4|NOT COMPLETED|Phase A+||24
942920|NCT01360645|2279881|P3|NOT COMPLETED|Phase A+||0
942921|NCT01360645|2279882|P2|NOT COMPLETED|Phase A+||0
942922|NCT01360645|2279883|P1|NOT COMPLETED|Phase A+||0
942923|NCT01360645|2279880|P4|COMPLETED|Phase A+||307
942924|NCT01360645|2279881|P3|COMPLETED|Phase A+||0
942925|NCT01360645|2279882|P2|COMPLETED|Phase A+||0
942926|NCT01360645|2279883|P1|COMPLETED|Phase A+||0
942927|NCT01360645|2279880|P4|STARTED|Phase A+||331
942928|NCT01360645|2279881|P3|STARTED|Phase A+||0
942929|NCT01360645|2279882|P2|STARTED|Phase A+||0
942930|NCT01360645|2279883|P1|STARTED|Phase A+||0
942931|NCT01360645|2279880|P4|NOT COMPLETED|Phase B (6 Weeks)||0
942932|NCT01360645|2279881|P3|NOT COMPLETED|Phase B (6 Weeks)||13
942933|NCT01360645|2279882|P2|NOT COMPLETED|Phase B (6 Weeks)||14
942934|NCT01360645|2279883|P1|NOT COMPLETED|Phase B (6 Weeks)||0
942935|NCT01360645|2279880|P4|COMPLETED|Phase B (6 Weeks)||0
942936|NCT01360645|2279881|P3|COMPLETED|Phase B (6 Weeks)||178
942937|NCT01360645|2279882|P2|COMPLETED|Phase B (6 Weeks)||174
942938|NCT01360645|2279883|P1|COMPLETED|Phase B (6 Weeks)||0
942939|NCT01360645|2279880|P4|STARTED|Phase B (6 Weeks)||0
942940|NCT01360645|2279881|P3|STARTED|Phase B (6 Weeks)||191
942941|NCT01360645|2279882|P2|STARTED|Phase B (6 Weeks)||188
942942|NCT01360645|2279883|P1|STARTED|Phase B (6 Weeks)||0
942943|NCT01360645|2279880|P4|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
942944|NCT01360645|2279881|P3|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
942945|NCT01360645|2279882|P2|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
942946|NCT01360645|2279883|P1|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||114
942947|NCT01360645|2279880|P4|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
942948|NCT01360645|2279881|P3|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
942949|NCT01360645|2279882|P2|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
942950|NCT01360645|2279883|P1|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||710
942951|NCT01360645|2279880|P4|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
942952|NCT01360645|2279881|P3|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
942953|NCT01360645|2279882|P2|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
942954|NCT01360645|2279883|P1|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)|826 participants were enrolled but 2 participants discontinued trial before taking study medication.|824
942955|NCT01360632|2279938|P5|NOT COMPLETED|Phase A+||25
942956|NCT01360632|2279939|P4|NOT COMPLETED|Phase A+||0
942957|NCT01360632|2279940|P3|NOT COMPLETED|Phase A+||0
942958|NCT01360632|2279941|P2|NOT COMPLETED|Phase A+||0
942959|NCT01360632|2279942|P1|NOT COMPLETED|Phase A+||0
942960|NCT01360632|2279938|P5|COMPLETED|Phase A+||575
942961|NCT01360632|2279939|P4|COMPLETED|Phase A+||0
942962|NCT01360632|2279940|P3|COMPLETED|Phase A+||0
942963|NCT01360632|2279941|P2|COMPLETED|Phase A+||0
942964|NCT01360632|2279942|P1|COMPLETED|Phase A+||0
942965|NCT01360632|2279938|P5|STARTED|Phase A+||600
942966|NCT01360632|2279939|P4|STARTED|Phase A+||0
942967|NCT01360632|2279940|P3|STARTED|Phase A+||0
942968|NCT01360632|2279941|P2|STARTED|Phase A+||0
942969|NCT01360632|2279942|P1|STARTED|Phase A+||0
942970|NCT01360632|2279938|P5|NOT COMPLETED|Phase B (6 Weeks)||0
942971|NCT01360632|2279939|P4|NOT COMPLETED|Phase B (6 Weeks)||13
942972|NCT01360632|2279940|P3|NOT COMPLETED|Phase B (6 Weeks)||20
942973|NCT01360632|2279941|P2|NOT COMPLETED|Phase B (6 Weeks)||10
942974|NCT01360632|2279942|P1|NOT COMPLETED|Phase B (6 Weeks)||0
942975|NCT01360632|2279938|P5|COMPLETED|Phase B (6 Weeks)||0
942976|NCT01360632|2279939|P4|COMPLETED|Phase B (6 Weeks)||208
942977|NCT01360632|2279940|P3|COMPLETED|Phase B (6 Weeks)||210
942978|NCT01360632|2279941|P2|COMPLETED|Phase B (6 Weeks)||216
942979|NCT01360632|2279942|P1|COMPLETED|Phase B (6 Weeks)||0
942980|NCT01360632|2279938|P5|STARTED|Phase B (6 Weeks)||0
942981|NCT01360632|2279939|P4|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|221
942982|NCT01360632|2279940|P3|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|230
942983|NCT01360632|2279941|P2|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|226
942984|NCT01360632|2279942|P1|STARTED|Phase B (6 Weeks)||0
942985|NCT01360632|2279938|P5|NOT COMPLETED|Phase A (8 Weeks)||0
942986|NCT01360632|2279939|P4|NOT COMPLETED|Phase A (8 Weeks)||0
942987|NCT01360632|2279940|P3|NOT COMPLETED|Phase A (8 Weeks)||0
942988|NCT01360632|2279941|P2|NOT COMPLETED|Phase A (8 Weeks)||0
942989|NCT01360632|2279942|P1|NOT COMPLETED|Phase A (8 Weeks)||255
942990|NCT01360632|2279938|P5|COMPLETED|Phase A (8 Weeks)||0
942991|NCT01360632|2279939|P4|COMPLETED|Phase A (8 Weeks)||0
942992|NCT01360632|2279940|P3|COMPLETED|Phase A (8 Weeks)||0
942993|NCT01360632|2279941|P2|COMPLETED|Phase A (8 Weeks)||0
942994|NCT01360632|2279942|P1|COMPLETED|Phase A (8 Weeks)||1277
942995|NCT01360632|2279938|P5|STARTED|Phase A (8 Weeks)||0
942996|NCT01360632|2279939|P4|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
942997|NCT01360632|2279940|P3|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
942998|NCT01360632|2279941|P2|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
942999|NCT01360632|2279942|P1|STARTED|Phase A (8 Weeks)|A total of 1539 participants were enrolled, 7 discontinued before taking any sponsor-provided ADT|1532
943000|NCT01360554|2280021|P2|NOT COMPLETED|Overall Study||439
943001|NCT01360554|2280022|P1|NOT COMPLETED|Overall Study||439
943002|NCT01360554|2280021|P2|COMPLETED|Overall Study||0
943003|NCT01360554|2280022|P1|COMPLETED|Overall Study||0
943004|NCT01360554|2280021|P2|Treated|Overall Study||436
943005|NCT01360554|2280022|P1|Treated|Overall Study||436
943006|NCT01360554|2280021|P2|STARTED|Overall Study|Three participants were randomized but not treated.|439
943007|NCT01360554|2280022|P1|STARTED|Overall Study|Three participants were randomized but not treated.|439
943008|NCT01360450|2280060|P2|NOT COMPLETED|Overall Study||0
943009|NCT01360450|2280061|P1|NOT COMPLETED|Overall Study||0
943010|NCT01360450|2280060|P2|COMPLETED|Overall Study||6
943011|NCT01360450|2280061|P1|COMPLETED|Overall Study||6
943012|NCT01360450|2280060|P2|Completed Treatment|Overall Study||6
943013|NCT01360450|2280061|P1|Completed Treatment|Overall Study||6
943014|NCT01360450|2280060|P2|STARTED|Overall Study||6
943015|NCT01360450|2280061|P1|STARTED|Overall Study||6
943016|NCT01360021|2280074|P3|NOT COMPLETED|Overall Study||7
943017|NCT01360021|2280075|P2|NOT COMPLETED|Overall Study||4
943018|NCT01360021|2280076|P1|NOT COMPLETED|Overall Study||8
943019|NCT01360021|2280074|P3|COMPLETED|Overall Study|Patients who completed study|65
943020|NCT01360021|2280075|P2|COMPLETED|Overall Study|Patients who completed study|67
943021|NCT01360021|2280076|P1|COMPLETED|Overall Study|Patients who completed study|63
943022|NCT01360021|2280074|P3|STARTED|Overall Study|Patients randomized|72
943023|NCT01360021|2280075|P2|STARTED|Overall Study|Patients randomized|71
943024|NCT01360021|2280076|P1|STARTED|Overall Study|Patients randomized|71
943025|NCT01359943|2280102|P3|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
943026|NCT01359943|2280103|P2|NOT COMPLETED|Follow-up (Weeks 52 - 60)||15
943027|NCT01359943|2280104|P1|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
943028|NCT01359943|2280102|P3|COMPLETED|Follow-up (Weeks 52 - 60)||36
943029|NCT01359943|2280103|P2|COMPLETED|Follow-up (Weeks 52 - 60)||69
943030|NCT01359943|2280104|P1|COMPLETED|Follow-up (Weeks 52 - 60)||78
943031|NCT01359943|2280102|P3|STARTED|Follow-up (Weeks 52 - 60)||44
943032|NCT01359943|2280103|P2|STARTED|Follow-up (Weeks 52 - 60)||84
943033|NCT01359943|2280104|P1|STARTED|Follow-up (Weeks 52 - 60)||86
943034|NCT01359943|2280102|P3|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
943035|NCT01359943|2280103|P2|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||13
943036|NCT01359943|2280104|P1|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
943037|NCT01359943|2280102|P3|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||36
943038|NCT01359943|2280103|P2|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||71
943039|NCT01359943|2280104|P1|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||78
943040|NCT01359943|2280102|P3|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||44
943041|NCT01359943|2280103|P2|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)|One participant, who was continuing as of week 12, did not receive study drug at week 16.|84
943042|NCT01359943|2280104|P1|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||86
943043|NCT01359943|2280102|P3|NOT COMPLETED|Double-blind (Weeks 0 - 16)||0
943044|NCT01359943|2280103|P2|NOT COMPLETED|Double-blind (Weeks 0 - 16)||4
943045|NCT01359943|2280104|P1|NOT COMPLETED|Double-blind (Weeks 0 - 16)||2
943046|NCT01359943|2280102|P3|COMPLETED|Double-blind (Weeks 0 - 16)||44
943047|NCT01359943|2280103|P2|COMPLETED|Double-blind (Weeks 0 - 16)||85
943048|NCT01359943|2280104|P1|COMPLETED|Double-blind (Weeks 0 - 16)||86
943049|NCT01359943|2280102|P3|STARTED|Double-blind (Weeks 0 - 16)||44
943050|NCT01359943|2280103|P2|STARTED|Double-blind (Weeks 0 - 16)||89
943051|NCT01359943|2280104|P1|STARTED|Double-blind (Weeks 0 - 16)||88
943052|NCT01359904|2280152|P2|NOT COMPLETED|Overall Study||0
943053|NCT01359904|2280153|P1|NOT COMPLETED|Overall Study||1
943054|NCT01359904|2280152|P2|COMPLETED|Overall Study||19
943055|NCT01359904|2280153|P1|COMPLETED|Overall Study||14
943056|NCT01359904|2280152|P2|STARTED|Overall Study||19
943057|NCT01359904|2280153|P1|STARTED|Overall Study||15
943058|NCT01359748|2280169|P4|NOT COMPLETED|Overall Study||0
943059|NCT01359748|2280170|P3|NOT COMPLETED|Overall Study||0
943060|NCT01359748|2280171|P2|NOT COMPLETED|Overall Study||0
943061|NCT01359748|2280172|P1|NOT COMPLETED|Overall Study||0
943062|NCT01359748|2280169|P4|COMPLETED|Overall Study||11
943063|NCT01359748|2280170|P3|COMPLETED|Overall Study||10
943064|NCT01359748|2280171|P2|COMPLETED|Overall Study||20
943065|NCT01359748|2280172|P1|COMPLETED|Overall Study||48
943066|NCT01359748|2280169|P4|STARTED|Overall Study||11
943067|NCT01359748|2280170|P3|STARTED|Overall Study||10
943068|NCT01359748|2280171|P2|STARTED|Overall Study||20
943069|NCT01359748|2280172|P1|STARTED|Overall Study||48
943070|NCT01359735|2280182|P2|NOT COMPLETED|Overall Study||0
943071|NCT01359735|2280183|P1|NOT COMPLETED|Overall Study||0
943072|NCT01359735|2280182|P2|COMPLETED|Overall Study||4
943073|NCT01359735|2280183|P1|COMPLETED|Overall Study||4
943074|NCT01359735|2280182|P2|STARTED|Overall Study||4
943075|NCT01359735|2280183|P1|STARTED|Overall Study||4
943076|NCT01359644|2280207|P10|NOT COMPLETED|Follow-up Period||0
943077|NCT01359644|2280208|P9|NOT COMPLETED|Follow-up Period||0
943078|NCT01359644|2280209|P8|NOT COMPLETED|Follow-up Period||2
943079|NCT01359644|2280210|P7|NOT COMPLETED|Follow-up Period||1
943080|NCT01359644|2280211|P6|NOT COMPLETED|Follow-up Period||1
943081|NCT01359644|2280212|P5|NOT COMPLETED|Follow-up Period||0
943082|NCT01359644|2280213|P4|NOT COMPLETED|Follow-up Period||0
943083|NCT01359644|2280214|P3|NOT COMPLETED|Follow-up Period||0
943084|NCT01359644|2280215|P2|NOT COMPLETED|Follow-up Period||0
943085|NCT01359644|2280216|P1|NOT COMPLETED|Follow-up Period||0
943086|NCT01359644|2280207|P10|COMPLETED|Follow-up Period||20
943087|NCT01359644|2280208|P9|COMPLETED|Follow-up Period||21
943088|NCT01359644|2280209|P8|COMPLETED|Follow-up Period||39
943089|NCT01359644|2280210|P7|COMPLETED|Follow-up Period||40
943090|NCT01359644|2280211|P6|COMPLETED|Follow-up Period||12
943091|NCT01359644|2280212|P5|COMPLETED|Follow-up Period||15
943092|NCT01359644|2280213|P4|COMPLETED|Follow-up Period||14
943093|NCT01359644|2280214|P3|COMPLETED|Follow-up Period||14
943094|NCT01359644|2280215|P2|COMPLETED|Follow-up Period||16
943095|NCT01359644|2280216|P1|COMPLETED|Follow-up Period||15
943096|NCT01359644|2280207|P10|STARTED|Follow-up Period||20
943097|NCT01359644|2280208|P9|STARTED|Follow-up Period||21
943098|NCT01359644|2280209|P8|STARTED|Follow-up Period||41
943099|NCT01359644|2280210|P7|STARTED|Follow-up Period||41
943100|NCT01359644|2280211|P6|STARTED|Follow-up Period||13
943101|NCT01359644|2280212|P5|STARTED|Follow-up Period||15
943102|NCT01359644|2280213|P4|STARTED|Follow-up Period||14
943103|NCT01359644|2280214|P3|STARTED|Follow-up Period||14
943104|NCT01359644|2280215|P2|STARTED|Follow-up Period||16
943105|NCT01359644|2280216|P1|STARTED|Follow-up Period||15
943106|NCT01359644|2280207|P10|NOT COMPLETED|Treatment Period||0
943107|NCT01359644|2280208|P9|NOT COMPLETED|Treatment Period||0
943108|NCT01359644|2280209|P8|NOT COMPLETED|Treatment Period||0
943109|NCT01359644|2280210|P7|NOT COMPLETED|Treatment Period||0
943110|NCT01359644|2280211|P6|NOT COMPLETED|Treatment Period||2
943111|NCT01359644|2280212|P5|NOT COMPLETED|Treatment Period||0
943112|NCT01359644|2280213|P4|NOT COMPLETED|Treatment Period||0
943113|NCT01359644|2280214|P3|NOT COMPLETED|Treatment Period||1
943114|NCT01359644|2280215|P2|NOT COMPLETED|Treatment Period||1
943115|NCT01359644|2280216|P1|NOT COMPLETED|Treatment Period||0
943116|NCT01359644|2280207|P10|COMPLETED|Treatment Period||20
943117|NCT01359644|2280208|P9|COMPLETED|Treatment Period||21
943118|NCT01359644|2280209|P8|COMPLETED|Treatment Period||41
943119|NCT01359644|2280210|P7|COMPLETED|Treatment Period||41
943120|NCT01359644|2280211|P6|COMPLETED|Treatment Period||12
943121|NCT01359644|2280212|P5|COMPLETED|Treatment Period||15
943122|NCT01359644|2280213|P4|COMPLETED|Treatment Period||14
943123|NCT01359644|2280214|P3|COMPLETED|Treatment Period||13
943124|NCT01359644|2280215|P2|COMPLETED|Treatment Period||15
943125|NCT01359644|2280216|P1|COMPLETED|Treatment Period||15
943126|NCT01359644|2280207|P10|STARTED|Treatment Period||20
943127|NCT01359644|2280208|P9|STARTED|Treatment Period||21
943128|NCT01359644|2280209|P8|STARTED|Treatment Period||41
943129|NCT01359644|2280210|P7|STARTED|Treatment Period||41
943130|NCT01359644|2280211|P6|STARTED|Treatment Period||14
943131|NCT01359644|2280212|P5|STARTED|Treatment Period||15
943132|NCT01359644|2280213|P4|STARTED|Treatment Period||14
943133|NCT01359644|2280214|P3|STARTED|Treatment Period||14
943134|NCT01359644|2280215|P2|STARTED|Treatment Period||16
943135|NCT01359644|2280216|P1|STARTED|Treatment Period||15
943136|NCT01359449|2280260|P2|NOT COMPLETED|Overall Study||4
943137|NCT01359449|2280261|P1|NOT COMPLETED|Overall Study||4
943138|NCT01359449|2280260|P2|COMPLETED|Overall Study||58
943139|NCT01359449|2280261|P1|COMPLETED|Overall Study||57
943140|NCT01359449|2280260|P2|STARTED|Overall Study||62
943141|NCT01359449|2280261|P1|STARTED|Overall Study||61
943142|NCT01359410|2280285|P2|NOT COMPLETED|Overall Study||0
943143|NCT01359410|2280286|P1|NOT COMPLETED|Overall Study||0
943144|NCT01359410|2280285|P2|COMPLETED|Overall Study||46
943145|NCT01359410|2280286|P1|COMPLETED|Overall Study||54
943146|NCT01359410|2280285|P2|STARTED|Overall Study||46
943147|NCT01359410|2280286|P1|STARTED|Overall Study||54
943148|NCT01359371|2280300|P1|NOT COMPLETED|Overall Study||0
943149|NCT01359371|2280300|P1|COMPLETED|Overall Study||41
943150|NCT01359371|2280300|P1|STARTED|Overall Study||41
943151|NCT01359254|2280307|P2|NOT COMPLETED|Overall Study||0
943152|NCT01359254|2280308|P1|NOT COMPLETED|Overall Study||1
943153|NCT01359254|2280307|P2|COMPLETED|Overall Study||0
943154|NCT01359254|2280308|P1|COMPLETED|Overall Study||0
943155|NCT01359254|2280307|P2|STARTED|Overall Study||0
943156|NCT01359254|2280308|P1|STARTED|Overall Study||1
943157|NCT01359150|2280318|P2|NOT COMPLETED|Overall Study||5
943158|NCT01359150|2280319|P1|NOT COMPLETED|Overall Study||7
943159|NCT01359150|2280318|P2|COMPLETED|Overall Study||106
943160|NCT01359150|2280319|P1|COMPLETED|Overall Study||105
943161|NCT01359150|2280318|P2|STARTED|Overall Study||111
943162|NCT01359150|2280319|P1|STARTED|Overall Study||112
943163|NCT01359111|2280341|P1|NOT COMPLETED|Overall Study||0
943164|NCT01359111|2280341|P1|COMPLETED|Overall Study||20
943165|NCT01359111|2280341|P1|STARTED|Overall Study||20
943166|NCT01358864|2280356|P8|NOT COMPLETED|Overall Study||55
943167|NCT01358864|2280357|P7|NOT COMPLETED|Overall Study||65
943168|NCT01358864|2280358|P6|NOT COMPLETED|Overall Study||13
943169|NCT01358864|2280359|P5|NOT COMPLETED|Overall Study||11
943170|NCT01358864|2280360|P4|NOT COMPLETED|Overall Study||19
943171|NCT01358864|2280361|P3|NOT COMPLETED|Overall Study||16
943172|NCT01358864|2280362|P2|NOT COMPLETED|Overall Study||13
943173|NCT01358864|2280363|P1|NOT COMPLETED|Overall Study||31
943174|NCT01358864|2280356|P8|COMPLETED|Overall Study||85
943175|NCT01358864|2280357|P7|COMPLETED|Overall Study||81
943176|NCT01358864|2280358|P6|COMPLETED|Overall Study||42
943177|NCT01358864|2280359|P5|COMPLETED|Overall Study||46
943178|NCT01358864|2280360|P4|COMPLETED|Overall Study||10
943179|NCT01358864|2280361|P3|COMPLETED|Overall Study||87
943180|NCT01358864|2280362|P2|COMPLETED|Overall Study||86
943181|NCT01358864|2280363|P1|COMPLETED|Overall Study||18
943182|NCT01358864|2280356|P8|STARTED|Overall Study||140
943183|NCT01358864|2280357|P7|STARTED|Overall Study||146
943184|NCT01358864|2280358|P6|STARTED|Overall Study||55
943185|NCT01358864|2280359|P5|STARTED|Overall Study||57
943186|NCT01358864|2280360|P4|STARTED|Overall Study||29
943187|NCT01358864|2280361|P3|STARTED|Overall Study||103
943188|NCT01358864|2280362|P2|STARTED|Overall Study||99
943189|NCT01358864|2280363|P1|STARTED|Overall Study||49
943190|NCT01358825|2280454|P2|NOT COMPLETED|Overall Study||1
943191|NCT01358825|2280455|P1|NOT COMPLETED|Overall Study||0
943192|NCT01358825|2280454|P2|COMPLETED|Overall Study||45
943193|NCT01358825|2280455|P1|COMPLETED|Overall Study||12
943194|NCT01358825|2280454|P2|STARTED|Overall Study||46
943195|NCT01358825|2280455|P1|STARTED|Overall Study||12
943196|NCT01358760|2280479|P3|NOT COMPLETED|Overall Study||25
943197|NCT01358760|2280480|P2|NOT COMPLETED|Overall Study||20
943198|NCT01358760|2280481|P1|NOT COMPLETED|Overall Study||22
943199|NCT01358760|2280479|P3|COMPLETED|Overall Study||125
943200|NCT01358760|2280480|P2|COMPLETED|Overall Study||128
943201|NCT01358760|2280481|P1|COMPLETED|Overall Study||130
943202|NCT01358760|2280479|P3|ITT Population|Overall Study||134
943203|NCT01358760|2280480|P2|ITT Population|Overall Study||134
943204|NCT01358760|2280481|P1|ITT Population|Overall Study||139
943205|NCT01358760|2280479|P3|Safety Population|Overall Study||148
943206|NCT01358760|2280480|P2|Safety Population|Overall Study||143
943207|NCT01358760|2280481|P1|Safety Population|Overall Study||150
943208|NCT01358760|2280479|P3|STARTED|Overall Study||150
943209|NCT01358760|2280480|P2|STARTED|Overall Study||148
943210|NCT01358760|2280481|P1|STARTED|Overall Study||152
943211|NCT01358734|2280516|P3|NOT COMPLETED|Overall Study||29
943212|NCT01358734|2280517|P2|NOT COMPLETED|Overall Study||37
943213|NCT01358734|2280518|P1|NOT COMPLETED|Overall Study||15
943214|NCT01358734|2280516|P3|COMPLETED|Overall Study|Includes participants still receiving study treatment|5
943215|NCT01358734|2280517|P2|COMPLETED|Overall Study|Includes participants still receiving study treatment|2
943216|NCT01358734|2280518|P1|COMPLETED|Overall Study||0
943217|NCT01358734|2280516|P3|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|32
943218|NCT01358734|2280517|P2|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|38
943219|NCT01358734|2280518|P1|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|14
943220|NCT01358734|2280516|P3|STARTED|Overall Study||34
943221|NCT01358734|2280517|P2|STARTED|Overall Study||39
943222|NCT01358734|2280518|P1|STARTED|Overall Study||15
943223|NCT01358708|2280537|P2|NOT COMPLETED|Open-Label Treatment Phase||0
943224|NCT01358708|2280538|P1|NOT COMPLETED|Open-Label Treatment Phase||0
943225|NCT01358708|2280537|P2|COMPLETED|Open-Label Treatment Phase||12
943226|NCT01358708|2280538|P1|COMPLETED|Open-Label Treatment Phase||5
943227|NCT01358708|2280537|P2|STARTED|Open-Label Treatment Phase|Number of subjects on PLACEBO during double-blind treatment and entering the Open-Label Phase|12
943228|NCT01358708|2280538|P1|STARTED|Open-Label Treatment Phase|Number of subjects on LACTEOL® during double-blind treatment and entering the Open-Label Phase|5
943229|NCT01358708|2280537|P2|NOT COMPLETED|Double-Blind Treatment Phase||0
943230|NCT01358708|2280538|P1|NOT COMPLETED|Double-Blind Treatment Phase||3
943231|NCT01358708|2280537|P2|COMPLETED|Double-Blind Treatment Phase||13
943232|NCT01358708|2280538|P1|COMPLETED|Double-Blind Treatment Phase||10
943233|NCT01358708|2280537|P2|Received Study Medication|Double-Blind Treatment Phase||13
943234|NCT01358708|2280538|P1|Received Study Medication|Double-Blind Treatment Phase|For 1 subject, unused med not returned to the site and intake of study medication not confirmed.|12
943235|NCT01358708|2280537|P2|Randomized|Double-Blind Treatment Phase||13
943236|NCT01358708|2280538|P1|Randomized|Double-Blind Treatment Phase||13
943237|NCT01358708|2280537|P2|STARTED|Double-Blind Treatment Phase||13
943238|NCT01358708|2280538|P1|STARTED|Double-Blind Treatment Phase||13
943239|NCT01357551|2280559|P2|NOT COMPLETED|Overall Study||11
943240|NCT01357551|2280560|P1|NOT COMPLETED|Overall Study||22
943241|NCT01357551|2280559|P2|COMPLETED|Overall Study||101
943242|NCT01357551|2280560|P1|COMPLETED|Overall Study||88
943243|NCT01357551|2280559|P2|STARTED|Overall Study||112
943244|NCT01357551|2280560|P1|STARTED|Overall Study||110
943245|NCT01358578|2280576|P6|NOT COMPLETED|Follow-up Period||0
943246|NCT01358578|2280577|P5|NOT COMPLETED|Follow-up Period||0
943247|NCT01358578|2280578|P4|NOT COMPLETED|Follow-up Period||19
943248|NCT01358578|2280579|P3|NOT COMPLETED|Follow-up Period||5
943249|NCT01358578|2280580|P2|NOT COMPLETED|Follow-up Period||6
943250|NCT01358578|2280581|P1|NOT COMPLETED|Follow-up Period||10
943251|NCT01358578|2280576|P6|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
943252|NCT01358578|2280577|P5|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
943331|NCT01358357|2280654|P1|COMPLETED|Open Label Phase||0
943253|NCT01358578|2280578|P4|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|260
943254|NCT01358578|2280579|P3|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|21
943255|NCT01358578|2280580|P2|COMPLETED|Follow-up Period||119
943256|NCT01358578|2280581|P1|COMPLETED|Follow-up Period||138
943257|NCT01358578|2280576|P6|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
943258|NCT01358578|2280577|P5|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
943259|NCT01358578|2280578|P4|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|279
943260|NCT01358578|2280579|P3|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|26
943261|NCT01358578|2280580|P2|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 300 mg dose|125
943262|NCT01358578|2280581|P1|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 150 mg dose|148
943263|NCT01358578|2280576|P6|NOT COMPLETED|Maintenance Period||11
943264|NCT01358578|2280577|P5|NOT COMPLETED|Maintenance Period||17
943265|NCT01358578|2280578|P4|NOT COMPLETED|Maintenance Period||42
943266|NCT01358578|2280579|P3|NOT COMPLETED|Maintenance Period||2
943267|NCT01358578|2280580|P2|NOT COMPLETED|Maintenance Period||22
943268|NCT01358578|2280581|P1|NOT COMPLETED|Maintenance Period||39
943269|NCT01358578|2280576|P6|COMPLETED|Maintenance Period||131
943270|NCT01358578|2280577|P5|COMPLETED|Maintenance Period||125
943271|NCT01358578|2280578|P4|COMPLETED|Maintenance Period||263
943272|NCT01358578|2280579|P3|COMPLETED|Maintenance Period||15
943273|NCT01358578|2280580|P2|COMPLETED|Maintenance Period||290
943274|NCT01358578|2280581|P1|COMPLETED|Maintenance Period||276
943275|NCT01358578|2280576|P6|STARTED|Maintenance Period||142
943276|NCT01358578|2280577|P5|STARTED|Maintenance Period||142
943277|NCT01358578|2280578|P4|STARTED|Maintenance Period||305
943278|NCT01358578|2280579|P3|STARTED|Maintenance Period||17
943279|NCT01358578|2280580|P2|STARTED|Maintenance Period||312
943280|NCT01358578|2280581|P1|STARTED|Maintenance Period||315
943281|NCT01358578|2280576|P6|NOT COMPLETED|Induction Period||0
943282|NCT01358578|2280577|P5|NOT COMPLETED|Induction Period||0
943283|NCT01358578|2280578|P4|NOT COMPLETED|Induction Period||21
943284|NCT01358578|2280579|P3|NOT COMPLETED|Induction Period||25
943285|NCT01358578|2280580|P2|NOT COMPLETED|Induction Period||15
943286|NCT01358578|2280581|P1|NOT COMPLETED|Induction Period||12
943287|NCT01358578|2280576|P6|COMPLETED|Induction Period|These groups are populated after the induction period|0
943288|NCT01358578|2280577|P5|COMPLETED|Induction Period|These groups are populated after the induction period|0
943289|NCT01358578|2280578|P4|COMPLETED|Induction Period||305
943290|NCT01358578|2280579|P3|COMPLETED|Induction Period||301
943291|NCT01358578|2280580|P2|COMPLETED|Induction Period||312
943292|NCT01358578|2280581|P1|COMPLETED|Induction Period||315
943293|NCT01358578|2280576|P6|STARTED|Induction Period|These groups are populated after the induction period|0
943294|NCT01358578|2280577|P5|STARTED|Induction Period|These groups are populated after the induction period|0
943295|NCT01358578|2280578|P4|STARTED|Induction Period||326
943296|NCT01358578|2280579|P3|STARTED|Induction Period||326
943297|NCT01358578|2280580|P2|STARTED|Induction Period||327
943298|NCT01358578|2280581|P1|STARTED|Induction Period||327
943299|NCT01358526|2280633|P3|NOT COMPLETED|Double-blind Phase||121
943300|NCT01358526|2280634|P2|NOT COMPLETED|Double-blind Phase||80
943301|NCT01358526|2280635|P1|NOT COMPLETED|Double-blind Phase||0
943302|NCT01358526|2280633|P3|COMPLETED|Double-blind Phase||181
943303|NCT01358526|2280634|P2|COMPLETED|Double-blind Phase||218
943304|NCT01358526|2280635|P1|COMPLETED|Double-blind Phase||0
943305|NCT01358526|2280633|P3|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|302
943306|NCT01358526|2280634|P2|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|298
943307|NCT01358526|2280635|P1|STARTED|Double-blind Phase||0
943308|NCT01358526|2280633|P3|NOT COMPLETED|Open-label Titration Period||0
943309|NCT01358526|2280634|P2|NOT COMPLETED|Open-label Titration Period||0
943310|NCT01358526|2280635|P1|NOT COMPLETED|Open-label Titration Period||494
943311|NCT01358526|2280633|P3|COMPLETED|Open-label Titration Period||0
943312|NCT01358526|2280634|P2|COMPLETED|Open-label Titration Period||0
943313|NCT01358526|2280635|P1|COMPLETED|Open-label Titration Period|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|601
943314|NCT01358526|2280633|P3|STARTED|Open-label Titration Period||0
943315|NCT01358526|2280634|P2|STARTED|Open-label Titration Period||0
943316|NCT01358526|2280635|P1|STARTED|Open-label Titration Period||1095
943317|NCT01358357|2280652|P3|NOT COMPLETED|Double-Blind Phase||0
943318|NCT01358357|2280653|P2|NOT COMPLETED|Double-Blind Phase||100
943319|NCT01358357|2280654|P1|NOT COMPLETED|Double-Blind Phase||80
943320|NCT01358357|2280652|P3|COMPLETED|Double-Blind Phase||0
943321|NCT01358357|2280653|P2|COMPLETED|Double-Blind Phase||150
943322|NCT01358357|2280654|P1|COMPLETED|Double-Blind Phase||166
943323|NCT01358357|2280652|P3|STARTED|Double-Blind Phase||0
943324|NCT01358357|2280653|P2|STARTED|Double-Blind Phase||250
943325|NCT01358357|2280654|P1|STARTED|Double-Blind Phase||246
943326|NCT01358357|2280652|P3|NOT COMPLETED|Open Label Phase||462
943327|NCT01358357|2280653|P2|NOT COMPLETED|Open Label Phase||0
943328|NCT01358357|2280654|P1|NOT COMPLETED|Open Label Phase||0
943329|NCT01358357|2280652|P3|COMPLETED|Open Label Phase||503
943330|NCT01358357|2280653|P2|COMPLETED|Open Label Phase||0
943332|NCT01358357|2280652|P3|STARTED|Open Label Phase||965
943333|NCT01358357|2280653|P2|STARTED|Open Label Phase||0
943334|NCT01358357|2280654|P1|STARTED|Open Label Phase||0
943335|NCT01358175|2280690|P3|NOT COMPLETED|Overall Study||32
943336|NCT01358175|2280691|P2|NOT COMPLETED|Overall Study||28
943337|NCT01358175|2280692|P1|NOT COMPLETED|Overall Study||21
943338|NCT01358175|2280690|P3|COMPLETED|Overall Study||90
943339|NCT01358175|2280691|P2|COMPLETED|Overall Study||97
943340|NCT01358175|2280692|P1|COMPLETED|Overall Study||103
943341|NCT01358175|2280690|P3|STARTED|Overall Study||122
943342|NCT01358175|2280691|P2|STARTED|Overall Study||125
943343|NCT01358175|2280692|P1|STARTED|Overall Study||124
943344|NCT01357980|2280729|P4|NOT COMPLETED|Overall Study||0
943345|NCT01357980|2280730|P3|NOT COMPLETED|Overall Study||1
943346|NCT01357980|2280731|P2|NOT COMPLETED|Overall Study||1
943347|NCT01357980|2280732|P1|NOT COMPLETED|Overall Study||0
943348|NCT01357980|2280729|P4|COMPLETED|Overall Study||7
943349|NCT01357980|2280730|P3|COMPLETED|Overall Study||16
943350|NCT01357980|2280731|P2|COMPLETED|Overall Study||6
943351|NCT01357980|2280732|P1|COMPLETED|Overall Study||16
943352|NCT01357980|2280729|P4|STARTED|Overall Study||7
943353|NCT01357980|2280730|P3|STARTED|Overall Study||17
943354|NCT01357980|2280731|P2|STARTED|Overall Study||7
943355|NCT01357980|2280732|P1|STARTED|Overall Study||16
943356|NCT01357915|2280776|P2|NOT COMPLETED|Overall Study||0
943357|NCT01357915|2280777|P1|NOT COMPLETED|Overall Study||3
943358|NCT01357915|2280776|P2|COMPLETED|Overall Study||17
943359|NCT01357915|2280777|P1|COMPLETED|Overall Study||27
943360|NCT01357915|2280776|P2|STARTED|Overall Study||17
943361|NCT01357915|2280777|P1|STARTED|Overall Study||30
943362|NCT01357889|2280792|P2|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||4
943363|NCT01357889|2280793|P1|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||3
943364|NCT01357889|2280792|P2|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
943365|NCT01357889|2280793|P1|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
943366|NCT01357889|2280792|P2|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|142
943367|NCT01357889|2280793|P1|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|141
943368|NCT01357889|2280792|P2|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
943369|NCT01357889|2280793|P1|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
943370|NCT01357889|2280792|P2|COMPLETED|Multiple-dose Phase (MDP) (Overall)||126
943371|NCT01357889|2280793|P1|COMPLETED|Multiple-dose Phase (MDP) (Overall)||125
943372|NCT01357889|2280792|P2|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|142
943373|NCT01357889|2280793|P1|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|141
943374|NCT01357889|2280792|P2|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||2
943375|NCT01357889|2280793|P1|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||4
943376|NCT01357889|2280792|P2|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||79
943377|NCT01357889|2280793|P1|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||82
943378|NCT01357889|2280792|P2|STARTED|Single-dose Phase (BE Phase: 28 Days)||81
943379|NCT01357889|2280793|P1|STARTED|Single-dose Phase (BE Phase: 28 Days)||86
943380|NCT01357850|2280837|P4|NOT COMPLETED|Overall Study||0
943381|NCT01357850|2280838|P3|NOT COMPLETED|Overall Study||0
943382|NCT01357850|2280839|P2|NOT COMPLETED|Overall Study||0
943383|NCT01357850|2280840|P1|NOT COMPLETED|Overall Study||1
943384|NCT01357850|2280837|P4|COMPLETED|Overall Study||27
943385|NCT01357850|2280838|P3|COMPLETED|Overall Study||13
943386|NCT01357850|2280839|P2|COMPLETED|Overall Study||12
943387|NCT01357850|2280840|P1|COMPLETED|Overall Study||29
943388|NCT01357850|2280837|P4|STARTED|Overall Study||27
943389|NCT01357850|2280838|P3|STARTED|Overall Study||13
943390|NCT01357850|2280839|P2|STARTED|Overall Study||12
943391|NCT01357850|2280840|P1|STARTED|Overall Study||30
943392|NCT01357720|2280914|P2|NOT COMPLETED|Overall Study||5
943393|NCT01357720|2280915|P1|NOT COMPLETED|Overall Study||2
943394|NCT01357720|2280914|P2|COMPLETED|Overall Study||195
943395|NCT01357720|2280915|P1|COMPLETED|Overall Study||198
943396|NCT01357720|2280914|P2|STARTED|Overall Study||200
943397|NCT01357720|2280915|P1|STARTED|Overall Study||200
943398|NCT01357655|2280931|P2|NOT COMPLETED|Overall Study||0
943399|NCT01357655|2280932|P1|NOT COMPLETED|Overall Study||66
943400|NCT01357655|2280931|P2|COMPLETED|Overall Study||0
943401|NCT01357655|2280932|P1|COMPLETED|Overall Study||0
943402|NCT01357655|2280931|P2|STARTED|Overall Study||0
943403|NCT01357655|2280932|P1|STARTED|Overall Study||66
943404|NCT01357616|2280949|P2|NOT COMPLETED|Overall Study||9
943405|NCT01357616|2280950|P1|NOT COMPLETED|Overall Study||10
943406|NCT01357616|2280949|P2|COMPLETED|Overall Study||153
943407|NCT01357616|2280950|P1|COMPLETED|Overall Study||156
943408|NCT01357616|2280949|P2|STARTED|Overall Study||162
943409|NCT01357616|2280950|P1|STARTED|Overall Study||166
943410|NCT01357512|2280964|P2|NOT COMPLETED|Overall Study||5
943411|NCT01357512|2280965|P1|NOT COMPLETED|Overall Study||12
943412|NCT01357512|2280964|P2|COMPLETED|Overall Study||60
943413|NCT01357512|2280965|P1|COMPLETED|Overall Study||53
943414|NCT01357512|2280964|P2|STARTED|Overall Study||65
943415|NCT01357512|2280965|P1|STARTED|Overall Study||65
943416|NCT01357239|2280977|P4|NOT COMPLETED|Stratum II: Partially-Methylated||2
943417|NCT01357239|2280978|P3|NOT COMPLETED|Stratum II: Partially-Methylated||1
943418|NCT01357239|2280979|P2|NOT COMPLETED|Stratum II: Partially-Methylated||0
943419|NCT01357239|2280980|P1|NOT COMPLETED|Stratum II: Partially-Methylated||0
943420|NCT01357239|2280977|P4|COMPLETED|Stratum II: Partially-Methylated||18
943421|NCT01357239|2280978|P3|COMPLETED|Stratum II: Partially-Methylated||21
943422|NCT01357239|2280979|P2|COMPLETED|Stratum II: Partially-Methylated||21
943423|NCT01357239|2280980|P1|COMPLETED|Stratum II: Partially-Methylated||23
943424|NCT01357239|2280977|P4|STARTED|Stratum II: Partially-Methylated||20
943425|NCT01357239|2280978|P3|STARTED|Stratum II: Partially-Methylated||22
943426|NCT01357239|2280979|P2|STARTED|Stratum II: Partially-Methylated||21
943427|NCT01357239|2280980|P1|STARTED|Stratum II: Partially-Methylated||23
943428|NCT01357239|2280977|P4|NOT COMPLETED|Stratum I: Fully-Methylated||0
943429|NCT01357239|2280978|P3|NOT COMPLETED|Stratum I: Fully-Methylated||1
943430|NCT01357239|2280979|P2|NOT COMPLETED|Stratum I: Fully-Methylated||0
943431|NCT01357239|2280980|P1|NOT COMPLETED|Stratum I: Fully-Methylated||0
943432|NCT01357239|2280977|P4|COMPLETED|Stratum I: Fully-Methylated||22
943433|NCT01357239|2280978|P3|COMPLETED|Stratum I: Fully-Methylated||16
943434|NCT01357239|2280979|P2|COMPLETED|Stratum I: Fully-Methylated||6
943435|NCT01357239|2280980|P1|COMPLETED|Stratum I: Fully-Methylated||8
943436|NCT01357239|2280977|P4|STARTED|Stratum I: Fully-Methylated||22
943437|NCT01357239|2280978|P3|STARTED|Stratum I: Fully-Methylated||17
943438|NCT01357239|2280979|P2|STARTED|Stratum I: Fully-Methylated||6
943439|NCT01357239|2280980|P1|STARTED|Stratum I: Fully-Methylated||8
943440|NCT01357239|2280977|P4|NOT COMPLETED|Stratum: All Patients||2
943441|NCT01357239|2280978|P3|NOT COMPLETED|Stratum: All Patients||2
943442|NCT01357239|2280979|P2|NOT COMPLETED|Stratum: All Patients||0
943443|NCT01357239|2280980|P1|NOT COMPLETED|Stratum: All Patients||0
943444|NCT01357239|2280977|P4|COMPLETED|Stratum: All Patients||40
943445|NCT01357239|2280978|P3|COMPLETED|Stratum: All Patients||37
943446|NCT01357239|2280979|P2|COMPLETED|Stratum: All Patients||27
943447|NCT01357239|2280980|P1|COMPLETED|Stratum: All Patients||31
943448|NCT01357239|2280977|P4|STARTED|Stratum: All Patients||42
943449|NCT01357239|2280978|P3|STARTED|Stratum: All Patients||39
943450|NCT01357239|2280979|P2|STARTED|Stratum: All Patients||27
943451|NCT01357239|2280980|P1|STARTED|Stratum: All Patients||31
943452|NCT01357161|2281038|P3|NOT COMPLETED|Part 2 (Double-Blind Comparison)||62
943453|NCT01357161|2281039|P2|NOT COMPLETED|Part 2 (Double-Blind Comparison)||59
943454|NCT01357161|2281040|P1|NOT COMPLETED|Part 2 (Double-Blind Comparison)||0
943455|NCT01357161|2281038|P3|COMPLETED|Part 2 (Double-Blind Comparison)||0
943456|NCT01357161|2281039|P2|COMPLETED|Part 2 (Double-Blind Comparison)||0
943457|NCT01357161|2281040|P1|COMPLETED|Part 2 (Double-Blind Comparison)||0
943458|NCT01357161|2281038|P3|Treated|Part 2 (Double-Blind Comparison)||60
943459|NCT01357161|2281039|P2|Treated|Part 2 (Double-Blind Comparison)||59
943460|NCT01357161|2281040|P1|Treated|Part 2 (Double-Blind Comparison)||0
943461|NCT01357161|2281038|P3|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|62
943462|NCT01357161|2281039|P2|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|59
943463|NCT01357161|2281040|P1|STARTED|Part 2 (Double-Blind Comparison)||0
943464|NCT01357161|2281038|P3|NOT COMPLETED|Part 1 (Open Label Run-in)||0
943465|NCT01357161|2281039|P2|NOT COMPLETED|Part 1 (Open Label Run-in)||0
943466|NCT01357161|2281040|P1|NOT COMPLETED|Part 1 (Open Label Run-in)||15
943467|NCT01357161|2281038|P3|COMPLETED|Part 1 (Open Label Run-in)||0
943468|NCT01357161|2281039|P2|COMPLETED|Part 1 (Open Label Run-in)||0
943469|NCT01357161|2281040|P1|COMPLETED|Part 1 (Open Label Run-in)||0
943470|NCT01357161|2281038|P3|STARTED|Part 1 (Open Label Run-in)||0
943471|NCT01357161|2281039|P2|STARTED|Part 1 (Open Label Run-in)||0
943472|NCT01357161|2281040|P1|STARTED|Part 1 (Open Label Run-in)||15
943473|NCT01357148|2281069|P1|NOT COMPLETED|Overall Study||0
943474|NCT01357148|2281069|P1|COMPLETED|Overall Study||143
943475|NCT01357148|2281069|P1|STARTED|Overall Study||143
943476|NCT01357135|2281079|P3|NOT COMPLETED|Overall Study||263
943477|NCT01357135|2281080|P2|NOT COMPLETED|Overall Study||223
943478|NCT01357135|2281081|P1|NOT COMPLETED|Overall Study||598
943479|NCT01357135|2281079|P3|COMPLETED|Overall Study||583
943480|NCT01357135|2281080|P2|COMPLETED|Overall Study||510
943481|NCT01357135|2281081|P1|COMPLETED|Overall Study||1276
943482|NCT01357135|2281079|P3|STARTED|Overall Study||846
943483|NCT01357135|2281080|P2|STARTED|Overall Study||733
943484|NCT01357135|2281081|P1|STARTED|Overall Study||1874
943485|NCT01356966|2281092|P2|NOT COMPLETED|Overall Study||2
943486|NCT01356966|2281093|P1|NOT COMPLETED|Overall Study||2
943487|NCT01356966|2281092|P2|COMPLETED|Overall Study||12
943488|NCT01356966|2281093|P1|COMPLETED|Overall Study||16
943489|NCT01356966|2281092|P2|STARTED|Overall Study||14
943490|NCT01356966|2281093|P1|STARTED|Overall Study||18
943491|NCT01356940|2281105|P2|NOT COMPLETED|Second Intervention (28 Days)||0
943492|NCT01356940|2281106|P1|NOT COMPLETED|Second Intervention (28 Days)||1
943493|NCT01356940|2281105|P2|COMPLETED|Second Intervention (28 Days)||21
943494|NCT01356940|2281106|P1|COMPLETED|Second Intervention (28 Days)||20
943495|NCT01356940|2281105|P2|STARTED|Second Intervention (28 Days)||21
943496|NCT01356940|2281106|P1|STARTED|Second Intervention (28 Days)||21
943497|NCT01356940|2281105|P2|NOT COMPLETED|Washout (14 Days)||0
943498|NCT01356940|2281106|P1|NOT COMPLETED|Washout (14 Days)||0
943499|NCT01356940|2281105|P2|COMPLETED|Washout (14 Days)||21
943500|NCT01356940|2281106|P1|COMPLETED|Washout (14 Days)||21
943501|NCT01356940|2281105|P2|STARTED|Washout (14 Days)||21
943502|NCT01356940|2281106|P1|STARTED|Washout (14 Days)||21
943503|NCT01356940|2281105|P2|NOT COMPLETED|First Intervention (28 Days)||0
943504|NCT01356940|2281106|P1|NOT COMPLETED|First Intervention (28 Days)||1
943505|NCT01356940|2281105|P2|COMPLETED|First Intervention (28 Days)||21
943506|NCT01356940|2281106|P1|COMPLETED|First Intervention (28 Days)||21
943507|NCT01356940|2281105|P2|STARTED|First Intervention (28 Days)||21
943508|NCT01356940|2281106|P1|STARTED|First Intervention (28 Days)||22
943509|NCT01356667|2281114|P2|NOT COMPLETED|Overall Study||6
943510|NCT01356667|2281115|P1|NOT COMPLETED|Overall Study||4
943511|NCT01356667|2281114|P2|COMPLETED|Overall Study||0
943512|NCT01356667|2281115|P1|COMPLETED|Overall Study||0
943513|NCT01356667|2281114|P2|STARTED|Overall Study||6
943514|NCT01356667|2281115|P1|STARTED|Overall Study||4
943515|NCT01356602|2281128|P3|NOT COMPLETED|Overall Study||24
943516|NCT01356602|2281129|P2|NOT COMPLETED|Overall Study||15
943517|NCT01356602|2281130|P1|NOT COMPLETED|Overall Study||9
943518|NCT01356602|2281128|P3|COMPLETED|Overall Study||108
943519|NCT01356602|2281129|P2|COMPLETED|Overall Study||117
943520|NCT01356602|2281130|P1|COMPLETED|Overall Study||124
943521|NCT01356602|2281128|P3|Full Analysis Set|Overall Study||129
943522|NCT01356602|2281129|P2|Full Analysis Set|Overall Study||129
943523|NCT01356602|2281130|P1|Full Analysis Set|Overall Study||131
943524|NCT01356602|2281128|P3|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
943525|NCT01356602|2281129|P2|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
943526|NCT01356602|2281130|P1|Safety Set|Overall Study|In this arm, 1 patient had only 3 placebo injections and 3 patients also took other active drug.|133
943527|NCT01356602|2281128|P3|STARTED|Overall Study||132
943528|NCT01356602|2281129|P2|STARTED|Overall Study||132
943529|NCT01356602|2281130|P1|STARTED|Overall Study||133
943530|NCT01356589|2281189|P1|NOT COMPLETED|Overall Study||5
943531|NCT01356589|2281189|P1|COMPLETED|Overall Study||1283
943532|NCT01356589|2281189|P1|Treated|Overall Study||1285
943533|NCT01356589|2281189|P1|STARTED|Overall Study||1288
943534|NCT01356498|2281201|P6|NOT COMPLETED|Overall Study||14
943535|NCT01356498|2281202|P5|NOT COMPLETED|Overall Study||20
943536|NCT01356498|2281203|P4|NOT COMPLETED|Overall Study||14
943537|NCT01356498|2281204|P3|NOT COMPLETED|Overall Study||12
943538|NCT01356498|2281205|P2|NOT COMPLETED|Overall Study||8
943539|NCT01356498|2281206|P1|NOT COMPLETED|Overall Study||11
943540|NCT01356498|2281201|P6|COMPLETED|Overall Study||2
943541|NCT01356498|2281202|P5|COMPLETED|Overall Study||8
943542|NCT01356498|2281203|P4|COMPLETED|Overall Study||8
943543|NCT01356498|2281204|P3|COMPLETED|Overall Study||11
943544|NCT01356498|2281205|P2|COMPLETED|Overall Study||17
943545|NCT01356498|2281206|P1|COMPLETED|Overall Study||24
943546|NCT01356498|2281201|P6|STARTED|Overall Study||16
943547|NCT01356498|2281202|P5|STARTED|Overall Study||28
943548|NCT01356498|2281203|P4|STARTED|Overall Study||22
943549|NCT01356498|2281204|P3|STARTED|Overall Study||23
943550|NCT01356498|2281205|P2|STARTED|Overall Study|2 other patients received no investigational drug in C0407 but elected to be followed in Observation|25
943551|NCT01356498|2281206|P1|STARTED|Overall Study||35
943552|NCT01356407|2281246|P2|NOT COMPLETED|Overall Study||4
943553|NCT01356407|2281247|P1|NOT COMPLETED|Overall Study||6
943554|NCT01356407|2281246|P2|COMPLETED|Overall Study||146
943555|NCT01356407|2281247|P1|COMPLETED|Overall Study||144
943556|NCT01356407|2281246|P2|STARTED|Overall Study||150
943557|NCT01356407|2281247|P1|STARTED|Overall Study||150
943558|NCT01356147|2281265|P2|NOT COMPLETED|Overall Study||0
943559|NCT01356147|2281266|P1|NOT COMPLETED|Overall Study||0
943560|NCT01356147|2281265|P2|COMPLETED|Overall Study||6
943561|NCT01356147|2281266|P1|COMPLETED|Overall Study||5
943562|NCT01356147|2281265|P2|STARTED|Overall Study||6
943563|NCT01356147|2281266|P1|STARTED|Overall Study||5
943564|NCT01355978|2281272|P1|NOT COMPLETED|Overall Study||4
943565|NCT01355978|2281272|P1|COMPLETED|Overall Study||18
943566|NCT01355978|2281272|P1|STARTED|Overall Study||22
943567|NCT01355705|2281278|P1|NOT COMPLETED|Overall Study||0
943568|NCT01355705|2281278|P1|COMPLETED|Overall Study||14
943569|NCT01355705|2281278|P1|STARTED|Overall Study||14
943570|NCT01355679|2281285|P1|NOT COMPLETED|Overall Study||2
943571|NCT01355679|2281285|P1|COMPLETED|Overall Study||14
943572|NCT01355679|2281285|P1|STARTED|Overall Study||16
943573|NCT01355627|2281294|P2|NOT COMPLETED|Overall Study||38
943574|NCT01355627|2281295|P1|NOT COMPLETED|Overall Study||33
943575|NCT01355627|2281294|P2|COMPLETED|Overall Study||326
943576|NCT01355627|2281295|P1|COMPLETED|Overall Study||329
943577|NCT01355627|2281294|P2|Full Analysis Set|Overall Study|One participant randomized to Current Practice actually received TachoSil®.|365
943578|NCT01355627|2281295|P1|Full Analysis Set|Overall Study|One participant's data for final follow-up is missing, completion status could not be confirmed.|361
943579|NCT01355627|2281294|P2|Safety Analysis Set|Overall Study||364
943580|NCT01355627|2281295|P1|Safety Analysis Set|Overall Study||362
943581|NCT01355627|2281294|P2|STARTED|Overall Study||364
943582|NCT01355627|2281295|P1|STARTED|Overall Study||362
943583|NCT01355588|2281307|P4|NOT COMPLETED|Fourth Intervention (After Washout)||0
943584|NCT01355588|2281308|P3|NOT COMPLETED|Fourth Intervention (After Washout)||0
943585|NCT01355588|2281309|P2|NOT COMPLETED|Fourth Intervention (After Washout)||0
943586|NCT01355588|2281310|P1|NOT COMPLETED|Fourth Intervention (After Washout)||0
943587|NCT01355588|2281307|P4|COMPLETED|Fourth Intervention (After Washout)||4
943588|NCT01355588|2281308|P3|COMPLETED|Fourth Intervention (After Washout)||4
943589|NCT01355588|2281309|P2|COMPLETED|Fourth Intervention (After Washout)||4
943590|NCT01355588|2281310|P1|COMPLETED|Fourth Intervention (After Washout)||4
943591|NCT01355588|2281307|P4|STARTED|Fourth Intervention (After Washout)||4
943592|NCT01355588|2281308|P3|STARTED|Fourth Intervention (After Washout)||4
943593|NCT01355588|2281309|P2|STARTED|Fourth Intervention (After Washout)||4
943594|NCT01355588|2281310|P1|STARTED|Fourth Intervention (After Washout)||4
943595|NCT01355588|2281307|P4|NOT COMPLETED|Washout (3-7 Days)||0
943596|NCT01355588|2281308|P3|NOT COMPLETED|Washout (3-7 Days)||0
943597|NCT01355588|2281309|P2|NOT COMPLETED|Washout (3-7 Days)||0
943598|NCT01355588|2281310|P1|NOT COMPLETED|Washout (3-7 Days)||0
943599|NCT01355588|2281307|P4|COMPLETED|Washout (3-7 Days)||4
943600|NCT01355588|2281308|P3|COMPLETED|Washout (3-7 Days)||4
943601|NCT01355588|2281309|P2|COMPLETED|Washout (3-7 Days)||4
943602|NCT01355588|2281310|P1|COMPLETED|Washout (3-7 Days)||4
943603|NCT01355588|2281307|P4|STARTED|Washout (3-7 Days)||4
943604|NCT01355588|2281308|P3|STARTED|Washout (3-7 Days)||4
943605|NCT01355588|2281309|P2|STARTED|Washout (3-7 Days)||4
943606|NCT01355588|2281310|P1|STARTED|Washout (3-7 Days)||4
943607|NCT01355588|2281307|P4|NOT COMPLETED|Third Intervention (After Washout)||0
943608|NCT01355588|2281308|P3|NOT COMPLETED|Third Intervention (After Washout)||0
943609|NCT01355588|2281309|P2|NOT COMPLETED|Third Intervention (After Washout)||0
943610|NCT01355588|2281310|P1|NOT COMPLETED|Third Intervention (After Washout)||0
943611|NCT01355588|2281307|P4|COMPLETED|Third Intervention (After Washout)||4
943612|NCT01355588|2281308|P3|COMPLETED|Third Intervention (After Washout)||4
943613|NCT01355588|2281309|P2|COMPLETED|Third Intervention (After Washout)||4
943614|NCT01355588|2281310|P1|COMPLETED|Third Intervention (After Washout)||4
943615|NCT01355588|2281307|P4|STARTED|Third Intervention (After Washout)||4
943616|NCT01355588|2281308|P3|STARTED|Third Intervention (After Washout)||4
943617|NCT01355588|2281309|P2|STARTED|Third Intervention (After Washout)||4
943618|NCT01355588|2281310|P1|STARTED|Third Intervention (After Washout)||4
943619|NCT01355588|2281307|P4|NOT COMPLETED|Washout (3-7 Days)||0
943620|NCT01355588|2281308|P3|NOT COMPLETED|Washout (3-7 Days)||0
943621|NCT01355588|2281309|P2|NOT COMPLETED|Washout (3-7 Days)||0
943622|NCT01355588|2281310|P1|NOT COMPLETED|Washout (3-7 Days)||0
943623|NCT01355588|2281307|P4|COMPLETED|Washout (3-7 Days)||4
943624|NCT01355588|2281308|P3|COMPLETED|Washout (3-7 Days)||4
943625|NCT01355588|2281309|P2|COMPLETED|Washout (3-7 Days)||4
943626|NCT01355588|2281310|P1|COMPLETED|Washout (3-7 Days)||4
943627|NCT01355588|2281307|P4|STARTED|Washout (3-7 Days)||4
943628|NCT01355588|2281308|P3|STARTED|Washout (3-7 Days)||4
943629|NCT01355588|2281309|P2|STARTED|Washout (3-7 Days)||4
943630|NCT01355588|2281310|P1|STARTED|Washout (3-7 Days)||4
943631|NCT01355588|2281307|P4|NOT COMPLETED|Second Intervention (After Washout)||0
943632|NCT01355588|2281308|P3|NOT COMPLETED|Second Intervention (After Washout)||0
943633|NCT01355588|2281309|P2|NOT COMPLETED|Second Intervention (After Washout)||0
943634|NCT01355588|2281310|P1|NOT COMPLETED|Second Intervention (After Washout)||0
943635|NCT01355588|2281307|P4|COMPLETED|Second Intervention (After Washout)||4
943636|NCT01355588|2281308|P3|COMPLETED|Second Intervention (After Washout)||4
943637|NCT01355588|2281309|P2|COMPLETED|Second Intervention (After Washout)||4
943638|NCT01355588|2281310|P1|COMPLETED|Second Intervention (After Washout)||4
943639|NCT01355588|2281307|P4|STARTED|Second Intervention (After Washout)||4
943640|NCT01355588|2281308|P3|STARTED|Second Intervention (After Washout)||4
943641|NCT01355588|2281309|P2|STARTED|Second Intervention (After Washout)||4
943642|NCT01355588|2281310|P1|STARTED|Second Intervention (After Washout)||4
943643|NCT01355588|2281307|P4|NOT COMPLETED|Washout (3-7 Days)||0
943644|NCT01355588|2281308|P3|NOT COMPLETED|Washout (3-7 Days)||0
943645|NCT01355588|2281309|P2|NOT COMPLETED|Washout (3-7 Days)||0
943646|NCT01355588|2281310|P1|NOT COMPLETED|Washout (3-7 Days)||0
943647|NCT01355588|2281307|P4|COMPLETED|Washout (3-7 Days)||4
943648|NCT01355588|2281308|P3|COMPLETED|Washout (3-7 Days)||4
943649|NCT01355588|2281309|P2|COMPLETED|Washout (3-7 Days)||4
943650|NCT01355588|2281310|P1|COMPLETED|Washout (3-7 Days)||4
943651|NCT01355588|2281307|P4|STARTED|Washout (3-7 Days)||4
943652|NCT01355588|2281308|P3|STARTED|Washout (3-7 Days)||4
943653|NCT01355588|2281309|P2|STARTED|Washout (3-7 Days)||4
943654|NCT01355588|2281310|P1|STARTED|Washout (3-7 Days)||4
943655|NCT01355588|2281307|P4|NOT COMPLETED|First Intervention (Day 1)||0
943656|NCT01355588|2281308|P3|NOT COMPLETED|First Intervention (Day 1)||0
943657|NCT01355588|2281309|P2|NOT COMPLETED|First Intervention (Day 1)||0
943658|NCT01355588|2281310|P1|NOT COMPLETED|First Intervention (Day 1)||0
943659|NCT01355588|2281307|P4|COMPLETED|First Intervention (Day 1)||4
943660|NCT01355588|2281308|P3|COMPLETED|First Intervention (Day 1)||4
943661|NCT01355588|2281309|P2|COMPLETED|First Intervention (Day 1)||4
943662|NCT01355588|2281310|P1|COMPLETED|First Intervention (Day 1)||4
943663|NCT01355588|2281307|P4|STARTED|First Intervention (Day 1)||4
943664|NCT01355588|2281308|P3|STARTED|First Intervention (Day 1)||4
943665|NCT01355588|2281309|P2|STARTED|First Intervention (Day 1)||4
943666|NCT01355588|2281310|P1|STARTED|First Intervention (Day 1)||4
943667|NCT01355523|2281334|P2|NOT COMPLETED|Overall Study||10
943668|NCT01355523|2281335|P1|NOT COMPLETED|Overall Study||1
943669|NCT01355523|2281334|P2|COMPLETED|Overall Study||16
943670|NCT01355523|2281335|P1|COMPLETED|Overall Study||27
943671|NCT01355523|2281334|P2|STARTED|Overall Study||26
943672|NCT01355523|2281335|P1|STARTED|Overall Study||28
943673|NCT01355484|2281379|P2|NOT COMPLETED|Overall Study||54
943674|NCT01355484|2281380|P1|NOT COMPLETED|Overall Study||51
943675|NCT01355484|2281379|P2|COMPLETED|Overall Study||107
943676|NCT01355484|2281380|P1|COMPLETED|Overall Study||109
943677|NCT01355484|2281379|P2|STARTED|Overall Study||161
943678|NCT01355484|2281380|P1|STARTED|Overall Study||160
943679|NCT01355471|2281390|P2|NOT COMPLETED|Overall Study||3
943680|NCT01355471|2281391|P1|NOT COMPLETED|Overall Study||7
943681|NCT01355471|2281390|P2|COMPLETED|Overall Study||142
943682|NCT01355471|2281391|P1|COMPLETED|Overall Study||141
943683|NCT01355471|2281390|P2|STARTED|Overall Study||145
943684|NCT01355471|2281391|P1|STARTED|Overall Study||148
943685|NCT01355458|2281399|P2|NOT COMPLETED|Overall Study||4
943686|NCT01355458|2281400|P1|NOT COMPLETED|Overall Study||2
943687|NCT01355458|2281399|P2|COMPLETED|Overall Study||127
943688|NCT01355458|2281400|P1|COMPLETED|Overall Study||127
943689|NCT01355458|2281399|P2|STARTED|Overall Study||131
943690|NCT01355458|2281400|P1|STARTED|Overall Study||129
943691|NCT01355419|2281406|P1|NOT COMPLETED|Overall Study||8
943692|NCT01355419|2281406|P1|COMPLETED|Overall Study||142
943693|NCT01355419|2281406|P1|STARTED|Overall Study||150
943694|NCT01355302|2281411|P3|NOT COMPLETED|Phase 2||0
943695|NCT01355302|2281412|P2|NOT COMPLETED|Phase 2||0
943696|NCT01355302|2281413|P1|NOT COMPLETED|Phase 2||0
943697|NCT01355302|2281411|P3|COMPLETED|Phase 2||0
943698|NCT01355302|2281412|P2|COMPLETED|Phase 2||0
943699|NCT01355302|2281413|P1|COMPLETED|Phase 2||0
943700|NCT01355302|2281411|P3|STARTED|Phase 2|The study was terminated prior to enrollment|0
943701|NCT01355302|2281412|P2|STARTED|Phase 2|The study was terminated prior to enrollment|0
943702|NCT01355302|2281413|P1|STARTED|Phase 2|Treatment arm not designated for phase 2.|0
943703|NCT01355302|2281411|P3|NOT COMPLETED|Phase 1b||0
943704|NCT01355302|2281412|P2|NOT COMPLETED|Phase 1b||0
943705|NCT01355302|2281413|P1|NOT COMPLETED|Phase 1b||6
943706|NCT01355302|2281411|P3|COMPLETED|Phase 1b||0
943707|NCT01355302|2281412|P2|COMPLETED|Phase 1b||0
943708|NCT01355302|2281413|P1|COMPLETED|Phase 1b|The subject who completed 6 cycles was withdrawn by sponsor request.|1
943709|NCT01355302|2281411|P3|STARTED|Phase 1b||0
943710|NCT01355302|2281412|P2|STARTED|Phase 1b||0
943711|NCT01355302|2281413|P1|STARTED|Phase 1b|Replaced 1 subject; who discontinued study drug in first cycle|7
943712|NCT01355224|2281428|P4|NOT COMPLETED|Overall Study||29
943713|NCT01355224|2281429|P3|NOT COMPLETED|Overall Study||19
943714|NCT01355224|2281430|P2|NOT COMPLETED|Overall Study||23
943715|NCT01355224|2281431|P1|NOT COMPLETED|Overall Study||31
943716|NCT01355224|2281428|P4|COMPLETED|Overall Study||172
943717|NCT01355224|2281429|P3|COMPLETED|Overall Study||177
943718|NCT01355224|2281430|P2|COMPLETED|Overall Study||180
943719|NCT01355224|2281431|P1|COMPLETED|Overall Study||167
943720|NCT01355224|2281428|P4|Competed Baseline|Overall Study||193
943721|NCT01355224|2281429|P3|Competed Baseline|Overall Study||193
943722|NCT01355224|2281430|P2|Competed Baseline|Overall Study||200
943723|NCT01355224|2281431|P1|Competed Baseline|Overall Study||191
943724|NCT01355224|2281428|P4|STARTED|Overall Study||201
943725|NCT01355224|2281429|P3|STARTED|Overall Study||196
943726|NCT01355224|2281430|P2|STARTED|Overall Study||203
943727|NCT01355224|2281431|P1|STARTED|Overall Study||198
943728|NCT01355081|2281454|P3|NOT COMPLETED|Overall Study||11
943729|NCT01355081|2281455|P2|NOT COMPLETED|Overall Study||10
943730|NCT01355081|2281456|P1|NOT COMPLETED|Overall Study||7
943731|NCT01355081|2281454|P3|COMPLETED|Overall Study||113
943732|NCT01355081|2281455|P2|COMPLETED|Overall Study||113
943733|NCT01355081|2281456|P1|COMPLETED|Overall Study||112
943734|NCT01355081|2281454|P3|STARTED|Overall Study||124
943735|NCT01355081|2281455|P2|STARTED|Overall Study||123
943736|NCT01355081|2281456|P1|STARTED|Overall Study||119
943737|NCT01355068|2281479|P2|NOT COMPLETED|Second Intervention Period||0
943738|NCT01355068|2281480|P1|NOT COMPLETED|Second Intervention Period||0
943739|NCT01355068|2281479|P2|COMPLETED|Second Intervention Period||11
943740|NCT01355068|2281480|P1|COMPLETED|Second Intervention Period||13
943741|NCT01355068|2281479|P2|STARTED|Second Intervention Period||11
943742|NCT01355068|2281480|P1|STARTED|Second Intervention Period||13
943743|NCT01355068|2281479|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
943744|NCT01355068|2281480|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
943745|NCT01355068|2281479|P2|COMPLETED|Washout Period (at Least 7 Days)||11
943746|NCT01355068|2281480|P1|COMPLETED|Washout Period (at Least 7 Days)||13
943747|NCT01355068|2281479|P2|STARTED|Washout Period (at Least 7 Days)||11
943748|NCT01355068|2281480|P1|STARTED|Washout Period (at Least 7 Days)||13
943749|NCT01355068|2281479|P2|NOT COMPLETED|First Intervention Period||2
943750|NCT01355068|2281480|P1|NOT COMPLETED|First Intervention Period||0
943751|NCT01355068|2281479|P2|COMPLETED|First Intervention Period||11
943752|NCT01355068|2281480|P1|COMPLETED|First Intervention Period||13
943753|NCT01355068|2281479|P2|STARTED|First Intervention Period||13
943754|NCT01355068|2281480|P1|STARTED|First Intervention Period||13
943755|NCT01354990|2281496|P1|NOT COMPLETED|Overall Study||0
943756|NCT01354990|2281496|P1|COMPLETED|Overall Study||2974
943757|NCT01354990|2281496|P1|STARTED|Overall Study||2974
943758|NCT01354938|2281503|P1|NOT COMPLETED|Overall Study||1
943759|NCT01354938|2281503|P1|COMPLETED|Overall Study||219
943760|NCT01354938|2281503|P1|STARTED|Overall Study||220
943761|NCT01354899|2281509|P1|NOT COMPLETED|Overall Study||3
943762|NCT01354899|2281509|P1|COMPLETED|Overall Study||21
943763|NCT01354899|2281509|P1|STARTED|Overall Study||24
943764|NCT01354652|2281517|P3|NOT COMPLETED|Overall Study||0
943765|NCT01354652|2281518|P2|NOT COMPLETED|Overall Study||2
943766|NCT01354652|2281519|P1|NOT COMPLETED|Overall Study||3
943767|NCT01354652|2281517|P3|COMPLETED|Overall Study||0
943768|NCT01354652|2281518|P2|COMPLETED|Overall Study||0
943769|NCT01354652|2281519|P1|COMPLETED|Overall Study||0
943770|NCT01354652|2281517|P3|STARTED|Overall Study||0
943771|NCT01354652|2281518|P2|STARTED|Overall Study||2
943772|NCT01354652|2281519|P1|STARTED|Overall Study||3
943791|NCT01354314|2281556|P4|NOT COMPLETED|Overall Study||6
943792|NCT01354314|2281557|P3|NOT COMPLETED|Overall Study||8
943793|NCT01354314|2281558|P2|NOT COMPLETED|Overall Study||3
943794|NCT01354314|2281559|P1|NOT COMPLETED|Overall Study||6
943795|NCT01354314|2281556|P4|COMPLETED|Overall Study||5
943796|NCT01354314|2281557|P3|COMPLETED|Overall Study||3
943797|NCT01354314|2281558|P2|COMPLETED|Overall Study||8
943798|NCT01354314|2281559|P1|COMPLETED|Overall Study||6
943799|NCT01354314|2281556|P4|Completed (ITT)|Overall Study||10
943800|NCT01354314|2281557|P3|Completed (ITT)|Overall Study||9
943801|NCT01354314|2281558|P2|Completed (ITT)|Overall Study||11
943802|NCT01354314|2281559|P1|Completed (ITT)|Overall Study||11
943803|NCT01354314|2281556|P4|STARTED|Overall Study||11
943804|NCT01354314|2281557|P3|STARTED|Overall Study||11
943805|NCT01354314|2281558|P2|STARTED|Overall Study||11
943806|NCT01354314|2281559|P1|STARTED|Overall Study||12
943807|NCT01354223|2281695|P2|NOT COMPLETED|Overall Study||1
943808|NCT01354223|2281696|P1|NOT COMPLETED|Overall Study||3
943809|NCT01354223|2281695|P2|COMPLETED|Overall Study||29
943810|NCT01354223|2281696|P1|COMPLETED|Overall Study||57
943811|NCT01354223|2281695|P2|STARTED|Overall Study||30
943812|NCT01354223|2281696|P1|STARTED|Overall Study||60
943813|NCT01354197|2281712|P1|NOT COMPLETED|Overall Study||0
943814|NCT01354197|2281712|P1|COMPLETED|Overall Study||4652
943815|NCT01354197|2281712|P1|STARTED|Overall Study||4652
943816|NCT01354145|2281720|P2|NOT COMPLETED|Overall Study||34
943817|NCT01354145|2281721|P1|NOT COMPLETED|Overall Study||39
943818|NCT01354145|2281720|P2|COMPLETED|Overall Study||63
943819|NCT01354145|2281721|P1|COMPLETED|Overall Study||58
943820|NCT01354145|2281720|P2|STARTED|Overall Study||97
943821|NCT01354145|2281721|P1|STARTED|Overall Study||97
943822|NCT01354132|2281755|P2|NOT COMPLETED|1 Month Post Study Medication||3
943823|NCT01354132|2281756|P1|NOT COMPLETED|1 Month Post Study Medication||1
943824|NCT01354132|2281755|P2|COMPLETED|1 Month Post Study Medication||16
943825|NCT01354132|2281756|P1|COMPLETED|1 Month Post Study Medication||21
943826|NCT01354132|2281755|P2|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||16
943827|NCT01354132|2281756|P1|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||21
943828|NCT01354132|2281755|P2|STARTED|1 Month Post Study Medication||19
943829|NCT01354132|2281756|P1|STARTED|1 Month Post Study Medication||22
943830|NCT01354132|2281755|P2|NOT COMPLETED|Double Blind (Visits 1-7)||11
943831|NCT01354132|2281756|P1|NOT COMPLETED|Double Blind (Visits 1-7)||9
943832|NCT01354132|2281755|P2|COMPLETED|Double Blind (Visits 1-7)||19
943833|NCT01354132|2281756|P1|COMPLETED|Double Blind (Visits 1-7)||22
943834|NCT01354132|2281755|P2|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||4
943835|NCT01354132|2281756|P1|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||2
943836|NCT01354132|2281755|P2|Stopped After First Visit|Double Blind (Visits 1-7)||2
943837|NCT01354132|2281756|P1|Stopped After First Visit|Double Blind (Visits 1-7)||3
943838|NCT01354132|2281755|P2|Completed More Than 1 Visit|Double Blind (Visits 1-7)||5
943839|NCT01354132|2281756|P1|Completed More Than 1 Visit|Double Blind (Visits 1-7)||4
943840|NCT01354132|2281755|P2|STARTED|Double Blind (Visits 1-7)|11 did not compete 7 study visits|30
943841|NCT01354132|2281756|P1|STARTED|Double Blind (Visits 1-7)|9 did not compete 7 study visits|31
943842|NCT01354132|2281755|P2|NOT COMPLETED|Randomization||1
943843|NCT01354132|2281756|P1|NOT COMPLETED|Randomization||1
943844|NCT01354132|2281755|P2|COMPLETED|Randomization||30
943845|NCT01354132|2281756|P1|COMPLETED|Randomization||31
943846|NCT01354132|2281755|P2|STARTED|Randomization|1 never took study medication due to subject withdrawal|31
943847|NCT01354132|2281756|P1|STARTED|Randomization|1 never took study medication dropped by physician decision (White matter lesion on MRI)|32
943848|NCT01354106|2281794|P1|NOT COMPLETED|Overall Study||2
943849|NCT01354106|2281794|P1|COMPLETED|Overall Study||24
943850|NCT01354106|2281794|P1|STARTED|Overall Study||26
943851|NCT01354028|2281800|P2|NOT COMPLETED|Overall Study||5
943852|NCT01354028|2281801|P1|NOT COMPLETED|Overall Study||2
943853|NCT01354028|2281800|P2|COMPLETED|Overall Study||10
943854|NCT01354028|2281801|P1|COMPLETED|Overall Study||13
943855|NCT01354028|2281800|P2|STARTED|Overall Study||15
943856|NCT01354028|2281801|P1|STARTED|Overall Study||15
943857|NCT01354015|2281815|P2|NOT COMPLETED|Overall Study||5
943858|NCT01354015|2281816|P1|NOT COMPLETED|Overall Study||6
943859|NCT01354015|2281815|P2|COMPLETED|Overall Study||43
943860|NCT01354015|2281816|P1|COMPLETED|Overall Study||44
943861|NCT01354015|2281815|P2|STARTED|Overall Study||48
943862|NCT01354015|2281816|P1|STARTED|Overall Study||50
943863|NCT01353976|2281826|P2|NOT COMPLETED|Overall Study||51
943864|NCT01353976|2281827|P1|NOT COMPLETED|Overall Study||48
943865|NCT01353976|2281826|P2|COMPLETED|Overall Study||83
943866|NCT01353976|2281827|P1|COMPLETED|Overall Study||82
943867|NCT01353976|2281826|P2|STARTED|Overall Study||134
943868|NCT01353976|2281827|P1|STARTED|Overall Study||130
943869|NCT01353963|2281837|P1|NOT COMPLETED|Overall Study||2
943870|NCT01353963|2281837|P1|COMPLETED|Overall Study||11
943871|NCT01353963|2281837|P1|STARTED|Overall Study||13
943872|NCT01353911|2281855|P8|NOT COMPLETED|Overall Study||15
943873|NCT01353911|2281856|P7|NOT COMPLETED|Overall Study||6
943874|NCT01353911|2281857|P6|NOT COMPLETED|Overall Study||7
943875|NCT01353911|2281858|P5|NOT COMPLETED|Overall Study||6
943876|NCT01353911|2281859|P4|NOT COMPLETED|Overall Study||2
943877|NCT01353911|2281860|P3|NOT COMPLETED|Overall Study||9
943878|NCT01353911|2281861|P2|NOT COMPLETED|Overall Study||9
943879|NCT01353911|2281862|P1|NOT COMPLETED|Overall Study||8
943880|NCT01353911|2281855|P8|COMPLETED|Overall Study||51
943881|NCT01353911|2281856|P7|COMPLETED|Overall Study||30
943882|NCT01353911|2281857|P6|COMPLETED|Overall Study||36
943883|NCT01353911|2281858|P5|COMPLETED|Overall Study||23
943884|NCT01353911|2281859|P4|COMPLETED|Overall Study||22
943885|NCT01353911|2281860|P3|COMPLETED|Overall Study||59
943886|NCT01353911|2281861|P2|COMPLETED|Overall Study||57
943887|NCT01353911|2281862|P1|COMPLETED|Overall Study||28
943888|NCT01353911|2281855|P8|STARTED|Overall Study||66
943889|NCT01353911|2281856|P7|STARTED|Overall Study||36
943890|NCT01353911|2281857|P6|STARTED|Overall Study||43
943891|NCT01353911|2281858|P5|STARTED|Overall Study||29
943892|NCT01353911|2281859|P4|STARTED|Overall Study||24
943893|NCT01353911|2281860|P3|STARTED|Overall Study||68
943894|NCT01353911|2281861|P2|STARTED|Overall Study||66
943895|NCT01353911|2281862|P1|STARTED|Overall Study||36
943896|NCT01353898|2281942|P6|NOT COMPLETED|Overall Study||1
943897|NCT01353898|2281943|P5|NOT COMPLETED|Overall Study||0
943898|NCT01353898|2281944|P4|NOT COMPLETED|Overall Study||0
943899|NCT01353898|2281945|P3|NOT COMPLETED|Overall Study||0
943900|NCT01353898|2281946|P2|NOT COMPLETED|Overall Study||0
943901|NCT01353898|2281947|P1|NOT COMPLETED|Overall Study||0
943902|NCT01353898|2281942|P6|COMPLETED|Overall Study||1
943903|NCT01353898|2281943|P5|COMPLETED|Overall Study||2
943904|NCT01353898|2281944|P4|COMPLETED|Overall Study||2
943905|NCT01353898|2281945|P3|COMPLETED|Overall Study||2
943906|NCT01353898|2281946|P2|COMPLETED|Overall Study||2
943907|NCT01353898|2281947|P1|COMPLETED|Overall Study||2
943908|NCT01353898|2281942|P6|STARTED|Overall Study||2
943909|NCT01353898|2281943|P5|STARTED|Overall Study||2
943910|NCT01353898|2281944|P4|STARTED|Overall Study||2
943911|NCT01353898|2281945|P3|STARTED|Overall Study||2
943912|NCT01353898|2281946|P2|STARTED|Overall Study||2
943913|NCT01353898|2281947|P1|STARTED|Overall Study||2
943914|NCT01353859|2281973|P1|NOT COMPLETED|Overall Study||4
943915|NCT01353859|2281973|P1|COMPLETED|Overall Study||35
943916|NCT01353859|2281973|P1|STARTED|Overall Study||39
943917|NCT01353664|2281986|P1|NOT COMPLETED|Overall Study||19
943918|NCT01353664|2281986|P1|COMPLETED|Overall Study|Completed = Number of participants who continued on Romidepsin treatment|0
943919|NCT01353664|2281986|P1|STARTED|Overall Study|Participants who received at least 1 dose of study drug.|19
943920|NCT01353586|2281992|P2|NOT COMPLETED|Overall Study||2
943921|NCT01353586|2281993|P1|NOT COMPLETED|Overall Study||7
943922|NCT01353586|2281992|P2|COMPLETED|Overall Study||17
943923|NCT01353586|2281993|P1|COMPLETED|Overall Study||160
943924|NCT01353586|2281992|P2|Participated in SNA Substudy|Overall Study||19
943925|NCT01353586|2281993|P1|Participated in SNA Substudy|Overall Study||19
943926|NCT01353586|2281992|P2|Participated in Roll-in Phase|Overall Study||0
943927|NCT01353586|2281993|P1|Participated in Roll-in Phase|Overall Study||22
943928|NCT01353586|2281992|P2|Participated in Workflow Phase|Overall Study||0
943929|NCT01353586|2281993|P1|Participated in Workflow Phase|Overall Study||20
943930|NCT01353586|2281992|P2|STARTED|Overall Study||19
943931|NCT01353586|2281993|P1|STARTED|Overall Study||167
943932|NCT01353508|2282011|P4|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
943933|NCT01353508|2282012|P3|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
943934|NCT01353508|2282013|P2|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
943935|NCT01353508|2282014|P1|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||1
943936|NCT01353508|2282011|P4|COMPLETED|Period 2 - Second Intervention (7 Days)||7
943937|NCT01353508|2282012|P3|COMPLETED|Period 2 - Second Intervention (7 Days)||8
943938|NCT01353508|2282013|P2|COMPLETED|Period 2 - Second Intervention (7 Days)||8
943939|NCT01353508|2282014|P1|COMPLETED|Period 2 - Second Intervention (7 Days)||7
943940|NCT01353508|2282011|P4|STARTED|Period 2 - Second Intervention (7 Days)||7
943941|NCT01353508|2282012|P3|STARTED|Period 2 - Second Intervention (7 Days)||8
943942|NCT01353508|2282013|P2|STARTED|Period 2 - Second Intervention (7 Days)||8
943943|NCT01353508|2282014|P1|STARTED|Period 2 - Second Intervention (7 Days)||8
943944|NCT01353508|2282011|P4|NOT COMPLETED|Period 1 - First Intervention (7 Days)||1
943945|NCT01353508|2282012|P3|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
943946|NCT01353508|2282013|P2|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
943947|NCT01353508|2282014|P1|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
943948|NCT01353508|2282011|P4|COMPLETED|Period 1 - First Intervention (7 Days)||7
943949|NCT01353508|2282012|P3|COMPLETED|Period 1 - First Intervention (7 Days)||8
943950|NCT01353508|2282013|P2|COMPLETED|Period 1 - First Intervention (7 Days)||8
943951|NCT01353508|2282014|P1|COMPLETED|Period 1 - First Intervention (7 Days)||8
943952|NCT01353508|2282011|P4|STARTED|Period 1 - First Intervention (7 Days)||8
943953|NCT01353508|2282012|P3|STARTED|Period 1 - First Intervention (7 Days)||8
943954|NCT01353508|2282013|P2|STARTED|Period 1 - First Intervention (7 Days)||8
943955|NCT01353508|2282014|P1|STARTED|Period 1 - First Intervention (7 Days)||8
943956|NCT01353274|2282092|P1|NOT COMPLETED|Overall Study||28
943957|NCT01353274|2282092|P1|COMPLETED|Overall Study||1129
943958|NCT01353274|2282092|P1|STARTED|Overall Study||1157
943959|NCT01353222|2282102|P2|NOT COMPLETED|Overall Study||72
943960|NCT01353222|2282103|P1|NOT COMPLETED|Overall Study||70
943961|NCT01353222|2282102|P2|COMPLETED|Overall Study||0
943962|NCT01353222|2282103|P1|COMPLETED|Overall Study||0
943963|NCT01353222|2282102|P2|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||72
943964|NCT01353222|2282103|P1|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||0
943965|NCT01353222|2282102|P2|DN24-02 Arm ≥1 Leukapheresis|Overall Study||0
943966|NCT01353222|2282103|P1|DN24-02 Arm ≥1 Leukapheresis|Overall Study||67
943967|NCT01353222|2282102|P2|STARTED|Overall Study||72
943968|NCT01353222|2282103|P1|STARTED|Overall Study||70
943969|NCT01353144|2282111|P2|NOT COMPLETED|Overall Study||8
943970|NCT01353144|2282112|P1|NOT COMPLETED|Overall Study||9
943971|NCT01353144|2282111|P2|COMPLETED|Overall Study||81
943972|NCT01353144|2282112|P1|COMPLETED|Overall Study||80
943973|NCT01353144|2282111|P2|STARTED|Overall Study||89
943974|NCT01353144|2282112|P1|STARTED|Overall Study||89
943975|NCT01353079|2282122|P2|NOT COMPLETED|Overall Study||21
943976|NCT01353079|2282123|P1|NOT COMPLETED|Overall Study||27
943977|NCT01353079|2282122|P2|COMPLETED|Overall Study||190
943978|NCT01353079|2282123|P1|COMPLETED|Overall Study||191
943979|NCT01353079|2282122|P2|STARTED|Overall Study||211
943980|NCT01353079|2282123|P1|STARTED|Overall Study||218
943981|NCT01352845|2282137|P2|NOT COMPLETED|Overall Study||203
943982|NCT01352845|2282138|P1|NOT COMPLETED|Overall Study||671
943983|NCT01352845|2282137|P2|COMPLETED|Overall Study||619
943984|NCT01352845|2282138|P1|COMPLETED|Overall Study||1800
943985|NCT01352845|2282137|P2|STARTED|Overall Study||822
943986|NCT01352845|2282138|P1|STARTED|Overall Study||2471
943987|NCT01352793|2282227|P2|NOT COMPLETED|Overall Study||245
943988|NCT01352793|2282228|P1|NOT COMPLETED|Overall Study||585
943989|NCT01352793|2282227|P2|COMPLETED|Overall Study||1663
943990|NCT01352793|2282228|P1|COMPLETED|Overall Study||3219
943991|NCT01352793|2282227|P2|Vaccination 3|Overall Study||1710
943992|NCT01352793|2282228|P1|Vaccination 3|Overall Study||3314
943993|NCT01352793|2282227|P2|Vaccination 2|Overall Study||1806
943994|NCT01352793|2282228|P1|Vaccination 2|Overall Study||3530
943995|NCT01352793|2282227|P2|Vaccination 1|Overall Study||1908
943996|NCT01352793|2282228|P1|Vaccination 1|Overall Study||3796
943997|NCT01352793|2282227|P2|STARTED|Overall Study||1908
943998|NCT01352793|2282228|P1|STARTED|Overall Study||3804
943999|NCT01352741|2282252|P2|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
944000|NCT01352741|2282253|P1|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
944001|NCT01352741|2282252|P2|COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
944002|NCT01352741|2282253|P1|COMPLETED|Open-Label Tapentadol Pick-Up Arm||37
944003|NCT01352741|2282252|P2|STARTED|Open-Label Tapentadol Pick-Up Arm|Participants did not continue treatment. They were switched to tapentadol PR or discontinued.|0
944004|NCT01352741|2282253|P1|STARTED|Open-Label Tapentadol Pick-Up Arm|19 from tapentadol in the comparative phase and 18 from tapentadol & pregabalin entered this arm.|37
944005|NCT01352741|2282252|P2|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||0
944006|NCT01352741|2282253|P1|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||8
944007|NCT01352741|2282252|P2|COMPLETED|Open-Label Tapentadol Continuation Arm||0
944008|NCT01352741|2282253|P1|COMPLETED|Open-Label Tapentadol Continuation Arm||51
944009|NCT01352741|2282252|P2|Full Analysis Set|Open-Label Tapentadol Continuation Arm||0
944010|NCT01352741|2282253|P1|Full Analysis Set|Open-Label Tapentadol Continuation Arm||57
944011|NCT01352741|2282252|P2|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||0
944012|NCT01352741|2282253|P1|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||2
944013|NCT01352741|2282252|P2|STARTED|Open-Label Tapentadol Continuation Arm|In this period no tapentadol PR and pregabalin treatment was planned by the protocol.|0
944014|NCT01352741|2282253|P1|STARTED|Open-Label Tapentadol Continuation Arm|59 of the 73 participants that did not qualify for the comparative period entered this arm.|59
944015|NCT01352741|2282252|P2|NOT COMPLETED|Double-blind Comparative Period||26
944016|NCT01352741|2282253|P1|NOT COMPLETED|Double-blind Comparative Period||28
944017|NCT01352741|2282252|P2|COMPLETED|Double-blind Comparative Period||133
944018|NCT01352741|2282253|P1|COMPLETED|Double-blind Comparative Period||126
944019|NCT01352741|2282252|P2|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||137
944020|NCT01352741|2282253|P1|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||123
944021|NCT01352741|2282252|P2|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||137
944022|NCT01352741|2282253|P1|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||123
944023|NCT01352741|2282252|P2|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||137
944024|NCT01352741|2282253|P1|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||123
944025|NCT01352741|2282252|P2|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||137
944026|NCT01352741|2282253|P1|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||123
944027|NCT01352741|2282252|P2|EQ-5D Per Protocol Set|Double-blind Comparative Period||143
944028|NCT01352741|2282253|P1|EQ-5D Per Protocol Set|Double-blind Comparative Period||131
944029|NCT01352741|2282252|P2|SF-12 Per Protocol Set|Double-blind Comparative Period||143
944030|NCT01352741|2282253|P1|SF-12 Per Protocol Set|Double-blind Comparative Period||131
944031|NCT01352741|2282252|P2|painDetect Per Protocol Set|Double-blind Comparative Period||127
944032|NCT01352741|2282253|P1|painDetect Per Protocol Set|Double-blind Comparative Period||109
944033|NCT01352741|2282252|P2|Per Protocol Set|Double-blind Comparative Period||149
944034|NCT01352741|2282253|P1|Per Protocol Set|Double-blind Comparative Period||139
944035|NCT01352741|2282252|P2|Major Protocol Deviations|Double-blind Comparative Period||8
944036|NCT01352741|2282253|P1|Major Protocol Deviations|Double-blind Comparative Period||13
944037|NCT01352741|2282252|P2|Full Analysis Set|Double-blind Comparative Period||157
944038|NCT01352741|2282253|P1|Full Analysis Set|Double-blind Comparative Period||152
944039|NCT01352741|2282252|P2|No Pain Assessments Available|Double-blind Comparative Period||2
944040|NCT01352741|2282253|P1|No Pain Assessments Available|Double-blind Comparative Period||2
944041|NCT01352741|2282252|P2|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||18
944042|NCT01352741|2282253|P1|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||19
944043|NCT01352741|2282252|P2|STARTED|Double-blind Comparative Period|159 of the 313 participants that qualified were randomized to tapentadol and pregabalin treatment.|159
944044|NCT01352741|2282253|P1|STARTED|Double-blind Comparative Period|Of the 313 participants that qualified for randomization 154 were randomized to tapentadol.|154
944045|NCT01352741|2282252|P2|NOT COMPLETED|Open-label Tapentadol Titration Period||0
944046|NCT01352741|2282253|P1|NOT COMPLETED|Open-label Tapentadol Titration Period||73
944047|NCT01352741|2282252|P2|COMPLETED|Open-label Tapentadol Titration Period||0
944048|NCT01352741|2282253|P1|COMPLETED|Open-label Tapentadol Titration Period|59 of 73 participants not completing the titration period entered the open-label continuation arm.|372
944049|NCT01352741|2282252|P2|Full Analysis Set|Open-label Tapentadol Titration Period||0
944050|NCT01352741|2282253|P1|Full Analysis Set|Open-label Tapentadol Titration Period||436
944051|NCT01352741|2282252|P2|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||0
944052|NCT01352741|2282253|P1|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||59
944053|NCT01352741|2282252|P2|STARTED|Open-label Tapentadol Titration Period||0
944054|NCT01352741|2282253|P1|STARTED|Open-label Tapentadol Titration Period|All participants started with 2 x 50 mg tapentadol PR and titrated upwards in steps of 100 mg/day.|445
944055|NCT01352715|2282347|P2|NOT COMPLETED|Overall Study||46
944056|NCT01352715|2282348|P1|NOT COMPLETED|Overall Study||45
944057|NCT01352715|2282347|P2|COMPLETED|Overall Study||209
944058|NCT01352715|2282348|P1|COMPLETED|Overall Study||215
944059|NCT01352715|2282347|P2|STARTED|Overall Study||255
944060|NCT01352715|2282348|P1|STARTED|Overall Study||260
944061|NCT01352585|2282370|P1|NOT COMPLETED|Overall Study||11
944062|NCT01352585|2282370|P1|COMPLETED|Overall Study||36
944063|NCT01352585|2282370|P1|STARTED|Overall Study||47
944064|NCT01352546|2282381|P1|NOT COMPLETED|Overall Study||0
944065|NCT01352546|2282381|P1|COMPLETED|Overall Study||31
944066|NCT01352546|2282381|P1|STARTED|Overall Study||31
944067|NCT01352507|2282387|P2|NOT COMPLETED|Extension Phase||0
944068|NCT01352507|2282388|P1|NOT COMPLETED|Extension Phase||0
944069|NCT01352507|2282387|P2|COMPLETED|Extension Phase||173
944070|NCT01352507|2282388|P1|COMPLETED|Extension Phase||164
944071|NCT01352507|2282387|P2|STARTED|Extension Phase||173
944072|NCT01352507|2282388|P1|STARTED|Extension Phase||164
944073|NCT01352507|2282387|P2|NOT COMPLETED|Treatment Period 2||3
944074|NCT01352507|2282388|P1|NOT COMPLETED|Treatment Period 2||6
944075|NCT01352507|2282387|P2|COMPLETED|Treatment Period 2|Seven participants who completed Treatment Period 2 chose not to enter the Extension Phase.|180
944076|NCT01352507|2282388|P1|COMPLETED|Treatment Period 2|Six participants who completed Treatment Period 2 chose not to enter the Extension Phase.|170
944077|NCT01352507|2282387|P2|Received Treatment|Treatment Period 2||181
944078|NCT01352507|2282388|P1|Received Treatment|Treatment Period 2||173
944079|NCT01352507|2282387|P2|STARTED|Treatment Period 2||183
944080|NCT01352507|2282388|P1|STARTED|Treatment Period 2||176
944081|NCT01352507|2282387|P2|NOT COMPLETED|Washout Period||1
944082|NCT01352507|2282388|P1|NOT COMPLETED|Washout Period||0
944083|NCT01352507|2282387|P2|COMPLETED|Washout Period||183
944084|NCT01352507|2282388|P1|COMPLETED|Washout Period||176
944085|NCT01352507|2282387|P2|STARTED|Washout Period||184
944086|NCT01352507|2282388|P1|STARTED|Washout Period||176
944087|NCT01352507|2282387|P2|NOT COMPLETED|Treatment Period 1||9
944088|NCT01352507|2282388|P1|NOT COMPLETED|Treatment Period 1||14
944089|NCT01352507|2282387|P2|COMPLETED|Treatment Period 1||184
944090|NCT01352507|2282388|P1|COMPLETED|Treatment Period 1||176
944091|NCT01352507|2282387|P2|Received Treatment|Treatment Period 1||188
944092|NCT01352507|2282388|P1|Received Treatment|Treatment Period 1||182
944093|NCT01352507|2282387|P2|STARTED|Treatment Period 1||193
944094|NCT01352507|2282388|P1|STARTED|Treatment Period 1||190
944095|NCT01352468|2282421|P2|NOT COMPLETED|Overall Study||4
944096|NCT01352468|2282422|P1|NOT COMPLETED|Overall Study||5
944097|NCT01352468|2282421|P2|COMPLETED|Overall Study||18
944098|NCT01352468|2282422|P1|COMPLETED|Overall Study||17
944099|NCT01352468|2282421|P2|STARTED|Overall Study||22
944100|NCT01352468|2282422|P1|STARTED|Overall Study||22
944101|NCT01352442|2282432|P1|NOT COMPLETED|Overall Study||12
944102|NCT01352442|2282432|P1|COMPLETED|Overall Study||139
944103|NCT01352442|2282432|P1|STARTED|Overall Study||151
944104|NCT01352416|2282441|P4|NOT COMPLETED|Overall Study||1
944105|NCT01352416|2282442|P3|NOT COMPLETED|Overall Study||2
944106|NCT01352416|2282443|P2|NOT COMPLETED|Overall Study||2
944107|NCT01352416|2282444|P1|NOT COMPLETED|Overall Study||1
944108|NCT01352416|2282441|P4|COMPLETED|Overall Study||1
944109|NCT01352416|2282442|P3|COMPLETED|Overall Study||0
944110|NCT01352416|2282443|P2|COMPLETED|Overall Study||5
944111|NCT01352416|2282444|P1|COMPLETED|Overall Study||3
944112|NCT01352416|2282441|P4|STARTED|Overall Study||2
944113|NCT01352416|2282442|P3|STARTED|Overall Study||2
944114|NCT01352416|2282443|P2|STARTED|Overall Study||7
944115|NCT01352416|2282444|P1|STARTED|Overall Study||4
944116|NCT01352117|2282456|P2|NOT COMPLETED|Overall Study||96
944117|NCT01352117|2282457|P1|NOT COMPLETED|Overall Study||68
944118|NCT01352117|2282456|P2|COMPLETED|Overall Study||0
944119|NCT01352117|2282457|P1|COMPLETED|Overall Study||28
944120|NCT01352117|2282456|P2|Study Week 96 Data Potential|Overall Study||61
944121|NCT01352117|2282457|P1|Study Week 96 Data Potential|Overall Study||58
944122|NCT01352117|2282456|P2|Study Week 48 Data Potential|Overall Study||83
944123|NCT01352117|2282457|P1|Study Week 48 Data Potential|Overall Study||80
944124|NCT01352117|2282456|P2|Entered Step 2 to Initiate Delayed ET|Overall Study|Only Arm A participants could enter Step 2 to receive delayed ET.|0
944125|NCT01352117|2282457|P1|Entered Step 2 to Initiate Delayed ET|Overall Study||32
944126|NCT01352117|2282456|P2|STARTED|Overall Study||96
944127|NCT01352117|2282457|P1|STARTED|Overall Study||96
944128|NCT01351623|2282509|P1|NOT COMPLETED|Overall Study||9
944129|NCT01351623|2282509|P1|COMPLETED|Overall Study||35
944130|NCT01351623|2282509|P1|STARTED|Overall Study||44
944131|NCT01351506|2282515|P1|NOT COMPLETED|Overall Study||137
944132|NCT01351506|2282515|P1|COMPLETED|Overall Study||465
944133|NCT01351506|2282515|P1|STARTED|Overall Study||602
944134|NCT01351480|2282525|P1|NOT COMPLETED|Overall Study||8
944135|NCT01351480|2282525|P1|COMPLETED|Overall Study||26
944136|NCT01351480|2282525|P1|STARTED|Overall Study||34
944137|NCT01351415|2282535|P2|NOT COMPLETED|Overall Study||240
944138|NCT01351415|2282536|P1|NOT COMPLETED|Overall Study||245
944139|NCT01351415|2282535|P2|COMPLETED|Overall Study||0
944140|NCT01351415|2282536|P1|COMPLETED|Overall Study||0
944141|NCT01351415|2282535|P2|Treated Participants|Overall Study||232
944142|NCT01351415|2282536|P1|Treated Participants|Overall Study||243
944143|NCT01351415|2282535|P2|STARTED|Overall Study||240
944144|NCT01351415|2282536|P1|STARTED|Overall Study||245
944145|NCT01351337|2282556|P1|NOT COMPLETED|Overall Study||0
944146|NCT01351337|2282556|P1|COMPLETED|Overall Study||58
944147|NCT01351337|2282556|P1|STARTED|Overall Study||58
944148|NCT01351090|2282565|P3|NOT COMPLETED|Overall Study||6
944149|NCT01351090|2282566|P2|NOT COMPLETED|Overall Study||11
944150|NCT01351090|2282567|P1|NOT COMPLETED|Overall Study||11
944151|NCT01351090|2282565|P3|COMPLETED|Overall Study||36
944152|NCT01351090|2282566|P2|COMPLETED|Overall Study||31
944153|NCT01351090|2282567|P1|COMPLETED|Overall Study||32
944154|NCT01351090|2282565|P3|STARTED|Overall Study||42
944155|NCT01351090|2282566|P2|STARTED|Overall Study||42
944156|NCT01351090|2282567|P1|STARTED|Overall Study||43
944157|NCT01351077|2282586|P2|NOT COMPLETED|Overall Study||0
944158|NCT01351077|2282587|P1|NOT COMPLETED|Overall Study||0
944159|NCT01351077|2282586|P2|COMPLETED|Overall Study||180
944160|NCT01351077|2282587|P1|COMPLETED|Overall Study||180
944161|NCT01351077|2282586|P2|STARTED|Overall Study||180
944162|NCT01351077|2282587|P1|STARTED|Overall Study||180
944163|NCT01351064|2282603|P2|NOT COMPLETED|Overall Study||0
944164|NCT01351064|2282604|P1|NOT COMPLETED|Overall Study||0
944165|NCT01351064|2282603|P2|COMPLETED|Overall Study||42
944166|NCT01351064|2282604|P1|COMPLETED|Overall Study||42
944167|NCT01351064|2282603|P2|STARTED|Overall Study||42
944168|NCT01351064|2282604|P1|STARTED|Overall Study||42
944169|NCT01351025|2282614|P2|NOT COMPLETED|Week 44 - 48||0
944170|NCT01351025|2282615|P1|NOT COMPLETED|Week 44 - 48||0
944171|NCT01351025|2282614|P2|COMPLETED|Week 44 - 48||43
944172|NCT01351025|2282615|P1|COMPLETED|Week 44 - 48||42
944173|NCT01351025|2282614|P2|STARTED|Week 44 - 48||43
944174|NCT01351025|2282615|P1|STARTED|Week 44 - 48||42
944175|NCT01351025|2282614|P2|NOT COMPLETED|Week 24 - 44||4
944176|NCT01351025|2282615|P1|NOT COMPLETED|Week 24 - 44||1
944177|NCT01351025|2282614|P2|COMPLETED|Week 24 - 44||43
944178|NCT01351025|2282615|P1|COMPLETED|Week 24 - 44||42
944179|NCT01351025|2282614|P2|STARTED|Week 24 - 44||47
944180|NCT01351025|2282615|P1|STARTED|Week 24 - 44||43
944181|NCT01351025|2282614|P2|NOT COMPLETED|Week 20 - 24||0
944182|NCT01351025|2282615|P1|NOT COMPLETED|Week 20 - 24||0
944183|NCT01351025|2282614|P2|COMPLETED|Week 20 - 24||47
944184|NCT01351025|2282615|P1|COMPLETED|Week 20 - 24||43
944185|NCT01351025|2282614|P2|STARTED|Week 20 - 24||47
944186|NCT01351025|2282615|P1|STARTED|Week 20 - 24||43
944187|NCT01351025|2282614|P2|NOT COMPLETED|Week 0 - 20||1
944188|NCT01351025|2282615|P1|NOT COMPLETED|Week 0 - 20||3
944189|NCT01351025|2282614|P2|COMPLETED|Week 0 - 20||47
944190|NCT01351025|2282615|P1|COMPLETED|Week 0 - 20||43
944191|NCT01351025|2282614|P2|STARTED|Week 0 - 20||48
944192|NCT01351025|2282615|P1|STARTED|Week 0 - 20||46
944193|NCT01350999|2282648|P3|NOT COMPLETED|Overall Study||21
944194|NCT01350999|2282649|P2|NOT COMPLETED|Overall Study||14
944195|NCT01350999|2282650|P1|NOT COMPLETED|Overall Study||8
944196|NCT01350999|2282648|P3|COMPLETED|Overall Study||146
944197|NCT01350999|2282649|P2|COMPLETED|Overall Study||157
944198|NCT01350999|2282650|P1|COMPLETED|Overall Study||157
944199|NCT01350999|2282648|P3|Treated|Overall Study||167
944200|NCT01350999|2282649|P2|Treated|Overall Study||171
944201|NCT01350999|2282650|P1|Treated|Overall Study||165
944202|NCT01350999|2282648|P3|STARTED|Overall Study||167
944203|NCT01350999|2282649|P2|STARTED|Overall Study||171
944204|NCT01350999|2282650|P1|STARTED|Overall Study||165
944205|NCT01350973|2282688|P3|NOT COMPLETED|Overall Study||8
944206|NCT01350973|2282689|P2|NOT COMPLETED|Overall Study||8
944207|NCT01350973|2282690|P1|NOT COMPLETED|Overall Study||6
944208|NCT01350973|2282688|P3|COMPLETED|Overall Study||187
944209|NCT01350973|2282689|P2|COMPLETED|Overall Study||202
944210|NCT01350973|2282690|P1|COMPLETED|Overall Study||200
944211|NCT01350973|2282688|P3|Received Treatment|Overall Study||195
944212|NCT01350973|2282689|P2|Received Treatment|Overall Study||210
944213|NCT01350973|2282690|P1|Received Treatment|Overall Study||205
944214|NCT01350973|2282688|P3|STARTED|Overall Study||195
944215|NCT01350973|2282689|P2|STARTED|Overall Study||210
944216|NCT01350973|2282690|P1|STARTED|Overall Study||206
944217|NCT01350947|2282725|P1|NOT COMPLETED|Overall Study||0
944218|NCT01350947|2282725|P1|COMPLETED|Overall Study||11
944219|NCT01350947|2282725|P1|STARTED|Overall Study||11
944232|NCT01350804|2282754|P4|NOT COMPLETED|Extension Study, Weeks 52 - 260||23
944233|NCT01350804|2282755|P3|NOT COMPLETED|Extension Study, Weeks 52 - 260||72
944234|NCT01350804|2282756|P2|NOT COMPLETED|Extension Study, Weeks 52 - 260||79
944235|NCT01350804|2282757|P1|NOT COMPLETED|Extension Study, Weeks 52 - 260||80
944236|NCT01350804|2282754|P4|COMPLETED|Extension Study, Weeks 52 - 260||0
944237|NCT01350804|2282755|P3|COMPLETED|Extension Study, Weeks 52 - 260||0
944238|NCT01350804|2282756|P2|COMPLETED|Extension Study, Weeks 52 - 260||0
944239|NCT01350804|2282757|P1|COMPLETED|Extension Study, Weeks 52 - 260||0
944240|NCT01350804|2282754|P4|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|23
944241|NCT01350804|2282755|P3|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|72
944242|NCT01350804|2282756|P2|STARTED|Extension Study, Weeks 52 - 260||79
944243|NCT01350804|2282757|P1|STARTED|Extension Study, Weeks 52 - 260||80
944244|NCT01350804|2282754|P4|NOT COMPLETED|Core Study||26
944245|NCT01350804|2282755|P3|NOT COMPLETED|Core Study||47
944246|NCT01350804|2282756|P2|NOT COMPLETED|Core Study||47
944247|NCT01350804|2282757|P1|NOT COMPLETED|Core Study||41
944248|NCT01350804|2282754|P4|COMPLETED|Core Study||112
944249|NCT01350804|2282755|P3|COMPLETED|Core Study||91
944250|NCT01350804|2282756|P2|COMPLETED|Core Study||90
944251|NCT01350804|2282757|P1|COMPLETED|Core Study||97
944252|NCT01350804|2282754|P4|Full Analysis Set|Core Study||138
944253|NCT01350804|2282755|P3|Full Analysis Set|Core Study||138
944254|NCT01350804|2282756|P2|Full Analysis Set|Core Study||137
944255|NCT01350804|2282757|P1|Full Analysis Set|Core Study||138
944256|NCT01350804|2282754|P4|Treatment Switch to AIN457 at Week 24|Core Study||37
944257|NCT01350804|2282755|P3|Treatment Switch to AIN457 at Week 24|Core Study||45
944258|NCT01350804|2282756|P2|Treatment Switch to AIN457 at Week 24|Core Study||0
944259|NCT01350804|2282757|P1|Treatment Switch to AIN457 at Week 24|Core Study||0
944260|NCT01350804|2282754|P4|Tratment Switch to AIN457 at Week 16|Core Study||0
944261|NCT01350804|2282755|P3|Tratment Switch to AIN457 at Week 16|Core Study|15 participantsdiscontinued prior to the treatment switch|78
944262|NCT01350804|2282756|P2|Tratment Switch to AIN457 at Week 16|Core Study||0
944263|NCT01350804|2282757|P1|Tratment Switch to AIN457 at Week 16|Core Study||0
944264|NCT01350804|2282754|P4|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|137
944265|NCT01350804|2282755|P3|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|139
944266|NCT01350804|2282756|P2|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|136
944267|NCT01350804|2282757|P1|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|137
944268|NCT01350804|2282754|P4|STARTED|Core Study||138
944269|NCT01350804|2282755|P3|STARTED|Core Study||138
944270|NCT01350804|2282756|P2|STARTED|Core Study||137
944271|NCT01350804|2282757|P1|STARTED|Core Study||138
944272|NCT01350583|2282846|P1|NOT COMPLETED|Overall Study||0
944273|NCT01350583|2282846|P1|COMPLETED|Overall Study||2
944274|NCT01350583|2282846|P1|STARTED|Overall Study||2
944275|NCT01350544|2282854|P2|NOT COMPLETED|Overall Study||22
944276|NCT01350544|2282855|P1|NOT COMPLETED|Overall Study||23
944277|NCT01350544|2282854|P2|COMPLETED|Overall Study||86
944278|NCT01350544|2282855|P1|COMPLETED|Overall Study||85
944279|NCT01350544|2282854|P2|STARTED|Overall Study||108
944280|NCT01350544|2282855|P1|STARTED|Overall Study||108
944281|NCT01350479|2282863|P2|NOT COMPLETED|Overall Study||0
944282|NCT01350479|2282864|P1|NOT COMPLETED|Overall Study||0
944283|NCT01350479|2282863|P2|COMPLETED|Overall Study||106
944284|NCT01350479|2282864|P1|COMPLETED|Overall Study||94
944285|NCT01350479|2282863|P2|STARTED|Overall Study||106
944286|NCT01350479|2282864|P1|STARTED|Overall Study||94
944287|NCT01350414|2282870|P1|NOT COMPLETED|Overall Study||19
944288|NCT01350414|2282870|P1|COMPLETED|Overall Study||162
944289|NCT01350414|2282870|P1|Year 5|Overall Study||162
944290|NCT01350414|2282870|P1|Year 4|Overall Study||159
944291|NCT01350414|2282870|P1|Year 3|Overall Study||162
944292|NCT01350414|2282870|P1|Year 2|Overall Study||165
944293|NCT01350414|2282870|P1|STARTED|Overall Study||181
944294|NCT01350388|2282889|P2|NOT COMPLETED|Overall Study||1
944295|NCT01350388|2282890|P1|NOT COMPLETED|Overall Study||3
944296|NCT01350388|2282889|P2|COMPLETED|Overall Study||39
944297|NCT01350388|2282890|P1|COMPLETED|Overall Study||37
944298|NCT01350388|2282889|P2|STARTED|Overall Study||40
944299|NCT01350388|2282890|P1|STARTED|Overall Study||40
944300|NCT01350271|2282909|P3|NOT COMPLETED|Overall Study||26
944301|NCT01350271|2282910|P2|NOT COMPLETED|Overall Study||17
944302|NCT01350271|2282911|P1|NOT COMPLETED|Overall Study||21
944303|NCT01350271|2282909|P3|COMPLETED|Overall Study||48
944304|NCT01350271|2282910|P2|COMPLETED|Overall Study||53
944305|NCT01350271|2282911|P1|COMPLETED|Overall Study||49
944306|NCT01350271|2282909|P3|STARTED|Overall Study||74
944307|NCT01350271|2282910|P2|STARTED|Overall Study||70
944308|NCT01350271|2282911|P1|STARTED|Overall Study||70
944309|NCT01350258|2282925|P1|NOT COMPLETED|Overall Study||0
944310|NCT01350258|2282925|P1|COMPLETED|Overall Study||8
944311|NCT01350258|2282925|P1|STARTED|Overall Study||8
944312|NCT01350245|2282934|P1|NOT COMPLETED|Overall Study||0
944313|NCT01350245|2282934|P1|COMPLETED|Overall Study||28
944314|NCT01350245|2282934|P1|STARTED|Overall Study||28
944315|NCT01350232|2282939|P1|NOT COMPLETED|Overall Study||0
944316|NCT01350232|2282939|P1|COMPLETED|Overall Study||2
944317|NCT01350232|2282939|P1|STARTED|Overall Study||2
944318|NCT01350128|2282950|P1|NOT COMPLETED|Overall Study||14
944319|NCT01350128|2282950|P1|COMPLETED|Overall Study||89
944320|NCT01350128|2282950|P1|Atrovent HFA 34 µg BID|Overall Study||48
944321|NCT01350128|2282950|P1|Placebo MDI BID|Overall Study||48
944322|NCT01350128|2282950|P1|GP MDI 4.6 µg BID|Overall Study||45
944323|NCT01350128|2282950|P1|GP MDI 9 µg BID|Overall Study||49
944324|NCT01350128|2282950|P1|GP MDI 18 µg BID|Overall Study||49
944325|NCT01350128|2282950|P1|GP MDI 36 µg BID|Overall Study|Glycopyrronium Metered Dose Inhaler|49
944326|NCT01350128|2282950|P1|STARTED|Overall Study||103
944327|NCT01350115|2283014|P2|NOT COMPLETED|Long Term Follow-Up (All Patients)||2
944328|NCT01350115|2283015|P1|NOT COMPLETED|Long Term Follow-Up (All Patients)||1
944329|NCT01350115|2283014|P2|COMPLETED|Long Term Follow-Up (All Patients)||0
944330|NCT01350115|2283015|P1|COMPLETED|Long Term Follow-Up (All Patients)||7
944331|NCT01350115|2283014|P2|STARTED|Long Term Follow-Up (All Patients)||2
944332|NCT01350115|2283015|P1|STARTED|Long Term Follow-Up (All Patients)||8
944333|NCT01350115|2283014|P2|NOT COMPLETED|Core Study (All Patients)||0
944334|NCT01350115|2283015|P1|NOT COMPLETED|Core Study (All Patients)||0
944335|NCT01350115|2283014|P2|COMPLETED|Core Study (All Patients)||2
944336|NCT01350115|2283015|P1|COMPLETED|Core Study (All Patients)||8
944337|NCT01350115|2283014|P2|Pharmacodynamic Set|Core Study (All Patients)||2
944338|NCT01350115|2283015|P1|Pharmacodynamic Set|Core Study (All Patients)||7
944339|NCT01350115|2283014|P2|Safety Anlysis Set|Core Study (All Patients)||2
944340|NCT01350115|2283015|P1|Safety Anlysis Set|Core Study (All Patients)||8
944341|NCT01350115|2283014|P2|STARTED|Core Study (All Patients)||2
944342|NCT01350115|2283015|P1|STARTED|Core Study (All Patients)||8
944343|NCT01349972|2283029|P2|NOT COMPLETED|Overall Study||2
944344|NCT01349972|2283030|P1|NOT COMPLETED|Overall Study||5
944345|NCT01349972|2283029|P2|COMPLETED|Overall Study||56
944346|NCT01349972|2283030|P1|COMPLETED|Overall Study||109
944347|NCT01349972|2283029|P2|STARTED|Overall Study||58
944348|NCT01349972|2283030|P1|STARTED|Overall Study||114
944349|NCT01349959|2283046|P1|NOT COMPLETED|Overall Study||7
944350|NCT01349959|2283046|P1|COMPLETED|Overall Study||33
944351|NCT01349959|2283046|P1|STARTED|Overall Study|58 consented, 18 failed screening and did not receive study treatment|40
944352|NCT01349933|2283052|P1|NOT COMPLETED|Overall Study||0
944353|NCT01349933|2283052|P1|COMPLETED|Overall Study||21
944354|NCT01349933|2283052|P1|STARTED|Overall Study||21
944355|NCT01349920|2283057|P1|NOT COMPLETED|Overall Study||0
944356|NCT01349920|2283057|P1|COMPLETED|Overall Study||15
944357|NCT01349920|2283057|P1|STARTED|Overall Study||15
944358|NCT01349907|2283077|P2|NOT COMPLETED|Overall Study||43
944359|NCT01349907|2283078|P1|NOT COMPLETED|Overall Study||139
944360|NCT01349907|2283077|P2|COMPLETED|Overall Study||38
944361|NCT01349907|2283078|P1|COMPLETED|Overall Study||102
944362|NCT01349907|2283077|P2|STARTED|Overall Study|Enrolled and Treated|81
944363|NCT01349907|2283078|P1|STARTED|Overall Study|Enrolled and Treated|241
944364|NCT01349829|2283116|P2|NOT COMPLETED|Overall Study||23
944365|NCT01349829|2283117|P1|NOT COMPLETED|Overall Study||9
944366|NCT01349829|2283116|P2|COMPLETED|Overall Study||102
944367|NCT01349829|2283117|P1|COMPLETED|Overall Study||117
944368|NCT01349829|2283116|P2|STARTED|Overall Study||125
944369|NCT01349829|2283117|P1|STARTED|Overall Study||126
944370|NCT01349816|2283135|P1|NOT COMPLETED|Overall Study||30
944371|NCT01349816|2283135|P1|COMPLETED|Overall Study||155
944372|NCT01349816|2283135|P1|FF MDI 9.6 µg|Overall Study||61
944373|NCT01349816|2283135|P1|GFF MDI 9/9.6 µg|Overall Study||57
944374|NCT01349816|2283135|P1|GFF MDI 18/9.6 µg|Overall Study||57
944375|NCT01349816|2283135|P1|GFF MDI 36/9.6 µg|Overall Study||56
944376|NCT01349816|2283135|P1|GFF MDI 36/7.2 µg|Overall Study||58
944377|NCT01349816|2283135|P1|GP MDI 36 µg|Overall Study||61
944378|NCT01349816|2283135|P1|STARTED|Overall Study||185
944379|NCT01349803|2283201|P4|NOT COMPLETED|Overall Study||2
944380|NCT01349803|2283202|P3|NOT COMPLETED|Overall Study||3
944381|NCT01349803|2283203|P2|NOT COMPLETED|Overall Study||1
944382|NCT01349803|2283204|P1|NOT COMPLETED|Overall Study||1
944383|NCT01349803|2283201|P4|COMPLETED|Overall Study||57
944384|NCT01349803|2283202|P3|COMPLETED|Overall Study||57
944385|NCT01349803|2283203|P2|COMPLETED|Overall Study||57
944386|NCT01349803|2283204|P1|COMPLETED|Overall Study||59
944387|NCT01349803|2283201|P4|STARTED|Overall Study||59
944388|NCT01349803|2283202|P3|STARTED|Overall Study||60
944389|NCT01349803|2283203|P2|STARTED|Overall Study||58
944390|NCT01349803|2283204|P1|STARTED|Overall Study||60
944391|NCT01349790|2283274|P1|NOT COMPLETED|Overall Study||9
944392|NCT01349790|2283274|P1|COMPLETED|Overall Study||31
944393|NCT01349790|2283274|P1|STARTED|Overall Study||40
944394|NCT01349595|2283295|P2|NOT COMPLETED|Overall Study||2
944395|NCT01349595|2283296|P1|NOT COMPLETED|Overall Study||2
944396|NCT01349595|2283295|P2|COMPLETED|Overall Study||0
944397|NCT01349595|2283296|P1|COMPLETED|Overall Study||0
944398|NCT01349595|2283295|P2|STARTED|Overall Study||2
944399|NCT01349595|2283296|P1|STARTED|Overall Study||2
944400|NCT01349491|2283304|P2|NOT COMPLETED|Overall Study||0
944401|NCT01349491|2283305|P1|NOT COMPLETED|Overall Study||0
944402|NCT01349491|2283304|P2|COMPLETED|Overall Study||5
944403|NCT01349491|2283305|P1|COMPLETED|Overall Study||5
944404|NCT01349491|2283304|P2|STARTED|Overall Study||5
944405|NCT01349491|2283305|P1|STARTED|Overall Study||5
944406|NCT01349465|2283313|P2|NOT COMPLETED|Overall Study||22
944407|NCT01349465|2283314|P1|NOT COMPLETED|Overall Study||18
944408|NCT01349465|2283313|P2|COMPLETED|Overall Study||27
944409|NCT01349465|2283314|P1|COMPLETED|Overall Study||182
944410|NCT01349465|2283313|P2|STARTED|Overall Study||49
944411|NCT01349465|2283314|P1|STARTED|Overall Study||200
944412|NCT01349231|2283326|P1|NOT COMPLETED|Overall Study||0
944413|NCT01349231|2283326|P1|COMPLETED|Overall Study||10
944414|NCT01349231|2283326|P1|STARTED|Overall Study||10
944415|NCT01349192|2283335|P2|NOT COMPLETED|Overall Study||6
944416|NCT01349192|2283336|P1|NOT COMPLETED|Overall Study||3
944417|NCT01349192|2283335|P2|COMPLETED|Overall Study||17
944418|NCT01349192|2283336|P1|COMPLETED|Overall Study||21
944419|NCT01349192|2283335|P2|Withdrawals|Overall Study||6
944420|NCT01349192|2283336|P1|Withdrawals|Overall Study||3
944421|NCT01349192|2283335|P2|Evaluable for Primary Endpoint|Overall Study||19
944422|NCT01349192|2283336|P1|Evaluable for Primary Endpoint|Overall Study||22
944423|NCT01349192|2283335|P2|STARTED|Overall Study||23
944424|NCT01349192|2283336|P1|STARTED|Overall Study||24
944425|NCT01349114|2283350|P2|NOT COMPLETED|Overall Study||0
944426|NCT01349114|2283351|P1|NOT COMPLETED|Overall Study||0
944427|NCT01349114|2283350|P2|COMPLETED|Overall Study||11
944428|NCT01349114|2283351|P1|COMPLETED|Overall Study||10
944429|NCT01349114|2283350|P2|STARTED|Overall Study||11
944430|NCT01349114|2283351|P1|STARTED|Overall Study||10
944431|NCT01348854|2283361|P2|NOT COMPLETED|Overall Study||1
944432|NCT01348854|2283362|P1|NOT COMPLETED|Overall Study||3
944433|NCT01348854|2283361|P2|COMPLETED|Overall Study|9 eyes of 5 participants|5
944434|NCT01348854|2283362|P1|COMPLETED|Overall Study|47 eyes of 31 participants|31
944435|NCT01348854|2283361|P2|STARTED|Overall Study|10 eyes of 6 participants|6
944436|NCT01348854|2283362|P1|STARTED|Overall Study|53 eyes of 34 participants|34
944437|NCT01348789|2283370|P1|NOT COMPLETED|Overall Study||4
944438|NCT01348789|2283370|P1|COMPLETED|Overall Study|4 subjects did not complete all 3 treatments but were evaluated for primary and secondary endpoints.|33
944439|NCT01348789|2283370|P1|STARTED|Overall Study||37
944440|NCT01348776|2283381|P1|NOT COMPLETED|Overall Study||3
944441|NCT01348776|2283381|P1|COMPLETED|Overall Study||84
944442|NCT01348776|2283381|P1|STARTED|Overall Study|3 subjects were lost to follow-up: 2 after the 1-month follow-up, 1 after performing 4 treatments|87
944443|NCT01348607|2283397|P3|NOT COMPLETED|Overall Study||0
944444|NCT01348607|2283398|P2|NOT COMPLETED|Overall Study||0
944445|NCT01348607|2283399|P1|NOT COMPLETED|Overall Study||0
944446|NCT01348607|2283397|P3|COMPLETED|Overall Study||0
944447|NCT01348607|2283398|P2|COMPLETED|Overall Study||0
944448|NCT01348607|2283399|P1|COMPLETED|Overall Study||1
944449|NCT01348607|2283397|P3|STARTED|Overall Study||0
944450|NCT01348607|2283398|P2|STARTED|Overall Study||0
944451|NCT01348607|2283399|P1|STARTED|Overall Study||1
944452|NCT01348425|2283412|P2|NOT COMPLETED|Overall Study||1
944453|NCT01348425|2283413|P1|NOT COMPLETED|Overall Study||1
944454|NCT01348425|2283412|P2|COMPLETED|Overall Study||13
944455|NCT01348425|2283413|P1|COMPLETED|Overall Study||30
944456|NCT01348425|2283412|P2|STARTED|Overall Study||14
944457|NCT01348425|2283413|P1|STARTED|Overall Study||31
944458|NCT01348165|2283425|P7|NOT COMPLETED|Overall Study||1
944459|NCT01348165|2283426|P6|NOT COMPLETED|Overall Study||0
944460|NCT01348165|2283427|P5|NOT COMPLETED|Overall Study||0
944461|NCT01348165|2283428|P4|NOT COMPLETED|Overall Study||0
944462|NCT01348165|2283429|P3|NOT COMPLETED|Overall Study||0
944463|NCT01348165|2283430|P2|NOT COMPLETED|Overall Study||0
944464|NCT01348165|2283431|P1|NOT COMPLETED|Overall Study||0
944465|NCT01348165|2283425|P7|COMPLETED|Overall Study||5
944466|NCT01348165|2283426|P6|COMPLETED|Overall Study||1
944467|NCT01348165|2283427|P5|COMPLETED|Overall Study||6
944468|NCT01348165|2283428|P4|COMPLETED|Overall Study||6
944469|NCT01348165|2283429|P3|COMPLETED|Overall Study||6
944470|NCT01348165|2283430|P2|COMPLETED|Overall Study||5
944471|NCT01348165|2283431|P1|COMPLETED|Overall Study||10
944472|NCT01348165|2283425|P7|STARTED|Overall Study||6
944473|NCT01348165|2283426|P6|STARTED|Overall Study||1
944474|NCT01348165|2283427|P5|STARTED|Overall Study||6
944475|NCT01348165|2283428|P4|STARTED|Overall Study||6
944476|NCT01348165|2283429|P3|STARTED|Overall Study||6
944477|NCT01348165|2283430|P2|STARTED|Overall Study||5
944478|NCT01348165|2283431|P1|STARTED|Overall Study||10
944479|NCT01348139|2283560|P6|NOT COMPLETED|Period 6||0
944480|NCT01348139|2283561|P5|NOT COMPLETED|Period 6||0
944481|NCT01348139|2283562|P4|NOT COMPLETED|Period 6||0
944482|NCT01348139|2283563|P3|NOT COMPLETED|Period 6||0
944483|NCT01348139|2283564|P2|NOT COMPLETED|Period 6||0
944484|NCT01348139|2283565|P1|NOT COMPLETED|Period 6||0
944485|NCT01348139|2283560|P6|COMPLETED|Period 6||4
944486|NCT01348139|2283561|P5|COMPLETED|Period 6||5
944487|NCT01348139|2283562|P4|COMPLETED|Period 6||4
944488|NCT01348139|2283563|P3|COMPLETED|Period 6||4
944489|NCT01348139|2283564|P2|COMPLETED|Period 6||4
944490|NCT01348139|2283565|P1|COMPLETED|Period 6||4
944491|NCT01348139|2283560|P6|STARTED|Period 6||4
944492|NCT01348139|2283561|P5|STARTED|Period 6||5
944493|NCT01348139|2283562|P4|STARTED|Period 6||4
944494|NCT01348139|2283563|P3|STARTED|Period 6||4
944495|NCT01348139|2283564|P2|STARTED|Period 6||4
944496|NCT01348139|2283565|P1|STARTED|Period 6||4
944497|NCT01348139|2283560|P6|NOT COMPLETED|Period 5||0
944498|NCT01348139|2283561|P5|NOT COMPLETED|Period 5||0
944499|NCT01348139|2283562|P4|NOT COMPLETED|Period 5||0
944500|NCT01348139|2283563|P3|NOT COMPLETED|Period 5||0
944501|NCT01348139|2283564|P2|NOT COMPLETED|Period 5||0
944502|NCT01348139|2283565|P1|NOT COMPLETED|Period 5||0
944503|NCT01348139|2283560|P6|COMPLETED|Period 5||4
944504|NCT01348139|2283561|P5|COMPLETED|Period 5||5
944505|NCT01348139|2283562|P4|COMPLETED|Period 5||4
944506|NCT01348139|2283563|P3|COMPLETED|Period 5||4
944507|NCT01348139|2283564|P2|COMPLETED|Period 5||4
944508|NCT01348139|2283565|P1|COMPLETED|Period 5||4
944509|NCT01348139|2283560|P6|STARTED|Period 5||4
944510|NCT01348139|2283561|P5|STARTED|Period 5||5
944511|NCT01348139|2283562|P4|STARTED|Period 5||4
944512|NCT01348139|2283563|P3|STARTED|Period 5||4
944513|NCT01348139|2283564|P2|STARTED|Period 5||4
944514|NCT01348139|2283565|P1|STARTED|Period 5||4
944515|NCT01348139|2283560|P6|NOT COMPLETED|Period 4||0
944516|NCT01348139|2283561|P5|NOT COMPLETED|Period 4||0
944517|NCT01348139|2283562|P4|NOT COMPLETED|Period 4||0
944518|NCT01348139|2283563|P3|NOT COMPLETED|Period 4||0
944519|NCT01348139|2283564|P2|NOT COMPLETED|Period 4||0
944520|NCT01348139|2283565|P1|NOT COMPLETED|Period 4||0
944521|NCT01348139|2283560|P6|COMPLETED|Period 4||4
944522|NCT01348139|2283561|P5|COMPLETED|Period 4||5
944523|NCT01348139|2283562|P4|COMPLETED|Period 4||4
944524|NCT01348139|2283563|P3|COMPLETED|Period 4||4
944525|NCT01348139|2283564|P2|COMPLETED|Period 4||4
944526|NCT01348139|2283565|P1|COMPLETED|Period 4||4
944527|NCT01348139|2283560|P6|STARTED|Period 4||4
944528|NCT01348139|2283561|P5|STARTED|Period 4||5
944529|NCT01348139|2283562|P4|STARTED|Period 4||4
944530|NCT01348139|2283563|P3|STARTED|Period 4||4
944531|NCT01348139|2283564|P2|STARTED|Period 4||4
944532|NCT01348139|2283565|P1|STARTED|Period 4||4
944533|NCT01348139|2283560|P6|NOT COMPLETED|Period 3||0
944534|NCT01348139|2283561|P5|NOT COMPLETED|Period 3||0
944535|NCT01348139|2283562|P4|NOT COMPLETED|Period 3||0
944536|NCT01348139|2283563|P3|NOT COMPLETED|Period 3||0
944537|NCT01348139|2283564|P2|NOT COMPLETED|Period 3||0
944538|NCT01348139|2283565|P1|NOT COMPLETED|Period 3||0
944539|NCT01348139|2283560|P6|COMPLETED|Period 3||4
944540|NCT01348139|2283561|P5|COMPLETED|Period 3||5
944541|NCT01348139|2283562|P4|COMPLETED|Period 3||4
944542|NCT01348139|2283563|P3|COMPLETED|Period 3||4
944543|NCT01348139|2283564|P2|COMPLETED|Period 3||4
944544|NCT01348139|2283565|P1|COMPLETED|Period 3||4
944545|NCT01348139|2283560|P6|STARTED|Period 3||4
944546|NCT01348139|2283561|P5|STARTED|Period 3||5
944547|NCT01348139|2283562|P4|STARTED|Period 3||4
944548|NCT01348139|2283563|P3|STARTED|Period 3||4
944549|NCT01348139|2283564|P2|STARTED|Period 3||4
944550|NCT01348139|2283565|P1|STARTED|Period 3||4
944551|NCT01348139|2283560|P6|NOT COMPLETED|Period 2||0
944552|NCT01348139|2283561|P5|NOT COMPLETED|Period 2||0
944553|NCT01348139|2283562|P4|NOT COMPLETED|Period 2||0
944554|NCT01348139|2283563|P3|NOT COMPLETED|Period 2||0
944555|NCT01348139|2283564|P2|NOT COMPLETED|Period 2||0
944556|NCT01348139|2283565|P1|NOT COMPLETED|Period 2||0
944557|NCT01348139|2283560|P6|COMPLETED|Period 2||4
944558|NCT01348139|2283561|P5|COMPLETED|Period 2||5
944559|NCT01348139|2283562|P4|COMPLETED|Period 2||4
944560|NCT01348139|2283563|P3|COMPLETED|Period 2||4
944561|NCT01348139|2283564|P2|COMPLETED|Period 2||4
944562|NCT01348139|2283565|P1|COMPLETED|Period 2||4
944563|NCT01348139|2283560|P6|STARTED|Period 2||4
944564|NCT01348139|2283561|P5|STARTED|Period 2||5
944565|NCT01348139|2283562|P4|STARTED|Period 2||4
944566|NCT01348139|2283563|P3|STARTED|Period 2||4
944567|NCT01348139|2283564|P2|STARTED|Period 2||4
944568|NCT01348139|2283565|P1|STARTED|Period 2||4
944569|NCT01348139|2283560|P6|NOT COMPLETED|Period 1||0
944570|NCT01348139|2283561|P5|NOT COMPLETED|Period 1||0
944571|NCT01348139|2283562|P4|NOT COMPLETED|Period 1||0
944572|NCT01348139|2283563|P3|NOT COMPLETED|Period 1||0
944573|NCT01348139|2283564|P2|NOT COMPLETED|Period 1||0
944574|NCT01348139|2283565|P1|NOT COMPLETED|Period 1||1
944575|NCT01348139|2283560|P6|COMPLETED|Period 1||4
944576|NCT01348139|2283561|P5|COMPLETED|Period 1||5
944577|NCT01348139|2283562|P4|COMPLETED|Period 1||4
944578|NCT01348139|2283563|P3|COMPLETED|Period 1||4
944579|NCT01348139|2283564|P2|COMPLETED|Period 1||4
944580|NCT01348139|2283565|P1|COMPLETED|Period 1||4
944581|NCT01348139|2283560|P6|STARTED|Period 1||4
944582|NCT01348139|2283561|P5|STARTED|Period 1||5
944583|NCT01348139|2283562|P4|STARTED|Period 1||4
944584|NCT01348139|2283563|P3|STARTED|Period 1||4
944585|NCT01348139|2283564|P2|STARTED|Period 1||4
944586|NCT01348139|2283565|P1|STARTED|Period 1||5
944587|NCT01348100|2283646|P7|NOT COMPLETED|Overall Study||3
944588|NCT01348100|2283647|P6|NOT COMPLETED|Overall Study||2
944589|NCT01348100|2283648|P5|NOT COMPLETED|Overall Study||1
944590|NCT01348100|2283649|P4|NOT COMPLETED|Overall Study||1
944591|NCT01348100|2283650|P3|NOT COMPLETED|Overall Study||2
944592|NCT01348100|2283651|P2|NOT COMPLETED|Overall Study||0
944593|NCT01348100|2283652|P1|NOT COMPLETED|Overall Study||0
944594|NCT01348100|2283646|P7|COMPLETED|Overall Study||13
944595|NCT01348100|2283647|P6|COMPLETED|Overall Study||14
944596|NCT01348100|2283648|P5|COMPLETED|Overall Study||14
944597|NCT01348100|2283649|P4|COMPLETED|Overall Study||14
944598|NCT01348100|2283650|P3|COMPLETED|Overall Study||13
944599|NCT01348100|2283651|P2|COMPLETED|Overall Study||2
944600|NCT01348100|2283652|P1|COMPLETED|Overall Study||2
944601|NCT01348100|2283646|P7|STARTED|Overall Study||16
944602|NCT01348100|2283647|P6|STARTED|Overall Study||16
944603|NCT01348100|2283648|P5|STARTED|Overall Study||15
944604|NCT01348100|2283649|P4|STARTED|Overall Study||15
944605|NCT01348100|2283650|P3|STARTED|Overall Study||15
944606|NCT01348100|2283651|P2|STARTED|Overall Study||2
944607|NCT01348100|2283652|P1|STARTED|Overall Study||2
944608|NCT01348087|2283697|P1|NOT COMPLETED|Overall Study||148
944609|NCT01348087|2283697|P1|COMPLETED|Overall Study||0
944610|NCT01348087|2283697|P1|STARTED|Overall Study||148
944611|NCT01347931|2283711|P1|NOT COMPLETED|NIOV System||0
944612|NCT01347931|2283711|P1|COMPLETED|NIOV System||29
944613|NCT01347931|2283711|P1|STARTED|NIOV System||29
944614|NCT01347931|2283711|P1|NOT COMPLETED|Standard Oxygen Therapy||1
944615|NCT01347931|2283711|P1|COMPLETED|Standard Oxygen Therapy||29
944616|NCT01347931|2283711|P1|STARTED|Standard Oxygen Therapy||30
944617|NCT01347879|2283723|P2|NOT COMPLETED|Overall Study||17
944618|NCT01347879|2283724|P1|NOT COMPLETED|Overall Study||7
944619|NCT01347879|2283723|P2|COMPLETED|Overall Study||83
944620|NCT01347879|2283724|P1|COMPLETED|Overall Study||46
944621|NCT01347879|2283723|P2|STARTED|Overall Study||100
944622|NCT01347879|2283724|P1|STARTED|Overall Study||53
944623|NCT01347840|2283756|P1|NOT COMPLETED|Overall Study||1
944624|NCT01347840|2283756|P1|COMPLETED|Overall Study||0
944625|NCT01347840|2283756|P1|STARTED|Overall Study|1 subject enrolled but withdrew consent|1
944626|NCT00000125|2283771|P2|NOT COMPLETED|Overall Study||238
944627|NCT00000125|2283772|P1|NOT COMPLETED|Overall Study||239
944628|NCT00000125|2283771|P2|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|579
944629|NCT00000125|2283772|P1|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|580
944630|NCT00000125|2283771|P2|Completed OHTS Phase I, June 2002|Overall Study||702
944631|NCT00000125|2283772|P1|Completed OHTS Phase I, June 2002|Overall Study||706
944632|NCT00000125|2283771|P2|STARTED|Overall Study||817
944633|NCT00000125|2283772|P1|STARTED|Overall Study||819
944634|NCT00000134|2283781|P3|NOT COMPLETED|Overall Study||0
944635|NCT00000134|2283782|P2|NOT COMPLETED|Overall Study||0
944636|NCT00000134|2283783|P1|NOT COMPLETED|Overall Study||0
944637|NCT00000134|2283781|P3|COMPLETED|Overall Study||96
944638|NCT00000134|2283782|P2|COMPLETED|Overall Study||94
944639|NCT00000134|2283783|P1|COMPLETED|Overall Study||89
944640|NCT00000134|2283781|P3|STARTED|Overall Study||96
944641|NCT00000134|2283782|P2|STARTED|Overall Study||94
944642|NCT00000134|2283783|P1|STARTED|Overall Study||89
944643|NCT00000135|2283793|P2|NOT COMPLETED|Overall Study||14
944644|NCT00000135|2283794|P1|NOT COMPLETED|Overall Study||27
944645|NCT00000135|2283793|P2|COMPLETED|Overall Study||91
944646|NCT00000135|2283794|P1|COMPLETED|Overall Study||77
944647|NCT00000135|2283793|P2|STARTED|Overall Study||105
944648|NCT00000135|2283794|P1|STARTED|Overall Study||104
944649|NCT00000136|2283802|P2|NOT COMPLETED|Overall Study||0
944650|NCT00000136|2283803|P1|NOT COMPLETED|Overall Study||0
944651|NCT00000136|2283802|P2|COMPLETED|Overall Study||127
944652|NCT00000136|2283803|P1|COMPLETED|Overall Study||107
944653|NCT00000136|2283802|P2|STARTED|Overall Study||127
944654|NCT00000136|2283803|P1|STARTED|Overall Study||107
944655|NCT00000142|2283812|P3|NOT COMPLETED|Overall Study||0
944656|NCT00000142|2283813|P2|NOT COMPLETED|Overall Study||0
944657|NCT00000142|2283814|P1|NOT COMPLETED|Overall Study||0
944658|NCT00000142|2283812|P3|COMPLETED|Overall Study||12
944659|NCT00000142|2283813|P2|COMPLETED|Overall Study||26
944660|NCT00000142|2283814|P1|COMPLETED|Overall Study||26
944661|NCT00000142|2283812|P3|STARTED|Overall Study||12
944662|NCT00000142|2283813|P2|STARTED|Overall Study||26
944663|NCT00000142|2283814|P1|STARTED|Overall Study||26
944664|NCT00000143|2283824|P2|NOT COMPLETED|Overall Study||0
944665|NCT00000143|2283825|P1|NOT COMPLETED|Overall Study||0
944666|NCT00000143|2283824|P2|COMPLETED|Overall Study||30
944667|NCT00000143|2283825|P1|COMPLETED|Overall Study||31
944668|NCT00000143|2283824|P2|STARTED|Overall Study||30
944669|NCT00000143|2283825|P1|STARTED|Overall Study||31
944670|NCT00000371|2283833|P2|NOT COMPLETED|Overall Study||16
944671|NCT00000371|2283834|P1|NOT COMPLETED|Overall Study||13
944672|NCT00000371|2283833|P2|COMPLETED|Overall Study||12
944673|NCT00000371|2283834|P1|COMPLETED|Overall Study||14
944674|NCT00000371|2283833|P2|STARTED|Overall Study||28
944675|NCT00000371|2283834|P1|STARTED|Overall Study||27
944676|NCT00000378|2283842|P2|NOT COMPLETED|Overall Study||14
944677|NCT00000378|2283843|P1|NOT COMPLETED|Overall Study||16
944678|NCT00000378|2283842|P2|COMPLETED|Overall Study||38
944679|NCT00000378|2283843|P1|COMPLETED|Overall Study||42
944680|NCT00000378|2283842|P2|STARTED|Overall Study||52
944681|NCT00000378|2283843|P1|STARTED|Overall Study||58
944682|NCT00000392|2283851|P2|NOT COMPLETED|Overall Study||32
944683|NCT00000392|2283852|P1|NOT COMPLETED|Overall Study||40
944684|NCT00000392|2283851|P2|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|77
944685|NCT00000392|2283852|P1|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|66
944686|NCT00000392|2283851|P2|STARTED|Overall Study||109
944687|NCT00000392|2283852|P1|STARTED|Overall Study||106
944688|NCT00000479|2283864|P4|NOT COMPLETED|Overall Study||0
944689|NCT00000479|2283865|P3|NOT COMPLETED|Overall Study||0
944690|NCT00000479|2283866|P2|NOT COMPLETED|Overall Study||0
944691|NCT00000479|2283867|P1|NOT COMPLETED|Overall Study||0
944692|NCT00000479|2283864|P4|COMPLETED|Overall Study||9971
944693|NCT00000479|2283865|P3|COMPLETED|Overall Study||9966
944694|NCT00000479|2283866|P2|COMPLETED|Overall Study||9971
944695|NCT00000479|2283867|P1|COMPLETED|Overall Study||9968
944696|NCT00000479|2283864|P4|STARTED|Overall Study||9971
944697|NCT00000479|2283865|P3|STARTED|Overall Study||9966
944698|NCT00000479|2283866|P2|STARTED|Overall Study||9971
944699|NCT00000479|2283867|P1|STARTED|Overall Study||9968
944700|NCT00000575|2283884|P3|NOT COMPLETED|Overall Study||0
944701|NCT00000575|2283885|P2|NOT COMPLETED|Overall Study||0
944702|NCT00000575|2283886|P1|NOT COMPLETED|Overall Study||0
944703|NCT00000575|2283884|P3|COMPLETED|Overall Study||418
944704|NCT00000575|2283885|P2|COMPLETED|Overall Study||312
944705|NCT00000575|2283886|P1|COMPLETED|Overall Study||311
944706|NCT00000575|2283884|P3|STARTED|Overall Study||418
944707|NCT00000575|2283885|P2|STARTED|Overall Study||312
944708|NCT00000575|2283886|P1|STARTED|Overall Study||311
944709|NCT00000620|2283914|P8|NOT COMPLETED|Overall Study||146
944710|NCT00000620|2283915|P7|NOT COMPLETED|Overall Study||149
944711|NCT00000620|2283916|P6|NOT COMPLETED|Overall Study||152
944712|NCT00000620|2283917|P5|NOT COMPLETED|Overall Study||135
944713|NCT00000620|2283918|P4|NOT COMPLETED|Overall Study||178
944714|NCT00000620|2283919|P3|NOT COMPLETED|Overall Study||170
944715|NCT00000620|2283920|P2|NOT COMPLETED|Overall Study||136
944716|NCT00000620|2283921|P1|NOT COMPLETED|Overall Study||162
944717|NCT00000620|2283914|P8|COMPLETED|Overall Study||1224
944718|NCT00000620|2283915|P7|COMPLETED|Overall Study||1242
944719|NCT00000620|2283916|P6|COMPLETED|Overall Study||1026
944720|NCT00000620|2283917|P5|COMPLETED|Overall Study||1049
944721|NCT00000620|2283918|P4|COMPLETED|Overall Study||1205
944722|NCT00000620|2283919|P3|COMPLETED|Overall Study||1204
944723|NCT00000620|2283920|P2|COMPLETED|Overall Study||1057
944724|NCT00000620|2283921|P1|COMPLETED|Overall Study||1016
944725|NCT00000620|2283914|P8|STARTED|Overall Study||1370
944726|NCT00000620|2283915|P7|STARTED|Overall Study||1391
944727|NCT00000620|2283916|P6|STARTED|Overall Study||1178
944728|NCT00000620|2283917|P5|STARTED|Overall Study||1184
944729|NCT00000620|2283918|P4|STARTED|Overall Study||1383
944730|NCT00000620|2283919|P3|STARTED|Overall Study||1374
944731|NCT00000620|2283920|P2|STARTED|Overall Study||1193
944732|NCT00000620|2283921|P1|STARTED|Overall Study||1178
944733|NCT00001151|2283937|P1|NOT COMPLETED|Overall Study||5
944734|NCT00001151|2283937|P1|COMPLETED|Overall Study||1
944735|NCT00001151|2283937|P1|STARTED|Overall Study||6
944736|NCT00001566|2283941|P1|NOT COMPLETED|Overall Study||19
944737|NCT00001566|2283941|P1|COMPLETED|Overall Study||23
944738|NCT00001566|2283941|P1|Completed Immunotherapy|Overall Study||23
944739|NCT00001566|2283941|P1|STARTED|Overall Study||42
944740|NCT00001575|2283953|P1|NOT COMPLETED|Overall Study||45
944741|NCT00001575|2283953|P1|COMPLETED|Overall Study||42
944742|NCT00001575|2283953|P1|Treated|Overall Study||65
944743|NCT00001575|2283953|P1|STARTED|Overall Study||87
944744|NCT00001586|2283961|P2|NOT COMPLETED|Overall Study||0
944745|NCT00001586|2283962|P1|NOT COMPLETED|Overall Study||0
944746|NCT00001586|2283961|P2|COMPLETED|Overall Study||56
944747|NCT00001586|2283962|P1|COMPLETED|Overall Study||49
944748|NCT00001586|2283961|P2|STARTED|Overall Study||56
944749|NCT00001586|2283962|P1|STARTED|Overall Study||49
944756|NCT00001656|2283995|P2|NOT COMPLETED|Overall Study||0
944757|NCT00001656|2283996|P1|NOT COMPLETED|Overall Study||1
944758|NCT00001656|2283995|P2|COMPLETED|Overall Study||12
944759|NCT00001656|2283996|P1|COMPLETED|Overall Study||12
944760|NCT00001656|2283995|P2|STARTED|Overall Study||12
944761|NCT00001656|2283996|P1|STARTED|Overall Study||13
944762|NCT00001703|2284024|P1|NOT COMPLETED|Overall Study||5
944763|NCT00001703|2284024|P1|COMPLETED|Overall Study||1
944764|NCT00001703|2284024|P1|Peptide Stock Completed|Overall Study|off therapy reason for 3 patients|3
944765|NCT00001703|2284024|P1|STARTED|Overall Study||6
944766|NCT00001723|2284031|P2|NOT COMPLETED|Overall Study||16
944767|NCT00001723|2284032|P1|NOT COMPLETED|Overall Study||13
944768|NCT00001723|2284031|P2|COMPLETED|Overall Study||84
944769|NCT00001723|2284032|P1|COMPLETED|Overall Study||87
944770|NCT00001723|2284031|P2|STARTED|Overall Study||100
944771|NCT00001723|2284032|P1|STARTED|Overall Study||100
944772|NCT00001941|2284048|P5|NOT COMPLETED|Overall Study||1
944773|NCT00001941|2284049|P4|NOT COMPLETED|Overall Study||0
944774|NCT00001941|2284050|P3|NOT COMPLETED|Overall Study||0
944775|NCT00001941|2284051|P2|NOT COMPLETED|Overall Study||0
944776|NCT00001941|2284052|P1|NOT COMPLETED|Overall Study||0
944777|NCT00001941|2284048|P5|COMPLETED|Overall Study||19
944778|NCT00001941|2284049|P4|COMPLETED|Overall Study||3
944779|NCT00001941|2284050|P3|COMPLETED|Overall Study||3
944780|NCT00001941|2284051|P2|COMPLETED|Overall Study||5
944781|NCT00001941|2284052|P1|COMPLETED|Overall Study||3
944782|NCT00001941|2284048|P5|STARTED|Overall Study||20
944783|NCT00001941|2284049|P4|STARTED|Overall Study||3
944784|NCT00001941|2284050|P3|STARTED|Overall Study||3
944785|NCT00001941|2284051|P2|STARTED|Overall Study||5
944786|NCT00001941|2284052|P1|STARTED|Overall Study||3
944787|NCT00001959|2284059|P1|NOT COMPLETED|Overall Study||3
944788|NCT00001959|2284059|P1|COMPLETED|Overall Study||18
944789|NCT00001959|2284059|P1|STARTED|Overall Study||21
944790|NCT00001962|2284065|P1|NOT COMPLETED|Overall Study||28
944791|NCT00001962|2284065|P1|COMPLETED|Overall Study||72
944792|NCT00001962|2284065|P1|STARTED|Overall Study||100
944793|NCT00001984|2284069|P1|NOT COMPLETED|Overall Study||0
944794|NCT00001984|2284069|P1|COMPLETED|Overall Study||5
944795|NCT00001984|2284069|P1|STARTED|Overall Study||5
944796|NCT00001262|2284082|P3|NOT COMPLETED|Overall Study||0
944797|NCT00001262|2284083|P2|NOT COMPLETED|Overall Study||14
944798|NCT00001262|2284084|P1|NOT COMPLETED|Overall Study||10
944799|NCT00001262|2284082|P3|COMPLETED|Overall Study||3
944800|NCT00001262|2284083|P2|COMPLETED|Overall Study||8
944801|NCT00001262|2284084|P1|COMPLETED|Overall Study||25
944802|NCT00001262|2284082|P3|STARTED|Overall Study||3
944803|NCT00001262|2284083|P2|STARTED|Overall Study||22
944804|NCT00001262|2284084|P1|STARTED|Overall Study||35
944805|NCT00001304|2284112|P2|NOT COMPLETED|Overall Study||0
944806|NCT00001304|2284113|P1|NOT COMPLETED|Overall Study||0
944807|NCT00001304|2284112|P2|COMPLETED|Overall Study||14
944808|NCT00001304|2284113|P1|COMPLETED|Overall Study||13
944809|NCT00001304|2284112|P2|STARTED|Overall Study||14
944810|NCT00001304|2284113|P1|STARTED|Overall Study||13
944811|NCT00001213|2284131|P1|NOT COMPLETED|Overall Study||18
944812|NCT00001213|2284131|P1|COMPLETED|Overall Study||310
944813|NCT00001213|2284131|P1|STARTED|Overall Study||328
944814|NCT00001832|2284150|P15|NOT COMPLETED|Treatment Period||0
944815|NCT00001832|2284151|P14|NOT COMPLETED|Treatment Period||0
944816|NCT00001832|2284152|P13|NOT COMPLETED|Treatment Period||0
944817|NCT00001832|2284153|P12|NOT COMPLETED|Treatment Period||0
944818|NCT00001832|2284154|P11|NOT COMPLETED|Treatment Period||0
944819|NCT00001832|2284155|P10|NOT COMPLETED|Treatment Period||0
944820|NCT00001832|2284156|P9|NOT COMPLETED|Treatment Period||0
944821|NCT00001832|2284157|P8|NOT COMPLETED|Treatment Period||1
944822|NCT00001832|2284158|P7|NOT COMPLETED|Treatment Period||0
944823|NCT00001832|2284159|P6|NOT COMPLETED|Treatment Period||1
944824|NCT00001832|2284160|P5|NOT COMPLETED|Treatment Period||0
944825|NCT00001832|2284161|P4|NOT COMPLETED|Treatment Period||0
944826|NCT00001832|2284162|P3|NOT COMPLETED|Treatment Period||0
944827|NCT00001832|2284163|P2|NOT COMPLETED|Treatment Period||0
944828|NCT00001832|2284164|P1|NOT COMPLETED|Treatment Period||0
944829|NCT00001832|2284150|P15|COMPLETED|Treatment Period||2
944830|NCT00001832|2284151|P14|COMPLETED|Treatment Period||3
944831|NCT00001832|2284152|P13|COMPLETED|Treatment Period||6
944832|NCT00001832|2284153|P12|COMPLETED|Treatment Period||7
944833|NCT00001832|2284154|P11|COMPLETED|Treatment Period||1
944834|NCT00001832|2284155|P10|COMPLETED|Treatment Period||6
944835|NCT00001832|2284156|P9|COMPLETED|Treatment Period||8
944836|NCT00001832|2284157|P8|COMPLETED|Treatment Period||6
944837|NCT00001832|2284158|P7|COMPLETED|Treatment Period||4
944838|NCT00001832|2284159|P6|COMPLETED|Treatment Period||50
944839|NCT00001832|2284160|P5|COMPLETED|Treatment Period||6
944840|NCT00001832|2284161|P4|COMPLETED|Treatment Period||3
944841|NCT00001832|2284162|P3|COMPLETED|Treatment Period||3
944842|NCT00001832|2284163|P2|COMPLETED|Treatment Period||3
944843|NCT00001832|2284164|P1|COMPLETED|Treatment Period||0
944844|NCT00001832|2284150|P15|STARTED|Treatment Period||2
944845|NCT00001832|2284151|P14|STARTED|Treatment Period||3
944846|NCT00001832|2284152|P13|STARTED|Treatment Period||6
944847|NCT00001832|2284153|P12|STARTED|Treatment Period||7
944848|NCT00001832|2284154|P11|STARTED|Treatment Period||1
944849|NCT00001832|2284155|P10|STARTED|Treatment Period||6
944850|NCT00001832|2284156|P9|STARTED|Treatment Period||8
944851|NCT00001832|2284157|P8|STARTED|Treatment Period||7
944852|NCT00001832|2284158|P7|STARTED|Treatment Period||4
944853|NCT00001832|2284159|P6|STARTED|Treatment Period||51
944854|NCT00001832|2284160|P5|STARTED|Treatment Period||6
944855|NCT00001832|2284161|P4|STARTED|Treatment Period||3
944856|NCT00001832|2284162|P3|STARTED|Treatment Period||3
944857|NCT00001832|2284163|P2|STARTED|Treatment Period||3
944858|NCT00001832|2284164|P1|STARTED|Treatment Period||0
944859|NCT00001832|2284150|P15|NOT COMPLETED|Apheresis Period||0
944860|NCT00001832|2284151|P14|NOT COMPLETED|Apheresis Period||0
944861|NCT00001832|2284152|P13|NOT COMPLETED|Apheresis Period||0
944862|NCT00001832|2284153|P12|NOT COMPLETED|Apheresis Period||0
944863|NCT00001832|2284154|P11|NOT COMPLETED|Apheresis Period||0
944864|NCT00001832|2284155|P10|NOT COMPLETED|Apheresis Period||0
944865|NCT00001832|2284156|P9|NOT COMPLETED|Apheresis Period||0
944866|NCT00001832|2284157|P8|NOT COMPLETED|Apheresis Period||0
944867|NCT00001832|2284158|P7|NOT COMPLETED|Apheresis Period||0
944868|NCT00001832|2284159|P6|NOT COMPLETED|Apheresis Period||0
944869|NCT00001832|2284160|P5|NOT COMPLETED|Apheresis Period||0
944870|NCT00001832|2284161|P4|NOT COMPLETED|Apheresis Period||0
944871|NCT00001832|2284162|P3|NOT COMPLETED|Apheresis Period||0
944872|NCT00001832|2284163|P2|NOT COMPLETED|Apheresis Period||0
944873|NCT00001832|2284164|P1|NOT COMPLETED|Apheresis Period||60
944874|NCT00001832|2284150|P15|COMPLETED|Apheresis Period||0
944875|NCT00001832|2284151|P14|COMPLETED|Apheresis Period||0
944876|NCT00001832|2284152|P13|COMPLETED|Apheresis Period||0
944877|NCT00001832|2284153|P12|COMPLETED|Apheresis Period||0
944878|NCT00001832|2284154|P11|COMPLETED|Apheresis Period||0
944879|NCT00001832|2284155|P10|COMPLETED|Apheresis Period||0
944880|NCT00001832|2284156|P9|COMPLETED|Apheresis Period||0
944881|NCT00001832|2284157|P8|COMPLETED|Apheresis Period||0
944882|NCT00001832|2284158|P7|COMPLETED|Apheresis Period||0
944883|NCT00001832|2284159|P6|COMPLETED|Apheresis Period||0
944884|NCT00001832|2284160|P5|COMPLETED|Apheresis Period||0
944885|NCT00001832|2284161|P4|COMPLETED|Apheresis Period||0
944886|NCT00001832|2284162|P3|COMPLETED|Apheresis Period||0
944887|NCT00001832|2284163|P2|COMPLETED|Apheresis Period||0
944888|NCT00001832|2284164|P1|COMPLETED|Apheresis Period||110
944889|NCT00001832|2284150|P15|STARTED|Apheresis Period||0
944890|NCT00001832|2284151|P14|STARTED|Apheresis Period||0
944891|NCT00001832|2284152|P13|STARTED|Apheresis Period||0
944892|NCT00001832|2284153|P12|STARTED|Apheresis Period||0
944893|NCT00001832|2284154|P11|STARTED|Apheresis Period||0
944894|NCT00001832|2284155|P10|STARTED|Apheresis Period||0
944895|NCT00001832|2284156|P9|STARTED|Apheresis Period||0
944896|NCT00001832|2284157|P8|STARTED|Apheresis Period||0
944897|NCT00001832|2284158|P7|STARTED|Apheresis Period||0
944898|NCT00001832|2284159|P6|STARTED|Apheresis Period||0
944899|NCT00001832|2284160|P5|STARTED|Apheresis Period||0
944900|NCT00001832|2284161|P4|STARTED|Apheresis Period||0
944901|NCT00001832|2284162|P3|STARTED|Apheresis Period||0
944902|NCT00001832|2284163|P2|STARTED|Apheresis Period||0
944903|NCT00001832|2284164|P1|STARTED|Apheresis Period||170
944904|NCT00002525|2284210|P2|NOT COMPLETED|Overall Study||0
944905|NCT00002525|2284211|P1|NOT COMPLETED|Overall Study||186
944906|NCT00002525|2284210|P2|COMPLETED|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|428
944907|NCT00002525|2284211|P1|COMPLETED|Overall Study||241
944908|NCT00002525|2284210|P2|Dukes' B2 Stage|Overall Study||139
944909|NCT00002525|2284211|P1|Dukes' B2 Stage|Overall Study||150
944910|NCT00002525|2284210|P2|Dukes' B3 or C Stage|Overall Study||158
944911|NCT00002525|2284211|P1|Dukes' B3 or C Stage|Overall Study|"Primary population: pts with Duke's B3, C disease. 158 such pts on No perioperative 5-FU arm"|156
944912|NCT00002525|2284210|P2|Treated|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|0
944913|NCT00002525|2284211|P1|Treated|Overall Study||419
944914|NCT00002525|2284210|P2|STARTED|Overall Study||428
944915|NCT00002525|2284211|P1|STARTED|Overall Study|859 patients were enrolled to the study, but 4 patients were not randomized to any treatment arm|427
944916|NCT00002540|2284227|P2|NOT COMPLETED|Overall Study||2464
944917|NCT00002540|2284228|P1|NOT COMPLETED|Overall Study||801
944918|NCT00002540|2284227|P2|COMPLETED|Overall Study||35876
944919|NCT00002540|2284228|P1|COMPLETED|Overall Study||37544
944920|NCT00002540|2284227|P2|STARTED|Overall Study||38340
944921|NCT00002540|2284228|P1|STARTED|Overall Study||38345
944922|NCT00002558|2284256|P2|NOT COMPLETED|Overall Study||1
944923|NCT00002558|2284257|P1|NOT COMPLETED|Overall Study||0
944924|NCT00002558|2284256|P2|COMPLETED|Overall Study||15
944925|NCT00002558|2284257|P1|COMPLETED|Overall Study||92
944926|NCT00002558|2284256|P2|STARTED|Overall Study||16
944927|NCT00002558|2284257|P1|STARTED|Overall Study||92
944928|NCT00002597|2284265|P2|NOT COMPLETED|Overall Study||23
944929|NCT00002597|2284266|P1|NOT COMPLETED|Overall Study||26
944930|NCT00002597|2284265|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|992
944931|NCT00002597|2284266|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|987
944932|NCT00002597|2284265|P2|STARTED|Overall Study||1015
944933|NCT00002597|2284266|P1|STARTED|Overall Study||1013
944934|NCT00002601|2284288|P1|NOT COMPLETED|Overall Study||0
944935|NCT00002601|2284288|P1|COMPLETED|Overall Study||13
944936|NCT00002601|2284288|P1|STARTED|Overall Study||13
944937|NCT00002651|2284298|P3|NOT COMPLETED|Consolidation and Randomization||860
944938|NCT00002651|2284299|P2|NOT COMPLETED|Consolidation and Randomization||838
944939|NCT00002651|2284300|P1|NOT COMPLETED|Consolidation and Randomization||0
944940|NCT00002651|2284298|P3|COMPLETED|Consolidation and Randomization||22
944941|NCT00002651|2284299|P2|COMPLETED|Consolidation and Randomization||29
944942|NCT00002651|2284300|P1|COMPLETED|Consolidation and Randomization||0
944943|NCT00002651|2284298|P3|Assessable for Toxicity|Consolidation and Randomization||702
944944|NCT00002651|2284299|P2|Assessable for Toxicity|Consolidation and Randomization||732
944945|NCT00002651|2284300|P1|Assessable for Toxicity|Consolidation and Randomization||0
944946|NCT00002651|2284298|P3|Eligible|Consolidation and Randomization||770
944947|NCT00002651|2284299|P2|Eligible|Consolidation and Randomization||765
944948|NCT00002651|2284300|P1|Eligible|Consolidation and Randomization||0
944949|NCT00002651|2284298|P3|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|882
944950|NCT00002651|2284299|P2|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|867
944951|NCT00002651|2284300|P1|STARTED|Consolidation and Randomization||0
944952|NCT00002651|2284298|P3|NOT COMPLETED|Induction||0
944953|NCT00002651|2284299|P2|NOT COMPLETED|Induction||0
944954|NCT00002651|2284300|P1|NOT COMPLETED|Induction||1343
944955|NCT00002651|2284298|P3|COMPLETED|Induction||0
944956|NCT00002651|2284299|P2|COMPLETED|Induction||0
944957|NCT00002651|2284300|P1|COMPLETED|Induction||1697
944958|NCT00002651|2284298|P3|Eligible and Began Protocol Therapy|Induction||0
944959|NCT00002651|2284299|P2|Eligible and Began Protocol Therapy|Induction||0
944960|NCT00002651|2284300|P1|Eligible and Began Protocol Therapy|Induction||2950
944961|NCT00002651|2284298|P3|Eligible|Induction||0
944962|NCT00002651|2284299|P2|Eligible|Induction||0
944963|NCT00002651|2284300|P1|Eligible|Induction||2950
944964|NCT00002651|2284298|P3|STARTED|Induction||0
944965|NCT00002651|2284299|P2|STARTED|Induction||0
944966|NCT00002651|2284300|P1|STARTED|Induction||3040
944967|NCT00002766|2284318|P2|NOT COMPLETED|Overall Study||4
944968|NCT00002766|2284319|P1|NOT COMPLETED|Overall Study||3
944969|NCT00002766|2284318|P2|COMPLETED|Overall Study||85
944970|NCT00002766|2284319|P1|COMPLETED|Overall Study||78
944971|NCT00002766|2284318|P2|STARTED|Overall Study||89
944972|NCT00002766|2284319|P1|STARTED|Overall Study||81
944973|NCT00002842|2284325|P1|NOT COMPLETED|Overall Study||27
944974|NCT00002842|2284325|P1|COMPLETED|Overall Study||22
944975|NCT00002842|2284325|P1|STARTED|Overall Study||49
944976|NCT00002850|2284332|P3|NOT COMPLETED|Overall Study||4
944977|NCT00002850|2284333|P2|NOT COMPLETED|Overall Study||2
944978|NCT00002850|2284334|P1|NOT COMPLETED|Overall Study||5
944979|NCT00002850|2284332|P3|COMPLETED|Overall Study||63
944980|NCT00002850|2284333|P2|COMPLETED|Overall Study||74
944981|NCT00002850|2284334|P1|COMPLETED|Overall Study||64
944982|NCT00002850|2284332|P3|STARTED|Overall Study||67
944983|NCT00002850|2284333|P2|STARTED|Overall Study||76
944984|NCT00002850|2284334|P1|STARTED|Overall Study||69
944985|NCT00002874|2284344|P2|NOT COMPLETED|Overall Study||35
944986|NCT00002874|2284345|P1|NOT COMPLETED|Overall Study||45
944987|NCT00002874|2284344|P2|COMPLETED|Overall Study||384
944988|NCT00002874|2284345|P1|COMPLETED|Overall Study||376
944989|NCT00002874|2284344|P2|STARTED|Overall Study||419
944990|NCT00002874|2284345|P1|STARTED|Overall Study||421
944991|NCT00002931|2284367|P1|NOT COMPLETED|Overall Study||2
944992|NCT00002931|2284367|P1|COMPLETED|Overall Study||46
944993|NCT00002931|2284367|P1|STARTED|Overall Study||48
944994|NCT00002975|2284373|P1|NOT COMPLETED|Overall Study||5
944995|NCT00002975|2284373|P1|COMPLETED|Overall Study||175
944996|NCT00002975|2284373|P1|Treated With Study Therapy|Overall Study||175
944997|NCT00002975|2284373|P1|STARTED|Overall Study||180
944998|NCT00003138|2284379|P2|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||7
944999|NCT00003138|2284380|P1|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||6
945000|NCT00003138|2284379|P2|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
945001|NCT00003138|2284380|P1|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
945002|NCT00003138|2284379|P2|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||7
945003|NCT00003138|2284380|P1|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||6
945004|NCT00003138|2284379|P2|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||20
945005|NCT00003138|2284380|P1|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||12
945006|NCT00003138|2284379|P2|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
945007|NCT00003138|2284380|P1|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
945008|NCT00003138|2284379|P2|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||19
945009|NCT00003138|2284380|P1|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||12
945010|NCT00003138|2284379|P2|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||20
945011|NCT00003138|2284380|P1|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||12
945012|NCT00003138|2284379|P2|NOT COMPLETED|Step 2 (Cross Over)||0
945013|NCT00003138|2284380|P1|NOT COMPLETED|Step 2 (Cross Over)||26
945014|NCT00003138|2284379|P2|COMPLETED|Step 2 (Cross Over)||0
945015|NCT00003138|2284380|P1|COMPLETED|Step 2 (Cross Over)||0
945016|NCT00003138|2284379|P2|STARTED|Step 2 (Cross Over)|Only patients in the supportive care arm are eligible to cross over to the Erythropoietin arm.|0
945017|NCT00003138|2284380|P1|STARTED|Step 2 (Cross Over)||26
945018|NCT00003138|2284379|P2|NOT COMPLETED|Step 1||57
945019|NCT00003138|2284380|P1|NOT COMPLETED|Step 1||61
945020|NCT00003138|2284379|P2|COMPLETED|Step 1||0
945021|NCT00003138|2284380|P1|COMPLETED|Step 1||0
945022|NCT00003138|2284379|P2|Patients With Transfusion Data|Step 1||42
945023|NCT00003138|2284380|P1|Patients With Transfusion Data|Step 1||37
945024|NCT00003138|2284379|P2|Patients With QOL Data at 4 Months|Step 1||42
945025|NCT00003138|2284380|P1|Patients With QOL Data at 4 Months|Step 1||42
945026|NCT00003138|2284379|P2|Eligible and Treated|Step 1||50
945027|NCT00003138|2284380|P1|Eligible and Treated|Step 1||52
945028|NCT00003138|2284379|P2|Treated|Step 1||53
945029|NCT00003138|2284380|P1|Treated|Step 1||56
945030|NCT00003138|2284379|P2|Patients With Complete Data|Step 1||53
945031|NCT00003138|2284380|P1|Patients With Complete Data|Step 1||57
945032|NCT00003138|2284379|P2|STARTED|Step 1||57
945033|NCT00003138|2284380|P1|STARTED|Step 1||61
945034|NCT00003199|2284393|P1|NOT COMPLETED|Overall Study||22
945035|NCT00003199|2284393|P1|COMPLETED|Overall Study||28
945036|NCT00003199|2284393|P1|STARTED|Overall Study||50
945037|NCT00003222|2284401|P2|NOT COMPLETED|Overall Study||1
945038|NCT00003222|2284402|P1|NOT COMPLETED|Overall Study||0
945039|NCT00003222|2284401|P2|COMPLETED|Overall Study|Decline in performance status between enrollment and initiation of therapy.|27
945040|NCT00003222|2284402|P1|COMPLETED|Overall Study||13
945041|NCT00003222|2284401|P2|STARTED|Overall Study||28
945042|NCT00003222|2284402|P1|STARTED|Overall Study||13
945043|NCT00003224|2284418|P6|NOT COMPLETED|Overall Study||0
945044|NCT00003224|2284419|P5|NOT COMPLETED|Overall Study||0
945045|NCT00003224|2284420|P4|NOT COMPLETED|Overall Study||0
945046|NCT00003224|2284421|P3|NOT COMPLETED|Overall Study||0
945047|NCT00003224|2284422|P2|NOT COMPLETED|Overall Study||0
945048|NCT00003224|2284423|P1|NOT COMPLETED|Overall Study||0
945049|NCT00003224|2284418|P6|COMPLETED|Overall Study||3
945050|NCT00003224|2284419|P5|COMPLETED|Overall Study||4
945051|NCT00003224|2284420|P4|COMPLETED|Overall Study||2
945052|NCT00003224|2284421|P3|COMPLETED|Overall Study||4
945053|NCT00003224|2284422|P2|COMPLETED|Overall Study||5
945054|NCT00003224|2284423|P1|COMPLETED|Overall Study||4
945055|NCT00003224|2284418|P6|STARTED|Overall Study||3
945056|NCT00003224|2284419|P5|STARTED|Overall Study||4
945057|NCT00003224|2284420|P4|STARTED|Overall Study||2
945058|NCT00003224|2284421|P3|STARTED|Overall Study||4
945059|NCT00003224|2284422|P2|STARTED|Overall Study||5
945060|NCT00003224|2284423|P1|STARTED|Overall Study||4
945061|NCT00003377|2284446|P5|NOT COMPLETED|Period II||1
945062|NCT00003377|2284447|P4|NOT COMPLETED|Period II||0
945063|NCT00003377|2284448|P3|NOT COMPLETED|Period II||0
945064|NCT00003377|2284449|P2|NOT COMPLETED|Period II||0
945065|NCT00003377|2284450|P1|NOT COMPLETED|Period II||0
945066|NCT00003377|2284446|P5|COMPLETED|Period II||16
945067|NCT00003377|2284447|P4|COMPLETED|Period II||0
945068|NCT00003377|2284448|P3|COMPLETED|Period II||0
945069|NCT00003377|2284449|P2|COMPLETED|Period II||0
945070|NCT00003377|2284450|P1|COMPLETED|Period II||0
945071|NCT00003377|2284446|P5|STARTED|Period II|All pts enrolled on Per II received cisplatin 40 mg/m2 & paclitaxel 40 mg/m2 concurrent w/ radiation|17
945072|NCT00003377|2284447|P4|STARTED|Period II|Patients participated at this dose level only in Period I.|0
945073|NCT00003377|2284448|P3|STARTED|Period II|Patients participated at this dose level only in Period I.|0
945074|NCT00003377|2284449|P2|STARTED|Period II|Patients participated at this dose level only in Period I.|0
945075|NCT00003377|2284450|P1|STARTED|Period II|Patients participated at this dose level only in Period I.|0
945076|NCT00003377|2284446|P5|NOT COMPLETED|Period I||0
945077|NCT00003377|2284447|P4|NOT COMPLETED|Period I||1
945078|NCT00003377|2284448|P3|NOT COMPLETED|Period I||1
945079|NCT00003377|2284449|P2|NOT COMPLETED|Period I||0
945080|NCT00003377|2284450|P1|NOT COMPLETED|Period I||0
945081|NCT00003377|2284446|P5|COMPLETED|Period I||0
945082|NCT00003377|2284447|P4|COMPLETED|Period I||2
945083|NCT00003377|2284448|P3|COMPLETED|Period I||2
945084|NCT00003377|2284449|P2|COMPLETED|Period I||3
945085|NCT00003377|2284450|P1|COMPLETED|Period I||3
945086|NCT00003377|2284446|P5|STARTED|Period I||0
945087|NCT00003377|2284447|P4|STARTED|Period I||3
945088|NCT00003377|2284448|P3|STARTED|Period I||3
945089|NCT00003377|2284449|P2|STARTED|Period I||3
945090|NCT00003377|2284450|P1|STARTED|Period I||3
945091|NCT00003389|2284466|P2|NOT COMPLETED|Overall Study||60
945092|NCT00003389|2284467|P1|NOT COMPLETED|Overall Study||98
945093|NCT00003389|2284466|P2|COMPLETED|Overall Study||366
945094|NCT00003389|2284467|P1|COMPLETED|Overall Study||330
945095|NCT00003389|2284466|P2|Eligible Patients|Overall Study||399
945096|NCT00003389|2284467|P1|Eligible Patients|Overall Study||395
945097|NCT00003389|2284466|P2|Treated Pts w/ Toxicity Data Available|Overall Study||422
945098|NCT00003389|2284467|P1|Treated Pts w/ Toxicity Data Available|Overall Study||414
945099|NCT00003389|2284466|P2|STARTED|Overall Study||426
945100|NCT00003389|2284467|P1|STARTED|Overall Study||428
945101|NCT00003457|2284477|P1|NOT COMPLETED|Overall Study||9
945102|NCT00003457|2284477|P1|COMPLETED|Overall Study||31
945103|NCT00003457|2284477|P1|STARTED|Overall Study||40
945104|NCT00003458|2284482|P1|NOT COMPLETED|Overall Study||4
945105|NCT00003458|2284482|P1|COMPLETED|Overall Study||30
945106|NCT00003458|2284482|P1|STARTED|Overall Study||34
945107|NCT00003459|2284487|P1|NOT COMPLETED|Overall Study||9
945108|NCT00003459|2284487|P1|COMPLETED|Overall Study|Nine patients were not evaluable.|31
945109|NCT00003459|2284487|P1|STARTED|Overall Study||40
945110|NCT00003460|2284492|P1|NOT COMPLETED|Overall Study||1
945111|NCT00003460|2284492|P1|COMPLETED|Overall Study|One patient was not evaluable.|12
945112|NCT00003460|2284492|P1|STARTED|Overall Study||13
945113|NCT00003468|2284497|P1|NOT COMPLETED|Overall Study||2
945114|NCT00003468|2284497|P1|COMPLETED|Overall Study|Two patients were not evaluable.|9
945115|NCT00003468|2284497|P1|STARTED|Overall Study||11
945116|NCT00003469|2284502|P1|NOT COMPLETED|Overall Study||0
945117|NCT00003469|2284502|P1|COMPLETED|Overall Study||4
945118|NCT00003469|2284502|P1|STARTED|Overall Study||4
945119|NCT00003470|2284507|P1|NOT COMPLETED|Overall Study||6
945120|NCT00003470|2284507|P1|COMPLETED|Overall Study||21
945121|NCT00003470|2284507|P1|STARTED|Overall Study||27
945122|NCT00003473|2284512|P1|NOT COMPLETED|Overall Study||3
945123|NCT00003473|2284512|P1|COMPLETED|Overall Study||17
945124|NCT00003473|2284512|P1|STARTED|Overall Study||20
945125|NCT00003475|2284517|P1|NOT COMPLETED|Overall Study||13
945126|NCT00003475|2284517|P1|COMPLETED|Overall Study||27
945127|NCT00003475|2284517|P1|STARTED|Overall Study||40
945128|NCT00003476|2284522|P1|NOT COMPLETED|Overall Study||1
945129|NCT00003476|2284522|P1|COMPLETED|Overall Study||7
945130|NCT00003476|2284522|P1|STARTED|Overall Study||8
945131|NCT00003477|2284527|P1|NOT COMPLETED|Overall Study||4
945132|NCT00003477|2284527|P1|COMPLETED|Overall Study||8
945133|NCT00003477|2284527|P1|STARTED|Overall Study||12
945134|NCT00003479|2284532|P1|NOT COMPLETED|Overall Study||3
945135|NCT00003479|2284532|P1|COMPLETED|Overall Study||6
945136|NCT00003479|2284532|P1|STARTED|Overall Study||9
945137|NCT00003483|2284537|P1|NOT COMPLETED|Overall Study||1
945138|NCT00003483|2284537|P1|COMPLETED|Overall Study||2
945139|NCT00003483|2284537|P1|STARTED|Overall Study||3
945140|NCT00003537|2284542|P1|NOT COMPLETED|Overall Study||1
945141|NCT00003537|2284542|P1|COMPLETED|Overall Study||18
945142|NCT00003537|2284542|P1|STARTED|Overall Study||19
945143|NCT00003590|2284547|P1|NOT COMPLETED|Overall Study||22
945144|NCT00003590|2284547|P1|COMPLETED|Overall Study|Patients were to receive Hydroxyurea up to 2 years in absence of progressive disease.|7
945145|NCT00003590|2284547|P1|Eligible and Began Protocol Therapy|Overall Study||28
945146|NCT00003590|2284547|P1|Eligible|Overall Study||28
945147|NCT00003590|2284547|P1|STARTED|Overall Study||29
945151|NCT00003726|2284558|P1|NOT COMPLETED|Overall Study||1
945152|NCT00003726|2284558|P1|COMPLETED|Overall Study|Funding was pulled on the trial and therefore no other participants were enrolled|0
945153|NCT00003726|2284558|P1|STARTED|Overall Study||1
945154|NCT00003782|2284565|P3|NOT COMPLETED|Overall Study||26
945155|NCT00003782|2284566|P2|NOT COMPLETED|Overall Study||31
945156|NCT00003782|2284567|P1|NOT COMPLETED|Overall Study||30
945157|NCT00003782|2284565|P3|COMPLETED|Overall Study||1758
945158|NCT00003782|2284566|P2|COMPLETED|Overall Study||1753
945159|NCT00003782|2284567|P1|COMPLETED|Overall Study||1753
945160|NCT00003782|2284565|P3|STARTED|Overall Study||1784
945161|NCT00003782|2284566|P2|STARTED|Overall Study||1784
945162|NCT00003782|2284567|P1|STARTED|Overall Study||1783
945163|NCT00003820|2284575|P2|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
945164|NCT00003820|2284576|P1|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
945165|NCT00003820|2284575|P2|COMPLETED|Cycle 4 (Maintenance Treatment)|Patients with treatment assessment at 24 months|16
945166|NCT00003820|2284576|P1|COMPLETED|Cycle 4 (Maintenance Treatment)||0
945167|NCT00003820|2284575|P2|STARTED|Cycle 4 (Maintenance Treatment)|Patients with treatment response/stable disease at 18 months|16
945168|NCT00003820|2284576|P1|STARTED|Cycle 4 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
945169|NCT00003820|2284575|P2|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
945170|NCT00003820|2284576|P1|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
945171|NCT00003820|2284575|P2|COMPLETED|Cycle 3 (Maintenance Treatment)|Patients with treatment assessment at 18 months|16
945172|NCT00003820|2284576|P1|COMPLETED|Cycle 3 (Maintenance Treatment)||0
945173|NCT00003820|2284575|P2|STARTED|Cycle 3 (Maintenance Treatment)|Patients with treatment response/stable disease at 12 months|16
945174|NCT00003820|2284576|P1|STARTED|Cycle 3 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
945175|NCT00003820|2284575|P2|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
945176|NCT00003820|2284576|P1|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
945177|NCT00003820|2284575|P2|COMPLETED|Cycle 2 (Maintenance Treatment)|Patients with treatment assessment at 12 months|16
945178|NCT00003820|2284576|P1|COMPLETED|Cycle 2 (Maintenance Treatment)||0
945179|NCT00003820|2284575|P2|STARTED|Cycle 2 (Maintenance Treatment)|Pts with treatment response/stable disease at 6 mos, & eligible to continue.|16
945180|NCT00003820|2284576|P1|STARTED|Cycle 2 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
945181|NCT00003820|2284575|P2|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
945182|NCT00003820|2284576|P1|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
945183|NCT00003820|2284575|P2|COMPLETED|Cycle 1 (Initial Treatment)||16
945184|NCT00003820|2284576|P1|COMPLETED|Cycle 1 (Initial Treatment)||23
945185|NCT00003820|2284575|P2|STARTED|Cycle 1 (Initial Treatment)||16
945186|NCT00003820|2284576|P1|STARTED|Cycle 1 (Initial Treatment)||23
945187|NCT00003298|2284582|P1|NOT COMPLETED|Step 2 (Adjuvant Therapy)||6
945188|NCT00003298|2284582|P1|COMPLETED|Step 2 (Adjuvant Therapy)||4
945189|NCT00003298|2284582|P1|Eligible and Treated on Step 2|Step 2 (Adjuvant Therapy)||7
945190|NCT00003298|2284582|P1|STARTED|Step 2 (Adjuvant Therapy)||10
945191|NCT00003298|2284582|P1|NOT COMPLETED|Re-register to Step 2 After Surgery||18
945192|NCT00003298|2284582|P1|COMPLETED|Re-register to Step 2 After Surgery||10
945193|NCT00003298|2284582|P1|STARTED|Re-register to Step 2 After Surgery||28
945194|NCT00003298|2284582|P1|NOT COMPLETED|Surgery||7
945195|NCT00003298|2284582|P1|COMPLETED|Surgery|1 patient did not complete neoadjuvant therapy but went to surgery anyway, not included here.|28
945196|NCT00003298|2284582|P1|STARTED|Surgery||35
945197|NCT00003298|2284582|P1|NOT COMPLETED|Step 1 (Neoadjuvant Therapy)||4
945198|NCT00003298|2284582|P1|COMPLETED|Step 1 (Neoadjuvant Therapy)||35
945199|NCT00003298|2284582|P1|Complete 3 Cycles of Neoadjuvant Therapy|Step 1 (Neoadjuvant Therapy)||35
945200|NCT00003298|2284582|P1|Eligible and Treated|Step 1 (Neoadjuvant Therapy)||38
945201|NCT00003298|2284582|P1|STARTED|Step 1 (Neoadjuvant Therapy)||39
945202|NCT00003869|2284592|P2|NOT COMPLETED|Overall Study||12
945203|NCT00003869|2284593|P1|NOT COMPLETED|Overall Study||41
945204|NCT00003869|2284592|P2|COMPLETED|Overall Study||80
945205|NCT00003869|2284593|P1|COMPLETED|Overall Study||53
945206|NCT00003869|2284592|P2|STARTED|Overall Study||92
945207|NCT00003869|2284593|P1|STARTED|Overall Study||94
945208|NCT00003875|2284609|P1|NOT COMPLETED|Overall Study||1
945209|NCT00003875|2284609|P1|COMPLETED|Overall Study||29
945210|NCT00003875|2284609|P1|STARTED|Overall Study||30
945211|NCT00003895|2284618|P2|NOT COMPLETED|Overall Study||4
945212|NCT00003895|2284619|P1|NOT COMPLETED|Overall Study||7
945213|NCT00003895|2284618|P2|COMPLETED|Overall Study||14
945214|NCT00003895|2284619|P1|COMPLETED|Overall Study||11
945215|NCT00003895|2284618|P2|STARTED|Overall Study||18
945216|NCT00003895|2284619|P1|STARTED|Overall Study||18
945217|NCT00003896|2284625|P1|NOT COMPLETED|Overall Study||29
945218|NCT00003896|2284625|P1|COMPLETED|Overall Study||39
945219|NCT00003896|2284625|P1|Eligible|Overall Study|2 eligible patients did not have any toxicity assessments reported.|63
945220|NCT00003896|2284625|P1|STARTED|Overall Study||68
945221|NCT00004143|2284631|P1|NOT COMPLETED|Overall Study||0
945222|NCT00004143|2284631|P1|COMPLETED|Overall Study||2
945223|NCT00004143|2284631|P1|STARTED|Overall Study||2
945224|NCT00004146|2284640|P1|NOT COMPLETED|Overall Study||0
945225|NCT00004146|2284640|P1|COMPLETED|Overall Study||55
945226|NCT00004146|2284640|P1|STARTED|Overall Study||55
945227|NCT00004228|2284654|P7|NOT COMPLETED|Overall Study||12
945228|NCT00004228|2284655|P6|NOT COMPLETED|Overall Study||14
945229|NCT00004228|2284656|P5|NOT COMPLETED|Overall Study||16
945230|NCT00004228|2284657|P4|NOT COMPLETED|Overall Study||7
945231|NCT00004228|2284658|P3|NOT COMPLETED|Overall Study||19
945232|NCT00004228|2284659|P2|NOT COMPLETED|Overall Study||15
945233|NCT00004228|2284660|P1|NOT COMPLETED|Overall Study||9
945234|NCT00004228|2284654|P7|COMPLETED|Overall Study||45
945235|NCT00004228|2284655|P6|COMPLETED|Overall Study||51
945236|NCT00004228|2284656|P5|COMPLETED|Overall Study||51
945237|NCT00004228|2284657|P4|COMPLETED|Overall Study||6
945238|NCT00004228|2284658|P3|COMPLETED|Overall Study||46
945239|NCT00004228|2284659|P2|COMPLETED|Overall Study||51
945240|NCT00004228|2284660|P1|COMPLETED|Overall Study||51
945241|NCT00004228|2284654|P7|STARTED|Overall Study||57
945242|NCT00004228|2284655|P6|STARTED|Overall Study||65
945243|NCT00004228|2284656|P5|STARTED|Overall Study||67
945244|NCT00004228|2284657|P4|STARTED|Overall Study||13
945245|NCT00004228|2284658|P3|STARTED|Overall Study||65
945246|NCT00004228|2284659|P2|STARTED|Overall Study||66
945247|NCT00004228|2284660|P1|STARTED|Overall Study||60
945248|NCT00003631|2284686|P3|NOT COMPLETED|Overall Study||9
945249|NCT00003631|2284687|P2|NOT COMPLETED|Overall Study||1
945250|NCT00003631|2284688|P1|NOT COMPLETED|Overall Study||3
945251|NCT00003631|2284686|P3|COMPLETED|Overall Study||15
945252|NCT00003631|2284687|P2|COMPLETED|Overall Study||43
945253|NCT00003631|2284688|P1|COMPLETED|Overall Study||47
945254|NCT00003631|2284686|P3|STARTED|Overall Study||24
945255|NCT00003631|2284687|P2|STARTED|Overall Study||44
945256|NCT00003631|2284688|P1|STARTED|Overall Study||50
945257|NCT00003641|2284698|P2|NOT COMPLETED|Overall Study||174
945258|NCT00003641|2284699|P1|NOT COMPLETED|Overall Study||569
945259|NCT00003641|2284698|P2|COMPLETED|Overall Study||407
945260|NCT00003641|2284699|P1|COMPLETED|Overall Study||0
945261|NCT00003641|2284698|P2|Toxicity Assessed|Overall Study||568
945262|NCT00003641|2284699|P1|Toxicity Assessed|Overall Study|439 patients on arm I had their toxicity assessed even though they did not receive any treatment|439
945263|NCT00003641|2284698|P2|Treated|Overall Study||569
945264|NCT00003641|2284699|P1|Treated|Overall Study|Patients on arm I should undergo observation, but 2 patients received interferon therapy|2
945265|NCT00003641|2284698|P2|STARTED|Overall Study||581
945266|NCT00003641|2284699|P1|STARTED|Overall Study||569
945267|NCT00004412|2284710|P3|NOT COMPLETED|Crossover Period||0
945268|NCT00004412|2284711|P2|NOT COMPLETED|Crossover Period||0
945269|NCT00004412|2284712|P1|NOT COMPLETED|Crossover Period||0
945270|NCT00004412|2284710|P3|COMPLETED|Crossover Period|Three subjects, from Arm I, who crossed- over to Arm II completed the study.|3
945271|NCT00004412|2284711|P2|COMPLETED|Crossover Period|Twelve subjects in this arm completed the study.|12
945272|NCT00004412|2284712|P1|COMPLETED|Crossover Period|Eight subjects in this arm completed study without crossing over.|8
945273|NCT00004412|2284710|P3|STARTED|Crossover Period|Three of Randomized Period's Arm I elected to move to Crossover Period's Crossover Arm.|3
945274|NCT00004412|2284711|P2|STARTED|Crossover Period|Twelve patients were randomized to the Arginine Butyrate plus Standard local care dressing Arm|12
945275|NCT00004412|2284712|P1|STARTED|Crossover Period|Eight subjects were randomized to Standard of Care dressing Arm|8
945276|NCT00004412|2284710|P3|NOT COMPLETED|Randomized Period||0
945277|NCT00004412|2284711|P2|NOT COMPLETED|Randomized Period||0
945278|NCT00004412|2284712|P1|NOT COMPLETED|Randomized Period||3
945279|NCT00004412|2284710|P3|COMPLETED|Randomized Period||0
945280|NCT00004412|2284711|P2|COMPLETED|Randomized Period||12
945281|NCT00004412|2284712|P1|COMPLETED|Randomized Period||8
945282|NCT00004412|2284710|P3|STARTED|Randomized Period||0
945283|NCT00004412|2284711|P2|STARTED|Randomized Period||12
945284|NCT00004412|2284712|P1|STARTED|Randomized Period||11
945285|NCT00004859|2284722|P2|NOT COMPLETED|Overall Study||282
945286|NCT00004859|2284723|P1|NOT COMPLETED|Overall Study||118
945287|NCT00004859|2284722|P2|COMPLETED|Overall Study||12
945288|NCT00004859|2284723|P1|COMPLETED|Overall Study||177
945289|NCT00004859|2284722|P2|Treated and Having Toxicity Data|Overall Study|1 patient had missing record for toxicity|288
945290|NCT00004859|2284723|P1|Treated and Having Toxicity Data|Overall Study||289
945291|NCT00004859|2284722|P2|Treated|Overall Study||289
945292|NCT00004859|2284723|P1|Treated|Overall Study||289
945293|NCT00004859|2284722|P2|Eligible|Overall Study||271
945294|NCT00004859|2284723|P1|Eligible|Overall Study||275
945295|NCT00004859|2284722|P2|STARTED|Overall Study||294
945296|NCT00004859|2284723|P1|STARTED|Overall Study||295
945297|NCT00004888|2284735|P2|NOT COMPLETED|Overall Study||24
945298|NCT00004888|2284736|P1|NOT COMPLETED|Overall Study||11
945299|NCT00004888|2284735|P2|COMPLETED|Overall Study||22
945300|NCT00004888|2284736|P1|COMPLETED|Overall Study||27
945301|NCT00004888|2284735|P2|STARTED|Overall Study|Of the 48 pts, 2 were ineligible.|46
945302|NCT00004888|2284736|P1|STARTED|Overall Study|Of the 41 pts, 3 were ineligible.|38
945303|NCT00004978|2284754|P2|NOT COMPLETED|Overall Study||270
945304|NCT00004978|2284755|P1|NOT COMPLETED|Overall Study||244
945305|NCT00004978|2284754|P2|COMPLETED|Overall Study||1790
945306|NCT00004978|2284755|P1|COMPLETED|Overall Study||1846
945307|NCT00004978|2284754|P2|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2060
945308|NCT00004978|2284755|P1|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2090
945309|NCT00004980|2284781|P2|NOT COMPLETED|Overall Study||2
945310|NCT00004980|2284782|P1|NOT COMPLETED|Overall Study||2
945311|NCT00004980|2284781|P2|COMPLETED|Overall Study||21
945312|NCT00004980|2284782|P1|COMPLETED|Overall Study||25
945313|NCT00004980|2284781|P2|STARTED|Overall Study||23
945314|NCT00004980|2284782|P1|STARTED|Overall Study||27
945315|NCT00003901|2284794|P1|NOT COMPLETED|Overall Study||17
945316|NCT00003901|2284794|P1|COMPLETED|Overall Study||1030
945317|NCT00003901|2284794|P1|STARTED|Overall Study||1047
945318|NCT00003907|2284807|P2|NOT COMPLETED|Overall Study||23
945319|NCT00003907|2284808|P1|NOT COMPLETED|Overall Study||13
945320|NCT00003907|2284807|P2|COMPLETED|Overall Study||8
945321|NCT00003907|2284808|P1|COMPLETED|Overall Study||6
945322|NCT00003907|2284807|P2|Eligible and Treated|Overall Study||29
945323|NCT00003907|2284808|P1|Eligible and Treated|Overall Study||17
945324|NCT00003907|2284807|P2|Received Protocol Therapy (Treated)|Overall Study||31
945325|NCT00003907|2284808|P1|Received Protocol Therapy (Treated)|Overall Study||18
945326|NCT00003907|2284807|P2|Eligible|Overall Study||29
945327|NCT00003907|2284808|P1|Eligible|Overall Study||18
945328|NCT00003907|2284807|P2|STARTED|Overall Study||31
945329|NCT00003907|2284808|P1|STARTED|Overall Study||19
945330|NCT00003910|2284818|P2|NOT COMPLETED|Step 2||0
945331|NCT00003910|2284819|P1|NOT COMPLETED|Step 2||0
945332|NCT00003910|2284818|P2|COMPLETED|Step 2||16
945333|NCT00003910|2284819|P1|COMPLETED|Step 2||0
945334|NCT00003910|2284818|P2|STARTED|Step 2|The 16 includes 2 ineligible pts.|16
945335|NCT00003910|2284819|P1|STARTED|Step 2||0
945336|NCT00003910|2284818|P2|NOT COMPLETED|Step 1||0
945337|NCT00003910|2284819|P1|NOT COMPLETED|Step 1||0
945338|NCT00003910|2284818|P2|COMPLETED|Step 1||0
945339|NCT00003910|2284819|P1|COMPLETED|Step 1||55
945340|NCT00003910|2284818|P2|STARTED|Step 1||0
945341|NCT00003910|2284819|P1|STARTED|Step 1|Of 59 (step 1), 4 pts were ineligible.|55
945342|NCT00004054|2284826|P2|NOT COMPLETED|Overall Study||0
945343|NCT00004054|2284827|P1|NOT COMPLETED|Overall Study||0
945344|NCT00004054|2284826|P2|COMPLETED|Overall Study||200
945345|NCT00004054|2284827|P1|COMPLETED|Overall Study||197
945346|NCT00004054|2284826|P2|STARTED|Overall Study||200
945347|NCT00004054|2284827|P1|STARTED|Overall Study||197
945348|NCT00004092|2284835|P2|NOT COMPLETED|Overall Study||0
945349|NCT00004092|2284836|P1|NOT COMPLETED|Overall Study||0
945350|NCT00004092|2284835|P2|COMPLETED|Overall Study||51
945351|NCT00004092|2284836|P1|COMPLETED|Overall Study||21
945352|NCT00004092|2284835|P2|STARTED|Overall Study||51
945353|NCT00004092|2284836|P1|STARTED|Overall Study||21
945354|NCT00004500|2284846|P2|NOT COMPLETED|Overall Study||0
945355|NCT00004500|2284847|P1|NOT COMPLETED|Overall Study||0
945356|NCT00004500|2284846|P2|COMPLETED|Overall Study||31
945357|NCT00004500|2284847|P1|COMPLETED|Overall Study||38
945358|NCT00004500|2284846|P2|1 Year Follow-Up|Overall Study||24
945359|NCT00004500|2284847|P1|1 Year Follow-Up|Overall Study||24
945360|NCT00004500|2284846|P2|STARTED|Overall Study||31
945361|NCT00004500|2284847|P1|STARTED|Overall Study||38
945362|NCT00004547|2284860|P3|NOT COMPLETED|Overall Study||22
945363|NCT00004547|2284861|P2|NOT COMPLETED|Overall Study||9
945364|NCT00004547|2284862|P1|NOT COMPLETED|Overall Study||22
945365|NCT00004547|2284860|P3|COMPLETED|Overall Study||35
945366|NCT00004547|2284861|P2|COMPLETED|Overall Study||39
945367|NCT00004547|2284862|P1|COMPLETED|Overall Study||61
945368|NCT00004547|2284860|P3|Not Evaluable|Overall Study||23
945369|NCT00004547|2284861|P2|Not Evaluable|Overall Study||9
945370|NCT00004547|2284862|P1|Not Evaluable|Overall Study||21
945371|NCT00004547|2284860|P3|STARTED|Overall Study||57
945372|NCT00004547|2284861|P2|STARTED|Overall Study||48
945373|NCT00004547|2284862|P1|STARTED|Overall Study||83
945374|NCT00004562|2284882|P2|NOT COMPLETED|Overall Study||91
945375|NCT00004562|2284883|P1|NOT COMPLETED|Overall Study||102
945376|NCT00004562|2284882|P2|COMPLETED|Overall Study||1009
945377|NCT00004562|2284883|P1|COMPLETED|Overall Study||999
945378|NCT00004562|2284882|P2|STARTED|Overall Study||1100
945379|NCT00004562|2284883|P1|STARTED|Overall Study||1101
945380|NCT00004563|2284893|P2|NOT COMPLETED|Overall Study||24
945381|NCT00004563|2284894|P1|NOT COMPLETED|Overall Study||25
945382|NCT00004563|2284893|P2|COMPLETED|Overall Study||55
945383|NCT00004563|2284894|P1|COMPLETED|Overall Study||54
945384|NCT00004563|2284893|P2|STARTED|Overall Study||79
945385|NCT00004563|2284894|P1|STARTED|Overall Study||79
945386|NCT00004635|2284906|P2|NOT COMPLETED|Period Two||9
945387|NCT00004635|2284907|P1|NOT COMPLETED|Period Two||6
945388|NCT00004635|2284906|P2|COMPLETED|Period Two||50
945389|NCT00004635|2284907|P1|COMPLETED|Period Two||38
945390|NCT00004635|2284906|P2|STARTED|Period Two||59
945391|NCT00004635|2284907|P1|STARTED|Period Two||44
945392|NCT00004635|2284906|P2|NOT COMPLETED|Period One||6
945393|NCT00004635|2284907|P1|NOT COMPLETED|Period One||6
945394|NCT00004635|2284906|P2|COMPLETED|Period One||74
945395|NCT00004635|2284907|P1|COMPLETED|Period One||73
945396|NCT00004635|2284906|P2|Received Treatment|Period One||75
945397|NCT00004635|2284907|P1|Received Treatment|Period One||73
945398|NCT00004635|2284906|P2|STARTED|Period One||80
945399|NCT00004635|2284907|P1|STARTED|Period One||79
945400|NCT00004732|2284919|P2|NOT COMPLETED|Overall Study||111
945401|NCT00004732|2284920|P1|NOT COMPLETED|Overall Study||69
945402|NCT00004732|2284919|P2|COMPLETED|Overall Study||1129
945403|NCT00004732|2284920|P1|COMPLETED|Overall Study||1193
945404|NCT00004732|2284919|P2|STARTED|Overall Study||1240
945405|NCT00004732|2284920|P1|STARTED|Overall Study||1262
945406|NCT00005047|2284932|P4|NOT COMPLETED|Overall Study||0
945407|NCT00005047|2284933|P3|NOT COMPLETED|Overall Study||0
945408|NCT00005047|2284934|P2|NOT COMPLETED|Overall Study||0
945409|NCT00005047|2284935|P1|NOT COMPLETED|Overall Study||19
945410|NCT00005047|2284932|P4|COMPLETED|Overall Study||158
945411|NCT00005047|2284933|P3|COMPLETED|Overall Study||227
945412|NCT00005047|2284934|P2|COMPLETED|Overall Study||56
945413|NCT00005047|2284935|P1|COMPLETED|Overall Study||39
945414|NCT00005047|2284932|P4|STARTED|Overall Study||158
945415|NCT00005047|2284933|P3|STARTED|Overall Study||227
945416|NCT00005047|2284934|P2|STARTED|Overall Study||56
945417|NCT00005047|2284935|P1|STARTED|Overall Study||58
945418|NCT00005879|2284951|P2|NOT COMPLETED|Overall Study||10
945419|NCT00005879|2284952|P1|NOT COMPLETED|Overall Study||8
945420|NCT00005879|2284951|P2|COMPLETED|Overall Study||88
945421|NCT00005879|2284952|P1|COMPLETED|Overall Study||93
945422|NCT00005879|2284951|P2|STARTED|Overall Study||98
945423|NCT00005879|2284952|P1|STARTED|Overall Study||101
945424|NCT00005901|2284962|P2|NOT COMPLETED|Overall Study||0
945425|NCT00005901|2284963|P1|NOT COMPLETED|Overall Study||0
945426|NCT00005901|2284962|P2|COMPLETED|Overall Study||15
945427|NCT00005901|2284963|P1|COMPLETED|Overall Study||19
945428|NCT00005901|2284962|P2|STARTED|Overall Study||15
945429|NCT00005901|2284963|P1|STARTED|Overall Study||19
945430|NCT00005906|2284979|P1|NOT COMPLETED|Overall Study||3
945431|NCT00005906|2284979|P1|COMPLETED|Overall Study||1
945432|NCT00005906|2284979|P1|STARTED|Overall Study||4
945433|NCT00005908|2284985|P2|NOT COMPLETED|Overall Study||0
945434|NCT00005908|2284986|P1|NOT COMPLETED|Overall Study||1
945435|NCT00005908|2284985|P2|COMPLETED|Overall Study||20
945436|NCT00005908|2284986|P1|COMPLETED|Overall Study||9
945437|NCT00005908|2284985|P2|STARTED|Overall Study||20
945438|NCT00005908|2284986|P1|STARTED|Overall Study||10
945439|NCT00005937|2284995|P1|NOT COMPLETED|Overall Study||5
945440|NCT00005937|2284995|P1|COMPLETED|Overall Study||37
945441|NCT00005937|2284995|P1|STARTED|Overall Study||42
945442|NCT00005947|2285001|P2|NOT COMPLETED|Overall Study||41
945443|NCT00005947|2285002|P1|NOT COMPLETED|Overall Study||57
945444|NCT00005947|2285001|P2|COMPLETED|Overall Study||4
945445|NCT00005947|2285002|P1|COMPLETED|Overall Study||25
945446|NCT00005947|2285001|P2|STARTED|Overall Study||45
945447|NCT00005947|2285002|P1|STARTED|Overall Study||82
945448|NCT00005957|2285012|P2|NOT COMPLETED|Overall Study||28
945449|NCT00005957|2285013|P1|NOT COMPLETED|Overall Study||8
945450|NCT00005957|2285012|P2|COMPLETED|Overall Study||888
945451|NCT00005957|2285013|P1|COMPLETED|Overall Study||908
945452|NCT00005957|2285012|P2|STARTED|Overall Study||916
945453|NCT00005957|2285013|P1|STARTED|Overall Study||916
945454|NCT00006011|2285024|P3|NOT COMPLETED|Overall Study||73
945455|NCT00006011|2285025|P2|NOT COMPLETED|Overall Study||77
945456|NCT00006011|2285026|P1|NOT COMPLETED|Overall Study||65
945457|NCT00006011|2285024|P3|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|0
945458|NCT00006011|2285025|P2|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|221
945459|NCT00006011|2285026|P1|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|223
945460|NCT00006011|2285024|P3|STARTED|Overall Study|total number of participants enrolled, that only received radiation treatment.|73
945461|NCT00006011|2285025|P2|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 2 of study.|298
945462|NCT00006011|2285026|P1|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 1 of study.|288
945463|NCT00006409|2285038|P6|NOT COMPLETED|Post-3 Year Intervention||62
945464|NCT00006409|2285039|P5|NOT COMPLETED|Post-3 Year Intervention||62
945465|NCT00006409|2285040|P4|NOT COMPLETED|Post-3 Year Intervention||0
945466|NCT00006409|2285041|P3|NOT COMPLETED|Post-3 Year Intervention||0
945467|NCT00006409|2285042|P2|NOT COMPLETED|Post-3 Year Intervention||0
945468|NCT00006409|2285043|P1|NOT COMPLETED|Post-3 Year Intervention||0
945469|NCT00006409|2285038|P6|COMPLETED|Post-3 Year Intervention||1714
945470|NCT00006409|2285039|P5|COMPLETED|Post-3 Year Intervention||1664
945471|NCT00006409|2285040|P4|COMPLETED|Post-3 Year Intervention||0
945472|NCT00006409|2285041|P3|COMPLETED|Post-3 Year Intervention||0
945473|NCT00006409|2285042|P2|COMPLETED|Post-3 Year Intervention||0
945474|NCT00006409|2285043|P1|COMPLETED|Post-3 Year Intervention||0
945475|NCT00006409|2285038|P6|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1776
945476|NCT00006409|2285039|P5|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1726
945477|NCT00006409|2285040|P4|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
945478|NCT00006409|2285041|P3|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
945479|NCT00006409|2285042|P2|STARTED|Post-3 Year Intervention||0
945480|NCT00006409|2285043|P1|STARTED|Post-3 Year Intervention||0
945481|NCT00006409|2285038|P6|NOT COMPLETED|Post-2 Year Intervention||0
945482|NCT00006409|2285039|P5|NOT COMPLETED|Post-2 Year Intervention||0
945483|NCT00006409|2285040|P4|NOT COMPLETED|Post-2 Year Intervention||168
945484|NCT00006409|2285041|P3|NOT COMPLETED|Post-2 Year Intervention||251
945485|NCT00006409|2285042|P2|NOT COMPLETED|Post-2 Year Intervention||0
945486|NCT00006409|2285043|P1|NOT COMPLETED|Post-2 Year Intervention||0
945487|NCT00006409|2285038|P6|COMPLETED|Post-2 Year Intervention||0
945488|NCT00006409|2285039|P5|COMPLETED|Post-2 Year Intervention||0
945489|NCT00006409|2285040|P4|COMPLETED|Post-2 Year Intervention||1545
945490|NCT00006409|2285041|P3|COMPLETED|Post-2 Year Intervention||1540
945491|NCT00006409|2285042|P2|COMPLETED|Post-2 Year Intervention||0
945492|NCT00006409|2285043|P1|COMPLETED|Post-2 Year Intervention||0
945493|NCT00006409|2285038|P6|STARTED|Post-2 Year Intervention||0
945494|NCT00006409|2285039|P5|STARTED|Post-2 Year Intervention||0
945495|NCT00006409|2285040|P4|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1713
945496|NCT00006409|2285041|P3|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1791
945497|NCT00006409|2285042|P2|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
945498|NCT00006409|2285043|P1|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
945499|NCT00006409|2285038|P6|NOT COMPLETED|Baseline||0
945500|NCT00006409|2285039|P5|NOT COMPLETED|Baseline||0
945501|NCT00006409|2285040|P4|NOT COMPLETED|Baseline||0
945502|NCT00006409|2285041|P3|NOT COMPLETED|Baseline||0
945503|NCT00006409|2285042|P2|NOT COMPLETED|Baseline||70
945504|NCT00006409|2285043|P1|NOT COMPLETED|Baseline||48
945505|NCT00006409|2285038|P6|COMPLETED|Baseline||0
945506|NCT00006409|2285039|P5|COMPLETED|Baseline||0
945507|NCT00006409|2285040|P4|COMPLETED|Baseline||0
945508|NCT00006409|2285041|P3|COMPLETED|Baseline||0
945509|NCT00006409|2285042|P2|COMPLETED|Baseline||786
945510|NCT00006409|2285043|P1|COMPLETED|Baseline||817
945511|NCT00006409|2285038|P6|STARTED|Baseline||0
945512|NCT00006409|2285039|P5|STARTED|Baseline||0
945513|NCT00006409|2285040|P4|STARTED|Baseline||0
945514|NCT00006409|2285041|P3|STARTED|Baseline||0
945515|NCT00006409|2285042|P2|STARTED|Baseline||856
945516|NCT00006409|2285043|P1|STARTED|Baseline||865
945517|NCT00006478|2285063|P1|NOT COMPLETED|Overall Study||7
945518|NCT00006478|2285063|P1|COMPLETED|Overall Study||12
945519|NCT00006478|2285063|P1|STARTED|Overall Study||19
945520|NCT00006489|2285071|P4|NOT COMPLETED|Overall Study||11
945521|NCT00006489|2285072|P3|NOT COMPLETED|Overall Study||15
945522|NCT00006489|2285073|P2|NOT COMPLETED|Overall Study||14
945523|NCT00006489|2285074|P1|NOT COMPLETED|Overall Study||13
945524|NCT00006489|2285071|P4|COMPLETED|Overall Study||32
945525|NCT00006489|2285072|P3|COMPLETED|Overall Study||25
945526|NCT00006489|2285073|P2|COMPLETED|Overall Study||26
945527|NCT00006489|2285074|P1|COMPLETED|Overall Study||29
945528|NCT00006489|2285071|P4|STARTED|Overall Study||43
945529|NCT00006489|2285072|P3|STARTED|Overall Study||40
945530|NCT00006489|2285073|P2|STARTED|Overall Study||40
945531|NCT00006489|2285074|P1|STARTED|Overall Study||42
945532|NCT00006604|2285099|P17|NOT COMPLETED|Overall Study||9
945533|NCT00006604|2285100|P16|NOT COMPLETED|Overall Study||5
945534|NCT00006604|2285101|P15|NOT COMPLETED|Overall Study||10
945535|NCT00006604|2285102|P14|NOT COMPLETED|Overall Study||6
945536|NCT00006604|2285103|P13|NOT COMPLETED|Overall Study||4
945537|NCT00006604|2285104|P12|NOT COMPLETED|Overall Study||6
945538|NCT00006604|2285105|P11|NOT COMPLETED|Overall Study||8
945539|NCT00006604|2285106|P10|NOT COMPLETED|Overall Study||19
945540|NCT00006604|2285107|P9|NOT COMPLETED|Overall Study||1
945541|NCT00006604|2285108|P8|NOT COMPLETED|Overall Study||3
945542|NCT00006604|2285109|P7|NOT COMPLETED|Overall Study||9
945543|NCT00006604|2285110|P6|NOT COMPLETED|Overall Study||3
945544|NCT00006604|2285111|P5|NOT COMPLETED|Overall Study||2
945545|NCT00006604|2285112|P4|NOT COMPLETED|Overall Study||5
945546|NCT00006604|2285113|P3|NOT COMPLETED|Overall Study||4
945547|NCT00006604|2285114|P2|NOT COMPLETED|Overall Study||0
945548|NCT00006604|2285115|P1|NOT COMPLETED|Overall Study||2
945549|NCT00006604|2285099|P17|COMPLETED|Overall Study||6
945550|NCT00006604|2285100|P16|COMPLETED|Overall Study||1
945551|NCT00006604|2285101|P15|COMPLETED|Overall Study||14
945552|NCT00006604|2285102|P14|COMPLETED|Overall Study||0
945553|NCT00006604|2285103|P13|COMPLETED|Overall Study||22
945554|NCT00006604|2285104|P12|COMPLETED|Overall Study||6
945555|NCT00006604|2285105|P11|COMPLETED|Overall Study||13
945556|NCT00006604|2285106|P10|COMPLETED|Overall Study||6
945557|NCT00006604|2285107|P9|COMPLETED|Overall Study||4
945558|NCT00006604|2285108|P8|COMPLETED|Overall Study||2
945559|NCT00006604|2285109|P7|COMPLETED|Overall Study||12
945560|NCT00006604|2285110|P6|COMPLETED|Overall Study||2
945561|NCT00006604|2285111|P5|COMPLETED|Overall Study||3
945562|NCT00006604|2285112|P4|COMPLETED|Overall Study||1
945563|NCT00006604|2285113|P3|COMPLETED|Overall Study||1
945564|NCT00006604|2285114|P2|COMPLETED|Overall Study||2
945565|NCT00006604|2285115|P1|COMPLETED|Overall Study||4
945566|NCT00006604|2285099|P17|STARTED|Overall Study||15
945567|NCT00006604|2285100|P16|STARTED|Overall Study||6
945568|NCT00006604|2285101|P15|STARTED|Overall Study||24
945569|NCT00006604|2285102|P14|STARTED|Overall Study||6
945570|NCT00006604|2285103|P13|STARTED|Overall Study||26
945571|NCT00006604|2285104|P12|STARTED|Overall Study||12
945572|NCT00006604|2285105|P11|STARTED|Overall Study||21
945573|NCT00006604|2285106|P10|STARTED|Overall Study||25
945574|NCT00006604|2285107|P9|STARTED|Overall Study||5
945575|NCT00006604|2285108|P8|STARTED|Overall Study||5
945576|NCT00006604|2285109|P7|STARTED|Overall Study||21
945577|NCT00006604|2285110|P6|STARTED|Overall Study||5
945578|NCT00006604|2285111|P5|STARTED|Overall Study||5
945579|NCT00006604|2285112|P4|STARTED|Overall Study||6
945580|NCT00006604|2285113|P3|STARTED|Overall Study||5
945581|NCT00006604|2285114|P2|STARTED|Overall Study||2
945582|NCT00006604|2285115|P1|STARTED|Overall Study||6
945583|NCT00006721|2285232|P3|NOT COMPLETED|Overall Study||33
945584|NCT00006721|2285233|P2|NOT COMPLETED|Overall Study||25
945585|NCT00006721|2285234|P1|NOT COMPLETED|Overall Study||4
945586|NCT00006721|2285232|P3|COMPLETED|Overall Study||242
945587|NCT00006721|2285233|P2|COMPLETED|Overall Study||254
945588|NCT00006721|2285234|P1|COMPLETED|Overall Study||13
945589|NCT00006721|2285232|P3|Eligible and Began Protocol Therapy|Overall Study||265
945590|NCT00006721|2285233|P2|Eligible and Began Protocol Therapy|Overall Study||267
945591|NCT00006721|2285234|P1|Eligible and Began Protocol Therapy|Overall Study||14
945592|NCT00006721|2285232|P3|Eligible|Overall Study||265
945593|NCT00006721|2285233|P2|Eligible|Overall Study||267
945594|NCT00006721|2285234|P1|Eligible|Overall Study||15
945595|NCT00006721|2285232|P3|STARTED|Overall Study||275
945596|NCT00006721|2285233|P2|STARTED|Overall Study||279
945597|NCT00006721|2285234|P1|STARTED|Overall Study||17
945598|NCT00006903|2285254|P3|NOT COMPLETED|Overall Study||6
945599|NCT00006903|2285255|P2|NOT COMPLETED|Overall Study||4
945600|NCT00006903|2285256|P1|NOT COMPLETED|Overall Study||10
945601|NCT00006903|2285254|P3|COMPLETED|Overall Study||27
945602|NCT00006903|2285255|P2|COMPLETED|Overall Study||20
945603|NCT00006903|2285256|P1|COMPLETED|Overall Study||0
945604|NCT00006903|2285254|P3|STARTED|Overall Study||33
945605|NCT00006903|2285255|P2|STARTED|Overall Study||24
945606|NCT00006903|2285256|P1|STARTED|Overall Study||10
945607|NCT00006916|2285261|P1|NOT COMPLETED|Overall Study||5
945608|NCT00006916|2285261|P1|COMPLETED|Overall Study|Subjects with survival data for the primary analysis are considered to have completed the study.|14
945609|NCT00006916|2285261|P1|STARTED|Overall Study||19
945610|NCT00007345|2285267|P2|NOT COMPLETED|Overall Study||11
945611|NCT00007345|2285268|P1|NOT COMPLETED|Overall Study||2
945612|NCT00007345|2285267|P2|COMPLETED|Overall Study||73
945613|NCT00007345|2285268|P1|COMPLETED|Overall Study||45
945614|NCT00007345|2285267|P2|STARTED|Overall Study||84
945615|NCT00007345|2285268|P1|STARTED|Overall Study||47
945616|NCT00007475|2285289|P4|NOT COMPLETED|Overall Study||0
945617|NCT00007475|2285290|P3|NOT COMPLETED|Overall Study||0
945618|NCT00007475|2285291|P2|NOT COMPLETED|Overall Study||0
945619|NCT00007475|2285292|P1|NOT COMPLETED|Overall Study||4
945620|NCT00007475|2285289|P4|COMPLETED|Overall Study||0
945621|NCT00007475|2285290|P3|COMPLETED|Overall Study||2
945622|NCT00007475|2285291|P2|COMPLETED|Overall Study||1
945623|NCT00007475|2285292|P1|COMPLETED|Overall Study||8
945624|NCT00007475|2285289|P4|Initiate Cyclophosphamide|Overall Study||0
945625|NCT00007475|2285290|P3|Initiate Cyclophosphamide|Overall Study||2
945626|NCT00007475|2285291|P2|Initiate Cyclophosphamide|Overall Study||1
945627|NCT00007475|2285292|P1|Initiate Cyclophosphamide|Overall Study||12
945628|NCT00007475|2285289|P4|Initial Plasma Exchange|Overall Study||0
945629|NCT00007475|2285290|P3|Initial Plasma Exchange|Overall Study||2
945630|NCT00007475|2285291|P2|Initial Plasma Exchange|Overall Study||1
945631|NCT00007475|2285292|P1|Initial Plasma Exchange|Overall Study||12
945632|NCT00007475|2285289|P4|Post-initial Transplant Proteinuria|Overall Study||0
945633|NCT00007475|2285290|P3|Post-initial Transplant Proteinuria|Overall Study||2
945634|NCT00007475|2285291|P2|Post-initial Transplant Proteinuria|Overall Study||1
945635|NCT00007475|2285292|P1|Post-initial Transplant Proteinuria|Overall Study||12
945636|NCT00007475|2285289|P4|Initial Transplant|Overall Study||0
945637|NCT00007475|2285290|P3|Initial Transplant|Overall Study||2
945638|NCT00007475|2285291|P2|Initial Transplant|Overall Study||1
945639|NCT00007475|2285292|P1|Initial Transplant|Overall Study||12
945730|NCT00006237|2285439|P1|Eligible|Overall Study||203
945640|NCT00007475|2285289|P4|FSGS Permeability Factor (FPF) Assayed|Overall Study||0
945641|NCT00007475|2285290|P3|FSGS Permeability Factor (FPF) Assayed|Overall Study||2
945642|NCT00007475|2285291|P2|FSGS Permeability Factor (FPF) Assayed|Overall Study||1
945643|NCT00007475|2285292|P1|FSGS Permeability Factor (FPF) Assayed|Overall Study|FSGS Permeability Factor's provisional assay only applied to minority of early enrollees, by design.|0
945644|NCT00007475|2285289|P4|STARTED|Overall Study||0
945645|NCT00007475|2285290|P3|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|2
945646|NCT00007475|2285291|P2|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|1
945647|NCT00007475|2285292|P1|STARTED|Overall Study|[ arm reflects un-assayed participants' disposition ]|12
945648|NCT00007644|2285314|P2|NOT COMPLETED|Overall Study||0
945649|NCT00007644|2285315|P1|NOT COMPLETED|Overall Study||0
945650|NCT00007644|2285314|P2|COMPLETED|Overall Study||367
945651|NCT00007644|2285315|P1|COMPLETED|Overall Study||364
945652|NCT00007644|2285314|P2|STARTED|Overall Study||367
945653|NCT00007644|2285315|P1|STARTED|Overall Study||364
945654|NCT00005669|2285323|P2|NOT COMPLETED|Overall Study||7
945655|NCT00005669|2285324|P1|NOT COMPLETED|Overall Study||8
945656|NCT00005669|2285323|P2|COMPLETED|Overall Study||40
945657|NCT00005669|2285324|P1|COMPLETED|Overall Study||45
945658|NCT00005669|2285323|P2|STARTED|Overall Study||47
945659|NCT00005669|2285324|P1|STARTED|Overall Study||53
945660|NCT00010439|2285338|P1|NOT COMPLETED|Overall Study||0
945661|NCT00010439|2285338|P1|COMPLETED|Overall Study||10
945662|NCT00010439|2285338|P1|6 Months|Overall Study||10
945663|NCT00010439|2285338|P1|STARTED|Overall Study||10
945664|NCT00010803|2285345|P2|NOT COMPLETED|Overall Study||98
945665|NCT00010803|2285346|P1|NOT COMPLETED|Overall Study||97
945666|NCT00010803|2285345|P2|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1426
945667|NCT00010803|2285346|P1|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1448
945668|NCT00010803|2285345|P2|STARTED|Overall Study|Randomized|1524
945669|NCT00010803|2285346|P1|STARTED|Overall Study|Randomized|1545
945670|NCT00011986|2285361|P5|NOT COMPLETED|Overall Study||0
945671|NCT00011986|2285362|P4|NOT COMPLETED|Overall Study||0
945672|NCT00011986|2285363|P3|NOT COMPLETED|Overall Study||0
945673|NCT00011986|2285364|P2|NOT COMPLETED|Overall Study||0
945674|NCT00011986|2285365|P1|NOT COMPLETED|Overall Study||0
945675|NCT00011986|2285361|P5|COMPLETED|Overall Study||861
945676|NCT00011986|2285362|P4|COMPLETED|Overall Study||861
945677|NCT00011986|2285363|P3|COMPLETED|Overall Study||862
945678|NCT00011986|2285364|P2|COMPLETED|Overall Study||864
945679|NCT00011986|2285365|P1|COMPLETED|Overall Study||864
945680|NCT00011986|2285361|P5|Initiated Treatment|Overall Study||851
945681|NCT00011986|2285362|P4|Initiated Treatment|Overall Study||846
945682|NCT00011986|2285363|P3|Initiated Treatment|Overall Study||854
945683|NCT00011986|2285364|P2|Initiated Treatment|Overall Study||860
945684|NCT00011986|2285365|P1|Initiated Treatment|Overall Study||862
945685|NCT00011986|2285361|P5|STARTED|Overall Study||861
945686|NCT00011986|2285362|P4|STARTED|Overall Study||861
945687|NCT00011986|2285363|P3|STARTED|Overall Study||862
945688|NCT00011986|2285364|P2|STARTED|Overall Study||864
945689|NCT00011986|2285365|P1|STARTED|Overall Study||864
945690|NCT00012012|2285379|P2|NOT COMPLETED|Overall Study||3
945691|NCT00012012|2285380|P1|NOT COMPLETED|Overall Study||1
945692|NCT00012012|2285379|P2|COMPLETED|Overall Study||15
945693|NCT00012012|2285380|P1|COMPLETED|Overall Study||26
945694|NCT00012012|2285379|P2|STARTED|Overall Study||18
945695|NCT00012012|2285380|P1|STARTED|Overall Study||27
945696|NCT00012298|2285393|P7|NOT COMPLETED|Overall Study||0
945697|NCT00012298|2285394|P6|NOT COMPLETED|Overall Study||0
945698|NCT00012298|2285395|P5|NOT COMPLETED|Overall Study||0
945699|NCT00012298|2285396|P4|NOT COMPLETED|Overall Study||0
945700|NCT00012298|2285397|P3|NOT COMPLETED|Overall Study||0
945701|NCT00012298|2285398|P2|NOT COMPLETED|Overall Study||0
945702|NCT00012298|2285399|P1|NOT COMPLETED|Overall Study||0
945703|NCT00012298|2285393|P7|COMPLETED|Overall Study||39
945704|NCT00012298|2285394|P6|COMPLETED|Overall Study||6
945705|NCT00012298|2285395|P5|COMPLETED|Overall Study||5
945706|NCT00012298|2285396|P4|COMPLETED|Overall Study||4
945707|NCT00012298|2285397|P3|COMPLETED|Overall Study||9
945708|NCT00012298|2285398|P2|COMPLETED|Overall Study||7
945709|NCT00012298|2285399|P1|COMPLETED|Overall Study||11
945710|NCT00012298|2285393|P7|STARTED|Overall Study||39
945711|NCT00012298|2285394|P6|STARTED|Overall Study||6
945712|NCT00012298|2285395|P5|STARTED|Overall Study||5
945713|NCT00012298|2285396|P4|STARTED|Overall Study||4
945714|NCT00012298|2285397|P3|STARTED|Overall Study||9
945715|NCT00012298|2285398|P2|STARTED|Overall Study||7
945716|NCT00012298|2285399|P1|STARTED|Overall Study||11
945717|NCT00006110|2285423|P2|NOT COMPLETED|Overall Study||0
945718|NCT00006110|2285424|P1|NOT COMPLETED|Overall Study||0
945719|NCT00006110|2285423|P2|COMPLETED|Overall Study||30
945720|NCT00006110|2285424|P1|COMPLETED|Overall Study||52
945721|NCT00006110|2285423|P2|STARTED|Overall Study||30
945722|NCT00006110|2285424|P1|STARTED|Overall Study||52
945723|NCT00006237|2285438|P2|NOT COMPLETED|Overall Study||61
945724|NCT00006237|2285439|P1|NOT COMPLETED|Overall Study||125
945725|NCT00006237|2285438|P2|COMPLETED|Overall Study||159
945726|NCT00006237|2285439|P1|COMPLETED|Overall Study||87
945727|NCT00006237|2285438|P2|Eligible and Treated|Overall Study||199
945728|NCT00006237|2285439|P1|Eligible and Treated|Overall Study||203
945729|NCT00006237|2285438|P2|Eligible|Overall Study||200
945731|NCT00006237|2285438|P2|STARTED|Overall Study||220
945732|NCT00006237|2285439|P1|STARTED|Overall Study||212
945733|NCT00006244|2285449|P1|NOT COMPLETED|Overall Study||0
945734|NCT00006244|2285449|P1|COMPLETED|Overall Study||36
945735|NCT00006244|2285449|P1|STARTED|Overall Study||36
945736|NCT00006289|2285460|P2|NOT COMPLETED|Second Intervention (5 Weeks)||1
945737|NCT00006289|2285461|P1|NOT COMPLETED|Second Intervention (5 Weeks)||1
945738|NCT00006289|2285460|P2|COMPLETED|Second Intervention (5 Weeks)||9
945739|NCT00006289|2285461|P1|COMPLETED|Second Intervention (5 Weeks)||9
945740|NCT00006289|2285460|P2|STARTED|Second Intervention (5 Weeks)||10
945741|NCT00006289|2285461|P1|STARTED|Second Intervention (5 Weeks)||10
945742|NCT00006289|2285460|P2|NOT COMPLETED|Washout (>= 1 Week)||0
945743|NCT00006289|2285461|P1|NOT COMPLETED|Washout (>= 1 Week)||0
945744|NCT00006289|2285460|P2|COMPLETED|Washout (>= 1 Week)||10
945745|NCT00006289|2285461|P1|COMPLETED|Washout (>= 1 Week)||10
945746|NCT00006289|2285460|P2|STARTED|Washout (>= 1 Week)||10
945747|NCT00006289|2285461|P1|STARTED|Washout (>= 1 Week)||10
945748|NCT00006289|2285460|P2|NOT COMPLETED|First Intervention (5 Weeks)||0
945749|NCT00006289|2285461|P1|NOT COMPLETED|First Intervention (5 Weeks)||1
945750|NCT00006289|2285460|P2|COMPLETED|First Intervention (5 Weeks)||10
945751|NCT00006289|2285461|P1|COMPLETED|First Intervention (5 Weeks)||10
945752|NCT00006289|2285460|P2|STARTED|First Intervention (5 Weeks)||10
945753|NCT00006289|2285461|P1|STARTED|First Intervention (5 Weeks)||11
945754|NCT00006305|2285481|P4|NOT COMPLETED|Overall Study||14
945755|NCT00006305|2285482|P3|NOT COMPLETED|Overall Study||15
945756|NCT00006305|2285483|P2|NOT COMPLETED|Overall Study||10
945757|NCT00006305|2285484|P1|NOT COMPLETED|Overall Study||17
945758|NCT00006305|2285481|P4|COMPLETED|Overall Study||585
945759|NCT00006305|2285482|P3|COMPLETED|Overall Study||578
945760|NCT00006305|2285483|P2|COMPLETED|Overall Study||574
945761|NCT00006305|2285484|P1|COMPLETED|Overall Study||575
945762|NCT00006305|2285481|P4|STARTED|Overall Study||599
945763|NCT00006305|2285482|P3|STARTED|Overall Study||593
945764|NCT00006305|2285483|P2|STARTED|Overall Study||584
945765|NCT00006305|2285484|P1|STARTED|Overall Study||592
945766|NCT00006389|2285498|P1|NOT COMPLETED|Overall Study||1
945767|NCT00006389|2285498|P1|COMPLETED|Overall Study||11
945768|NCT00006389|2285498|P1|STARTED|Overall Study||12
945769|NCT00006392|2285508|P4|NOT COMPLETED|Overall Study||160
945770|NCT00006392|2285509|P3|NOT COMPLETED|Overall Study||160
945771|NCT00006392|2285510|P2|NOT COMPLETED|Overall Study||158
945772|NCT00006392|2285511|P1|NOT COMPLETED|Overall Study||167
945773|NCT00006392|2285508|P4|COMPLETED|Overall Study||8696
945774|NCT00006392|2285509|P3|COMPLETED|Overall Study||8703
945775|NCT00006392|2285510|P2|COMPLETED|Overall Study||8752
945776|NCT00006392|2285511|P1|COMPLETED|Overall Study||8737
945777|NCT00006392|2285508|P4|STARTED|Overall Study||8856
945778|NCT00006392|2285509|P3|STARTED|Overall Study||8863
945779|NCT00006392|2285510|P2|STARTED|Overall Study||8910
945780|NCT00006392|2285511|P1|STARTED|Overall Study||8904
945781|NCT00014495|2285545|P4|NOT COMPLETED|Overall Study||1
945782|NCT00014495|2285546|P3|NOT COMPLETED|Overall Study||1
945783|NCT00014495|2285547|P2|NOT COMPLETED|Overall Study||0
945784|NCT00014495|2285548|P1|NOT COMPLETED|Overall Study||0
945785|NCT00014495|2285545|P4|COMPLETED|Overall Study||5
945786|NCT00014495|2285546|P3|COMPLETED|Overall Study||19
945787|NCT00014495|2285547|P2|COMPLETED|Overall Study||3
945788|NCT00014495|2285548|P1|COMPLETED|Overall Study||3
945789|NCT00014495|2285545|P4|STARTED|Overall Study||6
945790|NCT00014495|2285546|P3|STARTED|Overall Study||20
945791|NCT00014495|2285547|P2|STARTED|Overall Study||3
945792|NCT00014495|2285548|P1|STARTED|Overall Study||3
945793|NCT00014560|2285555|P1|NOT COMPLETED|Overall Study||3
945794|NCT00014560|2285555|P1|COMPLETED|Overall Study||0
945795|NCT00014560|2285555|P1|STARTED|Overall Study||3
945796|NCT00014911|2285559|P1|NOT COMPLETED|Overall Study||11
945797|NCT00014911|2285559|P1|COMPLETED|Overall Study|One subject experienced pneumonia, myocardial infarction, and acute renal failure|25
945798|NCT00014911|2285559|P1|STARTED|Overall Study||36
945799|NCT00015457|2285568|P2|NOT COMPLETED|Second Intervention||0
945800|NCT00015457|2285569|P1|NOT COMPLETED|Second Intervention||1
945801|NCT00015457|2285568|P2|COMPLETED|Second Intervention||5
945802|NCT00015457|2285569|P1|COMPLETED|Second Intervention||7
945803|NCT00015457|2285568|P2|STARTED|Second Intervention||5
945804|NCT00015457|2285569|P1|STARTED|Second Intervention||8
945805|NCT00015457|2285568|P2|NOT COMPLETED|First Intervention||3
945806|NCT00015457|2285569|P1|NOT COMPLETED|First Intervention||0
945807|NCT00015457|2285568|P2|COMPLETED|First Intervention||5
945808|NCT00015457|2285569|P1|COMPLETED|First Intervention||8
945809|NCT00015457|2285568|P2|STARTED|First Intervention||8
945810|NCT00015457|2285569|P1|STARTED|First Intervention||8
945811|NCT00015847|2285577|P1|NOT COMPLETED|Overall Study||0
945812|NCT00015847|2285577|P1|COMPLETED|Overall Study||25
945813|NCT00015847|2285577|P1|STARTED|Overall Study||25
945814|NCT00016354|2285583|P8|NOT COMPLETED|Overall Study||1
945815|NCT00016354|2285584|P7|NOT COMPLETED|Overall Study||0
945816|NCT00016354|2285585|P6|NOT COMPLETED|Overall Study||0
945817|NCT00016354|2285586|P5|NOT COMPLETED|Overall Study||0
945818|NCT00016354|2285587|P4|NOT COMPLETED|Overall Study||0
945819|NCT00016354|2285588|P3|NOT COMPLETED|Overall Study||0
945820|NCT00016354|2285589|P2|NOT COMPLETED|Overall Study||0
945821|NCT00016354|2285590|P1|NOT COMPLETED|Overall Study||0
945822|NCT00016354|2285583|P8|COMPLETED|Overall Study||6
945823|NCT00016354|2285584|P7|COMPLETED|Overall Study||6
945824|NCT00016354|2285585|P6|COMPLETED|Overall Study||1
945825|NCT00016354|2285586|P5|COMPLETED|Overall Study||1
945826|NCT00016354|2285587|P4|COMPLETED|Overall Study||1
945827|NCT00016354|2285588|P3|COMPLETED|Overall Study||1
945828|NCT00016354|2285589|P2|COMPLETED|Overall Study||1
945829|NCT00016354|2285590|P1|COMPLETED|Overall Study||1
945830|NCT00016354|2285583|P8|STARTED|Overall Study||7
945831|NCT00016354|2285584|P7|STARTED|Overall Study||6
945832|NCT00016354|2285585|P6|STARTED|Overall Study||1
945833|NCT00016354|2285586|P5|STARTED|Overall Study||1
945834|NCT00016354|2285587|P4|STARTED|Overall Study||1
945835|NCT00016354|2285588|P3|STARTED|Overall Study||1
945836|NCT00016354|2285589|P2|STARTED|Overall Study||1
945837|NCT00016354|2285590|P1|STARTED|Overall Study||1
945838|NCT00006151|2285596|P2|NOT COMPLETED|Overall Study||14
945839|NCT00006151|2285597|P1|NOT COMPLETED|Overall Study||13
945840|NCT00006151|2285596|P2|COMPLETED|Overall Study||16
945841|NCT00006151|2285597|P1|COMPLETED|Overall Study||17
945842|NCT00006151|2285596|P2|STARTED|Overall Study||30
945843|NCT00006151|2285597|P1|STARTED|Overall Study||30
945844|NCT00006156|2285605|P2|NOT COMPLETED|Overall Study||0
945845|NCT00006156|2285606|P1|NOT COMPLETED|Overall Study||0
945846|NCT00006156|2285605|P2|COMPLETED|Overall Study||7
945847|NCT00006156|2285606|P1|COMPLETED|Overall Study||42
945848|NCT00006156|2285605|P2|STARTED|Overall Study||7
945849|NCT00006156|2285606|P1|STARTED|Overall Study||42
945850|NCT00006164|2285615|P2|NOT COMPLETED|Overall Study||81
945851|NCT00006164|2285616|P1|NOT COMPLETED|Overall Study||70
945852|NCT00006164|2285615|P2|COMPLETED|Overall Study|81 Withdrew or were lost to followup; 9 took peginterferon outside of protocol|452
945853|NCT00006164|2285616|P1|COMPLETED|Overall Study|70 Withdrew or were lost to followup; 158 Discontinued peginterferon but were followed|447
945854|NCT00006164|2285615|P2|STARTED|Overall Study||533
945855|NCT00006164|2285616|P1|STARTED|Overall Study||517
945856|NCT00006170|2285644|P4|NOT COMPLETED|Overall Study||39
945857|NCT00006170|2285645|P3|NOT COMPLETED|Overall Study||43
945858|NCT00006170|2285646|P2|NOT COMPLETED|Overall Study||50
945859|NCT00006170|2285647|P1|NOT COMPLETED|Overall Study||49
945860|NCT00006170|2285644|P4|COMPLETED|Overall Study||28
945861|NCT00006170|2285645|P3|COMPLETED|Overall Study||46
945862|NCT00006170|2285646|P2|COMPLETED|Overall Study||37
945863|NCT00006170|2285647|P1|COMPLETED|Overall Study||57
945864|NCT00006170|2285644|P4|STARTED|Overall Study||67
945865|NCT00006170|2285645|P3|STARTED|Overall Study||89
945866|NCT00006170|2285646|P2|STARTED|Overall Study||87
945867|NCT00006170|2285647|P1|STARTED|Overall Study||106
945868|NCT00006178|2285665|P1|NOT COMPLETED|Overall Study||0
945869|NCT00006178|2285665|P1|COMPLETED|Overall Study||12
945870|NCT00006178|2285665|P1|STARTED|Overall Study||12
945877|NCT00008138|2285682|P1|NOT COMPLETED|Post-Cytoreduction Chemotherapy||8
945878|NCT00008138|2285682|P1|COMPLETED|Post-Cytoreduction Chemotherapy||18
945879|NCT00008138|2285682|P1|STARTED|Post-Cytoreduction Chemotherapy|Among 36 patients from previous period, 5 patients rejected and 5 patients are ineligible.|26
945880|NCT00008138|2285682|P1|NOT COMPLETED|Interval Debulking||2
945881|NCT00008138|2285682|P1|COMPLETED|Interval Debulking||36
945882|NCT00008138|2285682|P1|Received Protocol Surgery|Interval Debulking||36
945883|NCT00008138|2285682|P1|STARTED|Interval Debulking||38
945884|NCT00008138|2285682|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||20
945885|NCT00008138|2285682|P1|COMPLETED|Neoadjuvant Chemotherapy||38
945886|NCT00008138|2285682|P1|Eligible|Neoadjuvant Chemotherapy||58
945887|NCT00008138|2285682|P1|STARTED|Neoadjuvant Chemotherapy||58
945888|NCT00008385|2285690|P2|NOT COMPLETED|Overall Study||802
945889|NCT00008385|2285691|P1|NOT COMPLETED|Overall Study||387
945890|NCT00008385|2285690|P2|COMPLETED|Overall Study||238
945891|NCT00008385|2285691|P1|COMPLETED|Overall Study||134
945892|NCT00008385|2285690|P2|Off Treatment Reasons Reported|Overall Study||795
945893|NCT00008385|2285691|P1|Off Treatment Reasons Reported|Overall Study||398
945894|NCT00008385|2285690|P2|Treated|Overall Study||865
945895|NCT00008385|2285691|P1|Treated|Overall Study||477
945896|NCT00008385|2285690|P2|STARTED|Overall Study||1040
945897|NCT00008385|2285691|P1|STARTED|Overall Study||521
945898|NCT00009737|2285703|P2|NOT COMPLETED|Overall Study||123
945899|NCT00009737|2285704|P1|NOT COMPLETED|Overall Study||170
945900|NCT00009737|2285703|P2|COMPLETED|Overall Study||860
945901|NCT00009737|2285704|P1|COMPLETED|Overall Study||834
945902|NCT00009737|2285703|P2|STARTED|Overall Study||983
945903|NCT00009737|2285704|P1|STARTED|Overall Study||1004
945904|NCT00010257|2285722|P2|NOT COMPLETED|Overall Study||0
945905|NCT00010257|2285723|P1|NOT COMPLETED|Overall Study||1
945906|NCT00010257|2285722|P2|COMPLETED|Overall Study||21
945907|NCT00010257|2285723|P1|COMPLETED|Overall Study||24
945908|NCT00010257|2285722|P2|STARTED|Overall Study||21
945909|NCT00010257|2285723|P1|STARTED|Overall Study||25
945910|NCT00016913|2285731|P1|NOT COMPLETED|Overall Study||0
945911|NCT00016913|2285731|P1|COMPLETED|Overall Study||27
945912|NCT00016913|2285731|P1|STARTED|Overall Study||27
945913|NCT00019604|2285737|P1|NOT COMPLETED|Overall Study||39
945914|NCT00019604|2285737|P1|COMPLETED|Overall Study||5
945915|NCT00019604|2285737|P1|STARTED|Overall Study||44
945916|NCT00019747|2285752|P2|NOT COMPLETED|Overall Study||0
945917|NCT00019747|2285753|P1|NOT COMPLETED|Overall Study||0
945918|NCT00019747|2285752|P2|COMPLETED|Overall Study||16
945919|NCT00019747|2285753|P1|COMPLETED|Overall Study||23
945920|NCT00019747|2285752|P2|STARTED|Overall Study||16
945921|NCT00019747|2285753|P1|STARTED|Overall Study||23
945922|NCT00020722|2285759|P1|NOT COMPLETED|Overall Study||0
945923|NCT00020722|2285759|P1|COMPLETED|Overall Study||7
945924|NCT00020722|2285759|P1|STARTED|Overall Study||7
945925|NCT00021229|2285767|P3|NOT COMPLETED|Overall Study||16
945926|NCT00021229|2285768|P2|NOT COMPLETED|Overall Study||33
945927|NCT00021229|2285769|P1|NOT COMPLETED|Overall Study||35
945928|NCT00021229|2285767|P3|COMPLETED|Overall Study||0
945929|NCT00021229|2285768|P2|COMPLETED|Overall Study||0
945930|NCT00021229|2285769|P1|COMPLETED|Overall Study|1 participant completed 13 courses of therapy|1
945931|NCT00021229|2285767|P3|Enrolled in Phase II|Overall Study|Participants from stratum IIB did not participate in the phase II part of the study.|0
945932|NCT00021229|2285768|P2|Enrolled in Phase II|Overall Study|Participants from stratum IIA did not participate in the phase II part of the study.|0
945933|NCT00021229|2285769|P1|Enrolled in Phase II|Overall Study|Thirteen participants treated at the MTD in the phase I were also part of the phase II.|14
945934|NCT00021229|2285767|P3|Maximum Tolerated Dose (MTD) Estimation|Overall Study|4 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|12
945935|NCT00021229|2285768|P2|Maximum Tolerated Dose (MTD) Estimation|Overall Study|13 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|20
945936|NCT00021229|2285769|P1|Maximum Tolerated Dose (MTD) Estimation|Overall Study|12 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|23
945937|NCT00021229|2285767|P3|Enrolled in Phase I|Overall Study||16
945938|NCT00021229|2285768|P2|Enrolled in Phase I|Overall Study||33
945939|NCT00021229|2285769|P1|Enrolled in Phase I|Overall Study||35
945940|NCT00021229|2285767|P3|STARTED|Overall Study||16
945941|NCT00021229|2285768|P2|STARTED|Overall Study||33
945942|NCT00021229|2285769|P1|STARTED|Overall Study||36
945943|NCT00021255|2285798|P3|NOT COMPLETED|Overall Study||149
945944|NCT00021255|2285799|P2|NOT COMPLETED|Overall Study||270
945945|NCT00021255|2285800|P1|NOT COMPLETED|Overall Study||121
945946|NCT00021255|2285798|P3|COMPLETED|Overall Study||926
945947|NCT00021255|2285799|P2|COMPLETED|Overall Study||804
945948|NCT00021255|2285800|P1|COMPLETED|Overall Study||952
945949|NCT00021255|2285798|P3|Safety Population|Overall Study|1056 participants received TCH.|1056
945950|NCT00021255|2285799|P2|Safety Population|Overall Study|1100 participants received AC-TH (1066 from AC-TH arm, 33 from AC-T arm and 1 from TCH arm).|1100
945951|NCT00021255|2285800|P1|Safety Population|Overall Study|1018 participants received AC-T (1012 from AC-T arm, 6 from AC-TH arm).|1018
945952|NCT00021255|2285798|P3|Treated|Overall Study||1057
945953|NCT00021255|2285799|P2|Treated|Overall Study||1072
945954|NCT00021255|2285800|P1|Treated|Overall Study||1045
945955|NCT00021255|2285798|P3|STARTED|Overall Study|Randomized|1075
945956|NCT00021255|2285799|P2|STARTED|Overall Study|Randomized|1074
945957|NCT00021255|2285800|P1|STARTED|Overall Study|Randomized|1073
945958|NCT00021541|2285816|P2|NOT COMPLETED|Period 2-crossover||11
945959|NCT00021541|2285817|P1|NOT COMPLETED|Period 2-crossover||10
945960|NCT00021541|2285816|P2|COMPLETED|Period 2-crossover||12
945961|NCT00021541|2285817|P1|COMPLETED|Period 2-crossover||10
945962|NCT00021541|2285816|P2|STARTED|Period 2-crossover||23
945963|NCT00021541|2285817|P1|STARTED|Period 2-crossover||20
945964|NCT00021541|2285816|P2|NOT COMPLETED|Period 1-First Treatment||8
945965|NCT00021541|2285817|P1|NOT COMPLETED|Period 1-First Treatment||11
945966|NCT00021541|2285816|P2|COMPLETED|Period 1-First Treatment||23
945967|NCT00021541|2285817|P1|COMPLETED|Period 1-First Treatment||20
945968|NCT00021541|2285816|P2|Ineligible Patients|Period 1-First Treatment||2
945969|NCT00021541|2285817|P1|Ineligible Patients|Period 1-First Treatment||0
945970|NCT00021541|2285816|P2|Pts Who Progressed to Second Treatment|Period 1-First Treatment||23
945971|NCT00021541|2285817|P1|Pts Who Progressed to Second Treatment|Period 1-First Treatment||20
945972|NCT00021541|2285816|P2|STARTED|Period 1-First Treatment|These are the patients randomized to receive placebo. Two of these patients were deemed ineligible.|31
945973|NCT00021541|2285817|P1|STARTED|Period 1-First Treatment||31
945974|NCT00013611|2285825|P2|NOT COMPLETED|Overall Study||100
945975|NCT00013611|2285826|P1|NOT COMPLETED|Overall Study||91
945976|NCT00013611|2285825|P2|COMPLETED|Overall Study||746
945977|NCT00013611|2285826|P1|COMPLETED|Overall Study||758
945978|NCT00013611|2285825|P2|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|846
945979|NCT00013611|2285826|P1|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|849
945980|NCT00022490|2285842|P1|NOT COMPLETED|Overall Study||0
945981|NCT00022490|2285842|P1|COMPLETED|Overall Study||24
945982|NCT00022490|2285842|P1|STARTED|Overall Study||24
945983|NCT00022516|2285848|P2|NOT COMPLETED|Overall Study||230
945984|NCT00022516|2285849|P1|NOT COMPLETED|Overall Study||3
945985|NCT00022516|2285848|P2|COMPLETED|Overall Study||314
945986|NCT00022516|2285849|P1|COMPLETED|Overall Study||539
945987|NCT00022516|2285848|P2|STARTED|Overall Study||544
945988|NCT00022516|2285849|P1|STARTED|Overall Study||542
945989|NCT00022659|2285861|P1|NOT COMPLETED|Overall Study||2
945990|NCT00022659|2285861|P1|COMPLETED|Overall Study|Eligible and treated patients.|62
945991|NCT00022659|2285861|P1|STARTED|Overall Study||64
945992|NCT00022672|2285869|P2|NOT COMPLETED|Extension Phase||51
945993|NCT00022672|2285870|P1|NOT COMPLETED|Extension Phase||3
945994|NCT00022672|2285869|P2|COMPLETED|Extension Phase||7
945995|NCT00022672|2285870|P1|COMPLETED|Extension Phase||11
945996|NCT00022672|2285869|P2|Safety Set: Received Study Drug|Extension Phase||58
945997|NCT00022672|2285870|P1|Safety Set: Received Study Drug|Extension Phase||14
945998|NCT00022672|2285869|P2|STARTED|Extension Phase||58
945999|NCT00022672|2285870|P1|STARTED|Extension Phase|2 patients completed Main Phase; but did not enter Extension (1-did not cooperate and 1-withdrew).|14
946000|NCT00022672|2285869|P2|NOT COMPLETED|Main Phase: 24 Months||100
946001|NCT00022672|2285870|P1|NOT COMPLETED|Main Phase: 24 Months||87
946002|NCT00022672|2285869|P2|COMPLETED|Main Phase: 24 Months||4
946003|NCT00022672|2285870|P1|COMPLETED|Main Phase: 24 Months||16
946004|NCT00022672|2285869|P2|Safety Set: Received Study Drug|Main Phase: 24 Months||104
946005|NCT00022672|2285870|P1|Safety Set: Received Study Drug|Main Phase: 24 Months||103
946006|NCT00022672|2285869|P2|STARTED|Main Phase: 24 Months||104
946007|NCT00022672|2285870|P1|STARTED|Main Phase: 24 Months||103
946008|NCT00022698|2285905|P2|NOT COMPLETED|Overall Study||35
946009|NCT00022698|2285906|P1|NOT COMPLETED|Overall Study||8
946010|NCT00022698|2285905|P2|COMPLETED|Overall Study||17
946011|NCT00022698|2285906|P1|COMPLETED|Overall Study||7
946012|NCT00022698|2285905|P2|STARTED|Overall Study||52
946013|NCT00022698|2285906|P1|STARTED|Overall Study||15
946014|NCT00022763|2285931|P2|NOT COMPLETED|Overall Study||17
946015|NCT00022763|2285932|P1|NOT COMPLETED|Overall Study||9
946016|NCT00022763|2285931|P2|COMPLETED|Overall Study||11
946017|NCT00022763|2285932|P1|COMPLETED|Overall Study||15
946018|NCT00022763|2285931|P2|STARTED|Overall Study||28
946019|NCT00022763|2285932|P1|STARTED|Overall Study||24
946020|NCT00023309|2285957|P2|NOT COMPLETED|Overall Study||0
946021|NCT00023309|2285958|P1|NOT COMPLETED|Overall Study||0
946022|NCT00023309|2285957|P2|COMPLETED|Overall Study||19
946023|NCT00023309|2285958|P1|COMPLETED|Overall Study||22
946024|NCT00023309|2285957|P2|STARTED|Overall Study||19
946025|NCT00023309|2285958|P1|STARTED|Overall Study||22
946026|NCT00023322|2285972|P1|NOT COMPLETED|Overall Study||1
946027|NCT00023322|2285972|P1|COMPLETED|Overall Study||12
946028|NCT00023322|2285972|P1|STARTED|Overall Study||13
946029|NCT00023452|2285979|P2|NOT COMPLETED|Overall Study||872
946030|NCT00023452|2285980|P1|NOT COMPLETED|Overall Study||1323
946031|NCT00023452|2285979|P2|COMPLETED|Overall Study||3273
946032|NCT00023452|2285980|P1|COMPLETED|Overall Study||2585
946033|NCT00023452|2285979|P2|Completed Study|Overall Study||3475
946034|NCT00023452|2285980|P1|Completed Study|Overall Study||3174
946035|NCT00023452|2285979|P2|Not Treated|Overall Study||105
946036|NCT00023452|2285980|P1|Not Treated|Overall Study||149
946037|NCT00023452|2285979|P2|Completed Treatment|Overall Study||3273
946038|NCT00023452|2285980|P1|Completed Treatment|Overall Study||2585
946039|NCT00023452|2285979|P2|Enrolled as Part of a Cluster|Overall Study||971
946040|NCT00023452|2285980|P1|Enrolled as Part of a Cluster|Overall Study||718
946041|NCT00023452|2285979|P2|Randomized|Overall Study||3174
946042|NCT00023452|2285980|P1|Randomized|Overall Study||3190
946043|NCT00023452|2285979|P2|STARTED|Overall Study||4145
946044|NCT00023452|2285980|P1|STARTED|Overall Study||3908
946045|NCT00023595|2286009|P5|NOT COMPLETED|10 Year Follow up||0
946046|NCT00023595|2286010|P4|NOT COMPLETED|10 Year Follow up||0
946047|NCT00023595|2286011|P3|NOT COMPLETED|10 Year Follow up||3
946048|NCT00023595|2286012|P2|NOT COMPLETED|10 Year Follow up||10
946049|NCT00023595|2286013|P1|NOT COMPLETED|10 Year Follow up||12
946050|NCT00023595|2286009|P5|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
946051|NCT00023595|2286010|P4|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
946052|NCT00023595|2286011|P3|COMPLETED|10 Year Follow up||73
946053|NCT00023595|2286012|P2|COMPLETED|10 Year Follow up||524
946054|NCT00023595|2286013|P1|COMPLETED|10 Year Follow up||590
946055|NCT00023595|2286009|P5|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
946056|NCT00023595|2286010|P4|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
946057|NCT00023595|2286011|P3|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|76
946058|NCT00023595|2286012|P2|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|534
946059|NCT00023595|2286013|P1|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|602
946060|NCT00023595|2286009|P5|NOT COMPLETED|5 Year Follow up||3
946061|NCT00023595|2286010|P4|NOT COMPLETED|5 Year Follow up||7
946062|NCT00023595|2286011|P3|NOT COMPLETED|5 Year Follow up||1
946063|NCT00023595|2286012|P2|NOT COMPLETED|5 Year Follow up||2
946064|NCT00023595|2286013|P1|NOT COMPLETED|5 Year Follow up||2
946065|NCT00023595|2286009|P5|COMPLETED|5 Year Follow up||498
946066|NCT00023595|2286010|P4|COMPLETED|5 Year Follow up||416
946067|NCT00023595|2286011|P3|COMPLETED|5 Year Follow up||75
946068|NCT00023595|2286012|P2|COMPLETED|5 Year Follow up||532
946069|NCT00023595|2286013|P1|COMPLETED|5 Year Follow up||600
946070|NCT00023595|2286009|P5|STARTED|5 Year Follow up||501
946071|NCT00023595|2286010|P4|STARTED|5 Year Follow up|76 of stratum B pts who were randomized to med therapy + CABG group belong to both H01 and H02.|423
946072|NCT00023595|2286011|P3|STARTED|5 Year Follow up||76
946073|NCT00023595|2286012|P2|STARTED|5 Year Follow up||534
946074|NCT00023595|2286013|P1|STARTED|5 Year Follow up||602
946075|NCT00023673|2286225|P4|NOT COMPLETED|Overall Study||2
946076|NCT00023673|2286226|P3|NOT COMPLETED|Overall Study||0
946077|NCT00023673|2286227|P2|NOT COMPLETED|Overall Study||0
946078|NCT00023673|2286228|P1|NOT COMPLETED|Overall Study||0
946079|NCT00023673|2286225|P4|COMPLETED|Overall Study|Phase II subjects contributing data to primary analysis are considered to have completed the study.|44
946080|NCT00023673|2286226|P3|COMPLETED|Overall Study|This arm was not used since further de-escalation was not required.|0
946081|NCT00023673|2286227|P2|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|9
946082|NCT00023673|2286228|P1|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|8
946083|NCT00023673|2286225|P4|STARTED|Overall Study||46
946084|NCT00023673|2286226|P3|STARTED|Overall Study||0
946085|NCT00023673|2286227|P2|STARTED|Overall Study||9
946086|NCT00023673|2286228|P1|STARTED|Overall Study||8
946087|NCT00023712|2286237|P2|NOT COMPLETED|Overall Study||1
946088|NCT00023712|2286238|P1|NOT COMPLETED|Overall Study||2
946089|NCT00023712|2286237|P2|COMPLETED|Overall Study|total number of participants eligible and evaluable|29
946090|NCT00023712|2286238|P1|COMPLETED|Overall Study|total number of participants eligible and evaluable|26
946091|NCT00023712|2286237|P2|STARTED|Overall Study|total number of participants enrolled on study|30
946092|NCT00023712|2286238|P1|STARTED|Overall Study|total number of participants enrolled on study|28
946093|NCT00023764|2286250|P1|NOT COMPLETED|Overall Study||14
946094|NCT00023764|2286250|P1|COMPLETED|Overall Study||89
946095|NCT00023764|2286250|P1|STARTED|Overall Study||103
946096|NCT00024102|2286257|P2|NOT COMPLETED|Overall Study||0
946097|NCT00024102|2286258|P1|NOT COMPLETED|Overall Study||0
946098|NCT00024102|2286257|P2|COMPLETED|Overall Study||307
946099|NCT00024102|2286258|P1|COMPLETED|Overall Study||326
946100|NCT00024102|2286257|P2|STARTED|Overall Study||307
946101|NCT00024102|2286258|P1|STARTED|Overall Study||326
946102|NCT00024167|2286273|P2|NOT COMPLETED|Overall Study||47
946103|NCT00024167|2286274|P1|NOT COMPLETED|Overall Study||53
946104|NCT00024167|2286273|P2|COMPLETED|Overall Study||15
946105|NCT00024167|2286274|P1|COMPLETED|Overall Study||12
946106|NCT00024167|2286273|P2|Induction Treatment Option 2 Completed|Overall Study||41
946107|NCT00024167|2286274|P1|Induction Treatment Option 2 Completed|Overall Study||43
946108|NCT00024167|2286273|P2|Induction Treatment Option 1 Completed|Overall Study||21
946109|NCT00024167|2286274|P1|Induction Treatment Option 1 Completed|Overall Study||22
946110|NCT00024167|2286273|P2|STARTED|Overall Study||62
946111|NCT00024167|2286274|P1|STARTED|Overall Study||65
946112|NCT00024258|2286283|P1|NOT COMPLETED|Overall Study||9
946113|NCT00024258|2286283|P1|COMPLETED|Overall Study||13
946114|NCT00024258|2286283|P1|STARTED|Overall Study||22
946115|NCT00025155|2286287|P1|NOT COMPLETED|Overall Study||2
946116|NCT00025155|2286287|P1|COMPLETED|Overall Study|Patients who were eligible and received any study treatment.|49
946117|NCT00025155|2286287|P1|STARTED|Overall Study||51
946118|NCT00025233|2286293|P1|NOT COMPLETED|Overall Study||4
946119|NCT00025233|2286293|P1|COMPLETED|Overall Study||46
946120|NCT00025233|2286293|P1|STARTED|Overall Study||50
946121|NCT00025259|2286306|P7|NOT COMPLETED|Overall Study||51
946122|NCT00025259|2286307|P6|NOT COMPLETED|Overall Study||52
946123|NCT00025259|2286308|P5|NOT COMPLETED|Overall Study||36
946124|NCT00025259|2286309|P4|NOT COMPLETED|Overall Study||114
946125|NCT00025259|2286310|P3|NOT COMPLETED|Overall Study||81
946126|NCT00025259|2286311|P2|NOT COMPLETED|Overall Study||89
946127|NCT00025259|2286312|P1|NOT COMPLETED|Overall Study||45
946128|NCT00025259|2286306|P7|COMPLETED|Overall Study||102
946129|NCT00025259|2286307|P6|COMPLETED|Overall Study||101
946130|NCT00025259|2286308|P5|COMPLETED|Overall Study||6
946131|NCT00025259|2286309|P4|COMPLETED|Overall Study||457
946132|NCT00025259|2286310|P3|COMPLETED|Overall Study||301
946133|NCT00025259|2286311|P2|COMPLETED|Overall Study||292
946134|NCT00025259|2286312|P1|COMPLETED|Overall Study||7
946135|NCT00025259|2286306|P7|STARTED|Overall Study||153
946136|NCT00025259|2286307|P6|STARTED|Overall Study||153
946137|NCT00025259|2286308|P5|STARTED|Overall Study||42
946138|NCT00025259|2286309|P4|STARTED|Overall Study||571
946139|NCT00025259|2286310|P3|STARTED|Overall Study||382
946140|NCT00025259|2286311|P2|STARTED|Overall Study||381
946141|NCT00025259|2286312|P1|STARTED|Overall Study||52
946142|NCT00017563|2286348|P1|NOT COMPLETED|Overall Study||1
946143|NCT00017563|2286348|P1|COMPLETED|Overall Study||56
946144|NCT00017563|2286348|P1|STARTED|Overall Study||57
946145|NCT00018031|2286352|P1|NOT COMPLETED|Overall Study||0
946146|NCT00018031|2286352|P1|COMPLETED|Overall Study||36
946147|NCT00018031|2286352|P1|STARTED|Overall Study||36
946148|NCT00025506|2286356|P1|NOT COMPLETED|Overall Study||10
946149|NCT00025506|2286356|P1|COMPLETED|Overall Study|Eligible and treated patients.|45
946150|NCT00025506|2286356|P1|STARTED|Overall Study||55
946151|NCT00025662|2286362|P1|NOT COMPLETED|Overall Study||3
946152|NCT00025662|2286362|P1|COMPLETED|Overall Study|One patient who received a transplant did not meet eligibility and was a special exemption.|22
946153|NCT00025662|2286362|P1|STARTED|Overall Study||25
946154|NCT00027378|2286372|P2|NOT COMPLETED|Overall Study||3
946155|NCT00027378|2286373|P1|NOT COMPLETED|Overall Study||0
946156|NCT00027378|2286372|P2|COMPLETED|Overall Study||23
946157|NCT00027378|2286373|P1|COMPLETED|Overall Study||24
946158|NCT00027378|2286372|P2|STARTED|Overall Study||26
946159|NCT00027378|2286373|P1|STARTED|Overall Study||24
946160|NCT00027560|2286381|P1|NOT COMPLETED|Overall Study||1
946161|NCT00027560|2286381|P1|COMPLETED|Overall Study||50
946162|NCT00027560|2286381|P1|STARTED|Overall Study||51
946163|NCT00027846|2286393|P3|NOT COMPLETED|Overall Study||37
946164|NCT00027846|2286394|P2|NOT COMPLETED|Overall Study||68
946165|NCT00027846|2286395|P1|NOT COMPLETED|Overall Study||2
946166|NCT00027846|2286393|P3|COMPLETED|Overall Study||41
946167|NCT00027846|2286394|P2|COMPLETED|Overall Study||219
946168|NCT00027846|2286395|P1|COMPLETED|Overall Study||11
946169|NCT00027846|2286393|P3|STARTED|Overall Study||78
946170|NCT00027846|2286394|P2|STARTED|Overall Study||287
946171|NCT00027846|2286395|P1|STARTED|Overall Study||13
946172|NCT00028002|2286413|P1|NOT COMPLETED|Overall Study||11
946173|NCT00028002|2286413|P1|COMPLETED|Overall Study|Subjects comtributing data to the primary analysis are considered to have completed the study.|52
946174|NCT00028002|2286413|P1|STARTED|Overall Study||63
946175|NCT00028093|2286419|P2|NOT COMPLETED|Overall Study||0
946176|NCT00028093|2286420|P1|NOT COMPLETED|Overall Study||0
946177|NCT00028093|2286419|P2|COMPLETED|Overall Study||25
946178|NCT00028093|2286420|P1|COMPLETED|Overall Study||25
946179|NCT00028093|2286419|P2|STARTED|Overall Study||25
946180|NCT00028093|2286420|P1|STARTED|Overall Study||25
946181|NCT00028262|2286426|P1|NOT COMPLETED|Overall Study||1
946182|NCT00028262|2286426|P1|COMPLETED|Overall Study||9
946183|NCT00028262|2286426|P1|STARTED|Overall Study||10
946184|NCT00028769|2286430|P1|NOT COMPLETED|Overall Study||41
946185|NCT00028769|2286430|P1|COMPLETED|Overall Study|Patients receive protocol treatments until evidence of disease progression|0
946186|NCT00028769|2286430|P1|Eligible and Began Protocol Therapy|Overall Study|One patient refused all protocol treatment and was not evaluable for the present analysis|35
946187|NCT00028769|2286430|P1|Eligible|Overall Study||36
946188|NCT00028769|2286430|P1|STARTED|Overall Study||41
946189|NCT00029107|2286438|P2|NOT COMPLETED|Overall Study||0
946190|NCT00029107|2286439|P1|NOT COMPLETED|Overall Study||0
946191|NCT00029107|2286438|P2|COMPLETED|Overall Study||12
946192|NCT00029107|2286439|P1|COMPLETED|Overall Study||12
946193|NCT00029107|2286438|P2|STARTED|Overall Study||12
946194|NCT00029107|2286439|P1|STARTED|Overall Study||12
946195|NCT00029146|2286447|P2|NOT COMPLETED|Overall Study||1
946196|NCT00029146|2286448|P1|NOT COMPLETED|Overall Study||2
946197|NCT00029146|2286447|P2|COMPLETED|Overall Study||97
946198|NCT00029146|2286448|P1|COMPLETED|Overall Study||95
946199|NCT00029146|2286447|P2|STARTED|Overall Study||98
946200|NCT00029146|2286448|P1|STARTED|Overall Study||97
946201|NCT00029172|2286475|P1|NOT COMPLETED|Overall Study||6
946202|NCT00029172|2286475|P1|COMPLETED|Overall Study||182
946203|NCT00029172|2286475|P1|STARTED|Overall Study||188
946204|NCT00029536|2286483|P4|NOT COMPLETED|Overall Study||0
946205|NCT00029536|2286484|P3|NOT COMPLETED|Overall Study||0
946206|NCT00029536|2286485|P2|NOT COMPLETED|Overall Study||0
946207|NCT00029536|2286486|P1|NOT COMPLETED|Overall Study||0
946208|NCT00029536|2286483|P4|COMPLETED|Overall Study||59
946209|NCT00029536|2286484|P3|COMPLETED|Overall Study||105
946210|NCT00029536|2286485|P2|COMPLETED|Overall Study||45
946211|NCT00029536|2286486|P1|COMPLETED|Overall Study||85
946212|NCT00029536|2286483|P4|STARTED|Overall Study||59
946213|NCT00029536|2286484|P3|STARTED|Overall Study||105
946214|NCT00029536|2286485|P2|STARTED|Overall Study||45
946215|NCT00029536|2286486|P1|STARTED|Overall Study||85
946216|NCT00022633|2286512|P2|NOT COMPLETED|Overall Study||5
946217|NCT00022633|2286513|P1|NOT COMPLETED|Overall Study||32
946218|NCT00022633|2286512|P2|COMPLETED|Overall Study||5
946219|NCT00022633|2286513|P1|COMPLETED|Overall Study||23
946220|NCT00022633|2286512|P2|Eligible|Overall Study||10
946221|NCT00022633|2286513|P1|Eligible|Overall Study||51
946222|NCT00022633|2286512|P2|STARTED|Overall Study||10
946223|NCT00022633|2286513|P1|STARTED|Overall Study||55
946224|NCT00030147|2286528|P4|NOT COMPLETED|Overall Study||0
946225|NCT00030147|2286529|P3|NOT COMPLETED|Overall Study||0
946226|NCT00030147|2286530|P2|NOT COMPLETED|Overall Study||1
946227|NCT00030147|2286531|P1|NOT COMPLETED|Overall Study||0
946228|NCT00030147|2286528|P4|COMPLETED|Overall Study||11
946229|NCT00030147|2286529|P3|COMPLETED|Overall Study||16
946230|NCT00030147|2286530|P2|COMPLETED|Overall Study||18
946231|NCT00030147|2286531|P1|COMPLETED|Overall Study||17
946232|NCT00030147|2286528|P4|STARTED|Overall Study||11
946233|NCT00030147|2286529|P3|STARTED|Overall Study||16
946234|NCT00030147|2286530|P2|STARTED|Overall Study||19
946235|NCT00030147|2286531|P1|STARTED|Overall Study||17
946236|NCT00032487|2286547|P2|NOT COMPLETED|Overall Study||120
946237|NCT00032487|2286548|P1|NOT COMPLETED|Overall Study||139
946238|NCT00032487|2286547|P2|COMPLETED|Overall Study||772
946239|NCT00032487|2286548|P1|COMPLETED|Overall Study||760
946240|NCT00032487|2286547|P2|STARTED|Overall Study||892
946241|NCT00032487|2286548|P1|STARTED|Overall Study||899
946242|NCT00032591|2286558|P2|NOT COMPLETED|Follow-up||5
946243|NCT00032591|2286559|P1|NOT COMPLETED|Follow-up||2
946244|NCT00032591|2286558|P2|COMPLETED|Follow-up|1452 were included in analysis with greater than 1 day of follow-up|1452
946245|NCT00032591|2286559|P1|COMPLETED|Follow-up|1463 were included in analysis with greater than 1 day of follow-up|1463
946246|NCT00032591|2286558|P2|STARTED|Follow-up|5 were lost to follow-up, all with Atrial Fibrillation, no Mechanical Heart Valves|1457
946247|NCT00032591|2286559|P1|STARTED|Follow-up|2 were lost to follow-up, both with Atrial Fibrillation, no Mechanical Heart Valves|1465
946248|NCT00032591|2286558|P2|NOT COMPLETED|Randomization||0
946249|NCT00032591|2286559|P1|NOT COMPLETED|Randomization||0
946250|NCT00032591|2286558|P2|COMPLETED|Randomization|1457 were assigned to clinic testing|1457
946251|NCT00032591|2286559|P1|COMPLETED|Randomization|1465 were assigned to self-testing|1465
946252|NCT00032591|2286558|P2|STARTED|Randomization||1457
946253|NCT00032591|2286559|P1|STARTED|Randomization|2922 underwent randomization|1465
946254|NCT00032591|2286558|P2|NOT COMPLETED|Screening||415
946255|NCT00032591|2286559|P1|NOT COMPLETED|Screening||408
946256|NCT00032591|2286558|P2|COMPLETED|Screening||1457
946257|NCT00032591|2286559|P1|COMPLETED|Screening|823 were excluded from the study|1465
946258|NCT00032591|2286558|P2|STARTED|Screening|Treatment assigned at randomization; screening counts by arm represent half of the total screened.|1872
946259|NCT00032591|2286559|P1|STARTED|Screening|3745 patients provided informed consent and were screened for participation.|1873
946260|NCT00032630|2286575|P2|NOT COMPLETED|Overall Study||43
946261|NCT00032630|2286576|P1|NOT COMPLETED|Overall Study||49
946262|NCT00032630|2286575|P2|COMPLETED|Overall Study||1061
946263|NCT00032630|2286576|P1|COMPLETED|Overall Study||1050
946264|NCT00032630|2286575|P2|STARTED|Overall Study||1104
946265|NCT00032630|2286576|P1|STARTED|Overall Study||1099
946266|NCT00033293|2286586|P2|NOT COMPLETED|Overall Study||18
946267|NCT00033293|2286587|P1|NOT COMPLETED|Overall Study||10
946268|NCT00033293|2286586|P2|COMPLETED|Overall Study||9
946269|NCT00033293|2286587|P1|COMPLETED|Overall Study||16
946270|NCT00033293|2286586|P2|STARTED|Overall Study||27
946271|NCT00033293|2286587|P1|STARTED|Overall Study||26
946272|NCT00033371|2286607|P2|NOT COMPLETED|Overall Study||10
946273|NCT00033371|2286608|P1|NOT COMPLETED|Overall Study||6
946274|NCT00033371|2286607|P2|COMPLETED|Overall Study||47
946275|NCT00033371|2286608|P1|COMPLETED|Overall Study||49
946276|NCT00033371|2286607|P2|STARTED|Overall Study||57
946277|NCT00033371|2286608|P1|STARTED|Overall Study||55
946278|NCT00033514|2286616|P2|NOT COMPLETED|Overall Study||4
946279|NCT00033514|2286617|P1|NOT COMPLETED|Overall Study||1
946280|NCT00033514|2286616|P2|COMPLETED|Overall Study||7
946281|NCT00033514|2286617|P1|COMPLETED|Overall Study||15
946282|NCT00033514|2286616|P2|STARTED|Overall Study||11
946283|NCT00033514|2286617|P1|STARTED|Overall Study||16
946284|NCT00033540|2286625|P1|NOT COMPLETED|Overall Study||57
946285|NCT00033540|2286625|P1|COMPLETED|Overall Study||0
946286|NCT00033540|2286625|P1|Eligible and Began Protocol Therapy|Overall Study|One patient went off study prior to any toxicity assessments and is not evaluable for toxicities.|52
946287|NCT00033540|2286625|P1|Eligible|Overall Study||54
946288|NCT00033540|2286625|P1|STARTED|Overall Study||57
946289|NCT00033631|2286635|P2|NOT COMPLETED|Overall Study||15
946290|NCT00033631|2286636|P1|NOT COMPLETED|Overall Study||18
946291|NCT00033631|2286635|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|748
946292|NCT00033631|2286636|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|751
946293|NCT00033631|2286635|P2|STARTED|Overall Study||763
946294|NCT00033631|2286636|P1|STARTED|Overall Study||769
946295|NCT00033657|2286656|P2|NOT COMPLETED|Adjuvant Chemotherapy||17
946296|NCT00033657|2286657|P1|NOT COMPLETED|Adjuvant Chemotherapy||18
946297|NCT00033657|2286656|P2|COMPLETED|Adjuvant Chemotherapy||16
946298|NCT00033657|2286657|P1|COMPLETED|Adjuvant Chemotherapy||18
946299|NCT00033657|2286656|P2|STARTED|Adjuvant Chemotherapy||33
946300|NCT00033657|2286657|P1|STARTED|Adjuvant Chemotherapy||36
946301|NCT00033657|2286656|P2|NOT COMPLETED|Surgical Resection||3
946302|NCT00033657|2286657|P1|NOT COMPLETED|Surgical Resection||0
946303|NCT00033657|2286656|P2|COMPLETED|Surgical Resection||33
946304|NCT00033657|2286657|P1|COMPLETED|Surgical Resection||36
946305|NCT00033657|2286656|P2|STARTED|Surgical Resection||36
946306|NCT00033657|2286657|P1|STARTED|Surgical Resection||36
946307|NCT00033657|2286656|P2|NOT COMPLETED|Neoadjuvant Chemotherapy||11
946308|NCT00033657|2286657|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||14
946309|NCT00033657|2286656|P2|COMPLETED|Neoadjuvant Chemotherapy||36
946310|NCT00033657|2286657|P1|COMPLETED|Neoadjuvant Chemotherapy||36
946311|NCT00033657|2286656|P2|Eligible and Treated|Neoadjuvant Chemotherapy||42
946312|NCT00033657|2286657|P1|Eligible and Treated|Neoadjuvant Chemotherapy||39
946313|NCT00033657|2286656|P2|Eligible|Neoadjuvant Chemotherapy||43
946314|NCT00033657|2286657|P1|Eligible|Neoadjuvant Chemotherapy||42
946315|NCT00033657|2286656|P2|STARTED|Neoadjuvant Chemotherapy||47
946316|NCT00033657|2286657|P1|STARTED|Neoadjuvant Chemotherapy||50
946317|NCT00033917|2286671|P2|NOT COMPLETED|Overall Study||0
946318|NCT00033917|2286672|P1|NOT COMPLETED|Overall Study||0
946319|NCT00033917|2286671|P2|COMPLETED|Overall Study||222
946320|NCT00033917|2286672|P1|COMPLETED|Overall Study||209
946321|NCT00033917|2286671|P2|STARTED|Overall Study||222
946322|NCT00033917|2286672|P1|STARTED|Overall Study||209
946323|NCT00025883|2286684|P1|NOT COMPLETED|Overall Study||17
946324|NCT00025883|2286684|P1|COMPLETED|Overall Study||86
946325|NCT00025883|2286684|P1|Partial Lipodystrophy|Overall Study||40
946326|NCT00025883|2286684|P1|Generalized Lipodystrophy|Overall Study||63
946327|NCT00025883|2286684|P1|STARTED|Overall Study||103
946328|NCT00026221|2286694|P3|NOT COMPLETED|Overall Study||0
946329|NCT00026221|2286695|P2|NOT COMPLETED|Overall Study||0
946330|NCT00026221|2286696|P1|NOT COMPLETED|Overall Study||0
946331|NCT00026221|2286694|P3|COMPLETED|Overall Study||25
946332|NCT00026221|2286695|P2|COMPLETED|Overall Study||16
946333|NCT00026221|2286696|P1|COMPLETED|Overall Study||16
946334|NCT00026221|2286694|P3|STARTED|Overall Study||25
946335|NCT00026221|2286695|P2|STARTED|Overall Study||16
946336|NCT00026221|2286696|P1|STARTED|Overall Study||16
946337|NCT00026312|2286715|P2|NOT COMPLETED|Overall Study||269
946338|NCT00026312|2286716|P1|NOT COMPLETED|Overall Study||34
946339|NCT00026312|2286715|P2|COMPLETED|Overall Study||1064
946340|NCT00026312|2286716|P1|COMPLETED|Overall Study||82
946341|NCT00026312|2286715|P2|STARTED|Overall Study||1333
946342|NCT00026312|2286716|P1|STARTED|Overall Study||116
946343|NCT00026494|2286735|P4|NOT COMPLETED|Overall Study||0
946344|NCT00026494|2286736|P3|NOT COMPLETED|Overall Study||6
946345|NCT00026494|2286737|P2|NOT COMPLETED|Overall Study||0
946346|NCT00026494|2286738|P1|NOT COMPLETED|Overall Study||2
946347|NCT00026494|2286735|P4|COMPLETED|Overall Study||16
946348|NCT00026494|2286736|P3|COMPLETED|Overall Study||16
946349|NCT00026494|2286737|P2|COMPLETED|Overall Study||4
946350|NCT00026494|2286738|P1|COMPLETED|Overall Study||5
946351|NCT00026494|2286735|P4|STARTED|Overall Study||16
946352|NCT00026494|2286736|P3|STARTED|Overall Study||22
946353|NCT00026494|2286737|P2|STARTED|Overall Study||4
946354|NCT00026494|2286738|P1|STARTED|Overall Study||7
946355|NCT00027027|2286753|P5|NOT COMPLETED|Overall Study||8
946356|NCT00027027|2286754|P4|NOT COMPLETED|Overall Study||3
946357|NCT00027027|2286755|P3|NOT COMPLETED|Overall Study||4
946358|NCT00027027|2286756|P2|NOT COMPLETED|Overall Study||3
946359|NCT00027027|2286757|P1|NOT COMPLETED|Overall Study||3
946360|NCT00027027|2286753|P5|COMPLETED|Overall Study||0
946361|NCT00027027|2286754|P4|COMPLETED|Overall Study||0
946362|NCT00027027|2286755|P3|COMPLETED|Overall Study||0
946363|NCT00027027|2286756|P2|COMPLETED|Overall Study||0
946364|NCT00027027|2286757|P1|COMPLETED|Overall Study||0
946365|NCT00027027|2286753|P5|Treated Beyond Cycle 2|Overall Study||4
946366|NCT00027027|2286754|P4|Treated Beyond Cycle 2|Overall Study||2
946367|NCT00027027|2286755|P3|Treated Beyond Cycle 2|Overall Study||2
946368|NCT00027027|2286756|P2|Treated Beyond Cycle 2|Overall Study||1
946369|NCT00027027|2286757|P1|Treated Beyond Cycle 2|Overall Study||1
946370|NCT00027027|2286753|P5|Discontinued at Cycle 2|Overall Study||3
946371|NCT00027027|2286754|P4|Discontinued at Cycle 2|Overall Study||1
946372|NCT00027027|2286755|P3|Discontinued at Cycle 2|Overall Study||1
946373|NCT00027027|2286756|P2|Discontinued at Cycle 2|Overall Study||2
946374|NCT00027027|2286757|P1|Discontinued at Cycle 2|Overall Study||2
946375|NCT00027027|2286753|P5|Completed 2 Cycles of Treatment|Overall Study||7
946376|NCT00027027|2286754|P4|Completed 2 Cycles of Treatment|Overall Study||3
946377|NCT00027027|2286755|P3|Completed 2 Cycles of Treatment|Overall Study||3
946378|NCT00027027|2286756|P2|Completed 2 Cycles of Treatment|Overall Study||3
946379|NCT00027027|2286757|P1|Completed 2 Cycles of Treatment|Overall Study||3
946380|NCT00027027|2286753|P5|Discontinued Before 2 Treatment Cycles|Overall Study||1
946381|NCT00027027|2286754|P4|Discontinued Before 2 Treatment Cycles|Overall Study||0
946382|NCT00027027|2286755|P3|Discontinued Before 2 Treatment Cycles|Overall Study||1
946383|NCT00027027|2286756|P2|Discontinued Before 2 Treatment Cycles|Overall Study||0
946384|NCT00027027|2286757|P1|Discontinued Before 2 Treatment Cycles|Overall Study||0
946385|NCT00027027|2286753|P5|STARTED|Overall Study||8
946386|NCT00027027|2286754|P4|STARTED|Overall Study||3
946387|NCT00027027|2286755|P3|STARTED|Overall Study||4
946388|NCT00027027|2286756|P2|STARTED|Overall Study||3
946389|NCT00027027|2286757|P1|STARTED|Overall Study||3
946390|NCT00035555|2286805|P3|NOT COMPLETED|Overall Study||22
946391|NCT00035555|2286806|P2|NOT COMPLETED|Overall Study||16
946392|NCT00035555|2286807|P1|NOT COMPLETED|Overall Study||16
946393|NCT00035555|2286805|P3|COMPLETED|Overall Study||51
946394|NCT00035555|2286806|P2|COMPLETED|Overall Study||55
946395|NCT00035555|2286807|P1|COMPLETED|Overall Study||58
946396|NCT00035555|2286805|P3|Number Who Received Study Drug|Overall Study||71
946397|NCT00035555|2286806|P2|Number Who Received Study Drug|Overall Study||71
946398|NCT00035555|2286807|P1|Number Who Received Study Drug|Overall Study||74
946399|NCT00035555|2286805|P3|Number Who Had Undergone Transplantation|Overall Study||73
946400|NCT00035555|2286806|P2|Number Who Had Undergone Transplantation|Overall Study||71
946401|NCT00035555|2286807|P1|Number Who Had Undergone Transplantation|Overall Study||74
946402|NCT00035555|2286805|P3|STARTED|Overall Study|Randomized patients|73
946403|NCT00035555|2286806|P2|STARTED|Overall Study|Randomized patients|71
946404|NCT00035555|2286807|P1|STARTED|Overall Study|Randomized patients|74
946405|NCT00035815|2286850|P2|NOT COMPLETED|Overall Study||11
946406|NCT00035815|2286851|P1|NOT COMPLETED|Overall Study||17
946407|NCT00035815|2286850|P2|COMPLETED|Overall Study||152
946408|NCT00035815|2286851|P1|COMPLETED|Overall Study||150
946409|NCT00035815|2286850|P2|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|163
946410|NCT00035815|2286851|P1|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|167
946411|NCT00035932|2286864|P3|NOT COMPLETED|Overall Study||49
946412|NCT00035932|2286865|P2|NOT COMPLETED|Overall Study||60
946413|NCT00035932|2286866|P1|NOT COMPLETED|Overall Study||56
946414|NCT00035932|2286864|P3|COMPLETED|Overall Study|59 remained on treatment, 10 completed at Week 96|69
946415|NCT00035932|2286865|P2|COMPLETED|Overall Study|50 remained on treatment, 0 completed at Week 96|50
946416|NCT00035932|2286866|P1|COMPLETED|Overall Study|63 remained on treatment, 0 completed at Week 96|63
946417|NCT00035932|2286864|P3|Discontinued on or After Week 96|Overall Study||6
946418|NCT00035932|2286865|P2|Discontinued on or After Week 96|Overall Study||4
946419|NCT00035932|2286866|P1|Discontinued on or After Week 96|Overall Study||4
946420|NCT00035932|2286864|P3|Discontinued Between Weeks 48 and 96|Overall Study||30
946421|NCT00035932|2286865|P2|Discontinued Between Weeks 48 and 96|Overall Study||27
946422|NCT00035932|2286866|P1|Discontinued Between Weeks 48 and 96|Overall Study||26
946423|NCT00035932|2286864|P3|Discontinued Prior to Week 48 Visit|Overall Study||13
946424|NCT00035932|2286865|P2|Discontinued Prior to Week 48 Visit|Overall Study||29
946425|NCT00035932|2286866|P1|Discontinued Prior to Week 48 Visit|Overall Study||26
946426|NCT00035932|2286864|P3|STARTED|Overall Study|123 randomized, 118 treated|118
946427|NCT00035932|2286865|P2|STARTED|Overall Study|115 randomized, 110 treated|110
946428|NCT00035932|2286866|P1|STARTED|Overall Study|120 randomized, 119 treated|119
946429|NCT00036270|2286992|P2|NOT COMPLETED|Study Treatment to 5 Year Report||3488
946430|NCT00036270|2286993|P1|NOT COMPLETED|Study Treatment to 5 Year Report||2565
946431|NCT00036270|2286992|P2|COMPLETED|Study Treatment to 5 Year Report||1380
946432|NCT00036270|2286993|P1|COMPLETED|Study Treatment to 5 Year Report||2333
946433|NCT00036270|2286992|P2|Treated|Study Treatment to 5 Year Report||4814
946434|NCT00036270|2286993|P1|Treated|Study Treatment to 5 Year Report||4852
946435|NCT00036270|2286992|P2|STARTED|Study Treatment to 5 Year Report||4868
946436|NCT00036270|2286993|P1|STARTED|Study Treatment to 5 Year Report||4898
946437|NCT00036270|2286992|P2|NOT COMPLETED|Randomized to Study Treatment||7
946438|NCT00036270|2286993|P1|NOT COMPLETED|Randomized to Study Treatment||6
946439|NCT00036270|2286992|P2|COMPLETED|Randomized to Study Treatment||4868
946440|NCT00036270|2286993|P1|COMPLETED|Randomized to Study Treatment||4898
946441|NCT00036270|2286992|P2|STARTED|Randomized to Study Treatment||4875
946442|NCT00036270|2286993|P1|STARTED|Randomized to Study Treatment||4904
946443|NCT00036569|2287009|P1|NOT COMPLETED|Overall Study||0
946444|NCT00036569|2287009|P1|COMPLETED|Overall Study||32
946445|NCT00036569|2287009|P1|STARTED|Overall Study||32
946446|NCT00036738|2287018|P1|NOT COMPLETED|Overall Study||0
946447|NCT00036738|2287018|P1|COMPLETED|Overall Study||28
946448|NCT00036738|2287018|P1|STARTED|Overall Study||28
946449|NCT00037830|2287027|P3|NOT COMPLETED|Overall Study||1
946450|NCT00037830|2287028|P2|NOT COMPLETED|Overall Study||7
946451|NCT00037830|2287029|P1|NOT COMPLETED|Overall Study||10
946452|NCT00037830|2287027|P3|COMPLETED|Overall Study||16
946453|NCT00037830|2287028|P2|COMPLETED|Overall Study||31
946454|NCT00037830|2287029|P1|COMPLETED|Overall Study||29
946455|NCT00037830|2287027|P3|STARTED|Overall Study||17
946456|NCT00037830|2287028|P2|STARTED|Overall Study||38
946457|NCT00037830|2287029|P1|STARTED|Overall Study||39
946458|NCT00030823|2287050|P1|NOT COMPLETED|Overall Study||1
946459|NCT00030823|2287050|P1|COMPLETED|Overall Study||13
946460|NCT00030823|2287050|P1|STARTED|Overall Study||14
946461|NCT00030901|2287056|P3|NOT COMPLETED|Randomization||88
946462|NCT00030901|2287057|P2|NOT COMPLETED|Randomization||101
946463|NCT00030901|2287058|P1|NOT COMPLETED|Randomization||0
946464|NCT00030901|2287056|P3|COMPLETED|Randomization||137
946465|NCT00030901|2287057|P2|COMPLETED|Randomization||126
946466|NCT00030901|2287058|P1|COMPLETED|Randomization||0
946467|NCT00030901|2287056|P3|Eligible|Randomization||211
946468|NCT00030901|2287057|P2|Eligible|Randomization||212
946469|NCT00030901|2287058|P1|Eligible|Randomization||0
946470|NCT00030901|2287056|P3|STARTED|Randomization||225
946471|NCT00030901|2287057|P2|STARTED|Randomization||227
946472|NCT00030901|2287058|P1|STARTED|Randomization||0
946473|NCT00030901|2287056|P3|NOT COMPLETED|Initial Registration||0
946474|NCT00030901|2287057|P2|NOT COMPLETED|Initial Registration||0
946475|NCT00030901|2287058|P1|NOT COMPLETED|Initial Registration||167
946476|NCT00030901|2287056|P3|COMPLETED|Initial Registration||0
946477|NCT00030901|2287057|P2|COMPLETED|Initial Registration||0
946478|NCT00030901|2287058|P1|COMPLETED|Initial Registration||452
946479|NCT00030901|2287056|P3|STARTED|Initial Registration||0
946480|NCT00030901|2287057|P2|STARTED|Initial Registration||0
946481|NCT00030901|2287058|P1|STARTED|Initial Registration||619
946482|NCT00030992|2287066|P1|NOT COMPLETED|Overall Study||0
946483|NCT00030992|2287066|P1|COMPLETED|Overall Study||102
946484|NCT00030992|2287066|P1|STARTED|Overall Study||102
946485|NCT00031447|2287073|P2|NOT COMPLETED|Overall Study||7
946486|NCT00031447|2287074|P1|NOT COMPLETED|Overall Study||10
946487|NCT00031447|2287073|P2|COMPLETED|Overall Study||8
946488|NCT00031447|2287074|P1|COMPLETED|Overall Study||4
946489|NCT00031447|2287073|P2|STARTED|Overall Study||15
946490|NCT00031447|2287074|P1|STARTED|Overall Study||14
946491|NCT00031460|2287088|P2|NOT COMPLETED|Overall Study||14
946492|NCT00031460|2287089|P1|NOT COMPLETED|Overall Study||9
946493|NCT00031460|2287088|P2|COMPLETED|Overall Study||8
946494|NCT00031460|2287089|P1|COMPLETED|Overall Study||15
946495|NCT00031460|2287088|P2|STARTED|Overall Study||22
946496|NCT00031460|2287089|P1|STARTED|Overall Study||24
946503|NCT00031551|2287130|P2|NOT COMPLETED|Overall Study||0
946504|NCT00031551|2287131|P1|NOT COMPLETED|Overall Study||2
946505|NCT00031551|2287130|P2|COMPLETED|Overall Study||25
946506|NCT00031551|2287131|P1|COMPLETED|Overall Study||0
946507|NCT00031551|2287130|P2|STARTED|Overall Study||25
946508|NCT00031551|2287131|P1|STARTED|Overall Study||2
946509|NCT00031694|2287141|P1|NOT COMPLETED|Overall Study||19
946510|NCT00031694|2287141|P1|COMPLETED|Overall Study||0
946511|NCT00031694|2287141|P1|STARTED|Overall Study||19
946512|NCT00038103|2287147|P2|NOT COMPLETED|Overall Study||56
946513|NCT00038103|2287148|P1|NOT COMPLETED|Overall Study||55
946514|NCT00038103|2287147|P2|COMPLETED|Overall Study||0
946515|NCT00038103|2287148|P1|COMPLETED|Overall Study||0
946516|NCT00038103|2287147|P2|End of Treatment|Overall Study|patients remained on treatment until discontinued|56
946517|NCT00038103|2287148|P1|End of Treatment|Overall Study|patients remained on treatment until discontinued|53
946518|NCT00038103|2287147|P2|STARTED|Overall Study||56
946519|NCT00038103|2287148|P1|STARTED|Overall Study||55
946520|NCT00040664|2287168|P4|NOT COMPLETED|Overall Study||27
946521|NCT00040664|2287169|P3|NOT COMPLETED|Overall Study||13
946522|NCT00040664|2287170|P2|NOT COMPLETED|Overall Study||13
946523|NCT00040664|2287171|P1|NOT COMPLETED|Overall Study||53
946524|NCT00040664|2287168|P4|COMPLETED|Overall Study||8
946525|NCT00040664|2287169|P3|COMPLETED|Overall Study||4
946526|NCT00040664|2287170|P2|COMPLETED|Overall Study||4
946527|NCT00040664|2287171|P1|COMPLETED|Overall Study||16
946528|NCT00040664|2287168|P4|STARTED|Overall Study||35
946529|NCT00040664|2287169|P3|STARTED|Overall Study||17
946530|NCT00040664|2287170|P2|STARTED|Overall Study||17
946531|NCT00040664|2287171|P1|STARTED|Overall Study|All (69) enrolled on QD; 10 switched to twice daily. Participant flow not collected for this group.|69
946532|NCT00040742|2287223|P4|NOT COMPLETED|Overall Study||34
946533|NCT00040742|2287224|P3|NOT COMPLETED|Overall Study||46
946534|NCT00040742|2287225|P2|NOT COMPLETED|Overall Study||49
946535|NCT00040742|2287226|P1|NOT COMPLETED|Overall Study||39
946536|NCT00040742|2287223|P4|COMPLETED|Overall Study||152
946537|NCT00040742|2287224|P3|COMPLETED|Overall Study||141
946538|NCT00040742|2287225|P2|COMPLETED|Overall Study||134
946539|NCT00040742|2287226|P1|COMPLETED|Overall Study||149
946540|NCT00040742|2287223|P4|STARTED|Overall Study|One subject found to be ineligible after randomization. No baseline data collected.|186
946541|NCT00040742|2287224|P3|STARTED|Overall Study||187
946542|NCT00040742|2287225|P2|STARTED|Overall Study||183
946543|NCT00040742|2287226|P1|STARTED|Overall Study||188
946544|NCT00040846|2287246|P6|NOT COMPLETED|Overall Study||0
946545|NCT00040846|2287247|P5|NOT COMPLETED|Overall Study||0
946546|NCT00040846|2287248|P4|NOT COMPLETED|Overall Study||0
946547|NCT00040846|2287249|P3|NOT COMPLETED|Overall Study||0
946548|NCT00040846|2287250|P2|NOT COMPLETED|Overall Study||0
946549|NCT00040846|2287251|P1|NOT COMPLETED|Overall Study||0
946550|NCT00040846|2287246|P6|COMPLETED|Overall Study||0
946551|NCT00040846|2287247|P5|COMPLETED|Overall Study||0
946552|NCT00040846|2287248|P4|COMPLETED|Overall Study||0
946553|NCT00040846|2287249|P3|COMPLETED|Overall Study||0
946554|NCT00040846|2287250|P2|COMPLETED|Overall Study||0
946555|NCT00040846|2287251|P1|COMPLETED|Overall Study||60
946556|NCT00040846|2287246|P6|STARTED|Overall Study||0
946557|NCT00040846|2287247|P5|STARTED|Overall Study||0
946558|NCT00040846|2287248|P4|STARTED|Overall Study||0
946559|NCT00040846|2287249|P3|STARTED|Overall Study||0
946560|NCT00040846|2287250|P2|STARTED|Overall Study||0
946561|NCT00040846|2287251|P1|STARTED|Overall Study||60
946562|NCT00040937|2287289|P1|NOT COMPLETED|Maintenance||0
946563|NCT00040937|2287289|P1|COMPLETED|Maintenance|Patients remained on protocol therapy until progression.|76
946564|NCT00040937|2287289|P1|STARTED|Maintenance||76
946565|NCT00040937|2287289|P1|NOT COMPLETED|Autologous PBSCT||31
946566|NCT00040937|2287289|P1|COMPLETED|Autologous PBSCT||77
946567|NCT00040937|2287289|P1|STARTED|Autologous PBSCT|108 registered to this period; 105 were eligible and analyzable; 105 were assessable for toxicity.|108
946568|NCT00040937|2287289|P1|NOT COMPLETED|Induction/PBSC Mobilization||37
946569|NCT00040937|2287289|P1|COMPLETED|Induction/PBSC Mobilization||110
946570|NCT00040937|2287289|P1|STARTED|Induction/PBSC Mobilization|147 registered to this period; 142 were eligible and analyzable; 140 were assessable for toxicity.|147
946571|NCT00041067|2287296|P1|NOT COMPLETED|Overall Study||76
946572|NCT00041067|2287296|P1|COMPLETED|Overall Study||0
946573|NCT00041067|2287296|P1|Eligible|Overall Study||74
946574|NCT00041067|2287296|P1|STARTED|Overall Study||76
946575|NCT00041080|2287305|P2|NOT COMPLETED|Overall Study||10
946576|NCT00041080|2287306|P1|NOT COMPLETED|Overall Study||30
946577|NCT00041080|2287305|P2|COMPLETED|Overall Study||60
946578|NCT00041080|2287306|P1|COMPLETED|Overall Study||39
946579|NCT00041080|2287305|P2|STARTED|Overall Study|number patients enrolled on study|70
946580|NCT00041080|2287306|P1|STARTED|Overall Study|number patients enrolled on study|69
946581|NCT00041119|2287316|P4|NOT COMPLETED|Overall Study||0
946582|NCT00041119|2287317|P3|NOT COMPLETED|Overall Study||0
946583|NCT00041119|2287318|P2|NOT COMPLETED|Overall Study||0
946584|NCT00041119|2287319|P1|NOT COMPLETED|Overall Study||0
946585|NCT00041119|2287316|P4|COMPLETED|Overall Study||789
946586|NCT00041119|2287317|P3|COMPLETED|Overall Study||1151
946587|NCT00041119|2287318|P2|COMPLETED|Overall Study||789
946588|NCT00041119|2287319|P1|COMPLETED|Overall Study||1142
946589|NCT00041119|2287316|P4|STARTED|Overall Study||789
946590|NCT00041119|2287317|P3|STARTED|Overall Study||1151
946591|NCT00041119|2287318|P2|STARTED|Overall Study||789
946592|NCT00041119|2287319|P1|STARTED|Overall Study||1142
946593|NCT00041132|2287339|P1|NOT COMPLETED|Overall Study||30
946594|NCT00041132|2287339|P1|COMPLETED|Overall Study||26
946595|NCT00041132|2287339|P1|Eligible and Began Protocol Therapy|Overall Study||49
946596|NCT00041132|2287339|P1|Eligible|Overall Study||49
946597|NCT00041132|2287339|P1|STARTED|Overall Study||56
946598|NCT00041392|2287347|P2|NOT COMPLETED|Overall Study||0
946599|NCT00041392|2287348|P1|NOT COMPLETED|Overall Study||0
946600|NCT00041392|2287347|P2|COMPLETED|Overall Study||191
946601|NCT00041392|2287348|P1|COMPLETED|Overall Study||198
946602|NCT00041392|2287347|P2|STARTED|Overall Study||191
946603|NCT00041392|2287348|P1|STARTED|Overall Study||198
946604|NCT00041470|2287354|P1|NOT COMPLETED|Overall Study||38
946605|NCT00041470|2287354|P1|COMPLETED|Overall Study||0
946606|NCT00041470|2287354|P1|STARTED|Overall Study||38
946607|NCT00041717|2287361|P2|NOT COMPLETED|Overall Study||12
946608|NCT00041717|2287362|P1|NOT COMPLETED|Overall Study||33
946609|NCT00041717|2287361|P2|COMPLETED|Overall Study||86
946610|NCT00041717|2287362|P1|COMPLETED|Overall Study||81
946611|NCT00041717|2287361|P2|STARTED|Overall Study||98
946612|NCT00041717|2287362|P1|STARTED|Overall Study||114
946613|NCT00041756|2287375|P5|NOT COMPLETED|Overall Study||60
946614|NCT00041756|2287376|P4|NOT COMPLETED|Overall Study||16
946615|NCT00041756|2287377|P3|NOT COMPLETED|Overall Study||13
946616|NCT00041756|2287378|P2|NOT COMPLETED|Overall Study||15
946617|NCT00041756|2287379|P1|NOT COMPLETED|Overall Study||8
946618|NCT00041756|2287375|P5|COMPLETED|Overall Study||19
946619|NCT00041756|2287376|P4|COMPLETED|Overall Study||64
946620|NCT00041756|2287377|P3|COMPLETED|Overall Study||66
946621|NCT00041756|2287378|P2|COMPLETED|Overall Study||65
946622|NCT00041756|2287379|P1|COMPLETED|Overall Study||69
946623|NCT00041756|2287375|P5|STARTED|Overall Study||79
946624|NCT00041756|2287376|P4|STARTED|Overall Study||80
946625|NCT00041756|2287377|P3|STARTED|Overall Study||79
946626|NCT00041756|2287378|P2|STARTED|Overall Study||80
946627|NCT00041756|2287379|P1|STARTED|Overall Study||77
946628|NCT00041938|2287398|P2|NOT COMPLETED|Overall Study||31
946629|NCT00041938|2287399|P1|NOT COMPLETED|Overall Study||38
946630|NCT00041938|2287398|P2|COMPLETED|Overall Study||1111
946631|NCT00041938|2287399|P1|COMPLETED|Overall Study||1125
946632|NCT00041938|2287398|P2|Withdrew Consent|Overall Study||14
946633|NCT00041938|2287399|P1|Withdrew Consent|Overall Study||20
946634|NCT00041938|2287398|P2|Lost to Follow-up|Overall Study||17
946635|NCT00041938|2287399|P1|Lost to Follow-up|Overall Study||18
946636|NCT00041938|2287398|P2|Only Vital Status Known|Overall Study||46
946637|NCT00041938|2287399|P1|Only Vital Status Known|Overall Study||44
946638|NCT00041938|2287398|P2|Primary Endpoint|Overall Study||302
946639|NCT00041938|2287399|P1|Primary Endpoint|Overall Study||320
946640|NCT00041938|2287398|P2|Completed Follow-up|Overall Study||745
946641|NCT00041938|2287399|P1|Completed Follow-up|Overall Study||761
946642|NCT00041938|2287398|P2|STARTED|Overall Study||1142
946643|NCT00041938|2287399|P1|STARTED|Overall Study||1163
946644|NCT00042224|2287429|P2|NOT COMPLETED|Overall Study||3
946645|NCT00042224|2287430|P1|NOT COMPLETED|Overall Study||3
946646|NCT00042224|2287429|P2|COMPLETED|Overall Study||16
946647|NCT00042224|2287430|P1|COMPLETED|Overall Study||17
946648|NCT00042224|2287429|P2|STARTED|Overall Study||19
946649|NCT00042224|2287430|P1|STARTED|Overall Study||20
946650|NCT00042432|2287438|P2|NOT COMPLETED|Overall Study||7
946651|NCT00042432|2287439|P1|NOT COMPLETED|Overall Study||9
946652|NCT00042432|2287438|P2|COMPLETED|Overall Study||20
946653|NCT00042432|2287439|P1|COMPLETED|Overall Study||18
946654|NCT00042432|2287438|P2|STARTED|Overall Study||27
946655|NCT00042432|2287439|P1|STARTED|Overall Study||27
946656|NCT00042939|2287449|P2|NOT COMPLETED|Overall Study||21
946657|NCT00042939|2287450|P1|NOT COMPLETED|Overall Study||24
946658|NCT00042939|2287449|P2|COMPLETED|Overall Study||25
946659|NCT00042939|2287450|P1|COMPLETED|Overall Study||24
946660|NCT00042939|2287449|P2|Patients With EGFR Results Available|Overall Study||31
946661|NCT00042939|2287450|P1|Patients With EGFR Results Available|Overall Study||30
946662|NCT00042939|2287449|P2|Eligible and Began Protocol Therapy|Overall Study||43
946663|NCT00042939|2287450|P1|Eligible and Began Protocol Therapy|Overall Study||44
946664|NCT00042939|2287449|P2|Treated|Overall Study||45
946665|NCT00042939|2287450|P1|Treated|Overall Study||46
946666|NCT00042939|2287449|P2|STARTED|Overall Study||46
946667|NCT00042939|2287450|P1|STARTED|Overall Study||48
946668|NCT00042991|2287471|P7|NOT COMPLETED|Overall Study||2
946669|NCT00042991|2287472|P6|NOT COMPLETED|Overall Study||5
946670|NCT00042991|2287473|P5|NOT COMPLETED|Overall Study||3
946671|NCT00042991|2287474|P4|NOT COMPLETED|Overall Study||2
946672|NCT00042991|2287475|P3|NOT COMPLETED|Overall Study||6
946673|NCT00042991|2287476|P2|NOT COMPLETED|Overall Study||40
946674|NCT00042991|2287477|P1|NOT COMPLETED|Overall Study||6
946675|NCT00042991|2287471|P7|COMPLETED|Overall Study||1
946676|NCT00042991|2287472|P6|COMPLETED|Overall Study||0
946677|NCT00042991|2287473|P5|COMPLETED|Overall Study||0
946678|NCT00042991|2287474|P4|COMPLETED|Overall Study||0
946679|NCT00042991|2287475|P3|COMPLETED|Overall Study||1
946680|NCT00042991|2287476|P2|COMPLETED|Overall Study||3
946681|NCT00042991|2287477|P1|COMPLETED|Overall Study||0
946682|NCT00042991|2287471|P7|Phase-II Trial|Overall Study||0
946683|NCT00042991|2287472|P6|Phase-II Trial|Overall Study||0
946684|NCT00042991|2287473|P5|Phase-II Trial|Overall Study||0
946685|NCT00042991|2287474|P4|Phase-II Trial|Overall Study||0
946686|NCT00042991|2287475|P3|Phase-II Trial|Overall Study||0
946687|NCT00042991|2287476|P2|Phase-II Trial|Overall Study||36
946688|NCT00042991|2287477|P1|Phase-II Trial|Overall Study||0
946689|NCT00042991|2287471|P7|Phase-I Trial|Overall Study||3
946690|NCT00042991|2287472|P6|Phase-I Trial|Overall Study||5
946691|NCT00042991|2287473|P5|Phase-I Trial|Overall Study||3
946692|NCT00042991|2287474|P4|Phase-I Trial|Overall Study||2
946693|NCT00042991|2287475|P3|Phase-I Trial|Overall Study||7
946694|NCT00042991|2287476|P2|Phase-I Trial|Overall Study|These seven patients contributed to both Phase-I and Phase-II objectives.|7
946695|NCT00042991|2287477|P1|Phase-I Trial|Overall Study||6
946696|NCT00042991|2287471|P7|STARTED|Overall Study||3
946697|NCT00042991|2287472|P6|STARTED|Overall Study||5
946698|NCT00042991|2287473|P5|STARTED|Overall Study||3
946699|NCT00042991|2287474|P4|STARTED|Overall Study||2
946700|NCT00042991|2287475|P3|STARTED|Overall Study||7
946701|NCT00042991|2287476|P2|STARTED|Overall Study|These 43 patients form the Phase-II cohort, seven contributing from the Phase-I trial.|43
946702|NCT00042991|2287477|P1|STARTED|Overall Study||6
946703|NCT00043186|2287527|P9|NOT COMPLETED|Overall Study||17
946704|NCT00043186|2287528|P8|NOT COMPLETED|Overall Study||16
946705|NCT00043186|2287529|P7|NOT COMPLETED|Overall Study||17
946706|NCT00043186|2287530|P6|NOT COMPLETED|Overall Study||8
946707|NCT00043186|2287531|P5|NOT COMPLETED|Overall Study||18
946708|NCT00043186|2287532|P4|NOT COMPLETED|Overall Study||22
946709|NCT00043186|2287533|P3|NOT COMPLETED|Overall Study||20
946710|NCT00043186|2287534|P2|NOT COMPLETED|Overall Study||15
946711|NCT00043186|2287535|P1|NOT COMPLETED|Overall Study||17
946712|NCT00043186|2287527|P9|COMPLETED|Overall Study||30
946713|NCT00043186|2287528|P8|COMPLETED|Overall Study||31
946714|NCT00043186|2287529|P7|COMPLETED|Overall Study||25
946715|NCT00043186|2287530|P6|COMPLETED|Overall Study||39
946716|NCT00043186|2287531|P5|COMPLETED|Overall Study||36
946717|NCT00043186|2287532|P4|COMPLETED|Overall Study||19
946718|NCT00043186|2287533|P3|COMPLETED|Overall Study||24
946719|NCT00043186|2287534|P2|COMPLETED|Overall Study||29
946720|NCT00043186|2287535|P1|COMPLETED|Overall Study||29
946721|NCT00043186|2287527|P9|STARTED|Overall Study||47
946722|NCT00043186|2287528|P8|STARTED|Overall Study||47
946723|NCT00043186|2287529|P7|STARTED|Overall Study||42
946724|NCT00043186|2287530|P6|STARTED|Overall Study||47
946725|NCT00043186|2287531|P5|STARTED|Overall Study||54
946726|NCT00043186|2287532|P4|STARTED|Overall Study||41
946727|NCT00043186|2287533|P3|STARTED|Overall Study||44
946728|NCT00043186|2287534|P2|STARTED|Overall Study||44
946729|NCT00043186|2287535|P1|STARTED|Overall Study||46
946730|NCT00046930|2287863|P2|NOT COMPLETED|Overall Study||4
946731|NCT00046930|2287864|P1|NOT COMPLETED|Overall Study||12
946732|NCT00046930|2287863|P2|COMPLETED|Overall Study||221
946733|NCT00046930|2287864|P1|COMPLETED|Overall Study||212
946734|NCT00046930|2287863|P2|STARTED|Overall Study||225
946735|NCT00046930|2287864|P1|STARTED|Overall Study||224
946736|NCT00047008|2287879|P2|NOT COMPLETED|Overall Study||11
946737|NCT00047008|2287880|P1|NOT COMPLETED|Overall Study||11
946738|NCT00047008|2287879|P2|COMPLETED|Overall Study||360
946739|NCT00047008|2287880|P1|COMPLETED|Overall Study||361
946740|NCT00047008|2287879|P2|STARTED|Overall Study||371
946741|NCT00047008|2287880|P1|STARTED|Overall Study||372
946742|NCT00047320|2287886|P1|NOT COMPLETED|Overall Study||28
946743|NCT00047320|2287886|P1|COMPLETED|Overall Study||76
946744|NCT00047320|2287886|P1|STARTED|Overall Study||104
946745|NCT00047385|2287892|P2|NOT COMPLETED|Overall Study||500
946746|NCT00047385|2287893|P1|NOT COMPLETED|Overall Study||267
946747|NCT00047385|2287892|P2|COMPLETED|Overall Study||26232
946748|NCT00047385|2287893|P1|COMPLETED|Overall Study|Had at least one screening exam.|26455
946749|NCT00047385|2287892|P2|STARTED|Overall Study||26732
946750|NCT00047385|2287893|P1|STARTED|Overall Study||26722
946751|NCT00047463|2287913|P2|NOT COMPLETED|Overall Study||3
946752|NCT00047463|2287914|P1|NOT COMPLETED|Overall Study||0
946753|NCT00047463|2287913|P2|COMPLETED|Overall Study||19
946754|NCT00047463|2287914|P1|COMPLETED|Overall Study||13
946755|NCT00047463|2287913|P2|STARTED|Overall Study||22
946756|NCT00047463|2287914|P1|STARTED|Overall Study||13
946757|NCT00047619|2287925|P2|NOT COMPLETED|Overall Study||0
946758|NCT00047619|2287926|P1|NOT COMPLETED|Overall Study||0
946759|NCT00047619|2287925|P2|COMPLETED|Overall Study||14
946760|NCT00047619|2287926|P1|COMPLETED|Overall Study||14
946761|NCT00047619|2287925|P2|STARTED|Overall Study||14
946762|NCT00047619|2287926|P1|STARTED|Overall Study||14
946763|NCT00047697|2287936|P2|NOT COMPLETED|Overall Study||2
946764|NCT00047697|2287937|P1|NOT COMPLETED|Overall Study||0
946765|NCT00047697|2287936|P2|COMPLETED|Overall Study||14
946766|NCT00047697|2287937|P1|COMPLETED|Overall Study||18
946767|NCT00047697|2287936|P2|STARTED|Overall Study||16
946768|NCT00047697|2287937|P1|STARTED|Overall Study||18
946769|NCT00047879|2287949|P2|NOT COMPLETED|Overall Study||3
946770|NCT00047879|2287950|P1|NOT COMPLETED|Overall Study||4
946771|NCT00047879|2287949|P2|COMPLETED|Overall Study||0
946772|NCT00047879|2287950|P1|COMPLETED|Overall Study||0
946773|NCT00047879|2287949|P2|STARTED|Overall Study||3
946774|NCT00047879|2287950|P1|STARTED|Overall Study||4
946775|NCT00048035|2287966|P8|NOT COMPLETED|Extension Year 2||3
946776|NCT00048035|2287967|P7|NOT COMPLETED|Extension Year 2||3
946777|NCT00048035|2287968|P6|NOT COMPLETED|Extension Year 2||0
946778|NCT00048035|2287969|P5|NOT COMPLETED|Extension Year 2||0
946779|NCT00048035|2287970|P4|NOT COMPLETED|Extension Year 2||0
946780|NCT00048035|2287971|P3|NOT COMPLETED|Extension Year 2||0
946781|NCT00048035|2287972|P2|NOT COMPLETED|Extension Year 2||0
946782|NCT00048035|2287973|P1|NOT COMPLETED|Extension Year 2||0
946783|NCT00048035|2287966|P8|COMPLETED|Extension Year 2||10
946784|NCT00048035|2287967|P7|COMPLETED|Extension Year 2||11
946785|NCT00048035|2287968|P6|COMPLETED|Extension Year 2||0
946786|NCT00048035|2287969|P5|COMPLETED|Extension Year 2||0
946787|NCT00048035|2287970|P4|COMPLETED|Extension Year 2||0
946788|NCT00048035|2287971|P3|COMPLETED|Extension Year 2||0
946789|NCT00048035|2287972|P2|COMPLETED|Extension Year 2||0
946790|NCT00048035|2287973|P1|COMPLETED|Extension Year 2||0
946791|NCT00048035|2287966|P8|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|13
946792|NCT00048035|2287967|P7|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
946793|NCT00048035|2287968|P6|STARTED|Extension Year 2||0
946794|NCT00048035|2287969|P5|STARTED|Extension Year 2||0
946795|NCT00048035|2287970|P4|STARTED|Extension Year 2||0
946796|NCT00048035|2287971|P3|STARTED|Extension Year 2||0
946797|NCT00048035|2287972|P2|STARTED|Extension Year 2||0
946798|NCT00048035|2287973|P1|STARTED|Extension Year 2||0
946799|NCT00048035|2287966|P8|NOT COMPLETED|Extension Year 1||11
946800|NCT00048035|2287967|P7|NOT COMPLETED|Extension Year 1||11
946801|NCT00048035|2287968|P6|NOT COMPLETED|Extension Year 1||0
946802|NCT00048035|2287969|P5|NOT COMPLETED|Extension Year 1||0
946803|NCT00048035|2287970|P4|NOT COMPLETED|Extension Year 1||0
946804|NCT00048035|2287971|P3|NOT COMPLETED|Extension Year 1||0
946805|NCT00048035|2287972|P2|NOT COMPLETED|Extension Year 1||0
946806|NCT00048035|2287973|P1|NOT COMPLETED|Extension Year 1||0
946807|NCT00048035|2287966|P8|COMPLETED|Extension Year 1||15
946808|NCT00048035|2287967|P7|COMPLETED|Extension Year 1||16
946809|NCT00048035|2287968|P6|COMPLETED|Extension Year 1||0
946810|NCT00048035|2287969|P5|COMPLETED|Extension Year 1||0
946811|NCT00048035|2287970|P4|COMPLETED|Extension Year 1||0
946812|NCT00048035|2287971|P3|COMPLETED|Extension Year 1||0
946813|NCT00048035|2287972|P2|COMPLETED|Extension Year 1||0
946814|NCT00048035|2287973|P1|COMPLETED|Extension Year 1||0
946815|NCT00048035|2287966|P8|STARTED|Extension Year 1|Participants (Cohorts 2, 4 and 6) who completed core, entered extension period (entry optional).|26
946816|NCT00048035|2287967|P7|STARTED|Extension Year 1|Participants (Cohorts 1, 3, and 5) who completed core, entered extension period (entry optional).|27
946817|NCT00048035|2287968|P6|STARTED|Extension Year 1||0
946818|NCT00048035|2287969|P5|STARTED|Extension Year 1||0
946819|NCT00048035|2287970|P4|STARTED|Extension Year 1||0
946820|NCT00048035|2287971|P3|STARTED|Extension Year 1||0
946821|NCT00048035|2287972|P2|STARTED|Extension Year 1||0
946822|NCT00048035|2287973|P1|STARTED|Extension Year 1||0
946823|NCT00048035|2287966|P8|NOT COMPLETED|Core Period||0
946824|NCT00048035|2287967|P7|NOT COMPLETED|Core Period||0
946825|NCT00048035|2287968|P6|NOT COMPLETED|Core Period||1
946826|NCT00048035|2287969|P5|NOT COMPLETED|Core Period||1
946827|NCT00048035|2287970|P4|NOT COMPLETED|Core Period||1
946828|NCT00048035|2287971|P3|NOT COMPLETED|Core Period||1
946829|NCT00048035|2287972|P2|NOT COMPLETED|Core Period||2
946830|NCT00048035|2287973|P1|NOT COMPLETED|Core Period||4
946831|NCT00048035|2287966|P8|COMPLETED|Core Period||0
946832|NCT00048035|2287967|P7|COMPLETED|Core Period||0
946833|NCT00048035|2287968|P6|COMPLETED|Core Period||14
946834|NCT00048035|2287969|P5|COMPLETED|Core Period||15
946835|NCT00048035|2287970|P4|COMPLETED|Core Period||14
946836|NCT00048035|2287971|P3|COMPLETED|Core Period||14
946837|NCT00048035|2287972|P2|COMPLETED|Core Period||13
946838|NCT00048035|2287973|P1|COMPLETED|Core Period||11
946839|NCT00048035|2287966|P8|STARTED|Core Period||0
946840|NCT00048035|2287967|P7|STARTED|Core Period||0
946841|NCT00048035|2287968|P6|STARTED|Core Period||15
946842|NCT00048035|2287969|P5|STARTED|Core Period||16
946843|NCT00048035|2287970|P4|STARTED|Core Period||15
946844|NCT00048035|2287971|P3|STARTED|Core Period||15
946845|NCT00048035|2287972|P2|STARTED|Core Period||15
946846|NCT00048035|2287973|P1|STARTED|Core Period||15
946847|NCT00048061|2288013|P4|NOT COMPLETED|Overall Study||79
946848|NCT00048061|2288014|P3|NOT COMPLETED|Overall Study||84
946849|NCT00048061|2288015|P2|NOT COMPLETED|Overall Study||73
946850|NCT00048061|2288016|P1|NOT COMPLETED|Overall Study||75
946851|NCT00048061|2288013|P4|COMPLETED|Overall Study||322
946852|NCT00048061|2288014|P3|COMPLETED|Overall Study||316
946853|NCT00048061|2288015|P2|COMPLETED|Overall Study||328
946854|NCT00048061|2288016|P1|COMPLETED|Overall Study||325
946855|NCT00048061|2288013|P4|STARTED|Overall Study||401
946856|NCT00048061|2288014|P3|STARTED|Overall Study||400
946857|NCT00048061|2288015|P2|STARTED|Overall Study||401
946858|NCT00048061|2288016|P1|STARTED|Overall Study||400
946859|NCT00048074|2288089|P3|NOT COMPLETED|Overall Study||97
946860|NCT00048074|2288090|P2|NOT COMPLETED|Overall Study||87
946861|NCT00048074|2288091|P1|NOT COMPLETED|Overall Study||81
946862|NCT00048074|2288089|P3|COMPLETED|Overall Study||372
946863|NCT00048074|2288090|P2|COMPLETED|Overall Study||361
946864|NCT00048074|2288091|P1|COMPLETED|Overall Study||384
946865|NCT00048074|2288089|P3|STARTED|Overall Study||469
946866|NCT00048074|2288090|P2|STARTED|Overall Study||448
946867|NCT00048074|2288091|P1|STARTED|Overall Study||465
946868|NCT00048165|2288146|P2|NOT COMPLETED|Completed 12 Months Study||3
946869|NCT00048165|2288147|P1|NOT COMPLETED|Completed 12 Months Study||3
946870|NCT00048165|2288146|P2|COMPLETED|Completed 12 Months Study||167
946871|NCT00048165|2288147|P1|COMPLETED|Completed 12 Months Study||162
946872|NCT00048165|2288146|P2|STARTED|Completed 12 Months Study||170
946873|NCT00048165|2288147|P1|STARTED|Completed 12 Months Study||165
946874|NCT00048165|2288146|P2|NOT COMPLETED|Completed 6 Months Study||48
946875|NCT00048165|2288147|P1|NOT COMPLETED|Completed 6 Months Study||51
946876|NCT00048165|2288146|P2|COMPLETED|Completed 6 Months Study||170
946877|NCT00048165|2288147|P1|COMPLETED|Completed 6 Months Study||165
946878|NCT00048165|2288146|P2|STARTED|Completed 6 Months Study||218
946879|NCT00048165|2288147|P1|STARTED|Completed 6 Months Study||216
946880|NCT00048347|2288179|P1|NOT COMPLETED|Overall Study||2
946881|NCT00048347|2288179|P1|COMPLETED|Overall Study||16
946882|NCT00048347|2288179|P1|STARTED|Overall Study||18
947051|NCT00049127|2288801|P1|COMPLETED|Overall Study||12
946883|NCT00048542|2288187|P8|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
946884|NCT00048542|2288188|P7|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
946885|NCT00048542|2288189|P6|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
946886|NCT00048542|2288190|P5|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
946887|NCT00048542|2288191|P4|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
946888|NCT00048542|2288192|P3|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
946889|NCT00048542|2288193|P2|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
946890|NCT00048542|2288194|P1|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
946891|NCT00048542|2288187|P8|COMPLETED|Open-Label Extension Fixed Dose Phase||25
946892|NCT00048542|2288188|P7|COMPLETED|Open-Label Extension Fixed Dose Phase||37
946893|NCT00048542|2288189|P6|COMPLETED|Open-Label Extension Fixed Dose Phase||0
946894|NCT00048542|2288190|P5|COMPLETED|Open-Label Extension Fixed Dose Phase||0
946895|NCT00048542|2288191|P4|COMPLETED|Open-Label Extension Fixed Dose Phase||0
946896|NCT00048542|2288192|P3|COMPLETED|Open-Label Extension Fixed Dose Phase||0
946897|NCT00048542|2288193|P2|COMPLETED|Open-Label Extension Fixed Dose Phase||0
946898|NCT00048542|2288194|P1|COMPLETED|Open-Label Extension Fixed Dose Phase||0
946899|NCT00048542|2288187|P8|STARTED|Open-Label Extension Fixed Dose Phase||47
946900|NCT00048542|2288188|P7|STARTED|Open-Label Extension Fixed Dose Phase||59
946901|NCT00048542|2288189|P6|STARTED|Open-Label Extension Fixed Dose Phase||0
946902|NCT00048542|2288190|P5|STARTED|Open-Label Extension Fixed Dose Phase||0
946903|NCT00048542|2288191|P4|STARTED|Open-Label Extension Fixed Dose Phase||0
946904|NCT00048542|2288192|P3|STARTED|Open-Label Extension Fixed Dose Phase||0
946905|NCT00048542|2288193|P2|STARTED|Open-Label Extension Fixed Dose Phase||0
946906|NCT00048542|2288194|P1|STARTED|Open-Label Extension Fixed Dose Phase||0
946907|NCT00048542|2288187|P8|NOT COMPLETED|Open-Label Extension BSA Phase||0
946908|NCT00048542|2288188|P7|NOT COMPLETED|Open-Label Extension BSA Phase||0
946909|NCT00048542|2288189|P6|NOT COMPLETED|Open-Label Extension BSA Phase||10
946910|NCT00048542|2288190|P5|NOT COMPLETED|Open-Label Extension BSA Phase||12
946911|NCT00048542|2288191|P4|NOT COMPLETED|Open-Label Extension BSA Phase||0
946912|NCT00048542|2288192|P3|NOT COMPLETED|Open-Label Extension BSA Phase||0
946913|NCT00048542|2288193|P2|NOT COMPLETED|Open-Label Extension BSA Phase||0
946914|NCT00048542|2288194|P1|NOT COMPLETED|Open-Label Extension BSA Phase||0
946915|NCT00048542|2288187|P8|COMPLETED|Open-Label Extension BSA Phase||0
946916|NCT00048542|2288188|P7|COMPLETED|Open-Label Extension BSA Phase||0
946917|NCT00048542|2288189|P6|COMPLETED|Open-Label Extension BSA Phase||47
946918|NCT00048542|2288190|P5|COMPLETED|Open-Label Extension BSA Phase||59
946919|NCT00048542|2288191|P4|COMPLETED|Open-Label Extension BSA Phase||0
946920|NCT00048542|2288192|P3|COMPLETED|Open-Label Extension BSA Phase||0
946921|NCT00048542|2288193|P2|COMPLETED|Open-Label Extension BSA Phase||0
946922|NCT00048542|2288194|P1|COMPLETED|Open-Label Extension BSA Phase||0
946923|NCT00048542|2288187|P8|STARTED|Open-Label Extension BSA Phase||0
946924|NCT00048542|2288188|P7|STARTED|Open-Label Extension BSA Phase||0
946925|NCT00048542|2288189|P6|STARTED|Open-Label Extension BSA Phase||57
946926|NCT00048542|2288190|P5|STARTED|Open-Label Extension BSA Phase||71
946927|NCT00048542|2288191|P4|STARTED|Open-Label Extension BSA Phase||0
946928|NCT00048542|2288192|P3|STARTED|Open-Label Extension BSA Phase||0
946929|NCT00048542|2288193|P2|STARTED|Open-Label Extension BSA Phase||0
946930|NCT00048542|2288194|P1|STARTED|Open-Label Extension BSA Phase||0
946931|NCT00048542|2288187|P8|NOT COMPLETED|Double-Blind Phase||0
946932|NCT00048542|2288188|P7|NOT COMPLETED|Double-Blind Phase||0
946933|NCT00048542|2288189|P6|NOT COMPLETED|Double-Blind Phase||0
946934|NCT00048542|2288190|P5|NOT COMPLETED|Double-Blind Phase||0
946935|NCT00048542|2288191|P4|NOT COMPLETED|Double-Blind Phase||0
946936|NCT00048542|2288192|P3|NOT COMPLETED|Double-Blind Phase||1
946937|NCT00048542|2288193|P2|NOT COMPLETED|Double-Blind Phase||1
946938|NCT00048542|2288194|P1|NOT COMPLETED|Double-Blind Phase||3
946939|NCT00048542|2288187|P8|COMPLETED|Double-Blind Phase||0
946940|NCT00048542|2288188|P7|COMPLETED|Double-Blind Phase||0
946941|NCT00048542|2288189|P6|COMPLETED|Double-Blind Phase||0
946942|NCT00048542|2288190|P5|COMPLETED|Double-Blind Phase||0
946943|NCT00048542|2288191|P4|COMPLETED|Double-Blind Phase||28
946944|NCT00048542|2288192|P3|COMPLETED|Double-Blind Phase||29
946945|NCT00048542|2288193|P2|COMPLETED|Double-Blind Phase||36
946946|NCT00048542|2288194|P1|COMPLETED|Double-Blind Phase||35
946947|NCT00048542|2288187|P8|STARTED|Double-Blind Phase||0
946948|NCT00048542|2288188|P7|STARTED|Double-Blind Phase||0
946949|NCT00048542|2288189|P6|STARTED|Double-Blind Phase||0
946950|NCT00048542|2288190|P5|STARTED|Double-Blind Phase||0
946951|NCT00048542|2288191|P4|STARTED|Double-Blind Phase||28
946952|NCT00048542|2288192|P3|STARTED|Double-Blind Phase||30
946953|NCT00048542|2288193|P2|STARTED|Double-Blind Phase||37
946954|NCT00048542|2288194|P1|STARTED|Double-Blind Phase|For all groups, started indicates when the subjects entered the double-blind treatment phase.|38
946955|NCT00048568|2288262|P3|NOT COMPLETED|Open-Label Period||160
946956|NCT00048568|2288263|P2|NOT COMPLETED|Open-Label Period||0
946957|NCT00048568|2288264|P1|NOT COMPLETED|Open-Label Period||0
946958|NCT00048568|2288262|P3|COMPLETED|Open-Label Period||379
946959|NCT00048568|2288263|P2|COMPLETED|Open-Label Period||0
946960|NCT00048568|2288264|P1|COMPLETED|Open-Label Period||0
946961|NCT00048568|2288262|P3|STARTED|Open-Label Period||539
946962|NCT00048568|2288263|P2|STARTED|Open-Label Period||0
946963|NCT00048568|2288264|P1|STARTED|Open-Label Period||0
946964|NCT00048568|2288262|P3|NOT COMPLETED|Double-Blind Period Days 170 to 365||0
946965|NCT00048568|2288263|P2|NOT COMPLETED|Double-Blind Period Days 170 to 365||12
946966|NCT00048568|2288264|P1|NOT COMPLETED|Double-Blind Period Days 170 to 365||16
946967|NCT00048568|2288262|P3|COMPLETED|Double-Blind Period Days 170 to 365||0
946968|NCT00048568|2288263|P2|COMPLETED|Double-Blind Period Days 170 to 365||162
946969|NCT00048568|2288264|P1|COMPLETED|Double-Blind Period Days 170 to 365||385
946970|NCT00048568|2288262|P3|STARTED|Double-Blind Period Days 170 to 365||0
946971|NCT00048568|2288263|P2|STARTED|Double-Blind Period Days 170 to 365||174
946972|NCT00048568|2288264|P1|STARTED|Double-Blind Period Days 170 to 365||401
946973|NCT00048568|2288262|P3|NOT COMPLETED|Double-Blind Period Days 1 to 169||0
946974|NCT00048568|2288263|P2|NOT COMPLETED|Double-Blind Period Days 1 to 169||45
946975|NCT00048568|2288264|P1|NOT COMPLETED|Double-Blind Period Days 1 to 169||32
946976|NCT00048568|2288262|P3|COMPLETED|Double-Blind Period Days 1 to 169||0
946977|NCT00048568|2288263|P2|COMPLETED|Double-Blind Period Days 1 to 169||174
946978|NCT00048568|2288264|P1|COMPLETED|Double-Blind Period Days 1 to 169||401
946979|NCT00048568|2288262|P3|STARTED|Double-Blind Period Days 1 to 169||0
946980|NCT00048568|2288263|P2|STARTED|Double-Blind Period Days 1 to 169||219
946981|NCT00048568|2288264|P1|STARTED|Double-Blind Period Days 1 to 169||433
946982|NCT00048581|2288554|P3|NOT COMPLETED|Open-Label Period||167
946983|NCT00048581|2288555|P2|NOT COMPLETED|Open-Label Period||0
946984|NCT00048581|2288556|P1|NOT COMPLETED|Open-Label Period||0
946985|NCT00048581|2288554|P3|COMPLETED|Open-Label Period||150
946986|NCT00048581|2288555|P2|COMPLETED|Open-Label Period||0
946987|NCT00048581|2288556|P1|COMPLETED|Open-Label Period||0
946988|NCT00048581|2288554|P3|STARTED|Open-Label Period||317
946989|NCT00048581|2288555|P2|STARTED|Open-Label Period||0
946990|NCT00048581|2288556|P1|STARTED|Open-Label Period||0
946991|NCT00048581|2288554|P3|NOT COMPLETED|Double-Blind Period||0
946992|NCT00048581|2288555|P2|NOT COMPLETED|Double-Blind Period||34
946993|NCT00048581|2288556|P1|NOT COMPLETED|Double-Blind Period||35
946994|NCT00048581|2288554|P3|COMPLETED|Double-Blind Period||0
946995|NCT00048581|2288555|P2|COMPLETED|Double-Blind Period||99
946996|NCT00048581|2288556|P1|COMPLETED|Double-Blind Period||223
946997|NCT00048581|2288554|P3|STARTED|Double-Blind Period||0
946998|NCT00048581|2288555|P2|STARTED|Double-Blind Period||133
946999|NCT00048581|2288556|P1|STARTED|Double-Blind Period||258
947000|NCT00048724|2288723|P2|NOT COMPLETED|Overall Study||118
947001|NCT00048724|2288724|P1|NOT COMPLETED|Overall Study||116
947002|NCT00048724|2288723|P2|COMPLETED|Overall Study||197
947003|NCT00048724|2288724|P1|COMPLETED|Overall Study||195
947004|NCT00048724|2288723|P2|STARTED|Overall Study||315
947005|NCT00048724|2288724|P1|STARTED|Overall Study||311
947006|NCT00048737|2288732|P1|NOT COMPLETED|Overall Study||0
947007|NCT00048737|2288732|P1|COMPLETED|Overall Study||70
947008|NCT00048737|2288732|P1|STARTED|Overall Study||70
947009|NCT00048893|2288736|P1|NOT COMPLETED|Overall Study||0
947010|NCT00048893|2288736|P1|COMPLETED|Overall Study||37
947011|NCT00048893|2288736|P1|STARTED|Overall Study||37
947012|NCT00048932|2288749|P3|NOT COMPLETED|Open Label Period (OL)||441
947013|NCT00048932|2288750|P2|NOT COMPLETED|Open Label Period (OL)||0
947014|NCT00048932|2288751|P1|NOT COMPLETED|Open Label Period (OL)||0
947015|NCT00048932|2288749|P3|COMPLETED|Open Label Period (OL)||743
947016|NCT00048932|2288750|P2|COMPLETED|Open Label Period (OL)||0
947017|NCT00048932|2288751|P1|COMPLETED|Open Label Period (OL)||0
947018|NCT00048932|2288749|P3|STARTED|Open Label Period (OL)|47 participants who completed the double-blind did not enter the open-label|1184
947019|NCT00048932|2288750|P2|STARTED|Open Label Period (OL)||0
947020|NCT00048932|2288751|P1|STARTED|Open Label Period (OL)||0
947021|NCT00048932|2288749|P3|NOT COMPLETED|Double Blind Period (DB)||0
947022|NCT00048932|2288750|P2|NOT COMPLETED|Double Blind Period (DB)||87
947023|NCT00048932|2288751|P1|NOT COMPLETED|Double Blind Period (DB)||123
947024|NCT00048932|2288749|P3|COMPLETED|Double Blind Period (DB)||0
947025|NCT00048932|2288750|P2|COMPLETED|Double Blind Period (DB)||395
947026|NCT00048932|2288751|P1|COMPLETED|Double Blind Period (DB)||836
947027|NCT00048932|2288749|P3|STARTED|Double Blind Period (DB)||0
947028|NCT00048932|2288750|P2|STARTED|Double Blind Period (DB)|Number Treated|482
947029|NCT00048932|2288751|P1|STARTED|Double Blind Period (DB)|Number Treated|959
947030|NCT00048997|2288777|P2|NOT COMPLETED|Overall Study||3
947031|NCT00048997|2288778|P1|NOT COMPLETED|Overall Study||13
947032|NCT00048997|2288777|P2|COMPLETED|Overall Study||177
947033|NCT00048997|2288778|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|163
947034|NCT00048997|2288777|P2|STARTED|Overall Study||180
947035|NCT00048997|2288778|P1|STARTED|Overall Study||176
947036|NCT00049036|2288785|P2|NOT COMPLETED|Overall Study||0
947037|NCT00049036|2288786|P1|NOT COMPLETED|Overall Study||0
947038|NCT00049036|2288785|P2|COMPLETED|Overall Study||55
947039|NCT00049036|2288786|P1|COMPLETED|Overall Study||51
947040|NCT00049036|2288785|P2|STARTED|Overall Study||55
947041|NCT00049036|2288786|P1|STARTED|Overall Study||51
947042|NCT00049127|2288797|P5|NOT COMPLETED|Overall Study||0
947043|NCT00049127|2288798|P4|NOT COMPLETED|Overall Study||0
947044|NCT00049127|2288799|P3|NOT COMPLETED|Overall Study||1
947045|NCT00049127|2288800|P2|NOT COMPLETED|Overall Study||0
947046|NCT00049127|2288801|P1|NOT COMPLETED|Overall Study||0
947047|NCT00049127|2288797|P5|COMPLETED|Overall Study||12
947048|NCT00049127|2288798|P4|COMPLETED|Overall Study||0
947049|NCT00049127|2288799|P3|COMPLETED|Overall Study||39
947050|NCT00049127|2288800|P2|COMPLETED|Overall Study||0
947052|NCT00049127|2288797|P5|STARTED|Overall Study||12
947053|NCT00049127|2288798|P4|STARTED|Overall Study||0
947054|NCT00049127|2288799|P3|STARTED|Overall Study||40
947055|NCT00049127|2288800|P2|STARTED|Overall Study||0
947056|NCT00049127|2288801|P1|STARTED|Overall Study||12
947057|NCT00049257|2288828|P1|NOT COMPLETED|Follow-up Period for Survival Status||4
947058|NCT00049257|2288828|P1|COMPLETED|Follow-up Period for Survival Status||41
947059|NCT00049257|2288828|P1|STARTED|Follow-up Period for Survival Status||45
947060|NCT00049257|2288828|P1|NOT COMPLETED|Carboplatin, Paclitaxel||13
947061|NCT00049257|2288828|P1|COMPLETED|Carboplatin, Paclitaxel|13 participants did not complete treatment|45
947062|NCT00049257|2288828|P1|STARTED|Carboplatin, Paclitaxel||58
947063|NCT00049322|2288837|P2|NOT COMPLETED|Overall Study||6
947064|NCT00049322|2288838|P1|NOT COMPLETED|Overall Study||1
947065|NCT00049322|2288837|P2|COMPLETED|Overall Study||9
947066|NCT00049322|2288838|P1|COMPLETED|Overall Study||14
947067|NCT00049322|2288837|P2|STARTED|Overall Study||15
947068|NCT00049322|2288838|P1|STARTED|Overall Study||15
947069|NCT00049504|2288850|P1|NOT COMPLETED|Overall Study||0
947070|NCT00049504|2288850|P1|COMPLETED|Overall Study||55
947071|NCT00049504|2288850|P1|STARTED|Overall Study||55
947072|NCT00049517|2288858|P6|NOT COMPLETED|Conditioning/Transplant||6
947073|NCT00049517|2288859|P5|NOT COMPLETED|Conditioning/Transplant||6
947074|NCT00049517|2288860|P4|NOT COMPLETED|Conditioning/Transplant||43
947075|NCT00049517|2288861|P3|NOT COMPLETED|Conditioning/Transplant||38
947076|NCT00049517|2288862|P2|NOT COMPLETED|Conditioning/Transplant||50
947077|NCT00049517|2288863|P1|NOT COMPLETED|Conditioning/Transplant||52
947078|NCT00049517|2288858|P6|COMPLETED|Conditioning/Transplant||18
947079|NCT00049517|2288859|P5|COMPLETED|Conditioning/Transplant||15
947080|NCT00049517|2288860|P4|COMPLETED|Conditioning/Transplant||32
947081|NCT00049517|2288861|P3|COMPLETED|Conditioning/Transplant||25
947082|NCT00049517|2288862|P2|COMPLETED|Conditioning/Transplant||40
947083|NCT00049517|2288863|P1|COMPLETED|Conditioning/Transplant||27
947084|NCT00049517|2288858|P6|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 24 patients received Allogeneic HCT without randomization.|0
947085|NCT00049517|2288859|P5|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 21 patients received Allogeneic HCT without randomization.|0
947086|NCT00049517|2288860|P4|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||75
947087|NCT00049517|2288861|P3|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||63
947088|NCT00049517|2288862|P2|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 17 patients received Autologous HCT without randomization.|73
947089|NCT00049517|2288863|P1|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 20 patients received Autologous HCT without randomization.|59
947090|NCT00049517|2288858|P6|STARTED|Conditioning/Transplant||24
947091|NCT00049517|2288859|P5|STARTED|Conditioning/Transplant||21
947092|NCT00049517|2288860|P4|STARTED|Conditioning/Transplant||75
947093|NCT00049517|2288861|P3|STARTED|Conditioning/Transplant||63
947094|NCT00049517|2288862|P2|STARTED|Conditioning/Transplant||90
947095|NCT00049517|2288863|P1|STARTED|Conditioning/Transplant||79
947096|NCT00049517|2288858|P6|NOT COMPLETED|Induction||54
947097|NCT00049517|2288859|P5|NOT COMPLETED|Induction||60
947098|NCT00049517|2288860|P4|NOT COMPLETED|Induction||0
947099|NCT00049517|2288861|P3|NOT COMPLETED|Induction||0
947100|NCT00049517|2288862|P2|NOT COMPLETED|Induction||0
947101|NCT00049517|2288863|P1|NOT COMPLETED|Induction||0
947102|NCT00049517|2288858|P6|COMPLETED|Induction||108
947103|NCT00049517|2288859|P5|COMPLETED|Induction||128
947104|NCT00049517|2288860|P4|COMPLETED|Induction||75
947105|NCT00049517|2288861|P3|COMPLETED|Induction||63
947106|NCT00049517|2288862|P2|COMPLETED|Induction||90
947107|NCT00049517|2288863|P1|COMPLETED|Induction||79
947108|NCT00049517|2288858|P6|Treated|Induction||160
947109|NCT00049517|2288859|P5|Treated|Induction||186
947110|NCT00049517|2288860|P4|Treated|Induction||75
947111|NCT00049517|2288861|P3|Treated|Induction||63
947112|NCT00049517|2288862|P2|Treated|Induction||90
947113|NCT00049517|2288863|P1|Treated|Induction||79
947114|NCT00049517|2288858|P6|STARTED|Induction||162
947115|NCT00049517|2288859|P5|STARTED|Induction||188
947116|NCT00049517|2288860|P4|STARTED|Induction||75
947117|NCT00049517|2288861|P3|STARTED|Induction||63
947118|NCT00049517|2288862|P2|STARTED|Induction||90
947119|NCT00049517|2288863|P1|STARTED|Induction||79
947120|NCT00049530|2288873|P1|NOT COMPLETED|Overall Study||32
947121|NCT00049530|2288873|P1|COMPLETED|Overall Study||0
947122|NCT00049530|2288873|P1|Eligible and Treated|Overall Study||29
947123|NCT00049530|2288873|P1|STARTED|Overall Study||32
947124|NCT00049543|2288882|P2|NOT COMPLETED|Overall Study||9
947125|NCT00049543|2288883|P1|NOT COMPLETED|Overall Study||2
947126|NCT00049543|2288882|P2|COMPLETED|Overall Study||243
947127|NCT00049543|2288883|P1|COMPLETED|Overall Study||249
947128|NCT00049543|2288882|P2|STARTED|Overall Study||252
947129|NCT00049543|2288883|P1|STARTED|Overall Study||251
947130|NCT00038467|2288895|P2|NOT COMPLETED|Overall Study||542
947131|NCT00038467|2288896|P1|NOT COMPLETED|Overall Study||542
947132|NCT00038467|2288895|P2|COMPLETED|Overall Study||1830
947133|NCT00038467|2288896|P1|COMPLETED|Overall Study||1810
947134|NCT00038467|2288895|P2|Treated|Overall Study|7 participants randomized to receive tamoxifen, received exemestane. Reported as per randomization.|2337
947135|NCT00038467|2288896|P1|Treated|Overall Study|8 participants randomized to receive exemestane, received tamoxifen. Reported as per randomization.|2321
947136|NCT00038467|2288895|P2|STARTED|Overall Study||2372
947137|NCT00038467|2288896|P1|STARTED|Overall Study||2352
947138|NCT00038610|2288956|P1|NOT COMPLETED|Overall Study||0
947139|NCT00038610|2288956|P1|COMPLETED|Overall Study||54
947140|NCT00038610|2288956|P1|STARTED|Overall Study||54
947141|NCT00038857|2288962|P1|NOT COMPLETED|Overall Study||1
947142|NCT00038857|2288962|P1|COMPLETED|Overall Study||28
947143|NCT00038857|2288962|P1|STARTED|Overall Study||29
947144|NCT00038948|2288968|P2|NOT COMPLETED|Overall Study||77
947145|NCT00038948|2288969|P1|NOT COMPLETED|Overall Study||169
947146|NCT00038948|2288968|P2|COMPLETED|Overall Study||198
947147|NCT00038948|2288969|P1|COMPLETED|Overall Study||386
947148|NCT00038948|2288968|P2|STARTED|Overall Study||275
947149|NCT00038948|2288969|P1|STARTED|Overall Study||555
947150|NCT00039130|2288981|P1|NOT COMPLETED|Overall Study||30
947151|NCT00039130|2288981|P1|COMPLETED|Overall Study||75
947152|NCT00039130|2288981|P1|STARTED|Overall Study||105
947153|NCT00039195|2288987|P1|NOT COMPLETED|Overall Study||0
947154|NCT00039195|2288987|P1|COMPLETED|Overall Study||98
947155|NCT00039195|2288987|P1|STARTED|Overall Study||98
947156|NCT00039377|2288991|P4|NOT COMPLETED|Course 5 (Transplant Assignments)||0
947157|NCT00039377|2288992|P3|NOT COMPLETED|Course 5 (Transplant Assignments)||0
947158|NCT00039377|2288993|P2|NOT COMPLETED|Course 5 (Transplant Assignments)||0
947159|NCT00039377|2288994|P1|NOT COMPLETED|Course 5 (Transplant Assignments)||0
947160|NCT00039377|2288991|P4|COMPLETED|Course 5 (Transplant Assignments)||1
947161|NCT00039377|2288992|P3|COMPLETED|Course 5 (Transplant Assignments)||19
947162|NCT00039377|2288993|P2|COMPLETED|Course 5 (Transplant Assignments)||15
947163|NCT00039377|2288994|P1|COMPLETED|Course 5 (Transplant Assignments)||0
947164|NCT00039377|2288991|P4|STARTED|Course 5 (Transplant Assignments)||1
947165|NCT00039377|2288992|P3|STARTED|Course 5 (Transplant Assignments)||19
947166|NCT00039377|2288993|P2|STARTED|Course 5 (Transplant Assignments)||15
947167|NCT00039377|2288994|P1|STARTED|Course 5 (Transplant Assignments)|After Course I-IV, participants were grouped into autologous, allogeneic or no transplant arms.|0
947168|NCT00039377|2288991|P4|NOT COMPLETED|Initial Registration||0
947169|NCT00039377|2288992|P3|NOT COMPLETED|Initial Registration||0
947170|NCT00039377|2288993|P2|NOT COMPLETED|Initial Registration||0
947171|NCT00039377|2288994|P1|NOT COMPLETED|Initial Registration||22
947172|NCT00039377|2288991|P4|COMPLETED|Initial Registration||0
947173|NCT00039377|2288992|P3|COMPLETED|Initial Registration||0
947174|NCT00039377|2288993|P2|COMPLETED|Initial Registration||0
947175|NCT00039377|2288994|P1|COMPLETED|Initial Registration||35
947176|NCT00039377|2288991|P4|STARTED|Initial Registration||0
947177|NCT00039377|2288992|P3|STARTED|Initial Registration||0
947178|NCT00039377|2288993|P2|STARTED|Initial Registration||0
947179|NCT00039377|2288994|P1|STARTED|Initial Registration||57
947180|NCT00039741|2289010|P4|NOT COMPLETED|Overall Study||14
947181|NCT00039741|2289011|P3|NOT COMPLETED|Overall Study||11
947182|NCT00039741|2289012|P2|NOT COMPLETED|Overall Study||12
947183|NCT00039741|2289013|P1|NOT COMPLETED|Overall Study||15
947184|NCT00039741|2289010|P4|COMPLETED|Overall Study||50
947185|NCT00039741|2289011|P3|COMPLETED|Overall Study||54
947186|NCT00039741|2289012|P2|COMPLETED|Overall Study||56
947187|NCT00039741|2289013|P1|COMPLETED|Overall Study||51
947188|NCT00039741|2289010|P4|Death|Overall Study||0
947189|NCT00039741|2289011|P3|Death|Overall Study||0
947190|NCT00039741|2289012|P2|Death|Overall Study||1
947191|NCT00039741|2289013|P1|Death|Overall Study||0
947192|NCT00039741|2289010|P4|STARTED|Overall Study||64
947193|NCT00039741|2289011|P3|STARTED|Overall Study||65
947194|NCT00039741|2289012|P2|STARTED|Overall Study||68
947195|NCT00039741|2289013|P1|STARTED|Overall Study||66
947196|NCT00039871|2289055|P1|NOT COMPLETED|Overall Study||1384
947197|NCT00039871|2289055|P1|COMPLETED|Overall Study||928
947198|NCT00039871|2289055|P1|STARTED|Overall Study|Enrolled 2333; 21 subjects excluded due to GCP non-compliance|2312
947199|NCT00040365|2289061|P1|NOT COMPLETED|Overall Study||11
947200|NCT00040365|2289061|P1|COMPLETED|Overall Study||19
947201|NCT00040365|2289061|P1|Completed Follow Up Phase|Overall Study||19
947202|NCT00040365|2289061|P1|STARTED|Overall Study||30
947203|NCT00049842|2289072|P2|NOT COMPLETED|Follow-up Phase||5
947204|NCT00049842|2289073|P1|NOT COMPLETED|Follow-up Phase||7
947205|NCT00049842|2289072|P2|COMPLETED|Follow-up Phase||189
947206|NCT00049842|2289073|P1|COMPLETED|Follow-up Phase||211
947207|NCT00049842|2289072|P2|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|194
947208|NCT00049842|2289073|P1|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|218
947209|NCT00049842|2289072|P2|NOT COMPLETED|Treatment Phase||78
947210|NCT00049842|2289073|P1|NOT COMPLETED|Treatment Phase||93
947211|NCT00049842|2289072|P2|COMPLETED|Treatment Phase||192
947212|NCT00049842|2289073|P1|COMPLETED|Treatment Phase||177
947213|NCT00049842|2289072|P2|STARTED|Treatment Phase||270
947214|NCT00049842|2289073|P1|STARTED|Treatment Phase||270
947215|NCT00050011|2289091|P2|NOT COMPLETED|Overall Study||126
947216|NCT00050011|2289092|P1|NOT COMPLETED|Overall Study||121
947217|NCT00050011|2289091|P2|COMPLETED|Overall Study||175
947218|NCT00050011|2289092|P1|COMPLETED|Overall Study||180
947219|NCT00050011|2289091|P2|Intent-to-treat Population|Overall Study||300
947220|NCT00050011|2289092|P1|Intent-to-treat Population|Overall Study||300
947221|NCT00050011|2289091|P2|STARTED|Overall Study||301
947222|NCT00050011|2289092|P1|STARTED|Overall Study||301
947223|NCT00050622|2289112|P1|NOT COMPLETED|Overall Study||1
947224|NCT00050622|2289112|P1|COMPLETED|Overall Study||153
947225|NCT00050622|2289112|P1|STARTED|Overall Study||154
947226|NCT00050778|2289151|P3|NOT COMPLETED|Overall Study||18
947227|NCT00050778|2289152|P2|NOT COMPLETED|Overall Study||21
947228|NCT00050778|2289153|P1|NOT COMPLETED|Overall Study||45
947229|NCT00050778|2289151|P3|COMPLETED|Overall Study||92
947230|NCT00050778|2289152|P2|COMPLETED|Overall Study||92
947231|NCT00050778|2289153|P1|COMPLETED|Overall Study||66
947232|NCT00050778|2289151|P3|Treated|Overall Study||108
947233|NCT00050778|2289152|P2|Treated|Overall Study||108
947234|NCT00050778|2289153|P1|Treated|Overall Study||107
947235|NCT00050778|2289151|P3|STARTED|Overall Study||110
947236|NCT00050778|2289152|P2|STARTED|Overall Study||113
947237|NCT00050778|2289153|P1|STARTED|Overall Study|Randomized.|111
947238|NCT00050960|2289181|P2|NOT COMPLETED|Overall Study||304
947239|NCT00050960|2289182|P1|NOT COMPLETED|Overall Study||302
947240|NCT00050960|2289181|P2|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|2
947241|NCT00050960|2289182|P1|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|4
947242|NCT00050960|2289181|P2|STARTED|Overall Study||306
947243|NCT00050960|2289182|P1|STARTED|Overall Study||306
947244|NCT00050986|2289188|P1|NOT COMPLETED|Overall Study||2
947245|NCT00050986|2289188|P1|COMPLETED|Overall Study|Two participants had withdrawn consents before the study treatment was initiated.|53
947246|NCT00050986|2289188|P1|STARTED|Overall Study||55
947247|NCT00051025|2289194|P2|NOT COMPLETED|Overall Study||4
947248|NCT00051025|2289195|P1|NOT COMPLETED|Overall Study||2
947249|NCT00051025|2289194|P2|COMPLETED|Overall Study||0
947250|NCT00051025|2289195|P1|COMPLETED|Overall Study||3
947251|NCT00051025|2289194|P2|STARTED|Overall Study||4
947252|NCT00051025|2289195|P1|STARTED|Overall Study||5
947253|NCT00051168|2289203|P1|NOT COMPLETED|Overall Study||135
947254|NCT00051168|2289203|P1|COMPLETED|Overall Study||367
947255|NCT00051168|2289203|P1|STARTED|Overall Study||502
947272|NCT00051558|2289246|P2|NOT COMPLETED|Overall Study||96
947273|NCT00051558|2289247|P1|NOT COMPLETED|Overall Study||91
947274|NCT00051558|2289246|P2|COMPLETED|Overall Study||118
947275|NCT00051558|2289247|P1|COMPLETED|Overall Study||123
947276|NCT00051558|2289246|P2|STARTED|Overall Study||214
947277|NCT00051558|2289247|P1|STARTED|Overall Study||214
947278|NCT00051636|2289283|P2|NOT COMPLETED|Period 2- Extended Observation Period||30
947279|NCT00051636|2289284|P1|NOT COMPLETED|Period 2- Extended Observation Period||70
947280|NCT00051636|2289283|P2|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease|22
947281|NCT00051636|2289284|P1|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|5
947282|NCT00051636|2289283|P2|STARTED|Period 2- Extended Observation Period||52
947283|NCT00051636|2289284|P1|STARTED|Period 2- Extended Observation Period||75
947284|NCT00051636|2289283|P2|NOT COMPLETED|Period 1 - Core||6
947285|NCT00051636|2289284|P1|NOT COMPLETED|Period 1 - Core||4
947286|NCT00051636|2289283|P2|COMPLETED|Period 1 - Core||76
947287|NCT00051636|2289284|P1|COMPLETED|Period 1 - Core||86
947288|NCT00051636|2289283|P2|STARTED|Period 1 - Core||82
947289|NCT00051636|2289284|P1|STARTED|Period 1 - Core||90
947290|NCT00052078|2289314|P4|NOT COMPLETED|Overall Study||15
947291|NCT00052078|2289315|P3|NOT COMPLETED|Overall Study||13
947292|NCT00052078|2289316|P2|NOT COMPLETED|Overall Study||6
947293|NCT00052078|2289317|P1|NOT COMPLETED|Overall Study||23
947294|NCT00052078|2289314|P4|COMPLETED|Overall Study||61
947295|NCT00052078|2289315|P3|COMPLETED|Overall Study||127
947296|NCT00052078|2289316|P2|COMPLETED|Overall Study||133
947297|NCT00052078|2289317|P1|COMPLETED|Overall Study||110
947298|NCT00052078|2289314|P4|STARTED|Overall Study||76
947299|NCT00052078|2289315|P3|STARTED|Overall Study||140
947300|NCT00052078|2289316|P2|STARTED|Overall Study||139
947301|NCT00052078|2289317|P1|STARTED|Overall Study||133
947302|NCT00052429|2289327|P1|NOT COMPLETED|Overall Study||0
947303|NCT00052429|2289327|P1|COMPLETED|Overall Study||25
947304|NCT00052429|2289327|P1|STARTED|Overall Study||25
947305|NCT00052715|2289332|P1|NOT COMPLETED|Overall Study||1
947306|NCT00052715|2289332|P1|COMPLETED|Overall Study||30
947307|NCT00052715|2289332|P1|STARTED|Overall Study||31
947308|NCT00052962|2289341|P2|NOT COMPLETED|Overall Study||2
947309|NCT00052962|2289342|P1|NOT COMPLETED|Overall Study||1
947310|NCT00052962|2289341|P2|COMPLETED|Overall Study||15
947311|NCT00052962|2289342|P1|COMPLETED|Overall Study||12
947312|NCT00052962|2289341|P2|STARTED|Overall Study||17
947313|NCT00052962|2289342|P1|STARTED|Overall Study||13
947314|NCT00053014|2289350|P1|NOT COMPLETED|Overall Study||0
947315|NCT00053014|2289350|P1|COMPLETED|Overall Study||5
947316|NCT00053014|2289350|P1|STARTED|Overall Study||5
947329|NCT00044512|2289376|P1|NOT COMPLETED|Follow Up||2
947330|NCT00044512|2289376|P1|COMPLETED|Follow Up||135
947331|NCT00044512|2289376|P1|STARTED|Follow Up||137
947332|NCT00044512|2289376|P1|NOT COMPLETED|Treatment||0
947333|NCT00044512|2289376|P1|COMPLETED|Treatment||137
947334|NCT00044512|2289376|P1|STARTED|Treatment||137
947335|NCT00044655|2289389|P2|NOT COMPLETED|Overall Study||38
947336|NCT00044655|2289390|P1|NOT COMPLETED|Overall Study||20
947337|NCT00044655|2289389|P2|COMPLETED|Overall Study||79
947338|NCT00044655|2289390|P1|COMPLETED|Overall Study||82
947339|NCT00044655|2289389|P2|STARTED|Overall Study||117
947340|NCT00044655|2289390|P1|STARTED|Overall Study||102
947341|NCT00045032|2289399|P3|NOT COMPLETED|Overall Study||726
947342|NCT00045032|2289400|P2|NOT COMPLETED|Overall Study||708
947343|NCT00045032|2289401|P1|NOT COMPLETED|Overall Study||863
947344|NCT00045032|2289399|P3|COMPLETED|Overall Study||974
947345|NCT00045032|2289400|P2|COMPLETED|Overall Study||994
947346|NCT00045032|2289401|P1|COMPLETED|Overall Study||834
947347|NCT00045032|2289399|P3|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
947348|NCT00045032|2289400|P2|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
947349|NCT00045032|2289401|P1|Crossover to Adjuvant Herceptin|Overall Study||888
947350|NCT00045032|2289399|P3|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1700
947351|NCT00045032|2289400|P2|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1702
947352|NCT00045032|2289401|P1|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1697
947353|NCT00045110|2289531|P3|NOT COMPLETED|775mg Dose Escalation||0
947354|NCT00045110|2289532|P2|NOT COMPLETED|775mg Dose Escalation||0
947355|NCT00045110|2289533|P1|NOT COMPLETED|775mg Dose Escalation||0
947356|NCT00045110|2289531|P3|COMPLETED|775mg Dose Escalation||0
947357|NCT00045110|2289532|P2|COMPLETED|775mg Dose Escalation||0
947358|NCT00045110|2289533|P1|COMPLETED|775mg Dose Escalation||7
947359|NCT00045110|2289531|P3|STARTED|775mg Dose Escalation||0
947360|NCT00045110|2289532|P2|STARTED|775mg Dose Escalation||0
947361|NCT00045110|2289533|P1|STARTED|775mg Dose Escalation||7
947362|NCT00045110|2289531|P3|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
947363|NCT00045110|2289532|P2|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
947364|NCT00045110|2289533|P1|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
947365|NCT00045110|2289531|P3|COMPLETED|650mg Phase 1 Dose Escalation||0
947366|NCT00045110|2289532|P2|COMPLETED|650mg Phase 1 Dose Escalation||0
947367|NCT00045110|2289533|P1|COMPLETED|650mg Phase 1 Dose Escalation||6
947368|NCT00045110|2289531|P3|STARTED|650mg Phase 1 Dose Escalation||0
947369|NCT00045110|2289532|P2|STARTED|650mg Phase 1 Dose Escalation||0
947370|NCT00045110|2289533|P1|STARTED|650mg Phase 1 Dose Escalation||6
947371|NCT00045110|2289531|P3|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
947372|NCT00045110|2289532|P2|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
947373|NCT00045110|2289533|P1|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
947374|NCT00045110|2289531|P3|COMPLETED|525mg Phase 1 Dose Escalation||0
947375|NCT00045110|2289532|P2|COMPLETED|525mg Phase 1 Dose Escalation||0
947376|NCT00045110|2289533|P1|COMPLETED|525mg Phase 1 Dose Escalation||3
947377|NCT00045110|2289531|P3|STARTED|525mg Phase 1 Dose Escalation||0
947378|NCT00045110|2289532|P2|STARTED|525mg Phase 1 Dose Escalation||0
947379|NCT00045110|2289533|P1|STARTED|525mg Phase 1 Dose Escalation||3
947380|NCT00045110|2289531|P3|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
947381|NCT00045110|2289532|P2|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
947382|NCT00045110|2289533|P1|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
947383|NCT00045110|2289531|P3|COMPLETED|400mg Phase 1 Dose Escalation||0
947384|NCT00045110|2289532|P2|COMPLETED|400mg Phase 1 Dose Escalation||0
947385|NCT00045110|2289533|P1|COMPLETED|400mg Phase 1 Dose Escalation||3
947386|NCT00045110|2289531|P3|STARTED|400mg Phase 1 Dose Escalation||0
947387|NCT00045110|2289532|P2|STARTED|400mg Phase 1 Dose Escalation||0
947388|NCT00045110|2289533|P1|STARTED|400mg Phase 1 Dose Escalation||3
947389|NCT00045110|2289531|P3|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
947390|NCT00045110|2289532|P2|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
947391|NCT00045110|2289533|P1|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
947392|NCT00045110|2289531|P3|COMPLETED|275mg Phase 1 Dose Escalation||0
947393|NCT00045110|2289532|P2|COMPLETED|275mg Phase 1 Dose Escalation||0
947394|NCT00045110|2289533|P1|COMPLETED|275mg Phase 1 Dose Escalation||3
947395|NCT00045110|2289531|P3|STARTED|275mg Phase 1 Dose Escalation||0
947396|NCT00045110|2289532|P2|STARTED|275mg Phase 1 Dose Escalation||0
947397|NCT00045110|2289533|P1|STARTED|275mg Phase 1 Dose Escalation||3
947398|NCT00045110|2289531|P3|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
947399|NCT00045110|2289532|P2|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
947400|NCT00045110|2289533|P1|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
947401|NCT00045110|2289531|P3|COMPLETED|200mg Phase 1 Dose Escalation||0
947402|NCT00045110|2289532|P2|COMPLETED|200mg Phase 1 Dose Escalation||0
947403|NCT00045110|2289533|P1|COMPLETED|200mg Phase 1 Dose Escalation||4
947404|NCT00045110|2289531|P3|STARTED|200mg Phase 1 Dose Escalation||0
947405|NCT00045110|2289532|P2|STARTED|200mg Phase 1 Dose Escalation||0
947406|NCT00045110|2289533|P1|STARTED|200mg Phase 1 Dose Escalation||4
947407|NCT00045110|2289531|P3|NOT COMPLETED|100mg Phase 1 Dose Escalalation||2
947408|NCT00045110|2289532|P2|NOT COMPLETED|100mg Phase 1 Dose Escalalation||6
947409|NCT00045110|2289533|P1|NOT COMPLETED|100mg Phase 1 Dose Escalalation||0
947410|NCT00045110|2289531|P3|COMPLETED|100mg Phase 1 Dose Escalalation||43
947411|NCT00045110|2289532|P2|COMPLETED|100mg Phase 1 Dose Escalalation||53
947412|NCT00045110|2289533|P1|COMPLETED|100mg Phase 1 Dose Escalalation||6
947413|NCT00045110|2289531|P3|STARTED|100mg Phase 1 Dose Escalalation||45
947414|NCT00045110|2289532|P2|STARTED|100mg Phase 1 Dose Escalalation||59
947415|NCT00045110|2289533|P1|STARTED|100mg Phase 1 Dose Escalalation||6
947416|NCT00045162|2289581|P2|NOT COMPLETED|Overall Study||118
947417|NCT00045162|2289582|P1|NOT COMPLETED|Overall Study||142
947418|NCT00045162|2289581|P2|COMPLETED|Overall Study||217
947419|NCT00045162|2289582|P1|COMPLETED|Overall Study||194
947420|NCT00045162|2289581|P2|STARTED|Overall Study||335
947421|NCT00045162|2289582|P1|STARTED|Overall Study||336
947422|NCT00045305|2289594|P1|NOT COMPLETED|Overall Study||14
947423|NCT00045305|2289594|P1|COMPLETED|Overall Study||3
947424|NCT00045305|2289594|P1|Eligible and Treated|Overall Study||17
947425|NCT00045305|2289594|P1|STARTED|Overall Study||17
947426|NCT00045435|2289603|P1|NOT COMPLETED|Overall Study||0
947427|NCT00045435|2289603|P1|COMPLETED|Overall Study||17
947428|NCT00045435|2289603|P1|STARTED|Overall Study||17
947429|NCT00045487|2289612|P1|NOT COMPLETED|Overall Study||11
947430|NCT00045487|2289612|P1|COMPLETED|Overall Study||30
947431|NCT00045487|2289612|P1|STARTED|Overall Study||41
947432|NCT00045630|2289616|P1|NOT COMPLETED|Overall Study||6
947433|NCT00045630|2289616|P1|COMPLETED|Overall Study||71
947434|NCT00045630|2289616|P1|Eligible and Began Protocol Therapy|Overall Study||74
947435|NCT00045630|2289616|P1|Eligible|Overall Study||75
947436|NCT00045630|2289616|P1|STARTED|Overall Study||77
947455|NCT00045734|2289650|P1|NOT COMPLETED|Overall Study||1
947456|NCT00045734|2289650|P1|COMPLETED|Overall Study||22
947457|NCT00045734|2289650|P1|STARTED|Overall Study||23
947458|NCT00045942|2289671|P9|NOT COMPLETED|PKC412A2104E2||6
947459|NCT00045942|2289672|P8|NOT COMPLETED|PKC412A2104E2||7
947460|NCT00045942|2289673|P7|NOT COMPLETED|PKC412A2104E2||7
947461|NCT00045942|2289674|P6|NOT COMPLETED|PKC412A2104E2||9
947462|NCT00045942|2289675|P5|NOT COMPLETED|PKC412A2104E2||0
947463|NCT00045942|2289676|P4|NOT COMPLETED|PKC412A2104E2||0
947464|NCT00045942|2289677|P3|NOT COMPLETED|PKC412A2104E2||0
947465|NCT00045942|2289678|P2|NOT COMPLETED|PKC412A2104E2||0
947466|NCT00045942|2289679|P1|NOT COMPLETED|PKC412A2104E2||0
947467|NCT00045942|2289671|P9|COMPLETED|PKC412A2104E2||0
947468|NCT00045942|2289672|P8|COMPLETED|PKC412A2104E2||0
947469|NCT00045942|2289673|P7|COMPLETED|PKC412A2104E2||0
947470|NCT00045942|2289674|P6|COMPLETED|PKC412A2104E2||0
947471|NCT00045942|2289675|P5|COMPLETED|PKC412A2104E2||0
947472|NCT00045942|2289676|P4|COMPLETED|PKC412A2104E2||0
947473|NCT00045942|2289677|P3|COMPLETED|PKC412A2104E2||0
947474|NCT00045942|2289678|P2|COMPLETED|PKC412A2104E2||0
947475|NCT00045942|2289679|P1|COMPLETED|PKC412A2104E2||0
947476|NCT00045942|2289671|P9|Primary Efficacy|PKC412A2104E2||6
947477|NCT00045942|2289672|P8|Primary Efficacy|PKC412A2104E2||7
947478|NCT00045942|2289673|P7|Primary Efficacy|PKC412A2104E2||7
947479|NCT00045942|2289674|P6|Primary Efficacy|PKC412A2104E2||9
947480|NCT00045942|2289675|P5|Primary Efficacy|PKC412A2104E2||0
947481|NCT00045942|2289676|P4|Primary Efficacy|PKC412A2104E2||0
947482|NCT00045942|2289677|P3|Primary Efficacy|PKC412A2104E2||0
947483|NCT00045942|2289678|P2|Primary Efficacy|PKC412A2104E2||0
947484|NCT00045942|2289679|P1|Primary Efficacy|PKC412A2104E2||0
947485|NCT00045942|2289671|P9|STARTED|PKC412A2104E2||6
947486|NCT00045942|2289672|P8|STARTED|PKC412A2104E2||7
947487|NCT00045942|2289673|P7|STARTED|PKC412A2104E2||7
947488|NCT00045942|2289674|P6|STARTED|PKC412A2104E2||9
947489|NCT00045942|2289675|P5|STARTED|PKC412A2104E2||0
947490|NCT00045942|2289676|P4|STARTED|PKC412A2104E2||0
947491|NCT00045942|2289677|P3|STARTED|PKC412A2104E2||0
947492|NCT00045942|2289678|P2|STARTED|PKC412A2104E2||0
947493|NCT00045942|2289679|P1|STARTED|PKC412A2104E2||0
947494|NCT00045942|2289671|P9|NOT COMPLETED|PKC412A2104E1||0
947495|NCT00045942|2289672|P8|NOT COMPLETED|PKC412A2104E1||0
947496|NCT00045942|2289673|P7|NOT COMPLETED|PKC412A2104E1||0
947497|NCT00045942|2289674|P6|NOT COMPLETED|PKC412A2104E1||0
947498|NCT00045942|2289675|P5|NOT COMPLETED|PKC412A2104E1||27
947499|NCT00045942|2289676|P4|NOT COMPLETED|PKC412A2104E1||33
947500|NCT00045942|2289677|P3|NOT COMPLETED|PKC412A2104E1||17
947501|NCT00045942|2289678|P2|NOT COMPLETED|PKC412A2104E1||18
947502|NCT00045942|2289679|P1|NOT COMPLETED|PKC412A2104E1||0
947503|NCT00045942|2289671|P9|COMPLETED|PKC412A2104E1||0
947504|NCT00045942|2289672|P8|COMPLETED|PKC412A2104E1||0
947505|NCT00045942|2289673|P7|COMPLETED|PKC412A2104E1||0
947506|NCT00045942|2289674|P6|COMPLETED|PKC412A2104E1||0
947507|NCT00045942|2289675|P5|COMPLETED|PKC412A2104E1||0
947508|NCT00045942|2289676|P4|COMPLETED|PKC412A2104E1||0
947509|NCT00045942|2289677|P3|COMPLETED|PKC412A2104E1||0
947510|NCT00045942|2289678|P2|COMPLETED|PKC412A2104E1||0
947511|NCT00045942|2289679|P1|COMPLETED|PKC412A2104E1||0
947512|NCT00045942|2289671|P9|Primary Efficacy|PKC412A2104E1||0
947513|NCT00045942|2289672|P8|Primary Efficacy|PKC412A2104E1||0
947514|NCT00045942|2289673|P7|Primary Efficacy|PKC412A2104E1||0
947515|NCT00045942|2289674|P6|Primary Efficacy|PKC412A2104E1||0
947516|NCT00045942|2289675|P5|Primary Efficacy|PKC412A2104E1||25
947517|NCT00045942|2289676|P4|Primary Efficacy|PKC412A2104E1||32
947518|NCT00045942|2289677|P3|Primary Efficacy|PKC412A2104E1||17
947519|NCT00045942|2289678|P2|Primary Efficacy|PKC412A2104E1||18
947520|NCT00045942|2289679|P1|Primary Efficacy|PKC412A2104E1||0
947521|NCT00045942|2289671|P9|STARTED|PKC412A2104E1||0
947522|NCT00045942|2289672|P8|STARTED|PKC412A2104E1||0
947523|NCT00045942|2289673|P7|STARTED|PKC412A2104E1||0
947524|NCT00045942|2289674|P6|STARTED|PKC412A2104E1||0
947525|NCT00045942|2289675|P5|STARTED|PKC412A2104E1||27
947526|NCT00045942|2289676|P4|STARTED|PKC412A2104E1||33
947527|NCT00045942|2289677|P3|STARTED|PKC412A2104E1||17
947528|NCT00045942|2289678|P2|STARTED|PKC412A2104E1||18
947529|NCT00045942|2289679|P1|STARTED|PKC412A2104E1||0
947530|NCT00045942|2289671|P9|NOT COMPLETED|PKC412A2104 (Core)||0
947531|NCT00045942|2289672|P8|NOT COMPLETED|PKC412A2104 (Core)||0
947532|NCT00045942|2289673|P7|NOT COMPLETED|PKC412A2104 (Core)||0
947533|NCT00045942|2289674|P6|NOT COMPLETED|PKC412A2104 (Core)||0
947534|NCT00045942|2289675|P5|NOT COMPLETED|PKC412A2104 (Core)||0
947535|NCT00045942|2289676|P4|NOT COMPLETED|PKC412A2104 (Core)||0
947536|NCT00045942|2289677|P3|NOT COMPLETED|PKC412A2104 (Core)||0
947537|NCT00045942|2289678|P2|NOT COMPLETED|PKC412A2104 (Core)||0
947538|NCT00045942|2289679|P1|NOT COMPLETED|PKC412A2104 (Core)||20
947539|NCT00045942|2289671|P9|COMPLETED|PKC412A2104 (Core)||0
947540|NCT00045942|2289672|P8|COMPLETED|PKC412A2104 (Core)||0
947541|NCT00045942|2289673|P7|COMPLETED|PKC412A2104 (Core)||0
947542|NCT00045942|2289674|P6|COMPLETED|PKC412A2104 (Core)||0
947543|NCT00045942|2289675|P5|COMPLETED|PKC412A2104 (Core)||0
947544|NCT00045942|2289676|P4|COMPLETED|PKC412A2104 (Core)||0
947545|NCT00045942|2289677|P3|COMPLETED|PKC412A2104 (Core)||0
947546|NCT00045942|2289678|P2|COMPLETED|PKC412A2104 (Core)||0
947547|NCT00045942|2289679|P1|COMPLETED|PKC412A2104 (Core)||0
947548|NCT00045942|2289671|P9|Core Primary Efficacy|PKC412A2104 (Core)||0
947549|NCT00045942|2289672|P8|Core Primary Efficacy|PKC412A2104 (Core)||0
947550|NCT00045942|2289673|P7|Core Primary Efficacy|PKC412A2104 (Core)||0
947551|NCT00045942|2289674|P6|Core Primary Efficacy|PKC412A2104 (Core)||0
947552|NCT00045942|2289675|P5|Core Primary Efficacy|PKC412A2104 (Core)||0
947553|NCT00045942|2289676|P4|Core Primary Efficacy|PKC412A2104 (Core)||0
947554|NCT00045942|2289677|P3|Core Primary Efficacy|PKC412A2104 (Core)||0
947555|NCT00045942|2289678|P2|Core Primary Efficacy|PKC412A2104 (Core)||0
947556|NCT00045942|2289679|P1|Core Primary Efficacy|PKC412A2104 (Core)||20
947557|NCT00045942|2289671|P9|STARTED|PKC412A2104 (Core)||0
947558|NCT00045942|2289672|P8|STARTED|PKC412A2104 (Core)||0
947559|NCT00045942|2289673|P7|STARTED|PKC412A2104 (Core)||0
947560|NCT00045942|2289674|P6|STARTED|PKC412A2104 (Core)||0
947561|NCT00045942|2289675|P5|STARTED|PKC412A2104 (Core)||0
947562|NCT00045942|2289676|P4|STARTED|PKC412A2104 (Core)||0
947563|NCT00045942|2289677|P3|STARTED|PKC412A2104 (Core)||0
947564|NCT00045942|2289678|P2|STARTED|PKC412A2104 (Core)||0
947565|NCT00045942|2289679|P1|STARTED|PKC412A2104 (Core)||20
947566|NCT00046228|2289762|P3|NOT COMPLETED|1 Year||12
947567|NCT00046228|2289763|P2|NOT COMPLETED|1 Year||14
947568|NCT00046228|2289764|P1|NOT COMPLETED|1 Year||19
947569|NCT00046228|2289762|P3|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window|816
947570|NCT00046228|2289763|P2|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|804
947571|NCT00046228|2289764|P1|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|787
947572|NCT00046228|2289762|P3|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|828
947573|NCT00046228|2289763|P2|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|818
947574|NCT00046228|2289764|P1|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|806
947575|NCT00046228|2289762|P3|NOT COMPLETED|90 Days||15
947576|NCT00046228|2289763|P2|NOT COMPLETED|90 Days||8
947577|NCT00046228|2289764|P1|NOT COMPLETED|90 Days||13
947654|NCT00046891|2289871|P1|NOT COMPLETED|Overall Study||29
947578|NCT00046228|2289762|P3|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|813
947579|NCT00046228|2289763|P2|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|810
947580|NCT00046228|2289764|P1|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|793
947581|NCT00046228|2289762|P3|STARTED|90 Days||828
947582|NCT00046228|2289763|P2|STARTED|90 Days||818
947583|NCT00046228|2289764|P1|STARTED|90 Days||806
947584|NCT00046475|2289801|P3|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
947585|NCT00046475|2289802|P2|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||1
947586|NCT00046475|2289803|P1|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
947587|NCT00046475|2289801|P3|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||59
947588|NCT00046475|2289802|P2|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||44
947589|NCT00046475|2289803|P1|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
947590|NCT00046475|2289801|P3|STARTED|Treatment Period 2 (Up to 2 Weeks)||59
947591|NCT00046475|2289802|P2|STARTED|Treatment Period 2 (Up to 2 Weeks)||45
947592|NCT00046475|2289803|P1|STARTED|Treatment Period 2 (Up to 2 Weeks)||0
947593|NCT00046475|2289801|P3|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||1
947594|NCT00046475|2289802|P2|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
947595|NCT00046475|2289803|P1|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
947596|NCT00046475|2289801|P3|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||59
947597|NCT00046475|2289802|P2|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||45
947598|NCT00046475|2289803|P1|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
947599|NCT00046475|2289801|P3|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|60
947600|NCT00046475|2289802|P2|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|45
947601|NCT00046475|2289803|P1|STARTED|Treatment Period 1 (Up to 2 Weeks)||0
947602|NCT00046475|2289801|P3|NOT COMPLETED|Titration (1 Week)||0
947603|NCT00046475|2289802|P2|NOT COMPLETED|Titration (1 Week)||0
947604|NCT00046475|2289803|P1|NOT COMPLETED|Titration (1 Week)||0
947605|NCT00046475|2289801|P3|COMPLETED|Titration (1 Week)||0
947606|NCT00046475|2289802|P2|COMPLETED|Titration (1 Week)||0
947607|NCT00046475|2289803|P1|COMPLETED|Titration (1 Week)||136
947608|NCT00046475|2289801|P3|STARTED|Titration (1 Week)||0
947609|NCT00046475|2289802|P2|STARTED|Titration (1 Week)||0
947610|NCT00046475|2289803|P1|STARTED|Titration (1 Week)||136
947611|NCT00046475|2289801|P3|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
947612|NCT00046475|2289802|P2|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
947613|NCT00046475|2289803|P1|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||4
947614|NCT00046475|2289801|P3|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
947615|NCT00046475|2289802|P2|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
947616|NCT00046475|2289803|P1|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||136
947617|NCT00046475|2289801|P3|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
947618|NCT00046475|2289802|P2|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
947619|NCT00046475|2289803|P1|STARTED|Screening/Washout Period (Up to 2 Weeks)||140
947620|NCT00046566|2289842|P3|NOT COMPLETED|Intervention 3 (8 Weeks)||0
947621|NCT00046566|2289843|P2|NOT COMPLETED|Intervention 3 (8 Weeks)||0
947622|NCT00046566|2289844|P1|NOT COMPLETED|Intervention 3 (8 Weeks)||0
947623|NCT00046566|2289842|P3|COMPLETED|Intervention 3 (8 Weeks)||88
947624|NCT00046566|2289843|P2|COMPLETED|Intervention 3 (8 Weeks)||92
947625|NCT00046566|2289844|P1|COMPLETED|Intervention 3 (8 Weeks)||93
947626|NCT00046566|2289842|P3|STARTED|Intervention 3 (8 Weeks)||88
947627|NCT00046566|2289843|P2|STARTED|Intervention 3 (8 Weeks)||92
947628|NCT00046566|2289844|P1|STARTED|Intervention 3 (8 Weeks)||93
947629|NCT00046566|2289842|P3|NOT COMPLETED|Intervention 2 (8 Weeks)||13
947630|NCT00046566|2289843|P2|NOT COMPLETED|Intervention 2 (8 Weeks)||12
947631|NCT00046566|2289844|P1|NOT COMPLETED|Intervention 2 (8 Weeks)||8
947632|NCT00046566|2289842|P3|COMPLETED|Intervention 2 (8 Weeks)||88
947633|NCT00046566|2289843|P2|COMPLETED|Intervention 2 (8 Weeks)||92
947634|NCT00046566|2289844|P1|COMPLETED|Intervention 2 (8 Weeks)||93
947635|NCT00046566|2289842|P3|STARTED|Intervention 2 (8 Weeks)|Soy protein 8 weeks|101
947636|NCT00046566|2289843|P2|STARTED|Intervention 2 (8 Weeks)|Carbohydrate 8 weeks|104
947637|NCT00046566|2289844|P1|STARTED|Intervention 2 (8 Weeks)|Milk protein 8 weeks|101
947638|NCT00046566|2289842|P3|NOT COMPLETED|Intervention 1 (8 Weeks)||17
947639|NCT00046566|2289843|P2|NOT COMPLETED|Intervention 1 (8 Weeks)||13
947640|NCT00046566|2289844|P1|NOT COMPLETED|Intervention 1 (8 Weeks)||16
947641|NCT00046566|2289842|P3|COMPLETED|Intervention 1 (8 Weeks)||101
947642|NCT00046566|2289843|P2|COMPLETED|Intervention 1 (8 Weeks)||104
947643|NCT00046566|2289844|P1|COMPLETED|Intervention 1 (8 Weeks)||101
947644|NCT00046566|2289842|P3|STARTED|Intervention 1 (8 Weeks)|Carbohydrate 8 weeks|118
947645|NCT00046566|2289843|P2|STARTED|Intervention 1 (8 Weeks)|Milk protein 8 weeks|117
947646|NCT00046566|2289844|P1|STARTED|Intervention 1 (8 Weeks)|Soy protein 8 weeks|117
947647|NCT00046839|2289860|P2|NOT COMPLETED|Overall Study||2
947648|NCT00046839|2289861|P1|NOT COMPLETED|Overall Study||1
947649|NCT00046839|2289860|P2|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|11
947650|NCT00046839|2289861|P1|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|7
947651|NCT00046839|2289860|P2|STARTED|Overall Study||13
947652|NCT00046839|2289861|P1|STARTED|Overall Study||8
947653|NCT00046891|2289870|P2|NOT COMPLETED|Overall Study||30
947655|NCT00046891|2289870|P2|COMPLETED|Overall Study||83
947656|NCT00046891|2289871|P1|COMPLETED|Overall Study||84
947657|NCT00046891|2289870|P2|STARTED|Overall Study||113
947658|NCT00046891|2289871|P1|STARTED|Overall Study||113
947659|NCT00053365|2289889|P1|NOT COMPLETED|Overall Study||6
947660|NCT00053365|2289889|P1|COMPLETED|Overall Study||55
947661|NCT00053365|2289889|P1|STARTED|Overall Study||61
947662|NCT00053417|2289898|P4|NOT COMPLETED|Overall Study||6
947663|NCT00053417|2289899|P3|NOT COMPLETED|Overall Study||1
947664|NCT00053417|2289900|P2|NOT COMPLETED|Overall Study||2
947665|NCT00053417|2289901|P1|NOT COMPLETED|Overall Study||2
947666|NCT00053417|2289898|P4|COMPLETED|Overall Study||51
947667|NCT00053417|2289899|P3|COMPLETED|Overall Study||49
947668|NCT00053417|2289900|P2|COMPLETED|Overall Study||50
947669|NCT00053417|2289901|P1|COMPLETED|Overall Study||45
947670|NCT00053417|2289898|P4|STARTED|Overall Study||57
947671|NCT00053417|2289899|P3|STARTED|Overall Study||50
947672|NCT00053417|2289900|P2|STARTED|Overall Study||52
947673|NCT00053417|2289901|P1|STARTED|Overall Study||47
947674|NCT00053482|2289916|P5|NOT COMPLETED|Overall Study||0
947675|NCT00053482|2289917|P4|NOT COMPLETED|Overall Study||0
947676|NCT00053482|2289918|P3|NOT COMPLETED|Overall Study||0
947677|NCT00053482|2289919|P2|NOT COMPLETED|Overall Study||0
947678|NCT00053482|2289920|P1|NOT COMPLETED|Overall Study||0
947679|NCT00053482|2289916|P5|COMPLETED|Overall Study||52
947680|NCT00053482|2289917|P4|COMPLETED|Overall Study||50
947681|NCT00053482|2289918|P3|COMPLETED|Overall Study||102
947682|NCT00053482|2289919|P2|COMPLETED|Overall Study||102
947683|NCT00053482|2289920|P1|COMPLETED|Overall Study||51
947684|NCT00053482|2289916|P5|STARTED|Overall Study||52
947685|NCT00053482|2289917|P4|STARTED|Overall Study||50
947686|NCT00053482|2289918|P3|STARTED|Overall Study||102
947687|NCT00053482|2289919|P2|STARTED|Overall Study||102
947688|NCT00053482|2289920|P1|STARTED|Overall Study||51
947689|NCT00053495|2289972|P5|NOT COMPLETED|Overall Study||0
947690|NCT00053495|2289973|P4|NOT COMPLETED|Overall Study||0
947691|NCT00053495|2289974|P3|NOT COMPLETED|Overall Study||0
947692|NCT00053495|2289975|P2|NOT COMPLETED|Overall Study||0
947693|NCT00053495|2289976|P1|NOT COMPLETED|Overall Study||0
947694|NCT00053495|2289972|P5|COMPLETED|Overall Study||49
947695|NCT00053495|2289973|P4|COMPLETED|Overall Study||51
947696|NCT00053495|2289974|P3|COMPLETED|Overall Study||101
947697|NCT00053495|2289975|P2|COMPLETED|Overall Study||101
947698|NCT00053495|2289976|P1|COMPLETED|Overall Study||51
947699|NCT00053495|2289972|P5|STARTED|Overall Study||49
947700|NCT00053495|2289973|P4|STARTED|Overall Study||51
947701|NCT00053495|2289974|P3|STARTED|Overall Study||101
947702|NCT00053495|2289975|P2|STARTED|Overall Study||101
947703|NCT00053495|2289976|P1|STARTED|Overall Study||51
947704|NCT00053677|2290025|P2|NOT COMPLETED|Overall Study||6
947705|NCT00053677|2290026|P1|NOT COMPLETED|Overall Study||22
947706|NCT00053677|2290025|P2|COMPLETED|Overall Study||13
947707|NCT00053677|2290026|P1|COMPLETED|Overall Study||36
947708|NCT00053677|2290025|P2|STARTED|Overall Study||19
947709|NCT00053677|2290026|P1|STARTED|Overall Study||58
947710|NCT00053703|2290035|P3|NOT COMPLETED|Overall Study||15
947711|NCT00053703|2290036|P2|NOT COMPLETED|Overall Study||13
947712|NCT00053703|2290037|P1|NOT COMPLETED|Overall Study||18
947713|NCT00053703|2290035|P3|COMPLETED|Overall Study||25
947714|NCT00053703|2290036|P2|COMPLETED|Overall Study||28
947715|NCT00053703|2290037|P1|COMPLETED|Overall Study||17
947716|NCT00053703|2290035|P3|STARTED|Overall Study||40
947717|NCT00053703|2290036|P2|STARTED|Overall Study||41
947718|NCT00053703|2290037|P1|STARTED|Overall Study||35
947719|NCT00057941|2290062|P2|NOT COMPLETED|Overall Study||74
947720|NCT00057941|2290063|P1|NOT COMPLETED|Overall Study||74
947721|NCT00057941|2290062|P2|COMPLETED|Overall Study||0
947722|NCT00057941|2290063|P1|COMPLETED|Overall Study||0
947723|NCT00057941|2290062|P2|Eligible|Overall Study||69
947724|NCT00057941|2290063|P1|Eligible|Overall Study||72
947725|NCT00057941|2290062|P2|Treated|Overall Study||74
947726|NCT00057941|2290063|P1|Treated|Overall Study||74
947727|NCT00057941|2290062|P2|STARTED|Overall Study||74
947728|NCT00057941|2290063|P1|STARTED|Overall Study||74
947729|NCT00057954|2290069|P1|NOT COMPLETED|Overall Study||2
947730|NCT00057954|2290069|P1|COMPLETED|Overall Study||4
947731|NCT00057954|2290069|P1|STARTED|Overall Study||6
947732|NCT00058019|2290077|P2|NOT COMPLETED|Overall Study||0
947733|NCT00058019|2290078|P1|NOT COMPLETED|Overall Study||0
947734|NCT00058019|2290077|P2|COMPLETED|Overall Study||12
947735|NCT00058019|2290078|P1|COMPLETED|Overall Study||39
947736|NCT00058019|2290077|P2|STARTED|Overall Study||12
947737|NCT00058019|2290078|P1|STARTED|Overall Study||39
947738|NCT00058214|2290091|P1|NOT COMPLETED|Overall Study||1
947739|NCT00058214|2290091|P1|COMPLETED|Overall Study||24
947740|NCT00058214|2290091|P1|STARTED|Overall Study||25
947741|NCT00058240|2290100|P4|NOT COMPLETED|Second Dose Level||0
947742|NCT00058240|2290101|P3|NOT COMPLETED|Second Dose Level||0
947743|NCT00058240|2290102|P2|NOT COMPLETED|Second Dose Level||0
947744|NCT00058240|2290103|P1|NOT COMPLETED|Second Dose Level||0
947745|NCT00058240|2290100|P4|COMPLETED|Second Dose Level||4
947746|NCT00058240|2290101|P3|COMPLETED|Second Dose Level||2
947747|NCT00058240|2290102|P2|COMPLETED|Second Dose Level||0
947748|NCT00058240|2290103|P1|COMPLETED|Second Dose Level||0
947749|NCT00058240|2290100|P4|STARTED|Second Dose Level|4 patients previously relapsed on a different Dose level and were retreated at Dose level 4.|4
947750|NCT00058240|2290101|P3|STARTED|Second Dose Level|2 patients were previously treated at Dose level 1, relapsed, and retreated at Dose level 3.|2
947751|NCT00058240|2290102|P2|STARTED|Second Dose Level||0
947752|NCT00058240|2290103|P1|STARTED|Second Dose Level||0
947753|NCT00058240|2290100|P4|NOT COMPLETED|First Dose Level||0
947754|NCT00058240|2290101|P3|NOT COMPLETED|First Dose Level||0
947755|NCT00058240|2290102|P2|NOT COMPLETED|First Dose Level||0
947756|NCT00058240|2290103|P1|NOT COMPLETED|First Dose Level||0
947757|NCT00058240|2290100|P4|COMPLETED|First Dose Level||12
947758|NCT00058240|2290101|P3|COMPLETED|First Dose Level||17
947759|NCT00058240|2290102|P2|COMPLETED|First Dose Level||3
947760|NCT00058240|2290103|P1|COMPLETED|First Dose Level||20
947761|NCT00058240|2290100|P4|Treated|First Dose Level||12
947762|NCT00058240|2290101|P3|Treated|First Dose Level||17
947763|NCT00058240|2290102|P2|Treated|First Dose Level||3
947764|NCT00058240|2290103|P1|Treated|First Dose Level||20
947765|NCT00058240|2290100|P4|STARTED|First Dose Level||12
947766|NCT00058240|2290101|P3|STARTED|First Dose Level||17
947767|NCT00058240|2290102|P2|STARTED|First Dose Level||3
947768|NCT00058240|2290103|P1|STARTED|First Dose Level||20
947769|NCT00058539|2290113|P1|NOT COMPLETED|Overall Study||42
947770|NCT00058539|2290113|P1|COMPLETED|Overall Study||0
947771|NCT00058539|2290113|P1|STARTED|Overall Study||42
947772|NCT00058552|2290125|P2|NOT COMPLETED|Overall Study||62
947773|NCT00058552|2290126|P1|NOT COMPLETED|Overall Study||65
947774|NCT00058552|2290125|P2|COMPLETED|Overall Study||2
947775|NCT00058552|2290126|P1|COMPLETED|Overall Study||0
947776|NCT00058552|2290125|P2|STARTED|Overall Study||64
947777|NCT00058552|2290126|P1|STARTED|Overall Study||65
947778|NCT00058825|2290144|P1|NOT COMPLETED|Overall Study||22
947779|NCT00058825|2290144|P1|COMPLETED|Overall Study||5
947780|NCT00058825|2290144|P1|STARTED|Overall Study||27
947781|NCT00059215|2290162|P4|NOT COMPLETED|Overall Study||15
947782|NCT00059215|2290163|P3|NOT COMPLETED|Overall Study||15
947783|NCT00059215|2290164|P2|NOT COMPLETED|Overall Study||14
947784|NCT00059215|2290165|P1|NOT COMPLETED|Overall Study||13
947785|NCT00059215|2290162|P4|COMPLETED|Overall Study||239
947786|NCT00059215|2290163|P3|COMPLETED|Overall Study||236
947787|NCT00059215|2290164|P2|COMPLETED|Overall Study||186
947788|NCT00059215|2290165|P1|COMPLETED|Overall Study|One subject discontinued before receiving treatment and is not included in the evaluable set.|187
947789|NCT00059215|2290162|P4|STARTED|Overall Study||254
947790|NCT00059215|2290163|P3|STARTED|Overall Study||251
947791|NCT00059215|2290164|P2|STARTED|Overall Study||200
947792|NCT00059215|2290165|P1|STARTED|Overall Study||200
947793|NCT00059332|2290193|P2|NOT COMPLETED|Overall Study||2
947794|NCT00059332|2290194|P1|NOT COMPLETED|Overall Study||3
947795|NCT00059332|2290193|P2|COMPLETED|Overall Study||855
947796|NCT00059332|2290194|P1|COMPLETED|Overall Study||840
947797|NCT00059332|2290193|P2|STARTED|Overall Study||857
947798|NCT00059332|2290194|P1|STARTED|Overall Study||843
947799|NCT00059475|2290224|P8|NOT COMPLETED|Overall Study||0
947800|NCT00059475|2290225|P7|NOT COMPLETED|Overall Study||0
947801|NCT00059475|2290226|P6|NOT COMPLETED|Overall Study||0
947802|NCT00059475|2290227|P5|NOT COMPLETED|Overall Study||0
947803|NCT00059475|2290228|P4|NOT COMPLETED|Overall Study||0
947804|NCT00059475|2290229|P3|NOT COMPLETED|Overall Study||0
947805|NCT00059475|2290230|P2|NOT COMPLETED|Overall Study||0
947806|NCT00059475|2290231|P1|NOT COMPLETED|Overall Study||0
947807|NCT00059475|2290224|P8|COMPLETED|Overall Study||7
947808|NCT00059475|2290225|P7|COMPLETED|Overall Study||34
947809|NCT00059475|2290226|P6|COMPLETED|Overall Study||2
947810|NCT00059475|2290227|P5|COMPLETED|Overall Study||33
947811|NCT00059475|2290228|P4|COMPLETED|Overall Study||3
947812|NCT00059475|2290229|P3|COMPLETED|Overall Study||24
947813|NCT00059475|2290230|P2|COMPLETED|Overall Study||2
947814|NCT00059475|2290231|P1|COMPLETED|Overall Study||33
947815|NCT00059475|2290224|P8|STARTED|Overall Study||7
947816|NCT00059475|2290225|P7|STARTED|Overall Study||34
947817|NCT00059475|2290226|P6|STARTED|Overall Study||2
947818|NCT00059475|2290227|P5|STARTED|Overall Study||33
947819|NCT00059475|2290228|P4|STARTED|Overall Study||3
947820|NCT00059475|2290229|P3|STARTED|Overall Study||24
947821|NCT00059475|2290230|P2|STARTED|Overall Study||2
947822|NCT00059475|2290231|P1|STARTED|Overall Study||33
947823|NCT00059787|2290257|P1|NOT COMPLETED|Overall Study||20
947824|NCT00059787|2290257|P1|COMPLETED|Overall Study||36
947825|NCT00059787|2290257|P1|STARTED|Overall Study||56
947826|NCT00059839|2290267|P2|NOT COMPLETED|Overall Study||17
947827|NCT00059839|2290268|P1|NOT COMPLETED|Overall Study||12
947828|NCT00059839|2290267|P2|COMPLETED|Overall Study||47
947829|NCT00059839|2290268|P1|COMPLETED|Overall Study||53
947830|NCT00059839|2290267|P2|STARTED|Overall Study||64
947831|NCT00059839|2290268|P1|STARTED|Overall Study||65
947832|NCT00060008|2290274|P1|NOT COMPLETED|Overall Study||0
947833|NCT00060008|2290274|P1|COMPLETED|Overall Study||18
947834|NCT00060008|2290274|P1|STARTED|Overall Study||18
947835|NCT00060333|2290279|P1|NOT COMPLETED|Overall Study||0
947836|NCT00060333|2290279|P1|COMPLETED|Overall Study||20
947837|NCT00060333|2290279|P1|STARTED|Overall Study||20
947838|NCT00060346|2290290|P1|NOT COMPLETED|Overall Study||0
947839|NCT00060346|2290290|P1|COMPLETED|Overall Study||16
947840|NCT00060346|2290290|P1|Eligible and Treated|Overall Study||16
947841|NCT00060346|2290290|P1|STARTED|Overall Study||16
947854|NCT00060840|2290313|P2|NOT COMPLETED|Overall Study||9
947855|NCT00060840|2290314|P1|NOT COMPLETED|Overall Study||4
947856|NCT00060840|2290313|P2|COMPLETED|Overall Study||68
947857|NCT00060840|2290314|P1|COMPLETED|Overall Study||69
947858|NCT00060840|2290313|P2|STARTED|Overall Study||77
947859|NCT00060840|2290314|P1|STARTED|Overall Study||73
947860|NCT00043550|2290323|P3|NOT COMPLETED|Overall Study||20
947861|NCT00043550|2290324|P2|NOT COMPLETED|Overall Study||12
947862|NCT00043550|2290325|P1|NOT COMPLETED|Overall Study||22
947863|NCT00043550|2290323|P3|COMPLETED|Overall Study||30
947864|NCT00043550|2290324|P2|COMPLETED|Overall Study||39
947865|NCT00043550|2290325|P1|COMPLETED|Overall Study||33
947866|NCT00043550|2290323|P3|Week 8 Completed|Overall Study||35
947867|NCT00043550|2290324|P2|Week 8 Completed|Overall Study||40
947868|NCT00043550|2290325|P1|Week 8 Completed|Overall Study||35
947869|NCT00043550|2290323|P3|STARTED|Overall Study||50
947870|NCT00043550|2290324|P2|STARTED|Overall Study||51
947871|NCT00043550|2290325|P1|STARTED|Overall Study||55
947872|NCT00043979|2290335|P3|NOT COMPLETED|Period 2||0
947873|NCT00043979|2290336|P2|NOT COMPLETED|Period 2||0
947874|NCT00043979|2290337|P1|NOT COMPLETED|Period 2||0
947875|NCT00043979|2290335|P3|COMPLETED|Period 2||10
947876|NCT00043979|2290336|P2|COMPLETED|Period 2||13
947877|NCT00043979|2290337|P1|COMPLETED|Period 2||0
947878|NCT00043979|2290335|P3|STARTED|Period 2||10
947879|NCT00043979|2290336|P2|STARTED|Period 2||13
947880|NCT00043979|2290337|P1|STARTED|Period 2||0
947881|NCT00043979|2290335|P3|NOT COMPLETED|Period 1||3
947882|NCT00043979|2290336|P2|NOT COMPLETED|Period 1||4
947883|NCT00043979|2290337|P1|NOT COMPLETED|Period 1||7
947884|NCT00043979|2290335|P3|COMPLETED|Period 1||10
947885|NCT00043979|2290336|P2|COMPLETED|Period 1||13
947886|NCT00043979|2290337|P1|COMPLETED|Period 1||23
947887|NCT00043979|2290335|P3|STARTED|Period 1||13
947888|NCT00043979|2290336|P2|STARTED|Period 1||17
947889|NCT00043979|2290337|P1|STARTED|Period 1||30
947890|NCT00044005|2290358|P3|NOT COMPLETED|Overall Study||22
947891|NCT00044005|2290359|P2|NOT COMPLETED|Overall Study||14
947892|NCT00044005|2290360|P1|NOT COMPLETED|Overall Study||19
947893|NCT00044005|2290358|P3|COMPLETED|Overall Study||11
947894|NCT00044005|2290359|P2|COMPLETED|Overall Study||19
947895|NCT00044005|2290360|P1|COMPLETED|Overall Study||13
947896|NCT00044005|2290358|P3|STARTED|Overall Study||33
947897|NCT00044005|2290359|P2|STARTED|Overall Study||33
947898|NCT00044005|2290360|P1|STARTED|Overall Study||32
947899|NCT00044044|2290373|P5|NOT COMPLETED|Overall Study||36
947900|NCT00044044|2290374|P4|NOT COMPLETED|Overall Study||44
947901|NCT00044044|2290375|P3|NOT COMPLETED|Overall Study||40
947902|NCT00044044|2290376|P2|NOT COMPLETED|Overall Study||41
947903|NCT00044044|2290377|P1|NOT COMPLETED|Overall Study||44
947904|NCT00044044|2290373|P5|COMPLETED|Overall Study||36
947905|NCT00044044|2290374|P4|COMPLETED|Overall Study||29
947906|NCT00044044|2290375|P3|COMPLETED|Overall Study||31
947907|NCT00044044|2290376|P2|COMPLETED|Overall Study||28
947908|NCT00044044|2290377|P1|COMPLETED|Overall Study||27
947909|NCT00044044|2290373|P5|STARTED|Overall Study||72
947910|NCT00044044|2290374|P4|STARTED|Overall Study||73
947911|NCT00044044|2290375|P3|STARTED|Overall Study||71
947912|NCT00044044|2290376|P2|STARTED|Overall Study||69
947913|NCT00044044|2290377|P1|STARTED|Overall Study||71
947914|NCT00050089|2290408|P4|NOT COMPLETED|Overall Study||0
947915|NCT00050089|2290409|P3|NOT COMPLETED|Overall Study||0
947916|NCT00050089|2290410|P2|NOT COMPLETED|Overall Study||0
947917|NCT00050089|2290411|P1|NOT COMPLETED|Overall Study||0
947918|NCT00050089|2290408|P4|COMPLETED|Overall Study|For primary outcome assessment|78
947919|NCT00050089|2290409|P3|COMPLETED|Overall Study|For primary outcome assessment|86
947920|NCT00050089|2290410|P2|COMPLETED|Overall Study|For primary outcome assessment|98
947921|NCT00050089|2290411|P1|COMPLETED|Overall Study|For primary outcome assessment|106
947922|NCT00050089|2290408|P4|Baseline|Overall Study||78
947923|NCT00050089|2290409|P3|Baseline|Overall Study||86
947924|NCT00050089|2290410|P2|Baseline|Overall Study|14 participants randomized in the UK Option scheme (not shown in 2X2 baseline data)|84
947925|NCT00050089|2290411|P1|Baseline|Overall Study|15 participants randomized in the UK Option scheme (not displayed in the 2X2 baseline data)|91
947926|NCT00050089|2290408|P4|STARTED|Overall Study||78
947927|NCT00050089|2290409|P3|STARTED|Overall Study||86
947928|NCT00050089|2290410|P2|STARTED|Overall Study||98
947929|NCT00050089|2290411|P1|STARTED|Overall Study||106
947930|NCT00050167|2290431|P2|NOT COMPLETED|Overall Study||1
947931|NCT00050167|2290432|P1|NOT COMPLETED|Overall Study||1
947932|NCT00050167|2290431|P2|COMPLETED|Overall Study||300
947933|NCT00050167|2290432|P1|COMPLETED|Overall Study||301
947934|NCT00050167|2290431|P2|STARTED|Overall Study||301
947935|NCT00050167|2290432|P1|STARTED|Overall Study||302
947936|NCT00060944|2290440|P2|NOT COMPLETED|Overall Study||134
947937|NCT00060944|2290441|P1|NOT COMPLETED|Overall Study||136
947938|NCT00060944|2290440|P2|COMPLETED|Overall Study||0
947939|NCT00060944|2290441|P1|COMPLETED|Overall Study||0
947940|NCT00060944|2290440|P2|Treated|Overall Study||130
947941|NCT00060944|2290441|P1|Treated|Overall Study||130
947942|NCT00060944|2290440|P2|STARTED|Overall Study||134
947943|NCT00060944|2290441|P1|STARTED|Overall Study||136
947944|NCT00061048|2290455|P1|NOT COMPLETED|Overall Study||22
947945|NCT00061048|2290455|P1|COMPLETED|Overall Study|Began protocol specified follow-up period.|7
947946|NCT00061048|2290455|P1|STARTED|Overall Study||29
947947|NCT00061633|2290465|P2|NOT COMPLETED|Overall Study||11
947948|NCT00061633|2290466|P1|NOT COMPLETED|Overall Study||5
947949|NCT00061633|2290465|P2|COMPLETED|Overall Study||74
947950|NCT00061633|2290466|P1|COMPLETED|Overall Study||79
947951|NCT00061633|2290465|P2|STARTED|Overall Study||85
947952|NCT00061633|2290466|P1|STARTED|Overall Study||84
947953|NCT00061893|2290472|P1|NOT COMPLETED|Overall Study||18
947954|NCT00061893|2290472|P1|COMPLETED|Overall Study||20
947955|NCT00061893|2290472|P1|STARTED|Overall Study||38
947956|NCT00061932|2290479|P2|NOT COMPLETED|Overall Study||4
947957|NCT00061932|2290480|P1|NOT COMPLETED|Overall Study||13
947958|NCT00061932|2290479|P2|COMPLETED|Overall Study||8
947959|NCT00061932|2290480|P1|COMPLETED|Overall Study||16
947960|NCT00061932|2290479|P2|STARTED|Overall Study||12
947961|NCT00061932|2290480|P1|STARTED|Overall Study||29
947962|NCT00061945|2290488|P2|NOT COMPLETED|Course IV: Alemtuzumab||16
947963|NCT00061945|2290489|P1|NOT COMPLETED|Course IV: Alemtuzumab||7
947964|NCT00061945|2290488|P2|COMPLETED|Course IV: Alemtuzumab||50
947965|NCT00061945|2290489|P1|COMPLETED|Course IV: Alemtuzumab||18
947966|NCT00061945|2290488|P2|STARTED|Course IV: Alemtuzumab||66
947967|NCT00061945|2290489|P1|STARTED|Course IV: Alemtuzumab||25
947968|NCT00061945|2290488|P2|NOT COMPLETED|Registration Through Course 3||115
947969|NCT00061945|2290489|P1|NOT COMPLETED|Registration Through Course 3||94
947970|NCT00061945|2290488|P2|COMPLETED|Registration Through Course 3||66
947971|NCT00061945|2290489|P1|COMPLETED|Registration Through Course 3||25
947972|NCT00061945|2290488|P2|STARTED|Registration Through Course 3||181
947973|NCT00061945|2290489|P1|STARTED|Registration Through Course 3||119
947974|NCT00062010|2290497|P1|NOT COMPLETED|Overall Study||3
947975|NCT00062010|2290497|P1|COMPLETED|Overall Study||34
947976|NCT00062010|2290497|P1|Eligible and Treated|Overall Study||34
947977|NCT00062010|2290497|P1|STARTED|Overall Study||37
947978|NCT00062374|2290503|P1|NOT COMPLETED|Overall Study||12
947979|NCT00062374|2290503|P1|COMPLETED|Overall Study||43
947980|NCT00062374|2290503|P1|STARTED|Overall Study||55
947981|NCT00062439|2290508|P1|NOT COMPLETED|Consolidation Chemotherapy||2
947982|NCT00062439|2290508|P1|COMPLETED|Consolidation Chemotherapy||20
947983|NCT00062439|2290508|P1|STARTED|Consolidation Chemotherapy||22
947984|NCT00062439|2290508|P1|NOT COMPLETED|Surgery||7
947985|NCT00062439|2290508|P1|COMPLETED|Surgery||22
947986|NCT00062439|2290508|P1|STARTED|Surgery||29
947987|NCT00062439|2290508|P1|NOT COMPLETED|Post Chemoradiation Assessment||9
947988|NCT00062439|2290508|P1|COMPLETED|Post Chemoradiation Assessment||29
947989|NCT00062439|2290508|P1|STARTED|Post Chemoradiation Assessment||38
947990|NCT00062439|2290508|P1|NOT COMPLETED|Induction Chemotherapy + Radiotherapy||8
947991|NCT00062439|2290508|P1|COMPLETED|Induction Chemotherapy + Radiotherapy||38
947992|NCT00062439|2290508|P1|STARTED|Induction Chemotherapy + Radiotherapy||46
947993|NCT00062647|2290522|P2|NOT COMPLETED|Overall Study||13
947994|NCT00062647|2290523|P1|NOT COMPLETED|Overall Study||16
947995|NCT00062647|2290522|P2|COMPLETED|Overall Study||17
947996|NCT00062647|2290523|P1|COMPLETED|Overall Study||14
947997|NCT00062647|2290522|P2|STARTED|Overall Study||30
947998|NCT00062647|2290523|P1|STARTED|Overall Study||30
947999|NCT00062738|2290532|P3|NOT COMPLETED|Overall Study||0
948000|NCT00062738|2290533|P2|NOT COMPLETED|Overall Study||0
948001|NCT00062738|2290534|P1|NOT COMPLETED|Overall Study||0
948002|NCT00062738|2290532|P3|COMPLETED|Overall Study||17
948003|NCT00062738|2290533|P2|COMPLETED|Overall Study||18
948004|NCT00062738|2290534|P1|COMPLETED|Overall Study||17
948005|NCT00062738|2290532|P3|STARTED|Overall Study||17
948006|NCT00062738|2290533|P2|STARTED|Overall Study||18
948007|NCT00062738|2290534|P1|STARTED|Overall Study||17
948008|NCT00062751|2290550|P5|NOT COMPLETED|Overall Study||6
948009|NCT00062751|2290551|P4|NOT COMPLETED|Overall Study||5
948010|NCT00062751|2290552|P3|NOT COMPLETED|Overall Study||30
948011|NCT00062751|2290553|P2|NOT COMPLETED|Overall Study||30
948012|NCT00062751|2290554|P1|NOT COMPLETED|Overall Study||33
948013|NCT00062751|2290550|P5|COMPLETED|Overall Study||0
948014|NCT00062751|2290551|P4|COMPLETED|Overall Study||1
948015|NCT00062751|2290552|P3|COMPLETED|Overall Study||3
948016|NCT00062751|2290553|P2|COMPLETED|Overall Study||0
948017|NCT00062751|2290554|P1|COMPLETED|Overall Study||0
948018|NCT00062751|2290550|P5|STARTED|Overall Study||6
948019|NCT00062751|2290551|P4|STARTED|Overall Study||6
948020|NCT00062751|2290552|P3|STARTED|Overall Study||33
948021|NCT00062751|2290553|P2|STARTED|Overall Study||30
948022|NCT00062751|2290554|P1|STARTED|Overall Study||33
948023|NCT00062764|2290622|P1|NOT COMPLETED|Overall Study||0
948024|NCT00062764|2290622|P1|COMPLETED|Overall Study||18
948025|NCT00062764|2290622|P1|STARTED|Overall Study||18
948026|NCT00063154|2290630|P1|NOT COMPLETED|Overall Study||51
948027|NCT00063154|2290630|P1|COMPLETED|Overall Study||0
948028|NCT00063154|2290630|P1|STARTED|Overall Study||51
948029|NCT00063232|2290637|P1|NOT COMPLETED|Overall Study||0
948030|NCT00063232|2290637|P1|COMPLETED|Overall Study||26
948031|NCT00063232|2290637|P1|STARTED|Overall Study||26
948032|NCT00063258|2290645|P2|NOT COMPLETED|Overall Study||0
948033|NCT00063258|2290646|P1|NOT COMPLETED|Overall Study||4
948034|NCT00063258|2290645|P2|COMPLETED|Overall Study||0
948035|NCT00063258|2290646|P1|COMPLETED|Overall Study||1
948036|NCT00063258|2290645|P2|STARTED|Overall Study||0
948037|NCT00063258|2290646|P1|STARTED|Overall Study||5
948038|NCT00063362|2290654|P2|NOT COMPLETED|Overall Study||4
948039|NCT00063362|2290655|P1|NOT COMPLETED|Overall Study||4
948040|NCT00063362|2290654|P2|COMPLETED|Overall Study||22
948041|NCT00063362|2290655|P1|COMPLETED|Overall Study||19
948042|NCT00063362|2290654|P2|STARTED|Overall Study||26
948043|NCT00063362|2290655|P1|STARTED|Overall Study||23
948044|NCT00063570|2290663|P2|NOT COMPLETED|Overall Study||0
948045|NCT00063570|2290664|P1|NOT COMPLETED|Overall Study||0
948046|NCT00063570|2290663|P2|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|21
948047|NCT00063570|2290664|P1|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|52
948048|NCT00063570|2290663|P2|STARTED|Overall Study||21
948049|NCT00063570|2290664|P1|STARTED|Overall Study||52
948050|NCT00063622|2290681|P3|NOT COMPLETED|Overall Study||11
948051|NCT00063622|2290682|P2|NOT COMPLETED|Overall Study||4
948052|NCT00063622|2290683|P1|NOT COMPLETED|Overall Study||10
948053|NCT00063622|2290681|P3|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|72
948054|NCT00063622|2290682|P2|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|80
948055|NCT00063622|2290683|P1|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|70
948056|NCT00063622|2290681|P3|STARTED|Overall Study||83
948057|NCT00063622|2290682|P2|STARTED|Overall Study||84
948058|NCT00063622|2290683|P1|STARTED|Overall Study||80
948059|NCT00063635|2290709|P3|NOT COMPLETED|Overall Study||9
948060|NCT00063635|2290710|P2|NOT COMPLETED|Overall Study||8
948061|NCT00063635|2290711|P1|NOT COMPLETED|Overall Study||6
948062|NCT00063635|2290709|P3|COMPLETED|Overall Study||49
948063|NCT00063635|2290710|P2|COMPLETED|Overall Study||50
948064|NCT00063635|2290711|P1|COMPLETED|Overall Study||51
948065|NCT00063635|2290709|P3|STARTED|Overall Study||58
948066|NCT00063635|2290710|P2|STARTED|Overall Study||58
948067|NCT00063635|2290711|P1|STARTED|Overall Study||57
948068|NCT00063934|2290749|P1|NOT COMPLETED|Overall Study||1
948069|NCT00063934|2290749|P1|COMPLETED|Overall Study||30
948070|NCT00063934|2290749|P1|STARTED|Overall Study||31
948071|NCT00063986|2290755|P1|NOT COMPLETED|Overall Study||6
948072|NCT00063986|2290755|P1|COMPLETED|Overall Study||104
948073|NCT00063986|2290755|P1|Eligible and Treated|Overall Study||104
948074|NCT00063986|2290755|P1|Treated|Overall Study||105
948075|NCT00063986|2290755|P1|STARTED|Overall Study||110
948076|NCT00064025|2290767|P1|NOT COMPLETED|Overall Study||7
948077|NCT00064025|2290767|P1|COMPLETED|Overall Study||68
948078|NCT00064025|2290767|P1|STARTED|Overall Study||75
948079|NCT00064038|2290776|P3|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||2
948080|NCT00064038|2290777|P2|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
948081|NCT00064038|2290778|P1|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
948082|NCT00064038|2290776|P3|COMPLETED|Crossover to Lenalidomide+Dexamethasone||40
948083|NCT00064038|2290777|P2|COMPLETED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
948084|NCT00064038|2290778|P1|COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
948085|NCT00064038|2290776|P3|Safety Population|Crossover to Lenalidomide+Dexamethasone||40
948086|NCT00064038|2290777|P2|Safety Population|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
948087|NCT00064038|2290778|P1|Safety Population|Crossover to Lenalidomide+Dexamethasone||0
948088|NCT00064038|2290776|P3|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||40
948089|NCT00064038|2290777|P2|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
948090|NCT00064038|2290778|P1|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||0
948091|NCT00064038|2290776|P3|STARTED|Crossover to Lenalidomide+Dexamethasone||42
948092|NCT00064038|2290777|P2|STARTED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
948093|NCT00064038|2290778|P1|STARTED|Crossover to Lenalidomide+Dexamethasone||0
948094|NCT00064038|2290776|P3|NOT COMPLETED|Initial Randomization||0
948095|NCT00064038|2290777|P2|NOT COMPLETED|Initial Randomization||98
948096|NCT00064038|2290778|P1|NOT COMPLETED|Initial Randomization||100
948097|NCT00064038|2290776|P3|COMPLETED|Initial Randomization||0
948098|NCT00064038|2290777|P2|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
948099|NCT00064038|2290778|P1|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
948100|NCT00064038|2290776|P3|Safety Population|Initial Randomization||0
948101|NCT00064038|2290777|P2|Safety Population|Initial Randomization||94
948102|NCT00064038|2290778|P1|Safety Population|Initial Randomization||96
948103|NCT00064038|2290776|P3|Eligible and Analyzable|Initial Randomization||0
948104|NCT00064038|2290777|P2|Eligible and Analyzable|Initial Randomization||95
948105|NCT00064038|2290778|P1|Eligible and Analyzable|Initial Randomization||97
948106|NCT00064038|2290776|P3|STARTED|Initial Randomization||0
948107|NCT00064038|2290777|P2|STARTED|Initial Randomization||98
948108|NCT00064038|2290778|P1|STARTED|Initial Randomization||100
948109|NCT00055237|2290790|P2|NOT COMPLETED|Overall Study||0
948110|NCT00055237|2290791|P1|NOT COMPLETED|Overall Study||0
948111|NCT00055237|2290790|P2|COMPLETED|Overall Study||2
948112|NCT00055237|2290791|P1|COMPLETED|Overall Study||17
948113|NCT00055237|2290790|P2|STARTED|Overall Study||2
948114|NCT00055237|2290791|P1|STARTED|Overall Study||17
948115|NCT00055471|2290799|P3|NOT COMPLETED|Period 2: Extension Period||0
948116|NCT00055471|2290800|P2|NOT COMPLETED|Period 2: Extension Period||0
948117|NCT00055471|2290801|P1|NOT COMPLETED|Period 2: Extension Period||0
948118|NCT00055471|2290799|P3|COMPLETED|Period 2: Extension Period||0
948119|NCT00055471|2290800|P2|COMPLETED|Period 2: Extension Period||6
948120|NCT00055471|2290801|P1|COMPLETED|Period 2: Extension Period||3
948121|NCT00055471|2290799|P3|STARTED|Period 2: Extension Period||0
948122|NCT00055471|2290800|P2|STARTED|Period 2: Extension Period|2 pts discontinued after completion of Period1,therefore 9 pts proceeded to participate in Period2|6
948123|NCT00055471|2290801|P1|STARTED|Period 2: Extension Period|Period 2 - attend Pts who,in the opinion of the Investigator,show benefit from treatment with ZD4054|3
948124|NCT00055471|2290799|P3|NOT COMPLETED|Period 1: Dose Escalation Period||3
948125|NCT00055471|2290800|P2|NOT COMPLETED|Period 1: Dose Escalation Period||2
948126|NCT00055471|2290801|P1|NOT COMPLETED|Period 1: Dose Escalation Period||0
948127|NCT00055471|2290799|P3|COMPLETED|Period 1: Dose Escalation Period||0
948128|NCT00055471|2290800|P2|COMPLETED|Period 1: Dose Escalation Period||8
948129|NCT00055471|2290801|P1|COMPLETED|Period 1: Dose Escalation Period||3
948130|NCT00055471|2290799|P3|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|3
948131|NCT00055471|2290800|P2|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|10
948132|NCT00055471|2290801|P1|STARTED|Period 1: Dose Escalation Period||3
948133|NCT00055497|2290831|P4|NOT COMPLETED|Overall Study||90
948134|NCT00055497|2290832|P3|NOT COMPLETED|Overall Study||2
948135|NCT00055497|2290833|P2|NOT COMPLETED|Overall Study||3
948136|NCT00055497|2290834|P1|NOT COMPLETED|Overall Study||5
948137|NCT00055497|2290831|P4|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|131
948138|NCT00055497|2290832|P3|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
948139|NCT00055497|2290833|P2|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
948140|NCT00055497|2290834|P1|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|13
948141|NCT00055497|2290831|P4|STARTED|Overall Study|17 participants who discontinued at/before Week 4 are counted here because they were not randomized.|221
948142|NCT00055497|2290832|P3|STARTED|Overall Study||18
948143|NCT00055497|2290833|P2|STARTED|Overall Study||19
948144|NCT00055497|2290834|P1|STARTED|Overall Study||18
948145|NCT00055601|2290878|P2|NOT COMPLETED|Overall Study||2
948146|NCT00055601|2290879|P1|NOT COMPLETED|Overall Study||2
948147|NCT00055601|2290878|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
948148|NCT00055601|2290879|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|46
948149|NCT00055601|2290878|P2|STARTED|Overall Study||49
948150|NCT00055601|2290879|P1|STARTED|Overall Study||48
948151|NCT00055692|2290889|P1|NOT COMPLETED|Overall Study||0
948152|NCT00055692|2290889|P1|COMPLETED|Overall Study||46
948153|NCT00055692|2290889|P1|STARTED|Overall Study||46
948172|NCT00056316|2290915|P2|NOT COMPLETED|Overall Study||3
948173|NCT00056316|2290916|P1|NOT COMPLETED|Overall Study||3
948174|NCT00056316|2290915|P2|COMPLETED|Overall Study||38
948175|NCT00056316|2290916|P1|COMPLETED|Overall Study||30
948176|NCT00056316|2290915|P2|STARTED|Overall Study|over-enrolled due to potential higher rates of drop-out.|41
948177|NCT00056316|2290916|P1|STARTED|Overall Study||33
948178|NCT00056407|2290930|P2|NOT COMPLETED|Overall Study||1193
948179|NCT00056407|2290931|P1|NOT COMPLETED|Overall Study||1211
948180|NCT00056407|2290930|P2|COMPLETED|Overall Study||2912
948181|NCT00056407|2290931|P1|COMPLETED|Overall Study||2915
948182|NCT00056407|2290930|P2|STARTED|Overall Study||4105
948183|NCT00056407|2290931|P1|STARTED|Overall Study||4126
948184|NCT00056472|2290989|P2|NOT COMPLETED|Overall Study||69
948185|NCT00056472|2290990|P1|NOT COMPLETED|Overall Study||48
948186|NCT00056472|2290989|P2|COMPLETED|Overall Study||61
948187|NCT00056472|2290990|P1|COMPLETED|Overall Study||81
948188|NCT00056472|2290989|P2|STARTED|Overall Study||130
948189|NCT00056472|2290990|P1|STARTED|Overall Study||129
948190|NCT00056498|2291002|P2|NOT COMPLETED|Overall Study||7
948191|NCT00056498|2291003|P1|NOT COMPLETED|Overall Study||5
948192|NCT00056498|2291002|P2|COMPLETED|Overall Study||28
948193|NCT00056498|2291003|P1|COMPLETED|Overall Study||25
948194|NCT00056498|2291002|P2|STARTED|Overall Study||35
948195|NCT00056498|2291003|P1|STARTED|Overall Study||30
948196|NCT00056550|2291009|P1|NOT COMPLETED|Overall Study||0
948197|NCT00056550|2291009|P1|COMPLETED|Overall Study||14
948198|NCT00056550|2291009|P1|STARTED|Overall Study||14
948199|NCT00056563|2291016|P2|NOT COMPLETED|Overall Study||0
948200|NCT00056563|2291017|P1|NOT COMPLETED|Overall Study||0
948201|NCT00056563|2291016|P2|COMPLETED|Overall Study||134
948202|NCT00056563|2291017|P1|COMPLETED|Overall Study||121
948203|NCT00056563|2291016|P2|STARTED|Overall Study||134
948204|NCT00056563|2291017|P1|STARTED|Overall Study||121
948205|NCT00056862|2291027|P2|NOT COMPLETED|Overall Study||0
948206|NCT00056862|2291028|P1|NOT COMPLETED|Overall Study||1
948207|NCT00056862|2291027|P2|COMPLETED|Overall Study||27
948208|NCT00056862|2291028|P1|COMPLETED|Overall Study||30
948209|NCT00056862|2291027|P2|STARTED|Overall Study||27
948210|NCT00056862|2291028|P1|STARTED|Overall Study||31
948211|NCT00057330|2291044|P2|NOT COMPLETED|Overall Study||920
948212|NCT00057330|2291045|P1|NOT COMPLETED|Overall Study||1132
948213|NCT00057330|2291044|P2|COMPLETED|Overall Study||2826
948214|NCT00057330|2291045|P1|COMPLETED|Overall Study||3445
948215|NCT00057330|2291044|P2|STARTED|Overall Study||3746
948216|NCT00057330|2291045|P1|STARTED|Overall Study||4577
948217|NCT00057551|2291076|P3|NOT COMPLETED|Overall Study||16
948218|NCT00057551|2291077|P2|NOT COMPLETED|Overall Study||27
948219|NCT00057551|2291078|P1|NOT COMPLETED|Overall Study||25
948220|NCT00057551|2291076|P3|COMPLETED|Overall Study||80
948221|NCT00057551|2291077|P2|COMPLETED|Overall Study||168
948222|NCT00057551|2291078|P1|COMPLETED|Overall Study||175
948223|NCT00057551|2291076|P3|STARTED|Overall Study||96
948224|NCT00057551|2291077|P2|STARTED|Overall Study||195
948225|NCT00057551|2291078|P1|STARTED|Overall Study||200
948226|NCT00057577|2291088|P2|NOT COMPLETED|Overall Study||0
948227|NCT00057577|2291089|P1|NOT COMPLETED|Overall Study||0
948228|NCT00057577|2291088|P2|COMPLETED|Overall Study||225
948229|NCT00057577|2291089|P1|COMPLETED|Overall Study||227
948230|NCT00057577|2291088|P2|STARTED|Overall Study||225
948231|NCT00057577|2291089|P1|STARTED|Overall Study||227
948232|NCT00057681|2291106|P3|NOT COMPLETED|Overall Study||34
948233|NCT00057681|2291107|P2|NOT COMPLETED|Overall Study||72
948234|NCT00057681|2291108|P1|NOT COMPLETED|Overall Study||65
948235|NCT00057681|2291106|P3|COMPLETED|Overall Study||69
948236|NCT00057681|2291107|P2|COMPLETED|Overall Study||67
948237|NCT00057681|2291108|P1|COMPLETED|Overall Study||72
948238|NCT00057681|2291106|P3|STARTED|Overall Study||103
948239|NCT00057681|2291107|P2|STARTED|Overall Study||139
948240|NCT00057681|2291108|P1|STARTED|Overall Study||137
948241|NCT00057746|2291125|P3|NOT COMPLETED|Overall Study||1
948242|NCT00057746|2291126|P2|NOT COMPLETED|Overall Study||0
948243|NCT00057746|2291127|P1|NOT COMPLETED|Overall Study||0
948244|NCT00057746|2291125|P3|COMPLETED|Overall Study||66
948245|NCT00057746|2291126|P2|COMPLETED|Overall Study||67
948246|NCT00057746|2291127|P1|COMPLETED|Overall Study||131
948247|NCT00057746|2291125|P3|STARTED|Overall Study||67
948248|NCT00057746|2291126|P2|STARTED|Overall Study||67
948249|NCT00057746|2291127|P1|STARTED|Overall Study||131
948250|NCT00057785|2291135|P1|NOT COMPLETED|Overall Study||0
948251|NCT00057785|2291135|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|68
948252|NCT00057785|2291135|P1|STARTED|Overall Study||68
948253|NCT00057811|2291141|P2|NOT COMPLETED|Overall Study||12
948254|NCT00057811|2291142|P1|NOT COMPLETED|Overall Study||10
948255|NCT00057811|2291141|P2|COMPLETED|Overall Study||34
948256|NCT00057811|2291142|P1|COMPLETED|Overall Study||41
948257|NCT00057811|2291141|P2|STARTED|Overall Study||46
948258|NCT00057811|2291142|P1|STARTED|Overall Study||51
948259|NCT00057837|2291156|P2|NOT COMPLETED|Overall Study||39
948260|NCT00057837|2291157|P1|NOT COMPLETED|Overall Study||31
948261|NCT00057837|2291156|P2|COMPLETED|Overall Study||31
948262|NCT00057837|2291157|P1|COMPLETED|Overall Study||39
948263|NCT00057837|2291156|P2|Patients With Response|Overall Study||38
948264|NCT00057837|2291157|P1|Patients With Response|Overall Study||46
948265|NCT00057837|2291156|P2|Eligible and Treated|Overall Study||66
948266|NCT00057837|2291157|P1|Eligible and Treated|Overall Study||66
948267|NCT00057837|2291156|P2|Treated|Overall Study||68
948268|NCT00057837|2291157|P1|Treated|Overall Study||69
948269|NCT00057837|2291156|P2|STARTED|Overall Study||70
948270|NCT00057837|2291157|P1|STARTED|Overall Study||70
948271|NCT00057863|2291167|P1|NOT COMPLETED|Overall Study||3
948272|NCT00057863|2291167|P1|COMPLETED|Overall Study||32
948273|NCT00057863|2291167|P1|STARTED|Overall Study||35
948274|NCT00057876|2291176|P2|NOT COMPLETED|Overall Study||27
948275|NCT00057876|2291177|P1|NOT COMPLETED|Overall Study||29
948276|NCT00057876|2291176|P2|COMPLETED|Overall Study||9
948277|NCT00057876|2291177|P1|COMPLETED|Overall Study||9
948278|NCT00057876|2291176|P2|Eligible and Treated|Overall Study||34
948279|NCT00057876|2291177|P1|Eligible and Treated|Overall Study||34
948280|NCT00057876|2291176|P2|Began Protocol Therapy|Overall Study||34
948281|NCT00057876|2291177|P1|Began Protocol Therapy|Overall Study||35
948282|NCT00057876|2291176|P2|Eligible|Overall Study||34
948283|NCT00057876|2291177|P1|Eligible|Overall Study||37
948284|NCT00057876|2291176|P2|STARTED|Overall Study||36
948285|NCT00057876|2291177|P1|STARTED|Overall Study||38
948286|NCT00064259|2291187|P4|NOT COMPLETED|Overall Study||1
948287|NCT00064259|2291188|P3|NOT COMPLETED|Overall Study||0
948288|NCT00064259|2291189|P2|NOT COMPLETED|Overall Study||0
948289|NCT00064259|2291190|P1|NOT COMPLETED|Overall Study||1
948290|NCT00064259|2291187|P4|COMPLETED|Overall Study||0
948291|NCT00064259|2291188|P3|COMPLETED|Overall Study||6
948292|NCT00064259|2291189|P2|COMPLETED|Overall Study||4
948293|NCT00064259|2291190|P1|COMPLETED|Overall Study||3
948294|NCT00064259|2291187|P4|STARTED|Overall Study||1
948295|NCT00064259|2291188|P3|STARTED|Overall Study||6
948296|NCT00064259|2291189|P2|STARTED|Overall Study||4
948297|NCT00064259|2291190|P1|STARTED|Overall Study||4
948298|NCT00064298|2291196|P2|NOT COMPLETED|Overall Study||5
948299|NCT00064298|2291197|P1|NOT COMPLETED|Overall Study||6
948300|NCT00064298|2291196|P2|COMPLETED|Overall Study||57
948301|NCT00064298|2291197|P1|COMPLETED|Overall Study||66
948302|NCT00064298|2291196|P2|STARTED|Overall Study||62
948303|NCT00064298|2291197|P1|STARTED|Overall Study||72
948304|NCT00064350|2291208|P3|NOT COMPLETED|Cross-Over||0
948305|NCT00064350|2291209|P2|NOT COMPLETED|Cross-Over||14
948306|NCT00064350|2291210|P1|NOT COMPLETED|Cross-Over||6
948307|NCT00064350|2291208|P3|COMPLETED|Cross-Over||0
948308|NCT00064350|2291209|P2|COMPLETED|Cross-Over||13
948309|NCT00064350|2291210|P1|COMPLETED|Cross-Over||4
948310|NCT00064350|2291208|P3|Eligible and Treated|Cross-Over||0
948311|NCT00064350|2291209|P2|Eligible and Treated|Cross-Over||21
948312|NCT00064350|2291210|P1|Eligible and Treated|Cross-Over||7
948313|NCT00064350|2291208|P3|Treated|Cross-Over||0
948314|NCT00064350|2291209|P2|Treated|Cross-Over||26
948315|NCT00064350|2291210|P1|Treated|Cross-Over||9
948316|NCT00064350|2291208|P3|STARTED|Cross-Over||0
948317|NCT00064350|2291209|P2|STARTED|Cross-Over||27
948318|NCT00064350|2291210|P1|STARTED|Cross-Over||10
948319|NCT00064350|2291208|P3|NOT COMPLETED|Randomization||0
948320|NCT00064350|2291209|P2|NOT COMPLETED|Randomization||18
948321|NCT00064350|2291210|P1|NOT COMPLETED|Randomization||26
948322|NCT00064350|2291208|P3|COMPLETED|Randomization||0
948323|NCT00064350|2291209|P2|COMPLETED|Randomization||28
948324|NCT00064350|2291210|P1|COMPLETED|Randomization||33
948325|NCT00064350|2291208|P3|Eligible and Treated|Randomization||0
948326|NCT00064350|2291209|P2|Eligible and Treated|Randomization||31
948327|NCT00064350|2291210|P1|Eligible and Treated|Randomization||50
948328|NCT00064350|2291208|P3|Treated|Randomization||0
948329|NCT00064350|2291209|P2|Treated|Randomization||40
948330|NCT00064350|2291210|P1|Treated|Randomization||55
948331|NCT00064350|2291208|P3|STARTED|Randomization||0
948332|NCT00064350|2291209|P2|STARTED|Randomization||46
948333|NCT00064350|2291210|P1|STARTED|Randomization||59
948334|NCT00064350|2291208|P3|NOT COMPLETED|Induction Treatment||236
948335|NCT00064350|2291209|P2|NOT COMPLETED|Induction Treatment||9
948336|NCT00064350|2291210|P1|NOT COMPLETED|Induction Treatment||8
948337|NCT00064350|2291208|P3|COMPLETED|Induction Treatment||1
948338|NCT00064350|2291209|P2|COMPLETED|Induction Treatment||37
948339|NCT00064350|2291210|P1|COMPLETED|Induction Treatment||51
948340|NCT00064350|2291208|P3|Eligible and Treated|Induction Treatment||194
948341|NCT00064350|2291209|P2|Eligible and Treated|Induction Treatment||46
948342|NCT00064350|2291210|P1|Eligible and Treated|Induction Treatment||59
948343|NCT00064350|2291208|P3|Treated|Induction Treatment||228
948344|NCT00064350|2291209|P2|Treated|Induction Treatment||46
948345|NCT00064350|2291210|P1|Treated|Induction Treatment||59
948346|NCT00064350|2291208|P3|STARTED|Induction Treatment||237
948347|NCT00064350|2291209|P2|STARTED|Induction Treatment||46
948348|NCT00064350|2291210|P1|STARTED|Induction Treatment||59
948349|NCT00064987|2291227|P2|NOT COMPLETED|Overall Study||0
948350|NCT00064987|2291228|P1|NOT COMPLETED|Overall Study||3
948351|NCT00064987|2291227|P2|COMPLETED|Overall Study||6
948352|NCT00064987|2291228|P1|COMPLETED|Overall Study||7
948353|NCT00064987|2291227|P2|STARTED|Overall Study||6
948354|NCT00064987|2291228|P1|STARTED|Overall Study||10
948355|NCT00065065|2291248|P2|NOT COMPLETED|Overall Study||20
948356|NCT00065065|2291249|P1|NOT COMPLETED|Overall Study||10
948357|NCT00065065|2291248|P2|COMPLETED|Overall Study||33
948358|NCT00065065|2291249|P1|COMPLETED|Overall Study||42
948359|NCT00065065|2291248|P2|STARTED|Overall Study||53
948360|NCT00065065|2291249|P1|STARTED|Overall Study||52
948361|NCT00065156|2291257|P1|NOT COMPLETED|Overall Study||124
948362|NCT00065156|2291257|P1|COMPLETED|Overall Study|24 patients rolled over to free drug due to sponsor closure of study.|24
948363|NCT00065156|2291257|P1|Modified Intent to Treat Population|Overall Study||94
948364|NCT00065156|2291257|P1|STARTED|Overall Study||148
948365|NCT00065260|2291274|P2|NOT COMPLETED|Overall Study||1
948366|NCT00065260|2291275|P1|NOT COMPLETED|Overall Study||0
948367|NCT00065260|2291274|P2|COMPLETED|Overall Study||26
948368|NCT00065260|2291275|P1|COMPLETED|Overall Study||27
948369|NCT00065260|2291274|P2|STARTED|Overall Study||27
948370|NCT00065260|2291275|P1|STARTED|Overall Study||27
948371|NCT00065429|2291288|P7|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
948372|NCT00065429|2291289|P6|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
948373|NCT00065429|2291290|P5|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||6
948374|NCT00065429|2291291|P4|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
948375|NCT00065429|2291292|P3|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
948376|NCT00065429|2291293|P2|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
948377|NCT00065429|2291294|P1|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
948378|NCT00065429|2291288|P7|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
948379|NCT00065429|2291289|P6|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
948380|NCT00065429|2291290|P5|COMPLETED|Phase II - Apr 2003 - Aug 2008||26
948381|NCT00065429|2291291|P4|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
948382|NCT00065429|2291292|P3|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
948383|NCT00065429|2291293|P2|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
948384|NCT00065429|2291294|P1|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
948385|NCT00065429|2291288|P7|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
948386|NCT00065429|2291289|P6|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
948387|NCT00065429|2291290|P5|STARTED|Phase II - Apr 2003 - Aug 2008|All 32 patients enrolled in Phase 2 were at 60 mg/m2.|32
948388|NCT00065429|2291291|P4|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
948389|NCT00065429|2291292|P3|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
948390|NCT00065429|2291293|P2|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
948391|NCT00065429|2291294|P1|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
948392|NCT00065429|2291288|P7|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
948393|NCT00065429|2291289|P6|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
948394|NCT00065429|2291290|P5|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
948395|NCT00065429|2291291|P4|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
948396|NCT00065429|2291292|P3|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
948397|NCT00065429|2291293|P2|NOT COMPLETED|Phase I - May 2001 - Oct 2002||0
948398|NCT00065429|2291294|P1|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
948399|NCT00065429|2291288|P7|COMPLETED|Phase I - May 2001 - Oct 2002||2
948400|NCT00065429|2291289|P6|COMPLETED|Phase I - May 2001 - Oct 2002||2
948401|NCT00065429|2291290|P5|COMPLETED|Phase I - May 2001 - Oct 2002||8
948402|NCT00065429|2291291|P4|COMPLETED|Phase I - May 2001 - Oct 2002||3
948403|NCT00065429|2291292|P3|COMPLETED|Phase I - May 2001 - Oct 2002||3
948404|NCT00065429|2291293|P2|COMPLETED|Phase I - May 2001 - Oct 2002||3
948405|NCT00065429|2291294|P1|COMPLETED|Phase I - May 2001 - Oct 2002||3
948406|NCT00065429|2291288|P7|STARTED|Phase I - May 2001 - Oct 2002||4
948407|NCT00065429|2291289|P6|STARTED|Phase I - May 2001 - Oct 2002||4
948408|NCT00065429|2291290|P5|STARTED|Phase I - May 2001 - Oct 2002||9
948409|NCT00065429|2291291|P4|STARTED|Phase I - May 2001 - Oct 2002||4
948410|NCT00065429|2291292|P3|STARTED|Phase I - May 2001 - Oct 2002||4
948411|NCT00065429|2291293|P2|STARTED|Phase I - May 2001 - Oct 2002||3
948412|NCT00065429|2291294|P1|STARTED|Phase I - May 2001 - Oct 2002||4
948413|NCT00065442|2291308|P2|NOT COMPLETED|Overall Study||220
948414|NCT00065442|2291309|P1|NOT COMPLETED|Overall Study||125
948415|NCT00065442|2291308|P2|COMPLETED|Overall Study||121
948416|NCT00065442|2291309|P1|COMPLETED|Overall Study||46
948417|NCT00065442|2291308|P2|STARTED|Overall Study||341
948418|NCT00065442|2291309|P1|STARTED|Overall Study||171
948419|NCT00065468|2291320|P3|NOT COMPLETED|Overall Study||210
948420|NCT00065468|2291321|P2|NOT COMPLETED|Overall Study||209
948421|NCT00065468|2291322|P1|NOT COMPLETED|Overall Study||207
948422|NCT00065468|2291320|P3|COMPLETED|Overall Study||0
948423|NCT00065468|2291321|P2|COMPLETED|Overall Study||0
948424|NCT00065468|2291322|P1|COMPLETED|Overall Study||0
948425|NCT00065468|2291320|P3|Received Treatment|Overall Study||208
948426|NCT00065468|2291321|P2|Received Treatment|Overall Study||208
948427|NCT00065468|2291322|P1|Received Treatment|Overall Study||200
948428|NCT00065468|2291320|P3|STARTED|Overall Study||210
948429|NCT00065468|2291321|P2|STARTED|Overall Study||209
948430|NCT00065468|2291322|P1|STARTED|Overall Study||207
948431|NCT00065507|2291353|P2|NOT COMPLETED|Overall Study||29
948432|NCT00065507|2291354|P1|NOT COMPLETED|Overall Study||29
948433|NCT00065507|2291353|P2|COMPLETED|Overall Study|Completed first 48 weeks of treatment|62
948434|NCT00065507|2291354|P1|COMPLETED|Overall Study|Completed first 48 weeks of treatment|71
948435|NCT00065507|2291353|P2|Treated, 24-Week Follow-Up Population|Overall Study||28
948436|NCT00065507|2291354|P1|Treated, 24-Week Follow-Up Population|Overall Study||25
948437|NCT00065507|2291353|P2|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
948438|NCT00065507|2291354|P1|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
948439|NCT00065507|2291353|P2|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
948440|NCT00065507|2291354|P1|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
948441|NCT00065507|2291353|P2|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|91
948442|NCT00065507|2291354|P1|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|100
948443|NCT00065507|2291353|P2|STARTED|Overall Study|94 participants were randomized; 3 never treated.|91
948444|NCT00065507|2291354|P1|STARTED|Overall Study|101 participants were randomized; 1 never treated.|100
948445|NCT00065611|2291418|P2|NOT COMPLETED|Overall Study||1
948446|NCT00065611|2291419|P1|NOT COMPLETED|Overall Study||0
948447|NCT00065611|2291418|P2|COMPLETED|Overall Study||3
948448|NCT00065611|2291419|P1|COMPLETED|Overall Study||4
948449|NCT00065611|2291418|P2|STARTED|Overall Study||4
948450|NCT00065611|2291419|P1|STARTED|Overall Study||4
948451|NCT00065806|2291431|P2|NOT COMPLETED|Overall Study||19
948452|NCT00065806|2291432|P1|NOT COMPLETED|Overall Study||20
948453|NCT00065806|2291431|P2|COMPLETED|Overall Study||89
948454|NCT00065806|2291432|P1|COMPLETED|Overall Study||93
948455|NCT00065806|2291431|P2|STARTED|Overall Study||108
948456|NCT00065806|2291432|P1|STARTED|Overall Study||113
948457|NCT00066066|2291477|P6|NOT COMPLETED|Overall Study||5
948458|NCT00066066|2291478|P5|NOT COMPLETED|Overall Study||3
948459|NCT00066066|2291479|P4|NOT COMPLETED|Overall Study||4
948460|NCT00066066|2291480|P3|NOT COMPLETED|Overall Study||7
948461|NCT00066066|2291481|P2|NOT COMPLETED|Overall Study||4
948462|NCT00066066|2291482|P1|NOT COMPLETED|Overall Study||6
948463|NCT00066066|2291477|P6|COMPLETED|Overall Study|20 enrolled, 15 analyzed,9 subjects had complete data,6 subjects had data carried forward.|15
948464|NCT00066066|2291478|P5|COMPLETED|Overall Study|27 enrolled, 24 analyzed,19 subjects had complete data,5 subjects had data carried forward.|24
948465|NCT00066066|2291479|P4|COMPLETED|Overall Study|20 enrolled, 16 analyzed,11 subjects had complete data,5 subjects had data carried forward.|16
948466|NCT00066066|2291480|P3|COMPLETED|Overall Study|30 enrolled, 23 analyzed,21 subjects had complete data,2 subjects had data carried forward.|23
948467|NCT00066066|2291481|P2|COMPLETED|Overall Study|22 enrolled, 18 analyzed,11 subjects had complete data,7 subjects had data carried forward.|18
948468|NCT00066066|2291482|P1|COMPLETED|Overall Study|27 enrolled, 21 analyzed,18 subjects had complete data,3 subjects had data carried forward.|21
948469|NCT00066066|2291477|P6|12 Month|Overall Study||9
948470|NCT00066066|2291478|P5|12 Month|Overall Study||19
948471|NCT00066066|2291479|P4|12 Month|Overall Study||11
948472|NCT00066066|2291480|P3|12 Month|Overall Study||21
948473|NCT00066066|2291481|P2|12 Month|Overall Study||11
948474|NCT00066066|2291482|P1|12 Month|Overall Study||18
948475|NCT00066066|2291477|P6|6 Month|Overall Study||14
948476|NCT00066066|2291478|P5|6 Month|Overall Study||21
948477|NCT00066066|2291479|P4|6 Month|Overall Study||13
948478|NCT00066066|2291480|P3|6 Month|Overall Study||23
948479|NCT00066066|2291481|P2|6 Month|Overall Study||13
948480|NCT00066066|2291482|P1|6 Month|Overall Study||19
948481|NCT00066066|2291477|P6|3 Month|Overall Study||15
948482|NCT00066066|2291478|P5|3 Month|Overall Study||22
948483|NCT00066066|2291479|P4|3 Month|Overall Study||16
948484|NCT00066066|2291480|P3|3 Month|Overall Study||23
948485|NCT00066066|2291481|P2|3 Month|Overall Study||17
948486|NCT00066066|2291482|P1|3 Month|Overall Study||21
948487|NCT00066066|2291477|P6|Baseline|Overall Study||20
948488|NCT00066066|2291478|P5|Baseline|Overall Study||27
948489|NCT00066066|2291479|P4|Baseline|Overall Study||20
948490|NCT00066066|2291480|P3|Baseline|Overall Study||30
948491|NCT00066066|2291481|P2|Baseline|Overall Study||22
948492|NCT00066066|2291482|P1|Baseline|Overall Study||27
948493|NCT00066066|2291477|P6|STARTED|Overall Study||20
948494|NCT00066066|2291478|P5|STARTED|Overall Study||27
948495|NCT00066066|2291479|P4|STARTED|Overall Study||20
948496|NCT00066066|2291480|P3|STARTED|Overall Study||30
948497|NCT00066066|2291481|P2|STARTED|Overall Study||22
948498|NCT00066066|2291482|P1|STARTED|Overall Study||27
948499|NCT00066170|2291500|P4|NOT COMPLETED|Overall Study||9
948500|NCT00066170|2291501|P3|NOT COMPLETED|Overall Study||4
948501|NCT00066170|2291502|P2|NOT COMPLETED|Overall Study||10
948502|NCT00066170|2291503|P1|NOT COMPLETED|Overall Study||7
948503|NCT00066170|2291500|P4|COMPLETED|Overall Study||48
948504|NCT00066170|2291501|P3|COMPLETED|Overall Study||59
948505|NCT00066170|2291502|P2|COMPLETED|Overall Study||45
948506|NCT00066170|2291503|P1|COMPLETED|Overall Study||49
948507|NCT00066170|2291500|P4|Intent to Treat|Overall Study||54
948508|NCT00066170|2291501|P3|Intent to Treat|Overall Study||63
948509|NCT00066170|2291502|P2|Intent to Treat|Overall Study||50
948510|NCT00066170|2291503|P1|Intent to Treat|Overall Study||55
948511|NCT00066170|2291500|P4|STARTED|Overall Study||57
948512|NCT00066170|2291501|P3|STARTED|Overall Study||63
948513|NCT00066170|2291502|P2|STARTED|Overall Study||55
948514|NCT00066170|2291503|P1|STARTED|Overall Study||56
948515|NCT00066222|2291513|P1|NOT COMPLETED|Overall Study||1
948516|NCT00066222|2291513|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|71
948517|NCT00066222|2291513|P1|STARTED|Overall Study||72
948518|NCT00066365|2291519|P2|NOT COMPLETED|Overall Study||14
948519|NCT00066365|2291520|P1|NOT COMPLETED|Overall Study||23
948520|NCT00066365|2291519|P2|COMPLETED|Overall Study||4
948521|NCT00066365|2291520|P1|COMPLETED|Overall Study||8
948522|NCT00066365|2291519|P2|STARTED|Overall Study||18
948523|NCT00066365|2291520|P1|STARTED|Overall Study||31
948524|NCT00066469|2291548|P1|NOT COMPLETED|Overall Study||16
948525|NCT00066469|2291548|P1|COMPLETED|Overall Study||39
948526|NCT00066469|2291548|P1|STARTED|Overall Study||55
948533|NCT00066690|2291564|P3|NOT COMPLETED|Overall Study||564
948534|NCT00066690|2291565|P2|NOT COMPLETED|Overall Study||522
948535|NCT00066690|2291566|P1|NOT COMPLETED|Overall Study||598
948536|NCT00066690|2291564|P3|COMPLETED|Overall Study||457
948537|NCT00066690|2291565|P2|COMPLETED|Overall Study||502
948538|NCT00066690|2291566|P1|COMPLETED|Overall Study||423
948539|NCT00066690|2291564|P3|STARTED|Overall Study||1021
948540|NCT00066690|2291565|P2|STARTED|Overall Study||1024
948541|NCT00066690|2291566|P1|STARTED|Overall Study||1021
948542|NCT00066703|2291582|P2|NOT COMPLETED|Overall Study||582
948543|NCT00066703|2291583|P1|NOT COMPLETED|Overall Study||612
948544|NCT00066703|2291582|P2|COMPLETED|Overall Study||756
948545|NCT00066703|2291583|P1|COMPLETED|Overall Study||722
948546|NCT00066703|2291582|P2|STARTED|Overall Study||1338
948547|NCT00066703|2291583|P1|STARTED|Overall Study||1334
948548|NCT00066742|2291593|P1|NOT COMPLETED|Consolidation Chemotherapy||3
948549|NCT00066742|2291593|P1|COMPLETED|Consolidation Chemotherapy||39
948550|NCT00066742|2291593|P1|Eligible|Consolidation Chemotherapy||40
948551|NCT00066742|2291593|P1|STARTED|Consolidation Chemotherapy||42
948552|NCT00066742|2291593|P1|NOT COMPLETED|Induction Chemoradiotherapy||29
948553|NCT00066742|2291593|P1|COMPLETED|Induction Chemoradiotherapy||43
948554|NCT00066742|2291593|P1|Began Protocol Treatment|Induction Chemoradiotherapy||68
948555|NCT00066742|2291593|P1|Eligible|Induction Chemoradiotherapy||69
948556|NCT00066742|2291593|P1|STARTED|Induction Chemoradiotherapy||72
948557|NCT00066781|2291602|P2|NOT COMPLETED|Overall Study||0
948558|NCT00066781|2291603|P1|NOT COMPLETED|Overall Study||0
948559|NCT00066781|2291602|P2|COMPLETED|Overall Study||17
948560|NCT00066781|2291603|P1|COMPLETED|Overall Study||14
948561|NCT00066781|2291602|P2|STARTED|Overall Study||17
948562|NCT00066781|2291603|P1|STARTED|Overall Study||14
948563|NCT00066807|2291615|P2|NOT COMPLETED|Overall Study||15
948564|NCT00066807|2291616|P1|NOT COMPLETED|Overall Study||14
948565|NCT00066807|2291615|P2|COMPLETED|Overall Study||0
948566|NCT00066807|2291616|P1|COMPLETED|Overall Study||0
948567|NCT00066807|2291615|P2|STARTED|Overall Study||15
948568|NCT00066807|2291616|P1|STARTED|Overall Study||14
948569|NCT00066937|2291632|P4|NOT COMPLETED|6 Month Follow-up||1
948570|NCT00066937|2291633|P3|NOT COMPLETED|6 Month Follow-up||3
948571|NCT00066937|2291634|P2|NOT COMPLETED|6 Month Follow-up||3
948572|NCT00066937|2291635|P1|NOT COMPLETED|6 Month Follow-up||7
948573|NCT00066937|2291632|P4|COMPLETED|6 Month Follow-up||14
948574|NCT00066937|2291633|P3|COMPLETED|6 Month Follow-up||22
948575|NCT00066937|2291634|P2|COMPLETED|6 Month Follow-up||29
948576|NCT00066937|2291635|P1|COMPLETED|6 Month Follow-up||26
948577|NCT00066937|2291632|P4|STARTED|6 Month Follow-up||15
948578|NCT00066937|2291633|P3|STARTED|6 Month Follow-up||25
948579|NCT00066937|2291634|P2|STARTED|6 Month Follow-up||32
948580|NCT00066937|2291635|P1|STARTED|6 Month Follow-up||33
948581|NCT00066937|2291632|P4|NOT COMPLETED|3 Month Follow-up||4
948582|NCT00066937|2291633|P3|NOT COMPLETED|3 Month Follow-up||1
948583|NCT00066937|2291634|P2|NOT COMPLETED|3 Month Follow-up||1
948584|NCT00066937|2291635|P1|NOT COMPLETED|3 Month Follow-up||5
948585|NCT00066937|2291632|P4|COMPLETED|3 Month Follow-up||15
948586|NCT00066937|2291633|P3|COMPLETED|3 Month Follow-up||25
948587|NCT00066937|2291634|P2|COMPLETED|3 Month Follow-up||32
948588|NCT00066937|2291635|P1|COMPLETED|3 Month Follow-up||33
948589|NCT00066937|2291632|P4|STARTED|3 Month Follow-up||19
948590|NCT00066937|2291633|P3|STARTED|3 Month Follow-up||26
948591|NCT00066937|2291634|P2|STARTED|3 Month Follow-up||33
948592|NCT00066937|2291635|P1|STARTED|3 Month Follow-up||38
948593|NCT00066937|2291632|P4|NOT COMPLETED|Treatment Phase||5
948594|NCT00066937|2291633|P3|NOT COMPLETED|Treatment Phase||11
948595|NCT00066937|2291634|P2|NOT COMPLETED|Treatment Phase||5
948596|NCT00066937|2291635|P1|NOT COMPLETED|Treatment Phase||3
948597|NCT00066937|2291632|P4|COMPLETED|Treatment Phase||19
948598|NCT00066937|2291633|P3|COMPLETED|Treatment Phase||26
948599|NCT00066937|2291634|P2|COMPLETED|Treatment Phase||33
948600|NCT00066937|2291635|P1|COMPLETED|Treatment Phase||38
948601|NCT00066937|2291632|P4|STARTED|Treatment Phase||24
948602|NCT00066937|2291633|P3|STARTED|Treatment Phase||37
948603|NCT00066937|2291634|P2|STARTED|Treatment Phase||38
948604|NCT00066937|2291635|P1|STARTED|Treatment Phase||41
948605|NCT00066963|2291660|P3|NOT COMPLETED|Overall Study||39
948606|NCT00066963|2291661|P2|NOT COMPLETED|Overall Study||31
948607|NCT00066963|2291662|P1|NOT COMPLETED|Overall Study||26
948608|NCT00066963|2291660|P3|COMPLETED|Overall Study||87
948609|NCT00066963|2291661|P2|COMPLETED|Overall Study||93
948610|NCT00066963|2291662|P1|COMPLETED|Overall Study|any follow-up|100
948611|NCT00066963|2291660|P3|STARTED|Overall Study||126
948612|NCT00066963|2291661|P2|STARTED|Overall Study||124
948613|NCT00066963|2291662|P1|STARTED|Overall Study||126
948614|NCT00067236|2291672|P2|NOT COMPLETED|Overall Study||26
948615|NCT00067236|2291673|P1|NOT COMPLETED|Overall Study||20
948616|NCT00067236|2291672|P2|COMPLETED|Overall Study||99
948617|NCT00067236|2291673|P1|COMPLETED|Overall Study||108
948618|NCT00067236|2291672|P2|STARTED|Overall Study||125
948619|NCT00067236|2291673|P1|STARTED|Overall Study||128
948620|NCT00067470|2291681|P2|NOT COMPLETED|Overall Study||1
948621|NCT00067470|2291682|P1|NOT COMPLETED|Overall Study||0
948622|NCT00067470|2291681|P2|COMPLETED|Overall Study||19
948623|NCT00067470|2291682|P1|COMPLETED|Overall Study||19
948624|NCT00067470|2291681|P2|STARTED|Overall Study||20
948625|NCT00067470|2291682|P1|STARTED|Overall Study||19
948626|NCT00053846|2291694|P2|NOT COMPLETED|Overall Study||27
948627|NCT00053846|2291695|P1|NOT COMPLETED|Overall Study||26
948628|NCT00053846|2291694|P2|COMPLETED|Overall Study||192
948629|NCT00053846|2291695|P1|COMPLETED|Overall Study||187
948630|NCT00053846|2291694|P2|STARTED|Overall Study||219
948631|NCT00053846|2291695|P1|STARTED|Overall Study||213
948632|NCT00054028|2291703|P1|NOT COMPLETED|Overall Study||0
948633|NCT00054028|2291703|P1|COMPLETED|Overall Study||31
948634|NCT00054028|2291703|P1|Phase II|Overall Study||22
948635|NCT00054028|2291703|P1|Phase I|Overall Study||9
948636|NCT00054028|2291703|P1|STARTED|Overall Study||31
948637|NCT00054132|2291709|P1|NOT COMPLETED|Overall Study||1
948638|NCT00054132|2291709|P1|COMPLETED|Overall Study||37
948639|NCT00054132|2291709|P1|STARTED|Overall Study||38
948640|NCT00054275|2291718|P1|NOT COMPLETED|Overall Study||11
948641|NCT00054275|2291718|P1|COMPLETED|Overall Study||28
948642|NCT00054275|2291718|P1|STARTED|Overall Study||39
948643|NCT00054327|2291730|P6|NOT COMPLETED|Overall Study||0
948644|NCT00054327|2291731|P5|NOT COMPLETED|Overall Study||0
948645|NCT00054327|2291732|P4|NOT COMPLETED|Overall Study||0
948646|NCT00054327|2291733|P3|NOT COMPLETED|Overall Study||0
948647|NCT00054327|2291734|P2|NOT COMPLETED|Overall Study||0
948648|NCT00054327|2291735|P1|NOT COMPLETED|Overall Study||1
948649|NCT00054327|2291730|P6|COMPLETED|Overall Study||2
948650|NCT00054327|2291731|P5|COMPLETED|Overall Study||10
948651|NCT00054327|2291732|P4|COMPLETED|Overall Study||4
948652|NCT00054327|2291733|P3|COMPLETED|Overall Study||3
948653|NCT00054327|2291734|P2|COMPLETED|Overall Study||4
948654|NCT00054327|2291735|P1|COMPLETED|Overall Study||10
948655|NCT00054327|2291730|P6|STARTED|Overall Study||2
948656|NCT00054327|2291731|P5|STARTED|Overall Study||10
948657|NCT00054327|2291732|P4|STARTED|Overall Study||4
948658|NCT00054327|2291733|P3|STARTED|Overall Study||3
948659|NCT00054327|2291734|P2|STARTED|Overall Study||4
948660|NCT00054327|2291735|P1|STARTED|Overall Study||11
948661|NCT00054639|2291773|P1|NOT COMPLETED|Overall Study||2
948662|NCT00054639|2291773|P1|COMPLETED|Overall Study||46
948663|NCT00054639|2291773|P1|STARTED|Overall Study||48
948664|NCT00054665|2291777|P2|NOT COMPLETED|Part B||0
948665|NCT00054665|2291778|P1|NOT COMPLETED|Part B||0
948666|NCT00054665|2291777|P2|COMPLETED|Part B||44
948667|NCT00054665|2291778|P1|COMPLETED|Part B||0
948668|NCT00054665|2291777|P2|STARTED|Part B|26 participants received only Part B|44
948669|NCT00054665|2291778|P1|STARTED|Part B||0
948670|NCT00054665|2291777|P2|NOT COMPLETED|Part A||0
948671|NCT00054665|2291778|P1|NOT COMPLETED|Part A||0
948672|NCT00054665|2291777|P2|COMPLETED|Part A||0
948673|NCT00054665|2291778|P1|COMPLETED|Part A||23
948674|NCT00054665|2291777|P2|STARTED|Part A||0
948675|NCT00054665|2291778|P1|STARTED|Part A|5 participants only received Part A and 18 participants received Part B after Part A.|23
948676|NCT00054691|2291786|P1|NOT COMPLETED|Overall Study||3
948677|NCT00054691|2291786|P1|COMPLETED|Overall Study||37
948678|NCT00054691|2291786|P1|STARTED|Overall Study||40
948679|NCT00054704|2291793|P2|NOT COMPLETED|Overall Study||5
948680|NCT00054704|2291794|P1|NOT COMPLETED|Overall Study||5
948681|NCT00054704|2291793|P2|COMPLETED|Overall Study||6
948682|NCT00054704|2291794|P1|COMPLETED|Overall Study||4
948683|NCT00054704|2291793|P2|STARTED|Overall Study||11
948684|NCT00054704|2291794|P1|STARTED|Overall Study||9
948685|NCT00054717|2291802|P2|NOT COMPLETED|Overall Study||299
948686|NCT00054717|2291803|P1|NOT COMPLETED|Overall Study||262
948687|NCT00054717|2291802|P2|COMPLETED|Overall Study||18
948688|NCT00054717|2291803|P1|COMPLETED|Overall Study||51
948689|NCT00054717|2291802|P2|STARTED|Overall Study||317
948690|NCT00054717|2291803|P1|STARTED|Overall Study||313
948691|NCT00054847|2291991|P2|NOT COMPLETED|Overall Study||100
948692|NCT00054847|2291992|P1|NOT COMPLETED|Overall Study||98
948693|NCT00054847|2291991|P2|COMPLETED|Overall Study||266
948694|NCT00054847|2291992|P1|COMPLETED|Overall Study||269
948695|NCT00054847|2291991|P2|STARTED|Overall Study||366
948696|NCT00054847|2291992|P1|STARTED|Overall Study||367
948697|NCT00061373|2292006|P2|NOT COMPLETED|Overall Study||0
948698|NCT00061373|2292007|P1|NOT COMPLETED|Overall Study||0
948699|NCT00061373|2292006|P2|COMPLETED|Overall Study||3
948700|NCT00061373|2292007|P1|COMPLETED|Overall Study||15
948701|NCT00061373|2292006|P2|Aspirin and Tinzaparin|Overall Study||3
948702|NCT00061373|2292007|P1|Aspirin and Tinzaparin|Overall Study||15
948703|NCT00061373|2292006|P2|STARTED|Overall Study||3
948704|NCT00061373|2292007|P1|STARTED|Overall Study||15
948705|NCT00067808|2292026|P3|NOT COMPLETED|Overall Study||0
948706|NCT00067808|2292027|P2|NOT COMPLETED|Overall Study||0
948707|NCT00067808|2292028|P1|NOT COMPLETED|Overall Study||0
948708|NCT00067808|2292026|P3|COMPLETED|Overall Study||14
948709|NCT00067808|2292027|P2|COMPLETED|Overall Study||93
948710|NCT00067808|2292028|P1|COMPLETED|Overall Study||17
948711|NCT00067808|2292026|P3|STARTED|Overall Study||14
948712|NCT00067808|2292027|P2|STARTED|Overall Study||93
948713|NCT00067808|2292028|P1|STARTED|Overall Study||17
948714|NCT00069641|2292039|P3|NOT COMPLETED|Overall Study||1
948715|NCT00069641|2292040|P2|NOT COMPLETED|Overall Study||0
948716|NCT00069641|2292041|P1|NOT COMPLETED|Overall Study||1
948717|NCT00069641|2292039|P3|COMPLETED|Overall Study||31
948718|NCT00069641|2292040|P2|COMPLETED|Overall Study||32
948719|NCT00069641|2292041|P1|COMPLETED|Overall Study||31
948720|NCT00069641|2292039|P3|STARTED|Overall Study||32
948721|NCT00069641|2292040|P2|STARTED|Overall Study||32
948722|NCT00069641|2292041|P1|STARTED|Overall Study||32
948723|NCT00069784|2292068|P2|NOT COMPLETED|Overall Study||0
948724|NCT00069784|2292069|P1|NOT COMPLETED|Overall Study||1212
948725|NCT00069784|2292068|P2|COMPLETED|Overall Study|not applicable (no treatment)|6273
948726|NCT00069784|2292069|P1|COMPLETED|Overall Study|completed study treatment|5052
948727|NCT00069784|2292068|P2|Safety Population (Treated)|Overall Study|patients randomized to standard care arm|6273
948728|NCT00069784|2292069|P1|Safety Population (Treated)|Overall Study|randomized patients who received at least one dose of insulin glargine|6231
948729|NCT00069784|2292068|P2|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6273
948730|NCT00069784|2292069|P1|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6264
948731|NCT00069823|2292089|P2|NOT COMPLETED|Overall Study||3
948732|NCT00069823|2292090|P1|NOT COMPLETED|Overall Study||6
948733|NCT00069823|2292089|P2|COMPLETED|Overall Study||200
948734|NCT00069823|2292090|P1|COMPLETED|Overall Study||193
948735|NCT00069823|2292089|P2|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|203
948736|NCT00069823|2292090|P1|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|199
948737|NCT00069953|2292130|P1|NOT COMPLETED|Overall Study||2
948738|NCT00069953|2292130|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study|41
948739|NCT00069953|2292130|P1|STARTED|Overall Study||43
948740|NCT00070018|2292134|P1|NOT COMPLETED|Overall Study||4
948741|NCT00070018|2292134|P1|COMPLETED|Overall Study||42
948742|NCT00070018|2292134|P1|Eligible and Began Protocol Therapy|Overall Study||46
948743|NCT00070018|2292134|P1|Eligible|Overall Study||46
948744|NCT00070018|2292134|P1|STARTED|Overall Study||46
948745|NCT00070109|2292143|P5|NOT COMPLETED|Overall Study||8
948746|NCT00070109|2292144|P4|NOT COMPLETED|Overall Study||20
948747|NCT00070109|2292145|P3|NOT COMPLETED|Overall Study||8
948748|NCT00070109|2292146|P2|NOT COMPLETED|Overall Study||6
948749|NCT00070109|2292147|P1|NOT COMPLETED|Overall Study||8
948750|NCT00070109|2292143|P5|COMPLETED|Overall Study||0
948751|NCT00070109|2292144|P4|COMPLETED|Overall Study||0
948752|NCT00070109|2292145|P3|COMPLETED|Overall Study||0
948753|NCT00070109|2292146|P2|COMPLETED|Overall Study||0
948754|NCT00070109|2292147|P1|COMPLETED|Overall Study||0
948755|NCT00070109|2292143|P5|STARTED|Overall Study||8
948756|NCT00070109|2292144|P4|STARTED|Overall Study||20
948757|NCT00070109|2292145|P3|STARTED|Overall Study||8
948758|NCT00070109|2292146|P2|STARTED|Overall Study||6
948759|NCT00070109|2292147|P1|STARTED|Overall Study||8
948760|NCT00070135|2292160|P1|NOT COMPLETED|Overall Study||0
948761|NCT00070135|2292160|P1|COMPLETED|Overall Study||114
948762|NCT00070135|2292160|P1|STARTED|Overall Study||114
948763|NCT00070291|2292166|P1|NOT COMPLETED|Step 2||1
948764|NCT00070291|2292166|P1|COMPLETED|Step 2||0
948765|NCT00070291|2292166|P1|STARTED|Step 2|One patient completed step 1, but opted to get alternative therapy. One patient entered step 2.|1
948766|NCT00070291|2292166|P1|NOT COMPLETED|Step 1||2
948767|NCT00070291|2292166|P1|COMPLETED|Step 1||2
948768|NCT00070291|2292166|P1|Treated|Step 1||3
948769|NCT00070291|2292166|P1|STARTED|Step 1||4
948770|NCT00070317|2292171|P1|NOT COMPLETED|Overall Study||13
948771|NCT00070317|2292171|P1|COMPLETED|Overall Study||89
948772|NCT00070317|2292171|P1|STARTED|Overall Study||102
948793|NCT00070564|2292213|P6|NOT COMPLETED|Overall Study||52
948794|NCT00070564|2292214|P5|NOT COMPLETED|Overall Study||79
948795|NCT00070564|2292215|P4|NOT COMPLETED|Overall Study||167
948796|NCT00070564|2292216|P3|NOT COMPLETED|Overall Study||171
948797|NCT00070564|2292217|P2|NOT COMPLETED|Overall Study||203
948798|NCT00070564|2292218|P1|NOT COMPLETED|Overall Study||200
948799|NCT00070564|2292213|P6|COMPLETED|Overall Study||244
948800|NCT00070564|2292214|P5|COMPLETED|Overall Study||203
948801|NCT00070564|2292215|P4|COMPLETED|Overall Study||481
948802|NCT00070564|2292216|P3|COMPLETED|Overall Study||526
948803|NCT00070564|2292217|P2|COMPLETED|Overall Study||490
948804|NCT00070564|2292218|P1|COMPLETED|Overall Study||478
948805|NCT00070564|2292213|P6|STARTED|Overall Study||296
948806|NCT00070564|2292214|P5|STARTED|Overall Study||282
948807|NCT00070564|2292215|P4|STARTED|Overall Study||648
948808|NCT00070564|2292216|P3|STARTED|Overall Study||697
948809|NCT00070564|2292217|P2|STARTED|Overall Study||693
948810|NCT00070564|2292218|P1|STARTED|Overall Study||678
948811|NCT00070941|2292263|P3|NOT COMPLETED|Overall Study||4
948812|NCT00070941|2292264|P2|NOT COMPLETED|Overall Study||8
948813|NCT00070941|2292265|P1|NOT COMPLETED|Overall Study||10
948814|NCT00070941|2292263|P3|COMPLETED|Overall Study||2
948815|NCT00070941|2292264|P2|COMPLETED|Overall Study||3
948816|NCT00070941|2292265|P1|COMPLETED|Overall Study||2
948817|NCT00070941|2292263|P3|STARTED|Overall Study||6
948818|NCT00070941|2292264|P2|STARTED|Overall Study||11
948819|NCT00070941|2292265|P1|STARTED|Overall Study||12
948820|NCT00071006|2292273|P1|NOT COMPLETED|Overall Study||12
948821|NCT00071006|2292273|P1|COMPLETED|Overall Study||0
948822|NCT00071006|2292273|P1|STARTED|Overall Study||12
948823|NCT00071032|2292285|P2|NOT COMPLETED|Overall Study||8
948824|NCT00071032|2292286|P1|NOT COMPLETED|Overall Study||9
948825|NCT00071032|2292285|P2|COMPLETED|Overall Study||1001
948826|NCT00071032|2292286|P1|COMPLETED|Overall Study||998
948827|NCT00071032|2292285|P2|STARTED|Overall Study||1009
948828|NCT00071032|2292286|P1|STARTED|Overall Study||1007
948829|NCT00071058|2292294|P1|NOT COMPLETED|Overall Study||1
948830|NCT00071058|2292294|P1|COMPLETED|Overall Study||49
948831|NCT00071058|2292294|P1|STARTED|Overall Study||50
948832|NCT00071110|2292301|P2|NOT COMPLETED|Overall Study||4
948833|NCT00071110|2292302|P1|NOT COMPLETED|Overall Study||0
948834|NCT00071110|2292301|P2|COMPLETED|Overall Study||25
948835|NCT00071110|2292302|P1|COMPLETED|Overall Study||28
948836|NCT00071110|2292301|P2|STARTED|Overall Study||29
948837|NCT00071110|2292302|P1|STARTED|Overall Study||28
948838|NCT00071396|2292314|P1|NOT COMPLETED|Overall Study||3
948839|NCT00071396|2292314|P1|COMPLETED|Overall Study|Evaluable for response.|41
948840|NCT00071396|2292314|P1|STARTED|Overall Study||44
948841|NCT00071487|2292322|P4|NOT COMPLETED|24-Week Open-Label Extension Period||23
948842|NCT00071487|2292323|P3|NOT COMPLETED|24-Week Open-Label Extension Period||1
948843|NCT00071487|2292324|P2|NOT COMPLETED|24-Week Open-Label Extension Period||0
948844|NCT00071487|2292325|P1|NOT COMPLETED|24-Week Open-Label Extension Period||0
948845|NCT00071487|2292322|P4|COMPLETED|24-Week Open-Label Extension Period||279
948846|NCT00071487|2292323|P3|COMPLETED|24-Week Open-Label Extension Period||23
948847|NCT00071487|2292324|P2|COMPLETED|24-Week Open-Label Extension Period||19
948848|NCT00071487|2292325|P1|COMPLETED|24-Week Open-Label Extension Period||0
948849|NCT00071487|2292322|P4|STARTED|24-Week Open-Label Extension Period|Of 90: 85 continued with 10 mg/kg; 5 elected not to continue in the open-label extension period.|302
948850|NCT00071487|2292323|P3|STARTED|24-Week Open-Label Extension Period|Of 94: 64 switched to 10 mg/kg; 6 elected not to continue in the open-label extension period.|24
948851|NCT00071487|2292324|P2|STARTED|24-Week Open-Label Extension Period|Of 87: 65 switched to 10 mg/kg; 3 elected not to continue in the open-label extension period.|19
948852|NCT00071487|2292325|P1|STARTED|24-Week Open-Label Extension Period|Of 93: 88 switched to 10 mg/kg; 5 elected not to continue in the open-label extension period.|0
948853|NCT00071487|2292322|P4|NOT COMPLETED|52-Week Double-Blind Period||21
948854|NCT00071487|2292323|P3|NOT COMPLETED|52-Week Double-Blind Period||17
948855|NCT00071487|2292324|P2|NOT COMPLETED|52-Week Double-Blind Period||27
948856|NCT00071487|2292325|P1|NOT COMPLETED|52-Week Double-Blind Period||20
948857|NCT00071487|2292322|P4|COMPLETED|52-Week Double-Blind Period||90
948858|NCT00071487|2292323|P3|COMPLETED|52-Week Double-Blind Period||94
948859|NCT00071487|2292324|P2|COMPLETED|52-Week Double-Blind Period||87
948860|NCT00071487|2292325|P1|COMPLETED|52-Week Double-Blind Period||93
948861|NCT00071487|2292322|P4|STARTED|52-Week Double-Blind Period||111
948862|NCT00071487|2292323|P3|STARTED|52-Week Double-Blind Period||111
948863|NCT00071487|2292324|P2|STARTED|52-Week Double-Blind Period||114
948864|NCT00071487|2292325|P1|STARTED|52-Week Double-Blind Period||113
948865|NCT00071513|2292371|P2|NOT COMPLETED|Follow-up Assessment||6
948866|NCT00071513|2292372|P1|NOT COMPLETED|Follow-up Assessment||6
948867|NCT00071513|2292371|P2|COMPLETED|Follow-up Assessment||247
948868|NCT00071513|2292372|P1|COMPLETED|Follow-up Assessment||233
948869|NCT00071513|2292371|P2|STARTED|Follow-up Assessment||253
948870|NCT00071513|2292372|P1|STARTED|Follow-up Assessment||239
948871|NCT00071513|2292371|P2|NOT COMPLETED|Intervention Component||3
948872|NCT00071513|2292372|P1|NOT COMPLETED|Intervention Component||2
948873|NCT00071513|2292371|P2|COMPLETED|Intervention Component||253
948874|NCT00071513|2292372|P1|COMPLETED|Intervention Component||239
948875|NCT00071513|2292371|P2|STARTED|Intervention Component||256
948876|NCT00071513|2292372|P1|STARTED|Intervention Component||241
948877|NCT00071721|2292382|P2|NOT COMPLETED|Overall Study||91
948878|NCT00071721|2292383|P1|NOT COMPLETED|Overall Study||72
948879|NCT00071721|2292382|P2|COMPLETED|Overall Study||69
948880|NCT00071721|2292383|P1|COMPLETED|Overall Study||81
948881|NCT00071721|2292382|P2|STARTED|Overall Study||160
948882|NCT00071721|2292383|P1|STARTED|Overall Study||153
948883|NCT00071760|2292399|P1|NOT COMPLETED|Overall Study||54
948884|NCT00071760|2292399|P1|COMPLETED|Overall Study||0
948885|NCT00071760|2292399|P1|Ongoing|Overall Study||25
948886|NCT00071760|2292399|P1|STARTED|Overall Study||54
948887|NCT00071799|2292460|P2|NOT COMPLETED|Overall Study||98
948888|NCT00071799|2292461|P1|NOT COMPLETED|Overall Study||70
948889|NCT00071799|2292460|P2|COMPLETED|Overall Study|Includes patients who died or transformed to AML during treatment, or were still receiving drug.|81
948890|NCT00071799|2292461|P1|COMPLETED|Overall Study|Includes those who died or transformed to AML, or receiving drug + eligible for extension period.|109
948891|NCT00071799|2292460|P2|STARTED|Overall Study|Best supportive care: 105, Low-dose cytarabine: 49, Standard chemotherapy: 25 patients|179
948892|NCT00071799|2292461|P1|STARTED|Overall Study||179
948893|NCT00071812|2292505|P4|NOT COMPLETED|24-Week Open-Label Extension Period||40
948894|NCT00071812|2292506|P3|NOT COMPLETED|24-Week Open-Label Extension Period||1
948895|NCT00071812|2292507|P2|NOT COMPLETED|24-Week Open-Label Extension Period||0
948896|NCT00071812|2292508|P1|NOT COMPLETED|24-Week Open-Label Extension Period||0
948897|NCT00071812|2292505|P4|COMPLETED|24-Week Open-Label Extension Period||178
948898|NCT00071812|2292506|P3|COMPLETED|24-Week Open-Label Extension Period||7
948899|NCT00071812|2292507|P2|COMPLETED|24-Week Open-Label Extension Period||11
948900|NCT00071812|2292508|P1|COMPLETED|24-Week Open-Label Extension Period||0
948901|NCT00071812|2292505|P4|STARTED|24-Week Open-Label Extension Period|Of 60: 56 continued with 10 mg/kg; 4 elected not to continue in the open-label extension.|218
948902|NCT00071812|2292506|P3|STARTED|24-Week Open-Label Extension Period|Of 63: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|8
948903|NCT00071812|2292507|P2|STARTED|24-Week Open-Label Extension Period|Of 66: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|11
948904|NCT00071812|2292508|P1|STARTED|24-Week Open-Label Extension Period|Of 59: 56 switched to 10 mg/kg; 3 elected not to continue in the open-label extension.|0
948905|NCT00071812|2292505|P4|NOT COMPLETED|24-Week Double-Blind Period||11
948906|NCT00071812|2292506|P3|NOT COMPLETED|24-Week Double-Blind Period||8
948907|NCT00071812|2292507|P2|NOT COMPLETED|24-Week Double-Blind Period||6
948908|NCT00071812|2292508|P1|NOT COMPLETED|24-Week Double-Blind Period||10
948909|NCT00071812|2292505|P4|COMPLETED|24-Week Double-Blind Period||60
948910|NCT00071812|2292506|P3|COMPLETED|24-Week Double-Blind Period||63
948911|NCT00071812|2292507|P2|COMPLETED|24-Week Double-Blind Period||66
948912|NCT00071812|2292508|P1|COMPLETED|24-Week Double-Blind Period||59
948913|NCT00071812|2292505|P4|STARTED|24-Week Double-Blind Period||71
948914|NCT00071812|2292506|P3|STARTED|24-Week Double-Blind Period||71
948915|NCT00071812|2292507|P2|STARTED|24-Week Double-Blind Period||72
948916|NCT00071812|2292508|P1|STARTED|24-Week Double-Blind Period||69
948917|NCT00071890|2292550|P2|NOT COMPLETED|Overall Study||0
948918|NCT00071890|2292551|P1|NOT COMPLETED|Overall Study||0
948919|NCT00071890|2292550|P2|COMPLETED|Overall Study|"1 withdrawal
1 lost of follow-up
1 death 67 patients analysed"|67
948920|NCT00071890|2292551|P1|COMPLETED|Overall Study|"1 withdrawal
1 death 81 patients analysed"|81
948921|NCT00071890|2292550|P2|STARTED|Overall Study|1 patients stopped HAART at week 0|67
948922|NCT00071890|2292551|P1|STARTED|Overall Study|3 patients did not received Interleukin-2|81
948923|NCT00071981|2292565|P4|NOT COMPLETED|Overall Study||45
948924|NCT00071981|2292566|P3|NOT COMPLETED|Overall Study||37
948925|NCT00071981|2292567|P2|NOT COMPLETED|Overall Study||41
948926|NCT00071981|2292568|P1|NOT COMPLETED|Overall Study||46
948927|NCT00071981|2292565|P4|COMPLETED|Overall Study||3
948928|NCT00071981|2292566|P3|COMPLETED|Overall Study||0
948929|NCT00071981|2292567|P2|COMPLETED|Overall Study||2
948930|NCT00071981|2292568|P1|COMPLETED|Overall Study||1
948931|NCT00071981|2292565|P4|Have Helper T Cell Response Data|Overall Study||39
948932|NCT00071981|2292566|P3|Have Helper T Cell Response Data|Overall Study||25
948933|NCT00071981|2292567|P2|Have Helper T Cell Response Data|Overall Study||27
948934|NCT00071981|2292568|P1|Have Helper T Cell Response Data|Overall Study||37
948935|NCT00071981|2292565|P4|Have CTL Response Data|Overall Study||41
948936|NCT00071981|2292566|P3|Have CTL Response Data|Overall Study||29
948937|NCT00071981|2292567|P2|Have CTL Response Data|Overall Study||30
948938|NCT00071981|2292568|P1|Have CTL Response Data|Overall Study||40
948939|NCT00071981|2292565|P4|Eligible and Treated|Overall Study||42
948940|NCT00071981|2292566|P3|Eligible and Treated|Overall Study||32
948941|NCT00071981|2292567|P2|Eligible and Treated|Overall Study||33
948942|NCT00071981|2292568|P1|Eligible and Treated|Overall Study||41
948943|NCT00071981|2292565|P4|Treated|Overall Study||48
948944|NCT00071981|2292566|P3|Treated|Overall Study||36
948945|NCT00071981|2292567|P2|Treated|Overall Study||38
948946|NCT00071981|2292568|P1|Treated|Overall Study||45
948947|NCT00071981|2292565|P4|Eligible|Overall Study||42
948948|NCT00071981|2292566|P3|Eligible|Overall Study||33
948949|NCT00071981|2292567|P2|Eligible|Overall Study||36
948950|NCT00071981|2292568|P1|Eligible|Overall Study||43
948951|NCT00071981|2292565|P4|STARTED|Overall Study||48
948952|NCT00071981|2292566|P3|STARTED|Overall Study||37
948953|NCT00071981|2292567|P2|STARTED|Overall Study||43
948954|NCT00071981|2292568|P1|STARTED|Overall Study||47
948955|NCT00072176|2292596|P2|NOT COMPLETED|Overall Study||1
948956|NCT00072176|2292597|P1|NOT COMPLETED|Overall Study||1
948957|NCT00072176|2292596|P2|COMPLETED|Overall Study||27
948958|NCT00072176|2292597|P1|COMPLETED|Overall Study||33
948959|NCT00072176|2292596|P2|STARTED|Overall Study||28
948960|NCT00072176|2292597|P1|STARTED|Overall Study||34
948961|NCT00072189|2292605|P1|NOT COMPLETED|Overall Study||1
948962|NCT00072189|2292605|P1|COMPLETED|Overall Study||16
948963|NCT00072189|2292605|P1|STARTED|Overall Study||17
948964|NCT00064662|2292613|P2|NOT COMPLETED|Overall Study||61
948965|NCT00064662|2292614|P1|NOT COMPLETED|Overall Study||74
948966|NCT00064662|2292613|P2|COMPLETED|Overall Study||265
948967|NCT00064662|2292614|P1|COMPLETED|Overall Study||255
948968|NCT00064662|2292613|P2|STARTED|Overall Study||326
948969|NCT00064662|2292614|P1|STARTED|Overall Study||329
948970|NCT00064701|2292625|P3|NOT COMPLETED|Clinical Continuation Phase||140
948971|NCT00064701|2292626|P2|NOT COMPLETED|Clinical Continuation Phase||178
948972|NCT00064701|2292627|P1|NOT COMPLETED|Clinical Continuation Phase||170
948973|NCT00064701|2292625|P3|COMPLETED|Clinical Continuation Phase||11
948974|NCT00064701|2292626|P2|COMPLETED|Clinical Continuation Phase||4
948975|NCT00064701|2292627|P1|COMPLETED|Clinical Continuation Phase||9
948976|NCT00064701|2292625|P3|STARTED|Clinical Continuation Phase||151
948977|NCT00064701|2292626|P2|STARTED|Clinical Continuation Phase|One participant did not enter the Clinical Continuation phase|182
948978|NCT00064701|2292627|P1|STARTED|Clinical Continuation Phase||179
948979|NCT00064701|2292625|P3|NOT COMPLETED|One Year Post-transplant||72
948980|NCT00064701|2292626|P2|NOT COMPLETED|One Year Post-transplant||43
948981|NCT00064701|2292627|P1|NOT COMPLETED|One Year Post-transplant||40
948982|NCT00064701|2292625|P3|COMPLETED|One Year Post-transplant||151
948983|NCT00064701|2292626|P2|COMPLETED|One Year Post-transplant||183
948984|NCT00064701|2292627|P1|COMPLETED|One Year Post-transplant||179
948985|NCT00064701|2292625|P3|Received Study Drug|One Year Post-transplant||212
948986|NCT00064701|2292626|P2|Received Study Drug|One Year Post-transplant||214
948987|NCT00064701|2292627|P1|Received Study Drug|One Year Post-transplant||212
948988|NCT00064701|2292625|P3|STARTED|One Year Post-transplant||223
948989|NCT00064701|2292626|P2|STARTED|One Year Post-transplant||226
948990|NCT00064701|2292627|P1|STARTED|One Year Post-transplant||219
948997|NCT00064792|2292710|P2|NOT COMPLETED|Overall Study||0
948998|NCT00064792|2292711|P1|NOT COMPLETED|Overall Study||5
948999|NCT00064792|2292710|P2|COMPLETED|Overall Study||10
949000|NCT00064792|2292711|P1|COMPLETED|Overall Study||8
949001|NCT00064792|2292710|P2|STARTED|Overall Study||10
949002|NCT00064792|2292711|P1|STARTED|Overall Study||13
949003|NCT00064844|2292721|P2|NOT COMPLETED|Overall Study||19
949004|NCT00064844|2292722|P1|NOT COMPLETED|Overall Study||8
949005|NCT00064844|2292721|P2|COMPLETED|Overall Study||32
949006|NCT00064844|2292722|P1|COMPLETED|Overall Study||37
949007|NCT00064844|2292721|P2|12 Month Follow-up|Overall Study||32
949008|NCT00064844|2292722|P1|12 Month Follow-up|Overall Study||37
949009|NCT00064844|2292721|P2|6 Month Follow-up|Overall Study||40
949010|NCT00064844|2292722|P1|6 Month Follow-up|Overall Study||39
949011|NCT00064844|2292721|P2|3 Month Follow-up|Overall Study||47
949012|NCT00064844|2292722|P1|3 Month Follow-up|Overall Study||40
949013|NCT00064844|2292721|P2|2 Week Follow-up|Overall Study||51
949014|NCT00064844|2292722|P1|2 Week Follow-up|Overall Study||45
949015|NCT00064844|2292721|P2|STARTED|Overall Study||51
949016|NCT00064844|2292722|P1|STARTED|Overall Study||45
949017|NCT00072280|2292732|P2|NOT COMPLETED|Follow-up||2
949018|NCT00072280|2292733|P1|NOT COMPLETED|Follow-up||2
949019|NCT00072280|2292732|P2|COMPLETED|Follow-up||0
949020|NCT00072280|2292733|P1|COMPLETED|Follow-up||0
949021|NCT00072280|2292732|P2|STARTED|Follow-up||2
949022|NCT00072280|2292733|P1|STARTED|Follow-up||2
949023|NCT00072280|2292732|P2|NOT COMPLETED|Treatment||2
949024|NCT00072280|2292733|P1|NOT COMPLETED|Treatment||1
949025|NCT00072280|2292732|P2|COMPLETED|Treatment||2
949026|NCT00072280|2292733|P1|COMPLETED|Treatment||2
949027|NCT00072280|2292732|P2|STARTED|Treatment||4
949028|NCT00072280|2292733|P1|STARTED|Treatment||3
949029|NCT00072293|2292740|P2|NOT COMPLETED|Overall Study||2
949030|NCT00072293|2292741|P1|NOT COMPLETED|Overall Study||1
949031|NCT00072293|2292740|P2|COMPLETED|Overall Study||467
949032|NCT00072293|2292741|P1|COMPLETED|Overall Study||464
949033|NCT00072293|2292740|P2|STARTED|Overall Study||469
949034|NCT00072293|2292741|P1|STARTED|Overall Study||465
949035|NCT00072449|2292751|P1|NOT COMPLETED|Overall Study||0
949036|NCT00072449|2292751|P1|COMPLETED|Overall Study||12
949037|NCT00072449|2292751|P1|STARTED|Overall Study||12
949038|NCT00072475|2292758|P1|NOT COMPLETED|Overall Study||97
949039|NCT00072475|2292758|P1|COMPLETED|Overall Study||45
949040|NCT00072475|2292758|P1|STARTED|Overall Study||142
949041|NCT00072514|2292766|P1|NOT COMPLETED|Overall Study||4
949042|NCT00072514|2292766|P1|COMPLETED|Overall Study||51
949043|NCT00072514|2292766|P1|STARTED|Overall Study||55
949044|NCT00072566|2292773|P1|NOT COMPLETED|Overall Study||0
949045|NCT00072566|2292773|P1|COMPLETED|Overall Study||70
949046|NCT00072566|2292773|P1|STARTED|Overall Study||70
949047|NCT00073307|2292781|P3|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||156
949048|NCT00073307|2292782|P2|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
949049|NCT00073307|2292783|P1|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||134
949050|NCT00073307|2292781|P3|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||143
949051|NCT00073307|2292782|P2|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
949052|NCT00073307|2292783|P1|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||120
949053|NCT00073307|2292781|P3|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||216
949054|NCT00073307|2292782|P2|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||0
949055|NCT00073307|2292783|P1|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||219
949056|NCT00073307|2292781|P3|STARTED|Open Label-Sorafenib Only [30Jun2008]||299
949057|NCT00073307|2292782|P2|STARTED|Open Label-Sorafenib Only [30Jun2008]|Placebo treatment ended ~ 31May2005. Those who continued, switched to receive Sorafenib.|0
949058|NCT00073307|2292783|P1|STARTED|Open Label-Sorafenib Only [30Jun2008]||254
949059|NCT00073307|2292781|P3|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||0
949060|NCT00073307|2292782|P2|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||153
949061|NCT00073307|2292783|P1|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||197
949062|NCT00073307|2292781|P3|COMPLETED|Double-Blind (DB, as of ~31May2005)||0
949063|NCT00073307|2292782|P2|COMPLETED|Double-Blind (DB, as of ~31May2005)||299
949064|NCT00073307|2292783|P1|COMPLETED|Double-Blind (DB, as of ~31May2005)||254
949065|NCT00073307|2292781|P3|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||0
949066|NCT00073307|2292782|P2|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
949067|NCT00073307|2292783|P1|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
949068|NCT00073307|2292781|P3|STARTED|Double-Blind (DB, as of ~31May2005)||0
949069|NCT00073307|2292782|P2|STARTED|Double-Blind (DB, as of ~31May2005)||452
949070|NCT00073307|2292783|P1|STARTED|Double-Blind (DB, as of ~31May2005)||451
949071|NCT00073333|2292804|P3|NOT COMPLETED|Overall Study||0
949072|NCT00073333|2292805|P2|NOT COMPLETED|Overall Study||14
949073|NCT00073333|2292806|P1|NOT COMPLETED|Overall Study||14
949074|NCT00073333|2292804|P3|COMPLETED|Overall Study||19
949075|NCT00073333|2292805|P2|COMPLETED|Overall Study||27
949076|NCT00073333|2292806|P1|COMPLETED|Overall Study||32
949077|NCT00073333|2292804|P3|STARTED|Overall Study||19
949078|NCT00073333|2292805|P2|STARTED|Overall Study||41
949079|NCT00073333|2292806|P1|STARTED|Overall Study||46
949080|NCT00073528|2292816|P2|NOT COMPLETED|Overall Study||642
949081|NCT00073528|2292817|P1|NOT COMPLETED|Overall Study||644
949082|NCT00073528|2292816|P2|COMPLETED|Overall Study||0
949083|NCT00073528|2292817|P1|COMPLETED|Overall Study||0
949084|NCT00073528|2292816|P2|Ongoing|Overall Study|These participants are still on study and do not yet have end of study data available.|344
949085|NCT00073528|2292817|P1|Ongoing|Overall Study|These participants are still on study and do not yet have end of study data available.|349
949086|NCT00073528|2292816|P2|STARTED|Overall Study||642
949087|NCT00073528|2292817|P1|STARTED|Overall Study||644
949088|NCT00073918|2292891|P1|NOT COMPLETED|Overall Study||4
949089|NCT00073918|2292891|P1|COMPLETED|Overall Study||107
949090|NCT00073918|2292891|P1|STARTED|Overall Study||111
949091|NCT00073983|2292898|P1|NOT COMPLETED|Overall Study||1
949092|NCT00073983|2292898|P1|COMPLETED|Overall Study|One patient in the chondrosarcoma subtype was not evaluable.|53
949093|NCT00073983|2292898|P1|STARTED|Overall Study||54
949094|NCT00074035|2292913|P1|NOT COMPLETED|Overall Study||0
949095|NCT00074035|2292913|P1|COMPLETED|Overall Study||38
949096|NCT00074035|2292913|P1|STARTED|Overall Study||38
949097|NCT00074152|2292922|P2|NOT COMPLETED|Overall Study||33
949098|NCT00074152|2292923|P1|NOT COMPLETED|Overall Study||55
949099|NCT00074152|2292922|P2|COMPLETED|Overall Study||52
949100|NCT00074152|2292923|P1|COMPLETED|Overall Study||22
949101|NCT00074152|2292922|P2|STARTED|Overall Study||85
949102|NCT00074152|2292923|P1|STARTED|Overall Study||77
949103|NCT00074165|2292933|P1|NOT COMPLETED|Overall Study||0
949104|NCT00074165|2292933|P1|COMPLETED|Overall Study||17
949105|NCT00074165|2292933|P1|STARTED|Overall Study||17
949106|NCT00074269|2292938|P1|NOT COMPLETED|Overall Study||0
949107|NCT00074269|2292938|P1|COMPLETED|Overall Study||5
949108|NCT00074269|2292938|P1|STARTED|Overall Study||5
949109|NCT00074412|2292944|P2|NOT COMPLETED|Overall Study||84
949110|NCT00074412|2292945|P1|NOT COMPLETED|Overall Study||82
949111|NCT00074412|2292944|P2|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|675
949112|NCT00074412|2292945|P1|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|681
949113|NCT00074412|2292944|P2|Month 12 Visit|Overall Study||735
949114|NCT00074412|2292945|P1|Month 12 Visit|Overall Study||733
949115|NCT00074412|2292944|P2|Month 9 Visit|Overall Study||741
949116|NCT00074412|2292945|P1|Month 9 Visit|Overall Study||741
949117|NCT00074412|2292944|P2|Month 6 Visit|Overall Study||748
949118|NCT00074412|2292945|P1|Month 6 Visit|Overall Study||748
949119|NCT00074412|2292944|P2|Month 5 Visit|Overall Study||750
949120|NCT00074412|2292945|P1|Month 5 Visit|Overall Study||756
949121|NCT00074412|2292944|P2|Month 4 Visit|Overall Study||752
949122|NCT00074412|2292945|P1|Month 4 Visit|Overall Study||758
949123|NCT00074412|2292944|P2|Month 3 Visit|Overall Study||755
949124|NCT00074412|2292945|P1|Month 3 Visit|Overall Study||759
949125|NCT00074412|2292944|P2|Week 8 Visit|Overall Study||759
949126|NCT00074412|2292945|P1|Week 8 Visit|Overall Study||759
949127|NCT00074412|2292944|P2|STARTED|Overall Study|Number of infants randomized at 6 weeks.|759
949128|NCT00074412|2292945|P1|STARTED|Overall Study|Number of infants randomized at 6 weeks.|763
949129|NCT00074581|2292961|P2|NOT COMPLETED|Overall Study||226
949130|NCT00074581|2292962|P1|NOT COMPLETED|Overall Study||244
949131|NCT00074581|2292961|P2|COMPLETED|Overall Study||1541
949132|NCT00074581|2292962|P1|COMPLETED|Overall Study||1545
949133|NCT00074581|2292961|P2|STARTED|Overall Study|877 HIV-infected index cases and 890 HIV-uninfected partners|1767
949134|NCT00074581|2292962|P1|STARTED|Overall Study|886 HIV-infected index cases and 903 HIV-uninfected partners|1789
949135|NCT00074711|2292972|P2|NOT COMPLETED|Overall Study||15
949136|NCT00074711|2292973|P1|NOT COMPLETED|Overall Study||15
949137|NCT00074711|2292972|P2|COMPLETED|Overall Study||106
949138|NCT00074711|2292973|P1|COMPLETED|Overall Study||105
949139|NCT00074711|2292972|P2|STARTED|Overall Study||121
949140|NCT00074711|2292973|P1|STARTED|Overall Study||120
949141|NCT00074802|2292991|P2|NOT COMPLETED|Overall Study||7
949142|NCT00074802|2292992|P1|NOT COMPLETED|Overall Study||9
949143|NCT00074802|2292991|P2|COMPLETED|Overall Study||25
949144|NCT00074802|2292992|P1|COMPLETED|Overall Study||20
949145|NCT00074802|2292991|P2|STARTED|Overall Study||32
949146|NCT00074802|2292992|P1|STARTED|Overall Study||29
949147|NCT00074815|2293013|P3|NOT COMPLETED|Overall Study||12
949148|NCT00074815|2293014|P2|NOT COMPLETED|Overall Study||6
949149|NCT00074815|2293015|P1|NOT COMPLETED|Overall Study||5
949150|NCT00074815|2293013|P3|COMPLETED|Overall Study||30
949151|NCT00074815|2293014|P2|COMPLETED|Overall Study||34
949152|NCT00074815|2293015|P1|COMPLETED|Overall Study||37
949153|NCT00074815|2293013|P3|STARTED|Overall Study||42
949154|NCT00074815|2293014|P2|STARTED|Overall Study||40
949155|NCT00074815|2293015|P1|STARTED|Overall Study||42
949156|NCT00074958|2293023|P1|NOT COMPLETED|Overall Study||1
949157|NCT00074958|2293023|P1|COMPLETED|Overall Study||15
949158|NCT00074958|2293023|P1|STARTED|Overall Study||16
949159|NCT00074984|2293030|P2|NOT COMPLETED|Overall Study||8
949160|NCT00074984|2293031|P1|NOT COMPLETED|Overall Study||3
949161|NCT00074984|2293030|P2|COMPLETED|Overall Study||43
949162|NCT00074984|2293031|P1|COMPLETED|Overall Study||28
949163|NCT00074984|2293030|P2|STARTED|Overall Study||51
949164|NCT00074984|2293031|P1|STARTED|Overall Study||31
949165|NCT00075023|2293048|P2|NOT COMPLETED|Part Two||0
949166|NCT00075023|2293049|P1|NOT COMPLETED|Part Two||0
949167|NCT00075023|2293048|P2|COMPLETED|Part Two||0
949168|NCT00075023|2293049|P1|COMPLETED|Part Two||0
949169|NCT00075023|2293048|P2|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
949170|NCT00075023|2293049|P1|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
949171|NCT00075023|2293048|P2|NOT COMPLETED|Pilot Study||2
949172|NCT00075023|2293049|P1|NOT COMPLETED|Pilot Study||2
949173|NCT00075023|2293048|P2|COMPLETED|Pilot Study||3
949174|NCT00075023|2293049|P1|COMPLETED|Pilot Study||3
949175|NCT00075023|2293048|P2|STARTED|Pilot Study||5
949176|NCT00075023|2293049|P1|STARTED|Pilot Study||5
949177|NCT00075088|2293058|P2|NOT COMPLETED|Overall Study||0
949178|NCT00075088|2293059|P1|NOT COMPLETED|Overall Study||0
949179|NCT00075088|2293058|P2|COMPLETED|Overall Study||391
949180|NCT00075088|2293059|P1|COMPLETED|Overall Study||403
949181|NCT00075088|2293058|P2|STARTED|Overall Study||391
949182|NCT00075088|2293059|P1|STARTED|Overall Study||403
949183|NCT00075218|2293072|P3|NOT COMPLETED|Open-Label Treatment||255
949184|NCT00075218|2293073|P2|NOT COMPLETED|Open-Label Treatment||0
949185|NCT00075218|2293074|P1|NOT COMPLETED|Open-Label Treatment||0
949186|NCT00075218|2293072|P3|COMPLETED|Open-Label Treatment||0
949187|NCT00075218|2293073|P2|COMPLETED|Open-Label Treatment||0
949188|NCT00075218|2293074|P1|COMPLETED|Open-Label Treatment||0
949189|NCT00075218|2293072|P3|STARTED|Open-Label Treatment||255
949190|NCT00075218|2293073|P2|STARTED|Open-Label Treatment||0
949191|NCT00075218|2293074|P1|STARTED|Open-Label Treatment||0
949192|NCT00075218|2293072|P3|NOT COMPLETED|Double-Blind Treatment||0
949193|NCT00075218|2293073|P2|NOT COMPLETED|Double-Blind Treatment||15
949194|NCT00075218|2293074|P1|NOT COMPLETED|Double-Blind Treatment||91
949195|NCT00075218|2293072|P3|COMPLETED|Double-Blind Treatment||0
949196|NCT00075218|2293073|P2|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|103
949197|NCT00075218|2293074|P1|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|152
949198|NCT00075218|2293072|P3|Crossed Over to Open-Label Treatment|Double-Blind Treatment||0
949199|NCT00075218|2293073|P2|Crossed Over to Open-Label Treatment|Double-Blind Treatment||103
949200|NCT00075218|2293074|P1|Crossed Over to Open-Label Treatment|Double-Blind Treatment||152
949201|NCT00075218|2293072|P3|Received Double-Blind Treatment|Double-Blind Treatment||0
949202|NCT00075218|2293073|P2|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|114
949203|NCT00075218|2293074|P1|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|228
949204|NCT00075218|2293072|P3|STARTED|Double-Blind Treatment||0
949205|NCT00075218|2293073|P2|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|118
949206|NCT00075218|2293074|P1|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|243
949207|NCT00075270|2293109|P2|NOT COMPLETED|Overall Study||284
949208|NCT00075270|2293110|P1|NOT COMPLETED|Overall Study||286
949209|NCT00075270|2293109|P2|COMPLETED|Overall Study||4
949210|NCT00075270|2293110|P1|COMPLETED|Overall Study||5
949211|NCT00075270|2293109|P2|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|13
949212|NCT00075270|2293110|P1|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|26
949213|NCT00075270|2293109|P2|STARTED|Overall Study||288
949214|NCT00075270|2293110|P1|STARTED|Overall Study||291
949215|NCT00075400|2293154|P1|NOT COMPLETED|Overall Study||3
949216|NCT00075400|2293154|P1|COMPLETED|Overall Study|Eligible and treated patients.|23
949217|NCT00075400|2293154|P1|STARTED|Overall Study||26
949218|NCT00075478|2293162|P2|NOT COMPLETED|Overall Study||1
949219|NCT00075478|2293163|P1|NOT COMPLETED|Overall Study||1
949220|NCT00075478|2293162|P2|COMPLETED|Overall Study||44
949221|NCT00075478|2293163|P1|COMPLETED|Overall Study||41
949222|NCT00075478|2293162|P2|STARTED|Overall Study||45
949223|NCT00075478|2293163|P1|STARTED|Overall Study||42
949224|NCT00075504|2293185|P2|NOT COMPLETED|Overall Study||7
949225|NCT00075504|2293186|P1|NOT COMPLETED|Overall Study||9
949226|NCT00075504|2293185|P2|COMPLETED|Overall Study||3
949227|NCT00075504|2293186|P1|COMPLETED|Overall Study||14
949228|NCT00075504|2293185|P2|STARTED|Overall Study||10
949229|NCT00075504|2293186|P1|STARTED|Overall Study||23
949230|NCT00075582|2293198|P2|NOT COMPLETED|Overall Study||35
949231|NCT00075582|2293199|P1|NOT COMPLETED|Overall Study||50
949232|NCT00075582|2293198|P2|COMPLETED|Overall Study||50
949233|NCT00075582|2293199|P1|COMPLETED|Overall Study||255
949234|NCT00075582|2293198|P2|STARTED|Overall Study||85
949235|NCT00075582|2293199|P1|STARTED|Overall Study||305
949236|NCT00075608|2293207|P1|NOT COMPLETED|Overall Study||0
949237|NCT00075608|2293207|P1|COMPLETED|Overall Study||12
949238|NCT00075608|2293207|P1|STARTED|Overall Study||12
949239|NCT00075725|2293225|P12|NOT COMPLETED|Overall Study||18
949240|NCT00075725|2293226|P11|NOT COMPLETED|Overall Study||9
949241|NCT00075725|2293227|P10|NOT COMPLETED|Overall Study||18
949242|NCT00075725|2293228|P9|NOT COMPLETED|Overall Study||117
949243|NCT00075725|2293229|P8|NOT COMPLETED|Overall Study||295
949244|NCT00075725|2293230|P7|NOT COMPLETED|Overall Study||75
949245|NCT00075725|2293231|P6|NOT COMPLETED|Overall Study||313
949246|NCT00075725|2293232|P5|NOT COMPLETED|Overall Study||66
949247|NCT00075725|2293233|P4|NOT COMPLETED|Overall Study||78
949248|NCT00075725|2293234|P3|NOT COMPLETED|Overall Study||121
949249|NCT00075725|2293235|P2|NOT COMPLETED|Overall Study||49
949250|NCT00075725|2293236|P1|NOT COMPLETED|Overall Study||74
949251|NCT00075725|2293225|P12|COMPLETED|Overall Study||10
949252|NCT00075725|2293226|P11|COMPLETED|Overall Study||3
949253|NCT00075725|2293227|P10|COMPLETED|Overall Study||16
949254|NCT00075725|2293228|P9|COMPLETED|Overall Study||185
949255|NCT00075725|2293229|P8|COMPLETED|Overall Study||401
949256|NCT00075725|2293230|P7|COMPLETED|Overall Study||171
949257|NCT00075725|2293231|P6|COMPLETED|Overall Study||397
949258|NCT00075725|2293232|P5|COMPLETED|Overall Study||166
949259|NCT00075725|2293233|P4|COMPLETED|Overall Study||168
949260|NCT00075725|2293234|P3|COMPLETED|Overall Study||175
949261|NCT00075725|2293235|P2|COMPLETED|Overall Study||57
949262|NCT00075725|2293236|P1|COMPLETED|Overall Study||172
949263|NCT00075725|2293225|P12|STARTED|Overall Study||28
949264|NCT00075725|2293226|P11|STARTED|Overall Study||12
949265|NCT00075725|2293227|P10|STARTED|Overall Study||34
949266|NCT00075725|2293228|P9|STARTED|Overall Study||302
949267|NCT00075725|2293229|P8|STARTED|Overall Study||696
949268|NCT00075725|2293230|P7|STARTED|Overall Study||246
949269|NCT00075725|2293231|P6|STARTED|Overall Study||710
949270|NCT00075725|2293232|P5|STARTED|Overall Study||232
949271|NCT00075725|2293233|P4|STARTED|Overall Study||246
949272|NCT00075725|2293234|P3|STARTED|Overall Study||296
949273|NCT00075725|2293235|P2|STARTED|Overall Study||106
949274|NCT00075725|2293236|P1|STARTED|Overall Study||246
949275|NCT00075764|2293327|P2|NOT COMPLETED|Overall Study||349
949276|NCT00075764|2293328|P1|NOT COMPLETED|Overall Study||345
949277|NCT00075764|2293327|P2|COMPLETED|Overall Study||0
949278|NCT00075764|2293328|P1|COMPLETED|Overall Study||0
949279|NCT00075764|2293327|P2|STARTED|Overall Study||349
949280|NCT00075764|2293328|P1|STARTED|Overall Study||345
949281|NCT00075803|2293342|P2|NOT COMPLETED|Overall Study||0
949282|NCT00075803|2293343|P1|NOT COMPLETED|Overall Study||0
949283|NCT00075803|2293342|P2|COMPLETED|Overall Study||305
949284|NCT00075803|2293343|P1|COMPLETED|Overall Study||295
949285|NCT00075803|2293342|P2|STARTED|Overall Study||305
949286|NCT00075803|2293343|P1|STARTED|Overall Study||295
949287|NCT00075816|2293371|P2|NOT COMPLETED|Overall Study||11
949288|NCT00075816|2293372|P1|NOT COMPLETED|Overall Study||14
949289|NCT00075816|2293371|P2|COMPLETED|Overall Study||262
949290|NCT00075816|2293372|P1|COMPLETED|Overall Study||264
949291|NCT00075816|2293371|P2|STARTED|Overall Study||273
949292|NCT00075816|2293372|P1|STARTED|Overall Study||278
949293|NCT00075829|2293414|P4|NOT COMPLETED|Overall Study||24
949294|NCT00075829|2293415|P3|NOT COMPLETED|Overall Study||34
949295|NCT00075829|2293416|P2|NOT COMPLETED|Overall Study||118
949296|NCT00075829|2293417|P1|NOT COMPLETED|Overall Study||258
949297|NCT00075829|2293414|P4|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|13
949298|NCT00075829|2293415|P3|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|14
949299|NCT00075829|2293416|P2|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|71
949300|NCT00075829|2293417|P1|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|178
949301|NCT00075829|2293414|P4|STARTED|Overall Study||37
949302|NCT00075829|2293415|P3|STARTED|Overall Study||48
949303|NCT00075829|2293416|P2|STARTED|Overall Study||189
949304|NCT00075829|2293417|P1|STARTED|Overall Study||436
949305|NCT00067990|2293447|P2|NOT COMPLETED|Overall Study||22
949306|NCT00067990|2293448|P1|NOT COMPLETED|Overall Study||10
949307|NCT00067990|2293447|P2|COMPLETED|Overall Study||54
949308|NCT00067990|2293448|P1|COMPLETED|Overall Study||67
949309|NCT00067990|2293447|P2|STARTED|Overall Study||76
949310|NCT00067990|2293448|P1|STARTED|Overall Study||77
949311|NCT00068107|2293456|P1|NOT COMPLETED|Overall Study||9
949312|NCT00068107|2293456|P1|COMPLETED|Overall Study||3
949313|NCT00068107|2293456|P1|STARTED|Overall Study||12
949314|NCT00068237|2293467|P1|NOT COMPLETED|Overall Study||5
949315|NCT00068237|2293467|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
949316|NCT00068237|2293467|P1|STARTED|Overall Study||49
949317|NCT00068341|2293474|P3|NOT COMPLETED|Overall Study||0
949318|NCT00068341|2293475|P2|NOT COMPLETED|Overall Study||0
949319|NCT00068341|2293476|P1|NOT COMPLETED|Overall Study||0
949320|NCT00068341|2293474|P3|COMPLETED|Overall Study||44
949321|NCT00068341|2293475|P2|COMPLETED|Overall Study||15
949322|NCT00068341|2293476|P1|COMPLETED|Overall Study||15
949323|NCT00068341|2293474|P3|STARTED|Overall Study||44
949324|NCT00068341|2293475|P2|STARTED|Overall Study||15
949325|NCT00068341|2293476|P1|STARTED|Overall Study||15
949326|NCT00068380|2293497|P1|NOT COMPLETED|Overall Study||5
949327|NCT00068380|2293497|P1|COMPLETED|Overall Study||12
949328|NCT00068380|2293497|P1|STARTED|Overall Study||17
949329|NCT00068393|2293501|P1|NOT COMPLETED|Overall Study||10
949330|NCT00068393|2293501|P1|COMPLETED|Overall Study||29
949331|NCT00068393|2293501|P1|Eligible and Treated|Overall Study||38
949332|NCT00068393|2293501|P1|STARTED|Overall Study||39
949333|NCT00068419|2293507|P1|NOT COMPLETED|Overall Study||60
949334|NCT00068419|2293507|P1|COMPLETED|Overall Study|Participant flow data reported here are for the period of protocol therapy.|10
949335|NCT00068419|2293507|P1|STARTED|Overall Study||70
949336|NCT00068575|2293511|P1|NOT COMPLETED|Overall Study||0
949337|NCT00068575|2293511|P1|COMPLETED|Overall Study||28
949338|NCT00068575|2293511|P1|STARTED|Overall Study||28
949339|NCT00068588|2293518|P3|NOT COMPLETED|Overall Study||4
949340|NCT00068588|2293519|P2|NOT COMPLETED|Overall Study||0
949341|NCT00068588|2293520|P1|NOT COMPLETED|Overall Study||0
949342|NCT00068588|2293518|P3|COMPLETED|Overall Study||17
949343|NCT00068588|2293519|P2|COMPLETED|Overall Study||3
949344|NCT00068588|2293520|P1|COMPLETED|Overall Study||0
949345|NCT00068588|2293518|P3|STARTED|Overall Study||21
949346|NCT00068588|2293519|P2|STARTED|Overall Study||3
949347|NCT00068588|2293520|P1|STARTED|Overall Study||0
949348|NCT00068601|2293532|P2|NOT COMPLETED|Overall Study||60
949349|NCT00068601|2293533|P1|NOT COMPLETED|Overall Study||62
949350|NCT00068601|2293532|P2|COMPLETED|Overall Study||66
949351|NCT00068601|2293533|P1|COMPLETED|Overall Study||69
949352|NCT00068601|2293532|P2|STARTED|Overall Study||126
949353|NCT00068601|2293533|P1|STARTED|Overall Study||131
949354|NCT00068718|2293543|P1|NOT COMPLETED|Overall Study||0
949355|NCT00068718|2293543|P1|COMPLETED|Overall Study||35
949356|NCT00068718|2293543|P1|STARTED|Overall Study||35
949357|NCT00068770|2293555|P2|NOT COMPLETED|Overall Study||0
949358|NCT00068770|2293556|P1|NOT COMPLETED|Overall Study||0
949359|NCT00068770|2293555|P2|COMPLETED|Overall Study||22
949360|NCT00068770|2293556|P1|COMPLETED|Overall Study||13
949361|NCT00068770|2293555|P2|STARTED|Overall Study||22
949362|NCT00068770|2293556|P1|STARTED|Overall Study||13
949363|NCT00068822|2293566|P2|NOT COMPLETED|Optional Crossover Intervention||0
949364|NCT00068822|2293567|P1|NOT COMPLETED|Optional Crossover Intervention||0
949365|NCT00068822|2293566|P2|COMPLETED|Optional Crossover Intervention||29
949366|NCT00068822|2293567|P1|COMPLETED|Optional Crossover Intervention||9
949367|NCT00068822|2293566|P2|Crossover at Month 3|Optional Crossover Intervention||27
949368|NCT00068822|2293567|P1|Crossover at Month 3|Optional Crossover Intervention||8
949369|NCT00068822|2293566|P2|Crossover at Month 1|Optional Crossover Intervention||2
949370|NCT00068822|2293567|P1|Crossover at Month 1|Optional Crossover Intervention||1
949371|NCT00068822|2293566|P2|STARTED|Optional Crossover Intervention||29
949372|NCT00068822|2293567|P1|STARTED|Optional Crossover Intervention||9
949373|NCT00068822|2293566|P2|NOT COMPLETED|First Randomized Intervention||2
949374|NCT00068822|2293567|P1|NOT COMPLETED|First Randomized Intervention||1
949375|NCT00068822|2293566|P2|COMPLETED|First Randomized Intervention||61
949376|NCT00068822|2293567|P1|COMPLETED|First Randomized Intervention||67
949377|NCT00068822|2293566|P2|STARTED|First Randomized Intervention||63
949378|NCT00068822|2293567|P1|STARTED|First Randomized Intervention||68
949379|NCT00069095|2293583|P6|NOT COMPLETED|Follow-up Phase||101
949380|NCT00069095|2293584|P5|NOT COMPLETED|Follow-up Phase||92
949381|NCT00069095|2293585|P4|NOT COMPLETED|Follow-up Phase||112
949382|NCT00069095|2293586|P3|NOT COMPLETED|Follow-up Phase||120
949383|NCT00069095|2293587|P2|NOT COMPLETED|Follow-up Phase||206
949384|NCT00069095|2293588|P1|NOT COMPLETED|Follow-up Phase||174
949385|NCT00069095|2293583|P6|COMPLETED|Follow-up Phase||171
949386|NCT00069095|2293584|P5|COMPLETED|Follow-up Phase||186
949387|NCT00069095|2293585|P4|COMPLETED|Follow-up Phase||187
949388|NCT00069095|2293586|P3|COMPLETED|Follow-up Phase||178
949389|NCT00069095|2293587|P2|COMPLETED|Follow-up Phase||93
949390|NCT00069095|2293588|P1|COMPLETED|Follow-up Phase||110
949391|NCT00069095|2293583|P6|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|272
949392|NCT00069095|2293584|P5|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|278
949393|NCT00069095|2293585|P4|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
949394|NCT00069095|2293586|P3|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|298
949395|NCT00069095|2293587|P2|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
949396|NCT00069095|2293588|P1|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|284
949397|NCT00069095|2293583|P6|NOT COMPLETED|Post-study Treatment Phase||29
949398|NCT00069095|2293584|P5|NOT COMPLETED|Post-study Treatment Phase||36
949399|NCT00069095|2293585|P4|NOT COMPLETED|Post-study Treatment Phase||17
949400|NCT00069095|2293586|P3|NOT COMPLETED|Post-study Treatment Phase||21
949401|NCT00069095|2293587|P2|NOT COMPLETED|Post-study Treatment Phase||13
949402|NCT00069095|2293588|P1|NOT COMPLETED|Post-study Treatment Phase||8
949403|NCT00069095|2293583|P6|COMPLETED|Post-study Treatment Phase||0
949404|NCT00069095|2293584|P5|COMPLETED|Post-study Treatment Phase||0
949405|NCT00069095|2293585|P4|COMPLETED|Post-study Treatment Phase||0
949406|NCT00069095|2293586|P3|COMPLETED|Post-study Treatment Phase||0
949407|NCT00069095|2293587|P2|COMPLETED|Post-study Treatment Phase||0
949408|NCT00069095|2293588|P1|COMPLETED|Post-study Treatment Phase||0
949409|NCT00069095|2293583|P6|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|29
949410|NCT00069095|2293584|P5|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|36
949411|NCT00069095|2293585|P4|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|17
949412|NCT00069095|2293586|P3|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|21
949413|NCT00069095|2293587|P2|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|13
949414|NCT00069095|2293588|P1|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|8
949415|NCT00069095|2293583|P6|NOT COMPLETED|Primary Treatment Phase||301
949416|NCT00069095|2293584|P5|NOT COMPLETED|Primary Treatment Phase||302
949417|NCT00069095|2293585|P4|NOT COMPLETED|Primary Treatment Phase||320
949418|NCT00069095|2293586|P3|NOT COMPLETED|Primary Treatment Phase||314
949419|NCT00069095|2293587|P2|NOT COMPLETED|Primary Treatment Phase||302
949420|NCT00069095|2293588|P1|NOT COMPLETED|Primary Treatment Phase||295
949421|NCT00069095|2293583|P6|COMPLETED|Primary Treatment Phase||48
949422|NCT00069095|2293584|P5|COMPLETED|Primary Treatment Phase||48
949423|NCT00069095|2293585|P4|COMPLETED|Primary Treatment Phase||31
949424|NCT00069095|2293586|P3|COMPLETED|Primary Treatment Phase||36
949425|NCT00069095|2293587|P2|COMPLETED|Primary Treatment Phase||15
949426|NCT00069095|2293588|P1|COMPLETED|Primary Treatment Phase||22
949427|NCT00069095|2293583|P6|STARTED|Primary Treatment Phase||349
949428|NCT00069095|2293584|P5|STARTED|Primary Treatment Phase||350
949429|NCT00069095|2293585|P4|STARTED|Primary Treatment Phase||351
949430|NCT00069095|2293586|P3|STARTED|Primary Treatment Phase||350
949431|NCT00069095|2293587|P2|STARTED|Primary Treatment Phase||317
949432|NCT00069095|2293588|P1|STARTED|Primary Treatment Phase||317
949433|NCT00069108|2293642|P2|NOT COMPLETED|Overall Study||219
949434|NCT00069108|2293643|P1|NOT COMPLETED|Overall Study||213
949435|NCT00069108|2293642|P2|COMPLETED|Overall Study||95
949436|NCT00069108|2293643|P1|COMPLETED|Overall Study||100
949437|NCT00069108|2293642|P2|STARTED|Overall Study||314
949438|NCT00069108|2293643|P1|STARTED|Overall Study||313
949439|NCT00069121|2293671|P2|NOT COMPLETED|Overall Study||276
949440|NCT00069121|2293672|P1|NOT COMPLETED|Overall Study||302
949441|NCT00069121|2293671|P2|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|668
949442|NCT00069121|2293672|P1|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|640
949443|NCT00069121|2293671|P2|Received Treatment|Overall Study|Safety Population|938
949444|NCT00069121|2293672|P1|Received Treatment|Overall Study|Safety Population|926
949445|NCT00069121|2293671|P2|STARTED|Overall Study||944
949446|NCT00069121|2293672|P1|STARTED|Overall Study||942
949447|NCT00069160|2293694|P2|NOT COMPLETED|Overall Study||0
949448|NCT00069160|2293695|P1|NOT COMPLETED|Overall Study||0
949449|NCT00069160|2293694|P2|COMPLETED|Overall Study||25
949450|NCT00069160|2293695|P1|COMPLETED|Overall Study||23
949451|NCT00069160|2293694|P2|STARTED|Overall Study||25
949452|NCT00069160|2293695|P1|STARTED|Overall Study||23
949480|NCT00069264|2293715|P1|NOT COMPLETED|Overall Study||32
949481|NCT00069264|2293715|P1|COMPLETED|Overall Study||0
949482|NCT00069264|2293715|P1|STARTED|Overall Study||32
949483|NCT00069277|2293719|P1|NOT COMPLETED|Overall Study||21
949484|NCT00069277|2293719|P1|COMPLETED|Overall Study||0
949485|NCT00069277|2293719|P1|STARTED|Overall Study||21
949486|NCT00069329|2293723|P1|NOT COMPLETED|Overall Study||2
949487|NCT00069329|2293723|P1|COMPLETED|Overall Study||41
949488|NCT00069329|2293723|P1|STARTED|Overall Study||43
949489|NCT00075881|2293747|P1|NOT COMPLETED|Overall Study||43
949490|NCT00075881|2293747|P1|COMPLETED|Overall Study||1
949491|NCT00075881|2293747|P1|Reinduction Treatment|Overall Study||7
949492|NCT00075881|2293747|P1|Maintenance Treatment|Overall Study||15
949493|NCT00075881|2293747|P1|Induction Treatment|Overall Study||42
949494|NCT00075881|2293747|P1|Treated|Overall Study||42
949495|NCT00075881|2293747|P1|Eligible|Overall Study||43
949496|NCT00075881|2293747|P1|STARTED|Overall Study||44
949497|NCT00075946|2293758|P5|NOT COMPLETED|Overall Study||188
949498|NCT00075946|2293759|P4|NOT COMPLETED|Overall Study||30
949499|NCT00075946|2293760|P3|NOT COMPLETED|Overall Study||28
949500|NCT00075946|2293761|P2|NOT COMPLETED|Overall Study||151
949501|NCT00075946|2293762|P1|NOT COMPLETED|Overall Study||148
949502|NCT00075946|2293758|P5|COMPLETED|Overall Study||0
949503|NCT00075946|2293759|P4|COMPLETED|Overall Study||0
949504|NCT00075946|2293760|P3|COMPLETED|Overall Study||0
949505|NCT00075946|2293761|P2|COMPLETED|Overall Study||0
949506|NCT00075946|2293762|P1|COMPLETED|Overall Study||0
949507|NCT00075946|2293758|P5|Included in Primary Analysis|Overall Study||0
949508|NCT00075946|2293759|P4|Included in Primary Analysis|Overall Study||29
949509|NCT00075946|2293760|P3|Included in Primary Analysis|Overall Study||23
949510|NCT00075946|2293761|P2|Included in Primary Analysis|Overall Study||146
949511|NCT00075946|2293762|P1|Included in Primary Analysis|Overall Study||143
949512|NCT00075946|2293758|P5|Treated and With Toxicity Data Available|Overall Study||154
949513|NCT00075946|2293759|P4|Treated and With Toxicity Data Available|Overall Study||29
949514|NCT00075946|2293760|P3|Treated and With Toxicity Data Available|Overall Study||27
949515|NCT00075946|2293761|P2|Treated and With Toxicity Data Available|Overall Study||148
949516|NCT00075946|2293762|P1|Treated and With Toxicity Data Available|Overall Study||142
949517|NCT00075946|2293758|P5|STARTED|Overall Study||188
949518|NCT00075946|2293759|P4|STARTED|Overall Study||30
949519|NCT00075946|2293760|P3|STARTED|Overall Study||28
949520|NCT00075946|2293761|P2|STARTED|Overall Study||151
949521|NCT00075946|2293762|P1|STARTED|Overall Study||148
949522|NCT00076011|2293777|P1|NOT COMPLETED|Overall Study||52
949523|NCT00076011|2293777|P1|COMPLETED|Overall Study||0
949524|NCT00076011|2293777|P1|STARTED|Overall Study||52
949525|NCT00076024|2293788|P4|NOT COMPLETED|Phase 2, Open-label||16
949526|NCT00076024|2293789|P3|NOT COMPLETED|Phase 2, Open-label||0
949527|NCT00076024|2293790|P2|NOT COMPLETED|Phase 2, Open-label||0
949528|NCT00076024|2293791|P1|NOT COMPLETED|Phase 2, Open-label||0
949529|NCT00076024|2293788|P4|COMPLETED|Phase 2, Open-label||0
949530|NCT00076024|2293789|P3|COMPLETED|Phase 2, Open-label||0
949531|NCT00076024|2293790|P2|COMPLETED|Phase 2, Open-label||0
949532|NCT00076024|2293791|P1|COMPLETED|Phase 2, Open-label||0
949533|NCT00076024|2293788|P4|STARTED|Phase 2, Open-label||16
949534|NCT00076024|2293789|P3|STARTED|Phase 2, Open-label||0
949535|NCT00076024|2293790|P2|STARTED|Phase 2, Open-label||0
949536|NCT00076024|2293791|P1|STARTED|Phase 2, Open-label||0
949537|NCT00076024|2293788|P4|NOT COMPLETED|Phase 2, Double-blind||0
949538|NCT00076024|2293789|P3|NOT COMPLETED|Phase 2, Double-blind||56
949539|NCT00076024|2293790|P2|NOT COMPLETED|Phase 2, Double-blind||112
949540|NCT00076024|2293791|P1|NOT COMPLETED|Phase 2, Double-blind||0
949541|NCT00076024|2293788|P4|COMPLETED|Phase 2, Double-blind||0
949542|NCT00076024|2293789|P3|COMPLETED|Phase 2, Double-blind||0
949543|NCT00076024|2293790|P2|COMPLETED|Phase 2, Double-blind||0
949544|NCT00076024|2293791|P1|COMPLETED|Phase 2, Double-blind||0
949545|NCT00076024|2293788|P4|Treated|Phase 2, Double-blind||0
949546|NCT00076024|2293789|P3|Treated|Phase 2, Double-blind||56
949547|NCT00076024|2293790|P2|Treated|Phase 2, Double-blind||111
949548|NCT00076024|2293791|P1|Treated|Phase 2, Double-blind||0
949549|NCT00076024|2293788|P4|STARTED|Phase 2, Double-blind||0
949550|NCT00076024|2293789|P3|STARTED|Phase 2, Double-blind||56
949551|NCT00076024|2293790|P2|STARTED|Phase 2, Double-blind||112
949552|NCT00076024|2293791|P1|STARTED|Phase 2, Double-blind||0
949553|NCT00076024|2293788|P4|NOT COMPLETED|Phase 1, Lead-in||0
949554|NCT00076024|2293789|P3|NOT COMPLETED|Phase 1, Lead-in||0
949555|NCT00076024|2293790|P2|NOT COMPLETED|Phase 1, Lead-in||0
949556|NCT00076024|2293791|P1|NOT COMPLETED|Phase 1, Lead-in||6
949557|NCT00076024|2293788|P4|COMPLETED|Phase 1, Lead-in||0
949558|NCT00076024|2293789|P3|COMPLETED|Phase 1, Lead-in||0
949559|NCT00076024|2293790|P2|COMPLETED|Phase 1, Lead-in||0
949560|NCT00076024|2293791|P1|COMPLETED|Phase 1, Lead-in||0
949561|NCT00076024|2293788|P4|STARTED|Phase 1, Lead-in||0
949562|NCT00076024|2293789|P3|STARTED|Phase 1, Lead-in||0
949563|NCT00076024|2293790|P2|STARTED|Phase 1, Lead-in||0
949564|NCT00076024|2293791|P1|STARTED|Phase 1, Lead-in||6
949565|NCT00076050|2293807|P2|NOT COMPLETED|Overall Study||43
949566|NCT00076050|2293808|P1|NOT COMPLETED|Overall Study||23
949567|NCT00076050|2293807|P2|COMPLETED|Overall Study||83
949568|NCT00076050|2293808|P1|COMPLETED|Overall Study||99
949569|NCT00076050|2293807|P2|STARTED|Overall Study||126
949570|NCT00076050|2293808|P1|STARTED|Overall Study||122
949571|NCT00076102|2293818|P1|NOT COMPLETED|Overall Study||0
949572|NCT00076102|2293818|P1|COMPLETED|Overall Study||36
949573|NCT00076102|2293818|P1|STARTED|Overall Study||36
949574|NCT00076219|2293825|P2|NOT COMPLETED|Overall Study||11
949575|NCT00076219|2293826|P1|NOT COMPLETED|Overall Study||18
949576|NCT00076219|2293825|P2|COMPLETED|Overall Study||550
949577|NCT00076219|2293826|P1|COMPLETED|Overall Study||545
949578|NCT00076219|2293825|P2|STARTED|Overall Study||561
949579|NCT00076219|2293826|P1|STARTED|Overall Study||563
949580|NCT00076245|2293836|P4|NOT COMPLETED|Overall Study||1
949581|NCT00076245|2293837|P3|NOT COMPLETED|Overall Study||0
949582|NCT00076245|2293838|P2|NOT COMPLETED|Overall Study||0
949583|NCT00076245|2293839|P1|NOT COMPLETED|Overall Study||0
949584|NCT00076245|2293836|P4|COMPLETED|Overall Study||14
949585|NCT00076245|2293837|P3|COMPLETED|Overall Study||15
949586|NCT00076245|2293838|P2|COMPLETED|Overall Study||15
949587|NCT00076245|2293839|P1|COMPLETED|Overall Study||16
949588|NCT00076245|2293836|P4|STARTED|Overall Study||15
949589|NCT00076245|2293837|P3|STARTED|Overall Study||15
949590|NCT00076245|2293838|P2|STARTED|Overall Study||15
949591|NCT00076245|2293839|P1|STARTED|Overall Study||16
949592|NCT00078286|2293855|P2|NOT COMPLETED|Overall Study||83
949593|NCT00078286|2293856|P1|NOT COMPLETED|Overall Study||96
949594|NCT00078286|2293855|P2|COMPLETED|Overall Study||152
949595|NCT00078286|2293856|P1|COMPLETED|Overall Study||138
949596|NCT00078286|2293855|P2|STARTED|Overall Study||235
949597|NCT00078286|2293856|P1|STARTED|Overall Study||234
949598|NCT00078312|2293864|P1|NOT COMPLETED|Overall Study||177
949599|NCT00078312|2293864|P1|COMPLETED|Overall Study||151
949600|NCT00078312|2293864|P1|STARTED|Overall Study||328
949601|NCT00078325|2293871|P3|NOT COMPLETED|Overall Study||11
949602|NCT00078325|2293872|P2|NOT COMPLETED|Overall Study||19
949603|NCT00078325|2293873|P1|NOT COMPLETED|Overall Study||21
949604|NCT00078325|2293871|P3|COMPLETED|Overall Study||120
949605|NCT00078325|2293872|P2|COMPLETED|Overall Study||114
949606|NCT00078325|2293873|P1|COMPLETED|Overall Study||110
949607|NCT00078325|2293871|P3|STARTED|Overall Study||131
949608|NCT00078325|2293872|P2|STARTED|Overall Study||133
949609|NCT00078325|2293873|P1|STARTED|Overall Study||131
949610|NCT00078377|2293887|P3|NOT COMPLETED|Overall Study||9
949611|NCT00078377|2293888|P2|NOT COMPLETED|Overall Study||16
949612|NCT00078377|2293889|P1|NOT COMPLETED|Overall Study||11
949613|NCT00078377|2293887|P3|COMPLETED|Overall Study||55
949614|NCT00078377|2293888|P2|COMPLETED|Overall Study||49
949615|NCT00078377|2293889|P1|COMPLETED|Overall Study||56
949616|NCT00078377|2293887|P3|STARTED|Overall Study||64
949617|NCT00078377|2293888|P2|STARTED|Overall Study||65
949618|NCT00078377|2293889|P1|STARTED|Overall Study||67
949619|NCT00078403|2293905|P3|NOT COMPLETED|Overall Study||28
949620|NCT00078403|2293906|P2|NOT COMPLETED|Overall Study||16
949621|NCT00078403|2293907|P1|NOT COMPLETED|Overall Study||18
949622|NCT00078403|2293905|P3|COMPLETED|Overall Study||141
949623|NCT00078403|2293906|P2|COMPLETED|Overall Study||26
949624|NCT00078403|2293907|P1|COMPLETED|Overall Study||26
949625|NCT00078403|2293905|P3|STARTED|Overall Study||169
949626|NCT00078403|2293906|P2|STARTED|Overall Study|Eligible at pre-assignment (40), direct (1), Arm C week 36 non-response (1).|42
949627|NCT00078403|2293907|P1|STARTED|Overall Study|Eligible at pre-assignment (40), direct (2), Arm C week 36 non-response (1), EVR inadvertently (1).|44
949628|NCT00078559|2293964|P1|NOT COMPLETED|Overall Study||0
949629|NCT00078559|2293964|P1|COMPLETED|Overall Study|1 subject stopped study drug due to a severe but non-serious AE, and completed the trial|10
949630|NCT00078559|2293964|P1|STARTED|Overall Study||10
949631|NCT00078715|2293990|P2|NOT COMPLETED|Second Intervention||0
949632|NCT00078715|2293991|P1|NOT COMPLETED|Second Intervention||0
949633|NCT00078715|2293990|P2|COMPLETED|Second Intervention||4
949634|NCT00078715|2293991|P1|COMPLETED|Second Intervention||2
949635|NCT00078715|2293990|P2|STARTED|Second Intervention||4
949636|NCT00078715|2293991|P1|STARTED|Second Intervention||2
949637|NCT00078715|2293990|P2|NOT COMPLETED|First Intervention||0
949638|NCT00078715|2293991|P1|NOT COMPLETED|First Intervention||0
949639|NCT00078715|2293990|P2|COMPLETED|First Intervention||4
949640|NCT00078715|2293991|P1|COMPLETED|First Intervention||2
949641|NCT00078715|2293990|P2|STARTED|First Intervention||4
949642|NCT00078715|2293991|P1|STARTED|First Intervention||2
949643|NCT00078728|2293999|P2|NOT COMPLETED|Overall Study||3
949644|NCT00078728|2294000|P1|NOT COMPLETED|Overall Study||4
949645|NCT00078728|2293999|P2|COMPLETED|Overall Study||17
949646|NCT00078728|2294000|P1|COMPLETED|Overall Study||16
949647|NCT00078728|2293999|P2|STARTED|Overall Study||20
949648|NCT00078728|2294000|P1|STARTED|Overall Study||20
949649|NCT00078754|2294009|P3|NOT COMPLETED|Overall Study||15
949650|NCT00078754|2294010|P2|NOT COMPLETED|Overall Study||19
949651|NCT00078754|2294011|P1|NOT COMPLETED|Overall Study||15
949652|NCT00078754|2294009|P3|COMPLETED|Overall Study||16
949653|NCT00078754|2294010|P2|COMPLETED|Overall Study||11
949654|NCT00078754|2294011|P1|COMPLETED|Overall Study||14
949655|NCT00078754|2294009|P3|STARTED|Overall Study||31
949656|NCT00078754|2294010|P2|STARTED|Overall Study||30
949657|NCT00078754|2294011|P1|STARTED|Overall Study||29
949658|NCT00078767|2294021|P2|NOT COMPLETED|Overall Study||1
949659|NCT00078767|2294022|P1|NOT COMPLETED|Overall Study||1
949660|NCT00078767|2294021|P2|COMPLETED|Overall Study||11
949661|NCT00078767|2294022|P1|COMPLETED|Overall Study||11
949662|NCT00078767|2294021|P2|STARTED|Overall Study||12
949663|NCT00078767|2294022|P1|STARTED|Overall Study||12
949664|NCT00078949|2294040|P4|NOT COMPLETED|Maintenance||3
949665|NCT00078949|2294041|P3|NOT COMPLETED|Maintenance||3
949666|NCT00078949|2294042|P2|NOT COMPLETED|Maintenance||0
949667|NCT00078949|2294043|P1|NOT COMPLETED|Maintenance||0
949668|NCT00078949|2294040|P4|COMPLETED|Maintenance||112
949669|NCT00078949|2294041|P3|COMPLETED|Maintenance||112
949670|NCT00078949|2294042|P2|COMPLETED|Maintenance||0
949671|NCT00078949|2294043|P1|COMPLETED|Maintenance||0
949672|NCT00078949|2294040|P4|STARTED|Maintenance||115
949673|NCT00078949|2294041|P3|STARTED|Maintenance||115
949674|NCT00078949|2294042|P2|STARTED|Maintenance||0
949675|NCT00078949|2294043|P1|STARTED|Maintenance||0
949676|NCT00078949|2294040|P4|NOT COMPLETED|Salvage||0
949677|NCT00078949|2294041|P3|NOT COMPLETED|Salvage||0
949678|NCT00078949|2294042|P2|NOT COMPLETED|Salvage||5
949679|NCT00078949|2294043|P1|NOT COMPLETED|Salvage||4
949680|NCT00078949|2294040|P4|COMPLETED|Salvage||0
949681|NCT00078949|2294041|P3|COMPLETED|Salvage||0
949682|NCT00078949|2294042|P2|COMPLETED|Salvage||304
949683|NCT00078949|2294043|P1|COMPLETED|Salvage||306
949684|NCT00078949|2294040|P4|STARTED|Salvage||0
949685|NCT00078949|2294041|P3|STARTED|Salvage||0
949686|NCT00078949|2294042|P2|STARTED|Salvage||309
949687|NCT00078949|2294043|P1|STARTED|Salvage||310
949688|NCT00079001|2294057|P2|NOT COMPLETED|Overall Study||0
949689|NCT00079001|2294058|P1|NOT COMPLETED|Overall Study||0
949690|NCT00079001|2294057|P2|COMPLETED|Overall Study||322
949691|NCT00079001|2294058|P1|COMPLETED|Overall Study||323
949692|NCT00079001|2294057|P2|STARTED|Overall Study||322
949693|NCT00079001|2294058|P1|STARTED|Overall Study||323
949694|NCT00079040|2294068|P1|NOT COMPLETED|Overall Study||2
949695|NCT00079040|2294068|P1|COMPLETED|Overall Study||63
949696|NCT00079040|2294068|P1|STARTED|Overall Study||65
949697|NCT00079183|2294074|P1|NOT COMPLETED|Overall Study||7
949698|NCT00079183|2294074|P1|COMPLETED|Overall Study||37
949699|NCT00079183|2294074|P1|Drop Outs|Overall Study||7
949700|NCT00079183|2294074|P1|STARTED|Overall Study||44
949701|NCT00079274|2294096|P7|NOT COMPLETED|Overall Study||0
949702|NCT00079274|2294097|P6|NOT COMPLETED|Overall Study||20
949703|NCT00079274|2294098|P5|NOT COMPLETED|Overall Study||15
949704|NCT00079274|2294099|P4|NOT COMPLETED|Overall Study||444
949705|NCT00079274|2294100|P3|NOT COMPLETED|Overall Study||27
949706|NCT00079274|2294101|P2|NOT COMPLETED|Overall Study||27
949707|NCT00079274|2294102|P1|NOT COMPLETED|Overall Study||321
949708|NCT00079274|2294096|P7|COMPLETED|Overall Study||332
949709|NCT00079274|2294097|P6|COMPLETED|Overall Study||26
949710|NCT00079274|2294098|P5|COMPLETED|Overall Study||30
949711|NCT00079274|2294099|P4|COMPLETED|Overall Study||906
949712|NCT00079274|2294100|P3|COMPLETED|Overall Study||84
949713|NCT00079274|2294101|P2|COMPLETED|Overall Study||84
949714|NCT00079274|2294102|P1|COMPLETED|Overall Study||1081
949715|NCT00079274|2294096|P7|STARTED|Overall Study||332
949716|NCT00079274|2294097|P6|STARTED|Overall Study||46
949717|NCT00079274|2294098|P5|STARTED|Overall Study||45
949718|NCT00079274|2294099|P4|STARTED|Overall Study||1350
949719|NCT00079274|2294100|P3|STARTED|Overall Study||111
949720|NCT00079274|2294101|P2|STARTED|Overall Study||111
949721|NCT00079274|2294102|P1|STARTED|Overall Study||1402
949722|NCT00079326|2294117|P2|NOT COMPLETED|Overall Study||0
949723|NCT00079326|2294118|P1|NOT COMPLETED|Overall Study||0
949724|NCT00079326|2294117|P2|COMPLETED|Overall Study||24
949725|NCT00079326|2294118|P1|COMPLETED|Overall Study||15
949726|NCT00079326|2294117|P2|STARTED|Overall Study||24
949727|NCT00079326|2294118|P1|STARTED|Overall Study||15
949728|NCT00079339|2294128|P3|NOT COMPLETED|Overall Study||6
949729|NCT00079339|2294129|P2|NOT COMPLETED|Overall Study||39
949730|NCT00079339|2294130|P1|NOT COMPLETED|Overall Study||5
949731|NCT00079339|2294128|P3|COMPLETED|Overall Study||0
949732|NCT00079339|2294129|P2|COMPLETED|Overall Study||1
949733|NCT00079339|2294130|P1|COMPLETED|Overall Study||0
949734|NCT00079339|2294128|P3|Enrolled in Phase II|Overall Study|Participants treated at the 150 mg/m2 dose level did not participate in the phase II part.|0
949735|NCT00079339|2294129|P2|Enrolled in Phase II|Overall Study|This number includes the 6 patients enrolled on the phase I part.|40
949736|NCT00079339|2294130|P1|Enrolled in Phase II|Overall Study|Participants treated at the 100 mg/m2 dose level did not participate in the phase II part.|0
949737|NCT00079339|2294128|P3|Maximum Tolerated Dose (MTD) Estimation|Overall Study|One participant enrolled in the phase I part did not complete the 8 week MTD estimation period.|5
949738|NCT00079339|2294129|P2|Maximum Tolerated Dose (MTD) Estimation|Overall Study||6
949739|NCT00079339|2294130|P1|Maximum Tolerated Dose (MTD) Estimation|Overall Study|2 participants enrolled in the phase I part did not complete the 8 week MTD estimation period.|3
949740|NCT00079339|2294128|P3|Enrolled in Phase I|Overall Study||6
949741|NCT00079339|2294129|P2|Enrolled in Phase I|Overall Study||6
949742|NCT00079339|2294130|P1|Enrolled in Phase I|Overall Study||5
949743|NCT00079339|2294128|P3|STARTED|Overall Study||6
949744|NCT00079339|2294129|P2|STARTED|Overall Study||40
949745|NCT00079339|2294130|P1|STARTED|Overall Study||5
949746|NCT00079391|2294144|P1|NOT COMPLETED|Overall Study||1
949747|NCT00079391|2294144|P1|COMPLETED|Overall Study||49
949748|NCT00079391|2294144|P1|STARTED|Overall Study|1 of these withdrew after consent.|50
949749|NCT00079417|2294153|P1|NOT COMPLETED|Overall Study||9
949750|NCT00079417|2294153|P1|COMPLETED|Overall Study||19
949751|NCT00079417|2294153|P1|STARTED|Overall Study||28
949752|NCT00079677|2294159|P2|NOT COMPLETED|Overall Study||14
949753|NCT00079677|2294160|P1|NOT COMPLETED|Overall Study||20
949754|NCT00079677|2294159|P2|COMPLETED|Overall Study||118
949755|NCT00079677|2294160|P1|COMPLETED|Overall Study||111
949756|NCT00079677|2294159|P2|STARTED|Overall Study||132
949757|NCT00079677|2294160|P1|STARTED|Overall Study||131
949758|NCT00079781|2294171|P3|NOT COMPLETED|Follow-up Period||2
949759|NCT00079781|2294172|P2|NOT COMPLETED|Follow-up Period||0
949760|NCT00079781|2294173|P1|NOT COMPLETED|Follow-up Period||4
949761|NCT00079781|2294171|P3|COMPLETED|Follow-up Period||12
949762|NCT00079781|2294172|P2|COMPLETED|Follow-up Period||9
949763|NCT00079781|2294173|P1|COMPLETED|Follow-up Period||38
949764|NCT00079781|2294171|P3|STARTED|Follow-up Period||14
949765|NCT00079781|2294172|P2|STARTED|Follow-up Period||9
949766|NCT00079781|2294173|P1|STARTED|Follow-up Period||42
949767|NCT00079781|2294171|P3|NOT COMPLETED|Evaluation Period||0
949768|NCT00079781|2294172|P2|NOT COMPLETED|Evaluation Period||0
949769|NCT00079781|2294173|P1|NOT COMPLETED|Evaluation Period||0
949770|NCT00079781|2294171|P3|COMPLETED|Evaluation Period||14
949771|NCT00079781|2294172|P2|COMPLETED|Evaluation Period||9
949772|NCT00079781|2294173|P1|COMPLETED|Evaluation Period||42
949773|NCT00079781|2294171|P3|STARTED|Evaluation Period||14
949774|NCT00079781|2294172|P2|STARTED|Evaluation Period||9
949775|NCT00079781|2294173|P1|STARTED|Evaluation Period||42
949776|NCT00079781|2294171|P3|NOT COMPLETED|Pre-implant Period||1
949777|NCT00079781|2294172|P2|NOT COMPLETED|Pre-implant Period||1
949778|NCT00079781|2294173|P1|NOT COMPLETED|Pre-implant Period||3
949779|NCT00079781|2294171|P3|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|14
949780|NCT00079781|2294172|P2|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|9
949781|NCT00079781|2294173|P1|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|42
949782|NCT00079781|2294171|P3|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|15
949783|NCT00079781|2294172|P2|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|10
949784|NCT00079781|2294173|P1|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|45
949785|NCT00079937|2294182|P2|NOT COMPLETED|Overall Study||32
949786|NCT00079937|2294183|P1|NOT COMPLETED|Overall Study||69
949787|NCT00079937|2294182|P2|COMPLETED|Overall Study||175
949788|NCT00079937|2294183|P1|COMPLETED|Overall Study||352
949789|NCT00079937|2294182|P2|STARTED|Overall Study||207
949790|NCT00079937|2294183|P1|STARTED|Overall Study||421
949791|NCT00080119|2294203|P4|NOT COMPLETED|Overall Study||163
949792|NCT00080119|2294204|P3|NOT COMPLETED|Overall Study||165
949793|NCT00080119|2294205|P2|NOT COMPLETED|Overall Study||62
949794|NCT00080119|2294206|P1|NOT COMPLETED|Overall Study||56
949795|NCT00080119|2294203|P4|COMPLETED|Overall Study||111
949796|NCT00080119|2294204|P3|COMPLETED|Overall Study||108
949797|NCT00080119|2294205|P2|COMPLETED|Overall Study||339
949798|NCT00080119|2294206|P1|COMPLETED|Overall Study||347
949799|NCT00080119|2294203|P4|STARTED|Overall Study||274
949800|NCT00080119|2294204|P3|STARTED|Overall Study||273
949801|NCT00080119|2294205|P2|STARTED|Overall Study||401
949802|NCT00080119|2294206|P1|STARTED|Overall Study||403
949803|NCT00080223|2294238|P1|NOT COMPLETED|Overall Study||76
949804|NCT00080223|2294238|P1|COMPLETED|Overall Study||7
949805|NCT00080223|2294238|P1|STARTED|Overall Study||83
949806|NCT00080288|2294248|P2|NOT COMPLETED|Overall Study||38
949807|NCT00080288|2294249|P1|NOT COMPLETED|Overall Study||30
949808|NCT00080288|2294248|P2|COMPLETED|Overall Study||89
949809|NCT00080288|2294249|P1|COMPLETED|Overall Study||97
949810|NCT00080288|2294248|P2|STARTED|Overall Study||127
949811|NCT00080288|2294249|P1|STARTED|Overall Study||127
949812|NCT00080301|2294259|P2|NOT COMPLETED|Overall Study||11
949813|NCT00080301|2294260|P1|NOT COMPLETED|Overall Study||5
949814|NCT00080301|2294259|P2|COMPLETED|Overall Study|Participants who are off treatment|366
949815|NCT00080301|2294260|P1|COMPLETED|Overall Study|Participants who are off treatment|370
949816|NCT00080301|2294259|P2|Still on Treatment|Overall Study||1
949817|NCT00080301|2294260|P1|Still on Treatment|Overall Study||0
949818|NCT00080301|2294259|P2|Never Treated|Overall Study||10
949819|NCT00080301|2294260|P1|Never Treated|Overall Study||5
949820|NCT00080301|2294259|P2|STARTED|Overall Study||377
949821|NCT00080301|2294260|P1|STARTED|Overall Study||375
949822|NCT00080470|2294280|P2|NOT COMPLETED|Overall Study||28
949823|NCT00080470|2294281|P1|NOT COMPLETED|Overall Study||34
949824|NCT00080470|2294280|P2|COMPLETED|Overall Study||14
949825|NCT00080470|2294281|P1|COMPLETED|Overall Study||11
949826|NCT00080470|2294280|P2|STARTED|Overall Study||42
949827|NCT00080470|2294281|P1|STARTED|Overall Study||45
949828|NCT00080483|2294291|P2|NOT COMPLETED|Overall Study||2
949829|NCT00080483|2294292|P1|NOT COMPLETED|Overall Study||2
949830|NCT00080483|2294291|P2|COMPLETED|Overall Study||16
949831|NCT00080483|2294292|P1|COMPLETED|Overall Study||15
949832|NCT00080483|2294291|P2|STARTED|Overall Study||18
949833|NCT00080483|2294292|P1|STARTED|Overall Study||17
949834|NCT00080535|2294298|P1|NOT COMPLETED|Overall Study||0
949835|NCT00080535|2294298|P1|COMPLETED|Overall Study||10
949836|NCT00080535|2294298|P1|STARTED|Overall Study||10
949837|NCT00072761|2294305|P2|NOT COMPLETED|Overall Study||2
949838|NCT00072761|2294306|P1|NOT COMPLETED|Overall Study||9
949839|NCT00072761|2294305|P2|COMPLETED|Overall Study||95
949840|NCT00072761|2294306|P1|COMPLETED|Overall Study||90
949841|NCT00072761|2294305|P2|STARTED|Overall Study||97
949842|NCT00072761|2294306|P1|STARTED|Overall Study||99
949843|NCT00073008|2294314|P2|NOT COMPLETED|Overall Study||63
949844|NCT00073008|2294315|P1|NOT COMPLETED|Overall Study||62
949845|NCT00073008|2294314|P2|COMPLETED|Overall Study||3
949846|NCT00073008|2294315|P1|COMPLETED|Overall Study||3
949847|NCT00073008|2294314|P2|STARTED|Overall Study||66
949848|NCT00073008|2294315|P1|STARTED|Overall Study||65
949849|NCT00073021|2294347|P2|NOT COMPLETED|Overall Study||16
949850|NCT00073021|2294348|P1|NOT COMPLETED|Overall Study||26
949851|NCT00073021|2294347|P2|COMPLETED|Overall Study||113
949852|NCT00073021|2294348|P1|COMPLETED|Overall Study||113
949853|NCT00073021|2294347|P2|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|129
949854|NCT00073021|2294348|P1|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|139
949858|NCT00080899|2294387|P1|NOT COMPLETED|Overall Study||1
949859|NCT00080899|2294387|P1|COMPLETED|Overall Study||22
949860|NCT00080899|2294387|P1|STARTED|Overall Study||23
949861|NCT00080912|2294394|P2|NOT COMPLETED|Overall Study||0
949862|NCT00080912|2294395|P1|NOT COMPLETED|Overall Study||0
949863|NCT00080912|2294394|P2|COMPLETED|Overall Study||425
949864|NCT00080912|2294395|P1|COMPLETED|Overall Study||425
949865|NCT00080912|2294394|P2|STARTED|Overall Study||425
949866|NCT00080912|2294395|P1|STARTED|Overall Study||425
949867|NCT00080938|2294401|P1|NOT COMPLETED|Overall Study||24
949868|NCT00080938|2294401|P1|COMPLETED|Overall Study||2
949869|NCT00080938|2294401|P1|Eligible and Treated|Overall Study||21
949870|NCT00080938|2294401|P1|Began Protocol Therapy|Overall Study||25
949871|NCT00080938|2294401|P1|STARTED|Overall Study||26
949872|NCT00081497|2294410|P2|NOT COMPLETED|Overall Study||2
949873|NCT00081497|2294411|P1|NOT COMPLETED|Overall Study||3
949874|NCT00081497|2294410|P2|COMPLETED|Overall Study||37
949875|NCT00081497|2294411|P1|COMPLETED|Overall Study||25
949876|NCT00081497|2294410|P2|STARTED|Overall Study|Patients who were randomized to Fabrazyme in AGAL-008-00 (NCT00074984).|39
949877|NCT00081497|2294411|P1|STARTED|Overall Study|Patients who were randomized to placebo in AGAL-008-00 (NCT00074984).|28
949878|NCT00081653|2294428|P2|NOT COMPLETED|Overall Study||37
949879|NCT00081653|2294429|P1|NOT COMPLETED|Overall Study||47
949880|NCT00081653|2294428|P2|COMPLETED|Overall Study|Completed 3 years of treatment|324
949881|NCT00081653|2294429|P1|COMPLETED|Overall Study|Completed 3 years of treatment|311
949882|NCT00081653|2294428|P2|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|361
949883|NCT00081653|2294429|P1|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|358
949884|NCT00081731|2294447|P2|NOT COMPLETED|Overall Study||8
949885|NCT00081731|2294448|P1|NOT COMPLETED|Overall Study||8
949886|NCT00081731|2294447|P2|COMPLETED|Overall Study||459
949887|NCT00081731|2294448|P1|COMPLETED|Overall Study||472
949888|NCT00081731|2294447|P2|STARTED|Overall Study||467
949889|NCT00081731|2294448|P1|STARTED|Overall Study||480
949890|NCT00081770|2294469|P3|NOT COMPLETED|Overall Study||456
949891|NCT00081770|2294470|P2|NOT COMPLETED|Overall Study||546
949892|NCT00081770|2294471|P1|NOT COMPLETED|Overall Study||502
949893|NCT00081770|2294469|P3|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|579
949894|NCT00081770|2294470|P2|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|470
949895|NCT00081770|2294471|P1|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|517
949896|NCT00081770|2294469|P3|STARTED|Overall Study||1035
949897|NCT00081770|2294470|P2|STARTED|Overall Study||1016
949898|NCT00081770|2294471|P1|STARTED|Overall Study||1019
949899|NCT00081861|2294488|P1|NOT COMPLETED|Overall Study||0
949900|NCT00081861|2294488|P1|COMPLETED|Overall Study||13
949901|NCT00081861|2294488|P1|STARTED|Overall Study||13
949905|NCT00082017|2294496|P2|NOT COMPLETED|Overall Study||0
949906|NCT00082017|2294497|P1|NOT COMPLETED|Overall Study||0
949907|NCT00082017|2294496|P2|COMPLETED|Overall Study||9
949908|NCT00082017|2294497|P1|COMPLETED|Overall Study||11
949909|NCT00082017|2294496|P2|STARTED|Overall Study||9
949910|NCT00082017|2294497|P1|STARTED|Overall Study||11
949911|NCT00082173|2294515|P2|NOT COMPLETED|Overall Study||11
949912|NCT00082173|2294516|P1|NOT COMPLETED|Overall Study||10
949913|NCT00082173|2294515|P2|COMPLETED|Overall Study||61
949914|NCT00082173|2294516|P1|COMPLETED|Overall Study||64
949915|NCT00082173|2294515|P2|STARTED|Overall Study||72
949916|NCT00082173|2294516|P1|STARTED|Overall Study||74
949917|NCT00082329|2294524|P1|NOT COMPLETED|Overall Study||0
949918|NCT00082329|2294524|P1|COMPLETED|Overall Study||9
949919|NCT00082329|2294524|P1|STARTED|Overall Study||9
949920|NCT00082342|2294530|P2|NOT COMPLETED|Overall Study||0
949921|NCT00082342|2294531|P1|NOT COMPLETED|Overall Study||0
949922|NCT00082342|2294530|P2|COMPLETED|Overall Study||12
949923|NCT00082342|2294531|P1|COMPLETED|Overall Study||13
949924|NCT00082342|2294530|P2|STARTED|Overall Study||12
949925|NCT00082342|2294531|P1|STARTED|Overall Study||13
949926|NCT00082355|2294551|P1|NOT COMPLETED|5 Year Recurrent Thromboembolism Rate||28
949927|NCT00082355|2294551|P1|COMPLETED|5 Year Recurrent Thromboembolism Rate|data will not be complied until 2014|0
949928|NCT00082355|2294551|P1|STARTED|5 Year Recurrent Thromboembolism Rate||28
949929|NCT00082355|2294551|P1|NOT COMPLETED|Initial Results of Thrombolytic Therapy||2
949930|NCT00082355|2294551|P1|COMPLETED|Initial Results of Thrombolytic Therapy||28
949931|NCT00082355|2294551|P1|STARTED|Initial Results of Thrombolytic Therapy||30
949932|NCT00082368|2294556|P1|NOT COMPLETED|Overall Study||1
949933|NCT00082368|2294556|P1|COMPLETED|Overall Study||11
949934|NCT00082368|2294556|P1|STARTED|Overall Study||12
949935|NCT00082381|2294563|P2|NOT COMPLETED|Overall Study||26
949936|NCT00082381|2294564|P1|NOT COMPLETED|Overall Study||55
949937|NCT00082381|2294563|P2|COMPLETED|Overall Study||242
949938|NCT00082381|2294564|P1|COMPLETED|Overall Study||228
949939|NCT00082381|2294563|P2|Received Treatment (Intent to Treat)|Overall Study||267
949940|NCT00082381|2294564|P1|Received Treatment (Intent to Treat)|Overall Study||282
949941|NCT00082381|2294563|P2|STARTED|Overall Study||268
949942|NCT00082381|2294564|P1|STARTED|Overall Study||283
949943|NCT00082407|2294584|P2|NOT COMPLETED|Overall Study||27
949944|NCT00082407|2294585|P1|NOT COMPLETED|Overall Study||56
949945|NCT00082407|2294584|P2|COMPLETED|Overall Study||223
949946|NCT00082407|2294585|P1|COMPLETED|Overall Study||199
949947|NCT00082407|2294584|P2|Received Treatment (Intent to Treat)|Overall Study||248
949948|NCT00082407|2294585|P1|Received Treatment (Intent to Treat)|Overall Study||253
949949|NCT00082407|2294584|P2|STARTED|Overall Study||250
949950|NCT00082407|2294585|P1|STARTED|Overall Study||255
949951|NCT00082433|2294605|P2|NOT COMPLETED|Overall Study||597
949952|NCT00082433|2294606|P1|NOT COMPLETED|Overall Study||594
949953|NCT00082433|2294605|P2|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
949954|NCT00082433|2294606|P1|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
949955|NCT00082433|2294605|P2|STARTED|Overall Study||612
949956|NCT00082433|2294606|P1|STARTED|Overall Study||609
949957|NCT00082758|2294627|P3|NOT COMPLETED|Overall Study||0
949958|NCT00082758|2294628|P2|NOT COMPLETED|Overall Study||17
949959|NCT00082758|2294629|P1|NOT COMPLETED|Overall Study||15
949960|NCT00082758|2294627|P3|COMPLETED|Overall Study||0
949961|NCT00082758|2294628|P2|COMPLETED|Overall Study||7
949962|NCT00082758|2294629|P1|COMPLETED|Overall Study||0
949963|NCT00082758|2294627|P3|STARTED|Overall Study||0
949964|NCT00082758|2294628|P2|STARTED|Overall Study||24
949965|NCT00082758|2294629|P1|STARTED|Overall Study||15
949966|NCT00082810|2294637|P1|NOT COMPLETED|Overall Study||31
949967|NCT00082810|2294637|P1|COMPLETED|Overall Study||2
949968|NCT00082810|2294637|P1|STARTED|Overall Study||33
949969|NCT00082888|2294644|P1|NOT COMPLETED|Overall Study||22
949970|NCT00082888|2294644|P1|COMPLETED|Overall Study||71
949971|NCT00082888|2294644|P1|STARTED|Overall Study||93
949972|NCT00083122|2294650|P2|NOT COMPLETED|Overall Study||0
949973|NCT00083122|2294651|P1|NOT COMPLETED|Overall Study||0
949974|NCT00083122|2294650|P2|COMPLETED|Overall Study||5
949975|NCT00083122|2294651|P1|COMPLETED|Overall Study||40
949976|NCT00083122|2294650|P2|STARTED|Overall Study||5
949977|NCT00083122|2294651|P1|STARTED|Overall Study||40
949984|NCT00083226|2294681|P1|NOT COMPLETED|Overall Study||42
949985|NCT00083226|2294681|P1|COMPLETED|Overall Study||0
949986|NCT00083226|2294681|P1|STARTED|Overall Study||42
949987|NCT00083382|2294687|P1|NOT COMPLETED|Overall Study||0
949988|NCT00083382|2294687|P1|COMPLETED|Overall Study||83
949989|NCT00083382|2294687|P1|STARTED|Overall Study||83
949990|NCT00083551|2294693|P2|NOT COMPLETED|Overall Study||0
949991|NCT00083551|2294694|P1|NOT COMPLETED|Overall Study||0
949992|NCT00083551|2294693|P2|COMPLETED|Overall Study||345
949993|NCT00083551|2294694|P1|COMPLETED|Overall Study||323
949994|NCT00083551|2294693|P2|STARTED|Overall Study||345
949995|NCT00083551|2294694|P1|STARTED|Overall Study||323
949996|NCT00083616|2294700|P1|NOT COMPLETED|Overall Study||31
949997|NCT00083616|2294700|P1|COMPLETED|Overall Study|Completed safety followup or died on study as of the data cut-off date of 22 December 2006|154
949998|NCT00083616|2294700|P1|Received Study Medication|Overall Study||182
949999|NCT00083616|2294700|P1|STARTED|Overall Study||185
950000|NCT00083720|2294712|P1|NOT COMPLETED|Overall Study||0
950001|NCT00083720|2294712|P1|COMPLETED|Overall Study|Two patients died prior to receiving cetuximab.|85
950002|NCT00083720|2294712|P1|STARTED|Overall Study|Patients analyzed for efficacy who met the epidermal growth factor receptor (EGFR) negative criteria|85
950003|NCT00083759|2294724|P2|NOT COMPLETED|Overall Study||83
950004|NCT00083759|2294725|P1|NOT COMPLETED|Overall Study||84
950005|NCT00083759|2294724|P2|COMPLETED|Overall Study||66
950006|NCT00083759|2294725|P1|COMPLETED|Overall Study||66
950007|NCT00083759|2294724|P2|STARTED|Overall Study|149 subjects enrolled, 136 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|149
950008|NCT00083759|2294725|P1|STARTED|Overall Study|150 subjects enrolled, 137 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|150
950009|NCT00083889|2294735|P2|NOT COMPLETED|Overall Study||375
950010|NCT00083889|2294736|P1|NOT COMPLETED|Overall Study||375
950011|NCT00083889|2294735|P2|COMPLETED|Overall Study|Discontinuation crossover subjects: AEs 5,consent withdrawn 2, lack efficacy 13, sponsor decision 5.|0
950012|NCT00083889|2294736|P1|COMPLETED|Overall Study||0
950013|NCT00083889|2294735|P2|Received Treatment|Overall Study|15 subjects randomized to IFN-α discontinued before receiving their first dose of study medication.|360
950014|NCT00083889|2294736|P1|Received Treatment|Overall Study||375
950015|NCT00083889|2294735|P2|STARTED|Overall Study||375
950016|NCT00083889|2294736|P1|STARTED|Overall Study||375
950023|NCT00084084|2294794|P1|NOT COMPLETED|Phase 2 (Transition to Replagal AF)||1
950024|NCT00084084|2294794|P1|COMPLETED|Phase 2 (Transition to Replagal AF)||10
950025|NCT00084084|2294794|P1|STARTED|Phase 2 (Transition to Replagal AF)|The 11 patients remaining in TKT029 at the time Replagal AF was made available continued to Phase 2.|11
950026|NCT00084084|2294794|P1|NOT COMPLETED|Phase 1 (Treatment With Replagal RB)||1
950027|NCT00084084|2294794|P1|COMPLETED|Phase 1 (Treatment With Replagal RB)||16
950028|NCT00084084|2294794|P1|STARTED|Phase 1 (Treatment With Replagal RB)||17
950029|NCT00084136|2294805|P3|NOT COMPLETED|NRTI Comparison||82
950030|NCT00084136|2294806|P2|NOT COMPLETED|NRTI Comparison||0
950031|NCT00084136|2294807|P1|NOT COMPLETED|NRTI Comparison||101
950032|NCT00084136|2294805|P3|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|444
950033|NCT00084136|2294806|P2|COMPLETED|NRTI Comparison||0
950034|NCT00084136|2294807|P1|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|418
950035|NCT00084136|2294805|P3|STARTED|NRTI Comparison||526
950036|NCT00084136|2294806|P2|STARTED|NRTI Comparison||0
950037|NCT00084136|2294807|P1|STARTED|NRTI Comparison||519
950038|NCT00084136|2294805|P3|NOT COMPLETED|PI Comparison||0
950039|NCT00084136|2294806|P2|NOT COMPLETED|PI Comparison||47
950040|NCT00084136|2294807|P1|NOT COMPLETED|PI Comparison||55
950041|NCT00084136|2294805|P3|COMPLETED|PI Comparison||0
950042|NCT00084136|2294806|P2|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|479
950043|NCT00084136|2294807|P1|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|464
950044|NCT00084136|2294805|P3|STARTED|PI Comparison||0
950045|NCT00084136|2294806|P2|STARTED|PI Comparison||526
950046|NCT00084136|2294807|P1|STARTED|PI Comparison||519
950047|NCT00076258|2294868|P2|NOT COMPLETED|Overall Study||3
950048|NCT00076258|2294869|P1|NOT COMPLETED|Overall Study||1
950049|NCT00076258|2294868|P2|COMPLETED|Overall Study||61
950050|NCT00076258|2294869|P1|COMPLETED|Overall Study||61
950051|NCT00076258|2294868|P2|STARTED|Overall Study||64
950052|NCT00076258|2294869|P1|STARTED|Overall Study||62
950053|NCT00076336|2294877|P2|NOT COMPLETED|Overall Study||56
950054|NCT00076336|2294878|P1|NOT COMPLETED|Overall Study||52
950055|NCT00076336|2294877|P2|COMPLETED|Overall Study||60
950056|NCT00076336|2294878|P1|COMPLETED|Overall Study||64
950057|NCT00076336|2294877|P2|Completed Week 104|Overall Study||62
950058|NCT00076336|2294878|P1|Completed Week 104|Overall Study||70
950059|NCT00076336|2294877|P2|Completed Week 52|Overall Study||94
950060|NCT00076336|2294878|P1|Completed Week 52|Overall Study||97
950061|NCT00076336|2294877|P2|Intent to Treat (ITT) Population|Overall Study|2 patients had no HBV DNA assessments after baseline and were excluded from ITT population.|114
950062|NCT00076336|2294878|P1|Intent to Treat (ITT) Population|Overall Study|1 patient had no HBV DNA assessments after baseline and was excluded from ITT population.|114
950063|NCT00076336|2294877|P2|Safety Population|Overall Study||116
950064|NCT00076336|2294878|P1|Safety Population|Overall Study|1 patient was randomized but never received study drug and not included in safety population.|115
950065|NCT00076336|2294877|P2|STARTED|Overall Study||116
950066|NCT00076336|2294878|P1|STARTED|Overall Study||116
950067|NCT00076570|2294894|P2|NOT COMPLETED|Overall Study||8
950068|NCT00076570|2294895|P1|NOT COMPLETED|Overall Study||8
950069|NCT00076570|2294894|P2|COMPLETED|Overall Study||8
950070|NCT00076570|2294895|P1|COMPLETED|Overall Study||7
950071|NCT00076570|2294894|P2|STARTED|Overall Study||16
950072|NCT00076570|2294895|P1|STARTED|Overall Study||15
950073|NCT00076687|2294906|P3|NOT COMPLETED|Overall Study||4
950074|NCT00076687|2294907|P2|NOT COMPLETED|Overall Study||5
950075|NCT00076687|2294908|P1|NOT COMPLETED|Overall Study||6
950076|NCT00076687|2294906|P3|COMPLETED|Overall Study||51
950077|NCT00076687|2294907|P2|COMPLETED|Overall Study||47
950078|NCT00076687|2294908|P1|COMPLETED|Overall Study||42
950079|NCT00076687|2294906|P3|STARTED|Overall Study||55
950080|NCT00076687|2294907|P2|STARTED|Overall Study||52
950081|NCT00076687|2294908|P1|STARTED|Overall Study||48
950082|NCT00076752|2294925|P1|NOT COMPLETED|Overall Study||3
950083|NCT00076752|2294925|P1|COMPLETED|Overall Study||6
950084|NCT00076752|2294925|P1|STARTED|Overall Study||9
950085|NCT00076804|2294946|P2|NOT COMPLETED|Overall Study||69
950086|NCT00076804|2294947|P1|NOT COMPLETED|Overall Study||60
950087|NCT00076804|2294946|P2|COMPLETED|Overall Study|102 completed week 48, 68 completed week 96|68
950088|NCT00076804|2294947|P1|COMPLETED|Overall Study|111 completed week 48, 77 completed week 96.|77
950089|NCT00076804|2294946|P2|STARTED|Overall Study||137
950090|NCT00076804|2294947|P1|STARTED|Overall Study||137
950091|NCT00076999|2294963|P5|NOT COMPLETED|Overall Study||25
950092|NCT00076999|2294964|P4|NOT COMPLETED|Overall Study||1
950093|NCT00076999|2294965|P3|NOT COMPLETED|Overall Study||17
950094|NCT00076999|2294966|P2|NOT COMPLETED|Overall Study||24
950095|NCT00076999|2294967|P1|NOT COMPLETED|Overall Study||12
950096|NCT00076999|2294963|P5|COMPLETED|Overall Study||9
950097|NCT00076999|2294964|P4|COMPLETED|Overall Study||5
950098|NCT00076999|2294965|P3|COMPLETED|Overall Study||2
950099|NCT00076999|2294966|P2|COMPLETED|Overall Study||7
950100|NCT00076999|2294967|P1|COMPLETED|Overall Study||13
950101|NCT00076999|2294963|P5|STARTED|Overall Study||34
950102|NCT00076999|2294964|P4|STARTED|Overall Study||6
950103|NCT00076999|2294965|P3|STARTED|Overall Study||19
950104|NCT00076999|2294966|P2|STARTED|Overall Study||31
950105|NCT00076999|2294967|P1|STARTED|Overall Study||25
950106|NCT00077207|2295084|P1|NOT COMPLETED|Overall Study||30
950107|NCT00077207|2295084|P1|COMPLETED|Overall Study||36
950108|NCT00077207|2295084|P1|STARTED|Overall Study||66
950109|NCT00077376|2295089|P1|NOT COMPLETED|Overall Study||22
950110|NCT00077376|2295089|P1|COMPLETED|Overall Study||39
950111|NCT00077376|2295089|P1|HER2+ in Central Testing|Overall Study||39
950112|NCT00077376|2295089|P1|Treated|Overall Study||59
950113|NCT00077376|2295089|P1|STARTED|Overall Study||61
950114|NCT00077610|2295103|P3|NOT COMPLETED|Overall Study||46
950115|NCT00077610|2295104|P2|NOT COMPLETED|Overall Study||56
950116|NCT00077610|2295105|P1|NOT COMPLETED|Overall Study||54
950117|NCT00077610|2295103|P3|COMPLETED|Overall Study||180
950118|NCT00077610|2295104|P2|COMPLETED|Overall Study||168
950119|NCT00077610|2295105|P1|COMPLETED|Overall Study||169
950120|NCT00077610|2295103|P3|Started Treatment|Overall Study||225
950121|NCT00077610|2295104|P2|Started Treatment|Overall Study||220
950122|NCT00077610|2295105|P1|Started Treatment|Overall Study||221
950123|NCT00077610|2295103|P3|STARTED|Overall Study||226
950124|NCT00077610|2295104|P2|STARTED|Overall Study||224
950125|NCT00077610|2295105|P1|STARTED|Overall Study||223
950126|NCT00077623|2295137|P3|NOT COMPLETED|Overall Study||32
950127|NCT00077623|2295138|P2|NOT COMPLETED|Overall Study||43
950128|NCT00077623|2295139|P1|NOT COMPLETED|Overall Study||36
950129|NCT00077623|2295137|P3|COMPLETED|Overall Study||159
950130|NCT00077623|2295138|P2|COMPLETED|Overall Study||148
950131|NCT00077623|2295139|P1|COMPLETED|Overall Study||154
950132|NCT00077623|2295137|P3|STARTED|Overall Study||191
950133|NCT00077623|2295138|P2|STARTED|Overall Study||191
950134|NCT00077623|2295139|P1|STARTED|Overall Study||190
950135|NCT00077636|2295173|P2|NOT COMPLETED|Overall Study||92
950136|NCT00077636|2295174|P1|NOT COMPLETED|Overall Study||44
950137|NCT00077636|2295173|P2|COMPLETED|Overall Study||641
950138|NCT00077636|2295174|P1|COMPLETED|Overall Study||692
950139|NCT00077636|2295173|P2|STARTED|Overall Study||733
950140|NCT00077636|2295174|P1|STARTED|Overall Study||736
950141|NCT00077649|2295196|P4|NOT COMPLETED|Overall Study||17
950142|NCT00077649|2295197|P3|NOT COMPLETED|Overall Study||15
950143|NCT00077649|2295198|P2|NOT COMPLETED|Overall Study||9
950144|NCT00077649|2295199|P1|NOT COMPLETED|Overall Study||14
950145|NCT00077649|2295196|P4|COMPLETED|Overall Study||30
950146|NCT00077649|2295197|P3|COMPLETED|Overall Study||32
950147|NCT00077649|2295198|P2|COMPLETED|Overall Study||38
950148|NCT00077649|2295199|P1|COMPLETED|Overall Study||33
950149|NCT00077649|2295196|P4|Completed 24 Weeks of Follow-up|Overall Study||31
950150|NCT00077649|2295197|P3|Completed 24 Weeks of Follow-up|Overall Study||36
950151|NCT00077649|2295198|P2|Completed 24 Weeks of Follow-up|Overall Study||40
950152|NCT00077649|2295199|P1|Completed 24 Weeks of Follow-up|Overall Study||36
950153|NCT00077649|2295196|P4|STARTED|Overall Study||47
950154|NCT00077649|2295197|P3|STARTED|Overall Study||47
950155|NCT00077649|2295198|P2|STARTED|Overall Study||47
950156|NCT00077649|2295199|P1|STARTED|Overall Study||47
950157|NCT00077675|2295247|P2|NOT COMPLETED|Overall Study||9
950158|NCT00077675|2295248|P1|NOT COMPLETED|Overall Study||11
950159|NCT00077675|2295247|P2|COMPLETED|Overall Study||89
950160|NCT00077675|2295248|P1|COMPLETED|Overall Study||92
950161|NCT00077675|2295247|P2|STARTED|Overall Study||98
950162|NCT00077675|2295248|P1|STARTED|Overall Study||103
950163|NCT00077766|2295256|P2|NOT COMPLETED|Overall Study||25
950164|NCT00077766|2295257|P1|NOT COMPLETED|Overall Study||39
950165|NCT00077766|2295256|P2|COMPLETED|Overall Study||131
950166|NCT00077766|2295257|P1|COMPLETED|Overall Study||118
950167|NCT00077766|2295256|P2|STARTED|Overall Study||156
950168|NCT00077766|2295257|P1|STARTED|Overall Study||157
950169|NCT00077857|2295277|P2|NOT COMPLETED|Overall Study||204
950170|NCT00077857|2295278|P1|NOT COMPLETED|Overall Study||201
950171|NCT00077857|2295277|P2|COMPLETED|Overall Study||31
950172|NCT00077857|2295278|P1|COMPLETED|Overall Study||34
950173|NCT00077857|2295277|P2|Safety Population: Actual Dose Received|Overall Study||248
950174|NCT00077857|2295278|P1|Safety Population: Actual Dose Received|Overall Study|14 patients in the 1250 dose arm received a lower dose and were included in the 825 arm for Safety.|217
950175|NCT00077857|2295277|P2|Received Study Drug|Overall Study||234
950176|NCT00077857|2295278|P1|Received Study Drug|Overall Study||231
950177|NCT00077857|2295277|P2|STARTED|Overall Study||235
950178|NCT00077857|2295278|P1|STARTED|Overall Study||235
950179|NCT00077922|2295296|P1|NOT COMPLETED|Overall Study||0
950180|NCT00077922|2295296|P1|COMPLETED|Overall Study||15
950181|NCT00077922|2295296|P1|STARTED|Overall Study||15
950182|NCT00077974|2295301|P1|NOT COMPLETED|Overall Study||104
950183|NCT00077974|2295301|P1|COMPLETED|Overall Study||2
950184|NCT00077974|2295301|P1|STARTED|Overall Study||106
950185|NCT00084266|2295318|P2|NOT COMPLETED|Overall Study||423
950186|NCT00084266|2295319|P1|NOT COMPLETED|Overall Study||441
950187|NCT00084266|2295318|P2|COMPLETED|Overall Study||184
950188|NCT00084266|2295319|P1|COMPLETED|Overall Study||177
950189|NCT00084266|2295318|P2|Treated|Overall Study||587
950190|NCT00084266|2295319|P1|Treated|Overall Study||597
950191|NCT00084266|2295318|P2|STARTED|Overall Study||607
950192|NCT00084266|2295319|P1|STARTED|Overall Study||618
950193|NCT00084318|2295355|P2|NOT COMPLETED|Overall Study||13
950194|NCT00084318|2295356|P1|NOT COMPLETED|Overall Study||22
950195|NCT00084318|2295355|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|106
950196|NCT00084318|2295356|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|97
950197|NCT00084318|2295355|P2|STARTED|Overall Study||119
950198|NCT00084318|2295356|P1|STARTED|Overall Study||119
950199|NCT00084383|2295372|P1|NOT COMPLETED|Overall Study||47
950200|NCT00084383|2295372|P1|COMPLETED|Overall Study||13
950201|NCT00084383|2295372|P1|STARTED|Overall Study||60
950202|NCT00084409|2295379|P2|NOT COMPLETED|Overall Study||12
950203|NCT00084409|2295380|P1|NOT COMPLETED|Overall Study||15
950204|NCT00084409|2295379|P2|COMPLETED|Overall Study|4 Current, 8 former|65
950205|NCT00084409|2295380|P1|COMPLETED|Overall Study|9 current, 6 former|60
950206|NCT00084409|2295379|P2|STARTED|Overall Study|41 current, 36 former|77
950207|NCT00084409|2295380|P1|STARTED|Overall Study|40 Current, 35 former|75
950208|NCT00084487|2295408|P1|NOT COMPLETED|Overall Study||1
950209|NCT00084487|2295408|P1|COMPLETED|Overall Study||20
950210|NCT00084487|2295408|P1|STARTED|Overall Study||21
950211|NCT00088153|2295418|P2|NOT COMPLETED|Overall Study||25
950212|NCT00088153|2295419|P1|NOT COMPLETED|Overall Study||24
950213|NCT00088153|2295418|P2|COMPLETED|Overall Study||30
950214|NCT00088153|2295419|P1|COMPLETED|Overall Study||31
950215|NCT00088153|2295418|P2|STARTED|Overall Study||55
950216|NCT00088153|2295419|P1|STARTED|Overall Study||55
950217|NCT00088166|2295431|P2|NOT COMPLETED|Overall Study||61
950218|NCT00088166|2295432|P1|NOT COMPLETED|Overall Study||53
950219|NCT00088166|2295431|P2|COMPLETED|Overall Study||39
950220|NCT00088166|2295432|P1|COMPLETED|Overall Study||47
950221|NCT00088166|2295431|P2|STARTED|Overall Study||100
950222|NCT00088166|2295432|P1|STARTED|Overall Study||100
950223|NCT00088218|2295456|P2|NOT COMPLETED|Overall Study||0
950224|NCT00088218|2295457|P1|NOT COMPLETED|Overall Study||0
950225|NCT00088218|2295456|P2|COMPLETED|Overall Study||79
950226|NCT00088218|2295457|P1|COMPLETED|Overall Study||16
950227|NCT00088218|2295456|P2|STARTED|Overall Study||79
950228|NCT00088218|2295457|P1|STARTED|Overall Study||16
950229|NCT00088374|2295463|P1|NOT COMPLETED|Overall Study||2
950230|NCT00088374|2295463|P1|COMPLETED|Overall Study||7
950231|NCT00088374|2295463|P1|STARTED|Overall Study||9
950232|NCT00088465|2295472|P1|NOT COMPLETED|Overall Study||561
950233|NCT00088465|2295472|P1|COMPLETED|Overall Study||370
950234|NCT00088465|2295472|P1|STARTED|Overall Study||931
950235|NCT00088530|2295497|P2|NOT COMPLETED|Overall Study||54
950236|NCT00088530|2295498|P1|NOT COMPLETED|Overall Study||50
950237|NCT00088530|2295497|P2|COMPLETED|Overall Study||16
950238|NCT00088530|2295498|P1|COMPLETED|Overall Study||20
950239|NCT00088530|2295497|P2|STARTED|Overall Study||70
950240|NCT00088530|2295498|P1|STARTED|Overall Study||70
950241|NCT00088595|2295510|P1|NOT COMPLETED|Overall Study||28
950242|NCT00088595|2295510|P1|COMPLETED|Overall Study||17
950243|NCT00088595|2295510|P1|STARTED|Overall Study||45
950244|NCT00088621|2295526|P1|NOT COMPLETED|Overall Study||54
950245|NCT00088621|2295526|P1|COMPLETED|Overall Study||7
950246|NCT00088621|2295526|P1|STARTED|Overall Study||61
950247|NCT00088634|2295532|P2|NOT COMPLETED|Overall Study||43
950248|NCT00088634|2295533|P1|NOT COMPLETED|Overall Study||38
950249|NCT00088634|2295532|P2|COMPLETED|Overall Study||47
950250|NCT00088634|2295533|P1|COMPLETED|Overall Study||52
950251|NCT00088634|2295532|P2|STARTED|Overall Study||90
950252|NCT00088634|2295533|P1|STARTED|Overall Study||90
950253|NCT00088881|2295545|P1|NOT COMPLETED|Step 3 - Radiation Therapy||0
950254|NCT00088881|2295545|P1|COMPLETED|Step 3 - Radiation Therapy||1
950255|NCT00088881|2295545|P1|STARTED|Step 3 - Radiation Therapy||1
950256|NCT00088881|2295545|P1|NOT COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||11
950257|NCT00088881|2295545|P1|COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||45
950258|NCT00088881|2295545|P1|Eligible and Treated|Step 2 - Zevalin™ Radioimmunotherapy||48
950259|NCT00088881|2295545|P1|STARTED|Step 2 - Zevalin™ Radioimmunotherapy|This includes all patients who received step 2 treatment regardless of eligibility.|56
950260|NCT00088881|2295545|P1|NOT COMPLETED|Step 1 - R-CHOP||14
950261|NCT00088881|2295545|P1|COMPLETED|Step 1 - R-CHOP||48
950262|NCT00088881|2295545|P1|Eligible and Treated|Step 1 - R-CHOP||53
950263|NCT00088881|2295545|P1|STARTED|Step 1 - R-CHOP||62
950264|NCT00088907|2295556|P2|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||0
950265|NCT00088907|2295557|P1|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||24
950266|NCT00088907|2295556|P2|COMPLETED|Single Gefitinib Treatment (Step 2)||0
950267|NCT00088907|2295557|P1|COMPLETED|Single Gefitinib Treatment (Step 2)||0
950268|NCT00088907|2295556|P2|Treated|Single Gefitinib Treatment (Step 2)||0
950269|NCT00088907|2295557|P1|Treated|Single Gefitinib Treatment (Step 2)||19
950270|NCT00088907|2295556|P2|STARTED|Single Gefitinib Treatment (Step 2)|Cross over to single gefitinib therapy at progression was allowed for patients on Arm I only.|0
950271|NCT00088907|2295557|P1|STARTED|Single Gefitinib Treatment (Step 2)|Patients on Arm I could cross over to gefitinib after disease progression on step 1.|24
950272|NCT00088907|2295556|P2|NOT COMPLETED|Randomized Study (Step 1)||134
950273|NCT00088907|2295557|P1|NOT COMPLETED|Randomized Study (Step 1)||136
950274|NCT00088907|2295556|P2|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles|0
950275|NCT00088907|2295557|P1|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles.|0
950276|NCT00088907|2295556|P2|Eligible and Treated|Randomized Study (Step 1)||122
950277|NCT00088907|2295557|P1|Eligible and Treated|Randomized Study (Step 1)||117
950278|NCT00088907|2295556|P2|Eligible|Randomized Study (Step 1)||122
950279|NCT00088907|2295557|P1|Eligible|Randomized Study (Step 1)||117
950280|NCT00088907|2295556|P2|Treated|Randomized Study (Step 1)||124
950281|NCT00088907|2295557|P1|Treated|Randomized Study (Step 1)||129
950282|NCT00088907|2295556|P2|STARTED|Randomized Study (Step 1)||134
950283|NCT00088907|2295557|P1|STARTED|Randomized Study (Step 1)||136
950284|NCT00088972|2295570|P2|NOT COMPLETED|Overall Study||4
950285|NCT00088972|2295571|P1|NOT COMPLETED|Overall Study||2
950286|NCT00088972|2295570|P2|COMPLETED|Overall Study||1
950287|NCT00088972|2295571|P1|COMPLETED|Overall Study||1
950288|NCT00088972|2295570|P2|STARTED|Overall Study||5
950289|NCT00088972|2295571|P1|STARTED|Overall Study||3
950290|NCT00088985|2295577|P1|NOT COMPLETED|Overall Study||3
950291|NCT00088985|2295577|P1|COMPLETED|Overall Study||4
950292|NCT00088985|2295577|P1|STARTED|Overall Study||7
950293|NCT00089011|2295584|P2|NOT COMPLETED|Overall Study||0
950294|NCT00089011|2295585|P1|NOT COMPLETED|Overall Study||0
950295|NCT00089011|2295584|P2|COMPLETED|Overall Study||50
950296|NCT00089011|2295585|P1|COMPLETED|Overall Study||100
950297|NCT00089011|2295584|P2|STARTED|Overall Study||50
950298|NCT00089011|2295585|P1|STARTED|Overall Study||100
950299|NCT00089076|2295605|P1|NOT COMPLETED|Overall Study||10
950300|NCT00089076|2295605|P1|COMPLETED|Overall Study||8
950301|NCT00089076|2295605|P1|STARTED|Overall Study||18
950302|NCT00089141|2295618|P2|NOT COMPLETED|Overall Study||24
950303|NCT00089141|2295619|P1|NOT COMPLETED|Overall Study||18
950304|NCT00089141|2295618|P2|COMPLETED|Overall Study||53
950305|NCT00089141|2295619|P1|COMPLETED|Overall Study||56
950306|NCT00089141|2295618|P2|STARTED|Overall Study||77
950307|NCT00089141|2295619|P1|STARTED|Overall Study||74
950308|NCT00089297|2295641|P1|NOT COMPLETED|Overall Study||38
950309|NCT00089297|2295641|P1|COMPLETED|Overall Study||36
950310|NCT00089297|2295641|P1|Eligible|Overall Study||63
950311|NCT00089297|2295641|P1|Treated|Overall Study||70
950312|NCT00089297|2295641|P1|STARTED|Overall Study||74
950313|NCT00089414|2295651|P3|NOT COMPLETED|Overall Study||0
950314|NCT00089414|2295652|P2|NOT COMPLETED|Overall Study||0
950315|NCT00089414|2295653|P1|NOT COMPLETED|Overall Study||0
950316|NCT00089414|2295651|P3|COMPLETED|Overall Study||2
950317|NCT00089414|2295652|P2|COMPLETED|Overall Study||1
950318|NCT00089414|2295653|P1|COMPLETED|Overall Study||2
950319|NCT00089414|2295651|P3|STARTED|Overall Study||2
950320|NCT00089414|2295652|P2|STARTED|Overall Study||1
950321|NCT00089414|2295653|P1|STARTED|Overall Study||2
950322|NCT00089479|2295669|P2|NOT COMPLETED|Overall Study||289
950323|NCT00089479|2295670|P1|NOT COMPLETED|Overall Study||331
950324|NCT00089479|2295669|P2|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|1018
950325|NCT00089479|2295670|P1|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|973
950326|NCT00089479|2295669|P2|Received Treatment|Overall Study|Safety Population (includes 5 patients randomized to ACT, who received ACXT)|1283
950327|NCT00089479|2295670|P1|Received Treatment|Overall Study|Safety Population (includes 19 patients randomized to ACXT, who received ACT)|1305
950328|NCT00089479|2295669|P2|STARTED|Overall Study||1307
950329|NCT00089479|2295670|P1|STARTED|Overall Study||1304
950330|NCT00089505|2295698|P4|NOT COMPLETED|Overall Study||21
950331|NCT00089505|2295699|P3|NOT COMPLETED|Overall Study||21
950332|NCT00089505|2295700|P2|NOT COMPLETED|Overall Study||2
950333|NCT00089505|2295701|P1|NOT COMPLETED|Overall Study||9
950334|NCT00089505|2295698|P4|COMPLETED|Overall Study||230
950335|NCT00089505|2295699|P3|COMPLETED|Overall Study||228
950336|NCT00089505|2295700|P2|COMPLETED|Overall Study|The results for NVP/LPV_r were through database cutoff for DSMB review (by 6 October 2008).|118
950337|NCT00089505|2295701|P1|COMPLETED|Overall Study|The results for NVP/NVP were through database cutoff for DSMB review (by 6 October 2008).|112
950338|NCT00089505|2295698|P4|STARTED|Overall Study||251
950339|NCT00089505|2295699|P3|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|249
950340|NCT00089505|2295700|P2|STARTED|Overall Study||120
950341|NCT00089505|2295701|P1|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|121
950342|NCT00089544|2295745|P2|NOT COMPLETED|Overall Study||0
950343|NCT00089544|2295746|P1|NOT COMPLETED|Overall Study||1
950344|NCT00089544|2295745|P2|COMPLETED|Overall Study||7
950345|NCT00089544|2295746|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|15
950346|NCT00089544|2295745|P2|STARTED|Overall Study||7
950347|NCT00089544|2295746|P1|STARTED|Overall Study||16
950348|NCT00089583|2295758|P2|NOT COMPLETED|Overall Study||38
950349|NCT00089583|2295759|P1|NOT COMPLETED|Overall Study||7
950350|NCT00089583|2295758|P2|COMPLETED|Overall Study||51
950351|NCT00089583|2295759|P1|COMPLETED|Overall Study||13
950352|NCT00089583|2295758|P2|STARTED|Overall Study||89
950353|NCT00089583|2295759|P1|STARTED|Overall Study||20
950354|NCT00089609|2295853|P2|NOT COMPLETED|Overall Study||1
950355|NCT00089609|2295854|P1|NOT COMPLETED|Overall Study||3
950356|NCT00089609|2295853|P2|COMPLETED|Overall Study||12
950357|NCT00089609|2295854|P1|COMPLETED|Overall Study||57
950358|NCT00089609|2295853|P2|STARTED|Overall Study||13
950359|NCT00089609|2295854|P1|STARTED|Overall Study||60
950360|NCT00089635|2295871|P1|NOT COMPLETED|Overall Study||43
950361|NCT00089635|2295871|P1|COMPLETED|Overall Study||160
950362|NCT00089635|2295871|P1|STARTED|Overall Study||203
950363|NCT00089648|2295883|P1|NOT COMPLETED|Overall Study||41
950364|NCT00089648|2295883|P1|COMPLETED|Overall Study||20
950365|NCT00089648|2295883|P1|STARTED|Overall Study||61
950366|NCT00089661|2295901|P2|NOT COMPLETED|Overall Study||26
950367|NCT00089661|2295902|P1|NOT COMPLETED|Overall Study||21
950368|NCT00089661|2295901|P2|COMPLETED|Overall Study||99
950369|NCT00089661|2295902|P1|COMPLETED|Overall Study||106
950370|NCT00089661|2295901|P2|STARTED|Overall Study||125
950371|NCT00089661|2295902|P1|STARTED|Overall Study||127
950372|NCT00089674|2295920|P2|NOT COMPLETED|Overall Study||267
950373|NCT00089674|2295921|P1|NOT COMPLETED|Overall Study||289
950374|NCT00089674|2295920|P2|COMPLETED|Overall Study||467
950375|NCT00089674|2295921|P1|COMPLETED|Overall Study||445
950376|NCT00089674|2295920|P2|Received Study Drug|Overall Study||726
950377|NCT00089674|2295921|P1|Received Study Drug|Overall Study||730
950378|NCT00089674|2295920|P2|STARTED|Overall Study||734
950379|NCT00089674|2295921|P1|STARTED|Overall Study||734
950380|NCT00089752|2295947|P2|NOT COMPLETED|Overall Study||22
950381|NCT00089752|2295948|P1|NOT COMPLETED|Overall Study||20
950382|NCT00089752|2295947|P2|COMPLETED|Overall Study||118
950383|NCT00089752|2295948|P1|COMPLETED|Overall Study||121
950384|NCT00089752|2295947|P2|STARTED|Overall Study||140
950385|NCT00089752|2295948|P1|STARTED|Overall Study||141
950386|NCT00089778|2295969|P3|NOT COMPLETED|Overall Study||1
950387|NCT00089778|2295970|P2|NOT COMPLETED|Overall Study||0
950388|NCT00089778|2295971|P1|NOT COMPLETED|Overall Study||0
950389|NCT00089778|2295969|P3|COMPLETED|Overall Study||7
950390|NCT00089778|2295970|P2|COMPLETED|Overall Study||1
950391|NCT00089778|2295971|P1|COMPLETED|Overall Study||2
950392|NCT00089778|2295969|P3|STARTED|Overall Study||8
950393|NCT00089778|2295970|P2|STARTED|Overall Study||1
950394|NCT00089778|2295971|P1|STARTED|Overall Study||2
950395|NCT00089791|2295984|P2|NOT COMPLETED|Overall Study||630
950396|NCT00089791|2295985|P1|NOT COMPLETED|Overall Study||700
950397|NCT00089791|2295984|P2|COMPLETED|Overall Study||3272
950398|NCT00089791|2295985|P1|COMPLETED|Overall Study||3206
950399|NCT00089791|2295984|P2|Safety Analysis Set|Overall Study||3886
950400|NCT00089791|2295985|P1|Safety Analysis Set|Overall Study|7 participants in the placebo arm received ≥1 dose of denosumab & were analyzed in the denosumab arm|3876
950401|NCT00089791|2295984|P2|Received Study Medication|Overall Study||3879
950402|NCT00089791|2295985|P1|Received Study Medication|Overall Study||3883
950403|NCT00089791|2295984|P2|STARTED|Overall Study||3902
950404|NCT00089791|2295985|P1|STARTED|Overall Study||3906
950405|NCT00089843|2295999|P4|NOT COMPLETED|Overall Study||7
950406|NCT00089843|2296000|P3|NOT COMPLETED|Overall Study||5
950407|NCT00089843|2296001|P2|NOT COMPLETED|Overall Study||4
950408|NCT00089843|2296002|P1|NOT COMPLETED|Overall Study||2
950409|NCT00089843|2295999|P4|COMPLETED|Overall Study||11
950410|NCT00089843|2296000|P3|COMPLETED|Overall Study||15
950411|NCT00089843|2296001|P2|COMPLETED|Overall Study||16
950412|NCT00089843|2296002|P1|COMPLETED|Overall Study||17
950413|NCT00089843|2295999|P4|STARTED|Overall Study||18
950414|NCT00089843|2296000|P3|STARTED|Overall Study||20
950415|NCT00089843|2296001|P2|STARTED|Overall Study||20
950416|NCT00089843|2296002|P1|STARTED|Overall Study||19
950417|NCT00089895|2296014|P2|NOT COMPLETED|Overall Study||42
950418|NCT00089895|2296015|P1|NOT COMPLETED|Overall Study||35
950419|NCT00089895|2296014|P2|COMPLETED|Overall Study|Number of Subjects treated|4642
950420|NCT00089895|2296015|P1|COMPLETED|Overall Study|Number of Subjects treated|4687
950421|NCT00089895|2296014|P2|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4684
950422|NCT00089895|2296015|P1|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4722
950423|NCT00089986|2296026|P3|NOT COMPLETED|Overall Study||10
950424|NCT00089986|2296027|P2|NOT COMPLETED|Overall Study||24
950425|NCT00089986|2296028|P1|NOT COMPLETED|Overall Study||15
950426|NCT00089986|2296026|P3|COMPLETED|Overall Study||172
950427|NCT00089986|2296027|P2|COMPLETED|Overall Study||574
950428|NCT00089986|2296028|P1|COMPLETED|Overall Study||584
950429|NCT00089986|2296026|P3|STARTED|Overall Study||182
950430|NCT00089986|2296027|P2|STARTED|Overall Study||598
950431|NCT00089986|2296028|P1|STARTED|Overall Study||599
950432|NCT00089999|2296047|P2|NOT COMPLETED|Overall Study||69
950433|NCT00089999|2296048|P1|NOT COMPLETED|Overall Study||69
950434|NCT00089999|2296047|P2|COMPLETED|Overall Study||0
950435|NCT00089999|2296048|P1|COMPLETED|Overall Study||0
950436|NCT00089999|2296047|P2|STARTED|Overall Study||69
950437|NCT00089999|2296048|P1|STARTED|Overall Study||69
950438|NCT00090051|2296070|P2|NOT COMPLETED|Overall Study||95
950439|NCT00090051|2296071|P1|NOT COMPLETED|Overall Study||109
950440|NCT00090051|2296070|P2|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|181
950441|NCT00090051|2296071|P1|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|167
950442|NCT00090051|2296070|P2|Safety Population; Received Study Drug|Overall Study||274
950443|NCT00090051|2296071|P1|Safety Population; Received Study Drug|Overall Study||272
950444|NCT00090051|2296070|P2|STARTED|Overall Study||276
950445|NCT00090051|2296071|P1|STARTED|Overall Study||276
950446|NCT00090103|2296108|P3|NOT COMPLETED|16-Week Safety Follow-up Period||457
950447|NCT00090103|2296109|P2|NOT COMPLETED|16-Week Safety Follow-up Period||410
950448|NCT00090103|2296110|P1|NOT COMPLETED|16-Week Safety Follow-up Period||374
950449|NCT00090103|2296108|P3|COMPLETED|16-Week Safety Follow-up Period||1143
950450|NCT00090103|2296109|P2|COMPLETED|16-Week Safety Follow-up Period||1205
950451|NCT00090103|2296110|P1|COMPLETED|16-Week Safety Follow-up Period||1224
950452|NCT00090103|2296108|P3|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1600
950453|NCT00090103|2296109|P2|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1615
950454|NCT00090103|2296110|P1|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1598
950455|NCT00090103|2296108|P3|NOT COMPLETED|Four-Year Double-Blind Treatment Period||622
950456|NCT00090103|2296109|P2|NOT COMPLETED|Four-Year Double-Blind Treatment Period||530
950457|NCT00090103|2296110|P1|NOT COMPLETED|Four-Year Double-Blind Treatment Period||497
950458|NCT00090103|2296108|P3|COMPLETED|Four-Year Double-Blind Treatment Period||989
950459|NCT00090103|2296109|P2|COMPLETED|Four-Year Double-Blind Treatment Period||1093
950460|NCT00090103|2296110|P1|COMPLETED|Four-Year Double-Blind Treatment Period||1113
950461|NCT00090103|2296108|P3|STARTED|Four-Year Double-Blind Treatment Period||1611
950462|NCT00090103|2296109|P2|STARTED|Four-Year Double-Blind Treatment Period||1623
950463|NCT00090103|2296110|P1|STARTED|Four-Year Double-Blind Treatment Period||1610
950464|NCT00090142|2296208|P2|NOT COMPLETED|Treatment Period II||0
950465|NCT00090142|2296209|P1|NOT COMPLETED|Treatment Period II||1
950466|NCT00090142|2296208|P2|COMPLETED|Treatment Period II||28
950467|NCT00090142|2296209|P1|COMPLETED|Treatment Period II||25
950468|NCT00090142|2296208|P2|STARTED|Treatment Period II||28
950469|NCT00090142|2296209|P1|STARTED|Treatment Period II||26
950470|NCT00090142|2296208|P2|NOT COMPLETED|Treatment Period I||3
950471|NCT00090142|2296209|P1|NOT COMPLETED|Treatment Period I||5
950472|NCT00090142|2296208|P2|COMPLETED|Treatment Period I||28
950473|NCT00090142|2296209|P1|COMPLETED|Treatment Period I||26
950474|NCT00090142|2296208|P2|STARTED|Treatment Period I||31
950475|NCT00090142|2296209|P1|STARTED|Treatment Period I|1 patient was lost to follow-up after randomization and did not receive any study drug.|31
950476|NCT00090220|2296239|P6|NOT COMPLETED|Long-term Follow-up (EXT2)||28
950477|NCT00090220|2296240|P5|NOT COMPLETED|Long-term Follow-up (EXT2)||44
950478|NCT00090220|2296241|P4|NOT COMPLETED|Long-term Follow-up (EXT2)||0
950479|NCT00090220|2296242|P3|NOT COMPLETED|Long-term Follow-up (EXT2)||0
950480|NCT00090220|2296243|P2|NOT COMPLETED|Long-term Follow-up (EXT2)||0
950481|NCT00090220|2296244|P1|NOT COMPLETED|Long-term Follow-up (EXT2)||0
950482|NCT00090220|2296239|P6|COMPLETED|Long-term Follow-up (EXT2)||623
950483|NCT00090220|2296240|P5|COMPLETED|Long-term Follow-up (EXT2)||641
950484|NCT00090220|2296241|P4|COMPLETED|Long-term Follow-up (EXT2)||0
950485|NCT00090220|2296242|P3|COMPLETED|Long-term Follow-up (EXT2)||0
950486|NCT00090220|2296243|P2|COMPLETED|Long-term Follow-up (EXT2)||0
950487|NCT00090220|2296244|P1|COMPLETED|Long-term Follow-up (EXT2)||0
950488|NCT00090220|2296239|P6|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|651
950489|NCT00090220|2296240|P5|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|685
950490|NCT00090220|2296241|P4|STARTED|Long-term Follow-up (EXT2)||0
950491|NCT00090220|2296242|P3|STARTED|Long-term Follow-up (EXT2)||0
950492|NCT00090220|2296243|P2|STARTED|Long-term Follow-up (EXT2)||0
950493|NCT00090220|2296244|P1|STARTED|Long-term Follow-up (EXT2)||0
950494|NCT00090220|2296239|P6|NOT COMPLETED|Extension 1 (EXT1)||0
950495|NCT00090220|2296240|P5|NOT COMPLETED|Extension 1 (EXT1)||0
950496|NCT00090220|2296241|P4|NOT COMPLETED|Extension 1 (EXT1)||2
950497|NCT00090220|2296242|P3|NOT COMPLETED|Extension 1 (EXT1)||55
950498|NCT00090220|2296243|P2|NOT COMPLETED|Extension 1 (EXT1)||0
950499|NCT00090220|2296244|P1|NOT COMPLETED|Extension 1 (EXT1)||0
950500|NCT00090220|2296239|P6|COMPLETED|Extension 1 (EXT1)||0
950501|NCT00090220|2296240|P5|COMPLETED|Extension 1 (EXT1)||0
950502|NCT00090220|2296241|P4|COMPLETED|Extension 1 (EXT1)||5
950503|NCT00090220|2296242|P3|COMPLETED|Extension 1 (EXT1)||1267
950504|NCT00090220|2296243|P2|COMPLETED|Extension 1 (EXT1)||0
950505|NCT00090220|2296244|P1|COMPLETED|Extension 1 (EXT1)||0
950506|NCT00090220|2296239|P6|Vaccinated|Extension 1 (EXT1)||0
950507|NCT00090220|2296240|P5|Vaccinated|Extension 1 (EXT1)||0
950508|NCT00090220|2296241|P4|Vaccinated|Extension 1 (EXT1)||7
950509|NCT00090220|2296242|P3|Vaccinated|Extension 1 (EXT1)||1321
950510|NCT00090220|2296243|P2|Vaccinated|Extension 1 (EXT1)||0
950511|NCT00090220|2296244|P1|Vaccinated|Extension 1 (EXT1)||0
950512|NCT00090220|2296239|P6|STARTED|Extension 1 (EXT1)||0
950513|NCT00090220|2296240|P5|STARTED|Extension 1 (EXT1)||0
950514|NCT00090220|2296241|P4|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|7
950515|NCT00090220|2296242|P3|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1322
950516|NCT00090220|2296243|P2|STARTED|Extension 1 (EXT1)||0
950517|NCT00090220|2296244|P1|STARTED|Extension 1 (EXT1)||0
950518|NCT00090220|2296239|P6|NOT COMPLETED|Base Study Follow-up Period||0
950519|NCT00090220|2296240|P5|NOT COMPLETED|Base Study Follow-up Period||0
950520|NCT00090220|2296241|P4|NOT COMPLETED|Base Study Follow-up Period||0
950521|NCT00090220|2296242|P3|NOT COMPLETED|Base Study Follow-up Period||0
950522|NCT00090220|2296243|P2|NOT COMPLETED|Base Study Follow-up Period||164
950523|NCT00090220|2296244|P1|NOT COMPLETED|Base Study Follow-up Period||160
950524|NCT00090220|2296239|P6|COMPLETED|Base Study Follow-up Period||0
950525|NCT00090220|2296240|P5|COMPLETED|Base Study Follow-up Period||0
950526|NCT00090220|2296241|P4|COMPLETED|Base Study Follow-up Period||0
950527|NCT00090220|2296242|P3|COMPLETED|Base Study Follow-up Period||0
950528|NCT00090220|2296243|P2|COMPLETED|Base Study Follow-up Period||1687
950529|NCT00090220|2296244|P1|COMPLETED|Base Study Follow-up Period||1695
950530|NCT00090220|2296239|P6|STARTED|Base Study Follow-up Period||0
950531|NCT00090220|2296240|P5|STARTED|Base Study Follow-up Period||0
950532|NCT00090220|2296241|P4|STARTED|Base Study Follow-up Period||0
950533|NCT00090220|2296242|P3|STARTED|Base Study Follow-up Period||0
950534|NCT00090220|2296243|P2|STARTED|Base Study Follow-up Period|5 participants did not complete the Vaccination Period but entered the Follow-up Period.|1851
950611|NCT00090285|2296381|P3|Vaccinated|Base Study Vaccination Period||0
950535|NCT00090220|2296244|P1|STARTED|Base Study Follow-up Period|8 participants did not complete the Vaccination Period but entered the Follow-up Period.|1855
950536|NCT00090220|2296239|P6|NOT COMPLETED|Base Study Vaccination Period||0
950537|NCT00090220|2296240|P5|NOT COMPLETED|Base Study Vaccination Period||0
950538|NCT00090220|2296241|P4|NOT COMPLETED|Base Study Vaccination Period||0
950539|NCT00090220|2296242|P3|NOT COMPLETED|Base Study Vaccination Period||0
950540|NCT00090220|2296243|P2|NOT COMPLETED|Base Study Vaccination Period||63
950541|NCT00090220|2296244|P1|NOT COMPLETED|Base Study Vaccination Period||64
950542|NCT00090220|2296239|P6|COMPLETED|Base Study Vaccination Period||0
950543|NCT00090220|2296240|P5|COMPLETED|Base Study Vaccination Period||0
950544|NCT00090220|2296241|P4|COMPLETED|Base Study Vaccination Period||0
950545|NCT00090220|2296242|P3|COMPLETED|Base Study Vaccination Period||0
950546|NCT00090220|2296243|P2|COMPLETED|Base Study Vaccination Period||1845
950547|NCT00090220|2296244|P1|COMPLETED|Base Study Vaccination Period||1847
950548|NCT00090220|2296239|P6|Vaccinated|Base Study Vaccination Period||0
950549|NCT00090220|2296240|P5|Vaccinated|Base Study Vaccination Period||0
950550|NCT00090220|2296241|P4|Vaccinated|Base Study Vaccination Period||0
950551|NCT00090220|2296242|P3|Vaccinated|Base Study Vaccination Period||0
950552|NCT00090220|2296243|P2|Vaccinated|Base Study Vaccination Period||1907
950553|NCT00090220|2296244|P1|Vaccinated|Base Study Vaccination Period||1910
950554|NCT00090220|2296239|P6|STARTED|Base Study Vaccination Period||0
950555|NCT00090220|2296240|P5|STARTED|Base Study Vaccination Period||0
950556|NCT00090220|2296241|P4|STARTED|Base Study Vaccination Period||0
950557|NCT00090220|2296242|P3|STARTED|Base Study Vaccination Period||0
950558|NCT00090220|2296243|P2|STARTED|Base Study Vaccination Period||1908
950559|NCT00090220|2296244|P1|STARTED|Base Study Vaccination Period||1911
950560|NCT00090233|2296338|P2|NOT COMPLETED|Overall Study||5065
950561|NCT00090233|2296339|P1|NOT COMPLETED|Overall Study||4999
950562|NCT00090233|2296338|P2|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29565
950563|NCT00090233|2296339|P1|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29645
950564|NCT00090233|2296338|P2|Vaccinated at Visit 3|Overall Study||29598
950565|NCT00090233|2296339|P1|Vaccinated at Visit 3|Overall Study||29667
950566|NCT00090233|2296338|P2|Vaccinated at Visit 2|Overall Study||31066
950567|NCT00090233|2296339|P1|Vaccinated at Visit 2|Overall Study||31052
950568|NCT00090233|2296338|P2|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 627|34003
950569|NCT00090233|2296339|P1|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 609|34035
950570|NCT00090233|2296338|P2|STARTED|Overall Study|Evaluated by data safety monitoring board when they recommended stopping enrollment|34630
950571|NCT00090233|2296339|P1|STARTED|Overall Study|Evaluated by data safety monitoring board (DSMB) when they recommended stopping enrollment|34644
950572|NCT00090259|2296363|P2|NOT COMPLETED|Overall Study||48
950573|NCT00090259|2296364|P1|NOT COMPLETED|Overall Study||62
950574|NCT00090259|2296363|P2|COMPLETED|Overall Study|Completed follow-up: 1005 on drug, 233 off drug,& 635 at death (death was considered an endpoint)|1873
950575|NCT00090259|2296364|P1|COMPLETED|Overall Study|Completed follow-up: 963 on drug, 223 off drug, & 665 at death (death was considered an endpoint)|1851
950576|NCT00090259|2296363|P2|STARTED|Overall Study||1921
950577|NCT00090259|2296364|P1|STARTED|Overall Study||1913
950578|NCT00090285|2296380|P4|NOT COMPLETED|Extension 1||1
950579|NCT00090285|2296381|P3|NOT COMPLETED|Extension 1||57
950580|NCT00090285|2296382|P2|NOT COMPLETED|Extension 1||0
950581|NCT00090285|2296383|P1|NOT COMPLETED|Extension 1||0
950582|NCT00090285|2296380|P4|COMPLETED|Extension 1||15
950583|NCT00090285|2296381|P3|COMPLETED|Extension 1||1041
950584|NCT00090285|2296382|P2|COMPLETED|Extension 1||0
950585|NCT00090285|2296383|P1|COMPLETED|Extension 1||0
950586|NCT00090285|2296380|P4|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|16
950587|NCT00090285|2296381|P3|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1098
950588|NCT00090285|2296382|P2|STARTED|Extension 1||0
950589|NCT00090285|2296383|P1|STARTED|Extension 1||0
950590|NCT00090285|2296380|P4|NOT COMPLETED|Base Study Follow-up Period||0
950591|NCT00090285|2296381|P3|NOT COMPLETED|Base Study Follow-up Period||0
950592|NCT00090285|2296382|P2|NOT COMPLETED|Base Study Follow-up Period||342
950593|NCT00090285|2296383|P1|NOT COMPLETED|Base Study Follow-up Period||335
950594|NCT00090285|2296380|P4|COMPLETED|Base Study Follow-up Period||0
950595|NCT00090285|2296381|P3|COMPLETED|Base Study Follow-up Period||0
950596|NCT00090285|2296382|P2|COMPLETED|Base Study Follow-up Period||1479
950597|NCT00090285|2296383|P1|COMPLETED|Base Study Follow-up Period||1487
950598|NCT00090285|2296380|P4|STARTED|Base Study Follow-up Period||0
950599|NCT00090285|2296381|P3|STARTED|Base Study Follow-up Period||0
950600|NCT00090285|2296382|P2|STARTED|Base Study Follow-up Period|7 subjects who did not receive 3 doses of placebo in base study continued into the Follow-up Period|1821
950601|NCT00090285|2296383|P1|STARTED|Base Study Follow-up Period|4 subjects who did not receive 3 doses of vaccine in base study continued into the Follow-up Period|1822
950602|NCT00090285|2296380|P4|NOT COMPLETED|Base Study Vaccination Period||0
950603|NCT00090285|2296381|P3|NOT COMPLETED|Base Study Vaccination Period||0
950604|NCT00090285|2296382|P2|NOT COMPLETED|Base Study Vaccination Period||219
950605|NCT00090285|2296383|P1|NOT COMPLETED|Base Study Vaccination Period||214
950606|NCT00090285|2296380|P4|COMPLETED|Base Study Vaccination Period||0
950607|NCT00090285|2296381|P3|COMPLETED|Base Study Vaccination Period||0
950608|NCT00090285|2296382|P2|COMPLETED|Base Study Vaccination Period||1814
950609|NCT00090285|2296383|P1|COMPLETED|Base Study Vaccination Period||1818
950610|NCT00090285|2296380|P4|Vaccinated|Base Study Vaccination Period||0
950612|NCT00090285|2296382|P2|Vaccinated|Base Study Vaccination Period||2030
950613|NCT00090285|2296383|P1|Vaccinated|Base Study Vaccination Period||2025
950614|NCT00090285|2296380|P4|STARTED|Base Study Vaccination Period||0
950615|NCT00090285|2296381|P3|STARTED|Base Study Vaccination Period||0
950616|NCT00090285|2296382|P2|STARTED|Base Study Vaccination Period||2033
950617|NCT00090285|2296383|P1|STARTED|Base Study Vaccination Period||2032
950618|NCT00090363|2296403|P3|NOT COMPLETED|Overall Study||96
950619|NCT00090363|2296404|P2|NOT COMPLETED|Overall Study||107
950620|NCT00090363|2296405|P1|NOT COMPLETED|Overall Study||106
950621|NCT00090363|2296403|P3|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|2
950622|NCT00090363|2296404|P2|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|0
950623|NCT00090363|2296405|P1|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|1
950624|NCT00090363|2296403|P3|Received Study Treatment.|Overall Study||98
950625|NCT00090363|2296404|P2|Received Study Treatment.|Overall Study||107
950626|NCT00090363|2296405|P1|Received Study Treatment.|Overall Study||107
950627|NCT00090363|2296403|P3|STARTED|Overall Study||98
950628|NCT00090363|2296404|P2|STARTED|Overall Study||107
950629|NCT00090363|2296405|P1|STARTED|Overall Study||107
950630|NCT00090402|2296428|P3|NOT COMPLETED|Overall Study||1
950631|NCT00090402|2296429|P2|NOT COMPLETED|Overall Study||2
950632|NCT00090402|2296430|P1|NOT COMPLETED|Overall Study||2
950633|NCT00090402|2296428|P3|COMPLETED|Overall Study||12
950634|NCT00090402|2296429|P2|COMPLETED|Overall Study||11
950635|NCT00090402|2296430|P1|COMPLETED|Overall Study||11
950636|NCT00090402|2296428|P3|STARTED|Overall Study||13
950637|NCT00090402|2296429|P2|STARTED|Overall Study||13
950638|NCT00090402|2296430|P1|STARTED|Overall Study||13
950639|NCT00090493|2296444|P1|NOT COMPLETED|Overall Study||2
950640|NCT00090493|2296444|P1|COMPLETED|Overall Study||2
950641|NCT00090493|2296444|P1|STARTED|Overall Study||4
950642|NCT00090519|2296450|P2|NOT COMPLETED|Overall Study||75
950643|NCT00090519|2296451|P1|NOT COMPLETED|Overall Study||73
950644|NCT00090519|2296450|P2|COMPLETED|Overall Study||285
950645|NCT00090519|2296451|P1|COMPLETED|Overall Study||298
950646|NCT00090519|2296450|P2|STARTED|Overall Study||360
950647|NCT00090519|2296451|P1|STARTED|Overall Study||371
950648|NCT00090545|2296477|P2|NOT COMPLETED|Overall Study||24
950649|NCT00090545|2296478|P1|NOT COMPLETED|Overall Study||22
950650|NCT00090545|2296477|P2|COMPLETED|Overall Study||0
950651|NCT00090545|2296478|P1|COMPLETED|Overall Study||0
950652|NCT00090545|2296477|P2|STARTED|Overall Study||24
950653|NCT00090545|2296478|P1|STARTED|Overall Study||22
950654|NCT00090584|2296488|P2|NOT COMPLETED|Baseline to 8 Months||41
950655|NCT00090584|2296489|P1|NOT COMPLETED|Baseline to 8 Months||44
950656|NCT00090584|2296488|P2|COMPLETED|Baseline to 8 Months||112
950657|NCT00090584|2296489|P1|COMPLETED|Baseline to 8 Months||110
950658|NCT00090584|2296488|P2|STARTED|Baseline to 8 Months||153
950659|NCT00090584|2296489|P1|STARTED|Baseline to 8 Months||154
950660|NCT00090584|2296488|P2|NOT COMPLETED|Baseline to 10 Weeks||12
950661|NCT00090584|2296489|P1|NOT COMPLETED|Baseline to 10 Weeks||15
950662|NCT00090584|2296488|P2|COMPLETED|Baseline to 10 Weeks||141
950663|NCT00090584|2296489|P1|COMPLETED|Baseline to 10 Weeks||139
950664|NCT00090584|2296488|P2|STARTED|Baseline to 10 Weeks||153
950665|NCT00090584|2296489|P1|STARTED|Baseline to 10 Weeks||154
950666|NCT00090610|2296521|P2|NOT COMPLETED|Overall Study||1
950667|NCT00090610|2296522|P1|NOT COMPLETED|Overall Study||1
950668|NCT00090610|2296521|P2|COMPLETED|Overall Study||74
950669|NCT00090610|2296522|P1|COMPLETED|Overall Study||74
950670|NCT00090610|2296521|P2|STARTED|Overall Study||75
950671|NCT00090610|2296522|P1|STARTED|Overall Study||75
950672|NCT00090753|2296538|P2|NOT COMPLETED|Extended Treatment Period||191
950673|NCT00090753|2296539|P1|NOT COMPLETED|Extended Treatment Period||359
950674|NCT00090753|2296538|P2|COMPLETED|Extended Treatment Period||59
950675|NCT00090753|2296539|P1|COMPLETED|Extended Treatment Period||94
950676|NCT00090753|2296538|P2|STARTED|Extended Treatment Period|52 patients who completed the first treatment period refused to enter the extended treatment period.|250
950677|NCT00090753|2296539|P1|STARTED|Extended Treatment Period|39 patients who completed the first treatment period refused to enter the extended treatment period.|453
950678|NCT00090753|2296538|P2|NOT COMPLETED|First Treatment Period||178
950679|NCT00090753|2296539|P1|NOT COMPLETED|First Treatment Period||256
950680|NCT00090753|2296538|P2|COMPLETED|First Treatment Period||302
950681|NCT00090753|2296539|P1|COMPLETED|First Treatment Period||492
950682|NCT00090753|2296538|P2|STARTED|First Treatment Period||480
950683|NCT00090753|2296539|P1|STARTED|First Treatment Period||748
950684|NCT00081159|2296549|P2|NOT COMPLETED|Overall Study||5
950685|NCT00081159|2296550|P1|NOT COMPLETED|Overall Study||2
950686|NCT00081159|2296549|P2|COMPLETED|Overall Study||35
950687|NCT00081159|2296550|P1|COMPLETED|Overall Study||37
950688|NCT00081159|2296549|P2|STARTED|Overall Study||40
950689|NCT00081159|2296550|P1|STARTED|Overall Study||39
950690|NCT00081263|2296562|P2|NOT COMPLETED|Overall Study||22
950691|NCT00081263|2296563|P1|NOT COMPLETED|Overall Study||17
950692|NCT00081263|2296562|P2|COMPLETED|Overall Study||41
950693|NCT00081263|2296563|P1|COMPLETED|Overall Study||50
950694|NCT00081263|2296562|P2|STARTED|Overall Study||63
950695|NCT00081263|2296563|P1|STARTED|Overall Study||67
950696|NCT00081289|2296573|P2|NOT COMPLETED|Overall Study||21
950697|NCT00081289|2296574|P1|NOT COMPLETED|Overall Study||21
950698|NCT00081289|2296573|P2|COMPLETED|Overall Study||52
950699|NCT00081289|2296574|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
950700|NCT00081289|2296573|P2|STARTED|Overall Study||73
950701|NCT00081289|2296574|P1|STARTED|Overall Study||73
950702|NCT00081328|2296583|P3|NOT COMPLETED|Overall Study||0
950703|NCT00081328|2296584|P2|NOT COMPLETED|Overall Study||0
950704|NCT00081328|2296585|P1|NOT COMPLETED|Overall Study||0
950705|NCT00081328|2296583|P3|COMPLETED|Overall Study||234
950706|NCT00081328|2296584|P2|COMPLETED|Overall Study||233
950707|NCT00081328|2296585|P1|COMPLETED|Overall Study||232
950708|NCT00081328|2296583|P3|STARTED|Overall Study||234
950709|NCT00081328|2296584|P2|STARTED|Overall Study||233
950710|NCT00081328|2296585|P1|STARTED|Overall Study||232
950711|NCT00081458|2296626|P3|NOT COMPLETED|Overall Study||4
950712|NCT00081458|2296627|P2|NOT COMPLETED|Overall Study||8
950713|NCT00081458|2296628|P1|NOT COMPLETED|Overall Study||1
950714|NCT00081458|2296626|P3|COMPLETED|Overall Study||29
950715|NCT00081458|2296627|P2|COMPLETED|Overall Study||27
950716|NCT00081458|2296628|P1|COMPLETED|Overall Study||15
950717|NCT00081458|2296626|P3|Received Treatment|Overall Study|1 subject was randomized but did not receive the study drug|32
950718|NCT00081458|2296627|P2|Received Treatment|Overall Study||35
950719|NCT00081458|2296628|P1|Received Treatment|Overall Study||16
950720|NCT00081458|2296626|P3|STARTED|Overall Study||33
950721|NCT00081458|2296627|P2|STARTED|Overall Study||35
950722|NCT00081458|2296628|P1|STARTED|Overall Study||16
950723|NCT00090766|2296642|P3|NOT COMPLETED|Overall Study||3
950724|NCT00090766|2296643|P2|NOT COMPLETED|Overall Study||2
950725|NCT00090766|2296644|P1|NOT COMPLETED|Overall Study||3
950726|NCT00090766|2296642|P3|COMPLETED|Overall Study||22
950727|NCT00090766|2296643|P2|COMPLETED|Overall Study||19
950728|NCT00090766|2296644|P1|COMPLETED|Overall Study||14
950729|NCT00090766|2296642|P3|STARTED|Overall Study||25
950730|NCT00090766|2296643|P2|STARTED|Overall Study||21
950731|NCT00090766|2296644|P1|STARTED|Overall Study||17
950732|NCT00090779|2296686|P2|NOT COMPLETED|Step 3||5
950733|NCT00090779|2296687|P1|NOT COMPLETED|Step 3||7
950734|NCT00090779|2296686|P2|COMPLETED|Step 3||0
950735|NCT00090779|2296687|P1|COMPLETED|Step 3||0
950736|NCT00090779|2296686|P2|STARTED|Step 3||5
950737|NCT00090779|2296687|P1|STARTED|Step 3||7
950738|NCT00090779|2296686|P2|NOT COMPLETED|Step 2||18
950739|NCT00090779|2296687|P1|NOT COMPLETED|Step 2||6
950740|NCT00090779|2296686|P2|COMPLETED|Step 2||1
950741|NCT00090779|2296687|P1|COMPLETED|Step 2||0
950742|NCT00090779|2296686|P2|STARTED|Step 2|Three with two consecutive CD4<350cells/mm^3 and one with CDC category B event didn't enter step 2.|19
950743|NCT00090779|2296687|P1|STARTED|Step 2|One subject who had two consecutive CD4<350cells/mm^3 did not enter step 2.|6
950744|NCT00090779|2296686|P2|NOT COMPLETED|Step 1||15
950745|NCT00090779|2296687|P1|NOT COMPLETED|Step 1||11
950746|NCT00090779|2296686|P2|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|49
950747|NCT00090779|2296687|P1|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|55
950748|NCT00090779|2296686|P2|STARTED|Step 1||64
950749|NCT00090779|2296687|P1|STARTED|Step 1||66
950750|NCT00090844|2296710|P2|NOT COMPLETED|Overall Study||1
950751|NCT00090844|2296711|P1|NOT COMPLETED|Overall Study||1
950752|NCT00090844|2296710|P2|COMPLETED|Overall Study||21
950753|NCT00090844|2296711|P1|COMPLETED|Overall Study||26
950754|NCT00090844|2296710|P2|STARTED|Overall Study||22
950755|NCT00090844|2296711|P1|STARTED|Overall Study||27
950756|NCT00090857|2296719|P2|NOT COMPLETED|Overall Study||3
950757|NCT00090857|2296720|P1|NOT COMPLETED|Overall Study||4
950758|NCT00090857|2296719|P2|COMPLETED|Overall Study||13
950759|NCT00090857|2296720|P1|COMPLETED|Overall Study||29
950760|NCT00090857|2296719|P2|STARTED|Overall Study||16
950761|NCT00090857|2296720|P1|STARTED|Overall Study||33
950762|NCT00090987|2296748|P1|NOT COMPLETED|Overall Study||21
950763|NCT00090987|2296748|P1|COMPLETED|Overall Study||9
950764|NCT00090987|2296748|P1|STARTED|Overall Study||30
950765|NCT00091026|2296754|P2|NOT COMPLETED|Overall Study||3
950766|NCT00091026|2296755|P1|NOT COMPLETED|Overall Study||1
950767|NCT00091026|2296754|P2|COMPLETED|Overall Study||68
950768|NCT00091026|2296755|P1|COMPLETED|Overall Study||71
950769|NCT00091026|2296754|P2|STARTED|Overall Study||71
950770|NCT00091026|2296755|P1|STARTED|Overall Study||72
950771|NCT00091169|2296767|P2|NOT COMPLETED|Overall Study||53
950772|NCT00091169|2296768|P1|NOT COMPLETED|Overall Study||57
950773|NCT00091169|2296767|P2|COMPLETED|Overall Study||134
950774|NCT00091169|2296768|P1|COMPLETED|Overall Study||132
950775|NCT00091169|2296767|P2|Treated|Overall Study||170
950776|NCT00091169|2296768|P1|Treated|Overall Study||163
950777|NCT00091169|2296767|P2|STARTED|Overall Study||187
950778|NCT00091169|2296768|P1|STARTED|Overall Study||189
950779|NCT00094497|2296786|P2|NOT COMPLETED|Overall Study||0
950780|NCT00094497|2296787|P1|NOT COMPLETED|Overall Study||0
950781|NCT00094497|2296786|P2|COMPLETED|Overall Study||153
950782|NCT00094497|2296787|P1|COMPLETED|Overall Study||151
950783|NCT00094497|2296786|P2|Received Second Line Therapy|Overall Study||101
950784|NCT00094497|2296787|P1|Received Second Line Therapy|Overall Study||84
950785|NCT00094497|2296786|P2|Treated|Overall Study||149
950786|NCT00094497|2296787|P1|Treated|Overall Study||148
950787|NCT00094497|2296786|P2|STARTED|Overall Study||153
950788|NCT00094497|2296787|P1|STARTED|Overall Study||151
950789|NCT00094536|2296801|P1|NOT COMPLETED|Treatment and Follow-up||31
950790|NCT00094536|2296801|P1|COMPLETED|Treatment and Follow-up|51 subjects successfully completed the study.|51
950791|NCT00094536|2296801|P1|36 Month Follow-up|Treatment and Follow-up||51
950792|NCT00094536|2296801|P1|24 Month Follow-up|Treatment and Follow-up||53
950793|NCT00094536|2296801|P1|12 Month Follow-up|Treatment and Follow-up|69 subjects were evaluated at 1-year post-treatment for the primary endpoint of success.|69
950794|NCT00094536|2296801|P1|STARTED|Treatment and Follow-up|82 subjects qualified for and underwent the study treatment.|82
950795|NCT00094536|2296801|P1|NOT COMPLETED|Inclusion Exclusion Evaluation||24
950796|NCT00094536|2296801|P1|COMPLETED|Inclusion Exclusion Evaluation||82
950797|NCT00094536|2296801|P1|STARTED|Inclusion Exclusion Evaluation||106
950798|NCT00094575|2296807|P2|NOT COMPLETED|Overall Study||146
950799|NCT00094575|2296808|P1|NOT COMPLETED|Overall Study||146
950800|NCT00094575|2296807|P2|COMPLETED|Overall Study||291
950801|NCT00094575|2296808|P1|COMPLETED|Overall Study||298
950802|NCT00094575|2296807|P2|STARTED|Overall Study||437
950803|NCT00094575|2296808|P1|STARTED|Overall Study||444
950804|NCT00094653|2296831|P3|NOT COMPLETED|Overall Study||126
950805|NCT00094653|2296832|P2|NOT COMPLETED|Overall Study||106
950806|NCT00094653|2296833|P1|NOT COMPLETED|Overall Study||321
950807|NCT00094653|2296831|P3|COMPLETED|Overall Study||10
950808|NCT00094653|2296832|P2|COMPLETED|Overall Study||31
950809|NCT00094653|2296833|P1|COMPLETED|Overall Study||82
950810|NCT00094653|2296831|P3|Treated|Overall Study||131
950811|NCT00094653|2296832|P2|Treated|Overall Study||131
950812|NCT00094653|2296833|P1|Treated|Overall Study||381
950813|NCT00094653|2296831|P3|STARTED|Overall Study||136
950814|NCT00094653|2296832|P2|STARTED|Overall Study||137
950815|NCT00094653|2296833|P1|STARTED|Overall Study||403
950816|NCT00094757|2296897|P3|NOT COMPLETED|Overall Study||30
950817|NCT00094757|2296898|P2|NOT COMPLETED|Overall Study||62
950818|NCT00094757|2296899|P1|NOT COMPLETED|Overall Study||53
950819|NCT00094757|2296897|P3|COMPLETED|Overall Study||80
950820|NCT00094757|2296898|P2|COMPLETED|Overall Study||144
950821|NCT00094757|2296899|P1|COMPLETED|Overall Study||152
950822|NCT00094757|2296897|P3|STARTED|Overall Study||110
950823|NCT00094757|2296898|P2|STARTED|Overall Study||206
950824|NCT00094757|2296899|P1|STARTED|Overall Study||205
950825|NCT00094770|2296918|P2|NOT COMPLETED|Year 2 (Week 0 to Week 104)||320
950826|NCT00094770|2296919|P1|NOT COMPLETED|Year 2 (Week 0 to Week 104)||333
950827|NCT00094770|2296918|P2|COMPLETED|Year 2 (Week 0 to Week 104)||264
950828|NCT00094770|2296919|P1|COMPLETED|Year 2 (Week 0 to Week 104)||255
950829|NCT00094770|2296918|P2|STARTED|Year 2 (Week 0 to Week 104)||584
950830|NCT00094770|2296919|P1|STARTED|Year 2 (Week 0 to Week 104)||588
950831|NCT00094770|2296918|P2|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||172
950832|NCT00094770|2296919|P1|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||202
950833|NCT00094770|2296918|P2|COMPLETED|Year 1 ( Week 0 to Week 52)|11 Participants who Completed Week 52, Did NOT Enter second year|412
950834|NCT00094770|2296919|P1|COMPLETED|Year 1 ( Week 0 to Week 52)|4 Participants who Completed Week 52, Did NOT Enter second year|386
950835|NCT00094770|2296918|P2|STARTED|Year 1 ( Week 0 to Week 52)||584
950836|NCT00094770|2296919|P1|STARTED|Year 1 ( Week 0 to Week 52)||588
950837|NCT00094809|2296949|P2|NOT COMPLETED|Overall Study||65
950838|NCT00094809|2296950|P1|NOT COMPLETED|Overall Study||52
950839|NCT00094809|2296949|P2|COMPLETED|Overall Study|Subjects who completed treatment and LTFU|61
950840|NCT00094809|2296950|P1|COMPLETED|Overall Study|Subjects who completed treatment and Long term follow up (LTFU)|74
950841|NCT00094809|2296949|P2|Completed All 4 Cycles of Treatment|Overall Study||90
950842|NCT00094809|2296950|P1|Completed All 4 Cycles of Treatment|Overall Study||98
950843|NCT00094809|2296949|P2|Properly Consented; Received Study Drug|Overall Study||118
950844|NCT00094809|2296950|P1|Properly Consented; Received Study Drug|Overall Study||123
950845|NCT00094809|2296949|P2|Received Study Drug|Overall Study||118
950846|NCT00094809|2296950|P1|Received Study Drug|Overall Study||124
950847|NCT00094809|2296949|P2|STARTED|Overall Study||126
950848|NCT00094809|2296950|P1|STARTED|Overall Study||126
950849|NCT00094835|2296981|P7|NOT COMPLETED|Overall Study||2
950850|NCT00094835|2296982|P6|NOT COMPLETED|Overall Study||3
950851|NCT00094835|2296983|P5|NOT COMPLETED|Overall Study||4
950852|NCT00094835|2296984|P4|NOT COMPLETED|Overall Study||1
950853|NCT00094835|2296985|P3|NOT COMPLETED|Overall Study||3
950854|NCT00094835|2296986|P2|NOT COMPLETED|Overall Study||3
950855|NCT00094835|2296987|P1|NOT COMPLETED|Overall Study||4
950856|NCT00094835|2296981|P7|COMPLETED|Overall Study||4
950857|NCT00094835|2296982|P6|COMPLETED|Overall Study||3
950858|NCT00094835|2296983|P5|COMPLETED|Overall Study||3
950859|NCT00094835|2296984|P4|COMPLETED|Overall Study||4
950860|NCT00094835|2296985|P3|COMPLETED|Overall Study||4
950861|NCT00094835|2296986|P2|COMPLETED|Overall Study||8
950862|NCT00094835|2296987|P1|COMPLETED|Overall Study||5
950863|NCT00094835|2296981|P7|Treated With Motesanib|Overall Study||6
950864|NCT00094835|2296982|P6|Treated With Motesanib|Overall Study||5
950865|NCT00094835|2296983|P5|Treated With Motesanib|Overall Study||7
950866|NCT00094835|2296984|P4|Treated With Motesanib|Overall Study||4
950867|NCT00094835|2296985|P3|Treated With Motesanib|Overall Study||6
950868|NCT00094835|2296986|P2|Treated With Motesanib|Overall Study||11
950869|NCT00094835|2296987|P1|Treated With Motesanib|Overall Study||6
950870|NCT00094835|2296981|P7|STARTED|Overall Study||6
950871|NCT00094835|2296982|P6|STARTED|Overall Study||6
950872|NCT00094835|2296983|P5|STARTED|Overall Study||7
950873|NCT00094835|2296984|P4|STARTED|Overall Study||5
950874|NCT00094835|2296985|P3|STARTED|Overall Study||7
950875|NCT00094835|2296986|P2|STARTED|Overall Study||11
950876|NCT00094835|2296987|P1|STARTED|Overall Study||9
950877|NCT00094861|2297065|P2|NOT COMPLETED|Overall Study||9
950878|NCT00094861|2297066|P1|NOT COMPLETED|Overall Study||18
950879|NCT00094861|2297065|P2|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|40
950880|NCT00094861|2297066|P1|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|28
950881|NCT00094861|2297065|P2|Participants Treated|Overall Study||48
950882|NCT00094861|2297066|P1|Participants Treated|Overall Study||46
950883|NCT00094861|2297065|P2|STARTED|Overall Study||49
950884|NCT00094861|2297066|P1|STARTED|Overall Study||46
950885|NCT00094887|2297088|P2|NOT COMPLETED|Overall Study||6
950886|NCT00094887|2297089|P1|NOT COMPLETED|Overall Study||5
950887|NCT00094887|2297088|P2|COMPLETED|Overall Study||69
950888|NCT00094887|2297089|P1|COMPLETED|Overall Study||70
950889|NCT00094887|2297088|P2|STARTED|Overall Study|75|75
950890|NCT00094887|2297089|P1|STARTED|Overall Study|75|75
950891|NCT00094900|2297095|P1|NOT COMPLETED|Overall Study||1
950892|NCT00094900|2297095|P1|COMPLETED|Overall Study||10
950893|NCT00094900|2297095|P1|STARTED|Overall Study||11
950894|NCT00095056|2297197|P2|NOT COMPLETED|Phase B (Weeks 12-54)||5
950895|NCT00095056|2297198|P1|NOT COMPLETED|Phase B (Weeks 12-54)||10
950896|NCT00095056|2297197|P2|COMPLETED|Phase B (Weeks 12-54)||20
950897|NCT00095056|2297198|P1|COMPLETED|Phase B (Weeks 12-54)||46
950898|NCT00095056|2297197|P2|STARTED|Phase B (Weeks 12-54)||25
950899|NCT00095056|2297198|P1|STARTED|Phase B (Weeks 12-54)|2 randomized patients completed Period 1 but did not enter Period 2.|56
950900|NCT00095056|2297197|P2|NOT COMPLETED|Phase A (Weeks 0-12)||1
950901|NCT00095056|2297198|P1|NOT COMPLETED|Phase A (Weeks 0-12)||7
950902|NCT00095056|2297197|P2|COMPLETED|Phase A (Weeks 0-12)||25
950903|NCT00095056|2297198|P1|COMPLETED|Phase A (Weeks 0-12)||58
950904|NCT00095056|2297197|P2|STARTED|Phase A (Weeks 0-12)||26
950905|NCT00095056|2297198|P1|STARTED|Phase A (Weeks 0-12)||65
950906|NCT00095121|2297208|P2|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||19
950907|NCT00095121|2297209|P1|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||62
950908|NCT00095121|2297208|P2|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|35
950909|NCT00095121|2297209|P1|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|46
950910|NCT00095121|2297208|P2|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||11
950911|NCT00095121|2297209|P1|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||21
950912|NCT00095121|2297208|P2|STARTED|Open-Label (Study Weeks 49 Through 240)||54
950913|NCT00095121|2297209|P1|STARTED|Open-Label (Study Weeks 49 Through 240)||108
950914|NCT00095121|2297208|P2|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||0
950915|NCT00095121|2297209|P1|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||3
950916|NCT00095121|2297208|P2|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||58
950917|NCT00095121|2297209|P1|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||112
950918|NCT00095121|2297208|P2|STARTED|Double-Blind (Study Weeks 0 Through 48)||58
950919|NCT00095121|2297209|P1|STARTED|Double-Blind (Study Weeks 0 Through 48)||115
950920|NCT00095147|2297256|P5|NOT COMPLETED|Long-term Extension Period||45
950921|NCT00095147|2297257|P4|NOT COMPLETED|Long-term Extension Period||0
950922|NCT00095147|2297258|P3|NOT COMPLETED|Long-term Extension Period||0
950923|NCT00095147|2297259|P2|NOT COMPLETED|Long-term Extension Period||0
950924|NCT00095147|2297260|P1|NOT COMPLETED|Long-term Extension Period||0
950925|NCT00095147|2297256|P5|COMPLETED|Long-term Extension Period||327
950926|NCT00095147|2297257|P4|COMPLETED|Long-term Extension Period||0
950927|NCT00095147|2297258|P3|COMPLETED|Long-term Extension Period||0
950928|NCT00095147|2297259|P2|COMPLETED|Long-term Extension Period||0
950929|NCT00095147|2297260|P1|COMPLETED|Long-term Extension Period||0
950930|NCT00095147|2297256|P5|STARTED|Long-term Extension Period||372
950931|NCT00095147|2297257|P4|STARTED|Long-term Extension Period||0
950932|NCT00095147|2297258|P3|STARTED|Long-term Extension Period||0
950933|NCT00095147|2297259|P2|STARTED|Long-term Extension Period||0
950934|NCT00095147|2297260|P1|STARTED|Long-term Extension Period||0
950935|NCT00095147|2297256|P5|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
950936|NCT00095147|2297257|P4|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||3
950937|NCT00095147|2297258|P3|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
950938|NCT00095147|2297259|P2|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||11
950939|NCT00095147|2297260|P1|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||8
950940|NCT00095147|2297256|P5|COMPLETED|Double-blind Period 2 (Days 198-365)||0
950941|NCT00095147|2297257|P4|COMPLETED|Double-blind Period 2 (Days 198-365)||104
950942|NCT00095147|2297258|P3|COMPLETED|Double-blind Period 2 (Days 198-365)||0
950943|NCT00095147|2297259|P2|COMPLETED|Double-blind Period 2 (Days 198-365)||141
950944|NCT00095147|2297260|P1|COMPLETED|Double-blind Period 2 (Days 198-365)||139
950945|NCT00095147|2297256|P5|STARTED|Double-blind Period 2 (Days 198-365)||0
950946|NCT00095147|2297257|P4|STARTED|Double-blind Period 2 (Days 198-365)||107
950947|NCT00095147|2297258|P3|STARTED|Double-blind Period 2 (Days 198-365)||0
950948|NCT00095147|2297259|P2|STARTED|Double-blind Period 2 (Days 198-365)||152
950949|NCT00095147|2297260|P1|STARTED|Double-blind Period 2 (Days 198-365)||147
950950|NCT00095147|2297256|P5|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
950951|NCT00095147|2297257|P4|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
950952|NCT00095147|2297258|P3|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||3
950953|NCT00095147|2297259|P2|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||13
950954|NCT00095147|2297260|P1|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||9
950955|NCT00095147|2297256|P5|COMPLETED|Double-blind Period 1 (Days 1-197)||0
950956|NCT00095147|2297257|P4|COMPLETED|Double-blind Period 1 (Days 1-197)||0
950957|NCT00095147|2297258|P3|COMPLETED|Double-blind Period 1 (Days 1-197)||107
950958|NCT00095147|2297259|P2|COMPLETED|Double-blind Period 1 (Days 1-197)||152
950959|NCT00095147|2297260|P1|COMPLETED|Double-blind Period 1 (Days 1-197)||147
950960|NCT00095147|2297256|P5|STARTED|Double-blind Period 1 (Days 1-197)||0
950961|NCT00095147|2297257|P4|STARTED|Double-blind Period 1 (Days 1-197)||0
950962|NCT00095147|2297258|P3|STARTED|Double-blind Period 1 (Days 1-197)||110
950963|NCT00095147|2297259|P2|STARTED|Double-blind Period 1 (Days 1-197)||165
950964|NCT00095147|2297260|P1|STARTED|Double-blind Period 1 (Days 1-197)||156
950965|NCT00095173|2297453|P6|NOT COMPLETED|Open-Label Extension Phase (Period C)||32
950966|NCT00095173|2297454|P5|NOT COMPLETED|Open-Label Extension Phase (Period C)||29
950967|NCT00095173|2297455|P4|NOT COMPLETED|Open-Label Extension Phase (Period C)||23
950968|NCT00095173|2297456|P3|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
950969|NCT00095173|2297457|P2|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
950970|NCT00095173|2297458|P1|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
950971|NCT00095173|2297453|P6|COMPLETED|Open-Label Extension Phase (Period C)||27
950972|NCT00095173|2297454|P5|COMPLETED|Open-Label Extension Phase (Period C)||29
950973|NCT00095173|2297455|P4|COMPLETED|Open-Label Extension Phase (Period C)||13
950974|NCT00095173|2297456|P3|COMPLETED|Open-Label Extension Phase (Period C)||0
950975|NCT00095173|2297457|P2|COMPLETED|Open-Label Extension Phase (Period C)||0
950976|NCT00095173|2297458|P1|COMPLETED|Open-Label Extension Phase (Period C)||0
950977|NCT00095173|2297453|P6|STARTED|Open-Label Extension Phase (Period C)|Includes 33 who discontinued Period B due to a flare and 26 who completed Period B with no flare|59
950978|NCT00095173|2297454|P5|STARTED|Open-Label Extension Phase (Period C)|Includes 47 who completed Period B with no flare and 11 who discontinued Period B due to a flare|58
950979|NCT00095173|2297455|P4|STARTED|Open-Label Extension Phase (Period C)|Participants were non-responders from Period A who re-entered in Period C.|36
950980|NCT00095173|2297456|P3|STARTED|Open-Label Extension Phase (Period C)||0
950981|NCT00095173|2297457|P2|STARTED|Open-Label Extension Phase (Period C)||0
950982|NCT00095173|2297458|P1|STARTED|Open-Label Extension Phase (Period C)||0
950983|NCT00095173|2297453|P6|NOT COMPLETED|Double-Blind Phase (Period B)||0
950984|NCT00095173|2297454|P5|NOT COMPLETED|Double-Blind Phase (Period B)||0
950985|NCT00095173|2297455|P4|NOT COMPLETED|Double-Blind Phase (Period B)||0
950986|NCT00095173|2297456|P3|NOT COMPLETED|Double-Blind Phase (Period B)||31
950987|NCT00095173|2297457|P2|NOT COMPLETED|Double-Blind Phase (Period B)||11
950988|NCT00095173|2297458|P1|NOT COMPLETED|Double-Blind Phase (Period B)||0
950989|NCT00095173|2297453|P6|COMPLETED|Double-Blind Phase (Period B)||0
950990|NCT00095173|2297454|P5|COMPLETED|Double-Blind Phase (Period B)||0
950991|NCT00095173|2297455|P4|COMPLETED|Double-Blind Phase (Period B)||0
950992|NCT00095173|2297456|P3|COMPLETED|Double-Blind Phase (Period B)||31
950993|NCT00095173|2297457|P2|COMPLETED|Double-Blind Phase (Period B)||49
950994|NCT00095173|2297458|P1|COMPLETED|Double-Blind Phase (Period B)||0
950995|NCT00095173|2297453|P6|STARTED|Double-Blind Phase (Period B)||0
950996|NCT00095173|2297454|P5|STARTED|Double-Blind Phase (Period B)||0
950997|NCT00095173|2297455|P4|STARTED|Double-Blind Phase (Period B)||0
950998|NCT00095173|2297456|P3|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|62
950999|NCT00095173|2297457|P2|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|60
951000|NCT00095173|2297458|P1|STARTED|Double-Blind Phase (Period B)|All participants did not continue; responders entered Period B; non-responders re-entered Period C.|0
951001|NCT00095173|2297453|P6|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
951002|NCT00095173|2297454|P5|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
951003|NCT00095173|2297455|P4|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
951004|NCT00095173|2297456|P3|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
951005|NCT00095173|2297457|P2|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
951006|NCT00095173|2297458|P1|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||20
951007|NCT00095173|2297453|P6|COMPLETED|Open-Label Lead-In Phase (Period A)||0
951008|NCT00095173|2297454|P5|COMPLETED|Open-Label Lead-In Phase (Period A)||0
951009|NCT00095173|2297455|P4|COMPLETED|Open-Label Lead-In Phase (Period A)||0
951010|NCT00095173|2297456|P3|COMPLETED|Open-Label Lead-In Phase (Period A)||0
951011|NCT00095173|2297457|P2|COMPLETED|Open-Label Lead-In Phase (Period A)||0
951012|NCT00095173|2297458|P1|COMPLETED|Open-Label Lead-In Phase (Period A)||170
951013|NCT00095173|2297453|P6|STARTED|Open-Label Lead-In Phase (Period A)||0
951014|NCT00095173|2297454|P5|STARTED|Open-Label Lead-In Phase (Period A)||0
951015|NCT00095173|2297455|P4|STARTED|Open-Label Lead-In Phase (Period A)||0
951016|NCT00095173|2297456|P3|STARTED|Open-Label Lead-In Phase (Period A)||0
951017|NCT00095173|2297457|P2|STARTED|Open-Label Lead-In Phase (Period A)||0
951018|NCT00095173|2297458|P1|STARTED|Open-Label Lead-In Phase (Period A)||190
951019|NCT00095199|2297497|P4|NOT COMPLETED|Overall Study||143
951020|NCT00095199|2297498|P3|NOT COMPLETED|Overall Study||160
951021|NCT00095199|2297499|P2|NOT COMPLETED|Overall Study||242
951022|NCT00095199|2297500|P1|NOT COMPLETED|Overall Study||296
951023|NCT00095199|2297497|P4|COMPLETED|Overall Study||23
951024|NCT00095199|2297498|P3|COMPLETED|Overall Study||7
951025|NCT00095199|2297499|P2|COMPLETED|Overall Study||62
951026|NCT00095199|2297500|P1|COMPLETED|Overall Study||6
951027|NCT00095199|2297497|P4|STARTED|Overall Study||166
951028|NCT00095199|2297498|P3|STARTED|Overall Study||167
951029|NCT00095199|2297499|P2|STARTED|Overall Study||304
951030|NCT00095199|2297500|P1|STARTED|Overall Study|1 participant has no data in database; not included in analyses. Data was lost/destroyed at site.|302
951031|NCT00095212|2297540|P2|NOT COMPLETED|Overall Study||3
951032|NCT00095212|2297541|P1|NOT COMPLETED|Overall Study||1
951033|NCT00095212|2297540|P2|COMPLETED|Overall Study||9
951034|NCT00095212|2297541|P1|COMPLETED|Overall Study||12
951035|NCT00095212|2297540|P2|STARTED|Overall Study||12
951036|NCT00095212|2297541|P1|STARTED|Overall Study||13
951037|NCT00095238|2297569|P2|NOT COMPLETED|Overall Study||852
951038|NCT00095238|2297570|P1|NOT COMPLETED|Overall Study||857
951039|NCT00095238|2297569|P2|COMPLETED|Overall Study|completed double-blind therapy|1209
951040|NCT00095238|2297570|P1|COMPLETED|Overall Study|completed double-blind therapy|1210
951041|NCT00095238|2297569|P2|Safety (Treated) Population|Overall Study|One participant randomized to irbesartan received placebo.|2062
951042|NCT00095238|2297570|P1|Safety (Treated) Population|Overall Study|Two participants were randomized but not treated; 1 randomized to irbesartan received placebo|2064
951043|NCT00095238|2297569|P2|STARTED|Overall Study|number randomized|2061
951044|NCT00095238|2297570|P1|STARTED|Overall Study|number randomized|2067
951045|NCT00095303|2297632|P2|NOT COMPLETED|Follow Up Study||58
951046|NCT00095303|2297633|P1|NOT COMPLETED|Follow Up Study||59
951047|NCT00095303|2297632|P2|COMPLETED|Follow Up Study||121
951048|NCT00095303|2297633|P1|COMPLETED|Follow Up Study||140
951049|NCT00095303|2297632|P2|STARTED|Follow Up Study|179 (TAU) gave permission for future contact; not a requirement to finish Main to start Follow up|179
951050|NCT00095303|2297633|P1|STARTED|Follow Up Study|199 (BSFT) gave permission for future contact; not a requirement to finish Main to start Follow up|199
951051|NCT00095303|2297632|P2|NOT COMPLETED|Main Study||87
951052|NCT00095303|2297633|P1|NOT COMPLETED|Main Study||91
951053|NCT00095303|2297632|P2|COMPLETED|Main Study||148
951054|NCT00095303|2297633|P1|COMPLETED|Main Study||154
951055|NCT00095303|2297632|P2|STARTED|Main Study||235
951056|NCT00095303|2297633|P1|STARTED|Main Study||245
951057|NCT00095498|2297702|P3|NOT COMPLETED|Overall Study||39
951058|NCT00095498|2297703|P2|NOT COMPLETED|Overall Study||35
951059|NCT00095498|2297704|P1|NOT COMPLETED|Overall Study||37
951060|NCT00095498|2297702|P3|COMPLETED|Overall Study||39
951061|NCT00095498|2297703|P2|COMPLETED|Overall Study||38
951062|NCT00095498|2297704|P1|COMPLETED|Overall Study||39
951063|NCT00095498|2297702|P3|Received Investigational Product|Overall Study||75
951064|NCT00095498|2297703|P2|Received Investigational Product|Overall Study||71
951065|NCT00095498|2297704|P1|Received Investigational Product|Overall Study||72
951066|NCT00095498|2297702|P3|STARTED|Overall Study||78
951067|NCT00095498|2297703|P2|STARTED|Overall Study||73
951068|NCT00095498|2297704|P1|STARTED|Overall Study||76
951069|NCT00095563|2298129|P1|NOT COMPLETED|Overall Study||0
951070|NCT00095563|2298129|P1|COMPLETED|Overall Study||39
951071|NCT00095563|2298129|P1|STARTED|Overall Study||39
951072|NCT00095576|2298140|P2|NOT COMPLETED|Overall Study||1481
951073|NCT00095576|2298141|P1|NOT COMPLETED|Overall Study||1475
951074|NCT00095576|2298140|P2|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|14
951075|NCT00095576|2298141|P1|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|9
951076|NCT00095576|2298140|P2|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1361
951077|NCT00095576|2298141|P1|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1328
951078|NCT00095576|2298140|P2|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1443
951079|NCT00095576|2298141|P1|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1426
951080|NCT00095576|2298140|P2|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1495
951081|NCT00095576|2298141|P1|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1484
951082|NCT00095576|2298140|P2|STARTED|Overall Study||1495
951083|NCT00095576|2298141|P1|STARTED|Overall Study||1484
951084|NCT00095628|2298153|P1|NOT COMPLETED|Overall Study||1
951085|NCT00095628|2298153|P1|COMPLETED|Overall Study||20
951086|NCT00095628|2298153|P1|STARTED|Overall Study||21
951090|NCT00095836|2298185|P1|NOT COMPLETED|Overall Study||4
951091|NCT00095836|2298185|P1|COMPLETED|Overall Study||23
951092|NCT00095836|2298185|P1|STARTED|Overall Study||27
951093|NCT00095875|2298194|P2|NOT COMPLETED|Overall Study||9
951094|NCT00095875|2298195|P1|NOT COMPLETED|Overall Study||14
951095|NCT00095875|2298194|P2|COMPLETED|Overall Study||66
951096|NCT00095875|2298195|P1|COMPLETED|Overall Study||56
951097|NCT00095875|2298194|P2|STARTED|Overall Study||75
951098|NCT00095875|2298195|P1|STARTED|Overall Study||70
951099|NCT00095940|2298210|P9|NOT COMPLETED|Lapatinib Continuation/Phase II||13
951100|NCT00095940|2298211|P8|NOT COMPLETED|Lapatinib Continuation/Phase II||2
951101|NCT00095940|2298212|P7|NOT COMPLETED|Lapatinib Continuation/Phase II||2
951102|NCT00095940|2298213|P6|NOT COMPLETED|Lapatinib Continuation/Phase II||13
951103|NCT00095940|2298214|P5|NOT COMPLETED|Lapatinib Continuation/Phase II||0
951104|NCT00095940|2298215|P4|NOT COMPLETED|Lapatinib Continuation/Phase II||0
951105|NCT00095940|2298216|P3|NOT COMPLETED|Lapatinib Continuation/Phase II||16
951106|NCT00095940|2298217|P2|NOT COMPLETED|Lapatinib Continuation/Phase II||2
951107|NCT00095940|2298218|P1|NOT COMPLETED|Lapatinib Continuation/Phase II||2
951108|NCT00095940|2298210|P9|COMPLETED|Lapatinib Continuation/Phase II||1
951109|NCT00095940|2298211|P8|COMPLETED|Lapatinib Continuation/Phase II||0
951110|NCT00095940|2298212|P7|COMPLETED|Lapatinib Continuation/Phase II||0
951111|NCT00095940|2298213|P6|COMPLETED|Lapatinib Continuation/Phase II||0
951112|NCT00095940|2298214|P5|COMPLETED|Lapatinib Continuation/Phase II||0
951113|NCT00095940|2298215|P4|COMPLETED|Lapatinib Continuation/Phase II||0
951114|NCT00095940|2298216|P3|COMPLETED|Lapatinib Continuation/Phase II||1
951115|NCT00095940|2298217|P2|COMPLETED|Lapatinib Continuation/Phase II||0
951116|NCT00095940|2298218|P1|COMPLETED|Lapatinib Continuation/Phase II||0
951117|NCT00095940|2298210|P9|STARTED|Lapatinib Continuation/Phase II||14
951118|NCT00095940|2298211|P8|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
951119|NCT00095940|2298212|P7|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
951120|NCT00095940|2298213|P6|STARTED|Lapatinib Continuation/Phase II||13
951121|NCT00095940|2298214|P5|STARTED|Lapatinib Continuation/Phase II||0
951122|NCT00095940|2298215|P4|STARTED|Lapatinib Continuation/Phase II||0
951123|NCT00095940|2298216|P3|STARTED|Lapatinib Continuation/Phase II||17
951124|NCT00095940|2298217|P2|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
951125|NCT00095940|2298218|P1|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
951126|NCT00095940|2298210|P9|NOT COMPLETED|Molecular Biology Phase||0
951127|NCT00095940|2298211|P8|NOT COMPLETED|Molecular Biology Phase||0
951128|NCT00095940|2298212|P7|NOT COMPLETED|Molecular Biology Phase||0
951129|NCT00095940|2298213|P6|NOT COMPLETED|Molecular Biology Phase||0
951130|NCT00095940|2298214|P5|NOT COMPLETED|Molecular Biology Phase||0
951131|NCT00095940|2298215|P4|NOT COMPLETED|Molecular Biology Phase||0
951132|NCT00095940|2298216|P3|NOT COMPLETED|Molecular Biology Phase||0
951133|NCT00095940|2298217|P2|NOT COMPLETED|Molecular Biology Phase||0
951134|NCT00095940|2298218|P1|NOT COMPLETED|Molecular Biology Phase||0
951135|NCT00095940|2298210|P9|COMPLETED|Molecular Biology Phase||0
951136|NCT00095940|2298211|P8|COMPLETED|Molecular Biology Phase||2
951137|NCT00095940|2298212|P7|COMPLETED|Molecular Biology Phase||2
951138|NCT00095940|2298213|P6|COMPLETED|Molecular Biology Phase||0
951139|NCT00095940|2298214|P5|COMPLETED|Molecular Biology Phase||0
951140|NCT00095940|2298215|P4|COMPLETED|Molecular Biology Phase||0
951141|NCT00095940|2298216|P3|COMPLETED|Molecular Biology Phase||0
951142|NCT00095940|2298217|P2|COMPLETED|Molecular Biology Phase||2
951143|NCT00095940|2298218|P1|COMPLETED|Molecular Biology Phase||2
951144|NCT00095940|2298210|P9|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
951145|NCT00095940|2298211|P8|STARTED|Molecular Biology Phase||2
951146|NCT00095940|2298212|P7|STARTED|Molecular Biology Phase||2
951147|NCT00095940|2298213|P6|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
951148|NCT00095940|2298214|P5|STARTED|Molecular Biology Phase||0
951149|NCT00095940|2298215|P4|STARTED|Molecular Biology Phase||0
951150|NCT00095940|2298216|P3|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
951151|NCT00095940|2298217|P2|STARTED|Molecular Biology Phase||2
951152|NCT00095940|2298218|P1|STARTED|Molecular Biology Phase||2
951153|NCT00095979|2298240|P1|NOT COMPLETED|Overall Study||2
951154|NCT00095979|2298240|P1|COMPLETED|Overall Study||50
951155|NCT00095979|2298240|P1|STARTED|Overall Study||52
951156|NCT00096018|2298248|P2|NOT COMPLETED|Overall Study||14
951157|NCT00096018|2298249|P1|NOT COMPLETED|Overall Study||2
951158|NCT00096018|2298248|P2|COMPLETED|Overall Study||16
951159|NCT00096018|2298249|P1|COMPLETED|Overall Study||11
951160|NCT00096018|2298248|P2|Treated With Study Therapy|Overall Study||25
951161|NCT00096018|2298249|P1|Treated With Study Therapy|Overall Study||13
951162|NCT00096018|2298248|P2|STARTED|Overall Study||30
951163|NCT00096018|2298249|P1|STARTED|Overall Study||13
951164|NCT00096031|2298257|P1|NOT COMPLETED|Overall Study||63
951165|NCT00096031|2298257|P1|COMPLETED|Overall Study||0
951166|NCT00096031|2298257|P1|Eligible and Began Protocol Therapy|Overall Study||55
951167|NCT00096031|2298257|P1|Eligible|Overall Study||57
951168|NCT00096031|2298257|P1|STARTED|Overall Study||63
951169|NCT00096044|2298263|P1|NOT COMPLETED|Overall Study||34
951170|NCT00096044|2298263|P1|COMPLETED|Overall Study||11
951171|NCT00096044|2298263|P1|STARTED|Overall Study||45
951172|NCT00096109|2298272|P1|NOT COMPLETED|Overall Study||0
951173|NCT00096109|2298272|P1|COMPLETED|Overall Study||11
951174|NCT00096109|2298272|P1|STARTED|Overall Study||11
951175|NCT00096122|2298278|P1|NOT COMPLETED|Overall Study||0
951176|NCT00096122|2298278|P1|COMPLETED|Overall Study||95
951177|NCT00096122|2298278|P1|STARTED|Overall Study||95
951178|NCT00096135|2298284|P2|NOT COMPLETED|Overall Study||15
951179|NCT00096135|2298285|P1|NOT COMPLETED|Overall Study||63
951180|NCT00096135|2298284|P2|COMPLETED|Overall Study||27
951181|NCT00096135|2298285|P1|COMPLETED|Overall Study||63
951182|NCT00096135|2298284|P2|STARTED|Overall Study||42
951183|NCT00096135|2298285|P1|STARTED|Overall Study||126
951184|NCT00096161|2298295|P4|NOT COMPLETED|Overall Study||0
951185|NCT00096161|2298296|P3|NOT COMPLETED|Overall Study||0
951186|NCT00096161|2298297|P2|NOT COMPLETED|Overall Study||0
951187|NCT00096161|2298298|P1|NOT COMPLETED|Overall Study||0
951188|NCT00096161|2298295|P4|COMPLETED|Overall Study||0
951189|NCT00096161|2298296|P3|COMPLETED|Overall Study||6
951190|NCT00096161|2298297|P2|COMPLETED|Overall Study||10
951191|NCT00096161|2298298|P1|COMPLETED|Overall Study||20
951192|NCT00096161|2298295|P4|STARTED|Overall Study||0
951193|NCT00096161|2298296|P3|STARTED|Overall Study||6
951194|NCT00096161|2298297|P2|STARTED|Overall Study||10
951195|NCT00096161|2298298|P1|STARTED|Overall Study||20
951196|NCT00096174|2298328|P1|NOT COMPLETED|Overall Study||62
951197|NCT00096174|2298328|P1|COMPLETED|Overall Study||7
951198|NCT00096174|2298328|P1|Eligible and Treated|Overall Study|6 treated patients were ineligible|60
951199|NCT00096174|2298328|P1|Began Protocol Therapy|Overall Study|3 patients never started treatment|66
951200|NCT00096174|2298328|P1|STARTED|Overall Study||69
951201|NCT00096200|2298337|P3|NOT COMPLETED|Overall Study||0
951202|NCT00096200|2298338|P2|NOT COMPLETED|Overall Study||7
951203|NCT00096200|2298339|P1|NOT COMPLETED|Overall Study||1
951204|NCT00096200|2298337|P3|COMPLETED|Overall Study||5
951205|NCT00096200|2298338|P2|COMPLETED|Overall Study||23
951206|NCT00096200|2298339|P1|COMPLETED|Overall Study||8
951207|NCT00096200|2298337|P3|STARTED|Overall Study||5
951208|NCT00096200|2298338|P2|STARTED|Overall Study||30
951209|NCT00096200|2298339|P1|STARTED|Overall Study||9
951210|NCT00096226|2298347|P1|NOT COMPLETED|Overall Study||17
951211|NCT00096226|2298347|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|43
951212|NCT00096226|2298347|P1|STARTED|Overall Study||60
951213|NCT00096265|2298354|P3|NOT COMPLETED|Overall Study||0
951214|NCT00096265|2298355|P2|NOT COMPLETED|Overall Study||0
951215|NCT00096265|2298356|P1|NOT COMPLETED|Overall Study||1
951216|NCT00096265|2298354|P3|COMPLETED|Overall Study||41
951217|NCT00096265|2298355|P2|COMPLETED|Overall Study||40
951218|NCT00096265|2298356|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
951219|NCT00096265|2298354|P3|STARTED|Overall Study||41
951220|NCT00096265|2298355|P2|STARTED|Overall Study||40
951221|NCT00096265|2298356|P1|STARTED|Overall Study||45
951222|NCT00096278|2298366|P2|NOT COMPLETED|Overall Study||20
951223|NCT00096278|2298367|P1|NOT COMPLETED|Overall Study||18
951224|NCT00096278|2298366|P2|COMPLETED|Overall Study||1334
951225|NCT00096278|2298367|P1|COMPLETED|Overall Study||1338
951226|NCT00096278|2298366|P2|STARTED|Overall Study||1354
951227|NCT00096278|2298367|P1|STARTED|Overall Study||1356
951228|NCT00096356|2298375|P2|NOT COMPLETED|Overall Study||53
951229|NCT00096356|2298376|P1|NOT COMPLETED|Overall Study||44
951230|NCT00096356|2298375|P2|COMPLETED|Overall Study||61
951231|NCT00096356|2298376|P1|COMPLETED|Overall Study||78
951232|NCT00096356|2298375|P2|STARTED|Overall Study||114
951233|NCT00096356|2298376|P1|STARTED|Overall Study||122
951234|NCT00096382|2298388|P2|NOT COMPLETED|Overall Study||0
951235|NCT00096382|2298389|P1|NOT COMPLETED|Overall Study||2
951236|NCT00096382|2298388|P2|COMPLETED|Overall Study||3
951237|NCT00096382|2298389|P1|COMPLETED|Overall Study||21
951238|NCT00096382|2298388|P2|STARTED|Overall Study||3
951239|NCT00096382|2298389|P1|STARTED|Overall Study||23
951240|NCT00096447|2298397|P1|NOT COMPLETED|Overall Study||1
951241|NCT00096447|2298397|P1|COMPLETED|Overall Study|Eligible and treated patients.|30
951242|NCT00096447|2298397|P1|STARTED|Overall Study||31
951243|NCT00096460|2298405|P2|NOT COMPLETED|Overall Study||1
951244|NCT00096460|2298406|P1|NOT COMPLETED|Overall Study||7
951245|NCT00096460|2298405|P2|COMPLETED|Overall Study||7
951246|NCT00096460|2298406|P1|COMPLETED|Overall Study||15
951247|NCT00096460|2298405|P2|STARTED|Overall Study||8
951248|NCT00096460|2298406|P1|STARTED|Overall Study||22
951249|NCT00096486|2298416|P4|NOT COMPLETED|Overall Study||2
951250|NCT00096486|2298417|P3|NOT COMPLETED|Overall Study||2
951251|NCT00096486|2298418|P2|NOT COMPLETED|Overall Study||0
951252|NCT00096486|2298419|P1|NOT COMPLETED|Overall Study||0
951253|NCT00096486|2298416|P4|COMPLETED|Overall Study||36
951254|NCT00096486|2298417|P3|COMPLETED|Overall Study||24
951255|NCT00096486|2298418|P2|COMPLETED|Overall Study||6
951256|NCT00096486|2298419|P1|COMPLETED|Overall Study||4
951257|NCT00096486|2298416|P4|STARTED|Overall Study||38
951258|NCT00096486|2298417|P3|STARTED|Overall Study||26
951259|NCT00096486|2298418|P2|STARTED|Overall Study||6
951260|NCT00096486|2298419|P1|STARTED|Overall Study||4
951261|NCT00096538|2298429|P1|NOT COMPLETED|Overall Study||1
951262|NCT00096538|2298429|P1|COMPLETED|Overall Study||5
951263|NCT00096538|2298429|P1|STARTED|Overall Study||6
951264|NCT00096681|2298433|P1|NOT COMPLETED|Overall Study||0
951265|NCT00096681|2298433|P1|COMPLETED|Overall Study||762
951266|NCT00096681|2298433|P1|STARTED|Overall Study||762
951267|NCT00096785|2298440|P2|NOT COMPLETED|Overall Study||1
951268|NCT00096785|2298441|P1|NOT COMPLETED|Overall Study||2
951269|NCT00096785|2298440|P2|COMPLETED|Overall Study|As randomized cohort|33
951270|NCT00096785|2298441|P1|COMPLETED|Overall Study|As randomized cohort|33
951271|NCT00096785|2298440|P2|As-Treated Population|Overall Study||33
951272|NCT00096785|2298441|P1|As-Treated Population|Overall Study||36
951273|NCT00096785|2298440|P2|As-Randomized Population|Overall Study||34
951274|NCT00096785|2298441|P1|As-Randomized Population|Overall Study||35
951275|NCT00096785|2298440|P2|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 34; as treated=33)|34
951276|NCT00096785|2298441|P1|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 35; as treated=36)|35
951277|NCT00096941|2298465|P1|NOT COMPLETED|Overall Study||3
951278|NCT00096941|2298465|P1|COMPLETED|Overall Study||0
951279|NCT00096941|2298465|P1|STARTED|Overall Study||3
951280|NCT00096954|2298472|P2|NOT COMPLETED|Overall Study||20
951281|NCT00096954|2298473|P1|NOT COMPLETED|Overall Study||24
951282|NCT00096954|2298472|P2|COMPLETED|Overall Study||154
951283|NCT00096954|2298473|P1|COMPLETED|Overall Study||135
951284|NCT00096954|2298472|P2|Received Study Drug|Overall Study||171
951285|NCT00096954|2298473|P1|Received Study Drug|Overall Study||157
951286|NCT00096954|2298472|P2|STARTED|Overall Study||174
951287|NCT00096954|2298473|P1|STARTED|Overall Study||159
951288|NCT00096993|2298487|P2|NOT COMPLETED|Overall Study||65
951289|NCT00096993|2298488|P1|NOT COMPLETED|Overall Study||65
951290|NCT00096993|2298487|P2|COMPLETED|Overall Study||0
951291|NCT00096993|2298488|P1|COMPLETED|Overall Study||1
951292|NCT00096993|2298487|P2|STARTED|Overall Study||65
951293|NCT00096993|2298488|P1|STARTED|Overall Study||66
951294|NCT00085423|2298502|P1|NOT COMPLETED|Overall Study||2
951295|NCT00085423|2298502|P1|COMPLETED|Overall Study||18
951296|NCT00085423|2298502|P1|STARTED|Overall Study||20
951297|NCT00085436|2298508|P1|NOT COMPLETED|Overall Study||0
951298|NCT00085436|2298508|P1|COMPLETED|Overall Study||18
951299|NCT00085436|2298508|P1|STARTED|Overall Study||18
951300|NCT00085540|2298514|P2|NOT COMPLETED|Overall Study||2
951301|NCT00085540|2298515|P1|NOT COMPLETED|Overall Study||0
951302|NCT00085540|2298514|P2|COMPLETED|Overall Study||40
951303|NCT00085540|2298515|P1|COMPLETED|Overall Study||8
951304|NCT00085540|2298514|P2|STARTED|Overall Study||42
951305|NCT00085540|2298515|P1|STARTED|Overall Study||8
951306|NCT00085566|2298525|P3|NOT COMPLETED|Overall Study||14
951307|NCT00085566|2298526|P2|NOT COMPLETED|Overall Study||0
951308|NCT00085566|2298527|P1|NOT COMPLETED|Overall Study||0
951309|NCT00085566|2298525|P3|COMPLETED|Overall Study||43
951310|NCT00085566|2298526|P2|COMPLETED|Overall Study||3
951311|NCT00085566|2298527|P1|COMPLETED|Overall Study||3
951312|NCT00085566|2298525|P3|STARTED|Overall Study||57
951313|NCT00085566|2298526|P2|STARTED|Overall Study||3
951314|NCT00085566|2298527|P1|STARTED|Overall Study||3
951315|NCT00085631|2298535|P3|NOT COMPLETED|Overall Study||7
951316|NCT00085631|2298536|P2|NOT COMPLETED|Overall Study||11
951317|NCT00085631|2298537|P1|NOT COMPLETED|Overall Study||4
951318|NCT00085631|2298535|P3|COMPLETED|Overall Study||32
951319|NCT00085631|2298536|P2|COMPLETED|Overall Study||38
951320|NCT00085631|2298537|P1|COMPLETED|Overall Study||9
951321|NCT00085631|2298535|P3|STARTED|Overall Study||39
951322|NCT00085631|2298536|P2|STARTED|Overall Study||49
951323|NCT00085631|2298537|P1|STARTED|Overall Study||13
951324|NCT00085644|2298546|P3|NOT COMPLETED|Open-Label Period||109
951325|NCT00085644|2298547|P2|NOT COMPLETED|Open-Label Period||0
951326|NCT00085644|2298548|P1|NOT COMPLETED|Open-Label Period||0
951327|NCT00085644|2298546|P3|COMPLETED|Open-Label Period||202
951328|NCT00085644|2298547|P2|COMPLETED|Open-Label Period||0
951329|NCT00085644|2298548|P1|COMPLETED|Open-Label Period||0
951330|NCT00085644|2298546|P3|STARTED|Open-Label Period|1 subject who discontinued for personal reasons subsequently died 450 days after last dose.|311
951331|NCT00085644|2298547|P2|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
951332|NCT00085644|2298548|P1|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
951333|NCT00085644|2298546|P3|NOT COMPLETED|Double-Blind Period||0
951334|NCT00085644|2298547|P2|NOT COMPLETED|Double-Blind Period||6
951335|NCT00085644|2298548|P1|NOT COMPLETED|Double-Blind Period||13
951336|NCT00085644|2298546|P3|COMPLETED|Double-Blind Period||0
951337|NCT00085644|2298547|P2|COMPLETED|Double-Blind Period||101
951338|NCT00085644|2298548|P1|COMPLETED|Double-Blind Period||195
951339|NCT00085644|2298546|P3|STARTED|Double-Blind Period|This treatment group is not applicable to the Double-Blind Period.|0
951340|NCT00085644|2298547|P2|STARTED|Double-Blind Period||107
951341|NCT00085644|2298548|P1|STARTED|Double-Blind Period||208
951342|NCT00085709|2298591|P2|NOT COMPLETED|Overall Study||50
951343|NCT00085709|2298592|P1|NOT COMPLETED|Overall Study||53
951344|NCT00085709|2298591|P2|COMPLETED|Overall Study||270
951345|NCT00085709|2298592|P1|COMPLETED|Overall Study||264
951346|NCT00085709|2298591|P2|Eligible and Did Not Withdraw Consent|Overall Study||300
951347|NCT00085709|2298592|P1|Eligible and Did Not Withdraw Consent|Overall Study||296
951348|NCT00085709|2298591|P2|Eligible|Overall Study||301
951349|NCT00085709|2298592|P1|Eligible|Overall Study||298
951350|NCT00085709|2298591|P2|STARTED|Overall Study||320
951351|NCT00085709|2298592|P1|STARTED|Overall Study||317
951352|NCT00085735|2298612|P6|NOT COMPLETED|Overall Study||31
951353|NCT00085735|2298613|P5|NOT COMPLETED|Overall Study||42
951354|NCT00085735|2298614|P4|NOT COMPLETED|Overall Study||19
951355|NCT00085735|2298615|P3|NOT COMPLETED|Overall Study||17
951356|NCT00085735|2298616|P2|NOT COMPLETED|Overall Study||10
951357|NCT00085735|2298617|P1|NOT COMPLETED|Overall Study||12
951358|NCT00085735|2298612|P6|COMPLETED|Overall Study||115
951359|NCT00085735|2298613|P5|COMPLETED|Overall Study||105
951360|NCT00085735|2298614|P4|COMPLETED|Overall Study||46
951361|NCT00085735|2298615|P3|COMPLETED|Overall Study||46
951362|NCT00085735|2298616|P2|COMPLETED|Overall Study||54
951363|NCT00085735|2298617|P1|COMPLETED|Overall Study||52
951364|NCT00085735|2298612|P6|STARTED|Overall Study||146
951365|NCT00085735|2298613|P5|STARTED|Overall Study||147
951366|NCT00085735|2298614|P4|STARTED|Overall Study||65
951367|NCT00085735|2298615|P3|STARTED|Overall Study||63
951368|NCT00085735|2298616|P2|STARTED|Overall Study||64
951369|NCT00085735|2298617|P1|STARTED|Overall Study||64
951370|NCT00085839|2298645|P2|NOT COMPLETED|Overall Study||0
951371|NCT00085839|2298646|P1|NOT COMPLETED|Overall Study||0
951372|NCT00085839|2298645|P2|COMPLETED|Overall Study||51
951373|NCT00085839|2298646|P1|COMPLETED|Overall Study||52
951374|NCT00085839|2298645|P2|STARTED|Overall Study||51
951375|NCT00085839|2298646|P1|STARTED|Overall Study||52
951376|NCT00085917|2298658|P2|NOT COMPLETED|Overall Study||3
951377|NCT00085917|2298659|P1|NOT COMPLETED|Overall Study||4
951378|NCT00085917|2298658|P2|COMPLETED|Overall Study||11
951379|NCT00085917|2298659|P1|COMPLETED|Overall Study||11
951380|NCT00085917|2298658|P2|STARTED|Overall Study||14
951381|NCT00085917|2298659|P1|STARTED|Overall Study||15
951382|NCT00086047|2298671|P2|NOT COMPLETED|Overall Study||7
951383|NCT00086047|2298672|P1|NOT COMPLETED|Overall Study||7
951384|NCT00086047|2298671|P2|COMPLETED|Overall Study||50
951385|NCT00086047|2298672|P1|COMPLETED|Overall Study||50
951386|NCT00086047|2298671|P2|STARTED|Overall Study||57
951387|NCT00086047|2298672|P1|STARTED|Overall Study||57
951388|NCT00086138|2298680|P2|NOT COMPLETED|Overall Study||3
951389|NCT00086138|2298681|P1|NOT COMPLETED|Overall Study||4
951390|NCT00086138|2298680|P2|COMPLETED|Overall Study||64
951391|NCT00086138|2298681|P1|COMPLETED|Overall Study||60
951392|NCT00086138|2298680|P2|STARTED|Overall Study||67
951393|NCT00086138|2298681|P1|STARTED|Overall Study||64
951394|NCT00086190|2298692|P3|NOT COMPLETED|Overall Study||6
951395|NCT00086190|2298693|P2|NOT COMPLETED|Overall Study||4
951396|NCT00086190|2298694|P1|NOT COMPLETED|Overall Study||8
951397|NCT00086190|2298692|P3|COMPLETED|Overall Study||33
951398|NCT00086190|2298693|P2|COMPLETED|Overall Study||30
951399|NCT00086190|2298694|P1|COMPLETED|Overall Study||34
951400|NCT00086190|2298692|P3|STARTED|Overall Study||39
951401|NCT00086190|2298693|P2|STARTED|Overall Study||34
951402|NCT00086190|2298694|P1|STARTED|Overall Study||42
951403|NCT00086281|2298765|P15|NOT COMPLETED|Phase 2||0
951404|NCT00086281|2298766|P14|NOT COMPLETED|Phase 2||1
951405|NCT00086281|2298767|P13|NOT COMPLETED|Phase 2||1
951406|NCT00086281|2298768|P12|NOT COMPLETED|Phase 2||0
951407|NCT00086281|2298769|P11|NOT COMPLETED|Phase 2||0
951408|NCT00086281|2298770|P10|NOT COMPLETED|Phase 2||0
951409|NCT00086281|2298771|P9|NOT COMPLETED|Phase 2||0
951410|NCT00086281|2298772|P8|NOT COMPLETED|Phase 2||0
951411|NCT00086281|2298773|P7|NOT COMPLETED|Phase 2||0
951412|NCT00086281|2298774|P6|NOT COMPLETED|Phase 2||0
951413|NCT00086281|2298775|P5|NOT COMPLETED|Phase 2||0
951414|NCT00086281|2298776|P4|NOT COMPLETED|Phase 2||0
951415|NCT00086281|2298777|P3|NOT COMPLETED|Phase 2||0
951416|NCT00086281|2298778|P2|NOT COMPLETED|Phase 2||0
951417|NCT00086281|2298779|P1|NOT COMPLETED|Phase 2||0
951418|NCT00086281|2298765|P15|COMPLETED|Phase 2||0
951419|NCT00086281|2298766|P14|COMPLETED|Phase 2||26
951420|NCT00086281|2298767|P13|COMPLETED|Phase 2||22
951421|NCT00086281|2298768|P12|COMPLETED|Phase 2||0
951422|NCT00086281|2298769|P11|COMPLETED|Phase 2||0
951423|NCT00086281|2298770|P10|COMPLETED|Phase 2||0
951424|NCT00086281|2298771|P9|COMPLETED|Phase 2||0
951425|NCT00086281|2298772|P8|COMPLETED|Phase 2||0
951426|NCT00086281|2298773|P7|COMPLETED|Phase 2||0
951427|NCT00086281|2298774|P6|COMPLETED|Phase 2||0
951428|NCT00086281|2298775|P5|COMPLETED|Phase 2||0
951429|NCT00086281|2298776|P4|COMPLETED|Phase 2||0
951430|NCT00086281|2298777|P3|COMPLETED|Phase 2||0
951431|NCT00086281|2298778|P2|COMPLETED|Phase 2||0
951432|NCT00086281|2298779|P1|COMPLETED|Phase 2||0
951433|NCT00086281|2298765|P15|STARTED|Phase 2||0
951434|NCT00086281|2298766|P14|STARTED|Phase 2||27
951435|NCT00086281|2298767|P13|STARTED|Phase 2||23
951436|NCT00086281|2298768|P12|STARTED|Phase 2||0
951437|NCT00086281|2298769|P11|STARTED|Phase 2||0
951438|NCT00086281|2298770|P10|STARTED|Phase 2||0
951439|NCT00086281|2298771|P9|STARTED|Phase 2||0
951440|NCT00086281|2298772|P8|STARTED|Phase 2||0
951441|NCT00086281|2298773|P7|STARTED|Phase 2||0
951442|NCT00086281|2298774|P6|STARTED|Phase 2||0
951443|NCT00086281|2298775|P5|STARTED|Phase 2||0
951444|NCT00086281|2298776|P4|STARTED|Phase 2||0
951445|NCT00086281|2298777|P3|STARTED|Phase 2||0
951446|NCT00086281|2298778|P2|STARTED|Phase 2||0
951447|NCT00086281|2298779|P1|STARTED|Phase 2||0
951448|NCT00086281|2298765|P15|NOT COMPLETED|Phase 1||3
951449|NCT00086281|2298766|P14|NOT COMPLETED|Phase 1||1
951450|NCT00086281|2298767|P13|NOT COMPLETED|Phase 1||1
951451|NCT00086281|2298768|P12|NOT COMPLETED|Phase 1||1
951452|NCT00086281|2298769|P11|NOT COMPLETED|Phase 1||3
951453|NCT00086281|2298770|P10|NOT COMPLETED|Phase 1||1
951454|NCT00086281|2298771|P9|NOT COMPLETED|Phase 1||0
951455|NCT00086281|2298772|P8|NOT COMPLETED|Phase 1||0
951456|NCT00086281|2298773|P7|NOT COMPLETED|Phase 1||0
951457|NCT00086281|2298774|P6|NOT COMPLETED|Phase 1||0
951458|NCT00086281|2298775|P5|NOT COMPLETED|Phase 1||0
951459|NCT00086281|2298776|P4|NOT COMPLETED|Phase 1||0
951460|NCT00086281|2298777|P3|NOT COMPLETED|Phase 1||0
951461|NCT00086281|2298778|P2|NOT COMPLETED|Phase 1||0
951462|NCT00086281|2298779|P1|NOT COMPLETED|Phase 1||0
951463|NCT00086281|2298765|P15|COMPLETED|Phase 1||0
951464|NCT00086281|2298766|P14|COMPLETED|Phase 1||0
951465|NCT00086281|2298767|P13|COMPLETED|Phase 1||0
951466|NCT00086281|2298768|P12|COMPLETED|Phase 1||0
951467|NCT00086281|2298769|P11|COMPLETED|Phase 1||0
951468|NCT00086281|2298770|P10|COMPLETED|Phase 1||0
951469|NCT00086281|2298771|P9|COMPLETED|Phase 1||2
951470|NCT00086281|2298772|P8|COMPLETED|Phase 1||1
951471|NCT00086281|2298773|P7|COMPLETED|Phase 1||1
951472|NCT00086281|2298774|P6|COMPLETED|Phase 1||3
951473|NCT00086281|2298775|P5|COMPLETED|Phase 1||1
951474|NCT00086281|2298776|P4|COMPLETED|Phase 1||11
951475|NCT00086281|2298777|P3|COMPLETED|Phase 1||8
951476|NCT00086281|2298778|P2|COMPLETED|Phase 1||12
951477|NCT00086281|2298779|P1|COMPLETED|Phase 1||11
951478|NCT00086281|2298765|P15|STARTED|Phase 1||3
951479|NCT00086281|2298766|P14|STARTED|Phase 1||1
951480|NCT00086281|2298767|P13|STARTED|Phase 1||1
951481|NCT00086281|2298768|P12|STARTED|Phase 1||1
951482|NCT00086281|2298769|P11|STARTED|Phase 1||3
951483|NCT00086281|2298770|P10|STARTED|Phase 1||1
951484|NCT00086281|2298771|P9|STARTED|Phase 1||2
951485|NCT00086281|2298772|P8|STARTED|Phase 1||1
951486|NCT00086281|2298773|P7|STARTED|Phase 1||1
951487|NCT00086281|2298774|P6|STARTED|Phase 1||3
951488|NCT00086281|2298775|P5|STARTED|Phase 1||1
951489|NCT00086281|2298776|P4|STARTED|Phase 1||11
951490|NCT00086281|2298777|P3|STARTED|Phase 1||8
951491|NCT00086281|2298778|P2|STARTED|Phase 1||12
951492|NCT00086281|2298779|P1|STARTED|Phase 1||11
951493|NCT00086307|2298792|P3|NOT COMPLETED|Overall Study||8
951494|NCT00086307|2298793|P2|NOT COMPLETED|Overall Study||1
951495|NCT00086307|2298794|P1|NOT COMPLETED|Overall Study||2
951496|NCT00086307|2298792|P3|COMPLETED|Overall Study||5
951497|NCT00086307|2298793|P2|COMPLETED|Overall Study||12
951498|NCT00086307|2298794|P1|COMPLETED|Overall Study||11
951499|NCT00086307|2298792|P3|STARTED|Overall Study||13
951500|NCT00086307|2298793|P2|STARTED|Overall Study||13
951501|NCT00086307|2298794|P1|STARTED|Overall Study||13
951502|NCT00086346|2298804|P2|NOT COMPLETED|Patients Dosed With Test Article||23
951503|NCT00086346|2298805|P1|NOT COMPLETED|Patients Dosed With Test Article||140
951504|NCT00086346|2298804|P2|COMPLETED|Patients Dosed With Test Article||187
951505|NCT00086346|2298805|P1|COMPLETED|Patients Dosed With Test Article||249
951506|NCT00086346|2298804|P2|STARTED|Patients Dosed With Test Article||210
951507|NCT00086346|2298805|P1|STARTED|Patients Dosed With Test Article||389
951508|NCT00086346|2298804|P2|NOT COMPLETED|Randomization||4
951509|NCT00086346|2298805|P1|NOT COMPLETED|Randomization||4
951510|NCT00086346|2298804|P2|COMPLETED|Randomization||210
951511|NCT00086346|2298805|P1|COMPLETED|Randomization||389
951512|NCT00086346|2298804|P2|STARTED|Randomization||214
951513|NCT00086346|2298805|P1|STARTED|Randomization||393
951514|NCT00086385|2298821|P4|NOT COMPLETED|Overall Study||1
951515|NCT00086385|2298822|P3|NOT COMPLETED|Overall Study||1
951516|NCT00086385|2298823|P2|NOT COMPLETED|Overall Study||2
951517|NCT00086385|2298824|P1|NOT COMPLETED|Overall Study||2
951518|NCT00086385|2298821|P4|COMPLETED|Overall Study||98
951519|NCT00086385|2298822|P3|COMPLETED|Overall Study||103
951520|NCT00086385|2298823|P2|COMPLETED|Overall Study||97
951521|NCT00086385|2298824|P1|COMPLETED|Overall Study||98
951522|NCT00086385|2298821|P4|STARTED|Overall Study||99
951523|NCT00086385|2298822|P3|STARTED|Overall Study||104
951524|NCT00086385|2298823|P2|STARTED|Overall Study||99
951525|NCT00086385|2298824|P1|STARTED|Overall Study||100
951526|NCT00086411|2298838|P4|NOT COMPLETED|Overall Study||12
951527|NCT00086411|2298839|P3|NOT COMPLETED|Overall Study||13
951528|NCT00086411|2298840|P2|NOT COMPLETED|Overall Study||11
951529|NCT00086411|2298841|P1|NOT COMPLETED|Overall Study||11
951530|NCT00086411|2298838|P4|COMPLETED|Overall Study||53
951531|NCT00086411|2298839|P3|COMPLETED|Overall Study||49
951532|NCT00086411|2298840|P2|COMPLETED|Overall Study||52
951533|NCT00086411|2298841|P1|COMPLETED|Overall Study||59
951534|NCT00086411|2298838|P4|STARTED|Overall Study||65
951535|NCT00086411|2298839|P3|STARTED|Overall Study||62
951536|NCT00086411|2298840|P2|STARTED|Overall Study||63
951537|NCT00086411|2298841|P1|STARTED|Overall Study||70
951538|NCT00086450|2298853|P2|NOT COMPLETED|Overall Study||0
951539|NCT00086450|2298854|P1|NOT COMPLETED|Overall Study||0
951540|NCT00086450|2298853|P2|COMPLETED|Overall Study||947
951541|NCT00086450|2298854|P1|COMPLETED|Overall Study||953
951542|NCT00086450|2298853|P2|STARTED|Overall Study||947
951543|NCT00086450|2298854|P1|STARTED|Overall Study||953
951544|NCT00086502|2298868|P2|NOT COMPLETED|Overall Study||20
951545|NCT00086502|2298869|P1|NOT COMPLETED|Overall Study||26
951546|NCT00086502|2298868|P2|COMPLETED|Overall Study||158
951547|NCT00086502|2298869|P1|COMPLETED|Overall Study||149
951548|NCT00086502|2298868|P2|STARTED|Overall Study||178
951549|NCT00086502|2298869|P1|STARTED|Overall Study||175
951550|NCT00086515|2298879|P2|NOT COMPLETED|Phase B (Weeks 24-104)||55
951551|NCT00086515|2298880|P1|NOT COMPLETED|Phase B (Weeks 24-104)||190
951552|NCT00086515|2298879|P2|COMPLETED|Phase B (Weeks 24-104)||109
951553|NCT00086515|2298880|P1|COMPLETED|Phase B (Weeks 24-104)||201
951554|NCT00086515|2298879|P2|STARTED|Phase B (Weeks 24-104)||164
951555|NCT00086515|2298880|P1|STARTED|Phase B (Weeks 24-104)||391
951556|NCT00086515|2298879|P2|NOT COMPLETED|Phase A to Phase B Transition Period||28
951557|NCT00086515|2298880|P1|NOT COMPLETED|Phase A to Phase B Transition Period||24
951558|NCT00086515|2298879|P2|COMPLETED|Phase A to Phase B Transition Period||164
951559|NCT00086515|2298880|P1|COMPLETED|Phase A to Phase B Transition Period||391
951560|NCT00086515|2298879|P2|STARTED|Phase A to Phase B Transition Period||192
951561|NCT00086515|2298880|P1|STARTED|Phase A to Phase B Transition Period||415
951562|NCT00086515|2298879|P2|NOT COMPLETED|Phase A (Weeks 0-24)||45
951563|NCT00086515|2298880|P1|NOT COMPLETED|Phase A (Weeks 0-24)||49
951564|NCT00086515|2298879|P2|COMPLETED|Phase A (Weeks 0-24)||192
951565|NCT00086515|2298880|P1|COMPLETED|Phase A (Weeks 0-24)||415
951566|NCT00086515|2298879|P2|STARTED|Phase A (Weeks 0-24)||237
951567|NCT00086515|2298880|P1|STARTED|Phase A (Weeks 0-24)||464
951568|NCT00086580|2298892|P2|NOT COMPLETED|Observation Period||65
951569|NCT00086580|2298893|P1|NOT COMPLETED|Observation Period||46
951570|NCT00086580|2298892|P2|COMPLETED|Observation Period||56
951571|NCT00086580|2298893|P1|COMPLETED|Observation Period||49
951572|NCT00086580|2298892|P2|STARTED|Observation Period||121
951573|NCT00086580|2298893|P1|STARTED|Observation Period||95
951574|NCT00086580|2298892|P2|NOT COMPLETED|Follow-up Period||119
951575|NCT00086580|2298893|P1|NOT COMPLETED|Follow-up Period||104
951576|NCT00086580|2298892|P2|COMPLETED|Follow-up Period||18
951577|NCT00086580|2298893|P1|COMPLETED|Follow-up Period||37
951578|NCT00086580|2298892|P2|STARTED|Follow-up Period||137
951579|NCT00086580|2298893|P1|STARTED|Follow-up Period||141
951580|NCT00086580|2298892|P2|NOT COMPLETED|Treatment Period||60
951581|NCT00086580|2298893|P1|NOT COMPLETED|Treatment Period||65
951582|NCT00086580|2298892|P2|COMPLETED|Treatment Period|Finished 6 cycles of study drug|107
951583|NCT00086580|2298893|P1|COMPLETED|Treatment Period|Finished 6 cycles of study drugs|103
951584|NCT00086580|2298892|P2|Safety Population|Treatment Period|Two participants did not receive treatment|165
951585|NCT00086580|2298893|P1|Safety Population|Treatment Period|Four participants did not receive treatment|164
951586|NCT00086580|2298892|P2|STARTED|Treatment Period||167
951587|NCT00086580|2298893|P1|STARTED|Treatment Period||168
951588|NCT00086619|2298939|P2|NOT COMPLETED|Overall Study||17
951589|NCT00086619|2298940|P1|NOT COMPLETED|Overall Study||15
951590|NCT00086619|2298939|P2|COMPLETED|Overall Study||23
951591|NCT00086619|2298940|P1|COMPLETED|Overall Study||25
951592|NCT00086619|2298939|P2|Completed 12 Month Visit|Overall Study||26
951593|NCT00086619|2298940|P1|Completed 12 Month Visit|Overall Study||26
951594|NCT00086619|2298939|P2|Completed Baseline Visit|Overall Study||36
951595|NCT00086619|2298940|P1|Completed Baseline Visit|Overall Study||34
951596|NCT00086619|2298939|P2|STARTED|Overall Study||40
951597|NCT00086619|2298940|P1|STARTED|Overall Study||40
951598|NCT00086684|2298951|P3|NOT COMPLETED|Overall Study||53
951599|NCT00086684|2298952|P2|NOT COMPLETED|Overall Study||55
951600|NCT00086684|2298953|P1|NOT COMPLETED|Overall Study||55
951601|NCT00086684|2298951|P3|COMPLETED|Overall Study||69
951602|NCT00086684|2298952|P2|COMPLETED|Overall Study||74
951603|NCT00086684|2298953|P1|COMPLETED|Overall Study||63
951604|NCT00086684|2298951|P3|STARTED|Overall Study||122
951605|NCT00086684|2298952|P2|STARTED|Overall Study||129
951606|NCT00086684|2298953|P1|STARTED|Overall Study||118
951607|NCT00086957|2298964|P3|NOT COMPLETED|Overall Study||0
951608|NCT00086957|2298965|P2|NOT COMPLETED|Overall Study||0
951609|NCT00086957|2298966|P1|NOT COMPLETED|Overall Study||0
951610|NCT00086957|2298964|P3|COMPLETED|Overall Study||22
951611|NCT00086957|2298965|P2|COMPLETED|Overall Study||7
951612|NCT00086957|2298966|P1|COMPLETED|Overall Study||2
951613|NCT00086957|2298964|P3|STARTED|Overall Study||22
951614|NCT00086957|2298965|P2|STARTED|Overall Study||7
951615|NCT00086957|2298966|P1|STARTED|Overall Study||2
951616|NCT00086996|2298976|P1|NOT COMPLETED|Overall Study||64
951617|NCT00086996|2298976|P1|COMPLETED|Overall Study||34
951618|NCT00086996|2298976|P1|Eligible and Began Protocol Therapy|Overall Study||93
951619|NCT00086996|2298976|P1|Eligible|Overall Study||93
951620|NCT00086996|2298976|P1|STARTED|Overall Study||98
951621|NCT00087139|2298986|P3|NOT COMPLETED|Overall Study||36
951622|NCT00087139|2298987|P2|NOT COMPLETED|Overall Study||49
951623|NCT00087139|2298988|P1|NOT COMPLETED|Overall Study||39
951624|NCT00087139|2298986|P3|COMPLETED|Overall Study||0
951625|NCT00087139|2298987|P2|COMPLETED|Overall Study||0
951626|NCT00087139|2298988|P1|COMPLETED|Overall Study||0
951627|NCT00087139|2298986|P3|Patients w/ Measurable Disease Response|Overall Study||0
951628|NCT00087139|2298987|P2|Patients w/ Measurable Disease Response|Overall Study||2
951629|NCT00087139|2298988|P1|Patients w/ Measurable Disease Response|Overall Study||5
951630|NCT00087139|2298986|P3|Patients With PSA Response|Overall Study||4
951631|NCT00087139|2298987|P2|Patients With PSA Response|Overall Study||8
951632|NCT00087139|2298988|P1|Patients With PSA Response|Overall Study||10
951633|NCT00087139|2298986|P3|Patients With Measurable Disease|Overall Study||24
951634|NCT00087139|2298987|P2|Patients With Measurable Disease|Overall Study||25
951635|NCT00087139|2298988|P1|Patients With Measurable Disease|Overall Study||22
951636|NCT00087139|2298986|P3|Patients for the Analysis of PSA Respons|Overall Study||22
951637|NCT00087139|2298987|P2|Patients for the Analysis of PSA Respons|Overall Study||34
951638|NCT00087139|2298988|P1|Patients for the Analysis of PSA Respons|Overall Study||30
951639|NCT00087139|2298986|P3|Eligible and Treated|Overall Study||32
951640|NCT00087139|2298987|P2|Eligible and Treated|Overall Study||42
951641|NCT00087139|2298988|P1|Eligible and Treated|Overall Study||35
951642|NCT00087139|2298986|P3|Treated|Overall Study||36
951643|NCT00087139|2298987|P2|Treated|Overall Study||48
951644|NCT00087139|2298988|P1|Treated|Overall Study||39
951645|NCT00087139|2298986|P3|STARTED|Overall Study||36
951646|NCT00087139|2298987|P2|STARTED|Overall Study||49
951647|NCT00087139|2298988|P1|STARTED|Overall Study||39
951648|NCT00087152|2299003|P1|NOT COMPLETED|Overall Study||6
951649|NCT00087152|2299003|P1|COMPLETED|Overall Study||21
951650|NCT00087152|2299003|P1|STARTED|Overall Study||27
951651|NCT00087438|2299009|P1|NOT COMPLETED|Overall Study||4
951652|NCT00087438|2299009|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|55
951653|NCT00087438|2299009|P1|STARTED|Overall Study||59
951654|NCT00087490|2299015|P2|NOT COMPLETED|Overall Study||269
951655|NCT00087490|2299016|P1|NOT COMPLETED|Overall Study||258
951656|NCT00087490|2299015|P2|COMPLETED|Overall Study||264
951657|NCT00087490|2299016|P1|COMPLETED|Overall Study||286
951658|NCT00087490|2299015|P2|Treated|Overall Study||515
951659|NCT00087490|2299016|P1|Treated|Overall Study||537
951660|NCT00087490|2299015|P2|STARTED|Overall Study||533
951661|NCT00087490|2299016|P1|STARTED|Overall Study||544
951662|NCT00087516|2299053|P4|NOT COMPLETED|Overall Study||85
951663|NCT00087516|2299054|P3|NOT COMPLETED|Overall Study||97
951664|NCT00087516|2299055|P2|NOT COMPLETED|Overall Study||169
951665|NCT00087516|2299056|P1|NOT COMPLETED|Overall Study||161
951666|NCT00087516|2299053|P4|COMPLETED|Overall Study||38
951667|NCT00087516|2299054|P3|COMPLETED|Overall Study||33
951668|NCT00087516|2299055|P2|COMPLETED|Overall Study||81
951669|NCT00087516|2299056|P1|COMPLETED|Overall Study||77
951670|NCT00087516|2299053|P4|STARTED|Overall Study||123
951671|NCT00087516|2299054|P3|STARTED|Overall Study||130
951672|NCT00087516|2299055|P2|STARTED|Overall Study||250
951673|NCT00087516|2299056|P1|STARTED|Overall Study||238
951674|NCT00087529|2299085|P2|NOT COMPLETED|Overall Study||68
951675|NCT00087529|2299086|P1|NOT COMPLETED|Overall Study||31
951676|NCT00087529|2299085|P2|COMPLETED|Overall Study||224
951677|NCT00087529|2299086|P1|COMPLETED|Overall Study||116
951678|NCT00087529|2299085|P2|STARTED|Overall Study||292
951679|NCT00087529|2299086|P1|STARTED|Overall Study||147
951680|NCT00087555|2299101|P3|NOT COMPLETED|Overall Study||21
951681|NCT00087555|2299102|P2|NOT COMPLETED|Overall Study||11
951682|NCT00087555|2299103|P1|NOT COMPLETED|Overall Study||12
951683|NCT00087555|2299101|P3|COMPLETED|Overall Study||46
951684|NCT00087555|2299102|P2|COMPLETED|Overall Study||51
951685|NCT00087555|2299103|P1|COMPLETED|Overall Study||54
951686|NCT00087555|2299101|P3|Treated|Overall Study||67
951687|NCT00087555|2299102|P2|Treated|Overall Study||60
951688|NCT00087555|2299103|P1|Treated|Overall Study||65
951689|NCT00087555|2299101|P3|STARTED|Overall Study||67
951690|NCT00087555|2299102|P2|STARTED|Overall Study||62
951691|NCT00087555|2299103|P1|STARTED|Overall Study||66
951692|NCT00087568|2299113|P2|NOT COMPLETED|Overall Study||2
951693|NCT00087568|2299114|P1|NOT COMPLETED|Overall Study||30
951694|NCT00087568|2299113|P2|COMPLETED|Overall Study||23
951695|NCT00087568|2299114|P1|COMPLETED|Overall Study||2
951696|NCT00087568|2299113|P2|STARTED|Overall Study||25
951697|NCT00087568|2299114|P1|STARTED|Overall Study||32
951698|NCT00087594|2299140|P2|NOT COMPLETED|Overall Study||12
951699|NCT00087594|2299141|P1|NOT COMPLETED|Overall Study||8
951700|NCT00087594|2299140|P2|COMPLETED|Overall Study||12
951701|NCT00087594|2299141|P1|COMPLETED|Overall Study||16
951702|NCT00087594|2299140|P2|STARTED|Overall Study||24
951703|NCT00087594|2299141|P1|STARTED|Overall Study||24
951704|NCT00087607|2299175|P2|NOT COMPLETED|Overall Study||122
951705|NCT00087607|2299176|P1|NOT COMPLETED|Overall Study||122
951706|NCT00087607|2299175|P2|COMPLETED|Overall Study||71
951707|NCT00087607|2299176|P1|COMPLETED|Overall Study||70
951708|NCT00087607|2299175|P2|STARTED|Overall Study||193
951709|NCT00087607|2299176|P1|STARTED|Overall Study||192
951710|NCT00087633|2299216|P2|NOT COMPLETED|Overall Study||17
951711|NCT00087633|2299217|P1|NOT COMPLETED|Overall Study||24
951712|NCT00087633|2299216|P2|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|43
951713|NCT00087633|2299217|P1|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|31
951714|NCT00087633|2299216|P2|STARTED|Overall Study|Randomized|60
951715|NCT00087633|2299217|P1|STARTED|Overall Study|Randomized|55
951716|NCT00087646|2299229|P4|NOT COMPLETED|Overall Study||84
951717|NCT00087646|2299230|P3|NOT COMPLETED|Overall Study||65
951718|NCT00087646|2299231|P2|NOT COMPLETED|Overall Study||42
951719|NCT00087646|2299232|P1|NOT COMPLETED|Overall Study||135
951720|NCT00087646|2299229|P4|COMPLETED|Overall Study||229
951721|NCT00087646|2299230|P3|COMPLETED|Overall Study||91
951722|NCT00087646|2299231|P2|COMPLETED|Overall Study||114
951723|NCT00087646|2299232|P1|COMPLETED|Overall Study||182
951724|NCT00087646|2299229|P4|STARTED|Overall Study||313
951725|NCT00087646|2299230|P3|STARTED|Overall Study||156
951726|NCT00087646|2299231|P2|STARTED|Overall Study||156
951727|NCT00087646|2299232|P1|STARTED|Overall Study||317
951728|NCT00087672|2299258|P1|NOT COMPLETED|Overall Study||0
951729|NCT00087672|2299258|P1|COMPLETED|Overall Study||41
951730|NCT00087672|2299258|P1|STARTED|Overall Study||41
951731|NCT00087685|2299262|P1|NOT COMPLETED|Overall Study||14
951732|NCT00087685|2299262|P1|COMPLETED|Overall Study||21
951733|NCT00087685|2299262|P1|STARTED|Overall Study||35
951734|NCT00087698|2299267|P1|NOT COMPLETED|Overall Study||36
951735|NCT00087698|2299267|P1|COMPLETED|Overall Study||41
951736|NCT00087698|2299267|P1|STARTED|Overall Study||77
951737|NCT00097253|2299276|P1|NOT COMPLETED|Water (Control)||0
951738|NCT00097253|2299276|P1|COMPLETED|Water (Control)||56
951739|NCT00097253|2299276|P1|STARTED|Water (Control)||56
951740|NCT00097253|2299276|P1|NOT COMPLETED|Lemon||0
951741|NCT00097253|2299276|P1|COMPLETED|Lemon||56
951742|NCT00097253|2299276|P1|STARTED|Lemon||56
951743|NCT00097253|2299276|P1|NOT COMPLETED|Lavender||0
951744|NCT00097253|2299276|P1|COMPLETED|Lavender||56
951745|NCT00097253|2299276|P1|STARTED|Lavender||56
951746|NCT00097370|2299291|P1|NOT COMPLETED|Stage 3||59
951747|NCT00097370|2299291|P1|COMPLETED|Stage 3||0
951748|NCT00097370|2299291|P1|STARTED|Stage 3|Participants continued from Stage 2.|59
951749|NCT00097370|2299291|P1|NOT COMPLETED|Stage 2||13
951750|NCT00097370|2299291|P1|COMPLETED|Stage 2||59
951751|NCT00097370|2299291|P1|STARTED|Stage 2|41 participants entered from study MHE100185 and 31 participants continued from Stage 1.|72
951752|NCT00097370|2299291|P1|NOT COMPLETED|Stage 1||6
951753|NCT00097370|2299291|P1|COMPLETED|Stage 1||31
951754|NCT00097370|2299291|P1|STARTED|Stage 1|Participants entered from study MHE100185.|37
951755|NCT00097448|2299310|P2|NOT COMPLETED|Overall Study||1
951756|NCT00097448|2299311|P1|NOT COMPLETED|Overall Study||4
951757|NCT00097448|2299310|P2|COMPLETED|Overall Study||129
951758|NCT00097448|2299311|P1|COMPLETED|Overall Study||121
951759|NCT00097448|2299310|P2|STARTED|Overall Study||130
951760|NCT00097448|2299311|P1|STARTED|Overall Study||125
951761|NCT00097500|2299319|P2|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||4
951762|NCT00097500|2299320|P1|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||5
951763|NCT00097500|2299319|P2|COMPLETED|Off-drug Period (Week 52 to Week 64)||26
951764|NCT00097500|2299320|P1|COMPLETED|Off-drug Period (Week 52 to Week 64)||25
951765|NCT00097500|2299319|P2|STARTED|Off-drug Period (Week 52 to Week 64)|Insulin Glargine is discontinued, metformin is continued|30
951766|NCT00097500|2299320|P1|STARTED|Off-drug Period (Week 52 to Week 64)|Exenatide is discontinued, metformin is continued|30
951767|NCT00097500|2299319|P2|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||3
951768|NCT00097500|2299320|P1|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||6
951769|NCT00097500|2299319|P2|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
951770|NCT00097500|2299320|P1|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
951771|NCT00097500|2299319|P2|STARTED|On-drug Period (Week 0 to Week 52)||33
951772|NCT00097500|2299320|P1|STARTED|On-drug Period (Week 0 to Week 52)||36
951773|NCT00097539|2299349|P7|NOT COMPLETED|Overall Study||171
951774|NCT00097539|2299350|P6|NOT COMPLETED|Overall Study||5892
951775|NCT00097539|2299351|P5|NOT COMPLETED|Overall Study||1758
951776|NCT00097539|2299352|P4|NOT COMPLETED|Overall Study||3585
951777|NCT00097539|2299353|P3|NOT COMPLETED|Overall Study||9108
951778|NCT00097539|2299354|P2|NOT COMPLETED|Overall Study||6531
951779|NCT00097539|2299355|P1|NOT COMPLETED|Overall Study||19066
951780|NCT00097539|2299349|P7|COMPLETED|Overall Study||68
951781|NCT00097539|2299350|P6|COMPLETED|Overall Study||2118
951782|NCT00097539|2299351|P5|COMPLETED|Overall Study||386
951783|NCT00097539|2299352|P4|COMPLETED|Overall Study||2066
951784|NCT00097539|2299353|P3|COMPLETED|Overall Study||3411
951785|NCT00097539|2299354|P2|COMPLETED|Overall Study||2825
951786|NCT00097539|2299355|P1|COMPLETED|Overall Study||8220
951787|NCT00097539|2299349|P7|STARTED|Overall Study||239
951788|NCT00097539|2299350|P6|STARTED|Overall Study||8010
951789|NCT00097539|2299351|P5|STARTED|Overall Study||2144
951790|NCT00097539|2299352|P4|STARTED|Overall Study||5651
951791|NCT00097539|2299353|P3|STARTED|Overall Study||12519
951792|NCT00097539|2299354|P2|STARTED|Overall Study||9356
951793|NCT00097539|2299355|P1|STARTED|Overall Study||27286
951794|NCT00097591|2299401|P2|NOT COMPLETED|Overall Study||394
951795|NCT00097591|2299402|P1|NOT COMPLETED|Overall Study||410
951796|NCT00097591|2299401|P2|COMPLETED|Overall Study||6401
951797|NCT00097591|2299402|P1|COMPLETED|Overall Study||6403
951798|NCT00097591|2299401|P2|STARTED|Overall Study|4 subjects randomized but not analyzed due to an incomplete informed consent document|6795
951799|NCT00097591|2299402|P1|STARTED|Overall Study|7 subjects randomized but not analyzed due to an incomplete informed consent document|6813
951800|NCT00097695|2299422|P4|NOT COMPLETED|The Open Label Extension (OLE) Phase||5
951801|NCT00097695|2299423|P3|NOT COMPLETED|The Open Label Extension (OLE) Phase||2
951802|NCT00097695|2299424|P2|NOT COMPLETED|The Open Label Extension (OLE) Phase||15
951803|NCT00097695|2299425|P1|NOT COMPLETED|The Open Label Extension (OLE) Phase||13
951804|NCT00097695|2299422|P4|COMPLETED|The Open Label Extension (OLE) Phase||15
951805|NCT00097695|2299423|P3|COMPLETED|The Open Label Extension (OLE) Phase||1
951806|NCT00097695|2299424|P2|COMPLETED|The Open Label Extension (OLE) Phase||11
951807|NCT00097695|2299425|P1|COMPLETED|The Open Label Extension (OLE) Phase||10
951808|NCT00097695|2299422|P4|STARTED|The Open Label Extension (OLE) Phase||20
951809|NCT00097695|2299423|P3|STARTED|The Open Label Extension (OLE) Phase||3
951810|NCT00097695|2299424|P2|STARTED|The Open Label Extension (OLE) Phase||26
951811|NCT00097695|2299425|P1|STARTED|The Open Label Extension (OLE) Phase||23
951812|NCT00097695|2299422|P4|NOT COMPLETED|The Controlled Phase||20
951813|NCT00097695|2299423|P3|NOT COMPLETED|The Controlled Phase||5
951814|NCT00097695|2299424|P2|NOT COMPLETED|The Controlled Phase||3
951815|NCT00097695|2299425|P1|NOT COMPLETED|The Controlled Phase||4
951816|NCT00097695|2299422|P4|COMPLETED|The Controlled Phase|Patients screened and found eligible but did not have HAE attack or attack was not severe enough|0
951817|NCT00097695|2299423|P3|COMPLETED|The Controlled Phase||3
951818|NCT00097695|2299424|P2|COMPLETED|The Controlled Phase||26
951819|NCT00097695|2299425|P1|COMPLETED|The Controlled Phase||23
951820|NCT00097695|2299422|P4|STARTED|The Controlled Phase||20
951821|NCT00097695|2299423|P3|STARTED|The Controlled Phase||8
951822|NCT00097695|2299424|P2|STARTED|The Controlled Phase||29
951823|NCT00097695|2299425|P1|STARTED|The Controlled Phase||27
951824|NCT00097708|2299442|P3|NOT COMPLETED|Overall Study||65
951825|NCT00097708|2299443|P2|NOT COMPLETED|Overall Study||56
951826|NCT00097708|2299444|P1|NOT COMPLETED|Overall Study||64
951827|NCT00097708|2299442|P3|COMPLETED|Overall Study||97
951828|NCT00097708|2299443|P2|COMPLETED|Overall Study||120
951829|NCT00097708|2299444|P1|COMPLETED|Overall Study||109
951830|NCT00097708|2299442|P3|Treated|Overall Study||160
951831|NCT00097708|2299443|P2|Treated|Overall Study||176
951832|NCT00097708|2299444|P1|Treated|Overall Study||171
951833|NCT00097708|2299442|P3|Intent-to-Treat (ITT)|Overall Study||149
951834|NCT00097708|2299443|P2|Intent-to-Treat (ITT)|Overall Study||169
951835|NCT00097708|2299444|P1|Intent-to-Treat (ITT)|Overall Study||165
951836|NCT00097708|2299442|P3|STARTED|Overall Study||162
951837|NCT00097708|2299443|P2|STARTED|Overall Study||176
951838|NCT00097708|2299444|P1|STARTED|Overall Study||173
951839|NCT00097721|2299454|P2|NOT COMPLETED|Overall Study||33
951840|NCT00097721|2299455|P1|NOT COMPLETED|Overall Study||71
951841|NCT00097721|2299454|P2|COMPLETED|Overall Study||0
951842|NCT00097721|2299455|P1|COMPLETED|Overall Study||0
951843|NCT00097721|2299454|P2|STARTED|Overall Study||33
951844|NCT00097721|2299455|P1|STARTED|Overall Study|The number started is all enrolled subjects.BL Characteristics consists of Safety Population.|71
951845|NCT00097773|2299473|P4|NOT COMPLETED|Overall Study||3
951846|NCT00097773|2299474|P3|NOT COMPLETED|Overall Study||8
951847|NCT00097773|2299475|P2|NOT COMPLETED|Overall Study||8
951848|NCT00097773|2299476|P1|NOT COMPLETED|Overall Study||8
951849|NCT00097773|2299473|P4|COMPLETED|Overall Study||73
951850|NCT00097773|2299474|P3|COMPLETED|Overall Study||68
951851|NCT00097773|2299475|P2|COMPLETED|Overall Study||68
951852|NCT00097773|2299476|P1|COMPLETED|Overall Study||68
951853|NCT00097773|2299473|P4|STARTED|Overall Study||76
951854|NCT00097773|2299474|P3|STARTED|Overall Study||76
951855|NCT00097773|2299475|P2|STARTED|Overall Study||76
951856|NCT00097773|2299476|P1|STARTED|Overall Study||76
951857|NCT00097786|2299498|P4|NOT COMPLETED|Overall Study||310
951858|NCT00097786|2299499|P3|NOT COMPLETED|Overall Study||313
951859|NCT00097786|2299500|P2|NOT COMPLETED|Overall Study||292
951860|NCT00097786|2299501|P1|NOT COMPLETED|Overall Study||296
951861|NCT00097786|2299498|P4|COMPLETED|Overall Study||2036
951862|NCT00097786|2299499|P3|COMPLETED|Overall Study||2016
951863|NCT00097786|2299500|P2|COMPLETED|Overall Study||2023
951864|NCT00097786|2299501|P1|COMPLETED|Overall Study|"Completed means completed follow up for all cause death."|2020
951865|NCT00097786|2299498|P4|Complete Follow-up for Core CV EPs|Overall Study||1988
951866|NCT00097786|2299499|P3|Complete Follow-up for Core CV EPs|Overall Study||1966
951867|NCT00097786|2299500|P2|Complete Follow-up for Core CV EPs|Overall Study||1963
951868|NCT00097786|2299501|P1|Complete Follow-up for Core CV EPs|Overall Study||1948
951869|NCT00097786|2299498|P4|Complete Follow-up for Extended CV EPs|Overall Study||2015
951870|NCT00097786|2299499|P3|Complete Follow-up for Extended CV EPs|Overall Study||1987
951871|NCT00097786|2299500|P2|Complete Follow-up for Extended CV EPs|Overall Study||1985
951872|NCT00097786|2299501|P1|Complete Follow-up for Extended CV EPs|Overall Study||1969
951873|NCT00097786|2299498|P4|Complete FU for Progression to Diabetes|Overall Study||1762
951874|NCT00097786|2299499|P3|Complete FU for Progression to Diabetes|Overall Study||1734
951875|NCT00097786|2299500|P2|Complete FU for Progression to Diabetes|Overall Study||1712
951876|NCT00097786|2299501|P1|Complete FU for Progression to Diabetes|Overall Study||1709
951877|NCT00097786|2299498|P4|STARTED|Overall Study||2346
951878|NCT00097786|2299499|P3|STARTED|Overall Study||2329
951879|NCT00097786|2299500|P2|STARTED|Overall Study||2315
951880|NCT00097786|2299501|P1|STARTED|Overall Study|"Started indicates Full Analysis Set (FAS) population. Initially enrolled 9518, 212 excluded."|2316
951881|NCT00097981|2299521|P2|NOT COMPLETED|Overall Study||100
951882|NCT00097981|2299522|P1|NOT COMPLETED|Overall Study||106
951883|NCT00097981|2299521|P2|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|12
951884|NCT00097981|2299522|P1|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|7
951885|NCT00097981|2299521|P2|Received Study Medication|Overall Study||106
951886|NCT00097981|2299522|P1|Received Study Medication|Overall Study||110
951887|NCT00097981|2299521|P2|STARTED|Overall Study|Enrollment at randomization|112
951888|NCT00097981|2299522|P1|STARTED|Overall Study|Enrollment at randomization|113
951889|NCT00098059|2299542|P2|NOT COMPLETED|Overall Study||1
951890|NCT00098059|2299543|P1|NOT COMPLETED|Overall Study||0
951891|NCT00098059|2299542|P2|COMPLETED|Overall Study||46
951892|NCT00098059|2299543|P1|COMPLETED|Overall Study||27
951893|NCT00098059|2299542|P2|STARTED|Overall Study||47
951894|NCT00098059|2299543|P1|STARTED|Overall Study||27
951895|NCT00098254|2299587|P1|NOT COMPLETED|Overall Study||3
951896|NCT00098254|2299587|P1|COMPLETED|Overall Study||34
951897|NCT00098254|2299587|P1|STARTED|Overall Study||37
951898|NCT00098293|2299609|P5|NOT COMPLETED|Supplemental Phase (SP)||33
951899|NCT00098293|2299610|P4|NOT COMPLETED|Supplemental Phase (SP)||0
951900|NCT00098293|2299611|P3|NOT COMPLETED|Supplemental Phase (SP)||0
951901|NCT00098293|2299612|P2|NOT COMPLETED|Supplemental Phase (SP)||0
951902|NCT00098293|2299613|P1|NOT COMPLETED|Supplemental Phase (SP)||0
951903|NCT00098293|2299609|P5|COMPLETED|Supplemental Phase (SP)||94
951904|NCT00098293|2299610|P4|COMPLETED|Supplemental Phase (SP)||0
951905|NCT00098293|2299611|P3|COMPLETED|Supplemental Phase (SP)||0
951906|NCT00098293|2299612|P2|COMPLETED|Supplemental Phase (SP)||0
951907|NCT00098293|2299613|P1|COMPLETED|Supplemental Phase (SP)||0
951908|NCT00098293|2299609|P5|STARTED|Supplemental Phase (SP)||127
951909|NCT00098293|2299610|P4|STARTED|Supplemental Phase (SP)||0
951910|NCT00098293|2299611|P3|STARTED|Supplemental Phase (SP)||0
951911|NCT00098293|2299612|P2|STARTED|Supplemental Phase (SP)||0
951912|NCT00098293|2299613|P1|STARTED|Supplemental Phase (SP)||0
951913|NCT00098293|2299609|P5|NOT COMPLETED|Open-label (OL) Phase||0
951914|NCT00098293|2299610|P4|NOT COMPLETED|Open-label (OL) Phase||65
951915|NCT00098293|2299611|P3|NOT COMPLETED|Open-label (OL) Phase||41
951916|NCT00098293|2299612|P2|NOT COMPLETED|Open-label (OL) Phase||25
951917|NCT00098293|2299613|P1|NOT COMPLETED|Open-label (OL) Phase||0
951918|NCT00098293|2299609|P5|COMPLETED|Open-label (OL) Phase||0
951919|NCT00098293|2299610|P4|COMPLETED|Open-label (OL) Phase||65
951920|NCT00098293|2299611|P3|COMPLETED|Open-label (OL) Phase||158
951921|NCT00098293|2299612|P2|COMPLETED|Open-label (OL) Phase||177
951922|NCT00098293|2299613|P1|COMPLETED|Open-label (OL) Phase||0
951923|NCT00098293|2299609|P5|STARTED|Open-label (OL) Phase||0
951924|NCT00098293|2299610|P4|STARTED|Open-label (OL) Phase||130
951925|NCT00098293|2299611|P3|STARTED|Open-label (OL) Phase||199
951926|NCT00098293|2299612|P2|STARTED|Open-label (OL) Phase||202
951927|NCT00098293|2299613|P1|STARTED|Open-label (OL) Phase||0
951928|NCT00098293|2299609|P5|NOT COMPLETED|Between DB and OL Phase||0
951929|NCT00098293|2299610|P4|NOT COMPLETED|Between DB and OL Phase||0
951930|NCT00098293|2299611|P3|NOT COMPLETED|Between DB and OL Phase||3
951931|NCT00098293|2299612|P2|NOT COMPLETED|Between DB and OL Phase||0
951932|NCT00098293|2299613|P1|NOT COMPLETED|Between DB and OL Phase||0
951933|NCT00098293|2299609|P5|COMPLETED|Between DB and OL Phase||0
951934|NCT00098293|2299610|P4|COMPLETED|Between DB and OL Phase||0
951935|NCT00098293|2299611|P3|COMPLETED|Between DB and OL Phase||199
951936|NCT00098293|2299612|P2|COMPLETED|Between DB and OL Phase||202
951937|NCT00098293|2299613|P1|COMPLETED|Between DB and OL Phase||0
951938|NCT00098293|2299609|P5|STARTED|Between DB and OL Phase||0
951939|NCT00098293|2299610|P4|STARTED|Between DB and OL Phase||0
951940|NCT00098293|2299611|P3|STARTED|Between DB and OL Phase||202
951941|NCT00098293|2299612|P2|STARTED|Between DB and OL Phase||202
951942|NCT00098293|2299613|P1|STARTED|Between DB and OL Phase||0
951943|NCT00098293|2299609|P5|NOT COMPLETED|Double-blind (DB) Phase||0
951944|NCT00098293|2299610|P4|NOT COMPLETED|Double-blind (DB) Phase||0
951945|NCT00098293|2299611|P3|NOT COMPLETED|Double-blind (DB) Phase||170
951946|NCT00098293|2299612|P2|NOT COMPLETED|Double-blind (DB) Phase||166
951947|NCT00098293|2299613|P1|NOT COMPLETED|Double-blind (DB) Phase||177
951948|NCT00098293|2299609|P5|COMPLETED|Double-blind (DB) Phase||0
951949|NCT00098293|2299610|P4|COMPLETED|Double-blind (DB) Phase||0
951950|NCT00098293|2299611|P3|COMPLETED|Double-blind (DB) Phase||202
951951|NCT00098293|2299612|P2|COMPLETED|Double-blind (DB) Phase||202
951952|NCT00098293|2299613|P1|COMPLETED|Double-blind (DB) Phase||0
951953|NCT00098293|2299609|P5|Treated|Double-blind (DB) Phase||0
951954|NCT00098293|2299610|P4|Treated|Double-blind (DB) Phase||0
951955|NCT00098293|2299611|P3|Treated|Double-blind (DB) Phase||361
951956|NCT00098293|2299612|P2|Treated|Double-blind (DB) Phase||360
951957|NCT00098293|2299613|P1|Treated|Double-blind (DB) Phase||174
951958|NCT00098293|2299609|P5|STARTED|Double-blind (DB) Phase||0
951959|NCT00098293|2299610|P4|STARTED|Double-blind (DB) Phase||0
951960|NCT00098293|2299611|P3|STARTED|Double-blind (DB) Phase||372
951961|NCT00098293|2299612|P2|STARTED|Double-blind (DB) Phase||368
951962|NCT00098293|2299613|P1|STARTED|Double-blind (DB) Phase||177
951963|NCT00098306|2299669|P7|NOT COMPLETED|Observational Phase||26
951964|NCT00098306|2299670|P6|NOT COMPLETED|Observational Phase||46
951965|NCT00098306|2299671|P5|NOT COMPLETED|Observational Phase||0
951966|NCT00098306|2299672|P4|NOT COMPLETED|Observational Phase||0
951967|NCT00098306|2299673|P3|NOT COMPLETED|Observational Phase||0
951968|NCT00098306|2299674|P2|NOT COMPLETED|Observational Phase||0
951969|NCT00098306|2299675|P1|NOT COMPLETED|Observational Phase||0
951970|NCT00098306|2299669|P7|COMPLETED|Observational Phase||55
951971|NCT00098306|2299670|P6|COMPLETED|Observational Phase||204
951972|NCT00098306|2299671|P5|COMPLETED|Observational Phase||0
951973|NCT00098306|2299672|P4|COMPLETED|Observational Phase||0
951974|NCT00098306|2299673|P3|COMPLETED|Observational Phase||0
951975|NCT00098306|2299674|P2|COMPLETED|Observational Phase||0
951976|NCT00098306|2299675|P1|COMPLETED|Observational Phase||0
951977|NCT00098306|2299669|P7|STARTED|Observational Phase||81
951978|NCT00098306|2299670|P6|STARTED|Observational Phase||250
951979|NCT00098306|2299671|P5|STARTED|Observational Phase||0
951980|NCT00098306|2299672|P4|STARTED|Observational Phase||0
951981|NCT00098306|2299673|P3|STARTED|Observational Phase||0
951982|NCT00098306|2299674|P2|STARTED|Observational Phase||0
951983|NCT00098306|2299675|P1|STARTED|Observational Phase||0
951984|NCT00098306|2299669|P7|NOT COMPLETED|Open Label||0
951985|NCT00098306|2299670|P6|NOT COMPLETED|Open Label||0
951986|NCT00098306|2299671|P5|NOT COMPLETED|Open Label||62
951987|NCT00098306|2299672|P4|NOT COMPLETED|Open Label||327
951988|NCT00098306|2299673|P3|NOT COMPLETED|Open Label||0
951989|NCT00098306|2299674|P2|NOT COMPLETED|Open Label||0
951990|NCT00098306|2299675|P1|NOT COMPLETED|Open Label||0
951991|NCT00098306|2299669|P7|COMPLETED|Open Label||0
951992|NCT00098306|2299670|P6|COMPLETED|Open Label||0
951993|NCT00098306|2299671|P5|COMPLETED|Open Label||0
951994|NCT00098306|2299672|P4|COMPLETED|Open Label||0
951995|NCT00098306|2299673|P3|COMPLETED|Open Label||0
951996|NCT00098306|2299674|P2|COMPLETED|Open Label||0
951997|NCT00098306|2299675|P1|COMPLETED|Open Label||0
951998|NCT00098306|2299669|P7|STARTED|Open Label||0
951999|NCT00098306|2299670|P6|STARTED|Open Label||0
952000|NCT00098306|2299671|P5|STARTED|Open Label||62
952001|NCT00098306|2299672|P4|STARTED|Open Label||327
952002|NCT00098306|2299673|P3|STARTED|Open Label||0
952003|NCT00098306|2299674|P2|STARTED|Open Label||0
952004|NCT00098306|2299675|P1|STARTED|Open Label||0
952005|NCT00098306|2299669|P7|NOT COMPLETED|Double Blind||0
952006|NCT00098306|2299670|P6|NOT COMPLETED|Double Blind||0
952007|NCT00098306|2299671|P5|NOT COMPLETED|Double Blind||0
952008|NCT00098306|2299672|P4|NOT COMPLETED|Double Blind||0
952009|NCT00098306|2299673|P3|NOT COMPLETED|Double Blind||120
952010|NCT00098306|2299674|P2|NOT COMPLETED|Double Blind||240
952011|NCT00098306|2299675|P1|NOT COMPLETED|Double Blind||241
952012|NCT00098306|2299669|P7|COMPLETED|Double Blind||0
952013|NCT00098306|2299670|P6|COMPLETED|Double Blind||0
952014|NCT00098306|2299671|P5|COMPLETED|Double Blind||0
952015|NCT00098306|2299672|P4|COMPLETED|Double Blind||0
952016|NCT00098306|2299673|P3|COMPLETED|Double Blind||0
952017|NCT00098306|2299674|P2|COMPLETED|Double Blind||0
952018|NCT00098306|2299675|P1|COMPLETED|Double Blind||0
952019|NCT00098306|2299669|P7|Treated|Double Blind||0
952020|NCT00098306|2299670|P6|Treated|Double Blind||0
952021|NCT00098306|2299671|P5|Treated|Double Blind||0
952022|NCT00098306|2299672|P4|Treated|Double Blind||0
952023|NCT00098306|2299673|P3|Treated|Double Blind||118
952024|NCT00098306|2299674|P2|Treated|Double Blind||235
952025|NCT00098306|2299675|P1|Treated|Double Blind||232
952026|NCT00098306|2299669|P7|STARTED|Double Blind||0
952027|NCT00098306|2299670|P6|STARTED|Double Blind||0
952028|NCT00098306|2299671|P5|STARTED|Double Blind||0
952029|NCT00098306|2299672|P4|STARTED|Double Blind||0
952030|NCT00098306|2299673|P3|STARTED|Double Blind||120
952031|NCT00098306|2299674|P2|STARTED|Double Blind||240
952032|NCT00098306|2299675|P1|STARTED|Double Blind||241
952033|NCT00098345|2299738|P1|NOT COMPLETED|Overall Study||13
952034|NCT00098345|2299738|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|17
952035|NCT00098345|2299738|P1|STARTED|Overall Study||30
952036|NCT00098371|2299748|P1|NOT COMPLETED|Overall Study||0
952037|NCT00098371|2299748|P1|COMPLETED|Overall Study||64
952038|NCT00098371|2299748|P1|STARTED|Overall Study||64
952079|NCT00098670|2299790|P1|NOT COMPLETED|Overall Study||0
952080|NCT00098670|2299790|P1|COMPLETED|Overall Study||102
952081|NCT00098670|2299790|P1|STARTED|Overall Study||102
952082|NCT00098722|2299802|P7|NOT COMPLETED|Observation Phase||17
952083|NCT00098722|2299803|P6|NOT COMPLETED|Observation Phase||45
952084|NCT00098722|2299804|P5|NOT COMPLETED|Observation Phase||0
952085|NCT00098722|2299805|P4|NOT COMPLETED|Observation Phase||0
952086|NCT00098722|2299806|P3|NOT COMPLETED|Observation Phase||0
952087|NCT00098722|2299807|P2|NOT COMPLETED|Observation Phase||0
952088|NCT00098722|2299808|P1|NOT COMPLETED|Observation Phase||0
952089|NCT00098722|2299802|P7|COMPLETED|Observation Phase||48
952090|NCT00098722|2299803|P6|COMPLETED|Observation Phase||160
952091|NCT00098722|2299804|P5|COMPLETED|Observation Phase||0
952092|NCT00098722|2299805|P4|COMPLETED|Observation Phase||0
952093|NCT00098722|2299806|P3|COMPLETED|Observation Phase||0
952094|NCT00098722|2299807|P2|COMPLETED|Observation Phase||0
952095|NCT00098722|2299808|P1|COMPLETED|Observation Phase||0
952096|NCT00098722|2299802|P7|STARTED|Observation Phase||65
952097|NCT00098722|2299803|P6|STARTED|Observation Phase||205
952098|NCT00098722|2299804|P5|STARTED|Observation Phase||0
952099|NCT00098722|2299805|P4|STARTED|Observation Phase||0
952100|NCT00098722|2299806|P3|STARTED|Observation Phase||0
952101|NCT00098722|2299807|P2|STARTED|Observation Phase||0
952102|NCT00098722|2299808|P1|STARTED|Observation Phase||0
952103|NCT00098722|2299802|P7|NOT COMPLETED|Open Label Phase||0
952104|NCT00098722|2299803|P6|NOT COMPLETED|Open Label Phase||0
952105|NCT00098722|2299804|P5|NOT COMPLETED|Open Label Phase||50
952106|NCT00098722|2299805|P4|NOT COMPLETED|Open Label Phase||272
952107|NCT00098722|2299806|P3|NOT COMPLETED|Open Label Phase||0
952108|NCT00098722|2299807|P2|NOT COMPLETED|Open Label Phase||0
952109|NCT00098722|2299808|P1|NOT COMPLETED|Open Label Phase||0
952110|NCT00098722|2299802|P7|COMPLETED|Open Label Phase||0
952111|NCT00098722|2299803|P6|COMPLETED|Open Label Phase||0
952112|NCT00098722|2299804|P5|COMPLETED|Open Label Phase||0
952113|NCT00098722|2299805|P4|COMPLETED|Open Label Phase||0
952114|NCT00098722|2299806|P3|COMPLETED|Open Label Phase||0
952115|NCT00098722|2299807|P2|COMPLETED|Open Label Phase||0
952116|NCT00098722|2299808|P1|COMPLETED|Open Label Phase||0
952117|NCT00098722|2299802|P7|STARTED|Open Label Phase||0
952118|NCT00098722|2299803|P6|STARTED|Open Label Phase||0
952119|NCT00098722|2299804|P5|STARTED|Open Label Phase||50
952120|NCT00098722|2299805|P4|STARTED|Open Label Phase||272
952121|NCT00098722|2299806|P3|STARTED|Open Label Phase||0
952122|NCT00098722|2299807|P2|STARTED|Open Label Phase||0
952123|NCT00098722|2299808|P1|STARTED|Open Label Phase||0
952124|NCT00098722|2299802|P7|NOT COMPLETED|Double Blind Phase||0
952125|NCT00098722|2299803|P6|NOT COMPLETED|Double Blind Phase||0
952126|NCT00098722|2299804|P5|NOT COMPLETED|Double Blind Phase||0
952127|NCT00098722|2299805|P4|NOT COMPLETED|Double Blind Phase||0
952128|NCT00098722|2299806|P3|NOT COMPLETED|Double Blind Phase||94
952129|NCT00098722|2299807|P2|NOT COMPLETED|Double Blind Phase||194
952130|NCT00098722|2299808|P1|NOT COMPLETED|Double Blind Phase||186
952131|NCT00098722|2299802|P7|COMPLETED|Double Blind Phase||0
952132|NCT00098722|2299803|P6|COMPLETED|Double Blind Phase||0
952133|NCT00098722|2299804|P5|COMPLETED|Double Blind Phase||0
952134|NCT00098722|2299805|P4|COMPLETED|Double Blind Phase||0
952135|NCT00098722|2299806|P3|COMPLETED|Double Blind Phase||0
952136|NCT00098722|2299807|P2|COMPLETED|Double Blind Phase||0
952137|NCT00098722|2299808|P1|COMPLETED|Double Blind Phase||0
952138|NCT00098722|2299802|P7|Treated|Double Blind Phase||0
952139|NCT00098722|2299803|P6|Treated|Double Blind Phase||0
952140|NCT00098722|2299804|P5|Treated|Double Blind Phase||0
952141|NCT00098722|2299805|P4|Treated|Double Blind Phase||0
952142|NCT00098722|2299806|P3|Treated|Double Blind Phase||91
952143|NCT00098722|2299807|P2|Treated|Double Blind Phase||191
952144|NCT00098722|2299808|P1|Treated|Double Blind Phase||182
952145|NCT00098722|2299802|P7|STARTED|Double Blind Phase||0
952146|NCT00098722|2299803|P6|STARTED|Double Blind Phase||0
952147|NCT00098722|2299804|P5|STARTED|Double Blind Phase||0
952148|NCT00098722|2299805|P4|STARTED|Double Blind Phase||0
952149|NCT00098722|2299806|P3|STARTED|Double Blind Phase||94
952150|NCT00098722|2299807|P2|STARTED|Double Blind Phase||194
952151|NCT00098722|2299808|P1|STARTED|Double Blind Phase||186
952152|NCT00098748|2299874|P3|NOT COMPLETED|Continued on Open-Label Treatment||0
952153|NCT00098748|2299875|P2|NOT COMPLETED|Continued on Open-Label Treatment||15
952154|NCT00098748|2299876|P1|NOT COMPLETED|Continued on Open-Label Treatment||8
952155|NCT00098748|2299874|P3|COMPLETED|Continued on Open-Label Treatment||0
952156|NCT00098748|2299875|P2|COMPLETED|Continued on Open-Label Treatment||10
952157|NCT00098748|2299876|P1|COMPLETED|Continued on Open-Label Treatment||7
952158|NCT00098748|2299874|P3|STARTED|Continued on Open-Label Treatment|Placebo group not offered open-label maraviroc due to study not reaching primary endpoint at Week 24|0
952159|NCT00098748|2299875|P2|STARTED|Continued on Open-Label Treatment||25
952160|NCT00098748|2299876|P1|STARTED|Continued on Open-Label Treatment||15
952161|NCT00098748|2299874|P3|NOT COMPLETED|Received Study Treatment||44
952162|NCT00098748|2299875|P2|NOT COMPLETED|Received Study Treatment||36
952163|NCT00098748|2299876|P1|NOT COMPLETED|Received Study Treatment||48
952164|NCT00098748|2299874|P3|COMPLETED|Received Study Treatment||18
952165|NCT00098748|2299875|P2|COMPLETED|Received Study Treatment||25
952166|NCT00098748|2299876|P1|COMPLETED|Received Study Treatment||15
952167|NCT00098748|2299874|P3|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||58
952168|NCT00098748|2299875|P2|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||52
952169|NCT00098748|2299876|P1|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment|Dual-tropic: Virus capable of using both CCR5 and CXCR4 coreceptors for cell entry.|57
952170|NCT00098748|2299874|P3|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, Placebo = 61 subjects in Adverse event tables.|62
952171|NCT00098748|2299875|P2|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, BID = 62 subjects in Adverse event tables.|61
952172|NCT00098748|2299876|P1|STARTED|Received Study Treatment||63
952173|NCT00098748|2299874|P3|NOT COMPLETED|Assigned to Study Treatment||2
952174|NCT00098748|2299875|P2|NOT COMPLETED|Assigned to Study Treatment||2
952175|NCT00098748|2299876|P1|NOT COMPLETED|Assigned to Study Treatment||0
952176|NCT00098748|2299874|P3|COMPLETED|Assigned to Study Treatment||62
952177|NCT00098748|2299875|P2|COMPLETED|Assigned to Study Treatment||61
952178|NCT00098748|2299876|P1|COMPLETED|Assigned to Study Treatment||63
952179|NCT00098748|2299874|P3|STARTED|Assigned to Study Treatment||64
952180|NCT00098748|2299875|P2|STARTED|Assigned to Study Treatment||63
952181|NCT00098748|2299876|P1|STARTED|Assigned to Study Treatment||63
952182|NCT00098774|2299929|P1|NOT COMPLETED|Overall Study||18
952183|NCT00098774|2299929|P1|COMPLETED|Overall Study||26
952184|NCT00098774|2299929|P1|STARTED|Overall Study||44
952185|NCT00098787|2299939|P3|NOT COMPLETED|Overall Study||63
952186|NCT00098787|2299940|P2|NOT COMPLETED|Overall Study||75
952187|NCT00098787|2299941|P1|NOT COMPLETED|Overall Study||73
952188|NCT00098787|2299939|P3|COMPLETED|Overall Study||0
952189|NCT00098787|2299940|P2|COMPLETED|Overall Study||0
952190|NCT00098787|2299941|P1|COMPLETED|Overall Study||0
952191|NCT00098787|2299939|P3|Eligible and Treated|Overall Study||59
952192|NCT00098787|2299940|P2|Eligible and Treated|Overall Study||66
952193|NCT00098787|2299941|P1|Eligible and Treated|Overall Study||61
952194|NCT00098787|2299939|P3|Treated|Overall Study||62
952195|NCT00098787|2299940|P2|Treated|Overall Study||73
952196|NCT00098787|2299941|P1|Treated|Overall Study||70
952197|NCT00098787|2299939|P3|STARTED|Overall Study||63
952198|NCT00098787|2299940|P2|STARTED|Overall Study||75
952199|NCT00098787|2299941|P1|STARTED|Overall Study||73
952200|NCT00098813|2299955|P1|NOT COMPLETED|Overall Study||19
952201|NCT00098813|2299955|P1|COMPLETED|Overall Study||1
952202|NCT00098813|2299955|P1|STARTED|Overall Study||20
952203|NCT00098839|2299961|P2|NOT COMPLETED|Overall Study||33
952204|NCT00098839|2299962|P1|NOT COMPLETED|Overall Study||32
952205|NCT00098839|2299961|P2|COMPLETED|Overall Study||27
952206|NCT00098839|2299962|P1|COMPLETED|Overall Study||24
952207|NCT00098839|2299961|P2|STARTED|Overall Study||60
952208|NCT00098839|2299962|P1|STARTED|Overall Study||56
952209|NCT00098865|2299972|P1|NOT COMPLETED|Overall Study||9
952210|NCT00098865|2299972|P1|COMPLETED|Overall Study||6
952211|NCT00098865|2299972|P1|STARTED|Overall Study||15
952212|NCT00098956|2299978|P1|NOT COMPLETED|Overall Study||0
952213|NCT00098956|2299978|P1|COMPLETED|Overall Study||19
952214|NCT00098956|2299978|P1|STARTED|Overall Study||19
952215|NCT00099021|2299983|P1|NOT COMPLETED|Overall Study||0
952216|NCT00099021|2299983|P1|COMPLETED|Overall Study||21
952217|NCT00099021|2299983|P1|STARTED|Overall Study||21
952218|NCT00099047|2299991|P2|NOT COMPLETED|Overall Study||0
952219|NCT00099047|2299992|P1|NOT COMPLETED|Overall Study||0
952220|NCT00099047|2299991|P2|COMPLETED|Overall Study||12
952221|NCT00099047|2299992|P1|COMPLETED|Overall Study||11
952222|NCT00099047|2299991|P2|STARTED|Overall Study||12
952223|NCT00099047|2299992|P1|STARTED|Overall Study||11
952224|NCT00099268|2300000|P2|NOT COMPLETED|Overall Study||82
952225|NCT00099268|2300001|P1|NOT COMPLETED|Overall Study||92
952226|NCT00099268|2300000|P2|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa group within 30 days of treatment discontinuation|291
952227|NCT00099268|2300001|P1|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa/entacapone group within 30 days of treatment discontinuation|282
952228|NCT00099268|2300000|P2|Intent-to-Treat|Overall Study||372
952229|NCT00099268|2300001|P1|Intent-to-Treat|Overall Study|One patient from each group discontinued without receiving a single dose of study drug.|373
952230|NCT00099268|2300000|P2|STARTED|Overall Study||373
952231|NCT00099268|2300001|P1|STARTED|Overall Study||374
952232|NCT00099359|2300020|P3|NOT COMPLETED|Overall Study||68
952233|NCT00099359|2300021|P2|NOT COMPLETED|Overall Study||65
952234|NCT00099359|2300022|P1|NOT COMPLETED|Overall Study||54
952235|NCT00099359|2300020|P3|COMPLETED|Overall Study||506
952236|NCT00099359|2300021|P2|COMPLETED|Overall Study||515
952237|NCT00099359|2300022|P1|COMPLETED|Overall Study||527
952238|NCT00099359|2300020|P3|STARTED|Overall Study||574
952239|NCT00099359|2300021|P2|STARTED|Overall Study||580
952240|NCT00099359|2300022|P1|STARTED|Overall Study||581
952241|NCT00099437|2300045|P2|NOT COMPLETED|Overall Study||349
952242|NCT00099437|2300046|P1|NOT COMPLETED|Overall Study||366
952243|NCT00099437|2300045|P2|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|13
952244|NCT00099437|2300046|P1|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|8
952245|NCT00099437|2300045|P2|STARTED|Overall Study|randomised patients|362
952246|NCT00099437|2300046|P1|STARTED|Overall Study|randomised patients|374
952247|NCT00099632|2300072|P6|NOT COMPLETED|Overall Study||2
952248|NCT00099632|2300073|P5|NOT COMPLETED|Overall Study||1
952249|NCT00099632|2300074|P4|NOT COMPLETED|Overall Study||1
952250|NCT00099632|2300075|P3|NOT COMPLETED|Overall Study||3
952251|NCT00099632|2300076|P2|NOT COMPLETED|Overall Study||1
952252|NCT00099632|2300077|P1|NOT COMPLETED|Overall Study||1
952253|NCT00099632|2300072|P6|COMPLETED|Overall Study||66
952254|NCT00099632|2300073|P5|COMPLETED|Overall Study||70
952255|NCT00099632|2300074|P4|COMPLETED|Overall Study||66
952256|NCT00099632|2300075|P3|COMPLETED|Overall Study||72
952257|NCT00099632|2300076|P2|COMPLETED|Overall Study||67
952258|NCT00099632|2300077|P1|COMPLETED|Overall Study||72
952259|NCT00099632|2300072|P6|STARTED|Overall Study||68
952260|NCT00099632|2300073|P5|STARTED|Overall Study||71
952261|NCT00099632|2300074|P4|STARTED|Overall Study||67
952262|NCT00099632|2300075|P3|STARTED|Overall Study||75
952263|NCT00099632|2300076|P2|STARTED|Overall Study||68
952264|NCT00099632|2300077|P1|STARTED|Overall Study||73
952265|NCT00099983|2300117|P2|NOT COMPLETED|Overall Study||25
952266|NCT00099983|2300118|P1|NOT COMPLETED|Overall Study||24
952267|NCT00099983|2300117|P2|COMPLETED|Overall Study||124
952268|NCT00099983|2300118|P1|COMPLETED|Overall Study||123
952269|NCT00099983|2300117|P2|STARTED|Overall Study||149
952270|NCT00099983|2300118|P1|STARTED|Overall Study||147
952271|NCT00100048|2300129|P6|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
952272|NCT00100048|2300130|P5|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||0
952273|NCT00100048|2300131|P4|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||10
952274|NCT00100048|2300132|P3|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
952346|NCT00084864|2300282|P4|STARTED|Overall Study||4
952275|NCT00100048|2300133|P2|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||9
952276|NCT00100048|2300134|P1|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||14
952277|NCT00100048|2300129|P6|COMPLETED|Cohort I & II-Combination Therapy Phase||26
952278|NCT00100048|2300130|P5|COMPLETED|Cohort I & II-Combination Therapy Phase||0
952279|NCT00100048|2300131|P4|COMPLETED|Cohort I & II-Combination Therapy Phase||30
952280|NCT00100048|2300132|P3|COMPLETED|Cohort I & II-Combination Therapy Phase||28
952281|NCT00100048|2300133|P2|COMPLETED|Cohort I & II-Combination Therapy Phase||31
952282|NCT00100048|2300134|P1|COMPLETED|Cohort I & II-Combination Therapy Phase||27
952283|NCT00100048|2300129|P6|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|1
952284|NCT00100048|2300130|P5|Never Treated|Cohort I & II-Combination Therapy Phase||0
952285|NCT00100048|2300131|P4|Never Treated|Cohort I & II-Combination Therapy Phase||0
952286|NCT00100048|2300132|P3|Never Treated|Cohort I & II-Combination Therapy Phase||0
952287|NCT00100048|2300133|P2|Never Treated|Cohort I & II-Combination Therapy Phase||0
952288|NCT00100048|2300134|P1|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|2
952289|NCT00100048|2300129|P6|Treated|Cohort I & II-Combination Therapy Phase||38
952290|NCT00100048|2300130|P5|Treated|Cohort I & II-Combination Therapy Phase||0
952291|NCT00100048|2300131|P4|Treated|Cohort I & II-Combination Therapy Phase||40
952292|NCT00100048|2300132|P3|Treated|Cohort I & II-Combination Therapy Phase||41
952293|NCT00100048|2300133|P2|Treated|Cohort I & II-Combination Therapy Phase||40
952294|NCT00100048|2300134|P1|Treated|Cohort I & II-Combination Therapy Phase||39
952295|NCT00100048|2300129|P6|STARTED|Cohort I & II-Combination Therapy Phase|4 subjects from the Monotherapy Phase (Placebo)and 35 new subjects|39
952296|NCT00100048|2300130|P5|STARTED|Cohort I & II-Combination Therapy Phase|participants only assigned Placebo in Cohort I-Monotherapy Phase.|0
952297|NCT00100048|2300131|P4|STARTED|Cohort I & II-Combination Therapy Phase|8 subjects from the Monotherapy Phase and 32 new subjects|40
952298|NCT00100048|2300132|P3|STARTED|Cohort I & II-Combination Therapy Phase|6 subjects from the Monotherapy Phase and 35 new subjects|41
952299|NCT00100048|2300133|P2|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 33 new subjects|40
952300|NCT00100048|2300134|P1|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 34 new subjects|41
952301|NCT00100048|2300129|P6|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
952302|NCT00100048|2300130|P5|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
952303|NCT00100048|2300131|P4|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
952304|NCT00100048|2300132|P3|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
952305|NCT00100048|2300133|P2|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
952306|NCT00100048|2300134|P1|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
952307|NCT00100048|2300129|P6|COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
952308|NCT00100048|2300130|P5|COMPLETED|Cohort I-Monotherapy Phase 10 Days|4 Subjects Continued to Cohort II, as part of the Efavirenz 600 mg q.d. arm|7
952309|NCT00100048|2300131|P4|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|8
952310|NCT00100048|2300132|P3|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|6
952311|NCT00100048|2300133|P2|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
952312|NCT00100048|2300134|P1|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
952313|NCT00100048|2300129|P6|Treated|Cohort I-Monotherapy Phase 10 Days||0
952314|NCT00100048|2300130|P5|Treated|Cohort I-Monotherapy Phase 10 Days||7
952315|NCT00100048|2300131|P4|Treated|Cohort I-Monotherapy Phase 10 Days||8
952316|NCT00100048|2300132|P3|Treated|Cohort I-Monotherapy Phase 10 Days||6
952317|NCT00100048|2300133|P2|Treated|Cohort I-Monotherapy Phase 10 Days||7
952318|NCT00100048|2300134|P1|Treated|Cohort I-Monotherapy Phase 10 Days||7
952319|NCT00100048|2300129|P6|STARTED|Cohort I-Monotherapy Phase 10 Days|participants only assigned Efavirenz 600 mg q.h.s in Cohort II Combined-Combination Therapy Phase|0
952320|NCT00100048|2300130|P5|STARTED|Cohort I-Monotherapy Phase 10 Days||7
952321|NCT00100048|2300131|P4|STARTED|Cohort I-Monotherapy Phase 10 Days||8
952322|NCT00100048|2300132|P3|STARTED|Cohort I-Monotherapy Phase 10 Days||6
952323|NCT00100048|2300133|P2|STARTED|Cohort I-Monotherapy Phase 10 Days||7
952324|NCT00100048|2300134|P1|STARTED|Cohort I-Monotherapy Phase 10 Days||7
952325|NCT00084617|2300241|P1|NOT COMPLETED|Overall Study||9
952326|NCT00084617|2300241|P1|COMPLETED|Overall Study||30
952327|NCT00084617|2300241|P1|STARTED|Overall Study||39
952328|NCT00084682|2300247|P1|NOT COMPLETED|Overall Study||1
952329|NCT00084682|2300247|P1|COMPLETED|Overall Study||13
952330|NCT00084682|2300247|P1|STARTED|Overall Study||14
952331|NCT00084747|2300251|P1|NOT COMPLETED|Overall Study||13
952332|NCT00084747|2300251|P1|COMPLETED|Overall Study||17
952333|NCT00084747|2300251|P1|STARTED|Overall Study||30
952334|NCT00084838|2300256|P1|NOT COMPLETED|Overall Study||13
952335|NCT00084838|2300256|P1|COMPLETED|Overall Study||12
952336|NCT00084838|2300256|P1|Eligible and Treated|Overall Study|4 ineligible pts upon central path review (n=3) and per DFCI IRB (n=1); 1 pt withdrew before rcv trt|20
952337|NCT00084838|2300256|P1|STARTED|Overall Study||25
952338|NCT00084864|2300282|P4|NOT COMPLETED|Overall Study||0
952339|NCT00084864|2300283|P3|NOT COMPLETED|Overall Study||0
952340|NCT00084864|2300284|P2|NOT COMPLETED|Overall Study||0
952341|NCT00084864|2300285|P1|NOT COMPLETED|Overall Study||1
952342|NCT00084864|2300282|P4|COMPLETED|Overall Study||4
952343|NCT00084864|2300283|P3|COMPLETED|Overall Study||4
952344|NCT00084864|2300284|P2|COMPLETED|Overall Study||7
952345|NCT00084864|2300285|P1|COMPLETED|Overall Study||9
952347|NCT00084864|2300283|P3|STARTED|Overall Study||4
952348|NCT00084864|2300284|P2|STARTED|Overall Study||7
952349|NCT00084864|2300285|P1|STARTED|Overall Study||10
952350|NCT00085098|2300313|P2|NOT COMPLETED|Overall Study||2
952351|NCT00085098|2300314|P1|NOT COMPLETED|Overall Study||1
952352|NCT00085098|2300313|P2|COMPLETED|Overall Study||11
952353|NCT00085098|2300314|P1|COMPLETED|Overall Study||10
952354|NCT00085098|2300313|P2|STARTED|Overall Study||13
952355|NCT00085098|2300314|P1|STARTED|Overall Study||11
952356|NCT00085202|2300322|P2|NOT COMPLETED|Overall Study||24
952357|NCT00085202|2300323|P1|NOT COMPLETED|Overall Study||18
952358|NCT00085202|2300322|P2|COMPLETED|Overall Study||120
952359|NCT00085202|2300323|P1|COMPLETED|Overall Study||251
952360|NCT00085202|2300322|P2|STARTED|Overall Study||144
952361|NCT00085202|2300323|P1|STARTED|Overall Study||269
952362|NCT00085254|2300337|P3|NOT COMPLETED|Overall Study||0
952363|NCT00085254|2300338|P2|NOT COMPLETED|Overall Study||0
952364|NCT00085254|2300339|P1|NOT COMPLETED|Overall Study||0
952365|NCT00085254|2300337|P3|COMPLETED|Overall Study||48
952366|NCT00085254|2300338|P2|COMPLETED|Overall Study||46
952367|NCT00085254|2300339|P1|COMPLETED|Overall Study||18
952368|NCT00085254|2300337|P3|STARTED|Overall Study||48
952369|NCT00085254|2300338|P2|STARTED|Overall Study||46
952370|NCT00085254|2300339|P1|STARTED|Overall Study||18
952371|NCT00085293|2300353|P1|NOT COMPLETED|Overall Study||0
952372|NCT00085293|2300353|P1|COMPLETED|Overall Study||12
952373|NCT00085293|2300353|P1|STARTED|Overall Study||12
952374|NCT00085410|2300358|P1|NOT COMPLETED|Overall Study||0
952375|NCT00085410|2300358|P1|COMPLETED|Overall Study||20
952376|NCT00085410|2300358|P1|STARTED|Overall Study||20
952377|NCT00091260|2300372|P1|NOT COMPLETED|Overall Study||0
952378|NCT00091260|2300372|P1|COMPLETED|Overall Study||82
952379|NCT00091260|2300372|P1|STARTED|Overall Study||82
952380|NCT00091273|2300378|P1|NOT COMPLETED|Overall Study||0
952381|NCT00091273|2300378|P1|COMPLETED|Overall Study||9
952382|NCT00091273|2300378|P1|STARTED|Overall Study||9
952383|NCT00091390|2300384|P1|NOT COMPLETED|Overall Study||4
952384|NCT00091390|2300384|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|125
952385|NCT00091390|2300384|P1|STARTED|Overall Study||129
952386|NCT00091442|2300390|P2|NOT COMPLETED|Overall Study||373
952387|NCT00091442|2300391|P1|NOT COMPLETED|Overall Study||369
952388|NCT00091442|2300390|P2|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|5
952389|NCT00091442|2300391|P1|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|4
952390|NCT00091442|2300390|P2|STARTED|Overall Study||378
952391|NCT00091442|2300391|P1|STARTED|Overall Study||373
952392|NCT00091507|2300403|P2|NOT COMPLETED|Overall Study||19
952393|NCT00091507|2300404|P1|NOT COMPLETED|Overall Study||21
952394|NCT00091507|2300403|P2|COMPLETED|Overall Study||460
952395|NCT00091507|2300404|P1|COMPLETED|Overall Study||411
952396|NCT00091507|2300403|P2|STARTED|Overall Study||479
952397|NCT00091507|2300404|P1|STARTED|Overall Study||432
952398|NCT00091949|2300420|P2|NOT COMPLETED|Overall Study||151
952399|NCT00091949|2300421|P1|NOT COMPLETED|Overall Study||175
952400|NCT00091949|2300420|P2|COMPLETED|Overall Study||1786
952401|NCT00091949|2300421|P1|COMPLETED|Overall Study||1764
952402|NCT00091949|2300420|P2|STARTED|Overall Study||1937
952403|NCT00091949|2300421|P1|STARTED|Overall Study||1939
952404|NCT00091962|2300442|P3|NOT COMPLETED|Overall Study||0
952405|NCT00091962|2300443|P2|NOT COMPLETED|Overall Study||0
952406|NCT00091962|2300444|P1|NOT COMPLETED|Overall Study||0
952407|NCT00091962|2300442|P3|COMPLETED|Overall Study||151
952408|NCT00091962|2300443|P2|COMPLETED|Overall Study||152
952409|NCT00091962|2300444|P1|COMPLETED|Overall Study||150
952410|NCT00091962|2300442|P3|STARTED|Overall Study||151
952411|NCT00091962|2300443|P2|STARTED|Overall Study||152
952412|NCT00091962|2300444|P1|STARTED|Overall Study||150
952413|NCT00092118|2300463|P2|NOT COMPLETED|Overall Study||89
952414|NCT00092118|2300464|P1|NOT COMPLETED|Overall Study||84
952415|NCT00092118|2300463|P2|COMPLETED|Overall Study||913
952416|NCT00092118|2300464|P1|COMPLETED|Overall Study||906
952417|NCT00092118|2300463|P2|STARTED|Overall Study|2 patients discontinued after randomization due to adverse experience that began pre-randomization.|1002
952418|NCT00092118|2300464|P1|STARTED|Overall Study|1 patient discontinued after randomization due to a adverse experience that began pre-randomization.|990
952419|NCT00092131|2300474|P2|NOT COMPLETED|Treatment Period II||1
952420|NCT00092131|2300475|P1|NOT COMPLETED|Treatment Period II||0
952421|NCT00092131|2300474|P2|COMPLETED|Treatment Period II||25
952422|NCT00092131|2300475|P1|COMPLETED|Treatment Period II||24
952423|NCT00092131|2300474|P2|STARTED|Treatment Period II|1 patient discontinued after taking Period II study medication, due to asthma exacerbation|26
952424|NCT00092131|2300475|P1|STARTED|Treatment Period II||24
952425|NCT00092131|2300474|P2|NOT COMPLETED|Treatment Period I||0
952426|NCT00092131|2300475|P1|NOT COMPLETED|Treatment Period I||1
952427|NCT00092131|2300474|P2|COMPLETED|Treatment Period I||26
952428|NCT00092131|2300475|P1|COMPLETED|Treatment Period I||24
952429|NCT00092131|2300474|P2|STARTED|Treatment Period I||26
952430|NCT00092131|2300475|P1|STARTED|Treatment Period I|1 patient discontinued due to influenza which started in washout (11 days after Period I medication)|25
952431|NCT00092417|2300505|P2|NOT COMPLETED|Overall Study||1
952432|NCT00092417|2300506|P1|NOT COMPLETED|Overall Study||5
952433|NCT00092417|2300505|P2|COMPLETED|Overall Study|Received the lower potency zoster vaccine & completed 42 days of safety follow-up post vaccination|233
952434|NCT00092417|2300506|P1|COMPLETED|Overall Study|Received the higher potency zoster vaccine & completed 42 days of safety follow-up post vaccination|459
952435|NCT00092417|2300505|P2|Vaccinated|Overall Study||234
952436|NCT00092417|2300506|P1|Vaccinated|Overall Study|3 participants were allocated,not vaccinated; they are not reported in the Baseline Characteristics|461
952437|NCT00092417|2300505|P2|STARTED|Overall Study|Started Period Group 2|234
952438|NCT00092417|2300506|P1|STARTED|Overall Study|Started Period Group 1|464
952439|NCT00092443|2300522|P2|NOT COMPLETED|Overall Study||54
952440|NCT00092443|2300523|P1|NOT COMPLETED|Overall Study||58
952441|NCT00092443|2300522|P2|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|607
952442|NCT00092443|2300523|P1|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|593
952443|NCT00092443|2300522|P2|Vaccinated at Visit 3|Overall Study||608
952444|NCT00092443|2300523|P1|Vaccinated at Visit 3|Overall Study||593
952445|NCT00092443|2300522|P2|Vaccinated at Visit 2|Overall Study||627
952446|NCT00092443|2300523|P1|Vaccinated at Visit 2|Overall Study||618
952447|NCT00092443|2300522|P2|Vaccinated at Visit 1|Overall Study||660
952448|NCT00092443|2300523|P1|Vaccinated at Visit 1|Overall Study||650
952449|NCT00092443|2300522|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|661
952450|NCT00092443|2300523|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|651
952451|NCT00092456|2300543|P4|NOT COMPLETED|Overall Study||16
952452|NCT00092456|2300544|P3|NOT COMPLETED|Overall Study||29
952453|NCT00092456|2300545|P2|NOT COMPLETED|Overall Study||17
952454|NCT00092456|2300546|P1|NOT COMPLETED|Overall Study||25
952455|NCT00092456|2300543|P4|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|97
952456|NCT00092456|2300544|P3|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|200
952457|NCT00092456|2300545|P2|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|208
952458|NCT00092456|2300546|P1|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|201
952459|NCT00092456|2300543|P4|Vaccinated at Visit 3|Overall Study||98
952460|NCT00092456|2300544|P3|Vaccinated at Visit 3|Overall Study||200
952461|NCT00092456|2300545|P2|Vaccinated at Visit 3|Overall Study||210
952462|NCT00092456|2300546|P1|Vaccinated at Visit 3|Overall Study||202
952463|NCT00092456|2300543|P4|Vaccinated at Visit 2|Overall Study||104
952464|NCT00092456|2300544|P3|Vaccinated at Visit 2|Overall Study||210
952465|NCT00092456|2300545|P2|Vaccinated at Visit 2|Overall Study||217
952466|NCT00092456|2300546|P1|Vaccinated at Visit 2|Overall Study||208
952467|NCT00092456|2300543|P4|Vaccinated at Visit 1|Overall Study||113
952468|NCT00092456|2300544|P3|Vaccinated at Visit 1|Overall Study||229
952469|NCT00092456|2300545|P2|Vaccinated at Visit 1|Overall Study||225
952470|NCT00092456|2300546|P1|Vaccinated at Visit 1|Overall Study||226
952471|NCT00092456|2300543|P4|STARTED|Overall Study|Subjects assigned to Placebo-matching RotaTeq™|113
952472|NCT00092456|2300544|P3|STARTED|Overall Study|Subject assigned to ~6.91 X 10^7 IU/Dose of RotaTeq™ - Lot 3|229
952473|NCT00092456|2300545|P2|STARTED|Overall Study|Subject assigned to ~8.01 X 10^7 IU/Dose of RotaTeq™ - Lot 2|225
952474|NCT00092456|2300546|P1|STARTED|Overall Study|Subject assigned to ~8.81 X 10^7 IU/Dose of RotaTeq™ - Lot 1|226
952475|NCT00092495|2300596|P5|NOT COMPLETED|Extension Study||0
952476|NCT00092495|2300597|P4|NOT COMPLETED|Extension Study||0
952477|NCT00092495|2300598|P3|NOT COMPLETED|Extension Study||0
952478|NCT00092495|2300599|P2|NOT COMPLETED|Extension Study||0
952479|NCT00092495|2300600|P1|NOT COMPLETED|Extension Study||0
952480|NCT00092495|2300596|P5|COMPLETED|Extension Study||12
952481|NCT00092495|2300597|P4|COMPLETED|Extension Study||0
952482|NCT00092495|2300598|P3|COMPLETED|Extension Study||0
952483|NCT00092495|2300599|P2|COMPLETED|Extension Study||0
952484|NCT00092495|2300600|P1|COMPLETED|Extension Study||0
952485|NCT00092495|2300596|P5|STARTED|Extension Study||12
952486|NCT00092495|2300597|P4|STARTED|Extension Study||0
952487|NCT00092495|2300598|P3|STARTED|Extension Study||0
952488|NCT00092495|2300599|P2|STARTED|Extension Study||0
952489|NCT00092495|2300600|P1|STARTED|Extension Study||0
952490|NCT00092495|2300596|P5|NOT COMPLETED|Base Study Follow-up Period||0
952491|NCT00092495|2300597|P4|NOT COMPLETED|Base Study Follow-up Period||14
952492|NCT00092495|2300598|P3|NOT COMPLETED|Base Study Follow-up Period||4
952493|NCT00092495|2300599|P2|NOT COMPLETED|Base Study Follow-up Period||3
952494|NCT00092495|2300600|P1|NOT COMPLETED|Base Study Follow-up Period||3
952495|NCT00092495|2300596|P5|COMPLETED|Base Study Follow-up Period||0
952496|NCT00092495|2300597|P4|COMPLETED|Base Study Follow-up Period||446
952497|NCT00092495|2300598|P3|COMPLETED|Base Study Follow-up Period||126
952498|NCT00092495|2300599|P2|COMPLETED|Base Study Follow-up Period||122
952499|NCT00092495|2300600|P1|COMPLETED|Base Study Follow-up Period||112
952500|NCT00092495|2300596|P5|STARTED|Base Study Follow-up Period||0
952501|NCT00092495|2300597|P4|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|460
952502|NCT00092495|2300598|P3|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|130
952503|NCT00092495|2300599|P2|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|125
952504|NCT00092495|2300600|P1|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|115
952505|NCT00092495|2300596|P5|NOT COMPLETED|Base Study Vaccination Period||0
952506|NCT00092495|2300597|P4|NOT COMPLETED|Base Study Vaccination Period||88
952507|NCT00092495|2300598|P3|NOT COMPLETED|Base Study Vaccination Period||34
952508|NCT00092495|2300599|P2|NOT COMPLETED|Base Study Vaccination Period||22
952509|NCT00092495|2300600|P1|NOT COMPLETED|Base Study Vaccination Period||37
952510|NCT00092495|2300596|P5|COMPLETED|Base Study Vaccination Period||0
952511|NCT00092495|2300597|P4|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|1441
952512|NCT00092495|2300598|P3|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|474
952513|NCT00092495|2300599|P2|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|492
952514|NCT00092495|2300600|P1|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|467
952515|NCT00092495|2300596|P5|Without Long-term Follow-up|Base Study Vaccination Period||0
952516|NCT00092495|2300597|P4|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|73
952517|NCT00092495|2300598|P3|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|28
952518|NCT00092495|2300599|P2|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|20
952519|NCT00092495|2300600|P1|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|34
952520|NCT00092495|2300596|P5|With Long-term Follow-up *|Base Study Vaccination Period||0
952521|NCT00092495|2300597|P4|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|10
952522|NCT00092495|2300598|P3|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|6
952523|NCT00092495|2300599|P2|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
952524|NCT00092495|2300600|P1|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
952525|NCT00092495|2300596|P5|STARTED|Base Study Vaccination Period||0
952526|NCT00092495|2300597|P4|STARTED|Base Study Vaccination Period||1529
952527|NCT00092495|2300598|P3|STARTED|Base Study Vaccination Period||508
952528|NCT00092495|2300599|P2|STARTED|Base Study Vaccination Period||514
952529|NCT00092495|2300600|P1|STARTED|Base Study Vaccination Period||504
952530|NCT00092521|2300665|P4|NOT COMPLETED|Extension Study (Group 4)||209
952531|NCT00092521|2300666|P3|NOT COMPLETED|Extension Study (Group 4)||0
952532|NCT00092521|2300667|P2|NOT COMPLETED|Extension Study (Group 4)||0
952533|NCT00092521|2300668|P1|NOT COMPLETED|Extension Study (Group 4)||0
952534|NCT00092521|2300665|P4|COMPLETED|Extension Study (Group 4)||635
952535|NCT00092521|2300666|P3|COMPLETED|Extension Study (Group 4)||0
952536|NCT00092521|2300667|P2|COMPLETED|Extension Study (Group 4)||0
952537|NCT00092521|2300668|P1|COMPLETED|Extension Study (Group 4)||0
952538|NCT00092521|2300665|P4|Received >=1 Dose in Extension Study|Extension Study (Group 4)||801
952539|NCT00092521|2300666|P3|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
952540|NCT00092521|2300667|P2|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
952541|NCT00092521|2300668|P1|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
952542|NCT00092521|2300665|P4|Initiated Extension Study|Extension Study (Group 4)||829
952543|NCT00092521|2300666|P3|Initiated Extension Study|Extension Study (Group 4)||0
952544|NCT00092521|2300667|P2|Initiated Extension Study|Extension Study (Group 4)||0
952545|NCT00092521|2300668|P1|Initiated Extension Study|Extension Study (Group 4)||0
952546|NCT00092521|2300665|P4|STARTED|Extension Study (Group 4)||844
952547|NCT00092521|2300666|P3|STARTED|Extension Study (Group 4)||0
952548|NCT00092521|2300667|P2|STARTED|Extension Study (Group 4)||0
952549|NCT00092521|2300668|P1|STARTED|Extension Study (Group 4)||0
952550|NCT00092521|2300665|P4|NOT COMPLETED|Follow-Up (After Month 7)||0
952551|NCT00092521|2300666|P3|NOT COMPLETED|Follow-Up (After Month 7)||648
952552|NCT00092521|2300667|P2|NOT COMPLETED|Follow-Up (After Month 7)||136
952553|NCT00092521|2300668|P1|NOT COMPLETED|Follow-Up (After Month 7)||246
952554|NCT00092521|2300665|P4|COMPLETED|Follow-Up (After Month 7)||0
952555|NCT00092521|2300666|P3|COMPLETED|Follow-Up (After Month 7)||1959
952556|NCT00092521|2300667|P2|COMPLETED|Follow-Up (After Month 7)||155
952557|NCT00092521|2300668|P1|COMPLETED|Follow-Up (After Month 7)||2353
952558|NCT00092521|2300665|P4|STARTED|Follow-Up (After Month 7)||0
952559|NCT00092521|2300666|P3|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2607
952560|NCT00092521|2300667|P2|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|291
952561|NCT00092521|2300668|P1|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2599
952562|NCT00092521|2300665|P4|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||0
952563|NCT00092521|2300666|P3|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||146
952564|NCT00092521|2300667|P2|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||14
952565|NCT00092521|2300668|P1|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||140
952566|NCT00092521|2300665|P4|COMPLETED|Vaccination (Day 1 Through Month 7)||0
952567|NCT00092521|2300666|P3|COMPLETED|Vaccination (Day 1 Through Month 7)||2586
952568|NCT00092521|2300667|P2|COMPLETED|Vaccination (Day 1 Through Month 7)||290
952569|NCT00092521|2300668|P1|COMPLETED|Vaccination (Day 1 Through Month 7)||2583
952570|NCT00092521|2300665|P4|STARTED|Vaccination (Day 1 Through Month 7)||0
952571|NCT00092521|2300666|P3|STARTED|Vaccination (Day 1 Through Month 7)||2732
952572|NCT00092521|2300667|P2|STARTED|Vaccination (Day 1 Through Month 7)||304
952573|NCT00092521|2300668|P1|STARTED|Vaccination (Day 1 Through Month 7)||2723
952574|NCT00092534|2300680|P3|NOT COMPLETED|Extension Study||145
952575|NCT00092534|2300681|P2|NOT COMPLETED|Extension Study||0
952576|NCT00092534|2300682|P1|NOT COMPLETED|Extension Study||0
952577|NCT00092534|2300680|P3|COMPLETED|Extension Study||449
952578|NCT00092534|2300681|P2|COMPLETED|Extension Study||0
952579|NCT00092534|2300682|P1|COMPLETED|Extension Study||0
952580|NCT00092534|2300680|P3|STARTED|Extension Study||594
952581|NCT00092534|2300681|P2|STARTED|Extension Study||0
952582|NCT00092534|2300682|P1|STARTED|Extension Study||0
952583|NCT00092534|2300680|P3|NOT COMPLETED|Base Study Follow Up Period||0
952584|NCT00092534|2300681|P2|NOT COMPLETED|Base Study Follow Up Period||694
952585|NCT00092534|2300682|P1|NOT COMPLETED|Base Study Follow Up Period||316
952586|NCT00092534|2300680|P3|COMPLETED|Base Study Follow Up Period||0
952587|NCT00092534|2300681|P2|COMPLETED|Base Study Follow Up Period||5277
952588|NCT00092534|2300682|P1|COMPLETED|Base Study Follow Up Period||5626
952589|NCT00092534|2300680|P3|STARTED|Base Study Follow Up Period||0
952590|NCT00092534|2300681|P2|STARTED|Base Study Follow Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5971
952591|NCT00092534|2300682|P1|STARTED|Base Study Follow Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5942
952592|NCT00092534|2300680|P3|NOT COMPLETED|Base Study Vaccination Period||0
952593|NCT00092534|2300681|P2|NOT COMPLETED|Base Study Vaccination Period||126
952594|NCT00092534|2300682|P1|NOT COMPLETED|Base Study Vaccination Period||171
952595|NCT00092534|2300680|P3|COMPLETED|Base Study Vaccination Period||0
952596|NCT00092534|2300681|P2|COMPLETED|Base Study Vaccination Period||5954
952597|NCT00092534|2300682|P1|COMPLETED|Base Study Vaccination Period||5916
952598|NCT00092534|2300680|P3|STARTED|Base Study Vaccination Period||0
952599|NCT00092534|2300681|P2|STARTED|Base Study Vaccination Period||6080
952600|NCT00092534|2300682|P1|STARTED|Base Study Vaccination Period||6087
952601|NCT00092547|2300699|P3|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
952602|NCT00092547|2300700|P2|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
952603|NCT00092547|2300701|P1|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
952604|NCT00092547|2300699|P3|COMPLETED|Long-term Follow-up (Month 126 Visit)||211
952605|NCT00092547|2300700|P2|COMPLETED|Long-term Follow-up (Month 126 Visit)||0
952606|NCT00092547|2300701|P1|COMPLETED|Long-term Follow-up (Month 126 Visit)||454
952607|NCT00092547|2300699|P3|STARTED|Long-term Follow-up (Month 126 Visit)||211
952608|NCT00092547|2300700|P2|STARTED|Long-term Follow-up (Month 126 Visit)||0
952609|NCT00092547|2300701|P1|STARTED|Long-term Follow-up (Month 126 Visit)||454
952610|NCT00092547|2300699|P3|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
952611|NCT00092547|2300700|P2|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
952612|NCT00092547|2300701|P1|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
952613|NCT00092547|2300699|P3|COMPLETED|Long-term Follow-up (Month 96 Visit)||267
952614|NCT00092547|2300700|P2|COMPLETED|Long-term Follow-up (Month 96 Visit)||0
952615|NCT00092547|2300701|P1|COMPLETED|Long-term Follow-up (Month 96 Visit)||508
952616|NCT00092547|2300699|P3|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|267
952617|NCT00092547|2300700|P2|STARTED|Long-term Follow-up (Month 96 Visit)||0
952618|NCT00092547|2300701|P1|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|508
952619|NCT00092547|2300699|P3|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
952620|NCT00092547|2300700|P2|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
952621|NCT00092547|2300701|P1|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
952622|NCT00092547|2300699|P3|COMPLETED|Long-term Follow-up (Month 72 Visit)||276
952623|NCT00092547|2300700|P2|COMPLETED|Long-term Follow-up (Month 72 Visit)||0
952624|NCT00092547|2300701|P1|COMPLETED|Long-term Follow-up (Month 72 Visit)||550
952625|NCT00092547|2300699|P3|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|276
952626|NCT00092547|2300700|P2|STARTED|Long-term Follow-up (Month 72 Visit)||0
952627|NCT00092547|2300701|P1|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|550
952628|NCT00092547|2300699|P3|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
952629|NCT00092547|2300700|P2|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
952630|NCT00092547|2300701|P1|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||1
952631|NCT00092547|2300699|P3|COMPLETED|Long-term Follow-up (Month 42 Visit)||308
952632|NCT00092547|2300700|P2|COMPLETED|Long-term Follow-up (Month 42 Visit)||0
952633|NCT00092547|2300701|P1|COMPLETED|Long-term Follow-up (Month 42 Visit)||611
952634|NCT00092547|2300699|P3|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|308
952635|NCT00092547|2300700|P2|STARTED|Long-term Follow-up (Month 42 Visit)||0
952636|NCT00092547|2300701|P1|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|612
952637|NCT00092547|2300699|P3|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||16
952638|NCT00092547|2300700|P2|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
952639|NCT00092547|2300701|P1|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||23
952640|NCT00092547|2300699|P3|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||469
952641|NCT00092547|2300700|P2|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
952642|NCT00092547|2300701|P1|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||933
952716|NCT00093379|2300857|P1|COMPLETED|Overall Study||20
952643|NCT00092547|2300699|P3|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||482
952644|NCT00092547|2300700|P2|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
952645|NCT00092547|2300701|P1|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
952646|NCT00092547|2300699|P3|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|485
952647|NCT00092547|2300700|P2|STARTED|Extension Vaccine Phase (Month 30 to 37)||0
952648|NCT00092547|2300701|P1|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|956
952649|NCT00092547|2300699|P3|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
952650|NCT00092547|2300700|P2|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||5
952651|NCT00092547|2300701|P1|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||8
952652|NCT00092547|2300699|P3|COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
952653|NCT00092547|2300700|P2|COMPLETED|Base Follow-up Phase (Month 18 to 30)||485
952654|NCT00092547|2300701|P1|COMPLETED|Base Follow-up Phase (Month 18 to 30)||956
952655|NCT00092547|2300699|P3|STARTED|Base Follow-up Phase (Month 18 to 30)||0
952656|NCT00092547|2300700|P2|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|490
952657|NCT00092547|2300701|P1|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|964
952658|NCT00092547|2300699|P3|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
952659|NCT00092547|2300700|P2|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||14
952660|NCT00092547|2300701|P1|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||20
952661|NCT00092547|2300699|P3|COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
952662|NCT00092547|2300700|P2|COMPLETED|Base Follow-up Phase (Month 7 to 18)||551
952663|NCT00092547|2300701|P1|COMPLETED|Base Follow-up Phase (Month 7 to 18)||1108
952664|NCT00092547|2300699|P3|STARTED|Base Follow-up Phase (Month 7 to 18)||0
952665|NCT00092547|2300700|P2|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|565
952666|NCT00092547|2300701|P1|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|1128
952667|NCT00092547|2300699|P3|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
952668|NCT00092547|2300700|P2|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||36
952669|NCT00092547|2300701|P1|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||63
952670|NCT00092547|2300699|P3|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
952671|NCT00092547|2300700|P2|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||561
952672|NCT00092547|2300701|P1|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||1121
952673|NCT00092547|2300699|P3|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||0
952674|NCT00092547|2300700|P2|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||596
952675|NCT00092547|2300701|P1|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||1179
952676|NCT00092547|2300699|P3|STARTED|Base Vaccine Phase (Day 1 to Month 7)||0
952677|NCT00092547|2300700|P2|STARTED|Base Vaccine Phase (Day 1 to Month 7)||597
952678|NCT00092547|2300701|P1|STARTED|Base Vaccine Phase (Day 1 to Month 7)||1184
952679|NCT00092677|2300745|P2|NOT COMPLETED|Overall Study||11
952680|NCT00092677|2300746|P1|NOT COMPLETED|Overall Study||5
952681|NCT00092677|2300745|P2|COMPLETED|Overall Study|Placebo: 698 (on drug), 120 (after drug discon), 100 (at death)|918
952682|NCT00092677|2300746|P1|COMPLETED|Overall Study|EZ/Simva: 694 (on drug), 140 (after drug discon), 105 (at death)|939
952683|NCT00092677|2300745|P2|STARTED|Overall Study||929
952684|NCT00092677|2300746|P1|STARTED|Overall Study||944
952685|NCT00093015|2300790|P2|NOT COMPLETED|Overall Study||664
952686|NCT00093015|2300791|P1|NOT COMPLETED|Overall Study||665
952687|NCT00093015|2300790|P2|COMPLETED|Overall Study||1348
952688|NCT00093015|2300791|P1|COMPLETED|Overall Study||1361
952689|NCT00093015|2300790|P2|Received Study Medication|Overall Study||2004
952690|NCT00093015|2300791|P1|Received Study Medication|Overall Study||2019
952691|NCT00093015|2300790|P2|STARTED|Overall Study||2012
952692|NCT00093015|2300791|P1|STARTED|Overall Study||2026
952693|NCT00093041|2300823|P6|NOT COMPLETED|Overall Study||3
952694|NCT00093041|2300824|P5|NOT COMPLETED|Overall Study||1
952695|NCT00093041|2300825|P4|NOT COMPLETED|Overall Study||1
952696|NCT00093041|2300826|P3|NOT COMPLETED|Overall Study||2
952697|NCT00093041|2300827|P2|NOT COMPLETED|Overall Study||3
952698|NCT00093041|2300828|P1|NOT COMPLETED|Overall Study||2
952699|NCT00093041|2300823|P6|COMPLETED|Overall Study|Three discontinued during multiple dose period|4
952700|NCT00093041|2300824|P5|COMPLETED|Overall Study|One discontinued during multiple dose period|3
952701|NCT00093041|2300825|P4|COMPLETED|Overall Study|One discontinued during single dose period|3
952702|NCT00093041|2300826|P3|COMPLETED|Overall Study|Two discontinued during single dose period|3
952703|NCT00093041|2300827|P2|COMPLETED|Overall Study|Three discontinued during single dose period|1
952704|NCT00093041|2300828|P1|COMPLETED|Overall Study|One discontinued during single dose period and one during multiple dose period|2
952705|NCT00093041|2300823|P6|STARTED|Overall Study||7
952706|NCT00093041|2300824|P5|STARTED|Overall Study||4
952707|NCT00093041|2300825|P4|STARTED|Overall Study||4
952708|NCT00093041|2300826|P3|STARTED|Overall Study||5
952709|NCT00093041|2300827|P2|STARTED|Overall Study||4
952710|NCT00093041|2300828|P1|STARTED|Overall Study||4
952711|NCT00093145|2300848|P1|NOT COMPLETED|Overall Study||17
952712|NCT00093145|2300848|P1|COMPLETED|Overall Study|Treatment completed upon progressive disease|15
952713|NCT00093145|2300848|P1|At Least One Response Assessment|Overall Study||31
952714|NCT00093145|2300848|P1|STARTED|Overall Study||32
952715|NCT00093379|2300857|P1|NOT COMPLETED|Overall Study||0
952717|NCT00093379|2300857|P1|STARTED|Overall Study||20
952718|NCT00093470|2300865|P2|NOT COMPLETED|Overall Study||0
952719|NCT00093470|2300866|P1|NOT COMPLETED|Overall Study||73
952720|NCT00093470|2300865|P2|COMPLETED|Overall Study|Patients underwent observation only.|71
952721|NCT00093470|2300866|P1|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
952722|NCT00093470|2300865|P2|Patients With Toxicity Assessment|Overall Study||69
952723|NCT00093470|2300866|P1|Patients With Toxicity Assessment|Overall Study||72
952724|NCT00093470|2300865|P2|Treated|Overall Study||71
952725|NCT00093470|2300866|P1|Treated|Overall Study||72
952726|NCT00093470|2300865|P2|STARTED|Overall Study||71
952727|NCT00093470|2300866|P1|STARTED|Overall Study||73
952728|NCT00093496|2300876|P2|NOT COMPLETED|Overall Study||3
952729|NCT00093496|2300877|P1|NOT COMPLETED|Overall Study||1
952730|NCT00093496|2300876|P2|COMPLETED|Overall Study||11
952731|NCT00093496|2300877|P1|COMPLETED|Overall Study||14
952732|NCT00093496|2300876|P2|STARTED|Overall Study||14
952733|NCT00093496|2300877|P1|STARTED|Overall Study||15
952734|NCT00093756|2300890|P2|NOT COMPLETED|Overall Study||0
952735|NCT00093756|2300891|P1|NOT COMPLETED|Overall Study||0
952736|NCT00093756|2300890|P2|COMPLETED|Overall Study||27
952737|NCT00093756|2300891|P1|COMPLETED|Overall Study||21
952738|NCT00093756|2300890|P2|STARTED|Overall Study||27
952739|NCT00093756|2300891|P1|STARTED|Overall Study||21
952740|NCT00093782|2300896|P1|NOT COMPLETED|Overall Study||0
952741|NCT00093782|2300896|P1|COMPLETED|Overall Study||36
952742|NCT00093782|2300896|P1|STARTED|Overall Study||36
952743|NCT00093808|2300906|P1|NOT COMPLETED|Overall Study||2
952744|NCT00093808|2300906|P1|COMPLETED|Overall Study||45
952745|NCT00093808|2300906|P1|STARTED|Overall Study||47
952746|NCT00093847|2300915|P2|NOT COMPLETED|Overall Study||10
952747|NCT00093847|2300916|P1|NOT COMPLETED|Overall Study||8
952748|NCT00093847|2300915|P2|COMPLETED|Overall Study||24
952749|NCT00093847|2300916|P1|COMPLETED|Overall Study||31
952750|NCT00093847|2300915|P2|STARTED|Overall Study||34
952751|NCT00093847|2300916|P1|STARTED|Overall Study||39
952752|NCT00094055|2300924|P1|NOT COMPLETED|Overall Study||60
952753|NCT00094055|2300924|P1|COMPLETED|Overall Study||0
952754|NCT00094055|2300924|P1|STARTED|Overall Study||60
952755|NCT00094094|2300933|P1|NOT COMPLETED|Overall Study||32
952756|NCT00094094|2300933|P1|COMPLETED|Overall Study||0
952757|NCT00094094|2300933|P1|STARTED|Overall Study||32
952758|NCT00094107|2300942|P1|NOT COMPLETED|Overall Study||32
952759|NCT00094107|2300942|P1|COMPLETED|Overall Study||0
952760|NCT00094107|2300942|P1|STARTED|Overall Study||32
952761|NCT00094172|2300953|P2|NOT COMPLETED|Overall Study||7
952762|NCT00094172|2300954|P1|NOT COMPLETED|Overall Study||14
952763|NCT00094172|2300953|P2|COMPLETED|Overall Study||25
952764|NCT00094172|2300954|P1|COMPLETED|Overall Study||36
952765|NCT00094172|2300953|P2|STARTED|Overall Study|Safety Sample: 32; Intent-to-Treat Sample: 32; Per Protocol Sample: 28|32
952766|NCT00094172|2300954|P1|STARTED|Overall Study|Safety Sample: 49; Intent-to-Treat Sample: 49; Per Protocol Sample: 39|50
952767|NCT00094302|2300966|P2|NOT COMPLETED|Overall Study||406
952768|NCT00094302|2300967|P1|NOT COMPLETED|Overall Study||417
952769|NCT00094302|2300966|P2|COMPLETED|Overall Study||1316
952770|NCT00094302|2300967|P1|COMPLETED|Overall Study||1306
952771|NCT00094302|2300966|P2|STARTED|Overall Study||1722
952772|NCT00094302|2300967|P1|STARTED|Overall Study||1723
952773|NCT00094328|2301021|P1|NOT COMPLETED|Overall Study||1
952774|NCT00094328|2301021|P1|COMPLETED|Overall Study|Completed 12 months on treatment|13
952775|NCT00094328|2301021|P1|STARTED|Overall Study|Received treatment|14
952776|NCT00094458|2301032|P6|NOT COMPLETED|OLE: Open-Label Extension||4
952777|NCT00094458|2301033|P5|NOT COMPLETED|OLE: Open-Label Extension||5
952778|NCT00094458|2301034|P4|NOT COMPLETED|OLE: Open-Label Extension||1
952779|NCT00094458|2301035|P3|NOT COMPLETED|OLE: Open-Label Extension||0
952780|NCT00094458|2301036|P2|NOT COMPLETED|OLE: Open-Label Extension||0
952781|NCT00094458|2301037|P1|NOT COMPLETED|OLE: Open-Label Extension||0
952782|NCT00094458|2301032|P6|COMPLETED|OLE: Open-Label Extension||13
952783|NCT00094458|2301033|P5|COMPLETED|OLE: Open-Label Extension||13
952784|NCT00094458|2301034|P4|COMPLETED|OLE: Open-Label Extension||7
952785|NCT00094458|2301035|P3|COMPLETED|OLE: Open-Label Extension||0
952786|NCT00094458|2301036|P2|COMPLETED|OLE: Open-Label Extension||0
952787|NCT00094458|2301037|P1|COMPLETED|OLE: Open-Label Extension||0
952788|NCT00094458|2301032|P6|STARTED|OLE: Open-Label Extension||17
952789|NCT00094458|2301033|P5|STARTED|OLE: Open-Label Extension||18
952790|NCT00094458|2301034|P4|STARTED|OLE: Open-Label Extension||8
952791|NCT00094458|2301035|P3|STARTED|OLE: Open-Label Extension||0
952792|NCT00094458|2301036|P2|STARTED|OLE: Open-Label Extension||0
952793|NCT00094458|2301037|P1|STARTED|OLE: Open-Label Extension||0
952794|NCT00094458|2301032|P6|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
952795|NCT00094458|2301033|P5|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
952796|NCT00094458|2301034|P4|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
952797|NCT00094458|2301035|P3|NOT COMPLETED|Study Extension: Week 30 Through Week 50||18
952798|NCT00094458|2301036|P2|NOT COMPLETED|Study Extension: Week 30 Through Week 50||12
952799|NCT00094458|2301037|P1|NOT COMPLETED|Study Extension: Week 30 Through Week 50||8
952800|NCT00094458|2301032|P6|COMPLETED|Study Extension: Week 30 Through Week 50||0
952801|NCT00094458|2301033|P5|COMPLETED|Study Extension: Week 30 Through Week 50||0
952802|NCT00094458|2301034|P4|COMPLETED|Study Extension: Week 30 Through Week 50||0
952803|NCT00094458|2301035|P3|COMPLETED|Study Extension: Week 30 Through Week 50||90
952804|NCT00094458|2301036|P2|COMPLETED|Study Extension: Week 30 Through Week 50||85
952805|NCT00094458|2301037|P1|COMPLETED|Study Extension: Week 30 Through Week 50||67
952806|NCT00094458|2301032|P6|STARTED|Study Extension: Week 30 Through Week 50||0
952807|NCT00094458|2301033|P5|STARTED|Study Extension: Week 30 Through Week 50||0
952808|NCT00094458|2301034|P4|STARTED|Study Extension: Week 30 Through Week 50||0
952809|NCT00094458|2301035|P3|STARTED|Study Extension: Week 30 Through Week 50||108
952810|NCT00094458|2301036|P2|STARTED|Study Extension: Week 30 Through Week 50||97
952811|NCT00094458|2301037|P1|STARTED|Study Extension: Week 30 Through Week 50||75
952812|NCT00094458|2301032|P6|NOT COMPLETED|Main Study: Through Week 30||0
952813|NCT00094458|2301033|P5|NOT COMPLETED|Main Study: Through Week 30||0
952814|NCT00094458|2301034|P4|NOT COMPLETED|Main Study: Through Week 30||0
952815|NCT00094458|2301035|P3|NOT COMPLETED|Main Study: Through Week 30||48
952816|NCT00094458|2301036|P2|NOT COMPLETED|Main Study: Through Week 30||58
952817|NCT00094458|2301037|P1|NOT COMPLETED|Main Study: Through Week 30||84
952818|NCT00094458|2301032|P6|COMPLETED|Main Study: Through Week 30||0
952819|NCT00094458|2301033|P5|COMPLETED|Main Study: Through Week 30||0
952820|NCT00094458|2301034|P4|COMPLETED|Main Study: Through Week 30||0
952821|NCT00094458|2301035|P3|COMPLETED|Main Study: Through Week 30||121
952822|NCT00094458|2301036|P2|COMPLETED|Main Study: Through Week 30||111
952823|NCT00094458|2301037|P1|COMPLETED|Main Study: Through Week 30||86
952824|NCT00094458|2301032|P6|STARTED|Main Study: Through Week 30||0
952825|NCT00094458|2301033|P5|STARTED|Main Study: Through Week 30||0
952826|NCT00094458|2301034|P4|STARTED|Main Study: Through Week 30||0
952827|NCT00094458|2301035|P3|STARTED|Main Study: Through Week 30||169
952828|NCT00094458|2301036|P2|STARTED|Main Study: Through Week 30||169
952829|NCT00094458|2301037|P1|STARTED|Main Study: Through Week 30||170
952830|NCT00100178|2301078|P3|NOT COMPLETED|Overall Study||10
952831|NCT00100178|2301079|P2|NOT COMPLETED|Overall Study||10
952832|NCT00100178|2301080|P1|NOT COMPLETED|Overall Study||9
952833|NCT00100178|2301078|P3|COMPLETED|Overall Study||32
952834|NCT00100178|2301079|P2|COMPLETED|Overall Study||21
952835|NCT00100178|2301080|P1|COMPLETED|Overall Study||32
952836|NCT00100178|2301078|P3|STARTED|Overall Study||42
952837|NCT00100178|2301079|P2|STARTED|Overall Study|12 subjects randomized to the MMF alone group were excluded from analysis due to randomization error|31
952838|NCT00100178|2301080|P1|STARTED|Overall Study||41
952845|NCT00100659|2301103|P2|NOT COMPLETED|Overall Study||2
952846|NCT00100659|2301104|P1|NOT COMPLETED|Overall Study||3
952847|NCT00100659|2301103|P2|COMPLETED|Overall Study||57
952848|NCT00100659|2301104|P1|COMPLETED|Overall Study||52
952849|NCT00100659|2301103|P2|STARTED|Overall Study||59
952850|NCT00100659|2301104|P1|STARTED|Overall Study||55
952851|NCT00100698|2301112|P2|NOT COMPLETED|Overall Study||2
952852|NCT00100698|2301113|P1|NOT COMPLETED|Overall Study||6
952853|NCT00100698|2301112|P2|COMPLETED|Overall Study||27
952854|NCT00100698|2301113|P1|COMPLETED|Overall Study||21
952855|NCT00100698|2301112|P2|STARTED|Overall Study||29
952856|NCT00100698|2301113|P1|STARTED|Overall Study||27
952857|NCT00100789|2301153|P1|NOT COMPLETED|Overall Study||64
952858|NCT00100789|2301153|P1|COMPLETED|Overall Study||3
952859|NCT00100789|2301153|P1|Eligible and Began Protocol Therapy|Overall Study||63
952860|NCT00100789|2301153|P1|Eligible|Overall Study||64
952861|NCT00100789|2301153|P1|STARTED|Overall Study||67
952862|NCT00100802|2301160|P1|NOT COMPLETED|Overall Study||80
952863|NCT00100802|2301160|P1|COMPLETED|Overall Study||38
952864|NCT00100802|2301160|P1|STARTED|Overall Study||118
952865|NCT00100815|2301165|P1|NOT COMPLETED|Overall Study||49
952866|NCT00100815|2301165|P1|COMPLETED|Overall Study||1
952867|NCT00100815|2301165|P1|STARTED|Overall Study||50
952868|NCT00100841|2301173|P1|NOT COMPLETED|Overall Study||0
952869|NCT00100841|2301173|P1|COMPLETED|Overall Study||66
952870|NCT00100841|2301173|P1|STARTED|Overall Study||66
952871|NCT00100932|2301180|P2|NOT COMPLETED|Overall Study||27
952872|NCT00100932|2301181|P1|NOT COMPLETED|Overall Study||73
952873|NCT00100932|2301180|P2|COMPLETED|Overall Study||1
952874|NCT00100932|2301181|P1|COMPLETED|Overall Study||5
952875|NCT00100932|2301180|P2|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|28
952876|NCT00100932|2301181|P1|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|78
952877|NCT00101036|2301193|P2|NOT COMPLETED|Overall Study||0
952878|NCT00101036|2301194|P1|NOT COMPLETED|Overall Study||0
952879|NCT00101036|2301193|P2|COMPLETED|Overall Study||40
952880|NCT00101036|2301194|P1|COMPLETED|Overall Study||17
952881|NCT00101036|2301193|P2|STARTED|Overall Study||40
952882|NCT00101036|2301194|P1|STARTED|Overall Study||17
952883|NCT00101101|2301204|P1|NOT COMPLETED|Overall Study||20
952884|NCT00101101|2301204|P1|COMPLETED|Overall Study|Participants who received at least one vaccine injection.|23
952885|NCT00101101|2301204|P1|STARTED|Overall Study||43
952886|NCT00101166|2301210|P1|NOT COMPLETED|Overall Study||10
952887|NCT00101166|2301210|P1|COMPLETED|Overall Study||18
952888|NCT00101166|2301210|P1|STARTED|Overall Study||28
952889|NCT00101192|2301218|P1|NOT COMPLETED|Overall Study||7
952890|NCT00101192|2301218|P1|COMPLETED|Overall Study||69
952891|NCT00101192|2301218|P1|STARTED|Overall Study||76
952892|NCT00101283|2301224|P2|NOT COMPLETED|Overall Study||3
952893|NCT00101283|2301225|P1|NOT COMPLETED|Overall Study||0
952894|NCT00101283|2301224|P2|COMPLETED|Overall Study||13
952895|NCT00101283|2301225|P1|COMPLETED|Overall Study||16
952896|NCT00101283|2301224|P2|Began Treatment|Overall Study||13
952897|NCT00101283|2301225|P1|Began Treatment|Overall Study||16
952898|NCT00101283|2301224|P2|STARTED|Overall Study||16
952899|NCT00101283|2301225|P1|STARTED|Overall Study||16
952900|NCT00101361|2301237|P2|NOT COMPLETED|Overall Study||0
952901|NCT00101361|2301238|P1|NOT COMPLETED|Overall Study||0
952902|NCT00101361|2301237|P2|COMPLETED|Overall Study||104
952903|NCT00101361|2301238|P1|COMPLETED|Overall Study||108
952904|NCT00101361|2301237|P2|STARTED|Overall Study||104
952905|NCT00101361|2301238|P1|STARTED|Overall Study||108
952906|NCT00101400|2301244|P1|NOT COMPLETED|Survival Follow-Up||7
952907|NCT00101400|2301244|P1|COMPLETED|Survival Follow-Up|44 subjects reached endpoint (death); 7 subjects were still alive|44
952908|NCT00101400|2301244|P1|STARTED|Survival Follow-Up|3 subjects died during previous period (completion as defined in protocol)|51
952909|NCT00101400|2301244|P1|NOT COMPLETED|Treatment||0
952910|NCT00101400|2301244|P1|COMPLETED|Treatment|Reasons for treatment termination: 4 Adverse Events, 3 Deaths, 46 Progression, 1 Withdrawal.|54
952911|NCT00101400|2301244|P1|STARTED|Treatment|Treated until disease progression, unacceptable sorafenib-related toxicity or withdrawal of consent.|54
952912|NCT00101413|2301253|P1|NOT COMPLETED|Overall Study||0
952913|NCT00101413|2301253|P1|COMPLETED|Overall Study|Safety data collected for 4 subjects after 30 Jun 2005 until 11 Apr 2008.|52
952914|NCT00101413|2301253|P1|STARTED|Overall Study||52
952915|NCT00101439|2301263|P2|NOT COMPLETED|Period 2||2
952916|NCT00101439|2301264|P1|NOT COMPLETED|Period 2||0
952917|NCT00101439|2301263|P2|COMPLETED|Period 2||28
952918|NCT00101439|2301264|P1|COMPLETED|Period 2||28
952919|NCT00101439|2301263|P2|STARTED|Period 2||30
952920|NCT00101439|2301264|P1|STARTED|Period 2||28
952921|NCT00101439|2301263|P2|NOT COMPLETED|Period 1||0
952922|NCT00101439|2301264|P1|NOT COMPLETED|Period 1||0
952923|NCT00101439|2301263|P2|COMPLETED|Period 1||30
952924|NCT00101439|2301264|P1|COMPLETED|Period 1||28
952925|NCT00101439|2301263|P2|STARTED|Period 1||30
952926|NCT00101439|2301264|P1|STARTED|Period 1||28
952927|NCT00101452|2301275|P3|NOT COMPLETED|Overall Study||43
952928|NCT00101452|2301276|P2|NOT COMPLETED|Overall Study||43
952929|NCT00101452|2301277|P1|NOT COMPLETED|Overall Study||44
952930|NCT00101452|2301275|P3|COMPLETED|Overall Study||22
952931|NCT00101452|2301276|P2|COMPLETED|Overall Study||26
952932|NCT00101452|2301277|P1|COMPLETED|Overall Study||21
952933|NCT00101452|2301275|P3|STARTED|Overall Study||65
952934|NCT00101452|2301276|P2|STARTED|Overall Study||69
952935|NCT00101452|2301277|P1|STARTED|Overall Study||65
952936|NCT00101582|2301291|P2|NOT COMPLETED|Overall Study||15
952937|NCT00101582|2301292|P1|NOT COMPLETED|Overall Study||11
952938|NCT00101582|2301291|P2|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|79
952939|NCT00101582|2301292|P1|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|83
952940|NCT00101582|2301291|P2|Received Study Drug|Overall Study||94
952941|NCT00101582|2301292|P1|Received Study Drug|Overall Study||91
952942|NCT00101582|2301291|P2|STARTED|Overall Study||94
952943|NCT00101582|2301292|P1|STARTED|Overall Study||94
952944|NCT00101647|2301314|P2|NOT COMPLETED|Overall Study||0
952945|NCT00101647|2301315|P1|NOT COMPLETED|Overall Study||0
952946|NCT00101647|2301314|P2|COMPLETED|Overall Study||161
952947|NCT00101647|2301315|P1|COMPLETED|Overall Study||13
952948|NCT00101647|2301314|P2|STARTED|Overall Study|Randomized|161
952949|NCT00101647|2301315|P1|STARTED|Overall Study|Randomized|13
952950|NCT00101660|2301365|P2|NOT COMPLETED|Overall Study||0
952951|NCT00101660|2301366|P1|NOT COMPLETED|Overall Study||0
952952|NCT00101660|2301365|P2|COMPLETED|Overall Study||288
952953|NCT00101660|2301366|P1|COMPLETED|Overall Study||99
952954|NCT00101660|2301365|P2|STARTED|Overall Study||288
952955|NCT00101660|2301366|P1|STARTED|Overall Study||99
952956|NCT00101686|2301392|P10|NOT COMPLETED|Overall Study||30
952957|NCT00101686|2301393|P9|NOT COMPLETED|Overall Study||30
952958|NCT00101686|2301394|P8|NOT COMPLETED|Overall Study||30
952959|NCT00101686|2301395|P7|NOT COMPLETED|Overall Study||27
952960|NCT00101686|2301396|P6|NOT COMPLETED|Overall Study||72
952961|NCT00101686|2301397|P5|NOT COMPLETED|Overall Study||73
952962|NCT00101686|2301398|P4|NOT COMPLETED|Overall Study||72
952963|NCT00101686|2301399|P3|NOT COMPLETED|Overall Study||69
952964|NCT00101686|2301400|P2|NOT COMPLETED|Overall Study||73
952965|NCT00101686|2301401|P1|NOT COMPLETED|Overall Study||71
952966|NCT00101686|2301392|P10|COMPLETED|Overall Study|Patients treated until disease progression.|0
952967|NCT00101686|2301393|P9|COMPLETED|Overall Study|Patients treated until disease progression.|0
952968|NCT00101686|2301394|P8|COMPLETED|Overall Study|Patients treated until disease progression.|0
952969|NCT00101686|2301395|P7|COMPLETED|Overall Study|Patients treated until disease progression.|0
952970|NCT00101686|2301396|P6|COMPLETED|Overall Study|Patients treated until disease progression.|0
952971|NCT00101686|2301397|P5|COMPLETED|Overall Study|Patients treated until disease progression.|0
952972|NCT00101686|2301398|P4|COMPLETED|Overall Study|Patients treated until disease progression.|0
952973|NCT00101686|2301399|P3|COMPLETED|Overall Study|Patients treated until disease progression.|0
952974|NCT00101686|2301400|P2|COMPLETED|Overall Study|Patients treated until disease progression.|0
952975|NCT00101686|2301401|P1|COMPLETED|Overall Study|Patients treated until disease progression.|0
952976|NCT00101686|2301392|P10|Received Treatment|Overall Study||29
952977|NCT00101686|2301393|P9|Received Treatment|Overall Study||30
952978|NCT00101686|2301394|P8|Received Treatment|Overall Study||29
952979|NCT00101686|2301395|P7|Received Treatment|Overall Study||27
952980|NCT00101686|2301396|P6|Received Treatment|Overall Study||70
952981|NCT00101686|2301397|P5|Received Treatment|Overall Study||71
952982|NCT00101686|2301398|P4|Received Treatment|Overall Study||70
952983|NCT00101686|2301399|P3|Received Treatment|Overall Study||67
952984|NCT00101686|2301400|P2|Received Treatment|Overall Study||67
952985|NCT00101686|2301401|P1|Received Treatment|Overall Study||70
952986|NCT00101686|2301392|P10|STARTED|Overall Study||30
952987|NCT00101686|2301393|P9|STARTED|Overall Study||30
952988|NCT00101686|2301394|P8|STARTED|Overall Study||30
952989|NCT00101686|2301395|P7|STARTED|Overall Study||27
952990|NCT00101686|2301396|P6|STARTED|Overall Study||72
952991|NCT00101686|2301397|P5|STARTED|Overall Study||73
952992|NCT00101686|2301398|P4|STARTED|Overall Study||72
952993|NCT00101686|2301399|P3|STARTED|Overall Study||69
952994|NCT00101686|2301400|P2|STARTED|Overall Study||73
952995|NCT00101686|2301401|P1|STARTED|Overall Study||71
952996|NCT00101816|2301448|P2|NOT COMPLETED|Overall Study||0
952997|NCT00101816|2301449|P1|NOT COMPLETED|Overall Study||0
952998|NCT00101816|2301448|P2|COMPLETED|Overall Study||99
952999|NCT00101816|2301449|P1|COMPLETED|Overall Study||10
953000|NCT00101816|2301448|P2|STARTED|Overall Study||99
953001|NCT00101816|2301449|P1|STARTED|Overall Study||10
953002|NCT00101868|2301498|P2|NOT COMPLETED|Overall Study||32
953003|NCT00101868|2301499|P1|NOT COMPLETED|Overall Study||29
953004|NCT00101868|2301498|P2|COMPLETED|Overall Study|zero hospital physician with zero patients lost to follow up|283
953005|NCT00101868|2301499|P1|COMPLETED|Overall Study|1 hospital physician with zero patients lost to follow up|287
953006|NCT00101868|2301498|P2|STARTED|Overall Study|35 hospital physicians allocated to usual care discharge|315
953007|NCT00101868|2301499|P1|STARTED|Overall Study|35 hospital physicians allocated to discharge software|316
953008|NCT00101907|2301515|P6|NOT COMPLETED|Overall Study||0
953009|NCT00101907|2301516|P5|NOT COMPLETED|Overall Study||5
953010|NCT00101907|2301517|P4|NOT COMPLETED|Overall Study||1
953011|NCT00101907|2301518|P3|NOT COMPLETED|Overall Study||1
953012|NCT00101907|2301519|P2|NOT COMPLETED|Overall Study||1
953013|NCT00101907|2301520|P1|NOT COMPLETED|Overall Study||2
953014|NCT00101907|2301515|P6|COMPLETED|Overall Study||2
953015|NCT00101907|2301516|P5|COMPLETED|Overall Study||6
953016|NCT00101907|2301517|P4|COMPLETED|Overall Study||5
953017|NCT00101907|2301518|P3|COMPLETED|Overall Study||5
953018|NCT00101907|2301519|P2|COMPLETED|Overall Study||7
953019|NCT00101907|2301520|P1|COMPLETED|Overall Study||6
953020|NCT00101907|2301515|P6|STARTED|Overall Study||2
953021|NCT00101907|2301516|P5|STARTED|Overall Study||11
953022|NCT00101907|2301517|P4|STARTED|Overall Study||6
953023|NCT00101907|2301518|P3|STARTED|Overall Study||6
953024|NCT00101907|2301519|P2|STARTED|Overall Study||8
953025|NCT00101907|2301520|P1|STARTED|Overall Study||8
953026|NCT00101933|2301562|P2|NOT COMPLETED|Overall Study||0
953027|NCT00101933|2301563|P1|NOT COMPLETED|Overall Study||0
953028|NCT00101933|2301562|P2|COMPLETED|Overall Study||55
953029|NCT00101933|2301563|P1|COMPLETED|Overall Study||54
953030|NCT00101933|2301562|P2|STARTED|Overall Study||55
953031|NCT00101933|2301563|P1|STARTED|Overall Study||54
953032|NCT00102063|2301586|P3|NOT COMPLETED|Overall Study||10
953033|NCT00102063|2301587|P2|NOT COMPLETED|Overall Study||18
953034|NCT00102063|2301588|P1|NOT COMPLETED|Overall Study||16
953035|NCT00102063|2301586|P3|COMPLETED|Overall Study||90
953036|NCT00102063|2301587|P2|COMPLETED|Overall Study||84
953037|NCT00102063|2301588|P1|COMPLETED|Overall Study||84
953038|NCT00102063|2301586|P3|STARTED|Overall Study||100
953039|NCT00102063|2301587|P2|STARTED|Overall Study||102
953040|NCT00102063|2301588|P1|STARTED|Overall Study||100
953041|NCT00102440|2301620|P3|NOT COMPLETED|Overall Study||66
953042|NCT00102440|2301621|P2|NOT COMPLETED|Overall Study||98
953043|NCT00102440|2301622|P1|NOT COMPLETED|Overall Study||88
953044|NCT00102440|2301620|P3|COMPLETED|Overall Study||187
953045|NCT00102440|2301621|P2|COMPLETED|Overall Study||153
953046|NCT00102440|2301622|P1|COMPLETED|Overall Study||168
953047|NCT00102440|2301620|P3|STARTED|Overall Study||253
953048|NCT00102440|2301621|P2|STARTED|Overall Study||251
953049|NCT00102440|2301622|P1|STARTED|Overall Study||256
953050|NCT00102518|2301669|P1|NOT COMPLETED|Overall Study||87
953051|NCT00102518|2301669|P1|COMPLETED|Overall Study||238
953052|NCT00102518|2301669|P1|STARTED|Overall Study||325
953053|NCT00102531|2301677|P2|NOT COMPLETED|Overall Study||11
953054|NCT00102531|2301678|P1|NOT COMPLETED|Overall Study||5
953055|NCT00102531|2301677|P2|COMPLETED|Overall Study||1
953056|NCT00102531|2301678|P1|COMPLETED|Overall Study||2
953057|NCT00102531|2301677|P2|STARTED|Overall Study||12
953058|NCT00102531|2301678|P1|STARTED|Overall Study||7
953059|NCT00102596|2301684|P2|NOT COMPLETED|Part C||0
953060|NCT00102596|2301685|P1|NOT COMPLETED|Part C||0
953061|NCT00102596|2301684|P2|COMPLETED|Part C||2
953062|NCT00102596|2301685|P1|COMPLETED|Part C||0
953063|NCT00102596|2301684|P2|STARTED|Part C|Only 2 patients participated in Part C|2
953064|NCT00102596|2301685|P1|STARTED|Part C||0
953065|NCT00102596|2301684|P2|NOT COMPLETED|Part B||0
953066|NCT00102596|2301685|P1|NOT COMPLETED|Part B||0
953067|NCT00102596|2301684|P2|COMPLETED|Part B||10
953068|NCT00102596|2301685|P1|COMPLETED|Part B||0
953069|NCT00102596|2301684|P2|STARTED|Part B||10
953070|NCT00102596|2301685|P1|STARTED|Part B|Participants from Part A did not continue to Part B|0
953071|NCT00102596|2301684|P2|NOT COMPLETED|Part A||0
953072|NCT00102596|2301685|P1|NOT COMPLETED|Part A||7
953073|NCT00102596|2301684|P2|COMPLETED|Part A||0
953074|NCT00102596|2301685|P1|COMPLETED|Part A||4
953075|NCT00102596|2301684|P2|Participants Assigned Treatment|Part A||0
953076|NCT00102596|2301685|P1|Participants Assigned Treatment|Part A||5
953077|NCT00102596|2301684|P2|STARTED|Part A||0
953078|NCT00102596|2301685|P1|STARTED|Part A||11
953079|NCT00102687|2301697|P5|NOT COMPLETED|Maintenance Period||13
953080|NCT00102687|2301698|P4|NOT COMPLETED|Maintenance Period||10
953081|NCT00102687|2301699|P3|NOT COMPLETED|Maintenance Period||6
953082|NCT00102687|2301700|P2|NOT COMPLETED|Maintenance Period||4
953083|NCT00102687|2301701|P1|NOT COMPLETED|Maintenance Period||7
953084|NCT00102687|2301697|P5|COMPLETED|Maintenance Period||8
953085|NCT00102687|2301698|P4|COMPLETED|Maintenance Period||12
953086|NCT00102687|2301699|P3|COMPLETED|Maintenance Period||2
953087|NCT00102687|2301700|P2|COMPLETED|Maintenance Period||2
953088|NCT00102687|2301701|P1|COMPLETED|Maintenance Period||6
953089|NCT00102687|2301697|P5|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|21
953090|NCT00102687|2301698|P4|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|22
953091|NCT00102687|2301699|P3|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|8
953092|NCT00102687|2301700|P2|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|6
953093|NCT00102687|2301701|P1|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|13
953094|NCT00102687|2301697|P5|NOT COMPLETED|Initial Period||0
953095|NCT00102687|2301698|P4|NOT COMPLETED|Initial Period||0
953096|NCT00102687|2301699|P3|NOT COMPLETED|Initial Period||26
953097|NCT00102687|2301700|P2|NOT COMPLETED|Initial Period||28
953098|NCT00102687|2301701|P1|NOT COMPLETED|Initial Period||18
953099|NCT00102687|2301697|P5|COMPLETED|Initial Period||0
953100|NCT00102687|2301698|P4|COMPLETED|Initial Period||0
953101|NCT00102687|2301699|P3|COMPLETED|Initial Period||25
953102|NCT00102687|2301700|P2|COMPLETED|Initial Period||22
953103|NCT00102687|2301701|P1|COMPLETED|Initial Period||32
953104|NCT00102687|2301697|P5|STARTED|Initial Period||0
953105|NCT00102687|2301698|P4|STARTED|Initial Period||0
953106|NCT00102687|2301699|P3|STARTED|Initial Period|3 randomized participants did not receive treatment.|51
953107|NCT00102687|2301700|P2|STARTED|Initial Period||50
953108|NCT00102687|2301701|P1|STARTED|Initial Period||50
953109|NCT00102804|2301767|P2|NOT COMPLETED|Overall Study||222
953110|NCT00102804|2301768|P1|NOT COMPLETED|Overall Study||441
953111|NCT00102804|2301767|P2|COMPLETED|Overall Study||0
953112|NCT00102804|2301768|P1|COMPLETED|Overall Study||0
953113|NCT00102804|2301767|P2|Received at Least 1 Dose of Study Drug|Overall Study|Four participants randomized to placebo received pemetrexed.|222
953114|NCT00102804|2301768|P1|Received at Least 1 Dose of Study Drug|Overall Study||434
953115|NCT00102804|2301767|P2|STARTED|Overall Study||222
953116|NCT00102804|2301768|P1|STARTED|Overall Study||441
953117|NCT00103012|2301789|P3|NOT COMPLETED|Overall Study||4
953118|NCT00103012|2301790|P2|NOT COMPLETED|Overall Study||1
953119|NCT00103012|2301791|P1|NOT COMPLETED|Overall Study||3
953120|NCT00103012|2301789|P3|COMPLETED|Overall Study||12
953121|NCT00103012|2301790|P2|COMPLETED|Overall Study||13
953122|NCT00103012|2301791|P1|COMPLETED|Overall Study||14
953123|NCT00103012|2301789|P3|STARTED|Overall Study||16
953124|NCT00103012|2301790|P2|STARTED|Overall Study||14
953125|NCT00103012|2301791|P1|STARTED|Overall Study||17
953126|NCT00103116|2301799|P1|NOT COMPLETED|Overall Study||0
953127|NCT00103116|2301799|P1|COMPLETED|Overall Study||32
953128|NCT00103116|2301799|P1|STARTED|Overall Study||32
953129|NCT00103142|2301806|P2|NOT COMPLETED|Overall Study||1
953130|NCT00103142|2301807|P1|NOT COMPLETED|Overall Study||3
953131|NCT00103142|2301806|P2|COMPLETED|Overall Study||36
953132|NCT00103142|2301807|P1|COMPLETED|Overall Study||33
953133|NCT00103142|2301806|P2|STARTED|Overall Study||37
953134|NCT00103142|2301807|P1|STARTED|Overall Study||36
953135|NCT00103194|2301815|P1|NOT COMPLETED|Overall Study||31
953136|NCT00103194|2301815|P1|COMPLETED|Overall Study||18
953137|NCT00103194|2301815|P1|Eligible and Treated|Overall Study||35
953138|NCT00103194|2301815|P1|Eligible|Overall Study||35
953139|NCT00103194|2301815|P1|Treated|Overall Study||49
953140|NCT00103194|2301815|P1|STARTED|Overall Study||49
953141|NCT00091572|2301824|P2|NOT COMPLETED|Overall Study||82
953142|NCT00091572|2301825|P1|NOT COMPLETED|Overall Study||95
953143|NCT00091572|2301824|P2|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|348
953144|NCT00091572|2301825|P1|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|334
953145|NCT00091572|2301824|P2|STARTED|Overall Study|9 subjects in dacarbazine group not treated.|430
953146|NCT00091572|2301825|P1|STARTED|Overall Study|10 subjects in temozolomide group not treated.|429
953147|NCT00091793|2301839|P2|NOT COMPLETED|Overall Study||22
953148|NCT00091793|2301840|P1|NOT COMPLETED|Overall Study||24
953149|NCT00091793|2301839|P2|COMPLETED|Overall Study||144
953150|NCT00091793|2301840|P1|COMPLETED|Overall Study||142
953151|NCT00091793|2301839|P2|STARTED|Overall Study||166
953152|NCT00091793|2301840|P1|STARTED|Overall Study||166
953153|NCT00091819|2301864|P2|NOT COMPLETED|Overall Study||46
953154|NCT00091819|2301865|P1|NOT COMPLETED|Overall Study||42
953155|NCT00091819|2301864|P2|COMPLETED|Overall Study||387
953156|NCT00091819|2301865|P1|COMPLETED|Overall Study||387
953157|NCT00091819|2301864|P2|STARTED|Overall Study||433
953158|NCT00091819|2301865|P1|STARTED|Overall Study||429
953159|NCT00091832|2301877|P6|NOT COMPLETED|Overall Study||11
953160|NCT00091832|2301878|P5|NOT COMPLETED|Overall Study||15
953161|NCT00091832|2301879|P4|NOT COMPLETED|Overall Study||14
953162|NCT00091832|2301880|P3|NOT COMPLETED|Overall Study||12
953163|NCT00091832|2301881|P2|NOT COMPLETED|Overall Study||11
953164|NCT00091832|2301882|P1|NOT COMPLETED|Overall Study||14
953165|NCT00091832|2301877|P6|COMPLETED|Overall Study||32
953166|NCT00091832|2301878|P5|COMPLETED|Overall Study||27
953167|NCT00091832|2301879|P4|COMPLETED|Overall Study||29
953168|NCT00091832|2301880|P3|COMPLETED|Overall Study||30
953169|NCT00091832|2301881|P2|COMPLETED|Overall Study||31
953170|NCT00091832|2301882|P1|COMPLETED|Overall Study||29
953171|NCT00091832|2301877|P6|Received Study Medication|Overall Study||43
953172|NCT00091832|2301878|P5|Received Study Medication|Overall Study||42
953173|NCT00091832|2301879|P4|Received Study Medication|Overall Study||43
953174|NCT00091832|2301880|P3|Received Study Medication|Overall Study||41
953175|NCT00091832|2301881|P2|Received Study Medication|Overall Study||42
953176|NCT00091832|2301882|P1|Received Study Medication|Overall Study||43
953177|NCT00091832|2301877|P6|STARTED|Overall Study||43
953178|NCT00091832|2301878|P5|STARTED|Overall Study||42
953179|NCT00091832|2301879|P4|STARTED|Overall Study||43
953180|NCT00091832|2301880|P3|STARTED|Overall Study||42
953181|NCT00091832|2301881|P2|STARTED|Overall Study||42
953182|NCT00091832|2301882|P1|STARTED|Overall Study||43
953183|NCT00103207|2301998|P1|NOT COMPLETED|Overall Study||38
953184|NCT00103207|2301998|P1|COMPLETED|Overall Study||34
953185|NCT00103207|2301998|P1|Eligible Patients w/ Smoking Status Data|Overall Study||37
953186|NCT00103207|2301998|P1|Eligible Patients w/ Confirmed Diagnosis|Overall Study||41
953187|NCT00103207|2301998|P1|STARTED|Overall Study||72
953188|NCT00103259|2302010|P2|NOT COMPLETED|Overall Study||12
953189|NCT00103259|2302011|P1|NOT COMPLETED|Overall Study||12
953190|NCT00103259|2302010|P2|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.This number is for stage I.|32
953191|NCT00103259|2302011|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|15
953192|NCT00103259|2302010|P2|Eligible Patients Who Cross Over|Overall Study||10
953193|NCT00103259|2302011|P1|Eligible Patients Who Cross Over|Overall Study||0
953194|NCT00103259|2302010|P2|Cross Over to the Other Arm|Overall Study|11 patients who progressed on bortezomib crossed over to Arm I. 10 of them were eligible|11
953195|NCT00103259|2302011|P1|Cross Over to the Other Arm|Overall Study||0
953196|NCT00103259|2302010|P2|Eligible and Treated|Overall Study||38
953197|NCT00103259|2302011|P1|Eligible and Treated|Overall Study||23
953198|NCT00103259|2302010|P2|Treated|Overall Study||41
953199|NCT00103259|2302011|P1|Treated|Overall Study||23
953200|NCT00103259|2302010|P2|Eligible|Overall Study||41
953201|NCT00103259|2302011|P1|Eligible|Overall Study||27
953202|NCT00103259|2302010|P2|STARTED|Overall Study||44
953203|NCT00103259|2302011|P1|STARTED|Overall Study||27
953204|NCT00103311|2302025|P2|NOT COMPLETED|Overall Study||1
953205|NCT00103311|2302026|P1|NOT COMPLETED|Overall Study||4
953206|NCT00103311|2302025|P2|COMPLETED|Overall Study||30
953207|NCT00103311|2302026|P1|COMPLETED|Overall Study||29
953208|NCT00103311|2302025|P2|STARTED|Overall Study||31
953209|NCT00103311|2302026|P1|STARTED|Overall Study||33
953210|NCT00103506|2302038|P2|NOT COMPLETED|Overall Study||324
953211|NCT00103506|2302039|P1|NOT COMPLETED|Overall Study||322
953212|NCT00103506|2302038|P2|COMPLETED|Overall Study||0
953213|NCT00103506|2302039|P1|COMPLETED|Overall Study||0
953214|NCT00103506|2302038|P2|STARTED|Overall Study||324
953215|NCT00103506|2302039|P1|STARTED|Overall Study||322
953216|NCT00105534|2302051|P2|NOT COMPLETED|Overall Study||33
953217|NCT00105534|2302052|P1|NOT COMPLETED|Overall Study||22
953218|NCT00105534|2302051|P2|COMPLETED|Overall Study||317
953219|NCT00105534|2302052|P1|COMPLETED|Overall Study||313
953220|NCT00105534|2302051|P2|STARTED|Overall Study||350
953221|NCT00105534|2302052|P1|STARTED|Overall Study||335
953225|NCT00105586|2302082|P2|NOT COMPLETED|Overall Study||16
953226|NCT00105586|2302083|P1|NOT COMPLETED|Overall Study||17
953227|NCT00105586|2302082|P2|COMPLETED|Overall Study||69
953228|NCT00105586|2302083|P1|COMPLETED|Overall Study||75
953229|NCT00105586|2302082|P2|STARTED|Overall Study||85
953230|NCT00105586|2302083|P1|STARTED|Overall Study||92
953231|NCT00105989|2302091|P2|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||69
953232|NCT00105989|2302092|P1|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||50
953233|NCT00105989|2302091|P2|COMPLETED|Maintenance - Double-Blind:Week 34-86||73
953234|NCT00105989|2302092|P1|COMPLETED|Maintenance - Double-Blind:Week 34-86||96
953235|NCT00105989|2302091|P2|STARTED|Maintenance - Double-Blind:Week 34-86||142
953236|NCT00105989|2302092|P1|STARTED|Maintenance - Double-Blind:Week 34-86||146
953237|NCT00105989|2302091|P2|NOT COMPLETED|Continuation - Open Label:Week 10-34||0
953238|NCT00105989|2302092|P1|NOT COMPLETED|Continuation - Open Label:Week 10-34||125
953239|NCT00105989|2302091|P2|COMPLETED|Continuation - Open Label:Week 10-34||0
953240|NCT00105989|2302092|P1|COMPLETED|Continuation - Open Label:Week 10-34||288
953241|NCT00105989|2302091|P2|STARTED|Continuation - Open Label:Week 10-34||0
953242|NCT00105989|2302092|P1|STARTED|Continuation - Open Label:Week 10-34||413
953243|NCT00105989|2302091|P2|NOT COMPLETED|Acute - Open Label: Week 0-10||0
953244|NCT00105989|2302092|P1|NOT COMPLETED|Acute - Open Label: Week 0-10||101
953245|NCT00105989|2302091|P2|COMPLETED|Acute - Open Label: Week 0-10||0
953246|NCT00105989|2302092|P1|COMPLETED|Acute - Open Label: Week 0-10||413
953247|NCT00105989|2302091|P2|STARTED|Acute - Open Label: Week 0-10||0
953248|NCT00105989|2302092|P1|STARTED|Acute - Open Label: Week 0-10||514
953249|NCT00106002|2302206|P1|NOT COMPLETED|Overall Study||2
953250|NCT00106002|2302206|P1|COMPLETED|Overall Study|Completed means that the patient was evaluable for response.|35
953251|NCT00106002|2302206|P1|STARTED|Overall Study||37
953252|NCT00106028|2302216|P2|NOT COMPLETED|Overall Study||12
953253|NCT00106028|2302217|P1|NOT COMPLETED|Overall Study||6
953254|NCT00106028|2302216|P2|COMPLETED|Overall Study|Completed Month 36|82
953255|NCT00106028|2302217|P1|COMPLETED|Overall Study|Completed Month 36|43
953256|NCT00106028|2302216|P2|Month 12 Completed/Started Open Label|Overall Study||87
953257|NCT00106028|2302217|P1|Month 12 Completed/Started Open Label|Overall Study||49
953258|NCT00106028|2302216|P2|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|94
953259|NCT00106028|2302217|P1|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|49
953260|NCT00106080|2302313|P2|NOT COMPLETED|Overall Study||27
953261|NCT00106080|2302314|P1|NOT COMPLETED|Overall Study||43
953262|NCT00106080|2302313|P2|COMPLETED|Overall Study||155
953263|NCT00106080|2302314|P1|COMPLETED|Overall Study||151
953264|NCT00106080|2302313|P2|STARTED|Overall Study||182
953265|NCT00106080|2302314|P1|STARTED|Overall Study||194
953266|NCT00106106|2302324|P2|NOT COMPLETED|Overall Study||4
953267|NCT00106106|2302325|P1|NOT COMPLETED|Overall Study||4
953268|NCT00106106|2302324|P2|COMPLETED|Overall Study|Although 19 subjects completed all other assessments for the study, only 15 completed both MRS scans|19
953269|NCT00106106|2302325|P1|COMPLETED|Overall Study|Although 22 subjects completed all other assessments for the study, only 18 completed both MRS scans|22
953270|NCT00106106|2302324|P2|Completed Both MRS Scans|Overall Study||15
953271|NCT00106106|2302325|P1|Completed Both MRS Scans|Overall Study||18
953272|NCT00106106|2302324|P2|STARTED|Overall Study||23
953273|NCT00106106|2302325|P1|STARTED|Overall Study||26
953274|NCT00106119|2302333|P2|NOT COMPLETED|Second Intervention||0
953275|NCT00106119|2302334|P1|NOT COMPLETED|Second Intervention||0
953276|NCT00106119|2302333|P2|COMPLETED|Second Intervention||7
953277|NCT00106119|2302334|P1|COMPLETED|Second Intervention||7
953278|NCT00106119|2302333|P2|STARTED|Second Intervention||7
953279|NCT00106119|2302334|P1|STARTED|Second Intervention||7
953280|NCT00106119|2302333|P2|NOT COMPLETED|Washout Period of 30 Days||0
953281|NCT00106119|2302334|P1|NOT COMPLETED|Washout Period of 30 Days||0
953282|NCT00106119|2302333|P2|COMPLETED|Washout Period of 30 Days||7
953283|NCT00106119|2302334|P1|COMPLETED|Washout Period of 30 Days||7
953284|NCT00106119|2302333|P2|STARTED|Washout Period of 30 Days||7
953285|NCT00106119|2302334|P1|STARTED|Washout Period of 30 Days||7
953286|NCT00106119|2302333|P2|NOT COMPLETED|First Intervention||0
953287|NCT00106119|2302334|P1|NOT COMPLETED|First Intervention||0
953288|NCT00106119|2302333|P2|COMPLETED|First Intervention||7
953289|NCT00106119|2302334|P1|COMPLETED|First Intervention||7
953290|NCT00106119|2302333|P2|STARTED|First Intervention||7
953291|NCT00106119|2302334|P1|STARTED|First Intervention||7
953292|NCT00106184|2302354|P2|NOT COMPLETED|Overall Study||2
953293|NCT00106184|2302355|P1|NOT COMPLETED|Overall Study||3
953294|NCT00106184|2302354|P2|COMPLETED|Overall Study||102
953295|NCT00106184|2302355|P1|COMPLETED|Overall Study||93
953296|NCT00106184|2302354|P2|Treated|Overall Study|104 subjects were randomized.|102
953297|NCT00106184|2302355|P1|Treated|Overall Study|96 subjects were randomized.|93
953298|NCT00106184|2302354|P2|STARTED|Overall Study||104
953299|NCT00106184|2302355|P1|STARTED|Overall Study||96
953300|NCT00106249|2302367|P2|NOT COMPLETED|Overall Study||2
953301|NCT00106249|2302368|P1|NOT COMPLETED|Overall Study||3
953302|NCT00106249|2302367|P2|COMPLETED|Overall Study||11
953303|NCT00106249|2302368|P1|COMPLETED|Overall Study||11
953304|NCT00106249|2302367|P2|STARTED|Overall Study||13
953305|NCT00106249|2302368|P1|STARTED|Overall Study||14
953306|NCT00106353|2302380|P7|NOT COMPLETED|Part 2||16
953307|NCT00106353|2302381|P6|NOT COMPLETED|Part 2||18
953308|NCT00106353|2302382|P5|NOT COMPLETED|Part 2||16
953309|NCT00106353|2302383|P4|NOT COMPLETED|Part 2||0
953310|NCT00106353|2302384|P3|NOT COMPLETED|Part 2||0
953311|NCT00106353|2302385|P2|NOT COMPLETED|Part 2||0
953312|NCT00106353|2302386|P1|NOT COMPLETED|Part 2||0
953313|NCT00106353|2302380|P7|COMPLETED|Part 2||0
953314|NCT00106353|2302381|P6|COMPLETED|Part 2||1
953315|NCT00106353|2302382|P5|COMPLETED|Part 2||1
953316|NCT00106353|2302383|P4|COMPLETED|Part 2||0
953317|NCT00106353|2302384|P3|COMPLETED|Part 2||0
953318|NCT00106353|2302385|P2|COMPLETED|Part 2||0
953319|NCT00106353|2302386|P1|COMPLETED|Part 2||0
953320|NCT00106353|2302380|P7|STARTED|Part 2||16
953321|NCT00106353|2302381|P6|STARTED|Part 2||19
953322|NCT00106353|2302382|P5|STARTED|Part 2||17
953323|NCT00106353|2302383|P4|STARTED|Part 2||0
953324|NCT00106353|2302384|P3|STARTED|Part 2||0
953325|NCT00106353|2302385|P2|STARTED|Part 2||0
953326|NCT00106353|2302386|P1|STARTED|Part 2||0
953327|NCT00106353|2302380|P7|NOT COMPLETED|Part 1||0
953328|NCT00106353|2302381|P6|NOT COMPLETED|Part 1||0
953329|NCT00106353|2302382|P5|NOT COMPLETED|Part 1||0
953330|NCT00106353|2302383|P4|NOT COMPLETED|Part 1||7
953331|NCT00106353|2302384|P3|NOT COMPLETED|Part 1||3
953332|NCT00106353|2302385|P2|NOT COMPLETED|Part 1||5
953333|NCT00106353|2302386|P1|NOT COMPLETED|Part 1||4
953334|NCT00106353|2302380|P7|COMPLETED|Part 1||0
953335|NCT00106353|2302381|P6|COMPLETED|Part 1||0
953336|NCT00106353|2302382|P5|COMPLETED|Part 1||0
953337|NCT00106353|2302383|P4|COMPLETED|Part 1||0
953338|NCT00106353|2302384|P3|COMPLETED|Part 1||0
953339|NCT00106353|2302385|P2|COMPLETED|Part 1||0
953340|NCT00106353|2302386|P1|COMPLETED|Part 1||0
953341|NCT00106353|2302380|P7|STARTED|Part 1||0
953342|NCT00106353|2302381|P6|STARTED|Part 1||0
953343|NCT00106353|2302382|P5|STARTED|Part 1||0
953344|NCT00106353|2302383|P4|STARTED|Part 1||7
953345|NCT00106353|2302384|P3|STARTED|Part 1||3
953346|NCT00106353|2302385|P2|STARTED|Part 1||5
953347|NCT00106353|2302386|P1|STARTED|Part 1||4
953348|NCT00106392|2302513|P2|NOT COMPLETED|Overall Study||27
953349|NCT00106392|2302514|P1|NOT COMPLETED|Overall Study||26
953350|NCT00106392|2302513|P2|COMPLETED|Overall Study||42
953351|NCT00106392|2302514|P1|COMPLETED|Overall Study||36
953352|NCT00106392|2302513|P2|Full Analysis Set (FAS)|Overall Study||61
953353|NCT00106392|2302514|P1|Full Analysis Set (FAS)|Overall Study||53
953354|NCT00106392|2302513|P2|Baseline Participants|Overall Study|4 patients withdrew: all prior to surgery and study drug|65
953355|NCT00106392|2302514|P1|Baseline Participants|Overall Study|3 patients withdrew: 2 prior to surgery and study drug; 1 took study drug but did not have surgery|59
953356|NCT00106392|2302513|P2|STARTED|Overall Study||69
953357|NCT00106392|2302514|P1|STARTED|Overall Study||62
953358|NCT00106431|2302530|P1|NOT COMPLETED|Overall Study||65
953359|NCT00106431|2302530|P1|COMPLETED|Overall Study|37 represents the number of patients who reached at least 6 months treatment|37
953360|NCT00106431|2302530|P1|STARTED|Overall Study||102
953361|NCT00106535|2302543|P4|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||190
953362|NCT00106535|2302544|P3|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
953363|NCT00106535|2302545|P2|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
953364|NCT00106535|2302546|P1|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
953365|NCT00106535|2302543|P4|COMPLETED|Long-term Extension Period (Year 3 to 5)|Completed the study.|704
953366|NCT00106535|2302544|P3|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
953367|NCT00106535|2302545|P2|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
953368|NCT00106535|2302546|P1|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
953369|NCT00106535|2302543|P4|STARTED|Long-term Extension Period (Year 3 to 5)|Entered the Long-term Extension.|894
953370|NCT00106535|2302544|P3|STARTED|Long-term Extension Period (Year 3 to 5)||0
953371|NCT00106535|2302545|P2|STARTED|Long-term Extension Period (Year 3 to 5)||0
953372|NCT00106535|2302546|P1|STARTED|Long-term Extension Period (Year 3 to 5)||0
953373|NCT00106535|2302543|P4|NOT COMPLETED|2-year Placebo Controlled Period||0
953374|NCT00106535|2302544|P3|NOT COMPLETED|2-year Placebo Controlled Period||91
953375|NCT00106535|2302545|P2|NOT COMPLETED|2-year Placebo Controlled Period||92
953376|NCT00106535|2302546|P1|NOT COMPLETED|2-year Placebo Controlled Period||107
953377|NCT00106535|2302543|P4|COMPLETED|2-year Placebo Controlled Period||0
953378|NCT00106535|2302544|P3|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 306 participants randomized to the TCZ 8 mg/kg arm entered the LTE period.|310
953379|NCT00106535|2302545|P2|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 304 participants randomized to the TCZ 4 mg/kg arm entered the LTE period.|309
953380|NCT00106535|2302546|P1|COMPLETED|2-year Placebo Controlled Period|Completed Week 104 (Year 2). 284 participants randomized to the Placebo arm entered the LTE period.|287
953381|NCT00106535|2302543|P4|Completed Week 52|2-year Placebo Controlled Period||0
953382|NCT00106535|2302544|P3|Completed Week 52|2-year Placebo Controlled Period||338
953383|NCT00106535|2302545|P2|Completed Week 52|2-year Placebo Controlled Period||342
953384|NCT00106535|2302546|P1|Completed Week 52|2-year Placebo Controlled Period||326
953385|NCT00106535|2302543|P4|Completed Week 24|2-year Placebo Controlled Period||0
953386|NCT00106535|2302544|P3|Completed Week 24|2-year Placebo Controlled Period||366
953387|NCT00106535|2302545|P2|Completed Week 24|2-year Placebo Controlled Period||373
953388|NCT00106535|2302546|P1|Completed Week 24|2-year Placebo Controlled Period||356
953389|NCT00106535|2302543|P4|Safety: Actual Treatment Received|2-year Placebo Controlled Period||0
953390|NCT00106535|2302544|P3|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
953391|NCT00106535|2302545|P2|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
953392|NCT00106535|2302546|P1|Safety: Actual Treatment Received|2-year Placebo Controlled Period||392
953393|NCT00106535|2302543|P4|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||0
953394|NCT00106535|2302544|P3|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||398
953395|NCT00106535|2302545|P2|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||399
953396|NCT00106535|2302546|P1|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||393
953397|NCT00106535|2302543|P4|STARTED|2-year Placebo Controlled Period||0
953398|NCT00106535|2302544|P3|STARTED|2-year Placebo Controlled Period||401
953399|NCT00106535|2302545|P2|STARTED|2-year Placebo Controlled Period||401
953400|NCT00106535|2302546|P1|STARTED|2-year Placebo Controlled Period||394
953401|NCT00106626|2302843|P4|NOT COMPLETED|Overall Study||13
953402|NCT00106626|2302844|P3|NOT COMPLETED|Overall Study||12
953403|NCT00106626|2302845|P2|NOT COMPLETED|Overall Study||6
953404|NCT00106626|2302846|P1|NOT COMPLETED|Overall Study||10
953405|NCT00106626|2302843|P4|COMPLETED|Overall Study||3
953406|NCT00106626|2302844|P3|COMPLETED|Overall Study||2
953407|NCT00106626|2302845|P2|COMPLETED|Overall Study||3
953408|NCT00106626|2302846|P1|COMPLETED|Overall Study||3
953409|NCT00106626|2302843|P4|STARTED|Overall Study||16
953410|NCT00106626|2302844|P3|STARTED|Overall Study||14
953411|NCT00106626|2302845|P2|STARTED|Overall Study||9
953412|NCT00106626|2302846|P1|STARTED|Overall Study||13
953413|NCT00106639|2302864|P3|NOT COMPLETED|Overall Study||2
953414|NCT00106639|2302865|P2|NOT COMPLETED|Overall Study||7
953415|NCT00106639|2302866|P1|NOT COMPLETED|Overall Study||3
953416|NCT00106639|2302864|P3|COMPLETED|Overall Study||19
953417|NCT00106639|2302865|P2|COMPLETED|Overall Study||13
953418|NCT00106639|2302866|P1|COMPLETED|Overall Study||17
953419|NCT00106639|2302864|P3|STARTED|Overall Study||21
953420|NCT00106639|2302865|P2|STARTED|Overall Study||20
953421|NCT00106639|2302866|P1|STARTED|Overall Study||20
953422|NCT00106704|2302991|P2|NOT COMPLETED|Overall Study||151
953423|NCT00106704|2302992|P1|NOT COMPLETED|Overall Study||131
953424|NCT00106704|2302991|P2|COMPLETED|Overall Study||68
953425|NCT00106704|2302992|P1|COMPLETED|Overall Study||91
953426|NCT00106704|2302991|P2|STARTED|Overall Study||219
953427|NCT00106704|2302992|P1|STARTED|Overall Study||222
953428|NCT00106938|2303002|P2|NOT COMPLETED|Overall Study||71
953429|NCT00106938|2303003|P1|NOT COMPLETED|Overall Study||176
953430|NCT00106938|2303002|P2|COMPLETED|Overall Study||293
953431|NCT00106938|2303003|P1|COMPLETED|Overall Study||913
953432|NCT00106938|2303002|P2|STARTED|Overall Study||364
953433|NCT00106938|2303003|P1|STARTED|Overall Study||1089
953434|NCT00106964|2303073|P3|NOT COMPLETED|Overall Study||7
953435|NCT00106964|2303074|P2|NOT COMPLETED|Overall Study||15
953436|NCT00106964|2303075|P1|NOT COMPLETED|Overall Study||13
953437|NCT00106964|2303073|P3|COMPLETED|Overall Study|The number of those who completed the vaccine series was 120.|120
953438|NCT00106964|2303074|P2|COMPLETED|Overall Study|The number of those who completed the vaccine series was 111.|111
953439|NCT00106964|2303075|P1|COMPLETED|Overall Study|The number of those those who completed the vaccine series was 105.|105
953440|NCT00106964|2303073|P3|STARTED|Overall Study||127
953441|NCT00106964|2303074|P2|STARTED|Overall Study||126
953442|NCT00106964|2303075|P1|STARTED|Overall Study||118
953443|NCT00107042|2303100|P2|NOT COMPLETED|Overall Study||16
953444|NCT00107042|2303101|P1|NOT COMPLETED|Overall Study||22
953445|NCT00107042|2303100|P2|COMPLETED|Overall Study||47
953446|NCT00107042|2303101|P1|COMPLETED|Overall Study||38
953447|NCT00107042|2303100|P2|STARTED|Overall Study||63
953448|NCT00107042|2303101|P1|STARTED|Overall Study||60
953449|NCT00107120|2303166|P2|NOT COMPLETED|Overall Study||24
953450|NCT00107120|2303167|P1|NOT COMPLETED|Overall Study||29
953451|NCT00107120|2303166|P2|COMPLETED|Overall Study||133
953452|NCT00107120|2303167|P1|COMPLETED|Overall Study||126
953453|NCT00107120|2303166|P2|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|157
953454|NCT00107120|2303167|P1|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|155
953455|NCT00107172|2303179|P2|NOT COMPLETED|Overall Study||5
953456|NCT00107172|2303180|P1|NOT COMPLETED|Overall Study||5
953457|NCT00107172|2303179|P2|COMPLETED|Overall Study||103
953458|NCT00107172|2303180|P1|COMPLETED|Overall Study||109
953459|NCT00107172|2303179|P2|STARTED|Overall Study||108
953460|NCT00107172|2303180|P1|STARTED|Overall Study||114
953461|NCT00107198|2303208|P1|NOT COMPLETED|Overall Study||52
953462|NCT00107198|2303208|P1|COMPLETED|Overall Study||136
953463|NCT00107198|2303208|P1|STARTED|Overall Study||188
953464|NCT00107276|2303216|P1|NOT COMPLETED|Overall Study||72
953465|NCT00107276|2303216|P1|COMPLETED|Overall Study||40
953466|NCT00107276|2303216|P1|Eligible|Overall Study||96
953467|NCT00107276|2303216|P1|STARTED|Overall Study||112
953468|NCT00107315|2303222|P1|NOT COMPLETED|Overall Study||15
953469|NCT00107315|2303222|P1|COMPLETED|Overall Study||1
953470|NCT00107315|2303222|P1|STARTED|Overall Study||16
953471|NCT00107380|2303229|P1|NOT COMPLETED|Overall Study||30
953472|NCT00107380|2303229|P1|COMPLETED|Overall Study||56
953473|NCT00107380|2303229|P1|Eligible|Overall Study||84
953474|NCT00107380|2303229|P1|STARTED|Overall Study||86
953475|NCT00107536|2303235|P1|NOT COMPLETED|Overall Study||0
953476|NCT00107536|2303235|P1|COMPLETED|Overall Study||26
953477|NCT00107536|2303235|P1|STARTED|Overall Study||26
953478|NCT00107575|2303247|P2|NOT COMPLETED|Overall Study||10
953479|NCT00107575|2303248|P1|NOT COMPLETED|Overall Study||11
953480|NCT00107575|2303247|P2|COMPLETED|Overall Study||107
953481|NCT00107575|2303248|P1|COMPLETED|Overall Study||108
953482|NCT00107575|2303247|P2|STARTED|Overall Study||117
953483|NCT00107575|2303248|P1|STARTED|Overall Study||119
953484|NCT00107614|2303262|P1|NOT COMPLETED|Overall Study||12
953485|NCT00107614|2303262|P1|COMPLETED|Overall Study||0
953486|NCT00107614|2303262|P1|STARTED|Overall Study||12
953487|NCT00107653|2303268|P2|NOT COMPLETED|Overall Study||76
953488|NCT00107653|2303269|P1|NOT COMPLETED|Overall Study||79
953489|NCT00107653|2303268|P2|COMPLETED|Overall Study||224
953490|NCT00107653|2303269|P1|COMPLETED|Overall Study||190
953491|NCT00107653|2303268|P2|STARTED|Overall Study||300
953492|NCT00107653|2303269|P1|STARTED|Overall Study||269
953493|NCT00107783|2303317|P2|NOT COMPLETED|Overall Study||4
953494|NCT00107783|2303318|P1|NOT COMPLETED|Overall Study||3
953495|NCT00107783|2303317|P2|COMPLETED|Overall Study||16
953496|NCT00107783|2303318|P1|COMPLETED|Overall Study||17
953497|NCT00107783|2303317|P2|STARTED|Overall Study||20
953498|NCT00107783|2303318|P1|STARTED|Overall Study||20
953499|NCT00107900|2303338|P6|NOT COMPLETED|Overall Study||9
953500|NCT00107900|2303339|P5|NOT COMPLETED|Overall Study||21
953501|NCT00107900|2303340|P4|NOT COMPLETED|Overall Study||12
953502|NCT00107900|2303341|P3|NOT COMPLETED|Overall Study||25
953503|NCT00107900|2303342|P2|NOT COMPLETED|Overall Study||3
953504|NCT00107900|2303343|P1|NOT COMPLETED|Overall Study||10
953505|NCT00107900|2303338|P6|COMPLETED|Overall Study||94
953506|NCT00107900|2303339|P5|COMPLETED|Overall Study||94
953507|NCT00107900|2303340|P4|COMPLETED|Overall Study||87
953508|NCT00107900|2303341|P3|COMPLETED|Overall Study||104
953509|NCT00107900|2303342|P2|COMPLETED|Overall Study||72
953510|NCT00107900|2303343|P1|COMPLETED|Overall Study||75
953511|NCT00107900|2303338|P6|STARTED|Overall Study||103
953512|NCT00107900|2303339|P5|STARTED|Overall Study||115
953513|NCT00107900|2303340|P4|STARTED|Overall Study||99
953514|NCT00107900|2303341|P3|STARTED|Overall Study||129
953515|NCT00107900|2303342|P2|STARTED|Overall Study||75
953516|NCT00107900|2303343|P1|STARTED|Overall Study||85
953517|NCT00107952|2303377|P2|NOT COMPLETED|Overall Study||81
953518|NCT00107952|2303378|P1|NOT COMPLETED|Overall Study||95
953519|NCT00107952|2303377|P2|COMPLETED|Overall Study||299
953520|NCT00107952|2303378|P1|COMPLETED|Overall Study||286
953521|NCT00107952|2303377|P2|STARTED|Overall Study||380
953522|NCT00107952|2303378|P1|STARTED|Overall Study||381
953523|NCT00107978|2303386|P2|NOT COMPLETED|Overall Study||50
953524|NCT00107978|2303387|P1|NOT COMPLETED|Overall Study||33
953525|NCT00107978|2303386|P2|COMPLETED|Overall Study||431
953526|NCT00107978|2303387|P1|COMPLETED|Overall Study||425
953527|NCT00107978|2303386|P2|STARTED|Overall Study||481
953528|NCT00107978|2303387|P1|STARTED|Overall Study||458
953529|NCT00107991|2303393|P1|NOT COMPLETED|18-Week Post Treatment Assessment||2
953530|NCT00107991|2303393|P1|COMPLETED|18-Week Post Treatment Assessment||8
953531|NCT00107991|2303393|P1|STARTED|18-Week Post Treatment Assessment||10
953532|NCT00107991|2303393|P1|NOT COMPLETED|12 Week Treatment Period||5
953533|NCT00107991|2303393|P1|COMPLETED|12 Week Treatment Period||10
953534|NCT00107991|2303393|P1|STARTED|12 Week Treatment Period||15
953535|NCT00107991|2303393|P1|NOT COMPLETED|Eligibility Assessment||23
953536|NCT00107991|2303393|P1|COMPLETED|Eligibility Assessment||15
953537|NCT00107991|2303393|P1|STARTED|Eligibility Assessment||38
953538|NCT00108069|2303403|P2|NOT COMPLETED|Overall Study||13
953539|NCT00108069|2303404|P1|NOT COMPLETED|Overall Study||30
953540|NCT00108069|2303403|P2|COMPLETED|Overall Study||0
953541|NCT00108069|2303404|P1|COMPLETED|Overall Study||0
953542|NCT00108069|2303403|P2|STARTED|Overall Study||13
953543|NCT00108069|2303404|P1|STARTED|Overall Study||30
953544|NCT00108082|2303421|P3|NOT COMPLETED|Overall Study||43
953545|NCT00108082|2303422|P2|NOT COMPLETED|Overall Study||32
953546|NCT00108082|2303423|P1|NOT COMPLETED|Overall Study||38
953547|NCT00108082|2303421|P3|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
953548|NCT00108082|2303422|P2|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|68
953549|NCT00108082|2303423|P1|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
953550|NCT00108082|2303421|P3|STARTED|Overall Study||96
953551|NCT00108082|2303422|P2|STARTED|Overall Study||100
953552|NCT00108082|2303423|P1|STARTED|Overall Study||91
953553|NCT00108160|2303472|P2|NOT COMPLETED|Overall Study||21
953554|NCT00108160|2303473|P1|NOT COMPLETED|Overall Study||39
953555|NCT00108160|2303472|P2|COMPLETED|Overall Study|Participants who completed 18 months of placebo or developed new (recurrent) S. aureus infection.|42
953556|NCT00108160|2303473|P1|COMPLETED|Overall Study|Patients who completed 18 months of mupirocin or developed new (recurrent) S. aureus infection.|44
953557|NCT00108160|2303472|P2|Completed Visit 7 (18 mo)|Overall Study||31
953558|NCT00108160|2303473|P1|Completed Visit 7 (18 mo)|Overall Study||34
953559|NCT00108160|2303472|P2|Completed Visit 6 (15 mo)|Overall Study||33
953560|NCT00108160|2303473|P1|Completed Visit 6 (15 mo)|Overall Study||36
953561|NCT00108160|2303472|P2|Completed Visit 5 (12 mo)|Overall Study||37
953562|NCT00108160|2303473|P1|Completed Visit 5 (12 mo)|Overall Study||37
953563|NCT00108160|2303472|P2|Completed Visit 4 (9 mo)|Overall Study||37
953564|NCT00108160|2303473|P1|Completed Visit 4 (9 mo)|Overall Study||38
953565|NCT00108160|2303472|P2|Completed Visit 3 (6 mo)|Overall Study||38
953566|NCT00108160|2303473|P1|Completed Visit 3 (6 mo)|Overall Study||44
953567|NCT00108160|2303472|P2|Completed Visit 2 (3 mo)|Overall Study||46
953568|NCT00108160|2303473|P1|Completed Visit 2 (3 mo)|Overall Study||54
953569|NCT00108160|2303472|P2|Completed Visit 1 (2 Wks)|Overall Study||54
953570|NCT00108160|2303473|P1|Completed Visit 1 (2 Wks)|Overall Study||72
953571|NCT00108160|2303472|P2|Completed Visit 0 (Baseline)|Overall Study|3 patients who signed a consent and were randomized did not complete the initial visit to start drug|60
953572|NCT00108160|2303473|P1|Completed Visit 0 (Baseline)|Overall Study|4 patients who signed consent and were randomized did not complete the initial visit to start drug|79
953573|NCT00108160|2303472|P2|STARTED|Overall Study||63
953574|NCT00108160|2303473|P1|STARTED|Overall Study||83
953575|NCT00108277|2303486|P3|NOT COMPLETED|Overall Study||16
953576|NCT00108277|2303487|P2|NOT COMPLETED|Overall Study||12
953577|NCT00108277|2303488|P1|NOT COMPLETED|Overall Study||10
953578|NCT00108277|2303486|P3|COMPLETED|Overall Study||19
953579|NCT00108277|2303487|P2|COMPLETED|Overall Study||16
953580|NCT00108277|2303488|P1|COMPLETED|Overall Study||19
953581|NCT00108277|2303486|P3|STARTED|Overall Study||35
953582|NCT00108277|2303487|P2|STARTED|Overall Study||28
953583|NCT00108277|2303488|P1|STARTED|Overall Study||29
953584|NCT00108303|2303499|P3|NOT COMPLETED|Overall Study||0
953585|NCT00108303|2303500|P2|NOT COMPLETED|Overall Study||0
953586|NCT00108303|2303501|P1|NOT COMPLETED|Overall Study||0
953587|NCT00108303|2303499|P3|COMPLETED|Overall Study||180
953588|NCT00108303|2303500|P2|COMPLETED|Overall Study||179
953589|NCT00108303|2303501|P1|COMPLETED|Overall Study||179
953590|NCT00108303|2303499|P3|STARTED|Overall Study||180
953591|NCT00108303|2303500|P2|STARTED|Overall Study||179
953592|NCT00108303|2303501|P1|STARTED|Overall Study||179
953593|NCT00108342|2303515|P2|NOT COMPLETED|Overall Study||0
953594|NCT00108342|2303516|P1|NOT COMPLETED|Overall Study||1
953595|NCT00108342|2303515|P2|COMPLETED|Overall Study||9
953596|NCT00108342|2303516|P1|COMPLETED|Overall Study||7
953597|NCT00108342|2303515|P2|STARTED|Overall Study||9
953598|NCT00108342|2303516|P1|STARTED|Overall Study||8
953599|NCT00108355|2303524|P2|NOT COMPLETED|Overall Study||2
953600|NCT00108355|2303525|P1|NOT COMPLETED|Overall Study||2
953601|NCT00108355|2303524|P2|COMPLETED|Overall Study||12
953602|NCT00108355|2303525|P1|COMPLETED|Overall Study||13
953603|NCT00108355|2303524|P2|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis, other loculated ascites.|14
953604|NCT00108355|2303525|P1|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis , other loculated ascites.|15
953605|NCT00108433|2303535|P2|NOT COMPLETED|Overall Study||17
953606|NCT00108433|2303536|P1|NOT COMPLETED|Overall Study||21
953607|NCT00108433|2303535|P2|COMPLETED|Overall Study||14
953608|NCT00108433|2303536|P1|COMPLETED|Overall Study||9
953609|NCT00108433|2303535|P2|STARTED|Overall Study||31
953610|NCT00108433|2303536|P1|STARTED|Overall Study||30
953611|NCT00110890|2303552|P2|NOT COMPLETED|Overall Study||179
953612|NCT00110890|2303553|P1|NOT COMPLETED|Overall Study||361
953613|NCT00110890|2303552|P2|COMPLETED|Overall Study|Follow-up Phase|5
953614|NCT00110890|2303553|P1|COMPLETED|Overall Study|Follow-up Phase|7
953615|NCT00110890|2303552|P2|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|150
953616|NCT00110890|2303553|P1|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|280
953617|NCT00110890|2303552|P2|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|170
953618|NCT00110890|2303553|P1|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|316
953619|NCT00110890|2303552|P2|STARTED|Overall Study||184
953620|NCT00110890|2303553|P1|STARTED|Overall Study||368
953621|NCT00110994|2303569|P2|NOT COMPLETED|Long Term Follow-up||17
953622|NCT00110994|2303570|P1|NOT COMPLETED|Long Term Follow-up||19
953623|NCT00110994|2303569|P2|COMPLETED|Long Term Follow-up||30
953624|NCT00110994|2303570|P1|COMPLETED|Long Term Follow-up||22
953625|NCT00110994|2303569|P2|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|47
953626|NCT00110994|2303570|P1|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|41
953627|NCT00110994|2303569|P2|NOT COMPLETED|Active Follow-up||2
953628|NCT00110994|2303570|P1|NOT COMPLETED|Active Follow-up||1
953629|NCT00110994|2303569|P2|COMPLETED|Active Follow-up||0
953630|NCT00110994|2303570|P1|COMPLETED|Active Follow-up||0
953631|NCT00110994|2303569|P2|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|2
953632|NCT00110994|2303570|P1|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|1
953633|NCT00110994|2303569|P2|NOT COMPLETED|Double-blind (DB) Treatment||47
953634|NCT00110994|2303570|P1|NOT COMPLETED|Double-blind (DB) Treatment||42
953635|NCT00110994|2303569|P2|COMPLETED|Double-blind (DB) Treatment||3
953636|NCT00110994|2303570|P1|COMPLETED|Double-blind (DB) Treatment||9
953637|NCT00110994|2303569|P2|Received Treatment|Double-blind (DB) Treatment|Safety population|50
953638|NCT00110994|2303570|P1|Received Treatment|Double-blind (DB) Treatment|Safety population|51
953639|NCT00110994|2303569|P2|STARTED|Double-blind (DB) Treatment|ITT population|50
953640|NCT00110994|2303570|P1|STARTED|Double-blind (DB) Treatment|ITT population|51
953641|NCT00111007|2303596|P2|NOT COMPLETED|Long Term Follow-up||45
953642|NCT00111007|2303597|P1|NOT COMPLETED|Long Term Follow-up||47
953643|NCT00111007|2303596|P2|COMPLETED|Long Term Follow-up||62
953644|NCT00111007|2303597|P1|COMPLETED|Long Term Follow-up||54
953645|NCT00111007|2303596|P2|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|107
953646|NCT00111007|2303597|P1|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|101
953647|NCT00111007|2303596|P2|NOT COMPLETED|Active Follow-up||2
953648|NCT00111007|2303597|P1|NOT COMPLETED|Active Follow-up||6
953649|NCT00111007|2303596|P2|COMPLETED|Active Follow-up||2
953650|NCT00111007|2303597|P1|COMPLETED|Active Follow-up||0
953651|NCT00111007|2303596|P2|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|4
953652|NCT00111007|2303597|P1|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|6
953653|NCT00111007|2303596|P2|NOT COMPLETED|Double-blind (DB) Treatment||111
953654|NCT00111007|2303597|P1|NOT COMPLETED|Double-blind (DB) Treatment||108
953655|NCT00111007|2303596|P2|COMPLETED|Double-blind (DB) Treatment||24
953656|NCT00111007|2303597|P1|COMPLETED|Double-blind (DB) Treatment||27
953657|NCT00111007|2303596|P2|Received Treatment|Double-blind (DB) Treatment|Safety population|134
953658|NCT00111007|2303597|P1|Received Treatment|Double-blind (DB) Treatment|Safety population|134
953659|NCT00111007|2303596|P2|STARTED|Double-blind (DB) Treatment|ITT population|135
953660|NCT00111007|2303597|P1|STARTED|Double-blind (DB) Treatment|ITT population|135
953661|NCT00111657|2303611|P1|NOT COMPLETED|Overall Study||16
953662|NCT00111657|2303611|P1|COMPLETED|Overall Study|Completed all intended doses.|21
953663|NCT00111657|2303611|P1|STARTED|Overall Study|37 consented. 30 initiated treatment. 29 completed at least 1 dose.|37
953664|NCT00111761|2303623|P2|NOT COMPLETED|Part 2||0
953665|NCT00111761|2303624|P1|NOT COMPLETED|Part 2||8
953666|NCT00111761|2303623|P2|COMPLETED|Part 2||0
953667|NCT00111761|2303624|P1|COMPLETED|Part 2||16
953668|NCT00111761|2303623|P2|STARTED|Part 2|This treatment group was used in Part 1 only|0
953669|NCT00111761|2303624|P1|STARTED|Part 2||24
953670|NCT00111761|2303623|P2|NOT COMPLETED|Part 1||5
953671|NCT00111761|2303624|P1|NOT COMPLETED|Part 1||0
953672|NCT00111761|2303623|P2|COMPLETED|Part 1|Completed through safety followup|14
953673|NCT00111761|2303624|P1|COMPLETED|Part 1||0
953674|NCT00111761|2303623|P2|STARTED|Part 1||19
953675|NCT00111761|2303624|P1|STARTED|Part 1|This treatment group was not initiated until Part 2|0
953676|NCT00111813|2303641|P6|NOT COMPLETED|Overall Study||6
953677|NCT00111813|2303642|P5|NOT COMPLETED|Overall Study||6
953678|NCT00111813|2303643|P4|NOT COMPLETED|Overall Study||5
953679|NCT00111813|2303644|P3|NOT COMPLETED|Overall Study||10
953680|NCT00111813|2303645|P2|NOT COMPLETED|Overall Study||3
953681|NCT00111813|2303646|P1|NOT COMPLETED|Overall Study||3
953682|NCT00111813|2303641|P6|COMPLETED|Overall Study||0
953683|NCT00111813|2303642|P5|COMPLETED|Overall Study||0
953684|NCT00111813|2303643|P4|COMPLETED|Overall Study||1
953685|NCT00111813|2303644|P3|COMPLETED|Overall Study||0
953686|NCT00111813|2303645|P2|COMPLETED|Overall Study||0
953687|NCT00111813|2303646|P1|COMPLETED|Overall Study||0
953688|NCT00111813|2303641|P6|STARTED|Overall Study||6
953689|NCT00111813|2303642|P5|STARTED|Overall Study||6
953690|NCT00111813|2303643|P4|STARTED|Overall Study||6
953691|NCT00111813|2303644|P3|STARTED|Overall Study||10
953692|NCT00111813|2303645|P2|STARTED|Overall Study||3
953693|NCT00111813|2303646|P1|STARTED|Overall Study||3
953694|NCT00111917|2303681|P2|NOT COMPLETED|Overall Study||1
953695|NCT00111917|2303682|P1|NOT COMPLETED|Overall Study||1
953696|NCT00111917|2303681|P2|COMPLETED|Overall Study||3
953697|NCT00111917|2303682|P1|COMPLETED|Overall Study||8
953698|NCT00111917|2303681|P2|STARTED|Overall Study||4
953699|NCT00111917|2303682|P1|STARTED|Overall Study||9
953700|NCT00112047|2303696|P2|NOT COMPLETED|Atripla Phase||20
953701|NCT00112047|2303697|P1|NOT COMPLETED|Atripla Phase||18
953702|NCT00112047|2303696|P2|COMPLETED|Atripla Phase||106
953703|NCT00112047|2303697|P1|COMPLETED|Atripla Phase||142
953704|NCT00112047|2303696|P2|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|126
953705|NCT00112047|2303697|P1|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|160
953706|NCT00112047|2303696|P2|NOT COMPLETED|Randomized Phase||88
953707|NCT00112047|2303697|P1|NOT COMPLETED|Randomized Phase||70
953708|NCT00112047|2303696|P2|COMPLETED|Randomized Phase||166
953709|NCT00112047|2303697|P1|COMPLETED|Randomized Phase||187
953710|NCT00112047|2303696|P2|STARTED|Randomized Phase|ITT analysis population|254
953711|NCT00112047|2303697|P1|STARTED|Randomized Phase|Intention to treat (ITT) population N=255 (2 participants had received prior antiretroviral therapy)|257
953712|NCT00112112|2303797|P2|NOT COMPLETED|Overall Study||0
953713|NCT00112112|2303798|P1|NOT COMPLETED|Overall Study||0
953714|NCT00112112|2303797|P2|COMPLETED|Overall Study||10
953715|NCT00112112|2303798|P1|COMPLETED|Overall Study||10
953716|NCT00112112|2303797|P2|STARTED|Overall Study||10
953717|NCT00112112|2303798|P1|STARTED|Overall Study||10
953718|NCT00112151|2303944|P6|NOT COMPLETED|Overall Study||3
953719|NCT00112151|2303945|P5|NOT COMPLETED|Overall Study||6
953720|NCT00112151|2303946|P4|NOT COMPLETED|Overall Study||3
953721|NCT00112151|2303947|P3|NOT COMPLETED|Overall Study||3
953722|NCT00112151|2303948|P2|NOT COMPLETED|Overall Study||5
953723|NCT00112151|2303949|P1|NOT COMPLETED|Overall Study||4
953724|NCT00112151|2303944|P6|COMPLETED|Overall Study||25
953725|NCT00112151|2303945|P5|COMPLETED|Overall Study||22
953726|NCT00112151|2303946|P4|COMPLETED|Overall Study||24
953727|NCT00112151|2303947|P3|COMPLETED|Overall Study||25
953728|NCT00112151|2303948|P2|COMPLETED|Overall Study||23
953729|NCT00112151|2303949|P1|COMPLETED|Overall Study||24
953730|NCT00112151|2303944|P6|STARTED|Overall Study||28
953731|NCT00112151|2303945|P5|STARTED|Overall Study||28
953732|NCT00112151|2303946|P4|STARTED|Overall Study||27
953733|NCT00112151|2303947|P3|STARTED|Overall Study||28
953734|NCT00112151|2303948|P2|STARTED|Overall Study||28
953735|NCT00112151|2303949|P1|STARTED|Overall Study||28
953736|NCT00112294|2303980|P2|NOT COMPLETED|Overall Study||0
953737|NCT00112294|2303981|P1|NOT COMPLETED|Overall Study||5
953738|NCT00112294|2303980|P2|COMPLETED|Overall Study|Off all study therapies.|320
953739|NCT00112294|2303981|P1|COMPLETED|Overall Study|Off all study therapies.|320
953740|NCT00112294|2303980|P2|Never Treated|Overall Study|Number by randomized group = 20, but 2 participants received C/T/C instead of T/C.|18
953741|NCT00112294|2303981|P1|Never Treated|Overall Study|Number by randomized group = 11, but 2 participants received C/T/C instead of T/C.|13
953742|NCT00112294|2303980|P2|STARTED|Overall Study|338 randomized and 320 treated.|320
953743|NCT00112294|2303981|P1|STARTED|Overall Study|338 randomized and 325 treated.|325
953744|NCT00112359|2304021|P2|NOT COMPLETED|Overall Study||13
953745|NCT00112359|2304022|P1|NOT COMPLETED|Overall Study||27
953746|NCT00112359|2304021|P2|COMPLETED|Overall Study||67
953747|NCT00112359|2304022|P1|COMPLETED|Overall Study||57
953748|NCT00112359|2304021|P2|STARTED|Overall Study||80
953749|NCT00112359|2304022|P1|STARTED|Overall Study||84
953750|NCT00112385|2304048|P2|NOT COMPLETED|Overall Study||1
953751|NCT00112385|2304049|P1|NOT COMPLETED|Overall Study||1
953752|NCT00112385|2304048|P2|COMPLETED|Overall Study||4
953753|NCT00112385|2304049|P1|COMPLETED|Overall Study||10
953754|NCT00112385|2304048|P2|STARTED|Overall Study||5
953755|NCT00112385|2304049|P1|STARTED|Overall Study||11
953756|NCT00112437|2304142|P15|NOT COMPLETED|12 Month Extension (Year 3)||1
953757|NCT00112437|2304143|P14|NOT COMPLETED|12 Month Extension (Year 3)||2
953758|NCT00112437|2304144|P13|NOT COMPLETED|12 Month Extension (Year 3)||1
953759|NCT00112437|2304145|P12|NOT COMPLETED|12 Month Extension (Year 3)||3
953760|NCT00112437|2304146|P11|NOT COMPLETED|12 Month Extension (Year 3)||4
953761|NCT00112437|2304147|P10|NOT COMPLETED|12 Month Extension (Year 3)||1
953762|NCT00112437|2304148|P9|NOT COMPLETED|12 Month Extension (Year 3)||1
953763|NCT00112437|2304149|P8|NOT COMPLETED|12 Month Extension (Year 3)||0
953764|NCT00112437|2304150|P7|NOT COMPLETED|12 Month Extension (Year 3)||5
953765|NCT00112437|2304151|P6|NOT COMPLETED|12 Month Extension (Year 3)||2
953766|NCT00112437|2304152|P5|NOT COMPLETED|12 Month Extension (Year 3)||0
953767|NCT00112437|2304153|P4|NOT COMPLETED|12 Month Extension (Year 3)||0
953768|NCT00112437|2304154|P3|NOT COMPLETED|12 Month Extension (Year 3)||0
953769|NCT00112437|2304155|P2|NOT COMPLETED|12 Month Extension (Year 3)||0
953770|NCT00112437|2304156|P1|NOT COMPLETED|12 Month Extension (Year 3)||0
953771|NCT00112437|2304142|P15|COMPLETED|12 Month Extension (Year 3)||19
953772|NCT00112437|2304143|P14|COMPLETED|12 Month Extension (Year 3)||16
953773|NCT00112437|2304144|P13|COMPLETED|12 Month Extension (Year 3)||20
953774|NCT00112437|2304145|P12|COMPLETED|12 Month Extension (Year 3)||16
953775|NCT00112437|2304146|P11|COMPLETED|12 Month Extension (Year 3)||13
953776|NCT00112437|2304147|P10|COMPLETED|12 Month Extension (Year 3)||17
953777|NCT00112437|2304148|P9|COMPLETED|12 Month Extension (Year 3)||16
953778|NCT00112437|2304149|P8|COMPLETED|12 Month Extension (Year 3)||18
953779|NCT00112437|2304150|P7|COMPLETED|12 Month Extension (Year 3)||17
953780|NCT00112437|2304151|P6|COMPLETED|12 Month Extension (Year 3)||17
953781|NCT00112437|2304152|P5|COMPLETED|12 Month Extension (Year 3)||0
953782|NCT00112437|2304153|P4|COMPLETED|12 Month Extension (Year 3)||0
953783|NCT00112437|2304154|P3|COMPLETED|12 Month Extension (Year 3)||0
953784|NCT00112437|2304155|P2|COMPLETED|12 Month Extension (Year 3)||0
953785|NCT00112437|2304156|P1|COMPLETED|12 Month Extension (Year 3)||0
953786|NCT00112437|2304142|P15|STARTED|12 Month Extension (Year 3)||20
953787|NCT00112437|2304143|P14|STARTED|12 Month Extension (Year 3)||18
953788|NCT00112437|2304144|P13|STARTED|12 Month Extension (Year 3)||21
953789|NCT00112437|2304145|P12|STARTED|12 Month Extension (Year 3)||19
953790|NCT00112437|2304146|P11|STARTED|12 Month Extension (Year 3)||17
953791|NCT00112437|2304147|P10|STARTED|12 Month Extension (Year 3)||18
953792|NCT00112437|2304148|P9|STARTED|12 Month Extension (Year 3)||17
953793|NCT00112437|2304149|P8|STARTED|12 Month Extension (Year 3)||18
953794|NCT00112437|2304150|P7|STARTED|12 Month Extension (Year 3)||22
953795|NCT00112437|2304151|P6|STARTED|12 Month Extension (Year 3)||19
953796|NCT00112437|2304152|P5|STARTED|12 Month Extension (Year 3)||0
953797|NCT00112437|2304153|P4|STARTED|12 Month Extension (Year 3)||0
953798|NCT00112437|2304154|P3|STARTED|12 Month Extension (Year 3)||0
953799|NCT00112437|2304155|P2|STARTED|12 Month Extension (Year 3)||0
953800|NCT00112437|2304156|P1|STARTED|12 Month Extension (Year 3)||0
953801|NCT00112437|2304142|P15|NOT COMPLETED|12 Month Extension||0
953802|NCT00112437|2304143|P14|NOT COMPLETED|12 Month Extension||0
953803|NCT00112437|2304144|P13|NOT COMPLETED|12 Month Extension||0
953804|NCT00112437|2304145|P12|NOT COMPLETED|12 Month Extension||0
953805|NCT00112437|2304146|P11|NOT COMPLETED|12 Month Extension||0
953806|NCT00112437|2304147|P10|NOT COMPLETED|12 Month Extension||0
953807|NCT00112437|2304148|P9|NOT COMPLETED|12 Month Extension||0
953808|NCT00112437|2304149|P8|NOT COMPLETED|12 Month Extension||0
953809|NCT00112437|2304150|P7|NOT COMPLETED|12 Month Extension||0
953810|NCT00112437|2304151|P6|NOT COMPLETED|12 Month Extension||0
953811|NCT00112437|2304152|P5|NOT COMPLETED|12 Month Extension||13
953812|NCT00112437|2304153|P4|NOT COMPLETED|12 Month Extension||7
953813|NCT00112437|2304154|P3|NOT COMPLETED|12 Month Extension||8
953814|NCT00112437|2304155|P2|NOT COMPLETED|12 Month Extension||9
953815|NCT00112437|2304156|P1|NOT COMPLETED|12 Month Extension||3
953816|NCT00112437|2304142|P15|COMPLETED|12 Month Extension||0
953817|NCT00112437|2304143|P14|COMPLETED|12 Month Extension||0
953818|NCT00112437|2304144|P13|COMPLETED|12 Month Extension||0
953819|NCT00112437|2304145|P12|COMPLETED|12 Month Extension||0
953820|NCT00112437|2304146|P11|COMPLETED|12 Month Extension||0
953821|NCT00112437|2304147|P10|COMPLETED|12 Month Extension||0
953822|NCT00112437|2304148|P9|COMPLETED|12 Month Extension||0
953823|NCT00112437|2304149|P8|COMPLETED|12 Month Extension||0
953824|NCT00112437|2304150|P7|COMPLETED|12 Month Extension||0
953825|NCT00112437|2304151|P6|COMPLETED|12 Month Extension||0
953826|NCT00112437|2304152|P5|COMPLETED|12 Month Extension||50
953827|NCT00112437|2304153|P4|COMPLETED|12 Month Extension||62
953828|NCT00112437|2304154|P3|COMPLETED|12 Month Extension||55
953829|NCT00112437|2304155|P2|COMPLETED|12 Month Extension||53
953830|NCT00112437|2304156|P1|COMPLETED|12 Month Extension||60
953831|NCT00112437|2304142|P15|STARTED|12 Month Extension||0
953832|NCT00112437|2304143|P14|STARTED|12 Month Extension||0
953833|NCT00112437|2304144|P13|STARTED|12 Month Extension||0
953834|NCT00112437|2304145|P12|STARTED|12 Month Extension||0
953835|NCT00112437|2304146|P11|STARTED|12 Month Extension||0
953836|NCT00112437|2304147|P10|STARTED|12 Month Extension||0
953837|NCT00112437|2304148|P9|STARTED|12 Month Extension||0
953838|NCT00112437|2304149|P8|STARTED|12 Month Extension||0
953839|NCT00112437|2304150|P7|STARTED|12 Month Extension||0
953840|NCT00112437|2304151|P6|STARTED|12 Month Extension||0
953841|NCT00112437|2304152|P5|STARTED|12 Month Extension||63
953842|NCT00112437|2304153|P4|STARTED|12 Month Extension||69
953843|NCT00112437|2304154|P3|STARTED|12 Month Extension||63
953844|NCT00112437|2304155|P2|STARTED|12 Month Extension||62
953845|NCT00112437|2304156|P1|STARTED|12 Month Extension||63
953846|NCT00112437|2304142|P15|NOT COMPLETED|12 Month Base Study||0
953847|NCT00112437|2304143|P14|NOT COMPLETED|12 Month Base Study||0
953848|NCT00112437|2304144|P13|NOT COMPLETED|12 Month Base Study||0
953849|NCT00112437|2304145|P12|NOT COMPLETED|12 Month Base Study||0
953850|NCT00112437|2304146|P11|NOT COMPLETED|12 Month Base Study||0
953851|NCT00112437|2304147|P10|NOT COMPLETED|12 Month Base Study||0
953852|NCT00112437|2304148|P9|NOT COMPLETED|12 Month Base Study||0
953853|NCT00112437|2304149|P8|NOT COMPLETED|12 Month Base Study||0
953854|NCT00112437|2304150|P7|NOT COMPLETED|12 Month Base Study||0
953855|NCT00112437|2304151|P6|NOT COMPLETED|12 Month Base Study||0
953856|NCT00112437|2304152|P5|NOT COMPLETED|12 Month Base Study||12
953857|NCT00112437|2304153|P4|NOT COMPLETED|12 Month Base Study||8
953858|NCT00112437|2304154|P3|NOT COMPLETED|12 Month Base Study||12
953859|NCT00112437|2304155|P2|NOT COMPLETED|12 Month Base Study||18
953860|NCT00112437|2304156|P1|NOT COMPLETED|12 Month Base Study||15
953861|NCT00112437|2304142|P15|COMPLETED|12 Month Base Study||0
953862|NCT00112437|2304143|P14|COMPLETED|12 Month Base Study||0
953863|NCT00112437|2304144|P13|COMPLETED|12 Month Base Study||0
953864|NCT00112437|2304145|P12|COMPLETED|12 Month Base Study||0
953865|NCT00112437|2304146|P11|COMPLETED|12 Month Base Study||0
953866|NCT00112437|2304147|P10|COMPLETED|12 Month Base Study||0
953867|NCT00112437|2304148|P9|COMPLETED|12 Month Base Study||0
953868|NCT00112437|2304149|P8|COMPLETED|12 Month Base Study||0
953869|NCT00112437|2304150|P7|COMPLETED|12 Month Base Study||0
953870|NCT00112437|2304151|P6|COMPLETED|12 Month Base Study||0
953871|NCT00112437|2304152|P5|COMPLETED|12 Month Base Study|1 patient completed the base study after Demcember 19, 2006 & is not included in the completed total|66
953872|NCT00112437|2304153|P4|COMPLETED|12 Month Base Study||71
953873|NCT00112437|2304154|P3|COMPLETED|12 Month Base Study||65
953874|NCT00112437|2304155|P2|COMPLETED|12 Month Base Study|1 patient completed the base study after Demcember 19, 2006 & is not included in the completed total|64
953875|NCT00112437|2304156|P1|COMPLETED|12 Month Base Study|1 patient completed the base study after Demcember 19, 2006 & is not included in the completed total|68
953876|NCT00112437|2304142|P15|STARTED|12 Month Base Study||0
953877|NCT00112437|2304143|P14|STARTED|12 Month Base Study||0
953878|NCT00112437|2304144|P13|STARTED|12 Month Base Study||0
953879|NCT00112437|2304145|P12|STARTED|12 Month Base Study||0
953880|NCT00112437|2304146|P11|STARTED|12 Month Base Study||0
953881|NCT00112437|2304147|P10|STARTED|12 Month Base Study||0
953882|NCT00112437|2304148|P9|STARTED|12 Month Base Study||0
953883|NCT00112437|2304149|P8|STARTED|12 Month Base Study||0
953884|NCT00112437|2304150|P7|STARTED|12 Month Base Study||0
953885|NCT00112437|2304151|P6|STARTED|12 Month Base Study||0
953886|NCT00112437|2304152|P5|STARTED|12 Month Base Study||78
953887|NCT00112437|2304153|P4|STARTED|12 Month Base Study||79
953888|NCT00112437|2304154|P3|STARTED|12 Month Base Study||77
953889|NCT00112437|2304155|P2|STARTED|12 Month Base Study||82
953890|NCT00112437|2304156|P1|STARTED|12 Month Base Study||83
953891|NCT00112463|2304413|P1|NOT COMPLETED|Overall Study||39
953892|NCT00112463|2304413|P1|COMPLETED|Overall Study||1
953893|NCT00112463|2304413|P1|STARTED|Overall Study||40
953894|NCT00112489|2304420|P1|NOT COMPLETED|Overall Study||40
953895|NCT00112489|2304420|P1|COMPLETED|Overall Study|Completed regimen due to progression|15
953896|NCT00112489|2304420|P1|STARTED|Overall Study|All patients enrolled on study|55
953897|NCT00112593|2304424|P1|NOT COMPLETED|Overall Study||0
953898|NCT00112593|2304424|P1|COMPLETED|Overall Study||5
953899|NCT00112593|2304424|P1|STARTED|Overall Study||5
953900|NCT00112671|2304433|P1|NOT COMPLETED|Overall Study||0
953901|NCT00112671|2304433|P1|COMPLETED|Overall Study||17
953902|NCT00112671|2304433|P1|STARTED|Overall Study||17
953903|NCT00112723|2304439|P3|NOT COMPLETED|Overall Study||2
953904|NCT00112723|2304440|P2|NOT COMPLETED|Overall Study||7
953905|NCT00112723|2304441|P1|NOT COMPLETED|Overall Study||2
953906|NCT00112723|2304439|P3|COMPLETED|Overall Study||12
953907|NCT00112723|2304440|P2|COMPLETED|Overall Study||12
953908|NCT00112723|2304441|P1|COMPLETED|Overall Study||11
953909|NCT00112723|2304439|P3|Patients Evaluable for Toxicity|Overall Study||12
953910|NCT00112723|2304440|P2|Patients Evaluable for Toxicity|Overall Study||12
953911|NCT00112723|2304441|P1|Patients Evaluable for Toxicity|Overall Study||11
953912|NCT00112723|2304439|P3|STARTED|Overall Study||14
953913|NCT00112723|2304440|P2|STARTED|Overall Study||19
953914|NCT00112723|2304441|P1|STARTED|Overall Study||13
953915|NCT00112736|2304469|P2|NOT COMPLETED|Overall Study||0
953916|NCT00112736|2304470|P1|NOT COMPLETED|Overall Study||1
953917|NCT00112736|2304469|P2|COMPLETED|Overall Study|12 additional pts from phase 1 study were used in analysis for Phase 2 as they were treated at MTD|47
953918|NCT00112736|2304470|P1|COMPLETED|Overall Study|12 of Phase I pts treated at MTD and hence considered part of the Phase II analysis|21
953919|NCT00112736|2304469|P2|STARTED|Overall Study||47
953920|NCT00112736|2304470|P1|STARTED|Overall Study||22
953921|NCT00112840|2304486|P3|NOT COMPLETED|Overall Study||6
953922|NCT00112840|2304487|P2|NOT COMPLETED|Overall Study||0
953923|NCT00112840|2304488|P1|NOT COMPLETED|Overall Study||2
953924|NCT00112840|2304486|P3|COMPLETED|Overall Study||40
953925|NCT00112840|2304487|P2|COMPLETED|Overall Study||6
953926|NCT00112840|2304488|P1|COMPLETED|Overall Study||6
953927|NCT00112840|2304486|P3|STARTED|Overall Study||46
953928|NCT00112840|2304487|P2|STARTED|Overall Study||6
953929|NCT00112840|2304488|P1|STARTED|Overall Study||8
953930|NCT00112866|2304506|P2|NOT COMPLETED|Overall Study||2
953931|NCT00112866|2304507|P1|NOT COMPLETED|Overall Study||2
953932|NCT00112866|2304506|P2|COMPLETED|Overall Study||13
953933|NCT00112866|2304507|P1|COMPLETED|Overall Study||13
953934|NCT00112866|2304506|P2|STARTED|Overall Study||15
953935|NCT00112866|2304507|P1|STARTED|Overall Study||15
953936|NCT00112905|2304526|P1|NOT COMPLETED|Overall Study||12
953937|NCT00112905|2304526|P1|COMPLETED|Overall Study||15
953938|NCT00112905|2304526|P1|Eligible and Treated|Overall Study||22
953939|NCT00112905|2304526|P1|STARTED|Overall Study||27
953940|NCT00112918|2304536|P3|NOT COMPLETED|Overall Study||299
953941|NCT00112918|2304537|P2|NOT COMPLETED|Overall Study||345
953942|NCT00112918|2304538|P1|NOT COMPLETED|Overall Study||297
953943|NCT00112918|2304536|P3|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|846
953944|NCT00112918|2304537|P2|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|810
953945|NCT00112918|2304538|P1|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|854
953946|NCT00112918|2304536|P3|Stage III Disease Population|Overall Study||952
953947|NCT00112918|2304537|P2|Stage III Disease Population|Overall Study||960
953948|NCT00112918|2304538|P1|Stage III Disease Population|Overall Study||955
953949|NCT00112918|2304536|P3|Received Treatment|Overall Study||1135
953950|NCT00112918|2304537|P2|Received Treatment|Overall Study|Includes two patients from FOLFOX4 who received Bv and were assigned to FOLFOX4+Bv safety analysis|1145
953951|NCT00112918|2304538|P1|Received Treatment|Overall Study||1126
953952|NCT00112918|2304536|P3|STARTED|Overall Study||1145
953953|NCT00112918|2304537|P2|STARTED|Overall Study||1155
953954|NCT00112918|2304538|P1|STARTED|Overall Study||1151
953955|NCT00113022|2304563|P2|NOT COMPLETED|Overall Study||2
953956|NCT00113022|2304564|P1|NOT COMPLETED|Overall Study||3
953957|NCT00113022|2304563|P2|COMPLETED|Overall Study||2
953958|NCT00113022|2304564|P1|COMPLETED|Overall Study||2
953959|NCT00113022|2304563|P2|STARTED|Overall Study||4
953960|NCT00113022|2304564|P1|STARTED|Overall Study||5
953961|NCT00113087|2304572|P2|NOT COMPLETED|Overall Study||21
953962|NCT00113087|2304573|P1|NOT COMPLETED|Overall Study||24
953963|NCT00113087|2304572|P2|COMPLETED|Overall Study||94
953964|NCT00113087|2304573|P1|COMPLETED|Overall Study||91
953965|NCT00113087|2304572|P2|STARTED|Overall Study||115
953966|NCT00113087|2304573|P1|STARTED|Overall Study||115
953967|NCT00113217|2304635|P1|NOT COMPLETED|Overall Study||0
953968|NCT00113217|2304635|P1|COMPLETED|Overall Study||50
953969|NCT00113217|2304635|P1|STARTED|Overall Study||50
953970|NCT00113230|2304639|P1|NOT COMPLETED|Overall Study||0
953971|NCT00113230|2304639|P1|COMPLETED|Overall Study||25
953972|NCT00113230|2304639|P1|STARTED|Overall Study||25
953973|NCT00113269|2304647|P4|NOT COMPLETED|Overall Study||40
953974|NCT00113269|2304648|P3|NOT COMPLETED|Overall Study||41
953975|NCT00113269|2304649|P2|NOT COMPLETED|Overall Study||22
953976|NCT00113269|2304650|P1|NOT COMPLETED|Overall Study||25
953977|NCT00113269|2304647|P4|COMPLETED|Overall Study||140
953978|NCT00113269|2304648|P3|COMPLETED|Overall Study||134
953979|NCT00113269|2304649|P2|COMPLETED|Overall Study||48
953980|NCT00113269|2304650|P1|COMPLETED|Overall Study||51
953981|NCT00113269|2304647|P4|Received Treatment|Overall Study||171
953982|NCT00113269|2304648|P3|Received Treatment|Overall Study||164
953983|NCT00113269|2304649|P2|Received Treatment|Overall Study||69
953984|NCT00113269|2304650|P1|Received Treatment|Overall Study||70
953985|NCT00113269|2304647|P4|STARTED|Overall Study||180
953986|NCT00113269|2304648|P3|STARTED|Overall Study||175
953987|NCT00113269|2304649|P2|STARTED|Overall Study||70
953988|NCT00113269|2304650|P1|STARTED|Overall Study||76
953989|NCT00113295|2304702|P2|NOT COMPLETED|Overall Study||1
953990|NCT00113295|2304703|P1|NOT COMPLETED|Overall Study||5
953991|NCT00113295|2304702|P2|COMPLETED|Overall Study||10
953992|NCT00113295|2304703|P1|COMPLETED|Overall Study||6
953993|NCT00113295|2304702|P2|STARTED|Overall Study||11
953994|NCT00113295|2304703|P1|STARTED|Overall Study||11
953995|NCT00113321|2304718|P1|NOT COMPLETED|Overall Study||0
953996|NCT00113321|2304718|P1|COMPLETED|Overall Study||16
953997|NCT00113321|2304718|P1|STARTED|Overall Study||16
953998|NCT00113334|2304722|P1|NOT COMPLETED|Overall Study||0
953999|NCT00113334|2304722|P1|COMPLETED|Overall Study||6
954000|NCT00113334|2304722|P1|STARTED|Overall Study||6
954001|NCT00113360|2304726|P1|NOT COMPLETED|Overall Study||7
954002|NCT00113360|2304726|P1|COMPLETED|Overall Study||60
954003|NCT00113360|2304726|P1|STARTED|Overall Study|67 participants were enrolled for screening.|67
954004|NCT00113373|2304730|P1|NOT COMPLETED|Overall Study||3
954005|NCT00113373|2304730|P1|COMPLETED|Overall Study|Eligible and treated patients.|25
954006|NCT00113373|2304730|P1|STARTED|Overall Study||28
954007|NCT00113386|2304738|P2|NOT COMPLETED|Overall Study||4
954008|NCT00113386|2304739|P1|NOT COMPLETED|Overall Study||7
954009|NCT00113386|2304738|P2|COMPLETED|Overall Study||5
954010|NCT00113386|2304739|P1|COMPLETED|Overall Study||3
954011|NCT00113386|2304738|P2|STARTED|Overall Study||9
954012|NCT00113386|2304739|P1|STARTED|Overall Study||10
954013|NCT00113399|2304747|P2|NOT COMPLETED|Overall Study||5
954014|NCT00113399|2304748|P1|NOT COMPLETED|Overall Study||2
954015|NCT00113399|2304747|P2|COMPLETED|Overall Study||3
954016|NCT00113399|2304748|P1|COMPLETED|Overall Study||5
954017|NCT00113399|2304747|P2|STARTED|Overall Study||8
954018|NCT00113399|2304748|P1|STARTED|Overall Study||7
954019|NCT00103610|2304756|P2|NOT COMPLETED|Overall Study||80
954020|NCT00103610|2304757|P1|NOT COMPLETED|Overall Study||38
954021|NCT00103610|2304756|P2|COMPLETED|Overall Study||68
954022|NCT00103610|2304757|P1|COMPLETED|Overall Study||112
954023|NCT00103610|2304756|P2|STARTED|Overall Study||148
954024|NCT00103610|2304757|P1|STARTED|Overall Study||150
954025|NCT00103662|2304781|P2|NOT COMPLETED|Overall Study||33
954026|NCT00103662|2304782|P1|NOT COMPLETED|Overall Study||19
954027|NCT00103662|2304781|P2|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|121
954028|NCT00103662|2304782|P1|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|129
954029|NCT00103662|2304781|P2|STARTED|Overall Study||154
954030|NCT00103662|2304782|P1|STARTED|Overall Study||148
954031|NCT00103740|2304808|P2|NOT COMPLETED|Period 2 - Extended Observation Period||36
954032|NCT00103740|2304809|P1|NOT COMPLETED|Period 2 - Extended Observation Period||69
954033|NCT00103740|2304808|P2|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|27
954034|NCT00103740|2304809|P1|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|9
954035|NCT00103740|2304808|P2|STARTED|Period 2 - Extended Observation Period||63
954036|NCT00103740|2304809|P1|STARTED|Period 2 - Extended Observation Period||78
954037|NCT00103740|2304808|P2|NOT COMPLETED|Period 1 - Core||4
954038|NCT00103740|2304809|P1|NOT COMPLETED|Period 1 - Core||7
954039|NCT00103740|2304808|P2|COMPLETED|Period 1 - Core||89
954040|NCT00103740|2304809|P1|COMPLETED|Period 1 - Core||85
954041|NCT00103740|2304808|P2|STARTED|Period 1 - Core||93
954042|NCT00103740|2304809|P1|STARTED|Period 1 - Core||92
954043|NCT00103844|2304837|P2|NOT COMPLETED|Overall Study||0
954044|NCT00103844|2304838|P1|NOT COMPLETED|Overall Study||0
954045|NCT00103844|2304837|P2|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|49
954046|NCT00103844|2304838|P1|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|101
954047|NCT00103844|2304837|P2|Crossed Over|Overall Study|40 participants from the imatinib arm crossed over the dasatinib|40
954048|NCT00103844|2304838|P1|Crossed Over|Overall Study|22 participants from the dasatinib arm crossed over to imatinib|22
954049|NCT00103844|2304837|P2|STARTED|Overall Study||49
954050|NCT00103844|2304838|P1|STARTED|Overall Study||101
954051|NCT00103857|2304876|P7|NOT COMPLETED|50-Week Extension Study||0
954052|NCT00103857|2304877|P6|NOT COMPLETED|50-Week Extension Study||20
954053|NCT00103857|2304878|P5|NOT COMPLETED|50-Week Extension Study||21
954054|NCT00103857|2304879|P4|NOT COMPLETED|50-Week Extension Study||36
954055|NCT00103857|2304880|P3|NOT COMPLETED|50-Week Extension Study||26
954056|NCT00103857|2304881|P2|NOT COMPLETED|50-Week Extension Study||27
954057|NCT00103857|2304882|P1|NOT COMPLETED|50-Week Extension Study||38
954058|NCT00103857|2304876|P7|COMPLETED|50-Week Extension Study||0
954059|NCT00103857|2304877|P6|COMPLETED|50-Week Extension Study||78
954060|NCT00103857|2304878|P5|COMPLETED|50-Week Extension Study||101
954061|NCT00103857|2304879|P4|COMPLETED|50-Week Extension Study||98
954062|NCT00103857|2304880|P3|COMPLETED|50-Week Extension Study||95
954063|NCT00103857|2304881|P2|COMPLETED|50-Week Extension Study||80
954064|NCT00103857|2304882|P1|COMPLETED|50-Week Extension Study||65
954065|NCT00103857|2304876|P7|STARTED|50-Week Extension Study||0
954066|NCT00103857|2304877|P6|STARTED|50-Week Extension Study|17 randomized patients completed Period 1 but did not enter Period 2.|98
954067|NCT00103857|2304878|P5|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|122
954068|NCT00103857|2304879|P4|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|134
954069|NCT00103857|2304880|P3|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|121
954070|NCT00103857|2304881|P2|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|107
954071|NCT00103857|2304882|P1|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|103
954072|NCT00103857|2304876|P7|NOT COMPLETED|54-Week Base Study||38
954073|NCT00103857|2304877|P6|NOT COMPLETED|54-Week Base Study||61
954074|NCT00103857|2304878|P5|NOT COMPLETED|54-Week Base Study||41
954075|NCT00103857|2304879|P4|NOT COMPLETED|54-Week Base Study||42
954076|NCT00103857|2304880|P3|NOT COMPLETED|54-Week Base Study||47
954077|NCT00103857|2304881|P2|NOT COMPLETED|54-Week Base Study||56
954078|NCT00103857|2304882|P1|NOT COMPLETED|54-Week Base Study||57
954079|NCT00103857|2304876|P7|COMPLETED|54-Week Base Study||79
954080|NCT00103857|2304877|P6|COMPLETED|54-Week Base Study||115
954081|NCT00103857|2304878|P5|COMPLETED|54-Week Base Study||141
954082|NCT00103857|2304879|P4|COMPLETED|54-Week Base Study||148
954083|NCT00103857|2304880|P3|COMPLETED|54-Week Base Study||135
954084|NCT00103857|2304881|P2|COMPLETED|54-Week Base Study||126
954085|NCT00103857|2304882|P1|COMPLETED|54-Week Base Study||122
954086|NCT00103857|2304876|P7|STARTED|54-Week Base Study|Results for the OLC are through Week 24. Results for the 6 randomized groups are through Week 54.|117
954087|NCT00103857|2304877|P6|STARTED|54-Week Base Study||176
954088|NCT00103857|2304878|P5|STARTED|54-Week Base Study||182
954089|NCT00103857|2304879|P4|STARTED|54-Week Base Study||190
954090|NCT00103857|2304880|P3|STARTED|54-Week Base Study||182
954091|NCT00103857|2304881|P2|STARTED|54-Week Base Study||182
954092|NCT00103857|2304882|P1|STARTED|54-Week Base Study||179
954093|NCT00104052|2304945|P1|NOT COMPLETED|Overall Study||29
954094|NCT00104052|2304945|P1|COMPLETED|Overall Study||78
954095|NCT00104052|2304945|P1|STARTED|Overall Study||107
954096|NCT00104104|2304951|P2|NOT COMPLETED|Overall Study||72
954097|NCT00104104|2304952|P1|NOT COMPLETED|Overall Study||75
954098|NCT00104104|2304951|P2|COMPLETED|Overall Study||17
954099|NCT00104104|2304952|P1|COMPLETED|Overall Study||15
954100|NCT00104104|2304951|P2|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 4 patients in this arm were excluded.|84
954101|NCT00104104|2304952|P1|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 3 patients in this arm were excluded.|85
954102|NCT00104104|2304951|P2|Safety Population (Including Site 74)|Overall Study||88
954103|NCT00104104|2304952|P1|Safety Population (Including Site 74)|Overall Study||88
954104|NCT00104104|2304951|P2|STARTED|Overall Study|1 Participants in the 30-minute infusion group did not receive study drug.|89
954105|NCT00104104|2304952|P1|STARTED|Overall Study|2 Participants in the 15-minute infusion group did not receive study drug.|90
954106|NCT00104234|2304968|P2|NOT COMPLETED|Overall Study||1
954107|NCT00104234|2304969|P1|NOT COMPLETED|Overall Study||0
954108|NCT00104234|2304968|P2|COMPLETED|Overall Study||19
954109|NCT00104234|2304969|P1|COMPLETED|Overall Study||19
954110|NCT00104234|2304968|P2|STARTED|Overall Study||20
954111|NCT00104234|2304969|P1|STARTED|Overall Study||19
954112|NCT00104247|2304979|P2|NOT COMPLETED|Overall Study||1
954113|NCT00104247|2304980|P1|NOT COMPLETED|Overall Study||1
954114|NCT00104247|2304979|P2|COMPLETED|Overall Study|One subject withdrew at Week 4, but is included in the data analysis|46
954115|NCT00104247|2304980|P1|COMPLETED|Overall Study|Subject withdrew prior to dosing|41
954116|NCT00104247|2304979|P2|STARTED|Overall Study||47
954117|NCT00104247|2304980|P1|STARTED|Overall Study||42
954118|NCT00104299|2304988|P2|NOT COMPLETED|Overall Study||10
954119|NCT00104299|2304989|P1|NOT COMPLETED|Overall Study||9
954120|NCT00104299|2304988|P2|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|88
954121|NCT00104299|2304989|P1|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|90
954122|NCT00104299|2304988|P2|STARTED|Overall Study||98
954123|NCT00104299|2304989|P1|STARTED|Overall Study||99
954124|NCT00104416|2305011|P5|NOT COMPLETED|Continuation Phase||5
954125|NCT00104416|2305012|P4|NOT COMPLETED|Continuation Phase||2
954126|NCT00104416|2305013|P3|NOT COMPLETED|Continuation Phase||6
954127|NCT00104416|2305014|P2|NOT COMPLETED|Continuation Phase||0
954128|NCT00104416|2305015|P1|NOT COMPLETED|Continuation Phase||0
954129|NCT00104416|2305011|P5|COMPLETED|Continuation Phase||27
954130|NCT00104416|2305012|P4|COMPLETED|Continuation Phase||65
954131|NCT00104416|2305013|P3|COMPLETED|Continuation Phase||63
954132|NCT00104416|2305014|P2|COMPLETED|Continuation Phase||0
954133|NCT00104416|2305015|P1|COMPLETED|Continuation Phase||0
954134|NCT00104416|2305011|P5|STARTED|Continuation Phase||32
954135|NCT00104416|2305012|P4|STARTED|Continuation Phase|One participant did not complete the Double-Blind Phase but was enrolled in the Continuation Phase.|67
954136|NCT00104416|2305013|P3|STARTED|Continuation Phase||69
954137|NCT00104416|2305014|P2|STARTED|Continuation Phase||0
954138|NCT00104416|2305015|P1|STARTED|Continuation Phase||0
954139|NCT00104416|2305011|P5|NOT COMPLETED|Double-Blind Phase||0
954140|NCT00104416|2305012|P4|NOT COMPLETED|Double-Blind Phase||0
954141|NCT00104416|2305013|P3|NOT COMPLETED|Double-Blind Phase||0
954142|NCT00104416|2305014|P2|NOT COMPLETED|Double-Blind Phase||10
954143|NCT00104416|2305015|P1|NOT COMPLETED|Double-Blind Phase||8
954144|NCT00104416|2305011|P5|COMPLETED|Double-Blind Phase||0
954145|NCT00104416|2305012|P4|COMPLETED|Double-Blind Phase||0
954146|NCT00104416|2305013|P3|COMPLETED|Double-Blind Phase||0
954147|NCT00104416|2305014|P2|COMPLETED|Double-Blind Phase||66
954148|NCT00104416|2305015|P1|COMPLETED|Double-Blind Phase||69
954149|NCT00104416|2305011|P5|STARTED|Double-Blind Phase||0
954150|NCT00104416|2305012|P4|STARTED|Double-Blind Phase||0
954151|NCT00104416|2305013|P3|STARTED|Double-Blind Phase||0
954152|NCT00104416|2305014|P2|STARTED|Double-Blind Phase||76
954153|NCT00104416|2305015|P1|STARTED|Double-Blind Phase||77
954154|NCT00104520|2305060|P2|NOT COMPLETED|Overall Study||71
954155|NCT00104520|2305061|P1|NOT COMPLETED|Overall Study||50
954156|NCT00104520|2305060|P2|COMPLETED|Overall Study||64
954157|NCT00104520|2305061|P1|COMPLETED|Overall Study||26
954158|NCT00104520|2305060|P2|STARTED|Overall Study||135
954159|NCT00104520|2305061|P1|STARTED|Overall Study||76
954160|NCT00104572|2305082|P3|NOT COMPLETED|Overall Study||0
954161|NCT00104572|2305083|P2|NOT COMPLETED|Overall Study||3
954162|NCT00104572|2305084|P1|NOT COMPLETED|Overall Study||3
954163|NCT00104572|2305082|P3|COMPLETED|Overall Study||9
954164|NCT00104572|2305083|P2|COMPLETED|Overall Study||10
954165|NCT00104572|2305084|P1|COMPLETED|Overall Study||10
954166|NCT00104572|2305082|P3|STARTED|Overall Study|(N=11) in placebo, physician removed 2 men due to total testosterone>450 ng/DL, N=9 analysed.|9
954167|NCT00104572|2305083|P2|STARTED|Overall Study|These are the analysed subjects|13
954168|NCT00104572|2305084|P1|STARTED|Overall Study|These are the analysed subjects|13
954169|NCT00104637|2305092|P2|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
954170|NCT00104637|2305093|P1|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
954171|NCT00104637|2305092|P2|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||4
954172|NCT00104637|2305093|P1|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||5
954173|NCT00104637|2305092|P2|STARTED|Period 3 ( TREATMENT: 4 Weeks)||4
954174|NCT00104637|2305093|P1|STARTED|Period 3 ( TREATMENT: 4 Weeks)||5
954175|NCT00104637|2305092|P2|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
954176|NCT00104637|2305093|P1|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
954177|NCT00104637|2305092|P2|COMPLETED|Period 2 (WASHOUT: 1 Week)||4
954178|NCT00104637|2305093|P1|COMPLETED|Period 2 (WASHOUT: 1 Week)||5
954179|NCT00104637|2305092|P2|STARTED|Period 2 (WASHOUT: 1 Week)||4
954180|NCT00104637|2305093|P1|STARTED|Period 2 (WASHOUT: 1 Week)||5
954181|NCT00104637|2305092|P2|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||0
954182|NCT00104637|2305093|P1|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||1
954183|NCT00104637|2305092|P2|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||4
954184|NCT00104637|2305093|P1|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||5
954185|NCT00104637|2305092|P2|STARTED|Period 1: ( TREATMENT: 4 Weeks)||4
954186|NCT00104637|2305093|P1|STARTED|Period 1: ( TREATMENT: 4 Weeks)||6
954187|NCT00104650|2305122|P3|NOT COMPLETED|Follow-up Period||10
954188|NCT00104650|2305123|P2|NOT COMPLETED|Follow-up Period||13
954189|NCT00104650|2305124|P1|NOT COMPLETED|Follow-up Period||11
954190|NCT00104650|2305122|P3|COMPLETED|Follow-up Period||18
954191|NCT00104650|2305123|P2|COMPLETED|Follow-up Period||12
954192|NCT00104650|2305124|P1|COMPLETED|Follow-up Period||14
954193|NCT00104650|2305122|P3|STARTED|Follow-up Period||28
954194|NCT00104650|2305123|P2|STARTED|Follow-up Period||25
954195|NCT00104650|2305124|P1|STARTED|Follow-up Period||25
954196|NCT00104650|2305122|P3|NOT COMPLETED|Treatment Period (25 Weeks)||10
954197|NCT00104650|2305123|P2|NOT COMPLETED|Treatment Period (25 Weeks)||11
954198|NCT00104650|2305124|P1|NOT COMPLETED|Treatment Period (25 Weeks)||12
954199|NCT00104650|2305122|P3|COMPLETED|Treatment Period (25 Weeks)||28
954200|NCT00104650|2305123|P2|COMPLETED|Treatment Period (25 Weeks)||25
954201|NCT00104650|2305124|P1|COMPLETED|Treatment Period (25 Weeks)||25
954202|NCT00104650|2305122|P3|Received Investigational Product|Treatment Period (25 Weeks)||38
954203|NCT00104650|2305123|P2|Received Investigational Product|Treatment Period (25 Weeks)||35
954204|NCT00104650|2305124|P1|Received Investigational Product|Treatment Period (25 Weeks)||35
954205|NCT00104650|2305122|P3|STARTED|Treatment Period (25 Weeks)||38
954206|NCT00104650|2305123|P2|STARTED|Treatment Period (25 Weeks)||36
954207|NCT00104650|2305124|P1|STARTED|Treatment Period (25 Weeks)||37
954208|NCT00104728|2305156|P1|NOT COMPLETED|Overall Study||19
954209|NCT00104728|2305156|P1|COMPLETED|Overall Study||23
954210|NCT00104728|2305156|P1|STARTED|Overall Study|42 consented on study|42
954211|NCT00104871|2305161|P1|NOT COMPLETED|Overall Study||1
954212|NCT00104871|2305161|P1|COMPLETED|Overall Study||21
954213|NCT00104871|2305161|P1|STARTED|Overall Study||22
954214|NCT00104884|2305166|P1|NOT COMPLETED|Overall Study||4
954215|NCT00104884|2305166|P1|COMPLETED|Overall Study||0
954216|NCT00104884|2305166|P1|STARTED|Overall Study||4
954217|NCT00105001|2305173|P3|NOT COMPLETED|Overall Study||0
954218|NCT00105001|2305174|P2|NOT COMPLETED|Overall Study||0
954219|NCT00105001|2305175|P1|NOT COMPLETED|Overall Study||0
954220|NCT00105001|2305173|P3|COMPLETED|Overall Study||69
954221|NCT00105001|2305174|P2|COMPLETED|Overall Study||71
954222|NCT00105001|2305175|P1|COMPLETED|Overall Study||70
954223|NCT00105001|2305173|P3|STARTED|Overall Study||69
954224|NCT00105001|2305174|P2|STARTED|Overall Study||71
954225|NCT00105001|2305175|P1|STARTED|Overall Study||70
954226|NCT00105027|2305201|P6|NOT COMPLETED|Overall Study||13
954227|NCT00105027|2305202|P5|NOT COMPLETED|Overall Study||15
954228|NCT00105027|2305203|P4|NOT COMPLETED|Overall Study||16
954229|NCT00105027|2305204|P3|NOT COMPLETED|Overall Study||9
954230|NCT00105027|2305205|P2|NOT COMPLETED|Overall Study||9
954231|NCT00105027|2305206|P1|NOT COMPLETED|Overall Study||15
954232|NCT00105027|2305201|P6|COMPLETED|Overall Study||125
954233|NCT00105027|2305202|P5|COMPLETED|Overall Study||121
954234|NCT00105027|2305203|P4|COMPLETED|Overall Study||121
954235|NCT00105027|2305204|P3|COMPLETED|Overall Study||82
954236|NCT00105027|2305205|P2|COMPLETED|Overall Study||83
954237|NCT00105027|2305206|P1|COMPLETED|Overall Study||73
954238|NCT00105027|2305201|P6|STARTED|Overall Study||138
954239|NCT00105027|2305202|P5|STARTED|Overall Study||136
954240|NCT00105027|2305203|P4|STARTED|Overall Study||137
954241|NCT00105027|2305204|P3|STARTED|Overall Study||91
954242|NCT00105027|2305205|P2|STARTED|Overall Study||92
954243|NCT00105027|2305206|P1|STARTED|Overall Study||88
954244|NCT00105066|2305222|P2|NOT COMPLETED|Overall Study||5
954245|NCT00105066|2305223|P1|NOT COMPLETED|Overall Study||2
954246|NCT00105066|2305222|P2|COMPLETED|Overall Study||45
954247|NCT00105066|2305223|P1|COMPLETED|Overall Study||25
954248|NCT00105066|2305222|P2|STARTED|Overall Study||50
954249|NCT00105066|2305223|P1|STARTED|Overall Study||27
954250|NCT00105079|2305235|P2|NOT COMPLETED|Overall Study||35
954251|NCT00105079|2305236|P1|NOT COMPLETED|Overall Study||39
954252|NCT00105079|2305235|P2|COMPLETED|Overall Study||135
954253|NCT00105079|2305236|P1|COMPLETED|Overall Study||128
954254|NCT00105079|2305235|P2|Safety Population|Overall Study||168
954255|NCT00105079|2305236|P1|Safety Population|Overall Study||163
954256|NCT00105079|2305235|P2|STARTED|Overall Study||170
954257|NCT00105079|2305236|P1|STARTED|Overall Study||167
954258|NCT00105157|2305256|P4|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||18
954259|NCT00105157|2305257|P3|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
954260|NCT00105157|2305258|P2|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
954261|NCT00105157|2305259|P1|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||9
954262|NCT00105157|2305256|P4|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||19
954263|NCT00105157|2305257|P3|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||5
954264|NCT00105157|2305258|P2|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||7
954265|NCT00105157|2305259|P1|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||2
954266|NCT00105157|2305256|P4|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|37
954267|NCT00105157|2305257|P3|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
954268|NCT00105157|2305258|P2|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|13
954269|NCT00105157|2305259|P1|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
954270|NCT00105157|2305256|P4|NOT COMPLETED|Open-Label Continuation of DB||1
954271|NCT00105157|2305257|P3|NOT COMPLETED|Open-Label Continuation of DB||9
954272|NCT00105157|2305258|P2|NOT COMPLETED|Open-Label Continuation of DB||10
954273|NCT00105157|2305259|P1|NOT COMPLETED|Open-Label Continuation of DB||7
954274|NCT00105157|2305256|P4|COMPLETED|Open-Label Continuation of DB||5
954275|NCT00105157|2305257|P3|COMPLETED|Open-Label Continuation of DB||24
954276|NCT00105157|2305258|P2|COMPLETED|Open-Label Continuation of DB||21
954277|NCT00105157|2305259|P1|COMPLETED|Open-Label Continuation of DB||23
954278|NCT00105157|2305256|P4|STARTED|Open-Label Continuation of DB||6
954279|NCT00105157|2305257|P3|STARTED|Open-Label Continuation of DB||33
954280|NCT00105157|2305258|P2|STARTED|Open-Label Continuation of DB||31
954281|NCT00105157|2305259|P1|STARTED|Open-Label Continuation of DB||30
954282|NCT00105157|2305256|P4|NOT COMPLETED|Double-Blind (DB)||39
954283|NCT00105157|2305257|P3|NOT COMPLETED|Double-Blind (DB)||12
954284|NCT00105157|2305258|P2|NOT COMPLETED|Double-Blind (DB)||14
954285|NCT00105157|2305259|P1|NOT COMPLETED|Double-Blind (DB)||14
954286|NCT00105157|2305256|P4|COMPLETED|Double-Blind (DB)||6
954287|NCT00105157|2305257|P3|COMPLETED|Double-Blind (DB)||33
954288|NCT00105157|2305258|P2|COMPLETED|Double-Blind (DB)||31
954289|NCT00105157|2305259|P1|COMPLETED|Double-Blind (DB)||30
954290|NCT00105157|2305256|P4|Treated|Double-Blind (DB)||45
954291|NCT00105157|2305257|P3|Treated|Double-Blind (DB)||45
954292|NCT00105157|2305258|P2|Treated|Double-Blind (DB)||45
954293|NCT00105157|2305259|P1|Treated|Double-Blind (DB)||43
954294|NCT00105157|2305256|P4|STARTED|Double-Blind (DB)||45
954295|NCT00105157|2305257|P3|STARTED|Double-Blind (DB)||45
954296|NCT00105157|2305258|P2|STARTED|Double-Blind (DB)||45
954297|NCT00105157|2305259|P1|STARTED|Double-Blind (DB)||44
954298|NCT00105183|2305454|P3|NOT COMPLETED|Overall Study||23
954299|NCT00105183|2305455|P2|NOT COMPLETED|Overall Study||19
954300|NCT00105183|2305456|P1|NOT COMPLETED|Overall Study||22
954301|NCT00105183|2305454|P3|COMPLETED|Overall Study|Completed at least 12 months follow up|39
954302|NCT00105183|2305455|P2|COMPLETED|Overall Study|Completed at least 12 months follow up|60
954303|NCT00105183|2305456|P1|COMPLETED|Overall Study|Completed at least 12 months follow up|60
954304|NCT00105183|2305454|P3|STARTED|Overall Study|Randomized|62
954305|NCT00105183|2305455|P2|STARTED|Overall Study|Randomized|79
954306|NCT00105183|2305456|P1|STARTED|Overall Study|Randomized|82
954307|NCT00105196|2305490|P2|NOT COMPLETED|Overall Study||23
954308|NCT00105196|2305491|P1|NOT COMPLETED|Overall Study||30
954309|NCT00105196|2305490|P2|COMPLETED|Overall Study||149
954310|NCT00105196|2305491|P1|COMPLETED|Overall Study||147
954311|NCT00105196|2305490|P2|STARTED|Overall Study||172
954312|NCT00105196|2305491|P1|STARTED|Overall Study||177
954313|NCT00105235|2305511|P1|NOT COMPLETED|Overall Study||7
954314|NCT00105235|2305511|P1|COMPLETED|Overall Study||20
954315|NCT00105235|2305511|P1|STARTED|Overall Study||27
954316|NCT00105443|2305524|P4|NOT COMPLETED|Follow-up and/or Open Label Nexavar||47
954317|NCT00105443|2305525|P3|NOT COMPLETED|Follow-up and/or Open Label Nexavar||245
954318|NCT00105443|2305526|P2|NOT COMPLETED|Follow-up and/or Open Label Nexavar||57
954319|NCT00105443|2305527|P1|NOT COMPLETED|Follow-up and/or Open Label Nexavar||228
954320|NCT00105443|2305524|P4|COMPLETED|Follow-up and/or Open Label Nexavar|47 participants in total (36 + 11) received Open Label Sorafenib treatment (Subjects at Risk)|0
954321|NCT00105443|2305525|P3|COMPLETED|Follow-up and/or Open Label Nexavar||0
954322|NCT00105443|2305526|P2|COMPLETED|Follow-up and/or Open Label Nexavar|57 participants in total (47 + 10) received Open Label Sorafenib treatment (Subjects at Risk)|0
954323|NCT00105443|2305527|P1|COMPLETED|Follow-up and/or Open Label Nexavar||0
954324|NCT00105443|2305524|P4|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||11
954325|NCT00105443|2305525|P3|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
954326|NCT00105443|2305526|P2|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||10
954327|NCT00105443|2305527|P1|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
954328|NCT00105443|2305524|P4|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|36
954329|NCT00105443|2305525|P3|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
954330|NCT00105443|2305526|P2|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|47
954331|NCT00105443|2305527|P1|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
954332|NCT00105443|2305524|P4|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
954333|NCT00105443|2305525|P3|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|245
954334|NCT00105443|2305526|P2|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
954335|NCT00105443|2305527|P1|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|228
954336|NCT00105443|2305524|P4|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 36 participants directly switched to Open Label (OL) Sorafenib treatment|47
954337|NCT00105443|2305525|P3|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 245 participants directly switched to Follow-up (FU)|245
954338|NCT00105443|2305526|P2|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 47 participants directly switched to Open Label (OL) Sorafenib treatment|57
954339|NCT00105443|2305527|P1|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 228 participants directly switched to Follow-up (FU)|228
954340|NCT00105443|2305524|P4|NOT COMPLETED|Double-Blind Treatment||0
954341|NCT00105443|2305525|P3|NOT COMPLETED|Double-Blind Treatment||11
954342|NCT00105443|2305526|P2|NOT COMPLETED|Double-Blind Treatment||0
954343|NCT00105443|2305527|P1|NOT COMPLETED|Double-Blind Treatment||14
954344|NCT00105443|2305524|P4|COMPLETED|Double-Blind Treatment|36 participants switched to Sorafenib Open Label (OL); 11 first to FU prior to also switch to OL|47
954345|NCT00105443|2305525|P3|COMPLETED|Double-Blind Treatment|245 participants directly switched to the Follow-up (FU) phase|245
954346|NCT00105443|2305526|P2|COMPLETED|Double-Blind Treatment|47 participants continued with Sorafenib Open Label (OL); 10 first to FU prior to also switch to OL|57
954347|NCT00105443|2305527|P1|COMPLETED|Double-Blind Treatment|228 participants directly switched to the Follow-up (FU) phase only|228
954348|NCT00105443|2305524|P4|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4 as well as RG5|47
954349|NCT00105443|2305525|P3|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4|255
954350|NCT00105443|2305526|P2|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3|57
954351|NCT00105443|2305527|P1|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3 (RG = Reporting Group for Safety Data)|240
954352|NCT00105443|2305524|P4|STARTED|Double-Blind Treatment||47
954353|NCT00105443|2305525|P3|STARTED|Double-Blind Treatment||256
954354|NCT00105443|2305526|P2|STARTED|Double-Blind Treatment||57
954355|NCT00105443|2305527|P1|STARTED|Double-Blind Treatment||242
954356|NCT00105469|2305556|P2|NOT COMPLETED|Overall Study||11
954357|NCT00105469|2305557|P1|NOT COMPLETED|Overall Study||22
954358|NCT00105469|2305556|P2|COMPLETED|Overall Study||367
954359|NCT00105469|2305557|P1|COMPLETED|Overall Study||343
954360|NCT00105469|2305556|P2|STARTED|Overall Study||378
954361|NCT00105469|2305557|P1|STARTED|Overall Study||365
954362|NCT00105482|2305567|P2|NOT COMPLETED|Overall Study||55
954363|NCT00105482|2305568|P1|NOT COMPLETED|Overall Study||59
954364|NCT00105482|2305567|P2|COMPLETED|Overall Study||30
954365|NCT00105482|2305568|P1|COMPLETED|Overall Study||28
954366|NCT00105482|2305567|P2|STARTED|Overall Study||85
954367|NCT00105482|2305568|P1|STARTED|Overall Study||87
954368|NCT00113425|2305582|P1|NOT COMPLETED|Overall Study||15
954369|NCT00113425|2305582|P1|COMPLETED|Overall Study||29
954370|NCT00113425|2305582|P1|STARTED|Overall Study||44
954371|NCT00113490|2305602|P2|NOT COMPLETED|Overall Study||3
954372|NCT00113490|2305603|P1|NOT COMPLETED|Overall Study||2
954373|NCT00113490|2305602|P2|COMPLETED|Overall Study||67
954374|NCT00113490|2305603|P1|COMPLETED|Overall Study||64
954375|NCT00113490|2305602|P2|STARTED|Overall Study||70
954376|NCT00113490|2305603|P1|STARTED|Overall Study||66
954377|NCT00113516|2305616|P2|NOT COMPLETED|Part 2||66
954378|NCT00113516|2305617|P1|NOT COMPLETED|Part 2||0
954379|NCT00113516|2305616|P2|COMPLETED|Part 2||0
954380|NCT00113516|2305617|P1|COMPLETED|Part 2||0
954381|NCT00113516|2305616|P2|STARTED|Part 2||66
954382|NCT00113516|2305617|P1|STARTED|Part 2||0
954383|NCT00113516|2305616|P2|NOT COMPLETED|Part 1||0
954384|NCT00113516|2305617|P1|NOT COMPLETED|Part 1||84
954385|NCT00113516|2305616|P2|COMPLETED|Part 1||0
954386|NCT00113516|2305617|P1|COMPLETED|Part 1|66 subjects continued into Part 2 of the study.|0
954387|NCT00113516|2305616|P2|STARTED|Part 1||0
954388|NCT00113516|2305617|P1|STARTED|Part 1||84
954389|NCT00113529|2305658|P1|NOT COMPLETED|Overall Study||34
954390|NCT00113529|2305658|P1|COMPLETED|Overall Study|Subject discontinued from the study and continued treatment on commercially available sunitinib.|1
954391|NCT00113529|2305658|P1|STARTED|Overall Study|Phase 2 included 4 subjects from Phase 1 and 31 from Phase 2, for a total of 35 subjects.|35
954392|NCT00113568|2305691|P1|NOT COMPLETED|Overall Study||545
954393|NCT00113568|2305691|P1|COMPLETED|Overall Study||239
954394|NCT00113568|2305691|P1|Intent to Treat Population|Overall Study||723
954395|NCT00113568|2305691|P1|STARTED|Overall Study||784
954396|NCT00113607|2305705|P2|NOT COMPLETED|Overall Study||337
954397|NCT00113607|2305706|P1|NOT COMPLETED|Overall Study||335
954398|NCT00113607|2305705|P2|COMPLETED|Overall Study||0
954399|NCT00113607|2305706|P1|COMPLETED|Overall Study||0
954400|NCT00113607|2305705|P2|STARTED|Overall Study|Number of randomized participants|337
954401|NCT00113607|2305706|P1|STARTED|Overall Study|Number of randomized participants|335
954408|NCT00114127|2305737|P2|NOT COMPLETED|Overall Study||4
954409|NCT00114127|2305738|P1|NOT COMPLETED|Overall Study||4
954410|NCT00114127|2305737|P2|COMPLETED|Overall Study||11
954411|NCT00114127|2305738|P1|COMPLETED|Overall Study||9
954412|NCT00114127|2305737|P2|STARTED|Overall Study||15
954413|NCT00114127|2305738|P1|STARTED|Overall Study||13
954414|NCT00114166|2305746|P1|NOT COMPLETED|Overall Study||1
954415|NCT00114166|2305746|P1|COMPLETED|Overall Study|total numbers of eligible and evaluable participants|80
954416|NCT00114166|2305746|P1|Registered to Regimen II|Overall Study||65
954417|NCT00114166|2305746|P1|Registered to Regimen I|Overall Study||15
954418|NCT00114166|2305746|P1|STARTED|Overall Study|total number of participants enrolled|81
954419|NCT00114244|2305754|P2|NOT COMPLETED|Overall Study||7
954420|NCT00114244|2305755|P1|NOT COMPLETED|Overall Study||2
954421|NCT00114244|2305754|P2|COMPLETED|Overall Study||30
954422|NCT00114244|2305755|P1|COMPLETED|Overall Study||13
954423|NCT00114244|2305754|P2|STARTED|Overall Study||37
954424|NCT00114244|2305755|P1|STARTED|Overall Study||15
954425|NCT00114504|2305767|P2|NOT COMPLETED|Overall Study||0
954426|NCT00114504|2305768|P1|NOT COMPLETED|Overall Study||0
954427|NCT00114504|2305767|P2|COMPLETED|Overall Study||22
954428|NCT00114504|2305768|P1|COMPLETED|Overall Study||21
954429|NCT00114504|2305767|P2|STARTED|Overall Study||22
954430|NCT00114504|2305768|P1|STARTED|Overall Study||21
954431|NCT00114517|2305782|P4|NOT COMPLETED|Overall Study||10
954432|NCT00114517|2305783|P3|NOT COMPLETED|Overall Study||14
954433|NCT00114517|2305784|P2|NOT COMPLETED|Overall Study||11
954434|NCT00114517|2305785|P1|NOT COMPLETED|Overall Study||12
954435|NCT00114517|2305782|P4|COMPLETED|Overall Study||176
954436|NCT00114517|2305783|P3|COMPLETED|Overall Study||172
954437|NCT00114517|2305784|P2|COMPLETED|Overall Study||123
954438|NCT00114517|2305785|P1|COMPLETED|Overall Study||125
954439|NCT00114517|2305782|P4|STARTED|Overall Study||186
954440|NCT00114517|2305783|P3|STARTED|Overall Study||186
954441|NCT00114517|2305784|P2|STARTED|Overall Study||134
954442|NCT00114517|2305785|P1|STARTED|Overall Study||137
954443|NCT00114530|2305797|P2|NOT COMPLETED|Overall Study||20
954444|NCT00114530|2305798|P1|NOT COMPLETED|Overall Study||9
954445|NCT00114530|2305797|P2|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient’s 54 mo visit)|19
954446|NCT00114530|2305798|P1|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient’s 54 mo visit)|27
954447|NCT00114530|2305797|P2|STARTED|Overall Study||39
954448|NCT00114530|2305798|P1|STARTED|Overall Study||36
954449|NCT00114634|2305903|P1|NOT COMPLETED|Overall Study||3
954450|NCT00114634|2305903|P1|COMPLETED|Overall Study|Assessment forms lost by one failure to complete and return forms by two|10
954451|NCT00114634|2305903|P1|STARTED|Overall Study||13
954470|NCT00114959|2305996|P1|NOT COMPLETED|Overall Study||8
954471|NCT00114959|2305996|P1|COMPLETED|Overall Study|protocol definition of completed study is having received >= 4 cycles of treatment|7
954472|NCT00114959|2305996|P1|STARTED|Overall Study||15
954473|NCT00114972|2306005|P2|NOT COMPLETED|Overall Study||12
954474|NCT00114972|2306006|P1|NOT COMPLETED|Overall Study||48
954475|NCT00114972|2306005|P2|COMPLETED|Overall Study||891
954476|NCT00114972|2306006|P1|COMPLETED|Overall Study||849
954477|NCT00114972|2306005|P2|STARTED|Overall Study||903
954478|NCT00114972|2306006|P1|STARTED|Overall Study||897
954479|NCT00115063|2306028|P2|NOT COMPLETED|Overall Study||104
954480|NCT00115063|2306029|P1|NOT COMPLETED|Overall Study||99
954481|NCT00115063|2306028|P2|COMPLETED|Overall Study||86
954482|NCT00115063|2306029|P1|COMPLETED|Overall Study||101
954483|NCT00115063|2306028|P2|STARTED|Overall Study||190
954484|NCT00115063|2306029|P1|STARTED|Overall Study||200
954485|NCT00115297|2306047|P2|NOT COMPLETED|Overall Study||0
954486|NCT00115297|2306048|P1|NOT COMPLETED|Overall Study||0
954487|NCT00115297|2306047|P2|COMPLETED|Overall Study||32
954488|NCT00115297|2306048|P1|COMPLETED|Overall Study||30
954489|NCT00115297|2306047|P2|STARTED|Overall Study||32
954490|NCT00115297|2306048|P1|STARTED|Overall Study||30
954491|NCT00115349|2306060|P2|NOT COMPLETED|Overall Study||9
954492|NCT00115349|2306061|P1|NOT COMPLETED|Overall Study||11
954493|NCT00115349|2306060|P2|COMPLETED|Overall Study|study closed due to low enrollment.|0
954494|NCT00115349|2306061|P1|COMPLETED|Overall Study|Study closed due to low enrollment.|0
954495|NCT00115349|2306060|P2|STARTED|Overall Study|Target was 43 subjects in this arm.|9
954496|NCT00115349|2306061|P1|STARTED|Overall Study|Target was 43 subjects in this arm.|11
954497|NCT00115739|2306067|P1|NOT COMPLETED|Overall Study||3
954498|NCT00115739|2306067|P1|COMPLETED|Overall Study||8
954499|NCT00115739|2306067|P1|STARTED|Overall Study||11
954500|NCT00115765|2306078|P4|NOT COMPLETED|Overall Study||31
954501|NCT00115765|2306079|P3|NOT COMPLETED|Overall Study||121
954502|NCT00115765|2306080|P2|NOT COMPLETED|Overall Study||100
954503|NCT00115765|2306081|P1|NOT COMPLETED|Overall Study||35
954504|NCT00115765|2306078|P4|COMPLETED|Overall Study|Participants who were on study at closure or died|84
954505|NCT00115765|2306079|P3|COMPLETED|Overall Study|Participants who were on study at closure or died|289
954506|NCT00115765|2306080|P2|COMPLETED|Overall Study|Participants who were on study at closure or died|313
954507|NCT00115765|2306081|P1|COMPLETED|Overall Study|Participants who were on study at closure or died|80
954508|NCT00115765|2306078|P4|STARTED|Overall Study||115
954509|NCT00115765|2306079|P3|STARTED|Overall Study||410
954510|NCT00115765|2306080|P2|STARTED|Overall Study||413
954511|NCT00115765|2306081|P1|STARTED|Overall Study||115
954512|NCT00115804|2306119|P1|NOT COMPLETED|Overall Study||2
954513|NCT00115804|2306119|P1|COMPLETED|Overall Study||4
954514|NCT00115804|2306119|P1|STARTED|Overall Study||6
954515|NCT00115869|2306132|P2|NOT COMPLETED|Overall Study||296
954516|NCT00115869|2306133|P1|NOT COMPLETED|Overall Study||317
954517|NCT00115869|2306132|P2|COMPLETED|Overall Study|Follow-up at two years post high school.|3881
954518|NCT00115869|2306133|P1|COMPLETED|Overall Study||3894
954519|NCT00115869|2306132|P2|Completed Data Collection at 12th Grade|Overall Study||3847
954520|NCT00115869|2306133|P1|Completed Data Collection at 12th Grade|Overall Study||3876
954521|NCT00115869|2306132|P2|STARTED|Overall Study||4177
954522|NCT00115869|2306133|P1|STARTED|Overall Study||4211
954523|NCT00115934|2306143|P2|NOT COMPLETED|Overall Study||2
954524|NCT00115934|2306144|P1|NOT COMPLETED|Overall Study||4
954525|NCT00115934|2306143|P2|COMPLETED|Overall Study||274
954526|NCT00115934|2306144|P1|COMPLETED|Overall Study||275
954527|NCT00115934|2306143|P2|STARTED|Overall Study|276 randomized to RVPAS, but 2 did not have a Norwood surgery and were excluded from analyses.|276
954528|NCT00115934|2306144|P1|STARTED|Overall Study|279 randomized to MBTS, but 3 did not have a Norwood surgery; one was withdrawn-with limited data.|279
954529|NCT00116168|2306186|P4|NOT COMPLETED|Overall Study||0
954530|NCT00116168|2306187|P3|NOT COMPLETED|Overall Study||0
954531|NCT00116168|2306188|P2|NOT COMPLETED|Overall Study||5
954532|NCT00116168|2306189|P1|NOT COMPLETED|Overall Study||6
954533|NCT00116168|2306186|P4|COMPLETED|Overall Study||6
954534|NCT00116168|2306187|P3|COMPLETED|Overall Study||6
954535|NCT00116168|2306188|P2|COMPLETED|Overall Study||6
954536|NCT00116168|2306189|P1|COMPLETED|Overall Study||0
954537|NCT00116168|2306186|P4|STARTED|Overall Study||6
954538|NCT00116168|2306187|P3|STARTED|Overall Study||6
954539|NCT00116168|2306188|P2|STARTED|Overall Study||11
954540|NCT00116168|2306189|P1|STARTED|Overall Study||6
954541|NCT00116207|2306253|P2|NOT COMPLETED|Overall Study||4
954542|NCT00116207|2306254|P1|NOT COMPLETED|Overall Study||9
954543|NCT00116207|2306253|P2|COMPLETED|Overall Study||18
954544|NCT00116207|2306254|P1|COMPLETED|Overall Study||13
954545|NCT00116207|2306253|P2|STARTED|Overall Study||22
954546|NCT00116207|2306254|P1|STARTED|Overall Study||22
954547|NCT00116272|2306268|P2|NOT COMPLETED|Overall Study||6
954548|NCT00116272|2306269|P1|NOT COMPLETED|Overall Study||11
954549|NCT00116272|2306268|P2|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|158
954550|NCT00116272|2306269|P1|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|359
954551|NCT00116272|2306268|P2|STARTED|Overall Study||164
954552|NCT00116272|2306269|P1|STARTED|Overall Study||370
954559|NCT00108485|2306340|P2|NOT COMPLETED|Overall Study||2
954560|NCT00108485|2306341|P1|NOT COMPLETED|Overall Study||3
954561|NCT00108485|2306340|P2|COMPLETED|Overall Study||2
954562|NCT00108485|2306341|P1|COMPLETED|Overall Study||2
954563|NCT00108485|2306340|P2|STARTED|Overall Study||4
954564|NCT00108485|2306341|P1|STARTED|Overall Study||5
954565|NCT00108524|2306349|P2|NOT COMPLETED|Overall Study||18
954566|NCT00108524|2306350|P1|NOT COMPLETED|Overall Study||29
954567|NCT00108524|2306349|P2|COMPLETED|Overall Study||61
954568|NCT00108524|2306350|P1|COMPLETED|Overall Study||52
954569|NCT00108524|2306349|P2|STARTED|Overall Study||79
954570|NCT00108524|2306350|P1|STARTED|Overall Study||81
954571|NCT00108550|2306362|P2|NOT COMPLETED|Overall Study||16
954572|NCT00108550|2306363|P1|NOT COMPLETED|Overall Study||16
954573|NCT00108550|2306362|P2|COMPLETED|Overall Study||37
954574|NCT00108550|2306363|P1|COMPLETED|Overall Study||39
954575|NCT00108550|2306362|P2|STARTED|Overall Study||53
954576|NCT00108550|2306363|P1|STARTED|Overall Study||55
954577|NCT00108628|2306373|P2|NOT COMPLETED|Overall Study||10
954578|NCT00108628|2306374|P1|NOT COMPLETED|Overall Study||20
954579|NCT00108628|2306373|P2|COMPLETED|Overall Study||53
954580|NCT00108628|2306374|P1|COMPLETED|Overall Study||41
954581|NCT00108628|2306373|P2|Completed Treatment|Overall Study||57
954582|NCT00108628|2306374|P1|Completed Treatment|Overall Study||42
954583|NCT00108628|2306373|P2|Received One or More Sessions|Overall Study||58
954584|NCT00108628|2306374|P1|Received One or More Sessions|Overall Study||53
954585|NCT00108628|2306373|P2|STARTED|Overall Study||63
954586|NCT00108628|2306374|P1|STARTED|Overall Study||61
954587|NCT00108732|2306398|P1|NOT COMPLETED|Step 2 (Androgen Ablation and Vaccine)||5
954588|NCT00108732|2306398|P1|COMPLETED|Step 2 (Androgen Ablation and Vaccine)||26
954589|NCT00108732|2306398|P1|STARTED|Step 2 (Androgen Ablation and Vaccine)||31
954590|NCT00108732|2306398|P1|NOT COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||14
954591|NCT00108732|2306398|P1|COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||36
954592|NCT00108732|2306398|P1|Eligible and Treated|Step 1 (Vaccinia/Fowlpox/GM-CSF)||40
954593|NCT00108732|2306398|P1|STARTED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||50
954594|NCT00108862|2306407|P2|NOT COMPLETED|Overall Study||62
954595|NCT00108862|2306408|P1|NOT COMPLETED|Overall Study||68
954596|NCT00108862|2306407|P2|COMPLETED|Overall Study||339
954597|NCT00108862|2306408|P1|COMPLETED|Overall Study||337
954598|NCT00108862|2306407|P2|STARTED|Overall Study|Three participants who were deemed clinically ineligible and taken off study were omitted.|401
954599|NCT00108862|2306408|P1|STARTED|Overall Study||405
954600|NCT00108953|2306438|P2|NOT COMPLETED|Follow-up||33
954601|NCT00108953|2306439|P1|NOT COMPLETED|Follow-up||29
954602|NCT00108953|2306438|P2|COMPLETED|Follow-up||12
954603|NCT00108953|2306439|P1|COMPLETED|Follow-up||11
954604|NCT00108953|2306438|P2|STARTED|Follow-up|45 out of 49 patients were followed after end of double blind treatment|45
954605|NCT00108953|2306439|P1|STARTED|Follow-up|40 out of 47 patients were followed after end of double blind treatment|40
954606|NCT00108953|2306438|P2|NOT COMPLETED|Treatment Period||0
954607|NCT00108953|2306439|P1|NOT COMPLETED|Treatment Period||0
954608|NCT00108953|2306438|P2|COMPLETED|Treatment Period|No patient under study medication anymore|49
954609|NCT00108953|2306439|P1|COMPLETED|Treatment Period|No patient under study medication anymore|47
954610|NCT00108953|2306438|P2|STARTED|Treatment Period|ITT population|49
954611|NCT00108953|2306439|P1|STARTED|Treatment Period|ITT population|47
954612|NCT00109005|2306461|P2|NOT COMPLETED|Overall Study||0
954613|NCT00109005|2306462|P1|NOT COMPLETED|Overall Study||0
954614|NCT00109005|2306461|P2|COMPLETED|Overall Study||9
954615|NCT00109005|2306462|P1|COMPLETED|Overall Study||8
954616|NCT00109005|2306461|P2|STARTED|Overall Study||9
954617|NCT00109005|2306462|P1|STARTED|Overall Study||8
954618|NCT00109031|2306478|P4|NOT COMPLETED|Overall Study||0
954619|NCT00109031|2306479|P3|NOT COMPLETED|Overall Study||2
954620|NCT00109031|2306480|P2|NOT COMPLETED|Overall Study||2
954621|NCT00109031|2306481|P1|NOT COMPLETED|Overall Study||0
954622|NCT00109031|2306478|P4|COMPLETED|Overall Study||12
954623|NCT00109031|2306479|P3|COMPLETED|Overall Study||12
954624|NCT00109031|2306480|P2|COMPLETED|Overall Study||8
954625|NCT00109031|2306481|P1|COMPLETED|Overall Study||11
954626|NCT00109031|2306478|P4|STARTED|Overall Study||12
954627|NCT00109031|2306479|P3|STARTED|Overall Study||14
954628|NCT00109031|2306480|P2|STARTED|Overall Study||10
954629|NCT00109031|2306481|P1|STARTED|Overall Study||11
954630|NCT00109343|2306518|P3|NOT COMPLETED|Overall Study||30
954631|NCT00109343|2306519|P2|NOT COMPLETED|Overall Study||37
954632|NCT00109343|2306520|P1|NOT COMPLETED|Overall Study||64
954633|NCT00109343|2306518|P3|COMPLETED|Overall Study||229
954634|NCT00109343|2306519|P2|COMPLETED|Overall Study||221
954635|NCT00109343|2306520|P1|COMPLETED|Overall Study||446
954636|NCT00109343|2306518|P3|Vaccinated at Visit 4|Overall Study||240
954637|NCT00109343|2306519|P2|Vaccinated at Visit 4|Overall Study||235
954638|NCT00109343|2306520|P1|Vaccinated at Visit 4|Overall Study||466
954639|NCT00109343|2306518|P3|Vaccinated at Visit 2|Overall Study||246
954640|NCT00109343|2306519|P2|Vaccinated at Visit 2|Overall Study||246
954641|NCT00109343|2306520|P1|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects in Group 1 were not vaccinated at Visit 2|0
954642|NCT00109343|2306518|P3|Vaccinated at Visit 1|Overall Study||259
954643|NCT00109343|2306519|P2|Vaccinated at Visit 1|Overall Study||258
954644|NCT00109343|2306520|P1|Vaccinated at Visit 1|Overall Study||510
954645|NCT00109343|2306518|P3|STARTED|Overall Study||259
954646|NCT00109343|2306519|P2|STARTED|Overall Study||258
954647|NCT00109343|2306520|P1|STARTED|Overall Study||510
954648|NCT00109473|2306563|P2|NOT COMPLETED|52 Week Extension Phase||5
954649|NCT00109473|2306564|P1|NOT COMPLETED|52 Week Extension Phase||4
954650|NCT00109473|2306563|P2|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|3
954651|NCT00109473|2306564|P1|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|5
954652|NCT00109473|2306563|P2|Analyzed|52 Week Extension Phase||8
954653|NCT00109473|2306564|P1|Analyzed|52 Week Extension Phase||9
954654|NCT00109473|2306563|P2|STARTED|52 Week Extension Phase||8
954655|NCT00109473|2306564|P1|STARTED|52 Week Extension Phase||9
954656|NCT00109473|2306563|P2|NOT COMPLETED|Week 12 to Week 24||0
954657|NCT00109473|2306564|P1|NOT COMPLETED|Week 12 to Week 24||1
954658|NCT00109473|2306563|P2|COMPLETED|Week 12 to Week 24|one subject discontinued intervention due to active disease requiring surgery|9
954659|NCT00109473|2306564|P1|COMPLETED|Week 12 to Week 24|One subject withdrew consent|9
954660|NCT00109473|2306563|P2|Analyzed|Week 12 to Week 24||9
954661|NCT00109473|2306564|P1|Analyzed|Week 12 to Week 24||9
954662|NCT00109473|2306563|P2|STARTED|Week 12 to Week 24||9
954663|NCT00109473|2306564|P1|STARTED|Week 12 to Week 24||10
954664|NCT00109473|2306563|P2|NOT COMPLETED|Baseline (0 Through 12 Weeks)||1
954665|NCT00109473|2306564|P1|NOT COMPLETED|Baseline (0 Through 12 Weeks)||0
954666|NCT00109473|2306563|P2|COMPLETED|Baseline (0 Through 12 Weeks)|One subject discontinued intervention because of active disease requiring imfliximab|9
954667|NCT00109473|2306564|P1|COMPLETED|Baseline (0 Through 12 Weeks)||10
954668|NCT00109473|2306563|P2|Analyzed|Baseline (0 Through 12 Weeks)||10
954669|NCT00109473|2306564|P1|Analyzed|Baseline (0 Through 12 Weeks)||10
954670|NCT00109473|2306563|P2|STARTED|Baseline (0 Through 12 Weeks)||10
954671|NCT00109473|2306564|P1|STARTED|Baseline (0 Through 12 Weeks)|11 subjects allocated to Group A; one withdrew consent, only 10 receieved intervention.|10
954672|NCT00109577|2306585|P2|NOT COMPLETED|Overall Study||3
954673|NCT00109577|2306586|P1|NOT COMPLETED|Overall Study||3
954674|NCT00109577|2306585|P2|COMPLETED|Overall Study||17
954675|NCT00109577|2306586|P1|COMPLETED|Overall Study||17
954676|NCT00109577|2306585|P2|STARTED|Overall Study||20
954677|NCT00109577|2306586|P1|STARTED|Overall Study||20
954678|NCT00109590|2306595|P3|NOT COMPLETED|Overall Study||4
954679|NCT00109590|2306596|P2|NOT COMPLETED|Overall Study||2
954680|NCT00109590|2306597|P1|NOT COMPLETED|Overall Study||2
954681|NCT00109590|2306595|P3|COMPLETED|Overall Study||56
954682|NCT00109590|2306596|P2|COMPLETED|Overall Study||56
954683|NCT00109590|2306597|P1|COMPLETED|Overall Study||55
954684|NCT00109590|2306595|P3|RECEIVED TREATMENT|Overall Study||57
954685|NCT00109590|2306596|P2|RECEIVED TREATMENT|Overall Study||56
954686|NCT00109590|2306597|P1|RECEIVED TREATMENT|Overall Study||56
954687|NCT00109590|2306595|P3|STARTED|Overall Study||60
954688|NCT00109590|2306596|P2|STARTED|Overall Study||58
954689|NCT00109590|2306597|P1|STARTED|Overall Study||57
954690|NCT00109733|2306639|P2|NOT COMPLETED|Overall Study||4
954691|NCT00109733|2306640|P1|NOT COMPLETED|Overall Study||2
954692|NCT00109733|2306639|P2|COMPLETED|Overall Study||12
954693|NCT00109733|2306640|P1|COMPLETED|Overall Study||13
954694|NCT00109733|2306639|P2|STARTED|Overall Study||16
954695|NCT00109733|2306640|P1|STARTED|Overall Study||15
954696|NCT00109772|2306656|P2|NOT COMPLETED|Open-label Extension||49
954697|NCT00109772|2306657|P1|NOT COMPLETED|Open-label Extension||45
954698|NCT00109772|2306656|P2|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|29
954699|NCT00109772|2306657|P1|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|19
954700|NCT00109772|2306656|P2|STARTED|Open-label Extension|One double-blind participant did not continue into the open-label extension|78
954701|NCT00109772|2306657|P1|STARTED|Open-label Extension|Four double-blind participants did not continue into the open-label extension|64
954702|NCT00109772|2306656|P2|NOT COMPLETED|Double-blind Treatment||15
954703|NCT00109772|2306657|P1|NOT COMPLETED|Double-blind Treatment||22
954704|NCT00109772|2306656|P2|COMPLETED|Double-blind Treatment||79
954705|NCT00109772|2306657|P1|COMPLETED|Double-blind Treatment||68
954706|NCT00109772|2306656|P2|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|93
954707|NCT00109772|2306657|P1|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|87
954708|NCT00109772|2306656|P2|STARTED|Double-blind Treatment||94
954709|NCT00109772|2306657|P1|STARTED|Double-blind Treatment||90
954710|NCT00109837|2306695|P1|NOT COMPLETED|Overall Study||23
954711|NCT00109837|2306695|P1|COMPLETED|Overall Study||56
954712|NCT00109837|2306695|P1|Eligible and Ph- and Treated|Overall Study||60
954713|NCT00109837|2306695|P1|Eligible and Ph-|Overall Study||61
954714|NCT00109837|2306695|P1|Eligible|Overall Study||78
954715|NCT00109837|2306695|P1|STARTED|Overall Study||79
954716|NCT00109850|2306703|P1|NOT COMPLETED|Overall Study||4
954717|NCT00109850|2306703|P1|COMPLETED|Overall Study||18
954718|NCT00109850|2306703|P1|Eligible and Began Protocol Therapy|Overall Study||21
954719|NCT00109850|2306703|P1|Eligible|Overall Study||21
954720|NCT00109850|2306703|P1|STARTED|Overall Study||22
954721|NCT00109876|2306710|P1|NOT COMPLETED|Overall Study||0
954722|NCT00109876|2306710|P1|COMPLETED|Overall Study||51
954723|NCT00109876|2306710|P1|STARTED|Overall Study||51
954724|NCT00109928|2306720|P1|NOT COMPLETED|Overall Study||13
954725|NCT00109928|2306720|P1|COMPLETED|Overall Study||21
954726|NCT00109928|2306720|P1|Eligible and Began Protocol Therapy|Overall Study||33
954727|NCT00109928|2306720|P1|Eligible|Overall Study||33
954728|NCT00109928|2306720|P1|STARTED|Overall Study||34
954729|NCT00109967|2306729|P2|NOT COMPLETED|Overall Study||6
954730|NCT00109967|2306730|P1|NOT COMPLETED|Overall Study||20
954731|NCT00109967|2306729|P2|COMPLETED|Overall Study||15
954732|NCT00109967|2306730|P1|COMPLETED|Overall Study||30
954733|NCT00109967|2306729|P2|STARTED|Overall Study||21
954734|NCT00109967|2306730|P1|STARTED|Overall Study||50
954735|NCT00110019|2306746|P2|NOT COMPLETED|Overall Study||413
954736|NCT00110019|2306747|P1|NOT COMPLETED|Overall Study||406
954737|NCT00110019|2306746|P2|COMPLETED|Overall Study||0
954738|NCT00110019|2306747|P1|COMPLETED|Overall Study||4
954739|NCT00110019|2306746|P2|Treated|Overall Study||397
954740|NCT00110019|2306747|P1|Treated|Overall Study||393
954741|NCT00110019|2306746|P2|Eligible|Overall Study||398
954742|NCT00110019|2306747|P1|Eligible|Overall Study||395
954743|NCT00110019|2306746|P2|STARTED|Overall Study||413
954744|NCT00110019|2306747|P1|STARTED|Overall Study||410
954745|NCT00110084|2306757|P1|NOT COMPLETED|Overall Study||28
954746|NCT00110084|2306757|P1|COMPLETED|Overall Study||22
954747|NCT00110084|2306757|P1|STARTED|Overall Study||50
954748|NCT00110136|2306764|P1|NOT COMPLETED|Overall Study||0
954749|NCT00110136|2306764|P1|COMPLETED|Overall Study||9
954750|NCT00110136|2306764|P1|STARTED|Overall Study||9
954751|NCT00110214|2306775|P2|NOT COMPLETED|Overall Study||503
954752|NCT00110214|2306776|P1|NOT COMPLETED|Overall Study||509
954753|NCT00110214|2306775|P2|COMPLETED|Overall Study||21
954754|NCT00110214|2306776|P1|COMPLETED|Overall Study||17
954755|NCT00110214|2306775|P2|STARTED|Overall Study||524
954756|NCT00110214|2306776|P1|STARTED|Overall Study||526
954757|NCT00110305|2306792|P2|NOT COMPLETED|Overall Study||32
954758|NCT00110305|2306793|P1|NOT COMPLETED|Overall Study||114
954759|NCT00110305|2306792|P2|COMPLETED|Overall Study||57
954760|NCT00110305|2306793|P1|COMPLETED|Overall Study||165
954761|NCT00110305|2306792|P2|STARTED|Overall Study||89
954762|NCT00110305|2306793|P1|STARTED|Overall Study||279
954763|NCT00110357|2306846|P2|NOT COMPLETED|Overall Study||19
954764|NCT00110357|2306847|P1|NOT COMPLETED|Overall Study||27
954765|NCT00110357|2306846|P2|COMPLETED|Overall Study|Number Still on Study|0
954766|NCT00110357|2306847|P1|COMPLETED|Overall Study|Number Still on Study|0
954767|NCT00110357|2306846|P2|STARTED|Overall Study||19
954768|NCT00110357|2306847|P1|STARTED|Overall Study||27
954769|NCT00110396|2306931|P1|NOT COMPLETED|Overall Study||36
954770|NCT00110396|2306931|P1|COMPLETED|Overall Study|260 participants included in the Safety Population.207 completed treatment. 224 completed the trial|224
954771|NCT00110396|2306931|P1|STARTED|Overall Study||260
954772|NCT00110461|2306940|P3|NOT COMPLETED|Acute Phase||23
954773|NCT00110461|2306941|P2|NOT COMPLETED|Acute Phase||22
954774|NCT00110461|2306942|P1|NOT COMPLETED|Acute Phase||14
954775|NCT00110461|2306940|P3|COMPLETED|Acute Phase||76
954776|NCT00110461|2306941|P2|COMPLETED|Acute Phase||77
954777|NCT00110461|2306942|P1|COMPLETED|Acute Phase||84
954778|NCT00110461|2306940|P3|STARTED|Acute Phase||99
954779|NCT00110461|2306941|P2|STARTED|Acute Phase||99
954780|NCT00110461|2306942|P1|STARTED|Acute Phase||98
954781|NCT00110461|2306940|P3|NOT COMPLETED|30-Week, Double-blind Treatment Phase||87
954782|NCT00110461|2306941|P2|NOT COMPLETED|30-Week, Double-blind Treatment Phase||77
954783|NCT00110461|2306942|P1|NOT COMPLETED|30-Week, Double-blind Treatment Phase||64
954784|NCT00110461|2306940|P3|COMPLETED|30-Week, Double-blind Treatment Phase||12
954785|NCT00110461|2306941|P2|COMPLETED|30-Week, Double-blind Treatment Phase||22
954786|NCT00110461|2306942|P1|COMPLETED|30-Week, Double-blind Treatment Phase||34
954787|NCT00110461|2306940|P3|STARTED|30-Week, Double-blind Treatment Phase||99
954788|NCT00110461|2306941|P2|STARTED|30-Week, Double-blind Treatment Phase||99
954789|NCT00110461|2306942|P1|STARTED|30-Week, Double-blind Treatment Phase||98
954790|NCT00110513|2307037|P1|NOT COMPLETED|Overall Study||0
954791|NCT00110513|2307037|P1|COMPLETED|Overall Study||18
954792|NCT00110513|2307037|P1|STARTED|Overall Study||18
954793|NCT00110617|2307043|P2|NOT COMPLETED|Overall Study||29
954794|NCT00110617|2307044|P1|NOT COMPLETED|Overall Study||39
954795|NCT00110617|2307043|P2|COMPLETED|Overall Study||39
954796|NCT00110617|2307044|P1|COMPLETED|Overall Study||96
954797|NCT00110617|2307043|P2|On Going at Week 24|Overall Study||53
954798|NCT00110617|2307044|P1|On Going at Week 24|Overall Study||126
954799|NCT00110617|2307043|P2|Full Analysis 2; Received ICL670|Overall Study||53
954800|NCT00110617|2307044|P1|Full Analysis 2; Received ICL670|Overall Study||135
954801|NCT00110617|2307043|P2|Safety Set 1; Received Study Drug|Overall Study||56
954802|NCT00110617|2307044|P1|Safety Set 1; Received Study Drug|Overall Study||135
954803|NCT00110617|2307043|P2|STARTED|Overall Study|Full Analysis Set 1 does not include 9 participants who were excluded due to GCP violations.|68
954804|NCT00110617|2307044|P1|STARTED|Overall Study||135
954805|NCT00110812|2307060|P3|NOT COMPLETED|Extended Follow-up||4
954806|NCT00110812|2307061|P2|NOT COMPLETED|Extended Follow-up||4
954807|NCT00110812|2307062|P1|NOT COMPLETED|Extended Follow-up||2
954808|NCT00110812|2307060|P3|COMPLETED|Extended Follow-up||69
954809|NCT00110812|2307061|P2|COMPLETED|Extended Follow-up||65
954810|NCT00110812|2307062|P1|COMPLETED|Extended Follow-up||78
954811|NCT00110812|2307060|P3|STARTED|Extended Follow-up||73
954812|NCT00110812|2307061|P2|STARTED|Extended Follow-up||69
954813|NCT00110812|2307062|P1|STARTED|Extended Follow-up||80
954814|NCT00110812|2307060|P3|NOT COMPLETED|Main Study||13
954815|NCT00110812|2307061|P2|NOT COMPLETED|Main Study||11
954816|NCT00110812|2307062|P1|NOT COMPLETED|Main Study||8
954817|NCT00110812|2307060|P3|COMPLETED|Main Study||74
954818|NCT00110812|2307061|P2|COMPLETED|Main Study||78
954819|NCT00110812|2307062|P1|COMPLETED|Main Study||83
954820|NCT00110812|2307060|P3|STARTED|Main Study||87
954821|NCT00110812|2307061|P2|STARTED|Main Study||89
954822|NCT00110812|2307062|P1|STARTED|Main Study||91
954823|NCT00116649|2307105|P1|NOT COMPLETED|Overall Study||155
954824|NCT00116649|2307105|P1|COMPLETED|Overall Study||396
954825|NCT00116649|2307105|P1|STARTED|Overall Study|586 screened (34 not eligible) 552 enrolled 551 study population (1 subject not treated)|551
954826|NCT00116688|2307112|P2|NOT COMPLETED|Overall Study||4
954827|NCT00116688|2307113|P1|NOT COMPLETED|Overall Study||92
954828|NCT00116688|2307112|P2|COMPLETED|Overall Study||17
954829|NCT00116688|2307113|P1|COMPLETED|Overall Study||200
954830|NCT00116688|2307112|P2|Received Study Medication|Overall Study||20
954831|NCT00116688|2307113|P1|Received Study Medication|Overall Study||291
954832|NCT00116688|2307112|P2|STARTED|Overall Study||21
954833|NCT00116688|2307113|P1|STARTED|Overall Study||292
954834|NCT00116753|2307131|P3|NOT COMPLETED|Overall Study||24
954835|NCT00116753|2307132|P2|NOT COMPLETED|Overall Study||30
954836|NCT00116753|2307133|P1|NOT COMPLETED|Overall Study||32
954837|NCT00116753|2307131|P3|COMPLETED|Overall Study||128
954838|NCT00116753|2307132|P2|COMPLETED|Overall Study||125
954839|NCT00116753|2307133|P1|COMPLETED|Overall Study||121
954840|NCT00116753|2307131|P3|ITT Population|Overall Study||147
954841|NCT00116753|2307132|P2|ITT Population|Overall Study||150
954842|NCT00116753|2307133|P1|ITT Population|Overall Study||150
954843|NCT00116753|2307131|P3|STARTED|Overall Study||152
954844|NCT00116753|2307132|P2|STARTED|Overall Study||155
954845|NCT00116753|2307133|P1|STARTED|Overall Study|Randomised.|153
954846|NCT00116779|2307155|P2|NOT COMPLETED|Overall Study||19
954847|NCT00116779|2307156|P1|NOT COMPLETED|Overall Study||21
954848|NCT00116779|2307155|P2|COMPLETED|Overall Study||45
954849|NCT00116779|2307156|P1|COMPLETED|Overall Study||42
954850|NCT00116779|2307155|P2|STARTED|Overall Study|Randomized and treated; intent-to-treat population|64
954851|NCT00116779|2307156|P1|STARTED|Overall Study|Randomized and treated; Intent-to-treat population|63
954852|NCT00116805|2307188|P2|NOT COMPLETED|Open-label Period Weeks 433 - 480||0
954853|NCT00116805|2307189|P1|NOT COMPLETED|Open-label Period Weeks 433 - 480||4
954854|NCT00116805|2307188|P2|COMPLETED|Open-label Period Weeks 433 - 480||29
954855|NCT00116805|2307189|P1|COMPLETED|Open-label Period Weeks 433 - 480||53
954856|NCT00116805|2307188|P2|STARTED|Open-label Period Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|29
954857|NCT00116805|2307189|P1|STARTED|Open-label Period Weeks 433 - 480||57
954858|NCT00116805|2307188|P2|NOT COMPLETED|Open-label Period Weeks 385 - 432||0
954859|NCT00116805|2307189|P1|NOT COMPLETED|Open-label Period Weeks 385 - 432||2
954860|NCT00116805|2307188|P2|COMPLETED|Open-label Period Weeks 385 - 432||30
954861|NCT00116805|2307189|P1|COMPLETED|Open-label Period Weeks 385 - 432||57
954862|NCT00116805|2307188|P2|STARTED|Open-label Period Weeks 385 - 432|26 participants completed 384 weeks but did not continue on study.|30
954863|NCT00116805|2307189|P1|STARTED|Open-label Period Weeks 385 - 432|31 participants completed 384 weeks but did not continue on study.|59
954864|NCT00116805|2307188|P2|NOT COMPLETED|Open-label Period Weeks 337 - 384||1
954865|NCT00116805|2307189|P1|NOT COMPLETED|Open-label Period Weeks 337 - 384||8
954866|NCT00116805|2307188|P2|COMPLETED|Open-label Period Weeks 337 - 384||56
954867|NCT00116805|2307189|P1|COMPLETED|Open-label Period Weeks 337 - 384||90
954868|NCT00116805|2307188|P2|STARTED|Open-label Period Weeks 337 - 384||57
954869|NCT00116805|2307189|P1|STARTED|Open-label Period Weeks 337 - 384||98
954870|NCT00116805|2307188|P2|NOT COMPLETED|Open-label Period Weeks 289 - 336||7
954871|NCT00116805|2307189|P1|NOT COMPLETED|Open-label Period Weeks 289 - 336||6
954872|NCT00116805|2307188|P2|COMPLETED|Open-label Period Weeks 289 - 336||57
954873|NCT00116805|2307189|P1|COMPLETED|Open-label Period Weeks 289 - 336||98
954874|NCT00116805|2307188|P2|STARTED|Open-label Period Weeks 289 - 336||64
954875|NCT00116805|2307189|P1|STARTED|Open-label Period Weeks 289 - 336||104
954876|NCT00116805|2307188|P2|NOT COMPLETED|Open-label Period Weeks 241 - 288||0
954877|NCT00116805|2307189|P1|NOT COMPLETED|Open-label Period Weeks 241 - 288||6
954878|NCT00116805|2307188|P2|COMPLETED|Open-label Period Weeks 241 - 288||64
954879|NCT00116805|2307189|P1|COMPLETED|Open-label Period Weeks 241 - 288||104
954880|NCT00116805|2307188|P2|STARTED|Open-label Period Weeks 241 - 288||64
954881|NCT00116805|2307189|P1|STARTED|Open-label Period Weeks 241 - 288||110
954882|NCT00116805|2307188|P2|NOT COMPLETED|Open-label Period Weeks 193 - 240||4
954883|NCT00116805|2307189|P1|NOT COMPLETED|Open-label Period Weeks 193 - 240||13
954884|NCT00116805|2307188|P2|COMPLETED|Open-label Period Weeks 193 - 240||64
954885|NCT00116805|2307189|P1|COMPLETED|Open-label Period Weeks 193 - 240||110
954886|NCT00116805|2307188|P2|STARTED|Open-label Period Weeks 193 - 240||68
954887|NCT00116805|2307189|P1|STARTED|Open-label Period Weeks 193 - 240||123
954888|NCT00116805|2307188|P2|NOT COMPLETED|Open-label Period Weeks 145 - 192||6
954889|NCT00116805|2307189|P1|NOT COMPLETED|Open-label Period Weeks 145 - 192||10
954890|NCT00116805|2307188|P2|COMPLETED|Open-label Period Weeks 145 - 192||68
954891|NCT00116805|2307189|P1|COMPLETED|Open-label Period Weeks 145 - 192||123
954892|NCT00116805|2307188|P2|STARTED|Open-label Period Weeks 145 - 192||74
954893|NCT00116805|2307189|P1|STARTED|Open-label Period Weeks 145 - 192||133
954894|NCT00116805|2307188|P2|NOT COMPLETED|Open-label Period Weeks 97 - 144||9
954895|NCT00116805|2307189|P1|NOT COMPLETED|Open-label Period Weeks 97 - 144||11
954896|NCT00116805|2307188|P2|COMPLETED|Open-label Period Weeks 97 - 144||74
954897|NCT00116805|2307189|P1|COMPLETED|Open-label Period Weeks 97 - 144||133
954898|NCT00116805|2307188|P2|STARTED|Open-label Period Weeks 97 - 144||83
954899|NCT00116805|2307189|P1|STARTED|Open-label Period Weeks 97 - 144||144
954900|NCT00116805|2307188|P2|NOT COMPLETED|Open-label Period Weeks 49 - 96||1
954901|NCT00116805|2307189|P1|NOT COMPLETED|Open-label Period Weeks 49 - 96||10
954902|NCT00116805|2307188|P2|COMPLETED|Open-label Period Weeks 49 - 96||83
954903|NCT00116805|2307189|P1|COMPLETED|Open-label Period Weeks 49 - 96||144
954904|NCT00116805|2307188|P2|STARTED|Open-label Period Weeks 49 - 96|1 participant completed 48 weeks but did not continue on study.|84
954905|NCT00116805|2307189|P1|STARTED|Open-label Period Weeks 49 - 96|11 participants completed 48 weeks but did not continue on study.|154
954906|NCT00116805|2307188|P2|NOT COMPLETED|Double-blind Period Through Week 48||5
954907|NCT00116805|2307189|P1|NOT COMPLETED|Double-blind Period Through Week 48||11
954908|NCT00116805|2307188|P2|COMPLETED|Double-blind Period Through Week 48||85
954909|NCT00116805|2307189|P1|COMPLETED|Double-blind Period Through Week 48||165
954910|NCT00116805|2307188|P2|STARTED|Double-blind Period Through Week 48||90
954911|NCT00116805|2307189|P1|STARTED|Double-blind Period Through Week 48||176
954912|NCT00116831|2307282|P2|NOT COMPLETED|Overall Study||72
954913|NCT00116831|2307283|P1|NOT COMPLETED|Overall Study||73
954914|NCT00116831|2307282|P2|COMPLETED|Overall Study||259
954915|NCT00116831|2307283|P1|COMPLETED|Overall Study||264
954916|NCT00116831|2307282|P2|STARTED|Overall Study||331
954917|NCT00116831|2307283|P1|STARTED|Overall Study||337
954918|NCT00117156|2307359|P1|NOT COMPLETED|Overall Study||11
954919|NCT00117156|2307359|P1|COMPLETED|Overall Study||15
954920|NCT00117156|2307359|P1|STARTED|Overall Study||26
954921|NCT00117286|2307369|P2|NOT COMPLETED|Overall Study||21
954922|NCT00117286|2307370|P1|NOT COMPLETED|Overall Study||28
954923|NCT00117286|2307369|P2|COMPLETED|Overall Study||6
954924|NCT00117286|2307370|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|2
954925|NCT00117286|2307369|P2|Switched to Higher Dose|Overall Study||17
954926|NCT00117286|2307370|P1|Switched to Higher Dose|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL)|17
954927|NCT00117286|2307369|P2|STARTED|Overall Study||27
954928|NCT00117286|2307370|P1|STARTED|Overall Study|Safety analysis set|30
954929|NCT00117312|2307382|P4|NOT COMPLETED|Overall Study||21
954930|NCT00117312|2307383|P3|NOT COMPLETED|Overall Study||24
954931|NCT00117312|2307384|P2|NOT COMPLETED|Overall Study||20
954932|NCT00117312|2307385|P1|NOT COMPLETED|Overall Study||10
954933|NCT00117312|2307382|P4|COMPLETED|Overall Study||3
954934|NCT00117312|2307383|P3|COMPLETED|Overall Study||0
954935|NCT00117312|2307384|P2|COMPLETED|Overall Study|Defined as those patients ongoing when the extension study was terminated|4
954936|NCT00117312|2307385|P1|COMPLETED|Overall Study||0
954937|NCT00117312|2307382|P4|Started FE200486 CS06A|Overall Study||9
954938|NCT00117312|2307383|P3|Started FE200486 CS06A|Overall Study||16
954939|NCT00117312|2307384|P2|Started FE200486 CS06A|Overall Study||11
954940|NCT00117312|2307385|P1|Started FE200486 CS06A|Overall Study||1
954941|NCT00117312|2307382|P4|STARTED|Overall Study||24
954942|NCT00117312|2307383|P3|STARTED|Overall Study||24
954943|NCT00117312|2307384|P2|STARTED|Overall Study||24
954944|NCT00117312|2307385|P1|STARTED|Overall Study||10
954945|NCT00117338|2307401|P2|NOT COMPLETED|Overall Study||4
954946|NCT00117338|2307402|P1|NOT COMPLETED|Overall Study||5
954947|NCT00117338|2307401|P2|COMPLETED|Overall Study||127
954948|NCT00117338|2307402|P1|COMPLETED|Overall Study||140
954949|NCT00117338|2307401|P2|STARTED|Overall Study||131
954950|NCT00117338|2307402|P1|STARTED|Overall Study||145
954951|NCT00117559|2307422|P2|NOT COMPLETED|Overall Study||1
954952|NCT00117559|2307423|P1|NOT COMPLETED|Overall Study||1
954953|NCT00117559|2307422|P2|COMPLETED|Overall Study||9
954954|NCT00117559|2307423|P1|COMPLETED|Overall Study||8
954955|NCT00117559|2307422|P2|STARTED|Overall Study||10
954956|NCT00117559|2307423|P1|STARTED|Overall Study||9
954957|NCT00117585|2307429|P1|NOT COMPLETED|Overall Study||0
954958|NCT00117585|2307429|P1|COMPLETED|Overall Study||341
954959|NCT00117585|2307429|P1|STARTED|Overall Study||341
954990|NCT00117637|2307470|P2|NOT COMPLETED|Second Intervention (Period 2)||22
954991|NCT00117637|2307471|P1|NOT COMPLETED|Second Intervention (Period 2)||10
954992|NCT00117637|2307470|P2|COMPLETED|Second Intervention (Period 2)||39
954993|NCT00117637|2307471|P1|COMPLETED|Second Intervention (Period 2)||39
954994|NCT00117637|2307470|P2|Subjects Received Treatment|Second Intervention (Period 2)||61
954995|NCT00117637|2307471|P1|Subjects Received Treatment|Second Intervention (Period 2)||49
954996|NCT00117637|2307470|P2|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|61
954997|NCT00117637|2307471|P1|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|49
954998|NCT00117637|2307470|P2|NOT COMPLETED|First Intervention (Period 1)||25
954999|NCT00117637|2307471|P1|NOT COMPLETED|First Intervention (Period 1)||18
955000|NCT00117637|2307470|P2|COMPLETED|First Intervention (Period 1)||67
955001|NCT00117637|2307471|P1|COMPLETED|First Intervention (Period 1)||79
955002|NCT00117637|2307470|P2|Subjects Received Treatment|First Intervention (Period 1)||90
955003|NCT00117637|2307471|P1|Subjects Received Treatment|First Intervention (Period 1)||97
955004|NCT00117637|2307470|P2|STARTED|First Intervention (Period 1)||92
955005|NCT00117637|2307471|P1|STARTED|First Intervention (Period 1)||97
955006|NCT00117676|2307545|P2|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
955007|NCT00117676|2307546|P1|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
955008|NCT00117676|2307545|P2|COMPLETED|Open-label Period: Weeks 433 - 480||41
955009|NCT00117676|2307546|P1|COMPLETED|Open-label Period: Weeks 433 - 480||80
955010|NCT00117676|2307545|P2|STARTED|Open-label Period: Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|43
955011|NCT00117676|2307546|P1|STARTED|Open-label Period: Weeks 433 - 480||82
955012|NCT00117676|2307545|P2|NOT COMPLETED|Open-label Period: Weeks 385 - 432||2
955013|NCT00117676|2307546|P1|NOT COMPLETED|Open-label Period: Weeks 385 - 432||0
955014|NCT00117676|2307545|P2|COMPLETED|Open-label Period: Weeks 385 - 432||44
955015|NCT00117676|2307546|P1|COMPLETED|Open-label Period: Weeks 385 - 432||82
955016|NCT00117676|2307545|P2|STARTED|Open-label Period: Weeks 385 - 432|44 participants completed 384 weeks but did not continue on study.|46
955017|NCT00117676|2307546|P1|STARTED|Open-label Period: Weeks 385 - 432|94 participants completed 384 weeks but did not continue on study.|82
955018|NCT00117676|2307545|P2|NOT COMPLETED|Open-label Period: Weeks 337 - 384||3
955019|NCT00117676|2307546|P1|NOT COMPLETED|Open-label Period: Weeks 337 - 384||7
955020|NCT00117676|2307545|P2|COMPLETED|Open-label Period: Weeks 337 - 384||90
955021|NCT00117676|2307546|P1|COMPLETED|Open-label Period: Weeks 337 - 384||176
955022|NCT00117676|2307545|P2|STARTED|Open-label Period: Weeks 337 - 384||93
955023|NCT00117676|2307546|P1|STARTED|Open-label Period: Weeks 337 - 384||183
955024|NCT00117676|2307545|P2|NOT COMPLETED|Open-label Period: Weeks 289 - 336||7
955025|NCT00117676|2307546|P1|NOT COMPLETED|Open-label Period: Weeks 289 - 336||9
955026|NCT00117676|2307545|P2|COMPLETED|Open-label Period: Weeks 289 - 336||93
955027|NCT00117676|2307546|P1|COMPLETED|Open-label Period: Weeks 289 - 336||183
955028|NCT00117676|2307545|P2|STARTED|Open-label Period: Weeks 289 - 336||100
955029|NCT00117676|2307546|P1|STARTED|Open-label Period: Weeks 289 - 336||192
955030|NCT00117676|2307545|P2|NOT COMPLETED|Open-label Period: Weeks 241 - 288||3
955031|NCT00117676|2307546|P1|NOT COMPLETED|Open-label Period: Weeks 241 - 288||10
955032|NCT00117676|2307545|P2|COMPLETED|Open-label Period: Weeks 241 - 288||100
955033|NCT00117676|2307546|P1|COMPLETED|Open-label Period: Weeks 241 - 288||192
955034|NCT00117676|2307545|P2|STARTED|Open-label Period: Weeks 241 - 288||103
955035|NCT00117676|2307546|P1|STARTED|Open-label Period: Weeks 241 - 288||202
955036|NCT00117676|2307545|P2|NOT COMPLETED|Open-label Period: Weeks 193 - 240||3
955037|NCT00117676|2307546|P1|NOT COMPLETED|Open-label Period: Weeks 193 - 240||7
955038|NCT00117676|2307545|P2|COMPLETED|Open-label Period: Weeks 193 - 240||103
955039|NCT00117676|2307546|P1|COMPLETED|Open-label Period: Weeks 193 - 240||202
955040|NCT00117676|2307545|P2|STARTED|Open-label Period: Weeks 193 - 240||106
955041|NCT00117676|2307546|P1|STARTED|Open-label Period: Weeks 193 - 240||209
955042|NCT00117676|2307545|P2|NOT COMPLETED|Open-label Period: Weeks 145 - 192||3
955043|NCT00117676|2307546|P1|NOT COMPLETED|Open-label Period: Weeks 145 - 192||10
955044|NCT00117676|2307545|P2|COMPLETED|Open-label Period: Weeks 145 - 192||106
955045|NCT00117676|2307546|P1|COMPLETED|Open-label Period: Weeks 145 - 192||209
955046|NCT00117676|2307545|P2|STARTED|Open-label Period: Weeks 145 - 192||109
955047|NCT00117676|2307546|P1|STARTED|Open-label Period: Weeks 145 - 192||219
955048|NCT00117676|2307545|P2|NOT COMPLETED|Open-label Period: Weeks 97 - 144||1
955049|NCT00117676|2307546|P1|NOT COMPLETED|Open-label Period: Weeks 97 - 144||6
955050|NCT00117676|2307545|P2|COMPLETED|Open-label Period: Weeks 97 - 144||109
955051|NCT00117676|2307546|P1|COMPLETED|Open-label Period: Weeks 97 - 144||219
955052|NCT00117676|2307545|P2|STARTED|Open-label Period: Weeks 97 - 144||110
955053|NCT00117676|2307546|P1|STARTED|Open-label Period: Weeks 97 - 144||225
955054|NCT00117676|2307545|P2|NOT COMPLETED|Open-label Period: Weeks 49 - 96||2
955055|NCT00117676|2307546|P1|NOT COMPLETED|Open-label Period: Weeks 49 - 96||10
955056|NCT00117676|2307545|P2|COMPLETED|Open-label Period: Weeks 49 - 96||110
955057|NCT00117676|2307546|P1|COMPLETED|Open-label Period: Weeks 49 - 96||225
955058|NCT00117676|2307545|P2|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|112
955059|NCT00117676|2307546|P1|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|235
955060|NCT00117676|2307545|P2|NOT COMPLETED|Double-blind Period Through Week 48||7
955061|NCT00117676|2307546|P1|NOT COMPLETED|Double-blind Period Through Week 48||10
955062|NCT00117676|2307545|P2|COMPLETED|Double-blind Period Through Week 48||121
955063|NCT00117676|2307546|P1|COMPLETED|Double-blind Period Through Week 48||244
955064|NCT00117676|2307545|P2|STARTED|Double-blind Period Through Week 48||128
955065|NCT00117676|2307546|P1|STARTED|Double-blind Period Through Week 48||254
955066|NCT00117715|2307633|P1|NOT COMPLETED|Overall Study||72
955067|NCT00117715|2307633|P1|COMPLETED|Overall Study||49
955068|NCT00117715|2307633|P1|5 Year|Overall Study||49
955069|NCT00117715|2307633|P1|4.5 Year|Overall Study||55
955070|NCT00117715|2307633|P1|4 Year|Overall Study||58
955071|NCT00117715|2307633|P1|3.5 Year|Overall Study||60
955072|NCT00117715|2307633|P1|3 Year|Overall Study||61
955073|NCT00117715|2307633|P1|2.5 Year|Overall Study||70
955074|NCT00117715|2307633|P1|2 Year|Overall Study||76
955075|NCT00117715|2307633|P1|1.5 Year|Overall Study||85
955076|NCT00117715|2307633|P1|1 Year|Overall Study||88
955077|NCT00117715|2307633|P1|STARTED|Overall Study||121
955078|NCT00117793|2307639|P1|NOT COMPLETED|Overall Study||12
955079|NCT00117793|2307639|P1|COMPLETED|Overall Study||5
955080|NCT00117793|2307639|P1|STARTED|Overall Study||17
955081|NCT00117806|2307656|P2|NOT COMPLETED|Overall Study||16
955082|NCT00117806|2307657|P1|NOT COMPLETED|Overall Study||38
955083|NCT00117806|2307656|P2|COMPLETED|Overall Study||60
955084|NCT00117806|2307657|P1|COMPLETED|Overall Study||43
955085|NCT00117806|2307656|P2|STARTED|Overall Study||76
955086|NCT00117806|2307657|P1|STARTED|Overall Study||81
955087|NCT00117845|2307667|P1|NOT COMPLETED|Overall Study||1
955088|NCT00117845|2307667|P1|COMPLETED|Overall Study||16
955089|NCT00117845|2307667|P1|STARTED|Overall Study||17
955090|NCT00117949|2307676|P4|NOT COMPLETED|Overall Study||24
955091|NCT00117949|2307677|P3|NOT COMPLETED|Overall Study||24
955092|NCT00117949|2307678|P2|NOT COMPLETED|Overall Study||24
955093|NCT00117949|2307679|P1|NOT COMPLETED|Overall Study||10
955094|NCT00117949|2307676|P4|COMPLETED|Overall Study||0
955095|NCT00117949|2307677|P3|COMPLETED|Overall Study||0
955096|NCT00117949|2307678|P2|COMPLETED|Overall Study||0
955097|NCT00117949|2307679|P1|COMPLETED|Overall Study||0
955098|NCT00117949|2307676|P4|STARTED|Overall Study||24
955099|NCT00117949|2307677|P3|STARTED|Overall Study||24
955100|NCT00117949|2307678|P2|STARTED|Overall Study||24
955101|NCT00117949|2307679|P1|STARTED|Overall Study|Dose level terminated prematurely due to inadequate testosterone response|10
955102|NCT00117962|2307715|P2|NOT COMPLETED|Overall Study||25
955103|NCT00117962|2307716|P1|NOT COMPLETED|Overall Study||22
955104|NCT00117962|2307715|P2|COMPLETED|Overall Study||28
955105|NCT00117962|2307716|P1|COMPLETED|Overall Study||26
955106|NCT00117962|2307715|P2|STARTED|Overall Study||53
955107|NCT00117962|2307716|P1|STARTED|Overall Study||48
955108|NCT00117988|2307728|P1|NOT COMPLETED|Overall Study||4
955109|NCT00117988|2307728|P1|COMPLETED|Overall Study||18
955110|NCT00117988|2307728|P1|STARTED|Overall Study||22
955111|NCT00118040|2307735|P3|NOT COMPLETED|Overall Study||6
955112|NCT00118040|2307736|P2|NOT COMPLETED|Overall Study||2
955113|NCT00118040|2307737|P1|NOT COMPLETED|Overall Study||1
955114|NCT00118040|2307735|P3|COMPLETED|Overall Study||14
955115|NCT00118040|2307736|P2|COMPLETED|Overall Study||18
955116|NCT00118040|2307737|P1|COMPLETED|Overall Study||19
955117|NCT00118040|2307735|P3|STARTED|Overall Study||20
955118|NCT00118040|2307736|P2|STARTED|Overall Study||20
955119|NCT00118040|2307737|P1|STARTED|Overall Study||20
955120|NCT00118053|2307798|P1|NOT COMPLETED|Overall Study||0
955121|NCT00118053|2307798|P1|COMPLETED|Overall Study||5
955122|NCT00118053|2307798|P1|STARTED|Overall Study||5
955123|NCT00118092|2307805|P1|NOT COMPLETED|Overall Study||2
955124|NCT00118092|2307805|P1|COMPLETED|Overall Study||15
955125|NCT00118092|2307805|P1|STARTED|Overall Study||17
955126|NCT00118131|2307813|P1|NOT COMPLETED|Overall Study||0
955127|NCT00118131|2307813|P1|COMPLETED|Overall Study||49
955128|NCT00118131|2307813|P1|STARTED|Overall Study||49
955129|NCT00118144|2307820|P1|NOT COMPLETED|Overall Study||1
955130|NCT00118144|2307820|P1|COMPLETED|Overall Study||41
955131|NCT00118144|2307820|P1|STARTED|Overall Study||42
955132|NCT00118157|2307826|P1|NOT COMPLETED|Overall Study||12
955133|NCT00118157|2307826|P1|COMPLETED|Overall Study||7
955134|NCT00118157|2307826|P1|STARTED|Overall Study||19
955135|NCT00118248|2307832|P2|NOT COMPLETED|Overall Study||0
955136|NCT00118248|2307833|P1|NOT COMPLETED|Overall Study||0
955137|NCT00118248|2307832|P2|COMPLETED|Overall Study||24
955138|NCT00118248|2307833|P1|COMPLETED|Overall Study||17
955139|NCT00118248|2307832|P2|STARTED|Overall Study||24
955140|NCT00118248|2307833|P1|STARTED|Overall Study||17
955141|NCT00118287|2307846|P1|NOT COMPLETED|Overall Study||2
955142|NCT00118287|2307846|P1|COMPLETED|Overall Study||30
955143|NCT00118287|2307846|P1|STARTED|Overall Study||32
955144|NCT00118352|2307853|P3|NOT COMPLETED|Overall Study||0
955145|NCT00118352|2307854|P2|NOT COMPLETED|Overall Study||0
955146|NCT00118352|2307855|P1|NOT COMPLETED|Overall Study||0
955147|NCT00118352|2307853|P3|COMPLETED|Overall Study||0
955148|NCT00118352|2307854|P2|COMPLETED|Overall Study||0
955149|NCT00118352|2307855|P1|COMPLETED|Overall Study||12
955150|NCT00118352|2307853|P3|STARTED|Overall Study||0
955151|NCT00118352|2307854|P2|STARTED|Overall Study||0
955152|NCT00118352|2307855|P1|STARTED|Overall Study||12
955153|NCT00118365|2307883|P2|NOT COMPLETED|Overall Study||60
955154|NCT00118365|2307884|P1|NOT COMPLETED|Overall Study||59
955155|NCT00118365|2307883|P2|COMPLETED|Overall Study||124
955156|NCT00118365|2307884|P1|COMPLETED|Overall Study||132
955157|NCT00118365|2307883|P2|STARTED|Overall Study||184
955158|NCT00118365|2307884|P1|STARTED|Overall Study||191
955159|NCT00118378|2307952|P2|NOT COMPLETED|Overall Study||8
955160|NCT00118378|2307953|P1|NOT COMPLETED|Overall Study||2
955161|NCT00118378|2307952|P2|COMPLETED|Overall Study||45
955162|NCT00118378|2307953|P1|COMPLETED|Overall Study||60
955163|NCT00118378|2307952|P2|STARTED|Overall Study||53
955164|NCT00118378|2307953|P1|STARTED|Overall Study||62
955165|NCT00118404|2307968|P3|NOT COMPLETED|Overall Study||20
955166|NCT00118404|2307969|P2|NOT COMPLETED|Overall Study||16
955167|NCT00118404|2307970|P1|NOT COMPLETED|Overall Study||24
955168|NCT00118404|2307968|P3|COMPLETED|Overall Study||49
955169|NCT00118404|2307969|P2|COMPLETED|Overall Study||70
955170|NCT00118404|2307970|P1|COMPLETED|Overall Study||62
955171|NCT00118404|2307968|P3|STARTED|Overall Study||69
955172|NCT00118404|2307969|P2|STARTED|Overall Study||86
955173|NCT00118404|2307970|P1|STARTED|Overall Study||86
955174|NCT00118417|2307984|P2|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
955175|NCT00118417|2307985|P1|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
955176|NCT00118417|2307984|P2|COMPLETED|Phase III (Weeks 12 to 24)||9
955177|NCT00118417|2307985|P1|COMPLETED|Phase III (Weeks 12 to 24)||8
955178|NCT00118417|2307984|P2|STARTED|Phase III (Weeks 12 to 24)||10
955179|NCT00118417|2307985|P1|STARTED|Phase III (Weeks 12 to 24)||9
955180|NCT00118417|2307984|P2|NOT COMPLETED|Phase II (Weeks 6 to 12)||3
955181|NCT00118417|2307985|P1|NOT COMPLETED|Phase II (Weeks 6 to 12)||2
955182|NCT00118417|2307984|P2|COMPLETED|Phase II (Weeks 6 to 12)||10
955183|NCT00118417|2307985|P1|COMPLETED|Phase II (Weeks 6 to 12)||9
955184|NCT00118417|2307984|P2|STARTED|Phase II (Weeks 6 to 12)||13
955185|NCT00118417|2307985|P1|STARTED|Phase II (Weeks 6 to 12)|Three new participants on Phase 1 endpoint doses of SSRIs entered at Phase 2.|11
955186|NCT00118417|2307984|P2|NOT COMPLETED|Phase I (Weeks 0 to 6)||0
955187|NCT00118417|2307985|P1|NOT COMPLETED|Phase I (Weeks 0 to 6)||18
955188|NCT00118417|2307984|P2|COMPLETED|Phase I (Weeks 0 to 6)||0
955189|NCT00118417|2307985|P1|COMPLETED|Phase I (Weeks 0 to 6)||21
955190|NCT00118417|2307984|P2|STARTED|Phase I (Weeks 0 to 6)|In Phase 1, all participants received open label SSRI - no second treatment arm.|0
955191|NCT00118417|2307985|P1|STARTED|Phase I (Weeks 0 to 6)||39
955192|NCT00118430|2307998|P3|NOT COMPLETED|Overall Study||28
955193|NCT00118430|2307999|P2|NOT COMPLETED|Overall Study||24
955194|NCT00118430|2308000|P1|NOT COMPLETED|Overall Study||21
955195|NCT00118430|2307998|P3|COMPLETED|Overall Study||222
955196|NCT00118430|2307999|P2|COMPLETED|Overall Study|127 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|103
955197|NCT00118430|2308000|P1|COMPLETED|Overall Study|123 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|102
955198|NCT00118430|2307998|P3|STARTED|Overall Study||250
955199|NCT00118430|2307999|P2|STARTED|Overall Study||127
955200|NCT00118430|2308000|P1|STARTED|Overall Study||123
955201|NCT00118482|2308017|P2|NOT COMPLETED|Overall Study||29
955202|NCT00118482|2308018|P1|NOT COMPLETED|Overall Study||30
955203|NCT00118482|2308017|P2|COMPLETED|Overall Study||76
955204|NCT00118482|2308018|P1|COMPLETED|Overall Study|210 in the Intention To Treat analysis|75
955205|NCT00118482|2308017|P2|STARTED|Overall Study||105
955206|NCT00118482|2308018|P1|STARTED|Overall Study|3 patients signed the consent but did not take the study medication.|105
955207|NCT00118534|2308028|P2|NOT COMPLETED|Overall Study||0
955208|NCT00118534|2308029|P1|NOT COMPLETED|Overall Study||0
955209|NCT00118534|2308028|P2|COMPLETED|Overall Study||471
955210|NCT00118534|2308029|P1|COMPLETED|Overall Study||472
955211|NCT00118534|2308028|P2|STARTED|Overall Study||471
955212|NCT00118534|2308029|P1|STARTED|Overall Study||472
955213|NCT00118703|2308113|P2|NOT COMPLETED|Overall Study||9
955214|NCT00118703|2308114|P1|NOT COMPLETED|Overall Study||5
955215|NCT00118703|2308113|P2|COMPLETED|Overall Study||165
955216|NCT00118703|2308114|P1|COMPLETED|Overall Study||168
955217|NCT00118703|2308113|P2|STARTED|Overall Study||174
955218|NCT00118703|2308114|P1|STARTED|Overall Study||173
955219|NCT00118742|2308126|P2|NOT COMPLETED|Overall Study||66
955220|NCT00118742|2308127|P1|NOT COMPLETED|Overall Study||49
955221|NCT00118742|2308126|P2|COMPLETED|Overall Study||82
955222|NCT00118742|2308127|P1|COMPLETED|Overall Study||96
955223|NCT00118742|2308126|P2|STARTED|Overall Study||148
955224|NCT00118742|2308127|P1|STARTED|Overall Study||145
955225|NCT00118755|2308141|P2|NOT COMPLETED|Overall Study||215
955226|NCT00118755|2308142|P1|NOT COMPLETED|Overall Study||210
955227|NCT00118755|2308141|P2|COMPLETED|Overall Study||3
955228|NCT00118755|2308142|P1|COMPLETED|Overall Study||7
955229|NCT00118755|2308141|P2|Safety Population|Overall Study||211
955230|NCT00118755|2308142|P1|Safety Population|Overall Study||208
955231|NCT00118755|2308141|P2|STARTED|Overall Study||218
955232|NCT00118755|2308142|P1|STARTED|Overall Study||217
955233|NCT00118898|2308158|P4|NOT COMPLETED|Overall Study||141
955234|NCT00118898|2308159|P3|NOT COMPLETED|Overall Study||123
955235|NCT00118898|2308160|P2|NOT COMPLETED|Overall Study||141
955236|NCT00118898|2308161|P1|NOT COMPLETED|Overall Study||121
955237|NCT00118898|2308158|P4|COMPLETED|Overall Study||322
955238|NCT00118898|2308159|P3|COMPLETED|Overall Study||342
955239|NCT00118898|2308160|P2|COMPLETED|Overall Study||324
955240|NCT00118898|2308161|P1|COMPLETED|Overall Study||343
955241|NCT00118898|2308158|P4|Initiated Treatment|Overall Study||462
955242|NCT00118898|2308159|P3|Initiated Treatment|Overall Study||464
955243|NCT00118898|2308160|P2|Initiated Treatment|Overall Study||461
955244|NCT00118898|2308161|P1|Initiated Treatment|Overall Study||461
955245|NCT00118898|2308158|P4|STARTED|Overall Study||463
955246|NCT00118898|2308159|P3|STARTED|Overall Study||465
955247|NCT00118898|2308160|P2|STARTED|Overall Study||465
955248|NCT00118898|2308161|P1|STARTED|Overall Study||464
955249|NCT00118911|2308257|P2|NOT COMPLETED|Overall Study||5
955250|NCT00118911|2308258|P1|NOT COMPLETED|Overall Study||2
955251|NCT00118911|2308257|P2|COMPLETED|Overall Study||38
955252|NCT00118911|2308258|P1|COMPLETED|Overall Study||41
955253|NCT00118911|2308257|P2|12 Month Follow-up|Overall Study|2 participants did not complete the 6 month follow-up but did complete the 12 month follow-up|32
955254|NCT00118911|2308258|P1|12 Month Follow-up|Overall Study|1 participant did not complete the 6 month follow-up but did complete the 12 month follow-up|38
955255|NCT00118911|2308257|P2|6 Month Follow-up|Overall Study||30
955256|NCT00118911|2308258|P1|6 Month Follow-up|Overall Study||37
955257|NCT00118911|2308257|P2|Completed Post-Treatment Assessment|Overall Study||37
955258|NCT00118911|2308258|P1|Completed Post-Treatment Assessment|Overall Study||41
955259|NCT00118911|2308257|P2|Received Intervention as Assigned|Overall Study||38
955260|NCT00118911|2308258|P1|Received Intervention as Assigned|Overall Study||41
955261|NCT00118911|2308257|P2|STARTED|Overall Study||43
955262|NCT00118911|2308258|P1|STARTED|Overall Study||43
955263|NCT00119015|2308268|P3|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
955264|NCT00119015|2308269|P2|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
955354|NCT00119678|2308457|P2|COMPLETED|Open-label Treatment Period||0
955265|NCT00119015|2308270|P1|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
955266|NCT00119015|2308268|P3|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||26
955267|NCT00119015|2308269|P2|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||28
955268|NCT00119015|2308270|P1|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
955269|NCT00119015|2308268|P3|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|26
955270|NCT00119015|2308269|P2|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|28
955271|NCT00119015|2308270|P1|STARTED|Double-Blind, Randomized Phase (2 Weeks)||0
955272|NCT00119015|2308268|P3|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
955273|NCT00119015|2308269|P2|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
955274|NCT00119015|2308270|P1|NOT COMPLETED|Open-Label Phase (2 Weeks)||48
955275|NCT00119015|2308268|P3|COMPLETED|Open-Label Phase (2 Weeks)||0
955276|NCT00119015|2308269|P2|COMPLETED|Open-Label Phase (2 Weeks)||0
955277|NCT00119015|2308270|P1|COMPLETED|Open-Label Phase (2 Weeks)||54
955278|NCT00119015|2308268|P3|STARTED|Open-Label Phase (2 Weeks)||0
955279|NCT00119015|2308269|P2|STARTED|Open-Label Phase (2 Weeks)||0
955280|NCT00119015|2308270|P1|STARTED|Open-Label Phase (2 Weeks)||102
955281|NCT00119041|2308287|P3|NOT COMPLETED|Overall Study||0
955282|NCT00119041|2308288|P2|NOT COMPLETED|Overall Study||0
955283|NCT00119041|2308289|P1|NOT COMPLETED|Overall Study||0
955284|NCT00119041|2308287|P3|COMPLETED|Overall Study||22
955285|NCT00119041|2308288|P2|COMPLETED|Overall Study||83
955286|NCT00119041|2308289|P1|COMPLETED|Overall Study||199
955287|NCT00119041|2308287|P3|STARTED|Overall Study||22
955288|NCT00119041|2308288|P2|STARTED|Overall Study||83
955289|NCT00119041|2308289|P1|STARTED|Overall Study||199
955290|NCT00119158|2308300|P2|NOT COMPLETED|Placebo Treatment||0
955291|NCT00119158|2308301|P1|NOT COMPLETED|Placebo Treatment||0
955292|NCT00119158|2308300|P2|COMPLETED|Placebo Treatment||45
955293|NCT00119158|2308301|P1|COMPLETED|Placebo Treatment||45
955294|NCT00119158|2308300|P2|STARTED|Placebo Treatment||45
955295|NCT00119158|2308301|P1|STARTED|Placebo Treatment||45
955296|NCT00119158|2308300|P2|NOT COMPLETED|Active Treatment||0
955297|NCT00119158|2308301|P1|NOT COMPLETED|Active Treatment||0
955298|NCT00119158|2308300|P2|COMPLETED|Active Treatment||45
955299|NCT00119158|2308301|P1|COMPLETED|Active Treatment||45
955300|NCT00119158|2308300|P2|STARTED|Active Treatment||45
955301|NCT00119158|2308301|P1|STARTED|Active Treatment|patients are self controls|45
955302|NCT00119262|2308311|P2|NOT COMPLETED|Overall Study||58
955303|NCT00119262|2308312|P1|NOT COMPLETED|Overall Study||46
955304|NCT00119262|2308311|P2|COMPLETED|Overall Study||64
955305|NCT00119262|2308312|P1|COMPLETED|Overall Study||58
955306|NCT00119262|2308311|P2|Eligible and Treated|Overall Study||119
955307|NCT00119262|2308312|P1|Eligible and Treated|Overall Study||102
955308|NCT00119262|2308311|P2|Treated|Overall Study||120
955309|NCT00119262|2308312|P1|Treated|Overall Study||103
955310|NCT00119262|2308311|P2|Eligible|Overall Study||120
955311|NCT00119262|2308312|P1|Eligible|Overall Study||103
955312|NCT00119262|2308311|P2|STARTED|Overall Study||122
955313|NCT00119262|2308312|P1|STARTED|Overall Study||104
955314|NCT00119379|2308324|P2|NOT COMPLETED|Overall Study||1
955315|NCT00119379|2308325|P1|NOT COMPLETED|Overall Study||4
955316|NCT00119379|2308324|P2|COMPLETED|Overall Study||23
955317|NCT00119379|2308325|P1|COMPLETED|Overall Study||22
955318|NCT00119379|2308324|P2|STARTED|Overall Study||24
955319|NCT00119379|2308325|P1|STARTED|Overall Study||26
955320|NCT00119392|2308341|P1|NOT COMPLETED|Overall Study||5
955321|NCT00119392|2308341|P1|COMPLETED|Overall Study||40
955322|NCT00119392|2308341|P1|STARTED|Overall Study||45
955323|NCT00119405|2308349|P1|NOT COMPLETED|Overall Study||1
955324|NCT00119405|2308349|P1|COMPLETED|Overall Study||17
955325|NCT00119405|2308349|P1|STARTED|Overall Study||18
955326|NCT00113763|2308355|P2|NOT COMPLETED|Overall Study||26
955327|NCT00113763|2308356|P1|NOT COMPLETED|Overall Study||73
955328|NCT00113763|2308355|P2|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|206
955329|NCT00113763|2308356|P1|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|158
955330|NCT00113763|2308355|P2|Received Study Drug|Overall Study||0
955331|NCT00113763|2308356|P1|Received Study Drug|Overall Study||229
955332|NCT00113763|2308355|P2|STARTED|Overall Study||232
955333|NCT00113763|2308356|P1|STARTED|Overall Study||231
955334|NCT00113841|2308382|P2|NOT COMPLETED|Overall Study||2
955335|NCT00113841|2308383|P1|NOT COMPLETED|Overall Study||1
955336|NCT00113841|2308382|P2|COMPLETED|Overall Study||15
955337|NCT00113841|2308383|P1|COMPLETED|Overall Study||15
955338|NCT00113841|2308382|P2|STARTED|Overall Study||17
955339|NCT00113841|2308383|P1|STARTED|Overall Study||16
955340|NCT00113880|2308392|P3|NOT COMPLETED|Overall Study||0
955341|NCT00113880|2308393|P2|NOT COMPLETED|Overall Study||0
955342|NCT00113880|2308394|P1|NOT COMPLETED|Overall Study||0
955343|NCT00113880|2308392|P3|COMPLETED|Overall Study||62492
955344|NCT00113880|2308393|P2|COMPLETED|Overall Study||71949
955345|NCT00113880|2308394|P1|COMPLETED|Overall Study||63061
955346|NCT00113880|2308392|P3|STARTED|Overall Study||62492
955347|NCT00113880|2308393|P2|STARTED|Overall Study||71949
955348|NCT00113880|2308394|P1|STARTED|Overall Study||63061
955352|NCT00119678|2308457|P2|NOT COMPLETED|Open-label Treatment Period||0
955353|NCT00119678|2308458|P1|NOT COMPLETED|Open-label Treatment Period||110
955355|NCT00119678|2308458|P1|COMPLETED|Open-label Treatment Period||0
955356|NCT00119678|2308457|P2|STARTED|Open-label Treatment Period||0
955357|NCT00119678|2308458|P1|STARTED|Open-label Treatment Period|Number of participants treated|110
955358|NCT00119678|2308457|P2|NOT COMPLETED|Double-blind Treatment Period||26
955359|NCT00119678|2308458|P1|NOT COMPLETED|Double-blind Treatment Period||41
955360|NCT00119678|2308457|P2|COMPLETED|Double-blind Treatment Period||35
955361|NCT00119678|2308458|P1|COMPLETED|Double-blind Treatment Period||81
955362|NCT00119678|2308457|P2|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||57
955363|NCT00119678|2308458|P1|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||118
955364|NCT00119678|2308457|P2|RANDOMIZED AND TREATED|Double-blind Treatment Period||59
955365|NCT00119678|2308458|P1|RANDOMIZED AND TREATED|Double-blind Treatment Period||121
955366|NCT00119678|2308457|P2|STARTED|Double-blind Treatment Period||61
955367|NCT00119678|2308458|P1|STARTED|Double-blind Treatment Period||122
955368|NCT00121134|2308508|P4|NOT COMPLETED|Overall Study||9
955369|NCT00121134|2308509|P3|NOT COMPLETED|Overall Study||21
955370|NCT00121134|2308510|P2|NOT COMPLETED|Overall Study||15
955371|NCT00121134|2308511|P1|NOT COMPLETED|Overall Study||16
955372|NCT00121134|2308508|P4|COMPLETED|Overall Study||31
955373|NCT00121134|2308509|P3|COMPLETED|Overall Study||20
955374|NCT00121134|2308510|P2|COMPLETED|Overall Study||26
955375|NCT00121134|2308511|P1|COMPLETED|Overall Study||24
955376|NCT00121134|2308508|P4|STARTED|Overall Study||40
955377|NCT00121134|2308509|P3|STARTED|Overall Study||41
955378|NCT00121134|2308510|P2|STARTED|Overall Study||41
955379|NCT00121134|2308511|P1|STARTED|Overall Study||40
955380|NCT00121186|2308521|P1|NOT COMPLETED|Overall Study||0
955381|NCT00121186|2308521|P1|COMPLETED|Overall Study||1
955382|NCT00121186|2308521|P1|STARTED|Overall Study||1
955383|NCT00121199|2308526|P1|NOT COMPLETED|Overall Study||28
955384|NCT00121199|2308526|P1|COMPLETED|Overall Study||45
955385|NCT00121199|2308526|P1|Eligible and Began Protocol Therapy|Overall Study||64
955386|NCT00121199|2308526|P1|Eligible|Overall Study||64
955387|NCT00121199|2308526|P1|STARTED|Overall Study||73
955388|NCT00121225|2308533|P1|NOT COMPLETED|Overall Study||0
955389|NCT00121225|2308533|P1|COMPLETED|Overall Study||32
955390|NCT00121225|2308533|P1|STARTED|Overall Study||32
955391|NCT00121238|2308537|P1|NOT COMPLETED|Overall Study||3
955392|NCT00121238|2308537|P1|COMPLETED|Overall Study|2 were later deemed ineligible (PSA rise), censored from efficacy but included for toxicity analysis|13
955393|NCT00121238|2308537|P1|STARTED|Overall Study||16
955394|NCT00121472|2308545|P1|NOT COMPLETED|Overall Study||0
955395|NCT00121472|2308545|P1|COMPLETED|Overall Study|Followed for at least 1 year after implantation of HM II LVAS.|194
955396|NCT00121472|2308545|P1|STARTED|Overall Study||194
955397|NCT00121485|2308558|P2|NOT COMPLETED|Overall Study||7
955398|NCT00121485|2308559|P1|NOT COMPLETED|Overall Study||1
955399|NCT00121485|2308558|P2|COMPLETED|Overall Study||59
955400|NCT00121485|2308559|P1|COMPLETED|Overall Study||133
955401|NCT00121485|2308558|P2|STARTED|Overall Study||66
955402|NCT00121485|2308559|P1|STARTED|Overall Study||134
955461|NCT00121719|2308827|P14|NOT COMPLETED|Overall Study||7
955462|NCT00121719|2308828|P13|NOT COMPLETED|Overall Study||24
955463|NCT00121719|2308829|P12|NOT COMPLETED|Overall Study||5
955464|NCT00121719|2308830|P11|NOT COMPLETED|Overall Study||6
955465|NCT00121719|2308831|P10|NOT COMPLETED|Overall Study||3
955466|NCT00121719|2308832|P9|NOT COMPLETED|Overall Study||6
955467|NCT00121719|2308833|P8|NOT COMPLETED|Overall Study||9
955468|NCT00121719|2308834|P7|NOT COMPLETED|Overall Study||12
955469|NCT00121719|2308835|P6|NOT COMPLETED|Overall Study||3
955470|NCT00121719|2308836|P5|NOT COMPLETED|Overall Study||3
955471|NCT00121719|2308837|P4|NOT COMPLETED|Overall Study||3
955472|NCT00121719|2308838|P3|NOT COMPLETED|Overall Study||4
955473|NCT00121719|2308839|P2|NOT COMPLETED|Overall Study||4
955474|NCT00121719|2308840|P1|NOT COMPLETED|Overall Study||4
955475|NCT00121719|2308827|P14|COMPLETED|Overall Study||0
955476|NCT00121719|2308828|P13|COMPLETED|Overall Study||0
955477|NCT00121719|2308829|P12|COMPLETED|Overall Study||0
955478|NCT00121719|2308830|P11|COMPLETED|Overall Study||0
955479|NCT00121719|2308831|P10|COMPLETED|Overall Study||0
955480|NCT00121719|2308832|P9|COMPLETED|Overall Study||0
955481|NCT00121719|2308833|P8|COMPLETED|Overall Study||0
955482|NCT00121719|2308834|P7|COMPLETED|Overall Study||0
955483|NCT00121719|2308835|P6|COMPLETED|Overall Study||0
955484|NCT00121719|2308836|P5|COMPLETED|Overall Study||0
955485|NCT00121719|2308837|P4|COMPLETED|Overall Study||0
955486|NCT00121719|2308838|P3|COMPLETED|Overall Study||0
955487|NCT00121719|2308839|P2|COMPLETED|Overall Study||0
955488|NCT00121719|2308840|P1|COMPLETED|Overall Study||0
955489|NCT00121719|2308827|P14|STARTED|Overall Study||7
955490|NCT00121719|2308828|P13|STARTED|Overall Study||24
955491|NCT00121719|2308829|P12|STARTED|Overall Study||5
955492|NCT00121719|2308830|P11|STARTED|Overall Study||6
955493|NCT00121719|2308831|P10|STARTED|Overall Study||3
955494|NCT00121719|2308832|P9|STARTED|Overall Study||6
955495|NCT00121719|2308833|P8|STARTED|Overall Study||9
955496|NCT00121719|2308834|P7|STARTED|Overall Study||12
955497|NCT00121719|2308835|P6|STARTED|Overall Study||3
955498|NCT00121719|2308836|P5|STARTED|Overall Study||3
955499|NCT00121719|2308837|P4|STARTED|Overall Study||3
955500|NCT00121719|2308838|P3|STARTED|Overall Study||4
955501|NCT00121719|2308839|P2|STARTED|Overall Study||4
955502|NCT00121719|2308840|P1|STARTED|Overall Study||4
955503|NCT00121810|2309015|P2|NOT COMPLETED|Overall Study||39
955504|NCT00121810|2309016|P1|NOT COMPLETED|Overall Study||30
955505|NCT00121810|2309015|P2|COMPLETED|Overall Study||115
955506|NCT00121810|2309016|P1|COMPLETED|Overall Study||121
955507|NCT00121810|2309015|P2|Intent-to-Treat (ITT) Population|Overall Study||151
955508|NCT00121810|2309016|P1|Intent-to-Treat (ITT) Population|Overall Study||148
955509|NCT00121810|2309015|P2|Safety Population|Overall Study||153
955510|NCT00121810|2309016|P1|Safety Population|Overall Study||148
955511|NCT00121810|2309015|P2|STARTED|Overall Study||154
955512|NCT00121810|2309016|P1|STARTED|Overall Study||151
955513|NCT00121836|2309030|P1|NOT COMPLETED|Overall Study||55
955514|NCT00121836|2309030|P1|COMPLETED|Overall Study||54
955515|NCT00121836|2309030|P1|STARTED|Overall Study||109
955516|NCT00122109|2309041|P2|NOT COMPLETED|Overall Study||7
955517|NCT00122109|2309042|P1|NOT COMPLETED|Overall Study||6
955518|NCT00122109|2309041|P2|COMPLETED|Overall Study||57
955519|NCT00122109|2309042|P1|COMPLETED|Overall Study||55
955520|NCT00122109|2309041|P2|STARTED|Overall Study|ITT|64
955521|NCT00122109|2309042|P1|STARTED|Overall Study|ITT|61
955522|NCT00122135|2309068|P2|NOT COMPLETED|Overall Study||0
955523|NCT00122135|2309069|P1|NOT COMPLETED|Overall Study||3
955524|NCT00122135|2309068|P2|COMPLETED|Overall Study||60
955525|NCT00122135|2309069|P1|COMPLETED|Overall Study||57
955526|NCT00122135|2309068|P2|STARTED|Overall Study||60
955527|NCT00122135|2309069|P1|STARTED|Overall Study||60
955528|NCT00122187|2309077|P2|NOT COMPLETED|Overall Study||2
955529|NCT00122187|2309078|P1|NOT COMPLETED|Overall Study||2
955530|NCT00122187|2309077|P2|COMPLETED|Overall Study||2
955531|NCT00122187|2309078|P1|COMPLETED|Overall Study||2
955532|NCT00122187|2309077|P2|Post-intervention Data Collection|Overall Study||2
955533|NCT00122187|2309078|P1|Post-intervention Data Collection|Overall Study||2
955534|NCT00122187|2309077|P2|Intervention Implemented|Overall Study||4
955535|NCT00122187|2309078|P1|Intervention Implemented|Overall Study||3
955536|NCT00122187|2309077|P2|Randomized to Intervention or Usual Care|Overall Study||4
955537|NCT00122187|2309078|P1|Randomized to Intervention or Usual Care|Overall Study||4
955538|NCT00122187|2309077|P2|Matched by Colonoscopy Volume|Overall Study||4
955539|NCT00122187|2309078|P1|Matched by Colonoscopy Volume|Overall Study||4
955540|NCT00122187|2309077|P2|STARTED|Overall Study||4
955541|NCT00122187|2309078|P1|STARTED|Overall Study||4
955542|NCT00122317|2309090|P1|NOT COMPLETED|Overall Study||11
955543|NCT00122317|2309090|P1|COMPLETED|Overall Study||176
955544|NCT00122317|2309090|P1|STARTED|Overall Study||187
955545|NCT00122369|2309097|P3|NOT COMPLETED|Overall Study||0
955546|NCT00122369|2309098|P2|NOT COMPLETED|Overall Study||0
955547|NCT00122369|2309099|P1|NOT COMPLETED|Overall Study||0
955548|NCT00122369|2309097|P3|COMPLETED|Overall Study||78
955549|NCT00122369|2309098|P2|COMPLETED|Overall Study||82
955550|NCT00122369|2309099|P1|COMPLETED|Overall Study||76
955551|NCT00122369|2309097|P3|STARTED|Overall Study||78
955552|NCT00122369|2309098|P2|STARTED|Overall Study||82
955553|NCT00122369|2309099|P1|STARTED|Overall Study||76
955554|NCT00122382|2309190|P3|NOT COMPLETED|Open-Label Study||26
955555|NCT00122382|2309191|P2|NOT COMPLETED|Open-Label Study||0
955556|NCT00122382|2309192|P1|NOT COMPLETED|Open-Label Study||0
955557|NCT00122382|2309190|P3|COMPLETED|Open-Label Study||433
955558|NCT00122382|2309191|P2|COMPLETED|Open-Label Study||0
955559|NCT00122382|2309192|P1|COMPLETED|Open-Label Study||0
955560|NCT00122382|2309190|P3|STARTED|Open-Label Study||459
955561|NCT00122382|2309191|P2|STARTED|Open-Label Study||0
955562|NCT00122382|2309192|P1|STARTED|Open-Label Study||0
955563|NCT00122382|2309190|P3|NOT COMPLETED|Double-Blind Study||0
955564|NCT00122382|2309191|P2|NOT COMPLETED|Double-Blind Study||28
955565|NCT00122382|2309192|P1|NOT COMPLETED|Double-Blind Study||24
955566|NCT00122382|2309190|P3|COMPLETED|Double-Blind Study||0
955567|NCT00122382|2309191|P2|COMPLETED|Double-Blind Study||227
955568|NCT00122382|2309192|P1|COMPLETED|Double-Blind Study||232
955569|NCT00122382|2309190|P3|Treated|Double-Blind Study||0
955570|NCT00122382|2309191|P2|Treated|Double-Blind Study||253
955571|NCT00122382|2309192|P1|Treated|Double-Blind Study||256
955572|NCT00122382|2309190|P3|STARTED|Double-Blind Study||0
955573|NCT00122382|2309191|P2|STARTED|Double-Blind Study|participants randomized|255
955574|NCT00122382|2309192|P1|STARTED|Double-Blind Study|participants randomized|256
955575|NCT00122447|2309246|P4|NOT COMPLETED|Overall Study||3
955576|NCT00122447|2309247|P3|NOT COMPLETED|Overall Study||1
955577|NCT00122447|2309248|P2|NOT COMPLETED|Overall Study||5
955578|NCT00122447|2309249|P1|NOT COMPLETED|Overall Study||1
955579|NCT00122447|2309246|P4|COMPLETED|Overall Study||14
955580|NCT00122447|2309247|P3|COMPLETED|Overall Study||16
955581|NCT00122447|2309248|P2|COMPLETED|Overall Study||13
955582|NCT00122447|2309249|P1|COMPLETED|Overall Study||17
955583|NCT00122447|2309246|P4|STARTED|Overall Study||17
955584|NCT00122447|2309247|P3|STARTED|Overall Study||17
955585|NCT00122447|2309248|P2|STARTED|Overall Study||18
955586|NCT00122447|2309249|P1|STARTED|Overall Study||18
955587|NCT00122460|2309269|P2|NOT COMPLETED|Overall Study||1
955588|NCT00122460|2309270|P1|NOT COMPLETED|Overall Study||7
955589|NCT00122460|2309269|P2|COMPLETED|Overall Study||219
955590|NCT00122460|2309270|P1|COMPLETED|Overall Study||215
955591|NCT00122460|2309269|P2|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|220
955592|NCT00122460|2309270|P1|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|222
955593|NCT00122681|2309294|P2|NOT COMPLETED|Overall Study||1521
955594|NCT00122681|2309295|P1|NOT COMPLETED|Overall Study||1514
955595|NCT00122681|2309294|P2|COMPLETED|Overall Study||7798
955596|NCT00122681|2309295|P1|COMPLETED|Overall Study||7811
955597|NCT00122681|2309294|P2|STARTED|Overall Study||9319
955598|NCT00122681|2309295|P1|STARTED|Overall Study||9325
955599|NCT00122954|2309369|P2|NOT COMPLETED|Overall Study||3
955600|NCT00122954|2309370|P1|NOT COMPLETED|Overall Study||2
955601|NCT00122954|2309369|P2|COMPLETED|Overall Study||18
955602|NCT00122954|2309370|P1|COMPLETED|Overall Study||16
955603|NCT00122954|2309369|P2|STARTED|Overall Study||21
955604|NCT00122954|2309370|P1|STARTED|Overall Study||18
955605|NCT00122980|2309380|P2|NOT COMPLETED|Overall Study||40
955606|NCT00122980|2309381|P1|NOT COMPLETED|Overall Study||43
955607|NCT00122980|2309380|P2|COMPLETED|Overall Study|Study terminated early|26
955608|NCT00122980|2309381|P1|COMPLETED|Overall Study|Study terminated early|24
955609|NCT00122980|2309380|P2|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 66|66
955610|NCT00122980|2309381|P1|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 67|67
955611|NCT00123123|2309406|P3|NOT COMPLETED|Overall Study||0
955612|NCT00123123|2309407|P2|NOT COMPLETED|Overall Study||0
955613|NCT00123123|2309408|P1|NOT COMPLETED|Overall Study||0
955614|NCT00123123|2309406|P3|COMPLETED|Overall Study||58
955615|NCT00123123|2309407|P2|COMPLETED|Overall Study||58
955616|NCT00123123|2309408|P1|COMPLETED|Overall Study||59
955617|NCT00123123|2309406|P3|STARTED|Overall Study||58
955618|NCT00123123|2309407|P2|STARTED|Overall Study||58
955619|NCT00123123|2309408|P1|STARTED|Overall Study||59
955620|NCT00123162|2309421|P2|NOT COMPLETED|Overall Study||0
955621|NCT00123162|2309422|P1|NOT COMPLETED|Overall Study||0
955622|NCT00123162|2309421|P2|COMPLETED|Overall Study||12
955623|NCT00123162|2309422|P1|COMPLETED|Overall Study||13
955624|NCT00123162|2309421|P2|STARTED|Overall Study||12
955625|NCT00123162|2309422|P1|STARTED|Overall Study||13
955626|NCT00123409|2309432|P2|NOT COMPLETED|Overall Study||3
955627|NCT00123409|2309433|P1|NOT COMPLETED|Overall Study||4
955628|NCT00123409|2309432|P2|COMPLETED|Overall Study||71
955629|NCT00123409|2309433|P1|COMPLETED|Overall Study||68
955630|NCT00123409|2309432|P2|STARTED|Overall Study||74
955631|NCT00123409|2309433|P1|STARTED|Overall Study||72
955632|NCT00123422|2309444|P3|NOT COMPLETED|Overall Study||10
955633|NCT00123422|2309445|P2|NOT COMPLETED|Overall Study||6
955634|NCT00123422|2309446|P1|NOT COMPLETED|Overall Study||4
955635|NCT00123422|2309444|P3|COMPLETED|Overall Study||25
955636|NCT00123422|2309445|P2|COMPLETED|Overall Study||27
955637|NCT00123422|2309446|P1|COMPLETED|Overall Study||31
955638|NCT00123422|2309444|P3|8-week Testing|Overall Study||27
955639|NCT00123422|2309445|P2|8-week Testing|Overall Study||30
955640|NCT00123422|2309446|P1|8-week Testing|Overall Study||32
955641|NCT00123422|2309444|P3|STARTED|Overall Study||35
955642|NCT00123422|2309445|P2|STARTED|Overall Study||33
955643|NCT00123422|2309446|P1|STARTED|Overall Study||35
955644|NCT00123474|2309461|P4|NOT COMPLETED|As Treated at Study Closure||167
955645|NCT00123474|2309462|P3|NOT COMPLETED|As Treated at Study Closure||167
955646|NCT00123474|2309463|P2|NOT COMPLETED|As Treated at Study Closure||163
955647|NCT00123474|2309464|P1|NOT COMPLETED|As Treated at Study Closure||165
955648|NCT00123474|2309461|P4|COMPLETED|As Treated at Study Closure||0
955649|NCT00123474|2309462|P3|COMPLETED|As Treated at Study Closure|Randomized to 100 mg QD but received 50 mg BID.|0
955650|NCT00123474|2309463|P2|COMPLETED|As Treated at Study Closure||0
955651|NCT00123474|2309464|P1|COMPLETED|As Treated at Study Closure||0
955652|NCT00123474|2309461|P4|STARTED|As Treated at Study Closure||167
955653|NCT00123474|2309462|P3|STARTED|As Treated at Study Closure||167
955654|NCT00123474|2309463|P2|STARTED|As Treated at Study Closure||163
955655|NCT00123474|2309464|P1|STARTED|As Treated at Study Closure|Randomized to 50 mg BID but received 100 mg QD.|165
955656|NCT00123474|2309461|P4|NOT COMPLETED|Randomized to Treatment||1
955657|NCT00123474|2309462|P3|NOT COMPLETED|Randomized to Treatment||2
955658|NCT00123474|2309463|P2|NOT COMPLETED|Randomized to Treatment||4
955659|NCT00123474|2309464|P1|NOT COMPLETED|Randomized to Treatment||1
955660|NCT00123474|2309461|P4|COMPLETED|Randomized to Treatment||167
955661|NCT00123474|2309462|P3|COMPLETED|Randomized to Treatment||166
955662|NCT00123474|2309463|P2|COMPLETED|Randomized to Treatment||163
955663|NCT00123474|2309464|P1|COMPLETED|Randomized to Treatment||166
955664|NCT00123474|2309461|P4|STARTED|Randomized to Treatment||168
955665|NCT00123474|2309462|P3|STARTED|Randomized to Treatment||168
955666|NCT00123474|2309463|P2|STARTED|Randomized to Treatment||167
955667|NCT00123474|2309464|P1|STARTED|Randomized to Treatment||167
955668|NCT00123487|2309557|P2|NOT COMPLETED|Treated With Study Drug||305
955669|NCT00123487|2309558|P1|NOT COMPLETED|Treated With Study Drug||304
955670|NCT00123487|2309557|P2|COMPLETED|Treated With Study Drug||0
955671|NCT00123487|2309558|P1|COMPLETED|Treated With Study Drug||0
955672|NCT00123487|2309557|P2|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 305 represents actual BID treatment.|305
955673|NCT00123487|2309558|P1|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 304 represents actual QD treatment.|304
955674|NCT00123487|2309557|P2|NOT COMPLETED|Randomized||1
955675|NCT00123487|2309558|P1|NOT COMPLETED|Randomized||1
955676|NCT00123487|2309557|P2|COMPLETED|Randomized||304
955677|NCT00123487|2309558|P1|COMPLETED|Randomized||305
955678|NCT00123487|2309557|P2|STARTED|Randomized||305
955679|NCT00123487|2309558|P1|STARTED|Randomized||306
955680|NCT00116857|2309600|P2|NOT COMPLETED|Overall Study||4
955681|NCT00116857|2309601|P1|NOT COMPLETED|Overall Study||3
955682|NCT00116857|2309600|P2|COMPLETED|Overall Study||56
955683|NCT00116857|2309601|P1|COMPLETED|Overall Study||59
955684|NCT00116857|2309600|P2|STARTED|Overall Study||60
955685|NCT00116857|2309601|P1|STARTED|Overall Study||62
955686|NCT00123604|2309609|P2|NOT COMPLETED|Overall Study||1
955687|NCT00123604|2309610|P1|NOT COMPLETED|Overall Study||1
955688|NCT00123604|2309609|P2|COMPLETED|Overall Study||16
955689|NCT00123604|2309610|P1|COMPLETED|Overall Study||18
955690|NCT00123604|2309609|P2|STARTED|Overall Study||17
955691|NCT00123604|2309610|P1|STARTED|Overall Study||19
955692|NCT00123630|2309618|P2|NOT COMPLETED|Overall Study||0
955693|NCT00123630|2309619|P1|NOT COMPLETED|Overall Study||0
955694|NCT00123630|2309618|P2|COMPLETED|Overall Study||15
955695|NCT00123630|2309619|P1|COMPLETED|Overall Study||15
955696|NCT00123630|2309618|P2|STARTED|Overall Study||15
955697|NCT00123630|2309619|P1|STARTED|Overall Study||15
955698|NCT00123643|2309627|P2|NOT COMPLETED|Overall Study||0
955699|NCT00123643|2309628|P1|NOT COMPLETED|Overall Study||0
955700|NCT00123643|2309627|P2|COMPLETED|Overall Study||16
955701|NCT00123643|2309628|P1|COMPLETED|Overall Study||20
955702|NCT00123643|2309627|P2|STARTED|Overall Study||16
955703|NCT00123643|2309628|P1|STARTED|Overall Study||20
955704|NCT00123682|2309638|P4|NOT COMPLETED|Overall Study||95
955705|NCT00123682|2309639|P3|NOT COMPLETED|Overall Study||154
955706|NCT00123682|2309640|P2|NOT COMPLETED|Overall Study||203
955707|NCT00123682|2309641|P1|NOT COMPLETED|Overall Study||320
955708|NCT00123682|2309638|P4|COMPLETED|Overall Study||430
955709|NCT00123682|2309639|P3|COMPLETED|Overall Study||438
955710|NCT00123682|2309640|P2|COMPLETED|Overall Study||731
955711|NCT00123682|2309641|P1|COMPLETED|Overall Study||749
955712|NCT00123682|2309638|P4|STARTED|Overall Study||525
955713|NCT00123682|2309639|P3|STARTED|Overall Study||592
955714|NCT00123682|2309640|P2|STARTED|Overall Study||934
955715|NCT00123682|2309641|P1|STARTED|Overall Study||1069
955716|NCT00123734|2309659|P1|NOT COMPLETED|Overall Study||8
955717|NCT00123734|2309659|P1|COMPLETED|Overall Study||74
955718|NCT00123734|2309659|P1|STARTED|Overall Study||82
955719|NCT00124449|2309692|P2|NOT COMPLETED|18-Month Untreated Observation Period||13
955720|NCT00124449|2309693|P1|NOT COMPLETED|18-Month Untreated Observation Period||15
955721|NCT00124449|2309692|P2|COMPLETED|18-Month Untreated Observation Period||4
955722|NCT00124449|2309693|P1|COMPLETED|18-Month Untreated Observation Period||7
955723|NCT00124449|2309692|P2|Completed Year 1 of Study|18-Month Untreated Observation Period||9
955724|NCT00124449|2309693|P1|Completed Year 1 of Study|18-Month Untreated Observation Period||14
955725|NCT00124449|2309692|P2|STARTED|18-Month Untreated Observation Period||17
955726|NCT00124449|2309693|P1|STARTED|18-Month Untreated Observation Period||22
955727|NCT00124449|2309692|P2|NOT COMPLETED|6-month Double-Blind Treatment Period||11
955728|NCT00124449|2309693|P1|NOT COMPLETED|6-month Double-Blind Treatment Period||6
955729|NCT00124449|2309692|P2|COMPLETED|6-month Double-Blind Treatment Period||17
955730|NCT00124449|2309693|P1|COMPLETED|6-month Double-Blind Treatment Period||22
955731|NCT00124449|2309692|P2|STARTED|6-month Double-Blind Treatment Period||28
955732|NCT00124449|2309693|P1|STARTED|6-month Double-Blind Treatment Period||28
955733|NCT00124462|2309728|P2|NOT COMPLETED|Overall Study||13
955734|NCT00124462|2309729|P1|NOT COMPLETED|Overall Study||11
955735|NCT00124462|2309728|P2|COMPLETED|Overall Study||27
955736|NCT00124462|2309729|P1|COMPLETED|Overall Study||29
955737|NCT00124462|2309728|P2|STARTED|Overall Study||40
955738|NCT00124462|2309729|P1|STARTED|Overall Study||40
955739|NCT00124579|2309737|P1|NOT COMPLETED|Maintenance||2
955740|NCT00124579|2309737|P1|COMPLETED|Maintenance||0
955741|NCT00124579|2309737|P1|STARTED|Maintenance||2
955742|NCT00124579|2309737|P1|NOT COMPLETED|Induction||5
955743|NCT00124579|2309737|P1|COMPLETED|Induction||2
955744|NCT00124579|2309737|P1|STARTED|Induction||7
955745|NCT00124618|2309743|P1|NOT COMPLETED|Overall Study||1
955746|NCT00124618|2309743|P1|COMPLETED|Overall Study||57
955747|NCT00124618|2309743|P1|STARTED|Overall Study||58
955748|NCT00124657|2309753|P3|NOT COMPLETED|Overall Study||32
955749|NCT00124657|2309754|P2|NOT COMPLETED|Overall Study||5
955750|NCT00124657|2309755|P1|NOT COMPLETED|Overall Study||16
955751|NCT00124657|2309753|P3|COMPLETED|Overall Study||7
955752|NCT00124657|2309754|P2|COMPLETED|Overall Study||0
955753|NCT00124657|2309755|P1|COMPLETED|Overall Study||2
955754|NCT00124657|2309753|P3|STARTED|Overall Study||39
955755|NCT00124657|2309754|P2|STARTED|Overall Study||5
955756|NCT00124657|2309755|P1|STARTED|Overall Study||18
955757|NCT00124709|2309792|P2|NOT COMPLETED|Overall Study||272
955758|NCT00124709|2309793|P1|NOT COMPLETED|Overall Study||255
955759|NCT00124709|2309792|P2|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|273
955760|NCT00124709|2309793|P1|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|291
955761|NCT00124709|2309792|P2|Patients Who Received Study Medication|Overall Study||544
955762|NCT00124709|2309793|P1|Patients Who Received Study Medication|Overall Study||543
955763|NCT00124709|2309792|P2|STARTED|Overall Study||545
955764|NCT00124709|2309793|P1|STARTED|Overall Study||546
955765|NCT00124735|2309817|P10|NOT COMPLETED|Overall Study||2
955766|NCT00124735|2309818|P9|NOT COMPLETED|Overall Study||3
955767|NCT00124735|2309819|P8|NOT COMPLETED|Overall Study||1
955768|NCT00124735|2309820|P7|NOT COMPLETED|Overall Study||0
955769|NCT00124735|2309821|P6|NOT COMPLETED|Overall Study||2
955770|NCT00124735|2309822|P5|NOT COMPLETED|Overall Study||2
955771|NCT00124735|2309823|P4|NOT COMPLETED|Overall Study||3
955772|NCT00124735|2309824|P3|NOT COMPLETED|Overall Study||0
955773|NCT00124735|2309825|P2|NOT COMPLETED|Overall Study||2
955774|NCT00124735|2309826|P1|NOT COMPLETED|Overall Study||1
955775|NCT00124735|2309817|P10|COMPLETED|Overall Study||18
955776|NCT00124735|2309818|P9|COMPLETED|Overall Study||22
955777|NCT00124735|2309819|P8|COMPLETED|Overall Study||19
955778|NCT00124735|2309820|P7|COMPLETED|Overall Study||6
955779|NCT00124735|2309821|P6|COMPLETED|Overall Study||5
955780|NCT00124735|2309822|P5|COMPLETED|Overall Study||17
955781|NCT00124735|2309823|P4|COMPLETED|Overall Study||18
955782|NCT00124735|2309824|P3|COMPLETED|Overall Study||18
955783|NCT00124735|2309825|P2|COMPLETED|Overall Study||6
955784|NCT00124735|2309826|P1|COMPLETED|Overall Study||4
955785|NCT00124735|2309817|P10|STARTED|Overall Study||20
955786|NCT00124735|2309818|P9|STARTED|Overall Study||25
955787|NCT00124735|2309819|P8|STARTED|Overall Study||20
955788|NCT00124735|2309820|P7|STARTED|Overall Study||6
955789|NCT00124735|2309821|P6|STARTED|Overall Study||7
955790|NCT00124735|2309822|P5|STARTED|Overall Study||19
955791|NCT00124735|2309823|P4|STARTED|Overall Study||21
955792|NCT00124735|2309824|P3|STARTED|Overall Study||18
955793|NCT00124735|2309825|P2|STARTED|Overall Study||8
955794|NCT00124735|2309826|P1|STARTED|Overall Study||5
955795|NCT00124748|2309872|P2|NOT COMPLETED|Overall Study||284
955796|NCT00124748|2309873|P1|NOT COMPLETED|Overall Study||143
955797|NCT00124748|2309872|P2|COMPLETED|Overall Study||35
955798|NCT00124748|2309873|P1|COMPLETED|Overall Study||14
955799|NCT00124748|2309872|P2|Safety Population|Overall Study||316
955800|NCT00124748|2309873|P1|Safety Population|Overall Study||157
955801|NCT00124748|2309872|P2|STARTED|Overall Study||319
955802|NCT00124748|2309873|P1|STARTED|Overall Study||157
955803|NCT00124943|2309919|P4|NOT COMPLETED|Phase II||5
955804|NCT00124943|2309920|P3|NOT COMPLETED|Phase II||0
955805|NCT00124943|2309921|P2|NOT COMPLETED|Phase II||2
955806|NCT00124943|2309922|P1|NOT COMPLETED|Phase II||0
955807|NCT00124943|2309919|P4|COMPLETED|Phase II||50
955808|NCT00124943|2309920|P3|COMPLETED|Phase II||3
955809|NCT00124943|2309921|P2|COMPLETED|Phase II||49
955810|NCT00124943|2309922|P1|COMPLETED|Phase II||3
955811|NCT00124943|2309919|P4|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|55
955812|NCT00124943|2309920|P3|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
955813|NCT00124943|2309921|P2|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|51
955814|NCT00124943|2309922|P1|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
955815|NCT00124943|2309919|P4|NOT COMPLETED|Phase I||0
955816|NCT00124943|2309920|P3|NOT COMPLETED|Phase I||0
955817|NCT00124943|2309921|P2|NOT COMPLETED|Phase I||0
955818|NCT00124943|2309922|P1|NOT COMPLETED|Phase I||0
955819|NCT00124943|2309919|P4|COMPLETED|Phase I||3
955820|NCT00124943|2309920|P3|COMPLETED|Phase I||3
955821|NCT00124943|2309921|P2|COMPLETED|Phase I||3
955822|NCT00124943|2309922|P1|COMPLETED|Phase I||3
955823|NCT00124943|2309919|P4|STARTED|Phase I||3
955824|NCT00124943|2309920|P3|STARTED|Phase I||3
955825|NCT00124943|2309921|P2|STARTED|Phase I||3
955826|NCT00124943|2309922|P1|STARTED|Phase I||3
955827|NCT00124982|2309962|P3|NOT COMPLETED|Long-term Period||89
955828|NCT00124982|2309963|P2|NOT COMPLETED|Long-term Period||0
955829|NCT00124982|2309964|P1|NOT COMPLETED|Long-term Period||0
955830|NCT00124982|2309962|P3|COMPLETED|Long-term Period||441
955831|NCT00124982|2309963|P2|COMPLETED|Long-term Period||0
955832|NCT00124982|2309964|P1|COMPLETED|Long-term Period||0
955833|NCT00124982|2309962|P3|STARTED|Long-term Period|A large number did not continue due to a rollover from study drug to commercially available drug.|530
955834|NCT00124982|2309963|P2|STARTED|Long-term Period||0
955835|NCT00124982|2309964|P1|STARTED|Long-term Period||0
955836|NCT00124982|2309962|P3|NOT COMPLETED|Short-term Period||0
955837|NCT00124982|2309963|P2|NOT COMPLETED|Short-term Period||114
955838|NCT00124982|2309964|P1|NOT COMPLETED|Short-term Period||72
955839|NCT00124982|2309962|P3|COMPLETED|Short-term Period||0
955840|NCT00124982|2309963|P2|COMPLETED|Short-term Period||483
955841|NCT00124982|2309964|P1|COMPLETED|Short-term Period||377
955842|NCT00124982|2309962|P3|STARTED|Short-term Period||0
955843|NCT00124982|2309963|P2|STARTED|Short-term Period||597
955844|NCT00124982|2309964|P1|STARTED|Short-term Period||449
955845|NCT00125034|2310044|P2|NOT COMPLETED|Overall Study||0
955846|NCT00125034|2310045|P1|NOT COMPLETED|Overall Study||0
955847|NCT00125034|2310044|P2|COMPLETED|Overall Study||168
955848|NCT00125034|2310045|P1|COMPLETED|Overall Study||170
955849|NCT00125034|2310044|P2|STARTED|Overall Study|Randomized & treated|168
955850|NCT00125034|2310045|P1|STARTED|Overall Study|Randomized & treated. 1 subject was not randomized correctly and was excluded in the ITT population.|170
955851|NCT00125138|2310079|P4|NOT COMPLETED|Overall Study||5
955852|NCT00125138|2310080|P3|NOT COMPLETED|Overall Study||4
955853|NCT00125138|2310081|P2|NOT COMPLETED|Overall Study||3
955854|NCT00125138|2310082|P1|NOT COMPLETED|Overall Study||3
955855|NCT00125138|2310079|P4|COMPLETED|Overall Study||25
955856|NCT00125138|2310080|P3|COMPLETED|Overall Study||21
955857|NCT00125138|2310081|P2|COMPLETED|Overall Study||17
955858|NCT00125138|2310082|P1|COMPLETED|Overall Study||12
955859|NCT00125138|2310079|P4|STARTED|Overall Study||30
955860|NCT00125138|2310080|P3|STARTED|Overall Study||25
955861|NCT00125138|2310081|P2|STARTED|Overall Study|One subject requested withdrawal prior to treatment; data for the subject are excluded from results.|20
955862|NCT00125138|2310082|P1|STARTED|Overall Study||15
955863|NCT00125164|2310100|P4|NOT COMPLETED|Overall Study||6
955864|NCT00125164|2310101|P3|NOT COMPLETED|Overall Study||4
955865|NCT00125164|2310102|P2|NOT COMPLETED|Overall Study||0
955866|NCT00125164|2310103|P1|NOT COMPLETED|Overall Study||2
955867|NCT00125164|2310100|P4|COMPLETED|Overall Study||45
955868|NCT00125164|2310101|P3|COMPLETED|Overall Study||40
955869|NCT00125164|2310102|P2|COMPLETED|Overall Study||16
955870|NCT00125164|2310103|P1|COMPLETED|Overall Study||23
955871|NCT00125164|2310100|P4|STARTED|Overall Study||51
955872|NCT00125164|2310101|P3|STARTED|Overall Study||44
955873|NCT00125164|2310102|P2|STARTED|Overall Study||16
955874|NCT00125164|2310103|P1|STARTED|Overall Study||25
955875|NCT00125190|2310153|P1|NOT COMPLETED|Overall Study||15
955876|NCT00125190|2310153|P1|COMPLETED|Overall Study||30
955877|NCT00125190|2310153|P1|STARTED|Overall Study||45
955878|NCT00125242|2310169|P2|NOT COMPLETED|Overall Study||2
955879|NCT00125242|2310170|P1|NOT COMPLETED|Overall Study||7
955880|NCT00125242|2310169|P2|COMPLETED|Overall Study||14
955881|NCT00125242|2310170|P1|COMPLETED|Overall Study||87
955882|NCT00125242|2310169|P2|STARTED|Overall Study||16
955883|NCT00125242|2310170|P1|STARTED|Overall Study||94
955884|NCT00125268|2310177|P2|NOT COMPLETED|Overall Study||1
955885|NCT00125268|2310178|P1|NOT COMPLETED|Overall Study||1
955886|NCT00125268|2310177|P2|COMPLETED|Overall Study||13
955887|NCT00125268|2310178|P1|COMPLETED|Overall Study||15
955888|NCT00125268|2310177|P2|STARTED|Overall Study||14
955889|NCT00125268|2310178|P1|STARTED|Overall Study||16
955890|NCT00125515|2310191|P3|NOT COMPLETED|Overall Study||21
955891|NCT00125515|2310192|P2|NOT COMPLETED|Overall Study||20
955892|NCT00125515|2310193|P1|NOT COMPLETED|Overall Study||20
955893|NCT00125515|2310191|P3|COMPLETED|Overall Study||6
955894|NCT00125515|2310192|P2|COMPLETED|Overall Study||7
955895|NCT00125515|2310193|P1|COMPLETED|Overall Study||7
955896|NCT00125515|2310191|P3|STARTED|Overall Study||27
955897|NCT00125515|2310192|P2|STARTED|Overall Study||27
955898|NCT00125515|2310193|P1|STARTED|Overall Study||27
955899|NCT00125528|2310203|P2|NOT COMPLETED|Overall Study||1
955900|NCT00125528|2310204|P1|NOT COMPLETED|Overall Study||2
955901|NCT00125528|2310203|P2|COMPLETED|Overall Study||20
955902|NCT00125528|2310204|P1|COMPLETED|Overall Study||18
955903|NCT00125528|2310203|P2|STARTED|Overall Study||21
955904|NCT00125528|2310204|P1|STARTED|Overall Study||20
955905|NCT00125593|2310214|P2|NOT COMPLETED|Overall Study||103
955906|NCT00125593|2310215|P1|NOT COMPLETED|Overall Study||101
955907|NCT00125593|2310214|P2|COMPLETED|Overall Study||4517
955908|NCT00125593|2310215|P1|COMPLETED|Overall Study||4549
955909|NCT00125593|2310214|P2|STARTED|Overall Study||4620
955910|NCT00125593|2310215|P1|STARTED|Overall Study||4650
955911|NCT00125619|2310235|P2|NOT COMPLETED|Overall Study||0
955912|NCT00125619|2310236|P1|NOT COMPLETED|Overall Study||0
955913|NCT00125619|2310235|P2|COMPLETED|Overall Study||8
955914|NCT00125619|2310236|P1|COMPLETED|Overall Study||8
955915|NCT00125619|2310235|P2|STARTED|Overall Study||8
955916|NCT00125619|2310236|P1|STARTED|Overall Study||8
955917|NCT00125658|2310256|P2|NOT COMPLETED|Overall Study||0
955918|NCT00125658|2310257|P1|NOT COMPLETED|Overall Study||0
955919|NCT00125658|2310256|P2|COMPLETED|Overall Study||6
955920|NCT00125658|2310257|P1|COMPLETED|Overall Study||8
955921|NCT00125658|2310256|P2|STARTED|Overall Study||6
955922|NCT00125658|2310257|P1|STARTED|Overall Study||8
955923|NCT00125931|2310275|P1|NOT COMPLETED|Overall Study||0
955924|NCT00125931|2310275|P1|COMPLETED|Overall Study||10
955925|NCT00125931|2310275|P1|STARTED|Overall Study||10
955926|NCT00125957|2310282|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
955927|NCT00125957|2310283|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
955928|NCT00125957|2310282|P2|COMPLETED|Second Intervention (3 Weeks)||17
955929|NCT00125957|2310283|P1|COMPLETED|Second Intervention (3 Weeks)||15
955930|NCT00125957|2310282|P2|STARTED|Second Intervention (3 Weeks)||17
955931|NCT00125957|2310283|P1|STARTED|Second Intervention (3 Weeks)||15
955932|NCT00125957|2310282|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
955933|NCT00125957|2310283|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
955934|NCT00125957|2310282|P2|COMPLETED|First Intervention (3 Weeks)||17
955935|NCT00125957|2310283|P1|COMPLETED|First Intervention (3 Weeks)||15
955936|NCT00125957|2310282|P2|STARTED|First Intervention (3 Weeks)||17
955937|NCT00125957|2310283|P1|STARTED|First Intervention (3 Weeks)||15
955938|NCT00126113|2310293|P2|NOT COMPLETED|Overall Study||2
955939|NCT00126113|2310294|P1|NOT COMPLETED|Overall Study||3
955940|NCT00126113|2310293|P2|COMPLETED|Overall Study||35
955941|NCT00126113|2310294|P1|COMPLETED|Overall Study||34
955942|NCT00126113|2310293|P2|STARTED|Overall Study||37
955943|NCT00126113|2310294|P1|STARTED|Overall Study||37
955944|NCT00126126|2310308|P2|NOT COMPLETED|Overall Study||2
955945|NCT00126126|2310309|P1|NOT COMPLETED|Overall Study||0
955946|NCT00126126|2310308|P2|COMPLETED|Overall Study||7
955947|NCT00126126|2310309|P1|COMPLETED|Overall Study||9
955948|NCT00126126|2310308|P2|STARTED|Overall Study||9
955949|NCT00126126|2310309|P1|STARTED|Overall Study||9
955950|NCT00126191|2310319|P2|NOT COMPLETED|Overall Study||2
955951|NCT00126191|2310320|P1|NOT COMPLETED|Overall Study||0
955952|NCT00126191|2310319|P2|COMPLETED|Overall Study|1 pt off study during cycle 1 due to toxicity|6
955953|NCT00126191|2310320|P1|COMPLETED|Overall Study||2
955954|NCT00126191|2310319|P2|STARTED|Overall Study||8
955955|NCT00126191|2310320|P1|STARTED|Overall Study||2
955956|NCT00126425|2310330|P2|NOT COMPLETED|Overall Study||11
955957|NCT00126425|2310331|P1|NOT COMPLETED|Overall Study||41
955958|NCT00126425|2310330|P2|COMPLETED|Overall Study||37
955959|NCT00126425|2310331|P1|COMPLETED|Overall Study||498
955960|NCT00126425|2310330|P2|STARTED|Overall Study||48
955961|NCT00126425|2310331|P1|STARTED|Overall Study||539
955962|NCT00126438|2310339|P2|NOT COMPLETED|Overall Study||10
955963|NCT00126438|2310340|P1|NOT COMPLETED|Overall Study||34
955964|NCT00126438|2310339|P2|COMPLETED|Overall Study||52
955965|NCT00126438|2310340|P1|COMPLETED|Overall Study||419
955966|NCT00126438|2310339|P2|STARTED|Overall Study||62
955967|NCT00126438|2310340|P1|STARTED|Overall Study||453
955968|NCT00126490|2310346|P1|NOT COMPLETED|Overall Study||1
955969|NCT00126490|2310346|P1|COMPLETED|Overall Study||18
955970|NCT00126490|2310346|P1|STARTED|Overall Study||19
955971|NCT00126503|2310356|P2|NOT COMPLETED|Overall Study||21
955972|NCT00126503|2310357|P1|NOT COMPLETED|Overall Study||47
955973|NCT00126503|2310356|P2|COMPLETED|Overall Study||0
955974|NCT00126503|2310357|P1|COMPLETED|Overall Study||1
955975|NCT00126503|2310356|P2|STARTED|Overall Study||21
955976|NCT00126503|2310357|P1|STARTED|Overall Study||48
955977|NCT00126555|2310369|P1|NOT COMPLETED|Overall Study||6
955978|NCT00126555|2310369|P1|COMPLETED|Overall Study||17
955979|NCT00126555|2310369|P1|STARTED|Overall Study||23
955980|NCT00126568|2310383|P1|NOT COMPLETED|Overall Study||2
955981|NCT00126568|2310383|P1|COMPLETED|Overall Study|Disease progression at beginning of study, not evaluable|18
955982|NCT00126568|2310383|P1|STARTED|Overall Study||20
955989|NCT00126594|2310414|P2|NOT COMPLETED|Overall Study||37
955990|NCT00126594|2310415|P1|NOT COMPLETED|Overall Study||39
955991|NCT00126594|2310414|P2|COMPLETED|Overall Study||3
955992|NCT00126594|2310415|P1|COMPLETED|Overall Study||1
955993|NCT00126594|2310414|P2|STARTED|Overall Study||40
955994|NCT00126594|2310415|P1|STARTED|Overall Study||40
955995|NCT00126659|2310433|P3|NOT COMPLETED|Overall Study||2
955996|NCT00126659|2310434|P2|NOT COMPLETED|Overall Study||0
955997|NCT00126659|2310435|P1|NOT COMPLETED|Overall Study||0
955998|NCT00126659|2310433|P3|COMPLETED|Overall Study||2
955999|NCT00126659|2310434|P2|COMPLETED|Overall Study||3
956000|NCT00126659|2310435|P1|COMPLETED|Overall Study||3
956001|NCT00126659|2310433|P3|STARTED|Overall Study||4
956002|NCT00126659|2310434|P2|STARTED|Overall Study||3
956003|NCT00126659|2310435|P1|STARTED|Overall Study||3
956004|NCT00126737|2310445|P4|NOT COMPLETED|Overall Study||7
956005|NCT00126737|2310446|P3|NOT COMPLETED|Overall Study||6
956006|NCT00126737|2310447|P2|NOT COMPLETED|Overall Study||3
956007|NCT00126737|2310448|P1|NOT COMPLETED|Overall Study||6
956008|NCT00126737|2310445|P4|COMPLETED|Overall Study||18
956009|NCT00126737|2310446|P3|COMPLETED|Overall Study||24
956010|NCT00126737|2310447|P2|COMPLETED|Overall Study||24
956011|NCT00126737|2310448|P1|COMPLETED|Overall Study||22
956012|NCT00126737|2310445|P4|STARTED|Overall Study||25
956013|NCT00126737|2310446|P3|STARTED|Overall Study||30
956014|NCT00126737|2310447|P2|STARTED|Overall Study||27
956015|NCT00126737|2310448|P1|STARTED|Overall Study||28
956016|NCT00126750|2310476|P2|NOT COMPLETED|Overall Study||266
956017|NCT00126750|2310477|P1|NOT COMPLETED|Overall Study||180
956018|NCT00126750|2310476|P2|COMPLETED|Overall Study|Total providers at clinic locations were given the option to 'enroll'.|196
956019|NCT00126750|2310477|P1|COMPLETED|Overall Study|Total providers at participating clinic locations were given the option to 'enroll'.|205
956020|NCT00126750|2310476|P2|STARTED|Overall Study|Number of providers from 84 clinics|462
956021|NCT00126750|2310477|P1|STARTED|Overall Study|Number of providers from 84 clinics|385
956022|NCT00120042|2310486|P3|NOT COMPLETED|Overall Study||0
956023|NCT00120042|2310487|P2|NOT COMPLETED|Overall Study||0
956024|NCT00120042|2310488|P1|NOT COMPLETED|Overall Study||0
956025|NCT00120042|2310486|P3|COMPLETED|Overall Study||83
956026|NCT00120042|2310487|P2|COMPLETED|Overall Study||83
956027|NCT00120042|2310488|P1|COMPLETED|Overall Study||85
956028|NCT00120042|2310486|P3|STARTED|Overall Study||83
956029|NCT00120042|2310487|P2|STARTED|Overall Study||83
956030|NCT00120042|2310488|P1|STARTED|Overall Study||85
956031|NCT00120250|2310496|P2|NOT COMPLETED|Overall Study||2
956032|NCT00120250|2310497|P1|NOT COMPLETED|Overall Study||1
956033|NCT00120250|2310496|P2|COMPLETED|Overall Study||12
956034|NCT00120250|2310497|P1|COMPLETED|Overall Study||12
956035|NCT00120250|2310496|P2|STARTED|Overall Study||14
956036|NCT00120250|2310497|P1|STARTED|Overall Study||13
956037|NCT00120289|2310512|P2|NOT COMPLETED|Overall Study||109
956038|NCT00120289|2310513|P1|NOT COMPLETED|Overall Study||121
956039|NCT00120289|2310512|P2|COMPLETED|Overall Study||1587
956040|NCT00120289|2310513|P1|COMPLETED|Overall Study||1597
956041|NCT00120289|2310512|P2|STARTED|Overall Study||1696
956042|NCT00120289|2310513|P1|STARTED|Overall Study||1718
956043|NCT00120406|2310527|P2|NOT COMPLETED|Overall Study||16
956044|NCT00120406|2310528|P1|NOT COMPLETED|Overall Study||19
956045|NCT00120406|2310527|P2|COMPLETED|Overall Study||222
956046|NCT00120406|2310528|P1|COMPLETED|Overall Study||217
956047|NCT00120406|2310527|P2|STARTED|Overall Study||238
956048|NCT00120406|2310528|P1|STARTED|Overall Study||236
956049|NCT00120523|2310538|P2|NOT COMPLETED|Follow-Up Period||24
956050|NCT00120523|2310539|P1|NOT COMPLETED|Follow-Up Period||30
956051|NCT00120523|2310538|P2|COMPLETED|Follow-Up Period||46
956052|NCT00120523|2310539|P1|COMPLETED|Follow-Up Period||90
956053|NCT00120523|2310538|P2|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|70
956054|NCT00120523|2310539|P1|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|120
956055|NCT00120523|2310538|P2|NOT COMPLETED|Treatment Period||339
956056|NCT00120523|2310539|P1|NOT COMPLETED|Treatment Period||369
956057|NCT00120523|2310538|P2|COMPLETED|Treatment Period||874
956058|NCT00120523|2310539|P1|COMPLETED|Treatment Period||836
956059|NCT00120523|2310538|P2|STARTED|Treatment Period||1213
956060|NCT00120523|2310539|P1|STARTED|Treatment Period||1205
956061|NCT00120627|2310563|P2|NOT COMPLETED|Overall Study||5
956062|NCT00120627|2310564|P1|NOT COMPLETED|Overall Study||5
956063|NCT00120627|2310563|P2|COMPLETED|Overall Study|Three people refused the post-assessments CAPS interview only.|70
956064|NCT00120627|2310564|P1|COMPLETED|Overall Study||66
956065|NCT00120627|2310563|P2|Did Not Complete Post-tx Assessments|Overall Study|Three people dropped out but no reason given.|3
956246|NCT00127855|2310866|P5|COMPLETED|Polysaccharide Challenge Dose||77
956066|NCT00120627|2310564|P1|Did Not Complete Post-tx Assessments|Overall Study|One person had a scheduling conflict and two people were incarcerated.|3
956067|NCT00120627|2310563|P2|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and an unknown reason.|73
956068|NCT00120627|2310564|P1|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and illness.|69
956069|NCT00120627|2310563|P2|STARTED|Overall Study|This was the number that enrolled and was randomly assigned to receive the control condition.|75
956070|NCT00120627|2310564|P1|STARTED|Overall Study|This is the number who enrolled and was randomly assigned to receive the Mantram Repetition Program.|71
956071|NCT00120874|2310590|P2|NOT COMPLETED|Overall Study||1
956072|NCT00120874|2310591|P1|NOT COMPLETED|Overall Study||0
956073|NCT00120874|2310590|P2|COMPLETED|Overall Study||9
956074|NCT00120874|2310591|P1|COMPLETED|Overall Study||10
956075|NCT00120874|2310590|P2|Completed Study; Started Extension Study|Overall Study||10
956076|NCT00120874|2310591|P1|Completed Study; Started Extension Study|Overall Study||10
956077|NCT00120874|2310590|P2|STARTED|Overall Study||10
956078|NCT00120874|2310591|P1|STARTED|Overall Study||10
956079|NCT00126776|2310629|P2|NOT COMPLETED|Overall Study||0
956080|NCT00126776|2310630|P1|NOT COMPLETED|Overall Study||0
956081|NCT00126776|2310629|P2|COMPLETED|Overall Study||371
956082|NCT00126776|2310630|P1|COMPLETED|Overall Study||372
956083|NCT00126776|2310629|P2|STARTED|Overall Study||371
956084|NCT00126776|2310630|P1|STARTED|Overall Study||372
956085|NCT00127036|2310636|P2|NOT COMPLETED|Overall Study||11
956086|NCT00127036|2310637|P1|NOT COMPLETED|Overall Study||8
956087|NCT00127036|2310636|P2|COMPLETED|Overall Study|20 Participants were evaluable.|20
956088|NCT00127036|2310637|P1|COMPLETED|Overall Study|26 Participants were evaluable.|26
956089|NCT00127036|2310636|P2|STARTED|Overall Study||31
956090|NCT00127036|2310637|P1|STARTED|Overall Study||34
956091|NCT00127101|2310653|P6|NOT COMPLETED|Continuation Phase||3
956092|NCT00127101|2310654|P5|NOT COMPLETED|Continuation Phase||3
956093|NCT00127101|2310655|P4|NOT COMPLETED|Continuation Phase||0
956094|NCT00127101|2310656|P3|NOT COMPLETED|Continuation Phase||1
956095|NCT00127101|2310657|P2|NOT COMPLETED|Continuation Phase||0
956096|NCT00127101|2310658|P1|NOT COMPLETED|Continuation Phase||0
956097|NCT00127101|2310653|P6|COMPLETED|Continuation Phase||0
956098|NCT00127101|2310654|P5|COMPLETED|Continuation Phase||0
956099|NCT00127101|2310655|P4|COMPLETED|Continuation Phase||0
956100|NCT00127101|2310656|P3|COMPLETED|Continuation Phase||0
956101|NCT00127101|2310657|P2|COMPLETED|Continuation Phase||0
956102|NCT00127101|2310658|P1|COMPLETED|Continuation Phase||0
956103|NCT00127101|2310653|P6|STARTED|Continuation Phase||3
956104|NCT00127101|2310654|P5|STARTED|Continuation Phase||3
956105|NCT00127101|2310655|P4|STARTED|Continuation Phase|No patients from the 2b Cohort entered into the extension phase|0
956106|NCT00127101|2310656|P3|STARTED|Continuation Phase||1
956107|NCT00127101|2310657|P2|STARTED|Continuation Phase||0
956108|NCT00127101|2310658|P1|STARTED|Continuation Phase||0
956109|NCT00127101|2310653|P6|NOT COMPLETED|Base Protocol||1
956110|NCT00127101|2310654|P5|NOT COMPLETED|Base Protocol||2
956111|NCT00127101|2310655|P4|NOT COMPLETED|Base Protocol||0
956112|NCT00127101|2310656|P3|NOT COMPLETED|Base Protocol||2
956113|NCT00127101|2310657|P2|NOT COMPLETED|Base Protocol||4
956114|NCT00127101|2310658|P1|NOT COMPLETED|Base Protocol||2
956115|NCT00127101|2310653|P6|COMPLETED|Base Protocol||3
956116|NCT00127101|2310654|P5|COMPLETED|Base Protocol||3
956117|NCT00127101|2310655|P4|COMPLETED|Base Protocol||3
956118|NCT00127101|2310656|P3|COMPLETED|Base Protocol||1
956119|NCT00127101|2310657|P2|COMPLETED|Base Protocol||1
956120|NCT00127101|2310658|P1|COMPLETED|Base Protocol||1
956121|NCT00127101|2310653|P6|STARTED|Base Protocol||4
956122|NCT00127101|2310654|P5|STARTED|Base Protocol||5
956123|NCT00127101|2310655|P4|STARTED|Base Protocol||3
956124|NCT00127101|2310656|P3|STARTED|Base Protocol||3
956125|NCT00127101|2310657|P2|STARTED|Base Protocol||5
956126|NCT00127101|2310658|P1|STARTED|Base Protocol||3
956127|NCT00127166|2310680|P2|NOT COMPLETED|Period II||0
956128|NCT00127166|2310681|P1|NOT COMPLETED|Period II||3
956129|NCT00127166|2310680|P2|COMPLETED|Period II||73
956130|NCT00127166|2310681|P1|COMPLETED|Period II||72
956131|NCT00127166|2310680|P2|STARTED|Period II||73
956132|NCT00127166|2310681|P1|STARTED|Period II||75
956133|NCT00127166|2310680|P2|NOT COMPLETED|Washout Period||1
956134|NCT00127166|2310681|P1|NOT COMPLETED|Washout Period||0
956135|NCT00127166|2310680|P2|COMPLETED|Washout Period||73
956136|NCT00127166|2310681|P1|COMPLETED|Washout Period||75
956137|NCT00127166|2310680|P2|STARTED|Washout Period||74
956138|NCT00127166|2310681|P1|STARTED|Washout Period||75
956139|NCT00127166|2310680|P2|NOT COMPLETED|Period I||2
956140|NCT00127166|2310681|P1|NOT COMPLETED|Period I||3
956141|NCT00127166|2310680|P2|COMPLETED|Period I||74
956142|NCT00127166|2310681|P1|COMPLETED|Period I||75
956143|NCT00127166|2310680|P2|STARTED|Period I||76
956144|NCT00127166|2310681|P1|STARTED|Period I||78
956145|NCT00127192|2310700|P5|NOT COMPLETED|Overall Study||5
956146|NCT00127192|2310701|P4|NOT COMPLETED|Overall Study||1
956147|NCT00127192|2310702|P3|NOT COMPLETED|Overall Study||2
956148|NCT00127192|2310703|P2|NOT COMPLETED|Overall Study||1
956149|NCT00127192|2310704|P1|NOT COMPLETED|Overall Study||3
956150|NCT00127192|2310700|P5|COMPLETED|Overall Study||68
956151|NCT00127192|2310701|P4|COMPLETED|Overall Study||67
956152|NCT00127192|2310702|P3|COMPLETED|Overall Study||68
956153|NCT00127192|2310703|P2|COMPLETED|Overall Study||71
956154|NCT00127192|2310704|P1|COMPLETED|Overall Study||77
956155|NCT00127192|2310700|P5|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|73
956156|NCT00127192|2310701|P4|STARTED|Overall Study|Study enrolled slightly less than the target of N=70|68
956157|NCT00127192|2310702|P3|STARTED|Overall Study|Study enrolled as per the target of N=70|70
956158|NCT00127192|2310703|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|72
956159|NCT00127192|2310704|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|80
956160|NCT00127218|2310728|P2|NOT COMPLETED|Overall Study||15
956161|NCT00127218|2310729|P1|NOT COMPLETED|Overall Study||13
956162|NCT00127218|2310728|P2|COMPLETED|Overall Study||58
956163|NCT00127218|2310729|P1|COMPLETED|Overall Study||59
956164|NCT00127218|2310728|P2|STARTED|Overall Study||73
956165|NCT00127218|2310729|P1|STARTED|Overall Study||72
956166|NCT00127413|2310739|P4|NOT COMPLETED|Overall Study||2
956167|NCT00127413|2310740|P3|NOT COMPLETED|Overall Study||8
956168|NCT00127413|2310741|P2|NOT COMPLETED|Overall Study||4
956169|NCT00127413|2310742|P1|NOT COMPLETED|Overall Study||6
956170|NCT00127413|2310739|P4|COMPLETED|Overall Study||5
956171|NCT00127413|2310740|P3|COMPLETED|Overall Study||5
956172|NCT00127413|2310741|P2|COMPLETED|Overall Study||6
956173|NCT00127413|2310742|P1|COMPLETED|Overall Study||6
956174|NCT00127413|2310739|P4|STARTED|Overall Study||7
956175|NCT00127413|2310740|P3|STARTED|Overall Study||13
956176|NCT00127413|2310741|P2|STARTED|Overall Study||10
956177|NCT00127413|2310742|P1|STARTED|Overall Study||12
956178|NCT00127530|2310754|P2|NOT COMPLETED|Overall Study||21
956179|NCT00127530|2310755|P1|NOT COMPLETED|Overall Study||1
956180|NCT00127530|2310754|P2|COMPLETED|Overall Study||207
956181|NCT00127530|2310755|P1|COMPLETED|Overall Study||71
956182|NCT00127530|2310754|P2|STARTED|Overall Study||228
956183|NCT00127530|2310755|P1|STARTED|Overall Study||72
956184|NCT00127660|2310765|P4|NOT COMPLETED|Overall Study||0
956185|NCT00127660|2310766|P3|NOT COMPLETED|Overall Study||5
956186|NCT00127660|2310767|P2|NOT COMPLETED|Overall Study||3
956187|NCT00127660|2310768|P1|NOT COMPLETED|Overall Study||3
956188|NCT00127660|2310765|P4|COMPLETED|Overall Study||150
956189|NCT00127660|2310766|P3|COMPLETED|Overall Study||143
956190|NCT00127660|2310767|P2|COMPLETED|Overall Study||151
956191|NCT00127660|2310768|P1|COMPLETED|Overall Study||150
956192|NCT00127660|2310765|P4|STARTED|Overall Study||150
956193|NCT00127660|2310766|P3|STARTED|Overall Study||148
956194|NCT00127660|2310767|P2|STARTED|Overall Study||154
956195|NCT00127660|2310768|P1|STARTED|Overall Study||153
956196|NCT00127712|2310780|P2|NOT COMPLETED|Overall Study||0
956197|NCT00127712|2310781|P1|NOT COMPLETED|Overall Study||5
956198|NCT00127712|2310780|P2|COMPLETED|Overall Study||65
956199|NCT00127712|2310781|P1|COMPLETED|Overall Study||60
956200|NCT00127712|2310780|P2|STARTED|Overall Study||65
956201|NCT00127712|2310781|P1|STARTED|Overall Study||65
956202|NCT00127790|2310797|P4|NOT COMPLETED|Post-Treatment||0
956203|NCT00127790|2310798|P3|NOT COMPLETED|Post-Treatment||0
956204|NCT00127790|2310799|P2|NOT COMPLETED|Post-Treatment||0
956205|NCT00127790|2310800|P1|NOT COMPLETED|Post-Treatment||0
956206|NCT00127790|2310797|P4|COMPLETED|Post-Treatment||4
956207|NCT00127790|2310798|P3|COMPLETED|Post-Treatment||6
956208|NCT00127790|2310799|P2|COMPLETED|Post-Treatment||5
956209|NCT00127790|2310800|P1|COMPLETED|Post-Treatment||6
956210|NCT00127790|2310797|P4|STARTED|Post-Treatment||4
956211|NCT00127790|2310798|P3|STARTED|Post-Treatment||6
956212|NCT00127790|2310799|P2|STARTED|Post-Treatment||5
956213|NCT00127790|2310800|P1|STARTED|Post-Treatment||6
956214|NCT00127790|2310797|P4|NOT COMPLETED|Pre-Treatment||0
956215|NCT00127790|2310798|P3|NOT COMPLETED|Pre-Treatment||0
956216|NCT00127790|2310799|P2|NOT COMPLETED|Pre-Treatment||0
956217|NCT00127790|2310800|P1|NOT COMPLETED|Pre-Treatment||0
956218|NCT00127790|2310797|P4|COMPLETED|Pre-Treatment||4
956219|NCT00127790|2310798|P3|COMPLETED|Pre-Treatment||6
956220|NCT00127790|2310799|P2|COMPLETED|Pre-Treatment||5
956221|NCT00127790|2310800|P1|COMPLETED|Pre-Treatment||6
956222|NCT00127790|2310797|P4|STARTED|Pre-Treatment||4
956223|NCT00127790|2310798|P3|STARTED|Pre-Treatment||6
956224|NCT00127790|2310799|P2|STARTED|Pre-Treatment||5
956225|NCT00127790|2310800|P1|STARTED|Pre-Treatment|7 enrolled subjects were withdrawn prior to randomization; 21 of 28 enrolled were randomized.|6
956226|NCT00127803|2310826|P4|NOT COMPLETED|Overall Study||1
956227|NCT00127803|2310827|P3|NOT COMPLETED|Overall Study||0
956228|NCT00127803|2310828|P2|NOT COMPLETED|Overall Study||0
956229|NCT00127803|2310829|P1|NOT COMPLETED|Overall Study||3
956230|NCT00127803|2310826|P4|COMPLETED|Overall Study||11
956231|NCT00127803|2310827|P3|COMPLETED|Overall Study||12
956232|NCT00127803|2310828|P2|COMPLETED|Overall Study||13
956233|NCT00127803|2310829|P1|COMPLETED|Overall Study||10
956234|NCT00127803|2310826|P4|STARTED|Overall Study||12
956235|NCT00127803|2310827|P3|STARTED|Overall Study||12
956236|NCT00127803|2310828|P2|STARTED|Overall Study||13
956237|NCT00127803|2310829|P1|STARTED|Overall Study||13
956238|NCT00127842|2310847|P1|NOT COMPLETED|Overall Study||39
956239|NCT00127842|2310847|P1|COMPLETED|Overall Study||71
956240|NCT00127842|2310847|P1|STARTED|Overall Study||110
956241|NCT00127855|2310866|P5|NOT COMPLETED|Polysaccharide Challenge Dose||0
956242|NCT00127855|2310867|P4|NOT COMPLETED|Polysaccharide Challenge Dose||0
956243|NCT00127855|2310868|P3|NOT COMPLETED|Polysaccharide Challenge Dose||0
956244|NCT00127855|2310869|P2|NOT COMPLETED|Polysaccharide Challenge Dose||0
956245|NCT00127855|2310870|P1|NOT COMPLETED|Polysaccharide Challenge Dose||0
956247|NCT00127855|2310867|P4|COMPLETED|Polysaccharide Challenge Dose||81
956248|NCT00127855|2310868|P3|COMPLETED|Polysaccharide Challenge Dose||77
956249|NCT00127855|2310869|P2|COMPLETED|Polysaccharide Challenge Dose||79
956250|NCT00127855|2310870|P1|COMPLETED|Polysaccharide Challenge Dose||80
956251|NCT00127855|2310866|P5|STARTED|Polysaccharide Challenge Dose||77
956252|NCT00127855|2310867|P4|STARTED|Polysaccharide Challenge Dose||81
956253|NCT00127855|2310868|P3|STARTED|Polysaccharide Challenge Dose||77
956254|NCT00127855|2310869|P2|STARTED|Polysaccharide Challenge Dose||79
956255|NCT00127855|2310870|P1|STARTED|Polysaccharide Challenge Dose||80
956256|NCT00127855|2310866|P5|NOT COMPLETED|Primary Vaccination Course||4
956257|NCT00127855|2310867|P4|NOT COMPLETED|Primary Vaccination Course||0
956258|NCT00127855|2310868|P3|NOT COMPLETED|Primary Vaccination Course||2
956259|NCT00127855|2310869|P2|NOT COMPLETED|Primary Vaccination Course||1
956260|NCT00127855|2310870|P1|NOT COMPLETED|Primary Vaccination Course||2
956261|NCT00127855|2310866|P5|COMPLETED|Primary Vaccination Course||78
956262|NCT00127855|2310867|P4|COMPLETED|Primary Vaccination Course||81
956263|NCT00127855|2310868|P3|COMPLETED|Primary Vaccination Course||78
956264|NCT00127855|2310869|P2|COMPLETED|Primary Vaccination Course||81
956265|NCT00127855|2310870|P1|COMPLETED|Primary Vaccination Course||80
956266|NCT00127855|2310866|P5|STARTED|Primary Vaccination Course||82
956267|NCT00127855|2310867|P4|STARTED|Primary Vaccination Course||81
956268|NCT00127855|2310868|P3|STARTED|Primary Vaccination Course||80
956269|NCT00127855|2310869|P2|STARTED|Primary Vaccination Course||82
956270|NCT00127855|2310870|P1|STARTED|Primary Vaccination Course||82
956271|NCT00127933|2311054|P2|NOT COMPLETED|Overall Study||0
956272|NCT00127933|2311055|P1|NOT COMPLETED|Overall Study||1
956273|NCT00127933|2311054|P2|COMPLETED|Overall Study||34
956274|NCT00127933|2311055|P1|COMPLETED|Overall Study||122
956275|NCT00127933|2311054|P2|Postoperative|Overall Study||27
956276|NCT00127933|2311055|P1|Postoperative|Overall Study||98
956277|NCT00127933|2311054|P2|Quality of Life Population|Overall Study||33
956278|NCT00127933|2311055|P1|Quality of Life Population|Overall Study||118
956279|NCT00127933|2311054|P2|Safety Population|Overall Study||34
956280|NCT00127933|2311055|P1|Safety Population|Overall Study||122
956281|NCT00127933|2311054|P2|Clinical Response|Overall Study||34
956282|NCT00127933|2311055|P1|Clinical Response|Overall Study||122
956283|NCT00127933|2311054|P2|Pathological Response|Overall Study||28
956284|NCT00127933|2311055|P1|Pathological Response|Overall Study||101
956285|NCT00127933|2311054|P2|STARTED|Overall Study||34
956286|NCT00127933|2311055|P1|STARTED|Overall Study||123
956287|NCT00128180|2311073|P2|NOT COMPLETED|Overall Study||0
956288|NCT00128180|2311074|P1|NOT COMPLETED|Overall Study||0
956289|NCT00128180|2311073|P2|COMPLETED|Overall Study||34
956290|NCT00128180|2311074|P1|COMPLETED|Overall Study||32
956291|NCT00128180|2311073|P2|STARTED|Overall Study||34
956292|NCT00128180|2311074|P1|STARTED|Overall Study||32
956293|NCT00128193|2311110|P12|NOT COMPLETED|Overall Study||2
956294|NCT00128193|2311111|P11|NOT COMPLETED|Overall Study||3
956295|NCT00128193|2311112|P10|NOT COMPLETED|Overall Study||2
956296|NCT00128193|2311113|P9|NOT COMPLETED|Overall Study||2
956297|NCT00128193|2311114|P8|NOT COMPLETED|Overall Study||0
956298|NCT00128193|2311115|P7|NOT COMPLETED|Overall Study||4
956299|NCT00128193|2311116|P6|NOT COMPLETED|Overall Study||3
956300|NCT00128193|2311117|P5|NOT COMPLETED|Overall Study||2
956301|NCT00128193|2311118|P4|NOT COMPLETED|Overall Study||1
956302|NCT00128193|2311119|P3|NOT COMPLETED|Overall Study||3
956303|NCT00128193|2311120|P2|NOT COMPLETED|Overall Study||0
956304|NCT00128193|2311121|P1|NOT COMPLETED|Overall Study||0
956305|NCT00128193|2311110|P12|COMPLETED|Overall Study||18
956306|NCT00128193|2311111|P11|COMPLETED|Overall Study||17
956307|NCT00128193|2311112|P10|COMPLETED|Overall Study||18
956308|NCT00128193|2311113|P9|COMPLETED|Overall Study||18
956309|NCT00128193|2311114|P8|COMPLETED|Overall Study||20
956310|NCT00128193|2311115|P7|COMPLETED|Overall Study||16
956311|NCT00128193|2311116|P6|COMPLETED|Overall Study||17
956312|NCT00128193|2311117|P5|COMPLETED|Overall Study||18
956313|NCT00128193|2311118|P4|COMPLETED|Overall Study||44
956314|NCT00128193|2311119|P3|COMPLETED|Overall Study||42
956315|NCT00128193|2311120|P2|COMPLETED|Overall Study||5
956316|NCT00128193|2311121|P1|COMPLETED|Overall Study||5
956317|NCT00128193|2311110|P12|STARTED|Overall Study||20
956318|NCT00128193|2311111|P11|STARTED|Overall Study||20
956319|NCT00128193|2311112|P10|STARTED|Overall Study||20
956320|NCT00128193|2311113|P9|STARTED|Overall Study||20
956321|NCT00128193|2311114|P8|STARTED|Overall Study||20
956322|NCT00128193|2311115|P7|STARTED|Overall Study||20
956323|NCT00128193|2311116|P6|STARTED|Overall Study||20
956324|NCT00128193|2311117|P5|STARTED|Overall Study||20
956325|NCT00128193|2311118|P4|STARTED|Overall Study||45
956326|NCT00128193|2311119|P3|STARTED|Overall Study||45
956327|NCT00128193|2311120|P2|STARTED|Overall Study||5
956328|NCT00128193|2311121|P1|STARTED|Overall Study||5
956329|NCT00128206|2311357|P2|NOT COMPLETED|Overall Study||120
956330|NCT00128206|2311358|P1|NOT COMPLETED|Overall Study||137
956331|NCT00128206|2311357|P2|COMPLETED|Overall Study||60
956332|NCT00128206|2311358|P1|COMPLETED|Overall Study||47
956333|NCT00128206|2311357|P2|STARTED|Overall Study||180
956334|NCT00128206|2311358|P1|STARTED|Overall Study||184
956335|NCT00128219|2311366|P2|NOT COMPLETED|Overall Study||71
956336|NCT00128219|2311367|P1|NOT COMPLETED|Overall Study||69
956337|NCT00128219|2311366|P2|COMPLETED|Overall Study||263
956338|NCT00128219|2311367|P1|COMPLETED|Overall Study||264
956339|NCT00128219|2311366|P2|STARTED|Overall Study||334
956340|NCT00128219|2311367|P1|STARTED|Overall Study||333
956341|NCT00128401|2311451|P2|NOT COMPLETED|Overall Study||4
956342|NCT00128401|2311452|P1|NOT COMPLETED|Overall Study||6
956343|NCT00128401|2311451|P2|COMPLETED|Overall Study||15
956344|NCT00128401|2311452|P1|COMPLETED|Overall Study||14
956345|NCT00128401|2311451|P2|STARTED|Overall Study||19
956346|NCT00128401|2311452|P1|STARTED|Overall Study||20
956347|NCT00128492|2311463|P2|NOT COMPLETED|Overall Study||59
956348|NCT00128492|2311464|P1|NOT COMPLETED|Overall Study||20
956349|NCT00128492|2311463|P2|COMPLETED|Overall Study||130
956350|NCT00128492|2311464|P1|COMPLETED|Overall Study||65
956351|NCT00128492|2311463|P2|STARTED|Overall Study||189
956352|NCT00128492|2311464|P1|STARTED|Overall Study||85
956353|NCT00128661|2311524|P2|NOT COMPLETED|Overall Study||258
956354|NCT00128661|2311525|P1|NOT COMPLETED|Overall Study||274
956355|NCT00128661|2311524|P2|COMPLETED|Overall Study||3481
956356|NCT00128661|2311525|P1|COMPLETED|Overall Study||3453
956357|NCT00128661|2311524|P2|STARTED|Overall Study||3739
956358|NCT00128661|2311525|P1|STARTED|Overall Study||3727
956359|NCT00128713|2311572|P3|NOT COMPLETED|Overall Study||0
956360|NCT00128713|2311573|P2|NOT COMPLETED|Overall Study||0
956361|NCT00128713|2311574|P1|NOT COMPLETED|Overall Study||0
956362|NCT00128713|2311572|P3|COMPLETED|Overall Study||449
956363|NCT00128713|2311573|P2|COMPLETED|Overall Study||449
956364|NCT00128713|2311574|P1|COMPLETED|Overall Study||453
956365|NCT00128713|2311572|P3|STARTED|Overall Study||449
956366|NCT00128713|2311573|P2|STARTED|Overall Study||449
956367|NCT00128713|2311574|P1|STARTED|Overall Study||453
956368|NCT00128830|2311594|P1|NOT COMPLETED|Overall Study||72
956369|NCT00128830|2311594|P1|COMPLETED|Overall Study||139
956370|NCT00128830|2311594|P1|STARTED|Overall Study||211
956371|NCT00128921|2311612|P3|NOT COMPLETED|Overall Study||0
956372|NCT00128921|2311613|P2|NOT COMPLETED|Overall Study||5
956373|NCT00128921|2311614|P1|NOT COMPLETED|Overall Study||5
956374|NCT00128921|2311612|P3|COMPLETED|Overall Study||0
956375|NCT00128921|2311613|P2|COMPLETED|Overall Study||3
956376|NCT00128921|2311614|P1|COMPLETED|Overall Study||5
956377|NCT00128921|2311612|P3|Received Bortezomib|Overall Study||0
956378|NCT00128921|2311613|P2|Received Bortezomib|Overall Study||6
956379|NCT00128921|2311614|P1|Received Bortezomib|Overall Study||10
956380|NCT00128921|2311612|P3|STARTED|Overall Study||0
956381|NCT00128921|2311613|P2|STARTED|Overall Study||8
956382|NCT00128921|2311614|P1|STARTED|Overall Study||10
956383|NCT00129116|2311636|P5|NOT COMPLETED|Booster Phase||1
956384|NCT00129116|2311637|P4|NOT COMPLETED|Booster Phase||0
956385|NCT00129116|2311638|P3|NOT COMPLETED|Booster Phase||0
956386|NCT00129116|2311639|P2|NOT COMPLETED|Booster Phase||0
956387|NCT00129116|2311640|P1|NOT COMPLETED|Booster Phase||2
956388|NCT00129116|2311636|P5|COMPLETED|Booster Phase||43
956389|NCT00129116|2311637|P4|COMPLETED|Booster Phase||44
956390|NCT00129116|2311638|P3|COMPLETED|Booster Phase||44
956391|NCT00129116|2311639|P2|COMPLETED|Booster Phase||42
956392|NCT00129116|2311640|P1|COMPLETED|Booster Phase||45
956393|NCT00129116|2311636|P5|STARTED|Booster Phase||44
956394|NCT00129116|2311637|P4|STARTED|Booster Phase||44
956395|NCT00129116|2311638|P3|STARTED|Booster Phase||44
956396|NCT00129116|2311639|P2|STARTED|Booster Phase||42
956397|NCT00129116|2311640|P1|STARTED|Booster Phase||47
956398|NCT00129116|2311636|P5|NOT COMPLETED|Primary Phase||1
956399|NCT00129116|2311637|P4|NOT COMPLETED|Primary Phase||1
956400|NCT00129116|2311638|P3|NOT COMPLETED|Primary Phase||1
956401|NCT00129116|2311639|P2|NOT COMPLETED|Primary Phase||4
956402|NCT00129116|2311640|P1|NOT COMPLETED|Primary Phase||2
956403|NCT00129116|2311636|P5|COMPLETED|Primary Phase||76
956404|NCT00129116|2311637|P4|COMPLETED|Primary Phase||77
956405|NCT00129116|2311638|P3|COMPLETED|Primary Phase||77
956406|NCT00129116|2311639|P2|COMPLETED|Primary Phase||73
956407|NCT00129116|2311640|P1|COMPLETED|Primary Phase||76
956408|NCT00129116|2311636|P5|STARTED|Primary Phase||77
956409|NCT00129116|2311637|P4|STARTED|Primary Phase||78
956410|NCT00129116|2311638|P3|STARTED|Primary Phase||78
956411|NCT00129116|2311639|P2|STARTED|Primary Phase||77
956412|NCT00129116|2311640|P1|STARTED|Primary Phase||78
956413|NCT00129129|2311905|P5|NOT COMPLETED|Fourth Dose Phase||6
956414|NCT00129129|2311906|P4|NOT COMPLETED|Fourth Dose Phase||4
956415|NCT00129129|2311907|P3|NOT COMPLETED|Fourth Dose Phase||0
956416|NCT00129129|2311908|P2|NOT COMPLETED|Fourth Dose Phase||0
956417|NCT00129129|2311909|P1|NOT COMPLETED|Fourth Dose Phase||4
956418|NCT00129129|2311905|P5|COMPLETED|Fourth Dose Phase||124
956419|NCT00129129|2311906|P4|COMPLETED|Fourth Dose Phase||128
956420|NCT00129129|2311907|P3|COMPLETED|Fourth Dose Phase||0
956421|NCT00129129|2311908|P2|COMPLETED|Fourth Dose Phase||0
956422|NCT00129129|2311909|P1|COMPLETED|Fourth Dose Phase||232
956423|NCT00129129|2311905|P5|STARTED|Fourth Dose Phase||130
956424|NCT00129129|2311906|P4|STARTED|Fourth Dose Phase||132
956425|NCT00129129|2311907|P3|STARTED|Fourth Dose Phase||0
956426|NCT00129129|2311908|P2|STARTED|Fourth Dose Phase||0
956427|NCT00129129|2311909|P1|STARTED|Fourth Dose Phase||236
956428|NCT00129129|2311905|P5|NOT COMPLETED|Primary Phase||0
956429|NCT00129129|2311906|P4|NOT COMPLETED|Primary Phase||0
956430|NCT00129129|2311907|P3|NOT COMPLETED|Primary Phase||0
956431|NCT00129129|2311908|P2|NOT COMPLETED|Primary Phase||25
956432|NCT00129129|2311909|P1|NOT COMPLETED|Primary Phase||25
956433|NCT00129129|2311905|P5|COMPLETED|Primary Phase||0
956434|NCT00129129|2311906|P4|COMPLETED|Primary Phase||0
956435|NCT00129129|2311907|P3|COMPLETED|Primary Phase||150
956436|NCT00129129|2311908|P2|COMPLETED|Primary Phase||294
956437|NCT00129129|2311909|P1|COMPLETED|Primary Phase||262
956438|NCT00129129|2311905|P5|STARTED|Primary Phase||0
956439|NCT00129129|2311906|P4|STARTED|Primary Phase||0
956440|NCT00129129|2311907|P3|STARTED|Primary Phase||150
956441|NCT00129129|2311908|P2|STARTED|Primary Phase||319
956442|NCT00129129|2311909|P1|STARTED|Primary Phase||287
956443|NCT00129220|2312114|P3|NOT COMPLETED|Study Period III||10
956444|NCT00129220|2312115|P2|NOT COMPLETED|Study Period III||1
956445|NCT00129220|2312116|P1|NOT COMPLETED|Study Period III||13
956446|NCT00129220|2312114|P3|COMPLETED|Study Period III||42
956447|NCT00129220|2312115|P2|COMPLETED|Study Period III||7
956448|NCT00129220|2312116|P1|COMPLETED|Study Period III||59
956449|NCT00129220|2312114|P3|STARTED|Study Period III||52
956450|NCT00129220|2312115|P2|STARTED|Study Period III||8
956451|NCT00129220|2312116|P1|STARTED|Study Period III||72
956452|NCT00129220|2312114|P3|NOT COMPLETED|Study Period II||47
956453|NCT00129220|2312115|P2|NOT COMPLETED|Study Period II||12
956454|NCT00129220|2312116|P1|NOT COMPLETED|Study Period II||33
956455|NCT00129220|2312114|P3|COMPLETED|Study Period II||52
956456|NCT00129220|2312115|P2|COMPLETED|Study Period II||8
956457|NCT00129220|2312116|P1|COMPLETED|Study Period II||72
956458|NCT00129220|2312114|P3|Received at Least One Dose of Study Drug|Study Period II||97
956459|NCT00129220|2312115|P2|Received at Least One Dose of Study Drug|Study Period II||20
956460|NCT00129220|2312116|P1|Received at Least One Dose of Study Drug|Study Period II||104
956461|NCT00129220|2312114|P3|STARTED|Study Period II||99
956462|NCT00129220|2312115|P2|STARTED|Study Period II||20
956463|NCT00129220|2312116|P1|STARTED|Study Period II||105
956464|NCT00129246|2312155|P2|NOT COMPLETED|Overall Study||0
956465|NCT00129246|2312156|P1|NOT COMPLETED|Overall Study||0
956466|NCT00129246|2312155|P2|COMPLETED|Overall Study||20
956467|NCT00129246|2312156|P1|COMPLETED|Overall Study||20
956468|NCT00129246|2312155|P2|STARTED|Overall Study||20
956469|NCT00129246|2312156|P1|STARTED|Overall Study||20
956470|NCT00129259|2312170|P2|NOT COMPLETED|Overall Study||3
956471|NCT00129259|2312171|P1|NOT COMPLETED|Overall Study||3
956472|NCT00129259|2312170|P2|COMPLETED|Overall Study||22
956473|NCT00129259|2312171|P1|COMPLETED|Overall Study||49
956474|NCT00129259|2312170|P2|Received All or Part of Cycle 2|Overall Study||0
956475|NCT00129259|2312171|P1|Received All or Part of Cycle 2|Overall Study||40
956476|NCT00129259|2312170|P2|Received All or Part of Cycle 1|Overall Study||0
956477|NCT00129259|2312171|P1|Received All or Part of Cycle 1|Overall Study||52
956478|NCT00129259|2312170|P2|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|25
956479|NCT00129259|2312171|P1|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|52
956480|NCT00129272|2312183|P2|NOT COMPLETED|Overall Study||22
956481|NCT00129272|2312184|P1|NOT COMPLETED|Overall Study||17
956482|NCT00129272|2312183|P2|COMPLETED|Overall Study||51
956483|NCT00129272|2312184|P1|COMPLETED|Overall Study||54
956484|NCT00129272|2312183|P2|STARTED|Overall Study||73
956485|NCT00129272|2312184|P1|STARTED|Overall Study||71
956486|NCT00129311|2312194|P2|NOT COMPLETED|Overall Study||19
956487|NCT00129311|2312195|P1|NOT COMPLETED|Overall Study||12
956488|NCT00129311|2312194|P2|COMPLETED|Overall Study||31
956489|NCT00129311|2312195|P1|COMPLETED|Overall Study||39
956490|NCT00129311|2312194|P2|STARTED|Overall Study||50
956491|NCT00129311|2312195|P1|STARTED|Overall Study||51
956492|NCT00129402|2312205|P7|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||6
956493|NCT00129402|2312206|P6|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
956494|NCT00129402|2312207|P5|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
956495|NCT00129402|2312208|P4|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
956496|NCT00129402|2312209|P3|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
956497|NCT00129402|2312210|P2|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
956498|NCT00129402|2312211|P1|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
956499|NCT00129402|2312205|P7|COMPLETED|Start Period3 to End Period3(Week 34-53)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|222
956500|NCT00129402|2312206|P6|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
956501|NCT00129402|2312207|P5|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
956502|NCT00129402|2312208|P4|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
956503|NCT00129402|2312209|P3|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
956504|NCT00129402|2312210|P2|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
956505|NCT00129402|2312211|P1|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
956506|NCT00129402|2312205|P7|STARTED|Start Period3 to End Period3(Week 34-53)|In Period 3, all subjects from Period 1 and Period 2 were combined into one treatment group.|228
956507|NCT00129402|2312206|P6|STARTED|Start Period3 to End Period3(Week 34-53)||0
956508|NCT00129402|2312207|P5|STARTED|Start Period3 to End Period3(Week 34-53)||0
956509|NCT00129402|2312208|P4|STARTED|Start Period3 to End Period3(Week 34-53)||0
956510|NCT00129402|2312209|P3|STARTED|Start Period3 to End Period3(Week 34-53)||0
956511|NCT00129402|2312210|P2|STARTED|Start Period3 to End Period3(Week 34-53)||0
956512|NCT00129402|2312211|P1|STARTED|Start Period3 to End Period3(Week 34-53)||0
956513|NCT00129402|2312205|P7|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
956514|NCT00129402|2312206|P6|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||5
956515|NCT00129402|2312207|P5|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
956516|NCT00129402|2312208|P4|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
956517|NCT00129402|2312209|P3|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||8
956518|NCT00129402|2312210|P2|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
956519|NCT00129402|2312211|P1|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
956520|NCT00129402|2312205|P7|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
956521|NCT00129402|2312206|P6|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|113
956522|NCT00129402|2312207|P5|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
956523|NCT00129402|2312208|P4|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
956524|NCT00129402|2312209|P3|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|114
956525|NCT00129402|2312210|P2|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
956526|NCT00129402|2312211|P1|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
956527|NCT00129402|2312205|P7|STARTED|Start Period2 to End Period2 (Week 7-33)||0
956528|NCT00129402|2312206|P6|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received simvastatin monotherapy|118
956529|NCT00129402|2312207|P5|STARTED|Start Period2 to End Period2 (Week 7-33)||0
956530|NCT00129402|2312208|P4|STARTED|Start Period2 to End Period2 (Week 7-33)||0
956531|NCT00129402|2312209|P3|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received ezetimibe with simvastatin|122
956532|NCT00129402|2312210|P2|STARTED|Start Period2 to End Period2 (Week 7-33)||0
956533|NCT00129402|2312211|P1|STARTED|Start Period2 to End Period2 (Week 7-33)||0
956534|NCT00129402|2312205|P7|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
956535|NCT00129402|2312206|P6|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
956536|NCT00129402|2312207|P5|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
956537|NCT00129402|2312208|P4|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
956538|NCT00129402|2312209|P3|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
956539|NCT00129402|2312210|P2|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
956540|NCT00129402|2312211|P1|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
956541|NCT00129402|2312205|P7|COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
956542|NCT00129402|2312206|P6|COMPLETED|Start Period1 to End Period1 (Week 1-6)||40
956543|NCT00129402|2312207|P5|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
956544|NCT00129402|2312208|P4|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
956545|NCT00129402|2312209|P3|COMPLETED|Start Period1 to End Period1 (Week 1-6)||41
956546|NCT00129402|2312210|P2|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
956547|NCT00129402|2312211|P1|COMPLETED|Start Period1 to End Period1 (Week 1-6)||43
956548|NCT00129402|2312205|P7|STARTED|Start Period1 to End Period1 (Week 1-6)||0
956549|NCT00129402|2312206|P6|STARTED|Start Period1 to End Period1 (Week 1-6)||42
956550|NCT00129402|2312207|P5|STARTED|Start Period1 to End Period1 (Week 1-6)||40
956551|NCT00129402|2312208|P4|STARTED|Start Period1 to End Period1 (Week 1-6)||40
956552|NCT00129402|2312209|P3|STARTED|Start Period1 to End Period1 (Week 1-6)||43
956553|NCT00129402|2312210|P2|STARTED|Start Period1 to End Period1 (Week 1-6)||40
956554|NCT00129402|2312211|P1|STARTED|Start Period1 to End Period1 (Week 1-6)||43
956555|NCT00129441|2312230|P2|NOT COMPLETED|Overall Study||0
956556|NCT00129441|2312231|P1|NOT COMPLETED|Overall Study||0
956557|NCT00129441|2312230|P2|COMPLETED|Overall Study||6
956558|NCT00129441|2312231|P1|COMPLETED|Overall Study||9
956559|NCT00129441|2312230|P2|Year 1, Visit 8|Overall Study||6
956560|NCT00129441|2312231|P1|Year 1, Visit 8|Overall Study||9
956561|NCT00129441|2312230|P2|Week 26, Visit 7|Overall Study||6
956562|NCT00129441|2312231|P1|Week 26, Visit 7|Overall Study||9
956563|NCT00129441|2312230|P2|Week 5, Visit 6|Overall Study||6
956564|NCT00129441|2312231|P1|Week 5, Visit 6|Overall Study||9
956565|NCT00129441|2312230|P2|Week 4, Visit 5|Overall Study||6
956566|NCT00129441|2312231|P1|Week 4, Visit 5|Overall Study||9
956567|NCT00129441|2312230|P2|Week 3, Visit 4|Overall Study||6
956568|NCT00129441|2312231|P1|Week 3, Visit 4|Overall Study||9
956569|NCT00129441|2312230|P2|Week 2, Visit 3|Overall Study||6
956570|NCT00129441|2312231|P1|Week 2, Visit 3|Overall Study||9
956571|NCT00129441|2312230|P2|Week 1, Visit 2|Overall Study||6
956572|NCT00129441|2312231|P1|Week 1, Visit 2|Overall Study||9
956573|NCT00129441|2312230|P2|Baseline, Visit 1|Overall Study||6
956574|NCT00129441|2312231|P1|Baseline, Visit 1|Overall Study|Baseline # only includes those who completed 4-week trial (one L-830982 subject did not complete).|9
956575|NCT00129441|2312230|P2|STARTED|Overall Study||6
956576|NCT00129441|2312231|P1|STARTED|Overall Study||9
956577|NCT00129467|2312253|P2|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
956578|NCT00129467|2312254|P1|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
956579|NCT00129467|2312253|P2|COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
956580|NCT00129467|2312254|P1|COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
956581|NCT00129467|2312253|P2|STARTED|Open Label for SSRI+Methylphenidate Arm||0
956582|NCT00129467|2312254|P1|STARTED|Open Label for SSRI+Methylphenidate Arm|Eligible if in methylphenidate arm & had 50% reduction in Montgomery-Asberg Depression Rating score|4
956583|NCT00129467|2312253|P2|NOT COMPLETED|Received Intervention||4
956584|NCT00129467|2312254|P1|NOT COMPLETED|Received Intervention||6
956585|NCT00129467|2312253|P2|COMPLETED|Received Intervention||13
956586|NCT00129467|2312254|P1|COMPLETED|Received Intervention||9
956587|NCT00129467|2312253|P2|STARTED|Received Intervention||17
956588|NCT00129467|2312254|P1|STARTED|Received Intervention||15
956589|NCT00129480|2312262|P2|NOT COMPLETED|Overall Study||0
956590|NCT00129480|2312263|P1|NOT COMPLETED|Overall Study||0
956591|NCT00129480|2312262|P2|COMPLETED|Overall Study||214
956592|NCT00129480|2312263|P1|COMPLETED|Overall Study||187
956593|NCT00129480|2312262|P2|STARTED|Overall Study||214
956594|NCT00129480|2312263|P1|STARTED|Overall Study||187
956595|NCT00129545|2312272|P3|NOT COMPLETED|Overall Study||111
956596|NCT00129545|2312273|P2|NOT COMPLETED|Overall Study||164
956597|NCT00129545|2312274|P1|NOT COMPLETED|Overall Study||26
956598|NCT00129545|2312272|P3|COMPLETED|Overall Study||133
956599|NCT00129545|2312273|P2|COMPLETED|Overall Study||299
956600|NCT00129545|2312274|P1|COMPLETED|Overall Study||67
956601|NCT00129545|2312272|P3|STARTED|Overall Study||244
956602|NCT00129545|2312273|P2|STARTED|Overall Study|2:1 randomization WATCHMAN to warfarin|463
956603|NCT00129545|2312274|P1|STARTED|Overall Study||93
956604|NCT00129623|2312286|P2|NOT COMPLETED|Overall Study||12
956605|NCT00129623|2312287|P1|NOT COMPLETED|Overall Study||10
956606|NCT00129623|2312286|P2|COMPLETED|Overall Study||65
956607|NCT00129623|2312287|P1|COMPLETED|Overall Study||73
956608|NCT00129623|2312286|P2|Intent-to-treat (ITT)/ Safety Population|Overall Study||77
956609|NCT00129623|2312287|P1|Intent-to-treat (ITT)/ Safety Population|Overall Study||83
956610|NCT00129623|2312286|P2|STARTED|Overall Study||77
956611|NCT00129623|2312287|P1|STARTED|Overall Study||83
956612|NCT00123955|2312311|P2|NOT COMPLETED|Overall Study||4
956613|NCT00123955|2312312|P1|NOT COMPLETED|Overall Study||5
956614|NCT00123955|2312311|P2|COMPLETED|Overall Study||34
956615|NCT00123955|2312312|P1|COMPLETED|Overall Study||37
956616|NCT00123955|2312311|P2|STARTED|Overall Study||38
956617|NCT00123955|2312312|P1|STARTED|Overall Study||42
956618|NCT00124020|2312320|P2|NOT COMPLETED|Overall Study||91
956619|NCT00124020|2312321|P1|NOT COMPLETED|Overall Study||88
956620|NCT00124020|2312320|P2|COMPLETED|Overall Study||289
956621|NCT00124020|2312321|P1|COMPLETED|Overall Study||289
956622|NCT00124020|2312320|P2|STARTED|Overall Study||380
956623|NCT00124020|2312321|P1|STARTED|Overall Study||377
956624|NCT00124072|2312331|P4|NOT COMPLETED|Overall Study||500
956625|NCT00124072|2312332|P3|NOT COMPLETED|Overall Study||492
956626|NCT00124072|2312333|P2|NOT COMPLETED|Overall Study||512
956627|NCT00124072|2312334|P1|NOT COMPLETED|Overall Study||514
956628|NCT00124072|2312331|P4|COMPLETED|Overall Study||2515
956629|NCT00124072|2312332|P3|COMPLETED|Overall Study||2524
956630|NCT00124072|2312333|P2|COMPLETED|Overall Study||2504
956631|NCT00124072|2312334|P1|COMPLETED|Overall Study||2503
956632|NCT00124072|2312331|P4|STARTED|Overall Study||3015
956633|NCT00124072|2312332|P3|STARTED|Overall Study||3016
956634|NCT00124072|2312333|P2|STARTED|Overall Study||3016
956635|NCT00124072|2312334|P1|STARTED|Overall Study||3017
956636|NCT00124176|2312346|P2|NOT COMPLETED|Overall Study||0
956637|NCT00124176|2312347|P1|NOT COMPLETED|Overall Study||0
956638|NCT00124176|2312346|P2|COMPLETED|Overall Study||41
956639|NCT00124176|2312347|P1|COMPLETED|Overall Study||40
956640|NCT00124176|2312346|P2|Received Study Drug|Overall Study||41
956641|NCT00124176|2312347|P1|Received Study Drug|Overall Study|3 never started on drug due to improvement but were kept in the study by intention to treat.|37
956642|NCT00124176|2312346|P2|STARTED|Overall Study||41
956643|NCT00124176|2312347|P1|STARTED|Overall Study||40
956644|NCT00129727|2312361|P1|NOT COMPLETED|Overall Study||5
956645|NCT00129727|2312361|P1|COMPLETED|Overall Study||57
956646|NCT00129727|2312361|P1|STARTED|Overall Study||62
956647|NCT00129766|2312369|P2|NOT COMPLETED|Overall Study||59
956648|NCT00129766|2312370|P1|NOT COMPLETED|Overall Study||60
956649|NCT00129766|2312369|P2|COMPLETED|Overall Study||3270
956650|NCT00129766|2312370|P1|COMPLETED|Overall Study||3246
956651|NCT00129766|2312369|P2|STARTED|Overall Study||3329
956652|NCT00129766|2312370|P1|STARTED|Overall Study||3306
956653|NCT00129961|2312410|P2|NOT COMPLETED|Overall Study||23
956654|NCT00129961|2312411|P1|NOT COMPLETED|Overall Study||19
956655|NCT00129961|2312410|P2|COMPLETED|Overall Study||24
956656|NCT00129961|2312411|P1|COMPLETED|Overall Study||20
956657|NCT00129961|2312410|P2|STARTED|Overall Study||47
956658|NCT00129961|2312411|P1|STARTED|Overall Study||39
956659|NCT00129974|2312445|P1|NOT COMPLETED|Overall Study||1
956660|NCT00129974|2312445|P1|COMPLETED|Overall Study||0
956661|NCT00129974|2312445|P1|STARTED|Overall Study||1
956662|NCT00130117|2312452|P2|NOT COMPLETED|Overall Study||3
956663|NCT00130117|2312453|P1|NOT COMPLETED|Overall Study||4
956664|NCT00130117|2312452|P2|COMPLETED|Overall Study||6
956665|NCT00130117|2312453|P1|COMPLETED|Overall Study||7
956666|NCT00130117|2312452|P2|STARTED|Overall Study||9
956667|NCT00130117|2312453|P1|STARTED|Overall Study||11
956668|NCT00130247|2312476|P2|NOT COMPLETED|Overall Study||4
956669|NCT00130247|2312477|P1|NOT COMPLETED|Overall Study||2
956670|NCT00130247|2312476|P2|COMPLETED|Overall Study||194
956671|NCT00130247|2312477|P1|COMPLETED|Overall Study||194
956672|NCT00130247|2312476|P2|STARTED|Overall Study||198
956673|NCT00130247|2312477|P1|STARTED|Overall Study||196
956674|NCT00130286|2312497|P4|NOT COMPLETED|Overall Study||2
956675|NCT00130286|2312498|P3|NOT COMPLETED|Overall Study||4
956676|NCT00130286|2312499|P2|NOT COMPLETED|Overall Study||3
956677|NCT00130286|2312500|P1|NOT COMPLETED|Overall Study||0
956678|NCT00130286|2312497|P4|COMPLETED|Overall Study||17
956679|NCT00130286|2312498|P3|COMPLETED|Overall Study||13
956680|NCT00130286|2312499|P2|COMPLETED|Overall Study||16
956681|NCT00130286|2312500|P1|COMPLETED|Overall Study||22
956682|NCT00130286|2312497|P4|STARTED|Overall Study||19
956683|NCT00130286|2312498|P3|STARTED|Overall Study||17
956684|NCT00130286|2312499|P2|STARTED|Overall Study||19
956685|NCT00130286|2312500|P1|STARTED|Overall Study||22
956686|NCT00130520|2312518|P1|NOT COMPLETED|Overall Study||39
956687|NCT00130520|2312518|P1|COMPLETED|Overall Study||1
956688|NCT00130520|2312518|P1|Completion of at Least One Cycle|Overall Study||39
956689|NCT00130520|2312518|P1|STARTED|Overall Study|85 women were screened for eligibility, 56 consented, 40 treated.|40
956690|NCT00130637|2312524|P1|NOT COMPLETED|Overall Study||3
956691|NCT00130637|2312524|P1|COMPLETED|Overall Study||3
956692|NCT00130637|2312524|P1|STARTED|Overall Study||6
956693|NCT00130689|2312529|P1|NOT COMPLETED|Overall Study||43
956694|NCT00130689|2312529|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
956695|NCT00130689|2312529|P1|Treated|Overall Study||35
956696|NCT00130689|2312529|P1|Eligible|Overall Study||37
956697|NCT00130689|2312529|P1|STARTED|Overall Study||43
956706|NCT00130780|2312550|P2|NOT COMPLETED|Overall Study||0
956707|NCT00130780|2312551|P1|NOT COMPLETED|Overall Study||0
956708|NCT00130780|2312550|P2|COMPLETED|Overall Study||20
956709|NCT00130780|2312551|P1|COMPLETED|Overall Study||51
956710|NCT00130780|2312550|P2|STARTED|Overall Study||20
956711|NCT00130780|2312551|P1|STARTED|Overall Study||51
956712|NCT00130793|2312559|P2|NOT COMPLETED|Overall Study||4
956713|NCT00130793|2312560|P1|NOT COMPLETED|Overall Study||3
956714|NCT00130793|2312559|P2|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned VRC at Week 4|181
956715|NCT00130793|2312560|P1|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned vaccination report card (VRC) at Week 4|180
956716|NCT00130793|2312559|P2|Vaccinated|Overall Study||185
956717|NCT00130793|2312560|P1|Vaccinated|Overall Study|One subject was allocated but not vaccinated.|182
956718|NCT00130793|2312559|P2|STARTED|Overall Study||185
956719|NCT00130793|2312560|P1|STARTED|Overall Study||183
956720|NCT00130832|2312572|P2|NOT COMPLETED|Overall Study||17
956721|NCT00130832|2312573|P1|NOT COMPLETED|Overall Study||16
956722|NCT00130832|2312572|P2|COMPLETED|Overall Study|Those who received all 3 doses; last 2 blood draws ~42 days postdose 3 of RotaTeq™ and postdose OPV|346
956723|NCT00130832|2312573|P1|COMPLETED|Overall Study|Those who received all 3 doses of concomitant RotaTeq™/ OPV with blood draw ~42 days postdose 3|356
956724|NCT00130832|2312572|P2|STARTED|Overall Study||363
956725|NCT00130832|2312573|P1|STARTED|Overall Study||372
956726|NCT00130923|2312585|P2|NOT COMPLETED|Overall Study||14
956727|NCT00130923|2312586|P1|NOT COMPLETED|Overall Study||13
956728|NCT00130923|2312585|P2|COMPLETED|Overall Study||32
956729|NCT00130923|2312586|P1|COMPLETED|Overall Study||36
956730|NCT00130923|2312585|P2|STARTED|Overall Study||46
956731|NCT00130923|2312586|P1|STARTED|Overall Study||49
956732|NCT00131248|2312592|P2|NOT COMPLETED|Intervention 3 (4-day Course)||0
956733|NCT00131248|2312593|P1|NOT COMPLETED|Intervention 3 (4-day Course)||0
956734|NCT00131248|2312592|P2|COMPLETED|Intervention 3 (4-day Course)||9
956735|NCT00131248|2312593|P1|COMPLETED|Intervention 3 (4-day Course)||8
956736|NCT00131248|2312592|P2|STARTED|Intervention 3 (4-day Course)||9
956737|NCT00131248|2312593|P1|STARTED|Intervention 3 (4-day Course)||8
956738|NCT00131248|2312592|P2|NOT COMPLETED|Washout 2 (24 Hours)||0
956739|NCT00131248|2312593|P1|NOT COMPLETED|Washout 2 (24 Hours)||0
956740|NCT00131248|2312592|P2|COMPLETED|Washout 2 (24 Hours)||9
956741|NCT00131248|2312593|P1|COMPLETED|Washout 2 (24 Hours)||8
956742|NCT00131248|2312592|P2|STARTED|Washout 2 (24 Hours)||9
956743|NCT00131248|2312593|P1|STARTED|Washout 2 (24 Hours)||8
956744|NCT00131248|2312592|P2|NOT COMPLETED|Intervention 2 (7-day Course)||0
956745|NCT00131248|2312593|P1|NOT COMPLETED|Intervention 2 (7-day Course)||0
956746|NCT00131248|2312592|P2|COMPLETED|Intervention 2 (7-day Course)||9
956747|NCT00131248|2312593|P1|COMPLETED|Intervention 2 (7-day Course)||8
956748|NCT00131248|2312592|P2|STARTED|Intervention 2 (7-day Course)||9
956749|NCT00131248|2312593|P1|STARTED|Intervention 2 (7-day Course)||8
956750|NCT00131248|2312592|P2|NOT COMPLETED|Washout (24 Hour)||0
956751|NCT00131248|2312593|P1|NOT COMPLETED|Washout (24 Hour)||0
956752|NCT00131248|2312592|P2|COMPLETED|Washout (24 Hour)||9
956753|NCT00131248|2312593|P1|COMPLETED|Washout (24 Hour)||8
956754|NCT00131248|2312592|P2|STARTED|Washout (24 Hour)||9
956755|NCT00131248|2312593|P1|STARTED|Washout (24 Hour)||8
956756|NCT00131248|2312592|P2|NOT COMPLETED|Intervention 1 (3-day Course)||0
956757|NCT00131248|2312593|P1|NOT COMPLETED|Intervention 1 (3-day Course)||1
956758|NCT00131248|2312592|P2|COMPLETED|Intervention 1 (3-day Course)||9
956759|NCT00131248|2312593|P1|COMPLETED|Intervention 1 (3-day Course)||8
956760|NCT00131248|2312592|P2|STARTED|Intervention 1 (3-day Course)||9
956761|NCT00131248|2312593|P1|STARTED|Intervention 1 (3-day Course)||9
956762|NCT00131352|2312601|P2|NOT COMPLETED|Repeat Treatment Period||0
956763|NCT00131352|2312602|P1|NOT COMPLETED|Repeat Treatment Period||2
956764|NCT00131352|2312601|P2|COMPLETED|Repeat Treatment Period||0
956765|NCT00131352|2312602|P1|COMPLETED|Repeat Treatment Period||158
956766|NCT00131352|2312601|P2|STARTED|Repeat Treatment Period||0
956849|NCT00131885|2312787|P3|NOT COMPLETED|Time 2: Second Intervention||0
956767|NCT00131352|2312602|P1|STARTED|Repeat Treatment Period|Safety population: 77 Synvisc + 83 Saline Control participants from the Initial Treatment period.|160
956768|NCT00131352|2312601|P2|NOT COMPLETED|Initial Treatment Period||12
956769|NCT00131352|2312602|P1|NOT COMPLETED|Initial Treatment Period||9
956770|NCT00131352|2312601|P2|COMPLETED|Initial Treatment Period||118
956771|NCT00131352|2312602|P1|COMPLETED|Initial Treatment Period||114
956772|NCT00131352|2312601|P2|Intent to Treat Population|Initial Treatment Period||129
956773|NCT00131352|2312602|P1|Intent to Treat Population|Initial Treatment Period||124
956774|NCT00131352|2312601|P2|STARTED|Initial Treatment Period|Safety population|130
956775|NCT00131352|2312602|P1|STARTED|Initial Treatment Period|Safety population|123
956776|NCT00131378|2312628|P4|NOT COMPLETED|Overall Study||9
956777|NCT00131378|2312629|P3|NOT COMPLETED|Overall Study||10
956778|NCT00131378|2312630|P2|NOT COMPLETED|Overall Study||18
956779|NCT00131378|2312631|P1|NOT COMPLETED|Overall Study||11
956780|NCT00131378|2312628|P4|COMPLETED|Overall Study||21
956781|NCT00131378|2312629|P3|COMPLETED|Overall Study||22
956782|NCT00131378|2312630|P2|COMPLETED|Overall Study||22
956783|NCT00131378|2312631|P1|COMPLETED|Overall Study||29
956784|NCT00131378|2312628|P4|STARTED|Overall Study||30
956785|NCT00131378|2312629|P3|STARTED|Overall Study||32
956786|NCT00131378|2312630|P2|STARTED|Overall Study||40
956787|NCT00131378|2312631|P1|STARTED|Overall Study||40
956788|NCT00131456|2312655|P2|NOT COMPLETED|Overall Study||20
956789|NCT00131456|2312656|P1|NOT COMPLETED|Overall Study||19
956790|NCT00131456|2312655|P2|COMPLETED|Overall Study||31
956791|NCT00131456|2312656|P1|COMPLETED|Overall Study||33
956792|NCT00131456|2312655|P2|STARTED|Overall Study||51
956793|NCT00131456|2312656|P1|STARTED|Overall Study||52
956794|NCT00131508|2312664|P2|NOT COMPLETED|Overall Study||8
956795|NCT00131508|2312665|P1|NOT COMPLETED|Overall Study||3
956796|NCT00131508|2312664|P2|COMPLETED|Overall Study||5
956797|NCT00131508|2312665|P1|COMPLETED|Overall Study||9
956798|NCT00131508|2312664|P2|STARTED|Overall Study||13
956799|NCT00131508|2312665|P1|STARTED|Overall Study||12
956800|NCT00131573|2312689|P2|NOT COMPLETED|Overall Study||26
956801|NCT00131573|2312690|P1|NOT COMPLETED|Overall Study||33
956802|NCT00131573|2312689|P2|COMPLETED|Overall Study||13
956803|NCT00131573|2312690|P1|COMPLETED|Overall Study||13
956804|NCT00131573|2312689|P2|STARTED|Overall Study||39
956805|NCT00131573|2312690|P1|STARTED|Overall Study||46
956806|NCT00131664|2312701|P6|NOT COMPLETED|Second Period (Additional Drug Added)||3
956807|NCT00131664|2312702|P5|NOT COMPLETED|Second Period (Additional Drug Added)||1
956808|NCT00131664|2312703|P4|NOT COMPLETED|Second Period (Additional Drug Added)||2
956809|NCT00131664|2312704|P3|NOT COMPLETED|Second Period (Additional Drug Added)||3
956810|NCT00131664|2312705|P2|NOT COMPLETED|Second Period (Additional Drug Added)||4
956811|NCT00131664|2312706|P1|NOT COMPLETED|Second Period (Additional Drug Added)||9
956812|NCT00131664|2312701|P6|COMPLETED|Second Period (Additional Drug Added)||22
956813|NCT00131664|2312702|P5|COMPLETED|Second Period (Additional Drug Added)||15
956814|NCT00131664|2312703|P4|COMPLETED|Second Period (Additional Drug Added)||19
956815|NCT00131664|2312704|P3|COMPLETED|Second Period (Additional Drug Added)||76
956816|NCT00131664|2312705|P2|COMPLETED|Second Period (Additional Drug Added)||97
956817|NCT00131664|2312706|P1|COMPLETED|Second Period (Additional Drug Added)||81
956818|NCT00131664|2312701|P6|STARTED|Second Period (Additional Drug Added)||25
956819|NCT00131664|2312702|P5|STARTED|Second Period (Additional Drug Added)||16
956820|NCT00131664|2312703|P4|STARTED|Second Period (Additional Drug Added)||21
956821|NCT00131664|2312704|P3|STARTED|Second Period (Additional Drug Added)|25 had added Amaryl at Month 6|79
956822|NCT00131664|2312705|P2|STARTED|Second Period (Additional Drug Added)|16 had added Amaryl at Month 6|101
956823|NCT00131664|2312706|P1|STARTED|Second Period (Additional Drug Added)|21 had added Metformin at Month 6|90
956824|NCT00131664|2312701|P6|NOT COMPLETED|First Period (First 6 Months)||0
956825|NCT00131664|2312702|P5|NOT COMPLETED|First Period (First 6 Months)||0
956826|NCT00131664|2312703|P4|NOT COMPLETED|First Period (First 6 Months)||0
956827|NCT00131664|2312704|P3|NOT COMPLETED|First Period (First 6 Months)||16
956828|NCT00131664|2312705|P2|NOT COMPLETED|First Period (First 6 Months)||18
956829|NCT00131664|2312706|P1|NOT COMPLETED|First Period (First 6 Months)||25
956830|NCT00131664|2312701|P6|COMPLETED|First Period (First 6 Months)||0
956831|NCT00131664|2312702|P5|COMPLETED|First Period (First 6 Months)||0
956832|NCT00131664|2312703|P4|COMPLETED|First Period (First 6 Months)||0
956833|NCT00131664|2312704|P3|COMPLETED|First Period (First 6 Months)||104
956834|NCT00131664|2312705|P2|COMPLETED|First Period (First 6 Months)||117
956835|NCT00131664|2312706|P1|COMPLETED|First Period (First 6 Months)||111
956836|NCT00131664|2312701|P6|STARTED|First Period (First 6 Months)||0
956837|NCT00131664|2312702|P5|STARTED|First Period (First 6 Months)||0
956838|NCT00131664|2312703|P4|STARTED|First Period (First 6 Months)||0
956839|NCT00131664|2312704|P3|STARTED|First Period (First 6 Months)||120
956840|NCT00131664|2312705|P2|STARTED|First Period (First 6 Months)||135
956841|NCT00131664|2312706|P1|STARTED|First Period (First 6 Months)||136
956842|NCT00131677|2312767|P2|NOT COMPLETED|Overall Study||39
956843|NCT00131677|2312768|P1|NOT COMPLETED|Overall Study||30
956844|NCT00131677|2312767|P2|COMPLETED|Overall Study||160
956845|NCT00131677|2312768|P1|COMPLETED|Overall Study||171
956846|NCT00131677|2312767|P2|STARTED|Overall Study|199 randomized to placebo; 99 to start immediately and 100 after a 9 month delay.|199
956847|NCT00131677|2312768|P1|STARTED|Overall Study|201 randomized to active drug; 101 to start immediately and 100 after a 9 month delay.|201
956848|NCT00131885|2312786|P4|NOT COMPLETED|Time 2: Second Intervention||0
956850|NCT00131885|2312788|P2|NOT COMPLETED|Time 2: Second Intervention||0
956851|NCT00131885|2312789|P1|NOT COMPLETED|Time 2: Second Intervention||0
956852|NCT00131885|2312786|P4|COMPLETED|Time 2: Second Intervention||9
956853|NCT00131885|2312787|P3|COMPLETED|Time 2: Second Intervention||9
956854|NCT00131885|2312788|P2|COMPLETED|Time 2: Second Intervention||9
956855|NCT00131885|2312789|P1|COMPLETED|Time 2: Second Intervention||9
956856|NCT00131885|2312786|P4|STARTED|Time 2: Second Intervention||9
956857|NCT00131885|2312787|P3|STARTED|Time 2: Second Intervention||9
956858|NCT00131885|2312788|P2|STARTED|Time 2: Second Intervention||9
956859|NCT00131885|2312789|P1|STARTED|Time 2: Second Intervention||9
956860|NCT00131885|2312786|P4|NOT COMPLETED|Time 1: First Intervention||0
956861|NCT00131885|2312787|P3|NOT COMPLETED|Time 1: First Intervention||0
956862|NCT00131885|2312788|P2|NOT COMPLETED|Time 1: First Intervention||0
956863|NCT00131885|2312789|P1|NOT COMPLETED|Time 1: First Intervention||0
956864|NCT00131885|2312786|P4|COMPLETED|Time 1: First Intervention||9
956865|NCT00131885|2312787|P3|COMPLETED|Time 1: First Intervention||9
956866|NCT00131885|2312788|P2|COMPLETED|Time 1: First Intervention||9
956867|NCT00131885|2312789|P1|COMPLETED|Time 1: First Intervention||9
956868|NCT00131885|2312786|P4|STARTED|Time 1: First Intervention||9
956869|NCT00131885|2312787|P3|STARTED|Time 1: First Intervention||9
956870|NCT00131885|2312788|P2|STARTED|Time 1: First Intervention||9
956871|NCT00131885|2312789|P1|STARTED|Time 1: First Intervention||9
956872|NCT00131911|2312821|P2|NOT COMPLETED|Overall Study||0
956873|NCT00131911|2312822|P1|NOT COMPLETED|Overall Study||1
956874|NCT00131911|2312821|P2|COMPLETED|Overall Study||42
956875|NCT00131911|2312822|P1|COMPLETED|Overall Study||50
956876|NCT00131911|2312821|P2|STARTED|Overall Study||42
956877|NCT00131911|2312822|P1|STARTED|Overall Study||51
956878|NCT00131937|2312835|P1|NOT COMPLETED|Overall Study||14
956879|NCT00131937|2312835|P1|COMPLETED|Overall Study||0
956880|NCT00131937|2312835|P1|STARTED|Overall Study||14
956881|NCT00132002|2312841|P1|NOT COMPLETED|Overall Study||0
956882|NCT00132002|2312841|P1|COMPLETED|Overall Study||14
956883|NCT00132002|2312841|P1|STARTED|Overall Study||14
956884|NCT00132028|2312847|P1|NOT COMPLETED|Overall Study||27
956885|NCT00132028|2312847|P1|COMPLETED|Overall Study|"Since there was no maximum number of cycles, patients could not complete treatment."|0
956886|NCT00132028|2312847|P1|Eligible and Began Protocol Therapy|Overall Study||25
956887|NCT00132028|2312847|P1|Eligible|Overall Study||25
956888|NCT00132028|2312847|P1|STARTED|Overall Study||27
956889|NCT00132132|2312855|P2|NOT COMPLETED|Overall Study||2
956890|NCT00132132|2312856|P1|NOT COMPLETED|Overall Study||7
956891|NCT00132132|2312855|P2|COMPLETED|Overall Study||13
956892|NCT00132132|2312856|P1|COMPLETED|Overall Study||8
956893|NCT00132132|2312855|P2|STARTED|Overall Study||15
956894|NCT00132132|2312856|P1|STARTED|Overall Study||15
956895|NCT00132314|2312866|P2|NOT COMPLETED|Overall Study||72
956896|NCT00132314|2312867|P1|NOT COMPLETED|Overall Study||73
956897|NCT00132314|2312866|P2|COMPLETED|Overall Study||120
956898|NCT00132314|2312867|P1|COMPLETED|Overall Study||117
956899|NCT00132314|2312866|P2|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort.|182
956900|NCT00132314|2312867|P1|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort|187
956901|NCT00132314|2312866|P2|Received Treatment|Overall Study||185
956902|NCT00132314|2312867|P1|Received Treatment|Overall Study||188
956903|NCT00132314|2312866|P2|STARTED|Overall Study||192
956904|NCT00132314|2312867|P1|STARTED|Overall Study||190
956905|NCT00132496|2312877|P2|NOT COMPLETED|Overall Study||2
956906|NCT00132496|2312878|P1|NOT COMPLETED|Overall Study||2
956907|NCT00132496|2312877|P2|COMPLETED|Overall Study||55
956908|NCT00132496|2312878|P1|COMPLETED|Overall Study||52
956909|NCT00132496|2312877|P2|STARTED|Overall Study||57
956910|NCT00132496|2312878|P1|STARTED|Overall Study||54
956911|NCT00132678|2312886|P3|NOT COMPLETED|Period IV (Double-Blind Treatment)||0
956912|NCT00132678|2312887|P2|NOT COMPLETED|Period IV (Double-Blind Treatment)||40
956913|NCT00132678|2312888|P1|NOT COMPLETED|Period IV (Double-Blind Treatment)||37
956914|NCT00132678|2312886|P3|COMPLETED|Period IV (Double-Blind Treatment)||0
956915|NCT00132678|2312887|P2|COMPLETED|Period IV (Double-Blind Treatment)||109
956916|NCT00132678|2312888|P1|COMPLETED|Period IV (Double-Blind Treatment)||117
956917|NCT00132678|2312886|P3|STARTED|Period IV (Double-Blind Treatment)||0
956918|NCT00132678|2312887|P2|STARTED|Period IV (Double-Blind Treatment)||149
956919|NCT00132678|2312888|P1|STARTED|Period IV (Double-Blind Treatment)||154
956920|NCT00132678|2312886|P3|NOT COMPLETED|Period III (Open-Label Stabilization)||0
956921|NCT00132678|2312887|P2|NOT COMPLETED|Period III (Open-Label Stabilization)||0
956922|NCT00132678|2312888|P1|NOT COMPLETED|Period III (Open-Label Stabilization)||198
956923|NCT00132678|2312886|P3|COMPLETED|Period III (Open-Label Stabilization)||0
956924|NCT00132678|2312887|P2|COMPLETED|Period III (Open-Label Stabilization)||0
956925|NCT00132678|2312888|P1|COMPLETED|Period III (Open-Label Stabilization)||303
956926|NCT00132678|2312886|P3|STARTED|Period III (Open-Label Stabilization)||0
956927|NCT00132678|2312887|P2|STARTED|Period III (Open-Label Stabilization)||0
956928|NCT00132678|2312888|P1|STARTED|Period III (Open-Label Stabilization)||501
956929|NCT00132678|2312886|P3|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||58
956930|NCT00132678|2312887|P2|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
956931|NCT00132678|2312888|P1|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
956932|NCT00132678|2312886|P3|COMPLETED|Period II (Open-Label Oral Risperidone)||382
956933|NCT00132678|2312887|P2|COMPLETED|Period II (Open-Label Oral Risperidone)||0
956934|NCT00132678|2312888|P1|COMPLETED|Period II (Open-Label Oral Risperidone)||0
956935|NCT00132678|2312886|P3|STARTED|Period II (Open-Label Oral Risperidone)||440
956936|NCT00132678|2312887|P2|STARTED|Period II (Open-Label Oral Risperidone)||0
956937|NCT00132678|2312888|P1|STARTED|Period II (Open-Label Oral Risperidone)||0
956938|NCT00132691|2312902|P2|NOT COMPLETED|Overall Study||12
956939|NCT00132691|2312903|P1|NOT COMPLETED|Overall Study||11
956940|NCT00132691|2312902|P2|COMPLETED|Overall Study|114 participants completed the 2-year anniversary visit|114
956941|NCT00132691|2312903|P1|COMPLETED|Overall Study|118 participants completed the 2-year anniversary visit|118
956942|NCT00132691|2312902|P2|STARTED|Overall Study|126 participants were assigned to systemic treatment; 121 received systemic therapy|126
956943|NCT00132691|2312903|P1|STARTED|Overall Study|129 participants were assigned to implant; 122 received implant|129
956944|NCT00132730|2312945|P6|NOT COMPLETED|Period V - Open-label Extension (EXT2)||2
956945|NCT00132730|2312946|P5|NOT COMPLETED|Period V - Open-label Extension (EXT2)||7
956946|NCT00132730|2312947|P4|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
956947|NCT00132730|2312948|P3|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
956948|NCT00132730|2312949|P2|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
956949|NCT00132730|2312950|P1|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
956950|NCT00132730|2312945|P6|COMPLETED|Period V - Open-label Extension (EXT2)||0
956951|NCT00132730|2312946|P5|COMPLETED|Period V - Open-label Extension (EXT2)||0
956952|NCT00132730|2312947|P4|COMPLETED|Period V - Open-label Extension (EXT2)||0
956953|NCT00132730|2312948|P3|COMPLETED|Period V - Open-label Extension (EXT2)||0
956954|NCT00132730|2312949|P2|COMPLETED|Period V - Open-label Extension (EXT2)||0
956955|NCT00132730|2312950|P1|COMPLETED|Period V - Open-label Extension (EXT2)||0
956956|NCT00132730|2312945|P6|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|2
956957|NCT00132730|2312946|P5|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|7
956958|NCT00132730|2312947|P4|STARTED|Period V - Open-label Extension (EXT2)||0
956959|NCT00132730|2312948|P3|STARTED|Period V - Open-label Extension (EXT2)||0
956960|NCT00132730|2312949|P2|STARTED|Period V - Open-label Extension (EXT2)||0
956961|NCT00132730|2312950|P1|STARTED|Period V - Open-label Extension (EXT2)||0
956962|NCT00132730|2312945|P6|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||68
956963|NCT00132730|2312946|P5|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||179
956964|NCT00132730|2312947|P4|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
956965|NCT00132730|2312948|P3|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
956966|NCT00132730|2312949|P2|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
956967|NCT00132730|2312950|P1|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
956968|NCT00132730|2312945|P6|COMPLETED|Period IV - Open-label Extension (EXT2)||3
956969|NCT00132730|2312946|P5|COMPLETED|Period IV - Open-label Extension (EXT2)||8
956970|NCT00132730|2312947|P4|COMPLETED|Period IV - Open-label Extension (EXT2)||0
956971|NCT00132730|2312948|P3|COMPLETED|Period IV - Open-label Extension (EXT2)||0
956972|NCT00132730|2312949|P2|COMPLETED|Period IV - Open-label Extension (EXT2)||0
956973|NCT00132730|2312950|P1|COMPLETED|Period IV - Open-label Extension (EXT2)||0
956974|NCT00132730|2312945|P6|STARTED|Period IV - Open-label Extension (EXT2)|Includes paricipants from Period III. Not all eligible participants entered EXT2|71
956975|NCT00132730|2312946|P5|STARTED|Period IV - Open-label Extension (EXT2)|Includes participants from Period III. Not all eligible participants entered EXT2|187
956976|NCT00132730|2312947|P4|STARTED|Period IV - Open-label Extension (EXT2)||0
956977|NCT00132730|2312948|P3|STARTED|Period IV - Open-label Extension (EXT2)||0
956978|NCT00132730|2312949|P2|STARTED|Period IV - Open-label Extension (EXT2)||0
956979|NCT00132730|2312950|P1|STARTED|Period IV - Open-label Extension (EXT2)||0
956980|NCT00132730|2312945|P6|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
956981|NCT00132730|2312946|P5|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
956982|NCT00132730|2312947|P4|NOT COMPLETED|Period III - Blinded Extension (EXT1)||25
956983|NCT00132730|2312948|P3|NOT COMPLETED|Period III - Blinded Extension (EXT1)||82
956984|NCT00132730|2312949|P2|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
956985|NCT00132730|2312950|P1|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
956986|NCT00132730|2312945|P6|COMPLETED|Period III - Blinded Extension (EXT1)||0
956987|NCT00132730|2312946|P5|COMPLETED|Period III - Blinded Extension (EXT1)||0
956988|NCT00132730|2312947|P4|COMPLETED|Period III - Blinded Extension (EXT1)||82
956989|NCT00132730|2312948|P3|COMPLETED|Period III - Blinded Extension (EXT1)||235
956990|NCT00132730|2312949|P2|COMPLETED|Period III - Blinded Extension (EXT1)||0
956991|NCT00132730|2312950|P1|COMPLETED|Period III - Blinded Extension (EXT1)||0
956992|NCT00132730|2312945|P6|STARTED|Period III - Blinded Extension (EXT1)||0
956993|NCT00132730|2312946|P5|STARTED|Period III - Blinded Extension (EXT1)||0
956994|NCT00132730|2312947|P4|STARTED|Period III - Blinded Extension (EXT1)|Not all eligible participants entered EXT1|107
956995|NCT00132730|2312948|P3|STARTED|Period III - Blinded Extension (EXT1)|Includes all MK-0873 participants from Period II. Not all eligible participants entered EXT1|317
956996|NCT00132730|2312949|P2|STARTED|Period III - Blinded Extension (EXT1)||0
956997|NCT00132730|2312950|P1|STARTED|Period III - Blinded Extension (EXT1)||0
956998|NCT00132730|2312945|P6|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
956999|NCT00132730|2312946|P5|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
957000|NCT00132730|2312947|P4|NOT COMPLETED|Period II - 12-week Treatment (Base)||22
957001|NCT00132730|2312948|P3|NOT COMPLETED|Period II - 12-week Treatment (Base)||18
957002|NCT00132730|2312949|P2|NOT COMPLETED|Period II - 12-week Treatment (Base)||15
957003|NCT00132730|2312950|P1|NOT COMPLETED|Period II - 12-week Treatment (Base)||23
957004|NCT00132730|2312945|P6|COMPLETED|Period II - 12-week Treatment (Base)||0
957005|NCT00132730|2312946|P5|COMPLETED|Period II - 12-week Treatment (Base)||0
957006|NCT00132730|2312947|P4|COMPLETED|Period II - 12-week Treatment (Base)||131
957007|NCT00132730|2312948|P3|COMPLETED|Period II - 12-week Treatment (Base)||135
957008|NCT00132730|2312949|P2|COMPLETED|Period II - 12-week Treatment (Base)||133
957009|NCT00132730|2312950|P1|COMPLETED|Period II - 12-week Treatment (Base)||127
957010|NCT00132730|2312945|P6|STARTED|Period II - 12-week Treatment (Base)||0
957011|NCT00132730|2312946|P5|STARTED|Period II - 12-week Treatment (Base)||0
957012|NCT00132730|2312947|P4|STARTED|Period II - 12-week Treatment (Base)||153
957013|NCT00132730|2312948|P3|STARTED|Period II - 12-week Treatment (Base)||153
957014|NCT00132730|2312949|P2|STARTED|Period II - 12-week Treatment (Base)||148
957015|NCT00132730|2312950|P1|STARTED|Period II - 12-week Treatment (Base)||150
957016|NCT00132730|2312945|P6|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
957017|NCT00132730|2312946|P5|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
957018|NCT00132730|2312947|P4|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
957019|NCT00132730|2312948|P3|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
957020|NCT00132730|2312949|P2|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
957021|NCT00132730|2312950|P1|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
957022|NCT00132730|2312945|P6|COMPLETED|Period I - Placebo Run-in (Base)||0
957023|NCT00132730|2312946|P5|COMPLETED|Period I - Placebo Run-in (Base)||0
957024|NCT00132730|2312947|P4|COMPLETED|Period I - Placebo Run-in (Base)||153
957025|NCT00132730|2312948|P3|COMPLETED|Period I - Placebo Run-in (Base)||153
957026|NCT00132730|2312949|P2|COMPLETED|Period I - Placebo Run-in (Base)||148
957027|NCT00132730|2312950|P1|COMPLETED|Period I - Placebo Run-in (Base)||150
957028|NCT00132730|2312945|P6|STARTED|Period I - Placebo Run-in (Base)||0
957029|NCT00132730|2312946|P5|STARTED|Period I - Placebo Run-in (Base)||0
957030|NCT00132730|2312947|P4|STARTED|Period I - Placebo Run-in (Base)||153
957031|NCT00132730|2312948|P3|STARTED|Period I - Placebo Run-in (Base)||153
957032|NCT00132730|2312949|P2|STARTED|Period I - Placebo Run-in (Base)||148
957033|NCT00132730|2312950|P1|STARTED|Period I - Placebo Run-in (Base)||150
957034|NCT00132769|2312994|P2|NOT COMPLETED|Overall Study||11
957035|NCT00132769|2312995|P1|NOT COMPLETED|Overall Study||11
957036|NCT00132769|2312994|P2|COMPLETED|Overall Study||42
957037|NCT00132769|2312995|P1|COMPLETED|Overall Study||42
957038|NCT00132769|2312994|P2|STARTED|Overall Study||53
957039|NCT00132769|2312995|P1|STARTED|Overall Study||53
957040|NCT00132808|2313020|P3|NOT COMPLETED|Stratum II||9
957041|NCT00132808|2313021|P2|NOT COMPLETED|Stratum II||15
957042|NCT00132808|2313022|P1|NOT COMPLETED|Stratum II||8
957043|NCT00132808|2313020|P3|COMPLETED|Stratum II||116
957044|NCT00132808|2313021|P2|COMPLETED|Stratum II||96
957045|NCT00132808|2313022|P1|COMPLETED|Stratum II||113
957046|NCT00132808|2313020|P3|STARTED|Stratum II||125
957047|NCT00132808|2313021|P2|STARTED|Stratum II||111
957048|NCT00132808|2313022|P1|STARTED|Stratum II||121
957049|NCT00132808|2313020|P3|NOT COMPLETED|Stratum I||5
957050|NCT00132808|2313021|P2|NOT COMPLETED|Stratum I||12
957051|NCT00132808|2313022|P1|NOT COMPLETED|Stratum I||9
957052|NCT00132808|2313020|P3|COMPLETED|Stratum I||72
957053|NCT00132808|2313021|P2|COMPLETED|Stratum I||58
957054|NCT00132808|2313022|P1|COMPLETED|Stratum I||68
957055|NCT00132808|2313020|P3|STARTED|Stratum I||77
957056|NCT00132808|2313021|P2|STARTED|Stratum I||70
957057|NCT00132808|2313022|P1|STARTED|Stratum I||77
957058|NCT00132873|2313045|P1|NOT COMPLETED|Overall Study||9
957059|NCT00132873|2313045|P1|COMPLETED|Overall Study||50
957060|NCT00132873|2313045|P1|STARTED|Overall Study||59
957061|NCT00136695|2313052|P2|NOT COMPLETED|Overall Study||8
957062|NCT00136695|2313053|P1|NOT COMPLETED|Overall Study||11
957063|NCT00136695|2313052|P2|COMPLETED|Overall Study||35
957064|NCT00136695|2313053|P1|COMPLETED|Overall Study||34
957065|NCT00136695|2313052|P2|STARTED|Overall Study||43
957066|NCT00136695|2313053|P1|STARTED|Overall Study||45
957067|NCT00136760|2313063|P4|NOT COMPLETED|Overall Study||0
957068|NCT00136760|2313064|P3|NOT COMPLETED|Overall Study||0
957069|NCT00136760|2313065|P2|NOT COMPLETED|Overall Study||0
957070|NCT00136760|2313066|P1|NOT COMPLETED|Overall Study||0
957071|NCT00136760|2313063|P4|COMPLETED|Overall Study||13
957072|NCT00136760|2313064|P3|COMPLETED|Overall Study||11
957073|NCT00136760|2313065|P2|COMPLETED|Overall Study||16
957074|NCT00136760|2313066|P1|COMPLETED|Overall Study||12
957075|NCT00136760|2313063|P4|STARTED|Overall Study||13
957076|NCT00136760|2313064|P3|STARTED|Overall Study||11
957077|NCT00136760|2313065|P2|STARTED|Overall Study||16
957078|NCT00136760|2313066|P1|STARTED|Overall Study||12
957079|NCT00136812|2313082|P2|NOT COMPLETED|Overall Study||0
957080|NCT00136812|2313083|P1|NOT COMPLETED|Overall Study||0
957081|NCT00136812|2313082|P2|COMPLETED|Overall Study||113
957082|NCT00136812|2313083|P1|COMPLETED|Overall Study||111
957083|NCT00136812|2313082|P2|STARTED|Overall Study||113
957084|NCT00136812|2313083|P1|STARTED|Overall Study||111
957085|NCT00136838|2313089|P2|NOT COMPLETED|Second Intervention ( 5 Days)||0
957086|NCT00136838|2313090|P1|NOT COMPLETED|Second Intervention ( 5 Days)||0
957087|NCT00136838|2313089|P2|COMPLETED|Second Intervention ( 5 Days)||6
957088|NCT00136838|2313090|P1|COMPLETED|Second Intervention ( 5 Days)||6
957089|NCT00136838|2313089|P2|STARTED|Second Intervention ( 5 Days)||6
957090|NCT00136838|2313090|P1|STARTED|Second Intervention ( 5 Days)||6
957091|NCT00136838|2313089|P2|NOT COMPLETED|First Intervention ( 5 Days)||0
957092|NCT00136838|2313090|P1|NOT COMPLETED|First Intervention ( 5 Days)||0
957093|NCT00136838|2313089|P2|COMPLETED|First Intervention ( 5 Days)||6
957094|NCT00136838|2313090|P1|COMPLETED|First Intervention ( 5 Days)||6
957095|NCT00136838|2313089|P2|STARTED|First Intervention ( 5 Days)||6
957096|NCT00136838|2313090|P1|STARTED|First Intervention ( 5 Days)||6
957097|NCT00136916|2313100|P2|NOT COMPLETED|Overall Study||104
957098|NCT00136916|2313101|P1|NOT COMPLETED|Overall Study||125
957099|NCT00136916|2313100|P2|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|212
957100|NCT00136916|2313101|P1|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|194
957101|NCT00136916|2313100|P2|Received Treatment|Overall Study||311
957102|NCT00136916|2313101|P1|Received Treatment|Overall Study||316
957103|NCT00136916|2313100|P2|STARTED|Overall Study||316
957104|NCT00136916|2313101|P1|STARTED|Overall Study||319
957105|NCT00136955|2313155|P1|NOT COMPLETED|Overall Study||23
957106|NCT00136955|2313155|P1|COMPLETED|Overall Study||18
957107|NCT00136955|2313155|P1|STARTED|Overall Study||41
957108|NCT00137046|2313164|P2|NOT COMPLETED|Overall Study||93
957109|NCT00137046|2313165|P1|NOT COMPLETED|Overall Study||99
957110|NCT00137046|2313164|P2|COMPLETED|Overall Study||198
957111|NCT00137046|2313165|P1|COMPLETED|Overall Study|Completed subjects were those subjects who did not discontinue while on active drug.|192
957112|NCT00137046|2313164|P2|Received Study Treatment|Overall Study||290
957113|NCT00137046|2313165|P1|Received Study Treatment|Overall Study||290
957114|NCT00137046|2313164|P2|STARTED|Overall Study|One subject was randomized to subcutaneous insulin but never received treatment.|291
957115|NCT00137046|2313165|P1|STARTED|Overall Study|One subject was randomized to inhaled insulin but never received treatment.|291
957116|NCT00137111|2313217|P4|NOT COMPLETED|Total Therapy||0
957117|NCT00137111|2313218|P3|NOT COMPLETED|Total Therapy||0
957118|NCT00137111|2313219|P2|NOT COMPLETED|Total Therapy||0
957119|NCT00137111|2313220|P1|NOT COMPLETED|Total Therapy||40
957120|NCT00137111|2313217|P4|COMPLETED|Total Therapy||0
957121|NCT00137111|2313218|P3|COMPLETED|Total Therapy||0
957122|NCT00137111|2313219|P2|COMPLETED|Total Therapy||0
957123|NCT00137111|2313220|P1|COMPLETED|Total Therapy||458
957124|NCT00137111|2313217|P4|STARTED|Total Therapy||0
957125|NCT00137111|2313218|P3|STARTED|Total Therapy||0
957126|NCT00137111|2313219|P2|STARTED|Total Therapy||0
957127|NCT00137111|2313220|P1|STARTED|Total Therapy||498
957128|NCT00137111|2313217|P4|NOT COMPLETED|Window Therapy||0
957129|NCT00137111|2313218|P3|NOT COMPLETED|Window Therapy||0
957130|NCT00137111|2313219|P2|NOT COMPLETED|Window Therapy||0
957131|NCT00137111|2313220|P1|NOT COMPLETED|Window Therapy||0
957132|NCT00137111|2313217|P4|COMPLETED|Window Therapy||142
957133|NCT00137111|2313218|P3|COMPLETED|Window Therapy||180
957134|NCT00137111|2313219|P2|COMPLETED|Window Therapy||176
957135|NCT00137111|2313220|P1|COMPLETED|Window Therapy||0
957136|NCT00137111|2313217|P4|STARTED|Window Therapy||142
957137|NCT00137111|2313218|P3|STARTED|Window Therapy||180
957138|NCT00137111|2313219|P2|STARTED|Window Therapy||176
957139|NCT00137111|2313220|P1|STARTED|Window Therapy||0
957140|NCT00137267|2313234|P2|NOT COMPLETED|Overall Study||21
957141|NCT00137267|2313235|P1|NOT COMPLETED|Overall Study||15
957142|NCT00137267|2313234|P2|COMPLETED|Overall Study||26
957143|NCT00137267|2313235|P1|COMPLETED|Overall Study||40
957144|NCT00137267|2313234|P2|STARTED|Overall Study||47
957145|NCT00137267|2313235|P1|STARTED|Overall Study||55
957146|NCT00137280|2313245|P2|NOT COMPLETED|Overall Study||55
957147|NCT00137280|2313246|P1|NOT COMPLETED|Overall Study||84
957148|NCT00137280|2313245|P2|COMPLETED|Overall Study||357
957149|NCT00137280|2313246|P1|COMPLETED|Overall Study||305
957150|NCT00137280|2313245|P2|STARTED|Overall Study||412
957151|NCT00137280|2313246|P1|STARTED|Overall Study||389
957152|NCT00137423|2313260|P2|NOT COMPLETED|Overall Study||44
957153|NCT00137423|2313261|P1|NOT COMPLETED|Overall Study||39
957154|NCT00137423|2313260|P2|COMPLETED|Overall Study||9
957155|NCT00137423|2313261|P1|COMPLETED|Overall Study||15
957156|NCT00137423|2313260|P2|STARTED|Overall Study||53
957157|NCT00137423|2313261|P1|STARTED|Overall Study||54
957158|NCT00137436|2313281|P1|NOT COMPLETED|Overall Study||43
957159|NCT00137436|2313281|P1|COMPLETED|Overall Study||12
957160|NCT00137436|2313281|P1|STARTED|Overall Study|Phase 2 did not include 38 participants from Phase 1.|55
957161|NCT00137449|2313300|P2|NOT COMPLETED|Overall Study||18
957162|NCT00137449|2313301|P1|NOT COMPLETED|Overall Study||16
957163|NCT00137449|2313300|P2|COMPLETED|Overall Study||12
957164|NCT00137449|2313301|P1|COMPLETED|Overall Study||14
957165|NCT00137449|2313300|P2|STARTED|Overall Study||30
957166|NCT00137449|2313301|P1|STARTED|Overall Study||30
957167|NCT00137631|2313340|P2|NOT COMPLETED|Overall Study||41
957168|NCT00137631|2313341|P1|NOT COMPLETED|Overall Study||37
957169|NCT00137631|2313340|P2|COMPLETED|Overall Study||133
957170|NCT00137631|2313341|P1|COMPLETED|Overall Study||127
957171|NCT00137631|2313340|P2|Completed 6-month Follow-up|Overall Study|8 participants who were lost to follow-up at 3-months were retained at 6-months|133
957172|NCT00137631|2313341|P1|Completed 6-month Follow-up|Overall Study|7 participants who were lost to follow-up at 3-months were retained at 6-months|127
957173|NCT00137631|2313340|P2|Complete 3-month Follow-up|Overall Study||125
957174|NCT00137631|2313341|P1|Complete 3-month Follow-up|Overall Study||120
957175|NCT00137631|2313340|P2|STARTED|Overall Study||174
957176|NCT00137631|2313341|P1|STARTED|Overall Study||164
957177|NCT00137969|2313357|P2|NOT COMPLETED|Overall Study||21
957178|NCT00137969|2313358|P1|NOT COMPLETED|Overall Study||67
957179|NCT00137969|2313357|P2|COMPLETED|Overall Study||67
957180|NCT00137969|2313358|P1|COMPLETED|Overall Study||107
957181|NCT00137969|2313357|P2|Received Study Drug|Overall Study||88
957182|NCT00137969|2313358|P1|Received Study Drug|Overall Study||169
957183|NCT00137969|2313357|P2|STARTED|Overall Study||88
957184|NCT00137969|2313358|P1|STARTED|Overall Study||174
957185|NCT00138034|2313380|P2|NOT COMPLETED|Overall Study||3
957186|NCT00138034|2313381|P1|NOT COMPLETED|Overall Study||3
957187|NCT00138034|2313380|P2|COMPLETED|Overall Study||20
957188|NCT00138034|2313381|P1|COMPLETED|Overall Study||23
957189|NCT00138034|2313380|P2|STARTED|Overall Study||23
957190|NCT00138034|2313381|P1|STARTED|Overall Study||26
957191|NCT00138073|2313389|P1|NOT COMPLETED|Overall Study||55
957192|NCT00138073|2313389|P1|COMPLETED|Overall Study||0
957193|NCT00138073|2313389|P1|Pre-intervention Testing|Overall Study||55
957194|NCT00138073|2313389|P1|STARTED|Overall Study||55
957195|NCT00138125|2313394|P1|NOT COMPLETED|Overall Study||0
957196|NCT00138125|2313394|P1|COMPLETED|Overall Study||2
957197|NCT00138125|2313394|P1|STARTED|Overall Study||2
957198|NCT00138151|2313398|P1|NOT COMPLETED|Overall Study||4
957199|NCT00138151|2313398|P1|COMPLETED|Overall Study||29
957200|NCT00138151|2313398|P1|STARTED|Overall Study||33
957201|NCT00138203|2313404|P1|NOT COMPLETED|Overall Study||0
957202|NCT00138203|2313404|P1|COMPLETED|Overall Study||16
957203|NCT00138203|2313404|P1|STARTED|Overall Study||16
957204|NCT00138294|2313410|P1|NOT COMPLETED|Overall Study||0
957205|NCT00138294|2313410|P1|COMPLETED|Overall Study||29255
957206|NCT00138294|2313410|P1|STARTED|Overall Study||29255
957219|NCT00138645|2313495|P2|NOT COMPLETED|Overall Study||7
957220|NCT00138645|2313496|P1|NOT COMPLETED|Overall Study||6
957221|NCT00138645|2313495|P2|COMPLETED|Overall Study||23
957222|NCT00138645|2313496|P1|COMPLETED|Overall Study||24
957223|NCT00138645|2313495|P2|STARTED|Overall Study||30
957224|NCT00138645|2313496|P1|STARTED|Overall Study||30
957225|NCT00138658|2313502|P1|NOT COMPLETED|Overall Study||61
957226|NCT00138658|2313502|P1|COMPLETED|Overall Study||20
957227|NCT00138658|2313502|P1|STARTED|Overall Study||81
957228|NCT00138671|2313514|P2|NOT COMPLETED|Overall Study||16
957229|NCT00138671|2313515|P1|NOT COMPLETED|Overall Study||13
957230|NCT00138671|2313514|P2|COMPLETED|Overall Study||30
957231|NCT00138671|2313515|P1|COMPLETED|Overall Study||46
957232|NCT00138671|2313514|P2|STARTED|Overall Study||46
957233|NCT00138671|2313515|P1|STARTED|Overall Study||59
957234|NCT00130039|2313567|P2|NOT COMPLETED|Overall Study||18
957235|NCT00130039|2313568|P1|NOT COMPLETED|Overall Study||30
957236|NCT00130039|2313567|P2|COMPLETED|Overall Study|full analysis set|207
957237|NCT00130039|2313568|P1|COMPLETED|Overall Study|full analysis set|202
957238|NCT00130039|2313567|P2|STARTED|Overall Study||225
957239|NCT00130039|2313568|P1|STARTED|Overall Study||232
957240|NCT00143247|2313584|P1|NOT COMPLETED|Overall Study||156
957241|NCT00143247|2313584|P1|COMPLETED|Overall Study||17
957242|NCT00143247|2313584|P1|STARTED|Overall Study|173=total subjects of current + 3 previous protocols|173
957243|NCT00143312|2313598|P1|NOT COMPLETED|Overall Study||16
957244|NCT00143312|2313598|P1|COMPLETED|Overall Study||29
957245|NCT00143312|2313598|P1|STARTED|Overall Study||45
957246|NCT00143390|2313610|P2|NOT COMPLETED|Overall Study||149
957247|NCT00143390|2313611|P1|NOT COMPLETED|Overall Study||149
957248|NCT00143390|2313610|P2|COMPLETED|Overall Study||0
957249|NCT00143390|2313611|P1|COMPLETED|Overall Study||0
957250|NCT00143390|2313610|P2|STARTED|Overall Study||149
957251|NCT00143390|2313611|P1|STARTED|Overall Study||149
957252|NCT00143403|2313629|P2|NOT COMPLETED|Overall Study||46
957253|NCT00143403|2313630|P1|NOT COMPLETED|Overall Study||35
957254|NCT00143403|2313629|P2|COMPLETED|Overall Study|Received maximum number of cycles.|115
957255|NCT00143403|2313630|P1|COMPLETED|Overall Study|Received maximum number of cycles.|125
957256|NCT00143403|2313629|P2|Treated|Overall Study||153
957257|NCT00143403|2313630|P1|Treated|Overall Study||153
957258|NCT00143403|2313629|P2|STARTED|Overall Study||161
957259|NCT00143403|2313630|P1|STARTED|Overall Study||160
957260|NCT00143455|2313642|P4|NOT COMPLETED|Cohort 2||93
957261|NCT00143455|2313643|P3|NOT COMPLETED|Cohort 2||106
957262|NCT00143455|2313644|P2|NOT COMPLETED|Cohort 2||0
957263|NCT00143455|2313645|P1|NOT COMPLETED|Cohort 2||0
957264|NCT00143455|2313642|P4|COMPLETED|Cohort 2||111
957265|NCT00143455|2313643|P3|COMPLETED|Cohort 2||97
957266|NCT00143455|2313644|P2|COMPLETED|Cohort 2||0
957267|NCT00143455|2313645|P1|COMPLETED|Cohort 2||0
957268|NCT00143455|2313642|P4|Received Treatment|Cohort 2||203
957269|NCT00143455|2313643|P3|Received Treatment|Cohort 2||202
957270|NCT00143455|2313644|P2|Received Treatment|Cohort 2||0
957271|NCT00143455|2313645|P1|Received Treatment|Cohort 2||0
957272|NCT00143455|2313642|P4|STARTED|Cohort 2||204
957273|NCT00143455|2313643|P3|STARTED|Cohort 2||203
957274|NCT00143455|2313644|P2|STARTED|Cohort 2||0
957275|NCT00143455|2313645|P1|STARTED|Cohort 2||0
957276|NCT00143455|2313642|P4|NOT COMPLETED|Cohort 1||0
957277|NCT00143455|2313643|P3|NOT COMPLETED|Cohort 1||0
957278|NCT00143455|2313644|P2|NOT COMPLETED|Cohort 1||17
957279|NCT00143455|2313645|P1|NOT COMPLETED|Cohort 1||14
957280|NCT00143455|2313642|P4|COMPLETED|Cohort 1||0
957281|NCT00143455|2313643|P3|COMPLETED|Cohort 1||0
957282|NCT00143455|2313644|P2|COMPLETED|Cohort 1||22
957283|NCT00143455|2313645|P1|COMPLETED|Cohort 1||25
957284|NCT00143455|2313642|P4|Received Treatment|Cohort 1||0
957285|NCT00143455|2313643|P3|Received Treatment|Cohort 1||0
957286|NCT00143455|2313644|P2|Received Treatment|Cohort 1||38
957287|NCT00143455|2313645|P1|Received Treatment|Cohort 1||39
957288|NCT00143455|2313642|P4|STARTED|Cohort 1||0
957289|NCT00143455|2313643|P3|STARTED|Cohort 1||0
957290|NCT00143455|2313644|P2|STARTED|Cohort 1||39
957291|NCT00143455|2313645|P1|STARTED|Cohort 1||39
957292|NCT00143507|2313679|P2|NOT COMPLETED|Overall Study||652
957293|NCT00143507|2313680|P1|NOT COMPLETED|Overall Study||687
957294|NCT00143507|2313679|P2|COMPLETED|Overall Study||4786
957295|NCT00143507|2313680|P1|COMPLETED|Overall Study||4792
957296|NCT00143507|2313679|P2|STARTED|Overall Study||5438
957297|NCT00143507|2313680|P1|STARTED|Overall Study||5479
957298|NCT00143598|2313712|P2|NOT COMPLETED|Overall Study||94
957299|NCT00143598|2313713|P1|NOT COMPLETED|Overall Study||92
957300|NCT00143598|2313712|P2|COMPLETED|Overall Study||302
957301|NCT00143598|2313713|P1|COMPLETED|Overall Study||318
957302|NCT00143598|2313712|P2|STARTED|Overall Study||396
957303|NCT00143598|2313713|P1|STARTED|Overall Study||410
957304|NCT00143819|2313727|P2|NOT COMPLETED|Overall Study||3
957305|NCT00143819|2313728|P1|NOT COMPLETED|Overall Study||2
957306|NCT00143819|2313727|P2|COMPLETED|Overall Study||5
957307|NCT00143819|2313728|P1|COMPLETED|Overall Study||3
957308|NCT00143819|2313727|P2|STARTED|Overall Study||8
957309|NCT00143819|2313728|P1|STARTED|Overall Study||5
957310|NCT00143845|2313741|P1|NOT COMPLETED|Overall Study||0
957311|NCT00143845|2313741|P1|COMPLETED|Overall Study||54
957312|NCT00143845|2313741|P1|STARTED|Overall Study||54
957313|NCT00144027|2313749|P2|NOT COMPLETED|Overall Study||11
957314|NCT00144027|2313750|P1|NOT COMPLETED|Overall Study||3
957315|NCT00144027|2313749|P2|COMPLETED|Overall Study|participants who completed 12-month follow-up|25
957316|NCT00144027|2313750|P1|COMPLETED|Overall Study|participants who completed 12-month follow-up|36
957317|NCT00144027|2313749|P2|Completed 6 Month Assessment|Overall Study||24
957318|NCT00144027|2313750|P1|Completed 6 Month Assessment|Overall Study||37
957319|NCT00144027|2313749|P2|Completed Baseline Assessment|Overall Study||29
957320|NCT00144027|2313750|P1|Completed Baseline Assessment|Overall Study||39
957321|NCT00144027|2313749|P2|STARTED|Overall Study|participants who consented|36
957322|NCT00144027|2313750|P1|STARTED|Overall Study|participants who consented|39
957323|NCT00144170|2313758|P2|NOT COMPLETED|Overall Study||396
957324|NCT00144170|2313759|P1|NOT COMPLETED|Overall Study||352
957325|NCT00144170|2313758|P2|COMPLETED|Overall Study||32
957326|NCT00144170|2313759|P1|COMPLETED|Overall Study||86
957327|NCT00144170|2313758|P2|STARTED|Overall Study||428
957328|NCT00144170|2313759|P1|STARTED|Overall Study||438
957329|NCT00144300|2313949|P2|NOT COMPLETED|Overall Study||28
957330|NCT00144300|2313950|P1|NOT COMPLETED|Overall Study||29
957331|NCT00144300|2313949|P2|COMPLETED|Overall Study||97
957332|NCT00144300|2313950|P1|COMPLETED|Overall Study||92
957333|NCT00144300|2313949|P2|STARTED|Overall Study||125
957334|NCT00144300|2313950|P1|STARTED|Overall Study||121
957335|NCT00144339|2313998|P2|NOT COMPLETED|Overall Study||1099
957336|NCT00144339|2313999|P1|NOT COMPLETED|Overall Study||1358
957337|NCT00144339|2313998|P2|COMPLETED|Overall Study||1887
957338|NCT00144339|2313999|P1|COMPLETED|Overall Study||1648
957339|NCT00144339|2313998|P2|STARTED|Overall Study||2986
957340|NCT00144339|2313999|P1|STARTED|Overall Study||3006
957341|NCT00144391|2314207|P2|NOT COMPLETED|Overall Study||0
957342|NCT00144391|2314208|P1|NOT COMPLETED|Overall Study||0
957343|NCT00144391|2314207|P2|COMPLETED|Overall Study||9
957344|NCT00144391|2314208|P1|COMPLETED|Overall Study||11
957345|NCT00144391|2314207|P2|STARTED|Overall Study||9
957346|NCT00144391|2314208|P1|STARTED|Overall Study||11
957347|NCT00144781|2314218|P4|NOT COMPLETED|Overall Study||0
957348|NCT00144781|2314219|P3|NOT COMPLETED|Overall Study||0
957349|NCT00144781|2314220|P2|NOT COMPLETED|Overall Study||2
957350|NCT00144781|2314221|P1|NOT COMPLETED|Overall Study||0
957351|NCT00144781|2314218|P4|COMPLETED|Overall Study||9
957352|NCT00144781|2314219|P3|COMPLETED|Overall Study||8
957353|NCT00144781|2314220|P2|COMPLETED|Overall Study||7
957354|NCT00144781|2314221|P1|COMPLETED|Overall Study||8
957355|NCT00144781|2314218|P4|STARTED|Overall Study||9
957356|NCT00144781|2314219|P3|STARTED|Overall Study||8
957357|NCT00144781|2314220|P2|STARTED|Overall Study||9
957358|NCT00144781|2314221|P1|STARTED|Overall Study||8
957359|NCT00144963|2314239|P1|NOT COMPLETED|Overall Study||0
957360|NCT00144963|2314239|P1|COMPLETED|Overall Study||36
957361|NCT00144963|2314239|P1|STARTED|Overall Study||36
957362|NCT00145041|2314243|P1|NOT COMPLETED|Overall Study||0
957363|NCT00145041|2314243|P1|COMPLETED|Overall Study||7
957364|NCT00145041|2314243|P1|STARTED|Overall Study||7
957365|NCT00145119|2314249|P1|NOT COMPLETED|Overall Study||45
957366|NCT00145119|2314249|P1|COMPLETED|Overall Study||267
957367|NCT00145119|2314249|P1|STARTED|Overall Study||312
957368|NCT00145249|2314256|P3|NOT COMPLETED|Overall Study||17
957369|NCT00145249|2314257|P2|NOT COMPLETED|Overall Study||15
957370|NCT00145249|2314258|P1|NOT COMPLETED|Overall Study||11
957371|NCT00145249|2314256|P3|COMPLETED|Overall Study||31
957372|NCT00145249|2314257|P2|COMPLETED|Overall Study||33
957373|NCT00145249|2314258|P1|COMPLETED|Overall Study||36
957374|NCT00145249|2314256|P3|STARTED|Overall Study|48 subjects randomized; 49 treated-3 subjects randomized to AmphoB+Fluc400 rec'd AmphoB+Fluc800|48
957375|NCT00145249|2314257|P2|STARTED|Overall Study|48 subjects randomized; 47 subjects treated-2 subjects randomized to AmphoB rec'd AmphoB+Fluc400|48
957376|NCT00145249|2314258|P1|STARTED|Overall Study|47 subjects randomized; 45 subjects treated|47
957377|NCT00145327|2314302|P3|NOT COMPLETED|Overall Study||248
957378|NCT00145327|2314303|P2|NOT COMPLETED|Overall Study||124
957379|NCT00145327|2314304|P1|NOT COMPLETED|Overall Study||142
957380|NCT00145327|2314302|P3|COMPLETED|Overall Study||975
957381|NCT00145327|2314303|P2|COMPLETED|Overall Study||493
957382|NCT00145327|2314304|P1|COMPLETED|Overall Study||474
957383|NCT00145327|2314302|P3|STARTED|Overall Study|Group P3Z3 have non-randomized participants|1223
957384|NCT00145327|2314303|P2|STARTED|Overall Study||617
957385|NCT00145327|2314304|P1|STARTED|Overall Study|Group Z6 and Group Z3P3 have randomized participants.|616
957386|NCT00145418|2314357|P1|NOT COMPLETED|Overall Study||0
957387|NCT00145418|2314357|P1|COMPLETED|Overall Study||15
957388|NCT00145418|2314357|P1|STARTED|Overall Study||15
957389|NCT00134381|2314364|P6|NOT COMPLETED|Overall Study||2
957390|NCT00134381|2314365|P5|NOT COMPLETED|Overall Study||0
957391|NCT00134381|2314366|P4|NOT COMPLETED|Overall Study||0
957392|NCT00134381|2314367|P3|NOT COMPLETED|Overall Study||0
957393|NCT00134381|2314368|P2|NOT COMPLETED|Overall Study||0
957394|NCT00134381|2314369|P1|NOT COMPLETED|Overall Study||0
957395|NCT00134381|2314364|P6|COMPLETED|Overall Study||29
957396|NCT00134381|2314365|P5|COMPLETED|Overall Study||31
957397|NCT00134381|2314366|P4|COMPLETED|Overall Study||2
957398|NCT00134381|2314367|P3|COMPLETED|Overall Study||1
957399|NCT00134381|2314368|P2|COMPLETED|Overall Study||2
957400|NCT00134381|2314369|P1|COMPLETED|Overall Study||1
957401|NCT00134381|2314364|P6|STARTED|Overall Study||31
957402|NCT00134381|2314365|P5|STARTED|Overall Study||31
957403|NCT00134381|2314366|P4|STARTED|Overall Study||2
957404|NCT00134381|2314367|P3|STARTED|Overall Study||1
957405|NCT00134381|2314368|P2|STARTED|Overall Study||2
957406|NCT00134381|2314369|P1|STARTED|Overall Study||1
957407|NCT00134563|2314405|P3|NOT COMPLETED|Overall Study||96
957408|NCT00134563|2314406|P2|NOT COMPLETED|Overall Study||92
957409|NCT00134563|2314407|P1|NOT COMPLETED|Overall Study||104
957410|NCT00134563|2314405|P3|COMPLETED|Overall Study|completed treatment period|263
957411|NCT00134563|2314406|P2|COMPLETED|Overall Study|completed treatment period|274
957412|NCT00134563|2314407|P1|COMPLETED|Overall Study|completed treatment period|259
957413|NCT00134563|2314405|P3|Treated|Overall Study|one participant received doses of Teriflunomide 7 mg|358
957414|NCT00134563|2314406|P2|Treated|Overall Study||365
957415|NCT00134563|2314407|P1|Treated|Overall Study|Two participants received doses of Teriflunomide 7 mg, one participant doses of Teriflunomide 14 mg|363
957416|NCT00134563|2314405|P3|STARTED|Overall Study|Randomized|359
957417|NCT00134563|2314406|P2|STARTED|Overall Study|Randomized|366
957418|NCT00134563|2314407|P1|STARTED|Overall Study|Randomized|363
957419|NCT00134719|2314433|P3|NOT COMPLETED|Fourth Dose Vaccination Phase||1
957420|NCT00134719|2314434|P2|NOT COMPLETED|Fourth Dose Vaccination Phase||3
957421|NCT00134719|2314435|P1|NOT COMPLETED|Fourth Dose Vaccination Phase||2
957422|NCT00134719|2314433|P3|COMPLETED|Fourth Dose Vaccination Phase||203
957423|NCT00134719|2314434|P2|COMPLETED|Fourth Dose Vaccination Phase||203
957424|NCT00134719|2314435|P1|COMPLETED|Fourth Dose Vaccination Phase||623
957425|NCT00134719|2314433|P3|STARTED|Fourth Dose Vaccination Phase||204
957426|NCT00134719|2314434|P2|STARTED|Fourth Dose Vaccination Phase||206
957427|NCT00134719|2314435|P1|STARTED|Fourth Dose Vaccination Phase||625
957428|NCT00134719|2314433|P3|NOT COMPLETED|Primary Vaccination Phase||5
957429|NCT00134719|2314434|P2|NOT COMPLETED|Primary Vaccination Phase||6
957430|NCT00134719|2314435|P1|NOT COMPLETED|Primary Vaccination Phase||14
957431|NCT00134719|2314433|P3|COMPLETED|Primary Vaccination Phase||216
957432|NCT00134719|2314434|P2|COMPLETED|Primary Vaccination Phase||215
957433|NCT00134719|2314435|P1|COMPLETED|Primary Vaccination Phase||647
957434|NCT00134719|2314433|P3|STARTED|Primary Vaccination Phase||221
957435|NCT00134719|2314434|P2|STARTED|Primary Vaccination Phase||221
957436|NCT00134719|2314435|P1|STARTED|Primary Vaccination Phase||661
957437|NCT00134784|2314567|P4|NOT COMPLETED|Overall Study||1
957438|NCT00134784|2314568|P3|NOT COMPLETED|Overall Study||2
957439|NCT00134784|2314569|P2|NOT COMPLETED|Overall Study||2
957440|NCT00134784|2314570|P1|NOT COMPLETED|Overall Study||2
957441|NCT00134784|2314567|P4|COMPLETED|Overall Study||37
957442|NCT00134784|2314568|P3|COMPLETED|Overall Study||35
957443|NCT00134784|2314569|P2|COMPLETED|Overall Study||36
957444|NCT00134784|2314570|P1|COMPLETED|Overall Study||27
957445|NCT00134784|2314567|P4|STARTED|Overall Study||38
957446|NCT00134784|2314568|P3|STARTED|Overall Study||37
957447|NCT00134784|2314569|P2|STARTED|Overall Study||38
957448|NCT00134784|2314570|P1|STARTED|Overall Study||29
957449|NCT00134901|2314579|P2|NOT COMPLETED|Overall Study||15
957450|NCT00134901|2314580|P1|NOT COMPLETED|Overall Study||17
957451|NCT00134901|2314579|P2|COMPLETED|Overall Study||27
957452|NCT00134901|2314580|P1|COMPLETED|Overall Study||22
957453|NCT00134901|2314579|P2|STARTED|Overall Study||42
957454|NCT00134901|2314580|P1|STARTED|Overall Study||39
957455|NCT00135200|2314588|P1|NOT COMPLETED|Overall Study||0
957456|NCT00135200|2314588|P1|COMPLETED|Overall Study||16
957457|NCT00135200|2314588|P1|STARTED|Overall Study||16
957458|NCT00135330|2314596|P3|NOT COMPLETED|Overall Study||11
957459|NCT00135330|2314597|P2|NOT COMPLETED|Overall Study||13
957460|NCT00135330|2314598|P1|NOT COMPLETED|Overall Study||12
957461|NCT00135330|2314596|P3|COMPLETED|Overall Study||34
957462|NCT00135330|2314597|P2|COMPLETED|Overall Study||34
957463|NCT00135330|2314598|P1|COMPLETED|Overall Study||33
957464|NCT00135330|2314596|P3|STARTED|Overall Study||45
957465|NCT00135330|2314597|P2|STARTED|Overall Study||47
957466|NCT00135330|2314598|P1|STARTED|Overall Study||45
957467|NCT00135356|2314692|P2|NOT COMPLETED|Overall Study||9
957468|NCT00135356|2314693|P1|NOT COMPLETED|Overall Study||17
957469|NCT00135356|2314692|P2|COMPLETED|Overall Study||60
957470|NCT00135356|2314693|P1|COMPLETED|Overall Study||114
957471|NCT00135356|2314692|P2|Discontinued on or After Week 96 Visit|Overall Study||0
957472|NCT00135356|2314693|P1|Discontinued on or After Week 96 Visit|Overall Study||1
957473|NCT00135356|2314692|P2|Discontinued Prior to Week 96 Visit|Overall Study||9
957474|NCT00135356|2314693|P1|Discontinued Prior to Week 96 Visit|Overall Study||16
957475|NCT00135356|2314692|P2|STARTED|Overall Study|Number randomized and treated(1 randomized and never treated subject not included in this number.)|69
957476|NCT00135356|2314693|P1|STARTED|Overall Study|Number randomized and treated|131
957477|NCT00135694|2314736|P3|NOT COMPLETED|Overall Study||7
957478|NCT00135694|2314737|P2|NOT COMPLETED|Overall Study||21
957479|NCT00135694|2314738|P1|NOT COMPLETED|Overall Study||180
957480|NCT00135694|2314736|P3|COMPLETED|Overall Study||11
957481|NCT00135694|2314737|P2|COMPLETED|Overall Study||56
957482|NCT00135694|2314738|P1|COMPLETED|Overall Study|Subjects were assessed as ineligible for random assignment and subsequently terminated per protocol.|0
957483|NCT00135694|2314736|P3|STARTED|Overall Study||18
957484|NCT00135694|2314737|P2|STARTED|Overall Study||77
957485|NCT00135694|2314738|P1|STARTED|Overall Study||180
957486|NCT00135798|2314759|P3|NOT COMPLETED|Overall Study||0
957487|NCT00135798|2314760|P2|NOT COMPLETED|Overall Study||0
957488|NCT00135798|2314761|P1|NOT COMPLETED|Overall Study||0
957489|NCT00135798|2314759|P3|COMPLETED|Overall Study||32
957490|NCT00135798|2314760|P2|COMPLETED|Overall Study||31
957491|NCT00135798|2314761|P1|COMPLETED|Overall Study||16
957492|NCT00135798|2314759|P3|STARTED|Overall Study||32
957493|NCT00135798|2314760|P2|STARTED|Overall Study||31
957494|NCT00135798|2314761|P1|STARTED|Overall Study||16
957495|NCT00136084|2314779|P2|NOT COMPLETED|Overall Study||42
957496|NCT00136084|2314780|P1|NOT COMPLETED|Overall Study||48
957497|NCT00136084|2314779|P2|COMPLETED|Overall Study||72
957498|NCT00136084|2314780|P1|COMPLETED|Overall Study||61
957499|NCT00136084|2314779|P2|STARTED|Overall Study||114
957500|NCT00136084|2314780|P1|STARTED|Overall Study||109
957501|NCT00136318|2314795|P2|NOT COMPLETED|Overall Study||7
957502|NCT00136318|2314796|P1|NOT COMPLETED|Overall Study||7
957503|NCT00136318|2314795|P2|COMPLETED|Overall Study||84
957504|NCT00136318|2314796|P1|COMPLETED|Overall Study|reached end-point of antiviral treatment|83
957505|NCT00136318|2314795|P2|STARTED|Overall Study|Took first dose of study medication|91
957506|NCT00136318|2314796|P1|STARTED|Overall Study|Took first dose of study medication|90
957507|NCT00136357|2314812|P2|NOT COMPLETED|Overall Study||2
957508|NCT00136357|2314813|P1|NOT COMPLETED|Overall Study||3
957509|NCT00136357|2314812|P2|COMPLETED|Overall Study||39
957510|NCT00136357|2314813|P1|COMPLETED|Overall Study||38
957511|NCT00136357|2314812|P2|STARTED|Overall Study||41
957512|NCT00136357|2314813|P1|STARTED|Overall Study||41
957513|NCT00145496|2314821|P2|NOT COMPLETED|Overall Study||81
957514|NCT00145496|2314822|P1|NOT COMPLETED|Overall Study||123
957515|NCT00145496|2314821|P2|COMPLETED|Overall Study||143
957516|NCT00145496|2314822|P1|COMPLETED|Overall Study||121
957517|NCT00145496|2314821|P2|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|224
957518|NCT00145496|2314822|P1|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|244
957519|NCT00145509|2314834|P2|NOT COMPLETED|Overall Study||21
957520|NCT00145509|2314835|P1|NOT COMPLETED|Overall Study||22
957521|NCT00145509|2314834|P2|COMPLETED|Overall Study||15
957522|NCT00145509|2314835|P1|COMPLETED|Overall Study||19
957523|NCT00145509|2314834|P2|STARTED|Overall Study||36
957524|NCT00145509|2314835|P1|STARTED|Overall Study||41
957525|NCT00145574|2314850|P3|NOT COMPLETED|Open Label Long-term Extension||11
957526|NCT00145574|2314851|P2|NOT COMPLETED|Open Label Long-term Extension||0
957527|NCT00145574|2314852|P1|NOT COMPLETED|Open Label Long-term Extension||0
957528|NCT00145574|2314850|P3|COMPLETED|Open Label Long-term Extension||173
957529|NCT00145574|2314851|P2|COMPLETED|Open Label Long-term Extension||0
957530|NCT00145574|2314852|P1|COMPLETED|Open Label Long-term Extension||0
957531|NCT00145574|2314850|P3|STARTED|Open Label Long-term Extension|2 participants discontinued after completing double-blind but before starting open label.|184
957532|NCT00145574|2314851|P2|STARTED|Open Label Long-term Extension||0
957533|NCT00145574|2314852|P1|STARTED|Open Label Long-term Extension||0
957534|NCT00145574|2314850|P3|NOT COMPLETED|Double Blind||2
957535|NCT00145574|2314851|P2|NOT COMPLETED|Double Blind||5
957536|NCT00145574|2314852|P1|NOT COMPLETED|Double Blind||1
957537|NCT00145574|2314850|P3|COMPLETED|Double Blind||62
957538|NCT00145574|2314851|P2|COMPLETED|Double Blind||60
957539|NCT00145574|2314852|P1|COMPLETED|Double Blind||64
957540|NCT00145574|2314850|P3|STARTED|Double Blind||64
957541|NCT00145574|2314851|P2|STARTED|Double Blind||65
957542|NCT00145574|2314852|P1|STARTED|Double Blind||65
957543|NCT00145587|2314909|P2|NOT COMPLETED|Overall Study||0
957544|NCT00145587|2314910|P1|NOT COMPLETED|Overall Study||0
957545|NCT00145587|2314909|P2|COMPLETED|Overall Study||1
957546|NCT00145587|2314910|P1|COMPLETED|Overall Study||5
957547|NCT00145587|2314909|P2|STARTED|Overall Study||1
957548|NCT00145587|2314910|P1|STARTED|Overall Study||5
957549|NCT00145600|2314920|P4|NOT COMPLETED|Overall Study||16
957550|NCT00145600|2314921|P3|NOT COMPLETED|Overall Study||5
957551|NCT00145600|2314922|P2|NOT COMPLETED|Overall Study||10
957552|NCT00145600|2314923|P1|NOT COMPLETED|Overall Study||8
957553|NCT00145600|2314920|P4|COMPLETED|Overall Study||130
957554|NCT00145600|2314921|P3|COMPLETED|Overall Study||8
957555|NCT00145600|2314922|P2|COMPLETED|Overall Study||36
957556|NCT00145600|2314923|P1|COMPLETED|Overall Study||83
957557|NCT00145600|2314920|P4|STARTED|Overall Study||146
957558|NCT00145600|2314921|P3|STARTED|Overall Study||13
957559|NCT00145600|2314922|P2|STARTED|Overall Study||46
957560|NCT00145600|2314923|P1|STARTED|Overall Study||91
957561|NCT00145626|2315037|P1|NOT COMPLETED|Overall Study||5
957562|NCT00145626|2315037|P1|COMPLETED|Overall Study||14
957563|NCT00145626|2315037|P1|STARTED|Overall Study||19
957564|NCT00145704|2315081|P2|NOT COMPLETED|Overall Study||3
957565|NCT00145704|2315082|P1|NOT COMPLETED|Overall Study||3
957566|NCT00145704|2315081|P2|COMPLETED|Overall Study||0
957567|NCT00145704|2315082|P1|COMPLETED|Overall Study||0
957568|NCT00145704|2315081|P2|STARTED|Overall Study||3
957569|NCT00145704|2315082|P1|STARTED|Overall Study||3
957570|NCT00145795|2315090|P2|NOT COMPLETED|Overall Study||0
957571|NCT00145795|2315091|P1|NOT COMPLETED|Overall Study||1
957572|NCT00145795|2315090|P2|COMPLETED|Overall Study||10
957573|NCT00145795|2315091|P1|COMPLETED|Overall Study|1 patient discontinued early due to grade II gastrointestinal symptoms.|9
957574|NCT00145795|2315090|P2|STARTED|Overall Study||10
957575|NCT00145795|2315091|P1|STARTED|Overall Study||10
957576|NCT00146757|2315115|P2|NOT COMPLETED|Overall Study||0
957577|NCT00146757|2315116|P1|NOT COMPLETED|Overall Study||2
957578|NCT00146757|2315115|P2|COMPLETED|Overall Study||4
957579|NCT00146757|2315116|P1|COMPLETED|Overall Study||14
957580|NCT00146757|2315115|P2|STARTED|Overall Study||4
957581|NCT00146757|2315116|P1|STARTED|Overall Study||16
957582|NCT00146770|2315135|P2|NOT COMPLETED|Overall Study||0
957583|NCT00146770|2315136|P1|NOT COMPLETED|Overall Study||5
957584|NCT00146770|2315135|P2|COMPLETED|Overall Study||22
957585|NCT00146770|2315136|P1|COMPLETED|Overall Study||18
957586|NCT00146770|2315135|P2|STARTED|Overall Study||22
957587|NCT00146770|2315136|P1|STARTED|Overall Study||23
957588|NCT00146848|2315157|P3|NOT COMPLETED|Post-randomization||39
957589|NCT00146848|2315158|P2|NOT COMPLETED|Post-randomization||47
957590|NCT00146848|2315159|P1|NOT COMPLETED|Post-randomization||38
957591|NCT00146848|2315157|P3|COMPLETED|Post-randomization||431
957592|NCT00146848|2315158|P2|COMPLETED|Post-randomization||441
957593|NCT00146848|2315159|P1|COMPLETED|Post-randomization||437
957594|NCT00146848|2315157|P3|STARTED|Post-randomization||470
957595|NCT00146848|2315158|P2|STARTED|Post-randomization||488
957596|NCT00146848|2315159|P1|STARTED|Post-randomization||475
957597|NCT00146848|2315157|P3|NOT COMPLETED|Pre-randomization||0
957598|NCT00146848|2315158|P2|NOT COMPLETED|Pre-randomization||0
957599|NCT00146848|2315159|P1|NOT COMPLETED|Pre-randomization||309
957600|NCT00146848|2315157|P3|COMPLETED|Pre-randomization||0
957601|NCT00146848|2315158|P2|COMPLETED|Pre-randomization||0
957602|NCT00146848|2315159|P1|COMPLETED|Pre-randomization|Reached 6-week visit and were randomized|1433
957603|NCT00146848|2315157|P3|STARTED|Pre-randomization||0
957604|NCT00146848|2315158|P2|STARTED|Pre-randomization||0
957605|NCT00146848|2315159|P1|STARTED|Pre-randomization|Registered|1742
957606|NCT00147030|2315175|P2|NOT COMPLETED|Overall Study||0
957607|NCT00147030|2315176|P1|NOT COMPLETED|Overall Study||0
957608|NCT00147030|2315175|P2|COMPLETED|Overall Study||162
957609|NCT00147030|2315176|P1|COMPLETED|Overall Study||163
957610|NCT00147030|2315175|P2|STARTED|Overall Study||162
957611|NCT00147030|2315176|P1|STARTED|Overall Study||163
957612|NCT00147199|2315226|P2|NOT COMPLETED|Overall Study||10
957613|NCT00147199|2315227|P1|NOT COMPLETED|Overall Study||13
957614|NCT00147199|2315226|P2|COMPLETED|Overall Study||110
957615|NCT00147199|2315227|P1|COMPLETED|Overall Study||102
957616|NCT00147199|2315226|P2|STARTED|Overall Study||120
957617|NCT00147199|2315227|P1|STARTED|Overall Study||115
957618|NCT00147212|2315249|P1|NOT COMPLETED|Overall Study||0
957619|NCT00147212|2315249|P1|COMPLETED|Overall Study||50
957620|NCT00147212|2315249|P1|STARTED|Overall Study||50
957621|NCT00147225|2315259|P6|NOT COMPLETED|Overall Study||2
957622|NCT00147225|2315260|P5|NOT COMPLETED|Overall Study||1
957623|NCT00147225|2315261|P4|NOT COMPLETED|Overall Study||1
957624|NCT00147225|2315262|P3|NOT COMPLETED|Overall Study||2
957625|NCT00147225|2315263|P2|NOT COMPLETED|Overall Study||0
957626|NCT00147225|2315264|P1|NOT COMPLETED|Overall Study||1
957627|NCT00147225|2315259|P6|COMPLETED|Overall Study||10
957628|NCT00147225|2315260|P5|COMPLETED|Overall Study||10
957629|NCT00147225|2315261|P4|COMPLETED|Overall Study||10
957630|NCT00147225|2315262|P3|COMPLETED|Overall Study||6
957631|NCT00147225|2315263|P2|COMPLETED|Overall Study||6
957632|NCT00147225|2315264|P1|COMPLETED|Overall Study||6
957633|NCT00147225|2315259|P6|STARTED|Overall Study||12
957634|NCT00147225|2315260|P5|STARTED|Overall Study||11
957635|NCT00147225|2315261|P4|STARTED|Overall Study||11
957636|NCT00147225|2315262|P3|STARTED|Overall Study||8
957637|NCT00147225|2315263|P2|STARTED|Overall Study||6
957638|NCT00147225|2315264|P1|STARTED|Overall Study||7
957639|NCT00147238|2315284|P1|NOT COMPLETED|Overall Study||8
957640|NCT00147238|2315284|P1|COMPLETED|Overall Study||2
957641|NCT00147238|2315284|P1|STARTED|Overall Study||10
957642|NCT00147277|2315290|P2|NOT COMPLETED|Overall Study||0
957643|NCT00147277|2315291|P1|NOT COMPLETED|Overall Study||0
957644|NCT00147277|2315290|P2|COMPLETED|Overall Study||450
957645|NCT00147277|2315291|P1|COMPLETED|Overall Study||475
957646|NCT00147277|2315290|P2|STARTED|Overall Study||450
957647|NCT00147277|2315291|P1|STARTED|Overall Study||475
957648|NCT00147290|2315297|P2|NOT COMPLETED|Overall Study||0
957649|NCT00147290|2315298|P1|NOT COMPLETED|Overall Study||0
957650|NCT00147290|2315297|P2|COMPLETED|Overall Study||260
957651|NCT00147290|2315298|P1|COMPLETED|Overall Study||266
957652|NCT00147290|2315297|P2|STARTED|Overall Study||260
957653|NCT00147290|2315298|P1|STARTED|Overall Study||266
957654|NCT00147316|2315302|P1|NOT COMPLETED|Overall Study||0
957655|NCT00147316|2315302|P1|COMPLETED|Overall Study||103
957656|NCT00147316|2315302|P1|STARTED|Overall Study||103
957657|NCT00147446|2315309|P2|NOT COMPLETED|Overall Study||0
957658|NCT00147446|2315310|P1|NOT COMPLETED|Overall Study||0
957659|NCT00147446|2315309|P2|COMPLETED|Overall Study||61
957660|NCT00147446|2315310|P1|COMPLETED|Overall Study||60
957661|NCT00147446|2315309|P2|STARTED|Overall Study||61
957662|NCT00147446|2315310|P1|STARTED|Overall Study||60
957663|NCT00147498|2315322|P4|NOT COMPLETED|Overall Study||17
957664|NCT00147498|2315323|P3|NOT COMPLETED|Overall Study||17
957665|NCT00147498|2315324|P2|NOT COMPLETED|Overall Study||9
957666|NCT00147498|2315325|P1|NOT COMPLETED|Overall Study||3
957667|NCT00147498|2315322|P4|COMPLETED|Overall Study||48
957668|NCT00147498|2315323|P3|COMPLETED|Overall Study||52
957669|NCT00147498|2315324|P2|COMPLETED|Overall Study||60
957670|NCT00147498|2315325|P1|COMPLETED|Overall Study||58
957671|NCT00147498|2315322|P4|STARTED|Overall Study||65
957672|NCT00147498|2315323|P3|STARTED|Overall Study||69
957673|NCT00147498|2315324|P2|STARTED|Overall Study||69
957674|NCT00147498|2315325|P1|STARTED|Overall Study||61
957675|NCT00147537|2315423|P11|NOT COMPLETED|Phase 2||52
957676|NCT00147537|2315424|P10|NOT COMPLETED|Phase 2||161
957677|NCT00147537|2315425|P9|NOT COMPLETED|Phase 2||0
957678|NCT00147537|2315426|P8|NOT COMPLETED|Phase 2||0
957679|NCT00147537|2315427|P7|NOT COMPLETED|Phase 2||0
957680|NCT00147537|2315428|P6|NOT COMPLETED|Phase 2||0
957681|NCT00147537|2315429|P5|NOT COMPLETED|Phase 2||0
957682|NCT00147537|2315430|P4|NOT COMPLETED|Phase 2||0
957683|NCT00147537|2315431|P3|NOT COMPLETED|Phase 2||0
957684|NCT00147537|2315432|P2|NOT COMPLETED|Phase 2||0
957685|NCT00147537|2315433|P1|NOT COMPLETED|Phase 2||0
957686|NCT00147537|2315423|P11|COMPLETED|Phase 2||3
957687|NCT00147537|2315424|P10|COMPLETED|Phase 2||5
957688|NCT00147537|2315425|P9|COMPLETED|Phase 2||0
957689|NCT00147537|2315426|P8|COMPLETED|Phase 2||0
957690|NCT00147537|2315427|P7|COMPLETED|Phase 2||0
957691|NCT00147537|2315428|P6|COMPLETED|Phase 2||0
957692|NCT00147537|2315429|P5|COMPLETED|Phase 2||0
957693|NCT00147537|2315430|P4|COMPLETED|Phase 2||0
957694|NCT00147537|2315431|P3|COMPLETED|Phase 2||0
957695|NCT00147537|2315432|P2|COMPLETED|Phase 2||0
957696|NCT00147537|2315433|P1|COMPLETED|Phase 2||0
957697|NCT00147537|2315423|P11|STARTED|Phase 2|55 randomized; 56 treated-1 randomized but not treated, 2 randomized to F+P+C rec'd P+C|55
957698|NCT00147537|2315424|P10|STARTED|Phase 2|166 particpants randomized; 163 participants treated|166
957699|NCT00147537|2315425|P9|STARTED|Phase 2||0
957700|NCT00147537|2315426|P8|STARTED|Phase 2||0
957701|NCT00147537|2315427|P7|STARTED|Phase 2||0
957702|NCT00147537|2315428|P6|STARTED|Phase 2||0
957703|NCT00147537|2315429|P5|STARTED|Phase 2||0
957704|NCT00147537|2315430|P4|STARTED|Phase 2||0
957705|NCT00147537|2315431|P3|STARTED|Phase 2||0
957706|NCT00147537|2315432|P2|STARTED|Phase 2||0
957707|NCT00147537|2315433|P1|STARTED|Phase 2||0
957708|NCT00147537|2315423|P11|NOT COMPLETED|Phase 1b||0
957709|NCT00147537|2315424|P10|NOT COMPLETED|Phase 1b||0
957710|NCT00147537|2315425|P9|NOT COMPLETED|Phase 1b||17
957711|NCT00147537|2315426|P8|NOT COMPLETED|Phase 1b||7
957712|NCT00147537|2315427|P7|NOT COMPLETED|Phase 1b||18
957713|NCT00147537|2315428|P6|NOT COMPLETED|Phase 1b||3
957714|NCT00147537|2315429|P5|NOT COMPLETED|Phase 1b||3
957715|NCT00147537|2315430|P4|NOT COMPLETED|Phase 1b||2
957716|NCT00147537|2315431|P3|NOT COMPLETED|Phase 1b||4
957717|NCT00147537|2315432|P2|NOT COMPLETED|Phase 1b||2
957718|NCT00147537|2315433|P1|NOT COMPLETED|Phase 1b||2
957719|NCT00147537|2315423|P11|COMPLETED|Phase 1b||0
957720|NCT00147537|2315424|P10|COMPLETED|Phase 1b||0
957721|NCT00147537|2315425|P9|COMPLETED|Phase 1b||1
957722|NCT00147537|2315426|P8|COMPLETED|Phase 1b||0
957723|NCT00147537|2315427|P7|COMPLETED|Phase 1b||0
957724|NCT00147537|2315428|P6|COMPLETED|Phase 1b||0
957725|NCT00147537|2315429|P5|COMPLETED|Phase 1b||0
957726|NCT00147537|2315430|P4|COMPLETED|Phase 1b||1
957727|NCT00147537|2315431|P3|COMPLETED|Phase 1b||0
957728|NCT00147537|2315432|P2|COMPLETED|Phase 1b||0
957729|NCT00147537|2315433|P1|COMPLETED|Phase 1b||1
957730|NCT00147537|2315423|P11|STARTED|Phase 1b||0
957731|NCT00147537|2315424|P10|STARTED|Phase 1b||0
957732|NCT00147537|2315425|P9|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
957733|NCT00147537|2315426|P8|STARTED|Phase 1b||7
957734|NCT00147537|2315427|P7|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
957735|NCT00147537|2315428|P6|STARTED|Phase 1b||3
957736|NCT00147537|2315429|P5|STARTED|Phase 1b||3
957737|NCT00147537|2315430|P4|STARTED|Phase 1b||3
957738|NCT00147537|2315431|P3|STARTED|Phase 1b||4
957739|NCT00147537|2315432|P2|STARTED|Phase 1b||2
957740|NCT00147537|2315433|P1|STARTED|Phase 1b||3
957741|NCT00147745|2315615|P3|NOT COMPLETED|Overall Study||0
957742|NCT00147745|2315616|P2|NOT COMPLETED|Overall Study||0
957743|NCT00147745|2315617|P1|NOT COMPLETED|Overall Study||1
957744|NCT00147745|2315615|P3|COMPLETED|Overall Study||6
957745|NCT00147745|2315616|P2|COMPLETED|Overall Study||14
957746|NCT00147745|2315617|P1|COMPLETED|Overall Study||15
957747|NCT00147745|2315615|P3|STARTED|Overall Study||6
957748|NCT00147745|2315616|P2|STARTED|Overall Study||14
957749|NCT00147745|2315617|P1|STARTED|Overall Study||16
957750|NCT00147823|2315637|P2|NOT COMPLETED|Overall Study||15
957751|NCT00147823|2315638|P1|NOT COMPLETED|Overall Study||13
957752|NCT00147823|2315637|P2|COMPLETED|Overall Study||16
957753|NCT00147823|2315638|P1|COMPLETED|Overall Study||19
957754|NCT00147823|2315637|P2|Month 24 Visit|Overall Study||18
957755|NCT00147823|2315638|P1|Month 24 Visit|Overall Study||21
957756|NCT00147823|2315637|P2|Month 18 Visit|Overall Study||20
957757|NCT00147823|2315638|P1|Month 18 Visit|Overall Study|As stated previously ea. subject is counted at each milestone, as data is collected at ea. timepoint|21
957758|NCT00147823|2315637|P2|Month 12 CT Scan|Overall Study||25
957759|NCT00147823|2315638|P1|Month 12 CT Scan|Overall Study||20
957760|NCT00147823|2315637|P2|Month 12 Visit|Overall Study|Subjects are counted at each milestone as that is when data is collectec|25
957761|NCT00147823|2315638|P1|Month 12 Visit|Overall Study||21
957762|NCT00147823|2315637|P2|Month 6 Visit|Overall Study||21
957763|NCT00147823|2315638|P1|Month 6 Visit|Overall Study||25
957764|NCT00147823|2315637|P2|Month 3 Visit|Overall Study||24
957765|NCT00147823|2315638|P1|Month 3 Visit|Overall Study||25
957766|NCT00147823|2315637|P2|Week 6 Visit|Overall Study||28
957767|NCT00147823|2315638|P1|Week 6 Visit|Overall Study||26
957768|NCT00147823|2315637|P2|STARTED|Overall Study||31
957769|NCT00147823|2315638|P1|STARTED|Overall Study||32
957770|NCT00147966|2315666|P1|NOT COMPLETED|Overall Study||0
957771|NCT00147966|2315666|P1|COMPLETED|Overall Study||24
957772|NCT00147966|2315666|P1|STARTED|Overall Study||24
957773|NCT00148109|2315672|P2|NOT COMPLETED|Overall Study||20
957774|NCT00148109|2315673|P1|NOT COMPLETED|Overall Study||12
957775|NCT00148109|2315672|P2|COMPLETED|Overall Study||1
957776|NCT00148109|2315673|P1|COMPLETED|Overall Study||3
957777|NCT00148109|2315672|P2|STARTED|Overall Study||21
957778|NCT00148109|2315673|P1|STARTED|Overall Study||15
957779|NCT00148122|2315683|P1|NOT COMPLETED|Overall Study||2
957780|NCT00148122|2315683|P1|COMPLETED|Overall Study||38
957781|NCT00148122|2315683|P1|STARTED|Overall Study||40
957782|NCT00148317|2315689|P1|NOT COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||11
957783|NCT00148317|2315689|P1|COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||27
957784|NCT00148317|2315689|P1|STARTED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||38
957785|NCT00148317|2315689|P1|NOT COMPLETED|Consolidation (VEL + DEX)||0
957786|NCT00148317|2315689|P1|COMPLETED|Consolidation (VEL + DEX)||38
957787|NCT00148317|2315689|P1|no DOXIL Added|Consolidation (VEL + DEX)||10
957788|NCT00148317|2315689|P1|DOXIL Added at Cycle 5|Consolidation (VEL + DEX)||12
957789|NCT00148317|2315689|P1|DOXIL Added at Cycle 3|Consolidation (VEL + DEX)||16
957790|NCT00148317|2315689|P1|STARTED|Consolidation (VEL + DEX)||38
957791|NCT00148668|2315698|P2|NOT COMPLETED|Overall Study||0
957792|NCT00148668|2315699|P1|NOT COMPLETED|Overall Study||0
957793|NCT00148668|2315698|P2|COMPLETED|Overall Study||40
957794|NCT00148668|2315699|P1|COMPLETED|Overall Study||41
957795|NCT00148668|2315698|P2|STARTED|Overall Study||40
957796|NCT00148668|2315699|P1|STARTED|Overall Study||41
957797|NCT00148733|2315707|P2|NOT COMPLETED|Overall Study||15
957798|NCT00148733|2315708|P1|NOT COMPLETED|Overall Study||14
957799|NCT00148733|2315707|P2|COMPLETED|Overall Study||1299
957800|NCT00148733|2315708|P1|COMPLETED|Overall Study||1300
957801|NCT00148733|2315707|P2|STARTED|Overall Study||1314
957802|NCT00148733|2315708|P1|STARTED|Overall Study||1314
957803|NCT00148759|2315716|P2|NOT COMPLETED|Overall Study||1
957804|NCT00148759|2315717|P1|NOT COMPLETED|Overall Study||2
957805|NCT00148759|2315716|P2|COMPLETED|Overall Study||11
957806|NCT00148759|2315717|P1|COMPLETED|Overall Study||9
957807|NCT00148759|2315716|P2|24-hr PK Sampling|Overall Study||11
957808|NCT00148759|2315717|P1|24-hr PK Sampling|Overall Study||9
957809|NCT00148759|2315716|P2|STARTED|Overall Study||12
957810|NCT00148759|2315717|P1|STARTED|Overall Study||11
957811|NCT00148798|2315727|P2|NOT COMPLETED|Overall Study||0
957812|NCT00148798|2315728|P1|NOT COMPLETED|Overall Study||0
957813|NCT00148798|2315727|P2|COMPLETED|Overall Study||568
957814|NCT00148798|2315728|P1|COMPLETED|Overall Study||557
957815|NCT00148798|2315727|P2|STARTED|Overall Study|ITT Population|568
957816|NCT00148798|2315728|P1|STARTED|Overall Study|Intent To Treat (ITT) Population|557
957817|NCT00148954|2315750|P2|NOT COMPLETED|Overall Study||300
957818|NCT00148954|2315751|P1|NOT COMPLETED|Overall Study||307
957819|NCT00148954|2315750|P2|COMPLETED|Overall Study||677
957820|NCT00148954|2315751|P1|COMPLETED|Overall Study||678
957821|NCT00148954|2315750|P2|STARTED|Overall Study||977
957822|NCT00148954|2315751|P1|STARTED|Overall Study||985
957823|NCT00149214|2315759|P2|NOT COMPLETED|Overall Study||17
957824|NCT00149214|2315760|P1|NOT COMPLETED|Overall Study||26
957825|NCT00149214|2315759|P2|COMPLETED|Overall Study||105
957918|NCT00141297|2316199|P1|NOT COMPLETED|Overall Study||3
957826|NCT00149214|2315760|P1|COMPLETED|Overall Study|The patient treated with Cyclophosphamide (C) was included in that arm (C) for safety analysis.|109
957827|NCT00149214|2315759|P2|STARTED|Overall Study||122
957828|NCT00149214|2315760|P1|STARTED|Overall Study|One patient randomized to Pemetrexed (P) was treated with Cyclophosphamide (C).|135
957829|NCT00149227|2315776|P2|NOT COMPLETED|Overall Study||0
957830|NCT00149227|2315777|P1|NOT COMPLETED|Overall Study||0
957831|NCT00149227|2315776|P2|COMPLETED|Overall Study||1514
957832|NCT00149227|2315777|P1|COMPLETED|Overall Study||1517
957833|NCT00149227|2315776|P2|STARTED|Overall Study||1514
957834|NCT00149227|2315777|P1|STARTED|Overall Study||1517
957835|NCT00133575|2315808|P7|NOT COMPLETED|Overall Study||3
957836|NCT00133575|2315809|P6|NOT COMPLETED|Overall Study||1
957837|NCT00133575|2315810|P5|NOT COMPLETED|Overall Study||4
957838|NCT00133575|2315811|P4|NOT COMPLETED|Overall Study||1
957839|NCT00133575|2315812|P3|NOT COMPLETED|Overall Study||2
957840|NCT00133575|2315813|P2|NOT COMPLETED|Overall Study||0
957841|NCT00133575|2315814|P1|NOT COMPLETED|Overall Study||0
957842|NCT00133575|2315808|P7|COMPLETED|Overall Study||9
957843|NCT00133575|2315809|P6|COMPLETED|Overall Study||9
957844|NCT00133575|2315810|P5|COMPLETED|Overall Study||6
957845|NCT00133575|2315811|P4|COMPLETED|Overall Study||9
957846|NCT00133575|2315812|P3|COMPLETED|Overall Study||8
957847|NCT00133575|2315813|P2|COMPLETED|Overall Study||10
957848|NCT00133575|2315814|P1|COMPLETED|Overall Study||10
957849|NCT00133575|2315808|P7|STARTED|Overall Study||12
957850|NCT00133575|2315809|P6|STARTED|Overall Study||10
957851|NCT00133575|2315810|P5|STARTED|Overall Study||10
957852|NCT00133575|2315811|P4|STARTED|Overall Study||10
957853|NCT00133575|2315812|P3|STARTED|Overall Study||10
957854|NCT00133575|2315813|P2|STARTED|Overall Study||10
957855|NCT00133575|2315814|P1|STARTED|Overall Study||10
957856|NCT00133705|2315923|P2|NOT COMPLETED|Overall Study||3
957857|NCT00133705|2315924|P1|NOT COMPLETED|Overall Study||2
957858|NCT00133705|2315923|P2|COMPLETED|Overall Study||17
957859|NCT00133705|2315924|P1|COMPLETED|Overall Study||20
957860|NCT00133705|2315923|P2|STARTED|Overall Study||20
957861|NCT00133705|2315924|P1|STARTED|Overall Study||22
957862|NCT00140556|2315930|P1|NOT COMPLETED|Chemoradiotherapy Period||0
957863|NCT00140556|2315930|P1|COMPLETED|Chemoradiotherapy Period||28
957864|NCT00140556|2315930|P1|STARTED|Chemoradiotherapy Period||28
957865|NCT00140556|2315930|P1|NOT COMPLETED|Pre Radiation Period: Avastin / Tarceva||0
957866|NCT00140556|2315930|P1|COMPLETED|Pre Radiation Period: Avastin / Tarceva||28
957867|NCT00140556|2315930|P1|STARTED|Pre Radiation Period: Avastin / Tarceva||28
957868|NCT00140621|2315934|P1|NOT COMPLETED|Overall Study||0
957869|NCT00140621|2315934|P1|COMPLETED|Overall Study||6
957870|NCT00140621|2315934|P1|STARTED|Overall Study||6
957871|NCT00140842|2315946|P2|NOT COMPLETED|Overall Study||0
957872|NCT00140842|2315947|P1|NOT COMPLETED|Overall Study||0
957873|NCT00140842|2315946|P2|COMPLETED|Overall Study||15
957874|NCT00140842|2315947|P1|COMPLETED|Overall Study||15
957875|NCT00140842|2315946|P2|STARTED|Overall Study||15
957876|NCT00140842|2315947|P1|STARTED|Overall Study||15
957877|NCT00141037|2315957|P2|NOT COMPLETED|Overall Study||18
957878|NCT00141037|2315958|P1|NOT COMPLETED|Overall Study||10
957879|NCT00141037|2315957|P2|COMPLETED|Overall Study|8 subjects had reduced follow-up|52
957880|NCT00141037|2315958|P1|COMPLETED|Overall Study|16 subjects had reduced follow-up|50
957881|NCT00141037|2315957|P2|STARTED|Overall Study||70
957882|NCT00141037|2315958|P1|STARTED|Overall Study||60
957883|NCT00141102|2315968|P2|NOT COMPLETED|Overall Study||625
957884|NCT00141102|2315969|P1|NOT COMPLETED|Overall Study||508
957885|NCT00141102|2315968|P2|COMPLETED|Overall Study||1621
957886|NCT00141102|2315969|P1|COMPLETED|Overall Study||1730
957887|NCT00141102|2315968|P2|Received Treatment|Overall Study||2237
957888|NCT00141102|2315969|P1|Received Treatment|Overall Study||2223
957889|NCT00141102|2315968|P2|STARTED|Overall Study||2246
957890|NCT00141102|2315969|P1|STARTED|Overall Study||2238
957891|NCT00141115|2316007|P1|NOT COMPLETED|Overall Study||1
957892|NCT00141115|2316007|P1|COMPLETED|Overall Study||2
957893|NCT00141115|2316007|P1|STARTED|Overall Study||3
957894|NCT00141219|2316013|P2|NOT COMPLETED|Overall Study||16
957895|NCT00141219|2316014|P1|NOT COMPLETED|Overall Study||24
957896|NCT00141219|2316013|P2|COMPLETED|Overall Study||62
957897|NCT00141219|2316014|P1|COMPLETED|Overall Study||138
957898|NCT00141219|2316013|P2|STARTED|Overall Study||78
957899|NCT00141219|2316014|P1|STARTED|Overall Study||162
957900|NCT00141271|2316067|P3|NOT COMPLETED|Overall Study||57
957901|NCT00141271|2316068|P2|NOT COMPLETED|Overall Study||63
957902|NCT00141271|2316069|P1|NOT COMPLETED|Overall Study||80
957903|NCT00141271|2316067|P3|COMPLETED|Overall Study||111
957904|NCT00141271|2316068|P2|COMPLETED|Overall Study||102
957905|NCT00141271|2316069|P1|COMPLETED|Overall Study||91
957906|NCT00141271|2316067|P3|STARTED|Overall Study||168
957907|NCT00141271|2316068|P2|STARTED|Overall Study||165
957908|NCT00141271|2316069|P1|STARTED|Overall Study||171
957909|NCT00141297|2316190|P10|NOT COMPLETED|Overall Study||6
957910|NCT00141297|2316191|P9|NOT COMPLETED|Overall Study||20
957911|NCT00141297|2316192|P8|NOT COMPLETED|Overall Study||4
957912|NCT00141297|2316193|P7|NOT COMPLETED|Overall Study||3
957913|NCT00141297|2316194|P6|NOT COMPLETED|Overall Study||3
957914|NCT00141297|2316195|P5|NOT COMPLETED|Overall Study||22
957915|NCT00141297|2316196|P4|NOT COMPLETED|Overall Study||3
957916|NCT00141297|2316197|P3|NOT COMPLETED|Overall Study||7
957917|NCT00141297|2316198|P2|NOT COMPLETED|Overall Study||3
957919|NCT00141297|2316190|P10|COMPLETED|Overall Study||0
957920|NCT00141297|2316191|P9|COMPLETED|Overall Study||0
957921|NCT00141297|2316192|P8|COMPLETED|Overall Study||0
957922|NCT00141297|2316193|P7|COMPLETED|Overall Study||0
957923|NCT00141297|2316194|P6|COMPLETED|Overall Study||0
957924|NCT00141297|2316195|P5|COMPLETED|Overall Study||0
957925|NCT00141297|2316196|P4|COMPLETED|Overall Study||0
957926|NCT00141297|2316197|P3|COMPLETED|Overall Study||0
957927|NCT00141297|2316198|P2|COMPLETED|Overall Study||0
957928|NCT00141297|2316199|P1|COMPLETED|Overall Study||0
957929|NCT00141297|2316190|P10|STARTED|Overall Study||6
957930|NCT00141297|2316191|P9|STARTED|Overall Study||20
957931|NCT00141297|2316192|P8|STARTED|Overall Study||4
957932|NCT00141297|2316193|P7|STARTED|Overall Study||3
957933|NCT00141297|2316194|P6|STARTED|Overall Study||3
957934|NCT00141297|2316195|P5|STARTED|Overall Study||22
957935|NCT00141297|2316196|P4|STARTED|Overall Study||3
957936|NCT00141297|2316197|P3|STARTED|Overall Study||7
957937|NCT00141297|2316198|P2|STARTED|Overall Study||3
957938|NCT00141297|2316199|P1|STARTED|Overall Study||3
957939|NCT00141453|2316476|P2|NOT COMPLETED|Overall Study||5
957940|NCT00141453|2316477|P1|NOT COMPLETED|Overall Study||6
957941|NCT00141453|2316476|P2|COMPLETED|Overall Study||284
957942|NCT00141453|2316477|P1|COMPLETED|Overall Study||282
957943|NCT00141453|2316476|P2|STARTED|Overall Study||289
957944|NCT00141453|2316477|P1|STARTED|Overall Study||288
957945|NCT00141518|2316492|P3|NOT COMPLETED|Overall Study||6
957946|NCT00141518|2316493|P2|NOT COMPLETED|Overall Study||6
957947|NCT00141518|2316494|P1|NOT COMPLETED|Overall Study||16
957948|NCT00141518|2316492|P3|COMPLETED|Overall Study||12
957949|NCT00141518|2316493|P2|COMPLETED|Overall Study||16
957950|NCT00141518|2316494|P1|COMPLETED|Overall Study||21
957951|NCT00141518|2316492|P3|Full Analysis Sample|Overall Study||18
957952|NCT00141518|2316493|P2|Full Analysis Sample|Overall Study||22
957953|NCT00141518|2316494|P1|Full Analysis Sample|Overall Study||27
957954|NCT00141518|2316492|P3|Safety Sample|Overall Study||18
957955|NCT00141518|2316493|P2|Safety Sample|Overall Study||22
957956|NCT00141518|2316494|P1|Safety Sample|Overall Study||36
957957|NCT00141518|2316492|P3|STARTED|Overall Study||18
957958|NCT00141518|2316493|P2|STARTED|Overall Study||22
957959|NCT00141518|2316494|P1|STARTED|Overall Study||37
957960|NCT00141726|2316681|P1|NOT COMPLETED|Overall Study||3
957961|NCT00141726|2316681|P1|COMPLETED|Overall Study||31
957962|NCT00141726|2316681|P1|STARTED|Overall Study||34
957963|NCT00141739|2316686|P1|NOT COMPLETED|Overall Study||0
957964|NCT00141739|2316686|P1|COMPLETED|Overall Study||100
957965|NCT00141739|2316686|P1|STARTED|Overall Study|Number of evaluable patients|100
957966|NCT00141765|2316697|P1|NOT COMPLETED|Overall Study||0
957967|NCT00141765|2316697|P1|COMPLETED|Overall Study||25
957968|NCT00141765|2316697|P1|STARTED|Overall Study||25
957969|NCT00141778|2316704|P3|NOT COMPLETED|Started Study Medication||4
957970|NCT00141778|2316705|P2|NOT COMPLETED|Started Study Medication||7
957971|NCT00141778|2316706|P1|NOT COMPLETED|Started Study Medication||2
957972|NCT00141778|2316704|P3|COMPLETED|Started Study Medication||143
957973|NCT00141778|2316705|P2|COMPLETED|Started Study Medication||144
957974|NCT00141778|2316706|P1|COMPLETED|Started Study Medication||145
957975|NCT00141778|2316704|P3|STARTED|Started Study Medication||147
957976|NCT00141778|2316705|P2|STARTED|Started Study Medication||151
957977|NCT00141778|2316706|P1|STARTED|Started Study Medication||147
957978|NCT00141778|2316704|P3|NOT COMPLETED|Randomization Prior to Study Med||6
957979|NCT00141778|2316705|P2|NOT COMPLETED|Randomization Prior to Study Med||2
957980|NCT00141778|2316706|P1|NOT COMPLETED|Randomization Prior to Study Med||5
957981|NCT00141778|2316704|P3|COMPLETED|Randomization Prior to Study Med||147
957982|NCT00141778|2316705|P2|COMPLETED|Randomization Prior to Study Med||151
957983|NCT00141778|2316706|P1|COMPLETED|Randomization Prior to Study Med||147
957984|NCT00141778|2316704|P3|STARTED|Randomization Prior to Study Med||153
957985|NCT00141778|2316705|P2|STARTED|Randomization Prior to Study Med||153
957986|NCT00141778|2316706|P1|STARTED|Randomization Prior to Study Med||152
957987|NCT00141817|2316748|P4|NOT COMPLETED|Overall Study||0
957988|NCT00141817|2316749|P3|NOT COMPLETED|Overall Study||1
957989|NCT00141817|2316750|P2|NOT COMPLETED|Overall Study||0
957990|NCT00141817|2316751|P1|NOT COMPLETED|Overall Study||1
957991|NCT00141817|2316748|P4|COMPLETED|Overall Study||13
957992|NCT00141817|2316749|P3|COMPLETED|Overall Study||10
957993|NCT00141817|2316750|P2|COMPLETED|Overall Study||10
957994|NCT00141817|2316751|P1|COMPLETED|Overall Study||6
957995|NCT00141817|2316748|P4|STARTED|Overall Study||13
957996|NCT00141817|2316749|P3|STARTED|Overall Study||11
957997|NCT00141817|2316750|P2|STARTED|Overall Study||10
957998|NCT00141817|2316751|P1|STARTED|Overall Study||7
957999|NCT00141921|2316789|P1|NOT COMPLETED|Overall Study||141
958000|NCT00141921|2316789|P1|COMPLETED|Overall Study||41
958001|NCT00141921|2316789|P1|Received Treatment|Overall Study||181
958002|NCT00141921|2316789|P1|STARTED|Overall Study||182
958003|NCT00142116|2316811|P1|NOT COMPLETED|Overall Study||0
958004|NCT00142116|2316811|P1|COMPLETED|Overall Study||25
958005|NCT00142116|2316811|P1|STARTED|Overall Study||25
958006|NCT00142168|2316816|P1|NOT COMPLETED|Overall Study||0
958007|NCT00142168|2316816|P1|COMPLETED|Overall Study||16
958008|NCT00142168|2316816|P1|STARTED|Overall Study||16
958009|NCT00142298|2316833|P10|NOT COMPLETED|Overall Study||0
958010|NCT00142298|2316834|P9|NOT COMPLETED|Overall Study||5
958011|NCT00142298|2316835|P8|NOT COMPLETED|Overall Study||8
958012|NCT00142298|2316836|P7|NOT COMPLETED|Overall Study||8
958013|NCT00142298|2316837|P6|NOT COMPLETED|Overall Study||16
958014|NCT00142298|2316838|P5|NOT COMPLETED|Overall Study||10
958015|NCT00142298|2316839|P4|NOT COMPLETED|Overall Study||85
958016|NCT00142298|2316840|P3|NOT COMPLETED|Overall Study||33
958017|NCT00142298|2316841|P2|NOT COMPLETED|Overall Study||176
958018|NCT00142298|2316842|P1|NOT COMPLETED|Overall Study||160
958019|NCT00142298|2316833|P10|COMPLETED|Overall Study||13
958020|NCT00142298|2316834|P9|COMPLETED|Overall Study||52
958021|NCT00142298|2316835|P8|COMPLETED|Overall Study||58
958022|NCT00142298|2316836|P7|COMPLETED|Overall Study||15
958023|NCT00142298|2316837|P6|COMPLETED|Overall Study||10
958024|NCT00142298|2316838|P5|COMPLETED|Overall Study||46
958025|NCT00142298|2316839|P4|COMPLETED|Overall Study||121
958026|NCT00142298|2316840|P3|COMPLETED|Overall Study||90
958027|NCT00142298|2316841|P2|COMPLETED|Overall Study||456
958028|NCT00142298|2316842|P1|COMPLETED|Overall Study|Completed week 104/week 208.|507
958029|NCT00142298|2316833|P10|Per Protocol Population|Overall Study||13
958030|NCT00142298|2316834|P9|Per Protocol Population|Overall Study||56
958031|NCT00142298|2316835|P8|Per Protocol Population|Overall Study||64
958032|NCT00142298|2316836|P7|Per Protocol Population|Overall Study||19
958033|NCT00142298|2316837|P6|Per Protocol Population|Overall Study||25
958034|NCT00142298|2316838|P5|Per Protocol Population|Overall Study||50
958035|NCT00142298|2316839|P4|Per Protocol Population|Overall Study||202
958036|NCT00142298|2316840|P3|Per Protocol Population|Overall Study||120
958037|NCT00142298|2316841|P2|Per Protocol Population|Overall Study||606
958038|NCT00142298|2316842|P1|Per Protocol Population|Overall Study||635
958039|NCT00142298|2316833|P10|Safety Population|Overall Study||13
958040|NCT00142298|2316834|P9|Safety Population|Overall Study||57
958041|NCT00142298|2316835|P8|Safety Population|Overall Study||66
958042|NCT00142298|2316836|P7|Safety Population|Overall Study||23
958043|NCT00142298|2316837|P6|Safety Population|Overall Study||26
958044|NCT00142298|2316838|P5|Safety Population|Overall Study||50
958045|NCT00142298|2316839|P4|Safety Population|Overall Study||206
958046|NCT00142298|2316840|P3|Safety Population|Overall Study||122
958047|NCT00142298|2316841|P2|Safety Population|Overall Study||626
958048|NCT00142298|2316842|P1|Safety Population|Overall Study||655
958049|NCT00142298|2316833|P10|STARTED|Overall Study||13
958050|NCT00142298|2316834|P9|STARTED|Overall Study||57
958051|NCT00142298|2316835|P8|STARTED|Overall Study||66
958052|NCT00142298|2316836|P7|STARTED|Overall Study||23
958053|NCT00142298|2316837|P6|STARTED|Overall Study||26
958054|NCT00142298|2316838|P5|STARTED|Overall Study||56
958055|NCT00142298|2316839|P4|STARTED|Overall Study||206
958056|NCT00142298|2316840|P3|STARTED|Overall Study||123
958057|NCT00142298|2316841|P2|STARTED|Overall Study||632
958058|NCT00142298|2316842|P1|STARTED|Overall Study||667
958059|NCT00142415|2316870|P6|NOT COMPLETED|Overall Study||2
958060|NCT00142415|2316871|P5|NOT COMPLETED|Overall Study||1
958061|NCT00142415|2316872|P4|NOT COMPLETED|Overall Study||0
958062|NCT00142415|2316873|P3|NOT COMPLETED|Overall Study||0
958063|NCT00142415|2316874|P2|NOT COMPLETED|Overall Study||0
958064|NCT00142415|2316875|P1|NOT COMPLETED|Overall Study||0
958065|NCT00142415|2316870|P6|COMPLETED|Overall Study||6
958066|NCT00142415|2316871|P5|COMPLETED|Overall Study||2
958067|NCT00142415|2316872|P4|COMPLETED|Overall Study||3
958068|NCT00142415|2316873|P3|COMPLETED|Overall Study||6
958069|NCT00142415|2316874|P2|COMPLETED|Overall Study||3
958070|NCT00142415|2316875|P1|COMPLETED|Overall Study||3
958071|NCT00142415|2316870|P6|STARTED|Overall Study||8
958072|NCT00142415|2316871|P5|STARTED|Overall Study||3
958073|NCT00142415|2316872|P4|STARTED|Overall Study||3
958074|NCT00142415|2316873|P3|STARTED|Overall Study||6
958075|NCT00142415|2316874|P2|STARTED|Overall Study||3
958076|NCT00142415|2316875|P1|STARTED|Overall Study||3
958077|NCT00142597|2316905|P2|NOT COMPLETED|Overall Study||1
958078|NCT00142597|2316906|P1|NOT COMPLETED|Overall Study||3
958079|NCT00142597|2316905|P2|COMPLETED|Overall Study|N=10 completed PET imaging|22
958080|NCT00142597|2316906|P1|COMPLETED|Overall Study|N=10 completed PET imaging|20
958081|NCT00142597|2316905|P2|STARTED|Overall Study|N=10 underwent PET imaging|23
958082|NCT00142597|2316906|P1|STARTED|Overall Study|N=10 underwent PET imaging|23
958083|NCT00142818|2316916|P4|NOT COMPLETED|Overall Study||22
958084|NCT00142818|2316917|P3|NOT COMPLETED|Overall Study||13
958085|NCT00142818|2316918|P2|NOT COMPLETED|Overall Study||21
958086|NCT00142818|2316919|P1|NOT COMPLETED|Overall Study||17
958087|NCT00142818|2316916|P4|COMPLETED|Overall Study||20
958088|NCT00142818|2316917|P3|COMPLETED|Overall Study||24
958089|NCT00142818|2316918|P2|COMPLETED|Overall Study||19
958090|NCT00142818|2316919|P1|COMPLETED|Overall Study||28
958091|NCT00142818|2316916|P4|STARTED|Overall Study||42
958092|NCT00142818|2316917|P3|STARTED|Overall Study||37
958093|NCT00142818|2316918|P2|STARTED|Overall Study||40
958094|NCT00142818|2316919|P1|STARTED|Overall Study||45
958095|NCT00142909|2316931|P2|NOT COMPLETED|Medications Begin||3
958096|NCT00142909|2316932|P1|NOT COMPLETED|Medications Begin||9
958097|NCT00142909|2316931|P2|COMPLETED|Medications Begin||31
958098|NCT00142909|2316932|P1|COMPLETED|Medications Begin||26
958099|NCT00142909|2316931|P2|STARTED|Medications Begin||34
958100|NCT00142909|2316932|P1|STARTED|Medications Begin||35
958101|NCT00142909|2316931|P2|NOT COMPLETED|Randomization||10
958102|NCT00142909|2316932|P1|NOT COMPLETED|Randomization||7
958103|NCT00142909|2316931|P2|COMPLETED|Randomization||34
958104|NCT00142909|2316932|P1|COMPLETED|Randomization||35
958105|NCT00142909|2316931|P2|STARTED|Randomization||44
958106|NCT00142909|2316932|P1|STARTED|Randomization||42
958107|NCT00142935|2316951|P3|NOT COMPLETED|Overall Study||7
958108|NCT00142935|2316952|P2|NOT COMPLETED|Overall Study||8
958109|NCT00142935|2316953|P1|NOT COMPLETED|Overall Study||3
958110|NCT00142935|2316951|P3|COMPLETED|Overall Study||23
958111|NCT00142935|2316952|P2|COMPLETED|Overall Study||20
958112|NCT00142935|2316953|P1|COMPLETED|Overall Study||26
958113|NCT00142935|2316951|P3|STARTED|Overall Study||30
958114|NCT00142935|2316952|P2|STARTED|Overall Study||28
958115|NCT00142935|2316953|P1|STARTED|Overall Study||29
958116|NCT00149994|2316978|P2|NOT COMPLETED|Overall Study||1
958117|NCT00149994|2316979|P1|NOT COMPLETED|Overall Study||1
958118|NCT00149994|2316978|P2|COMPLETED|Overall Study||85
958119|NCT00149994|2316979|P1|COMPLETED|Overall Study|"Completed indicates intention to treat (ITT) population."|84
958120|NCT00149994|2316978|P2|STARTED|Overall Study||86
958121|NCT00149994|2316979|P1|STARTED|Overall Study|"Started indicates Safety population."|85
958122|NCT00150176|2316987|P2|NOT COMPLETED|Overall Study||120
958123|NCT00150176|2316988|P1|NOT COMPLETED|Overall Study||59
958124|NCT00150176|2316987|P2|COMPLETED|Overall Study||72
958125|NCT00150176|2316988|P1|COMPLETED|Overall Study||135
958126|NCT00150176|2316987|P2|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|192
958127|NCT00150176|2316988|P1|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|194
958128|NCT00150345|2316999|P2|NOT COMPLETED|Overall Study||32
958129|NCT00150345|2317000|P1|NOT COMPLETED|Overall Study||34
958130|NCT00150345|2316999|P2|COMPLETED|Overall Study||34
958131|NCT00150345|2317000|P1|COMPLETED|Overall Study||47
958132|NCT00150345|2316999|P2|STARTED|Overall Study||66
958133|NCT00150345|2317000|P1|STARTED|Overall Study||81
958134|NCT00150462|2317073|P11|NOT COMPLETED|Overall Study||3
958135|NCT00150462|2317074|P10|NOT COMPLETED|Overall Study||6
958136|NCT00150462|2317075|P9|NOT COMPLETED|Overall Study||6
958137|NCT00150462|2317076|P8|NOT COMPLETED|Overall Study||8
958138|NCT00150462|2317077|P7|NOT COMPLETED|Overall Study||3
958139|NCT00150462|2317078|P6|NOT COMPLETED|Overall Study||4
958140|NCT00150462|2317079|P5|NOT COMPLETED|Overall Study||3
958141|NCT00150462|2317080|P4|NOT COMPLETED|Overall Study||3
958142|NCT00150462|2317081|P3|NOT COMPLETED|Overall Study||4
958143|NCT00150462|2317082|P2|NOT COMPLETED|Overall Study||3
958144|NCT00150462|2317083|P1|NOT COMPLETED|Overall Study||3
958145|NCT00150462|2317073|P11|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
958146|NCT00150462|2317074|P10|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
958147|NCT00150462|2317075|P9|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
958148|NCT00150462|2317076|P8|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
958149|NCT00150462|2317077|P7|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
958150|NCT00150462|2317078|P6|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
958151|NCT00150462|2317079|P5|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
958152|NCT00150462|2317080|P4|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
958153|NCT00150462|2317081|P3|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
958154|NCT00150462|2317082|P2|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
958155|NCT00150462|2317083|P1|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
958156|NCT00150462|2317073|P11|STARTED|Overall Study||4
958157|NCT00150462|2317074|P10|STARTED|Overall Study||7
958158|NCT00150462|2317075|P9|STARTED|Overall Study||6
958159|NCT00150462|2317076|P8|STARTED|Overall Study||8
958160|NCT00150462|2317077|P7|STARTED|Overall Study||3
958161|NCT00150462|2317078|P6|STARTED|Overall Study||4
958162|NCT00150462|2317079|P5|STARTED|Overall Study||3
958163|NCT00150462|2317080|P4|STARTED|Overall Study||3
958164|NCT00150462|2317081|P3|STARTED|Overall Study||4
958165|NCT00150462|2317082|P2|STARTED|Overall Study||3
958166|NCT00150462|2317083|P1|STARTED|Overall Study||3
958167|NCT00150592|2317193|P2|NOT COMPLETED|Overall Study||3
958168|NCT00150592|2317194|P1|NOT COMPLETED|Overall Study||7
958169|NCT00150592|2317193|P2|COMPLETED|Overall Study||54
958170|NCT00150592|2317194|P1|COMPLETED|Overall Study||114
958171|NCT00150592|2317193|P2|STARTED|Overall Study||57
958172|NCT00150592|2317194|P1|STARTED|Overall Study||121
958173|NCT00150618|2317219|P5|NOT COMPLETED|Overall Study||25
958174|NCT00150618|2317220|P4|NOT COMPLETED|Overall Study||26
958175|NCT00150618|2317221|P3|NOT COMPLETED|Overall Study||27
958176|NCT00150618|2317222|P2|NOT COMPLETED|Overall Study||18
958177|NCT00150618|2317223|P1|NOT COMPLETED|Overall Study||17
958178|NCT00150618|2317219|P5|COMPLETED|Overall Study||41
958179|NCT00150618|2317220|P4|COMPLETED|Overall Study||40
958180|NCT00150618|2317221|P3|COMPLETED|Overall Study||38
958181|NCT00150618|2317222|P2|COMPLETED|Overall Study||47
958182|NCT00150618|2317223|P1|COMPLETED|Overall Study||45
958183|NCT00150618|2317219|P5|STARTED|Overall Study||66
958184|NCT00150618|2317220|P4|STARTED|Overall Study||66
958185|NCT00150618|2317221|P3|STARTED|Overall Study||65
958186|NCT00150618|2317222|P2|STARTED|Overall Study||65
958187|NCT00150618|2317223|P1|STARTED|Overall Study||62
958188|NCT00150969|2317257|P2|NOT COMPLETED|24-48 Month Extension||100
958189|NCT00150969|2317258|P1|NOT COMPLETED|24-48 Month Extension||88
958190|NCT00150969|2317257|P2|COMPLETED|24-48 Month Extension||40
958191|NCT00150969|2317258|P1|COMPLETED|24-48 Month Extension||33
958192|NCT00150969|2317257|P2|STARTED|24-48 Month Extension||140
958193|NCT00150969|2317258|P1|STARTED|24-48 Month Extension||121
958194|NCT00150969|2317257|P2|NOT COMPLETED|24 Month Main Study||21
958195|NCT00150969|2317258|P1|NOT COMPLETED|24 Month Main Study||19
958196|NCT00150969|2317257|P2|COMPLETED|24 Month Main Study||202
958197|NCT00150969|2317258|P1|COMPLETED|24 Month Main Study||198
958198|NCT00150969|2317257|P2|STARTED|24 Month Main Study||223
958199|NCT00150969|2317258|P1|STARTED|24 Month Main Study||217
958200|NCT00151281|2317290|P1|NOT COMPLETED|Overall Study||3
958201|NCT00151281|2317290|P1|COMPLETED|Overall Study||22
958202|NCT00151281|2317290|P1|STARTED|Overall Study||25
958203|NCT00151320|2317299|P1|NOT COMPLETED|Overall Study||0
958204|NCT00151320|2317299|P1|COMPLETED|Overall Study||76
958205|NCT00151320|2317299|P1|STARTED|Overall Study||76
958206|NCT00151372|2317306|P2|NOT COMPLETED|Overall Study||29
958207|NCT00151372|2317307|P1|NOT COMPLETED|Overall Study||29
958208|NCT00151372|2317306|P2|COMPLETED|Overall Study||45
958209|NCT00151372|2317307|P1|COMPLETED|Overall Study||38
958210|NCT00151372|2317306|P2|STARTED|Overall Study||74
958211|NCT00151372|2317307|P1|STARTED|Overall Study||67
958218|NCT00151476|2317327|P2|NOT COMPLETED|FAP Analyzed Subjects||3
958219|NCT00151476|2317328|P1|NOT COMPLETED|FAP Analyzed Subjects||0
958220|NCT00151476|2317327|P2|COMPLETED|FAP Analyzed Subjects||51
958221|NCT00151476|2317328|P1|COMPLETED|FAP Analyzed Subjects||13
958222|NCT00151476|2317327|P2|STARTED|FAP Analyzed Subjects||54
958223|NCT00151476|2317328|P1|STARTED|FAP Analyzed Subjects||13
958224|NCT00151476|2317327|P2|NOT COMPLETED|FAP Identified Subjects||1
958225|NCT00151476|2317328|P1|NOT COMPLETED|FAP Identified Subjects||0
958226|NCT00151476|2317327|P2|COMPLETED|FAP Identified Subjects||54
958227|NCT00151476|2317328|P1|COMPLETED|FAP Identified Subjects||13
958228|NCT00151476|2317327|P2|STARTED|FAP Identified Subjects||55
958229|NCT00151476|2317328|P1|STARTED|FAP Identified Subjects||13
958230|NCT00151775|2317388|P12|NOT COMPLETED|Period 4: Open Label||0
958231|NCT00151775|2317389|P11|NOT COMPLETED|Period 4: Open Label||0
958232|NCT00151775|2317390|P10|NOT COMPLETED|Period 4: Open Label||21
958233|NCT00151775|2317391|P9|NOT COMPLETED|Period 4: Open Label||0
958234|NCT00151775|2317392|P8|NOT COMPLETED|Period 4: Open Label||0
958235|NCT00151775|2317393|P7|NOT COMPLETED|Period 4: Open Label||0
958236|NCT00151775|2317394|P6|NOT COMPLETED|Period 4: Open Label||0
958237|NCT00151775|2317395|P5|NOT COMPLETED|Period 4: Open Label||30
958238|NCT00151775|2317396|P4|NOT COMPLETED|Period 4: Open Label||0
958239|NCT00151775|2317397|P3|NOT COMPLETED|Period 4: Open Label||0
958240|NCT00151775|2317398|P2|NOT COMPLETED|Period 4: Open Label||0
958241|NCT00151775|2317399|P1|NOT COMPLETED|Period 4: Open Label||0
958242|NCT00151775|2317388|P12|COMPLETED|Period 4: Open Label||0
958243|NCT00151775|2317389|P11|COMPLETED|Period 4: Open Label||57
958244|NCT00151775|2317390|P10|COMPLETED|Period 4: Open Label||83
958245|NCT00151775|2317391|P9|COMPLETED|Period 4: Open Label||0
958246|NCT00151775|2317392|P8|COMPLETED|Period 4: Open Label||0
958247|NCT00151775|2317393|P7|COMPLETED|Period 4: Open Label||0
958248|NCT00151775|2317394|P6|COMPLETED|Period 4: Open Label||0
958249|NCT00151775|2317395|P5|COMPLETED|Period 4: Open Label||149
958250|NCT00151775|2317396|P4|COMPLETED|Period 4: Open Label||0
958251|NCT00151775|2317397|P3|COMPLETED|Period 4: Open Label||0
958252|NCT00151775|2317398|P2|COMPLETED|Period 4: Open Label||0
958253|NCT00151775|2317399|P1|COMPLETED|Period 4: Open Label||0
958254|NCT00151775|2317388|P12|STARTED|Period 4: Open Label||0
958255|NCT00151775|2317389|P11|STARTED|Period 4: Open Label||57
958256|NCT00151775|2317390|P10|STARTED|Period 4: Open Label||104
958257|NCT00151775|2317391|P9|STARTED|Period 4: Open Label||0
958258|NCT00151775|2317392|P8|STARTED|Period 4: Open Label||0
958259|NCT00151775|2317393|P7|STARTED|Period 4: Open Label||0
958260|NCT00151775|2317394|P6|STARTED|Period 4: Open Label||0
958261|NCT00151775|2317395|P5|STARTED|Period 4: Open Label||179
958262|NCT00151775|2317396|P4|STARTED|Period 4: Open Label||0
958263|NCT00151775|2317397|P3|STARTED|Period 4: Open Label||0
958264|NCT00151775|2317398|P2|STARTED|Period 4: Open Label||0
958265|NCT00151775|2317399|P1|STARTED|Period 4: Open Label||0
958266|NCT00151775|2317388|P12|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
958267|NCT00151775|2317389|P11|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
958268|NCT00151775|2317390|P10|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
958269|NCT00151775|2317391|P9|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
958270|NCT00151775|2317392|P8|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
958271|NCT00151775|2317393|P7|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
958272|NCT00151775|2317394|P6|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
958273|NCT00151775|2317395|P5|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
958274|NCT00151775|2317396|P4|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
958275|NCT00151775|2317397|P3|NOT COMPLETED|Period 3: Double-blind, Withdrawal||3
958276|NCT00151775|2317398|P2|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
958277|NCT00151775|2317399|P1|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
958278|NCT00151775|2317388|P12|COMPLETED|Period 3: Double-blind, Withdrawal||28
958279|NCT00151775|2317389|P11|COMPLETED|Period 3: Double-blind, Withdrawal||29
958280|NCT00151775|2317390|P10|COMPLETED|Period 3: Double-blind, Withdrawal||0
958281|NCT00151775|2317391|P9|COMPLETED|Period 3: Double-blind, Withdrawal||26
958282|NCT00151775|2317392|P8|COMPLETED|Period 3: Double-blind, Withdrawal||27
958283|NCT00151775|2317393|P7|COMPLETED|Period 3: Double-blind, Withdrawal||26
958284|NCT00151775|2317394|P6|COMPLETED|Period 3: Double-blind, Withdrawal||25
958285|NCT00151775|2317395|P5|COMPLETED|Period 3: Double-blind, Withdrawal||0
958286|NCT00151775|2317396|P4|COMPLETED|Period 3: Double-blind, Withdrawal||44
958287|NCT00151775|2317397|P3|COMPLETED|Period 3: Double-blind, Withdrawal||42
958288|NCT00151775|2317398|P2|COMPLETED|Period 3: Double-blind, Withdrawal||45
958289|NCT00151775|2317399|P1|COMPLETED|Period 3: Double-blind, Withdrawal||48
958290|NCT00151775|2317388|P12|STARTED|Period 3: Double-blind, Withdrawal||29
958291|NCT00151775|2317389|P11|STARTED|Period 3: Double-blind, Withdrawal||29
958292|NCT00151775|2317390|P10|STARTED|Period 3: Double-blind, Withdrawal||0
958293|NCT00151775|2317391|P9|STARTED|Period 3: Double-blind, Withdrawal||26
958294|NCT00151775|2317392|P8|STARTED|Period 3: Double-blind, Withdrawal||28
958295|NCT00151775|2317393|P7|STARTED|Period 3: Double-blind, Withdrawal||27
958296|NCT00151775|2317394|P6|STARTED|Period 3: Double-blind, Withdrawal||26
958297|NCT00151775|2317395|P5|STARTED|Period 3: Double-blind, Withdrawal||0
958298|NCT00151775|2317396|P4|STARTED|Period 3: Double-blind, Withdrawal||44
958299|NCT00151775|2317397|P3|STARTED|Period 3: Double-blind, Withdrawal||45
958300|NCT00151775|2317398|P2|STARTED|Period 3: Double-blind, Withdrawal||45
958301|NCT00151775|2317399|P1|STARTED|Period 3: Double-blind, Withdrawal||48
958302|NCT00151775|2317388|P12|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
958303|NCT00151775|2317389|P11|NOT COMPLETED|Period 2 - Double-Blind Dose Response||1
958304|NCT00151775|2317390|P10|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
958305|NCT00151775|2317391|P9|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
958306|NCT00151775|2317392|P8|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
958307|NCT00151775|2317393|P7|NOT COMPLETED|Period 2 - Double-Blind Dose Response||3
958308|NCT00151775|2317394|P6|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
958309|NCT00151775|2317395|P5|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
958310|NCT00151775|2317396|P4|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
958311|NCT00151775|2317397|P3|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
958312|NCT00151775|2317398|P2|NOT COMPLETED|Period 2 - Double-Blind Dose Response||6
958313|NCT00151775|2317399|P1|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
958314|NCT00151775|2317388|P12|COMPLETED|Period 2 - Double-Blind Dose Response||0
958315|NCT00151775|2317389|P11|COMPLETED|Period 2 - Double-Blind Dose Response||59
958316|NCT00151775|2317390|P10|COMPLETED|Period 2 - Double-Blind Dose Response||0
958317|NCT00151775|2317391|P9|COMPLETED|Period 2 - Double-Blind Dose Response||0
958318|NCT00151775|2317392|P8|COMPLETED|Period 2 - Double-Blind Dose Response||0
958319|NCT00151775|2317393|P7|COMPLETED|Period 2 - Double-Blind Dose Response||53
958320|NCT00151775|2317394|P6|COMPLETED|Period 2 - Double-Blind Dose Response||54
958321|NCT00151775|2317395|P5|COMPLETED|Period 2 - Double-Blind Dose Response||0
958322|NCT00151775|2317396|P4|COMPLETED|Period 2 - Double-Blind Dose Response||0
958323|NCT00151775|2317397|P3|COMPLETED|Period 2 - Double-Blind Dose Response||0
958324|NCT00151775|2317398|P2|COMPLETED|Period 2 - Double-Blind Dose Response||89
958325|NCT00151775|2317399|P1|COMPLETED|Period 2 - Double-Blind Dose Response||93
958326|NCT00151775|2317388|P12|STARTED|Period 2 - Double-Blind Dose Response||0
958327|NCT00151775|2317389|P11|STARTED|Period 2 - Double-Blind Dose Response||60
958328|NCT00151775|2317390|P10|STARTED|Period 2 - Double-Blind Dose Response||0
958329|NCT00151775|2317391|P9|STARTED|Period 2 - Double-Blind Dose Response||0
958330|NCT00151775|2317392|P8|STARTED|Period 2 - Double-Blind Dose Response||0
958331|NCT00151775|2317393|P7|STARTED|Period 2 - Double-Blind Dose Response||56
958332|NCT00151775|2317394|P6|STARTED|Period 2 - Double-Blind Dose Response||56
958333|NCT00151775|2317395|P5|STARTED|Period 2 - Double-Blind Dose Response||0
958334|NCT00151775|2317396|P4|STARTED|Period 2 - Double-Blind Dose Response||0
958335|NCT00151775|2317397|P3|STARTED|Period 2 - Double-Blind Dose Response||0
958336|NCT00151775|2317398|P2|STARTED|Period 2 - Double-Blind Dose Response||95
958337|NCT00151775|2317399|P1|STARTED|Period 2 - Double-Blind Dose Response||95
958338|NCT00151814|2317443|P3|NOT COMPLETED|Overall Study||0
958339|NCT00151814|2317444|P2|NOT COMPLETED|Overall Study||0
958340|NCT00151814|2317445|P1|NOT COMPLETED|Overall Study||0
958341|NCT00151814|2317443|P3|COMPLETED|Overall Study||10
958342|NCT00151814|2317444|P2|COMPLETED|Overall Study||10
958343|NCT00151814|2317445|P1|COMPLETED|Overall Study||4
958344|NCT00151814|2317443|P3|STARTED|Overall Study||10
958345|NCT00151814|2317444|P2|STARTED|Overall Study||10
958346|NCT00151814|2317445|P1|STARTED|Overall Study||4
958347|NCT00151892|2317468|P2|NOT COMPLETED|Overall Study||83
958348|NCT00151892|2317469|P1|NOT COMPLETED|Overall Study||76
958349|NCT00151892|2317468|P2|COMPLETED|Overall Study||330
958350|NCT00151892|2317469|P1|COMPLETED|Overall Study||340
958351|NCT00151892|2317468|P2|STARTED|Overall Study||413
958352|NCT00151892|2317469|P1|STARTED|Overall Study||416
958353|NCT00151996|2317485|P2|NOT COMPLETED|Overall Study||7
958354|NCT00151996|2317486|P1|NOT COMPLETED|Overall Study||5
958355|NCT00151996|2317485|P2|COMPLETED|Overall Study||26
958356|NCT00151996|2317486|P1|COMPLETED|Overall Study||37
958357|NCT00151996|2317485|P2|STARTED|Overall Study||33
958358|NCT00151996|2317486|P1|STARTED|Overall Study||42
958359|NCT00152009|2317504|P4|NOT COMPLETED|Overall Study||33
958360|NCT00152009|2317505|P3|NOT COMPLETED|Overall Study||37
958361|NCT00152009|2317506|P2|NOT COMPLETED|Overall Study||31
958362|NCT00152009|2317507|P1|NOT COMPLETED|Overall Study||29
958363|NCT00152009|2317504|P4|COMPLETED|Overall Study||53
958364|NCT00152009|2317505|P3|COMPLETED|Overall Study||49
958365|NCT00152009|2317506|P2|COMPLETED|Overall Study||55
958366|NCT00152009|2317507|P1|COMPLETED|Overall Study||58
958367|NCT00152009|2317504|P4|STARTED|Overall Study||86
958368|NCT00152009|2317505|P3|STARTED|Overall Study||86
958369|NCT00152009|2317506|P2|STARTED|Overall Study||86
958370|NCT00152009|2317507|P1|STARTED|Overall Study||87
958371|NCT00133809|2317537|P1|NOT COMPLETED|Overall Study||0
958372|NCT00133809|2317537|P1|COMPLETED|Overall Study||8
958373|NCT00133809|2317537|P1|STARTED|Overall Study||8
958374|NCT00133952|2317546|P2|NOT COMPLETED|Overall Study||28
958375|NCT00133952|2317547|P1|NOT COMPLETED|Overall Study||42
958376|NCT00133952|2317546|P2|COMPLETED|Overall Study||124
958377|NCT00133952|2317547|P1|COMPLETED|Overall Study||115
958378|NCT00133952|2317546|P2|Received at Least One Dose of Study Drug|Overall Study||149
958379|NCT00133952|2317547|P1|Received at Least One Dose of Study Drug|Overall Study||153
958380|NCT00133952|2317546|P2|STARTED|Overall Study||152
958381|NCT00133952|2317547|P1|STARTED|Overall Study||157
958382|NCT00133978|2317573|P4|NOT COMPLETED|Overall Study||2
958383|NCT00133978|2317574|P3|NOT COMPLETED|Overall Study||0
958384|NCT00133978|2317575|P2|NOT COMPLETED|Overall Study||1
958385|NCT00133978|2317576|P1|NOT COMPLETED|Overall Study||2
958386|NCT00133978|2317573|P4|COMPLETED|Overall Study||300
958387|NCT00133978|2317574|P3|COMPLETED|Overall Study||310
958388|NCT00133978|2317575|P2|COMPLETED|Overall Study||307
958389|NCT00133978|2317576|P1|COMPLETED|Overall Study||301
958390|NCT00133978|2317573|P4|STARTED|Overall Study||302
958391|NCT00133978|2317574|P3|STARTED|Overall Study||310
958392|NCT00133978|2317575|P2|STARTED|Overall Study||308
958393|NCT00133978|2317576|P1|STARTED|Overall Study||303
958394|NCT00134004|2317598|P1|NOT COMPLETED|Overall Study||0
958395|NCT00134004|2317598|P1|COMPLETED|Overall Study||210
958396|NCT00134004|2317598|P1|STARTED|Overall Study||210
958397|NCT00134043|2317608|P2|NOT COMPLETED|Overall Study||0
958398|NCT00134043|2317609|P1|NOT COMPLETED|Overall Study||0
958399|NCT00134043|2317608|P2|COMPLETED|Overall Study||3
958400|NCT00134043|2317609|P1|COMPLETED|Overall Study||16
958401|NCT00134043|2317608|P2|STARTED|Overall Study||3
958402|NCT00134043|2317609|P1|STARTED|Overall Study||16
958403|NCT00134056|2317616|P2|NOT COMPLETED|Eligible for Protocol Assigned Treatment||315
958404|NCT00134056|2317617|P1|NOT COMPLETED|Eligible for Protocol Assigned Treatment||327
958405|NCT00134056|2317616|P2|COMPLETED|Eligible for Protocol Assigned Treatment||185
958406|NCT00134056|2317617|P1|COMPLETED|Eligible for Protocol Assigned Treatment||169
958407|NCT00134056|2317616|P2|STARTED|Eligible for Protocol Assigned Treatment||500
958408|NCT00134056|2317617|P1|STARTED|Eligible for Protocol Assigned Treatment||496
958409|NCT00134056|2317616|P2|NOT COMPLETED|Randomization||20
958410|NCT00134056|2317617|P1|NOT COMPLETED|Randomization||22
958411|NCT00134056|2317616|P2|COMPLETED|Randomization||500
958412|NCT00134056|2317617|P1|COMPLETED|Randomization||496
958413|NCT00134056|2317616|P2|STARTED|Randomization||520
958414|NCT00134056|2317617|P1|STARTED|Randomization||518
958415|NCT00139477|2317639|P2|NOT COMPLETED|Second Intervention -6Months to 12Months||5
958416|NCT00139477|2317640|P1|NOT COMPLETED|Second Intervention -6Months to 12Months||5
958417|NCT00139477|2317639|P2|COMPLETED|Second Intervention -6Months to 12Months||18
958418|NCT00139477|2317640|P1|COMPLETED|Second Intervention -6Months to 12Months||14
958419|NCT00139477|2317639|P2|STARTED|Second Intervention -6Months to 12Months||23
958420|NCT00139477|2317640|P1|STARTED|Second Intervention -6Months to 12Months||19
958421|NCT00139477|2317639|P2|NOT COMPLETED|First Intervention -Baseline to 6Months||12
958422|NCT00139477|2317640|P1|NOT COMPLETED|First Intervention -Baseline to 6Months||12
958423|NCT00139477|2317639|P2|COMPLETED|First Intervention -Baseline to 6Months||23
958424|NCT00139477|2317640|P1|COMPLETED|First Intervention -Baseline to 6Months||19
958425|NCT00139477|2317639|P2|STARTED|First Intervention -Baseline to 6Months||35
958426|NCT00139477|2317640|P1|STARTED|First Intervention -Baseline to 6Months||31
958427|NCT00139659|2317662|P2|NOT COMPLETED|Overall Study||18
958428|NCT00139659|2317663|P1|NOT COMPLETED|Overall Study||40
958429|NCT00139659|2317662|P2|COMPLETED|Overall Study||123
958430|NCT00139659|2317663|P1|COMPLETED|Overall Study||106
958431|NCT00139659|2317662|P2|STARTED|Overall Study|1 subject randomized DC'd before receiving subcutaneous insulin and is not included in # of subjects|141
958432|NCT00139659|2317663|P1|STARTED|Overall Study|1 subject randomized was DC'd prior to receiving inhaled insulin but received subcutaneous insulin|146
958433|NCT00139737|2317739|P1|NOT COMPLETED|Overall Study||341
958434|NCT00139737|2317739|P1|COMPLETED|Overall Study||3
958435|NCT00139737|2317739|P1|Received Treatment|Overall Study||331
958436|NCT00139737|2317739|P1|STARTED|Overall Study||344
958437|NCT00139776|2317745|P4|NOT COMPLETED|Period III||106
958438|NCT00139776|2317746|P3|NOT COMPLETED|Period III||76
958439|NCT00139776|2317747|P2|NOT COMPLETED|Period III||0
958440|NCT00139776|2317748|P1|NOT COMPLETED|Period III||0
958441|NCT00139776|2317745|P4|COMPLETED|Period III||321
958442|NCT00139776|2317746|P3|COMPLETED|Period III||355
958443|NCT00139776|2317747|P2|COMPLETED|Period III||0
958444|NCT00139776|2317748|P1|COMPLETED|Period III||0
958537|NCT00140413|2317890|P1|NOT COMPLETED|Overall Study||3
958445|NCT00139776|2317745|P4|STARTED|Period III|Randomized 435: 8 participants not treated|427
958446|NCT00139776|2317746|P3|STARTED|Period III|Randomized 440: 9 participants not treated|431
958447|NCT00139776|2317747|P2|STARTED|Period III||0
958448|NCT00139776|2317748|P1|STARTED|Period III||0
958449|NCT00139776|2317745|P4|NOT COMPLETED|Period II||0
958450|NCT00139776|2317746|P3|NOT COMPLETED|Period II||0
958451|NCT00139776|2317747|P2|NOT COMPLETED|Period II||322
958452|NCT00139776|2317748|P1|NOT COMPLETED|Period II||0
958453|NCT00139776|2317745|P4|COMPLETED|Period II||0
958454|NCT00139776|2317746|P3|COMPLETED|Period II||0
958455|NCT00139776|2317747|P2|COMPLETED|Period II||875
958456|NCT00139776|2317748|P1|COMPLETED|Period II||0
958457|NCT00139776|2317745|P4|STARTED|Period II||0
958458|NCT00139776|2317746|P3|STARTED|Period II||0
958459|NCT00139776|2317747|P2|STARTED|Period II||1197
958460|NCT00139776|2317748|P1|STARTED|Period II||0
958461|NCT00139776|2317745|P4|NOT COMPLETED|Period I||0
958462|NCT00139776|2317746|P3|NOT COMPLETED|Period I||0
958463|NCT00139776|2317747|P2|NOT COMPLETED|Period I||0
958464|NCT00139776|2317748|P1|NOT COMPLETED|Period I||575
958465|NCT00139776|2317745|P4|COMPLETED|Period I||0
958466|NCT00139776|2317746|P3|COMPLETED|Period I||0
958467|NCT00139776|2317747|P2|COMPLETED|Period I||0
958468|NCT00139776|2317748|P1|COMPLETED|Period I||1197
958469|NCT00139776|2317745|P4|STARTED|Period I||0
958470|NCT00139776|2317746|P3|STARTED|Period I||0
958471|NCT00139776|2317747|P2|STARTED|Period I||0
958472|NCT00139776|2317748|P1|STARTED|Period I||1772
958473|NCT00139997|2317785|P2|NOT COMPLETED|Overall Study||2
958474|NCT00139997|2317786|P1|NOT COMPLETED|Overall Study||1
958475|NCT00139997|2317785|P2|COMPLETED|Overall Study||9
958476|NCT00139997|2317786|P1|COMPLETED|Overall Study||14
958477|NCT00139997|2317785|P2|STARTED|Overall Study||11
958478|NCT00139997|2317786|P1|STARTED|Overall Study||15
958479|NCT00140140|2317797|P3|NOT COMPLETED|Overall Study||2
958480|NCT00140140|2317798|P2|NOT COMPLETED|Overall Study||2
958481|NCT00140140|2317799|P1|NOT COMPLETED|Overall Study||2
958482|NCT00140140|2317797|P3|COMPLETED|Overall Study|Progressive disease|4
958483|NCT00140140|2317798|P2|COMPLETED|Overall Study|Progressive disease|4
958484|NCT00140140|2317799|P1|COMPLETED|Overall Study|Progressive disease|2
958485|NCT00140140|2317797|P3|STARTED|Overall Study||6
958486|NCT00140140|2317798|P2|STARTED|Overall Study||6
958487|NCT00140140|2317799|P1|STARTED|Overall Study||4
958488|NCT00140231|2317838|P2|NOT COMPLETED|Fasting State With Leptin and Crossover||0
958489|NCT00140231|2317839|P1|NOT COMPLETED|Fasting State With Leptin and Crossover||0
958490|NCT00140231|2317838|P2|COMPLETED|Fasting State With Leptin and Crossover||6
958491|NCT00140231|2317839|P1|COMPLETED|Fasting State With Leptin and Crossover||7
958492|NCT00140231|2317838|P2|STARTED|Fasting State With Leptin and Crossover||6
958493|NCT00140231|2317839|P1|STARTED|Fasting State With Leptin and Crossover||7
958494|NCT00140231|2317838|P2|NOT COMPLETED|Washout 8 Weeks||0
958495|NCT00140231|2317839|P1|NOT COMPLETED|Washout 8 Weeks||0
958496|NCT00140231|2317838|P2|COMPLETED|Washout 8 Weeks||6
958497|NCT00140231|2317839|P1|COMPLETED|Washout 8 Weeks||7
958498|NCT00140231|2317838|P2|STARTED|Washout 8 Weeks||6
958499|NCT00140231|2317839|P1|STARTED|Washout 8 Weeks||7
958500|NCT00140231|2317838|P2|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
958501|NCT00140231|2317839|P1|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
958502|NCT00140231|2317838|P2|COMPLETED|First Fasting State 3 Days With Placebo||6
958503|NCT00140231|2317839|P1|COMPLETED|First Fasting State 3 Days With Placebo||7
958504|NCT00140231|2317838|P2|STARTED|First Fasting State 3 Days With Placebo||6
958505|NCT00140231|2317839|P1|STARTED|First Fasting State 3 Days With Placebo||7
958506|NCT00140231|2317838|P2|NOT COMPLETED|Washout 8weeks||0
958507|NCT00140231|2317839|P1|NOT COMPLETED|Washout 8weeks||0
958508|NCT00140231|2317838|P2|COMPLETED|Washout 8weeks||6
958509|NCT00140231|2317839|P1|COMPLETED|Washout 8weeks||7
958510|NCT00140231|2317838|P2|STARTED|Washout 8weeks||6
958511|NCT00140231|2317839|P1|STARTED|Washout 8weeks||7
958512|NCT00140231|2317838|P2|NOT COMPLETED|Fed State 1 Day- day5||0
958513|NCT00140231|2317839|P1|NOT COMPLETED|Fed State 1 Day- day5||0
958514|NCT00140231|2317838|P2|COMPLETED|Fed State 1 Day- day5||6
958515|NCT00140231|2317839|P1|COMPLETED|Fed State 1 Day- day5||7
958516|NCT00140231|2317838|P2|STARTED|Fed State 1 Day- day5||6
958517|NCT00140231|2317839|P1|STARTED|Fed State 1 Day- day5||7
958518|NCT00140244|2317855|P2|NOT COMPLETED|Intervention 2||2
958519|NCT00140244|2317856|P1|NOT COMPLETED|Intervention 2||0
958520|NCT00140244|2317855|P2|COMPLETED|Intervention 2||2
958521|NCT00140244|2317856|P1|COMPLETED|Intervention 2||3
958522|NCT00140244|2317855|P2|STARTED|Intervention 2||4
958523|NCT00140244|2317856|P1|STARTED|Intervention 2||3
958524|NCT00140244|2317855|P2|NOT COMPLETED|Washout||0
958525|NCT00140244|2317856|P1|NOT COMPLETED|Washout||0
958526|NCT00140244|2317855|P2|COMPLETED|Washout||4
958527|NCT00140244|2317856|P1|COMPLETED|Washout||3
958528|NCT00140244|2317855|P2|STARTED|Washout||4
958529|NCT00140244|2317856|P1|STARTED|Washout||3
958530|NCT00140244|2317855|P2|NOT COMPLETED|Intervention 1||0
958531|NCT00140244|2317856|P1|NOT COMPLETED|Intervention 1||0
958532|NCT00140244|2317855|P2|COMPLETED|Intervention 1||4
958533|NCT00140244|2317856|P1|COMPLETED|Intervention 1||3
958534|NCT00140244|2317855|P2|STARTED|Intervention 1||4
958535|NCT00140244|2317856|P1|STARTED|Intervention 1||3
958536|NCT00140413|2317889|P2|NOT COMPLETED|Overall Study||0
958538|NCT00140413|2317889|P2|COMPLETED|Overall Study|Crossed over subjects were treated as controls for purpose of intent to treat analysis.|7
958539|NCT00140413|2317890|P1|COMPLETED|Overall Study||10
958540|NCT00140413|2317889|P2|Received at Least One Dose of GH|Overall Study|Controls were crossed over to GH if they met criteria for growth deceleration during the study.|3
958541|NCT00140413|2317890|P1|Received at Least One Dose of GH|Overall Study||13
958542|NCT00140413|2317889|P2|STARTED|Overall Study||7
958543|NCT00140413|2317890|P1|STARTED|Overall Study||13
958544|NCT00140426|2317899|P2|NOT COMPLETED|Overall Study||3
958545|NCT00140426|2317900|P1|NOT COMPLETED|Overall Study||0
958546|NCT00140426|2317899|P2|COMPLETED|Overall Study||16
958547|NCT00140426|2317900|P1|COMPLETED|Overall Study||22
958548|NCT00140426|2317899|P2|STARTED|Overall Study||19
958549|NCT00140426|2317900|P1|STARTED|Overall Study||22
958550|NCT00146328|2317933|P3|NOT COMPLETED|Overall Study||291
958551|NCT00146328|2317934|P2|NOT COMPLETED|Overall Study||154
958552|NCT00146328|2317935|P1|NOT COMPLETED|Overall Study||141
958553|NCT00146328|2317933|P3|COMPLETED|Overall Study||158
958554|NCT00146328|2317934|P2|COMPLETED|Overall Study||101
958555|NCT00146328|2317935|P1|COMPLETED|Overall Study||150
958556|NCT00146328|2317933|P3|STARTED|Overall Study||449
958557|NCT00146328|2317934|P2|STARTED|Overall Study||255
958558|NCT00146328|2317935|P1|STARTED|Overall Study||291
958559|NCT00152516|2318018|P1|NOT COMPLETED|Overall Study||75
958560|NCT00152516|2318018|P1|COMPLETED|Overall Study|Subjects ongoing until study close-out|180
958561|NCT00152516|2318018|P1|STARTED|Overall Study|Subjects that were dispensed at least 1 dose of study medication|255
958580|NCT00153920|2318073|P1|NOT COMPLETED|Overall Study||30
958581|NCT00153920|2318073|P1|COMPLETED|Overall Study||36
958582|NCT00153920|2318073|P1|Eligible and Treated|Overall Study||64
958583|NCT00153920|2318073|P1|STARTED|Overall Study||66
958584|NCT00153985|2318082|P1|NOT COMPLETED|Overall Study||0
958585|NCT00153985|2318082|P1|COMPLETED|Overall Study||2
958586|NCT00153985|2318082|P1|STARTED|Overall Study||2
958587|NCT00154063|2318090|P2|NOT COMPLETED|Overall Study||22
958588|NCT00154063|2318091|P1|NOT COMPLETED|Overall Study||12
958589|NCT00154063|2318090|P2|COMPLETED|Overall Study||80
958590|NCT00154063|2318091|P1|COMPLETED|Overall Study||92
958591|NCT00154063|2318090|P2|STARTED|Overall Study||102
958592|NCT00154063|2318091|P1|STARTED|Overall Study||104
958593|NCT00154102|2318149|P2|NOT COMPLETED|Overall Study||2
958594|NCT00154102|2318150|P1|NOT COMPLETED|Overall Study||7
958595|NCT00154102|2318149|P2|COMPLETED|Overall Study||597
958596|NCT00154102|2318150|P1|COMPLETED|Overall Study||592
958597|NCT00154102|2318149|P2|STARTED|Overall Study|Randomized and treated subjects; 3 additional subjects were treated but not randomised|599
958598|NCT00154102|2318150|P1|STARTED|Overall Study|Randomized and treated subjects; 1 additional subject was treated but not randomised|599
958599|NCT00154284|2318186|P2|NOT COMPLETED|Overall Study||13
958600|NCT00154284|2318187|P1|NOT COMPLETED|Overall Study||7
958601|NCT00154284|2318186|P2|COMPLETED|Overall Study||42
958602|NCT00154284|2318187|P1|COMPLETED|Overall Study|"Completed means patients completed on study medication.All patients of both arms completed study."|52
958603|NCT00154284|2318186|P2|Intent to Treat (ITT) Population|Overall Study||53
958604|NCT00154284|2318187|P1|Intent to Treat (ITT) Population|Overall Study||57
958605|NCT00154284|2318186|P2|STARTED|Overall Study||55
958606|NCT00154284|2318187|P1|STARTED|Overall Study|"Started indicates Safety Population (randomized patients and treated after randomization.)"|59
958607|NCT00154297|2318201|P2|NOT COMPLETED|Overall Study||7
958608|NCT00154297|2318202|P1|NOT COMPLETED|Overall Study||8
958609|NCT00154297|2318201|P2|COMPLETED|Overall Study|Completed study by 12 month.|67
958610|NCT00154297|2318202|P1|COMPLETED|Overall Study|Completed study by 12 month.|57
958611|NCT00154297|2318201|P2|STARTED|Overall Study|Randomized population.|74
958612|NCT00154297|2318202|P1|STARTED|Overall Study|Randomized population.|65
958613|NCT00154310|2318220|P2|NOT COMPLETED|Overall Study||28
958614|NCT00154310|2318221|P1|NOT COMPLETED|Overall Study||37
958615|NCT00154310|2318220|P2|COMPLETED|Overall Study||117
958616|NCT00154310|2318221|P1|COMPLETED|Overall Study||118
958617|NCT00154310|2318220|P2|STARTED|Overall Study||145
958618|NCT00154310|2318221|P1|STARTED|Overall Study|"Started indicates enrolled participants. Randomized participants for two arms are 154 and 146."|155
958619|NCT00154375|2318237|P2|NOT COMPLETED|Overall Study||106
958620|NCT00154375|2318238|P1|NOT COMPLETED|Overall Study||113
958621|NCT00154375|2318237|P2|COMPLETED|Overall Study||14
958622|NCT00154375|2318238|P1|COMPLETED|Overall Study||7
958623|NCT00154375|2318237|P2|Not Exposed to Study Treatment|Overall Study||2
958624|NCT00154375|2318238|P1|Not Exposed to Study Treatment|Overall Study|4 randomized patients didn't receive study treatment were excluded from the safety analyses.|2
958625|NCT00154375|2318237|P2|Discontinued Study Treatment|Overall Study||104
958626|NCT00154375|2318238|P1|Discontinued Study Treatment|Overall Study||111
958627|NCT00154375|2318237|P2|STARTED|Overall Study||120
958628|NCT00154375|2318238|P1|STARTED|Overall Study||120
958629|NCT00154466|2318250|P3|NOT COMPLETED|Overall Study||0
958630|NCT00154466|2318251|P2|NOT COMPLETED|Overall Study||0
958631|NCT00154466|2318252|P1|NOT COMPLETED|Overall Study||0
958632|NCT00154466|2318250|P3|COMPLETED|Overall Study||19
958633|NCT00154466|2318251|P2|COMPLETED|Overall Study||19
958634|NCT00154466|2318252|P1|COMPLETED|Overall Study||20
958635|NCT00154466|2318250|P3|STARTED|Overall Study|Healthy controls underwent the test of myocardial perfusion only at baseline.|19
958636|NCT00154466|2318251|P2|STARTED|Overall Study||19
958637|NCT00154466|2318252|P1|STARTED|Overall Study||20
958638|NCT00149630|2318264|P2|NOT COMPLETED|Overall Study||5
958639|NCT00149630|2318265|P1|NOT COMPLETED|Overall Study||8
958640|NCT00149630|2318264|P2|COMPLETED|Overall Study||35
958641|NCT00149630|2318265|P1|COMPLETED|Overall Study||26
958642|NCT00149630|2318264|P2|STARTED|Overall Study||40
958643|NCT00149630|2318265|P1|STARTED|Overall Study||34
958644|NCT00149643|2318277|P2|NOT COMPLETED|Overall Study||36
958645|NCT00149643|2318278|P1|NOT COMPLETED|Overall Study||34
958646|NCT00149643|2318277|P2|COMPLETED|Overall Study||0
958647|NCT00149643|2318278|P1|COMPLETED|Overall Study||0
958648|NCT00149643|2318277|P2|STARTED|Overall Study||36
958649|NCT00149643|2318278|P1|STARTED|Overall Study||34
958650|NCT00149669|2318290|P2|NOT COMPLETED|Overall Study||5
958651|NCT00149669|2318291|P1|NOT COMPLETED|Overall Study||3
958652|NCT00149669|2318290|P2|COMPLETED|Overall Study||30
958653|NCT00149669|2318291|P1|COMPLETED|Overall Study||29
958654|NCT00149669|2318290|P2|STARTED|Overall Study||35
958655|NCT00149669|2318291|P1|STARTED|Overall Study||32
958656|NCT00149747|2318311|P2|NOT COMPLETED|Overall Study||3
958657|NCT00149747|2318312|P1|NOT COMPLETED|Overall Study||4
958658|NCT00149747|2318311|P2|COMPLETED|Overall Study||27
958659|NCT00149747|2318312|P1|COMPLETED|Overall Study||32
958660|NCT00149747|2318311|P2|STARTED|Overall Study||30
958661|NCT00149747|2318312|P1|STARTED|Overall Study||36
958662|NCT00149799|2318324|P3|NOT COMPLETED|Discontinuation (Phase II)||9
958663|NCT00149799|2318325|P2|NOT COMPLETED|Discontinuation (Phase II)||3
958664|NCT00149799|2318326|P1|NOT COMPLETED|Discontinuation (Phase II)||0
958665|NCT00149799|2318324|P3|COMPLETED|Discontinuation (Phase II)||21
958666|NCT00149799|2318325|P2|COMPLETED|Discontinuation (Phase II)||25
958667|NCT00149799|2318326|P1|COMPLETED|Discontinuation (Phase II)||0
958668|NCT00149799|2318324|P3|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I were randomized in Phase II|30
958669|NCT00149799|2318325|P2|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I were randomized in Phase II|28
958670|NCT00149799|2318326|P1|STARTED|Discontinuation (Phase II)||0
958671|NCT00149799|2318324|P3|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
958672|NCT00149799|2318325|P2|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
958673|NCT00149799|2318326|P1|NOT COMPLETED|Open Label Escitalopram (Phase I)||26
958674|NCT00149799|2318324|P3|COMPLETED|Open Label Escitalopram (Phase I)||0
958675|NCT00149799|2318325|P2|COMPLETED|Open Label Escitalopram (Phase I)||0
958676|NCT00149799|2318326|P1|COMPLETED|Open Label Escitalopram (Phase I)|14 completers were non-responders and 2 responders terminated the study after completing Phase I|74
958677|NCT00149799|2318324|P3|STARTED|Open Label Escitalopram (Phase I)||0
958678|NCT00149799|2318325|P2|STARTED|Open Label Escitalopram (Phase I)||0
958679|NCT00149799|2318326|P1|STARTED|Open Label Escitalopram (Phase I)||100
958680|NCT00149825|2318336|P2|NOT COMPLETED|Overall Study||3
958681|NCT00149825|2318337|P1|NOT COMPLETED|Overall Study||5
958682|NCT00149825|2318336|P2|COMPLETED|Overall Study||12
958683|NCT00149825|2318337|P1|COMPLETED|Overall Study||10
958684|NCT00149825|2318336|P2|STARTED|Overall Study||15
958685|NCT00149825|2318337|P1|STARTED|Overall Study||15
958686|NCT00149890|2318347|P2|NOT COMPLETED|Overall Study||18
958687|NCT00149890|2318348|P1|NOT COMPLETED|Overall Study||13
958688|NCT00149890|2318347|P2|COMPLETED|Overall Study||20
958689|NCT00149890|2318348|P1|COMPLETED|Overall Study||26
958690|NCT00149890|2318347|P2|STARTED|Overall Study||38
958691|NCT00149890|2318348|P1|STARTED|Overall Study|"Started indicates all screened and treated participants."|39
958695|NCT00156065|2318373|P3|NOT COMPLETED|Overall Study||27
958696|NCT00156065|2318374|P2|NOT COMPLETED|Overall Study||63
958697|NCT00156065|2318375|P1|NOT COMPLETED|Overall Study||31
958698|NCT00156065|2318373|P3|COMPLETED|Overall Study||16
958699|NCT00156065|2318374|P2|COMPLETED|Overall Study||30
958700|NCT00156065|2318375|P1|COMPLETED|Overall Study||20
958701|NCT00156065|2318373|P3|STARTED|Overall Study||43
958702|NCT00156065|2318374|P2|STARTED|Overall Study||93
958703|NCT00156065|2318375|P1|STARTED|Overall Study||51
958704|NCT00156910|2318388|P2|NOT COMPLETED|Open-Label Phase (OL)||55
958705|NCT00156910|2318389|P1|NOT COMPLETED|Open-Label Phase (OL)||33
958706|NCT00156910|2318388|P2|COMPLETED|Open-Label Phase (OL)||231
958707|NCT00156910|2318389|P1|COMPLETED|Open-Label Phase (OL)||252
958708|NCT00156910|2318388|P2|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL Phase|286
958709|NCT00156910|2318389|P1|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|285
958710|NCT00156910|2318388|P2|NOT COMPLETED|Double-Blind Phase (DB)||43
958711|NCT00156910|2318389|P1|NOT COMPLETED|Double-Blind Phase (DB)||45
958712|NCT00156910|2318388|P2|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|295
958713|NCT00156910|2318389|P1|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|296
958714|NCT00156910|2318388|P2|STARTED|Double-Blind Phase (DB)||338
958715|NCT00156910|2318389|P1|STARTED|Double-Blind Phase (DB)||341
958716|NCT00156923|2318405|P2|NOT COMPLETED|Overall Study||32
958717|NCT00156923|2318406|P1|NOT COMPLETED|Overall Study||34
958718|NCT00156923|2318405|P2|COMPLETED|Overall Study||20
958719|NCT00156923|2318406|P1|COMPLETED|Overall Study||22
958720|NCT00156923|2318405|P2|STARTED|Overall Study||52
958721|NCT00156923|2318406|P1|STARTED|Overall Study||56
958722|NCT00156936|2318414|P2|NOT COMPLETED|Overall Study||11
958723|NCT00156936|2318415|P1|NOT COMPLETED|Overall Study||72
958724|NCT00156936|2318414|P2|COMPLETED|Overall Study||5
958725|NCT00156936|2318415|P1|COMPLETED|Overall Study||20
958726|NCT00156936|2318414|P2|STARTED|Overall Study||16
958727|NCT00156936|2318415|P1|STARTED|Overall Study||92
958740|NCT00157157|2318506|P1|NOT COMPLETED|Overall Study||11
958741|NCT00157157|2318506|P1|COMPLETED|Overall Study||44
958742|NCT00157157|2318506|P1|STARTED|Overall Study||55
958743|NCT00157196|2318529|P1|NOT COMPLETED|Overall Study||9
958744|NCT00157196|2318529|P1|COMPLETED|Overall Study||13
958745|NCT00157196|2318529|P1|STARTED|Overall Study||22
958746|NCT00157209|2318537|P2|NOT COMPLETED|Overall Study||0
958747|NCT00157209|2318538|P1|NOT COMPLETED|Overall Study||10
958748|NCT00157209|2318537|P2|COMPLETED|Overall Study||83
958749|NCT00157209|2318538|P1|COMPLETED|Overall Study||78
958750|NCT00157209|2318537|P2|STARTED|Overall Study||83
958751|NCT00157209|2318538|P1|STARTED|Overall Study||88
958752|NCT00157248|2318556|P4|NOT COMPLETED|Overall Study||47
958753|NCT00157248|2318557|P3|NOT COMPLETED|Overall Study||21
958754|NCT00157248|2318558|P2|NOT COMPLETED|Overall Study||37
958755|NCT00157248|2318559|P1|NOT COMPLETED|Overall Study||48
958756|NCT00157248|2318556|P4|COMPLETED|Overall Study||77
958757|NCT00157248|2318557|P3|COMPLETED|Overall Study||29
958758|NCT00157248|2318558|P2|COMPLETED|Overall Study||52
958759|NCT00157248|2318559|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation of study medication.|50
958760|NCT00157248|2318556|P4|STARTED|Overall Study||124
958761|NCT00157248|2318557|P3|STARTED|Overall Study||50
958762|NCT00157248|2318558|P2|STARTED|Overall Study||89
958763|NCT00157248|2318559|P1|STARTED|Overall Study|Started: Participant completed previous trial on Dabigatran and took study drug of present trial.|98
958764|NCT00157573|2318663|P2|NOT COMPLETED|Overall Study||0
958765|NCT00157573|2318664|P1|NOT COMPLETED|Overall Study||0
958766|NCT00157573|2318663|P2|COMPLETED|Overall Study||37
958767|NCT00157573|2318664|P1|COMPLETED|Overall Study||35
958768|NCT00157573|2318663|P2|STARTED|Overall Study||37
958769|NCT00157573|2318664|P1|STARTED|Overall Study||35
958770|NCT00157755|2318675|P6|NOT COMPLETED|Overall Study||5
958771|NCT00157755|2318676|P5|NOT COMPLETED|Overall Study||2
958772|NCT00157755|2318677|P4|NOT COMPLETED|Overall Study||4
958773|NCT00157755|2318678|P3|NOT COMPLETED|Overall Study||7
958774|NCT00157755|2318679|P2|NOT COMPLETED|Overall Study||4
958775|NCT00157755|2318680|P1|NOT COMPLETED|Overall Study||2
958776|NCT00157755|2318675|P6|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|0
958777|NCT00157755|2318676|P5|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|10
958778|NCT00157755|2318677|P4|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|11
958779|NCT00157755|2318678|P3|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|3
958780|NCT00157755|2318679|P2|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|15
958781|NCT00157755|2318680|P1|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|24
958782|NCT00157755|2318675|P6|STARTED|Overall Study||5
958783|NCT00157755|2318676|P5|STARTED|Overall Study||12
958784|NCT00157755|2318677|P4|STARTED|Overall Study||15
958785|NCT00157755|2318678|P3|STARTED|Overall Study||10
958786|NCT00157755|2318679|P2|STARTED|Overall Study||19
958787|NCT00157755|2318680|P1|STARTED|Overall Study||26
958788|NCT00157820|2318705|P3|NOT COMPLETED|2nd 8 Months||14
958789|NCT00157820|2318706|P2|NOT COMPLETED|2nd 8 Months||13
958790|NCT00157820|2318707|P1|NOT COMPLETED|2nd 8 Months||5
958791|NCT00157820|2318705|P3|COMPLETED|2nd 8 Months||94
958792|NCT00157820|2318706|P2|COMPLETED|2nd 8 Months||88
958793|NCT00157820|2318707|P1|COMPLETED|2nd 8 Months||98
958794|NCT00157820|2318705|P3|STARTED|2nd 8 Months||108
958795|NCT00157820|2318706|P2|STARTED|2nd 8 Months||101
958796|NCT00157820|2318707|P1|STARTED|2nd 8 Months||103
958797|NCT00157820|2318705|P3|NOT COMPLETED|1 Month Wash Out Period||0
958798|NCT00157820|2318706|P2|NOT COMPLETED|1 Month Wash Out Period||0
958799|NCT00157820|2318707|P1|NOT COMPLETED|1 Month Wash Out Period||0
958800|NCT00157820|2318705|P3|COMPLETED|1 Month Wash Out Period||108
958801|NCT00157820|2318706|P2|COMPLETED|1 Month Wash Out Period||101
958802|NCT00157820|2318707|P1|COMPLETED|1 Month Wash Out Period||103
958803|NCT00157820|2318705|P3|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in DC true period, that are now carried to SC sim period|108
958804|NCT00157820|2318706|P2|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in SC sim period, that are now carried to DC true period|101
958805|NCT00157820|2318707|P1|STARTED|1 Month Wash Out Period||103
958806|NCT00157820|2318705|P3|NOT COMPLETED|1st 8 Month||6
958807|NCT00157820|2318706|P2|NOT COMPLETED|1st 8 Month||12
958808|NCT00157820|2318707|P1|NOT COMPLETED|1st 8 Month||8
958809|NCT00157820|2318705|P3|COMPLETED|1st 8 Month||106
958810|NCT00157820|2318706|P2|COMPLETED|1st 8 Month||99
958811|NCT00157820|2318707|P1|COMPLETED|1st 8 Month||103
958812|NCT00157820|2318705|P3|STARTED|1st 8 Month||112
958813|NCT00157820|2318706|P2|STARTED|1st 8 Month||111
958814|NCT00157820|2318707|P1|STARTED|1st 8 Month||111
958815|NCT00157820|2318705|P3|NOT COMPLETED|Randomized||8
958816|NCT00157820|2318706|P2|NOT COMPLETED|Randomized||5
958817|NCT00157820|2318707|P1|NOT COMPLETED|Randomized||7
958818|NCT00157820|2318705|P3|COMPLETED|Randomized||112
958819|NCT00157820|2318706|P2|COMPLETED|Randomized||111
958820|NCT00157820|2318707|P1|COMPLETED|Randomized||111
958821|NCT00157820|2318705|P3|STARTED|Randomized||120
958822|NCT00157820|2318706|P2|STARTED|Randomized||116
958823|NCT00157820|2318707|P1|STARTED|Randomized||118
958824|NCT00157950|2318720|P2|NOT COMPLETED|Overall Study||0
958825|NCT00157950|2318721|P1|NOT COMPLETED|Overall Study||1
958826|NCT00157950|2318720|P2|COMPLETED|Overall Study||59
958827|NCT00157950|2318721|P1|COMPLETED|Overall Study||116
958828|NCT00157950|2318720|P2|Vaccinated at Dose 3|Overall Study||59
958829|NCT00157950|2318721|P1|Vaccinated at Dose 3|Overall Study||116
958830|NCT00157950|2318720|P2|Vaccinated at Dose 2|Overall Study||59
958831|NCT00157950|2318721|P1|Vaccinated at Dose 2|Overall Study||117
958832|NCT00157950|2318720|P2|Vaccinated at Dose 1|Overall Study||59
958833|NCT00157950|2318721|P1|Vaccinated at Dose 1|Overall Study||117
958834|NCT00157950|2318720|P2|STARTED|Overall Study||59
958835|NCT00157950|2318721|P1|STARTED|Overall Study||117
958836|NCT00158054|2318737|P2|NOT COMPLETED|Overall Study||3
958837|NCT00158054|2318738|P1|NOT COMPLETED|Overall Study||10
958838|NCT00158054|2318737|P2|COMPLETED|Overall Study||74
958839|NCT00158054|2318738|P1|COMPLETED|Overall Study||70
958840|NCT00158054|2318737|P2|STARTED|Overall Study||77
958841|NCT00158054|2318738|P1|STARTED|Overall Study||80
958842|NCT00158184|2318752|P2|NOT COMPLETED|Overall Study||2
958843|NCT00158184|2318753|P1|NOT COMPLETED|Overall Study||6
958844|NCT00158184|2318752|P2|COMPLETED|Overall Study||9
958845|NCT00158184|2318753|P1|COMPLETED|Overall Study||10
958846|NCT00158184|2318752|P2|STARTED|Overall Study||11
958847|NCT00158184|2318753|P1|STARTED|Overall Study||16
958848|NCT00158197|2318765|P4|NOT COMPLETED|Overall Study||0
958849|NCT00158197|2318766|P3|NOT COMPLETED|Overall Study||0
958850|NCT00158197|2318767|P2|NOT COMPLETED|Overall Study||0
958851|NCT00158197|2318768|P1|NOT COMPLETED|Overall Study||0
958852|NCT00158197|2318765|P4|COMPLETED|Overall Study||29
958853|NCT00158197|2318766|P3|COMPLETED|Overall Study||28
958854|NCT00158197|2318767|P2|COMPLETED|Overall Study||30
958855|NCT00158197|2318768|P1|COMPLETED|Overall Study||32
958856|NCT00158197|2318765|P4|STARTED|Overall Study||29
958857|NCT00158197|2318766|P3|STARTED|Overall Study||28
958858|NCT00158197|2318767|P2|STARTED|Overall Study||30
958859|NCT00158197|2318768|P1|STARTED|Overall Study||32
958860|NCT00158223|2318788|P2|NOT COMPLETED|Overall Study||3
958861|NCT00158223|2318789|P1|NOT COMPLETED|Overall Study||5
958862|NCT00158223|2318788|P2|COMPLETED|Overall Study||22
958863|NCT00158223|2318789|P1|COMPLETED|Overall Study||23
958864|NCT00158223|2318788|P2|STARTED|Overall Study||25
958865|NCT00158223|2318789|P1|STARTED|Overall Study||28
958866|NCT00158249|2318801|P2|NOT COMPLETED|Overall Study||0
958867|NCT00158249|2318802|P1|NOT COMPLETED|Overall Study||2
958868|NCT00158249|2318801|P2|COMPLETED|Overall Study||10
958869|NCT00158249|2318802|P1|COMPLETED|Overall Study||9
958870|NCT00158249|2318801|P2|STARTED|Overall Study||10
958871|NCT00158249|2318802|P1|STARTED|Overall Study||11
958872|NCT00158262|2318812|P2|NOT COMPLETED|Overall Study||1
958873|NCT00158262|2318813|P1|NOT COMPLETED|Overall Study||1
958874|NCT00158262|2318812|P2|COMPLETED|Overall Study||21
958875|NCT00158262|2318813|P1|COMPLETED|Overall Study||20
958876|NCT00158262|2318812|P2|STARTED|Overall Study||22
958877|NCT00158262|2318813|P1|STARTED|Overall Study||21
958878|NCT00158379|2318823|P1|NOT COMPLETED|Overall Study||0
958879|NCT00158379|2318823|P1|COMPLETED|Overall Study||105
958880|NCT00158379|2318823|P1|STARTED|Overall Study||105
958881|NCT00158600|2318830|P2|NOT COMPLETED|Overall Study||4
958882|NCT00158600|2318831|P1|NOT COMPLETED|Overall Study||5
958883|NCT00158600|2318830|P2|COMPLETED|Overall Study||26
958884|NCT00158600|2318831|P1|COMPLETED|Overall Study||55
958885|NCT00158600|2318830|P2|STARTED|Overall Study||30
958886|NCT00158600|2318831|P1|STARTED|Overall Study||60
958887|NCT00158743|2318851|P2|NOT COMPLETED|Overall Study||7
958888|NCT00158743|2318852|P1|NOT COMPLETED|Overall Study||9
958889|NCT00158743|2318851|P2|COMPLETED|Overall Study||20
958890|NCT00158743|2318852|P1|COMPLETED|Overall Study||15
958891|NCT00158743|2318851|P2|STARTED|Overall Study||27
958892|NCT00158743|2318852|P1|STARTED|Overall Study||24
958893|NCT00158756|2318863|P5|NOT COMPLETED|Overall Study||3
958894|NCT00158756|2318864|P4|NOT COMPLETED|Overall Study||1
958895|NCT00158756|2318865|P3|NOT COMPLETED|Overall Study||8
958896|NCT00158756|2318866|P2|NOT COMPLETED|Overall Study||0
958897|NCT00158756|2318867|P1|NOT COMPLETED|Overall Study||5
958898|NCT00158756|2318863|P5|COMPLETED|Overall Study||96
958899|NCT00158756|2318864|P4|COMPLETED|Overall Study||22
958900|NCT00158756|2318865|P3|COMPLETED|Overall Study||73
958901|NCT00158756|2318866|P2|COMPLETED|Overall Study||25
958902|NCT00158756|2318867|P1|COMPLETED|Overall Study||75
958903|NCT00158756|2318863|P5|STARTED|Overall Study||99
958904|NCT00158756|2318864|P4|STARTED|Overall Study||23
958905|NCT00158756|2318865|P3|STARTED|Overall Study||81
958906|NCT00158756|2318866|P2|STARTED|Overall Study||25
958907|NCT00158756|2318867|P1|STARTED|Overall Study||80
958908|NCT00158925|2318962|P1|NOT COMPLETED|Overall Study||12
958909|NCT00158925|2318962|P1|COMPLETED|Overall Study||84
958910|NCT00158925|2318962|P1|STARTED|Overall Study|96 subjects were implanted or attempted with the study lead|96
958911|NCT00159419|2318972|P2|NOT COMPLETED|Overall Study||0
958912|NCT00159419|2318973|P1|NOT COMPLETED|Overall Study||0
958913|NCT00159419|2318972|P2|COMPLETED|Overall Study||9
958914|NCT00159419|2318973|P1|COMPLETED|Overall Study||9
958915|NCT00159419|2318972|P2|STARTED|Overall Study||9
958916|NCT00159419|2318973|P1|STARTED|Overall Study||9
958917|NCT00159432|2318979|P1|NOT COMPLETED|Overall Study||10
958918|NCT00159432|2318979|P1|COMPLETED|Overall Study||53
958919|NCT00159432|2318979|P1|STARTED|Overall Study||63
958920|NCT00152763|2318988|P4|NOT COMPLETED|Overall Study||14
958921|NCT00152763|2318989|P3|NOT COMPLETED|Overall Study||4
958922|NCT00152763|2318990|P2|NOT COMPLETED|Overall Study||5
958923|NCT00152763|2318991|P1|NOT COMPLETED|Overall Study||10
958924|NCT00152763|2318988|P4|COMPLETED|Overall Study||63
958925|NCT00152763|2318989|P3|COMPLETED|Overall Study||16
958926|NCT00152763|2318990|P2|COMPLETED|Overall Study||14
958927|NCT00152763|2318991|P1|COMPLETED|Overall Study||67
958928|NCT00152763|2318988|P4|STARTED|Overall Study||77
958929|NCT00152763|2318989|P3|STARTED|Overall Study||20
958930|NCT00152763|2318990|P2|STARTED|Overall Study||19
958931|NCT00152763|2318991|P1|STARTED|Overall Study||77
958932|NCT00152971|2319110|P3|NOT COMPLETED|Treatment||80
958933|NCT00152971|2319111|P2|NOT COMPLETED|Treatment||63
958934|NCT00152971|2319112|P1|NOT COMPLETED|Treatment||71
958935|NCT00152971|2319110|P3|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|788
958936|NCT00152971|2319111|P2|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|808
958937|NCT00152971|2319112|P1|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|786
958938|NCT00152971|2319110|P3|STARTED|Treatment||868
958939|NCT00152971|2319111|P2|STARTED|Treatment||871
958940|NCT00152971|2319112|P1|STARTED|Treatment||857
958941|NCT00152971|2319110|P3|NOT COMPLETED|Overall Study||49
958942|NCT00152971|2319111|P2|NOT COMPLETED|Overall Study||48
958943|NCT00152971|2319112|P1|NOT COMPLETED|Overall Study||51
958944|NCT00152971|2319110|P3|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|819
958945|NCT00152971|2319111|P2|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|823
958946|NCT00152971|2319112|P1|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|806
958947|NCT00152971|2319110|P3|STARTED|Overall Study||868
958948|NCT00152971|2319111|P2|STARTED|Overall Study||871
958949|NCT00152971|2319112|P1|STARTED|Overall Study||857
958950|NCT00153062|2319148|P4|NOT COMPLETED|Overall Study||411
958951|NCT00153062|2319149|P3|NOT COMPLETED|Overall Study||415
958952|NCT00153062|2319150|P2|NOT COMPLETED|Overall Study||406
958953|NCT00153062|2319151|P1|NOT COMPLETED|Overall Study||387
958954|NCT00153062|2319148|P4|COMPLETED|Overall Study||4680
958955|NCT00153062|2319149|P3|COMPLETED|Overall Study||4645
958956|NCT00153062|2319150|P2|COMPLETED|Overall Study||4689
958957|NCT00153062|2319151|P1|COMPLETED|Overall Study||4699
958958|NCT00153062|2319148|P4|STARTED|Overall Study||5091
958959|NCT00153062|2319149|P3|STARTED|Overall Study||5060
958960|NCT00153062|2319150|P2|STARTED|Overall Study||5095
958961|NCT00153062|2319151|P1|STARTED|Overall Study||5086
958962|NCT00153101|2319172|P5|NOT COMPLETED|Overall Study||10
958963|NCT00153101|2319173|P4|NOT COMPLETED|Overall Study||8
958964|NCT00153101|2319174|P3|NOT COMPLETED|Overall Study||15
958965|NCT00153101|2319175|P2|NOT COMPLETED|Overall Study||18
958966|NCT00153101|2319176|P1|NOT COMPLETED|Overall Study||17
958967|NCT00153101|2319172|P5|COMPLETED|Overall Study||2962
958968|NCT00153101|2319173|P4|COMPLETED|Overall Study||2946
958969|NCT00153101|2319174|P3|COMPLETED|Overall Study||8561
958970|NCT00153101|2319175|P2|COMPLETED|Overall Study||8524
958971|NCT00153101|2319176|P1|COMPLETED|Overall Study||8485
958972|NCT00153101|2319172|P5|STARTED|Overall Study||2972
958973|NCT00153101|2319173|P4|STARTED|Overall Study||2954
958974|NCT00153101|2319174|P3|STARTED|Overall Study||8576
958975|NCT00153101|2319175|P2|STARTED|Overall Study||8542
958976|NCT00153101|2319176|P1|STARTED|Overall Study||8502
958977|NCT00153166|2319283|P3|NOT COMPLETED|Overall Study||0
958978|NCT00153166|2319284|P2|NOT COMPLETED|Overall Study||0
958979|NCT00153166|2319285|P1|NOT COMPLETED|Overall Study||0
958980|NCT00153166|2319283|P3|COMPLETED|Overall Study||28
958981|NCT00153166|2319284|P2|COMPLETED|Overall Study||37
958982|NCT00153166|2319285|P1|COMPLETED|Overall Study||11
958983|NCT00153166|2319283|P3|Received Placebo and Placebo|Overall Study||7
958984|NCT00153166|2319284|P2|Received Placebo and Placebo|Overall Study||9
958985|NCT00153166|2319285|P1|Received Placebo and Placebo|Overall Study||3
958986|NCT00153166|2319283|P3|Received Placebo and Pioglitazone|Overall Study||7
958987|NCT00153166|2319284|P2|Received Placebo and Pioglitazone|Overall Study||10
958988|NCT00153166|2319285|P1|Received Placebo and Pioglitazone|Overall Study||3
958989|NCT00153166|2319283|P3|Received Atorvastatin and Placebo|Overall Study||7
958990|NCT00153166|2319284|P2|Received Atorvastatin and Placebo|Overall Study||9
958991|NCT00153166|2319285|P1|Received Atorvastatin and Placebo|Overall Study||2
958992|NCT00153166|2319283|P3|Received Atorvastatin and Pioglitazone|Overall Study||7
958993|NCT00153166|2319284|P2|Received Atorvastatin and Pioglitazone|Overall Study||9
958994|NCT00153166|2319285|P1|Received Atorvastatin and Pioglitazone|Overall Study||3
958995|NCT00153166|2319283|P3|STARTED|Overall Study||28
958996|NCT00153166|2319284|P2|STARTED|Overall Study||37
958997|NCT00153166|2319285|P1|STARTED|Overall Study||11
958998|NCT00153179|2319299|P4|NOT COMPLETED|Study Visit Day 2||0
958999|NCT00153179|2319300|P3|NOT COMPLETED|Study Visit Day 2||0
959000|NCT00153179|2319301|P2|NOT COMPLETED|Study Visit Day 2||0
959001|NCT00153179|2319302|P1|NOT COMPLETED|Study Visit Day 2||0
959002|NCT00153179|2319299|P4|COMPLETED|Study Visit Day 2||7
959003|NCT00153179|2319300|P3|COMPLETED|Study Visit Day 2||11
959004|NCT00153179|2319301|P2|COMPLETED|Study Visit Day 2||8
959005|NCT00153179|2319302|P1|COMPLETED|Study Visit Day 2||9
959006|NCT00153179|2319299|P4|STARTED|Study Visit Day 2||7
959007|NCT00153179|2319300|P3|STARTED|Study Visit Day 2||11
959008|NCT00153179|2319301|P2|STARTED|Study Visit Day 2||8
959009|NCT00153179|2319302|P1|STARTED|Study Visit Day 2||9
959010|NCT00153179|2319299|P4|NOT COMPLETED|Study Visit Day 1||0
959011|NCT00153179|2319300|P3|NOT COMPLETED|Study Visit Day 1||0
959012|NCT00153179|2319301|P2|NOT COMPLETED|Study Visit Day 1||0
959013|NCT00153179|2319302|P1|NOT COMPLETED|Study Visit Day 1||0
959014|NCT00153179|2319299|P4|COMPLETED|Study Visit Day 1||9
959015|NCT00153179|2319300|P3|COMPLETED|Study Visit Day 1||13
959016|NCT00153179|2319301|P2|COMPLETED|Study Visit Day 1||8
959017|NCT00153179|2319302|P1|COMPLETED|Study Visit Day 1||10
959018|NCT00153179|2319299|P4|STARTED|Study Visit Day 1||9
959019|NCT00153179|2319300|P3|STARTED|Study Visit Day 1||13
959020|NCT00153179|2319301|P2|STARTED|Study Visit Day 1||8
959021|NCT00153179|2319302|P1|STARTED|Study Visit Day 1||10
959022|NCT00159783|2319313|P3|NOT COMPLETED|Overall Study||39
959023|NCT00159783|2319314|P2|NOT COMPLETED|Overall Study||27
959024|NCT00159783|2319315|P1|NOT COMPLETED|Overall Study||19
959025|NCT00159783|2319313|P3|COMPLETED|Overall Study||68
959026|NCT00159783|2319314|P2|COMPLETED|Overall Study||52
959027|NCT00159783|2319315|P1|COMPLETED|Overall Study||13
959028|NCT00159783|2319313|P3|STARTED|Overall Study||107
959029|NCT00159783|2319314|P2|STARTED|Overall Study||79
959030|NCT00159783|2319315|P1|STARTED|Overall Study||32
959031|NCT00159822|2319345|P1|NOT COMPLETED|Post-treatment Follow-up Period||3
959032|NCT00159822|2319345|P1|COMPLETED|Post-treatment Follow-up Period||23
959033|NCT00159822|2319345|P1|STARTED|Post-treatment Follow-up Period||26
959034|NCT00159822|2319345|P1|NOT COMPLETED|Voriconazole Treatment Period||22
959035|NCT00159822|2319345|P1|COMPLETED|Voriconazole Treatment Period|Number of subjects completed treatment: 36 up to month 6 (M6); 26 after M6.|26
959036|NCT00159822|2319345|P1|STARTED|Voriconazole Treatment Period||48
959037|NCT00160524|2319360|P1|NOT COMPLETED|Overall Study||478
959038|NCT00160524|2319360|P1|COMPLETED|Overall Study||117
959039|NCT00160524|2319360|P1|STARTED|Overall Study|One subject was enrolled erroneously and has no data in the database.|595
959040|NCT00160563|2319374|P3|NOT COMPLETED|Overall Study||90
959041|NCT00160563|2319375|P2|NOT COMPLETED|Overall Study||45
959042|NCT00160563|2319376|P1|NOT COMPLETED|Overall Study||51
959043|NCT00160563|2319374|P3|COMPLETED|Overall Study||11
959044|NCT00160563|2319375|P2|COMPLETED|Overall Study||2
959045|NCT00160563|2319376|P1|COMPLETED|Overall Study||8
959046|NCT00160563|2319374|P3|STARTED|Overall Study||101
959047|NCT00160563|2319375|P2|STARTED|Overall Study||47
959048|NCT00160563|2319376|P1|STARTED|Overall Study||59
959049|NCT00160641|2319388|P1|NOT COMPLETED|Overall Study||221
959050|NCT00160641|2319388|P1|COMPLETED|Overall Study||346
959051|NCT00160641|2319388|P1|STARTED|Overall Study||567
959052|NCT00160693|2319419|P1|NOT COMPLETED|Overall Study||235
959053|NCT00160693|2319419|P1|COMPLETED|Overall Study||167
959054|NCT00160693|2319419|P1|STARTED|Overall Study||402
959055|NCT00160706|2319436|P1|NOT COMPLETED|Overall Study||286
959056|NCT00160706|2319436|P1|COMPLETED|Overall Study||24
959057|NCT00160706|2319436|P1|STARTED|Overall Study||310
959058|NCT00161213|2319448|P1|NOT COMPLETED|Overall Study||2
959059|NCT00161213|2319448|P1|COMPLETED|Overall Study||42
959060|NCT00161213|2319448|P1|STARTED|Overall Study||44
959061|NCT00161382|2319457|P2|NOT COMPLETED|Overall Study||289
959062|NCT00161382|2319458|P1|NOT COMPLETED|Overall Study||249
959063|NCT00161382|2319457|P2|COMPLETED|Overall Study|Number of control students included in the analyzed cohort (i.e., completed 9th-grade survey)|558
959064|NCT00161382|2319458|P1|COMPLETED|Overall Study|Number of intervention students included in the analyzed cohort (i.e., completed 9th-grade survey)|349
959065|NCT00161382|2319457|P2|STARTED|Overall Study|Number of students allocated to comparison group|847
959066|NCT00161382|2319458|P1|STARTED|Overall Study|Number of students allocated to intervention group|598
959067|NCT00161473|2319466|P2|NOT COMPLETED|Overall Study||6
959068|NCT00161473|2319467|P1|NOT COMPLETED|Overall Study||5
959069|NCT00161473|2319466|P2|COMPLETED|Overall Study||6
959070|NCT00161473|2319467|P1|COMPLETED|Overall Study||7
959071|NCT00161473|2319466|P2|STARTED|Overall Study||12
959072|NCT00161473|2319467|P1|STARTED|Overall Study||12
959073|NCT00161616|2319481|P2|NOT COMPLETED|Overall Study||19
959074|NCT00161616|2319482|P1|NOT COMPLETED|Overall Study||26
959075|NCT00161616|2319481|P2|COMPLETED|Overall Study||119
959076|NCT00161616|2319482|P1|COMPLETED|Overall Study||113
959077|NCT00161616|2319481|P2|STARTED|Overall Study||138
959078|NCT00161616|2319482|P1|STARTED|Overall Study||139
959079|NCT00162032|2319492|P2|NOT COMPLETED|Overall Study||2
959080|NCT00162032|2319493|P1|NOT COMPLETED|Overall Study||5
959081|NCT00162032|2319492|P2|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|114
959082|NCT00162032|2319493|P1|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|324
959083|NCT00162032|2319492|P2|STARTED|Overall Study||116
959084|NCT00162032|2319493|P1|STARTED|Overall Study||329
959085|NCT00162097|2319505|P4|NOT COMPLETED|Overall Study||1
959086|NCT00162097|2319506|P3|NOT COMPLETED|Overall Study||0
959087|NCT00162097|2319507|P2|NOT COMPLETED|Overall Study||0
959088|NCT00162097|2319508|P1|NOT COMPLETED|Overall Study||0
959089|NCT00162097|2319505|P4|COMPLETED|Overall Study||6
959090|NCT00162097|2319506|P3|COMPLETED|Overall Study||1
959091|NCT00162097|2319507|P2|COMPLETED|Overall Study||2
959092|NCT00162097|2319508|P1|COMPLETED|Overall Study||6
959093|NCT00162097|2319505|P4|STARTED|Overall Study|Treated on Day 1. One participant enrolled twice in the study and is hence counted twice|7
959094|NCT00162097|2319506|P3|STARTED|Overall Study|Treated on Day 1|1
959095|NCT00162097|2319507|P2|STARTED|Overall Study|Treated on Day 1|2
959096|NCT00162097|2319508|P1|STARTED|Overall Study|Treated on Day 1|6
959129|NCT00162136|2319618|P1|NOT COMPLETED|Overall Study||35
959130|NCT00162136|2319618|P1|COMPLETED|Overall Study|Number of Participants still on treatment at study termination|0
959131|NCT00162136|2319618|P1|STARTED|Overall Study||35
959132|NCT00162266|2319645|P4|NOT COMPLETED|Open-Label Period||137
959133|NCT00162266|2319646|P3|NOT COMPLETED|Open-Label Period||0
959134|NCT00162266|2319647|P2|NOT COMPLETED|Open-Label Period||0
959135|NCT00162266|2319648|P1|NOT COMPLETED|Open-Label Period||0
959136|NCT00162266|2319645|P4|COMPLETED|Open-Label Period||82
959137|NCT00162266|2319646|P3|COMPLETED|Open-Label Period||0
959138|NCT00162266|2319647|P2|COMPLETED|Open-Label Period||0
959139|NCT00162266|2319648|P1|COMPLETED|Open-Label Period||0
959140|NCT00162266|2319645|P4|STARTED|Open-Label Period||219
959141|NCT00162266|2319646|P3|STARTED|Open-Label Period||0
959142|NCT00162266|2319647|P2|STARTED|Open-Label Period||0
959143|NCT00162266|2319648|P1|STARTED|Open-Label Period||0
959144|NCT00162266|2319645|P4|NOT COMPLETED|Double-Blind Period||0
959145|NCT00162266|2319646|P3|NOT COMPLETED|Double-Blind Period||48
959146|NCT00162266|2319647|P2|NOT COMPLETED|Double-Blind Period||31
959147|NCT00162266|2319648|P1|NOT COMPLETED|Double-Blind Period||25
959148|NCT00162266|2319645|P4|COMPLETED|Double-Blind Period||0
959149|NCT00162266|2319646|P3|COMPLETED|Double-Blind Period||71
959150|NCT00162266|2319647|P2|COMPLETED|Double-Blind Period||74
959151|NCT00162266|2319648|P1|COMPLETED|Double-Blind Period||90
959152|NCT00162266|2319645|P4|Completed Day 1 to Day 181|Double-Blind Period||0
959153|NCT00162266|2319646|P3|Completed Day 1 to Day 181|Double-Blind Period||78
959154|NCT00162266|2319647|P2|Completed Day 1 to Day 181|Double-Blind Period||80
959155|NCT00162266|2319648|P1|Completed Day 1 to Day 181|Double-Blind Period||98
959156|NCT00162266|2319645|P4|STARTED|Double-Blind Period||0
959157|NCT00162266|2319646|P3|STARTED|Double-Blind Period||119
959158|NCT00162266|2319647|P2|STARTED|Double-Blind Period||105
959159|NCT00162266|2319648|P1|STARTED|Double-Blind Period||115
959160|NCT00162370|2319843|P1|NOT COMPLETED|Efficacy Population||51
959161|NCT00162370|2319843|P1|COMPLETED|Efficacy Population|Efficacy population, completed rest/stress echo with Definity & completed 2 and/or 5 year follow up|315
959162|NCT00162370|2319843|P1|STARTED|Efficacy Population||366
959163|NCT00162370|2319843|P1|NOT COMPLETED|Completed Echocardiography Imaging||0
959164|NCT00162370|2319843|P1|COMPLETED|Completed Echocardiography Imaging|number of subjects who under went Definity-enhanced rest and stress echocardiogram|366
959165|NCT00162370|2319843|P1|STARTED|Completed Echocardiography Imaging|Received at least one dose of Definity|366
959166|NCT00162773|2319848|P1|NOT COMPLETED|Overall Study||22
959167|NCT00162773|2319848|P1|COMPLETED|Overall Study||7
959168|NCT00162773|2319848|P1|STARTED|Overall Study||29
959169|NCT00156247|2319852|P1|NOT COMPLETED|Overall Study||4
959170|NCT00156247|2319852|P1|COMPLETED|Overall Study||5
959171|NCT00156247|2319852|P1|STARTED|Overall Study||9
959172|NCT00156390|2319860|P2|NOT COMPLETED|Overall Study||8
959173|NCT00156390|2319861|P1|NOT COMPLETED|Overall Study||14
959174|NCT00156390|2319860|P2|COMPLETED|Overall Study||69
959175|NCT00156390|2319861|P1|COMPLETED|Overall Study||96
959176|NCT00156390|2319860|P2|STARTED|Overall Study||77
959177|NCT00156390|2319861|P1|STARTED|Overall Study||110
959178|NCT00156533|2319871|P4|NOT COMPLETED|Overall Study||2
959179|NCT00156533|2319872|P3|NOT COMPLETED|Overall Study||2
959180|NCT00156533|2319873|P2|NOT COMPLETED|Overall Study||2
959181|NCT00156533|2319874|P1|NOT COMPLETED|Overall Study||2
959182|NCT00156533|2319871|P4|COMPLETED|Overall Study||3
959183|NCT00156533|2319872|P3|COMPLETED|Overall Study||3
959184|NCT00156533|2319873|P2|COMPLETED|Overall Study||3
959185|NCT00156533|2319874|P1|COMPLETED|Overall Study||3
959186|NCT00156533|2319871|P4|STARTED|Overall Study||5
959187|NCT00156533|2319872|P3|STARTED|Overall Study||5
959188|NCT00156533|2319873|P2|STARTED|Overall Study||5
959189|NCT00156533|2319874|P1|STARTED|Overall Study||5
959190|NCT00156715|2319888|P1|NOT COMPLETED|Overall Study||7
959191|NCT00156715|2319888|P1|COMPLETED|Overall Study||16
959192|NCT00156715|2319888|P1|STARTED|Overall Study||23
959193|NCT00156819|2319896|P3|NOT COMPLETED|Overall Study||3
959194|NCT00156819|2319897|P2|NOT COMPLETED|Overall Study||1
959195|NCT00156819|2319898|P1|NOT COMPLETED|Overall Study||1
959196|NCT00156819|2319896|P3|COMPLETED|Overall Study||162
959197|NCT00156819|2319897|P2|COMPLETED|Overall Study||165
959198|NCT00156819|2319898|P1|COMPLETED|Overall Study||168
959199|NCT00156819|2319896|P3|STARTED|Overall Study||165
959200|NCT00156819|2319897|P2|STARTED|Overall Study||166
959201|NCT00156819|2319898|P1|STARTED|Overall Study||169
959202|NCT00162942|2319908|P2|NOT COMPLETED|Overall Study||52
959203|NCT00162942|2319909|P1|NOT COMPLETED|Overall Study||106
959204|NCT00162942|2319908|P2|COMPLETED|Overall Study||26
959205|NCT00162942|2319909|P1|COMPLETED|Overall Study||51
959206|NCT00162942|2319908|P2|Week 12|Overall Study||61
959207|NCT00162942|2319909|P1|Week 12|Overall Study||127
959208|NCT00162942|2319908|P2|STARTED|Overall Study||78
959209|NCT00162942|2319909|P1|STARTED|Overall Study||157
959210|NCT00162981|2319959|P2|NOT COMPLETED|Overall Study||6
959211|NCT00162981|2319960|P1|NOT COMPLETED|Overall Study||4
959212|NCT00162981|2319959|P2|COMPLETED|Overall Study||30
959213|NCT00162981|2319960|P1|COMPLETED|Overall Study||28
959214|NCT00162981|2319959|P2|STARTED|Overall Study||36
959215|NCT00162981|2319960|P1|STARTED|Overall Study||32
959216|NCT00163020|2319976|P2|NOT COMPLETED|Overall Study||2
959217|NCT00163020|2319977|P1|NOT COMPLETED|Overall Study||0
959218|NCT00163020|2319976|P2|COMPLETED|Overall Study|Twins = 78 Triplets = 25|103
959219|NCT00163020|2319977|P1|COMPLETED|Overall Study|Twins = 160 Triplets = 56|216
959220|NCT00163020|2319976|P2|STARTED|Overall Study|Twins = 80 Triplets = 25|105
959221|NCT00163020|2319977|P1|STARTED|Overall Study|Twins = 160 Triplets = 56|216
959222|NCT00163657|2320018|P3|NOT COMPLETED|Overall Study||37
959223|NCT00163657|2320019|P2|NOT COMPLETED|Overall Study||23
959224|NCT00163657|2320020|P1|NOT COMPLETED|Overall Study||20
959225|NCT00163657|2320018|P3|COMPLETED|Overall Study||116
959226|NCT00163657|2320019|P2|COMPLETED|Overall Study||56
959227|NCT00163657|2320020|P1|COMPLETED|Overall Study||60
959228|NCT00163657|2320018|P3|STARTED|Overall Study||153
959229|NCT00163657|2320019|P2|STARTED|Overall Study||79
959230|NCT00163657|2320020|P1|STARTED|Overall Study||80
959231|NCT00165503|2320031|P1|NOT COMPLETED|Overall Study||16
959232|NCT00165503|2320031|P1|COMPLETED|Overall Study||0
959233|NCT00165503|2320031|P1|STARTED|Overall Study||16
959234|NCT00165646|2320038|P3|NOT COMPLETED|Overall Study||4
959235|NCT00165646|2320039|P2|NOT COMPLETED|Overall Study||5
959236|NCT00165646|2320040|P1|NOT COMPLETED|Overall Study||5
959237|NCT00165646|2320038|P3|COMPLETED|Overall Study||98
959238|NCT00165646|2320039|P2|COMPLETED|Overall Study||88
959239|NCT00165646|2320040|P1|COMPLETED|Overall Study||88
959240|NCT00165646|2320038|P3|STARTED|Overall Study||102
959241|NCT00165646|2320039|P2|STARTED|Overall Study||93
959242|NCT00165646|2320040|P1|STARTED|Overall Study||93
959243|NCT00165672|2320050|P2|NOT COMPLETED|Overall Study||1
959244|NCT00165672|2320051|P1|NOT COMPLETED|Overall Study||0
959245|NCT00165672|2320050|P2|COMPLETED|Overall Study||12
959246|NCT00165672|2320051|P1|COMPLETED|Overall Study||13
959247|NCT00165672|2320050|P2|STARTED|Overall Study||13
959248|NCT00165672|2320051|P1|STARTED|Overall Study||13
959249|NCT00165698|2320059|P2|NOT COMPLETED|Overall Study||15
959250|NCT00165698|2320060|P1|NOT COMPLETED|Overall Study||8
959251|NCT00165698|2320059|P2|COMPLETED|Overall Study||105
959252|NCT00165698|2320060|P1|COMPLETED|Overall Study||112
959253|NCT00165698|2320059|P2|STARTED|Overall Study||120
959254|NCT00165698|2320060|P1|STARTED|Overall Study||120
959255|NCT00165776|2320088|P4|NOT COMPLETED|Overall Study||2
959256|NCT00165776|2320089|P3|NOT COMPLETED|Overall Study||2
959257|NCT00165776|2320090|P2|NOT COMPLETED|Overall Study||1
959258|NCT00165776|2320091|P1|NOT COMPLETED|Overall Study||4
959259|NCT00165776|2320088|P4|COMPLETED|Overall Study||29
959260|NCT00165776|2320089|P3|COMPLETED|Overall Study||31
959261|NCT00165776|2320090|P2|COMPLETED|Overall Study||33
959262|NCT00165776|2320091|P1|COMPLETED|Overall Study||31
959263|NCT00165776|2320088|P4|STARTED|Overall Study||31
959264|NCT00165776|2320089|P3|STARTED|Overall Study||33
959265|NCT00165776|2320090|P2|STARTED|Overall Study||34
959266|NCT00165776|2320091|P1|STARTED|Overall Study||35
959267|NCT00165789|2320129|P4|NOT COMPLETED|Overall Study||14
959268|NCT00165789|2320130|P3|NOT COMPLETED|Overall Study||1
959269|NCT00165789|2320131|P2|NOT COMPLETED|Overall Study||4
959270|NCT00165789|2320132|P1|NOT COMPLETED|Overall Study||0
959271|NCT00165789|2320129|P4|COMPLETED|Overall Study||21
959272|NCT00165789|2320130|P3|COMPLETED|Overall Study||11
959273|NCT00165789|2320131|P2|COMPLETED|Overall Study||16
959274|NCT00165789|2320132|P1|COMPLETED|Overall Study||8
959275|NCT00165789|2320129|P4|STARTED|Overall Study||35
959276|NCT00165789|2320130|P3|STARTED|Overall Study||12
959277|NCT00165789|2320131|P2|STARTED|Overall Study||20
959278|NCT00165789|2320132|P1|STARTED|Overall Study||8
959279|NCT00165841|2320184|P2|NOT COMPLETED|Overall Study||62
959280|NCT00165841|2320185|P1|NOT COMPLETED|Overall Study||30
959281|NCT00165841|2320184|P2|COMPLETED|Overall Study||35
959282|NCT00165841|2320185|P1|COMPLETED|Overall Study||73
959283|NCT00165841|2320184|P2|STARTED|Overall Study||97
959284|NCT00165841|2320185|P1|STARTED|Overall Study||103
959285|NCT00165958|2320193|P2|NOT COMPLETED|Overall Study||2
959286|NCT00165958|2320194|P1|NOT COMPLETED|Overall Study||1
959287|NCT00165958|2320193|P2|COMPLETED|Overall Study||19
959288|NCT00165958|2320194|P1|COMPLETED|Overall Study||18
959289|NCT00165958|2320193|P2|STARTED|Overall Study||21
959290|NCT00165958|2320194|P1|STARTED|Overall Study||19
959291|NCT00165984|2320200|P1|NOT COMPLETED|Overall Study||15
959292|NCT00165984|2320200|P1|COMPLETED|Overall Study||150
959293|NCT00165984|2320200|P1|STARTED|Overall Study||165
959294|NCT00159861|2320209|P2|NOT COMPLETED|Extension Study - up to 3 Years||71
959295|NCT00159861|2320210|P1|NOT COMPLETED|Extension Study - up to 3 Years||62
959296|NCT00159861|2320209|P2|COMPLETED|Extension Study - up to 3 Years||56
959297|NCT00159861|2320210|P1|COMPLETED|Extension Study - up to 3 Years||53
959298|NCT00159861|2320209|P2|Treated|Extension Study - up to 3 Years||127
959299|NCT00159861|2320210|P1|Treated|Extension Study - up to 3 Years||115
959300|NCT00159861|2320209|P2|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|127
959301|NCT00159861|2320210|P1|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|115
959302|NCT00159861|2320209|P2|NOT COMPLETED|Core Study - 16 Weeks||12
959303|NCT00159861|2320210|P1|NOT COMPLETED|Core Study - 16 Weeks||25
959304|NCT00159861|2320209|P2|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 127; Did not enter A1481153: 7|122
959305|NCT00159861|2320210|P1|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 115; Did not enter A1481153: 16|108
959306|NCT00159861|2320209|P2|Treated|Core Study - 16 Weeks||134
959307|NCT00159861|2320210|P1|Treated|Core Study - 16 Weeks||131
959308|NCT00159861|2320209|P2|STARTED|Core Study - 16 Weeks||134
959309|NCT00159861|2320210|P1|STARTED|Core Study - 16 Weeks||133
959310|NCT00159874|2320238|P7|NOT COMPLETED|Overall Study||5
959311|NCT00159874|2320239|P6|NOT COMPLETED|Overall Study||12
959312|NCT00159874|2320240|P5|NOT COMPLETED|Overall Study||8
959313|NCT00159874|2320241|P4|NOT COMPLETED|Overall Study||6
959314|NCT00159874|2320242|P3|NOT COMPLETED|Overall Study||43
959315|NCT00159874|2320243|P2|NOT COMPLETED|Overall Study||30
959316|NCT00159874|2320244|P1|NOT COMPLETED|Overall Study||20
959317|NCT00159874|2320238|P7|COMPLETED|Overall Study||0
959318|NCT00159874|2320239|P6|COMPLETED|Overall Study||11
959319|NCT00159874|2320240|P5|COMPLETED|Overall Study||11
959320|NCT00159874|2320241|P4|COMPLETED|Overall Study||7
959321|NCT00159874|2320242|P3|COMPLETED|Overall Study||34
959322|NCT00159874|2320243|P2|COMPLETED|Overall Study||25
959323|NCT00159874|2320244|P1|COMPLETED|Overall Study||22
959324|NCT00159874|2320238|P7|Treated|Overall Study||5
959325|NCT00159874|2320239|P6|Treated|Overall Study||23
959326|NCT00159874|2320240|P5|Treated|Overall Study||19
959327|NCT00159874|2320241|P4|Treated|Overall Study||13
959328|NCT00159874|2320242|P3|Treated|Overall Study||77
959329|NCT00159874|2320243|P2|Treated|Overall Study||55
959330|NCT00159874|2320244|P1|Treated|Overall Study||42
959331|NCT00159874|2320238|P7|STARTED|Overall Study||5
959332|NCT00159874|2320239|P6|STARTED|Overall Study||23
959333|NCT00159874|2320240|P5|STARTED|Overall Study||19
959334|NCT00159874|2320241|P4|STARTED|Overall Study||13
959335|NCT00159874|2320242|P3|STARTED|Overall Study||77
959336|NCT00159874|2320243|P2|STARTED|Overall Study||55
959337|NCT00159874|2320244|P1|STARTED|Overall Study||42
959338|NCT00159913|2320416|P4|NOT COMPLETED|Overall Study||2
959339|NCT00159913|2320417|P3|NOT COMPLETED|Overall Study||2
959340|NCT00159913|2320418|P2|NOT COMPLETED|Overall Study||0
959341|NCT00159913|2320419|P1|NOT COMPLETED|Overall Study||2
959342|NCT00159913|2320416|P4|COMPLETED|Overall Study||58
959343|NCT00159913|2320417|P3|COMPLETED|Overall Study||75
959344|NCT00159913|2320418|P2|COMPLETED|Overall Study||55
959345|NCT00159913|2320419|P1|COMPLETED|Overall Study||40
959346|NCT00159913|2320416|P4|STARTED|Overall Study||60
959347|NCT00159913|2320417|P3|STARTED|Overall Study||77
959348|NCT00159913|2320418|P2|STARTED|Overall Study||55
959349|NCT00159913|2320419|P1|STARTED|Overall Study||42
959350|NCT00159965|2320488|P2|NOT COMPLETED|Overall Study||5
959351|NCT00159965|2320489|P1|NOT COMPLETED|Overall Study||7
959352|NCT00159965|2320488|P2|COMPLETED|Overall Study||14
959353|NCT00159965|2320489|P1|COMPLETED|Overall Study||12
959354|NCT00159965|2320488|P2|STARTED|Overall Study||19
959355|NCT00159965|2320489|P1|STARTED|Overall Study||19
959356|NCT00160199|2320523|P2|NOT COMPLETED|Overall Study||37
959357|NCT00160199|2320524|P1|NOT COMPLETED|Overall Study||24
959358|NCT00160199|2320523|P2|COMPLETED|Overall Study||81
959359|NCT00160199|2320524|P1|COMPLETED|Overall Study||98
959360|NCT00160199|2320523|P2|STARTED|Overall Study||118
959361|NCT00160199|2320524|P1|STARTED|Overall Study||122
959362|NCT00160251|2320548|P8|NOT COMPLETED|Post-amendment 2||55
959363|NCT00160251|2320549|P7|NOT COMPLETED|Post-amendment 2||0
959364|NCT00160251|2320550|P6|NOT COMPLETED|Post-amendment 2||0
959365|NCT00160251|2320551|P5|NOT COMPLETED|Post-amendment 2||0
959366|NCT00160251|2320552|P4|NOT COMPLETED|Post-amendment 2||0
959367|NCT00160251|2320553|P3|NOT COMPLETED|Post-amendment 2||0
959368|NCT00160251|2320554|P2|NOT COMPLETED|Post-amendment 2||0
959369|NCT00160251|2320555|P1|NOT COMPLETED|Post-amendment 2||0
959370|NCT00160251|2320548|P8|COMPLETED|Post-amendment 2||88
959371|NCT00160251|2320549|P7|COMPLETED|Post-amendment 2||0
959372|NCT00160251|2320550|P6|COMPLETED|Post-amendment 2||0
959373|NCT00160251|2320551|P5|COMPLETED|Post-amendment 2||0
959374|NCT00160251|2320552|P4|COMPLETED|Post-amendment 2||0
959375|NCT00160251|2320553|P3|COMPLETED|Post-amendment 2||0
959376|NCT00160251|2320554|P2|COMPLETED|Post-amendment 2||0
959377|NCT00160251|2320555|P1|COMPLETED|Post-amendment 2||0
959378|NCT00160251|2320548|P8|STARTED|Post-amendment 2||143
959379|NCT00160251|2320549|P7|STARTED|Post-amendment 2||0
959380|NCT00160251|2320550|P6|STARTED|Post-amendment 2||0
959381|NCT00160251|2320551|P5|STARTED|Post-amendment 2||0
959382|NCT00160251|2320552|P4|STARTED|Post-amendment 2||0
959383|NCT00160251|2320553|P3|STARTED|Post-amendment 2||0
959384|NCT00160251|2320554|P2|STARTED|Post-amendment 2||0
959385|NCT00160251|2320555|P1|STARTED|Post-amendment 2||0
959386|NCT00160251|2320548|P8|NOT COMPLETED|Prior to Amendment 2||0
959387|NCT00160251|2320549|P7|NOT COMPLETED|Prior to Amendment 2||4
959388|NCT00160251|2320550|P6|NOT COMPLETED|Prior to Amendment 2||83
959389|NCT00160251|2320551|P5|NOT COMPLETED|Prior to Amendment 2||28
959390|NCT00160251|2320552|P4|NOT COMPLETED|Prior to Amendment 2||40
959391|NCT00160251|2320553|P3|NOT COMPLETED|Prior to Amendment 2||44
959392|NCT00160251|2320554|P2|NOT COMPLETED|Prior to Amendment 2||6
959393|NCT00160251|2320555|P1|NOT COMPLETED|Prior to Amendment 2||9
959394|NCT00160251|2320548|P8|COMPLETED|Prior to Amendment 2||0
959395|NCT00160251|2320549|P7|COMPLETED|Prior to Amendment 2||61
959396|NCT00160251|2320550|P6|COMPLETED|Prior to Amendment 2||14
959397|NCT00160251|2320551|P5|COMPLETED|Prior to Amendment 2||21
959398|NCT00160251|2320552|P4|COMPLETED|Prior to Amendment 2||9
959399|NCT00160251|2320553|P3|COMPLETED|Prior to Amendment 2||4
959400|NCT00160251|2320554|P2|COMPLETED|Prior to Amendment 2||28
959401|NCT00160251|2320555|P1|COMPLETED|Prior to Amendment 2||6
959402|NCT00160251|2320548|P8|STARTED|Prior to Amendment 2||0
959403|NCT00160251|2320549|P7|STARTED|Prior to Amendment 2||65
959404|NCT00160251|2320550|P6|STARTED|Prior to Amendment 2||97
959405|NCT00160251|2320551|P5|STARTED|Prior to Amendment 2||49
959406|NCT00160251|2320552|P4|STARTED|Prior to Amendment 2||49
959407|NCT00160251|2320553|P3|STARTED|Prior to Amendment 2||48
959408|NCT00160251|2320554|P2|STARTED|Prior to Amendment 2||34
959409|NCT00160251|2320555|P1|STARTED|Prior to Amendment 2||15
959410|NCT00166036|2320631|P2|NOT COMPLETED|Overall Study||0
959411|NCT00166036|2320632|P1|NOT COMPLETED|Overall Study||0
959412|NCT00166036|2320631|P2|COMPLETED|Overall Study||19
959413|NCT00166036|2320632|P1|COMPLETED|Overall Study||17
959414|NCT00166036|2320631|P2|STARTED|Overall Study||19
959415|NCT00166036|2320632|P1|STARTED|Overall Study||17
959416|NCT00166114|2320642|P2|NOT COMPLETED|Overall Study||6
959417|NCT00166114|2320643|P1|NOT COMPLETED|Overall Study||14
959418|NCT00166114|2320642|P2|COMPLETED|Overall Study||13
959419|NCT00166114|2320643|P1|COMPLETED|Overall Study||7
959420|NCT00166114|2320642|P2|STARTED|Overall Study||19
959421|NCT00166114|2320643|P1|STARTED|Overall Study||21
959422|NCT00166166|2320651|P2|NOT COMPLETED|Overall Study||0
959423|NCT00166166|2320652|P1|NOT COMPLETED|Overall Study||0
959424|NCT00166166|2320651|P2|COMPLETED|Overall Study||71
959425|NCT00166166|2320652|P1|COMPLETED|Overall Study||103
959426|NCT00166166|2320651|P2|STARTED|Overall Study||71
959427|NCT00166166|2320652|P1|STARTED|Overall Study||103
959428|NCT00166205|2320673|P1|NOT COMPLETED|Overall Study||48
959429|NCT00166205|2320673|P1|COMPLETED|Overall Study||228
959430|NCT00166205|2320673|P1|Intervention - SAGB Surgery|Overall Study||276
959431|NCT00166205|2320673|P1|STARTED|Overall Study||276
959432|NCT00166296|2320689|P2|NOT COMPLETED|Overall Study||9
959433|NCT00166296|2320690|P1|NOT COMPLETED|Overall Study||7
959434|NCT00166296|2320689|P2|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|57
959435|NCT00166296|2320690|P1|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|60
959436|NCT00166296|2320689|P2|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|63
959437|NCT00166296|2320690|P1|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|66
959438|NCT00166296|2320689|P2|STARTED|Overall Study|Randomized patients|66
959439|NCT00166296|2320690|P1|STARTED|Overall Study|Randomized patients|67
959440|NCT00167778|2320702|P1|NOT COMPLETED|Overall Study||1
959441|NCT00167778|2320702|P1|COMPLETED|Overall Study||10
959442|NCT00167778|2320702|P1|STARTED|Overall Study||11
959443|NCT00168038|2320751|P1|NOT COMPLETED|Overall Study||2
959444|NCT00168038|2320751|P1|COMPLETED|Overall Study||55
959445|NCT00168038|2320751|P1|STARTED|Overall Study||57
959446|NCT00168064|2320765|P2|NOT COMPLETED|Overall Study||44
959447|NCT00168064|2320766|P1|NOT COMPLETED|Overall Study||49
959448|NCT00168064|2320765|P2|COMPLETED|Overall Study||86
959449|NCT00168064|2320766|P1|COMPLETED|Overall Study||81
959450|NCT00168064|2320765|P2|STARTED|Overall Study|127 participants received AP formulation|130
959451|NCT00168064|2320766|P1|STARTED|Overall Study|128 participants received PG formulation|130
959452|NCT00168103|2320777|P4|NOT COMPLETED|Overall Study||0
959453|NCT00168103|2320778|P3|NOT COMPLETED|Overall Study||1
959454|NCT00168103|2320779|P2|NOT COMPLETED|Overall Study||5
959455|NCT00168103|2320780|P1|NOT COMPLETED|Overall Study||2
959456|NCT00168103|2320777|P4|COMPLETED|Overall Study||1
959457|NCT00168103|2320778|P3|COMPLETED|Overall Study||41
959458|NCT00168103|2320779|P2|COMPLETED|Overall Study||38
959459|NCT00168103|2320780|P1|COMPLETED|Overall Study|1 randomized subject received open-label rescue medication before receiving randomized treatment.|38
959460|NCT00168103|2320777|P4|STARTED|Overall Study||1
959461|NCT00168103|2320778|P3|STARTED|Overall Study||42
959462|NCT00168103|2320779|P2|STARTED|Overall Study||43
959463|NCT00168103|2320780|P1|STARTED|Overall Study||40
959464|NCT00168298|2320803|P3|NOT COMPLETED|Open-Label Period||8
959465|NCT00168298|2320804|P2|NOT COMPLETED|Open-Label Period||5
959466|NCT00168298|2320805|P1|NOT COMPLETED|Open-Label Period||7
959467|NCT00168298|2320803|P3|COMPLETED|Open-Label Period||160
959468|NCT00168298|2320804|P2|COMPLETED|Open-Label Period||168
959469|NCT00168298|2320805|P1|COMPLETED|Open-Label Period||172
959470|NCT00168298|2320803|P3|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|168
959471|NCT00168298|2320804|P2|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|173
959472|NCT00168298|2320805|P1|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|179
959473|NCT00168298|2320803|P3|NOT COMPLETED|Double-Blind Period||15
959474|NCT00168298|2320804|P2|NOT COMPLETED|Double-Blind Period||12
959475|NCT00168298|2320805|P1|NOT COMPLETED|Double-Blind Period||12
959476|NCT00168298|2320803|P3|COMPLETED|Double-Blind Period||209
959477|NCT00168298|2320804|P2|COMPLETED|Double-Blind Period||206
959478|NCT00168298|2320805|P1|COMPLETED|Double-Blind Period||214
959479|NCT00168298|2320803|P3|STARTED|Double-Blind Period||224
959480|NCT00168298|2320804|P2|STARTED|Double-Blind Period||218
959481|NCT00168298|2320805|P1|STARTED|Double-Blind Period||226
959482|NCT00168311|2320824|P2|NOT COMPLETED|Overall Study||2
959483|NCT00168311|2320825|P1|NOT COMPLETED|Overall Study||0
959484|NCT00168311|2320824|P2|COMPLETED|Overall Study||8
959485|NCT00168311|2320825|P1|COMPLETED|Overall Study||12
959486|NCT00168311|2320824|P2|STARTED|Overall Study||10
959487|NCT00168311|2320825|P1|STARTED|Overall Study||12
959488|NCT00168324|2320834|P3|NOT COMPLETED|Open-Label Period||6
959489|NCT00168324|2320835|P2|NOT COMPLETED|Open-Label Period||8
959490|NCT00168324|2320836|P1|NOT COMPLETED|Open-Label Period||4
959491|NCT00168324|2320834|P3|COMPLETED|Open-Label Period||152
959492|NCT00168324|2320835|P2|COMPLETED|Open-Label Period||147
959493|NCT00168324|2320836|P1|COMPLETED|Open-Label Period||160
959494|NCT00168324|2320834|P3|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|158
959495|NCT00168324|2320835|P2|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|155
959496|NCT00168324|2320836|P1|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|164
959497|NCT00168324|2320834|P3|NOT COMPLETED|Double-Blind Period||13
959498|NCT00168324|2320835|P2|NOT COMPLETED|Double-Blind Period||7
959499|NCT00168324|2320836|P1|NOT COMPLETED|Double-Blind Period||12
959500|NCT00168324|2320834|P3|COMPLETED|Double-Blind Period||189
959501|NCT00168324|2320835|P2|COMPLETED|Double-Blind Period||189
959502|NCT00168324|2320836|P1|COMPLETED|Double-Blind Period||189
959503|NCT00168324|2320834|P3|STARTED|Double-Blind Period||202
959504|NCT00168324|2320835|P2|STARTED|Double-Blind Period||196
959505|NCT00168324|2320836|P1|STARTED|Double-Blind Period||201
959506|NCT00168337|2320859|P3|NOT COMPLETED|Overall Study||103
959507|NCT00168337|2320860|P2|NOT COMPLETED|Overall Study||69
959508|NCT00168337|2320861|P1|NOT COMPLETED|Overall Study||70
959509|NCT00168337|2320859|P3|COMPLETED|Overall Study||82
959510|NCT00168337|2320860|P2|COMPLETED|Overall Study||112
959511|NCT00168337|2320861|P1|COMPLETED|Overall Study||118
959512|NCT00168337|2320859|P3|STARTED|Overall Study||185
959513|NCT00168337|2320860|P2|STARTED|Overall Study||181
959514|NCT00168337|2320861|P1|STARTED|Overall Study||188
959515|NCT00168389|2320890|P3|NOT COMPLETED|Overall Study||95
959516|NCT00168389|2320891|P2|NOT COMPLETED|Overall Study||48
959517|NCT00168389|2320892|P1|NOT COMPLETED|Overall Study||56
959518|NCT00168389|2320890|P3|COMPLETED|Overall Study||70
959519|NCT00168389|2320891|P2|COMPLETED|Overall Study||118
959520|NCT00168389|2320892|P1|COMPLETED|Overall Study||107
959521|NCT00168389|2320890|P3|STARTED|Overall Study||165
959522|NCT00168389|2320891|P2|STARTED|Overall Study||166
959523|NCT00168389|2320892|P1|STARTED|Overall Study||163
959524|NCT00168428|2320920|P2|NOT COMPLETED|Open-Label Phase (OL)||68
959525|NCT00168428|2320921|P1|NOT COMPLETED|Open-Label Phase (OL)||44
959526|NCT00168428|2320920|P2|COMPLETED|Open-Label Phase (OL)||261
959527|NCT00168428|2320921|P1|COMPLETED|Open-Label Phase (OL)||261
959528|NCT00168428|2320920|P2|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL phase|329
959529|NCT00168428|2320921|P1|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|305
959530|NCT00168428|2320920|P2|NOT COMPLETED|Double-Blind Phase (DB)||24
959531|NCT00168428|2320921|P1|NOT COMPLETED|Double-Blind Phase (DB)||36
959532|NCT00168428|2320920|P2|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|334
959533|NCT00168428|2320921|P1|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|311
959534|NCT00168428|2320920|P2|STARTED|Double-Blind Phase (DB)||358
959535|NCT00168428|2320921|P1|STARTED|Double-Blind Phase (DB)||347
959536|NCT00168454|2320943|P6|NOT COMPLETED|Overall Study||6
959537|NCT00168454|2320944|P5|NOT COMPLETED|Overall Study||6
959538|NCT00168454|2320945|P4|NOT COMPLETED|Overall Study||9
959539|NCT00168454|2320946|P3|NOT COMPLETED|Overall Study||6
959540|NCT00168454|2320947|P2|NOT COMPLETED|Overall Study||7
959541|NCT00168454|2320948|P1|NOT COMPLETED|Overall Study||7
959542|NCT00168454|2320943|P6|COMPLETED|Overall Study||50
959543|NCT00168454|2320944|P5|COMPLETED|Overall Study||47
959544|NCT00168454|2320945|P4|COMPLETED|Overall Study||40
959545|NCT00168454|2320946|P3|COMPLETED|Overall Study||48
959546|NCT00168454|2320947|P2|COMPLETED|Overall Study||50
959547|NCT00168454|2320948|P1|COMPLETED|Overall Study||37
959548|NCT00168454|2320943|P6|STARTED|Overall Study||56
959549|NCT00168454|2320944|P5|STARTED|Overall Study||53
959550|NCT00168454|2320945|P4|STARTED|Overall Study||49
959551|NCT00168454|2320946|P3|STARTED|Overall Study||54
959552|NCT00168454|2320947|P2|STARTED|Overall Study||57
959553|NCT00168454|2320948|P1|STARTED|Overall Study||44
959554|NCT00168805|2320995|P3|NOT COMPLETED|Treatment||62
959555|NCT00168805|2320996|P2|NOT COMPLETED|Treatment||56
959556|NCT00168805|2320997|P1|NOT COMPLETED|Treatment||49
959557|NCT00168805|2320995|P3|COMPLETED|Treatment||632
959558|NCT00168805|2320996|P2|COMPLETED|Treatment||647
959559|NCT00168805|2320997|P1|COMPLETED|Treatment||630
959560|NCT00168805|2320995|P3|STARTED|Treatment||694
959561|NCT00168805|2320996|P2|STARTED|Treatment||703
959562|NCT00168805|2320997|P1|STARTED|Treatment||679
959563|NCT00168805|2320995|P3|NOT COMPLETED|Overall Study||78
959564|NCT00168805|2320996|P2|NOT COMPLETED|Overall Study||78
959565|NCT00168805|2320997|P1|NOT COMPLETED|Overall Study||71
959566|NCT00168805|2320995|P3|COMPLETED|Overall Study||616
959567|NCT00168805|2320996|P2|COMPLETED|Overall Study||625
959568|NCT00168805|2320997|P1|COMPLETED|Overall Study||608
959569|NCT00168805|2320995|P3|STARTED|Overall Study||694
959570|NCT00168805|2320996|P2|STARTED|Overall Study||703
959571|NCT00168805|2320997|P1|STARTED|Overall Study||679
959572|NCT00168818|2321041|P3|NOT COMPLETED|Treatment||133
959573|NCT00168818|2321042|P2|NOT COMPLETED|Treatment||151
959574|NCT00168818|2321043|P1|NOT COMPLETED|Treatment||133
959575|NCT00168818|2321041|P3|COMPLETED|Treatment||1021
959576|NCT00168818|2321042|P2|COMPLETED|Treatment||1012
959577|NCT00168818|2321043|P1|COMPLETED|Treatment||1013
959578|NCT00168818|2321041|P3|STARTED|Treatment||1154
959579|NCT00168818|2321042|P2|STARTED|Treatment||1163
959580|NCT00168818|2321043|P1|STARTED|Treatment||1146
959581|NCT00168818|2321041|P3|NOT COMPLETED|Overall Study||124
959582|NCT00168818|2321042|P2|NOT COMPLETED|Overall Study||109
959583|NCT00168818|2321043|P1|NOT COMPLETED|Overall Study||117
959584|NCT00168818|2321041|P3|COMPLETED|Overall Study||1030
959585|NCT00168818|2321042|P2|COMPLETED|Overall Study||1054
959586|NCT00168818|2321043|P1|COMPLETED|Overall Study||1029
959587|NCT00168818|2321041|P3|STARTED|Overall Study||1154
959588|NCT00168818|2321042|P2|STARTED|Overall Study||1163
959589|NCT00168818|2321043|P1|STARTED|Overall Study||1146
959590|NCT00168831|2321087|P3|NOT COMPLETED|Overall Study||114
959591|NCT00168831|2321088|P2|NOT COMPLETED|Overall Study||81
959592|NCT00168831|2321089|P1|NOT COMPLETED|Overall Study||60
959593|NCT00168831|2321087|P3|COMPLETED|Overall Study||220
959594|NCT00168831|2321088|P2|COMPLETED|Overall Study||254
959595|NCT00168831|2321089|P1|COMPLETED|Overall Study||278
959596|NCT00168831|2321087|P3|STARTED|Overall Study||334
959597|NCT00168831|2321088|P2|STARTED|Overall Study||335
959598|NCT00168831|2321089|P1|STARTED|Overall Study||338
959599|NCT00168844|2321271|P3|NOT COMPLETED|Overall Study||91
959600|NCT00168844|2321272|P2|NOT COMPLETED|Overall Study||55
959601|NCT00168844|2321273|P1|NOT COMPLETED|Overall Study||55
959602|NCT00168844|2321271|P3|COMPLETED|Overall Study||228
959603|NCT00168844|2321272|P2|COMPLETED|Overall Study||277
959604|NCT00168844|2321273|P1|COMPLETED|Overall Study||277
959605|NCT00168844|2321271|P3|STARTED|Overall Study||319
959606|NCT00168844|2321272|P2|STARTED|Overall Study||332
959607|NCT00168844|2321273|P1|STARTED|Overall Study||332
959608|NCT00169442|2321458|P6|NOT COMPLETED|Overall Study||2
959609|NCT00169442|2321459|P5|NOT COMPLETED|Overall Study||1
959610|NCT00169442|2321460|P4|NOT COMPLETED|Overall Study||0
959611|NCT00169442|2321461|P3|NOT COMPLETED|Overall Study||1
959612|NCT00169442|2321462|P2|NOT COMPLETED|Overall Study||1
959613|NCT00169442|2321463|P1|NOT COMPLETED|Overall Study||0
959614|NCT00169442|2321458|P6|COMPLETED|Overall Study||41
959615|NCT00169442|2321459|P5|COMPLETED|Overall Study||41
959616|NCT00169442|2321460|P4|COMPLETED|Overall Study||250
959617|NCT00169442|2321461|P3|COMPLETED|Overall Study||166
959618|NCT00169442|2321462|P2|COMPLETED|Overall Study||123
959619|NCT00169442|2321463|P1|COMPLETED|Overall Study||119
959620|NCT00169442|2321458|P6|STARTED|Overall Study||43
959621|NCT00169442|2321459|P5|STARTED|Overall Study||42
959622|NCT00169442|2321460|P4|STARTED|Overall Study||250
959623|NCT00169442|2321461|P3|STARTED|Overall Study||167
959624|NCT00169442|2321462|P2|STARTED|Overall Study||124
959625|NCT00169442|2321463|P1|STARTED|Overall Study||119
959626|NCT00170157|2321570|P2|NOT COMPLETED|Treatment Period 2 Crossover||0
959627|NCT00170157|2321571|P1|NOT COMPLETED|Treatment Period 2 Crossover||0
959628|NCT00170157|2321570|P2|COMPLETED|Treatment Period 2 Crossover||41
959629|NCT00170157|2321571|P1|COMPLETED|Treatment Period 2 Crossover||0
959630|NCT00170157|2321570|P2|STARTED|Treatment Period 2 Crossover||41
959631|NCT00170157|2321571|P1|STARTED|Treatment Period 2 Crossover|Participants initially randomized to this arm were not eligible for crossover.|0
959632|NCT00170157|2321570|P2|NOT COMPLETED|Washout Period of 14 Days||17
959633|NCT00170157|2321571|P1|NOT COMPLETED|Washout Period of 14 Days||0
959634|NCT00170157|2321570|P2|COMPLETED|Washout Period of 14 Days||41
959635|NCT00170157|2321571|P1|COMPLETED|Washout Period of 14 Days||0
959636|NCT00170157|2321570|P2|STARTED|Washout Period of 14 Days||58
959637|NCT00170157|2321571|P1|STARTED|Washout Period of 14 Days|Participants initially randomized to this arm were not eligible for crossover.|0
959638|NCT00170157|2321570|P2|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
959639|NCT00170157|2321571|P1|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
959640|NCT00170157|2321570|P2|COMPLETED|Treatment Period 1 Initial Randomization||58
959641|NCT00170157|2321571|P1|COMPLETED|Treatment Period 1 Initial Randomization||54
959642|NCT00170157|2321570|P2|STARTED|Treatment Period 1 Initial Randomization||58
959643|NCT00170157|2321571|P1|STARTED|Treatment Period 1 Initial Randomization||54
959644|NCT00163189|2321577|P1|NOT COMPLETED|Overall Study||63
959645|NCT00163189|2321577|P1|COMPLETED|Overall Study||35
959646|NCT00163189|2321577|P1|STARTED|Overall Study||98
959647|NCT00163215|2321599|P1|NOT COMPLETED|Overall Study||15
959648|NCT00163215|2321599|P1|COMPLETED|Overall Study||31
959649|NCT00163215|2321599|P1|STARTED|Overall Study||46
959659|NCT00171704|2321700|P2|NOT COMPLETED|Overall Study||49
959660|NCT00171704|2321701|P1|NOT COMPLETED|Overall Study||44
959661|NCT00171704|2321700|P2|COMPLETED|Overall Study||81
959662|NCT00171704|2321701|P1|COMPLETED|Overall Study||89
959663|NCT00171704|2321700|P2|STARTED|Overall Study||130
959664|NCT00171704|2321701|P1|STARTED|Overall Study||133
959665|NCT00171834|2321728|P7|NOT COMPLETED|Overall Study||4
959666|NCT00171834|2321729|P6|NOT COMPLETED|Overall Study||35
959667|NCT00171834|2321730|P5|NOT COMPLETED|Overall Study||8
959668|NCT00171834|2321731|P4|NOT COMPLETED|Overall Study||12
959669|NCT00171834|2321732|P3|NOT COMPLETED|Overall Study||12
959670|NCT00171834|2321733|P2|NOT COMPLETED|Overall Study||12
959671|NCT00171834|2321734|P1|NOT COMPLETED|Overall Study||6
959672|NCT00171834|2321728|P7|COMPLETED|Overall Study||0
959673|NCT00171834|2321729|P6|COMPLETED|Overall Study||0
959674|NCT00171834|2321730|P5|COMPLETED|Overall Study||0
959675|NCT00171834|2321731|P4|COMPLETED|Overall Study||0
959676|NCT00171834|2321732|P3|COMPLETED|Overall Study||0
959677|NCT00171834|2321733|P2|COMPLETED|Overall Study||0
959678|NCT00171834|2321734|P1|COMPLETED|Overall Study||0
959679|NCT00171834|2321728|P7|Completed 6 Cycles of Treatment|Overall Study||0
959680|NCT00171834|2321729|P6|Completed 6 Cycles of Treatment|Overall Study||1
959681|NCT00171834|2321730|P5|Completed 6 Cycles of Treatment|Overall Study||2
959682|NCT00171834|2321731|P4|Completed 6 Cycles of Treatment|Overall Study||0
959683|NCT00171834|2321732|P3|Completed 6 Cycles of Treatment|Overall Study||1
959684|NCT00171834|2321733|P2|Completed 6 Cycles of Treatment|Overall Study||0
959685|NCT00171834|2321734|P1|Completed 6 Cycles of Treatment|Overall Study||0
959686|NCT00171834|2321728|P7|STARTED|Overall Study||4
959687|NCT00171834|2321729|P6|STARTED|Overall Study||35
959688|NCT00171834|2321730|P5|STARTED|Overall Study||8
959689|NCT00171834|2321731|P4|STARTED|Overall Study||12
959690|NCT00171834|2321732|P3|STARTED|Overall Study||12
959691|NCT00171834|2321733|P2|STARTED|Overall Study||12
959692|NCT00171834|2321734|P1|STARTED|Overall Study||6
959693|NCT00171873|2321774|P2|NOT COMPLETED|Overall Study||3
959694|NCT00171873|2321775|P1|NOT COMPLETED|Overall Study||9
959695|NCT00171873|2321774|P2|COMPLETED|Overall Study||40
959696|NCT00171873|2321775|P1|COMPLETED|Overall Study||33
959697|NCT00171873|2321774|P2|STARTED|Overall Study||43
959698|NCT00171873|2321775|P1|STARTED|Overall Study||42
959699|NCT00171925|2321783|P2|NOT COMPLETED|Overall Study||31
959700|NCT00171925|2321784|P1|NOT COMPLETED|Overall Study||30
959701|NCT00171925|2321783|P2|COMPLETED|Overall Study||40
959702|NCT00171925|2321784|P1|COMPLETED|Overall Study||42
959703|NCT00171925|2321783|P2|STARTED|Overall Study||71
959704|NCT00171925|2321784|P1|STARTED|Overall Study||72
959705|NCT00172042|2321796|P2|NOT COMPLETED|Overall Study||125
959706|NCT00172042|2321797|P1|NOT COMPLETED|Overall Study||158
959707|NCT00172042|2321796|P2|COMPLETED|Overall Study||86
959708|NCT00172042|2321797|P1|COMPLETED|Overall Study||68
959709|NCT00172042|2321796|P2|STARTED|Overall Study||211
959710|NCT00172042|2321797|P1|STARTED|Overall Study||226
959711|NCT00172185|2321821|P4|NOT COMPLETED|Overall Study||4
959712|NCT00172185|2321822|P3|NOT COMPLETED|Overall Study||5
959713|NCT00172185|2321823|P2|NOT COMPLETED|Overall Study||2
959714|NCT00172185|2321824|P1|NOT COMPLETED|Overall Study||0
959715|NCT00172185|2321821|P4|COMPLETED|Overall Study||23
959716|NCT00172185|2321822|P3|COMPLETED|Overall Study||20
959717|NCT00172185|2321823|P2|COMPLETED|Overall Study||5
959718|NCT00172185|2321824|P1|COMPLETED|Overall Study||6
959719|NCT00172185|2321821|P4|STARTED|Overall Study||27
959720|NCT00172185|2321822|P3|STARTED|Overall Study||25
959721|NCT00172185|2321823|P2|STARTED|Overall Study||7
959722|NCT00172185|2321824|P1|STARTED|Overall Study||6
959723|NCT00166361|2321840|P2|NOT COMPLETED|Overall Study||0
959724|NCT00166361|2321841|P1|NOT COMPLETED|Overall Study||0
959725|NCT00166361|2321840|P2|COMPLETED|Overall Study||10
959726|NCT00166361|2321841|P1|COMPLETED|Overall Study||14
959727|NCT00166361|2321840|P2|STARTED|Overall Study||10
959728|NCT00166361|2321841|P1|STARTED|Overall Study||14
959729|NCT00166504|2321849|P2|NOT COMPLETED|Overall Study||4
959730|NCT00166504|2321850|P1|NOT COMPLETED|Overall Study||5
959731|NCT00166504|2321849|P2|COMPLETED|Overall Study||91
959732|NCT00166504|2321850|P1|COMPLETED|Overall Study||103
959733|NCT00166504|2321849|P2|STARTED|Overall Study||95
959734|NCT00166504|2321850|P1|STARTED|Overall Study||108
959735|NCT00166517|2321858|P2|NOT COMPLETED|Overall Study||2
959736|NCT00166517|2321859|P1|NOT COMPLETED|Overall Study||5
959737|NCT00166517|2321858|P2|COMPLETED|Overall Study||61
959738|NCT00166517|2321859|P1|COMPLETED|Overall Study||110
959739|NCT00166517|2321858|P2|Vaccinated at Visit 3|Overall Study||61
959740|NCT00166517|2321859|P1|Vaccinated at Visit 3|Overall Study||110
959741|NCT00166517|2321858|P2|Vaccinated at Visit 2|Overall Study||61
959742|NCT00166517|2321859|P1|Vaccinated at Visit 2|Overall Study||112
959743|NCT00166517|2321858|P2|Vaccinated at Visit 1|Overall Study||63
959744|NCT00166517|2321859|P1|Vaccinated at Visit 1|Overall Study||115
959745|NCT00166517|2321858|P2|STARTED|Overall Study||63
959746|NCT00166517|2321859|P1|STARTED|Overall Study||115
959747|NCT00166712|2321869|P2|NOT COMPLETED|Overall Study||5
959748|NCT00166712|2321870|P1|NOT COMPLETED|Overall Study||2
959749|NCT00166712|2321869|P2|COMPLETED|Overall Study|Completed study participation.|11
959750|NCT00166712|2321870|P1|COMPLETED|Overall Study|Completed study participation.|22
959751|NCT00166712|2321869|P2|Phase 3|Overall Study|# weaned off Sirolimus at 12 months post-transplant.|0
959752|NCT00166712|2321870|P1|Phase 3|Overall Study|Subjects from Phase 2b who were weaned off Sirolimus @ 12 months post-transplant.|0
959753|NCT00166712|2321869|P2|Phase 2b|Overall Study|Subjects weaned off Sirolimus|0
959754|NCT00166712|2321870|P1|Phase 2b|Overall Study|Subjects converted to Sirolimus post-transplant.|3
959755|NCT00166712|2321869|P2|Phase 2a|Overall Study|Subject who remained on Sirolimus at 6 months post-transplant.|12
959756|NCT00166712|2321870|P1|Phase 2a|Overall Study|Subjects who remained on Prograf at 6mo post-transplant.|19
959757|NCT00166712|2321869|P2|Phase 1|Overall Study|Evaluated at 6 month post-transplant to potentially be weaned off Sirolimus.|12
959758|NCT00166712|2321870|P1|Phase 1|Overall Study|Evaluated for rejection at 6months post-transplant|22
959759|NCT00166712|2321869|P2|STARTED|Overall Study|Consented: Randomized-Group 2. Given Sirolimus & MMF prior to surgery, Alemtuzumab day of surgery.|16
959760|NCT00166712|2321870|P1|STARTED|Overall Study|Consented:Randomized-Group 1. Given MMF prior to surgery, Alemtuzumab & TAC (Prograf) day of surgery|24
959761|NCT00167102|2321887|P2|NOT COMPLETED|Overall Study||0
959762|NCT00167102|2321888|P1|NOT COMPLETED|Overall Study||0
959763|NCT00167102|2321887|P2|COMPLETED|Overall Study||22
959764|NCT00167102|2321888|P1|COMPLETED|Overall Study||23
959765|NCT00167102|2321887|P2|STARTED|Overall Study||22
959766|NCT00167102|2321888|P1|STARTED|Overall Study||23
959767|NCT00167180|2321898|P2|NOT COMPLETED|Overall Study||0
959768|NCT00167180|2321899|P1|NOT COMPLETED|Overall Study||0
959769|NCT00167180|2321898|P2|COMPLETED|Overall Study||57
959770|NCT00167180|2321899|P1|COMPLETED|Overall Study||0
959771|NCT00167180|2321898|P2|STARTED|Overall Study||57
959772|NCT00167180|2321899|P1|STARTED|Overall Study||0
959773|NCT00167206|2321913|P1|NOT COMPLETED|Overall Study||0
959774|NCT00167206|2321913|P1|COMPLETED|Overall Study||16
959775|NCT00167206|2321913|P1|STARTED|Overall Study||16
959776|NCT00167245|2321927|P2|NOT COMPLETED|Overall Study||41
959777|NCT00167245|2321928|P1|NOT COMPLETED|Overall Study||29
959778|NCT00167245|2321927|P2|COMPLETED|Overall Study||46
959779|NCT00167245|2321928|P1|COMPLETED|Overall Study||54
959780|NCT00167245|2321927|P2|STARTED|Overall Study||87
959781|NCT00167245|2321928|P1|STARTED|Overall Study||83
959782|NCT00167310|2321938|P2|NOT COMPLETED|Overall Study||10
959783|NCT00167310|2321939|P1|NOT COMPLETED|Overall Study||8
959784|NCT00167310|2321938|P2|COMPLETED|Overall Study||18
959785|NCT00167310|2321939|P1|COMPLETED|Overall Study||21
959786|NCT00167310|2321938|P2|STARTED|Overall Study||28
959787|NCT00167310|2321939|P1|STARTED|Overall Study||29
959788|NCT00167388|2321951|P4|NOT COMPLETED|Overall Study||0
959789|NCT00167388|2321952|P3|NOT COMPLETED|Overall Study||0
959790|NCT00167388|2321953|P2|NOT COMPLETED|Overall Study||0
959791|NCT00167388|2321954|P1|NOT COMPLETED|Overall Study||0
959792|NCT00167388|2321951|P4|COMPLETED|Overall Study||6
959793|NCT00167388|2321952|P3|COMPLETED|Overall Study||6
959794|NCT00167388|2321953|P2|COMPLETED|Overall Study||5
959795|NCT00167388|2321954|P1|COMPLETED|Overall Study||5
959796|NCT00167388|2321951|P4|Completed Doppler Study|Overall Study||6
959797|NCT00167388|2321952|P3|Completed Doppler Study|Overall Study||6
959798|NCT00167388|2321953|P2|Completed Doppler Study|Overall Study||5
959799|NCT00167388|2321954|P1|Completed Doppler Study|Overall Study||5
959800|NCT00167388|2321951|P4|STARTED|Overall Study||6
959801|NCT00167388|2321952|P3|STARTED|Overall Study||6
959802|NCT00167388|2321953|P2|STARTED|Overall Study||5
959803|NCT00167388|2321954|P1|STARTED|Overall Study||5
959804|NCT00167544|2321964|P2|NOT COMPLETED|Overall Study||0
959805|NCT00167544|2321965|P1|NOT COMPLETED|Overall Study||1
959806|NCT00167544|2321964|P2|COMPLETED|Overall Study||33
959807|NCT00167544|2321965|P1|COMPLETED|Overall Study||30
959808|NCT00167544|2321964|P2|STARTED|Overall Study||33
959809|NCT00167544|2321965|P1|STARTED|Overall Study||31
959810|NCT00174187|2321981|P3|NOT COMPLETED|Period 2 (After 3 Years)||8
959811|NCT00174187|2321982|P2|NOT COMPLETED|Period 2 (After 3 Years)||0
959812|NCT00174187|2321983|P1|NOT COMPLETED|Period 2 (After 3 Years)||0
959813|NCT00174187|2321981|P3|COMPLETED|Period 2 (After 3 Years)||13
959814|NCT00174187|2321982|P2|COMPLETED|Period 2 (After 3 Years)||0
959815|NCT00174187|2321983|P1|COMPLETED|Period 2 (After 3 Years)||0
959816|NCT00174187|2321981|P3|STARTED|Period 2 (After 3 Years)||21
959817|NCT00174187|2321982|P2|STARTED|Period 2 (After 3 Years)||0
959818|NCT00174187|2321983|P1|STARTED|Period 2 (After 3 Years)||0
959819|NCT00174187|2321981|P3|NOT COMPLETED|Between Period 1 and Period 2||5
959820|NCT00174187|2321982|P2|NOT COMPLETED|Between Period 1 and Period 2||0
959821|NCT00174187|2321983|P1|NOT COMPLETED|Between Period 1 and Period 2||0
959822|NCT00174187|2321981|P3|COMPLETED|Between Period 1 and Period 2||21
959823|NCT00174187|2321982|P2|COMPLETED|Between Period 1 and Period 2||0
959824|NCT00174187|2321983|P1|COMPLETED|Between Period 1 and Period 2||0
959825|NCT00174187|2321981|P3|Consented|Between Period 1 and Period 2||24
959826|NCT00174187|2321982|P2|Consented|Between Period 1 and Period 2||0
959827|NCT00174187|2321983|P1|Consented|Between Period 1 and Period 2||0
959828|NCT00174187|2321981|P3|STARTED|Between Period 1 and Period 2||26
959829|NCT00174187|2321982|P2|STARTED|Between Period 1 and Period 2||0
959830|NCT00174187|2321983|P1|STARTED|Between Period 1 and Period 2||0
959831|NCT00174187|2321981|P3|NOT COMPLETED|Period 1 (up to 3 Years)||0
959832|NCT00174187|2321982|P2|NOT COMPLETED|Period 1 (up to 3 Years)||4
959833|NCT00174187|2321983|P1|NOT COMPLETED|Period 1 (up to 3 Years)||0
959834|NCT00174187|2321981|P3|COMPLETED|Period 1 (up to 3 Years)||0
959835|NCT00174187|2321982|P2|COMPLETED|Period 1 (up to 3 Years)||11
959836|NCT00174187|2321983|P1|COMPLETED|Period 1 (up to 3 Years)||15
959837|NCT00174187|2321981|P3|STARTED|Period 1 (up to 3 Years)||0
959838|NCT00174187|2321982|P2|STARTED|Period 1 (up to 3 Years)||15
959839|NCT00174187|2321983|P1|STARTED|Period 1 (up to 3 Years)||15
959840|NCT00174252|2322044|P1|NOT COMPLETED|Overall Study||2
959841|NCT00174252|2322044|P1|COMPLETED|Overall Study||55
959842|NCT00174252|2322044|P1|STARTED|Overall Study||57
959843|NCT00174265|2322079|P2|NOT COMPLETED|Overall Study||21
959844|NCT00174265|2322080|P1|NOT COMPLETED|Overall Study||29
959845|NCT00174265|2322079|P2|COMPLETED|Overall Study||89
959846|NCT00174265|2322080|P1|COMPLETED|Overall Study||57
959847|NCT00174265|2322079|P2|STARTED|Overall Study||110
959848|NCT00174265|2322080|P1|STARTED|Overall Study|85 participants received randomized treatment assignment and at least one dose of study medication.|86
959849|NCT00174291|2322090|P2|NOT COMPLETED|Overall Study||6
959850|NCT00174291|2322091|P1|NOT COMPLETED|Overall Study||5
959851|NCT00174291|2322090|P2|COMPLETED|Overall Study||4
959852|NCT00174291|2322091|P1|COMPLETED|Overall Study||6
959853|NCT00174291|2322090|P2|STARTED|Overall Study||10
959854|NCT00174291|2322091|P1|STARTED|Overall Study||11
959855|NCT00175877|2322119|P1|NOT COMPLETED|Overall Study||349
959856|NCT00175877|2322119|P1|COMPLETED|Overall Study||497
959857|NCT00175877|2322119|P1|STARTED|Overall Study||846
959858|NCT00176202|2322152|P2|NOT COMPLETED|Overall Study||16
959859|NCT00176202|2322153|P1|NOT COMPLETED|Overall Study||5
959860|NCT00176202|2322152|P2|COMPLETED|Overall Study||17
959861|NCT00176202|2322153|P1|COMPLETED|Overall Study||27
959862|NCT00176202|2322152|P2|STARTED|Overall Study||33
959863|NCT00176202|2322153|P1|STARTED|Overall Study||32
959864|NCT00176228|2322165|P1|NOT COMPLETED|Overall Study||2
959865|NCT00176228|2322165|P1|COMPLETED|Overall Study|Study ended|46
959866|NCT00176228|2322165|P1|STARTED|Overall Study|When study began|48
959867|NCT00176254|2322170|P1|NOT COMPLETED|Overall Study||1
959868|NCT00176254|2322170|P1|COMPLETED|Overall Study|1 patient only received 1 cycle and refused further induction, another progressed in neck nodes|39
959869|NCT00176254|2322170|P1|STARTED|Overall Study||40
959870|NCT00176306|2322178|P1|NOT COMPLETED|Overall Study||0
959871|NCT00176306|2322178|P1|COMPLETED|Overall Study||15
959872|NCT00176306|2322178|P1|STARTED|Overall Study||15
959873|NCT00176436|2322184|P2|NOT COMPLETED|Overall Study||5
959874|NCT00176436|2322185|P1|NOT COMPLETED|Overall Study||6
959875|NCT00176436|2322184|P2|COMPLETED|Overall Study||12
959876|NCT00176436|2322185|P1|COMPLETED|Overall Study||14
959877|NCT00176436|2322184|P2|STARTED|Overall Study||17
959878|NCT00176436|2322185|P1|STARTED|Overall Study||20
959879|NCT00176462|2322193|P2|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
959880|NCT00176462|2322194|P1|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
959881|NCT00176462|2322193|P2|COMPLETED|Continuation -up to 30mos Post Remission||26
959882|NCT00176462|2322194|P1|COMPLETED|Continuation -up to 30mos Post Remission||19
959883|NCT00176462|2322193|P2|STARTED|Continuation -up to 30mos Post Remission||26
959884|NCT00176462|2322194|P1|STARTED|Continuation -up to 30mos Post Remission||19
959885|NCT00176462|2322193|P2|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||3
959886|NCT00176462|2322194|P1|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||1
959887|NCT00176462|2322193|P2|COMPLETED|Intensive Continuation (8X8-week Cycles)||26
959888|NCT00176462|2322194|P1|COMPLETED|Intensive Continuation (8X8-week Cycles)||19
959889|NCT00176462|2322193|P2|STARTED|Intensive Continuation (8X8-week Cycles)||29
959890|NCT00176462|2322194|P1|STARTED|Intensive Continuation (8X8-week Cycles)||20
959891|NCT00176462|2322193|P2|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
959892|NCT00176462|2322194|P1|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
959893|NCT00176462|2322193|P2|COMPLETED|Delayed Intensification (8 Weeks)||29
959894|NCT00176462|2322194|P1|COMPLETED|Delayed Intensification (8 Weeks)||20
959895|NCT00176462|2322193|P2|STARTED|Delayed Intensification (8 Weeks)||29
959896|NCT00176462|2322194|P1|STARTED|Delayed Intensification (8 Weeks)||20
959897|NCT00176462|2322193|P2|NOT COMPLETED|Consolidation (12 Weeks)||5
959898|NCT00176462|2322194|P1|NOT COMPLETED|Consolidation (12 Weeks)||0
959899|NCT00176462|2322193|P2|COMPLETED|Consolidation (12 Weeks)||29
959900|NCT00176462|2322194|P1|COMPLETED|Consolidation (12 Weeks)||20
959901|NCT00176462|2322193|P2|STARTED|Consolidation (12 Weeks)||34
959902|NCT00176462|2322194|P1|STARTED|Consolidation (12 Weeks)||20
959903|NCT00176462|2322193|P2|NOT COMPLETED|Induction (4 Weeks)||5
959904|NCT00176462|2322194|P1|NOT COMPLETED|Induction (4 Weeks)||1
959905|NCT00176462|2322193|P2|COMPLETED|Induction (4 Weeks)||34
959906|NCT00176462|2322194|P1|COMPLETED|Induction (4 Weeks)||20
959907|NCT00176462|2322193|P2|STARTED|Induction (4 Weeks)||39
959908|NCT00176462|2322194|P1|STARTED|Induction (4 Weeks)||21
959909|NCT00176488|2322201|P1|NOT COMPLETED|Overall Study||1
959910|NCT00176488|2322201|P1|COMPLETED|Overall Study||30
959911|NCT00176488|2322201|P1|STARTED|Overall Study||31
959912|NCT00176501|2322207|P1|NOT COMPLETED|Overall Study||0
959913|NCT00176501|2322207|P1|COMPLETED|Overall Study||3
959914|NCT00176501|2322207|P1|STARTED|Overall Study||3
959915|NCT00176605|2322213|P1|NOT COMPLETED|Overall Study||2
959916|NCT00176605|2322213|P1|COMPLETED|Overall Study||13
959917|NCT00176605|2322213|P1|STARTED|Overall Study||15
959918|NCT00176631|2322218|P1|NOT COMPLETED|Overall Study||0
959919|NCT00176631|2322218|P1|COMPLETED|Overall Study||10
959920|NCT00176631|2322218|P1|STARTED|Overall Study||10
959921|NCT00176644|2322223|P1|NOT COMPLETED|Overall Study||1
959922|NCT00176644|2322223|P1|COMPLETED|Overall Study||22
959923|NCT00176644|2322223|P1|STARTED|Overall Study||23
959924|NCT00176800|2322231|P1|NOT COMPLETED|Overall Study||0
959925|NCT00176800|2322231|P1|COMPLETED|Overall Study||69
959926|NCT00176800|2322231|P1|STARTED|Overall Study||69
959927|NCT00176826|2322237|P1|NOT COMPLETED|Overall Study||0
959928|NCT00176826|2322237|P1|COMPLETED|Overall Study||22
959929|NCT00176826|2322237|P1|STARTED|Overall Study||22
959930|NCT00176839|2322247|P1|NOT COMPLETED|Overall Study||0
959931|NCT00176839|2322247|P1|COMPLETED|Overall Study||11
959932|NCT00176839|2322247|P1|STARTED|Overall Study||11
959933|NCT00176852|2322259|P3|NOT COMPLETED|Overall Study||0
959934|NCT00176852|2322260|P2|NOT COMPLETED|Overall Study||0
959935|NCT00176852|2322261|P1|NOT COMPLETED|Overall Study||0
959936|NCT00176852|2322259|P3|COMPLETED|Overall Study||14
959937|NCT00176852|2322260|P2|COMPLETED|Overall Study||5
959938|NCT00176852|2322261|P1|COMPLETED|Overall Study||3
959939|NCT00176852|2322259|P3|STARTED|Overall Study||14
959940|NCT00176852|2322260|P2|STARTED|Overall Study||5
959941|NCT00176852|2322261|P1|STARTED|Overall Study||3
959942|NCT00176865|2322323|P3|NOT COMPLETED|Overall Study||0
959943|NCT00176865|2322324|P2|NOT COMPLETED|Overall Study||0
959944|NCT00176865|2322325|P1|NOT COMPLETED|Overall Study||0
959945|NCT00176865|2322323|P3|COMPLETED|Overall Study||6
959946|NCT00176865|2322324|P2|COMPLETED|Overall Study||10
959947|NCT00176865|2322325|P1|COMPLETED|Overall Study||3
959948|NCT00176865|2322323|P3|STARTED|Overall Study||6
959949|NCT00176865|2322324|P2|STARTED|Overall Study||10
959950|NCT00176865|2322325|P1|STARTED|Overall Study||3
959951|NCT00176878|2322360|P1|NOT COMPLETED|Overall Study||0
959952|NCT00176878|2322360|P1|COMPLETED|Overall Study||10
959953|NCT00176878|2322360|P1|STARTED|Overall Study||10
959954|NCT00176904|2322369|P1|NOT COMPLETED|Overall Study||0
959955|NCT00176904|2322369|P1|COMPLETED|Overall Study||135
959956|NCT00176904|2322369|P1|STARTED|Overall Study||135
959957|NCT00176917|2322377|P1|NOT COMPLETED|Overall Study||0
959958|NCT00176917|2322377|P1|COMPLETED|Overall Study||41
959959|NCT00176917|2322377|P1|STARTED|Overall Study||41
959960|NCT00177164|2322386|P2|NOT COMPLETED|Overall Study||16
959961|NCT00177164|2322387|P1|NOT COMPLETED|Overall Study||9
959962|NCT00177164|2322386|P2|COMPLETED|Overall Study||9
959963|NCT00177164|2322387|P1|COMPLETED|Overall Study||14
959964|NCT00177164|2322386|P2|STARTED|Overall Study||25
959965|NCT00177164|2322387|P1|STARTED|Overall Study||23
959966|NCT00177216|2322402|P3|NOT COMPLETED|Overall Study||1
959967|NCT00177216|2322403|P2|NOT COMPLETED|Overall Study||3
959968|NCT00177216|2322404|P1|NOT COMPLETED|Overall Study||6
959969|NCT00177216|2322402|P3|COMPLETED|Overall Study||19
959970|NCT00177216|2322403|P2|COMPLETED|Overall Study||20
959971|NCT00177216|2322404|P1|COMPLETED|Overall Study||20
959972|NCT00177216|2322402|P3|STARTED|Overall Study||20
959973|NCT00177216|2322403|P2|STARTED|Overall Study||23
959974|NCT00177216|2322404|P1|STARTED|Overall Study||26
959975|NCT00177255|2322418|P1|NOT COMPLETED|Overall Study||0
959976|NCT00177255|2322418|P1|COMPLETED|Overall Study||39
959977|NCT00177255|2322418|P1|STARTED|Overall Study||39
959978|NCT00177294|2322425|P2|NOT COMPLETED|Overall Study||5
959979|NCT00177294|2322426|P1|NOT COMPLETED|Overall Study||7
959980|NCT00177294|2322425|P2|COMPLETED|Overall Study||59
959981|NCT00177294|2322426|P1|COMPLETED|Overall Study||53
959982|NCT00177294|2322425|P2|STARTED|Overall Study||64
959983|NCT00177294|2322426|P1|STARTED|Overall Study||60
959984|NCT00177307|2322432|P1|NOT COMPLETED|Overall Study||1
959985|NCT00177307|2322432|P1|COMPLETED|Overall Study||39
959986|NCT00177307|2322432|P1|STARTED|Overall Study||40
959987|NCT00177671|2322441|P2|NOT COMPLETED|Overall Study||14
959988|NCT00177671|2322442|P1|NOT COMPLETED|Overall Study||25
959989|NCT00177671|2322441|P2|COMPLETED|Overall Study||49
959990|NCT00177671|2322442|P1|COMPLETED|Overall Study||42
959991|NCT00177671|2322441|P2|Month 24|Overall Study||49
959992|NCT00177671|2322442|P1|Month 24|Overall Study||42
959993|NCT00177671|2322441|P2|Month 12|Overall Study||57
959994|NCT00177671|2322442|P1|Month 12|Overall Study||45
959995|NCT00177671|2322441|P2|STARTED|Overall Study||63
959996|NCT00177671|2322442|P1|STARTED|Overall Study||67
959997|NCT00177866|2322456|P2|NOT COMPLETED|Overall Study||0
959998|NCT00177866|2322457|P1|NOT COMPLETED|Overall Study||0
959999|NCT00177866|2322456|P2|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
960000|NCT00177866|2322457|P1|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
960001|NCT00177866|2322456|P2|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
960002|NCT00177866|2322457|P1|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
960003|NCT00177970|2322467|P2|NOT COMPLETED|Overall Study||0
960004|NCT00177970|2322468|P1|NOT COMPLETED|Overall Study||0
960005|NCT00177970|2322467|P2|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
960006|NCT00177970|2322468|P1|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
960007|NCT00177970|2322467|P2|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
960008|NCT00177970|2322468|P1|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
960009|NCT00178126|2322490|P2|NOT COMPLETED|Overall Study||27
960010|NCT00178126|2322491|P1|NOT COMPLETED|Overall Study||25
960011|NCT00178126|2322490|P2|COMPLETED|Overall Study||86
960012|NCT00178126|2322491|P1|COMPLETED|Overall Study||94
960013|NCT00178126|2322490|P2|STARTED|Overall Study||113
960014|NCT00178126|2322491|P1|STARTED|Overall Study||119
960015|NCT00178178|2322501|P4|NOT COMPLETED|Overall Study||0
960016|NCT00178178|2322502|P3|NOT COMPLETED|Overall Study||0
960017|NCT00178178|2322503|P2|NOT COMPLETED|Overall Study||0
960018|NCT00178178|2322504|P1|NOT COMPLETED|Overall Study||0
960019|NCT00178178|2322501|P4|COMPLETED|Overall Study||24
960020|NCT00178178|2322502|P3|COMPLETED|Overall Study||24
960021|NCT00178178|2322503|P2|COMPLETED|Overall Study||24
960022|NCT00178178|2322504|P1|COMPLETED|Overall Study||24
960023|NCT00178178|2322501|P4|STARTED|Overall Study||24
960024|NCT00178178|2322502|P3|STARTED|Overall Study||24
960025|NCT00178178|2322503|P2|STARTED|Overall Study||24
960026|NCT00178178|2322504|P1|STARTED|Overall Study||24
960027|NCT00178191|2322517|P3|NOT COMPLETED|Overall Study||0
960028|NCT00178191|2322518|P2|NOT COMPLETED|Overall Study||0
960029|NCT00178191|2322519|P1|NOT COMPLETED|Overall Study||0
960030|NCT00178191|2322517|P3|COMPLETED|Overall Study||7
960031|NCT00178191|2322518|P2|COMPLETED|Overall Study||10
960032|NCT00178191|2322519|P1|COMPLETED|Overall Study||11
960033|NCT00178191|2322517|P3|STARTED|Overall Study||7
960034|NCT00178191|2322518|P2|STARTED|Overall Study||10
960035|NCT00178191|2322519|P1|STARTED|Overall Study||11
960036|NCT00170625|2322527|P1|NOT COMPLETED|Overall Study||0
960037|NCT00170625|2322527|P1|COMPLETED|Overall Study||26
960038|NCT00170625|2322527|P1|STARTED|Overall Study||26
960039|NCT00170846|2322535|P3|NOT COMPLETED|Overall Study||13
960040|NCT00170846|2322536|P2|NOT COMPLETED|Overall Study||19
960041|NCT00170846|2322537|P1|NOT COMPLETED|Overall Study||11
960042|NCT00170846|2322535|P3|COMPLETED|Overall Study||131
960043|NCT00170846|2322536|P2|COMPLETED|Overall Study||108
960044|NCT00170846|2322537|P1|COMPLETED|Overall Study||112
960045|NCT00170846|2322535|P3|STARTED|Overall Study||144
960046|NCT00170846|2322536|P2|STARTED|Overall Study||127
960047|NCT00170846|2322537|P1|STARTED|Overall Study||123
960048|NCT00170950|2322553|P2|NOT COMPLETED|Overall Study||910
960049|NCT00170950|2322554|P1|NOT COMPLETED|Overall Study||885
960050|NCT00170950|2322553|P2|COMPLETED|Overall Study||4852
960051|NCT00170950|2322554|P1|COMPLETED|Overall Study||4859
960052|NCT00170950|2322553|P2|STARTED|Overall Study||5762
960053|NCT00170950|2322554|P1|STARTED|Overall Study||5744
960054|NCT00171054|2322566|P2|NOT COMPLETED|Overall Study||12
960055|NCT00171054|2322567|P1|NOT COMPLETED|Overall Study||10
960056|NCT00171054|2322566|P2|COMPLETED|Overall Study||50
960057|NCT00171054|2322567|P1|COMPLETED|Overall Study||53
960058|NCT00171054|2322566|P2|STARTED|Overall Study||62
960059|NCT00171054|2322567|P1|STARTED|Overall Study||63
960060|NCT00171210|2322599|P2|NOT COMPLETED|Overall Study||115
960061|NCT00171210|2322600|P1|NOT COMPLETED|Overall Study||69
960062|NCT00171210|2322599|P2|COMPLETED|Overall Study||181
960063|NCT00171210|2322600|P1|COMPLETED|Overall Study||190
960064|NCT00171210|2322599|P2|STARTED EXTENSION STUDY|Overall Study||247
960065|NCT00171210|2322600|P1|STARTED EXTENSION STUDY|Overall Study||259
960066|NCT00171210|2322599|P2|STARTED|Overall Study||296
960067|NCT00171210|2322600|P1|STARTED|Overall Study||259
960068|NCT00171301|2322630|P2|NOT COMPLETED|Overall Study||9
960069|NCT00171301|2322631|P1|NOT COMPLETED|Overall Study||8
960070|NCT00171301|2322630|P2|COMPLETED|Overall Study||62
960071|NCT00171301|2322631|P1|COMPLETED|Overall Study||154
960072|NCT00171301|2322630|P2|Received Deferasirox|Overall Study||69
960073|NCT00171301|2322631|P1|Received Deferasirox|Overall Study||162
960074|NCT00171301|2322630|P2|STARTED|Overall Study|2 participants in this group never received deferasirox.|71
960075|NCT00171301|2322631|P1|STARTED|Overall Study||162
960076|NCT00171314|2322644|P2|NOT COMPLETED|Overall Study||78
960077|NCT00171314|2322645|P1|NOT COMPLETED|Overall Study||91
960078|NCT00171314|2322644|P2|COMPLETED|Overall Study||186
960079|NCT00171314|2322645|P1|COMPLETED|Overall Study||172
960080|NCT00171314|2322644|P2|Safety Population|Overall Study|"Treatment Actually Received = 10 from upfront Arm and 259 from delayed Arm"|269
960081|NCT00171314|2322645|P1|Safety Population|Overall Study|"Treatment Actually Received = 251 from upfront Arm and 3 from delayed Arm"|254
960082|NCT00171314|2322644|P2|STARTED|Overall Study||264
960083|NCT00171314|2322645|P1|STARTED|Overall Study|2 patients in each arm were randomized but not treated.|263
960084|NCT00171340|2322661|P2|NOT COMPLETED|Overall Study||135
960085|NCT00171340|2322662|P1|NOT COMPLETED|Overall Study||124
960086|NCT00171340|2322661|P2|COMPLETED|Overall Study||398
960087|NCT00171340|2322662|P1|COMPLETED|Overall Study||408
960088|NCT00171340|2322661|P2|STARTED|Overall Study||533
960089|NCT00171340|2322662|P1|STARTED|Overall Study||532
960090|NCT00178256|2322676|P4|NOT COMPLETED|Overall Study||2
960091|NCT00178256|2322677|P3|NOT COMPLETED|Overall Study||0
960092|NCT00178256|2322678|P2|NOT COMPLETED|Overall Study||1
960093|NCT00178256|2322679|P1|NOT COMPLETED|Overall Study||4
960094|NCT00178256|2322676|P4|COMPLETED|Overall Study||16
960095|NCT00178256|2322677|P3|COMPLETED|Overall Study||6
960096|NCT00178256|2322678|P2|COMPLETED|Overall Study||6
960097|NCT00178256|2322679|P1|COMPLETED|Overall Study||6
960098|NCT00178256|2322676|P4|STARTED|Overall Study||18
960099|NCT00178256|2322677|P3|STARTED|Overall Study||6
960100|NCT00178256|2322678|P2|STARTED|Overall Study||7
960101|NCT00178256|2322679|P1|STARTED|Overall Study||10
960102|NCT00178464|2322686|P1|NOT COMPLETED|Overall Study||2
960103|NCT00178464|2322686|P1|COMPLETED|Overall Study||9
960104|NCT00178464|2322686|P1|STARTED|Overall Study||11
960105|NCT00178477|2322691|P1|NOT COMPLETED|Overall Study||5
960106|NCT00178477|2322691|P1|COMPLETED|Overall Study||5
960107|NCT00178477|2322691|P1|STARTED|Overall Study||10
960108|NCT00178503|2322695|P1|NOT COMPLETED|MPH Trial: High Dose||0
960109|NCT00178503|2322695|P1|COMPLETED|MPH Trial: High Dose||24
960110|NCT00178503|2322695|P1|STARTED|MPH Trial: High Dose||24
960111|NCT00178503|2322695|P1|NOT COMPLETED|MPH Trial: Med Dose||0
960112|NCT00178503|2322695|P1|COMPLETED|MPH Trial: Med Dose||24
960113|NCT00178503|2322695|P1|STARTED|MPH Trial: Med Dose||24
960114|NCT00178503|2322695|P1|NOT COMPLETED|MPH Trial: Low Dose||0
960115|NCT00178503|2322695|P1|COMPLETED|MPH Trial: Low Dose||24
960116|NCT00178503|2322695|P1|STARTED|MPH Trial: Low Dose||24
960117|NCT00178503|2322695|P1|NOT COMPLETED|MPH Trial: Placebo||0
960118|NCT00178503|2322695|P1|COMPLETED|MPH Trial: Placebo||24
960119|NCT00178503|2322695|P1|STARTED|MPH Trial: Placebo||24
960120|NCT00180271|2322715|P2|NOT COMPLETED|Overall Study||0
960121|NCT00180271|2322716|P1|NOT COMPLETED|Overall Study||0
960122|NCT00180271|2322715|P2|COMPLETED|Overall Study||731
960123|NCT00180271|2322716|P1|COMPLETED|Overall Study||1089
960124|NCT00180271|2322715|P2|STARTED|Overall Study||731
960125|NCT00180271|2322716|P1|STARTED|Overall Study||1089
960126|NCT00180323|2322722|P1|NOT COMPLETED|Overall Study||0
960127|NCT00180323|2322722|P1|COMPLETED|Overall Study||43
960128|NCT00180323|2322722|P1|STARTED|Overall Study||43
960129|NCT00180479|2322731|P2|NOT COMPLETED|Overall Study||13
960130|NCT00180479|2322732|P1|NOT COMPLETED|Overall Study||16
960131|NCT00180479|2322731|P2|COMPLETED|Overall Study||320
960132|NCT00180479|2322732|P1|COMPLETED|Overall Study||653
960133|NCT00180479|2322731|P2|STARTED|Overall Study|1 patient randomized never signed consent, therefore no data collected. Analysis group = 332.|333
960134|NCT00180479|2322732|P1|STARTED|Overall Study||669
960135|NCT00180687|2322828|P4|NOT COMPLETED|Overall Study||0
960136|NCT00180687|2322829|P3|NOT COMPLETED|Overall Study||0
960137|NCT00180687|2322830|P2|NOT COMPLETED|Overall Study||0
960138|NCT00180687|2322831|P1|NOT COMPLETED|Overall Study||0
960139|NCT00180687|2322828|P4|COMPLETED|Overall Study||20
960140|NCT00180687|2322829|P3|COMPLETED|Overall Study||20
960141|NCT00180687|2322830|P2|COMPLETED|Overall Study||20
960142|NCT00180687|2322831|P1|COMPLETED|Overall Study||20
960143|NCT00180687|2322828|P4|STARTED|Overall Study||20
960144|NCT00180687|2322829|P3|STARTED|Overall Study||20
960145|NCT00180687|2322830|P2|STARTED|Overall Study||20
960146|NCT00180687|2322831|P1|STARTED|Overall Study||20
960147|NCT00181155|2322853|P2|NOT COMPLETED|Overall Study||0
960148|NCT00181155|2322854|P1|NOT COMPLETED|Overall Study||2
960149|NCT00181155|2322853|P2|COMPLETED|Overall Study||3
960150|NCT00181155|2322854|P1|COMPLETED|Overall Study||13
960151|NCT00181155|2322853|P2|STARTED|Overall Study||3
960152|NCT00181155|2322854|P1|STARTED|Overall Study||15
960153|NCT00181610|2322865|P3|NOT COMPLETED|Overall Study||0
960154|NCT00181610|2322866|P2|NOT COMPLETED|Overall Study||1
960155|NCT00181610|2322867|P1|NOT COMPLETED|Overall Study||0
960156|NCT00181610|2322865|P3|COMPLETED|Overall Study||3
960157|NCT00181610|2322866|P2|COMPLETED|Overall Study||3
960158|NCT00181610|2322867|P1|COMPLETED|Overall Study||4
960159|NCT00181610|2322865|P3|STARTED|Overall Study||3
960160|NCT00181610|2322866|P2|STARTED|Overall Study||4
960161|NCT00181610|2322867|P1|STARTED|Overall Study||4
960162|NCT00181623|2322875|P1|NOT COMPLETED|Overall Study||1
960163|NCT00181623|2322875|P1|COMPLETED|Overall Study||5
960164|NCT00181623|2322875|P1|STARTED|Overall Study||6
960165|NCT00181714|2322879|P1|NOT COMPLETED|Began Treatment With OROS-MPH||124
960166|NCT00181714|2322879|P1|COMPLETED|Began Treatment With OROS-MPH||30
960167|NCT00181714|2322879|P1|STARTED|Began Treatment With OROS-MPH||154
960168|NCT00181714|2322879|P1|NOT COMPLETED|Signed Consent/Enrolled||49
960169|NCT00181714|2322879|P1|COMPLETED|Signed Consent/Enrolled||154
960170|NCT00181714|2322879|P1|STARTED|Signed Consent/Enrolled||203
960171|NCT00181766|2322883|P1|NOT COMPLETED|Overall Study||12
960172|NCT00181766|2322883|P1|COMPLETED|Overall Study|Completed the trial.|33
960173|NCT00181766|2322883|P1|STARTED|Overall Study|Number of subjects enrolled and treated with Atomoxetine.|45
960174|NCT00181844|2322888|P1|NOT COMPLETED|Exposed to Study Medication||17
960175|NCT00181844|2322888|P1|COMPLETED|Exposed to Study Medication||22
960176|NCT00181844|2322888|P1|STARTED|Exposed to Study Medication||39
960177|NCT00181844|2322888|P1|NOT COMPLETED|Signed Consent||12
960178|NCT00181844|2322888|P1|COMPLETED|Signed Consent||39
960179|NCT00181844|2322888|P1|STARTED|Signed Consent||51
960180|NCT00181883|2322892|P1|NOT COMPLETED|Overall Study||10
960181|NCT00181883|2322892|P1|COMPLETED|Overall Study||20
960182|NCT00181883|2322892|P1|STARTED|Overall Study||30
960183|NCT00182000|2322898|P2|NOT COMPLETED|Overall Study||2
960184|NCT00182000|2322899|P1|NOT COMPLETED|Overall Study||5
960185|NCT00182000|2322898|P2|COMPLETED|Overall Study||13
960186|NCT00182000|2322899|P1|COMPLETED|Overall Study||9
960187|NCT00182000|2322898|P2|STARTED|Overall Study||15
960188|NCT00182000|2322899|P1|STARTED|Overall Study||14
960189|NCT00182078|2322907|P2|NOT COMPLETED|Overall Study||0
960190|NCT00182078|2322908|P1|NOT COMPLETED|Overall Study||1
960191|NCT00182078|2322907|P2|COMPLETED|Overall Study||17
960192|NCT00182078|2322908|P1|COMPLETED|Overall Study||8
960193|NCT00182078|2322907|P2|STARTED|Overall Study||17
960194|NCT00182078|2322908|P1|STARTED|Overall Study||9
960195|NCT00182091|2322922|P4|NOT COMPLETED|Overall Study||0
960196|NCT00182091|2322923|P3|NOT COMPLETED|Overall Study||0
960197|NCT00182091|2322924|P2|NOT COMPLETED|Overall Study||0
960198|NCT00182091|2322925|P1|NOT COMPLETED|Overall Study||1
960199|NCT00182091|2322922|P4|COMPLETED|Overall Study||20
960200|NCT00182091|2322923|P3|COMPLETED|Overall Study||25
960201|NCT00182091|2322924|P2|COMPLETED|Overall Study||15
960202|NCT00182091|2322925|P1|COMPLETED|Overall Study||14
960203|NCT00182091|2322922|P4|STARTED|Overall Study||20
960204|NCT00182091|2322923|P3|STARTED|Overall Study||25
960205|NCT00182091|2322924|P2|STARTED|Overall Study||15
960206|NCT00182091|2322925|P1|STARTED|Overall Study||15
960207|NCT00182637|2322939|P1|NOT COMPLETED|Overall Study||3
960208|NCT00182637|2322939|P1|COMPLETED|Overall Study|off study date|2
960209|NCT00182637|2322939|P1|STARTED|Overall Study|active/on treatment date|5
960210|NCT00182689|2322947|P2|NOT COMPLETED|Overall Study||49
960211|NCT00182689|2322948|P1|NOT COMPLETED|Overall Study||40
960212|NCT00182689|2322947|P2|COMPLETED|Overall Study||0
960213|NCT00182689|2322948|P1|COMPLETED|Overall Study||0
960214|NCT00182689|2322947|P2|Eligible and Began Protocol Therapy|Overall Study||45
960215|NCT00182689|2322948|P1|Eligible and Began Protocol Therapy|Overall Study||38
960216|NCT00182689|2322947|P2|Eligible|Overall Study||45
960217|NCT00182689|2322948|P1|Eligible|Overall Study||39
960218|NCT00182689|2322947|P2|STARTED|Overall Study||49
960219|NCT00182689|2322948|P1|STARTED|Overall Study||40
960220|NCT00182728|2322958|P1|NOT COMPLETED|Overall Study||0
960221|NCT00182728|2322958|P1|COMPLETED|Overall Study||71
960222|NCT00182728|2322958|P1|STARTED|Overall Study||71
960223|NCT00174382|2322968|P1|NOT COMPLETED|Overall Study||33
960224|NCT00174382|2322968|P1|COMPLETED|Overall Study||116
960225|NCT00174382|2322968|P1|STARTED|Overall Study|148 are summarized below: 1 subject entered the study but was lost to follow up.|149
960226|NCT00174447|2322985|P1|NOT COMPLETED|Overall Study||38
960227|NCT00174447|2322985|P1|COMPLETED|Overall Study||5
960228|NCT00174447|2322985|P1|STARTED|Overall Study||43
960229|NCT00174460|2322996|P2|NOT COMPLETED|Overall Study||1
960230|NCT00174460|2322997|P1|NOT COMPLETED|Overall Study||0
960231|NCT00174460|2322996|P2|COMPLETED|Overall Study||14
960232|NCT00174460|2322997|P1|COMPLETED|Overall Study||18
960233|NCT00174460|2322996|P2|Received Study Treatment|Overall Study||14
960234|NCT00174460|2322997|P1|Received Study Treatment|Overall Study||18
960235|NCT00174460|2322996|P2|STARTED|Overall Study||15
960236|NCT00174460|2322997|P1|STARTED|Overall Study||18
960237|NCT00174785|2323045|P2|NOT COMPLETED|Overall Study||716
960238|NCT00174785|2323046|P1|NOT COMPLETED|Overall Study||696
960239|NCT00174785|2323045|P2|COMPLETED|Overall Study|completed study drug|1611
960240|NCT00174785|2323046|P1|COMPLETED|Overall Study|completed study drug|1605
960241|NCT00174785|2323045|P2|STARTED|Overall Study|randomized patients; among them, 14 patients did not receive any study drug in the placebo group|2327
960242|NCT00174785|2323046|P1|STARTED|Overall Study|randomized patients; among them, 10 patients did not receive any study drug in the dronedarone group|2301
960243|NCT00174915|2323065|P5|NOT COMPLETED|Overall Study||33
960244|NCT00174915|2323066|P4|NOT COMPLETED|Overall Study||57
960245|NCT00174915|2323067|P3|NOT COMPLETED|Overall Study||48
960246|NCT00174915|2323068|P2|NOT COMPLETED|Overall Study||69
960247|NCT00174915|2323069|P1|NOT COMPLETED|Overall Study||93
960248|NCT00174915|2323065|P5|COMPLETED|Overall Study||101
960249|NCT00174915|2323066|P4|COMPLETED|Overall Study||211
960250|NCT00174915|2323067|P3|COMPLETED|Overall Study||86
960251|NCT00174915|2323068|P2|COMPLETED|Overall Study||200
960252|NCT00174915|2323069|P1|COMPLETED|Overall Study||174
960253|NCT00174915|2323065|P5|STARTED|Overall Study||134
960254|NCT00174915|2323066|P4|STARTED|Overall Study||268
960255|NCT00174915|2323067|P3|STARTED|Overall Study||134
960256|NCT00174915|2323068|P2|STARTED|Overall Study||269
960257|NCT00174915|2323069|P1|STARTED|Overall Study||267
960258|NCT00174941|2323129|P4|NOT COMPLETED|Overall Study||58
960259|NCT00174941|2323130|P3|NOT COMPLETED|Overall Study||18
960260|NCT00174941|2323131|P2|NOT COMPLETED|Overall Study||38
960261|NCT00174941|2323132|P1|NOT COMPLETED|Overall Study||2
960262|NCT00174941|2323129|P4|COMPLETED|Overall Study||58
960263|NCT00174941|2323130|P3|COMPLETED|Overall Study||11
960264|NCT00174941|2323131|P2|COMPLETED|Overall Study||41
960265|NCT00174941|2323132|P1|COMPLETED|Overall Study||6
960266|NCT00174941|2323129|P4|STARTED|Overall Study||116
960267|NCT00174941|2323130|P3|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|29
960268|NCT00174941|2323131|P2|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|79
960269|NCT00174941|2323132|P1|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|8
960270|NCT00174954|2323202|P1|NOT COMPLETED|Overall Study||4
960271|NCT00174954|2323202|P1|COMPLETED|Overall Study||28
960272|NCT00174954|2323202|P1|STARTED|Overall Study||32
960273|NCT00174967|2323211|P4|NOT COMPLETED|Overall Study||2
960274|NCT00174967|2323212|P3|NOT COMPLETED|Overall Study||2
960275|NCT00174967|2323213|P2|NOT COMPLETED|Overall Study||3
960276|NCT00174967|2323214|P1|NOT COMPLETED|Overall Study||1
960277|NCT00174967|2323211|P4|COMPLETED|Overall Study||36
960278|NCT00174967|2323212|P3|COMPLETED|Overall Study||36
960279|NCT00174967|2323213|P2|COMPLETED|Overall Study||37
960280|NCT00174967|2323214|P1|COMPLETED|Overall Study||36
960281|NCT00174967|2323211|P4|STARTED|Overall Study||38
960282|NCT00174967|2323212|P3|STARTED|Overall Study||38
960283|NCT00174967|2323213|P2|STARTED|Overall Study||40
960284|NCT00174967|2323214|P1|STARTED|Overall Study||37
960285|NCT00175006|2323260|P1|NOT COMPLETED|Overall Study||0
960286|NCT00175006|2323260|P1|COMPLETED|Overall Study||13
960287|NCT00175006|2323260|P1|STARTED|Overall Study||13
960288|NCT00175019|2323268|P3|NOT COMPLETED|Overall Study||57
960289|NCT00175019|2323269|P2|NOT COMPLETED|Overall Study||171
960290|NCT00175019|2323270|P1|NOT COMPLETED|Overall Study||194
960291|NCT00175019|2323268|P3|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|35
960292|NCT00175019|2323269|P2|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|217
960293|NCT00175019|2323270|P1|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|412
960294|NCT00175019|2323268|P3|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|92
960295|NCT00175019|2323269|P2|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|388
960296|NCT00175019|2323270|P1|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|606
960297|NCT00182754|2323316|P2|NOT COMPLETED|Overall Study||0
960298|NCT00182754|2323317|P1|NOT COMPLETED|Overall Study||0
960299|NCT00182754|2323316|P2|COMPLETED|Overall Study||17
960300|NCT00182754|2323317|P1|COMPLETED|Overall Study||16
960301|NCT00182754|2323316|P2|STARTED|Overall Study||17
960302|NCT00182754|2323317|P1|STARTED|Overall Study||16
960303|NCT00182767|2323327|P5|NOT COMPLETED|Overall Study||0
960304|NCT00182767|2323328|P4|NOT COMPLETED|Overall Study||0
960305|NCT00182767|2323329|P3|NOT COMPLETED|Overall Study||0
960306|NCT00182767|2323330|P2|NOT COMPLETED|Overall Study||0
960307|NCT00182767|2323331|P1|NOT COMPLETED|Overall Study||0
960308|NCT00182767|2323327|P5|COMPLETED|Overall Study||24
960309|NCT00182767|2323328|P4|COMPLETED|Overall Study||3
960310|NCT00182767|2323329|P3|COMPLETED|Overall Study||6
960311|NCT00182767|2323330|P2|COMPLETED|Overall Study||6
960312|NCT00182767|2323331|P1|COMPLETED|Overall Study||6
960313|NCT00182767|2323327|P5|STARTED|Overall Study||24
960314|NCT00182767|2323328|P4|STARTED|Overall Study||3
960315|NCT00182767|2323329|P3|STARTED|Overall Study||6
960316|NCT00182767|2323330|P2|STARTED|Overall Study||6
960317|NCT00182767|2323331|P1|STARTED|Overall Study||6
960318|NCT00182793|2323346|P1|NOT COMPLETED|Overall Study||0
960319|NCT00182793|2323346|P1|COMPLETED|Overall Study||32
960320|NCT00182793|2323346|P1|STARTED|Overall Study||32
960321|NCT00183963|2323355|P4|NOT COMPLETED|Overall Study||1
960322|NCT00183963|2323356|P3|NOT COMPLETED|Overall Study||1
960323|NCT00183963|2323357|P2|NOT COMPLETED|Overall Study||1
960324|NCT00183963|2323358|P1|NOT COMPLETED|Overall Study||1
960325|NCT00183963|2323355|P4|COMPLETED|Overall Study||0
960326|NCT00183963|2323356|P3|COMPLETED|Overall Study||0
960327|NCT00183963|2323357|P2|COMPLETED|Overall Study||0
960328|NCT00183963|2323358|P1|COMPLETED|Overall Study||0
960329|NCT00183963|2323355|P4|STARTED|Overall Study||1
960330|NCT00183963|2323356|P3|STARTED|Overall Study||1
960331|NCT00183963|2323357|P2|STARTED|Overall Study||1
960332|NCT00183963|2323358|P1|STARTED|Overall Study||1
960333|NCT00184002|2323372|P1|NOT COMPLETED|Overall Study||17
960334|NCT00184002|2323372|P1|COMPLETED|Overall Study||51
960335|NCT00184002|2323372|P1|STARTED|Overall Study||68
960336|NCT00184028|2323377|P1|NOT COMPLETED|Overall Study||10
960337|NCT00184028|2323377|P1|COMPLETED|Overall Study||2
960338|NCT00184028|2323377|P1|STARTED|Overall Study||12
960339|NCT00184054|2323382|P1|NOT COMPLETED|Overall Study||1
960340|NCT00184054|2323382|P1|COMPLETED|Overall Study||10
960341|NCT00184054|2323382|P1|STARTED|Overall Study||11
960342|NCT00184093|2323387|P1|NOT COMPLETED|Overall Study||9
960343|NCT00184093|2323387|P1|COMPLETED|Overall Study||26
960344|NCT00184093|2323387|P1|STARTED|Overall Study|Phase 1 participants = 6 Phase 2 participants = 29|35
960345|NCT00184548|2323396|P4|NOT COMPLETED|Overall Study||7
960346|NCT00184548|2323397|P3|NOT COMPLETED|Overall Study||3
960347|NCT00184548|2323398|P2|NOT COMPLETED|Overall Study||13
960348|NCT00184548|2323399|P1|NOT COMPLETED|Overall Study||8
960349|NCT00184548|2323396|P4|COMPLETED|Overall Study||38
960350|NCT00184548|2323397|P3|COMPLETED|Overall Study||44
960351|NCT00184548|2323398|P2|COMPLETED|Overall Study||242
960352|NCT00184548|2323399|P1|COMPLETED|Overall Study||218
960353|NCT00184548|2323396|P4|Exposed|Overall Study|Four subjects withdrew due to ineligibility, one subject died. Excluded from safety analysis set|40
960354|NCT00184548|2323397|P3|Exposed|Overall Study|One subject withdrew due to ineligibility. Excluded from safety analysis set|46
960355|NCT00184548|2323398|P2|Exposed|Overall Study|Three subjects withdrew due to ineligibility, two subjects died. Excluded from safety analysis set|250
960356|NCT00184548|2323399|P1|Exposed|Overall Study|Two subjects withdrew due to ineligibility. Excluded from safety analysis set|224
960357|NCT00184548|2323396|P4|STARTED|Overall Study||45
960358|NCT00184548|2323397|P3|STARTED|Overall Study||47
960359|NCT00184548|2323398|P2|STARTED|Overall Study||255
960360|NCT00184548|2323399|P1|STARTED|Overall Study||226
960361|NCT00184600|2323436|P3|NOT COMPLETED|Overall Study||34
960362|NCT00184600|2323437|P2|NOT COMPLETED|Overall Study||51
960363|NCT00184600|2323438|P1|NOT COMPLETED|Overall Study||45
960364|NCT00184600|2323436|P3|COMPLETED|Overall Study||201
960365|NCT00184600|2323437|P2|COMPLETED|Overall Study||188
960366|NCT00184600|2323438|P1|COMPLETED|Overall Study||189
960367|NCT00184600|2323436|P3|STARTED|Overall Study||235
960368|NCT00184600|2323437|P2|STARTED|Overall Study||239
960369|NCT00184600|2323438|P1|STARTED|Overall Study||234
960370|NCT00184717|2323491|P5|NOT COMPLETED|Extension Period (GHLIQUID-1517)||5
960371|NCT00184717|2323492|P4|NOT COMPLETED|Extension Period (GHLIQUID-1517)||3
960372|NCT00184717|2323493|P3|NOT COMPLETED|Extension Period (GHLIQUID-1517)||0
960373|NCT00184717|2323494|P2|NOT COMPLETED|Extension Period (GHLIQUID-1517)||6
960374|NCT00184717|2323495|P1|NOT COMPLETED|Extension Period (GHLIQUID-1517)||10
960375|NCT00184717|2323491|P5|COMPLETED|Extension Period (GHLIQUID-1517)||5
960376|NCT00184717|2323492|P4|COMPLETED|Extension Period (GHLIQUID-1517)||7
960377|NCT00184717|2323493|P3|COMPLETED|Extension Period (GHLIQUID-1517)||0
960378|NCT00184717|2323494|P2|COMPLETED|Extension Period (GHLIQUID-1517)||27
960379|NCT00184717|2323495|P1|COMPLETED|Extension Period (GHLIQUID-1517)||23
960380|NCT00184717|2323491|P5|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
960381|NCT00184717|2323492|P4|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
960382|NCT00184717|2323493|P3|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised to receive 0.033 or 0.067 mg|0
960383|NCT00184717|2323494|P2|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
960384|NCT00184717|2323495|P1|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
960385|NCT00184717|2323491|P5|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
960386|NCT00184717|2323492|P4|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
960387|NCT00184717|2323493|P3|NOT COMPLETED|Main Period (GHLIQUID-1516)||1
960388|NCT00184717|2323494|P2|NOT COMPLETED|Main Period (GHLIQUID-1516)||2
960389|NCT00184717|2323495|P1|NOT COMPLETED|Main Period (GHLIQUID-1516)||3
960390|NCT00184717|2323491|P5|COMPLETED|Main Period (GHLIQUID-1516)||0
960391|NCT00184717|2323492|P4|COMPLETED|Main Period (GHLIQUID-1516)||0
960392|NCT00184717|2323493|P3|COMPLETED|Main Period (GHLIQUID-1516)||20
960393|NCT00184717|2323494|P2|COMPLETED|Main Period (GHLIQUID-1516)||36
960394|NCT00184717|2323495|P1|COMPLETED|Main Period (GHLIQUID-1516)||36
960395|NCT00184717|2323491|P5|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
960396|NCT00184717|2323492|P4|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
960397|NCT00184717|2323493|P3|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||21
960398|NCT00184717|2323494|P2|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
960399|NCT00184717|2323495|P1|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
960400|NCT00184717|2323491|P5|STARTED|Main Period (GHLIQUID-1516)||0
960401|NCT00184717|2323492|P4|STARTED|Main Period (GHLIQUID-1516)||0
960402|NCT00184717|2323493|P3|STARTED|Main Period (GHLIQUID-1516)||21
960403|NCT00184717|2323494|P2|STARTED|Main Period (GHLIQUID-1516)||38
960404|NCT00184717|2323495|P1|STARTED|Main Period (GHLIQUID-1516)||39
960405|NCT00185211|2323535|P2|NOT COMPLETED|Follow-up Study (91031 - This Study)||34
960406|NCT00185211|2323536|P1|NOT COMPLETED|Follow-up Study (91031 - This Study)||26
960407|NCT00185211|2323535|P2|COMPLETED|Follow-up Study (91031 - This Study)||123
960408|NCT00185211|2323536|P1|COMPLETED|Follow-up Study (91031 - This Study)||235
960409|NCT00185211|2323535|P2|STARTED|Follow-up Study (91031 - This Study)|9 of the 166 subjects completing the placebo-controlled study did not consent to the Follow-up.|157
960410|NCT00185211|2323536|P1|STARTED|Follow-up Study (91031 - This Study)|10 of the 271 subjects completing the placebo-controlled study did not consent to the Follow-up.|261
960411|NCT00185211|2323535|P2|NOT COMPLETED|Placebo-controlled Study (92012)||10
960412|NCT00185211|2323536|P1|NOT COMPLETED|Placebo-controlled Study (92012)||21
960413|NCT00185211|2323535|P2|COMPLETED|Placebo-controlled Study (92012)||166
960414|NCT00185211|2323536|P1|COMPLETED|Placebo-controlled Study (92012)||271
960415|NCT00185211|2323535|P2|STARTED|Placebo-controlled Study (92012)||176
960416|NCT00185211|2323536|P1|STARTED|Placebo-controlled Study (92012)||292
960417|NCT00185380|2323564|P3|NOT COMPLETED|Overall Study||74
960418|NCT00185380|2323565|P2|NOT COMPLETED|Overall Study||72
960419|NCT00185380|2323566|P1|NOT COMPLETED|Overall Study||66
960420|NCT00185380|2323564|P3|COMPLETED|Overall Study||182
960421|NCT00185380|2323565|P2|COMPLETED|Overall Study||174
960422|NCT00185380|2323566|P1|COMPLETED|Overall Study||174
960423|NCT00185380|2323564|P3|Subjects Received Treatment|Overall Study||254
960424|NCT00185380|2323565|P2|Subjects Received Treatment|Overall Study||245
960425|NCT00185380|2323566|P1|Subjects Received Treatment|Overall Study||239
960426|NCT00185380|2323564|P3|STARTED|Overall Study||256
960427|NCT00185380|2323565|P2|STARTED|Overall Study||246
960428|NCT00185380|2323566|P1|STARTED|Overall Study||240
960429|NCT00185458|2323592|P1|NOT COMPLETED|HRT Phase||27
960430|NCT00185458|2323592|P1|COMPLETED|HRT Phase||141
960431|NCT00185458|2323592|P1|STARTED|HRT Phase|168 subjects were eligible for the HRT phase out 336 who completed contraception phase.|168
960432|NCT00185458|2323592|P1|NOT COMPLETED|Contraception Phase||58
960433|NCT00185458|2323592|P1|COMPLETED|Contraception Phase||336
960434|NCT00185458|2323592|P1|STARTED|Contraception Phase||394
960435|NCT00185588|2323656|P4|NOT COMPLETED|Overall Study||4
960436|NCT00185588|2323657|P3|NOT COMPLETED|Overall Study||6
960437|NCT00185588|2323658|P2|NOT COMPLETED|Overall Study||2
960438|NCT00185588|2323659|P1|NOT COMPLETED|Overall Study||3
960439|NCT00185588|2323656|P4|COMPLETED|Overall Study||13
960440|NCT00185588|2323657|P3|COMPLETED|Overall Study||0
960441|NCT00185588|2323658|P2|COMPLETED|Overall Study||2
960442|NCT00185588|2323659|P1|COMPLETED|Overall Study||3
960443|NCT00185588|2323656|P4|STARTED|Overall Study||17
960444|NCT00185588|2323657|P3|STARTED|Overall Study||6
960445|NCT00185588|2323658|P2|STARTED|Overall Study||4
960446|NCT00185588|2323659|P1|STARTED|Overall Study||6
960447|NCT00185640|2323673|P1|NOT COMPLETED|Overall Study||145
960448|NCT00185640|2323673|P1|COMPLETED|Overall Study||158
960449|NCT00185640|2323673|P1|90 Days Post-transplant|Overall Study||161
960450|NCT00185640|2323673|P1|Transplanted|Overall Study||296
960451|NCT00185640|2323673|P1|STARTED|Overall Study||303
960452|NCT00185679|2323682|P1|NOT COMPLETED|Overall Study||0
960453|NCT00185679|2323682|P1|COMPLETED|Overall Study||13
960454|NCT00185679|2323682|P1|STARTED|Overall Study||13
960455|NCT00185692|2323688|P1|NOT COMPLETED|Overall Study||16
960456|NCT00185692|2323688|P1|COMPLETED|Overall Study||0
960457|NCT00185692|2323688|P1|STARTED|Overall Study||16
960458|NCT00185965|2323695|P2|NOT COMPLETED|Overall Study||1
960459|NCT00185965|2323696|P1|NOT COMPLETED|Overall Study||0
960460|NCT00185965|2323695|P2|COMPLETED|Overall Study||14
960461|NCT00185965|2323696|P1|COMPLETED|Overall Study||15
960462|NCT00185965|2323695|P2|STARTED|Overall Study||15
960463|NCT00185965|2323696|P1|STARTED|Overall Study||15
960464|NCT00186017|2323704|P2|NOT COMPLETED|Overall Study||3
960465|NCT00186017|2323705|P1|NOT COMPLETED|Overall Study||2
960466|NCT00186017|2323704|P2|COMPLETED|Overall Study||22
960467|NCT00186017|2323705|P1|COMPLETED|Overall Study||23
960468|NCT00186017|2323704|P2|STARTED|Overall Study||25
960469|NCT00186017|2323705|P1|STARTED|Overall Study||25
960470|NCT00186043|2323719|P2|NOT COMPLETED|Overall Study||13
960471|NCT00186043|2323720|P1|NOT COMPLETED|Overall Study||15
960472|NCT00186043|2323719|P2|COMPLETED|Overall Study||12
960473|NCT00186043|2323720|P1|COMPLETED|Overall Study||15
960474|NCT00186043|2323719|P2|STARTED|Overall Study||25
960475|NCT00186043|2323720|P1|STARTED|Overall Study||30
960476|NCT00186056|2323732|P2|NOT COMPLETED|Overall Study||1
960477|NCT00186056|2323733|P1|NOT COMPLETED|Overall Study||2
960478|NCT00186056|2323732|P2|COMPLETED|Overall Study||16
960479|NCT00186056|2323733|P1|COMPLETED|Overall Study||12
960480|NCT00186056|2323732|P2|STARTED|Overall Study||17
960481|NCT00186056|2323733|P1|STARTED|Overall Study||14
960482|NCT00186069|2323741|P2|NOT COMPLETED|Overall Study||0
960483|NCT00186069|2323742|P1|NOT COMPLETED|Overall Study||0
960484|NCT00186069|2323741|P2|COMPLETED|Overall Study||15
960485|NCT00186069|2323742|P1|COMPLETED|Overall Study||15
960486|NCT00186069|2323741|P2|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
960487|NCT00186069|2323742|P1|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
960488|NCT00186186|2323752|P1|NOT COMPLETED|Overall Study||8
960489|NCT00186186|2323752|P1|COMPLETED|Overall Study||20
960490|NCT00186186|2323752|P1|STARTED|Overall Study||28
960491|NCT00178633|2323757|P1|NOT COMPLETED|Overall Study||6
960492|NCT00178633|2323757|P1|COMPLETED|Overall Study||37
960493|NCT00178633|2323757|P1|STARTED|Overall Study||43
960494|NCT00178685|2323768|P3|NOT COMPLETED|Overall Study||196
960495|NCT00178685|2323769|P2|NOT COMPLETED|Overall Study||204
960496|NCT00178685|2323770|P1|NOT COMPLETED|Overall Study||111
960497|NCT00178685|2323768|P3|COMPLETED|Overall Study||128
960498|NCT00178685|2323769|P2|COMPLETED|Overall Study||120
960499|NCT00178685|2323770|P1|COMPLETED|Overall Study||61
960500|NCT00178685|2323768|P3|STARTED|Overall Study||324
960501|NCT00178685|2323769|P2|STARTED|Overall Study||324
960502|NCT00178685|2323770|P1|STARTED|Overall Study||172
960503|NCT00178711|2323783|P2|NOT COMPLETED|Overall Study||0
960504|NCT00178711|2323784|P1|NOT COMPLETED|Overall Study||0
960505|NCT00178711|2323783|P2|COMPLETED|Overall Study||45
960506|NCT00178711|2323784|P1|COMPLETED|Overall Study||52
960507|NCT00178711|2323783|P2|STARTED|Overall Study||45
960508|NCT00178711|2323784|P1|STARTED|Overall Study||52
960509|NCT00178841|2323792|P1|NOT COMPLETED|Overall Study||0
960510|NCT00178841|2323792|P1|COMPLETED|Overall Study||4
960511|NCT00178841|2323792|P1|STARTED|Overall Study||4
960512|NCT00178919|2323800|P2|NOT COMPLETED|Overall Study||25
960513|NCT00178919|2323801|P1|NOT COMPLETED|Overall Study||0
960514|NCT00178919|2323800|P2|COMPLETED|Overall Study||68
960515|NCT00178919|2323801|P1|COMPLETED|Overall Study||19
960516|NCT00178919|2323800|P2|STARTED|Overall Study||93
960517|NCT00178919|2323801|P1|STARTED|Overall Study||19
960518|NCT00179309|2323811|P2|NOT COMPLETED|Crossover||0
960519|NCT00179309|2323812|P1|NOT COMPLETED|Crossover||0
960520|NCT00179309|2323811|P2|COMPLETED|Crossover||3
960521|NCT00179309|2323812|P1|COMPLETED|Crossover||0
960522|NCT00179309|2323811|P2|STARTED|Crossover|Crossover was allowed so that patients randomized to B could receive the vaccine upon progression.|3
960523|NCT00179309|2323812|P1|STARTED|Crossover||0
960524|NCT00179309|2323811|P2|NOT COMPLETED|Treatment||5
960525|NCT00179309|2323812|P1|NOT COMPLETED|Treatment||4
960526|NCT00179309|2323811|P2|COMPLETED|Treatment||18
960527|NCT00179309|2323812|P1|COMPLETED|Treatment||21
960528|NCT00179309|2323811|P2|STARTED|Treatment||23
960529|NCT00179309|2323812|P1|STARTED|Treatment||25
960530|NCT00179413|2323822|P2|NOT COMPLETED|Overall Study||115
960531|NCT00179413|2323823|P1|NOT COMPLETED|Overall Study||125
960532|NCT00179413|2323822|P2|COMPLETED|Overall Study||152
960533|NCT00179413|2323823|P1|COMPLETED|Overall Study||157
960534|NCT00179413|2323822|P2|STARTED|Overall Study||267
960535|NCT00179413|2323823|P1|STARTED|Overall Study||282
960536|NCT00179478|2323835|P2|NOT COMPLETED|Overall Study||15
960537|NCT00179478|2323836|P1|NOT COMPLETED|Overall Study||13
960538|NCT00179478|2323835|P2|COMPLETED|Overall Study||59
960539|NCT00179478|2323836|P1|COMPLETED|Overall Study||68
960540|NCT00179478|2323835|P2|STARTED|Overall Study||74
960541|NCT00179478|2323836|P1|STARTED|Overall Study||81
960542|NCT00179517|2323849|P2|NOT COMPLETED|Overall Study||1
960543|NCT00179517|2323850|P1|NOT COMPLETED|Overall Study||2
960544|NCT00179517|2323849|P2|COMPLETED|Overall Study||19
960545|NCT00179517|2323850|P1|COMPLETED|Overall Study||18
960546|NCT00179517|2323849|P2|STARTED|Overall Study||20
960547|NCT00179517|2323850|P1|STARTED|Overall Study||20
960548|NCT00179621|2323875|P4|NOT COMPLETED|Open-Label Period||43
960549|NCT00179621|2323876|P3|NOT COMPLETED|Open-Label Period||28
960550|NCT00179621|2323877|P2|NOT COMPLETED|Open-Label Period||28
960551|NCT00179621|2323878|P1|NOT COMPLETED|Open-Label Period||0
960552|NCT00179621|2323875|P4|COMPLETED|Open-Label Period||13
960553|NCT00179621|2323876|P3|COMPLETED|Open-Label Period||19
960554|NCT00179621|2323877|P2|COMPLETED|Open-Label Period||14
960555|NCT00179621|2323878|P1|COMPLETED|Open-Label Period||0
960556|NCT00179621|2323875|P4|STARTED|Open-Label Period|'Started' includes 1 participant who completed double-blind and 55 who discontinued double-blind.|56
960557|NCT00179621|2323876|P3|STARTED|Open-Label Period|'Started' includes 39 participants who completed double-blind and 8 who discontinued double-blind.|47
960558|NCT00179621|2323877|P2|STARTED|Open-Label Period|'Started' includes 23 participants who completed double-blind and 19 who discontinued double-blind.|42
960559|NCT00179621|2323878|P1|STARTED|Open-Label Period||0
960560|NCT00179621|2323875|P4|NOT COMPLETED|Double-Blind Period||0
960561|NCT00179621|2323876|P3|NOT COMPLETED|Double-Blind Period||30
960562|NCT00179621|2323877|P2|NOT COMPLETED|Double-Blind Period||46
960563|NCT00179621|2323878|P1|NOT COMPLETED|Double-Blind Period||64
960564|NCT00179621|2323875|P4|COMPLETED|Double-Blind Period||0
960565|NCT00179621|2323876|P3|COMPLETED|Double-Blind Period||39
960566|NCT00179621|2323877|P2|COMPLETED|Double-Blind Period||23
960567|NCT00179621|2323878|P1|COMPLETED|Double-Blind Period||3
960568|NCT00179621|2323875|P4|STARTED|Double-Blind Period||0
960569|NCT00179621|2323876|P3|STARTED|Double-Blind Period||69
960570|NCT00179621|2323877|P2|STARTED|Double-Blind Period||69
960571|NCT00179621|2323878|P1|STARTED|Double-Blind Period||67
960572|NCT00179647|2323929|P1|NOT COMPLETED|Overall Study||1913
960573|NCT00179647|2323929|P1|COMPLETED|Overall Study|Subjects participated in study until they presented with reason for discontinuation.|0
960574|NCT00179647|2323929|P1|STARTED|Overall Study||1913
960575|NCT00179660|2323933|P1|NOT COMPLETED|Overall Study||50
960576|NCT00179660|2323933|P1|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
960577|NCT00179660|2323933|P1|Completed 12 Cycles of Treatment|Overall Study||12
960578|NCT00179660|2323933|P1|Received Study Drug|Overall Study||49
960579|NCT00179660|2323933|P1|STARTED|Overall Study||50
960580|NCT00179673|2323942|P1|NOT COMPLETED|Overall Study||43
960581|NCT00179673|2323942|P1|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
960582|NCT00179673|2323942|P1|Received Study Drug|Overall Study||43
960583|NCT00179673|2323942|P1|STARTED|Overall Study||43
960584|NCT00179959|2323952|P2|NOT COMPLETED|Overall Study||3
960585|NCT00179959|2323953|P1|NOT COMPLETED|Overall Study||6
960586|NCT00179959|2323952|P2|COMPLETED|Overall Study||13
960587|NCT00179959|2323953|P1|COMPLETED|Overall Study||9
960588|NCT00179959|2323952|P2|STARTED|Overall Study||16
960589|NCT00179959|2323953|P1|STARTED|Overall Study||15
960590|NCT00186446|2323959|P1|NOT COMPLETED|Overall Study||9
960591|NCT00186446|2323959|P1|COMPLETED|Overall Study||11
960592|NCT00186446|2323959|P1|STARTED|Overall Study||20
960593|NCT00186485|2323965|P1|NOT COMPLETED|Overall Study||3
960594|NCT00186485|2323965|P1|COMPLETED|Overall Study||25
960595|NCT00186485|2323965|P1|STARTED|Overall Study||28
960596|NCT00186537|2323974|P3|NOT COMPLETED|Overall Study||3
960597|NCT00186537|2323975|P2|NOT COMPLETED|Overall Study||0
960598|NCT00186537|2323976|P1|NOT COMPLETED|Overall Study||7
960599|NCT00186537|2323974|P3|COMPLETED|Overall Study||13
960600|NCT00186537|2323975|P2|COMPLETED|Overall Study||12
960601|NCT00186537|2323976|P1|COMPLETED|Overall Study||12
960602|NCT00186537|2323974|P3|STARTED|Overall Study||16
960603|NCT00186537|2323975|P2|STARTED|Overall Study||12
960604|NCT00186537|2323976|P1|STARTED|Overall Study||19
960605|NCT00190671|2323992|P2|NOT COMPLETED|Overall Study||42
960606|NCT00190671|2323993|P1|NOT COMPLETED|Overall Study||27
960607|NCT00190671|2323992|P2|COMPLETED|Overall Study||19
960608|NCT00190671|2323993|P1|COMPLETED|Overall Study||15
960609|NCT00190671|2323992|P2|STARTED|Overall Study||61
960610|NCT00190671|2323993|P1|STARTED|Overall Study||42
960611|NCT00190684|2324011|P1|NOT COMPLETED|Overall Study||1489
960612|NCT00190684|2324011|P1|COMPLETED|Overall Study|Number of patients that completed overall study (through Period VI)|64
960613|NCT00190684|2324011|P1|Received at Least 1 Dose of Study Drug|Overall Study|1553 patients entered the study; 1551 were enrolled and received study drug.|1551
960614|NCT00190684|2324011|P1|STARTED|Overall Study||1553
960615|NCT00190749|2324032|P2|NOT COMPLETED|Overall Study||31
960616|NCT00190749|2324033|P1|NOT COMPLETED|Overall Study||26
960617|NCT00190749|2324032|P2|COMPLETED|Overall Study||31
960618|NCT00190749|2324033|P1|COMPLETED|Overall Study||42
960619|NCT00190749|2324032|P2|STARTED|Overall Study||62
960620|NCT00190749|2324033|P1|STARTED|Overall Study||68
960621|NCT00190775|2324099|P2|NOT COMPLETED|Overall Study||100
960622|NCT00190775|2324100|P1|NOT COMPLETED|Overall Study||149
960623|NCT00190775|2324099|P2|COMPLETED|Overall Study||134
960624|NCT00190775|2324100|P1|COMPLETED|Overall Study||119
960625|NCT00190775|2324099|P2|Received Study Drug|Overall Study||234
960626|NCT00190775|2324100|P1|Received Study Drug|Overall Study||266
960627|NCT00190775|2324099|P2|STARTED|Overall Study||234
960628|NCT00190775|2324100|P1|STARTED|Overall Study||268
960629|NCT00190983|2324169|P1|NOT COMPLETED|Overall Study||2
960630|NCT00190983|2324169|P1|COMPLETED|Overall Study|Completed means patient received treatment and was evaluable for response.|27
960631|NCT00190983|2324169|P1|STARTED|Overall Study||29
960632|NCT00191100|2324178|P2|NOT COMPLETED|Overall Study||12
960633|NCT00191100|2324179|P1|NOT COMPLETED|Overall Study||42
960634|NCT00191100|2324178|P2|COMPLETED|Overall Study||244
960635|NCT00191100|2324179|P1|COMPLETED|Overall Study||217
960636|NCT00191100|2324178|P2|STARTED|Overall Study||256
960637|NCT00191100|2324179|P1|STARTED|Overall Study||259
960638|NCT00191113|2324197|P2|NOT COMPLETED|Addendum 3||0
960639|NCT00191113|2324198|P1|NOT COMPLETED|Addendum 3||0
960640|NCT00191113|2324197|P2|COMPLETED|Addendum 3||37
960641|NCT00191113|2324198|P1|COMPLETED|Addendum 3||20
960642|NCT00191113|2324197|P2|STARTED|Addendum 3||37
960643|NCT00191113|2324198|P1|STARTED|Addendum 3||20
960644|NCT00191113|2324197|P2|NOT COMPLETED|Addendum 2||17
960645|NCT00191113|2324198|P1|NOT COMPLETED|Addendum 2||10
960646|NCT00191113|2324197|P2|COMPLETED|Addendum 2||31
960647|NCT00191113|2324198|P1|COMPLETED|Addendum 2||18
960648|NCT00191113|2324197|P2|STARTED|Addendum 2||48
960649|NCT00191113|2324198|P1|STARTED|Addendum 2||28
960650|NCT00191113|2324197|P2|NOT COMPLETED|Addendum 1||0
960651|NCT00191113|2324198|P1|NOT COMPLETED|Addendum 1||0
960652|NCT00191113|2324197|P2|COMPLETED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
960653|NCT00191113|2324198|P1|COMPLETED|Addendum 1||2
960654|NCT00191113|2324197|P2|STARTED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
960655|NCT00191113|2324198|P1|STARTED|Addendum 1||2
960656|NCT00191113|2324197|P2|NOT COMPLETED|Core Study||15
960657|NCT00191113|2324198|P1|NOT COMPLETED|Core Study||35
960658|NCT00191113|2324197|P2|COMPLETED|Core Study||61
960659|NCT00191113|2324198|P1|COMPLETED|Core Study||43
960660|NCT00191113|2324197|P2|STARTED|Core Study||76
960661|NCT00191113|2324198|P1|STARTED|Core Study||78
960662|NCT00191139|2324240|P2|NOT COMPLETED|Overall Study||12
960663|NCT00191139|2324241|P1|NOT COMPLETED|Overall Study||5
960664|NCT00191139|2324240|P2|COMPLETED|Overall Study||20
960665|NCT00191139|2324241|P1|COMPLETED|Overall Study||27
960666|NCT00191139|2324240|P2|STARTED|Overall Study||32
960667|NCT00191139|2324241|P1|STARTED|Overall Study||32
960668|NCT00191152|2324257|P2|NOT COMPLETED|Crossover Treatment||28
960669|NCT00191152|2324258|P1|NOT COMPLETED|Crossover Treatment||27
960670|NCT00191152|2324257|P2|COMPLETED|Crossover Treatment||53
960671|NCT00191152|2324258|P1|COMPLETED|Crossover Treatment||50
960672|NCT00191152|2324257|P2|Received Treatment|Crossover Treatment||80
960673|NCT00191152|2324258|P1|Received Treatment|Crossover Treatment||76
960674|NCT00191152|2324257|P2|STARTED|Crossover Treatment||81
960675|NCT00191152|2324258|P1|STARTED|Crossover Treatment||77
960676|NCT00191152|2324257|P2|NOT COMPLETED|Initial Treatment||153
960677|NCT00191152|2324258|P1|NOT COMPLETED|Initial Treatment||141
960678|NCT00191152|2324257|P2|COMPLETED|Initial Treatment||83
960679|NCT00191152|2324258|P1|COMPLETED|Initial Treatment||98
960680|NCT00191152|2324257|P2|Received Initial Treatment|Initial Treatment||227
960681|NCT00191152|2324258|P1|Received Initial Treatment|Initial Treatment||236
960682|NCT00191152|2324257|P2|STARTED|Initial Treatment||236
960683|NCT00191152|2324258|P1|STARTED|Initial Treatment||239
960684|NCT00191165|2324290|P2|NOT COMPLETED|Overall Study||2
960685|NCT00191165|2324291|P1|NOT COMPLETED|Overall Study||2
960686|NCT00191165|2324290|P2|COMPLETED|Overall Study||11
960687|NCT00191165|2324291|P1|COMPLETED|Overall Study||12
960688|NCT00191165|2324290|P2|STARTED|Overall Study||13
960689|NCT00191165|2324291|P1|STARTED|Overall Study||14
960690|NCT00191191|2324303|P2|NOT COMPLETED|Overall Study||112
960691|NCT00191191|2324304|P1|NOT COMPLETED|Overall Study||114
960692|NCT00191191|2324303|P2|COMPLETED|Overall Study||0
960693|NCT00191191|2324304|P1|COMPLETED|Overall Study||0
960694|NCT00191191|2324303|P2|Full Analysis Set Population|Overall Study||108
960695|NCT00191191|2324304|P1|Full Analysis Set Population|Overall Study||108
960696|NCT00191191|2324303|P2|Safety Analysis Population|Overall Study||111
960697|NCT00191191|2324304|P1|Safety Analysis Population|Overall Study||114
960698|NCT00191191|2324303|P2|STARTED|Overall Study||112
960699|NCT00191191|2324304|P1|STARTED|Overall Study||114
960700|NCT00191269|2324320|P2|NOT COMPLETED|Overall Study||58
960701|NCT00191269|2324321|P1|NOT COMPLETED|Overall Study||6
960702|NCT00191269|2324320|P2|COMPLETED|Overall Study||4
960703|NCT00191269|2324321|P1|COMPLETED|Overall Study||0
960704|NCT00191269|2324320|P2|STARTED|Overall Study||62
960705|NCT00191269|2324321|P1|STARTED|Overall Study||6
960706|NCT00191282|2324337|P2|NOT COMPLETED|Overall Study||212
960707|NCT00191282|2324338|P1|NOT COMPLETED|Overall Study||220
960708|NCT00191282|2324337|P2|COMPLETED|Overall Study||346
960709|NCT00191282|2324338|P1|COMPLETED|Overall Study||338
960710|NCT00191282|2324337|P2|STARTED|Overall Study||558
960711|NCT00191282|2324338|P1|STARTED|Overall Study||558
960712|NCT00191308|2324396|P1|NOT COMPLETED|Overall Study||1
960713|NCT00191308|2324396|P1|COMPLETED|Overall Study||29
960714|NCT00191308|2324396|P1|STARTED|Overall Study||30
960715|NCT00191334|2324404|P1|NOT COMPLETED|Overall Study||17
960716|NCT00191334|2324404|P1|COMPLETED|Overall Study||33
960717|NCT00191334|2324404|P1|STARTED|Overall Study||50
960718|NCT00191386|2324412|P1|NOT COMPLETED|Overall Study||160
960719|NCT00191386|2324412|P1|COMPLETED|Overall Study||68
960720|NCT00191386|2324412|P1|3 Years|Overall Study||65
960721|NCT00191386|2324412|P1|2 Years|Overall Study||105
960722|NCT00191386|2324412|P1|12 Months|Overall Study||149
960723|NCT00191386|2324412|P1|6 Months|Overall Study||183
960724|NCT00191386|2324412|P1|STARTED|Overall Study||228
960725|NCT00191451|2324422|P3|NOT COMPLETED|Overall Study||14
960726|NCT00191451|2324423|P2|NOT COMPLETED|Overall Study||14
960727|NCT00191451|2324424|P1|NOT COMPLETED|Overall Study||7
960728|NCT00191451|2324422|P3|COMPLETED|Overall Study||35
960729|NCT00191451|2324423|P2|COMPLETED|Overall Study||37
960730|NCT00191451|2324424|P1|COMPLETED|Overall Study||43
960731|NCT00191451|2324422|P3|Received at Least One Dose of Study Drug|Overall Study||47
960732|NCT00191451|2324423|P2|Received at Least One Dose of Study Drug|Overall Study||48
960733|NCT00191451|2324424|P1|Received at Least One Dose of Study Drug|Overall Study||50
960734|NCT00191451|2324422|P3|STARTED|Overall Study||49
960735|NCT00191451|2324423|P2|STARTED|Overall Study||51
960736|NCT00191451|2324424|P1|STARTED|Overall Study||50
960737|NCT00191477|2324446|P2|NOT COMPLETED|Overall Study||129
960738|NCT00191477|2324447|P1|NOT COMPLETED|Overall Study||138
960739|NCT00191477|2324446|P2|COMPLETED|Overall Study||47
960740|NCT00191477|2324447|P1|COMPLETED|Overall Study||41
960741|NCT00191477|2324446|P2|Received Study Drug|Overall Study||162
960742|NCT00191477|2324447|P1|Received Study Drug|Overall Study||166
960743|NCT00191477|2324446|P2|STARTED|Overall Study||176
960744|NCT00191477|2324447|P1|STARTED|Overall Study||179
960745|NCT00191646|2324465|P2|NOT COMPLETED|Overall Study||153
960746|NCT00191646|2324466|P1|NOT COMPLETED|Overall Study||171
960747|NCT00191646|2324465|P2|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|261
960748|NCT00191646|2324466|P1|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|246
960749|NCT00191646|2324465|P2|Received Crossover Therapy|Overall Study||78
960750|NCT00191646|2324466|P1|Received Crossover Therapy|Overall Study||77
960751|NCT00191646|2324465|P2|Received Consolidation Therapy|Overall Study||183
960752|NCT00191646|2324466|P1|Received Consolidation Therapy|Overall Study||169
960753|NCT00191646|2324465|P2|Received Induction Therapy|Overall Study||409
960754|NCT00191646|2324466|P1|Received Induction Therapy|Overall Study||411
960755|NCT00191646|2324465|P2|STARTED|Overall Study||414
960756|NCT00191646|2324466|P1|STARTED|Overall Study||417
960757|NCT00191724|2324489|P5|NOT COMPLETED|Overall Study||3
960758|NCT00191724|2324490|P4|NOT COMPLETED|Overall Study||3
960759|NCT00191724|2324491|P3|NOT COMPLETED|Overall Study||1
960760|NCT00191724|2324492|P2|NOT COMPLETED|Overall Study||1
960761|NCT00191724|2324493|P1|NOT COMPLETED|Overall Study||1
960762|NCT00191724|2324489|P5|COMPLETED|Overall Study||12
960763|NCT00191724|2324490|P4|COMPLETED|Overall Study||5
960764|NCT00191724|2324491|P3|COMPLETED|Overall Study||8
960765|NCT00191724|2324492|P2|COMPLETED|Overall Study||8
960766|NCT00191724|2324493|P1|COMPLETED|Overall Study||5
960767|NCT00191724|2324489|P5|STARTED|Overall Study||15
960768|NCT00191724|2324490|P4|STARTED|Overall Study||8
960769|NCT00191724|2324491|P3|STARTED|Overall Study||9
960770|NCT00191724|2324492|P2|STARTED|Overall Study||9
960771|NCT00191724|2324493|P1|STARTED|Overall Study||6
960772|NCT00191789|2324520|P1|NOT COMPLETED|Overall Study||25
960773|NCT00191789|2324520|P1|COMPLETED|Overall Study||40
960774|NCT00191789|2324520|P1|STARTED|Overall Study||65
960775|NCT00191815|2324532|P1|NOT COMPLETED|Overall Study||40
960776|NCT00191815|2324532|P1|COMPLETED|Overall Study||30
960777|NCT00191815|2324532|P1|Treated|Overall Study||67
960778|NCT00191815|2324532|P1|STARTED|Overall Study||70
960779|NCT00191854|2324547|P3|NOT COMPLETED|Overall Study||39
960780|NCT00191854|2324548|P2|NOT COMPLETED|Overall Study||30
960781|NCT00191854|2324549|P1|NOT COMPLETED|Overall Study||37
960782|NCT00191854|2324547|P3|COMPLETED|Overall Study||12
960783|NCT00191854|2324548|P2|COMPLETED|Overall Study||17
960784|NCT00191854|2324549|P1|COMPLETED|Overall Study||12
960785|NCT00191854|2324547|P3|Received at Least One Dose of Study Drug|Overall Study|Screen failure: discontinued prior to receiving study drug.|50
960786|NCT00191854|2324548|P2|Received at Least One Dose of Study Drug|Overall Study||47
960787|NCT00191854|2324549|P1|Received at Least One Dose of Study Drug|Overall Study||49
960788|NCT00191854|2324547|P3|STARTED|Overall Study||51
960789|NCT00191854|2324548|P2|STARTED|Overall Study||47
960790|NCT00191854|2324549|P1|STARTED|Overall Study||49
960791|NCT00191906|2324573|P4|NOT COMPLETED|Study Period III||0
960792|NCT00191906|2324574|P3|NOT COMPLETED|Study Period III||0
960793|NCT00191906|2324575|P2|NOT COMPLETED|Study Period III||4
960794|NCT00191906|2324576|P1|NOT COMPLETED|Study Period III||5
960795|NCT00191906|2324573|P4|COMPLETED|Study Period III||0
960796|NCT00191906|2324574|P3|COMPLETED|Study Period III||0
960797|NCT00191906|2324575|P2|COMPLETED|Study Period III||7
960798|NCT00191906|2324576|P1|COMPLETED|Study Period III||9
960799|NCT00191906|2324573|P4|STARTED|Study Period III||0
960800|NCT00191906|2324574|P3|STARTED|Study Period III||0
960801|NCT00191906|2324575|P2|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|11
960802|NCT00191906|2324576|P1|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|14
960803|NCT00191906|2324573|P4|NOT COMPLETED|Study Period II||0
960804|NCT00191906|2324574|P3|NOT COMPLETED|Study Period II||1
960805|NCT00191906|2324575|P2|NOT COMPLETED|Study Period II||5
960806|NCT00191906|2324576|P1|NOT COMPLETED|Study Period II||0
960807|NCT00191906|2324573|P4|COMPLETED|Study Period II||18
960808|NCT00191906|2324574|P3|COMPLETED|Study Period II||26
960809|NCT00191906|2324575|P2|COMPLETED|Study Period II||32
960810|NCT00191906|2324576|P1|COMPLETED|Study Period II||39
960811|NCT00191906|2324573|P4|STARTED|Study Period II||18
960812|NCT00191906|2324574|P3|STARTED|Study Period II||27
960813|NCT00191906|2324575|P2|STARTED|Study Period II||37
960814|NCT00191906|2324576|P1|STARTED|Study Period II||39
960815|NCT00191945|2324618|P2|NOT COMPLETED|Open-Label Treatment Extension||0
960816|NCT00191945|2324619|P1|NOT COMPLETED|Open-Label Treatment Extension||0
960817|NCT00191945|2324618|P2|COMPLETED|Open-Label Treatment Extension||48
960818|NCT00191945|2324619|P1|COMPLETED|Open-Label Treatment Extension||94
960819|NCT00191945|2324618|P2|STARTED|Open-Label Treatment Extension||48
960820|NCT00191945|2324619|P1|STARTED|Open-Label Treatment Extension||94
960821|NCT00191945|2324618|P2|NOT COMPLETED|Double-Blind Acute Treatment||3
960822|NCT00191945|2324619|P1|NOT COMPLETED|Double-Blind Acute Treatment||6
960823|NCT00191945|2324618|P2|COMPLETED|Double-Blind Acute Treatment||48
960824|NCT00191945|2324619|P1|COMPLETED|Double-Blind Acute Treatment||94
960825|NCT00191945|2324618|P2|STARTED|Double-Blind Acute Treatment||51
960826|NCT00191945|2324619|P1|STARTED|Double-Blind Acute Treatment||100
960827|NCT00191984|2324651|P1|NOT COMPLETED|Overall Study||39
960828|NCT00191984|2324651|P1|COMPLETED|Overall Study||7
960829|NCT00191984|2324651|P1|STARTED|Overall Study||46
960830|NCT00192023|2324661|P2|NOT COMPLETED|Period IV - Optional Open-Label||0
960831|NCT00192023|2324662|P1|NOT COMPLETED|Period IV - Optional Open-Label||75
960832|NCT00192023|2324661|P2|COMPLETED|Period IV - Optional Open-Label||0
960833|NCT00192023|2324662|P1|COMPLETED|Period IV - Optional Open-Label||49
960834|NCT00192023|2324661|P2|STARTED|Period IV - Optional Open-Label|Placebo patients received atomoxetine during the optional open-label period.|0
960835|NCT00192023|2324662|P1|STARTED|Period IV - Optional Open-Label||124
960836|NCT00192023|2324661|P2|NOT COMPLETED|Period III - Double-Blind||0
960837|NCT00192023|2324662|P1|NOT COMPLETED|Period III - Double-Blind||7
960838|NCT00192023|2324661|P2|COMPLETED|Period III - Double-Blind|2 patients who completed the protocol did not enter the optional open-label period.|32
960839|NCT00192023|2324662|P1|COMPLETED|Period III - Double-Blind|6 patients who completed the protocol did not enter optional open-label period.|100
960840|NCT00192023|2324661|P2|STARTED|Period III - Double-Blind||32
960841|NCT00192023|2324662|P1|STARTED|Period III - Double-Blind||107
960842|NCT00192036|2324684|P1|NOT COMPLETED|Overall Study||21
960843|NCT00192036|2324684|P1|COMPLETED|Overall Study||28
960844|NCT00192036|2324684|P1|STARTED|Overall Study||49
960845|NCT00192075|2324694|P2|NOT COMPLETED|Overall Study||19
960846|NCT00192075|2324695|P1|NOT COMPLETED|Overall Study||39
960847|NCT00192075|2324694|P2|COMPLETED|Overall Study||23
960848|NCT00192075|2324695|P1|COMPLETED|Overall Study||3
960849|NCT00192075|2324694|P2|STARTED|Overall Study||42
960850|NCT00192075|2324695|P1|STARTED|Overall Study||42
960851|NCT00183092|2324722|P4|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
960852|NCT00183092|2324723|P3|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
960853|NCT00183092|2324724|P2|NOT COMPLETED|Open-label Period (Month 2 Until Death)||14
960854|NCT00183092|2324725|P1|NOT COMPLETED|Open-label Period (Month 2 Until Death)||10
960855|NCT00183092|2324722|P4|COMPLETED|Open-label Period (Month 2 Until Death)||0
960856|NCT00183092|2324723|P3|COMPLETED|Open-label Period (Month 2 Until Death)||0
960857|NCT00183092|2324724|P2|COMPLETED|Open-label Period (Month 2 Until Death)||0
960858|NCT00183092|2324725|P1|COMPLETED|Open-label Period (Month 2 Until Death)||0
960859|NCT00183092|2324722|P4|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Placebo opted to continue assigned drug during open-label period|1
960860|NCT00183092|2324723|P3|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Quinacrine opted to continue assigned drug during open-label period|1
960861|NCT00183092|2324724|P2|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Placebo opted to begin open-label Quinacrine at Month 2|14
960862|NCT00183092|2324725|P1|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Quinacrine opted to begin open-label Quinacrine at Month 2|10
960863|NCT00183092|2324722|P4|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
960864|NCT00183092|2324723|P3|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
960865|NCT00183092|2324724|P2|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
960866|NCT00183092|2324725|P1|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
960867|NCT00183092|2324722|P4|COMPLETED|Double-blind (Baseline - Month 2)||0
960868|NCT00183092|2324723|P3|COMPLETED|Double-blind (Baseline - Month 2)||0
960869|NCT00183092|2324724|P2|COMPLETED|Double-blind (Baseline - Month 2)||16
960870|NCT00183092|2324725|P1|COMPLETED|Double-blind (Baseline - Month 2)||11
960871|NCT00183092|2324722|P4|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
960872|NCT00183092|2324723|P3|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
960873|NCT00183092|2324724|P2|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||16
960874|NCT00183092|2324725|P1|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||10
960875|NCT00183092|2324722|P4|Alive at Month 2|Double-blind (Baseline - Month 2)||0
960876|NCT00183092|2324723|P3|Alive at Month 2|Double-blind (Baseline - Month 2)||0
960877|NCT00183092|2324724|P2|Alive at Month 2|Double-blind (Baseline - Month 2)||19
960878|NCT00183092|2324725|P1|Alive at Month 2|Double-blind (Baseline - Month 2)||13
960879|NCT00183092|2324722|P4|STARTED|Double-blind (Baseline - Month 2)||0
960880|NCT00183092|2324723|P3|STARTED|Double-blind (Baseline - Month 2)||0
960881|NCT00183092|2324724|P2|STARTED|Double-blind (Baseline - Month 2)||28
960882|NCT00183092|2324725|P1|STARTED|Double-blind (Baseline - Month 2)||23
960883|NCT00183196|2324749|P3|NOT COMPLETED|Overall Study||18
960884|NCT00183196|2324750|P2|NOT COMPLETED|Overall Study||15
960885|NCT00183196|2324751|P1|NOT COMPLETED|Overall Study||20
960886|NCT00183196|2324749|P3|COMPLETED|Overall Study||32
960887|NCT00183196|2324750|P2|COMPLETED|Overall Study||35
960888|NCT00183196|2324751|P1|COMPLETED|Overall Study||30
960889|NCT00183196|2324749|P3|STARTED|Overall Study|1 subject had no post-randomization data|50
960890|NCT00183196|2324750|P2|STARTED|Overall Study|1 subject had no post-randomization data|50
960891|NCT00183196|2324751|P1|STARTED|Overall Study|2 subjects had no post-randomization data|50
960892|NCT00183248|2324761|P2|NOT COMPLETED|Overall Study||1
960893|NCT00183248|2324762|P1|NOT COMPLETED|Overall Study||1
960894|NCT00183248|2324761|P2|COMPLETED|Overall Study||4
960895|NCT00183248|2324762|P1|COMPLETED|Overall Study||3
960896|NCT00183248|2324761|P2|STARTED|Overall Study||5
960897|NCT00183248|2324762|P1|STARTED|Overall Study||4
960898|NCT00183274|2324780|P6|NOT COMPLETED|Phase 3: Double-Blind||4
960899|NCT00183274|2324781|P5|NOT COMPLETED|Phase 3: Double-Blind||20
960900|NCT00183274|2324782|P4|NOT COMPLETED|Phase 3: Double-Blind||2
960901|NCT00183274|2324783|P3|NOT COMPLETED|Phase 3: Double-Blind||0
960902|NCT00183274|2324784|P2|NOT COMPLETED|Phase 3: Double-Blind||0
960903|NCT00183274|2324785|P1|NOT COMPLETED|Phase 3: Double-Blind||0
960904|NCT00183274|2324780|P6|COMPLETED|Phase 3: Double-Blind|2 lost to relapse and 2 lost to dropout|6
960905|NCT00183274|2324781|P5|COMPLETED|Phase 3: Double-Blind|11 lost to relapse and 9 lost to dropout|14
960906|NCT00183274|2324782|P4|COMPLETED|Phase 3: Double-Blind|1 lost to relapse and 1 lost to dropout|13
960907|NCT00183274|2324783|P3|COMPLETED|Phase 3: Double-Blind||0
960908|NCT00183274|2324784|P2|COMPLETED|Phase 3: Double-Blind||0
960909|NCT00183274|2324785|P1|COMPLETED|Phase 3: Double-Blind||0
960910|NCT00183274|2324780|P6|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|10
960911|NCT00183274|2324781|P5|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|34
960912|NCT00183274|2324782|P4|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|15
960913|NCT00183274|2324783|P3|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
960914|NCT00183274|2324784|P2|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
960915|NCT00183274|2324785|P1|STARTED|Phase 3: Double-Blind||0
960916|NCT00183274|2324780|P6|NOT COMPLETED|Phase 2: Double-Blind||0
960917|NCT00183274|2324781|P5|NOT COMPLETED|Phase 2: Double-Blind||0
960918|NCT00183274|2324782|P4|NOT COMPLETED|Phase 2: Double-Blind||0
960919|NCT00183274|2324783|P3|NOT COMPLETED|Phase 2: Double-Blind||43
960920|NCT00183274|2324784|P2|NOT COMPLETED|Phase 2: Double-Blind||26
960921|NCT00183274|2324785|P1|NOT COMPLETED|Phase 2: Double-Blind||0
960922|NCT00183274|2324780|P6|COMPLETED|Phase 2: Double-Blind||0
960923|NCT00183274|2324781|P5|COMPLETED|Phase 2: Double-Blind||0
960924|NCT00183274|2324782|P4|COMPLETED|Phase 2: Double-Blind||0
960925|NCT00183274|2324783|P3|COMPLETED|Phase 2: Double-Blind|29 lost to relapse, 14 lost to dropout|11
960926|NCT00183274|2324784|P2|COMPLETED|Phase 2: Double-Blind|8 lost to relapse, 18 lost to dropout|56
960927|NCT00183274|2324785|P1|COMPLETED|Phase 2: Double-Blind||0
960928|NCT00183274|2324780|P6|STARTED|Phase 2: Double-Blind||0
960929|NCT00183274|2324781|P5|STARTED|Phase 2: Double-Blind||0
960930|NCT00183274|2324782|P4|STARTED|Phase 2: Double-Blind||0
960931|NCT00183274|2324783|P3|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|54
960932|NCT00183274|2324784|P2|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|82
960933|NCT00183274|2324785|P1|STARTED|Phase 2: Double-Blind|This phase ended after 6 months. There were no longer participants in this phase.|0
960934|NCT00183274|2324780|P6|NOT COMPLETED|Phase 1: Open-Label||0
960935|NCT00183274|2324781|P5|NOT COMPLETED|Phase 1: Open-Label||0
960936|NCT00183274|2324782|P4|NOT COMPLETED|Phase 1: Open-Label||0
960937|NCT00183274|2324783|P3|NOT COMPLETED|Phase 1: Open-Label||0
960938|NCT00183274|2324784|P2|NOT COMPLETED|Phase 1: Open-Label||0
960939|NCT00183274|2324785|P1|NOT COMPLETED|Phase 1: Open-Label||110
960940|NCT00183274|2324780|P6|COMPLETED|Phase 1: Open-Label||0
960941|NCT00183274|2324781|P5|COMPLETED|Phase 1: Open-Label||0
960942|NCT00183274|2324782|P4|COMPLETED|Phase 1: Open-Label||0
960943|NCT00183274|2324783|P3|COMPLETED|Phase 1: Open-Label||0
960944|NCT00183274|2324784|P2|COMPLETED|Phase 1: Open-Label||0
960945|NCT00183274|2324785|P1|COMPLETED|Phase 1: Open-Label|110 dropouts during phase 1|158
960946|NCT00183274|2324780|P6|STARTED|Phase 1: Open-Label||0
960947|NCT00183274|2324781|P5|STARTED|Phase 1: Open-Label||0
960948|NCT00183274|2324782|P4|STARTED|Phase 1: Open-Label||0
960949|NCT00183274|2324783|P3|STARTED|Phase 1: Open-Label||0
960950|NCT00183274|2324784|P2|STARTED|Phase 1: Open-Label||0
960951|NCT00183274|2324785|P1|STARTED|Phase 1: Open-Label||268
960952|NCT00183339|2324802|P2|NOT COMPLETED|Overall Study||4
960953|NCT00183339|2324803|P1|NOT COMPLETED|Overall Study||6
960954|NCT00183339|2324802|P2|COMPLETED|Overall Study||4
960955|NCT00183339|2324803|P1|COMPLETED|Overall Study||4
960956|NCT00183339|2324802|P2|STARTED|Overall Study||8
960957|NCT00183339|2324803|P1|STARTED|Overall Study||10
960958|NCT00183430|2324817|P2|NOT COMPLETED|Overall Study||0
960959|NCT00183430|2324818|P1|NOT COMPLETED|Overall Study||6
960960|NCT00183430|2324817|P2|COMPLETED|Overall Study||11
960961|NCT00183430|2324818|P1|COMPLETED|Overall Study||3
960962|NCT00183430|2324817|P2|STARTED|Overall Study||11
960963|NCT00183430|2324818|P1|STARTED|Overall Study||9
960964|NCT00183456|2324832|P4|NOT COMPLETED|Overall Study||28
960965|NCT00183456|2324833|P3|NOT COMPLETED|Overall Study||16
960966|NCT00183456|2324834|P2|NOT COMPLETED|Overall Study||1
960967|NCT00183456|2324835|P1|NOT COMPLETED|Overall Study||3
960968|NCT00183456|2324832|P4|COMPLETED|Overall Study|total # of non-randomized index participants that completed any follow-up|220
960969|NCT00183456|2324833|P3|COMPLETED|Overall Study|total # of network participants that completed any follow-up|313
960970|NCT00183456|2324834|P2|COMPLETED|Overall Study|total # of comparison condition participants that completed any follow-up|83
960971|NCT00183456|2324835|P1|COMPLETED|Overall Study|total # of intervention participants that completed any follow-up (6, 12, or 18 month Follow-up)|82
960972|NCT00183456|2324832|P4|18 Month Follow-up|Overall Study||207
960973|NCT00183456|2324833|P3|18 Month Follow-up|Overall Study||303
960974|NCT00183456|2324834|P2|18 Month Follow-up|Overall Study||81
960975|NCT00183456|2324835|P1|18 Month Follow-up|Overall Study||80
960976|NCT00183456|2324832|P4|12 Month Follow-up|Overall Study||186
960977|NCT00183456|2324833|P3|12 Month Follow-up|Overall Study||267
960978|NCT00183456|2324834|P2|12 Month Follow-up|Overall Study||74
960979|NCT00183456|2324835|P1|12 Month Follow-up|Overall Study||76
960980|NCT00183456|2324832|P4|6 Month Follow-up|Overall Study||175
960981|NCT00183456|2324833|P3|6 Month Follow-up|Overall Study||278
960982|NCT00183456|2324834|P2|6 Month Follow-up|Overall Study||77
960983|NCT00183456|2324835|P1|6 Month Follow-up|Overall Study||74
960984|NCT00183456|2324832|P4|STARTED|Overall Study||248
960985|NCT00183456|2324833|P3|STARTED|Overall Study||329
960986|NCT00183456|2324834|P2|STARTED|Overall Study||84
960987|NCT00183456|2324835|P1|STARTED|Overall Study||85
960988|NCT00183469|2324883|P2|NOT COMPLETED|Overall Study||29
960989|NCT00183469|2324884|P1|NOT COMPLETED|Overall Study||28
960990|NCT00183469|2324883|P2|COMPLETED|Overall Study||16
960991|NCT00183469|2324884|P1|COMPLETED|Overall Study||13
960992|NCT00183469|2324883|P2|STARTED|Overall Study||45
960993|NCT00183469|2324884|P1|STARTED|Overall Study||41
960994|NCT00183625|2324892|P4|NOT COMPLETED|Overall Study||14
960995|NCT00183625|2324893|P3|NOT COMPLETED|Overall Study||19
960996|NCT00183625|2324894|P2|NOT COMPLETED|Overall Study||18
960997|NCT00183625|2324895|P1|NOT COMPLETED|Overall Study||18
960998|NCT00183625|2324892|P4|COMPLETED|Overall Study||10
960999|NCT00183625|2324893|P3|COMPLETED|Overall Study||9
961000|NCT00183625|2324894|P2|COMPLETED|Overall Study||10
961001|NCT00183625|2324895|P1|COMPLETED|Overall Study||9
961002|NCT00183625|2324892|P4|Obtained Employment|Overall Study||14
961003|NCT00183625|2324893|P3|Obtained Employment|Overall Study||14
961004|NCT00183625|2324894|P2|Obtained Employment|Overall Study||18
961005|NCT00183625|2324895|P1|Obtained Employment|Overall Study||21
961006|NCT00183625|2324892|P4|STARTED|Overall Study||24
961007|NCT00183625|2324893|P3|STARTED|Overall Study||28
961008|NCT00183625|2324894|P2|STARTED|Overall Study||28
961009|NCT00183625|2324895|P1|STARTED|Overall Study||27
961010|NCT00183677|2324903|P1|NOT COMPLETED|Overall Study||44
961011|NCT00183677|2324903|P1|COMPLETED|Overall Study||53
961012|NCT00183677|2324903|P1|STARTED|Overall Study||97
961013|NCT00183729|2324909|P2|NOT COMPLETED|Overall Study||5
961014|NCT00183729|2324910|P1|NOT COMPLETED|Overall Study||3
961015|NCT00183729|2324909|P2|COMPLETED|Overall Study||13
961016|NCT00183729|2324910|P1|COMPLETED|Overall Study||14
961017|NCT00183729|2324909|P2|STARTED|Overall Study||18
961018|NCT00183729|2324910|P1|STARTED|Overall Study||17
961019|NCT00183794|2324916|P1|NOT COMPLETED|Overall Study||0
961020|NCT00183794|2324916|P1|COMPLETED|Overall Study||20
961021|NCT00183794|2324916|P1|STARTED|Overall Study||20
961022|NCT00192296|2324925|P4|NOT COMPLETED|Overall Study||0
961023|NCT00192296|2324926|P3|NOT COMPLETED|Overall Study||0
961024|NCT00192296|2324927|P2|NOT COMPLETED|Overall Study||1
961025|NCT00192296|2324928|P1|NOT COMPLETED|Overall Study||0
961026|NCT00192296|2324925|P4|COMPLETED|Overall Study||6
961027|NCT00192296|2324926|P3|COMPLETED|Overall Study||6
961028|NCT00192296|2324927|P2|COMPLETED|Overall Study||5
961029|NCT00192296|2324928|P1|COMPLETED|Overall Study||6
961030|NCT00192296|2324925|P4|STARTED|Overall Study||6
961031|NCT00192296|2324926|P3|STARTED|Overall Study||6
961032|NCT00192296|2324927|P2|STARTED|Overall Study||6
961033|NCT00192296|2324928|P1|STARTED|Overall Study||6
961034|NCT00193037|2324984|P2|NOT COMPLETED|Crossover Treatment||0
961035|NCT00193037|2324985|P1|NOT COMPLETED|Crossover Treatment||0
961036|NCT00193037|2324984|P2|COMPLETED|Crossover Treatment||24
961037|NCT00193037|2324985|P1|COMPLETED|Crossover Treatment||32
961038|NCT00193037|2324984|P2|STARTED|Crossover Treatment||24
961039|NCT00193037|2324985|P1|STARTED|Crossover Treatment||32
961040|NCT00193037|2324984|P2|NOT COMPLETED|Randomized Treatment||28
961041|NCT00193037|2324985|P1|NOT COMPLETED|Randomized Treatment||18
961042|NCT00193037|2324984|P2|COMPLETED|Randomized Treatment||24
961043|NCT00193037|2324985|P1|COMPLETED|Randomized Treatment||32
961044|NCT00193037|2324984|P2|STARTED|Randomized Treatment||52
961045|NCT00193037|2324985|P1|STARTED|Randomized Treatment||50
961046|NCT00193050|2324993|P1|NOT COMPLETED|Adjuvant||10
961047|NCT00193050|2324993|P1|COMPLETED|Adjuvant||77
961048|NCT00193050|2324993|P1|STARTED|Adjuvant|16 patients never initiated postoperative adjuvant therapy|87
961049|NCT00193050|2324993|P1|NOT COMPLETED|Surgery||0
961050|NCT00193050|2324993|P1|COMPLETED|Surgery||103
961051|NCT00193050|2324993|P1|STARTED|Surgery|2 patients had surgery after 2 cycles of neoadjuvant treatment|103
961052|NCT00193050|2324993|P1|NOT COMPLETED|Neoadjuvant Treatment||9
961053|NCT00193050|2324993|P1|COMPLETED|Neoadjuvant Treatment||101
961054|NCT00193050|2324993|P1|STARTED|Neoadjuvant Treatment||110
961055|NCT00193063|2324997|P1|NOT COMPLETED|Overall Study||4
961056|NCT00193063|2324997|P1|COMPLETED|Overall Study||37
961057|NCT00193063|2324997|P1|STARTED|Overall Study||41
961058|NCT00193128|2325005|P2|NOT COMPLETED|Overall Study||10
961059|NCT00193128|2325006|P1|NOT COMPLETED|Overall Study||0
961060|NCT00193128|2325005|P2|COMPLETED|Overall Study||39
961061|NCT00193128|2325006|P1|COMPLETED|Overall Study||10
961062|NCT00193128|2325005|P2|STARTED|Overall Study||49
961063|NCT00193128|2325006|P1|STARTED|Overall Study||10
961064|NCT00193180|2325012|P1|NOT COMPLETED|Overall Study||10
961065|NCT00193180|2325012|P1|COMPLETED|Overall Study||27
961066|NCT00193180|2325012|P1|STARTED|Overall Study||37
961067|NCT00193206|2325018|P1|NOT COMPLETED|Postoperative Therapy||14
961068|NCT00193206|2325018|P1|COMPLETED|Postoperative Therapy||102
961069|NCT00193206|2325018|P1|STARTED|Postoperative Therapy||116
961070|NCT00193206|2325018|P1|NOT COMPLETED|Surgery||0
961071|NCT00193206|2325018|P1|COMPLETED|Surgery||116
961072|NCT00193206|2325018|P1|STARTED|Surgery||116
961073|NCT00193206|2325018|P1|NOT COMPLETED|Preoperative Therapy||7
961074|NCT00193206|2325018|P1|COMPLETED|Preoperative Therapy||116
961075|NCT00193206|2325018|P1|STARTED|Preoperative Therapy||123
961076|NCT00193219|2325022|P1|NOT COMPLETED|Overall Study||30
961077|NCT00193219|2325022|P1|COMPLETED|Overall Study||6
961078|NCT00193219|2325022|P1|STARTED|Overall Study||36
961079|NCT00193258|2325028|P1|NOT COMPLETED|Overall Study||0
961080|NCT00193258|2325028|P1|COMPLETED|Overall Study||94
961081|NCT00193258|2325028|P1|STARTED|Overall Study||94
961082|NCT00193375|2325034|P1|NOT COMPLETED|Overall Study||19
961083|NCT00193375|2325034|P1|COMPLETED|Overall Study||41
961084|NCT00193375|2325034|P1|STARTED|Overall Study||60
961085|NCT00193414|2325040|P1|NOT COMPLETED|Overall Study||58
961086|NCT00193414|2325040|P1|COMPLETED|Overall Study||14
961087|NCT00193414|2325040|P1|STARTED|Overall Study||72
961088|NCT00193427|2325046|P1|NOT COMPLETED|Overall Study||49
961089|NCT00193427|2325046|P1|COMPLETED|Overall Study||26
961090|NCT00193427|2325046|P1|STARTED|Overall Study||75
961091|NCT00193453|2325053|P1|NOT COMPLETED|Overall Study||48
961092|NCT00193453|2325053|P1|COMPLETED|Overall Study||21
961093|NCT00193453|2325053|P1|STARTED|Overall Study||69
961094|NCT00193479|2325059|P1|NOT COMPLETED|Maintenance Rituximab||0
961095|NCT00193479|2325059|P1|COMPLETED|Maintenance Rituximab||44
961096|NCT00193479|2325059|P1|STARTED|Maintenance Rituximab||44
961097|NCT00193479|2325059|P1|NOT COMPLETED|Induction Chemotherapy||3
961098|NCT00193479|2325059|P1|COMPLETED|Induction Chemotherapy||48
961099|NCT00193479|2325059|P1|STARTED|Induction Chemotherapy||51
961100|NCT00193492|2325065|P2|NOT COMPLETED|Overall Study||15
961101|NCT00193492|2325066|P1|NOT COMPLETED|Overall Study||17
961102|NCT00193492|2325065|P2|COMPLETED|Overall Study||14
961103|NCT00193492|2325066|P1|COMPLETED|Overall Study||14
961104|NCT00193492|2325065|P2|STARTED|Overall Study||29
961105|NCT00193492|2325066|P1|STARTED|Overall Study||31
961106|NCT00193596|2325076|P2|NOT COMPLETED|Overall Study||66
961107|NCT00193596|2325077|P1|NOT COMPLETED|Overall Study||56
961108|NCT00193596|2325076|P2|COMPLETED|Overall Study||39
961109|NCT00193596|2325077|P1|COMPLETED|Overall Study||37
961110|NCT00193596|2325076|P2|STARTED|Overall Study||105
961111|NCT00193596|2325077|P1|STARTED|Overall Study||93
961112|NCT00193609|2325085|P1|NOT COMPLETED|Overall Study||4
961113|NCT00193609|2325085|P1|COMPLETED|Overall Study||44
961114|NCT00193609|2325085|P1|STARTED|Overall Study||48
961115|NCT00194012|2325092|P2|NOT COMPLETED|Open Label Extension (OLE)||6
961116|NCT00194012|2325093|P1|NOT COMPLETED|Open Label Extension (OLE)||5
961117|NCT00194012|2325092|P2|COMPLETED|Open Label Extension (OLE)||15
961118|NCT00194012|2325093|P1|COMPLETED|Open Label Extension (OLE)||17
961119|NCT00194012|2325092|P2|STARTED|Open Label Extension (OLE)|Participants from placebo group started OLE (eligible even if randomized period not completed).|21
961120|NCT00194012|2325093|P1|STARTED|Open Label Extension (OLE)|Participants from aripiprazole group started OLE (eligible even if randomized period not completed).|22
961121|NCT00194012|2325092|P2|NOT COMPLETED|Randomized Phase||25
961122|NCT00194012|2325093|P1|NOT COMPLETED|Randomized Phase||16
961123|NCT00194012|2325092|P2|COMPLETED|Randomized Phase||6
961124|NCT00194012|2325093|P1|COMPLETED|Randomized Phase||15
961125|NCT00194012|2325092|P2|Received More Than One Dose|Randomized Phase||29
961126|NCT00194012|2325093|P1|Received More Than One Dose|Randomized Phase||30
961127|NCT00194012|2325092|P2|STARTED|Randomized Phase||31
961128|NCT00194012|2325093|P1|STARTED|Randomized Phase||31
961129|NCT00194025|2325129|P1|NOT COMPLETED|Overall Study||5
961130|NCT00194025|2325129|P1|COMPLETED|Overall Study|5 participants withdrew prematurely|15
961131|NCT00194025|2325129|P1|STARTED|Overall Study|The intent-to-treat population received at least one dose of valproate semisodium.|20
961132|NCT00194077|2325144|P2|NOT COMPLETED|Overall Study||30
961133|NCT00194077|2325145|P1|NOT COMPLETED|Overall Study||24
961134|NCT00194077|2325144|P2|COMPLETED|Overall Study|"Lack of efficacy:
hypomania n=17 Cycling n=6 Mania n=5 Mixed state n=1 Concern regarding tx n=1"|0
961135|NCT00194077|2325145|P1|COMPLETED|Overall Study|"Lack of efficacy:
Hypomania n=12 Cycling n=5 Mixed state=4 Mania n=1"|6
961136|NCT00194077|2325144|P2|STARTED|Overall Study||30
961137|NCT00194077|2325145|P1|STARTED|Overall Study||30
961144|NCT00194532|2325162|P2|NOT COMPLETED|Overall Study||0
961145|NCT00194532|2325163|P1|NOT COMPLETED|Overall Study||0
961146|NCT00194532|2325162|P2|COMPLETED|Overall Study||150
961147|NCT00194532|2325163|P1|COMPLETED|Overall Study||150
961148|NCT00194532|2325162|P2|STARTED|Overall Study||150
961149|NCT00194532|2325163|P1|STARTED|Overall Study||150
961150|NCT00194610|2325173|P2|NOT COMPLETED|Overall Study||0
961151|NCT00194610|2325174|P1|NOT COMPLETED|Overall Study||0
961152|NCT00194610|2325173|P2|COMPLETED|Overall Study||9
961153|NCT00194610|2325174|P1|COMPLETED|Overall Study||11
961154|NCT00194610|2325173|P2|STARTED|Overall Study||9
961155|NCT00194610|2325174|P1|STARTED|Overall Study||11
961156|NCT00194675|2325182|P2|NOT COMPLETED|Overall Study||2
961157|NCT00194675|2325183|P1|NOT COMPLETED|Overall Study||5
961158|NCT00194675|2325182|P2|COMPLETED|Overall Study||24
961159|NCT00194675|2325183|P1|COMPLETED|Overall Study||22
961160|NCT00194675|2325182|P2|STARTED|Overall Study||26
961161|NCT00194675|2325183|P1|STARTED|Overall Study||27
961162|NCT00194792|2325199|P1|NOT COMPLETED|Overall Study||1
961163|NCT00194792|2325199|P1|COMPLETED|Overall Study||27
961164|NCT00194792|2325199|P1|STARTED|Overall Study||28
961165|NCT00194896|2325213|P4|NOT COMPLETED|Overall Study||12
961166|NCT00194896|2325214|P3|NOT COMPLETED|Overall Study||6
961167|NCT00194896|2325215|P2|NOT COMPLETED|Overall Study||5
961168|NCT00194896|2325216|P1|NOT COMPLETED|Overall Study||11
961169|NCT00194896|2325213|P4|COMPLETED|Overall Study||9
961170|NCT00194896|2325214|P3|COMPLETED|Overall Study||7
961171|NCT00194896|2325215|P2|COMPLETED|Overall Study||10
961172|NCT00194896|2325216|P1|COMPLETED|Overall Study||4
961173|NCT00194896|2325213|P4|STARTED|Overall Study||21
961174|NCT00194896|2325214|P3|STARTED|Overall Study||13
961175|NCT00194896|2325215|P2|STARTED|Overall Study||15
961176|NCT00194896|2325216|P1|STARTED|Overall Study||15
961177|NCT00195013|2325232|P2|NOT COMPLETED|Overall Study||1
961178|NCT00195013|2325233|P1|NOT COMPLETED|Overall Study||2
961179|NCT00195013|2325232|P2|COMPLETED|Overall Study||15
961180|NCT00195013|2325233|P1|COMPLETED|Overall Study||12
961181|NCT00195013|2325232|P2|STARTED|Overall Study||16
961182|NCT00195013|2325233|P1|STARTED|Overall Study||14
961183|NCT00195039|2325239|P1|NOT COMPLETED|Overall Study||0
961184|NCT00195039|2325239|P1|COMPLETED|Overall Study||47
961185|NCT00195039|2325239|P1|STARTED|Overall Study||47
961186|NCT00187200|2325252|P2|NOT COMPLETED|Overall Study||18
961187|NCT00187200|2325253|P1|NOT COMPLETED|Overall Study||18
961188|NCT00187200|2325252|P2|COMPLETED|Overall Study||26
961189|NCT00187200|2325253|P1|COMPLETED|Overall Study||31
961190|NCT00187200|2325252|P2|STARTED|Overall Study||44
961191|NCT00187200|2325253|P1|STARTED|Overall Study||49
961192|NCT00187226|2325271|P6|NOT COMPLETED|Overall Study||0
961193|NCT00187226|2325272|P5|NOT COMPLETED|Overall Study||0
961194|NCT00187226|2325273|P4|NOT COMPLETED|Overall Study||0
961195|NCT00187226|2325274|P3|NOT COMPLETED|Overall Study||0
961196|NCT00187226|2325275|P2|NOT COMPLETED|Overall Study||0
961197|NCT00187226|2325276|P1|NOT COMPLETED|Overall Study||0
961198|NCT00187226|2325271|P6|COMPLETED|Overall Study||1
961199|NCT00187226|2325272|P5|COMPLETED|Overall Study||34
961200|NCT00187226|2325273|P4|COMPLETED|Overall Study||2
961201|NCT00187226|2325274|P3|COMPLETED|Overall Study||28
961202|NCT00187226|2325275|P2|COMPLETED|Overall Study||49
961203|NCT00187226|2325276|P1|COMPLETED|Overall Study||88
961204|NCT00187226|2325271|P6|STARTED|Overall Study||1
961205|NCT00187226|2325272|P5|STARTED|Overall Study||34
961206|NCT00187226|2325273|P4|STARTED|Overall Study||2
961207|NCT00187226|2325274|P3|STARTED|Overall Study||28
961208|NCT00187226|2325275|P2|STARTED|Overall Study||49
961209|NCT00187226|2325276|P1|STARTED|Overall Study||88
961210|NCT00187486|2325290|P1|NOT COMPLETED|Overall Study||1
961211|NCT00187486|2325290|P1|COMPLETED|Overall Study||65
961212|NCT00187486|2325290|P1|STARTED|Overall Study||66
961213|NCT00187655|2325295|P1|NOT COMPLETED|Overall Study||0
961214|NCT00187655|2325295|P1|COMPLETED|Overall Study||24
961215|NCT00187655|2325295|P1|STARTED|Overall Study||24
961216|NCT00187681|2325302|P2|NOT COMPLETED|Overall Study||0
961217|NCT00187681|2325303|P1|NOT COMPLETED|Overall Study||0
961218|NCT00187681|2325302|P2|COMPLETED|Overall Study||8
961219|NCT00187681|2325303|P1|COMPLETED|Overall Study||12
961220|NCT00187681|2325302|P2|STARTED|Overall Study||8
961221|NCT00187681|2325303|P1|STARTED|Overall Study||12
961222|NCT00187720|2325313|P2|NOT COMPLETED|Overall Study||0
961223|NCT00187720|2325314|P1|NOT COMPLETED|Overall Study||0
961224|NCT00187720|2325313|P2|COMPLETED|Overall Study||14
961225|NCT00187720|2325314|P1|COMPLETED|Overall Study||9
961226|NCT00187720|2325313|P2|STARTED|Overall Study||14
961227|NCT00187720|2325314|P1|STARTED|Overall Study||9
961228|NCT00187876|2325322|P2|NOT COMPLETED|Overall Study||0
961229|NCT00187876|2325323|P1|NOT COMPLETED|Overall Study||0
961230|NCT00187876|2325322|P2|COMPLETED|Overall Study||43
961231|NCT00187876|2325323|P1|COMPLETED|Overall Study||24
961232|NCT00187876|2325322|P2|STARTED|Overall Study||43
961233|NCT00187876|2325323|P1|STARTED|Overall Study||24
961240|NCT00189098|2325342|P2|NOT COMPLETED|Overall Study||6
961241|NCT00189098|2325343|P1|NOT COMPLETED|Overall Study||5
961242|NCT00189098|2325342|P2|COMPLETED|Overall Study||44
961243|NCT00189098|2325343|P1|COMPLETED|Overall Study||46
961244|NCT00189098|2325342|P2|STARTED|Overall Study||50
961245|NCT00189098|2325343|P1|STARTED|Overall Study||51
961246|NCT00189137|2325361|P2|NOT COMPLETED|Overall Study||0
961247|NCT00189137|2325362|P1|NOT COMPLETED|Overall Study||0
961248|NCT00189137|2325361|P2|COMPLETED|Overall Study||43
961249|NCT00189137|2325362|P1|COMPLETED|Overall Study||37
961250|NCT00189137|2325361|P2|STARTED|Overall Study||43
961251|NCT00189137|2325362|P1|STARTED|Overall Study||37
961252|NCT00189202|2325370|P1|NOT COMPLETED|Overall Study||5
961253|NCT00189202|2325370|P1|COMPLETED|Overall Study||44
961254|NCT00189202|2325370|P1|STARTED|Overall Study||49
961255|NCT00189306|2325379|P1|NOT COMPLETED|Long-Term Follow-up||38
961256|NCT00189306|2325379|P1|COMPLETED|Long-Term Follow-up||119
961257|NCT00189306|2325379|P1|STARTED|Long-Term Follow-up||157
961258|NCT00189306|2325379|P1|NOT COMPLETED|Posttreatment Period||12
961259|NCT00189306|2325379|P1|COMPLETED|Posttreatment Period|11 subjects discontinued during the 12-week Posttreatment Period|157
961260|NCT00189306|2325379|P1|STARTED|Posttreatment Period|5 of the 169 discontinued, but 4 returned for the Posttreatment Period|169
961261|NCT00189306|2325379|P1|NOT COMPLETED|Treatment Period||5
961262|NCT00189306|2325379|P1|COMPLETED|Treatment Period|5 subjects discontinued during treatment - 4 subjects returned for the Posttreatment Period|164
961263|NCT00189306|2325379|P1|STARTED|Treatment Period||169
961264|NCT00189423|2325386|P2|NOT COMPLETED|Overall Study||766
961265|NCT00189423|2325387|P1|NOT COMPLETED|Overall Study||765
961266|NCT00189423|2325386|P2|COMPLETED|Overall Study||74
961267|NCT00189423|2325387|P1|COMPLETED|Overall Study||48
961268|NCT00189423|2325386|P2|STARTED|Overall Study||840
961269|NCT00189423|2325387|P1|STARTED|Overall Study||813
961270|NCT00189436|2325409|P2|NOT COMPLETED|Overall Study||5
961271|NCT00189436|2325410|P1|NOT COMPLETED|Overall Study||8
961272|NCT00189436|2325409|P2|COMPLETED|Overall Study||25
961273|NCT00189436|2325410|P1|COMPLETED|Overall Study||23
961274|NCT00189436|2325409|P2|STARTED|Overall Study||30
961275|NCT00189436|2325410|P1|STARTED|Overall Study||31
961276|NCT00189462|2325418|P2|NOT COMPLETED|Overall Study||21
961277|NCT00189462|2325419|P1|NOT COMPLETED|Overall Study||23
961278|NCT00189462|2325418|P2|COMPLETED|Overall Study||28
961279|NCT00189462|2325419|P1|COMPLETED|Overall Study||27
961280|NCT00189462|2325418|P2|STARTED|Overall Study||49
961281|NCT00189462|2325419|P1|STARTED|Overall Study||50
961282|NCT00189475|2325427|P2|NOT COMPLETED|Overall Study||0
961283|NCT00189475|2325428|P1|NOT COMPLETED|Overall Study||0
961284|NCT00189475|2325427|P2|COMPLETED|Overall Study||42
961285|NCT00189475|2325428|P1|COMPLETED|Overall Study||42
961286|NCT00189475|2325427|P2|STARTED|Overall Study||42
961287|NCT00189475|2325428|P1|STARTED|Overall Study||42
961288|NCT00189488|2325436|P2|NOT COMPLETED|Overall Study||22
961289|NCT00189488|2325437|P1|NOT COMPLETED|Overall Study||15
961290|NCT00189488|2325436|P2|COMPLETED|Overall Study||55
961291|NCT00189488|2325437|P1|COMPLETED|Overall Study||63
961292|NCT00189488|2325436|P2|Received Palifermin/Placebo|Overall Study||76
961293|NCT00189488|2325437|P1|Received Palifermin/Placebo|Overall Study||75
961294|NCT00189488|2325436|P2|STARTED|Overall Study||77
961295|NCT00189488|2325437|P1|STARTED|Overall Study||78
961302|NCT00195260|2325478|P11|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||23
961303|NCT00195260|2325479|P10|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||38
961304|NCT00195260|2325480|P9|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||33
961305|NCT00195260|2325481|P8|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
961306|NCT00195260|2325482|P7|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
961307|NCT00195260|2325483|P6|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
961308|NCT00195260|2325484|P5|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
961309|NCT00195260|2325485|P4|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
961310|NCT00195260|2325486|P3|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
961311|NCT00195260|2325487|P2|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
961312|NCT00195260|2325488|P1|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
961313|NCT00195260|2325478|P11|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||2
961314|NCT00195260|2325479|P10|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
961315|NCT00195260|2325480|P9|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||4
961316|NCT00195260|2325481|P8|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
961317|NCT00195260|2325482|P7|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
961318|NCT00195260|2325483|P6|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
961319|NCT00195260|2325484|P5|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
961320|NCT00195260|2325485|P4|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
961321|NCT00195260|2325486|P3|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
961322|NCT00195260|2325487|P2|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
961323|NCT00195260|2325488|P1|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
961324|NCT00195260|2325478|P11|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||25
961325|NCT00195260|2325479|P10|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||38
961326|NCT00195260|2325480|P9|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||37
961327|NCT00195260|2325481|P8|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
961328|NCT00195260|2325482|P7|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
961329|NCT00195260|2325483|P6|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
961330|NCT00195260|2325484|P5|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
961331|NCT00195260|2325485|P4|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
961332|NCT00195260|2325486|P3|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
961333|NCT00195260|2325487|P2|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
961334|NCT00195260|2325488|P1|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
961335|NCT00195260|2325478|P11|NOT COMPLETED|Part 1: Dose Escalation||0
961336|NCT00195260|2325479|P10|NOT COMPLETED|Part 1: Dose Escalation||0
961337|NCT00195260|2325480|P9|NOT COMPLETED|Part 1: Dose Escalation||0
961338|NCT00195260|2325481|P8|NOT COMPLETED|Part 1: Dose Escalation||6
961339|NCT00195260|2325482|P7|NOT COMPLETED|Part 1: Dose Escalation||10
961340|NCT00195260|2325483|P6|NOT COMPLETED|Part 1: Dose Escalation||7
961341|NCT00195260|2325484|P5|NOT COMPLETED|Part 1: Dose Escalation||7
961342|NCT00195260|2325485|P4|NOT COMPLETED|Part 1: Dose Escalation||7
961343|NCT00195260|2325486|P3|NOT COMPLETED|Part 1: Dose Escalation||6
961344|NCT00195260|2325487|P2|NOT COMPLETED|Part 1: Dose Escalation||4
961345|NCT00195260|2325488|P1|NOT COMPLETED|Part 1: Dose Escalation||4
961346|NCT00195260|2325478|P11|COMPLETED|Part 1: Dose Escalation||0
961347|NCT00195260|2325479|P10|COMPLETED|Part 1: Dose Escalation||0
961348|NCT00195260|2325480|P9|COMPLETED|Part 1: Dose Escalation||0
961349|NCT00195260|2325481|P8|COMPLETED|Part 1: Dose Escalation||0
961350|NCT00195260|2325482|P7|COMPLETED|Part 1: Dose Escalation||0
961351|NCT00195260|2325483|P6|COMPLETED|Part 1: Dose Escalation||0
961352|NCT00195260|2325484|P5|COMPLETED|Part 1: Dose Escalation||0
961353|NCT00195260|2325485|P4|COMPLETED|Part 1: Dose Escalation||0
961354|NCT00195260|2325486|P3|COMPLETED|Part 1: Dose Escalation||0
961355|NCT00195260|2325487|P2|COMPLETED|Part 1: Dose Escalation||0
961356|NCT00195260|2325488|P1|COMPLETED|Part 1: Dose Escalation||0
961357|NCT00195260|2325478|P11|STARTED|Part 1: Dose Escalation||0
961358|NCT00195260|2325479|P10|STARTED|Part 1: Dose Escalation||0
961359|NCT00195260|2325480|P9|STARTED|Part 1: Dose Escalation||0
961360|NCT00195260|2325481|P8|STARTED|Part 1: Dose Escalation||6
961361|NCT00195260|2325482|P7|STARTED|Part 1: Dose Escalation||10
961362|NCT00195260|2325483|P6|STARTED|Part 1: Dose Escalation||7
961363|NCT00195260|2325484|P5|STARTED|Part 1: Dose Escalation||7
961364|NCT00195260|2325485|P4|STARTED|Part 1: Dose Escalation||7
961365|NCT00195260|2325486|P3|STARTED|Part 1: Dose Escalation||6
961366|NCT00195260|2325487|P2|STARTED|Part 1: Dose Escalation||4
961367|NCT00195260|2325488|P1|STARTED|Part 1: Dose Escalation||4
961368|NCT00195273|2325636|P2|NOT COMPLETED|Overall Study||14
961369|NCT00195273|2325637|P1|NOT COMPLETED|Overall Study||21
961370|NCT00195273|2325636|P2|COMPLETED|Overall Study||16
961371|NCT00195273|2325637|P1|COMPLETED|Overall Study||10
961372|NCT00195273|2325636|P2|STARTED|Overall Study||30
961373|NCT00195273|2325637|P1|STARTED|Overall Study||31
961374|NCT00195338|2325649|P1|NOT COMPLETED|Overall Study||12
961375|NCT00195338|2325649|P1|COMPLETED|Overall Study||13
961376|NCT00195338|2325649|P1|STARTED|Overall Study||25
961377|NCT00195351|2325659|P2|NOT COMPLETED|Overall Study||16
961378|NCT00195351|2325660|P1|NOT COMPLETED|Overall Study||21
961379|NCT00195351|2325659|P2|COMPLETED|Overall Study||215
961380|NCT00195351|2325660|P1|COMPLETED|Overall Study||215
961381|NCT00195351|2325659|P2|STARTED|Overall Study||231
961382|NCT00195351|2325660|P1|STARTED|Overall Study||236
961383|NCT00195403|2325670|P1|NOT COMPLETED|Overall Study||0
961384|NCT00195403|2325670|P1|COMPLETED|Overall Study||1014
961385|NCT00195403|2325670|P1|STARTED|Overall Study||1014
961386|NCT00195429|2325678|P2|NOT COMPLETED|Overall Study||5
961387|NCT00195429|2325679|P1|NOT COMPLETED|Overall Study||5
961388|NCT00195429|2325678|P2|COMPLETED|Overall Study||18
961389|NCT00195429|2325679|P1|COMPLETED|Overall Study||19
961390|NCT00195429|2325678|P2|STARTED|Overall Study||23
961391|NCT00195429|2325679|P1|STARTED|Overall Study||24
961392|NCT00195442|2325687|P1|NOT COMPLETED|Overall Study||136
961393|NCT00195442|2325687|P1|COMPLETED|Overall Study||152
961394|NCT00195442|2325687|P1|STARTED|Overall Study||288
961395|NCT00195494|2325706|P6|NOT COMPLETED|Year 2||0
961396|NCT00195494|2325707|P5|NOT COMPLETED|Year 2||0
961397|NCT00195494|2325708|P4|NOT COMPLETED|Year 2||23
961398|NCT00195494|2325709|P3|NOT COMPLETED|Year 2||18
961399|NCT00195494|2325710|P2|NOT COMPLETED|Year 2||16
961400|NCT00195494|2325711|P1|NOT COMPLETED|Year 2||7
961401|NCT00195494|2325706|P6|COMPLETED|Year 2||0
961402|NCT00195494|2325707|P5|COMPLETED|Year 2||0
961403|NCT00195494|2325708|P4|COMPLETED|Year 2||76
961404|NCT00195494|2325709|P3|COMPLETED|Year 2||93
961405|NCT00195494|2325710|P2|COMPLETED|Year 2||74
961406|NCT00195494|2325711|P1|COMPLETED|Year 2||104
961407|NCT00195494|2325706|P6|STARTED|Year 2||0
961408|NCT00195494|2325707|P5|STARTED|Year 2||0
961409|NCT00195494|2325708|P4|STARTED|Year 2||99
961410|NCT00195494|2325709|P3|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
961411|NCT00195494|2325710|P2|STARTED|Year 2||90
961412|NCT00195494|2325711|P1|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
961413|NCT00195494|2325706|P6|NOT COMPLETED|Year 1||53
961414|NCT00195494|2325707|P5|NOT COMPLETED|Year 1||79
961415|NCT00195494|2325708|P4|NOT COMPLETED|Year 1||0
961416|NCT00195494|2325709|P3|NOT COMPLETED|Year 1||0
961417|NCT00195494|2325710|P2|NOT COMPLETED|Year 1||0
961418|NCT00195494|2325711|P1|NOT COMPLETED|Year 1||0
961419|NCT00195494|2325706|P6|COMPLETED|Year 1||221
961420|NCT00195494|2325707|P5|COMPLETED|Year 1||189
961421|NCT00195494|2325708|P4|COMPLETED|Year 1||0
961422|NCT00195494|2325709|P3|COMPLETED|Year 1||0
961423|NCT00195494|2325710|P2|COMPLETED|Year 1||0
961424|NCT00195494|2325711|P1|COMPLETED|Year 1||0
961425|NCT00195494|2325706|P6|STARTED|Year 1||274
961426|NCT00195494|2325707|P5|STARTED|Year 1||268
961427|NCT00195494|2325708|P4|STARTED|Year 1||0
961428|NCT00195494|2325709|P3|STARTED|Year 1||0
961429|NCT00195494|2325710|P2|STARTED|Year 1||0
961430|NCT00195494|2325711|P1|STARTED|Year 1||0
961431|NCT00195507|2325731|P2|NOT COMPLETED|Overall Study||118
961432|NCT00195507|2325732|P1|NOT COMPLETED|Overall Study||99
961433|NCT00195507|2325731|P2|COMPLETED|Overall Study||245
961434|NCT00195507|2325732|P1|COMPLETED|Overall Study||258
961435|NCT00195507|2325731|P2|STARTED|Overall Study||363
961436|NCT00195507|2325732|P1|STARTED|Overall Study||357
961437|NCT00199381|2325744|P1|NOT COMPLETED|Overall Study||504
961438|NCT00199381|2325744|P1|COMPLETED|Overall Study|Premature study termination by the Sponsor.|0
961439|NCT00199381|2325744|P1|STARTED|Overall Study||504
961440|NCT00199914|2325750|P2|NOT COMPLETED|Overall Study||6
961441|NCT00199914|2325751|P1|NOT COMPLETED|Overall Study||3
961442|NCT00199914|2325750|P2|COMPLETED|Overall Study||54
961443|NCT00199914|2325751|P1|COMPLETED|Overall Study||50
961444|NCT00199914|2325750|P2|STARTED|Overall Study||60
961445|NCT00199914|2325751|P1|STARTED|Overall Study||53
961446|NCT00200057|2325757|P1|NOT COMPLETED|Overall Study||9
961447|NCT00200057|2325757|P1|COMPLETED|Overall Study||111
961448|NCT00200057|2325757|P1|12 Month Follow-up|Overall Study||111
961449|NCT00200057|2325757|P1|6 Month Follow-up|Overall Study||114
961450|NCT00200057|2325757|P1|3 Month Follow-up|Overall Study||116
961451|NCT00200057|2325757|P1|1 Month Follow-up|Overall Study||117
961452|NCT00200057|2325757|P1|STARTED|Overall Study||120
961453|NCT00200343|2325770|P3|NOT COMPLETED|Overall Study||13
961454|NCT00200343|2325771|P2|NOT COMPLETED|Overall Study||8
961455|NCT00200343|2325772|P1|NOT COMPLETED|Overall Study||16
961456|NCT00200343|2325770|P3|COMPLETED|Overall Study||184
961457|NCT00200343|2325771|P2|COMPLETED|Overall Study||192
961458|NCT00200343|2325772|P1|COMPLETED|Overall Study||183
961459|NCT00200343|2325770|P3|STARTED|Overall Study||197
961460|NCT00200343|2325771|P2|STARTED|Overall Study||200
961461|NCT00200343|2325772|P1|STARTED|Overall Study||199
961462|NCT00200356|2325797|P2|NOT COMPLETED|Overall Study||7
961463|NCT00200356|2325798|P1|NOT COMPLETED|Overall Study||8
961464|NCT00200356|2325797|P2|COMPLETED|Overall Study||195
961465|NCT00200356|2325798|P1|COMPLETED|Overall Study||191
961466|NCT00200356|2325797|P2|Safety Analysis Set|Overall Study||198
961467|NCT00200356|2325798|P1|Safety Analysis Set|Overall Study||194
961468|NCT00200356|2325797|P2|STARTED|Overall Study||202
961469|NCT00200356|2325798|P1|STARTED|Overall Study||199
961470|NCT00200785|2325824|P2|NOT COMPLETED|Second Intervention||0
961471|NCT00200785|2325825|P1|NOT COMPLETED|Second Intervention||0
961472|NCT00200785|2325824|P2|COMPLETED|Second Intervention||6
961473|NCT00200785|2325825|P1|COMPLETED|Second Intervention||9
961474|NCT00200785|2325824|P2|STARTED|Second Intervention||6
961475|NCT00200785|2325825|P1|STARTED|Second Intervention||9
961476|NCT00200785|2325824|P2|NOT COMPLETED|Washout Period of 1 Week||0
961477|NCT00200785|2325825|P1|NOT COMPLETED|Washout Period of 1 Week||0
961478|NCT00200785|2325824|P2|COMPLETED|Washout Period of 1 Week||6
961479|NCT00200785|2325825|P1|COMPLETED|Washout Period of 1 Week||9
961480|NCT00200785|2325824|P2|STARTED|Washout Period of 1 Week||6
961481|NCT00200785|2325825|P1|STARTED|Washout Period of 1 Week||9
961482|NCT00200785|2325824|P2|NOT COMPLETED|First Intervention||0
961483|NCT00200785|2325825|P1|NOT COMPLETED|First Intervention||0
961484|NCT00200785|2325824|P2|COMPLETED|First Intervention||6
961485|NCT00200785|2325825|P1|COMPLETED|First Intervention||9
961486|NCT00200785|2325824|P2|STARTED|First Intervention||6
961487|NCT00200785|2325825|P1|STARTED|First Intervention||9
961488|NCT00200967|2325835|P2|NOT COMPLETED|Run-out Period||0
961489|NCT00200967|2325836|P1|NOT COMPLETED|Run-out Period||1
961490|NCT00200967|2325835|P2|COMPLETED|Run-out Period||41
961491|NCT00200967|2325836|P1|COMPLETED|Run-out Period||34
961492|NCT00200967|2325835|P2|STARTED|Run-out Period||41
961493|NCT00200967|2325836|P1|STARTED|Run-out Period||35
961494|NCT00200967|2325835|P2|NOT COMPLETED|Second Treatment Period||2
961495|NCT00200967|2325836|P1|NOT COMPLETED|Second Treatment Period||1
961496|NCT00200967|2325835|P2|COMPLETED|Second Treatment Period||41
961497|NCT00200967|2325836|P1|COMPLETED|Second Treatment Period||35
961498|NCT00200967|2325835|P2|STARTED|Second Treatment Period||43
961499|NCT00200967|2325836|P1|STARTED|Second Treatment Period||36
961500|NCT00200967|2325835|P2|NOT COMPLETED|Wash-out Period||1
961501|NCT00200967|2325836|P1|NOT COMPLETED|Wash-out Period||0
961502|NCT00200967|2325835|P2|COMPLETED|Wash-out Period||43
961503|NCT00200967|2325836|P1|COMPLETED|Wash-out Period||36
961504|NCT00200967|2325835|P2|STARTED|Wash-out Period||44
961505|NCT00200967|2325836|P1|STARTED|Wash-out Period||36
961506|NCT00200967|2325835|P2|NOT COMPLETED|First Treatment Period||1
961507|NCT00200967|2325836|P1|NOT COMPLETED|First Treatment Period||6
961508|NCT00200967|2325835|P2|COMPLETED|First Treatment Period||44
961509|NCT00200967|2325836|P1|COMPLETED|First Treatment Period||36
961510|NCT00200967|2325835|P2|First Treatment Period|First Treatment Period||45
961511|NCT00200967|2325836|P1|First Treatment Period|First Treatment Period||42
961512|NCT00200967|2325835|P2|STARTED|First Treatment Period||45
961513|NCT00200967|2325836|P1|STARTED|First Treatment Period||42
961514|NCT00201006|2325867|P3|NOT COMPLETED|Overall Study||4
961515|NCT00201006|2325868|P2|NOT COMPLETED|Overall Study||2
961516|NCT00201006|2325869|P1|NOT COMPLETED|Overall Study||8
961517|NCT00201006|2325867|P3|COMPLETED|Overall Study||75
961518|NCT00201006|2325868|P2|COMPLETED|Overall Study||70
961519|NCT00201006|2325869|P1|COMPLETED|Overall Study||75
961520|NCT00201006|2325867|P3|STARTED|Overall Study||79
961521|NCT00201006|2325868|P2|STARTED|Overall Study||72
961522|NCT00201006|2325869|P1|STARTED|Overall Study||83
961523|NCT00201123|2325880|P3|NOT COMPLETED|Overall Study||9
961524|NCT00201123|2325881|P2|NOT COMPLETED|Overall Study||4
961525|NCT00201123|2325882|P1|NOT COMPLETED|Overall Study||6
961526|NCT00201123|2325880|P3|COMPLETED|Overall Study||23
961527|NCT00201123|2325881|P2|COMPLETED|Overall Study||28
961528|NCT00201123|2325882|P1|COMPLETED|Overall Study||26
961529|NCT00201123|2325880|P3|Did Not Meet Continuation Criteria|Overall Study||5
961530|NCT00201123|2325881|P2|Did Not Meet Continuation Criteria|Overall Study||0
961531|NCT00201123|2325882|P1|Did Not Meet Continuation Criteria|Overall Study||2
961532|NCT00201123|2325880|P3|STARTED|Overall Study||32
961533|NCT00201123|2325881|P2|STARTED|Overall Study||32
961534|NCT00201123|2325882|P1|STARTED|Overall Study||32
961535|NCT00201201|2325898|P2|NOT COMPLETED|Overall Study||7
961536|NCT00201201|2325899|P1|NOT COMPLETED|Overall Study||5
961537|NCT00201201|2325898|P2|COMPLETED|Overall Study||66
961538|NCT00201201|2325899|P1|COMPLETED|Overall Study||82
961539|NCT00201201|2325898|P2|STARTED|Overall Study||73
961540|NCT00201201|2325899|P1|STARTED|Overall Study||87
961541|NCT00201240|2325915|P1|NOT COMPLETED|Overall Study||3
961542|NCT00201240|2325915|P1|COMPLETED|Overall Study||44
961543|NCT00201240|2325915|P1|STARTED|Overall Study||47
961544|NCT00201409|2325933|P2|NOT COMPLETED|Overall Study||1
961545|NCT00201409|2325934|P1|NOT COMPLETED|Overall Study||1
961546|NCT00201409|2325933|P2|COMPLETED|Overall Study||66
961547|NCT00201409|2325934|P1|COMPLETED|Overall Study||64
961548|NCT00201409|2325933|P2|STARTED|Overall Study||67
961549|NCT00201409|2325934|P1|STARTED|Overall Study||65
961550|NCT00186875|2325946|P2|NOT COMPLETED|Overall Study||0
961551|NCT00186875|2325947|P1|NOT COMPLETED|Overall Study||0
961552|NCT00186875|2325946|P2|COMPLETED|Overall Study||14
961553|NCT00186875|2325947|P1|COMPLETED|Overall Study||26
961554|NCT00186875|2325946|P2|STARTED|Overall Study||14
961555|NCT00186875|2325947|P1|STARTED|Overall Study||26
961556|NCT00186888|2325964|P3|NOT COMPLETED|Overall Study||0
961557|NCT00186888|2325965|P2|NOT COMPLETED|Overall Study||3
961558|NCT00186888|2325966|P1|NOT COMPLETED|Overall Study||4
961559|NCT00186888|2325964|P3|COMPLETED|Overall Study||55
961560|NCT00186888|2325965|P2|COMPLETED|Overall Study||24
961561|NCT00186888|2325966|P1|COMPLETED|Overall Study||19
961562|NCT00186888|2325964|P3|Window Therapy|Overall Study||0
961563|NCT00186888|2325965|P2|Window Therapy|Overall Study||27
961564|NCT00186888|2325966|P1|Window Therapy|Overall Study||0
961565|NCT00186888|2325964|P3|STARTED|Overall Study||55
961566|NCT00186888|2325965|P2|STARTED|Overall Study||27
961567|NCT00186888|2325966|P1|STARTED|Overall Study||23
961568|NCT00186901|2326033|P3|NOT COMPLETED|Overall Study||149
961569|NCT00186901|2326034|P2|NOT COMPLETED|Overall Study||45
961570|NCT00186901|2326035|P1|NOT COMPLETED|Overall Study||49
961571|NCT00186901|2326033|P3|COMPLETED|Overall Study||0
961572|NCT00186901|2326034|P2|COMPLETED|Overall Study||96
961573|NCT00186901|2326035|P1|COMPLETED|Overall Study||85
961574|NCT00186901|2326033|P3|24 Month Follow-up|Overall Study||0
961575|NCT00186901|2326034|P2|24 Month Follow-up|Overall Study||107
961576|NCT00186901|2326035|P1|24 Month Follow-up|Overall Study||106
961577|NCT00186901|2326033|P3|12 Month Follow-up|Overall Study||0
961578|NCT00186901|2326034|P2|12 Month Follow-up|Overall Study||122
961579|NCT00186901|2326035|P1|12 Month Follow-up|Overall Study||117
961580|NCT00186901|2326033|P3|Baseline|Overall Study||0
961581|NCT00186901|2326034|P2|Baseline|Overall Study||141
961582|NCT00186901|2326035|P1|Baseline|Overall Study||134
961583|NCT00186901|2326033|P3|STARTED|Overall Study||149
961584|NCT00186901|2326034|P2|STARTED|Overall Study||141
961585|NCT00186901|2326035|P1|STARTED|Overall Study||134
961586|NCT00187096|2326075|P3|NOT COMPLETED|Overall Study||1
961587|NCT00187096|2326076|P2|NOT COMPLETED|Overall Study||0
961588|NCT00187096|2326077|P1|NOT COMPLETED|Overall Study||0
961589|NCT00187096|2326075|P3|COMPLETED|Overall Study||11
961590|NCT00187096|2326076|P2|COMPLETED|Overall Study||3
961591|NCT00187096|2326077|P1|COMPLETED|Overall Study||10
961592|NCT00187096|2326075|P3|STARTED|Overall Study||12
961593|NCT00187096|2326076|P2|STARTED|Overall Study||3
961594|NCT00187096|2326077|P1|STARTED|Overall Study||10
961595|NCT00187135|2326118|P6|NOT COMPLETED|Visit Three||6
961596|NCT00187135|2326119|P5|NOT COMPLETED|Visit Three||8
961597|NCT00187135|2326120|P4|NOT COMPLETED|Visit Three||9
961598|NCT00187135|2326121|P3|NOT COMPLETED|Visit Three||9
961599|NCT00187135|2326122|P2|NOT COMPLETED|Visit Three||7
961600|NCT00187135|2326123|P1|NOT COMPLETED|Visit Three||7
961601|NCT00187135|2326118|P6|COMPLETED|Visit Three||12
961602|NCT00187135|2326119|P5|COMPLETED|Visit Three||11
961603|NCT00187135|2326120|P4|COMPLETED|Visit Three||9
961604|NCT00187135|2326121|P3|COMPLETED|Visit Three||14
961605|NCT00187135|2326122|P2|COMPLETED|Visit Three||17
961606|NCT00187135|2326123|P1|COMPLETED|Visit Three||14
961607|NCT00187135|2326118|P6|STARTED|Visit Three||18
961608|NCT00187135|2326119|P5|STARTED|Visit Three||19
961609|NCT00187135|2326120|P4|STARTED|Visit Three||18
961610|NCT00187135|2326121|P3|STARTED|Visit Three||23
961611|NCT00187135|2326122|P2|STARTED|Visit Three||24
961612|NCT00187135|2326123|P1|STARTED|Visit Three||21
961613|NCT00187135|2326118|P6|NOT COMPLETED|Visit Two||8
961614|NCT00187135|2326119|P5|NOT COMPLETED|Visit Two||6
961615|NCT00187135|2326120|P4|NOT COMPLETED|Visit Two||8
961616|NCT00187135|2326121|P3|NOT COMPLETED|Visit Two||2
961617|NCT00187135|2326122|P2|NOT COMPLETED|Visit Two||3
961618|NCT00187135|2326123|P1|NOT COMPLETED|Visit Two||5
961619|NCT00187135|2326118|P6|COMPLETED|Visit Two||18
961620|NCT00187135|2326119|P5|COMPLETED|Visit Two||19
961621|NCT00187135|2326120|P4|COMPLETED|Visit Two||18
961622|NCT00187135|2326121|P3|COMPLETED|Visit Two||23
961623|NCT00187135|2326122|P2|COMPLETED|Visit Two||24
961624|NCT00187135|2326123|P1|COMPLETED|Visit Two||21
961625|NCT00187135|2326118|P6|STARTED|Visit Two||26
961626|NCT00187135|2326119|P5|STARTED|Visit Two||25
961627|NCT00187135|2326120|P4|STARTED|Visit Two||26
961628|NCT00187135|2326121|P3|STARTED|Visit Two||25
961629|NCT00187135|2326122|P2|STARTED|Visit Two||27
961630|NCT00187135|2326123|P1|STARTED|Visit Two||26
961631|NCT00187135|2326118|P6|NOT COMPLETED|Visit One||2
961632|NCT00187135|2326119|P5|NOT COMPLETED|Visit One||0
961633|NCT00187135|2326120|P4|NOT COMPLETED|Visit One||0
961634|NCT00187135|2326121|P3|NOT COMPLETED|Visit One||0
961635|NCT00187135|2326122|P2|NOT COMPLETED|Visit One||1
961636|NCT00187135|2326123|P1|NOT COMPLETED|Visit One||4
961637|NCT00187135|2326118|P6|COMPLETED|Visit One||26
961638|NCT00187135|2326119|P5|COMPLETED|Visit One||25
961639|NCT00187135|2326120|P4|COMPLETED|Visit One||26
961640|NCT00187135|2326121|P3|COMPLETED|Visit One||25
961641|NCT00187135|2326122|P2|COMPLETED|Visit One||27
961642|NCT00187135|2326123|P1|COMPLETED|Visit One||26
961643|NCT00187135|2326118|P6|STARTED|Visit One||28
961644|NCT00187135|2326119|P5|STARTED|Visit One||25
961645|NCT00187135|2326120|P4|STARTED|Visit One||26
961646|NCT00187135|2326121|P3|STARTED|Visit One||25
961647|NCT00187135|2326122|P2|STARTED|Visit One||28
961648|NCT00187135|2326123|P1|STARTED|Visit One||30
961649|NCT00192647|2326145|P2|NOT COMPLETED|Overall Study||146
961650|NCT00192647|2326146|P1|NOT COMPLETED|Overall Study||128
961651|NCT00192647|2326145|P2|COMPLETED|Overall Study||302
961652|NCT00192647|2326146|P1|COMPLETED|Overall Study||320
961653|NCT00192647|2326145|P2|Treated|Overall Study||438
961654|NCT00192647|2326146|P1|Treated|Overall Study||433
961655|NCT00192647|2326145|P2|STARTED|Overall Study||448
961656|NCT00192647|2326146|P1|STARTED|Overall Study||448
961657|NCT00201448|2326164|P2|NOT COMPLETED|Overall Study||0
961658|NCT00201448|2326165|P1|NOT COMPLETED|Overall Study||0
961659|NCT00201448|2326164|P2|COMPLETED|Overall Study||40
961660|NCT00201448|2326165|P1|COMPLETED|Overall Study||42
961661|NCT00201448|2326164|P2|STARTED|Overall Study||40
961662|NCT00201448|2326165|P1|STARTED|Overall Study||42
961663|NCT00201643|2326175|P2|NOT COMPLETED|Overall Study||4
961664|NCT00201643|2326176|P1|NOT COMPLETED|Overall Study||5
961665|NCT00201643|2326175|P2|COMPLETED|Overall Study||210
961666|NCT00201643|2326176|P1|COMPLETED|Overall Study||218
961667|NCT00201643|2326175|P2|STARTED|Overall Study||214
961668|NCT00201643|2326176|P1|STARTED|Overall Study||223
961669|NCT00201734|2326200|P2|NOT COMPLETED|Overall Study||0
961670|NCT00201734|2326201|P1|NOT COMPLETED|Overall Study||3
961671|NCT00201734|2326200|P2|COMPLETED|Overall Study||25
961672|NCT00201734|2326201|P1|COMPLETED|Overall Study||29
961673|NCT00201734|2326200|P2|Patients Not Evaluable|Overall Study||0
961674|NCT00201734|2326201|P1|Patients Not Evaluable|Overall Study||3
961675|NCT00201734|2326200|P2|STARTED|Overall Study||25
961676|NCT00201734|2326201|P1|STARTED|Overall Study||32
961677|NCT00201773|2326216|P1|NOT COMPLETED|Overall Study||6
961678|NCT00201773|2326216|P1|COMPLETED|Overall Study||16
961679|NCT00201773|2326216|P1|Stopped Exemestane After 4 Weeks|Overall Study||1
961680|NCT00201773|2326216|P1|Received All Exemestane Therapy|Overall Study||5
961681|NCT00201773|2326216|P1|Completed 8 Weeks of Planned Therapy|Overall Study||16
961682|NCT00201773|2326216|P1|STARTED|Overall Study||22
961683|NCT00203047|2326225|P2|NOT COMPLETED|Overall Study||203
961684|NCT00203047|2326226|P1|NOT COMPLETED|Overall Study||191
961685|NCT00203047|2326225|P2|COMPLETED|Overall Study||7
961686|NCT00203047|2326226|P1|COMPLETED|Overall Study||13
961687|NCT00203047|2326225|P2|In Database as of January 29, 2009|Overall Study||209
961688|NCT00203047|2326226|P1|In Database as of January 29, 2009|Overall Study||199
961689|NCT00203047|2326225|P2|STARTED|Overall Study||210
961690|NCT00203047|2326226|P1|STARTED|Overall Study||204
961691|NCT00203203|2326240|P2|NOT COMPLETED|Overall Study||0
961692|NCT00203203|2326241|P1|NOT COMPLETED|Overall Study||1
961693|NCT00203203|2326240|P2|COMPLETED|Overall Study||20
961694|NCT00203203|2326241|P1|COMPLETED|Overall Study||9
961695|NCT00203203|2326240|P2|STARTED|Overall Study||20
961696|NCT00203203|2326241|P1|STARTED|Overall Study||10
961697|NCT00203216|2326271|P1|NOT COMPLETED|Overall Study||4
961698|NCT00203216|2326271|P1|COMPLETED|Overall Study||27
961699|NCT00203216|2326271|P1|STARTED|Overall Study||31
961700|NCT00203229|2326277|P2|NOT COMPLETED|Overall Study||3
961701|NCT00203229|2326278|P1|NOT COMPLETED|Overall Study||3
961702|NCT00203229|2326277|P2|COMPLETED|Overall Study||7
961703|NCT00203229|2326278|P1|COMPLETED|Overall Study||7
961704|NCT00203229|2326277|P2|STARTED|Overall Study||10
961705|NCT00203229|2326278|P1|STARTED|Overall Study||10
961706|NCT00203242|2326284|P1|NOT COMPLETED|Overall Study||1
961707|NCT00203242|2326284|P1|COMPLETED|Overall Study||14
961708|NCT00203242|2326284|P1|STARTED|Overall Study||15
961709|NCT00203268|2326288|P1|NOT COMPLETED|Late Treatment||0
961710|NCT00203268|2326288|P1|COMPLETED|Late Treatment||9
961711|NCT00203268|2326288|P1|STARTED|Late Treatment||9
961712|NCT00203268|2326288|P1|NOT COMPLETED|Early Treatment||4
961713|NCT00203268|2326288|P1|COMPLETED|Early Treatment||9
961714|NCT00203268|2326288|P1|STARTED|Early Treatment||13
961715|NCT00203294|2326296|P2|NOT COMPLETED|Overall Study||13
961716|NCT00203294|2326297|P1|NOT COMPLETED|Overall Study||8
961717|NCT00203294|2326296|P2|COMPLETED|Overall Study||10
961718|NCT00203294|2326297|P1|COMPLETED|Overall Study||14
961719|NCT00203294|2326296|P2|STARTED|Overall Study||23
961720|NCT00203294|2326297|P1|STARTED|Overall Study||22
961721|NCT00203307|2326305|P2|NOT COMPLETED|Second Intervention||0
961722|NCT00203307|2326306|P1|NOT COMPLETED|Second Intervention||0
961723|NCT00203307|2326305|P2|COMPLETED|Second Intervention||0
961724|NCT00203307|2326306|P1|COMPLETED|Second Intervention||1
961725|NCT00203307|2326305|P2|STARTED|Second Intervention||0
961726|NCT00203307|2326306|P1|STARTED|Second Intervention|2 subjects dropped out of the 1st intervention period, due to fatugue.|1
961727|NCT00203307|2326305|P2|NOT COMPLETED|First Intervention||0
961728|NCT00203307|2326306|P1|NOT COMPLETED|First Intervention||2
961729|NCT00203307|2326305|P2|COMPLETED|First Intervention||0
961730|NCT00203307|2326306|P1|COMPLETED|First Intervention||1
961731|NCT00203307|2326305|P2|STARTED|First Intervention||0
961732|NCT00203307|2326306|P1|STARTED|First Intervention|Double-blind cross-over design. Study terminated early. Results not analyzed.|3
961733|NCT00203411|2326312|P1|NOT COMPLETED|Follow-up||4
961734|NCT00203411|2326312|P1|COMPLETED|Follow-up||41
961735|NCT00203411|2326312|P1|STARTED|Follow-up||45
961736|NCT00203411|2326312|P1|NOT COMPLETED|Treatment Period||0
961737|NCT00203411|2326312|P1|COMPLETED|Treatment Period||45
961738|NCT00203411|2326312|P1|STARTED|Treatment Period||45
961739|NCT00203424|2326319|P1|NOT COMPLETED|Follow-up Period||6
961740|NCT00203424|2326319|P1|COMPLETED|Follow-up Period||10
961741|NCT00203424|2326319|P1|STARTED|Follow-up Period|followup includes 11 pts that completed treatment + 5 pts who stopped treatment due to adverse event|16
961742|NCT00203424|2326319|P1|NOT COMPLETED|Treatment Period||11
961743|NCT00203424|2326319|P1|COMPLETED|Treatment Period|Of 11 pts that did not complete treatment,5 stopped due to adverse event and entered followup period|11
961744|NCT00203424|2326319|P1|STARTED|Treatment Period|23 subjects registered for treatment, 1 withdrew consent after registration,22 received treatment.|22
961745|NCT00203476|2326329|P3|NOT COMPLETED|Overall Study||0
961746|NCT00203476|2326330|P2|NOT COMPLETED|Overall Study||1
961747|NCT00203476|2326331|P1|NOT COMPLETED|Overall Study||1
961748|NCT00203476|2326329|P3|COMPLETED|Overall Study||10
961749|NCT00203476|2326330|P2|COMPLETED|Overall Study||9
961750|NCT00203476|2326331|P1|COMPLETED|Overall Study||9
961751|NCT00203476|2326329|P3|STARTED|Overall Study||10
961752|NCT00203476|2326330|P2|STARTED|Overall Study||10
961753|NCT00203476|2326331|P1|STARTED|Overall Study||10
961754|NCT00203502|2326348|P1|NOT COMPLETED|Overall Study||1
961755|NCT00203502|2326348|P1|COMPLETED|Overall Study||39
961756|NCT00203502|2326348|P1|STARTED|Overall Study||40
961757|NCT00203892|2326359|P3|NOT COMPLETED|Overall Study||0
961758|NCT00203892|2326360|P2|NOT COMPLETED|Overall Study||2
961759|NCT00203892|2326361|P1|NOT COMPLETED|Overall Study||2
961760|NCT00203892|2326359|P3|COMPLETED|Overall Study||6
961761|NCT00203892|2326360|P2|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|8
961762|NCT00203892|2326361|P1|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|5
961763|NCT00203892|2326359|P3|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|4
961764|NCT00203892|2326360|P2|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
961765|NCT00203892|2326361|P1|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
961766|NCT00203892|2326359|P3|STARTED|Overall Study||6
961767|NCT00203892|2326360|P2|STARTED|Overall Study||10
961768|NCT00203892|2326361|P1|STARTED|Overall Study||7
961769|NCT00203931|2326374|P2|NOT COMPLETED|Overall Study||5
961770|NCT00203931|2326375|P1|NOT COMPLETED|Overall Study||7
961771|NCT00203931|2326374|P2|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|23
961772|NCT00203931|2326375|P1|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|20
961773|NCT00203931|2326374|P2|STARTED|Overall Study||28
961774|NCT00203931|2326375|P1|STARTED|Overall Study||27
961775|NCT00203996|2326395|P10|NOT COMPLETED|Overall Study||1
961776|NCT00203996|2326396|P9|NOT COMPLETED|Overall Study||0
961777|NCT00203996|2326397|P8|NOT COMPLETED|Overall Study||2
961778|NCT00203996|2326398|P7|NOT COMPLETED|Overall Study||0
961779|NCT00203996|2326399|P6|NOT COMPLETED|Overall Study||0
961780|NCT00203996|2326400|P5|NOT COMPLETED|Overall Study||1
961781|NCT00203996|2326401|P4|NOT COMPLETED|Overall Study||10
961782|NCT00203996|2326402|P3|NOT COMPLETED|Overall Study||0
961783|NCT00203996|2326403|P2|NOT COMPLETED|Overall Study||0
961784|NCT00203996|2326404|P1|NOT COMPLETED|Overall Study||0
961785|NCT00203996|2326395|P10|COMPLETED|Overall Study||2
961786|NCT00203996|2326396|P9|COMPLETED|Overall Study||2
961787|NCT00203996|2326397|P8|COMPLETED|Overall Study||2
961788|NCT00203996|2326398|P7|COMPLETED|Overall Study||2
961789|NCT00203996|2326399|P6|COMPLETED|Overall Study||3
961790|NCT00203996|2326400|P5|COMPLETED|Overall Study||3
961791|NCT00203996|2326401|P4|COMPLETED|Overall Study||9
961792|NCT00203996|2326402|P3|COMPLETED|Overall Study||0
961793|NCT00203996|2326403|P2|COMPLETED|Overall Study||0
961794|NCT00203996|2326404|P1|COMPLETED|Overall Study||0
961795|NCT00203996|2326395|P10|Aim 3 Only: Third Intervention|Overall Study||2
961796|NCT00203996|2326396|P9|Aim 3 Only: Third Intervention|Overall Study||2
961797|NCT00203996|2326397|P8|Aim 3 Only: Third Intervention|Overall Study||2
961798|NCT00203996|2326398|P7|Aim 3 Only: Third Intervention|Overall Study||2
961799|NCT00203996|2326399|P6|Aim 3 Only: Third Intervention|Overall Study||3
961800|NCT00203996|2326400|P5|Aim 3 Only: Third Intervention|Overall Study||0
961801|NCT00203996|2326401|P4|Aim 3 Only: Third Intervention|Overall Study||0
961802|NCT00203996|2326402|P3|Aim 3 Only: Third Intervention|Overall Study||0
961803|NCT00203996|2326403|P2|Aim 3 Only: Third Intervention|Overall Study||0
961804|NCT00203996|2326404|P1|Aim 3 Only: Third Intervention|Overall Study||0
961805|NCT00203996|2326395|P10|Aim 3 Only: Second Washout|Overall Study||2
961806|NCT00203996|2326396|P9|Aim 3 Only: Second Washout|Overall Study||2
961807|NCT00203996|2326397|P8|Aim 3 Only: Second Washout|Overall Study||2
961808|NCT00203996|2326398|P7|Aim 3 Only: Second Washout|Overall Study||2
961809|NCT00203996|2326399|P6|Aim 3 Only: Second Washout|Overall Study||3
961810|NCT00203996|2326400|P5|Aim 3 Only: Second Washout|Overall Study||0
961811|NCT00203996|2326401|P4|Aim 3 Only: Second Washout|Overall Study||0
961812|NCT00203996|2326402|P3|Aim 3 Only: Second Washout|Overall Study||0
961813|NCT00203996|2326403|P2|Aim 3 Only: Second Washout|Overall Study||0
961814|NCT00203996|2326404|P1|Aim 3 Only: Second Washout|Overall Study||0
961815|NCT00203996|2326395|P10|Aim 3 Only: Second Intervention|Overall Study||2
961816|NCT00203996|2326396|P9|Aim 3 Only: Second Intervention|Overall Study||2
961817|NCT00203996|2326397|P8|Aim 3 Only: Second Intervention|Overall Study||2
961818|NCT00203996|2326398|P7|Aim 3 Only: Second Intervention|Overall Study||2
961819|NCT00203996|2326399|P6|Aim 3 Only: Second Intervention|Overall Study||3
961820|NCT00203996|2326400|P5|Aim 3 Only: Second Intervention|Overall Study||0
961821|NCT00203996|2326401|P4|Aim 3 Only: Second Intervention|Overall Study||0
961822|NCT00203996|2326402|P3|Aim 3 Only: Second Intervention|Overall Study||0
961823|NCT00203996|2326403|P2|Aim 3 Only: Second Intervention|Overall Study||0
961824|NCT00203996|2326404|P1|Aim 3 Only: Second Intervention|Overall Study||0
961825|NCT00203996|2326395|P10|Aim 3 Only: Washout|Overall Study||2
961826|NCT00203996|2326396|P9|Aim 3 Only: Washout|Overall Study||2
961827|NCT00203996|2326397|P8|Aim 3 Only: Washout|Overall Study||2
961828|NCT00203996|2326398|P7|Aim 3 Only: Washout|Overall Study||2
961829|NCT00203996|2326399|P6|Aim 3 Only: Washout|Overall Study||3
961830|NCT00203996|2326400|P5|Aim 3 Only: Washout|Overall Study||0
961831|NCT00203996|2326401|P4|Aim 3 Only: Washout|Overall Study||0
961832|NCT00203996|2326402|P3|Aim 3 Only: Washout|Overall Study||0
961833|NCT00203996|2326403|P2|Aim 3 Only: Washout|Overall Study||0
961834|NCT00203996|2326404|P1|Aim 3 Only: Washout|Overall Study||0
961835|NCT00203996|2326395|P10|Aim 3 Only: First Intervention|Overall Study||3
961836|NCT00203996|2326396|P9|Aim 3 Only: First Intervention|Overall Study||2
961837|NCT00203996|2326397|P8|Aim 3 Only: First Intervention|Overall Study||4
961838|NCT00203996|2326398|P7|Aim 3 Only: First Intervention|Overall Study||2
961839|NCT00203996|2326399|P6|Aim 3 Only: First Intervention|Overall Study||3
961840|NCT00203996|2326400|P5|Aim 3 Only: First Intervention|Overall Study||0
961841|NCT00203996|2326401|P4|Aim 3 Only: First Intervention|Overall Study||0
961842|NCT00203996|2326402|P3|Aim 3 Only: First Intervention|Overall Study||0
961843|NCT00203996|2326403|P2|Aim 3 Only: First Intervention|Overall Study||0
961844|NCT00203996|2326404|P1|Aim 3 Only: First Intervention|Overall Study||0
961845|NCT00203996|2326395|P10|STARTED|Overall Study||3
961846|NCT00203996|2326396|P9|STARTED|Overall Study||2
961847|NCT00203996|2326397|P8|STARTED|Overall Study||4
961848|NCT00203996|2326398|P7|STARTED|Overall Study||2
961849|NCT00203996|2326399|P6|STARTED|Overall Study||3
961850|NCT00203996|2326400|P5|STARTED|Overall Study||4
961851|NCT00203996|2326401|P4|STARTED|Overall Study||19
961852|NCT00203996|2326402|P3|STARTED|Overall Study||0
961853|NCT00203996|2326403|P2|STARTED|Overall Study||0
961854|NCT00203996|2326404|P1|STARTED|Overall Study||0
961855|NCT00204373|2326451|P1|NOT COMPLETED|Overall Study||0
961856|NCT00204373|2326451|P1|COMPLETED|Overall Study||72
961857|NCT00204373|2326451|P1|STARTED|Overall Study||72
961858|NCT00204932|2326458|P2|NOT COMPLETED|Overall Study||6
961859|NCT00204932|2326459|P1|NOT COMPLETED|Overall Study||2
961860|NCT00204932|2326458|P2|COMPLETED|Overall Study||18
961861|NCT00204932|2326459|P1|COMPLETED|Overall Study||22
961862|NCT00204932|2326458|P2|STARTED|Overall Study||24
961863|NCT00204932|2326459|P1|STARTED|Overall Study||24
961864|NCT00205049|2326467|P2|NOT COMPLETED|Overall Study||0
961865|NCT00205049|2326468|P1|NOT COMPLETED|Overall Study||0
961866|NCT00205049|2326467|P2|COMPLETED|Overall Study||0
961867|NCT00205049|2326468|P1|COMPLETED|Overall Study||0
961868|NCT00205049|2326467|P2|STARTED|Overall Study||0
961869|NCT00205049|2326468|P1|STARTED|Overall Study||0
961870|NCT00205374|2326476|P2|NOT COMPLETED|Overall Study||0
961871|NCT00205374|2326477|P1|NOT COMPLETED|Overall Study||0
961872|NCT00205374|2326476|P2|COMPLETED|Overall Study||9
961873|NCT00205374|2326477|P1|COMPLETED|Overall Study||10
961874|NCT00205374|2326476|P2|STARTED|Overall Study||9
961875|NCT00205374|2326477|P1|STARTED|Overall Study||10
961876|NCT00196326|2326485|P1|NOT COMPLETED|Overall Study||986
961877|NCT00196326|2326485|P1|COMPLETED|Overall Study||1249
961878|NCT00196326|2326485|P1|Pregnancy Intent-to-treat Cohort (PITT)|Overall Study|Completed one cycle and 18-35 years old|1735
961879|NCT00196326|2326485|P1|Safety Population|Overall Study|Treated participants|2185
961880|NCT00196326|2326485|P1|STARTED|Overall Study|Took at least one dose of study medication|2235
961881|NCT00196716|2326491|P1|NOT COMPLETED|0.3 mg/kg Period||0
961882|NCT00196716|2326491|P1|COMPLETED|0.3 mg/kg Period||21
961883|NCT00196716|2326491|P1|STARTED|0.3 mg/kg Period||21
961884|NCT00196716|2326491|P1|NOT COMPLETED|1.0 mg/kg Period||0
961885|NCT00196716|2326491|P1|COMPLETED|1.0 mg/kg Period||21
961886|NCT00196716|2326491|P1|STARTED|1.0 mg/kg Period||21
961887|NCT00196937|2326504|P3|NOT COMPLETED|Overall Study||7
961888|NCT00196937|2326505|P2|NOT COMPLETED|Overall Study||5
961889|NCT00196937|2326506|P1|NOT COMPLETED|Overall Study||9
961890|NCT00196937|2326504|P3|COMPLETED|Overall Study||204
961891|NCT00196937|2326505|P2|COMPLETED|Overall Study||221
961892|NCT00196937|2326506|P1|COMPLETED|Overall Study||220
961893|NCT00196937|2326504|P3|STARTED|Overall Study||211
961894|NCT00196937|2326505|P2|STARTED|Overall Study||226
961895|NCT00196937|2326506|P1|STARTED|Overall Study||229
961896|NCT00196976|2326558|P14|NOT COMPLETED|Booster Study||0
961897|NCT00196976|2326559|P13|NOT COMPLETED|Booster Study||0
961898|NCT00196976|2326560|P12|NOT COMPLETED|Booster Study||2
961899|NCT00196976|2326561|P11|NOT COMPLETED|Booster Study||2
961900|NCT00196976|2326562|P10|NOT COMPLETED|Booster Study||0
961901|NCT00196976|2326563|P9|NOT COMPLETED|Booster Study||0
961902|NCT00196976|2326564|P8|NOT COMPLETED|Booster Study||0
961903|NCT00196976|2326565|P7|NOT COMPLETED|Booster Study||0
961904|NCT00196976|2326566|P6|NOT COMPLETED|Booster Study||0
961905|NCT00196976|2326567|P5|NOT COMPLETED|Booster Study||0
961906|NCT00196976|2326568|P4|NOT COMPLETED|Booster Study||0
961907|NCT00196976|2326569|P3|NOT COMPLETED|Booster Study||0
961908|NCT00196976|2326570|P2|NOT COMPLETED|Booster Study||0
961909|NCT00196976|2326571|P1|NOT COMPLETED|Booster Study||0
961910|NCT00196976|2326558|P14|COMPLETED|Booster Study||43
961911|NCT00196976|2326559|P13|COMPLETED|Booster Study||45
961912|NCT00196976|2326560|P12|COMPLETED|Booster Study||30
961913|NCT00196976|2326561|P11|COMPLETED|Booster Study||31
961914|NCT00196976|2326562|P10|COMPLETED|Booster Study||0
961915|NCT00196976|2326563|P9|COMPLETED|Booster Study||0
961916|NCT00196976|2326564|P8|COMPLETED|Booster Study||0
961917|NCT00196976|2326565|P7|COMPLETED|Booster Study||0
961918|NCT00196976|2326566|P6|COMPLETED|Booster Study||0
961919|NCT00196976|2326567|P5|COMPLETED|Booster Study||0
961920|NCT00196976|2326568|P4|COMPLETED|Booster Study||0
961921|NCT00196976|2326569|P3|COMPLETED|Booster Study||0
961922|NCT00196976|2326570|P2|COMPLETED|Booster Study||0
961923|NCT00196976|2326571|P1|COMPLETED|Booster Study||0
961924|NCT00196976|2326558|P14|STARTED|Booster Study||43
961925|NCT00196976|2326559|P13|STARTED|Booster Study||45
961926|NCT00196976|2326560|P12|STARTED|Booster Study||32
961927|NCT00196976|2326561|P11|STARTED|Booster Study||33
961928|NCT00196976|2326562|P10|STARTED|Booster Study||0
961929|NCT00196976|2326563|P9|STARTED|Booster Study||0
961930|NCT00196976|2326564|P8|STARTED|Booster Study||0
961931|NCT00196976|2326565|P7|STARTED|Booster Study||0
961932|NCT00196976|2326566|P6|STARTED|Booster Study||0
961933|NCT00196976|2326567|P5|STARTED|Booster Study||0
961934|NCT00196976|2326568|P4|STARTED|Booster Study||0
961935|NCT00196976|2326569|P3|STARTED|Booster Study||0
961936|NCT00196976|2326570|P2|STARTED|Booster Study||0
961937|NCT00196976|2326571|P1|STARTED|Booster Study||0
961938|NCT00196976|2326558|P14|NOT COMPLETED|Primary Study||0
961939|NCT00196976|2326559|P13|NOT COMPLETED|Primary Study||0
961940|NCT00196976|2326560|P12|NOT COMPLETED|Primary Study||0
961941|NCT00196976|2326561|P11|NOT COMPLETED|Primary Study||0
961942|NCT00196976|2326562|P10|NOT COMPLETED|Primary Study||1
961943|NCT00196976|2326563|P9|NOT COMPLETED|Primary Study||0
961944|NCT00196976|2326564|P8|NOT COMPLETED|Primary Study||3
961945|NCT00196976|2326565|P7|NOT COMPLETED|Primary Study||0
961946|NCT00196976|2326566|P6|NOT COMPLETED|Primary Study||2
961947|NCT00196976|2326567|P5|NOT COMPLETED|Primary Study||3
961948|NCT00196976|2326568|P4|NOT COMPLETED|Primary Study||1
961949|NCT00196976|2326569|P3|NOT COMPLETED|Primary Study||4
961950|NCT00196976|2326570|P2|NOT COMPLETED|Primary Study||1
961951|NCT00196976|2326571|P1|NOT COMPLETED|Primary Study||1
961952|NCT00196976|2326558|P14|COMPLETED|Primary Study||0
961953|NCT00196976|2326559|P13|COMPLETED|Primary Study||0
961954|NCT00196976|2326560|P12|COMPLETED|Primary Study||0
961955|NCT00196976|2326561|P11|COMPLETED|Primary Study||0
961956|NCT00196976|2326562|P10|COMPLETED|Primary Study||51
961957|NCT00196976|2326563|P9|COMPLETED|Primary Study||52
961958|NCT00196976|2326564|P8|COMPLETED|Primary Study||49
961959|NCT00196976|2326565|P7|COMPLETED|Primary Study||50
961960|NCT00196976|2326566|P6|COMPLETED|Primary Study||52
961961|NCT00196976|2326567|P5|COMPLETED|Primary Study||37
961962|NCT00196976|2326568|P4|COMPLETED|Primary Study||39
961963|NCT00196976|2326569|P3|COMPLETED|Primary Study||37
961964|NCT00196976|2326570|P2|COMPLETED|Primary Study||40
961965|NCT00196976|2326571|P1|COMPLETED|Primary Study||38
961966|NCT00196976|2326558|P14|STARTED|Primary Study||0
961967|NCT00196976|2326559|P13|STARTED|Primary Study||0
961968|NCT00196976|2326560|P12|STARTED|Primary Study||0
961969|NCT00196976|2326561|P11|STARTED|Primary Study||0
961970|NCT00196976|2326562|P10|STARTED|Primary Study||52
961971|NCT00196976|2326563|P9|STARTED|Primary Study||52
961972|NCT00196976|2326564|P8|STARTED|Primary Study||52
961973|NCT00196976|2326565|P7|STARTED|Primary Study||50
961974|NCT00196976|2326566|P6|STARTED|Primary Study||54
961975|NCT00196976|2326567|P5|STARTED|Primary Study||40
961976|NCT00196976|2326568|P4|STARTED|Primary Study||40
961977|NCT00196976|2326569|P3|STARTED|Primary Study||41
961978|NCT00196976|2326570|P2|STARTED|Primary Study||41
961979|NCT00196976|2326571|P1|STARTED|Primary Study||39
961980|NCT00197002|2326767|P3|NOT COMPLETED|Overall Study||17
961981|NCT00197002|2326768|P2|NOT COMPLETED|Overall Study||18
961982|NCT00197002|2326769|P1|NOT COMPLETED|Overall Study||22
961983|NCT00197002|2326767|P3|COMPLETED|Overall Study||132
961984|NCT00197002|2326768|P2|COMPLETED|Overall Study||119
961985|NCT00197002|2326769|P1|COMPLETED|Overall Study||125
961986|NCT00197002|2326767|P3|STARTED|Overall Study||149
961987|NCT00197002|2326768|P2|STARTED|Overall Study||137
961988|NCT00197002|2326769|P1|STARTED|Overall Study||147
961989|NCT00197015|2326809|P3|NOT COMPLETED|Overall Study||77
961990|NCT00197015|2326810|P2|NOT COMPLETED|Overall Study||89
961991|NCT00197015|2326811|P1|NOT COMPLETED|Overall Study||50
961992|NCT00197015|2326809|P3|COMPLETED|Overall Study||385
961993|NCT00197015|2326810|P2|COMPLETED|Overall Study||366
961994|NCT00197015|2326811|P1|COMPLETED|Overall Study||274
961995|NCT00197015|2326809|P3|STARTED|Overall Study||462
961996|NCT00197015|2326810|P2|STARTED|Overall Study||455
961997|NCT00197015|2326811|P1|STARTED|Overall Study||324
961998|NCT00197028|2326869|P2|NOT COMPLETED|Overall Study||21
961999|NCT00197028|2326870|P1|NOT COMPLETED|Overall Study||16
962000|NCT00197028|2326869|P2|COMPLETED|Overall Study||86
962001|NCT00197028|2326870|P1|COMPLETED|Overall Study||91
962002|NCT00197028|2326869|P2|STARTED|Overall Study||107
962003|NCT00197028|2326870|P1|STARTED|Overall Study||107
962004|NCT00197106|2326912|P3|NOT COMPLETED|Overall Treatment Period||6
962005|NCT00197106|2326913|P2|NOT COMPLETED|Overall Treatment Period||1
962006|NCT00197106|2326914|P1|NOT COMPLETED|Overall Treatment Period||0
962007|NCT00197106|2326912|P3|COMPLETED|Overall Treatment Period||74
962008|NCT00197106|2326913|P2|COMPLETED|Overall Treatment Period||77
962009|NCT00197106|2326914|P1|COMPLETED|Overall Treatment Period||0
962010|NCT00197106|2326912|P3|STARTED|Overall Treatment Period||80
962011|NCT00197106|2326913|P2|STARTED|Overall Treatment Period||78
962012|NCT00197106|2326914|P1|STARTED|Overall Treatment Period||0
962013|NCT00197106|2326912|P3|NOT COMPLETED|4-Week Run-In Period||0
962014|NCT00197106|2326913|P2|NOT COMPLETED|4-Week Run-In Period||0
962015|NCT00197106|2326914|P1|NOT COMPLETED|4-Week Run-In Period||99
962016|NCT00197106|2326912|P3|COMPLETED|4-Week Run-In Period||0
962017|NCT00197106|2326913|P2|COMPLETED|4-Week Run-In Period||0
962018|NCT00197106|2326914|P1|COMPLETED|4-Week Run-In Period||158
962019|NCT00197106|2326912|P3|STARTED|4-Week Run-In Period||0
962020|NCT00197106|2326913|P2|STARTED|4-Week Run-In Period||0
962021|NCT00197106|2326914|P1|STARTED|4-Week Run-In Period||257
962022|NCT00197119|2326950|P2|NOT COMPLETED|Year 10||0
962023|NCT00197119|2326951|P1|NOT COMPLETED|Year 10||0
962024|NCT00197119|2326950|P2|COMPLETED|Year 10||108
962025|NCT00197119|2326951|P1|COMPLETED|Year 10||120
962026|NCT00197119|2326950|P2|STARTED|Year 10|Six subjects participating in the Year 9 time point did not return for the current time point.|108
962027|NCT00197119|2326951|P1|STARTED|Year 10|One subject participating in the Year 9 time point did not return for the current time point.|120
962028|NCT00197119|2326950|P2|NOT COMPLETED|Year 9||0
962029|NCT00197119|2326951|P1|NOT COMPLETED|Year 9||0
962030|NCT00197119|2326950|P2|COMPLETED|Year 9||114
962031|NCT00197119|2326951|P1|COMPLETED|Year 9||121
962032|NCT00197119|2326950|P2|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|114
962033|NCT00197119|2326951|P1|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|121
962034|NCT00197119|2326950|P2|NOT COMPLETED|Year 8||0
962035|NCT00197119|2326951|P1|NOT COMPLETED|Year 8||0
962036|NCT00197119|2326950|P2|COMPLETED|Year 8||115
962037|NCT00197119|2326951|P1|COMPLETED|Year 8||122
962038|NCT00197119|2326950|P2|STARTED|Year 8|One additional subject (compared to Year 7) participated in the current follow-up time point.|115
962039|NCT00197119|2326951|P1|STARTED|Year 8||122
962040|NCT00197119|2326950|P2|NOT COMPLETED|Year 7||0
962041|NCT00197119|2326951|P1|NOT COMPLETED|Year 7||0
962042|NCT00197119|2326950|P2|COMPLETED|Year 7||114
962043|NCT00197119|2326951|P1|COMPLETED|Year 7||122
962044|NCT00197119|2326950|P2|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|114
962045|NCT00197119|2326951|P1|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|122
962046|NCT00197119|2326950|P2|NOT COMPLETED|Year 6||0
962047|NCT00197119|2326951|P1|NOT COMPLETED|Year 6||0
962048|NCT00197119|2326950|P2|COMPLETED|Year 6||118
962049|NCT00197119|2326951|P1|COMPLETED|Year 6||126
962050|NCT00197119|2326950|P2|STARTED|Year 6||118
962051|NCT00197119|2326951|P1|STARTED|Year 6||126
962052|NCT00197184|2326963|P2|NOT COMPLETED|Overall Study||0
962053|NCT00197184|2326964|P1|NOT COMPLETED|Overall Study||0
962054|NCT00197184|2326963|P2|COMPLETED|Overall Study||137
962055|NCT00197184|2326964|P1|COMPLETED|Overall Study||139
962056|NCT00197184|2326963|P2|STARTED|Overall Study||137
962057|NCT00197184|2326964|P1|STARTED|Overall Study||139
962058|NCT00197236|2326989|P3|NOT COMPLETED|Overall Study||23
962059|NCT00197236|2326990|P2|NOT COMPLETED|Overall Study||17
962060|NCT00197236|2326991|P1|NOT COMPLETED|Overall Study||14
962061|NCT00197236|2326989|P3|COMPLETED|Overall Study||109
962062|NCT00197236|2326990|P2|COMPLETED|Overall Study||110
962063|NCT00197236|2326991|P1|COMPLETED|Overall Study||121
962064|NCT00197236|2326989|P3|STARTED|Overall Study||132
962065|NCT00197236|2326990|P2|STARTED|Overall Study||127
962066|NCT00197236|2326991|P1|STARTED|Overall Study||135
962067|NCT00197392|2327040|P2|NOT COMPLETED|Overall Study||86
962068|NCT00197392|2327041|P1|NOT COMPLETED|Overall Study||88
962069|NCT00197392|2327040|P2|COMPLETED|Overall Study||134
962070|NCT00197392|2327041|P1|COMPLETED|Overall Study||126
962071|NCT00197392|2327040|P2|Per Protocol|Overall Study||134
962072|NCT00197392|2327041|P1|Per Protocol|Overall Study||126
962073|NCT00197392|2327040|P2|Evaluable|Overall Study||181
962074|NCT00197392|2327041|P1|Evaluable|Overall Study||176
962075|NCT00197392|2327040|P2|Modified Intent to Treat|Overall Study||210
962076|NCT00197392|2327041|P1|Modified Intent to Treat|Overall Study||209
962077|NCT00197392|2327040|P2|Safety Population|Overall Study||220
962078|NCT00197392|2327041|P1|Safety Population|Overall Study||214
962079|NCT00197392|2327040|P2|STARTED|Overall Study||220
962080|NCT00197392|2327041|P1|STARTED|Overall Study||214
962081|NCT00197496|2327072|P2|NOT COMPLETED|Follow-up||1
962082|NCT00197496|2327073|P1|NOT COMPLETED|Follow-up||2
962083|NCT00197496|2327072|P2|COMPLETED|Follow-up||4
962084|NCT00197496|2327073|P1|COMPLETED|Follow-up||10
962085|NCT00197496|2327072|P2|STARTED|Follow-up||5
962086|NCT00197496|2327073|P1|STARTED|Follow-up||12
962087|NCT00197496|2327072|P2|NOT COMPLETED|Baseline to Discharge||2
962088|NCT00197496|2327073|P1|NOT COMPLETED|Baseline to Discharge||2
962089|NCT00197496|2327072|P2|COMPLETED|Baseline to Discharge||5
962090|NCT00197496|2327073|P1|COMPLETED|Baseline to Discharge||12
962091|NCT00197496|2327072|P2|STARTED|Baseline to Discharge||7
962092|NCT00197496|2327073|P1|STARTED|Baseline to Discharge||14
962093|NCT00198029|2327086|P1|NOT COMPLETED|Overall Study||4
962094|NCT00198029|2327086|P1|COMPLETED|Overall Study||28
962095|NCT00198029|2327086|P1|STARTED|Overall Study||32
962096|NCT00198042|2327091|P1|NOT COMPLETED|Overall Study||0
962097|NCT00198042|2327091|P1|COMPLETED|Overall Study||18
962098|NCT00198042|2327091|P1|STARTED|Overall Study||18
962099|NCT00198081|2327097|P2|NOT COMPLETED|Overall Study||0
962100|NCT00198081|2327098|P1|NOT COMPLETED|Overall Study||1
962101|NCT00198081|2327097|P2|COMPLETED|Overall Study|No enrollment on this arm.|0
962102|NCT00198081|2327098|P1|COMPLETED|Overall Study||4
962103|NCT00198081|2327097|P2|STARTED|Overall Study|No enrollment on this arm.|0
962104|NCT00198081|2327098|P1|STARTED|Overall Study|Eight (8) persons consented to participate but 3 withdrew prior to beginning protocol treatment.|5
962105|NCT00198133|2327126|P2|NOT COMPLETED|Overall Study||8
962106|NCT00198133|2327127|P1|NOT COMPLETED|Overall Study||5
962107|NCT00198133|2327126|P2|COMPLETED|Overall Study||3
962108|NCT00198133|2327127|P1|COMPLETED|Overall Study||11
962109|NCT00198133|2327126|P2|STARTED|Overall Study||11
962110|NCT00198133|2327127|P1|STARTED|Overall Study||16
962111|NCT00198822|2327140|P3|NOT COMPLETED|Overall Study||21
962112|NCT00198822|2327141|P2|NOT COMPLETED|Overall Study||20
962113|NCT00198822|2327142|P1|NOT COMPLETED|Overall Study||14
962114|NCT00198822|2327140|P3|COMPLETED|Overall Study|No. of consented pregnant women in beta-catorene arm with vital status known at 12 weeks postpartum|19998
962115|NCT00198822|2327141|P2|COMPLETED|Overall Study|No. of consented pregnant women in vitamin A arm with vital status known at 12 weeks postpartum|19806
962116|NCT00198822|2327142|P1|COMPLETED|Overall Study|No. of consented pregnant women in placebo arm with vital status known at 12 weeks postpartum|19862
962117|NCT00198822|2327140|P3|STARTED|Overall Study|No. of consenting pregnant women in the beta-catorene arm of trial cohort|20019
962118|NCT00198822|2327141|P2|STARTED|Overall Study|No. of consenting pregnant women in the vitamin A arm of trial cohort|19826
962119|NCT00198822|2327142|P1|STARTED|Overall Study|No. of consenting pregnant women in the placebo arm of trial cohort|19876
962126|NCT00205712|2327188|P2|NOT COMPLETED|Overall Study||1
962127|NCT00205712|2327189|P1|NOT COMPLETED|Overall Study||0
962128|NCT00205712|2327188|P2|COMPLETED|Overall Study||19
962129|NCT00205712|2327189|P1|COMPLETED|Overall Study||20
962130|NCT00205712|2327188|P2|STARTED|Overall Study||20
962131|NCT00205712|2327189|P1|STARTED|Overall Study||20
962132|NCT00205777|2327203|P6|NOT COMPLETED|Study Extension II||282
962133|NCT00205777|2327204|P5|NOT COMPLETED|Study Extension II||0
962134|NCT00205777|2327205|P4|NOT COMPLETED|Study Extension II||149
962135|NCT00205777|2327206|P3|NOT COMPLETED|Study Extension II||0
962136|NCT00205777|2327207|P2|NOT COMPLETED|Study Extension II||0
962137|NCT00205777|2327208|P1|NOT COMPLETED|Study Extension II||0
962138|NCT00205777|2327203|P6|COMPLETED|Study Extension II||860
962139|NCT00205777|2327204|P5|COMPLETED|Study Extension II||0
962140|NCT00205777|2327205|P4|COMPLETED|Study Extension II||441
962141|NCT00205777|2327206|P3|COMPLETED|Study Extension II||0
962142|NCT00205777|2327207|P2|COMPLETED|Study Extension II||0
962143|NCT00205777|2327208|P1|COMPLETED|Study Extension II||0
962144|NCT00205777|2327203|P6|TREATED|Study Extension II||1011
962145|NCT00205777|2327204|P5|TREATED|Study Extension II||0
962146|NCT00205777|2327205|P4|TREATED|Study Extension II||519
962147|NCT00205777|2327206|P3|TREATED|Study Extension II||0
962148|NCT00205777|2327207|P2|TREATED|Study Extension II||0
962149|NCT00205777|2327208|P1|TREATED|Study Extension II||0
962150|NCT00205777|2327203|P6|STARTED|Study Extension II||1142
962151|NCT00205777|2327204|P5|STARTED|Study Extension II||0
962152|NCT00205777|2327205|P4|STARTED|Study Extension II||590
962153|NCT00205777|2327206|P3|STARTED|Study Extension II||0
962154|NCT00205777|2327207|P2|STARTED|Study Extension II||0
962155|NCT00205777|2327208|P1|STARTED|Study Extension II||0
962156|NCT00205777|2327203|P6|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
962157|NCT00205777|2327204|P5|NOT COMPLETED|Completed SE I, Entered Extension SE II||258
962158|NCT00205777|2327205|P4|NOT COMPLETED|Completed SE I, Entered Extension SE II||240
962159|NCT00205777|2327206|P3|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
962160|NCT00205777|2327207|P2|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
962161|NCT00205777|2327208|P1|NOT COMPLETED|Completed SE I, Entered Extension SE II||273
962162|NCT00205777|2327203|P6|COMPLETED|Completed SE I, Entered Extension SE II||0
962163|NCT00205777|2327204|P5|COMPLETED|Completed SE I, Entered Extension SE II||582
962164|NCT00205777|2327205|P4|COMPLETED|Completed SE I, Entered Extension SE II||590
962165|NCT00205777|2327206|P3|COMPLETED|Completed SE I, Entered Extension SE II||0
962166|NCT00205777|2327207|P2|COMPLETED|Completed SE I, Entered Extension SE II||0
962167|NCT00205777|2327208|P1|COMPLETED|Completed SE I, Entered Extension SE II||560
962168|NCT00205777|2327203|P6|STARTED|Completed SE I, Entered Extension SE II||0
962169|NCT00205777|2327204|P5|STARTED|Completed SE I, Entered Extension SE II||840
962170|NCT00205777|2327205|P4|STARTED|Completed SE I, Entered Extension SE II||830
962171|NCT00205777|2327206|P3|STARTED|Completed SE I, Entered Extension SE II||0
962172|NCT00205777|2327207|P2|STARTED|Completed SE I, Entered Extension SE II||0
962173|NCT00205777|2327208|P1|STARTED|Completed SE I, Entered Extension SE II||833
962174|NCT00205777|2327203|P6|NOT COMPLETED|Study Extension I||0
962175|NCT00205777|2327204|P5|NOT COMPLETED|Study Extension I||201
962176|NCT00205777|2327205|P4|NOT COMPLETED|Study Extension I||228
962177|NCT00205777|2327206|P3|NOT COMPLETED|Study Extension I||1070
962178|NCT00205777|2327207|P2|NOT COMPLETED|Study Extension I||0
962179|NCT00205777|2327208|P1|NOT COMPLETED|Study Extension I||214
962180|NCT00205777|2327203|P6|COMPLETED|Study Extension I||0
962181|NCT00205777|2327204|P5|COMPLETED|Study Extension I||840
962182|NCT00205777|2327205|P4|COMPLETED|Study Extension I||830
962183|NCT00205777|2327206|P3|COMPLETED|Study Extension I||0
962184|NCT00205777|2327207|P2|COMPLETED|Study Extension I||0
962185|NCT00205777|2327208|P1|COMPLETED|Study Extension I||833
962186|NCT00205777|2327203|P6|STARTED|Study Extension I||0
962187|NCT00205777|2327204|P5|STARTED|Study Extension I||1041
962188|NCT00205777|2327205|P4|STARTED|Study Extension I||1058
962189|NCT00205777|2327206|P3|STARTED|Study Extension I||1070
962190|NCT00205777|2327207|P2|STARTED|Study Extension I||0
962191|NCT00205777|2327208|P1|STARTED|Study Extension I||1047
962192|NCT00205777|2327203|P6|NOT COMPLETED|Completed Core Study, Entered SE I||0
962193|NCT00205777|2327204|P5|NOT COMPLETED|Completed Core Study, Entered SE I||0
962194|NCT00205777|2327205|P4|NOT COMPLETED|Completed Core Study, Entered SE I||224
962195|NCT00205777|2327206|P3|NOT COMPLETED|Completed Core Study, Entered SE I||207
962196|NCT00205777|2327207|P2|NOT COMPLETED|Completed Core Study, Entered SE I||204
962197|NCT00205777|2327208|P1|NOT COMPLETED|Completed Core Study, Entered SE I||232
962198|NCT00205777|2327203|P6|COMPLETED|Completed Core Study, Entered SE I||0
962199|NCT00205777|2327204|P5|COMPLETED|Completed Core Study, Entered SE I||0
962200|NCT00205777|2327205|P4|COMPLETED|Completed Core Study, Entered SE I||1058
962201|NCT00205777|2327206|P3|COMPLETED|Completed Core Study, Entered SE I||1070
962202|NCT00205777|2327207|P2|COMPLETED|Completed Core Study, Entered SE I||1041
962203|NCT00205777|2327208|P1|COMPLETED|Completed Core Study, Entered SE I||1047
962204|NCT00205777|2327203|P6|STARTED|Completed Core Study, Entered SE I||0
962205|NCT00205777|2327204|P5|STARTED|Completed Core Study, Entered SE I||0
962206|NCT00205777|2327205|P4|STARTED|Completed Core Study, Entered SE I||1282
962207|NCT00205777|2327206|P3|STARTED|Completed Core Study, Entered SE I||1277
962208|NCT00205777|2327207|P2|STARTED|Completed Core Study, Entered SE I||1245
962209|NCT00205777|2327208|P1|STARTED|Completed Core Study, Entered SE I||1279
962210|NCT00205777|2327203|P6|NOT COMPLETED|Core Study (Up to 3 Years)||0
962211|NCT00205777|2327204|P5|NOT COMPLETED|Core Study (Up to 3 Years)||0
962212|NCT00205777|2327205|P4|NOT COMPLETED|Core Study (Up to 3 Years)||632
962213|NCT00205777|2327206|P3|NOT COMPLETED|Core Study (Up to 3 Years)||607
962214|NCT00205777|2327207|P2|NOT COMPLETED|Core Study (Up to 3 Years)||659
962215|NCT00205777|2327208|P1|NOT COMPLETED|Core Study (Up to 3 Years)||628
962216|NCT00205777|2327203|P6|COMPLETED|Core Study (Up to 3 Years)||0
962217|NCT00205777|2327204|P5|COMPLETED|Core Study (Up to 3 Years)||0
962218|NCT00205777|2327205|P4|COMPLETED|Core Study (Up to 3 Years)||1282
962219|NCT00205777|2327206|P3|COMPLETED|Core Study (Up to 3 Years)||1277
962220|NCT00205777|2327207|P2|COMPLETED|Core Study (Up to 3 Years)||1245
962221|NCT00205777|2327208|P1|COMPLETED|Core Study (Up to 3 Years)||1279
962222|NCT00205777|2327203|P6|TREATED|Core Study (Up to 3 Years)||0
962223|NCT00205777|2327204|P5|TREATED|Core Study (Up to 3 Years)||0
962224|NCT00205777|2327205|P4|TREATED|Core Study (Up to 3 Years)||1885
962225|NCT00205777|2327206|P3|TREATED|Core Study (Up to 3 Years)||1849
962226|NCT00205777|2327207|P2|TREATED|Core Study (Up to 3 Years)||1872
962227|NCT00205777|2327208|P1|TREATED|Core Study (Up to 3 Years)||1886
962228|NCT00205777|2327203|P6|STARTED|Core Study (Up to 3 Years)||0
962229|NCT00205777|2327204|P5|STARTED|Core Study (Up to 3 Years)||0
962230|NCT00205777|2327205|P4|STARTED|Core Study (Up to 3 Years)||1914
962231|NCT00205777|2327206|P3|STARTED|Core Study (Up to 3 Years)||1884
962232|NCT00205777|2327207|P2|STARTED|Core Study (Up to 3 Years)||1904
962233|NCT00205777|2327208|P1|STARTED|Core Study (Up to 3 Years)||1907
962234|NCT00205803|2327417|P2|NOT COMPLETED|Toddler Dose||3
962235|NCT00205803|2327418|P1|NOT COMPLETED|Toddler Dose||2
962236|NCT00205803|2327417|P2|COMPLETED|Toddler Dose||100
962237|NCT00205803|2327418|P1|COMPLETED|Toddler Dose||84
962238|NCT00205803|2327417|P2|STARTED|Toddler Dose||103
962239|NCT00205803|2327418|P1|STARTED|Toddler Dose||86
962240|NCT00205803|2327417|P2|NOT COMPLETED|After Infant Series||13
962241|NCT00205803|2327418|P1|NOT COMPLETED|After Infant Series||18
962242|NCT00205803|2327417|P2|COMPLETED|After Infant Series||103
962243|NCT00205803|2327418|P1|COMPLETED|After Infant Series||86
962244|NCT00205803|2327417|P2|STARTED|After Infant Series||116
962245|NCT00205803|2327418|P1|STARTED|After Infant Series||104
962246|NCT00205803|2327417|P2|NOT COMPLETED|Infant Series||11
962247|NCT00205803|2327418|P1|NOT COMPLETED|Infant Series||18
962248|NCT00205803|2327417|P2|COMPLETED|Infant Series||116
962249|NCT00205803|2327418|P1|COMPLETED|Infant Series||104
962250|NCT00205803|2327417|P2|Vaccinated Dose 3|Infant Series||118
962251|NCT00205803|2327418|P1|Vaccinated Dose 3|Infant Series||110
962252|NCT00205803|2327417|P2|Vaccinated Dose 2|Infant Series||122
962253|NCT00205803|2327418|P1|Vaccinated Dose 2|Infant Series||115
962254|NCT00205803|2327417|P2|Vaccinated Dose 1|Infant Series||126
962255|NCT00205803|2327418|P1|Vaccinated Dose 1|Infant Series||121
962256|NCT00205803|2327417|P2|STARTED|Infant Series||127
962257|NCT00205803|2327418|P1|STARTED|Infant Series||122
962258|NCT00205855|2327470|P1|NOT COMPLETED|Overall Study||21
962259|NCT00205855|2327470|P1|COMPLETED|Overall Study||44
962260|NCT00205855|2327470|P1|STARTED|Overall Study||65
962261|NCT00205881|2327474|P1|NOT COMPLETED|Overall Study||16
962262|NCT00205881|2327474|P1|COMPLETED|Overall Study|32 enrolled. 1 unilateral. 25 bilateral for data analysis at 8 months. 16 completed study.|16
962263|NCT00205881|2327474|P1|STARTED|Overall Study||32
962264|NCT00206076|2327481|P2|NOT COMPLETED|Overall Study||1
962265|NCT00206076|2327482|P1|NOT COMPLETED|Overall Study||3
962266|NCT00206076|2327481|P2|COMPLETED|Overall Study||9
962267|NCT00206076|2327482|P1|COMPLETED|Overall Study||6
962268|NCT00206076|2327481|P2|STARTED|Overall Study||10
962269|NCT00206076|2327482|P1|STARTED|Overall Study||9
962270|NCT00206102|2327494|P2|NOT COMPLETED|Overall Study||315
962271|NCT00206102|2327495|P1|NOT COMPLETED|Overall Study||408
962272|NCT00206102|2327494|P2|COMPLETED|Overall Study||187
962273|NCT00206102|2327495|P1|COMPLETED|Overall Study||188
962274|NCT00206102|2327494|P2|STARTED|Overall Study||502
962275|NCT00206102|2327495|P1|STARTED|Overall Study||596
962276|NCT00206427|2327529|P1|NOT COMPLETED|Overall Study||2
962277|NCT00206427|2327529|P1|COMPLETED|Overall Study|Complete 6-week therapy|47
962278|NCT00206427|2327529|P1|STARTED|Overall Study|Received First Dose|49
962279|NCT00206440|2327535|P2|NOT COMPLETED|Overall Study||4
962280|NCT00206440|2327536|P1|NOT COMPLETED|Overall Study||5
962281|NCT00206440|2327535|P2|COMPLETED|Overall Study||18
962282|NCT00206440|2327536|P1|COMPLETED|Overall Study||16
962283|NCT00206440|2327535|P2|STARTED|Overall Study||22
962284|NCT00206440|2327536|P1|STARTED|Overall Study||21
962285|NCT00206518|2327544|P2|NOT COMPLETED|Overall Study||6
962286|NCT00206518|2327545|P1|NOT COMPLETED|Overall Study||10
962287|NCT00206518|2327544|P2|COMPLETED|Overall Study||78
962288|NCT00206518|2327545|P1|COMPLETED|Overall Study||73
962289|NCT00206518|2327544|P2|STARTED|Overall Study||84
962290|NCT00206518|2327545|P1|STARTED|Overall Study||83
962291|NCT00206726|2327555|P1|NOT COMPLETED|Overall Study||51
962292|NCT00206726|2327555|P1|COMPLETED|Overall Study|4-6 cycles of treatment with assessments at 2, 6, and 9 months post last dose|9
962293|NCT00206726|2327555|P1|4 Cycles Completed|Overall Study|per protocol population|41
962294|NCT00206726|2327555|P1|Treatment Started|Overall Study|Safety population (3 withdrew consent prior to receiving study drug)|57
962295|NCT00206726|2327555|P1|STARTED|Overall Study||60
962296|NCT00207090|2327564|P1|NOT COMPLETED|Overall Study||7
962297|NCT00207090|2327564|P1|COMPLETED|Overall Study||8
962298|NCT00207090|2327564|P1|STARTED|Overall Study|Number of participants treated|15
962299|NCT00207142|2327596|P4|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
962300|NCT00207142|2327597|P3|NOT COMPLETED|Maintenance Phase/Rescue Phase||13
962301|NCT00207142|2327598|P2|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
962302|NCT00207142|2327599|P1|NOT COMPLETED|Maintenance Phase/Rescue Phase||0
962303|NCT00207142|2327596|P4|COMPLETED|Maintenance Phase/Rescue Phase||41
962304|NCT00207142|2327597|P3|COMPLETED|Maintenance Phase/Rescue Phase||72
962305|NCT00207142|2327598|P2|COMPLETED|Maintenance Phase/Rescue Phase||78
962306|NCT00207142|2327599|P1|COMPLETED|Maintenance Phase/Rescue Phase||0
962307|NCT00207142|2327596|P4|STARTED|Maintenance Phase/Rescue Phase||50
962308|NCT00207142|2327597|P3|STARTED|Maintenance Phase/Rescue Phase||85
962309|NCT00207142|2327598|P2|STARTED|Maintenance Phase/Rescue Phase||87
962310|NCT00207142|2327599|P1|STARTED|Maintenance Phase/Rescue Phase||0
962311|NCT00207142|2327596|P4|NOT COMPLETED|Induction Phase||0
962312|NCT00207142|2327597|P3|NOT COMPLETED|Induction Phase||0
962313|NCT00207142|2327598|P2|NOT COMPLETED|Induction Phase||0
962314|NCT00207142|2327599|P1|NOT COMPLETED|Induction Phase||30
962315|NCT00207142|2327596|P4|COMPLETED|Induction Phase||0
962316|NCT00207142|2327597|P3|COMPLETED|Induction Phase||0
962317|NCT00207142|2327598|P2|COMPLETED|Induction Phase||0
962318|NCT00207142|2327599|P1|COMPLETED|Induction Phase|Subjects randomized into Maintenance Phase=172 (87 ATV +85 ATV/RTV); Rescue Phase subjects=50|222
962319|NCT00207142|2327596|P4|STARTED|Induction Phase||0
962320|NCT00207142|2327597|P3|STARTED|Induction Phase||0
962321|NCT00207142|2327598|P2|STARTED|Induction Phase||0
962322|NCT00207142|2327599|P1|STARTED|Induction Phase||252
962323|NCT00207714|2327641|P5|NOT COMPLETED|Overall Study||5
962324|NCT00207714|2327642|P4|NOT COMPLETED|Overall Study||8
962325|NCT00207714|2327643|P3|NOT COMPLETED|Overall Study||10
962326|NCT00207714|2327644|P2|NOT COMPLETED|Overall Study||7
962327|NCT00207714|2327645|P1|NOT COMPLETED|Overall Study||14
962328|NCT00207714|2327641|P5|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|29
962329|NCT00207714|2327642|P4|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|26
962330|NCT00207714|2327643|P3|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|24
962331|NCT00207714|2327644|P2|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|28
962332|NCT00207714|2327645|P1|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|21
962333|NCT00207714|2327641|P5|STARTED|Overall Study||34
962334|NCT00207714|2327642|P4|STARTED|Overall Study||34
962335|NCT00207714|2327643|P3|STARTED|Overall Study||34
962336|NCT00207714|2327644|P2|STARTED|Overall Study||35
962337|NCT00207714|2327645|P1|STARTED|Overall Study||35
962338|NCT00207727|2327669|P5|NOT COMPLETED|Overall Study||34
962339|NCT00207727|2327670|P4|NOT COMPLETED|Overall Study||37
962340|NCT00207727|2327671|P3|NOT COMPLETED|Overall Study||41
962341|NCT00207727|2327672|P2|NOT COMPLETED|Overall Study||42
962342|NCT00207727|2327673|P1|NOT COMPLETED|Overall Study||38
962343|NCT00207727|2327669|P5|COMPLETED|Overall Study||16
962344|NCT00207727|2327670|P4|COMPLETED|Overall Study||13
962345|NCT00207727|2327671|P3|COMPLETED|Overall Study||9
962346|NCT00207727|2327672|P2|COMPLETED|Overall Study||8
962347|NCT00207727|2327673|P1|COMPLETED|Overall Study||11
962348|NCT00207727|2327669|P5|STARTED|Overall Study||50
962349|NCT00207727|2327670|P4|STARTED|Overall Study||50
962350|NCT00207727|2327671|P3|STARTED|Overall Study||50
962351|NCT00207727|2327672|P2|STARTED|Overall Study||50
962352|NCT00207727|2327673|P1|STARTED|Overall Study||49
962353|NCT00207740|2327699|P4|NOT COMPLETED|Overall Study||43
962354|NCT00207740|2327700|P3|NOT COMPLETED|Overall Study||40
962355|NCT00207740|2327701|P2|NOT COMPLETED|Overall Study||41
962356|NCT00207740|2327702|P1|NOT COMPLETED|Overall Study||29
962357|NCT00207740|2327699|P4|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|35
962358|NCT00207740|2327700|P3|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
962359|NCT00207740|2327701|P2|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
962360|NCT00207740|2327702|P1|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|49
962361|NCT00207740|2327699|P4|STARTED|Overall Study||78
962362|NCT00207740|2327700|P3|STARTED|Overall Study||76
962363|NCT00207740|2327701|P2|STARTED|Overall Study||77
962364|NCT00207740|2327702|P1|STARTED|Overall Study||78
962365|NCT00207883|2327745|P2|NOT COMPLETED|Overall Study||0
962366|NCT00207883|2327746|P1|NOT COMPLETED|Overall Study||0
962367|NCT00207883|2327745|P2|COMPLETED|Overall Study||119
962368|NCT00207883|2327746|P1|COMPLETED|Overall Study||93
962369|NCT00207883|2327745|P2|STARTED|Overall Study||119
962370|NCT00207883|2327746|P1|STARTED|Overall Study||93
962374|NCT00208091|2327758|P1|NOT COMPLETED|Overall Study||0
962375|NCT00208091|2327758|P1|COMPLETED|Overall Study||16
962376|NCT00208091|2327758|P1|STARTED|Overall Study||16
962377|NCT00195650|2327766|P1|NOT COMPLETED|Overall Study||525
962378|NCT00195650|2327766|P1|COMPLETED|Overall Study||321
962379|NCT00195650|2327766|P1|STARTED|Overall Study|Participants who received at least 1 adalimumab dose in study;3 enrolled did not receive adalimumab.|846
962380|NCT00195663|2327783|P3|NOT COMPLETED|Open-Label Extension Period||97
962381|NCT00195663|2327784|P2|NOT COMPLETED|Open-Label Extension Period||74
962382|NCT00195663|2327785|P1|NOT COMPLETED|Open-Label Extension Period||76
962383|NCT00195663|2327783|P3|COMPLETED|Open-Label Extension Period||86
962384|NCT00195663|2327784|P2|COMPLETED|Open-Label Extension Period||85
962385|NCT00195663|2327785|P1|COMPLETED|Open-Label Extension Period||79
962386|NCT00195663|2327783|P3|STARTED|Open-Label Extension Period||183
962387|NCT00195663|2327784|P2|STARTED|Open-Label Extension Period||159
962388|NCT00195663|2327785|P1|STARTED|Open-Label Extension Period||155
962389|NCT00195663|2327783|P3|NOT COMPLETED|2-year Double-blind Treatment Period||72
962390|NCT00195663|2327784|P2|NOT COMPLETED|2-year Double-blind Treatment Period||108
962391|NCT00195663|2327785|P1|NOT COMPLETED|2-year Double-blind Treatment Period||93
962392|NCT00195663|2327783|P3|COMPLETED|2-year Double-blind Treatment Period||196
962393|NCT00195663|2327784|P2|COMPLETED|2-year Double-blind Treatment Period||166
962394|NCT00195663|2327785|P1|COMPLETED|2-year Double-blind Treatment Period||164
962395|NCT00195663|2327783|P3|STARTED|2-year Double-blind Treatment Period||268
962396|NCT00195663|2327784|P2|STARTED|2-year Double-blind Treatment Period||274
962397|NCT00195663|2327785|P1|STARTED|2-year Double-blind Treatment Period||257
962398|NCT00195676|2327879|P1|NOT COMPLETED|Period R - Retreatment 16 Weeks||35
962399|NCT00195676|2327879|P1|COMPLETED|Period R - Retreatment 16 Weeks||490
962400|NCT00195676|2327879|P1|STARTED|Period R - Retreatment 16 Weeks|Number who entered from Period W, including those who did and did not relapse in that period.|525
962401|NCT00195676|2327879|P1|NOT COMPLETED|Period W (Withdrawal) - No Treatment||608
962402|NCT00195676|2327879|P1|COMPLETED|Period W (Withdrawal) - No Treatment|Non-completers may have entered Period R, whether or not they relapsed (PGA >= 3).|0
962403|NCT00195676|2327879|P1|STARTED|Period W (Withdrawal) - No Treatment|Period O completers with a Physician's Global Assessment =<2 who continued into Periods W and R.|608
962404|NCT00195676|2327879|P1|NOT COMPLETED|Period O - Open-label Treatment||606
962405|NCT00195676|2327879|P1|COMPLETED|Period O - Open-label Treatment|254 Period O completers did not consent or were not eligible to continue into Period W and Period R.|862
962406|NCT00195676|2327879|P1|STARTED|Period O - Open-label Treatment|Number receiving adalimumab in Period O (1 additional participant enrolled but did not receive drug)|1468
962407|NCT00195702|2327893|P6|NOT COMPLETED|Open-label Extension Phase||78
962408|NCT00195702|2327894|P5|NOT COMPLETED|Open-label Extension Phase||78
962409|NCT00195702|2327895|P4|NOT COMPLETED|Open-label Extension Phase||99
962410|NCT00195702|2327896|P3|NOT COMPLETED|Open-label Extension Phase||0
962411|NCT00195702|2327897|P2|NOT COMPLETED|Open-label Extension Phase||0
962412|NCT00195702|2327898|P1|NOT COMPLETED|Open-label Extension Phase||0
962413|NCT00195702|2327893|P6|COMPLETED|Open-label Extension Phase||56
962414|NCT00195702|2327894|P5|COMPLETED|Open-label Extension Phase||80
962415|NCT00195702|2327895|P4|COMPLETED|Open-label Extension Phase||66
962416|NCT00195702|2327896|P3|COMPLETED|Open-label Extension Phase||0
962417|NCT00195702|2327897|P2|COMPLETED|Open-label Extension Phase||0
962418|NCT00195702|2327898|P1|COMPLETED|Open-label Extension Phase||0
962419|NCT00195702|2327893|P6|STARTED|Open-label Extension Phase|6 subjects completed the double-blind phase but did not enter the open-label extension phase.|134
962420|NCT00195702|2327894|P5|STARTED|Open-label Extension Phase|1 subject completed the double-blind phase but did not enter the open-label extension phase.|158
962421|NCT00195702|2327895|P4|STARTED|Open-label Extension Phase|3 subjects completed the double-blind phase but did not enter the open-label extension phase.|165
962422|NCT00195702|2327896|P3|STARTED|Open-label Extension Phase||0
962423|NCT00195702|2327897|P2|STARTED|Open-label Extension Phase||0
962424|NCT00195702|2327898|P1|STARTED|Open-label Extension Phase||0
962425|NCT00195702|2327893|P6|NOT COMPLETED|Double-blind Phase||0
962426|NCT00195702|2327894|P5|NOT COMPLETED|Double-blind Phase||0
962427|NCT00195702|2327895|P4|NOT COMPLETED|Double-blind Phase||0
962428|NCT00195702|2327896|P3|NOT COMPLETED|Double-blind Phase||60
962429|NCT00195702|2327897|P2|NOT COMPLETED|Double-blind Phase||48
962430|NCT00195702|2327898|P1|NOT COMPLETED|Double-blind Phase||44
962431|NCT00195702|2327893|P6|COMPLETED|Double-blind Phase||0
962432|NCT00195702|2327894|P5|COMPLETED|Double-blind Phase||0
962433|NCT00195702|2327895|P4|COMPLETED|Double-blind Phase||0
962434|NCT00195702|2327896|P3|COMPLETED|Double-blind Phase||140
962435|NCT00195702|2327897|P2|COMPLETED|Double-blind Phase||159
962436|NCT00195702|2327898|P1|COMPLETED|Double-blind Phase||168
962437|NCT00195702|2327893|P6|STARTED|Double-blind Phase||0
962438|NCT00195702|2327894|P5|STARTED|Double-blind Phase||0
962439|NCT00195702|2327895|P4|STARTED|Double-blind Phase||0
962440|NCT00195702|2327896|P3|STARTED|Double-blind Phase||200
962441|NCT00195702|2327897|P2|STARTED|Double-blind Phase||207
962442|NCT00195702|2327898|P1|STARTED|Double-blind Phase|For all groups, started indicates when the subjects entered the 52-week double-blind phase.|212
962443|NCT00195715|2327962|P1|NOT COMPLETED|Overall Study||377
962444|NCT00195715|2327962|P1|COMPLETED|Overall Study||400
962445|NCT00195715|2327962|P1|STARTED|Overall Study||777
962446|NCT00195819|2327990|P2|NOT COMPLETED|Open-label||20
962447|NCT00195819|2327991|P1|NOT COMPLETED|Open-label||0
962448|NCT00195819|2327990|P2|COMPLETED|Open-label||62
962449|NCT00195819|2327991|P1|COMPLETED|Open-label||0
962450|NCT00195819|2327990|P2|STARTED|Open-label||82
962451|NCT00195819|2327991|P1|STARTED|Open-label||0
962452|NCT00195819|2327990|P2|NOT COMPLETED|Double-Blind||0
962453|NCT00195819|2327991|P1|NOT COMPLETED|Double-Blind||2
962454|NCT00195819|2327990|P2|COMPLETED|Double-Blind||38
962455|NCT00195819|2327991|P1|COMPLETED|Double-Blind||42
962456|NCT00195819|2327990|P2|STARTED|Double-Blind||38
962457|NCT00195819|2327991|P1|STARTED|Double-Blind||44
962458|NCT00196105|2328044|P3|NOT COMPLETED|Overall Study||7
962459|NCT00196105|2328045|P2|NOT COMPLETED|Overall Study||5
962460|NCT00196105|2328046|P1|NOT COMPLETED|Overall Study||4
962461|NCT00196105|2328044|P3|COMPLETED|Overall Study||82
962462|NCT00196105|2328045|P2|COMPLETED|Overall Study||83
962463|NCT00196105|2328046|P1|COMPLETED|Overall Study||60
962464|NCT00196105|2328044|P3|STARTED|Overall Study||89
962465|NCT00196105|2328045|P2|STARTED|Overall Study||88
962466|NCT00196105|2328046|P1|STARTED|Overall Study||64
962467|NCT00196196|2328066|P1|NOT COMPLETED|Overall Study||7
962468|NCT00196196|2328066|P1|COMPLETED|Overall Study||267
962469|NCT00196196|2328066|P1|STARTED|Overall Study||274
962470|NCT00196313|2328073|P2|NOT COMPLETED|Overall Study||8
962471|NCT00196313|2328074|P1|NOT COMPLETED|Overall Study||11
962472|NCT00196313|2328073|P2|COMPLETED|Overall Study||40
962473|NCT00196313|2328074|P1|COMPLETED|Overall Study||36
962474|NCT00196313|2328073|P2|STARTED|Overall Study||48
962475|NCT00196313|2328074|P1|STARTED|Overall Study||47
962476|NCT00201825|2328088|P1|NOT COMPLETED|Overall Study||0
962477|NCT00201825|2328088|P1|COMPLETED|Overall Study||29
962478|NCT00201825|2328088|P1|STARTED|Overall Study||29
962479|NCT00201838|2328097|P2|NOT COMPLETED|Overall Study||0
962480|NCT00201838|2328098|P1|NOT COMPLETED|Overall Study||0
962481|NCT00201838|2328097|P2|COMPLETED|Overall Study||8
962482|NCT00201838|2328098|P1|COMPLETED|Overall Study||30
962483|NCT00201838|2328097|P2|Treatment Cohort|Overall Study||8
962484|NCT00201838|2328098|P1|Treatment Cohort|Overall Study||30
962485|NCT00201838|2328097|P2|STARTED|Overall Study||8
962486|NCT00201838|2328098|P1|STARTED|Overall Study||30
962487|NCT00201851|2328115|P3|NOT COMPLETED|Overall Study||1
962488|NCT00201851|2328116|P2|NOT COMPLETED|Overall Study||2
962489|NCT00201851|2328117|P1|NOT COMPLETED|Overall Study||8
962490|NCT00201851|2328115|P3|COMPLETED|Overall Study||230
962491|NCT00201851|2328116|P2|COMPLETED|Overall Study||255
962492|NCT00201851|2328117|P1|COMPLETED|Overall Study||244
962493|NCT00201851|2328115|P3|STARTED|Overall Study||231
962494|NCT00201851|2328116|P2|STARTED|Overall Study||257
962495|NCT00201851|2328117|P1|STARTED|Overall Study||252
962496|NCT00201864|2328125|P1|NOT COMPLETED|Overall Study||0
962497|NCT00201864|2328125|P1|COMPLETED|Overall Study||40
962498|NCT00201864|2328125|P1|STARTED|Overall Study||40
962499|NCT00201877|2328133|P1|NOT COMPLETED|Overall Study||0
962500|NCT00201877|2328133|P1|COMPLETED|Overall Study||25
962501|NCT00201877|2328133|P1|STARTED|Overall Study||25
962502|NCT00202449|2328142|P3|NOT COMPLETED|Overall Study||12
962503|NCT00202449|2328143|P2|NOT COMPLETED|Overall Study||11
962504|NCT00202449|2328144|P1|NOT COMPLETED|Overall Study||11
962505|NCT00202449|2328142|P3|COMPLETED|Overall Study||9
962506|NCT00202449|2328143|P2|COMPLETED|Overall Study||9
962507|NCT00202449|2328144|P1|COMPLETED|Overall Study||7
962508|NCT00202449|2328142|P3|STARTED|Overall Study||21
962509|NCT00202449|2328143|P2|STARTED|Overall Study||20
962510|NCT00202449|2328144|P1|STARTED|Overall Study||18
962511|NCT00202722|2328158|P1|NOT COMPLETED|Overall Study||0
962512|NCT00202722|2328158|P1|COMPLETED|Overall Study||41
962513|NCT00202722|2328158|P1|STARTED|Overall Study||41
962514|NCT00202839|2328165|P2|NOT COMPLETED|Overall Study||10
962515|NCT00202839|2328166|P1|NOT COMPLETED|Overall Study||24
962516|NCT00202839|2328165|P2|COMPLETED|Overall Study||72
962517|NCT00202839|2328166|P1|COMPLETED|Overall Study||54
962518|NCT00202839|2328165|P2|STARTED|Overall Study||82
962519|NCT00202839|2328166|P1|STARTED|Overall Study||78
962520|NCT00202878|2328176|P2|NOT COMPLETED|Overall Study||2217
962521|NCT00202878|2328177|P1|NOT COMPLETED|Overall Study||2199
962522|NCT00202878|2328176|P2|COMPLETED|Overall Study||6860
962523|NCT00202878|2328177|P1|COMPLETED|Overall Study||6868
962524|NCT00202878|2328176|P2|STARTED|Overall Study||9077
962525|NCT00202878|2328177|P1|STARTED|Overall Study||9067
962526|NCT00208325|2328193|P4|NOT COMPLETED|Overall Study||14
962527|NCT00208325|2328194|P3|NOT COMPLETED|Overall Study||14
962528|NCT00208325|2328195|P2|NOT COMPLETED|Overall Study||54
962529|NCT00208325|2328196|P1|NOT COMPLETED|Overall Study||51
962530|NCT00208325|2328193|P4|COMPLETED|Overall Study||147
962531|NCT00208325|2328194|P3|COMPLETED|Overall Study||156
962532|NCT00208325|2328195|P2|COMPLETED|Overall Study||142
962533|NCT00208325|2328196|P1|COMPLETED|Overall Study||142
962534|NCT00208325|2328193|P4|STARTED|Overall Study||161
962535|NCT00208325|2328194|P3|STARTED|Overall Study||170
962536|NCT00208325|2328195|P2|STARTED|Overall Study||196
962537|NCT00208325|2328196|P1|STARTED|Overall Study||193
962538|NCT00208494|2328306|P2|NOT COMPLETED|Overall Study||34
962539|NCT00208494|2328307|P1|NOT COMPLETED|Overall Study||30
962540|NCT00208494|2328306|P2|COMPLETED|Overall Study||162
962541|NCT00208494|2328307|P1|COMPLETED|Overall Study||164
962542|NCT00208494|2328306|P2|STARTED|Overall Study||196
962543|NCT00208494|2328307|P1|STARTED|Overall Study||194
962544|NCT00208507|2328315|P2|NOT COMPLETED|Overall Study||8
962545|NCT00208507|2328316|P1|NOT COMPLETED|Overall Study||14
962546|NCT00208507|2328315|P2|COMPLETED|Overall Study||79
962547|NCT00208507|2328316|P1|COMPLETED|Overall Study||163
962548|NCT00208507|2328315|P2|STARTED|Overall Study||87
962549|NCT00208507|2328316|P1|STARTED|Overall Study||177
962550|NCT00209417|2328324|P2|NOT COMPLETED|Overall Study||0
962551|NCT00209417|2328325|P1|NOT COMPLETED|Overall Study||0
962552|NCT00209417|2328324|P2|COMPLETED|Overall Study||327
962553|NCT00209417|2328325|P1|COMPLETED|Overall Study||321
962554|NCT00209417|2328324|P2|STARTED|Overall Study||327
962555|NCT00209417|2328325|P1|STARTED|Overall Study||321
962556|NCT00209560|2328335|P2|NOT COMPLETED|Overall Study||0
962557|NCT00209560|2328336|P1|NOT COMPLETED|Overall Study||1
962558|NCT00209560|2328335|P2|COMPLETED|Overall Study||42
962559|NCT00209560|2328336|P1|COMPLETED|Overall Study||120
962560|NCT00209560|2328335|P2|STARTED|Overall Study||42
962561|NCT00209560|2328336|P1|STARTED|Overall Study||121
962562|NCT00210470|2328344|P1|NOT COMPLETED|Overall Study||1
962563|NCT00210470|2328344|P1|COMPLETED|Overall Study||26
962564|NCT00210470|2328344|P1|STARTED|Overall Study||27
962565|NCT00210626|2328350|P2|NOT COMPLETED|Overall Study||45
962566|NCT00210626|2328351|P1|NOT COMPLETED|Overall Study||48
962567|NCT00210626|2328350|P2|COMPLETED|Overall Study||50
962568|NCT00210626|2328351|P1|COMPLETED|Overall Study||49
962569|NCT00210626|2328350|P2|STARTED|Overall Study||95
962570|NCT00210626|2328351|P1|STARTED|Overall Study||97
962571|NCT00210639|2328361|P2|NOT COMPLETED|Overall Study||42
962572|NCT00210639|2328362|P1|NOT COMPLETED|Overall Study||63
962573|NCT00210639|2328361|P2|COMPLETED|Overall Study||41
962574|NCT00210639|2328362|P1|COMPLETED|Overall Study||61
962575|NCT00210639|2328361|P2|STARTED|Overall Study||83
962576|NCT00210639|2328362|P1|STARTED|Overall Study||124
962577|NCT00211081|2328368|P1|NOT COMPLETED|Overall Study||2
962578|NCT00211081|2328368|P1|COMPLETED|Overall Study|Study completed in 2008|10
962579|NCT00211081|2328368|P1|STARTED|Overall Study|Study started in 2006|12
962580|NCT00211172|2328374|P2|NOT COMPLETED|Overall Study||32
962581|NCT00211172|2328375|P1|NOT COMPLETED|Overall Study||39
962582|NCT00211172|2328374|P2|COMPLETED|Overall Study|32 patients died or lost health plan eligibility|426
962583|NCT00211172|2328375|P1|COMPLETED|Overall Study|39 patients died or lost health plan eligibility|410
962584|NCT00211172|2328374|P2|STARTED|Overall Study||458
962585|NCT00211172|2328375|P1|STARTED|Overall Study||449
962631|NCT00211510|2328477|P2|NOT COMPLETED|Overall Study||2
962632|NCT00211510|2328478|P1|NOT COMPLETED|Overall Study||6
962633|NCT00211510|2328477|P2|COMPLETED|Overall Study||72
962634|NCT00211510|2328478|P1|COMPLETED|Overall Study||66
962635|NCT00211510|2328477|P2|STARTED|Overall Study||74
962636|NCT00211510|2328478|P1|STARTED|Overall Study||72
962637|NCT00211536|2328496|P2|NOT COMPLETED|Overall Study||7
962638|NCT00211536|2328497|P1|NOT COMPLETED|Overall Study||4
962639|NCT00211536|2328496|P2|COMPLETED|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|47
962640|NCT00211536|2328497|P1|COMPLETED|Overall Study||49
962641|NCT00211536|2328496|P2|As Treated Data Analysis Set|Overall Study||48
962642|NCT00211536|2328497|P1|As Treated Data Analysis Set|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|52
962643|NCT00211536|2328496|P2|STARTED|Overall Study||54
962644|NCT00211536|2328497|P1|STARTED|Overall Study||53
962645|NCT00211692|2328513|P2|NOT COMPLETED|Overall Study||0
962646|NCT00211692|2328514|P1|NOT COMPLETED|Overall Study||0
962647|NCT00211692|2328513|P2|COMPLETED|Overall Study||31
962648|NCT00211692|2328514|P1|COMPLETED|Overall Study||33
962649|NCT00211692|2328513|P2|STARTED|Overall Study||31
962650|NCT00211692|2328514|P1|STARTED|Overall Study||33
962651|NCT00211809|2328522|P1|NOT COMPLETED|Overall Study||6
962652|NCT00211809|2328522|P1|COMPLETED|Overall Study||11
962653|NCT00211809|2328522|P1|STARTED|Overall Study||17
962654|NCT00211887|2328539|P3|NOT COMPLETED|Overall Study||36
962655|NCT00211887|2328540|P2|NOT COMPLETED|Overall Study||56
962656|NCT00211887|2328541|P1|NOT COMPLETED|Overall Study||102
962657|NCT00211887|2328539|P3|COMPLETED|Overall Study||223
962658|NCT00211887|2328540|P2|COMPLETED|Overall Study||194
962659|NCT00211887|2328541|P1|COMPLETED|Overall Study||397
962660|NCT00211887|2328539|P3|STARTED|Overall Study||259
962661|NCT00211887|2328540|P2|STARTED|Overall Study||250
962662|NCT00211887|2328541|P1|STARTED|Overall Study||499
962663|NCT00212134|2328560|P2|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||1
962664|NCT00212134|2328561|P1|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||0
962665|NCT00212134|2328560|P2|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)|Patient lost to follow-up.|56
962666|NCT00212134|2328561|P1|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||57
962667|NCT00212134|2328560|P2|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
962668|NCT00212134|2328561|P1|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
962669|NCT00212134|2328560|P2|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
962670|NCT00212134|2328561|P1|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
962671|NCT00212134|2328560|P2|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
962672|NCT00212134|2328561|P1|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
962673|NCT00212134|2328560|P2|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
962674|NCT00212134|2328561|P1|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
962675|NCT00212134|2328560|P2|STARTED|Phase 1 (to Age 1 Year)||57
962676|NCT00212134|2328561|P1|STARTED|Phase 1 (to Age 1 Year)||57
962677|NCT00213135|2328582|P3|NOT COMPLETED|Overall Study||57
962678|NCT00213135|2328583|P2|NOT COMPLETED|Overall Study||35
962679|NCT00213135|2328584|P1|NOT COMPLETED|Overall Study||50
962680|NCT00213135|2328582|P3|COMPLETED|Overall Study||380
962681|NCT00213135|2328583|P2|COMPLETED|Overall Study||398
962682|NCT00213135|2328584|P1|COMPLETED|Overall Study||406
962683|NCT00213135|2328582|P3|STARTED|Overall Study||437
962684|NCT00213135|2328583|P2|STARTED|Overall Study||433
962685|NCT00213135|2328584|P1|STARTED|Overall Study||456
962686|NCT00214019|2328601|P1|NOT COMPLETED|Overall Study||30
962687|NCT00214019|2328601|P1|COMPLETED|Overall Study||6
962688|NCT00214019|2328601|P1|Fluticasone/Salmeterol Arm|Overall Study||6
962689|NCT00214019|2328601|P1|Fluticasone/Placebo Arm|Overall Study||6
962690|NCT00214019|2328601|P1|Placebo/Salmeterol Arm|Overall Study||6
962691|NCT00214019|2328601|P1|Placebo/Placebo Arm|Overall Study||6
962692|NCT00214019|2328601|P1|STARTED|Overall Study||36
962693|NCT00214201|2328610|P2|NOT COMPLETED|Overall Study||2
962694|NCT00214201|2328611|P1|NOT COMPLETED|Overall Study||2
962695|NCT00214201|2328610|P2|COMPLETED|Overall Study||18
962696|NCT00214201|2328611|P1|COMPLETED|Overall Study||18
962697|NCT00214201|2328610|P2|STARTED|Overall Study||20
962698|NCT00214201|2328611|P1|STARTED|Overall Study||20
962699|NCT00214383|2328623|P2|NOT COMPLETED|Overall Study||26
962700|NCT00214383|2328624|P1|NOT COMPLETED|Overall Study||16
962701|NCT00214383|2328623|P2|COMPLETED|Overall Study||127
962702|NCT00214383|2328624|P1|COMPLETED|Overall Study||132
962703|NCT00214383|2328623|P2|STARTED|Overall Study||153
962704|NCT00214383|2328624|P1|STARTED|Overall Study||148
962705|NCT00214461|2328638|P4|NOT COMPLETED|Overall Study||1
962706|NCT00214461|2328639|P3|NOT COMPLETED|Overall Study||2
962707|NCT00214461|2328640|P2|NOT COMPLETED|Overall Study||0
962708|NCT00214461|2328641|P1|NOT COMPLETED|Overall Study||0
962709|NCT00214461|2328638|P4|COMPLETED|Overall Study||11
962710|NCT00214461|2328639|P3|COMPLETED|Overall Study||10
962711|NCT00214461|2328640|P2|COMPLETED|Overall Study||12
962712|NCT00214461|2328641|P1|COMPLETED|Overall Study||12
962713|NCT00214461|2328638|P4|STARTED|Overall Study||12
962714|NCT00214461|2328639|P3|STARTED|Overall Study||12
962715|NCT00214461|2328640|P2|STARTED|Overall Study||12
962716|NCT00214461|2328641|P1|STARTED|Overall Study||12
962717|NCT00214487|2328657|P2|NOT COMPLETED|Overall Study||3
962718|NCT00214487|2328658|P1|NOT COMPLETED|Overall Study||5
962719|NCT00214487|2328657|P2|COMPLETED|Overall Study||40
962720|NCT00214487|2328658|P1|COMPLETED|Overall Study||38
962721|NCT00214487|2328657|P2|STARTED|Overall Study||43
962722|NCT00214487|2328658|P1|STARTED|Overall Study||43
962723|NCT00214526|2328666|P2|NOT COMPLETED|Post-Treatment Period||0
962724|NCT00214526|2328667|P1|NOT COMPLETED|Post-Treatment Period||1
962725|NCT00214526|2328666|P2|COMPLETED|Post-Treatment Period||49
962726|NCT00214526|2328667|P1|COMPLETED|Post-Treatment Period||52
962727|NCT00214526|2328666|P2|STARTED|Post-Treatment Period||49
962728|NCT00214526|2328667|P1|STARTED|Post-Treatment Period||53
962729|NCT00214526|2328666|P2|NOT COMPLETED|Treatment Period||5
962730|NCT00214526|2328667|P1|NOT COMPLETED|Treatment Period||2
962731|NCT00214526|2328666|P2|COMPLETED|Treatment Period||49
962732|NCT00214526|2328667|P1|COMPLETED|Treatment Period||53
962733|NCT00214526|2328666|P2|STARTED|Treatment Period||54
962734|NCT00214526|2328667|P1|STARTED|Treatment Period||55
962735|NCT00214526|2328666|P2|NOT COMPLETED|Randomized||2
962736|NCT00214526|2328667|P1|NOT COMPLETED|Randomized||1
962737|NCT00214526|2328666|P2|COMPLETED|Randomized||54
962738|NCT00214526|2328667|P1|COMPLETED|Randomized||55
962739|NCT00214526|2328666|P2|STARTED|Randomized||56
962740|NCT00214526|2328667|P1|STARTED|Randomized||56
962741|NCT00214539|2328695|P2|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
962742|NCT00214539|2328696|P1|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
962743|NCT00214539|2328695|P2|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||17
962744|NCT00214539|2328696|P1|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||15
962745|NCT00214539|2328695|P2|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||17
962746|NCT00214539|2328696|P1|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||15
962747|NCT00214539|2328695|P2|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
962748|NCT00214539|2328696|P1|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
962749|NCT00214539|2328695|P2|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||17
962750|NCT00214539|2328696|P1|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||15
962751|NCT00214539|2328695|P2|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||17
962752|NCT00214539|2328696|P1|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||15
962753|NCT00214539|2328695|P2|NOT COMPLETED|Treatment Period||0
962754|NCT00214539|2328696|P1|NOT COMPLETED|Treatment Period||0
962755|NCT00214539|2328695|P2|COMPLETED|Treatment Period||17
962756|NCT00214539|2328696|P1|COMPLETED|Treatment Period||15
962757|NCT00214539|2328695|P2|STARTED|Treatment Period||17
962758|NCT00214539|2328696|P1|STARTED|Treatment Period||15
962759|NCT00214539|2328695|P2|NOT COMPLETED|Randomized||0
962760|NCT00214539|2328696|P1|NOT COMPLETED|Randomized||2
962761|NCT00214539|2328695|P2|COMPLETED|Randomized||17
962762|NCT00214539|2328696|P1|COMPLETED|Randomized||15
962763|NCT00214539|2328695|P2|STARTED|Randomized||17
962764|NCT00214539|2328696|P1|STARTED|Randomized||17
962765|NCT00214786|2328720|P1|NOT COMPLETED|Overall Study||3
962766|NCT00214786|2328720|P1|COMPLETED|Overall Study||1
962767|NCT00214786|2328720|P1|STARTED|Overall Study||4
962768|NCT00214903|2328737|P4|NOT COMPLETED|Overall Study||0
962769|NCT00214903|2328738|P3|NOT COMPLETED|Overall Study||0
962770|NCT00214903|2328739|P2|NOT COMPLETED|Overall Study||0
962771|NCT00214903|2328740|P1|NOT COMPLETED|Overall Study||0
962772|NCT00214903|2328737|P4|COMPLETED|Overall Study||3057
962773|NCT00214903|2328738|P3|COMPLETED|Overall Study||4113
962774|NCT00214903|2328739|P2|COMPLETED|Overall Study||13384
962775|NCT00214903|2328740|P1|COMPLETED|Overall Study||10043
962776|NCT00214903|2328737|P4|STARTED|Overall Study||3057
962777|NCT00214903|2328738|P3|STARTED|Overall Study||4113
962778|NCT00214903|2328739|P2|STARTED|Overall Study||13384
962779|NCT00214903|2328740|P1|STARTED|Overall Study||10043
962780|NCT00215137|2328754|P3|NOT COMPLETED|Randomization Period||0
962781|NCT00215137|2328755|P2|NOT COMPLETED|Randomization Period||2
962782|NCT00215137|2328756|P1|NOT COMPLETED|Randomization Period||0
962783|NCT00215137|2328754|P3|COMPLETED|Randomization Period||5
962784|NCT00215137|2328755|P2|COMPLETED|Randomization Period||5
962785|NCT00215137|2328756|P1|COMPLETED|Randomization Period||0
962786|NCT00215137|2328754|P3|STARTED|Randomization Period||5
962787|NCT00215137|2328755|P2|STARTED|Randomization Period||7
962788|NCT00215137|2328756|P1|STARTED|Randomization Period||0
962789|NCT00215137|2328754|P3|NOT COMPLETED|Open Label Escitalopram||0
962790|NCT00215137|2328755|P2|NOT COMPLETED|Open Label Escitalopram||0
962791|NCT00215137|2328756|P1|NOT COMPLETED|Open Label Escitalopram||1
962792|NCT00215137|2328754|P3|COMPLETED|Open Label Escitalopram||0
962793|NCT00215137|2328755|P2|COMPLETED|Open Label Escitalopram||0
962794|NCT00215137|2328756|P1|COMPLETED|Open Label Escitalopram||13
962795|NCT00215137|2328754|P3|STARTED|Open Label Escitalopram||0
962796|NCT00215137|2328755|P2|STARTED|Open Label Escitalopram||0
962797|NCT00215137|2328756|P1|STARTED|Open Label Escitalopram||14
962798|NCT00215150|2328764|P1|NOT COMPLETED|Randomization Phase Placebo||1
962799|NCT00215150|2328764|P1|COMPLETED|Randomization Phase Placebo||10
962800|NCT00215150|2328764|P1|STARTED|Randomization Phase Placebo||11
962801|NCT00215150|2328764|P1|NOT COMPLETED|Randomization Phase Ziprasidone||3
962802|NCT00215150|2328764|P1|COMPLETED|Randomization Phase Ziprasidone||7
962803|NCT00215150|2328764|P1|STARTED|Randomization Phase Ziprasidone||10
962804|NCT00215150|2328764|P1|NOT COMPLETED|Open Label Phase||30
962805|NCT00215150|2328764|P1|COMPLETED|Open Label Phase||21
962806|NCT00215150|2328764|P1|STARTED|Open Label Phase|Number of subjects consented|51
962807|NCT00208767|2328774|P2|NOT COMPLETED|Overall Study||7
962808|NCT00208767|2328775|P1|NOT COMPLETED|Overall Study||27
962809|NCT00208767|2328774|P2|COMPLETED|Overall Study||33
962810|NCT00208767|2328775|P1|COMPLETED|Overall Study||53
962811|NCT00208767|2328774|P2|STARTED|Overall Study||40
962812|NCT00208767|2328775|P1|STARTED|Overall Study||80
962813|NCT00208949|2328783|P2|NOT COMPLETED|Overall Study||0
962814|NCT00208949|2328784|P1|NOT COMPLETED|Overall Study||0
962815|NCT00208949|2328783|P2|COMPLETED|Overall Study||25
962816|NCT00208949|2328784|P1|COMPLETED|Overall Study||25
962817|NCT00208949|2328783|P2|STARTED|Overall Study||25
962818|NCT00208949|2328784|P1|STARTED|Overall Study||25
962819|NCT00208975|2328792|P1|NOT COMPLETED|Overall Study||0
962820|NCT00208975|2328792|P1|COMPLETED|Overall Study||15
962821|NCT00208975|2328792|P1|STARTED|Overall Study||15
962822|NCT00209027|2328799|P2|NOT COMPLETED|Overall Study||0
962823|NCT00209027|2328800|P1|NOT COMPLETED|Overall Study||10
962824|NCT00209027|2328799|P2|COMPLETED|Overall Study||10
962825|NCT00209027|2328800|P1|COMPLETED|Overall Study||0
962826|NCT00209027|2328799|P2|STARTED|Overall Study||10
962827|NCT00209027|2328800|P1|STARTED|Overall Study||10
962828|NCT00209092|2328808|P2|NOT COMPLETED|Overall Study||2
962829|NCT00209092|2328809|P1|NOT COMPLETED|Overall Study||8
962830|NCT00209092|2328808|P2|COMPLETED|Overall Study||24
962831|NCT00209092|2328809|P1|COMPLETED|Overall Study||17
962832|NCT00209092|2328808|P2|STARTED|Overall Study||26
962833|NCT00209092|2328809|P1|STARTED|Overall Study||25
962834|NCT00209131|2328819|P2|NOT COMPLETED|Overall Study||11
962835|NCT00209131|2328820|P1|NOT COMPLETED|Overall Study||15
962836|NCT00209131|2328819|P2|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
962837|NCT00209131|2328820|P1|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
962838|NCT00209131|2328819|P2|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|11
962839|NCT00209131|2328820|P1|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|15
962840|NCT00209170|2328830|P2|NOT COMPLETED|Overall Study||3
962841|NCT00209170|2328831|P1|NOT COMPLETED|Overall Study||2
962842|NCT00209170|2328830|P2|COMPLETED|Overall Study||4
962843|NCT00209170|2328831|P1|COMPLETED|Overall Study||5
962844|NCT00209170|2328830|P2|STARTED|Overall Study||7
962845|NCT00209170|2328831|P1|STARTED|Overall Study||7
962846|NCT00209274|2328839|P2|NOT COMPLETED|Overall Study||45
962847|NCT00209274|2328840|P1|NOT COMPLETED|Overall Study||72
962848|NCT00209274|2328839|P2|COMPLETED|Overall Study||50
962849|NCT00209274|2328840|P1|COMPLETED|Overall Study||112
962850|NCT00209274|2328839|P2|STARTED|Overall Study||95
962851|NCT00209274|2328840|P1|STARTED|Overall Study||184
962852|NCT00209339|2329126|P1|NOT COMPLETED|At 5 Years Follow-up||8
962853|NCT00209339|2329126|P1|COMPLETED|At 5 Years Follow-up||15
962854|NCT00209339|2329126|P1|STARTED|At 5 Years Follow-up||23
962855|NCT00209339|2329126|P1|NOT COMPLETED|At 4 Years Follow-up||5
962856|NCT00209339|2329126|P1|COMPLETED|At 4 Years Follow-up||23
962857|NCT00209339|2329126|P1|STARTED|At 4 Years Follow-up||28
962858|NCT00209339|2329126|P1|NOT COMPLETED|At 3 Years Follow-up||1
962859|NCT00209339|2329126|P1|COMPLETED|At 3 Years Follow-up||28
962860|NCT00209339|2329126|P1|STARTED|At 3 Years Follow-up||29
962861|NCT00209339|2329126|P1|NOT COMPLETED|At 24 Months Follow-up||11
962862|NCT00209339|2329126|P1|COMPLETED|At 24 Months Follow-up||29
962863|NCT00209339|2329126|P1|STARTED|At 24 Months Follow-up||40
962864|NCT00209339|2329126|P1|NOT COMPLETED|At 12 Months Follow-up||15
962865|NCT00209339|2329126|P1|COMPLETED|At 12 Months Follow-up||40
962866|NCT00209339|2329126|P1|STARTED|At 12 Months Follow-up||55
962867|NCT00215540|2329211|P3|NOT COMPLETED|Overall Study||0
962868|NCT00215540|2329212|P2|NOT COMPLETED|Overall Study||0
962869|NCT00215540|2329213|P1|NOT COMPLETED|Overall Study||1
962870|NCT00215540|2329211|P3|COMPLETED|Overall Study||44
962871|NCT00215540|2329212|P2|COMPLETED|Overall Study||47
962872|NCT00215540|2329213|P1|COMPLETED|Overall Study||44
962873|NCT00215540|2329211|P3|STARTED|Overall Study||44
962874|NCT00215540|2329212|P2|STARTED|Overall Study||47
962875|NCT00215540|2329213|P1|STARTED|Overall Study||45
962876|NCT00215553|2329255|P7|NOT COMPLETED|Overall Study||0
962877|NCT00215553|2329256|P6|NOT COMPLETED|Overall Study||6
962878|NCT00215553|2329257|P5|NOT COMPLETED|Overall Study||2
962879|NCT00215553|2329258|P4|NOT COMPLETED|Overall Study||1
962880|NCT00215553|2329259|P3|NOT COMPLETED|Overall Study||2
962881|NCT00215553|2329260|P2|NOT COMPLETED|Overall Study||1
962882|NCT00215553|2329261|P1|NOT COMPLETED|Overall Study||0
962883|NCT00215553|2329255|P7|COMPLETED|Overall Study||36
962884|NCT00215553|2329256|P6|COMPLETED|Overall Study|6 Subjects discontinued due to AE|32
962885|NCT00215553|2329257|P5|COMPLETED|Overall Study|2 Subjects discontinued due to AE|26
962973|NCT00216125|2329390|P2|STARTED|Randomization Phase||84
962886|NCT00215553|2329258|P4|COMPLETED|Overall Study|1 Subject discontinued due to AE|4
962887|NCT00215553|2329259|P3|COMPLETED|Overall Study|2 Subjects discontinued due to AE|4
962888|NCT00215553|2329260|P2|COMPLETED|Overall Study|1 Subject discontinued due to AE|5
962889|NCT00215553|2329261|P1|COMPLETED|Overall Study||5
962890|NCT00215553|2329255|P7|STARTED|Overall Study||36
962891|NCT00215553|2329256|P6|STARTED|Overall Study||38
962892|NCT00215553|2329257|P5|STARTED|Overall Study||28
962893|NCT00215553|2329258|P4|STARTED|Overall Study||5
962894|NCT00215553|2329259|P3|STARTED|Overall Study||6
962895|NCT00215553|2329260|P2|STARTED|Overall Study||6
962896|NCT00215553|2329261|P1|STARTED|Overall Study||5
962897|NCT00215657|2329299|P8|NOT COMPLETED|Overall Study||16
962898|NCT00215657|2329300|P7|NOT COMPLETED|Overall Study||23
962899|NCT00215657|2329301|P6|NOT COMPLETED|Overall Study||20
962900|NCT00215657|2329302|P5|NOT COMPLETED|Overall Study||23
962901|NCT00215657|2329303|P4|NOT COMPLETED|Overall Study||18
962902|NCT00215657|2329304|P3|NOT COMPLETED|Overall Study||11
962903|NCT00215657|2329305|P2|NOT COMPLETED|Overall Study||11
962904|NCT00215657|2329306|P1|NOT COMPLETED|Overall Study||22
962905|NCT00215657|2329299|P8|COMPLETED|Overall Study||11
962906|NCT00215657|2329300|P7|COMPLETED|Overall Study||4
962907|NCT00215657|2329301|P6|COMPLETED|Overall Study||4
962908|NCT00215657|2329302|P5|COMPLETED|Overall Study||4
962909|NCT00215657|2329303|P4|COMPLETED|Overall Study||6
962910|NCT00215657|2329304|P3|COMPLETED|Overall Study||2
962911|NCT00215657|2329305|P2|COMPLETED|Overall Study||1
962912|NCT00215657|2329306|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study.|4
962913|NCT00215657|2329299|P8|Started FE200486 CS07A|Overall Study||23
962914|NCT00215657|2329300|P7|Started FE200486 CS07A|Overall Study||14
962915|NCT00215657|2329301|P6|Started FE200486 CS07A|Overall Study||20
962916|NCT00215657|2329302|P5|Started FE200486 CS07A|Overall Study||17
962917|NCT00215657|2329303|P4|Started FE200486 CS07A|Overall Study||24
962918|NCT00215657|2329304|P3|Started FE200486 CS07A|Overall Study||7
962919|NCT00215657|2329305|P2|Started FE200486 CS07A|Overall Study||6
962920|NCT00215657|2329306|P1|Started FE200486 CS07A|Overall Study||20
962921|NCT00215657|2329299|P8|Intention-to-treat Population|Overall Study||27
962922|NCT00215657|2329300|P7|Intention-to-treat Population|Overall Study||24
962923|NCT00215657|2329301|P6|Intention-to-treat Population|Overall Study||24
962924|NCT00215657|2329302|P5|Intention-to-treat Population|Overall Study||24
962925|NCT00215657|2329303|P4|Intention-to-treat Population|Overall Study||24
962926|NCT00215657|2329304|P3|Intention-to-treat Population|Overall Study||12
962927|NCT00215657|2329305|P2|Intention-to-treat Population|Overall Study||12
962928|NCT00215657|2329306|P1|Intention-to-treat Population|Overall Study||25
962929|NCT00215657|2329299|P8|STARTED|Overall Study||27
962930|NCT00215657|2329300|P7|STARTED|Overall Study||27
962931|NCT00215657|2329301|P6|STARTED|Overall Study||24
962932|NCT00215657|2329302|P5|STARTED|Overall Study||27
962933|NCT00215657|2329303|P4|STARTED|Overall Study||24
962934|NCT00215657|2329304|P3|STARTED|Overall Study||13
962935|NCT00215657|2329305|P2|STARTED|Overall Study||12
962936|NCT00215657|2329306|P1|STARTED|Overall Study||26
962937|NCT00215683|2329335|P3|NOT COMPLETED|Overall Study||32
962938|NCT00215683|2329336|P2|NOT COMPLETED|Overall Study||26
962939|NCT00215683|2329337|P1|NOT COMPLETED|Overall Study||29
962940|NCT00215683|2329335|P3|COMPLETED|Overall Study||12
962941|NCT00215683|2329336|P2|COMPLETED|Overall Study||22
962942|NCT00215683|2329337|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|16
962943|NCT00215683|2329335|P3|Switched to 160 mg|Overall Study||36
962944|NCT00215683|2329336|P2|Switched to 160 mg|Overall Study||41
962945|NCT00215683|2329337|P1|Switched to 160 mg|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL) for all participants|32
962946|NCT00215683|2329335|P3|STARTED|Overall Study||44
962947|NCT00215683|2329336|P2|STARTED|Overall Study||48
962948|NCT00215683|2329337|P1|STARTED|Overall Study|Safety analysis set|45
962949|NCT00216060|2329350|P2|NOT COMPLETED|Overall Study||0
962950|NCT00216060|2329351|P1|NOT COMPLETED|Overall Study||0
962951|NCT00216060|2329350|P2|COMPLETED|Overall Study||31
962952|NCT00216060|2329351|P1|COMPLETED|Overall Study||32
962953|NCT00216060|2329350|P2|STARTED|Overall Study||31
962954|NCT00216060|2329351|P1|STARTED|Overall Study||32
962955|NCT00216086|2329371|P1|NOT COMPLETED|Overall Study||4
962956|NCT00216086|2329371|P1|COMPLETED|Overall Study||18
962957|NCT00216086|2329371|P1|STARTED|Overall Study||22
962958|NCT00216099|2329378|P1|NOT COMPLETED|Overall Study||1
962959|NCT00216099|2329378|P1|COMPLETED|Overall Study||48
962960|NCT00216099|2329378|P1|Response Analysis|Overall Study||48
962961|NCT00216099|2329378|P1|Toxicity Analysis|Overall Study||49
962962|NCT00216099|2329378|P1|STARTED|Overall Study||49
962963|NCT00216125|2329389|P3|NOT COMPLETED|Randomization Phase||8
962964|NCT00216125|2329390|P2|NOT COMPLETED|Randomization Phase||11
962965|NCT00216125|2329391|P1|NOT COMPLETED|Randomization Phase||0
962966|NCT00216125|2329389|P3|COMPLETED|Randomization Phase||74
962967|NCT00216125|2329390|P2|COMPLETED|Randomization Phase||73
962968|NCT00216125|2329391|P1|COMPLETED|Randomization Phase||0
962969|NCT00216125|2329389|P3|DSMB Cohort for Futility|Randomization Phase||74
962970|NCT00216125|2329390|P2|DSMB Cohort for Futility|Randomization Phase||73
962971|NCT00216125|2329391|P1|DSMB Cohort for Futility|Randomization Phase||0
962972|NCT00216125|2329389|P3|STARTED|Randomization Phase||82
962974|NCT00216125|2329391|P1|STARTED|Randomization Phase||0
962975|NCT00216125|2329389|P3|NOT COMPLETED|Pre-Randomization Phase||0
962976|NCT00216125|2329390|P2|NOT COMPLETED|Pre-Randomization Phase||0
962977|NCT00216125|2329391|P1|NOT COMPLETED|Pre-Randomization Phase||77
962978|NCT00216125|2329389|P3|COMPLETED|Pre-Randomization Phase||0
962979|NCT00216125|2329390|P2|COMPLETED|Pre-Randomization Phase||0
962980|NCT00216125|2329391|P1|COMPLETED|Pre-Randomization Phase||166
962981|NCT00216125|2329389|P3|DSMB Cohort for Futility|Pre-Randomization Phase||0
962982|NCT00216125|2329390|P2|DSMB Cohort for Futility|Pre-Randomization Phase||0
962983|NCT00216125|2329391|P1|DSMB Cohort for Futility|Pre-Randomization Phase||203
962984|NCT00216125|2329389|P3|STARTED|Pre-Randomization Phase||0
962985|NCT00216125|2329390|P2|STARTED|Pre-Randomization Phase||0
962986|NCT00216125|2329391|P1|STARTED|Pre-Randomization Phase||243
962987|NCT00216203|2329400|P1|NOT COMPLETED|Overall Study||2
962988|NCT00216203|2329400|P1|COMPLETED|Overall Study||34
962989|NCT00216203|2329400|P1|STARTED|Overall Study||36
962990|NCT00216320|2329411|P3|NOT COMPLETED|Phase 2 (Weeks 6 -12)||1
962991|NCT00216320|2329412|P2|NOT COMPLETED|Phase 2 (Weeks 6 -12)||4
962992|NCT00216320|2329413|P1|NOT COMPLETED|Phase 2 (Weeks 6 -12)||5
962993|NCT00216320|2329411|P3|COMPLETED|Phase 2 (Weeks 6 -12)||24
962994|NCT00216320|2329412|P2|COMPLETED|Phase 2 (Weeks 6 -12)||31
962995|NCT00216320|2329413|P1|COMPLETED|Phase 2 (Weeks 6 -12)||38
962996|NCT00216320|2329411|P3|STARTED|Phase 2 (Weeks 6 -12)||25
962997|NCT00216320|2329412|P2|STARTED|Phase 2 (Weeks 6 -12)||35
962998|NCT00216320|2329413|P1|STARTED|Phase 2 (Weeks 6 -12)||43
962999|NCT00216320|2329411|P3|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||5
963000|NCT00216320|2329412|P2|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||4
963001|NCT00216320|2329413|P1|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||0
963002|NCT00216320|2329411|P3|COMPLETED|Phase 1 (Weeks 0 - 6)||25
963003|NCT00216320|2329412|P2|COMPLETED|Phase 1 (Weeks 0 - 6)||35
963004|NCT00216320|2329413|P1|COMPLETED|Phase 1 (Weeks 0 - 6)||43
963005|NCT00216320|2329411|P3|STARTED|Phase 1 (Weeks 0 - 6)||30
963006|NCT00216320|2329412|P2|STARTED|Phase 1 (Weeks 0 - 6)||39
963007|NCT00216320|2329413|P1|STARTED|Phase 1 (Weeks 0 - 6)||43
963008|NCT00216476|2329430|P3|NOT COMPLETED|Overall Study||17
963009|NCT00216476|2329431|P2|NOT COMPLETED|Overall Study||107
963010|NCT00216476|2329432|P1|NOT COMPLETED|Overall Study||105
963011|NCT00216476|2329430|P3|COMPLETED|Overall Study||28
963012|NCT00216476|2329431|P2|COMPLETED|Overall Study||230
963013|NCT00216476|2329432|P1|COMPLETED|Overall Study||224
963014|NCT00216476|2329430|P3|STARTED|Overall Study||45
963015|NCT00216476|2329431|P2|STARTED|Overall Study||337
963016|NCT00216476|2329432|P1|STARTED|Overall Study||329
963017|NCT00216671|2329451|P2|NOT COMPLETED|Overall Study||50
963018|NCT00216671|2329452|P1|NOT COMPLETED|Overall Study||35
963019|NCT00216671|2329451|P2|COMPLETED|Overall Study||60
963020|NCT00216671|2329452|P1|COMPLETED|Overall Study||75
963021|NCT00216671|2329451|P2|STARTED|Overall Study||110
963022|NCT00216671|2329452|P1|STARTED|Overall Study||110
963023|NCT00216736|2329470|P2|NOT COMPLETED|Overall Study||1
963024|NCT00216736|2329471|P1|NOT COMPLETED|Overall Study||1
963025|NCT00216736|2329470|P2|COMPLETED|Overall Study||30
963026|NCT00216736|2329471|P1|COMPLETED|Overall Study||31
963027|NCT00216736|2329470|P2|STARTED|Overall Study||31
963028|NCT00216736|2329471|P1|STARTED|Overall Study||32
963029|NCT00217022|2329485|P2|NOT COMPLETED|Overall Study||1
963030|NCT00217022|2329486|P1|NOT COMPLETED|Overall Study||1
963031|NCT00217022|2329485|P2|COMPLETED|Overall Study||3
963032|NCT00217022|2329486|P1|COMPLETED|Overall Study||11
963033|NCT00217022|2329485|P2|STARTED|Overall Study||4
963034|NCT00217022|2329486|P1|STARTED|Overall Study||12
963035|NCT00217087|2329496|P2|NOT COMPLETED|Overall Study||20
963036|NCT00217087|2329497|P1|NOT COMPLETED|Overall Study||11
963037|NCT00217087|2329496|P2|COMPLETED|Overall Study||17
963038|NCT00217087|2329497|P1|COMPLETED|Overall Study||25
963039|NCT00217087|2329496|P2|STARTED|Overall Study||37
963040|NCT00217087|2329497|P1|STARTED|Overall Study||36
963041|NCT00217399|2329509|P1|NOT COMPLETED|Overall Study||0
963042|NCT00217399|2329509|P1|COMPLETED|Overall Study||35
963043|NCT00217399|2329509|P1|STARTED|Overall Study||35
963044|NCT00217425|2329515|P1|NOT COMPLETED|Overall Study||37
963045|NCT00217425|2329515|P1|COMPLETED|Overall Study||9
963046|NCT00217425|2329515|P1|Eligible and Treated|Overall Study||39
963047|NCT00217425|2329515|P1|Treated|Overall Study||44
963048|NCT00217425|2329515|P1|STARTED|Overall Study||46
963049|NCT00217438|2329523|P2|NOT COMPLETED|Overall Study||1
963050|NCT00217438|2329524|P1|NOT COMPLETED|Overall Study||0
963051|NCT00217438|2329523|P2|COMPLETED|Overall Study|One patient did not complete Day 80-120 evaluation tests after returning to referring physician.|63
963052|NCT00217438|2329524|P1|COMPLETED|Overall Study||66
963053|NCT00217438|2329523|P2|STARTED|Overall Study||64
963054|NCT00217438|2329524|P1|STARTED|Overall Study||66
963055|NCT00217464|2329532|P1|NOT COMPLETED|Overall Study||17
963056|NCT00217464|2329532|P1|COMPLETED|Overall Study||0
963057|NCT00217464|2329532|P1|STARTED|Overall Study||17
963058|NCT00217490|2329541|P4|NOT COMPLETED|Overall Study||23
963059|NCT00217490|2329542|P3|NOT COMPLETED|Overall Study||24
963060|NCT00217490|2329543|P2|NOT COMPLETED|Overall Study||25
963061|NCT00217490|2329544|P1|NOT COMPLETED|Overall Study||17
963062|NCT00217490|2329541|P4|COMPLETED|Overall Study||130
963063|NCT00217490|2329542|P3|COMPLETED|Overall Study||131
963064|NCT00217490|2329543|P2|COMPLETED|Overall Study||128
963065|NCT00217490|2329544|P1|COMPLETED|Overall Study||137
963066|NCT00217490|2329541|P4|STARTED|Overall Study||153
963067|NCT00217490|2329542|P3|STARTED|Overall Study||155
963068|NCT00217490|2329543|P2|STARTED|Overall Study||153
963069|NCT00217490|2329544|P1|STARTED|Overall Study||154
963070|NCT00217581|2329558|P1|NOT COMPLETED|Overall Study||1
963071|NCT00217581|2329558|P1|COMPLETED|Overall Study||38
963072|NCT00217581|2329558|P1|STARTED|Overall Study||39
963073|NCT00217620|2329562|P1|NOT COMPLETED|Overall Study||51
963074|NCT00217620|2329562|P1|COMPLETED|Overall Study||0
963075|NCT00217620|2329562|P1|Eligible and Began Protocol Therapy|Overall Study||37
963076|NCT00217620|2329562|P1|Eligible|Overall Study||38
963077|NCT00217620|2329562|P1|STARTED|Overall Study||51
963078|NCT00217672|2329573|P2|NOT COMPLETED|Follow-up||0
963079|NCT00217672|2329574|P1|NOT COMPLETED|Follow-up||5
963080|NCT00217672|2329573|P2|COMPLETED|Follow-up||0
963081|NCT00217672|2329574|P1|COMPLETED|Follow-up||69
963082|NCT00217672|2329573|P2|STARTED|Follow-up||0
963083|NCT00217672|2329574|P1|STARTED|Follow-up|when bevacizumab became available, converted to a 1-arm open-label trial (67+7=74)|74
963084|NCT00217672|2329573|P2|NOT COMPLETED|Treatment||7
963085|NCT00217672|2329574|P1|NOT COMPLETED|Treatment||67
963086|NCT00217672|2329573|P2|COMPLETED|Treatment||0
963087|NCT00217672|2329574|P1|COMPLETED|Treatment||0
963088|NCT00217672|2329573|P2|STARTED|Treatment|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
963089|NCT00217672|2329574|P1|STARTED|Treatment||67
963090|NCT00217672|2329573|P2|NOT COMPLETED|Allocation||0
963091|NCT00217672|2329574|P1|NOT COMPLETED|Allocation||2
963092|NCT00217672|2329573|P2|COMPLETED|Allocation||7
963093|NCT00217672|2329574|P1|COMPLETED|Allocation||67
963094|NCT00217672|2329573|P2|STARTED|Allocation|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
963095|NCT00217672|2329574|P1|STARTED|Allocation||69
963096|NCT00217724|2329580|P2|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||0
963097|NCT00217724|2329581|P1|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||1
963098|NCT00217724|2329580|P2|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||5
963099|NCT00217724|2329581|P1|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||8
963100|NCT00217724|2329580|P2|STARTED|Course 2, (Glutamine/Placebo Crossover)||5
963101|NCT00217724|2329581|P1|STARTED|Course 2, (Glutamine/Placebo Crossover)||9
963102|NCT00217724|2329580|P2|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||1
963103|NCT00217724|2329581|P1|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||3
963104|NCT00217724|2329580|P2|COMPLETED|Course 1, (Glutamine/Placebo Arms)||9
963105|NCT00217724|2329581|P1|COMPLETED|Course 1, (Glutamine/Placebo Arms)||5
963106|NCT00217724|2329580|P2|STARTED|Course 1, (Glutamine/Placebo Arms)||10
963107|NCT00217724|2329581|P1|STARTED|Course 1, (Glutamine/Placebo Arms)||8
963108|NCT00217971|2329591|P2|NOT COMPLETED|Overall Study||33
963109|NCT00217971|2329592|P1|NOT COMPLETED|Overall Study||24
963110|NCT00217971|2329591|P2|COMPLETED|Overall Study||44
963111|NCT00217971|2329592|P1|COMPLETED|Overall Study||55
963112|NCT00217971|2329591|P2|STARTED|Overall Study||77
963113|NCT00217971|2329592|P1|STARTED|Overall Study||79
963114|NCT00218023|2329602|P4|NOT COMPLETED|Overall Study||7
963115|NCT00218023|2329603|P3|NOT COMPLETED|Overall Study||10
963116|NCT00218023|2329604|P2|NOT COMPLETED|Overall Study||15
963117|NCT00218023|2329605|P1|NOT COMPLETED|Overall Study||13
963118|NCT00218023|2329602|P4|COMPLETED|Overall Study||11
963119|NCT00218023|2329603|P3|COMPLETED|Overall Study||6
963120|NCT00218023|2329604|P2|COMPLETED|Overall Study||10
963121|NCT00218023|2329605|P1|COMPLETED|Overall Study||9
963122|NCT00218023|2329602|P4|Received Drug or Placebo in Phase II|Overall Study||18
963123|NCT00218023|2329603|P3|Received Drug or Placebo in Phase II|Overall Study||15
963124|NCT00218023|2329604|P2|Received Drug or Placebo in Phase II|Overall Study||24
963125|NCT00218023|2329605|P1|Received Drug or Placebo in Phase II|Overall Study||18
963126|NCT00218023|2329602|P4|STARTED|Overall Study||18
963127|NCT00218023|2329603|P3|STARTED|Overall Study||16
963128|NCT00218023|2329604|P2|STARTED|Overall Study||25
963129|NCT00218023|2329605|P1|STARTED|Overall Study||22
963130|NCT00218062|2329623|P4|NOT COMPLETED|Overall Study||13
963131|NCT00218062|2329624|P3|NOT COMPLETED|Overall Study||12
963132|NCT00218062|2329625|P2|NOT COMPLETED|Overall Study||16
963133|NCT00218062|2329626|P1|NOT COMPLETED|Overall Study||15
963134|NCT00218062|2329623|P4|COMPLETED|Overall Study||3
963135|NCT00218062|2329624|P3|COMPLETED|Overall Study||3
963136|NCT00218062|2329625|P2|COMPLETED|Overall Study||4
963137|NCT00218062|2329626|P1|COMPLETED|Overall Study||7
963138|NCT00218062|2329623|P4|Received First Dose of Study Medication|Overall Study||12
963139|NCT00218062|2329624|P3|Received First Dose of Study Medication|Overall Study||10
963140|NCT00218062|2329625|P2|Received First Dose of Study Medication|Overall Study||11
963141|NCT00218062|2329626|P1|Received First Dose of Study Medication|Overall Study||16
963142|NCT00218062|2329623|P4|STARTED|Overall Study||16
963143|NCT00218062|2329624|P3|STARTED|Overall Study||15
963144|NCT00218062|2329625|P2|STARTED|Overall Study||20
963145|NCT00218062|2329626|P1|STARTED|Overall Study||22
963152|NCT00218335|2329675|P4|NOT COMPLETED|Overall Study||36
963153|NCT00218335|2329676|P3|NOT COMPLETED|Overall Study||54
963154|NCT00218335|2329677|P2|NOT COMPLETED|Overall Study||3
963155|NCT00218335|2329678|P1|NOT COMPLETED|Overall Study||6
963156|NCT00218335|2329675|P4|COMPLETED|Overall Study||388
963157|NCT00218335|2329676|P3|COMPLETED|Overall Study||319
963158|NCT00218335|2329677|P2|COMPLETED|Overall Study||110
963159|NCT00218335|2329678|P1|COMPLETED|Overall Study||108
963160|NCT00218335|2329675|P4|18 Month Follow-up|Overall Study||368
963161|NCT00218335|2329676|P3|18 Month Follow-up|Overall Study||296
963162|NCT00218335|2329677|P2|18 Month Follow-up|Overall Study||108
963163|NCT00218335|2329678|P1|18 Month Follow-up|Overall Study||101
963164|NCT00218335|2329675|P4|12 Month Follow-up|Overall Study||303
963165|NCT00218335|2329676|P3|12 Month Follow-up|Overall Study||244
963166|NCT00218335|2329677|P2|12 Month Follow-up|Overall Study||102
963167|NCT00218335|2329678|P1|12 Month Follow-up|Overall Study||95
963168|NCT00218335|2329675|P4|6 Month Follow-up|Overall Study||301
963169|NCT00218335|2329676|P3|6 Month Follow-up|Overall Study||219
963170|NCT00218335|2329677|P2|6 Month Follow-up|Overall Study||99
963171|NCT00218335|2329678|P1|6 Month Follow-up|Overall Study||103
963172|NCT00218335|2329675|P4|STARTED|Overall Study||424
963173|NCT00218335|2329676|P3|STARTED|Overall Study||373
963174|NCT00218335|2329677|P2|STARTED|Overall Study||113
963175|NCT00218335|2329678|P1|STARTED|Overall Study||114
963176|NCT00218439|2329742|P2|NOT COMPLETED|Second Intervention (4 Weeks)||5
963177|NCT00218439|2329743|P1|NOT COMPLETED|Second Intervention (4 Weeks)||7
963178|NCT00218439|2329742|P2|COMPLETED|Second Intervention (4 Weeks)||30
963179|NCT00218439|2329743|P1|COMPLETED|Second Intervention (4 Weeks)||33
963180|NCT00218439|2329742|P2|STARTED|Second Intervention (4 Weeks)||35
963181|NCT00218439|2329743|P1|STARTED|Second Intervention (4 Weeks)||40
963182|NCT00218439|2329742|P2|NOT COMPLETED|First Intervention (4 Weeks)||12
963183|NCT00218439|2329743|P1|NOT COMPLETED|First Intervention (4 Weeks)||18
963184|NCT00218439|2329742|P2|COMPLETED|First Intervention (4 Weeks)||35
963185|NCT00218439|2329743|P1|COMPLETED|First Intervention (4 Weeks)||40
963186|NCT00218439|2329742|P2|STARTED|First Intervention (4 Weeks)||47
963187|NCT00218439|2329743|P1|STARTED|First Intervention (4 Weeks)||58
963188|NCT00218465|2329759|P2|NOT COMPLETED|Overall Study||18
963189|NCT00218465|2329760|P1|NOT COMPLETED|Overall Study||17
963190|NCT00218465|2329759|P2|COMPLETED|Overall Study||30
963191|NCT00218465|2329760|P1|COMPLETED|Overall Study||33
963192|NCT00218465|2329759|P2|STARTED|Overall Study||48
963193|NCT00218465|2329760|P1|STARTED|Overall Study||50
963194|NCT00218543|2329770|P1|NOT COMPLETED|Overall Study||15
963195|NCT00218543|2329770|P1|COMPLETED|Overall Study|13 reached the maintenance dose phase of treatment; 9 completed at least six weeks of treatment.|5
963196|NCT00218543|2329770|P1|STARTED|Overall Study||20
963197|NCT00212264|2329778|P3|NOT COMPLETED|Overall Study||4
963198|NCT00212264|2329779|P2|NOT COMPLETED|Overall Study||16
963199|NCT00212264|2329780|P1|NOT COMPLETED|Overall Study||12
963200|NCT00212264|2329778|P3|COMPLETED|Overall Study||64
963201|NCT00212264|2329779|P2|COMPLETED|Overall Study||54
963202|NCT00212264|2329780|P1|COMPLETED|Overall Study||58
963203|NCT00212264|2329778|P3|STARTED|Overall Study||68
963204|NCT00212264|2329779|P2|STARTED|Overall Study||70
963205|NCT00212264|2329780|P1|STARTED|Overall Study||70
963206|NCT00212355|2329790|P1|NOT COMPLETED|Overall Study||3
963207|NCT00212355|2329790|P1|COMPLETED|Overall Study||34
963208|NCT00212355|2329790|P1|STARTED|Overall Study||37
963209|NCT00212758|2329794|P2|NOT COMPLETED|Standard Therapy of GH (12 Months)||1
963210|NCT00212758|2329795|P1|NOT COMPLETED|Standard Therapy of GH (12 Months)||2
963211|NCT00212758|2329794|P2|COMPLETED|Standard Therapy of GH (12 Months)||8
963212|NCT00212758|2329795|P1|COMPLETED|Standard Therapy of GH (12 Months)||6
963213|NCT00212758|2329794|P2|STARTED|Standard Therapy of GH (12 Months)||9
963214|NCT00212758|2329795|P1|STARTED|Standard Therapy of GH (12 Months)||8
963215|NCT00212758|2329794|P2|NOT COMPLETED|Second Intervention (7 Days)||0
963216|NCT00212758|2329795|P1|NOT COMPLETED|Second Intervention (7 Days)||0
963217|NCT00212758|2329794|P2|COMPLETED|Second Intervention (7 Days)||9
963218|NCT00212758|2329795|P1|COMPLETED|Second Intervention (7 Days)||8
963219|NCT00212758|2329794|P2|STARTED|Second Intervention (7 Days)||9
963220|NCT00212758|2329795|P1|STARTED|Second Intervention (7 Days)||8
963221|NCT00212758|2329794|P2|NOT COMPLETED|Wash Out Period (2 Weeks)||0
963222|NCT00212758|2329795|P1|NOT COMPLETED|Wash Out Period (2 Weeks)||0
963223|NCT00212758|2329794|P2|COMPLETED|Wash Out Period (2 Weeks)||9
963224|NCT00212758|2329795|P1|COMPLETED|Wash Out Period (2 Weeks)||8
963225|NCT00212758|2329794|P2|STARTED|Wash Out Period (2 Weeks)||9
963226|NCT00212758|2329795|P1|STARTED|Wash Out Period (2 Weeks)||8
963227|NCT00212758|2329794|P2|NOT COMPLETED|First Intervention (7 Days)||0
963228|NCT00212758|2329795|P1|NOT COMPLETED|First Intervention (7 Days)||0
963229|NCT00212758|2329794|P2|COMPLETED|First Intervention (7 Days)||9
963230|NCT00212758|2329795|P1|COMPLETED|First Intervention (7 Days)||8
963231|NCT00212758|2329794|P2|STARTED|First Intervention (7 Days)||9
963232|NCT00212758|2329795|P1|STARTED|First Intervention (7 Days)||8
963233|NCT00218634|2329803|P2|NOT COMPLETED|Overall Study||15
963234|NCT00218634|2329804|P1|NOT COMPLETED|Overall Study||8
963235|NCT00218634|2329803|P2|COMPLETED|Overall Study||30
963236|NCT00218634|2329804|P1|COMPLETED|Overall Study||36
963237|NCT00218634|2329803|P2|STARTED|Overall Study||45
963238|NCT00218634|2329804|P1|STARTED|Overall Study||44
963239|NCT00219141|2329827|P3|NOT COMPLETED|Overall Study||12
963240|NCT00219141|2329828|P2|NOT COMPLETED|Overall Study||21
963241|NCT00219141|2329829|P1|NOT COMPLETED|Overall Study||14
963242|NCT00219141|2329827|P3|COMPLETED|Overall Study||142
963243|NCT00219141|2329828|P2|COMPLETED|Overall Study||131
963244|NCT00219141|2329829|P1|COMPLETED|Overall Study||140
963245|NCT00219141|2329827|P3|STARTED|Overall Study||154
963246|NCT00219141|2329828|P2|STARTED|Overall Study||152
963247|NCT00219141|2329829|P1|STARTED|Overall Study||154
963248|NCT00219284|2329875|P2|NOT COMPLETED|Extension Phase - 8 Weeks||7
963249|NCT00219284|2329876|P1|NOT COMPLETED|Extension Phase - 8 Weeks||2
963250|NCT00219284|2329875|P2|COMPLETED|Extension Phase - 8 Weeks||99
963251|NCT00219284|2329876|P1|COMPLETED|Extension Phase - 8 Weeks||112
963252|NCT00219284|2329875|P2|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|106
963253|NCT00219284|2329876|P1|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|114
963254|NCT00219284|2329875|P2|NOT COMPLETED|Treatment Phase - 16 Weeks||51
963255|NCT00219284|2329876|P1|NOT COMPLETED|Treatment Phase - 16 Weeks||44
963256|NCT00219284|2329875|P2|COMPLETED|Treatment Phase - 16 Weeks||128
963257|NCT00219284|2329876|P1|COMPLETED|Treatment Phase - 16 Weeks||136
963258|NCT00219284|2329875|P2|STARTED|Treatment Phase - 16 Weeks||179
963259|NCT00219284|2329876|P1|STARTED|Treatment Phase - 16 Weeks||180
963266|NCT00219544|2329902|P2|NOT COMPLETED|Double Blind Treatment Period||0
963267|NCT00219544|2329903|P1|NOT COMPLETED|Double Blind Treatment Period||0
963268|NCT00219544|2329902|P2|COMPLETED|Double Blind Treatment Period||77
963269|NCT00219544|2329903|P1|COMPLETED|Double Blind Treatment Period||80
963270|NCT00219544|2329902|P2|STARTED|Double Blind Treatment Period||77
963271|NCT00219544|2329903|P1|STARTED|Double Blind Treatment Period||80
963272|NCT00219544|2329902|P2|NOT COMPLETED|Single Blind Treatment Period||0
963273|NCT00219544|2329903|P1|NOT COMPLETED|Single Blind Treatment Period||22
963274|NCT00219544|2329902|P2|COMPLETED|Single Blind Treatment Period||0
963275|NCT00219544|2329903|P1|COMPLETED|Single Blind Treatment Period||234
963276|NCT00219544|2329902|P2|STARTED|Single Blind Treatment Period||0
963277|NCT00219544|2329903|P1|STARTED|Single Blind Treatment Period||256
963278|NCT00219557|2329944|P3|NOT COMPLETED|Phase 2||33
963279|NCT00219557|2329945|P2|NOT COMPLETED|Phase 2||69
963280|NCT00219557|2329946|P1|NOT COMPLETED|Phase 2||0
963281|NCT00219557|2329944|P3|COMPLETED|Phase 2||1
963282|NCT00219557|2329945|P2|COMPLETED|Phase 2||0
963283|NCT00219557|2329946|P1|COMPLETED|Phase 2||0
963284|NCT00219557|2329944|P3|Treated|Phase 2||31
963285|NCT00219557|2329945|P2|Treated|Phase 2||68
963286|NCT00219557|2329946|P1|Treated|Phase 2||0
963287|NCT00219557|2329944|P3|STARTED|Phase 2||34
963288|NCT00219557|2329945|P2|STARTED|Phase 2||69
963289|NCT00219557|2329946|P1|STARTED|Phase 2||0
963290|NCT00219557|2329944|P3|NOT COMPLETED|Phase 1||0
963291|NCT00219557|2329945|P2|NOT COMPLETED|Phase 1||0
963292|NCT00219557|2329946|P1|NOT COMPLETED|Phase 1||7
963293|NCT00219557|2329944|P3|COMPLETED|Phase 1||0
963294|NCT00219557|2329945|P2|COMPLETED|Phase 1||0
963295|NCT00219557|2329946|P1|COMPLETED|Phase 1||1
963296|NCT00219557|2329944|P3|STARTED|Phase 1||0
963297|NCT00219557|2329945|P2|STARTED|Phase 1||0
963298|NCT00219557|2329946|P1|STARTED|Phase 1||8
963299|NCT00220636|2329974|P1|NOT COMPLETED|Overall Study||4
963300|NCT00220636|2329974|P1|COMPLETED|Overall Study||11
963301|NCT00220636|2329974|P1|STARTED|Overall Study||15
963302|NCT00220701|2329983|P2|NOT COMPLETED|Overall Study||4
963303|NCT00220701|2329984|P1|NOT COMPLETED|Overall Study||5
963304|NCT00220701|2329983|P2|COMPLETED|Overall Study||13
963305|NCT00220701|2329984|P1|COMPLETED|Overall Study||12
963306|NCT00220701|2329983|P2|STARTED|Overall Study||17
963307|NCT00220701|2329984|P1|STARTED|Overall Study||17
963308|NCT00220727|2330002|P2|NOT COMPLETED|Second Infusion (Week <6)||0
963309|NCT00220727|2330003|P1|NOT COMPLETED|Second Infusion (Week <6)||1
963310|NCT00220727|2330002|P2|COMPLETED|Second Infusion (Week <6)||4
963311|NCT00220727|2330003|P1|COMPLETED|Second Infusion (Week <6)||3
963312|NCT00220727|2330002|P2|STARTED|Second Infusion (Week <6)||4
963313|NCT00220727|2330003|P1|STARTED|Second Infusion (Week <6)||4
963314|NCT00220727|2330002|P2|NOT COMPLETED|First Infusion (Week 0)||0
963315|NCT00220727|2330003|P1|NOT COMPLETED|First Infusion (Week 0)||0
963316|NCT00220727|2330002|P2|COMPLETED|First Infusion (Week 0)||4
963317|NCT00220727|2330003|P1|COMPLETED|First Infusion (Week 0)||4
963318|NCT00220727|2330002|P2|STARTED|First Infusion (Week 0)||4
963319|NCT00220727|2330003|P1|STARTED|First Infusion (Week 0)||4
963320|NCT00220740|2330019|P2|NOT COMPLETED|Withdrawal Period||15
963321|NCT00220740|2330020|P1|NOT COMPLETED|Withdrawal Period||6
963322|NCT00220740|2330019|P2|COMPLETED|Withdrawal Period||16
963323|NCT00220740|2330020|P1|COMPLETED|Withdrawal Period||37
963324|NCT00220740|2330019|P2|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|31
963325|NCT00220740|2330020|P1|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|43
963326|NCT00220740|2330019|P2|NOT COMPLETED|Rescue Treatment||18
963327|NCT00220740|2330020|P1|NOT COMPLETED|Rescue Treatment||19
963328|NCT00220740|2330019|P2|COMPLETED|Rescue Treatment||5
963329|NCT00220740|2330020|P1|COMPLETED|Rescue Treatment||26
963330|NCT00220740|2330019|P2|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|23
963331|NCT00220740|2330020|P1|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|45
963332|NCT00220740|2330019|P2|NOT COMPLETED|Efficacy Period||46
963333|NCT00220740|2330020|P1|NOT COMPLETED|Efficacy Period||26
963334|NCT00220740|2330019|P2|COMPLETED|Efficacy Period||12
963335|NCT00220740|2330020|P1|COMPLETED|Efficacy Period||33
963336|NCT00220740|2330019|P2|STARTED|Efficacy Period||58
963337|NCT00220740|2330020|P1|STARTED|Efficacy Period||59
963338|NCT00220779|2330035|P3|NOT COMPLETED|Overall Study||4
963339|NCT00220779|2330036|P2|NOT COMPLETED|Overall Study||4
963340|NCT00220779|2330037|P1|NOT COMPLETED|Overall Study||7
963341|NCT00220779|2330035|P3|COMPLETED|Overall Study||37
963342|NCT00220779|2330036|P2|COMPLETED|Overall Study||38
963343|NCT00220779|2330037|P1|COMPLETED|Overall Study||38
963344|NCT00220779|2330035|P3|STARTED|Overall Study||41
963345|NCT00220779|2330036|P2|STARTED|Overall Study||42
963346|NCT00220779|2330037|P1|STARTED|Overall Study||45
963347|NCT00220805|2330047|P2|NOT COMPLETED|Overall Study||11
963348|NCT00220805|2330048|P1|NOT COMPLETED|Overall Study||8
963349|NCT00220805|2330047|P2|COMPLETED|Overall Study||16
963350|NCT00220805|2330048|P1|COMPLETED|Overall Study||22
963351|NCT00220805|2330047|P2|STARTED|Overall Study||27
963352|NCT00220805|2330048|P1|STARTED|Overall Study||30
963353|NCT00220961|2330068|P2|NOT COMPLETED|Overall Study||90
963354|NCT00220961|2330069|P1|NOT COMPLETED|Overall Study||71
963355|NCT00220961|2330068|P2|COMPLETED|Overall Study||213
963356|NCT00220961|2330069|P1|COMPLETED|Overall Study||228
963357|NCT00220961|2330068|P2|STARTED|Overall Study||303
963358|NCT00220961|2330069|P1|STARTED|Overall Study||299
963359|NCT00221195|2330085|P2|NOT COMPLETED|Overall Study||3
963360|NCT00221195|2330086|P1|NOT COMPLETED|Overall Study||5
963361|NCT00221195|2330085|P2|COMPLETED|Overall Study||14
963362|NCT00221195|2330086|P1|COMPLETED|Overall Study||12
963363|NCT00221195|2330085|P2|STARTED|Overall Study||17
963364|NCT00221195|2330086|P1|STARTED|Overall Study||17
963365|NCT00221299|2330096|P4|NOT COMPLETED|Overall Study||1
963366|NCT00221299|2330097|P3|NOT COMPLETED|Overall Study||0
963367|NCT00221299|2330098|P2|NOT COMPLETED|Overall Study||2
963368|NCT00221299|2330099|P1|NOT COMPLETED|Overall Study||1
963369|NCT00221299|2330096|P4|COMPLETED|Overall Study||10
963370|NCT00221299|2330097|P3|COMPLETED|Overall Study||14
963371|NCT00221299|2330098|P2|COMPLETED|Overall Study||11
963372|NCT00221299|2330099|P1|COMPLETED|Overall Study||10
963373|NCT00221299|2330096|P4|STARTED|Overall Study||11
963374|NCT00221299|2330097|P3|STARTED|Overall Study||14
963375|NCT00221299|2330098|P2|STARTED|Overall Study||13
963376|NCT00221299|2330099|P1|STARTED|Overall Study||11
963377|NCT00215787|2330107|P1|NOT COMPLETED|Overall Study||0
963378|NCT00215787|2330107|P1|COMPLETED|Overall Study||20
963379|NCT00215787|2330107|P1|STARTED|Overall Study||20
963380|NCT00215930|2330111|P1|NOT COMPLETED|Overall Study||0
963381|NCT00215930|2330111|P1|COMPLETED|Overall Study||53
963382|NCT00215930|2330111|P1|STARTED|Overall Study||53
963383|NCT00215943|2330119|P2|NOT COMPLETED|Overall Study||14
963384|NCT00215943|2330120|P1|NOT COMPLETED|Overall Study||9
963385|NCT00215943|2330119|P2|COMPLETED|Overall Study||23
963386|NCT00215943|2330120|P1|COMPLETED|Overall Study||27
963387|NCT00215943|2330119|P2|STARTED|Overall Study||37
963388|NCT00215943|2330120|P1|STARTED|Overall Study||36
963389|NCT00222105|2330132|P1|NOT COMPLETED|Overall Study||14
963390|NCT00222105|2330132|P1|COMPLETED|Overall Study||11
963391|NCT00222105|2330132|P1|STARTED|Overall Study||25
963392|NCT00222729|2330137|P1|NOT COMPLETED|Overall Study||3
963393|NCT00222729|2330137|P1|COMPLETED|Overall Study||37
963394|NCT00222729|2330137|P1|STARTED|Overall Study||40
963395|NCT00223236|2330146|P2|NOT COMPLETED|Overall Study||14
963396|NCT00223236|2330147|P1|NOT COMPLETED|Overall Study||7
963397|NCT00223236|2330146|P2|COMPLETED|Overall Study|4 completed 12 week trial.|4
963398|NCT00223236|2330147|P1|COMPLETED|Overall Study|9 completed 12 week trial.|9
963399|NCT00223236|2330146|P2|STARTED|Overall Study|21 completed baseline assessment but 18 completed at least one treatment visit.|18
963400|NCT00223236|2330147|P1|STARTED|Overall Study|23 completed baseline assessment but 16 completed at least one treatment visit.|16
963401|NCT00223496|2330159|P1|NOT COMPLETED|Overall Study||22
963402|NCT00223496|2330159|P1|COMPLETED|Overall Study||10
963403|NCT00223496|2330159|P1|STARTED|Overall Study|32 people consented, 19 were baselined|32
963404|NCT00223652|2330165|P2|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||4
963405|NCT00223652|2330166|P1|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||1
963406|NCT00223652|2330165|P2|COMPLETED|T-CBT and TAU 6 Month Follow-up||37
963407|NCT00223652|2330166|P1|COMPLETED|T-CBT and TAU 6 Month Follow-up||39
963408|NCT00223652|2330165|P2|STARTED|T-CBT and TAU 6 Month Follow-up||41
963409|NCT00223652|2330166|P1|STARTED|T-CBT and TAU 6 Month Follow-up||40
963410|NCT00223652|2330165|P2|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
963411|NCT00223652|2330166|P1|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
963412|NCT00223652|2330165|P2|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||41
963413|NCT00223652|2330166|P1|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||40
963414|NCT00223652|2330165|P2|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||41
963415|NCT00223652|2330166|P1|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||40
963416|NCT00223652|2330165|P2|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||3
963417|NCT00223652|2330166|P1|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||1
963418|NCT00223652|2330165|P2|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||41
963419|NCT00223652|2330166|P1|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||40
963420|NCT00223652|2330165|P2|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||44
963421|NCT00223652|2330166|P1|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||41
963422|NCT00223678|2330184|P2|NOT COMPLETED|Overall Study||0
963423|NCT00223678|2330185|P1|NOT COMPLETED|Overall Study||0
963424|NCT00223678|2330184|P2|COMPLETED|Overall Study||7
963425|NCT00223678|2330185|P1|COMPLETED|Overall Study||13
963426|NCT00223678|2330184|P2|STARTED|Overall Study||7
963427|NCT00223678|2330185|P1|STARTED|Overall Study||13
963428|NCT00223704|2330194|P3|NOT COMPLETED|Overall Study||0
963429|NCT00223704|2330195|P2|NOT COMPLETED|Overall Study||0
963430|NCT00223704|2330196|P1|NOT COMPLETED|Overall Study||0
963431|NCT00223704|2330194|P3|COMPLETED|Overall Study||40
963432|NCT00223704|2330195|P2|COMPLETED|Overall Study||37
963433|NCT00223704|2330196|P1|COMPLETED|Overall Study||38
963434|NCT00223704|2330194|P3|STARTED|Overall Study||40
963435|NCT00223704|2330195|P2|STARTED|Overall Study||37
963436|NCT00223704|2330196|P1|STARTED|Overall Study||38
963449|NCT00223808|2330227|P3|NOT COMPLETED|Overall Study||5
963450|NCT00223808|2330228|P2|NOT COMPLETED|Overall Study||5
963451|NCT00223808|2330229|P1|NOT COMPLETED|Overall Study||3
963452|NCT00223808|2330227|P3|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|18
963453|NCT00223808|2330228|P2|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|17
963454|NCT00223808|2330229|P1|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|19
963455|NCT00223808|2330227|P3|STARTED|Overall Study||23
963456|NCT00223808|2330228|P2|STARTED|Overall Study||22
963457|NCT00223808|2330229|P1|STARTED|Overall Study||22
963458|NCT00223821|2330248|P2|NOT COMPLETED|Overall Study||10
963459|NCT00223821|2330249|P1|NOT COMPLETED|Overall Study||4
963460|NCT00223821|2330248|P2|COMPLETED|Overall Study||22
963461|NCT00223821|2330249|P1|COMPLETED|Overall Study||28
963462|NCT00223821|2330248|P2|Completed 6-month Follow-up|Overall Study||25
963463|NCT00223821|2330249|P1|Completed 6-month Follow-up|Overall Study||28
963464|NCT00223821|2330248|P2|Completed Post-treatment Assessment|Overall Study||27
963465|NCT00223821|2330249|P1|Completed Post-treatment Assessment|Overall Study||31
963466|NCT00223821|2330248|P2|Completed Therapy|Overall Study||28
963467|NCT00223821|2330249|P1|Completed Therapy|Overall Study||31
963468|NCT00223821|2330248|P2|STARTED|Overall Study||32
963469|NCT00223821|2330249|P1|STARTED|Overall Study||32
963470|NCT00223977|2330260|P3|NOT COMPLETED|Overall Study||3
963471|NCT00223977|2330261|P2|NOT COMPLETED|Overall Study||11
963472|NCT00223977|2330262|P1|NOT COMPLETED|Overall Study||9
963473|NCT00223977|2330260|P3|COMPLETED|Overall Study||39
963474|NCT00223977|2330261|P2|COMPLETED|Overall Study||47
963475|NCT00223977|2330262|P1|COMPLETED|Overall Study||37
963476|NCT00223977|2330260|P3|STARTED|Overall Study||42
963477|NCT00223977|2330261|P2|STARTED|Overall Study||58
963478|NCT00223977|2330262|P1|STARTED|Overall Study||46
963479|NCT00224003|2330282|P1|NOT COMPLETED|Overall Study||7
963480|NCT00224003|2330282|P1|COMPLETED|Overall Study|Last patient out: March 31, 2004|16
963481|NCT00224003|2330282|P1|STARTED|Overall Study|First patient in: April 2, 2003|23
963482|NCT00224016|2330288|P2|NOT COMPLETED|Follow-Up Period||0
963483|NCT00224016|2330289|P1|NOT COMPLETED|Follow-Up Period||0
963484|NCT00224016|2330288|P2|COMPLETED|Follow-Up Period||0
963485|NCT00224016|2330289|P1|COMPLETED|Follow-Up Period||35
963486|NCT00224016|2330288|P2|STARTED|Follow-Up Period|This group of subjects did not proceed to follow-up period.|0
963487|NCT00224016|2330289|P1|STARTED|Follow-Up Period||35
963488|NCT00224016|2330288|P2|NOT COMPLETED|Maintenance Period||1
963489|NCT00224016|2330289|P1|NOT COMPLETED|Maintenance Period||2
963490|NCT00224016|2330288|P2|COMPLETED|Maintenance Period||14
963491|NCT00224016|2330289|P1|COMPLETED|Maintenance Period||36
963492|NCT00224016|2330288|P2|STARTED|Maintenance Period||15
963493|NCT00224016|2330289|P1|STARTED|Maintenance Period||38
963494|NCT00224016|2330288|P2|NOT COMPLETED|Titration Period||1
963495|NCT00224016|2330289|P1|NOT COMPLETED|Titration Period||1
963496|NCT00224016|2330288|P2|COMPLETED|Titration Period||15
963497|NCT00224016|2330289|P1|COMPLETED|Titration Period||38
963498|NCT00224016|2330288|P2|STARTED|Titration Period||16
963499|NCT00224016|2330289|P1|STARTED|Titration Period||39
963500|NCT00224029|2330297|P1|NOT COMPLETED|Overall Study||6
963501|NCT00224029|2330297|P1|COMPLETED|Overall Study||18
963502|NCT00224029|2330297|P1|STARTED|Overall Study||24
963503|NCT00224042|2330303|P2|NOT COMPLETED|Overall Study||6
963504|NCT00224042|2330304|P1|NOT COMPLETED|Overall Study||6
963505|NCT00224042|2330303|P2|COMPLETED|Overall Study||20
963506|NCT00224042|2330304|P1|COMPLETED|Overall Study||20
963507|NCT00224042|2330303|P2|STARTED|Overall Study||26
963508|NCT00224042|2330304|P1|STARTED|Overall Study||26
963509|NCT00224055|2330318|P2|NOT COMPLETED|Overall Study||14
963510|NCT00224055|2330319|P1|NOT COMPLETED|Overall Study||15
963511|NCT00224055|2330318|P2|COMPLETED|Overall Study||31
963512|NCT00224055|2330319|P1|COMPLETED|Overall Study||29
963513|NCT00224055|2330318|P2|STARTED|Overall Study||45
963514|NCT00224055|2330319|P1|STARTED|Overall Study||44
963515|NCT00224107|2330329|P2|NOT COMPLETED|Overall Study||14
963516|NCT00224107|2330330|P1|NOT COMPLETED|Overall Study||31
963517|NCT00224107|2330329|P2|COMPLETED|Overall Study||214
963518|NCT00224107|2330330|P1|COMPLETED|Overall Study||202
963519|NCT00224107|2330329|P2|STARTED|Overall Study||228
963520|NCT00224107|2330330|P1|STARTED|Overall Study||233
963521|NCT00224120|2330340|P2|NOT COMPLETED|Overall Study||24
963522|NCT00224120|2330341|P1|NOT COMPLETED|Overall Study||22
963523|NCT00224120|2330340|P2|COMPLETED|Overall Study||205
963524|NCT00224120|2330341|P1|COMPLETED|Overall Study||211
963525|NCT00224120|2330340|P2|STARTED|Overall Study||229
963526|NCT00224120|2330341|P1|STARTED|Overall Study||233
963527|NCT00224133|2330349|P1|NOT COMPLETED|Overall Study||226
963528|NCT00224133|2330349|P1|COMPLETED|Overall Study||435
963529|NCT00224133|2330349|P1|STARTED|Overall Study||661
963530|NCT00224289|2330353|P1|NOT COMPLETED|Overall Study||0
963531|NCT00224289|2330353|P1|COMPLETED|Overall Study||17
963532|NCT00224289|2330353|P1|STARTED|Overall Study||17
963533|NCT00224484|2330361|P3|NOT COMPLETED|Overall Study||62
963534|NCT00224484|2330362|P2|NOT COMPLETED|Overall Study||65
963535|NCT00224484|2330363|P1|NOT COMPLETED|Overall Study||146
963536|NCT00224484|2330361|P3|COMPLETED|Overall Study||1425
963537|NCT00224484|2330362|P2|COMPLETED|Overall Study||1426
963538|NCT00224484|2330363|P1|COMPLETED|Overall Study||2831
963539|NCT00224484|2330361|P3|STARTED|Overall Study||1487
963540|NCT00224484|2330362|P2|STARTED|Overall Study||1491
963541|NCT00224484|2330363|P1|STARTED|Overall Study||2977
963542|NCT00224770|2330425|P3|NOT COMPLETED|Overall Study||0
963543|NCT00224770|2330426|P2|NOT COMPLETED|Overall Study||2
963544|NCT00224770|2330427|P1|NOT COMPLETED|Overall Study||4
963545|NCT00224770|2330425|P3|COMPLETED|Overall Study||14
963546|NCT00224770|2330426|P2|COMPLETED|Overall Study||52
963547|NCT00224770|2330427|P1|COMPLETED|Overall Study||38
963548|NCT00224770|2330425|P3|STARTED|Overall Study||14
963549|NCT00224770|2330426|P2|STARTED|Overall Study||54
963550|NCT00224770|2330427|P1|STARTED|Overall Study||42
963551|NCT00225212|2330459|P1|NOT COMPLETED|Overall Study||6
963552|NCT00225212|2330459|P1|COMPLETED|Overall Study||29
963553|NCT00225212|2330459|P1|STARTED|Overall Study||35
963554|NCT00225251|2330466|P2|NOT COMPLETED|Overall Study||1
963555|NCT00225251|2330467|P1|NOT COMPLETED|Overall Study||1
963556|NCT00225251|2330466|P2|COMPLETED|Overall Study||6
963557|NCT00225251|2330467|P1|COMPLETED|Overall Study||10
963558|NCT00225251|2330466|P2|STARTED|Overall Study||7
963559|NCT00225251|2330467|P1|STARTED|Overall Study||11
963560|NCT00225277|2330483|P2|NOT COMPLETED|Overall Study||95
963561|NCT00225277|2330484|P1|NOT COMPLETED|Overall Study||97
963562|NCT00225277|2330483|P2|COMPLETED|Overall Study||178
963563|NCT00225277|2330484|P1|COMPLETED|Overall Study||177
963564|NCT00225277|2330483|P2|STARTED|Overall Study|Mean treatment durations were 56.3 weeks (glimepiride) and 56.5 weeks (pioglitazone).|273
963565|NCT00225277|2330484|P1|STARTED|Overall Study|274 subjects randomized, but four subjects did not receive drug.|274
963566|NCT00225420|2330500|P3|NOT COMPLETED|Overall Study||0
963567|NCT00225420|2330501|P2|NOT COMPLETED|Overall Study||0
963568|NCT00225420|2330502|P1|NOT COMPLETED|Overall Study||0
963569|NCT00225420|2330500|P3|COMPLETED|Overall Study||3
963570|NCT00225420|2330501|P2|COMPLETED|Overall Study||6
963571|NCT00225420|2330502|P1|COMPLETED|Overall Study||9
963572|NCT00225420|2330500|P3|STARTED|Overall Study||3
963573|NCT00225420|2330501|P2|STARTED|Overall Study||6
963574|NCT00225420|2330502|P1|STARTED|Overall Study||9
963575|NCT00225498|2330509|P1|NOT COMPLETED|Overall Study||0
963576|NCT00225498|2330509|P1|COMPLETED|Overall Study|The only analyses with adequate statistical power were of the 10 ziprasidone nonresponders.|10
963577|NCT00225498|2330509|P1|STARTED|Overall Study||10
963578|NCT00225732|2330515|P2|NOT COMPLETED|Overall Study||0
963579|NCT00225732|2330516|P1|NOT COMPLETED|Overall Study||0
963580|NCT00225732|2330515|P2|COMPLETED|Overall Study||166
963581|NCT00225732|2330516|P1|COMPLETED|Overall Study||153
963582|NCT00225732|2330515|P2|STARTED|Overall Study||166
963583|NCT00225732|2330516|P1|STARTED|Overall Study||153
963584|NCT00225784|2330522|P1|NOT COMPLETED|Overall Study||4
963585|NCT00225784|2330522|P1|COMPLETED|Overall Study||33
963586|NCT00225784|2330522|P1|STARTED|Overall Study||37
963587|NCT00226239|2330533|P1|NOT COMPLETED|Maintenance Cetuximab||14
963588|NCT00226239|2330533|P1|COMPLETED|Maintenance Cetuximab||17
963589|NCT00226239|2330533|P1|STARTED|Maintenance Cetuximab||31
963590|NCT00226239|2330533|P1|NOT COMPLETED|XPE, Definitive Therapy||4
963591|NCT00226239|2330533|P1|COMPLETED|XPE, Definitive Therapy||33
963592|NCT00226239|2330533|P1|STARTED|XPE, Definitive Therapy||37
963593|NCT00226239|2330533|P1|NOT COMPLETED|TPE, Induction Therapy||2
963594|NCT00226239|2330533|P1|COMPLETED|TPE, Induction Therapy||37
963595|NCT00226239|2330533|P1|STARTED|TPE, Induction Therapy||39
963596|NCT00226577|2330542|P1|NOT COMPLETED|Overall Study||0
963597|NCT00226577|2330542|P1|COMPLETED|Overall Study||52
963598|NCT00226577|2330542|P1|STARTED|Overall Study||52
963599|NCT00226590|2330550|P1|NOT COMPLETED|Overall Study||0
963600|NCT00226590|2330550|P1|COMPLETED|Overall Study||39
963601|NCT00226590|2330550|P1|STARTED|Overall Study||39
963602|NCT00226655|2330557|P1|NOT COMPLETED|Overall Study||79
963603|NCT00226655|2330557|P1|COMPLETED|Overall Study||33
963604|NCT00226655|2330557|P1|STARTED|Overall Study||112
963605|NCT00226811|2330561|P1|NOT COMPLETED|Overall Study||76
963606|NCT00226811|2330561|P1|COMPLETED|Overall Study||2
963607|NCT00226811|2330561|P1|STARTED|Overall Study||78
963608|NCT00227019|2330571|P1|NOT COMPLETED|Overall Study||0
963609|NCT00227019|2330571|P1|COMPLETED|Overall Study||16
963610|NCT00227019|2330571|P1|STARTED|Overall Study||16
963611|NCT00227266|2330580|P3|NOT COMPLETED|Overall Study||4
963612|NCT00227266|2330581|P2|NOT COMPLETED|Overall Study||0
963613|NCT00227266|2330582|P1|NOT COMPLETED|Overall Study||1
963614|NCT00227266|2330580|P3|COMPLETED|Overall Study||29
963615|NCT00227266|2330581|P2|COMPLETED|Overall Study||30
963616|NCT00227266|2330582|P1|COMPLETED|Overall Study||30
963617|NCT00227266|2330580|P3|STARTED|Overall Study||33
963618|NCT00227266|2330581|P2|STARTED|Overall Study||30
963619|NCT00227266|2330582|P1|STARTED|Overall Study||31
963620|NCT00227305|2330602|P1|NOT COMPLETED|Overall Study||144
963621|NCT00227305|2330602|P1|COMPLETED|Overall Study|Completed 26 weeks|237
963622|NCT00227305|2330602|P1|Drug Received|Overall Study|safety population|380
963623|NCT00227305|2330602|P1|STARTED|Overall Study|enrolled|381
963624|NCT00227344|2330618|P2|NOT COMPLETED|Overall Study||5
963625|NCT00227344|2330619|P1|NOT COMPLETED|Overall Study||12
963626|NCT00227344|2330618|P2|COMPLETED|Overall Study||37
963627|NCT00227344|2330619|P1|COMPLETED|Overall Study||75
963628|NCT00227344|2330618|P2|STARTED|Overall Study||42
963629|NCT00227344|2330619|P1|STARTED|Overall Study||87
963630|NCT00227370|2330641|P2|NOT COMPLETED|Overall Study||24
963631|NCT00227370|2330642|P1|NOT COMPLETED|Overall Study||21
963632|NCT00227370|2330641|P2|COMPLETED|Overall Study||46
963633|NCT00227370|2330642|P1|COMPLETED|Overall Study||45
963634|NCT00227370|2330641|P2|STARTED|Overall Study|Treatment Group|70
963635|NCT00227370|2330642|P1|STARTED|Overall Study|Placebo Group|66
963636|NCT00227539|2330660|P1|NOT COMPLETED|Overall Study||1
963637|NCT00227539|2330660|P1|COMPLETED|Overall Study||24
963638|NCT00227539|2330660|P1|STARTED|Overall Study||25
963639|NCT00227591|2330666|P1|NOT COMPLETED|Overall Study||1
963640|NCT00227591|2330666|P1|COMPLETED|Overall Study||47
963641|NCT00227591|2330666|P1|Began Treatment|Overall Study||47
963642|NCT00227591|2330666|P1|STARTED|Overall Study|48 pts registered to the study|48
963643|NCT00227721|2330670|P1|NOT COMPLETED|Overall Study||1
963644|NCT00227721|2330670|P1|COMPLETED|Overall Study||29
963645|NCT00227721|2330670|P1|STARTED|Overall Study||30
963646|NCT00227760|2330674|P1|NOT COMPLETED|Overall Study||0
963647|NCT00227760|2330674|P1|COMPLETED|Overall Study||44
963648|NCT00227760|2330674|P1|STARTED|Overall Study||44
963649|NCT00227903|2330682|P2|NOT COMPLETED|Overall Study||10
963650|NCT00227903|2330683|P1|NOT COMPLETED|Overall Study||5
963651|NCT00227903|2330682|P2|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|82
963652|NCT00227903|2330683|P1|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|86
963653|NCT00227903|2330682|P2|Received ≥ 1 Follow-up Assessment|Overall Study|4 participants did not receive any treatment sessions.|82
963654|NCT00227903|2330683|P1|Received ≥ 1 Follow-up Assessment|Overall Study|1 participant did not receive any treatment sessions.|86
963655|NCT00227903|2330682|P2|STARTED|Overall Study||92
963656|NCT00227903|2330683|P1|STARTED|Overall Study||91
963657|NCT00227994|2330745|P2|NOT COMPLETED|Overall Study||7
963658|NCT00227994|2330746|P1|NOT COMPLETED|Overall Study||7
963659|NCT00227994|2330745|P2|COMPLETED|Overall Study||13
963660|NCT00227994|2330746|P1|COMPLETED|Overall Study||13
963661|NCT00227994|2330745|P2|STARTED|Overall Study||20
963662|NCT00227994|2330746|P1|STARTED|Overall Study||20
963663|NCT00228384|2330756|P2|NOT COMPLETED|Overall Study||29
963664|NCT00228384|2330757|P1|NOT COMPLETED|Overall Study||29
963665|NCT00228384|2330756|P2|COMPLETED|Overall Study||47
963666|NCT00228384|2330757|P1|COMPLETED|Overall Study||43
963667|NCT00228384|2330756|P2|Three Year Follow-up (Final)|Overall Study||47
963668|NCT00228384|2330757|P1|Three Year Follow-up (Final)|Overall Study||43
963669|NCT00228384|2330756|P2|30-Day Follow-up (Safety Outcome)|Overall Study||72
963670|NCT00228384|2330757|P1|30-Day Follow-up (Safety Outcome)|Overall Study||69
963671|NCT00228384|2330756|P2|Baseline|Overall Study||76
963672|NCT00228384|2330757|P1|Baseline|Overall Study||72
963673|NCT00228384|2330756|P2|STARTED|Overall Study||76
963674|NCT00228384|2330757|P1|STARTED|Overall Study||72
963675|NCT00228553|2330795|P1|NOT COMPLETED|Overall Study||430
963676|NCT00228553|2330795|P1|COMPLETED|Overall Study||313
963677|NCT00228553|2330795|P1|STARTED|Overall Study||743
963678|NCT00228566|2330799|P1|NOT COMPLETED|Overall Study||71
963679|NCT00228566|2330799|P1|COMPLETED|Overall Study||176
963680|NCT00228566|2330799|P1|STARTED|Overall Study||247
963681|NCT00228813|2330803|P1|NOT COMPLETED|Overall Study||4
963682|NCT00228813|2330803|P1|COMPLETED|Overall Study||4
963683|NCT00228813|2330803|P1|STARTED|Overall Study||8
963684|NCT00228917|2330813|P4|NOT COMPLETED|Overall Study||0
963685|NCT00228917|2330814|P3|NOT COMPLETED|Overall Study||0
963686|NCT00228917|2330815|P2|NOT COMPLETED|Overall Study||3
963687|NCT00228917|2330816|P1|NOT COMPLETED|Overall Study||1
963688|NCT00228917|2330813|P4|COMPLETED|Overall Study||107
963689|NCT00228917|2330814|P3|COMPLETED|Overall Study||213
963690|NCT00228917|2330815|P2|COMPLETED|Overall Study||320
963691|NCT00228917|2330816|P1|COMPLETED|Overall Study||646
963692|NCT00228917|2330813|P4|STARTED|Overall Study||107
963693|NCT00228917|2330814|P3|STARTED|Overall Study||213
963694|NCT00228917|2330815|P2|STARTED|Overall Study||323
963695|NCT00228917|2330816|P1|STARTED|Overall Study||647
963696|NCT00228943|2330842|P1|NOT COMPLETED|Week 2||1
963697|NCT00228943|2330842|P1|COMPLETED|Week 2||27
963698|NCT00228943|2330842|P1|STARTED|Week 2||28
963699|NCT00228943|2330842|P1|NOT COMPLETED|Week 1||0
963700|NCT00228943|2330842|P1|COMPLETED|Week 1||28
963701|NCT00228943|2330842|P1|STARTED|Week 1||28
963702|NCT00229203|2330852|P2|NOT COMPLETED|Overall Study||19
963703|NCT00229203|2330853|P1|NOT COMPLETED|Overall Study||32
963704|NCT00229203|2330852|P2|COMPLETED|Overall Study||0
963705|NCT00229203|2330853|P1|COMPLETED|Overall Study||0
963706|NCT00229203|2330852|P2|STARTED|Overall Study||19
963707|NCT00229203|2330853|P1|STARTED|Overall Study||32
963708|NCT00229619|2330865|P1|NOT COMPLETED|Overall Study||0
963709|NCT00229619|2330865|P1|COMPLETED|Overall Study||11
963710|NCT00229619|2330865|P1|STARTED|Overall Study||11
963711|NCT00229658|2330871|P2|NOT COMPLETED|Overall Study||167
963712|NCT00229658|2330872|P1|NOT COMPLETED|Overall Study||225
963713|NCT00229658|2330871|P2|COMPLETED|Overall Study||364
963714|NCT00229658|2330872|P1|COMPLETED|Overall Study||541
963715|NCT00229658|2330871|P2|STARTED|Overall Study||531
963716|NCT00229658|2330872|P1|STARTED|Overall Study||766
963717|NCT00229723|2330907|P7|NOT COMPLETED|Maintenance Phase||10
963718|NCT00229723|2330908|P6|NOT COMPLETED|Maintenance Phase||19
963719|NCT00229723|2330909|P5|NOT COMPLETED|Maintenance Phase||15
963720|NCT00229723|2330910|P4|NOT COMPLETED|Maintenance Phase||17
963721|NCT00229723|2330911|P3|NOT COMPLETED|Maintenance Phase||9
963722|NCT00229723|2330912|P2|NOT COMPLETED|Maintenance Phase||14
963723|NCT00229723|2330913|P1|NOT COMPLETED|Maintenance Phase||25
963724|NCT00229723|2330907|P7|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
963725|NCT00229723|2330908|P6|COMPLETED|Maintenance Phase|Completed study on randomized treatment|12
963726|NCT00229723|2330909|P5|COMPLETED|Maintenance Phase|Completed study on randomized treatment|7
963727|NCT00229723|2330910|P4|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
963728|NCT00229723|2330911|P3|COMPLETED|Maintenance Phase|Completed study on randomized treatment|16
963729|NCT00229723|2330912|P2|COMPLETED|Maintenance Phase|Completed study on randomized treatment|5
963730|NCT00229723|2330913|P1|COMPLETED|Maintenance Phase|Completed study on randomized treatment|25
963731|NCT00229723|2330907|P7|STARTED|Maintenance Phase||19
963732|NCT00229723|2330908|P6|STARTED|Maintenance Phase||31
963733|NCT00229723|2330909|P5|STARTED|Maintenance Phase||22
963734|NCT00229723|2330910|P4|STARTED|Maintenance Phase||26
963735|NCT00229723|2330911|P3|STARTED|Maintenance Phase||25
963736|NCT00229723|2330912|P2|STARTED|Maintenance Phase||19
963737|NCT00229723|2330913|P1|STARTED|Maintenance Phase||50
963738|NCT00229723|2330907|P7|NOT COMPLETED|Concomitant Phase||3
963739|NCT00229723|2330908|P6|NOT COMPLETED|Concomitant Phase||3
963740|NCT00229723|2330909|P5|NOT COMPLETED|Concomitant Phase||2
963741|NCT00229723|2330910|P4|NOT COMPLETED|Concomitant Phase||5
963742|NCT00229723|2330911|P3|NOT COMPLETED|Concomitant Phase||6
963743|NCT00229723|2330912|P2|NOT COMPLETED|Concomitant Phase||5
963744|NCT00229723|2330913|P1|NOT COMPLETED|Concomitant Phase||10
963745|NCT00229723|2330907|P7|COMPLETED|Concomitant Phase||19
963746|NCT00229723|2330908|P6|COMPLETED|Concomitant Phase||31
963747|NCT00229723|2330909|P5|COMPLETED|Concomitant Phase||22
963748|NCT00229723|2330910|P4|COMPLETED|Concomitant Phase||26
963749|NCT00229723|2330911|P3|COMPLETED|Concomitant Phase||25
963750|NCT00229723|2330912|P2|COMPLETED|Concomitant Phase||19
963751|NCT00229723|2330913|P1|COMPLETED|Concomitant Phase||50
963752|NCT00229723|2330907|P7|STARTED|Concomitant Phase|Received randomized treatment|22
963753|NCT00229723|2330908|P6|STARTED|Concomitant Phase|Received randomized treatment|34
963754|NCT00229723|2330909|P5|STARTED|Concomitant Phase|Received randomized treatment|24
963755|NCT00229723|2330910|P4|STARTED|Concomitant Phase|Received randomized treatment|31
963756|NCT00229723|2330911|P3|STARTED|Concomitant Phase|Received randomized treatment|31
963757|NCT00229723|2330912|P2|STARTED|Concomitant Phase|Received randomized treatment|24
963758|NCT00229723|2330913|P1|STARTED|Concomitant Phase|Received randomized treatment|60
963759|NCT00229931|2330966|P2|NOT COMPLETED|Overall Study||2
963760|NCT00229931|2330967|P1|NOT COMPLETED|Overall Study||4
963761|NCT00229931|2330966|P2|COMPLETED|Overall Study||3
963762|NCT00229931|2330967|P1|COMPLETED|Overall Study||2
963763|NCT00229931|2330966|P2|STARTED|Overall Study||5
963764|NCT00229931|2330967|P1|STARTED|Overall Study||6
963765|NCT00229957|2330977|P2|NOT COMPLETED|Overall Study||12
963766|NCT00229957|2330978|P1|NOT COMPLETED|Overall Study||20
963767|NCT00229957|2330977|P2|COMPLETED|Overall Study||139
963768|NCT00229957|2330978|P1|COMPLETED|Overall Study||132
963769|NCT00229957|2330977|P2|STARTED|Overall Study||151
963770|NCT00229957|2330978|P1|STARTED|Overall Study||152
963771|NCT00229970|2330987|P3|NOT COMPLETED|Overall Study||0
963772|NCT00229970|2330988|P2|NOT COMPLETED|Overall Study||0
963773|NCT00229970|2330989|P1|NOT COMPLETED|Overall Study||0
963774|NCT00229970|2330987|P3|COMPLETED|Overall Study||75
963775|NCT00229970|2330988|P2|COMPLETED|Overall Study||72
963776|NCT00229970|2330989|P1|COMPLETED|Overall Study||78
963777|NCT00229970|2330987|P3|STARTED|Overall Study||75
963778|NCT00229970|2330988|P2|STARTED|Overall Study||72
963779|NCT00229970|2330989|P1|STARTED|Overall Study||78
963780|NCT00230009|2330999|P2|NOT COMPLETED|Follow-up||26
963781|NCT00230009|2331000|P1|NOT COMPLETED|Follow-up||31
963782|NCT00230009|2330999|P2|COMPLETED|Follow-up||24
963783|NCT00230009|2331000|P1|COMPLETED|Follow-up||19
963784|NCT00230009|2330999|P2|STARTED|Follow-up||50
963785|NCT00230009|2331000|P1|STARTED|Follow-up||50
963786|NCT00230009|2330999|P2|NOT COMPLETED|Single Session Intervention/Control||0
963787|NCT00230009|2331000|P1|NOT COMPLETED|Single Session Intervention/Control||0
963788|NCT00230009|2330999|P2|COMPLETED|Single Session Intervention/Control||50
963789|NCT00230009|2331000|P1|COMPLETED|Single Session Intervention/Control||50
963790|NCT00230009|2330999|P2|STARTED|Single Session Intervention/Control||50
963791|NCT00230009|2331000|P1|STARTED|Single Session Intervention/Control||50
963792|NCT00230022|2331016|P2|NOT COMPLETED|Overall Study||0
963793|NCT00230022|2331017|P1|NOT COMPLETED|Overall Study||0
963794|NCT00230022|2331016|P2|COMPLETED|Overall Study||15
963795|NCT00230022|2331017|P1|COMPLETED|Overall Study||15
963796|NCT00230022|2331016|P2|STARTED|Overall Study||15
963797|NCT00230022|2331017|P1|STARTED|Overall Study||15
963798|NCT00230048|2331025|P2|NOT COMPLETED|Overall Study||18
963799|NCT00230048|2331026|P1|NOT COMPLETED|Overall Study||13
963800|NCT00230048|2331025|P2|COMPLETED|Overall Study||37
963801|NCT00230048|2331026|P1|COMPLETED|Overall Study||39
963802|NCT00230048|2331025|P2|Completed Intervention/Control Session|Overall Study||55
963803|NCT00230048|2331026|P1|Completed Intervention/Control Session|Overall Study||52
963804|NCT00230048|2331025|P2|STARTED|Overall Study||55
963805|NCT00230048|2331026|P1|STARTED|Overall Study||52
963806|NCT00230100|2331036|P2|NOT COMPLETED|Overall Study||0
963807|NCT00230100|2331037|P1|NOT COMPLETED|Overall Study||0
963808|NCT00230100|2331036|P2|COMPLETED|Overall Study||17
963809|NCT00230100|2331037|P1|COMPLETED|Overall Study||29
963810|NCT00230100|2331036|P2|STARTED|Overall Study||17
963811|NCT00230100|2331037|P1|STARTED|Overall Study||29
963812|NCT00230126|2331059|P2|NOT COMPLETED|Overall Study||1
963813|NCT00230126|2331060|P1|NOT COMPLETED|Overall Study||2
963814|NCT00230126|2331059|P2|COMPLETED|Overall Study||27
963815|NCT00230126|2331060|P1|COMPLETED|Overall Study||28
963816|NCT00230126|2331059|P2|STARTED|Overall Study||28
963817|NCT00230126|2331060|P1|STARTED|Overall Study||30
963818|NCT00230178|2331073|P3|NOT COMPLETED|Overall Study||7
963819|NCT00230178|2331074|P2|NOT COMPLETED|Overall Study||7
963820|NCT00230178|2331075|P1|NOT COMPLETED|Overall Study||4
963821|NCT00230178|2331073|P3|COMPLETED|Overall Study||86
963822|NCT00230178|2331074|P2|COMPLETED|Overall Study||86
963823|NCT00230178|2331075|P1|COMPLETED|Overall Study||90
963824|NCT00230178|2331073|P3|Treated|Overall Study||91
963825|NCT00230178|2331074|P2|Treated|Overall Study||92
963826|NCT00230178|2331075|P1|Treated|Overall Study|Modified ITT population: ITT patients with at least 1 dose of study drug|92
963827|NCT00230178|2331073|P3|STARTED|Overall Study||93
963828|NCT00230178|2331074|P2|STARTED|Overall Study||93
963829|NCT00230178|2331075|P1|STARTED|Overall Study|Intent-to-treat (ITT)population: randomized patients|94
963830|NCT00230282|2331089|P1|NOT COMPLETED|Maintanence Therapy With Alemtuzumab||0
963831|NCT00230282|2331089|P1|COMPLETED|Maintanence Therapy With Alemtuzumab||17
963832|NCT00230282|2331089|P1|STARTED|Maintanence Therapy With Alemtuzumab||17
963833|NCT00230282|2331089|P1|NOT COMPLETED|Fludarabine + Cyclophosphamide||8
963834|NCT00230282|2331089|P1|COMPLETED|Fludarabine + Cyclophosphamide||17
963835|NCT00230282|2331089|P1|STARTED|Fludarabine + Cyclophosphamide||25
963836|NCT00230737|2331097|P3|NOT COMPLETED|Overall Study||0
963837|NCT00230737|2331098|P2|NOT COMPLETED|Overall Study||0
963838|NCT00230737|2331099|P1|NOT COMPLETED|Overall Study||0
963839|NCT00230737|2331097|P3|COMPLETED|Overall Study||8
963840|NCT00230737|2331098|P2|COMPLETED|Overall Study||10
963841|NCT00230737|2331099|P1|COMPLETED|Overall Study||9
963842|NCT00230737|2331097|P3|STARTED|Overall Study||8
963843|NCT00230737|2331098|P2|STARTED|Overall Study||10
963844|NCT00230737|2331099|P1|STARTED|Overall Study||9
963845|NCT00230802|2331109|P2|NOT COMPLETED|Overall Study||0
963846|NCT00230802|2331110|P1|NOT COMPLETED|Overall Study||0
963847|NCT00230802|2331109|P2|COMPLETED|Overall Study||23
963848|NCT00230802|2331110|P1|COMPLETED|Overall Study||25
963849|NCT00230802|2331109|P2|STARTED|Overall Study||23
963850|NCT00230802|2331110|P1|STARTED|Overall Study||25
963851|NCT00224874|2331124|P4|NOT COMPLETED|Overall Study||0
963852|NCT00224874|2331125|P3|NOT COMPLETED|Overall Study||1
963853|NCT00224874|2331126|P2|NOT COMPLETED|Overall Study||0
963854|NCT00224874|2331127|P1|NOT COMPLETED|Overall Study||0
963855|NCT00224874|2331124|P4|COMPLETED|Overall Study||42
963856|NCT00224874|2331125|P3|COMPLETED|Overall Study||46
963857|NCT00224874|2331126|P2|COMPLETED|Overall Study||45
963858|NCT00224874|2331127|P1|COMPLETED|Overall Study||46
963859|NCT00224874|2331124|P4|STARTED|Overall Study||42
963860|NCT00224874|2331125|P3|STARTED|Overall Study||47
963861|NCT00224874|2331126|P2|STARTED|Overall Study||45
963862|NCT00224874|2331127|P1|STARTED|Overall Study||46
963863|NCT00224952|2331172|P3|NOT COMPLETED|Overall Study||0
963864|NCT00224952|2331173|P2|NOT COMPLETED|Overall Study||0
963865|NCT00224952|2331174|P1|NOT COMPLETED|Overall Study||0
963866|NCT00224952|2331172|P3|COMPLETED|Overall Study||134
963867|NCT00224952|2331173|P2|COMPLETED|Overall Study||87
963868|NCT00224952|2331174|P1|COMPLETED|Overall Study||53
963869|NCT00224952|2331172|P3|STARTED|Overall Study||134
963870|NCT00224952|2331173|P2|STARTED|Overall Study||87
963871|NCT00224952|2331174|P1|STARTED|Overall Study||53
963872|NCT00225017|2331187|P2|NOT COMPLETED|Overall Study||1
963873|NCT00225017|2331188|P1|NOT COMPLETED|Overall Study||0
963874|NCT00225017|2331187|P2|COMPLETED|Overall Study|1 subject did not complete week 24 assessments|23
963875|NCT00225017|2331188|P1|COMPLETED|Overall Study||26
963876|NCT00225017|2331187|P2|STARTED|Overall Study||24
963877|NCT00225017|2331188|P1|STARTED|Overall Study||26
963878|NCT00225147|2331202|P4|NOT COMPLETED|Open-label Phase||10
963879|NCT00225147|2331203|P3|NOT COMPLETED|Open-label Phase||0
963880|NCT00225147|2331204|P2|NOT COMPLETED|Open-label Phase||0
963881|NCT00225147|2331205|P1|NOT COMPLETED|Open-label Phase||0
963882|NCT00225147|2331202|P4|COMPLETED|Open-label Phase||52
963883|NCT00225147|2331203|P3|COMPLETED|Open-label Phase||0
963884|NCT00225147|2331204|P2|COMPLETED|Open-label Phase||0
963885|NCT00225147|2331205|P1|COMPLETED|Open-label Phase||0
963886|NCT00225147|2331202|P4|STARTED|Open-label Phase||62
963887|NCT00225147|2331203|P3|STARTED|Open-label Phase||0
963888|NCT00225147|2331204|P2|STARTED|Open-label Phase||0
963889|NCT00225147|2331205|P1|STARTED|Open-label Phase||0
963890|NCT00225147|2331202|P4|NOT COMPLETED|Double-blind Phase||0
963891|NCT00225147|2331203|P3|NOT COMPLETED|Double-blind Phase||0
963892|NCT00225147|2331204|P2|NOT COMPLETED|Double-blind Phase||0
963893|NCT00225147|2331205|P1|NOT COMPLETED|Double-blind Phase||0
963894|NCT00225147|2331202|P4|COMPLETED|Double-blind Phase||0
963895|NCT00225147|2331203|P3|COMPLETED|Double-blind Phase||13
963896|NCT00225147|2331204|P2|COMPLETED|Double-blind Phase||12
963897|NCT00225147|2331205|P1|COMPLETED|Double-blind Phase||13
963898|NCT00225147|2331202|P4|STARTED|Double-blind Phase||0
963899|NCT00225147|2331203|P3|STARTED|Double-blind Phase||13
963900|NCT00225147|2331204|P2|STARTED|Double-blind Phase||12
963901|NCT00225147|2331205|P1|STARTED|Double-blind Phase||13
963902|NCT00230971|2331221|P2|NOT COMPLETED|Baseline Participants||19
963903|NCT00230971|2331222|P1|NOT COMPLETED|Baseline Participants||22
963904|NCT00230971|2331221|P2|COMPLETED|Baseline Participants||216
963905|NCT00230971|2331222|P1|COMPLETED|Baseline Participants||210
963906|NCT00230971|2331221|P2|STARTED|Baseline Participants||235
963907|NCT00230971|2331222|P1|STARTED|Baseline Participants||232
963908|NCT00230971|2331221|P2|NOT COMPLETED|Randomization||3
963909|NCT00230971|2331222|P1|NOT COMPLETED|Randomization||3
963910|NCT00230971|2331221|P2|COMPLETED|Randomization||235
963911|NCT00230971|2331222|P1|COMPLETED|Randomization||232
963912|NCT00230971|2331221|P2|STARTED|Randomization||238
963913|NCT00230971|2331222|P1|STARTED|Randomization||235
963914|NCT00231062|2331234|P1|NOT COMPLETED|Overall Study||6
963915|NCT00231062|2331234|P1|COMPLETED|Overall Study||109
963916|NCT00231062|2331234|P1|STARTED|Overall Study||115
963917|NCT00231114|2331242|P2|NOT COMPLETED|Post-Treatment Period||1
963918|NCT00231114|2331243|P1|NOT COMPLETED|Post-Treatment Period||8
963919|NCT00231114|2331242|P2|COMPLETED|Post-Treatment Period||97
963920|NCT00231114|2331243|P1|COMPLETED|Post-Treatment Period||181
963921|NCT00231114|2331242|P2|STARTED|Post-Treatment Period||98
963922|NCT00231114|2331243|P1|STARTED|Post-Treatment Period||189
963923|NCT00231114|2331242|P2|NOT COMPLETED|Treatment Period||0
963924|NCT00231114|2331243|P1|NOT COMPLETED|Treatment Period||1
963925|NCT00231114|2331242|P2|COMPLETED|Treatment Period||98
963926|NCT00231114|2331243|P1|COMPLETED|Treatment Period||189
963927|NCT00231114|2331242|P2|STARTED|Treatment Period||98
963928|NCT00231114|2331243|P1|STARTED|Treatment Period||190
963929|NCT00231114|2331242|P2|NOT COMPLETED|Randomized||3
963930|NCT00231114|2331243|P1|NOT COMPLETED|Randomized||6
963931|NCT00231114|2331242|P2|COMPLETED|Randomized||98
963932|NCT00231114|2331243|P1|COMPLETED|Randomized||190
963933|NCT00231114|2331242|P2|STARTED|Randomized||101
963934|NCT00231114|2331243|P1|STARTED|Randomized||196
963935|NCT00231153|2331281|P2|NOT COMPLETED|Overall Study||188
963936|NCT00231153|2331282|P1|NOT COMPLETED|Overall Study||217
963937|NCT00231153|2331281|P2|COMPLETED|Overall Study||720
963938|NCT00231153|2331282|P1|COMPLETED|Overall Study||690
963939|NCT00231153|2331281|P2|STARTED|Overall Study|Subjects randomized to povidone-iodine who received at least one dose of study treatment.|908
963940|NCT00231153|2331282|P1|STARTED|Overall Study|Subjects randomized to omiganan 1% gel who received at least one dose of study treatment.|907
963941|NCT00231179|2331292|P2|NOT COMPLETED|Overall Study||24
963942|NCT00231179|2331293|P1|NOT COMPLETED|Overall Study||24
963943|NCT00231179|2331292|P2|COMPLETED|Overall Study|126 (93%) in the control group completed the five year follow-up visit.|126
963944|NCT00231179|2331293|P1|COMPLETED|Overall Study|128 (95%) in intervention group completed the five year follow-up visit.|128
963945|NCT00231179|2331292|P2|STARTED|Overall Study||150
963946|NCT00231179|2331293|P1|STARTED|Overall Study||152
963947|NCT00234494|2331307|P1|NOT COMPLETED|Overall Study||2
963948|NCT00234494|2331307|P1|COMPLETED|Overall Study||43
963949|NCT00234494|2331307|P1|STARTED|Overall Study||45
963950|NCT00234832|2331316|P2|NOT COMPLETED|Overall Study||996
963951|NCT00234832|2331317|P1|NOT COMPLETED|Overall Study||1016
963952|NCT00234832|2331316|P2|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3902
963953|NCT00234832|2331317|P1|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3890
963954|NCT00234832|2331316|P2|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4898
964047|NCT00235833|2331672|P1|COMPLETED|Overall Study||9
963955|NCT00234832|2331317|P1|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4906
963956|NCT00234884|2331342|P1|NOT COMPLETED|Overall Study||1630
963957|NCT00234884|2331342|P1|COMPLETED|Overall Study||1805
963958|NCT00234884|2331342|P1|STARTED|Overall Study||3435
963959|NCT00235326|2331352|P2|NOT COMPLETED|Overall Study||1400
963960|NCT00235326|2331353|P1|NOT COMPLETED|Overall Study||746
963961|NCT00235326|2331352|P2|COMPLETED|Overall Study||1586
963962|NCT00235326|2331353|P1|COMPLETED|Overall Study||829
963963|NCT00235326|2331352|P2|STARTED|Overall Study||2986
963964|NCT00235326|2331353|P1|STARTED|Overall Study||1575
963965|NCT00235391|2331363|P6|NOT COMPLETED|Overall Study||4
963966|NCT00235391|2331364|P5|NOT COMPLETED|Overall Study||12
963967|NCT00235391|2331365|P4|NOT COMPLETED|Overall Study||220
963968|NCT00235391|2331366|P3|NOT COMPLETED|Overall Study||24
963969|NCT00235391|2331367|P2|NOT COMPLETED|Overall Study||18
963970|NCT00235391|2331368|P1|NOT COMPLETED|Overall Study||12
963971|NCT00235391|2331363|P6|COMPLETED|Overall Study||3
963972|NCT00235391|2331364|P5|COMPLETED|Overall Study||31
963973|NCT00235391|2331365|P4|COMPLETED|Overall Study||944
963974|NCT00235391|2331366|P3|COMPLETED|Overall Study||148
963975|NCT00235391|2331367|P2|COMPLETED|Overall Study||182
963976|NCT00235391|2331368|P1|COMPLETED|Overall Study||85
963977|NCT00235391|2331363|P6|Deferasirox Treatment|Overall Study||7
963978|NCT00235391|2331364|P5|Deferasirox Treatment|Overall Study||43
963979|NCT00235391|2331365|P4|Deferasirox Treatment|Overall Study||1164
963980|NCT00235391|2331366|P3|Deferasirox Treatment|Overall Study||172
963981|NCT00235391|2331367|P2|Deferasirox Treatment|Overall Study||200
963982|NCT00235391|2331368|P1|Deferasirox Treatment|Overall Study||97
963983|NCT00235391|2331363|P6|STARTED|Overall Study||7
963984|NCT00235391|2331364|P5|STARTED|Overall Study||43
963985|NCT00235391|2331365|P4|STARTED|Overall Study||1164
963986|NCT00235391|2331366|P3|STARTED|Overall Study||172
963987|NCT00235391|2331367|P2|STARTED|Overall Study||200
963988|NCT00235391|2331368|P1|STARTED|Overall Study||97
963989|NCT00235443|2331389|P6|NOT COMPLETED|Overall Study||45
963990|NCT00235443|2331390|P5|NOT COMPLETED|Overall Study||30
963991|NCT00235443|2331391|P4|NOT COMPLETED|Overall Study||97
963992|NCT00235443|2331392|P3|NOT COMPLETED|Overall Study||62
963993|NCT00235443|2331393|P2|NOT COMPLETED|Overall Study||38
963994|NCT00235443|2331394|P1|NOT COMPLETED|Overall Study||8
963995|NCT00235443|2331389|P6|COMPLETED|Overall Study||9
963996|NCT00235443|2331390|P5|COMPLETED|Overall Study||9
963997|NCT00235443|2331391|P4|COMPLETED|Overall Study||108
963998|NCT00235443|2331392|P3|COMPLETED|Overall Study||23
963999|NCT00235443|2331393|P2|COMPLETED|Overall Study||19
964000|NCT00235443|2331394|P1|COMPLETED|Overall Study||3
964001|NCT00235443|2331389|P6|STARTED|Overall Study||54
964002|NCT00235443|2331390|P5|STARTED|Overall Study||39
964003|NCT00235443|2331391|P4|STARTED|Overall Study||205
964004|NCT00235443|2331392|P3|STARTED|Overall Study||85
964005|NCT00235443|2331393|P2|STARTED|Overall Study||57
964006|NCT00235443|2331394|P1|STARTED|Overall Study||11
964007|NCT00235456|2331531|P2|NOT COMPLETED|Overall Study||7
964008|NCT00235456|2331532|P1|NOT COMPLETED|Overall Study||2
964009|NCT00235456|2331531|P2|COMPLETED|Overall Study||143
964010|NCT00235456|2331532|P1|COMPLETED|Overall Study||148
964011|NCT00235456|2331531|P2|STARTED|Overall Study||150
964012|NCT00235456|2331532|P1|STARTED|Overall Study||150
964013|NCT00235573|2331548|P1|NOT COMPLETED|Overall Study||0
964014|NCT00235573|2331548|P1|COMPLETED|Overall Study||21
964015|NCT00235573|2331548|P1|STARTED|Overall Study|35 subjects screened; 14 not eligible; 21 started and completed study|21
964016|NCT00235716|2331556|P4|NOT COMPLETED|Overall Study||62
964017|NCT00235716|2331557|P3|NOT COMPLETED|Overall Study||65
964018|NCT00235716|2331558|P2|NOT COMPLETED|Overall Study||67
964019|NCT00235716|2331559|P1|NOT COMPLETED|Overall Study||62
964020|NCT00235716|2331556|P4|COMPLETED|Overall Study||90
964021|NCT00235716|2331557|P3|COMPLETED|Overall Study||89
964022|NCT00235716|2331558|P2|COMPLETED|Overall Study||88
964023|NCT00235716|2331559|P1|COMPLETED|Overall Study||90
964024|NCT00235716|2331556|P4|STARTED|Overall Study||152
964025|NCT00235716|2331557|P3|STARTED|Overall Study||154
964026|NCT00235716|2331558|P2|STARTED|Overall Study||155
964027|NCT00235716|2331559|P1|STARTED|Overall Study||152
964028|NCT00235755|2331596|P3|NOT COMPLETED|12-Week Maintenance Phase||31
964029|NCT00235755|2331597|P2|NOT COMPLETED|12-Week Maintenance Phase||27
964030|NCT00235755|2331598|P1|NOT COMPLETED|12-Week Maintenance Phase||16
964031|NCT00235755|2331596|P3|COMPLETED|12-Week Maintenance Phase||122
964032|NCT00235755|2331597|P2|COMPLETED|12-Week Maintenance Phase||135
964033|NCT00235755|2331598|P1|COMPLETED|12-Week Maintenance Phase||152
964034|NCT00235755|2331596|P3|STARTED|12-Week Maintenance Phase||153
964035|NCT00235755|2331597|P2|STARTED|12-Week Maintenance Phase||162
964036|NCT00235755|2331598|P1|STARTED|12-Week Maintenance Phase||168
964037|NCT00235755|2331596|P3|NOT COMPLETED|4-Week Titration Phase||26
964038|NCT00235755|2331597|P2|NOT COMPLETED|4-Week Titration Phase||19
964039|NCT00235755|2331598|P1|NOT COMPLETED|4-Week Titration Phase||11
964040|NCT00235755|2331596|P3|COMPLETED|4-Week Titration Phase||153
964041|NCT00235755|2331597|P2|COMPLETED|4-Week Titration Phase||162
964042|NCT00235755|2331598|P1|COMPLETED|4-Week Titration Phase||168
964043|NCT00235755|2331596|P3|STARTED|4-Week Titration Phase||179
964044|NCT00235755|2331597|P2|STARTED|4-Week Titration Phase||181
964045|NCT00235755|2331598|P1|STARTED|4-Week Titration Phase||179
964046|NCT00235833|2331672|P1|NOT COMPLETED|Overall Study||16
964048|NCT00235833|2331672|P1|STARTED|Overall Study||25
964049|NCT00235872|2331685|P1|NOT COMPLETED|Overall Study||147
964050|NCT00235872|2331685|P1|COMPLETED|Overall Study||162
964051|NCT00235872|2331685|P1|STARTED|Overall Study||309
964052|NCT00235989|2331704|P6|NOT COMPLETED|Extension Treatment Period (ET)||0
964053|NCT00235989|2331705|P5|NOT COMPLETED|Extension Treatment Period (ET)||0
964054|NCT00235989|2331706|P4|NOT COMPLETED|Extension Treatment Period (ET)||6
964055|NCT00235989|2331707|P3|NOT COMPLETED|Extension Treatment Period (ET)||5
964056|NCT00235989|2331708|P2|NOT COMPLETED|Extension Treatment Period (ET)||4
964057|NCT00235989|2331709|P1|NOT COMPLETED|Extension Treatment Period (ET)||8
964058|NCT00235989|2331704|P6|COMPLETED|Extension Treatment Period (ET)||0
964059|NCT00235989|2331705|P5|COMPLETED|Extension Treatment Period (ET)||0
964060|NCT00235989|2331706|P4|COMPLETED|Extension Treatment Period (ET)||14
964061|NCT00235989|2331707|P3|COMPLETED|Extension Treatment Period (ET)||14
964062|NCT00235989|2331708|P2|COMPLETED|Extension Treatment Period (ET)||2
964063|NCT00235989|2331709|P1|COMPLETED|Extension Treatment Period (ET)||8
964064|NCT00235989|2331704|P6|STARTED|Extension Treatment Period (ET)||0
964065|NCT00235989|2331705|P5|STARTED|Extension Treatment Period (ET)||0
964066|NCT00235989|2331706|P4|STARTED|Extension Treatment Period (ET)||20
964067|NCT00235989|2331707|P3|STARTED|Extension Treatment Period (ET)||19
964068|NCT00235989|2331708|P2|STARTED|Extension Treatment Period (ET)||6
964069|NCT00235989|2331709|P1|STARTED|Extension Treatment Period (ET)||16
964070|NCT00235989|2331704|P6|NOT COMPLETED|Core Treatment Period (CT)||2
964071|NCT00235989|2331705|P5|NOT COMPLETED|Core Treatment Period (CT)||0
964072|NCT00235989|2331706|P4|NOT COMPLETED|Core Treatment Period (CT)||0
964073|NCT00235989|2331707|P3|NOT COMPLETED|Core Treatment Period (CT)||0
964074|NCT00235989|2331708|P2|NOT COMPLETED|Core Treatment Period (CT)||0
964075|NCT00235989|2331709|P1|NOT COMPLETED|Core Treatment Period (CT)||0
964076|NCT00235989|2331704|P6|COMPLETED|Core Treatment Period (CT)||25
964077|NCT00235989|2331705|P5|COMPLETED|Core Treatment Period (CT)||36
964078|NCT00235989|2331706|P4|COMPLETED|Core Treatment Period (CT)||0
964079|NCT00235989|2331707|P3|COMPLETED|Core Treatment Period (CT)||0
964080|NCT00235989|2331708|P2|COMPLETED|Core Treatment Period (CT)||0
964081|NCT00235989|2331709|P1|COMPLETED|Core Treatment Period (CT)||0
964082|NCT00235989|2331704|P6|STARTED|Core Treatment Period (CT)||27
964083|NCT00235989|2331705|P5|STARTED|Core Treatment Period (CT)||36
964084|NCT00235989|2331706|P4|STARTED|Core Treatment Period (CT)||0
964085|NCT00235989|2331707|P3|STARTED|Core Treatment Period (CT)||0
964086|NCT00235989|2331708|P2|STARTED|Core Treatment Period (CT)||0
964087|NCT00235989|2331709|P1|STARTED|Core Treatment Period (CT)||0
964088|NCT00236080|2331728|P5|NOT COMPLETED|Overall Study||1
964089|NCT00236080|2331729|P4|NOT COMPLETED|Overall Study||2
964090|NCT00236080|2331730|P3|NOT COMPLETED|Overall Study||5
964091|NCT00236080|2331731|P2|NOT COMPLETED|Overall Study||1
964092|NCT00236080|2331732|P1|NOT COMPLETED|Overall Study||2
964093|NCT00236080|2331728|P5|COMPLETED|Overall Study||26
964094|NCT00236080|2331729|P4|COMPLETED|Overall Study||23
964095|NCT00236080|2331730|P3|COMPLETED|Overall Study||22
964096|NCT00236080|2331731|P2|COMPLETED|Overall Study||27
964097|NCT00236080|2331732|P1|COMPLETED|Overall Study||27
964098|NCT00236080|2331728|P5|STARTED|Overall Study||27
964099|NCT00236080|2331729|P4|STARTED|Overall Study||25
964100|NCT00236080|2331730|P3|STARTED|Overall Study||27
964101|NCT00236080|2331731|P2|STARTED|Overall Study||28
964102|NCT00236080|2331732|P1|STARTED|Overall Study||29
964103|NCT00236184|2331751|P2|NOT COMPLETED|Overall Study||11
964104|NCT00236184|2331752|P1|NOT COMPLETED|Overall Study||18
964105|NCT00236184|2331751|P2|COMPLETED|Overall Study||308
964106|NCT00236184|2331752|P1|COMPLETED|Overall Study||292
964107|NCT00236184|2331751|P2|STARTED|Overall Study||319
964108|NCT00236184|2331752|P1|STARTED|Overall Study||310
964109|NCT00236197|2331760|P2|NOT COMPLETED|Overall Study||14
964110|NCT00236197|2331761|P1|NOT COMPLETED|Overall Study||5
964111|NCT00236197|2331760|P2|COMPLETED|Overall Study||293
964112|NCT00236197|2331761|P1|COMPLETED|Overall Study||307
964113|NCT00236197|2331760|P2|STARTED|Overall Study||307
964114|NCT00236197|2331761|P1|STARTED|Overall Study||312
964115|NCT00236899|2331771|P4|NOT COMPLETED|Overall Study||40
964116|NCT00236899|2331772|P3|NOT COMPLETED|Overall Study||44
964117|NCT00236899|2331773|P2|NOT COMPLETED|Overall Study||40
964118|NCT00236899|2331774|P1|NOT COMPLETED|Overall Study||42
964119|NCT00236899|2331771|P4|COMPLETED|Overall Study||19
964120|NCT00236899|2331772|P3|COMPLETED|Overall Study||14
964121|NCT00236899|2331773|P2|COMPLETED|Overall Study||24
964122|NCT00236899|2331774|P1|COMPLETED|Overall Study||18
964123|NCT00236899|2331771|P4|STARTED|Overall Study||59
964124|NCT00236899|2331772|P3|STARTED|Overall Study||58
964125|NCT00236899|2331773|P2|STARTED|Overall Study||64
964126|NCT00236899|2331774|P1|STARTED|Overall Study||60
964127|NCT00236938|2331806|P2|NOT COMPLETED|Overall Study||20
964128|NCT00236938|2331807|P1|NOT COMPLETED|Overall Study||13
964129|NCT00236938|2331806|P2|COMPLETED|Overall Study||26
964130|NCT00236938|2331807|P1|COMPLETED|Overall Study||62
964131|NCT00236938|2331806|P2|STARTED|Overall Study||46
964132|NCT00236938|2331807|P1|STARTED|Overall Study||75
964133|NCT00236951|2331823|P4|NOT COMPLETED|Overall Study||31
964134|NCT00236951|2331824|P3|NOT COMPLETED|Overall Study||19
964135|NCT00236951|2331825|P2|NOT COMPLETED|Overall Study||31
964136|NCT00236951|2331826|P1|NOT COMPLETED|Overall Study||26
964137|NCT00236951|2331823|P4|COMPLETED|Overall Study||17
964138|NCT00236951|2331824|P3|COMPLETED|Overall Study||21
964139|NCT00236951|2331825|P2|COMPLETED|Overall Study||46
964140|NCT00236951|2331826|P1|COMPLETED|Overall Study||33
964141|NCT00236951|2331823|P4|STARTED|Overall Study||48
964142|NCT00236951|2331824|P3|STARTED|Overall Study||40
964143|NCT00236951|2331825|P2|STARTED|Overall Study||77
964144|NCT00236951|2331826|P1|STARTED|Overall Study||59
964145|NCT00236977|2331838|P2|NOT COMPLETED|Overall Study||19
964146|NCT00236977|2331839|P1|NOT COMPLETED|Overall Study||21
964147|NCT00236977|2331838|P2|COMPLETED|Overall Study||72
964148|NCT00236977|2331839|P1|COMPLETED|Overall Study||70
964149|NCT00236977|2331838|P2|STARTED|Overall Study||91
964150|NCT00236977|2331839|P1|STARTED|Overall Study||91
964151|NCT00237042|2331860|P3|NOT COMPLETED|Long Term (12 Month) Follow up||9
964152|NCT00237042|2331861|P2|NOT COMPLETED|Long Term (12 Month) Follow up||9
964153|NCT00237042|2331862|P1|NOT COMPLETED|Long Term (12 Month) Follow up||11
964154|NCT00237042|2331860|P3|COMPLETED|Long Term (12 Month) Follow up||48
964155|NCT00237042|2331861|P2|COMPLETED|Long Term (12 Month) Follow up||46
964156|NCT00237042|2331862|P1|COMPLETED|Long Term (12 Month) Follow up||48
964157|NCT00237042|2331860|P3|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
964158|NCT00237042|2331861|P2|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
964159|NCT00237042|2331862|P1|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
964160|NCT00237042|2331860|P3|NOT COMPLETED|Short Term (6 Month) Follow up||11
964161|NCT00237042|2331861|P2|NOT COMPLETED|Short Term (6 Month) Follow up||8
964162|NCT00237042|2331862|P1|NOT COMPLETED|Short Term (6 Month) Follow up||9
964163|NCT00237042|2331860|P3|COMPLETED|Short Term (6 Month) Follow up||46
964164|NCT00237042|2331861|P2|COMPLETED|Short Term (6 Month) Follow up||47
964165|NCT00237042|2331862|P1|COMPLETED|Short Term (6 Month) Follow up||50
964166|NCT00237042|2331860|P3|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
964167|NCT00237042|2331861|P2|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
964168|NCT00237042|2331862|P1|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
964169|NCT00237042|2331860|P3|NOT COMPLETED|Treatment||38
964170|NCT00237042|2331861|P2|NOT COMPLETED|Treatment||7
964171|NCT00237042|2331862|P1|NOT COMPLETED|Treatment||6
964172|NCT00237042|2331860|P3|COMPLETED|Treatment||36
964173|NCT00237042|2331861|P2|COMPLETED|Treatment||50
964174|NCT00237042|2331862|P1|COMPLETED|Treatment||54
964175|NCT00237042|2331860|P3|STARTED|Treatment||74
964176|NCT00237042|2331861|P2|STARTED|Treatment||57
964177|NCT00237042|2331862|P1|STARTED|Treatment||60
964178|NCT00237185|2331881|P2|NOT COMPLETED|Extension||19
964179|NCT00237185|2331882|P1|NOT COMPLETED|Extension||16
964180|NCT00237185|2331881|P2|COMPLETED|Extension||13
964181|NCT00237185|2331882|P1|COMPLETED|Extension||8
964182|NCT00237185|2331881|P2|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|32
964183|NCT00237185|2331882|P1|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|24
964184|NCT00237185|2331881|P2|NOT COMPLETED|Core||37
964185|NCT00237185|2331882|P1|NOT COMPLETED|Core||44
964186|NCT00237185|2331881|P2|COMPLETED|Core||37
964187|NCT00237185|2331882|P1|COMPLETED|Core||30
964188|NCT00237185|2331881|P2|Treated Participants|Core||74
964189|NCT00237185|2331882|P1|Treated Participants|Core||73
964190|NCT00237185|2331881|P2|STARTED|Core||74
964191|NCT00237185|2331882|P1|STARTED|Core||74
964192|NCT00237458|2331910|P1|NOT COMPLETED|Overall Study||3
964193|NCT00237458|2331910|P1|COMPLETED|Overall Study||4
964194|NCT00237458|2331910|P1|STARTED|Overall Study||7
964195|NCT00237666|2331926|P1|NOT COMPLETED|Overall Study||6
964196|NCT00237666|2331926|P1|COMPLETED|Overall Study||24
964197|NCT00237666|2331926|P1|STARTED|Overall Study||30
964198|NCT00237692|2331940|P4|NOT COMPLETED|Overall Study||19
964199|NCT00237692|2331941|P3|NOT COMPLETED|Overall Study||22
964200|NCT00237692|2331942|P2|NOT COMPLETED|Overall Study||14
964201|NCT00237692|2331943|P1|NOT COMPLETED|Overall Study||18
964202|NCT00237692|2331940|P4|COMPLETED|Overall Study||128
964203|NCT00237692|2331941|P3|COMPLETED|Overall Study||127
964204|NCT00237692|2331942|P2|COMPLETED|Overall Study||134
964205|NCT00237692|2331943|P1|COMPLETED|Overall Study||129
964206|NCT00237692|2331940|P4|18 Month f/u|Overall Study||122
964207|NCT00237692|2331941|P3|18 Month f/u|Overall Study||126
964208|NCT00237692|2331942|P2|18 Month f/u|Overall Study||131
964209|NCT00237692|2331943|P1|18 Month f/u|Overall Study||124
964210|NCT00237692|2331940|P4|12 Month f/u|Overall Study||127
964211|NCT00237692|2331941|P3|12 Month f/u|Overall Study||132
964212|NCT00237692|2331942|P2|12 Month f/u|Overall Study||127
964213|NCT00237692|2331943|P1|12 Month f/u|Overall Study||137
964214|NCT00237692|2331940|P4|6 Month f/u|Overall Study||134
964215|NCT00237692|2331941|P3|6 Month f/u|Overall Study||135
964216|NCT00237692|2331942|P2|6 Month f/u|Overall Study||134
964217|NCT00237692|2331943|P1|6 Month f/u|Overall Study||132
964218|NCT00237692|2331940|P4|STARTED|Overall Study||147
964219|NCT00237692|2331941|P3|STARTED|Overall Study||149
964220|NCT00237692|2331942|P2|STARTED|Overall Study||148
964221|NCT00237692|2331943|P1|STARTED|Overall Study||147
964222|NCT00237718|2331975|P2|NOT COMPLETED|Overall Study||41
964223|NCT00237718|2331976|P1|NOT COMPLETED|Overall Study||46
964224|NCT00237718|2331975|P2|COMPLETED|Overall Study||124
964225|NCT00237718|2331976|P1|COMPLETED|Overall Study||114
964226|NCT00237718|2331975|P2|STARTED|Overall Study||165
964227|NCT00237718|2331976|P1|STARTED|Overall Study||160
964228|NCT00237744|2331987|P3|NOT COMPLETED|Overall Study||0
964229|NCT00237744|2331988|P2|NOT COMPLETED|Overall Study||1
964230|NCT00237744|2331989|P1|NOT COMPLETED|Overall Study||3
964231|NCT00237744|2331987|P3|COMPLETED|Overall Study||18
964232|NCT00237744|2331988|P2|COMPLETED|Overall Study||10
964233|NCT00237744|2331989|P1|COMPLETED|Overall Study||8
964234|NCT00237744|2331987|P3|STARTED|Overall Study||18
964235|NCT00237744|2331988|P2|STARTED|Overall Study||11
964236|NCT00237744|2331989|P1|STARTED|Overall Study||11
964237|NCT00237770|2332002|P2|NOT COMPLETED|Overall Study||0
964238|NCT00237770|2332003|P1|NOT COMPLETED|Overall Study||0
964239|NCT00237770|2332002|P2|COMPLETED|Overall Study||7
964240|NCT00237770|2332003|P1|COMPLETED|Overall Study||9
964241|NCT00237770|2332002|P2|STARTED|Overall Study||7
964242|NCT00237770|2332003|P1|STARTED|Overall Study||9
964243|NCT00237796|2332015|P2|NOT COMPLETED|Overall Study||5
964244|NCT00237796|2332016|P1|NOT COMPLETED|Overall Study||10
964245|NCT00237796|2332015|P2|COMPLETED|Overall Study||33
964246|NCT00237796|2332016|P1|COMPLETED|Overall Study||31
964247|NCT00237796|2332015|P2|STARTED|Overall Study||38
964248|NCT00237796|2332016|P1|STARTED|Overall Study||41
964249|NCT00237809|2332038|P4|NOT COMPLETED|Overall Study||9
964250|NCT00237809|2332039|P3|NOT COMPLETED|Overall Study||9
964251|NCT00237809|2332040|P2|NOT COMPLETED|Overall Study||10
964252|NCT00237809|2332041|P1|NOT COMPLETED|Overall Study||11
964253|NCT00237809|2332038|P4|COMPLETED|Overall Study||17
964254|NCT00237809|2332039|P3|COMPLETED|Overall Study||15
964255|NCT00237809|2332040|P2|COMPLETED|Overall Study||17
964256|NCT00237809|2332041|P1|COMPLETED|Overall Study||16
964257|NCT00237809|2332038|P4|STARTED|Overall Study||26
964258|NCT00237809|2332039|P3|STARTED|Overall Study||24
964259|NCT00237809|2332040|P2|STARTED|Overall Study||27
964260|NCT00237809|2332041|P1|STARTED|Overall Study||27
964261|NCT00238108|2332077|P2|NOT COMPLETED|Overall Study||0
964262|NCT00238108|2332078|P1|NOT COMPLETED|Overall Study||0
964263|NCT00238108|2332077|P2|COMPLETED|Overall Study||8
964264|NCT00238108|2332078|P1|COMPLETED|Overall Study||8
964265|NCT00238108|2332077|P2|STARTED|Overall Study||8
964266|NCT00238108|2332078|P1|STARTED|Overall Study||8
964267|NCT00238121|2332086|P2|NOT COMPLETED|Overall Study||2
964268|NCT00238121|2332087|P1|NOT COMPLETED|Overall Study||3
964269|NCT00238121|2332086|P2|COMPLETED|Overall Study||14
964270|NCT00238121|2332087|P1|COMPLETED|Overall Study||37
964271|NCT00238121|2332086|P2|STARTED|Overall Study||16
964272|NCT00238121|2332087|P1|STARTED|Overall Study||40
964273|NCT00238238|2332101|P3|NOT COMPLETED|Overall Study||0
964274|NCT00238238|2332102|P2|NOT COMPLETED|Overall Study||3
964275|NCT00238238|2332103|P1|NOT COMPLETED|Overall Study||0
964276|NCT00238238|2332101|P3|COMPLETED|Overall Study||46
964277|NCT00238238|2332102|P2|COMPLETED|Overall Study||45
964278|NCT00238238|2332103|P1|COMPLETED|Overall Study||3
964279|NCT00238238|2332101|P3|STARTED|Overall Study||46
964280|NCT00238238|2332102|P2|STARTED|Overall Study||48
964281|NCT00238238|2332103|P1|STARTED|Overall Study||3
964282|NCT00238264|2332114|P1|NOT COMPLETED|Overall Study||36
964283|NCT00238264|2332114|P1|COMPLETED|Overall Study||56
964284|NCT00238264|2332114|P1|STARTED|Overall Study||92
964285|NCT00238303|2332127|P3|NOT COMPLETED|Overall Study||9
964286|NCT00238303|2332128|P2|NOT COMPLETED|Overall Study||2
964287|NCT00238303|2332129|P1|NOT COMPLETED|Overall Study||15
964288|NCT00238303|2332127|P3|COMPLETED|Overall Study||11
964289|NCT00238303|2332128|P2|COMPLETED|Overall Study||13
964290|NCT00238303|2332129|P1|COMPLETED|Overall Study||53
964291|NCT00238303|2332127|P3|STARTED|Overall Study||20
964292|NCT00238303|2332128|P2|STARTED|Overall Study||15
964293|NCT00238303|2332129|P1|STARTED|Overall Study||68
964294|NCT00238355|2332146|P1|NOT COMPLETED|Overall Study||3
964295|NCT00238355|2332146|P1|COMPLETED|Overall Study||10
964296|NCT00238355|2332146|P1|STARTED|Overall Study||13
964297|NCT00238420|2332152|P2|NOT COMPLETED|Overall Study||1
964298|NCT00238420|2332153|P1|NOT COMPLETED|Overall Study||1
964299|NCT00238420|2332152|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
964300|NCT00238420|2332153|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|21
964301|NCT00238420|2332152|P2|STARTED|Overall Study||48
964302|NCT00238420|2332153|P1|STARTED|Overall Study||22
964306|NCT00238615|2332168|P1|NOT COMPLETED|Overall Study||0
964307|NCT00238615|2332168|P1|COMPLETED|Overall Study||13
964308|NCT00238615|2332168|P1|STARTED|Overall Study||13
964309|NCT00239005|2332176|P2|NOT COMPLETED|Overall Study||12
964310|NCT00239005|2332177|P1|NOT COMPLETED|Overall Study||12
964311|NCT00239005|2332176|P2|COMPLETED|Overall Study||53
964312|NCT00239005|2332177|P1|COMPLETED|Overall Study||57
964313|NCT00239005|2332176|P2|Intention-to-treat Population (ITT)|Overall Study||61
964314|NCT00239005|2332177|P1|Intention-to-treat Population (ITT)|Overall Study||68
964315|NCT00239005|2332176|P2|STARTED|Overall Study||65
964316|NCT00239005|2332177|P1|STARTED|Overall Study||69
964317|NCT00239226|2332191|P4|NOT COMPLETED|Overall Study||3
964318|NCT00239226|2332192|P3|NOT COMPLETED|Overall Study||1
964319|NCT00239226|2332193|P2|NOT COMPLETED|Overall Study||0
964320|NCT00239226|2332194|P1|NOT COMPLETED|Overall Study||1
964321|NCT00239226|2332191|P4|COMPLETED|Overall Study||14
964322|NCT00239226|2332192|P3|COMPLETED|Overall Study||36
964323|NCT00239226|2332193|P2|COMPLETED|Overall Study||18
964324|NCT00239226|2332194|P1|COMPLETED|Overall Study||29
964325|NCT00239226|2332191|P4|STARTED|Overall Study||17
964326|NCT00239226|2332192|P3|STARTED|Overall Study||37
964327|NCT00239226|2332193|P2|STARTED|Overall Study||18
964328|NCT00239226|2332194|P1|STARTED|Overall Study||30
964329|NCT00239356|2332206|P2|NOT COMPLETED|Overall Study||9
964330|NCT00239356|2332207|P1|NOT COMPLETED|Overall Study||39
964331|NCT00239356|2332206|P2|COMPLETED|Overall Study||11
964332|NCT00239356|2332207|P1|COMPLETED|Overall Study||58
964333|NCT00239356|2332206|P2|STARTED|Overall Study||20
964334|NCT00239356|2332207|P1|STARTED|Overall Study||97
964335|NCT00239642|2332228|P3|NOT COMPLETED|Overall Study||2
964336|NCT00239642|2332229|P2|NOT COMPLETED|Overall Study||0
964337|NCT00239642|2332230|P1|NOT COMPLETED|Overall Study||2
964338|NCT00239642|2332228|P3|COMPLETED|Overall Study||47
964339|NCT00239642|2332229|P2|COMPLETED|Overall Study||47
964340|NCT00239642|2332230|P1|COMPLETED|Overall Study||47
964341|NCT00239642|2332228|P3|STARTED|Overall Study||49
964342|NCT00239642|2332229|P2|STARTED|Overall Study||47
964343|NCT00239642|2332230|P1|STARTED|Overall Study||49
964344|NCT00239681|2332264|P2|NOT COMPLETED|Overall Study||715
964345|NCT00239681|2332265|P1|NOT COMPLETED|Overall Study||693
964346|NCT00239681|2332264|P2|COMPLETED|Overall Study||8186
964347|NCT00239681|2332265|P1|COMPLETED|Overall Study||8208
964348|NCT00239681|2332264|P2|Randomized and Treated (Safety Pop)|Overall Study||8864
964349|NCT00239681|2332265|P1|Randomized and Treated (Safety Pop)|Overall Study||8869
964350|NCT00239681|2332264|P2|STARTED|Overall Study||8901
964351|NCT00239681|2332265|P1|STARTED|Overall Study||8901
964352|NCT00239720|2332283|P2|NOT COMPLETED|Overall Study||1
964353|NCT00239720|2332284|P1|NOT COMPLETED|Overall Study||1
964354|NCT00239720|2332283|P2|COMPLETED|Overall Study|One participant lost to follow-up|0
964355|NCT00239720|2332284|P1|COMPLETED|Overall Study|One participant discontinued due to an adverse event|2
964356|NCT00239720|2332283|P2|STARTED|Overall Study||1
964357|NCT00239720|2332284|P1|STARTED|Overall Study||3
964358|NCT00239733|2332290|P1|NOT COMPLETED|Overall Study||0
964359|NCT00239733|2332290|P1|COMPLETED|Overall Study||6
964360|NCT00239733|2332290|P1|STARTED|Overall Study||6
964361|NCT00239837|2332297|P2|NOT COMPLETED|Overall Study||7
964362|NCT00239837|2332298|P1|NOT COMPLETED|Overall Study||3
964363|NCT00239837|2332297|P2|COMPLETED|Overall Study|3-year follow-up|45
964364|NCT00239837|2332298|P1|COMPLETED|Overall Study|3-year follow-up|45
964365|NCT00239837|2332297|P2|6 Months|Overall Study||50
964366|NCT00239837|2332298|P1|6 Months|Overall Study||48
964367|NCT00239837|2332297|P2|STARTED|Overall Study||52
964368|NCT00239837|2332298|P1|STARTED|Overall Study||48
964369|NCT00232141|2332320|P2|NOT COMPLETED|Overall Study||26
964370|NCT00232141|2332321|P1|NOT COMPLETED|Overall Study||31
964371|NCT00232141|2332320|P2|COMPLETED|Overall Study||125
964372|NCT00232141|2332321|P1|COMPLETED|Overall Study||120
964373|NCT00232141|2332320|P2|STARTED|Overall Study||151
964374|NCT00232141|2332321|P1|STARTED|Overall Study||151
964375|NCT00232180|2332391|P3|NOT COMPLETED|Open Label Phase||148
964376|NCT00232180|2332392|P2|NOT COMPLETED|Open Label Phase||0
964377|NCT00232180|2332393|P1|NOT COMPLETED|Open Label Phase||0
964378|NCT00232180|2332391|P3|COMPLETED|Open Label Phase||1098
964379|NCT00232180|2332392|P2|COMPLETED|Open Label Phase||0
964380|NCT00232180|2332393|P1|COMPLETED|Open Label Phase||0
964381|NCT00232180|2332391|P3|Treated|Open Label Phase||1245
964382|NCT00232180|2332392|P2|Treated|Open Label Phase||0
964383|NCT00232180|2332393|P1|Treated|Open Label Phase||0
964384|NCT00232180|2332391|P3|STARTED|Open Label Phase||1246
964385|NCT00232180|2332392|P2|STARTED|Open Label Phase||0
964386|NCT00232180|2332393|P1|STARTED|Open Label Phase||0
964387|NCT00232180|2332391|P3|NOT COMPLETED|Double-blind (DB) Phase||0
964388|NCT00232180|2332392|P2|NOT COMPLETED|Double-blind (DB) Phase||605
964389|NCT00232180|2332393|P1|NOT COMPLETED|Double-blind (DB) Phase||541
964390|NCT00232180|2332391|P3|COMPLETED|Double-blind (DB) Phase||0
964391|NCT00232180|2332392|P2|COMPLETED|Double-blind (DB) Phase||771
964392|NCT00232180|2332393|P1|COMPLETED|Double-blind (DB) Phase||826
964393|NCT00232180|2332391|P3|Treated|Double-blind (DB) Phase||0
964394|NCT00232180|2332392|P2|Treated|Double-blind (DB) Phase||1372
964395|NCT00232180|2332393|P1|Treated|Double-blind (DB) Phase||1364
964396|NCT00232180|2332391|P3|STARTED|Double-blind (DB) Phase||0
964397|NCT00232180|2332392|P2|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1376
964398|NCT00232180|2332393|P1|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1367
964399|NCT00232479|2332436|P1|NOT COMPLETED|Overall Study||0
964400|NCT00232479|2332436|P1|COMPLETED|Overall Study||44
964401|NCT00232479|2332436|P1|STARTED|Overall Study||44
964402|NCT00232505|2332443|P2|NOT COMPLETED|Overall Study||11
964403|NCT00232505|2332444|P1|NOT COMPLETED|Overall Study||5
964404|NCT00232505|2332443|P2|COMPLETED|Overall Study||60
964405|NCT00232505|2332444|P1|COMPLETED|Overall Study||26
964406|NCT00232505|2332443|P2|Off Protocol|Overall Study||0
964407|NCT00232505|2332444|P1|Off Protocol|Overall Study||5
964408|NCT00232505|2332443|P2|Early Progressors|Overall Study||5
964409|NCT00232505|2332444|P1|Early Progressors|Overall Study||2
964410|NCT00232505|2332443|P2|Not Evaluable|Overall Study||6
964411|NCT00232505|2332444|P1|Not Evaluable|Overall Study||0
964412|NCT00232505|2332443|P2|STARTED|Overall Study||71
964413|NCT00232505|2332444|P1|STARTED|Overall Study||31
964414|NCT00232544|2332459|P2|NOT COMPLETED|Overall Study||15
964415|NCT00232544|2332460|P1|NOT COMPLETED|Overall Study||20
964416|NCT00232544|2332459|P2|COMPLETED|Overall Study||111
964417|NCT00232544|2332460|P1|COMPLETED|Overall Study||104
964418|NCT00232544|2332459|P2|STARTED|Overall Study||126
964419|NCT00232544|2332460|P1|STARTED|Overall Study||124
964420|NCT00232557|2332470|P2|NOT COMPLETED|Overall Study||5
964421|NCT00232557|2332471|P1|NOT COMPLETED|Overall Study||3
964422|NCT00232557|2332470|P2|COMPLETED|Overall Study||60
964423|NCT00232557|2332471|P1|COMPLETED|Overall Study||68
964424|NCT00232557|2332470|P2|STARTED|Overall Study||65
964425|NCT00232557|2332471|P1|STARTED|Overall Study||71
964426|NCT00232583|2332481|P2|NOT COMPLETED|Overall Study||13
964427|NCT00232583|2332482|P1|NOT COMPLETED|Overall Study||10
964428|NCT00232583|2332481|P2|COMPLETED|Overall Study||16
964429|NCT00232583|2332482|P1|COMPLETED|Overall Study||19
964430|NCT00232583|2332481|P2|STARTED|Overall Study||29
964431|NCT00232583|2332482|P1|STARTED|Overall Study||29
964432|NCT00232596|2332490|P2|NOT COMPLETED|12-Week Maintenance Phase||28
964433|NCT00232596|2332491|P1|NOT COMPLETED|12-Week Maintenance Phase||12
964434|NCT00232596|2332490|P2|COMPLETED|12-Week Maintenance Phase||97
964435|NCT00232596|2332491|P1|COMPLETED|12-Week Maintenance Phase|One participant withdrew after being considered a “completer” and is listed as an early withdraw.|126
964436|NCT00232596|2332490|P2|STARTED|12-Week Maintenance Phase||125
964437|NCT00232596|2332491|P1|STARTED|12-Week Maintenance Phase||138
964438|NCT00232596|2332490|P2|NOT COMPLETED|6-Week Titration Phase||29
964439|NCT00232596|2332491|P1|NOT COMPLETED|6-Week Titration Phase||14
964440|NCT00232596|2332490|P2|COMPLETED|6-Week Titration Phase||125
964441|NCT00232596|2332491|P1|COMPLETED|6-Week Titration Phase||138
964442|NCT00232596|2332490|P2|STARTED|6-Week Titration Phase||154
964443|NCT00232596|2332491|P1|STARTED|6-Week Titration Phase||152
964444|NCT00232739|2332541|P1|NOT COMPLETED|Overall Study||9
964445|NCT00232739|2332541|P1|COMPLETED|Overall Study||91
964446|NCT00232739|2332541|P1|STARTED|Overall Study||100
964447|NCT00233064|2332560|P2|NOT COMPLETED|Overall Study||12
964448|NCT00233064|2332561|P1|NOT COMPLETED|Overall Study||14
964449|NCT00233064|2332560|P2|COMPLETED|Overall Study||190
964450|NCT00233064|2332561|P1|COMPLETED|Overall Study||197
964451|NCT00233064|2332560|P2|STARTED|Overall Study||202
964452|NCT00233064|2332561|P1|STARTED|Overall Study||211
964453|NCT00233090|2332570|P2|NOT COMPLETED|Overall Study||0
964454|NCT00233090|2332571|P1|NOT COMPLETED|Overall Study||0
964455|NCT00233090|2332570|P2|COMPLETED|Overall Study||9
964456|NCT00233090|2332571|P1|COMPLETED|Overall Study||12
964457|NCT00233090|2332570|P2|STARTED|Overall Study||9
964458|NCT00233090|2332571|P1|STARTED|Overall Study||12
964459|NCT00233103|2332593|P2|NOT COMPLETED|Overall Study||6
964460|NCT00233103|2332594|P1|NOT COMPLETED|Overall Study||5
964461|NCT00233103|2332593|P2|COMPLETED|Overall Study||19
964462|NCT00233103|2332594|P1|COMPLETED|Overall Study||22
964463|NCT00233103|2332593|P2|STARTED|Overall Study||25
964464|NCT00233103|2332594|P1|STARTED|Overall Study||27
964489|NCT00233402|2332629|P2|NOT COMPLETED|Overall Study||124
964490|NCT00233402|2332630|P1|NOT COMPLETED|Overall Study||104
964491|NCT00233402|2332629|P2|COMPLETED|Overall Study||271
964492|NCT00233402|2332630|P1|COMPLETED|Overall Study||280
964493|NCT00233402|2332629|P2|STARTED|Overall Study||395
964494|NCT00233402|2332630|P1|STARTED|Overall Study||384
964495|NCT00233454|2332641|P1|NOT COMPLETED|Overall Study||6
964496|NCT00233454|2332641|P1|COMPLETED|Overall Study||20
964497|NCT00233454|2332641|P1|2 Months (for Response Rate)|Overall Study||26
964498|NCT00233454|2332641|P1|STARTED|Overall Study||26
964499|NCT00233519|2332648|P2|NOT COMPLETED|Overall Study||1
964500|NCT00233519|2332649|P1|NOT COMPLETED|Overall Study||1
964501|NCT00233519|2332648|P2|COMPLETED|Overall Study||9
964502|NCT00233519|2332649|P1|COMPLETED|Overall Study||6
964503|NCT00233519|2332648|P2|STARTED|Overall Study||10
964504|NCT00233519|2332649|P1|STARTED|Overall Study||7
964505|NCT00233948|2332657|P6|NOT COMPLETED|Overall Study||0
964506|NCT00233948|2332658|P5|NOT COMPLETED|Overall Study||0
964507|NCT00233948|2332659|P4|NOT COMPLETED|Overall Study||0
964508|NCT00233948|2332660|P3|NOT COMPLETED|Overall Study||0
964509|NCT00233948|2332661|P2|NOT COMPLETED|Overall Study||0
964510|NCT00233948|2332662|P1|NOT COMPLETED|Overall Study||1
964511|NCT00233948|2332657|P6|COMPLETED|Overall Study||12
964512|NCT00233948|2332658|P5|COMPLETED|Overall Study||4
964513|NCT00233948|2332659|P4|COMPLETED|Overall Study||3
964514|NCT00233948|2332660|P3|COMPLETED|Overall Study||3
964515|NCT00233948|2332661|P2|COMPLETED|Overall Study||3
964516|NCT00233948|2332662|P1|COMPLETED|Overall Study||3
964517|NCT00233948|2332657|P6|STARTED|Overall Study||12
964518|NCT00233948|2332658|P5|STARTED|Overall Study||4
964519|NCT00233948|2332659|P4|STARTED|Overall Study||3
964520|NCT00233948|2332660|P3|STARTED|Overall Study||3
964521|NCT00233948|2332661|P2|STARTED|Overall Study||3
964522|NCT00233948|2332662|P1|STARTED|Overall Study||4
964523|NCT00233987|2332677|P1|NOT COMPLETED|Overall Study||15
964524|NCT00233987|2332677|P1|COMPLETED|Overall Study||83
964525|NCT00233987|2332677|P1|Eligible and Treated|Overall Study||92
964526|NCT00233987|2332677|P1|Eligible|Overall Study||94
964527|NCT00233987|2332677|P1|STARTED|Overall Study||98
964528|NCT00234039|2332684|P1|NOT COMPLETED|Overall Study||50
964529|NCT00234039|2332684|P1|COMPLETED|Overall Study||8
964530|NCT00234039|2332684|P1|Eligible and Began Protocol Therapy|Overall Study||47
964531|NCT00234039|2332684|P1|Eligible|Overall Study||49
964532|NCT00234039|2332684|P1|STARTED|Overall Study||58
964533|NCT00234065|2332693|P2|NOT COMPLETED|Overall Study||356
964534|NCT00234065|2332694|P1|NOT COMPLETED|Overall Study||475
964535|NCT00234065|2332693|P2|COMPLETED|Overall Study||1004
964536|NCT00234065|2332694|P1|COMPLETED|Overall Study||881
964537|NCT00234065|2332693|P2|STARTED|Overall Study||1360
964538|NCT00234065|2332694|P1|STARTED|Overall Study||1356
964539|NCT00234078|2332714|P4|NOT COMPLETED|Overall Study||4
964540|NCT00234078|2332715|P3|NOT COMPLETED|Overall Study||10
964541|NCT00234078|2332716|P2|NOT COMPLETED|Overall Study||9
964542|NCT00234078|2332717|P1|NOT COMPLETED|Overall Study||6
964543|NCT00234078|2332714|P4|COMPLETED|Overall Study||68
964544|NCT00234078|2332715|P3|COMPLETED|Overall Study||64
964545|NCT00234078|2332716|P2|COMPLETED|Overall Study||63
964546|NCT00234078|2332717|P1|COMPLETED|Overall Study||66
964547|NCT00234078|2332714|P4|STARTED|Overall Study||72
964548|NCT00234078|2332715|P3|STARTED|Overall Study||74
964549|NCT00234078|2332716|P2|STARTED|Overall Study||72
964550|NCT00234078|2332717|P1|STARTED|Overall Study||72
964551|NCT00234104|2332743|P4|NOT COMPLETED|Overall Study||8
964552|NCT00234104|2332744|P3|NOT COMPLETED|Overall Study||5
964553|NCT00234104|2332745|P2|NOT COMPLETED|Overall Study||1
964554|NCT00234104|2332746|P1|NOT COMPLETED|Overall Study||4
964555|NCT00234104|2332743|P4|COMPLETED|Overall Study||21
964556|NCT00234104|2332744|P3|COMPLETED|Overall Study||29
964557|NCT00234104|2332745|P2|COMPLETED|Overall Study||28
964558|NCT00234104|2332746|P1|COMPLETED|Overall Study||26
964559|NCT00234104|2332743|P4|STARTED|Overall Study||29
964560|NCT00234104|2332744|P3|STARTED|Overall Study||34
964561|NCT00234104|2332745|P2|STARTED|Overall Study||29
964562|NCT00234104|2332746|P1|STARTED|Overall Study||30
964563|NCT00234286|2332756|P1|NOT COMPLETED|Overall Study||0
964564|NCT00234286|2332756|P1|COMPLETED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
964565|NCT00234286|2332756|P1|STARTED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
964566|NCT00239928|2332791|P1|NOT COMPLETED|Overall Study||10
964567|NCT00239928|2332791|P1|COMPLETED|Overall Study||51
964568|NCT00239928|2332791|P1|STARTED|Overall Study||61
964569|NCT00240071|2332801|P1|NOT COMPLETED|Overall Study||3
964570|NCT00240071|2332801|P1|COMPLETED|Overall Study|3 patients withdrew consent after 29, 5 and 3 1/2 months on study.|27
964571|NCT00240071|2332801|P1|STARTED|Overall Study||30
964572|NCT00240097|2332805|P1|NOT COMPLETED|Part II||23
964573|NCT00240097|2332805|P1|COMPLETED|Part II||3
964574|NCT00240097|2332805|P1|STARTED|Part II||26
964575|NCT00240097|2332805|P1|NOT COMPLETED|Part I||4
964576|NCT00240097|2332805|P1|COMPLETED|Part I||26
964577|NCT00240097|2332805|P1|STARTED|Part I||30
964578|NCT00240110|2332817|P2|NOT COMPLETED|Overall Study||7
964579|NCT00240110|2332818|P1|NOT COMPLETED|Overall Study||6
964580|NCT00240110|2332817|P2|COMPLETED|Overall Study||6
964581|NCT00240110|2332818|P1|COMPLETED|Overall Study||7
964582|NCT00240110|2332817|P2|STARTED|Overall Study||13
964583|NCT00240110|2332818|P1|STARTED|Overall Study||13
964584|NCT00240162|2332826|P1|NOT COMPLETED|Overall Study||0
964585|NCT00240162|2332826|P1|COMPLETED|Overall Study||21
964586|NCT00240162|2332826|P1|STARTED|Overall Study||21
964587|NCT00240227|2332833|P1|NOT COMPLETED|Overall Study||0
964588|NCT00240227|2332833|P1|COMPLETED|Overall Study||8
964589|NCT00240227|2332833|P1|STARTED|Overall Study||8
964853|NCT00231816|2333396|P1|NOT COMPLETED|Overall Study||16
964596|NCT00241904|2332856|P2|NOT COMPLETED|Overall Study||24
964597|NCT00241904|2332857|P1|NOT COMPLETED|Overall Study||34
964598|NCT00241904|2332856|P2|COMPLETED|Overall Study||240
964599|NCT00241904|2332857|P1|COMPLETED|Overall Study||227
964600|NCT00241904|2332856|P2|STARTED|Overall Study||264
964601|NCT00241904|2332857|P1|STARTED|Overall Study||261
964602|NCT00242216|2332871|P2|NOT COMPLETED|Overall Study||22
964603|NCT00242216|2332872|P1|NOT COMPLETED|Overall Study||18
964604|NCT00242216|2332871|P2|COMPLETED|Overall Study||15
964605|NCT00242216|2332872|P1|COMPLETED|Overall Study||21
964606|NCT00242216|2332871|P2|STARTED|Overall Study||37
964607|NCT00242216|2332872|P1|STARTED|Overall Study||39
964608|NCT00242385|2332880|P2|NOT COMPLETED|Period 2||0
964609|NCT00242385|2332881|P1|NOT COMPLETED|Period 2||0
964610|NCT00242385|2332880|P2|COMPLETED|Period 2||11
964611|NCT00242385|2332881|P1|COMPLETED|Period 2||14
964612|NCT00242385|2332880|P2|STARTED|Period 2||11
964613|NCT00242385|2332881|P1|STARTED|Period 2||14
964614|NCT00242385|2332880|P2|NOT COMPLETED|Period 1||0
964615|NCT00242385|2332881|P1|NOT COMPLETED|Period 1||0
964616|NCT00242385|2332880|P2|COMPLETED|Period 1||11
964617|NCT00242385|2332881|P1|COMPLETED|Period 1||14
964618|NCT00242385|2332880|P2|STARTED|Period 1||11
964619|NCT00242385|2332881|P1|STARTED|Period 1||14
964620|NCT00242502|2332905|P1|NOT COMPLETED|Overall Study||0
964621|NCT00242502|2332905|P1|COMPLETED|Overall Study||59
964622|NCT00242502|2332905|P1|STARTED|Overall Study||59
964623|NCT00242567|2332911|P2|NOT COMPLETED|Overall Study||140
964624|NCT00242567|2332912|P1|NOT COMPLETED|Overall Study||166
964625|NCT00242567|2332911|P2|COMPLETED|Overall Study||123
964626|NCT00242567|2332912|P1|COMPLETED|Overall Study||93
964627|NCT00242567|2332911|P2|Never Received Study Drug|Overall Study||191
964628|NCT00242567|2332912|P1|Never Received Study Drug|Overall Study||0
964629|NCT00242567|2332911|P2|Received at Least 1 Dose of Study Drug|Overall Study||72
964630|NCT00242567|2332912|P1|Received at Least 1 Dose of Study Drug|Overall Study||259
964631|NCT00242567|2332911|P2|STARTED|Overall Study||263
964632|NCT00242567|2332912|P1|STARTED|Overall Study||259
964633|NCT00242580|2332931|P3|NOT COMPLETED|Overall Study||14
964634|NCT00242580|2332932|P2|NOT COMPLETED|Overall Study||12
964635|NCT00242580|2332933|P1|NOT COMPLETED|Overall Study||10
964636|NCT00242580|2332931|P3|COMPLETED|Overall Study||24
964637|NCT00242580|2332932|P2|COMPLETED|Overall Study||29
964638|NCT00242580|2332933|P1|COMPLETED|Overall Study|"Completed indicates 12 month data."|22
964639|NCT00242580|2332931|P3|STARTED|Overall Study||38
964640|NCT00242580|2332932|P2|STARTED|Overall Study||41
964641|NCT00242580|2332933|P1|STARTED|Overall Study||32
964642|NCT00242619|2332958|P2|NOT COMPLETED|Overall Study||0
964643|NCT00242619|2332959|P1|NOT COMPLETED|Overall Study||0
964644|NCT00242619|2332958|P2|COMPLETED|Overall Study||4
964645|NCT00242619|2332959|P1|COMPLETED|Overall Study||8
964646|NCT00242619|2332958|P2|STARTED|Overall Study||4
964647|NCT00242619|2332959|P1|STARTED|Overall Study||8
964648|NCT00242632|2332969|P2|NOT COMPLETED|Overall Study||0
964649|NCT00242632|2332970|P1|NOT COMPLETED|Overall Study||0
964650|NCT00242632|2332969|P2|COMPLETED|Overall Study||11
964651|NCT00242632|2332970|P1|COMPLETED|Overall Study||11
964652|NCT00242632|2332969|P2|STARTED|Overall Study||11
964653|NCT00242632|2332970|P1|STARTED|Overall Study||11
964654|NCT00242658|2332978|P2|NOT COMPLETED|Overall Study||19
964655|NCT00242658|2332979|P1|NOT COMPLETED|Overall Study||22
964656|NCT00242658|2332978|P2|COMPLETED|Overall Study||188
964657|NCT00242658|2332979|P1|COMPLETED|Overall Study||165
964658|NCT00242658|2332978|P2|STARTED|Overall Study||207
964659|NCT00242658|2332979|P1|STARTED|Overall Study||187
964660|NCT00242684|2332987|P1|NOT COMPLETED|Overall Study||0
964661|NCT00242684|2332987|P1|COMPLETED|Overall Study||446
964662|NCT00242684|2332987|P1|STARTED|Overall Study||446
964663|NCT00242710|2332996|P4|NOT COMPLETED|Study Extension (up to Year 2)||10
964664|NCT00242710|2332997|P3|NOT COMPLETED|Study Extension (up to Year 2)||15
964665|NCT00242710|2332998|P2|NOT COMPLETED|Study Extension (up to Year 2)||29
964666|NCT00242710|2332999|P1|NOT COMPLETED|Study Extension (up to Year 2)||27
964667|NCT00242710|2332996|P4|COMPLETED|Study Extension (up to Year 2)||84
964668|NCT00242710|2332997|P3|COMPLETED|Study Extension (up to Year 2)||69
964669|NCT00242710|2332998|P2|COMPLETED|Study Extension (up to Year 2)||148
964670|NCT00242710|2332999|P1|COMPLETED|Study Extension (up to Year 2)||141
964671|NCT00242710|2332996|P4|STARTED|Study Extension (up to Year 2)||94
964672|NCT00242710|2332997|P3|STARTED|Study Extension (up to Year 2)||84
964673|NCT00242710|2332998|P2|STARTED|Study Extension (up to Year 2)||177
964674|NCT00242710|2332999|P1|STARTED|Study Extension (up to Year 2)||168
964675|NCT00242710|2332996|P4|NOT COMPLETED|Period Between Core Study and Extension||49
964676|NCT00242710|2332997|P3|NOT COMPLETED|Period Between Core Study and Extension||48
964677|NCT00242710|2332998|P2|NOT COMPLETED|Period Between Core Study and Extension||112
964678|NCT00242710|2332999|P1|NOT COMPLETED|Period Between Core Study and Extension||119
964679|NCT00242710|2332996|P4|COMPLETED|Period Between Core Study and Extension||94
964680|NCT00242710|2332997|P3|COMPLETED|Period Between Core Study and Extension||84
964681|NCT00242710|2332998|P2|COMPLETED|Period Between Core Study and Extension||177
964682|NCT00242710|2332999|P1|COMPLETED|Period Between Core Study and Extension||168
964683|NCT00242710|2332996|P4|STARTED|Period Between Core Study and Extension||143
964684|NCT00242710|2332997|P3|STARTED|Period Between Core Study and Extension||132
964685|NCT00242710|2332998|P2|STARTED|Period Between Core Study and Extension||289
964686|NCT00242710|2332999|P1|STARTED|Period Between Core Study and Extension||287
964687|NCT00242710|2332996|P4|NOT COMPLETED|Core Study (up to Year 1)||31
964688|NCT00242710|2332997|P3|NOT COMPLETED|Core Study (up to Year 1)||51
964689|NCT00242710|2332998|P2|NOT COMPLETED|Core Study (up to Year 1)||64
964690|NCT00242710|2332999|P1|NOT COMPLETED|Core Study (up to Year 1)||86
964691|NCT00242710|2332996|P4|COMPLETED|Core Study (up to Year 1)||143
964692|NCT00242710|2332997|P3|COMPLETED|Core Study (up to Year 1)||132
964693|NCT00242710|2332998|P2|COMPLETED|Core Study (up to Year 1)||289
964694|NCT00242710|2332999|P1|COMPLETED|Core Study (up to Year 1)||287
964695|NCT00242710|2332996|P4|Treated|Core Study (up to Year 1)||172
964696|NCT00242710|2332997|P3|Treated|Core Study (up to Year 1)||179
964697|NCT00242710|2332998|P2|Treated|Core Study (up to Year 1)||349
964698|NCT00242710|2332999|P1|Treated|Core Study (up to Year 1)||361
964699|NCT00242710|2332996|P4|STARTED|Core Study (up to Year 1)||174
964700|NCT00242710|2332997|P3|STARTED|Core Study (up to Year 1)||183
964701|NCT00242710|2332998|P2|STARTED|Core Study (up to Year 1)||353
964702|NCT00242710|2332999|P1|STARTED|Core Study (up to Year 1)||373
964703|NCT00243022|2333051|P2|NOT COMPLETED|Overall Study||1
964704|NCT00243022|2333052|P1|NOT COMPLETED|Overall Study||2
964705|NCT00243022|2333051|P2|COMPLETED|Overall Study||4
964706|NCT00243022|2333052|P1|COMPLETED|Overall Study||5
964707|NCT00243022|2333051|P2|STARTED|Overall Study||5
964708|NCT00243022|2333052|P1|STARTED|Overall Study||7
964709|NCT00243061|2333070|P1|NOT COMPLETED|Overall Study||0
964710|NCT00243061|2333070|P1|COMPLETED|Overall Study||24
964711|NCT00243061|2333070|P1|STARTED|Overall Study||24
964712|NCT00243074|2333079|P1|NOT COMPLETED|Overall Study||54
964713|NCT00243074|2333079|P1|COMPLETED|Overall Study||0
964714|NCT00243074|2333079|P1|STARTED|Overall Study||54
964715|NCT00243191|2333088|P1|NOT COMPLETED|Overall Study||0
964716|NCT00243191|2333088|P1|COMPLETED|Overall Study||18
964717|NCT00243191|2333088|P1|STARTED|Overall Study||18
964718|NCT00243243|2333094|P2|NOT COMPLETED|Overall Study||0
964719|NCT00243243|2333095|P1|NOT COMPLETED|Overall Study||0
964720|NCT00243243|2333094|P2|COMPLETED|Overall Study||10
964721|NCT00243243|2333095|P1|COMPLETED|Overall Study||10
964722|NCT00243243|2333094|P2|STARTED|Overall Study||10
964723|NCT00243243|2333095|P1|STARTED|Overall Study||10
964724|NCT00243269|2333105|P4|NOT COMPLETED|Overall Study||4
964725|NCT00243269|2333106|P3|NOT COMPLETED|Overall Study||1
964726|NCT00243269|2333107|P2|NOT COMPLETED|Overall Study||1
964727|NCT00243269|2333108|P1|NOT COMPLETED|Overall Study||3
964728|NCT00243269|2333105|P4|COMPLETED|Overall Study||25
964729|NCT00243269|2333106|P3|COMPLETED|Overall Study||11
964730|NCT00243269|2333107|P2|COMPLETED|Overall Study||10
964731|NCT00243269|2333108|P1|COMPLETED|Overall Study||28
964732|NCT00243269|2333105|P4|STARTED|Overall Study||29
964733|NCT00243269|2333106|P3|STARTED|Overall Study||12
964734|NCT00243269|2333107|P2|STARTED|Overall Study||11
964735|NCT00243269|2333108|P1|STARTED|Overall Study||31
964736|NCT00243347|2333122|P1|NOT COMPLETED|Overall Study||19
964737|NCT00243347|2333122|P1|COMPLETED|Overall Study|Completed study|0
964738|NCT00243347|2333122|P1|STARTED|Overall Study|Treated|19
964739|NCT00243386|2333127|P3|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
964740|NCT00243386|2333128|P2|NOT COMPLETED|PK-Driven or Standard Prophylaxis||3
964741|NCT00243386|2333129|P1|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
964742|NCT00243386|2333127|P3|COMPLETED|PK-Driven or Standard Prophylaxis||32
964743|NCT00243386|2333128|P2|COMPLETED|PK-Driven or Standard Prophylaxis||31
964744|NCT00243386|2333129|P1|COMPLETED|PK-Driven or Standard Prophylaxis||0
964745|NCT00243386|2333127|P3|STARTED|PK-Driven or Standard Prophylaxis||32
964746|NCT00243386|2333128|P2|STARTED|PK-Driven or Standard Prophylaxis||34
964747|NCT00243386|2333129|P1|STARTED|PK-Driven or Standard Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
964748|NCT00243386|2333127|P3|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
964749|NCT00243386|2333128|P2|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
964750|NCT00243386|2333129|P1|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||3
964751|NCT00243386|2333127|P3|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
964752|NCT00243386|2333128|P2|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
964753|NCT00243386|2333129|P1|COMPLETED|End of Part 1, But Prior to Prophylaxis||66
964754|NCT00243386|2333127|P3|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
964755|NCT00243386|2333128|P2|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
964756|NCT00243386|2333129|P1|STARTED|End of Part 1, But Prior to Prophylaxis||69
964757|NCT00243386|2333127|P3|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
964758|NCT00243386|2333128|P2|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
964759|NCT00243386|2333129|P1|NOT COMPLETED|On-Demand Regimen (Study Part 1)||4
964760|NCT00243386|2333127|P3|COMPLETED|On-Demand Regimen (Study Part 1)||0
964761|NCT00243386|2333128|P2|COMPLETED|On-Demand Regimen (Study Part 1)||0
964762|NCT00243386|2333129|P1|COMPLETED|On-Demand Regimen (Study Part 1)||69
964763|NCT00243386|2333127|P3|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
964926|NCT00244621|2333434|P1|COMPLETED|Double-blind Treatment Period||27
964764|NCT00243386|2333128|P2|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
964765|NCT00243386|2333129|P1|STARTED|On-Demand Regimen (Study Part 1)||73
964766|NCT00243412|2333196|P2|NOT COMPLETED|Overall Study||11
964767|NCT00243412|2333197|P1|NOT COMPLETED|Overall Study||10
964768|NCT00243412|2333196|P2|COMPLETED|Overall Study|Completed Week 104|10
964769|NCT00243412|2333197|P1|COMPLETED|Overall Study|Completed Week 104|11
964770|NCT00243412|2333196|P2|Safety Evaluable|Overall Study||20
964771|NCT00243412|2333197|P1|Safety Evaluable|Overall Study||21
964772|NCT00243412|2333196|P2|STARTED|Overall Study|Intent to treat|21
964773|NCT00243412|2333197|P1|STARTED|Overall Study|Intent to treat|21
964774|NCT00243503|2333223|P1|NOT COMPLETED|Overall Study||58
964775|NCT00243503|2333223|P1|COMPLETED|Overall Study||2
964776|NCT00243503|2333223|P1|STARTED|Overall Study|3 participants discontinued and only took Trastuzumab.|60
964777|NCT00243659|2333240|P2|NOT COMPLETED|Overall Study||3
964778|NCT00243659|2333241|P1|NOT COMPLETED|Overall Study||2
964779|NCT00243659|2333240|P2|COMPLETED|Overall Study||5
964780|NCT00243659|2333241|P1|COMPLETED|Overall Study||20
964781|NCT00243659|2333240|P2|STARTED|Overall Study||8
964782|NCT00243659|2333241|P1|STARTED|Overall Study||22
964783|NCT00243919|2333252|P3|NOT COMPLETED|Overall Study||11
964784|NCT00243919|2333253|P2|NOT COMPLETED|Overall Study||18
964785|NCT00243919|2333254|P1|NOT COMPLETED|Overall Study||17
964786|NCT00243919|2333252|P3|COMPLETED|Overall Study||115
964787|NCT00243919|2333253|P2|COMPLETED|Overall Study||125
964788|NCT00243919|2333254|P1|COMPLETED|Overall Study||122
964789|NCT00243919|2333252|P3|STARTED|Overall Study||126
964790|NCT00243919|2333253|P2|STARTED|Overall Study||143
964791|NCT00243919|2333254|P1|STARTED|Overall Study||139
964792|NCT00243932|2333298|P3|NOT COMPLETED|Stage 2: Efficacy||0
964793|NCT00243932|2333299|P2|NOT COMPLETED|Stage 2: Efficacy||0
964794|NCT00243932|2333300|P1|NOT COMPLETED|Stage 2: Efficacy||0
964795|NCT00243932|2333298|P3|COMPLETED|Stage 2: Efficacy||0
964796|NCT00243932|2333299|P2|COMPLETED|Stage 2: Efficacy||40
964797|NCT00243932|2333300|P1|COMPLETED|Stage 2: Efficacy||40
964798|NCT00243932|2333298|P3|STARTED|Stage 2: Efficacy|No new pts. randomized because selection procedure in Stage 1 selected the 2,700 mg dose.|0
964799|NCT00243932|2333299|P2|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
964800|NCT00243932|2333300|P1|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
964801|NCT00243932|2333298|P3|NOT COMPLETED|Stage 1: Dose Selection||0
964802|NCT00243932|2333299|P2|NOT COMPLETED|Stage 1: Dose Selection||0
964803|NCT00243932|2333300|P1|NOT COMPLETED|Stage 1: Dose Selection||2
964804|NCT00243932|2333298|P3|COMPLETED|Stage 1: Dose Selection||35
964805|NCT00243932|2333299|P2|COMPLETED|Stage 1: Dose Selection||35
964806|NCT00243932|2333300|P1|COMPLETED|Stage 1: Dose Selection||33
964807|NCT00243932|2333298|P3|STARTED|Stage 1: Dose Selection||35
964808|NCT00243932|2333299|P2|STARTED|Stage 1: Dose Selection||35
964809|NCT00243932|2333300|P1|STARTED|Stage 1: Dose Selection||35
964810|NCT00244010|2333310|P2|NOT COMPLETED|Overall Study||0
964811|NCT00244010|2333311|P1|NOT COMPLETED|Overall Study||0
964812|NCT00244010|2333310|P2|COMPLETED|Overall Study||2
964813|NCT00244010|2333311|P1|COMPLETED|Overall Study||2
964814|NCT00244010|2333310|P2|STARTED|Overall Study||2
964815|NCT00244010|2333311|P1|STARTED|Overall Study||2
964816|NCT00244101|2333320|P3|NOT COMPLETED|Overall Study||0
964817|NCT00244101|2333321|P2|NOT COMPLETED|Overall Study||0
964818|NCT00244101|2333322|P1|NOT COMPLETED|Overall Study||0
964819|NCT00244101|2333320|P3|COMPLETED|Overall Study||216
964820|NCT00244101|2333321|P2|COMPLETED|Overall Study||223
964821|NCT00244101|2333322|P1|COMPLETED|Overall Study||209
964822|NCT00244101|2333320|P3|STARTED|Overall Study||216
964823|NCT00244101|2333321|P2|STARTED|Overall Study||223
964824|NCT00244101|2333322|P1|STARTED|Overall Study||209
964825|NCT00244140|2333332|P2|NOT COMPLETED|Overall Study||0
964826|NCT00244140|2333333|P1|NOT COMPLETED|Overall Study||0
964827|NCT00244140|2333332|P2|COMPLETED|Overall Study||22
964828|NCT00244140|2333333|P1|COMPLETED|Overall Study||412
964829|NCT00244140|2333332|P2|STARTED|Overall Study||22
964830|NCT00244140|2333333|P1|STARTED|Overall Study||412
964831|NCT00231283|2333345|P1|NOT COMPLETED|Overall Study||5
964832|NCT00231283|2333345|P1|COMPLETED|Overall Study||95
964833|NCT00231283|2333345|P1|STARTED|Overall Study||100
964834|NCT00231309|2333352|P1|NOT COMPLETED|Overall Study||0
964835|NCT00231309|2333352|P1|COMPLETED|Overall Study||10
964836|NCT00231309|2333352|P1|STARTED|Overall Study||10
964837|NCT00231465|2333357|P1|NOT COMPLETED|Overall Study||2
964838|NCT00231465|2333357|P1|COMPLETED|Overall Study||42
964839|NCT00231465|2333357|P1|STARTED|Overall Study||44
964840|NCT00231478|2333365|P2|NOT COMPLETED|Overall Study||6
964841|NCT00231478|2333366|P1|NOT COMPLETED|Overall Study||8
964842|NCT00231478|2333365|P2|COMPLETED|Overall Study||78
964843|NCT00231478|2333366|P1|COMPLETED|Overall Study||79
964844|NCT00231478|2333365|P2|STARTED|Overall Study||84
964845|NCT00231478|2333366|P1|STARTED|Overall Study||87
964846|NCT00231777|2333380|P2|NOT COMPLETED|Overall Study||2
964847|NCT00231777|2333381|P1|NOT COMPLETED|Overall Study||6
964848|NCT00231777|2333380|P2|COMPLETED|Overall Study||44
964849|NCT00231777|2333381|P1|COMPLETED|Overall Study||164
964850|NCT00231777|2333380|P2|STARTED|Overall Study||46
964851|NCT00231777|2333381|P1|STARTED|Overall Study||170
964852|NCT00231816|2333395|P2|NOT COMPLETED|Overall Study||12
964854|NCT00231816|2333395|P2|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|369
964855|NCT00231816|2333396|P1|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|366
964856|NCT00231816|2333395|P2|Vaccinated at Visit 2|Overall Study||371
964857|NCT00231816|2333396|P1|Vaccinated at Visit 2|Overall Study||369
964858|NCT00231816|2333395|P2|Vaccinated at Visit 1|Overall Study|One participant was randomized but not vaccinated|380
964859|NCT00231816|2333396|P1|Vaccinated at Visit 1|Overall Study||382
964860|NCT00231816|2333395|P2|STARTED|Overall Study||381
964861|NCT00231816|2333396|P1|STARTED|Overall Study||382
964862|NCT00244374|2333409|P5|NOT COMPLETED|Vaccine Adherence Cohort||0
964863|NCT00244374|2333410|P4|NOT COMPLETED|Vaccine Adherence Cohort||0
964864|NCT00244374|2333411|P3|NOT COMPLETED|Vaccine Adherence Cohort||0
964865|NCT00244374|2333412|P2|NOT COMPLETED|Vaccine Adherence Cohort||0
964866|NCT00244374|2333413|P1|NOT COMPLETED|Vaccine Adherence Cohort||0
964867|NCT00244374|2333409|P5|COMPLETED|Vaccine Adherence Cohort||41
964868|NCT00244374|2333410|P4|COMPLETED|Vaccine Adherence Cohort||36
964869|NCT00244374|2333411|P3|COMPLETED|Vaccine Adherence Cohort||43
964870|NCT00244374|2333412|P2|COMPLETED|Vaccine Adherence Cohort||47
964871|NCT00244374|2333413|P1|COMPLETED|Vaccine Adherence Cohort||0
964872|NCT00244374|2333409|P5|STARTED|Vaccine Adherence Cohort||41
964873|NCT00244374|2333410|P4|STARTED|Vaccine Adherence Cohort||36
964874|NCT00244374|2333411|P3|STARTED|Vaccine Adherence Cohort||43
964875|NCT00244374|2333412|P2|STARTED|Vaccine Adherence Cohort||47
964876|NCT00244374|2333413|P1|STARTED|Vaccine Adherence Cohort|Eligible and willing cross-sectional study participants progressed to adherence cohort randomization|0
964877|NCT00244374|2333409|P5|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
964878|NCT00244374|2333410|P4|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
964879|NCT00244374|2333411|P3|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
964880|NCT00244374|2333412|P2|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
964881|NCT00244374|2333413|P1|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||273
964882|NCT00244374|2333409|P5|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
964883|NCT00244374|2333410|P4|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
964884|NCT00244374|2333411|P3|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
964885|NCT00244374|2333412|P2|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
964886|NCT00244374|2333413|P1|COMPLETED|Evaluation for Vaccine Adherence Cohort||167
964887|NCT00244374|2333409|P5|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
964888|NCT00244374|2333410|P4|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
964889|NCT00244374|2333411|P3|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
964890|NCT00244374|2333412|P2|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
964891|NCT00244374|2333413|P1|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||217
964892|NCT00244374|2333409|P5|STARTED|Evaluation for Vaccine Adherence Cohort||0
964893|NCT00244374|2333410|P4|STARTED|Evaluation for Vaccine Adherence Cohort||0
964894|NCT00244374|2333411|P3|STARTED|Evaluation for Vaccine Adherence Cohort||0
964895|NCT00244374|2333412|P2|STARTED|Evaluation for Vaccine Adherence Cohort||0
964896|NCT00244374|2333413|P1|STARTED|Evaluation for Vaccine Adherence Cohort|440 study participants enrolled prior to 3/31/2007 were evaluated for vaccine adherence cohort|440
964897|NCT00244374|2333409|P5|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
964898|NCT00244374|2333410|P4|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
964899|NCT00244374|2333411|P3|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
964900|NCT00244374|2333412|P2|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
964901|NCT00244374|2333413|P1|NOT COMPLETED|Pre-Randomization Cross-sectional Study||137
964902|NCT00244374|2333409|P5|COMPLETED|Pre-Randomization Cross-sectional Study||0
964903|NCT00244374|2333410|P4|COMPLETED|Pre-Randomization Cross-sectional Study||0
964904|NCT00244374|2333411|P3|COMPLETED|Pre-Randomization Cross-sectional Study||0
964905|NCT00244374|2333412|P2|COMPLETED|Pre-Randomization Cross-sectional Study||0
964906|NCT00244374|2333413|P1|COMPLETED|Pre-Randomization Cross-sectional Study||409
964907|NCT00244374|2333409|P5|STARTED|Pre-Randomization Cross-sectional Study||0
964908|NCT00244374|2333410|P4|STARTED|Pre-Randomization Cross-sectional Study||0
964909|NCT00244374|2333411|P3|STARTED|Pre-Randomization Cross-sectional Study||0
964910|NCT00244374|2333412|P2|STARTED|Pre-Randomization Cross-sectional Study||0
964911|NCT00244374|2333413|P1|STARTED|Pre-Randomization Cross-sectional Study||546
964912|NCT00244621|2333432|P3|NOT COMPLETED|Open-label Treatment Period||2
964913|NCT00244621|2333433|P2|NOT COMPLETED|Open-label Treatment Period||1
964914|NCT00244621|2333434|P1|NOT COMPLETED|Open-label Treatment Period||1
964915|NCT00244621|2333432|P3|COMPLETED|Open-label Treatment Period||28
964916|NCT00244621|2333433|P2|COMPLETED|Open-label Treatment Period||28
964917|NCT00244621|2333434|P1|COMPLETED|Open-label Treatment Period||25
964918|NCT00244621|2333432|P3|STARTED|Open-label Treatment Period||30
964919|NCT00244621|2333433|P2|STARTED|Open-label Treatment Period||29
964920|NCT00244621|2333434|P1|STARTED|Open-label Treatment Period|One participant discontinued study due to Adverse Event after completing the double-blind period.|26
964921|NCT00244621|2333432|P3|NOT COMPLETED|Double-blind Treatment Period||2
964922|NCT00244621|2333433|P2|NOT COMPLETED|Double-blind Treatment Period||3
964923|NCT00244621|2333434|P1|NOT COMPLETED|Double-blind Treatment Period||2
964924|NCT00244621|2333432|P3|COMPLETED|Double-blind Treatment Period||30
964925|NCT00244621|2333433|P2|COMPLETED|Double-blind Treatment Period||29
964927|NCT00244621|2333432|P3|STARTED|Double-blind Treatment Period||32
964928|NCT00244621|2333433|P2|STARTED|Double-blind Treatment Period||32
964929|NCT00244621|2333434|P1|STARTED|Double-blind Treatment Period||29
964930|NCT00245102|2333457|P6|NOT COMPLETED|Overall Study||4
964931|NCT00245102|2333458|P5|NOT COMPLETED|Overall Study||0
964932|NCT00245102|2333459|P4|NOT COMPLETED|Overall Study||3
964933|NCT00245102|2333460|P3|NOT COMPLETED|Overall Study||7
964934|NCT00245102|2333461|P2|NOT COMPLETED|Overall Study||4
964935|NCT00245102|2333462|P1|NOT COMPLETED|Overall Study||7
964936|NCT00245102|2333457|P6|COMPLETED|Overall Study||19
964937|NCT00245102|2333458|P5|COMPLETED|Overall Study||5
964938|NCT00245102|2333459|P4|COMPLETED|Overall Study||10
964939|NCT00245102|2333460|P3|COMPLETED|Overall Study||39
964940|NCT00245102|2333461|P2|COMPLETED|Overall Study||12
964941|NCT00245102|2333462|P1|COMPLETED|Overall Study||37
964942|NCT00245102|2333457|P6|STARTED|Overall Study||23
964943|NCT00245102|2333458|P5|STARTED|Overall Study||5
964944|NCT00245102|2333459|P4|STARTED|Overall Study||13
964945|NCT00245102|2333460|P3|STARTED|Overall Study||46
964946|NCT00245102|2333461|P2|STARTED|Overall Study||16
964947|NCT00245102|2333462|P1|STARTED|Overall Study||44
964948|NCT00245128|2333476|P1|NOT COMPLETED|Overall Study||10
964949|NCT00245128|2333476|P1|COMPLETED|Overall Study||0
964950|NCT00245128|2333476|P1|STARTED|Overall Study||10
964951|NCT00245219|2333483|P3|NOT COMPLETED|Overall Study||2
964952|NCT00245219|2333484|P2|NOT COMPLETED|Overall Study||6
964953|NCT00245219|2333485|P1|NOT COMPLETED|Overall Study||6
964954|NCT00245219|2333483|P3|COMPLETED|Overall Study||58
964955|NCT00245219|2333484|P2|COMPLETED|Overall Study||88
964956|NCT00245219|2333485|P1|COMPLETED|Overall Study||85
964957|NCT00245219|2333483|P3|STARTED|Overall Study||60
964958|NCT00245219|2333484|P2|STARTED|Overall Study||94
964959|NCT00245219|2333485|P1|STARTED|Overall Study||91
964960|NCT00245466|2333502|P3|NOT COMPLETED|Overall Study||37
964961|NCT00245466|2333503|P2|NOT COMPLETED|Overall Study||44
964962|NCT00245466|2333504|P1|NOT COMPLETED|Overall Study||36
964963|NCT00245466|2333502|P3|COMPLETED|Overall Study||3
964964|NCT00245466|2333503|P2|COMPLETED|Overall Study||2
964965|NCT00245466|2333504|P1|COMPLETED|Overall Study|Defined as those participants ongoing when the extension study was terminated|7
964966|NCT00245466|2333502|P3|Started FE200486 CS02A|Overall Study||26
964967|NCT00245466|2333503|P2|Started FE200486 CS02A|Overall Study||30
964968|NCT00245466|2333504|P1|Started FE200486 CS02A|Overall Study||32
964969|NCT00245466|2333502|P3|STARTED|Overall Study||40
964970|NCT00245466|2333503|P2|STARTED|Overall Study||46
964971|NCT00245466|2333504|P1|STARTED|Overall Study||43
964972|NCT00245557|2333520|P2|NOT COMPLETED|Overall Study||16
964973|NCT00245557|2333521|P1|NOT COMPLETED|Overall Study||6
964974|NCT00245557|2333520|P2|COMPLETED|Overall Study||10
964975|NCT00245557|2333521|P1|COMPLETED|Overall Study||11
964976|NCT00245557|2333520|P2|STARTED|Overall Study||26
964977|NCT00245557|2333521|P1|STARTED|Overall Study||17
964978|NCT00245570|2333532|P6|NOT COMPLETED|Treatment Period IV||0
964979|NCT00245570|2333533|P5|NOT COMPLETED|Treatment Period IV||0
964980|NCT00245570|2333534|P4|NOT COMPLETED|Treatment Period IV||0
964981|NCT00245570|2333535|P3|NOT COMPLETED|Treatment Period IV||0
964982|NCT00245570|2333536|P2|NOT COMPLETED|Treatment Period IV||0
964983|NCT00245570|2333537|P1|NOT COMPLETED|Treatment Period IV||0
964984|NCT00245570|2333532|P6|COMPLETED|Treatment Period IV||8
964985|NCT00245570|2333533|P5|COMPLETED|Treatment Period IV||8
964986|NCT00245570|2333534|P4|COMPLETED|Treatment Period IV||8
964987|NCT00245570|2333535|P3|COMPLETED|Treatment Period IV||8
964988|NCT00245570|2333536|P2|COMPLETED|Treatment Period IV||7
964989|NCT00245570|2333537|P1|COMPLETED|Treatment Period IV||7
964990|NCT00245570|2333532|P6|STARTED|Treatment Period IV||8
964991|NCT00245570|2333533|P5|STARTED|Treatment Period IV||8
964992|NCT00245570|2333534|P4|STARTED|Treatment Period IV||8
964993|NCT00245570|2333535|P3|STARTED|Treatment Period IV||8
964994|NCT00245570|2333536|P2|STARTED|Treatment Period IV||7
964995|NCT00245570|2333537|P1|STARTED|Treatment Period IV||7
964996|NCT00245570|2333532|P6|NOT COMPLETED|Washout Between Periods III and IV||0
964997|NCT00245570|2333533|P5|NOT COMPLETED|Washout Between Periods III and IV||0
964998|NCT00245570|2333534|P4|NOT COMPLETED|Washout Between Periods III and IV||0
964999|NCT00245570|2333535|P3|NOT COMPLETED|Washout Between Periods III and IV||0
965000|NCT00245570|2333536|P2|NOT COMPLETED|Washout Between Periods III and IV||1
965001|NCT00245570|2333537|P1|NOT COMPLETED|Washout Between Periods III and IV||0
965002|NCT00245570|2333532|P6|COMPLETED|Washout Between Periods III and IV||8
965003|NCT00245570|2333533|P5|COMPLETED|Washout Between Periods III and IV||8
965004|NCT00245570|2333534|P4|COMPLETED|Washout Between Periods III and IV||8
965005|NCT00245570|2333535|P3|COMPLETED|Washout Between Periods III and IV||8
965006|NCT00245570|2333536|P2|COMPLETED|Washout Between Periods III and IV||7
965007|NCT00245570|2333537|P1|COMPLETED|Washout Between Periods III and IV||7
965008|NCT00245570|2333532|P6|STARTED|Washout Between Periods III and IV||8
965009|NCT00245570|2333533|P5|STARTED|Washout Between Periods III and IV||8
965010|NCT00245570|2333534|P4|STARTED|Washout Between Periods III and IV||8
965011|NCT00245570|2333535|P3|STARTED|Washout Between Periods III and IV||8
965012|NCT00245570|2333536|P2|STARTED|Washout Between Periods III and IV|1 pt in the montelukast/placebo/salmeterol group discontinued during washout period 2 after placebo|8
965013|NCT00245570|2333537|P1|STARTED|Washout Between Periods III and IV||7
965014|NCT00245570|2333532|P6|NOT COMPLETED|Treatment Period III||0
965015|NCT00245570|2333533|P5|NOT COMPLETED|Treatment Period III||0
965016|NCT00245570|2333534|P4|NOT COMPLETED|Treatment Period III||0
965017|NCT00245570|2333535|P3|NOT COMPLETED|Treatment Period III||0
965018|NCT00245570|2333536|P2|NOT COMPLETED|Treatment Period III||0
965019|NCT00245570|2333537|P1|NOT COMPLETED|Treatment Period III||0
965020|NCT00245570|2333532|P6|COMPLETED|Treatment Period III||8
965021|NCT00245570|2333533|P5|COMPLETED|Treatment Period III||8
965022|NCT00245570|2333534|P4|COMPLETED|Treatment Period III||8
965023|NCT00245570|2333535|P3|COMPLETED|Treatment Period III||8
965024|NCT00245570|2333536|P2|COMPLETED|Treatment Period III||8
965025|NCT00245570|2333537|P1|COMPLETED|Treatment Period III||7
965026|NCT00245570|2333532|P6|STARTED|Treatment Period III||8
965027|NCT00245570|2333533|P5|STARTED|Treatment Period III||8
965028|NCT00245570|2333534|P4|STARTED|Treatment Period III||8
965029|NCT00245570|2333535|P3|STARTED|Treatment Period III||8
965030|NCT00245570|2333536|P2|STARTED|Treatment Period III||8
965031|NCT00245570|2333537|P1|STARTED|Treatment Period III||7
965032|NCT00245570|2333532|P6|NOT COMPLETED|Washout Between Periods II and III||0
965033|NCT00245570|2333533|P5|NOT COMPLETED|Washout Between Periods II and III||0
965034|NCT00245570|2333534|P4|NOT COMPLETED|Washout Between Periods II and III||0
965035|NCT00245570|2333535|P3|NOT COMPLETED|Washout Between Periods II and III||0
965036|NCT00245570|2333536|P2|NOT COMPLETED|Washout Between Periods II and III||0
965037|NCT00245570|2333537|P1|NOT COMPLETED|Washout Between Periods II and III||0
965038|NCT00245570|2333532|P6|COMPLETED|Washout Between Periods II and III||8
965039|NCT00245570|2333533|P5|COMPLETED|Washout Between Periods II and III||8
965040|NCT00245570|2333534|P4|COMPLETED|Washout Between Periods II and III||8
965041|NCT00245570|2333535|P3|COMPLETED|Washout Between Periods II and III||8
965042|NCT00245570|2333536|P2|COMPLETED|Washout Between Periods II and III||8
965043|NCT00245570|2333537|P1|COMPLETED|Washout Between Periods II and III||7
965044|NCT00245570|2333532|P6|STARTED|Washout Between Periods II and III||8
965045|NCT00245570|2333533|P5|STARTED|Washout Between Periods II and III||8
965046|NCT00245570|2333534|P4|STARTED|Washout Between Periods II and III||8
965047|NCT00245570|2333535|P3|STARTED|Washout Between Periods II and III||8
965048|NCT00245570|2333536|P2|STARTED|Washout Between Periods II and III||8
965049|NCT00245570|2333537|P1|STARTED|Washout Between Periods II and III||7
965050|NCT00245570|2333532|P6|NOT COMPLETED|Treatment Period II||0
965051|NCT00245570|2333533|P5|NOT COMPLETED|Treatment Period II||0
965052|NCT00245570|2333534|P4|NOT COMPLETED|Treatment Period II||0
965053|NCT00245570|2333535|P3|NOT COMPLETED|Treatment Period II||0
965054|NCT00245570|2333536|P2|NOT COMPLETED|Treatment Period II||0
965055|NCT00245570|2333537|P1|NOT COMPLETED|Treatment Period II||0
965056|NCT00245570|2333532|P6|COMPLETED|Treatment Period II||8
965057|NCT00245570|2333533|P5|COMPLETED|Treatment Period II||8
965058|NCT00245570|2333534|P4|COMPLETED|Treatment Period II||8
965059|NCT00245570|2333535|P3|COMPLETED|Treatment Period II||8
965060|NCT00245570|2333536|P2|COMPLETED|Treatment Period II||8
965061|NCT00245570|2333537|P1|COMPLETED|Treatment Period II||7
965062|NCT00245570|2333532|P6|STARTED|Treatment Period II||8
965063|NCT00245570|2333533|P5|STARTED|Treatment Period II||8
965064|NCT00245570|2333534|P4|STARTED|Treatment Period II||8
965065|NCT00245570|2333535|P3|STARTED|Treatment Period II||8
965066|NCT00245570|2333536|P2|STARTED|Treatment Period II||8
965067|NCT00245570|2333537|P1|STARTED|Treatment Period II||7
965068|NCT00245635|2333583|P2|NOT COMPLETED|Overall Study||0
965069|NCT00245635|2333584|P1|NOT COMPLETED|Overall Study||0
965070|NCT00245635|2333583|P2|COMPLETED|Overall Study||18
965071|NCT00245635|2333584|P1|COMPLETED|Overall Study||25
965072|NCT00245635|2333583|P2|STARTED|Overall Study||18
965073|NCT00245635|2333584|P1|STARTED|Overall Study||25
965074|NCT00245856|2333590|P2|NOT COMPLETED|Period Two||1
965075|NCT00245856|2333591|P1|NOT COMPLETED|Period Two||0
965076|NCT00245856|2333590|P2|COMPLETED|Period Two||38
965077|NCT00245856|2333591|P1|COMPLETED|Period Two||0
965078|NCT00245856|2333590|P2|STARTED|Period Two||39
965079|NCT00245856|2333591|P1|STARTED|Period Two||0
965080|NCT00245856|2333590|P2|NOT COMPLETED|Period One||0
965081|NCT00245856|2333591|P1|NOT COMPLETED|Period One||0
965082|NCT00245856|2333590|P2|COMPLETED|Period One||0
965083|NCT00245856|2333591|P1|COMPLETED|Period One||28
965084|NCT00245856|2333590|P2|STARTED|Period One||0
965085|NCT00245856|2333591|P1|STARTED|Period One||28
965086|NCT00245960|2333600|P2|NOT COMPLETED|Overall Study||28
965087|NCT00245960|2333601|P1|NOT COMPLETED|Overall Study||29
965088|NCT00245960|2333600|P2|COMPLETED|Overall Study||345
965089|NCT00245960|2333601|P1|COMPLETED|Overall Study||350
965090|NCT00245960|2333600|P2|STARTED|Overall Study||373
965091|NCT00245960|2333601|P1|STARTED|Overall Study||379
965092|NCT00246012|2333618|P9|NOT COMPLETED|Overall Study||28
965093|NCT00246012|2333619|P8|NOT COMPLETED|Overall Study||28
965094|NCT00246012|2333620|P7|NOT COMPLETED|Overall Study||31
965095|NCT00246012|2333621|P6|NOT COMPLETED|Overall Study||28
965096|NCT00246012|2333622|P5|NOT COMPLETED|Overall Study||3
965097|NCT00246012|2333623|P4|NOT COMPLETED|Overall Study||3
965098|NCT00246012|2333624|P3|NOT COMPLETED|Overall Study||2
965099|NCT00246012|2333625|P2|NOT COMPLETED|Overall Study||1
965100|NCT00246012|2333626|P1|NOT COMPLETED|Overall Study||3
965101|NCT00246012|2333618|P9|COMPLETED|Overall Study||4
965102|NCT00246012|2333619|P8|COMPLETED|Overall Study||5
965103|NCT00246012|2333620|P7|COMPLETED|Overall Study||1
965104|NCT00246012|2333621|P6|COMPLETED|Overall Study||4
965105|NCT00246012|2333622|P5|COMPLETED|Overall Study||0
965106|NCT00246012|2333623|P4|COMPLETED|Overall Study||0
965107|NCT00246012|2333624|P3|COMPLETED|Overall Study||1
965108|NCT00246012|2333625|P2|COMPLETED|Overall Study||2
965109|NCT00246012|2333626|P1|COMPLETED|Overall Study||0
965110|NCT00246012|2333618|P9|Treated|Overall Study||32
965111|NCT00246012|2333619|P8|Treated|Overall Study||33
965112|NCT00246012|2333620|P7|Treated|Overall Study||31
965113|NCT00246012|2333621|P6|Treated|Overall Study||31
965114|NCT00246012|2333622|P5|Treated|Overall Study||3
965115|NCT00246012|2333623|P4|Treated|Overall Study||3
965116|NCT00246012|2333624|P3|Treated|Overall Study||3
965117|NCT00246012|2333625|P2|Treated|Overall Study||3
965118|NCT00246012|2333626|P1|Treated|Overall Study||3
965119|NCT00246012|2333618|P9|STARTED|Overall Study||32
965120|NCT00246012|2333619|P8|STARTED|Overall Study||33
965121|NCT00246012|2333620|P7|STARTED|Overall Study||32
965122|NCT00246012|2333621|P6|STARTED|Overall Study||32
965123|NCT00246012|2333622|P5|STARTED|Overall Study||3
965124|NCT00246012|2333623|P4|STARTED|Overall Study||3
965125|NCT00246012|2333624|P3|STARTED|Overall Study||3
965126|NCT00246012|2333625|P2|STARTED|Overall Study||3
965127|NCT00246012|2333626|P1|STARTED|Overall Study||3
965128|NCT00246025|2333723|P4|NOT COMPLETED|Overall Study||13
965129|NCT00246025|2333724|P3|NOT COMPLETED|Overall Study||10
965130|NCT00246025|2333725|P2|NOT COMPLETED|Overall Study||9
965131|NCT00246025|2333726|P1|NOT COMPLETED|Overall Study||10
965132|NCT00246025|2333723|P4|COMPLETED|Overall Study||116
965133|NCT00246025|2333724|P3|COMPLETED|Overall Study||116
965134|NCT00246025|2333725|P2|COMPLETED|Overall Study||124
965135|NCT00246025|2333726|P1|COMPLETED|Overall Study||114
965136|NCT00246025|2333723|P4|STARTED|Overall Study||129
965137|NCT00246025|2333724|P3|STARTED|Overall Study||126
965138|NCT00246025|2333725|P2|STARTED|Overall Study||133
965139|NCT00246025|2333726|P1|STARTED|Overall Study||124
965140|NCT00246090|2333776|P1|NOT COMPLETED|Overall Study||295
965141|NCT00246090|2333776|P1|COMPLETED|Overall Study||3
965142|NCT00246090|2333776|P1|STARTED|Overall Study||298
965143|NCT00246259|2333783|P2|NOT COMPLETED|Overall Study||26
965144|NCT00246259|2333784|P1|NOT COMPLETED|Overall Study||28
965145|NCT00246259|2333783|P2|COMPLETED|Overall Study||15
965146|NCT00246259|2333784|P1|COMPLETED|Overall Study||16
965147|NCT00246259|2333783|P2|Eligible for Intent-to-treat (ITT)|Overall Study||35
965148|NCT00246259|2333784|P1|Eligible for Intent-to-treat (ITT)|Overall Study||42
965149|NCT00246259|2333783|P2|STARTED|Overall Study||41
965150|NCT00246259|2333784|P1|STARTED|Overall Study||44
965151|NCT00246324|2333818|P1|NOT COMPLETED|Overall Study||1
965152|NCT00246324|2333818|P1|COMPLETED|Overall Study||15
965153|NCT00246324|2333818|P1|STARTED|Overall Study||16
965154|NCT00246337|2333832|P9|NOT COMPLETED|Overall Study||11
965155|NCT00246337|2333833|P8|NOT COMPLETED|Overall Study||13
965156|NCT00246337|2333834|P7|NOT COMPLETED|Overall Study||9
965157|NCT00246337|2333835|P6|NOT COMPLETED|Overall Study||15
965158|NCT00246337|2333836|P5|NOT COMPLETED|Overall Study||4
965159|NCT00246337|2333837|P4|NOT COMPLETED|Overall Study||1
965160|NCT00246337|2333838|P3|NOT COMPLETED|Overall Study||3
965161|NCT00246337|2333839|P2|NOT COMPLETED|Overall Study||2
965162|NCT00246337|2333840|P1|NOT COMPLETED|Overall Study||32
965163|NCT00246337|2333832|P9|COMPLETED|Overall Study||34
965164|NCT00246337|2333833|P8|COMPLETED|Overall Study||40
965165|NCT00246337|2333834|P7|COMPLETED|Overall Study||45
965166|NCT00246337|2333835|P6|COMPLETED|Overall Study||39
965167|NCT00246337|2333836|P5|COMPLETED|Overall Study||12
965168|NCT00246337|2333837|P4|COMPLETED|Overall Study||16
965169|NCT00246337|2333838|P3|COMPLETED|Overall Study||15
965170|NCT00246337|2333839|P2|COMPLETED|Overall Study||14
965171|NCT00246337|2333840|P1|COMPLETED|Overall Study||115
965172|NCT00246337|2333832|P9|Completed Period (Both Doses)|Overall Study||15
965173|NCT00246337|2333833|P8|Completed Period (Both Doses)|Overall Study||13
965174|NCT00246337|2333834|P7|Completed Period (Both Doses)|Overall Study||16
965175|NCT00246337|2333835|P6|Completed Period (Both Doses)|Overall Study||10
965176|NCT00246337|2333836|P5|Completed Period (Both Doses)|Overall Study||4
965177|NCT00246337|2333837|P4|Completed Period (Both Doses)|Overall Study||11
965178|NCT00246337|2333838|P3|Completed Period (Both Doses)|Overall Study||6
965179|NCT00246337|2333839|P2|Completed Period (Both Doses)|Overall Study||10
965180|NCT00246337|2333840|P1|Completed Period (Both Doses)|Overall Study||69
965181|NCT00246337|2333832|P9|Completed Period (Initial Dose)|Overall Study||19
965182|NCT00246337|2333833|P8|Completed Period (Initial Dose)|Overall Study||27
965183|NCT00246337|2333834|P7|Completed Period (Initial Dose)|Overall Study||29
965184|NCT00246337|2333835|P6|Completed Period (Initial Dose)|Overall Study||29
965185|NCT00246337|2333836|P5|Completed Period (Initial Dose)|Overall Study||8
965186|NCT00246337|2333837|P4|Completed Period (Initial Dose)|Overall Study||5
965187|NCT00246337|2333838|P3|Completed Period (Initial Dose)|Overall Study||9
965188|NCT00246337|2333839|P2|Completed Period (Initial Dose)|Overall Study||4
965189|NCT00246337|2333840|P1|Completed Period (Initial Dose)|Overall Study||46
965190|NCT00246337|2333832|P9|STARTED|Overall Study||45
965191|NCT00246337|2333833|P8|STARTED|Overall Study||53
965192|NCT00246337|2333834|P7|STARTED|Overall Study||54
965193|NCT00246337|2333835|P6|STARTED|Overall Study||54
965194|NCT00246337|2333836|P5|STARTED|Overall Study||16
965195|NCT00246337|2333837|P4|STARTED|Overall Study||17
965196|NCT00246337|2333838|P3|STARTED|Overall Study||18
965197|NCT00246337|2333839|P2|STARTED|Overall Study||16
965198|NCT00246337|2333840|P1|STARTED|Overall Study||147
965199|NCT00246376|2333892|P5|NOT COMPLETED|Overall Study||17
965200|NCT00246376|2333893|P4|NOT COMPLETED|Overall Study||26
965201|NCT00246376|2333894|P3|NOT COMPLETED|Overall Study||16
965202|NCT00246376|2333895|P2|NOT COMPLETED|Overall Study||19
965203|NCT00246376|2333896|P1|NOT COMPLETED|Overall Study||15
965204|NCT00246376|2333892|P5|COMPLETED|Overall Study||28
965205|NCT00246376|2333893|P4|COMPLETED|Overall Study||21
965206|NCT00246376|2333894|P3|COMPLETED|Overall Study||29
965207|NCT00246376|2333895|P2|COMPLETED|Overall Study||24
965208|NCT00246376|2333896|P1|COMPLETED|Overall Study||26
965209|NCT00246376|2333892|P5|After Dietary run-in at Two Weeks|Overall Study||42
965210|NCT00246376|2333893|P4|After Dietary run-in at Two Weeks|Overall Study||40
965211|NCT00246376|2333894|P3|After Dietary run-in at Two Weeks|Overall Study||41
965212|NCT00246376|2333895|P2|After Dietary run-in at Two Weeks|Overall Study||38
965213|NCT00246376|2333896|P1|After Dietary run-in at Two Weeks|Overall Study||30
965214|NCT00246376|2333892|P5|STARTED|Overall Study||45
965215|NCT00246376|2333893|P4|STARTED|Overall Study||47
965216|NCT00246376|2333894|P3|STARTED|Overall Study||45
965217|NCT00246376|2333895|P2|STARTED|Overall Study||43
965218|NCT00246376|2333896|P1|STARTED|Overall Study||41
965219|NCT00246519|2333940|P2|NOT COMPLETED|Overall Study||64
965220|NCT00246519|2333941|P1|NOT COMPLETED|Overall Study||56
965221|NCT00246519|2333940|P2|COMPLETED|Overall Study||382
965222|NCT00246519|2333941|P1|COMPLETED|Overall Study||386
965223|NCT00246519|2333940|P2|STARTED|Overall Study||446
965224|NCT00246519|2333941|P1|STARTED|Overall Study||442
965225|NCT00246571|2333949|P2|NOT COMPLETED|Overall Study||104
965226|NCT00246571|2333950|P1|NOT COMPLETED|Overall Study||113
965227|NCT00246571|2333949|P2|COMPLETED|Overall Study||0
965228|NCT00246571|2333950|P1|COMPLETED|Overall Study||0
965229|NCT00246571|2333949|P2|Randomized But Not Treated|Overall Study||1
965230|NCT00246571|2333950|P1|Randomized But Not Treated|Overall Study||3
965231|NCT00246571|2333949|P2|STARTED|Overall Study||104
965232|NCT00246571|2333950|P1|STARTED|Overall Study||113
965233|NCT00246753|2333988|P1|NOT COMPLETED|Overall Study||8
965234|NCT00246753|2333988|P1|COMPLETED|Overall Study||21
965235|NCT00246753|2333988|P1|STARTED|Overall Study||29
965236|NCT00246805|2333996|P2|NOT COMPLETED|Phase 2||0
965237|NCT00246805|2333997|P1|NOT COMPLETED|Phase 2||0
965238|NCT00246805|2333996|P2|COMPLETED|Phase 2||33
965239|NCT00246805|2333997|P1|COMPLETED|Phase 2||33
965240|NCT00246805|2333996|P2|STARTED|Phase 2||33
965241|NCT00246805|2333997|P1|STARTED|Phase 2||33
965242|NCT00246805|2333996|P2|NOT COMPLETED|Phase 1||0
965243|NCT00246805|2333997|P1|NOT COMPLETED|Phase 1||1
965244|NCT00246805|2333996|P2|COMPLETED|Phase 1||33
965245|NCT00246805|2333997|P1|COMPLETED|Phase 1||33
965246|NCT00246805|2333996|P2|STARTED|Phase 1||33
965247|NCT00246805|2333997|P1|STARTED|Phase 1||34
965248|NCT00247273|2334005|P2|NOT COMPLETED|Overall Study||137
965249|NCT00247273|2334006|P1|NOT COMPLETED|Overall Study||146
965250|NCT00247273|2334005|P2|COMPLETED|Overall Study||513
965251|NCT00247273|2334006|P1|COMPLETED|Overall Study||498
965252|NCT00247273|2334005|P2|Intent to Treat Population|Overall Study||650
965253|NCT00247273|2334006|P1|Intent to Treat Population|Overall Study|Two subjects not included as they did not take any study medication.|642
965254|NCT00247273|2334005|P2|STARTED|Overall Study||650
965255|NCT00247273|2334006|P1|STARTED|Overall Study||644
965256|NCT00247377|2334052|P2|NOT COMPLETED|Overall Study||0
965257|NCT00247377|2334053|P1|NOT COMPLETED|Overall Study||0
965258|NCT00247377|2334052|P2|COMPLETED|Overall Study||86
965259|NCT00247377|2334053|P1|COMPLETED|Overall Study||111
965260|NCT00247377|2334052|P2|STARTED|Overall Study||86
965261|NCT00247377|2334053|P1|STARTED|Overall Study||111
965262|NCT00247416|2334079|P2|NOT COMPLETED|Overall Study||2
965263|NCT00247416|2334080|P1|NOT COMPLETED|Overall Study||1
965264|NCT00247416|2334079|P2|COMPLETED|Overall Study||31
965265|NCT00247416|2334080|P1|COMPLETED|Overall Study||25
965266|NCT00247416|2334079|P2|STARTED|Overall Study||33
965267|NCT00247416|2334080|P1|STARTED|Overall Study||26
965268|NCT00247611|2334094|P2|NOT COMPLETED|On Protocol Sample||125
965269|NCT00247611|2334095|P1|NOT COMPLETED|On Protocol Sample||111
965270|NCT00247611|2334094|P2|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|152
965271|NCT00247611|2334095|P1|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|176
965272|NCT00247611|2334094|P2|STARTED|On Protocol Sample|ITT sample participants|277
965273|NCT00247611|2334095|P1|STARTED|On Protocol Sample|ITT sample participants|287
965274|NCT00247611|2334094|P2|NOT COMPLETED|Intention to Treat Sample||13
965275|NCT00247611|2334095|P1|NOT COMPLETED|Intention to Treat Sample||17
965276|NCT00247611|2334094|P2|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|277
965277|NCT00247611|2334095|P1|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|287
965278|NCT00247611|2334094|P2|STARTED|Intention to Treat Sample|Participants randomized|290
965279|NCT00247611|2334095|P1|STARTED|Intention to Treat Sample|Participants randomized|304
965280|NCT00247611|2334094|P2|NOT COMPLETED|Baselined||13
965281|NCT00247611|2334095|P1|NOT COMPLETED|Baselined||17
965282|NCT00247611|2334094|P2|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|277
965366|NCT00240526|2334178|P2|NOT COMPLETED|Year 16||0
965283|NCT00247611|2334095|P1|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|287
965284|NCT00247611|2334094|P2|STARTED|Baselined|Participants randomized|290
965285|NCT00247611|2334095|P1|STARTED|Baselined|Participants randomized|304
965286|NCT00240331|2334113|P2|NOT COMPLETED|Overall Study||134
965287|NCT00240331|2334114|P1|NOT COMPLETED|Overall Study||126
965288|NCT00240331|2334113|P2|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1250
965289|NCT00240331|2334114|P1|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1263
965290|NCT00240331|2334113|P2|STARTED|Overall Study|One patient was incorrectly randomised and not included in the analyses|1384
965291|NCT00240331|2334114|P1|STARTED|Overall Study|Two patients were incorrectly randomised and not included in the analyses.|1389
965292|NCT00240487|2334134|P2|NOT COMPLETED|Overall Study||0
965293|NCT00240487|2334135|P1|NOT COMPLETED|Overall Study||0
965294|NCT00240487|2334134|P2|COMPLETED|Overall Study||28
965295|NCT00240487|2334135|P1|COMPLETED|Overall Study||24
965296|NCT00240487|2334134|P2|STARTED|Overall Study||28
965297|NCT00240487|2334135|P1|STARTED|Overall Study||24
965298|NCT00240500|2334147|P6|NOT COMPLETED|Overall Study||1
965299|NCT00240500|2334148|P5|NOT COMPLETED|Overall Study||3
965300|NCT00240500|2334149|P4|NOT COMPLETED|Overall Study||4
965301|NCT00240500|2334150|P3|NOT COMPLETED|Overall Study||3
965302|NCT00240500|2334151|P2|NOT COMPLETED|Overall Study||3
965303|NCT00240500|2334152|P1|NOT COMPLETED|Overall Study||1
965304|NCT00240500|2334147|P6|COMPLETED|Overall Study||2
965305|NCT00240500|2334148|P5|COMPLETED|Overall Study||26
965306|NCT00240500|2334149|P4|COMPLETED|Overall Study||19
965307|NCT00240500|2334150|P3|COMPLETED|Overall Study||14
965308|NCT00240500|2334151|P2|COMPLETED|Overall Study||17
965309|NCT00240500|2334152|P1|COMPLETED|Overall Study||16
965310|NCT00240500|2334147|P6|STARTED|Overall Study||3
965311|NCT00240500|2334148|P5|STARTED|Overall Study||29
965312|NCT00240500|2334149|P4|STARTED|Overall Study||23
965313|NCT00240500|2334150|P3|STARTED|Overall Study||17
965314|NCT00240500|2334151|P2|STARTED|Overall Study||20
965315|NCT00240500|2334152|P1|STARTED|Overall Study||17
965316|NCT00240526|2334176|P4|NOT COMPLETED|Year 20||0
965317|NCT00240526|2334177|P3|NOT COMPLETED|Year 20||0
965318|NCT00240526|2334178|P2|NOT COMPLETED|Year 20||0
965319|NCT00240526|2334179|P1|NOT COMPLETED|Year 20||0
965320|NCT00240526|2334176|P4|COMPLETED|Year 20||20
965321|NCT00240526|2334177|P3|COMPLETED|Year 20||13
965322|NCT00240526|2334178|P2|COMPLETED|Year 20||17
965323|NCT00240526|2334179|P1|COMPLETED|Year 20||19
965324|NCT00240526|2334176|P4|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|20
965325|NCT00240526|2334177|P3|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|13
965326|NCT00240526|2334178|P2|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|17
965327|NCT00240526|2334179|P1|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|19
965328|NCT00240526|2334176|P4|NOT COMPLETED|Year 19||0
965329|NCT00240526|2334177|P3|NOT COMPLETED|Year 19||0
965330|NCT00240526|2334178|P2|NOT COMPLETED|Year 19||0
965331|NCT00240526|2334179|P1|NOT COMPLETED|Year 19||0
965332|NCT00240526|2334176|P4|COMPLETED|Year 19||18
965333|NCT00240526|2334177|P3|COMPLETED|Year 19||12
965334|NCT00240526|2334178|P2|COMPLETED|Year 19||16
965335|NCT00240526|2334179|P1|COMPLETED|Year 19||17
965336|NCT00240526|2334176|P4|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|18
965337|NCT00240526|2334177|P3|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|12
965338|NCT00240526|2334178|P2|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|16
965339|NCT00240526|2334179|P1|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|17
965340|NCT00240526|2334176|P4|NOT COMPLETED|Year 18||0
965341|NCT00240526|2334177|P3|NOT COMPLETED|Year 18||0
965342|NCT00240526|2334178|P2|NOT COMPLETED|Year 18||0
965343|NCT00240526|2334179|P1|NOT COMPLETED|Year 18||0
965344|NCT00240526|2334176|P4|COMPLETED|Year 18||20
965345|NCT00240526|2334177|P3|COMPLETED|Year 18||14
965346|NCT00240526|2334178|P2|COMPLETED|Year 18||17
965347|NCT00240526|2334179|P1|COMPLETED|Year 18||16
965348|NCT00240526|2334176|P4|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|20
965349|NCT00240526|2334177|P3|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|14
965350|NCT00240526|2334178|P2|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|17
965351|NCT00240526|2334179|P1|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|16
965352|NCT00240526|2334176|P4|NOT COMPLETED|Year 17||0
965353|NCT00240526|2334177|P3|NOT COMPLETED|Year 17||0
965354|NCT00240526|2334178|P2|NOT COMPLETED|Year 17||0
965355|NCT00240526|2334179|P1|NOT COMPLETED|Year 17||0
965356|NCT00240526|2334176|P4|COMPLETED|Year 17||20
965357|NCT00240526|2334177|P3|COMPLETED|Year 17||13
965358|NCT00240526|2334178|P2|COMPLETED|Year 17||17
965359|NCT00240526|2334179|P1|COMPLETED|Year 17||19
965360|NCT00240526|2334176|P4|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|20
965361|NCT00240526|2334177|P3|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|13
965362|NCT00240526|2334178|P2|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|17
965363|NCT00240526|2334179|P1|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|19
965364|NCT00240526|2334176|P4|NOT COMPLETED|Year 16||0
965365|NCT00240526|2334177|P3|NOT COMPLETED|Year 16||0
965367|NCT00240526|2334179|P1|NOT COMPLETED|Year 16||0
965368|NCT00240526|2334176|P4|COMPLETED|Year 16||22
965369|NCT00240526|2334177|P3|COMPLETED|Year 16||16
965370|NCT00240526|2334178|P2|COMPLETED|Year 16||19
965371|NCT00240526|2334179|P1|COMPLETED|Year 16||17
965372|NCT00240526|2334176|P4|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|22
965373|NCT00240526|2334177|P3|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|16
965374|NCT00240526|2334178|P2|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|19
965375|NCT00240526|2334179|P1|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|17
965376|NCT00240526|2334176|P4|NOT COMPLETED|Year 15||0
965377|NCT00240526|2334177|P3|NOT COMPLETED|Year 15||0
965378|NCT00240526|2334178|P2|NOT COMPLETED|Year 15||0
965379|NCT00240526|2334179|P1|NOT COMPLETED|Year 15||0
965380|NCT00240526|2334176|P4|COMPLETED|Year 15||21
965381|NCT00240526|2334177|P3|COMPLETED|Year 15||14
965382|NCT00240526|2334178|P2|COMPLETED|Year 15||19
965383|NCT00240526|2334179|P1|COMPLETED|Year 15||19
965384|NCT00240526|2334176|P4|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|21
965385|NCT00240526|2334177|P3|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|14
965386|NCT00240526|2334178|P2|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
965387|NCT00240526|2334179|P1|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
965388|NCT00240539|2334213|P4|NOT COMPLETED|Overall Study||0
965389|NCT00240539|2334214|P3|NOT COMPLETED|Overall Study||0
965390|NCT00240539|2334215|P2|NOT COMPLETED|Overall Study||0
965391|NCT00240539|2334216|P1|NOT COMPLETED|Overall Study||0
965392|NCT00240539|2334213|P4|COMPLETED|Overall Study||1
965393|NCT00240539|2334214|P3|COMPLETED|Overall Study||31
965394|NCT00240539|2334215|P2|COMPLETED|Overall Study||2
965395|NCT00240539|2334216|P1|COMPLETED|Overall Study||2
965396|NCT00240539|2334213|P4|STARTED|Overall Study||1
965397|NCT00240539|2334214|P3|STARTED|Overall Study||31
965398|NCT00240539|2334215|P2|STARTED|Overall Study||2
965399|NCT00240539|2334216|P1|STARTED|Overall Study||2
965400|NCT00240981|2334236|P2|NOT COMPLETED|Overall Study||33
965401|NCT00240981|2334237|P1|NOT COMPLETED|Overall Study||38
965402|NCT00240981|2334236|P2|COMPLETED|Overall Study||70
965403|NCT00240981|2334237|P1|COMPLETED|Overall Study||68
965404|NCT00240981|2334236|P2|Intent to Treat Sample|Overall Study||83
965405|NCT00240981|2334237|P1|Intent to Treat Sample|Overall Study||82
965406|NCT00240981|2334236|P2|STARTED|Overall Study||103
965407|NCT00240981|2334237|P1|STARTED|Overall Study||106
965408|NCT00240994|2334261|P1|NOT COMPLETED|Overall Study||3
965409|NCT00240994|2334261|P1|COMPLETED|Overall Study||32
965410|NCT00240994|2334261|P1|STARTED|Overall Study||35
965411|NCT00241176|2334265|P1|NOT COMPLETED|Overall Study||0
965412|NCT00241176|2334265|P1|COMPLETED|Overall Study||11
965413|NCT00241176|2334265|P1|STARTED|Overall Study||11
965414|NCT00241280|2334274|P2|NOT COMPLETED|Overall Study||68
965415|NCT00241280|2334275|P1|NOT COMPLETED|Overall Study||48
965416|NCT00241280|2334274|P2|COMPLETED|Overall Study||186
965417|NCT00241280|2334275|P1|COMPLETED|Overall Study||199
965418|NCT00241280|2334274|P2|STARTED|Overall Study||254
965419|NCT00241280|2334275|P1|STARTED|Overall Study||247
965420|NCT00241358|2334286|P3|NOT COMPLETED|Overall Study||1
965421|NCT00241358|2334287|P2|NOT COMPLETED|Overall Study||1
965422|NCT00241358|2334288|P1|NOT COMPLETED|Overall Study||0
965423|NCT00241358|2334286|P3|COMPLETED|Overall Study||20
965424|NCT00241358|2334287|P2|COMPLETED|Overall Study||45
965425|NCT00241358|2334288|P1|COMPLETED|Overall Study||25
965426|NCT00241358|2334286|P3|STARTED|Overall Study||21
965427|NCT00241358|2334287|P2|STARTED|Overall Study||46
965428|NCT00241358|2334288|P1|STARTED|Overall Study||25
965429|NCT00241644|2334323|P4|NOT COMPLETED|Second Efficacy Period (Year 2)||118
965430|NCT00241644|2334324|P3|NOT COMPLETED|Second Efficacy Period (Year 2)||64
965431|NCT00241644|2334325|P2|NOT COMPLETED|Second Efficacy Period (Year 2)||57
965432|NCT00241644|2334326|P1|NOT COMPLETED|Second Efficacy Period (Year 2)||61
965433|NCT00241644|2334323|P4|COMPLETED|Second Efficacy Period (Year 2)||1407
965434|NCT00241644|2334324|P3|COMPLETED|Second Efficacy Period (Year 2)||682
965435|NCT00241644|2334325|P2|COMPLETED|Second Efficacy Period (Year 2)||697
965436|NCT00241644|2334326|P1|COMPLETED|Second Efficacy Period (Year 2)||710
965437|NCT00241644|2334323|P4|STARTED|Second Efficacy Period (Year 2)||1525
965438|NCT00241644|2334324|P3|STARTED|Second Efficacy Period (Year 2)||746
965439|NCT00241644|2334325|P2|STARTED|Second Efficacy Period (Year 2)||754
965440|NCT00241644|2334326|P1|STARTED|Second Efficacy Period (Year 2)||771
965441|NCT00241644|2334323|P4|NOT COMPLETED|First Efficacy Period (Year 1)||495
965442|NCT00241644|2334324|P3|NOT COMPLETED|First Efficacy Period (Year 1)||249
965443|NCT00241644|2334325|P2|NOT COMPLETED|First Efficacy Period (Year 1)||268
965444|NCT00241644|2334326|P1|NOT COMPLETED|First Efficacy Period (Year 1)||227
965445|NCT00241644|2334323|P4|COMPLETED|First Efficacy Period (Year 1)||2803
965446|NCT00241644|2334324|P3|COMPLETED|First Efficacy Period (Year 1)||1392
965447|NCT00241644|2334325|P2|COMPLETED|First Efficacy Period (Year 1)||1383
965448|NCT00241644|2334326|P1|COMPLETED|First Efficacy Period (Year 1)||1420
965449|NCT00241644|2334323|P4|STARTED|First Efficacy Period (Year 1)||3298
965450|NCT00241644|2334324|P3|STARTED|First Efficacy Period (Year 1)||1641
965451|NCT00241644|2334325|P2|STARTED|First Efficacy Period (Year 1)||1651
965452|NCT00241644|2334326|P1|STARTED|First Efficacy Period (Year 1)||1647
965453|NCT00247676|2334408|P1|NOT COMPLETED|Overall Study||36
965454|NCT00247676|2334408|P1|COMPLETED|Overall Study||1
965455|NCT00247676|2334408|P1|STARTED|Overall Study||37
965456|NCT00247962|2334438|P2|NOT COMPLETED|Overall Study||19
965457|NCT00247962|2334439|P1|NOT COMPLETED|Overall Study||26
965458|NCT00247962|2334438|P2|COMPLETED|Overall Study||168
965459|NCT00247962|2334439|P1|COMPLETED|Overall Study||353
965460|NCT00247962|2334438|P2|STARTED|Overall Study||187
965461|NCT00247962|2334439|P1|STARTED|Overall Study||379
965468|NCT00249496|2334462|P2|NOT COMPLETED|Overall Study||1
965469|NCT00249496|2334463|P1|NOT COMPLETED|Overall Study||0
965470|NCT00249496|2334462|P2|COMPLETED|Overall Study||26
965471|NCT00249496|2334463|P1|COMPLETED|Overall Study||24
965472|NCT00249496|2334462|P2|STARTED|Overall Study||27
965473|NCT00249496|2334463|P1|STARTED|Overall Study||24
965474|NCT00249613|2334479|P2|NOT COMPLETED|12 Month Follow-up||15
965475|NCT00249613|2334480|P1|NOT COMPLETED|12 Month Follow-up||17
965476|NCT00249613|2334479|P2|COMPLETED|12 Month Follow-up||124
965477|NCT00249613|2334480|P1|COMPLETED|12 Month Follow-up||135
965478|NCT00249613|2334479|P2|STARTED|12 Month Follow-up||139
965479|NCT00249613|2334480|P1|STARTED|12 Month Follow-up||152
965480|NCT00249613|2334479|P2|NOT COMPLETED|Baseline||0
965481|NCT00249613|2334480|P1|NOT COMPLETED|Baseline||0
965482|NCT00249613|2334479|P2|COMPLETED|Baseline||139
965483|NCT00249613|2334480|P1|COMPLETED|Baseline||152
965484|NCT00249613|2334479|P2|STARTED|Baseline||139
965485|NCT00249613|2334480|P1|STARTED|Baseline||152
965486|NCT00249795|2334491|P2|NOT COMPLETED|Overall Study||1390
965487|NCT00249795|2334492|P1|NOT COMPLETED|Overall Study||1394
965488|NCT00249795|2334491|P2|COMPLETED|Overall Study|started and completed study drug|3108
965489|NCT00249795|2334492|P1|COMPLETED|Overall Study|started and completed study drug|3124
965490|NCT00249795|2334491|P2|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4498
965491|NCT00249795|2334492|P1|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4518
965492|NCT00249821|2334512|P2|NOT COMPLETED|Overall Study||1
965493|NCT00249821|2334513|P1|NOT COMPLETED|Overall Study||0
965494|NCT00249821|2334512|P2|COMPLETED|Overall Study||11
965495|NCT00249821|2334513|P1|COMPLETED|Overall Study||10
965496|NCT00249821|2334512|P2|STARTED|Overall Study||12
965497|NCT00249821|2334513|P1|STARTED|Overall Study||10
965498|NCT00249873|2334535|P2|NOT COMPLETED|Overall Study||1254
965499|NCT00249873|2334536|P1|NOT COMPLETED|Overall Study||1330
965500|NCT00249873|2334535|P2|COMPLETED|Overall Study|started and completed study drug|2528
965501|NCT00249873|2334536|P1|COMPLETED|Overall Study|started and completed study drug|2442
965502|NCT00249873|2334535|P2|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3782
965503|NCT00249873|2334536|P1|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3772
965504|NCT00250276|2334552|P4|NOT COMPLETED|Overall Study||19
965505|NCT00250276|2334553|P3|NOT COMPLETED|Overall Study||19
965506|NCT00250276|2334554|P2|NOT COMPLETED|Overall Study||21
965507|NCT00250276|2334555|P1|NOT COMPLETED|Overall Study||17
965508|NCT00250276|2334552|P4|COMPLETED|Overall Study||181
965509|NCT00250276|2334553|P3|COMPLETED|Overall Study||182
965510|NCT00250276|2334554|P2|COMPLETED|Overall Study||177
965511|NCT00250276|2334555|P1|COMPLETED|Overall Study||182
965512|NCT00250276|2334552|P4|STARTED|Overall Study||200
965513|NCT00250276|2334553|P3|STARTED|Overall Study||201
965514|NCT00250276|2334554|P2|STARTED|Overall Study||198
965515|NCT00250276|2334555|P1|STARTED|Overall Study||199
965516|NCT00250432|2334635|P2|NOT COMPLETED|Overall Study||47
965517|NCT00250432|2334636|P1|NOT COMPLETED|Overall Study||45
965518|NCT00250432|2334635|P2|COMPLETED|Overall Study||53
965519|NCT00250432|2334636|P1|COMPLETED|Overall Study||59
965520|NCT00250432|2334635|P2|STARTED|Overall Study||100
965521|NCT00250432|2334636|P1|STARTED|Overall Study||104
965522|NCT00250458|2334646|P2|NOT COMPLETED|Overall Study||17
965523|NCT00250458|2334647|P1|NOT COMPLETED|Overall Study||32
965524|NCT00250458|2334646|P2|COMPLETED|Overall Study||97
965525|NCT00250458|2334647|P1|COMPLETED|Overall Study||200
965526|NCT00250458|2334646|P2|STARTED|Overall Study||114
965527|NCT00250458|2334647|P1|STARTED|Overall Study||232
965534|NCT00250497|2334668|P2|NOT COMPLETED|Overall Study||15
965535|NCT00250497|2334669|P1|NOT COMPLETED|Overall Study||5
965536|NCT00250497|2334668|P2|COMPLETED|Overall Study||159
965537|NCT00250497|2334669|P1|COMPLETED|Overall Study||177
965538|NCT00250497|2334668|P2|STARTED|Overall Study||174
965539|NCT00250497|2334669|P1|STARTED|Overall Study||182
965540|NCT00250588|2334688|P3|NOT COMPLETED|Overall Study||13
965541|NCT00250588|2334689|P2|NOT COMPLETED|Overall Study||19
965542|NCT00250588|2334690|P1|NOT COMPLETED|Overall Study||9
965543|NCT00250588|2334688|P3|COMPLETED|Overall Study||74
965544|NCT00250588|2334689|P2|COMPLETED|Overall Study||65
965545|NCT00250588|2334690|P1|COMPLETED|Overall Study||72
965546|NCT00250588|2334688|P3|STARTED|Overall Study||87
965547|NCT00250588|2334689|P2|STARTED|Overall Study||84
965548|NCT00250588|2334690|P1|STARTED|Overall Study||81
965549|NCT00250679|2334707|P3|NOT COMPLETED|Overall Study||44
965550|NCT00250679|2334708|P2|NOT COMPLETED|Overall Study||49
965551|NCT00250679|2334709|P1|NOT COMPLETED|Overall Study||39
965552|NCT00250679|2334707|P3|COMPLETED|Overall Study||103
965553|NCT00250679|2334708|P2|COMPLETED|Overall Study||100
965554|NCT00250679|2334709|P1|COMPLETED|Overall Study||108
965555|NCT00250679|2334707|P3|STARTED|Overall Study||147
965556|NCT00250679|2334708|P2|STARTED|Overall Study||149
965557|NCT00250679|2334709|P1|STARTED|Overall Study||147
965558|NCT00250705|2334807|P1|NOT COMPLETED|Overall Study||2
965559|NCT00250705|2334807|P1|COMPLETED|Overall Study||10
965560|NCT00250705|2334807|P1|STARTED|Overall Study||12
965561|NCT00250718|2334815|P1|NOT COMPLETED|Overall Study||3
965562|NCT00250718|2334815|P1|COMPLETED|Overall Study||14
965563|NCT00250718|2334815|P1|Received Treatment|Overall Study||16
965564|NCT00250718|2334815|P1|STARTED|Overall Study||17
965565|NCT00250835|2334820|P1|NOT COMPLETED|Overall Study||1
965566|NCT00250835|2334820|P1|COMPLETED|Overall Study||37
965567|NCT00250835|2334820|P1|STARTED|Overall Study||38
965568|NCT00250926|2334829|P1|NOT COMPLETED|Overall Study||0
965569|NCT00250926|2334829|P1|COMPLETED|Overall Study||23
965570|NCT00250926|2334829|P1|STARTED|Overall Study||23
965571|NCT00251004|2334839|P3|NOT COMPLETED|Overall Study||31
965572|NCT00251004|2334840|P2|NOT COMPLETED|Overall Study||41
965573|NCT00251004|2334841|P1|NOT COMPLETED|Overall Study||45
965574|NCT00251004|2334839|P3|COMPLETED|Overall Study||246
965575|NCT00251004|2334840|P2|COMPLETED|Overall Study||238
965576|NCT00251004|2334841|P1|COMPLETED|Overall Study||232
965577|NCT00251004|2334839|P3|24 Month Analysis|Overall Study|Under 24 month analysis under group 3, 185 Completed study medication.|246
965578|NCT00251004|2334840|P2|24 Month Analysis|Overall Study|Under 24 month analysis under group 2, 161 Completed study medication.|238
965579|NCT00251004|2334841|P1|24 Month Analysis|Overall Study|Under 24 month analysis under group 1, 167 Completed study medication.|232
965580|NCT00251004|2334839|P3|12 Month Analysis|Overall Study|Under 12 month analysis under group 3, 200 Completed study medication.|253
965581|NCT00251004|2334840|P2|12 Month Analysis|Overall Study|Under 12 month analysis under group 2, 175 Completed study medication.|249
965582|NCT00251004|2334841|P1|12 Month Analysis|Overall Study|Under 12 month analysis under group 1, 179 Completed study medication.|241
965583|NCT00251004|2334839|P3|STARTED|Overall Study||277
965584|NCT00251004|2334840|P2|STARTED|Overall Study||279
965585|NCT00251004|2334841|P1|STARTED|Overall Study||277
965586|NCT00251225|2334858|P1|NOT COMPLETED|Overall Study||0
965587|NCT00251225|2334858|P1|COMPLETED|Overall Study||49
965588|NCT00251225|2334858|P1|STARTED|Overall Study||49
965589|NCT00251238|2334866|P2|NOT COMPLETED|Overall Study||0
965590|NCT00251238|2334867|P1|NOT COMPLETED|Overall Study||0
965591|NCT00251238|2334866|P2|COMPLETED|Overall Study||20
965592|NCT00251238|2334867|P1|COMPLETED|Overall Study||21
965593|NCT00251238|2334866|P2|STARTED|Overall Study||20
965594|NCT00251238|2334867|P1|STARTED|Overall Study||21
965595|NCT00251303|2334879|P2|NOT COMPLETED|Overall Study||1
965596|NCT00251303|2334880|P1|NOT COMPLETED|Overall Study||8
965597|NCT00251303|2334879|P2|COMPLETED|Overall Study||29
965598|NCT00251303|2334880|P1|COMPLETED|Overall Study||22
965599|NCT00251303|2334879|P2|STARTED|Overall Study||30
965600|NCT00251303|2334880|P1|STARTED|Overall Study|78 subjects signed any consent. 60 started drug (30 riluzole & 30 placebo).|30
965601|NCT00251316|2334890|P2|NOT COMPLETED|Overall Study||3
965602|NCT00251316|2334891|P1|NOT COMPLETED|Overall Study||2
965603|NCT00251316|2334890|P2|COMPLETED|Overall Study||14
965604|NCT00251316|2334891|P1|COMPLETED|Overall Study||15
965605|NCT00251316|2334890|P2|STARTED|Overall Study||17
965606|NCT00251316|2334891|P1|STARTED|Overall Study||17
965607|NCT00251589|2334901|P4|NOT COMPLETED|Overall Study||2
965608|NCT00251589|2334902|P3|NOT COMPLETED|Overall Study||2
965609|NCT00251589|2334903|P2|NOT COMPLETED|Overall Study||3
965610|NCT00251589|2334904|P1|NOT COMPLETED|Overall Study||15
965611|NCT00251589|2334901|P4|COMPLETED|Overall Study||0
965612|NCT00251589|2334902|P3|COMPLETED|Overall Study||0
965613|NCT00251589|2334903|P2|COMPLETED|Overall Study||0
965614|NCT00251589|2334904|P1|COMPLETED|Overall Study||1
965615|NCT00251589|2334901|P4|STARTED|Overall Study||2
965616|NCT00251589|2334902|P3|STARTED|Overall Study||2
965617|NCT00251589|2334903|P2|STARTED|Overall Study||3
965618|NCT00251589|2334904|P1|STARTED|Overall Study|4 of the 16 patients participated in Phase I and II portions. 12 participated in Phase II only.|16
965619|NCT00251641|2334941|P2|NOT COMPLETED|Overall Study||88
965620|NCT00251641|2334942|P1|NOT COMPLETED|Overall Study||112
965621|NCT00251641|2334941|P2|COMPLETED|Overall Study||127
965622|NCT00251641|2334942|P1|COMPLETED|Overall Study||541
965623|NCT00251641|2334941|P2|STARTED|Overall Study||215
965624|NCT00251641|2334942|P1|STARTED|Overall Study||653
965625|NCT00251693|2334959|P3|NOT COMPLETED|Overall Study||46
965626|NCT00251693|2334960|P2|NOT COMPLETED|Overall Study||44
965627|NCT00251693|2334961|P1|NOT COMPLETED|Overall Study||51
965628|NCT00251693|2334959|P3|COMPLETED|Overall Study||644
965629|NCT00251693|2334960|P2|COMPLETED|Overall Study||624
965630|NCT00251693|2334961|P1|COMPLETED|Overall Study||629
965631|NCT00251693|2334959|P3|STARTED|Overall Study||690
965632|NCT00251693|2334960|P2|STARTED|Overall Study||668
965633|NCT00251693|2334961|P1|STARTED|Overall Study||680
965634|NCT00251719|2334987|P3|NOT COMPLETED|Overall Study||30
965635|NCT00251719|2334988|P2|NOT COMPLETED|Overall Study||45
965636|NCT00251719|2334989|P1|NOT COMPLETED|Overall Study||53
965637|NCT00251719|2334987|P3|COMPLETED|Overall Study||643
965638|NCT00251719|2334988|P2|COMPLETED|Overall Study||642
965639|NCT00251719|2334989|P1|COMPLETED|Overall Study||641
965640|NCT00251719|2334987|P3|STARTED|Overall Study||673
965641|NCT00251719|2334988|P2|STARTED|Overall Study||687
965642|NCT00251719|2334989|P1|STARTED|Overall Study||694
965643|NCT00251745|2335015|P3|NOT COMPLETED|Overall Study||27
965644|NCT00251745|2335016|P2|NOT COMPLETED|Overall Study||27
965645|NCT00251745|2335017|P1|NOT COMPLETED|Overall Study||28
965646|NCT00251745|2335015|P3|COMPLETED|Overall Study||277
965647|NCT00251745|2335016|P2|COMPLETED|Overall Study||285
965648|NCT00251745|2335017|P1|COMPLETED|Overall Study||264
965649|NCT00251745|2335015|P3|STARTED|Overall Study||304
965650|NCT00251745|2335016|P2|STARTED|Overall Study||312
965651|NCT00251745|2335017|P1|STARTED|Overall Study||292
965652|NCT00251758|2335037|P3|NOT COMPLETED|Overall Study||27
965653|NCT00251758|2335038|P2|NOT COMPLETED|Overall Study||27
965654|NCT00251758|2335039|P1|NOT COMPLETED|Overall Study||28
965655|NCT00251758|2335037|P3|COMPLETED|Overall Study||277
965656|NCT00251758|2335038|P2|COMPLETED|Overall Study||285
965657|NCT00251758|2335039|P1|COMPLETED|Overall Study||264
965658|NCT00251758|2335037|P3|STARTED|Overall Study||304
965659|NCT00251758|2335038|P2|STARTED|Overall Study||312
965660|NCT00251758|2335039|P1|STARTED|Overall Study||292
965661|NCT00251862|2335059|P3|NOT COMPLETED|Overall Study||0
965662|NCT00251862|2335060|P2|NOT COMPLETED|Overall Study||0
965663|NCT00251862|2335061|P1|NOT COMPLETED|Overall Study||0
965664|NCT00251862|2335059|P3|COMPLETED|Overall Study||276
965665|NCT00251862|2335060|P2|COMPLETED|Overall Study||269
965666|NCT00251862|2335061|P1|COMPLETED|Overall Study||280
965667|NCT00251862|2335059|P3|STARTED|Overall Study||276
965668|NCT00251862|2335060|P2|STARTED|Overall Study||269
965669|NCT00251862|2335061|P1|STARTED|Overall Study||280
965670|NCT00251927|2335080|P2|NOT COMPLETED|Overall Study||74
965671|NCT00251927|2335081|P1|NOT COMPLETED|Overall Study||108
965672|NCT00251927|2335080|P2|COMPLETED|Overall Study|Completed 5 year visit|192
965673|NCT00251927|2335081|P1|COMPLETED|Overall Study|Completed 5 year visit|180
965674|NCT00251927|2335080|P2|STARTED|Overall Study|Randomised|266
965675|NCT00251927|2335081|P1|STARTED|Overall Study|Randomised|288
965676|NCT00244712|2335110|P2|NOT COMPLETED|Overall Study||124
965677|NCT00244712|2335111|P1|NOT COMPLETED|Overall Study||109
965678|NCT00244712|2335110|P2|COMPLETED|Overall Study||221
965679|NCT00244712|2335111|P1|COMPLETED|Overall Study||234
965680|NCT00244712|2335110|P2|STARTED|Overall Study||345
965681|NCT00244712|2335111|P1|STARTED|Overall Study||343
965682|NCT00244725|2335147|P4|NOT COMPLETED|Overall Study||21
965683|NCT00244725|2335148|P3|NOT COMPLETED|Overall Study||24
965684|NCT00244725|2335149|P2|NOT COMPLETED|Overall Study||19
965685|NCT00244725|2335150|P1|NOT COMPLETED|Overall Study||23
965686|NCT00244725|2335147|P4|COMPLETED|Overall Study||216
965687|NCT00244725|2335148|P3|COMPLETED|Overall Study||215
965688|NCT00244725|2335149|P2|COMPLETED|Overall Study||226
965689|NCT00244725|2335150|P1|COMPLETED|Overall Study||214
965690|NCT00244725|2335147|P4|STARTED|Overall Study||237
965691|NCT00244725|2335148|P3|STARTED|Overall Study||239
965692|NCT00244725|2335149|P2|STARTED|Overall Study||245
965693|NCT00244725|2335150|P1|STARTED|Overall Study||237
965694|NCT00244764|2335204|P1|NOT COMPLETED|Overall Study||96
965695|NCT00244764|2335204|P1|COMPLETED|Overall Study||129
965696|NCT00244764|2335204|P1|STARTED|Overall Study||225
965697|NCT00244855|2335213|P2|NOT COMPLETED|Overall Study||1
965698|NCT00244855|2335214|P1|NOT COMPLETED|Overall Study||0
965699|NCT00244855|2335213|P2|COMPLETED|Overall Study||24
965700|NCT00244855|2335214|P1|COMPLETED|Overall Study||7
965701|NCT00244855|2335213|P2|STARTED|Overall Study||25
965702|NCT00244855|2335214|P1|STARTED|Overall Study||7
965703|NCT00244881|2335222|P1|NOT COMPLETED|Overall Study||3
965704|NCT00244881|2335222|P1|COMPLETED|Overall Study||23
965705|NCT00244881|2335222|P1|STARTED|Overall Study||26
965706|NCT00244933|2335228|P1|NOT COMPLETED|Overall Study||2
965707|NCT00244933|2335228|P1|COMPLETED|Overall Study||17
965708|NCT00244933|2335228|P1|STARTED|Overall Study||19
965709|NCT00244985|2335232|P1|NOT COMPLETED|Overall Study||0
965710|NCT00244985|2335232|P1|COMPLETED|Overall Study||42
965711|NCT00244985|2335232|P1|STARTED|Overall Study||42
965712|NCT00245011|2335240|P1|NOT COMPLETED|Overall Study||1
965713|NCT00245011|2335240|P1|COMPLETED|Overall Study|Subject had disease progression prior to completing study.|10
965714|NCT00245011|2335240|P1|STARTED|Overall Study||11
965718|NCT00245050|2335256|P2|NOT COMPLETED|Overall Study||2
965719|NCT00245050|2335257|P1|NOT COMPLETED|Overall Study||3
965720|NCT00245050|2335256|P2|COMPLETED|Overall Study||14
965721|NCT00245050|2335257|P1|COMPLETED|Overall Study||15
965722|NCT00245050|2335256|P2|STARTED|Overall Study||16
965723|NCT00245050|2335257|P1|STARTED|Overall Study||18
965724|NCT00245063|2335267|P2|NOT COMPLETED|Overall Study||5
965725|NCT00245063|2335268|P1|NOT COMPLETED|Overall Study||7
965726|NCT00245063|2335267|P2|COMPLETED|Overall Study||8
965727|NCT00245063|2335268|P1|COMPLETED|Overall Study||5
965728|NCT00245063|2335267|P2|STARTED|Overall Study||13
965729|NCT00245063|2335268|P1|STARTED|Overall Study||12
965730|NCT00251979|2335276|P2|NOT COMPLETED|Overall Study||40
965731|NCT00251979|2335277|P1|NOT COMPLETED|Overall Study||38
965732|NCT00251979|2335276|P2|COMPLETED|Overall Study||349
965733|NCT00251979|2335277|P1|COMPLETED|Overall Study||337
965734|NCT00251979|2335276|P2|STARTED|Overall Study|ITT population|389
965735|NCT00251979|2335277|P1|STARTED|Overall Study|ITT population|375
965736|NCT00252057|2335309|P2|NOT COMPLETED|Overall Study||8
965737|NCT00252057|2335310|P1|NOT COMPLETED|Overall Study||3
965738|NCT00252057|2335309|P2|COMPLETED|Overall Study||368
965739|NCT00252057|2335310|P1|COMPLETED|Overall Study||370
965740|NCT00252057|2335309|P2|STARTED|Overall Study||376
965741|NCT00252057|2335310|P1|STARTED|Overall Study||373
965742|NCT00252174|2335319|P3|NOT COMPLETED|Overall Study||0
965743|NCT00252174|2335320|P2|NOT COMPLETED|Overall Study||1
965744|NCT00252174|2335321|P1|NOT COMPLETED|Overall Study||0
965745|NCT00252174|2335319|P3|COMPLETED|Overall Study||0
965746|NCT00252174|2335320|P2|COMPLETED|Overall Study||1
965747|NCT00252174|2335321|P1|COMPLETED|Overall Study||0
965748|NCT00252174|2335319|P3|STARTED|Overall Study|No subjects entered Stage 2|0
965749|NCT00252174|2335320|P2|STARTED|Overall Study|2 subjects entered the control arm in total|2
965750|NCT00252174|2335321|P1|STARTED|Overall Study|No subjects were randomized into Active Arm as only 2 subjects were randomized into the Control Arm.|0
965751|NCT00252187|2335358|P2|NOT COMPLETED|Overall Study||1
965752|NCT00252187|2335359|P1|NOT COMPLETED|Overall Study||4
965753|NCT00252187|2335358|P2|COMPLETED|Overall Study||20
965754|NCT00252187|2335359|P1|COMPLETED|Overall Study||20
965755|NCT00252187|2335358|P2|STARTED|Overall Study||21
965756|NCT00252187|2335359|P1|STARTED|Overall Study||24
965757|NCT00252239|2335383|P4|NOT COMPLETED|Overall Study||1
965758|NCT00252239|2335384|P3|NOT COMPLETED|Overall Study||2
965759|NCT00252239|2335385|P2|NOT COMPLETED|Overall Study||0
965760|NCT00252239|2335386|P1|NOT COMPLETED|Overall Study||1
965761|NCT00252239|2335383|P4|COMPLETED|Overall Study||30
965762|NCT00252239|2335384|P3|COMPLETED|Overall Study||17
965763|NCT00252239|2335385|P2|COMPLETED|Overall Study||31
965764|NCT00252239|2335386|P1|COMPLETED|Overall Study||30
965765|NCT00252239|2335383|P4|STARTED|Overall Study||31
965766|NCT00252239|2335384|P3|STARTED|Overall Study||19
965767|NCT00252239|2335385|P2|STARTED|Overall Study||31
965768|NCT00252239|2335386|P1|STARTED|Overall Study||31
965769|NCT00252967|2335398|P2|NOT COMPLETED|Overall Study||0
965770|NCT00252967|2335399|P1|NOT COMPLETED|Overall Study||0
965771|NCT00252967|2335398|P2|COMPLETED|Overall Study||33
965772|NCT00252967|2335399|P1|COMPLETED|Overall Study||31
965773|NCT00252967|2335398|P2|STARTED|Overall Study||33
965774|NCT00252967|2335399|P1|STARTED|Overall Study||31
965775|NCT00253019|2335424|P3|NOT COMPLETED|Overall Study||18
965776|NCT00253019|2335425|P2|NOT COMPLETED|Overall Study||31
965777|NCT00253019|2335426|P1|NOT COMPLETED|Overall Study||29
965778|NCT00253019|2335424|P3|COMPLETED|Overall Study||83
965779|NCT00253019|2335425|P2|COMPLETED|Overall Study||78
965780|NCT00253019|2335426|P1|COMPLETED|Overall Study||82
965781|NCT00253019|2335424|P3|STARTED|Overall Study||101
965782|NCT00253019|2335425|P2|STARTED|Overall Study||109
965783|NCT00253019|2335426|P1|STARTED|Overall Study||111
965784|NCT00253370|2335434|P1|NOT COMPLETED|Overall Study||43
965785|NCT00253370|2335434|P1|COMPLETED|Overall Study||1
965786|NCT00253370|2335434|P1|STARTED|Overall Study||44
965787|NCT00253435|2335442|P2|NOT COMPLETED|Overall Study||0
965788|NCT00253435|2335443|P1|NOT COMPLETED|Overall Study||0
965789|NCT00253435|2335442|P2|COMPLETED|Overall Study|Eight evaluable patients enrolled.|8
965790|NCT00253435|2335443|P1|COMPLETED|Overall Study|Forty-two evaluable poor risk patients enrolled.|42
965791|NCT00253435|2335442|P2|3rd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
965792|NCT00253435|2335443|P1|3rd Interim Analysis|Overall Study|Third interim analysis: need 4+ responses in first 35 patients. Goal met study continued.|10
965793|NCT00253435|2335442|P2|2nd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
965794|NCT00253435|2335443|P1|2nd Interim Analysis|Overall Study|Second interim analysis: need 3+ responses in first 25 patients. Goal met study continued.|10
965795|NCT00253435|2335442|P2|1st Interim Analysis|Overall Study|Only interim analysis: need 1+ response in first 10 patients.|8
965796|NCT00253435|2335443|P1|1st Interim Analysis|Overall Study|First interim analysis: need 2+ responses in first 15 patients. Goal met study continued.|15
965797|NCT00253435|2335442|P2|STARTED|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|8
965798|NCT00253435|2335443|P1|STARTED|Overall Study|Total number is 42|42
965799|NCT00253448|2335455|P1|NOT COMPLETED|Overall Study||1
965800|NCT00253448|2335455|P1|COMPLETED|Overall Study||34
965801|NCT00253448|2335455|P1|STARTED|Overall Study||35
965802|NCT00253513|2335459|P1|NOT COMPLETED|Overall Study||0
965803|NCT00253513|2335459|P1|COMPLETED|Overall Study||60
965804|NCT00253513|2335459|P1|STARTED|Overall Study||60
965805|NCT00253643|2335470|P4|NOT COMPLETED|Overall Study||3
965806|NCT00253643|2335471|P3|NOT COMPLETED|Overall Study||1
965807|NCT00253643|2335472|P2|NOT COMPLETED|Overall Study||0
965808|NCT00253643|2335473|P1|NOT COMPLETED|Overall Study||0
965809|NCT00253643|2335470|P4|COMPLETED|Overall Study||28
965810|NCT00253643|2335471|P3|COMPLETED|Overall Study||28
965811|NCT00253643|2335472|P2|COMPLETED|Overall Study||15
965812|NCT00253643|2335473|P1|COMPLETED|Overall Study||14
965813|NCT00253643|2335470|P4|STARTED|Overall Study||31
965814|NCT00253643|2335471|P3|STARTED|Overall Study||29
965815|NCT00253643|2335472|P2|STARTED|Overall Study||15
965816|NCT00253643|2335473|P1|STARTED|Overall Study||14
965817|NCT00253708|2335490|P3|NOT COMPLETED|Overall Study||1
965818|NCT00253708|2335491|P2|NOT COMPLETED|Overall Study||0
965819|NCT00253708|2335492|P1|NOT COMPLETED|Overall Study||0
965820|NCT00253708|2335490|P3|COMPLETED|Overall Study||8
965821|NCT00253708|2335491|P2|COMPLETED|Overall Study||10
965822|NCT00253708|2335492|P1|COMPLETED|Overall Study||20
965823|NCT00253708|2335490|P3|STARTED|Overall Study||9
965824|NCT00253708|2335491|P2|STARTED|Overall Study||10
965825|NCT00253708|2335492|P1|STARTED|Overall Study||20
965826|NCT00253747|2335520|P2|NOT COMPLETED|Overall Study||27
965827|NCT00253747|2335521|P1|NOT COMPLETED|Overall Study||24
965828|NCT00253747|2335520|P2|COMPLETED|Overall Study||101
965829|NCT00253747|2335521|P1|COMPLETED|Overall Study||103
965830|NCT00253747|2335520|P2|STARTED|Overall Study||128
965831|NCT00253747|2335521|P1|STARTED|Overall Study||127
965832|NCT00253890|2335541|P2|NOT COMPLETED|Overall Study||7
965833|NCT00253890|2335542|P1|NOT COMPLETED|Overall Study||7
965834|NCT00253890|2335541|P2|COMPLETED|Overall Study||61
965835|NCT00253890|2335542|P1|COMPLETED|Overall Study||62
965836|NCT00253890|2335541|P2|STARTED|Overall Study||68
965837|NCT00253890|2335542|P1|STARTED|Overall Study||69
965838|NCT00253981|2335550|P2|NOT COMPLETED|Overall Study||0
965839|NCT00253981|2335551|P1|NOT COMPLETED|Overall Study||0
965840|NCT00253981|2335550|P2|COMPLETED|Overall Study||14
965841|NCT00253981|2335551|P1|COMPLETED|Overall Study||16
965842|NCT00253981|2335550|P2|STARTED|Overall Study||14
965843|NCT00253981|2335551|P1|STARTED|Overall Study||16
965844|NCT00254072|2335559|P2|NOT COMPLETED|Overall Study||0
965845|NCT00254072|2335560|P1|NOT COMPLETED|Overall Study||0
965846|NCT00254072|2335559|P2|COMPLETED|Overall Study||175
965847|NCT00254072|2335560|P1|COMPLETED|Overall Study||180
965848|NCT00254072|2335559|P2|STARTED|Overall Study||175
965849|NCT00254072|2335560|P1|STARTED|Overall Study||180
965850|NCT00254163|2335568|P2|NOT COMPLETED|Overall Study||46
965851|NCT00254163|2335569|P1|NOT COMPLETED|Overall Study||45
965852|NCT00254163|2335568|P2|COMPLETED|Overall Study||46
965853|NCT00254163|2335569|P1|COMPLETED|Overall Study||47
965854|NCT00254163|2335568|P2|STARTED|Overall Study||92
965855|NCT00254163|2335569|P1|STARTED|Overall Study||92
965856|NCT00254293|2335597|P7|NOT COMPLETED|LTE Open Label Fixed Dosing||13
965857|NCT00254293|2335598|P6|NOT COMPLETED|LTE Open Label Fixed Dosing||0
965858|NCT00254293|2335599|P5|NOT COMPLETED|LTE Open Label Fixed Dosing||0
965859|NCT00254293|2335600|P4|NOT COMPLETED|LTE Open Label Fixed Dosing||0
965860|NCT00254293|2335601|P3|NOT COMPLETED|LTE Open Label Fixed Dosing||0
965861|NCT00254293|2335602|P2|NOT COMPLETED|LTE Open Label Fixed Dosing||0
965862|NCT00254293|2335603|P1|NOT COMPLETED|LTE Open Label Fixed Dosing||0
965863|NCT00254293|2335597|P7|COMPLETED|LTE Open Label Fixed Dosing||35
965864|NCT00254293|2335598|P6|COMPLETED|LTE Open Label Fixed Dosing||0
965865|NCT00254293|2335599|P5|COMPLETED|LTE Open Label Fixed Dosing||0
965866|NCT00254293|2335600|P4|COMPLETED|LTE Open Label Fixed Dosing||0
965867|NCT00254293|2335601|P3|COMPLETED|LTE Open Label Fixed Dosing||0
965868|NCT00254293|2335602|P2|COMPLETED|LTE Open Label Fixed Dosing||0
965869|NCT00254293|2335603|P1|COMPLETED|LTE Open Label Fixed Dosing||0
965870|NCT00254293|2335597|P7|STARTED|LTE Open Label Fixed Dosing||48
965871|NCT00254293|2335598|P6|STARTED|LTE Open Label Fixed Dosing||0
965872|NCT00254293|2335599|P5|STARTED|LTE Open Label Fixed Dosing||0
965873|NCT00254293|2335600|P4|STARTED|LTE Open Label Fixed Dosing||0
965874|NCT00254293|2335601|P3|STARTED|LTE Open Label Fixed Dosing||0
965875|NCT00254293|2335602|P2|STARTED|LTE Open Label Fixed Dosing||0
965876|NCT00254293|2335603|P1|STARTED|LTE Open Label Fixed Dosing||0
965877|NCT00254293|2335597|P7|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
965878|NCT00254293|2335598|P6|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
965879|NCT00254293|2335599|P5|NOT COMPLETED|LTE Open Label Variable SC Dosing||2
965880|NCT00254293|2335600|P4|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
965881|NCT00254293|2335601|P3|NOT COMPLETED|LTE Open Label Variable SC Dosing||10
965882|NCT00254293|2335602|P2|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
965883|NCT00254293|2335603|P1|NOT COMPLETED|LTE Open Label Variable SC Dosing||3
965884|NCT00254293|2335597|P7|COMPLETED|LTE Open Label Variable SC Dosing||0
965885|NCT00254293|2335598|P6|COMPLETED|LTE Open Label Variable SC Dosing||0
965886|NCT00254293|2335599|P5|COMPLETED|LTE Open Label Variable SC Dosing||8
965887|NCT00254293|2335600|P4|COMPLETED|LTE Open Label Variable SC Dosing||0
965888|NCT00254293|2335601|P3|COMPLETED|LTE Open Label Variable SC Dosing||32
965889|NCT00254293|2335602|P2|COMPLETED|LTE Open Label Variable SC Dosing||0
965890|NCT00254293|2335603|P1|COMPLETED|LTE Open Label Variable SC Dosing||8
965891|NCT00254293|2335597|P7|STARTED|LTE Open Label Variable SC Dosing|Participant rolled over from LTE (Variable Dose Period) to LTE (Fixed Dose Period).|0
965892|NCT00254293|2335598|P6|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to a variable SC dose group of 75, 125 or 200 mg Weekly by body weight.|0
965893|NCT00254293|2335599|P5|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to variable SC dose group (by body weight, >100kg).|10
965894|NCT00254293|2335600|P4|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
965895|NCT00254293|2335601|P3|STARTED|LTE Open Label Variable SC Dosing|Variable SC dose group: 125 mg Weekly, body weight <60 to >100kg (Groups 2, 3, 4 in ST Period).|42
965980|NCT00255047|2335832|P4|COMPLETED|Overall Study||502
965896|NCT00254293|2335602|P2|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
965897|NCT00254293|2335603|P1|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to 75mg SC dose group (by body weight, <60kg).|11
965898|NCT00254293|2335597|P7|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
965899|NCT00254293|2335598|P6|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
965900|NCT00254293|2335599|P5|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
965901|NCT00254293|2335600|P4|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
965902|NCT00254293|2335601|P3|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||3
965903|NCT00254293|2335602|P2|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
965904|NCT00254293|2335603|P1|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
965905|NCT00254293|2335597|P7|COMPLETED|Short Term (12 Week) Randomized Dosing||0
965906|NCT00254293|2335598|P6|COMPLETED|Short Term (12 Week) Randomized Dosing||17
965907|NCT00254293|2335599|P5|COMPLETED|Short Term (12 Week) Randomized Dosing||5
965908|NCT00254293|2335600|P4|COMPLETED|Short Term (12 Week) Randomized Dosing||5
965909|NCT00254293|2335601|P3|COMPLETED|Short Term (12 Week) Randomized Dosing||26
965910|NCT00254293|2335602|P2|COMPLETED|Short Term (12 Week) Randomized Dosing||3
965911|NCT00254293|2335603|P1|COMPLETED|Short Term (12 Week) Randomized Dosing||7
965912|NCT00254293|2335597|P7|STARTED|Short Term (12 Week) Randomized Dosing||0
965913|NCT00254293|2335598|P6|STARTED|Short Term (12 Week) Randomized Dosing|2, 2, 9, 2, and 2 were randomized to placebo in body weight Groups 1, 2, 3, 4, 5, respectively.|17
965914|NCT00254293|2335599|P5|STARTED|Short Term (12 Week) Randomized Dosing||5
965915|NCT00254293|2335600|P4|STARTED|Short Term (12 Week) Randomized Dosing||6
965916|NCT00254293|2335601|P3|STARTED|Short Term (12 Week) Randomized Dosing||29
965917|NCT00254293|2335602|P2|STARTED|Short Term (12 Week) Randomized Dosing||4
965918|NCT00254293|2335603|P1|STARTED|Short Term (12 Week) Randomized Dosing||7
965919|NCT00254462|2335686|P2|NOT COMPLETED|Overall Study||10
965920|NCT00254462|2335687|P1|NOT COMPLETED|Overall Study||8
965921|NCT00254462|2335686|P2|COMPLETED|Overall Study||39
965922|NCT00254462|2335687|P1|COMPLETED|Overall Study||36
965923|NCT00254462|2335686|P2|STARTED|Overall Study||49
965924|NCT00254462|2335687|P1|STARTED|Overall Study||44
965925|NCT00254501|2335697|P2|NOT COMPLETED|Overall Study||1
965926|NCT00254501|2335698|P1|NOT COMPLETED|Overall Study||1
965927|NCT00254501|2335697|P2|COMPLETED|Overall Study||36
965928|NCT00254501|2335698|P1|COMPLETED|Overall Study||31
965929|NCT00254501|2335697|P2|STARTED|Overall Study||37
965930|NCT00254501|2335698|P1|STARTED|Overall Study||32
965931|NCT00254540|2335712|P2|NOT COMPLETED|Overall Study||22
965932|NCT00254540|2335713|P1|NOT COMPLETED|Overall Study||19
965933|NCT00254540|2335712|P2|COMPLETED|Overall Study||4
965934|NCT00254540|2335713|P1|COMPLETED|Overall Study||6
965935|NCT00254540|2335712|P2|STARTED|Overall Study|All 26 subjects enrolled were included in Intent-To Treat population.|26
965936|NCT00254540|2335713|P1|STARTED|Overall Study|All 25 subjects enrolled were included in Intent-To Treat population.|25
965937|NCT00254566|2335742|P2|NOT COMPLETED|Overall Study||26
965938|NCT00254566|2335743|P1|NOT COMPLETED|Overall Study||31
965939|NCT00254566|2335742|P2|COMPLETED|Overall Study||172
965940|NCT00254566|2335743|P1|COMPLETED|Overall Study||167
965941|NCT00254566|2335742|P2|STARTED|Overall Study||198
965942|NCT00254566|2335743|P1|STARTED|Overall Study||198
965943|NCT00254592|2335765|P1|NOT COMPLETED|Overall Study||2
965944|NCT00254592|2335765|P1|COMPLETED|Overall Study||41
965945|NCT00254592|2335765|P1|STARTED|Overall Study||43
965946|NCT00254982|2335771|P2|NOT COMPLETED|Overall Study||31
965947|NCT00254982|2335772|P1|NOT COMPLETED|Overall Study||36
965948|NCT00254982|2335771|P2|COMPLETED|Overall Study||265
965949|NCT00254982|2335772|P1|COMPLETED|Overall Study||261
965950|NCT00254982|2335771|P2|STARTED|Overall Study||296
965951|NCT00254982|2335772|P1|STARTED|Overall Study||297
965952|NCT00254995|2335780|P2|NOT COMPLETED|Overall Study||0
965953|NCT00254995|2335781|P1|NOT COMPLETED|Overall Study||0
965954|NCT00254995|2335780|P2|COMPLETED|Overall Study||31065
965955|NCT00254995|2335781|P1|COMPLETED|Overall Study||31561
965956|NCT00254995|2335780|P2|STARTED|Overall Study||31065
965957|NCT00254995|2335781|P1|STARTED|Overall Study||31561
965958|NCT00255008|2335806|P4|NOT COMPLETED|Overall Study||22
965959|NCT00255008|2335807|P3|NOT COMPLETED|Overall Study||16
965960|NCT00255008|2335808|P2|NOT COMPLETED|Overall Study||9
965961|NCT00255008|2335809|P1|NOT COMPLETED|Overall Study||32
965962|NCT00255008|2335806|P4|COMPLETED|Overall Study||12
965963|NCT00255008|2335807|P3|COMPLETED|Overall Study||17
965964|NCT00255008|2335808|P2|COMPLETED|Overall Study||0
965965|NCT00255008|2335809|P1|COMPLETED|Overall Study|The study was terminated early and as a result only 42 patients completed the study.|13
965966|NCT00255008|2335806|P4|STARTED|Overall Study||34
965967|NCT00255008|2335807|P3|STARTED|Overall Study||33
965968|NCT00255008|2335808|P2|STARTED|Overall Study||9
965969|NCT00255008|2335809|P1|STARTED|Overall Study||45
965970|NCT00255034|2335821|P2|NOT COMPLETED|Overall Study||38
965971|NCT00255034|2335822|P1|NOT COMPLETED|Overall Study||15
965972|NCT00255034|2335821|P2|COMPLETED|Overall Study||26
965973|NCT00255034|2335822|P1|COMPLETED|Overall Study||64
965974|NCT00255034|2335821|P2|STARTED|Overall Study||64
965975|NCT00255034|2335822|P1|STARTED|Overall Study||79
965976|NCT00255047|2335832|P4|NOT COMPLETED|Overall Study||46
965977|NCT00255047|2335833|P3|NOT COMPLETED|Overall Study||50
965978|NCT00255047|2335834|P2|NOT COMPLETED|Overall Study||48
965979|NCT00255047|2335835|P1|NOT COMPLETED|Overall Study||48
965981|NCT00255047|2335833|P3|COMPLETED|Overall Study||496
965982|NCT00255047|2335834|P2|COMPLETED|Overall Study||487
965983|NCT00255047|2335835|P1|COMPLETED|Overall Study||490
965984|NCT00255047|2335832|P4|STARTED|Overall Study||548
965985|NCT00255047|2335833|P3|STARTED|Overall Study||546
965986|NCT00255047|2335834|P2|STARTED|Overall Study||535
965987|NCT00255047|2335835|P1|STARTED|Overall Study||538
965988|NCT00255086|2335859|P2|NOT COMPLETED|Overall Study||2
965989|NCT00255086|2335860|P1|NOT COMPLETED|Overall Study||2
965990|NCT00255086|2335859|P2|COMPLETED|Overall Study||6
965991|NCT00255086|2335860|P1|COMPLETED|Overall Study||7
965992|NCT00255086|2335859|P2|STARTED|Overall Study||8
965993|NCT00255086|2335860|P1|STARTED|Overall Study||9
965994|NCT00255125|2335870|P2|NOT COMPLETED|Overall Study||0
965995|NCT00255125|2335871|P1|NOT COMPLETED|Overall Study||0
965996|NCT00255125|2335870|P2|COMPLETED|Overall Study||42
965997|NCT00255125|2335871|P1|COMPLETED|Overall Study||44
965998|NCT00255125|2335870|P2|STARTED|Overall Study||42
965999|NCT00255125|2335871|P1|STARTED|Overall Study||44
966000|NCT00255151|2335880|P3|NOT COMPLETED|Overall Study||49
966001|NCT00255151|2335881|P2|NOT COMPLETED|Overall Study||49
966002|NCT00255151|2335882|P1|NOT COMPLETED|Overall Study||123
966003|NCT00255151|2335880|P3|COMPLETED|Overall Study||103
966004|NCT00255151|2335881|P2|COMPLETED|Overall Study||110
966005|NCT00255151|2335882|P1|COMPLETED|Overall Study||17
966006|NCT00255151|2335880|P3|STARTED|Overall Study||152
966007|NCT00255151|2335881|P2|STARTED|Overall Study||159
966008|NCT00255151|2335882|P1|STARTED|Overall Study||140
966009|NCT00255164|2335908|P3|NOT COMPLETED|Overall Study||49
966010|NCT00255164|2335909|P2|NOT COMPLETED|Overall Study||49
966011|NCT00255164|2335910|P1|NOT COMPLETED|Overall Study||123
966012|NCT00255164|2335908|P3|COMPLETED|Overall Study||103
966013|NCT00255164|2335909|P2|COMPLETED|Overall Study||110
966014|NCT00255164|2335910|P1|COMPLETED|Overall Study||17
966015|NCT00255164|2335908|P3|STARTED|Overall Study||152
966016|NCT00255164|2335909|P2|STARTED|Overall Study||159
966017|NCT00255164|2335910|P1|STARTED|Overall Study||140
966018|NCT00255177|2335937|P4|NOT COMPLETED|Overall Study||2
966019|NCT00255177|2335938|P3|NOT COMPLETED|Overall Study||1
966020|NCT00255177|2335939|P2|NOT COMPLETED|Overall Study||1
966021|NCT00255177|2335940|P1|NOT COMPLETED|Overall Study||2
966022|NCT00255177|2335937|P4|COMPLETED|Overall Study||4
966023|NCT00255177|2335938|P3|COMPLETED|Overall Study||12
966024|NCT00255177|2335939|P2|COMPLETED|Overall Study||13
966025|NCT00255177|2335940|P1|COMPLETED|Overall Study||9
966026|NCT00255177|2335937|P4|STARTED|Overall Study||6
966027|NCT00255177|2335938|P3|STARTED|Overall Study||13
966028|NCT00255177|2335939|P2|STARTED|Overall Study||14
966029|NCT00255177|2335940|P1|STARTED|Overall Study||11
966030|NCT00255190|2335952|P2|NOT COMPLETED|Overall Study||157
966031|NCT00255190|2335953|P1|NOT COMPLETED|Overall Study||50
966032|NCT00255190|2335952|P2|COMPLETED|Overall Study||281
966033|NCT00255190|2335953|P1|COMPLETED|Overall Study||103
966034|NCT00255190|2335952|P2|STARTED|Overall Study||438
966035|NCT00255190|2335953|P1|STARTED|Overall Study||153
966036|NCT00248170|2336019|P2|NOT COMPLETED|Overall Study||808
966037|NCT00248170|2336020|P1|NOT COMPLETED|Overall Study||761
966038|NCT00248170|2336019|P2|COMPLETED|Overall Study||1286
966039|NCT00248170|2336020|P1|COMPLETED|Overall Study||1317
966040|NCT00248170|2336019|P2|Safety Set|Overall Study||2062
966041|NCT00248170|2336020|P1|Safety Set|Overall Study||2049
966042|NCT00248170|2336019|P2|Intent-to-treat (ITT)|Overall Study||2075
966043|NCT00248170|2336020|P1|Intent-to-treat (ITT)|Overall Study||2061
966044|NCT00248170|2336019|P2|STARTED|Overall Study||2094
966045|NCT00248170|2336020|P1|STARTED|Overall Study||2078
966046|NCT00248287|2336042|P2|NOT COMPLETED|Overall Study||19
966047|NCT00248287|2336043|P1|NOT COMPLETED|Overall Study||24
966048|NCT00248287|2336042|P2|COMPLETED|Overall Study||60
966049|NCT00248287|2336043|P1|COMPLETED|Overall Study||51
966050|NCT00248287|2336042|P2|STARTED|Overall Study||79
966051|NCT00248287|2336043|P1|STARTED|Overall Study||75
966052|NCT00248495|2336055|P1|NOT COMPLETED|Overall Study||1
966053|NCT00248495|2336055|P1|COMPLETED|Overall Study||37
966054|NCT00248495|2336055|P1|STARTED|Overall Study||38
966055|NCT00248547|2336066|P2|NOT COMPLETED|Overall Study||0
966056|NCT00248547|2336067|P1|NOT COMPLETED|Overall Study||0
966057|NCT00248547|2336066|P2|COMPLETED|Overall Study||20
966058|NCT00248547|2336067|P1|COMPLETED|Overall Study||20
966059|NCT00248547|2336066|P2|STARTED|Overall Study||20
966060|NCT00248547|2336067|P1|STARTED|Overall Study||20
966061|NCT00248560|2336073|P1|NOT COMPLETED|Overall Study||0
966062|NCT00248560|2336073|P1|COMPLETED|Overall Study||36
966063|NCT00248560|2336073|P1|STARTED|Overall Study||36
966064|NCT00248612|2336081|P4|NOT COMPLETED|Overall Study||0
966065|NCT00248612|2336082|P3|NOT COMPLETED|Overall Study||0
966066|NCT00248612|2336083|P2|NOT COMPLETED|Overall Study||0
966067|NCT00248612|2336084|P1|NOT COMPLETED|Overall Study||0
966068|NCT00248612|2336081|P4|COMPLETED|Overall Study||22
966069|NCT00248612|2336082|P3|COMPLETED|Overall Study||14
966070|NCT00248612|2336083|P2|COMPLETED|Overall Study||21
966071|NCT00248612|2336084|P1|COMPLETED|Overall Study||24
966072|NCT00248612|2336081|P4|STARTED|Overall Study||22
966073|NCT00248612|2336082|P3|STARTED|Overall Study||14
966074|NCT00248612|2336083|P2|STARTED|Overall Study||21
966075|NCT00248612|2336084|P1|STARTED|Overall Study||24
966076|NCT00248625|2336128|P2|NOT COMPLETED|Overall Study||2
966077|NCT00248625|2336129|P1|NOT COMPLETED|Overall Study||0
966078|NCT00248625|2336128|P2|COMPLETED|Overall Study||90
966079|NCT00248625|2336129|P1|COMPLETED|Overall Study||92
966080|NCT00248625|2336128|P2|STARTED|Overall Study||92
966081|NCT00248625|2336129|P1|STARTED|Overall Study||92
966082|NCT00248638|2336151|P2|NOT COMPLETED|Overall Study||0
966083|NCT00248638|2336152|P1|NOT COMPLETED|Overall Study||0
966084|NCT00248638|2336151|P2|COMPLETED|Overall Study||75
966085|NCT00248638|2336152|P1|COMPLETED|Overall Study||75
966086|NCT00248638|2336151|P2|STARTED|Overall Study||75
966087|NCT00248638|2336152|P1|STARTED|Overall Study||75
966088|NCT00248651|2336163|P3|NOT COMPLETED|Overall Study||32
966089|NCT00248651|2336164|P2|NOT COMPLETED|Overall Study||40
966090|NCT00248651|2336165|P1|NOT COMPLETED|Overall Study||28
966091|NCT00248651|2336163|P3|COMPLETED|Overall Study||65
966092|NCT00248651|2336164|P2|COMPLETED|Overall Study||58
966093|NCT00248651|2336165|P1|COMPLETED|Overall Study||69
966094|NCT00248651|2336163|P3|Completed 12 Weeks of Treatment|Overall Study||75
966095|NCT00248651|2336164|P2|Completed 12 Weeks of Treatment|Overall Study||66
966096|NCT00248651|2336165|P1|Completed 12 Weeks of Treatment|Overall Study||78
966097|NCT00248651|2336163|P3|STARTED|Overall Study||97
966098|NCT00248651|2336164|P2|STARTED|Overall Study||98
966099|NCT00248651|2336165|P1|STARTED|Overall Study||97
966100|NCT00248781|2336184|P2|NOT COMPLETED|Overall Study||4
966101|NCT00248781|2336185|P1|NOT COMPLETED|Overall Study||10
966102|NCT00248781|2336184|P2|COMPLETED|Overall Study||47
966103|NCT00248781|2336185|P1|COMPLETED|Overall Study||42
966104|NCT00248781|2336184|P2|STARTED|Overall Study||51
966105|NCT00248781|2336185|P1|STARTED|Overall Study||52
966106|NCT00248794|2336212|P3|NOT COMPLETED|Overall Study||3
966107|NCT00248794|2336213|P2|NOT COMPLETED|Overall Study||8
966108|NCT00248794|2336214|P1|NOT COMPLETED|Overall Study||6
966109|NCT00248794|2336212|P3|COMPLETED|Overall Study||7
966110|NCT00248794|2336213|P2|COMPLETED|Overall Study||16
966111|NCT00248794|2336214|P1|COMPLETED|Overall Study||19
966112|NCT00248794|2336212|P3|STARTED|Overall Study||10
966113|NCT00248794|2336213|P2|STARTED|Overall Study||24
966114|NCT00248794|2336214|P1|STARTED|Overall Study||25
966115|NCT00248807|2336236|P2|NOT COMPLETED|Overall Study||0
966116|NCT00248807|2336237|P1|NOT COMPLETED|Overall Study||0
966117|NCT00248807|2336236|P2|COMPLETED|Overall Study||11
966118|NCT00248807|2336237|P1|COMPLETED|Overall Study||19
966119|NCT00248807|2336236|P2|STARTED|Overall Study||11
966120|NCT00248807|2336237|P1|STARTED|Overall Study||19
966121|NCT00249002|2336251|P1|NOT COMPLETED|Overall Study||7
966122|NCT00249002|2336251|P1|COMPLETED|Overall Study||2
966123|NCT00249002|2336251|P1|STARTED|Overall Study||9
966124|NCT00249249|2336271|P4|NOT COMPLETED|Overall Study||3
966125|NCT00249249|2336272|P3|NOT COMPLETED|Overall Study||15
966126|NCT00249249|2336273|P2|NOT COMPLETED|Overall Study||5
966127|NCT00249249|2336274|P1|NOT COMPLETED|Overall Study||20
966128|NCT00249249|2336271|P4|COMPLETED|Overall Study||100
966129|NCT00249249|2336272|P3|COMPLETED|Overall Study||288
966130|NCT00249249|2336273|P2|COMPLETED|Overall Study||98
966131|NCT00249249|2336274|P1|COMPLETED|Overall Study||301
966132|NCT00249249|2336271|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|103
966133|NCT00249249|2336272|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|300
966134|NCT00249249|2336273|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|102
966135|NCT00249249|2336274|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|316
966136|NCT00249249|2336271|P4|STARTED|Overall Study||103
966137|NCT00249249|2336272|P3|STARTED|Overall Study||303
966138|NCT00249249|2336273|P2|STARTED|Overall Study||103
966139|NCT00249249|2336274|P1|STARTED|Overall Study||321
966140|NCT00249288|2336330|P2|NOT COMPLETED|Overall Study||5
966141|NCT00249288|2336331|P1|NOT COMPLETED|Overall Study||5
966142|NCT00249288|2336330|P2|COMPLETED|Overall Study||14
966143|NCT00249288|2336331|P1|COMPLETED|Overall Study||14
966144|NCT00249288|2336330|P2|Initiated Treatment|Overall Study||15
966145|NCT00249288|2336331|P1|Initiated Treatment|Overall Study||17
966146|NCT00249288|2336330|P2|STARTED|Overall Study||19
966147|NCT00249288|2336331|P1|STARTED|Overall Study||19
966148|NCT00249379|2336339|P2|NOT COMPLETED|Overall Study||8
966149|NCT00249379|2336340|P1|NOT COMPLETED|Overall Study||8
966150|NCT00249379|2336339|P2|COMPLETED|Overall Study||4
966151|NCT00249379|2336340|P1|COMPLETED|Overall Study||6
966152|NCT00249379|2336339|P2|STARTED|Overall Study||12
966153|NCT00249379|2336340|P1|STARTED|Overall Study||14
966154|NCT00255684|2336352|P1|NOT COMPLETED|Overall Study||0
966155|NCT00255684|2336352|P1|COMPLETED|Overall Study||16
966156|NCT00255684|2336352|P1|STARTED|Overall Study||16
966157|NCT00255723|2336359|P2|NOT COMPLETED|Overall Study||2
966158|NCT00255723|2336360|P1|NOT COMPLETED|Overall Study||2
966159|NCT00255723|2336359|P2|COMPLETED|Overall Study||39
966160|NCT00255723|2336360|P1|COMPLETED|Overall Study||54
966161|NCT00255723|2336359|P2|STARTED|Overall Study||41
966162|NCT00255723|2336360|P1|STARTED|Overall Study||56
966163|NCT00258440|2336369|P3|NOT COMPLETED|Overall Study||1
966164|NCT00258440|2336370|P2|NOT COMPLETED|Overall Study||0
966165|NCT00258440|2336371|P1|NOT COMPLETED|Overall Study||0
966166|NCT00258440|2336369|P3|COMPLETED|Overall Study||5
966167|NCT00258440|2336370|P2|COMPLETED|Overall Study||0
966168|NCT00258440|2336371|P1|COMPLETED|Overall Study||1
966169|NCT00258440|2336369|P3|STARTED|Overall Study||6
966170|NCT00258440|2336370|P2|STARTED|Overall Study||0
966171|NCT00258440|2336371|P1|STARTED|Overall Study||1
966172|NCT00258674|2336385|P3|NOT COMPLETED|Overall Study||34
966173|NCT00258674|2336386|P2|NOT COMPLETED|Overall Study||53
966174|NCT00258674|2336387|P1|NOT COMPLETED|Overall Study||32
966175|NCT00258674|2336385|P3|COMPLETED|Overall Study||568
966176|NCT00258674|2336386|P2|COMPLETED|Overall Study||758
966177|NCT00258674|2336387|P1|COMPLETED|Overall Study||565
966178|NCT00258674|2336385|P3|STARTED|Overall Study||602
966179|NCT00258674|2336386|P2|STARTED|Overall Study||811
966180|NCT00258674|2336387|P1|STARTED|Overall Study||597
966181|NCT00258817|2336445|P2|NOT COMPLETED|Overall Study||0
966182|NCT00258817|2336446|P1|NOT COMPLETED|Overall Study||0
966183|NCT00258817|2336445|P2|COMPLETED|Overall Study||15
966184|NCT00258817|2336446|P1|COMPLETED|Overall Study||15
966185|NCT00258817|2336445|P2|STARTED|Overall Study||15
966186|NCT00258817|2336446|P1|STARTED|Overall Study||15
966187|NCT00258830|2336458|P2|NOT COMPLETED|Overall Study||0
966188|NCT00258830|2336459|P1|NOT COMPLETED|Overall Study||0
966189|NCT00258830|2336458|P2|COMPLETED|Overall Study||60
966190|NCT00258830|2336459|P1|COMPLETED|Overall Study||60
966191|NCT00258830|2336458|P2|STARTED|Overall Study||60
966192|NCT00258830|2336459|P1|STARTED|Overall Study||60
966193|NCT00258856|2336475|P4|NOT COMPLETED|Overall Study||1
966194|NCT00258856|2336476|P3|NOT COMPLETED|Overall Study||2
966195|NCT00258856|2336477|P2|NOT COMPLETED|Overall Study||0
966196|NCT00258856|2336478|P1|NOT COMPLETED|Overall Study||3
966197|NCT00258856|2336475|P4|COMPLETED|Overall Study||58
966198|NCT00258856|2336476|P3|COMPLETED|Overall Study||56
966199|NCT00258856|2336477|P2|COMPLETED|Overall Study||58
966200|NCT00258856|2336478|P1|COMPLETED|Overall Study||56
966201|NCT00258856|2336475|P4|STARTED|Overall Study||59
966202|NCT00258856|2336476|P3|STARTED|Overall Study||58
966203|NCT00258856|2336477|P2|STARTED|Overall Study||58
966204|NCT00258856|2336478|P1|STARTED|Overall Study||59
966205|NCT00258882|2336490|P2|NOT COMPLETED|Pregnancy Surveillance||0
966206|NCT00258882|2336491|P1|NOT COMPLETED|Pregnancy Surveillance||0
966207|NCT00258882|2336490|P2|COMPLETED|Pregnancy Surveillance||675
966208|NCT00258882|2336491|P1|COMPLETED|Pregnancy Surveillance||225
966209|NCT00258882|2336490|P2|STARTED|Pregnancy Surveillance|Non-vaccinated age-matched subjects with first positive pregnancy test in the same month (± 1 month)|675
966210|NCT00258882|2336491|P1|STARTED|Pregnancy Surveillance|Adacel recipients who were pregnant at the time of vaccination or within 28 days thereafter.|225
966211|NCT00258882|2336490|P2|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
966212|NCT00258882|2336491|P1|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
966213|NCT00258882|2336490|P2|COMPLETED|Adacel Recipients-Risk Interval Method||0
966214|NCT00258882|2336491|P1|COMPLETED|Adacel Recipients-Risk Interval Method||124139
966215|NCT00258882|2336490|P2|STARTED|Adacel Recipients-Risk Interval Method|Study participants served as their own controls for this analysis|0
966216|NCT00258882|2336491|P1|STARTED|Adacel Recipients-Risk Interval Method||124139
966217|NCT00258882|2336490|P2|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
966218|NCT00258882|2336491|P1|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
966219|NCT00258882|2336490|P2|COMPLETED|Adacel Recipients Historic Cohort Method||203154
966220|NCT00258882|2336491|P1|COMPLETED|Adacel Recipients Historic Cohort Method||124139
966221|NCT00258882|2336490|P2|STARTED|Adacel Recipients Historic Cohort Method||203154
966222|NCT00258882|2336491|P1|STARTED|Adacel Recipients Historic Cohort Method||124139
966223|NCT00258895|2336508|P2|NOT COMPLETED|Overall Study||3
966224|NCT00258895|2336509|P1|NOT COMPLETED|Overall Study||10
966225|NCT00258895|2336508|P2|COMPLETED|Overall Study||159
966226|NCT00258895|2336509|P1|COMPLETED|Overall Study||477
966227|NCT00258895|2336508|P2|STARTED|Overall Study||162
966228|NCT00258895|2336509|P1|STARTED|Overall Study||487
966229|NCT00258908|2336523|P1|NOT COMPLETED|Overall Study||0
966230|NCT00258908|2336523|P1|COMPLETED|Overall Study||112
966231|NCT00258908|2336523|P1|STARTED|Overall Study|3 participants were not vaccinated and were not included in the final analysis and in this report.|112
966232|NCT00259012|2336531|P2|NOT COMPLETED|Overall Study||4
966233|NCT00259012|2336532|P1|NOT COMPLETED|Overall Study||2
966234|NCT00259012|2336531|P2|COMPLETED|Overall Study||30
966235|NCT00259012|2336532|P1|COMPLETED|Overall Study||31
966236|NCT00259012|2336531|P2|STARTED|Overall Study||34
966237|NCT00259012|2336532|P1|STARTED|Overall Study||33
966238|NCT00259090|2336567|P3|NOT COMPLETED|Overall Study||0
966239|NCT00259090|2336568|P2|NOT COMPLETED|Overall Study||0
966240|NCT00259090|2336569|P1|NOT COMPLETED|Overall Study||0
966241|NCT00259090|2336567|P3|COMPLETED|Overall Study||37
966242|NCT00259090|2336568|P2|COMPLETED|Overall Study||31
966243|NCT00259090|2336569|P1|COMPLETED|Overall Study||35
966244|NCT00259090|2336567|P3|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|37
966245|NCT00259090|2336568|P2|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|31
966246|NCT00259090|2336569|P1|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|35
966247|NCT00259272|2336587|P4|NOT COMPLETED|Overall Study||21
966248|NCT00259272|2336588|P3|NOT COMPLETED|Overall Study||5
966249|NCT00259272|2336589|P2|NOT COMPLETED|Overall Study||7
966250|NCT00259272|2336590|P1|NOT COMPLETED|Overall Study||15
966251|NCT00259272|2336587|P4|COMPLETED|Overall Study||27
966252|NCT00259272|2336588|P3|COMPLETED|Overall Study||21
966253|NCT00259272|2336589|P2|COMPLETED|Overall Study||24
966254|NCT00259272|2336590|P1|COMPLETED|Overall Study||21
966255|NCT00259272|2336587|P4|STARTED|Overall Study||48
966256|NCT00259272|2336588|P3|STARTED|Overall Study||26
966257|NCT00259272|2336589|P2|STARTED|Overall Study||31
966258|NCT00259272|2336590|P1|STARTED|Overall Study||36
966259|NCT00259285|2336665|P1|NOT COMPLETED|Overall Study||0
966260|NCT00259285|2336665|P1|COMPLETED|Overall Study||10
966261|NCT00259285|2336665|P1|STARTED|Overall Study||10
966262|NCT00259298|2336671|P1|NOT COMPLETED|Overall Study||3
966263|NCT00259298|2336671|P1|COMPLETED|Overall Study||9
966264|NCT00259298|2336671|P1|Received at Least 1 Dose of Study Drug|Overall Study||10
966265|NCT00259298|2336671|P1|STARTED|Overall Study||12
966266|NCT00259610|2336683|P4|NOT COMPLETED|Overall Study||43
966267|NCT00259610|2336684|P3|NOT COMPLETED|Overall Study||73
966268|NCT00259610|2336685|P2|NOT COMPLETED|Overall Study||46
966269|NCT00259610|2336686|P1|NOT COMPLETED|Overall Study||76
966270|NCT00259610|2336683|P4|COMPLETED|Overall Study||81
966271|NCT00259610|2336684|P3|COMPLETED|Overall Study||182
966272|NCT00259610|2336685|P2|COMPLETED|Overall Study||86
966273|NCT00259610|2336686|P1|COMPLETED|Overall Study||168
966274|NCT00259610|2336683|P4|STARTED|Overall Study||124
966275|NCT00259610|2336684|P3|STARTED|Overall Study||255
966276|NCT00259610|2336685|P2|STARTED|Overall Study||132
966277|NCT00259610|2336686|P1|STARTED|Overall Study||244
966278|NCT00259649|2336700|P1|NOT COMPLETED|Overall Study||10
966279|NCT00259649|2336700|P1|COMPLETED|Overall Study||61
966280|NCT00259649|2336700|P1|STARTED|Overall Study||71
966281|NCT00259740|2336706|P2|NOT COMPLETED|Overall Study||53
966282|NCT00259740|2336707|P1|NOT COMPLETED|Overall Study||43
966283|NCT00259740|2336706|P2|COMPLETED|Overall Study||0
966284|NCT00259740|2336707|P1|COMPLETED|Overall Study||0
966285|NCT00259740|2336706|P2|Received Study Medication|Overall Study||53
966286|NCT00259740|2336707|P1|Received Study Medication|Overall Study||42
966287|NCT00259740|2336706|P2|STARTED|Overall Study||53
966288|NCT00259740|2336707|P1|STARTED|Overall Study||43
966289|NCT00259857|2336719|P2|NOT COMPLETED|24 Months Treatment||3
966290|NCT00259857|2336720|P1|NOT COMPLETED|24 Months Treatment||0
966291|NCT00259857|2336719|P2|COMPLETED|24 Months Treatment||6
966292|NCT00259857|2336720|P1|COMPLETED|24 Months Treatment||10
966293|NCT00259857|2336719|P2|STARTED|24 Months Treatment||9
966294|NCT00259857|2336720|P1|STARTED|24 Months Treatment||10
966295|NCT00259857|2336719|P2|NOT COMPLETED|12 Months Treatment||2
966296|NCT00259857|2336720|P1|NOT COMPLETED|12 Months Treatment||1
966297|NCT00259857|2336719|P2|COMPLETED|12 Months Treatment||9
966298|NCT00259857|2336720|P1|COMPLETED|12 Months Treatment||10
966299|NCT00259857|2336719|P2|STARTED|12 Months Treatment||11
966300|NCT00259857|2336720|P1|STARTED|12 Months Treatment||11
966301|NCT00260065|2336736|P1|NOT COMPLETED|Overall Study||93
966302|NCT00260065|2336736|P1|COMPLETED|Overall Study||6
966303|NCT00260065|2336736|P1|STARTED|Overall Study||99
966304|NCT00260195|2336743|P2|NOT COMPLETED|Overall Study||0
966305|NCT00260195|2336744|P1|NOT COMPLETED|Overall Study||0
966306|NCT00260195|2336743|P2|COMPLETED|Overall Study||37
966307|NCT00260195|2336744|P1|COMPLETED|Overall Study||39
966308|NCT00260195|2336743|P2|STARTED|Overall Study||37
966309|NCT00260195|2336744|P1|STARTED|Overall Study||39
966310|NCT00260208|2336758|P2|NOT COMPLETED|Overall Study||34
966311|NCT00260208|2336759|P1|NOT COMPLETED|Overall Study||47
966312|NCT00260208|2336758|P2|COMPLETED|Overall Study||138
966313|NCT00260208|2336759|P1|COMPLETED|Overall Study||137
966314|NCT00260208|2336758|P2|Modified ITT|Overall Study||96
966315|NCT00260208|2336759|P1|Modified ITT|Overall Study||101
966316|NCT00260208|2336758|P2|Intent to Treat (ITT) Population|Overall Study||169
966317|NCT00260208|2336759|P1|Intent to Treat (ITT) Population|Overall Study||182
966318|NCT00260208|2336758|P2|STARTED|Overall Study||172
966319|NCT00260208|2336759|P1|STARTED|Overall Study|"Started indicates safety population."|184
966320|NCT00260429|2336789|P2|NOT COMPLETED|Overall Study||0
966321|NCT00260429|2336790|P1|NOT COMPLETED|Overall Study||2
966322|NCT00260429|2336789|P2|COMPLETED|Overall Study||12
966323|NCT00260429|2336790|P1|COMPLETED|Overall Study||21
966324|NCT00260429|2336789|P2|STARTED|Overall Study||12
966325|NCT00260429|2336790|P1|STARTED|Overall Study||23
966326|NCT00260533|2336798|P2|NOT COMPLETED|Overall Study||3
966327|NCT00260533|2336799|P1|NOT COMPLETED|Overall Study||3
966328|NCT00260533|2336798|P2|COMPLETED|Overall Study||10
966329|NCT00260533|2336799|P1|COMPLETED|Overall Study||11
966330|NCT00260533|2336798|P2|STARTED|Overall Study||13
966331|NCT00260533|2336799|P1|STARTED|Overall Study||14
966332|NCT00260689|2336808|P3|NOT COMPLETED|Overall Study||15
966333|NCT00260689|2336809|P2|NOT COMPLETED|Overall Study||49
966334|NCT00260689|2336810|P1|NOT COMPLETED|Overall Study||41
966335|NCT00260689|2336808|P3|COMPLETED|Overall Study||1
966336|NCT00260689|2336809|P2|COMPLETED|Overall Study||11
966337|NCT00260689|2336810|P1|COMPLETED|Overall Study||19
966338|NCT00260689|2336808|P3|STARTED|Overall Study||16
966339|NCT00260689|2336809|P2|STARTED|Overall Study||60
966340|NCT00260689|2336810|P1|STARTED|Overall Study||60
966341|NCT00260832|2336826|P2|NOT COMPLETED|Overall Study||211
966342|NCT00260832|2336827|P1|NOT COMPLETED|Overall Study||228
966343|NCT00260832|2336826|P2|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|31
966344|NCT00260832|2336827|P1|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|15
966345|NCT00260832|2336826|P2|STARTED|Overall Study||242
966346|NCT00260832|2336827|P1|STARTED|Overall Study||243
966347|NCT00252382|2336833|P1|NOT COMPLETED|Overall Study||26
966348|NCT00252382|2336833|P1|COMPLETED|Overall Study||5
966349|NCT00252382|2336833|P1|STARTED|Overall Study||31
966350|NCT00252499|2336841|P3|NOT COMPLETED|Overall Study||0
966351|NCT00252499|2336842|P2|NOT COMPLETED|Overall Study||0
966352|NCT00252499|2336843|P1|NOT COMPLETED|Overall Study||1
966353|NCT00252499|2336841|P3|COMPLETED|Overall Study||6
966354|NCT00252499|2336842|P2|COMPLETED|Overall Study||2
966355|NCT00252499|2336843|P1|COMPLETED|Overall Study||4
966356|NCT00252499|2336841|P3|STARTED|Overall Study||6
966357|NCT00252499|2336842|P2|STARTED|Overall Study||2
966358|NCT00252499|2336843|P1|STARTED|Overall Study||5
966359|NCT00252512|2336868|P2|NOT COMPLETED|12 Month Follow up||1
966360|NCT00252512|2336869|P1|NOT COMPLETED|12 Month Follow up||9
966361|NCT00252512|2336868|P2|COMPLETED|12 Month Follow up||121
966362|NCT00252512|2336869|P1|COMPLETED|12 Month Follow up||123
966363|NCT00252512|2336868|P2|STARTED|12 Month Follow up||122
966364|NCT00252512|2336869|P1|STARTED|12 Month Follow up||132
966365|NCT00252512|2336868|P2|NOT COMPLETED|Six Month Follow up||12
966366|NCT00252512|2336869|P1|NOT COMPLETED|Six Month Follow up||4
966367|NCT00252512|2336868|P2|COMPLETED|Six Month Follow up||122
966368|NCT00252512|2336869|P1|COMPLETED|Six Month Follow up||132
966369|NCT00252512|2336868|P2|STARTED|Six Month Follow up||134
966370|NCT00252512|2336869|P1|STARTED|Six Month Follow up||136
966371|NCT00252512|2336868|P2|NOT COMPLETED|Intervention||31
966372|NCT00252512|2336869|P1|NOT COMPLETED|Intervention||29
966373|NCT00252512|2336868|P2|COMPLETED|Intervention||134
966374|NCT00252512|2336869|P1|COMPLETED|Intervention||136
966375|NCT00252512|2336868|P2|STARTED|Intervention||165
966376|NCT00252512|2336869|P1|STARTED|Intervention||165
966377|NCT00252538|2336875|P2|NOT COMPLETED|Overall Study||0
966378|NCT00252538|2336876|P1|NOT COMPLETED|Overall Study||0
966379|NCT00252538|2336875|P2|COMPLETED|Overall Study||114
966380|NCT00252538|2336876|P1|COMPLETED|Overall Study||19
966381|NCT00252538|2336875|P2|STARTED|Overall Study||114
966382|NCT00252538|2336876|P1|STARTED|Overall Study||19
966383|NCT00252564|2336883|P2|NOT COMPLETED|Overall Study||44
966384|NCT00252564|2336884|P1|NOT COMPLETED|Overall Study||39
966385|NCT00252564|2336883|P2|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|79
966386|NCT00252564|2336884|P1|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|85
966387|NCT00252564|2336883|P2|STARTED|Overall Study|From randomization|123
966388|NCT00252564|2336884|P1|STARTED|Overall Study|From randomization|124
966389|NCT00252590|2336899|P3|NOT COMPLETED|Overall Study||3
966390|NCT00252590|2336900|P2|NOT COMPLETED|Overall Study||2
966391|NCT00252590|2336901|P1|NOT COMPLETED|Overall Study||2
966392|NCT00252590|2336899|P3|COMPLETED|Overall Study||31
966393|NCT00252590|2336900|P2|COMPLETED|Overall Study||28
966394|NCT00252590|2336901|P1|COMPLETED|Overall Study||33
966395|NCT00252590|2336899|P3|STARTED|Overall Study||34
966396|NCT00252590|2336900|P2|STARTED|Overall Study||30
966397|NCT00252590|2336901|P1|STARTED|Overall Study||35
966398|NCT00252629|2336915|P3|NOT COMPLETED|Overall Study||0
966399|NCT00252629|2336916|P2|NOT COMPLETED|Overall Study||0
966400|NCT00252629|2336917|P1|NOT COMPLETED|Overall Study||1
966401|NCT00252629|2336915|P3|COMPLETED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
966402|NCT00252629|2336916|P2|COMPLETED|Overall Study||9
966403|NCT00252629|2336917|P1|COMPLETED|Overall Study|One participant assigned to therapeutic CPAP was excluded from the trial before starting treatment.|8
966404|NCT00252629|2336915|P3|STARTED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
966405|NCT00252629|2336916|P2|STARTED|Overall Study||9
966406|NCT00252629|2336917|P1|STARTED|Overall Study||9
966407|NCT00252694|2336932|P2|NOT COMPLETED|Overall Study||154
966408|NCT00252694|2336933|P1|NOT COMPLETED|Overall Study||144
966409|NCT00252694|2336932|P2|COMPLETED|Overall Study||800
966410|NCT00252694|2336933|P1|COMPLETED|Overall Study||807
966411|NCT00252694|2336932|P2|STARTED|Overall Study||954
966412|NCT00252694|2336933|P1|STARTED|Overall Study||951
966413|NCT00252720|2336947|P2|NOT COMPLETED|Overall Study||165
966414|NCT00252720|2336948|P1|NOT COMPLETED|Overall Study||132
966415|NCT00252720|2336947|P2|COMPLETED|Overall Study||789
966416|NCT00252720|2336948|P1|COMPLETED|Overall Study||819
966417|NCT00252720|2336947|P2|STARTED|Overall Study||954
966418|NCT00252720|2336948|P1|STARTED|Overall Study||951
966419|NCT00252733|2336962|P2|NOT COMPLETED|Overall Study||92
966420|NCT00252733|2336963|P1|NOT COMPLETED|Overall Study||106
966421|NCT00252733|2336962|P2|COMPLETED|Overall Study||618
966422|NCT00252733|2336963|P1|COMPLETED|Overall Study||605
966423|NCT00252733|2336962|P2|STARTED|Overall Study||710
966424|NCT00252733|2336963|P1|STARTED|Overall Study||711
966425|NCT00260962|2336973|P2|NOT COMPLETED|Overall Study||2
966426|NCT00260962|2336974|P1|NOT COMPLETED|Overall Study||4
966427|NCT00260962|2336973|P2|COMPLETED|Overall Study||14
966428|NCT00260962|2336974|P1|COMPLETED|Overall Study||14
966429|NCT00260962|2336973|P2|STARTED|Overall Study||16
966430|NCT00260962|2336974|P1|STARTED|Overall Study||18
966431|NCT00263887|2336984|P2|NOT COMPLETED|Overall Study||7
966432|NCT00263887|2336985|P1|NOT COMPLETED|Overall Study||3
966433|NCT00263887|2336984|P2|COMPLETED|Overall Study||32
966434|NCT00263887|2336985|P1|COMPLETED|Overall Study||35
966435|NCT00263887|2336984|P2|STARTED|Overall Study||39
966436|NCT00263887|2336985|P1|STARTED|Overall Study||38
966437|NCT00264004|2336995|P4|NOT COMPLETED|Overall Study||15
966438|NCT00264004|2336996|P3|NOT COMPLETED|Overall Study||14
966439|NCT00264004|2336997|P2|NOT COMPLETED|Overall Study||11
966440|NCT00264004|2336998|P1|NOT COMPLETED|Overall Study||17
966441|NCT00264004|2336995|P4|COMPLETED|Overall Study|Completed 12 weeks treatment|19
966442|NCT00264004|2336996|P3|COMPLETED|Overall Study|Completed 12 weeks treatment|16
966443|NCT00264004|2336997|P2|COMPLETED|Overall Study|Completed 12 weeks treatment|21
966444|NCT00264004|2336998|P1|COMPLETED|Overall Study|Completed 12 weeks treatment|13
966445|NCT00264004|2336995|P4|STARTED|Overall Study|Randomised|34
966446|NCT00264004|2336996|P3|STARTED|Overall Study|Randomised|30
966447|NCT00264004|2336997|P2|STARTED|Overall Study|Randomised|32
966448|NCT00264004|2336998|P1|STARTED|Overall Study|Randomised|30
966449|NCT00264147|2337029|P6|NOT COMPLETED|Treatment II Period||33
966450|NCT00264147|2337030|P5|NOT COMPLETED|Treatment II Period||33
966451|NCT00264147|2337031|P4|NOT COMPLETED|Treatment II Period||0
966452|NCT00264147|2337032|P3|NOT COMPLETED|Treatment II Period||0
966453|NCT00264147|2337033|P2|NOT COMPLETED|Treatment II Period||0
966454|NCT00264147|2337034|P1|NOT COMPLETED|Treatment II Period||0
966455|NCT00264147|2337029|P6|COMPLETED|Treatment II Period||116
966456|NCT00264147|2337030|P5|COMPLETED|Treatment II Period||147
966457|NCT00264147|2337031|P4|COMPLETED|Treatment II Period||0
966458|NCT00264147|2337032|P3|COMPLETED|Treatment II Period||0
966459|NCT00264147|2337033|P2|COMPLETED|Treatment II Period||0
966460|NCT00264147|2337034|P1|COMPLETED|Treatment II Period||0
966461|NCT00264147|2337029|P6|STARTED|Treatment II Period|Etoricoxib 10 mg (34), 30 mg (37), 60 mg (29), and placebo (49) reassigned to diclofenac (149)|149
966462|NCT00264147|2337030|P5|STARTED|Treatment II Period|Etoricoxib 10 mg (38), 30 mg (28), 60 mg (33), 90 mg (45) and placebo (36) reassigned to 90 mg (180)|180
966463|NCT00264147|2337031|P4|STARTED|Treatment II Period||0
966464|NCT00264147|2337032|P3|STARTED|Treatment II Period||0
966465|NCT00264147|2337033|P2|STARTED|Treatment II Period||0
966466|NCT00264147|2337034|P1|STARTED|Treatment II Period||0
966467|NCT00264147|2337029|P6|NOT COMPLETED|Treatment I Period||0
966468|NCT00264147|2337030|P5|NOT COMPLETED|Treatment I Period||56
966469|NCT00264147|2337031|P4|NOT COMPLETED|Treatment I Period||72
966470|NCT00264147|2337032|P3|NOT COMPLETED|Treatment I Period||77
966471|NCT00264147|2337033|P2|NOT COMPLETED|Treatment I Period||83
966472|NCT00264147|2337034|P1|NOT COMPLETED|Treatment I Period||98
966473|NCT00264147|2337029|P6|COMPLETED|Treatment I Period||0
966474|NCT00264147|2337030|P5|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|99
966475|NCT00264147|2337031|P4|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|68
966476|NCT00264147|2337032|P3|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|74
966477|NCT00264147|2337033|P2|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|71
966478|NCT00264147|2337034|P1|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|63
966479|NCT00264147|2337029|P6|STARTED|Treatment I Period||0
966480|NCT00264147|2337030|P5|STARTED|Treatment I Period||155
966481|NCT00264147|2337031|P4|STARTED|Treatment I Period||140
966482|NCT00264147|2337032|P3|STARTED|Treatment I Period||151
966483|NCT00264147|2337033|P2|STARTED|Treatment I Period||154
966484|NCT00264147|2337034|P1|STARTED|Treatment I Period||161
966485|NCT00264238|2337073|P1|NOT COMPLETED|Overall Study||1
966486|NCT00264238|2337073|P1|COMPLETED|Overall Study||14
966487|NCT00264238|2337073|P1|STARTED|Overall Study||15
966488|NCT00264290|2337082|P2|NOT COMPLETED|Observation (4 Weeks)||0
966489|NCT00264290|2337083|P1|NOT COMPLETED|Observation (4 Weeks)||0
966490|NCT00264290|2337082|P2|COMPLETED|Observation (4 Weeks)||14
966491|NCT00264290|2337083|P1|COMPLETED|Observation (4 Weeks)||15
966492|NCT00264290|2337082|P2|STARTED|Observation (4 Weeks)||14
966493|NCT00264290|2337083|P1|STARTED|Observation (4 Weeks)||15
966494|NCT00264290|2337082|P2|NOT COMPLETED|Intervention (8 Weeks)||0
966495|NCT00264290|2337083|P1|NOT COMPLETED|Intervention (8 Weeks)||1
966496|NCT00264290|2337082|P2|COMPLETED|Intervention (8 Weeks)||14
966497|NCT00264290|2337083|P1|COMPLETED|Intervention (8 Weeks)||15
966498|NCT00264290|2337082|P2|STARTED|Intervention (8 Weeks)||14
966499|NCT00264290|2337083|P1|STARTED|Intervention (8 Weeks)||16
966500|NCT00264303|2337091|P2|NOT COMPLETED|Overall Study||29
966501|NCT00264303|2337092|P1|NOT COMPLETED|Overall Study||25
966502|NCT00264303|2337091|P2|COMPLETED|Overall Study||419
966503|NCT00264303|2337092|P1|COMPLETED|Overall Study||413
966504|NCT00264303|2337091|P2|STARTED|Overall Study||448
966505|NCT00264303|2337092|P1|STARTED|Overall Study||438
966506|NCT00264381|2337110|P2|NOT COMPLETED|Overall Study||0
966507|NCT00264381|2337111|P1|NOT COMPLETED|Overall Study||0
966508|NCT00264381|2337110|P2|COMPLETED|Overall Study||37
966509|NCT00264381|2337111|P1|COMPLETED|Overall Study||35
966510|NCT00264381|2337110|P2|STARTED|Overall Study||37
966511|NCT00264381|2337111|P1|STARTED|Overall Study||35
966512|NCT00264498|2337125|P2|NOT COMPLETED|Crossover Treatment||9
966513|NCT00264498|2337126|P1|NOT COMPLETED|Crossover Treatment||6
966514|NCT00264498|2337125|P2|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
966515|NCT00264498|2337126|P1|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
966516|NCT00264498|2337125|P2|STARTED|Crossover Treatment||9
966517|NCT00264498|2337126|P1|STARTED|Crossover Treatment||6
966518|NCT00264498|2337125|P2|NOT COMPLETED|Randomized Treatment||18
966519|NCT00264498|2337126|P1|NOT COMPLETED|Randomized Treatment||17
966520|NCT00264498|2337125|P2|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
966521|NCT00264498|2337126|P1|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
966522|NCT00264498|2337125|P2|STARTED|Randomized Treatment||18
966523|NCT00264498|2337126|P1|STARTED|Randomized Treatment||17
966524|NCT00264537|2337136|P4|NOT COMPLETED|Overall Study||60
966525|NCT00264537|2337137|P3|NOT COMPLETED|Overall Study||50
966526|NCT00264537|2337138|P2|NOT COMPLETED|Overall Study||58
966527|NCT00264537|2337139|P1|NOT COMPLETED|Overall Study||50
966528|NCT00264537|2337136|P4|COMPLETED|Overall Study||99
966529|NCT00264537|2337137|P3|COMPLETED|Overall Study||109
966530|NCT00264537|2337138|P2|COMPLETED|Overall Study||101
966531|NCT00264537|2337139|P1|COMPLETED|Overall Study||110
966532|NCT00264537|2337136|P4|STARTED|Overall Study||159
966533|NCT00264537|2337137|P3|STARTED|Overall Study||159
966534|NCT00264537|2337138|P2|STARTED|Overall Study||159
966535|NCT00264537|2337139|P1|STARTED|Overall Study||160
966536|NCT00264550|2337173|P4|NOT COMPLETED|Overall Study||30
966537|NCT00264550|2337174|P3|NOT COMPLETED|Overall Study||17
966538|NCT00264550|2337175|P2|NOT COMPLETED|Overall Study||41
966539|NCT00264550|2337176|P1|NOT COMPLETED|Overall Study||43
966540|NCT00264550|2337173|P4|COMPLETED|Overall Study||59
966541|NCT00264550|2337174|P3|COMPLETED|Overall Study||72
966542|NCT00264550|2337175|P2|COMPLETED|Overall Study||92
966543|NCT00264550|2337176|P1|COMPLETED|Overall Study||90
966544|NCT00264550|2337173|P4|STARTED|Overall Study||89
966545|NCT00264550|2337174|P3|STARTED|Overall Study||89
966546|NCT00264550|2337175|P2|STARTED|Overall Study||133
966547|NCT00264550|2337176|P1|STARTED|Overall Study||133
966548|NCT00264576|2337213|P2|NOT COMPLETED|Overall Study||1
966549|NCT00264576|2337214|P1|NOT COMPLETED|Overall Study||1
966550|NCT00264576|2337213|P2|COMPLETED|Overall Study||304
966551|NCT00264576|2337214|P1|COMPLETED|Overall Study||307
966552|NCT00264576|2337213|P2|STARTED|Overall Study||305
966553|NCT00264576|2337214|P1|STARTED|Overall Study||308
966554|NCT00264641|2337236|P2|NOT COMPLETED|Overall Study||0
966555|NCT00264641|2337237|P1|NOT COMPLETED|Overall Study||0
966556|NCT00264641|2337236|P2|COMPLETED|Overall Study||10
966557|NCT00264641|2337237|P1|COMPLETED|Overall Study||10
966558|NCT00264641|2337236|P2|Initiation of the Study|Overall Study||10
966559|NCT00264641|2337237|P1|Initiation of the Study|Overall Study||10
966560|NCT00264641|2337236|P2|STARTED|Overall Study||10
966561|NCT00264641|2337237|P1|STARTED|Overall Study||10
966562|NCT00264797|2337244|P2|NOT COMPLETED|Overall Study||43
966563|NCT00264797|2337245|P1|NOT COMPLETED|Overall Study||33
966564|NCT00264797|2337244|P2|COMPLETED|Overall Study||109
966565|NCT00264797|2337245|P1|COMPLETED|Overall Study||118
966566|NCT00264797|2337244|P2|STARTED|Overall Study||152
966567|NCT00264797|2337245|P1|STARTED|Overall Study||151
966568|NCT00264810|2337259|P2|NOT COMPLETED|Open Label Evaluation Period||6
966569|NCT00264810|2337260|P1|NOT COMPLETED|Open Label Evaluation Period||6
966570|NCT00264810|2337259|P2|COMPLETED|Open Label Evaluation Period||86
966571|NCT00264810|2337260|P1|COMPLETED|Open Label Evaluation Period||89
966572|NCT00264810|2337259|P2|1-year Post-implant|Open Label Evaluation Period||90
966573|NCT00264810|2337260|P1|1-year Post-implant|Open Label Evaluation Period||92
966574|NCT00264810|2337259|P2|STARTED|Open Label Evaluation Period||92
966575|NCT00264810|2337260|P1|STARTED|Open Label Evaluation Period||95
966576|NCT00264810|2337259|P2|NOT COMPLETED|Blinded Evaluation Period||1
966577|NCT00264810|2337260|P1|NOT COMPLETED|Blinded Evaluation Period||1
966578|NCT00264810|2337259|P2|COMPLETED|Blinded Evaluation Period||92
966579|NCT00264810|2337260|P1|COMPLETED|Blinded Evaluation Period||95
966580|NCT00264810|2337259|P2|STARTED|Blinded Evaluation Period||93
966581|NCT00264810|2337260|P1|STARTED|Blinded Evaluation Period||96
966582|NCT00264810|2337259|P2|NOT COMPLETED|Stimulation Optimization Period||1
966583|NCT00264810|2337260|P1|NOT COMPLETED|Stimulation Optimization Period||1
966584|NCT00264810|2337259|P2|COMPLETED|Stimulation Optimization Period||93
966585|NCT00264810|2337260|P1|COMPLETED|Stimulation Optimization Period||96
966586|NCT00264810|2337259|P2|STARTED|Stimulation Optimization Period||94
966587|NCT00264810|2337260|P1|STARTED|Stimulation Optimization Period||97
966588|NCT00264810|2337259|P2|NOT COMPLETED|Post-Operative Stabilization Period||0
966589|NCT00264810|2337260|P1|NOT COMPLETED|Post-Operative Stabilization Period||0
966590|NCT00264810|2337259|P2|COMPLETED|Post-Operative Stabilization Period||94
966591|NCT00264810|2337260|P1|COMPLETED|Post-Operative Stabilization Period||97
966592|NCT00264810|2337259|P2|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
966593|NCT00264810|2337260|P1|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
966594|NCT00264810|2337259|P2|NOT COMPLETED|Baseline||26
966595|NCT00264810|2337260|P1|NOT COMPLETED|Baseline||23
966596|NCT00264810|2337259|P2|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
966597|NCT00264810|2337260|P1|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
966598|NCT00264810|2337259|P2|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
966599|NCT00264810|2337260|P1|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
966600|NCT00264849|2337270|P2|NOT COMPLETED|Overall Study||25
966601|NCT00264849|2337271|P1|NOT COMPLETED|Overall Study||22
966602|NCT00264849|2337270|P2|COMPLETED|Overall Study||106
966603|NCT00264849|2337271|P1|COMPLETED|Overall Study||253
966604|NCT00264849|2337270|P2|STARTED|Overall Study||131
966605|NCT00264849|2337271|P1|STARTED|Overall Study||275
966606|NCT00264875|2337305|P1|NOT COMPLETED|Overall Study||30
966607|NCT00264875|2337305|P1|COMPLETED|Overall Study||190
966608|NCT00264875|2337305|P1|STARTED|Overall Study||220
966609|NCT00265083|2337312|P3|NOT COMPLETED|Overall Study||42
966610|NCT00265083|2337313|P2|NOT COMPLETED|Overall Study||42
966611|NCT00265083|2337314|P1|NOT COMPLETED|Overall Study||17
966612|NCT00265083|2337312|P3|COMPLETED|Overall Study||98
966613|NCT00265083|2337313|P2|COMPLETED|Overall Study|One patient did not receive study agent.|96
966614|NCT00265083|2337314|P1|COMPLETED|Overall Study||61
966615|NCT00265083|2337312|P3|STARTED|Overall Study||140
966616|NCT00265083|2337313|P2|STARTED|Overall Study|One patient did not receive study agent.|138
966617|NCT00265083|2337314|P1|STARTED|Overall Study||78
966618|NCT00265096|2337338|P3|NOT COMPLETED|Overall Study||39
966619|NCT00265096|2337339|P2|NOT COMPLETED|Overall Study||51
966620|NCT00265096|2337340|P1|NOT COMPLETED|Overall Study||36
966621|NCT00265096|2337338|P3|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|107
966622|NCT00265096|2337339|P2|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|95
966623|NCT00265096|2337340|P1|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|77
966624|NCT00265096|2337338|P3|STARTED|Overall Study||146
966625|NCT00265096|2337339|P2|STARTED|Overall Study||146
966626|NCT00265096|2337340|P1|STARTED|Overall Study||113
966627|NCT00265109|2337369|P1|NOT COMPLETED|Overall Study||6
966628|NCT00265109|2337369|P1|COMPLETED|Overall Study||11
966629|NCT00265109|2337369|P1|STARTED|Overall Study||17
966630|NCT00265122|2337379|P6|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
966631|NCT00265122|2337380|P5|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||5
966632|NCT00265122|2337381|P4|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
966633|NCT00265122|2337382|P3|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
966634|NCT00265122|2337383|P2|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
966635|NCT00265122|2337384|P1|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||7
966636|NCT00265122|2337379|P6|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||12
966637|NCT00265122|2337380|P5|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||8
966638|NCT00265122|2337381|P4|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||20
966639|NCT00265122|2337382|P3|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||18
966640|NCT00265122|2337383|P2|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||22
966641|NCT00265122|2337384|P1|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||17
966642|NCT00265122|2337379|P6|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
966643|NCT00265122|2337380|P5|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
966644|NCT00265122|2337381|P4|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
966645|NCT00265122|2337382|P3|STARTED|Intervention Period 2 (Weeks 8 to 28):||22
966646|NCT00265122|2337383|P2|STARTED|Intervention Period 2 (Weeks 8 to 28):||23
966647|NCT00265122|2337384|P1|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
966648|NCT00265122|2337379|P6|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||0
966649|NCT00265122|2337380|P5|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||1
966650|NCT00265122|2337381|P4|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
966651|NCT00265122|2337382|P3|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||5
966652|NCT00265122|2337383|P2|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
966653|NCT00265122|2337384|P1|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
966654|NCT00265122|2337379|P6|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
966655|NCT00265122|2337380|P5|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
966656|NCT00265122|2337381|P4|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
966657|NCT00265122|2337382|P3|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||22
966658|NCT00265122|2337383|P2|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||23
966659|NCT00265122|2337384|P1|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
966660|NCT00265122|2337379|P6|STARTED|Intervention Period 1 (Weeks 0 to 8):||13
966661|NCT00265122|2337380|P5|STARTED|Intervention Period 1 (Weeks 0 to 8):||14
966662|NCT00265122|2337381|P4|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
966663|NCT00265122|2337382|P3|STARTED|Intervention Period 1 (Weeks 0 to 8):||27
966664|NCT00265122|2337383|P2|STARTED|Intervention Period 1 (Weeks 0 to 8):||25
966665|NCT00265122|2337384|P1|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
966666|NCT00265200|2337406|P1|NOT COMPLETED|Overall Study||4
966667|NCT00265200|2337406|P1|COMPLETED|Overall Study||24
966668|NCT00265200|2337406|P1|STARTED|Overall Study||28
966669|NCT00265239|2337412|P2|NOT COMPLETED|Overall Study||1
966670|NCT00265239|2337413|P1|NOT COMPLETED|Overall Study||2
966671|NCT00265239|2337412|P2|COMPLETED|Overall Study||51
966672|NCT00265239|2337413|P1|COMPLETED|Overall Study||50
966673|NCT00265239|2337412|P2|STARTED|Overall Study||52
966674|NCT00265239|2337413|P1|STARTED|Overall Study||52
966675|NCT00265317|2337429|P4|NOT COMPLETED|Phase 2||65
966676|NCT00265317|2337430|P3|NOT COMPLETED|Phase 2||64
966677|NCT00265317|2337431|P2|NOT COMPLETED|Phase 2||0
966678|NCT00265317|2337432|P1|NOT COMPLETED|Phase 2||0
966679|NCT00265317|2337429|P4|COMPLETED|Phase 2||2
966680|NCT00265317|2337430|P3|COMPLETED|Phase 2||1
966681|NCT00265317|2337431|P2|COMPLETED|Phase 2||0
966682|NCT00265317|2337432|P1|COMPLETED|Phase 2||0
966683|NCT00265317|2337429|P4|STARTED|Phase 2||67
966684|NCT00265317|2337430|P3|STARTED|Phase 2||65
966685|NCT00265317|2337431|P2|STARTED|Phase 2||0
966686|NCT00265317|2337432|P1|STARTED|Phase 2||0
966687|NCT00265317|2337429|P4|NOT COMPLETED|Lead-In||0
966688|NCT00265317|2337430|P3|NOT COMPLETED|Lead-In||0
966689|NCT00265317|2337431|P2|NOT COMPLETED|Lead-In||17
966690|NCT00265317|2337432|P1|NOT COMPLETED|Lead-In||12
966691|NCT00265317|2337429|P4|COMPLETED|Lead-In||0
966692|NCT00265317|2337430|P3|COMPLETED|Lead-In||0
966693|NCT00265317|2337431|P2|COMPLETED|Lead-In||0
966694|NCT00265317|2337432|P1|COMPLETED|Lead-In||1
966695|NCT00265317|2337429|P4|STARTED|Lead-In||0
966696|NCT00265317|2337430|P3|STARTED|Lead-In||0
966697|NCT00265317|2337431|P2|STARTED|Lead-In||17
966698|NCT00265317|2337432|P1|STARTED|Lead-In||13
966699|NCT00265330|2337545|P1|NOT COMPLETED|Overall Study||95
966700|NCT00265330|2337545|P1|COMPLETED|Overall Study||67
966701|NCT00265330|2337545|P1|STARTED|Overall Study||162
966702|NCT00265343|2337569|P2|NOT COMPLETED|Overall Study||19
966703|NCT00265343|2337570|P1|NOT COMPLETED|Overall Study||21
966704|NCT00265343|2337569|P2|COMPLETED|Overall Study||153
966705|NCT00265343|2337570|P1|COMPLETED|Overall Study||113
966706|NCT00265343|2337569|P2|STARTED|Overall Study||172
966707|NCT00265343|2337570|P1|STARTED|Overall Study||134
966708|NCT00265382|2337578|P1|NOT COMPLETED|Overall Study||145
966709|NCT00265382|2337578|P1|COMPLETED|Overall Study||76
966710|NCT00265382|2337578|P1|STARTED|Overall Study||221
966711|NCT00265395|2337598|P2|NOT COMPLETED|Overall Study||17
966712|NCT00265395|2337599|P1|NOT COMPLETED|Overall Study||8
966713|NCT00265395|2337598|P2|COMPLETED|Overall Study||56
966714|NCT00265395|2337599|P1|COMPLETED|Overall Study||78
966715|NCT00265395|2337598|P2|STARTED|Overall Study||73
966716|NCT00265395|2337599|P1|STARTED|Overall Study||86
966717|NCT00265473|2337604|P1|NOT COMPLETED|Overall Study||0
966718|NCT00265473|2337604|P1|COMPLETED|Overall Study||5
966719|NCT00265473|2337604|P1|STARTED|Overall Study||5
966720|NCT00265512|2337614|P2|NOT COMPLETED|Overall Study||95
966721|NCT00265512|2337615|P1|NOT COMPLETED|Overall Study||45
966722|NCT00265512|2337614|P2|COMPLETED|Overall Study||359
966723|NCT00265512|2337615|P1|COMPLETED|Overall Study||168
966724|NCT00265512|2337614|P2|STARTED|Overall Study||454
966725|NCT00265512|2337615|P1|STARTED|Overall Study||213
966726|NCT00265616|2337623|P2|NOT COMPLETED|Overall Study||0
966727|NCT00265616|2337624|P1|NOT COMPLETED|Overall Study||0
966728|NCT00265616|2337623|P2|COMPLETED|Overall Study||9
966729|NCT00265616|2337624|P1|COMPLETED|Overall Study||14
966730|NCT00265616|2337623|P2|STARTED|Overall Study||9
966731|NCT00265616|2337624|P1|STARTED|Overall Study||14
966732|NCT00265759|2337646|P4|NOT COMPLETED|Overall Study||9
966733|NCT00265759|2337647|P3|NOT COMPLETED|Overall Study||2
966734|NCT00265759|2337648|P2|NOT COMPLETED|Overall Study||1
966735|NCT00265759|2337649|P1|NOT COMPLETED|Overall Study||0
966736|NCT00265759|2337646|P4|COMPLETED|Overall Study||236
966737|NCT00265759|2337647|P3|COMPLETED|Overall Study||123
966738|NCT00265759|2337648|P2|COMPLETED|Overall Study||127
966739|NCT00265759|2337649|P1|COMPLETED|Overall Study||124
966740|NCT00265759|2337646|P4|STARTED|Overall Study||245
966741|NCT00265759|2337647|P3|STARTED|Overall Study||125
966742|NCT00265759|2337648|P2|STARTED|Overall Study||128
966743|NCT00265759|2337649|P1|STARTED|Overall Study||124
966744|NCT00265785|2337678|P1|NOT COMPLETED|Overall Study||27
966745|NCT00265785|2337678|P1|COMPLETED|Overall Study||0
966746|NCT00265785|2337678|P1|Eligible and Began Protocol Treatment|Overall Study||24
966747|NCT00265785|2337678|P1|Eligible|Overall Study||26
966748|NCT00265785|2337678|P1|STARTED|Overall Study||27
966749|NCT00265798|2337685|P1|NOT COMPLETED|Overall Study||0
966750|NCT00265798|2337685|P1|COMPLETED|Overall Study||38
966751|NCT00265798|2337685|P1|STARTED|Overall Study||38
966752|NCT00265850|2337694|P3|NOT COMPLETED|Overall Study||0
966753|NCT00265850|2337695|P2|NOT COMPLETED|Overall Study||0
966754|NCT00265850|2337696|P1|NOT COMPLETED|Overall Study||0
966755|NCT00265850|2337694|P3|COMPLETED|Overall Study||533
966756|NCT00265850|2337695|P2|COMPLETED|Overall Study||902
966757|NCT00265850|2337696|P1|COMPLETED|Overall Study||899
966758|NCT00265850|2337694|P3|STARTED|Overall Study||533
966759|NCT00265850|2337695|P2|STARTED|Overall Study||902
966760|NCT00265850|2337696|P1|STARTED|Overall Study||899
966761|NCT00265889|2337706|P1|NOT COMPLETED|Overall Study||5
966762|NCT00265889|2337706|P1|COMPLETED|Overall Study||37
966763|NCT00265889|2337706|P1|Cycle 2: 2nd Regimen/Transplant|Overall Study||37
966764|NCT00265889|2337706|P1|Cycle 1: 1st Regimen/Transplant|Overall Study||37
966765|NCT00265889|2337706|P1|STARTED|Overall Study||42
966766|NCT00266032|2337715|P3|NOT COMPLETED|Open-label Safety Extension||25
966767|NCT00266032|2337716|P2|NOT COMPLETED|Open-label Safety Extension||14
966768|NCT00266032|2337717|P1|NOT COMPLETED|Open-label Safety Extension||41
966769|NCT00266032|2337715|P3|COMPLETED|Open-label Safety Extension||140
966770|NCT00266032|2337716|P2|COMPLETED|Open-label Safety Extension||115
966771|NCT00266032|2337717|P1|COMPLETED|Open-label Safety Extension||448
966772|NCT00266032|2337715|P3|STARTED|Open-label Safety Extension|21 subjects continued their treatment in second period (safety extension)|165
966773|NCT00266032|2337716|P2|STARTED|Open-label Safety Extension|7 subjects continued their treatment in second period (safety extension)|129
966774|NCT00266032|2337717|P1|STARTED|Open-label Safety Extension|treatment for subjects of all 3 treatment groups in 2nd period, except for 28 in subgroups|489
966775|NCT00266032|2337715|P3|NOT COMPLETED|Treatment||47
966776|NCT00266032|2337716|P2|NOT COMPLETED|Treatment||64
966777|NCT00266032|2337717|P1|NOT COMPLETED|Treatment||111
966778|NCT00266032|2337715|P3|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|192
966779|NCT00266032|2337716|P2|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|172
966780|NCT00266032|2337717|P1|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|580
966781|NCT00266032|2337715|P3|Patients Treated and in FAS|Treatment|FAS|216
966782|NCT00266032|2337716|P2|Patients Treated and in FAS|Treatment|FAS|209
966783|NCT00266032|2337717|P1|Patients Treated and in FAS|Treatment|FAS|642
966784|NCT00266032|2337715|P3|Patients Treated|Treatment||229
966785|NCT00266032|2337716|P2|Patients Treated|Treatment||221
966786|NCT00266032|2337717|P1|Patients Treated|Treatment||684
966787|NCT00266032|2337715|P3|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|239
966788|NCT00266032|2337716|P2|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|236
966789|NCT00266032|2337717|P1|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|691
966790|NCT00266110|2337745|P1|NOT COMPLETED|Overall Study||7
966791|NCT00266110|2337745|P1|COMPLETED|Overall Study||10
966792|NCT00266110|2337745|P1|STARTED|Overall Study||17
966793|NCT00266227|2337751|P3|NOT COMPLETED|Retreatment: Week 48 to Week 72||0
966794|NCT00266227|2337752|P2|NOT COMPLETED|Retreatment: Week 48 to Week 72||42
966795|NCT00266227|2337753|P1|NOT COMPLETED|Retreatment: Week 48 to Week 72||64
966796|NCT00266227|2337751|P3|COMPLETED|Retreatment: Week 48 to Week 72||0
966797|NCT00266227|2337752|P2|COMPLETED|Retreatment: Week 48 to Week 72||92
966798|NCT00266227|2337753|P1|COMPLETED|Retreatment: Week 48 to Week 72||227
966799|NCT00266227|2337751|P3|STARTED|Retreatment: Week 48 to Week 72||0
966800|NCT00266227|2337752|P2|STARTED|Retreatment: Week 48 to Week 72||134
966801|NCT00266227|2337753|P1|STARTED|Retreatment: Week 48 to Week 72||291
966802|NCT00266227|2337751|P3|NOT COMPLETED|Retreatment: Up to Week 48||0
966803|NCT00266227|2337752|P2|NOT COMPLETED|Retreatment: Up to Week 48||23
966804|NCT00266227|2337753|P1|NOT COMPLETED|Retreatment: Up to Week 48||27
966805|NCT00266227|2337751|P3|COMPLETED|Retreatment: Up to Week 48||0
966806|NCT00266227|2337752|P2|COMPLETED|Retreatment: Up to Week 48||134
966807|NCT00266227|2337753|P1|COMPLETED|Retreatment: Up to Week 48||291
966808|NCT00266227|2337751|P3|STARTED|Retreatment: Up to Week 48||0
966809|NCT00266227|2337752|P2|STARTED|Retreatment: Up to Week 48||157
966810|NCT00266227|2337753|P1|STARTED|Retreatment: Up to Week 48||318
966811|NCT00266227|2337751|P3|NOT COMPLETED|Initial Treatment||77
966812|NCT00266227|2337752|P2|NOT COMPLETED|Initial Treatment||0
966813|NCT00266227|2337753|P1|NOT COMPLETED|Initial Treatment||0
966814|NCT00266227|2337751|P3|COMPLETED|Initial Treatment||482
966815|NCT00266227|2337752|P2|COMPLETED|Initial Treatment||0
966816|NCT00266227|2337753|P1|COMPLETED|Initial Treatment||0
966817|NCT00266227|2337751|P3|STARTED|Initial Treatment||559
966818|NCT00266227|2337752|P2|STARTED|Initial Treatment||0
966819|NCT00266227|2337753|P1|STARTED|Initial Treatment||0
966820|NCT00266279|2337798|P1|NOT COMPLETED|Overall Study||2
966821|NCT00266279|2337798|P1|COMPLETED|Overall Study||15
966822|NCT00266279|2337798|P1|STARTED|Overall Study||17
966823|NCT00255970|2337804|P2|NOT COMPLETED|Overall Study||0
966824|NCT00255970|2337805|P1|NOT COMPLETED|Overall Study||0
966825|NCT00255970|2337804|P2|COMPLETED|Overall Study||19
966826|NCT00255970|2337805|P1|COMPLETED|Overall Study||21
966827|NCT00255970|2337804|P2|Final Visit Week 24|Overall Study||19
966828|NCT00255970|2337805|P1|Final Visit Week 24|Overall Study||21
966829|NCT00255970|2337804|P2|Screening Visit|Overall Study||19
966830|NCT00255970|2337805|P1|Screening Visit|Overall Study||21
966831|NCT00255970|2337804|P2|STARTED|Overall Study||19
966832|NCT00255970|2337805|P1|STARTED|Overall Study||21
966833|NCT00256204|2337827|P4|NOT COMPLETED|Overall Study||49
966834|NCT00256204|2337828|P3|NOT COMPLETED|Overall Study||54
966835|NCT00256204|2337829|P2|NOT COMPLETED|Overall Study||50
966836|NCT00256204|2337830|P1|NOT COMPLETED|Overall Study||67
966837|NCT00256204|2337827|P4|COMPLETED|Overall Study||244
966838|NCT00256204|2337828|P3|COMPLETED|Overall Study||241
966839|NCT00256204|2337829|P2|COMPLETED|Overall Study||238
966840|NCT00256204|2337830|P1|COMPLETED|Overall Study||231
966841|NCT00256204|2337827|P4|STARTED|Overall Study||293
966842|NCT00256204|2337828|P3|STARTED|Overall Study||295
966843|NCT00256204|2337829|P2|STARTED|Overall Study||288
966844|NCT00256204|2337830|P1|STARTED|Overall Study||298
966845|NCT00256243|2337843|P1|NOT COMPLETED|Overall Study||10
966846|NCT00256243|2337843|P1|COMPLETED|Overall Study||38
966847|NCT00256243|2337843|P1|STARTED|Overall Study||48
966848|NCT00256295|2337848|P1|NOT COMPLETED|Overall Study||4
966849|NCT00256295|2337848|P1|COMPLETED|Overall Study||3
966850|NCT00256295|2337848|P1|STARTED|Overall Study|Of the 8 subjects consented, 1 withdrew prior to treatment.|7
966851|NCT00256698|2337856|P2|NOT COMPLETED|Overall Study||172
966852|NCT00256698|2337857|P1|NOT COMPLETED|Overall Study||167
966853|NCT00256698|2337856|P2|COMPLETED|Overall Study||84
966854|NCT00256698|2337857|P1|COMPLETED|Overall Study||91
966855|NCT00256698|2337856|P2|STARTED|Overall Study||256
966856|NCT00256698|2337857|P1|STARTED|Overall Study||258
966857|NCT00256724|2337877|P2|NOT COMPLETED|Overall Study||8
966858|NCT00256724|2337878|P1|NOT COMPLETED|Overall Study||5
966859|NCT00256724|2337877|P2|COMPLETED|Overall Study||16
966860|NCT00256724|2337878|P1|COMPLETED|Overall Study||18
966861|NCT00256724|2337877|P2|STARTED|Overall Study||24
966862|NCT00256724|2337878|P1|STARTED|Overall Study||23
966908|NCT00256984|2338025|P1|NOT COMPLETED|Overall Study||16
966909|NCT00256984|2338025|P1|COMPLETED|Overall Study||59
966910|NCT00256984|2338025|P1|STARTED|Overall Study||75
966911|NCT00256997|2338037|P2|NOT COMPLETED|Overall Study||55
966912|NCT00256997|2338038|P1|NOT COMPLETED|Overall Study||48
966913|NCT00256997|2338037|P2|COMPLETED|Overall Study||31
966914|NCT00256997|2338038|P1|COMPLETED|Overall Study||33
966915|NCT00256997|2338037|P2|Treated|Overall Study||86
966916|NCT00256997|2338038|P1|Treated|Overall Study||79
966917|NCT00256997|2338037|P2|STARTED|Overall Study||86
966918|NCT00256997|2338038|P1|STARTED|Overall Study||81
966919|NCT00257010|2338062|P1|NOT COMPLETED|Overall Study||128
966920|NCT00257010|2338062|P1|COMPLETED|Overall Study||319
966921|NCT00257010|2338062|P1|STARTED|Overall Study||447
966922|NCT00257166|2338073|P2|NOT COMPLETED|Overall Study||37
966923|NCT00257166|2338074|P1|NOT COMPLETED|Overall Study||53
966924|NCT00257166|2338073|P2|COMPLETED|Overall Study||51
966925|NCT00257166|2338074|P1|COMPLETED|Overall Study||97
966926|NCT00257166|2338073|P2|Treated|Overall Study||88
966927|NCT00257166|2338074|P1|Treated|Overall Study||149
966928|NCT00257166|2338073|P2|STARTED|Overall Study||88
966929|NCT00257166|2338074|P1|STARTED|Overall Study||150
966930|NCT00257192|2338088|P2|NOT COMPLETED|Overall Study||39
966931|NCT00257192|2338089|P1|NOT COMPLETED|Overall Study||58
966932|NCT00257192|2338088|P2|COMPLETED|Overall Study||52
966933|NCT00257192|2338089|P1|COMPLETED|Overall Study||135
966934|NCT00257192|2338088|P2|Received Study Treatment|Overall Study||90
966935|NCT00257192|2338089|P1|Received Study Treatment|Overall Study||193
966936|NCT00257192|2338088|P2|STARTED|Overall Study|Includes 1 subject randomized but not treated|91
966937|NCT00257192|2338089|P1|STARTED|Overall Study||193
966938|NCT00257309|2338133|P2|NOT COMPLETED|Overall Study||2
966939|NCT00257309|2338134|P1|NOT COMPLETED|Overall Study||2
966940|NCT00257309|2338133|P2|COMPLETED|Overall Study||130
966941|NCT00257309|2338134|P1|COMPLETED|Overall Study||132
966942|NCT00257309|2338133|P2|STARTED|Overall Study||132
966943|NCT00257309|2338134|P1|STARTED|Overall Study||134
966944|NCT00257322|2338142|P1|NOT COMPLETED|Overall Study||4
966945|NCT00257322|2338142|P1|COMPLETED|Overall Study|4 subjects withdrew from this study.|16
966946|NCT00257322|2338142|P1|STARTED|Overall Study|20 subjects accrued.|20
966947|NCT00257556|2338149|P2|NOT COMPLETED|Overall Study||10
966948|NCT00257556|2338150|P1|NOT COMPLETED|Overall Study||14
966949|NCT00257556|2338149|P2|COMPLETED|Overall Study||32
966950|NCT00257556|2338150|P1|COMPLETED|Overall Study||24
966951|NCT00257556|2338149|P2|All Patients Treated Population|Overall Study|Also the safety population. Three randomized patients did not receive study medication.|39
966952|NCT00257556|2338150|P1|All Patients Treated Population|Overall Study|Also the safety population. One randomized patient did not receive study medication.|37
966953|NCT00257556|2338149|P2|STARTED|Overall Study||42
966954|NCT00257556|2338150|P1|STARTED|Overall Study||38
966955|NCT00257608|2338178|P3|NOT COMPLETED|Post Chemotherapy Phase||244
966956|NCT00257608|2338179|P2|NOT COMPLETED|Post Chemotherapy Phase||264
966957|NCT00257608|2338180|P1|NOT COMPLETED|Post Chemotherapy Phase||0
966958|NCT00257608|2338178|P3|COMPLETED|Post Chemotherapy Phase||126
966959|NCT00257608|2338179|P2|COMPLETED|Post Chemotherapy Phase||109
966960|NCT00257608|2338180|P1|COMPLETED|Post Chemotherapy Phase||0
966961|NCT00257608|2338178|P3|STARTED|Post Chemotherapy Phase||370
966962|NCT00257608|2338179|P2|STARTED|Post Chemotherapy Phase||373
966963|NCT00257608|2338180|P1|STARTED|Post Chemotherapy Phase||0
966964|NCT00257608|2338178|P3|NOT COMPLETED|Chemotherapy Phase||0
966965|NCT00257608|2338179|P2|NOT COMPLETED|Chemotherapy Phase||0
966966|NCT00257608|2338180|P1|NOT COMPLETED|Chemotherapy Phase||376
966967|NCT00257608|2338178|P3|COMPLETED|Chemotherapy Phase||0
966968|NCT00257608|2338179|P2|COMPLETED|Chemotherapy Phase||0
966969|NCT00257608|2338180|P1|COMPLETED|Chemotherapy Phase||769
966970|NCT00257608|2338178|P3|STARTED|Chemotherapy Phase||0
966971|NCT00257608|2338179|P2|STARTED|Chemotherapy Phase||0
966972|NCT00257608|2338180|P1|STARTED|Chemotherapy Phase||1145
966973|NCT00257660|2338206|P2|NOT COMPLETED|Overall Study||23
966974|NCT00257660|2338207|P1|NOT COMPLETED|Overall Study||10
966975|NCT00257660|2338206|P2|COMPLETED|Overall Study||38
966976|NCT00257660|2338207|P1|COMPLETED|Overall Study||45
966977|NCT00257660|2338206|P2|STARTED|Overall Study||61
966978|NCT00257660|2338207|P1|STARTED|Overall Study||55
966979|NCT00257686|2338241|P6|NOT COMPLETED|Overall Study||9
966980|NCT00257686|2338242|P5|NOT COMPLETED|Overall Study||22
966981|NCT00257686|2338243|P4|NOT COMPLETED|Overall Study||11
966982|NCT00257686|2338244|P3|NOT COMPLETED|Overall Study||18
966983|NCT00257686|2338245|P2|NOT COMPLETED|Overall Study||19
966984|NCT00257686|2338246|P1|NOT COMPLETED|Overall Study||21
966985|NCT00257686|2338241|P6|COMPLETED|Overall Study||95
966986|NCT00257686|2338242|P5|COMPLETED|Overall Study||194
966987|NCT00257686|2338243|P4|COMPLETED|Overall Study||88
966988|NCT00257686|2338244|P3|COMPLETED|Overall Study||208
966989|NCT00257686|2338245|P2|COMPLETED|Overall Study||89
966990|NCT00257686|2338246|P1|COMPLETED|Overall Study||188
966991|NCT00257686|2338241|P6|Safety Population|Overall Study|Subjects who received at least one dose of study medication|102
966992|NCT00257686|2338242|P5|Safety Population|Overall Study|Subjects who received at least one dose of study medication|210
966993|NCT00257686|2338243|P4|Safety Population|Overall Study|Subjects who received at least one dose of study medication|96
966994|NCT00257686|2338244|P3|Safety Population|Overall Study|Subjects who received at least one dose of study medication|224
966995|NCT00257686|2338245|P2|Safety Population|Overall Study|Subjects who received at least one dose of study medication|103
966996|NCT00257686|2338246|P1|Safety Population|Overall Study|Subjects who received at least one dose of study medication|207
966997|NCT00257686|2338241|P6|STARTED|Overall Study||104
966998|NCT00257686|2338242|P5|STARTED|Overall Study||216
966999|NCT00257686|2338243|P4|STARTED|Overall Study||99
967000|NCT00257686|2338244|P3|STARTED|Overall Study||226
967001|NCT00257686|2338245|P2|STARTED|Overall Study||108
967002|NCT00257686|2338246|P1|STARTED|Overall Study||209
967003|NCT00257894|2338268|P2|NOT COMPLETED|Overall Study||5
967004|NCT00257894|2338269|P1|NOT COMPLETED|Overall Study||4
967005|NCT00257894|2338268|P2|COMPLETED|Overall Study||15
967006|NCT00257894|2338269|P1|COMPLETED|Overall Study||17
967007|NCT00257894|2338268|P2|STARTED|Overall Study||20
967008|NCT00257894|2338269|P1|STARTED|Overall Study||21
967009|NCT00257920|2338283|P2|NOT COMPLETED|Period: Second Intervention||1
967010|NCT00257920|2338284|P1|NOT COMPLETED|Period: Second Intervention||2
967011|NCT00257920|2338283|P2|COMPLETED|Period: Second Intervention||18
967012|NCT00257920|2338284|P1|COMPLETED|Period: Second Intervention||19
967013|NCT00257920|2338283|P2|STARTED|Period: Second Intervention||19
967014|NCT00257920|2338284|P1|STARTED|Period: Second Intervention||21
967015|NCT00257920|2338283|P2|NOT COMPLETED|Period: Washout Period of Two Weeks||1
967016|NCT00257920|2338284|P1|NOT COMPLETED|Period: Washout Period of Two Weeks||0
967017|NCT00257920|2338283|P2|COMPLETED|Period: Washout Period of Two Weeks||19
967018|NCT00257920|2338284|P1|COMPLETED|Period: Washout Period of Two Weeks||21
967019|NCT00257920|2338283|P2|STARTED|Period: Washout Period of Two Weeks||20
967020|NCT00257920|2338284|P1|STARTED|Period: Washout Period of Two Weeks||21
967021|NCT00257920|2338283|P2|NOT COMPLETED|Period: First Intervention||0
967022|NCT00257920|2338284|P1|NOT COMPLETED|Period: First Intervention||0
967023|NCT00257920|2338283|P2|COMPLETED|Period: First Intervention||20
967024|NCT00257920|2338284|P1|COMPLETED|Period: First Intervention||21
967025|NCT00257920|2338283|P2|STARTED|Period: First Intervention||20
967026|NCT00257920|2338284|P1|STARTED|Period: First Intervention||21
967027|NCT00257933|2338294|P2|NOT COMPLETED|Overall Study||0
967028|NCT00257933|2338295|P1|NOT COMPLETED|Overall Study||0
967029|NCT00257933|2338294|P2|COMPLETED|Overall Study||78
967030|NCT00257933|2338295|P1|COMPLETED|Overall Study||74
967031|NCT00257933|2338294|P2|STARTED|Overall Study||78
967032|NCT00257933|2338295|P1|STARTED|Overall Study||74
967033|NCT00258011|2338301|P1|NOT COMPLETED|Overall Study||0
967034|NCT00258011|2338301|P1|COMPLETED|Overall Study||3
967035|NCT00258011|2338301|P1|STARTED|Overall Study||3
967036|NCT00258154|2338308|P2|NOT COMPLETED|Overall Study||7
967037|NCT00258154|2338309|P1|NOT COMPLETED|Overall Study||9
967038|NCT00258154|2338308|P2|COMPLETED|Overall Study|Subjects who completed the study.|195
967039|NCT00258154|2338309|P1|COMPLETED|Overall Study|Subjects who completed the study.|192
967040|NCT00258154|2338308|P2|Vaccinated at Visit 3|Overall Study||197
967041|NCT00258154|2338309|P1|Vaccinated at Visit 3|Overall Study||195
967042|NCT00258154|2338308|P2|Vaccinated at Visit 2|Overall Study||198
967043|NCT00258154|2338309|P1|Vaccinated at Visit 2|Overall Study||198
967044|NCT00258154|2338308|P2|Vaccinated at Visit 1|Overall Study||202
967045|NCT00258154|2338309|P1|Vaccinated at Visit 1|Overall Study||201
967046|NCT00258154|2338308|P2|STARTED|Overall Study|Healthy infants who started in the Placebo concomitantly with INFANRIX™ hexa group.|202
967047|NCT00258154|2338309|P1|STARTED|Overall Study|Healthy infants who started in the RotaTeq™ concomitantly with INFANRIX™ hexa group.|201
967048|NCT00258206|2338377|P1|NOT COMPLETED|Overall Study||0
967049|NCT00258206|2338377|P1|COMPLETED|Overall Study||21
967050|NCT00258206|2338377|P1|STARTED|Overall Study||21
967051|NCT00258310|2338381|P1|NOT COMPLETED|Overall Study||0
967052|NCT00258310|2338381|P1|COMPLETED|Overall Study||35
967053|NCT00258310|2338381|P1|STARTED|Overall Study||35
967054|NCT00258349|2338385|P1|NOT COMPLETED|Overall Study||0
967055|NCT00258349|2338385|P1|COMPLETED|Overall Study||16
967056|NCT00258349|2338385|P1|HER2-positive by Central Review|Overall Study||10
967057|NCT00258349|2338385|P1|STARTED|Overall Study||16
967058|NCT00258362|2338392|P1|NOT COMPLETED|Overall Study||0
967059|NCT00258362|2338392|P1|COMPLETED|Overall Study||41
967060|NCT00258362|2338392|P1|STARTED|Overall Study||41
967061|NCT00266409|2338401|P4|NOT COMPLETED|Overall Study||22
967062|NCT00266409|2338402|P3|NOT COMPLETED|Overall Study||17
967063|NCT00266409|2338403|P2|NOT COMPLETED|Overall Study||46
967064|NCT00266409|2338404|P1|NOT COMPLETED|Overall Study||45
967065|NCT00266409|2338401|P4|COMPLETED|Overall Study||49
967066|NCT00266409|2338402|P3|COMPLETED|Overall Study||55
967067|NCT00266409|2338403|P2|COMPLETED|Overall Study||92
967068|NCT00266409|2338404|P1|COMPLETED|Overall Study||92
967069|NCT00266409|2338401|P4|STARTED|Overall Study||71
967070|NCT00266409|2338402|P3|STARTED|Overall Study||72
967071|NCT00266409|2338403|P2|STARTED|Overall Study||138
967072|NCT00266409|2338404|P1|STARTED|Overall Study||137
967073|NCT00266630|2338688|P2|NOT COMPLETED|Overall Study||28
967074|NCT00266630|2338689|P1|NOT COMPLETED|Overall Study||42
967075|NCT00266630|2338688|P2|COMPLETED|Overall Study||11
967076|NCT00266630|2338689|P1|COMPLETED|Overall Study||58
967077|NCT00266630|2338688|P2|STARTED|Overall Study||39
967078|NCT00266630|2338689|P1|STARTED|Overall Study||100
967079|NCT00267670|2338729|P2|NOT COMPLETED|Overall Study||0
967080|NCT00267670|2338730|P1|NOT COMPLETED|Overall Study||4
967081|NCT00267670|2338729|P2|COMPLETED|Overall Study||7
967082|NCT00267670|2338730|P1|COMPLETED|Overall Study||15
967083|NCT00267670|2338729|P2|STARTED|Overall Study||7
967084|NCT00267670|2338730|P1|STARTED|Overall Study||19
967085|NCT00267696|2338742|P1|NOT COMPLETED|Overall Study||0
967086|NCT00267696|2338742|P1|COMPLETED|Overall Study||45
967087|NCT00267696|2338742|P1|STARTED|Overall Study||45
967088|NCT00267748|2338750|P3|NOT COMPLETED|Randomized Period||132
967089|NCT00267748|2338751|P2|NOT COMPLETED|Randomized Period||127
967090|NCT00267748|2338752|P1|NOT COMPLETED|Randomized Period||0
967091|NCT00267748|2338750|P3|COMPLETED|Randomized Period||14
967092|NCT00267748|2338751|P2|COMPLETED|Randomized Period||19
967093|NCT00267748|2338752|P1|COMPLETED|Randomized Period||0
967094|NCT00267748|2338750|P3|Treated|Randomized Period||143
967095|NCT00267748|2338751|P2|Treated|Randomized Period||146
967096|NCT00267748|2338752|P1|Treated|Randomized Period||0
967097|NCT00267748|2338750|P3|STARTED|Randomized Period||146
967098|NCT00267748|2338751|P2|STARTED|Randomized Period||146
967099|NCT00267748|2338752|P1|STARTED|Randomized Period||0
967100|NCT00267748|2338750|P3|NOT COMPLETED|Non-randomized Period||0
967101|NCT00267748|2338751|P2|NOT COMPLETED|Non-randomized Period||0
967102|NCT00267748|2338752|P1|NOT COMPLETED|Non-randomized Period||23
967103|NCT00267748|2338750|P3|COMPLETED|Non-randomized Period||0
967104|NCT00267748|2338751|P2|COMPLETED|Non-randomized Period||0
967105|NCT00267748|2338752|P1|COMPLETED|Non-randomized Period||2
967106|NCT00267748|2338750|P3|STARTED|Non-randomized Period||0
967107|NCT00267748|2338751|P2|STARTED|Non-randomized Period||0
967108|NCT00267748|2338752|P1|STARTED|Non-randomized Period||25
967109|NCT00267774|2338771|P2|NOT COMPLETED|Overall Study||0
967110|NCT00267774|2338772|P1|NOT COMPLETED|Overall Study||0
967111|NCT00267774|2338771|P2|COMPLETED|Overall Study||496
967112|NCT00267774|2338772|P1|COMPLETED|Overall Study||509
967113|NCT00267774|2338771|P2|STARTED|Overall Study||496
967114|NCT00267774|2338772|P1|STARTED|Overall Study||509
967115|NCT00267956|2338780|P4|NOT COMPLETED|After Controlled Period||2
967116|NCT00267956|2338781|P3|NOT COMPLETED|After Controlled Period||5
967117|NCT00267956|2338782|P2|NOT COMPLETED|After Controlled Period||0
967118|NCT00267956|2338783|P1|NOT COMPLETED|After Controlled Period||0
967119|NCT00267956|2338780|P4|COMPLETED|After Controlled Period||70
967120|NCT00267956|2338781|P3|COMPLETED|After Controlled Period||52
967121|NCT00267956|2338782|P2|COMPLETED|After Controlled Period||0
967122|NCT00267956|2338783|P1|COMPLETED|After Controlled Period||0
967123|NCT00267956|2338780|P4|STARTED|After Controlled Period||72
967124|NCT00267956|2338781|P3|STARTED|After Controlled Period||57
967125|NCT00267956|2338782|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
967126|NCT00267956|2338783|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
967127|NCT00267956|2338780|P4|NOT COMPLETED|Controlled Period||0
967128|NCT00267956|2338781|P3|NOT COMPLETED|Controlled Period||0
967129|NCT00267956|2338782|P2|NOT COMPLETED|Controlled Period||4
967130|NCT00267956|2338783|P1|NOT COMPLETED|Controlled Period||13
967131|NCT00267956|2338780|P4|COMPLETED|Controlled Period||0
967132|NCT00267956|2338781|P3|COMPLETED|Controlled Period||0
967133|NCT00267956|2338782|P2|COMPLETED|Controlled Period||72
967134|NCT00267956|2338783|P1|COMPLETED|Controlled Period||57
967135|NCT00267956|2338780|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
967136|NCT00267956|2338781|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
967137|NCT00267956|2338782|P2|STARTED|Controlled Period||76
967138|NCT00267956|2338783|P1|STARTED|Controlled Period||70
967139|NCT00267969|2338804|P7|NOT COMPLETED|After Controlled Period||72
967140|NCT00267969|2338805|P6|NOT COMPLETED|After Controlled Period||82
967141|NCT00267969|2338806|P5|NOT COMPLETED|After Controlled Period||35
967142|NCT00267969|2338807|P4|NOT COMPLETED|After Controlled Period||36
967143|NCT00267969|2338808|P3|NOT COMPLETED|After Controlled Period||0
967144|NCT00267969|2338809|P2|NOT COMPLETED|After Controlled Period||0
967145|NCT00267969|2338810|P1|NOT COMPLETED|After Controlled Period||0
967146|NCT00267969|2338804|P7|COMPLETED|After Controlled Period||173
967147|NCT00267969|2338805|P6|COMPLETED|After Controlled Period||172
967148|NCT00267969|2338806|P5|COMPLETED|After Controlled Period||85
967149|NCT00267969|2338807|P4|COMPLETED|After Controlled Period||87
967150|NCT00267969|2338808|P3|COMPLETED|After Controlled Period||0
967151|NCT00267969|2338809|P2|COMPLETED|After Controlled Period||0
967152|NCT00267969|2338810|P1|COMPLETED|After Controlled Period||0
967153|NCT00267969|2338804|P7|STARTED|After Controlled Period||245
967154|NCT00267969|2338805|P6|STARTED|After Controlled Period||254
967155|NCT00267969|2338806|P5|STARTED|After Controlled Period||120
967156|NCT00267969|2338807|P4|STARTED|After Controlled Period||123
967157|NCT00267969|2338808|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
967158|NCT00267969|2338809|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
967159|NCT00267969|2338810|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
967160|NCT00267969|2338804|P7|NOT COMPLETED|Controlled Period||0
967161|NCT00267969|2338805|P6|NOT COMPLETED|Controlled Period||0
967162|NCT00267969|2338806|P5|NOT COMPLETED|Controlled Period||0
967163|NCT00267969|2338807|P4|NOT COMPLETED|Controlled Period||0
967164|NCT00267969|2338808|P3|NOT COMPLETED|Controlled Period||11
967165|NCT00267969|2338809|P2|NOT COMPLETED|Controlled Period||1
967166|NCT00267969|2338810|P1|NOT COMPLETED|Controlled Period||12
967167|NCT00267969|2338804|P7|COMPLETED|Controlled Period||0
967168|NCT00267969|2338805|P6|COMPLETED|Controlled Period||0
967169|NCT00267969|2338806|P5|COMPLETED|Controlled Period||0
967170|NCT00267969|2338807|P4|COMPLETED|Controlled Period||0
967171|NCT00267969|2338808|P3|COMPLETED|Controlled Period||245
967172|NCT00267969|2338809|P2|COMPLETED|Controlled Period||254
967173|NCT00267969|2338810|P1|COMPLETED|Controlled Period||243
967174|NCT00267969|2338804|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
967175|NCT00267969|2338805|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
967176|NCT00267969|2338806|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
967177|NCT00267969|2338807|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
967178|NCT00267969|2338808|P3|STARTED|Controlled Period|Number of patients randomized|256
967179|NCT00267969|2338809|P2|STARTED|Controlled Period|Number of patients randomized|255
967180|NCT00267969|2338810|P1|STARTED|Controlled Period|Number of patients randomized|255
967181|NCT00268203|2338834|P1|NOT COMPLETED|Overall Study||647
967182|NCT00268203|2338834|P1|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|118
967183|NCT00268203|2338834|P1|Completed 2 Years of Follow-up|Overall Study||62
967184|NCT00268203|2338834|P1|STARTED|Overall Study||765
967185|NCT00268242|2338845|P1|NOT COMPLETED|Overall Study||1
967186|NCT00268242|2338845|P1|COMPLETED|Overall Study||23
967187|NCT00268242|2338845|P1|STARTED|Overall Study||24
967188|NCT00268346|2338856|P2|NOT COMPLETED|Overall Study||3
967189|NCT00268346|2338857|P1|NOT COMPLETED|Overall Study||0
967190|NCT00268346|2338856|P2|COMPLETED|Overall Study||37
967191|NCT00268346|2338857|P1|COMPLETED|Overall Study||18
967192|NCT00268346|2338856|P2|Started Treatment|Overall Study||40
967193|NCT00268346|2338857|P1|Started Treatment|Overall Study||18
967194|NCT00268346|2338856|P2|STARTED|Overall Study||40
967195|NCT00268346|2338857|P1|STARTED|Overall Study||18
967196|NCT00268437|2338863|P1|NOT COMPLETED|Overall Study||1
967197|NCT00268437|2338863|P1|COMPLETED|Overall Study||26
967198|NCT00268437|2338863|P1|STARTED|Overall Study||27
967199|NCT00268463|2338870|P2|NOT COMPLETED|Overall Study||12
967200|NCT00268463|2338871|P1|NOT COMPLETED|Overall Study||10
967201|NCT00268463|2338870|P2|COMPLETED|Overall Study||0
967202|NCT00268463|2338871|P1|COMPLETED|Overall Study||0
967203|NCT00268463|2338870|P2|STARTED|Overall Study||12
967204|NCT00268463|2338871|P1|STARTED|Overall Study||10
967205|NCT00268762|2338877|P1|NOT COMPLETED|Overall Study||0
967206|NCT00268762|2338877|P1|COMPLETED|Overall Study||65
967207|NCT00268762|2338877|P1|STARTED|Overall Study||65
967208|NCT00268892|2338886|P3|NOT COMPLETED|Overall Study||39
967209|NCT00268892|2338887|P2|NOT COMPLETED|Overall Study||42
967210|NCT00268892|2338888|P1|NOT COMPLETED|Overall Study||39
967211|NCT00268892|2338886|P3|COMPLETED|Overall Study||54
967212|NCT00268892|2338887|P2|COMPLETED|Overall Study||53
967213|NCT00268892|2338888|P1|COMPLETED|Overall Study||51
967214|NCT00268892|2338886|P3|Switched to Higher Dose|Overall Study||76
967215|NCT00268892|2338887|P2|Switched to Higher Dose|Overall Study||68
967216|NCT00268892|2338888|P1|Switched to Higher Dose|Overall Study||59
967217|NCT00268892|2338886|P3|STARTED|Overall Study||93
967218|NCT00268892|2338887|P2|STARTED|Overall Study||95
967219|NCT00268892|2338888|P1|STARTED|Overall Study||90
967220|NCT00268905|2338902|P3|NOT COMPLETED|Overall Study||12
967221|NCT00268905|2338903|P2|NOT COMPLETED|Overall Study||9
967222|NCT00268905|2338904|P1|NOT COMPLETED|Overall Study||43
967223|NCT00268905|2338902|P3|COMPLETED|Overall Study||0
967224|NCT00268905|2338903|P2|COMPLETED|Overall Study||0
967225|NCT00268905|2338904|P1|COMPLETED|Overall Study||0
967226|NCT00268905|2338902|P3|STARTED|Overall Study||12
967227|NCT00268905|2338903|P2|STARTED|Overall Study||9
967228|NCT00268905|2338904|P1|STARTED|Overall Study||43
967229|NCT00268983|2338920|P2|NOT COMPLETED|Overall Study||0
967230|NCT00268983|2338921|P1|NOT COMPLETED|Overall Study||3
967231|NCT00268983|2338920|P2|COMPLETED|Overall Study||8
967232|NCT00268983|2338921|P1|COMPLETED|Overall Study||3
967233|NCT00268983|2338920|P2|STARTED|Overall Study||8
967234|NCT00268983|2338921|P1|STARTED|Overall Study||6
967235|NCT00269113|2338963|P2|NOT COMPLETED|Overall Study||37
967236|NCT00269113|2338964|P1|NOT COMPLETED|Overall Study||74
967237|NCT00269113|2338963|P2|COMPLETED|Overall Study||146
967238|NCT00269113|2338964|P1|COMPLETED|Overall Study||103
967239|NCT00269113|2338963|P2|STARTED|Overall Study||183
967240|NCT00269113|2338964|P1|STARTED|Overall Study||177
967241|NCT00269152|2338984|P2|NOT COMPLETED|Overall Study||10
967242|NCT00269152|2338985|P1|NOT COMPLETED|Overall Study||18
967243|NCT00269152|2338984|P2|COMPLETED|Overall Study||49
967244|NCT00269152|2338985|P1|COMPLETED|Overall Study||45
967245|NCT00269152|2338984|P2|STARTED|Overall Study|4 were randomized without receiving any study drug.|59
967246|NCT00269152|2338985|P1|STARTED|Overall Study|One participant in Pemetrexed+Carboplatin actually received Pemetrexed+Cisplatin|63
967247|NCT00269477|2339003|P4|NOT COMPLETED|Overall Study||0
967248|NCT00269477|2339004|P3|NOT COMPLETED|Overall Study||1
967249|NCT00269477|2339005|P2|NOT COMPLETED|Overall Study||6
967250|NCT00269477|2339006|P1|NOT COMPLETED|Overall Study||5
967251|NCT00269477|2339003|P4|COMPLETED|Overall Study||60
967252|NCT00269477|2339004|P3|COMPLETED|Overall Study||57
967253|NCT00269477|2339005|P2|COMPLETED|Overall Study||12
967254|NCT00269477|2339006|P1|COMPLETED|Overall Study||4
967255|NCT00269477|2339003|P4|STARTED|Overall Study||60
967256|NCT00269477|2339004|P3|STARTED|Overall Study||58
967257|NCT00269477|2339005|P2|STARTED|Overall Study||18
967258|NCT00269477|2339006|P1|STARTED|Overall Study||9
967259|NCT00269633|2339022|P2|NOT COMPLETED|Overall Study||0
967260|NCT00269633|2339023|P1|NOT COMPLETED|Overall Study||1
967261|NCT00269633|2339022|P2|COMPLETED|Overall Study||5
967262|NCT00269633|2339023|P1|COMPLETED|Overall Study||3
967263|NCT00269633|2339022|P2|STARTED|Overall Study||5
967264|NCT00269633|2339023|P1|STARTED|Overall Study||4
967265|NCT00269919|2339029|P1|NOT COMPLETED|Overall Study||27
967266|NCT00269919|2339029|P1|COMPLETED|Overall Study||13
967267|NCT00269919|2339029|P1|Treated|Overall Study||39
967268|NCT00269919|2339029|P1|STARTED|Overall Study||40
967269|NCT00270205|2339050|P4|NOT COMPLETED|Overall Study||1
967270|NCT00270205|2339051|P3|NOT COMPLETED|Overall Study||0
967271|NCT00270205|2339052|P2|NOT COMPLETED|Overall Study||0
967272|NCT00270205|2339053|P1|NOT COMPLETED|Overall Study||1
967273|NCT00270205|2339050|P4|COMPLETED|Overall Study||6
967274|NCT00270205|2339051|P3|COMPLETED|Overall Study||6
967275|NCT00270205|2339052|P2|COMPLETED|Overall Study||6
967276|NCT00270205|2339053|P1|COMPLETED|Overall Study||5
967277|NCT00270205|2339050|P4|STARTED|Overall Study||7
967278|NCT00270205|2339051|P3|STARTED|Overall Study||6
967279|NCT00270205|2339052|P2|STARTED|Overall Study|7 participants enrolled. One never started study vaccination and was excluded from all analyses.|6
967280|NCT00270205|2339053|P1|STARTED|Overall Study||6
967281|NCT00270231|2339163|P2|NOT COMPLETED|Second Intervention||1
967282|NCT00270231|2339164|P1|NOT COMPLETED|Second Intervention||0
967283|NCT00270231|2339163|P2|COMPLETED|Second Intervention||30
967284|NCT00270231|2339164|P1|COMPLETED|Second Intervention||30
967285|NCT00270231|2339163|P2|STARTED|Second Intervention||31
967286|NCT00270231|2339164|P1|STARTED|Second Intervention||30
967287|NCT00270231|2339163|P2|NOT COMPLETED|Washout Period||0
967288|NCT00270231|2339164|P1|NOT COMPLETED|Washout Period||1
967289|NCT00270231|2339163|P2|COMPLETED|Washout Period||31
967290|NCT00270231|2339164|P1|COMPLETED|Washout Period||30
967291|NCT00270231|2339163|P2|STARTED|Washout Period||31
967292|NCT00270231|2339164|P1|STARTED|Washout Period||31
967293|NCT00270231|2339163|P2|NOT COMPLETED|First Intervention||1
967294|NCT00270231|2339164|P1|NOT COMPLETED|First Intervention||1
967295|NCT00270231|2339163|P2|COMPLETED|First Intervention||31
967296|NCT00270231|2339164|P1|COMPLETED|First Intervention||31
967297|NCT00270231|2339163|P2|STARTED|First Intervention||32
967298|NCT00270231|2339164|P1|STARTED|First Intervention||32
967299|NCT00255840|2339172|P2|NOT COMPLETED|Overall Study||70
967300|NCT00255840|2339173|P1|NOT COMPLETED|Overall Study||63
967301|NCT00255840|2339172|P2|COMPLETED|Overall Study||334
967302|NCT00255840|2339173|P1|COMPLETED|Overall Study||345
967303|NCT00255840|2339172|P2|STARTED|Overall Study||404
967304|NCT00255840|2339173|P1|STARTED|Overall Study||408
967305|NCT00261443|2339181|P3|NOT COMPLETED|4: Extension Phase||2
967306|NCT00261443|2339182|P2|NOT COMPLETED|4: Extension Phase||3
967307|NCT00261443|2339183|P1|NOT COMPLETED|4: Extension Phase||0
967308|NCT00261443|2339181|P3|COMPLETED|4: Extension Phase||21
967309|NCT00261443|2339182|P2|COMPLETED|4: Extension Phase||16
967310|NCT00261443|2339183|P1|COMPLETED|4: Extension Phase||0
967311|NCT00261443|2339181|P3|STARTED|4: Extension Phase||23
967312|NCT00261443|2339182|P2|STARTED|4: Extension Phase||19
967313|NCT00261443|2339183|P1|STARTED|4: Extension Phase||0
967314|NCT00261443|2339181|P3|NOT COMPLETED|3: Assessment of Relapse||65
967315|NCT00261443|2339182|P2|NOT COMPLETED|3: Assessment of Relapse||80
967316|NCT00261443|2339183|P1|NOT COMPLETED|3: Assessment of Relapse||0
967317|NCT00261443|2339181|P3|COMPLETED|3: Assessment of Relapse||103
967318|NCT00261443|2339182|P2|COMPLETED|3: Assessment of Relapse||89
967319|NCT00261443|2339183|P1|COMPLETED|3: Assessment of Relapse||0
967320|NCT00261443|2339181|P3|STARTED|3: Assessment of Relapse||168
967321|NCT00261443|2339182|P2|STARTED|3: Assessment of Relapse||169
967322|NCT00261443|2339183|P1|STARTED|3: Assessment of Relapse||0
967323|NCT00261443|2339181|P3|NOT COMPLETED|2: Stability & Maintenance of Stability||0
967324|NCT00261443|2339182|P2|NOT COMPLETED|2: Stability & Maintenance of Stability||0
967325|NCT00261443|2339183|P1|NOT COMPLETED|2: Stability & Maintenance of Stability||340
967326|NCT00261443|2339181|P3|COMPLETED|2: Stability & Maintenance of Stability||0
967327|NCT00261443|2339182|P2|COMPLETED|2: Stability & Maintenance of Stability||0
967328|NCT00261443|2339183|P1|COMPLETED|2: Stability & Maintenance of Stability||346
967329|NCT00261443|2339181|P3|STARTED|2: Stability & Maintenance of Stability||0
967330|NCT00261443|2339182|P2|STARTED|2: Stability & Maintenance of Stability||0
967331|NCT00261443|2339183|P1|STARTED|2: Stability & Maintenance of Stability||686
967332|NCT00261443|2339181|P3|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
967333|NCT00261443|2339182|P2|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
967334|NCT00261443|2339183|P1|NOT COMPLETED|1: Confirmation of Partial Nonresponse||584
967335|NCT00261443|2339181|P3|COMPLETED|1: Confirmation of Partial Nonresponse||0
967336|NCT00261443|2339182|P2|COMPLETED|1: Confirmation of Partial Nonresponse||0
967337|NCT00261443|2339183|P1|COMPLETED|1: Confirmation of Partial Nonresponse||686
967338|NCT00261443|2339181|P3|STARTED|1: Confirmation of Partial Nonresponse||0
967339|NCT00261443|2339182|P2|STARTED|1: Confirmation of Partial Nonresponse||0
967340|NCT00261443|2339183|P1|STARTED|1: Confirmation of Partial Nonresponse||1270
967341|NCT00261495|2339440|P2|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
967342|NCT00261495|2339441|P1|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||10
967343|NCT00261495|2339440|P2|COMPLETED|Extension Phase (Weeks 24 to 52)||47
967344|NCT00261495|2339441|P1|COMPLETED|Extension Phase (Weeks 24 to 52)||50
967345|NCT00261495|2339440|P2|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (85 subjects).|52
967346|NCT00261495|2339441|P1|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (80 subjects).|60
967347|NCT00261495|2339440|P2|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||48
967348|NCT00261495|2339441|P1|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||66
967349|NCT00261495|2339440|P2|COMPLETED|Maintenance Phase (Weeks 4 to 24)||137
967350|NCT00261495|2339441|P1|COMPLETED|Maintenance Phase (Weeks 4 to 24)||140
967351|NCT00261495|2339440|P2|STARTED|Maintenance Phase (Weeks 4 to 24)||185
967352|NCT00261495|2339441|P1|STARTED|Maintenance Phase (Weeks 4 to 24)||206
967353|NCT00261495|2339440|P2|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||65
967354|NCT00261495|2339441|P1|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||48
967355|NCT00261495|2339440|P2|COMPLETED|Titration Phase (Weeks 0 to 4)||185
967356|NCT00261495|2339441|P1|COMPLETED|Titration Phase (Weeks 0 to 4)||206
967357|NCT00261495|2339440|P2|STARTED|Titration Phase (Weeks 0 to 4)||250
967358|NCT00261495|2339441|P1|STARTED|Titration Phase (Weeks 0 to 4)||254
967359|NCT00261716|2339605|P2|NOT COMPLETED|Overall Study||10
967360|NCT00261716|2339606|P1|NOT COMPLETED|Overall Study||6
967361|NCT00261716|2339605|P2|COMPLETED|Overall Study||11
967362|NCT00261716|2339606|P1|COMPLETED|Overall Study||11
967363|NCT00261716|2339605|P2|STARTED|Overall Study||21
967364|NCT00261716|2339606|P1|STARTED|Overall Study||17
967365|NCT00261833|2339626|P2|NOT COMPLETED|Overall Study||18
967366|NCT00261833|2339627|P1|NOT COMPLETED|Overall Study||9
967367|NCT00261833|2339626|P2|COMPLETED|Overall Study||69
967368|NCT00261833|2339627|P1|COMPLETED|Overall Study||84
967369|NCT00261833|2339626|P2|STARTED|Overall Study||87
967370|NCT00261833|2339627|P1|STARTED|Overall Study||93
967371|NCT00261846|2339668|P12|NOT COMPLETED|Period 2: Part 2 (Efficacy)||23
967372|NCT00261846|2339669|P11|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
967373|NCT00261846|2339670|P10|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
967374|NCT00261846|2339671|P9|NOT COMPLETED|Period 2: Part 2 (Efficacy)||14
967375|NCT00261846|2339672|P8|NOT COMPLETED|Period 2: Part 2 (Efficacy)||29
967376|NCT00261846|2339673|P7|NOT COMPLETED|Period 2: Part 2 (Efficacy)||22
967377|NCT00261846|2339674|P6|NOT COMPLETED|Period 2: Part 2 (Efficacy)||2
967378|NCT00261846|2339675|P5|NOT COMPLETED|Period 2: Part 2 (Efficacy)||50
967379|NCT00261846|2339676|P4|NOT COMPLETED|Period 2: Part 2 (Efficacy)||135
967380|NCT00261846|2339677|P3|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
967381|NCT00261846|2339678|P2|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
967382|NCT00261846|2339679|P1|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
967383|NCT00261846|2339668|P12|COMPLETED|Period 2: Part 2 (Efficacy)||1
967384|NCT00261846|2339669|P11|COMPLETED|Period 2: Part 2 (Efficacy)||15
967385|NCT00261846|2339670|P10|COMPLETED|Period 2: Part 2 (Efficacy)||30
967386|NCT00261846|2339671|P9|COMPLETED|Period 2: Part 2 (Efficacy)||12
967387|NCT00261846|2339672|P8|COMPLETED|Period 2: Part 2 (Efficacy)||21
967388|NCT00261846|2339673|P7|COMPLETED|Period 2: Part 2 (Efficacy)||16
967389|NCT00261846|2339674|P6|COMPLETED|Period 2: Part 2 (Efficacy)||3
967390|NCT00261846|2339675|P5|COMPLETED|Period 2: Part 2 (Efficacy)||39
967391|NCT00261846|2339676|P4|COMPLETED|Period 2: Part 2 (Efficacy)||60
967392|NCT00261846|2339677|P3|COMPLETED|Period 2: Part 2 (Efficacy)||0
967393|NCT00261846|2339678|P2|COMPLETED|Period 2: Part 2 (Efficacy)||0
967394|NCT00261846|2339679|P1|COMPLETED|Period 2: Part 2 (Efficacy)||0
967395|NCT00261846|2339668|P12|STARTED|Period 2: Part 2 (Efficacy)||24
967396|NCT00261846|2339669|P11|STARTED|Period 2: Part 2 (Efficacy)||64
967397|NCT00261846|2339670|P10|STARTED|Period 2: Part 2 (Efficacy)|1 participant from Part 1 (Bosutinib 600mg cohort) continued in Part 2 of the study.|79
967398|NCT00261846|2339671|P9|STARTED|Period 2: Part 2 (Efficacy)||26
967399|NCT00261846|2339672|P8|STARTED|Period 2: Part 2 (Efficacy)||50
967400|NCT00261846|2339673|P7|STARTED|Period 2: Part 2 (Efficacy)||38
967401|NCT00261846|2339674|P6|STARTED|Period 2: Part 2 (Efficacy)||5
967402|NCT00261846|2339675|P5|STARTED|Period 2: Part 2 (Efficacy)||89
967403|NCT00261846|2339676|P4|STARTED|Period 2: Part 2 (Efficacy)|17 participants from Part 1 (Bosutinib 400mg, 500mg, 600mg cohort) continued in Part 2 of the study.|195
967404|NCT00261846|2339677|P3|STARTED|Period 2: Part 2 (Efficacy)||0
967405|NCT00261846|2339678|P2|STARTED|Period 2: Part 2 (Efficacy)||0
967406|NCT00261846|2339679|P1|STARTED|Period 2: Part 2 (Efficacy)||0
967407|NCT00261846|2339668|P12|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
967408|NCT00261846|2339669|P11|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
967409|NCT00261846|2339670|P10|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
967410|NCT00261846|2339671|P9|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
967411|NCT00261846|2339672|P8|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
967412|NCT00261846|2339673|P7|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
967413|NCT00261846|2339674|P6|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
967414|NCT00261846|2339675|P5|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
967415|NCT00261846|2339676|P4|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
967416|NCT00261846|2339677|P3|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||12
967417|NCT00261846|2339678|P2|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
967418|NCT00261846|2339679|P1|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
967419|NCT00261846|2339668|P12|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
967420|NCT00261846|2339669|P11|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
967421|NCT00261846|2339670|P10|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
967422|NCT00261846|2339671|P9|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
967423|NCT00261846|2339672|P8|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
967424|NCT00261846|2339673|P7|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
967425|NCT00261846|2339674|P6|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
967426|NCT00261846|2339675|P5|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
967427|NCT00261846|2339676|P4|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
967428|NCT00261846|2339677|P3|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
967429|NCT00261846|2339678|P2|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
967430|NCT00261846|2339679|P1|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
967431|NCT00261846|2339668|P12|STARTED|Period 1: Part 1 (Dose Escalation)||0
967432|NCT00261846|2339669|P11|STARTED|Period 1: Part 1 (Dose Escalation)||0
967433|NCT00261846|2339670|P10|STARTED|Period 1: Part 1 (Dose Escalation)||0
967434|NCT00261846|2339671|P9|STARTED|Period 1: Part 1 (Dose Escalation)||0
967435|NCT00261846|2339672|P8|STARTED|Period 1: Part 1 (Dose Escalation)||0
967436|NCT00261846|2339673|P7|STARTED|Period 1: Part 1 (Dose Escalation)||0
967437|NCT00261846|2339674|P6|STARTED|Period 1: Part 1 (Dose Escalation)||0
967438|NCT00261846|2339675|P5|STARTED|Period 1: Part 1 (Dose Escalation)||0
967439|NCT00261846|2339676|P4|STARTED|Period 1: Part 1 (Dose Escalation)||0
967440|NCT00261846|2339677|P3|STARTED|Period 1: Part 1 (Dose Escalation)||12
967441|NCT00261846|2339678|P2|STARTED|Period 1: Part 1 (Dose Escalation)||3
967442|NCT00261846|2339679|P1|STARTED|Period 1: Part 1 (Dose Escalation)||3
967443|NCT00261950|2339936|P1|NOT COMPLETED|Overall Study||26
967444|NCT00261950|2339936|P1|COMPLETED|Overall Study||84
967445|NCT00261950|2339936|P1|STARTED|Overall Study||110
967446|NCT00262002|2339959|P7|NOT COMPLETED|Overall Study||6
967447|NCT00262002|2339960|P6|NOT COMPLETED|Overall Study||7
967448|NCT00262002|2339961|P5|NOT COMPLETED|Overall Study||7
967449|NCT00262002|2339962|P4|NOT COMPLETED|Overall Study||5
967450|NCT00262002|2339963|P3|NOT COMPLETED|Overall Study||0
967451|NCT00262002|2339964|P2|NOT COMPLETED|Overall Study||6
967452|NCT00262002|2339965|P1|NOT COMPLETED|Overall Study||11
967453|NCT00262002|2339959|P7|COMPLETED|Overall Study||84
967454|NCT00262002|2339960|P6|COMPLETED|Overall Study||83
967455|NCT00262002|2339961|P5|COMPLETED|Overall Study||91
967456|NCT00262002|2339962|P4|COMPLETED|Overall Study||93
967457|NCT00262002|2339963|P3|COMPLETED|Overall Study||45
967458|NCT00262002|2339964|P2|COMPLETED|Overall Study||84
967459|NCT00262002|2339965|P1|COMPLETED|Overall Study||79
967460|NCT00262002|2339959|P7|STARTED|Overall Study||90
967461|NCT00262002|2339960|P6|STARTED|Overall Study||90
967462|NCT00262002|2339961|P5|STARTED|Overall Study||98
967463|NCT00262002|2339962|P4|STARTED|Overall Study||98
967464|NCT00262002|2339963|P3|STARTED|Overall Study||45
967465|NCT00262002|2339964|P2|STARTED|Overall Study||90
967466|NCT00262002|2339965|P1|STARTED|Overall Study||90
967467|NCT00262028|2340067|P9|NOT COMPLETED|Overall Study||19
967468|NCT00262028|2340068|P8|NOT COMPLETED|Overall Study||18
967469|NCT00262028|2340069|P7|NOT COMPLETED|Overall Study||12
967470|NCT00262028|2340070|P6|NOT COMPLETED|Overall Study||13
967471|NCT00262028|2340071|P5|NOT COMPLETED|Overall Study||12
967472|NCT00262028|2340072|P4|NOT COMPLETED|Overall Study||23
967473|NCT00262028|2340073|P3|NOT COMPLETED|Overall Study||20
967474|NCT00262028|2340074|P2|NOT COMPLETED|Overall Study||27
967475|NCT00262028|2340075|P1|NOT COMPLETED|Overall Study||24
967476|NCT00262028|2340067|P9|COMPLETED|Overall Study||81
967477|NCT00262028|2340068|P8|COMPLETED|Overall Study||55
967478|NCT00262028|2340069|P7|COMPLETED|Overall Study||59
967479|NCT00262028|2340070|P6|COMPLETED|Overall Study||60
967480|NCT00262028|2340071|P5|COMPLETED|Overall Study||62
967481|NCT00262028|2340072|P4|COMPLETED|Overall Study||134
967482|NCT00262028|2340073|P3|COMPLETED|Overall Study||137
967483|NCT00262028|2340074|P2|COMPLETED|Overall Study||126
967484|NCT00262028|2340075|P1|COMPLETED|Overall Study||128
967485|NCT00262028|2340067|P9|STARTED|Overall Study||100
967486|NCT00262028|2340068|P8|STARTED|Overall Study||73
967487|NCT00262028|2340069|P7|STARTED|Overall Study||71
967488|NCT00262028|2340070|P6|STARTED|Overall Study||73
967489|NCT00262028|2340071|P5|STARTED|Overall Study||74
967490|NCT00262028|2340072|P4|STARTED|Overall Study||157
967491|NCT00262028|2340073|P3|STARTED|Overall Study||157
967492|NCT00262028|2340074|P2|STARTED|Overall Study||153
967493|NCT00262028|2340075|P1|STARTED|Overall Study||152
967494|NCT00262041|2340134|P3|NOT COMPLETED|Overall Study||6
967495|NCT00262041|2340135|P2|NOT COMPLETED|Overall Study||4
967496|NCT00262041|2340136|P1|NOT COMPLETED|Overall Study||2
967497|NCT00262041|2340134|P3|COMPLETED|Overall Study||203
967498|NCT00262041|2340135|P2|COMPLETED|Overall Study||147
967499|NCT00262041|2340136|P1|COMPLETED|Overall Study||162
967500|NCT00262041|2340134|P3|STARTED|Overall Study||209
967501|NCT00262041|2340135|P2|STARTED|Overall Study||151
967502|NCT00262041|2340136|P1|STARTED|Overall Study||164
967503|NCT00262067|2340160|P4|NOT COMPLETED|Overall Study||113
967504|NCT00262067|2340161|P3|NOT COMPLETED|Overall Study||216
967505|NCT00262067|2340162|P2|NOT COMPLETED|Overall Study||100
967506|NCT00262067|2340163|P1|NOT COMPLETED|Overall Study||219
967507|NCT00262067|2340160|P4|COMPLETED|Overall Study||93
967508|NCT00262067|2340161|P3|COMPLETED|Overall Study||193
967509|NCT00262067|2340162|P2|COMPLETED|Overall Study||107
967510|NCT00262067|2340163|P1|COMPLETED|Overall Study||196
967511|NCT00262067|2340160|P4|STARTED|Overall Study||206
967512|NCT00262067|2340161|P3|STARTED|Overall Study||409
967513|NCT00262067|2340162|P2|STARTED|Overall Study||207
967514|NCT00262067|2340163|P1|STARTED|Overall Study||415
967515|NCT00262080|2340196|P3|NOT COMPLETED|Repeat Dose Treatment Period||5
967516|NCT00262080|2340197|P2|NOT COMPLETED|Repeat Dose Treatment Period||1
967517|NCT00262080|2340198|P1|NOT COMPLETED|Repeat Dose Treatment Period||4
967518|NCT00262080|2340196|P3|COMPLETED|Repeat Dose Treatment Period||14
967519|NCT00262080|2340197|P2|COMPLETED|Repeat Dose Treatment Period||25
967520|NCT00262080|2340198|P1|COMPLETED|Repeat Dose Treatment Period|Some patients participated in only the double-blind or the open label phase.|18
967521|NCT00262080|2340196|P3|STARTED|Repeat Dose Treatment Period|This arm represents new patients, not treated in the double-blind part of the study.|19
967522|NCT00262080|2340197|P2|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|26
967523|NCT00262080|2340198|P1|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|22
967524|NCT00262080|2340196|P3|NOT COMPLETED|Double Blind Treatment Period||0
967525|NCT00262080|2340197|P2|NOT COMPLETED|Double Blind Treatment Period||0
967526|NCT00262080|2340198|P1|NOT COMPLETED|Double Blind Treatment Period||1
967527|NCT00262080|2340196|P3|COMPLETED|Double Blind Treatment Period||0
967528|NCT00262080|2340197|P2|COMPLETED|Double Blind Treatment Period||36
967529|NCT00262080|2340198|P1|COMPLETED|Double Blind Treatment Period||35
967530|NCT00262080|2340196|P3|STARTED|Double Blind Treatment Period||0
967531|NCT00262080|2340197|P2|STARTED|Double Blind Treatment Period|One patient was randomized to receive placebo but was treated with ecallantide.|36
967532|NCT00262080|2340198|P1|STARTED|Double Blind Treatment Period|One patient was randomized to receive ecallantide but was treated with placebo.|36
967533|NCT00262119|2340217|P3|NOT COMPLETED|Overall Study||58
967534|NCT00262119|2340218|P2|NOT COMPLETED|Overall Study||70
967535|NCT00262119|2340219|P1|NOT COMPLETED|Overall Study||58
967536|NCT00262119|2340217|P3|COMPLETED|Overall Study||325
967537|NCT00262119|2340218|P2|COMPLETED|Overall Study||328
967538|NCT00262119|2340219|P1|COMPLETED|Overall Study||327
967539|NCT00262119|2340217|P3|STARTED|Overall Study||383
967540|NCT00262119|2340218|P2|STARTED|Overall Study||398
967541|NCT00262119|2340219|P1|STARTED|Overall Study||385
967542|NCT00262223|2340238|P2|NOT COMPLETED|12-month Post-treatment Follow-up||7
967543|NCT00262223|2340239|P1|NOT COMPLETED|12-month Post-treatment Follow-up||7
967544|NCT00262223|2340238|P2|COMPLETED|12-month Post-treatment Follow-up||22
967545|NCT00262223|2340239|P1|COMPLETED|12-month Post-treatment Follow-up||21
967546|NCT00262223|2340238|P2|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
967547|NCT00262223|2340239|P1|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
967548|NCT00262223|2340238|P2|NOT COMPLETED|6-month Post-treatment Follow-up||1
967549|NCT00262223|2340239|P1|NOT COMPLETED|6-month Post-treatment Follow-up||6
967550|NCT00262223|2340238|P2|COMPLETED|6-month Post-treatment Follow-up||28
967551|NCT00262223|2340239|P1|COMPLETED|6-month Post-treatment Follow-up||22
967552|NCT00262223|2340238|P2|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
967553|NCT00262223|2340239|P1|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
967554|NCT00262223|2340238|P2|NOT COMPLETED|1-week Post-treatment Follow-up||4
967555|NCT00262223|2340239|P1|NOT COMPLETED|1-week Post-treatment Follow-up||4
967556|NCT00262223|2340238|P2|COMPLETED|1-week Post-treatment Follow-up||25
967557|NCT00262223|2340239|P1|COMPLETED|1-week Post-treatment Follow-up||24
967558|NCT00262223|2340238|P2|STARTED|1-week Post-treatment Follow-up||29
967559|NCT00262223|2340239|P1|STARTED|1-week Post-treatment Follow-up||28
967560|NCT00262223|2340238|P2|NOT COMPLETED|Treatment Phase||8
967561|NCT00262223|2340239|P1|NOT COMPLETED|Treatment Phase||4
967562|NCT00262223|2340238|P2|COMPLETED|Treatment Phase||29
967563|NCT00262223|2340239|P1|COMPLETED|Treatment Phase||28
967564|NCT00262223|2340238|P2|STARTED|Treatment Phase||37
967565|NCT00262223|2340239|P1|STARTED|Treatment Phase||32
967566|NCT00262301|2340250|P3|NOT COMPLETED|Open-label Phase||0
967567|NCT00262301|2340251|P2|NOT COMPLETED|Open-label Phase||0
967568|NCT00262301|2340252|P1|NOT COMPLETED|Open-label Phase||0
967569|NCT00262301|2340250|P3|COMPLETED|Open-label Phase||57
967570|NCT00262301|2340251|P2|COMPLETED|Open-label Phase||0
967571|NCT00262301|2340252|P1|COMPLETED|Open-label Phase||0
967572|NCT00262301|2340250|P3|STARTED|Open-label Phase|"14/57 patients crossed over from the double-blind phase (7/14 were treated with 100 U/kg rhC1INH)"|57
967573|NCT00262301|2340251|P2|STARTED|Open-label Phase||0
967574|NCT00262301|2340252|P1|STARTED|Open-label Phase||0
967575|NCT00262301|2340250|P3|NOT COMPLETED|Double-blind Phase||0
967576|NCT00262301|2340251|P2|NOT COMPLETED|Double-blind Phase||1
967577|NCT00262301|2340252|P1|NOT COMPLETED|Double-blind Phase||1
967578|NCT00262301|2340250|P3|COMPLETED|Double-blind Phase||0
967579|NCT00262301|2340251|P2|COMPLETED|Double-blind Phase||15
967580|NCT00262301|2340252|P1|COMPLETED|Double-blind Phase||15
967581|NCT00262301|2340250|P3|STARTED|Double-blind Phase||0
967582|NCT00262301|2340251|P2|STARTED|Double-blind Phase||16
967583|NCT00262301|2340252|P1|STARTED|Double-blind Phase||16
967584|NCT00262314|2340263|P1|NOT COMPLETED|Overall Study||337
967585|NCT00262314|2340263|P1|COMPLETED|Overall Study|Patients in the study for 5 years +/-3 months are considered to have completed the 5-year study|172
967586|NCT00262314|2340263|P1|STARTED|Overall Study|Patients with validated data who received at least 1 dose of Novantrone®|509
967587|NCT00262509|2340280|P2|NOT COMPLETED|Overall Study||0
967588|NCT00262509|2340281|P1|NOT COMPLETED|Overall Study||0
967589|NCT00262509|2340280|P2|COMPLETED|Overall Study||9
967590|NCT00262509|2340281|P1|COMPLETED|Overall Study||8
967591|NCT00262509|2340280|P2|STARTED|Overall Study||9
967592|NCT00262509|2340281|P1|STARTED|Overall Study||8
967593|NCT00262522|2340291|P4|NOT COMPLETED|Study Start Through 96 Weeks||0
967594|NCT00262522|2340292|P3|NOT COMPLETED|Study Start Through 96 Weeks||77
967595|NCT00262522|2340293|P2|NOT COMPLETED|Study Start Through 96 Weeks||0
967596|NCT00262522|2340294|P1|NOT COMPLETED|Study Start Through 96 Weeks||77
967597|NCT00262522|2340291|P4|COMPLETED|Study Start Through 96 Weeks||0
967598|NCT00262522|2340292|P3|COMPLETED|Study Start Through 96 Weeks||254
967599|NCT00262522|2340293|P2|COMPLETED|Study Start Through 96 Weeks||0
967600|NCT00262522|2340294|P1|COMPLETED|Study Start Through 96 Weeks||256
967601|NCT00262522|2340291|P4|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
967602|NCT00262522|2340292|P3|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|331
967603|NCT00262522|2340293|P2|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
967604|NCT00262522|2340294|P1|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|333
967605|NCT00262522|2340291|P4|NOT COMPLETED|Study Start Through 48 Weeks||0
967606|NCT00262522|2340292|P3|NOT COMPLETED|Study Start Through 48 Weeks||55
967607|NCT00262522|2340293|P2|NOT COMPLETED|Study Start Through 48 Weeks||0
967608|NCT00262522|2340294|P1|NOT COMPLETED|Study Start Through 48 Weeks||49
967609|NCT00262522|2340291|P4|COMPLETED|Study Start Through 48 Weeks||0
967610|NCT00262522|2340292|P3|COMPLETED|Study Start Through 48 Weeks||276
967611|NCT00262522|2340293|P2|COMPLETED|Study Start Through 48 Weeks||0
967612|NCT00262522|2340294|P1|COMPLETED|Study Start Through 48 Weeks||284
967613|NCT00262522|2340291|P4|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
967614|NCT00262522|2340292|P3|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|331
967615|NCT00262522|2340293|P2|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
967616|NCT00262522|2340294|P1|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|333
967617|NCT00262522|2340291|P4|NOT COMPLETED|Study Start Through 8 Weeks||5
967618|NCT00262522|2340292|P3|NOT COMPLETED|Study Start Through 8 Weeks||11
967619|NCT00262522|2340293|P2|NOT COMPLETED|Study Start Through 8 Weeks||5
967620|NCT00262522|2340294|P1|NOT COMPLETED|Study Start Through 8 Weeks||4
967621|NCT00262522|2340291|P4|COMPLETED|Study Start Through 8 Weeks||160
967622|NCT00262522|2340292|P3|COMPLETED|Study Start Through 8 Weeks||155
967623|NCT00262522|2340293|P2|COMPLETED|Study Start Through 8 Weeks||161
967624|NCT00262522|2340294|P1|COMPLETED|Study Start Through 8 Weeks||163
967625|NCT00262522|2340291|P4|STARTED|Study Start Through 8 Weeks||165
967626|NCT00262522|2340292|P3|STARTED|Study Start Through 8 Weeks||166
967627|NCT00262522|2340293|P2|STARTED|Study Start Through 8 Weeks||166
967628|NCT00262522|2340294|P1|STARTED|Study Start Through 8 Weeks||167
967629|NCT00262600|2340317|P3|NOT COMPLETED|Overall Study||266
967630|NCT00262600|2340318|P2|NOT COMPLETED|Overall Study||252
967631|NCT00262600|2340319|P1|NOT COMPLETED|Overall Study||235
967632|NCT00262600|2340317|P3|COMPLETED|Overall Study||5756
967633|NCT00262600|2340318|P2|COMPLETED|Overall Study||5824
967634|NCT00262600|2340319|P1|COMPLETED|Overall Study||5780
967635|NCT00262600|2340317|P3|STARTED|Overall Study||6022
967636|NCT00262600|2340318|P2|STARTED|Overall Study||6076
967637|NCT00262600|2340319|P1|STARTED|Overall Study||6015
967638|NCT00262639|2340346|P4|NOT COMPLETED|Overall Study||0
967639|NCT00262639|2340347|P3|NOT COMPLETED|Overall Study||0
967640|NCT00262639|2340348|P2|NOT COMPLETED|Overall Study||0
967641|NCT00262639|2340349|P1|NOT COMPLETED|Overall Study||0
967642|NCT00262639|2340346|P4|COMPLETED|Overall Study||7
967643|NCT00262639|2340347|P3|COMPLETED|Overall Study||9
967644|NCT00262639|2340348|P2|COMPLETED|Overall Study||26
967645|NCT00262639|2340349|P1|COMPLETED|Overall Study||18
967646|NCT00262639|2340346|P4|STARTED|Overall Study||7
967647|NCT00262639|2340347|P3|STARTED|Overall Study||9
967648|NCT00262639|2340348|P2|STARTED|Overall Study||26
967649|NCT00262639|2340349|P1|STARTED|Overall Study||18
967650|NCT00262730|2340363|P1|NOT COMPLETED|Overall Study||0
967651|NCT00262730|2340363|P1|COMPLETED|Overall Study||97
967652|NCT00262730|2340363|P1|STARTED|Overall Study||97
967653|NCT00262743|2340369|P2|NOT COMPLETED|Overall Study||12
967654|NCT00262743|2340370|P1|NOT COMPLETED|Overall Study||0
967655|NCT00262743|2340369|P2|COMPLETED|Overall Study||30
967656|NCT00262743|2340370|P1|COMPLETED|Overall Study||27
967657|NCT00262743|2340369|P2|STARTED|Overall Study||42
967658|NCT00262743|2340370|P1|STARTED|Overall Study||27
967659|NCT00262821|2340379|P2|NOT COMPLETED|Overall Study||19
967660|NCT00262821|2340380|P1|NOT COMPLETED|Overall Study||4
967661|NCT00262821|2340379|P2|COMPLETED|Overall Study||185
967662|NCT00262821|2340380|P1|COMPLETED|Overall Study||194
967663|NCT00262821|2340379|P2|STARTED|Overall Study||204
967664|NCT00262821|2340380|P1|STARTED|Overall Study||198
967665|NCT00262834|2340392|P2|NOT COMPLETED|Overall Study||4
967666|NCT00262834|2340393|P1|NOT COMPLETED|Overall Study||1
967667|NCT00262834|2340392|P2|COMPLETED|Overall Study||25
967668|NCT00262834|2340393|P1|COMPLETED|Overall Study||24
967669|NCT00262834|2340392|P2|STARTED|Overall Study||29
967670|NCT00262834|2340393|P1|STARTED|Overall Study||25
967671|NCT00262847|2340404|P3|NOT COMPLETED|Overall Study||396
967672|NCT00262847|2340405|P2|NOT COMPLETED|Overall Study||513
967673|NCT00262847|2340406|P1|NOT COMPLETED|Overall Study||518
967674|NCT00262847|2340404|P3|COMPLETED|Overall Study||227
967675|NCT00262847|2340405|P2|COMPLETED|Overall Study||112
967676|NCT00262847|2340406|P1|COMPLETED|Overall Study||107
967677|NCT00262847|2340404|P3|STARTED|Overall Study|Total enrolled and included in efficacy analysis|623
967678|NCT00262847|2340405|P2|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
967679|NCT00262847|2340406|P1|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
967680|NCT00262860|2340420|P1|NOT COMPLETED|Overall Study||2
967681|NCT00262860|2340420|P1|COMPLETED|Overall Study||16
967682|NCT00262860|2340420|P1|STARTED|Overall Study||18
967683|NCT00262873|2340426|P1|NOT COMPLETED|Overall Study||8
967684|NCT00262873|2340426|P1|COMPLETED|Overall Study||0
967685|NCT00262873|2340426|P1|STARTED|Overall Study||8
967686|NCT00262925|2340437|P1|NOT COMPLETED|Overall Study||11
967687|NCT00262925|2340437|P1|COMPLETED|Overall Study||1
967688|NCT00262925|2340437|P1|STARTED|Overall Study|7 patients were enrolled to step 1, and 5 patients were enrolled to step 2|12
967689|NCT00262951|2340443|P1|NOT COMPLETED|Overall Study||16
967690|NCT00262951|2340443|P1|COMPLETED|Overall Study||7
967691|NCT00262951|2340443|P1|STARTED|Overall Study||23
967692|NCT00262964|2340450|P4|NOT COMPLETED|Overall Study||0
967693|NCT00262964|2340451|P3|NOT COMPLETED|Overall Study||0
967694|NCT00262964|2340452|P2|NOT COMPLETED|Overall Study||0
967695|NCT00262964|2340453|P1|NOT COMPLETED|Overall Study||0
967696|NCT00262964|2340450|P4|COMPLETED|Overall Study||12
967697|NCT00262964|2340451|P3|COMPLETED|Overall Study||17
967698|NCT00262964|2340452|P2|COMPLETED|Overall Study||11
967699|NCT00262964|2340453|P1|COMPLETED|Overall Study||11
967700|NCT00262964|2340450|P4|STARTED|Overall Study||12
967701|NCT00262964|2340451|P3|STARTED|Overall Study||17
967702|NCT00262964|2340452|P2|STARTED|Overall Study||11
967703|NCT00262964|2340453|P1|STARTED|Overall Study||11
967704|NCT00263211|2340485|P2|NOT COMPLETED|Overall Study||1
967705|NCT00263211|2340486|P1|NOT COMPLETED|Overall Study||5
967706|NCT00263211|2340485|P2|COMPLETED|Overall Study||23
967707|NCT00263211|2340486|P1|COMPLETED|Overall Study||19
967708|NCT00263211|2340485|P2|STARTED|Overall Study||24
967709|NCT00263211|2340486|P1|STARTED|Overall Study||24
967710|NCT00263328|2340505|P3|NOT COMPLETED|Overall Study||7
967711|NCT00263328|2340506|P2|NOT COMPLETED|Overall Study||2
967712|NCT00263328|2340507|P1|NOT COMPLETED|Overall Study||8
967713|NCT00263328|2340505|P3|COMPLETED|Overall Study||6
967714|NCT00263328|2340506|P2|COMPLETED|Overall Study||12
967715|NCT00263328|2340507|P1|COMPLETED|Overall Study||10
967716|NCT00263328|2340505|P3|STARTED|Overall Study||13
967717|NCT00263328|2340506|P2|STARTED|Overall Study||14
967718|NCT00263328|2340507|P1|STARTED|Overall Study||18
967719|NCT00263666|2340665|P2|NOT COMPLETED|Overall Study||11
967720|NCT00263666|2340666|P1|NOT COMPLETED|Overall Study||7
967721|NCT00263666|2340665|P2|COMPLETED|Overall Study||39
967722|NCT00263666|2340666|P1|COMPLETED|Overall Study||43
967723|NCT00263666|2340665|P2|STARTED|Overall Study||50
967724|NCT00263666|2340666|P1|STARTED|Overall Study||50
967725|NCT00263757|2340719|P2|NOT COMPLETED|Overall Study||8
967726|NCT00263757|2340720|P1|NOT COMPLETED|Overall Study||8
967727|NCT00263757|2340719|P2|COMPLETED|Overall Study||5
967728|NCT00263757|2340720|P1|COMPLETED|Overall Study||4
967729|NCT00263757|2340719|P2|STARTED|Overall Study||13
967730|NCT00263757|2340720|P1|STARTED|Overall Study||12
967731|NCT00270257|2340732|P2|NOT COMPLETED|Overall Study||424
967732|NCT00270257|2340733|P1|NOT COMPLETED|Overall Study||412
967733|NCT00270257|2340732|P2|COMPLETED|Overall Study||204
967734|NCT00270257|2340733|P1|COMPLETED|Overall Study||211
967735|NCT00270257|2340732|P2|Visit 104|Overall Study||204
967736|NCT00270257|2340733|P1|Visit 104|Overall Study||211
967737|NCT00270257|2340732|P2|Week 78|Overall Study||285
967738|NCT00270257|2340733|P1|Week 78|Overall Study||283
967739|NCT00270257|2340732|P2|Week 52|Overall Study||340
967740|NCT00270257|2340733|P1|Week 52|Overall Study||362
967741|NCT00270257|2340732|P2|Week 26|Overall Study||440
967742|NCT00270257|2340733|P1|Week 26|Overall Study||460
967743|NCT00270257|2340732|P2|Week 8|Overall Study||443
967744|NCT00270257|2340733|P1|Week 8|Overall Study||510
967745|NCT00270257|2340732|P2|STARTED|Overall Study|1 excluded from analysis (enrollment date exceeded eligibility window by 13 days)|628
967746|NCT00270257|2340733|P1|STARTED|Overall Study||623
967747|NCT00270296|2340754|P3|NOT COMPLETED|Overall Study||61
967748|NCT00270296|2340755|P2|NOT COMPLETED|Overall Study||90
967749|NCT00270296|2340756|P1|NOT COMPLETED|Overall Study||99
967750|NCT00270296|2340754|P3|COMPLETED|Overall Study||109
967751|NCT00270296|2340755|P2|COMPLETED|Overall Study||185
967752|NCT00270296|2340756|P1|COMPLETED|Overall Study||186
967753|NCT00270296|2340754|P3|STARTED|Overall Study||170
967754|NCT00270296|2340755|P2|STARTED|Overall Study||275
967755|NCT00270296|2340756|P1|STARTED|Overall Study||285
967756|NCT00271219|2340769|P2|NOT COMPLETED|Overall Study||28
967757|NCT00271219|2340770|P1|NOT COMPLETED|Overall Study||16
967758|NCT00271219|2340769|P2|COMPLETED|Overall Study||58
967759|NCT00271219|2340770|P1|COMPLETED|Overall Study||73
967760|NCT00271219|2340769|P2|STARTED|Overall Study||86
967761|NCT00271219|2340770|P1|STARTED|Overall Study||89
967762|NCT00271375|2340797|P3|NOT COMPLETED|Overall Study||0
967763|NCT00271375|2340798|P2|NOT COMPLETED|Overall Study||0
967764|NCT00271375|2340799|P1|NOT COMPLETED|Overall Study||0
967765|NCT00271375|2340797|P3|COMPLETED|Overall Study||57
967766|NCT00271375|2340798|P2|COMPLETED|Overall Study||83
967767|NCT00271375|2340799|P1|COMPLETED|Overall Study||114
967768|NCT00271375|2340797|P3|STARTED|Overall Study||57
967769|NCT00271375|2340798|P2|STARTED|Overall Study||83
967770|NCT00271375|2340799|P1|STARTED|Overall Study||114
967771|NCT00271544|2340835|P1|NOT COMPLETED|Overall Study||20
967772|NCT00271544|2340835|P1|COMPLETED|Overall Study|Total number subjects successfully implanted 4196 lead.|170
967773|NCT00271544|2340835|P1|Model 4196 Lead Attempted|Overall Study|Total number of subjects attempted Model 4196 lead.|177
967774|NCT00271544|2340835|P1|Implant Attempted|Overall Study|Total number of subjects completed baseline and underwent system implant attempt.|186
967775|NCT00271544|2340835|P1|STARTED|Overall Study|Total number of subjects enrolled.|190
967776|NCT00271570|2340858|P2|NOT COMPLETED|Overall Study||0
967777|NCT00271570|2340859|P1|NOT COMPLETED|Overall Study||0
967778|NCT00271570|2340858|P2|COMPLETED|Overall Study||12
967779|NCT00271570|2340859|P1|COMPLETED|Overall Study||12
967780|NCT00271570|2340858|P2|STARTED|Overall Study||12
967781|NCT00271570|2340859|P1|STARTED|Overall Study||12
967782|NCT00271596|2340869|P2|NOT COMPLETED|Overall Study||1
967783|NCT00271596|2340870|P1|NOT COMPLETED|Overall Study||1
967784|NCT00271596|2340869|P2|COMPLETED|Overall Study||15
967785|NCT00271596|2340870|P1|COMPLETED|Overall Study||16
967786|NCT00271596|2340869|P2|STARTED|Overall Study||16
967787|NCT00271596|2340870|P1|STARTED|Overall Study||17
967788|NCT00271609|2340896|P2|NOT COMPLETED|Overall Study||3
967789|NCT00271609|2340897|P1|NOT COMPLETED|Overall Study||13
967790|NCT00271609|2340896|P2|COMPLETED|Overall Study||29
967791|NCT00271609|2340897|P1|COMPLETED|Overall Study||43
967792|NCT00271609|2340896|P2|STARTED|Overall Study||32
967793|NCT00271609|2340897|P1|STARTED|Overall Study||56
967794|NCT00271739|2340907|P2|NOT COMPLETED|Overall Study||105
967795|NCT00271739|2340908|P1|NOT COMPLETED|Overall Study||115
967796|NCT00271739|2340907|P2|COMPLETED|Overall Study||716
967797|NCT00271739|2340908|P1|COMPLETED|Overall Study||729
967798|NCT00271739|2340907|P2|STARTED|Overall Study||821
967799|NCT00271739|2340908|P1|STARTED|Overall Study||844
967800|NCT00271817|2340921|P3|NOT COMPLETED|Part 2||84
967801|NCT00271817|2340922|P2|NOT COMPLETED|Part 2||32
967802|NCT00271817|2340923|P1|NOT COMPLETED|Part 2||0
967803|NCT00271817|2340921|P3|COMPLETED|Part 2||401
967804|NCT00271817|2340922|P2|COMPLETED|Part 2||234
967805|NCT00271817|2340923|P1|COMPLETED|Part 2||0
967806|NCT00271817|2340921|P3|STARTED|Part 2|Includes 105 patients re-allocated from the niacin group in Part 1|485
967807|NCT00271817|2340922|P2|STARTED|Part 2|Includes 54 patients re-allocated from the niacin group in Part 1|266
967808|NCT00271817|2340923|P1|STARTED|Part 2|Patients completing the niacin group in Part 1, were re-allocated to one of the two arms in Part 2|0
967809|NCT00271817|2340921|P3|NOT COMPLETED|Part 1||285
967810|NCT00271817|2340922|P2|NOT COMPLETED|Part 1||59
967811|NCT00271817|2340923|P1|NOT COMPLETED|Part 1||106
967812|NCT00271817|2340921|P3|COMPLETED|Part 1|11 patients who completed Part 1 did not continue to Part 2|391
967813|NCT00271817|2340922|P2|COMPLETED|Part 1|1 patient who completed Part 1 did not continue to Part 2|213
967814|NCT00271817|2340923|P1|COMPLETED|Part 1|6 patients who completed Part 1 did not continue to Part 2; 1 patient never received drug in Part 2|166
967815|NCT00271817|2340921|P3|STARTED|Part 1||676
967816|NCT00271817|2340922|P2|STARTED|Part 1||272
967817|NCT00271817|2340923|P1|STARTED|Part 1||272
967818|NCT00271856|2340952|P2|NOT COMPLETED|Overall Study||18
967819|NCT00271856|2340953|P1|NOT COMPLETED|Overall Study||11
967820|NCT00271856|2340952|P2|COMPLETED|Overall Study||70
967821|NCT00271856|2340953|P1|COMPLETED|Overall Study||78
967822|NCT00271856|2340952|P2|STARTED|Overall Study||88
967823|NCT00271856|2340953|P1|STARTED|Overall Study||89
967824|NCT00271947|2340969|P1|NOT COMPLETED|Overall Study||1
967825|NCT00271947|2340969|P1|COMPLETED|Overall Study||0
967826|NCT00271947|2340969|P1|STARTED|Overall Study||1
967827|NCT00272038|2340973|P1|NOT COMPLETED|Overall Study||7
967828|NCT00272038|2340973|P1|COMPLETED|Overall Study||22
967829|NCT00272038|2340973|P1|STARTED|Overall Study||29
967830|NCT00272168|2340981|P2|NOT COMPLETED|Overall Study||10
967831|NCT00272168|2340982|P1|NOT COMPLETED|Overall Study||10
967832|NCT00272168|2340981|P2|COMPLETED|Overall Study||31
967833|NCT00272168|2340982|P1|COMPLETED|Overall Study||37
967834|NCT00272168|2340981|P2|STARTED|Overall Study||41
967835|NCT00272168|2340982|P1|STARTED|Overall Study||47
967836|NCT00272311|2341003|P5|NOT COMPLETED|Overall Study||0
967837|NCT00272311|2341004|P4|NOT COMPLETED|Overall Study||0
967838|NCT00272311|2341005|P3|NOT COMPLETED|Overall Study||0
967839|NCT00272311|2341006|P2|NOT COMPLETED|Overall Study||0
967840|NCT00272311|2341007|P1|NOT COMPLETED|Overall Study||0
967841|NCT00272311|2341003|P5|COMPLETED|Overall Study||14
967842|NCT00272311|2341004|P4|COMPLETED|Overall Study||14
967843|NCT00272311|2341005|P3|COMPLETED|Overall Study||14
967844|NCT00272311|2341006|P2|COMPLETED|Overall Study||14
967845|NCT00272311|2341007|P1|COMPLETED|Overall Study||14
967846|NCT00272311|2341003|P5|STARTED|Overall Study||14
967847|NCT00272311|2341004|P4|STARTED|Overall Study||14
967848|NCT00272311|2341005|P3|STARTED|Overall Study||14
967849|NCT00272311|2341006|P2|STARTED|Overall Study||14
967850|NCT00272311|2341007|P1|STARTED|Overall Study||14
967851|NCT00272337|2341024|P5|NOT COMPLETED|Overall Study||0
967852|NCT00272337|2341025|P4|NOT COMPLETED|Overall Study||0
967853|NCT00272337|2341026|P3|NOT COMPLETED|Overall Study||0
967854|NCT00272337|2341027|P2|NOT COMPLETED|Overall Study||0
967855|NCT00272337|2341028|P1|NOT COMPLETED|Overall Study||0
967856|NCT00272337|2341024|P5|COMPLETED|Overall Study||8
967857|NCT00272337|2341025|P4|COMPLETED|Overall Study||7
967858|NCT00272337|2341026|P3|COMPLETED|Overall Study||7
967859|NCT00272337|2341027|P2|COMPLETED|Overall Study||7
967860|NCT00272337|2341028|P1|COMPLETED|Overall Study||8
967861|NCT00272337|2341024|P5|STARTED|Overall Study||8
967862|NCT00272337|2341025|P4|STARTED|Overall Study||7
967863|NCT00272337|2341026|P3|STARTED|Overall Study||7
967864|NCT00272337|2341027|P2|STARTED|Overall Study||7
967865|NCT00272337|2341028|P1|STARTED|Overall Study||8
967866|NCT00272779|2341042|P2|NOT COMPLETED|Baseline Through Week 96||136
967867|NCT00272779|2341043|P1|NOT COMPLETED|Baseline Through Week 96||139
967868|NCT00272779|2341042|P2|COMPLETED|Baseline Through Week 96||307
967869|NCT00272779|2341043|P1|COMPLETED|Baseline Through Week 96||301
967870|NCT00272779|2341042|P2|RECEIVED ANY TREATMENT|Baseline Through Week 96|3 participants received ATV instead of LPV (treatment error) and 3 participants never treated|437
967871|NCT00272779|2341043|P1|RECEIVED ANY TREATMENT|Baseline Through Week 96|1 participant randomized to LPV received ATV instead (treatment error)|441
967872|NCT00272779|2341042|P2|STARTED|Baseline Through Week 96|Number randomized to LPV|443
967873|NCT00272779|2341043|P1|STARTED|Baseline Through Week 96|Number randomized to ATV|440
967874|NCT00272779|2341042|P2|NOT COMPLETED|Baseline Through Week 48||443
967875|NCT00272779|2341043|P1|NOT COMPLETED|Baseline Through Week 48||440
967876|NCT00272779|2341042|P2|COMPLETED|Baseline Through Week 48||0
967877|NCT00272779|2341043|P1|COMPLETED|Baseline Through Week 48||0
967878|NCT00272779|2341042|P2|STILL ON TREATMENT|Baseline Through Week 48||368
967879|NCT00272779|2341043|P1|STILL ON TREATMENT|Baseline Through Week 48||385
967880|NCT00272779|2341042|P2|Discontinued on or After Week 48|Baseline Through Week 48||14
967881|NCT00272779|2341043|P1|Discontinued on or After Week 48|Baseline Through Week 48||14
967882|NCT00272779|2341042|P2|Discontinued Before Week 48|Baseline Through Week 48||58
967883|NCT00272779|2341043|P1|Discontinued Before Week 48|Baseline Through Week 48||39
967884|NCT00272779|2341042|P2|TREATED AS RANDOMIZED|Baseline Through Week 48||440
967885|NCT00272779|2341043|P1|TREATED AS RANDOMIZED|Baseline Through Week 48||438
967886|NCT00272779|2341042|P2|RECEIVED ANY TREATMENT|Baseline Through Week 48|3 participants received ATV instead of LPV (treatment error), 3 participants never treated with LPV|437
967887|NCT00272779|2341043|P1|RECEIVED ANY TREATMENT|Baseline Through Week 48|1 participant randomized to LPV received ATV instead (treatment error)|441
967888|NCT00272779|2341042|P2|STARTED|Baseline Through Week 48|Number of participants randomized to LPV|443
967889|NCT00272779|2341043|P1|STARTED|Baseline Through Week 48|Number of participants randomized to ATV|440
967890|NCT00272792|2341224|P2|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||3
967891|NCT00272792|2341225|P1|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||1
967892|NCT00272792|2341224|P2|COMPLETED|Part 2: Blinded, Placebo Control Period||9
967893|NCT00272792|2341225|P1|COMPLETED|Part 2: Blinded, Placebo Control Period||32
967894|NCT00272792|2341224|P2|STARTED|Part 2: Blinded, Placebo Control Period||12
967895|NCT00272792|2341225|P1|STARTED|Part 2: Blinded, Placebo Control Period||33
967896|NCT00272792|2341224|P2|NOT COMPLETED|Part 1: Responsiveness||0
967897|NCT00272792|2341225|P1|NOT COMPLETED|Part 1: Responsiveness||1
967898|NCT00272792|2341224|P2|COMPLETED|Part 1: Responsiveness||0
967899|NCT00272792|2341225|P1|COMPLETED|Part 1: Responsiveness||89
967900|NCT00272792|2341224|P2|STARTED|Part 1: Responsiveness||0
967901|NCT00272792|2341225|P1|STARTED|Part 1: Responsiveness||90
967902|NCT00272961|2341238|P5|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
967903|NCT00272961|2341239|P4|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||3
967904|NCT00272961|2341240|P3|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
967905|NCT00272961|2341241|P2|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
967906|NCT00272961|2341242|P1|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||2
967907|NCT00272961|2341238|P5|COMPLETED|Treatment Phase: Week 3 Up to Week 12||6
967908|NCT00272961|2341239|P4|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
967909|NCT00272961|2341240|P3|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
967910|NCT00272961|2341241|P2|COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
967911|NCT00272961|2341242|P1|COMPLETED|Treatment Phase: Week 3 Up to Week 12||8
967912|NCT00272961|2341238|P5|STARTED|Treatment Phase: Week 3 Up to Week 12||10
967913|NCT00272961|2341239|P4|STARTED|Treatment Phase: Week 3 Up to Week 12||10
967914|NCT00272961|2341240|P3|STARTED|Treatment Phase: Week 3 Up to Week 12||11
967915|NCT00272961|2341241|P2|STARTED|Treatment Phase: Week 3 Up to Week 12||8
967916|NCT00272961|2341242|P1|STARTED|Treatment Phase: Week 3 Up to Week 12||10
967917|NCT00272961|2341238|P5|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
967918|NCT00272961|2341239|P4|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
967919|NCT00272961|2341240|P3|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
967920|NCT00272961|2341241|P2|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
967921|NCT00272961|2341242|P1|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||11
967922|NCT00272961|2341238|P5|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
967923|NCT00272961|2341239|P4|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
967924|NCT00272961|2341240|P3|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
967925|NCT00272961|2341241|P2|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
967926|NCT00272961|2341242|P1|COMPLETED|Placebo Run-in Phase: Up to Week 2||49
967927|NCT00272961|2341238|P5|STARTED|Placebo Run-in Phase: Up to Week 2||0
967928|NCT00272961|2341239|P4|STARTED|Placebo Run-in Phase: Up to Week 2||0
967929|NCT00272961|2341240|P3|STARTED|Placebo Run-in Phase: Up to Week 2||0
967930|NCT00272961|2341241|P2|STARTED|Placebo Run-in Phase: Up to Week 2||0
967931|NCT00272961|2341242|P1|STARTED|Placebo Run-in Phase: Up to Week 2||60
967932|NCT00272987|2341302|P3|NOT COMPLETED|Overall Study||19
967933|NCT00272987|2341303|P2|NOT COMPLETED|Overall Study||14
967934|NCT00272987|2341304|P1|NOT COMPLETED|Overall Study||21
967935|NCT00272987|2341302|P3|COMPLETED|Overall Study||1
967936|NCT00272987|2341303|P2|COMPLETED|Overall Study||0
967937|NCT00272987|2341304|P1|COMPLETED|Overall Study||8
967938|NCT00272987|2341302|P3|Ongoing|Overall Study||15
967939|NCT00272987|2341303|P2|Ongoing|Overall Study||14
967940|NCT00272987|2341304|P1|Ongoing|Overall Study||20
967941|NCT00272987|2341302|P3|STARTED|Overall Study||20
967942|NCT00272987|2341303|P2|STARTED|Overall Study||14
967943|NCT00272987|2341304|P1|STARTED|Overall Study||29
967944|NCT00273052|2341365|P2|NOT COMPLETED|Overall Study||88
967945|NCT00273052|2341366|P1|NOT COMPLETED|Overall Study||69
967946|NCT00273052|2341365|P2|COMPLETED|Overall Study||190
967947|NCT00273052|2341366|P1|COMPLETED|Overall Study||221
967948|NCT00273052|2341365|P2|STARTED|Overall Study||278
967949|NCT00273052|2341366|P1|STARTED|Overall Study||290
967950|NCT00273182|2341398|P1|NOT COMPLETED|Overall Study||985
967951|NCT00273182|2341398|P1|COMPLETED|Overall Study||1014
967952|NCT00273182|2341398|P1|STARTED|Overall Study||1999
967953|NCT00266656|2341408|P2|NOT COMPLETED|Overall Study||13
967954|NCT00266656|2341409|P1|NOT COMPLETED|Overall Study||14
967955|NCT00266656|2341408|P2|COMPLETED|Overall Study||20
967956|NCT00266656|2341409|P1|COMPLETED|Overall Study||22
967957|NCT00266656|2341408|P2|STARTED|Overall Study||33
967958|NCT00266656|2341409|P1|STARTED|Overall Study||36
967959|NCT00266695|2341431|P1|NOT COMPLETED|Overall Study||29
967960|NCT00266695|2341431|P1|COMPLETED|Overall Study||174
967961|NCT00266695|2341431|P1|STARTED|Overall Study||203
967962|NCT00266799|2341443|P2|NOT COMPLETED|Overall Study||34
967963|NCT00266799|2341444|P1|NOT COMPLETED|Overall Study||36
967964|NCT00266799|2341443|P2|COMPLETED|Overall Study||68
967965|NCT00266799|2341444|P1|COMPLETED|Overall Study||62
967966|NCT00266799|2341443|P2|STARTED|Overall Study||102
967967|NCT00266799|2341444|P1|STARTED|Overall Study||98
967968|NCT00266812|2341460|P2|NOT COMPLETED|Overall Study||11
967969|NCT00266812|2341461|P1|NOT COMPLETED|Overall Study||21
967970|NCT00266812|2341460|P2|COMPLETED|Overall Study||2
967971|NCT00266812|2341461|P1|COMPLETED|Overall Study||1
967972|NCT00266812|2341460|P2|STARTED|Overall Study||13
967973|NCT00266812|2341461|P1|STARTED|Overall Study||22
967974|NCT00266825|2341469|P2|NOT COMPLETED|Completed Follow-Up||24
967975|NCT00266825|2341470|P1|NOT COMPLETED|Completed Follow-Up||25
967976|NCT00266825|2341469|P2|COMPLETED|Completed Follow-Up||154
967977|NCT00266825|2341470|P1|COMPLETED|Completed Follow-Up||147
967978|NCT00266825|2341469|P2|STARTED|Completed Follow-Up||178
967979|NCT00266825|2341470|P1|STARTED|Completed Follow-Up||172
967980|NCT00266825|2341469|P2|NOT COMPLETED|Enrolled and Allocated Intervention||0
967981|NCT00266825|2341470|P1|NOT COMPLETED|Enrolled and Allocated Intervention||0
967982|NCT00266825|2341469|P2|COMPLETED|Enrolled and Allocated Intervention||178
967983|NCT00266825|2341470|P1|COMPLETED|Enrolled and Allocated Intervention||172
967984|NCT00266825|2341469|P2|STARTED|Enrolled and Allocated Intervention||178
967985|NCT00266825|2341470|P1|STARTED|Enrolled and Allocated Intervention||172
967992|NCT00267007|2341506|P2|NOT COMPLETED|Overall Study||1
967993|NCT00267007|2341507|P1|NOT COMPLETED|Overall Study||8
967994|NCT00267007|2341506|P2|COMPLETED|Overall Study||10
967995|NCT00267007|2341507|P1|COMPLETED|Overall Study||11
967996|NCT00267007|2341506|P2|STARTED|Overall Study||11
967997|NCT00267007|2341507|P1|STARTED|Overall Study|2 additional patients were randomized but never received study medication and no data were collected|19
967998|NCT00267046|2341517|P2|NOT COMPLETED|Overall Study||11
967999|NCT00267046|2341518|P1|NOT COMPLETED|Overall Study||12
968000|NCT00267046|2341517|P2|COMPLETED|Overall Study||5
968001|NCT00267046|2341518|P1|COMPLETED|Overall Study||20
968002|NCT00267046|2341517|P2|STARTED|Overall Study||16
968003|NCT00267046|2341518|P1|STARTED|Overall Study||32
968004|NCT00267059|2341526|P1|NOT COMPLETED|Overall Study||0
968005|NCT00267059|2341526|P1|COMPLETED|Overall Study||44
968006|NCT00267059|2341526|P1|STARTED|Overall Study||44
968007|NCT00267085|2341530|P1|NOT COMPLETED|Overall Study||0
968008|NCT00267085|2341530|P1|COMPLETED|Overall Study||10
968009|NCT00267085|2341530|P1|STARTED|Overall Study||10
968010|NCT00267098|2341542|P8|NOT COMPLETED|Overall Study||15
968011|NCT00267098|2341543|P7|NOT COMPLETED|Overall Study||46
968012|NCT00267098|2341544|P6|NOT COMPLETED|Overall Study||40
968013|NCT00267098|2341545|P5|NOT COMPLETED|Overall Study||37
968014|NCT00267098|2341546|P4|NOT COMPLETED|Overall Study||106
968015|NCT00267098|2341547|P3|NOT COMPLETED|Overall Study||94
968016|NCT00267098|2341548|P2|NOT COMPLETED|Overall Study||51
968017|NCT00267098|2341549|P1|NOT COMPLETED|Overall Study||109
968018|NCT00267098|2341542|P8|COMPLETED|Overall Study||5
968019|NCT00267098|2341543|P7|COMPLETED|Overall Study||55
968020|NCT00267098|2341544|P6|COMPLETED|Overall Study||66
968021|NCT00267098|2341545|P5|COMPLETED|Overall Study||10
968022|NCT00267098|2341546|P4|COMPLETED|Overall Study||135
968023|NCT00267098|2341547|P3|COMPLETED|Overall Study||149
968024|NCT00267098|2341548|P2|COMPLETED|Overall Study||0
968025|NCT00267098|2341549|P1|COMPLETED|Overall Study||0
968026|NCT00267098|2341542|P8|STARTED|Overall Study||20
968027|NCT00267098|2341543|P7|STARTED|Overall Study||101
968028|NCT00267098|2341544|P6|STARTED|Overall Study||106
968029|NCT00267098|2341545|P5|STARTED|Overall Study||47
968030|NCT00267098|2341546|P4|STARTED|Overall Study||241
968031|NCT00267098|2341547|P3|STARTED|Overall Study||243
968032|NCT00267098|2341548|P2|STARTED|Overall Study||51
968033|NCT00267098|2341549|P1|STARTED|Overall Study||109
968034|NCT00267111|2341684|P2|NOT COMPLETED|Overall Study||0
968035|NCT00267111|2341685|P1|NOT COMPLETED|Overall Study||0
968036|NCT00267111|2341684|P2|COMPLETED|Overall Study||55
968037|NCT00267111|2341685|P1|COMPLETED|Overall Study||55
968038|NCT00267111|2341684|P2|STARTED|Overall Study||55
968039|NCT00267111|2341685|P1|STARTED|Overall Study||55
968040|NCT00267150|2341693|P1|NOT COMPLETED|Overall Study||1
968041|NCT00267150|2341693|P1|COMPLETED|Overall Study||30
968042|NCT00267150|2341693|P1|STARTED|Overall Study||31
968043|NCT00267189|2341700|P2|NOT COMPLETED|Overall Study||1
968044|NCT00267189|2341701|P1|NOT COMPLETED|Overall Study||5
968045|NCT00267189|2341700|P2|COMPLETED|Overall Study||72
968046|NCT00267189|2341701|P1|COMPLETED|Overall Study|"Completed indicates completed study."|67
968047|NCT00267189|2341700|P2|Completed Study Medication|Overall Study||72
968048|NCT00267189|2341701|P1|Completed Study Medication|Overall Study||54
968049|NCT00267189|2341700|P2|STARTED|Overall Study||73
968050|NCT00267189|2341701|P1|STARTED|Overall Study|Intention to treat (ITT) population.|72
968051|NCT00267202|2341713|P2|NOT COMPLETED|Overall Study||34
968052|NCT00267202|2341714|P1|NOT COMPLETED|Overall Study||53
968053|NCT00267202|2341713|P2|COMPLETED|Overall Study||105
968054|NCT00267202|2341714|P1|COMPLETED|Overall Study||83
968055|NCT00267202|2341713|P2|STARTED|Overall Study||139
968056|NCT00267202|2341714|P1|STARTED|Overall Study||136
968057|NCT00267293|2341736|P3|NOT COMPLETED|Overall Study||0
968058|NCT00267293|2341737|P2|NOT COMPLETED|Overall Study||0
968059|NCT00267293|2341738|P1|NOT COMPLETED|Overall Study||0
968060|NCT00267293|2341736|P3|COMPLETED|Overall Study||20
968061|NCT00267293|2341737|P2|COMPLETED|Overall Study||20
968062|NCT00267293|2341738|P1|COMPLETED|Overall Study||20
968063|NCT00267293|2341736|P3|STARTED|Overall Study||20
968064|NCT00267293|2341737|P2|STARTED|Overall Study||20
968065|NCT00267293|2341738|P1|STARTED|Overall Study||20
968066|NCT00267488|2341746|P1|NOT COMPLETED|Overall Study||11
968067|NCT00267488|2341746|P1|COMPLETED|Overall Study||26
968068|NCT00267488|2341746|P1|STARTED|Overall Study||37
968069|NCT00267631|2341757|P2|NOT COMPLETED|Overall Study||0
968070|NCT00267631|2341758|P1|NOT COMPLETED|Overall Study||0
968071|NCT00267631|2341757|P2|COMPLETED|Overall Study||3031
968072|NCT00267631|2341758|P1|COMPLETED|Overall Study||2361
968073|NCT00267631|2341757|P2|STARTED|Overall Study||3031
968074|NCT00267631|2341758|P1|STARTED|Overall Study||2361
968075|NCT00267644|2341766|P2|NOT COMPLETED|Overall Study||0
968076|NCT00267644|2341767|P1|NOT COMPLETED|Overall Study||0
968077|NCT00267644|2341766|P2|COMPLETED|Overall Study||63
968078|NCT00267644|2341767|P1|COMPLETED|Overall Study||13
968079|NCT00267644|2341766|P2|STARTED|Overall Study||63
968080|NCT00267644|2341767|P1|STARTED|Overall Study||13
968081|NCT00273754|2341777|P2|NOT COMPLETED|Overall Study||0
968082|NCT00273754|2341778|P1|NOT COMPLETED|Overall Study||0
968083|NCT00273754|2341777|P2|COMPLETED|Overall Study||36
968084|NCT00273754|2341778|P1|COMPLETED|Overall Study||36
968085|NCT00273754|2341777|P2|STARTED|Overall Study||36
968086|NCT00273754|2341778|P1|STARTED|Overall Study||36
968087|NCT00273793|2341800|P6|NOT COMPLETED|Overall Study||0
968088|NCT00273793|2341801|P5|NOT COMPLETED|Overall Study||0
968089|NCT00273793|2341802|P4|NOT COMPLETED|Overall Study||0
968090|NCT00273793|2341803|P3|NOT COMPLETED|Overall Study||0
968091|NCT00273793|2341804|P2|NOT COMPLETED|Overall Study||0
968092|NCT00273793|2341805|P1|NOT COMPLETED|Overall Study||0
968093|NCT00273793|2341800|P6|COMPLETED|Overall Study||29
968094|NCT00273793|2341801|P5|COMPLETED|Overall Study||58
968095|NCT00273793|2341802|P4|COMPLETED|Overall Study||60
968096|NCT00273793|2341803|P3|COMPLETED|Overall Study||18
968097|NCT00273793|2341804|P2|COMPLETED|Overall Study||38
968098|NCT00273793|2341805|P1|COMPLETED|Overall Study||36
968099|NCT00273793|2341800|P6|STARTED|Overall Study||29
968100|NCT00273793|2341801|P5|STARTED|Overall Study||58
968101|NCT00273793|2341802|P4|STARTED|Overall Study||60
968102|NCT00273793|2341803|P3|STARTED|Overall Study||18
968103|NCT00273793|2341804|P2|STARTED|Overall Study||38
968104|NCT00273793|2341805|P1|STARTED|Overall Study||36
968105|NCT00273858|2341825|P1|NOT COMPLETED|Overall Study||537
968106|NCT00273858|2341825|P1|COMPLETED|Overall Study||343
968107|NCT00273858|2341825|P1|STARTED|Overall Study||880
968108|NCT00273910|2341840|P6|NOT COMPLETED|Overall Study||0
968109|NCT00273910|2341841|P5|NOT COMPLETED|Overall Study||0
968110|NCT00273910|2341842|P4|NOT COMPLETED|Overall Study||0
968111|NCT00273910|2341843|P3|NOT COMPLETED|Overall Study||0
968112|NCT00273910|2341844|P2|NOT COMPLETED|Overall Study||0
968113|NCT00273910|2341845|P1|NOT COMPLETED|Overall Study||0
968114|NCT00273910|2341840|P6|COMPLETED|Overall Study||14
968115|NCT00273910|2341841|P5|COMPLETED|Overall Study||15
968116|NCT00273910|2341842|P4|COMPLETED|Overall Study||19
968117|NCT00273910|2341843|P3|COMPLETED|Overall Study||18
968118|NCT00273910|2341844|P2|COMPLETED|Overall Study||19
968119|NCT00273910|2341845|P1|COMPLETED|Overall Study||19
968120|NCT00273910|2341840|P6|STARTED|Overall Study||14
968121|NCT00273910|2341841|P5|STARTED|Overall Study||15
968122|NCT00273910|2341842|P4|STARTED|Overall Study||19
968123|NCT00273910|2341843|P3|STARTED|Overall Study||18
968124|NCT00273910|2341844|P2|STARTED|Overall Study||19
968125|NCT00273910|2341845|P1|STARTED|Overall Study||19
968126|NCT00275821|2341868|P3|NOT COMPLETED|Overall Study||12
968127|NCT00275821|2341869|P2|NOT COMPLETED|Overall Study||23
968128|NCT00275821|2341870|P1|NOT COMPLETED|Overall Study||14
968129|NCT00275821|2341868|P3|COMPLETED|Overall Study||103
968130|NCT00275821|2341869|P2|COMPLETED|Overall Study||95
968131|NCT00275821|2341870|P1|COMPLETED|Overall Study||106
968132|NCT00275821|2341868|P3|STARTED|Overall Study||115
968133|NCT00275821|2341869|P2|STARTED|Overall Study||118
968134|NCT00275821|2341870|P1|STARTED|Overall Study||120
968135|NCT00275834|2341890|P3|NOT COMPLETED|Overall Study||1
968136|NCT00275834|2341891|P2|NOT COMPLETED|Overall Study||3
968137|NCT00275834|2341892|P1|NOT COMPLETED|Overall Study||3
968138|NCT00275834|2341890|P3|COMPLETED|Overall Study||74
968139|NCT00275834|2341891|P2|COMPLETED|Overall Study||73
968140|NCT00275834|2341892|P1|COMPLETED|Overall Study||71
968141|NCT00275834|2341890|P3|Completed Study While on Study Drug|Overall Study||62
968142|NCT00275834|2341891|P2|Completed Study While on Study Drug|Overall Study||51
968143|NCT00275834|2341892|P1|Completed Study While on Study Drug|Overall Study||54
968144|NCT00275834|2341890|P3|STARTED|Overall Study||75
968145|NCT00275834|2341891|P2|STARTED|Overall Study||76
968146|NCT00275834|2341892|P1|STARTED|Overall Study||74
968147|NCT00276016|2341927|P6|NOT COMPLETED|Intervention 3||0
968148|NCT00276016|2341928|P5|NOT COMPLETED|Intervention 3||0
968149|NCT00276016|2341929|P4|NOT COMPLETED|Intervention 3||0
968150|NCT00276016|2341930|P3|NOT COMPLETED|Intervention 3||0
968151|NCT00276016|2341931|P2|NOT COMPLETED|Intervention 3||0
968152|NCT00276016|2341932|P1|NOT COMPLETED|Intervention 3||0
968153|NCT00276016|2341927|P6|COMPLETED|Intervention 3||6
968154|NCT00276016|2341928|P5|COMPLETED|Intervention 3||6
968155|NCT00276016|2341929|P4|COMPLETED|Intervention 3||6
968156|NCT00276016|2341930|P3|COMPLETED|Intervention 3||7
968157|NCT00276016|2341931|P2|COMPLETED|Intervention 3||6
968158|NCT00276016|2341932|P1|COMPLETED|Intervention 3||7
968159|NCT00276016|2341927|P6|STARTED|Intervention 3||6
968160|NCT00276016|2341928|P5|STARTED|Intervention 3||6
968161|NCT00276016|2341929|P4|STARTED|Intervention 3||6
968162|NCT00276016|2341930|P3|STARTED|Intervention 3||7
968163|NCT00276016|2341931|P2|STARTED|Intervention 3||6
968164|NCT00276016|2341932|P1|STARTED|Intervention 3||7
968165|NCT00276016|2341927|P6|NOT COMPLETED|Wash Out 2||0
968166|NCT00276016|2341928|P5|NOT COMPLETED|Wash Out 2||0
968167|NCT00276016|2341929|P4|NOT COMPLETED|Wash Out 2||0
968168|NCT00276016|2341930|P3|NOT COMPLETED|Wash Out 2||0
968169|NCT00276016|2341931|P2|NOT COMPLETED|Wash Out 2||0
968170|NCT00276016|2341932|P1|NOT COMPLETED|Wash Out 2||0
968171|NCT00276016|2341927|P6|COMPLETED|Wash Out 2||6
968172|NCT00276016|2341928|P5|COMPLETED|Wash Out 2||6
968173|NCT00276016|2341929|P4|COMPLETED|Wash Out 2||6
968174|NCT00276016|2341930|P3|COMPLETED|Wash Out 2||7
968175|NCT00276016|2341931|P2|COMPLETED|Wash Out 2||6
968176|NCT00276016|2341932|P1|COMPLETED|Wash Out 2||7
968177|NCT00276016|2341927|P6|STARTED|Wash Out 2||6
968178|NCT00276016|2341928|P5|STARTED|Wash Out 2||6
968179|NCT00276016|2341929|P4|STARTED|Wash Out 2||6
968180|NCT00276016|2341930|P3|STARTED|Wash Out 2||7
968181|NCT00276016|2341931|P2|STARTED|Wash Out 2||6
968182|NCT00276016|2341932|P1|STARTED|Wash Out 2||7
968183|NCT00276016|2341927|P6|NOT COMPLETED|Intervention 2||0
968184|NCT00276016|2341928|P5|NOT COMPLETED|Intervention 2||0
968185|NCT00276016|2341929|P4|NOT COMPLETED|Intervention 2||0
968186|NCT00276016|2341930|P3|NOT COMPLETED|Intervention 2||0
968187|NCT00276016|2341931|P2|NOT COMPLETED|Intervention 2||0
968188|NCT00276016|2341932|P1|NOT COMPLETED|Intervention 2||0
968189|NCT00276016|2341927|P6|COMPLETED|Intervention 2||6
968190|NCT00276016|2341928|P5|COMPLETED|Intervention 2||6
968191|NCT00276016|2341929|P4|COMPLETED|Intervention 2||6
968192|NCT00276016|2341930|P3|COMPLETED|Intervention 2||7
968193|NCT00276016|2341931|P2|COMPLETED|Intervention 2||6
968194|NCT00276016|2341932|P1|COMPLETED|Intervention 2||7
968195|NCT00276016|2341927|P6|STARTED|Intervention 2||6
968196|NCT00276016|2341928|P5|STARTED|Intervention 2||6
968197|NCT00276016|2341929|P4|STARTED|Intervention 2||6
968198|NCT00276016|2341930|P3|STARTED|Intervention 2||7
968199|NCT00276016|2341931|P2|STARTED|Intervention 2||6
968200|NCT00276016|2341932|P1|STARTED|Intervention 2||7
968201|NCT00276016|2341927|P6|NOT COMPLETED|Wash Out 1||0
968202|NCT00276016|2341928|P5|NOT COMPLETED|Wash Out 1||0
968203|NCT00276016|2341929|P4|NOT COMPLETED|Wash Out 1||0
968204|NCT00276016|2341930|P3|NOT COMPLETED|Wash Out 1||0
968205|NCT00276016|2341931|P2|NOT COMPLETED|Wash Out 1||0
968206|NCT00276016|2341932|P1|NOT COMPLETED|Wash Out 1||0
968207|NCT00276016|2341927|P6|COMPLETED|Wash Out 1||6
968208|NCT00276016|2341928|P5|COMPLETED|Wash Out 1||6
968209|NCT00276016|2341929|P4|COMPLETED|Wash Out 1||6
968210|NCT00276016|2341930|P3|COMPLETED|Wash Out 1||7
968211|NCT00276016|2341931|P2|COMPLETED|Wash Out 1||6
968212|NCT00276016|2341932|P1|COMPLETED|Wash Out 1||7
968213|NCT00276016|2341927|P6|STARTED|Wash Out 1||6
968214|NCT00276016|2341928|P5|STARTED|Wash Out 1||6
968215|NCT00276016|2341929|P4|STARTED|Wash Out 1||6
968216|NCT00276016|2341930|P3|STARTED|Wash Out 1||7
968217|NCT00276016|2341931|P2|STARTED|Wash Out 1||6
968218|NCT00276016|2341932|P1|STARTED|Wash Out 1||7
968219|NCT00276016|2341927|P6|NOT COMPLETED|Intervention 1||0
968220|NCT00276016|2341928|P5|NOT COMPLETED|Intervention 1||0
968221|NCT00276016|2341929|P4|NOT COMPLETED|Intervention 1||0
968222|NCT00276016|2341930|P3|NOT COMPLETED|Intervention 1||0
968223|NCT00276016|2341931|P2|NOT COMPLETED|Intervention 1||1
968224|NCT00276016|2341932|P1|NOT COMPLETED|Intervention 1||0
968225|NCT00276016|2341927|P6|COMPLETED|Intervention 1||6
968226|NCT00276016|2341928|P5|COMPLETED|Intervention 1||6
968227|NCT00276016|2341929|P4|COMPLETED|Intervention 1||6
968228|NCT00276016|2341930|P3|COMPLETED|Intervention 1||7
968229|NCT00276016|2341931|P2|COMPLETED|Intervention 1||6
968230|NCT00276016|2341932|P1|COMPLETED|Intervention 1||7
968231|NCT00276016|2341927|P6|STARTED|Intervention 1||6
968232|NCT00276016|2341928|P5|STARTED|Intervention 1||6
968233|NCT00276016|2341929|P4|STARTED|Intervention 1||6
968234|NCT00276016|2341930|P3|STARTED|Intervention 1||7
968235|NCT00276016|2341931|P2|STARTED|Intervention 1||7
968236|NCT00276016|2341932|P1|STARTED|Intervention 1||7
968237|NCT00276094|2341944|P3|NOT COMPLETED|Overall Study||38
968238|NCT00276094|2341945|P2|NOT COMPLETED|Overall Study||42
968239|NCT00276094|2341946|P1|NOT COMPLETED|Overall Study||57
968240|NCT00276094|2341944|P3|COMPLETED|Overall Study||230
968241|NCT00276094|2341945|P2|COMPLETED|Overall Study||234
968242|NCT00276094|2341946|P1|COMPLETED|Overall Study||225
968243|NCT00276094|2341944|P3|STARTED|Overall Study||268
968244|NCT00276094|2341945|P2|STARTED|Overall Study||276
968245|NCT00276094|2341946|P1|STARTED|Overall Study||282
968246|NCT00276159|2341993|P1|NOT COMPLETED|Overall Study||6
968247|NCT00276159|2341993|P1|COMPLETED|Overall Study||0
968248|NCT00276159|2341993|P1|STARTED|Overall Study||6
968249|NCT00276250|2342003|P3|NOT COMPLETED|Overall Study||0
968250|NCT00276250|2342004|P2|NOT COMPLETED|Overall Study||0
968251|NCT00276250|2342005|P1|NOT COMPLETED|Overall Study||0
968252|NCT00276250|2342003|P3|COMPLETED|Overall Study||0
968253|NCT00276250|2342004|P2|COMPLETED|Overall Study||1
968254|NCT00276250|2342005|P1|COMPLETED|Overall Study||4
968255|NCT00276250|2342003|P3|STARTED|Overall Study||0
968256|NCT00276250|2342004|P2|STARTED|Overall Study||1
968257|NCT00276250|2342005|P1|STARTED|Overall Study||4
968258|NCT00276406|2342039|P2|NOT COMPLETED|Overall Study||0
968259|NCT00276406|2342040|P1|NOT COMPLETED|Overall Study||0
968260|NCT00276406|2342039|P2|COMPLETED|Overall Study||14
968261|NCT00276406|2342040|P1|COMPLETED|Overall Study|14 of 16 subjects tolerated 360mg daily, while 2 of 16 tolerated 180mg daily.|16
968262|NCT00276406|2342039|P2|STARTED|Overall Study||14
968263|NCT00276406|2342040|P1|STARTED|Overall Study||16
968264|NCT00276419|2342070|P2|NOT COMPLETED|Second Intervention||0
968265|NCT00276419|2342071|P1|NOT COMPLETED|Second Intervention||0
968266|NCT00276419|2342070|P2|COMPLETED|Second Intervention||8
968267|NCT00276419|2342071|P1|COMPLETED|Second Intervention||7
968268|NCT00276419|2342070|P2|STARTED|Second Intervention||8
968269|NCT00276419|2342071|P1|STARTED|Second Intervention||7
968270|NCT00276419|2342070|P2|NOT COMPLETED|Wash-out Phase||0
968271|NCT00276419|2342071|P1|NOT COMPLETED|Wash-out Phase||0
968272|NCT00276419|2342070|P2|COMPLETED|Wash-out Phase||8
968273|NCT00276419|2342071|P1|COMPLETED|Wash-out Phase||7
968274|NCT00276419|2342070|P2|STARTED|Wash-out Phase||8
968275|NCT00276419|2342071|P1|STARTED|Wash-out Phase||7
968276|NCT00276419|2342070|P2|NOT COMPLETED|First Intervention||2
968277|NCT00276419|2342071|P1|NOT COMPLETED|First Intervention||1
968278|NCT00276419|2342070|P2|COMPLETED|First Intervention||8
968279|NCT00276419|2342071|P1|COMPLETED|First Intervention||7
968280|NCT00276419|2342070|P2|STARTED|First Intervention||10
968281|NCT00276419|2342071|P1|STARTED|First Intervention||8
968282|NCT00276458|2342083|P2|NOT COMPLETED|Overall Study||7
968283|NCT00276458|2342084|P1|NOT COMPLETED|Overall Study||6
968284|NCT00276458|2342083|P2|COMPLETED|Overall Study||91
968285|NCT00276458|2342084|P1|COMPLETED|Overall Study||92
968286|NCT00276458|2342083|P2|STARTED|Overall Study||98
968287|NCT00276458|2342084|P1|STARTED|Overall Study||98
968288|NCT00276484|2342118|P2|NOT COMPLETED|Overall Study||13
968289|NCT00276484|2342119|P1|NOT COMPLETED|Overall Study||9
968290|NCT00276484|2342118|P2|COMPLETED|Overall Study||278
968291|NCT00276484|2342119|P1|COMPLETED|Overall Study||279
968292|NCT00276484|2342118|P2|STARTED|Overall Study||291
968293|NCT00276484|2342119|P1|STARTED|Overall Study||288
968294|NCT00276549|2342149|P1|NOT COMPLETED|Overall Study||0
968295|NCT00276549|2342149|P1|COMPLETED|Overall Study||35
968296|NCT00276549|2342149|P1|STARTED|Overall Study||35
968297|NCT00276614|2342154|P1|NOT COMPLETED|Overall Study||3
968298|NCT00276614|2342154|P1|COMPLETED|Overall Study||1
968299|NCT00276614|2342154|P1|STARTED|Overall Study||4
968300|NCT00276861|2342158|P1|NOT COMPLETED|Overall Study||0
968301|NCT00276861|2342158|P1|COMPLETED|Overall Study||10
968302|NCT00276861|2342158|P1|STARTED|Overall Study||10
968303|NCT00277095|2342163|P1|NOT COMPLETED|Overall Study||21
968304|NCT00277095|2342163|P1|COMPLETED|Overall Study|Details of patients who did not complete study are given below.|103
968305|NCT00277095|2342163|P1|STARTED|Overall Study|Anatomy of 1 patient did not allow ProACT to be implanted, hence only 123 patients were implanted.|124
968306|NCT00277212|2342167|P3|NOT COMPLETED|Phase 2 - Double-Blind Treatment||113
968307|NCT00277212|2342168|P2|NOT COMPLETED|Phase 2 - Double-Blind Treatment||120
968308|NCT00277212|2342169|P1|NOT COMPLETED|Phase 2 - Double-Blind Treatment||0
968309|NCT00277212|2342167|P3|COMPLETED|Phase 2 - Double-Blind Treatment||65
968310|NCT00277212|2342168|P2|COMPLETED|Phase 2 - Double-Blind Treatment||53
968311|NCT00277212|2342169|P1|COMPLETED|Phase 2 - Double-Blind Treatment||0
968312|NCT00277212|2342167|P3|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||174
968313|NCT00277212|2342168|P2|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||164
968314|NCT00277212|2342169|P1|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||0
968315|NCT00277212|2342167|P3|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||176
968316|NCT00277212|2342168|P2|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||165
968317|NCT00277212|2342169|P1|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||0
968318|NCT00277212|2342167|P3|STARTED|Phase 2 - Double-Blind Treatment|1 participant did not want to continue in the study for personal reasons, and did not enter Phase 2.|178
968319|NCT00277212|2342168|P2|STARTED|Phase 2 - Double-Blind Treatment||173
968320|NCT00277212|2342169|P1|STARTED|Phase 2 - Double-Blind Treatment||0
968321|NCT00277212|2342167|P3|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
968322|NCT00277212|2342168|P2|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
968323|NCT00277212|2342169|P1|NOT COMPLETED|Phase 1 - Single-Blind Treatment||435
968324|NCT00277212|2342167|P3|COMPLETED|Phase 1 - Single-Blind Treatment||0
968325|NCT00277212|2342168|P2|COMPLETED|Phase 1 - Single-Blind Treatment||0
968326|NCT00277212|2342169|P1|COMPLETED|Phase 1 - Single-Blind Treatment||352
968327|NCT00277212|2342167|P3|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
968328|NCT00277212|2342168|P2|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
968329|NCT00277212|2342169|P1|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||756
968330|NCT00277212|2342167|P3|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
968331|NCT00277212|2342168|P2|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
968332|NCT00277212|2342169|P1|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||787
968333|NCT00277212|2342167|P3|STARTED|Phase 1 - Single-Blind Treatment||0
968334|NCT00277212|2342168|P2|STARTED|Phase 1 - Single-Blind Treatment||0
968335|NCT00277212|2342169|P1|STARTED|Phase 1 - Single-Blind Treatment||787
968336|NCT00277355|2342209|P2|NOT COMPLETED|Overall Study||5
968337|NCT00277355|2342210|P1|NOT COMPLETED|Overall Study||14
968338|NCT00277355|2342209|P2|COMPLETED|Overall Study||22
968339|NCT00277355|2342210|P1|COMPLETED|Overall Study||73
968340|NCT00277355|2342209|P2|STARTED|Overall Study||27
968341|NCT00277355|2342210|P1|STARTED|Overall Study||87
968342|NCT00277394|2342220|P2|NOT COMPLETED|Overall Study||24
968343|NCT00277394|2342221|P1|NOT COMPLETED|Overall Study||37
968344|NCT00277394|2342220|P2|COMPLETED|Overall Study||246
968345|NCT00277394|2342221|P1|COMPLETED|Overall Study||232
968346|NCT00277394|2342220|P2|STARTED|Overall Study||270
968347|NCT00277394|2342221|P1|STARTED|Overall Study||269
968348|NCT00277446|2342231|P1|NOT COMPLETED|Overall Study||0
968349|NCT00277446|2342231|P1|COMPLETED|Overall Study||13
968350|NCT00277446|2342231|P1|STARTED|Overall Study||13
968351|NCT00277524|2342237|P4|NOT COMPLETED|Overall Study||0
968352|NCT00277524|2342238|P3|NOT COMPLETED|Overall Study||0
968353|NCT00277524|2342239|P2|NOT COMPLETED|Overall Study||0
968354|NCT00277524|2342240|P1|NOT COMPLETED|Overall Study||0
968355|NCT00277524|2342237|P4|COMPLETED|Overall Study||850
968356|NCT00277524|2342238|P3|COMPLETED|Overall Study||1088
968357|NCT00277524|2342239|P2|COMPLETED|Overall Study||324
968358|NCT00277524|2342240|P1|COMPLETED|Overall Study||621
968359|NCT00277524|2342237|P4|STARTED|Overall Study||850
968360|NCT00277524|2342238|P3|STARTED|Overall Study||1088
968361|NCT00277524|2342239|P2|STARTED|Overall Study||324
968362|NCT00277524|2342240|P1|STARTED|Overall Study||621
968363|NCT00278343|2342258|P1|NOT COMPLETED|Overall Study||0
968364|NCT00278343|2342258|P1|COMPLETED|Overall Study||74
968365|NCT00278343|2342258|P1|STARTED|Overall Study||74
968366|NCT00278395|2342265|P1|NOT COMPLETED|Overall Study||3
968367|NCT00278395|2342265|P1|COMPLETED|Overall Study||11
968368|NCT00278395|2342265|P1|STARTED|Overall Study||14
968369|NCT00270634|2342273|P4|NOT COMPLETED|Overall Study||5
968370|NCT00270634|2342274|P3|NOT COMPLETED|Overall Study||22
968371|NCT00270634|2342275|P2|NOT COMPLETED|Overall Study||13
968372|NCT00270634|2342276|P1|NOT COMPLETED|Overall Study||17
968373|NCT00270634|2342273|P4|COMPLETED|Overall Study||81
968374|NCT00270634|2342274|P3|COMPLETED|Overall Study||62
968375|NCT00270634|2342275|P2|COMPLETED|Overall Study||64
968376|NCT00270634|2342276|P1|COMPLETED|Overall Study||70
968377|NCT00270634|2342273|P4|STARTED|Overall Study||86
968378|NCT00270634|2342274|P3|STARTED|Overall Study||84
968379|NCT00270634|2342275|P2|STARTED|Overall Study||77
968380|NCT00270634|2342276|P1|STARTED|Overall Study||87
968381|NCT00270790|2342310|P1|NOT COMPLETED|Overall Study||5
968382|NCT00270790|2342310|P1|COMPLETED|Overall Study||16
968383|NCT00270790|2342310|P1|STARTED|Overall Study||21
968384|NCT00270842|2342318|P3|NOT COMPLETED|Overall Study||16
968385|NCT00270842|2342319|P2|NOT COMPLETED|Overall Study||16
968386|NCT00270842|2342320|P1|NOT COMPLETED|Overall Study||15
968387|NCT00270842|2342318|P3|COMPLETED|Overall Study||18
968388|NCT00270842|2342319|P2|COMPLETED|Overall Study||18
968389|NCT00270842|2342320|P1|COMPLETED|Overall Study||18
968390|NCT00270842|2342318|P3|STARTED|Overall Study||34
968391|NCT00270842|2342319|P2|STARTED|Overall Study||34
968392|NCT00270842|2342320|P1|STARTED|Overall Study||33
968393|NCT00270894|2342331|P1|NOT COMPLETED|Overall Study||2
968394|NCT00270894|2342331|P1|COMPLETED|Overall Study||28
968395|NCT00270894|2342331|P1|STARTED|Overall Study||30
968396|NCT00270998|2342344|P3|NOT COMPLETED|12 Month Follow-up||21
968397|NCT00270998|2342345|P2|NOT COMPLETED|12 Month Follow-up||25
968398|NCT00270998|2342346|P1|NOT COMPLETED|12 Month Follow-up||14
968399|NCT00270998|2342344|P3|COMPLETED|12 Month Follow-up||111
968400|NCT00270998|2342345|P2|COMPLETED|12 Month Follow-up||99
968401|NCT00270998|2342346|P1|COMPLETED|12 Month Follow-up||96
968402|NCT00270998|2342344|P3|STARTED|12 Month Follow-up||132
968403|NCT00270998|2342345|P2|STARTED|12 Month Follow-up||124
968404|NCT00270998|2342346|P1|STARTED|12 Month Follow-up||110
968405|NCT00270998|2342344|P3|NOT COMPLETED|3 Month Follow-up||18
968406|NCT00270998|2342345|P2|NOT COMPLETED|3 Month Follow-up||22
968407|NCT00270998|2342346|P1|NOT COMPLETED|3 Month Follow-up||39
968408|NCT00270998|2342344|P3|COMPLETED|3 Month Follow-up||132
968409|NCT00270998|2342345|P2|COMPLETED|3 Month Follow-up||124
968410|NCT00270998|2342346|P1|COMPLETED|3 Month Follow-up||110
968411|NCT00270998|2342344|P3|STARTED|3 Month Follow-up|1 participant randomized to combined found ineligible at first treatment visit, removed from study.|150
968412|NCT00270998|2342345|P2|STARTED|3 Month Follow-up||146
968413|NCT00270998|2342346|P1|STARTED|3 Month Follow-up||149
968414|NCT00271011|2342375|P1|NOT COMPLETED|Overall Study||0
968415|NCT00271011|2342375|P1|COMPLETED|Overall Study||13
968416|NCT00271011|2342375|P1|STARTED|Overall Study||13
968417|NCT00271024|2342384|P4|NOT COMPLETED|Overall Study||24
968418|NCT00271024|2342385|P3|NOT COMPLETED|Overall Study||23
968419|NCT00271024|2342386|P2|NOT COMPLETED|Overall Study||26
968420|NCT00271024|2342387|P1|NOT COMPLETED|Overall Study||22
968421|NCT00271024|2342384|P4|COMPLETED|Overall Study|Discontinued: 9 smoking related, 2 reaction to tablet, 4 time commitment, 1 other, 3 unspecified|64
968422|NCT00271024|2342385|P3|COMPLETED|Overall Study|Discontinued: 5 smoking related, 4 reaction to tablet, 4 time commitment, 3 other, 4 unspecified|65
968423|NCT00271024|2342386|P2|COMPLETED|Overall Study|Discontinued: 5 smoking related, 3 reaction to tablet, 2 time commitment, 1 other, 9 unspecified|51
968508|NCT00282113|2342581|P3|STARTED|Overall Study||29
968424|NCT00271024|2342387|P1|COMPLETED|Overall Study|Discontinued: 1 smoking related, 1 reaction to tablet, 6 time commitment, 2 other, 8 unspecified|58
968425|NCT00271024|2342384|P4|Received Study Treatment|Overall Study|n=5 did not start treatment (2 health problems, 1 wanted diff. treatment method, 2 lost interest)|83
968426|NCT00271024|2342385|P3|Received Study Treatment|Overall Study|n=3 did not start treatment (2 lost interest, 1 unknown)|85
968427|NCT00271024|2342386|P2|Received Study Treatment|Overall Study|n=6 did not start treatment (1 diff treat. desired, 3 lost interest, 1 began psych meds, 1 unknown)|71
968428|NCT00271024|2342387|P1|Received Study Treatment|Overall Study|n=4 did not start treatment (3 lost interest, 1 unknown)|76
968429|NCT00271024|2342384|P4|STARTED|Overall Study||88
968430|NCT00271024|2342385|P3|STARTED|Overall Study||88
968431|NCT00271024|2342386|P2|STARTED|Overall Study||77
968432|NCT00271024|2342387|P1|STARTED|Overall Study||80
968433|NCT00271154|2342431|P2|NOT COMPLETED|Overall Study||0
968434|NCT00271154|2342432|P1|NOT COMPLETED|Overall Study||0
968435|NCT00271154|2342431|P2|COMPLETED|Overall Study||419
968436|NCT00271154|2342432|P1|COMPLETED|Overall Study||191
968437|NCT00271154|2342431|P2|STARTED|Overall Study||419
968438|NCT00271154|2342432|P1|STARTED|Overall Study||191
968439|NCT00278473|2342443|P2|NOT COMPLETED|Overall Study||3
968440|NCT00278473|2342444|P1|NOT COMPLETED|Overall Study||4
968441|NCT00278473|2342443|P2|COMPLETED|Overall Study||40
968442|NCT00278473|2342444|P1|COMPLETED|Overall Study||41
968443|NCT00278473|2342443|P2|STARTED|Overall Study||43
968444|NCT00278473|2342444|P1|STARTED|Overall Study||45
968445|NCT00278525|2342462|P2|NOT COMPLETED|Overall Study||0
968446|NCT00278525|2342463|P1|NOT COMPLETED|Overall Study||0
968447|NCT00278525|2342462|P2|COMPLETED|Overall Study|7 participant crossed over to the HSCT arm and underwent HSCT, in accordance with the protocol.|10
968448|NCT00278525|2342463|P1|COMPLETED|Overall Study|7 participants crossed to HSCT arm in accordance with the protocol|9
968449|NCT00278525|2342462|P2|STARTED|Overall Study||10
968450|NCT00278525|2342463|P1|STARTED|Overall Study||9
968451|NCT00278655|2342471|P1|NOT COMPLETED|Overall Study||0
968452|NCT00278655|2342471|P1|COMPLETED|Overall Study||21
968453|NCT00278655|2342471|P1|STARTED|Overall Study||21
968454|NCT00281879|2342484|P8|NOT COMPLETED|Overall Study||1
968455|NCT00281879|2342485|P7|NOT COMPLETED|Overall Study||0
968456|NCT00281879|2342486|P6|NOT COMPLETED|Overall Study||9
968457|NCT00281879|2342487|P5|NOT COMPLETED|Overall Study||6
968458|NCT00281879|2342488|P4|NOT COMPLETED|Overall Study||0
968459|NCT00281879|2342489|P3|NOT COMPLETED|Overall Study||20
968460|NCT00281879|2342490|P2|NOT COMPLETED|Overall Study||36
968461|NCT00281879|2342491|P1|NOT COMPLETED|Overall Study||128
968462|NCT00281879|2342484|P8|COMPLETED|Overall Study||0
968463|NCT00281879|2342485|P7|COMPLETED|Overall Study||0
968464|NCT00281879|2342486|P6|COMPLETED|Overall Study||0
968465|NCT00281879|2342487|P5|COMPLETED|Overall Study||0
968466|NCT00281879|2342488|P4|COMPLETED|Overall Study||0
968467|NCT00281879|2342489|P3|COMPLETED|Overall Study||0
968468|NCT00281879|2342490|P2|COMPLETED|Overall Study||0
968469|NCT00281879|2342491|P1|COMPLETED|Overall Study||0
968470|NCT00281879|2342484|P8|STARTED|Overall Study||1
968471|NCT00281879|2342485|P7|STARTED|Overall Study||0
968472|NCT00281879|2342486|P6|STARTED|Overall Study||9
968473|NCT00281879|2342487|P5|STARTED|Overall Study||6
968474|NCT00281879|2342488|P4|STARTED|Overall Study||0
968475|NCT00281879|2342489|P3|STARTED|Overall Study||20
968476|NCT00281879|2342490|P2|STARTED|Overall Study||36
968477|NCT00281879|2342491|P1|STARTED|Overall Study||128
968478|NCT00281918|2342511|P2|NOT COMPLETED|Overall Study||108
968479|NCT00281918|2342512|P1|NOT COMPLETED|Overall Study||142
968480|NCT00281918|2342511|P2|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|300
968481|NCT00281918|2342512|P1|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|267
968482|NCT00281918|2342511|P2|Safety Population; Received Study Drug|Overall Study||402
968483|NCT00281918|2342512|P1|Safety Population; Received Study Drug|Overall Study||398
968484|NCT00281918|2342511|P2|STARTED|Overall Study|Informed consent unavailable for 5 patients at time of analysis; intent-to-treat population was 403.|408
968485|NCT00281918|2342512|P1|STARTED|Overall Study|Informed consent unavailable for 2 patients at time of analysis; intent-to-treat population was 407.|409
968486|NCT00281957|2342540|P2|NOT COMPLETED|Overall Study||42
968487|NCT00281957|2342541|P1|NOT COMPLETED|Overall Study||67
968488|NCT00281957|2342540|P2|COMPLETED|Overall Study||0
968489|NCT00281957|2342541|P1|COMPLETED|Overall Study||0
968490|NCT00281957|2342540|P2|Eligible and Received Treatment|Overall Study||39
968491|NCT00281957|2342541|P1|Eligible and Received Treatment|Overall Study||63
968492|NCT00281957|2342540|P2|Eligible|Overall Study||40
968493|NCT00281957|2342541|P1|Eligible|Overall Study||66
968494|NCT00281957|2342540|P2|STARTED|Overall Study||42
968495|NCT00281957|2342541|P1|STARTED|Overall Study||67
968496|NCT00282048|2342553|P1|NOT COMPLETED|Overall Study||62
968497|NCT00282048|2342553|P1|COMPLETED|Overall Study||0
968498|NCT00282048|2342553|P1|STARTED|Overall Study||62
968499|NCT00282087|2342565|P1|NOT COMPLETED|Overall Study||1
968500|NCT00282087|2342565|P1|COMPLETED|Overall Study|One patient died during cycle 1 of treatment because of infectious complications of AIDS.|46
968501|NCT00282087|2342565|P1|STARTED|Overall Study||47
968502|NCT00282113|2342581|P3|NOT COMPLETED|Overall Study||0
968503|NCT00282113|2342582|P2|NOT COMPLETED|Overall Study||0
968504|NCT00282113|2342583|P1|NOT COMPLETED|Overall Study||1
968505|NCT00282113|2342581|P3|COMPLETED|Overall Study||29
968506|NCT00282113|2342582|P2|COMPLETED|Overall Study||30
968507|NCT00282113|2342583|P1|COMPLETED|Overall Study||30
968509|NCT00282113|2342582|P2|STARTED|Overall Study||30
968510|NCT00282113|2342583|P1|STARTED|Overall Study||31
968511|NCT00282152|2342599|P2|NOT COMPLETED|Overall Study||0
968512|NCT00282152|2342600|P1|NOT COMPLETED|Overall Study||1
968513|NCT00282152|2342599|P2|COMPLETED|Overall Study||15
968514|NCT00282152|2342600|P1|COMPLETED|Overall Study||14
968515|NCT00282152|2342599|P2|STARTED|Overall Study||15
968516|NCT00282152|2342600|P1|STARTED|Overall Study||15
968517|NCT00282243|2342618|P1|NOT COMPLETED|Extension Treatment Period||22
968518|NCT00282243|2342618|P1|COMPLETED|Extension Treatment Period||43
968519|NCT00282243|2342618|P1|STARTED|Extension Treatment Period||65
968520|NCT00282243|2342618|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||5
968521|NCT00282243|2342618|P1|COMPLETED|Pharmacokinetic Treatment Period||65
968522|NCT00282243|2342618|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||69
968523|NCT00282243|2342618|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||70
968524|NCT00282243|2342618|P1|STARTED|Pharmacokinetic Treatment Period||70
968525|NCT00282256|2342642|P1|NOT COMPLETED|Extension Treatment Period||2
968526|NCT00282256|2342642|P1|COMPLETED|Extension Treatment Period||16
968527|NCT00282256|2342642|P1|STARTED|Extension Treatment Period||18
968528|NCT00282256|2342642|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||1
968529|NCT00282256|2342642|P1|COMPLETED|Pharmacokinetic Treatment Period||18
968530|NCT00282256|2342642|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||18
968531|NCT00282256|2342642|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||19
968532|NCT00282256|2342642|P1|STARTED|Pharmacokinetic Treatment Period||19
968533|NCT00282282|2342663|P1|NOT COMPLETED|Overall Study||0
968534|NCT00282282|2342663|P1|COMPLETED|Overall Study||29
968535|NCT00282282|2342663|P1|STARTED|Overall Study|31 patients enrolled but 2 patients did not go through with transplant|29
968536|NCT00282295|2342672|P3|NOT COMPLETED|Overall Study||8
968537|NCT00282295|2342673|P2|NOT COMPLETED|Overall Study||17
968538|NCT00282295|2342674|P1|NOT COMPLETED|Overall Study||3
968539|NCT00282295|2342672|P3|COMPLETED|Overall Study||441
968540|NCT00282295|2342673|P2|COMPLETED|Overall Study||429
968541|NCT00282295|2342674|P1|COMPLETED|Overall Study||443
968542|NCT00282295|2342672|P3|STARTED|Overall Study||449
968543|NCT00282295|2342673|P2|STARTED|Overall Study||446
968544|NCT00282295|2342674|P1|STARTED|Overall Study||446
968545|NCT00282308|2342725|P3|NOT COMPLETED|Safety Follow-up Period||19
968546|NCT00282308|2342726|P2|NOT COMPLETED|Safety Follow-up Period||0
968547|NCT00282308|2342727|P1|NOT COMPLETED|Safety Follow-up Period||0
968548|NCT00282308|2342725|P3|COMPLETED|Safety Follow-up Period||81
968549|NCT00282308|2342726|P2|COMPLETED|Safety Follow-up Period||0
968550|NCT00282308|2342727|P1|COMPLETED|Safety Follow-up Period||0
968551|NCT00282308|2342725|P3|STARTED|Safety Follow-up Period|Some patients entered this Safety Follow-up Period directly from the Treatment Period.|100
968552|NCT00282308|2342726|P2|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
968553|NCT00282308|2342727|P1|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
968554|NCT00282308|2342725|P3|NOT COMPLETED|Optional Extension Re-treatment Period||6
968555|NCT00282308|2342726|P2|NOT COMPLETED|Optional Extension Re-treatment Period||0
968556|NCT00282308|2342727|P1|NOT COMPLETED|Optional Extension Re-treatment Period||0
968557|NCT00282308|2342725|P3|COMPLETED|Optional Extension Re-treatment Period||72
968558|NCT00282308|2342726|P2|COMPLETED|Optional Extension Re-treatment Period||0
968559|NCT00282308|2342727|P1|COMPLETED|Optional Extension Re-treatment Period||0
968560|NCT00282308|2342725|P3|STARTED|Optional Extension Re-treatment Period|Not all patients who completed the Treatment Period entered this Optional Re-treatment Period.|78
968561|NCT00282308|2342726|P2|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
968562|NCT00282308|2342727|P1|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
968563|NCT00282308|2342725|P3|NOT COMPLETED|Treatment Period||0
968564|NCT00282308|2342726|P2|NOT COMPLETED|Treatment Period||6
968565|NCT00282308|2342727|P1|NOT COMPLETED|Treatment Period||4
968566|NCT00282308|2342725|P3|COMPLETED|Treatment Period||0
968567|NCT00282308|2342726|P2|COMPLETED|Treatment Period||28
968568|NCT00282308|2342727|P1|COMPLETED|Treatment Period||65
968569|NCT00282308|2342725|P3|STARTED|Treatment Period|Participant Flow is reported separately for the treatment groups for this Period.|0
968570|NCT00282308|2342726|P2|STARTED|Treatment Period||34
968571|NCT00282308|2342727|P1|STARTED|Treatment Period||69
968572|NCT00282334|2342756|P2|NOT COMPLETED|Overall Study||5
968573|NCT00282334|2342757|P1|NOT COMPLETED|Overall Study||8
968574|NCT00282334|2342756|P2|COMPLETED|Overall Study||118
968575|NCT00282334|2342757|P1|COMPLETED|Overall Study||105
968576|NCT00282334|2342756|P2|STARTED|Overall Study||123
968577|NCT00282334|2342757|P1|STARTED|Overall Study||113
968578|NCT00282347|2342765|P2|NOT COMPLETED|B Cell Follow-up Period||0
968579|NCT00282347|2342766|P1|NOT COMPLETED|B Cell Follow-up Period||5
968580|NCT00282347|2342765|P2|COMPLETED|B Cell Follow-up Period||4
968581|NCT00282347|2342766|P1|COMPLETED|B Cell Follow-up Period||15
968582|NCT00282347|2342765|P2|STARTED|B Cell Follow-up Period||4
968583|NCT00282347|2342766|P1|STARTED|B Cell Follow-up Period||20
968584|NCT00282347|2342765|P2|NOT COMPLETED|Safety Follow-up Period||6
968585|NCT00282347|2342766|P1|NOT COMPLETED|Safety Follow-up Period||3
968586|NCT00282347|2342765|P2|COMPLETED|Safety Follow-up Period||57
968587|NCT00282347|2342766|P1|COMPLETED|Safety Follow-up Period||64
968588|NCT00282347|2342765|P2|STARTED|Safety Follow-up Period||63
968589|NCT00282347|2342766|P1|STARTED|Safety Follow-up Period||67
968590|NCT00282347|2342765|P2|NOT COMPLETED|Treatment Period||9
968591|NCT00282347|2342766|P1|NOT COMPLETED|Treatment Period||5
968592|NCT00282347|2342765|P2|COMPLETED|Treatment Period||63
968593|NCT00282347|2342766|P1|COMPLETED|Treatment Period||67
968594|NCT00282347|2342765|P2|STARTED|Treatment Period||72
968595|NCT00282347|2342766|P1|STARTED|Treatment Period||72
968596|NCT00282438|2342792|P2|NOT COMPLETED|Overall Study||1
968597|NCT00282438|2342793|P1|NOT COMPLETED|Overall Study||1
968598|NCT00282438|2342792|P2|COMPLETED|Overall Study||0
968599|NCT00282438|2342793|P1|COMPLETED|Overall Study||0
968600|NCT00282438|2342792|P2|STARTED|Overall Study||1
968601|NCT00282438|2342793|P1|STARTED|Overall Study||1
968602|NCT00282464|2342801|P2|NOT COMPLETED|Overall Study||62
968603|NCT00282464|2342802|P1|NOT COMPLETED|Overall Study||73
968604|NCT00282464|2342801|P2|COMPLETED|Overall Study||134
968605|NCT00282464|2342802|P1|COMPLETED|Overall Study||112
968606|NCT00282464|2342801|P2|STARTED|Overall Study||196
968607|NCT00282464|2342802|P1|STARTED|Overall Study||185
968608|NCT00282568|2342850|P1|NOT COMPLETED|Extended Treatment Period||24
968609|NCT00282568|2342850|P1|COMPLETED|Extended Treatment Period||42
968610|NCT00282568|2342850|P1|STARTED|Extended Treatment Period|One patient who completed the PK period did not enter the extended treatment period.|66
968611|NCT00282568|2342850|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||3
968612|NCT00282568|2342850|P1|COMPLETED|Pharmacokinetic Treatment Period||67
968613|NCT00282568|2342850|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||67
968614|NCT00282568|2342850|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||68
968615|NCT00282568|2342850|P1|STARTED|Pharmacokinetic Treatment Period||70
968616|NCT00282672|2342878|P4|NOT COMPLETED|5 Year: Follow up||5
968617|NCT00282672|2342879|P3|NOT COMPLETED|5 Year: Follow up||0
968618|NCT00282672|2342880|P2|NOT COMPLETED|5 Year: Follow up||5
968619|NCT00282672|2342881|P1|NOT COMPLETED|5 Year: Follow up||1
968620|NCT00282672|2342878|P4|COMPLETED|5 Year: Follow up||20
968621|NCT00282672|2342879|P3|COMPLETED|5 Year: Follow up||12
968622|NCT00282672|2342880|P2|COMPLETED|5 Year: Follow up||27
968623|NCT00282672|2342881|P1|COMPLETED|5 Year: Follow up||14
968624|NCT00282672|2342878|P4|STARTED|5 Year: Follow up|11 withdrew|25
968625|NCT00282672|2342879|P3|STARTED|5 Year: Follow up|3 withdrew|12
968626|NCT00282672|2342880|P2|STARTED|5 Year: Follow up|7 withdrew|32
968627|NCT00282672|2342881|P1|STARTED|5 Year: Follow up|1 withdrew|15
968628|NCT00282672|2342878|P4|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||2
968629|NCT00282672|2342879|P3|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
968630|NCT00282672|2342880|P2|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
968631|NCT00282672|2342881|P1|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||3
968632|NCT00282672|2342878|P4|COMPLETED|2 Year: Sham Crossed Over to RFA||36
968633|NCT00282672|2342879|P3|COMPLETED|2 Year: Sham Crossed Over to RFA||15
968634|NCT00282672|2342880|P2|COMPLETED|2 Year: Sham Crossed Over to RFA||39
968635|NCT00282672|2342881|P1|COMPLETED|2 Year: Sham Crossed Over to RFA||16
968636|NCT00282672|2342878|P4|STARTED|2 Year: Sham Crossed Over to RFA||38
968637|NCT00282672|2342879|P3|STARTED|2 Year: Sham Crossed Over to RFA|16 Crossed over to RFA treatment|16
968638|NCT00282672|2342880|P2|STARTED|2 Year: Sham Crossed Over to RFA||40
968639|NCT00282672|2342881|P1|STARTED|2 Year: Sham Crossed Over to RFA|19 crossed over to RFA treatment|19
968640|NCT00282672|2342878|P4|NOT COMPLETED|1 Year||4
968641|NCT00282672|2342879|P3|NOT COMPLETED|1 Year||1
968642|NCT00282672|2342880|P2|NOT COMPLETED|1 Year||2
968643|NCT00282672|2342881|P1|NOT COMPLETED|1 Year||3
968644|NCT00282672|2342878|P4|COMPLETED|1 Year||38
968645|NCT00282672|2342879|P3|COMPLETED|1 Year||20
968646|NCT00282672|2342880|P2|COMPLETED|1 Year||40
968647|NCT00282672|2342881|P1|COMPLETED|1 Year||19
968648|NCT00282672|2342878|P4|STARTED|1 Year||42
968649|NCT00282672|2342879|P3|STARTED|1 Year||21
968650|NCT00282672|2342880|P2|STARTED|1 Year||42
968651|NCT00282672|2342881|P1|STARTED|1 Year||22
968652|NCT00282815|2342929|P2|NOT COMPLETED|Overall Study||6
968653|NCT00282815|2342930|P1|NOT COMPLETED|Overall Study||7
968654|NCT00282815|2342929|P2|COMPLETED|Overall Study||11
968655|NCT00282815|2342930|P1|COMPLETED|Overall Study||8
968656|NCT00282815|2342929|P2|STARTED|Overall Study||17
968657|NCT00282815|2342930|P1|STARTED|Overall Study||15
968658|NCT00282828|2342942|P3|NOT COMPLETED|Overall Study||9
968659|NCT00282828|2342943|P2|NOT COMPLETED|Overall Study||12
968660|NCT00282828|2342944|P1|NOT COMPLETED|Overall Study||6
968661|NCT00282828|2342942|P3|COMPLETED|Overall Study||50
968662|NCT00282828|2342943|P2|COMPLETED|Overall Study||47
968663|NCT00282828|2342944|P1|COMPLETED|Overall Study||57
968664|NCT00282828|2342942|P3|STARTED|Overall Study||59
968665|NCT00282828|2342943|P2|STARTED|Overall Study||59
968666|NCT00282828|2342944|P1|STARTED|Overall Study||63
968667|NCT00282867|2342958|P3|NOT COMPLETED|Overall Study||0
968668|NCT00282867|2342959|P2|NOT COMPLETED|Overall Study||1
968669|NCT00282867|2342960|P1|NOT COMPLETED|Overall Study||1
968670|NCT00282867|2342958|P3|COMPLETED|Overall Study||25
968671|NCT00282867|2342959|P2|COMPLETED|Overall Study||24
968672|NCT00282867|2342960|P1|COMPLETED|Overall Study||23
968673|NCT00282867|2342958|P3|STARTED|Overall Study||25
968674|NCT00282867|2342959|P2|STARTED|Overall Study||25
968675|NCT00282867|2342960|P1|STARTED|Overall Study||24
968676|NCT00282919|2342974|P1|NOT COMPLETED|Overall Study||7
968677|NCT00282919|2342974|P1|COMPLETED|Overall Study||103
968678|NCT00282919|2342974|P1|STARTED|Overall Study||110
968679|NCT00282971|2342988|P2|NOT COMPLETED|Overall Study||22
968680|NCT00282971|2342989|P1|NOT COMPLETED|Overall Study||34
968681|NCT00282971|2342988|P2|COMPLETED|Overall Study||149
968682|NCT00282971|2342989|P1|COMPLETED|Overall Study||146
968683|NCT00282971|2342988|P2|STARTED|Overall Study||171
968684|NCT00282971|2342989|P1|STARTED|Overall Study||180
968685|NCT00282984|2343001|P2|NOT COMPLETED|Overall Study||61
968686|NCT00282984|2343002|P1|NOT COMPLETED|Overall Study||51
968687|NCT00282984|2343001|P2|COMPLETED|Overall Study||289
968688|NCT00282984|2343002|P1|COMPLETED|Overall Study||302
968689|NCT00282984|2343001|P2|STARTED|Overall Study||350
968690|NCT00282984|2343002|P1|STARTED|Overall Study||353
968691|NCT00283049|2343029|P3|NOT COMPLETED|Overall Study||54
968692|NCT00283049|2343030|P2|NOT COMPLETED|Overall Study||45
968693|NCT00283049|2343031|P1|NOT COMPLETED|Overall Study||58
968694|NCT00283049|2343029|P3|COMPLETED|Overall Study||76
968695|NCT00283049|2343030|P2|COMPLETED|Overall Study||83
968696|NCT00283049|2343031|P1|COMPLETED|Overall Study||70
968697|NCT00283049|2343029|P3|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|130
968698|NCT00283049|2343030|P2|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|128
968699|NCT00283049|2343031|P1|STARTED|Overall Study|2 randomized patients did not receive study drug and were not included in the safety population|128
968700|NCT00283062|2343061|P4|NOT COMPLETED|Overall Study||49
968701|NCT00283062|2343062|P3|NOT COMPLETED|Overall Study||41
968702|NCT00283062|2343063|P2|NOT COMPLETED|Overall Study||7
968703|NCT00283062|2343064|P1|NOT COMPLETED|Overall Study||12
968704|NCT00283062|2343061|P4|COMPLETED|Overall Study||13
968705|NCT00283062|2343062|P3|COMPLETED|Overall Study||15
968706|NCT00283062|2343063|P2|COMPLETED|Overall Study||48
968707|NCT00283062|2343064|P1|COMPLETED|Overall Study||43
968708|NCT00283062|2343061|P4|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
968709|NCT00283062|2343062|P3|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||15
968710|NCT00283062|2343063|P2|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
968711|NCT00283062|2343064|P1|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||43
968712|NCT00283062|2343061|P4|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||13
968713|NCT00283062|2343062|P3|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||15
968714|NCT00283062|2343063|P2|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||48
968715|NCT00283062|2343064|P1|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||44
968716|NCT00283062|2343061|P4|ADMINISTERED STUDY TREATMENT|Overall Study||17
968717|NCT00283062|2343062|P3|ADMINISTERED STUDY TREATMENT|Overall Study||20
968718|NCT00283062|2343063|P2|ADMINISTERED STUDY TREATMENT|Overall Study||51
968719|NCT00283062|2343064|P1|ADMINISTERED STUDY TREATMENT|Overall Study||50
968720|NCT00283062|2343061|P4|STARTED|Overall Study||62
968721|NCT00283062|2343062|P3|STARTED|Overall Study||56
968722|NCT00283062|2343063|P2|STARTED|Overall Study||55
968723|NCT00283062|2343064|P1|STARTED|Overall Study||55
968724|NCT00283075|2343094|P2|NOT COMPLETED|Overall Study||0
968725|NCT00283075|2343095|P1|NOT COMPLETED|Overall Study||0
968726|NCT00283075|2343094|P2|COMPLETED|Overall Study||6
968727|NCT00283075|2343095|P1|COMPLETED|Overall Study||25
968728|NCT00283075|2343094|P2|STARTED|Overall Study||6
968729|NCT00283075|2343095|P1|STARTED|Overall Study||25
968730|NCT00283244|2343109|P3|NOT COMPLETED|Overall Study||51
968731|NCT00283244|2343110|P2|NOT COMPLETED|Overall Study||51
968732|NCT00283244|2343111|P1|NOT COMPLETED|Overall Study||18
968733|NCT00283244|2343109|P3|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 9 patients received 2nd line therapy|0
968734|NCT00283244|2343110|P2|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 12 patients received 2nd line therapy|0
968735|NCT00283244|2343111|P1|COMPLETED|Overall Study|19 patients went on to receive second line Erlotinib|26
968736|NCT00283244|2343109|P3|STARTED|Overall Study||51
968737|NCT00283244|2343110|P2|STARTED|Overall Study||51
968738|NCT00283244|2343111|P1|STARTED|Overall Study||44
968739|NCT00283296|2343131|P1|NOT COMPLETED|Overall Study||5
968740|NCT00283296|2343131|P1|COMPLETED|Overall Study|Completed in-lab and in-home trial.|9
968741|NCT00283296|2343131|P1|STARTED|Overall Study||14
968742|NCT00283387|2343137|P2|NOT COMPLETED|Second Intervention||0
968743|NCT00283387|2343138|P1|NOT COMPLETED|Second Intervention||0
968744|NCT00283387|2343137|P2|COMPLETED|Second Intervention||5
968745|NCT00283387|2343138|P1|COMPLETED|Second Intervention||5
968746|NCT00283387|2343137|P2|STARTED|Second Intervention||5
968747|NCT00283387|2343138|P1|STARTED|Second Intervention||5
968748|NCT00283387|2343137|P2|NOT COMPLETED|Washout Period of 2 Months||0
968749|NCT00283387|2343138|P1|NOT COMPLETED|Washout Period of 2 Months||0
968750|NCT00283387|2343137|P2|COMPLETED|Washout Period of 2 Months||5
968751|NCT00283387|2343138|P1|COMPLETED|Washout Period of 2 Months||5
968752|NCT00283387|2343137|P2|STARTED|Washout Period of 2 Months||5
968753|NCT00283387|2343138|P1|STARTED|Washout Period of 2 Months||5
968754|NCT00283387|2343137|P2|NOT COMPLETED|First Intervention||2
968755|NCT00283387|2343138|P1|NOT COMPLETED|First Intervention||1
968756|NCT00283387|2343137|P2|COMPLETED|First Intervention||5
968757|NCT00283387|2343138|P1|COMPLETED|First Intervention||5
968758|NCT00283387|2343137|P2|STARTED|First Intervention||7
968759|NCT00283387|2343138|P1|STARTED|First Intervention||6
968760|NCT00283400|2343148|P4|NOT COMPLETED|Overall Study||0
968761|NCT00283400|2343149|P3|NOT COMPLETED|Overall Study||1
968762|NCT00283400|2343150|P2|NOT COMPLETED|Overall Study||1
968763|NCT00283400|2343151|P1|NOT COMPLETED|Overall Study||2
968764|NCT00283400|2343148|P4|COMPLETED|Overall Study||0
968765|NCT00283400|2343149|P3|COMPLETED|Overall Study||6
968766|NCT00283400|2343150|P2|COMPLETED|Overall Study||19
968767|NCT00283400|2343151|P1|COMPLETED|Overall Study||18
968768|NCT00283400|2343148|P4|STARTED|Overall Study||0
968769|NCT00283400|2343149|P3|STARTED|Overall Study||7
968770|NCT00283400|2343150|P2|STARTED|Overall Study||20
968771|NCT00283400|2343151|P1|STARTED|Overall Study||20
968772|NCT00283439|2343173|P4|NOT COMPLETED|Overall Study||9
968773|NCT00283439|2343174|P3|NOT COMPLETED|Overall Study||11
968774|NCT00283439|2343175|P2|NOT COMPLETED|Overall Study||11
968775|NCT00283439|2343176|P1|NOT COMPLETED|Overall Study||8
968776|NCT00283439|2343173|P4|COMPLETED|Overall Study||0
968777|NCT00283439|2343174|P3|COMPLETED|Overall Study||0
968778|NCT00283439|2343175|P2|COMPLETED|Overall Study||0
968779|NCT00283439|2343176|P1|COMPLETED|Overall Study||0
968780|NCT00283439|2343173|P4|STARTED|Overall Study||9
968781|NCT00283439|2343174|P3|STARTED|Overall Study||11
968782|NCT00283439|2343175|P2|STARTED|Overall Study||11
968783|NCT00283439|2343176|P1|STARTED|Overall Study||8
968784|NCT00283595|2343200|P2|NOT COMPLETED|Overall Study||2
968785|NCT00283595|2343201|P1|NOT COMPLETED|Overall Study||1
968786|NCT00283595|2343200|P2|COMPLETED|Overall Study||9
968787|NCT00283595|2343201|P1|COMPLETED|Overall Study||9
968788|NCT00283595|2343200|P2|STARTED|Overall Study||11
968789|NCT00283595|2343201|P1|STARTED|Overall Study||10
968790|NCT00283686|2343213|P4|NOT COMPLETED|Overall Study||32
968791|NCT00283686|2343214|P3|NOT COMPLETED|Overall Study||33
968792|NCT00283686|2343215|P2|NOT COMPLETED|Overall Study||41
968793|NCT00283686|2343216|P1|NOT COMPLETED|Overall Study||29
968794|NCT00283686|2343213|P4|COMPLETED|Overall Study||109
968795|NCT00283686|2343214|P3|COMPLETED|Overall Study||111
968796|NCT00283686|2343215|P2|COMPLETED|Overall Study||92
968797|NCT00283686|2343216|P1|COMPLETED|Overall Study||111
968798|NCT00283686|2343213|P4|STARTED|Overall Study||141
968799|NCT00283686|2343214|P3|STARTED|Overall Study||144
968800|NCT00283686|2343215|P2|STARTED|Overall Study||133
968801|NCT00283686|2343216|P1|STARTED|Overall Study||140
968802|NCT00283712|2343260|P2|NOT COMPLETED|Overall Study||1
968803|NCT00283712|2343261|P1|NOT COMPLETED|Overall Study||0
968804|NCT00283712|2343260|P2|COMPLETED|Overall Study|One subject in placebo arm died prior to study completion.|9
968805|NCT00283712|2343261|P1|COMPLETED|Overall Study||10
968806|NCT00283712|2343260|P2|Per-Protocol Sample|Overall Study||7
968807|NCT00283712|2343261|P1|Per-Protocol Sample|Overall Study||6
968808|NCT00283712|2343260|P2|Safety Sample|Overall Study||10
968809|NCT00283712|2343261|P1|Safety Sample|Overall Study||10
968810|NCT00283712|2343260|P2|Intent-to-treat Sample|Overall Study||10
968811|NCT00283712|2343261|P1|Intent-to-treat Sample|Overall Study||10
968812|NCT00283712|2343260|P2|STARTED|Overall Study||10
968813|NCT00283712|2343261|P1|STARTED|Overall Study||10
968814|NCT00283816|2343297|P2|NOT COMPLETED|Overall Study||2
968815|NCT00283816|2343298|P1|NOT COMPLETED|Overall Study||2
968816|NCT00283816|2343297|P2|COMPLETED|Overall Study||16
968817|NCT00283816|2343298|P1|COMPLETED|Overall Study||16
968818|NCT00283816|2343297|P2|STARTED|Overall Study||18
968819|NCT00283816|2343298|P1|STARTED|Overall Study||18
968820|NCT00283842|2343315|P5|NOT COMPLETED|Overall Study||15
968821|NCT00283842|2343316|P4|NOT COMPLETED|Overall Study||27
968822|NCT00283842|2343317|P3|NOT COMPLETED|Overall Study||31
968823|NCT00283842|2343318|P2|NOT COMPLETED|Overall Study||18
968824|NCT00283842|2343319|P1|NOT COMPLETED|Overall Study||12
968825|NCT00283842|2343315|P5|COMPLETED|Overall Study||75
968826|NCT00283842|2343316|P4|COMPLETED|Overall Study||42
968827|NCT00283842|2343317|P3|COMPLETED|Overall Study||68
968828|NCT00283842|2343318|P2|COMPLETED|Overall Study||69
968829|NCT00283842|2343319|P1|COMPLETED|Overall Study||51
968830|NCT00283842|2343315|P5|STARTED|Overall Study||90
968831|NCT00283842|2343316|P4|STARTED|Overall Study||69
968832|NCT00283842|2343317|P3|STARTED|Overall Study||99
968833|NCT00283842|2343318|P2|STARTED|Overall Study||87
968834|NCT00283842|2343319|P1|STARTED|Overall Study||63
968835|NCT00283868|2343338|P2|NOT COMPLETED|Overall Study||8
968836|NCT00283868|2343339|P1|NOT COMPLETED|Overall Study||7
968837|NCT00283868|2343338|P2|COMPLETED|Overall Study||103
968838|NCT00283868|2343339|P1|COMPLETED|Overall Study||104
968839|NCT00283868|2343338|P2|STARTED|Overall Study||111
968840|NCT00283868|2343339|P1|STARTED|Overall Study||111
968841|NCT00284050|2343354|P3|NOT COMPLETED|Overall Study||9
968842|NCT00284050|2343355|P2|NOT COMPLETED|Overall Study||5
968843|NCT00284050|2343356|P1|NOT COMPLETED|Overall Study||5
968844|NCT00284050|2343354|P3|COMPLETED|Overall Study||40
968845|NCT00284050|2343355|P2|COMPLETED|Overall Study||46
968846|NCT00284050|2343356|P1|COMPLETED|Overall Study||46
968847|NCT00284050|2343354|P3|STARTED|Overall Study||49
968848|NCT00284050|2343355|P2|STARTED|Overall Study||51
968849|NCT00284050|2343356|P1|STARTED|Overall Study||51
968850|NCT00284089|2343374|P4|NOT COMPLETED|Extension Phase||12
968851|NCT00284089|2343375|P3|NOT COMPLETED|Extension Phase||6
968852|NCT00284089|2343376|P2|NOT COMPLETED|Extension Phase||0
968853|NCT00284089|2343377|P1|NOT COMPLETED|Extension Phase||2
968854|NCT00284089|2343374|P4|COMPLETED|Extension Phase||21
968855|NCT00284089|2343375|P3|COMPLETED|Extension Phase||22
968856|NCT00284089|2343376|P2|COMPLETED|Extension Phase||6
968857|NCT00284089|2343377|P1|COMPLETED|Extension Phase||1
968858|NCT00284089|2343374|P4|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|33
968859|NCT00284089|2343375|P3|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|28
968860|NCT00284089|2343376|P2|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|6
968861|NCT00284089|2343377|P1|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|3
968862|NCT00284089|2343374|P4|NOT COMPLETED|Multiple Dose Phase||4
968863|NCT00284089|2343375|P3|NOT COMPLETED|Multiple Dose Phase||4
968864|NCT00284089|2343376|P2|NOT COMPLETED|Multiple Dose Phase||0
968865|NCT00284089|2343377|P1|NOT COMPLETED|Multiple Dose Phase||1
968866|NCT00284089|2343374|P4|COMPLETED|Multiple Dose Phase||37
968867|NCT00284089|2343375|P3|COMPLETED|Multiple Dose Phase||31
968868|NCT00284089|2343376|P2|COMPLETED|Multiple Dose Phase||6
968869|NCT00284089|2343377|P1|COMPLETED|Multiple Dose Phase||4
968870|NCT00284089|2343374|P4|STARTED|Multiple Dose Phase||41
968871|NCT00284089|2343375|P3|STARTED|Multiple Dose Phase||35
968872|NCT00284089|2343376|P2|STARTED|Multiple Dose Phase||6
968873|NCT00284089|2343377|P1|STARTED|Multiple Dose Phase|1 subject chose to receive other treatment & discontinued before starting the multiple dose phase.|5
968874|NCT00284089|2343374|P4|NOT COMPLETED|Single Dose Phase||0
968875|NCT00284089|2343375|P3|NOT COMPLETED|Single Dose Phase||0
968876|NCT00284089|2343376|P2|NOT COMPLETED|Single Dose Phase||0
968877|NCT00284089|2343377|P1|NOT COMPLETED|Single Dose Phase||0
968878|NCT00284089|2343374|P4|COMPLETED|Single Dose Phase||0
968879|NCT00284089|2343375|P3|COMPLETED|Single Dose Phase||0
968880|NCT00284089|2343376|P2|COMPLETED|Single Dose Phase||6
968881|NCT00284089|2343377|P1|COMPLETED|Single Dose Phase||6
968882|NCT00284089|2343374|P4|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
968883|NCT00284089|2343375|P3|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
968884|NCT00284089|2343376|P2|STARTED|Single Dose Phase||6
968885|NCT00284089|2343377|P1|STARTED|Single Dose Phase||6
968886|NCT00284141|2343403|P1|NOT COMPLETED|Overall Study||98
968887|NCT00284141|2343403|P1|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were still ongoing treatment.|0
968888|NCT00284141|2343403|P1|ONGOING TREATMENT|Overall Study|Participants were still on study treatment at the clinical database cut-off date.|2
968889|NCT00284141|2343403|P1|TREATED|Overall Study|Participants received at least part of one dose of Aflibercept.|96
968890|NCT00284141|2343403|P1|STARTED|Overall Study||98
968891|NCT00284154|2343422|P1|NOT COMPLETED|Overall Study||42
968892|NCT00284154|2343422|P1|COMPLETED|Overall Study||9
968893|NCT00284154|2343422|P1|STARTED|Overall Study||51
968894|NCT00284180|2343431|P2|NOT COMPLETED|Overall Study||4
968895|NCT00284180|2343432|P1|NOT COMPLETED|Overall Study||0
968896|NCT00284180|2343431|P2|COMPLETED|Overall Study||17
968897|NCT00284180|2343432|P1|COMPLETED|Overall Study||11
968898|NCT00284180|2343431|P2|STARTED|Overall Study||21
968899|NCT00284180|2343432|P1|STARTED|Overall Study||11
968900|NCT00274261|2343440|P2|NOT COMPLETED|Overall Study||337
968901|NCT00274261|2343441|P1|NOT COMPLETED|Overall Study||489
968902|NCT00274261|2343440|P2|COMPLETED|Overall Study||296
968903|NCT00274261|2343441|P1|COMPLETED|Overall Study||443
968904|NCT00274261|2343440|P2|STARTED|Overall Study||633
968905|NCT00274261|2343441|P1|STARTED|Overall Study||932
968906|NCT00274287|2343447|P1|NOT COMPLETED|Overall Study||2
968907|NCT00274287|2343447|P1|COMPLETED|Overall Study||13
968908|NCT00274287|2343447|P1|STARTED|Overall Study||15
968909|NCT00274456|2343455|P4|NOT COMPLETED|Overall Study||45
968910|NCT00274456|2343456|P3|NOT COMPLETED|Overall Study||35
968911|NCT00274456|2343457|P2|NOT COMPLETED|Overall Study||27
968912|NCT00274456|2343458|P1|NOT COMPLETED|Overall Study||37
968913|NCT00274456|2343455|P4|COMPLETED|Overall Study|Treatment completed upon progressive disease|29
968914|NCT00274456|2343456|P3|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
968915|NCT00274456|2343457|P2|COMPLETED|Overall Study|Treatment completed upon progressive disease|49
968916|NCT00274456|2343458|P1|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
968917|NCT00274456|2343455|P4|At Least One Response Assessment|Overall Study||70
968918|NCT00274456|2343456|P3|At Least One Response Assessment|Overall Study||73
968919|NCT00274456|2343457|P2|At Least One Response Assessment|Overall Study||76
968920|NCT00274456|2343458|P1|At Least One Response Assessment|Overall Study||73
968921|NCT00274456|2343455|P4|STARTED|Overall Study||74
968922|NCT00274456|2343456|P3|STARTED|Overall Study||74
968923|NCT00274456|2343457|P2|STARTED|Overall Study||76
968924|NCT00274456|2343458|P1|STARTED|Overall Study||76
968925|NCT00274469|2343502|P2|NOT COMPLETED|Overall Study||50
968926|NCT00274469|2343503|P1|NOT COMPLETED|Overall Study||38
968927|NCT00274469|2343502|P2|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|53
968928|NCT00274469|2343503|P1|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|64
968929|NCT00274469|2343502|P2|STARTED|Overall Study|Number of patients randomized|103
968930|NCT00274469|2343503|P1|STARTED|Overall Study|Number of patients randomized|102
968931|NCT00274625|2343519|P2|NOT COMPLETED|Overall Study||62
968932|NCT00274625|2343520|P1|NOT COMPLETED|Overall Study||60
968933|NCT00274625|2343519|P2|COMPLETED|Overall Study||141
968934|NCT00274625|2343520|P1|COMPLETED|Overall Study||139
968935|NCT00274625|2343519|P2|STARTED|Overall Study||203
968936|NCT00274625|2343520|P1|STARTED|Overall Study||199
968937|NCT00274651|2343528|P2|NOT COMPLETED|Overall Study||20
968938|NCT00274651|2343529|P1|NOT COMPLETED|Overall Study||28
968939|NCT00274651|2343528|P2|COMPLETED|Overall Study||4
968940|NCT00274651|2343529|P1|COMPLETED|Overall Study||1
968941|NCT00274651|2343528|P2|STARTED|Overall Study||24
968942|NCT00274651|2343529|P1|STARTED|Overall Study||29
968943|NCT00274716|2343548|P6|NOT COMPLETED|Phase B||1
968944|NCT00274716|2343549|P5|NOT COMPLETED|Phase B||0
968945|NCT00274716|2343550|P4|NOT COMPLETED|Phase B||1
968946|NCT00274716|2343551|P3|NOT COMPLETED|Phase B||3
968947|NCT00274716|2343552|P2|NOT COMPLETED|Phase B||4
968948|NCT00274716|2343553|P1|NOT COMPLETED|Phase B||1
968949|NCT00274716|2343548|P6|COMPLETED|Phase B||14
968950|NCT00274716|2343549|P5|COMPLETED|Phase B||16
968951|NCT00274716|2343550|P4|COMPLETED|Phase B||41
968952|NCT00274716|2343551|P3|COMPLETED|Phase B||41
968953|NCT00274716|2343552|P2|COMPLETED|Phase B||40
968954|NCT00274716|2343553|P1|COMPLETED|Phase B||42
968955|NCT00274716|2343548|P6|STARTED|Phase B||15
968956|NCT00274716|2343549|P5|STARTED|Phase B||16
968957|NCT00274716|2343550|P4|STARTED|Phase B||42
968958|NCT00274716|2343551|P3|STARTED|Phase B||44
968959|NCT00274716|2343552|P2|STARTED|Phase B||44
968960|NCT00274716|2343553|P1|STARTED|Phase B||43
968961|NCT00274716|2343548|P6|NOT COMPLETED|Phase A||4
968962|NCT00274716|2343549|P5|NOT COMPLETED|Phase A||3
968963|NCT00274716|2343550|P4|NOT COMPLETED|Phase A||9
968964|NCT00274716|2343551|P3|NOT COMPLETED|Phase A||8
968965|NCT00274716|2343552|P2|NOT COMPLETED|Phase A||10
968966|NCT00274716|2343553|P1|NOT COMPLETED|Phase A||11
968967|NCT00274716|2343548|P6|COMPLETED|Phase A||15
968968|NCT00274716|2343549|P5|COMPLETED|Phase A||16
968969|NCT00274716|2343550|P4|COMPLETED|Phase A||42
968970|NCT00274716|2343551|P3|COMPLETED|Phase A||44
968971|NCT00274716|2343552|P2|COMPLETED|Phase A||44
968972|NCT00274716|2343553|P1|COMPLETED|Phase A||43
968973|NCT00274716|2343548|P6|STARTED|Phase A||19
968974|NCT00274716|2343549|P5|STARTED|Phase A||19
968975|NCT00274716|2343550|P4|STARTED|Phase A||51
968976|NCT00274716|2343551|P3|STARTED|Phase A||52
968977|NCT00274716|2343552|P2|STARTED|Phase A||54
968978|NCT00274716|2343553|P1|STARTED|Phase A||54
968979|NCT00274742|2343619|P6|NOT COMPLETED|Overall Study||3
968980|NCT00274742|2343620|P5|NOT COMPLETED|Overall Study||16
968981|NCT00274742|2343621|P4|NOT COMPLETED|Overall Study||5
968982|NCT00274742|2343622|P3|NOT COMPLETED|Overall Study||2
968983|NCT00274742|2343623|P2|NOT COMPLETED|Overall Study||8
968984|NCT00274742|2343624|P1|NOT COMPLETED|Overall Study||0
968985|NCT00274742|2343619|P6|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|1
968986|NCT00274742|2343620|P5|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|16
968987|NCT00274742|2343621|P4|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
968988|NCT00274742|2343622|P3|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
968989|NCT00274742|2343623|P2|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|5
968990|NCT00274742|2343624|P1|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|12
968991|NCT00274742|2343619|P6|STARTED|Overall Study||4
968992|NCT00274742|2343620|P5|STARTED|Overall Study||32
968993|NCT00274742|2343621|P4|STARTED|Overall Study||9
968994|NCT00274742|2343622|P3|STARTED|Overall Study||6
968995|NCT00274742|2343623|P2|STARTED|Overall Study||13
968996|NCT00274742|2343624|P1|STARTED|Overall Study||12
968997|NCT00274768|2343656|P1|NOT COMPLETED|Overall Study||0
968998|NCT00274768|2343656|P1|COMPLETED|Overall Study||26
968999|NCT00274768|2343656|P1|STARTED|Overall Study||26
969000|NCT00274781|2343660|P1|NOT COMPLETED|Overall Study||0
969001|NCT00274781|2343660|P1|COMPLETED|Overall Study||30
969002|NCT00274781|2343660|P1|STARTED|Overall Study||30
969003|NCT00274846|2343666|P1|NOT COMPLETED|Overall Study||1
969004|NCT00274846|2343666|P1|COMPLETED|Overall Study|Evaluable patients - received adequate natural killer (NK) cells|20
969005|NCT00274846|2343666|P1|STARTED|Overall Study||21
969006|NCT00274924|2343677|P3|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
969007|NCT00274924|2343678|P2|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||18
969008|NCT00274924|2343679|P1|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||7
969009|NCT00274924|2343677|P3|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
969010|NCT00274924|2343678|P2|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||58
969011|NCT00274924|2343679|P1|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||10
969012|NCT00274924|2343677|P3|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||0
969013|NCT00274924|2343678|P2|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||61
969014|NCT00274924|2343679|P1|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||13
969015|NCT00274924|2343677|P3|STARTED|Step 2 (Tx Based on Mid-treatment PET)||0
969016|NCT00274924|2343678|P2|STARTED|Step 2 (Tx Based on Mid-treatment PET)|One patient withdrew from the study after step 1 treatment.|76
969017|NCT00274924|2343679|P1|STARTED|Step 2 (Tx Based on Mid-treatment PET)|All patients who started step 2 therapy were included regardless of eligibility.|17
969018|NCT00274924|2343677|P3|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||6
969019|NCT00274924|2343678|P2|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||14
969020|NCT00274924|2343679|P1|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||4
969021|NCT00274924|2343677|P3|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||0
969022|NCT00274924|2343678|P2|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||63
969023|NCT00274924|2343679|P1|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||13
969024|NCT00274924|2343677|P3|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||4
969025|NCT00274924|2343678|P2|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||63
969026|NCT00274924|2343679|P1|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||13
969027|NCT00274924|2343677|P3|Treated|Step 1 (R-CHOP X 3 Cycles)||5
969028|NCT00274924|2343678|P2|Treated|Step 1 (R-CHOP X 3 Cycles)||77
969029|NCT00274924|2343679|P1|Treated|Step 1 (R-CHOP X 3 Cycles)||17
969030|NCT00274924|2343677|P3|STARTED|Step 1 (R-CHOP X 3 Cycles)||6
969031|NCT00274924|2343678|P2|STARTED|Step 1 (R-CHOP X 3 Cycles)||77
969032|NCT00274924|2343679|P1|STARTED|Step 1 (R-CHOP X 3 Cycles)||17
969033|NCT00274937|2343688|P1|NOT COMPLETED|Overall Study||20
969034|NCT00274937|2343688|P1|COMPLETED|Overall Study||91
969035|NCT00274937|2343688|P1|STARTED|Overall Study||111
969036|NCT00275002|2343697|P2|NOT COMPLETED|Overall Study||16
969037|NCT00275002|2343698|P1|NOT COMPLETED|Overall Study||22
969038|NCT00275002|2343697|P2|COMPLETED|Overall Study||0
969039|NCT00275002|2343698|P1|COMPLETED|Overall Study||3
969040|NCT00275002|2343697|P2|STARTED|Overall Study||16
969041|NCT00275002|2343698|P1|STARTED|Overall Study||25
969042|NCT00275028|2343706|P1|NOT COMPLETED|Overall Study||47
969043|NCT00275028|2343706|P1|COMPLETED|Overall Study|Participants are treated until one of the below milestones is reached. Completion is N/A.|0
969044|NCT00275028|2343706|P1|STARTED|Overall Study||47
969045|NCT00275262|2343713|P2|NOT COMPLETED|Overall Study||9
969046|NCT00275262|2343714|P1|NOT COMPLETED|Overall Study||6
969047|NCT00275262|2343713|P2|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|4
969048|NCT00275262|2343714|P1|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|6
969049|NCT00275262|2343713|P2|STARTED|Overall Study||13
969050|NCT00275262|2343714|P1|STARTED|Overall Study||12
969051|NCT00275275|2343731|P3|NOT COMPLETED|Overall Study||6
969052|NCT00275275|2343732|P2|NOT COMPLETED|Overall Study||2
969053|NCT00275275|2343733|P1|NOT COMPLETED|Overall Study||6
969054|NCT00275275|2343731|P3|COMPLETED|Overall Study||15
969055|NCT00275275|2343732|P2|COMPLETED|Overall Study||18
969056|NCT00275275|2343733|P1|COMPLETED|Overall Study||14
969057|NCT00275275|2343731|P3|STARTED|Overall Study|One participant was removed after enrollment and before any data was collected for him.|21
969058|NCT00275275|2343732|P2|STARTED|Overall Study||20
969059|NCT00275275|2343733|P1|STARTED|Overall Study||20
969060|NCT00275301|2343741|P1|NOT COMPLETED|Overall Study||5
969061|NCT00275301|2343741|P1|COMPLETED|Overall Study||14
969062|NCT00275301|2343741|P1|STARTED|Overall Study||19
969063|NCT00275340|2343747|P2|NOT COMPLETED|Overall Study||4
969064|NCT00275340|2343748|P1|NOT COMPLETED|Overall Study||2
969065|NCT00275340|2343747|P2|COMPLETED|Overall Study||45
969066|NCT00275340|2343748|P1|COMPLETED|Overall Study||50
969067|NCT00275340|2343747|P2|STARTED|Overall Study||49
969068|NCT00275340|2343748|P1|STARTED|Overall Study||52
969069|NCT00275392|2343754|P2|NOT COMPLETED|Overall Study||2
969070|NCT00275392|2343755|P1|NOT COMPLETED|Overall Study||0
969071|NCT00275392|2343754|P2|COMPLETED|Overall Study||17
969072|NCT00275392|2343755|P1|COMPLETED|Overall Study||20
969073|NCT00275392|2343754|P2|STARTED|Overall Study||19
969074|NCT00275392|2343755|P1|STARTED|Overall Study||20
969075|NCT00275561|2343765|P2|NOT COMPLETED|Overall Study||6
969076|NCT00275561|2343766|P1|NOT COMPLETED|Overall Study||2
969077|NCT00275561|2343765|P2|COMPLETED|Overall Study||15
969078|NCT00275561|2343766|P1|COMPLETED|Overall Study||19
969079|NCT00275561|2343765|P2|STARTED|Overall Study||21
969080|NCT00275561|2343766|P1|STARTED|Overall Study||21
969081|NCT00284518|2343780|P4|NOT COMPLETED|Overall Study||33
969082|NCT00284518|2343781|P3|NOT COMPLETED|Overall Study||28
969083|NCT00284518|2343782|P2|NOT COMPLETED|Overall Study||28
969084|NCT00284518|2343783|P1|NOT COMPLETED|Overall Study||26
969085|NCT00284518|2343780|P4|COMPLETED|Overall Study||61
969086|NCT00284518|2343781|P3|COMPLETED|Overall Study||67
969087|NCT00284518|2343782|P2|COMPLETED|Overall Study||66
969088|NCT00284518|2343783|P1|COMPLETED|Overall Study||71
969089|NCT00284518|2343780|P4|STARTED|Overall Study||94
969090|NCT00284518|2343781|P3|STARTED|Overall Study||95
969091|NCT00284518|2343782|P2|STARTED|Overall Study||94
969092|NCT00284518|2343783|P1|STARTED|Overall Study||97
969093|NCT00284557|2343823|P2|NOT COMPLETED|Overall Study||13
969094|NCT00284557|2343824|P1|NOT COMPLETED|Overall Study||9
969095|NCT00284557|2343823|P2|COMPLETED|Overall Study||50
969096|NCT00284557|2343824|P1|COMPLETED|Overall Study||58
969097|NCT00284557|2343823|P2|STARTED|Overall Study||63
969098|NCT00284557|2343824|P1|STARTED|Overall Study||67
969099|NCT00285207|2343834|P2|NOT COMPLETED|Overall Study||6
969100|NCT00285207|2343835|P1|NOT COMPLETED|Overall Study||9
969101|NCT00285207|2343834|P2|COMPLETED|Overall Study||71
969102|NCT00285207|2343835|P1|COMPLETED|Overall Study||61
969103|NCT00285207|2343834|P2|Treated|Overall Study||75
969104|NCT00285207|2343835|P1|Treated|Overall Study||63
969105|NCT00285207|2343834|P2|STARTED|Overall Study||77
969106|NCT00285207|2343835|P1|STARTED|Overall Study||70
969107|NCT00285246|2343841|P1|NOT COMPLETED|Overall Study||48
969108|NCT00285246|2343841|P1|COMPLETED|Overall Study|Number of participants who were eligible and completed at least one phase of data collection|790
969109|NCT00285246|2343841|P1|STARTED|Overall Study||838
969110|NCT00285467|2343850|P2|NOT COMPLETED|Overall Study||0
969111|NCT00285467|2343851|P1|NOT COMPLETED|Overall Study||0
969112|NCT00285467|2343850|P2|COMPLETED|Overall Study||22
969113|NCT00285467|2343851|P1|COMPLETED|Overall Study||25
969114|NCT00285467|2343850|P2|STARTED|Overall Study||22
969115|NCT00285467|2343851|P1|STARTED|Overall Study||25
969116|NCT00285584|2343861|P2|NOT COMPLETED|Month 9||3
969117|NCT00285584|2343862|P1|NOT COMPLETED|Month 9||1
969118|NCT00285584|2343861|P2|COMPLETED|Month 9||14
969119|NCT00285584|2343862|P1|COMPLETED|Month 9||15
969120|NCT00285584|2343861|P2|STARTED|Month 9||17
969121|NCT00285584|2343862|P1|STARTED|Month 9||16
969122|NCT00285584|2343861|P2|NOT COMPLETED|Month 6||1
969123|NCT00285584|2343862|P1|NOT COMPLETED|Month 6||0
969124|NCT00285584|2343861|P2|COMPLETED|Month 6||17
969125|NCT00285584|2343862|P1|COMPLETED|Month 6||16
969126|NCT00285584|2343861|P2|STARTED|Month 6||18
969127|NCT00285584|2343862|P1|STARTED|Month 6||16
969128|NCT00285584|2343861|P2|NOT COMPLETED|Month 3||3
969129|NCT00285584|2343862|P1|NOT COMPLETED|Month 3||4
969130|NCT00285584|2343861|P2|COMPLETED|Month 3||18
969131|NCT00285584|2343862|P1|COMPLETED|Month 3||16
969132|NCT00285584|2343861|P2|STARTED|Month 3||21
969133|NCT00285584|2343862|P1|STARTED|Month 3||20
969134|NCT00285584|2343861|P2|NOT COMPLETED|Enrollment (Month 0)||0
969135|NCT00285584|2343862|P1|NOT COMPLETED|Enrollment (Month 0)||0
969136|NCT00285584|2343861|P2|COMPLETED|Enrollment (Month 0)||21
969137|NCT00285584|2343862|P1|COMPLETED|Enrollment (Month 0)||20
969138|NCT00285584|2343861|P2|STARTED|Enrollment (Month 0)||21
969139|NCT00285584|2343862|P1|STARTED|Enrollment (Month 0)||20
969140|NCT00285649|2343877|P3|NOT COMPLETED|Overall Study||6
969141|NCT00285649|2343878|P2|NOT COMPLETED|Overall Study||6
969142|NCT00285649|2343879|P1|NOT COMPLETED|Overall Study||9
969143|NCT00285649|2343877|P3|COMPLETED|Overall Study||42
969144|NCT00285649|2343878|P2|COMPLETED|Overall Study||66
969145|NCT00285649|2343879|P1|COMPLETED|Overall Study||63
969146|NCT00285649|2343877|P3|STARTED|Overall Study||48
969147|NCT00285649|2343878|P2|STARTED|Overall Study||72
969148|NCT00285649|2343879|P1|STARTED|Overall Study||72
969149|NCT00285779|2343889|P2|NOT COMPLETED|Follow-up Period (wk 24-32)||0
969150|NCT00285779|2343890|P1|NOT COMPLETED|Follow-up Period (wk 24-32)||1
969151|NCT00285779|2343889|P2|COMPLETED|Follow-up Period (wk 24-32)||10
969152|NCT00285779|2343890|P1|COMPLETED|Follow-up Period (wk 24-32)||8
969153|NCT00285779|2343889|P2|STARTED|Follow-up Period (wk 24-32)||10
969154|NCT00285779|2343890|P1|STARTED|Follow-up Period (wk 24-32)||9
969155|NCT00285779|2343889|P2|NOT COMPLETED|Open Label Period (wk 12-24)||2
969156|NCT00285779|2343890|P1|NOT COMPLETED|Open Label Period (wk 12-24)||2
969157|NCT00285779|2343889|P2|COMPLETED|Open Label Period (wk 12-24)||10
969158|NCT00285779|2343890|P1|COMPLETED|Open Label Period (wk 12-24)||9
969159|NCT00285779|2343889|P2|STARTED|Open Label Period (wk 12-24)||12
969160|NCT00285779|2343890|P1|STARTED|Open Label Period (wk 12-24)||11
969161|NCT00285779|2343889|P2|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||1
969162|NCT00285779|2343890|P1|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||3
969163|NCT00285779|2343889|P2|COMPLETED|Placebo-controlled Period (wk 1-12)||12
969164|NCT00285779|2343890|P1|COMPLETED|Placebo-controlled Period (wk 1-12)||11
969165|NCT00285779|2343889|P2|STARTED|Placebo-controlled Period (wk 1-12)||13
969166|NCT00285779|2343890|P1|STARTED|Placebo-controlled Period (wk 1-12)||14
969167|NCT00285818|2343898|P2|NOT COMPLETED|Overall Study||2
969168|NCT00285818|2343899|P1|NOT COMPLETED|Overall Study||4
969169|NCT00285818|2343898|P2|COMPLETED|Overall Study||3
969170|NCT00285818|2343899|P1|COMPLETED|Overall Study||2
969171|NCT00285818|2343898|P2|STARTED|Overall Study||5
969172|NCT00285818|2343899|P1|STARTED|Overall Study||6
969173|NCT00285857|2343905|P1|NOT COMPLETED|Overall Study||4
969174|NCT00285857|2343905|P1|COMPLETED|Overall Study||26
969175|NCT00285857|2343905|P1|STARTED|Overall Study||30
969176|NCT00286078|2343918|P2|NOT COMPLETED|Overall Study||34
969177|NCT00286078|2343919|P1|NOT COMPLETED|Overall Study||32
969178|NCT00286078|2343918|P2|COMPLETED|Overall Study||34
969179|NCT00286078|2343919|P1|COMPLETED|Overall Study||40
969180|NCT00286078|2343918|P2|12 Weeks|Overall Study||62
969181|NCT00286078|2343919|P1|12 Weeks|Overall Study||63
969182|NCT00286078|2343918|P2|STARTED|Overall Study||68
969183|NCT00286078|2343919|P1|STARTED|Overall Study||72
969184|NCT00286091|2343929|P2|NOT COMPLETED|Open-label Treatment Phase||71
969185|NCT00286091|2343930|P1|NOT COMPLETED|Open-label Treatment Phase||77
969186|NCT00286091|2343929|P2|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
969187|NCT00286091|2343930|P1|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
969188|NCT00286091|2343929|P2|Received Treatment|Open-label Treatment Phase||101
969189|NCT00286091|2343930|P1|Received Treatment|Open-label Treatment Phase||109
969190|NCT00286091|2343929|P2|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|104
969191|NCT00286091|2343930|P1|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|110
969192|NCT00286091|2343929|P2|NOT COMPLETED|Double-blind Treatment Phase||593
969193|NCT00286091|2343930|P1|NOT COMPLETED|Double-blind Treatment Phase||584
969194|NCT00286091|2343929|P2|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|123
969195|NCT00286091|2343930|P1|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|132
969196|NCT00286091|2343929|P2|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|174
969197|NCT00286091|2343930|P1|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|164
969198|NCT00286091|2343929|P2|Received Treatment|Double-blind Treatment Phase||716
969294|NCT00286754|2344800|P1|COMPLETED|Overall Study||156
969199|NCT00286091|2343930|P1|Received Treatment|Double-blind Treatment Phase|4 participants received ≥ 1 dose of denosumab in error|709
969200|NCT00286091|2343929|P2|STARTED|Double-blind Treatment Phase||716
969201|NCT00286091|2343930|P1|STARTED|Double-blind Treatment Phase||716
969202|NCT00286156|2343945|P3|NOT COMPLETED|Overall Study||1
969203|NCT00286156|2343946|P2|NOT COMPLETED|Overall Study||1
969204|NCT00286156|2343947|P1|NOT COMPLETED|Overall Study||2
969205|NCT00286156|2343945|P3|COMPLETED|Overall Study||9
969206|NCT00286156|2343946|P2|COMPLETED|Overall Study||9
969207|NCT00286156|2343947|P1|COMPLETED|Overall Study||8
969208|NCT00286156|2343945|P3|STARTED|Overall Study||10
969209|NCT00286156|2343946|P2|STARTED|Overall Study||10
969210|NCT00286156|2343947|P1|STARTED|Overall Study||10
969211|NCT00286182|2343960|P2|NOT COMPLETED|Overall Study||3
969212|NCT00286182|2343961|P1|NOT COMPLETED|Overall Study||5
969213|NCT00286182|2343960|P2|COMPLETED|Overall Study||25
969214|NCT00286182|2343961|P1|COMPLETED|Overall Study||23
969215|NCT00286182|2343960|P2|STARTED|Overall Study||28
969216|NCT00286182|2343961|P1|STARTED|Overall Study||28
969217|NCT00286221|2343971|P4|NOT COMPLETED|Overall Study||6
969218|NCT00286221|2343972|P3|NOT COMPLETED|Overall Study||9
969219|NCT00286221|2343973|P2|NOT COMPLETED|Overall Study||5
969220|NCT00286221|2343974|P1|NOT COMPLETED|Overall Study||10
969221|NCT00286221|2343971|P4|COMPLETED|Overall Study||34
969222|NCT00286221|2343972|P3|COMPLETED|Overall Study||31
969223|NCT00286221|2343973|P2|COMPLETED|Overall Study||35
969224|NCT00286221|2343974|P1|COMPLETED|Overall Study||29
969225|NCT00286221|2343971|P4|STARTED|Overall Study||40
969226|NCT00286221|2343972|P3|STARTED|Overall Study||40
969227|NCT00286221|2343973|P2|STARTED|Overall Study||40
969228|NCT00286221|2343974|P1|STARTED|Overall Study||39
969229|NCT00286325|2343988|P1|NOT COMPLETED|Overall Study||0
969230|NCT00286325|2343988|P1|COMPLETED|Overall Study||8
969231|NCT00286325|2343988|P1|STARTED|Overall Study||8
969232|NCT00286429|2343999|P3|NOT COMPLETED|Overall Study||52
969233|NCT00286429|2344000|P2|NOT COMPLETED|Overall Study||48
969234|NCT00286429|2344001|P1|NOT COMPLETED|Overall Study||75
969235|NCT00286429|2343999|P3|COMPLETED|Overall Study||77
969236|NCT00286429|2344000|P2|COMPLETED|Overall Study||83
969237|NCT00286429|2344001|P1|COMPLETED|Overall Study||55
969238|NCT00286429|2343999|P3|STARTED|Overall Study||129
969239|NCT00286429|2344000|P2|STARTED|Overall Study||131
969240|NCT00286429|2344001|P1|STARTED|Overall Study||130
969241|NCT00286442|2344108|P3|NOT COMPLETED|Overall Study||32
969242|NCT00286442|2344109|P2|NOT COMPLETED|Overall Study||45
969243|NCT00286442|2344110|P1|NOT COMPLETED|Overall Study||37
969244|NCT00286442|2344108|P3|COMPLETED|Overall Study||72
969245|NCT00286442|2344109|P2|COMPLETED|Overall Study||165
969246|NCT00286442|2344110|P1|COMPLETED|Overall Study||176
969247|NCT00286442|2344108|P3|STARTED|Overall Study||104
969248|NCT00286442|2344109|P2|STARTED|Overall Study||210
969249|NCT00286442|2344110|P1|STARTED|Overall Study||213
969250|NCT00286455|2344271|P3|NOT COMPLETED|Overall Study||24
969251|NCT00286455|2344272|P2|NOT COMPLETED|Overall Study||28
969252|NCT00286455|2344273|P1|NOT COMPLETED|Overall Study||25
969253|NCT00286455|2344271|P3|COMPLETED|Overall Study||107
969254|NCT00286455|2344272|P2|COMPLETED|Overall Study||105
969255|NCT00286455|2344273|P1|COMPLETED|Overall Study||40
969256|NCT00286455|2344271|P3|STARTED|Overall Study||131
969257|NCT00286455|2344272|P2|STARTED|Overall Study||133
969258|NCT00286455|2344273|P1|STARTED|Overall Study||65
969259|NCT00286468|2344452|P3|NOT COMPLETED|Overall Study||50
969260|NCT00286468|2344453|P2|NOT COMPLETED|Overall Study||50
969261|NCT00286468|2344454|P1|NOT COMPLETED|Overall Study||37
969262|NCT00286468|2344452|P3|COMPLETED|Overall Study||148
969263|NCT00286468|2344453|P2|COMPLETED|Overall Study||153
969264|NCT00286468|2344454|P1|COMPLETED|Overall Study||62
969265|NCT00286468|2344452|P3|STARTED|Overall Study||198
969266|NCT00286468|2344453|P2|STARTED|Overall Study||203
969267|NCT00286468|2344454|P1|STARTED|Overall Study||99
969268|NCT00286494|2344615|P3|NOT COMPLETED|Overall Study||39
969269|NCT00286494|2344616|P2|NOT COMPLETED|Overall Study||44
969270|NCT00286494|2344617|P1|NOT COMPLETED|Overall Study||26
969271|NCT00286494|2344615|P3|COMPLETED|Overall Study||160
969272|NCT00286494|2344616|P2|COMPLETED|Overall Study||153
969273|NCT00286494|2344617|P1|COMPLETED|Overall Study||71
969274|NCT00286494|2344615|P3|STARTED|Overall Study||199
969275|NCT00286494|2344616|P2|STARTED|Overall Study||197
969276|NCT00286494|2344617|P1|STARTED|Overall Study||97
969277|NCT00286728|2344777|P2|NOT COMPLETED|Overall Study||29
969278|NCT00286728|2344778|P1|NOT COMPLETED|Overall Study||36
969279|NCT00286728|2344777|P2|COMPLETED|Overall Study||116
969280|NCT00286728|2344778|P1|COMPLETED|Overall Study||106
969281|NCT00286728|2344777|P2|STARTED|Overall Study||145
969282|NCT00286728|2344778|P1|STARTED|Overall Study||142
969283|NCT00286741|2344786|P2|NOT COMPLETED|Overall Study||17
969284|NCT00286741|2344787|P1|NOT COMPLETED|Overall Study||11
969285|NCT00286741|2344786|P2|COMPLETED|Overall Study||89
969286|NCT00286741|2344787|P1|COMPLETED|Overall Study||122
969287|NCT00286741|2344786|P2|STARTED|Overall Study||106
969288|NCT00286741|2344787|P1|STARTED|Overall Study||133
969289|NCT00286754|2344798|P3|NOT COMPLETED|Overall Study||10
969290|NCT00286754|2344799|P2|NOT COMPLETED|Overall Study||18
969291|NCT00286754|2344800|P1|NOT COMPLETED|Overall Study||20
969292|NCT00286754|2344798|P3|COMPLETED|Overall Study||170
969293|NCT00286754|2344799|P2|COMPLETED|Overall Study||159
969295|NCT00286754|2344798|P3|STARTED|Overall Study||180
969296|NCT00286754|2344799|P2|STARTED|Overall Study||177
969297|NCT00286754|2344800|P1|STARTED|Overall Study||176
969298|NCT00286949|2344832|P1|NOT COMPLETED|Overall Study||0
969299|NCT00286949|2344832|P1|COMPLETED|Overall Study||12
969300|NCT00286949|2344832|P1|STARTED|Overall Study||12
969301|NCT00287053|2344840|P2|NOT COMPLETED|Overall Study||1
969302|NCT00287053|2344841|P1|NOT COMPLETED|Overall Study||4
969303|NCT00287053|2344840|P2|COMPLETED|Overall Study||26
969304|NCT00287053|2344841|P1|COMPLETED|Overall Study||26
969305|NCT00287053|2344840|P2|STARTED|Overall Study||27
969306|NCT00287053|2344841|P1|STARTED|Overall Study||30
969307|NCT00287079|2344849|P2|NOT COMPLETED|Overall Study||1
969308|NCT00287079|2344850|P1|NOT COMPLETED|Overall Study||22
969309|NCT00287079|2344849|P2|COMPLETED|Overall Study||2
969310|NCT00287079|2344850|P1|COMPLETED|Overall Study||10
969311|NCT00287079|2344849|P2|STARTED|Overall Study||3
969312|NCT00287079|2344850|P1|STARTED|Overall Study||32
969313|NCT00287222|2344860|P1|NOT COMPLETED|Overall Study||0
969314|NCT00287222|2344860|P1|COMPLETED|Overall Study||21
969315|NCT00287222|2344860|P1|STARTED|Overall Study||21
969316|NCT00287339|2344866|P2|NOT COMPLETED|Overall Study||0
969317|NCT00287339|2344867|P1|NOT COMPLETED|Overall Study||0
969318|NCT00287339|2344866|P2|COMPLETED|Overall Study||18
969319|NCT00287339|2344867|P1|COMPLETED|Overall Study||22
969320|NCT00287339|2344866|P2|STARTED|Overall Study||18
969321|NCT00287339|2344867|P1|STARTED|Overall Study||22
969325|NCT00287586|2344882|P2|NOT COMPLETED|Overall Study||52
969326|NCT00287586|2344883|P1|NOT COMPLETED|Overall Study||45
969327|NCT00287586|2344882|P2|COMPLETED|Overall Study||100
969328|NCT00287586|2344883|P1|COMPLETED|Overall Study||111
969329|NCT00287586|2344882|P2|Intent-to-treat: Received Study Drug|Overall Study||151
969330|NCT00287586|2344883|P1|Intent-to-treat: Received Study Drug|Overall Study||155
969331|NCT00287586|2344882|P2|STARTED|Overall Study||152
969332|NCT00287586|2344883|P1|STARTED|Overall Study||156
969333|NCT00279591|2344921|P2|NOT COMPLETED|Overall Study||0
969334|NCT00279591|2344922|P1|NOT COMPLETED|Overall Study||0
969335|NCT00279591|2344921|P2|COMPLETED|Overall Study||46
969336|NCT00279591|2344922|P1|COMPLETED|Overall Study||48
969337|NCT00279591|2344921|P2|STARTED|Overall Study||46
969338|NCT00279591|2344922|P1|STARTED|Overall Study||48
969339|NCT00279708|2344938|P2|NOT COMPLETED|Overall Study||4
969340|NCT00279708|2344939|P1|NOT COMPLETED|Overall Study||3
969341|NCT00279708|2344938|P2|COMPLETED|Overall Study||24
969342|NCT00279708|2344939|P1|COMPLETED|Overall Study||24
969343|NCT00279708|2344938|P2|STARTED|Overall Study||28
969344|NCT00279708|2344939|P1|STARTED|Overall Study|"Started meaning randomized"|27
969345|NCT00279916|2344947|P2|NOT COMPLETED|Overall Study||5
969346|NCT00279916|2344948|P1|NOT COMPLETED|Overall Study||7
969347|NCT00279916|2344947|P2|COMPLETED|Overall Study||41
969348|NCT00279916|2344948|P1|COMPLETED|Overall Study||38
969349|NCT00279916|2344947|P2|STARTED|Overall Study||46
969350|NCT00279916|2344948|P1|STARTED|Overall Study||45
969351|NCT00279955|2344971|P3|NOT COMPLETED|Overall Study||0
969352|NCT00279955|2344972|P2|NOT COMPLETED|Overall Study||0
969353|NCT00279955|2344973|P1|NOT COMPLETED|Overall Study||0
969354|NCT00279955|2344971|P3|COMPLETED|Overall Study|They are still counted as completes, though they are never used for the analyses of objectives.|358
969355|NCT00279955|2344972|P2|COMPLETED|Overall Study||486
969356|NCT00279955|2344973|P1|COMPLETED|Overall Study||157
969357|NCT00279955|2344971|P3|STARTED|Overall Study||358
969358|NCT00279955|2344972|P2|STARTED|Overall Study||486
969359|NCT00279955|2344973|P1|STARTED|Overall Study||157
969360|NCT00280059|2344986|P2|NOT COMPLETED|Extension Phase||38
969361|NCT00280059|2344987|P1|NOT COMPLETED|Extension Phase||49
969362|NCT00280059|2344986|P2|COMPLETED|Extension Phase||177
969363|NCT00280059|2344987|P1|COMPLETED|Extension Phase||145
969364|NCT00280059|2344986|P2|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|215
969365|NCT00280059|2344987|P1|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|194
969366|NCT00280059|2344986|P2|NOT COMPLETED|Efficacy Assessment Phase||80
969367|NCT00280059|2344987|P1|NOT COMPLETED|Efficacy Assessment Phase||94
969368|NCT00280059|2344986|P2|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|250
969369|NCT00280059|2344987|P1|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|236
969370|NCT00280059|2344986|P2|STARTED|Efficacy Assessment Phase||330
969371|NCT00280059|2344987|P1|STARTED|Efficacy Assessment Phase||330
969372|NCT00280150|2345037|P4|NOT COMPLETED|Overall Study||10
969373|NCT00280150|2345038|P3|NOT COMPLETED|Overall Study||5
969374|NCT00280150|2345039|P2|NOT COMPLETED|Overall Study||1
969375|NCT00280150|2345040|P1|NOT COMPLETED|Overall Study||3
969376|NCT00280150|2345037|P4|COMPLETED|Overall Study||20
969377|NCT00280150|2345038|P3|COMPLETED|Overall Study||1
969378|NCT00280150|2345039|P2|COMPLETED|Overall Study||4
969379|NCT00280150|2345040|P1|COMPLETED|Overall Study||2
969380|NCT00280150|2345037|P4|Consolidation Therapy|Overall Study|Phase II participants did not receive consolidation therapy.|0
969381|NCT00280150|2345038|P3|Consolidation Therapy|Overall Study||3
969382|NCT00280150|2345039|P2|Consolidation Therapy|Overall Study||5
969383|NCT00280150|2345040|P1|Consolidation Therapy|Overall Study||2
969384|NCT00280150|2345037|P4|Cohort Induction|Overall Study||30
969385|NCT00280150|2345038|P3|Cohort Induction|Overall Study||6
969386|NCT00280150|2345039|P2|Cohort Induction|Overall Study||5
969387|NCT00280150|2345040|P1|Cohort Induction|Overall Study||5
969388|NCT00280150|2345037|P4|STARTED|Overall Study||30
969389|NCT00280150|2345038|P3|STARTED|Overall Study||6
969390|NCT00280150|2345039|P2|STARTED|Overall Study||5
969391|NCT00280150|2345040|P1|STARTED|Overall Study||5
969392|NCT00280241|2345053|P1|NOT COMPLETED|Overall Study||10
969393|NCT00280241|2345053|P1|COMPLETED|Overall Study||55
969394|NCT00280241|2345053|P1|STARTED|Overall Study||65
969395|NCT00280293|2345062|P2|NOT COMPLETED|Overall Study||23
969396|NCT00280293|2345063|P1|NOT COMPLETED|Overall Study||26
969397|NCT00280293|2345062|P2|COMPLETED|Overall Study||34
969398|NCT00280293|2345063|P1|COMPLETED|Overall Study||29
969399|NCT00280293|2345062|P2|STARTED|Overall Study||57
969400|NCT00280293|2345063|P1|STARTED|Overall Study||55
969401|NCT00280384|2345083|P8|NOT COMPLETED|Overall Study||0
969402|NCT00280384|2345084|P7|NOT COMPLETED|Overall Study||0
969403|NCT00280384|2345085|P6|NOT COMPLETED|Overall Study||0
969404|NCT00280384|2345086|P5|NOT COMPLETED|Overall Study||0
969405|NCT00280384|2345087|P4|NOT COMPLETED|Overall Study||0
969406|NCT00280384|2345088|P3|NOT COMPLETED|Overall Study||0
969407|NCT00280384|2345089|P2|NOT COMPLETED|Overall Study||0
969408|NCT00280384|2345090|P1|NOT COMPLETED|Overall Study||0
969409|NCT00280384|2345083|P8|COMPLETED|Overall Study||6
969410|NCT00280384|2345084|P7|COMPLETED|Overall Study||6
969411|NCT00280384|2345085|P6|COMPLETED|Overall Study||6
969412|NCT00280384|2345086|P5|COMPLETED|Overall Study||6
969413|NCT00280384|2345087|P4|COMPLETED|Overall Study||6
969414|NCT00280384|2345088|P3|COMPLETED|Overall Study||6
969415|NCT00280384|2345089|P2|COMPLETED|Overall Study||6
969416|NCT00280384|2345090|P1|COMPLETED|Overall Study||6
969417|NCT00280384|2345083|P8|STARTED|Overall Study||6
969418|NCT00280384|2345084|P7|STARTED|Overall Study||6
969419|NCT00280384|2345085|P6|STARTED|Overall Study||6
969420|NCT00280384|2345086|P5|STARTED|Overall Study||6
969421|NCT00280384|2345087|P4|STARTED|Overall Study||6
969422|NCT00280384|2345088|P3|STARTED|Overall Study||6
969423|NCT00280384|2345089|P2|STARTED|Overall Study||6
969424|NCT00280384|2345090|P1|STARTED|Overall Study||6
969425|NCT00280397|2345132|P1|NOT COMPLETED|Overall Study||1
969426|NCT00280397|2345132|P1|COMPLETED|Overall Study||26
969427|NCT00280397|2345132|P1|STARTED|Overall Study||27
969428|NCT00280566|2345141|P3|NOT COMPLETED|Period 2 Double Blind||57
969429|NCT00280566|2345142|P2|NOT COMPLETED|Period 2 Double Blind||43
969430|NCT00280566|2345143|P1|NOT COMPLETED|Period 2 Double Blind||0
969431|NCT00280566|2345141|P3|COMPLETED|Period 2 Double Blind||54
969432|NCT00280566|2345142|P2|COMPLETED|Period 2 Double Blind||84
969433|NCT00280566|2345143|P1|COMPLETED|Period 2 Double Blind||0
969434|NCT00280566|2345141|P3|STARTED|Period 2 Double Blind||111
969435|NCT00280566|2345142|P2|STARTED|Period 2 Double Blind||127
969436|NCT00280566|2345143|P1|STARTED|Period 2 Double Blind|1 subject in Period 1 did not want to be randomized into Period 2|0
969437|NCT00280566|2345141|P3|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
969438|NCT00280566|2345142|P2|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
969439|NCT00280566|2345143|P1|NOT COMPLETED|Period 1 Open Label Ziprasidone||343
969440|NCT00280566|2345141|P3|COMPLETED|Period 1 Open Label Ziprasidone||0
969441|NCT00280566|2345142|P2|COMPLETED|Period 1 Open Label Ziprasidone||0
969442|NCT00280566|2345143|P1|COMPLETED|Period 1 Open Label Ziprasidone|Subject excluded as described above is counted as 2; enrolled in 2 sites (2 identification numbers)|241
969443|NCT00280566|2345141|P3|STARTED|Period 1 Open Label Ziprasidone||0
969444|NCT00280566|2345142|P2|STARTED|Period 1 Open Label Ziprasidone||0
969445|NCT00280566|2345143|P1|STARTED|Period 1 Open Label Ziprasidone|1 subject inappropriately randomized into 2 different sites. Data from this subject was excluded.|584
969446|NCT00280683|2345170|P2|NOT COMPLETED|Overall Study||3
969447|NCT00280683|2345171|P1|NOT COMPLETED|Overall Study||2
969448|NCT00280683|2345170|P2|COMPLETED|Overall Study||7
969449|NCT00280683|2345171|P1|COMPLETED|Overall Study|Reasons for subjects discontinuing included inability to adhere to the schedule or adverse event.|8
969450|NCT00280683|2345170|P2|STARTED|Overall Study||10
969451|NCT00280683|2345171|P1|STARTED|Overall Study||10
969452|NCT00280735|2345179|P1|NOT COMPLETED|Overall Study||18
969453|NCT00280735|2345179|P1|COMPLETED|Overall Study||57
969454|NCT00280735|2345179|P1|Received Adequate Exposure|Overall Study||57
969455|NCT00280735|2345179|P1|Received Treatment|Overall Study||72
969456|NCT00280735|2345179|P1|STARTED|Overall Study||75
969457|NCT00280748|2345189|P1|NOT COMPLETED|Overall Study||4
969458|NCT00280748|2345189|P1|COMPLETED|Overall Study||6
969459|NCT00280748|2345189|P1|STARTED|Overall Study||10
969460|NCT00280826|2345199|P1|NOT COMPLETED|Overall Study||0
969461|NCT00280826|2345199|P1|COMPLETED|Overall Study||6
969462|NCT00280826|2345199|P1|STARTED|Overall Study||6
969463|NCT00280904|2345207|P1|NOT COMPLETED|Overall Study||0
969464|NCT00280904|2345207|P1|COMPLETED|Overall Study||433
969465|NCT00280904|2345207|P1|STARTED|Overall Study||433
969466|NCT00280917|2345216|P4|NOT COMPLETED|Overall Study||2
969467|NCT00280917|2345217|P3|NOT COMPLETED|Overall Study||6
969468|NCT00280917|2345218|P2|NOT COMPLETED|Overall Study||6
969469|NCT00280917|2345219|P1|NOT COMPLETED|Overall Study||2
969470|NCT00280917|2345216|P4|COMPLETED|Overall Study||61
969471|NCT00280917|2345217|P3|COMPLETED|Overall Study||57
969472|NCT00280917|2345218|P2|COMPLETED|Overall Study||57
969473|NCT00280917|2345219|P1|COMPLETED|Overall Study||63
969474|NCT00280917|2345216|P4|STARTED|Overall Study||63
969475|NCT00280917|2345217|P3|STARTED|Overall Study||63
969476|NCT00280917|2345218|P2|STARTED|Overall Study||63
969477|NCT00280917|2345219|P1|STARTED|Overall Study||65
969478|NCT00281021|2345229|P1|NOT COMPLETED|Overall Study||2
969479|NCT00281021|2345229|P1|COMPLETED|Overall Study||24
969480|NCT00281021|2345229|P1|STARTED|Overall Study||26
969481|NCT00281099|2345235|P2|NOT COMPLETED|Overall Study||222
969482|NCT00281099|2345236|P1|NOT COMPLETED|Overall Study||205
969483|NCT00281099|2345235|P2|COMPLETED|Overall Study||296
969484|NCT00281099|2345236|P1|COMPLETED|Overall Study||308
969485|NCT00281099|2345235|P2|STARTED|Overall Study||518
969486|NCT00281099|2345236|P1|STARTED|Overall Study||513
969487|NCT00281320|2345279|P2|NOT COMPLETED|Overall Study||21
969488|NCT00281320|2345280|P1|NOT COMPLETED|Overall Study||25
969489|NCT00281320|2345279|P2|COMPLETED|Overall Study||40
969490|NCT00281320|2345280|P1|COMPLETED|Overall Study||36
969491|NCT00281320|2345279|P2|STARTED|Overall Study||61
969492|NCT00281320|2345280|P1|STARTED|Overall Study||61
969493|NCT00281463|2345300|P1|NOT COMPLETED|Overall Study||0
969494|NCT00281463|2345300|P1|COMPLETED|Overall Study||45
969495|NCT00281463|2345300|P1|STARTED|Overall Study||45
969496|NCT00281528|2345308|P3|NOT COMPLETED|Overall Study||79
969497|NCT00281528|2345309|P2|NOT COMPLETED|Overall Study||54
969498|NCT00281528|2345310|P1|NOT COMPLETED|Overall Study||75
969499|NCT00281528|2345308|P3|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
969500|NCT00281528|2345309|P2|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
969501|NCT00281528|2345310|P1|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
969502|NCT00281528|2345308|P3|STARTED|Overall Study||79
969503|NCT00281528|2345309|P2|STARTED|Overall Study||54
969504|NCT00281528|2345310|P1|STARTED|Overall Study||75
969505|NCT00281580|2345370|P16|NOT COMPLETED|Overall Study||13
969506|NCT00281580|2345371|P15|NOT COMPLETED|Overall Study||7
969507|NCT00281580|2345372|P14|NOT COMPLETED|Overall Study||7
969508|NCT00281580|2345373|P13|NOT COMPLETED|Overall Study||13
969509|NCT00281580|2345374|P12|NOT COMPLETED|Overall Study||10
969510|NCT00281580|2345375|P11|NOT COMPLETED|Overall Study||4
969511|NCT00281580|2345376|P10|NOT COMPLETED|Overall Study||12
969512|NCT00281580|2345377|P9|NOT COMPLETED|Overall Study||8
969513|NCT00281580|2345378|P8|NOT COMPLETED|Overall Study||1
969514|NCT00281580|2345379|P7|NOT COMPLETED|Overall Study||5
969515|NCT00281580|2345380|P6|NOT COMPLETED|Overall Study||3
969516|NCT00281580|2345381|P5|NOT COMPLETED|Overall Study||4
969517|NCT00281580|2345382|P4|NOT COMPLETED|Overall Study||17
969518|NCT00281580|2345383|P3|NOT COMPLETED|Overall Study||5
969519|NCT00281580|2345384|P2|NOT COMPLETED|Overall Study||1
969520|NCT00281580|2345385|P1|NOT COMPLETED|Overall Study||7
969521|NCT00281580|2345370|P16|COMPLETED|Overall Study||116
969522|NCT00281580|2345371|P15|COMPLETED|Overall Study||133
969523|NCT00281580|2345372|P14|COMPLETED|Overall Study||43
969524|NCT00281580|2345373|P13|COMPLETED|Overall Study||129
969525|NCT00281580|2345374|P12|COMPLETED|Overall Study||136
969526|NCT00281580|2345375|P11|COMPLETED|Overall Study||44
969527|NCT00281580|2345376|P10|COMPLETED|Overall Study||117
969528|NCT00281580|2345377|P9|COMPLETED|Overall Study||135
969529|NCT00281580|2345378|P8|COMPLETED|Overall Study||46
969530|NCT00281580|2345379|P7|COMPLETED|Overall Study||39
969531|NCT00281580|2345380|P6|COMPLETED|Overall Study||43
969532|NCT00281580|2345381|P5|COMPLETED|Overall Study||40
969533|NCT00281580|2345382|P4|COMPLETED|Overall Study||118
969534|NCT00281580|2345383|P3|COMPLETED|Overall Study||125
969535|NCT00281580|2345384|P2|COMPLETED|Overall Study||41
969536|NCT00281580|2345385|P1|COMPLETED|Overall Study||39
969537|NCT00281580|2345370|P16|STARTED|Overall Study||129
969538|NCT00281580|2345371|P15|STARTED|Overall Study||140
969539|NCT00281580|2345372|P14|STARTED|Overall Study||50
969540|NCT00281580|2345373|P13|STARTED|Overall Study||142
969541|NCT00281580|2345374|P12|STARTED|Overall Study||146
969542|NCT00281580|2345375|P11|STARTED|Overall Study||48
969543|NCT00281580|2345376|P10|STARTED|Overall Study||129
969544|NCT00281580|2345377|P9|STARTED|Overall Study||143
969545|NCT00281580|2345378|P8|STARTED|Overall Study||47
969546|NCT00281580|2345379|P7|STARTED|Overall Study||44
969547|NCT00281580|2345380|P6|STARTED|Overall Study||46
969548|NCT00281580|2345381|P5|STARTED|Overall Study||44
969549|NCT00281580|2345382|P4|STARTED|Overall Study||135
969550|NCT00281580|2345383|P3|STARTED|Overall Study||130
969551|NCT00281580|2345384|P2|STARTED|Overall Study||42
969552|NCT00281580|2345385|P1|STARTED|Overall Study||46
969553|NCT00281632|2345729|P1|NOT COMPLETED|Overall Study||36
969554|NCT00281632|2345729|P1|COMPLETED|Overall Study|Three participants were ongoing in the study at the time of the data cut-off (30 Apr 2008).|0
969555|NCT00281632|2345729|P1|STARTED|Overall Study||36
969556|NCT00281658|2345757|P3|NOT COMPLETED|Open-label Monotherapy Extension Phase||101
969557|NCT00281658|2345758|P2|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
969558|NCT00281658|2345759|P1|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
969559|NCT00281658|2345757|P3|COMPLETED|Open-label Monotherapy Extension Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|48
969560|NCT00281658|2345758|P2|COMPLETED|Open-label Monotherapy Extension Phase||0
969561|NCT00281658|2345759|P1|COMPLETED|Open-label Monotherapy Extension Phase||0
969562|NCT00281658|2345757|P3|STARTED|Open-label Monotherapy Extension Phase||149
969563|NCT00281658|2345758|P2|STARTED|Open-label Monotherapy Extension Phase||0
969564|NCT00281658|2345759|P1|STARTED|Open-label Monotherapy Extension Phase||0
969565|NCT00281658|2345757|P3|NOT COMPLETED|Double-blind, Randomized Phase||0
969566|NCT00281658|2345758|P2|NOT COMPLETED|Double-blind, Randomized Phase||54
969567|NCT00281658|2345759|P1|NOT COMPLETED|Double-blind, Randomized Phase||137
969568|NCT00281658|2345757|P3|COMPLETED|Double-blind, Randomized Phase||0
969569|NCT00281658|2345758|P2|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|168
969570|NCT00281658|2345759|P1|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|85
969571|NCT00281658|2345757|P3|STARTED|Double-blind, Randomized Phase||0
969572|NCT00281658|2345758|P2|STARTED|Double-blind, Randomized Phase|Of these participants, 149 entered the open-label extension phase.|222
969573|NCT00281658|2345759|P1|STARTED|Double-blind, Randomized Phase||222
969574|NCT00281697|2345778|P2|NOT COMPLETED|Overall Study||197
969575|NCT00281697|2345779|P1|NOT COMPLETED|Overall Study||401
969576|NCT00281697|2345778|P2|COMPLETED|Overall Study||28
969577|NCT00281697|2345779|P1|COMPLETED|Overall Study||58
969578|NCT00281697|2345778|P2|STARTED|Overall Study||225
969579|NCT00281697|2345779|P1|STARTED|Overall Study||459
969580|NCT00281827|2345795|P1|NOT COMPLETED|Overall Study||0
969581|NCT00281827|2345795|P1|COMPLETED|Overall Study|All patients received 3 cycles of therapy; 2 did not receive all 3 thalidomide cycles|22
969582|NCT00281827|2345795|P1|STARTED|Overall Study||22
969583|NCT00281840|2345804|P1|NOT COMPLETED|Overall Study||25
969584|NCT00281840|2345804|P1|COMPLETED|Overall Study||5
969585|NCT00281840|2345804|P1|STARTED|Overall Study||30
969586|NCT00287716|2345812|P3|NOT COMPLETED|Overall Study||31
969587|NCT00287716|2345813|P2|NOT COMPLETED|Overall Study||17
969588|NCT00287716|2345814|P1|NOT COMPLETED|Overall Study||38
969589|NCT00287716|2345812|P3|COMPLETED|Overall Study||143
969590|NCT00287716|2345813|P2|COMPLETED|Overall Study||70
969591|NCT00287716|2345814|P1|COMPLETED|Overall Study||136
969592|NCT00287716|2345812|P3|STARTED|Overall Study||174
969593|NCT00287716|2345813|P2|STARTED|Overall Study||87
969594|NCT00287716|2345814|P1|STARTED|Overall Study||174
969595|NCT00287729|2345845|P2|NOT COMPLETED|Overall Study||31
969596|NCT00287729|2345846|P1|NOT COMPLETED|Overall Study||34
969597|NCT00287729|2345845|P2|COMPLETED|Overall Study||142
969598|NCT00287729|2345846|P1|COMPLETED|Overall Study||137
969599|NCT00287729|2345845|P2|STARTED|Overall Study||173
969600|NCT00287729|2345846|P1|STARTED|Overall Study||171
969601|NCT00287872|2345866|P1|NOT COMPLETED|Overall Study||0
969602|NCT00287872|2345866|P1|COMPLETED|Overall Study||30
969603|NCT00287872|2345866|P1|STARTED|Overall Study||30
969604|NCT00288509|2345871|P1|NOT COMPLETED|Treatment Cycle 4||8
969605|NCT00288509|2345871|P1|COMPLETED|Treatment Cycle 4||80
969606|NCT00288509|2345871|P1|STARTED|Treatment Cycle 4|3 subjects completed Cycle 3 but withdrew before Cycle 4, treatment stopped according to protocol|88
969607|NCT00288509|2345871|P1|NOT COMPLETED|Treatment Cycle 3||5
969608|NCT00288509|2345871|P1|COMPLETED|Treatment Cycle 3||91
969609|NCT00288509|2345871|P1|STARTED|Treatment Cycle 3|One subject completed Cycle 2 but withdrew before Cycle 3 due to insufficient clinical response|96
969610|NCT00288509|2345871|P1|NOT COMPLETED|Treatment Cycle 2||3
969611|NCT00288509|2345871|P1|COMPLETED|Treatment Cycle 2||97
969612|NCT00288509|2345871|P1|STARTED|Treatment Cycle 2|2 subjects completed Cycle 1 but withdrew before Cycle 2 due to insufficient clinical response|100
969613|NCT00288509|2345871|P1|NOT COMPLETED|Treatment Cycle 1||6
969614|NCT00288509|2345871|P1|COMPLETED|Treatment Cycle 1||102
969615|NCT00288509|2345871|P1|STARTED|Treatment Cycle 1||108
969616|NCT00288574|2345880|P2|NOT COMPLETED|Overall Study||0
969617|NCT00288574|2345881|P1|NOT COMPLETED|Overall Study||0
969618|NCT00288574|2345880|P2|COMPLETED|Overall Study||44
969619|NCT00288574|2345881|P1|COMPLETED|Overall Study||49
969620|NCT00288574|2345880|P2|STARTED|Overall Study||44
969621|NCT00288574|2345881|P1|STARTED|Overall Study||49
969622|NCT00288587|2345889|P2|NOT COMPLETED|Overall Study||10
969623|NCT00288587|2345890|P1|NOT COMPLETED|Overall Study||5
969624|NCT00288587|2345889|P2|COMPLETED|Overall Study||7
969625|NCT00288587|2345890|P1|COMPLETED|Overall Study||14
969626|NCT00288587|2345889|P2|STARTED|Overall Study||17
969627|NCT00288587|2345890|P1|STARTED|Overall Study||19
969628|NCT00288600|2345906|P2|NOT COMPLETED|Overall Study||0
969629|NCT00288600|2345907|P1|NOT COMPLETED|Overall Study||0
969630|NCT00288600|2345906|P2|COMPLETED|Overall Study||46
969631|NCT00288600|2345907|P1|COMPLETED|Overall Study||46
969632|NCT00288600|2345906|P2|STARTED|Overall Study||46
969633|NCT00288600|2345907|P1|STARTED|Overall Study||46
969634|NCT00288626|2345913|P1|NOT COMPLETED|Overall Study||7
969635|NCT00288626|2345913|P1|COMPLETED|Overall Study||17
969636|NCT00288626|2345913|P1|STARTED|Overall Study||24
969637|NCT00288639|2345936|P1|NOT COMPLETED|Overall Study||12
969638|NCT00288639|2345936|P1|COMPLETED|Overall Study||86
969639|NCT00288639|2345936|P1|STARTED|Overall Study||98
969640|NCT00288704|2345956|P3|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||20
969641|NCT00288704|2345957|P2|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
969642|NCT00288704|2345958|P1|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
969643|NCT00288704|2345956|P3|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||81
969644|NCT00288704|2345957|P2|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
969645|NCT00288704|2345958|P1|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
969646|NCT00288704|2345956|P3|STARTED|Open-Label Extension (OLE) Weeks 24-117||101
969647|NCT00288704|2345957|P2|STARTED|Open-Label Extension (OLE) Weeks 24-117||0
969648|NCT00288704|2345958|P1|STARTED|Open-Label Extension (OLE) Weeks 24-117|After week 24, all subjects are treated with Open label rilonacept.|0
969649|NCT00288704|2345956|P3|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
969650|NCT00288704|2345957|P2|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||1
969651|NCT00288704|2345958|P1|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
969652|NCT00288704|2345956|P3|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
969653|NCT00288704|2345957|P2|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||21
969654|NCT00288704|2345958|P1|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||23
969655|NCT00288704|2345956|P3|STARTED|Part B, Randomized Withdrawal, Wks 15-24||0
969656|NCT00288704|2345957|P2|STARTED|Part B, Randomized Withdrawal, Wks 15-24||22
969657|NCT00288704|2345958|P1|STARTED|Part B, Randomized Withdrawal, Wks 15-24|1 subject discontinued during weeks 6-14 due to non-compliance with study drug dosing procedures.|23
969658|NCT00288704|2345956|P3|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
969659|NCT00288704|2345957|P2|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||1
969660|NCT00288704|2345958|P1|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
969661|NCT00288704|2345956|P3|COMPLETED|Part A, Double Blind, Weeks 1-6||0
969662|NCT00288704|2345957|P2|COMPLETED|Part A, Double Blind, Weeks 1-6||22
969663|NCT00288704|2345958|P1|COMPLETED|Part A, Double Blind, Weeks 1-6||24
969664|NCT00288704|2345956|P3|STARTED|Part A, Double Blind, Weeks 1-6|Subjects enrolled into the open-label phase do not complete this part of the study.|0
969665|NCT00288704|2345957|P2|STARTED|Part A, Double Blind, Weeks 1-6||23
969666|NCT00288704|2345958|P1|STARTED|Part A, Double Blind, Weeks 1-6||24
969667|NCT00288860|2345987|P2|NOT COMPLETED|Overall Study||97
969668|NCT00288860|2345988|P1|NOT COMPLETED|Overall Study||102
969669|NCT00288860|2345987|P2|COMPLETED|Overall Study|328 completed 4 or 12 month survey. Used all with intake (n=417) in intent to treat.|328
969670|NCT00288860|2345988|P1|COMPLETED|Overall Study|310 completed either 4 or 12 month survey. Used all with intake (n = 408) in intent-to-treat.|310
969671|NCT00288860|2345987|P2|Completed 12 Month fu Survey|Overall Study||281
969672|NCT00288860|2345988|P1|Completed 12 Month fu Survey|Overall Study||257
969673|NCT00288860|2345987|P2|Completed 4 Month fu Survey|Overall Study||299
969674|NCT00288860|2345988|P1|Completed 4 Month fu Survey|Overall Study||275
969675|NCT00288860|2345987|P2|Completed Intake Survey|Overall Study||417
969676|NCT00288860|2345988|P1|Completed Intake Survey|Overall Study||408
969677|NCT00288860|2345987|P2|STARTED|Overall Study||425
969678|NCT00288860|2345988|P1|STARTED|Overall Study||412
969679|NCT00288886|2346000|P2|NOT COMPLETED|Overall Study||11
969680|NCT00288886|2346001|P1|NOT COMPLETED|Overall Study||11
969681|NCT00288886|2346000|P2|COMPLETED|Overall Study||81
969682|NCT00288886|2346001|P1|COMPLETED|Overall Study||80
969683|NCT00288886|2346000|P2|12-month Follow Up|Overall Study||81
969684|NCT00288886|2346001|P1|12-month Follow Up|Overall Study||80
969685|NCT00288886|2346000|P2|6-month Follow Up|Overall Study||84
969686|NCT00288886|2346001|P1|6-month Follow Up|Overall Study||85
969687|NCT00288886|2346000|P2|3-month Follow Up|Overall Study||85
969688|NCT00288886|2346001|P1|3-month Follow Up|Overall Study||82
969689|NCT00288886|2346000|P2|STARTED|Overall Study||92
969690|NCT00288886|2346001|P1|STARTED|Overall Study||91
969691|NCT00288912|2346022|P3|NOT COMPLETED|Overall Study||28
969692|NCT00288912|2346023|P2|NOT COMPLETED|Overall Study||17
969693|NCT00288912|2346024|P1|NOT COMPLETED|Overall Study||17
969694|NCT00288912|2346022|P3|COMPLETED|Overall Study||146
969695|NCT00288912|2346023|P2|COMPLETED|Overall Study||157
969696|NCT00288912|2346024|P1|COMPLETED|Overall Study||158
969697|NCT00288912|2346022|P3|STARTED|Overall Study||174
969698|NCT00288912|2346023|P2|STARTED|Overall Study||174
969699|NCT00288912|2346024|P1|STARTED|Overall Study||175
969700|NCT00289016|2346041|P1|NOT COMPLETED|Overall Study||37
969701|NCT00289016|2346041|P1|COMPLETED|Overall Study||13
969702|NCT00289016|2346041|P1|STARTED|Overall Study||50
969703|NCT00289094|2346052|P2|NOT COMPLETED|Overall Study||47
969704|NCT00289094|2346053|P1|NOT COMPLETED|Overall Study||47
969705|NCT00289094|2346052|P2|COMPLETED|Overall Study||2
969706|NCT00289094|2346053|P1|COMPLETED|Overall Study||3
969707|NCT00289094|2346052|P2|STARTED|Overall Study||49
969708|NCT00289094|2346053|P1|STARTED|Overall Study||50
969709|NCT00289107|2346061|P2|NOT COMPLETED|Overall Study||44
969710|NCT00289107|2346062|P1|NOT COMPLETED|Overall Study||53
969711|NCT00289107|2346061|P2|COMPLETED|Overall Study||28
969712|NCT00289107|2346062|P1|COMPLETED|Overall Study||24
969713|NCT00289107|2346061|P2|STARTED|Overall Study||72
969714|NCT00289107|2346062|P1|STARTED|Overall Study||77
969715|NCT00289120|2346068|P1|NOT COMPLETED|Overall Study||0
969716|NCT00289120|2346068|P1|COMPLETED|Overall Study||13
969717|NCT00289120|2346068|P1|STARTED|Overall Study||13
969718|NCT00289133|2346086|P2|NOT COMPLETED|Overall Study||298
969719|NCT00289133|2346087|P1|NOT COMPLETED|Overall Study||272
969720|NCT00289133|2346086|P2|COMPLETED|Overall Study||179
969721|NCT00289133|2346087|P1|COMPLETED|Overall Study||189
969722|NCT00289133|2346086|P2|STARTED|Overall Study||477
969723|NCT00289133|2346087|P1|STARTED|Overall Study||461
969724|NCT00289185|2346111|P2|NOT COMPLETED|Overall Study||26
969725|NCT00289185|2346112|P1|NOT COMPLETED|Overall Study||28
969726|NCT00289185|2346111|P2|COMPLETED|Overall Study||144
969727|NCT00289185|2346112|P1|COMPLETED|Overall Study||142
969728|NCT00289185|2346111|P2|STARTED|Overall Study||170
969729|NCT00289185|2346112|P1|STARTED|Overall Study||170
969730|NCT00289211|2346160|P3|NOT COMPLETED|Overall Study||10
969731|NCT00289211|2346161|P2|NOT COMPLETED|Overall Study||1
969732|NCT00289211|2346162|P1|NOT COMPLETED|Overall Study||0
969733|NCT00289211|2346160|P3|COMPLETED|Overall Study||2
969734|NCT00289211|2346161|P2|COMPLETED|Overall Study||34
969735|NCT00289211|2346162|P1|COMPLETED|Overall Study||36
969736|NCT00289211|2346160|P3|STARTED|Overall Study||12
969737|NCT00289211|2346161|P2|STARTED|Overall Study||35
969738|NCT00289211|2346162|P1|STARTED|Overall Study||36
969739|NCT00289276|2346180|P2|NOT COMPLETED|Second Part of FAST Study (Expansion)||3
969740|NCT00289276|2346181|P1|NOT COMPLETED|Second Part of FAST Study (Expansion)||0
969741|NCT00289276|2346180|P2|COMPLETED|Second Part of FAST Study (Expansion)||106
969742|NCT00289276|2346181|P1|COMPLETED|Second Part of FAST Study (Expansion)||0
969743|NCT00289276|2346180|P2|STARTED|Second Part of FAST Study (Expansion)||109
969744|NCT00289276|2346181|P1|STARTED|Second Part of FAST Study (Expansion)||0
969745|NCT00289276|2346180|P2|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
969746|NCT00289276|2346181|P1|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
969747|NCT00289276|2346180|P2|COMPLETED|First Part of FAST Study (Pivotal)||0
969748|NCT00289276|2346181|P1|COMPLETED|First Part of FAST Study (Pivotal)||47
969749|NCT00289276|2346180|P2|STARTED|First Part of FAST Study (Pivotal)||0
969750|NCT00289276|2346181|P1|STARTED|First Part of FAST Study (Pivotal)|11 patients were re-consented under version 7 of the CIP, but are included in Pivotal results only|47
969751|NCT00289289|2346196|P3|NOT COMPLETED|Overall Study||49
969752|NCT00289289|2346197|P2|NOT COMPLETED|Overall Study||10
969753|NCT00289289|2346198|P1|NOT COMPLETED|Overall Study||19
969754|NCT00289289|2346196|P3|COMPLETED|Overall Study||95
969755|NCT00289289|2346197|P2|COMPLETED|Overall Study||114
969756|NCT00289289|2346198|P1|COMPLETED|Overall Study||113
969757|NCT00289289|2346196|P3|STARTED|Overall Study||144
969758|NCT00289289|2346197|P2|STARTED|Overall Study||124
969759|NCT00289289|2346198|P1|STARTED|Overall Study||132
969760|NCT00289341|2346213|P2|NOT COMPLETED|Overall Study||0
969761|NCT00289341|2346214|P1|NOT COMPLETED|Overall Study||0
969762|NCT00289341|2346213|P2|COMPLETED|Overall Study||12
969763|NCT00289341|2346214|P1|COMPLETED|Overall Study||12
969764|NCT00289341|2346213|P2|STARTED|Overall Study||12
969765|NCT00289341|2346214|P1|STARTED|Overall Study||12
969766|NCT00289458|2346227|P3|NOT COMPLETED|Overall Study||6
969767|NCT00289458|2346228|P2|NOT COMPLETED|Overall Study||6
969768|NCT00289458|2346229|P1|NOT COMPLETED|Overall Study||6
969769|NCT00289458|2346227|P3|COMPLETED|Overall Study||22
969770|NCT00289458|2346228|P2|COMPLETED|Overall Study||20
969771|NCT00289458|2346229|P1|COMPLETED|Overall Study||19
969772|NCT00289458|2346227|P3|STARTED|Overall Study||28
969773|NCT00289458|2346228|P2|STARTED|Overall Study||26
969774|NCT00289458|2346229|P1|STARTED|Overall Study||25
969775|NCT00289471|2346252|P1|NOT COMPLETED|Overall Study||0
969776|NCT00289471|2346252|P1|COMPLETED|Overall Study||630
969777|NCT00289471|2346252|P1|STARTED|Overall Study||630
969805|NCT00289718|2346297|P1|NOT COMPLETED|Overall Study||0
969806|NCT00289718|2346297|P1|COMPLETED|Overall Study||51
969807|NCT00289718|2346297|P1|STARTED|Overall Study||51
969808|NCT00289744|2346309|P3|NOT COMPLETED|Additional Dose Phase||0
969809|NCT00289744|2346310|P2|NOT COMPLETED|Additional Dose Phase||0
969810|NCT00289744|2346311|P1|NOT COMPLETED|Additional Dose Phase||0
969811|NCT00289744|2346309|P3|COMPLETED|Additional Dose Phase||6
969812|NCT00289744|2346310|P2|COMPLETED|Additional Dose Phase||19
969813|NCT00289744|2346311|P1|COMPLETED|Additional Dose Phase||0
969814|NCT00289744|2346309|P3|STARTED|Additional Dose Phase||6
969815|NCT00289744|2346310|P2|STARTED|Additional Dose Phase||19
969816|NCT00289744|2346311|P1|STARTED|Additional Dose Phase||0
969817|NCT00289744|2346309|P3|NOT COMPLETED|Year 10 Long-term Follow-up||0
969818|NCT00289744|2346310|P2|NOT COMPLETED|Year 10 Long-term Follow-up||0
969819|NCT00289744|2346311|P1|NOT COMPLETED|Year 10 Long-term Follow-up||0
969820|NCT00289744|2346309|P3|COMPLETED|Year 10 Long-term Follow-up||0
969821|NCT00289744|2346310|P2|COMPLETED|Year 10 Long-term Follow-up||0
969822|NCT00289744|2346311|P1|COMPLETED|Year 10 Long-term Follow-up||171
969823|NCT00289744|2346309|P3|STARTED|Year 10 Long-term Follow-up||0
969824|NCT00289744|2346310|P2|STARTED|Year 10 Long-term Follow-up||0
969825|NCT00289744|2346311|P1|STARTED|Year 10 Long-term Follow-up|Subjects who came back at Year 10 blood sampling time-point|171
969826|NCT00289744|2346309|P3|NOT COMPLETED|Year 9 Long-term Follow-up||0
969827|NCT00289744|2346310|P2|NOT COMPLETED|Year 9 Long-term Follow-up||0
969828|NCT00289744|2346311|P1|NOT COMPLETED|Year 9 Long-term Follow-up||0
969829|NCT00289744|2346309|P3|COMPLETED|Year 9 Long-term Follow-up||0
969830|NCT00289744|2346310|P2|COMPLETED|Year 9 Long-term Follow-up||0
969831|NCT00289744|2346311|P1|COMPLETED|Year 9 Long-term Follow-up||173
969832|NCT00289744|2346309|P3|STARTED|Year 9 Long-term Follow-up||0
969833|NCT00289744|2346310|P2|STARTED|Year 9 Long-term Follow-up||0
969834|NCT00289744|2346311|P1|STARTED|Year 9 Long-term Follow-up|Subjects who came back at Year 9 blood sampling time-point|173
969835|NCT00289744|2346309|P3|NOT COMPLETED|Year 8 Long-term Follow-up||0
969836|NCT00289744|2346310|P2|NOT COMPLETED|Year 8 Long-term Follow-up||0
969837|NCT00289744|2346311|P1|NOT COMPLETED|Year 8 Long-term Follow-up||0
969838|NCT00289744|2346309|P3|COMPLETED|Year 8 Long-term Follow-up||0
969839|NCT00289744|2346310|P2|COMPLETED|Year 8 Long-term Follow-up||0
969840|NCT00289744|2346311|P1|COMPLETED|Year 8 Long-term Follow-up||174
969841|NCT00289744|2346309|P3|STARTED|Year 8 Long-term Follow-up||0
969842|NCT00289744|2346310|P2|STARTED|Year 8 Long-term Follow-up||0
969843|NCT00289744|2346311|P1|STARTED|Year 8 Long-term Follow-up|Subjects who came back at Year 8 blood sampling time-point|174
969844|NCT00289744|2346309|P3|NOT COMPLETED|Year 7 Long-term Follow-up||0
969845|NCT00289744|2346310|P2|NOT COMPLETED|Year 7 Long-term Follow-up||0
969846|NCT00289744|2346311|P1|NOT COMPLETED|Year 7 Long-term Follow-up||0
969847|NCT00289744|2346309|P3|COMPLETED|Year 7 Long-term Follow-up||0
969848|NCT00289744|2346310|P2|COMPLETED|Year 7 Long-term Follow-up||0
969849|NCT00289744|2346311|P1|COMPLETED|Year 7 Long-term Follow-up||175
969850|NCT00289744|2346309|P3|STARTED|Year 7 Long-term Follow-up||0
969851|NCT00289744|2346310|P2|STARTED|Year 7 Long-term Follow-up||0
969852|NCT00289744|2346311|P1|STARTED|Year 7 Long-term Follow-up|Subjects who came back at Year 7 blood sampling time-point|175
969853|NCT00289744|2346309|P3|NOT COMPLETED|Year 6 Long-term Follow-up||0
969854|NCT00289744|2346310|P2|NOT COMPLETED|Year 6 Long-term Follow-up||0
969855|NCT00289744|2346311|P1|NOT COMPLETED|Year 6 Long-term Follow-up||0
969856|NCT00289744|2346309|P3|COMPLETED|Year 6 Long-term Follow-up||0
969857|NCT00289744|2346310|P2|COMPLETED|Year 6 Long-term Follow-up||0
969858|NCT00289744|2346311|P1|COMPLETED|Year 6 Long-term Follow-up||178
969859|NCT00289744|2346309|P3|STARTED|Year 6 Long-term Follow-up||0
969860|NCT00289744|2346310|P2|STARTED|Year 6 Long-term Follow-up||0
969861|NCT00289744|2346311|P1|STARTED|Year 6 Long-term Follow-up|Number of subjects who come back at Year 6 blood sampling time-point|178
969862|NCT00289757|2346329|P1|NOT COMPLETED|Overall Study||0
969863|NCT00289757|2346329|P1|COMPLETED|Overall Study||78
969864|NCT00289757|2346329|P1|STARTED|Overall Study||78
969865|NCT00289770|2346340|P1|NOT COMPLETED|Year 15||1
969866|NCT00289770|2346340|P1|COMPLETED|Year 15||49
969867|NCT00289770|2346340|P1|STARTED|Year 15||50
969868|NCT00289770|2346340|P1|NOT COMPLETED|Year 14||0
969869|NCT00289770|2346340|P1|COMPLETED|Year 14||43
969870|NCT00289770|2346340|P1|STARTED|Year 14||43
969871|NCT00289770|2346340|P1|NOT COMPLETED|Year 13||0
969872|NCT00289770|2346340|P1|COMPLETED|Year 13||37
969873|NCT00289770|2346340|P1|STARTED|Year 13||37
969874|NCT00289770|2346340|P1|NOT COMPLETED|Year 12||0
969875|NCT00289770|2346340|P1|COMPLETED|Year 12||40
969876|NCT00289770|2346340|P1|STARTED|Year 12||40
969877|NCT00289770|2346340|P1|NOT COMPLETED|Year 11||0
969878|NCT00289770|2346340|P1|COMPLETED|Year 11||37
969879|NCT00289770|2346340|P1|STARTED|Year 11||37
969880|NCT00289783|2346354|P2|NOT COMPLETED|Fourth Dose Phase||24
969881|NCT00289783|2346355|P1|NOT COMPLETED|Fourth Dose Phase||87
969882|NCT00289783|2346354|P2|COMPLETED|Fourth Dose Phase||899
969883|NCT00289783|2346355|P1|COMPLETED|Fourth Dose Phase||2682
969884|NCT00289783|2346354|P2|STARTED|Fourth Dose Phase||923
969885|NCT00289783|2346355|P1|STARTED|Fourth Dose Phase||2769
969886|NCT00289783|2346354|P2|NOT COMPLETED|Primary Phase||83
969887|NCT00289783|2346355|P1|NOT COMPLETED|Primary Phase||248
969888|NCT00289783|2346354|P2|COMPLETED|Primary Phase||961
969889|NCT00289783|2346355|P1|COMPLETED|Primary Phase||2888
969890|NCT00289783|2346354|P2|STARTED|Primary Phase||1044
969891|NCT00289783|2346355|P1|STARTED|Primary Phase||3136
969892|NCT00289848|2346535|P2|NOT COMPLETED|Overall Study||45
969893|NCT00289848|2346536|P1|NOT COMPLETED|Overall Study||46
969894|NCT00289848|2346535|P2|COMPLETED|Overall Study||133
969895|NCT00289848|2346536|P1|COMPLETED|Overall Study||306
969896|NCT00289848|2346535|P2|STARTED|Overall Study||178
969897|NCT00289848|2346536|P1|STARTED|Overall Study||352
969898|NCT00289874|2346548|P2|NOT COMPLETED|Overall Study||8
969899|NCT00289874|2346549|P1|NOT COMPLETED|Overall Study||6
969900|NCT00289874|2346548|P2|COMPLETED|Overall Study||210
969901|NCT00289874|2346549|P1|COMPLETED|Overall Study||197
969902|NCT00289874|2346548|P2|STARTED|Overall Study||218
969903|NCT00289874|2346549|P1|STARTED|Overall Study||203
969904|NCT00289887|2346559|P2|NOT COMPLETED|Overall Study||29
969905|NCT00289887|2346560|P1|NOT COMPLETED|Overall Study||22
969906|NCT00289887|2346559|P2|COMPLETED|Overall Study||105
969907|NCT00289887|2346560|P1|COMPLETED|Overall Study||105
969908|NCT00289887|2346559|P2|STARTED|Overall Study||134
969909|NCT00289887|2346560|P1|STARTED|Overall Study||127
969910|NCT00289900|2346582|P6|NOT COMPLETED|Overall Study||61
969911|NCT00289900|2346583|P5|NOT COMPLETED|Overall Study||45
969912|NCT00289900|2346584|P4|NOT COMPLETED|Overall Study||59
969913|NCT00289900|2346585|P3|NOT COMPLETED|Overall Study||33
969914|NCT00289900|2346586|P2|NOT COMPLETED|Overall Study||120
969915|NCT00289900|2346587|P1|NOT COMPLETED|Overall Study||68
969916|NCT00289900|2346582|P6|COMPLETED|Overall Study||372
969917|NCT00289900|2346583|P5|COMPLETED|Overall Study||392
969918|NCT00289900|2346584|P4|COMPLETED|Overall Study||380
969919|NCT00289900|2346585|P3|COMPLETED|Overall Study||265
969920|NCT00289900|2346586|P2|COMPLETED|Overall Study||316
969921|NCT00289900|2346587|P1|COMPLETED|Overall Study||229
969922|NCT00289900|2346582|P6|Treated|Overall Study||433
969923|NCT00289900|2346583|P5|Treated|Overall Study||437
969924|NCT00289900|2346584|P4|Treated|Overall Study||439
969925|NCT00289900|2346585|P3|Treated|Overall Study||298
969926|NCT00289900|2346586|P2|Treated|Overall Study||435
969927|NCT00289900|2346587|P1|Treated|Overall Study||297
969928|NCT00289900|2346582|P6|STARTED|Overall Study||433
969929|NCT00289900|2346583|P5|STARTED|Overall Study||437
969930|NCT00289900|2346584|P4|STARTED|Overall Study||439
969931|NCT00289900|2346585|P3|STARTED|Overall Study||298
969932|NCT00289900|2346586|P2|STARTED|Overall Study||436
969933|NCT00289900|2346587|P1|STARTED|Overall Study||297
969934|NCT00289913|2346694|P5|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
969935|NCT00289913|2346695|P4|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
969936|NCT00289913|2346696|P3|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
969937|NCT00289913|2346697|P2|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
969938|NCT00289913|2346698|P1|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
969939|NCT00289913|2346694|P5|COMPLETED|Visit 4 (Stage I and Stage II)||597
969940|NCT00289913|2346695|P4|COMPLETED|Visit 4 (Stage I and Stage II)||131
969941|NCT00289913|2346696|P3|COMPLETED|Visit 4 (Stage I and Stage II)||138
969942|NCT00289913|2346697|P2|COMPLETED|Visit 4 (Stage I and Stage II)||106
969943|NCT00289913|2346698|P1|COMPLETED|Visit 4 (Stage I and Stage II)||122
969944|NCT00289913|2346694|P5|STARTED|Visit 4 (Stage I and Stage II)||597
969945|NCT00289913|2346695|P4|STARTED|Visit 4 (Stage I and Stage II)||131
969946|NCT00289913|2346696|P3|STARTED|Visit 4 (Stage I and Stage II)||138
969947|NCT00289913|2346697|P2|STARTED|Visit 4 (Stage I and Stage II)||106
969948|NCT00289913|2346698|P1|STARTED|Visit 4 (Stage I and Stage II)||122
969949|NCT00289913|2346694|P5|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
969950|NCT00289913|2346695|P4|NOT COMPLETED|Visit 3 (Stage I and Stage II)||4
969951|NCT00289913|2346696|P3|NOT COMPLETED|Visit 3 (Stage I and Stage II)||2
969952|NCT00289913|2346697|P2|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
969953|NCT00289913|2346698|P1|NOT COMPLETED|Visit 3 (Stage I and Stage II)||9
969954|NCT00289913|2346694|P5|COMPLETED|Visit 3 (Stage I and Stage II)||597
969955|NCT00289913|2346695|P4|COMPLETED|Visit 3 (Stage I and Stage II)||131
969956|NCT00289913|2346696|P3|COMPLETED|Visit 3 (Stage I and Stage II)||138
969957|NCT00289913|2346697|P2|COMPLETED|Visit 3 (Stage I and Stage II)||106
969958|NCT00289913|2346698|P1|COMPLETED|Visit 3 (Stage I and Stage II)||122
969959|NCT00289913|2346694|P5|STARTED|Visit 3 (Stage I and Stage II)||605
969960|NCT00289913|2346695|P4|STARTED|Visit 3 (Stage I and Stage II)||135
969961|NCT00289913|2346696|P3|STARTED|Visit 3 (Stage I and Stage II)||140
969962|NCT00289913|2346697|P2|STARTED|Visit 3 (Stage I and Stage II)||114
969963|NCT00289913|2346698|P1|STARTED|Visit 3 (Stage I and Stage II)||131
969964|NCT00289913|2346694|P5|NOT COMPLETED|Visit 2 (Stage I and Stage II)||40
969965|NCT00289913|2346695|P4|NOT COMPLETED|Visit 2 (Stage I and Stage II)||6
969966|NCT00289913|2346696|P3|NOT COMPLETED|Visit 2 (Stage I and Stage II)||10
969967|NCT00289913|2346697|P2|NOT COMPLETED|Visit 2 (Stage I and Stage II)||21
969968|NCT00289913|2346698|P1|NOT COMPLETED|Visit 2 (Stage I and Stage II)||15
969969|NCT00289913|2346694|P5|COMPLETED|Visit 2 (Stage I and Stage II)||605
969970|NCT00289913|2346695|P4|COMPLETED|Visit 2 (Stage I and Stage II)||135
969971|NCT00289913|2346696|P3|COMPLETED|Visit 2 (Stage I and Stage II)||140
969972|NCT00289913|2346697|P2|COMPLETED|Visit 2 (Stage I and Stage II)||114
969973|NCT00289913|2346698|P1|COMPLETED|Visit 2 (Stage I and Stage II)||131
969974|NCT00289913|2346694|P5|STARTED|Visit 2 (Stage I and Stage II)|No vaccine administered at Visit 2 (Stage II), therefore there was no safety F/U period.|645
969975|NCT00289913|2346695|P4|STARTED|Visit 2 (Stage I and Stage II)||141
969976|NCT00289913|2346696|P3|STARTED|Visit 2 (Stage I and Stage II)||150
969977|NCT00289913|2346697|P2|STARTED|Visit 2 (Stage I and Stage II)||135
969978|NCT00289913|2346698|P1|STARTED|Visit 2 (Stage I and Stage II)||146
969979|NCT00289913|2346694|P5|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
969980|NCT00289913|2346695|P4|NOT COMPLETED|Visit 1 (Stage I and Stage II)||11
969981|NCT00289913|2346696|P3|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
969982|NCT00289913|2346697|P2|NOT COMPLETED|Visit 1 (Stage I and Stage II)||16
969983|NCT00289913|2346698|P1|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
969984|NCT00289913|2346694|P5|COMPLETED|Visit 1 (Stage I and Stage II)||645
969985|NCT00289913|2346695|P4|COMPLETED|Visit 1 (Stage I and Stage II)||141
969986|NCT00289913|2346696|P3|COMPLETED|Visit 1 (Stage I and Stage II)||150
969987|NCT00289913|2346697|P2|COMPLETED|Visit 1 (Stage I and Stage II)||135
969988|NCT00289913|2346698|P1|COMPLETED|Visit 1 (Stage I and Stage II)||146
969989|NCT00289913|2346694|P5|STARTED|Visit 1 (Stage I and Stage II)|Participants were enrolled during Stage II.|654
969990|NCT00289913|2346695|P4|STARTED|Visit 1 (Stage I and Stage II)||152
969991|NCT00289913|2346696|P3|STARTED|Visit 1 (Stage I and Stage II)||159
969992|NCT00289913|2346697|P2|STARTED|Visit 1 (Stage I and Stage II)||151
969993|NCT00289913|2346698|P1|STARTED|Visit 1 (Stage I and Stage II)||155
969994|NCT00289978|2346726|P3|NOT COMPLETED|Overall Study||86
969995|NCT00289978|2346727|P2|NOT COMPLETED|Overall Study||56
969996|NCT00289978|2346728|P1|NOT COMPLETED|Overall Study||97
969997|NCT00289978|2346726|P3|COMPLETED|Overall Study|303 completed on study drug, 29 completed off study drug.|332
969998|NCT00289978|2346727|P2|COMPLETED|Overall Study|345 completed on study drug, 24 completed off study drug.|369
969999|NCT00289978|2346728|P1|COMPLETED|Overall Study|296 completed on study drug, 35 completed off study drug.|332
970000|NCT00289978|2346726|P3|STARTED|Overall Study||418
970001|NCT00289978|2346727|P2|STARTED|Overall Study||425
970002|NCT00289978|2346728|P1|STARTED|Overall Study||429
970003|NCT00289991|2346744|P2|NOT COMPLETED|Overall Study||80
970004|NCT00289991|2346745|P1|NOT COMPLETED|Overall Study||58
970005|NCT00289991|2346744|P2|COMPLETED|Overall Study||175
970006|NCT00289991|2346745|P1|COMPLETED|Overall Study||176
970007|NCT00289991|2346744|P2|STARTED|Overall Study||255
970008|NCT00289991|2346745|P1|STARTED|Overall Study||234
970009|NCT00290147|2346769|P2|NOT COMPLETED|Overall Study||0
970010|NCT00290147|2346770|P1|NOT COMPLETED|Overall Study||0
970011|NCT00290147|2346769|P2|COMPLETED|Overall Study||12
970012|NCT00290147|2346770|P1|COMPLETED|Overall Study||10
970013|NCT00290147|2346769|P2|STARTED|Overall Study||12
970014|NCT00290147|2346770|P1|STARTED|Overall Study||10
970015|NCT00290186|2346780|P2|NOT COMPLETED|Overall Study||5
970016|NCT00290186|2346781|P1|NOT COMPLETED|Overall Study||5
970017|NCT00290186|2346780|P2|COMPLETED|Overall Study||19
970018|NCT00290186|2346781|P1|COMPLETED|Overall Study||20
970019|NCT00290186|2346780|P2|Completed 6-month Followup Assessments|Overall Study||19
970020|NCT00290186|2346781|P1|Completed 6-month Followup Assessments|Overall Study||20
970021|NCT00290186|2346780|P2|Completed 3-month Followup Assessments|Overall Study||21
970022|NCT00290186|2346781|P1|Completed 3-month Followup Assessments|Overall Study||20
970023|NCT00290186|2346780|P2|Completed Post-treatment Assessments|Overall Study||22
970024|NCT00290186|2346781|P1|Completed Post-treatment Assessments|Overall Study||24
970025|NCT00290186|2346780|P2|Completed 8 Weeks of Treatment|Overall Study||22
970026|NCT00290186|2346781|P1|Completed 8 Weeks of Treatment|Overall Study||24
970027|NCT00290186|2346780|P2|Completed Baseline Assessments|Overall Study||24
970028|NCT00290186|2346781|P1|Completed Baseline Assessments|Overall Study||25
970029|NCT00290186|2346780|P2|STARTED|Overall Study||24
970030|NCT00290186|2346781|P1|STARTED|Overall Study||25
970031|NCT00290199|2346821|P2|NOT COMPLETED|Overall Study||0
970032|NCT00290199|2346822|P1|NOT COMPLETED|Overall Study||0
970033|NCT00290199|2346821|P2|COMPLETED|Overall Study||82
970034|NCT00290199|2346822|P1|COMPLETED|Overall Study||87
970035|NCT00290199|2346821|P2|STARTED|Overall Study||82
970036|NCT00290199|2346822|P1|STARTED|Overall Study||87
970037|NCT00290238|2346836|P2|NOT COMPLETED|Overall Study||41
970038|NCT00290238|2346837|P1|NOT COMPLETED|Overall Study||42
970039|NCT00290238|2346836|P2|COMPLETED|Overall Study||24
970040|NCT00290238|2346837|P1|COMPLETED|Overall Study||15
970041|NCT00290238|2346836|P2|STARTED|Overall Study|One subject had an invalid birth date and was excluded from the Age Categorical counts.|65
970042|NCT00290238|2346837|P1|STARTED|Overall Study||57
970043|NCT00290251|2346845|P3|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
970044|NCT00290251|2346846|P2|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
970045|NCT00290251|2346847|P1|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
970046|NCT00290251|2346845|P3|COMPLETED|Elective Extension (to 12 Months no Rx)||5
970047|NCT00290251|2346846|P2|COMPLETED|Elective Extension (to 12 Months no Rx)||3
970048|NCT00290251|2346847|P1|COMPLETED|Elective Extension (to 12 Months no Rx)||5
970049|NCT00290251|2346845|P3|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|5
970050|NCT00290251|2346846|P2|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|3
970051|NCT00290251|2346847|P1|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|5
970052|NCT00290251|2346845|P3|NOT COMPLETED|Treatment 2 (Months 4 - 6)||0
970053|NCT00290251|2346846|P2|NOT COMPLETED|Treatment 2 (Months 4 - 6)||0
970054|NCT00290251|2346847|P1|NOT COMPLETED|Treatment 2 (Months 4 - 6)||2
970055|NCT00290251|2346845|P3|COMPLETED|Treatment 2 (Months 4 - 6)||0
970056|NCT00290251|2346846|P2|COMPLETED|Treatment 2 (Months 4 - 6)||5
970057|NCT00290251|2346847|P1|COMPLETED|Treatment 2 (Months 4 - 6)||6
970058|NCT00290251|2346845|P3|STARTED|Treatment 2 (Months 4 - 6)|Women were randomized from PLC to ulipristal acetate or continued same dose ulipristal acetate|0
970059|NCT00290251|2346846|P2|STARTED|Treatment 2 (Months 4 - 6)|2 crossed over from placebo; others in treatment 1 PLC or ulipristal acetate 10 grp did not continue|5
970060|NCT00290251|2346847|P1|STARTED|Treatment 2 (Months 4 - 6)|2 crossed over from placebo; others in treatment 1 PLC or ulipristal acetate 20 did not continue|8
970061|NCT00290251|2346845|P3|NOT COMPLETED|Treatment 1 (Months 1 - 3)||2
970062|NCT00290251|2346846|P2|NOT COMPLETED|Treatment 1 (Months 1 - 3)||1
970063|NCT00290251|2346847|P1|NOT COMPLETED|Treatment 1 (Months 1 - 3)||1
970064|NCT00290251|2346845|P3|COMPLETED|Treatment 1 (Months 1 - 3)||12
970065|NCT00290251|2346846|P2|COMPLETED|Treatment 1 (Months 1 - 3)||13
970066|NCT00290251|2346847|P1|COMPLETED|Treatment 1 (Months 1 - 3)||13
970067|NCT00290251|2346845|P3|STARTED|Treatment 1 (Months 1 - 3)||14
970068|NCT00290251|2346846|P2|STARTED|Treatment 1 (Months 1 - 3)||14
970069|NCT00290251|2346847|P1|STARTED|Treatment 1 (Months 1 - 3)||14
970070|NCT00290290|2346859|P2|NOT COMPLETED|Overall Study||18
970071|NCT00290290|2346860|P1|NOT COMPLETED|Overall Study||18
970072|NCT00290290|2346859|P2|COMPLETED|Overall Study||391
970073|NCT00290290|2346860|P1|COMPLETED|Overall Study||422
970074|NCT00290290|2346859|P2|STARTED|Overall Study||409
970075|NCT00290290|2346860|P1|STARTED|Overall Study||440
970076|NCT00290329|2346869|P3|NOT COMPLETED|Overall Study||0
970077|NCT00290329|2346870|P2|NOT COMPLETED|Overall Study||0
970078|NCT00290329|2346871|P1|NOT COMPLETED|Overall Study||0
970079|NCT00290329|2346869|P3|COMPLETED|Overall Study||61
970080|NCT00290329|2346870|P2|COMPLETED|Overall Study||86
970081|NCT00290329|2346871|P1|COMPLETED|Overall Study||102
970082|NCT00290329|2346869|P3|STARTED|Overall Study||61
970083|NCT00290329|2346870|P2|STARTED|Overall Study||86
970084|NCT00290329|2346871|P1|STARTED|Overall Study||102
970085|NCT00290407|2346891|P1|NOT COMPLETED|Overall Study||0
970086|NCT00290407|2346891|P1|COMPLETED|Overall Study||2
970087|NCT00290407|2346891|P1|STARTED|Overall Study||2
970088|NCT00290472|2346898|P3|NOT COMPLETED|Overall Study||0
970089|NCT00290472|2346899|P2|NOT COMPLETED|Overall Study||0
970090|NCT00290472|2346900|P1|NOT COMPLETED|Overall Study||0
970091|NCT00290472|2346898|P3|COMPLETED|Overall Study||18
970092|NCT00290472|2346899|P2|COMPLETED|Overall Study||39
970093|NCT00290472|2346900|P1|COMPLETED|Overall Study||32
970094|NCT00290472|2346898|P3|STARTED|Overall Study||18
970095|NCT00290472|2346899|P2|STARTED|Overall Study||39
970096|NCT00290472|2346900|P1|STARTED|Overall Study||32
970097|NCT00290537|2346912|P2|NOT COMPLETED|Overall Study||0
970098|NCT00290537|2346913|P1|NOT COMPLETED|Overall Study||0
970099|NCT00290537|2346912|P2|COMPLETED|Overall Study||0
970100|NCT00290537|2346913|P1|COMPLETED|Overall Study||4
970101|NCT00290537|2346912|P2|STARTED|Overall Study||0
970102|NCT00290537|2346913|P1|STARTED|Overall Study||4
970103|NCT00290615|2346918|P1|NOT COMPLETED|Overall Study||0
970104|NCT00290615|2346918|P1|COMPLETED|Overall Study||30
970105|NCT00290615|2346918|P1|STARTED|Overall Study||30
970106|NCT00290654|2346925|P1|NOT COMPLETED|Overall Study||0
970107|NCT00290654|2346925|P1|COMPLETED|Overall Study||41
970108|NCT00290654|2346925|P1|STARTED|Overall Study||41
970112|NCT00290732|2346943|P5|NOT COMPLETED|Overall Study||0
970113|NCT00290732|2346944|P4|NOT COMPLETED|Overall Study||0
970114|NCT00290732|2346945|P3|NOT COMPLETED|Overall Study||1
970115|NCT00290732|2346946|P2|NOT COMPLETED|Overall Study||1
970116|NCT00290732|2346947|P1|NOT COMPLETED|Overall Study||0
970117|NCT00290732|2346943|P5|COMPLETED|Overall Study||3
970118|NCT00290732|2346944|P4|COMPLETED|Overall Study||6
970119|NCT00290732|2346945|P3|COMPLETED|Overall Study||3
970120|NCT00290732|2346946|P2|COMPLETED|Overall Study||3
970121|NCT00290732|2346947|P1|COMPLETED|Overall Study||3
970122|NCT00290732|2346943|P5|STARTED|Overall Study||3
970123|NCT00290732|2346944|P4|STARTED|Overall Study||6
970124|NCT00290732|2346945|P3|STARTED|Overall Study||4
970125|NCT00290732|2346946|P2|STARTED|Overall Study||4
970126|NCT00290732|2346947|P1|STARTED|Overall Study||3
970127|NCT00290758|2346967|P2|NOT COMPLETED|Post Intervention rFNA||5
970128|NCT00290758|2346968|P1|NOT COMPLETED|Post Intervention rFNA||6
970129|NCT00290758|2346967|P2|COMPLETED|Post Intervention rFNA||49
970130|NCT00290758|2346968|P1|COMPLETED|Post Intervention rFNA||49
970131|NCT00290758|2346967|P2|STARTED|Post Intervention rFNA||54
970132|NCT00290758|2346968|P1|STARTED|Post Intervention rFNA||55
970133|NCT00290758|2346967|P2|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||10
970134|NCT00290758|2346968|P1|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||7
970135|NCT00290758|2346967|P2|COMPLETED|Pre-Intervention rFNA Through Follow-Up||54
970136|NCT00290758|2346968|P1|COMPLETED|Pre-Intervention rFNA Through Follow-Up||55
970137|NCT00290758|2346967|P2|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||54
970138|NCT00290758|2346968|P1|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||55
970139|NCT00290758|2346967|P2|Treatment|Pre-Intervention rFNA Through Follow-Up||64
970140|NCT00290758|2346968|P1|Treatment|Pre-Intervention rFNA Through Follow-Up||61
970141|NCT00290758|2346967|P2|Randomization|Pre-Intervention rFNA Through Follow-Up||62
970142|NCT00290758|2346968|P1|Randomization|Pre-Intervention rFNA Through Follow-Up||62
970143|NCT00290758|2346967|P2|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||64
970144|NCT00290758|2346968|P1|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||62
970145|NCT00290758|2346967|P2|STARTED|Pre-Intervention rFNA Through Follow-Up||64
970146|NCT00290758|2346968|P1|STARTED|Pre-Intervention rFNA Through Follow-Up||62
970147|NCT00278863|2346990|P2|NOT COMPLETED|Overall Study||2
970148|NCT00278863|2346991|P1|NOT COMPLETED|Overall Study||5
970149|NCT00278863|2346990|P2|COMPLETED|Overall Study||45
970150|NCT00278863|2346991|P1|COMPLETED|Overall Study||44
970151|NCT00278863|2346990|P2|STARTED|Overall Study||47
970152|NCT00278863|2346991|P1|STARTED|Overall Study||49
970153|NCT00278876|2346999|P1|NOT COMPLETED|Overall Study||9
970154|NCT00278876|2346999|P1|COMPLETED|Overall Study||38
970155|NCT00278876|2346999|P1|STARTED|Overall Study||47
970156|NCT00278889|2347008|P3|NOT COMPLETED|Overall Study||20
970157|NCT00278889|2347009|P2|NOT COMPLETED|Overall Study||27
970158|NCT00278889|2347010|P1|NOT COMPLETED|Overall Study||25
970159|NCT00278889|2347008|P3|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
970160|NCT00278889|2347009|P2|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|47
970161|NCT00278889|2347010|P1|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
970162|NCT00278889|2347008|P3|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|19
970163|NCT00278889|2347009|P2|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|20
970164|NCT00278889|2347010|P1|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|16
970165|NCT00278889|2347008|P3|STARTED|Overall Study|Randomised|68
970166|NCT00278889|2347009|P2|STARTED|Overall Study|Randomised|74
970167|NCT00278889|2347010|P1|STARTED|Overall Study|Randomised|73
970168|NCT00278915|2347036|P1|NOT COMPLETED|Overall Study||1
970169|NCT00278915|2347036|P1|COMPLETED|Overall Study||29
970170|NCT00278915|2347036|P1|STARTED|Overall Study|First 6 patients were dosed at 2mg/kg then increased to 4 mg/kg. Remaining 24 were dosed at 4mg/kg.|30
970171|NCT00278954|2347069|P1|NOT COMPLETED|Overall Study||5
970172|NCT00278954|2347069|P1|COMPLETED|Overall Study||45
970173|NCT00278954|2347069|P1|STARTED|Overall Study||50
970174|NCT00278993|2347077|P1|NOT COMPLETED|Overall Study||107
970175|NCT00278993|2347077|P1|COMPLETED|Overall Study||1
970176|NCT00278993|2347077|P1|STARTED|Overall Study||108
970177|NCT00279201|2347087|P6|NOT COMPLETED|Intensification Addendum||37
970178|NCT00279201|2347088|P5|NOT COMPLETED|Intensification Addendum||29
970179|NCT00279201|2347089|P4|NOT COMPLETED|Intensification Addendum||28
970180|NCT00279201|2347090|P3|NOT COMPLETED|Intensification Addendum||23
970181|NCT00279201|2347091|P2|NOT COMPLETED|Intensification Addendum||0
970182|NCT00279201|2347092|P1|NOT COMPLETED|Intensification Addendum||0
970183|NCT00279201|2347087|P6|COMPLETED|Intensification Addendum||162
970184|NCT00279201|2347088|P5|COMPLETED|Intensification Addendum||142
970185|NCT00279201|2347089|P4|COMPLETED|Intensification Addendum||172
970186|NCT00279201|2347090|P3|COMPLETED|Intensification Addendum||151
970187|NCT00279201|2347091|P2|COMPLETED|Intensification Addendum||0
970188|NCT00279201|2347092|P1|COMPLETED|Intensification Addendum||0
970189|NCT00279201|2347087|P6|STARTED|Intensification Addendum||199
970190|NCT00279201|2347088|P5|STARTED|Intensification Addendum||171
970191|NCT00279201|2347089|P4|STARTED|Intensification Addendum||200
970192|NCT00279201|2347090|P3|STARTED|Intensification Addendum||174
970193|NCT00279201|2347091|P2|STARTED|Intensification Addendum||0
970194|NCT00279201|2347092|P1|STARTED|Intensification Addendum||0
970195|NCT00279201|2347087|P6|NOT COMPLETED|Maintenance||0
970196|NCT00279201|2347088|P5|NOT COMPLETED|Maintenance||0
970197|NCT00279201|2347089|P4|NOT COMPLETED|Maintenance||0
970198|NCT00279201|2347090|P3|NOT COMPLETED|Maintenance||0
970199|NCT00279201|2347091|P2|NOT COMPLETED|Maintenance||234
970200|NCT00279201|2347092|P1|NOT COMPLETED|Maintenance||231
970201|NCT00279201|2347087|P6|COMPLETED|Maintenance||0
970202|NCT00279201|2347088|P5|COMPLETED|Maintenance||0
970203|NCT00279201|2347089|P4|COMPLETED|Maintenance||0
970204|NCT00279201|2347090|P3|COMPLETED|Maintenance||0
970205|NCT00279201|2347091|P2|COMPLETED|Maintenance||239
970206|NCT00279201|2347092|P1|COMPLETED|Maintenance||188
970207|NCT00279201|2347087|P6|STARTED|Maintenance||0
970208|NCT00279201|2347088|P5|STARTED|Maintenance||0
970209|NCT00279201|2347089|P4|STARTED|Maintenance||0
970210|NCT00279201|2347090|P3|STARTED|Maintenance||0
970211|NCT00279201|2347091|P2|STARTED|Maintenance|82 left the study after initiation. 345 had HbA1c>7% and enrolled in intensification addendum.|473
970212|NCT00279201|2347092|P1|STARTED|Maintenance|100 left the study after initiation. 399 had HbA1c>7% and enrolled in intensification addendum.|419
970213|NCT00279201|2347087|P6|NOT COMPLETED|Initiation||0
970214|NCT00279201|2347088|P5|NOT COMPLETED|Initiation||0
970215|NCT00279201|2347089|P4|NOT COMPLETED|Initiation||0
970216|NCT00279201|2347090|P3|NOT COMPLETED|Initiation||0
970217|NCT00279201|2347091|P2|NOT COMPLETED|Initiation||145
970218|NCT00279201|2347092|P1|NOT COMPLETED|Initiation||128
970219|NCT00279201|2347087|P6|COMPLETED|Initiation||0
970220|NCT00279201|2347088|P5|COMPLETED|Initiation||0
970221|NCT00279201|2347089|P4|COMPLETED|Initiation||0
970222|NCT00279201|2347090|P3|COMPLETED|Initiation||0
970223|NCT00279201|2347091|P2|COMPLETED|Initiation||900
970224|NCT00279201|2347092|P1|COMPLETED|Initiation||918
970225|NCT00279201|2347087|P6|STARTED|Initiation||0
970226|NCT00279201|2347088|P5|STARTED|Initiation||0
970227|NCT00279201|2347089|P4|STARTED|Initiation||0
970228|NCT00279201|2347090|P3|STARTED|Initiation||0
970229|NCT00279201|2347091|P2|STARTED|Initiation||1045
970230|NCT00279201|2347092|P1|STARTED|Initiation||1046
970231|NCT00279214|2347238|P2|NOT COMPLETED|Overall Study||2
970232|NCT00279214|2347239|P1|NOT COMPLETED|Overall Study||3
970233|NCT00279214|2347238|P2|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
970234|NCT00279214|2347239|P1|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
970235|NCT00279214|2347238|P2|STARTED|Overall Study||21
970236|NCT00279214|2347239|P1|STARTED|Overall Study||22
970237|NCT00279305|2347269|P2|NOT COMPLETED|Overall Study||1
970238|NCT00279305|2347270|P1|NOT COMPLETED|Overall Study||8
970239|NCT00279305|2347269|P2|COMPLETED|Overall Study||29
970240|NCT00279305|2347270|P1|COMPLETED|Overall Study||49
970241|NCT00279305|2347269|P2|STARTED|Overall Study||30
970242|NCT00279305|2347270|P1|STARTED|Overall Study||57
970243|NCT00284739|2347278|P2|NOT COMPLETED|Overall Study||0
970244|NCT00284739|2347279|P1|NOT COMPLETED|Overall Study||0
970245|NCT00284739|2347278|P2|COMPLETED|Overall Study||9
970246|NCT00284739|2347279|P1|COMPLETED|Overall Study||11
970247|NCT00284739|2347278|P2|STARTED|Overall Study||9
970248|NCT00284739|2347279|P1|STARTED|Overall Study||11
970249|NCT00284856|2347292|P3|NOT COMPLETED|Overall Study||60
970250|NCT00284856|2347293|P2|NOT COMPLETED|Overall Study||50
970251|NCT00284856|2347294|P1|NOT COMPLETED|Overall Study||51
970252|NCT00284856|2347292|P3|COMPLETED|Overall Study||276
970253|NCT00284856|2347293|P2|COMPLETED|Overall Study||286
970254|NCT00284856|2347294|P1|COMPLETED|Overall Study||296
970255|NCT00284856|2347292|P3|STARTED|Overall Study||336
970256|NCT00284856|2347293|P2|STARTED|Overall Study||336
970257|NCT00284856|2347294|P1|STARTED|Overall Study||347
970258|NCT00284934|2347310|P2|NOT COMPLETED|Overall Study||3
970259|NCT00284934|2347311|P1|NOT COMPLETED|Overall Study||4
970260|NCT00284934|2347310|P2|COMPLETED|Overall Study||43
970261|NCT00284934|2347311|P1|COMPLETED|Overall Study||44
970262|NCT00284934|2347310|P2|Intent-to-treat Population (ITT)|Overall Study||45
970263|NCT00284934|2347311|P1|Intent-to-treat Population (ITT)|Overall Study||47
970264|NCT00284934|2347310|P2|STARTED|Overall Study||46
970265|NCT00284934|2347311|P1|STARTED|Overall Study||48
970266|NCT00285012|2347325|P2|NOT COMPLETED|Received Study Tx||94
970267|NCT00285012|2347326|P1|NOT COMPLETED|Received Study Tx||72
970268|NCT00285012|2347325|P2|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|157
970269|NCT00285012|2347326|P1|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|176
970270|NCT00285012|2347325|P2|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=14 AE;3 Lack of efficacy;10 Lost to follow up;25 subject withdrawal;6 other, unknown|58
970271|NCT00285012|2347326|P1|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=12 Adverse Event (AE); 10 Lost to follow up; 13 subject withdrawal; 6 other, unknown|41
970272|NCT00285012|2347325|P2|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|193
970273|NCT00285012|2347326|P1|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|207
970274|NCT00285012|2347325|P2|STARTED|Received Study Tx||251
970275|NCT00285012|2347326|P1|STARTED|Received Study Tx||248
970276|NCT00285012|2347325|P2|NOT COMPLETED|Assigned to Study Treatment (Tx)||3
970277|NCT00285012|2347326|P1|NOT COMPLETED|Assigned to Study Treatment (Tx)||2
970278|NCT00285012|2347325|P2|COMPLETED|Assigned to Study Treatment (Tx)||251
970279|NCT00285012|2347326|P1|COMPLETED|Assigned to Study Treatment (Tx)||248
970280|NCT00285012|2347325|P2|STARTED|Assigned to Study Treatment (Tx)||254
970281|NCT00285012|2347326|P1|STARTED|Assigned to Study Treatment (Tx)||250
970282|NCT00290771|2347352|P2|NOT COMPLETED|Overall Study||97
970283|NCT00290771|2347353|P1|NOT COMPLETED|Overall Study||127
970284|NCT00290771|2347352|P2|COMPLETED|Overall Study||3
970285|NCT00290771|2347353|P1|COMPLETED|Overall Study||4
970286|NCT00290771|2347352|P2|STARTED|Overall Study||100
970287|NCT00290771|2347353|P1|STARTED|Overall Study||131
970288|NCT00290810|2347375|P1|NOT COMPLETED|Overall Study||0
970289|NCT00290810|2347375|P1|COMPLETED|Overall Study||12
970290|NCT00290810|2347375|P1|STARTED|Overall Study||12
970291|NCT00290888|2347384|P2|NOT COMPLETED|Overall Study||1
970292|NCT00290888|2347385|P1|NOT COMPLETED|Overall Study||3
970293|NCT00290888|2347384|P2|COMPLETED|Overall Study||44
970294|NCT00290888|2347385|P1|COMPLETED|Overall Study||38
970295|NCT00290888|2347384|P2|STARTED|Overall Study||45
970296|NCT00290888|2347385|P1|STARTED|Overall Study||41
970297|NCT00291018|2347396|P3|NOT COMPLETED|Overall Study||43
970298|NCT00291018|2347397|P2|NOT COMPLETED|Overall Study||42
970299|NCT00291018|2347398|P1|NOT COMPLETED|Overall Study||25
970300|NCT00291018|2347396|P3|COMPLETED|Overall Study|Evaluated at 84 Months|93
970301|NCT00291018|2347397|P2|COMPLETED|Overall Study|Evaluated at 84 Months|64
970302|NCT00291018|2347398|P1|COMPLETED|Overall Study|Evaluated at 84 Months|78
970303|NCT00291018|2347396|P3|Evaluated at 24 Months|Overall Study||105
970304|NCT00291018|2347397|P2|Evaluated at 24 Months|Overall Study||92
970305|NCT00291018|2347398|P1|Evaluated at 24 Months|Overall Study||99
970306|NCT00291018|2347396|P3|STARTED|Overall Study|Started =Subjects Enrolled and Treated. 140 PDC-CA subjects were Enrolled but only 136 were Treated|136
970307|NCT00291018|2347397|P2|STARTED|Overall Study|Started = Subjects Enrolled and Treated. 117 ACDF subjects were Enrolled but only 106 were Treated|106
970308|NCT00291018|2347398|P1|STARTED|Overall Study|Started = Subjects Enrolled and Treated. 111 PDC subjects were Enrolled but only 103 were Treated|103
970309|NCT00294554|2347438|P2|NOT COMPLETED|Overall Study||2
970310|NCT00294554|2347439|P1|NOT COMPLETED|Overall Study||0
970311|NCT00294554|2347438|P2|COMPLETED|Overall Study|"1 S withdrew @ 20 wks for lack perceived benefit
1 S withdrawn @ 13 wks b/o extreme agitation"|8
970312|NCT00294554|2347439|P1|COMPLETED|Overall Study||10
970313|NCT00294554|2347438|P2|STARTED|Overall Study||10
970314|NCT00294554|2347439|P1|STARTED|Overall Study||10
970315|NCT00294645|2347449|P2|NOT COMPLETED|Overall Study||92
970316|NCT00294645|2347450|P1|NOT COMPLETED|Overall Study||48
970317|NCT00294645|2347449|P2|COMPLETED|Overall Study||510
970318|NCT00294645|2347450|P1|COMPLETED|Overall Study||247
970319|NCT00294645|2347449|P2|STARTED|Overall Study||602
970320|NCT00294645|2347450|P1|STARTED|Overall Study||295
970321|NCT00294658|2347484|P2|NOT COMPLETED|Overall Study||9
970322|NCT00294658|2347485|P1|NOT COMPLETED|Overall Study||6
970323|NCT00294658|2347484|P2|COMPLETED|Overall Study||51
970324|NCT00294658|2347485|P1|COMPLETED|Overall Study||60
970325|NCT00294658|2347484|P2|STARTED|Overall Study||60
970326|NCT00294658|2347485|P1|STARTED|Overall Study||66
970327|NCT00294671|2347549|P2|NOT COMPLETED|Overall Study||40
970328|NCT00294671|2347550|P1|NOT COMPLETED|Overall Study||27
970329|NCT00294671|2347549|P2|COMPLETED|Overall Study||26
970330|NCT00294671|2347550|P1|COMPLETED|Overall Study||37
970331|NCT00294671|2347549|P2|STARTED|Overall Study||66
970332|NCT00294671|2347550|P1|STARTED|Overall Study||64
970333|NCT00294684|2347566|P2|NOT COMPLETED|Overall Study||8
970334|NCT00294684|2347567|P1|NOT COMPLETED|Overall Study||5
970335|NCT00294684|2347566|P2|COMPLETED|Overall Study||62
970336|NCT00294684|2347567|P1|COMPLETED|Overall Study||65
970337|NCT00294684|2347566|P2|STARTED|Overall Study||70
970338|NCT00294684|2347567|P1|STARTED|Overall Study||70
970339|NCT00294723|2347608|P3|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||20
970340|NCT00294723|2347609|P2|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||21
970341|NCT00294723|2347610|P1|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||28
970342|NCT00294723|2347608|P3|COMPLETED|Additional Open-Label Extension 91 Weeks||8
970343|NCT00294723|2347609|P2|COMPLETED|Additional Open-Label Extension 91 Weeks||32
970344|NCT00294723|2347610|P1|COMPLETED|Additional Open-Label Extension 91 Weeks||34
970345|NCT00294723|2347608|P3|STARTED|Additional Open-Label Extension 91 Weeks|69 subjects did not continue into the extension period|28
970346|NCT00294723|2347609|P2|STARTED|Additional Open-Label Extension 91 Weeks|57 subjects did not continue into the extension period|53
970347|NCT00294723|2347610|P1|STARTED|Additional Open-Label Extension 91 Weeks|52 subjects did not continue into the extension period|62
970348|NCT00294723|2347608|P3|NOT COMPLETED|Open-Label Extension 52 Weeks||40
970349|NCT00294723|2347609|P2|NOT COMPLETED|Open-Label Extension 52 Weeks||39
970350|NCT00294723|2347610|P1|NOT COMPLETED|Open-Label Extension 52 Weeks||40
970351|NCT00294723|2347608|P3|COMPLETED|Open-Label Extension 52 Weeks||97
970352|NCT00294723|2347609|P2|COMPLETED|Open-Label Extension 52 Weeks||110
970353|NCT00294723|2347610|P1|COMPLETED|Open-Label Extension 52 Weeks||114
970354|NCT00294723|2347608|P3|STARTED|Open-Label Extension 52 Weeks|15 subjects did not continue into the extension period|137
970355|NCT00294723|2347609|P2|STARTED|Open-Label Extension 52 Weeks|13 subjects did not continue into the extension period|149
970356|NCT00294723|2347610|P1|STARTED|Open-Label Extension 52 Weeks|19 subjects did not continue into the extension period|154
970357|NCT00294723|2347608|P3|NOT COMPLETED|Double-Blind Period 52 Weeks||96
970358|NCT00294723|2347609|P2|NOT COMPLETED|Double-Blind Period 52 Weeks||89
970359|NCT00294723|2347610|P1|NOT COMPLETED|Double-Blind Period 52 Weeks||74
970360|NCT00294723|2347608|P3|COMPLETED|Double-Blind Period 52 Weeks||152
970361|NCT00294723|2347609|P2|COMPLETED|Double-Blind Period 52 Weeks||162
970362|NCT00294723|2347610|P1|COMPLETED|Double-Blind Period 52 Weeks||173
970363|NCT00294723|2347608|P3|Exposed to Study Drug|Double-Blind Period 52 Weeks||248
970364|NCT00294723|2347609|P2|Exposed to Study Drug|Double-Blind Period 52 Weeks||251
970365|NCT00294723|2347610|P1|Exposed to Study Drug|Double-Blind Period 52 Weeks|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|246
970366|NCT00294723|2347608|P3|STARTED|Double-Blind Period 52 Weeks|Randomised|248
970367|NCT00294723|2347609|P2|STARTED|Double-Blind Period 52 Weeks|Randomised|251
970368|NCT00294723|2347610|P1|STARTED|Double-Blind Period 52 Weeks|Randomised|247
970369|NCT00294762|2347671|P2|NOT COMPLETED|Overall Study||3
970370|NCT00294762|2347672|P1|NOT COMPLETED|Overall Study||3
970371|NCT00294762|2347671|P2|COMPLETED|Overall Study||68
970372|NCT00294762|2347672|P1|COMPLETED|Overall Study||69
970373|NCT00294762|2347671|P2|STARTED|Overall Study||71
970374|NCT00294762|2347672|P1|STARTED|Overall Study||72
970375|NCT00295009|2347694|P6|NOT COMPLETED|Overall Study||269
970376|NCT00295009|2347695|P5|NOT COMPLETED|Overall Study||58
970377|NCT00295009|2347696|P4|NOT COMPLETED|Overall Study||25
970378|NCT00295009|2347697|P3|NOT COMPLETED|Overall Study||12
970379|NCT00295009|2347698|P2|NOT COMPLETED|Overall Study||49
970380|NCT00295009|2347699|P1|NOT COMPLETED|Overall Study||41
970381|NCT00295009|2347694|P6|COMPLETED|Overall Study|Continued Access patients were only followed out to 24 months|0
970382|NCT00295009|2347695|P5|COMPLETED|Overall Study|Completed 60 month visit|116
970383|NCT00295009|2347696|P4|COMPLETED|Overall Study|Completed 60 month visit|57
970384|NCT00295009|2347697|P3|COMPLETED|Overall Study|Completed 60 month visit|39
970385|NCT00295009|2347698|P2|COMPLETED|Overall Study|Completed 60 month visit|134
970386|NCT00295009|2347699|P1|COMPLETED|Overall Study|Completed 60 month visit|52
970387|NCT00295009|2347694|P6|Completed 24 Month Analysis|Overall Study||198
970388|NCT00295009|2347695|P5|Completed 24 Month Analysis|Overall Study||133
970389|NCT00295009|2347696|P4|Completed 24 Month Analysis|Overall Study||60
970390|NCT00295009|2347697|P3|Completed 24 Month Analysis|Overall Study||45
970391|NCT00295009|2347698|P2|Completed 24 Month Analysis|Overall Study||148
970392|NCT00295009|2347699|P1|Completed 24 Month Analysis|Overall Study||71
970393|NCT00295009|2347694|P6|Treated|Overall Study||259
970394|NCT00295009|2347695|P5|Treated|Overall Study||165
970395|NCT00295009|2347696|P4|Treated|Overall Study||72
970396|NCT00295009|2347697|P3|Treated|Overall Study||50
970397|NCT00295009|2347698|P2|Treated|Overall Study||162
970398|NCT00295009|2347699|P1|Treated|Overall Study||80
970399|NCT00295009|2347694|P6|STARTED|Overall Study||269
970400|NCT00295009|2347695|P5|STARTED|Overall Study||174
970401|NCT00295009|2347696|P4|STARTED|Overall Study||82
970402|NCT00295009|2347697|P3|STARTED|Overall Study||51
970403|NCT00295009|2347698|P2|STARTED|Overall Study||183
970404|NCT00295009|2347699|P1|STARTED|Overall Study||93
970405|NCT00295061|2347721|P2|NOT COMPLETED|Overall Study||0
970406|NCT00295061|2347722|P1|NOT COMPLETED|Overall Study||0
970407|NCT00295061|2347721|P2|COMPLETED|Overall Study||12
970408|NCT00295061|2347722|P1|COMPLETED|Overall Study||12
970409|NCT00295061|2347721|P2|STARTED|Overall Study||12
970410|NCT00295061|2347722|P1|STARTED|Overall Study||12
970411|NCT00295490|2347732|P4|NOT COMPLETED|Overall Study||5
970412|NCT00295490|2347733|P3|NOT COMPLETED|Overall Study||4
970413|NCT00295490|2347734|P2|NOT COMPLETED|Overall Study||4
970414|NCT00295490|2347735|P1|NOT COMPLETED|Overall Study||1
970415|NCT00295490|2347732|P4|COMPLETED|Overall Study||12
970416|NCT00295490|2347733|P3|COMPLETED|Overall Study||12
970417|NCT00295490|2347734|P2|COMPLETED|Overall Study||15
970418|NCT00295490|2347735|P1|COMPLETED|Overall Study||14
970419|NCT00295490|2347732|P4|STARTED|Overall Study||17
970420|NCT00295490|2347733|P3|STARTED|Overall Study||16
970421|NCT00295490|2347734|P2|STARTED|Overall Study||19
970422|NCT00295490|2347735|P1|STARTED|Overall Study||15
970423|NCT00295503|2347773|P1|NOT COMPLETED|Overall Study||0
970424|NCT00295503|2347773|P1|COMPLETED|Overall Study||53
970425|NCT00295503|2347773|P1|STARTED|Overall Study||53
970426|NCT00295633|2347782|P3|NOT COMPLETED|Overall Study||76
970427|NCT00295633|2347783|P2|NOT COMPLETED|Overall Study||67
970428|NCT00295633|2347784|P1|NOT COMPLETED|Overall Study||62
970429|NCT00295633|2347782|P3|COMPLETED|Overall Study||108
970430|NCT00295633|2347783|P2|COMPLETED|Overall Study||119
970431|NCT00295633|2347784|P1|COMPLETED|Overall Study||133
970432|NCT00295633|2347782|P3|Completed Study Without Being Rescued|Overall Study||51
970433|NCT00295633|2347783|P2|Completed Study Without Being Rescued|Overall Study||82
970434|NCT00295633|2347784|P1|Completed Study Without Being Rescued|Overall Study||88
970435|NCT00295633|2347782|P3|STARTED|Overall Study||184
970436|NCT00295633|2347783|P2|STARTED|Overall Study||186
970437|NCT00295633|2347784|P1|STARTED|Overall Study||195
970438|NCT00295750|2347804|P3|NOT COMPLETED|Overall Study||32
970439|NCT00295750|2347805|P2|NOT COMPLETED|Overall Study||41
970440|NCT00295750|2347806|P1|NOT COMPLETED|Overall Study||43
970441|NCT00295750|2347804|P3|COMPLETED|Overall Study||172
970442|NCT00295750|2347805|P2|COMPLETED|Overall Study||169
970443|NCT00295750|2347806|P1|COMPLETED|Overall Study||163
970444|NCT00295750|2347804|P3|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|201
970445|NCT00295750|2347805|P2|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|207
970446|NCT00295750|2347806|P1|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|202
970447|NCT00295750|2347804|P3|STARTED|Overall Study|randomized|204
970448|NCT00295750|2347805|P2|STARTED|Overall Study|randomized|210
970449|NCT00295750|2347806|P1|STARTED|Overall Study|randomized|206
970450|NCT00295854|2347841|P3|NOT COMPLETED|Overall Study||15
970451|NCT00295854|2347842|P2|NOT COMPLETED|Overall Study||21
970452|NCT00295854|2347843|P1|NOT COMPLETED|Overall Study||18
970453|NCT00295854|2347841|P3|COMPLETED|Overall Study||87
970454|NCT00295854|2347842|P2|COMPLETED|Overall Study||87
970455|NCT00295854|2347843|P1|COMPLETED|Overall Study||77
970456|NCT00295854|2347841|P3|ITT Population (N=296)|Overall Study||99
970457|NCT00295854|2347842|P2|ITT Population (N=296)|Overall Study||105
970458|NCT00295854|2347843|P1|ITT Population (N=296)|Overall Study||92
970459|NCT00295854|2347841|P3|Safety Population (N=304)|Overall Study||101
970460|NCT00295854|2347842|P2|Safety Population (N=304)|Overall Study||108
970461|NCT00295854|2347843|P1|Safety Population (N=304)|Overall Study||95
970462|NCT00295854|2347841|P3|STARTED|Overall Study||102
970463|NCT00295854|2347842|P2|STARTED|Overall Study||108
970464|NCT00295854|2347843|P1|STARTED|Overall Study||95
970465|NCT00295880|2347854|P1|NOT COMPLETED|Overall Study||2
970466|NCT00295880|2347854|P1|COMPLETED|Overall Study||10
970467|NCT00295880|2347854|P1|STARTED|Overall Study||12
970468|NCT00296036|2347867|P6|NOT COMPLETED|Overall Study||4
970469|NCT00296036|2347868|P5|NOT COMPLETED|Overall Study||2
970470|NCT00296036|2347869|P4|NOT COMPLETED|Overall Study||1
970471|NCT00296036|2347870|P3|NOT COMPLETED|Overall Study||2
970472|NCT00296036|2347871|P2|NOT COMPLETED|Overall Study||0
970473|NCT00296036|2347872|P1|NOT COMPLETED|Overall Study||1
970474|NCT00296036|2347867|P6|COMPLETED|Overall Study||28
970475|NCT00296036|2347868|P5|COMPLETED|Overall Study||31
970476|NCT00296036|2347869|P4|COMPLETED|Overall Study||16
970477|NCT00296036|2347870|P3|COMPLETED|Overall Study||16
970478|NCT00296036|2347871|P2|COMPLETED|Overall Study||18
970479|NCT00296036|2347872|P1|COMPLETED|Overall Study||18
970480|NCT00296036|2347867|P6|STARTED|Overall Study||32
970481|NCT00296036|2347868|P5|STARTED|Overall Study||33
970482|NCT00296036|2347869|P4|STARTED|Overall Study||17
970483|NCT00296036|2347870|P3|STARTED|Overall Study||18
970484|NCT00296036|2347871|P2|STARTED|Overall Study||18
970485|NCT00296036|2347872|P1|STARTED|Overall Study||19
970486|NCT00296192|2347903|P5|NOT COMPLETED|Overall Study||0
970487|NCT00296192|2347904|P4|NOT COMPLETED|Overall Study||0
970488|NCT00296192|2347905|P3|NOT COMPLETED|Overall Study||0
970489|NCT00296192|2347906|P2|NOT COMPLETED|Overall Study||0
970490|NCT00296192|2347907|P1|NOT COMPLETED|Overall Study||0
970491|NCT00296192|2347903|P5|COMPLETED|Overall Study||16
970492|NCT00296192|2347904|P4|COMPLETED|Overall Study||17
970493|NCT00296192|2347905|P3|COMPLETED|Overall Study||16
970494|NCT00296192|2347906|P2|COMPLETED|Overall Study||16
970495|NCT00296192|2347907|P1|COMPLETED|Overall Study||17
970496|NCT00296192|2347903|P5|STARTED|Overall Study||16
970497|NCT00296192|2347904|P4|STARTED|Overall Study||17
970498|NCT00296192|2347905|P3|STARTED|Overall Study||16
970499|NCT00296192|2347906|P2|STARTED|Overall Study||16
970500|NCT00296192|2347907|P1|STARTED|Overall Study||17
970501|NCT00296231|2347939|P1|NOT COMPLETED|Overall Study||0
970502|NCT00296231|2347939|P1|COMPLETED|Overall Study||14
970503|NCT00296231|2347939|P1|STARTED|Overall Study||14
970504|NCT00296244|2347946|P2|NOT COMPLETED|Overall Study||1
970505|NCT00296244|2347947|P1|NOT COMPLETED|Overall Study||0
970506|NCT00296244|2347946|P2|COMPLETED|Overall Study||19
970507|NCT00296244|2347947|P1|COMPLETED|Overall Study||20
970508|NCT00296244|2347946|P2|STARTED|Overall Study||20
970509|NCT00296244|2347947|P1|STARTED|Overall Study||20
970510|NCT00296296|2347965|P2|NOT COMPLETED|Overall Study||13
970511|NCT00296296|2347966|P1|NOT COMPLETED|Overall Study||2
970512|NCT00296296|2347965|P2|COMPLETED|Overall Study||5
970513|NCT00296296|2347966|P1|COMPLETED|Overall Study||9
970514|NCT00296296|2347965|P2|STARTED|Overall Study||18
970515|NCT00296296|2347966|P1|STARTED|Overall Study||11
970516|NCT00296322|2347980|P2|NOT COMPLETED|Overall Study||79
970517|NCT00296322|2347981|P1|NOT COMPLETED|Overall Study||21
970518|NCT00296322|2347980|P2|COMPLETED|Overall Study||184
970519|NCT00296322|2347981|P1|COMPLETED|Overall Study||237
970520|NCT00296322|2347980|P2|STARTED|Overall Study||263
970521|NCT00296322|2347981|P1|STARTED|Overall Study||258
970522|NCT00296335|2347993|P2|NOT COMPLETED|Overall Study||122
970523|NCT00296335|2347994|P1|NOT COMPLETED|Overall Study||30
970524|NCT00296335|2347993|P2|COMPLETED|Overall Study||309
970525|NCT00296335|2347994|P1|COMPLETED|Overall Study||394
970526|NCT00296335|2347993|P2|STARTED|Overall Study||431
970527|NCT00296335|2347994|P1|STARTED|Overall Study||424
970528|NCT00296374|2348007|P3|NOT COMPLETED|Overall Study||29
970529|NCT00296374|2348008|P2|NOT COMPLETED|Overall Study||23
970530|NCT00296374|2348009|P1|NOT COMPLETED|Overall Study||25
970531|NCT00296374|2348007|P3|COMPLETED|Overall Study||82
970532|NCT00296374|2348008|P2|COMPLETED|Overall Study||101
970533|NCT00296374|2348009|P1|COMPLETED|Overall Study||93
970534|NCT00296374|2348007|P3|STARTED|Overall Study||111
970535|NCT00296374|2348008|P2|STARTED|Overall Study||124
970536|NCT00296374|2348009|P1|STARTED|Overall Study||118
970537|NCT00296400|2348233|P3|NOT COMPLETED|Overall Study||13
970538|NCT00296400|2348234|P2|NOT COMPLETED|Overall Study||18
970539|NCT00296400|2348235|P1|NOT COMPLETED|Overall Study||17
970540|NCT00296400|2348233|P3|COMPLETED|Overall Study||67
970541|NCT00296400|2348234|P2|COMPLETED|Overall Study||69
970542|NCT00296400|2348235|P1|COMPLETED|Overall Study||53
970543|NCT00296400|2348233|P3|STARTED|Overall Study||80
970544|NCT00296400|2348234|P2|STARTED|Overall Study||87
970545|NCT00296400|2348235|P1|STARTED|Overall Study||70
970546|NCT00296491|2348460|P4|NOT COMPLETED|Overall Study||43
970547|NCT00296491|2348461|P3|NOT COMPLETED|Overall Study||43
970548|NCT00296491|2348462|P2|NOT COMPLETED|Overall Study||53
970549|NCT00296491|2348463|P1|NOT COMPLETED|Overall Study||42
970550|NCT00296491|2348460|P4|COMPLETED|Overall Study||138
970551|NCT00296491|2348461|P3|COMPLETED|Overall Study||137
970552|NCT00296491|2348462|P2|COMPLETED|Overall Study||129
970553|NCT00296491|2348463|P1|COMPLETED|Overall Study||140
970554|NCT00296491|2348460|P4|STARTED|Overall Study||181
970555|NCT00296491|2348461|P3|STARTED|Overall Study||180
970556|NCT00296491|2348462|P2|STARTED|Overall Study||182
970557|NCT00296491|2348463|P1|STARTED|Overall Study|Please note: Outcome Measures generally conducts analysis of 2 of the 4 Arms at a time.|182
970558|NCT00296504|2348497|P9|NOT COMPLETED|Final Analysis||21
970559|NCT00296504|2348498|P8|NOT COMPLETED|Final Analysis||0
970560|NCT00296504|2348499|P7|NOT COMPLETED|Final Analysis||0
970561|NCT00296504|2348500|P6|NOT COMPLETED|Final Analysis||0
970562|NCT00296504|2348501|P5|NOT COMPLETED|Final Analysis||0
970563|NCT00296504|2348502|P4|NOT COMPLETED|Final Analysis||0
970564|NCT00296504|2348503|P3|NOT COMPLETED|Final Analysis||0
970565|NCT00296504|2348504|P2|NOT COMPLETED|Final Analysis||0
970566|NCT00296504|2348505|P1|NOT COMPLETED|Final Analysis||0
970567|NCT00296504|2348497|P9|COMPLETED|Final Analysis||90
970568|NCT00296504|2348498|P8|COMPLETED|Final Analysis||0
970569|NCT00296504|2348499|P7|COMPLETED|Final Analysis||0
970570|NCT00296504|2348500|P6|COMPLETED|Final Analysis||0
970571|NCT00296504|2348501|P5|COMPLETED|Final Analysis||0
970572|NCT00296504|2348502|P4|COMPLETED|Final Analysis||0
970573|NCT00296504|2348503|P3|COMPLETED|Final Analysis||0
970574|NCT00296504|2348504|P2|COMPLETED|Final Analysis||0
970575|NCT00296504|2348505|P1|COMPLETED|Final Analysis||0
970576|NCT00296504|2348497|P9|STARTED|Final Analysis|Continued in study; commercial supplies of FPV were unavailable locally at end of Interim Analysis.|111
970577|NCT00296504|2348498|P8|STARTED|Final Analysis||0
970578|NCT00296504|2348499|P7|STARTED|Final Analysis||0
970579|NCT00296504|2348500|P6|STARTED|Final Analysis||0
970580|NCT00296504|2348501|P5|STARTED|Final Analysis||0
970581|NCT00296504|2348502|P4|STARTED|Final Analysis||0
970582|NCT00296504|2348503|P3|STARTED|Final Analysis||0
970583|NCT00296504|2348504|P2|STARTED|Final Analysis||0
970584|NCT00296504|2348505|P1|STARTED|Final Analysis||0
970585|NCT00296504|2348497|P9|NOT COMPLETED|Interim Analysis||0
970586|NCT00296504|2348498|P8|NOT COMPLETED|Interim Analysis||49
970587|NCT00296504|2348499|P7|NOT COMPLETED|Interim Analysis||74
970588|NCT00296504|2348500|P6|NOT COMPLETED|Interim Analysis||37
970589|NCT00296504|2348501|P5|NOT COMPLETED|Interim Analysis||37
970590|NCT00296504|2348502|P4|NOT COMPLETED|Interim Analysis||43
970591|NCT00296504|2348503|P3|NOT COMPLETED|Interim Analysis||105
970592|NCT00296504|2348504|P2|NOT COMPLETED|Interim Analysis||18
970593|NCT00296504|2348505|P1|NOT COMPLETED|Interim Analysis||76
970594|NCT00296504|2348497|P9|COMPLETED|Interim Analysis||0
970595|NCT00296504|2348498|P8|COMPLETED|Interim Analysis||37
970596|NCT00296504|2348499|P7|COMPLETED|Interim Analysis||30
970597|NCT00296504|2348500|P6|COMPLETED|Interim Analysis||41
970598|NCT00296504|2348501|P5|COMPLETED|Interim Analysis||36
970599|NCT00296504|2348502|P4|COMPLETED|Interim Analysis||11
970600|NCT00296504|2348503|P3|COMPLETED|Interim Analysis||116
970601|NCT00296504|2348504|P2|COMPLETED|Interim Analysis||0
970602|NCT00296504|2348505|P1|COMPLETED|Interim Analysis||43
970603|NCT00296504|2348497|P9|Ongoing|Interim Analysis||0
970604|NCT00296504|2348498|P8|Ongoing|Interim Analysis||1
970605|NCT00296504|2348499|P7|Ongoing|Interim Analysis||30
970606|NCT00296504|2348500|P6|Ongoing|Interim Analysis||0
970607|NCT00296504|2348501|P5|Ongoing|Interim Analysis||0
970608|NCT00296504|2348502|P4|Ongoing|Interim Analysis||22
970609|NCT00296504|2348503|P3|Ongoing|Interim Analysis||16
970610|NCT00296504|2348504|P2|Ongoing|Interim Analysis||12
970611|NCT00296504|2348505|P1|Ongoing|Interim Analysis||32
970612|NCT00296504|2348497|P9|STARTED|Interim Analysis||0
970613|NCT00296504|2348498|P8|STARTED|Interim Analysis||86
970614|NCT00296504|2348499|P7|STARTED|Interim Analysis||104
970615|NCT00296504|2348500|P6|STARTED|Interim Analysis||78
970616|NCT00296504|2348501|P5|STARTED|Interim Analysis||73
970617|NCT00296504|2348502|P4|STARTED|Interim Analysis||54
970618|NCT00296504|2348503|P3|STARTED|Interim Analysis||221
970619|NCT00296504|2348504|P2|STARTED|Interim Analysis||18
970620|NCT00296504|2348505|P1|STARTED|Interim Analysis||119
970621|NCT00296517|2348596|P2|NOT COMPLETED|Dose Level 3 - Weeks 3-12||62
970622|NCT00296517|2348597|P1|NOT COMPLETED|Dose Level 3 - Weeks 3-12||45
970623|NCT00296517|2348596|P2|COMPLETED|Dose Level 3 - Weeks 3-12||99
970624|NCT00296517|2348597|P1|COMPLETED|Dose Level 3 - Weeks 3-12||112
970625|NCT00296517|2348596|P2|STARTED|Dose Level 3 - Weeks 3-12||161
970626|NCT00296517|2348597|P1|STARTED|Dose Level 3 - Weeks 3-12||157
970627|NCT00296517|2348596|P2|NOT COMPLETED|Dose Level 2 - Week 2||5
970628|NCT00296517|2348597|P1|NOT COMPLETED|Dose Level 2 - Week 2||2
970629|NCT00296517|2348596|P2|COMPLETED|Dose Level 2 - Week 2||161
970630|NCT00296517|2348597|P1|COMPLETED|Dose Level 2 - Week 2||157
970631|NCT00296517|2348596|P2|STARTED|Dose Level 2 - Week 2||166
970632|NCT00296517|2348597|P1|STARTED|Dose Level 2 - Week 2||159
970633|NCT00296517|2348596|P2|NOT COMPLETED|Dose Level 1 - Week 1||0
970634|NCT00296517|2348597|P1|NOT COMPLETED|Dose Level 1 - Week 1||0
970635|NCT00296517|2348596|P2|COMPLETED|Dose Level 1 - Week 1||166
970636|NCT00296517|2348597|P1|COMPLETED|Dose Level 1 - Week 1||159
970637|NCT00296517|2348596|P2|STARTED|Dose Level 1 - Week 1||166
970638|NCT00296517|2348597|P1|STARTED|Dose Level 1 - Week 1||159
970639|NCT00296647|2348630|P5|NOT COMPLETED|Overall Study||20
970640|NCT00296647|2348631|P4|NOT COMPLETED|Overall Study||17
970641|NCT00296647|2348632|P3|NOT COMPLETED|Overall Study||34
970642|NCT00296647|2348633|P2|NOT COMPLETED|Overall Study||28
970643|NCT00296647|2348634|P1|NOT COMPLETED|Overall Study||32
970644|NCT00296647|2348630|P5|COMPLETED|Overall Study||248
970645|NCT00296647|2348631|P4|COMPLETED|Overall Study||262
970646|NCT00296647|2348632|P3|COMPLETED|Overall Study||222
970647|NCT00296647|2348633|P2|COMPLETED|Overall Study||233
970648|NCT00296647|2348634|P1|COMPLETED|Overall Study||250
970649|NCT00296647|2348630|P5|STARTED|Overall Study||268
970650|NCT00296647|2348631|P4|STARTED|Overall Study||279
970651|NCT00296647|2348632|P3|STARTED|Overall Study||256
970652|NCT00296647|2348633|P2|STARTED|Overall Study||261
970653|NCT00296647|2348634|P1|STARTED|Overall Study||282
970654|NCT00296816|2348648|P1|NOT COMPLETED|Overall Study||74
970655|NCT00296816|2348648|P1|COMPLETED|Overall Study|Completed study treatment for a minimum of three years|58
970656|NCT00296816|2348648|P1|STARTED|Overall Study||132
970657|NCT00297037|2348662|P2|NOT COMPLETED|Overall Study||0
970658|NCT00297037|2348663|P1|NOT COMPLETED|Overall Study||2
970659|NCT00297037|2348662|P2|COMPLETED|Overall Study||11
970660|NCT00297037|2348663|P1|COMPLETED|Overall Study||8
970661|NCT00297037|2348662|P2|STARTED|Overall Study||11
970662|NCT00297037|2348663|P1|STARTED|Overall Study||10
970663|NCT00288054|2348673|P1|NOT COMPLETED|Overall Study||24
970664|NCT00288054|2348673|P1|COMPLETED|Overall Study||0
970665|NCT00288054|2348673|P1|STARTED|Overall Study||24
970666|NCT00288067|2348681|P1|NOT COMPLETED|Overall Study||0
970667|NCT00288067|2348681|P1|COMPLETED|Overall Study||32
970668|NCT00288067|2348681|P1|STARTED|Overall Study||32
970669|NCT00288080|2348689|P2|NOT COMPLETED|Overall Study||23
970670|NCT00288080|2348690|P1|NOT COMPLETED|Overall Study||26
970671|NCT00288080|2348689|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|282
970672|NCT00288080|2348690|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|281
970673|NCT00288080|2348689|P2|STARTED|Overall Study||305
970674|NCT00288080|2348690|P1|STARTED|Overall Study||307
970675|NCT00297102|2348708|P2|NOT COMPLETED|Overall Study||233
970676|NCT00297102|2348709|P1|NOT COMPLETED|Overall Study||263
970677|NCT00297102|2348708|P2|COMPLETED|Overall Study||525
970678|NCT00297102|2348709|P1|COMPLETED|Overall Study||502
970679|NCT00297102|2348708|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|758
970680|NCT00297102|2348709|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|765
970681|NCT00297115|2348727|P2|NOT COMPLETED|Overall Study||246
970682|NCT00297115|2348728|P1|NOT COMPLETED|Overall Study||245
970683|NCT00297115|2348727|P2|COMPLETED|Overall Study||550
970684|NCT00297115|2348728|P1|COMPLETED|Overall Study||527
970685|NCT00297115|2348727|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|796
970686|NCT00297115|2348728|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|772
970687|NCT00297167|2348744|P3|NOT COMPLETED|Open-label Dose Normalization Period 2||0
970688|NCT00297167|2348745|P2|NOT COMPLETED|Open-label Dose Normalization Period 2||0
970689|NCT00297167|2348746|P1|NOT COMPLETED|Open-label Dose Normalization Period 2||0
970690|NCT00297167|2348744|P3|COMPLETED|Open-label Dose Normalization Period 2||31
970691|NCT00297167|2348745|P2|COMPLETED|Open-label Dose Normalization Period 2||0
970692|NCT00297167|2348746|P1|COMPLETED|Open-label Dose Normalization Period 2||0
970693|NCT00297167|2348744|P3|STARTED|Open-label Dose Normalization Period 2||31
970694|NCT00297167|2348745|P2|STARTED|Open-label Dose Normalization Period 2||0
970695|NCT00297167|2348746|P1|STARTED|Open-label Dose Normalization Period 2||0
970696|NCT00297167|2348744|P3|NOT COMPLETED|Second Double-blind Intervention Period||0
970697|NCT00297167|2348745|P2|NOT COMPLETED|Second Double-blind Intervention Period||0
970698|NCT00297167|2348746|P1|NOT COMPLETED|Second Double-blind Intervention Period||1
970699|NCT00297167|2348744|P3|COMPLETED|Second Double-blind Intervention Period||0
970700|NCT00297167|2348745|P2|COMPLETED|Second Double-blind Intervention Period||15
970701|NCT00297167|2348746|P1|COMPLETED|Second Double-blind Intervention Period||16
970702|NCT00297167|2348744|P3|STARTED|Second Double-blind Intervention Period||0
970703|NCT00297167|2348745|P2|STARTED|Second Double-blind Intervention Period||15
970704|NCT00297167|2348746|P1|STARTED|Second Double-blind Intervention Period||17
970705|NCT00297167|2348744|P3|NOT COMPLETED|Open-label Dose Normalization Period 1||1
970706|NCT00297167|2348745|P2|NOT COMPLETED|Open-label Dose Normalization Period 1||0
970707|NCT00297167|2348746|P1|NOT COMPLETED|Open-label Dose Normalization Period 1||0
970708|NCT00297167|2348744|P3|COMPLETED|Open-label Dose Normalization Period 1||32
970709|NCT00297167|2348745|P2|COMPLETED|Open-label Dose Normalization Period 1||0
970710|NCT00297167|2348746|P1|COMPLETED|Open-label Dose Normalization Period 1||0
970711|NCT00297167|2348744|P3|STARTED|Open-label Dose Normalization Period 1||33
970712|NCT00297167|2348745|P2|STARTED|Open-label Dose Normalization Period 1||0
970713|NCT00297167|2348746|P1|STARTED|Open-label Dose Normalization Period 1||0
970714|NCT00297167|2348744|P3|NOT COMPLETED|First Double-blind Intervention Period||0
970715|NCT00297167|2348745|P2|NOT COMPLETED|First Double-blind Intervention Period||0
970716|NCT00297167|2348746|P1|NOT COMPLETED|First Double-blind Intervention Period||0
970717|NCT00297167|2348744|P3|COMPLETED|First Double-blind Intervention Period||0
970718|NCT00297167|2348745|P2|COMPLETED|First Double-blind Intervention Period||16
970719|NCT00297167|2348746|P1|COMPLETED|First Double-blind Intervention Period||17
970720|NCT00297167|2348744|P3|STARTED|First Double-blind Intervention Period||0
970721|NCT00297167|2348745|P2|STARTED|First Double-blind Intervention Period||16
970722|NCT00297167|2348746|P1|STARTED|First Double-blind Intervention Period||17
970723|NCT00297232|2348770|P1|NOT COMPLETED|Overall Study||605
970724|NCT00297232|2348770|P1|COMPLETED|Overall Study||489
970725|NCT00297232|2348770|P1|STARTED|Overall Study||1094
970726|NCT00297258|2348776|P1|NOT COMPLETED|Overall Study||142
970727|NCT00297258|2348776|P1|COMPLETED|Overall Study||0
970728|NCT00297258|2348776|P1|STARTED|Overall Study||142
970729|NCT00298233|2348797|P4|NOT COMPLETED|Overall Study||0
970730|NCT00298233|2348798|P3|NOT COMPLETED|Overall Study||0
970731|NCT00298233|2348799|P2|NOT COMPLETED|Overall Study||0
970732|NCT00298233|2348800|P1|NOT COMPLETED|Overall Study||0
970733|NCT00298233|2348797|P4|COMPLETED|Overall Study||124
970734|NCT00298233|2348798|P3|COMPLETED|Overall Study||122
970735|NCT00298233|2348799|P2|COMPLETED|Overall Study||41
970736|NCT00298233|2348800|P1|COMPLETED|Overall Study||39
970737|NCT00298233|2348797|P4|STARTED|Overall Study||124
970738|NCT00298233|2348798|P3|STARTED|Overall Study||122
970739|NCT00298233|2348799|P2|STARTED|Overall Study||41
970740|NCT00298233|2348800|P1|STARTED|Overall Study||39
970741|NCT00298272|2348818|P2|NOT COMPLETED|Safety Follow-up Phase||4
970742|NCT00298272|2348819|P1|NOT COMPLETED|Safety Follow-up Phase||4
970743|NCT00298272|2348818|P2|COMPLETED|Safety Follow-up Phase||13
970744|NCT00298272|2348819|P1|COMPLETED|Safety Follow-up Phase||18
970745|NCT00298272|2348818|P2|STARTED|Safety Follow-up Phase||17
970746|NCT00298272|2348819|P1|STARTED|Safety Follow-up Phase||22
970747|NCT00298272|2348818|P2|NOT COMPLETED|Open Label Retreatment Phase||4
970748|NCT00298272|2348819|P1|NOT COMPLETED|Open Label Retreatment Phase||9
970749|NCT00298272|2348818|P2|COMPLETED|Open Label Retreatment Phase||12
970750|NCT00298272|2348819|P1|COMPLETED|Open Label Retreatment Phase||13
970751|NCT00298272|2348818|P2|Completed to Week 56|Open Label Retreatment Phase||12
970752|NCT00298272|2348819|P1|Completed to Week 56|Open Label Retreatment Phase||13
970753|NCT00298272|2348818|P2|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|15
970754|NCT00298272|2348819|P1|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|22
970755|NCT00298272|2348818|P2|STARTED|Open Label Retreatment Phase||16
970756|NCT00298272|2348819|P1|STARTED|Open Label Retreatment Phase||22
970757|NCT00298272|2348818|P2|NOT COMPLETED|Double-blind Phase||0
970758|NCT00298272|2348819|P1|NOT COMPLETED|Double-blind Phase||8
970759|NCT00298272|2348818|P2|COMPLETED|Double-blind Phase||18
970760|NCT00298272|2348819|P1|COMPLETED|Double-blind Phase||28
970761|NCT00298272|2348818|P2|Completed to Week 56|Double-blind Phase||3
970762|NCT00298272|2348819|P1|Completed to Week 56|Double-blind Phase||8
970763|NCT00298272|2348818|P2|Completed to Week 24|Double-blind Phase|received full course of placebo therapy|18
970764|NCT00298272|2348819|P1|Completed to Week 24|Double-blind Phase|received full course of rituximab therapy|31
970765|NCT00298272|2348818|P2|Safety Population|Double-blind Phase||18
970766|NCT00298272|2348819|P1|Safety Population|Double-blind Phase|received treatment|33
970767|NCT00298272|2348818|P2|STARTED|Double-blind Phase||18
970768|NCT00298272|2348819|P1|STARTED|Double-blind Phase|enrolled and randomized (2:1 scheme)|36
970769|NCT00298363|2348843|P3|NOT COMPLETED|Overall Study||6
970770|NCT00298363|2348844|P2|NOT COMPLETED|Overall Study||8
970771|NCT00298363|2348845|P1|NOT COMPLETED|Overall Study||17
970772|NCT00298363|2348843|P3|COMPLETED|Overall Study|13 completed while taking DB ETV; 3 completed following switch from DB ETV to OL FTC/TDF.|16
970773|NCT00298363|2348844|P2|COMPLETED|Overall Study|34 completed while taking DB FTC/TDF; 3 completed following switch from DB TDF to OL FTC/TDF.|37
970774|NCT00298363|2348845|P1|COMPLETED|Overall Study|22 completed while taking DB TDF; 6 completed following switch from DB TDF to OL FTC/TDF.|28
970775|NCT00298363|2348843|P3|STARTED|Overall Study||22
970776|NCT00298363|2348844|P2|STARTED|Overall Study||45
970777|NCT00298363|2348845|P1|STARTED|Overall Study||45
970778|NCT00298558|2349005|P4|NOT COMPLETED|10th Annual (A10)||163
970779|NCT00298558|2349006|P3|NOT COMPLETED|10th Annual (A10)||171
970780|NCT00298558|2349007|P2|NOT COMPLETED|10th Annual (A10)||153
970781|NCT00298558|2349008|P1|NOT COMPLETED|10th Annual (A10)||172
970782|NCT00298558|2349005|P4|COMPLETED|10th Annual (A10)||285
970783|NCT00298558|2349006|P3|COMPLETED|10th Annual (A10)||319
970784|NCT00298558|2349007|P2|COMPLETED|10th Annual (A10)||316
970785|NCT00298558|2349008|P1|COMPLETED|10th Annual (A10)||300
970786|NCT00298558|2349005|P4|STARTED|10th Annual (A10)||448
970787|NCT00298558|2349006|P3|STARTED|10th Annual (A10)||490
970788|NCT00298558|2349007|P2|STARTED|10th Annual (A10)||469
970789|NCT00298558|2349008|P1|STARTED|10th Annual (A10)||472
970790|NCT00298558|2349005|P4|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||104
970791|NCT00298558|2349006|P3|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||84
970792|NCT00298558|2349007|P2|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||86
970793|NCT00298558|2349008|P1|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||91
970794|NCT00298558|2349005|P4|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||448
970795|NCT00298558|2349006|P3|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||490
970796|NCT00298558|2349007|P2|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||469
970797|NCT00298558|2349008|P1|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||472
970798|NCT00298558|2349005|P4|STARTED|3rd Annual (A3) and 5th Annual (A5)||552
970799|NCT00298558|2349006|P3|STARTED|3rd Annual (A3) and 5th Annual (A5)||574
970800|NCT00298558|2349007|P2|STARTED|3rd Annual (A3) and 5th Annual (A5)||555
970801|NCT00298558|2349008|P1|STARTED|3rd Annual (A3) and 5th Annual (A5)||563
970802|NCT00298558|2349005|P4|NOT COMPLETED|3rd Annual Booster||0
970803|NCT00298558|2349006|P3|NOT COMPLETED|3rd Annual Booster||140
970804|NCT00298558|2349007|P2|NOT COMPLETED|3rd Annual Booster||128
970805|NCT00298558|2349008|P1|NOT COMPLETED|3rd Annual Booster||122
970806|NCT00298558|2349005|P4|COMPLETED|3rd Annual Booster||0
970807|NCT00298558|2349006|P3|COMPLETED|3rd Annual Booster||230
970808|NCT00298558|2349007|P2|COMPLETED|3rd Annual Booster||243
970809|NCT00298558|2349008|P1|COMPLETED|3rd Annual Booster||250
970810|NCT00298558|2349005|P4|STARTED|3rd Annual Booster||0
970811|NCT00298558|2349006|P3|STARTED|3rd Annual Booster||370
970812|NCT00298558|2349007|P2|STARTED|3rd Annual Booster||371
970813|NCT00298558|2349008|P1|STARTED|3rd Annual Booster||372
970814|NCT00298558|2349005|P4|NOT COMPLETED|2nd Annual (A2)||32
970815|NCT00298558|2349006|P3|NOT COMPLETED|2nd Annual (A2)||27
970816|NCT00298558|2349007|P2|NOT COMPLETED|2nd Annual (A2)||11
970817|NCT00298558|2349008|P1|NOT COMPLETED|2nd Annual (A2)||22
970818|NCT00298558|2349005|P4|COMPLETED|2nd Annual (A2)||552
970819|NCT00298558|2349006|P3|COMPLETED|2nd Annual (A2)||574
970820|NCT00298558|2349007|P2|COMPLETED|2nd Annual (A2)||555
970821|NCT00298558|2349008|P1|COMPLETED|2nd Annual (A2)||563
970822|NCT00298558|2349005|P4|STARTED|2nd Annual (A2)||584
970823|NCT00298558|2349006|P3|STARTED|2nd Annual (A2)||601
970824|NCT00298558|2349007|P2|STARTED|2nd Annual (A2)||566
970825|NCT00298558|2349008|P1|STARTED|2nd Annual (A2)||585
970826|NCT00298558|2349005|P4|NOT COMPLETED|1st Annual (A1)||55
970827|NCT00298558|2349006|P3|NOT COMPLETED|1st Annual (A1)||52
970828|NCT00298558|2349007|P2|NOT COMPLETED|1st Annual (A1)||63
970829|NCT00298558|2349008|P1|NOT COMPLETED|1st Annual (A1)||55
970830|NCT00298558|2349005|P4|COMPLETED|1st Annual (A1)||584
970831|NCT00298558|2349006|P3|COMPLETED|1st Annual (A1)||601
970832|NCT00298558|2349007|P2|COMPLETED|1st Annual (A1)||566
970833|NCT00298558|2349008|P1|COMPLETED|1st Annual (A1)||585
970834|NCT00298558|2349005|P4|STARTED|1st Annual (A1)||639
970835|NCT00298558|2349006|P3|STARTED|1st Annual (A1)||653
970836|NCT00298558|2349007|P2|STARTED|1st Annual (A1)||629
970837|NCT00298558|2349008|P1|STARTED|1st Annual (A1)||640
970838|NCT00298558|2349005|P4|NOT COMPLETED|Booster||0
970839|NCT00298558|2349006|P3|NOT COMPLETED|Booster||75
970840|NCT00298558|2349007|P2|NOT COMPLETED|Booster||70
970841|NCT00298558|2349008|P1|NOT COMPLETED|Booster||89
970842|NCT00298558|2349005|P4|COMPLETED|Booster||0
970843|NCT00298558|2349006|P3|COMPLETED|Booster||295
970844|NCT00298558|2349007|P2|COMPLETED|Booster||301
970845|NCT00298558|2349008|P1|COMPLETED|Booster||283
970846|NCT00298558|2349005|P4|STARTED|Booster||0
970847|NCT00298558|2349006|P3|STARTED|Booster||370
970848|NCT00298558|2349007|P2|STARTED|Booster||371
970849|NCT00298558|2349008|P1|STARTED|Booster||372
970850|NCT00298558|2349005|P4|NOT COMPLETED|Immediate Post Test||65
970851|NCT00298558|2349006|P3|NOT COMPLETED|Immediate Post Test||59
970852|NCT00298558|2349007|P2|NOT COMPLETED|Immediate Post Test||76
970853|NCT00298558|2349008|P1|NOT COMPLETED|Immediate Post Test||71
970854|NCT00298558|2349005|P4|COMPLETED|Immediate Post Test||639
970855|NCT00298558|2349006|P3|COMPLETED|Immediate Post Test||653
970856|NCT00298558|2349007|P2|COMPLETED|Immediate Post Test||629
970857|NCT00298558|2349008|P1|COMPLETED|Immediate Post Test||640
970858|NCT00298558|2349005|P4|STARTED|Immediate Post Test||704
970859|NCT00298558|2349006|P3|STARTED|Immediate Post Test||712
970860|NCT00298558|2349007|P2|STARTED|Immediate Post Test||705
970861|NCT00298558|2349008|P1|STARTED|Immediate Post Test||711
970862|NCT00298558|2349005|P4|NOT COMPLETED|Intervention||419
970863|NCT00298558|2349006|P3|NOT COMPLETED|Intervention||75
970864|NCT00298558|2349007|P2|NOT COMPLETED|Intervention||78
970865|NCT00298558|2349008|P1|NOT COMPLETED|Intervention||91
970866|NCT00298558|2349005|P4|COMPLETED|Intervention||285
970867|NCT00298558|2349006|P3|COMPLETED|Intervention||637
970868|NCT00298558|2349007|P2|COMPLETED|Intervention||627
970869|NCT00298558|2349008|P1|COMPLETED|Intervention||620
970870|NCT00298558|2349005|P4|STARTED|Intervention||704
970871|NCT00298558|2349006|P3|STARTED|Intervention||712
970872|NCT00298558|2349007|P2|STARTED|Intervention||705
970873|NCT00298558|2349008|P1|STARTED|Intervention||711
970874|NCT00298558|2349005|P4|NOT COMPLETED|Baseline||0
970875|NCT00298558|2349006|P3|NOT COMPLETED|Baseline||0
970876|NCT00298558|2349007|P2|NOT COMPLETED|Baseline||0
970877|NCT00298558|2349008|P1|NOT COMPLETED|Baseline||0
970878|NCT00298558|2349005|P4|COMPLETED|Baseline||704
970879|NCT00298558|2349006|P3|COMPLETED|Baseline||712
970880|NCT00298558|2349007|P2|COMPLETED|Baseline||705
970881|NCT00298558|2349008|P1|COMPLETED|Baseline||711
970882|NCT00298558|2349005|P4|STARTED|Baseline||704
970883|NCT00298558|2349006|P3|STARTED|Baseline||712
970884|NCT00298558|2349007|P2|STARTED|Baseline||705
970885|NCT00298558|2349008|P1|STARTED|Baseline||711
970886|NCT00298610|2349038|P1|NOT COMPLETED|Overall Study||0
970887|NCT00298610|2349038|P1|COMPLETED|Overall Study||30
970888|NCT00298610|2349038|P1|STARTED|Overall Study||30
970889|NCT00298740|2349048|P1|NOT COMPLETED|Overall Study||9
970890|NCT00298740|2349048|P1|COMPLETED|Overall Study||3
970891|NCT00298740|2349048|P1|STARTED|Overall Study||12
970892|NCT00298766|2349052|P1|NOT COMPLETED|Overall Study||46
970893|NCT00298766|2349052|P1|COMPLETED|Overall Study||24
970894|NCT00298766|2349052|P1|STARTED|Overall Study||70
970895|NCT00299000|2349063|P2|NOT COMPLETED|Overall Study||0
970896|NCT00299000|2349064|P1|NOT COMPLETED|Overall Study||0
970897|NCT00299000|2349063|P2|COMPLETED|Overall Study||2
970898|NCT00299000|2349064|P1|COMPLETED|Overall Study||2
970899|NCT00299000|2349063|P2|STARTED|Overall Study||2
970900|NCT00299000|2349064|P1|STARTED|Overall Study||2
970901|NCT00299104|2349079|P3|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||12
970902|NCT00299104|2349080|P2|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||9
970903|NCT00299104|2349081|P1|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||5
970904|NCT00299104|2349079|P3|COMPLETED|Extended Safety Follow-Up (ESFU) Period||39
970905|NCT00299104|2349080|P2|COMPLETED|Extended Safety Follow-Up (ESFU) Period||31
970906|NCT00299104|2349081|P1|COMPLETED|Extended Safety Follow-Up (ESFU) Period||29
970907|NCT00299104|2349079|P3|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|51
970908|NCT00299104|2349080|P2|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|40
970909|NCT00299104|2349081|P1|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|34
970910|NCT00299104|2349079|P3|NOT COMPLETED|Safety Follow-Up (SFU) Period||37
970911|NCT00299104|2349080|P2|NOT COMPLETED|Safety Follow-Up (SFU) Period||41
970912|NCT00299104|2349081|P1|NOT COMPLETED|Safety Follow-Up (SFU) Period||55
970913|NCT00299104|2349079|P3|COMPLETED|Safety Follow-Up (SFU) Period||176
970914|NCT00299104|2349080|P2|COMPLETED|Safety Follow-Up (SFU) Period||171
970915|NCT00299104|2349081|P1|COMPLETED|Safety Follow-Up (SFU) Period||129
970916|NCT00299104|2349079|P3|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|213
970917|NCT00299104|2349080|P2|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|212
970918|NCT00299104|2349081|P1|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|184
970919|NCT00299104|2349079|P3|NOT COMPLETED|Treatment Period||172
970920|NCT00299104|2349080|P2|NOT COMPLETED|Treatment Period||175
970921|NCT00299104|2349081|P1|NOT COMPLETED|Treatment Period||189
970922|NCT00299104|2349079|P3|COMPLETED|Treatment Period||80
970923|NCT00299104|2349080|P2|COMPLETED|Treatment Period||77
970924|NCT00299104|2349081|P1|COMPLETED|Treatment Period|Completed Week 152|62
970925|NCT00299104|2349079|P3|Completed Week 104|Treatment Period||216
970926|NCT00299104|2349080|P2|Completed Week 104|Treatment Period||213
970927|NCT00299104|2349081|P1|Completed Week 104|Treatment Period||178
970928|NCT00299104|2349079|P3|Completed Week 52|Treatment Period||232
970929|NCT00299104|2349080|P2|Completed Week 52|Treatment Period||227
970930|NCT00299104|2349081|P1|Completed Week 52|Treatment Period||213
970931|NCT00299104|2349079|P3|Completed Week 24|Treatment Period||241
970932|NCT00299104|2349080|P2|Completed Week 24|Treatment Period||240
970933|NCT00299104|2349081|P1|Completed Week 24|Treatment Period||227
970934|NCT00299104|2349079|P3|Safety/ITT: Received Study Drug|Treatment Period||250
970935|NCT00299104|2349080|P2|Safety/ITT: Received Study Drug|Treatment Period||249
970936|NCT00299104|2349081|P1|Safety/ITT: Received Study Drug|Treatment Period||249
970937|NCT00299104|2349079|P3|STARTED|Treatment Period||252
970938|NCT00299104|2349080|P2|STARTED|Treatment Period||252
970939|NCT00299104|2349081|P1|STARTED|Treatment Period||251
970940|NCT00299130|2349179|P3|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||6
970941|NCT00299130|2349180|P2|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||8
970942|NCT00299130|2349181|P1|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
970943|NCT00299130|2349179|P3|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||38
970944|NCT00299130|2349180|P2|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||74
970945|NCT00299130|2349181|P1|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
970946|NCT00299130|2349179|P3|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||44
970947|NCT00299130|2349180|P2|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||82
970948|NCT00299130|2349181|P1|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||0
970949|NCT00299130|2349179|P3|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
970950|NCT00299130|2349180|P2|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
970951|NCT00299130|2349181|P1|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
970952|NCT00299130|2349179|P3|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||123
970953|NCT00299130|2349180|P2|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||120
970954|NCT00299130|2349181|P1|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||122
970955|NCT00299130|2349179|P3|STARTED|Safety Follow-up (SFU) (48 Weeks)||168
970956|NCT00299130|2349180|P2|STARTED|Safety Follow-up (SFU) (48 Weeks)||165
970957|NCT00299130|2349181|P1|STARTED|Safety Follow-up (SFU) (48 Weeks)||167
970958|NCT00299130|2349179|P3|NOT COMPLETED|Treatment Period (up to 5 Years)||50
970959|NCT00299130|2349180|P2|NOT COMPLETED|Treatment Period (up to 5 Years)||43
970960|NCT00299130|2349181|P1|NOT COMPLETED|Treatment Period (up to 5 Years)||53
970961|NCT00299130|2349179|P3|COMPLETED|Treatment Period (up to 5 Years)||121
970962|NCT00299130|2349180|P2|COMPLETED|Treatment Period (up to 5 Years)||125
970963|NCT00299130|2349181|P1|COMPLETED|Treatment Period (up to 5 Years)||119
970964|NCT00299130|2349179|P3|Completed 144 Weeks|Treatment Period (up to 5 Years)||132
970965|NCT00299130|2349180|P2|Completed 144 Weeks|Treatment Period (up to 5 Years)||138
970966|NCT00299130|2349181|P1|Completed 144 Weeks|Treatment Period (up to 5 Years)||133
970967|NCT00299130|2349179|P3|Completed 48 Weeks|Treatment Period (up to 5 Years)||158
970968|NCT00299130|2349180|P2|Completed 48 Weeks|Treatment Period (up to 5 Years)||157
970969|NCT00299130|2349181|P1|Completed 48 Weeks|Treatment Period (up to 5 Years)||155
970970|NCT00299130|2349179|P3|Completed 24 Weeks|Treatment Period (up to 5 Years)||166
970971|NCT00299130|2349180|P2|Completed 24 Weeks|Treatment Period (up to 5 Years)||162
970972|NCT00299130|2349181|P1|Completed 24 Weeks|Treatment Period (up to 5 Years)||159
970973|NCT00299130|2349179|P3|Treated|Treatment Period (up to 5 Years)||170
970974|NCT00299130|2349180|P2|Treated|Treatment Period (up to 5 Years)||167
970975|NCT00299130|2349181|P1|Treated|Treatment Period (up to 5 Years)|155 participants in placebo arm switched to active therapy (rituximab 2 x 0.5g) between Weeks 16-48.|172
970976|NCT00299130|2349179|P3|STARTED|Treatment Period (up to 5 Years)||171
970977|NCT00299130|2349180|P2|STARTED|Treatment Period (up to 5 Years)||168
970978|NCT00299130|2349181|P1|STARTED|Treatment Period (up to 5 Years)||172
970979|NCT00299156|2349286|P3|NOT COMPLETED|Period 2 (Randomized)||0
970980|NCT00299156|2349287|P2|NOT COMPLETED|Period 2 (Randomized)||1
970981|NCT00299156|2349288|P1|NOT COMPLETED|Period 2 (Randomized)||0
970982|NCT00299156|2349286|P3|COMPLETED|Period 2 (Randomized)||16
970983|NCT00299156|2349287|P2|COMPLETED|Period 2 (Randomized)||16
970984|NCT00299156|2349288|P1|COMPLETED|Period 2 (Randomized)||0
970985|NCT00299156|2349286|P3|STARTED|Period 2 (Randomized)||16
970986|NCT00299156|2349287|P2|STARTED|Period 2 (Randomized)||17
970987|NCT00299156|2349288|P1|STARTED|Period 2 (Randomized)||0
970988|NCT00299156|2349286|P3|NOT COMPLETED|Period 1 (Non-Randomized)||0
970989|NCT00299156|2349287|P2|NOT COMPLETED|Period 1 (Non-Randomized)||0
970990|NCT00299156|2349288|P1|NOT COMPLETED|Period 1 (Non-Randomized)||0
970991|NCT00299156|2349286|P3|COMPLETED|Period 1 (Non-Randomized)||0
970992|NCT00299156|2349287|P2|COMPLETED|Period 1 (Non-Randomized)||0
970993|NCT00299156|2349288|P1|COMPLETED|Period 1 (Non-Randomized)||32
970994|NCT00299156|2349286|P3|STARTED|Period 1 (Non-Randomized)||0
970995|NCT00299156|2349287|P2|STARTED|Period 1 (Non-Randomized)||0
970996|NCT00299156|2349288|P1|STARTED|Period 1 (Non-Randomized)||32
970997|NCT00299221|2349298|P2|NOT COMPLETED|Overall Study||0
970998|NCT00299221|2349299|P1|NOT COMPLETED|Overall Study||0
970999|NCT00299221|2349298|P2|COMPLETED|Overall Study||71
971000|NCT00299221|2349299|P1|COMPLETED|Overall Study||79
971001|NCT00299221|2349298|P2|STARTED|Overall Study||71
971002|NCT00299221|2349299|P1|STARTED|Overall Study||79
971003|NCT00299416|2349313|P1|NOT COMPLETED|Overall Study||0
971004|NCT00299416|2349313|P1|COMPLETED|Overall Study||30
971005|NCT00299416|2349313|P1|STARTED|Overall Study||30
971006|NCT00299546|2349322|P3|NOT COMPLETED|Overall Study||86
971007|NCT00299546|2349323|P2|NOT COMPLETED|Overall Study||92
971008|NCT00299546|2349324|P1|NOT COMPLETED|Overall Study||100
971009|NCT00299546|2349322|P3|COMPLETED|Overall Study||67
971010|NCT00299546|2349323|P2|COMPLETED|Overall Study||61
971011|NCT00299546|2349324|P1|COMPLETED|Overall Study||55
971012|NCT00299546|2349322|P3|STARTED|Overall Study||153
971013|NCT00299546|2349323|P2|STARTED|Overall Study||153
971014|NCT00299546|2349324|P1|STARTED|Overall Study||155
971015|NCT00299689|2349349|P1|NOT COMPLETED|Overall Study||0
971016|NCT00299689|2349349|P1|COMPLETED|Overall Study||69
971017|NCT00299689|2349349|P1|STARTED|Overall Study||69
971018|NCT00299702|2349355|P2|NOT COMPLETED|Overall Study||50
971019|NCT00299702|2349356|P1|NOT COMPLETED|Overall Study||53
971020|NCT00299702|2349355|P2|COMPLETED|Overall Study||126
971021|NCT00299702|2349356|P1|COMPLETED|Overall Study||126
971022|NCT00299702|2349355|P2|STARTED|Overall Study||176
971023|NCT00299702|2349356|P1|STARTED|Overall Study||179
971024|NCT00299741|2349364|P1|NOT COMPLETED|Overall Study||0
971025|NCT00299741|2349364|P1|COMPLETED|Overall Study||36
971026|NCT00299741|2349364|P1|STARTED|Overall Study||36
971027|NCT00299975|2349372|P3|NOT COMPLETED|Overall Study||8
971028|NCT00299975|2349373|P2|NOT COMPLETED|Overall Study||1
971029|NCT00299975|2349374|P1|NOT COMPLETED|Overall Study||3
971030|NCT00299975|2349372|P3|COMPLETED|Overall Study||25
971031|NCT00299975|2349373|P2|COMPLETED|Overall Study||31
971032|NCT00299975|2349374|P1|COMPLETED|Overall Study||29
971033|NCT00299975|2349372|P3|Received Allocated Intervention|Overall Study||32
971034|NCT00299975|2349373|P2|Received Allocated Intervention|Overall Study||32
971035|NCT00299975|2349374|P1|Received Allocated Intervention|Overall Study||32
971036|NCT00299975|2349372|P3|STARTED|Overall Study||33
971037|NCT00299975|2349373|P2|STARTED|Overall Study||32
971038|NCT00299975|2349374|P1|STARTED|Overall Study||32
971039|NCT00300235|2349429|P5|NOT COMPLETED|Overall Study||0
971040|NCT00300235|2349430|P4|NOT COMPLETED|Overall Study||0
971041|NCT00300235|2349431|P3|NOT COMPLETED|Overall Study||0
971042|NCT00300235|2349432|P2|NOT COMPLETED|Overall Study||0
971043|NCT00300235|2349433|P1|NOT COMPLETED|Overall Study||0
971044|NCT00300235|2349429|P5|COMPLETED|Overall Study||251
971045|NCT00300235|2349430|P4|COMPLETED|Overall Study||362
971046|NCT00300235|2349431|P3|COMPLETED|Overall Study||398
971047|NCT00300235|2349432|P2|COMPLETED|Overall Study||240
971048|NCT00300235|2349433|P1|COMPLETED|Overall Study||208
971049|NCT00300235|2349429|P5|STARTED|Overall Study||251
971050|NCT00300235|2349430|P4|STARTED|Overall Study||362
971051|NCT00300235|2349431|P3|STARTED|Overall Study||398
971052|NCT00300235|2349432|P2|STARTED|Overall Study||240
971053|NCT00300235|2349433|P1|STARTED|Overall Study||208
971054|NCT00300274|2349448|P3|NOT COMPLETED|Overall Study||45
971055|NCT00300274|2349449|P2|NOT COMPLETED|Overall Study||27
971056|NCT00300274|2349450|P1|NOT COMPLETED|Overall Study||46
971057|NCT00300274|2349448|P3|COMPLETED|Overall Study||226
971058|NCT00300274|2349449|P2|COMPLETED|Overall Study||141
971059|NCT00300274|2349450|P1|COMPLETED|Overall Study||236
971060|NCT00300274|2349448|P3|Completed 12 Month|Overall Study||248
971061|NCT00300274|2349449|P2|Completed 12 Month|Overall Study||149
971062|NCT00300274|2349450|P1|Completed 12 Month|Overall Study||250
971063|NCT00300274|2349448|P3|STARTED|Overall Study||271
971064|NCT00300274|2349449|P2|STARTED|Overall Study||168
971065|NCT00300274|2349450|P1|STARTED|Overall Study||282
971066|NCT00300365|2349487|P2|NOT COMPLETED|Overall Study||2
971067|NCT00300365|2349488|P1|NOT COMPLETED|Overall Study||4
971068|NCT00300365|2349487|P2|COMPLETED|Overall Study||38
971069|NCT00300365|2349488|P1|COMPLETED|Overall Study||34
971070|NCT00300365|2349487|P2|STARTED|Overall Study||40
971071|NCT00300365|2349488|P1|STARTED|Overall Study||38
971072|NCT00300430|2349497|P3|NOT COMPLETED|Overall Study||151
971073|NCT00300430|2349498|P2|NOT COMPLETED|Overall Study||169
971074|NCT00300430|2349499|P1|NOT COMPLETED|Overall Study||367
971075|NCT00300430|2349497|P3|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|350
971076|NCT00300430|2349498|P2|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|345
971077|NCT00300430|2349499|P1|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|819
971078|NCT00300430|2349497|P3|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|501
971079|NCT00300430|2349498|P2|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|514
971080|NCT00300430|2349499|P1|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|1186
971081|NCT00300456|2349537|P6|NOT COMPLETED|Overall Study||11
971082|NCT00300456|2349538|P5|NOT COMPLETED|Overall Study||17
971083|NCT00300456|2349539|P4|NOT COMPLETED|Overall Study||14
971084|NCT00300456|2349540|P3|NOT COMPLETED|Overall Study||21
971085|NCT00300456|2349541|P2|NOT COMPLETED|Overall Study||16
971086|NCT00300456|2349542|P1|NOT COMPLETED|Overall Study||16
971087|NCT00300456|2349537|P6|COMPLETED|Overall Study||48
971088|NCT00300456|2349538|P5|COMPLETED|Overall Study||99
971089|NCT00300456|2349539|P4|COMPLETED|Overall Study||105
971090|NCT00300456|2349540|P3|COMPLETED|Overall Study||98
971091|NCT00300456|2349541|P2|COMPLETED|Overall Study||102
971092|NCT00300456|2349542|P1|COMPLETED|Overall Study||103
971093|NCT00300456|2349537|P6|STARTED|Overall Study||59
971094|NCT00300456|2349538|P5|STARTED|Overall Study||116
971095|NCT00300456|2349539|P4|STARTED|Overall Study||119
971096|NCT00300456|2349540|P3|STARTED|Overall Study||119
971097|NCT00300456|2349541|P2|STARTED|Overall Study||118
971098|NCT00300456|2349542|P1|STARTED|Overall Study|"For all arms, started means treated."|119
971099|NCT00300469|2349604|P6|NOT COMPLETED|Overall Study||9
971100|NCT00300469|2349605|P5|NOT COMPLETED|Overall Study||14
971101|NCT00300469|2349606|P4|NOT COMPLETED|Overall Study||9
971102|NCT00300469|2349607|P3|NOT COMPLETED|Overall Study||17
971103|NCT00300469|2349608|P2|NOT COMPLETED|Overall Study||21
971104|NCT00300469|2349609|P1|NOT COMPLETED|Overall Study||21
971105|NCT00300469|2349604|P6|COMPLETED|Overall Study||46
971106|NCT00300469|2349605|P5|COMPLETED|Overall Study||95
971107|NCT00300469|2349606|P4|COMPLETED|Overall Study||104
971108|NCT00300469|2349607|P3|COMPLETED|Overall Study||95
971109|NCT00300469|2349608|P2|COMPLETED|Overall Study||89
971110|NCT00300469|2349609|P1|COMPLETED|Overall Study||89
971111|NCT00300469|2349604|P6|STARTED|Overall Study||55
971112|NCT00300469|2349605|P5|STARTED|Overall Study||109
971113|NCT00300469|2349606|P4|STARTED|Overall Study||113
971114|NCT00300469|2349607|P3|STARTED|Overall Study||112
971115|NCT00300469|2349608|P2|STARTED|Overall Study||110
971116|NCT00300469|2349609|P1|STARTED|Overall Study|"For all arms, started means treated."|110
971117|NCT00300482|2349671|P6|NOT COMPLETED|Overall Study||16
971118|NCT00300482|2349672|P5|NOT COMPLETED|Overall Study||23
971119|NCT00300482|2349673|P4|NOT COMPLETED|Overall Study||24
971120|NCT00300482|2349674|P3|NOT COMPLETED|Overall Study||51
971121|NCT00300482|2349675|P2|NOT COMPLETED|Overall Study||41
971122|NCT00300482|2349676|P1|NOT COMPLETED|Overall Study||41
971123|NCT00300482|2349671|P6|COMPLETED|Overall Study||115
971124|NCT00300482|2349672|P5|COMPLETED|Overall Study||243
971125|NCT00300482|2349673|P4|COMPLETED|Overall Study||237
971126|NCT00300482|2349674|P3|COMPLETED|Overall Study||208
971127|NCT00300482|2349675|P2|COMPLETED|Overall Study||220
971128|NCT00300482|2349676|P1|COMPLETED|Overall Study||220
971129|NCT00300482|2349671|P6|STARTED|Overall Study||131
971130|NCT00300482|2349672|P5|STARTED|Overall Study||266
971131|NCT00300482|2349673|P4|STARTED|Overall Study||261
971132|NCT00300482|2349674|P3|STARTED|Overall Study||259
971133|NCT00300482|2349675|P2|STARTED|Overall Study||261
971134|NCT00300482|2349676|P1|STARTED|Overall Study|"For all arms, started means treated."|261
971135|NCT00300495|2349734|P2|NOT COMPLETED|Overall Study||1
971136|NCT00300495|2349735|P1|NOT COMPLETED|Overall Study||4
971137|NCT00300495|2349734|P2|COMPLETED|Overall Study||8
971138|NCT00300495|2349735|P1|COMPLETED|Overall Study||6
971139|NCT00300495|2349734|P2|STARTED|Overall Study||9
971140|NCT00300495|2349735|P1|STARTED|Overall Study||10
971141|NCT00300677|2349743|P1|NOT COMPLETED|Overall Study||0
971142|NCT00300677|2349743|P1|COMPLETED|Overall Study||12
971143|NCT00300677|2349743|P1|STARTED|Overall Study||12
971144|NCT00291135|2349750|P1|NOT COMPLETED|Overall Study||0
971145|NCT00291135|2349750|P1|COMPLETED|Overall Study||42
971146|NCT00291135|2349750|P1|STARTED|Overall Study||42
971147|NCT00291161|2349758|P4|NOT COMPLETED|Overall Study||65
971148|NCT00291161|2349759|P3|NOT COMPLETED|Overall Study||93
971149|NCT00291161|2349760|P2|NOT COMPLETED|Overall Study||58
971150|NCT00291161|2349761|P1|NOT COMPLETED|Overall Study||81
971151|NCT00291161|2349758|P4|COMPLETED|Overall Study||122
971152|NCT00291161|2349759|P3|COMPLETED|Overall Study||206
971153|NCT00291161|2349760|P2|COMPLETED|Overall Study||134
971154|NCT00291161|2349761|P1|COMPLETED|Overall Study||235
971155|NCT00291161|2349758|P4|STARTED|Overall Study||187
971156|NCT00291161|2349759|P3|STARTED|Overall Study||299
971157|NCT00291161|2349760|P2|STARTED|Overall Study||192
971158|NCT00291161|2349761|P1|STARTED|Overall Study||316
971159|NCT00291187|2349773|P4|NOT COMPLETED|Overall Study||0
971160|NCT00291187|2349774|P3|NOT COMPLETED|Overall Study||1
971161|NCT00291187|2349775|P2|NOT COMPLETED|Overall Study||0
971162|NCT00291187|2349776|P1|NOT COMPLETED|Overall Study||0
971163|NCT00291187|2349773|P4|COMPLETED|Overall Study||106
971164|NCT00291187|2349774|P3|COMPLETED|Overall Study||102
971165|NCT00291187|2349775|P2|COMPLETED|Overall Study||100
971166|NCT00291187|2349776|P1|COMPLETED|Overall Study||103
971167|NCT00291187|2349773|P4|STARTED|Overall Study||106
971168|NCT00291187|2349774|P3|STARTED|Overall Study||103
971169|NCT00291187|2349775|P2|STARTED|Overall Study||100
971170|NCT00291187|2349776|P1|STARTED|Overall Study||103
971171|NCT00291226|2349800|P2|NOT COMPLETED|Overall Study||1
971172|NCT00291226|2349801|P1|NOT COMPLETED|Overall Study||1
971173|NCT00291226|2349800|P2|COMPLETED|Overall Study||3
971174|NCT00291226|2349801|P1|COMPLETED|Overall Study||3
971175|NCT00291226|2349800|P2|STARTED|Overall Study||4
971176|NCT00291226|2349801|P1|STARTED|Overall Study||4
971177|NCT00291317|2349809|P1|NOT COMPLETED|Overall Study||0
971178|NCT00291317|2349809|P1|COMPLETED|Overall Study||6
971179|NCT00291317|2349809|P1|STARTED|Overall Study||6
971180|NCT00291330|2349816|P2|NOT COMPLETED|Overall Study||97
971181|NCT00291330|2349817|P1|NOT COMPLETED|Overall Study||101
971182|NCT00291330|2349816|P2|COMPLETED|Overall Study|Completed planned observation time|1169
971183|NCT00291330|2349817|P1|COMPLETED|Overall Study|Completed planned observation time|1172
971184|NCT00291330|2349816|P2|STARTED|Overall Study|Started Treatment|1266
971185|NCT00291330|2349817|P1|STARTED|Overall Study|Started Treatment|1273
971186|NCT00291343|2349841|P2|NOT COMPLETED|Overall Study||0
971187|NCT00291343|2349842|P1|NOT COMPLETED|Overall Study||0
971188|NCT00291343|2349841|P2|COMPLETED|Overall Study||93
971189|NCT00291343|2349842|P1|COMPLETED|Overall Study||203
971190|NCT00291343|2349841|P2|STARTED|Overall Study||93
971191|NCT00291343|2349842|P1|STARTED|Overall Study||203
971192|NCT00292162|2349872|P2|NOT COMPLETED|Overall Study||2
971193|NCT00292162|2349873|P1|NOT COMPLETED|Overall Study||1
971194|NCT00292162|2349872|P2|COMPLETED|Overall Study||20
971195|NCT00292162|2349873|P1|COMPLETED|Overall Study||18
971196|NCT00292162|2349872|P2|STARTED|Overall Study||22
971197|NCT00292162|2349873|P1|STARTED|Overall Study||19
971198|NCT00292188|2349891|P3|NOT COMPLETED|Double-Blind||29
971199|NCT00292188|2349892|P2|NOT COMPLETED|Double-Blind||31
971200|NCT00292188|2349893|P1|NOT COMPLETED|Double-Blind||0
971201|NCT00292188|2349891|P3|COMPLETED|Double-Blind||98
971202|NCT00292188|2349892|P2|COMPLETED|Double-Blind||96
971203|NCT00292188|2349893|P1|COMPLETED|Double-Blind||0
971204|NCT00292188|2349891|P3|STARTED|Double-Blind||127
971205|NCT00292188|2349892|P2|STARTED|Double-Blind||127
971206|NCT00292188|2349893|P1|STARTED|Double-Blind||0
971207|NCT00292188|2349891|P3|NOT COMPLETED|Single-Blind||0
971208|NCT00292188|2349892|P2|NOT COMPLETED|Single-Blind||0
971209|NCT00292188|2349893|P1|NOT COMPLETED|Single-Blind||114
971210|NCT00292188|2349891|P3|COMPLETED|Single-Blind||0
971211|NCT00292188|2349892|P2|COMPLETED|Single-Blind||0
971212|NCT00292188|2349893|P1|COMPLETED|Single-Blind||254
971213|NCT00292188|2349891|P3|Received Treatment|Single-Blind||0
971214|NCT00292188|2349892|P2|Received Treatment|Single-Blind||0
971215|NCT00292188|2349893|P1|Received Treatment|Single-Blind||367
971216|NCT00292188|2349891|P3|STARTED|Single-Blind||0
971217|NCT00292188|2349892|P2|STARTED|Single-Blind||0
971218|NCT00292188|2349893|P1|STARTED|Single-Blind||368
971219|NCT00292227|2349954|P3|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
971220|NCT00292227|2349955|P2|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
971221|NCT00292227|2349956|P1|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
971222|NCT00292227|2349954|P3|COMPLETED|Cross-over Period 2 (Day 39)||30
971223|NCT00292227|2349955|P2|COMPLETED|Cross-over Period 2 (Day 39)||31
971224|NCT00292227|2349956|P1|COMPLETED|Cross-over Period 2 (Day 39)||65
971225|NCT00292227|2349954|P3|STARTED|Cross-over Period 2 (Day 39)||30
971226|NCT00292227|2349955|P2|STARTED|Cross-over Period 2 (Day 39)||31
971227|NCT00292227|2349956|P1|STARTED|Cross-over Period 2 (Day 39)||65
971228|NCT00292227|2349954|P3|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
971229|NCT00292227|2349955|P2|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
971230|NCT00292227|2349956|P1|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
971231|NCT00292227|2349954|P3|COMPLETED|Cross-over Period 1 (Day 32)||30
971232|NCT00292227|2349955|P2|COMPLETED|Cross-over Period 1 (Day 32)||31
971233|NCT00292227|2349956|P1|COMPLETED|Cross-over Period 1 (Day 32)||65
971234|NCT00292227|2349954|P3|STARTED|Cross-over Period 1 (Day 32)||30
971235|NCT00292227|2349955|P2|STARTED|Cross-over Period 1 (Day 32)||31
971236|NCT00292227|2349956|P1|STARTED|Cross-over Period 1 (Day 32)||65
971237|NCT00292227|2349954|P3|NOT COMPLETED|Patch Period||3
971238|NCT00292227|2349955|P2|NOT COMPLETED|Patch Period||0
971239|NCT00292227|2349956|P1|NOT COMPLETED|Patch Period||1
971240|NCT00292227|2349954|P3|COMPLETED|Patch Period||30
971241|NCT00292227|2349955|P2|COMPLETED|Patch Period||31
971242|NCT00292227|2349956|P1|COMPLETED|Patch Period||65
971243|NCT00292227|2349954|P3|STARTED|Patch Period||33
971244|NCT00292227|2349955|P2|STARTED|Patch Period||31
971245|NCT00292227|2349956|P1|STARTED|Patch Period||66
971246|NCT00292318|2350038|P2|NOT COMPLETED|Overall Study||1
971247|NCT00292318|2350039|P1|NOT COMPLETED|Overall Study||2
971248|NCT00292318|2350038|P2|COMPLETED|Overall Study||2
971249|NCT00292318|2350039|P1|COMPLETED|Overall Study||2
971250|NCT00292318|2350038|P2|STARTED|Overall Study||3
971251|NCT00292318|2350039|P1|STARTED|Overall Study||4
971252|NCT00292370|2350050|P3|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||7
971253|NCT00292370|2350051|P2|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||4
971254|NCT00292370|2350052|P1|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
971255|NCT00292370|2350050|P3|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||18
971256|NCT00292370|2350051|P2|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||21
971257|NCT00292370|2350052|P1|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
971258|NCT00292370|2350050|P3|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
971259|NCT00292370|2350051|P2|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
971260|NCT00292370|2350052|P1|STARTED|Phase II: OLP + DB Quetiapine or Placebo|"78 Completed Ph I
28 Excluded Ph II:
20 responded
7 declined
1 medical
50 to Arm 2 & 3"|0
971261|NCT00292370|2350050|P3|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
971262|NCT00292370|2350051|P2|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
971263|NCT00292370|2350052|P1|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||46
971264|NCT00292370|2350050|P3|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
971265|NCT00292370|2350051|P2|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
971266|NCT00292370|2350052|P1|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||78
971267|NCT00292370|2350050|P3|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
971268|NCT00292370|2350051|P2|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
971269|NCT00292370|2350052|P1|STARTED|Phase I - Open-Label Paroxetine (OLP)||124
971270|NCT00292461|2350061|P2|NOT COMPLETED|Overall Study||6
971271|NCT00292461|2350062|P1|NOT COMPLETED|Overall Study||10
971272|NCT00292461|2350061|P2|COMPLETED|Overall Study||24
971273|NCT00292461|2350062|P1|COMPLETED|Overall Study||24
971274|NCT00292461|2350061|P2|STARTED|Overall Study||30
971275|NCT00292461|2350062|P1|STARTED|Overall Study||34
971276|NCT00292591|2350077|P3|NOT COMPLETED|Overall Study||58
971277|NCT00292591|2350078|P2|NOT COMPLETED|Overall Study||56
971278|NCT00292591|2350079|P1|NOT COMPLETED|Overall Study||64
971279|NCT00292591|2350077|P3|COMPLETED|Overall Study||110
971280|NCT00292591|2350078|P2|COMPLETED|Overall Study||111
971281|NCT00292591|2350079|P1|COMPLETED|Overall Study||102
971282|NCT00292591|2350077|P3|STARTED|Overall Study||168
971283|NCT00292591|2350078|P2|STARTED|Overall Study||167
971284|NCT00292591|2350079|P1|STARTED|Overall Study||166
971285|NCT00292981|2350087|P1|NOT COMPLETED|Overall Study||39
971286|NCT00292981|2350087|P1|COMPLETED|Overall Study||18
971287|NCT00292981|2350087|P1|STARTED|Overall Study||57
971288|NCT00293020|2350094|P1|NOT COMPLETED|Overall Study||162
971289|NCT00293020|2350094|P1|COMPLETED|Overall Study||82
971290|NCT00293020|2350094|P1|STARTED|Overall Study||244
971291|NCT00293059|2350100|P2|NOT COMPLETED|Overall Study||19
971292|NCT00293059|2350101|P1|NOT COMPLETED|Overall Study||35
971293|NCT00293059|2350100|P2|COMPLETED|Overall Study||51
971294|NCT00293059|2350101|P1|COMPLETED|Overall Study||85
971295|NCT00293059|2350100|P2|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|62
971296|NCT00293059|2350101|P1|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|113
971297|NCT00293059|2350100|P2|Cycle 3/Treatment Day 84|Overall Study||55
971298|NCT00293059|2350101|P1|Cycle 3/Treatment Day 84|Overall Study||100
971299|NCT00293059|2350100|P2|Cycle 1/Treatment Day 28|Overall Study||64
971300|NCT00293059|2350101|P1|Cycle 1/Treatment Day 28|Overall Study||115
971301|NCT00293059|2350100|P2|Subjects Received Treatment|Overall Study||66
971302|NCT00293059|2350101|P1|Subjects Received Treatment|Overall Study||119
971303|NCT00293059|2350100|P2|STARTED|Overall Study||70
971304|NCT00293059|2350101|P1|STARTED|Overall Study||120
971305|NCT00293241|2350215|P2|NOT COMPLETED|Overall Study||41
971306|NCT00293241|2350216|P1|NOT COMPLETED|Overall Study||36
971307|NCT00293241|2350215|P2|COMPLETED|Overall Study||265
971308|NCT00293241|2350216|P1|COMPLETED|Overall Study||263
971309|NCT00293241|2350215|P2|STARTED|Overall Study||306
971310|NCT00293241|2350216|P1|STARTED|Overall Study||299
971311|NCT00293254|2350260|P2|NOT COMPLETED|Open-Label Post Virologic Failure Phase||27
971312|NCT00293254|2350261|P1|NOT COMPLETED|Open-Label Post Virologic Failure Phase||31
971313|NCT00293254|2350260|P2|COMPLETED|Open-Label Post Virologic Failure Phase||37
971314|NCT00293254|2350261|P1|COMPLETED|Open-Label Post Virologic Failure Phase||19
971315|NCT00293254|2350260|P2|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|64
971316|NCT00293254|2350261|P1|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|50
971317|NCT00293254|2350260|P2|NOT COMPLETED|Extension - Open-Label Week 157-240||1
971318|NCT00293254|2350261|P1|NOT COMPLETED|Extension - Open-Label Week 157-240||10
971319|NCT00293254|2350260|P2|COMPLETED|Extension - Open-Label Week 157-240||18
971320|NCT00293254|2350261|P1|COMPLETED|Extension - Open-Label Week 157-240||110
971321|NCT00293254|2350260|P2|STARTED|Extension - Open-Label Week 157-240|6 of 25 participants who completed the double-blind phase did not enter this open-label phase.|19
971322|NCT00293254|2350261|P1|STARTED|Extension - Open-Label Week 157-240||120
971323|NCT00293254|2350260|P2|NOT COMPLETED|Extension - Double-Blind Week 49-156||29
971324|NCT00293254|2350261|P1|NOT COMPLETED|Extension - Double-Blind Week 49-156||57
971325|NCT00293254|2350260|P2|COMPLETED|Extension - Double-Blind Week 49-156||25
971326|NCT00293254|2350261|P1|COMPLETED|Extension - Double-Blind Week 49-156||120
971327|NCT00293254|2350260|P2|STARTED|Extension - Double-Blind Week 49-156|1 of 55 participants who completed Week 48 did not enter the extension study.|54
971328|NCT00293254|2350261|P1|STARTED|Extension - Double-Blind Week 49-156||177
971329|NCT00293254|2350260|P2|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||64
971330|NCT00293254|2350261|P1|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||55
971331|NCT00293254|2350260|P2|COMPLETED|Primary Study - Double-Blind Week 0-48||55
971332|NCT00293254|2350261|P1|COMPLETED|Primary Study - Double-Blind Week 0-48||177
971333|NCT00293254|2350260|P2|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the OLPVF phase|55
971334|NCT00293254|2350261|P1|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the Open-Label Post-Virologic Failure (OLPVF) Phase|177
971335|NCT00293254|2350260|P2|Treated|Primary Study - Double-Blind Week 0-48||119
971336|NCT00293254|2350261|P1|Treated|Primary Study - Double-Blind Week 0-48||230
971337|NCT00293254|2350260|P2|STARTED|Primary Study - Double-Blind Week 0-48||119
971338|NCT00293254|2350261|P1|STARTED|Primary Study - Double-Blind Week 0-48||232
971339|NCT00293267|2350301|P2|NOT COMPLETED|Open-Label Post Virologic Failure Phase||37
971340|NCT00293267|2350302|P1|NOT COMPLETED|Open-Label Post Virologic Failure Phase||33
971341|NCT00293267|2350301|P2|COMPLETED|Open-Label Post Virologic Failure Phase||29
971342|NCT00293267|2350302|P1|COMPLETED|Open-Label Post Virologic Failure Phase||15
971343|NCT00293267|2350301|P2|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|66
971344|NCT00293267|2350302|P1|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|48
971345|NCT00293267|2350301|P2|NOT COMPLETED|Extension - Open-Label Week 157-240||2
971346|NCT00293267|2350302|P1|NOT COMPLETED|Extension - Open-Label Week 157-240||20
971347|NCT00293267|2350301|P2|COMPLETED|Extension - Open-Label Week 157-240||26
971348|NCT00293267|2350302|P1|COMPLETED|Extension - Open-Label Week 157-240||111
971434|NCT00294515|2350584|P2|COMPLETED|Overall Study||132
971349|NCT00293267|2350301|P2|STARTED|Extension - Open-Label Week 157-240|7 of 35 participants who completed the double-blind phase did not enter this open-label phase|28
971350|NCT00293267|2350302|P1|STARTED|Extension - Open-Label Week 157-240|8 of 139 participants who completed the double-blind phase did not enter this open-label phase|131
971351|NCT00293267|2350301|P2|NOT COMPLETED|Extension - Double-Blind Week 49-156||15
971352|NCT00293267|2350302|P1|NOT COMPLETED|Extension - Double-Blind Week 49-156||52
971353|NCT00293267|2350301|P2|COMPLETED|Extension - Double-Blind Week 49-156||35
971354|NCT00293267|2350302|P1|COMPLETED|Extension - Double-Blind Week 49-156||139
971355|NCT00293267|2350301|P2|STARTED|Extension - Double-Blind Week 49-156||50
971356|NCT00293267|2350302|P1|STARTED|Extension - Double-Blind Week 49-156|2 participants who completed Week 48 did not enter the extension study|191
971357|NCT00293267|2350301|P2|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||68
971358|NCT00293267|2350302|P1|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||41
971359|NCT00293267|2350301|P2|COMPLETED|Primary Study - Double-Blind Week 0-48||50
971360|NCT00293267|2350302|P1|COMPLETED|Primary Study - Double-Blind Week 0-48||193
971361|NCT00293267|2350301|P2|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48||50
971362|NCT00293267|2350302|P1|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the open-label post virological failure (OLPVF) phase|193
971363|NCT00293267|2350301|P2|Treated|Primary Study - Double-Blind Week 0-48||118
971364|NCT00293267|2350302|P1|Treated|Primary Study - Double-Blind Week 0-48||232
971365|NCT00293267|2350301|P2|STARTED|Primary Study - Double-Blind Week 0-48||118
971366|NCT00293267|2350302|P1|STARTED|Primary Study - Double-Blind Week 0-48||234
971367|NCT00293293|2350342|P2|NOT COMPLETED|Overall Study||2
971368|NCT00293293|2350343|P1|NOT COMPLETED|Overall Study||2
971369|NCT00293293|2350342|P2|COMPLETED|Overall Study||21
971370|NCT00293293|2350343|P1|COMPLETED|Overall Study||18
971371|NCT00293293|2350342|P2|STARTED|Overall Study||23
971372|NCT00293293|2350343|P1|STARTED|Overall Study||20
971373|NCT00293384|2350369|P1|NOT COMPLETED|Overall Study||5
971374|NCT00293384|2350369|P1|COMPLETED|Overall Study||35
971375|NCT00293384|2350369|P1|STARTED|Overall Study||40
971376|NCT00293462|2350379|P3|NOT COMPLETED|Overall Study||10
971377|NCT00293462|2350380|P2|NOT COMPLETED|Overall Study||8
971378|NCT00293462|2350381|P1|NOT COMPLETED|Overall Study||7
971379|NCT00293462|2350379|P3|COMPLETED|Overall Study||21
971380|NCT00293462|2350380|P2|COMPLETED|Overall Study||21
971381|NCT00293462|2350381|P1|COMPLETED|Overall Study||24
971382|NCT00293462|2350379|P3|STARTED|Overall Study||31
971383|NCT00293462|2350380|P2|STARTED|Overall Study||29
971384|NCT00293462|2350381|P1|STARTED|Overall Study||31
971385|NCT00293540|2350402|P2|NOT COMPLETED|Overall Study||8
971386|NCT00293540|2350403|P1|NOT COMPLETED|Overall Study||7
971387|NCT00293540|2350402|P2|COMPLETED|Overall Study||119
971388|NCT00293540|2350403|P1|COMPLETED|Overall Study||115
971389|NCT00293540|2350402|P2|STARTED|Overall Study||127
971390|NCT00293540|2350403|P1|STARTED|Overall Study||122
971391|NCT00293579|2350409|P1|NOT COMPLETED|Overall Study||1
971392|NCT00293579|2350409|P1|COMPLETED|Overall Study||4
971393|NCT00293579|2350409|P1|STARTED|Overall Study||5
971394|NCT00293709|2350416|P1|NOT COMPLETED|Overall Study||47
971395|NCT00293709|2350416|P1|COMPLETED|Overall Study||102
971396|NCT00293709|2350416|P1|STARTED|Overall Study||149
971397|NCT00293722|2350430|P1|NOT COMPLETED|Overall Study||427
971398|NCT00293722|2350430|P1|COMPLETED|Overall Study||864
971399|NCT00293722|2350430|P1|STARTED|Overall Study||1291
971400|NCT00293813|2350447|P3|NOT COMPLETED|Overall Study||8
971401|NCT00293813|2350448|P2|NOT COMPLETED|Overall Study||9
971402|NCT00293813|2350449|P1|NOT COMPLETED|Overall Study||13
971403|NCT00293813|2350447|P3|COMPLETED|Overall Study||74
971404|NCT00293813|2350448|P2|COMPLETED|Overall Study||74
971405|NCT00293813|2350449|P1|COMPLETED|Overall Study||69
971406|NCT00293813|2350447|P3|STARTED|Overall Study||82
971407|NCT00293813|2350448|P2|STARTED|Overall Study||83
971408|NCT00293813|2350449|P1|STARTED|Overall Study||82
971409|NCT00294047|2350462|P2|NOT COMPLETED|Month 84||989
971410|NCT00294047|2350463|P1|NOT COMPLETED|Month 84||973
971411|NCT00294047|2350462|P2|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Aluminium Hydroxide Group = 2116|1881
971412|NCT00294047|2350463|P1|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Cervarix Group = 2146|1904
971413|NCT00294047|2350462|P2|STARTED|Month 84||2870
971414|NCT00294047|2350463|P1|STARTED|Month 84||2877
971415|NCT00294047|2350462|P2|NOT COMPLETED|Month 48||433
971416|NCT00294047|2350463|P1|NOT COMPLETED|Month 48||425
971417|NCT00294047|2350462|P2|COMPLETED|Month 48||2438
971418|NCT00294047|2350463|P1|COMPLETED|Month 48||2456
971419|NCT00294047|2350462|P2|Participated up to Month 48|Month 48||2281
971420|NCT00294047|2350463|P1|Participated up to Month 48|Month 48||2305
971421|NCT00294047|2350462|P2|STARTED|Month 48||2871
971422|NCT00294047|2350463|P1|STARTED|Month 48||2881
971423|NCT00294060|2350565|P1|NOT COMPLETED|Overall Study||1173
971424|NCT00294060|2350565|P1|COMPLETED|Overall Study||840
971425|NCT00294060|2350565|P1|STARTED|Overall Study||2013
971426|NCT00294398|2350573|P2|NOT COMPLETED|Overall Study||26
971427|NCT00294398|2350574|P1|NOT COMPLETED|Overall Study||21
971428|NCT00294398|2350573|P2|COMPLETED|Overall Study||48
971429|NCT00294398|2350574|P1|COMPLETED|Overall Study||57
971430|NCT00294398|2350573|P2|STARTED|Overall Study||74
971431|NCT00294398|2350574|P1|STARTED|Overall Study||78
971432|NCT00294515|2350584|P2|NOT COMPLETED|Overall Study||28
971433|NCT00294515|2350585|P1|NOT COMPLETED|Overall Study||34
971435|NCT00294515|2350585|P1|COMPLETED|Overall Study||132
971436|NCT00294515|2350584|P2|STARTED|Overall Study|Randomized|160
971437|NCT00294515|2350585|P1|STARTED|Overall Study|Randomized|166
971438|NCT00300742|2350599|P1|NOT COMPLETED|Overall Study||2
971439|NCT00300742|2350599|P1|COMPLETED|Overall Study||3
971440|NCT00300742|2350599|P1|STARTED|Overall Study||5
971441|NCT00300755|2350610|P3|NOT COMPLETED|Overall Study||2
971442|NCT00300755|2350611|P2|NOT COMPLETED|Overall Study||4
971443|NCT00300755|2350612|P1|NOT COMPLETED|Overall Study||1
971444|NCT00300755|2350610|P3|COMPLETED|Overall Study||19
971445|NCT00300755|2350611|P2|COMPLETED|Overall Study||17
971446|NCT00300755|2350612|P1|COMPLETED|Overall Study||17
971447|NCT00300755|2350610|P3|STARTED|Overall Study||21
971448|NCT00300755|2350611|P2|STARTED|Overall Study||21
971449|NCT00300755|2350612|P1|STARTED|Overall Study||18
971450|NCT00300781|2350631|P2|NOT COMPLETED|Overall Study||62
971451|NCT00300781|2350632|P1|NOT COMPLETED|Overall Study||63
971452|NCT00300781|2350631|P2|COMPLETED|Overall Study||8
971453|NCT00300781|2350632|P1|COMPLETED|Overall Study||3
971454|NCT00300781|2350631|P2|STARTED|Overall Study||70
971455|NCT00300781|2350632|P1|STARTED|Overall Study||66
971456|NCT00300885|2350646|P2|NOT COMPLETED|Follow-up||195
971457|NCT00300885|2350647|P1|NOT COMPLETED|Follow-up||178
971458|NCT00300885|2350646|P2|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|174
971459|NCT00300885|2350647|P1|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|176
971460|NCT00300885|2350646|P2|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|369
971461|NCT00300885|2350647|P1|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|354
971462|NCT00300885|2350646|P2|NOT COMPLETED|Treatment||374
971463|NCT00300885|2350647|P1|NOT COMPLETED|Treatment||373
971464|NCT00300885|2350646|P2|COMPLETED|Treatment||88
971465|NCT00300885|2350647|P1|COMPLETED|Treatment||91
971466|NCT00300885|2350646|P2|Received Treatment|Treatment||459
971467|NCT00300885|2350647|P1|Received Treatment|Treatment||463
971468|NCT00300885|2350646|P2|STARTED|Treatment|ongoing in double -blind treatment at data cut-off|462
971469|NCT00300885|2350647|P1|STARTED|Treatment||464
971470|NCT00301028|2350663|P1|NOT COMPLETED|Overall Study||0
971471|NCT00301028|2350663|P1|COMPLETED|Overall Study||47
971472|NCT00301028|2350663|P1|STARTED|Overall Study||47
971473|NCT00304161|2350669|P2|NOT COMPLETED|Overall Study||6
971474|NCT00304161|2350670|P1|NOT COMPLETED|Overall Study||6
971475|NCT00304161|2350669|P2|COMPLETED|Overall Study||21
971476|NCT00304161|2350670|P1|COMPLETED|Overall Study||22
971477|NCT00304161|2350669|P2|STARTED|Overall Study||27
971478|NCT00304161|2350670|P1|STARTED|Overall Study||28
971485|NCT00304265|2350689|P2|NOT COMPLETED|Overall Study||0
971486|NCT00304265|2350690|P1|NOT COMPLETED|Overall Study||0
971487|NCT00304265|2350689|P2|COMPLETED|Overall Study||98
971488|NCT00304265|2350690|P1|COMPLETED|Overall Study||117
971489|NCT00304265|2350689|P2|STARTED|Overall Study||98
971490|NCT00304265|2350690|P1|STARTED|Overall Study||117
971491|NCT00304278|2350696|P1|NOT COMPLETED|Overall Study||2
971492|NCT00304278|2350696|P1|COMPLETED|Overall Study||19
971493|NCT00304278|2350696|P1|STARTED|Overall Study||21
971494|NCT00304707|2350703|P2|NOT COMPLETED|Overall Study||6
971495|NCT00304707|2350704|P1|NOT COMPLETED|Overall Study||7
971496|NCT00304707|2350703|P2|COMPLETED|Overall Study||64
971497|NCT00304707|2350704|P1|COMPLETED|Overall Study||66
971498|NCT00304707|2350703|P2|STARTED|Overall Study||70
971499|NCT00304707|2350704|P1|STARTED|Overall Study||73
971500|NCT00304746|2350712|P2|NOT COMPLETED|Overall Study||0
971501|NCT00304746|2350713|P1|NOT COMPLETED|Overall Study||0
971502|NCT00304746|2350712|P2|COMPLETED|Overall Study||50
971503|NCT00304746|2350713|P1|COMPLETED|Overall Study||50
971504|NCT00304746|2350712|P2|STARTED|Overall Study||50
971505|NCT00304746|2350713|P1|STARTED|Overall Study||50
971506|NCT00304915|2350723|P2|NOT COMPLETED|Overall Study||16
971507|NCT00304915|2350724|P1|NOT COMPLETED|Overall Study||18
971508|NCT00304915|2350723|P2|COMPLETED|Overall Study||110
971509|NCT00304915|2350724|P1|COMPLETED|Overall Study||105
971510|NCT00304915|2350723|P2|STARTED|Overall Study||126
971511|NCT00304915|2350724|P1|STARTED|Overall Study||123
971512|NCT00304954|2350734|P4|NOT COMPLETED|Overall Study||0
971513|NCT00304954|2350735|P3|NOT COMPLETED|Overall Study||1
971514|NCT00304954|2350736|P2|NOT COMPLETED|Overall Study||0
971515|NCT00304954|2350737|P1|NOT COMPLETED|Overall Study||1
971516|NCT00304954|2350734|P4|COMPLETED|Overall Study||3
971517|NCT00304954|2350735|P3|COMPLETED|Overall Study||2
971518|NCT00304954|2350736|P2|COMPLETED|Overall Study||3
971519|NCT00304954|2350737|P1|COMPLETED|Overall Study||3
971520|NCT00304954|2350734|P4|STARTED|Overall Study||3
971521|NCT00304954|2350735|P3|STARTED|Overall Study||3
971522|NCT00304954|2350736|P2|STARTED|Overall Study||3
971523|NCT00304954|2350737|P1|STARTED|Overall Study||4
971524|NCT00305162|2350757|P2|NOT COMPLETED|1 Year Follow-up Period||65
971525|NCT00305162|2350758|P1|NOT COMPLETED|1 Year Follow-up Period||55
971526|NCT00305162|2350757|P2|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4382
971527|NCT00305162|2350758|P1|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4380
971528|NCT00305162|2350757|P2|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|444
971529|NCT00305162|2350758|P1|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|446
971530|NCT00305162|2350757|P2|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3818
971531|NCT00305162|2350758|P1|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3851
971532|NCT00305162|2350757|P2|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|504
971533|NCT00305162|2350758|P1|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|480
971534|NCT00305162|2350757|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3878
971535|NCT00305162|2350758|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3900
971536|NCT00305162|2350757|P2|STARTED|1 Year Follow-up Period||4447
971537|NCT00305162|2350758|P1|STARTED|1 Year Follow-up Period||4435
971538|NCT00305162|2350757|P2|NOT COMPLETED|30-day Follow-up Period||63
971539|NCT00305162|2350758|P1|NOT COMPLETED|30-day Follow-up Period||62
971540|NCT00305162|2350757|P2|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4384
971541|NCT00305162|2350758|P1|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4373
971542|NCT00305162|2350757|P2|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|444
971543|NCT00305162|2350758|P1|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|438
971544|NCT00305162|2350757|P2|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3827
971545|NCT00305162|2350758|P1|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3860
971546|NCT00305162|2350757|P2|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|501
971547|NCT00305162|2350758|P1|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|471
971548|NCT00305162|2350757|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3883
971549|NCT00305162|2350758|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3902
971550|NCT00305162|2350757|P2|STARTED|30-day Follow-up Period||4447
971551|NCT00305162|2350758|P1|STARTED|30-day Follow-up Period||4435
971552|NCT00305162|2350757|P2|NOT COMPLETED|48 Hour Follow-up Period||16
971553|NCT00305162|2350758|P1|NOT COMPLETED|48 Hour Follow-up Period||20
971554|NCT00305162|2350757|P2|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4431
971555|NCT00305162|2350758|P1|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4415
971556|NCT00305162|2350757|P2|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4365
971557|NCT00305162|2350758|P1|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4374
971558|NCT00305162|2350757|P2|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|447
971559|NCT00305162|2350758|P1|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|446
971560|NCT00305162|2350757|P2|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3865
971561|NCT00305162|2350758|P1|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3889
971562|NCT00305162|2350757|P2|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|507
971563|NCT00305162|2350758|P1|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|482
971564|NCT00305162|2350757|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3924
971565|NCT00305162|2350758|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3933
971566|NCT00305162|2350757|P2|STARTED|48 Hour Follow-up Period||4447
971567|NCT00305162|2350758|P1|STARTED|48 Hour Follow-up Period||4435
971568|NCT00305227|2350798|P2|NOT COMPLETED|Overall Study||6
971569|NCT00305227|2350799|P1|NOT COMPLETED|Overall Study||7
971570|NCT00305227|2350798|P2|COMPLETED|Overall Study|with at least 8 weeks of observation|44
971571|NCT00305227|2350799|P1|COMPLETED|Overall Study|with at least 8 weeks of observation|43
971572|NCT00305227|2350798|P2|STARTED|Overall Study||50
971573|NCT00305227|2350799|P1|STARTED|Overall Study||50
971574|NCT00305253|2350807|P2|NOT COMPLETED|Overall Study||1
971575|NCT00305253|2350808|P1|NOT COMPLETED|Overall Study||0
971576|NCT00305253|2350807|P2|COMPLETED|Overall Study||558
971577|NCT00305253|2350808|P1|COMPLETED|Overall Study||432
971578|NCT00305253|2350807|P2|STARTED|Overall Study||559
971579|NCT00305253|2350808|P1|STARTED|Overall Study||432
971580|NCT00305344|2350818|P1|NOT COMPLETED|Overall Study||0
971581|NCT00305344|2350818|P1|COMPLETED|Overall Study||23
971582|NCT00305344|2350818|P1|STARTED|Overall Study||23
971583|NCT00305448|2350825|P3|NOT COMPLETED|Overall Study||33
971584|NCT00305448|2350826|P2|NOT COMPLETED|Overall Study||34
971585|NCT00305448|2350827|P1|NOT COMPLETED|Overall Study||31
971586|NCT00305448|2350825|P3|COMPLETED|Overall Study||14
971587|NCT00305448|2350826|P2|COMPLETED|Overall Study||17
971588|NCT00305448|2350827|P1|COMPLETED|Overall Study||14
971589|NCT00305448|2350825|P3|STARTED|Overall Study||47
971590|NCT00305448|2350826|P2|STARTED|Overall Study||51
971591|NCT00305448|2350827|P1|STARTED|Overall Study||45
971592|NCT00305565|2350846|P3|NOT COMPLETED|Overall Study (ITT Population)||5
971593|NCT00305565|2350847|P2|NOT COMPLETED|Overall Study (ITT Population)||11
971594|NCT00305565|2350848|P1|NOT COMPLETED|Overall Study (ITT Population)||13
971595|NCT00305565|2350846|P3|COMPLETED|Overall Study (ITT Population)||102
971596|NCT00305565|2350847|P2|COMPLETED|Overall Study (ITT Population)||90
971597|NCT00305565|2350848|P1|COMPLETED|Overall Study (ITT Population)||89
971598|NCT00305565|2350846|P3|STARTED|Overall Study (ITT Population)||107
971599|NCT00305565|2350847|P2|STARTED|Overall Study (ITT Population)||101
971600|NCT00305565|2350848|P1|STARTED|Overall Study (ITT Population)||102
971601|NCT00305565|2350846|P3|NOT COMPLETED|Overall Study (Safety Population)||7
971602|NCT00305565|2350847|P2|NOT COMPLETED|Overall Study (Safety Population)||12
971603|NCT00305565|2350848|P1|NOT COMPLETED|Overall Study (Safety Population)||14
971604|NCT00305565|2350846|P3|COMPLETED|Overall Study (Safety Population)||106
971605|NCT00305565|2350847|P2|COMPLETED|Overall Study (Safety Population)||95
971606|NCT00305565|2350848|P1|COMPLETED|Overall Study (Safety Population)||97
971607|NCT00305565|2350846|P3|STARTED|Overall Study (Safety Population)||113
971608|NCT00305565|2350847|P2|STARTED|Overall Study (Safety Population)||107
971609|NCT00305565|2350848|P1|STARTED|Overall Study (Safety Population)||111
971610|NCT00305578|2350965|P2|NOT COMPLETED|Overall Study||2
971611|NCT00305578|2350966|P1|NOT COMPLETED|Overall Study||3
971612|NCT00305578|2350965|P2|COMPLETED|Overall Study||12
971613|NCT00305578|2350966|P1|COMPLETED|Overall Study||12
971614|NCT00305578|2350965|P2|STARTED|Overall Study||14
971615|NCT00305578|2350966|P1|STARTED|Overall Study||15
971616|NCT00305604|2350974|P2|NOT COMPLETED|Overall Study||47
971617|NCT00305604|2350975|P1|NOT COMPLETED|Overall Study||32
971618|NCT00305604|2350974|P2|COMPLETED|Overall Study||57
971619|NCT00305604|2350975|P1|COMPLETED|Overall Study||70
971620|NCT00305604|2350974|P2|STARTED|Overall Study||104
971621|NCT00305604|2350975|P1|STARTED|Overall Study||102
971622|NCT00305643|2350989|P2|NOT COMPLETED|Overall Study||0
971623|NCT00305643|2350990|P1|NOT COMPLETED|Overall Study||0
971624|NCT00305643|2350989|P2|COMPLETED|Overall Study||5
971625|NCT00305643|2350990|P1|COMPLETED|Overall Study||6
971626|NCT00305643|2350989|P2|STARTED|Overall Study||5
971627|NCT00305643|2350990|P1|STARTED|Overall Study||6
971628|NCT00305760|2350998|P1|NOT COMPLETED|Overall Study||47
971629|NCT00305760|2350998|P1|COMPLETED|Overall Study||13
971630|NCT00305760|2350998|P1|STARTED|Overall Study||60
971631|NCT00305773|2351004|P2|NOT COMPLETED|Overall Study||18
971632|NCT00305773|2351005|P1|NOT COMPLETED|Overall Study||14
971633|NCT00305773|2351004|P2|COMPLETED|Overall Study||4
971634|NCT00305773|2351005|P1|COMPLETED|Overall Study||1
971635|NCT00305773|2351004|P2|STARTED|Overall Study||22
971636|NCT00305773|2351005|P1|STARTED|Overall Study||15
971637|NCT00305864|2351023|P4|NOT COMPLETED|Overall Study||13
971638|NCT00305864|2351024|P3|NOT COMPLETED|Overall Study||1
971639|NCT00305864|2351025|P2|NOT COMPLETED|Overall Study||1
971640|NCT00305864|2351026|P1|NOT COMPLETED|Overall Study||0
971641|NCT00305864|2351023|P4|COMPLETED|Overall Study||81
971642|NCT00305864|2351024|P3|COMPLETED|Overall Study||6
971643|NCT00305864|2351025|P2|COMPLETED|Overall Study||9
971644|NCT00305864|2351026|P1|COMPLETED|Overall Study||7
971645|NCT00305864|2351023|P4|STARTED|Overall Study||94
971646|NCT00305864|2351024|P3|STARTED|Overall Study||7
971647|NCT00305864|2351025|P2|STARTED|Overall Study||10
971648|NCT00305864|2351026|P1|STARTED|Overall Study||7
971649|NCT00305877|2351038|P2|NOT COMPLETED|Overall Study||34
971650|NCT00305877|2351039|P1|NOT COMPLETED|Overall Study||24
971651|NCT00305877|2351038|P2|COMPLETED|Overall Study||34
971652|NCT00305877|2351039|P1|COMPLETED|Overall Study||45
971653|NCT00305877|2351038|P2|Included in Efficacy Analysis|Overall Study||62
971654|NCT00305877|2351039|P1|Included in Efficacy Analysis|Overall Study||65
971655|NCT00305877|2351038|P2|Eligible|Overall Study||66
971656|NCT00305877|2351039|P1|Eligible|Overall Study||66
971657|NCT00305877|2351038|P2|Treated|Overall Study||63
971658|NCT00305877|2351039|P1|Treated|Overall Study||67
971659|NCT00305877|2351038|P2|STARTED|Overall Study||68
971660|NCT00305877|2351039|P1|STARTED|Overall Study||69
971661|NCT00305942|2351049|P1|NOT COMPLETED|Overall Study||38
971662|NCT00305942|2351049|P1|COMPLETED|Overall Study||23
971663|NCT00305942|2351049|P1|STARTED|Overall Study||61
971670|NCT00306189|2351068|P4|NOT COMPLETED|Overall Study||5
971671|NCT00306189|2351069|P3|NOT COMPLETED|Overall Study||11
971672|NCT00306189|2351070|P2|NOT COMPLETED|Overall Study||6
971673|NCT00306189|2351071|P1|NOT COMPLETED|Overall Study||9
971674|NCT00306189|2351068|P4|COMPLETED|Overall Study||52
971675|NCT00306189|2351069|P3|COMPLETED|Overall Study||45
971676|NCT00306189|2351070|P2|COMPLETED|Overall Study||50
971677|NCT00306189|2351071|P1|COMPLETED|Overall Study||48
971678|NCT00306189|2351068|P4|STARTED|Overall Study||57
971679|NCT00306189|2351069|P3|STARTED|Overall Study||56
971680|NCT00306189|2351070|P2|STARTED|Overall Study||56
971681|NCT00306189|2351071|P1|STARTED|Overall Study||57
971682|NCT00306202|2351084|P3|NOT COMPLETED|Overall Study||0
971683|NCT00306202|2351085|P2|NOT COMPLETED|Overall Study||1
971684|NCT00306202|2351086|P1|NOT COMPLETED|Overall Study||6
971685|NCT00306202|2351084|P3|COMPLETED|Overall Study|Completed = Off-treatment|24
971686|NCT00306202|2351085|P2|COMPLETED|Overall Study|Completed = Off-treatment|16
971687|NCT00306202|2351086|P1|COMPLETED|Overall Study|Completed = Off-treatment|11
971688|NCT00306202|2351084|P3|STARTED|Overall Study|Started = Treated. 24 were enrolled; 1 no longer met study criteria and was never treated|24
971689|NCT00306202|2351085|P2|STARTED|Overall Study|Started=Treated. 20 were enrolled;3 never treated(2 no longer met study criteria;1 withdrew consent)|17
971690|NCT00306202|2351086|P1|STARTED|Overall Study|Started = Treated. 18 were enrolled; 1 no longer met study criteria and was never treated|17
971691|NCT00306384|2351245|P3|NOT COMPLETED|Overall Study||277
971692|NCT00306384|2351246|P2|NOT COMPLETED|Overall Study||508
971693|NCT00306384|2351247|P1|NOT COMPLETED|Overall Study||542
971694|NCT00306384|2351245|P3|COMPLETED|Overall Study||251
971695|NCT00306384|2351246|P2|COMPLETED|Overall Study||891
971696|NCT00306384|2351247|P1|COMPLETED|Overall Study||854
971697|NCT00306384|2351245|P3|Safety Set|Overall Study|Patients who received at least one dose of study drug|527
971698|NCT00306384|2351246|P2|Safety Set|Overall Study|Patients who received at least one dose of study drug|1398
971699|NCT00306384|2351247|P1|Safety Set|Overall Study|Patients who received at least one dose of study drug|1395
971700|NCT00306384|2351245|P3|STARTED|Overall Study||528
971701|NCT00306384|2351246|P2|STARTED|Overall Study||1399
971702|NCT00306384|2351247|P1|STARTED|Overall Study||1396
971703|NCT00306488|2351279|P2|NOT COMPLETED|Overall Study||1
971704|NCT00306488|2351280|P1|NOT COMPLETED|Overall Study||1
971705|NCT00306488|2351279|P2|COMPLETED|Overall Study||10
971706|NCT00306488|2351280|P1|COMPLETED|Overall Study||10
971707|NCT00306488|2351279|P2|STARTED|Overall Study||11
971708|NCT00306488|2351280|P1|STARTED|Overall Study||11
971709|NCT00306527|2351295|P4|NOT COMPLETED|Overall Study||6
971710|NCT00306527|2351296|P3|NOT COMPLETED|Overall Study||5
971711|NCT00306527|2351297|P2|NOT COMPLETED|Overall Study||7
971712|NCT00306527|2351298|P1|NOT COMPLETED|Overall Study||6
971713|NCT00306527|2351295|P4|COMPLETED|Overall Study||590
971714|NCT00306527|2351296|P3|COMPLETED|Overall Study|Additional death has been reported post study. Please refer to outcome measure-2.|567
971715|NCT00306527|2351297|P2|COMPLETED|Overall Study||527
971716|NCT00306527|2351298|P1|COMPLETED|Overall Study||527
971717|NCT00306527|2351295|P4|STARTED|Overall Study||596
971718|NCT00306527|2351296|P3|STARTED|Overall Study||572
971719|NCT00306527|2351297|P2|STARTED|Overall Study||534
971720|NCT00306527|2351298|P1|STARTED|Overall Study||533
971721|NCT00306592|2351352|P2|NOT COMPLETED|Overall Study||58
971722|NCT00306592|2351353|P1|NOT COMPLETED|Overall Study||31
971723|NCT00306592|2351352|P2|COMPLETED|Overall Study||632
971724|NCT00306592|2351353|P1|COMPLETED|Overall Study||373
971725|NCT00306592|2351352|P2|Entered 101-MS-321 Extension Study|Overall Study|pertains to participants transitioning from 101-MS-322 (NCT00306592) study only|0
971726|NCT00306592|2351353|P1|Entered 101-MS-321 Extension Study|Overall Study||22
971727|NCT00306592|2351352|P2|Completed at 48 Weeks|Overall Study||632
971728|NCT00306592|2351353|P1|Completed at 48 Weeks|Overall Study||81
971729|NCT00306592|2351352|P2|Completed Between 24 and 48 Weeks|Overall Study||0
971730|NCT00306592|2351353|P1|Completed Between 24 and 48 Weeks|Overall Study||85
971731|NCT00306592|2351352|P2|Completed at 24 Weeks|Overall Study||0
971732|NCT00306592|2351353|P1|Completed at 24 Weeks|Overall Study||207
971733|NCT00306592|2351352|P2|STARTED|Overall Study||690
971734|NCT00306592|2351353|P1|STARTED|Overall Study||404
971735|NCT00306670|2351361|P2|NOT COMPLETED|Overall Study||2
971736|NCT00306670|2351362|P1|NOT COMPLETED|Overall Study||0
971737|NCT00306670|2351361|P2|COMPLETED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued study before treatment initiated|0
971738|NCT00306670|2351362|P1|COMPLETED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
971739|NCT00306670|2351361|P2|STARTED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued trial before treatment started|2
971740|NCT00306670|2351362|P1|STARTED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
971741|NCT00291551|2351368|P1|NOT COMPLETED|Overall Study||13
971742|NCT00291551|2351368|P1|COMPLETED|Overall Study||26
971743|NCT00291551|2351368|P1|STARTED|Overall Study||39
971744|NCT00291577|2351383|P1|NOT COMPLETED|Overall Study||21
971745|NCT00291577|2351383|P1|COMPLETED|Overall Study|Subject End of Study=Completed; not per protocol reason. PI reason=withdrawn during active treatment|1
971746|NCT00291577|2351383|P1|STARTED|Overall Study||22
971747|NCT00291655|2351402|P1|NOT COMPLETED|Overall Study||15
971748|NCT00291655|2351402|P1|COMPLETED|Overall Study||115
971749|NCT00291655|2351402|P1|STARTED|Overall Study||130
971750|NCT00291694|2351409|P2|NOT COMPLETED|Overall Study||5
971751|NCT00291694|2351410|P1|NOT COMPLETED|Overall Study||3
971752|NCT00291694|2351409|P2|COMPLETED|Overall Study||43
971753|NCT00291694|2351410|P1|COMPLETED|Overall Study||21
971754|NCT00291694|2351409|P2|STARTED|Overall Study||48
971755|NCT00291694|2351410|P1|STARTED|Overall Study||24
971756|NCT00291876|2351424|P1|NOT COMPLETED|Overall Study||0
971757|NCT00291876|2351424|P1|COMPLETED|Overall Study||135
971758|NCT00291876|2351424|P1|STARTED|Overall Study||135
971759|NCT00297427|2351438|P2|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||0
971760|NCT00297427|2351439|P1|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||34
971843|NCT00298155|2351603|P2|COMPLETED|Overall Study||10
971761|NCT00297427|2351438|P2|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
971762|NCT00297427|2351439|P1|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Subjects who completed=/>1 follow-up visits and were evaluated for booster acupuncture|60
971763|NCT00297427|2351438|P2|STARTED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
971764|NCT00297427|2351439|P1|STARTED|Phase 3: Follow-up Post-True Acupuncture||94
971765|NCT00297427|2351438|P2|NOT COMPLETED|Phase 2: Optional Crossover for Sham||0
971766|NCT00297427|2351439|P1|NOT COMPLETED|Phase 2: Optional Crossover for Sham||16
971767|NCT00297427|2351438|P2|COMPLETED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
971768|NCT00297427|2351439|P1|COMPLETED|Phase 2: Optional Crossover for Sham||38
971769|NCT00297427|2351438|P2|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
971770|NCT00297427|2351439|P1|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|54 subjects completed the sham acupuncture & were offered the opportunity to cross-over; 12 declined|42
971771|NCT00297427|2351438|P2|STARTED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
971772|NCT00297427|2351439|P1|STARTED|Phase 2: Optional Crossover for Sham||54
971773|NCT00297427|2351438|P2|NOT COMPLETED|Phase 1: Initial Intervention||9
971774|NCT00297427|2351439|P1|NOT COMPLETED|Phase 1: Initial Intervention||8
971775|NCT00297427|2351438|P2|COMPLETED|Phase 1: Initial Intervention||54
971776|NCT00297427|2351439|P1|COMPLETED|Phase 1: Initial Intervention||56
971777|NCT00297427|2351438|P2|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|63
971778|NCT00297427|2351439|P1|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|64
971779|NCT00297492|2351483|P3|NOT COMPLETED|6 Month Follow-up||27
971780|NCT00297492|2351484|P2|NOT COMPLETED|6 Month Follow-up||49
971781|NCT00297492|2351485|P1|NOT COMPLETED|6 Month Follow-up||63
971782|NCT00297492|2351483|P3|COMPLETED|6 Month Follow-up||118
971783|NCT00297492|2351484|P2|COMPLETED|6 Month Follow-up||237
971784|NCT00297492|2351485|P1|COMPLETED|6 Month Follow-up||227
971785|NCT00297492|2351483|P3|STARTED|6 Month Follow-up||145
971786|NCT00297492|2351484|P2|STARTED|6 Month Follow-up||286
971787|NCT00297492|2351485|P1|STARTED|6 Month Follow-up||290
971788|NCT00297492|2351483|P3|NOT COMPLETED|Set Quit Date||5
971789|NCT00297492|2351484|P2|NOT COMPLETED|Set Quit Date||13
971790|NCT00297492|2351485|P1|NOT COMPLETED|Set Quit Date||7
971791|NCT00297492|2351483|P3|COMPLETED|Set Quit Date||145
971792|NCT00297492|2351484|P2|COMPLETED|Set Quit Date||286
971793|NCT00297492|2351485|P1|COMPLETED|Set Quit Date||290
971794|NCT00297492|2351483|P3|STARTED|Set Quit Date||150
971795|NCT00297492|2351484|P2|STARTED|Set Quit Date||299
971796|NCT00297492|2351485|P1|STARTED|Set Quit Date||297
971797|NCT00297596|2351493|P1|NOT COMPLETED|Overall Study||0
971798|NCT00297596|2351493|P1|COMPLETED|Overall Study||25
971799|NCT00297596|2351493|P1|STARTED|Overall Study||25
971800|NCT00297648|2351497|P1|NOT COMPLETED|Overall Study||36
971801|NCT00297648|2351497|P1|COMPLETED|Overall Study||53
971802|NCT00297648|2351497|P1|STARTED|Overall Study||89
971803|NCT00297778|2351538|P2|NOT COMPLETED|Overall Study||20
971804|NCT00297778|2351539|P1|NOT COMPLETED|Overall Study||19
971805|NCT00297778|2351538|P2|COMPLETED|Overall Study||124
971806|NCT00297778|2351539|P1|COMPLETED|Overall Study||133
971807|NCT00297778|2351538|P2|STARTED|Overall Study||144
971808|NCT00297778|2351539|P1|STARTED|Overall Study||152
971809|NCT00297830|2351576|P3|NOT COMPLETED|12 Month Visit||0
971810|NCT00297830|2351577|P2|NOT COMPLETED|12 Month Visit||6
971811|NCT00297830|2351578|P1|NOT COMPLETED|12 Month Visit||1
971812|NCT00297830|2351576|P3|COMPLETED|12 Month Visit||24
971813|NCT00297830|2351577|P2|COMPLETED|12 Month Visit||35
971814|NCT00297830|2351578|P1|COMPLETED|12 Month Visit||37
971815|NCT00297830|2351576|P3|STARTED|12 Month Visit||24
971816|NCT00297830|2351577|P2|STARTED|12 Month Visit||41
971817|NCT00297830|2351578|P1|STARTED|12 Month Visit||38
971818|NCT00297830|2351576|P3|NOT COMPLETED|6 Month Visit||3
971819|NCT00297830|2351577|P2|NOT COMPLETED|6 Month Visit||2
971820|NCT00297830|2351578|P1|NOT COMPLETED|6 Month Visit||3
971821|NCT00297830|2351576|P3|COMPLETED|6 Month Visit||24
971822|NCT00297830|2351577|P2|COMPLETED|6 Month Visit||41
971823|NCT00297830|2351578|P1|COMPLETED|6 Month Visit||38
971824|NCT00297830|2351576|P3|STARTED|6 Month Visit||27
971825|NCT00297830|2351577|P2|STARTED|6 Month Visit||43
971826|NCT00297830|2351578|P1|STARTED|6 Month Visit||41
971827|NCT00297830|2351576|P3|NOT COMPLETED|Baseline||0
971828|NCT00297830|2351577|P2|NOT COMPLETED|Baseline||0
971829|NCT00297830|2351578|P1|NOT COMPLETED|Baseline||0
971830|NCT00297830|2351576|P3|COMPLETED|Baseline||27
971831|NCT00297830|2351577|P2|COMPLETED|Baseline||43
971832|NCT00297830|2351578|P1|COMPLETED|Baseline||41
971833|NCT00297830|2351576|P3|STARTED|Baseline||27
971834|NCT00297830|2351577|P2|STARTED|Baseline||43
971835|NCT00297830|2351578|P1|STARTED|Baseline||41
971836|NCT00298090|2351595|P1|NOT COMPLETED|Overall Study||18
971837|NCT00298090|2351595|P1|COMPLETED|Overall Study|Eighteen subjects were not included in final analysis due to incomplete data sets|29
971838|NCT00298090|2351595|P1|STARTED|Overall Study||47
971839|NCT00298155|2351602|P3|NOT COMPLETED|Overall Study||0
971840|NCT00298155|2351603|P2|NOT COMPLETED|Overall Study||0
971841|NCT00298155|2351604|P1|NOT COMPLETED|Overall Study||0
971842|NCT00298155|2351602|P3|COMPLETED|Overall Study||13
971844|NCT00298155|2351604|P1|COMPLETED|Overall Study||12
971845|NCT00298155|2351602|P3|STARTED|Overall Study||13
971846|NCT00298155|2351603|P2|STARTED|Overall Study||10
971847|NCT00298155|2351604|P1|STARTED|Overall Study||12
971848|NCT00306787|2351617|P2|NOT COMPLETED|Overall Study||241
971849|NCT00306787|2351618|P1|NOT COMPLETED|Overall Study||234
971850|NCT00306787|2351617|P2|COMPLETED|Overall Study||359
971851|NCT00306787|2351618|P1|COMPLETED|Overall Study||345
971852|NCT00306787|2351617|P2|Intent to Treat (ITT) Population|Overall Study||381
971853|NCT00306787|2351618|P1|Intent to Treat (ITT) Population|Overall Study||370
971854|NCT00306787|2351617|P2|Received Study Drug (Safety Population)|Overall Study||385
971855|NCT00306787|2351618|P1|Received Study Drug (Safety Population)|Overall Study||371
971856|NCT00306787|2351617|P2|STARTED|Overall Study||600
971857|NCT00306787|2351618|P1|STARTED|Overall Study||579
971858|NCT00306852|2351636|P2|NOT COMPLETED|Overall Study||38
971859|NCT00306852|2351637|P1|NOT COMPLETED|Overall Study||29
971860|NCT00306852|2351636|P2|COMPLETED|Overall Study||69
971861|NCT00306852|2351637|P1|COMPLETED|Overall Study||76
971862|NCT00306852|2351636|P2|STARTED|Overall Study||107
971863|NCT00306852|2351637|P1|STARTED|Overall Study||105
971864|NCT00306891|2351657|P4|NOT COMPLETED|Part B||17
971865|NCT00306891|2351658|P3|NOT COMPLETED|Part B||11
971866|NCT00306891|2351659|P2|NOT COMPLETED|Part B||0
971867|NCT00306891|2351660|P1|NOT COMPLETED|Part B||0
971868|NCT00306891|2351657|P4|COMPLETED|Part B||14
971869|NCT00306891|2351658|P3|COMPLETED|Part B||5
971870|NCT00306891|2351659|P2|COMPLETED|Part B||0
971871|NCT00306891|2351660|P1|COMPLETED|Part B||0
971872|NCT00306891|2351657|P4|STARTED|Part B|in Part B: Cediranib Dose Escalation 11 new patients were randomized.|31
971873|NCT00306891|2351658|P3|STARTED|Part B|In Part B: Cediranib 45 mg Fixed Dose 4 new patients were randomized|16
971874|NCT00306891|2351659|P2|STARTED|Part B||0
971875|NCT00306891|2351660|P1|STARTED|Part B||0
971876|NCT00306891|2351657|P4|NOT COMPLETED|Part A||0
971877|NCT00306891|2351658|P3|NOT COMPLETED|Part A||0
971878|NCT00306891|2351659|P2|NOT COMPLETED|Part A||6
971879|NCT00306891|2351660|P1|NOT COMPLETED|Part A||5
971880|NCT00306891|2351657|P4|COMPLETED|Part A||0
971881|NCT00306891|2351658|P3|COMPLETED|Part A||0
971882|NCT00306891|2351659|P2|COMPLETED|Part A||16
971883|NCT00306891|2351660|P1|COMPLETED|Part A||18
971884|NCT00306891|2351657|P4|STARTED|Part A||0
971885|NCT00306891|2351658|P3|STARTED|Part A||0
971886|NCT00306891|2351659|P2|STARTED|Part A||22
971887|NCT00306891|2351660|P1|STARTED|Part A||23
971888|NCT00306917|2351683|P2|NOT COMPLETED|Overall Study||109
971889|NCT00306917|2351684|P1|NOT COMPLETED|Overall Study||108
971890|NCT00306917|2351683|P2|COMPLETED|Overall Study||15
971891|NCT00306917|2351684|P1|COMPLETED|Overall Study||13
971892|NCT00306917|2351683|P2|60 Month Follow up|Overall Study||15
971893|NCT00306917|2351684|P1|60 Month Follow up|Overall Study||13
971894|NCT00306917|2351683|P2|48 Month Follow up|Overall Study||22
971895|NCT00306917|2351684|P1|48 Month Follow up|Overall Study||29
971896|NCT00306917|2351683|P2|36 Month Follow up|Overall Study||42
971897|NCT00306917|2351684|P1|36 Month Follow up|Overall Study||56
971898|NCT00306917|2351683|P2|24 Month Follow up|Overall Study||71
971899|NCT00306917|2351684|P1|24 Month Follow up|Overall Study||60
971900|NCT00306917|2351683|P2|12 Month Follow|Overall Study||94
971901|NCT00306917|2351684|P1|12 Month Follow|Overall Study||86
971902|NCT00306917|2351683|P2|Postoperative to 6 Month Follow up|Overall Study||100
971903|NCT00306917|2351684|P1|Postoperative to 6 Month Follow up|Overall Study||93
971904|NCT00306917|2351683|P2|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|124
971905|NCT00306917|2351684|P1|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|121
971906|NCT00311155|2351690|P1|NOT COMPLETED|Overall Study||93
971907|NCT00311155|2351690|P1|COMPLETED|Overall Study|Some participants had multiple reasons for discontinuation|601
971908|NCT00311155|2351690|P1|STARTED|Overall Study||694
971909|NCT00311181|2351699|P1|NOT COMPLETED|Overall Study||96
971910|NCT00311181|2351699|P1|COMPLETED|Overall Study||121
971911|NCT00311181|2351699|P1|STARTED|Overall Study||217
971912|NCT00311311|2351707|P2|NOT COMPLETED|Overall Study||9
971913|NCT00311311|2351708|P1|NOT COMPLETED|Overall Study||8
971914|NCT00311311|2351707|P2|COMPLETED|Overall Study||26
971915|NCT00311311|2351708|P1|COMPLETED|Overall Study||29
971916|NCT00311311|2351707|P2|STARTED|Overall Study||35
971917|NCT00311311|2351708|P1|STARTED|Overall Study||37
971918|NCT00311363|2351761|P3|NOT COMPLETED|12-Week Double-Blind Treatment Period||12
971919|NCT00311363|2351762|P2|NOT COMPLETED|12-Week Double-Blind Treatment Period||14
971920|NCT00311363|2351763|P1|NOT COMPLETED|12-Week Double-Blind Treatment Period||0
971921|NCT00311363|2351761|P3|COMPLETED|12-Week Double-Blind Treatment Period||84
971922|NCT00311363|2351762|P2|COMPLETED|12-Week Double-Blind Treatment Period||84
971923|NCT00311363|2351763|P1|COMPLETED|12-Week Double-Blind Treatment Period||0
971924|NCT00311363|2351761|P3|STARTED|12-Week Double-Blind Treatment Period||96
971925|NCT00311363|2351762|P2|STARTED|12-Week Double-Blind Treatment Period||98
971926|NCT00311363|2351763|P1|STARTED|12-Week Double-Blind Treatment Period||0
971927|NCT00311363|2351761|P3|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
971928|NCT00311363|2351762|P2|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
971929|NCT00311363|2351763|P1|NOT COMPLETED|24-Week Single-Blind Treatment Period||106
971930|NCT00311363|2351761|P3|COMPLETED|24-Week Single-Blind Treatment Period||0
971931|NCT00311363|2351762|P2|COMPLETED|24-Week Single-Blind Treatment Period||0
971932|NCT00311363|2351763|P1|COMPLETED|24-Week Single-Blind Treatment Period||221
971933|NCT00311363|2351761|P3|STARTED|24-Week Single-Blind Treatment Period||0
971934|NCT00311363|2351762|P2|STARTED|24-Week Single-Blind Treatment Period||0
971935|NCT00311363|2351763|P1|STARTED|24-Week Single-Blind Treatment Period||327
971936|NCT00311376|2351824|P3|NOT COMPLETED|Treatment Cycle 2||0
971937|NCT00311376|2351825|P2|NOT COMPLETED|Treatment Cycle 2||13
971938|NCT00311376|2351826|P1|NOT COMPLETED|Treatment Cycle 2||9
971939|NCT00311376|2351824|P3|COMPLETED|Treatment Cycle 2||0
971940|NCT00311376|2351825|P2|COMPLETED|Treatment Cycle 2||112
971941|NCT00311376|2351826|P1|COMPLETED|Treatment Cycle 2||106
971942|NCT00311376|2351824|P3|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200U in Cycle 2|0
971943|NCT00311376|2351825|P2|STARTED|Treatment Cycle 2|74 from the 200U group + 51 from the Placebo group entered Cycle 2|125
971944|NCT00311376|2351826|P1|STARTED|Treatment Cycle 2|69 from the 300U group + 46 from the Placebo group entered Cycle 2|115
971945|NCT00311376|2351824|P3|NOT COMPLETED|Treatment Cycle 1||17
971946|NCT00311376|2351825|P2|NOT COMPLETED|Treatment Cycle 1||17
971947|NCT00311376|2351826|P1|NOT COMPLETED|Treatment Cycle 1||27
971948|NCT00311376|2351824|P3|COMPLETED|Treatment Cycle 1||132
971949|NCT00311376|2351825|P2|COMPLETED|Treatment Cycle 1||118
971950|NCT00311376|2351826|P1|COMPLETED|Treatment Cycle 1||105
971951|NCT00311376|2351824|P3|STARTED|Treatment Cycle 1||149
971952|NCT00311376|2351825|P2|STARTED|Treatment Cycle 1||135
971953|NCT00311376|2351826|P1|STARTED|Treatment Cycle 1||132
971954|NCT00311402|2351845|P2|NOT COMPLETED|Overall Study||177
971955|NCT00311402|2351846|P1|NOT COMPLETED|Overall Study||210
971956|NCT00311402|2351845|P2|COMPLETED|Overall Study||462
971957|NCT00311402|2351846|P1|COMPLETED|Overall Study||445
971958|NCT00311402|2351845|P2|STARTED|Overall Study||639
971959|NCT00311402|2351846|P1|STARTED|Overall Study||655
971960|NCT00311584|2351872|P2|NOT COMPLETED|Overall Study||23
971961|NCT00311584|2351873|P1|NOT COMPLETED|Overall Study||20
971962|NCT00311584|2351872|P2|COMPLETED|Overall Study||7
971963|NCT00311584|2351873|P1|COMPLETED|Overall Study||9
971964|NCT00311584|2351872|P2|STARTED|Overall Study||30
971965|NCT00311584|2351873|P1|STARTED|Overall Study||29
971966|NCT00311766|2351881|P2|NOT COMPLETED|Overall Study||5
971967|NCT00311766|2351882|P1|NOT COMPLETED|Overall Study||0
971968|NCT00311766|2351881|P2|COMPLETED|Overall Study||17
971969|NCT00311766|2351882|P1|COMPLETED|Overall Study||8
971970|NCT00311766|2351881|P2|STARTED|Overall Study||22
971971|NCT00311766|2351882|P1|STARTED|Overall Study||8
971972|NCT00312195|2351892|P2|NOT COMPLETED|Overall Study||6
971973|NCT00312195|2351893|P1|NOT COMPLETED|Overall Study||6
971974|NCT00312195|2351892|P2|COMPLETED|Overall Study||123
971975|NCT00312195|2351893|P1|COMPLETED|Overall Study||132
971976|NCT00312195|2351892|P2|STARTED|Overall Study||129
971977|NCT00312195|2351893|P1|STARTED|Overall Study||138
971978|NCT00312208|2351909|P2|NOT COMPLETED|Overall Study||123
971979|NCT00312208|2351910|P1|NOT COMPLETED|Overall Study||172
971980|NCT00312208|2351909|P2|COMPLETED|Overall Study||1526
971981|NCT00312208|2351910|P1|COMPLETED|Overall Study||1477
971982|NCT00312208|2351909|P2|STARTED|Overall Study|1649 patients randomized 1635 patients treated|1649
971983|NCT00312208|2351910|P1|STARTED|Overall Study|1649 patients randomized, 1634 patients treated|1649
971984|NCT00312221|2351921|P4|NOT COMPLETED|Double-blind Phase||70
971985|NCT00312221|2351922|P3|NOT COMPLETED|Double-blind Phase||72
971986|NCT00312221|2351923|P2|NOT COMPLETED|Double-blind Phase||59
971987|NCT00312221|2351924|P1|NOT COMPLETED|Double-blind Phase||0
971988|NCT00312221|2351921|P4|COMPLETED|Double-blind Phase||63
971989|NCT00312221|2351922|P3|COMPLETED|Double-blind Phase||77
971990|NCT00312221|2351923|P2|COMPLETED|Double-blind Phase||77
971991|NCT00312221|2351924|P1|COMPLETED|Double-blind Phase||0
971992|NCT00312221|2351921|P4|STARTED|Double-blind Phase||133
971993|NCT00312221|2351922|P3|STARTED|Double-blind Phase||149
971994|NCT00312221|2351923|P2|STARTED|Double-blind Phase||136
971995|NCT00312221|2351924|P1|STARTED|Double-blind Phase||0
971996|NCT00312221|2351921|P4|NOT COMPLETED|Open-label Run-in Period||0
971997|NCT00312221|2351922|P3|NOT COMPLETED|Open-label Run-in Period||0
971998|NCT00312221|2351923|P2|NOT COMPLETED|Open-label Run-in Period||0
971999|NCT00312221|2351924|P1|NOT COMPLETED|Open-label Run-in Period||234
972000|NCT00312221|2351921|P4|COMPLETED|Open-label Run-in Period||0
972001|NCT00312221|2351922|P3|COMPLETED|Open-label Run-in Period||0
972002|NCT00312221|2351923|P2|COMPLETED|Open-label Run-in Period||0
972003|NCT00312221|2351924|P1|COMPLETED|Open-label Run-in Period||418
972004|NCT00312221|2351921|P4|STARTED|Open-label Run-in Period||0
972005|NCT00312221|2351922|P3|STARTED|Open-label Run-in Period||0
972006|NCT00312221|2351923|P2|STARTED|Open-label Run-in Period||0
972007|NCT00312221|2351924|P1|STARTED|Open-label Run-in Period||652
972008|NCT00312338|2351944|P2|NOT COMPLETED|Overall Study||3
972009|NCT00312338|2351945|P1|NOT COMPLETED|Overall Study||22
972010|NCT00312338|2351944|P2|COMPLETED|Overall Study||54
972011|NCT00312338|2351945|P1|COMPLETED|Overall Study||83
972012|NCT00312338|2351944|P2|STARTED|Overall Study||57
972013|NCT00312338|2351945|P1|STARTED|Overall Study||105
972014|NCT00312377|2351957|P2|NOT COMPLETED|Overall Study||668
972015|NCT00312377|2351958|P1|NOT COMPLETED|Overall Study||644
972016|NCT00312377|2351957|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|29
972017|NCT00312377|2351958|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|50
972018|NCT00312377|2351957|P2|STARTED|Overall Study|randomised patients|697
972019|NCT00312377|2351958|P1|STARTED|Overall Study|randomised patients|694
972020|NCT00312494|2351983|P3|NOT COMPLETED|Overall Study||43
972021|NCT00312494|2351984|P2|NOT COMPLETED|Overall Study||58
972022|NCT00312494|2351985|P1|NOT COMPLETED|Overall Study||71
972023|NCT00312494|2351983|P3|COMPLETED|Overall Study||179
972024|NCT00312494|2351984|P2|COMPLETED|Overall Study||168
972025|NCT00312494|2351985|P1|COMPLETED|Overall Study|1 subject randomized to higher dose; received lower dose baseline and/or week 1; higher dose week 2.|161
972026|NCT00312494|2351983|P3|Received Study Treatment|Overall Study||217
972027|NCT00312494|2351984|P2|Received Study Treatment|Overall Study||216
972028|NCT00312494|2351985|P1|Received Study Treatment|Overall Study|1 subject randomized to higher dose; received lower dose at baseline, higher dose weeks 1 and 2.|223
972029|NCT00312494|2351983|P3|STARTED|Overall Study||222
972030|NCT00312494|2351984|P2|STARTED|Overall Study||226
972031|NCT00312494|2351985|P1|STARTED|Overall Study||232
972032|NCT00312572|2352019|P2|NOT COMPLETED|Overall Study||21
972033|NCT00312572|2352020|P1|NOT COMPLETED|Overall Study||16
972034|NCT00312572|2352019|P2|COMPLETED|Overall Study||82
972035|NCT00312572|2352020|P1|COMPLETED|Overall Study||85
972036|NCT00312572|2352019|P2|STARTED|Overall Study||103
972037|NCT00312572|2352020|P1|STARTED|Overall Study||101
972038|NCT00312728|2352028|P1|NOT COMPLETED|Overall Study||110
972039|NCT00312728|2352028|P1|COMPLETED|Overall Study||5
972040|NCT00312728|2352028|P1|STARTED|Overall Study||115
972041|NCT00312845|2352039|P2|NOT COMPLETED|Overall Study||95
972042|NCT00312845|2352040|P1|NOT COMPLETED|Overall Study||99
972043|NCT00312845|2352039|P2|COMPLETED|Overall Study||245
972044|NCT00312845|2352040|P1|COMPLETED|Overall Study||237
972045|NCT00312845|2352039|P2|STARTED|Overall Study||340
972046|NCT00312845|2352040|P1|STARTED|Overall Study||336
972047|NCT00312858|2352050|P2|NOT COMPLETED|Overall Study||93
972048|NCT00312858|2352051|P1|NOT COMPLETED|Overall Study||68
972049|NCT00312858|2352050|P2|COMPLETED|Overall Study||230
972050|NCT00312858|2352051|P1|COMPLETED|Overall Study||262
972051|NCT00312858|2352050|P2|Visit 4|Overall Study||240
972052|NCT00312858|2352051|P1|Visit 4|Overall Study||262
972053|NCT00312858|2352050|P2|Visit 3|Overall Study||261
972054|NCT00312858|2352051|P1|Visit 3|Overall Study||273
972055|NCT00312858|2352050|P2|Visit 2|Overall Study||294
972056|NCT00312858|2352051|P1|Visit 2|Overall Study||305
972057|NCT00312858|2352050|P2|Visit 1|Overall Study||323
972058|NCT00312858|2352051|P1|Visit 1|Overall Study||330
972059|NCT00312858|2352050|P2|STARTED|Overall Study||323
972060|NCT00312858|2352051|P1|STARTED|Overall Study||330
972061|NCT00312884|2352105|P2|NOT COMPLETED|Overall Study||12
972062|NCT00312884|2352106|P1|NOT COMPLETED|Overall Study||17
972063|NCT00312884|2352105|P2|COMPLETED|Overall Study||79
972064|NCT00312884|2352106|P1|COMPLETED|Overall Study||74
972065|NCT00312884|2352105|P2|STARTED|Overall Study||91
972066|NCT00312884|2352106|P1|STARTED|Overall Study||91
972067|NCT00312923|2352120|P2|NOT COMPLETED|Overall Study||6
972068|NCT00312923|2352121|P1|NOT COMPLETED|Overall Study||9
972069|NCT00312923|2352120|P2|COMPLETED|Overall Study||20
972070|NCT00312923|2352121|P1|COMPLETED|Overall Study||19
972071|NCT00312923|2352120|P2|STARTED|Overall Study||26
972072|NCT00312923|2352121|P1|STARTED|Overall Study||28
972073|NCT00313014|2352132|P3|NOT COMPLETED|Overall Study||61
972074|NCT00313014|2352133|P2|NOT COMPLETED|Overall Study||73
972075|NCT00313014|2352134|P1|NOT COMPLETED|Overall Study||93
972076|NCT00313014|2352132|P3|COMPLETED|Overall Study||159
972077|NCT00313014|2352133|P2|COMPLETED|Overall Study||146
972078|NCT00313014|2352134|P1|COMPLETED|Overall Study||128
972079|NCT00313014|2352132|P3|STARTED|Overall Study||220
972080|NCT00313014|2352133|P2|STARTED|Overall Study||219
972081|NCT00313014|2352134|P1|STARTED|Overall Study||221
972082|NCT00313144|2352152|P1|NOT COMPLETED|Overall Study||110
972083|NCT00313144|2352152|P1|COMPLETED|Overall Study||17
972084|NCT00313144|2352152|P1|STARTED|Overall Study||127
972085|NCT00313170|2352239|P3|NOT COMPLETED|Overall Study||32
972086|NCT00313170|2352240|P2|NOT COMPLETED|Overall Study||35
972087|NCT00313170|2352241|P1|NOT COMPLETED|Overall Study||36
972088|NCT00313170|2352239|P3|COMPLETED|Overall Study||14
972089|NCT00313170|2352240|P2|COMPLETED|Overall Study||16
972090|NCT00313170|2352241|P1|COMPLETED|Overall Study||11
972091|NCT00313170|2352239|P3|STARTED|Overall Study||46
972092|NCT00313170|2352240|P2|STARTED|Overall Study||51
972093|NCT00313170|2352241|P1|STARTED|Overall Study||47
972094|NCT00313209|2352259|P2|NOT COMPLETED|Overall Study||82
972095|NCT00313209|2352260|P1|NOT COMPLETED|Overall Study||107
972096|NCT00313209|2352259|P2|COMPLETED|Overall Study||385
972097|NCT00313209|2352260|P1|COMPLETED|Overall Study||359
972098|NCT00313209|2352259|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|467
972099|NCT00313209|2352260|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|466
972100|NCT00313300|2352279|P5|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
972101|NCT00313300|2352280|P4|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||5
972102|NCT00313300|2352281|P3|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
972103|NCT00313300|2352282|P2|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||0
972104|NCT00313300|2352283|P1|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||3
972105|NCT00313300|2352279|P5|COMPLETED|Follow-Up(30days)-Randomized Phase B||199
972106|NCT00313300|2352280|P4|COMPLETED|Follow-Up(30days)-Randomized Phase B||217
972107|NCT00313300|2352281|P3|COMPLETED|Follow-Up(30days)-Randomized Phase B||117
972108|NCT00313300|2352282|P2|COMPLETED|Follow-Up(30days)-Randomized Phase B||123
972109|NCT00313300|2352283|P1|COMPLETED|Follow-Up(30days)-Randomized Phase B||380
972110|NCT00313300|2352279|P5|STARTED|Follow-Up(30days)-Randomized Phase B||201
972111|NCT00313300|2352280|P4|STARTED|Follow-Up(30days)-Randomized Phase B||222
972112|NCT00313300|2352281|P3|STARTED|Follow-Up(30days)-Randomized Phase B||119
972113|NCT00313300|2352282|P2|STARTED|Follow-Up(30days)-Randomized Phase B||123
972114|NCT00313300|2352283|P1|STARTED|Follow-Up(30days)-Randomized Phase B||383
972115|NCT00313300|2352279|P5|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
972116|NCT00313300|2352280|P4|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
972117|NCT00313300|2352281|P3|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||2
972118|NCT00313300|2352282|P2|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||6
972119|NCT00313300|2352283|P1|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||5
972120|NCT00313300|2352279|P5|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
972121|NCT00313300|2352280|P4|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
972122|NCT00313300|2352281|P3|COMPLETED|Follow-Up(30days)-Randomized Phase A||172
972123|NCT00313300|2352282|P2|COMPLETED|Follow-Up(30days)-Randomized Phase A||156
972124|NCT00313300|2352283|P1|COMPLETED|Follow-Up(30days)-Randomized Phase A||158
972125|NCT00313300|2352279|P5|STARTED|Follow-Up(30days)-Randomized Phase A||0
972126|NCT00313300|2352280|P4|STARTED|Follow-Up(30days)-Randomized Phase A||0
972127|NCT00313300|2352281|P3|STARTED|Follow-Up(30days)-Randomized Phase A||174
972128|NCT00313300|2352282|P2|STARTED|Follow-Up(30days)-Randomized Phase A||162
972129|NCT00313300|2352283|P1|STARTED|Follow-Up(30days)-Randomized Phase A||163
972130|NCT00313300|2352279|P5|NOT COMPLETED|Randomized in Phase B (26 Weeks)||208
972131|NCT00313300|2352280|P4|NOT COMPLETED|Randomized in Phase B (26 Weeks)||233
972132|NCT00313300|2352281|P3|NOT COMPLETED|Randomized in Phase B (26 Weeks)||40
972133|NCT00313300|2352282|P2|NOT COMPLETED|Randomized in Phase B (26 Weeks)||33
972134|NCT00313300|2352283|P1|NOT COMPLETED|Randomized in Phase B (26 Weeks)||94
972135|NCT00313300|2352279|P5|COMPLETED|Randomized in Phase B (26 Weeks)||13
972136|NCT00313300|2352280|P4|COMPLETED|Randomized in Phase B (26 Weeks)||15
972137|NCT00313300|2352281|P3|COMPLETED|Randomized in Phase B (26 Weeks)||94
972138|NCT00313300|2352282|P2|COMPLETED|Randomized in Phase B (26 Weeks)||105
972139|NCT00313300|2352283|P1|COMPLETED|Randomized in Phase B (26 Weeks)||333
972140|NCT00313300|2352279|P5|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||221
972141|NCT00313300|2352280|P4|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||248
972142|NCT00313300|2352281|P3|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||110
972143|NCT00313300|2352282|P2|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||120
972144|NCT00313300|2352283|P1|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||368
972145|NCT00313300|2352279|P5|STARTED|Randomized in Phase B (26 Weeks)||221
972146|NCT00313300|2352280|P4|STARTED|Randomized in Phase B (26 Weeks)||248
972147|NCT00313300|2352281|P3|STARTED|Randomized in Phase B (26 Weeks)||134
972148|NCT00313300|2352282|P2|STARTED|Randomized in Phase B (26 Weeks)||138
972149|NCT00313300|2352283|P1|STARTED|Randomized in Phase B (26 Weeks)||427
972150|NCT00313300|2352279|P5|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
972151|NCT00313300|2352280|P4|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
972152|NCT00313300|2352281|P3|NOT COMPLETED|Randomized in Phase A (26 Weeks)||35
972153|NCT00313300|2352282|P2|NOT COMPLETED|Randomized in Phase A (26 Weeks)||39
972154|NCT00313300|2352283|P1|NOT COMPLETED|Randomized in Phase A (26 Weeks)||54
972155|NCT00313300|2352279|P5|COMPLETED|Randomized in Phase A (26 Weeks)||0
972156|NCT00313300|2352280|P4|COMPLETED|Randomized in Phase A (26 Weeks)||0
972157|NCT00313300|2352281|P3|COMPLETED|Randomized in Phase A (26 Weeks)||149
972158|NCT00313300|2352282|P2|COMPLETED|Randomized in Phase A (26 Weeks)||140
972159|NCT00313300|2352283|P1|COMPLETED|Randomized in Phase A (26 Weeks)||130
972160|NCT00313300|2352279|P5|STARTED|Randomized in Phase A (26 Weeks)||0
972161|NCT00313300|2352280|P4|STARTED|Randomized in Phase A (26 Weeks)||0
972162|NCT00313300|2352281|P3|STARTED|Randomized in Phase A (26 Weeks)||184
972163|NCT00313300|2352282|P2|STARTED|Randomized in Phase A (26 Weeks)||179
972164|NCT00313300|2352283|P1|STARTED|Randomized in Phase A (26 Weeks)||184
972165|NCT00313313|2352336|P3|NOT COMPLETED|Overall Study||82
972166|NCT00313313|2352337|P2|NOT COMPLETED|Overall Study||66
972167|NCT00313313|2352338|P1|NOT COMPLETED|Overall Study||63
972168|NCT00313313|2352336|P3|COMPLETED|Overall Study|26 subjects completed the study without being rescued|185
972169|NCT00313313|2352337|P2|COMPLETED|Overall Study|55 subjects completed the study without being rescued|187
972170|NCT00313313|2352338|P1|COMPLETED|Overall Study|61 subjects completed the study without being rescued|185
972171|NCT00313313|2352336|P3|STARTED|Overall Study||267
972172|NCT00313313|2352337|P2|STARTED|Overall Study||253
972173|NCT00313313|2352338|P1|STARTED|Overall Study||248
972174|NCT00301756|2352355|P1|NOT COMPLETED|Overall Study||0
972175|NCT00301756|2352355|P1|COMPLETED|Overall Study||32
972176|NCT00301756|2352355|P1|STARTED|Overall Study||32
972177|NCT00301808|2352364|P1|NOT COMPLETED|Overall Study||12
972178|NCT00301808|2352364|P1|COMPLETED|Overall Study||17
972179|NCT00301808|2352364|P1|STARTED|Overall Study||29
972180|NCT00301821|2352368|P1|NOT COMPLETED|Overall Study||26
972181|NCT00301821|2352368|P1|COMPLETED|Overall Study||81
972182|NCT00301821|2352368|P1|STARTED|Overall Study||107
972183|NCT00301834|2352375|P1|NOT COMPLETED|Overall Study||1
972184|NCT00301834|2352375|P1|COMPLETED|Overall Study||34
972185|NCT00301834|2352375|P1|STARTED|Overall Study||35
972186|NCT00301873|2352384|P1|NOT COMPLETED|Overall Study||0
972187|NCT00301873|2352384|P1|COMPLETED|Overall Study||59
972188|NCT00301873|2352384|P1|STARTED|Overall Study||59
972189|NCT00301964|2352390|P1|NOT COMPLETED|Overall Study||4
972190|NCT00301964|2352390|P1|COMPLETED|Overall Study|Total number of eligible and evaluable participants|52
972191|NCT00301964|2352390|P1|STARTED|Overall Study||56
972192|NCT00302003|2352395|P1|NOT COMPLETED|Overall Study||80
972193|NCT00302003|2352395|P1|COMPLETED|Overall Study||207
972194|NCT00302003|2352395|P1|STARTED|Overall Study||287
972195|NCT00302042|2352404|P2|NOT COMPLETED|Overall Study||8
972196|NCT00302042|2352405|P1|NOT COMPLETED|Overall Study||7
972197|NCT00302042|2352404|P2|COMPLETED|Overall Study||38
972198|NCT00302042|2352405|P1|COMPLETED|Overall Study||39
972199|NCT00302042|2352404|P2|STARTED|Overall Study||46
972200|NCT00302042|2352405|P1|STARTED|Overall Study||46
972201|NCT00302055|2352413|P2|NOT COMPLETED|Overall Study||13
972202|NCT00302055|2352414|P1|NOT COMPLETED|Overall Study||9
972203|NCT00302055|2352413|P2|COMPLETED|Overall Study||36
972204|NCT00302055|2352414|P1|COMPLETED|Overall Study||14
972205|NCT00302055|2352413|P2|STARTED|Overall Study||49
972206|NCT00302055|2352414|P1|STARTED|Overall Study||23
972207|NCT00302068|2352423|P3|NOT COMPLETED|Overall Study||1
972208|NCT00302068|2352424|P2|NOT COMPLETED|Overall Study||4
972209|NCT00302068|2352425|P1|NOT COMPLETED|Overall Study||1
972210|NCT00302068|2352423|P3|COMPLETED|Overall Study||23
972211|NCT00302068|2352424|P2|COMPLETED|Overall Study||36
972212|NCT00302068|2352425|P1|COMPLETED|Overall Study||36
972213|NCT00302068|2352423|P3|STARTED|Overall Study||24
972214|NCT00302068|2352424|P2|STARTED|Overall Study||40
972215|NCT00302068|2352425|P1|STARTED|Overall Study||37
972216|NCT00302081|2352454|P3|NOT COMPLETED|Overall Study||52
972217|NCT00302081|2352455|P2|NOT COMPLETED|Overall Study||43
972218|NCT00302081|2352456|P1|NOT COMPLETED|Overall Study||56
972219|NCT00302081|2352454|P3|COMPLETED|Overall Study||178
972220|NCT00302081|2352455|P2|COMPLETED|Overall Study||186
972221|NCT00302081|2352456|P1|COMPLETED|Overall Study||181
972222|NCT00302081|2352454|P3|STARTED|Overall Study||230
972223|NCT00302081|2352455|P2|STARTED|Overall Study||229
972224|NCT00302081|2352456|P1|STARTED|Overall Study||237
972225|NCT00302107|2352466|P2|NOT COMPLETED|Overall Study||9
972226|NCT00302107|2352467|P1|NOT COMPLETED|Overall Study||8
972227|NCT00302107|2352466|P2|COMPLETED|Overall Study||30
972228|NCT00302107|2352467|P1|COMPLETED|Overall Study||31
972229|NCT00302107|2352466|P2|STARTED|Overall Study||39
972230|NCT00302107|2352467|P1|STARTED|Overall Study||39
972231|NCT00302133|2352475|P2|NOT COMPLETED|Overall Study||4
972232|NCT00302133|2352476|P1|NOT COMPLETED|Overall Study||4
972233|NCT00302133|2352475|P2|COMPLETED|Overall Study||5
972234|NCT00302133|2352476|P1|COMPLETED|Overall Study||5
972235|NCT00302133|2352475|P2|STARTED|Overall Study||9
972236|NCT00302133|2352476|P1|STARTED|Overall Study||9
972237|NCT00302159|2352484|P1|NOT COMPLETED|Overall Study||2
972238|NCT00302159|2352484|P1|COMPLETED|Overall Study||41
972239|NCT00302159|2352484|P1|STARTED|Overall Study||43
972240|NCT00302211|2352496|P5|NOT COMPLETED|Open Label-Patients From Double-Blind||8
972241|NCT00302211|2352497|P4|NOT COMPLETED|Open Label-Patients From Double-Blind||8
972242|NCT00302211|2352498|P3|NOT COMPLETED|Open Label-Patients From Double-Blind||0
972243|NCT00302211|2352499|P2|NOT COMPLETED|Open Label-Patients From Double-Blind||0
972244|NCT00302211|2352500|P1|NOT COMPLETED|Open Label-Patients From Double-Blind||0
972245|NCT00302211|2352496|P5|COMPLETED|Open Label-Patients From Double-Blind||24
972246|NCT00302211|2352497|P4|COMPLETED|Open Label-Patients From Double-Blind||18
972247|NCT00302211|2352498|P3|COMPLETED|Open Label-Patients From Double-Blind||0
972248|NCT00302211|2352499|P2|COMPLETED|Open Label-Patients From Double-Blind||0
972249|NCT00302211|2352500|P1|COMPLETED|Open Label-Patients From Double-Blind||0
972250|NCT00302211|2352496|P5|STARTED|Open Label-Patients From Double-Blind|26 pts in 4x/day + placebo 2x/day DB phase & 6 pts in placebo 6x/day DB phase enrolled in OL 4x/day|32
972251|NCT00302211|2352497|P4|STARTED|Open Label-Patients From Double-Blind|21 patients (pts) in 6x/day DB phase & 5 patients in placebo 6x/day DB phase enrolled in OL 6x/day|26
972252|NCT00302211|2352498|P3|STARTED|Open Label-Patients From Double-Blind||0
972253|NCT00302211|2352499|P2|STARTED|Open Label-Patients From Double-Blind||0
972254|NCT00302211|2352500|P1|STARTED|Open Label-Patients From Double-Blind||0
972255|NCT00302211|2352496|P5|NOT COMPLETED|Double Blind Period (New Patients)||0
972256|NCT00302211|2352497|P4|NOT COMPLETED|Double Blind Period (New Patients)||0
972257|NCT00302211|2352498|P3|NOT COMPLETED|Double Blind Period (New Patients)||4
972258|NCT00302211|2352499|P2|NOT COMPLETED|Double Blind Period (New Patients)||2
972259|NCT00302211|2352500|P1|NOT COMPLETED|Double Blind Period (New Patients)||3
972260|NCT00302211|2352496|P5|COMPLETED|Double Blind Period (New Patients)||0
972261|NCT00302211|2352497|P4|COMPLETED|Double Blind Period (New Patients)||0
972262|NCT00302211|2352498|P3|COMPLETED|Double Blind Period (New Patients)||10
972263|NCT00302211|2352499|P2|COMPLETED|Double Blind Period (New Patients)||25
972264|NCT00302211|2352500|P1|COMPLETED|Double Blind Period (New Patients)||23
972265|NCT00302211|2352496|P5|STARTED|Double Blind Period (New Patients)||0
972266|NCT00302211|2352497|P4|STARTED|Double Blind Period (New Patients)||0
972267|NCT00302211|2352498|P3|STARTED|Double Blind Period (New Patients)|placebo plus sildenafil with or without bosentan|14
972268|NCT00302211|2352499|P2|STARTED|Double Blind Period (New Patients)|iloprost 4x/day plus sildenafil with or without bosentan|27
972269|NCT00302211|2352500|P1|STARTED|Double Blind Period (New Patients)|iloprost 6x/day plus sildenafil with or without bosentan|26
972270|NCT00302328|2352515|P3|NOT COMPLETED|Overall Study||0
972271|NCT00302328|2352516|P2|NOT COMPLETED|Overall Study||1
972272|NCT00302328|2352517|P1|NOT COMPLETED|Overall Study||0
972273|NCT00302328|2352515|P3|COMPLETED|Overall Study||18
972274|NCT00302328|2352516|P2|COMPLETED|Overall Study|developed cancer during the study|34
972275|NCT00302328|2352517|P1|COMPLETED|Overall Study||25
972276|NCT00302328|2352515|P3|STARTED|Overall Study||18
972277|NCT00302328|2352516|P2|STARTED|Overall Study||35
972278|NCT00302328|2352517|P1|STARTED|Overall Study||25
972279|NCT00302458|2352531|P1|NOT COMPLETED|Overall Study||3
972280|NCT00302458|2352531|P1|COMPLETED|Overall Study||26
972281|NCT00302458|2352531|P1|STARTED|Overall Study||29
972282|NCT00302718|2352543|P4|NOT COMPLETED|Overall Study||2
972283|NCT00302718|2352544|P3|NOT COMPLETED|Overall Study||2
972284|NCT00302718|2352545|P2|NOT COMPLETED|Overall Study||1
972285|NCT00302718|2352546|P1|NOT COMPLETED|Overall Study||1
972286|NCT00302718|2352543|P4|COMPLETED|Overall Study||19
972287|NCT00302718|2352544|P3|COMPLETED|Overall Study||19
972288|NCT00302718|2352545|P2|COMPLETED|Overall Study||20
972289|NCT00302718|2352546|P1|COMPLETED|Overall Study||19
972290|NCT00302718|2352543|P4|STARTED|Overall Study||21
972291|NCT00302718|2352544|P3|STARTED|Overall Study||21
972292|NCT00302718|2352545|P2|STARTED|Overall Study||21
972293|NCT00302718|2352546|P1|STARTED|Overall Study||20
972294|NCT00302848|2352581|P3|NOT COMPLETED|Overall Study||579
972295|NCT00302848|2352582|P2|NOT COMPLETED|Overall Study||419
972296|NCT00302848|2352583|P1|NOT COMPLETED|Overall Study||401
972297|NCT00302848|2352581|P3|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|25762
972298|NCT00302848|2352582|P2|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|15009
972299|NCT00302848|2352583|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|16133
972300|NCT00302848|2352581|P3|STARTED|Overall Study||26341
972301|NCT00302848|2352582|P2|STARTED|Overall Study||15428
972302|NCT00302848|2352583|P1|STARTED|Overall Study||16534
972303|NCT00302952|2352592|P2|NOT COMPLETED|Overall Study||5
972304|NCT00302952|2352593|P1|NOT COMPLETED|Overall Study||3
972305|NCT00302952|2352592|P2|COMPLETED|Overall Study||25
972306|NCT00302952|2352593|P1|COMPLETED|Overall Study||31
972307|NCT00302952|2352592|P2|Completed Intent-to-Treat (ITT)|Overall Study|One participant did not have a baseline C-reactive Protein and was excluded from the ITT population.|29
972308|NCT00302952|2352593|P1|Completed Intent-to-Treat (ITT)|Overall Study||34
972309|NCT00302952|2352592|P2|Started Intent-to-Treat (ITT)|Overall Study||30
972310|NCT00302952|2352593|P1|Started Intent-to-Treat (ITT)|Overall Study||34
972311|NCT00302952|2352592|P2|STARTED|Overall Study||30
972312|NCT00302952|2352593|P1|STARTED|Overall Study||34
972313|NCT00303069|2352631|P4|NOT COMPLETED|Overall Study||2
972314|NCT00303069|2352632|P3|NOT COMPLETED|Overall Study||1
972315|NCT00303069|2352633|P2|NOT COMPLETED|Overall Study||0
972316|NCT00303069|2352634|P1|NOT COMPLETED|Overall Study||2
972317|NCT00303069|2352631|P4|COMPLETED|Overall Study||29
972318|NCT00303069|2352632|P3|COMPLETED|Overall Study||33
972319|NCT00303069|2352633|P2|COMPLETED|Overall Study||28
972320|NCT00303069|2352634|P1|COMPLETED|Overall Study||29
972321|NCT00303069|2352631|P4|STARTED|Overall Study||31
972322|NCT00303069|2352632|P3|STARTED|Overall Study||34
972323|NCT00303069|2352633|P2|STARTED|Overall Study||28
972324|NCT00303069|2352634|P1|STARTED|Overall Study||31
972325|NCT00303108|2352655|P3|NOT COMPLETED|Overall Study||16
972326|NCT00303108|2352656|P2|NOT COMPLETED|Overall Study||9
972327|NCT00303108|2352657|P1|NOT COMPLETED|Overall Study||12
972328|NCT00303108|2352655|P3|COMPLETED|Overall Study||31
972329|NCT00303108|2352656|P2|COMPLETED|Overall Study||37
972330|NCT00303108|2352657|P1|COMPLETED|Overall Study||31
972331|NCT00303108|2352655|P3|STARTED|Overall Study||47
972332|NCT00303108|2352656|P2|STARTED|Overall Study||46
972333|NCT00303108|2352657|P1|STARTED|Overall Study||43
972334|NCT00303186|2352673|P1|NOT COMPLETED|Overall Study||52
972335|NCT00303186|2352673|P1|COMPLETED|Overall Study||55
972336|NCT00303186|2352673|P1|STARTED|Overall Study||107
972337|NCT00303316|2352706|P2|NOT COMPLETED|Overall Study||3
972338|NCT00303316|2352707|P1|NOT COMPLETED|Overall Study||2
972339|NCT00303316|2352706|P2|COMPLETED|Overall Study||223
972340|NCT00303316|2352707|P1|COMPLETED|Overall Study||230
972341|NCT00303316|2352706|P2|STARTED|Overall Study||226
972342|NCT00303316|2352707|P1|STARTED|Overall Study||232
972343|NCT00303329|2352721|P2|NOT COMPLETED|Overall Study||62
972344|NCT00303329|2352722|P1|NOT COMPLETED|Overall Study||35
972345|NCT00303329|2352721|P2|COMPLETED|Overall Study||37
972346|NCT00303329|2352722|P1|COMPLETED|Overall Study||50
972347|NCT00303329|2352721|P2|STARTED|Overall Study||99
972348|NCT00303329|2352722|P1|STARTED|Overall Study||85
972349|NCT00303446|2352736|P2|NOT COMPLETED|Overall Study||4
972350|NCT00303446|2352737|P1|NOT COMPLETED|Overall Study||2
972351|NCT00303446|2352736|P2|COMPLETED|Overall Study||21
972352|NCT00303446|2352737|P1|COMPLETED|Overall Study||23
972353|NCT00303446|2352736|P2|STARTED|Overall Study||25
972354|NCT00303446|2352737|P1|STARTED|Overall Study||25
972355|NCT00303459|2352773|P2|NOT COMPLETED|Overall Study||89
972356|NCT00303459|2352774|P1|NOT COMPLETED|Overall Study||83
972357|NCT00303459|2352773|P2|COMPLETED|Overall Study||86
972358|NCT00303459|2352774|P1|COMPLETED|Overall Study||76
972359|NCT00303459|2352773|P2|STARTED|Overall Study|One subject randomized to placebo did not receive study treatment|175
972360|NCT00303459|2352774|P1|STARTED|Overall Study||159
972361|NCT00303472|2352805|P7|NOT COMPLETED|Treatment Extension (Optional)||0
972362|NCT00303472|2352806|P6|NOT COMPLETED|Treatment Extension (Optional)||1
972363|NCT00303472|2352807|P5|NOT COMPLETED|Treatment Extension (Optional)||4
972364|NCT00303472|2352808|P4|NOT COMPLETED|Treatment Extension (Optional)||8
972365|NCT00303472|2352809|P3|NOT COMPLETED|Treatment Extension (Optional)||9
972366|NCT00303472|2352810|P2|NOT COMPLETED|Treatment Extension (Optional)||6
972367|NCT00303472|2352811|P1|NOT COMPLETED|Treatment Extension (Optional)||5
972368|NCT00303472|2352805|P7|COMPLETED|Treatment Extension (Optional)||1
972369|NCT00303472|2352806|P6|COMPLETED|Treatment Extension (Optional)||4
972370|NCT00303472|2352807|P5|COMPLETED|Treatment Extension (Optional)||1
972371|NCT00303472|2352808|P4|COMPLETED|Treatment Extension (Optional)||5
972372|NCT00303472|2352809|P3|COMPLETED|Treatment Extension (Optional)||2
972373|NCT00303472|2352810|P2|COMPLETED|Treatment Extension (Optional)||5
972374|NCT00303472|2352811|P1|COMPLETED|Treatment Extension (Optional)||1
972375|NCT00303472|2352805|P7|STARTED|Treatment Extension (Optional)||1
972376|NCT00303472|2352806|P6|STARTED|Treatment Extension (Optional)||5
972377|NCT00303472|2352807|P5|STARTED|Treatment Extension (Optional)||5
972378|NCT00303472|2352808|P4|STARTED|Treatment Extension (Optional)||13
972379|NCT00303472|2352809|P3|STARTED|Treatment Extension (Optional)||11
972380|NCT00303472|2352810|P2|STARTED|Treatment Extension (Optional)||11
972381|NCT00303472|2352811|P1|STARTED|Treatment Extension (Optional)||6
972382|NCT00303472|2352805|P7|NOT COMPLETED|Treatment Period||2
972383|NCT00303472|2352806|P6|NOT COMPLETED|Treatment Period||1
972384|NCT00303472|2352807|P5|NOT COMPLETED|Treatment Period||3
972385|NCT00303472|2352808|P4|NOT COMPLETED|Treatment Period||2
972386|NCT00303472|2352809|P3|NOT COMPLETED|Treatment Period||0
972387|NCT00303472|2352810|P2|NOT COMPLETED|Treatment Period||0
972388|NCT00303472|2352811|P1|NOT COMPLETED|Treatment Period||0
972389|NCT00303472|2352805|P7|COMPLETED|Treatment Period||3
972390|NCT00303472|2352806|P6|COMPLETED|Treatment Period||11
972391|NCT00303472|2352807|P5|COMPLETED|Treatment Period||8
972392|NCT00303472|2352808|P4|COMPLETED|Treatment Period||14
972393|NCT00303472|2352809|P3|COMPLETED|Treatment Period||11
972394|NCT00303472|2352810|P2|COMPLETED|Treatment Period||11
972395|NCT00303472|2352811|P1|COMPLETED|Treatment Period||6
972396|NCT00303472|2352805|P7|STARTED|Treatment Period||5
972397|NCT00303472|2352806|P6|STARTED|Treatment Period||12
972398|NCT00303472|2352807|P5|STARTED|Treatment Period||11
972399|NCT00303472|2352808|P4|STARTED|Treatment Period||16
972400|NCT00303472|2352809|P3|STARTED|Treatment Period||11
972401|NCT00303472|2352810|P2|STARTED|Treatment Period||11
972402|NCT00303472|2352811|P1|STARTED|Treatment Period||6
972403|NCT00303485|2352871|P2|NOT COMPLETED|Overall Study||2
972404|NCT00303485|2352872|P1|NOT COMPLETED|Overall Study||1
972405|NCT00303485|2352871|P2|COMPLETED|Overall Study||15
972406|NCT00303485|2352872|P1|COMPLETED|Overall Study||48
972407|NCT00303485|2352871|P2|STARTED|Overall Study||17
972408|NCT00303485|2352872|P1|STARTED|Overall Study||49
972409|NCT00303511|2352896|P1|NOT COMPLETED|Overall Study||0
972410|NCT00303511|2352896|P1|COMPLETED|Overall Study||10
972411|NCT00303511|2352896|P1|STARTED|Overall Study||10
972412|NCT00303602|2352902|P2|NOT COMPLETED|Overall Study||15
972413|NCT00303602|2352903|P1|NOT COMPLETED|Overall Study||19
972414|NCT00303602|2352902|P2|COMPLETED|Overall Study||50
972415|NCT00303602|2352903|P1|COMPLETED|Overall Study||65
972416|NCT00303602|2352902|P2|STARTED|Overall Study||65
972417|NCT00303602|2352903|P1|STARTED|Overall Study||84
972418|NCT00303628|2352945|P2|NOT COMPLETED|Overall Study||73
972419|NCT00303628|2352946|P1|NOT COMPLETED|Overall Study||50
972420|NCT00303628|2352945|P2|COMPLETED|Overall Study||106
972421|NCT00303628|2352946|P1|COMPLETED|Overall Study||126
972422|NCT00303628|2352945|P2|Treated|Overall Study||174
972423|NCT00303628|2352946|P1|Treated|Overall Study||173
972424|NCT00303628|2352945|P2|Eligible|Overall Study||177
972425|NCT00303628|2352946|P1|Eligible|Overall Study||171
972426|NCT00303628|2352945|P2|STARTED|Overall Study||179
972427|NCT00303628|2352946|P1|STARTED|Overall Study||176
972428|NCT00303667|2352964|P2|NOT COMPLETED|Overall Study||4
972429|NCT00303667|2352965|P1|NOT COMPLETED|Overall Study||0
972430|NCT00303667|2352964|P2|COMPLETED|Overall Study|Completed = remained alive and on study through Day 0 (day of transplant)|35
972431|NCT00303667|2352965|P1|COMPLETED|Overall Study||8
972432|NCT00303667|2352964|P2|STARTED|Overall Study||39
972433|NCT00303667|2352965|P1|STARTED|Overall Study||8
972434|NCT00303823|2352989|P2|NOT COMPLETED|Overall Study||10
972435|NCT00303823|2352990|P1|NOT COMPLETED|Overall Study||15
972436|NCT00303823|2352989|P2|COMPLETED|Overall Study||38
972437|NCT00303823|2352990|P1|COMPLETED|Overall Study||35
972438|NCT00303823|2352989|P2|STARTED|Overall Study||48
972439|NCT00303823|2352990|P1|STARTED|Overall Study||50
972440|NCT00303862|2353002|P1|NOT COMPLETED|Overall Study||0
972441|NCT00303862|2353002|P1|COMPLETED|Overall Study||10
972442|NCT00303862|2353002|P1|STARTED|Overall Study||10
972443|NCT00303901|2353009|P1|NOT COMPLETED|Overall Study||0
972444|NCT00303901|2353009|P1|COMPLETED|Overall Study||40
972445|NCT00303901|2353009|P1|STARTED|Overall Study||40
972446|NCT00303953|2353014|P1|NOT COMPLETED|Overall Study||19
972447|NCT00303953|2353014|P1|COMPLETED|Overall Study||3
972448|NCT00303953|2353014|P1|Eligible and Treated|Overall Study||20
972449|NCT00303953|2353014|P1|Eligible|Overall Study||21
972450|NCT00303953|2353014|P1|STARTED|Overall Study||22
972451|NCT00303966|2353020|P1|NOT COMPLETED|Overall Study||0
972452|NCT00303966|2353020|P1|COMPLETED|Overall Study||5
972453|NCT00303966|2353020|P1|STARTED|Overall Study||5
972454|NCT00303979|2353032|P3|NOT COMPLETED|Single Time Point (18 Month)||0
972455|NCT00303979|2353033|P2|NOT COMPLETED|Single Time Point (18 Month)||0
972456|NCT00303979|2353034|P1|NOT COMPLETED|Single Time Point (18 Month)||0
972457|NCT00303979|2353032|P3|COMPLETED|Single Time Point (18 Month)||9641
972458|NCT00303979|2353033|P2|COMPLETED|Single Time Point (18 Month)||0
972459|NCT00303979|2353034|P1|COMPLETED|Single Time Point (18 Month)||0
972460|NCT00303979|2353032|P3|STARTED|Single Time Point (18 Month)||9641
972461|NCT00303979|2353033|P2|STARTED|Single Time Point (18 Month)||0
972462|NCT00303979|2353034|P1|STARTED|Single Time Point (18 Month)||0
972463|NCT00303979|2353032|P3|NOT COMPLETED|Single Time Point (6 Month)||0
972464|NCT00303979|2353033|P2|NOT COMPLETED|Single Time Point (6 Month)||0
972465|NCT00303979|2353034|P1|NOT COMPLETED|Single Time Point (6 Month)||0
972466|NCT00303979|2353032|P3|COMPLETED|Single Time Point (6 Month)||0
972467|NCT00303979|2353033|P2|COMPLETED|Single Time Point (6 Month)||9992
972468|NCT00303979|2353034|P1|COMPLETED|Single Time Point (6 Month)||0
972469|NCT00303979|2353032|P3|STARTED|Single Time Point (6 Month)||0
972470|NCT00303979|2353033|P2|STARTED|Single Time Point (6 Month)||9992
972471|NCT00303979|2353034|P1|STARTED|Single Time Point (6 Month)||0
972472|NCT00303979|2353032|P3|NOT COMPLETED|Longitudinal (Baseline, 12 and 24 Month)||0
972473|NCT00303979|2353033|P2|NOT COMPLETED|Longitudinal (Baseline, 12 and 24 Month)||0
972474|NCT00303979|2353034|P1|NOT COMPLETED|Longitudinal (Baseline, 12 and 24 Month)||7572
972475|NCT00303979|2353032|P3|COMPLETED|Longitudinal (Baseline, 12 and 24 Month)||0
972476|NCT00303979|2353033|P2|COMPLETED|Longitudinal (Baseline, 12 and 24 Month)||0
972477|NCT00303979|2353034|P1|COMPLETED|Longitudinal (Baseline, 12 and 24 Month)|at 24 Month|7605
972478|NCT00303979|2353032|P3|STARTED|Longitudinal (Baseline, 12 and 24 Month)||0
972479|NCT00303979|2353033|P2|STARTED|Longitudinal (Baseline, 12 and 24 Month)||0
972480|NCT00303979|2353034|P1|STARTED|Longitudinal (Baseline, 12 and 24 Month)|at Baseline|15177
972481|NCT00304031|2353047|P3|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||2
972482|NCT00304031|2353048|P2|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
972483|NCT00304031|2353049|P1|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
972484|NCT00304031|2353047|P3|COMPLETED|Randomization to Adjuvant TMZ Arm|Subjects contributing data to the primary analysis are considered to have completed the study|420
972485|NCT00304031|2353048|P2|COMPLETED|Randomization to Adjuvant TMZ Arm|Subjects contributing data to the primary analysis are considered to have completed the study.|411
972486|NCT00304031|2353049|P1|COMPLETED|Randomization to Adjuvant TMZ Arm||0
972487|NCT00304031|2353047|P3|STARTED|Randomization to Adjuvant TMZ Arm|Patients who met requirements were randomized to an adjuvant TMZ arm after concomitant treatment.|422
972488|NCT00304031|2353048|P2|STARTED|Randomization to Adjuvant TMZ Arm|Patients who met requirements were randomized to an adjuvant TMZ arm after concomitant treatment.|411
972489|NCT00304031|2353049|P1|STARTED|Randomization to Adjuvant TMZ Arm|Patients who met requirements were randomized to an adjuvant TMZ arm after concomitant treatment.|0
972490|NCT00304031|2353047|P3|NOT COMPLETED|Concomitant Radiation Therapy and TMZ||0
972491|NCT00304031|2353048|P2|NOT COMPLETED|Concomitant Radiation Therapy and TMZ||0
972492|NCT00304031|2353049|P1|NOT COMPLETED|Concomitant Radiation Therapy and TMZ||292
972493|NCT00304031|2353047|P3|COMPLETED|Concomitant Radiation Therapy and TMZ||0
972494|NCT00304031|2353048|P2|COMPLETED|Concomitant Radiation Therapy and TMZ||0
972495|NCT00304031|2353049|P1|COMPLETED|Concomitant Radiation Therapy and TMZ|These patients successfully completed concomitant treatment and met requirements for randomization.|833
972496|NCT00304031|2353047|P3|STARTED|Concomitant Radiation Therapy and TMZ|Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
972497|NCT00304031|2353048|P2|STARTED|Concomitant Radiation Therapy and TMZ|Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
972498|NCT00304031|2353049|P1|STARTED|Concomitant Radiation Therapy and TMZ|All patients were registered to concomitant treatment; randomized after completing this treatment.|1125
972499|NCT00304031|2353047|P3|NOT COMPLETED|Registration||0
972500|NCT00304031|2353048|P2|NOT COMPLETED|Registration||0
972501|NCT00304031|2353049|P1|NOT COMPLETED|Registration||48
972502|NCT00304031|2353047|P3|COMPLETED|Registration||0
972503|NCT00304031|2353048|P2|COMPLETED|Registration||0
972504|NCT00304031|2353049|P1|COMPLETED|Registration|Patients determined to be ineligible after registration were excluded.|1125
972505|NCT00304031|2353047|P3|STARTED|Registration|Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
972506|NCT00304031|2353048|P2|STARTED|Registration|Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
972507|NCT00304031|2353049|P1|STARTED|Registration|All patients were registered to concomitant treatment; randomized after completing this treatment.|1173
972508|NCT00304070|2353059|P3|NOT COMPLETED|Overall Study||12
972509|NCT00304070|2353060|P2|NOT COMPLETED|Overall Study||7
972510|NCT00304070|2353061|P1|NOT COMPLETED|Overall Study||3
972511|NCT00304070|2353059|P3|COMPLETED|Overall Study||27
972512|NCT00304070|2353060|P2|COMPLETED|Overall Study||8
972513|NCT00304070|2353061|P1|COMPLETED|Overall Study||21
972514|NCT00304070|2353059|P3|STARTED|Overall Study||39
972515|NCT00304070|2353060|P2|STARTED|Overall Study||15
972516|NCT00304070|2353061|P1|STARTED|Overall Study||24
972517|NCT00304096|2353075|P2|NOT COMPLETED|Overall Study||0
972518|NCT00304096|2353076|P1|NOT COMPLETED|Overall Study||0
972519|NCT00304096|2353075|P2|COMPLETED|Overall Study|6 patients enrolled, 1 not treated|5
972520|NCT00304096|2353076|P1|COMPLETED|Overall Study||6
972521|NCT00304096|2353075|P2|STARTED|Overall Study||5
972522|NCT00304096|2353076|P1|STARTED|Overall Study||6
972523|NCT00313443|2353084|P1|NOT COMPLETED|Overall Study||0
972524|NCT00313443|2353084|P1|COMPLETED|Overall Study||30
972525|NCT00313443|2353084|P1|STARTED|Overall Study||30
972526|NCT00313586|2353096|P4|NOT COMPLETED|Overall Study||23
972527|NCT00313586|2353097|P3|NOT COMPLETED|Overall Study||24
972528|NCT00313586|2353098|P2|NOT COMPLETED|Overall Study||70
972529|NCT00313586|2353099|P1|NOT COMPLETED|Overall Study||70
972530|NCT00313586|2353096|P4|COMPLETED|Overall Study||0
972531|NCT00313586|2353097|P3|COMPLETED|Overall Study||0
972532|NCT00313586|2353098|P2|COMPLETED|Overall Study||5
972533|NCT00313586|2353099|P1|COMPLETED|Overall Study||5
972534|NCT00313586|2353096|P4|Treated|Overall Study||23
972535|NCT00313586|2353097|P3|Treated|Overall Study||24
972536|NCT00313586|2353098|P2|Treated|Overall Study||75
972537|NCT00313586|2353099|P1|Treated|Overall Study||74
972538|NCT00313586|2353096|P4|STARTED|Overall Study||23
972539|NCT00313586|2353097|P3|STARTED|Overall Study||24
972540|NCT00313586|2353098|P2|STARTED|Overall Study||75
972541|NCT00313586|2353099|P1|STARTED|Overall Study||75
972542|NCT00313612|2353109|P2|NOT COMPLETED|Overall Study||1
972543|NCT00313612|2353110|P1|NOT COMPLETED|Overall Study||0
972544|NCT00313612|2353109|P2|COMPLETED|Overall Study||19
972545|NCT00313612|2353110|P1|COMPLETED|Overall Study||19
972546|NCT00313612|2353109|P2|STARTED|Overall Study||20
972547|NCT00313612|2353110|P1|STARTED|Overall Study||19
972548|NCT00313703|2353122|P4|NOT COMPLETED|Overall Study||12
972549|NCT00313703|2353123|P3|NOT COMPLETED|Overall Study||5
972550|NCT00313703|2353124|P2|NOT COMPLETED|Overall Study||2
972551|NCT00313703|2353125|P1|NOT COMPLETED|Overall Study||11
972552|NCT00313703|2353122|P4|COMPLETED|Overall Study|Outcomes not reported due to heterogeneity of this group|0
972553|NCT00313703|2353123|P3|COMPLETED|Overall Study|Some subjects lost-to-follow-up|72
972554|NCT00313703|2353124|P2|COMPLETED|Overall Study|Some subjects lost-to follow-up|32
972555|NCT00313703|2353125|P1|COMPLETED|Overall Study|Some subjects lost to follow-up|175
972556|NCT00313703|2353122|P4|STARTED|Overall Study||12
972557|NCT00313703|2353123|P3|STARTED|Overall Study||77
972558|NCT00313703|2353124|P2|STARTED|Overall Study||34
972559|NCT00313703|2353125|P1|STARTED|Overall Study||186
972560|NCT00313716|2353145|P6|NOT COMPLETED|Overall Study||13
972561|NCT00313716|2353146|P5|NOT COMPLETED|Overall Study||6
972562|NCT00313716|2353147|P4|NOT COMPLETED|Overall Study||4
972563|NCT00313716|2353148|P3|NOT COMPLETED|Overall Study||12
972564|NCT00313716|2353149|P2|NOT COMPLETED|Overall Study||8
972565|NCT00313716|2353150|P1|NOT COMPLETED|Overall Study||5
972566|NCT00313716|2353145|P6|COMPLETED|Overall Study||35
972567|NCT00313716|2353146|P5|COMPLETED|Overall Study||27
972568|NCT00313716|2353147|P4|COMPLETED|Overall Study||16
972569|NCT00313716|2353148|P3|COMPLETED|Overall Study||38
972570|NCT00313716|2353149|P2|COMPLETED|Overall Study||23
972571|NCT00313716|2353150|P1|COMPLETED|Overall Study||13
972572|NCT00313716|2353145|P6|STARTED|Overall Study||48
972573|NCT00313716|2353146|P5|STARTED|Overall Study||33
972574|NCT00313716|2353147|P4|STARTED|Overall Study||20
972575|NCT00313716|2353148|P3|STARTED|Overall Study||50
972576|NCT00313716|2353149|P2|STARTED|Overall Study||31
972577|NCT00313716|2353150|P1|STARTED|Overall Study||18
972578|NCT00316862|2353173|P1|NOT COMPLETED|Overall Study||0
972579|NCT00316862|2353173|P1|COMPLETED|Overall Study||82
972580|NCT00316862|2353173|P1|STARTED|Overall Study||82
972581|NCT00316888|2353181|P2|NOT COMPLETED|Overall Study||8
972582|NCT00316888|2353182|P1|NOT COMPLETED|Overall Study||6
972583|NCT00316888|2353181|P2|COMPLETED|Overall Study||27
972584|NCT00316888|2353182|P1|COMPLETED|Overall Study||22
972585|NCT00316888|2353181|P2|Started Chemo+Radiation+Cetuximab|Overall Study||34
972586|NCT00316888|2353182|P1|Started Chemo+Radiation+Cetuximab|Overall Study|One patient did not start chemo+radiation therapy after completing induction therapy|27
972587|NCT00316888|2353181|P2|Started Induction Chemotherapy|Overall Study|Induction chemotherapy was removed for patients on this arm|0
972588|NCT00316888|2353182|P1|Started Induction Chemotherapy|Overall Study||28
972589|NCT00316888|2353181|P2|Treated|Overall Study||34
972590|NCT00316888|2353182|P1|Treated|Overall Study|Received induction and/or chemo+radiation therapy|28
972591|NCT00316888|2353181|P2|Eligible|Overall Study||35
972592|NCT00316888|2353182|P1|Eligible|Overall Study||28
972593|NCT00316888|2353181|P2|STARTED|Overall Study||35
972594|NCT00316888|2353182|P1|STARTED|Overall Study||28
972595|NCT00316914|2353198|P2|NOT COMPLETED|Overall Study||36
972596|NCT00316914|2353199|P1|NOT COMPLETED|Overall Study||33
972597|NCT00316914|2353198|P2|COMPLETED|Overall Study||16
972598|NCT00316914|2353199|P1|COMPLETED|Overall Study||17
972599|NCT00316914|2353198|P2|STARTED|Overall Study||52
972600|NCT00316914|2353199|P1|STARTED|Overall Study||50
972601|NCT00317044|2353230|P3|NOT COMPLETED|Overall Study||45
972602|NCT00317044|2353231|P2|NOT COMPLETED|Overall Study||40
972603|NCT00317044|2353232|P1|NOT COMPLETED|Overall Study||48
972604|NCT00317044|2353230|P3|COMPLETED|Overall Study||283
972605|NCT00317044|2353231|P2|COMPLETED|Overall Study||273
972606|NCT00317044|2353232|P1|COMPLETED|Overall Study||272
972607|NCT00317044|2353230|P3|STARTED|Overall Study||328
972608|NCT00317044|2353231|P2|STARTED|Overall Study||313
972609|NCT00317044|2353232|P1|STARTED|Overall Study||320
972610|NCT00317109|2353278|P2|NOT COMPLETED|Overall Study||0
972611|NCT00317109|2353279|P1|NOT COMPLETED|Overall Study||3
972612|NCT00317109|2353278|P2|COMPLETED|Overall Study||84
972613|NCT00317109|2353279|P1|COMPLETED|Overall Study||81
972614|NCT00317109|2353278|P2|STARTED|Overall Study||84
972615|NCT00317109|2353279|P1|STARTED|Overall Study||84
972616|NCT00317226|2353313|P1|NOT COMPLETED|Overall Study||23
972617|NCT00317226|2353313|P1|COMPLETED|Overall Study||104
972618|NCT00317226|2353313|P1|STARTED|Overall Study||127
972619|NCT00317239|2353319|P2|NOT COMPLETED|Overall Study||19
972620|NCT00317239|2353320|P1|NOT COMPLETED|Overall Study||13
972621|NCT00317239|2353319|P2|COMPLETED|Overall Study||84
972622|NCT00317239|2353320|P1|COMPLETED|Overall Study||134
972623|NCT00317239|2353319|P2|STARTED|Overall Study||103
972624|NCT00317239|2353320|P1|STARTED|Overall Study||147
972625|NCT00317473|2353332|P6|NOT COMPLETED|Overall Study||3
972626|NCT00317473|2353333|P5|NOT COMPLETED|Overall Study||8
972627|NCT00317473|2353334|P4|NOT COMPLETED|Overall Study||2
972628|NCT00317473|2353335|P3|NOT COMPLETED|Overall Study||3
972629|NCT00317473|2353336|P2|NOT COMPLETED|Overall Study||3
972630|NCT00317473|2353337|P1|NOT COMPLETED|Overall Study||4
972631|NCT00317473|2353332|P6|COMPLETED|Overall Study||12
972632|NCT00317473|2353333|P5|COMPLETED|Overall Study||22
972633|NCT00317473|2353334|P4|COMPLETED|Overall Study||13
972634|NCT00317473|2353335|P3|COMPLETED|Overall Study||27
972635|NCT00317473|2353336|P2|COMPLETED|Overall Study||12
972636|NCT00317473|2353337|P1|COMPLETED|Overall Study||26
972637|NCT00317473|2353332|P6|STARTED|Overall Study||15
972638|NCT00317473|2353333|P5|STARTED|Overall Study||30
972639|NCT00317473|2353334|P4|STARTED|Overall Study||15
972640|NCT00317473|2353335|P3|STARTED|Overall Study||30
972641|NCT00317473|2353336|P2|STARTED|Overall Study||15
972642|NCT00317473|2353337|P1|STARTED|Overall Study||30
972643|NCT00317642|2353363|P2|NOT COMPLETED|Overall Study||135
972644|NCT00317642|2353364|P1|NOT COMPLETED|Overall Study||122
972645|NCT00317642|2353363|P2|COMPLETED|Overall Study|achieved remission and completed consolidation|28
972646|NCT00317642|2353364|P1|COMPLETED|Overall Study|achieved remission and completed consolidation|41
972647|NCT00317642|2353363|P2|Received >= 1 Study Drug (Safety Set)|Overall Study||155
972648|NCT00317642|2353364|P1|Received >= 1 Study Drug (Safety Set)|Overall Study||161
972649|NCT00317642|2353363|P2|Full Analysis Set|Overall Study|AML Centrally Confirmed|158
972650|NCT00317642|2353364|P1|Full Analysis Set|Overall Study|AML Centrally Confirmed|162
972651|NCT00317642|2353363|P2|STARTED|Overall Study||163
972652|NCT00317642|2353364|P1|STARTED|Overall Study||163
972653|NCT00317720|2353437|P2|NOT COMPLETED|Overall Study||0
972654|NCT00317720|2353438|P1|NOT COMPLETED|Overall Study||0
972655|NCT00317720|2353437|P2|COMPLETED|Overall Study||7
972656|NCT00317720|2353438|P1|COMPLETED|Overall Study||40
972657|NCT00317720|2353437|P2|STARTED|Overall Study||7
972658|NCT00317720|2353438|P1|STARTED|Overall Study||40
972659|NCT00317941|2353445|P3|NOT COMPLETED|Overall Study||8
972660|NCT00317941|2353446|P2|NOT COMPLETED|Overall Study||5
972661|NCT00317941|2353447|P1|NOT COMPLETED|Overall Study||7
972662|NCT00317941|2353445|P3|COMPLETED|Overall Study||60
972663|NCT00317941|2353446|P2|COMPLETED|Overall Study||74
972664|NCT00317941|2353447|P1|COMPLETED|Overall Study||66
972665|NCT00317941|2353445|P3|Fulfilled Requirements PP Population|Overall Study||63
972666|NCT00317941|2353446|P2|Fulfilled Requirements PP Population|Overall Study||76
972667|NCT00317941|2353447|P1|Fulfilled Requirements PP Population|Overall Study||66
972668|NCT00317941|2353445|P3|Fulfilled Requirement Safety Population|Overall Study||65
972669|NCT00317941|2353446|P2|Fulfilled Requirement Safety Population|Overall Study||77
972670|NCT00317941|2353447|P1|Fulfilled Requirement Safety Population|Overall Study||73
972671|NCT00317941|2353445|P3|Participants Received Treatment|Overall Study||68
972672|NCT00317941|2353446|P2|Participants Received Treatment|Overall Study||79
972673|NCT00317941|2353447|P1|Participants Received Treatment|Overall Study||73
972674|NCT00317941|2353445|P3|STARTED|Overall Study||68
972675|NCT00317941|2353446|P2|STARTED|Overall Study||79
972676|NCT00317941|2353447|P1|STARTED|Overall Study||73
972677|NCT00318136|2353488|P1|NOT COMPLETED|Overall Study||45
972678|NCT00318136|2353488|P1|COMPLETED|Overall Study||2
972679|NCT00318136|2353488|P1|STARTED|Overall Study||47
972680|NCT00318292|2353497|P2|NOT COMPLETED|Overall Study||0
972681|NCT00318292|2353498|P1|NOT COMPLETED|Overall Study||0
972682|NCT00318292|2353497|P2|COMPLETED|Overall Study||45
972683|NCT00318292|2353498|P1|COMPLETED|Overall Study||45
972684|NCT00318292|2353497|P2|STARTED|Overall Study||45
972685|NCT00318292|2353498|P1|STARTED|Overall Study||45
972686|NCT00318370|2353504|P3|NOT COMPLETED|Period 3||33
972687|NCT00318370|2353505|P2|NOT COMPLETED|Period 3||0
972688|NCT00318370|2353506|P1|NOT COMPLETED|Period 3||0
972689|NCT00318370|2353504|P3|COMPLETED|Period 3||3
972690|NCT00318370|2353505|P2|COMPLETED|Period 3||0
972691|NCT00318370|2353506|P1|COMPLETED|Period 3||0
972692|NCT00318370|2353504|P3|STARTED|Period 3||36
972693|NCT00318370|2353505|P2|STARTED|Period 3||0
972694|NCT00318370|2353506|P1|STARTED|Period 3||0
972695|NCT00318370|2353504|P3|NOT COMPLETED|Period 2||0
972696|NCT00318370|2353505|P2|NOT COMPLETED|Period 2||11
972697|NCT00318370|2353506|P1|NOT COMPLETED|Period 2||0
972698|NCT00318370|2353504|P3|COMPLETED|Period 2||0
972699|NCT00318370|2353505|P2|COMPLETED|Period 2||36
972700|NCT00318370|2353506|P1|COMPLETED|Period 2||0
972701|NCT00318370|2353504|P3|STARTED|Period 2||0
972702|NCT00318370|2353505|P2|STARTED|Period 2|26 participants enrolled directly into Chemo Plus Far plus 21 participants from Far Only.|47
972703|NCT00318370|2353506|P1|STARTED|Period 2||0
972704|NCT00318370|2353504|P3|NOT COMPLETED|Period 1||0
972705|NCT00318370|2353505|P2|NOT COMPLETED|Period 1||0
972706|NCT00318370|2353506|P1|NOT COMPLETED|Period 1||7
972707|NCT00318370|2353504|P3|COMPLETED|Period 1||0
972708|NCT00318370|2353505|P2|COMPLETED|Period 1||0
972709|NCT00318370|2353506|P1|COMPLETED|Period 1|21 participants proceeded from Far Only to Chemo Plus Far.|21
972710|NCT00318370|2353504|P3|STARTED|Period 1||0
972711|NCT00318370|2353505|P2|STARTED|Period 1||0
972712|NCT00318370|2353506|P1|STARTED|Period 1||28
972713|NCT00318409|2353518|P2|NOT COMPLETED|Overall Study||1
972714|NCT00318409|2353519|P1|NOT COMPLETED|Overall Study||2
972715|NCT00318409|2353518|P2|COMPLETED|Overall Study||9
972716|NCT00318409|2353519|P1|COMPLETED|Overall Study||18
972717|NCT00318409|2353518|P2|STARTED|Overall Study||10
972718|NCT00318409|2353519|P1|STARTED|Overall Study||20
972719|NCT00318461|2353543|P5|NOT COMPLETED|Open-Label Extension, 18 Months||97
972720|NCT00318461|2353544|P4|NOT COMPLETED|Open-Label Extension, 18 Months||43
972721|NCT00318461|2353545|P3|NOT COMPLETED|Open-Label Extension, 18 Months||73
972722|NCT00318461|2353546|P2|NOT COMPLETED|Open-Label Extension, 18 Months||60
972723|NCT00318461|2353547|P1|NOT COMPLETED|Open-Label Extension, 18 Months||78
972724|NCT00318461|2353543|P5|COMPLETED|Open-Label Extension, 18 Months||113
972725|NCT00318461|2353544|P4|COMPLETED|Open-Label Extension, 18 Months||31
972726|NCT00318461|2353545|P3|COMPLETED|Open-Label Extension, 18 Months||118
972727|NCT00318461|2353546|P2|COMPLETED|Open-Label Extension, 18 Months||137
972728|NCT00318461|2353547|P1|COMPLETED|Open-Label Extension, 18 Months||130
972729|NCT00318461|2353543|P5|STARTED|Open-Label Extension, 18 Months||210
972730|NCT00318461|2353544|P4|STARTED|Open-Label Extension, 18 Months||74
972731|NCT00318461|2353545|P3|STARTED|Open-Label Extension, 18 Months||191
972732|NCT00318461|2353546|P2|STARTED|Open-Label Extension, 18 Months||197
972733|NCT00318461|2353547|P1|STARTED|Open-Label Extension, 18 Months||208
972734|NCT00318461|2353543|P5|NOT COMPLETED|Double-Blind, 6 Months||34
972735|NCT00318461|2353544|P4|NOT COMPLETED|Double-Blind, 6 Months||48
972736|NCT00318461|2353545|P3|NOT COMPLETED|Double-Blind, 6 Months||51
972737|NCT00318461|2353546|P2|NOT COMPLETED|Double-Blind, 6 Months||44
972738|NCT00318461|2353547|P1|NOT COMPLETED|Double-Blind, 6 Months||34
972739|NCT00318461|2353543|P5|COMPLETED|Double-Blind, 6 Months||210
972740|NCT00318461|2353544|P4|COMPLETED|Double-Blind, 6 Months||74
972741|NCT00318461|2353545|P3|COMPLETED|Double-Blind, 6 Months||191
972742|NCT00318461|2353546|P2|COMPLETED|Double-Blind, 6 Months||197
972743|NCT00318461|2353547|P1|COMPLETED|Double-Blind, 6 Months||208
972744|NCT00318461|2353543|P5|Exposed to Study Drug|Double-Blind, 6 Months|Subjects withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|242
972745|NCT00318461|2353544|P4|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|121
972746|NCT00318461|2353545|P3|Exposed to Study Drug|Double-Blind, 6 Months||242
972747|NCT00318461|2353546|P2|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|240
972748|NCT00318461|2353547|P1|Exposed to Study Drug|Double-Blind, 6 Months||242
972749|NCT00318461|2353543|P5|STARTED|Double-Blind, 6 Months|Randomised|244
972750|NCT00318461|2353544|P4|STARTED|Double-Blind, 6 Months|Randomised|122
972751|NCT00318461|2353545|P3|STARTED|Double-Blind, 6 Months|Randomised|242
972752|NCT00318461|2353546|P2|STARTED|Double-Blind, 6 Months|Randomised|241
972753|NCT00318461|2353547|P1|STARTED|Double-Blind, 6 Months|Randomised|242
972754|NCT00318474|2353626|P2|NOT COMPLETED|Overall Study||17
972755|NCT00318474|2353627|P1|NOT COMPLETED|Overall Study||18
972756|NCT00318474|2353626|P2|COMPLETED|Overall Study||10
972757|NCT00318474|2353627|P1|COMPLETED|Overall Study||7
972758|NCT00318474|2353626|P2|STARTED|Overall Study||27
972759|NCT00318474|2353627|P1|STARTED|Overall Study||25
972760|NCT00318565|2353633|P1|NOT COMPLETED|Overall Study||24
972761|NCT00318565|2353633|P1|COMPLETED|Overall Study||267
972762|NCT00318565|2353633|P1|STARTED|Overall Study||291
972763|NCT00318591|2353640|P2|NOT COMPLETED|Overall Study||45
972764|NCT00318591|2353641|P1|NOT COMPLETED|Overall Study||60
972765|NCT00318591|2353640|P2|COMPLETED|Overall Study||69
972766|NCT00318591|2353641|P1|COMPLETED|Overall Study||45
972767|NCT00318591|2353640|P2|STARTED|Overall Study||114
972768|NCT00318591|2353641|P1|STARTED|Overall Study||105
972769|NCT00318656|2353661|P2|NOT COMPLETED|Overall Study||2
972770|NCT00318656|2353662|P1|NOT COMPLETED|Overall Study||0
972771|NCT00318656|2353661|P2|COMPLETED|Overall Study|1 patient received by error avandamet treatment and 1 patient did not receive any treatment.|9
972772|NCT00318656|2353662|P1|COMPLETED|Overall Study||12
972773|NCT00318656|2353661|P2|STARTED|Overall Study||11
972774|NCT00318656|2353662|P1|STARTED|Overall Study||12
972775|NCT00318708|2353700|P2|NOT COMPLETED|Overall Study||5
972776|NCT00318708|2353701|P1|NOT COMPLETED|Overall Study||8
972777|NCT00318708|2353700|P2|COMPLETED|Overall Study||40
972778|NCT00318708|2353701|P1|COMPLETED|Overall Study||39
972779|NCT00318708|2353700|P2|8-week Milestone|Overall Study||42
972780|NCT00318708|2353701|P1|8-week Milestone|Overall Study||42
972781|NCT00318708|2353700|P2|STARTED|Overall Study||45
972782|NCT00318708|2353701|P1|STARTED|Overall Study||47
972783|NCT00318812|2353709|P2|NOT COMPLETED|Overall Study||0
972784|NCT00318812|2353710|P1|NOT COMPLETED|Overall Study||0
972785|NCT00318812|2353709|P2|COMPLETED|Overall Study||22
972786|NCT00318812|2353710|P1|COMPLETED|Overall Study||18
972787|NCT00318812|2353709|P2|STARTED|Overall Study||22
972788|NCT00318812|2353710|P1|STARTED|Overall Study||18
972789|NCT00318929|2353720|P1|NOT COMPLETED|Overall Study||0
972790|NCT00318929|2353720|P1|COMPLETED|Overall Study||14
972791|NCT00318929|2353720|P1|STARTED|Overall Study||14
972792|NCT00319020|2353726|P2|NOT COMPLETED|Overall Study||13
972793|NCT00319020|2353727|P1|NOT COMPLETED|Overall Study||7
972794|NCT00319020|2353726|P2|COMPLETED|Overall Study||8
972795|NCT00319020|2353727|P1|COMPLETED|Overall Study||8
972796|NCT00319020|2353726|P2|Enrollment in FUTURE 2 (F-2)|Overall Study||20
972797|NCT00319020|2353727|P1|Enrollment in FUTURE 2 (F-2)|Overall Study||13
972798|NCT00319020|2353726|P2|STARTED|Overall Study||21
972799|NCT00319020|2353727|P1|STARTED|Overall Study||15
972800|NCT00319046|2353756|P1|NOT COMPLETED|Overall Study||8
972801|NCT00319046|2353756|P1|COMPLETED|Overall Study||34
972802|NCT00319046|2353756|P1|STARTED|Overall Study|One patient was excluded from analysis as the baseline liver volume not available|42
972803|NCT00319098|2353767|P2|NOT COMPLETED|Overall Study||32
972804|NCT00319098|2353768|P1|NOT COMPLETED|Overall Study||135
972805|NCT00319098|2353767|P2|COMPLETED|Overall Study||1237
972806|NCT00319098|2353768|P1|COMPLETED|Overall Study||3667
972807|NCT00319098|2353767|P2|STARTED|Overall Study||1269
972808|NCT00319098|2353768|P1|STARTED|Overall Study||3802
972809|NCT00319111|2353826|P1|NOT COMPLETED|Overall Study||47
972810|NCT00319111|2353826|P1|COMPLETED|Overall Study||104
972811|NCT00319111|2353826|P1|STARTED|Overall Study|148 patients enrolled in BENEFIT OL & 3 prematurely discontinued from BENEFIT (NCT00313222)|151
972812|NCT00319254|2353836|P1|NOT COMPLETED|Overall Study||54
972813|NCT00319254|2353836|P1|COMPLETED|Overall Study||21
972814|NCT00319254|2353836|P1|Treated|Overall Study||73
972815|NCT00319254|2353836|P1|STARTED|Overall Study||75
972816|NCT00301080|2353849|P5|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
972817|NCT00301080|2353850|P4|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
972818|NCT00301080|2353851|P3|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
972819|NCT00301080|2353852|P2|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
972820|NCT00301080|2353853|P1|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
972821|NCT00301080|2353849|P5|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
972822|NCT00301080|2353850|P4|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
972823|NCT00301080|2353851|P3|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
972824|NCT00301080|2353852|P2|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
972825|NCT00301080|2353853|P1|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
972826|NCT00301080|2353849|P5|STARTED|Revised Version (3 Arms & 12 Weeks)||0
972827|NCT00301080|2353850|P4|STARTED|Revised Version (3 Arms & 12 Weeks)||0
972828|NCT00301080|2353851|P3|STARTED|Revised Version (3 Arms & 12 Weeks)||0
972829|NCT00301080|2353852|P2|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
972830|NCT00301080|2353853|P1|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
972831|NCT00301080|2353849|P5|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
972832|NCT00301080|2353850|P4|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
972833|NCT00301080|2353851|P3|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
972834|NCT00301080|2353852|P2|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
972835|NCT00301080|2353853|P1|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||1
972836|NCT00301080|2353849|P5|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
972837|NCT00301080|2353850|P4|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
972838|NCT00301080|2353851|P3|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
972839|NCT00301080|2353852|P2|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
972840|NCT00301080|2353853|P1|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
972841|NCT00301080|2353849|P5|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
972842|NCT00301080|2353850|P4|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
972843|NCT00301080|2353851|P3|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
972844|NCT00301080|2353852|P2|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
972845|NCT00301080|2353853|P1|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
972846|NCT00301080|2353849|P5|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
972847|NCT00301080|2353850|P4|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
972848|NCT00301080|2353851|P3|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
972849|NCT00301080|2353852|P2|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
972850|NCT00301080|2353853|P1|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
972851|NCT00301080|2353849|P5|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
972852|NCT00301080|2353850|P4|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
972853|NCT00301080|2353851|P3|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
972854|NCT00301080|2353852|P2|STARTED|Original Version (2 Arms & 4 Weeks)||3
972855|NCT00301080|2353853|P1|STARTED|Original Version (2 Arms & 4 Weeks)||4
972856|NCT00301262|2353884|P2|NOT COMPLETED|Open Label Phase (OL)||2
972857|NCT00301262|2353885|P1|NOT COMPLETED|Open Label Phase (OL)||4
972858|NCT00301262|2353884|P2|COMPLETED|Open Label Phase (OL)||67
972859|NCT00301262|2353885|P1|COMPLETED|Open Label Phase (OL)||79
972860|NCT00301262|2353884|P2|STARTED|Open Label Phase (OL)||69
972861|NCT00301262|2353885|P1|STARTED|Open Label Phase (OL)||83
972862|NCT00301262|2353884|P2|NOT COMPLETED|Double Blind Phase (DB)||13
972863|NCT00301262|2353885|P1|NOT COMPLETED|Double Blind Phase (DB)||10
972864|NCT00301262|2353884|P2|COMPLETED|Double Blind Phase (DB)||69
972865|NCT00301262|2353885|P1|COMPLETED|Double Blind Phase (DB)||84
972866|NCT00301262|2353884|P2|STARTED|Double Blind Phase (DB)||82
972867|NCT00301262|2353885|P1|STARTED|Double Blind Phase (DB)||94
972868|NCT00301366|2354043|P1|NOT COMPLETED|Overall Study||1
972869|NCT00301366|2354043|P1|COMPLETED|Overall Study||37
972870|NCT00301366|2354043|P1|STARTED|Overall Study||38
972871|NCT00301418|2354047|P1|NOT COMPLETED|Overall Study||0
972872|NCT00301418|2354047|P1|COMPLETED|Overall Study||11
972873|NCT00301418|2354047|P1|STARTED|Overall Study||11
972874|NCT00307034|2354055|P2|NOT COMPLETED|Overall Study||7
972875|NCT00307034|2354056|P1|NOT COMPLETED|Overall Study||2
972876|NCT00307034|2354055|P2|COMPLETED|Overall Study||169
972877|NCT00307034|2354056|P1|COMPLETED|Overall Study||173
972878|NCT00307034|2354055|P2|STARTED|Overall Study||176
972879|NCT00307034|2354056|P1|STARTED|Overall Study||175
972880|NCT00307047|2354096|P2|NOT COMPLETED|Overall Study||49
972881|NCT00307047|2354097|P1|NOT COMPLETED|Overall Study||69
972882|NCT00307047|2354096|P2|COMPLETED|Overall Study||1180
972883|NCT00307047|2354097|P1|COMPLETED|Overall Study||2389
972884|NCT00307047|2354096|P2|STARTED|Overall Study||1229
972885|NCT00307047|2354097|P1|STARTED|Overall Study||2458
972886|NCT00307086|2354233|P1|NOT COMPLETED|Overall Study||5
972887|NCT00307086|2354233|P1|COMPLETED|Overall Study||25
972888|NCT00307086|2354233|P1|STARTED|Overall Study||30
972889|NCT00307125|2354239|P3|NOT COMPLETED|Pilot Phase||1
972890|NCT00307125|2354240|P2|NOT COMPLETED|Pilot Phase||2
972891|NCT00307125|2354241|P1|NOT COMPLETED|Pilot Phase||0
972892|NCT00307125|2354239|P3|COMPLETED|Pilot Phase|1 participant had reduced follow-up|6
972893|NCT00307125|2354240|P2|COMPLETED|Pilot Phase|2 participants had reduced follow-up|13
972894|NCT00307125|2354241|P1|COMPLETED|Pilot Phase||0
972895|NCT00307125|2354239|P3|STARTED|Pilot Phase||7
972896|NCT00307125|2354240|P2|STARTED|Pilot Phase||15
972897|NCT00307125|2354241|P1|STARTED|Pilot Phase||0
972898|NCT00307125|2354239|P3|NOT COMPLETED|Screening Phase||0
972899|NCT00307125|2354240|P2|NOT COMPLETED|Screening Phase||0
972900|NCT00307125|2354241|P1|NOT COMPLETED|Screening Phase||454
972901|NCT00307125|2354239|P3|COMPLETED|Screening Phase||0
972902|NCT00307125|2354240|P2|COMPLETED|Screening Phase||0
972903|NCT00307125|2354241|P1|COMPLETED|Screening Phase||303
972904|NCT00307125|2354239|P3|STARTED|Screening Phase||0
972905|NCT00307125|2354240|P2|STARTED|Screening Phase||0
972906|NCT00307125|2354241|P1|STARTED|Screening Phase||757
972907|NCT00307151|2354267|P4|NOT COMPLETED|Overall Study||11
972908|NCT00307151|2354268|P3|NOT COMPLETED|Overall Study||20
972909|NCT00307151|2354269|P2|NOT COMPLETED|Overall Study||7
972910|NCT00307151|2354270|P1|NOT COMPLETED|Overall Study||11
972911|NCT00307151|2354267|P4|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|129
972912|NCT00307151|2354268|P3|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|127
972913|NCT00307151|2354269|P2|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|75
972914|NCT00307151|2354270|P1|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|71
972915|NCT00307151|2354267|P4|STARTED|Overall Study|One participant never started treatment, were not followed and not included in analysis.|140
972916|NCT00307151|2354268|P3|STARTED|Overall Study||147
972917|NCT00307151|2354269|P2|STARTED|Overall Study||82
972918|NCT00307151|2354270|P1|STARTED|Overall Study||82
972919|NCT00307164|2354314|P2|NOT COMPLETED|Overall Study||14
972920|NCT00307164|2354315|P1|NOT COMPLETED|Overall Study||15
972921|NCT00307164|2354314|P2|COMPLETED|Overall Study||68
972922|NCT00307164|2354315|P1|COMPLETED|Overall Study||68
972923|NCT00307164|2354314|P2|STARTED|Overall Study||82
972924|NCT00307164|2354315|P1|STARTED|Overall Study||83
972925|NCT00308516|2354353|P2|NOT COMPLETED|Overall Study||21
972926|NCT00308516|2354354|P1|NOT COMPLETED|Overall Study||29
972927|NCT00308516|2354353|P2|COMPLETED|Overall Study||10
972928|NCT00308516|2354354|P1|COMPLETED|Overall Study||6
972929|NCT00308516|2354353|P2|STARTED|Overall Study||31
972930|NCT00308516|2354354|P1|STARTED|Overall Study||35
972931|NCT00308555|2354362|P2|NOT COMPLETED|Overall Study||0
972932|NCT00308555|2354363|P1|NOT COMPLETED|Overall Study||3
972933|NCT00308555|2354362|P2|COMPLETED|Overall Study||11
972934|NCT00308555|2354363|P1|COMPLETED|Overall Study||10
972935|NCT00308555|2354362|P2|STARTED|Overall Study||11
972936|NCT00308555|2354363|P1|STARTED|Overall Study||13
972937|NCT00308581|2354369|P3|NOT COMPLETED|Randomized Maintenance Phase||0
972938|NCT00308581|2354370|P2|NOT COMPLETED|Randomized Maintenance Phase||103
972939|NCT00308581|2354371|P1|NOT COMPLETED|Randomized Maintenance Phase||105
972940|NCT00308581|2354369|P3|COMPLETED|Randomized Maintenance Phase||0
972941|NCT00308581|2354370|P2|COMPLETED|Randomized Maintenance Phase||83
972942|NCT00308581|2354371|P1|COMPLETED|Randomized Maintenance Phase||82
972943|NCT00308581|2354369|P3|STARTED|Randomized Maintenance Phase||0
972944|NCT00308581|2354370|P2|STARTED|Randomized Maintenance Phase||186
972945|NCT00308581|2354371|P1|STARTED|Randomized Maintenance Phase||187
972946|NCT00308581|2354369|P3|NOT COMPLETED|Induction Phase||166
972947|NCT00308581|2354370|P2|NOT COMPLETED|Induction Phase||0
972948|NCT00308581|2354371|P1|NOT COMPLETED|Induction Phase||0
972949|NCT00308581|2354369|P3|COMPLETED|Induction Phase||373
972950|NCT00308581|2354370|P2|COMPLETED|Induction Phase|Not applicable in this period|0
972951|NCT00308581|2354371|P1|COMPLETED|Induction Phase|Not applicable in this period|0
972952|NCT00308581|2354369|P3|STARTED|Induction Phase||539
972953|NCT00308581|2354370|P2|STARTED|Induction Phase|Not applicable in this period|0
972954|NCT00308581|2354371|P1|STARTED|Induction Phase|Not applicable in this period|0
972955|NCT00308620|2354498|P3|NOT COMPLETED|Overall Study||1
972956|NCT00308620|2354499|P2|NOT COMPLETED|Overall Study||1
972957|NCT00308620|2354500|P1|NOT COMPLETED|Overall Study||1
972958|NCT00308620|2354498|P3|COMPLETED|Overall Study||5
972959|NCT00308620|2354499|P2|COMPLETED|Overall Study||3
972960|NCT00308620|2354500|P1|COMPLETED|Overall Study||2
972961|NCT00308620|2354498|P3|STARTED|Overall Study||6
972962|NCT00308620|2354499|P2|STARTED|Overall Study||4
972963|NCT00308620|2354500|P1|STARTED|Overall Study||3
972964|NCT00308711|2354512|P3|NOT COMPLETED|Overall Study||5
972965|NCT00308711|2354513|P2|NOT COMPLETED|Overall Study||4
972966|NCT00308711|2354514|P1|NOT COMPLETED|Overall Study||2
972967|NCT00308711|2354512|P3|COMPLETED|Overall Study||431
972968|NCT00308711|2354513|P2|COMPLETED|Overall Study||440
972969|NCT00308711|2354514|P1|COMPLETED|Overall Study||426
972970|NCT00308711|2354512|P3|STARTED|Overall Study||436
972971|NCT00308711|2354513|P2|STARTED|Overall Study||444
972972|NCT00308711|2354514|P1|STARTED|Overall Study||428
972973|NCT00308737|2354549|P3|NOT COMPLETED|Overall Study||37
972974|NCT00308737|2354550|P2|NOT COMPLETED|Overall Study||289
972975|NCT00308737|2354551|P1|NOT COMPLETED|Overall Study||463
972976|NCT00308737|2354549|P3|COMPLETED|Overall Study||127
972977|NCT00308737|2354550|P2|COMPLETED|Overall Study||662
972978|NCT00308737|2354551|P1|COMPLETED|Overall Study||475
972979|NCT00308737|2354549|P3|STARTED|Overall Study||164
972980|NCT00308737|2354550|P2|STARTED|Overall Study||951
972981|NCT00308737|2354551|P1|STARTED|Overall Study||938
972982|NCT00308997|2354590|P2|NOT COMPLETED|Overall Study||1
972983|NCT00308997|2354591|P1|NOT COMPLETED|Overall Study||1
972984|NCT00308997|2354590|P2|COMPLETED|Overall Study||28
972985|NCT00308997|2354591|P1|COMPLETED|Overall Study||55
972986|NCT00308997|2354590|P2|STARTED|Overall Study||29
972987|NCT00308997|2354591|P1|STARTED|Overall Study||56
972988|NCT00309244|2354609|P2|NOT COMPLETED|Overall Study||97
972989|NCT00309244|2354610|P1|NOT COMPLETED|Overall Study||118
972990|NCT00309244|2354609|P2|COMPLETED|Overall Study||246
972991|NCT00309244|2354610|P1|COMPLETED|Overall Study||216
972992|NCT00309244|2354609|P2|STARTED|Overall Study||343
972993|NCT00309244|2354610|P1|STARTED|Overall Study||334
972994|NCT00309387|2354632|P2|NOT COMPLETED|Overall Study||159
972995|NCT00309387|2354633|P1|NOT COMPLETED|Overall Study||142
972996|NCT00309387|2354632|P2|COMPLETED|Overall Study||351
972997|NCT00309387|2354633|P1|COMPLETED|Overall Study||368
972998|NCT00309387|2354632|P2|STARTED|Overall Study||510
972999|NCT00309387|2354633|P1|STARTED|Overall Study||510
973000|NCT00309452|2354651|P2|NOT COMPLETED|Overall Study||0
973001|NCT00309452|2354652|P1|NOT COMPLETED|Overall Study||3
973002|NCT00309452|2354651|P2|COMPLETED|Overall Study||60
973003|NCT00309452|2354652|P1|COMPLETED|Overall Study||57
973004|NCT00309452|2354651|P2|STARTED|Overall Study||60
973005|NCT00309452|2354652|P1|STARTED|Overall Study||60
973006|NCT00309465|2354684|P6|NOT COMPLETED|Overall Study||0
973007|NCT00309465|2354685|P5|NOT COMPLETED|Overall Study||0
973008|NCT00309465|2354686|P4|NOT COMPLETED|Overall Study||1
973009|NCT00309465|2354687|P3|NOT COMPLETED|Overall Study||0
973010|NCT00309465|2354688|P2|NOT COMPLETED|Overall Study||0
973011|NCT00309465|2354689|P1|NOT COMPLETED|Overall Study||0
973012|NCT00309465|2354684|P6|COMPLETED|Overall Study||76
973013|NCT00309465|2354685|P5|COMPLETED|Overall Study||76
973014|NCT00309465|2354686|P4|COMPLETED|Overall Study|One subject was excluded due to eligibility error.|75
973015|NCT00309465|2354687|P3|COMPLETED|Overall Study||58
973016|NCT00309465|2354688|P2|COMPLETED|Overall Study||58
973017|NCT00309465|2354689|P1|COMPLETED|Overall Study||58
973018|NCT00309465|2354684|P6|STARTED|Overall Study||76
973019|NCT00309465|2354685|P5|STARTED|Overall Study||76
973020|NCT00309465|2354686|P4|STARTED|Overall Study||76
973021|NCT00309465|2354687|P3|STARTED|Overall Study||58
973022|NCT00309465|2354688|P2|STARTED|Overall Study||58
973023|NCT00309465|2354689|P1|STARTED|Overall Study||58
973024|NCT00309608|2354708|P5|NOT COMPLETED|Overall Study||4
973025|NCT00309608|2354709|P4|NOT COMPLETED|Overall Study||6
973026|NCT00309608|2354710|P3|NOT COMPLETED|Overall Study||10
973027|NCT00309608|2354711|P2|NOT COMPLETED|Overall Study||13
973028|NCT00309608|2354712|P1|NOT COMPLETED|Overall Study||14
973029|NCT00309608|2354708|P5|COMPLETED|Overall Study||61
973030|NCT00309608|2354709|P4|COMPLETED|Overall Study||60
973031|NCT00309608|2354710|P3|COMPLETED|Overall Study||56
973032|NCT00309608|2354711|P2|COMPLETED|Overall Study||52
973033|NCT00309608|2354712|P1|COMPLETED|Overall Study||57
973034|NCT00309608|2354708|P5|STARTED|Overall Study||65
973035|NCT00309608|2354709|P4|STARTED|Overall Study||66
973036|NCT00309608|2354710|P3|STARTED|Overall Study||66
973037|NCT00309608|2354711|P2|STARTED|Overall Study||65
973038|NCT00309608|2354712|P1|STARTED|Overall Study||71
973039|NCT00309738|2354735|P2|NOT COMPLETED|Overall Study||12
973040|NCT00309738|2354736|P1|NOT COMPLETED|Overall Study||13
973041|NCT00309738|2354735|P2|COMPLETED|Overall Study||107
973042|NCT00309738|2354736|P1|COMPLETED|Overall Study||223
973043|NCT00309738|2354735|P2|Safety Population|Overall Study|Subjects who received at least one dose of study medication|119
973044|NCT00309738|2354736|P1|Safety Population|Overall Study|Subjects who received at least one dose of study medication|233
973045|NCT00309738|2354735|P2|STARTED|Overall Study||119
973046|NCT00309738|2354736|P1|STARTED|Overall Study||236
973047|NCT00309751|2354746|P2|NOT COMPLETED|Overall Study||15
973048|NCT00309751|2354747|P1|NOT COMPLETED|Overall Study||31
973049|NCT00309751|2354746|P2|COMPLETED|Overall Study||124
973050|NCT00309751|2354747|P1|COMPLETED|Overall Study||248
973051|NCT00309751|2354746|P2|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|137
973052|NCT00309751|2354747|P1|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|275
973053|NCT00309751|2354746|P2|STARTED|Overall Study||139
973054|NCT00309751|2354747|P1|STARTED|Overall Study||279
973055|NCT00309777|2354759|P4|NOT COMPLETED|Overall Study||4
973056|NCT00309777|2354760|P3|NOT COMPLETED|Overall Study||19
973057|NCT00309777|2354761|P2|NOT COMPLETED|Overall Study||9
973058|NCT00309777|2354762|P1|NOT COMPLETED|Overall Study||23
973059|NCT00309777|2354759|P4|COMPLETED|Overall Study||107
973060|NCT00309777|2354760|P3|COMPLETED|Overall Study||304
973061|NCT00309777|2354761|P2|COMPLETED|Overall Study||99
973062|NCT00309777|2354762|P1|COMPLETED|Overall Study||292
973063|NCT00309777|2354759|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|110
973064|NCT00309777|2354760|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|320
973065|NCT00309777|2354761|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|107
973066|NCT00309777|2354762|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|311
973067|NCT00309777|2354759|P4|STARTED|Overall Study||111
973068|NCT00309777|2354760|P3|STARTED|Overall Study||323
973069|NCT00309777|2354761|P2|STARTED|Overall Study||108
973070|NCT00309777|2354762|P1|STARTED|Overall Study||315
973071|NCT00309907|2354776|P1|NOT COMPLETED|Overall Study||20
973072|NCT00309907|2354776|P1|COMPLETED|Overall Study||19
973073|NCT00309907|2354776|P1|STARTED|Overall Study||39
973074|NCT00309946|2354785|P1|NOT COMPLETED|Overall Study||1
973075|NCT00309946|2354785|P1|COMPLETED|Overall Study||50
973076|NCT00309946|2354785|P1|STARTED|Overall Study||51
973077|NCT00309985|2354793|P2|NOT COMPLETED|Overall Study||1
973078|NCT00309985|2354794|P1|NOT COMPLETED|Overall Study||62
973079|NCT00309985|2354793|P2|COMPLETED|Overall Study|"Arm B tx info was not collected so only 1 patient w/o follow-up data was considered not completed."|392
973080|NCT00309985|2354794|P1|COMPLETED|Overall Study||335
973081|NCT00309985|2354793|P2|Both Baseline and 3-month FACT-P Evals|Overall Study||299
973082|NCT00309985|2354794|P1|Both Baseline and 3-month FACT-P Evals|Overall Study||334
973083|NCT00309985|2354793|P2|Toxicity Analysis|Overall Study||392
973084|NCT00309985|2354794|P1|Toxicity Analysis|Overall Study||390
973085|NCT00309985|2354793|P2|STARTED|Overall Study||393
973086|NCT00309985|2354794|P1|STARTED|Overall Study||397
973087|NCT00310076|2354810|P1|NOT COMPLETED|Overall Study||3
973088|NCT00310076|2354810|P1|COMPLETED|Overall Study||26
973089|NCT00310076|2354810|P1|STARTED|Overall Study||29
973090|NCT00310310|2354816|P2|NOT COMPLETED|Overall Study||20
973091|NCT00310310|2354817|P1|NOT COMPLETED|Overall Study||30
973092|NCT00310310|2354816|P2|COMPLETED|Overall Study||100
973093|NCT00310310|2354817|P1|COMPLETED|Overall Study||90
973094|NCT00310310|2354816|P2|STARTED|Overall Study||120
973095|NCT00310310|2354817|P1|STARTED|Overall Study||120
973096|NCT00310362|2354844|P3|NOT COMPLETED|Overall Study||0
973097|NCT00310362|2354845|P2|NOT COMPLETED|Overall Study||0
973098|NCT00310362|2354846|P1|NOT COMPLETED|Overall Study||0
973099|NCT00310362|2354844|P3|COMPLETED|Overall Study||1206
973100|NCT00310362|2354845|P2|COMPLETED|Overall Study||1205
973101|NCT00310362|2354846|P1|COMPLETED|Overall Study||1199
973102|NCT00310362|2354844|P3|STARTED|Overall Study||1206
973103|NCT00310362|2354845|P2|STARTED|Overall Study||1205
973104|NCT00310362|2354846|P1|STARTED|Overall Study||1199
973105|NCT00310375|2354856|P2|NOT COMPLETED|Overall Study||68
973106|NCT00310375|2354857|P1|NOT COMPLETED|Overall Study||91
973107|NCT00310375|2354856|P2|COMPLETED|Overall Study||11
973108|NCT00310375|2354857|P1|COMPLETED|Overall Study||11
973109|NCT00310375|2354856|P2|STARTED|Overall Study||79
973110|NCT00310375|2354857|P1|STARTED|Overall Study||102
973117|NCT00310427|2354906|P2|NOT COMPLETED|Overall Study||1
973118|NCT00310427|2354907|P1|NOT COMPLETED|Overall Study||2
973119|NCT00310427|2354906|P2|COMPLETED|Overall Study||25
973120|NCT00310427|2354907|P1|COMPLETED|Overall Study||25
973121|NCT00310427|2354906|P2|STARTED|Overall Study||26
973122|NCT00310427|2354907|P1|STARTED|Overall Study||27
973123|NCT00310440|2354929|P2|NOT COMPLETED|Overall Study||13
973124|NCT00310440|2354930|P1|NOT COMPLETED|Overall Study||26
973125|NCT00310440|2354929|P2|COMPLETED|Overall Study||141
973126|NCT00310440|2354930|P1|COMPLETED|Overall Study||139
973127|NCT00310440|2354929|P2|STARTED|Overall Study||154
973128|NCT00310440|2354930|P1|STARTED|Overall Study||165
973129|NCT00310466|2354956|P2|NOT COMPLETED|Overall Study||12
973130|NCT00310466|2354957|P1|NOT COMPLETED|Overall Study||18
973131|NCT00310466|2354956|P2|COMPLETED|Overall Study||101
973132|NCT00310466|2354957|P1|COMPLETED|Overall Study||95
973133|NCT00310466|2354956|P2|STARTED|Overall Study||113
973134|NCT00310466|2354957|P1|STARTED|Overall Study||113
973135|NCT00310791|2354971|P2|NOT COMPLETED|Overall Study||10
973136|NCT00310791|2354972|P1|NOT COMPLETED|Overall Study||10
973137|NCT00310791|2354971|P2|COMPLETED|Overall Study||30
973138|NCT00310791|2354972|P1|COMPLETED|Overall Study||30
973139|NCT00310791|2354971|P2|STARTED|Overall Study||40
973140|NCT00310791|2354972|P1|STARTED|Overall Study||40
973141|NCT00310804|2354980|P2|NOT COMPLETED|Overall Study||0
973142|NCT00310804|2354981|P1|NOT COMPLETED|Overall Study||5
973143|NCT00310804|2354980|P2|COMPLETED|Overall Study||171
973144|NCT00310804|2354981|P1|COMPLETED|Overall Study||1024
973145|NCT00310804|2354980|P2|STARTED|Overall Study||171
973146|NCT00310804|2354981|P1|STARTED|Overall Study||1029
973147|NCT00310817|2355018|P4|NOT COMPLETED|Overall Study||8
973148|NCT00310817|2355019|P3|NOT COMPLETED|Overall Study||8
973149|NCT00310817|2355020|P2|NOT COMPLETED|Overall Study||8
973150|NCT00310817|2355021|P1|NOT COMPLETED|Overall Study||11
973151|NCT00310817|2355018|P4|COMPLETED|Overall Study||74
973152|NCT00310817|2355019|P3|COMPLETED|Overall Study||120
973153|NCT00310817|2355020|P2|COMPLETED|Overall Study||198
973154|NCT00310817|2355021|P1|COMPLETED|Overall Study||196
973155|NCT00310817|2355018|P4|STARTED|Overall Study||82
973156|NCT00310817|2355019|P3|STARTED|Overall Study||128
973157|NCT00310817|2355020|P2|STARTED|Overall Study||206
973158|NCT00310817|2355021|P1|STARTED|Overall Study||207
973159|NCT00310856|2355110|P3|NOT COMPLETED|Overall Study||8
973160|NCT00310856|2355111|P2|NOT COMPLETED|Overall Study||5
973161|NCT00310856|2355112|P1|NOT COMPLETED|Overall Study||5
973162|NCT00310856|2355110|P3|COMPLETED|Overall Study||42
973163|NCT00310856|2355111|P2|COMPLETED|Overall Study||56
973164|NCT00310856|2355112|P1|COMPLETED|Overall Study||59
973165|NCT00310856|2355110|P3|STARTED|Overall Study||50
973166|NCT00310856|2355111|P2|STARTED|Overall Study||61
973167|NCT00310856|2355112|P1|STARTED|Overall Study||64
973168|NCT00319436|2355134|P2|NOT COMPLETED|Overall Study||7
973169|NCT00319436|2355135|P1|NOT COMPLETED|Overall Study||6
973170|NCT00319436|2355134|P2|COMPLETED|Overall Study||17
973171|NCT00319436|2355135|P1|COMPLETED|Overall Study||17
973172|NCT00319436|2355134|P2|STARTED|Overall Study||24
973173|NCT00319436|2355135|P1|STARTED|Overall Study||23
973174|NCT00319449|2355155|P2|NOT COMPLETED|Overall Study||0
973175|NCT00319449|2355156|P1|NOT COMPLETED|Overall Study||2
973176|NCT00319449|2355155|P2|COMPLETED|Overall Study||12
973177|NCT00319449|2355156|P1|COMPLETED|Overall Study||8
973178|NCT00319449|2355155|P2|STARTED|Overall Study||12
973179|NCT00319449|2355156|P1|STARTED|Overall Study||10
973180|NCT00319501|2355168|P2|NOT COMPLETED|Open-label Extension Period||0
973181|NCT00319501|2355169|P1|NOT COMPLETED|Open-label Extension Period||51
973182|NCT00319501|2355168|P2|COMPLETED|Open-label Extension Period||0
973183|NCT00319501|2355169|P1|COMPLETED|Open-label Extension Period||0
973184|NCT00319501|2355168|P2|Received Treatment|Open-label Extension Period||0
973185|NCT00319501|2355169|P1|Received Treatment|Open-label Extension Period||33
973186|NCT00319501|2355168|P2|STARTED|Open-label Extension Period||0
973187|NCT00319501|2355169|P1|STARTED|Open-label Extension Period|Eligible participants who chose to continue treatment|51
973188|NCT00319501|2355168|P2|NOT COMPLETED|Open-label Period||0
973189|NCT00319501|2355169|P1|NOT COMPLETED|Open-label Period||116
973190|NCT00319501|2355168|P2|COMPLETED|Open-label Period||0
973191|NCT00319501|2355169|P1|COMPLETED|Open-label Period|Competed=continuing treatment|45
973192|NCT00319501|2355168|P2|Received Treatment|Open-label Period||0
973193|NCT00319501|2355169|P1|Received Treatment|Open-label Period||128
973194|NCT00319501|2355168|P2|STARTED|Open-label Period||0
973195|NCT00319501|2355169|P1|STARTED|Open-label Period|Participants who continued to meet eligibility requirements|161
973196|NCT00319501|2355168|P2|NOT COMPLETED|Double-blind Period||32
973197|NCT00319501|2355169|P1|NOT COMPLETED|Double-blind Period||43
973198|NCT00319501|2355168|P2|COMPLETED|Double-blind Period||78
973199|NCT00319501|2355169|P1|COMPLETED|Double-blind Period||81
973200|NCT00319501|2355168|P2|Received Treatment|Double-blind Period||81
973201|NCT00319501|2355169|P1|Received Treatment|Double-blind Period||82
973202|NCT00319501|2355168|P2|STARTED|Double-blind Period|Randomized participants|110
973203|NCT00319501|2355169|P1|STARTED|Double-blind Period|Randomized participants|124
973204|NCT00319553|2355195|P2|NOT COMPLETED|Overall Study||4
973205|NCT00319553|2355196|P1|NOT COMPLETED|Overall Study||4
973206|NCT00319553|2355195|P2|COMPLETED|Overall Study||317
973207|NCT00319553|2355196|P1|COMPLETED|Overall Study||319
973208|NCT00319553|2355195|P2|STARTED|Overall Study||321
973209|NCT00319553|2355196|P1|STARTED|Overall Study||323
973210|NCT00319592|2355210|P2|NOT COMPLETED|Overall Study||1
973211|NCT00319592|2355211|P1|NOT COMPLETED|Overall Study||1
973212|NCT00319592|2355210|P2|COMPLETED|Overall Study||29
973213|NCT00319592|2355211|P1|COMPLETED|Overall Study||29
973214|NCT00319592|2355210|P2|STARTED|Overall Study||30
973215|NCT00319592|2355211|P1|STARTED|Overall Study||30
973216|NCT00319644|2355227|P2|NOT COMPLETED|Overall Study||0
973217|NCT00319644|2355228|P1|NOT COMPLETED|Overall Study||0
973218|NCT00319644|2355227|P2|COMPLETED|Overall Study||16
973219|NCT00319644|2355228|P1|COMPLETED|Overall Study||21
973220|NCT00319644|2355227|P2|STARTED|Overall Study||16
973221|NCT00319644|2355228|P1|STARTED|Overall Study||21
973222|NCT00321672|2355240|P4|NOT COMPLETED|Overall Study||2
973223|NCT00321672|2355241|P3|NOT COMPLETED|Overall Study||11
973224|NCT00321672|2355242|P2|NOT COMPLETED|Overall Study||8
973225|NCT00321672|2355243|P1|NOT COMPLETED|Overall Study||12
973226|NCT00321672|2355240|P4|COMPLETED|Overall Study||71
973227|NCT00321672|2355241|P3|COMPLETED|Overall Study||156
973228|NCT00321672|2355242|P2|COMPLETED|Overall Study||81
973229|NCT00321672|2355243|P1|COMPLETED|Overall Study||153
973230|NCT00321672|2355240|P4|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|73
973231|NCT00321672|2355241|P3|STARTED|Overall Study||167
973232|NCT00321672|2355242|P2|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|89
973233|NCT00321672|2355243|P1|STARTED|Overall Study||165
973240|NCT00321698|2355282|P5|NOT COMPLETED|Phase II, MTD Dose||0
973241|NCT00321698|2355283|P4|NOT COMPLETED|Phase II, MTD Dose||0
973242|NCT00321698|2355284|P3|NOT COMPLETED|Phase II, MTD Dose||0
973243|NCT00321698|2355285|P2|NOT COMPLETED|Phase II, MTD Dose||0
973244|NCT00321698|2355286|P1|NOT COMPLETED|Phase II, MTD Dose||0
973245|NCT00321698|2355282|P5|COMPLETED|Phase II, MTD Dose||13
973246|NCT00321698|2355283|P4|COMPLETED|Phase II, MTD Dose||0
973247|NCT00321698|2355284|P3|COMPLETED|Phase II, MTD Dose||0
973248|NCT00321698|2355285|P2|COMPLETED|Phase II, MTD Dose||0
973249|NCT00321698|2355286|P1|COMPLETED|Phase II, MTD Dose||0
973250|NCT00321698|2355282|P5|STARTED|Phase II, MTD Dose|+1 screen failure|13
973251|NCT00321698|2355283|P4|STARTED|Phase II, MTD Dose||0
973252|NCT00321698|2355284|P3|STARTED|Phase II, MTD Dose||0
973253|NCT00321698|2355285|P2|STARTED|Phase II, MTD Dose||0
973254|NCT00321698|2355286|P1|STARTED|Phase II, MTD Dose||0
973255|NCT00321698|2355282|P5|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
973256|NCT00321698|2355283|P4|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
973257|NCT00321698|2355284|P3|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
973258|NCT00321698|2355285|P2|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
973259|NCT00321698|2355286|P1|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
973260|NCT00321698|2355282|P5|COMPLETED|Phase I, Rad Only & Dose 1-3||0
973261|NCT00321698|2355283|P4|COMPLETED|Phase I, Rad Only & Dose 1-3||3
973262|NCT00321698|2355284|P3|COMPLETED|Phase I, Rad Only & Dose 1-3||3
973263|NCT00321698|2355285|P2|COMPLETED|Phase I, Rad Only & Dose 1-3||3
973264|NCT00321698|2355286|P1|COMPLETED|Phase I, Rad Only & Dose 1-3||3
973265|NCT00321698|2355282|P5|STARTED|Phase I, Rad Only & Dose 1-3||0
973266|NCT00321698|2355283|P4|STARTED|Phase I, Rad Only & Dose 1-3||3
973267|NCT00321698|2355284|P3|STARTED|Phase I, Rad Only & Dose 1-3||3
973268|NCT00321698|2355285|P2|STARTED|Phase I, Rad Only & Dose 1-3||3
973269|NCT00321698|2355286|P1|STARTED|Phase I, Rad Only & Dose 1-3||3
973270|NCT00321711|2355305|P5|NOT COMPLETED|Part B||5
973271|NCT00321711|2355306|P4|NOT COMPLETED|Part B||6
973272|NCT00321711|2355307|P3|NOT COMPLETED|Part B||0
973273|NCT00321711|2355308|P2|NOT COMPLETED|Part B||0
973274|NCT00321711|2355309|P1|NOT COMPLETED|Part B||0
973275|NCT00321711|2355305|P5|COMPLETED|Part B||10
973276|NCT00321711|2355306|P4|COMPLETED|Part B||8
973277|NCT00321711|2355307|P3|COMPLETED|Part B||0
973278|NCT00321711|2355308|P2|COMPLETED|Part B||0
973279|NCT00321711|2355309|P1|COMPLETED|Part B||0
973280|NCT00321711|2355305|P5|STARTED|Part B||15
973281|NCT00321711|2355306|P4|STARTED|Part B||14
973282|NCT00321711|2355307|P3|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
973283|NCT00321711|2355308|P2|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
973284|NCT00321711|2355309|P1|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
973285|NCT00321711|2355305|P5|NOT COMPLETED|Part A||0
973286|NCT00321711|2355306|P4|NOT COMPLETED|Part A||0
973287|NCT00321711|2355307|P3|NOT COMPLETED|Part A||11
973288|NCT00321711|2355308|P2|NOT COMPLETED|Part A||10
973289|NCT00321711|2355309|P1|NOT COMPLETED|Part A||5
973290|NCT00321711|2355305|P5|COMPLETED|Part A||0
973291|NCT00321711|2355306|P4|COMPLETED|Part A||0
973292|NCT00321711|2355307|P3|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
973293|NCT00321711|2355308|P2|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
973294|NCT00321711|2355309|P1|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|8
973295|NCT00321711|2355305|P5|STARTED|Part A||0
973296|NCT00321711|2355306|P4|STARTED|Part A||0
973297|NCT00321711|2355307|P3|STARTED|Part A||14
973298|NCT00321711|2355308|P2|STARTED|Part A||13
973299|NCT00321711|2355309|P1|STARTED|Part A||13
973300|NCT00321737|2355339|P3|NOT COMPLETED|Overall Study||54
973301|NCT00321737|2355340|P2|NOT COMPLETED|Overall Study||48
973302|NCT00321737|2355341|P1|NOT COMPLETED|Overall Study||122
973303|NCT00321737|2355339|P3|COMPLETED|Overall Study||104
973304|NCT00321737|2355340|P2|COMPLETED|Overall Study||92
973305|NCT00321737|2355341|P1|COMPLETED|Overall Study||25
973306|NCT00321737|2355339|P3|STARTED|Overall Study||158
973307|NCT00321737|2355340|P2|STARTED|Overall Study||140
973308|NCT00321737|2355341|P1|STARTED|Overall Study||147
973309|NCT00321763|2355368|P4|NOT COMPLETED|Overall Study||5
973310|NCT00321763|2355369|P3|NOT COMPLETED|Overall Study||6
973311|NCT00321763|2355370|P2|NOT COMPLETED|Overall Study||2
973312|NCT00321763|2355371|P1|NOT COMPLETED|Overall Study||6
973313|NCT00321763|2355368|P4|COMPLETED|Overall Study||565
973314|NCT00321763|2355369|P3|COMPLETED|Overall Study||848
973315|NCT00321763|2355370|P2|COMPLETED|Overall Study||848
973316|NCT00321763|2355371|P1|COMPLETED|Overall Study||844
973317|NCT00321763|2355368|P4|STARTED|Overall Study||570
973318|NCT00321763|2355369|P3|STARTED|Overall Study||854
973319|NCT00321763|2355370|P2|STARTED|Overall Study||850
973320|NCT00321763|2355371|P1|STARTED|Overall Study||850
973321|NCT00321789|2355430|P2|NOT COMPLETED|Overall Study||16
973322|NCT00321789|2355431|P1|NOT COMPLETED|Overall Study||15
973323|NCT00321789|2355430|P2|COMPLETED|Overall Study||112
973324|NCT00321789|2355431|P1|COMPLETED|Overall Study||112
973325|NCT00321789|2355430|P2|STARTED|Overall Study||128
973326|NCT00321789|2355431|P1|STARTED|Overall Study||127
973327|NCT00321828|2355459|P1|NOT COMPLETED|Overall Study||4
973328|NCT00321828|2355459|P1|COMPLETED|Overall Study||86
973329|NCT00321828|2355459|P1|STARTED|Overall Study||90
973330|NCT00321854|2355465|P2|NOT COMPLETED|Overall Study||82
973331|NCT00321854|2355466|P1|NOT COMPLETED|Overall Study||63
973332|NCT00321854|2355465|P2|COMPLETED|Overall Study||192
973333|NCT00321854|2355466|P1|COMPLETED|Overall Study||198
973334|NCT00321854|2355465|P2|STARTED|Overall Study||274
973335|NCT00321854|2355466|P1|STARTED|Overall Study||261
973336|NCT00321893|2355586|P2|NOT COMPLETED|Overall Study||14
973337|NCT00321893|2355587|P1|NOT COMPLETED|Overall Study||24
973338|NCT00321893|2355586|P2|COMPLETED|Overall Study||87
973339|NCT00321893|2355587|P1|COMPLETED|Overall Study||77
973340|NCT00321893|2355586|P2|STARTED|Overall Study||101
973341|NCT00321893|2355587|P1|STARTED|Overall Study||101
973342|NCT00321906|2355601|P2|NOT COMPLETED|Overall Study||56
973343|NCT00321906|2355602|P1|NOT COMPLETED|Overall Study||46
973344|NCT00321906|2355601|P2|COMPLETED|Overall Study||31
973345|NCT00321906|2355602|P1|COMPLETED|Overall Study||48
973346|NCT00321906|2355601|P2|STARTED|Overall Study||87
973347|NCT00321906|2355602|P1|STARTED|Overall Study||94
973348|NCT00321919|2355624|P2|NOT COMPLETED|Overall Study||52
973349|NCT00321919|2355625|P1|NOT COMPLETED|Overall Study||75
973350|NCT00321919|2355624|P2|COMPLETED|Overall Study||250
973351|NCT00321919|2355625|P1|COMPLETED|Overall Study||226
973352|NCT00321919|2355624|P2|STARTED|Overall Study||302
973353|NCT00321919|2355625|P1|STARTED|Overall Study||301
973354|NCT00321932|2355667|P2|NOT COMPLETED|Overall Study||21
973355|NCT00321932|2355668|P1|NOT COMPLETED|Overall Study||10
973356|NCT00321932|2355667|P2|COMPLETED|Overall Study||11
973357|NCT00321932|2355668|P1|COMPLETED|Overall Study||19
973358|NCT00321932|2355667|P2|STARTED|Overall Study||32
973359|NCT00321932|2355668|P1|STARTED|Overall Study||29
973360|NCT00321984|2355693|P3|NOT COMPLETED|Overall Study||26
973361|NCT00321984|2355694|P2|NOT COMPLETED|Overall Study||21
973362|NCT00321984|2355695|P1|NOT COMPLETED|Overall Study||27
973363|NCT00321984|2355693|P3|COMPLETED|Overall Study||289
973364|NCT00321984|2355694|P2|COMPLETED|Overall Study||294
973365|NCT00321984|2355695|P1|COMPLETED|Overall Study||290
973366|NCT00321984|2355693|P3|STARTED|Overall Study||315
973367|NCT00321984|2355694|P2|STARTED|Overall Study||315
973368|NCT00321984|2355695|P1|STARTED|Overall Study||317
973369|NCT00322049|2355716|P4|NOT COMPLETED|Overall Study||1
973370|NCT00322049|2355717|P3|NOT COMPLETED|Overall Study||0
973371|NCT00322049|2355718|P2|NOT COMPLETED|Overall Study||1
973372|NCT00322049|2355719|P1|NOT COMPLETED|Overall Study||0
973373|NCT00322049|2355716|P4|COMPLETED|Overall Study||16
973374|NCT00322049|2355717|P3|COMPLETED|Overall Study||20
973375|NCT00322049|2355718|P2|COMPLETED|Overall Study||9
973376|NCT00322049|2355719|P1|COMPLETED|Overall Study||4
973377|NCT00322049|2355716|P4|STARTED|Overall Study||17
973378|NCT00322049|2355717|P3|STARTED|Overall Study||20
973379|NCT00322049|2355718|P2|STARTED|Overall Study||10
973380|NCT00322049|2355719|P1|STARTED|Overall Study||4
973381|NCT00322101|2355751|P2|NOT COMPLETED|Overall Study||0
973382|NCT00322101|2355752|P1|NOT COMPLETED|Overall Study||0
973383|NCT00322101|2355751|P2|COMPLETED|Overall Study||11
973384|NCT00322101|2355752|P1|COMPLETED|Overall Study||14
973385|NCT00322101|2355751|P2|STARTED|Overall Study||11
973386|NCT00322101|2355752|P1|STARTED|Overall Study||14
973387|NCT00322153|2355770|P2|NOT COMPLETED|Overall Study||69
973388|NCT00322153|2355771|P1|NOT COMPLETED|Overall Study||63
973389|NCT00322153|2355770|P2|COMPLETED|Overall Study||273
973390|NCT00322153|2355771|P1|COMPLETED|Overall Study||272
973391|NCT00322153|2355770|P2|SAFETY POPULATION|Overall Study|Safety population: one patient was randomized but did not receive double-blind study drug.|341
973392|NCT00322153|2355771|P1|SAFETY POPULATION|Overall Study|Safety population defined as all patients who took at least one dose of double-blind study drug.|335
973393|NCT00322153|2355770|P2|STARTED|Overall Study|Randomized to Memantine ER|342
973394|NCT00322153|2355771|P1|STARTED|Overall Study|Randomized to placebo|335
973395|NCT00322231|2355783|P2|NOT COMPLETED|Period 2||0
973396|NCT00322231|2355784|P1|NOT COMPLETED|Period 2||0
973397|NCT00322231|2355783|P2|COMPLETED|Period 2||49
973398|NCT00322231|2355784|P1|COMPLETED|Period 2||51
973399|NCT00322231|2355783|P2|STARTED|Period 2|One participant was lost between Period 1 and Period 2|49
973400|NCT00322231|2355784|P1|STARTED|Period 2||51
973401|NCT00322231|2355783|P2|NOT COMPLETED|Period 1||0
973402|NCT00322231|2355784|P1|NOT COMPLETED|Period 1||0
973403|NCT00322231|2355783|P2|COMPLETED|Period 1||50
973404|NCT00322231|2355784|P1|COMPLETED|Period 1||51
973405|NCT00322231|2355783|P2|STARTED|Period 1||50
973406|NCT00322231|2355784|P1|STARTED|Period 1||51
973407|NCT00322309|2355796|P2|NOT COMPLETED|Overall Study||4
973408|NCT00322309|2355797|P1|NOT COMPLETED|Overall Study||2
973409|NCT00322309|2355796|P2|COMPLETED|Overall Study||9
973410|NCT00322309|2355797|P1|COMPLETED|Overall Study||9
973411|NCT00322309|2355796|P2|STARTED|Overall Study||13
973412|NCT00322309|2355797|P1|STARTED|Overall Study||11
973413|NCT00322335|2355814|P3|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
973414|NCT00322335|2355815|P2|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
973415|NCT00322335|2355816|P1|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
973416|NCT00322335|2355814|P3|COMPLETED|Subjects 66 Months After Booster Dose||53
973417|NCT00322335|2355815|P2|COMPLETED|Subjects 66 Months After Booster Dose||104
973418|NCT00322335|2355816|P1|COMPLETED|Subjects 66 Months After Booster Dose||48
973419|NCT00322335|2355814|P3|STARTED|Subjects 66 Months After Booster Dose||53
973420|NCT00322335|2355815|P2|STARTED|Subjects 66 Months After Booster Dose||104
973421|NCT00322335|2355816|P1|STARTED|Subjects 66 Months After Booster Dose||48
973422|NCT00322335|2355814|P3|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
973423|NCT00322335|2355815|P2|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
973424|NCT00322335|2355816|P1|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
973425|NCT00322335|2355814|P3|COMPLETED|Subjects 54 Months After Booster Dose||56
973426|NCT00322335|2355815|P2|COMPLETED|Subjects 54 Months After Booster Dose||108
973427|NCT00322335|2355816|P1|COMPLETED|Subjects 54 Months After Booster Dose||50
973428|NCT00322335|2355814|P3|STARTED|Subjects 54 Months After Booster Dose||56
973429|NCT00322335|2355815|P2|STARTED|Subjects 54 Months After Booster Dose||108
973430|NCT00322335|2355816|P1|STARTED|Subjects 54 Months After Booster Dose||50
973431|NCT00322335|2355814|P3|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
973432|NCT00322335|2355815|P2|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
973433|NCT00322335|2355816|P1|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
973434|NCT00322335|2355814|P3|COMPLETED|Subjects 42 Months After Booster Dose||56
973435|NCT00322335|2355815|P2|COMPLETED|Subjects 42 Months After Booster Dose||113
973436|NCT00322335|2355816|P1|COMPLETED|Subjects 42 Months After Booster Dose||51
973437|NCT00322335|2355814|P3|STARTED|Subjects 42 Months After Booster Dose||56
973438|NCT00322335|2355815|P2|STARTED|Subjects 42 Months After Booster Dose||113
973439|NCT00322335|2355816|P1|STARTED|Subjects 42 Months After Booster Dose||51
973440|NCT00322335|2355814|P3|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
973441|NCT00322335|2355815|P2|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
973442|NCT00322335|2355816|P1|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
973443|NCT00322335|2355814|P3|COMPLETED|Subjects 30 Months After Booster Dose||57
973444|NCT00322335|2355815|P2|COMPLETED|Subjects 30 Months After Booster Dose||119
973445|NCT00322335|2355816|P1|COMPLETED|Subjects 30 Months After Booster Dose||54
973446|NCT00322335|2355814|P3|STARTED|Subjects 30 Months After Booster Dose|Subjects eliminated from previous timepoint were included again from this timepoint onwards|57
973447|NCT00322335|2355815|P2|STARTED|Subjects 30 Months After Booster Dose||119
973448|NCT00322335|2355816|P1|STARTED|Subjects 30 Months After Booster Dose||54
973449|NCT00322335|2355814|P3|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
973450|NCT00322335|2355815|P2|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
973451|NCT00322335|2355816|P1|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
973452|NCT00322335|2355814|P3|COMPLETED|Subjects 18 Months After Booster Dose||3
973453|NCT00322335|2355815|P2|COMPLETED|Subjects 18 Months After Booster Dose||123
973454|NCT00322335|2355816|P1|COMPLETED|Subjects 18 Months After Booster Dose||58
973455|NCT00322335|2355814|P3|STARTED|Subjects 18 Months After Booster Dose|Subjects who received Meningitec booster outside scope study NCT00323050 eliminated from this period|3
973456|NCT00322335|2355815|P2|STARTED|Subjects 18 Months After Booster Dose||123
973457|NCT00322335|2355816|P1|STARTED|Subjects 18 Months After Booster Dose||58
973458|NCT00322348|2355856|P2|NOT COMPLETED|Overall Study||33
973459|NCT00322348|2355857|P1|NOT COMPLETED|Overall Study||37
973460|NCT00322348|2355856|P2|COMPLETED|Overall Study|Number of participants completed up to Week 96|16
973461|NCT00322348|2355857|P1|COMPLETED|Overall Study|Number of participants completed up to Week 96|12
973462|NCT00322348|2355856|P2|Received Study Treatment|Overall Study||48
973463|NCT00322348|2355857|P1|Received Study Treatment|Overall Study||50
973464|NCT00322348|2355856|P2|STARTED|Overall Study||49
973465|NCT00322348|2355857|P1|STARTED|Overall Study||49
973466|NCT00322374|2355876|P4|NOT COMPLETED|Second Escalation||0
973467|NCT00322374|2355877|P3|NOT COMPLETED|Second Escalation||6
973468|NCT00322374|2355878|P2|NOT COMPLETED|Second Escalation||0
973469|NCT00322374|2355879|P1|NOT COMPLETED|Second Escalation||0
973470|NCT00322374|2355876|P4|COMPLETED|Second Escalation||0
973471|NCT00322374|2355877|P3|COMPLETED|Second Escalation||0
973472|NCT00322374|2355878|P2|COMPLETED|Second Escalation||0
973473|NCT00322374|2355879|P1|COMPLETED|Second Escalation||0
973474|NCT00322374|2355876|P4|STARTED|Second Escalation||0
973475|NCT00322374|2355877|P3|STARTED|Second Escalation||6
973476|NCT00322374|2355878|P2|STARTED|Second Escalation||0
973477|NCT00322374|2355879|P1|STARTED|Second Escalation||0
973478|NCT00322374|2355876|P4|NOT COMPLETED|First Escalation||0
973479|NCT00322374|2355877|P3|NOT COMPLETED|First Escalation||0
973480|NCT00322374|2355878|P2|NOT COMPLETED|First Escalation||30
973481|NCT00322374|2355879|P1|NOT COMPLETED|First Escalation||0
973482|NCT00322374|2355876|P4|COMPLETED|First Escalation||0
973483|NCT00322374|2355877|P3|COMPLETED|First Escalation||0
973484|NCT00322374|2355878|P2|COMPLETED|First Escalation||0
973485|NCT00322374|2355879|P1|COMPLETED|First Escalation||0
973486|NCT00322374|2355876|P4|STARTED|First Escalation||0
973487|NCT00322374|2355877|P3|STARTED|First Escalation||0
973488|NCT00322374|2355878|P2|STARTED|First Escalation||30
973489|NCT00322374|2355879|P1|STARTED|First Escalation||0
973490|NCT00322374|2355876|P4|NOT COMPLETED|Starting Dose||0
973491|NCT00322374|2355877|P3|NOT COMPLETED|Starting Dose||0
973492|NCT00322374|2355878|P2|NOT COMPLETED|Starting Dose||0
973493|NCT00322374|2355879|P1|NOT COMPLETED|Starting Dose||6
973494|NCT00322374|2355876|P4|COMPLETED|Starting Dose||0
973495|NCT00322374|2355877|P3|COMPLETED|Starting Dose||0
973496|NCT00322374|2355878|P2|COMPLETED|Starting Dose||0
973497|NCT00322374|2355879|P1|COMPLETED|Starting Dose||0
973498|NCT00322374|2355876|P4|STARTED|Starting Dose||0
973499|NCT00322374|2355877|P3|STARTED|Starting Dose||0
973500|NCT00322374|2355878|P2|STARTED|Starting Dose||0
973501|NCT00322374|2355879|P1|STARTED|Starting Dose||6
973502|NCT00322374|2355876|P4|NOT COMPLETED|Enrollment||0
973503|NCT00322374|2355877|P3|NOT COMPLETED|Enrollment||0
973504|NCT00322374|2355878|P2|NOT COMPLETED|Enrollment||0
973505|NCT00322374|2355879|P1|NOT COMPLETED|Enrollment||0
973506|NCT00322374|2355876|P4|COMPLETED|Enrollment||42
973507|NCT00322374|2355877|P3|COMPLETED|Enrollment||0
973508|NCT00322374|2355878|P2|COMPLETED|Enrollment||0
973509|NCT00322374|2355879|P1|COMPLETED|Enrollment||0
973510|NCT00322374|2355876|P4|STARTED|Enrollment||42
973511|NCT00322374|2355877|P3|STARTED|Enrollment||0
973512|NCT00322374|2355878|P2|STARTED|Enrollment||0
973513|NCT00322374|2355879|P1|STARTED|Enrollment||0
973514|NCT00322387|2355929|P2|NOT COMPLETED|Follow-up Period||3
973515|NCT00322387|2355930|P1|NOT COMPLETED|Follow-up Period||2
973516|NCT00322387|2355929|P2|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|23
973517|NCT00322387|2355930|P1|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|12
973518|NCT00322387|2355929|P2|STARTED|Follow-up Period|Participants who had transplants. One participant did not complete therapy but had a transplant.|26
973519|NCT00322387|2355930|P1|STARTED|Follow-up Period|Participants who had transplants|14
973520|NCT00322387|2355929|P2|NOT COMPLETED|Treatment Period||1
973521|NCT00322387|2355930|P1|NOT COMPLETED|Treatment Period||0
973522|NCT00322387|2355929|P2|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|25
973523|NCT00322387|2355930|P1|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|14
973524|NCT00322387|2355929|P2|STARTED|Treatment Period|Plerixafor PM=12, Plerixafor AM=9, Low CD34+ Count/Plerixafor PM=1, and Plerixafor After Chemo=4|26
973525|NCT00322387|2355930|P1|STARTED|Treatment Period|Plerixafor PM=7, Plerixafor AM=6, Low CD34+ Count/Plerixafor PM=0, and Plerixafor After Chemo=1|14
973526|NCT00322439|2355961|P1|NOT COMPLETED|Overall Study||1056
973527|NCT00322439|2355961|P1|COMPLETED|Overall Study||1455
973528|NCT00322439|2355961|P1|Received at Least 1 Dose of Etanercept|Overall Study||2510
973529|NCT00322439|2355961|P1|STARTED|Overall Study||2511
973530|NCT00322452|2355976|P2|NOT COMPLETED|Overall Study||276
973531|NCT00322452|2355977|P1|NOT COMPLETED|Overall Study||247
973532|NCT00322452|2355976|P2|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 84 remained at OS DCO (14 June 2010)|332
973533|NCT00322452|2355977|P1|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 97 remained at OS DCO (14 June 2010)|362
973534|NCT00322452|2355976|P2|STARTED|Overall Study|Number of patients randomized|608
973535|NCT00322452|2355977|P1|STARTED|Overall Study|Number of patients randomized|609
973548|NCT00322491|2356081|P2|NOT COMPLETED|Overall Study||2
973549|NCT00322491|2356082|P1|NOT COMPLETED|Overall Study||2
973550|NCT00322491|2356081|P2|COMPLETED|Overall Study||24
973551|NCT00322491|2356082|P1|COMPLETED|Overall Study||21
973552|NCT00322491|2356081|P2|STARTED|Overall Study||26
973553|NCT00322491|2356082|P1|STARTED|Overall Study||23
973554|NCT00322556|2356104|P1|NOT COMPLETED|Overall Study||12
973555|NCT00322556|2356104|P1|COMPLETED|Overall Study||43
973556|NCT00322556|2356104|P1|STARTED|Overall Study||55
973557|NCT00322621|2356118|P3|NOT COMPLETED|Period III - Maintenance / Rescue Phase||36
973558|NCT00322621|2356119|P2|NOT COMPLETED|Period III - Maintenance / Rescue Phase||29
973559|NCT00322621|2356120|P1|NOT COMPLETED|Period III - Maintenance / Rescue Phase||0
973560|NCT00322621|2356118|P3|COMPLETED|Period III - Maintenance / Rescue Phase||33
973561|NCT00322621|2356119|P2|COMPLETED|Period III - Maintenance / Rescue Phase||86
973562|NCT00322621|2356120|P1|COMPLETED|Period III - Maintenance / Rescue Phase||0
973563|NCT00322621|2356118|P3|STARTED|Period III - Maintenance / Rescue Phase||69
973564|NCT00322621|2356119|P2|STARTED|Period III - Maintenance / Rescue Phase||115
973565|NCT00322621|2356120|P1|STARTED|Period III - Maintenance / Rescue Phase||0
973566|NCT00322621|2356118|P3|NOT COMPLETED|Period II - Acute Therapy Phase||0
973567|NCT00322621|2356119|P2|NOT COMPLETED|Period II - Acute Therapy Phase||0
973568|NCT00322621|2356120|P1|NOT COMPLETED|Period II - Acute Therapy Phase||32
973569|NCT00322621|2356118|P3|COMPLETED|Period II - Acute Therapy Phase||0
973570|NCT00322621|2356119|P2|COMPLETED|Period II - Acute Therapy Phase||0
973571|NCT00322621|2356120|P1|COMPLETED|Period II - Acute Therapy Phase||184
973572|NCT00322621|2356118|P3|STARTED|Period II - Acute Therapy Phase||0
973573|NCT00322621|2356119|P2|STARTED|Period II - Acute Therapy Phase||0
973574|NCT00322621|2356120|P1|STARTED|Period II - Acute Therapy Phase||216
973575|NCT00322712|2356172|P1|NOT COMPLETED|Overall Study||1
973576|NCT00322712|2356172|P1|COMPLETED|Overall Study||11
973577|NCT00322712|2356172|P1|STARTED|Overall Study||12
973578|NCT00322777|2356178|P2|NOT COMPLETED|Overall Study||0
973579|NCT00322777|2356179|P1|NOT COMPLETED|Overall Study||0
973580|NCT00322777|2356178|P2|COMPLETED|Overall Study||45
973581|NCT00322777|2356179|P1|COMPLETED|Overall Study||39
973582|NCT00322777|2356178|P2|Data Collection at Week 24|Overall Study||45
973583|NCT00322777|2356179|P1|Data Collection at Week 24|Overall Study||39
973584|NCT00322777|2356178|P2|Data Collection at Week 16|Overall Study||45
973585|NCT00322777|2356179|P1|Data Collection at Week 16|Overall Study||39
973586|NCT00322777|2356178|P2|Data Collection at Week 8|Overall Study||45
973587|NCT00322777|2356179|P1|Data Collection at Week 8|Overall Study||39
973588|NCT00322777|2356178|P2|"Data Collection at BASELINE|"|Overall Study||45
973589|NCT00322777|2356179|P1|"Data Collection at BASELINE|"|Overall Study||39
973590|NCT00322777|2356178|P2|STARTED|Overall Study||45
973591|NCT00322777|2356179|P1|STARTED|Overall Study||39
973592|NCT00322842|2356191|P2|NOT COMPLETED|Overall Study||2
973593|NCT00322842|2356192|P1|NOT COMPLETED|Overall Study||2
973594|NCT00322842|2356191|P2|COMPLETED|Overall Study|One participant d/c treatment early, received a transplant, and was lost to follow-up after 6 months|29
973595|NCT00322842|2356192|P1|COMPLETED|Overall Study|One participant discontinued (d/c) treatment early, received a transplant, and completed the study.|2
973596|NCT00322842|2356191|P2|STARTED|Overall Study||31
973597|NCT00322842|2356192|P1|STARTED|Overall Study||4
973598|NCT00322855|2356217|P1|NOT COMPLETED|Overall Study||0
973599|NCT00322855|2356217|P1|COMPLETED|Overall Study||1
973600|NCT00322855|2356217|P1|STARTED|Overall Study||1
973601|NCT00322881|2356221|P1|NOT COMPLETED|Overall Study||5
973602|NCT00322881|2356221|P1|COMPLETED|Overall Study||7
973603|NCT00322881|2356221|P1|STARTED|Overall Study||12
973604|NCT00323037|2356227|P2|NOT COMPLETED|Overall Study||27
973605|NCT00323037|2356228|P1|NOT COMPLETED|Overall Study||33
973606|NCT00323037|2356227|P2|COMPLETED|Overall Study||126
973607|NCT00323037|2356228|P1|COMPLETED|Overall Study||132
973608|NCT00323037|2356227|P2|STARTED|Overall Study|Number randomized|153
973609|NCT00323037|2356228|P1|STARTED|Overall Study|Number randomized|165
973610|NCT00323115|2356232|P1|NOT COMPLETED|Adjuvant Therapy & Survival Follow-Up||8
973611|NCT00323115|2356232|P1|COMPLETED|Adjuvant Therapy & Survival Follow-Up||2
973612|NCT00323115|2356232|P1|STARTED|Adjuvant Therapy & Survival Follow-Up||10
973613|NCT00323115|2356232|P1|NOT COMPLETED|Vaccine Administration||1
973614|NCT00323115|2356232|P1|COMPLETED|Vaccine Administration||10
973615|NCT00323115|2356232|P1|STARTED|Vaccine Administration||11
973616|NCT00323193|2356239|P2|NOT COMPLETED|Overall Study||15
973617|NCT00323193|2356240|P1|NOT COMPLETED|Overall Study||23
973618|NCT00323193|2356239|P2|COMPLETED|Overall Study||41
973619|NCT00323193|2356240|P1|COMPLETED|Overall Study||30
973620|NCT00323193|2356239|P2|STARTED|Overall Study||56
973621|NCT00323193|2356240|P1|STARTED|Overall Study||53
973622|NCT00323258|2356250|P2|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
973623|NCT00323258|2356251|P1|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
973624|NCT00323258|2356250|P2|COMPLETED|Secondary Outcome (6 Mon Refill Records)||58
973625|NCT00323258|2356251|P1|COMPLETED|Secondary Outcome (6 Mon Refill Records)||57
973626|NCT00323258|2356250|P2|STARTED|Secondary Outcome (6 Mon Refill Records)||72
973627|NCT00323258|2356251|P1|STARTED|Secondary Outcome (6 Mon Refill Records)||71
973628|NCT00323258|2356250|P2|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||19
973629|NCT00323258|2356251|P1|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||16
973630|NCT00323258|2356250|P2|COMPLETED|Primary Outcome (Phone Call at 6 Months)||53
973631|NCT00323258|2356251|P1|COMPLETED|Primary Outcome (Phone Call at 6 Months)||55
973632|NCT00323258|2356250|P2|STARTED|Primary Outcome (Phone Call at 6 Months)||72
973633|NCT00323258|2356251|P1|STARTED|Primary Outcome (Phone Call at 6 Months)||71
973634|NCT00323271|2356267|P2|NOT COMPLETED|Overall Study||3
973635|NCT00323271|2356268|P1|NOT COMPLETED|Overall Study||2
973636|NCT00323271|2356267|P2|COMPLETED|Overall Study||9
973637|NCT00323271|2356268|P1|COMPLETED|Overall Study||11
973638|NCT00323271|2356267|P2|STARTED|Overall Study||12
973639|NCT00323271|2356268|P1|STARTED|Overall Study||13
973640|NCT00323284|2356278|P2|NOT COMPLETED|24 Months Follow-up||22
973641|NCT00323284|2356279|P1|NOT COMPLETED|24 Months Follow-up||18
973642|NCT00323284|2356278|P2|COMPLETED|24 Months Follow-up||101
973643|NCT00323284|2356279|P1|COMPLETED|24 Months Follow-up||98
973644|NCT00323284|2356278|P2|STARTED|24 Months Follow-up||123
973645|NCT00323284|2356279|P1|STARTED|24 Months Follow-up||116
973646|NCT00323284|2356278|P2|NOT COMPLETED|12 Months Follow-up||9
973647|NCT00323284|2356279|P1|NOT COMPLETED|12 Months Follow-up||5
973648|NCT00323284|2356278|P2|COMPLETED|12 Months Follow-up||114
973649|NCT00323284|2356279|P1|COMPLETED|12 Months Follow-up||111
973650|NCT00323284|2356278|P2|STARTED|12 Months Follow-up||123
973651|NCT00323284|2356279|P1|STARTED|12 Months Follow-up||116
973652|NCT00323297|2356289|P2|NOT COMPLETED|Part B (Open-label)||12
973653|NCT00323297|2356290|P1|NOT COMPLETED|Part B (Open-label)||9
973654|NCT00323297|2356289|P2|COMPLETED|Part B (Open-label)||31
973655|NCT00323297|2356290|P1|COMPLETED|Part B (Open-label)||39
973656|NCT00323297|2356289|P2|STARTED|Part B (Open-label)||43
973657|NCT00323297|2356290|P1|STARTED|Part B (Open-label)||48
973658|NCT00323297|2356289|P2|NOT COMPLETED|Part A (Double Blind Randomized)||7
973659|NCT00323297|2356290|P1|NOT COMPLETED|Part A (Double Blind Randomized)||5
973660|NCT00323297|2356289|P2|COMPLETED|Part A (Double Blind Randomized)||43
973661|NCT00323297|2356290|P1|COMPLETED|Part A (Double Blind Randomized)||48
973662|NCT00323297|2356289|P2|STARTED|Part A (Double Blind Randomized)||50
973663|NCT00323297|2356290|P1|STARTED|Part A (Double Blind Randomized)||53
973664|NCT00323310|2356306|P1|NOT COMPLETED|Overall Study||3
973665|NCT00323310|2356306|P1|COMPLETED|Overall Study||89
973666|NCT00323310|2356306|P1|STARTED|Overall Study||92
973667|NCT00323362|2356319|P1|NOT COMPLETED|Overall Study||0
973668|NCT00323362|2356319|P1|COMPLETED|Overall Study||17
973669|NCT00323362|2356319|P1|STARTED|Overall Study||17
973670|NCT00323427|2356327|P2|NOT COMPLETED|Overall Study||23
973671|NCT00323427|2356328|P1|NOT COMPLETED|Overall Study||31
973672|NCT00323427|2356327|P2|COMPLETED|Overall Study||43
973673|NCT00323427|2356328|P1|COMPLETED|Overall Study||38
973674|NCT00323427|2356327|P2|STARTED|Overall Study||66
973675|NCT00323427|2356328|P1|STARTED|Overall Study||69
973676|NCT00323479|2356338|P1|NOT COMPLETED|Overall Study||8
973677|NCT00323479|2356338|P1|COMPLETED|Overall Study|with at least 1 evaluation for primary efficacy endpoint|106
973678|NCT00323479|2356338|P1|Safety Population|Overall Study|Patients who taken at least one dose of treatment|110
973679|NCT00323479|2356338|P1|STARTED|Overall Study||114
973680|NCT00323492|2356349|P3|NOT COMPLETED|Study Phase 2||1
973681|NCT00323492|2356350|P2|NOT COMPLETED|Study Phase 2||1
973682|NCT00323492|2356351|P1|NOT COMPLETED|Study Phase 2||4
973683|NCT00323492|2356349|P3|COMPLETED|Study Phase 2||24
973684|NCT00323492|2356350|P2|COMPLETED|Study Phase 2||17
973685|NCT00323492|2356351|P1|COMPLETED|Study Phase 2||40
973686|NCT00323492|2356349|P3|STARTED|Study Phase 2|N=25 switched to Truvada in Phase 2.|25
973687|NCT00323492|2356350|P2|STARTED|Study Phase 2|2/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=20 (no switch to Truvada)|18
973688|NCT00323492|2356351|P1|STARTED|Study Phase 2|1/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=46|44
973689|NCT00323492|2356349|P3|NOT COMPLETED|Study Phase 1||0
973690|NCT00323492|2356350|P2|NOT COMPLETED|Study Phase 1||0
973691|NCT00323492|2356351|P1|NOT COMPLETED|Study Phase 1||2
973692|NCT00323492|2356349|P3|COMPLETED|Study Phase 1||0
973693|NCT00323492|2356350|P2|COMPLETED|Study Phase 1||45
973694|NCT00323492|2356351|P1|COMPLETED|Study Phase 1||45
973695|NCT00323492|2356349|P3|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||0
973696|NCT00323492|2356350|P2|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||45
973697|NCT00323492|2356351|P1|Intent-to-Treat (ITT) Analysis Set|Study Phase 1|One subject was excluded from ITT analysis set due to protocol violation.|46
973698|NCT00323492|2356349|P3|STARTED|Study Phase 1|Not applicable to Phase 1.|0
973699|NCT00323492|2356350|P2|STARTED|Study Phase 1||45
973700|NCT00323492|2356351|P1|STARTED|Study Phase 1||47
973701|NCT00323557|2356384|P2|NOT COMPLETED|Overall Study||0
973702|NCT00323557|2356385|P1|NOT COMPLETED|Overall Study||1
973703|NCT00323557|2356384|P2|COMPLETED|Overall Study||7
973704|NCT00323557|2356385|P1|COMPLETED|Overall Study||24
973705|NCT00323557|2356384|P2|STARTED|Overall Study||7
973706|NCT00323557|2356385|P1|STARTED|Overall Study|GM-CSF pre and post vaccine.|25
973707|NCT00323609|2356394|P4|NOT COMPLETED|Overall Study||15
973708|NCT00323609|2356395|P3|NOT COMPLETED|Overall Study||8
973709|NCT00323609|2356396|P2|NOT COMPLETED|Overall Study||99
973710|NCT00323609|2356397|P1|NOT COMPLETED|Overall Study||91
973711|NCT00323609|2356394|P4|COMPLETED|Overall Study||0
973712|NCT00323609|2356395|P3|COMPLETED|Overall Study||0
973713|NCT00323609|2356396|P2|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|91
973714|NCT00323609|2356397|P1|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|100
973715|NCT00323609|2356394|P4|STARTED|Overall Study||15
973716|NCT00323609|2356395|P3|STARTED|Overall Study||8
973717|NCT00323609|2356396|P2|STARTED|Overall Study||190
973718|NCT00323609|2356397|P1|STARTED|Overall Study||191
973719|NCT00323622|2356439|P8|NOT COMPLETED|Overall Study||15
973720|NCT00323622|2356440|P7|NOT COMPLETED|Overall Study||5
973721|NCT00323622|2356441|P6|NOT COMPLETED|Overall Study||74
973722|NCT00323622|2356442|P5|NOT COMPLETED|Overall Study||39
973723|NCT00323622|2356443|P4|NOT COMPLETED|Overall Study||12
973724|NCT00323622|2356444|P3|NOT COMPLETED|Overall Study||4
973725|NCT00323622|2356445|P2|NOT COMPLETED|Overall Study||92
973726|NCT00323622|2356446|P1|NOT COMPLETED|Overall Study||31
973727|NCT00323622|2356439|P8|COMPLETED|Overall Study||125
973728|NCT00323622|2356440|P7|COMPLETED|Overall Study||38
973729|NCT00323622|2356441|P6|COMPLETED|Overall Study||454
973730|NCT00323622|2356442|P5|COMPLETED|Overall Study||120
973731|NCT00323622|2356443|P4|COMPLETED|Overall Study||122
973732|NCT00323622|2356444|P3|COMPLETED|Overall Study||38
973733|NCT00323622|2356445|P2|COMPLETED|Overall Study||423
973734|NCT00323622|2356446|P1|COMPLETED|Overall Study||145
973735|NCT00323622|2356439|P8|STARTED|Overall Study||140
973736|NCT00323622|2356440|P7|STARTED|Overall Study||43
973737|NCT00323622|2356441|P6|STARTED|Overall Study||528
973738|NCT00323622|2356442|P5|STARTED|Overall Study||159
973739|NCT00323622|2356443|P4|STARTED|Overall Study||134
973740|NCT00323622|2356444|P3|STARTED|Overall Study||42
973741|NCT00323622|2356445|P2|STARTED|Overall Study||515
973742|NCT00323622|2356446|P1|STARTED|Overall Study||176
973743|NCT00323635|2356488|P2|NOT COMPLETED|Overall Study||0
973744|NCT00323635|2356489|P1|NOT COMPLETED|Overall Study||0
973745|NCT00323635|2356488|P2|COMPLETED|Overall Study||9
973746|NCT00323635|2356489|P1|COMPLETED|Overall Study||10
973747|NCT00323635|2356488|P2|STARTED|Overall Study||9
973748|NCT00323635|2356489|P1|STARTED|Overall Study||10
973749|NCT00323739|2356505|P1|NOT COMPLETED|Overall Study||0
973750|NCT00323739|2356505|P1|COMPLETED|Overall Study||80
973751|NCT00323739|2356505|P1|STARTED|Overall Study||80
973752|NCT00323869|2356510|P1|NOT COMPLETED|Overall Study||1
973753|NCT00323869|2356510|P1|COMPLETED|Overall Study||47
973754|NCT00323869|2356510|P1|Treatment Initiation|Overall Study|One participant died before receiving therapy, not included in analysis|47
973755|NCT00323869|2356510|P1|STARTED|Overall Study|Enrollment|48
973756|NCT00323882|2356527|P5|NOT COMPLETED|Overall Study||32
973757|NCT00323882|2356528|P4|NOT COMPLETED|Overall Study||7
973758|NCT00323882|2356529|P3|NOT COMPLETED|Overall Study||13
973759|NCT00323882|2356530|P2|NOT COMPLETED|Overall Study||6
973760|NCT00323882|2356531|P1|NOT COMPLETED|Overall Study||8
973761|NCT00323882|2356527|P5|COMPLETED|Overall Study||2
973762|NCT00323882|2356528|P4|COMPLETED|Overall Study||0
973763|NCT00323882|2356529|P3|COMPLETED|Overall Study||3
973764|NCT00323882|2356530|P2|COMPLETED|Overall Study||0
973765|NCT00323882|2356531|P1|COMPLETED|Overall Study||0
973766|NCT00323882|2356527|P5|STARTED|Overall Study||34
973767|NCT00323882|2356528|P4|STARTED|Overall Study||7
973768|NCT00323882|2356529|P3|STARTED|Overall Study||16
973769|NCT00323882|2356530|P2|STARTED|Overall Study||6
973770|NCT00323882|2356531|P1|STARTED|Overall Study||8
973771|NCT00324038|2356604|P2|NOT COMPLETED|Overall Study||51
973772|NCT00324038|2356605|P1|NOT COMPLETED|Overall Study||49
973773|NCT00324038|2356604|P2|COMPLETED|Overall Study||58
973774|NCT00324038|2356605|P1|COMPLETED|Overall Study||61
973775|NCT00324038|2356604|P2|STARTED|Overall Study||109
973776|NCT00324038|2356605|P1|STARTED|Overall Study||110
973777|NCT00324116|2356611|P1|NOT COMPLETED|Overall Study||32
973778|NCT00324116|2356611|P1|COMPLETED|Overall Study||49
973779|NCT00324116|2356611|P1|STARTED|Overall Study|subjects received treatment|81
973804|NCT00324168|2356656|P2|NOT COMPLETED|Overall Study||30
973805|NCT00324168|2356657|P1|NOT COMPLETED|Overall Study||28
973806|NCT00324168|2356656|P2|COMPLETED|Overall Study||220
973807|NCT00324168|2356657|P1|COMPLETED|Overall Study||222
973808|NCT00324168|2356656|P2|STARTED|Overall Study||250
973809|NCT00324168|2356657|P1|STARTED|Overall Study||250
973810|NCT00307294|2356683|P1|NOT COMPLETED|Overall Study||30
973811|NCT00307294|2356683|P1|COMPLETED|Overall Study||9
973812|NCT00307294|2356683|P1|STARTED|Overall Study||39
973813|NCT00307333|2356689|P2|NOT COMPLETED|Overall Study||3
973814|NCT00307333|2356690|P1|NOT COMPLETED|Overall Study||11
973815|NCT00307333|2356689|P2|COMPLETED|Overall Study||1489
973816|NCT00307333|2356690|P1|COMPLETED|Overall Study||1500
973817|NCT00307333|2356689|P2|STARTED|Overall Study||1492
973818|NCT00307333|2356690|P1|STARTED|Overall Study||1511
973819|NCT00307437|2356705|P7|NOT COMPLETED|After Controlled Period||113
973820|NCT00307437|2356706|P6|NOT COMPLETED|After Controlled Period||122
973821|NCT00307437|2356707|P5|NOT COMPLETED|After Controlled Period||55
973822|NCT00307437|2356708|P4|NOT COMPLETED|After Controlled Period||58
973823|NCT00307437|2356709|P3|NOT COMPLETED|After Controlled Period||0
973824|NCT00307437|2356710|P2|NOT COMPLETED|After Controlled Period||0
973825|NCT00307437|2356711|P1|NOT COMPLETED|After Controlled Period||0
973826|NCT00307437|2356705|P7|COMPLETED|After Controlled Period||289
973827|NCT00307437|2356706|P6|COMPLETED|After Controlled Period||281
973828|NCT00307437|2356707|P5|COMPLETED|After Controlled Period||140
973829|NCT00307437|2356708|P4|COMPLETED|After Controlled Period||139
973830|NCT00307437|2356709|P3|COMPLETED|After Controlled Period||0
973831|NCT00307437|2356710|P2|COMPLETED|After Controlled Period||0
973832|NCT00307437|2356711|P1|COMPLETED|After Controlled Period||0
973833|NCT00307437|2356705|P7|STARTED|After Controlled Period||402
973834|NCT00307437|2356706|P6|STARTED|After Controlled Period||403
973835|NCT00307437|2356707|P5|STARTED|After Controlled Period|2 participants from placebo group in CP did not crossover to this group after CP.|195
973836|NCT00307437|2356708|P4|STARTED|After Controlled Period||197
973837|NCT00307437|2356709|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
973838|NCT00307437|2356710|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
973839|NCT00307437|2356711|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
973840|NCT00307437|2356705|P7|NOT COMPLETED|Controlled Period||0
973841|NCT00307437|2356706|P6|NOT COMPLETED|Controlled Period||0
973842|NCT00307437|2356707|P5|NOT COMPLETED|Controlled Period||0
973843|NCT00307437|2356708|P4|NOT COMPLETED|Controlled Period||0
973844|NCT00307437|2356709|P3|NOT COMPLETED|Controlled Period||9
973845|NCT00307437|2356710|P2|NOT COMPLETED|Controlled Period||6
973846|NCT00307437|2356711|P1|NOT COMPLETED|Controlled Period||16
973847|NCT00307437|2356705|P7|COMPLETED|Controlled Period||0
973848|NCT00307437|2356706|P6|COMPLETED|Controlled Period||0
973849|NCT00307437|2356707|P5|COMPLETED|Controlled Period||0
973850|NCT00307437|2356708|P4|COMPLETED|Controlled Period||0
973851|NCT00307437|2356709|P3|COMPLETED|Controlled Period||402
973852|NCT00307437|2356710|P2|COMPLETED|Controlled Period||403
973853|NCT00307437|2356711|P1|COMPLETED|Controlled Period||394
973854|NCT00307437|2356705|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
973855|NCT00307437|2356706|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
973856|NCT00307437|2356707|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
973857|NCT00307437|2356708|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
973858|NCT00307437|2356709|P3|STARTED|Controlled Period||411
973859|NCT00307437|2356710|P2|STARTED|Controlled Period||409
973860|NCT00307437|2356711|P1|STARTED|Controlled Period||410
973861|NCT00307489|2356737|P2|NOT COMPLETED|Week 48 Through Week 168||6
973862|NCT00307489|2356738|P1|NOT COMPLETED|Week 48 Through Week 168||6
973863|NCT00307489|2356737|P2|COMPLETED|Week 48 Through Week 168|5 of the 44 subjects switched to open-label FTC/TDF prior to Week 168.|44
973864|NCT00307489|2356738|P1|COMPLETED|Week 48 Through Week 168|11 of the 46 subjects switched to open-label FTC/TDF prior to Week 168.|46
973865|NCT00307489|2356737|P2|STARTED|Week 48 Through Week 168||50
973866|NCT00307489|2356738|P1|STARTED|Week 48 Through Week 168||52
973867|NCT00307489|2356737|P2|NOT COMPLETED|Baseline Through Week 48||2
973868|NCT00307489|2356738|P1|NOT COMPLETED|Baseline Through Week 48||1
973869|NCT00307489|2356737|P2|COMPLETED|Baseline Through Week 48|9 of the 50 subjects switched to open-label FTC/TDF prior to Week 48.|50
973870|NCT00307489|2356738|P1|COMPLETED|Baseline Through Week 48|16 of the 52 subjects switched to open-label FTC/TDF prior to Week 48.|52
973871|NCT00307489|2356737|P2|STARTED|Baseline Through Week 48||52
973872|NCT00307489|2356738|P1|STARTED|Baseline Through Week 48||53
973873|NCT00307684|2356780|P3|NOT COMPLETED|Double Blind Phase||0
973874|NCT00307684|2356781|P2|NOT COMPLETED|Double Blind Phase||5
973875|NCT00307684|2356782|P1|NOT COMPLETED|Double Blind Phase||2
973876|NCT00307684|2356780|P3|COMPLETED|Double Blind Phase||0
973877|NCT00307684|2356781|P2|COMPLETED|Double Blind Phase||17
973878|NCT00307684|2356782|P1|COMPLETED|Double Blind Phase||21
973879|NCT00307684|2356780|P3|STARTED|Double Blind Phase||0
973880|NCT00307684|2356781|P2|STARTED|Double Blind Phase||22
973881|NCT00307684|2356782|P1|STARTED|Double Blind Phase||23
973882|NCT00307684|2356780|P3|NOT COMPLETED|Open Label Phase||56
973883|NCT00307684|2356781|P2|NOT COMPLETED|Open Label Phase||0
973884|NCT00307684|2356782|P1|NOT COMPLETED|Open Label Phase||0
973885|NCT00307684|2356780|P3|COMPLETED|Open Label Phase||99
973886|NCT00307684|2356781|P2|COMPLETED|Open Label Phase||0
973887|NCT00307684|2356782|P1|COMPLETED|Open Label Phase||0
973888|NCT00307684|2356780|P3|STARTED|Open Label Phase|1 screening failure|155
973889|NCT00307684|2356781|P2|STARTED|Open Label Phase||0
973890|NCT00307684|2356782|P1|STARTED|Open Label Phase||0
973891|NCT00307736|2356808|P4|NOT COMPLETED|Overall Study||3
973892|NCT00307736|2356809|P3|NOT COMPLETED|Overall Study||3
973893|NCT00307736|2356810|P2|NOT COMPLETED|Overall Study||0
973894|NCT00307736|2356811|P1|NOT COMPLETED|Overall Study||0
973895|NCT00307736|2356808|P4|COMPLETED|Overall Study||20
973896|NCT00307736|2356809|P3|COMPLETED|Overall Study||0
973897|NCT00307736|2356810|P2|COMPLETED|Overall Study||3
973898|NCT00307736|2356811|P1|COMPLETED|Overall Study||3
973899|NCT00307736|2356808|P4|STARTED|Overall Study||23
973900|NCT00307736|2356809|P3|STARTED|Overall Study||3
973901|NCT00307736|2356810|P2|STARTED|Overall Study||3
973902|NCT00307736|2356811|P1|STARTED|Overall Study||3
973903|NCT00307801|2356824|P2|NOT COMPLETED|Overall Study||17
973904|NCT00307801|2356825|P1|NOT COMPLETED|Overall Study||32
973905|NCT00307801|2356824|P2|COMPLETED|Overall Study||65
973906|NCT00307801|2356825|P1|COMPLETED|Overall Study||117
973907|NCT00307801|2356824|P2|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|77
973908|NCT00307801|2356825|P1|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|141
973909|NCT00307801|2356824|P2|Cycle 3, Visit 7, Treatment Day 84|Overall Study||71
973910|NCT00307801|2356825|P1|Cycle 3, Visit 7, Treatment Day 84|Overall Study||130
973911|NCT00307801|2356824|P2|Cycle 1, Visit 5, Baseline|Overall Study||81
973912|NCT00307801|2356825|P1|Cycle 1, Visit 5, Baseline|Overall Study||145
973913|NCT00307801|2356824|P2|Subjects Received Treatment|Overall Study||81
973914|NCT00307801|2356825|P1|Subjects Received Treatment|Overall Study||145
973915|NCT00307801|2356824|P2|STARTED|Overall Study||82
973916|NCT00307801|2356825|P1|STARTED|Overall Study||149
973917|NCT00307931|2356937|P1|NOT COMPLETED|Overall Study||1
973918|NCT00307931|2356937|P1|COMPLETED|Overall Study|Number of subjects who completed the Week 12 visit|15
973919|NCT00307931|2356937|P1|STARTED|Overall Study|Number of subjects who entered the study and have been treated|16
973920|NCT00314574|2356954|P2|NOT COMPLETED|Overall Study||83
973921|NCT00314574|2356955|P1|NOT COMPLETED|Overall Study||94
973922|NCT00314574|2356954|P2|COMPLETED|Overall Study||344
973923|NCT00314574|2356955|P1|COMPLETED|Overall Study||329
973924|NCT00314574|2356954|P2|Safety Population|Overall Study||428
973925|NCT00314574|2356955|P1|Safety Population|Overall Study|1 patient in the placebo arm received Xolair and was added to the Xolair arm for Safety analyses.|420
973926|NCT00314574|2356954|P2|Received at Least One Dose of Study Drug|Overall Study||427
973927|NCT00314574|2356955|P1|Received at Least One Dose of Study Drug|Overall Study||421
973928|NCT00314574|2356954|P2|STARTED|Overall Study||427
973929|NCT00314574|2356955|P1|STARTED|Overall Study||423
973930|NCT00314808|2356969|P1|NOT COMPLETED|Overall Study||8
973931|NCT00314808|2356969|P1|COMPLETED|Overall Study|Completed 2 cycles of Dronabinol or terminated early due to treatment-related adverse events (AE)|25
973932|NCT00314808|2356969|P1|STARTED|Overall Study||33
973933|NCT00314951|2356979|P2|NOT COMPLETED|Follow-up||34
973934|NCT00314951|2356980|P1|NOT COMPLETED|Follow-up||44
973935|NCT00314951|2356979|P2|COMPLETED|Follow-up||255
973936|NCT00314951|2356980|P1|COMPLETED|Follow-up||263
973937|NCT00314951|2356979|P2|STARTED|Follow-up||289
973938|NCT00314951|2356980|P1|STARTED|Follow-up||307
973939|NCT00314951|2356979|P2|NOT COMPLETED|Treatment||11
973940|NCT00314951|2356980|P1|NOT COMPLETED|Treatment||16
973941|NCT00314951|2356979|P2|COMPLETED|Treatment||289
973942|NCT00314951|2356980|P1|COMPLETED|Treatment||307
973943|NCT00314951|2356979|P2|STARTED|Treatment||300
973944|NCT00314951|2356980|P1|STARTED|Treatment||323
973945|NCT00314951|2356979|P2|NOT COMPLETED|Enrollment||6
973946|NCT00314951|2356980|P1|NOT COMPLETED|Enrollment||0
973947|NCT00314951|2356979|P2|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|300
973948|NCT00314951|2356980|P1|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|323
973949|NCT00314951|2356979|P2|STARTED|Enrollment||306
973950|NCT00314951|2356980|P1|STARTED|Enrollment||323
973951|NCT00315055|2356992|P2|NOT COMPLETED|Overall Study||5
973952|NCT00315055|2356993|P1|NOT COMPLETED|Overall Study||3
973953|NCT00315055|2356992|P2|COMPLETED|Overall Study||150
973954|NCT00315055|2356993|P1|COMPLETED|Overall Study||152
973955|NCT00315055|2356992|P2|STARTED|Overall Study||155
973956|NCT00315055|2356993|P1|STARTED|Overall Study||155
973957|NCT00315120|2357013|P4|NOT COMPLETED|Overall Study||0
973958|NCT00315120|2357014|P3|NOT COMPLETED|Overall Study||0
973959|NCT00315120|2357015|P2|NOT COMPLETED|Overall Study||0
973960|NCT00315120|2357016|P1|NOT COMPLETED|Overall Study||0
973961|NCT00315120|2357013|P4|COMPLETED|Overall Study||107
973962|NCT00315120|2357014|P3|COMPLETED|Overall Study||115
973963|NCT00315120|2357015|P2|COMPLETED|Overall Study||118
973964|NCT00315120|2357016|P1|COMPLETED|Overall Study||115
973965|NCT00315120|2357013|P4|STARTED|Overall Study||107
973966|NCT00315120|2357014|P3|STARTED|Overall Study||115
973967|NCT00315120|2357015|P2|STARTED|Overall Study||118
973968|NCT00315120|2357016|P1|STARTED|Overall Study||115
973969|NCT00315146|2357078|P4|NOT COMPLETED|Overall Study||0
973970|NCT00315146|2357079|P3|NOT COMPLETED|Overall Study||2
973971|NCT00315146|2357080|P2|NOT COMPLETED|Overall Study||3
973972|NCT00315146|2357081|P1|NOT COMPLETED|Overall Study||2
973973|NCT00315146|2357078|P4|COMPLETED|Overall Study||22
973974|NCT00315146|2357079|P3|COMPLETED|Overall Study||20
973975|NCT00315146|2357080|P2|COMPLETED|Overall Study||19
973976|NCT00315146|2357081|P1|COMPLETED|Overall Study||20
973977|NCT00315146|2357078|P4|STARTED|Overall Study||22
973978|NCT00315146|2357079|P3|STARTED|Overall Study||22
973979|NCT00315146|2357080|P2|STARTED|Overall Study||22
973980|NCT00315146|2357081|P1|STARTED|Overall Study||22
973981|NCT00315302|2357099|P4|NOT COMPLETED|Overall Study||3
973982|NCT00315302|2357100|P3|NOT COMPLETED|Overall Study||2
973983|NCT00315302|2357101|P2|NOT COMPLETED|Overall Study||2
973984|NCT00315302|2357102|P1|NOT COMPLETED|Overall Study||6
973985|NCT00315302|2357099|P4|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|31
973986|NCT00315302|2357100|P3|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|24
973987|NCT00315302|2357101|P2|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|88
973988|NCT00315302|2357102|P1|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|84
973989|NCT00315302|2357099|P4|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|11
973990|NCT00315302|2357100|P3|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|9
973991|NCT00315302|2357101|P2|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|13
973992|NCT00315302|2357102|P1|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|16
973993|NCT00315302|2357099|P4|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|31
973994|NCT00315302|2357100|P3|18 Week Primary Outcome Visit|Overall Study||24
973995|NCT00315302|2357101|P2|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|88
973996|NCT00315302|2357102|P1|18 Week Primary Outcome Visit|Overall Study||84
973997|NCT00315302|2357099|P4|10 Week Visit|Overall Study||29
973998|NCT00315302|2357100|P3|10 Week Visit|Overall Study||24
973999|NCT00315302|2357101|P2|10 Week Visit|Overall Study||85
974000|NCT00315302|2357102|P1|10 Week Visit|Overall Study|Can be higher as includes subjects who may have missed the 5 week visit|86
974001|NCT00315302|2357099|P4|5 Week Visit|Overall Study||30
974002|NCT00315302|2357100|P3|5 Week Visit|Overall Study||26
974003|NCT00315302|2357101|P2|5 Week Visit|Overall Study||86
974004|NCT00315302|2357102|P1|5 Week Visit|Overall Study||85
974005|NCT00315302|2357099|P4|STARTED|Overall Study||34
974006|NCT00315302|2357100|P3|STARTED|Overall Study||26
974007|NCT00315302|2357101|P2|STARTED|Overall Study||90
974008|NCT00315302|2357102|P1|STARTED|Overall Study||90
974009|NCT00315328|2357148|P4|NOT COMPLETED|Overall Study||2
974010|NCT00315328|2357149|P3|NOT COMPLETED|Overall Study||5
974011|NCT00315328|2357150|P2|NOT COMPLETED|Overall Study||7
974012|NCT00315328|2357151|P1|NOT COMPLETED|Overall Study||14
974013|NCT00315328|2357148|P4|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|20
974014|NCT00315328|2357149|P3|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|13
974015|NCT00315328|2357150|P2|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|88
974016|NCT00315328|2357151|P1|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|84
974017|NCT00315328|2357148|P4|5 Week Visit|Overall Study||19
974018|NCT00315328|2357149|P3|5 Week Visit|Overall Study||17
974019|NCT00315328|2357150|P2|5 Week Visit|Overall Study||89
974020|NCT00315328|2357151|P1|5 Week Visit|Overall Study||91
974021|NCT00315328|2357148|P4|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|22
974022|NCT00315328|2357149|P3|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|18
974023|NCT00315328|2357150|P2|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|95
974024|NCT00315328|2357151|P1|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|98
974025|NCT00315341|2357219|P2|NOT COMPLETED|Overall Study||138
974026|NCT00315341|2357220|P1|NOT COMPLETED|Overall Study||400
974027|NCT00315341|2357219|P2|COMPLETED|Overall Study||391
974028|NCT00315341|2357220|P1|COMPLETED|Overall Study||340
974029|NCT00315341|2357219|P2|STARTED|Overall Study||529
974030|NCT00315341|2357220|P1|STARTED|Overall Study||740
974031|NCT00315445|2357229|P3|NOT COMPLETED|Overall Study||24
974032|NCT00315445|2357230|P2|NOT COMPLETED|Overall Study||16
974033|NCT00315445|2357231|P1|NOT COMPLETED|Overall Study||27
974034|NCT00315445|2357229|P3|COMPLETED|Overall Study||22
974035|NCT00315445|2357230|P2|COMPLETED|Overall Study||27
974036|NCT00315445|2357231|P1|COMPLETED|Overall Study||18
974037|NCT00315445|2357229|P3|STARTED|Overall Study||46
974038|NCT00315445|2357230|P2|STARTED|Overall Study||43
974039|NCT00315445|2357231|P1|STARTED|Overall Study||45
974040|NCT00315458|2357304|P4|NOT COMPLETED|Overall Study||29
974041|NCT00315458|2357305|P3|NOT COMPLETED|Overall Study||52
974042|NCT00315458|2357306|P2|NOT COMPLETED|Overall Study||12
974043|NCT00315458|2357307|P1|NOT COMPLETED|Overall Study||3
974044|NCT00315458|2357304|P4|COMPLETED|Overall Study||10
974045|NCT00315458|2357305|P3|COMPLETED|Overall Study||107
974046|NCT00315458|2357306|P2|COMPLETED|Overall Study||44
974047|NCT00315458|2357307|P1|COMPLETED|Overall Study||48
974048|NCT00315458|2357304|P4|STARTED|Overall Study||39
974049|NCT00315458|2357305|P3|STARTED|Overall Study||159
974050|NCT00315458|2357306|P2|STARTED|Overall Study||56
974051|NCT00315458|2357307|P1|STARTED|Overall Study||51
974052|NCT00315588|2357317|P1|NOT COMPLETED|Overall Study||0
974053|NCT00315588|2357317|P1|COMPLETED|Overall Study||7
974054|NCT00315588|2357317|P1|STARTED|Overall Study||7
974055|NCT00315614|2357324|P1|NOT COMPLETED|Overall Study||0
974056|NCT00315614|2357324|P1|COMPLETED|Overall Study||3
974057|NCT00315614|2357324|P1|STARTED|Overall Study||3
974058|NCT00315627|2357331|P1|NOT COMPLETED|Overall Study||0
974059|NCT00315627|2357331|P1|COMPLETED|Overall Study||3
974060|NCT00315627|2357331|P1|STARTED|Overall Study||3
974061|NCT00315705|2357341|P1|NOT COMPLETED|Phase 2||25
974062|NCT00315705|2357341|P1|COMPLETED|Phase 2|No Phase 2 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
974063|NCT00315705|2357341|P1|STARTED|Phase 2|Phase 1 and phase 2 are separate populations|25
974064|NCT00315705|2357341|P1|NOT COMPLETED|Phase 1||25
974065|NCT00315705|2357341|P1|COMPLETED|Phase 1|No Phase 1 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
974066|NCT00315705|2357341|P1|STARTED|Phase 1||25
974067|NCT00315731|2357378|P1|NOT COMPLETED|Overall Study||6
974068|NCT00315731|2357378|P1|COMPLETED|Overall Study||9
974069|NCT00315731|2357378|P1|STARTED|Overall Study||15
974070|NCT00315822|2357406|P2|NOT COMPLETED|Overall Study||0
974071|NCT00315822|2357407|P1|NOT COMPLETED|Overall Study||0
974072|NCT00315822|2357406|P2|COMPLETED|Overall Study||202
974073|NCT00315822|2357407|P1|COMPLETED|Overall Study||198
974074|NCT00315822|2357406|P2|STARTED|Overall Study||202
974075|NCT00315822|2357407|P1|STARTED|Overall Study||198
974076|NCT00315939|2357415|P2|NOT COMPLETED|Admission 3 (3 Months)||2
974077|NCT00315939|2357416|P1|NOT COMPLETED|Admission 3 (3 Months)||4
974078|NCT00315939|2357415|P2|COMPLETED|Admission 3 (3 Months)||49
974079|NCT00315939|2357416|P1|COMPLETED|Admission 3 (3 Months)||48
974080|NCT00315939|2357415|P2|STARTED|Admission 3 (3 Months)||51
974081|NCT00315939|2357416|P1|STARTED|Admission 3 (3 Months)||52
974082|NCT00315939|2357415|P2|NOT COMPLETED|Admission 2 (3 Months)||4
974083|NCT00315939|2357416|P1|NOT COMPLETED|Admission 2 (3 Months)||4
974084|NCT00315939|2357415|P2|COMPLETED|Admission 2 (3 Months)||51
974085|NCT00315939|2357416|P1|COMPLETED|Admission 2 (3 Months)||52
974086|NCT00315939|2357415|P2|STARTED|Admission 2 (3 Months)||55
974087|NCT00315939|2357416|P1|STARTED|Admission 2 (3 Months)||56
974088|NCT00315939|2357415|P2|NOT COMPLETED|Admission 1 (3 Months)||6
974089|NCT00315939|2357416|P1|NOT COMPLETED|Admission 1 (3 Months)||3
974090|NCT00315939|2357415|P2|COMPLETED|Admission 1 (3 Months)||55
974091|NCT00315939|2357416|P1|COMPLETED|Admission 1 (3 Months)||56
974092|NCT00315939|2357415|P2|STARTED|Admission 1 (3 Months)||61
974093|NCT00315939|2357416|P1|STARTED|Admission 1 (3 Months)||59
974094|NCT00316004|2357425|P3|NOT COMPLETED|Overall Study||21
974095|NCT00316004|2357426|P2|NOT COMPLETED|Overall Study||14
974096|NCT00316004|2357427|P1|NOT COMPLETED|Overall Study||14
974097|NCT00316004|2357425|P3|COMPLETED|Overall Study||582
974098|NCT00316004|2357426|P2|COMPLETED|Overall Study||341
974099|NCT00316004|2357427|P1|COMPLETED|Overall Study||359
974100|NCT00316004|2357425|P3|STARTED|Overall Study||603
974101|NCT00316004|2357426|P2|STARTED|Overall Study||355
974102|NCT00316004|2357427|P1|STARTED|Overall Study||373
974103|NCT00316017|2357483|P3|NOT COMPLETED|Overall Study||19
974104|NCT00316017|2357484|P2|NOT COMPLETED|Overall Study||13
974105|NCT00316017|2357485|P1|NOT COMPLETED|Overall Study||11
974106|NCT00316017|2357483|P3|COMPLETED|Overall Study||376
974107|NCT00316017|2357484|P2|COMPLETED|Overall Study||256
974108|NCT00316017|2357485|P1|COMPLETED|Overall Study||220
974109|NCT00316017|2357483|P3|STARTED|Overall Study|19 of 19 not complete due to BONG|395
974110|NCT00316017|2357484|P2|STARTED|Overall Study|12 of 13 not completed due to BONG; 1 not completed was a prisoner who was excluded|269
974111|NCT00316017|2357485|P1|STARTED|Overall Study|"11 of 11 not completed due to Bag Opened Not Given (BONG)"|231
974112|NCT00316082|2357561|P5|NOT COMPLETED|Overall Study||26
974113|NCT00316082|2357562|P4|NOT COMPLETED|Overall Study||26
974114|NCT00316082|2357563|P3|NOT COMPLETED|Overall Study||27
974115|NCT00316082|2357564|P2|NOT COMPLETED|Overall Study||22
974116|NCT00316082|2357565|P1|NOT COMPLETED|Overall Study||33
974117|NCT00316082|2357561|P5|COMPLETED|Overall Study||48
974118|NCT00316082|2357562|P4|COMPLETED|Overall Study||46
974119|NCT00316082|2357563|P3|COMPLETED|Overall Study||44
974120|NCT00316082|2357564|P2|COMPLETED|Overall Study||52
974121|NCT00316082|2357565|P1|COMPLETED|Overall Study||41
974122|NCT00316082|2357561|P5|Completed Study Without Being Rescued|Overall Study||31
974123|NCT00316082|2357562|P4|Completed Study Without Being Rescued|Overall Study||27
974124|NCT00316082|2357563|P3|Completed Study Without Being Rescued|Overall Study||29
974125|NCT00316082|2357564|P2|Completed Study Without Being Rescued|Overall Study||35
974126|NCT00316082|2357565|P1|Completed Study Without Being Rescued|Overall Study||25
974127|NCT00316082|2357561|P5|STARTED|Overall Study||74
974128|NCT00316082|2357562|P4|STARTED|Overall Study||72
974129|NCT00316082|2357563|P3|STARTED|Overall Study||71
974130|NCT00316082|2357564|P2|STARTED|Overall Study||74
974131|NCT00316082|2357565|P1|STARTED|Overall Study||74
974132|NCT00316121|2357595|P2|NOT COMPLETED|Overall Study||9
974133|NCT00316121|2357596|P1|NOT COMPLETED|Overall Study||22
974134|NCT00316121|2357595|P2|COMPLETED|Overall Study||37
974135|NCT00316121|2357596|P1|COMPLETED|Overall Study||70
974136|NCT00316121|2357595|P2|STARTED|Overall Study||46
974137|NCT00316121|2357596|P1|STARTED|Overall Study||92
974138|NCT00316173|2357604|P2|NOT COMPLETED|Treatment Phase||42
974139|NCT00316173|2357605|P1|NOT COMPLETED|Treatment Phase||0
974140|NCT00316173|2357604|P2|COMPLETED|Treatment Phase||13
974141|NCT00316173|2357605|P1|COMPLETED|Treatment Phase||0
974142|NCT00316173|2357604|P2|STARTED|Treatment Phase||55
974143|NCT00316173|2357605|P1|STARTED|Treatment Phase||0
974144|NCT00316173|2357604|P2|NOT COMPLETED|Run-in Phase||0
974145|NCT00316173|2357605|P1|NOT COMPLETED|Run-in Phase||7
974146|NCT00316173|2357604|P2|COMPLETED|Run-in Phase||0
974147|NCT00316173|2357605|P1|COMPLETED|Run-in Phase||15
974148|NCT00316173|2357604|P2|STARTED|Run-in Phase||0
974149|NCT00316173|2357605|P1|STARTED|Run-in Phase||22
974150|NCT00316186|2357616|P1|NOT COMPLETED|Overall Study||12
974151|NCT00316186|2357616|P1|COMPLETED|Overall Study||21
974152|NCT00316186|2357616|P1|STARTED|Overall Study||33
974153|NCT00316199|2357628|P1|NOT COMPLETED|Overall Study||12
974154|NCT00316199|2357628|P1|COMPLETED|Overall Study||48
974155|NCT00316199|2357628|P1|STARTED|Overall Study||60
974156|NCT00316225|2357636|P1|NOT COMPLETED|Overall Study||25
974157|NCT00316225|2357636|P1|COMPLETED|Overall Study||6
974158|NCT00316225|2357636|P1|STARTED|Overall Study||31
974159|NCT00316264|2357648|P3|NOT COMPLETED|Overall Study||6
974160|NCT00316264|2357649|P2|NOT COMPLETED|Overall Study||7
974161|NCT00316264|2357650|P1|NOT COMPLETED|Overall Study||6
974162|NCT00316264|2357648|P3|COMPLETED|Overall Study||87
974163|NCT00316264|2357649|P2|COMPLETED|Overall Study||77
974164|NCT00316264|2357650|P1|COMPLETED|Overall Study||77
974165|NCT00316264|2357648|P3|STARTED|Overall Study||93
974166|NCT00316264|2357649|P2|STARTED|Overall Study||84
974167|NCT00316264|2357650|P1|STARTED|Overall Study||83
974168|NCT00316277|2357720|P2|NOT COMPLETED|Phase 2 (24 Weeks)||19
974169|NCT00316277|2357721|P1|NOT COMPLETED|Phase 2 (24 Weeks)||19
974170|NCT00316277|2357720|P2|COMPLETED|Phase 2 (24 Weeks)||161
974171|NCT00316277|2357721|P1|COMPLETED|Phase 2 (24 Weeks)||161
974172|NCT00316277|2357720|P2|STARTED|Phase 2 (24 Weeks)||180
974173|NCT00316277|2357721|P1|STARTED|Phase 2 (24 Weeks)||180
974174|NCT00316277|2357720|P2|NOT COMPLETED|Phase 1 (12 Weeks)||300
974175|NCT00316277|2357721|P1|NOT COMPLETED|Phase 1 (12 Weeks)||310
974176|NCT00316277|2357720|P2|COMPLETED|Phase 1 (12 Weeks)||24
974177|NCT00316277|2357721|P1|COMPLETED|Phase 1 (12 Weeks)||19
974178|NCT00316277|2357720|P2|STARTED|Phase 1 (12 Weeks)||324
974179|NCT00316277|2357721|P1|STARTED|Phase 1 (12 Weeks)||329
974180|NCT00316303|2357741|P2|NOT COMPLETED|Overall Study||16
974181|NCT00316303|2357742|P1|NOT COMPLETED|Overall Study||11
974182|NCT00316303|2357741|P2|COMPLETED|Overall Study||102
974183|NCT00316303|2357742|P1|COMPLETED|Overall Study||107
974184|NCT00316303|2357741|P2|STARTED|Overall Study||118
974185|NCT00316303|2357742|P1|STARTED|Overall Study||118
974186|NCT00316355|2357758|P2|NOT COMPLETED|Overall Study||7
974187|NCT00316355|2357759|P1|NOT COMPLETED|Overall Study||5
974188|NCT00316355|2357758|P2|COMPLETED|Overall Study||12
974189|NCT00316355|2357759|P1|COMPLETED|Overall Study||10
974190|NCT00316355|2357758|P2|Started Treatment|Overall Study||18
974191|NCT00316355|2357759|P1|Started Treatment|Overall Study||12
974192|NCT00316355|2357758|P2|STARTED|Overall Study||19
974193|NCT00316355|2357759|P1|STARTED|Overall Study||15
974194|NCT00316693|2357769|P2|NOT COMPLETED|Overall Study||85
974195|NCT00316693|2357770|P1|NOT COMPLETED|Overall Study||77
974196|NCT00316693|2357769|P2|COMPLETED|Overall Study||436
974197|NCT00316693|2357770|P1|COMPLETED|Overall Study||442
974198|NCT00316693|2357769|P2|STARTED|Overall Study||521
974199|NCT00316693|2357770|P1|STARTED|Overall Study||519
974200|NCT00316706|2357812|P2|NOT COMPLETED|Overall Study||48
974201|NCT00316706|2357813|P1|NOT COMPLETED|Overall Study||38
974202|NCT00316706|2357812|P2|COMPLETED|Overall Study|Subjects in Havrix group that completed the study at Month 24|571
974203|NCT00316706|2357813|P1|COMPLETED|Overall Study|Subjects in Cervarix group that completed the study at Month 48|588
974204|NCT00316706|2357812|P2|STARTED|Overall Study||619
974205|NCT00316706|2357813|P1|STARTED|Overall Study||626
974206|NCT00316719|2357829|P2|NOT COMPLETED|Overall Study||6
974207|NCT00316719|2357830|P1|NOT COMPLETED|Overall Study||2
974208|NCT00316719|2357829|P2|COMPLETED|Overall Study||47
974209|NCT00316719|2357830|P1|COMPLETED|Overall Study||50
974210|NCT00316719|2357829|P2|STARTED|Overall Study||53
974211|NCT00316719|2357830|P1|STARTED|Overall Study||52
974212|NCT00324233|2357856|P2|NOT COMPLETED|Second Period||7
974213|NCT00324233|2357857|P1|NOT COMPLETED|Second Period||5
974214|NCT00324233|2357856|P2|COMPLETED|Second Period||11
974215|NCT00324233|2357857|P1|COMPLETED|Second Period||12
974216|NCT00324233|2357856|P2|STARTED|Second Period||18
974217|NCT00324233|2357857|P1|STARTED|Second Period||17
974218|NCT00324233|2357856|P2|NOT COMPLETED|First Period||0
974219|NCT00324233|2357857|P1|NOT COMPLETED|First Period||1
974220|NCT00324233|2357856|P2|COMPLETED|First Period||18
974221|NCT00324233|2357857|P1|COMPLETED|First Period||17
974222|NCT00324233|2357856|P2|STARTED|First Period||18
974223|NCT00324233|2357857|P1|STARTED|First Period||18
974224|NCT00324259|2357865|P2|NOT COMPLETED|Overall Study||0
974225|NCT00324259|2357866|P1|NOT COMPLETED|Overall Study||0
974226|NCT00324259|2357865|P2|COMPLETED|Overall Study||32
974227|NCT00324259|2357866|P1|COMPLETED|Overall Study||34
974228|NCT00324259|2357865|P2|STARTED|Overall Study||32
974229|NCT00324259|2357866|P1|STARTED|Overall Study||34
974230|NCT00324272|2357889|P4|NOT COMPLETED|Overall Study||0
974231|NCT00324272|2357890|P3|NOT COMPLETED|Overall Study||0
974232|NCT00324272|2357891|P2|NOT COMPLETED|Overall Study||0
974233|NCT00324272|2357892|P1|NOT COMPLETED|Overall Study||0
974234|NCT00324272|2357889|P4|COMPLETED|Overall Study||18
974235|NCT00324272|2357890|P3|COMPLETED|Overall Study||18
974236|NCT00324272|2357891|P2|COMPLETED|Overall Study||20
974237|NCT00324272|2357892|P1|COMPLETED|Overall Study||18
974238|NCT00324272|2357889|P4|STARTED|Overall Study||18
974239|NCT00324272|2357890|P3|STARTED|Overall Study||18
974240|NCT00324272|2357891|P2|STARTED|Overall Study||20
974241|NCT00324272|2357892|P1|STARTED|Overall Study||18
974242|NCT00324350|2357928|P2|NOT COMPLETED|Overall Study||0
974243|NCT00324350|2357929|P1|NOT COMPLETED|Overall Study||0
974244|NCT00324350|2357928|P2|COMPLETED|Overall Study||3632
974245|NCT00324350|2357929|P1|COMPLETED|Overall Study||3655
974246|NCT00324350|2357928|P2|Falls Follow-Up|Overall Study||3418
974247|NCT00324350|2357929|P1|Falls Follow-Up|Overall Study||3364
974248|NCT00324350|2357928|P2|Non-Vertebral Fracture Follow-Up|Overall Study||3632
974249|NCT00324350|2357929|P1|Non-Vertebral Fracture Follow-Up|Overall Study||3655
974250|NCT00324350|2357928|P2|STARTED|Overall Study||3632
974251|NCT00324350|2357929|P1|STARTED|Overall Study||3655
974252|NCT00324415|2357939|P1|NOT COMPLETED|Overall Study||0
974253|NCT00324415|2357939|P1|COMPLETED|Overall Study||45
974254|NCT00324415|2357939|P1|STARTED|Overall Study||45
974255|NCT00325468|2357957|P5|NOT COMPLETED|Overall Study||8
974256|NCT00325468|2357958|P4|NOT COMPLETED|Overall Study||34
974257|NCT00325468|2357959|P3|NOT COMPLETED|Overall Study||4
974258|NCT00325468|2357960|P2|NOT COMPLETED|Overall Study||5
974259|NCT00325468|2357961|P1|NOT COMPLETED|Overall Study||11
974260|NCT00325468|2357957|P5|COMPLETED|Overall Study||14
974261|NCT00325468|2357958|P4|COMPLETED|Overall Study||90
974262|NCT00325468|2357959|P3|COMPLETED|Overall Study||10
974263|NCT00325468|2357960|P2|COMPLETED|Overall Study||12
974264|NCT00325468|2357961|P1|COMPLETED|Overall Study||12
974265|NCT00325468|2357957|P5|STARTED|Overall Study||22
974266|NCT00325468|2357958|P4|STARTED|Overall Study||124
974267|NCT00325468|2357959|P3|STARTED|Overall Study||14
974268|NCT00325468|2357960|P2|STARTED|Overall Study||17
974269|NCT00325468|2357961|P1|STARTED|Overall Study||23
974270|NCT00325598|2357996|P2|NOT COMPLETED|Overall Study||0
974271|NCT00325598|2357997|P1|NOT COMPLETED|Overall Study||0
974272|NCT00325598|2357996|P2|COMPLETED|Overall Study||50
974273|NCT00325598|2357997|P1|COMPLETED|Overall Study||50
974274|NCT00325598|2357996|P2|STARTED|Overall Study||50
974275|NCT00325598|2357997|P1|STARTED|Overall Study||50
974276|NCT00325754|2358009|P2|NOT COMPLETED|Overall Study||1
974277|NCT00325754|2358010|P1|NOT COMPLETED|Overall Study||4
974278|NCT00325754|2358009|P2|COMPLETED|Overall Study||10
974279|NCT00325754|2358010|P1|COMPLETED|Overall Study||7
974280|NCT00325754|2358009|P2|STARTED|Overall Study||11
974281|NCT00325754|2358010|P1|STARTED|Overall Study||11
974282|NCT00325780|2358024|P1|NOT COMPLETED|Overall Study||155
974283|NCT00325780|2358024|P1|COMPLETED|Overall Study||1200
974284|NCT00325780|2358024|P1|Safety Population|Overall Study|Patients who received at least one dose of study treatment in this extension study.|1353
974285|NCT00325780|2358024|P1|STARTED|Overall Study||1355
974292|NCT00325897|2358054|P2|NOT COMPLETED|Overall Study||13
974293|NCT00325897|2358055|P1|NOT COMPLETED|Overall Study||12
974294|NCT00325897|2358054|P2|COMPLETED|Overall Study||559
974295|NCT00325897|2358055|P1|COMPLETED|Overall Study||558
974296|NCT00325897|2358054|P2|STARTED|Overall Study||572
974297|NCT00325897|2358055|P1|STARTED|Overall Study||570
974298|NCT00326001|2358075|P2|NOT COMPLETED|Overall Study||8
974299|NCT00326001|2358076|P1|NOT COMPLETED|Overall Study||7
974300|NCT00326001|2358075|P2|COMPLETED|Overall Study||219
974301|NCT00326001|2358076|P1|COMPLETED|Overall Study||229
974302|NCT00326001|2358075|P2|STARTED|Overall Study||227
974303|NCT00326001|2358076|P1|STARTED|Overall Study||236
974304|NCT00326118|2358090|P2|NOT COMPLETED|Year 5 Follow up||0
974305|NCT00326118|2358091|P1|NOT COMPLETED|Year 5 Follow up||0
974306|NCT00326118|2358090|P2|COMPLETED|Year 5 Follow up||78
974307|NCT00326118|2358091|P1|COMPLETED|Year 5 Follow up||217
974308|NCT00326118|2358090|P2|STARTED|Year 5 Follow up||78
974309|NCT00326118|2358091|P1|STARTED|Year 5 Follow up||217
974310|NCT00326118|2358090|P2|NOT COMPLETED|Year 4 Follow-up||0
974311|NCT00326118|2358091|P1|NOT COMPLETED|Year 4 Follow-up||0
974312|NCT00326118|2358090|P2|COMPLETED|Year 4 Follow-up||80
974313|NCT00326118|2358091|P1|COMPLETED|Year 4 Follow-up||228
974314|NCT00326118|2358090|P2|STARTED|Year 4 Follow-up||80
974315|NCT00326118|2358091|P1|STARTED|Year 4 Follow-up||228
974316|NCT00326118|2358090|P2|NOT COMPLETED|Year 3 Follow-up||0
974317|NCT00326118|2358091|P1|NOT COMPLETED|Year 3 Follow-up||0
974318|NCT00326118|2358090|P2|COMPLETED|Year 3 Follow-up||89
974319|NCT00326118|2358091|P1|COMPLETED|Year 3 Follow-up||256
974320|NCT00326118|2358090|P2|STARTED|Year 3 Follow-up||89
974321|NCT00326118|2358091|P1|STARTED|Year 3 Follow-up||256
974322|NCT00326118|2358090|P2|NOT COMPLETED|Year 2 Follow-up||0
974323|NCT00326118|2358091|P1|NOT COMPLETED|Year 2 Follow-up||0
974324|NCT00326118|2358090|P2|COMPLETED|Year 2 Follow-up||92
974325|NCT00326118|2358091|P1|COMPLETED|Year 2 Follow-up||270
974326|NCT00326118|2358090|P2|STARTED|Year 2 Follow-up||92
974327|NCT00326118|2358091|P1|STARTED|Year 2 Follow-up||270
974328|NCT00326118|2358090|P2|NOT COMPLETED|Year 1 Follow-up||0
974329|NCT00326118|2358091|P1|NOT COMPLETED|Year 1 Follow-up||0
974330|NCT00326118|2358090|P2|COMPLETED|Year 1 Follow-up||100
974331|NCT00326118|2358091|P1|COMPLETED|Year 1 Follow-up||295
974332|NCT00326118|2358090|P2|STARTED|Year 1 Follow-up||100
974333|NCT00326118|2358091|P1|STARTED|Year 1 Follow-up||295
974334|NCT00326118|2358090|P2|NOT COMPLETED|Active Phase||1
974335|NCT00326118|2358091|P1|NOT COMPLETED|Active Phase||4
974336|NCT00326118|2358090|P2|COMPLETED|Active Phase||108
974337|NCT00326118|2358091|P1|COMPLETED|Active Phase||320
974338|NCT00326118|2358090|P2|STARTED|Active Phase||109
974339|NCT00326118|2358091|P1|STARTED|Active Phase||324
974340|NCT00326170|2358125|P1|NOT COMPLETED|Overall Study||0
974341|NCT00326170|2358125|P1|COMPLETED|Overall Study||34
974342|NCT00326170|2358125|P1|STARTED|Overall Study||34
974343|NCT00326183|2358131|P2|NOT COMPLETED|Overall Study||83
974344|NCT00326183|2358132|P1|NOT COMPLETED|Overall Study||200
974345|NCT00326183|2358131|P2|COMPLETED|Overall Study||264
974346|NCT00326183|2358132|P1|COMPLETED|Overall Study||1253
974347|NCT00326183|2358131|P2|Postvaccination 2 Post-safety Follow-up|Overall Study||271
974348|NCT00326183|2358132|P1|Postvaccination 2 Post-safety Follow-up|Overall Study||1265
974349|NCT00326183|2358131|P2|Vaccination 2 + Safety Follow-up|Overall Study||292
974350|NCT00326183|2358132|P1|Vaccination 2 + Safety Follow-up|Overall Study||1301
974351|NCT00326183|2358131|P2|Postvaccination 1 Post-safety Follow-up|Overall Study||325
974352|NCT00326183|2358132|P1|Postvaccination 1 Post-safety Follow-up|Overall Study||1393
974353|NCT00326183|2358131|P2|Vaccination 1 + Safety Follow-up|Overall Study||347
974354|NCT00326183|2358132|P1|Vaccination 1 + Safety Follow-up|Overall Study||1453
974355|NCT00326183|2358131|P2|STARTED|Overall Study||347
974356|NCT00326183|2358132|P1|STARTED|Overall Study||1453
974357|NCT00326196|2358160|P2|NOT COMPLETED|Overall Study||0
974358|NCT00326196|2358161|P1|NOT COMPLETED|Overall Study||0
974359|NCT00326196|2358160|P2|COMPLETED|Overall Study||97
974360|NCT00326196|2358161|P1|COMPLETED|Overall Study||101
974361|NCT00326196|2358160|P2|STARTED|Overall Study||97
974362|NCT00326196|2358161|P1|STARTED|Overall Study||101
974383|NCT00326495|2358188|P1|NOT COMPLETED|Overall Study||5
974384|NCT00326495|2358188|P1|COMPLETED|Overall Study||46
974385|NCT00326495|2358188|P1|STARTED|Overall Study||51
974386|NCT00326599|2358197|P4|NOT COMPLETED|Overall Study||19
974387|NCT00326599|2358198|P3|NOT COMPLETED|Overall Study||53
974388|NCT00326599|2358199|P2|NOT COMPLETED|Overall Study||1
974389|NCT00326599|2358200|P1|NOT COMPLETED|Overall Study||6
974390|NCT00326599|2358197|P4|COMPLETED|Overall Study||10
974391|NCT00326599|2358198|P3|COMPLETED|Overall Study||5
974392|NCT00326599|2358199|P2|COMPLETED|Overall Study||2
974393|NCT00326599|2358200|P1|COMPLETED|Overall Study||0
974394|NCT00326599|2358197|P4|STARTED|Overall Study||29
974395|NCT00326599|2358198|P3|STARTED|Overall Study||58
974396|NCT00326599|2358199|P2|STARTED|Overall Study||3
974397|NCT00326599|2358200|P1|STARTED|Overall Study||6
974398|NCT00326612|2358221|P2|NOT COMPLETED|Overall Study||137
974399|NCT00326612|2358222|P1|NOT COMPLETED|Overall Study||129
974400|NCT00326612|2358221|P2|COMPLETED|Overall Study||42
974401|NCT00326612|2358222|P1|COMPLETED|Overall Study||50
974402|NCT00326612|2358221|P2|STARTED|Overall Study||179
974403|NCT00326612|2358222|P1|STARTED|Overall Study||179
974404|NCT00326716|2358242|P4|NOT COMPLETED|Infants||0
974405|NCT00326716|2358243|P3|NOT COMPLETED|Infants||0
974406|NCT00326716|2358244|P2|NOT COMPLETED|Infants||0
974407|NCT00326716|2358245|P1|NOT COMPLETED|Infants||0
974408|NCT00326716|2358242|P4|COMPLETED|Infants||20
974409|NCT00326716|2358243|P3|COMPLETED|Infants||20
974410|NCT00326716|2358244|P2|COMPLETED|Infants||0
974411|NCT00326716|2358245|P1|COMPLETED|Infants||0
974412|NCT00326716|2358242|P4|STARTED|Infants|All infants were followed. One mother withdrew consent pre-delivery and her infant was not followed.|20
974413|NCT00326716|2358243|P3|STARTED|Infants|All infants were followed.|20
974414|NCT00326716|2358244|P2|STARTED|Infants||0
974415|NCT00326716|2358245|P1|STARTED|Infants||0
974416|NCT00326716|2358242|P4|NOT COMPLETED|Pre-Natal Mothers||0
974417|NCT00326716|2358243|P3|NOT COMPLETED|Pre-Natal Mothers||0
974418|NCT00326716|2358244|P2|NOT COMPLETED|Pre-Natal Mothers||2
974419|NCT00326716|2358245|P1|NOT COMPLETED|Pre-Natal Mothers||1
974420|NCT00326716|2358242|P4|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
974421|NCT00326716|2358243|P3|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
974422|NCT00326716|2358244|P2|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
974423|NCT00326716|2358245|P1|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
974424|NCT00326716|2358242|P4|STARTED|Pre-Natal Mothers||0
974425|NCT00326716|2358243|P3|STARTED|Pre-Natal Mothers||0
974426|NCT00326716|2358244|P2|STARTED|Pre-Natal Mothers||21
974427|NCT00326716|2358245|P1|STARTED|Pre-Natal Mothers||20
974428|NCT00326781|2358317|P2|NOT COMPLETED|Overall Study||32
974429|NCT00326781|2358318|P1|NOT COMPLETED|Overall Study||42
974430|NCT00326781|2358317|P2|COMPLETED|Overall Study||298
974431|NCT00326781|2358318|P1|COMPLETED|Overall Study||302
974432|NCT00326781|2358317|P2|STARTED|Overall Study||330
974433|NCT00326781|2358318|P1|STARTED|Overall Study||344
974434|NCT00326872|2358326|P1|NOT COMPLETED|Overall Study||0
974435|NCT00326872|2358326|P1|COMPLETED|Overall Study||26
974436|NCT00326872|2358326|P1|STARTED|Overall Study||26
974437|NCT00326885|2358335|P1|NOT COMPLETED|Overall Study||7
974438|NCT00326885|2358335|P1|COMPLETED|Overall Study||25
974439|NCT00326885|2358335|P1|STARTED|Overall Study||32
974440|NCT00326898|2358347|P3|NOT COMPLETED|Overall Study||203
974441|NCT00326898|2358348|P2|NOT COMPLETED|Overall Study||343
974442|NCT00326898|2358349|P1|NOT COMPLETED|Overall Study||351
974443|NCT00326898|2358347|P3|COMPLETED|Overall Study||444
974444|NCT00326898|2358348|P2|COMPLETED|Overall Study||306
974445|NCT00326898|2358349|P1|COMPLETED|Overall Study||296
974446|NCT00326898|2358347|P3|Patients With >=1 Follow-up MUGA Scan|Overall Study||580
974447|NCT00326898|2358348|P2|Patients With >=1 Follow-up MUGA Scan|Overall Study||510
974448|NCT00326898|2358349|P1|Patients With >=1 Follow-up MUGA Scan|Overall Study||513
974449|NCT00326898|2358347|P3|Patients With Clear Cell Histology|Overall Study||540
974450|NCT00326898|2358348|P2|Patients With Clear Cell Histology|Overall Study||540
974451|NCT00326898|2358349|P1|Patients With Clear Cell Histology|Overall Study||542
974452|NCT00326898|2358347|P3|Patients With Toxicity Data|Overall Study||626
974453|NCT00326898|2358348|P2|Patients With Toxicity Data|Overall Study||628
974454|NCT00326898|2358349|P1|Patients With Toxicity Data|Overall Study||625
974455|NCT00326898|2358347|P3|STARTED|Overall Study||647
974456|NCT00326898|2358348|P2|STARTED|Overall Study||649
974457|NCT00326898|2358349|P1|STARTED|Overall Study||647
974458|NCT00326911|2358368|P2|NOT COMPLETED|Overall Study||2
974459|NCT00326911|2358369|P1|NOT COMPLETED|Overall Study||1
974460|NCT00326911|2358368|P2|COMPLETED|Overall Study|This number reflects all treated patients.|29
974461|NCT00326911|2358369|P1|COMPLETED|Overall Study|This number reflects all treated patients.|29
974462|NCT00326911|2358368|P2|STARTED|Overall Study|This number reflects all randomized patients.|31
974463|NCT00326911|2358369|P1|STARTED|Overall Study|This number reflects all randomized patients.|30
974464|NCT00326950|2358419|P1|NOT COMPLETED|Overall Study||1
974465|NCT00326950|2358419|P1|COMPLETED|Overall Study||14
974466|NCT00326950|2358419|P1|STARTED|Overall Study||15
974467|NCT00326963|2358424|P1|NOT COMPLETED|Overall Study||33
974468|NCT00326963|2358424|P1|COMPLETED|Overall Study||107
974469|NCT00326963|2358424|P1|STARTED|Overall Study||140
974470|NCT00327015|2358448|P4|NOT COMPLETED|Overall Study||109
974471|NCT00327015|2358449|P3|NOT COMPLETED|Overall Study||126
974472|NCT00327015|2358450|P2|NOT COMPLETED|Overall Study||92
974473|NCT00327015|2358451|P1|NOT COMPLETED|Overall Study||91
974474|NCT00327015|2358448|P4|COMPLETED|Overall Study||219
974475|NCT00327015|2358449|P3|COMPLETED|Overall Study||209
974476|NCT00327015|2358450|P2|COMPLETED|Overall Study||231
974477|NCT00327015|2358451|P1|COMPLETED|Overall Study||229
974478|NCT00327015|2358448|P4|Completed Study Without Being Rescued|Overall Study||144
974479|NCT00327015|2358449|P3|Completed Study Without Being Rescued|Overall Study||113
974480|NCT00327015|2358450|P2|Completed Study Without Being Rescued|Overall Study||177
974481|NCT00327015|2358451|P1|Completed Study Without Being Rescued|Overall Study||179
974482|NCT00327015|2358448|P4|STARTED|Overall Study||328
974483|NCT00327015|2358449|P3|STARTED|Overall Study||335
974484|NCT00327015|2358450|P2|STARTED|Overall Study||323
974485|NCT00327015|2358451|P1|STARTED|Overall Study||320
974486|NCT00327171|2358495|P2|NOT COMPLETED|Overall Study||109
974487|NCT00327171|2358496|P1|NOT COMPLETED|Overall Study||108
974488|NCT00327171|2358495|P2|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|0
974489|NCT00327171|2358496|P1|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|1
974490|NCT00327171|2358495|P2|STARTED|Overall Study||109
974491|NCT00327171|2358496|P1|STARTED|Overall Study||109
974492|NCT00327340|2358526|P2|NOT COMPLETED|Overall Study||30
974493|NCT00327340|2358527|P1|NOT COMPLETED|Overall Study||15
974494|NCT00327340|2358526|P2|COMPLETED|Overall Study||16
974495|NCT00327340|2358527|P1|COMPLETED|Overall Study||8
974496|NCT00327340|2358526|P2|STARTED|Overall Study||46
974497|NCT00327340|2358527|P1|STARTED|Overall Study||23
974498|NCT00327392|2358539|P1|NOT COMPLETED|Overall Study||0
974499|NCT00327392|2358539|P1|COMPLETED|Overall Study||123
974500|NCT00327392|2358539|P1|STARTED|Overall Study||123
974501|NCT00327444|2358545|P2|NOT COMPLETED|Open Label Treatment (OL) Period||10
974502|NCT00327444|2358546|P1|NOT COMPLETED|Open Label Treatment (OL) Period||11
974503|NCT00327444|2358545|P2|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
974504|NCT00327444|2358546|P1|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
974505|NCT00327444|2358545|P2|ONGOING TREATMENT|Open Label Treatment (OL) Period||0
974506|NCT00327444|2358546|P1|ONGOING TREATMENT|Open Label Treatment (OL) Period||1
974507|NCT00327444|2358545|P2|STARTED|Open Label Treatment (OL) Period||10
974508|NCT00327444|2358546|P1|STARTED|Open Label Treatment (OL) Period||11
974509|NCT00327444|2358545|P2|NOT COMPLETED|Double Blind Treatment (DB) Period||29
974510|NCT00327444|2358546|P1|NOT COMPLETED|Double Blind Treatment (DB) Period||26
974511|NCT00327444|2358545|P2|COMPLETED|Double Blind Treatment (DB) Period||0
974512|NCT00327444|2358546|P1|COMPLETED|Double Blind Treatment (DB) Period||0
974513|NCT00327444|2358545|P2|SAFETY|Double Blind Treatment (DB) Period|Includes 1 from Placebo who received aflibercept in DB period|30
974514|NCT00327444|2358546|P1|SAFETY|Double Blind Treatment (DB) Period|Excludes one participant from the Placebo arm who received aflibercept in error in the DB period.|25
974515|NCT00327444|2358545|P2|STARTED|Double Blind Treatment (DB) Period||29
974516|NCT00327444|2358546|P1|STARTED|Double Blind Treatment (DB) Period||26
974517|NCT00327470|2358560|P2|NOT COMPLETED|Overall Study||63
974518|NCT00327470|2358561|P1|NOT COMPLETED|Overall Study||29
974519|NCT00327470|2358560|P2|COMPLETED|Overall Study||118
974520|NCT00327470|2358561|P1|COMPLETED|Overall Study||78
974521|NCT00327470|2358560|P2|Treated|Overall Study||179
974522|NCT00327470|2358561|P1|Treated|Overall Study||107
974523|NCT00327470|2358560|P2|STARTED|Overall Study||181
974524|NCT00327470|2358561|P1|STARTED|Overall Study||107
974525|NCT00327717|2358581|P2|NOT COMPLETED|Overall Study||14
974526|NCT00327717|2358582|P1|NOT COMPLETED|Overall Study||9
974527|NCT00327717|2358581|P2|COMPLETED|Overall Study||106
974528|NCT00327717|2358582|P1|COMPLETED|Overall Study||111
974529|NCT00327717|2358581|P2|STARTED|Overall Study||120
974530|NCT00327717|2358582|P1|STARTED|Overall Study||120
974531|NCT00313846|2358608|P2|NOT COMPLETED|Overall Study||11
974532|NCT00313846|2358609|P1|NOT COMPLETED|Overall Study||5
974533|NCT00313846|2358608|P2|COMPLETED|Overall Study||153
974534|NCT00313846|2358609|P1|COMPLETED|Overall Study||157
974535|NCT00313846|2358608|P2|STARTED|Overall Study|327 subjects were randomized: 1 subject was lost to follow-up (N = 326).|164
974536|NCT00313846|2358609|P1|STARTED|Overall Study||162
974537|NCT00313911|2358620|P2|NOT COMPLETED|Overall Study||41
974538|NCT00313911|2358621|P1|NOT COMPLETED|Overall Study||94
974539|NCT00313911|2358620|P2|COMPLETED|Overall Study||670
974540|NCT00313911|2358621|P1|COMPLETED|Overall Study||1328
974541|NCT00313911|2358620|P2|STARTED|Overall Study|A participant in this group mistakenly got Group 1 vaccine. N in outcomes adjusted accordingly.|711
974542|NCT00313911|2358621|P1|STARTED|Overall Study|N for outcomes adjusted to include participant in Group 2 that got vaccine assigned to this group.|1422
974543|NCT00314106|2358635|P2|NOT COMPLETED|Overall Study||0
974544|NCT00314106|2358636|P1|NOT COMPLETED|Overall Study||0
974545|NCT00314106|2358635|P2|COMPLETED|Overall Study||8
974546|NCT00314106|2358636|P1|COMPLETED|Overall Study||18
974547|NCT00314106|2358635|P2|STARTED|Overall Study||8
974548|NCT00314106|2358636|P1|STARTED|Overall Study||18
974549|NCT00314132|2358646|P2|NOT COMPLETED|Overall Study||18
974550|NCT00314132|2358647|P1|NOT COMPLETED|Overall Study||8
974551|NCT00314132|2358646|P2|COMPLETED|Overall Study||1583
974552|NCT00314132|2358647|P1|COMPLETED|Overall Study||395
974553|NCT00314132|2358646|P2|STARTED|Overall Study||1601
974554|NCT00314132|2358647|P1|STARTED|Overall Study||403
974555|NCT00314145|2358657|P2|NOT COMPLETED|Overall Study||29
974556|NCT00314145|2358658|P1|NOT COMPLETED|Overall Study||21
974557|NCT00314145|2358657|P2|COMPLETED|Overall Study||381
974558|NCT00314145|2358658|P1|COMPLETED|Overall Study||389
974559|NCT00314145|2358657|P2|STARTED|Overall Study||410
974560|NCT00314145|2358658|P1|STARTED|Overall Study||410
974561|NCT00314236|2358672|P2|NOT COMPLETED|Overall Study||2
974562|NCT00314236|2358673|P1|NOT COMPLETED|Overall Study||0
974563|NCT00314236|2358672|P2|COMPLETED|Overall Study||37
974564|NCT00314236|2358673|P1|COMPLETED|Overall Study||41
974565|NCT00314236|2358672|P2|STARTED|Overall Study||39
974566|NCT00314236|2358673|P1|STARTED|Overall Study||41
974567|NCT00314249|2358687|P2|NOT COMPLETED|Overall Study||163
974568|NCT00314249|2358688|P1|NOT COMPLETED|Overall Study||152
974569|NCT00314249|2358687|P2|COMPLETED|Overall Study||353
974570|NCT00314249|2358688|P1|COMPLETED|Overall Study||357
974571|NCT00314249|2358687|P2|STARTED|Overall Study||516
974572|NCT00314249|2358688|P1|STARTED|Overall Study||509
974573|NCT00314262|2358704|P1|NOT COMPLETED|Overall Study||5
974574|NCT00314262|2358704|P1|COMPLETED|Overall Study||7
974575|NCT00314262|2358704|P1|STARTED|Overall Study||12
974576|NCT00314327|2358710|P1|NOT COMPLETED|Overall Study||1
974577|NCT00314327|2358710|P1|COMPLETED|Overall Study||0
974578|NCT00314327|2358710|P1|STARTED|Overall Study||1
974579|NCT00314340|2358714|P1|NOT COMPLETED|Overall Study||1
974580|NCT00314340|2358714|P1|COMPLETED|Overall Study||11
974581|NCT00314340|2358714|P1|Placebo|Overall Study||12
974582|NCT00314340|2358714|P1|Hydrocodone Plus APAP|Overall Study||12
974583|NCT00314340|2358714|P1|ER Morphine|Overall Study||11
974584|NCT00314340|2358714|P1|STARTED|Overall Study||12
974585|NCT00314353|2358722|P2|NOT COMPLETED|Follow-up||0
974586|NCT00314353|2358723|P1|NOT COMPLETED|Follow-up||0
974587|NCT00314353|2358722|P2|COMPLETED|Follow-up||0
974588|NCT00314353|2358723|P1|COMPLETED|Follow-up||3
974589|NCT00314353|2358722|P2|STARTED|Follow-up||0
974590|NCT00314353|2358723|P1|STARTED|Follow-up|2 participants who completed 8 cycles plus 1 participant who did not complete 8 cycles therapy.|3
974591|NCT00314353|2358722|P2|NOT COMPLETED|Protocol Therapy (8 Cycles)||3
974592|NCT00314353|2358723|P1|NOT COMPLETED|Protocol Therapy (8 Cycles)||2
974593|NCT00314353|2358722|P2|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|0
974594|NCT00314353|2358723|P1|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|2
974595|NCT00314353|2358722|P2|STARTED|Protocol Therapy (8 Cycles)||3
974596|NCT00314353|2358723|P1|STARTED|Protocol Therapy (8 Cycles)||4
974597|NCT00314366|2358731|P2|NOT COMPLETED|Overall Study||0
974598|NCT00314366|2358732|P1|NOT COMPLETED|Overall Study||1
974599|NCT00314366|2358731|P2|COMPLETED|Overall Study||10
974600|NCT00314366|2358732|P1|COMPLETED|Overall Study||10
974601|NCT00314366|2358731|P2|STARTED|Overall Study||10
974602|NCT00314366|2358732|P1|STARTED|Overall Study||11
974603|NCT00319696|2358760|P1|NOT COMPLETED|Overall Study||60
974604|NCT00319696|2358760|P1|COMPLETED|Overall Study||56
974605|NCT00319696|2358760|P1|STARTED|Overall Study||116
974606|NCT00319735|2358784|P1|NOT COMPLETED|Overall Study||2
974607|NCT00319735|2358784|P1|COMPLETED|Overall Study||39
974608|NCT00319735|2358784|P1|STARTED|Overall Study||41
974609|NCT00319748|2358797|P1|NOT COMPLETED|Overall Study||0
974610|NCT00319748|2358797|P1|COMPLETED|Overall Study||13
974611|NCT00319748|2358797|P1|STARTED|Overall Study||13
974612|NCT00319982|2358809|P2|NOT COMPLETED|Overall Study||0
974613|NCT00319982|2358810|P1|NOT COMPLETED|Overall Study||1
974614|NCT00319982|2358809|P2|COMPLETED|Overall Study||20
974615|NCT00319982|2358810|P1|COMPLETED|Overall Study||18
974616|NCT00319982|2358809|P2|STARTED|Overall Study||20
974617|NCT00319982|2358810|P1|STARTED|Overall Study||19
974618|NCT00320112|2358830|P2|NOT COMPLETED|Overall Study||5
974619|NCT00320112|2358831|P1|NOT COMPLETED|Overall Study||8
974620|NCT00320112|2358830|P2|COMPLETED|Overall Study||114
974621|NCT00320112|2358831|P1|COMPLETED|Overall Study||117
974622|NCT00320112|2358830|P2|STARTED|Overall Study||119
974623|NCT00320112|2358831|P1|STARTED|Overall Study||125
974624|NCT00320190|2358845|P2|NOT COMPLETED|Long-term (12-month) Extension||2
974625|NCT00320190|2358846|P1|NOT COMPLETED|Long-term (12-month) Extension||9
974626|NCT00320190|2358845|P2|COMPLETED|Long-term (12-month) Extension||1
974627|NCT00320190|2358846|P1|COMPLETED|Long-term (12-month) Extension||2
974628|NCT00320190|2358845|P2|STARTED|Long-term (12-month) Extension||3
974629|NCT00320190|2358846|P1|STARTED|Long-term (12-month) Extension||11
974630|NCT00320190|2358845|P2|NOT COMPLETED|First 12 Months||10
974631|NCT00320190|2358846|P1|NOT COMPLETED|First 12 Months||8
974632|NCT00320190|2358845|P2|COMPLETED|First 12 Months||3
974633|NCT00320190|2358846|P1|COMPLETED|First 12 Months||11
974634|NCT00320190|2358845|P2|STARTED|First 12 Months||13
974635|NCT00320190|2358846|P1|STARTED|First 12 Months||19
974636|NCT00320216|2358869|P5|NOT COMPLETED|Overall Study||6
974637|NCT00320216|2358870|P4|NOT COMPLETED|Overall Study||3
974638|NCT00320216|2358871|P3|NOT COMPLETED|Overall Study||6
974639|NCT00320216|2358872|P2|NOT COMPLETED|Overall Study||10
974640|NCT00320216|2358873|P1|NOT COMPLETED|Overall Study||16
974641|NCT00320216|2358869|P5|COMPLETED|Overall Study||58
974642|NCT00320216|2358870|P4|COMPLETED|Overall Study||61
974643|NCT00320216|2358871|P3|COMPLETED|Overall Study||58
974644|NCT00320216|2358872|P2|COMPLETED|Overall Study||54
974645|NCT00320216|2358873|P1|COMPLETED|Overall Study||48
974646|NCT00320216|2358869|P5|STARTED|Overall Study||64
974647|NCT00320216|2358870|P4|STARTED|Overall Study||64
974648|NCT00320216|2358871|P3|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
974649|NCT00320216|2358872|P2|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
974650|NCT00320216|2358873|P1|STARTED|Overall Study||64
974651|NCT00320242|2358905|P2|NOT COMPLETED|Overall Study||4
974652|NCT00320242|2358906|P1|NOT COMPLETED|Overall Study||2
974653|NCT00320242|2358905|P2|COMPLETED|Overall Study||12
974654|NCT00320242|2358906|P1|COMPLETED|Overall Study||14
974655|NCT00320242|2358905|P2|STARTED|Overall Study||16
974656|NCT00320242|2358906|P1|STARTED|Overall Study||16
974657|NCT00320255|2358919|P6|NOT COMPLETED|Overall Study||0
974658|NCT00320255|2358920|P5|NOT COMPLETED|Overall Study||0
974659|NCT00320255|2358921|P4|NOT COMPLETED|Overall Study||8
974660|NCT00320255|2358922|P3|NOT COMPLETED|Overall Study||6
974661|NCT00320255|2358923|P2|NOT COMPLETED|Overall Study||7
974662|NCT00320255|2358924|P1|NOT COMPLETED|Overall Study||11
974663|NCT00320255|2358919|P6|COMPLETED|Overall Study||3
974664|NCT00320255|2358920|P5|COMPLETED|Overall Study||2
974665|NCT00320255|2358921|P4|COMPLETED|Overall Study||25
974666|NCT00320255|2358922|P3|COMPLETED|Overall Study||24
974667|NCT00320255|2358923|P2|COMPLETED|Overall Study||25
974668|NCT00320255|2358924|P1|COMPLETED|Overall Study||19
974669|NCT00320255|2358919|P6|Received Treatment|Overall Study||3
974670|NCT00320255|2358920|P5|Received Treatment|Overall Study||2
974671|NCT00320255|2358921|P4|Received Treatment|Overall Study||32
974672|NCT00320255|2358922|P3|Received Treatment|Overall Study||29
974673|NCT00320255|2358923|P2|Received Treatment|Overall Study||32
974674|NCT00320255|2358924|P1|Received Treatment|Overall Study||29
974675|NCT00320255|2358919|P6|STARTED|Overall Study||3
974676|NCT00320255|2358920|P5|STARTED|Overall Study||2
974677|NCT00320255|2358921|P4|STARTED|Overall Study||33
974678|NCT00320255|2358922|P3|STARTED|Overall Study||30
974679|NCT00320255|2358923|P2|STARTED|Overall Study||32
974680|NCT00320255|2358924|P1|STARTED|Overall Study||30
974681|NCT00320281|2359006|P2|NOT COMPLETED|Overall Study||0
974682|NCT00320281|2359007|P1|NOT COMPLETED|Overall Study||0
974683|NCT00320281|2359006|P2|COMPLETED|Overall Study||9
974684|NCT00320281|2359007|P1|COMPLETED|Overall Study||10
974685|NCT00320281|2359006|P2|STARTED|Overall Study||9
974686|NCT00320281|2359007|P1|STARTED|Overall Study||10
974687|NCT00320372|2359016|P2|NOT COMPLETED|Overall Study||163
974688|NCT00320372|2359017|P1|NOT COMPLETED|Overall Study||195
974689|NCT00320372|2359016|P2|COMPLETED|Overall Study||138
974690|NCT00320372|2359017|P1|COMPLETED|Overall Study||299
974691|NCT00320372|2359016|P2|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||0
974692|NCT00320372|2359017|P1|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||159
974693|NCT00320372|2359016|P2|VNS Therapy D-23 Original|Overall Study||0
974694|NCT00320372|2359017|P1|VNS Therapy D-23 Original|Overall Study||335
974695|NCT00320372|2359016|P2|STARTED|Overall Study||301
974696|NCT00320372|2359017|P1|STARTED|Overall Study||494
974697|NCT00320385|2359044|P2|NOT COMPLETED|Overall Study||22
974698|NCT00320385|2359045|P1|NOT COMPLETED|Overall Study||18
974699|NCT00320385|2359044|P2|COMPLETED|Overall Study||126
974700|NCT00320385|2359045|P1|COMPLETED|Overall Study||130
974701|NCT00320385|2359044|P2|STARTED|Overall Study||148
974702|NCT00320385|2359045|P1|STARTED|Overall Study||148
974703|NCT00320411|2359065|P1|NOT COMPLETED|Overall Study||4
974704|NCT00320411|2359065|P1|COMPLETED|Overall Study||58
974705|NCT00320411|2359065|P1|STARTED|Overall Study||62
974706|NCT00320489|2359088|P2|NOT COMPLETED|Overall Study||136
974707|NCT00320489|2359089|P1|NOT COMPLETED|Overall Study||145
974708|NCT00320489|2359088|P2|COMPLETED|Overall Study||124
974709|NCT00320489|2359089|P1|COMPLETED|Overall Study||119
974710|NCT00320489|2359088|P2|STARTED|Overall Study||260
974711|NCT00320489|2359089|P1|STARTED|Overall Study||264
974712|NCT00320515|2359145|P1|NOT COMPLETED|Overall Study||49
974713|NCT00320515|2359145|P1|COMPLETED|Overall Study||20
974714|NCT00320515|2359145|P1|STARTED|Overall Study||69
974715|NCT00320528|2359155|P3|NOT COMPLETED|Study Period III||106
974716|NCT00320528|2359156|P2|NOT COMPLETED|Study Period III||31
974717|NCT00320528|2359157|P1|NOT COMPLETED|Study Period III||87
974718|NCT00320528|2359155|P3|COMPLETED|Study Period III||2
974719|NCT00320528|2359156|P2|COMPLETED|Study Period III||0
974720|NCT00320528|2359157|P1|COMPLETED|Study Period III||0
974721|NCT00320528|2359155|P3|STARTED|Study Period III||108
974722|NCT00320528|2359156|P2|STARTED|Study Period III||31
974723|NCT00320528|2359157|P1|STARTED|Study Period III||87
974724|NCT00320528|2359155|P3|NOT COMPLETED|Study Period II||22
974725|NCT00320528|2359156|P2|NOT COMPLETED|Study Period II||10
974726|NCT00320528|2359157|P1|NOT COMPLETED|Study Period II||11
974727|NCT00320528|2359155|P3|COMPLETED|Study Period II||108
974728|NCT00320528|2359156|P2|COMPLETED|Study Period II||31
974729|NCT00320528|2359157|P1|COMPLETED|Study Period II||87
974730|NCT00320528|2359155|P3|Received at Least One Dose of Study Drug|Study Period II||128
974731|NCT00320528|2359156|P2|Received at Least One Dose of Study Drug|Study Period II||38
974732|NCT00320528|2359157|P1|Received at Least One Dose of Study Drug|Study Period II||97
974733|NCT00320528|2359155|P3|STARTED|Study Period II||130
974734|NCT00320528|2359156|P2|STARTED|Study Period II||41
974735|NCT00320528|2359157|P1|STARTED|Study Period II||98
974736|NCT00320541|2359194|P2|NOT COMPLETED|Overall Study||57
974737|NCT00320541|2359195|P1|NOT COMPLETED|Overall Study||50
974738|NCT00320541|2359194|P2|COMPLETED|Overall Study||36
974739|NCT00320541|2359195|P1|COMPLETED|Overall Study||44
974740|NCT00320541|2359194|P2|STARTED|Overall Study||93
974741|NCT00320541|2359195|P1|STARTED|Overall Study||94
974742|NCT00320593|2359221|P2|NOT COMPLETED|Overall Study||1
974743|NCT00320593|2359222|P1|NOT COMPLETED|Overall Study||7
974744|NCT00320593|2359221|P2|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|58
974745|NCT00320593|2359222|P1|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|52
974746|NCT00320593|2359221|P2|STARTED|Overall Study||59
974747|NCT00320593|2359222|P1|STARTED|Overall Study||59
974748|NCT00320606|2359244|P1|NOT COMPLETED|Overall Study||14
974749|NCT00320606|2359244|P1|COMPLETED|Overall Study|2 discontinued early, 12 ongoing in study|6
974750|NCT00320606|2359244|P1|STARTED|Overall Study||20
974751|NCT00320671|2359250|P2|NOT COMPLETED|Overall Study||38
974752|NCT00320671|2359251|P1|NOT COMPLETED|Overall Study||33
974753|NCT00320671|2359250|P2|COMPLETED|Overall Study||58
974754|NCT00320671|2359251|P1|COMPLETED|Overall Study||69
974755|NCT00320671|2359250|P2|STARTED|Overall Study||96
974756|NCT00320671|2359251|P1|STARTED|Overall Study||102
974757|NCT00320710|2359260|P3|NOT COMPLETED|Overall Study||5
974758|NCT00320710|2359261|P2|NOT COMPLETED|Overall Study||76
974759|NCT00320710|2359262|P1|NOT COMPLETED|Overall Study||94
974760|NCT00320710|2359260|P3|COMPLETED|Overall Study||8
974761|NCT00320710|2359261|P2|COMPLETED|Overall Study||127
974762|NCT00320710|2359262|P1|COMPLETED|Overall Study||106
974763|NCT00320710|2359260|P3|Treated (Safety Set)|Overall Study||13
974764|NCT00320710|2359261|P2|Treated (Safety Set)|Overall Study||202
974765|NCT00320710|2359262|P1|Treated (Safety Set)|Overall Study||198
974766|NCT00320710|2359260|P3|STARTED|Overall Study||13
974767|NCT00320710|2359261|P2|STARTED|Overall Study||203
974768|NCT00320710|2359262|P1|STARTED|Overall Study||200
974769|NCT00320749|2359283|P3|NOT COMPLETED|Overall Study||9
974770|NCT00320749|2359284|P2|NOT COMPLETED|Overall Study||2
974771|NCT00320749|2359285|P1|NOT COMPLETED|Overall Study||0
974772|NCT00320749|2359283|P3|COMPLETED|Overall Study||1
974773|NCT00320749|2359284|P2|COMPLETED|Overall Study||6
974774|NCT00320749|2359285|P1|COMPLETED|Overall Study||3
974775|NCT00320749|2359283|P3|STARTED|Overall Study||10
974776|NCT00320749|2359284|P2|STARTED|Overall Study||8
974777|NCT00320749|2359285|P1|STARTED|Overall Study||3
974778|NCT00320788|2359296|P5|NOT COMPLETED|Overall Study||5
974779|NCT00320788|2359297|P4|NOT COMPLETED|Overall Study||5
974780|NCT00320788|2359298|P3|NOT COMPLETED|Overall Study||3
974781|NCT00320788|2359299|P2|NOT COMPLETED|Overall Study||6
974782|NCT00320788|2359300|P1|NOT COMPLETED|Overall Study||6
974783|NCT00320788|2359296|P5|COMPLETED|Overall Study||26
974784|NCT00320788|2359297|P4|COMPLETED|Overall Study||27
974785|NCT00320788|2359298|P3|COMPLETED|Overall Study||29
974786|NCT00320788|2359299|P2|COMPLETED|Overall Study||26
974787|NCT00320788|2359300|P1|COMPLETED|Overall Study||26
974788|NCT00320788|2359296|P5|Participants Received Treatment (SAF)|Overall Study||31
974789|NCT00320788|2359297|P4|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
974790|NCT00320788|2359298|P3|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
974791|NCT00320788|2359299|P2|Participants Received Treatment (SAF)|Overall Study||32
974792|NCT00320788|2359300|P1|Participants Received Treatment (SAF)|Overall Study||32
974793|NCT00320788|2359296|P5|STARTED|Overall Study||31
974794|NCT00320788|2359297|P4|STARTED|Overall Study|Participants Randomized|32
974795|NCT00320788|2359298|P3|STARTED|Overall Study||32
974796|NCT00320788|2359299|P2|STARTED|Overall Study||32
974797|NCT00320788|2359300|P1|STARTED|Overall Study||32
974798|NCT00320801|2359345|P4|NOT COMPLETED|Extension Phase||48
974799|NCT00320801|2359346|P3|NOT COMPLETED|Extension Phase||0
974800|NCT00320801|2359347|P2|NOT COMPLETED|Extension Phase||0
974801|NCT00320801|2359348|P1|NOT COMPLETED|Extension Phase||0
974802|NCT00320801|2359345|P4|COMPLETED|Extension Phase||7
974803|NCT00320801|2359346|P3|COMPLETED|Extension Phase||0
974804|NCT00320801|2359347|P2|COMPLETED|Extension Phase||0
974805|NCT00320801|2359348|P1|COMPLETED|Extension Phase||0
974806|NCT00320801|2359345|P4|STARTED|Extension Phase||55
974807|NCT00320801|2359346|P3|STARTED|Extension Phase||0
974808|NCT00320801|2359347|P2|STARTED|Extension Phase||0
974809|NCT00320801|2359348|P1|STARTED|Extension Phase||0
974810|NCT00320801|2359345|P4|NOT COMPLETED|Double-blind Phase||0
974811|NCT00320801|2359346|P3|NOT COMPLETED|Double-blind Phase||14
974812|NCT00320801|2359347|P2|NOT COMPLETED|Double-blind Phase||11
974813|NCT00320801|2359348|P1|NOT COMPLETED|Double-blind Phase||0
974814|NCT00320801|2359345|P4|COMPLETED|Double-blind Phase||0
974815|NCT00320801|2359346|P3|COMPLETED|Double-blind Phase||35
974816|NCT00320801|2359347|P2|COMPLETED|Double-blind Phase||36
974817|NCT00320801|2359348|P1|COMPLETED|Double-blind Phase||0
974818|NCT00320801|2359345|P4|STARTED|Double-blind Phase||0
974819|NCT00320801|2359346|P3|STARTED|Double-blind Phase||49
974820|NCT00320801|2359347|P2|STARTED|Double-blind Phase||47
974821|NCT00320801|2359348|P1|STARTED|Double-blind Phase||0
974822|NCT00320801|2359345|P4|NOT COMPLETED|Open-label Run-in Period||0
974823|NCT00320801|2359346|P3|NOT COMPLETED|Open-label Run-in Period||0
974824|NCT00320801|2359347|P2|NOT COMPLETED|Open-label Run-in Period||0
974825|NCT00320801|2359348|P1|NOT COMPLETED|Open-label Run-in Period||92
974826|NCT00320801|2359345|P4|COMPLETED|Open-label Run-in Period||0
974827|NCT00320801|2359346|P3|COMPLETED|Open-label Run-in Period||0
974828|NCT00320801|2359347|P2|COMPLETED|Open-label Run-in Period||0
974829|NCT00320801|2359348|P1|COMPLETED|Open-label Run-in Period||96
974830|NCT00320801|2359345|P4|STARTED|Open-label Run-in Period||0
974831|NCT00320801|2359346|P3|STARTED|Open-label Run-in Period||0
974832|NCT00320801|2359347|P2|STARTED|Open-label Run-in Period||0
974833|NCT00320801|2359348|P1|STARTED|Open-label Run-in Period||188
974834|NCT00321269|2359360|P2|NOT COMPLETED|Overall Study||6
974835|NCT00321269|2359361|P1|NOT COMPLETED|Overall Study||8
974836|NCT00321269|2359360|P2|COMPLETED|Overall Study||68
974837|NCT00321269|2359361|P1|COMPLETED|Overall Study||66
974838|NCT00321269|2359360|P2|STARTED|Overall Study||74
974839|NCT00321269|2359361|P1|STARTED|Overall Study||74
974840|NCT00321321|2359369|P1|NOT COMPLETED|Overall Study||0
974841|NCT00321321|2359369|P1|COMPLETED|Overall Study||12
974842|NCT00321321|2359369|P1|STARTED|Overall Study||12
974843|NCT00321373|2359376|P3|NOT COMPLETED|Overall Study||3
974844|NCT00321373|2359377|P2|NOT COMPLETED|Overall Study||0
974845|NCT00321373|2359378|P1|NOT COMPLETED|Overall Study||2
974846|NCT00321373|2359376|P3|COMPLETED|Overall Study||404
974847|NCT00321373|2359377|P2|COMPLETED|Overall Study||406
974848|NCT00321373|2359378|P1|COMPLETED|Overall Study||405
974849|NCT00321373|2359376|P3|STARTED|Overall Study||407
974850|NCT00321373|2359377|P2|STARTED|Overall Study||406
974851|NCT00321373|2359378|P1|STARTED|Overall Study||407
974852|NCT00321464|2359403|P2|NOT COMPLETED|Overall Study||558
974853|NCT00321464|2359404|P1|NOT COMPLETED|Overall Study||559
974854|NCT00321464|2359403|P2|COMPLETED|Overall Study||468
974855|NCT00321464|2359404|P1|COMPLETED|Overall Study||461
974856|NCT00321464|2359403|P2|Received Investigational Product|Overall Study||1019
974857|NCT00321464|2359404|P1|Received Investigational Product|Overall Study||1014
974858|NCT00321464|2359403|P2|STARTED|Overall Study||1026
974859|NCT00321464|2359404|P1|STARTED|Overall Study||1020
974860|NCT00321594|2359416|P5|NOT COMPLETED|Phase II, MTD Dose||0
974861|NCT00321594|2359417|P4|NOT COMPLETED|Phase II, MTD Dose||0
974862|NCT00321594|2359418|P3|NOT COMPLETED|Phase II, MTD Dose||0
974863|NCT00321594|2359419|P2|NOT COMPLETED|Phase II, MTD Dose||0
974864|NCT00321594|2359420|P1|NOT COMPLETED|Phase II, MTD Dose||0
974865|NCT00321594|2359416|P5|COMPLETED|Phase II, MTD Dose||36
974866|NCT00321594|2359417|P4|COMPLETED|Phase II, MTD Dose||6
974867|NCT00321594|2359418|P3|COMPLETED|Phase II, MTD Dose||0
974868|NCT00321594|2359419|P2|COMPLETED|Phase II, MTD Dose||0
974869|NCT00321594|2359420|P1|COMPLETED|Phase II, MTD Dose||0
974870|NCT00321594|2359416|P5|STARTED|Phase II, MTD Dose|last six patients in Phase I, Level 4 include in Phase II MTD Dose total number = 6 + 36 = 42|36
974871|NCT00321594|2359417|P4|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|6
974872|NCT00321594|2359418|P3|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
974873|NCT00321594|2359419|P2|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
974874|NCT00321594|2359420|P1|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
974875|NCT00321594|2359416|P5|NOT COMPLETED|Phase I, Level 1-4||0
974876|NCT00321594|2359417|P4|NOT COMPLETED|Phase I, Level 1-4||0
974877|NCT00321594|2359418|P3|NOT COMPLETED|Phase I, Level 1-4||0
974878|NCT00321594|2359419|P2|NOT COMPLETED|Phase I, Level 1-4||0
974879|NCT00321594|2359420|P1|NOT COMPLETED|Phase I, Level 1-4||0
974880|NCT00321594|2359416|P5|COMPLETED|Phase I, Level 1-4||0
974881|NCT00321594|2359417|P4|COMPLETED|Phase I, Level 1-4||6
974882|NCT00321594|2359418|P3|COMPLETED|Phase I, Level 1-4||6
974883|NCT00321594|2359419|P2|COMPLETED|Phase I, Level 1-4||3
974884|NCT00321594|2359420|P1|COMPLETED|Phase I, Level 1-4||3
974885|NCT00321594|2359416|P5|STARTED|Phase I, Level 1-4||0
974886|NCT00321594|2359417|P4|STARTED|Phase I, Level 1-4||6
974887|NCT00321594|2359418|P3|STARTED|Phase I, Level 1-4||6
974888|NCT00321594|2359419|P2|STARTED|Phase I, Level 1-4||3
974889|NCT00321594|2359420|P1|STARTED|Phase I, Level 1-4||3
974890|NCT00321620|2359434|P2|NOT COMPLETED|Overall Study||722
974891|NCT00321620|2359435|P1|NOT COMPLETED|Overall Study||743
974892|NCT00321620|2359434|P2|COMPLETED|Overall Study||228
974893|NCT00321620|2359435|P1|COMPLETED|Overall Study||208
974894|NCT00321620|2359434|P2|Received Investigational Product|Overall Study||942
974895|NCT00321620|2359435|P1|Received Investigational Product|Overall Study||946
974896|NCT00321620|2359434|P2|STARTED|Overall Study||950
974897|NCT00321620|2359435|P1|STARTED|Overall Study||951
974898|NCT00321646|2359445|P1|NOT COMPLETED|Prostatectomy||0
974899|NCT00321646|2359445|P1|COMPLETED|Prostatectomy||37
974900|NCT00321646|2359445|P1|STARTED|Prostatectomy||37
974901|NCT00321646|2359445|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||4
974902|NCT00321646|2359445|P1|COMPLETED|Neoadjuvant Chemotherapy|1 pt withdrew before start of therapy, 38 completed 6 cycles neoadjuvant therapy.|38
974903|NCT00321646|2359445|P1|STARTED|Neoadjuvant Chemotherapy||42
974904|NCT00328016|2359452|P2|NOT COMPLETED|Overall Study||0
974905|NCT00328016|2359453|P1|NOT COMPLETED|Overall Study||0
974906|NCT00328016|2359452|P2|COMPLETED|Overall Study||21
974907|NCT00328016|2359453|P1|COMPLETED|Overall Study||23
974908|NCT00328016|2359452|P2|STARTED|Overall Study||21
974909|NCT00328016|2359453|P1|STARTED|Overall Study||23
974910|NCT00328042|2359465|P2|NOT COMPLETED|Overall Study||2
974911|NCT00328042|2359466|P1|NOT COMPLETED|Overall Study||0
974912|NCT00328042|2359465|P2|COMPLETED|Overall Study||63
974913|NCT00328042|2359466|P1|COMPLETED|Overall Study||69
974914|NCT00328042|2359465|P2|STARTED|Overall Study||65
974915|NCT00328042|2359466|P1|STARTED|Overall Study||69
974916|NCT00328094|2359476|P2|NOT COMPLETED|Overall Study||3
974917|NCT00328094|2359477|P1|NOT COMPLETED|Overall Study||3
974918|NCT00328094|2359476|P2|COMPLETED|Overall Study|3 did not receive interevention. 1 post induction arrest. 1 case cancelled.|122
974919|NCT00328094|2359477|P1|COMPLETED|Overall Study|2 did not receive intervention. 1 patient refusal|114
974920|NCT00328094|2359476|P2|STARTED|Overall Study||125
974921|NCT00328094|2359477|P1|STARTED|Overall Study||117
974922|NCT00328172|2359490|P5|NOT COMPLETED|Overall Study||5
974923|NCT00328172|2359491|P4|NOT COMPLETED|Overall Study||13
974924|NCT00328172|2359492|P3|NOT COMPLETED|Overall Study||10
974925|NCT00328172|2359493|P2|NOT COMPLETED|Overall Study||14
974926|NCT00328172|2359494|P1|NOT COMPLETED|Overall Study||22
974927|NCT00328172|2359490|P5|COMPLETED|Overall Study||60
974928|NCT00328172|2359491|P4|COMPLETED|Overall Study||42
974929|NCT00328172|2359492|P3|COMPLETED|Overall Study||47
974930|NCT00328172|2359493|P2|COMPLETED|Overall Study||44
974931|NCT00328172|2359494|P1|COMPLETED|Overall Study||45
974932|NCT00328172|2359490|P5|STARTED|Overall Study||65
974933|NCT00328172|2359491|P4|STARTED|Overall Study||55
974934|NCT00328172|2359492|P3|STARTED|Overall Study||57
974935|NCT00328172|2359493|P2|STARTED|Overall Study||58
974936|NCT00328172|2359494|P1|STARTED|Overall Study||67
974937|NCT00328198|2359516|P1|NOT COMPLETED|Follow-up||35
974938|NCT00328198|2359516|P1|COMPLETED|Follow-up||43
974939|NCT00328198|2359516|P1|STARTED|Follow-up|Eight participants did not enter Follow-up|78
974940|NCT00328198|2359516|P1|NOT COMPLETED|Treatment||38
974941|NCT00328198|2359516|P1|COMPLETED|Treatment|Depending upon protocol version, completed treatment was either 12 or 18 weeks in duration.|48
974942|NCT00328198|2359516|P1|STARTED|Treatment|16 participants escalated the dose. 70 participants started at the 30 mg target dose.|86
974943|NCT00328263|2359528|P2|NOT COMPLETED|Overall Study||4
974944|NCT00328263|2359529|P1|NOT COMPLETED|Overall Study||3
974945|NCT00328263|2359528|P2|COMPLETED|Overall Study|4 deaths occured during the study. None of the deaths were causally related to the study product.|217
974946|NCT00328263|2359529|P1|COMPLETED|Overall Study|3 deaths occured during the study. None of the deaths were causally related to the study product.|213
974947|NCT00328263|2359528|P2|STARTED|Overall Study||221
974948|NCT00328263|2359529|P1|STARTED|Overall Study||216
974949|NCT00328770|2359535|P1|NOT COMPLETED|Overall Study||0
974950|NCT00328770|2359535|P1|COMPLETED|Overall Study||70
974951|NCT00328770|2359535|P1|STARTED|Overall Study||70
974952|NCT00328783|2359541|P1|NOT COMPLETED|Overall Study||26
974953|NCT00328783|2359541|P1|COMPLETED|Overall Study||86
974954|NCT00328783|2359541|P1|STARTED|Overall Study||112
974955|NCT00328861|2359548|P2|NOT COMPLETED|Overall Study||0
974956|NCT00328861|2359549|P1|NOT COMPLETED|Overall Study||0
974957|NCT00328861|2359548|P2|COMPLETED|Overall Study||1
974958|NCT00328861|2359549|P1|COMPLETED|Overall Study||7
974959|NCT00328861|2359548|P2|STARTED|Overall Study||1
974960|NCT00328861|2359549|P1|STARTED|Overall Study||7
974961|NCT00328926|2359560|P3|NOT COMPLETED|Overall Study||2
974962|NCT00328926|2359561|P2|NOT COMPLETED|Overall Study||3
974963|NCT00328926|2359562|P1|NOT COMPLETED|Overall Study||2
974964|NCT00328926|2359560|P3|COMPLETED|Overall Study||1
974965|NCT00328926|2359561|P2|COMPLETED|Overall Study||0
974966|NCT00328926|2359562|P1|COMPLETED|Overall Study||3
974967|NCT00328926|2359560|P3|STARTED|Overall Study||3
974968|NCT00328926|2359561|P2|STARTED|Overall Study||3
974969|NCT00328926|2359562|P1|STARTED|Overall Study||5
974970|NCT00329030|2359578|P2|NOT COMPLETED|Overall Study||6
974971|NCT00329030|2359579|P1|NOT COMPLETED|Overall Study||8
974972|NCT00329030|2359578|P2|COMPLETED|Overall Study||107
974973|NCT00329030|2359579|P1|COMPLETED|Overall Study||103
974974|NCT00329030|2359578|P2|STARTED|Overall Study||113
974975|NCT00329030|2359579|P1|STARTED|Overall Study||111
974976|NCT00329108|2359609|P2|NOT COMPLETED|Overall Study||12
974977|NCT00329108|2359610|P1|NOT COMPLETED|Overall Study||10
974978|NCT00329108|2359609|P2|COMPLETED|Overall Study||2
974979|NCT00329108|2359610|P1|COMPLETED|Overall Study||5
974980|NCT00329108|2359609|P2|STARTED|Overall Study|study terminated due to poor recruitment|14
974981|NCT00329108|2359610|P1|STARTED|Overall Study|study terminated due to poor recruitment|15
974982|NCT00329160|2359616|P1|NOT COMPLETED|Overall Study||88
974983|NCT00329160|2359616|P1|COMPLETED|Overall Study||126
974984|NCT00329160|2359616|P1|Treatment Period|Overall Study||214
974985|NCT00329160|2359616|P1|Observation Period|Overall Study||214
974986|NCT00329160|2359616|P1|STARTED|Overall Study||214
974987|NCT00329238|2359625|P2|NOT COMPLETED|Overall Study||281
974988|NCT00329238|2359626|P1|NOT COMPLETED|Overall Study||276
974989|NCT00329238|2359625|P2|COMPLETED|Overall Study||1145
974990|NCT00329238|2359626|P1|COMPLETED|Overall Study||1154
974991|NCT00329238|2359625|P2|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1426
974992|NCT00329238|2359626|P1|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1430
974993|NCT00329407|2359662|P1|NOT COMPLETED|Overall Study||1
974994|NCT00329407|2359662|P1|COMPLETED|Overall Study||9
974995|NCT00329407|2359662|P1|STARTED|Overall Study||10
974996|NCT00329420|2359670|P3|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||1
974997|NCT00329420|2359671|P2|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||2
974998|NCT00329420|2359672|P1|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||4
974999|NCT00329420|2359670|P3|COMPLETED|4-weekly Dosing Phase (Responders Only)||6
975000|NCT00329420|2359671|P2|COMPLETED|4-weekly Dosing Phase (Responders Only)||5
975001|NCT00329420|2359672|P1|COMPLETED|4-weekly Dosing Phase (Responders Only)||8
975002|NCT00329420|2359670|P3|STARTED|4-weekly Dosing Phase (Responders Only)||7
975003|NCT00329420|2359671|P2|STARTED|4-weekly Dosing Phase (Responders Only)||7
975004|NCT00329420|2359672|P1|STARTED|4-weekly Dosing Phase (Responders Only)||12
975005|NCT00329420|2359670|P3|NOT COMPLETED|Re-induction Phase||8
975006|NCT00329420|2359671|P2|NOT COMPLETED|Re-induction Phase||6
975007|NCT00329420|2359672|P1|NOT COMPLETED|Re-induction Phase||6
975008|NCT00329420|2359670|P3|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
975009|NCT00329420|2359671|P2|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
975010|NCT00329420|2359672|P1|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|12
975011|NCT00329420|2359670|P3|STARTED|Re-induction Phase||15
975012|NCT00329420|2359671|P2|STARTED|Re-induction Phase||13
975013|NCT00329420|2359672|P1|STARTED|Re-induction Phase||18
975014|NCT00329433|2360053|P2|NOT COMPLETED|Overall Study||0
975015|NCT00329433|2360054|P1|NOT COMPLETED|Overall Study||0
975016|NCT00329433|2360053|P2|COMPLETED|Overall Study||59
975017|NCT00329433|2360054|P1|COMPLETED|Overall Study||61
975018|NCT00329433|2360053|P2|STARTED|Overall Study||59
975019|NCT00329433|2360054|P1|STARTED|Overall Study||61
975020|NCT00329524|2360060|P1|NOT COMPLETED|Overall Study||0
975021|NCT00329524|2360060|P1|COMPLETED|Overall Study||5
975022|NCT00329524|2360060|P1|STARTED|Overall Study||5
975023|NCT00329550|2360069|P3|NOT COMPLETED|Overall Study||4
975024|NCT00329550|2360070|P2|NOT COMPLETED|Overall Study||4
975025|NCT00329550|2360071|P1|NOT COMPLETED|Overall Study||4
975026|NCT00329550|2360069|P3|COMPLETED|Overall Study||12
975027|NCT00329550|2360070|P2|COMPLETED|Overall Study||11
975028|NCT00329550|2360071|P1|COMPLETED|Overall Study||5
975029|NCT00329550|2360069|P3|STARTED|Overall Study|1 subject in Safety Set is not in Full Analysis Set due to Good Clinical Practice non-compliance.|16
975030|NCT00329550|2360070|P2|STARTED|Overall Study||15
975031|NCT00329550|2360071|P1|STARTED|Overall Study||9
975032|NCT00329602|2360320|P3|NOT COMPLETED|40-Week Open-Label Treatment Phase||36
975033|NCT00329602|2360321|P2|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
975034|NCT00329602|2360322|P1|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
975035|NCT00329602|2360320|P3|COMPLETED|40-Week Open-Label Treatment Phase||233
975036|NCT00329602|2360321|P2|COMPLETED|40-Week Open-Label Treatment Phase||0
975037|NCT00329602|2360322|P1|COMPLETED|40-Week Open-Label Treatment Phase||0
975038|NCT00329602|2360320|P3|STARTED|40-Week Open-Label Treatment Phase|148 and 121 par. randomized to DB placebo and ropinirole IR, respectively, entered the OL phase.|269
975039|NCT00329602|2360321|P2|STARTED|40-Week Open-Label Treatment Phase||0
975040|NCT00329602|2360322|P1|STARTED|40-Week Open-Label Treatment Phase||0
975041|NCT00329602|2360320|P3|NOT COMPLETED|26-Week Double-Blind Treatment Phase||0
975042|NCT00329602|2360321|P2|NOT COMPLETED|26-Week Double-Blind Treatment Phase||99
975043|NCT00329602|2360322|P1|NOT COMPLETED|26-Week Double-Blind Treatment Phase||119
975044|NCT00329602|2360320|P3|COMPLETED|26-Week Double-Blind Treatment Phase||0
975045|NCT00329602|2360321|P2|COMPLETED|26-Week Double-Blind Treatment Phase||98
975046|NCT00329602|2360322|P1|COMPLETED|26-Week Double-Blind Treatment Phase||88
975047|NCT00329602|2360320|P3|STARTED|26-Week Double-Blind Treatment Phase||0
975048|NCT00329602|2360321|P2|STARTED|26-Week Double-Blind Treatment Phase||197
975049|NCT00329602|2360322|P1|STARTED|26-Week Double-Blind Treatment Phase|"Numbers of participants in the Participant Flow section are based on the Safety Population."|207
975050|NCT00329641|2360357|P1|NOT COMPLETED|Overall Study||6
975051|NCT00329641|2360357|P1|COMPLETED|Overall Study||19
975052|NCT00329641|2360357|P1|Eligible and Received Treatment|Overall Study||24
975053|NCT00329641|2360357|P1|Eligible|Overall Study||25
975054|NCT00329641|2360357|P1|STARTED|Overall Study||25
975055|NCT00329719|2360368|P4|NOT COMPLETED|Overall Study||1
975056|NCT00329719|2360369|P3|NOT COMPLETED|Overall Study||0
975057|NCT00329719|2360370|P2|NOT COMPLETED|Overall Study||0
975058|NCT00329719|2360371|P1|NOT COMPLETED|Overall Study||0
975059|NCT00329719|2360368|P4|COMPLETED|Overall Study||44
975060|NCT00329719|2360369|P3|COMPLETED|Overall Study||9
975061|NCT00329719|2360370|P2|COMPLETED|Overall Study||49
975062|NCT00329719|2360371|P1|COMPLETED|Overall Study||12
975063|NCT00329719|2360368|P4|STARTED|Overall Study||45
975064|NCT00329719|2360369|P3|STARTED|Overall Study||9
975065|NCT00329719|2360370|P2|STARTED|Overall Study||49
975066|NCT00329719|2360371|P1|STARTED|Overall Study||12
975067|NCT00329732|2360395|P2|NOT COMPLETED|Overall Study||0
975068|NCT00329732|2360396|P1|NOT COMPLETED|Overall Study||0
975069|NCT00329732|2360395|P2|COMPLETED|Overall Study||0
975070|NCT00329732|2360396|P1|COMPLETED|Overall Study||2
975071|NCT00329732|2360395|P2|STARTED|Overall Study||0
975072|NCT00329732|2360396|P1|STARTED|Overall Study||2
975073|NCT00329745|2360403|P2|NOT COMPLETED|Overall Study||102
975074|NCT00329745|2360404|P1|NOT COMPLETED|Overall Study||87
975075|NCT00329745|2360403|P2|COMPLETED|Overall Study||4226
975076|NCT00329745|2360404|P1|COMPLETED|Overall Study||4272
975077|NCT00329745|2360403|P2|STARTED|Overall Study||4328
975078|NCT00329745|2360404|P1|STARTED|Overall Study||4359
975079|NCT00329771|2360412|P1|NOT COMPLETED|Overall Study||3
975080|NCT00329771|2360412|P1|COMPLETED|Overall Study|3 subjects withdrew or were lost to follow-up|25
975081|NCT00329771|2360412|P1|STARTED|Overall Study||28
975082|NCT00329784|2360420|P4|NOT COMPLETED|Overall Study||0
975083|NCT00329784|2360421|P3|NOT COMPLETED|Overall Study||0
975084|NCT00329784|2360422|P2|NOT COMPLETED|Overall Study||5
975085|NCT00329784|2360423|P1|NOT COMPLETED|Overall Study||5
975086|NCT00329784|2360420|P4|COMPLETED|Overall Study||47
975087|NCT00329784|2360421|P3|COMPLETED|Overall Study||51
975088|NCT00329784|2360422|P2|COMPLETED|Overall Study||267
975089|NCT00329784|2360423|P1|COMPLETED|Overall Study||265
975090|NCT00329784|2360420|P4|STARTED|Overall Study||47
975091|NCT00329784|2360421|P3|STARTED|Overall Study||51
975092|NCT00329784|2360422|P2|STARTED|Overall Study||272
975093|NCT00329784|2360423|P1|STARTED|Overall Study||270
975094|NCT00329836|2360445|P1|NOT COMPLETED|Overall Study||0
975095|NCT00329836|2360445|P1|COMPLETED|Overall Study||41
975096|NCT00329836|2360445|P1|STARTED|Overall Study||41
975097|NCT00329849|2360451|P2|NOT COMPLETED|Overall Study||4
975098|NCT00329849|2360452|P1|NOT COMPLETED|Overall Study||6
975099|NCT00329849|2360451|P2|COMPLETED|Overall Study||546
975100|NCT00329849|2360452|P1|COMPLETED|Overall Study||944
975101|NCT00329849|2360451|P2|STARTED|Overall Study||550
975102|NCT00329849|2360452|P1|STARTED|Overall Study||950
975103|NCT00329901|2360475|P3|NOT COMPLETED|Overall Study||4
975104|NCT00329901|2360476|P2|NOT COMPLETED|Overall Study||5
975105|NCT00329901|2360477|P1|NOT COMPLETED|Overall Study||9
975106|NCT00329901|2360475|P3|COMPLETED|Overall Study||353
975107|NCT00329901|2360476|P2|COMPLETED|Overall Study||349
975108|NCT00329901|2360477|P1|COMPLETED|Overall Study||352
975109|NCT00329901|2360475|P3|STARTED|Overall Study||357
975110|NCT00329901|2360476|P2|STARTED|Overall Study||354
975111|NCT00329901|2360477|P1|STARTED|Overall Study||361
975112|NCT00330161|2360505|P1|NOT COMPLETED|Overall Study||0
975113|NCT00330161|2360505|P1|COMPLETED|Overall Study||29
975114|NCT00330161|2360505|P1|STARTED|Overall Study||29
975115|NCT00330174|2360516|P2|NOT COMPLETED|Overall Study||19
975116|NCT00330174|2360517|P1|NOT COMPLETED|Overall Study||22
975117|NCT00330174|2360516|P2|COMPLETED|Overall Study||26
975118|NCT00330174|2360517|P1|COMPLETED|Overall Study||23
975119|NCT00330174|2360516|P2|STARTED|Overall Study||45
975120|NCT00330174|2360517|P1|STARTED|Overall Study||45
975121|NCT00330343|2360529|P1|NOT COMPLETED|Overall Study||5
975122|NCT00330343|2360529|P1|COMPLETED|Overall Study||59
975123|NCT00330343|2360529|P1|STARTED|Overall Study||64
975124|NCT00330382|2360535|P2|NOT COMPLETED|Overall Study||17
975125|NCT00330382|2360536|P1|NOT COMPLETED|Overall Study||24
975126|NCT00330382|2360535|P2|COMPLETED|Overall Study||48
975127|NCT00330382|2360536|P1|COMPLETED|Overall Study||43
975128|NCT00330382|2360535|P2|STARTED|Overall Study||65
975129|NCT00330382|2360536|P1|STARTED|Overall Study||67
975130|NCT00330421|2360557|P2|NOT COMPLETED|Overall Study||0
975131|NCT00330421|2360558|P1|NOT COMPLETED|Overall Study||0
975132|NCT00330421|2360557|P2|COMPLETED|Overall Study||0
975133|NCT00330421|2360558|P1|COMPLETED|Overall Study||15
975134|NCT00330421|2360557|P2|STARTED|Overall Study||0
975135|NCT00330421|2360558|P1|STARTED|Overall Study||15
975136|NCT00330460|2360564|P2|NOT COMPLETED|Overall Study||33
975137|NCT00330460|2360565|P1|NOT COMPLETED|Overall Study||42
975138|NCT00330460|2360564|P2|COMPLETED|Overall Study||561
975139|NCT00330460|2360565|P1|COMPLETED|Overall Study||553
975140|NCT00330460|2360564|P2|STARTED|Overall Study||594
975141|NCT00330460|2360565|P1|STARTED|Overall Study||595
975142|NCT00330564|2360579|P1|NOT COMPLETED|Overall Study||0
975143|NCT00330564|2360579|P1|COMPLETED|Overall Study||15
975144|NCT00330564|2360579|P1|STARTED|Overall Study||15
975145|NCT00330616|2360584|P1|NOT COMPLETED|Overall Study||21
975146|NCT00330616|2360584|P1|COMPLETED|Overall Study||14
975147|NCT00330616|2360584|P1|STARTED|Overall Study||35
975148|NCT00330668|2360603|P1|NOT COMPLETED|Overall Study||114
975149|NCT00330668|2360603|P1|COMPLETED|Overall Study||0
975150|NCT00330668|2360603|P1|STARTED|Overall Study||114
975151|NCT00330681|2360612|P2|NOT COMPLETED|Overall Study||14
975152|NCT00330681|2360613|P1|NOT COMPLETED|Overall Study||9
975153|NCT00330681|2360612|P2|COMPLETED|Overall Study||90
975154|NCT00330681|2360613|P1|COMPLETED|Overall Study||93
975155|NCT00330681|2360612|P2|STARTED|Overall Study||104
975156|NCT00330681|2360613|P1|STARTED|Overall Study||102
975157|NCT00330733|2360637|P2|NOT COMPLETED|Overall Study||5
975158|NCT00330733|2360638|P1|NOT COMPLETED|Overall Study||7
975159|NCT00330733|2360637|P2|COMPLETED|Overall Study||29
975160|NCT00330733|2360638|P1|COMPLETED|Overall Study||30
975161|NCT00330733|2360637|P2|Received Study Medication|Overall Study||34
975162|NCT00330733|2360638|P1|Received Study Medication|Overall Study||36
975163|NCT00330733|2360637|P2|STARTED|Overall Study||34
975164|NCT00330733|2360638|P1|STARTED|Overall Study||37
975165|NCT00330759|2360646|P2|NOT COMPLETED|Overall Study||706
975166|NCT00330759|2360647|P1|NOT COMPLETED|Overall Study||712
975167|NCT00330759|2360646|P2|COMPLETED|Overall Study||180
975168|NCT00330759|2360647|P1|COMPLETED|Overall Study||178
975169|NCT00330759|2360646|P2|Received Investigational Product|Overall Study||878
975170|NCT00330759|2360647|P1|Received Investigational Product|Overall Study||878
975171|NCT00330759|2360646|P2|STARTED|Overall Study||886
975172|NCT00330759|2360647|P1|STARTED|Overall Study||890
975173|NCT00330876|2360657|P2|NOT COMPLETED|Overall Study||13
975174|NCT00330876|2360658|P1|NOT COMPLETED|Overall Study||71
975175|NCT00330876|2360657|P2|COMPLETED|Overall Study||77
975176|NCT00330876|2360658|P1|COMPLETED|Overall Study||378
975177|NCT00330876|2360657|P2|STARTED|Overall Study||90
975178|NCT00330876|2360658|P1|STARTED|Overall Study||449
975179|NCT00330915|2360666|P1|NOT COMPLETED|Overall Study||0
975180|NCT00330915|2360666|P1|COMPLETED|Overall Study||37
975181|NCT00330915|2360666|P1|STARTED|Overall Study||37
975182|NCT00330928|2360673|P1|NOT COMPLETED|Overall Study||17
975183|NCT00330928|2360673|P1|COMPLETED|Overall Study||89
975184|NCT00330928|2360673|P1|1 Year Phone Contact|Overall Study||89
975185|NCT00330928|2360673|P1|7 Day Phone Contact|Overall Study||99
975186|NCT00330928|2360673|P1|STARTED|Overall Study|Subjects that signed consent and were subject to research procedures.|106
975187|NCT00330967|2360680|P2|NOT COMPLETED|Overall Study||14
975188|NCT00330967|2360681|P1|NOT COMPLETED|Overall Study||0
975189|NCT00330967|2360680|P2|COMPLETED|Overall Study||11
975190|NCT00330967|2360681|P1|COMPLETED|Overall Study||0
975191|NCT00330967|2360680|P2|STARTED|Overall Study||25
975192|NCT00330967|2360681|P1|STARTED|Overall Study||0
975193|NCT00331006|2360692|P1|NOT COMPLETED|Follow-Up Phase II||3
975194|NCT00331006|2360692|P1|COMPLETED|Follow-Up Phase II||11
975195|NCT00331006|2360692|P1|STARTED|Follow-Up Phase II||14
975196|NCT00331006|2360692|P1|NOT COMPLETED|Follow-Up Phase I||1
975197|NCT00331006|2360692|P1|COMPLETED|Follow-Up Phase I||14
975198|NCT00331006|2360692|P1|STARTED|Follow-Up Phase I||15
975199|NCT00331006|2360692|P1|NOT COMPLETED|Treatment Phase||1
975200|NCT00331006|2360692|P1|COMPLETED|Treatment Phase||15
975201|NCT00331006|2360692|P1|STARTED|Treatment Phase||16
975202|NCT00331006|2360692|P1|NOT COMPLETED|Screening Phase||7
975203|NCT00331006|2360692|P1|COMPLETED|Screening Phase|subjects eligible for the treatment phase if inhibitor titer following Factor VIII was at least 5 BU|16
975204|NCT00331006|2360692|P1|STARTED|Screening Phase||23
975205|NCT00308061|2360705|P2|NOT COMPLETED|Overall Study||0
975206|NCT00308061|2360706|P1|NOT COMPLETED|Overall Study||0
975207|NCT00308061|2360705|P2|COMPLETED|Overall Study||20
975208|NCT00308061|2360706|P1|COMPLETED|Overall Study||20
975209|NCT00308061|2360705|P2|STARTED|Overall Study||20
975210|NCT00308061|2360706|P1|STARTED|Overall Study||20
975211|NCT00308074|2360713|P1|NOT COMPLETED|Overall Study||1
975212|NCT00308074|2360713|P1|COMPLETED|Overall Study||13
975213|NCT00308074|2360713|P1|STARTED|Overall Study||14
975214|NCT00308087|2360722|P2|NOT COMPLETED|Overall Study||37
975215|NCT00308087|2360723|P1|NOT COMPLETED|Overall Study||36
975216|NCT00308087|2360722|P2|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
975217|NCT00308087|2360723|P1|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
975218|NCT00308087|2360722|P2|STARTED|Overall Study||38
975219|NCT00308087|2360723|P1|STARTED|Overall Study||37
975220|NCT00308113|2360743|P4|NOT COMPLETED|Overall Study||1
975221|NCT00308113|2360744|P3|NOT COMPLETED|Overall Study||0
975222|NCT00308113|2360745|P2|NOT COMPLETED|Overall Study||0
975223|NCT00308113|2360746|P1|NOT COMPLETED|Overall Study||0
975224|NCT00308113|2360743|P4|COMPLETED|Overall Study||1
975225|NCT00308113|2360744|P3|COMPLETED|Overall Study||1
975226|NCT00308113|2360745|P2|COMPLETED|Overall Study||0
975227|NCT00308113|2360746|P1|COMPLETED|Overall Study||0
975228|NCT00308113|2360743|P4|STARTED|Overall Study||2
975229|NCT00308113|2360744|P3|STARTED|Overall Study||1
975230|NCT00308113|2360745|P2|STARTED|Overall Study||0
975231|NCT00308113|2360746|P1|STARTED|Overall Study||0
975232|NCT00308139|2360766|P2|NOT COMPLETED|Overall Study||87
975233|NCT00308139|2360767|P1|NOT COMPLETED|Overall Study||94
975234|NCT00308139|2360766|P2|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|64
975235|NCT00308139|2360767|P1|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|58
975236|NCT00308139|2360766|P2|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|130
975237|NCT00308139|2360767|P1|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|128
975238|NCT00308139|2360766|P2|Evaluable Meal Tolerance Cohort|Overall Study||24
975239|NCT00308139|2360767|P1|Evaluable Meal Tolerance Cohort|Overall Study||27
975240|NCT00308139|2360766|P2|Pharmacokinetics Population|Overall Study||0
975241|NCT00308139|2360767|P1|Pharmacokinetics Population|Overall Study||129
975242|NCT00308139|2360766|P2|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|145
975243|NCT00308139|2360767|P1|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|148
975244|NCT00308139|2360766|P2|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|147
975245|NCT00308139|2360767|P1|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|148
975246|NCT00308139|2360766|P2|STARTED|Overall Study||151
975247|NCT00308139|2360767|P1|STARTED|Overall Study||152
975248|NCT00308230|2360840|P3|NOT COMPLETED|Overall Study||0
975249|NCT00308230|2360841|P2|NOT COMPLETED|Overall Study||0
975250|NCT00308230|2360842|P1|NOT COMPLETED|Overall Study||0
975251|NCT00308230|2360840|P3|COMPLETED|Overall Study||20
975252|NCT00308230|2360841|P2|COMPLETED|Overall Study||8
975253|NCT00308230|2360842|P1|COMPLETED|Overall Study||6
975254|NCT00308230|2360840|P3|STARTED|Overall Study||20
975255|NCT00308230|2360841|P2|STARTED|Overall Study||8
975256|NCT00308230|2360842|P1|STARTED|Overall Study||6
975257|NCT00308308|2360852|P2|NOT COMPLETED|Overall Study||68
975258|NCT00308308|2360853|P1|NOT COMPLETED|Overall Study||103
975259|NCT00308308|2360852|P2|COMPLETED|Overall Study||220
975260|NCT00308308|2360853|P1|COMPLETED|Overall Study||198
975261|NCT00308308|2360852|P2|STARTED|Overall Study||288
975262|NCT00308308|2360853|P1|STARTED|Overall Study||301
975263|NCT00313781|2360875|P3|NOT COMPLETED|After Crossover||27
975264|NCT00313781|2360876|P2|NOT COMPLETED|After Crossover||0
975265|NCT00313781|2360877|P1|NOT COMPLETED|After Crossover||0
975266|NCT00313781|2360875|P3|COMPLETED|After Crossover||10
975267|NCT00313781|2360876|P2|COMPLETED|After Crossover||0
975268|NCT00313781|2360877|P1|COMPLETED|After Crossover||0
975269|NCT00313781|2360875|P3|STARTED|After Crossover||37
975270|NCT00313781|2360876|P2|STARTED|After Crossover||0
975271|NCT00313781|2360877|P1|STARTED|After Crossover||0
975272|NCT00313781|2360875|P3|NOT COMPLETED|Before Crossover||0
975273|NCT00313781|2360876|P2|NOT COMPLETED|Before Crossover||79
975274|NCT00313781|2360877|P1|NOT COMPLETED|Before Crossover||75
975275|NCT00313781|2360875|P3|COMPLETED|Before Crossover||0
975276|NCT00313781|2360876|P2|COMPLETED|Before Crossover||23
975277|NCT00313781|2360877|P1|COMPLETED|Before Crossover||27
975278|NCT00313781|2360875|P3|Treated|Before Crossover||0
975279|NCT00313781|2360876|P2|Treated|Before Crossover||102
975280|NCT00313781|2360877|P1|Treated|Before Crossover||97
975281|NCT00313781|2360875|P3|STARTED|Before Crossover||0
975282|NCT00313781|2360876|P2|STARTED|Before Crossover||102
975283|NCT00313781|2360877|P1|STARTED|Before Crossover||102
975284|NCT00313820|2360913|P2|NOT COMPLETED|Pregabalin or Placebo Treatment Period||19
975285|NCT00313820|2360914|P1|NOT COMPLETED|Pregabalin or Placebo Treatment Period||17
975286|NCT00313820|2360913|P2|COMPLETED|Pregabalin or Placebo Treatment Period||90
975287|NCT00313820|2360914|P1|COMPLETED|Pregabalin or Placebo Treatment Period||93
975288|NCT00313820|2360913|P2|STARTED|Pregabalin or Placebo Treatment Period||109
975289|NCT00313820|2360914|P1|STARTED|Pregabalin or Placebo Treatment Period||110
975290|NCT00313820|2360913|P2|NOT COMPLETED|Assigned to Treatment||0
975291|NCT00313820|2360914|P1|NOT COMPLETED|Assigned to Treatment||1
975292|NCT00313820|2360913|P2|COMPLETED|Assigned to Treatment||109
975293|NCT00313820|2360914|P1|COMPLETED|Assigned to Treatment||110
975294|NCT00313820|2360913|P2|STARTED|Assigned to Treatment||109
975295|NCT00313820|2360914|P1|STARTED|Assigned to Treatment||111
975296|NCT00324649|2360952|P2|NOT COMPLETED|Overall Study||5
975297|NCT00324649|2360953|P1|NOT COMPLETED|Overall Study||2
975298|NCT00324649|2360952|P2|COMPLETED|Overall Study||36
975299|NCT00324649|2360953|P1|COMPLETED|Overall Study||37
975300|NCT00324649|2360952|P2|STARTED|Overall Study||41
975301|NCT00324649|2360953|P1|STARTED|Overall Study||39
975302|NCT00324675|2360995|P2|NOT COMPLETED|Overall Study||0
975303|NCT00324675|2360996|P1|NOT COMPLETED|Overall Study||1
975304|NCT00324675|2360995|P2|COMPLETED|Overall Study||14
975305|NCT00324675|2360996|P1|COMPLETED|Overall Study||13
975306|NCT00324675|2360995|P2|STARTED|Overall Study||14
975307|NCT00324675|2360996|P1|STARTED|Overall Study||14
975308|NCT00324701|2361004|P2|NOT COMPLETED|Overall Study||17
975309|NCT00324701|2361005|P1|NOT COMPLETED|Overall Study||20
975310|NCT00324701|2361004|P2|COMPLETED|Overall Study||104
975311|NCT00324701|2361005|P1|COMPLETED|Overall Study||100
975312|NCT00324701|2361004|P2|Week 8 Assessment|Overall Study||107
975313|NCT00324701|2361005|P1|Week 8 Assessment|Overall Study||108
975314|NCT00324701|2361004|P2|STARTED|Overall Study||121
975315|NCT00324701|2361005|P1|STARTED|Overall Study||120
975316|NCT00324740|2361013|P3|NOT COMPLETED|Overall Study||1
975317|NCT00324740|2361014|P2|NOT COMPLETED|Overall Study||0
975318|NCT00324740|2361015|P1|NOT COMPLETED|Overall Study||1
975319|NCT00324740|2361013|P3|COMPLETED|Overall Study||3
975320|NCT00324740|2361014|P2|COMPLETED|Overall Study||3
975321|NCT00324740|2361015|P1|COMPLETED|Overall Study||6
975322|NCT00324740|2361013|P3|STARTED|Overall Study||4
975323|NCT00324740|2361014|P2|STARTED|Overall Study||3
975324|NCT00324740|2361015|P1|STARTED|Overall Study||7
975325|NCT00324857|2361026|P4|NOT COMPLETED|Overall Study||5
975326|NCT00324857|2361027|P3|NOT COMPLETED|Overall Study||7
975327|NCT00324857|2361028|P2|NOT COMPLETED|Overall Study||6
975328|NCT00324857|2361029|P1|NOT COMPLETED|Overall Study||6
975329|NCT00324857|2361026|P4|COMPLETED|Overall Study||158
975330|NCT00324857|2361027|P3|COMPLETED|Overall Study||158
975331|NCT00324857|2361028|P2|COMPLETED|Overall Study||162
975332|NCT00324857|2361029|P1|COMPLETED|Overall Study||161
975333|NCT00324857|2361026|P4|STARTED|Overall Study||163
975334|NCT00324857|2361027|P3|STARTED|Overall Study||165
975335|NCT00324857|2361028|P2|STARTED|Overall Study||168
975336|NCT00324857|2361029|P1|STARTED|Overall Study||167
975337|NCT00324870|2361039|P1|NOT COMPLETED|Overall Study||0
975338|NCT00324870|2361039|P1|COMPLETED|Overall Study||37
975339|NCT00324870|2361039|P1|STARTED|Overall Study||37
975346|NCT00324961|2361054|P1|NOT COMPLETED|Overall Study||43
975347|NCT00324961|2361054|P1|COMPLETED|Overall Study||490
975348|NCT00324961|2361054|P1|STARTED|Overall Study||533
975349|NCT00324987|2361069|P2|NOT COMPLETED|Overall Study||6
975350|NCT00324987|2361070|P1|NOT COMPLETED|Overall Study||6
975351|NCT00324987|2361069|P2|COMPLETED|Overall Study|Patients were to be treated until progression|0
975352|NCT00324987|2361070|P1|COMPLETED|Overall Study|Patients were to be treated until progression|0
975353|NCT00324987|2361069|P2|STARTED|Overall Study||6
975354|NCT00324987|2361070|P1|STARTED|Overall Study||6
975355|NCT00325039|2361086|P2|NOT COMPLETED|Overall Study||14
975356|NCT00325039|2361087|P1|NOT COMPLETED|Overall Study||18
975357|NCT00325039|2361086|P2|COMPLETED|Overall Study||285
975358|NCT00325039|2361087|P1|COMPLETED|Overall Study||280
975359|NCT00325039|2361086|P2|STARTED|Overall Study||299
975360|NCT00325039|2361087|P1|STARTED|Overall Study||298
975361|NCT00325078|2361104|P3|NOT COMPLETED|Overall Study||2
975362|NCT00325078|2361105|P2|NOT COMPLETED|Overall Study||5
975363|NCT00325078|2361106|P1|NOT COMPLETED|Overall Study||5
975364|NCT00325078|2361104|P3|COMPLETED|Overall Study||23
975365|NCT00325078|2361105|P2|COMPLETED|Overall Study||2
975366|NCT00325078|2361106|P1|COMPLETED|Overall Study||3
975367|NCT00325078|2361104|P3|STARTED|Overall Study||25
975368|NCT00325078|2361105|P2|STARTED|Overall Study||7
975369|NCT00325078|2361106|P1|STARTED|Overall Study||8
975370|NCT00325130|2361118|P2|NOT COMPLETED|Overall Study||30
975371|NCT00325130|2361119|P1|NOT COMPLETED|Overall Study||19
975372|NCT00325130|2361118|P2|COMPLETED|Overall Study||494
975373|NCT00325130|2361119|P1|COMPLETED|Overall Study||499
975374|NCT00325130|2361118|P2|STARTED|Overall Study||524
975375|NCT00325130|2361119|P1|STARTED|Overall Study||518
975376|NCT00325143|2361159|P1|NOT COMPLETED|Overall Study||26
975377|NCT00325143|2361159|P1|COMPLETED|Overall Study||676
975378|NCT00325143|2361159|P1|STARTED|Overall Study||702
975379|NCT00325156|2361166|P1|NOT COMPLETED|Overall Study||112
975380|NCT00325156|2361166|P1|COMPLETED|Overall Study||2478
975381|NCT00325156|2361166|P1|STARTED|Overall Study||2590
975382|NCT00325195|2361176|P3|NOT COMPLETED|Received Intervention: ITT Population||4
975383|NCT00325195|2361177|P2|NOT COMPLETED|Received Intervention: ITT Population||25
975384|NCT00325195|2361178|P1|NOT COMPLETED|Received Intervention: ITT Population||26
975385|NCT00325195|2361176|P3|COMPLETED|Received Intervention: ITT Population||39
975386|NCT00325195|2361177|P2|COMPLETED|Received Intervention: ITT Population||59
975387|NCT00325195|2361178|P1|COMPLETED|Received Intervention: ITT Population||59
975388|NCT00325195|2361176|P3|STARTED|Received Intervention: ITT Population||43
975389|NCT00325195|2361177|P2|STARTED|Received Intervention: ITT Population||84
975390|NCT00325195|2361178|P1|STARTED|Received Intervention: ITT Population||85
975391|NCT00325195|2361176|P3|NOT COMPLETED|Randomized||3
975392|NCT00325195|2361177|P2|NOT COMPLETED|Randomized||5
975393|NCT00325195|2361178|P1|NOT COMPLETED|Randomized||5
975394|NCT00325195|2361176|P3|COMPLETED|Randomized||43
975395|NCT00325195|2361177|P2|COMPLETED|Randomized||84
975396|NCT00325195|2361178|P1|COMPLETED|Randomized||85
975397|NCT00325195|2361176|P3|STARTED|Randomized||46
975398|NCT00325195|2361177|P2|STARTED|Randomized||89
975399|NCT00325195|2361178|P1|STARTED|Randomized||90
975400|NCT00325234|2361203|P2|NOT COMPLETED|Overall Study||66
975401|NCT00325234|2361204|P1|NOT COMPLETED|Overall Study||69
975402|NCT00325234|2361203|P2|COMPLETED|Overall Study||0
975403|NCT00325234|2361204|P1|COMPLETED|Overall Study||0
975404|NCT00325234|2361203|P2|Received At Least 1 Dose of Study Drug|Overall Study||66
975405|NCT00325234|2361204|P1|Received At Least 1 Dose of Study Drug|Overall Study||65
975406|NCT00325234|2361203|P2|STARTED|Overall Study||66
975407|NCT00325234|2361204|P1|STARTED|Overall Study||69
975408|NCT00325403|2361222|P2|NOT COMPLETED|Overall Study||51
975409|NCT00325403|2361223|P1|NOT COMPLETED|Overall Study||18
975410|NCT00325403|2361222|P2|COMPLETED|Overall Study|182 subjects receiving oral treprostinil completed the study on study drug|182
975411|NCT00325403|2361223|P1|COMPLETED|Overall Study|98 subjects receiving placebo completed the study on study drug|98
975412|NCT00325403|2361222|P2|STARTED|Overall Study||233
975413|NCT00325403|2361223|P1|STARTED|Overall Study||116
975414|NCT00325416|2361261|P2|NOT COMPLETED|Phase II: Treatment at MTD||2
975415|NCT00325416|2361262|P1|NOT COMPLETED|Phase II: Treatment at MTD||0
975416|NCT00325416|2361261|P2|COMPLETED|Phase II: Treatment at MTD||40
975417|NCT00325416|2361262|P1|COMPLETED|Phase II: Treatment at MTD||78
975418|NCT00325416|2361261|P2|Enrolled During Phase II|Phase II: Treatment at MTD||8
975419|NCT00325416|2361262|P1|Enrolled During Phase II|Phase II: Treatment at MTD||40
975420|NCT00325416|2361261|P2|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||34
975421|NCT00325416|2361262|P1|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||38
975422|NCT00325416|2361261|P2|STARTED|Phase II: Treatment at MTD||42
975423|NCT00325416|2361262|P1|STARTED|Phase II: Treatment at MTD||78
975424|NCT00325416|2361261|P2|NOT COMPLETED|Phase I: Dose Escalation||16
975425|NCT00325416|2361262|P1|NOT COMPLETED|Phase I: Dose Escalation||22
975426|NCT00325416|2361261|P2|COMPLETED|Phase I: Dose Escalation||44
975427|NCT00325416|2361262|P1|COMPLETED|Phase I: Dose Escalation||48
975428|NCT00325416|2361261|P2|STARTED|Phase I: Dose Escalation||60
975429|NCT00325416|2361262|P1|STARTED|Phase I: Dose Escalation||70
975430|NCT00325442|2361276|P2|NOT COMPLETED|Overall Study||21
975431|NCT00325442|2361277|P1|NOT COMPLETED|Overall Study||9
975432|NCT00325442|2361276|P2|COMPLETED|Overall Study||153
975433|NCT00325442|2361277|P1|COMPLETED|Overall Study||167
975434|NCT00325442|2361276|P2|STARTED|Overall Study||174
975435|NCT00325442|2361277|P1|STARTED|Overall Study||176
975439|NCT00331422|2361329|P1|NOT COMPLETED|Overall Study||5
975440|NCT00331422|2361329|P1|COMPLETED|Overall Study|Completed all 6 courses of chemotherapy and had surgery to remove all tumor lesions.|2
975441|NCT00331422|2361329|P1|STARTED|Overall Study|Patients who met study criteria and received at least one dose of study drug.|7
975442|NCT00331552|2361340|P2|NOT COMPLETED|Period 3: Phase II||0
975443|NCT00331552|2361341|P1|NOT COMPLETED|Period 3: Phase II||2
975444|NCT00331552|2361340|P2|COMPLETED|Period 3: Phase II||0
975445|NCT00331552|2361341|P1|COMPLETED|Period 3: Phase II||22
975446|NCT00331552|2361340|P2|STARTED|Period 3: Phase II||0
975447|NCT00331552|2361341|P1|STARTED|Period 3: Phase II||24
975448|NCT00331552|2361340|P2|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
975449|NCT00331552|2361341|P1|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
975450|NCT00331552|2361340|P2|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
975451|NCT00331552|2361341|P1|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
975452|NCT00331552|2361340|P2|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
975453|NCT00331552|2361341|P1|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
975454|NCT00331552|2361340|P2|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
975455|NCT00331552|2361341|P1|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
975456|NCT00331552|2361340|P2|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
975457|NCT00331552|2361341|P1|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
975458|NCT00331552|2361340|P2|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
975459|NCT00331552|2361341|P1|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
975460|NCT00332839|2361357|P2|NOT COMPLETED|Follow-up (Months 12 - 60)||3
975461|NCT00332839|2361358|P1|NOT COMPLETED|Follow-up (Months 12 - 60)||4
975462|NCT00332839|2361357|P2|COMPLETED|Follow-up (Months 12 - 60)||31
975463|NCT00332839|2361358|P1|COMPLETED|Follow-up (Months 12 - 60)||29
975464|NCT00332839|2361357|P2|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|34
975465|NCT00332839|2361358|P1|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|33
975466|NCT00332839|2361357|P2|NOT COMPLETED|Core (Months 0 - 12)||18
975467|NCT00332839|2361358|P1|NOT COMPLETED|Core (Months 0 - 12)||10
975468|NCT00332839|2361357|P2|COMPLETED|Core (Months 0 - 12)||28
975469|NCT00332839|2361358|P1|COMPLETED|Core (Months 0 - 12)||37
975470|NCT00332839|2361357|P2|Safety Set|Core (Months 0 - 12)||46
975471|NCT00332839|2361358|P1|Safety Set|Core (Months 0 - 12)||47
975472|NCT00332839|2361357|P2|STARTED|Core (Months 0 - 12)||46
975473|NCT00332839|2361358|P1|STARTED|Core (Months 0 - 12)||47
975474|NCT00333138|2361379|P3|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
975475|NCT00333138|2361380|P2|NOT COMPLETED|Extension Study (Month6 to End of Study)||42
975476|NCT00333138|2361381|P1|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
975477|NCT00333138|2361379|P3|COMPLETED|Extension Study (Month6 to End of Study)||37
975478|NCT00333138|2361380|P2|COMPLETED|Extension Study (Month6 to End of Study)||45
975479|NCT00333138|2361381|P1|COMPLETED|Extension Study (Month6 to End of Study)||40
975480|NCT00333138|2361379|P3|STARTED|Extension Study (Month6 to End of Study)||80
975481|NCT00333138|2361380|P2|STARTED|Extension Study (Month6 to End of Study)||87
975482|NCT00333138|2361381|P1|STARTED|Extension Study (Month6 to End of Study)||83
975483|NCT00333138|2361379|P3|NOT COMPLETED|Core Study (6 Months)||12
975484|NCT00333138|2361380|P2|NOT COMPLETED|Core Study (6 Months)||6
975485|NCT00333138|2361381|P1|NOT COMPLETED|Core Study (6 Months)||7
975486|NCT00333138|2361379|P3|COMPLETED|Core Study (6 Months)||82
975487|NCT00333138|2361380|P2|COMPLETED|Core Study (6 Months)||88
975488|NCT00333138|2361381|P1|COMPLETED|Core Study (6 Months)||86
975489|NCT00333138|2361379|P3|STARTED|Core Study (6 Months)||94
975490|NCT00333138|2361380|P2|STARTED|Core Study (6 Months)||94
975491|NCT00333138|2361381|P1|STARTED|Core Study (6 Months)||93
975492|NCT00333229|2361420|P2|NOT COMPLETED|Overall Study||1
975493|NCT00333229|2361421|P1|NOT COMPLETED|Overall Study||0
975494|NCT00333229|2361420|P2|COMPLETED|Overall Study||4
975495|NCT00333229|2361421|P1|COMPLETED|Overall Study||6
975496|NCT00333229|2361420|P2|STARTED|Overall Study||5
975497|NCT00333229|2361421|P1|STARTED|Overall Study||6
975498|NCT00333359|2361437|P2|NOT COMPLETED|Overall Study||122
975499|NCT00333359|2361438|P1|NOT COMPLETED|Overall Study||73
975500|NCT00333359|2361437|P2|COMPLETED|Overall Study||260
975501|NCT00333359|2361438|P1|COMPLETED|Overall Study||126
975502|NCT00333359|2361437|P2|STARTED|Overall Study||382
975503|NCT00333359|2361438|P1|STARTED|Overall Study||199
975504|NCT00333437|2361479|P1|NOT COMPLETED|Overall Study||0
975505|NCT00333437|2361479|P1|COMPLETED|Overall Study||7
975506|NCT00333437|2361479|P1|STARTED|Overall Study||7
975507|NCT00333619|2361489|P2|NOT COMPLETED|Overall Study||10
975508|NCT00333619|2361490|P1|NOT COMPLETED|Overall Study||21
975509|NCT00333619|2361489|P2|COMPLETED|Overall Study||99
975510|NCT00333619|2361490|P1|COMPLETED|Overall Study||89
975511|NCT00333619|2361489|P2|3-month Follow-up|Overall Study||105
975512|NCT00333619|2361490|P1|3-month Follow-up|Overall Study||101
975513|NCT00333619|2361489|P2|Post-treatment|Overall Study||109
975514|NCT00333619|2361490|P1|Post-treatment|Overall Study||109
975515|NCT00333619|2361489|P2|STARTED|Overall Study||109
975516|NCT00333619|2361490|P1|STARTED|Overall Study||110
975517|NCT00333710|2361501|P3|NOT COMPLETED|Overall Study||1
975518|NCT00333710|2361502|P2|NOT COMPLETED|Overall Study||4
975519|NCT00333710|2361503|P1|NOT COMPLETED|Overall Study||11
975520|NCT00333710|2361501|P3|COMPLETED|Overall Study||15
975521|NCT00333710|2361502|P2|COMPLETED|Overall Study||14
975522|NCT00333710|2361503|P1|COMPLETED|Overall Study||8
975523|NCT00333710|2361501|P3|STARTED|Overall Study||16
975524|NCT00333710|2361502|P2|STARTED|Overall Study||18
975525|NCT00333710|2361503|P1|STARTED|Overall Study||19
975526|NCT00333762|2361511|P1|NOT COMPLETED|Overall Study||4
975527|NCT00333762|2361511|P1|COMPLETED|Overall Study||0
975528|NCT00333762|2361511|P1|STARTED|Overall Study||4
975529|NCT00333775|2361518|P3|NOT COMPLETED|Overall Study||247
975530|NCT00333775|2361519|P2|NOT COMPLETED|Overall Study||248
975531|NCT00333775|2361520|P1|NOT COMPLETED|Overall Study||241
975532|NCT00333775|2361518|P3|COMPLETED|Overall Study||0
975533|NCT00333775|2361519|P2|COMPLETED|Overall Study||0
975534|NCT00333775|2361520|P1|COMPLETED|Overall Study||0
975535|NCT00333775|2361518|P3|Received Treatment|Overall Study||245
975536|NCT00333775|2361519|P2|Received Treatment|Overall Study||247
975537|NCT00333775|2361520|P1|Received Treatment|Overall Study||238
975538|NCT00333775|2361518|P3|STARTED|Overall Study||247
975539|NCT00333775|2361519|P2|STARTED|Overall Study||248
975540|NCT00333775|2361520|P1|STARTED|Overall Study||241
975541|NCT00333788|2361540|P1|NOT COMPLETED|Overall Study||162
975542|NCT00333788|2361540|P1|COMPLETED|Overall Study||71
975543|NCT00333788|2361540|P1|STARTED|Overall Study|Participant flow based on All Subjects population; Baseline characteristics based on ITT population.|233
975544|NCT00333801|2361569|P2|NOT COMPLETED|Overall Study||6
975545|NCT00333801|2361570|P1|NOT COMPLETED|Overall Study||8
975546|NCT00333801|2361569|P2|COMPLETED|Overall Study||36
975547|NCT00333801|2361570|P1|COMPLETED|Overall Study||35
975548|NCT00333801|2361569|P2|STARTED|Overall Study||42
975549|NCT00333801|2361570|P1|STARTED|Overall Study||43
975550|NCT00333814|2361591|P3|NOT COMPLETED|Overall Study||5
975551|NCT00333814|2361592|P2|NOT COMPLETED|Overall Study||4
975552|NCT00333814|2361593|P1|NOT COMPLETED|Overall Study||3
975553|NCT00333814|2361591|P3|COMPLETED|Overall Study||71
975554|NCT00333814|2361592|P2|COMPLETED|Overall Study||73
975555|NCT00333814|2361593|P1|COMPLETED|Overall Study||73
975556|NCT00333814|2361591|P3|STARTED|Overall Study||76
975557|NCT00333814|2361592|P2|STARTED|Overall Study||77
975558|NCT00333814|2361593|P1|STARTED|Overall Study||76
975559|NCT00333840|2361609|P4|NOT COMPLETED|Second-line Treatment Period||188
975560|NCT00333840|2361610|P3|NOT COMPLETED|Second-line Treatment Period||14
975561|NCT00333840|2361611|P2|NOT COMPLETED|Second-line Treatment Period||0
975562|NCT00333840|2361612|P1|NOT COMPLETED|Second-line Treatment Period||0
975563|NCT00333840|2361609|P4|COMPLETED|Second-line Treatment Period||175
975564|NCT00333840|2361610|P3|COMPLETED|Second-line Treatment Period||0
975565|NCT00333840|2361611|P2|COMPLETED|Second-line Treatment Period||0
975566|NCT00333840|2361612|P1|COMPLETED|Second-line Treatment Period||0
975567|NCT00333840|2361609|P4|STARTED|Second-line Treatment Period||363
975568|NCT00333840|2361610|P3|STARTED|Second-line Treatment Period||14
975569|NCT00333840|2361611|P2|STARTED|Second-line Treatment Period||0
975570|NCT00333840|2361612|P1|STARTED|Second-line Treatment Period||0
975571|NCT00333840|2361609|P4|NOT COMPLETED|First-line Treatment Period||0
975572|NCT00333840|2361610|P3|NOT COMPLETED|First-line Treatment Period||0
975573|NCT00333840|2361611|P2|NOT COMPLETED|First-line Treatment Period||546
975574|NCT00333840|2361612|P1|NOT COMPLETED|First-line Treatment Period||286
975575|NCT00333840|2361609|P4|COMPLETED|First-line Treatment Period||0
975576|NCT00333840|2361610|P3|COMPLETED|First-line Treatment Period||0
975577|NCT00333840|2361611|P2|COMPLETED|First-line Treatment Period||7
975578|NCT00333840|2361612|P1|COMPLETED|First-line Treatment Period||267
975579|NCT00333840|2361609|P4|Safety Population; Received Study Drug|First-line Treatment Period||0
975580|NCT00333840|2361610|P3|Safety Population; Received Study Drug|First-line Treatment Period||0
975581|NCT00333840|2361611|P2|Safety Population; Received Study Drug|First-line Treatment Period||533
975582|NCT00333840|2361612|P1|Safety Population; Received Study Drug|First-line Treatment Period||551
975583|NCT00333840|2361609|P4|STARTED|First-line Treatment Period||0
975584|NCT00333840|2361610|P3|STARTED|First-line Treatment Period||0
975585|NCT00333840|2361611|P2|STARTED|First-line Treatment Period||553
975586|NCT00333840|2361612|P1|STARTED|First-line Treatment Period||553
975587|NCT00333866|2361641|P4|NOT COMPLETED|Overall Study||66
975588|NCT00333866|2361642|P3|NOT COMPLETED|Overall Study||51
975589|NCT00333866|2361643|P2|NOT COMPLETED|Overall Study||64
975590|NCT00333866|2361644|P1|NOT COMPLETED|Overall Study||48
975591|NCT00333866|2361641|P4|COMPLETED|Overall Study||121
975592|NCT00333866|2361642|P3|COMPLETED|Overall Study||133
975593|NCT00333866|2361643|P2|COMPLETED|Overall Study||123
975594|NCT00333866|2361644|P1|COMPLETED|Overall Study||141
975595|NCT00333866|2361641|P4|TREATED|Overall Study||186
975596|NCT00333866|2361642|P3|TREATED|Overall Study||182
975597|NCT00333866|2361643|P2|TREATED|Overall Study||184
975598|NCT00333866|2361644|P1|TREATED|Overall Study||184
975599|NCT00333866|2361641|P4|STARTED|Overall Study||187
975600|NCT00333866|2361642|P3|STARTED|Overall Study||184
975601|NCT00333866|2361643|P2|STARTED|Overall Study||187
975602|NCT00333866|2361644|P1|STARTED|Overall Study||189
975603|NCT00333879|2361702|P1|NOT COMPLETED|Overall Study||0
975604|NCT00333879|2361702|P1|COMPLETED|Overall Study||4
975605|NCT00333879|2361702|P1|STARTED|Overall Study||4
975606|NCT00333970|2361709|P2|NOT COMPLETED|Overall Study||7
975607|NCT00333970|2361710|P1|NOT COMPLETED|Overall Study||13
975608|NCT00333970|2361709|P2|COMPLETED|Overall Study||18
975609|NCT00333970|2361710|P1|COMPLETED|Overall Study||37
975610|NCT00333970|2361709|P2|STARTED|Overall Study||25
975611|NCT00333970|2361710|P1|STARTED|Overall Study||50
975612|NCT00333983|2361719|P3|NOT COMPLETED|Overall Study||2
975613|NCT00333983|2361720|P2|NOT COMPLETED|Overall Study||5
975614|NCT00333983|2361721|P1|NOT COMPLETED|Overall Study||3
975615|NCT00333983|2361719|P3|COMPLETED|Overall Study||19
975616|NCT00333983|2361720|P2|COMPLETED|Overall Study||16
975617|NCT00333983|2361721|P1|COMPLETED|Overall Study||17
975618|NCT00333983|2361719|P3|STARTED|Overall Study||21
975619|NCT00333983|2361720|P2|STARTED|Overall Study||21
975620|NCT00333983|2361721|P1|STARTED|Overall Study||20
975621|NCT00334061|2361729|P1|NOT COMPLETED|Overall Study||0
975622|NCT00334061|2361729|P1|COMPLETED|Overall Study|November 2007|125
975623|NCT00334061|2361729|P1|STARTED|Overall Study|June 2006|125
975624|NCT00334074|2361738|P1|NOT COMPLETED|Overall Study||0
975625|NCT00334074|2361738|P1|COMPLETED|Overall Study||30
975626|NCT00334074|2361738|P1|STARTED|Overall Study||30
975627|NCT00334113|2361745|P2|NOT COMPLETED|Overall Study||3
975628|NCT00334113|2361746|P1|NOT COMPLETED|Overall Study||2
975629|NCT00334113|2361745|P2|COMPLETED|Overall Study||31
975630|NCT00334113|2361746|P1|COMPLETED|Overall Study||30
975631|NCT00334113|2361745|P2|STARTED|Overall Study||34
975632|NCT00334113|2361746|P1|STARTED|Overall Study||32
975633|NCT00334204|2361752|P1|NOT COMPLETED|Overall Study||2
975634|NCT00334204|2361752|P1|COMPLETED|Overall Study||56
975635|NCT00334204|2361752|P1|STARTED|Overall Study||58
975636|NCT00334282|2361760|P2|NOT COMPLETED|Overall Study||108
975637|NCT00334282|2361761|P1|NOT COMPLETED|Overall Study||222
975638|NCT00334282|2361760|P2|COMPLETED|Overall Study||37
975639|NCT00334282|2361761|P1|COMPLETED|Overall Study||68
975640|NCT00334282|2361760|P2|STARTED|Overall Study||145
975641|NCT00334282|2361761|P1|STARTED|Overall Study||290
975642|NCT00334295|2361784|P1|NOT COMPLETED|Overall Study||5
975643|NCT00334295|2361784|P1|COMPLETED|Overall Study||30
975644|NCT00334295|2361784|P1|STARTED|Overall Study||35
975645|NCT00334542|2361792|P1|NOT COMPLETED|Overall Study||5
975646|NCT00334542|2361792|P1|COMPLETED|Overall Study||45
975647|NCT00334542|2361792|P1|STARTED|Overall Study||50
975648|NCT00334633|2361800|P3|NOT COMPLETED|Overall Study||82
975649|NCT00334633|2361801|P2|NOT COMPLETED|Overall Study||82
975650|NCT00334633|2361802|P1|NOT COMPLETED|Overall Study||80
975651|NCT00334633|2361800|P3|COMPLETED|Overall Study||114
975652|NCT00334633|2361801|P2|COMPLETED|Overall Study||118
975653|NCT00334633|2361802|P1|COMPLETED|Overall Study||117
975654|NCT00334633|2361800|P3|STARTED|Overall Study||196
975655|NCT00334633|2361801|P2|STARTED|Overall Study||200
975656|NCT00334633|2361802|P1|STARTED|Overall Study||197
975657|NCT00334802|2361812|P2|NOT COMPLETED|Overall Study||40
975658|NCT00334802|2361813|P1|NOT COMPLETED|Overall Study||6
975659|NCT00334802|2361812|P2|COMPLETED|Overall Study||16
975660|NCT00334802|2361813|P1|COMPLETED|Overall Study||0
975661|NCT00334802|2361812|P2|STARTED|Overall Study||56
975662|NCT00334802|2361813|P1|STARTED|Overall Study||6
975663|NCT00334815|2361832|P2|NOT COMPLETED|Overall Study||10
975664|NCT00334815|2361833|P1|NOT COMPLETED|Overall Study||7
975665|NCT00334815|2361832|P2|COMPLETED|Overall Study||3
975666|NCT00334815|2361833|P1|COMPLETED|Overall Study||9
975667|NCT00334815|2361832|P2|STARTED|Overall Study||13
975668|NCT00334815|2361833|P1|STARTED|Overall Study||16
975669|NCT00334893|2361847|P2|NOT COMPLETED|Overall Study||0
975670|NCT00334893|2361848|P1|NOT COMPLETED|Overall Study||1
975671|NCT00334893|2361847|P2|COMPLETED|Overall Study||37
975672|NCT00334893|2361848|P1|COMPLETED|Overall Study||36
975673|NCT00334893|2361847|P2|STARTED|Overall Study||37
975674|NCT00334893|2361848|P1|STARTED|Overall Study||37
975675|NCT00334958|2361856|P2|NOT COMPLETED|Overall Study||24
975676|NCT00334958|2361857|P1|NOT COMPLETED|Overall Study||37
975677|NCT00334958|2361856|P2|COMPLETED|Overall Study||156
975678|NCT00334958|2361857|P1|COMPLETED|Overall Study||139
975679|NCT00334958|2361856|P2|STARTED|Overall Study|1 subject withdrawn prior to study drug dosing due to not obtaining labs|180
975680|NCT00334958|2361857|P1|STARTED|Overall Study||176
975681|NCT00335140|2361869|P1|NOT COMPLETED|Overall Study||1
975682|NCT00335140|2361869|P1|COMPLETED|Overall Study||25
975683|NCT00335140|2361869|P1|Treated|Overall Study||25
975684|NCT00335140|2361869|P1|Eligible|Overall Study||25
975685|NCT00335140|2361869|P1|STARTED|Overall Study||26
975686|NCT00335153|2361873|P1|NOT COMPLETED|Post-PEG-J Long-Term Treatment Period||52
975687|NCT00335153|2361873|P1|COMPLETED|Post-PEG-J Long-Term Treatment Period||272
975688|NCT00335153|2361873|P1|STARTED|Post-PEG-J Long-Term Treatment Period||324
975689|NCT00335153|2361873|P1|NOT COMPLETED|Nasojejunal (NJ) Test Period||30
975690|NCT00335153|2361873|P1|COMPLETED|Nasojejunal (NJ) Test Period||324
975691|NCT00335153|2361873|P1|STARTED|Nasojejunal (NJ) Test Period||354
975692|NCT00328510|2361912|P2|NOT COMPLETED|Overall Study||4
975693|NCT00328510|2361913|P1|NOT COMPLETED|Overall Study||10
975694|NCT00328510|2361912|P2|COMPLETED|Overall Study||37
975695|NCT00328510|2361913|P1|COMPLETED|Overall Study||32
975696|NCT00328510|2361912|P2|STARTED|Overall Study||41
975697|NCT00328510|2361913|P1|STARTED|Overall Study||42
975698|NCT00328562|2361919|P1|NOT COMPLETED|Overall Study||1
975699|NCT00328562|2361919|P1|COMPLETED|Overall Study||12
975700|NCT00328562|2361919|P1|STARTED|Overall Study||13
975701|NCT00328614|2361932|P6|NOT COMPLETED|Overall Study||1
975702|NCT00328614|2361933|P5|NOT COMPLETED|Overall Study||1
975703|NCT00328614|2361934|P4|NOT COMPLETED|Overall Study||1
975704|NCT00328614|2361935|P3|NOT COMPLETED|Overall Study||0
975705|NCT00328614|2361936|P2|NOT COMPLETED|Overall Study||0
975706|NCT00328614|2361937|P1|NOT COMPLETED|Overall Study||0
975707|NCT00328614|2361932|P6|COMPLETED|Overall Study||5
975708|NCT00328614|2361933|P5|COMPLETED|Overall Study||5
975709|NCT00328614|2361934|P4|COMPLETED|Overall Study||5
975710|NCT00328614|2361935|P3|COMPLETED|Overall Study||6
975711|NCT00328614|2361936|P2|COMPLETED|Overall Study||4
975712|NCT00328614|2361937|P1|COMPLETED|Overall Study||4
975713|NCT00328614|2361932|P6|STARTED|Overall Study||6
975714|NCT00328614|2361933|P5|STARTED|Overall Study||6
975715|NCT00328614|2361934|P4|STARTED|Overall Study||6
975716|NCT00328614|2361935|P3|STARTED|Overall Study||6
975717|NCT00328614|2361936|P2|STARTED|Overall Study||4
975718|NCT00328614|2361937|P1|STARTED|Overall Study||4
975719|NCT00328627|2361958|P12|NOT COMPLETED|Overall Study||16
975720|NCT00328627|2361959|P11|NOT COMPLETED|Overall Study||18
975721|NCT00328627|2361960|P10|NOT COMPLETED|Overall Study||32
975722|NCT00328627|2361961|P9|NOT COMPLETED|Overall Study||17
975723|NCT00328627|2361962|P8|NOT COMPLETED|Overall Study||14
975724|NCT00328627|2361963|P7|NOT COMPLETED|Overall Study||35
975725|NCT00328627|2361964|P6|NOT COMPLETED|Overall Study||20
975726|NCT00328627|2361965|P5|NOT COMPLETED|Overall Study||15
975727|NCT00328627|2361966|P4|NOT COMPLETED|Overall Study||37
975728|NCT00328627|2361967|P3|NOT COMPLETED|Overall Study||28
975729|NCT00328627|2361968|P2|NOT COMPLETED|Overall Study||31
975730|NCT00328627|2361969|P1|NOT COMPLETED|Overall Study||59
975731|NCT00328627|2361958|P12|COMPLETED|Overall Study||114
975732|NCT00328627|2361959|P11|COMPLETED|Overall Study||112
975733|NCT00328627|2361960|P10|COMPLETED|Overall Study||97
975734|NCT00328627|2361961|P9|COMPLETED|Overall Study||113
975735|NCT00328627|2361962|P8|COMPLETED|Overall Study||116
975736|NCT00328627|2361963|P7|COMPLETED|Overall Study||94
975737|NCT00328627|2361964|P6|COMPLETED|Overall Study||110
975738|NCT00328627|2361965|P5|COMPLETED|Overall Study||115
975739|NCT00328627|2361966|P4|COMPLETED|Overall Study||93
975740|NCT00328627|2361967|P3|COMPLETED|Overall Study||101
975741|NCT00328627|2361968|P2|COMPLETED|Overall Study||97
975742|NCT00328627|2361969|P1|COMPLETED|Overall Study||70
975743|NCT00328627|2361958|P12|Safety Set|Overall Study||130
975744|NCT00328627|2361959|P11|Safety Set|Overall Study||130
975745|NCT00328627|2361960|P10|Safety Set|Overall Study||129
975746|NCT00328627|2361961|P9|Safety Set|Overall Study||130
975747|NCT00328627|2361962|P8|Safety Set|Overall Study||130
975748|NCT00328627|2361963|P7|Safety Set|Overall Study||129
975749|NCT00328627|2361964|P6|Safety Set|Overall Study||130
975750|NCT00328627|2361965|P5|Safety Set|Overall Study||130
975751|NCT00328627|2361966|P4|Safety Set|Overall Study||129
975752|NCT00328627|2361967|P3|Safety Set|Overall Study||129
975753|NCT00328627|2361968|P2|Safety Set|Overall Study||128
975754|NCT00328627|2361969|P1|Safety Set|Overall Study|All patients who took at least 1 dose of double-blind study drug.|129
975755|NCT00328627|2361958|P12|STARTED|Overall Study||130
975756|NCT00328627|2361959|P11|STARTED|Overall Study||130
975757|NCT00328627|2361960|P10|STARTED|Overall Study||129
975758|NCT00328627|2361961|P9|STARTED|Overall Study||130
975759|NCT00328627|2361962|P8|STARTED|Overall Study||130
975760|NCT00328627|2361963|P7|STARTED|Overall Study||129
975761|NCT00328627|2361964|P6|STARTED|Overall Study||130
975762|NCT00328627|2361965|P5|STARTED|Overall Study||130
975763|NCT00328627|2361966|P4|STARTED|Overall Study||130
975764|NCT00328627|2361967|P3|STARTED|Overall Study||129
975765|NCT00328627|2361968|P2|STARTED|Overall Study||128
975766|NCT00328627|2361969|P1|STARTED|Overall Study||129
975767|NCT00335257|2363489|P3|NOT COMPLETED|Overall Study||0
975768|NCT00335257|2363490|P2|NOT COMPLETED|Overall Study||0
975769|NCT00335257|2363491|P1|NOT COMPLETED|Overall Study||0
975770|NCT00335257|2363489|P3|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|60190
975771|NCT00335257|2363490|P2|COMPLETED|Overall Study||9377
975772|NCT00335257|2363491|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|15542
975773|NCT00335257|2363489|P3|STARTED|Overall Study||60190
975774|NCT00335257|2363490|P2|STARTED|Overall Study||9377
975775|NCT00335257|2363491|P1|STARTED|Overall Study||15542
975776|NCT00335283|2363510|P2|NOT COMPLETED|Overall Study||5
975777|NCT00335283|2363511|P1|NOT COMPLETED|Overall Study||6
975778|NCT00335283|2363510|P2|COMPLETED|Overall Study||34
975779|NCT00335283|2363511|P1|COMPLETED|Overall Study||30
975780|NCT00335283|2363510|P2|STARTED|Overall Study||39
975781|NCT00335283|2363511|P1|STARTED|Overall Study||36
975782|NCT00335322|2363526|P3|NOT COMPLETED|Overall Study||2
975783|NCT00335322|2363527|P2|NOT COMPLETED|Overall Study||2
975784|NCT00335322|2363528|P1|NOT COMPLETED|Overall Study||1
975785|NCT00335322|2363526|P3|COMPLETED|Overall Study||103
975786|NCT00335322|2363527|P2|COMPLETED|Overall Study||105
975787|NCT00335322|2363528|P1|COMPLETED|Overall Study||114
975788|NCT00335322|2363526|P3|STARTED|Overall Study||105
975789|NCT00335322|2363527|P2|STARTED|Overall Study||107
975790|NCT00335322|2363528|P1|STARTED|Overall Study||115
975791|NCT00335452|2363540|P4|NOT COMPLETED|Overall Study||131
975792|NCT00335452|2363541|P3|NOT COMPLETED|Overall Study||159
975793|NCT00335452|2363542|P2|NOT COMPLETED|Overall Study||147
975794|NCT00335452|2363543|P1|NOT COMPLETED|Overall Study||158
975795|NCT00335452|2363540|P4|COMPLETED|Overall Study|Completed 30 days follow-up period|6122
975796|NCT00335452|2363541|P3|COMPLETED|Overall Study|Completed 30 days follow-up period|6108
975797|NCT00335452|2363542|P2|COMPLETED|Overall Study|Completed 30 days follow-up period|6107
975798|NCT00335452|2363543|P1|COMPLETED|Overall Study|Completed 30 days follow-up period|6154
975799|NCT00335452|2363540|P4|TREATED WITH ASA|Overall Study||6247
975800|NCT00335452|2363541|P3|TREATED WITH ASA|Overall Study||6261
975801|NCT00335452|2363542|P2|TREATED WITH ASA|Overall Study||6251
975802|NCT00335452|2363543|P1|TREATED WITH ASA|Overall Study||6302
975803|NCT00335452|2363540|P4|TREATED WITH CLOPIDOGREL|Overall Study||6217
975804|NCT00335452|2363541|P3|TREATED WITH CLOPIDOGREL|Overall Study||6228
975805|NCT00335452|2363542|P2|TREATED WITH CLOPIDOGREL|Overall Study||6218
975806|NCT00335452|2363543|P1|TREATED WITH CLOPIDOGREL|Overall Study||6271
975807|NCT00335452|2363540|P4|STARTED|Overall Study|Randomized|6253
975808|NCT00335452|2363541|P3|STARTED|Overall Study|Randomized|6267
975809|NCT00335452|2363542|P2|STARTED|Overall Study|Randomized|6254
975810|NCT00335452|2363543|P1|STARTED|Overall Study|Randomized|6312
975811|NCT00335478|2363565|P1|NOT COMPLETED|Overall Study||24
975812|NCT00335478|2363565|P1|COMPLETED|Overall Study||30
975813|NCT00335478|2363565|P1|STARTED|Overall Study||54
975814|NCT00335504|2363573|P4|NOT COMPLETED|Overall Study||0
975815|NCT00335504|2363574|P3|NOT COMPLETED|Overall Study||0
975816|NCT00335504|2363575|P2|NOT COMPLETED|Overall Study||0
975817|NCT00335504|2363576|P1|NOT COMPLETED|Overall Study||0
975818|NCT00335504|2363573|P4|COMPLETED|Overall Study||22
975819|NCT00335504|2363574|P3|COMPLETED|Overall Study||20
975820|NCT00335504|2363575|P2|COMPLETED|Overall Study||21
975821|NCT00335504|2363576|P1|COMPLETED|Overall Study||22
975822|NCT00335504|2363573|P4|STARTED|Overall Study||22
975823|NCT00335504|2363574|P3|STARTED|Overall Study||20
975824|NCT00335504|2363575|P2|STARTED|Overall Study||21
975825|NCT00335504|2363576|P1|STARTED|Overall Study||22
975826|NCT00335517|2363598|P1|NOT COMPLETED|Overall Study||2
975827|NCT00335517|2363598|P1|COMPLETED|Overall Study|Due to pharmacy error two patients were enolled and recieved EREM, but were not included in analysis|98
975828|NCT00335517|2363598|P1|STARTED|Overall Study||100
975829|NCT00335556|2363608|P6|NOT COMPLETED|Overall Study||1
975830|NCT00335556|2363609|P5|NOT COMPLETED|Overall Study||1
975831|NCT00335556|2363610|P4|NOT COMPLETED|Overall Study||5
975832|NCT00335556|2363611|P3|NOT COMPLETED|Overall Study||5
975833|NCT00335556|2363612|P2|NOT COMPLETED|Overall Study||34
975834|NCT00335556|2363613|P1|NOT COMPLETED|Overall Study||2
975835|NCT00335556|2363608|P6|COMPLETED|Overall Study||29
975836|NCT00335556|2363609|P5|COMPLETED|Overall Study||77
975837|NCT00335556|2363610|P4|COMPLETED|Overall Study||5
975838|NCT00335556|2363611|P3|COMPLETED|Overall Study||2
975839|NCT00335556|2363612|P2|COMPLETED|Overall Study||64
975840|NCT00335556|2363613|P1|COMPLETED|Overall Study||66
975841|NCT00335556|2363608|P6|STARTED|Overall Study||30
975842|NCT00335556|2363609|P5|STARTED|Overall Study||78
975843|NCT00335556|2363610|P4|STARTED|Overall Study||10
975844|NCT00335556|2363611|P3|STARTED|Overall Study||7
975845|NCT00335556|2363612|P2|STARTED|Overall Study||98
975846|NCT00335556|2363613|P1|STARTED|Overall Study||68
975847|NCT00335725|2363636|P2|NOT COMPLETED|Overall Study||5
975848|NCT00335725|2363637|P1|NOT COMPLETED|Overall Study||4
975849|NCT00335725|2363636|P2|COMPLETED|Overall Study||71
975850|NCT00335725|2363637|P1|COMPLETED|Overall Study||71
975851|NCT00335725|2363636|P2|STARTED|Overall Study||76
975852|NCT00335725|2363637|P1|STARTED|Overall Study||75
975853|NCT00335777|2363645|P1|NOT COMPLETED|Treated 2 Headaches Per Protocol||13
975854|NCT00335777|2363645|P1|COMPLETED|Treated 2 Headaches Per Protocol||22
975855|NCT00335777|2363645|P1|STARTED|Treated 2 Headaches Per Protocol||35
975856|NCT00335777|2363645|P1|NOT COMPLETED|Enrolled and Dispensed Study Medication||29
975857|NCT00335777|2363645|P1|COMPLETED|Enrolled and Dispensed Study Medication||35
975858|NCT00335777|2363645|P1|STARTED|Enrolled and Dispensed Study Medication|64 subjects enrolled. 35 treated 2 headaches, but 22/35 at appropriate times, as per protocol.|64
975859|NCT00335829|2363650|P1|NOT COMPLETED|Overall Study||3
975860|NCT00335829|2363650|P1|COMPLETED|Overall Study||23
975861|NCT00335829|2363650|P1|Received First TACE|Overall Study|1 patient left after receiving bevacizumab but prior to first TACE|25
975862|NCT00335829|2363650|P1|Received Bevacizumab|Overall Study||26
975863|NCT00335829|2363650|P1|STARTED|Overall Study||26
975864|NCT00335959|2363664|P1|NOT COMPLETED|Overall Study||3
975865|NCT00335959|2363664|P1|COMPLETED|Overall Study||4
975866|NCT00335959|2363664|P1|Eligible and Began Protocol Therapy|Overall Study||6
975867|NCT00335959|2363664|P1|Eligible|Overall Study||6
975868|NCT00335959|2363664|P1|STARTED|Overall Study||7
975869|NCT00335972|2363671|P2|NOT COMPLETED|Overall Study||3
975870|NCT00335972|2363672|P1|NOT COMPLETED|Overall Study||0
975871|NCT00335972|2363671|P2|COMPLETED|Overall Study||68
975872|NCT00335972|2363672|P1|COMPLETED|Overall Study||71
975873|NCT00335972|2363671|P2|STARTED|Overall Study||71
975874|NCT00335972|2363672|P1|STARTED|Overall Study||71
975875|NCT00336232|2363682|P1|NOT COMPLETED|High Vitamin K (500mcg Daily)||0
975876|NCT00336232|2363682|P1|COMPLETED|High Vitamin K (500mcg Daily)||42
975877|NCT00336232|2363682|P1|STARTED|High Vitamin K (500mcg Daily)||42
975878|NCT00336232|2363682|P1|NOT COMPLETED|Low Vitamin K (10mcg Daily)||0
975879|NCT00336232|2363682|P1|COMPLETED|Low Vitamin K (10mcg Daily)||42
975880|NCT00336232|2363682|P1|STARTED|Low Vitamin K (10mcg Daily)||42
975881|NCT00336232|2363682|P1|NOT COMPLETED|Baseline (200mcg Daily)||17
975882|NCT00336232|2363682|P1|COMPLETED|Baseline (200mcg Daily)||42
975883|NCT00336232|2363682|P1|STARTED|Baseline (200mcg Daily)||59
975884|NCT00336284|2363688|P2|NOT COMPLETED|Overall Study||151
975885|NCT00336284|2363689|P1|NOT COMPLETED|Overall Study||236
975886|NCT00336284|2363688|P2|COMPLETED|Overall Study||322
975887|NCT00336284|2363689|P1|COMPLETED|Overall Study||741
975888|NCT00336284|2363688|P2|STARTED|Overall Study||473
975889|NCT00336284|2363689|P1|STARTED|Overall Study||977
975890|NCT00336323|2363706|P5|NOT COMPLETED|Overall Study||3
975891|NCT00336323|2363707|P4|NOT COMPLETED|Overall Study||0
975892|NCT00336323|2363708|P3|NOT COMPLETED|Overall Study||1
975893|NCT00336323|2363709|P2|NOT COMPLETED|Overall Study||1
975894|NCT00336323|2363710|P1|NOT COMPLETED|Overall Study||0
975895|NCT00336323|2363706|P5|COMPLETED|Overall Study||19
975896|NCT00336323|2363707|P4|COMPLETED|Overall Study||22
975897|NCT00336323|2363708|P3|COMPLETED|Overall Study||23
975898|NCT00336323|2363709|P2|COMPLETED|Overall Study||21
975899|NCT00336323|2363710|P1|COMPLETED|Overall Study||19
975900|NCT00336323|2363706|P5|24 Week Visit|Overall Study||19
975901|NCT00336323|2363707|P4|24 Week Visit|Overall Study||22
975902|NCT00336323|2363708|P3|24 Week Visit|Overall Study|1 patient was dropped from the study|22
975903|NCT00336323|2363709|P2|24 Week Visit|Overall Study|1 patient was dropped from the study|20
975904|NCT00336323|2363710|P1|24 Week Visit|Overall Study||18
975905|NCT00336323|2363706|P5|18 Week Visit|Overall Study|1 patient was dropped from the study|18
975906|NCT00336323|2363707|P4|18 Week Visit|Overall Study||21
975907|NCT00336323|2363708|P3|18 Week Visit|Overall Study||23
975908|NCT00336323|2363709|P2|18 Week Visit|Overall Study||22
975909|NCT00336323|2363710|P1|18 Week Visit|Overall Study||19
975910|NCT00336323|2363706|P5|12 Week Visit|Overall Study|1 patient was dropped from study|20
975911|NCT00336323|2363707|P4|12 Week Visit|Overall Study||22
975912|NCT00336323|2363708|P3|12 Week Visit|Overall Study||24
975913|NCT00336323|2363709|P2|12 Week Visit|Overall Study||21
975914|NCT00336323|2363710|P1|12 Week Visit|Overall Study||19
975915|NCT00336323|2363706|P5|9 Week Visit|Overall Study||19
975916|NCT00336323|2363707|P4|9 Week Visit|Overall Study||21
975917|NCT00336323|2363708|P3|9 Week Visit|Overall Study||23
975918|NCT00336323|2363709|P2|9 Week Visit|Overall Study||21
975919|NCT00336323|2363710|P1|9 Week Visit|Overall Study||18
975920|NCT00336323|2363706|P5|6 Week Visit|Overall Study|1 patient was dropped - injection was given late at 9 wks for one patient|20
975921|NCT00336323|2363707|P4|6 Week Visit|Overall Study||22
975922|NCT00336323|2363708|P3|6 Week Visit|Overall Study||24
975923|NCT00336323|2363709|P2|6 Week Visit|Overall Study||22
975924|NCT00336323|2363710|P1|6 Week Visit|Overall Study||18
975925|NCT00336323|2363706|P5|3 Week Visit|Overall Study|Laser given late at six weeks for one patient|20
975926|NCT00336323|2363707|P4|3 Week Visit|Overall Study||22
975927|NCT00336323|2363708|P3|3 Week Visit|Overall Study||24
975928|NCT00336323|2363709|P2|3 Week Visit|Overall Study||21
975929|NCT00336323|2363710|P1|3 Week Visit|Overall Study||18
975930|NCT00336323|2363706|P5|STARTED|Overall Study||22
975931|NCT00336323|2363707|P4|STARTED|Overall Study||22
975932|NCT00336323|2363708|P3|STARTED|Overall Study||24
975933|NCT00336323|2363709|P2|STARTED|Overall Study||22
975934|NCT00336323|2363710|P1|STARTED|Overall Study||19
975935|NCT00336479|2363769|P4|NOT COMPLETED|Overall Study||4
975936|NCT00336479|2363770|P3|NOT COMPLETED|Overall Study||26
975937|NCT00336479|2363771|P2|NOT COMPLETED|Overall Study||25
975938|NCT00336479|2363772|P1|NOT COMPLETED|Overall Study||37
975939|NCT00336479|2363769|P4|COMPLETED|Overall Study||13
975940|NCT00336479|2363770|P3|COMPLETED|Overall Study||53
975941|NCT00336479|2363771|P2|COMPLETED|Overall Study||54
975942|NCT00336479|2363772|P1|COMPLETED|Overall Study||38
975943|NCT00336479|2363769|P4|STARTED|Overall Study||17
975944|NCT00336479|2363770|P3|STARTED|Overall Study||79
975945|NCT00336479|2363771|P2|STARTED|Overall Study||79
975946|NCT00336479|2363772|P1|STARTED|Overall Study||75
975947|NCT00336492|2363798|P3|NOT COMPLETED|Overall Study||11
975948|NCT00336492|2363799|P2|NOT COMPLETED|Overall Study||4
975949|NCT00336492|2363800|P1|NOT COMPLETED|Overall Study||15
975950|NCT00336492|2363798|P3|COMPLETED|Overall Study||12
975951|NCT00336492|2363799|P2|COMPLETED|Overall Study||18
975952|NCT00336492|2363800|P1|COMPLETED|Overall Study||0
975953|NCT00336492|2363798|P3|STARTED|Overall Study||23
975954|NCT00336492|2363799|P2|STARTED|Overall Study||22
975955|NCT00336492|2363800|P1|STARTED|Overall Study||15
975956|NCT00336505|2363810|P2|NOT COMPLETED|Overall Study||27
975957|NCT00336505|2363811|P1|NOT COMPLETED|Overall Study||37
975958|NCT00336505|2363810|P2|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|264
975959|NCT00336505|2363811|P1|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|254
975960|NCT00336505|2363810|P2|STARTED|Overall Study|All subjects who were randomized and dosed.|291
975961|NCT00336505|2363811|P1|STARTED|Overall Study|All subjects who were randomized and dosed.|291
975962|NCT00336544|2363825|P2|NOT COMPLETED|Overall Study||22
975963|NCT00336544|2363826|P1|NOT COMPLETED|Overall Study||19
975964|NCT00336544|2363825|P2|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|238
975965|NCT00336544|2363826|P1|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|242
975966|NCT00336544|2363825|P2|STARTED|Overall Study|All subjects who were randomized and dosed.|260
975967|NCT00336544|2363826|P1|STARTED|Overall Study|All subjects who were randomized and dosed.|261
975968|NCT00336583|2363838|P1|NOT COMPLETED|Overall Study||2
975969|NCT00336583|2363838|P1|COMPLETED|Overall Study||25
975970|NCT00336583|2363838|P1|STARTED|Overall Study||27
975971|NCT00336700|2363843|P1|NOT COMPLETED|Overall Study||0
975972|NCT00336700|2363843|P1|COMPLETED|Overall Study||25
975973|NCT00336700|2363843|P1|STARTED|Overall Study||25
975974|NCT00336817|2363854|P2|NOT COMPLETED|Overall Study||2
975975|NCT00336817|2363855|P1|NOT COMPLETED|Overall Study||1
975976|NCT00336817|2363854|P2|COMPLETED|Overall Study||13
975977|NCT00336817|2363855|P1|COMPLETED|Overall Study||14
975978|NCT00336817|2363854|P2|STARTED|Overall Study||15
975979|NCT00336817|2363855|P1|STARTED|Overall Study||15
975980|NCT00336856|2363885|P1|NOT COMPLETED|Overall Study||4
975981|NCT00336856|2363885|P1|COMPLETED|Overall Study||31
975982|NCT00336856|2363885|P1|STARTED|Overall Study|Number of patients consented and registered for the study|35
975983|NCT00336895|2363891|P1|NOT COMPLETED|Overall Study||4
975984|NCT00336895|2363891|P1|COMPLETED|Overall Study||26
975985|NCT00336895|2363891|P1|STARTED|Overall Study||30
975986|NCT00336973|2363897|P1|NOT COMPLETED|Overall Study||33
975987|NCT00336973|2363897|P1|COMPLETED|Overall Study||33
975988|NCT00336973|2363897|P1|STARTED|Overall Study||66
975989|NCT00337077|2363906|P3|NOT COMPLETED|Overall Study||25
975990|NCT00337077|2363907|P2|NOT COMPLETED|Overall Study||53
975991|NCT00337077|2363908|P1|NOT COMPLETED|Overall Study||43
975992|NCT00337077|2363906|P3|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
975993|NCT00337077|2363907|P2|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
975994|NCT00337077|2363908|P1|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
975995|NCT00337077|2363906|P3|Patients With Measurable Disease|Overall Study||13
975996|NCT00337077|2363907|P2|Patients With Measurable Disease|Overall Study||38
975997|NCT00337077|2363908|P1|Patients With Measurable Disease|Overall Study||26
975998|NCT00337077|2363906|P3|Eligible and Treated|Overall Study||24
975999|NCT00337077|2363907|P2|Eligible and Treated|Overall Study||51
976000|NCT00337077|2363908|P1|Eligible and Treated|Overall Study||41
976001|NCT00337077|2363906|P3|Toxicity Assessed|Overall Study||25
976002|NCT00337077|2363907|P2|Toxicity Assessed|Overall Study||51
976003|NCT00337077|2363908|P1|Toxicity Assessed|Overall Study||42
976004|NCT00337077|2363906|P3|Treated|Overall Study||25
976005|NCT00337077|2363907|P2|Treated|Overall Study||52
976006|NCT00337077|2363908|P1|Treated|Overall Study||42
976007|NCT00337077|2363906|P3|STARTED|Overall Study||25
976008|NCT00337077|2363907|P2|STARTED|Overall Study||53
976009|NCT00337077|2363908|P1|STARTED|Overall Study||43
976010|NCT00337103|2363919|P2|NOT COMPLETED|Overall Study||543
976011|NCT00337103|2363920|P1|NOT COMPLETED|Overall Study||549
976012|NCT00337103|2363919|P2|COMPLETED|Overall Study||5
976013|NCT00337103|2363920|P1|COMPLETED|Overall Study||5
976014|NCT00337103|2363919|P2|STARTED|Overall Study||548
976015|NCT00337103|2363920|P1|STARTED|Overall Study||554
976016|NCT00337129|2363928|P1|NOT COMPLETED|Overall Study||40
976017|NCT00337129|2363928|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until discontinuation criterion is met.|0
976018|NCT00337129|2363928|P1|STARTED|Overall Study||40
976019|NCT00337168|2363935|P1|NOT COMPLETED|Overall Study||8
976020|NCT00337168|2363935|P1|COMPLETED|Overall Study||29
976021|NCT00337168|2363935|P1|Eligible and Treated|Overall Study||36
976022|NCT00337168|2363935|P1|Eligible|Overall Study||37
976023|NCT00337168|2363935|P1|STARTED|Overall Study||37
976024|NCT00337194|2363944|P2|NOT COMPLETED|Overall Study||4
976025|NCT00337194|2363945|P1|NOT COMPLETED|Overall Study||12
976026|NCT00337194|2363944|P2|COMPLETED|Overall Study||3
976027|NCT00337194|2363945|P1|COMPLETED|Overall Study||11
976028|NCT00337194|2363944|P2|STARTED|Overall Study||7
976029|NCT00337194|2363945|P1|STARTED|Overall Study||23
976030|NCT00337207|2363960|P1|NOT COMPLETED|Overall Study||3
976031|NCT00337207|2363960|P1|COMPLETED|Overall Study||52
976032|NCT00337207|2363960|P1|STARTED|Overall Study||55
976033|NCT00337272|2363966|P2|NOT COMPLETED|Withdrawal Period||1
976034|NCT00337272|2363967|P1|NOT COMPLETED|Withdrawal Period||0
976035|NCT00337272|2363966|P2|COMPLETED|Withdrawal Period||6
976036|NCT00337272|2363967|P1|COMPLETED|Withdrawal Period||6
976037|NCT00337272|2363966|P2|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|7
976038|NCT00337272|2363967|P1|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|6
976039|NCT00337272|2363966|P2|NOT COMPLETED|Treatment Period||2
976040|NCT00337272|2363967|P1|NOT COMPLETED|Treatment Period||1
976041|NCT00337272|2363966|P2|COMPLETED|Treatment Period||7
976042|NCT00337272|2363967|P1|COMPLETED|Treatment Period||6
976043|NCT00337272|2363966|P2|Randomization|Treatment Period||9
976044|NCT00337272|2363967|P1|Randomization|Treatment Period||7
976045|NCT00337272|2363966|P2|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|9
976046|NCT00337272|2363967|P1|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|7
976047|NCT00337272|2363966|P2|NOT COMPLETED|Screening Period (Pre-randomization)||0
976048|NCT00337272|2363967|P1|NOT COMPLETED|Screening Period (Pre-randomization)||6
976049|NCT00337272|2363966|P2|COMPLETED|Screening Period (Pre-randomization)||0
976050|NCT00337272|2363967|P1|COMPLETED|Screening Period (Pre-randomization)|16 subjects completed the screening period and were eligible for randomization.|16
976051|NCT00337272|2363966|P2|STARTED|Screening Period (Pre-randomization)||0
976052|NCT00337272|2363967|P1|STARTED|Screening Period (Pre-randomization)|22 subjects were consented. All subjects received placebo during the 2 week screening period.|22
976053|NCT00337285|2363987|P1|NOT COMPLETED|Overall Study||158
976054|NCT00337285|2363987|P1|COMPLETED|Overall Study||191
976055|NCT00337285|2363987|P1|STARTED|Overall Study||349
976056|NCT00337350|2363995|P2|NOT COMPLETED|Overall Study||1
976057|NCT00337350|2363996|P1|NOT COMPLETED|Overall Study||1
976058|NCT00337350|2363995|P2|COMPLETED|Overall Study||10
976059|NCT00337350|2363996|P1|COMPLETED|Overall Study||8
976060|NCT00337350|2363995|P2|STARTED|Overall Study||11
976061|NCT00337350|2363996|P1|STARTED|Overall Study||9
976062|NCT00337428|2364008|P2|NOT COMPLETED|Overall Study||3
976063|NCT00337428|2364009|P1|NOT COMPLETED|Overall Study||4
976064|NCT00337428|2364008|P2|COMPLETED|Overall Study||421
976065|NCT00337428|2364009|P1|COMPLETED|Overall Study||415
976066|NCT00337428|2364008|P2|STARTED|Overall Study||424
976067|NCT00337428|2364009|P1|STARTED|Overall Study||419
976068|NCT00337467|2364047|P1|NOT COMPLETED|Overall Study||10
976069|NCT00337467|2364047|P1|COMPLETED|Overall Study||51
976070|NCT00337467|2364047|P1|Discontinued Prior to Week 96|Overall Study|5 of these participants discontinued prior to Week 48|10
976071|NCT00337467|2364047|P1|STARTED|Overall Study||61
976072|NCT00337571|2364068|P4|NOT COMPLETED|Overall Study||7
976073|NCT00337571|2364069|P3|NOT COMPLETED|Overall Study||10
976074|NCT00337571|2364070|P2|NOT COMPLETED|Overall Study||9
976075|NCT00337571|2364071|P1|NOT COMPLETED|Overall Study||14
976076|NCT00337571|2364068|P4|COMPLETED|Overall Study||47
976077|NCT00337571|2364069|P3|COMPLETED|Overall Study||49
976078|NCT00337571|2364070|P2|COMPLETED|Overall Study||44
976079|NCT00337571|2364071|P1|COMPLETED|Overall Study||38
976080|NCT00337571|2364068|P4|STARTED|Overall Study||54
976081|NCT00337571|2364069|P3|STARTED|Overall Study||59
976082|NCT00337571|2364070|P2|STARTED|Overall Study||53
976083|NCT00337571|2364071|P1|STARTED|Overall Study||52
976084|NCT00337610|2364111|P2|NOT COMPLETED|Overall Study||14
976085|NCT00337610|2364112|P1|NOT COMPLETED|Overall Study||17
976086|NCT00337610|2364111|P2|COMPLETED|Overall Study||80
976087|NCT00337610|2364112|P1|COMPLETED|Overall Study||79
976088|NCT00337610|2364111|P2|Completed Week 18|Overall Study||82
976089|NCT00337610|2364112|P1|Completed Week 18|Overall Study||89
976090|NCT00337610|2364111|P2|STARTED|Overall Study||94
976091|NCT00337610|2364112|P1|STARTED|Overall Study||96
976092|NCT00337662|2364127|P4|NOT COMPLETED|Study Period III||0
976093|NCT00337662|2364128|P3|NOT COMPLETED|Study Period III||44
976094|NCT00337662|2364129|P2|NOT COMPLETED|Study Period III||58
976095|NCT00337662|2364130|P1|NOT COMPLETED|Study Period III||60
976096|NCT00337662|2364127|P4|COMPLETED|Study Period III||0
976097|NCT00337662|2364128|P3|COMPLETED|Study Period III||100
976098|NCT00337662|2364129|P2|COMPLETED|Study Period III||134
976099|NCT00337662|2364130|P1|COMPLETED|Study Period III||126
976100|NCT00337662|2364127|P4|STARTED|Study Period III||0
976101|NCT00337662|2364128|P3|STARTED|Study Period III||144
976102|NCT00337662|2364129|P2|STARTED|Study Period III||192
976103|NCT00337662|2364130|P1|STARTED|Study Period III||186
976104|NCT00337662|2364127|P4|NOT COMPLETED|Study Period II||106
976105|NCT00337662|2364128|P3|NOT COMPLETED|Study Period II||0
976106|NCT00337662|2364129|P2|NOT COMPLETED|Study Period II||0
976107|NCT00337662|2364130|P1|NOT COMPLETED|Study Period II||0
976108|NCT00337662|2364127|P4|COMPLETED|Study Period II||522
976109|NCT00337662|2364128|P3|COMPLETED|Study Period II||0
976110|NCT00337662|2364129|P2|COMPLETED|Study Period II||0
976111|NCT00337662|2364130|P1|COMPLETED|Study Period II||0
976112|NCT00337662|2364127|P4|STARTED|Study Period II||628
976113|NCT00337662|2364128|P3|STARTED|Study Period II||0
976114|NCT00337662|2364129|P2|STARTED|Study Period II||0
976115|NCT00337662|2364130|P1|STARTED|Study Period II||0
976116|NCT00337675|2364185|P3|NOT COMPLETED|Overall Study||99
976117|NCT00337675|2364186|P2|NOT COMPLETED|Overall Study||103
976118|NCT00337675|2364187|P1|NOT COMPLETED|Overall Study||97
976119|NCT00337675|2364185|P3|COMPLETED|Overall Study||492
976120|NCT00337675|2364186|P2|COMPLETED|Overall Study||488
976121|NCT00337675|2364187|P1|COMPLETED|Overall Study||492
976122|NCT00337675|2364185|P3|STARTED|Overall Study||591
976123|NCT00337675|2364186|P2|STARTED|Overall Study||591
976124|NCT00337675|2364187|P1|STARTED|Overall Study||589
976125|NCT00337727|2364203|P2|NOT COMPLETED|Overall Study||12
976126|NCT00337727|2364204|P1|NOT COMPLETED|Overall Study||18
976127|NCT00337727|2364203|P2|COMPLETED|Overall Study||406
976128|NCT00337727|2364204|P1|COMPLETED|Overall Study||412
976129|NCT00337727|2364203|P2|STARTED|Overall Study||418
976130|NCT00337727|2364204|P1|STARTED|Overall Study||430
976131|NCT00337779|2364214|P2|NOT COMPLETED|Overall Study||79
976132|NCT00337779|2364215|P1|NOT COMPLETED|Overall Study||52
976133|NCT00337779|2364214|P2|COMPLETED|Overall Study||490
976134|NCT00337779|2364215|P1|COMPLETED|Overall Study||534
976135|NCT00337779|2364214|P2|STARTED|Overall Study||569
976136|NCT00337779|2364215|P1|STARTED|Overall Study||586
976137|NCT00337818|2364228|P3|NOT COMPLETED|Overall Study||107
976138|NCT00337818|2364229|P2|NOT COMPLETED|Overall Study||91
976139|NCT00337818|2364230|P1|NOT COMPLETED|Overall Study||289
976140|NCT00337818|2364228|P3|COMPLETED|Overall Study||51
976141|NCT00337818|2364229|P2|COMPLETED|Overall Study||63
976142|NCT00337818|2364230|P1|COMPLETED|Overall Study||169
976143|NCT00337818|2364228|P3|STARTED|Overall Study||158
976144|NCT00337818|2364229|P2|STARTED|Overall Study||154
976145|NCT00337818|2364230|P1|STARTED|Overall Study||458
976146|NCT00337935|2364252|P2|NOT COMPLETED|Overall Study||27
976147|NCT00337935|2364253|P1|NOT COMPLETED|Overall Study||10
976148|NCT00337935|2364252|P2|COMPLETED|Overall Study||91
976149|NCT00337935|2364253|P1|COMPLETED|Overall Study||29
976150|NCT00337935|2364252|P2|STARTED|Overall Study||118
976151|NCT00337935|2364253|P1|STARTED|Overall Study||39
976152|NCT00337987|2364263|P1|NOT COMPLETED|Overall Study||0
976153|NCT00337987|2364263|P1|COMPLETED|Overall Study||49
976154|NCT00337987|2364263|P1|STARTED|Overall Study||49
976155|NCT00338039|2364268|P1|NOT COMPLETED|Overall Study||0
976156|NCT00338039|2364268|P1|COMPLETED|Overall Study||69
976157|NCT00338039|2364268|P1|STARTED|Overall Study||69
976158|NCT00338104|2364276|P3|NOT COMPLETED|Overall Study||3
976159|NCT00338104|2364277|P2|NOT COMPLETED|Overall Study||1
976160|NCT00338104|2364278|P1|NOT COMPLETED|Overall Study||2
976161|NCT00338104|2364276|P3|COMPLETED|Overall Study||22
976162|NCT00338104|2364277|P2|COMPLETED|Overall Study||24
976163|NCT00338104|2364278|P1|COMPLETED|Overall Study||23
976164|NCT00338104|2364276|P3|STARTED|Overall Study||25
976165|NCT00338104|2364277|P2|STARTED|Overall Study||25
976166|NCT00338104|2364278|P1|STARTED|Overall Study||25
976167|NCT00331682|2364289|P1|NOT COMPLETED|Overall Study||1
976168|NCT00331682|2364289|P1|COMPLETED|Overall Study||9
976169|NCT00331682|2364289|P1|STARTED|Overall Study||10
976170|NCT00331760|2364297|P2|NOT COMPLETED|Overall Study||8
976171|NCT00331760|2364298|P1|NOT COMPLETED|Overall Study||15
976172|NCT00331760|2364297|P2|COMPLETED|Overall Study||40
976173|NCT00331760|2364298|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|43
976174|NCT00331760|2364297|P2|STARTED|Overall Study||48
976175|NCT00331760|2364298|P1|STARTED|Overall Study||58
976176|NCT00331773|2364306|P2|NOT COMPLETED|Overall Study||7
976177|NCT00331773|2364307|P1|NOT COMPLETED|Overall Study||16
976178|NCT00331773|2364306|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|550
976179|NCT00331773|2364307|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|542
976180|NCT00331773|2364306|P2|STARTED|Overall Study||557
976181|NCT00331773|2364307|P1|STARTED|Overall Study||558
976182|NCT00331799|2364333|P1|NOT COMPLETED|Overall Study||3
976183|NCT00331799|2364333|P1|COMPLETED|Overall Study||15
976184|NCT00331799|2364333|P1|STARTED|Overall Study||18
976185|NCT00331864|2364339|P2|NOT COMPLETED|Overall Study||4
976186|NCT00331864|2364340|P1|NOT COMPLETED|Overall Study||58
976187|NCT00331864|2364339|P2|COMPLETED|Overall Study||14
976188|NCT00331864|2364340|P1|COMPLETED|Overall Study||455
976189|NCT00331864|2364339|P2|STARTED|Overall Study||18
976190|NCT00331864|2364340|P1|STARTED|Overall Study||513
976191|NCT00332163|2364361|P2|NOT COMPLETED|Overall Study||0
976192|NCT00332163|2364362|P1|NOT COMPLETED|Overall Study||0
976193|NCT00332163|2364361|P2|COMPLETED|Overall Study||47
976194|NCT00332163|2364362|P1|COMPLETED|Overall Study||48
976195|NCT00332163|2364361|P2|Received Treatment|Overall Study||47
976196|NCT00332163|2364362|P1|Received Treatment|Overall Study||48
976197|NCT00332163|2364361|P2|STARTED|Overall Study||47
976198|NCT00332163|2364362|P1|STARTED|Overall Study||48
976199|NCT00332189|2364394|P1|NOT COMPLETED|Overall Study||21
976200|NCT00332189|2364394|P1|COMPLETED|Overall Study|Subjects in this extension study continued until there was market approval in their region.|90
976201|NCT00332189|2364394|P1|STARTED|Overall Study||111
976202|NCT00332241|2364401|P2|NOT COMPLETED|Overall Study||8
976203|NCT00332241|2364402|P1|NOT COMPLETED|Overall Study||15
976204|NCT00332241|2364401|P2|COMPLETED|Overall Study||39
976205|NCT00332241|2364402|P1|COMPLETED|Overall Study||36
976206|NCT00332241|2364401|P2|STARTED|Overall Study||47
976207|NCT00332241|2364402|P1|STARTED|Overall Study||51
976208|NCT00332332|2364422|P1|NOT COMPLETED|Overall Study||68
976209|NCT00332332|2364422|P1|COMPLETED|Overall Study||178
976210|NCT00332332|2364422|P1|Received Study Medication|Overall Study||230
976211|NCT00332332|2364422|P1|STARTED|Overall Study||246
976212|NCT00332462|2364429|P1|NOT COMPLETED|Overall Study||16
976213|NCT00332462|2364429|P1|COMPLETED|Overall Study||18
976214|NCT00332462|2364429|P1|Patients Treated With Sandimmun® Optoral|Overall Study||29
976215|NCT00332462|2364429|P1|Patients Treated With Sandimmun® i.v.|Overall Study||34
976216|NCT00332462|2364429|P1|STARTED|Overall Study|Safety and Intention to treat population.|34
976217|NCT00332488|2364439|P3|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||21
976218|NCT00332488|2364440|P2|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||2
976219|NCT00332488|2364441|P1|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||2
976220|NCT00332488|2364439|P3|COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||233
976221|NCT00332488|2364440|P2|COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||70
976222|NCT00332488|2364441|P1|COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||27
976223|NCT00332488|2364439|P3|STARTED|Transfer Treatment Phase (Weeks 12 – 24)|Subjects in this arm who met HbA1c criteria + subjects from other arms who did not|254
976224|NCT00332488|2364440|P2|STARTED|Transfer Treatment Phase (Weeks 12 – 24)|Subjects on treatment who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|72
976225|NCT00332488|2364441|P1|STARTED|Transfer Treatment Phase (Weeks 12 – 24)|Subjects on TI who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|29
976226|NCT00332488|2364439|P3|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||56
976227|NCT00332488|2364440|P2|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||18
976228|NCT00332488|2364441|P1|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||50
976229|NCT00332488|2364439|P3|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||119
976230|NCT00332488|2364440|P2|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||152
976231|NCT00332488|2364441|P1|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||133
976232|NCT00332488|2364439|P3|STARTED|Initial Treatment Phase (Weeks 0 - 12)||175
976233|NCT00332488|2364440|P2|STARTED|Initial Treatment Phase (Weeks 0 - 12)||170
976234|NCT00332488|2364441|P1|STARTED|Initial Treatment Phase (Weeks 0 - 12)||183
976235|NCT00332579|2364455|P2|NOT COMPLETED|Overall Study||1
976236|NCT00332579|2364456|P1|NOT COMPLETED|Overall Study||1
976237|NCT00332579|2364455|P2|COMPLETED|Overall Study||12
976238|NCT00332579|2364456|P1|COMPLETED|Overall Study||11
976239|NCT00332579|2364455|P2|STARTED|Overall Study||13
976240|NCT00332579|2364456|P1|STARTED|Overall Study||12
976241|NCT00332605|2364465|P3|NOT COMPLETED|Overall Study||8
976242|NCT00332605|2364466|P2|NOT COMPLETED|Overall Study||2
976243|NCT00332605|2364467|P1|NOT COMPLETED|Overall Study||2
976244|NCT00332605|2364465|P3|COMPLETED|Overall Study||9
976245|NCT00332605|2364466|P2|COMPLETED|Overall Study||12
976246|NCT00332605|2364467|P1|COMPLETED|Overall Study||12
976247|NCT00332605|2364465|P3|STARTED|Overall Study||17
976248|NCT00332605|2364466|P2|STARTED|Overall Study||14
976249|NCT00332605|2364467|P1|STARTED|Overall Study||14
976250|NCT00332644|2364481|P6|NOT COMPLETED|Overall Study||15
976251|NCT00332644|2364482|P5|NOT COMPLETED|Overall Study||12
976252|NCT00332644|2364483|P4|NOT COMPLETED|Overall Study||20
976253|NCT00332644|2364484|P3|NOT COMPLETED|Overall Study||9
976254|NCT00332644|2364485|P2|NOT COMPLETED|Overall Study||22
976255|NCT00332644|2364486|P1|NOT COMPLETED|Overall Study||12
976256|NCT00332644|2364481|P6|COMPLETED|Overall Study||174
976257|NCT00332644|2364482|P5|COMPLETED|Overall Study||250
976258|NCT00332644|2364483|P4|COMPLETED|Overall Study||244
976259|NCT00332644|2364484|P3|COMPLETED|Overall Study||258
976260|NCT00332644|2364485|P2|COMPLETED|Overall Study||238
976261|NCT00332644|2364486|P1|COMPLETED|Overall Study||250
976262|NCT00332644|2364481|P6|STARTED|Overall Study||189
976263|NCT00332644|2364482|P5|STARTED|Overall Study||262
976264|NCT00332644|2364483|P4|STARTED|Overall Study||264
976265|NCT00332644|2364484|P3|STARTED|Overall Study||267
976266|NCT00332644|2364485|P2|STARTED|Overall Study||260
976267|NCT00332644|2364486|P1|STARTED|Overall Study||262
976268|NCT00332696|2364502|P2|NOT COMPLETED|Overall Study||30
976269|NCT00332696|2364503|P1|NOT COMPLETED|Overall Study||30
976270|NCT00332696|2364502|P2|COMPLETED|Overall Study||2
976271|NCT00332696|2364503|P1|COMPLETED|Overall Study|Completed Month 3 Visit|2
976272|NCT00332696|2364502|P2|Completed Day 14 Visit|Overall Study||15
976273|NCT00332696|2364503|P1|Completed Day 14 Visit|Overall Study|Primary Endpoint|21
976274|NCT00332696|2364502|P2|STARTED|Overall Study||32
976275|NCT00332696|2364503|P1|STARTED|Overall Study||32
976276|NCT00332709|2364531|P2|NOT COMPLETED|Overall Study||20
976277|NCT00332709|2364532|P1|NOT COMPLETED|Overall Study||16
976278|NCT00332709|2364531|P2|COMPLETED|Overall Study||21
976279|NCT00332709|2364532|P1|COMPLETED|Overall Study||24
976280|NCT00332709|2364531|P2|STARTED|Overall Study||41
976281|NCT00332709|2364532|P1|STARTED|Overall Study||40
976282|NCT00332722|2364556|P2|NOT COMPLETED|Overall Study||0
976283|NCT00332722|2364557|P1|NOT COMPLETED|Overall Study||0
976284|NCT00332722|2364556|P2|COMPLETED|Overall Study||60
976285|NCT00332722|2364557|P1|COMPLETED|Overall Study||60
976286|NCT00332722|2364556|P2|STARTED|Overall Study||60
976287|NCT00332722|2364557|P1|STARTED|Overall Study||60
976288|NCT00338286|2364567|P2|NOT COMPLETED|Overall Study||370
976289|NCT00338286|2364568|P1|NOT COMPLETED|Overall Study||393
976290|NCT00338286|2364567|P2|COMPLETED|Overall Study||680
976291|NCT00338286|2364568|P1|COMPLETED|Overall Study||655
976292|NCT00338286|2364567|P2|STARTED|Overall Study||1050
976293|NCT00338286|2364568|P1|STARTED|Overall Study||1048
976294|NCT00338455|2364584|P2|NOT COMPLETED|Overall Study||1
976295|NCT00338455|2364585|P1|NOT COMPLETED|Overall Study||3
976296|NCT00338455|2364584|P2|COMPLETED|Overall Study||6
976297|NCT00338455|2364585|P1|COMPLETED|Overall Study||6
976298|NCT00338455|2364584|P2|Administered Study Drug|Overall Study||7
976299|NCT00338455|2364585|P1|Administered Study Drug|Overall Study||8
976300|NCT00338455|2364584|P2|STARTED|Overall Study||7
976301|NCT00338455|2364585|P1|STARTED|Overall Study||9
976302|NCT00338598|2364599|P2|NOT COMPLETED|Overall Study||2
976303|NCT00338598|2364600|P1|NOT COMPLETED|Overall Study||0
976304|NCT00338598|2364599|P2|COMPLETED|Overall Study||8
976305|NCT00338598|2364600|P1|COMPLETED|Overall Study||10
976306|NCT00338598|2364599|P2|STARTED|Overall Study||10
976307|NCT00338598|2364600|P1|STARTED|Overall Study||10
976308|NCT00342355|2364622|P4|NOT COMPLETED|Overall Study||0
976309|NCT00342355|2364623|P3|NOT COMPLETED|Overall Study||0
976310|NCT00342355|2364624|P2|NOT COMPLETED|Overall Study||0
976311|NCT00342355|2364625|P1|NOT COMPLETED|Overall Study||0
976312|NCT00342355|2364622|P4|COMPLETED|Overall Study||443
976313|NCT00342355|2364623|P3|COMPLETED|Overall Study||444
976314|NCT00342355|2364624|P2|COMPLETED|Overall Study||440
976315|NCT00342355|2364625|P1|COMPLETED|Overall Study||444
976316|NCT00342355|2364622|P4|STARTED|Overall Study||443
976317|NCT00342355|2364623|P3|STARTED|Overall Study||444
976318|NCT00342355|2364624|P2|STARTED|Overall Study||440
976319|NCT00342355|2364625|P1|STARTED|Overall Study||444
976320|NCT00342563|2364643|P4|NOT COMPLETED|Overall Study||6
976321|NCT00342563|2364644|P3|NOT COMPLETED|Overall Study||14
976322|NCT00342563|2364645|P2|NOT COMPLETED|Overall Study||8
976323|NCT00342563|2364646|P1|NOT COMPLETED|Overall Study||6
976324|NCT00342563|2364643|P4|COMPLETED|Overall Study||22
976325|NCT00342563|2364644|P3|COMPLETED|Overall Study||26
976326|NCT00342563|2364645|P2|COMPLETED|Overall Study||19
976327|NCT00342563|2364646|P1|COMPLETED|Overall Study||35
976328|NCT00342563|2364643|P4|STARTED|Overall Study||28
976329|NCT00342563|2364644|P3|STARTED|Overall Study||40
976330|NCT00342563|2364645|P2|STARTED|Overall Study||27
976331|NCT00342563|2364646|P1|STARTED|Overall Study||41
976332|NCT00342628|2364665|P3|NOT COMPLETED|Overall Study||19
976333|NCT00342628|2364666|P2|NOT COMPLETED|Overall Study||21
976334|NCT00342628|2364667|P1|NOT COMPLETED|Overall Study||20
976335|NCT00342628|2364665|P3|COMPLETED|Overall Study|97 completed 3 injections of DTP alone, 16 were lost-to-followup for blood drawing at 12 months.|81
976336|NCT00342628|2364666|P2|COMPLETED|Overall Study|83 completed 4 injections, 3 were lost-to-followup after 4th injection|80
976337|NCT00342628|2364667|P1|COMPLETED|Overall Study|84 completed 4 injections, 4 were lost-to-followup after the 4th injection|80
976338|NCT00342628|2364665|P3|STARTED|Overall Study||100
976339|NCT00342628|2364666|P2|STARTED|Overall Study||101
976340|NCT00342628|2364667|P1|STARTED|Overall Study||100
976341|NCT00343044|2364684|P1|NOT COMPLETED|Overall Study||0
976342|NCT00343044|2364684|P1|COMPLETED|Overall Study||40
976343|NCT00343044|2364684|P1|STARTED|Overall Study||40
976344|NCT00343083|2364691|P1|NOT COMPLETED|Overall Study||21
976345|NCT00343083|2364691|P1|COMPLETED|Overall Study||22
976346|NCT00343083|2364691|P1|STARTED|Overall Study||43
976347|NCT00343252|2364702|P2|NOT COMPLETED|18 Months (All Treated Participants)||81
976348|NCT00343252|2364703|P1|NOT COMPLETED|18 Months (All Treated Participants)||101
976349|NCT00343252|2364702|P2|COMPLETED|18 Months (All Treated Participants)||269
976350|NCT00343252|2364703|P1|COMPLETED|18 Months (All Treated Participants)||259
976351|NCT00343252|2364702|P2|STARTED|18 Months (All Treated Participants)||350
976352|NCT00343252|2364703|P1|STARTED|18 Months (All Treated Participants)||360
976353|NCT00343252|2364702|P2|NOT COMPLETED|12 Months (All Treated Participants)||69
976354|NCT00343252|2364703|P1|NOT COMPLETED|12 Months (All Treated Participants)||86
976355|NCT00343252|2364702|P2|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|281
976356|NCT00343252|2364703|P1|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|274
976357|NCT00343252|2364702|P2|STARTED|12 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
976358|NCT00343252|2364703|P1|STARTED|12 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
976359|NCT00343252|2364702|P2|NOT COMPLETED|6 Months (All Treated Participants)||44
976360|NCT00343252|2364703|P1|NOT COMPLETED|6 Months (All Treated Participants)||56
976361|NCT00343252|2364702|P2|COMPLETED|6 Months (All Treated Participants)||306
976362|NCT00343252|2364703|P1|COMPLETED|6 Months (All Treated Participants)||304
976363|NCT00343252|2364702|P2|STARTED|6 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
976364|NCT00343252|2364703|P1|STARTED|6 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
976365|NCT00343252|2364702|P2|NOT COMPLETED|All Randomized Participants||82
976366|NCT00343252|2364703|P1|NOT COMPLETED|All Randomized Participants||102
976367|NCT00343252|2364702|P2|COMPLETED|All Randomized Participants||269
976368|NCT00343252|2364703|P1|COMPLETED|All Randomized Participants||259
976369|NCT00343252|2364702|P2|STARTED|All Randomized Participants||351
976370|NCT00343252|2364703|P1|STARTED|All Randomized Participants||361
976371|NCT00343291|2364751|P2|NOT COMPLETED|Overall Study||56
976372|NCT00343291|2364752|P1|NOT COMPLETED|Overall Study||57
976373|NCT00343291|2364751|P2|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|5
976374|NCT00343291|2364752|P1|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|3
976375|NCT00343291|2364751|P2|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
976376|NCT00343291|2364752|P1|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
976377|NCT00343291|2364751|P2|STARTED|Overall Study||61
976378|NCT00343291|2364752|P1|STARTED|Overall Study||60
976379|NCT00343382|2364769|P3|NOT COMPLETED|Overall Study||17
976380|NCT00343382|2364770|P2|NOT COMPLETED|Overall Study||14
976381|NCT00343382|2364771|P1|NOT COMPLETED|Overall Study||4
976382|NCT00343382|2364769|P3|COMPLETED|Overall Study||49
976383|NCT00343382|2364770|P2|COMPLETED|Overall Study||51
976384|NCT00343382|2364771|P1|COMPLETED|Overall Study||60
976385|NCT00343382|2364769|P3|STARTED|Overall Study||66
976386|NCT00343382|2364770|P2|STARTED|Overall Study||65
976387|NCT00343382|2364771|P1|STARTED|Overall Study||64
976388|NCT00343460|2364794|P3|NOT COMPLETED|Cycle 2 - 4||0
976389|NCT00343460|2364795|P2|NOT COMPLETED|Cycle 2 - 4||50
976390|NCT00343460|2364796|P1|NOT COMPLETED|Cycle 2 - 4||56
976391|NCT00343460|2364794|P3|COMPLETED|Cycle 2 - 4||0
976392|NCT00343460|2364795|P2|COMPLETED|Cycle 2 - 4||515
976393|NCT00343460|2364796|P1|COMPLETED|Cycle 2 - 4||528
976394|NCT00343460|2364794|P3|STARTED|Cycle 2 - 4||0
976395|NCT00343460|2364795|P2|STARTED|Cycle 2 - 4||565
976396|NCT00343460|2364796|P1|STARTED|Cycle 2 - 4||584
976397|NCT00343460|2364794|P3|NOT COMPLETED|Cycle 1||18
976398|NCT00343460|2364795|P2|NOT COMPLETED|Cycle 1||22
976399|NCT00343460|2364796|P1|NOT COMPLETED|Cycle 1||22
976400|NCT00343460|2364794|P3|COMPLETED|Cycle 1||454
976401|NCT00343460|2364795|P2|COMPLETED|Cycle 1||459
976402|NCT00343460|2364796|P1|COMPLETED|Cycle 1||453
976403|NCT00343460|2364794|P3|STARTED|Cycle 1||472
976404|NCT00343460|2364795|P2|STARTED|Cycle 1||481
976405|NCT00343460|2364796|P1|STARTED|Cycle 1||475
976406|NCT00343512|2364867|P1|NOT COMPLETED|Overall Study||2
976407|NCT00343512|2364867|P1|COMPLETED|Overall Study||32
976408|NCT00343512|2364867|P1|STARTED|Overall Study||34
976409|NCT00343564|2364884|P11|NOT COMPLETED|Overall Study||0
976410|NCT00343564|2364885|P10|NOT COMPLETED|Overall Study||0
976411|NCT00343564|2364886|P9|NOT COMPLETED|Overall Study||0
976412|NCT00343564|2364887|P8|NOT COMPLETED|Overall Study||0
976413|NCT00343564|2364888|P7|NOT COMPLETED|Overall Study||0
976414|NCT00343564|2364889|P6|NOT COMPLETED|Overall Study||0
976415|NCT00343564|2364890|P5|NOT COMPLETED|Overall Study||0
976416|NCT00343564|2364891|P4|NOT COMPLETED|Overall Study||0
976417|NCT00343564|2364892|P3|NOT COMPLETED|Overall Study||0
976418|NCT00343564|2364893|P2|NOT COMPLETED|Overall Study||0
976419|NCT00343564|2364894|P1|NOT COMPLETED|Overall Study||0
976420|NCT00343564|2364884|P11|COMPLETED|Overall Study||8
976421|NCT00343564|2364885|P10|COMPLETED|Overall Study||8
976422|NCT00343564|2364886|P9|COMPLETED|Overall Study||3
976423|NCT00343564|2364887|P8|COMPLETED|Overall Study||3
976424|NCT00343564|2364888|P7|COMPLETED|Overall Study||4
976425|NCT00343564|2364889|P6|COMPLETED|Overall Study||9
976426|NCT00343564|2364890|P5|COMPLETED|Overall Study||10
976427|NCT00343564|2364891|P4|COMPLETED|Overall Study||7
976428|NCT00343564|2364892|P3|COMPLETED|Overall Study||3
976429|NCT00343564|2364893|P2|COMPLETED|Overall Study||7
976430|NCT00343564|2364894|P1|COMPLETED|Overall Study||6
976431|NCT00343564|2364884|P11|STARTED|Overall Study||8
976432|NCT00343564|2364885|P10|STARTED|Overall Study||8
976433|NCT00343564|2364886|P9|STARTED|Overall Study||3
976434|NCT00343564|2364887|P8|STARTED|Overall Study||3
976435|NCT00343564|2364888|P7|STARTED|Overall Study||4
976436|NCT00343564|2364889|P6|STARTED|Overall Study||9
976437|NCT00343564|2364890|P5|STARTED|Overall Study||10
976438|NCT00343564|2364891|P4|STARTED|Overall Study||7
976439|NCT00343564|2364892|P3|STARTED|Overall Study||3
976440|NCT00343564|2364893|P2|STARTED|Overall Study||7
976441|NCT00343564|2364894|P1|STARTED|Overall Study||6
976442|NCT00343785|2364909|P1|NOT COMPLETED|Overall Study||0
976443|NCT00343785|2364909|P1|COMPLETED|Overall Study||21
976444|NCT00343785|2364909|P1|STARTED|Overall Study||21
976445|NCT00343863|2364917|P2|NOT COMPLETED|Overall Study||0
976446|NCT00343863|2364918|P1|NOT COMPLETED|Overall Study||0
976447|NCT00343863|2364917|P2|COMPLETED|Overall Study||34
976448|NCT00343863|2364918|P1|COMPLETED|Overall Study||7
976449|NCT00343863|2364917|P2|STARTED|Overall Study||34
976450|NCT00343863|2364918|P1|STARTED|Overall Study||7
976451|NCT00343889|2364942|P2|NOT COMPLETED|Overall Study||1
976452|NCT00343889|2364943|P1|NOT COMPLETED|Overall Study||3
976453|NCT00343889|2364942|P2|COMPLETED|Overall Study||188
976454|NCT00343889|2364943|P1|COMPLETED|Overall Study||187
976455|NCT00343889|2364942|P2|STARTED|Overall Study||189
976456|NCT00343889|2364943|P1|STARTED|Overall Study||190
976457|NCT00343915|2364961|P2|NOT COMPLETED|Month 66 Follow-up||0
976458|NCT00343915|2364962|P1|NOT COMPLETED|Month 66 Follow-up||0
976459|NCT00343915|2364961|P2|COMPLETED|Month 66 Follow-up||76
976460|NCT00343915|2364962|P1|COMPLETED|Month 66 Follow-up||158
976461|NCT00343915|2364961|P2|STARTED|Month 66 Follow-up||76
976462|NCT00343915|2364962|P1|STARTED|Month 66 Follow-up|Subjects, previously vaccinated, that returned for the Month 66 follow-up.|158
976463|NCT00343915|2364961|P2|NOT COMPLETED|Month 54 Follow-up||0
976464|NCT00343915|2364962|P1|NOT COMPLETED|Month 54 Follow-up||0
976465|NCT00343915|2364961|P2|COMPLETED|Month 54 Follow-up||79
976466|NCT00343915|2364962|P1|COMPLETED|Month 54 Follow-up||166
976467|NCT00343915|2364961|P2|STARTED|Month 54 Follow-up||79
976468|NCT00343915|2364962|P1|STARTED|Month 54 Follow-up|Subjects, previously vaccinated, that returned for the Month 54 follow-up.|166
976469|NCT00343915|2364961|P2|NOT COMPLETED|Month 42 Follow-up||0
976470|NCT00343915|2364962|P1|NOT COMPLETED|Month 42 Follow-up||0
976471|NCT00343915|2364961|P2|COMPLETED|Month 42 Follow-up||84
976472|NCT00343915|2364962|P1|COMPLETED|Month 42 Follow-up||174
976473|NCT00343915|2364961|P2|STARTED|Month 42 Follow-up||84
976474|NCT00343915|2364962|P1|STARTED|Month 42 Follow-up|Subjects, previously vaccinated, that returned for the Month 42 follow-up.|174
976475|NCT00343915|2364961|P2|NOT COMPLETED|Month 30 Follow-up||0
976476|NCT00343915|2364962|P1|NOT COMPLETED|Month 30 Follow-up||0
976477|NCT00343915|2364961|P2|COMPLETED|Month 30 Follow-up||88
976478|NCT00343915|2364962|P1|COMPLETED|Month 30 Follow-up||179
976479|NCT00343915|2364961|P2|STARTED|Month 30 Follow-up||88
976480|NCT00343915|2364962|P1|STARTED|Month 30 Follow-up|Subjects, previously vaccinated, that returned for the Month 30 follow-up.|179
976481|NCT00343915|2364961|P2|NOT COMPLETED|Primary Study||3
976482|NCT00343915|2364962|P1|NOT COMPLETED|Primary Study||4
976483|NCT00343915|2364961|P2|COMPLETED|Primary Study||123
976484|NCT00343915|2364962|P1|COMPLETED|Primary Study||254
976485|NCT00343915|2364961|P2|STARTED|Primary Study||126
976486|NCT00343915|2364962|P1|STARTED|Primary Study||258
976487|NCT00344487|2364986|P1|NOT COMPLETED|Overall Study||1
976488|NCT00344487|2364986|P1|COMPLETED|Overall Study|One subject was withdrawn at month 9 because he was considered an immunologic failure on study.|2
976489|NCT00344487|2364986|P1|STARTED|Overall Study||3
976490|NCT00344500|2364992|P3|NOT COMPLETED|Overall Study||2
976491|NCT00344500|2364993|P2|NOT COMPLETED|Overall Study||35
976492|NCT00344500|2364994|P1|NOT COMPLETED|Overall Study||23
976493|NCT00344500|2364992|P3|COMPLETED|Overall Study||12
976494|NCT00344500|2364993|P2|COMPLETED|Overall Study||25
976495|NCT00344500|2364994|P1|COMPLETED|Overall Study||25
976496|NCT00344500|2364992|P3|STARTED|Overall Study||14
976497|NCT00344500|2364993|P2|STARTED|Overall Study||60
976498|NCT00344500|2364994|P1|STARTED|Overall Study||48
976499|NCT00344682|2365007|P2|NOT COMPLETED|Overall Study||1
976500|NCT00344682|2365008|P1|NOT COMPLETED|Overall Study||4
976501|NCT00344682|2365007|P2|COMPLETED|Overall Study||14
976502|NCT00344682|2365008|P1|COMPLETED|Overall Study||12
976503|NCT00344682|2365007|P2|STARTED|Overall Study||15
976504|NCT00344682|2365008|P1|STARTED|Overall Study||16
976505|NCT00344773|2365020|P1|NOT COMPLETED|Overall Study||21
976506|NCT00344773|2365020|P1|COMPLETED|Overall Study||25
976507|NCT00344773|2365020|P1|STARTED|Overall Study||46
976508|NCT00344968|2365029|P3|NOT COMPLETED|Overall Study||116
976509|NCT00344968|2365030|P2|NOT COMPLETED|Overall Study||102
976510|NCT00344968|2365031|P1|NOT COMPLETED|Overall Study||59
976511|NCT00344968|2365029|P3|COMPLETED|Overall Study||279
976512|NCT00344968|2365030|P2|COMPLETED|Overall Study||274
976513|NCT00344968|2365031|P1|COMPLETED|Overall Study||126
976514|NCT00344968|2365029|P3|STARTED|Overall Study||395
976515|NCT00344968|2365030|P2|STARTED|Overall Study||376
976516|NCT00344968|2365031|P1|STARTED|Overall Study||185
976517|NCT00345033|2365044|P2|NOT COMPLETED|Overall Study||4
976518|NCT00345033|2365045|P1|NOT COMPLETED|Overall Study||4
976519|NCT00345033|2365044|P2|COMPLETED|Overall Study||14
976520|NCT00345033|2365045|P1|COMPLETED|Overall Study||16
976521|NCT00345033|2365044|P2|STARTED|Overall Study||18
976522|NCT00345033|2365045|P1|STARTED|Overall Study||20
976523|NCT00345046|2365064|P3|NOT COMPLETED|Overall Study||2
976524|NCT00345046|2365065|P2|NOT COMPLETED|Overall Study||1
976525|NCT00345046|2365066|P1|NOT COMPLETED|Overall Study||1
976526|NCT00345046|2365064|P3|COMPLETED|Overall Study||14
976527|NCT00345046|2365065|P2|COMPLETED|Overall Study||21
976528|NCT00345046|2365066|P1|COMPLETED|Overall Study||17
976529|NCT00345046|2365064|P3|STARTED|Overall Study||16
976530|NCT00345046|2365065|P2|STARTED|Overall Study||22
976531|NCT00345046|2365066|P1|STARTED|Overall Study||18
976532|NCT00345176|2365078|P4|NOT COMPLETED|Overall Study||10
976533|NCT00345176|2365079|P3|NOT COMPLETED|Overall Study||6
976534|NCT00345176|2365080|P2|NOT COMPLETED|Overall Study||6
976535|NCT00345176|2365081|P1|NOT COMPLETED|Overall Study||5
976536|NCT00345176|2365078|P4|COMPLETED|Overall Study||1069
976537|NCT00345176|2365079|P3|COMPLETED|Overall Study||1062
976538|NCT00345176|2365080|P2|COMPLETED|Overall Study||1038
976539|NCT00345176|2365081|P1|COMPLETED|Overall Study||1007
976540|NCT00345176|2365078|P4|STARTED|Overall Study||1079
976541|NCT00345176|2365079|P3|STARTED|Overall Study||1068
976542|NCT00345176|2365080|P2|STARTED|Overall Study||1044
976543|NCT00345176|2365081|P1|STARTED|Overall Study||1012
976544|NCT00345254|2365103|P2|NOT COMPLETED|Overall Study||0
976545|NCT00345254|2365104|P1|NOT COMPLETED|Overall Study||0
976546|NCT00345254|2365103|P2|COMPLETED|Overall Study||30
976547|NCT00345254|2365104|P1|COMPLETED|Overall Study||30
976548|NCT00345254|2365103|P2|STARTED|Overall Study||30
976549|NCT00345254|2365104|P1|STARTED|Overall Study||30
976550|NCT00345293|2365110|P2|NOT COMPLETED|Overall Study||0
976551|NCT00345293|2365111|P1|NOT COMPLETED|Overall Study||2
976552|NCT00345293|2365110|P2|COMPLETED|Overall Study||3
976553|NCT00345293|2365111|P1|COMPLETED|Overall Study||8
976554|NCT00345293|2365110|P2|STARTED|Overall Study||3
976555|NCT00345293|2365111|P1|STARTED|Overall Study||10
976556|NCT00345332|2365120|P2|NOT COMPLETED|Overall Study||0
976557|NCT00345332|2365121|P1|NOT COMPLETED|Overall Study||0
976558|NCT00345332|2365120|P2|COMPLETED|Overall Study||20
976559|NCT00345332|2365121|P1|COMPLETED|Overall Study||11
976560|NCT00345332|2365120|P2|STARTED|Overall Study||20
976561|NCT00345332|2365121|P1|STARTED|Overall Study||11
976562|NCT00345371|2365131|P2|NOT COMPLETED|Overall Study||33
976563|NCT00345371|2365132|P1|NOT COMPLETED|Overall Study||30
976564|NCT00345371|2365131|P2|COMPLETED|Overall Study||38
976565|NCT00345371|2365132|P1|COMPLETED|Overall Study||39
976566|NCT00345371|2365131|P2|STARTED|Overall Study||71
976567|NCT00345371|2365132|P1|STARTED|Overall Study||69
976568|NCT00345384|2365142|P2|NOT COMPLETED|Overall Study||0
976569|NCT00345384|2365143|P1|NOT COMPLETED|Overall Study||0
976570|NCT00345384|2365142|P2|COMPLETED|Overall Study||19
976571|NCT00345384|2365143|P1|COMPLETED|Overall Study||19
976572|NCT00345384|2365142|P2|STARTED|Overall Study||19
976573|NCT00345384|2365143|P1|STARTED|Overall Study||19
976574|NCT00345397|2365151|P1|NOT COMPLETED|Overall Study||1
976575|NCT00345397|2365151|P1|COMPLETED|Overall Study||6
976576|NCT00345397|2365151|P1|STARTED|Overall Study||7
976577|NCT00345540|2365156|P1|NOT COMPLETED|Overall Study||1
976578|NCT00345540|2365156|P1|COMPLETED|Overall Study||15
976579|NCT00345540|2365156|P1|STARTED|Overall Study|1 subject enrolled but not treated (off-trial for patient discretion)|16
976580|NCT00345579|2365164|P2|NOT COMPLETED|Overall Study||65
976581|NCT00345579|2365165|P1|NOT COMPLETED|Overall Study||164
976582|NCT00345579|2365164|P2|COMPLETED|Overall Study||1048
976583|NCT00345579|2365165|P1|COMPLETED|Overall Study||3114
976584|NCT00345579|2365164|P2|STARTED|Overall Study||1113
976585|NCT00345579|2365165|P1|STARTED|Overall Study||3278
976586|NCT00345592|2365187|P2|NOT COMPLETED|Overall Study||24
976587|NCT00345592|2365188|P1|NOT COMPLETED|Overall Study||25
976588|NCT00345592|2365187|P2|COMPLETED|Overall Study||173
976589|NCT00345592|2365188|P1|COMPLETED|Overall Study||174
976590|NCT00345592|2365187|P2|STARTED|Overall Study||197
976591|NCT00345592|2365188|P1|STARTED|Overall Study||199
976592|NCT00345605|2365194|P2|NOT COMPLETED|Arm 2, Opposite Treatment||0
976593|NCT00345605|2365195|P1|NOT COMPLETED|Arm 2, Opposite Treatment||1
976594|NCT00345605|2365194|P2|COMPLETED|Arm 2, Opposite Treatment||6
976595|NCT00345605|2365195|P1|COMPLETED|Arm 2, Opposite Treatment||5
976596|NCT00345605|2365194|P2|STARTED|Arm 2, Opposite Treatment||6
976597|NCT00345605|2365195|P1|STARTED|Arm 2, Opposite Treatment||6
976598|NCT00345605|2365194|P2|NOT COMPLETED|Crossover Wash-out||0
976599|NCT00345605|2365195|P1|NOT COMPLETED|Crossover Wash-out||0
976600|NCT00345605|2365194|P2|COMPLETED|Crossover Wash-out||6
976601|NCT00345605|2365195|P1|COMPLETED|Crossover Wash-out||6
976602|NCT00345605|2365194|P2|STARTED|Crossover Wash-out||6
976603|NCT00345605|2365195|P1|STARTED|Crossover Wash-out||6
976604|NCT00345605|2365194|P2|NOT COMPLETED|Interval||0
976605|NCT00345605|2365195|P1|NOT COMPLETED|Interval||0
976606|NCT00345605|2365194|P2|COMPLETED|Interval||6
976607|NCT00345605|2365195|P1|COMPLETED|Interval||6
976608|NCT00345605|2365194|P2|STARTED|Interval||6
976609|NCT00345605|2365195|P1|STARTED|Interval||6
976610|NCT00345605|2365194|P2|NOT COMPLETED|Arm 1||1
976611|NCT00345605|2365195|P1|NOT COMPLETED|Arm 1||0
976612|NCT00345605|2365194|P2|COMPLETED|Arm 1||5
976613|NCT00345605|2365195|P1|COMPLETED|Arm 1||6
976614|NCT00345605|2365194|P2|STARTED|Arm 1||6
976615|NCT00345605|2365195|P1|STARTED|Arm 1||6
976616|NCT00345605|2365194|P2|NOT COMPLETED|Initial Washout||0
976617|NCT00345605|2365195|P1|NOT COMPLETED|Initial Washout||0
976618|NCT00345605|2365194|P2|COMPLETED|Initial Washout||6
976619|NCT00345605|2365195|P1|COMPLETED|Initial Washout||6
976620|NCT00345605|2365194|P2|STARTED|Initial Washout||6
976621|NCT00345605|2365195|P1|STARTED|Initial Washout||6
976622|NCT00345631|2365216|P3|NOT COMPLETED|Overall Study||6
976623|NCT00345631|2365217|P2|NOT COMPLETED|Overall Study||8
976624|NCT00345631|2365218|P1|NOT COMPLETED|Overall Study||4
976625|NCT00345631|2365216|P3|COMPLETED|Overall Study||128
976626|NCT00345631|2365217|P2|COMPLETED|Overall Study||259
976627|NCT00345631|2365218|P1|COMPLETED|Overall Study||83
976628|NCT00345631|2365216|P3|STARTED|Overall Study||134
976629|NCT00345631|2365217|P2|STARTED|Overall Study||267
976630|NCT00345631|2365218|P1|STARTED|Overall Study||87
976631|NCT00345683|2365252|P2|NOT COMPLETED|Overall Study||9
976632|NCT00345683|2365253|P1|NOT COMPLETED|Overall Study||25
976633|NCT00345683|2365252|P2|COMPLETED|Overall Study||1001
976634|NCT00345683|2365253|P1|COMPLETED|Overall Study||2985
976635|NCT00345683|2365252|P2|STARTED|Overall Study||1010
976636|NCT00345683|2365253|P1|STARTED|Overall Study||3010
976637|NCT00345839|2365275|P2|NOT COMPLETED|Overall Study||159
976638|NCT00345839|2365276|P1|NOT COMPLETED|Overall Study||149
976639|NCT00345839|2365275|P2|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1776
976640|NCT00345839|2365276|P1|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1799
976641|NCT00345839|2365275|P2|STARTED|Overall Study|Randomized to placebo|1935
976642|NCT00345839|2365276|P1|STARTED|Overall Study|Randomized to cinacalcet|1948
976643|NCT00345878|2365302|P2|NOT COMPLETED|Overall Study||1
976644|NCT00345878|2365303|P1|NOT COMPLETED|Overall Study||4
976645|NCT00345878|2365302|P2|COMPLETED|Overall Study||135
976646|NCT00345878|2365303|P1|COMPLETED|Overall Study||131
976647|NCT00345878|2365302|P2|STARTED|Overall Study||136
976648|NCT00345878|2365303|P1|STARTED|Overall Study||135
976649|NCT00346034|2365319|P1|NOT COMPLETED|Overall Study||57
976650|NCT00346034|2365319|P1|COMPLETED|Overall Study||300
976651|NCT00346034|2365319|P1|STARTED|Overall Study||357
976652|NCT00346151|2365324|P1|NOT COMPLETED|Overall Study||3
976653|NCT00346151|2365324|P1|COMPLETED|Overall Study||2
976654|NCT00346151|2365324|P1|STARTED|Overall Study||5
976655|NCT00346164|2365346|P4|NOT COMPLETED|Overall Study||106
976656|NCT00346164|2365347|P3|NOT COMPLETED|Overall Study||26
976657|NCT00346164|2365348|P2|NOT COMPLETED|Overall Study||7
976658|NCT00346164|2365349|P1|NOT COMPLETED|Overall Study||17
976659|NCT00346164|2365346|P4|COMPLETED|Overall Study||117
976660|NCT00346164|2365347|P3|COMPLETED|Overall Study||96
976661|NCT00346164|2365348|P2|COMPLETED|Overall Study||14
976662|NCT00346164|2365349|P1|COMPLETED|Overall Study||205
976663|NCT00346164|2365346|P4|STARTED|Overall Study||223
976664|NCT00346164|2365347|P3|STARTED|Overall Study||122
976665|NCT00346164|2365348|P2|STARTED|Overall Study||21
976666|NCT00346164|2365349|P1|STARTED|Overall Study||222
976667|NCT00346216|2365387|P3|NOT COMPLETED|Overall Study||2348
976668|NCT00346216|2365388|P2|NOT COMPLETED|Overall Study||2460
976669|NCT00346216|2365389|P1|NOT COMPLETED|Overall Study||2408
976670|NCT00346216|2365387|P3|COMPLETED|Overall Study||5621
976671|NCT00346216|2365388|P2|COMPLETED|Overall Study||5580
976672|NCT00346216|2365389|P1|COMPLETED|Overall Study||5664
976673|NCT00346216|2365387|P3|STARTED|Overall Study||7969
976674|NCT00346216|2365388|P2|STARTED|Overall Study||8040
976675|NCT00346216|2365389|P1|STARTED|Overall Study||8072
976676|NCT00346268|2365408|P2|NOT COMPLETED|Overall Study||3
976677|NCT00346268|2365409|P1|NOT COMPLETED|Overall Study||2
976678|NCT00346268|2365408|P2|COMPLETED|Overall Study||50
976679|NCT00346268|2365409|P1|COMPLETED|Overall Study||50
976680|NCT00346268|2365408|P2|STARTED|Overall Study||53
976681|NCT00346268|2365409|P1|STARTED|Overall Study||52
976682|NCT00346333|2365443|P2|NOT COMPLETED|Overall Study||8
976683|NCT00346333|2365444|P1|NOT COMPLETED|Overall Study||5
976684|NCT00346333|2365443|P2|COMPLETED|Overall Study||111
976685|NCT00346333|2365444|P1|COMPLETED|Overall Study||116
976686|NCT00346333|2365443|P2|STARTED|Overall Study||119
976687|NCT00346333|2365444|P1|STARTED|Overall Study||121
976688|NCT00346398|2365460|P2|NOT COMPLETED|Overall Study||2
976689|NCT00346398|2365461|P1|NOT COMPLETED|Overall Study||3
976690|NCT00346398|2365460|P2|COMPLETED|Overall Study||24
976691|NCT00346398|2365461|P1|COMPLETED|Overall Study||22
976692|NCT00346398|2365460|P2|STARTED|Overall Study||26
976693|NCT00346398|2365461|P1|STARTED|Overall Study||25
976694|NCT00346476|2365471|P1|NOT COMPLETED|Overall Study||0
976695|NCT00346476|2365471|P1|COMPLETED|Overall Study||1250
976696|NCT00346476|2365471|P1|STARTED|Overall Study||1250
976697|NCT00346632|2365478|P10|NOT COMPLETED|Overall Study||3
976698|NCT00346632|2365479|P9|NOT COMPLETED|Overall Study||4
976699|NCT00346632|2365480|P8|NOT COMPLETED|Overall Study||4
976700|NCT00346632|2365481|P7|NOT COMPLETED|Overall Study||5
976701|NCT00346632|2365482|P6|NOT COMPLETED|Overall Study||2
976702|NCT00346632|2365483|P5|NOT COMPLETED|Overall Study||4
976703|NCT00346632|2365484|P4|NOT COMPLETED|Overall Study||3
976704|NCT00346632|2365485|P3|NOT COMPLETED|Overall Study||6
976705|NCT00346632|2365486|P2|NOT COMPLETED|Overall Study||3
976706|NCT00346632|2365487|P1|NOT COMPLETED|Overall Study||3
976707|NCT00346632|2365478|P10|COMPLETED|Overall Study||0
976708|NCT00346632|2365479|P9|COMPLETED|Overall Study||0
976709|NCT00346632|2365480|P8|COMPLETED|Overall Study||0
976710|NCT00346632|2365481|P7|COMPLETED|Overall Study||0
976711|NCT00346632|2365482|P6|COMPLETED|Overall Study||0
976712|NCT00346632|2365483|P5|COMPLETED|Overall Study||0
976713|NCT00346632|2365484|P4|COMPLETED|Overall Study||0
976714|NCT00346632|2365485|P3|COMPLETED|Overall Study||0
976715|NCT00346632|2365486|P2|COMPLETED|Overall Study||0
976716|NCT00346632|2365487|P1|COMPLETED|Overall Study||0
976717|NCT00346632|2365478|P10|STARTED|Overall Study||3
976718|NCT00346632|2365479|P9|STARTED|Overall Study||4
976719|NCT00346632|2365480|P8|STARTED|Overall Study||4
976720|NCT00346632|2365481|P7|STARTED|Overall Study||5
976721|NCT00346632|2365482|P6|STARTED|Overall Study||2
976722|NCT00346632|2365483|P5|STARTED|Overall Study||4
976723|NCT00346632|2365484|P4|STARTED|Overall Study||3
976724|NCT00346632|2365485|P3|STARTED|Overall Study||6
976725|NCT00346632|2365486|P2|STARTED|Overall Study||3
976726|NCT00346632|2365487|P1|STARTED|Overall Study||3
976727|NCT00346697|2365632|P2|NOT COMPLETED|Overall Study||1
976728|NCT00346697|2365633|P1|NOT COMPLETED|Overall Study||0
976729|NCT00346697|2365632|P2|COMPLETED|Overall Study||23
976730|NCT00346697|2365633|P1|COMPLETED|Overall Study||24
976731|NCT00346697|2365632|P2|STARTED|Overall Study||24
976732|NCT00346697|2365633|P1|STARTED|Overall Study||24
976733|NCT00346905|2365667|P1|NOT COMPLETED|Overall Study||4
976734|NCT00346905|2365667|P1|COMPLETED|Overall Study||12
976735|NCT00346905|2365667|P1|STARTED|Overall Study||16
976736|NCT00338741|2365673|P2|NOT COMPLETED|Overall Study||0
976737|NCT00338741|2365674|P1|NOT COMPLETED|Overall Study||2
976738|NCT00338741|2365673|P2|COMPLETED|Overall Study||2
976739|NCT00338741|2365674|P1|COMPLETED|Overall Study||32
976740|NCT00338741|2365673|P2|STARTED|Overall Study||2
976741|NCT00338741|2365674|P1|STARTED|Overall Study|2 subjects signed a consent form but no data were received for either subject|34
976742|NCT00338806|2365684|P2|NOT COMPLETED|Follow-up||3
976743|NCT00338806|2365685|P1|NOT COMPLETED|Follow-up||1
976744|NCT00338806|2365684|P2|COMPLETED|Follow-up||1
976745|NCT00338806|2365685|P1|COMPLETED|Follow-up||1
976746|NCT00338806|2365684|P2|STARTED|Follow-up||4
976747|NCT00338806|2365685|P1|STARTED|Follow-up||2
976748|NCT00338806|2365684|P2|NOT COMPLETED|Acute Phase||1
976749|NCT00338806|2365685|P1|NOT COMPLETED|Acute Phase||0
976750|NCT00338806|2365684|P2|COMPLETED|Acute Phase||4
976751|NCT00338806|2365685|P1|COMPLETED|Acute Phase||2
976752|NCT00338806|2365684|P2|STARTED|Acute Phase||5
976753|NCT00338806|2365685|P1|STARTED|Acute Phase||2
976754|NCT00338884|2365745|P1|NOT COMPLETED|Overall Study||78
976755|NCT00338884|2365745|P1|COMPLETED|Overall Study||42
976756|NCT00338884|2365745|P1|Received Treatment|Overall Study||119
976757|NCT00338884|2365745|P1|STARTED|Overall Study||120
976758|NCT00338962|2365781|P4|NOT COMPLETED|Overall Study||3
976759|NCT00338962|2365782|P3|NOT COMPLETED|Overall Study||6
976760|NCT00338962|2365783|P2|NOT COMPLETED|Overall Study||4
976761|NCT00338962|2365784|P1|NOT COMPLETED|Overall Study||8
976762|NCT00338962|2365781|P4|COMPLETED|Overall Study||21
976763|NCT00338962|2365782|P3|COMPLETED|Overall Study||16
976764|NCT00338962|2365783|P2|COMPLETED|Overall Study||16
976765|NCT00338962|2365784|P1|COMPLETED|Overall Study||14
976766|NCT00338962|2365781|P4|STARTED|Overall Study||24
976767|NCT00338962|2365782|P3|STARTED|Overall Study||22
976768|NCT00338962|2365783|P2|STARTED|Overall Study||20
976769|NCT00338962|2365784|P1|STARTED|Overall Study||22
976770|NCT00338988|2365806|P1|NOT COMPLETED|Overall Study||1
976771|NCT00338988|2365806|P1|COMPLETED|Overall Study||43
976772|NCT00338988|2365806|P1|STARTED|Overall Study||44
976773|NCT00339040|2365813|P2|NOT COMPLETED|Stage II||2
976774|NCT00339040|2365814|P1|NOT COMPLETED|Stage II||10
976775|NCT00339040|2365813|P2|COMPLETED|Stage II||27
976776|NCT00339040|2365814|P1|COMPLETED|Stage II||84
976777|NCT00339040|2365813|P2|Vaccination 6 at Week 120|Stage II||27
976778|NCT00339040|2365814|P1|Vaccination 6 at Week 120|Stage II||0
976779|NCT00339040|2365813|P2|Vaccination 5 at Week 104|Stage II||28
976780|NCT00339040|2365814|P1|Vaccination 5 at Week 104|Stage II||0
976781|NCT00339040|2365813|P2|Vaccination 4 at Week 96|Stage II||29
976782|NCT00339040|2365814|P1|Vaccination 4 at Week 96|Stage II||84
976783|NCT00339040|2365813|P2|STARTED|Stage II||29
976784|NCT00339040|2365814|P1|STARTED|Stage II||94
976785|NCT00339040|2365813|P2|NOT COMPLETED|Stage I||1
976786|NCT00339040|2365814|P1|NOT COMPLETED|Stage I||2
976787|NCT00339040|2365813|P2|COMPLETED|Stage I||29
976788|NCT00339040|2365814|P1|COMPLETED|Stage I||94
976789|NCT00339040|2365813|P2|Vaccination 3 at Week 24|Stage I||30
976790|NCT00339040|2365814|P1|Vaccination 3 at Week 24|Stage I||94
976791|NCT00339040|2365813|P2|Vaccination 2 at Week 8|Stage I||30
976792|NCT00339040|2365814|P1|Vaccination 2 at Week 8|Stage I||95
976793|NCT00339040|2365813|P2|Vaccination 1 at Week 0|Stage I||30
976794|NCT00339040|2365814|P1|Vaccination 1 at Week 0|Stage I||96
976795|NCT00339040|2365813|P2|STARTED|Stage I||30
976796|NCT00339040|2365814|P1|STARTED|Stage I||96
976797|NCT00339079|2365836|P4|NOT COMPLETED|Overall Study||24
976798|NCT00339079|2365837|P3|NOT COMPLETED|Overall Study||18
976799|NCT00339079|2365838|P2|NOT COMPLETED|Overall Study||23
976800|NCT00339079|2365839|P1|NOT COMPLETED|Overall Study||33
976801|NCT00339079|2365836|P4|COMPLETED|Overall Study||29
976802|NCT00339079|2365837|P3|COMPLETED|Overall Study||27
976803|NCT00339079|2365838|P2|COMPLETED|Overall Study||21
976804|NCT00339079|2365839|P1|COMPLETED|Overall Study||20
976805|NCT00339079|2365836|P4|STARTED|Overall Study||53
976806|NCT00339079|2365837|P3|STARTED|Overall Study||45
976807|NCT00339079|2365838|P2|STARTED|Overall Study||44
976808|NCT00339079|2365839|P1|STARTED|Overall Study||53
976809|NCT00339144|2365856|P3|NOT COMPLETED|Overall Study||4
976810|NCT00339144|2365857|P2|NOT COMPLETED|Overall Study||3
976811|NCT00339144|2365858|P1|NOT COMPLETED|Overall Study||9
976812|NCT00339144|2365856|P3|COMPLETED|Overall Study||0
976813|NCT00339144|2365857|P2|COMPLETED|Overall Study||0
976814|NCT00339144|2365858|P1|COMPLETED|Overall Study||0
976815|NCT00339144|2365856|P3|STARTED|Overall Study|Number of participants enrolled and treated|4
976816|NCT00339144|2365857|P2|STARTED|Overall Study|Number of participants enrolled and treated|3
976817|NCT00339144|2365858|P1|STARTED|Overall Study|Number of participants enrolled and treated|9
976818|NCT00339183|2365942|P2|NOT COMPLETED|Overall Study||105
976819|NCT00339183|2365943|P1|NOT COMPLETED|Overall Study||121
976820|NCT00339183|2365942|P2|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|490
976821|NCT00339183|2365943|P1|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|470
976822|NCT00339183|2365942|P2|Received Study Drug|Overall Study||593
976823|NCT00339183|2365943|P1|Received Study Drug|Overall Study|Includes one participant who received FOLFIRI Alone|588
976824|NCT00339183|2365942|P2|STARTED|Overall Study||595
976825|NCT00339183|2365943|P1|STARTED|Overall Study||591
976826|NCT00339833|2365971|P2|NOT COMPLETED|Overall Study||8
976827|NCT00339833|2365972|P1|NOT COMPLETED|Overall Study||6
976828|NCT00339833|2365971|P2|COMPLETED|Overall Study||18
976829|NCT00339833|2365972|P1|COMPLETED|Overall Study||22
976830|NCT00339833|2365971|P2|STARTED|Overall Study||26
976831|NCT00339833|2365972|P1|STARTED|Overall Study||28
976832|NCT00340379|2365982|P2|NOT COMPLETED|Overall Study||9
976833|NCT00340379|2365983|P1|NOT COMPLETED|Overall Study||8
976834|NCT00340379|2365982|P2|COMPLETED|Overall Study||28
976835|NCT00340379|2365983|P1|COMPLETED|Overall Study||27
976836|NCT00340379|2365982|P2|STARTED|Overall Study||37
976837|NCT00340379|2365983|P1|STARTED|Overall Study||35
976838|NCT00340678|2365997|P4|NOT COMPLETED|Overall Study||0
976839|NCT00340678|2365998|P3|NOT COMPLETED|Overall Study||0
976840|NCT00340678|2365999|P2|NOT COMPLETED|Overall Study||0
976841|NCT00340678|2366000|P1|NOT COMPLETED|Overall Study||1
976842|NCT00340678|2365997|P4|COMPLETED|Overall Study||39
976843|NCT00340678|2365998|P3|COMPLETED|Overall Study||39
976844|NCT00340678|2365999|P2|COMPLETED|Overall Study||46
976845|NCT00340678|2366000|P1|COMPLETED|Overall Study||45
976846|NCT00340678|2365997|P4|STARTED|Overall Study||39
976847|NCT00340678|2365998|P3|STARTED|Overall Study||39
976848|NCT00340678|2365999|P2|STARTED|Overall Study||46
976849|NCT00340678|2366000|P1|STARTED|Overall Study||46
976850|NCT00340704|2366021|P9|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||29
976851|NCT00340704|2366022|P8|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||12
976852|NCT00340704|2366023|P7|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||53
976853|NCT00340704|2366024|P6|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||7
976854|NCT00340704|2366025|P5|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||5
976855|NCT00340704|2366026|P4|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||2
976856|NCT00340704|2366027|P3|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
976857|NCT00340704|2366028|P2|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
976858|NCT00340704|2366029|P1|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
976859|NCT00340704|2366021|P9|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
976860|NCT00340704|2366022|P8|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
976861|NCT00340704|2366023|P7|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
976862|NCT00340704|2366024|P6|COMPLETED|Group D- Denovo & 527.51 Rollover Study||30
976863|NCT00340704|2366025|P5|COMPLETED|Group D- Denovo & 527.51 Rollover Study||16
976864|NCT00340704|2366026|P4|COMPLETED|Group D- Denovo & 527.51 Rollover Study||27
976865|NCT00340704|2366027|P3|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
976866|NCT00340704|2366028|P2|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
976867|NCT00340704|2366029|P1|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
976868|NCT00340704|2366021|P9|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
976869|NCT00340704|2366022|P8|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
976870|NCT00340704|2366023|P7|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
976871|NCT00340704|2366024|P6|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||18
976872|NCT00340704|2366025|P5|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||5
976873|NCT00340704|2366026|P4|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||7
976874|NCT00340704|2366027|P3|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
976875|NCT00340704|2366028|P2|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
976876|NCT00340704|2366029|P1|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
976877|NCT00340704|2366021|P9|STARTED|Group D- Denovo & 527.51 Rollover Study||29
976878|NCT00340704|2366022|P8|STARTED|Group D- Denovo & 527.51 Rollover Study||13
976879|NCT00340704|2366023|P7|STARTED|Group D- Denovo & 527.51 Rollover Study||54
976880|NCT00340704|2366024|P6|STARTED|Group D- Denovo & 527.51 Rollover Study||37
976881|NCT00340704|2366025|P5|STARTED|Group D- Denovo & 527.51 Rollover Study||21
976882|NCT00340704|2366026|P4|STARTED|Group D- Denovo & 527.51 Rollover Study||29
976883|NCT00340704|2366027|P3|STARTED|Group D- Denovo & 527.51 Rollover Study||0
976884|NCT00340704|2366028|P2|STARTED|Group D- Denovo & 527.51 Rollover Study||0
976885|NCT00340704|2366029|P1|STARTED|Group D- Denovo & 527.51 Rollover Study||0
976886|NCT00340704|2366021|P9|NOT COMPLETED|PK Study||0
976887|NCT00340704|2366022|P8|NOT COMPLETED|PK Study||0
976888|NCT00340704|2366023|P7|NOT COMPLETED|PK Study||0
976889|NCT00340704|2366024|P6|NOT COMPLETED|PK Study||0
976890|NCT00340704|2366025|P5|NOT COMPLETED|PK Study||0
976891|NCT00340704|2366026|P4|NOT COMPLETED|PK Study||0
976892|NCT00340704|2366027|P3|NOT COMPLETED|PK Study||1
976893|NCT00340704|2366028|P2|NOT COMPLETED|PK Study||1
976894|NCT00340704|2366029|P1|NOT COMPLETED|PK Study||0
976895|NCT00340704|2366021|P9|COMPLETED|PK Study||0
976896|NCT00340704|2366022|P8|COMPLETED|PK Study||0
976897|NCT00340704|2366023|P7|COMPLETED|PK Study||0
976898|NCT00340704|2366024|P6|COMPLETED|PK Study||0
976899|NCT00340704|2366025|P5|COMPLETED|PK Study||0
976900|NCT00340704|2366026|P4|COMPLETED|PK Study||0
976901|NCT00340704|2366027|P3|COMPLETED|PK Study||10
976902|NCT00340704|2366028|P2|COMPLETED|PK Study||9
976903|NCT00340704|2366029|P1|COMPLETED|PK Study||10
976904|NCT00340704|2366021|P9|STARTED|PK Study||0
976905|NCT00340704|2366022|P8|STARTED|PK Study||0
976906|NCT00340704|2366023|P7|STARTED|PK Study||0
976907|NCT00340704|2366024|P6|STARTED|PK Study||0
976908|NCT00340704|2366025|P5|STARTED|PK Study||0
976909|NCT00340704|2366026|P4|STARTED|PK Study||0
976910|NCT00340704|2366027|P3|STARTED|PK Study||11
976911|NCT00340704|2366028|P2|STARTED|PK Study||10
976912|NCT00340704|2366029|P1|STARTED|PK Study||10
976913|NCT00340834|2366136|P5|NOT COMPLETED|Extension Phase of Study||44
976914|NCT00340834|2366137|P4|NOT COMPLETED|Extension Phase of Study||53
976915|NCT00340834|2366138|P3|NOT COMPLETED|Extension Phase of Study||0
976916|NCT00340834|2366139|P2|NOT COMPLETED|Extension Phase of Study||76
976917|NCT00340834|2366140|P1|NOT COMPLETED|Extension Phase of Study||85
976918|NCT00340834|2366136|P5|COMPLETED|Extension Phase of Study||123
976919|NCT00340834|2366137|P4|COMPLETED|Extension Phase of Study||123
976920|NCT00340834|2366138|P3|COMPLETED|Extension Phase of Study||0
976921|NCT00340834|2366139|P2|COMPLETED|Extension Phase of Study||281
976922|NCT00340834|2366140|P1|COMPLETED|Extension Phase of Study||245
976923|NCT00340834|2366136|P5|Received Study Drug|Extension Phase of Study||167
976924|NCT00340834|2366137|P4|Received Study Drug|Extension Phase of Study||174
976925|NCT00340834|2366138|P3|Received Study Drug|Extension Phase of Study||0
976926|NCT00340834|2366139|P2|Received Study Drug|Extension Phase of Study||356
976927|NCT00340834|2366140|P1|Received Study Drug|Extension Phase of Study||330
976928|NCT00340834|2366136|P5|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|167
976929|NCT00340834|2366137|P4|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|176
976930|NCT00340834|2366138|P3|STARTED|Extension Phase of Study|This group did not exist in the extension phase of the study.|0
976931|NCT00340834|2366139|P2|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|357
976932|NCT00340834|2366140|P1|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|330
976933|NCT00340834|2366136|P5|NOT COMPLETED|Core Phase of Study||0
976934|NCT00340834|2366137|P4|NOT COMPLETED|Core Phase of Study||0
976935|NCT00340834|2366138|P3|NOT COMPLETED|Core Phase of Study||49
976936|NCT00340834|2366139|P2|NOT COMPLETED|Core Phase of Study||33
976937|NCT00340834|2366140|P1|NOT COMPLETED|Core Phase of Study||57
976938|NCT00340834|2366136|P5|COMPLETED|Core Phase of Study||0
976939|NCT00340834|2366137|P4|COMPLETED|Core Phase of Study||0
976940|NCT00340834|2366138|P3|COMPLETED|Core Phase of Study|On study drug: 380, Off study drug: 6|386
976941|NCT00340834|2366139|P2|COMPLETED|Core Phase of Study|On study drug: 385, Off study drug: 13|398
976942|NCT00340834|2366140|P1|COMPLETED|Core Phase of Study|On study drug: 358, Off study drug: 11|369
976943|NCT00340834|2366136|P5|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
976944|NCT00340834|2366137|P4|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
976945|NCT00340834|2366138|P3|STARTED|Core Phase of Study||435
976946|NCT00340834|2366139|P2|STARTED|Core Phase of Study||431
976947|NCT00340834|2366140|P1|STARTED|Core Phase of Study||426
976948|NCT00347009|2366165|P1|NOT COMPLETED|Overall Study||27
976949|NCT00347009|2366165|P1|COMPLETED|Overall Study||128
976950|NCT00347009|2366165|P1|STARTED|Overall Study||155
976951|NCT00347022|2366184|P2|NOT COMPLETED|Overall Study||5
976952|NCT00347022|2366185|P1|NOT COMPLETED|Overall Study||12
976953|NCT00347022|2366184|P2|COMPLETED|Overall Study||66
976954|NCT00347022|2366185|P1|COMPLETED|Overall Study||62
976955|NCT00347022|2366184|P2|STARTED|Overall Study||71
976956|NCT00347022|2366185|P1|STARTED|Overall Study||74
976957|NCT00347269|2366193|P2|NOT COMPLETED|Overall Study||106
976958|NCT00347269|2366194|P1|NOT COMPLETED|Overall Study||94
976959|NCT00347269|2366193|P2|COMPLETED|Overall Study||395
976960|NCT00347269|2366194|P1|COMPLETED|Overall Study||409
976961|NCT00347269|2366193|P2|STARTED|Overall Study||501
976962|NCT00347269|2366194|P1|STARTED|Overall Study||503
976963|NCT00347308|2366200|P1|NOT COMPLETED|Overall Study||0
976964|NCT00347308|2366200|P1|COMPLETED|Overall Study||40
976965|NCT00347308|2366200|P1|STARTED|Overall Study||40
976966|NCT00348556|2366204|P1|NOT COMPLETED|Overall Study||1
976967|NCT00348556|2366204|P1|COMPLETED|Overall Study||3
976968|NCT00348556|2366204|P1|STARTED|Overall Study||4
976969|NCT00348673|2366217|P9|NOT COMPLETED|Stage 2||0
976970|NCT00348673|2366218|P8|NOT COMPLETED|Stage 2||0
976971|NCT00348673|2366219|P7|NOT COMPLETED|Stage 2||0
976972|NCT00348673|2366220|P6|NOT COMPLETED|Stage 2||0
976973|NCT00348673|2366221|P5|NOT COMPLETED|Stage 2||0
976974|NCT00348673|2366222|P4|NOT COMPLETED|Stage 2||0
976975|NCT00348673|2366223|P3|NOT COMPLETED|Stage 2||0
976976|NCT00348673|2366224|P2|NOT COMPLETED|Stage 2||0
976977|NCT00348673|2366225|P1|NOT COMPLETED|Stage 2||0
976978|NCT00348673|2366217|P9|COMPLETED|Stage 2||2
976979|NCT00348673|2366218|P8|COMPLETED|Stage 2||6
976980|NCT00348673|2366219|P7|COMPLETED|Stage 2||6
976981|NCT00348673|2366220|P6|COMPLETED|Stage 2||6
976982|NCT00348673|2366221|P5|COMPLETED|Stage 2||0
976983|NCT00348673|2366222|P4|COMPLETED|Stage 2||0
976984|NCT00348673|2366223|P3|COMPLETED|Stage 2||0
976985|NCT00348673|2366224|P2|COMPLETED|Stage 2||0
976986|NCT00348673|2366225|P1|COMPLETED|Stage 2||0
976987|NCT00348673|2366217|P9|STARTED|Stage 2||2
976988|NCT00348673|2366218|P8|STARTED|Stage 2||6
976989|NCT00348673|2366219|P7|STARTED|Stage 2||6
976990|NCT00348673|2366220|P6|STARTED|Stage 2||6
976991|NCT00348673|2366221|P5|STARTED|Stage 2||0
976992|NCT00348673|2366222|P4|STARTED|Stage 2||0
976993|NCT00348673|2366223|P3|STARTED|Stage 2||0
976994|NCT00348673|2366224|P2|STARTED|Stage 2||0
976995|NCT00348673|2366225|P1|STARTED|Stage 2||0
976996|NCT00348673|2366217|P9|NOT COMPLETED|Stage 1||0
976997|NCT00348673|2366218|P8|NOT COMPLETED|Stage 1||0
976998|NCT00348673|2366219|P7|NOT COMPLETED|Stage 1||0
976999|NCT00348673|2366220|P6|NOT COMPLETED|Stage 1||0
977000|NCT00348673|2366221|P5|NOT COMPLETED|Stage 1||0
977001|NCT00348673|2366222|P4|NOT COMPLETED|Stage 1||0
977002|NCT00348673|2366223|P3|NOT COMPLETED|Stage 1||1
977003|NCT00348673|2366224|P2|NOT COMPLETED|Stage 1||0
977004|NCT00348673|2366225|P1|NOT COMPLETED|Stage 1||0
977005|NCT00348673|2366217|P9|COMPLETED|Stage 1||0
977006|NCT00348673|2366218|P8|COMPLETED|Stage 1||0
977007|NCT00348673|2366219|P7|COMPLETED|Stage 1||0
977008|NCT00348673|2366220|P6|COMPLETED|Stage 1||0
977009|NCT00348673|2366221|P5|COMPLETED|Stage 1||4
977010|NCT00348673|2366222|P4|COMPLETED|Stage 1||6
977011|NCT00348673|2366223|P3|COMPLETED|Stage 1||6
977012|NCT00348673|2366224|P2|COMPLETED|Stage 1||6
977013|NCT00348673|2366225|P1|COMPLETED|Stage 1||6
977014|NCT00348673|2366217|P9|Treated|Stage 1||0
977015|NCT00348673|2366218|P8|Treated|Stage 1||0
977016|NCT00348673|2366219|P7|Treated|Stage 1||0
977017|NCT00348673|2366220|P6|Treated|Stage 1||0
977018|NCT00348673|2366221|P5|Treated|Stage 1||4
977019|NCT00348673|2366222|P4|Treated|Stage 1||6
977020|NCT00348673|2366223|P3|Treated|Stage 1||6
977021|NCT00348673|2366224|P2|Treated|Stage 1||6
977022|NCT00348673|2366225|P1|Treated|Stage 1||6
977023|NCT00348673|2366217|P9|STARTED|Stage 1||0
977024|NCT00348673|2366218|P8|STARTED|Stage 1||0
977025|NCT00348673|2366219|P7|STARTED|Stage 1||0
977026|NCT00348673|2366220|P6|STARTED|Stage 1||0
977027|NCT00348673|2366221|P5|STARTED|Stage 1||4
977028|NCT00348673|2366222|P4|STARTED|Stage 1||6
977029|NCT00348673|2366223|P3|STARTED|Stage 1||7
977030|NCT00348673|2366224|P2|STARTED|Stage 1||6
977031|NCT00348673|2366225|P1|STARTED|Stage 1||6
977032|NCT00348686|2366272|P1|NOT COMPLETED|Overall Study||66
977033|NCT00348686|2366272|P1|COMPLETED|Overall Study||249
977034|NCT00348686|2366272|P1|STARTED|Overall Study||315
977035|NCT00348790|2366281|P1|NOT COMPLETED|Completed Treatment||25
977036|NCT00348790|2366281|P1|COMPLETED|Completed Treatment||0
977037|NCT00348790|2366281|P1|STARTED|Completed Treatment||25
977038|NCT00348790|2366281|P1|NOT COMPLETED|Began Treatment||0
977039|NCT00348790|2366281|P1|COMPLETED|Began Treatment||25
977040|NCT00348790|2366281|P1|STARTED|Began Treatment||25
977041|NCT00348816|2366286|P1|NOT COMPLETED|Overall Study||1
977042|NCT00348816|2366286|P1|COMPLETED|Overall Study||19
977043|NCT00348816|2366286|P1|STARTED|Overall Study||20
977044|NCT00348881|2366293|P2|NOT COMPLETED|Overall Study||12
977045|NCT00348881|2366294|P1|NOT COMPLETED|Overall Study||17
977046|NCT00348881|2366293|P2|COMPLETED|Overall Study||697
977047|NCT00348881|2366294|P1|COMPLETED|Overall Study||1407
977048|NCT00348881|2366293|P2|STARTED|Overall Study||709
977049|NCT00348881|2366294|P1|STARTED|Overall Study||1424
977050|NCT00348933|2366306|P1|NOT COMPLETED|Overall Study||25
977051|NCT00348933|2366306|P1|COMPLETED|Overall Study||65
977052|NCT00348933|2366306|P1|STARTED|Overall Study||90
977053|NCT00349336|2366314|P2|NOT COMPLETED|Overall Study||14
977054|NCT00349336|2366315|P1|NOT COMPLETED|Overall Study||13
977055|NCT00349336|2366314|P2|COMPLETED|Overall Study||18
977056|NCT00349336|2366315|P1|COMPLETED|Overall Study||19
977057|NCT00349336|2366314|P2|STARTED|Overall Study||32
977058|NCT00349336|2366315|P1|STARTED|Overall Study||32
977059|NCT00349349|2366340|P3|NOT COMPLETED|Overall Study||6
977060|NCT00349349|2366341|P2|NOT COMPLETED|Overall Study||62
977061|NCT00349349|2366342|P1|NOT COMPLETED|Overall Study||53
977062|NCT00349349|2366340|P3|COMPLETED|Overall Study||10
977063|NCT00349349|2366341|P2|COMPLETED|Overall Study||50
977064|NCT00349349|2366342|P1|COMPLETED|Overall Study||42
977065|NCT00349349|2366340|P3|STARTED|Overall Study||16
977066|NCT00349349|2366341|P2|STARTED|Overall Study||112
977067|NCT00349349|2366342|P1|STARTED|Overall Study||95
977068|NCT00349388|2366408|P2|NOT COMPLETED|Overall Study||0
977069|NCT00349388|2366409|P1|NOT COMPLETED|Overall Study||0
977070|NCT00349388|2366408|P2|COMPLETED|Overall Study||1
977071|NCT00349388|2366409|P1|COMPLETED|Overall Study|no patients enrolled , therefore no patients completed|0
977072|NCT00349388|2366408|P2|STARTED|Overall Study||1
977073|NCT00349388|2366409|P1|STARTED|Overall Study|no patients enrolled|0
977074|NCT00349466|2366417|P2|NOT COMPLETED|Overall Study||3
977075|NCT00349466|2366418|P1|NOT COMPLETED|Overall Study||9
977076|NCT00349466|2366417|P2|COMPLETED|Overall Study||35
977077|NCT00349466|2366418|P1|COMPLETED|Overall Study||33
977078|NCT00349466|2366417|P2|STARTED|Overall Study||38
977079|NCT00349466|2366418|P1|STARTED|Overall Study||42
977080|NCT00349622|2366426|P2|NOT COMPLETED|Overall Study||96
977081|NCT00349622|2366427|P1|NOT COMPLETED|Overall Study||178
977082|NCT00349622|2366426|P2|COMPLETED|Overall Study||77
977083|NCT00349622|2366427|P1|COMPLETED|Overall Study||162
977084|NCT00349622|2366426|P2|STARTED|Overall Study||173
977085|NCT00349622|2366427|P1|STARTED|Overall Study||340
977086|NCT00349713|2366446|P3|NOT COMPLETED|Overall Study||0
977087|NCT00349713|2366447|P2|NOT COMPLETED|Overall Study||0
977088|NCT00349713|2366448|P1|NOT COMPLETED|Overall Study||0
977089|NCT00349713|2366446|P3|COMPLETED|Overall Study||20
977090|NCT00349713|2366447|P2|COMPLETED|Overall Study||20
977091|NCT00349713|2366448|P1|COMPLETED|Overall Study||20
977092|NCT00349713|2366446|P3|STARTED|Overall Study||20
977093|NCT00349713|2366447|P2|STARTED|Overall Study||20
977094|NCT00349713|2366448|P1|STARTED|Overall Study||20
977095|NCT00349752|2366470|P2|NOT COMPLETED|Overall Study||64
977096|NCT00349752|2366471|P1|NOT COMPLETED|Overall Study||59
977097|NCT00349752|2366470|P2|COMPLETED|Overall Study||23
977098|NCT00349752|2366471|P1|COMPLETED|Overall Study||28
977099|NCT00349752|2366470|P2|STARTED|Overall Study||87
977100|NCT00349752|2366471|P1|STARTED|Overall Study||87
977101|NCT00349908|2366499|P2|NOT COMPLETED|Overall Study||4
977102|NCT00349908|2366500|P1|NOT COMPLETED|Overall Study||0
977103|NCT00349908|2366499|P2|COMPLETED|Overall Study|9 returned for 30 day follow-up, 7 returned for 6 month and 6/7 had 6 month angiogram|6
977104|NCT00349908|2366500|P1|COMPLETED|Overall Study||10
977105|NCT00349908|2366499|P2|STARTED|Overall Study||10
977106|NCT00349908|2366500|P1|STARTED|Overall Study||10
977107|NCT00349921|2366522|P4|NOT COMPLETED|Second Spinal Injection||0
977108|NCT00349921|2366523|P3|NOT COMPLETED|Second Spinal Injection||0
977109|NCT00349921|2366524|P2|NOT COMPLETED|Second Spinal Injection||0
977110|NCT00349921|2366525|P1|NOT COMPLETED|Second Spinal Injection||0
977111|NCT00349921|2366522|P4|COMPLETED|Second Spinal Injection||1
977112|NCT00349921|2366523|P3|COMPLETED|Second Spinal Injection||0
977113|NCT00349921|2366524|P2|COMPLETED|Second Spinal Injection||10
977114|NCT00349921|2366525|P1|COMPLETED|Second Spinal Injection||9
977115|NCT00349921|2366522|P4|STARTED|Second Spinal Injection||1
977116|NCT00349921|2366523|P3|STARTED|Second Spinal Injection||0
977117|NCT00349921|2366524|P2|STARTED|Second Spinal Injection||10
977118|NCT00349921|2366525|P1|STARTED|Second Spinal Injection|One patient experienced an adverse event after period one and did not participate in period two|9
977119|NCT00349921|2366522|P4|NOT COMPLETED|First Spinal Injection||0
977120|NCT00349921|2366523|P3|NOT COMPLETED|First Spinal Injection||1
977121|NCT00349921|2366524|P2|NOT COMPLETED|First Spinal Injection||0
977122|NCT00349921|2366525|P1|NOT COMPLETED|First Spinal Injection||1
977123|NCT00349921|2366522|P4|COMPLETED|First Spinal Injection||1
977124|NCT00349921|2366523|P3|COMPLETED|First Spinal Injection||0
977125|NCT00349921|2366524|P2|COMPLETED|First Spinal Injection||10
977126|NCT00349921|2366525|P1|COMPLETED|First Spinal Injection||9
977127|NCT00349921|2366522|P4|STARTED|First Spinal Injection||1
977128|NCT00349921|2366523|P3|STARTED|First Spinal Injection||1
977129|NCT00349921|2366524|P2|STARTED|First Spinal Injection||10
977130|NCT00349921|2366525|P1|STARTED|First Spinal Injection||10
977131|NCT00350025|2366536|P2|NOT COMPLETED|Overall Study||2
977132|NCT00350025|2366537|P1|NOT COMPLETED|Overall Study||0
977133|NCT00350025|2366536|P2|COMPLETED|Overall Study||28
977134|NCT00350025|2366537|P1|COMPLETED|Overall Study||11
977135|NCT00350025|2366536|P2|STARTED|Overall Study||30
977136|NCT00350025|2366537|P1|STARTED|Overall Study||11
977137|NCT00350142|2366545|P1|NOT COMPLETED|Overall Study||0
977138|NCT00350142|2366545|P1|COMPLETED|Overall Study||20
977139|NCT00350142|2366545|P1|STARTED|Overall Study||20
977140|NCT00350207|2366553|P3|NOT COMPLETED|Overall Study||7
977141|NCT00350207|2366554|P2|NOT COMPLETED|Overall Study||6
977142|NCT00350207|2366555|P1|NOT COMPLETED|Overall Study||8
977143|NCT00350207|2366553|P3|COMPLETED|Overall Study||119
977144|NCT00350207|2366554|P2|COMPLETED|Overall Study||128
977145|NCT00350207|2366555|P1|COMPLETED|Overall Study||120
977146|NCT00350207|2366553|P3|STARTED|Overall Study||126
977147|NCT00350207|2366554|P2|STARTED|Overall Study||134
977148|NCT00350207|2366555|P1|STARTED|Overall Study||128
977149|NCT00350220|2366751|P2|NOT COMPLETED|Overall Study||0
977150|NCT00350220|2366752|P1|NOT COMPLETED|Overall Study||0
977151|NCT00350220|2366751|P2|COMPLETED|Overall Study||30
977152|NCT00350220|2366752|P1|COMPLETED|Overall Study||30
977153|NCT00350220|2366751|P2|STARTED|Overall Study||30
977154|NCT00350220|2366752|P1|STARTED|Overall Study||30
977155|NCT00350272|2366762|P2|NOT COMPLETED|Open-Label 84 Week Treatment||8
977156|NCT00350272|2366763|P1|NOT COMPLETED|Open-Label 84 Week Treatment||9
977157|NCT00350272|2366762|P2|COMPLETED|Open-Label 84 Week Treatment||27
977158|NCT00350272|2366763|P1|COMPLETED|Open-Label 84 Week Treatment||21
977159|NCT00350272|2366762|P2|STARTED|Open-Label 84 Week Treatment||35
977160|NCT00350272|2366763|P1|STARTED|Open-Label 84 Week Treatment||30
977161|NCT00350272|2366762|P2|NOT COMPLETED|Blinded 12 Week Treatment||2
977162|NCT00350272|2366763|P1|NOT COMPLETED|Blinded 12 Week Treatment||9
977163|NCT00350272|2366762|P2|COMPLETED|Blinded 12 Week Treatment||35
977164|NCT00350272|2366763|P1|COMPLETED|Blinded 12 Week Treatment||30
977165|NCT00350272|2366762|P2|STARTED|Blinded 12 Week Treatment||37
977166|NCT00350272|2366763|P1|STARTED|Blinded 12 Week Treatment||39
977167|NCT00350363|2366771|P1|NOT COMPLETED|Overall Study||0
977168|NCT00350363|2366771|P1|COMPLETED|Overall Study||60
977169|NCT00350363|2366771|P1|STARTED|Overall Study||60
977170|NCT00350402|2366777|P2|NOT COMPLETED|Overall Study||1
977171|NCT00350402|2366778|P1|NOT COMPLETED|Overall Study||1
977172|NCT00350402|2366777|P2|COMPLETED|Overall Study||20
977173|NCT00350402|2366778|P1|COMPLETED|Overall Study||20
977174|NCT00350402|2366777|P2|STARTED|Overall Study||21
977175|NCT00350402|2366778|P1|STARTED|Overall Study||21
977176|NCT00350519|2366792|P2|NOT COMPLETED|Overall Study||6
977177|NCT00350519|2366793|P1|NOT COMPLETED|Overall Study||4
977178|NCT00350519|2366792|P2|COMPLETED|Overall Study||13
977179|NCT00350519|2366793|P1|COMPLETED|Overall Study||14
977180|NCT00350519|2366792|P2|STARTED|Overall Study||19
977181|NCT00350519|2366793|P1|STARTED|Overall Study||18
977182|NCT00350532|2366807|P2|NOT COMPLETED|Overall Study||0
977183|NCT00350532|2366808|P1|NOT COMPLETED|Overall Study||0
977184|NCT00350532|2366807|P2|COMPLETED|Overall Study||19
977185|NCT00350532|2366808|P1|COMPLETED|Overall Study||24
977186|NCT00350532|2366807|P2|STARTED|Overall Study||19
977187|NCT00350532|2366808|P1|STARTED|Overall Study||24
977188|NCT00350623|2366817|P3|NOT COMPLETED|Overall Study||6
977189|NCT00350623|2366818|P2|NOT COMPLETED|Overall Study||4
977190|NCT00350623|2366819|P1|NOT COMPLETED|Overall Study||8
977191|NCT00350623|2366817|P3|COMPLETED|Overall Study||62
977192|NCT00350623|2366818|P2|COMPLETED|Overall Study||67
977193|NCT00350623|2366819|P1|COMPLETED|Overall Study||63
977194|NCT00350623|2366817|P3|STARTED|Overall Study||68
977195|NCT00350623|2366818|P2|STARTED|Overall Study||71
977196|NCT00350623|2366819|P1|STARTED|Overall Study||71
977197|NCT00350636|2366829|P2|NOT COMPLETED|Overall Study||45
977198|NCT00350636|2366830|P1|NOT COMPLETED|Overall Study||43
977199|NCT00350636|2366829|P2|COMPLETED|Overall Study||355
977200|NCT00350636|2366830|P1|COMPLETED|Overall Study||346
977201|NCT00350636|2366829|P2|STARTED|Overall Study||400
977202|NCT00350636|2366830|P1|STARTED|Overall Study||389
977203|NCT00350727|2366849|P3|NOT COMPLETED|Phase II||22
977204|NCT00350727|2366850|P2|NOT COMPLETED|Phase II||19
977205|NCT00350727|2366851|P1|NOT COMPLETED|Phase II||0
977206|NCT00350727|2366849|P3|COMPLETED|Phase II||0
977207|NCT00350727|2366850|P2|COMPLETED|Phase II||0
977208|NCT00350727|2366851|P1|COMPLETED|Phase II||0
977209|NCT00350727|2366849|P3|STARTED|Phase II||22
977210|NCT00350727|2366850|P2|STARTED|Phase II||19
977211|NCT00350727|2366851|P1|STARTED|Phase II||0
977212|NCT00350727|2366849|P3|NOT COMPLETED|Phase I: Dose Escalation||0
977213|NCT00350727|2366850|P2|NOT COMPLETED|Phase I: Dose Escalation||0
977214|NCT00350727|2366851|P1|NOT COMPLETED|Phase I: Dose Escalation||34
977215|NCT00350727|2366849|P3|COMPLETED|Phase I: Dose Escalation||0
977216|NCT00350727|2366850|P2|COMPLETED|Phase I: Dose Escalation||0
977217|NCT00350727|2366851|P1|COMPLETED|Phase I: Dose Escalation||0
977218|NCT00350727|2366849|P3|STARTED|Phase I: Dose Escalation||0
977219|NCT00350727|2366850|P2|STARTED|Phase I: Dose Escalation||0
977220|NCT00350727|2366851|P1|STARTED|Phase I: Dose Escalation||34
977221|NCT00350779|2366995|P2|NOT COMPLETED|Overall Study||21
977222|NCT00350779|2366996|P1|NOT COMPLETED|Overall Study||22
977223|NCT00350779|2366995|P2|COMPLETED|Overall Study||71
977224|NCT00350779|2366996|P1|COMPLETED|Overall Study||148
977225|NCT00350779|2366995|P2|STARTED|Overall Study||92
977226|NCT00350779|2366996|P1|STARTED|Overall Study||170
977227|NCT00350792|2367014|P1|NOT COMPLETED|Overall Study||33
977228|NCT00350792|2367014|P1|COMPLETED|Overall Study||29
977229|NCT00350792|2367014|P1|STARTED|Overall Study||62
977230|NCT00350844|2367022|P1|NOT COMPLETED|Overall Study||1
977231|NCT00350844|2367022|P1|COMPLETED|Overall Study||5
977232|NCT00350844|2367022|P1|STARTED|Overall Study||6
977233|NCT00350870|2367030|P4|NOT COMPLETED|Overall Study||15
977234|NCT00350870|2367031|P3|NOT COMPLETED|Overall Study||16
977235|NCT00350870|2367032|P2|NOT COMPLETED|Overall Study||17
977236|NCT00350870|2367033|P1|NOT COMPLETED|Overall Study||22
977237|NCT00350870|2367030|P4|COMPLETED|Overall Study||7
977238|NCT00350870|2367031|P3|COMPLETED|Overall Study||6
977239|NCT00350870|2367032|P2|COMPLETED|Overall Study||11
977240|NCT00350870|2367033|P1|COMPLETED|Overall Study||5
977241|NCT00350870|2367030|P4|Had at Least 1 Day of Med|Overall Study||19
977242|NCT00350870|2367031|P3|Had at Least 1 Day of Med|Overall Study||18
977243|NCT00350870|2367032|P2|Had at Least 1 Day of Med|Overall Study||24
977244|NCT00350870|2367033|P1|Had at Least 1 Day of Med|Overall Study||19
977245|NCT00350870|2367030|P4|STARTED|Overall Study||22
977246|NCT00350870|2367031|P3|STARTED|Overall Study||22
977247|NCT00350870|2367032|P2|STARTED|Overall Study||28
977248|NCT00350870|2367033|P1|STARTED|Overall Study||27
977249|NCT00351000|2367047|P1|NOT COMPLETED|Overall Study||3
977250|NCT00351000|2367047|P1|COMPLETED|Overall Study||21
977251|NCT00351000|2367047|P1|STARTED|Overall Study||24
977252|NCT00344019|2367057|P3|NOT COMPLETED|Overall Study||74
977253|NCT00344019|2367058|P2|NOT COMPLETED|Overall Study||0
977254|NCT00344019|2367059|P1|NOT COMPLETED|Overall Study||0
977255|NCT00344019|2367057|P3|COMPLETED|Overall Study||0
977256|NCT00344019|2367058|P2|COMPLETED|Overall Study||11
977257|NCT00344019|2367059|P1|COMPLETED|Overall Study||12
977258|NCT00344019|2367057|P3|STARTED|Overall Study||74
977259|NCT00344019|2367058|P2|STARTED|Overall Study||11
977260|NCT00344019|2367059|P1|STARTED|Overall Study||12
977261|NCT00344032|2367068|P2|NOT COMPLETED|Overall Study||10
977262|NCT00344032|2367069|P1|NOT COMPLETED|Overall Study||14
977263|NCT00344032|2367068|P2|COMPLETED|Overall Study||168
977264|NCT00344032|2367069|P1|COMPLETED|Overall Study||162
977265|NCT00344032|2367068|P2|STARTED|Overall Study||178
977266|NCT00344032|2367069|P1|STARTED|Overall Study||176
977267|NCT00344175|2367087|P2|NOT COMPLETED|Overall Study||10
977268|NCT00344175|2367088|P1|NOT COMPLETED|Overall Study||12
977269|NCT00344175|2367087|P2|COMPLETED|Overall Study||47
977270|NCT00344175|2367088|P1|COMPLETED|Overall Study||109
977271|NCT00344175|2367087|P2|STARTED|Overall Study||57
977272|NCT00344175|2367088|P1|STARTED|Overall Study||121
977273|NCT00344305|2367100|P2|NOT COMPLETED|Overall Study||1
977274|NCT00344305|2367101|P1|NOT COMPLETED|Overall Study||2
977275|NCT00344305|2367100|P2|COMPLETED|Overall Study||99
977276|NCT00344305|2367101|P1|COMPLETED|Overall Study||98
977277|NCT00344305|2367100|P2|STARTED|Overall Study||100
977278|NCT00344305|2367101|P1|STARTED|Overall Study||100
977279|NCT00344370|2367138|P2|NOT COMPLETED|Overall Study||3
977280|NCT00344370|2367139|P1|NOT COMPLETED|Overall Study||15
977281|NCT00344370|2367138|P2|COMPLETED|Overall Study||68
977282|NCT00344370|2367139|P1|COMPLETED|Overall Study||128
977283|NCT00344370|2367138|P2|STARTED|Overall Study||71
977284|NCT00344370|2367139|P1|STARTED|Overall Study||143
977285|NCT00344448|2367149|P2|NOT COMPLETED|Open Label||1
977286|NCT00344448|2367150|P1|NOT COMPLETED|Open Label||2
977287|NCT00344448|2367149|P2|COMPLETED|Open Label||2
977288|NCT00344448|2367150|P1|COMPLETED|Open Label||2
977289|NCT00344448|2367149|P2|STARTED|Open Label||3
977290|NCT00344448|2367150|P1|STARTED|Open Label||4
977291|NCT00344448|2367149|P2|NOT COMPLETED|Double Blind, Placebo Controlled||0
977292|NCT00344448|2367150|P1|NOT COMPLETED|Double Blind, Placebo Controlled||2
977293|NCT00344448|2367149|P2|COMPLETED|Double Blind, Placebo Controlled||3
977294|NCT00344448|2367150|P1|COMPLETED|Double Blind, Placebo Controlled||4
977295|NCT00344448|2367149|P2|STARTED|Double Blind, Placebo Controlled||3
977296|NCT00344448|2367150|P1|STARTED|Double Blind, Placebo Controlled||6
977297|NCT00344448|2367149|P2|NOT COMPLETED|Screening||1
977298|NCT00344448|2367150|P1|NOT COMPLETED|Screening||0
977299|NCT00344448|2367149|P2|COMPLETED|Screening||3
977300|NCT00344448|2367150|P1|COMPLETED|Screening||6
977301|NCT00344448|2367149|P2|STARTED|Screening||4
977302|NCT00344448|2367150|P1|STARTED|Screening|No randomization during the screening phase|6
977303|NCT00351039|2367156|P1|NOT COMPLETED|Overall Study||0
977304|NCT00351039|2367156|P1|COMPLETED|Overall Study|The study was halted before Phase II was initiated.|8
977305|NCT00351039|2367156|P1|STARTED|Overall Study||8
977306|NCT00351273|2367168|P3|NOT COMPLETED|Overall Study||5
977307|NCT00351273|2367169|P2|NOT COMPLETED|Overall Study||2
977308|NCT00351273|2367170|P1|NOT COMPLETED|Overall Study||1
977309|NCT00351273|2367168|P3|COMPLETED|Overall Study||10
977310|NCT00351273|2367169|P2|COMPLETED|Overall Study||10
977311|NCT00351273|2367170|P1|COMPLETED|Overall Study||14
977312|NCT00351273|2367168|P3|STARTED|Overall Study||15
977313|NCT00351273|2367169|P2|STARTED|Overall Study||12
977314|NCT00351273|2367170|P1|STARTED|Overall Study||15
977315|NCT00351299|2367180|P2|NOT COMPLETED|Overall Study||0
977316|NCT00351299|2367181|P1|NOT COMPLETED|Overall Study||0
977317|NCT00351299|2367180|P2|COMPLETED|Overall Study||28
977318|NCT00351299|2367181|P1|COMPLETED|Overall Study||25
977319|NCT00351299|2367180|P2|STARTED|Overall Study||28
977320|NCT00351299|2367181|P1|STARTED|Overall Study||25
977321|NCT00351468|2367195|P1|NOT COMPLETED|Overall Study||167
977322|NCT00351468|2367195|P1|COMPLETED|Overall Study||135
977323|NCT00351468|2367195|P1|Unknown - Not From Previous Trial|Overall Study|Mistakenly enrolled (not in any of the 3 trials) On 50 mg/d eltrombopag for 18 days and withdrawn|1
977324|NCT00351468|2367195|P1|Subjects From TRA108057 Repeat|Overall Study||43
977325|NCT00351468|2367195|P1|Subjects From TRA102537 Raise|Overall Study||146
977326|NCT00351468|2367195|P1|Subjects From TRA100773B|Overall Study||61
977327|NCT00351468|2367195|P1|Subjects From TRA100773A|Overall Study||51
977328|NCT00351468|2367195|P1|STARTED|Overall Study||302
977329|NCT00351533|2367212|P2|NOT COMPLETED|Overall Study||5
977330|NCT00351533|2367213|P1|NOT COMPLETED|Overall Study||2
977331|NCT00351533|2367212|P2|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|44
977332|NCT00351533|2367213|P1|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|39
977333|NCT00351533|2367212|P2|STARTED|Overall Study||49
977334|NCT00351533|2367213|P1|STARTED|Overall Study||41
977335|NCT00351741|2367275|P2|NOT COMPLETED|Overall Study||0
977336|NCT00351741|2367276|P1|NOT COMPLETED|Overall Study||0
977337|NCT00351741|2367275|P2|COMPLETED|Overall Study||31
977338|NCT00351741|2367276|P1|COMPLETED|Overall Study||31
977339|NCT00351741|2367275|P2|STARTED|Overall Study||31
977340|NCT00351741|2367276|P1|STARTED|Overall Study||31
977341|NCT00351819|2367296|P2|NOT COMPLETED|Overall Study||12
977342|NCT00351819|2367297|P1|NOT COMPLETED|Overall Study||7
977343|NCT00351819|2367296|P2|COMPLETED|Overall Study||29
977344|NCT00351819|2367297|P1|COMPLETED|Overall Study||36
977345|NCT00351819|2367296|P2|STARTED|Overall Study||41
977346|NCT00351819|2367297|P1|STARTED|Overall Study||43
977347|NCT00351936|2367345|P1|NOT COMPLETED|Overall Study||0
977348|NCT00351936|2367345|P1|COMPLETED|Overall Study||15
977349|NCT00351936|2367345|P1|STARTED|Overall Study||15
977350|NCT00352027|2367362|P1|NOT COMPLETED|Overall Study||3
977351|NCT00352027|2367362|P1|COMPLETED|Overall Study||77
977352|NCT00352027|2367362|P1|STARTED|Overall Study||80
977353|NCT00352053|2367633|P2|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||2
977354|NCT00352053|2367634|P1|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||1
977355|NCT00352053|2367633|P2|COMPLETED|Third Extension Phase (Weeks 240-294)||2
977356|NCT00352053|2367634|P1|COMPLETED|Third Extension Phase (Weeks 240-294)||0
977357|NCT00352053|2367633|P2|STARTED|Third Extension Phase (Weeks 240-294)|5 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|4
977358|NCT00352053|2367634|P1|STARTED|Third Extension Phase (Weeks 240-294)|3 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|1
977359|NCT00352053|2367633|P2|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
977360|NCT00352053|2367634|P1|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
977361|NCT00352053|2367633|P2|COMPLETED|Second Extension Phase (Weeks 144-240)||9
977362|NCT00352053|2367634|P1|COMPLETED|Second Extension Phase (Weeks 144-240)||4
977363|NCT00352053|2367633|P2|STARTED|Second Extension Phase (Weeks 144-240)|5 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|14
977364|NCT00352053|2367634|P1|STARTED|Second Extension Phase (Weeks 144-240)|3 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|9
977365|NCT00352053|2367633|P2|NOT COMPLETED|First Extension Phase (Weeks 48-144)||17
977366|NCT00352053|2367634|P1|NOT COMPLETED|First Extension Phase (Weeks 48-144)||12
977367|NCT00352053|2367633|P2|COMPLETED|First Extension Phase (Weeks 48-144)||19
977368|NCT00352053|2367634|P1|COMPLETED|First Extension Phase (Weeks 48-144)||12
977369|NCT00352053|2367633|P2|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|36
977370|NCT00352053|2367634|P1|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|24
977371|NCT00352053|2367633|P2|NOT COMPLETED|Double-Blind Phase (Through Week 48)||13
977372|NCT00352053|2367634|P1|NOT COMPLETED|Double-Blind Phase (Through Week 48)||18
977373|NCT00352053|2367633|P2|COMPLETED|Double-Blind Phase (Through Week 48)|The 10 participants discontinued for virologic failure enrolled early in the open-label extension.|29
977374|NCT00352053|2367634|P1|COMPLETED|Double-Blind Phase (Through Week 48)||27
977375|NCT00352053|2367633|P2|STARTED|Double-Blind Phase (Through Week 48)||42
977376|NCT00352053|2367634|P1|STARTED|Double-Blind Phase (Through Week 48)||45
977377|NCT00352105|2367801|P1|NOT COMPLETED|Overall Study||40
977378|NCT00352105|2367801|P1|COMPLETED|Overall Study||20
977379|NCT00352105|2367801|P1|STARTED|Overall Study||60
977380|NCT00352118|2367810|P1|NOT COMPLETED|Overall Study||4
977381|NCT00352118|2367810|P1|COMPLETED|Overall Study||0
977382|NCT00352118|2367810|P1|STARTED|Overall Study||4
977383|NCT00352365|2367820|P1|NOT COMPLETED|Maintenance Therapy||12
977384|NCT00352365|2367820|P1|COMPLETED|Maintenance Therapy||0
977385|NCT00352365|2367820|P1|Eligible and Began Protocol Therapy|Maintenance Therapy||8
977386|NCT00352365|2367820|P1|STARTED|Maintenance Therapy||12
977387|NCT00352365|2367820|P1|NOT COMPLETED|Induction Therapy||27
977388|NCT00352365|2367820|P1|COMPLETED|Induction Therapy||14
977389|NCT00352365|2367820|P1|Eligible and Began Protocol Therapy|Induction Therapy||37
977390|NCT00352365|2367820|P1|Eligible|Induction Therapy||38
977391|NCT00352365|2367820|P1|STARTED|Induction Therapy||41
977392|NCT00352417|2367832|P2|NOT COMPLETED|Overall Study||5
977393|NCT00352417|2367833|P1|NOT COMPLETED|Overall Study||5
977394|NCT00352417|2367832|P2|COMPLETED|Overall Study||21
977395|NCT00352417|2367833|P1|COMPLETED|Overall Study||19
977396|NCT00352417|2367832|P2|STARTED|Overall Study||26
977397|NCT00352417|2367833|P1|STARTED|Overall Study||24
977398|NCT00352534|2367849|P7|NOT COMPLETED|Final Risk Group Assignment||39
977399|NCT00352534|2367850|P6|NOT COMPLETED|Final Risk Group Assignment||45
977400|NCT00352534|2367851|P5|NOT COMPLETED|Final Risk Group Assignment||1
977401|NCT00352534|2367852|P4|NOT COMPLETED|Final Risk Group Assignment||3
977402|NCT00352534|2367853|P3|NOT COMPLETED|Final Risk Group Assignment||3
977403|NCT00352534|2367854|P2|NOT COMPLETED|Final Risk Group Assignment||0
977404|NCT00352534|2367855|P1|NOT COMPLETED|Final Risk Group Assignment||0
977405|NCT00352534|2367849|P7|COMPLETED|Final Risk Group Assignment||1
977406|NCT00352534|2367850|P6|COMPLETED|Final Risk Group Assignment||503
977407|NCT00352534|2367851|P5|COMPLETED|Final Risk Group Assignment||31
977408|NCT00352534|2367852|P4|COMPLETED|Final Risk Group Assignment||49
977409|NCT00352534|2367853|P3|COMPLETED|Final Risk Group Assignment||116
977410|NCT00352534|2367854|P2|COMPLETED|Final Risk Group Assignment||0
977411|NCT00352534|2367855|P1|COMPLETED|Final Risk Group Assignment||0
977412|NCT00352534|2367849|P7|STARTED|Final Risk Group Assignment||40
977413|NCT00352534|2367850|P6|STARTED|Final Risk Group Assignment||548
977414|NCT00352534|2367851|P5|STARTED|Final Risk Group Assignment||32
977415|NCT00352534|2367852|P4|STARTED|Final Risk Group Assignment||52
977416|NCT00352534|2367853|P3|STARTED|Final Risk Group Assignment||119
977417|NCT00352534|2367854|P2|STARTED|Final Risk Group Assignment||0
977418|NCT00352534|2367855|P1|STARTED|Final Risk Group Assignment||0
977419|NCT00352534|2367849|P7|NOT COMPLETED|Initial Staging||0
977420|NCT00352534|2367850|P6|NOT COMPLETED|Initial Staging||0
977421|NCT00352534|2367851|P5|NOT COMPLETED|Initial Staging||0
977422|NCT00352534|2367852|P4|NOT COMPLETED|Initial Staging||0
977423|NCT00352534|2367853|P3|NOT COMPLETED|Initial Staging||0
977424|NCT00352534|2367854|P2|NOT COMPLETED|Initial Staging||9
977425|NCT00352534|2367855|P1|NOT COMPLETED|Initial Staging||8
977426|NCT00352534|2367849|P7|COMPLETED|Initial Staging||0
977427|NCT00352534|2367850|P6|COMPLETED|Initial Staging||0
977428|NCT00352534|2367851|P5|COMPLETED|Initial Staging||0
977429|NCT00352534|2367852|P4|COMPLETED|Initial Staging||0
977430|NCT00352534|2367853|P3|COMPLETED|Initial Staging||0
977431|NCT00352534|2367854|P2|COMPLETED|Initial Staging||588
977432|NCT00352534|2367855|P1|COMPLETED|Initial Staging||203
977433|NCT00352534|2367849|P7|STARTED|Initial Staging||0
977434|NCT00352534|2367850|P6|STARTED|Initial Staging||0
977435|NCT00352534|2367851|P5|STARTED|Initial Staging||0
977436|NCT00352534|2367852|P4|STARTED|Initial Staging||0
977437|NCT00352534|2367853|P3|STARTED|Initial Staging||0
977438|NCT00352534|2367854|P2|STARTED|Initial Staging||597
977439|NCT00352534|2367855|P1|STARTED|Initial Staging||211
977440|NCT00352612|2367872|P2|NOT COMPLETED|Overall Study||0
977441|NCT00352612|2367873|P1|NOT COMPLETED|Overall Study||0
977442|NCT00352612|2367872|P2|COMPLETED|Overall Study||100
977443|NCT00352612|2367873|P1|COMPLETED|Overall Study||100
977444|NCT00352612|2367872|P2|STARTED|Overall Study||100
977445|NCT00352612|2367873|P1|STARTED|Overall Study||100
977446|NCT00352664|2367881|P2|NOT COMPLETED|Overall Study||0
977447|NCT00352664|2367882|P1|NOT COMPLETED|Overall Study||7
977448|NCT00352664|2367881|P2|COMPLETED|Overall Study||0
977449|NCT00352664|2367882|P1|COMPLETED|Overall Study||20
977450|NCT00352664|2367881|P2|STARTED|Overall Study||0
977451|NCT00352664|2367882|P1|STARTED|Overall Study||27
977452|NCT00352690|2367890|P2|NOT COMPLETED|Overall Study||0
977453|NCT00352690|2367891|P1|NOT COMPLETED|Overall Study||2
977454|NCT00352690|2367890|P2|COMPLETED|Overall Study||0
977455|NCT00352690|2367891|P1|COMPLETED|Overall Study||8
977456|NCT00352690|2367890|P2|STARTED|Overall Study||0
977457|NCT00352690|2367891|P1|STARTED|Overall Study||10
977458|NCT00352755|2367909|P1|NOT COMPLETED|Overall Study||2
977459|NCT00352755|2367909|P1|COMPLETED|Overall Study||16
977460|NCT00352755|2367909|P1|STARTED|Overall Study||18
977461|NCT00352781|2367917|P1|NOT COMPLETED|Overall Study||883
977462|NCT00352781|2367917|P1|COMPLETED|Overall Study||884
977463|NCT00352781|2367917|P1|STARTED|Overall Study||1767
977464|NCT00352846|2367924|P2|NOT COMPLETED|Overall Study||13
977465|NCT00352846|2367925|P1|NOT COMPLETED|Overall Study||8
977466|NCT00352846|2367924|P2|COMPLETED|Overall Study||24
977467|NCT00352846|2367925|P1|COMPLETED|Overall Study||29
977468|NCT00352846|2367924|P2|STARTED|Overall Study||37
977469|NCT00352846|2367925|P1|STARTED|Overall Study||37
977470|NCT00352885|2367933|P2|NOT COMPLETED|Overall Study||8
977471|NCT00352885|2367934|P1|NOT COMPLETED|Overall Study||5
977472|NCT00352885|2367933|P2|COMPLETED|Overall Study||3
977473|NCT00352885|2367934|P1|COMPLETED|Overall Study||4
977474|NCT00352885|2367933|P2|STARTED|Overall Study||11
977475|NCT00352885|2367934|P1|STARTED|Overall Study||9
977476|NCT00352911|2367942|P2|NOT COMPLETED|300mg Twice Daily (14 Days)||0
977477|NCT00352911|2367943|P1|NOT COMPLETED|300mg Twice Daily (14 Days)||1
977478|NCT00352911|2367942|P2|COMPLETED|300mg Twice Daily (14 Days)||3
977479|NCT00352911|2367943|P1|COMPLETED|300mg Twice Daily (14 Days)||15
977480|NCT00352911|2367942|P2|STARTED|300mg Twice Daily (14 Days)||3
977481|NCT00352911|2367943|P1|STARTED|300mg Twice Daily (14 Days)||16
977482|NCT00352911|2367942|P2|NOT COMPLETED|150mg Twice Daily (14 Days)||0
977483|NCT00352911|2367943|P1|NOT COMPLETED|150mg Twice Daily (14 Days)||0
977484|NCT00352911|2367942|P2|COMPLETED|150mg Twice Daily (14 Days)||3
977485|NCT00352911|2367943|P1|COMPLETED|150mg Twice Daily (14 Days)||16
977486|NCT00352911|2367942|P2|STARTED|150mg Twice Daily (14 Days)||3
977487|NCT00352911|2367943|P1|STARTED|150mg Twice Daily (14 Days)||16
977488|NCT00353119|2367951|P2|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
977489|NCT00353119|2367952|P1|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
977490|NCT00353119|2367951|P2|COMPLETED|Second Intervention Week 12 to Week 28||10
977491|NCT00353119|2367952|P1|COMPLETED|Second Intervention Week 12 to Week 28||5
977492|NCT00353119|2367951|P2|STARTED|Second Intervention Week 12 to Week 28||10
977493|NCT00353119|2367952|P1|STARTED|Second Intervention Week 12 to Week 28||5
977494|NCT00353119|2367951|P2|NOT COMPLETED|First Intervention Day 0 to Week 12||0
977495|NCT00353119|2367952|P1|NOT COMPLETED|First Intervention Day 0 to Week 12||0
977496|NCT00353119|2367951|P2|COMPLETED|First Intervention Day 0 to Week 12||10
977497|NCT00353119|2367952|P1|COMPLETED|First Intervention Day 0 to Week 12||5
977498|NCT00353119|2367951|P2|STARTED|First Intervention Day 0 to Week 12||10
977499|NCT00353119|2367952|P1|STARTED|First Intervention Day 0 to Week 12||5
977500|NCT00353262|2367962|P1|NOT COMPLETED|Overall Study||29
977501|NCT00353262|2367962|P1|COMPLETED|Overall Study||7
977502|NCT00353262|2367962|P1|STARTED|Overall Study||36
977503|NCT00353275|2367981|P2|NOT COMPLETED|Overall Study||0
977504|NCT00353275|2367982|P1|NOT COMPLETED|Overall Study||0
977505|NCT00353275|2367981|P2|COMPLETED|Overall Study||3
977506|NCT00353275|2367982|P1|COMPLETED|Overall Study||2
977507|NCT00353275|2367981|P2|STARTED|Overall Study||3
977508|NCT00353275|2367982|P1|STARTED|Overall Study||2
977509|NCT00353301|2367988|P1|NOT COMPLETED|Overall Study||0
977510|NCT00353301|2367988|P1|COMPLETED|Overall Study||25
977511|NCT00353301|2367988|P1|STARTED|Overall Study||25
977512|NCT00353366|2367993|P1|NOT COMPLETED|Overall Study||143
977513|NCT00353366|2367993|P1|COMPLETED|Overall Study||1289
977514|NCT00353366|2367993|P1|STARTED|Overall Study||1432
977515|NCT00353418|2368002|P2|NOT COMPLETED|Overall Study||158
977516|NCT00353418|2368003|P1|NOT COMPLETED|Overall Study||83
977517|NCT00353418|2368002|P2|COMPLETED|Overall Study||119
977518|NCT00353418|2368003|P1|COMPLETED|Overall Study||55
977519|NCT00353418|2368002|P2|STARTED|Overall Study||277
977520|NCT00353418|2368003|P1|STARTED|Overall Study||138
977521|NCT00353431|2368023|P2|NOT COMPLETED|Overall Study||0
977522|NCT00353431|2368024|P1|NOT COMPLETED|Overall Study||0
977523|NCT00353431|2368023|P2|COMPLETED|Overall Study||67
977524|NCT00353431|2368024|P1|COMPLETED|Overall Study||63
977525|NCT00353431|2368023|P2|STARTED|Overall Study||67
977526|NCT00353431|2368024|P1|STARTED|Overall Study||63
977527|NCT00353496|2368040|P2|NOT COMPLETED|Overall Study||17
977528|NCT00353496|2368041|P1|NOT COMPLETED|Overall Study||16
977529|NCT00353496|2368040|P2|COMPLETED|Overall Study||86
977530|NCT00353496|2368041|P1|COMPLETED|Overall Study|Patients who completed specified assessments or met primary efficacy endpoint criteria for an event.|85
977531|NCT00353496|2368040|P2|STARTED|Overall Study||103
977532|NCT00353496|2368041|P1|STARTED|Overall Study||101
977533|NCT00353652|2368062|P6|NOT COMPLETED|Overall Study||5
977534|NCT00353652|2368063|P5|NOT COMPLETED|Overall Study||5
977535|NCT00353652|2368064|P4|NOT COMPLETED|Overall Study||0
977536|NCT00353652|2368065|P3|NOT COMPLETED|Overall Study||0
977537|NCT00353652|2368066|P2|NOT COMPLETED|Overall Study||0
977538|NCT00353652|2368067|P1|NOT COMPLETED|Overall Study||0
977539|NCT00353652|2368062|P6|COMPLETED|Overall Study||18
977540|NCT00353652|2368063|P5|COMPLETED|Overall Study||18
977541|NCT00353652|2368064|P4|COMPLETED|Overall Study||7
977542|NCT00353652|2368065|P3|COMPLETED|Overall Study||17
977543|NCT00353652|2368066|P2|COMPLETED|Overall Study||17
977544|NCT00353652|2368067|P1|COMPLETED|Overall Study||17
977545|NCT00353652|2368062|P6|STARTED|Overall Study||23
977546|NCT00353652|2368063|P5|STARTED|Overall Study||23
977547|NCT00353652|2368064|P4|STARTED|Overall Study||7
977548|NCT00353652|2368065|P3|STARTED|Overall Study||17
977549|NCT00353652|2368066|P2|STARTED|Overall Study||17
977550|NCT00353652|2368067|P1|STARTED|Overall Study||17
977551|NCT00353704|2368083|P2|NOT COMPLETED|Overall Study||1
977552|NCT00353704|2368084|P1|NOT COMPLETED|Overall Study||3
977553|NCT00353704|2368083|P2|COMPLETED|Overall Study||24
977554|NCT00353704|2368084|P1|COMPLETED|Overall Study||22
977555|NCT00353704|2368083|P2|STARTED|Overall Study||25
977556|NCT00353704|2368084|P1|STARTED|Overall Study||25
977557|NCT00353795|2368092|P1|NOT COMPLETED|Overall Study||0
977558|NCT00353795|2368092|P1|COMPLETED|Overall Study||179
977559|NCT00353795|2368092|P1|STARTED|Overall Study||179
977560|NCT00353873|2368098|P2|NOT COMPLETED|Overall Study||3
977561|NCT00353873|2368099|P1|NOT COMPLETED|Overall Study||6
977562|NCT00353873|2368098|P2|COMPLETED|Overall Study||147
977563|NCT00353873|2368099|P1|COMPLETED|Overall Study||147
977564|NCT00353873|2368098|P2|STARTED|Overall Study||150
977565|NCT00353873|2368099|P1|STARTED|Overall Study||153
977566|NCT00347360|2368126|P15|NOT COMPLETED|Overall Study||4
977567|NCT00347360|2368127|P14|NOT COMPLETED|Overall Study||8
977568|NCT00347360|2368128|P13|NOT COMPLETED|Overall Study||10
977569|NCT00347360|2368129|P12|NOT COMPLETED|Overall Study||6
977570|NCT00347360|2368130|P11|NOT COMPLETED|Overall Study||5
977571|NCT00347360|2368131|P10|NOT COMPLETED|Overall Study||9
977572|NCT00347360|2368132|P9|NOT COMPLETED|Overall Study||6
977573|NCT00347360|2368133|P8|NOT COMPLETED|Overall Study||3
977574|NCT00347360|2368134|P7|NOT COMPLETED|Overall Study||7
977575|NCT00347360|2368135|P6|NOT COMPLETED|Overall Study||8
977576|NCT00347360|2368136|P5|NOT COMPLETED|Overall Study||5
977577|NCT00347360|2368137|P4|NOT COMPLETED|Overall Study||13
977578|NCT00347360|2368138|P3|NOT COMPLETED|Overall Study||6
977579|NCT00347360|2368139|P2|NOT COMPLETED|Overall Study||8
977580|NCT00347360|2368140|P1|NOT COMPLETED|Overall Study||5
977581|NCT00347360|2368126|P15|COMPLETED|Overall Study||39
977582|NCT00347360|2368127|P14|COMPLETED|Overall Study||36
977583|NCT00347360|2368128|P13|COMPLETED|Overall Study||34
977584|NCT00347360|2368129|P12|COMPLETED|Overall Study||37
977585|NCT00347360|2368130|P11|COMPLETED|Overall Study||39
977586|NCT00347360|2368131|P10|COMPLETED|Overall Study||35
977587|NCT00347360|2368132|P9|COMPLETED|Overall Study||38
977588|NCT00347360|2368133|P8|COMPLETED|Overall Study||40
977589|NCT00347360|2368134|P7|COMPLETED|Overall Study||37
977590|NCT00347360|2368135|P6|COMPLETED|Overall Study||36
977591|NCT00347360|2368136|P5|COMPLETED|Overall Study||39
977592|NCT00347360|2368137|P4|COMPLETED|Overall Study||30
977593|NCT00347360|2368138|P3|COMPLETED|Overall Study||37
977594|NCT00347360|2368139|P2|COMPLETED|Overall Study||35
977595|NCT00347360|2368140|P1|COMPLETED|Overall Study||39
977596|NCT00347360|2368126|P15|STARTED|Overall Study||43
977597|NCT00347360|2368127|P14|STARTED|Overall Study||44
977598|NCT00347360|2368128|P13|STARTED|Overall Study||44
977599|NCT00347360|2368129|P12|STARTED|Overall Study||43
977600|NCT00347360|2368130|P11|STARTED|Overall Study||44
977601|NCT00347360|2368131|P10|STARTED|Overall Study||44
977602|NCT00347360|2368132|P9|STARTED|Overall Study||44
977603|NCT00347360|2368133|P8|STARTED|Overall Study||43
977604|NCT00347360|2368134|P7|STARTED|Overall Study||44
977605|NCT00347360|2368135|P6|STARTED|Overall Study||44
977606|NCT00347360|2368136|P5|STARTED|Overall Study||44
977607|NCT00347360|2368137|P4|STARTED|Overall Study||43
977608|NCT00347360|2368138|P3|STARTED|Overall Study||43
977609|NCT00347360|2368139|P2|STARTED|Overall Study||43
977610|NCT00347360|2368140|P1|STARTED|Overall Study||44
977611|NCT00347438|2368322|P1|NOT COMPLETED|Overall Study||2
977612|NCT00347438|2368322|P1|COMPLETED|Overall Study||16
977613|NCT00347438|2368322|P1|STARTED|Overall Study||18
977614|NCT00347776|2368332|P3|NOT COMPLETED|12 Month Follow-up||19
977615|NCT00347776|2368333|P2|NOT COMPLETED|12 Month Follow-up||16
977616|NCT00347776|2368334|P1|NOT COMPLETED|12 Month Follow-up||23
977617|NCT00347776|2368332|P3|COMPLETED|12 Month Follow-up||436
977618|NCT00347776|2368333|P2|COMPLETED|12 Month Follow-up||446
977619|NCT00347776|2368334|P1|COMPLETED|12 Month Follow-up||425
977620|NCT00347776|2368332|P3|STARTED|12 Month Follow-up||455
977621|NCT00347776|2368333|P2|STARTED|12 Month Follow-up||462
977622|NCT00347776|2368334|P1|STARTED|12 Month Follow-up||448
977623|NCT00347776|2368332|P3|NOT COMPLETED|6 Month Follow-up||18
977624|NCT00347776|2368333|P2|NOT COMPLETED|6 Month Follow-up||13
977625|NCT00347776|2368334|P1|NOT COMPLETED|6 Month Follow-up||22
977626|NCT00347776|2368332|P3|COMPLETED|6 Month Follow-up|452 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|455
977627|NCT00347776|2368333|P2|COMPLETED|6 Month Follow-up|459 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|462
977628|NCT00347776|2368334|P1|COMPLETED|6 Month Follow-up|440 had no recurrence.8 were lost to follow-up but were still eligible for follow-up at next visits|448
977629|NCT00347776|2368332|P3|STARTED|6 Month Follow-up||473
977630|NCT00347776|2368333|P2|STARTED|6 Month Follow-up||475
977631|NCT00347776|2368334|P1|STARTED|6 Month Follow-up||470
977632|NCT00347776|2368332|P3|NOT COMPLETED|1.5 Month Follow-up||12
977633|NCT00347776|2368333|P2|NOT COMPLETED|1.5 Month Follow-up||8
977634|NCT00347776|2368334|P1|NOT COMPLETED|1.5 Month Follow-up||14
977635|NCT00347776|2368332|P3|COMPLETED|1.5 Month Follow-up|472 had no recurrence.1 was lost to follow-up but was still eligible for follow-up at next visits|473
977636|NCT00347776|2368333|P2|COMPLETED|1.5 Month Follow-up|473 had no recurrence.2 were lost to follow-up but were still eligible for follow-up at next visits|475
977637|NCT00347776|2368334|P1|COMPLETED|1.5 Month Follow-up||470
977638|NCT00347776|2368332|P3|STARTED|1.5 Month Follow-up||485
977639|NCT00347776|2368333|P2|STARTED|1.5 Month Follow-up||483
977640|NCT00347776|2368334|P1|STARTED|1.5 Month Follow-up||484
977641|NCT00347919|2368349|P3|NOT COMPLETED|Overall Study||38
977642|NCT00347919|2368350|P2|NOT COMPLETED|Overall Study||76
977643|NCT00347919|2368351|P1|NOT COMPLETED|Overall Study||71
977644|NCT00347919|2368349|P3|COMPLETED|Overall Study||2
977645|NCT00347919|2368350|P2|COMPLETED|Overall Study||0
977646|NCT00347919|2368351|P1|COMPLETED|Overall Study||2
977647|NCT00347919|2368349|P3|STARTED|Overall Study|Safety Population|40
977648|NCT00347919|2368350|P2|STARTED|Overall Study|Safety Population|76
977649|NCT00347919|2368351|P1|STARTED|Overall Study|Safety Population|73
977650|NCT00347932|2368373|P2|NOT COMPLETED|Overall Study||52
977651|NCT00347932|2368374|P1|NOT COMPLETED|Overall Study||31
977652|NCT00347932|2368373|P2|COMPLETED|Overall Study||430
977653|NCT00347932|2368374|P1|COMPLETED|Overall Study||444
977654|NCT00347932|2368373|P2|STARTED|Overall Study|As Randomized Population - received at least one dose of study medication|482
977655|NCT00347932|2368374|P1|STARTED|Overall Study|As Randomized population - received at least one dose of study medication|475
977656|NCT00347958|2368386|P1|NOT COMPLETED|Overall Study||4
977657|NCT00347958|2368386|P1|COMPLETED|Overall Study||540
977658|NCT00347958|2368386|P1|STARTED|Overall Study||544
977659|NCT00348140|2368396|P3|NOT COMPLETED|Overall Study||163
977660|NCT00348140|2368397|P2|NOT COMPLETED|Overall Study||139
977661|NCT00348140|2368398|P1|NOT COMPLETED|Overall Study||126
977662|NCT00348140|2368396|P3|COMPLETED|Overall Study||328
977663|NCT00348140|2368397|P2|COMPLETED|Overall Study||351
977664|NCT00348140|2368398|P1|COMPLETED|Overall Study||361
977665|NCT00348140|2368396|P3|STARTED|Overall Study||491
977666|NCT00348140|2368397|P2|STARTED|Overall Study||490
977667|NCT00348140|2368398|P1|STARTED|Overall Study||487
977668|NCT00348283|2368498|P2|NOT COMPLETED|Open Label||34
977669|NCT00348283|2368499|P1|NOT COMPLETED|Open Label||0
977670|NCT00348283|2368498|P2|COMPLETED|Open Label||66
977671|NCT00348283|2368499|P1|COMPLETED|Open Label||0
977672|NCT00348283|2368498|P2|STARTED|Open Label|14 subjects completed the Double Blind portion of the study but did not enter the Open Label period.|100
977673|NCT00348283|2368499|P1|STARTED|Open Label|No comparator was used in the Open Label portion of the study.|0
977674|NCT00348283|2368498|P2|NOT COMPLETED|Double Blind||10
977675|NCT00348283|2368499|P1|NOT COMPLETED|Double Blind||5
977676|NCT00348283|2368498|P2|COMPLETED|Double Blind||54
977677|NCT00348283|2368499|P1|COMPLETED|Double Blind||60
977678|NCT00348283|2368498|P2|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|64
977679|NCT00348283|2368499|P1|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|65
977680|NCT00348283|2368498|P2|NOT COMPLETED|Induction||6
977681|NCT00348283|2368499|P1|NOT COMPLETED|Induction||0
977682|NCT00348283|2368498|P2|COMPLETED|Induction|Subjects provided more than one reason for discontinuing during induction.|129
977683|NCT00348283|2368499|P1|COMPLETED|Induction||0
977684|NCT00348283|2368498|P2|STARTED|Induction|Subjects received an open- label dose of 80 mg adalimumab at Week 2 (induction dose).|135
977685|NCT00348283|2368499|P1|STARTED|Induction||0
977686|NCT00348348|2368517|P2|NOT COMPLETED|Overall Study||27
977687|NCT00348348|2368518|P1|NOT COMPLETED|Overall Study||25
977688|NCT00348348|2368517|P2|COMPLETED|Overall Study||555
977689|NCT00348348|2368518|P1|COMPLETED|Overall Study||554
977690|NCT00348348|2368517|P2|STARTED|Overall Study|Received at least one drop of study medication(Safety Population)|582
977691|NCT00348348|2368518|P1|STARTED|Overall Study|Received at least one drop of study medication (Safety Population)|579
977692|NCT00348374|2368532|P2|NOT COMPLETED|Overall Study||32
977693|NCT00348374|2368533|P1|NOT COMPLETED|Overall Study||19
977694|NCT00348374|2368532|P2|COMPLETED|Overall Study||71
977695|NCT00348374|2368533|P1|COMPLETED|Overall Study||69
977696|NCT00348374|2368532|P2|Received Study Treatment|Overall Study||96
977697|NCT00348374|2368533|P1|Received Study Treatment|Overall Study||88
977698|NCT00348374|2368532|P2|STARTED|Overall Study||103
977699|NCT00348374|2368533|P1|STARTED|Overall Study||88
977700|NCT00353977|2368578|P1|NOT COMPLETED|Overall Study||0
977701|NCT00353977|2368578|P1|COMPLETED|Overall Study||38
977702|NCT00353977|2368578|P1|STARTED|Overall Study||38
977703|NCT00354029|2368584|P2|NOT COMPLETED|Overall Study||2
977704|NCT00354029|2368585|P1|NOT COMPLETED|Overall Study||4
977705|NCT00354029|2368584|P2|COMPLETED|Overall Study||38
977706|NCT00354029|2368585|P1|COMPLETED|Overall Study||39
977707|NCT00354029|2368584|P2|STARTED|Overall Study||40
977708|NCT00354029|2368585|P1|STARTED|Overall Study||43
977709|NCT00354107|2368591|P1|NOT COMPLETED|Overall Study||5
977710|NCT00354107|2368591|P1|COMPLETED|Overall Study||0
977711|NCT00354107|2368591|P1|STARTED|Overall Study||5
977712|NCT00354159|2368597|P2|NOT COMPLETED|Long-term Follow-up||176
977713|NCT00354159|2368598|P1|NOT COMPLETED|Long-term Follow-up||180
977714|NCT00354159|2368597|P2|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
977715|NCT00354159|2368598|P1|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
977716|NCT00354159|2368597|P2|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|176
977717|NCT00354159|2368598|P1|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|180
977718|NCT00354159|2368597|P2|NOT COMPLETED|Randomized Study Period||22
977719|NCT00354159|2368598|P1|NOT COMPLETED|Randomized Study Period||22
977720|NCT00354159|2368597|P2|COMPLETED|Randomized Study Period||176
977721|NCT00354159|2368598|P1|COMPLETED|Randomized Study Period||180
977722|NCT00354159|2368597|P2|STARTED|Randomized Study Period||198
977723|NCT00354159|2368598|P1|STARTED|Randomized Study Period||202
977727|NCT00354341|2368661|P2|NOT COMPLETED|Overall Study||7
977728|NCT00354341|2368662|P1|NOT COMPLETED|Overall Study||3
977729|NCT00354341|2368661|P2|COMPLETED|Overall Study||75
977730|NCT00354341|2368662|P1|COMPLETED|Overall Study||85
977731|NCT00354341|2368661|P2|STARTED|Overall Study||82
977732|NCT00354341|2368662|P1|STARTED|Overall Study||88
977733|NCT00354432|2368682|P4|NOT COMPLETED|Overall Study||10
977734|NCT00354432|2368683|P3|NOT COMPLETED|Overall Study||10
977735|NCT00354432|2368684|P2|NOT COMPLETED|Overall Study||8
977736|NCT00354432|2368685|P1|NOT COMPLETED|Overall Study||6
977737|NCT00354432|2368682|P4|COMPLETED|Overall Study||20
977738|NCT00354432|2368683|P3|COMPLETED|Overall Study||20
977739|NCT00354432|2368684|P2|COMPLETED|Overall Study||22
977740|NCT00354432|2368685|P1|COMPLETED|Overall Study||24
977741|NCT00354432|2368682|P4|STARTED|Overall Study||30
977742|NCT00354432|2368683|P3|STARTED|Overall Study||30
977743|NCT00354432|2368684|P2|STARTED|Overall Study||30
977744|NCT00354432|2368685|P1|STARTED|Overall Study||30
977745|NCT00354484|2368701|P2|NOT COMPLETED|Overall Study||3
977746|NCT00354484|2368702|P1|NOT COMPLETED|Overall Study||4
977747|NCT00354484|2368701|P2|COMPLETED|Overall Study||144
977748|NCT00354484|2368702|P1|COMPLETED|Overall Study||138
977749|NCT00354484|2368701|P2|STARTED|Overall Study||147
977750|NCT00354484|2368702|P1|STARTED|Overall Study||142
977751|NCT00354601|2368708|P1|NOT COMPLETED|Overall Study||2
977752|NCT00354601|2368708|P1|COMPLETED|Overall Study||0
977753|NCT00354601|2368708|P1|STARTED|Overall Study||2
977754|NCT00354614|2368715|P1|NOT COMPLETED|Overall Study||28
977755|NCT00354614|2368715|P1|COMPLETED|Overall Study||53
977756|NCT00354614|2368715|P1|STARTED|Overall Study||81
977757|NCT00354640|2368719|P1|NOT COMPLETED|Overall Study||0
977758|NCT00354640|2368719|P1|COMPLETED|Overall Study||11
977759|NCT00354640|2368719|P1|STARTED|Overall Study||11
977760|NCT00354679|2368724|P1|NOT COMPLETED|Overall Study||1
977761|NCT00354679|2368724|P1|COMPLETED|Overall Study||33
977762|NCT00354679|2368724|P1|STARTED|Overall Study||34
977763|NCT00354744|2368728|P1|NOT COMPLETED|Overall Study||42
977764|NCT00354744|2368728|P1|COMPLETED|Overall Study||67
977765|NCT00354744|2368728|P1|STARTED|Overall Study||109
977766|NCT00354770|2368735|P2|NOT COMPLETED|Overall Study||3
977767|NCT00354770|2368736|P1|NOT COMPLETED|Overall Study||3
977768|NCT00354770|2368735|P2|COMPLETED|Overall Study||22
977769|NCT00354770|2368736|P1|COMPLETED|Overall Study||22
977770|NCT00354770|2368735|P2|STARTED|Overall Study||25
977771|NCT00354770|2368736|P1|STARTED|Overall Study||25
977772|NCT00354835|2368744|P2|NOT COMPLETED|Overall Study||61
977773|NCT00354835|2368745|P1|NOT COMPLETED|Overall Study||52
977774|NCT00354835|2368744|P2|COMPLETED|Overall Study||181
977775|NCT00354835|2368745|P1|COMPLETED|Overall Study||187
977776|NCT00354835|2368744|P2|STARTED|Overall Study||242
977777|NCT00354835|2368745|P1|STARTED|Overall Study||239
977778|NCT00354887|2368775|P1|NOT COMPLETED|Overall Study||1
977779|NCT00354887|2368775|P1|COMPLETED|Overall Study||29
977780|NCT00354887|2368775|P1|STARTED|Overall Study||30
977781|NCT00354913|2368779|P1|NOT COMPLETED|Overall Study||0
977782|NCT00354913|2368779|P1|COMPLETED|Overall Study||21
977783|NCT00354913|2368779|P1|STARTED|Overall Study||21
977784|NCT00354978|2368786|P1|NOT COMPLETED|Overall Study||0
977785|NCT00354978|2368786|P1|COMPLETED|Overall Study||43
977786|NCT00354978|2368786|P1|STARTED|Overall Study||43
977787|NCT00355030|2368792|P2|NOT COMPLETED|Study Period 2 Long Term Follow-Up||2
977788|NCT00355030|2368793|P1|NOT COMPLETED|Study Period 2 Long Term Follow-Up||1
977789|NCT00355030|2368792|P2|COMPLETED|Study Period 2 Long Term Follow-Up||17
977790|NCT00355030|2368793|P1|COMPLETED|Study Period 2 Long Term Follow-Up||19
977791|NCT00355030|2368792|P2|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|19
977792|NCT00355030|2368793|P1|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|20
977793|NCT00355030|2368792|P2|NOT COMPLETED|Study Period 1 Treatment||44
977794|NCT00355030|2368793|P1|NOT COMPLETED|Study Period 1 Treatment||45
977795|NCT00355030|2368792|P2|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
977796|NCT00355030|2368793|P1|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
977797|NCT00355030|2368792|P2|Received At Least One Dose of Study Drug|Study Period 1 Treatment|2 non-eligible participants received somatropin from previous control group|43
977798|NCT00355030|2368793|P1|Received At Least One Dose of Study Drug|Study Period 1 Treatment|1 non-eligible participant received somatropin from previous control group|45
977799|NCT00355030|2368792|P2|STARTED|Study Period 1 Treatment||45
977800|NCT00355030|2368793|P1|STARTED|Study Period 1 Treatment||46
977801|NCT00355082|2368817|P3|NOT COMPLETED|Continuation Phase||3
977802|NCT00355082|2368818|P2|NOT COMPLETED|Continuation Phase||0
977803|NCT00355082|2368819|P1|NOT COMPLETED|Continuation Phase||24
977804|NCT00355082|2368817|P3|COMPLETED|Continuation Phase||8
977805|NCT00355082|2368818|P2|COMPLETED|Continuation Phase||0
977806|NCT00355082|2368819|P1|COMPLETED|Continuation Phase||160
977807|NCT00355082|2368817|P3|STARTED|Continuation Phase|"See Pre-assign. Details for reasons why number starting CP does not equal number completing TP."|11
977808|NCT00355082|2368818|P2|STARTED|Continuation Phase||0
977809|NCT00355082|2368819|P1|STARTED|Continuation Phase|83 and 101 participants from the 250 and 300 mg groups (DB Phase), respectively, entered the CP.|184
977810|NCT00355082|2368817|P3|NOT COMPLETED|Double-Blind (DB) Treatment Phase||0
977811|NCT00355082|2368818|P2|NOT COMPLETED|Double-Blind (DB) Treatment Phase||34
977812|NCT00355082|2368819|P1|NOT COMPLETED|Double-Blind (DB) Treatment Phase||19
977813|NCT00355082|2368817|P3|COMPLETED|Double-Blind (DB) Treatment Phase||0
977814|NCT00355082|2368818|P2|COMPLETED|Double-Blind (DB) Treatment Phase||79
977815|NCT00355082|2368819|P1|COMPLETED|Double-Blind (DB) Treatment Phase||94
977816|NCT00355082|2368817|P3|STARTED|Double-Blind (DB) Treatment Phase||0
977817|NCT00355082|2368818|P2|STARTED|Double-Blind (DB) Treatment Phase|111 participants have baseline data; 2 participants did not receive study drug.|113
977818|NCT00355082|2368819|P1|STARTED|Double-Blind (DB) Treatment Phase|112 participants have baseline data; 1 participant did not receive study drug.|113
977828|NCT00355134|2368878|P5|NOT COMPLETED|Extension Phase||19
977829|NCT00355134|2368879|P4|NOT COMPLETED|Extension Phase||16
977830|NCT00355134|2368880|P3|NOT COMPLETED|Extension Phase||0
977831|NCT00355134|2368881|P2|NOT COMPLETED|Extension Phase||37
977832|NCT00355134|2368882|P1|NOT COMPLETED|Extension Phase||31
977833|NCT00355134|2368878|P5|COMPLETED|Extension Phase||88
977834|NCT00355134|2368879|P4|COMPLETED|Extension Phase||89
977835|NCT00355134|2368880|P3|COMPLETED|Extension Phase||0
977836|NCT00355134|2368881|P2|COMPLETED|Extension Phase||180
977837|NCT00355134|2368882|P1|COMPLETED|Extension Phase||172
977838|NCT00355134|2368878|P5|STARTED|Extension Phase||107
977839|NCT00355134|2368879|P4|STARTED|Extension Phase||105
977840|NCT00355134|2368880|P3|STARTED|Extension Phase||0
977841|NCT00355134|2368881|P2|STARTED|Extension Phase||217
977842|NCT00355134|2368882|P1|STARTED|Extension Phase||203
977843|NCT00355134|2368878|P5|NOT COMPLETED|Core Phase||0
977844|NCT00355134|2368879|P4|NOT COMPLETED|Core Phase||0
977845|NCT00355134|2368880|P3|NOT COMPLETED|Core Phase||100
977846|NCT00355134|2368881|P2|NOT COMPLETED|Core Phase||86
977847|NCT00355134|2368882|P1|NOT COMPLETED|Core Phase||119
977848|NCT00355134|2368878|P5|COMPLETED|Core Phase||0
977849|NCT00355134|2368879|P4|COMPLETED|Core Phase||0
977850|NCT00355134|2368880|P3|COMPLETED|Core Phase||255
977851|NCT00355134|2368881|P2|COMPLETED|Core Phase||272
977852|NCT00355134|2368882|P1|COMPLETED|Core Phase||251
977853|NCT00355134|2368878|P5|STARTED|Core Phase||0
977854|NCT00355134|2368879|P4|STARTED|Core Phase||0
977855|NCT00355134|2368880|P3|STARTED|Core Phase||355
977856|NCT00355134|2368881|P2|STARTED|Core Phase||358
977857|NCT00355134|2368882|P1|STARTED|Core Phase||370
977858|NCT00355147|2368924|P2|NOT COMPLETED|Overall Study||20
977859|NCT00355147|2368925|P1|NOT COMPLETED|Overall Study||18
977860|NCT00355147|2368924|P2|COMPLETED|Overall Study||67
977861|NCT00355147|2368925|P1|COMPLETED|Overall Study||69
977862|NCT00355147|2368924|P2|STARTED|Overall Study||87
977863|NCT00355147|2368925|P1|STARTED|Overall Study||87
977864|NCT00355199|2368941|P2|NOT COMPLETED|Overall Study||4
977865|NCT00355199|2368942|P1|NOT COMPLETED|Overall Study||7
977866|NCT00355199|2368941|P2|COMPLETED|Overall Study||122
977867|NCT00355199|2368942|P1|COMPLETED|Overall Study||113
977868|NCT00355199|2368941|P2|STARTED|Overall Study||126
977869|NCT00355199|2368942|P1|STARTED|Overall Study||120
977870|NCT00355368|2368958|P2|NOT COMPLETED|Overall Study||9
977871|NCT00355368|2368959|P1|NOT COMPLETED|Overall Study||10
977872|NCT00355368|2368958|P2|COMPLETED|Overall Study||201
977873|NCT00355368|2368959|P1|COMPLETED|Overall Study||200
977874|NCT00355368|2368958|P2|STARTED|Overall Study||210
977875|NCT00355368|2368959|P1|STARTED|Overall Study||210
977876|NCT00355394|2368973|P2|NOT COMPLETED|Overall Study||0
977877|NCT00355394|2368974|P1|NOT COMPLETED|Overall Study||0
977878|NCT00355394|2368973|P2|COMPLETED|Overall Study||16
977879|NCT00355394|2368974|P1|COMPLETED|Overall Study||15
977880|NCT00355394|2368973|P2|STARTED|Overall Study||16
977881|NCT00355394|2368974|P1|STARTED|Overall Study||15
977882|NCT00355472|2368990|P1|NOT COMPLETED|Overall Study||1
977883|NCT00355472|2368990|P1|COMPLETED|Overall Study||15
977884|NCT00355472|2368990|P1|STARTED|Overall Study||16
977885|NCT00355615|2369019|P5|NOT COMPLETED|40-week Rosuvastatin Open Label Period||9
977886|NCT00355615|2369020|P4|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
977887|NCT00355615|2369021|P3|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
977888|NCT00355615|2369022|P2|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
977889|NCT00355615|2369023|P1|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
977890|NCT00355615|2369019|P5|COMPLETED|40-week Rosuvastatin Open Label Period||164
977891|NCT00355615|2369020|P4|COMPLETED|40-week Rosuvastatin Open Label Period||0
977892|NCT00355615|2369021|P3|COMPLETED|40-week Rosuvastatin Open Label Period||0
977893|NCT00355615|2369022|P2|COMPLETED|40-week Rosuvastatin Open Label Period||0
977894|NCT00355615|2369023|P1|COMPLETED|40-week Rosuvastatin Open Label Period||0
977895|NCT00355615|2369019|P5|STARTED|40-week Rosuvastatin Open Label Period||173
977896|NCT00355615|2369020|P4|STARTED|40-week Rosuvastatin Open Label Period||0
977897|NCT00355615|2369021|P3|STARTED|40-week Rosuvastatin Open Label Period||0
977898|NCT00355615|2369022|P2|STARTED|40-week Rosuvastatin Open Label Period||0
977899|NCT00355615|2369023|P1|STARTED|40-week Rosuvastatin Open Label Period||0
977900|NCT00355615|2369019|P5|NOT COMPLETED|Randomized Double Blind Period||0
977901|NCT00355615|2369020|P4|NOT COMPLETED|Randomized Double Blind Period||1
977902|NCT00355615|2369021|P3|NOT COMPLETED|Randomized Double Blind Period||1
977903|NCT00355615|2369022|P2|NOT COMPLETED|Randomized Double Blind Period||0
977904|NCT00355615|2369023|P1|NOT COMPLETED|Randomized Double Blind Period||1
977905|NCT00355615|2369019|P5|COMPLETED|Randomized Double Blind Period||0
977906|NCT00355615|2369020|P4|COMPLETED|Randomized Double Blind Period|1 dropped out due to an adverse event|45
977907|NCT00355615|2369021|P3|COMPLETED|Randomized Double Blind Period|45 were randomized but 1 never received drug|44
977908|NCT00355615|2369022|P2|COMPLETED|Randomized Double Blind Period||44
977909|NCT00355615|2369023|P1|COMPLETED|Randomized Double Blind Period|1 dropped out due to adverse event|41
977910|NCT00355615|2369019|P5|STARTED|Randomized Double Blind Period|open label phase followed the randomized phase|0
977911|NCT00355615|2369020|P4|STARTED|Randomized Double Blind Period||46
977912|NCT00355615|2369021|P3|STARTED|Randomized Double Blind Period||45
977913|NCT00355615|2369022|P2|STARTED|Randomized Double Blind Period||44
977914|NCT00355615|2369023|P1|STARTED|Randomized Double Blind Period||42
977915|NCT00355706|2369084|P2|NOT COMPLETED|Overall Study||0
977916|NCT00355706|2369085|P1|NOT COMPLETED|Overall Study||0
977917|NCT00355706|2369084|P2|COMPLETED|Overall Study||50
977918|NCT00355706|2369085|P1|COMPLETED|Overall Study||50
977919|NCT00355706|2369084|P2|STARTED|Overall Study||50
977920|NCT00355706|2369085|P1|STARTED|Overall Study||50
977921|NCT00355784|2369098|P3|NOT COMPLETED|Overall Study||2
977922|NCT00355784|2369099|P2|NOT COMPLETED|Overall Study||0
977923|NCT00355784|2369100|P1|NOT COMPLETED|Overall Study||0
977924|NCT00355784|2369098|P3|COMPLETED|Overall Study||5
977925|NCT00355784|2369099|P2|COMPLETED|Overall Study||8
977926|NCT00355784|2369100|P1|COMPLETED|Overall Study||9
977927|NCT00355784|2369098|P3|STARTED|Overall Study||7
977928|NCT00355784|2369099|P2|STARTED|Overall Study||8
977929|NCT00355784|2369100|P1|STARTED|Overall Study||9
977930|NCT00355797|2369135|P3|NOT COMPLETED|Overall Study||142
977931|NCT00355797|2369136|P2|NOT COMPLETED|Overall Study||148
977932|NCT00355797|2369137|P1|NOT COMPLETED|Overall Study||240
977933|NCT00355797|2369135|P3|COMPLETED|Overall Study||239
977934|NCT00355797|2369136|P2|COMPLETED|Overall Study||221
977935|NCT00355797|2369137|P1|COMPLETED|Overall Study||501
977936|NCT00355797|2369135|P3|STARTED|Overall Study||381
977937|NCT00355797|2369136|P2|STARTED|Overall Study||369
977938|NCT00355797|2369137|P1|STARTED|Overall Study||741
977939|NCT00355914|2369168|P2|NOT COMPLETED|Overall Study||0
977940|NCT00355914|2369169|P1|NOT COMPLETED|Overall Study||0
977941|NCT00355914|2369168|P2|COMPLETED|Overall Study||60
977942|NCT00355914|2369169|P1|COMPLETED|Overall Study||60
977943|NCT00355914|2369168|P2|STARTED|Overall Study||60
977944|NCT00355914|2369169|P1|STARTED|Overall Study||60
977945|NCT00356031|2369177|P1|NOT COMPLETED|Overall Study||0
977946|NCT00356031|2369177|P1|COMPLETED|Overall Study||20
977947|NCT00356031|2369177|P1|STARTED|Overall Study||20
977948|NCT00356057|2369189|P3|NOT COMPLETED|Overall Study||12
977949|NCT00356057|2369190|P2|NOT COMPLETED|Overall Study||14
977950|NCT00356057|2369191|P1|NOT COMPLETED|Overall Study||13
977951|NCT00356057|2369189|P3|COMPLETED|Overall Study||22
977952|NCT00356057|2369190|P2|COMPLETED|Overall Study||47
977953|NCT00356057|2369191|P1|COMPLETED|Overall Study||45
977954|NCT00356057|2369189|P3|IMPLANTED|Overall Study||25
977955|NCT00356057|2369190|P2|IMPLANTED|Overall Study||52
977956|NCT00356057|2369191|P1|IMPLANTED|Overall Study||49
977957|NCT00356057|2369189|P3|STARTED|Overall Study||34
977958|NCT00356057|2369190|P2|STARTED|Overall Study||61
977959|NCT00356057|2369191|P1|STARTED|Overall Study||58
977960|NCT00356122|2369197|P1|NOT COMPLETED|FOLLOW-UP||41
977961|NCT00356122|2369197|P1|COMPLETED|FOLLOW-UP||12
977962|NCT00356122|2369197|P1|STARTED|FOLLOW-UP||53
977963|NCT00356122|2369197|P1|NOT COMPLETED|TREATMENT||45
977964|NCT00356122|2369197|P1|COMPLETED|TREATMENT||8
977965|NCT00356122|2369197|P1|STARTED|TREATMENT||53
977966|NCT00356135|2369208|P3|NOT COMPLETED|Overall Study||5
977967|NCT00356135|2369209|P2|NOT COMPLETED|Overall Study||2
977968|NCT00356135|2369210|P1|NOT COMPLETED|Overall Study||4
977969|NCT00356135|2369208|P3|COMPLETED|Overall Study||39
977970|NCT00356135|2369209|P2|COMPLETED|Overall Study||46
977971|NCT00356135|2369210|P1|COMPLETED|Overall Study||43
977972|NCT00356135|2369208|P3|STARTED|Overall Study||44
977973|NCT00356135|2369209|P2|STARTED|Overall Study||48
977974|NCT00356135|2369210|P1|STARTED|Overall Study||47
977975|NCT00356148|2369234|P2|NOT COMPLETED|Overall Study||1
977976|NCT00356148|2369235|P1|NOT COMPLETED|Overall Study||2
977977|NCT00356148|2369234|P2|COMPLETED|Overall Study||182
977978|NCT00356148|2369235|P1|COMPLETED|Overall Study||187
977979|NCT00356148|2369234|P2|STARTED|Overall Study||183
977980|NCT00356148|2369235|P1|STARTED|Overall Study||189
977981|NCT00356200|2369245|P2|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||2
977982|NCT00356200|2369246|P1|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
977983|NCT00356200|2369245|P2|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||3
977984|NCT00356200|2369246|P1|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
977985|NCT00356200|2369245|P2|STARTED|Cohort 2: 100 ug/ml (New Patients)||5
977986|NCT00356200|2369246|P1|STARTED|Cohort 2: 100 ug/ml (New Patients)||0
977987|NCT00356200|2369245|P2|NOT COMPLETED|Cohort 1: 10 ug/ml||0
977988|NCT00356200|2369246|P1|NOT COMPLETED|Cohort 1: 10 ug/ml||1
977989|NCT00356200|2369245|P2|COMPLETED|Cohort 1: 10 ug/ml||0
977990|NCT00356200|2369246|P1|COMPLETED|Cohort 1: 10 ug/ml||4
977991|NCT00356200|2369245|P2|STARTED|Cohort 1: 10 ug/ml||0
977992|NCT00356200|2369246|P1|STARTED|Cohort 1: 10 ug/ml||5
977993|NCT00356278|2369261|P3|NOT COMPLETED|Overall Study||19
977994|NCT00356278|2369262|P2|NOT COMPLETED|Overall Study||15
977995|NCT00356278|2369263|P1|NOT COMPLETED|Overall Study||25
977996|NCT00356278|2369261|P3|COMPLETED|Overall Study||34
977997|NCT00356278|2369262|P2|COMPLETED|Overall Study||35
977998|NCT00356278|2369263|P1|COMPLETED|Overall Study||28
977999|NCT00356278|2369261|P3|STARTED|Overall Study||53
978000|NCT00356278|2369262|P2|STARTED|Overall Study||50
978001|NCT00356278|2369263|P1|STARTED|Overall Study||53
978002|NCT00356304|2369300|P2|NOT COMPLETED|Overall Study||4
978003|NCT00356304|2369301|P1|NOT COMPLETED|Overall Study||2
978004|NCT00356304|2369300|P2|COMPLETED|Overall Study||20
978005|NCT00356304|2369301|P1|COMPLETED|Overall Study||24
978006|NCT00356304|2369300|P2|STARTED|Overall Study||24
978007|NCT00356304|2369301|P1|STARTED|Overall Study||26
978008|NCT00356408|2369313|P1|NOT COMPLETED|Overall Study||60
978009|NCT00356408|2369313|P1|COMPLETED|Overall Study||43
978010|NCT00356408|2369313|P1|STARTED|Overall Study|106 subjects enrolled, however only 103 were included in the Intent to Treat (ITT) population.|103
978011|NCT00356421|2369330|P2|NOT COMPLETED|Overall Study||17
978012|NCT00356421|2369331|P1|NOT COMPLETED|Overall Study||32
978013|NCT00356421|2369330|P2|COMPLETED|Overall Study||3
978014|NCT00356421|2369331|P1|COMPLETED|Overall Study||6
978015|NCT00356421|2369330|P2|STARTED|Overall Study||20
978016|NCT00356421|2369331|P1|STARTED|Overall Study||38
978017|NCT00356434|2369369|P2|NOT COMPLETED|Overall Study||0
978018|NCT00356434|2369370|P1|NOT COMPLETED|Overall Study||0
978019|NCT00356434|2369369|P2|COMPLETED|Overall Study||7
978020|NCT00356434|2369370|P1|COMPLETED|Overall Study||4
978021|NCT00356434|2369369|P2|STARTED|Overall Study||7
978022|NCT00356434|2369370|P1|STARTED|Overall Study||4
978023|NCT00356525|2369384|P4|NOT COMPLETED|Overall Study||9
978024|NCT00356525|2369385|P3|NOT COMPLETED|Overall Study||7
978025|NCT00356525|2369386|P2|NOT COMPLETED|Overall Study||11
978026|NCT00356525|2369387|P1|NOT COMPLETED|Overall Study||14
978027|NCT00356525|2369384|P4|COMPLETED|Overall Study||0
978028|NCT00356525|2369385|P3|COMPLETED|Overall Study||0
978029|NCT00356525|2369386|P2|COMPLETED|Overall Study||0
978030|NCT00356525|2369387|P1|COMPLETED|Overall Study||0
978031|NCT00356525|2369384|P4|STARTED|Overall Study||9
978032|NCT00356525|2369385|P3|STARTED|Overall Study||7
978033|NCT00356525|2369386|P2|STARTED|Overall Study||11
978034|NCT00356525|2369387|P1|STARTED|Overall Study||14
978035|NCT00356590|2369413|P1|NOT COMPLETED|Overall Study||274
978036|NCT00356590|2369413|P1|COMPLETED|Overall Study||194
978037|NCT00356590|2369413|P1|STARTED|Overall Study||468
978038|NCT00356811|2369445|P1|NOT COMPLETED|Overall Study||49
978039|NCT00356811|2369445|P1|COMPLETED|Overall Study||8
978040|NCT00356811|2369445|P1|STARTED|Overall Study||57
978041|NCT00356863|2369460|P2|NOT COMPLETED|Overall Study||75
978042|NCT00356863|2369461|P1|NOT COMPLETED|Overall Study||92
978043|NCT00356863|2369460|P2|COMPLETED|Overall Study||445
978044|NCT00356863|2369461|P1|COMPLETED|Overall Study||412
978045|NCT00356863|2369460|P2|STARTED|Overall Study||520
978046|NCT00356863|2369461|P1|STARTED|Overall Study||504
978047|NCT00356889|2369487|P1|NOT COMPLETED|Overall Study||3
978048|NCT00356889|2369487|P1|COMPLETED|Overall Study||53
978049|NCT00356889|2369487|P1|STARTED|Overall Study||56
978050|NCT00351351|2369496|P2|NOT COMPLETED|Overall Study||4
978051|NCT00351351|2369497|P1|NOT COMPLETED|Overall Study||9
978052|NCT00351351|2369496|P2|COMPLETED|Overall Study||32
978053|NCT00351351|2369497|P1|COMPLETED|Overall Study||25
978054|NCT00351351|2369496|P2|STARTED|Overall Study||36
978055|NCT00351351|2369497|P1|STARTED|Overall Study||34
978056|NCT00351377|2369503|P1|NOT COMPLETED|Overall Study||7
978057|NCT00351377|2369503|P1|COMPLETED|Overall Study||104
978058|NCT00351377|2369503|P1|STARTED|Overall Study||111
978059|NCT00351416|2369517|P2|NOT COMPLETED|Overall Study||0
978060|NCT00351416|2369518|P1|NOT COMPLETED|Overall Study||0
978061|NCT00351416|2369517|P2|COMPLETED|Overall Study||9
978062|NCT00351416|2369518|P1|COMPLETED|Overall Study||6
978063|NCT00351416|2369517|P2|STARTED|Overall Study||9
978064|NCT00351416|2369518|P1|STARTED|Overall Study||6
978065|NCT00356915|2369527|P3|NOT COMPLETED|Overall Study||42
978066|NCT00356915|2369528|P2|NOT COMPLETED|Overall Study||94
978067|NCT00356915|2369529|P1|NOT COMPLETED|Overall Study||76
978068|NCT00356915|2369527|P3|COMPLETED|Overall Study||156
978069|NCT00356915|2369528|P2|COMPLETED|Overall Study||496
978070|NCT00356915|2369529|P1|COMPLETED|Overall Study||517
978071|NCT00356915|2369527|P3|STARTED|Overall Study||198
978072|NCT00356915|2369528|P2|STARTED|Overall Study||590
978073|NCT00356915|2369529|P1|STARTED|Overall Study||593
978074|NCT00357006|2369549|P3|NOT COMPLETED|Overall Study||3
978075|NCT00357006|2369550|P2|NOT COMPLETED|Overall Study||5
978076|NCT00357006|2369551|P1|NOT COMPLETED|Overall Study||2
978077|NCT00357006|2369549|P3|COMPLETED|Overall Study||59
978078|NCT00357006|2369550|P2|COMPLETED|Overall Study||51
978079|NCT00357006|2369551|P1|COMPLETED|Overall Study||60
978080|NCT00357006|2369549|P3|STARTED|Overall Study||62
978081|NCT00357006|2369550|P2|STARTED|Overall Study||56
978082|NCT00357006|2369551|P1|STARTED|Overall Study||62
978083|NCT00357032|2369559|P1|NOT COMPLETED|Overall Study||0
978084|NCT00357032|2369559|P1|COMPLETED|Overall Study||12
978085|NCT00357032|2369559|P1|STARTED|Overall Study||12
978086|NCT00357097|2369566|P2|NOT COMPLETED|Overall Study||29
978087|NCT00357097|2369567|P1|NOT COMPLETED|Overall Study||54
978088|NCT00357097|2369566|P2|COMPLETED|Overall Study||38
978089|NCT00357097|2369567|P1|COMPLETED|Overall Study||145
978090|NCT00357097|2369566|P2|STARTED|Overall Study||67
978091|NCT00357097|2369567|P1|STARTED|Overall Study|199 were randomized. Only 198 took investigational product.|199
978092|NCT00357110|2369613|P2|NOT COMPLETED|Overall Study||5
978093|NCT00357110|2369614|P1|NOT COMPLETED|Overall Study||5
978094|NCT00357110|2369613|P2|COMPLETED|Overall Study||2
978095|NCT00357110|2369614|P1|COMPLETED|Overall Study||1
978096|NCT00357110|2369613|P2|STARTED|Overall Study||7
978097|NCT00357110|2369614|P1|STARTED|Overall Study||6
978098|NCT00357162|2369620|P1|NOT COMPLETED|Overall Study||0
978099|NCT00357162|2369620|P1|COMPLETED|Overall Study||21
978100|NCT00357162|2369620|P1|STARTED|Overall Study||21
978101|NCT00358644|2369628|P1|NOT COMPLETED|Overall Study||50
978102|NCT00358644|2369628|P1|COMPLETED|Overall Study||5
978103|NCT00358644|2369628|P1|STARTED|Overall Study||55
978104|NCT00358670|2369634|P2|NOT COMPLETED|Overall Study||219
978105|NCT00358670|2369635|P1|NOT COMPLETED|Overall Study||222
978106|NCT00358670|2369634|P2|COMPLETED|Overall Study||0
978107|NCT00358670|2369635|P1|COMPLETED|Overall Study||0
978108|NCT00358670|2369634|P2|STARTED|Overall Study||219
978109|NCT00358670|2369635|P1|STARTED|Overall Study||222
978110|NCT00358735|2369651|P2|NOT COMPLETED|Overall Study||17
978111|NCT00358735|2369652|P1|NOT COMPLETED|Overall Study||8
978112|NCT00358735|2369651|P2|COMPLETED|Overall Study|Efficacy|190
978113|NCT00358735|2369652|P1|COMPLETED|Overall Study|Efficacy|196
978114|NCT00358735|2369651|P2|Not Completed Safety|Overall Study||13
978115|NCT00358735|2369652|P1|Not Completed Safety|Overall Study||6
978116|NCT00358735|2369651|P2|Completed Safety|Overall Study||194
978117|NCT00358735|2369652|P1|Completed Safety|Overall Study||198
978118|NCT00358735|2369651|P2|STARTED|Overall Study||207
978119|NCT00358735|2369652|P1|STARTED|Overall Study||204
978120|NCT00358826|2369684|P8|NOT COMPLETED|MDCT Substudy||0
978121|NCT00358826|2369685|P7|NOT COMPLETED|MDCT Substudy||0
978122|NCT00358826|2369686|P6|NOT COMPLETED|MDCT Substudy||2
978123|NCT00358826|2369687|P5|NOT COMPLETED|MDCT Substudy||1
978124|NCT00358826|2369688|P4|NOT COMPLETED|MDCT Substudy||0
978125|NCT00358826|2369689|P3|NOT COMPLETED|MDCT Substudy||0
978126|NCT00358826|2369690|P2|NOT COMPLETED|MDCT Substudy||0
978127|NCT00358826|2369691|P1|NOT COMPLETED|MDCT Substudy||0
978128|NCT00358826|2369684|P8|COMPLETED|MDCT Substudy||27
978129|NCT00358826|2369685|P7|COMPLETED|MDCT Substudy||19
978130|NCT00358826|2369686|P6|COMPLETED|MDCT Substudy||20
978131|NCT00358826|2369687|P5|COMPLETED|MDCT Substudy||24
978132|NCT00358826|2369688|P4|COMPLETED|MDCT Substudy||0
978133|NCT00358826|2369689|P3|COMPLETED|MDCT Substudy||0
978134|NCT00358826|2369690|P2|COMPLETED|MDCT Substudy||0
978135|NCT00358826|2369691|P1|COMPLETED|MDCT Substudy||0
978136|NCT00358826|2369684|P8|STARTED|MDCT Substudy||27
978137|NCT00358826|2369685|P7|STARTED|MDCT Substudy||19
978138|NCT00358826|2369686|P6|STARTED|MDCT Substudy||22
978139|NCT00358826|2369687|P5|STARTED|MDCT Substudy||25
978140|NCT00358826|2369688|P4|STARTED|MDCT Substudy||0
978141|NCT00358826|2369689|P3|STARTED|MDCT Substudy||0
978142|NCT00358826|2369690|P2|STARTED|MDCT Substudy||0
978143|NCT00358826|2369691|P1|STARTED|MDCT Substudy||0
978144|NCT00358826|2369684|P8|NOT COMPLETED|Core Study||0
978145|NCT00358826|2369685|P7|NOT COMPLETED|Core Study||0
978146|NCT00358826|2369686|P6|NOT COMPLETED|Core Study||0
978147|NCT00358826|2369687|P5|NOT COMPLETED|Core Study||0
978148|NCT00358826|2369688|P4|NOT COMPLETED|Core Study||2
978149|NCT00358826|2369689|P3|NOT COMPLETED|Core Study||2
978150|NCT00358826|2369690|P2|NOT COMPLETED|Core Study||5
978151|NCT00358826|2369691|P1|NOT COMPLETED|Core Study||3
978152|NCT00358826|2369684|P8|COMPLETED|Core Study||0
978153|NCT00358826|2369685|P7|COMPLETED|Core Study||0
978154|NCT00358826|2369686|P6|COMPLETED|Core Study||0
978155|NCT00358826|2369687|P5|COMPLETED|Core Study||0
978156|NCT00358826|2369688|P4|COMPLETED|Core Study||50
978157|NCT00358826|2369689|P3|COMPLETED|Core Study||42
978158|NCT00358826|2369690|P2|COMPLETED|Core Study||41
978159|NCT00358826|2369691|P1|COMPLETED|Core Study||46
978160|NCT00358826|2369684|P8|STARTED|Core Study||0
978161|NCT00358826|2369685|P7|STARTED|Core Study||0
978162|NCT00358826|2369686|P6|STARTED|Core Study||0
978163|NCT00358826|2369687|P5|STARTED|Core Study||0
978164|NCT00358826|2369688|P4|STARTED|Core Study||52
978165|NCT00358826|2369689|P3|STARTED|Core Study||44
978166|NCT00358826|2369690|P2|STARTED|Core Study||46
978167|NCT00358826|2369691|P1|STARTED|Core Study||49
978168|NCT00358917|2369727|P2|NOT COMPLETED|Overall Study||69
978169|NCT00358917|2369728|P1|NOT COMPLETED|Overall Study||66
978170|NCT00358917|2369727|P2|COMPLETED|Overall Study||230
978171|NCT00358917|2369728|P1|COMPLETED|Overall Study||234
978172|NCT00358917|2369727|P2|STARTED|Overall Study||299
978173|NCT00358917|2369728|P1|STARTED|Overall Study||300
978174|NCT00358956|2369742|P1|NOT COMPLETED|Overall Study||8
978175|NCT00358956|2369742|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|11
978176|NCT00358956|2369742|P1|STARTED|Overall Study||19
978177|NCT00359021|2369754|P2|NOT COMPLETED|Overall Study||52
978178|NCT00359021|2369755|P1|NOT COMPLETED|Overall Study||81
978179|NCT00359021|2369754|P2|COMPLETED|Overall Study||195
978180|NCT00359021|2369755|P1|COMPLETED|Overall Study||175
978181|NCT00359021|2369754|P2|STARTED|Overall Study||247
978182|NCT00359021|2369755|P1|STARTED|Overall Study||256
978183|NCT00359138|2369770|P3|NOT COMPLETED|Overall Study||0
978184|NCT00359138|2369771|P2|NOT COMPLETED|Overall Study||0
978185|NCT00359138|2369772|P1|NOT COMPLETED|Overall Study||0
978186|NCT00359138|2369770|P3|COMPLETED|Overall Study||12
978187|NCT00359138|2369771|P2|COMPLETED|Overall Study||12
978188|NCT00359138|2369772|P1|COMPLETED|Overall Study||12
978189|NCT00359138|2369770|P3|STARTED|Overall Study||12
978190|NCT00359138|2369771|P2|STARTED|Overall Study||12
978191|NCT00359138|2369772|P1|STARTED|Overall Study||12
978192|NCT00359203|2369782|P2|NOT COMPLETED|Overall Study||0
978193|NCT00359203|2369783|P1|NOT COMPLETED|Overall Study||0
978194|NCT00359203|2369782|P2|COMPLETED|Overall Study||38
978195|NCT00359203|2369783|P1|COMPLETED|Overall Study||39
978196|NCT00359203|2369782|P2|STARTED|Overall Study||38
978197|NCT00359203|2369783|P1|STARTED|Overall Study||39
978198|NCT00359216|2369791|P2|NOT COMPLETED|Overall Study||1
978199|NCT00359216|2369792|P1|NOT COMPLETED|Overall Study||0
978200|NCT00359216|2369791|P2|COMPLETED|Overall Study|Completed treatment but simultaneously partaking in other study,final study procedures not performed|9
978201|NCT00359216|2369792|P1|COMPLETED|Overall Study||20
978202|NCT00359216|2369791|P2|STARTED|Overall Study||10
978203|NCT00359216|2369792|P1|STARTED|Overall Study||20
978204|NCT00359281|2369807|P9|NOT COMPLETED|Overall Study||0
978205|NCT00359281|2369808|P8|NOT COMPLETED|Overall Study||0
978206|NCT00359281|2369809|P7|NOT COMPLETED|Overall Study||2
978207|NCT00359281|2369810|P6|NOT COMPLETED|Overall Study||0
978208|NCT00359281|2369811|P5|NOT COMPLETED|Overall Study||0
978209|NCT00359281|2369812|P4|NOT COMPLETED|Overall Study||0
978210|NCT00359281|2369813|P3|NOT COMPLETED|Overall Study||0
978211|NCT00359281|2369814|P2|NOT COMPLETED|Overall Study||0
978212|NCT00359281|2369815|P1|NOT COMPLETED|Overall Study||1
978213|NCT00359281|2369807|P9|COMPLETED|Overall Study||20
978214|NCT00359281|2369808|P8|COMPLETED|Overall Study||15
978215|NCT00359281|2369809|P7|COMPLETED|Overall Study||16
978216|NCT00359281|2369810|P6|COMPLETED|Overall Study||15
978217|NCT00359281|2369811|P5|COMPLETED|Overall Study||10
978218|NCT00359281|2369812|P4|COMPLETED|Overall Study||10
978219|NCT00359281|2369813|P3|COMPLETED|Overall Study||10
978220|NCT00359281|2369814|P2|COMPLETED|Overall Study||15
978221|NCT00359281|2369815|P1|COMPLETED|Overall Study||15
978222|NCT00359281|2369807|P9|STARTED|Overall Study||20
978223|NCT00359281|2369808|P8|STARTED|Overall Study||15
978224|NCT00359281|2369809|P7|STARTED|Overall Study||18
978225|NCT00359281|2369810|P6|STARTED|Overall Study||15
978226|NCT00359281|2369811|P5|STARTED|Overall Study||10
978227|NCT00359281|2369812|P4|STARTED|Overall Study||10
978228|NCT00359281|2369813|P3|STARTED|Overall Study||10
978229|NCT00359281|2369814|P2|STARTED|Overall Study||15
978230|NCT00359281|2369815|P1|STARTED|Overall Study||16
978231|NCT00359424|2369847|P2|NOT COMPLETED|Overall Study||67
978232|NCT00359424|2369848|P1|NOT COMPLETED|Overall Study||130
978233|NCT00359424|2369847|P2|COMPLETED|Overall Study||155
978234|NCT00359424|2369848|P1|COMPLETED|Overall Study||304
978235|NCT00359424|2369847|P2|270 Day Follow up|Overall Study||159
978236|NCT00359424|2369848|P1|270 Day Follow up|Overall Study||313
978237|NCT00359424|2369847|P2|180 Day Follow up|Overall Study||167
978238|NCT00359424|2369848|P1|180 Day Follow up|Overall Study||325
978239|NCT00359424|2369847|P2|90 Day Follow up|Overall Study||172
978240|NCT00359424|2369848|P1|90 Day Follow up|Overall Study||343
978241|NCT00359424|2369847|P2|STARTED|Overall Study||222
978242|NCT00359424|2369848|P1|STARTED|Overall Study||434
978243|NCT00359619|2369885|P7|NOT COMPLETED|Overall Study||4
978244|NCT00359619|2369886|P6|NOT COMPLETED|Overall Study||5
978245|NCT00359619|2369887|P5|NOT COMPLETED|Overall Study||3
978246|NCT00359619|2369888|P4|NOT COMPLETED|Overall Study||3
978247|NCT00359619|2369889|P3|NOT COMPLETED|Overall Study||7
978248|NCT00359619|2369890|P2|NOT COMPLETED|Overall Study||5
978249|NCT00359619|2369891|P1|NOT COMPLETED|Overall Study||8
978250|NCT00359619|2369885|P7|COMPLETED|Overall Study||46
978251|NCT00359619|2369886|P6|COMPLETED|Overall Study||45
978252|NCT00359619|2369887|P5|COMPLETED|Overall Study||45
978253|NCT00359619|2369888|P4|COMPLETED|Overall Study||45
978254|NCT00359619|2369889|P3|COMPLETED|Overall Study||42
978255|NCT00359619|2369890|P2|COMPLETED|Overall Study||45
978256|NCT00359619|2369891|P1|COMPLETED|Overall Study||80
978257|NCT00359619|2369885|P7|STARTED|Overall Study||50
978258|NCT00359619|2369886|P6|STARTED|Overall Study||50
978259|NCT00359619|2369887|P5|STARTED|Overall Study||48
978260|NCT00359619|2369888|P4|STARTED|Overall Study||48
978261|NCT00359619|2369889|P3|STARTED|Overall Study||49
978262|NCT00359619|2369890|P2|STARTED|Overall Study||50
978263|NCT00359619|2369891|P1|STARTED|Overall Study||88
978264|NCT00359632|2370021|P2|NOT COMPLETED|Overall Study||0
978265|NCT00359632|2370022|P1|NOT COMPLETED|Overall Study||4
978266|NCT00359632|2370021|P2|COMPLETED|Overall Study||9
978267|NCT00359632|2370022|P1|COMPLETED|Overall Study||20
978268|NCT00359632|2370021|P2|STARTED|Overall Study||9
978269|NCT00359632|2370022|P1|STARTED|Overall Study||24
978276|NCT00359762|2370042|P5|NOT COMPLETED|Period I||0
978277|NCT00359762|2370043|P4|NOT COMPLETED|Period I||0
978278|NCT00359762|2370044|P3|NOT COMPLETED|Period I||0
978279|NCT00359762|2370045|P2|NOT COMPLETED|Period I||0
978280|NCT00359762|2370046|P1|NOT COMPLETED|Period I||0
978281|NCT00359762|2370042|P5|COMPLETED|Period I||0
978282|NCT00359762|2370043|P4|COMPLETED|Period I||0
978283|NCT00359762|2370044|P3|COMPLETED|Period I||0
978284|NCT00359762|2370045|P2|COMPLETED|Period I||0
978285|NCT00359762|2370046|P1|COMPLETED|Period I||0
978286|NCT00359762|2370042|P5|STARTED|Period I||0
978287|NCT00359762|2370043|P4|STARTED|Period I||0
978288|NCT00359762|2370044|P3|STARTED|Period I||0
978289|NCT00359762|2370045|P2|STARTED|Period I||0
978290|NCT00359762|2370046|P1|STARTED|Period I||0
978291|NCT00359762|2370042|P5|NOT COMPLETED|Period III||0
978292|NCT00359762|2370043|P4|NOT COMPLETED|Period III||65
978293|NCT00359762|2370044|P3|NOT COMPLETED|Period III||30
978294|NCT00359762|2370045|P2|NOT COMPLETED|Period III||29
978295|NCT00359762|2370046|P1|NOT COMPLETED|Period III||0
978296|NCT00359762|2370042|P5|COMPLETED|Period III||0
978297|NCT00359762|2370043|P4|COMPLETED|Period III||101
978298|NCT00359762|2370044|P3|COMPLETED|Period III||47
978299|NCT00359762|2370045|P2|COMPLETED|Period III||48
978300|NCT00359762|2370046|P1|COMPLETED|Period III||0
978301|NCT00359762|2370042|P5|Extension ITT Efficacy Population|Period III||0
978302|NCT00359762|2370043|P4|Extension ITT Efficacy Population|Period III||164
978303|NCT00359762|2370044|P3|Extension ITT Efficacy Population|Period III||75
978304|NCT00359762|2370045|P2|Extension ITT Efficacy Population|Period III||73
978305|NCT00359762|2370046|P1|Extension ITT Efficacy Population|Period III||0
978306|NCT00359762|2370042|P5|Extension ITT Safety Population|Period III||0
978307|NCT00359762|2370043|P4|Extension ITT Safety Population|Period III||166
978308|NCT00359762|2370044|P3|Extension ITT Safety Population|Period III||76
978309|NCT00359762|2370045|P2|Extension ITT Safety Population|Period III||74
978310|NCT00359762|2370046|P1|Extension ITT Safety Population|Period III||0
978311|NCT00359762|2370042|P5|STARTED|Period III||0
978312|NCT00359762|2370043|P4|STARTED|Period III||166
978313|NCT00359762|2370044|P3|STARTED|Period III||77
978314|NCT00359762|2370045|P2|STARTED|Period III||77
978315|NCT00359762|2370046|P1|STARTED|Period III||0
978316|NCT00359762|2370042|P5|NOT COMPLETED|Period II||174
978317|NCT00359762|2370043|P4|NOT COMPLETED|Period II||0
978318|NCT00359762|2370044|P3|NOT COMPLETED|Period II||0
978319|NCT00359762|2370045|P2|NOT COMPLETED|Period II||0
978320|NCT00359762|2370046|P1|NOT COMPLETED|Period II||128
978321|NCT00359762|2370042|P5|COMPLETED|Period II||341
978322|NCT00359762|2370043|P4|COMPLETED|Period II||0
978323|NCT00359762|2370044|P3|COMPLETED|Period II||0
978324|NCT00359762|2370045|P2|COMPLETED|Period II||0
978325|NCT00359762|2370046|P1|COMPLETED|Period II||386
978326|NCT00359762|2370042|P5|Without Treatment Failure|Period II||138
978327|NCT00359762|2370043|P4|Without Treatment Failure|Period II||0
978328|NCT00359762|2370044|P3|Without Treatment Failure|Period II||0
978329|NCT00359762|2370045|P2|Without Treatment Failure|Period II||0
978330|NCT00359762|2370046|P1|Without Treatment Failure|Period II||124
978331|NCT00359762|2370042|P5|Met Primary Endpoint|Period II||203
978332|NCT00359762|2370043|P4|Met Primary Endpoint|Period II||0
978333|NCT00359762|2370044|P3|Met Primary Endpoint|Period II||0
978334|NCT00359762|2370045|P2|Met Primary Endpoint|Period II||0
978335|NCT00359762|2370046|P1|Met Primary Endpoint|Period II||262
978336|NCT00359762|2370042|P5|ITT Efficacy Population|Period II||490
978337|NCT00359762|2370043|P4|ITT Efficacy Population|Period II||0
978338|NCT00359762|2370044|P3|ITT Efficacy Population|Period II||0
978339|NCT00359762|2370045|P2|ITT Efficacy Population|Period II||0
978340|NCT00359762|2370046|P1|ITT Efficacy Population|Period II||487
978341|NCT00359762|2370042|P5|Intent to Treat (ITT) Safety Population|Period II||511
978342|NCT00359762|2370043|P4|Intent to Treat (ITT) Safety Population|Period II||0
978343|NCT00359762|2370044|P3|Intent to Treat (ITT) Safety Population|Period II||0
978344|NCT00359762|2370045|P2|Intent to Treat (ITT) Safety Population|Period II||0
978345|NCT00359762|2370046|P1|Intent to Treat (ITT) Safety Population|Period II||508
978346|NCT00359762|2370042|P5|STARTED|Period II||515
978347|NCT00359762|2370043|P4|STARTED|Period II||0
978348|NCT00359762|2370044|P3|STARTED|Period II||0
978349|NCT00359762|2370045|P2|STARTED|Period II||0
978350|NCT00359762|2370046|P1|STARTED|Period II||514
978351|NCT00359788|2370109|P2|NOT COMPLETED|Overall Study||17
978352|NCT00359788|2370110|P1|NOT COMPLETED|Overall Study||23
978353|NCT00359788|2370109|P2|COMPLETED|Overall Study||159
978354|NCT00359788|2370110|P1|COMPLETED|Overall Study||150
978355|NCT00359788|2370109|P2|STARTED|Overall Study||176
978356|NCT00359788|2370110|P1|STARTED|Overall Study||173
978357|NCT00359801|2370344|P2|NOT COMPLETED|Overall Study||220
978358|NCT00359801|2370345|P1|NOT COMPLETED|Overall Study||305
978359|NCT00359801|2370344|P2|COMPLETED|Overall Study|4 additional subjects had missing data and final status (completed/discontinued) is unknown.|769
978360|NCT00359801|2370345|P1|COMPLETED|Overall Study|7 additional subjects had missing data and final status (completed/discontinued) is unknown.|682
978361|NCT00359801|2370344|P2|STARTED|Overall Study||989
978362|NCT00359801|2370345|P1|STARTED|Overall Study||987
978363|NCT00359944|2370380|P3|NOT COMPLETED|Overall Study||19
978364|NCT00359944|2370381|P2|NOT COMPLETED|Overall Study||19
978365|NCT00359944|2370382|P1|NOT COMPLETED|Overall Study||16
978366|NCT00359944|2370380|P3|COMPLETED|Overall Study||38
978367|NCT00359944|2370381|P2|COMPLETED|Overall Study||28
978368|NCT00359944|2370382|P1|COMPLETED|Overall Study||34
978369|NCT00359944|2370380|P3|STARTED|Overall Study||57
978370|NCT00359944|2370381|P2|STARTED|Overall Study||47
978371|NCT00359944|2370382|P1|STARTED|Overall Study||50
978372|NCT00359983|2370399|P3|NOT COMPLETED|Year 5 Persistence Follow-up||0
978373|NCT00359983|2370400|P2|NOT COMPLETED|Year 5 Persistence Follow-up||0
978374|NCT00359983|2370401|P1|NOT COMPLETED|Year 5 Persistence Follow-up||0
978375|NCT00359983|2370399|P3|COMPLETED|Year 5 Persistence Follow-up||42
978376|NCT00359983|2370400|P2|COMPLETED|Year 5 Persistence Follow-up||44
978377|NCT00359983|2370401|P1|COMPLETED|Year 5 Persistence Follow-up||95
978378|NCT00359983|2370399|P3|STARTED|Year 5 Persistence Follow-up||42
978379|NCT00359983|2370400|P2|STARTED|Year 5 Persistence Follow-up||44
978380|NCT00359983|2370401|P1|STARTED|Year 5 Persistence Follow-up||95
978381|NCT00359983|2370399|P3|NOT COMPLETED|Year 3 Persistence Follow-up||0
978382|NCT00359983|2370400|P2|NOT COMPLETED|Year 3 Persistence Follow-up||0
978383|NCT00359983|2370401|P1|NOT COMPLETED|Year 3 Persistence Follow-up||0
978384|NCT00359983|2370399|P3|COMPLETED|Year 3 Persistence Follow-up||51
978385|NCT00359983|2370400|P2|COMPLETED|Year 3 Persistence Follow-up||47
978386|NCT00359983|2370401|P1|COMPLETED|Year 3 Persistence Follow-up||103
978387|NCT00359983|2370399|P3|STARTED|Year 3 Persistence Follow-up||51
978388|NCT00359983|2370400|P2|STARTED|Year 3 Persistence Follow-up||47
978389|NCT00359983|2370401|P1|STARTED|Year 3 Persistence Follow-up||103
978390|NCT00359983|2370399|P3|NOT COMPLETED|Year 1 Persistence Follow-up||0
978391|NCT00359983|2370400|P2|NOT COMPLETED|Year 1 Persistence Follow-up||0
978392|NCT00359983|2370401|P1|NOT COMPLETED|Year 1 Persistence Follow-up||0
978393|NCT00359983|2370399|P3|COMPLETED|Year 1 Persistence Follow-up||62
978394|NCT00359983|2370400|P2|COMPLETED|Year 1 Persistence Follow-up||70
978395|NCT00359983|2370401|P1|COMPLETED|Year 1 Persistence Follow-up||138
978396|NCT00359983|2370399|P3|STARTED|Year 1 Persistence Follow-up||62
978397|NCT00359983|2370400|P2|STARTED|Year 1 Persistence Follow-up||70
978398|NCT00359983|2370401|P1|STARTED|Year 1 Persistence Follow-up||138
978399|NCT00360009|2370436|P3|NOT COMPLETED|Overall Study||3
978400|NCT00360009|2370437|P2|NOT COMPLETED|Overall Study||4
978401|NCT00360009|2370438|P1|NOT COMPLETED|Overall Study||0
978402|NCT00360009|2370436|P3|COMPLETED|Overall Study||23
978403|NCT00360009|2370437|P2|COMPLETED|Overall Study||22
978404|NCT00360009|2370438|P1|COMPLETED|Overall Study||10
978405|NCT00360009|2370436|P3|STARTED|Overall Study||26
978406|NCT00360009|2370437|P2|STARTED|Overall Study||26
978407|NCT00360009|2370438|P1|STARTED|Overall Study||10
978408|NCT00360126|2370476|P1|NOT COMPLETED|Overall Study||0
978409|NCT00360126|2370476|P1|COMPLETED|Overall Study||11
978410|NCT00360126|2370476|P1|STARTED|Overall Study||11
978411|NCT00360243|2370484|P4|NOT COMPLETED|Overall Study||125
978412|NCT00360243|2370485|P3|NOT COMPLETED|Overall Study||156
978413|NCT00360243|2370486|P2|NOT COMPLETED|Overall Study||120
978414|NCT00360243|2370487|P1|NOT COMPLETED|Overall Study||102
978415|NCT00360243|2370484|P4|COMPLETED|Overall Study||224
978416|NCT00360243|2370485|P3|COMPLETED|Overall Study||180
978417|NCT00360243|2370486|P2|COMPLETED|Overall Study||243
978418|NCT00360243|2370487|P1|COMPLETED|Overall Study||235
978419|NCT00360243|2370484|P4|STARTED|Overall Study||349
978420|NCT00360243|2370485|P3|STARTED|Overall Study||336
978421|NCT00360243|2370486|P2|STARTED|Overall Study||363
978422|NCT00360243|2370487|P1|STARTED|Overall Study||337
978423|NCT00360269|2370503|P2|NOT COMPLETED|Overall Study||12
978424|NCT00360269|2370504|P1|NOT COMPLETED|Overall Study||10
978425|NCT00360269|2370503|P2|COMPLETED|Overall Study||7
978426|NCT00360269|2370504|P1|COMPLETED|Overall Study||9
978427|NCT00360269|2370503|P2|STARTED|Overall Study||19
978428|NCT00360269|2370504|P1|STARTED|Overall Study||19
978429|NCT00360282|2370518|P4|NOT COMPLETED|Second Intervention||0
978430|NCT00360282|2370519|P3|NOT COMPLETED|Second Intervention||0
978431|NCT00360282|2370520|P2|NOT COMPLETED|Second Intervention||1
978432|NCT00360282|2370521|P1|NOT COMPLETED|Second Intervention||0
978433|NCT00360282|2370518|P4|COMPLETED|Second Intervention||6
978434|NCT00360282|2370519|P3|COMPLETED|Second Intervention||6
978435|NCT00360282|2370520|P2|COMPLETED|Second Intervention||7
978436|NCT00360282|2370521|P1|COMPLETED|Second Intervention||6
978437|NCT00360282|2370518|P4|STARTED|Second Intervention||6
978438|NCT00360282|2370519|P3|STARTED|Second Intervention||6
978439|NCT00360282|2370520|P2|STARTED|Second Intervention||8
978440|NCT00360282|2370521|P1|STARTED|Second Intervention||6
978441|NCT00360282|2370518|P4|NOT COMPLETED|Washout 1-3 Weeks||0
978442|NCT00360282|2370519|P3|NOT COMPLETED|Washout 1-3 Weeks||1
978443|NCT00360282|2370520|P2|NOT COMPLETED|Washout 1-3 Weeks||0
978444|NCT00360282|2370521|P1|NOT COMPLETED|Washout 1-3 Weeks||0
978445|NCT00360282|2370518|P4|COMPLETED|Washout 1-3 Weeks||6
978446|NCT00360282|2370519|P3|COMPLETED|Washout 1-3 Weeks||6
978447|NCT00360282|2370520|P2|COMPLETED|Washout 1-3 Weeks||8
978448|NCT00360282|2370521|P1|COMPLETED|Washout 1-3 Weeks||6
978449|NCT00360282|2370518|P4|STARTED|Washout 1-3 Weeks||6
978450|NCT00360282|2370519|P3|STARTED|Washout 1-3 Weeks||7
978451|NCT00360282|2370520|P2|STARTED|Washout 1-3 Weeks||8
978452|NCT00360282|2370521|P1|STARTED|Washout 1-3 Weeks||6
978453|NCT00360282|2370518|P4|NOT COMPLETED|First Intervention||0
978454|NCT00360282|2370519|P3|NOT COMPLETED|First Intervention||0
978455|NCT00360282|2370520|P2|NOT COMPLETED|First Intervention||0
978456|NCT00360282|2370521|P1|NOT COMPLETED|First Intervention||0
978457|NCT00360282|2370518|P4|COMPLETED|First Intervention||6
978458|NCT00360282|2370519|P3|COMPLETED|First Intervention||7
978459|NCT00360282|2370520|P2|COMPLETED|First Intervention||8
978460|NCT00360282|2370521|P1|COMPLETED|First Intervention||6
978461|NCT00360282|2370518|P4|STARTED|First Intervention||6
978462|NCT00360282|2370519|P3|STARTED|First Intervention||7
978463|NCT00360282|2370520|P2|STARTED|First Intervention||8
978464|NCT00360282|2370521|P1|STARTED|First Intervention||6
978465|NCT00360308|2370534|P3|NOT COMPLETED|Overall Study||88
978466|NCT00360308|2370535|P2|NOT COMPLETED|Overall Study||79
978467|NCT00360308|2370536|P1|NOT COMPLETED|Overall Study||76
978468|NCT00360308|2370534|P3|COMPLETED|Overall Study||154
978469|NCT00360308|2370535|P2|COMPLETED|Overall Study||155
978470|NCT00360308|2370536|P1|COMPLETED|Overall Study||171
978471|NCT00360308|2370534|P3|STARTED|Overall Study||242
978472|NCT00360308|2370535|P2|STARTED|Overall Study||234
978473|NCT00360308|2370536|P1|STARTED|Overall Study||247
978474|NCT00360334|2370555|P2|NOT COMPLETED|Overall Study||13
978475|NCT00360334|2370556|P1|NOT COMPLETED|Overall Study||19
978476|NCT00360334|2370555|P2|COMPLETED|Overall Study||104
978477|NCT00360334|2370556|P1|COMPLETED|Overall Study||99
978478|NCT00360334|2370555|P2|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|116
978479|NCT00360334|2370556|P1|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|118
978480|NCT00360334|2370555|P2|STARTED|Overall Study||117
978481|NCT00360334|2370556|P1|STARTED|Overall Study||118
978482|NCT00360360|2370616|P1|NOT COMPLETED|Overall Study||6
978483|NCT00360360|2370616|P1|COMPLETED|Overall Study||54
978484|NCT00360360|2370616|P1|STARTED|Overall Study||60
978485|NCT00360399|2370624|P3|NOT COMPLETED|Overall Study||46
978486|NCT00360399|2370625|P2|NOT COMPLETED|Overall Study||36
978487|NCT00360399|2370626|P1|NOT COMPLETED|Overall Study||28
978488|NCT00360399|2370624|P3|COMPLETED|Overall Study||69
978489|NCT00360399|2370625|P2|COMPLETED|Overall Study||79
978490|NCT00360399|2370626|P1|COMPLETED|Overall Study||86
978491|NCT00360399|2370624|P3|Had Post-randomization Assessment|Overall Study||105
978492|NCT00360399|2370625|P2|Had Post-randomization Assessment|Overall Study||106
978493|NCT00360399|2370626|P1|Had Post-randomization Assessment|Overall Study||105
978494|NCT00360399|2370624|P3|STARTED|Overall Study||115
978495|NCT00360399|2370625|P2|STARTED|Overall Study||115
978496|NCT00360399|2370626|P1|STARTED|Overall Study||114
978497|NCT00360412|2370651|P2|NOT COMPLETED|Overall Study||662
978498|NCT00360412|2370652|P1|NOT COMPLETED|Overall Study||333
978499|NCT00360412|2370651|P2|COMPLETED|Overall Study||2
978500|NCT00360412|2370652|P1|COMPLETED|Overall Study||0
978501|NCT00360412|2370651|P2|STARTED|Overall Study||664
978502|NCT00360412|2370652|P1|STARTED|Overall Study||333
978503|NCT00360490|2370666|P2|NOT COMPLETED|Overall Study||11
978504|NCT00360490|2370667|P1|NOT COMPLETED|Overall Study||9
978505|NCT00360490|2370666|P2|COMPLETED|Overall Study||72
978506|NCT00360490|2370667|P1|COMPLETED|Overall Study||73
978507|NCT00360490|2370666|P2|STARTED|Overall Study||83
978508|NCT00360490|2370667|P1|STARTED|Overall Study||82
978509|NCT00360529|2370703|P3|NOT COMPLETED|Overall Study||91
978510|NCT00360529|2370704|P2|NOT COMPLETED|Overall Study||65
978511|NCT00360529|2370705|P1|NOT COMPLETED|Overall Study||61
978512|NCT00360529|2370703|P3|COMPLETED|Overall Study||199
978513|NCT00360529|2370704|P2|COMPLETED|Overall Study||230
978514|NCT00360529|2370705|P1|COMPLETED|Overall Study||234
978515|NCT00360529|2370703|P3|STARTED|Overall Study||290
978516|NCT00360529|2370704|P2|STARTED|Overall Study||295
978517|NCT00360529|2370705|P1|STARTED|Overall Study||295
978518|NCT00360555|2370735|P4|NOT COMPLETED|Overall Study||112
978519|NCT00360555|2370736|P3|NOT COMPLETED|Overall Study||145
978520|NCT00360555|2370737|P2|NOT COMPLETED|Overall Study||134
978521|NCT00360555|2370738|P1|NOT COMPLETED|Overall Study||122
978522|NCT00360555|2370735|P4|COMPLETED|Overall Study||287
978523|NCT00360555|2370736|P3|COMPLETED|Overall Study||251
978524|NCT00360555|2370737|P2|COMPLETED|Overall Study||259
978525|NCT00360555|2370738|P1|COMPLETED|Overall Study||274
978526|NCT00360555|2370735|P4|STARTED|Overall Study||399
978527|NCT00360555|2370736|P3|STARTED|Overall Study||396
978528|NCT00360555|2370737|P2|STARTED|Overall Study||393
978529|NCT00360555|2370738|P1|STARTED|Overall Study||396
978530|NCT00360568|2370754|P2|NOT COMPLETED|Overall Study||5
978531|NCT00360568|2370755|P1|NOT COMPLETED|Overall Study||2
978532|NCT00360568|2370754|P2|COMPLETED|Overall Study||24
978533|NCT00360568|2370755|P1|COMPLETED|Overall Study||31
978534|NCT00360568|2370754|P2|STARTED|Overall Study||29
978535|NCT00360568|2370755|P1|STARTED|Overall Study||33
978536|NCT00360672|2370862|P1|NOT COMPLETED|Overall Study||0
978537|NCT00360672|2370862|P1|COMPLETED|Overall Study||27
978538|NCT00360672|2370862|P1|STARTED|Overall Study||27
978539|NCT00360685|2370868|P2|NOT COMPLETED|Overall Study||0
978540|NCT00360685|2370869|P1|NOT COMPLETED|Overall Study||0
978541|NCT00360685|2370868|P2|COMPLETED|Overall Study||42
978542|NCT00360685|2370869|P1|COMPLETED|Overall Study||47
978543|NCT00360685|2370868|P2|STARTED|Overall Study||42
978544|NCT00360685|2370869|P1|STARTED|Overall Study||47
978545|NCT00360698|2370881|P2|NOT COMPLETED|Treatment Period||1
978546|NCT00360698|2370882|P1|NOT COMPLETED|Treatment Period||1
978547|NCT00360698|2370881|P2|COMPLETED|Treatment Period||56
978548|NCT00360698|2370882|P1|COMPLETED|Treatment Period||48
978549|NCT00360698|2370881|P2|STARTED|Treatment Period||57
978550|NCT00360698|2370882|P1|STARTED|Treatment Period||49
978551|NCT00360698|2370881|P2|NOT COMPLETED|Run-In||10
978552|NCT00360698|2370882|P1|NOT COMPLETED|Run-In||0
978553|NCT00360698|2370881|P2|COMPLETED|Run-In|19 patients completed the run-in but were not eligible for randomization in the treatment period|125
978554|NCT00360698|2370882|P1|COMPLETED|Run-In||0
978555|NCT00360698|2370881|P2|STARTED|Run-In||135
978556|NCT00360698|2370882|P1|STARTED|Run-In||0
978557|NCT00360724|2370910|P2|NOT COMPLETED|Overall Study||4
978558|NCT00360724|2370911|P1|NOT COMPLETED|Overall Study||4
978559|NCT00360724|2370910|P2|COMPLETED|Overall Study||28
978560|NCT00360724|2370911|P1|COMPLETED|Overall Study||29
978561|NCT00360724|2370910|P2|STARTED|Overall Study||32
978562|NCT00360724|2370911|P1|STARTED|Overall Study||33
978563|NCT00360828|2370937|P1|NOT COMPLETED|Overall Study||1
978564|NCT00360828|2370937|P1|COMPLETED|Overall Study||9
978565|NCT00360828|2370937|P1|STARTED|Overall Study||10
978566|NCT00360971|2370947|P2|NOT COMPLETED|Overall Study||0
978567|NCT00360971|2370948|P1|NOT COMPLETED|Overall Study||0
978568|NCT00360971|2370947|P2|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|11
978569|NCT00360971|2370948|P1|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|10
978570|NCT00360971|2370947|P2|STARTED|Overall Study||11
978571|NCT00360971|2370948|P1|STARTED|Overall Study||10
978572|NCT00361140|2370957|P3|NOT COMPLETED|Overall Study||0
978573|NCT00361140|2370958|P2|NOT COMPLETED|Overall Study||0
978574|NCT00361140|2370959|P1|NOT COMPLETED|Overall Study||0
978575|NCT00361140|2370957|P3|COMPLETED|Overall Study||3
978576|NCT00361140|2370958|P2|COMPLETED|Overall Study||29
978577|NCT00361140|2370959|P1|COMPLETED|Overall Study||40
978578|NCT00361140|2370957|P3|STARTED|Overall Study||3
978579|NCT00361140|2370958|P2|STARTED|Overall Study||29
978580|NCT00361140|2370959|P1|STARTED|Overall Study||40
978581|NCT00361218|2370970|P1|NOT COMPLETED|Overall Study||23
978582|NCT00361218|2370970|P1|COMPLETED|Overall Study||30
978583|NCT00361218|2370970|P1|Completed Baseline Assessment|Overall Study||47
978584|NCT00361218|2370970|P1|STARTED|Overall Study|met eligibility criteria and enrolled in the study|53
978585|NCT00361231|2370974|P1|NOT COMPLETED|Overall Study||34
978586|NCT00361231|2370974|P1|COMPLETED|Overall Study||1
978587|NCT00361231|2370974|P1|STARTED|Overall Study||35
978588|NCT00361257|2370981|P2|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
978589|NCT00361257|2370982|P1|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
978590|NCT00361257|2370981|P2|COMPLETED|Step 2: Minocycline(Open Label) for All||19
978591|NCT00361257|2370982|P1|COMPLETED|Step 2: Minocycline(Open Label) for All||13
978592|NCT00361257|2370981|P2|STARTED|Step 2: Minocycline(Open Label) for All|43 participants completed Step 1; however, 9 decided not to enroll Step 2,so 43-9=34 started Step 2.|34
978593|NCT00361257|2370982|P1|STARTED|Step 2: Minocycline(Open Label) for All|40 participants completed Step 1; however,12 decided not to enroll Step 2,so 40-12=28 started Step 2|28
978594|NCT00361257|2370981|P2|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
978595|NCT00361257|2370982|P1|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
978596|NCT00361257|2370981|P2|COMPLETED|Step 1: Minocycline vs. Placebo||43
978597|NCT00361257|2370982|P1|COMPLETED|Step 1: Minocycline vs. Placebo||40
978598|NCT00361257|2370981|P2|STARTED|Step 1: Minocycline vs. Placebo||55
978599|NCT00361257|2370982|P1|STARTED|Step 1: Minocycline vs. Placebo||52
978600|NCT00361270|2371038|P4|NOT COMPLETED|Overall Study||13
978601|NCT00361270|2371039|P3|NOT COMPLETED|Overall Study||10
978602|NCT00361270|2371040|P2|NOT COMPLETED|Overall Study||14
978603|NCT00361270|2371041|P1|NOT COMPLETED|Overall Study||24
978604|NCT00361270|2371038|P4|COMPLETED|Overall Study||25
978605|NCT00361270|2371039|P3|COMPLETED|Overall Study||25
978606|NCT00361270|2371040|P2|COMPLETED|Overall Study||25
978607|NCT00361270|2371041|P1|COMPLETED|Overall Study||25
978608|NCT00361270|2371038|P4|STARTED|Overall Study||38
978609|NCT00361270|2371039|P3|STARTED|Overall Study||35
978610|NCT00361270|2371040|P2|STARTED|Overall Study||39
978611|NCT00361270|2371041|P1|STARTED|Overall Study||49
978612|NCT00361283|2371059|P1|NOT COMPLETED|Overall Study||27
978613|NCT00361283|2371059|P1|COMPLETED|Overall Study||81
978614|NCT00361283|2371059|P1|STARTED|Overall Study||108
978615|NCT00361335|2371068|P7|NOT COMPLETED|SC Period: Week E0 to Week E24||9
978616|NCT00361335|2371069|P6|NOT COMPLETED|SC Period: Week E0 to Week E24||1
978617|NCT00361335|2371070|P5|NOT COMPLETED|SC Period: Week E0 to Week E24||0
978618|NCT00361335|2371071|P4|NOT COMPLETED|SC Period: Week E0 to Week E24||4
978619|NCT00361335|2371072|P3|NOT COMPLETED|SC Period: Week E0 to Week E24||5
978620|NCT00361335|2371073|P2|NOT COMPLETED|SC Period: Week E0 to Week E24||3
978621|NCT00361335|2371074|P1|NOT COMPLETED|SC Period: Week E0 to Week E24||2
978622|NCT00361335|2371068|P7|COMPLETED|SC Period: Week E0 to Week E24||164
978623|NCT00361335|2371069|P6|COMPLETED|SC Period: Week E0 to Week E24||23
978624|NCT00361335|2371070|P5|COMPLETED|SC Period: Week E0 to Week E24||3
978625|NCT00361335|2371071|P4|COMPLETED|SC Period: Week E0 to Week E24||59
978626|NCT00361335|2371072|P3|COMPLETED|SC Period: Week E0 to Week E24||99
978627|NCT00361335|2371073|P2|COMPLETED|SC Period: Week E0 to Week E24||56
978628|NCT00361335|2371074|P1|COMPLETED|SC Period: Week E0 to Week E24||80
978629|NCT00361335|2371068|P7|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|173
978630|NCT00361335|2371069|P6|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|24
978631|NCT00361335|2371070|P5|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|3
978632|NCT00361335|2371071|P4|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|63
978633|NCT00361335|2371072|P3|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|104
978634|NCT00361335|2371073|P2|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|59
978635|NCT00361335|2371074|P1|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|82
978636|NCT00361335|2371068|P7|NOT COMPLETED|IV Period: Baseline to E0||0
978637|NCT00361335|2371069|P6|NOT COMPLETED|IV Period: Baseline to E0||0
978638|NCT00361335|2371070|P5|NOT COMPLETED|IV Period: Baseline to E0||24
978639|NCT00361335|2371071|P4|NOT COMPLETED|IV Period: Baseline to E0||27
978640|NCT00361335|2371072|P3|NOT COMPLETED|IV Period: Baseline to E0||21
978641|NCT00361335|2371073|P2|NOT COMPLETED|IV Period: Baseline to E0||29
978642|NCT00361335|2371074|P1|NOT COMPLETED|IV Period: Baseline to E0||20
978643|NCT00361335|2371068|P7|COMPLETED|IV Period: Baseline to E0||0
978644|NCT00361335|2371069|P6|COMPLETED|IV Period: Baseline to E0||0
978645|NCT00361335|2371070|P5|COMPLETED|IV Period: Baseline to E0||105
978646|NCT00361335|2371071|P4|COMPLETED|IV Period: Baseline to E0||102
978647|NCT00361335|2371072|P3|COMPLETED|IV Period: Baseline to E0||107
978648|NCT00361335|2371073|P2|COMPLETED|IV Period: Baseline to E0||99
978649|NCT00361335|2371074|P1|COMPLETED|IV Period: Baseline to E0||109
978650|NCT00361335|2371068|P7|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
978651|NCT00361335|2371069|P6|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
978652|NCT00361335|2371070|P5|STARTED|IV Period: Baseline to E0||129
978653|NCT00361335|2371071|P4|STARTED|IV Period: Baseline to E0||129
978654|NCT00361335|2371072|P3|STARTED|IV Period: Baseline to E0||128
978655|NCT00361335|2371073|P2|STARTED|IV Period: Baseline to E0||128
978656|NCT00361335|2371074|P1|STARTED|IV Period: Baseline to E0||129
978657|NCT00361374|2371121|P3|NOT COMPLETED|Overall Study||12
978658|NCT00361374|2371122|P2|NOT COMPLETED|Overall Study||15
978659|NCT00361374|2371123|P1|NOT COMPLETED|Overall Study||15
978660|NCT00361374|2371121|P3|COMPLETED|Overall Study||53
978661|NCT00361374|2371122|P2|COMPLETED|Overall Study||50
978662|NCT00361374|2371123|P1|COMPLETED|Overall Study||51
978663|NCT00361374|2371121|P3|STARTED|Overall Study||65
978664|NCT00361374|2371122|P2|STARTED|Overall Study||65
978665|NCT00361374|2371123|P1|STARTED|Overall Study||66
978666|NCT00361439|2371133|P2|NOT COMPLETED|Overall Study||0
978667|NCT00361439|2371134|P1|NOT COMPLETED|Overall Study||0
978668|NCT00361439|2371133|P2|COMPLETED|Overall Study||9
978669|NCT00361439|2371134|P1|COMPLETED|Overall Study||8
978670|NCT00361439|2371133|P2|STARTED|Overall Study||9
978671|NCT00361439|2371134|P1|STARTED|Overall Study||8
978672|NCT00361504|2371148|P2|NOT COMPLETED|Overall Study||145
978673|NCT00361504|2371149|P1|NOT COMPLETED|Overall Study||481
978674|NCT00361504|2371148|P2|COMPLETED|Overall Study||78
978675|NCT00361504|2371149|P1|COMPLETED|Overall Study||413
978676|NCT00361504|2371148|P2|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|223
978677|NCT00361504|2371149|P1|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|894
978678|NCT00363415|2371159|P2|NOT COMPLETED|Overall Study||249
978679|NCT00363415|2371160|P1|NOT COMPLETED|Overall Study||361
978680|NCT00363415|2371159|P2|COMPLETED|Overall Study||206
978681|NCT00363415|2371160|P1|COMPLETED|Overall Study||92
978682|NCT00363415|2371159|P2|Received at Least One Dose of Study Drug|Overall Study||447
978683|NCT00363415|2371160|P1|Received at Least One Dose of Study Drug|Overall Study||433
978684|NCT00363415|2371159|P2|STARTED|Overall Study||455
978685|NCT00363415|2371160|P1|STARTED|Overall Study||453
978686|NCT00363467|2371176|P1|NOT COMPLETED|Overall Study||1
978687|NCT00363467|2371176|P1|COMPLETED|Overall Study||2
978688|NCT00363467|2371176|P1|STARTED|Overall Study||3
978689|NCT00363545|2371186|P2|NOT COMPLETED|Overall Study||57
978690|NCT00363545|2371187|P1|NOT COMPLETED|Overall Study||44
978691|NCT00363545|2371186|P2|COMPLETED|Overall Study||581
978692|NCT00363545|2371187|P1|COMPLETED|Overall Study||592
978693|NCT00363545|2371186|P2|STARTED|Overall Study||638
978694|NCT00363545|2371187|P1|STARTED|Overall Study||636
978695|NCT00363675|2371205|P1|NOT COMPLETED|Overall Study||0
978696|NCT00363675|2371205|P1|COMPLETED|Overall Study||3
978697|NCT00363675|2371205|P1|Completed Testing|Overall Study||3
978698|NCT00363675|2371205|P1|STARTED|Overall Study||3
978699|NCT00363779|2371212|P1|NOT COMPLETED|Overall Study||0
978700|NCT00363779|2371212|P1|COMPLETED|Overall Study||5
978701|NCT00363779|2371212|P1|STARTED|Overall Study||5
978702|NCT00363805|2371220|P3|NOT COMPLETED|Overall Study||3
978703|NCT00363805|2371221|P2|NOT COMPLETED|Overall Study||6
978704|NCT00363805|2371222|P1|NOT COMPLETED|Overall Study||4
978705|NCT00363805|2371220|P3|COMPLETED|Overall Study||70
978706|NCT00363805|2371221|P2|COMPLETED|Overall Study||57
978707|NCT00363805|2371222|P1|COMPLETED|Overall Study||38
978708|NCT00363805|2371220|P3|STARTED|Overall Study||73
978709|NCT00363805|2371221|P2|STARTED|Overall Study||63
978710|NCT00363805|2371222|P1|STARTED|Overall Study||42
978711|NCT00363883|2371233|P1|NOT COMPLETED|Overall Study||0
978712|NCT00363883|2371233|P1|COMPLETED|Overall Study||14
978713|NCT00363883|2371233|P1|STARTED|Overall Study||14
978714|NCT00363896|2371241|P2|NOT COMPLETED|Overall Study||47
978715|NCT00363896|2371242|P1|NOT COMPLETED|Overall Study||89
978716|NCT00363896|2371241|P2|COMPLETED|Overall Study||169
978717|NCT00363896|2371242|P1|COMPLETED|Overall Study||538
978718|NCT00363896|2371241|P2|STARTED|Overall Study||216
978719|NCT00363896|2371242|P1|STARTED|Overall Study||627
978720|NCT00364013|2371256|P2|NOT COMPLETED|Overall Study||95
978721|NCT00364013|2371257|P1|NOT COMPLETED|Overall Study||101
978722|NCT00364013|2371256|P2|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|495
978723|NCT00364013|2371257|P1|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|492
978724|NCT00364013|2371256|P2|Received Study Drug|Overall Study||583
978725|NCT00364013|2371257|P1|Received Study Drug|Overall Study|One participant randomized to this group did not receive any panitumumab|586
978726|NCT00364013|2371256|P2|STARTED|Overall Study||590
978727|NCT00364013|2371257|P1|STARTED|Overall Study||593
978728|NCT00364130|2371285|P2|NOT COMPLETED|Post Intervention Follow-up Period||11
978729|NCT00364130|2371286|P1|NOT COMPLETED|Post Intervention Follow-up Period||5
978730|NCT00364130|2371285|P2|COMPLETED|Post Intervention Follow-up Period||50
978731|NCT00364130|2371286|P1|COMPLETED|Post Intervention Follow-up Period||55
978732|NCT00364130|2371285|P2|STARTED|Post Intervention Follow-up Period||61
978733|NCT00364130|2371286|P1|STARTED|Post Intervention Follow-up Period||60
978734|NCT00364130|2371285|P2|NOT COMPLETED|Intervention Period||8
978735|NCT00364130|2371286|P1|NOT COMPLETED|Intervention Period||9
978736|NCT00364130|2371285|P2|COMPLETED|Intervention Period||61
978737|NCT00364130|2371286|P1|COMPLETED|Intervention Period||60
978738|NCT00364130|2371285|P2|STARTED|Intervention Period||69
978739|NCT00364130|2371286|P1|STARTED|Intervention Period||69
978740|NCT00364156|2371308|P2|NOT COMPLETED|Overall Study||81
978741|NCT00364156|2371309|P1|NOT COMPLETED|Overall Study||79
978742|NCT00364156|2371308|P2|COMPLETED|Overall Study||205
978743|NCT00364156|2371309|P1|COMPLETED|Overall Study||203
978744|NCT00364156|2371308|P2|STARTED|Overall Study||286
978745|NCT00364156|2371309|P1|STARTED|Overall Study||282
978746|NCT00364182|2371318|P3|NOT COMPLETED|Fourth Intervention||0
978747|NCT00364182|2371319|P2|NOT COMPLETED|Fourth Intervention||0
978748|NCT00364182|2371320|P1|NOT COMPLETED|Fourth Intervention||0
978749|NCT00364182|2371318|P3|COMPLETED|Fourth Intervention||22
978750|NCT00364182|2371319|P2|COMPLETED|Fourth Intervention||19
978751|NCT00364182|2371320|P1|COMPLETED|Fourth Intervention||0
978752|NCT00364182|2371318|P3|STARTED|Fourth Intervention||22
978753|NCT00364182|2371319|P2|STARTED|Fourth Intervention||19
978754|NCT00364182|2371320|P1|STARTED|Fourth Intervention||0
978755|NCT00364182|2371318|P3|NOT COMPLETED|Third Intervention||1
978756|NCT00364182|2371319|P2|NOT COMPLETED|Third Intervention||1
978757|NCT00364182|2371320|P1|NOT COMPLETED|Third Intervention||0
978758|NCT00364182|2371318|P3|COMPLETED|Third Intervention||22
978759|NCT00364182|2371319|P2|COMPLETED|Third Intervention||19
978760|NCT00364182|2371320|P1|COMPLETED|Third Intervention||0
978761|NCT00364182|2371318|P3|STARTED|Third Intervention||23
978762|NCT00364182|2371319|P2|STARTED|Third Intervention||20
978763|NCT00364182|2371320|P1|STARTED|Third Intervention||0
978764|NCT00364182|2371318|P3|NOT COMPLETED|Second Intervention||2
978765|NCT00364182|2371319|P2|NOT COMPLETED|Second Intervention||2
978766|NCT00364182|2371320|P1|NOT COMPLETED|Second Intervention||0
978767|NCT00364182|2371318|P3|COMPLETED|Second Intervention||23
978768|NCT00364182|2371319|P2|COMPLETED|Second Intervention||20
978769|NCT00364182|2371320|P1|COMPLETED|Second Intervention||0
978770|NCT00364182|2371318|P3|Randomized|Second Intervention||25
978771|NCT00364182|2371319|P2|Randomized|Second Intervention||22
978772|NCT00364182|2371320|P1|Randomized|Second Intervention||0
978773|NCT00364182|2371318|P3|STARTED|Second Intervention||25
978774|NCT00364182|2371319|P2|STARTED|Second Intervention||22
978775|NCT00364182|2371320|P1|STARTED|Second Intervention||0
978776|NCT00364182|2371318|P3|NOT COMPLETED|First Intervention||0
978777|NCT00364182|2371319|P2|NOT COMPLETED|First Intervention||0
978778|NCT00364182|2371320|P1|NOT COMPLETED|First Intervention||3
978779|NCT00364182|2371318|P3|COMPLETED|First Intervention||25
978780|NCT00364182|2371319|P2|COMPLETED|First Intervention||22
978781|NCT00364182|2371320|P1|COMPLETED|First Intervention||0
978782|NCT00364182|2371318|P3|STARTED|First Intervention||25
978783|NCT00364182|2371319|P2|STARTED|First Intervention||22
978784|NCT00364182|2371320|P1|STARTED|First Intervention||3
978785|NCT00364286|2371352|P1|NOT COMPLETED|Overall Study||0
978786|NCT00364286|2371352|P1|COMPLETED|Overall Study||17
978787|NCT00364286|2371352|P1|STARTED|Overall Study||17
978788|NCT00364351|2371358|P2|NOT COMPLETED|Overall Study||583
978789|NCT00364351|2371359|P1|NOT COMPLETED|Overall Study||592
978790|NCT00364351|2371358|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|34
978791|NCT00364351|2371359|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|31
978792|NCT00364351|2371358|P2|STARTED|Overall Study|randomised patients|617
978793|NCT00364351|2371359|P1|STARTED|Overall Study|randomised patients|623
978794|NCT00364377|2371379|P2|NOT COMPLETED|Overall Study||0
978795|NCT00364377|2371380|P1|NOT COMPLETED|Overall Study||0
978796|NCT00364377|2371379|P2|COMPLETED|Overall Study||11
978797|NCT00364377|2371380|P1|COMPLETED|Overall Study||11
978798|NCT00364377|2371379|P2|STARTED|Overall Study||11
978799|NCT00364377|2371380|P1|STARTED|Overall Study||11
978800|NCT00364533|2371391|P5|NOT COMPLETED|Overall Study||51
978801|NCT00364533|2371392|P4|NOT COMPLETED|Overall Study||31
978802|NCT00364533|2371393|P3|NOT COMPLETED|Overall Study||45
978803|NCT00364533|2371394|P2|NOT COMPLETED|Overall Study||40
978804|NCT00364533|2371395|P1|NOT COMPLETED|Overall Study||42
978805|NCT00364533|2371391|P5|COMPLETED|Overall Study||24
978806|NCT00364533|2371392|P4|COMPLETED|Overall Study||36
978807|NCT00364533|2371393|P3|COMPLETED|Overall Study||30
978808|NCT00364533|2371394|P2|COMPLETED|Overall Study||31
978809|NCT00364533|2371395|P1|COMPLETED|Overall Study||35
978810|NCT00364533|2371391|P5|STARTED|Overall Study||75
978811|NCT00364533|2371392|P4|STARTED|Overall Study||67
978812|NCT00364533|2371393|P3|STARTED|Overall Study||75
978813|NCT00364533|2371394|P2|STARTED|Overall Study||71
978814|NCT00364533|2371395|P1|STARTED|Overall Study||77
978815|NCT00364611|2371419|P2|NOT COMPLETED|Overall Study||21
978816|NCT00364611|2371420|P1|NOT COMPLETED|Overall Study||51
978817|NCT00364611|2371419|P2|COMPLETED|Overall Study||0
978818|NCT00364611|2371420|P1|COMPLETED|Overall Study|Ongoing treatment (June 2011-initial analysis). Continued treatment till March 2012 (study closed).|1
978819|NCT00364611|2371419|P2|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|20
978820|NCT00364611|2371420|P1|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|52
978821|NCT00364611|2371419|P2|STARTED|Overall Study||21
978822|NCT00364611|2371420|P1|STARTED|Overall Study||52
978823|NCT00364793|2371442|P4|NOT COMPLETED|Overall Study||3
978824|NCT00364793|2371443|P3|NOT COMPLETED|Overall Study||4
978825|NCT00364793|2371444|P2|NOT COMPLETED|Overall Study||5
978826|NCT00364793|2371445|P1|NOT COMPLETED|Overall Study||8
978827|NCT00364793|2371442|P4|COMPLETED|Overall Study||5
978828|NCT00364793|2371443|P3|COMPLETED|Overall Study||0
978829|NCT00364793|2371444|P2|COMPLETED|Overall Study||5
978830|NCT00364793|2371445|P1|COMPLETED|Overall Study||7
978831|NCT00364793|2371442|P4|STARTED|Overall Study||8
978832|NCT00364793|2371443|P3|STARTED|Overall Study||4
978833|NCT00364793|2371444|P2|STARTED|Overall Study||10
978834|NCT00364793|2371445|P1|STARTED|Overall Study||15
978835|NCT00364819|2371579|P1|NOT COMPLETED|Overall Study||0
978836|NCT00364819|2371579|P1|COMPLETED|Overall Study||6
978837|NCT00364819|2371579|P1|STARTED|Overall Study||6
978838|NCT00364832|2371596|P12|NOT COMPLETED|Extension Year 2||3
978839|NCT00364832|2371597|P11|NOT COMPLETED|Extension Year 2||5
978840|NCT00364832|2371598|P10|NOT COMPLETED|Extension Year 2||5
978841|NCT00364832|2371599|P9|NOT COMPLETED|Extension Year 2||0
978842|NCT00364832|2371600|P8|NOT COMPLETED|Extension Year 2||0
978843|NCT00364832|2371601|P7|NOT COMPLETED|Extension Year 2||0
978844|NCT00364832|2371602|P6|NOT COMPLETED|Extension Year 2||0
978845|NCT00364832|2371603|P5|NOT COMPLETED|Extension Year 2||0
978846|NCT00364832|2371604|P4|NOT COMPLETED|Extension Year 2||0
978847|NCT00364832|2371605|P3|NOT COMPLETED|Extension Year 2||0
978848|NCT00364832|2371606|P2|NOT COMPLETED|Extension Year 2||0
978849|NCT00364832|2371607|P1|NOT COMPLETED|Extension Year 2||0
978850|NCT00364832|2371596|P12|COMPLETED|Extension Year 2||11
978851|NCT00364832|2371597|P11|COMPLETED|Extension Year 2||9
978852|NCT00364832|2371598|P10|COMPLETED|Extension Year 2||9
978853|NCT00364832|2371599|P9|COMPLETED|Extension Year 2||0
978854|NCT00364832|2371600|P8|COMPLETED|Extension Year 2||0
978855|NCT00364832|2371601|P7|COMPLETED|Extension Year 2||0
978856|NCT00364832|2371602|P6|COMPLETED|Extension Year 2||0
978857|NCT00364832|2371603|P5|COMPLETED|Extension Year 2||0
978858|NCT00364832|2371604|P4|COMPLETED|Extension Year 2||0
978859|NCT00364832|2371605|P3|COMPLETED|Extension Year 2||0
978860|NCT00364832|2371606|P2|COMPLETED|Extension Year 2||0
978861|NCT00364832|2371607|P1|COMPLETED|Extension Year 2||0
978862|NCT00364832|2371596|P12|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
978863|NCT00364832|2371597|P11|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
978864|NCT00364832|2371598|P10|STARTED|Extension Year 2||14
978865|NCT00364832|2371599|P9|STARTED|Extension Year 2||0
978866|NCT00364832|2371600|P8|STARTED|Extension Year 2||0
978867|NCT00364832|2371601|P7|STARTED|Extension Year 2||0
978868|NCT00364832|2371602|P6|STARTED|Extension Year 2||0
978869|NCT00364832|2371603|P5|STARTED|Extension Year 2||0
978870|NCT00364832|2371604|P4|STARTED|Extension Year 2||0
978871|NCT00364832|2371605|P3|STARTED|Extension Year 2||0
978872|NCT00364832|2371606|P2|STARTED|Extension Year 2||0
978873|NCT00364832|2371607|P1|STARTED|Extension Year 2||0
978874|NCT00364832|2371596|P12|NOT COMPLETED|Extension Year 1||10
978875|NCT00364832|2371597|P11|NOT COMPLETED|Extension Year 1||2
978876|NCT00364832|2371598|P10|NOT COMPLETED|Extension Year 1||4
978877|NCT00364832|2371599|P9|NOT COMPLETED|Extension Year 1||0
978878|NCT00364832|2371600|P8|NOT COMPLETED|Extension Year 1||0
978879|NCT00364832|2371601|P7|NOT COMPLETED|Extension Year 1||0
978880|NCT00364832|2371602|P6|NOT COMPLETED|Extension Year 1||0
978881|NCT00364832|2371603|P5|NOT COMPLETED|Extension Year 1||0
978882|NCT00364832|2371604|P4|NOT COMPLETED|Extension Year 1||0
978883|NCT00364832|2371605|P3|NOT COMPLETED|Extension Year 1||0
978884|NCT00364832|2371606|P2|NOT COMPLETED|Extension Year 1||0
978885|NCT00364832|2371607|P1|NOT COMPLETED|Extension Year 1||0
978886|NCT00364832|2371596|P12|COMPLETED|Extension Year 1||17
978887|NCT00364832|2371597|P11|COMPLETED|Extension Year 1||15
978888|NCT00364832|2371598|P10|COMPLETED|Extension Year 1||14
978889|NCT00364832|2371599|P9|COMPLETED|Extension Year 1||0
978890|NCT00364832|2371600|P8|COMPLETED|Extension Year 1||0
978891|NCT00364832|2371601|P7|COMPLETED|Extension Year 1||0
978892|NCT00364832|2371602|P6|COMPLETED|Extension Year 1||0
978893|NCT00364832|2371603|P5|COMPLETED|Extension Year 1||0
978894|NCT00364832|2371604|P4|COMPLETED|Extension Year 1||0
978895|NCT00364832|2371605|P3|COMPLETED|Extension Year 1||0
978896|NCT00364832|2371606|P2|COMPLETED|Extension Year 1||0
978897|NCT00364832|2371607|P1|COMPLETED|Extension Year 1||0
978898|NCT00364832|2371596|P12|STARTED|Extension Year 1|Participants (Cohorts C, F, and I) who completed core, entered extension period (entry optional).|27
978899|NCT00364832|2371597|P11|STARTED|Extension Year 1|Participants (Cohorts B, E, and H) who completed core, entered extension period (entry optional).|17
978900|NCT00364832|2371598|P10|STARTED|Extension Year 1|Participants (Cohorts A, D, and G) who completed core, entered extension period (entry optional).|18
978901|NCT00364832|2371599|P9|STARTED|Extension Year 1||0
978902|NCT00364832|2371600|P8|STARTED|Extension Year 1||0
978903|NCT00364832|2371601|P7|STARTED|Extension Year 1||0
978904|NCT00364832|2371602|P6|STARTED|Extension Year 1||0
978905|NCT00364832|2371603|P5|STARTED|Extension Year 1||0
978906|NCT00364832|2371604|P4|STARTED|Extension Year 1||0
978907|NCT00364832|2371605|P3|STARTED|Extension Year 1||0
978908|NCT00364832|2371606|P2|STARTED|Extension Year 1||0
978909|NCT00364832|2371607|P1|STARTED|Extension Year 1||0
978910|NCT00364832|2371596|P12|NOT COMPLETED|Core Period||0
978911|NCT00364832|2371597|P11|NOT COMPLETED|Core Period||0
978912|NCT00364832|2371598|P10|NOT COMPLETED|Core Period||0
978913|NCT00364832|2371599|P9|NOT COMPLETED|Core Period||0
978914|NCT00364832|2371600|P8|NOT COMPLETED|Core Period||1
978915|NCT00364832|2371601|P7|NOT COMPLETED|Core Period||4
978916|NCT00364832|2371602|P6|NOT COMPLETED|Core Period||0
978917|NCT00364832|2371603|P5|NOT COMPLETED|Core Period||0
978918|NCT00364832|2371604|P4|NOT COMPLETED|Core Period||1
978919|NCT00364832|2371605|P3|NOT COMPLETED|Core Period||1
978920|NCT00364832|2371606|P2|NOT COMPLETED|Core Period||2
978921|NCT00364832|2371607|P1|NOT COMPLETED|Core Period||2
978922|NCT00364832|2371596|P12|COMPLETED|Core Period||0
978923|NCT00364832|2371597|P11|COMPLETED|Core Period||0
978924|NCT00364832|2371598|P10|COMPLETED|Core Period||0
978925|NCT00364832|2371599|P9|COMPLETED|Core Period||16
978926|NCT00364832|2371600|P8|COMPLETED|Core Period||14
978927|NCT00364832|2371601|P7|COMPLETED|Core Period||12
978928|NCT00364832|2371602|P6|COMPLETED|Core Period||12
978929|NCT00364832|2371603|P5|COMPLETED|Core Period||16
978930|NCT00364832|2371604|P4|COMPLETED|Core Period||15
978931|NCT00364832|2371605|P3|COMPLETED|Core Period||14
978932|NCT00364832|2371606|P2|COMPLETED|Core Period||13
978933|NCT00364832|2371607|P1|COMPLETED|Core Period||14
978934|NCT00364832|2371596|P12|STARTED|Core Period||0
978935|NCT00364832|2371597|P11|STARTED|Core Period||0
978936|NCT00364832|2371598|P10|STARTED|Core Period||0
978937|NCT00364832|2371599|P9|STARTED|Core Period||16
978938|NCT00364832|2371600|P8|STARTED|Core Period||15
978939|NCT00364832|2371601|P7|STARTED|Core Period||16
978940|NCT00364832|2371602|P6|STARTED|Core Period||12
978941|NCT00364832|2371603|P5|STARTED|Core Period||16
978942|NCT00364832|2371604|P4|STARTED|Core Period||16
978943|NCT00364832|2371605|P3|STARTED|Core Period||15
978944|NCT00364832|2371606|P2|STARTED|Core Period||15
978945|NCT00364832|2371607|P1|STARTED|Core Period||16
978946|NCT00364845|2371662|P2|NOT COMPLETED|Overall Study||11
978947|NCT00364845|2371663|P1|NOT COMPLETED|Overall Study||11
978948|NCT00364845|2371662|P2|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|12
978949|NCT00364845|2371663|P1|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|17
978950|NCT00364845|2371662|P2|STARTED|Overall Study||23
978951|NCT00364845|2371663|P1|STARTED|Overall Study||28
978952|NCT00364858|2371677|P2|NOT COMPLETED|Overall Study||22
978953|NCT00364858|2371678|P1|NOT COMPLETED|Overall Study||7
978954|NCT00364858|2371677|P2|COMPLETED|Overall Study||40
978955|NCT00364858|2371678|P1|COMPLETED|Overall Study||26
978956|NCT00364858|2371677|P2|STARTED|Overall Study||62
978957|NCT00364858|2371678|P1|STARTED|Overall Study||33
978958|NCT00364923|2371691|P1|NOT COMPLETED|Survival Follow-up, After Pralatrexate||24
978959|NCT00364923|2371691|P1|COMPLETED|Survival Follow-up, After Pralatrexate|Pts who completed follow-up either died, were followed for 24 months, or withdrew|83
978960|NCT00364923|2371691|P1|STARTED|Survival Follow-up, After Pralatrexate|Patients (pts) who stop treatment with pralatrexate are followed for survival|107
978961|NCT00364923|2371691|P1|NOT COMPLETED|Treatment With Pralatrexate||4
978962|NCT00364923|2371691|P1|COMPLETED|Treatment With Pralatrexate|Treatment duration not limited. After treatment ends, patients attend survival follow-up visits.|107
978963|NCT00364923|2371691|P1|STARTED|Treatment With Pralatrexate|Received at least one dose of pralatrexate.|111
978964|NCT00364949|2371700|P2|NOT COMPLETED|Overall Study||0
978965|NCT00364949|2371701|P1|NOT COMPLETED|Overall Study||0
978966|NCT00364949|2371700|P2|COMPLETED|Overall Study||39
978967|NCT00364949|2371701|P1|COMPLETED|Overall Study||31
978968|NCT00364949|2371700|P2|STARTED|Overall Study||39
978969|NCT00364949|2371701|P1|STARTED|Overall Study||31
978970|NCT00365053|2371719|P1|NOT COMPLETED|Overall Study||0
978971|NCT00365053|2371719|P1|COMPLETED|Overall Study||13
978972|NCT00365053|2371719|P1|STARTED|Overall Study||13
978973|NCT00365105|2371727|P2|NOT COMPLETED|Overall Study||4
978974|NCT00365105|2371728|P1|NOT COMPLETED|Overall Study||6
978975|NCT00365105|2371727|P2|COMPLETED|Overall Study||128
978976|NCT00365105|2371728|P1|COMPLETED|Overall Study||123
978977|NCT00365105|2371727|P2|STARTED|Overall Study||132
978978|NCT00365105|2371728|P1|STARTED|Overall Study||129
978979|NCT00365144|2371734|P1|NOT COMPLETED|Overall Study||0
978980|NCT00365144|2371734|P1|COMPLETED|Overall Study||36
978981|NCT00365144|2371734|P1|STARTED|Overall Study||36
978982|NCT00365209|2371740|P1|NOT COMPLETED|Stage 2: Receiving 4g Curcumin||2
978983|NCT00365209|2371740|P1|COMPLETED|Stage 2: Receiving 4g Curcumin||19
978984|NCT00365209|2371740|P1|STARTED|Stage 2: Receiving 4g Curcumin||21
978985|NCT00365209|2371740|P1|NOT COMPLETED|Stage 1: Receiving 2g Curcumin||2
978986|NCT00365209|2371740|P1|COMPLETED|Stage 1: Receiving 2g Curcumin||21
978987|NCT00365209|2371740|P1|STARTED|Stage 1: Receiving 2g Curcumin||23
978988|NCT00365261|2371771|P2|NOT COMPLETED|Overall Study||3
978989|NCT00365261|2371772|P1|NOT COMPLETED|Overall Study||3
978990|NCT00365261|2371771|P2|COMPLETED|Overall Study||19
978991|NCT00365261|2371772|P1|COMPLETED|Overall Study||20
978992|NCT00365261|2371771|P2|STARTED|Overall Study||22
978993|NCT00365261|2371772|P1|STARTED|Overall Study||23
978994|NCT00365274|2371782|P1|NOT COMPLETED|Overall Study||0
978995|NCT00365274|2371782|P1|COMPLETED|Overall Study||6
978996|NCT00365274|2371782|P1|STARTED|Overall Study||6
978997|NCT00365300|2371788|P2|NOT COMPLETED|Double-blind Phase||9
978998|NCT00365300|2371789|P1|NOT COMPLETED|Double-blind Phase||11
978999|NCT00365300|2371788|P2|COMPLETED|Double-blind Phase||45
979000|NCT00365300|2371789|P1|COMPLETED|Double-blind Phase||43
979001|NCT00365300|2371788|P2|STARTED|Double-blind Phase||54
979002|NCT00365300|2371789|P1|STARTED|Double-blind Phase||54
979003|NCT00365300|2371788|P2|NOT COMPLETED|Open-label Phase||0
979004|NCT00365300|2371789|P1|NOT COMPLETED|Open-label Phase||22
979005|NCT00365300|2371788|P2|COMPLETED|Open-label Phase||0
979006|NCT00365300|2371789|P1|COMPLETED|Open-label Phase||107
979007|NCT00365300|2371788|P2|STARTED|Open-label Phase||0
979008|NCT00365300|2371789|P1|STARTED|Open-label Phase||129
979009|NCT00365352|2371801|P3|NOT COMPLETED|Overall Study||15
979010|NCT00365352|2371802|P2|NOT COMPLETED|Overall Study||11
979011|NCT00365352|2371803|P1|NOT COMPLETED|Overall Study||20
979012|NCT00365352|2371801|P3|COMPLETED|Overall Study||98
979013|NCT00365352|2371802|P2|COMPLETED|Overall Study||104
979014|NCT00365352|2371803|P1|COMPLETED|Overall Study||77
979015|NCT00365352|2371801|P3|Modified Intent-to-Treat Population|Overall Study||111
979016|NCT00365352|2371802|P2|Modified Intent-to-Treat Population|Overall Study||114
979017|NCT00365352|2371803|P1|Modified Intent-to-Treat Population|Overall Study||96
979018|NCT00365352|2371801|P3|Safety Population|Overall Study||111
979019|NCT00365352|2371802|P2|Safety Population|Overall Study||115
979020|NCT00365352|2371803|P1|Safety Population|Overall Study||96
979021|NCT00365352|2371801|P3|STARTED|Overall Study||113
979022|NCT00365352|2371802|P2|STARTED|Overall Study||115
979023|NCT00365352|2371803|P1|STARTED|Overall Study||97
979024|NCT00365365|2371888|P3|NOT COMPLETED|Overall Study||15
979025|NCT00365365|2371889|P2|NOT COMPLETED|Overall Study||36
979026|NCT00365365|2371890|P1|NOT COMPLETED|Overall Study||34
979027|NCT00365365|2371888|P3|COMPLETED|Overall Study||44
979028|NCT00365365|2371889|P2|COMPLETED|Overall Study||41
979029|NCT00365365|2371890|P1|COMPLETED|Overall Study||44
979030|NCT00365365|2371888|P3|COMPLETED TREATMENT|Overall Study||45
979031|NCT00365365|2371889|P2|COMPLETED TREATMENT|Overall Study||36
979032|NCT00365365|2371890|P1|COMPLETED TREATMENT|Overall Study||38
979033|NCT00365365|2371888|P3|TREATED (SAFETY POPULATION)|Overall Study||59
979034|NCT00365365|2371889|P2|TREATED (SAFETY POPULATION)|Overall Study||75
979035|NCT00365365|2371890|P1|TREATED (SAFETY POPULATION)|Overall Study||78
979036|NCT00365365|2371888|P3|STARTED|Overall Study||59
979037|NCT00365365|2371889|P2|STARTED|Overall Study||77
979038|NCT00365365|2371890|P1|STARTED|Overall Study||78
979039|NCT00365378|2371906|P3|NOT COMPLETED|Extension||197
979040|NCT00365378|2371907|P2|NOT COMPLETED|Extension||0
979041|NCT00365378|2371908|P1|NOT COMPLETED|Extension||0
979042|NCT00365378|2371906|P3|COMPLETED|Extension||203
979043|NCT00365378|2371907|P2|COMPLETED|Extension||0
979044|NCT00365378|2371908|P1|COMPLETED|Extension||0
979045|NCT00365378|2371906|P3|STARTED|Extension||400
979046|NCT00365378|2371907|P2|STARTED|Extension||0
979047|NCT00365378|2371908|P1|STARTED|Extension||0
979048|NCT00365378|2371906|P3|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||0
979049|NCT00365378|2371907|P2|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||202
979050|NCT00365378|2371908|P1|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||158
979051|NCT00365378|2371906|P3|COMPLETED|Follow-up (Month 7 Though Month 48)||0
979052|NCT00365378|2371907|P2|COMPLETED|Follow-up (Month 7 Though Month 48)||836
979053|NCT00365378|2371908|P1|COMPLETED|Follow-up (Month 7 Though Month 48)||835
979054|NCT00365378|2371906|P3|STARTED|Follow-up (Month 7 Though Month 48)||0
979055|NCT00365378|2371907|P2|STARTED|Follow-up (Month 7 Though Month 48)||1038
979056|NCT00365378|2371908|P1|STARTED|Follow-up (Month 7 Though Month 48)||993
979057|NCT00365378|2371906|P3|NOT COMPLETED|Vaccination (Day 1 to Month 7)||0
979058|NCT00365378|2371907|P2|NOT COMPLETED|Vaccination (Day 1 to Month 7)||167
979059|NCT00365378|2371908|P1|NOT COMPLETED|Vaccination (Day 1 to Month 7)||211
979060|NCT00365378|2371906|P3|COMPLETED|Vaccination (Day 1 to Month 7)||0
979061|NCT00365378|2371907|P2|COMPLETED|Vaccination (Day 1 to Month 7)||1038
979062|NCT00365378|2371908|P1|COMPLETED|Vaccination (Day 1 to Month 7)||993
979063|NCT00365378|2371906|P3|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||0
979064|NCT00365378|2371907|P2|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1198
979065|NCT00365378|2371908|P1|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1193
979066|NCT00365378|2371906|P3|STARTED|Vaccination (Day 1 to Month 7)||0
979067|NCT00365378|2371907|P2|STARTED|Vaccination (Day 1 to Month 7)||1205
979068|NCT00365378|2371908|P1|STARTED|Vaccination (Day 1 to Month 7)||1204
979069|NCT00365391|2371919|P1|NOT COMPLETED|Overall Study||0
979070|NCT00365391|2371919|P1|COMPLETED|Overall Study||27
979071|NCT00365391|2371919|P1|STARTED|Overall Study||27
979072|NCT00365417|2371927|P1|NOT COMPLETED|Overall Study||0
979073|NCT00365417|2371927|P1|COMPLETED|Overall Study||45
979074|NCT00365417|2371927|P1|STARTED|Overall Study||45
979075|NCT00365456|2371933|P2|NOT COMPLETED|Trial Period III (12 Months)||5
979076|NCT00365456|2371934|P1|NOT COMPLETED|Trial Period III (12 Months)||18
979077|NCT00365456|2371933|P2|COMPLETED|Trial Period III (12 Months)||127
979078|NCT00365456|2371934|P1|COMPLETED|Trial Period III (12 Months)||118
979079|NCT00365456|2371933|P2|STARTED|Trial Period III (12 Months)||132
979080|NCT00365456|2371934|P1|STARTED|Trial Period III (12 Months)||136
979081|NCT00365456|2371933|P2|NOT COMPLETED|Trial Period II (12 Months)||14
979082|NCT00365456|2371934|P1|NOT COMPLETED|Trial Period II (12 Months)||0
979083|NCT00365456|2371933|P2|COMPLETED|Trial Period II (12 Months)||268
979084|NCT00365456|2371934|P1|COMPLETED|Trial Period II (12 Months)||0
979085|NCT00365456|2371933|P2|STARTED|Trial Period II (12 Months)||282
979086|NCT00365456|2371934|P1|STARTED|Trial Period II (12 Months)||0
979087|NCT00365456|2371933|P2|NOT COMPLETED|Trial Period I (12 Months)||0
979088|NCT00365456|2371934|P1|NOT COMPLETED|Trial Period I (12 Months)||125
979089|NCT00365456|2371933|P2|COMPLETED|Trial Period I (12 Months)||0
979090|NCT00365456|2371934|P1|COMPLETED|Trial Period I (12 Months)||282
979091|NCT00365456|2371933|P2|STARTED|Trial Period I (12 Months)||0
979092|NCT00365456|2371934|P1|STARTED|Trial Period I (12 Months)||407
979093|NCT00365508|2371942|P2|NOT COMPLETED|Overall Study||154
979094|NCT00365508|2371943|P1|NOT COMPLETED|Overall Study||139
979095|NCT00365508|2371942|P2|COMPLETED|Overall Study||167
979096|NCT00365508|2371943|P1|COMPLETED|Overall Study||182
979097|NCT00365508|2371942|P2|STARTED|Overall Study||321
979098|NCT00365508|2371943|P1|STARTED|Overall Study||321
979099|NCT00365547|2371951|P1|NOT COMPLETED|Overall Study||3
979100|NCT00365547|2371951|P1|COMPLETED|Overall Study||43
979101|NCT00365547|2371951|P1|STARTED|Overall Study||46
979102|NCT00365599|2371959|P1|NOT COMPLETED|Overall Study||0
979103|NCT00365599|2371959|P1|COMPLETED|Overall Study||43
979104|NCT00365599|2371959|P1|STARTED|Overall Study||43
979105|NCT00365716|2371970|P7|NOT COMPLETED|Extension 2||10
979106|NCT00365716|2371971|P6|NOT COMPLETED|Extension 2||0
979107|NCT00365716|2371972|P5|NOT COMPLETED|Extension 2||0
979108|NCT00365716|2371973|P4|NOT COMPLETED|Extension 2||0
979109|NCT00365716|2371974|P3|NOT COMPLETED|Extension 2||0
979110|NCT00365716|2371975|P2|NOT COMPLETED|Extension 2||0
979111|NCT00365716|2371976|P1|NOT COMPLETED|Extension 2||0
979112|NCT00365716|2371970|P7|COMPLETED|Extension 2||7
979113|NCT00365716|2371971|P6|COMPLETED|Extension 2||0
979114|NCT00365716|2371972|P5|COMPLETED|Extension 2||0
979115|NCT00365716|2371973|P4|COMPLETED|Extension 2||0
979116|NCT00365716|2371974|P3|COMPLETED|Extension 2||0
979117|NCT00365716|2371975|P2|COMPLETED|Extension 2||0
979118|NCT00365716|2371976|P1|COMPLETED|Extension 2||0
979119|NCT00365716|2371970|P7|STARTED|Extension 2|17 Participants continued into Extension 2 from Extension 1|17
979120|NCT00365716|2371971|P6|STARTED|Extension 2||0
979121|NCT00365716|2371972|P5|STARTED|Extension 2||0
979122|NCT00365716|2371973|P4|STARTED|Extension 2||0
979123|NCT00365716|2371974|P3|STARTED|Extension 2||0
979124|NCT00365716|2371975|P2|STARTED|Extension 2||0
979125|NCT00365716|2371976|P1|STARTED|Extension 2||0
979126|NCT00365716|2371970|P7|NOT COMPLETED|Extension 1||0
979127|NCT00365716|2371971|P6|NOT COMPLETED|Extension 1||22
979128|NCT00365716|2371972|P5|NOT COMPLETED|Extension 1||0
979129|NCT00365716|2371973|P4|NOT COMPLETED|Extension 1||0
979130|NCT00365716|2371974|P3|NOT COMPLETED|Extension 1||0
979131|NCT00365716|2371975|P2|NOT COMPLETED|Extension 1||0
979132|NCT00365716|2371976|P1|NOT COMPLETED|Extension 1||0
979133|NCT00365716|2371970|P7|COMPLETED|Extension 1||0
979134|NCT00365716|2371971|P6|COMPLETED|Extension 1||219
979135|NCT00365716|2371972|P5|COMPLETED|Extension 1||0
979136|NCT00365716|2371973|P4|COMPLETED|Extension 1||0
979137|NCT00365716|2371974|P3|COMPLETED|Extension 1||0
979138|NCT00365716|2371975|P2|COMPLETED|Extension 1||0
979139|NCT00365716|2371976|P1|COMPLETED|Extension 1||0
979140|NCT00365716|2371970|P7|STARTED|Extension 1||0
979141|NCT00365716|2371971|P6|STARTED|Extension 1||241
979142|NCT00365716|2371972|P5|STARTED|Extension 1||0
979143|NCT00365716|2371973|P4|STARTED|Extension 1||0
979144|NCT00365716|2371974|P3|STARTED|Extension 1||0
979145|NCT00365716|2371975|P2|STARTED|Extension 1||0
979146|NCT00365716|2371976|P1|STARTED|Extension 1||0
979147|NCT00365716|2371970|P7|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
979148|NCT00365716|2371971|P6|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
979149|NCT00365716|2371972|P5|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||82
979150|NCT00365716|2371973|P4|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||79
979151|NCT00365716|2371974|P3|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||20
979152|NCT00365716|2371975|P2|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||15
979153|NCT00365716|2371976|P1|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||132
979154|NCT00365716|2371970|P7|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
979155|NCT00365716|2371971|P6|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
979156|NCT00365716|2371972|P5|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
979157|NCT00365716|2371973|P4|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
979158|NCT00365716|2371974|P3|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||251
979159|NCT00365716|2371975|P2|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||245
979160|NCT00365716|2371976|P1|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||137
979161|NCT00365716|2371970|P7|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
979162|NCT00365716|2371971|P6|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
979163|NCT00365716|2371972|P5|STARTED|Long Term Follow-up (Month 7 toMonth 36)||139
979164|NCT00365716|2371973|P4|STARTED|Long Term Follow-up (Month 7 toMonth 36)||136
979165|NCT00365716|2371974|P3|STARTED|Long Term Follow-up (Month 7 toMonth 36)||271
979166|NCT00365716|2371975|P2|STARTED|Long Term Follow-up (Month 7 toMonth 36)||260
979167|NCT00365716|2371976|P1|STARTED|Long Term Follow-up (Month 7 toMonth 36)||269
979168|NCT00365716|2371970|P7|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
979169|NCT00365716|2371971|P6|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
979170|NCT00365716|2371972|P5|NOT COMPLETED|Base Study (Day 1 to Month 7)||7
979171|NCT00365716|2371973|P4|NOT COMPLETED|Base Study (Day 1 to Month 7)||10
979172|NCT00365716|2371974|P3|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
979173|NCT00365716|2371975|P2|NOT COMPLETED|Base Study (Day 1 to Month 7)||24
979174|NCT00365716|2371976|P1|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
979175|NCT00365716|2371970|P7|COMPLETED|Base Study (Day 1 to Month 7)||0
979176|NCT00365716|2371971|P6|COMPLETED|Base Study (Day 1 to Month 7)||0
979177|NCT00365716|2371972|P5|COMPLETED|Base Study (Day 1 to Month 7)||139
979178|NCT00365716|2371973|P4|COMPLETED|Base Study (Day 1 to Month 7)||136
979179|NCT00365716|2371974|P3|COMPLETED|Base Study (Day 1 to Month 7)||271
979180|NCT00365716|2371975|P2|COMPLETED|Base Study (Day 1 to Month 7)||260
979181|NCT00365716|2371976|P1|COMPLETED|Base Study (Day 1 to Month 7)||269
979182|NCT00365716|2371970|P7|STARTED|Base Study (Day 1 to Month 7)||0
979183|NCT00365716|2371971|P6|STARTED|Base Study (Day 1 to Month 7)||0
979184|NCT00365716|2371972|P5|STARTED|Base Study (Day 1 to Month 7)||146
979185|NCT00365716|2371973|P4|STARTED|Base Study (Day 1 to Month 7)||146
979186|NCT00365716|2371974|P3|STARTED|Base Study (Day 1 to Month 7)||292
979187|NCT00365716|2371975|P2|STARTED|Base Study (Day 1 to Month 7)||284
979188|NCT00365716|2371976|P1|STARTED|Base Study (Day 1 to Month 7)||290
979189|NCT00365768|2371993|P2|NOT COMPLETED|Overall Study||0
979190|NCT00365768|2371994|P1|NOT COMPLETED|Overall Study||0
979191|NCT00365768|2371993|P2|COMPLETED|Overall Study||25
979192|NCT00365768|2371994|P1|COMPLETED|Overall Study||24
979193|NCT00365768|2371993|P2|STARTED|Overall Study||25
979194|NCT00365768|2371994|P1|STARTED|Overall Study||24
979195|NCT00365846|2372002|P1|NOT COMPLETED|Overall Study||1
979196|NCT00365846|2372002|P1|COMPLETED|Overall Study||28
979197|NCT00365846|2372002|P1|STARTED|Overall Study||29
979198|NCT00365859|2372014|P4|NOT COMPLETED|Overall Study||131
979199|NCT00365859|2372015|P3|NOT COMPLETED|Overall Study||67
979200|NCT00365859|2372016|P2|NOT COMPLETED|Overall Study||33
979201|NCT00365859|2372017|P1|NOT COMPLETED|Overall Study||31
979202|NCT00365859|2372014|P4|COMPLETED|Overall Study||199
979203|NCT00365859|2372015|P3|COMPLETED|Overall Study||107
979204|NCT00365859|2372016|P2|COMPLETED|Overall Study||37
979205|NCT00365859|2372017|P1|COMPLETED|Overall Study||55
979206|NCT00365859|2372014|P4|Efficacy Population|Overall Study||322
979207|NCT00365859|2372015|P3|Efficacy Population|Overall Study|3 lost to follow-up, 1 not included due to mild increased appetite, 1 to family emergency (total=5)|169
979208|NCT00365859|2372016|P2|Efficacy Population|Overall Study|1 not included due to increased alanine aminotransferase (ALT) prior to treatment with aripiprazole|69
979209|NCT00365859|2372017|P1|Efficacy Population|Overall Study|1 patient was lost to follow-up and 1 not included due to moderate sedation (total=2)|84
979210|NCT00365859|2372014|P4|Safety Population|Overall Study||330
979211|NCT00365859|2372015|P3|Safety Population|Overall Study||174
979212|NCT00365859|2372016|P2|Safety Population|Overall Study||70
979213|NCT00365859|2372017|P1|Safety Population|Overall Study||86
979214|NCT00365859|2372014|P4|STARTED|Overall Study||330
979215|NCT00365859|2372015|P3|STARTED|Overall Study||174
979216|NCT00365859|2372016|P2|STARTED|Overall Study||70
979217|NCT00365859|2372017|P1|STARTED|Overall Study||86
979218|NCT00365872|2372109|P3|NOT COMPLETED|Overall Study||0
979219|NCT00365872|2372110|P2|NOT COMPLETED|Overall Study||0
979220|NCT00365872|2372111|P1|NOT COMPLETED|Overall Study||0
979221|NCT00365872|2372109|P3|COMPLETED|Overall Study||6
979222|NCT00365872|2372110|P2|COMPLETED|Overall Study||6
979223|NCT00365872|2372111|P1|COMPLETED|Overall Study||5
979224|NCT00365872|2372109|P3|STARTED|Overall Study||6
979225|NCT00365872|2372110|P2|STARTED|Overall Study||6
979226|NCT00365872|2372111|P1|STARTED|Overall Study||5
979227|NCT00357331|2372123|P2|NOT COMPLETED|Overall Study||0
979228|NCT00357331|2372124|P1|NOT COMPLETED|Overall Study||0
979229|NCT00357331|2372123|P2|COMPLETED|Overall Study||41
979230|NCT00357331|2372124|P1|COMPLETED|Overall Study||42
979231|NCT00357331|2372123|P2|STARTED|Overall Study||41
979232|NCT00357331|2372124|P1|STARTED|Overall Study||42
979233|NCT00357370|2372137|P3|NOT COMPLETED|Cohort 2||2
979234|NCT00357370|2372138|P2|NOT COMPLETED|Cohort 2||7
979235|NCT00357370|2372139|P1|NOT COMPLETED|Cohort 2||2
979236|NCT00357370|2372137|P3|COMPLETED|Cohort 2||22
979237|NCT00357370|2372138|P2|COMPLETED|Cohort 2||16
979238|NCT00357370|2372139|P1|COMPLETED|Cohort 2||22
979239|NCT00357370|2372137|P3|STARTED|Cohort 2||24
979240|NCT00357370|2372138|P2|STARTED|Cohort 2||23
979241|NCT00357370|2372139|P1|STARTED|Cohort 2||24
979242|NCT00357370|2372137|P3|NOT COMPLETED|Cohort 1||0
979243|NCT00357370|2372138|P2|NOT COMPLETED|Cohort 1||0
979244|NCT00357370|2372139|P1|NOT COMPLETED|Cohort 1||0
979245|NCT00357370|2372137|P3|COMPLETED|Cohort 1||0
979246|NCT00357370|2372138|P2|COMPLETED|Cohort 1||0
979247|NCT00357370|2372139|P1|COMPLETED|Cohort 1||4
979248|NCT00357370|2372137|P3|STARTED|Cohort 1||0
979249|NCT00357370|2372138|P2|STARTED|Cohort 1||0
979250|NCT00357370|2372139|P1|STARTED|Cohort 1||4
979251|NCT00357396|2372164|P2|NOT COMPLETED|Overall Study||0
979252|NCT00357396|2372165|P1|NOT COMPLETED|Overall Study||1
979253|NCT00357396|2372164|P2|COMPLETED|Overall Study||4
979254|NCT00357396|2372165|P1|COMPLETED|Overall Study||5
979255|NCT00357396|2372164|P2|STARTED|Overall Study||4
979256|NCT00357396|2372165|P1|STARTED|Overall Study||6
979257|NCT00357500|2372170|P1|NOT COMPLETED|Overall Study||77
979258|NCT00357500|2372170|P1|COMPLETED|Overall Study||24
979259|NCT00357500|2372170|P1|Began Protocol Therapy|Overall Study|4 pts did not start treatment due either to removal of consent or inability to get insurance.|97
979260|NCT00357500|2372170|P1|STARTED|Overall Study||101
979261|NCT00357552|2372177|P1|NOT COMPLETED|Weeks 24 to 104||5
979262|NCT00357552|2372177|P1|COMPLETED|Weeks 24 to 104||117
979263|NCT00357552|2372177|P1|STARTED|Weeks 24 to 104||122
979264|NCT00357552|2372177|P1|NOT COMPLETED|Weeks 0 to 24||1
979265|NCT00357552|2372177|P1|COMPLETED|Weeks 0 to 24|One subject died prior to week 24.|122
979266|NCT00357552|2372177|P1|STARTED|Weeks 0 to 24||123
979267|NCT00357552|2372177|P1|NOT COMPLETED|Screening||84
979268|NCT00357552|2372177|P1|COMPLETED|Screening|The number of participants who completed this period, is the number of participants who enrolled.|123
979269|NCT00357552|2372177|P1|STARTED|Screening|The number of participants who started this period, is the number of participants who screened.|207
979276|NCT00357734|2372246|P1|NOT COMPLETED|Overall Study||4
979277|NCT00357734|2372246|P1|COMPLETED|Overall Study||10
979278|NCT00357734|2372246|P1|Patient Received 500 mg of ZD1839|Overall Study||1
979279|NCT00357734|2372246|P1|Patients Received 250 mg of ZD1839|Overall Study||13
979280|NCT00357734|2372246|P1|STARTED|Overall Study||14
979281|NCT00357760|2372257|P2|NOT COMPLETED|Overall Study||35
979282|NCT00357760|2372258|P1|NOT COMPLETED|Overall Study||59
979283|NCT00357760|2372257|P2|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
979284|NCT00357760|2372258|P1|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
979285|NCT00357760|2372257|P2|Patients Who Undergo Dose Escalation|Overall Study||16
979286|NCT00357760|2372258|P1|Patients Who Undergo Dose Escalation|Overall Study|Only patients who progressed on the low dose (Arm B) had the opportunity to undergo dose escalation.|0
979287|NCT00357760|2372257|P2|Eligible and Treated Patients|Overall Study||32
979288|NCT00357760|2372258|P1|Eligible and Treated Patients|Overall Study||57
979289|NCT00357760|2372257|P2|Patients Who Started Treatment|Overall Study||34
979290|NCT00357760|2372258|P1|Patients Who Started Treatment|Overall Study||57
979291|NCT00357760|2372257|P2|STARTED|Overall Study||35
979292|NCT00357760|2372258|P1|STARTED|Overall Study||59
979293|NCT00357877|2372270|P2|NOT COMPLETED|Overall Study||30
979294|NCT00357877|2372271|P1|NOT COMPLETED|Overall Study||26
979295|NCT00357877|2372270|P2|COMPLETED|Overall Study||460
979296|NCT00357877|2372271|P1|COMPLETED|Overall Study||467
979297|NCT00357877|2372270|P2|STARTED|Overall Study||490
979298|NCT00357877|2372271|P1|STARTED|Overall Study||493
979299|NCT00357903|2372285|P2|NOT COMPLETED|Overall Study||43
979300|NCT00357903|2372286|P1|NOT COMPLETED|Overall Study||363
979301|NCT00357903|2372285|P2|COMPLETED|Overall Study||15
979302|NCT00357903|2372286|P1|COMPLETED|Overall Study||218
979303|NCT00357903|2372285|P2|STARTED|Overall Study||58
979304|NCT00357903|2372286|P1|STARTED|Overall Study||581
979305|NCT00357955|2372326|P2|NOT COMPLETED|Overall Study||3
979306|NCT00357955|2372327|P1|NOT COMPLETED|Overall Study||6
979307|NCT00357955|2372326|P2|COMPLETED|Overall Study||51
979308|NCT00357955|2372327|P1|COMPLETED|Overall Study||58
979309|NCT00357955|2372326|P2|STARTED|Overall Study||54
979310|NCT00357955|2372327|P1|STARTED|Overall Study||64
979311|NCT00357968|2372335|P2|NOT COMPLETED|Crossover Maintenance Dose Phase||0
979312|NCT00357968|2372336|P1|NOT COMPLETED|Crossover Maintenance Dose Phase||0
979313|NCT00357968|2372335|P2|COMPLETED|Crossover Maintenance Dose Phase||55
979314|NCT00357968|2372336|P1|COMPLETED|Crossover Maintenance Dose Phase||54
979315|NCT00357968|2372335|P2|STARTED|Crossover Maintenance Dose Phase||55
979316|NCT00357968|2372336|P1|STARTED|Crossover Maintenance Dose Phase|1 subject discontinued study drug-did not take clopidogrel during the 2nd phase but completed study|54
979317|NCT00357968|2372335|P2|NOT COMPLETED|First Maintenance Dose Phase||44
979318|NCT00357968|2372336|P1|NOT COMPLETED|First Maintenance Dose Phase||48
979319|NCT00357968|2372335|P2|COMPLETED|First Maintenance Dose Phase||55
979320|NCT00357968|2372336|P1|COMPLETED|First Maintenance Dose Phase||54
979321|NCT00357968|2372335|P2|Started Maintenance Dose|First Maintenance Dose Phase||55
979322|NCT00357968|2372336|P1|Started Maintenance Dose|First Maintenance Dose Phase||55
979323|NCT00357968|2372335|P2|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||57
979324|NCT00357968|2372336|P1|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||55
979325|NCT00357968|2372335|P2|Received Loading Dose|First Maintenance Dose Phase||99
979326|NCT00357968|2372336|P1|Received Loading Dose|First Maintenance Dose Phase||102
979327|NCT00357968|2372335|P2|STARTED|First Maintenance Dose Phase||99
979328|NCT00357968|2372336|P1|STARTED|First Maintenance Dose Phase||102
979329|NCT00357994|2372380|P2|NOT COMPLETED|Overall Study||3
979330|NCT00357994|2372381|P1|NOT COMPLETED|Overall Study||2
979331|NCT00357994|2372380|P2|COMPLETED|Overall Study||31
979332|NCT00357994|2372381|P1|COMPLETED|Overall Study||35
979333|NCT00357994|2372380|P2|STARTED|Overall Study||34
979334|NCT00357994|2372381|P1|STARTED|Overall Study||37
979335|NCT00358007|2372433|P1|NOT COMPLETED|Overall Study||2
979336|NCT00358007|2372433|P1|COMPLETED|Overall Study||28
979337|NCT00358007|2372433|P1|STARTED|Overall Study||30
979338|NCT00358150|2372438|P1|NOT COMPLETED|Overall Study||7
979339|NCT00358150|2372438|P1|COMPLETED|Overall Study||19
979340|NCT00358150|2372438|P1|STARTED|Overall Study||26
979341|NCT00358215|2372462|P2|NOT COMPLETED|Overall Study||652
979342|NCT00358215|2372463|P1|NOT COMPLETED|Overall Study||679
979343|NCT00358215|2372462|P2|COMPLETED|Overall Study|Participants who completed investigational product|484
979344|NCT00358215|2372463|P1|COMPLETED|Overall Study|Participants who completed investigational product|463
979345|NCT00358215|2372462|P2|Received Investigational Product|Overall Study||1133
979346|NCT00358215|2372463|P1|Received Investigational Product|Overall Study||1140
979347|NCT00358215|2372462|P2|STARTED|Overall Study||1136
979348|NCT00358215|2372463|P1|STARTED|Overall Study||1142
979349|NCT00358332|2372481|P4|NOT COMPLETED|Overall Study||0
979350|NCT00358332|2372482|P3|NOT COMPLETED|Overall Study||1
979351|NCT00358332|2372483|P2|NOT COMPLETED|Overall Study||3
979352|NCT00358332|2372484|P1|NOT COMPLETED|Overall Study||0
979353|NCT00358332|2372481|P4|COMPLETED|Overall Study||25
979354|NCT00358332|2372482|P3|COMPLETED|Overall Study||29
979355|NCT00358332|2372483|P2|COMPLETED|Overall Study||27
979356|NCT00358332|2372484|P1|COMPLETED|Overall Study||15
979357|NCT00358332|2372481|P4|STARTED|Overall Study||25
979358|NCT00358332|2372482|P3|STARTED|Overall Study||30
979359|NCT00358332|2372483|P2|STARTED|Overall Study||30
979360|NCT00358332|2372484|P1|STARTED|Overall Study||15
979361|NCT00358436|2372536|P2|NOT COMPLETED|Overall Study||86
979362|NCT00358436|2372537|P1|NOT COMPLETED|Overall Study||154
979363|NCT00358436|2372536|P2|COMPLETED|Overall Study||118
979364|NCT00358436|2372537|P1|COMPLETED|Overall Study||446
979365|NCT00358436|2372536|P2|STARTED|Overall Study||204
979366|NCT00358436|2372537|P1|STARTED|Overall Study||600
979367|NCT00358449|2372552|P3|NOT COMPLETED|Overall Study||2
979368|NCT00358449|2372553|P2|NOT COMPLETED|Overall Study||1
979369|NCT00358449|2372554|P1|NOT COMPLETED|Overall Study||4
979370|NCT00358449|2372552|P3|COMPLETED|Overall Study||18
979371|NCT00358449|2372553|P2|COMPLETED|Overall Study||19
979372|NCT00358449|2372554|P1|COMPLETED|Overall Study||15
979373|NCT00358449|2372552|P3|STARTED|Overall Study||20
979374|NCT00358449|2372553|P2|STARTED|Overall Study||20
979375|NCT00358449|2372554|P1|STARTED|Overall Study||19
979376|NCT00358462|2372657|P2|NOT COMPLETED|Overall Study||64
979377|NCT00358462|2372658|P1|NOT COMPLETED|Overall Study||59
979378|NCT00358462|2372657|P2|COMPLETED|Overall Study||238
979379|NCT00358462|2372658|P1|COMPLETED|Overall Study||245
979380|NCT00358462|2372657|P2|STARTED|Overall Study||302
979381|NCT00358462|2372658|P1|STARTED|Overall Study||304
979382|NCT00358501|2372668|P2|NOT COMPLETED|Overall Study||0
979383|NCT00358501|2372669|P1|NOT COMPLETED|Overall Study||0
979384|NCT00358501|2372668|P2|COMPLETED|Overall Study||32
979385|NCT00358501|2372669|P1|COMPLETED|Overall Study||102
979386|NCT00358501|2372668|P2|STARTED|Overall Study||32
979387|NCT00358501|2372669|P1|STARTED|Overall Study||102
979388|NCT00358527|2372684|P2|NOT COMPLETED|Overall Study||3
979389|NCT00358527|2372685|P1|NOT COMPLETED|Overall Study||13
979390|NCT00358527|2372684|P2|COMPLETED|Overall Study||131
979391|NCT00358527|2372685|P1|COMPLETED|Overall Study||254
979392|NCT00358527|2372684|P2|STARTED|Overall Study||134
979393|NCT00358527|2372685|P1|STARTED|Overall Study||267
979394|NCT00358579|2372695|P2|NOT COMPLETED|Overall Study||0
979395|NCT00358579|2372696|P1|NOT COMPLETED|Overall Study||0
979396|NCT00358579|2372695|P2|COMPLETED|Overall Study||374
979397|NCT00358579|2372696|P1|COMPLETED|Overall Study||353
979398|NCT00358579|2372695|P2|STARTED|Overall Study||374
979399|NCT00358579|2372696|P1|STARTED|Overall Study||353
979400|NCT00365976|2372712|P2|NOT COMPLETED|Overall Study||5
979401|NCT00365976|2372713|P1|NOT COMPLETED|Overall Study||1
979402|NCT00365976|2372712|P2|COMPLETED|Overall Study||20
979403|NCT00365976|2372713|P1|COMPLETED|Overall Study||32
979404|NCT00365976|2372712|P2|STARTED|Overall Study||25
979405|NCT00365976|2372713|P1|STARTED|Overall Study||33
979406|NCT00366028|2372743|P2|NOT COMPLETED|Overall Study||0
979407|NCT00366028|2372744|P1|NOT COMPLETED|Overall Study||0
979408|NCT00366028|2372743|P2|COMPLETED|Overall Study||735
979409|NCT00366028|2372744|P1|COMPLETED|Overall Study||889
979410|NCT00366028|2372743|P2|STARTED|Overall Study||735
979411|NCT00366028|2372744|P1|STARTED|Overall Study||889
979412|NCT00366106|2372752|P1|NOT COMPLETED|Overall Study||0
979413|NCT00366106|2372752|P1|COMPLETED|Overall Study||32
979414|NCT00366106|2372752|P1|STARTED|Overall Study||32
979415|NCT00366249|2372761|P2|NOT COMPLETED|Overall Study||78
979416|NCT00366249|2372762|P1|NOT COMPLETED|Overall Study||131
979417|NCT00366249|2372761|P2|COMPLETED|Overall Study||430
979418|NCT00366249|2372762|P1|COMPLETED|Overall Study||422
979419|NCT00366249|2372761|P2|STARTED|Overall Study||508
979420|NCT00366249|2372762|P1|STARTED|Overall Study||553
979421|NCT00366275|2372776|P1|NOT COMPLETED|Overall Study||6
979422|NCT00366275|2372776|P1|COMPLETED|Overall Study||58
979423|NCT00366275|2372776|P1|STARTED|Overall Study||64
979424|NCT00371839|2372783|P3|NOT COMPLETED|Overall Study||2
979425|NCT00371839|2372784|P2|NOT COMPLETED|Overall Study||7
979426|NCT00371839|2372785|P1|NOT COMPLETED|Overall Study||17
979427|NCT00371839|2372783|P3|COMPLETED|Overall Study||7
979428|NCT00371839|2372784|P2|COMPLETED|Overall Study||13
979429|NCT00371839|2372785|P1|COMPLETED|Overall Study||32
979430|NCT00371839|2372783|P3|STARTED|Overall Study||9
979431|NCT00371839|2372784|P2|STARTED|Overall Study||20
979432|NCT00371839|2372785|P1|STARTED|Overall Study||49
979433|NCT00371865|2372793|P2|NOT COMPLETED|Overall Study||14
979434|NCT00371865|2372794|P1|NOT COMPLETED|Overall Study||15
979435|NCT00371865|2372793|P2|COMPLETED|Overall Study|8 withdrew before starting the intervention. 6 withdrew after starting the intervention.|43
979436|NCT00371865|2372794|P1|COMPLETED|Overall Study|7 withdrew before starting the intervention. 8 withdrew after starting the intervention.|42
979437|NCT00371865|2372793|P2|STARTED|Overall Study||57
979438|NCT00371865|2372794|P1|STARTED|Overall Study||57
979439|NCT00372060|2372810|P2|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||8
979440|NCT00372060|2372811|P1|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||14
979441|NCT00372060|2372810|P2|COMPLETED|Period II - Open-label (Weeks 12-52)||59
979442|NCT00372060|2372811|P1|COMPLETED|Period II - Open-label (Weeks 12-52)||49
979443|NCT00372060|2372810|P2|STARTED|Period II - Open-label (Weeks 12-52)||67
979444|NCT00372060|2372811|P1|STARTED|Period II - Open-label (Weeks 12-52)||63
979445|NCT00372060|2372810|P2|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||1
979446|NCT00372060|2372811|P1|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||3
979447|NCT00372060|2372810|P2|COMPLETED|Period I - Double-blind (Weeks 0-12)||67
979448|NCT00372060|2372811|P1|COMPLETED|Period I - Double-blind (Weeks 0-12)||63
979449|NCT00372060|2372810|P2|STARTED|Period I - Double-blind (Weeks 0-12)||68
979450|NCT00372060|2372811|P1|STARTED|Period I - Double-blind (Weeks 0-12)|The planned number of enrolled patients was 130. The actual number of enrolled patients was 134.|66
979451|NCT00372190|2372826|P2|NOT COMPLETED|Overall Study||1
979452|NCT00372190|2372827|P1|NOT COMPLETED|Overall Study||3
979453|NCT00372190|2372826|P2|COMPLETED|Overall Study||96
979454|NCT00372190|2372827|P1|COMPLETED|Overall Study||90
979455|NCT00372190|2372826|P2|STARTED|Overall Study|99 were allocated to conventional arm, however 2 never underwent any surgery|97
979456|NCT00372190|2372827|P1|STARTED|Overall Study|95 were allocated to mesh group, however 2 never underwent any surgery|93
979457|NCT00372385|2372843|P4|NOT COMPLETED|Overall Study||8
979458|NCT00372385|2372844|P3|NOT COMPLETED|Overall Study||10
979459|NCT00372385|2372845|P2|NOT COMPLETED|Overall Study||20
979460|NCT00372385|2372846|P1|NOT COMPLETED|Overall Study||33
979461|NCT00372385|2372843|P4|COMPLETED|Overall Study||70
979462|NCT00372385|2372844|P3|COMPLETED|Overall Study||72
979463|NCT00372385|2372845|P2|COMPLETED|Overall Study||61
979464|NCT00372385|2372846|P1|COMPLETED|Overall Study||49
979465|NCT00372385|2372843|P4|STARTED|Overall Study||78
979466|NCT00372385|2372844|P3|STARTED|Overall Study||82
979467|NCT00372385|2372845|P2|STARTED|Overall Study||81
979468|NCT00372385|2372846|P1|STARTED|Overall Study||82
979469|NCT00372411|2372876|P3|NOT COMPLETED|Overall Study||3
979470|NCT00372411|2372877|P2|NOT COMPLETED|Overall Study||8
979471|NCT00372411|2372878|P1|NOT COMPLETED|Overall Study||5
979472|NCT00372411|2372876|P3|COMPLETED|Overall Study||25
979473|NCT00372411|2372877|P2|COMPLETED|Overall Study||42
979474|NCT00372411|2372878|P1|COMPLETED|Overall Study||44
979475|NCT00372411|2372876|P3|STARTED|Overall Study||28
979476|NCT00372411|2372877|P2|STARTED|Overall Study||50
979477|NCT00372411|2372878|P1|STARTED|Overall Study||49
979478|NCT00372424|2372898|P1|NOT COMPLETED|Overall Study||26
979479|NCT00372424|2372898|P1|COMPLETED|Overall Study||0
979480|NCT00372424|2372898|P1|Treated|Overall Study||25
979481|NCT00372424|2372898|P1|STARTED|Overall Study||26
979482|NCT00372489|2372909|P1|NOT COMPLETED|Overall Study||79
979483|NCT00372489|2372909|P1|COMPLETED|Overall Study||2
979484|NCT00372489|2372909|P1|STARTED|Overall Study||81
979485|NCT00372528|2372913|P1|NOT COMPLETED|Overall Study||21
979486|NCT00372528|2372913|P1|COMPLETED|Overall Study||0
979487|NCT00372528|2372913|P1|STARTED|Overall Study||21
979488|NCT00372567|2372921|P3|NOT COMPLETED|Phase 3 Study||12
979489|NCT00372567|2372922|P2|NOT COMPLETED|Phase 3 Study||26
979490|NCT00372567|2372923|P1|NOT COMPLETED|Phase 3 Study||31
979491|NCT00372567|2372921|P3|COMPLETED|Phase 3 Study||0
979492|NCT00372567|2372922|P2|COMPLETED|Phase 3 Study||0
979493|NCT00372567|2372923|P1|COMPLETED|Phase 3 Study||0
979494|NCT00372567|2372921|P3|Received Treatment|Phase 3 Study||12
979495|NCT00372567|2372922|P2|Received Treatment|Phase 3 Study||25
979496|NCT00372567|2372923|P1|Received Treatment|Phase 3 Study||31
979497|NCT00372567|2372921|P3|STARTED|Phase 3 Study||12
979498|NCT00372567|2372922|P2|STARTED|Phase 3 Study||26
979499|NCT00372567|2372923|P1|STARTED|Phase 3 Study||31
979500|NCT00372567|2372921|P3|NOT COMPLETED|Phase 1 Sub-study||0
979501|NCT00372567|2372922|P2|NOT COMPLETED|Phase 1 Sub-study||0
979502|NCT00372567|2372923|P1|NOT COMPLETED|Phase 1 Sub-study||0
979503|NCT00372567|2372921|P3|COMPLETED|Phase 1 Sub-study||12
979504|NCT00372567|2372922|P2|COMPLETED|Phase 1 Sub-study||0
979505|NCT00372567|2372923|P1|COMPLETED|Phase 1 Sub-study||0
979506|NCT00372567|2372921|P3|STARTED|Phase 1 Sub-study||12
979507|NCT00372567|2372922|P2|STARTED|Phase 1 Sub-study||0
979508|NCT00372567|2372923|P1|STARTED|Phase 1 Sub-study||0
979509|NCT00372593|2372954|P3|NOT COMPLETED|Overall Study||4
979510|NCT00372593|2372955|P2|NOT COMPLETED|Overall Study||198
979511|NCT00372593|2372956|P1|NOT COMPLETED|Overall Study||204
979512|NCT00372593|2372954|P3|COMPLETED|Overall Study||3
979513|NCT00372593|2372955|P2|COMPLETED|Overall Study||334
979514|NCT00372593|2372956|P1|COMPLETED|Overall Study||327
979515|NCT00372593|2372954|P3|STARTED|Overall Study||7
979516|NCT00372593|2372955|P2|STARTED|Overall Study||532
979517|NCT00372593|2372956|P1|STARTED|Overall Study||531
979518|NCT00372619|2372989|P7|NOT COMPLETED|Overall Study||0
979519|NCT00372619|2372990|P6|NOT COMPLETED|Overall Study||3
979520|NCT00372619|2372991|P5|NOT COMPLETED|Overall Study||0
979521|NCT00372619|2372992|P4|NOT COMPLETED|Overall Study||0
979522|NCT00372619|2372993|P3|NOT COMPLETED|Overall Study||0
979523|NCT00372619|2372994|P2|NOT COMPLETED|Overall Study||0
979524|NCT00372619|2372995|P1|NOT COMPLETED|Overall Study||0
979525|NCT00372619|2372989|P7|COMPLETED|Overall Study||2
979526|NCT00372619|2372990|P6|COMPLETED|Overall Study||39
979527|NCT00372619|2372991|P5|COMPLETED|Overall Study||7
979528|NCT00372619|2372992|P4|COMPLETED|Overall Study||10
979529|NCT00372619|2372993|P3|COMPLETED|Overall Study||3
979530|NCT00372619|2372994|P2|COMPLETED|Overall Study||2
979531|NCT00372619|2372995|P1|COMPLETED|Overall Study||8
979532|NCT00372619|2372989|P7|STARTED|Overall Study||2
979533|NCT00372619|2372990|P6|STARTED|Overall Study||42
979534|NCT00372619|2372991|P5|STARTED|Overall Study||7
979535|NCT00372619|2372992|P4|STARTED|Overall Study||10
979536|NCT00372619|2372993|P3|STARTED|Overall Study||3
979537|NCT00372619|2372994|P2|STARTED|Overall Study||2
979538|NCT00372619|2372995|P1|STARTED|Overall Study||8
979539|NCT00372697|2373027|P2|NOT COMPLETED|Overall Study||1
979540|NCT00372697|2373028|P1|NOT COMPLETED|Overall Study||1
979541|NCT00372697|2373027|P2|COMPLETED|Overall Study||11
979542|NCT00372697|2373028|P1|COMPLETED|Overall Study||15
979543|NCT00372697|2373027|P2|STARTED|Overall Study||12
979544|NCT00372697|2373028|P1|STARTED|Overall Study||16
979545|NCT00372775|2373046|P1|NOT COMPLETED|Overall Study||63
979546|NCT00372775|2373046|P1|COMPLETED|Overall Study||3
979547|NCT00372775|2373046|P1|Received Treatment|Overall Study||64
979548|NCT00372775|2373046|P1|STARTED|Overall Study||66
979549|NCT00372970|2373068|P2|NOT COMPLETED|Overall Study||0
979550|NCT00372970|2373069|P1|NOT COMPLETED|Overall Study||0
979551|NCT00372970|2373068|P2|COMPLETED|Overall Study||16
979552|NCT00372970|2373069|P1|COMPLETED|Overall Study||16
979553|NCT00372970|2373068|P2|STARTED|Overall Study||16
979554|NCT00372970|2373069|P1|STARTED|Overall Study||16
979555|NCT00372996|2373077|P4|NOT COMPLETED|Overall Study||20
979556|NCT00372996|2373078|P3|NOT COMPLETED|Overall Study||28
979557|NCT00372996|2373079|P2|NOT COMPLETED|Overall Study||14
979558|NCT00372996|2373080|P1|NOT COMPLETED|Overall Study||37
979559|NCT00372996|2373077|P4|COMPLETED|Overall Study||23
979560|NCT00372996|2373078|P3|COMPLETED|Overall Study||33
979561|NCT00372996|2373079|P2|COMPLETED|Overall Study||22
979562|NCT00372996|2373080|P1|COMPLETED|Overall Study||42
979563|NCT00372996|2373077|P4|STARTED|Overall Study||43
979564|NCT00372996|2373078|P3|STARTED|Overall Study||61
979565|NCT00372996|2373079|P2|STARTED|Overall Study||36
979566|NCT00372996|2373080|P1|STARTED|Overall Study||79
979567|NCT00373113|2373106|P2|NOT COMPLETED|Overall Study||244
979568|NCT00373113|2373107|P1|NOT COMPLETED|Overall Study||238
979569|NCT00373113|2373106|P2|COMPLETED|Overall Study||0
979570|NCT00373113|2373107|P1|COMPLETED|Overall Study||0
979571|NCT00373113|2373106|P2|Received Treatment|Overall Study||240
979572|NCT00373113|2373107|P1|Received Treatment|Overall Study||238
979573|NCT00373113|2373106|P2|STARTED|Overall Study||244
979574|NCT00373113|2373107|P1|STARTED|Overall Study||238
979575|NCT00373256|2373129|P2|NOT COMPLETED|Overall Study||247
979576|NCT00373256|2373130|P1|NOT COMPLETED|Overall Study||241
979577|NCT00373256|2373129|P2|COMPLETED|Overall Study||0
979578|NCT00373256|2373130|P1|COMPLETED|Overall Study||0
979579|NCT00373256|2373129|P2|Treated|Overall Study||236
979580|NCT00373256|2373130|P1|Treated|Overall Study||235
979581|NCT00373256|2373129|P2|STARTED|Overall Study||247
979582|NCT00373256|2373130|P1|STARTED|Overall Study||241
979583|NCT00373269|2373156|P2|NOT COMPLETED|Overall Study||0
979584|NCT00373269|2373157|P1|NOT COMPLETED|Overall Study||0
979585|NCT00373269|2373156|P2|COMPLETED|Overall Study||10
979586|NCT00373269|2373157|P1|COMPLETED|Overall Study||11
979587|NCT00373269|2373156|P2|STARTED|Overall Study||10
979588|NCT00373269|2373157|P1|STARTED|Overall Study||11
979589|NCT00373295|2373165|P6|NOT COMPLETED|Intervention 3 (8 Days)||0
979590|NCT00373295|2373166|P5|NOT COMPLETED|Intervention 3 (8 Days)||0
979591|NCT00373295|2373167|P4|NOT COMPLETED|Intervention 3 (8 Days)||0
979592|NCT00373295|2373168|P3|NOT COMPLETED|Intervention 3 (8 Days)||0
979593|NCT00373295|2373169|P2|NOT COMPLETED|Intervention 3 (8 Days)||0
979594|NCT00373295|2373170|P1|NOT COMPLETED|Intervention 3 (8 Days)||0
979595|NCT00373295|2373165|P6|COMPLETED|Intervention 3 (8 Days)||2
979596|NCT00373295|2373166|P5|COMPLETED|Intervention 3 (8 Days)||2
979597|NCT00373295|2373167|P4|COMPLETED|Intervention 3 (8 Days)||2
979598|NCT00373295|2373168|P3|COMPLETED|Intervention 3 (8 Days)||1
979599|NCT00373295|2373169|P2|COMPLETED|Intervention 3 (8 Days)||1
979600|NCT00373295|2373170|P1|COMPLETED|Intervention 3 (8 Days)||2
979601|NCT00373295|2373165|P6|STARTED|Intervention 3 (8 Days)||2
979602|NCT00373295|2373166|P5|STARTED|Intervention 3 (8 Days)||2
979603|NCT00373295|2373167|P4|STARTED|Intervention 3 (8 Days)||2
979604|NCT00373295|2373168|P3|STARTED|Intervention 3 (8 Days)||1
979605|NCT00373295|2373169|P2|STARTED|Intervention 3 (8 Days)||1
979606|NCT00373295|2373170|P1|STARTED|Intervention 3 (8 Days)||2
979607|NCT00373295|2373165|P6|NOT COMPLETED|Intervention 2 (8 Days)||0
979608|NCT00373295|2373166|P5|NOT COMPLETED|Intervention 2 (8 Days)||0
979609|NCT00373295|2373167|P4|NOT COMPLETED|Intervention 2 (8 Days)||0
979610|NCT00373295|2373168|P3|NOT COMPLETED|Intervention 2 (8 Days)||0
979611|NCT00373295|2373169|P2|NOT COMPLETED|Intervention 2 (8 Days)||0
979612|NCT00373295|2373170|P1|NOT COMPLETED|Intervention 2 (8 Days)||0
979613|NCT00373295|2373165|P6|COMPLETED|Intervention 2 (8 Days)||2
979614|NCT00373295|2373166|P5|COMPLETED|Intervention 2 (8 Days)||2
979615|NCT00373295|2373167|P4|COMPLETED|Intervention 2 (8 Days)||2
979616|NCT00373295|2373168|P3|COMPLETED|Intervention 2 (8 Days)||1
979617|NCT00373295|2373169|P2|COMPLETED|Intervention 2 (8 Days)||1
979618|NCT00373295|2373170|P1|COMPLETED|Intervention 2 (8 Days)||2
979619|NCT00373295|2373165|P6|STARTED|Intervention 2 (8 Days)||2
979620|NCT00373295|2373166|P5|STARTED|Intervention 2 (8 Days)||2
979621|NCT00373295|2373167|P4|STARTED|Intervention 2 (8 Days)||2
979622|NCT00373295|2373168|P3|STARTED|Intervention 2 (8 Days)||1
979623|NCT00373295|2373169|P2|STARTED|Intervention 2 (8 Days)||1
979624|NCT00373295|2373170|P1|STARTED|Intervention 2 (8 Days)||2
979625|NCT00373295|2373165|P6|NOT COMPLETED|Intervention 1 (8 Days)||0
979626|NCT00373295|2373166|P5|NOT COMPLETED|Intervention 1 (8 Days)||1
979627|NCT00373295|2373167|P4|NOT COMPLETED|Intervention 1 (8 Days)||0
979628|NCT00373295|2373168|P3|NOT COMPLETED|Intervention 1 (8 Days)||0
979629|NCT00373295|2373169|P2|NOT COMPLETED|Intervention 1 (8 Days)||2
979630|NCT00373295|2373170|P1|NOT COMPLETED|Intervention 1 (8 Days)||0
979631|NCT00373295|2373165|P6|COMPLETED|Intervention 1 (8 Days)||2
979632|NCT00373295|2373166|P5|COMPLETED|Intervention 1 (8 Days)||2
979633|NCT00373295|2373167|P4|COMPLETED|Intervention 1 (8 Days)||2
979634|NCT00373295|2373168|P3|COMPLETED|Intervention 1 (8 Days)||1
979635|NCT00373295|2373169|P2|COMPLETED|Intervention 1 (8 Days)||1
979636|NCT00373295|2373170|P1|COMPLETED|Intervention 1 (8 Days)||2
979637|NCT00373295|2373165|P6|STARTED|Intervention 1 (8 Days)||2
979638|NCT00373295|2373166|P5|STARTED|Intervention 1 (8 Days)||3
979639|NCT00373295|2373167|P4|STARTED|Intervention 1 (8 Days)||2
979640|NCT00373295|2373168|P3|STARTED|Intervention 1 (8 Days)||1
979641|NCT00373295|2373169|P2|STARTED|Intervention 1 (8 Days)||3
979642|NCT00373295|2373170|P1|STARTED|Intervention 1 (8 Days)||2
979643|NCT00373334|2373181|P3|NOT COMPLETED|Overall Study||13
979644|NCT00373334|2373182|P2|NOT COMPLETED|Overall Study||18
979645|NCT00373334|2373183|P1|NOT COMPLETED|Overall Study||10
979646|NCT00373334|2373181|P3|COMPLETED|Overall Study||32
979647|NCT00373334|2373182|P2|COMPLETED|Overall Study||32
979648|NCT00373334|2373183|P1|COMPLETED|Overall Study||33
979649|NCT00373334|2373181|P3|STARTED|Overall Study||45
979650|NCT00373334|2373182|P2|STARTED|Overall Study||50
979651|NCT00373334|2373183|P1|STARTED|Overall Study||43
979652|NCT00373360|2373197|P1|NOT COMPLETED|Overall Study||0
979653|NCT00373360|2373197|P1|COMPLETED|Overall Study||10
979654|NCT00373360|2373197|P1|STARTED|Overall Study||10
979655|NCT00373425|2373230|P5|NOT COMPLETED|Overall Study||72
979656|NCT00373425|2373231|P4|NOT COMPLETED|Overall Study||11
979657|NCT00373425|2373232|P3|NOT COMPLETED|Overall Study||134
979658|NCT00373425|2373233|P2|NOT COMPLETED|Overall Study||153
979659|NCT00373425|2373234|P1|NOT COMPLETED|Overall Study||370
979660|NCT00373425|2373230|P5|COMPLETED|Overall Study|Completed 2 years of study treatment|60
979661|NCT00373425|2373231|P4|COMPLETED|Overall Study|Completed 2 years of study treatment|0
979662|NCT00373425|2373232|P3|COMPLETED|Overall Study|Completed 2 years of study treatment|0
979663|NCT00373425|2373233|P2|COMPLETED|Overall Study|Completed 2 years of study treatment|197
979664|NCT00373425|2373234|P1|COMPLETED|Overall Study|Completed 2 years of study treatment|253
979665|NCT00373425|2373230|P5|Received Treatment|Overall Study||132
979666|NCT00373425|2373231|P4|Received Treatment|Overall Study||7
979667|NCT00373425|2373232|P3|Received Treatment|Overall Study||134
979668|NCT00373425|2373233|P2|Received Treatment|Overall Study||342
979669|NCT00373425|2373234|P1|Received Treatment|Overall Study||612
979670|NCT00373425|2373230|P5|STARTED|Overall Study||132
979671|NCT00373425|2373231|P4|STARTED|Overall Study||11
979672|NCT00373425|2373232|P3|STARTED|Overall Study||134
979673|NCT00373425|2373233|P2|STARTED|Overall Study||350
979674|NCT00373425|2373234|P1|STARTED|Overall Study||623
979675|NCT00373490|2373261|P2|NOT COMPLETED|Overall Study||6
979676|NCT00373490|2373262|P1|NOT COMPLETED|Overall Study||9
979677|NCT00373490|2373261|P2|COMPLETED|Overall Study||0
979678|NCT00373490|2373262|P1|COMPLETED|Overall Study||1
979679|NCT00373490|2373261|P2|STARTED|Overall Study||6
979680|NCT00373490|2373262|P1|STARTED|Overall Study||10
979681|NCT00373529|2373280|P1|NOT COMPLETED|Overall Study||108
979682|NCT00373529|2373280|P1|COMPLETED|Overall Study|Completed: initiated full 6 cycles of treatment. Not Completed: initiated <6 cycles of treatment|8
979683|NCT00373529|2373280|P1|Full Analysis Set|Overall Study|3 Failed Independent Confirmation of AML; 1 consent violation|112
979684|NCT00373529|2373280|P1|STARTED|Overall Study||116
979685|NCT00373685|2373292|P2|NOT COMPLETED|Overall Study||1421
979686|NCT00373685|2373293|P1|NOT COMPLETED|Overall Study||1439
979687|NCT00373685|2373292|P2|COMPLETED|Overall Study||2611
979688|NCT00373685|2373293|P1|COMPLETED|Overall Study||2596
979689|NCT00373685|2373292|P2|Treated|Overall Study||3955
979690|NCT00373685|2373293|P1|Treated|Overall Study||3984
979691|NCT00373685|2373292|P2|STARTED|Overall Study||4032
979692|NCT00373685|2373293|P1|STARTED|Overall Study||4035
979693|NCT00373698|2373329|P2|NOT COMPLETED|Overall Study||0
979694|NCT00373698|2373330|P1|NOT COMPLETED|Overall Study||11
979695|NCT00373698|2373329|P2|COMPLETED|Overall Study||99
979696|NCT00373698|2373330|P1|COMPLETED|Overall Study||85
979697|NCT00373698|2373329|P2|STARTED|Overall Study||99
979698|NCT00373698|2373330|P1|STARTED|Overall Study||96
979699|NCT00373880|2373342|P1|NOT COMPLETED|Overall Study||18
979700|NCT00373880|2373342|P1|COMPLETED|Overall Study||8
979701|NCT00373880|2373342|P1|STARTED|Overall Study||26
979702|NCT00373958|2373372|P2|NOT COMPLETED|Toddler Dose||38
979703|NCT00373958|2373373|P1|NOT COMPLETED|Toddler Dose||30
979704|NCT00373958|2373372|P2|COMPLETED|Toddler Dose||252
979705|NCT00373958|2373373|P1|COMPLETED|Toddler Dose||264
979706|NCT00373958|2373372|P2|Vaccinated Toddler Dose|Toddler Dose||265
979707|NCT00373958|2373373|P1|Vaccinated Toddler Dose|Toddler Dose||272
979708|NCT00373958|2373372|P2|Withdrawn After Infant Series|Toddler Dose||25
979709|NCT00373958|2373373|P1|Withdrawn After Infant Series|Toddler Dose||22
979710|NCT00373958|2373372|P2|STARTED|Toddler Dose||290
979711|NCT00373958|2373373|P1|STARTED|Toddler Dose||294
979712|NCT00373958|2373372|P2|NOT COMPLETED|Infant Series||42
979713|NCT00373958|2373373|P1|NOT COMPLETED|Infant Series||40
979714|NCT00373958|2373372|P2|COMPLETED|Infant Series||290
979715|NCT00373958|2373373|P1|COMPLETED|Infant Series||294
979716|NCT00373958|2373372|P2|Vaccinated Dose 3|Infant Series||300
979717|NCT00373958|2373373|P1|Vaccinated Dose 3|Infant Series||298
979718|NCT00373958|2373372|P2|Vaccinated Dose 2|Infant Series||305
979719|NCT00373958|2373373|P1|Vaccinated Dose 2|Infant Series||309
979720|NCT00373958|2373372|P2|Vaccinated Dose 1|Infant Series||331
979721|NCT00373958|2373373|P1|Vaccinated Dose 1|Infant Series||332
979722|NCT00373958|2373372|P2|STARTED|Infant Series||332
979723|NCT00373958|2373373|P1|STARTED|Infant Series|One participant was prerandomized but not consented.|334
979724|NCT00374088|2373423|P2|NOT COMPLETED|Overall Study||1
979725|NCT00374088|2373424|P1|NOT COMPLETED|Overall Study||1
979726|NCT00374088|2373423|P2|COMPLETED|Overall Study||10
979727|NCT00374088|2373424|P1|COMPLETED|Overall Study||9
979728|NCT00374088|2373423|P2|STARTED|Overall Study||11
979729|NCT00374088|2373424|P1|STARTED|Overall Study||10
979730|NCT00374127|2373434|P1|NOT COMPLETED|Overall Study||11
979731|NCT00374127|2373434|P1|COMPLETED|Overall Study||24
979732|NCT00374127|2373434|P1|STARTED|Overall Study||35
979736|NCT00374231|2373472|P1|NOT COMPLETED|Overall Study||0
979737|NCT00374231|2373472|P1|COMPLETED|Overall Study||40
979738|NCT00374231|2373472|P1|STARTED|Overall Study||40
979739|NCT00374244|2373480|P2|NOT COMPLETED|Overall Study||0
979740|NCT00374244|2373481|P1|NOT COMPLETED|Overall Study||0
979741|NCT00374244|2373480|P2|COMPLETED|Overall Study||14
979742|NCT00374244|2373481|P1|COMPLETED|Overall Study||14
979743|NCT00374244|2373480|P2|STARTED|Overall Study||14
979744|NCT00374244|2373481|P1|STARTED|Overall Study||14
979745|NCT00374322|2373529|P2|NOT COMPLETED|Overall Study||1304
979746|NCT00374322|2373530|P1|NOT COMPLETED|Overall Study||1257
979747|NCT00374322|2373529|P2|COMPLETED|Overall Study||278
979748|NCT00374322|2373530|P1|COMPLETED|Overall Study||322
979749|NCT00374322|2373529|P2|Received >=1 Dose of Study Treatment|Overall Study||1576
979750|NCT00374322|2373530|P1|Received >=1 Dose of Study Treatment|Overall Study||1571
979751|NCT00374322|2373529|P2|STARTED|Overall Study||1582
979752|NCT00374322|2373530|P1|STARTED|Overall Study||1579
979753|NCT00374335|2373566|P1|NOT COMPLETED|Overall Study||0
979754|NCT00374335|2373566|P1|COMPLETED|Overall Study||261
979755|NCT00374335|2373566|P1|STARTED|Overall Study||261
979756|NCT00361569|2373575|P4|NOT COMPLETED|Overall Study||21
979757|NCT00361569|2373576|P3|NOT COMPLETED|Overall Study||18
979758|NCT00361569|2373577|P2|NOT COMPLETED|Overall Study||11
979759|NCT00361569|2373578|P1|NOT COMPLETED|Overall Study||12
979760|NCT00361569|2373575|P4|COMPLETED|Overall Study||135
979761|NCT00361569|2373576|P3|COMPLETED|Overall Study||137
979762|NCT00361569|2373577|P2|COMPLETED|Overall Study||150
979763|NCT00361569|2373578|P1|COMPLETED|Overall Study||138
979764|NCT00361569|2373575|P4|STARTED|Overall Study||156
979765|NCT00361569|2373576|P3|STARTED|Overall Study||155
979766|NCT00361569|2373577|P2|STARTED|Overall Study||161
979767|NCT00361569|2373578|P1|STARTED|Overall Study||150
979768|NCT00361595|2373600|P1|NOT COMPLETED|Overall Study||0
979769|NCT00361595|2373600|P1|COMPLETED|Overall Study||35
979770|NCT00361595|2373600|P1|STARTED|Overall Study||35
979771|NCT00361634|2373607|P1|NOT COMPLETED|Overall Study||2
979772|NCT00361634|2373607|P1|COMPLETED|Overall Study||12
979773|NCT00361634|2373607|P1|Treated|Overall Study|The safety analysis set consisted of all patients who received at least one dose of etanercept.|13
979774|NCT00361634|2373607|P1|STARTED|Overall Study||14
979775|NCT00361972|2373627|P2|NOT COMPLETED|Overall Study||0
979776|NCT00361972|2373628|P1|NOT COMPLETED|Overall Study||0
979777|NCT00361972|2373627|P2|COMPLETED|Overall Study||9
979778|NCT00361972|2373628|P1|COMPLETED|Overall Study||8
979779|NCT00361972|2373627|P2|STARTED|Overall Study||9
979780|NCT00361972|2373628|P1|STARTED|Overall Study||8
979781|NCT00362115|2373643|P7|NOT COMPLETED|Overall Study||12
979782|NCT00362115|2373644|P6|NOT COMPLETED|Overall Study||7
979783|NCT00362115|2373645|P5|NOT COMPLETED|Overall Study||7
979784|NCT00362115|2373646|P4|NOT COMPLETED|Overall Study||4
979785|NCT00362115|2373647|P3|NOT COMPLETED|Overall Study||7
979786|NCT00362115|2373648|P2|NOT COMPLETED|Overall Study||6
979787|NCT00362115|2373649|P1|NOT COMPLETED|Overall Study||2
979788|NCT00362115|2373643|P7|COMPLETED|Overall Study||52
979789|NCT00362115|2373644|P6|COMPLETED|Overall Study||57
979790|NCT00362115|2373645|P5|COMPLETED|Overall Study||57
979791|NCT00362115|2373646|P4|COMPLETED|Overall Study||59
979792|NCT00362115|2373647|P3|COMPLETED|Overall Study||57
979793|NCT00362115|2373648|P2|COMPLETED|Overall Study||59
979794|NCT00362115|2373649|P1|COMPLETED|Overall Study||63
979795|NCT00362115|2373643|P7|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
979796|NCT00362115|2373644|P6|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
979797|NCT00362115|2373645|P5|STARTED|Overall Study||64
979798|NCT00362115|2373646|P4|STARTED|Overall Study|1 participant failed to receive double-blind medication.|63
979799|NCT00362115|2373647|P3|STARTED|Overall Study||64
979800|NCT00362115|2373648|P2|STARTED|Overall Study|1 participant failed to receive double-blind medication.|65
979801|NCT00362115|2373649|P1|STARTED|Overall Study||65
979802|NCT00362128|2373798|P1|NOT COMPLETED|Overall Study||0
979803|NCT00362128|2373798|P1|COMPLETED|Overall Study|Enrollment was completed in October 2009.|2072
979804|NCT00362128|2373798|P1|STARTED|Overall Study|Enrollment was initiated in 2007.|2072
979805|NCT00362180|2373811|P9|NOT COMPLETED|20 Week Safety Follow-up||0
979806|NCT00362180|2373812|P8|NOT COMPLETED|20 Week Safety Follow-up||0
979807|NCT00362180|2373813|P7|NOT COMPLETED|20 Week Safety Follow-up||0
979808|NCT00362180|2373814|P6|NOT COMPLETED|20 Week Safety Follow-up||0
979809|NCT00362180|2373815|P5|NOT COMPLETED|20 Week Safety Follow-up||0
979810|NCT00362180|2373816|P4|NOT COMPLETED|20 Week Safety Follow-up||0
979811|NCT00362180|2373817|P3|NOT COMPLETED|20 Week Safety Follow-up||0
979812|NCT00362180|2373818|P2|NOT COMPLETED|20 Week Safety Follow-up||0
979813|NCT00362180|2373819|P1|NOT COMPLETED|20 Week Safety Follow-up||0
979814|NCT00362180|2373811|P9|COMPLETED|20 Week Safety Follow-up||1
979815|NCT00362180|2373812|P8|COMPLETED|20 Week Safety Follow-up||3
979816|NCT00362180|2373813|P7|COMPLETED|20 Week Safety Follow-up||0
979817|NCT00362180|2373814|P6|COMPLETED|20 Week Safety Follow-up||9
979818|NCT00362180|2373815|P5|COMPLETED|20 Week Safety Follow-up||11
979819|NCT00362180|2373816|P4|COMPLETED|20 Week Safety Follow-up||0
979820|NCT00362180|2373817|P3|COMPLETED|20 Week Safety Follow-up||1
979821|NCT00362180|2373818|P2|COMPLETED|20 Week Safety Follow-up||2
979822|NCT00362180|2373819|P1|COMPLETED|20 Week Safety Follow-up||3
979823|NCT00362180|2373811|P9|STARTED|20 Week Safety Follow-up||1
979824|NCT00362180|2373812|P8|STARTED|20 Week Safety Follow-up||3
979825|NCT00362180|2373813|P7|STARTED|20 Week Safety Follow-up|This observational cohort did not include a safety follow-up period.|0
979826|NCT00362180|2373814|P6|STARTED|20 Week Safety Follow-up||9
979827|NCT00362180|2373815|P5|STARTED|20 Week Safety Follow-up||11
979828|NCT00362180|2373816|P4|STARTED|20 Week Safety Follow-up||0
979829|NCT00362180|2373817|P3|STARTED|20 Week Safety Follow-up||1
979830|NCT00362180|2373818|P2|STARTED|20 Week Safety Follow-up||2
979831|NCT00362180|2373819|P1|STARTED|20 Week Safety Follow-up||3
979832|NCT00362180|2373811|P9|NOT COMPLETED|Treated Period||0
979833|NCT00362180|2373812|P8|NOT COMPLETED|Treated Period||1
979834|NCT00362180|2373813|P7|NOT COMPLETED|Treated Period||0
979835|NCT00362180|2373814|P6|NOT COMPLETED|Treated Period||1
979836|NCT00362180|2373815|P5|NOT COMPLETED|Treated Period||0
979837|NCT00362180|2373816|P4|NOT COMPLETED|Treated Period||0
979838|NCT00362180|2373817|P3|NOT COMPLETED|Treated Period||0
979839|NCT00362180|2373818|P2|NOT COMPLETED|Treated Period||0
979840|NCT00362180|2373819|P1|NOT COMPLETED|Treated Period||1
979841|NCT00362180|2373811|P9|COMPLETED|Treated Period||1
979842|NCT00362180|2373812|P8|COMPLETED|Treated Period||2
979843|NCT00362180|2373813|P7|COMPLETED|Treated Period||6
979844|NCT00362180|2373814|P6|COMPLETED|Treated Period||9
979845|NCT00362180|2373815|P5|COMPLETED|Treated Period||11
979846|NCT00362180|2373816|P4|COMPLETED|Treated Period||0
979847|NCT00362180|2373817|P3|COMPLETED|Treated Period||1
979848|NCT00362180|2373818|P2|COMPLETED|Treated Period||2
979849|NCT00362180|2373819|P1|COMPLETED|Treated Period||3
979850|NCT00362180|2373811|P9|STARTED|Treated Period||1
979851|NCT00362180|2373812|P8|STARTED|Treated Period||3
979852|NCT00362180|2373813|P7|STARTED|Treated Period||6
979853|NCT00362180|2373814|P6|STARTED|Treated Period||10
979854|NCT00362180|2373815|P5|STARTED|Treated Period||11
979855|NCT00362180|2373816|P4|STARTED|Treated Period||0
979856|NCT00362180|2373817|P3|STARTED|Treated Period||1
979857|NCT00362180|2373818|P2|STARTED|Treated Period||2
979858|NCT00362180|2373819|P1|STARTED|Treated Period||4
979859|NCT00362232|2373882|P2|NOT COMPLETED|Follow-up (30 (+ 5) Days)||39
979860|NCT00362232|2373883|P1|NOT COMPLETED|Follow-up (30 (+ 5) Days)||38
979861|NCT00362232|2373882|P2|COMPLETED|Follow-up (30 (+ 5) Days)||1416
979862|NCT00362232|2373883|P1|COMPLETED|Follow-up (30 (+ 5) Days)||1433
979863|NCT00362232|2373882|P2|STARTED|Follow-up (30 (+ 5) Days)||1455
979864|NCT00362232|2373883|P1|STARTED|Follow-up (30 (+ 5) Days)||1471
979865|NCT00362232|2373882|P2|NOT COMPLETED|Treatment (12 +/- 2 Days)||151
979866|NCT00362232|2373883|P1|NOT COMPLETED|Treatment (12 +/- 2 Days)||159
979867|NCT00362232|2373882|P2|COMPLETED|Treatment (12 +/- 2 Days)||1413
979868|NCT00362232|2373883|P1|COMPLETED|Treatment (12 +/- 2 Days)||1425
979869|NCT00362232|2373882|P2|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1508
979870|NCT00362232|2373883|P1|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1526
979871|NCT00362232|2373882|P2|STARTED|Treatment (12 +/- 2 Days)||1564
979872|NCT00362232|2373883|P1|STARTED|Treatment (12 +/- 2 Days)||1584
979873|NCT00362297|2373921|P2|NOT COMPLETED|Arm 2 (Cross-over to Other Dose)||0
979874|NCT00362297|2373922|P1|NOT COMPLETED|Arm 2 (Cross-over to Other Dose)||0
979875|NCT00362297|2373921|P2|COMPLETED|Arm 2 (Cross-over to Other Dose)||11
979876|NCT00362297|2373922|P1|COMPLETED|Arm 2 (Cross-over to Other Dose)||16
979877|NCT00362297|2373921|P2|STARTED|Arm 2 (Cross-over to Other Dose)||11
979878|NCT00362297|2373922|P1|STARTED|Arm 2 (Cross-over to Other Dose)||16
979879|NCT00362297|2373921|P2|NOT COMPLETED|Arm 1 (Initial Drug Assignment)||4
979880|NCT00362297|2373922|P1|NOT COMPLETED|Arm 1 (Initial Drug Assignment)||0
979881|NCT00362297|2373921|P2|COMPLETED|Arm 1 (Initial Drug Assignment)||11
979882|NCT00362297|2373922|P1|COMPLETED|Arm 1 (Initial Drug Assignment)||16
979883|NCT00362297|2373921|P2|STARTED|Arm 1 (Initial Drug Assignment)||15
979884|NCT00362297|2373922|P1|STARTED|Arm 1 (Initial Drug Assignment)||16
979885|NCT00362336|2373931|P3|NOT COMPLETED|Overall Study||3
979886|NCT00362336|2373932|P2|NOT COMPLETED|Overall Study||7
979887|NCT00362336|2373933|P1|NOT COMPLETED|Overall Study||10
979888|NCT00362336|2373931|P3|COMPLETED|Overall Study||134
979889|NCT00362336|2373932|P2|COMPLETED|Overall Study||235
979890|NCT00362336|2373933|P1|COMPLETED|Overall Study||233
979891|NCT00362336|2373931|P3|STARTED|Overall Study||137
979892|NCT00362336|2373932|P2|STARTED|Overall Study||242
979893|NCT00362336|2373933|P1|STARTED|Overall Study||243
979894|NCT00362375|2373961|P2|NOT COMPLETED|Overall Study||35
979895|NCT00362375|2373962|P1|NOT COMPLETED|Overall Study||40
979896|NCT00362375|2373961|P2|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|117
979897|NCT00362375|2373962|P1|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|121
979898|NCT00362375|2373961|P2|STARTED|Overall Study|Number eligible and randomized|152
979899|NCT00362375|2373962|P1|STARTED|Overall Study|Number eligible and randomized|161
979900|NCT00362401|2373979|P3|NOT COMPLETED|Overall Study||0
979901|NCT00362401|2373980|P2|NOT COMPLETED|Overall Study||0
979902|NCT00362401|2373981|P1|NOT COMPLETED|Overall Study||0
979903|NCT00362401|2373979|P3|COMPLETED|Overall Study||40
979904|NCT00362401|2373980|P2|COMPLETED|Overall Study||29
979905|NCT00362401|2373981|P1|COMPLETED|Overall Study||15
979906|NCT00362401|2373979|P3|STARTED|Overall Study||40
979907|NCT00362401|2373980|P2|STARTED|Overall Study||29
979908|NCT00362401|2373981|P1|STARTED|Overall Study||15
979909|NCT00362414|2373986|P1|NOT COMPLETED|Overall Study||3
979910|NCT00362414|2373986|P1|COMPLETED|Overall Study||12
979911|NCT00362414|2373986|P1|STARTED|Overall Study||15
979912|NCT00362440|2374005|P2|NOT COMPLETED|Overall Study||1
979913|NCT00362440|2374006|P1|NOT COMPLETED|Overall Study||2
979914|NCT00362440|2374005|P2|COMPLETED|Overall Study||3
979915|NCT00362440|2374006|P1|COMPLETED|Overall Study||3
979916|NCT00362440|2374005|P2|STARTED|Overall Study||4
979917|NCT00362440|2374006|P1|STARTED|Overall Study||5
979918|NCT00362453|2374018|P2|NOT COMPLETED|Overall Study||0
979919|NCT00362453|2374019|P1|NOT COMPLETED|Overall Study||0
979920|NCT00362453|2374018|P2|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
979921|NCT00362453|2374019|P1|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
979922|NCT00362453|2374018|P2|STARTED|Overall Study||20
979923|NCT00362453|2374019|P1|STARTED|Overall Study||20
979924|NCT00362466|2374051|P2|NOT COMPLETED|Overall Study||0
979925|NCT00362466|2374052|P1|NOT COMPLETED|Overall Study||0
979926|NCT00362466|2374051|P2|COMPLETED|Overall Study||1
979927|NCT00362466|2374052|P1|COMPLETED|Overall Study||2
979928|NCT00362466|2374051|P2|STARTED|Overall Study||1
979929|NCT00362466|2374052|P1|STARTED|Overall Study||2
979930|NCT00362609|2374074|P2|NOT COMPLETED|Overall Study||2
979931|NCT00362609|2374075|P1|NOT COMPLETED|Overall Study||0
979932|NCT00362609|2374074|P2|COMPLETED|Overall Study||38
979933|NCT00362609|2374075|P1|COMPLETED|Overall Study||19
979934|NCT00362609|2374074|P2|STARTED|Overall Study||40
979935|NCT00362609|2374075|P1|STARTED|Overall Study||19
979936|NCT00362648|2374091|P4|NOT COMPLETED|Overall Study||11
979937|NCT00362648|2374092|P3|NOT COMPLETED|Overall Study||9
979938|NCT00362648|2374093|P2|NOT COMPLETED|Overall Study||134
979939|NCT00362648|2374094|P1|NOT COMPLETED|Overall Study||126
979940|NCT00362648|2374091|P4|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1007
979941|NCT00362648|2374092|P3|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1009
979942|NCT00362648|2374093|P2|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2601
979943|NCT00362648|2374094|P1|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2607
979944|NCT00362648|2374091|P4|Vaccinated at Visit 3|Overall Study||1007
979945|NCT00362648|2374092|P3|Vaccinated at Visit 3|Overall Study||1009
979946|NCT00362648|2374093|P2|Vaccinated at Visit 3|Overall Study||2612
979947|NCT00362648|2374094|P1|Vaccinated at Visit 3|Overall Study||2613
979948|NCT00362648|2374091|P4|Vaccinated at Visit 2|Overall Study||1009
979949|NCT00362648|2374092|P3|Vaccinated at Visit 2|Overall Study||1013
979950|NCT00362648|2374093|P2|Vaccinated at Visit 2|Overall Study||2666
979951|NCT00362648|2374094|P1|Vaccinated at Visit 2|Overall Study||2657
979952|NCT00362648|2374091|P4|Vaccinated at Visit 1|Overall Study||1018
979953|NCT00362648|2374092|P3|Vaccinated at Visit 1|Overall Study||1018
979954|NCT00362648|2374093|P2|Vaccinated at Visit 1|Overall Study||2735
979955|NCT00362648|2374094|P1|Vaccinated at Visit 1|Overall Study||2733
979956|NCT00362648|2374091|P4|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
980046|NCT00375492|2374431|P2|COMPLETED|Overall Study||72
979957|NCT00362648|2374092|P3|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
979958|NCT00362648|2374093|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2735
979959|NCT00362648|2374094|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2733
979960|NCT00362817|2374110|P1|NOT COMPLETED|Overall Study||0
979961|NCT00362817|2374110|P1|COMPLETED|Overall Study||17
979962|NCT00362817|2374110|P1|STARTED|Overall Study||17
979963|NCT00362882|2374121|P2|NOT COMPLETED|Overall Study||0
979964|NCT00362882|2374122|P1|NOT COMPLETED|Overall Study||0
979965|NCT00362882|2374121|P2|COMPLETED|Overall Study||41
979966|NCT00362882|2374122|P1|COMPLETED|Overall Study||40
979967|NCT00362882|2374121|P2|STARTED|Overall Study||41
979968|NCT00362882|2374122|P1|STARTED|Overall Study||40
979969|NCT00363038|2374132|P1|NOT COMPLETED|Overall Study||0
979970|NCT00363038|2374132|P1|COMPLETED|Overall Study||16
979971|NCT00363038|2374132|P1|STARTED|Overall Study||16
979972|NCT00363051|2374138|P2|NOT COMPLETED|Overall Study||22
979973|NCT00363051|2374139|P1|NOT COMPLETED|Overall Study||38
979974|NCT00363051|2374138|P2|COMPLETED|Overall Study||23
979975|NCT00363051|2374139|P1|COMPLETED|Overall Study|Patients with documented disease progression per RECIST criteria|77
979976|NCT00363051|2374138|P2|STARTED|Overall Study||45
979977|NCT00363051|2374139|P1|STARTED|Overall Study||115
979978|NCT00363077|2374158|P2|NOT COMPLETED|Overall Study||0
979979|NCT00363077|2374159|P1|NOT COMPLETED|Overall Study||0
979980|NCT00363077|2374158|P2|COMPLETED|Overall Study||75
979981|NCT00363077|2374159|P1|COMPLETED|Overall Study||75
979982|NCT00363077|2374158|P2|STARTED|Overall Study||75
979983|NCT00363077|2374159|P1|STARTED|Overall Study||75
979984|NCT00363129|2374185|P2|NOT COMPLETED|Overall Study||33
979985|NCT00363129|2374186|P1|NOT COMPLETED|Overall Study||29
979986|NCT00363129|2374185|P2|COMPLETED|Overall Study||60
979987|NCT00363129|2374186|P1|COMPLETED|Overall Study||67
979988|NCT00363129|2374185|P2|STARTED|Overall Study||93
979989|NCT00363129|2374186|P1|STARTED|Overall Study||96
979990|NCT00363142|2374202|P2|NOT COMPLETED|Overall Study||3
979991|NCT00363142|2374203|P1|NOT COMPLETED|Overall Study||7
979992|NCT00363142|2374202|P2|COMPLETED|Overall Study||66
979993|NCT00363142|2374203|P1|COMPLETED|Overall Study||133
979994|NCT00363142|2374202|P2|STARTED|Overall Study||69
979995|NCT00363142|2374203|P1|STARTED|Overall Study||140
979996|NCT00363168|2374232|P2|NOT COMPLETED|Overall Study||0
979997|NCT00363168|2374233|P1|NOT COMPLETED|Overall Study||0
979998|NCT00363168|2374232|P2|COMPLETED|Overall Study||2
979999|NCT00363168|2374233|P1|COMPLETED|Overall Study||5
980000|NCT00363168|2374232|P2|STARTED|Overall Study||2
980001|NCT00363168|2374233|P1|STARTED|Overall Study||5
980002|NCT00363246|2374241|P1|NOT COMPLETED|Overall Study||97
980003|NCT00363246|2374241|P1|COMPLETED|Overall Study||669
980004|NCT00363246|2374241|P1|STARTED|Overall Study||766
980005|NCT00363298|2374248|P2|NOT COMPLETED|4-week Study Continuation Phase||0
980006|NCT00363298|2374249|P1|NOT COMPLETED|4-week Study Continuation Phase||1
980007|NCT00363298|2374248|P2|COMPLETED|4-week Study Continuation Phase||7
980008|NCT00363298|2374249|P1|COMPLETED|4-week Study Continuation Phase||5
980009|NCT00363298|2374248|P2|STARTED|4-week Study Continuation Phase||7
980010|NCT00363298|2374249|P1|STARTED|4-week Study Continuation Phase||6
980011|NCT00363298|2374248|P2|NOT COMPLETED|First Study Week||5
980012|NCT00363298|2374249|P1|NOT COMPLETED|First Study Week||6
980013|NCT00363298|2374248|P2|COMPLETED|First Study Week|At end of week 1, 7/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|7
980014|NCT00363298|2374249|P1|COMPLETED|First Study Week|At end of week 1, 6/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|6
980015|NCT00363298|2374248|P2|STARTED|First Study Week||12
980016|NCT00363298|2374249|P1|STARTED|First Study Week||12
980017|NCT00363311|2374259|P2|NOT COMPLETED|Overall Study||45
980018|NCT00363311|2374260|P1|NOT COMPLETED|Overall Study||76
980019|NCT00363311|2374259|P2|COMPLETED|Overall Study||102
980020|NCT00363311|2374260|P1|COMPLETED|Overall Study||79
980021|NCT00363311|2374259|P2|STARTED|Overall Study||147
980022|NCT00363311|2374260|P1|STARTED|Overall Study||155
980023|NCT00374543|2374326|P2|NOT COMPLETED|Overall Study||0
980024|NCT00374543|2374327|P1|NOT COMPLETED|Overall Study||0
980025|NCT00374543|2374326|P2|COMPLETED|Overall Study||1
980026|NCT00374543|2374327|P1|COMPLETED|Overall Study||2
980027|NCT00374543|2374326|P2|STARTED|Overall Study||1
980028|NCT00374543|2374327|P1|STARTED|Overall Study||2
980038|NCT00375427|2374406|P2|NOT COMPLETED|Overall Study||74
980039|NCT00375427|2374407|P1|NOT COMPLETED|Overall Study||60
980040|NCT00375427|2374406|P2|COMPLETED|Overall Study||142
980041|NCT00375427|2374407|P1|COMPLETED|Overall Study||149
980042|NCT00375427|2374406|P2|STARTED|Overall Study||216
980043|NCT00375427|2374407|P1|STARTED|Overall Study|Total enrollment was 430 but five patients were screened but not treated.|209
980044|NCT00375492|2374431|P2|NOT COMPLETED|Overall Study||26
980045|NCT00375492|2374432|P1|NOT COMPLETED|Overall Study||26
980047|NCT00375492|2374432|P1|COMPLETED|Overall Study||70
980048|NCT00375492|2374431|P2|STARTED|Overall Study||98
980049|NCT00375492|2374432|P1|STARTED|Overall Study||96
980050|NCT00375505|2374462|P2|NOT COMPLETED|Overall Study||2
980051|NCT00375505|2374463|P1|NOT COMPLETED|Overall Study||1
980052|NCT00375505|2374462|P2|COMPLETED|Overall Study||32
980053|NCT00375505|2374463|P1|COMPLETED|Overall Study||35
980054|NCT00375505|2374462|P2|STARTED|Overall Study||34
980055|NCT00375505|2374463|P1|STARTED|Overall Study||36
980056|NCT00375518|2374507|P2|NOT COMPLETED|Overall Study||17
980057|NCT00375518|2374508|P1|NOT COMPLETED|Overall Study||8
980058|NCT00375518|2374507|P2|COMPLETED|Overall Study||65
980059|NCT00375518|2374508|P1|COMPLETED|Overall Study||72
980060|NCT00375518|2374507|P2|STARTED|Overall Study||82
980061|NCT00375518|2374508|P1|STARTED|Overall Study||80
980062|NCT00375674|2374516|P2|NOT COMPLETED|Overall Study||115
980063|NCT00375674|2374517|P1|NOT COMPLETED|Overall Study||123
980064|NCT00375674|2374516|P2|COMPLETED|Overall Study||191
980065|NCT00375674|2374517|P1|COMPLETED|Overall Study||186
980066|NCT00375674|2374516|P2|STARTED|Overall Study||306
980067|NCT00375674|2374517|P1|STARTED|Overall Study||309
980068|NCT00375713|2374545|P2|NOT COMPLETED|Overall Study||23
980069|NCT00375713|2374546|P1|NOT COMPLETED|Overall Study||20
980070|NCT00375713|2374545|P2|COMPLETED|Overall Study|23 Patients were not treated or discontinued after randomization in Cetirizine group.|211
980071|NCT00375713|2374546|P1|COMPLETED|Overall Study|20 Patients were not treated or discontinued after randomization in Levocetirizine group.|212
980072|NCT00375713|2374545|P2|STARTED|Overall Study|Randomized population (N=234).|234
980073|NCT00375713|2374546|P1|STARTED|Overall Study|Randomized population (N=232).|232
980080|NCT00375934|2374577|P2|NOT COMPLETED|Overall Study||6
980081|NCT00375934|2374578|P1|NOT COMPLETED|Overall Study||3
980082|NCT00375934|2374577|P2|COMPLETED|Overall Study||95
980083|NCT00375934|2374578|P1|COMPLETED|Overall Study||96
980084|NCT00375934|2374577|P2|STARTED|Overall Study||101
980085|NCT00375934|2374578|P1|STARTED|Overall Study||99
980086|NCT00375973|2374606|P2|NOT COMPLETED|Overall Study||2
980087|NCT00375973|2374607|P1|NOT COMPLETED|Overall Study||10
980088|NCT00375973|2374606|P2|COMPLETED|Overall Study||28
980089|NCT00375973|2374607|P1|COMPLETED|Overall Study||20
980090|NCT00375973|2374606|P2|STARTED|Overall Study||30
980091|NCT00375973|2374607|P1|STARTED|Overall Study||30
980092|NCT00375999|2374625|P1|NOT COMPLETED|Overall Study||2
980093|NCT00375999|2374625|P1|COMPLETED|Overall Study||32
980094|NCT00375999|2374625|P1|STARTED|Overall Study||34
980095|NCT00376168|2374631|P2|NOT COMPLETED|Overall Study||1
980096|NCT00376168|2374632|P1|NOT COMPLETED|Overall Study||2
980097|NCT00376168|2374631|P2|COMPLETED|Overall Study||15
980098|NCT00376168|2374632|P1|COMPLETED|Overall Study||14
980099|NCT00376168|2374631|P2|STARTED|Overall Study|One patient randomized but not treated|16
980100|NCT00376168|2374632|P1|STARTED|Overall Study||16
980101|NCT00376220|2374648|P2|NOT COMPLETED|Overall Study||12
980102|NCT00376220|2374649|P1|NOT COMPLETED|Overall Study||10
980103|NCT00376220|2374648|P2|COMPLETED|Overall Study||35
980104|NCT00376220|2374649|P1|COMPLETED|Overall Study||37
980105|NCT00376220|2374648|P2|STARTED|Overall Study||47
980106|NCT00376220|2374649|P1|STARTED|Overall Study||47
980107|NCT00376259|2374657|P2|NOT COMPLETED|Overall Study||21
980108|NCT00376259|2374658|P1|NOT COMPLETED|Overall Study||22
980109|NCT00376259|2374657|P2|COMPLETED|Overall Study||0
980110|NCT00376259|2374658|P1|COMPLETED|Overall Study||0
980111|NCT00376259|2374657|P2|Received Study Drug|Overall Study||21
980112|NCT00376259|2374658|P1|Received Study Drug|Overall Study||21
980113|NCT00376259|2374657|P2|STARTED|Overall Study||21
980114|NCT00376259|2374658|P1|STARTED|Overall Study||22
980115|NCT00376363|2374672|P2|NOT COMPLETED|Overall Study||46
980116|NCT00376363|2374673|P1|NOT COMPLETED|Overall Study||56
980117|NCT00376363|2374672|P2|COMPLETED|Overall Study||87
980118|NCT00376363|2374673|P1|COMPLETED|Overall Study||87
980119|NCT00376363|2374672|P2|STARTED|Overall Study||133
980120|NCT00376363|2374673|P1|STARTED|Overall Study||143
980121|NCT00376506|2374685|P2|NOT COMPLETED|Overall Study||2
980122|NCT00376506|2374686|P1|NOT COMPLETED|Overall Study||0
980123|NCT00376506|2374685|P2|COMPLETED|Overall Study||4
980124|NCT00376506|2374686|P1|COMPLETED|Overall Study||4
980125|NCT00376506|2374685|P2|STARTED|Overall Study||6
980126|NCT00376506|2374686|P1|STARTED|Overall Study||4
980127|NCT00376532|2374704|P2|NOT COMPLETED|Overall Study||6
980128|NCT00376532|2374705|P1|NOT COMPLETED|Overall Study||6
980129|NCT00376532|2374704|P2|COMPLETED|Overall Study|Last non-event subject enrolled 3/18/2008.|26
980130|NCT00376532|2374705|P1|COMPLETED|Overall Study|Last event subject enrolled 2/22/2008|25
980131|NCT00376532|2374704|P2|STARTED|Overall Study|Subjects without an event were enrolled beginning 09/15/2006.|32
980132|NCT00376532|2374705|P1|STARTED|Overall Study|Subjects with an event were enrolled beginning 09/14/2006.|31
980133|NCT00376558|2374715|P2|NOT COMPLETED|Overall Study||0
980134|NCT00376558|2374716|P1|NOT COMPLETED|Overall Study||0
980135|NCT00376558|2374715|P2|COMPLETED|Overall Study||25
980136|NCT00376558|2374716|P1|COMPLETED|Overall Study||25
980137|NCT00376558|2374715|P2|STARTED|Overall Study||25
980138|NCT00376558|2374716|P1|STARTED|Overall Study||25
980139|NCT00376597|2374725|P2|NOT COMPLETED|Overall Study||3
980140|NCT00376597|2374726|P1|NOT COMPLETED|Overall Study||11
980141|NCT00376597|2374725|P2|COMPLETED|Overall Study||312
980142|NCT00376597|2374726|P1|COMPLETED|Overall Study||242
980143|NCT00376597|2374725|P2|STARTED|Overall Study||315
980144|NCT00376597|2374726|P1|STARTED|Overall Study||253
980145|NCT00376675|2374740|P2|NOT COMPLETED|Overall Study||14
980146|NCT00376675|2374741|P1|NOT COMPLETED|Overall Study||20
980147|NCT00376675|2374740|P2|COMPLETED|Overall Study||56
980148|NCT00376675|2374741|P1|COMPLETED|Overall Study||49
980149|NCT00376675|2374740|P2|STARTED|Overall Study||70
980150|NCT00376675|2374741|P1|STARTED|Overall Study||69
980154|NCT00376805|2374767|P1|NOT COMPLETED|Overall Study||0
980155|NCT00376805|2374767|P1|COMPLETED|Overall Study||6
980156|NCT00376805|2374767|P1|STARTED|Overall Study||6
980157|NCT00376935|2374778|P4|NOT COMPLETED|Overall Study||0
980158|NCT00376935|2374779|P3|NOT COMPLETED|Overall Study||0
980159|NCT00376935|2374780|P2|NOT COMPLETED|Overall Study||0
980160|NCT00376935|2374781|P1|NOT COMPLETED|Overall Study||0
980161|NCT00376935|2374778|P4|COMPLETED|Overall Study||24
980162|NCT00376935|2374779|P3|COMPLETED|Overall Study||25
980163|NCT00376935|2374780|P2|COMPLETED|Overall Study||25
980164|NCT00376935|2374781|P1|COMPLETED|Overall Study||25
980165|NCT00376935|2374778|P4|STARTED|Overall Study||24
980166|NCT00376935|2374779|P3|STARTED|Overall Study||25
980167|NCT00376935|2374780|P2|STARTED|Overall Study||25
980168|NCT00376935|2374781|P1|STARTED|Overall Study||25
980169|NCT00376948|2374819|P1|NOT COMPLETED|Overall Study||0
980170|NCT00376948|2374819|P1|COMPLETED|Overall Study||20
980171|NCT00376948|2374819|P1|STARTED|Overall Study||20
980172|NCT00376961|2374824|P2|NOT COMPLETED|Maintenance||23
980173|NCT00376961|2374825|P1|NOT COMPLETED|Maintenance||0
980174|NCT00376961|2374824|P2|COMPLETED|Maintenance||27
980175|NCT00376961|2374825|P1|COMPLETED|Maintenance||0
980176|NCT00376961|2374824|P2|Eligible|Maintenance||47
980177|NCT00376961|2374825|P1|Eligible|Maintenance||0
980178|NCT00376961|2374824|P2|STARTED|Maintenance||50
980179|NCT00376961|2374825|P1|STARTED|Maintenance||0
980180|NCT00376961|2374824|P2|NOT COMPLETED|Initial Registration||0
980181|NCT00376961|2374825|P1|NOT COMPLETED|Initial Registration||7
980182|NCT00376961|2374824|P2|COMPLETED|Initial Registration||0
980183|NCT00376961|2374825|P1|COMPLETED|Initial Registration||61
980184|NCT00376961|2374824|P2|Eligible|Initial Registration||0
980185|NCT00376961|2374825|P1|Eligible|Initial Registration||65
980186|NCT00376961|2374824|P2|STARTED|Initial Registration||0
980187|NCT00376961|2374825|P1|STARTED|Initial Registration||68
980188|NCT00377156|2374836|P2|NOT COMPLETED|Overall Study||54
980189|NCT00377156|2374837|P1|NOT COMPLETED|Overall Study||48
980190|NCT00377156|2374836|P2|COMPLETED|Overall Study||48
980191|NCT00377156|2374837|P1|COMPLETED|Overall Study||63
980192|NCT00377156|2374836|P2|STARTED|Overall Study||102
980193|NCT00377156|2374837|P1|STARTED|Overall Study||111
980194|NCT00377234|2374853|P2|NOT COMPLETED|Overall Study||31
980195|NCT00377234|2374854|P1|NOT COMPLETED|Overall Study||34
980196|NCT00377234|2374853|P2|COMPLETED|Overall Study||145
980197|NCT00377234|2374854|P1|COMPLETED|Overall Study||146
980198|NCT00377234|2374853|P2|Safety Analysis Set: Risedronate|Overall Study||174
980199|NCT00377234|2374854|P1|Safety Analysis Set: Risedronate|Overall Study||153
980200|NCT00377234|2374853|P2|Safety Analysis Set: Ibandronate|Overall Study||150
980201|NCT00377234|2374854|P1|Safety Analysis Set: Ibandronate|Overall Study||177
980202|NCT00377234|2374853|P2|Safety Analysis Set: Period 2|Overall Study||150
980203|NCT00377234|2374854|P1|Safety Analysis Set: Period 2|Overall Study||153
980204|NCT00377234|2374853|P2|Safety Analysis Set: Period 1|Overall Study||174
980205|NCT00377234|2374854|P1|Safety Analysis Set: Period 1|Overall Study||177
980206|NCT00377234|2374853|P2|Received Treatment|Overall Study||174
980207|NCT00377234|2374854|P1|Received Treatment|Overall Study||177
980208|NCT00377234|2374853|P2|Did Not Receive Study Treatment|Overall Study||2
980209|NCT00377234|2374854|P1|Did Not Receive Study Treatment|Overall Study||3
980210|NCT00377234|2374853|P2|Randomized|Overall Study||176
980211|NCT00377234|2374854|P1|Randomized|Overall Study||180
980212|NCT00377234|2374853|P2|STARTED|Overall Study||176
980213|NCT00377234|2374854|P1|STARTED|Overall Study||180
980214|NCT00377260|2374872|P2|NOT COMPLETED|Overall Study||5
980215|NCT00377260|2374873|P1|NOT COMPLETED|Overall Study||2
980216|NCT00377260|2374872|P2|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
980217|NCT00377260|2374873|P1|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
980218|NCT00377260|2374872|P2|STARTED|Overall Study||147
980219|NCT00377260|2374873|P1|STARTED|Overall Study||144
980220|NCT00377299|2374927|P2|NOT COMPLETED|Overall Study||24
980221|NCT00377299|2374928|P1|NOT COMPLETED|Overall Study||19
980222|NCT00377299|2374927|P2|COMPLETED|Overall Study||4
980223|NCT00377299|2374928|P1|COMPLETED|Overall Study||13
980224|NCT00377299|2374927|P2|STARTED|Overall Study||28
980225|NCT00377299|2374928|P1|STARTED|Overall Study||32
980226|NCT00377312|2374944|P2|NOT COMPLETED|Overall Study||1
980227|NCT00377312|2374945|P1|NOT COMPLETED|Overall Study||1
980228|NCT00377312|2374944|P2|COMPLETED|Overall Study||4
980229|NCT00377312|2374945|P1|COMPLETED|Overall Study||5
980230|NCT00377312|2374944|P2|STARTED|Overall Study||5
980231|NCT00377312|2374945|P1|STARTED|Overall Study||6
980232|NCT00377364|2374977|P2|NOT COMPLETED|Overall Study||0
980233|NCT00377364|2374978|P1|NOT COMPLETED|Overall Study||2
980234|NCT00377364|2374977|P2|COMPLETED|Overall Study||14
980235|NCT00377364|2374978|P1|COMPLETED|Overall Study||14
980236|NCT00377364|2374977|P2|STARTED|Overall Study||14
980237|NCT00377364|2374978|P1|STARTED|Overall Study||16
980238|NCT00377403|2375004|P2|NOT COMPLETED|Overall Study||7
980239|NCT00377403|2375005|P1|NOT COMPLETED|Overall Study||4
980240|NCT00377403|2375004|P2|COMPLETED|Overall Study|The number varied by day of follow-up from 71 to 77 in the symptomatic treatment only group.|74
980241|NCT00377403|2375005|P1|COMPLETED|Overall Study|The number varied by day of follow-up from 80 to 82 in the intervention group.|81
980242|NCT00377403|2375004|P2|Day 28 Assessment|Overall Study||77
980243|NCT00377403|2375005|P1|Day 28 Assessment|Overall Study||82
980244|NCT00377403|2375004|P2|Day 10 Assessment|Overall Study||71
980245|NCT00377403|2375005|P1|Day 10 Assessment|Overall Study||81
980246|NCT00377403|2375004|P2|Day 7 Assessment|Overall Study||75
980247|NCT00377403|2375005|P1|Day 7 Assessment|Overall Study||80
980248|NCT00377403|2375004|P2|Day -3 Assessment|Overall Study||74
980249|NCT00377403|2375005|P1|Day -3 Assessment|Overall Study||81
980250|NCT00377403|2375004|P2|STARTED|Overall Study||81
980251|NCT00377403|2375005|P1|STARTED|Overall Study||85
980252|NCT00377429|2375011|P1|NOT COMPLETED|Overall Study||15
980253|NCT00377429|2375011|P1|COMPLETED|Overall Study|Completed main study|32
980254|NCT00377429|2375011|P1|STARTED|Overall Study|Treated|47
980255|NCT00377455|2375020|P1|NOT COMPLETED|Overall Study||1
980256|NCT00377455|2375020|P1|COMPLETED|Overall Study||4
980257|NCT00377455|2375020|P1|STARTED|Overall Study||5
980258|NCT00377520|2375024|P1|NOT COMPLETED|Overall Study||1
980259|NCT00377520|2375024|P1|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|26
980260|NCT00377520|2375024|P1|STARTED|Overall Study||27
980261|NCT00377572|2375031|P2|NOT COMPLETED|Overall Study||54
980262|NCT00377572|2375032|P1|NOT COMPLETED|Overall Study||53
980263|NCT00377572|2375031|P2|COMPLETED|Overall Study||157
980264|NCT00377572|2375032|P1|COMPLETED|Overall Study||155
980265|NCT00377572|2375031|P2|STARTED|Overall Study||211
980266|NCT00377572|2375032|P1|STARTED|Overall Study||208
980267|NCT00369317|2375070|P1|NOT COMPLETED|Overall Study||20
980268|NCT00369317|2375070|P1|COMPLETED|Overall Study||185
980269|NCT00369317|2375070|P1|STARTED|Overall Study||205
980270|NCT00369343|2375086|P2|NOT COMPLETED|Open-label Phase||30
980271|NCT00369343|2375087|P1|NOT COMPLETED|Open-label Phase||57
980272|NCT00369343|2375086|P2|COMPLETED|Open-label Phase||79
980273|NCT00369343|2375087|P1|COMPLETED|Open-label Phase||155
980274|NCT00369343|2375086|P2|STARTED|Open-label Phase||109
980275|NCT00369343|2375087|P1|STARTED|Open-label Phase||212
980276|NCT00369343|2375086|P2|NOT COMPLETED|Double-blind Phase||16
980277|NCT00369343|2375087|P1|NOT COMPLETED|Double-blind Phase||44
980278|NCT00369343|2375086|P2|COMPLETED|Double-blind Phase||109
980279|NCT00369343|2375087|P1|COMPLETED|Double-blind Phase||212
980280|NCT00369343|2375086|P2|STARTED|Double-blind Phase||125
980281|NCT00369343|2375087|P1|STARTED|Double-blind Phase||256
980282|NCT00369382|2375122|P2|NOT COMPLETED|Overall Study||3
980283|NCT00369382|2375123|P1|NOT COMPLETED|Overall Study||10
980284|NCT00369382|2375122|P2|COMPLETED|Overall Study||54
980285|NCT00369382|2375123|P1|COMPLETED|Overall Study||49
980286|NCT00369382|2375122|P2|Completed Assigned Treatment Regimen|Overall Study||33
980287|NCT00369382|2375123|P1|Completed Assigned Treatment Regimen|Overall Study||48
980288|NCT00369382|2375122|P2|Received Treatment|Overall Study||57
980289|NCT00369382|2375123|P1|Received Treatment|Overall Study||57
980290|NCT00369382|2375122|P2|STARTED|Overall Study||57
980291|NCT00369382|2375123|P1|STARTED|Overall Study||59
980292|NCT00369486|2375159|P5|NOT COMPLETED|34-Week Visit||3
980293|NCT00369486|2375160|P4|NOT COMPLETED|34-Week Visit||3
980294|NCT00369486|2375161|P3|NOT COMPLETED|34-Week Visit||1
980295|NCT00369486|2375162|P2|NOT COMPLETED|34-Week Visit||1
980296|NCT00369486|2375163|P1|NOT COMPLETED|34-Week Visit||0
980297|NCT00369486|2375159|P5|COMPLETED|34-Week Visit|Number of eyes|22
980298|NCT00369486|2375160|P4|COMPLETED|34-Week Visit|Number of eyes|19
980299|NCT00369486|2375161|P3|COMPLETED|34-Week Visit|Number of eyes|22
980300|NCT00369486|2375162|P2|COMPLETED|34-Week Visit|Number of eyes|20
980301|NCT00369486|2375163|P1|COMPLETED|34-Week Visit|Number of eyes|38
980302|NCT00369486|2375159|P5|STARTED|34-Week Visit|Number of eyes that|25
980303|NCT00369486|2375160|P4|STARTED|34-Week Visit|Number of eyes|22
980304|NCT00369486|2375161|P3|STARTED|34-Week Visit|Number of eyes|23
980305|NCT00369486|2375162|P2|STARTED|34-Week Visit|Number of eyes|21
980306|NCT00369486|2375163|P1|STARTED|34-Week Visit|Number of eyes|38
980307|NCT00369486|2375159|P5|NOT COMPLETED|17-Week Visit||1
980308|NCT00369486|2375160|P4|NOT COMPLETED|17-Week Visit||1
980309|NCT00369486|2375161|P3|NOT COMPLETED|17-Week Visit||1
980310|NCT00369486|2375162|P2|NOT COMPLETED|17-Week Visit||0
980311|NCT00369486|2375163|P1|NOT COMPLETED|17-Week Visit||0
980312|NCT00369486|2375159|P5|COMPLETED|17-Week Visit|Number of eyes|24
980313|NCT00369486|2375160|P4|COMPLETED|17-Week Visit|Number of eyes|21
980314|NCT00369486|2375161|P3|COMPLETED|17-Week Visit|Number of eyes|22
980315|NCT00369486|2375162|P2|COMPLETED|17-Week Visit|Number of eyes|21
980316|NCT00369486|2375163|P1|COMPLETED|17-Week Visit|Number of eyes|38
980317|NCT00369486|2375159|P5|STARTED|17-Week Visit|Number of eyes|25
980318|NCT00369486|2375160|P4|STARTED|17-Week Visit|Number of eyes|22
980319|NCT00369486|2375161|P3|STARTED|17-Week Visit|Number of eyes|23
980320|NCT00369486|2375162|P2|STARTED|17-Week Visit|Number of eyes|21
980321|NCT00369486|2375163|P1|STARTED|17-Week Visit|Number of eyes|38
980322|NCT00369486|2375159|P5|NOT COMPLETED|8-Week Visit||1
980323|NCT00369486|2375160|P4|NOT COMPLETED|8-Week Visit||1
980324|NCT00369486|2375161|P3|NOT COMPLETED|8-Week Visit||0
980325|NCT00369486|2375162|P2|NOT COMPLETED|8-Week Visit||1
980326|NCT00369486|2375163|P1|NOT COMPLETED|8-Week Visit||0
980327|NCT00369486|2375159|P5|COMPLETED|8-Week Visit|Number of eyes|24
980328|NCT00369486|2375160|P4|COMPLETED|8-Week Visit|Number of eyes|21
980329|NCT00369486|2375161|P3|COMPLETED|8-Week Visit|Number of eyes|22
980330|NCT00369486|2375162|P2|COMPLETED|8-Week Visit|Number of eyes|20
980331|NCT00369486|2375163|P1|COMPLETED|8-Week Visit|Number of eyes|38
980332|NCT00369486|2375159|P5|STARTED|8-Week Visit|Number of eyes|25
980333|NCT00369486|2375160|P4|STARTED|8-Week Visit|Number of eyes|22
980334|NCT00369486|2375161|P3|STARTED|8-Week Visit|Number of eyes|22
980335|NCT00369486|2375162|P2|STARTED|8-Week Visit|Number of eyes|21
980336|NCT00369486|2375163|P1|STARTED|8-Week Visit|Number of eyes|38
980337|NCT00369486|2375159|P5|NOT COMPLETED|4-Week Visit||1
980338|NCT00369486|2375160|P4|NOT COMPLETED|4-Week Visit||2
980339|NCT00369486|2375161|P3|NOT COMPLETED|4-Week Visit||1
980340|NCT00369486|2375162|P2|NOT COMPLETED|4-Week Visit||2
980341|NCT00369486|2375163|P1|NOT COMPLETED|4-Week Visit||2
980342|NCT00369486|2375159|P5|COMPLETED|4-Week Visit|Number of eyes|24
980343|NCT00369486|2375160|P4|COMPLETED|4-Week Visit|Number of eyes|20
980344|NCT00369486|2375161|P3|COMPLETED|4-Week Visit|Number of eyes|22
980345|NCT00369486|2375162|P2|COMPLETED|4-Week Visit|Number of eyes;|19
980346|NCT00369486|2375163|P1|COMPLETED|4-Week Visit|Number of eyes|36
980347|NCT00369486|2375159|P5|STARTED|4-Week Visit|Number of eyes|25
980348|NCT00369486|2375160|P4|STARTED|4-Week Visit|Number of eyes|22
980349|NCT00369486|2375161|P3|STARTED|4-Week Visit|Number of eyes|23
980350|NCT00369486|2375162|P2|STARTED|4-Week Visit|Number of eyes|21
980351|NCT00369486|2375163|P1|STARTED|4-Week Visit|Number of eyes|38
980352|NCT00369512|2375200|P1|NOT COMPLETED|Overall Study||0
980353|NCT00369512|2375200|P1|COMPLETED|Overall Study||15
980354|NCT00369512|2375200|P1|STARTED|Overall Study||15
980355|NCT00369564|2375208|P2|NOT COMPLETED|Overall Study||23
980356|NCT00369564|2375209|P1|NOT COMPLETED|Overall Study||43
980357|NCT00369564|2375208|P2|COMPLETED|Overall Study||100
980358|NCT00369564|2375209|P1|COMPLETED|Overall Study||84
980359|NCT00369564|2375208|P2|STARTED|Overall Study||123
980360|NCT00369564|2375209|P1|STARTED|Overall Study||127
980361|NCT00369590|2375217|P2|NOT COMPLETED|Overall Study||0
980362|NCT00369590|2375218|P1|NOT COMPLETED|Overall Study||0
980363|NCT00369590|2375217|P2|COMPLETED|Overall Study||42
980364|NCT00369590|2375218|P1|COMPLETED|Overall Study||16
980365|NCT00369590|2375217|P2|STARTED|Overall Study||42
980366|NCT00369590|2375218|P1|STARTED|Overall Study||16
980367|NCT00369655|2375233|P1|NOT COMPLETED|Overall Study||2
980368|NCT00369655|2375233|P1|COMPLETED|Overall Study||19
980369|NCT00369655|2375233|P1|STARTED|Overall Study||21
980370|NCT00369668|2375245|P3|NOT COMPLETED|Overall Study||7
980371|NCT00369668|2375246|P2|NOT COMPLETED|Overall Study||5
980372|NCT00369668|2375247|P1|NOT COMPLETED|Overall Study||4
980373|NCT00369668|2375245|P3|COMPLETED|Overall Study||3
980374|NCT00369668|2375246|P2|COMPLETED|Overall Study||5
980375|NCT00369668|2375247|P1|COMPLETED|Overall Study||6
980376|NCT00369668|2375245|P3|STARTED|Overall Study||10
980377|NCT00369668|2375246|P2|STARTED|Overall Study||10
980378|NCT00369668|2375247|P1|STARTED|Overall Study|Original number of participants to be recruited for each group.|10
980379|NCT00369681|2375261|P1|NOT COMPLETED|Overall Study||1
980380|NCT00369681|2375261|P1|COMPLETED|Overall Study||49
980381|NCT00369681|2375261|P1|STARTED|Overall Study||50
980382|NCT00369746|2375269|P2|NOT COMPLETED|Overall Study||0
980383|NCT00369746|2375270|P1|NOT COMPLETED|Overall Study||0
980384|NCT00369746|2375269|P2|COMPLETED|Overall Study||536
980385|NCT00369746|2375270|P1|COMPLETED|Overall Study||138
980386|NCT00369746|2375269|P2|STARTED|Overall Study||536
980387|NCT00369746|2375270|P1|STARTED|Overall Study||138
980388|NCT00369785|2375282|P2|NOT COMPLETED|Overall Study||25
980389|NCT00369785|2375283|P1|NOT COMPLETED|Overall Study||27
980390|NCT00369785|2375282|P2|COMPLETED|Overall Study||74
980391|NCT00369785|2375283|P1|COMPLETED|Overall Study||72
980392|NCT00369785|2375282|P2|STARTED|Overall Study||99
980393|NCT00369785|2375283|P1|STARTED|Overall Study||99
980394|NCT00369824|2375297|P6|NOT COMPLETED|Overall Study||11
980395|NCT00369824|2375298|P5|NOT COMPLETED|Overall Study||18
980396|NCT00369824|2375299|P4|NOT COMPLETED|Overall Study||15
980397|NCT00369824|2375300|P3|NOT COMPLETED|Overall Study||12
980398|NCT00369824|2375301|P2|NOT COMPLETED|Overall Study||19
980399|NCT00369824|2375302|P1|NOT COMPLETED|Overall Study||15
980400|NCT00369824|2375297|P6|COMPLETED|Overall Study||204
980401|NCT00369824|2375298|P5|COMPLETED|Overall Study||196
980402|NCT00369824|2375299|P4|COMPLETED|Overall Study||199
980403|NCT00369824|2375300|P3|COMPLETED|Overall Study||202
980404|NCT00369824|2375301|P2|COMPLETED|Overall Study||195
980405|NCT00369824|2375302|P1|COMPLETED|Overall Study||197
980406|NCT00369824|2375297|P6|STARTED|Overall Study||215
980407|NCT00369824|2375298|P5|STARTED|Overall Study||214
980408|NCT00369824|2375299|P4|STARTED|Overall Study||214
980409|NCT00369824|2375300|P3|STARTED|Overall Study||214
980410|NCT00369824|2375301|P2|STARTED|Overall Study||214
980411|NCT00369824|2375302|P1|STARTED|Overall Study||212
980412|NCT00369915|2375402|P2|NOT COMPLETED|Overall Study||3
980413|NCT00369915|2375403|P1|NOT COMPLETED|Overall Study||6
980414|NCT00369915|2375402|P2|COMPLETED|Overall Study||4
980415|NCT00369915|2375403|P1|COMPLETED|Overall Study||4
980416|NCT00369915|2375402|P2|STARTED|Overall Study||7
980417|NCT00369915|2375403|P1|STARTED|Overall Study||10
980418|NCT00369928|2375414|P3|NOT COMPLETED|Overall Study||20
980419|NCT00369928|2375415|P2|NOT COMPLETED|Overall Study||16
980420|NCT00369928|2375416|P1|NOT COMPLETED|Overall Study||8
980421|NCT00369928|2375414|P3|COMPLETED|Overall Study||66
980422|NCT00369928|2375415|P2|COMPLETED|Overall Study||69
980423|NCT00369928|2375416|P1|COMPLETED|Overall Study||77
980424|NCT00369928|2375414|P3|STARTED|Overall Study||86
980425|NCT00369928|2375415|P2|STARTED|Overall Study||85
980426|NCT00369928|2375416|P1|STARTED|Overall Study||85
980427|NCT00369941|2375426|P2|NOT COMPLETED|Overall Study||100
980428|NCT00369941|2375427|P1|NOT COMPLETED|Overall Study||72
980429|NCT00369941|2375426|P2|COMPLETED|Overall Study||184
980430|NCT00369941|2375427|P1|COMPLETED|Overall Study||210
980431|NCT00369941|2375426|P2|Treated|Overall Study||282
980432|NCT00369941|2375427|P1|Treated|Overall Study||281
980433|NCT00369941|2375426|P2|STARTED|Overall Study||284
980434|NCT00369941|2375427|P1|STARTED|Overall Study||282
980435|NCT00369967|2375579|P2|NOT COMPLETED|Overall Study||12
980436|NCT00369967|2375580|P1|NOT COMPLETED|Overall Study||23
980437|NCT00369967|2375579|P2|COMPLETED|Overall Study||5
980438|NCT00369967|2375580|P1|COMPLETED|Overall Study||8
980439|NCT00369967|2375579|P2|STARTED|Overall Study||17
980440|NCT00369967|2375580|P1|STARTED|Overall Study||31
980441|NCT00370032|2375598|P2|NOT COMPLETED|Follow-up Period||0
980442|NCT00370032|2375599|P1|NOT COMPLETED|Follow-up Period||1
980443|NCT00370032|2375598|P2|COMPLETED|Follow-up Period||22
980444|NCT00370032|2375599|P1|COMPLETED|Follow-up Period||22
980445|NCT00370032|2375598|P2|STARTED|Follow-up Period||22
980446|NCT00370032|2375599|P1|STARTED|Follow-up Period||23
980447|NCT00370032|2375598|P2|NOT COMPLETED|Treatment Period 2||0
980448|NCT00370032|2375599|P1|NOT COMPLETED|Treatment Period 2||0
980449|NCT00370032|2375598|P2|COMPLETED|Treatment Period 2||22
980450|NCT00370032|2375599|P1|COMPLETED|Treatment Period 2||23
980451|NCT00370032|2375598|P2|STARTED|Treatment Period 2||22
980452|NCT00370032|2375599|P1|STARTED|Treatment Period 2||23
980453|NCT00370032|2375598|P2|NOT COMPLETED|Washout Period||2
980454|NCT00370032|2375599|P1|NOT COMPLETED|Washout Period||1
980455|NCT00370032|2375598|P2|COMPLETED|Washout Period||22
980456|NCT00370032|2375599|P1|COMPLETED|Washout Period||23
980457|NCT00370032|2375598|P2|STARTED|Washout Period||24
980458|NCT00370032|2375599|P1|STARTED|Washout Period||24
980459|NCT00370032|2375598|P2|NOT COMPLETED|Treatment Period 1||1
980460|NCT00370032|2375599|P1|NOT COMPLETED|Treatment Period 1||0
980461|NCT00370032|2375598|P2|COMPLETED|Treatment Period 1||24
980462|NCT00370032|2375599|P1|COMPLETED|Treatment Period 1||24
980463|NCT00370032|2375598|P2|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|25
980464|NCT00370032|2375599|P1|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|24
980465|NCT00370071|2375617|P1|NOT COMPLETED|Overall Study||2
980466|NCT00370071|2375617|P1|COMPLETED|Overall Study||37
980467|NCT00370071|2375617|P1|STARTED|Overall Study||39
980468|NCT00370149|2375634|P2|NOT COMPLETED|Overall Study||19
980469|NCT00370149|2375635|P1|NOT COMPLETED|Overall Study||19
980470|NCT00370149|2375634|P2|COMPLETED|Overall Study||142
980471|NCT00370149|2375635|P1|COMPLETED|Overall Study||146
980472|NCT00370149|2375634|P2|STARTED|Overall Study||161
980473|NCT00370149|2375635|P1|STARTED|Overall Study||165
980474|NCT00370292|2375647|P1|NOT COMPLETED|Overall Study||13
980475|NCT00370292|2375647|P1|COMPLETED|Overall Study||6
980476|NCT00370292|2375647|P1|STARTED|Overall Study||19
980477|NCT00370331|2375660|P2|NOT COMPLETED|Overall Study||23
980478|NCT00370331|2375661|P1|NOT COMPLETED|Overall Study||7
980479|NCT00370331|2375660|P2|COMPLETED|Overall Study||112
980480|NCT00370331|2375661|P1|COMPLETED|Overall Study||55
980481|NCT00370331|2375660|P2|STARTED|Overall Study||135
980482|NCT00370331|2375661|P1|STARTED|Overall Study||62
980483|NCT00370552|2375688|P3|NOT COMPLETED|Overall Study||32
980484|NCT00370552|2375689|P2|NOT COMPLETED|Overall Study||45
980485|NCT00370552|2375690|P1|NOT COMPLETED|Overall Study||46
980486|NCT00370552|2375688|P3|COMPLETED|Overall Study||0
980487|NCT00370552|2375689|P2|COMPLETED|Overall Study||0
980488|NCT00370552|2375690|P1|COMPLETED|Overall Study||0
980489|NCT00370552|2375688|P3|STARTED|Overall Study|Randomized|32
980490|NCT00370552|2375689|P2|STARTED|Overall Study|Randomized|45
980491|NCT00370552|2375690|P1|STARTED|Overall Study|Randomized|46
980492|NCT00370682|2375731|P3|NOT COMPLETED|Overall Study||1
980493|NCT00370682|2375732|P2|NOT COMPLETED|Overall Study||3
980494|NCT00370682|2375733|P1|NOT COMPLETED|Overall Study||0
980495|NCT00370682|2375731|P3|COMPLETED|Overall Study||39
980496|NCT00370682|2375732|P2|COMPLETED|Overall Study||37
980497|NCT00370682|2375733|P1|COMPLETED|Overall Study||40
980498|NCT00370682|2375731|P3|STARTED|Overall Study||40
980499|NCT00370682|2375732|P2|STARTED|Overall Study||40
980500|NCT00370682|2375733|P1|STARTED|Overall Study||40
980501|NCT00370838|2375774|P2|NOT COMPLETED|Taper||0
980502|NCT00370838|2375775|P1|NOT COMPLETED|Taper||0
980503|NCT00370838|2375774|P2|COMPLETED|Taper||3
980504|NCT00370838|2375775|P1|COMPLETED|Taper||7
980505|NCT00370838|2375774|P2|STARTED|Taper||3
980506|NCT00370838|2375775|P1|STARTED|Taper||7
980507|NCT00370838|2375774|P2|NOT COMPLETED|Period 2 (Days 65-107)||0
980508|NCT00370838|2375775|P1|NOT COMPLETED|Period 2 (Days 65-107)||0
980509|NCT00370838|2375774|P2|COMPLETED|Period 2 (Days 65-107)||3
980510|NCT00370838|2375775|P1|COMPLETED|Period 2 (Days 65-107)||7
980511|NCT00370838|2375774|P2|STARTED|Period 2 (Days 65-107)||3
980512|NCT00370838|2375775|P1|STARTED|Period 2 (Days 65-107)||7
980513|NCT00370838|2375774|P2|NOT COMPLETED|Washout (Days 51-64)||0
980514|NCT00370838|2375775|P1|NOT COMPLETED|Washout (Days 51-64)||0
980515|NCT00370838|2375774|P2|COMPLETED|Washout (Days 51-64)||3
980516|NCT00370838|2375775|P1|COMPLETED|Washout (Days 51-64)||7
980517|NCT00370838|2375774|P2|STARTED|Washout (Days 51-64)||3
980518|NCT00370838|2375775|P1|STARTED|Washout (Days 51-64)||7
980519|NCT00370838|2375774|P2|NOT COMPLETED|Period 1 (Days 8-50)||0
980520|NCT00370838|2375775|P1|NOT COMPLETED|Period 1 (Days 8-50)||0
980521|NCT00370838|2375774|P2|COMPLETED|Period 1 (Days 8-50)||3
980522|NCT00370838|2375775|P1|COMPLETED|Period 1 (Days 8-50)||7
980523|NCT00370838|2375774|P2|STARTED|Period 1 (Days 8-50)||3
980524|NCT00370838|2375775|P1|STARTED|Period 1 (Days 8-50)||7
980525|NCT00370994|2375795|P2|NOT COMPLETED|Overall Study||0
980526|NCT00370994|2375796|P1|NOT COMPLETED|Overall Study||0
980527|NCT00370994|2375795|P2|COMPLETED|Overall Study||60
980528|NCT00370994|2375796|P1|COMPLETED|Overall Study||60
980529|NCT00370994|2375795|P2|STARTED|Overall Study||60
980530|NCT00370994|2375796|P1|STARTED|Overall Study|Sample size was 200, due to the difficulties of recruiting we changed to 120|60
980531|NCT00371137|2375807|P3|NOT COMPLETED|Overall Study||79
980532|NCT00371137|2375808|P2|NOT COMPLETED|Overall Study||63
980533|NCT00371137|2375809|P1|NOT COMPLETED|Overall Study||72
980534|NCT00371137|2375807|P3|COMPLETED|Overall Study||104
980535|NCT00371137|2375808|P2|COMPLETED|Overall Study||119
980536|NCT00371137|2375809|P1|COMPLETED|Overall Study||111
980537|NCT00371137|2375807|P3|Treated|Overall Study||182
980538|NCT00371137|2375808|P2|Treated|Overall Study||182
980539|NCT00371137|2375809|P1|Treated|Overall Study||183
980540|NCT00371137|2375807|P3|STARTED|Overall Study||183
980541|NCT00371137|2375808|P2|STARTED|Overall Study||182
980542|NCT00371137|2375809|P1|STARTED|Overall Study||183
980543|NCT00371150|2375819|P2|NOT COMPLETED|Overall Study||2
980544|NCT00371150|2375820|P1|NOT COMPLETED|Overall Study||3
980545|NCT00371150|2375819|P2|COMPLETED|Overall Study|"Completion of treatment” means received treatment through Week 52"|4
980546|NCT00371150|2375820|P1|COMPLETED|Overall Study|"Completion of treatment” means received treatment through Week 52"|37
980547|NCT00371150|2375819|P2|Discontinued at or After Week 48 Visit|Overall Study||1
980548|NCT00371150|2375820|P1|Discontinued at or After Week 48 Visit|Overall Study||2
980549|NCT00371150|2375819|P2|Discontinued Prior to Week 48 Visit|Overall Study||1
980550|NCT00371150|2375820|P1|Discontinued Prior to Week 48 Visit|Overall Study||1
980551|NCT00371150|2375819|P2|STARTED|Overall Study||6
980552|NCT00371150|2375820|P1|STARTED|Overall Study||40
980553|NCT00371176|2375854|P2|NOT COMPLETED|Overall Study||8
980554|NCT00371176|2375855|P1|NOT COMPLETED|Overall Study||5
980555|NCT00371176|2375854|P2|COMPLETED|Overall Study||5
980556|NCT00371176|2375855|P1|COMPLETED|Overall Study||8
980557|NCT00371176|2375854|P2|Completed Treatment|Overall Study||9
980558|NCT00371176|2375855|P1|Completed Treatment|Overall Study||10
980559|NCT00371176|2375854|P2|STARTED|Overall Study||13
980560|NCT00371176|2375855|P1|STARTED|Overall Study||13
980561|NCT00371254|2375885|P2|NOT COMPLETED|Overall Study||21
980562|NCT00371254|2375886|P1|NOT COMPLETED|Overall Study||23
980563|NCT00371254|2375885|P2|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
980564|NCT00371254|2375886|P1|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
980565|NCT00371254|2375885|P2|STARTED|Overall Study|Number of participants treated|21
980566|NCT00371254|2375886|P1|STARTED|Overall Study|Number of participants treated|23
980567|NCT00371267|2375938|P2|NOT COMPLETED|Overall Study||18
980568|NCT00371267|2375939|P1|NOT COMPLETED|Overall Study||9
980569|NCT00371267|2375938|P2|COMPLETED|Overall Study||32
980570|NCT00371267|2375939|P1|COMPLETED|Overall Study||39
980571|NCT00371267|2375938|P2|STARTED|Overall Study||50
980572|NCT00371267|2375939|P1|STARTED|Overall Study||48
980573|NCT00371293|2375956|P3|NOT COMPLETED|Overall Study||16
980574|NCT00371293|2375957|P2|NOT COMPLETED|Overall Study||19
980575|NCT00371293|2375958|P1|NOT COMPLETED|Overall Study||10
980576|NCT00371293|2375956|P3|COMPLETED|Overall Study||46
980577|NCT00371293|2375957|P2|COMPLETED|Overall Study||42
980578|NCT00371293|2375958|P1|COMPLETED|Overall Study||48
980579|NCT00371293|2375956|P3|STARTED|Overall Study||62
980580|NCT00371293|2375957|P2|STARTED|Overall Study||61
980581|NCT00371293|2375958|P1|STARTED|Overall Study||58
980582|NCT00371345|2375980|P2|NOT COMPLETED|Overall Study||46
980583|NCT00371345|2375981|P1|NOT COMPLETED|Overall Study||24
980584|NCT00371345|2375980|P2|COMPLETED|Overall Study||0
980585|NCT00371345|2375981|P1|COMPLETED|Overall Study||0
980586|NCT00371345|2375980|P2|STARTED|Overall Study||46
980587|NCT00371345|2375981|P1|STARTED|Overall Study||24
980588|NCT00371397|2376038|P12|NOT COMPLETED|Session 3||0
980589|NCT00371397|2376039|P11|NOT COMPLETED|Session 3||0
980590|NCT00371397|2376040|P10|NOT COMPLETED|Session 3||0
980591|NCT00371397|2376041|P9|NOT COMPLETED|Session 3||0
980592|NCT00371397|2376042|P8|NOT COMPLETED|Session 3||0
980593|NCT00371397|2376043|P7|NOT COMPLETED|Session 3||0
980594|NCT00371397|2376044|P6|NOT COMPLETED|Session 3||0
980595|NCT00371397|2376045|P5|NOT COMPLETED|Session 3||0
980596|NCT00371397|2376046|P4|NOT COMPLETED|Session 3||0
980597|NCT00371397|2376047|P3|NOT COMPLETED|Session 3||0
980598|NCT00371397|2376048|P2|NOT COMPLETED|Session 3||0
980599|NCT00371397|2376049|P1|NOT COMPLETED|Session 3||0
980600|NCT00371397|2376038|P12|COMPLETED|Session 3||2
980601|NCT00371397|2376039|P11|COMPLETED|Session 3||4
980602|NCT00371397|2376040|P10|COMPLETED|Session 3||5
980603|NCT00371397|2376041|P9|COMPLETED|Session 3||6
980604|NCT00371397|2376042|P8|COMPLETED|Session 3||4
980605|NCT00371397|2376043|P7|COMPLETED|Session 3||4
980606|NCT00371397|2376044|P6|COMPLETED|Session 3||4
980607|NCT00371397|2376045|P5|COMPLETED|Session 3||3
980608|NCT00371397|2376046|P4|COMPLETED|Session 3||2
980609|NCT00371397|2376047|P3|COMPLETED|Session 3||5
980610|NCT00371397|2376048|P2|COMPLETED|Session 3||7
980611|NCT00371397|2376049|P1|COMPLETED|Session 3||4
980612|NCT00371397|2376038|P12|STARTED|Session 3||2
980613|NCT00371397|2376039|P11|STARTED|Session 3||4
980614|NCT00371397|2376040|P10|STARTED|Session 3||5
980615|NCT00371397|2376041|P9|STARTED|Session 3||6
980616|NCT00371397|2376042|P8|STARTED|Session 3||4
980617|NCT00371397|2376043|P7|STARTED|Session 3||4
980618|NCT00371397|2376044|P6|STARTED|Session 3||4
980619|NCT00371397|2376045|P5|STARTED|Session 3||3
980620|NCT00371397|2376046|P4|STARTED|Session 3||2
980621|NCT00371397|2376047|P3|STARTED|Session 3||5
980622|NCT00371397|2376048|P2|STARTED|Session 3||7
980623|NCT00371397|2376049|P1|STARTED|Session 3||4
980624|NCT00371397|2376038|P12|NOT COMPLETED|Session 2||0
980625|NCT00371397|2376039|P11|NOT COMPLETED|Session 2||0
980626|NCT00371397|2376040|P10|NOT COMPLETED|Session 2||0
980627|NCT00371397|2376041|P9|NOT COMPLETED|Session 2||0
980628|NCT00371397|2376042|P8|NOT COMPLETED|Session 2||0
980629|NCT00371397|2376043|P7|NOT COMPLETED|Session 2||0
980630|NCT00371397|2376044|P6|NOT COMPLETED|Session 2||0
980631|NCT00371397|2376045|P5|NOT COMPLETED|Session 2||0
980632|NCT00371397|2376046|P4|NOT COMPLETED|Session 2||0
980633|NCT00371397|2376047|P3|NOT COMPLETED|Session 2||0
980634|NCT00371397|2376048|P2|NOT COMPLETED|Session 2||0
980635|NCT00371397|2376049|P1|NOT COMPLETED|Session 2||0
980636|NCT00371397|2376038|P12|COMPLETED|Session 2||2
980637|NCT00371397|2376039|P11|COMPLETED|Session 2||4
980638|NCT00371397|2376040|P10|COMPLETED|Session 2||5
980639|NCT00371397|2376041|P9|COMPLETED|Session 2||6
980640|NCT00371397|2376042|P8|COMPLETED|Session 2||4
980641|NCT00371397|2376043|P7|COMPLETED|Session 2||4
980642|NCT00371397|2376044|P6|COMPLETED|Session 2||4
980643|NCT00371397|2376045|P5|COMPLETED|Session 2||3
980644|NCT00371397|2376046|P4|COMPLETED|Session 2||2
980645|NCT00371397|2376047|P3|COMPLETED|Session 2||5
980646|NCT00371397|2376048|P2|COMPLETED|Session 2||7
980647|NCT00371397|2376049|P1|COMPLETED|Session 2||4
980648|NCT00371397|2376038|P12|STARTED|Session 2||2
980649|NCT00371397|2376039|P11|STARTED|Session 2||4
980650|NCT00371397|2376040|P10|STARTED|Session 2||5
980651|NCT00371397|2376041|P9|STARTED|Session 2||6
980652|NCT00371397|2376042|P8|STARTED|Session 2||4
980653|NCT00371397|2376043|P7|STARTED|Session 2||4
980654|NCT00371397|2376044|P6|STARTED|Session 2||4
980655|NCT00371397|2376045|P5|STARTED|Session 2||3
980656|NCT00371397|2376046|P4|STARTED|Session 2||2
980657|NCT00371397|2376047|P3|STARTED|Session 2||5
980658|NCT00371397|2376048|P2|STARTED|Session 2||7
980659|NCT00371397|2376049|P1|STARTED|Session 2||4
980660|NCT00371397|2376038|P12|NOT COMPLETED|Session 1||0
980661|NCT00371397|2376039|P11|NOT COMPLETED|Session 1||0
980662|NCT00371397|2376040|P10|NOT COMPLETED|Session 1||0
980663|NCT00371397|2376041|P9|NOT COMPLETED|Session 1||0
980664|NCT00371397|2376042|P8|NOT COMPLETED|Session 1||1
980665|NCT00371397|2376043|P7|NOT COMPLETED|Session 1||0
980666|NCT00371397|2376044|P6|NOT COMPLETED|Session 1||0
980667|NCT00371397|2376045|P5|NOT COMPLETED|Session 1||0
980668|NCT00371397|2376046|P4|NOT COMPLETED|Session 1||0
980669|NCT00371397|2376047|P3|NOT COMPLETED|Session 1||0
980670|NCT00371397|2376048|P2|NOT COMPLETED|Session 1||0
980671|NCT00371397|2376049|P1|NOT COMPLETED|Session 1||1
980672|NCT00371397|2376038|P12|COMPLETED|Session 1||2
980673|NCT00371397|2376039|P11|COMPLETED|Session 1||4
980674|NCT00371397|2376040|P10|COMPLETED|Session 1||5
980675|NCT00371397|2376041|P9|COMPLETED|Session 1||6
980676|NCT00371397|2376042|P8|COMPLETED|Session 1||4
980677|NCT00371397|2376043|P7|COMPLETED|Session 1||4
980678|NCT00371397|2376044|P6|COMPLETED|Session 1||4
980679|NCT00371397|2376045|P5|COMPLETED|Session 1||3
980680|NCT00371397|2376046|P4|COMPLETED|Session 1||2
980681|NCT00371397|2376047|P3|COMPLETED|Session 1||5
980682|NCT00371397|2376048|P2|COMPLETED|Session 1||7
980683|NCT00371397|2376049|P1|COMPLETED|Session 1||4
980684|NCT00371397|2376038|P12|STARTED|Session 1||2
980685|NCT00371397|2376039|P11|STARTED|Session 1||4
980686|NCT00371397|2376040|P10|STARTED|Session 1||5
980687|NCT00371397|2376041|P9|STARTED|Session 1||6
980688|NCT00371397|2376042|P8|STARTED|Session 1||5
980689|NCT00371397|2376043|P7|STARTED|Session 1||4
980690|NCT00371397|2376044|P6|STARTED|Session 1||4
980691|NCT00371397|2376045|P5|STARTED|Session 1||3
980692|NCT00371397|2376046|P4|STARTED|Session 1||2
980693|NCT00371397|2376047|P3|STARTED|Session 1||5
980694|NCT00371397|2376048|P2|STARTED|Session 1||7
980695|NCT00371397|2376049|P1|STARTED|Session 1||5
980696|NCT00371436|2376057|P2|NOT COMPLETED|Overall Study||21
980697|NCT00371436|2376058|P1|NOT COMPLETED|Overall Study||34
980698|NCT00371436|2376057|P2|COMPLETED|Overall Study||68
980699|NCT00371436|2376058|P1|COMPLETED|Overall Study||58
980700|NCT00371436|2376057|P2|STARTED|Overall Study||89
980701|NCT00371436|2376058|P1|STARTED|Overall Study||92
980702|NCT00371449|2376064|P1|NOT COMPLETED|Overall Study||0
980703|NCT00371449|2376064|P1|COMPLETED|Overall Study||120
980704|NCT00371449|2376064|P1|STARTED|Overall Study||120
980705|NCT00371462|2376075|P2|NOT COMPLETED|Overall Study||8
980706|NCT00371462|2376076|P1|NOT COMPLETED|Overall Study||8
980707|NCT00371462|2376075|P2|COMPLETED|Overall Study||27
980708|NCT00371462|2376076|P1|COMPLETED|Overall Study||27
980709|NCT00371462|2376075|P2|STARTED|Overall Study||35
980710|NCT00371462|2376076|P1|STARTED|Overall Study||35
980711|NCT00371540|2376084|P2|NOT COMPLETED|Overall Study||9
980712|NCT00371540|2376085|P1|NOT COMPLETED|Overall Study||10
980713|NCT00371540|2376084|P2|COMPLETED|Overall Study||87
980714|NCT00371540|2376085|P1|COMPLETED|Overall Study||102
980715|NCT00371540|2376084|P2|STARTED|Overall Study||96
980716|NCT00371540|2376085|P1|STARTED|Overall Study||112
980717|NCT00371566|2376097|P2|NOT COMPLETED|Follow Up Phase||7
980718|NCT00371566|2376098|P1|NOT COMPLETED|Follow Up Phase||3
980719|NCT00371566|2376097|P2|COMPLETED|Follow Up Phase||58
980720|NCT00371566|2376098|P1|COMPLETED|Follow Up Phase||28
980721|NCT00371566|2376097|P2|STARTED|Follow Up Phase||65
980722|NCT00371566|2376098|P1|STARTED|Follow Up Phase||31
980723|NCT00371566|2376097|P2|NOT COMPLETED|Chemoradiation Phase||3
980724|NCT00371566|2376098|P1|NOT COMPLETED|Chemoradiation Phase||5
980725|NCT00371566|2376097|P2|COMPLETED|Chemoradiation Phase||65
980726|NCT00371566|2376098|P1|COMPLETED|Chemoradiation Phase||31
980727|NCT00371566|2376097|P2|STARTED|Chemoradiation Phase||68
980728|NCT00371566|2376098|P1|STARTED|Chemoradiation Phase||36
980729|NCT00371566|2376097|P2|NOT COMPLETED|Treatment Phase||3
980730|NCT00371566|2376098|P1|NOT COMPLETED|Treatment Phase||0
980731|NCT00371566|2376097|P2|COMPLETED|Treatment Phase|1 screen failure included in the ITT population|68
980732|NCT00371566|2376098|P1|COMPLETED|Treatment Phase||36
980733|NCT00371566|2376097|P2|STARTED|Treatment Phase||71
980734|NCT00371566|2376098|P1|STARTED|Treatment Phase||36
980735|NCT00371631|2376168|P1|NOT COMPLETED|Overall Study||0
980736|NCT00371631|2376168|P1|COMPLETED|Overall Study||13
980737|NCT00371631|2376168|P1|STARTED|Overall Study||13
980738|NCT00371644|2376175|P2|NOT COMPLETED|Overall Study||13
980739|NCT00371644|2376176|P1|NOT COMPLETED|Overall Study||28
980740|NCT00371644|2376175|P2|COMPLETED|Overall Study||44
980741|NCT00371644|2376176|P1|COMPLETED|Overall Study||44
980742|NCT00371644|2376175|P2|STARTED|Overall Study||57
980743|NCT00371644|2376176|P1|STARTED|Overall Study||72
980744|NCT00371683|2376184|P2|NOT COMPLETED|Follow-Up Period - Randomized Patients||72
980745|NCT00371683|2376185|P1|NOT COMPLETED|Follow-Up Period - Randomized Patients||61
980746|NCT00371683|2376184|P2|COMPLETED|Follow-Up Period - Randomized Patients||1461
980747|NCT00371683|2376185|P1|COMPLETED|Follow-Up Period - Randomized Patients||1492
980748|NCT00371683|2376184|P2|STARTED|Follow-Up Period - Randomized Patients||1533
980749|NCT00371683|2376185|P1|STARTED|Follow-Up Period - Randomized Patients||1553
980750|NCT00371683|2376184|P2|NOT COMPLETED|DB Treatment Period-Randomized Patients||107
980751|NCT00371683|2376185|P1|NOT COMPLETED|DB Treatment Period-Randomized Patients||90
980752|NCT00371683|2376184|P2|COMPLETED|DB Treatment Period-Randomized Patients||1489
980753|NCT00371683|2376185|P1|COMPLETED|DB Treatment Period-Randomized Patients||1509
980754|NCT00371683|2376184|P2|STARTED|DB Treatment Period-Randomized Patients||1596
980755|NCT00371683|2376185|P1|STARTED|DB Treatment Period-Randomized Patients||1599
980756|NCT00371761|2376239|P2|NOT COMPLETED|Overall Study||10
980757|NCT00371761|2376240|P1|NOT COMPLETED|Overall Study||8
980758|NCT00371761|2376239|P2|COMPLETED|Overall Study||2
980759|NCT00371761|2376240|P1|COMPLETED|Overall Study||5
980760|NCT00371761|2376239|P2|STARTED|Overall Study||12
980761|NCT00371761|2376240|P1|STARTED|Overall Study||13
980762|NCT00371787|2376248|P2|NOT COMPLETED|Overall Study||1
980763|NCT00371787|2376249|P1|NOT COMPLETED|Overall Study||3
980764|NCT00371787|2376248|P2|COMPLETED|Overall Study||11
980765|NCT00371787|2376249|P1|COMPLETED|Overall Study||23
980766|NCT00371787|2376248|P2|STARTED|Overall Study||12
980767|NCT00371787|2376249|P1|STARTED|Overall Study||26
980768|NCT00371826|2376264|P3|NOT COMPLETED|Extension Phase (24 Months)||2
980769|NCT00371826|2376265|P2|NOT COMPLETED|Extension Phase (24 Months)||10
980770|NCT00371826|2376266|P1|NOT COMPLETED|Extension Phase (24 Months)||5
980771|NCT00371826|2376264|P3|COMPLETED|Extension Phase (24 Months)||3
980772|NCT00371826|2376265|P2|COMPLETED|Extension Phase (24 Months)||29
980773|NCT00371826|2376266|P1|COMPLETED|Extension Phase (24 Months)||18
980774|NCT00371826|2376264|P3|Safety Set|Extension Phase (24 Months)|Patient withdrawn as per DMC suggestion had no efficacy data, but was included in safety set.|5
980775|NCT00371826|2376265|P2|Safety Set|Extension Phase (24 Months)|One patient mis-randomised to 1st arm but treated in this arm, evaluated for safety in this arm.|40
980776|NCT00371826|2376266|P1|Safety Set|Extension Phase (24 Months)|One patient randomized to this arm, was treated with the control regimen (CNI+MPA+Steroid)|22
980777|NCT00371826|2376264|P3|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)|One patient entered extension, was withdrawn (no efficacy data in extension) due to DMC suggestion|4
980778|NCT00371826|2376265|P2|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||39
980779|NCT00371826|2376266|P1|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||23
980780|NCT00371826|2376264|P3|STARTED|Extension Phase (24 Months)|One patient completed core, did not wish to continue to extension.|5
980781|NCT00371826|2376265|P2|STARTED|Extension Phase (24 Months)||39
980782|NCT00371826|2376266|P1|STARTED|Extension Phase (24 Months)|2 patients who completed 12 month core did not wish to continue in extension.|23
980783|NCT00371826|2376264|P3|NOT COMPLETED|Core Phase (12 Months)||24
980784|NCT00371826|2376265|P2|NOT COMPLETED|Core Phase (12 Months)||8
980785|NCT00371826|2376266|P1|NOT COMPLETED|Core Phase (12 Months)||24
980786|NCT00371826|2376264|P3|COMPLETED|Core Phase (12 Months)||6
980787|NCT00371826|2376265|P2|COMPLETED|Core Phase (12 Months)||39
980788|NCT00371826|2376266|P1|COMPLETED|Core Phase (12 Months)|"Completed means patients were still on study medication by month 12."|25
980789|NCT00371826|2376264|P3|Modified Intent to Treat (mITT)|Core Phase (12 Months)||6
980790|NCT00371826|2376265|P2|Modified Intent to Treat (mITT)|Core Phase (12 Months)||39
980791|NCT00371826|2376266|P1|Modified Intent to Treat (mITT)|Core Phase (12 Months)||27
980792|NCT00371826|2376264|P3|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||20
980793|NCT00371826|2376265|P2|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||44
980794|NCT00371826|2376266|P1|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||46
980795|NCT00371826|2376264|P3|STARTED|Core Phase (12 Months)||30
980796|NCT00371826|2376265|P2|STARTED|Core Phase (12 Months)||47
980797|NCT00371826|2376266|P1|STARTED|Core Phase (12 Months)|"Started indicates patients in Randomized, Intent to treat (ITT) and Safety set."|49
980798|NCT00377637|2376392|P4|NOT COMPLETED|Maintenance Phase||57
980799|NCT00377637|2376393|P3|NOT COMPLETED|Maintenance Phase||43
980800|NCT00377637|2376394|P2|NOT COMPLETED|Maintenance Phase||0
980801|NCT00377637|2376395|P1|NOT COMPLETED|Maintenance Phase||0
980802|NCT00377637|2376392|P4|COMPLETED|Maintenance Phase||54
980803|NCT00377637|2376393|P3|COMPLETED|Maintenance Phase||73
980804|NCT00377637|2376394|P2|COMPLETED|Maintenance Phase||0
980805|NCT00377637|2376395|P1|COMPLETED|Maintenance Phase||0
980806|NCT00377637|2376392|P4|STARTED|Maintenance Phase||111
980807|NCT00377637|2376393|P3|STARTED|Maintenance Phase||116
980808|NCT00377637|2376394|P2|STARTED|Maintenance Phase||0
980809|NCT00377637|2376395|P1|STARTED|Maintenance Phase||0
980810|NCT00377637|2376392|P4|NOT COMPLETED|Induction Phase||0
980811|NCT00377637|2376393|P3|NOT COMPLETED|Induction Phase||0
980812|NCT00377637|2376394|P2|NOT COMPLETED|Induction Phase||35
980813|NCT00377637|2376395|P1|NOT COMPLETED|Induction Phase||29
980814|NCT00377637|2376392|P4|COMPLETED|Induction Phase||0
980815|NCT00377637|2376393|P3|COMPLETED|Induction Phase||0
980816|NCT00377637|2376394|P2|COMPLETED|Induction Phase||150
980817|NCT00377637|2376395|P1|COMPLETED|Induction Phase||156
980818|NCT00377637|2376392|P4|Safety Population|Induction Phase||0
980819|NCT00377637|2376393|P3|Safety Population|Induction Phase||0
980820|NCT00377637|2376394|P2|Safety Population|Induction Phase||184
980821|NCT00377637|2376395|P1|Safety Population|Induction Phase||180
980822|NCT00377637|2376392|P4|STARTED|Induction Phase||0
980823|NCT00377637|2376393|P3|STARTED|Induction Phase||0
980824|NCT00377637|2376394|P2|STARTED|Induction Phase|Intent-To-Treat|185
980825|NCT00377637|2376395|P1|STARTED|Induction Phase|Intent-To-Treat|185
980826|NCT00377676|2376431|P2|NOT COMPLETED|Overall Study||322
980827|NCT00377676|2376432|P1|NOT COMPLETED|Overall Study||961
980828|NCT00377676|2376431|P2|COMPLETED|Overall Study||694
980829|NCT00377676|2376432|P1|COMPLETED|Overall Study||1093
980830|NCT00377676|2376431|P2|STARTED|Overall Study||1016
980831|NCT00377676|2376432|P1|STARTED|Overall Study|25 subjects did not receive study drug - thus 3070 were randomized and received drug|2054
980832|NCT00377741|2376446|P2|NOT COMPLETED|Overall Study||0
980833|NCT00377741|2376447|P1|NOT COMPLETED|Overall Study||0
980834|NCT00377741|2376446|P2|COMPLETED|Overall Study||15
980835|NCT00377741|2376447|P1|COMPLETED|Overall Study||16
980836|NCT00377741|2376446|P2|STARTED|Overall Study||15
980837|NCT00377741|2376447|P1|STARTED|Overall Study||16
980838|NCT00377819|2376463|P2|NOT COMPLETED|Overall Study||10
980839|NCT00377819|2376464|P1|NOT COMPLETED|Overall Study||13
980840|NCT00377819|2376463|P2|COMPLETED|Overall Study||243
980841|NCT00377819|2376464|P1|COMPLETED|Overall Study||238
980842|NCT00377819|2376463|P2|Received Study Medication|Overall Study||253
980843|NCT00377819|2376464|P1|Received Study Medication|Overall Study||249
980844|NCT00377819|2376463|P2|STARTED|Overall Study||253
980845|NCT00377819|2376464|P1|STARTED|Overall Study||251
980846|NCT00377832|2376476|P2|NOT COMPLETED|Overall Study||0
980847|NCT00377832|2376477|P1|NOT COMPLETED|Overall Study||0
980848|NCT00377832|2376476|P2|COMPLETED|Overall Study||6
980849|NCT00377832|2376477|P1|COMPLETED|Overall Study||7
980850|NCT00377832|2376476|P2|STARTED|Overall Study||6
980851|NCT00377832|2376477|P1|STARTED|Overall Study||7
980852|NCT00377858|2376499|P2|NOT COMPLETED|Overall Study||27
980853|NCT00377858|2376500|P1|NOT COMPLETED|Overall Study||31
980854|NCT00377858|2376499|P2|COMPLETED|Overall Study||215
980855|NCT00377858|2376500|P1|COMPLETED|Overall Study||211
980856|NCT00377858|2376499|P2|Had at Least One Post-Baseline Value|Overall Study||240
980857|NCT00377858|2376500|P1|Had at Least One Post-Baseline Value|Overall Study||239
980858|NCT00377858|2376499|P2|STARTED|Overall Study||242
980859|NCT00377858|2376500|P1|STARTED|Overall Study||242
980860|NCT00378014|2376530|P2|NOT COMPLETED|Extension (Month 12 to Month 59)||14
980861|NCT00378014|2376531|P1|NOT COMPLETED|Extension (Month 12 to Month 59)||14
980862|NCT00378014|2376530|P2|COMPLETED|Extension (Month 12 to Month 59)||26
980863|NCT00378014|2376531|P1|COMPLETED|Extension (Month 12 to Month 59)||27
980864|NCT00378014|2376530|P2|STARTED|Extension (Month 12 to Month 59)||40
980865|NCT00378014|2376531|P1|STARTED|Extension (Month 12 to Month 59)||41
980866|NCT00378014|2376530|P2|NOT COMPLETED|Core (Randomization to Month 11)||12
980867|NCT00378014|2376531|P1|NOT COMPLETED|Core (Randomization to Month 11)||14
980868|NCT00378014|2376530|P2|COMPLETED|Core (Randomization to Month 11)||90
980869|NCT00378014|2376531|P1|COMPLETED|Core (Randomization to Month 11)||87
980870|NCT00378014|2376530|P2|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|98
980871|NCT00378014|2376531|P1|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|96
980872|NCT00378014|2376530|P2|STARTED|Core (Randomization to Month 11)||102
980873|NCT00378014|2376531|P1|STARTED|Core (Randomization to Month 11)||101
980874|NCT00378079|2376558|P3|NOT COMPLETED|Overall Study||0
980875|NCT00378079|2376559|P2|NOT COMPLETED|Overall Study||1
980876|NCT00378079|2376560|P1|NOT COMPLETED|Overall Study||6
980877|NCT00378079|2376558|P3|COMPLETED|Overall Study||71
980878|NCT00378079|2376559|P2|COMPLETED|Overall Study||69
980879|NCT00378079|2376560|P1|COMPLETED|Overall Study||64
980880|NCT00378079|2376558|P3|STARTED|Overall Study||71
980881|NCT00378079|2376559|P2|STARTED|Overall Study||70
980882|NCT00378079|2376560|P1|STARTED|Overall Study||70
980883|NCT00378105|2376582|P2|NOT COMPLETED|Overall Study||30
980884|NCT00378105|2376583|P1|NOT COMPLETED|Overall Study||20
980885|NCT00378105|2376582|P2|COMPLETED|Overall Study||5
980886|NCT00378105|2376583|P1|COMPLETED|Overall Study||11
980887|NCT00378105|2376582|P2|STARTED|Overall Study||35
980888|NCT00378105|2376583|P1|STARTED|Overall Study|Out of 33 enrolled, two patients went off study before start of therapy.|31
980889|NCT00378209|2376592|P1|NOT COMPLETED|Overall Study||22
980890|NCT00378209|2376592|P1|COMPLETED|Overall Study|This included patients who completed at least 8 cycles of combination therapy with all drugs.|42
980891|NCT00378209|2376592|P1|STARTED|Overall Study|1 patient who never started treatment was excluded in the analysis.|64
980892|NCT00378326|2376600|P1|NOT COMPLETED|Overall Study||0
980893|NCT00378326|2376600|P1|COMPLETED|Overall Study||26
980894|NCT00378326|2376600|P1|STARTED|Overall Study||26
980895|NCT00378352|2376608|P6|NOT COMPLETED|Efficacy Phase||7
980896|NCT00378352|2376609|P5|NOT COMPLETED|Efficacy Phase||11
980897|NCT00378352|2376610|P4|NOT COMPLETED|Efficacy Phase||0
980898|NCT00378352|2376611|P3|NOT COMPLETED|Efficacy Phase||0
980899|NCT00378352|2376612|P2|NOT COMPLETED|Efficacy Phase||0
980900|NCT00378352|2376613|P1|NOT COMPLETED|Efficacy Phase||0
980901|NCT00378352|2376608|P6|COMPLETED|Efficacy Phase||59
980902|NCT00378352|2376609|P5|COMPLETED|Efficacy Phase||54
980903|NCT00378352|2376610|P4|COMPLETED|Efficacy Phase||0
980904|NCT00378352|2376611|P3|COMPLETED|Efficacy Phase||0
980905|NCT00378352|2376612|P2|COMPLETED|Efficacy Phase||0
980906|NCT00378352|2376613|P1|COMPLETED|Efficacy Phase||0
980907|NCT00378352|2376608|P6|Safety Analysis|Efficacy Phase||64
980908|NCT00378352|2376609|P5|Safety Analysis|Efficacy Phase|Two participants randomized to placebo received 60,000 units Epoetin alfa|67
980909|NCT00378352|2376610|P4|Safety Analysis|Efficacy Phase||0
980910|NCT00378352|2376611|P3|Safety Analysis|Efficacy Phase||0
980911|NCT00378352|2376612|P2|Safety Analysis|Efficacy Phase||0
980912|NCT00378352|2376613|P1|Safety Analysis|Efficacy Phase||0
980913|NCT00378352|2376608|P6|STARTED|Efficacy Phase||66
980914|NCT00378352|2376609|P5|STARTED|Efficacy Phase||65
980915|NCT00378352|2376610|P4|STARTED|Efficacy Phase||0
980916|NCT00378352|2376611|P3|STARTED|Efficacy Phase||0
980917|NCT00378352|2376612|P2|STARTED|Efficacy Phase||0
980918|NCT00378352|2376613|P1|STARTED|Efficacy Phase||0
980919|NCT00378352|2376608|P6|NOT COMPLETED|Dose Escalation 60,000 Units||0
980920|NCT00378352|2376609|P5|NOT COMPLETED|Dose Escalation 60,000 Units||0
980921|NCT00378352|2376610|P4|NOT COMPLETED|Dose Escalation 60,000 Units||1
980922|NCT00378352|2376611|P3|NOT COMPLETED|Dose Escalation 60,000 Units||3
980923|NCT00378352|2376612|P2|NOT COMPLETED|Dose Escalation 60,000 Units||0
980924|NCT00378352|2376613|P1|NOT COMPLETED|Dose Escalation 60,000 Units||0
980925|NCT00378352|2376608|P6|COMPLETED|Dose Escalation 60,000 Units||0
980926|NCT00378352|2376609|P5|COMPLETED|Dose Escalation 60,000 Units||0
980927|NCT00378352|2376610|P4|COMPLETED|Dose Escalation 60,000 Units||10
980928|NCT00378352|2376611|P3|COMPLETED|Dose Escalation 60,000 Units||17
980929|NCT00378352|2376612|P2|COMPLETED|Dose Escalation 60,000 Units||0
980930|NCT00378352|2376613|P1|COMPLETED|Dose Escalation 60,000 Units||0
980931|NCT00378352|2376608|P6|Safety Analysis|Dose Escalation 60,000 Units||0
980932|NCT00378352|2376609|P5|Safety Analysis|Dose Escalation 60,000 Units||0
980933|NCT00378352|2376610|P4|Safety Analysis|Dose Escalation 60,000 Units||11
980934|NCT00378352|2376611|P3|Safety Analysis|Dose Escalation 60,000 Units||19
980935|NCT00378352|2376612|P2|Safety Analysis|Dose Escalation 60,000 Units||0
980936|NCT00378352|2376613|P1|Safety Analysis|Dose Escalation 60,000 Units||0
980937|NCT00378352|2376608|P6|STARTED|Dose Escalation 60,000 Units||0
980938|NCT00378352|2376609|P5|STARTED|Dose Escalation 60,000 Units||0
980939|NCT00378352|2376610|P4|STARTED|Dose Escalation 60,000 Units||11
980940|NCT00378352|2376611|P3|STARTED|Dose Escalation 60,000 Units||20
980941|NCT00378352|2376612|P2|STARTED|Dose Escalation 60,000 Units||0
980942|NCT00378352|2376613|P1|STARTED|Dose Escalation 60,000 Units||0
980943|NCT00378352|2376608|P6|NOT COMPLETED|Dose Escalation 30,000 Units||0
980944|NCT00378352|2376609|P5|NOT COMPLETED|Dose Escalation 30,000 Units||0
980945|NCT00378352|2376610|P4|NOT COMPLETED|Dose Escalation 30,000 Units||2
980946|NCT00378352|2376611|P3|NOT COMPLETED|Dose Escalation 30,000 Units||0
980947|NCT00378352|2376612|P2|NOT COMPLETED|Dose Escalation 30,000 Units||3
980948|NCT00378352|2376613|P1|NOT COMPLETED|Dose Escalation 30,000 Units||0
980949|NCT00378352|2376608|P6|COMPLETED|Dose Escalation 30,000 Units||0
980950|NCT00378352|2376609|P5|COMPLETED|Dose Escalation 30,000 Units||0
980951|NCT00378352|2376610|P4|COMPLETED|Dose Escalation 30,000 Units||9
980952|NCT00378352|2376611|P3|COMPLETED|Dose Escalation 30,000 Units||0
980953|NCT00378352|2376612|P2|COMPLETED|Dose Escalation 30,000 Units||16
980954|NCT00378352|2376613|P1|COMPLETED|Dose Escalation 30,000 Units||0
980955|NCT00378352|2376608|P6|Safety Analysis|Dose Escalation 30,000 Units||0
980956|NCT00378352|2376609|P5|Safety Analysis|Dose Escalation 30,000 Units||0
980957|NCT00378352|2376610|P4|Safety Analysis|Dose Escalation 30,000 Units||11
980958|NCT00378352|2376611|P3|Safety Analysis|Dose Escalation 30,000 Units||0
980959|NCT00378352|2376612|P2|Safety Analysis|Dose Escalation 30,000 Units|One participant randomized to 60,000 units received 30,000 units|20
980960|NCT00378352|2376613|P1|Safety Analysis|Dose Escalation 30,000 Units||0
980961|NCT00378352|2376608|P6|STARTED|Dose Escalation 30,000 Units||0
980962|NCT00378352|2376609|P5|STARTED|Dose Escalation 30,000 Units||0
980963|NCT00378352|2376610|P4|STARTED|Dose Escalation 30,000 Units||11
980964|NCT00378352|2376611|P3|STARTED|Dose Escalation 30,000 Units||0
980965|NCT00378352|2376612|P2|STARTED|Dose Escalation 30,000 Units||19
980966|NCT00378352|2376613|P1|STARTED|Dose Escalation 30,000 Units||0
980967|NCT00378352|2376608|P6|NOT COMPLETED|Dose Escalation 15,000 Units||0
980968|NCT00378352|2376609|P5|NOT COMPLETED|Dose Escalation 15,000 Units||0
980969|NCT00378352|2376610|P4|NOT COMPLETED|Dose Escalation 15,000 Units||1
980970|NCT00378352|2376611|P3|NOT COMPLETED|Dose Escalation 15,000 Units||0
980971|NCT00378352|2376612|P2|NOT COMPLETED|Dose Escalation 15,000 Units||0
980972|NCT00378352|2376613|P1|NOT COMPLETED|Dose Escalation 15,000 Units||5
980973|NCT00378352|2376608|P6|COMPLETED|Dose Escalation 15,000 Units||0
980974|NCT00378352|2376609|P5|COMPLETED|Dose Escalation 15,000 Units||0
980975|NCT00378352|2376610|P4|COMPLETED|Dose Escalation 15,000 Units||10
980976|NCT00378352|2376611|P3|COMPLETED|Dose Escalation 15,000 Units||0
980977|NCT00378352|2376612|P2|COMPLETED|Dose Escalation 15,000 Units||0
980978|NCT00378352|2376613|P1|COMPLETED|Dose Escalation 15,000 Units||15
980979|NCT00378352|2376608|P6|Safety Analysis|Dose Escalation 15,000 Units||0
980980|NCT00378352|2376609|P5|Safety Analysis|Dose Escalation 15,000 Units||0
980981|NCT00378352|2376610|P4|Safety Analysis|Dose Escalation 15,000 Units||11
980982|NCT00378352|2376611|P3|Safety Analysis|Dose Escalation 15,000 Units||0
980983|NCT00378352|2376612|P2|Safety Analysis|Dose Escalation 15,000 Units||0
980984|NCT00378352|2376613|P1|Safety Analysis|Dose Escalation 15,000 Units||19
980985|NCT00378352|2376608|P6|STARTED|Dose Escalation 15,000 Units||0
980986|NCT00378352|2376609|P5|STARTED|Dose Escalation 15,000 Units||0
980987|NCT00378352|2376610|P4|STARTED|Dose Escalation 15,000 Units||11
980988|NCT00378352|2376611|P3|STARTED|Dose Escalation 15,000 Units||0
980989|NCT00378352|2376612|P2|STARTED|Dose Escalation 15,000 Units||0
980990|NCT00378352|2376613|P1|STARTED|Dose Escalation 15,000 Units||20
980991|NCT00378378|2376638|P3|NOT COMPLETED|Overall Study||2
980992|NCT00378378|2376639|P2|NOT COMPLETED|Overall Study||1
980993|NCT00378378|2376640|P1|NOT COMPLETED|Overall Study||0
980994|NCT00378378|2376638|P3|COMPLETED|Overall Study||24
980995|NCT00378378|2376639|P2|COMPLETED|Overall Study||49
980996|NCT00378378|2376640|P1|COMPLETED|Overall Study||51
980997|NCT00378378|2376638|P3|STARTED|Overall Study||26
980998|NCT00378378|2376639|P2|STARTED|Overall Study||50
980999|NCT00378378|2376640|P1|STARTED|Overall Study||51
981000|NCT00378508|2376653|P2|NOT COMPLETED|Overall Study||3
981001|NCT00378508|2376654|P1|NOT COMPLETED|Overall Study||2
981002|NCT00378508|2376653|P2|COMPLETED|Overall Study||31
981003|NCT00378508|2376654|P1|COMPLETED|Overall Study||27
981004|NCT00378508|2376653|P2|Received Intervention/Placebo|Overall Study||31
981005|NCT00378508|2376654|P1|Received Intervention/Placebo|Overall Study||28
981006|NCT00378508|2376653|P2|Randomized|Overall Study||34
981007|NCT00378508|2376654|P1|Randomized|Overall Study||29
981008|NCT00378508|2376653|P2|STARTED|Overall Study||34
981009|NCT00378508|2376654|P1|STARTED|Overall Study||29
981010|NCT00378534|2376670|P1|NOT COMPLETED|Overall Study||60
981011|NCT00378534|2376670|P1|COMPLETED|Overall Study|Transplantation Recipients|55
981012|NCT00378534|2376670|P1|STARTED|Overall Study||115
981013|NCT00378560|2376676|P2|NOT COMPLETED|Overall Study||58
981014|NCT00378560|2376677|P1|NOT COMPLETED|Overall Study||56
981015|NCT00378560|2376676|P2|COMPLETED|Overall Study||454
981016|NCT00378560|2376677|P1|COMPLETED|Overall Study||453
981017|NCT00378560|2376676|P2|Vaccinated|Overall Study||512
981018|NCT00378560|2376677|P1|Vaccinated|Overall Study||509
981019|NCT00378560|2376676|P2|STARTED|Overall Study||512
981020|NCT00378560|2376677|P1|STARTED|Overall Study||509
981021|NCT00378573|2376691|P1|NOT COMPLETED|Follow-up||14
981022|NCT00378573|2376691|P1|COMPLETED|Follow-up||3
981023|NCT00378573|2376691|P1|STARTED|Follow-up||17
981024|NCT00378573|2376691|P1|NOT COMPLETED|Treatment Period||17
981025|NCT00378573|2376691|P1|COMPLETED|Treatment Period|Patients who did not complete treatment moved directly to the follow-up phase of the study.|0
981026|NCT00378573|2376691|P1|STARTED|Treatment Period||17
981027|NCT00378599|2376697|P1|NOT COMPLETED|Overall Study||52
981028|NCT00378599|2376697|P1|COMPLETED|Overall Study||73
981029|NCT00378599|2376697|P1|STARTED|Overall Study||125
981030|NCT00378703|2376705|P4|NOT COMPLETED|Overall Study||91
981031|NCT00378703|2376706|P3|NOT COMPLETED|Overall Study||90
981032|NCT00378703|2376707|P2|NOT COMPLETED|Overall Study||91
981033|NCT00378703|2376708|P1|NOT COMPLETED|Overall Study||89
981034|NCT00378703|2376705|P4|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
981035|NCT00378703|2376706|P3|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
981036|NCT00378703|2376707|P2|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
981037|NCT00378703|2376708|P1|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
981038|NCT00378703|2376705|P4|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
981039|NCT00378703|2376706|P3|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|83
981040|NCT00378703|2376707|P2|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|80
981041|NCT00378703|2376708|P1|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
981042|NCT00378703|2376705|P4|Treated|Overall Study|Number of patients included in the toxicity analysis.|91
981043|NCT00378703|2376706|P3|Treated|Overall Study|Number of patients included in the toxicity analysis.|90
981044|NCT00378703|2376707|P2|Treated|Overall Study|Number of patients included in the toxicity analysis.|86
981045|NCT00378703|2376708|P1|Treated|Overall Study|Number of patients included in the toxicity analysis.|88
981046|NCT00378703|2376705|P4|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
981047|NCT00378703|2376706|P3|STARTED|Overall Study|Number of patients randomized to this treatment arm.|90
981048|NCT00378703|2376707|P2|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
981049|NCT00378703|2376708|P1|STARTED|Overall Study|Number of patients randomized to this treatment arm.|89
981050|NCT00378898|2376732|P2|NOT COMPLETED|Overall Study||6
981051|NCT00378898|2376733|P1|NOT COMPLETED|Overall Study||11
981052|NCT00378898|2376732|P2|COMPLETED|Overall Study||11
981053|NCT00378898|2376733|P1|COMPLETED|Overall Study||11
981054|NCT00378898|2376732|P2|STARTED|Overall Study||17
981055|NCT00378898|2376733|P1|STARTED|Overall Study||22
981056|NCT00379080|2376744|P3|NOT COMPLETED|Overall Study||0
981057|NCT00379080|2376745|P2|NOT COMPLETED|Overall Study||4
981058|NCT00379080|2376746|P1|NOT COMPLETED|Overall Study||0
981059|NCT00379080|2376744|P3|COMPLETED|Overall Study||31
981060|NCT00379080|2376745|P2|COMPLETED|Overall Study||15
981061|NCT00379080|2376746|P1|COMPLETED|Overall Study||6
981062|NCT00379080|2376744|P3|STARTED|Overall Study||31
981063|NCT00379080|2376745|P2|STARTED|Overall Study||19
981064|NCT00379080|2376746|P1|STARTED|Overall Study||6
981065|NCT00379197|2376789|P1|NOT COMPLETED|Overall Study||5
981066|NCT00379197|2376789|P1|COMPLETED|Overall Study||8
981067|NCT00379197|2376789|P1|STARTED|Overall Study||13
981068|NCT00379210|2376796|P2|NOT COMPLETED|Overall Study||7
981069|NCT00379210|2376797|P1|NOT COMPLETED|Overall Study||10
981070|NCT00379210|2376796|P2|COMPLETED|Overall Study||23
981071|NCT00379210|2376797|P1|COMPLETED|Overall Study||20
981072|NCT00379210|2376796|P2|STARTED|Overall Study||30
981073|NCT00379210|2376797|P1|STARTED|Overall Study||30
981074|NCT00379236|2376805|P3|NOT COMPLETED|Open-label Extension||55
981075|NCT00379236|2376806|P2|NOT COMPLETED|Open-label Extension||0
981076|NCT00379236|2376807|P1|NOT COMPLETED|Open-label Extension||0
981077|NCT00379236|2376805|P3|COMPLETED|Open-label Extension||378
981078|NCT00379236|2376806|P2|COMPLETED|Open-label Extension||0
981079|NCT00379236|2376807|P1|COMPLETED|Open-label Extension||0
981080|NCT00379236|2376805|P3|STARTED|Open-label Extension||433
981081|NCT00379236|2376806|P2|STARTED|Open-label Extension||0
981082|NCT00379236|2376807|P1|STARTED|Open-label Extension||0
981083|NCT00379236|2376805|P3|NOT COMPLETED|Double-blind||0
981084|NCT00379236|2376806|P2|NOT COMPLETED|Double-blind||36
981085|NCT00379236|2376807|P1|NOT COMPLETED|Double-blind||36
981086|NCT00379236|2376805|P3|COMPLETED|Double-blind||0
981087|NCT00379236|2376806|P2|COMPLETED|Double-blind|Data could not be retrieved for two participants|259
981088|NCT00379236|2376807|P1|COMPLETED|Double-blind|Data could not be retrieved for two participants|257
981089|NCT00379236|2376805|P3|STARTED|Double-blind||0
981090|NCT00379236|2376806|P2|STARTED|Double-blind||295
981091|NCT00379236|2376807|P1|STARTED|Double-blind||293
981092|NCT00379288|2376854|P4|NOT COMPLETED|Overall Study||8
981093|NCT00379288|2376855|P3|NOT COMPLETED|Overall Study||10
981094|NCT00379288|2376856|P2|NOT COMPLETED|Overall Study||22
981095|NCT00379288|2376857|P1|NOT COMPLETED|Overall Study||19
981096|NCT00379288|2376854|P4|COMPLETED|Overall Study||57
981097|NCT00379288|2376855|P3|COMPLETED|Overall Study||58
981098|NCT00379288|2376856|P2|COMPLETED|Overall Study||108
981099|NCT00379288|2376857|P1|COMPLETED|Overall Study||122
981100|NCT00379288|2376854|P4|STARTED|Overall Study||65
981101|NCT00379288|2376855|P3|STARTED|Overall Study||68
981102|NCT00379288|2376856|P2|STARTED|Overall Study||130
981103|NCT00379288|2376857|P1|STARTED|Overall Study||141
981104|NCT00379340|2376872|P5|NOT COMPLETED|Overall Study||14
981105|NCT00379340|2376873|P4|NOT COMPLETED|Overall Study||13
981106|NCT00379340|2376874|P3|NOT COMPLETED|Overall Study||2
981107|NCT00379340|2376875|P2|NOT COMPLETED|Overall Study||3
981108|NCT00379340|2376876|P1|NOT COMPLETED|Overall Study||13
981109|NCT00379340|2376872|P5|COMPLETED|Overall Study||9
981110|NCT00379340|2376873|P4|COMPLETED|Overall Study||37
981111|NCT00379340|2376874|P3|COMPLETED|Overall Study||50
981112|NCT00379340|2376875|P2|COMPLETED|Overall Study||132
981113|NCT00379340|2376876|P1|COMPLETED|Overall Study||107
981114|NCT00379340|2376872|P5|STARTED|Overall Study||23
981115|NCT00379340|2376873|P4|STARTED|Overall Study||50
981116|NCT00379340|2376874|P3|STARTED|Overall Study||52
981117|NCT00379340|2376875|P2|STARTED|Overall Study||135
981118|NCT00379340|2376876|P1|STARTED|Overall Study||120
981119|NCT00379353|2376891|P2|NOT COMPLETED|Overall Study||6
981120|NCT00379353|2376892|P1|NOT COMPLETED|Overall Study||11
981121|NCT00379353|2376891|P2|COMPLETED|Overall Study||9
981122|NCT00379353|2376892|P1|COMPLETED|Overall Study||5
981123|NCT00379353|2376891|P2|STARTED|Overall Study||15
981124|NCT00379353|2376892|P1|STARTED|Overall Study||16
981125|NCT00379574|2376922|P1|NOT COMPLETED|Overall Study||0
981126|NCT00379574|2376922|P1|COMPLETED|Overall Study|Phase I (9) + Phase II (40)|49
981127|NCT00379574|2376922|P1|STARTED|Overall Study|Phase I (9) + Phase II (40)|49
981128|NCT00379587|2376927|P1|NOT COMPLETED|Overall Study||2
981129|NCT00379587|2376927|P1|COMPLETED|Overall Study||63
981130|NCT00379587|2376927|P1|STARTED|Overall Study||65
981131|NCT00379639|2376939|P5|NOT COMPLETED|Overall Study||6
981132|NCT00379639|2376940|P4|NOT COMPLETED|Overall Study||6
981133|NCT00379639|2376941|P3|NOT COMPLETED|Overall Study||9
981134|NCT00379639|2376942|P2|NOT COMPLETED|Overall Study||5
981135|NCT00379639|2376943|P1|NOT COMPLETED|Overall Study||3
981136|NCT00379639|2376939|P5|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
981137|NCT00379639|2376940|P4|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
981138|NCT00379639|2376941|P3|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|1
981139|NCT00379639|2376942|P2|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|2
981140|NCT00379639|2376943|P1|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|4
981141|NCT00379639|2376939|P5|Completed 6 Cycles of Therapy|Overall Study||0
981142|NCT00379639|2376940|P4|Completed 6 Cycles of Therapy|Overall Study||0
981143|NCT00379639|2376941|P3|Completed 6 Cycles of Therapy|Overall Study||1
981144|NCT00379639|2376942|P2|Completed 6 Cycles of Therapy|Overall Study||2
981145|NCT00379639|2376943|P1|Completed 6 Cycles of Therapy|Overall Study||4
981146|NCT00379639|2376939|P5|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|3
981147|NCT00379639|2376940|P4|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|4
981148|NCT00379639|2376941|P3|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
981149|NCT00379639|2376942|P2|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
981150|NCT00379639|2376943|P1|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|6
981151|NCT00379639|2376939|P5|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
981152|NCT00379639|2376940|P4|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
981153|NCT00379639|2376941|P3|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|10
981154|NCT00379639|2376942|P2|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
981155|NCT00379639|2376943|P1|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
981156|NCT00379769|2376969|P6|NOT COMPLETED|Observational Follow-up||148
981157|NCT00379769|2376970|P5|NOT COMPLETED|Observational Follow-up||149
981158|NCT00379769|2376971|P4|NOT COMPLETED|Observational Follow-up||0
981159|NCT00379769|2376972|P3|NOT COMPLETED|Observational Follow-up||0
981160|NCT00379769|2376973|P2|NOT COMPLETED|Observational Follow-up||0
981161|NCT00379769|2376974|P1|NOT COMPLETED|Observational Follow-up||0
981162|NCT00379769|2376969|P6|COMPLETED|Observational Follow-up||1102
981163|NCT00379769|2376970|P5|COMPLETED|Observational Follow-up||1131
981164|NCT00379769|2376971|P4|COMPLETED|Observational Follow-up||0
981165|NCT00379769|2376972|P3|COMPLETED|Observational Follow-up||0
981166|NCT00379769|2376973|P2|COMPLETED|Observational Follow-up||0
981167|NCT00379769|2376974|P1|COMPLETED|Observational Follow-up||0
981168|NCT00379769|2376969|P6|STARTED|Observational Follow-up|647 from “SU in Addition to Background MET” arm; 603 from “MET in Addition to Background SU” arm.|1250
981169|NCT00379769|2376970|P5|STARTED|Observational Follow-up|665 from “RSG in Addition to Background MET” arm; 615 from “RGS in Addition to Background SU” arm.|1280
981170|NCT00379769|2376971|P4|STARTED|Observational Follow-up||0
981171|NCT00379769|2376972|P3|STARTED|Observational Follow-up||0
981172|NCT00379769|2376973|P2|STARTED|Observational Follow-up||0
981173|NCT00379769|2376974|P1|STARTED|Observational Follow-up||0
981174|NCT00379769|2376969|P6|NOT COMPLETED|Main Study||0
981175|NCT00379769|2376970|P5|NOT COMPLETED|Main Study||0
981176|NCT00379769|2376971|P4|NOT COMPLETED|Main Study||230
981177|NCT00379769|2376972|P3|NOT COMPLETED|Main Study||207
981178|NCT00379769|2376973|P2|NOT COMPLETED|Main Study||199
981179|NCT00379769|2376974|P1|NOT COMPLETED|Main Study||178
981180|NCT00379769|2376969|P6|COMPLETED|Main Study||0
981181|NCT00379769|2376970|P5|COMPLETED|Main Study||0
981182|NCT00379769|2376971|P4|COMPLETED|Main Study||892
981183|NCT00379769|2376972|P3|COMPLETED|Main Study||896
981184|NCT00379769|2376973|P2|COMPLETED|Main Study||906
981185|NCT00379769|2376974|P1|COMPLETED|Main Study||939
981186|NCT00379769|2376969|P6|STARTED|Main Study||0
981187|NCT00379769|2376970|P5|STARTED|Main Study||0
981188|NCT00379769|2376971|P4|STARTED|Main Study||1122
981189|NCT00379769|2376972|P3|STARTED|Main Study||1103
981190|NCT00379769|2376973|P2|STARTED|Main Study||1105
981191|NCT00379769|2376974|P1|STARTED|Main Study||1117
981192|NCT00379795|2377133|P5|NOT COMPLETED|Overall Study||49
981193|NCT00379795|2377134|P4|NOT COMPLETED|Overall Study||68
981194|NCT00379795|2377135|P3|NOT COMPLETED|Overall Study||93
981195|NCT00379795|2377136|P2|NOT COMPLETED|Overall Study||51
981196|NCT00379795|2377137|P1|NOT COMPLETED|Overall Study||476
981197|NCT00379795|2377133|P5|COMPLETED|Overall Study||14
981198|NCT00379795|2377134|P4|COMPLETED|Overall Study||6
981199|NCT00379795|2377135|P3|COMPLETED|Overall Study||23
981200|NCT00379795|2377136|P2|COMPLETED|Overall Study||23
981201|NCT00379795|2377137|P1|COMPLETED|Overall Study||50
981202|NCT00379795|2377133|P5|Received Ranibizumab in Extension Study|Overall Study||0
981203|NCT00379795|2377134|P4|Received Ranibizumab in Extension Study|Overall Study||55
981204|NCT00379795|2377135|P3|Received Ranibizumab in Extension Study|Overall Study||113
981205|NCT00379795|2377136|P2|Received Ranibizumab in Extension Study|Overall Study||41
981206|NCT00379795|2377137|P1|Received Ranibizumab in Extension Study|Overall Study||377
981207|NCT00379795|2377133|P5|STARTED|Overall Study||63
981208|NCT00379795|2377134|P4|STARTED|Overall Study||74
981209|NCT00379795|2377135|P3|STARTED|Overall Study||116
981210|NCT00379795|2377136|P2|STARTED|Overall Study||74
981211|NCT00379795|2377137|P1|STARTED|Overall Study||526
981212|NCT00379808|2377163|P2|NOT COMPLETED|Intervention Period 2 (4 Weeks)||1
981213|NCT00379808|2377164|P1|NOT COMPLETED|Intervention Period 2 (4 Weeks)||0
981214|NCT00379808|2377163|P2|COMPLETED|Intervention Period 2 (4 Weeks)||10
981215|NCT00379808|2377164|P1|COMPLETED|Intervention Period 2 (4 Weeks)||11
981216|NCT00379808|2377163|P2|STARTED|Intervention Period 2 (4 Weeks)||11
981217|NCT00379808|2377164|P1|STARTED|Intervention Period 2 (4 Weeks)||11
981218|NCT00379808|2377163|P2|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
981219|NCT00379808|2377164|P1|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
981220|NCT00379808|2377163|P2|COMPLETED|Intervention Period 1 (4 Weeks)||11
981221|NCT00379808|2377164|P1|COMPLETED|Intervention Period 1 (4 Weeks)||11
981222|NCT00379808|2377163|P2|STARTED|Intervention Period 1 (4 Weeks)||11
981223|NCT00379808|2377164|P1|STARTED|Intervention Period 1 (4 Weeks)||11
981236|NCT00379834|2377328|P1|NOT COMPLETED|Overall Study||2
981237|NCT00379834|2377328|P1|COMPLETED|Overall Study||8
981238|NCT00379834|2377328|P1|STARTED|Overall Study||10
981239|NCT00379899|2377334|P2|NOT COMPLETED|Overall Study||40
981240|NCT00379899|2377335|P1|NOT COMPLETED|Overall Study||40
981241|NCT00379899|2377334|P2|COMPLETED|Overall Study||140
981242|NCT00379899|2377335|P1|COMPLETED|Overall Study||140
981243|NCT00379899|2377334|P2|STARTED|Overall Study||180
981244|NCT00379899|2377335|P1|STARTED|Overall Study||180
981245|NCT00379912|2377365|P2|NOT COMPLETED|Overall Study||0
981246|NCT00379912|2377366|P1|NOT COMPLETED|Overall Study||1
981247|NCT00379912|2377365|P2|COMPLETED|Overall Study||8
981248|NCT00379912|2377366|P1|COMPLETED|Overall Study||6
981249|NCT00379912|2377365|P2|STARTED|Overall Study||8
981250|NCT00379912|2377366|P1|STARTED|Overall Study||7
981251|NCT00380029|2377384|P1|NOT COMPLETED|Overall Study||0
981252|NCT00380029|2377384|P1|COMPLETED|Overall Study||20
981253|NCT00380029|2377384|P1|STARTED|Overall Study||20
981254|NCT00380068|2377394|P1|NOT COMPLETED|Overall Study||69
981255|NCT00380068|2377394|P1|COMPLETED|Overall Study||155
981256|NCT00380068|2377394|P1|STARTED|Overall Study||224
981257|NCT00380081|2377420|P6|NOT COMPLETED|Overall Study||1
981258|NCT00380081|2377421|P5|NOT COMPLETED|Overall Study||1
981259|NCT00380081|2377422|P4|NOT COMPLETED|Overall Study||0
981260|NCT00380081|2377423|P3|NOT COMPLETED|Overall Study||0
981261|NCT00380081|2377424|P2|NOT COMPLETED|Overall Study||0
981262|NCT00380081|2377425|P1|NOT COMPLETED|Overall Study||0
981263|NCT00380081|2377420|P6|COMPLETED|Overall Study||13
981264|NCT00380081|2377421|P5|COMPLETED|Overall Study||12
981265|NCT00380081|2377422|P4|COMPLETED|Overall Study||15
981266|NCT00380081|2377423|P3|COMPLETED|Overall Study||13
981267|NCT00380081|2377424|P2|COMPLETED|Overall Study||13
981268|NCT00380081|2377425|P1|COMPLETED|Overall Study||14
981269|NCT00380081|2377420|P6|STARTED|Overall Study||14
981270|NCT00380081|2377421|P5|STARTED|Overall Study||13
981271|NCT00380081|2377422|P4|STARTED|Overall Study||15
981272|NCT00380081|2377423|P3|STARTED|Overall Study||13
981273|NCT00380081|2377424|P2|STARTED|Overall Study||13
981274|NCT00380081|2377425|P1|STARTED|Overall Study||14
981275|NCT00380250|2377477|P2|NOT COMPLETED|Overall Study||55
981276|NCT00380250|2377478|P1|NOT COMPLETED|Overall Study||99
981277|NCT00380250|2377477|P2|COMPLETED|Overall Study||139
981278|NCT00380250|2377478|P1|COMPLETED|Overall Study||297
981279|NCT00380250|2377477|P2|STARTED|Overall Study||194
981280|NCT00380250|2377478|P1|STARTED|Overall Study||396
981281|NCT00380367|2377540|P1|NOT COMPLETED|Overall Study||2
981282|NCT00380367|2377540|P1|COMPLETED|Overall Study||108
981283|NCT00380367|2377540|P1|STARTED|Overall Study||110
981284|NCT00366301|2377549|P4|NOT COMPLETED|Overall Study||8
981285|NCT00366301|2377550|P3|NOT COMPLETED|Overall Study||4
981286|NCT00366301|2377551|P2|NOT COMPLETED|Overall Study||6
981287|NCT00366301|2377552|P1|NOT COMPLETED|Overall Study||8
981288|NCT00366301|2377549|P4|COMPLETED|Overall Study||116
981289|NCT00366301|2377550|P3|COMPLETED|Overall Study||122
981290|NCT00366301|2377551|P2|COMPLETED|Overall Study||120
981291|NCT00366301|2377552|P1|COMPLETED|Overall Study||116
981292|NCT00366301|2377549|P4|Either 6W or 14W CRP Obtained|Overall Study||119
981293|NCT00366301|2377550|P3|Either 6W or 14W CRP Obtained|Overall Study||124
981294|NCT00366301|2377551|P2|Either 6W or 14W CRP Obtained|Overall Study||124
981295|NCT00366301|2377552|P1|Either 6W or 14W CRP Obtained|Overall Study||120
981296|NCT00366301|2377549|P4|STARTED|Overall Study||124
981297|NCT00366301|2377550|P3|STARTED|Overall Study||126
981298|NCT00366301|2377551|P2|STARTED|Overall Study||126
981299|NCT00366301|2377552|P1|STARTED|Overall Study||124
981300|NCT00366340|2377564|P2|NOT COMPLETED|Toddler Dose||1
981301|NCT00366340|2377565|P1|NOT COMPLETED|Toddler Dose||1
981302|NCT00366340|2377564|P2|COMPLETED|Toddler Dose||286
981303|NCT00366340|2377565|P1|COMPLETED|Toddler Dose||289
981304|NCT00366340|2377564|P2|STARTED|Toddler Dose||287
981305|NCT00366340|2377565|P1|STARTED|Toddler Dose||290
981306|NCT00366340|2377564|P2|NOT COMPLETED|After the Infant Series||6
981307|NCT00366340|2377565|P1|NOT COMPLETED|After the Infant Series||3
981308|NCT00366340|2377564|P2|COMPLETED|After the Infant Series||287
981309|NCT00366340|2377565|P1|COMPLETED|After the Infant Series||290
981310|NCT00366340|2377564|P2|STARTED|After the Infant Series||293
981311|NCT00366340|2377565|P1|STARTED|After the Infant Series||293
981312|NCT00366340|2377564|P2|NOT COMPLETED|Infant Series||10
981313|NCT00366340|2377565|P1|NOT COMPLETED|Infant Series||8
981314|NCT00366340|2377564|P2|COMPLETED|Infant Series||293
981315|NCT00366340|2377565|P1|COMPLETED|Infant Series||293
981316|NCT00366340|2377564|P2|Vaccinated Dose 3|Infant Series||293
981317|NCT00366340|2377565|P1|Vaccinated Dose 3|Infant Series||294
981318|NCT00366340|2377564|P2|Vaccinated Dose 2|Infant Series||297
981319|NCT00366340|2377565|P1|Vaccinated Dose 2|Infant Series||296
981320|NCT00366340|2377564|P2|Vaccinated Dose 1|Infant Series||303
981321|NCT00366340|2377565|P1|Vaccinated Dose 1|Infant Series||300
981322|NCT00366340|2377564|P2|STARTED|Infant Series||303
981323|NCT00366340|2377565|P1|STARTED|Infant Series||301
981324|NCT00366444|2377621|P2|NOT COMPLETED|Overall Study||2
981325|NCT00366444|2377622|P1|NOT COMPLETED|Overall Study||1
981326|NCT00366444|2377621|P2|COMPLETED|Overall Study||97
981327|NCT00366444|2377622|P1|COMPLETED|Overall Study||101
981328|NCT00366444|2377621|P2|STARTED|Overall Study||99
981329|NCT00366444|2377622|P1|STARTED|Overall Study||102
981330|NCT00366457|2377648|P1|NOT COMPLETED|Overall Study||2
981331|NCT00366457|2377648|P1|COMPLETED|Overall Study||30
981332|NCT00366457|2377648|P1|STARTED|Overall Study||32
981333|NCT00366548|2377657|P2|NOT COMPLETED|Toddler Dose||0
981334|NCT00366548|2377658|P1|NOT COMPLETED|Toddler Dose||0
981335|NCT00366548|2377657|P2|COMPLETED|Toddler Dose||244
981336|NCT00366548|2377658|P1|COMPLETED|Toddler Dose||240
981337|NCT00366548|2377657|P2|STARTED|Toddler Dose||244
981338|NCT00366548|2377658|P1|STARTED|Toddler Dose||240
981339|NCT00366548|2377657|P2|NOT COMPLETED|After Infant Series||1
981340|NCT00366548|2377658|P1|NOT COMPLETED|After Infant Series||6
981341|NCT00366548|2377657|P2|COMPLETED|After Infant Series||244
981342|NCT00366548|2377658|P1|COMPLETED|After Infant Series||240
981343|NCT00366548|2377657|P2|STARTED|After Infant Series||245
981344|NCT00366548|2377658|P1|STARTED|After Infant Series||246
981345|NCT00366548|2377657|P2|NOT COMPLETED|Infant Series||5
981346|NCT00366548|2377658|P1|NOT COMPLETED|Infant Series||4
981347|NCT00366548|2377657|P2|COMPLETED|Infant Series||245
981348|NCT00366548|2377658|P1|COMPLETED|Infant Series||246
981349|NCT00366548|2377657|P2|Vaccinated Dose 3|Infant Series||247
981350|NCT00366548|2377658|P1|Vaccinated Dose 3|Infant Series||246
981351|NCT00366548|2377657|P2|Vaccinated Dose 2|Infant Series||249
981352|NCT00366548|2377658|P1|Vaccinated Dose 2|Infant Series||246
981353|NCT00366548|2377657|P2|Vaccinated Dose 1|Infant Series||250
981354|NCT00366548|2377658|P1|Vaccinated Dose 1|Infant Series||250
981355|NCT00366548|2377657|P2|STARTED|Infant Series||250
981356|NCT00366548|2377658|P1|STARTED|Infant Series||250
981357|NCT00366626|2377694|P2|NOT COMPLETED|Overall Study||0
981358|NCT00366626|2377695|P1|NOT COMPLETED|Overall Study||0
981359|NCT00366626|2377694|P2|COMPLETED|Overall Study||45
981360|NCT00366626|2377695|P1|COMPLETED|Overall Study||38
981361|NCT00366626|2377694|P2|STARTED|Overall Study||45
981362|NCT00366626|2377695|P1|STARTED|Overall Study||38
981363|NCT00366678|2377709|P3|NOT COMPLETED|Toddler Dose||0
981364|NCT00366678|2377710|P2|NOT COMPLETED|Toddler Dose||1
981365|NCT00366678|2377711|P1|NOT COMPLETED|Toddler Dose||5
981366|NCT00366678|2377709|P3|COMPLETED|Toddler Dose||137
981367|NCT00366678|2377710|P2|COMPLETED|Toddler Dose||151
981368|NCT00366678|2377711|P1|COMPLETED|Toddler Dose||268
981369|NCT00366678|2377709|P3|STARTED|Toddler Dose||137
981370|NCT00366678|2377710|P2|STARTED|Toddler Dose||152
981371|NCT00366678|2377711|P1|STARTED|Toddler Dose||273
981372|NCT00366678|2377709|P3|NOT COMPLETED|After Infant||0
981373|NCT00366678|2377710|P2|NOT COMPLETED|After Infant||10
981374|NCT00366678|2377711|P1|NOT COMPLETED|After Infant||17
981375|NCT00366678|2377709|P3|COMPLETED|After Infant||0
981376|NCT00366678|2377710|P2|COMPLETED|After Infant||289
981377|NCT00366678|2377711|P1|COMPLETED|After Infant||273
981378|NCT00366678|2377709|P3|STARTED|After Infant||0
981379|NCT00366678|2377710|P2|STARTED|After Infant||299
981380|NCT00366678|2377711|P1|STARTED|After Infant||290
981381|NCT00366678|2377709|P3|NOT COMPLETED|Infant Series||0
981382|NCT00366678|2377710|P2|NOT COMPLETED|Infant Series||10
981383|NCT00366678|2377711|P1|NOT COMPLETED|Infant Series||14
981384|NCT00366678|2377709|P3|COMPLETED|Infant Series||0
981385|NCT00366678|2377710|P2|COMPLETED|Infant Series||299
981386|NCT00366678|2377711|P1|COMPLETED|Infant Series||290
981387|NCT00366678|2377709|P3|Vaccinated Dose 3|Infant Series||0
981388|NCT00366678|2377710|P2|Vaccinated Dose 3|Infant Series||302
981389|NCT00366678|2377711|P1|Vaccinated Dose 3|Infant Series||291
981390|NCT00366678|2377709|P3|Vaccinated Dose 2|Infant Series||0
981391|NCT00366678|2377710|P2|Vaccinated Dose 2|Infant Series||304
981392|NCT00366678|2377711|P1|Vaccinated Dose 2|Infant Series||295
981393|NCT00366678|2377709|P3|Vaccinated Dose 1|Infant Series||0
981394|NCT00366678|2377710|P2|Vaccinated Dose 1|Infant Series||309
981395|NCT00366678|2377711|P1|Vaccinated Dose 1|Infant Series||302
981396|NCT00366678|2377709|P3|STARTED|Infant Series||0
981397|NCT00366678|2377710|P2|STARTED|Infant Series||309
981398|NCT00366678|2377711|P1|STARTED|Infant Series||304
981399|NCT00367237|2377778|P2|NOT COMPLETED|Overall Study||11
981400|NCT00367237|2377779|P1|NOT COMPLETED|Overall Study||10
981401|NCT00367237|2377778|P2|COMPLETED|Overall Study||47
981402|NCT00367237|2377779|P1|COMPLETED|Overall Study||47
981403|NCT00367237|2377778|P2|STARTED|Overall Study|Number of subjects randomized|58
981404|NCT00367237|2377779|P1|STARTED|Overall Study|Number of subjects randomized|57
981405|NCT00367341|2377787|P2|NOT COMPLETED|Overall Study||0
981406|NCT00367341|2377788|P1|NOT COMPLETED|Overall Study||2
981407|NCT00367341|2377787|P2|COMPLETED|Overall Study||40
981408|NCT00367341|2377788|P1|COMPLETED|Overall Study||40
981409|NCT00367341|2377787|P2|STARTED|Overall Study||40
981410|NCT00367341|2377788|P1|STARTED|Overall Study||42
981411|NCT00367380|2377799|P3|NOT COMPLETED|Overall Study||0
981412|NCT00367380|2377800|P2|NOT COMPLETED|Overall Study||0
981413|NCT00367380|2377801|P1|NOT COMPLETED|Overall Study||0
981414|NCT00367380|2377799|P3|COMPLETED|Overall Study||6
981415|NCT00367380|2377800|P2|COMPLETED|Overall Study||6
981416|NCT00367380|2377801|P1|COMPLETED|Overall Study||6
981417|NCT00367380|2377799|P3|STARTED|Overall Study||6
981418|NCT00367380|2377800|P2|STARTED|Overall Study||6
981419|NCT00367380|2377801|P1|STARTED|Overall Study||6
981420|NCT00367432|2377809|P2|NOT COMPLETED|Second Period (up to 54 Months)||16
981421|NCT00367432|2377810|P1|NOT COMPLETED|Second Period (up to 54 Months)||87
981422|NCT00367432|2377809|P2|COMPLETED|Second Period (up to 54 Months)||69
981423|NCT00367432|2377810|P1|COMPLETED|Second Period (up to 54 Months)||188
981424|NCT00367432|2377809|P2|STARTED|Second Period (up to 54 Months)|85 subjects from N01020 [NCT00160615] entered Second Period of N01222|85
981425|NCT00367432|2377810|P1|STARTED|Second Period (up to 54 Months)|275 subjects from N01221 [NCT00280696] completed First Period and entered Second Period of N01222|275
981426|NCT00367432|2377809|P2|NOT COMPLETED|First Period (16 Weeks)||0
981427|NCT00367432|2377810|P1|NOT COMPLETED|First Period (16 Weeks)||38
981428|NCT00367432|2377809|P2|COMPLETED|First Period (16 Weeks)||0
981429|NCT00367432|2377810|P1|COMPLETED|First Period (16 Weeks)||275
981430|NCT00367432|2377809|P2|STARTED|First Period (16 Weeks)||0
981431|NCT00367432|2377810|P1|STARTED|First Period (16 Weeks)|Eligible subjects from preceding study N01221 [NCT00280696] entered the First Period of N01222|313
981432|NCT00367484|2377822|P1|NOT COMPLETED|Overall Study||17
981433|NCT00367484|2377822|P1|COMPLETED|Overall Study|Safety population = 460 Intent To Treat (ITT) population = 458|443
981434|NCT00367484|2377822|P1|STARTED|Overall Study||460
981435|NCT00367601|2377826|P1|NOT COMPLETED|Overall Study||0
981436|NCT00367601|2377826|P1|COMPLETED|Overall Study||25
981437|NCT00367601|2377826|P1|STARTED|Overall Study||25
981438|NCT00367640|2377836|P4|NOT COMPLETED|Overall Study||10
981439|NCT00367640|2377837|P3|NOT COMPLETED|Overall Study||19
981440|NCT00367640|2377838|P2|NOT COMPLETED|Overall Study||22
981441|NCT00367640|2377839|P1|NOT COMPLETED|Overall Study||18
981442|NCT00367640|2377836|P4|COMPLETED|Overall Study||146
981443|NCT00367640|2377837|P3|COMPLETED|Overall Study||141
981444|NCT00367640|2377838|P2|COMPLETED|Overall Study||133
981445|NCT00367640|2377839|P1|COMPLETED|Overall Study||139
981446|NCT00367640|2377836|P4|STARTED|Overall Study||156
981447|NCT00367640|2377837|P3|STARTED|Overall Study||160
981448|NCT00367640|2377838|P2|STARTED|Overall Study||155
981449|NCT00367640|2377839|P1|STARTED|Overall Study||157
981450|NCT00367679|2377849|P1|NOT COMPLETED|Overall Study||0
981451|NCT00367679|2377849|P1|COMPLETED|Overall Study||35
981452|NCT00367679|2377849|P1|STARTED|Overall Study||35
981453|NCT00367744|2377868|P2|NOT COMPLETED|Overall Study||5
981454|NCT00367744|2377869|P1|NOT COMPLETED|Overall Study||4
981455|NCT00367744|2377868|P2|COMPLETED|Overall Study||32
981456|NCT00367744|2377869|P1|COMPLETED|Overall Study||30
981457|NCT00367744|2377868|P2|STARTED|Overall Study||37
981458|NCT00367744|2377869|P1|STARTED|Overall Study||34
981459|NCT00367770|2377877|P1|NOT COMPLETED|Overall Study||2
981460|NCT00367770|2377877|P1|COMPLETED|Overall Study||35
981461|NCT00367770|2377877|P1|STARTED|Overall Study||37
981462|NCT00367835|2377885|P2|NOT COMPLETED|Overall Study||31
981463|NCT00367835|2377886|P1|NOT COMPLETED|Overall Study||29
981464|NCT00367835|2377885|P2|COMPLETED|Overall Study||48
981465|NCT00367835|2377886|P1|COMPLETED|Overall Study||109
981466|NCT00367835|2377885|P2|STARTED|Overall Study||79
981467|NCT00367835|2377886|P1|STARTED|Overall Study||138
981468|NCT00367991|2377914|P2|NOT COMPLETED|Overall Study||2
981469|NCT00367991|2377915|P1|NOT COMPLETED|Overall Study||2
981470|NCT00367991|2377914|P2|COMPLETED|Overall Study||13
981471|NCT00367991|2377915|P1|COMPLETED|Overall Study||27
981472|NCT00367991|2377914|P2|STARTED|Overall Study||15
981473|NCT00367991|2377915|P1|STARTED|Overall Study||29
981474|NCT00368069|2377923|P2|NOT COMPLETED|Overall Study||7
981475|NCT00368069|2377924|P1|NOT COMPLETED|Overall Study||8
981476|NCT00368069|2377923|P2|COMPLETED|Overall Study||72
981477|NCT00368069|2377924|P1|COMPLETED|Overall Study||71
981478|NCT00368069|2377923|P2|STARTED|Overall Study||79
981479|NCT00368069|2377924|P1|STARTED|Overall Study||79
981480|NCT00368108|2377943|P3|NOT COMPLETED|Overall Study||68
981481|NCT00368108|2377944|P2|NOT COMPLETED|Overall Study||53
981482|NCT00368108|2377945|P1|NOT COMPLETED|Overall Study||64
981483|NCT00368108|2377943|P3|COMPLETED|Overall Study||182
981484|NCT00368108|2377944|P2|COMPLETED|Overall Study||198
981485|NCT00368108|2377945|P1|COMPLETED|Overall Study||187
981486|NCT00368108|2377943|P3|STARTED|Overall Study||250
981487|NCT00368108|2377944|P2|STARTED|Overall Study||251
981488|NCT00368108|2377945|P1|STARTED|Overall Study|One subject had stopped medication prior to notifying staff. Remaining results will have 250.|251
981489|NCT00368251|2377965|P3|NOT COMPLETED|Overall Study||1
981490|NCT00368251|2377966|P2|NOT COMPLETED|Overall Study||0
981491|NCT00368251|2377967|P1|NOT COMPLETED|Overall Study||1
981492|NCT00368251|2377965|P3|COMPLETED|Overall Study||17
981493|NCT00368251|2377966|P2|COMPLETED|Overall Study||20
981494|NCT00368251|2377967|P1|COMPLETED|Overall Study||17
981495|NCT00368251|2377965|P3|STARTED|Overall Study||18
981496|NCT00368251|2377966|P2|STARTED|Overall Study||20
981497|NCT00368251|2377967|P1|STARTED|Overall Study||18
981498|NCT00368277|2377989|P2|NOT COMPLETED|Overall Study||108
981499|NCT00368277|2377990|P1|NOT COMPLETED|Overall Study||113
981500|NCT00368277|2377989|P2|COMPLETED|Overall Study||336
981501|NCT00368277|2377990|P1|COMPLETED|Overall Study||344
981502|NCT00368277|2377989|P2|STARTED|Overall Study||444
981503|NCT00368277|2377990|P1|STARTED|Overall Study||457
981504|NCT00368290|2378004|P2|NOT COMPLETED|Overall Study||10
981505|NCT00368290|2378005|P1|NOT COMPLETED|Overall Study||13
981506|NCT00368290|2378004|P2|COMPLETED|Overall Study||37
981507|NCT00368290|2378005|P1|COMPLETED|Overall Study||34
981508|NCT00368290|2378004|P2|STARTED|Overall Study||47
981509|NCT00368290|2378005|P1|STARTED|Overall Study||47
981510|NCT00368316|2378015|P2|NOT COMPLETED|Overall Study||46
981511|NCT00368316|2378016|P1|NOT COMPLETED|Overall Study||42
981512|NCT00368316|2378015|P2|COMPLETED|Overall Study||1319
981513|NCT00368316|2378016|P1|COMPLETED|Overall Study||1392
981514|NCT00368316|2378015|P2|STARTED|Overall Study||1365
981515|NCT00368316|2378016|P1|STARTED|Overall Study||1434
981516|NCT00368459|2378028|P2|NOT COMPLETED|Overall Study||1
981517|NCT00368459|2378029|P1|NOT COMPLETED|Overall Study||2
981518|NCT00368459|2378028|P2|COMPLETED|Overall Study||20
981519|NCT00368459|2378029|P1|COMPLETED|Overall Study||19
981520|NCT00368459|2378028|P2|STARTED|Overall Study||21
981521|NCT00368459|2378029|P1|STARTED|Overall Study||21
981522|NCT00368472|2378053|P1|NOT COMPLETED|Overall Study||105
981523|NCT00368472|2378053|P1|COMPLETED|Overall Study||33
981524|NCT00368472|2378053|P1|STARTED|Overall Study||138
981525|NCT00368537|2378061|P2|NOT COMPLETED|Baseline Participants||24
981526|NCT00368537|2378062|P1|NOT COMPLETED|Baseline Participants||24
981527|NCT00368537|2378061|P2|COMPLETED|Baseline Participants||239
981528|NCT00368537|2378062|P1|COMPLETED|Baseline Participants||244
981529|NCT00368537|2378061|P2|STARTED|Baseline Participants||263
981530|NCT00368537|2378062|P1|STARTED|Baseline Participants||268
981531|NCT00368537|2378061|P2|NOT COMPLETED|Randomization||6
981532|NCT00368537|2378062|P1|NOT COMPLETED|Randomization||13
981533|NCT00368537|2378061|P2|COMPLETED|Randomization||263
981534|NCT00368537|2378062|P1|COMPLETED|Randomization||268
981535|NCT00368537|2378061|P2|STARTED|Randomization||269
981536|NCT00368537|2378062|P1|STARTED|Randomization||281
981537|NCT00368550|2378078|P2|NOT COMPLETED|Overall Study||23
981538|NCT00368550|2378079|P1|NOT COMPLETED|Overall Study||28
981539|NCT00368550|2378078|P2|COMPLETED|Overall Study||48
981540|NCT00368550|2378079|P1|COMPLETED|Overall Study||35
981541|NCT00368550|2378078|P2|STARTED|Overall Study||71
981542|NCT00368550|2378079|P1|STARTED|Overall Study||63
981543|NCT00368641|2378091|P2|NOT COMPLETED|Overall Study||6
981544|NCT00368641|2378092|P1|NOT COMPLETED|Overall Study||6
981545|NCT00368641|2378091|P2|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
981546|NCT00368641|2378092|P1|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
981547|NCT00368641|2378091|P2|STARTED|Overall Study||6
981548|NCT00368641|2378092|P1|STARTED|Overall Study||6
981549|NCT00368745|2378100|P2|NOT COMPLETED|Double-blind Treatment Period||31
981550|NCT00368745|2378101|P1|NOT COMPLETED|Double-blind Treatment Period||26
981551|NCT00368745|2378100|P2|COMPLETED|Double-blind Treatment Period||19
981552|NCT00368745|2378101|P1|COMPLETED|Double-blind Treatment Period||30
981553|NCT00368745|2378100|P2|STARTED|Double-blind Treatment Period||50
981554|NCT00368745|2378101|P1|STARTED|Double-blind Treatment Period||56
981555|NCT00368745|2378100|P2|NOT COMPLETED|Randomized to Double-blind Treatment||1
981556|NCT00368745|2378101|P1|NOT COMPLETED|Randomized to Double-blind Treatment||1
981813|NCT00384930|2378587|P2|STARTED|Overall Study||209
981557|NCT00368745|2378100|P2|COMPLETED|Randomized to Double-blind Treatment|One subject did not want to participate in study.|50
981558|NCT00368745|2378101|P1|COMPLETED|Randomized to Double-blind Treatment|One subject did not return following randomization; study drug not dispensed.|56
981559|NCT00368745|2378100|P2|STARTED|Randomized to Double-blind Treatment||51
981560|NCT00368745|2378101|P1|STARTED|Randomized to Double-blind Treatment||57
981561|NCT00368849|2378131|P2|NOT COMPLETED|Overall Study||2
981562|NCT00368849|2378132|P1|NOT COMPLETED|Overall Study||0
981563|NCT00368849|2378131|P2|COMPLETED|Overall Study||8
981564|NCT00368849|2378132|P1|COMPLETED|Overall Study||10
981565|NCT00368849|2378131|P2|STARTED|Overall Study||10
981566|NCT00368849|2378132|P1|STARTED|Overall Study||10
981567|NCT00368875|2378146|P2|NOT COMPLETED|Overall Study||48
981568|NCT00368875|2378147|P1|NOT COMPLETED|Overall Study||6
981569|NCT00368875|2378146|P2|COMPLETED|Overall Study||0
981570|NCT00368875|2378147|P1|COMPLETED|Overall Study||0
981571|NCT00368875|2378146|P2|STARTED|Overall Study||48
981572|NCT00368875|2378147|P1|STARTED|Overall Study||6
981573|NCT00368927|2378157|P2|NOT COMPLETED|Overall Study||3
981574|NCT00368927|2378158|P1|NOT COMPLETED|Overall Study||5
981575|NCT00368927|2378157|P2|COMPLETED|Overall Study||27
981576|NCT00368927|2378158|P1|COMPLETED|Overall Study||26
981577|NCT00368927|2378157|P2|STARTED|Overall Study||30
981578|NCT00368927|2378158|P1|STARTED|Overall Study||31
981579|NCT00368940|2378168|P2|NOT COMPLETED|Completed 12-wk Treatment||5
981580|NCT00368940|2378169|P1|NOT COMPLETED|Completed 12-wk Treatment||6
981581|NCT00368940|2378168|P2|COMPLETED|Completed 12-wk Treatment||32
981582|NCT00368940|2378169|P1|COMPLETED|Completed 12-wk Treatment||31
981583|NCT00368940|2378168|P2|STARTED|Completed 12-wk Treatment||37
981584|NCT00368940|2378169|P1|STARTED|Completed 12-wk Treatment||37
981585|NCT00368940|2378168|P2|NOT COMPLETED|Intention-to-Treat||0
981586|NCT00368940|2378169|P1|NOT COMPLETED|Intention-to-Treat||0
981587|NCT00368940|2378168|P2|COMPLETED|Intention-to-Treat||37
981588|NCT00368940|2378169|P1|COMPLETED|Intention-to-Treat||37
981589|NCT00368940|2378168|P2|STARTED|Intention-to-Treat||37
981590|NCT00368940|2378169|P1|STARTED|Intention-to-Treat||37
981591|NCT00368966|2378183|P2|NOT COMPLETED|Toddler Dose||3
981592|NCT00368966|2378184|P1|NOT COMPLETED|Toddler Dose||1
981593|NCT00368966|2378183|P2|COMPLETED|Toddler Dose||286
981594|NCT00368966|2378184|P1|COMPLETED|Toddler Dose||292
981595|NCT00368966|2378183|P2|STARTED|Toddler Dose||289
981596|NCT00368966|2378184|P1|STARTED|Toddler Dose||293
981597|NCT00368966|2378183|P2|NOT COMPLETED|After Infant||5
981598|NCT00368966|2378184|P1|NOT COMPLETED|After Infant||6
981599|NCT00368966|2378183|P2|COMPLETED|After Infant||289
981600|NCT00368966|2378184|P1|COMPLETED|After Infant||293
981601|NCT00368966|2378183|P2|STARTED|After Infant||294
981602|NCT00368966|2378184|P1|STARTED|After Infant||299
981603|NCT00368966|2378183|P2|NOT COMPLETED|Infant Series||10
981604|NCT00368966|2378184|P1|NOT COMPLETED|Infant Series||16
981605|NCT00368966|2378183|P2|COMPLETED|Infant Series||294
981606|NCT00368966|2378184|P1|COMPLETED|Infant Series||299
981607|NCT00368966|2378183|P2|Vaccinated Dose 3|Infant Series|1 randomized but incorrectly given 13vPnC|296
981608|NCT00368966|2378184|P1|Vaccinated Dose 3|Infant Series||301
981609|NCT00368966|2378183|P2|Vaccinated Dose 2|Infant Series||298
981610|NCT00368966|2378184|P1|Vaccinated Dose 2|Infant Series|1 randomized but incorrectly given 7vPnC|307
981611|NCT00368966|2378183|P2|Vaccinated Dose 1|Infant Series|1 randomized to 7vPnC but given 13vPnC vaccine; 1 was withdrawn before receiving 7vPnC vaccine|302
981612|NCT00368966|2378184|P1|Vaccinated Dose 1|Infant Series||314
981613|NCT00368966|2378183|P2|STARTED|Infant Series||304
981614|NCT00368966|2378184|P1|STARTED|Infant Series||315
981615|NCT00368979|2378240|P2|NOT COMPLETED|Overall Study||30
981616|NCT00368979|2378241|P1|NOT COMPLETED|Overall Study||25
981617|NCT00368979|2378240|P2|COMPLETED|Overall Study||163
981618|NCT00368979|2378241|P1|COMPLETED|Overall Study||160
981619|NCT00368979|2378240|P2|STARTED|Overall Study||193
981620|NCT00368979|2378241|P1|STARTED|Overall Study||185
981621|NCT00368992|2378255|P1|NOT COMPLETED|Overall Study||110
981622|NCT00368992|2378255|P1|COMPLETED|Overall Study||0
981623|NCT00368992|2378255|P1|STARTED|Overall Study||110
981624|NCT00369122|2378262|P1|NOT COMPLETED|Overall Study||11
981625|NCT00369122|2378262|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|49
981626|NCT00369122|2378262|P1|STARTED|Overall Study||60
981627|NCT00369161|2378268|P2|NOT COMPLETED|Overall Study||24
981628|NCT00369161|2378269|P1|NOT COMPLETED|Overall Study||27
981629|NCT00369161|2378268|P2|COMPLETED|Overall Study||95
981630|NCT00369161|2378269|P1|COMPLETED|Overall Study||82
981631|NCT00369161|2378268|P2|Intention to Treat (ITT)|Overall Study||117
981632|NCT00369161|2378269|P1|Intention to Treat (ITT)|Overall Study||107
981633|NCT00369161|2378268|P2|STARTED|Overall Study||119
981634|NCT00369161|2378269|P1|STARTED|Overall Study|"Started indicates randomized and safety population."|109
981635|NCT00369226|2378281|P2|NOT COMPLETED|Phase II (45 Days)||0
981636|NCT00369226|2378282|P1|NOT COMPLETED|Phase II (45 Days)||0
981637|NCT00369226|2378281|P2|COMPLETED|Phase II (45 Days)|This includes 10 patients treated at candidate MTD in Phase I.|32
981638|NCT00369226|2378282|P1|COMPLETED|Phase II (45 Days)||0
981639|NCT00369226|2378281|P2|STARTED|Phase II (45 Days)||32
981640|NCT00369226|2378282|P1|STARTED|Phase II (45 Days)||0
981641|NCT00369226|2378281|P2|NOT COMPLETED|Phase I (45 Days)||0
981642|NCT00369226|2378282|P1|NOT COMPLETED|Phase I (45 Days)||0
981643|NCT00369226|2378281|P2|COMPLETED|Phase I (45 Days)||0
981644|NCT00369226|2378282|P1|COMPLETED|Phase I (45 Days)|Once MTD established, additional 10 patients were accrued at MTD to better estimate toxicity.|13
981645|NCT00369226|2378281|P2|STARTED|Phase I (45 Days)||0
981646|NCT00369226|2378282|P1|STARTED|Phase I (45 Days)||13
981647|NCT00369265|2378294|P2|NOT COMPLETED|Overall Study||7
981648|NCT00369265|2378295|P1|NOT COMPLETED|Overall Study||4
981649|NCT00369265|2378294|P2|COMPLETED|Overall Study||0
981650|NCT00369265|2378295|P1|COMPLETED|Overall Study||0
981651|NCT00369265|2378294|P2|STARTED|Overall Study||7
981652|NCT00369265|2378295|P1|STARTED|Overall Study||4
981653|NCT00369278|2378303|P2|NOT COMPLETED|Overall Study||21
981654|NCT00369278|2378304|P1|NOT COMPLETED|Overall Study||24
981655|NCT00369278|2378303|P2|COMPLETED|Overall Study||44
981656|NCT00369278|2378304|P1|COMPLETED|Overall Study||39
981657|NCT00369278|2378303|P2|STARTED|Overall Study||65
981658|NCT00369278|2378304|P1|STARTED|Overall Study||63
981659|NCT00374803|2378320|P2|NOT COMPLETED|Overall Study||0
981660|NCT00374803|2378321|P1|NOT COMPLETED|Overall Study||0
981661|NCT00374803|2378320|P2|COMPLETED|Overall Study||23
981662|NCT00374803|2378321|P1|COMPLETED|Overall Study||22
981663|NCT00374803|2378320|P2|STARTED|Overall Study||23
981664|NCT00374803|2378321|P1|STARTED|Overall Study||22
981665|NCT00374842|2378338|P3|NOT COMPLETED|Overall Study||0
981666|NCT00374842|2378339|P2|NOT COMPLETED|Overall Study||0
981667|NCT00374842|2378340|P1|NOT COMPLETED|Overall Study||0
981668|NCT00374842|2378338|P3|COMPLETED|Overall Study||100
981669|NCT00374842|2378339|P2|COMPLETED|Overall Study||100
981670|NCT00374842|2378340|P1|COMPLETED|Overall Study||100
981671|NCT00374842|2378338|P3|STARTED|Overall Study||100
981672|NCT00374842|2378339|P2|STARTED|Overall Study||100
981673|NCT00374842|2378340|P1|STARTED|Overall Study||100
981674|NCT00374868|2378369|P1|NOT COMPLETED|Overall Study||36
981675|NCT00374868|2378369|P1|COMPLETED|Overall Study||2
981676|NCT00374868|2378369|P1|STARTED|Overall Study||38
981691|NCT00380588|2378397|P2|NOT COMPLETED|Overall Study||40
981692|NCT00380588|2378398|P1|NOT COMPLETED|Overall Study||39
981693|NCT00380588|2378397|P2|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|2
981694|NCT00380588|2378398|P1|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|3
981695|NCT00380588|2378397|P2|Received at Least One Dose of Study Drug|Overall Study||42
981696|NCT00380588|2378398|P1|Received at Least One Dose of Study Drug|Overall Study||41
981697|NCT00380588|2378397|P2|STARTED|Overall Study||42
981698|NCT00380588|2378398|P1|STARTED|Overall Study||42
981699|NCT00380692|2378412|P2|NOT COMPLETED|Study Period III - Open Label||12
981700|NCT00380692|2378413|P1|NOT COMPLETED|Study Period III - Open Label||6
981701|NCT00380692|2378412|P2|COMPLETED|Study Period III - Open Label||34
981702|NCT00380692|2378413|P1|COMPLETED|Study Period III - Open Label||36
981703|NCT00380692|2378412|P2|STARTED|Study Period III - Open Label||46
981704|NCT00380692|2378413|P1|STARTED|Study Period III - Open Label|One patient who completed Study Period II did not enter Study Period III.|42
981705|NCT00380692|2378412|P2|NOT COMPLETED|Study Period II - Double Blind||3
981706|NCT00380692|2378413|P1|NOT COMPLETED|Study Period II - Double Blind||5
981707|NCT00380692|2378412|P2|COMPLETED|Study Period II - Double Blind||46
981708|NCT00380692|2378413|P1|COMPLETED|Study Period II - Double Blind||43
981709|NCT00380692|2378412|P2|STARTED|Study Period II - Double Blind||49
981710|NCT00380692|2378413|P1|STARTED|Study Period II - Double Blind||48
981711|NCT00380718|2378459|P1|NOT COMPLETED|Overall Study||18
981712|NCT00380718|2378459|P1|COMPLETED|Overall Study||15
981713|NCT00380718|2378459|P1|Received Escalated Dose in Cycle 2|Overall Study||25
981714|NCT00380718|2378459|P1|Received at Least One Dose of Study Drug|Overall Study||33
981715|NCT00380718|2378459|P1|STARTED|Overall Study||33
981716|NCT00384241|2378471|P2|NOT COMPLETED|Overall Study||0
981717|NCT00384241|2378472|P1|NOT COMPLETED|Overall Study||0
981718|NCT00384241|2378471|P2|COMPLETED|Overall Study||599
981719|NCT00384241|2378472|P1|COMPLETED|Overall Study||500
981720|NCT00384241|2378471|P2|STARTED|Overall Study||599
981721|NCT00384241|2378472|P1|STARTED|Overall Study||500
981722|NCT00384293|2378480|P3|NOT COMPLETED|Post-randomization Period||219
981723|NCT00384293|2378481|P2|NOT COMPLETED|Post-randomization Period||214
981724|NCT00384293|2378482|P1|NOT COMPLETED|Post-randomization Period||0
981725|NCT00384293|2378480|P3|COMPLETED|Post-randomization Period||0
981726|NCT00384293|2378481|P2|COMPLETED|Post-randomization Period||0
981727|NCT00384293|2378482|P1|COMPLETED|Post-randomization Period||0
981728|NCT00384293|2378480|P3|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||218
981729|NCT00384293|2378481|P2|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period|Received at least one dose of randomized study drug (All Patients as Treated Population)|214
981730|NCT00384293|2378482|P1|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||0
981731|NCT00384293|2378480|P3|STARTED|Post-randomization Period||219
981732|NCT00384293|2378481|P2|STARTED|Post-randomization Period||214
981733|NCT00384293|2378482|P1|STARTED|Post-randomization Period||0
981734|NCT00384293|2378480|P3|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
981735|NCT00384293|2378481|P2|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
981736|NCT00384293|2378482|P1|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||504
981737|NCT00384293|2378480|P3|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
981738|NCT00384293|2378481|P2|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
981739|NCT00384293|2378482|P1|COMPLETED|MK0524A Active Run-In, Pre-randomization||433
981740|NCT00384293|2378480|P3|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
981741|NCT00384293|2378481|P2|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
981742|NCT00384293|2378482|P1|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization|MK0524A dose increased to 2 g in active run-in period|813
981743|NCT00384293|2378480|P3|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
981744|NCT00384293|2378481|P2|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
981745|NCT00384293|2378482|P1|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization|Entered active run-in period and received MK0524A 1 g|937
981746|NCT00384293|2378480|P3|STARTED|MK0524A Active Run-In, Pre-randomization||0
981747|NCT00384293|2378481|P2|STARTED|MK0524A Active Run-In, Pre-randomization||0
981748|NCT00384293|2378482|P1|STARTED|MK0524A Active Run-In, Pre-randomization||937
981749|NCT00384332|2378495|P2|NOT COMPLETED|Overall Study||0
981750|NCT00384332|2378496|P1|NOT COMPLETED|Overall Study||4
981751|NCT00384332|2378495|P2|COMPLETED|Overall Study||10
981752|NCT00384332|2378496|P1|COMPLETED|Overall Study||9
981753|NCT00384332|2378495|P2|STARTED|Overall Study||10
981754|NCT00384332|2378496|P1|STARTED|Overall Study||13
981755|NCT00384397|2378507|P3|NOT COMPLETED|Overall Study||33
981756|NCT00384397|2378508|P2|NOT COMPLETED|Overall Study||46
981757|NCT00384397|2378509|P1|NOT COMPLETED|Overall Study||32
981758|NCT00384397|2378507|P3|COMPLETED|Overall Study||385
981759|NCT00384397|2378508|P2|COMPLETED|Overall Study||247
981760|NCT00384397|2378509|P1|COMPLETED|Overall Study||375
981761|NCT00384397|2378507|P3|STARTED|Overall Study||418
981762|NCT00384397|2378508|P2|STARTED|Overall Study||293
981763|NCT00384397|2378509|P1|STARTED|Overall Study||407
981764|NCT00384670|2378526|P1|NOT COMPLETED|Overall Study||0
981765|NCT00384670|2378526|P1|COMPLETED|Overall Study||7
981766|NCT00384670|2378526|P1|STARTED|Overall Study||7
981767|NCT00384748|2378538|P2|NOT COMPLETED|Overall Study||0
981768|NCT00384748|2378539|P1|NOT COMPLETED|Overall Study||0
981769|NCT00384748|2378538|P2|COMPLETED|Overall Study||23
981770|NCT00384748|2378539|P1|COMPLETED|Overall Study||25
981771|NCT00384748|2378538|P2|STARTED|Overall Study||23
981772|NCT00384748|2378539|P1|STARTED|Overall Study||25
981773|NCT00384813|2378547|P2|NOT COMPLETED|Overall Study||0
981774|NCT00384813|2378548|P1|NOT COMPLETED|Overall Study||2
981775|NCT00384813|2378547|P2|COMPLETED|Overall Study||20
981776|NCT00384813|2378548|P1|COMPLETED|Overall Study||21
981777|NCT00384813|2378547|P2|STARTED|Overall Study||20
981778|NCT00384813|2378548|P1|STARTED|Overall Study||23
981779|NCT00384865|2378558|P4|NOT COMPLETED|Overall Study||0
981780|NCT00384865|2378559|P3|NOT COMPLETED|Overall Study||0
981781|NCT00384865|2378560|P2|NOT COMPLETED|Overall Study||0
981782|NCT00384865|2378561|P1|NOT COMPLETED|Overall Study||0
981783|NCT00384865|2378558|P4|COMPLETED|Overall Study||16
981784|NCT00384865|2378559|P3|COMPLETED|Overall Study||16
981785|NCT00384865|2378560|P2|COMPLETED|Overall Study||16
981786|NCT00384865|2378561|P1|COMPLETED|Overall Study||16
981787|NCT00384865|2378558|P4|Completed Six Month Assessment|Overall Study||11
981788|NCT00384865|2378559|P3|Completed Six Month Assessment|Overall Study||15
981789|NCT00384865|2378560|P2|Completed Six Month Assessment|Overall Study||12
981790|NCT00384865|2378561|P1|Completed Six Month Assessment|Overall Study||11
981791|NCT00384865|2378558|P4|STARTED|Overall Study||16
981792|NCT00384865|2378559|P3|STARTED|Overall Study||16
981793|NCT00384865|2378560|P2|STARTED|Overall Study||16
981794|NCT00384865|2378561|P1|STARTED|Overall Study||16
981795|NCT00384930|2378584|P5|NOT COMPLETED|Overall Study||47
981796|NCT00384930|2378585|P4|NOT COMPLETED|Overall Study||41
981797|NCT00384930|2378586|P3|NOT COMPLETED|Overall Study||30
981798|NCT00384930|2378587|P2|NOT COMPLETED|Overall Study||27
981799|NCT00384930|2378588|P1|NOT COMPLETED|Overall Study||27
981800|NCT00384930|2378584|P5|COMPLETED|Overall Study||162
981801|NCT00384930|2378585|P4|COMPLETED|Overall Study||175
981802|NCT00384930|2378586|P3|COMPLETED|Overall Study||182
981803|NCT00384930|2378587|P2|COMPLETED|Overall Study||182
981804|NCT00384930|2378588|P1|COMPLETED|Overall Study||185
981805|NCT00384930|2378584|P5|Received Double-Blind Study Drug|Overall Study||209
981806|NCT00384930|2378585|P4|Received Double-Blind Study Drug|Overall Study||216
981807|NCT00384930|2378586|P3|Received Double-Blind Study Drug|Overall Study||212
981808|NCT00384930|2378587|P2|Received Double-Blind Study Drug|Overall Study||208
981809|NCT00384930|2378588|P1|Received Double-Blind Study Drug|Overall Study||211
981810|NCT00384930|2378584|P5|STARTED|Overall Study||209
981811|NCT00384930|2378585|P4|STARTED|Overall Study||216
981812|NCT00384930|2378586|P3|STARTED|Overall Study||212
981814|NCT00384930|2378588|P1|STARTED|Overall Study||212
981815|NCT00384956|2378642|P1|NOT COMPLETED|Overall Study||3
981816|NCT00384956|2378642|P1|COMPLETED|Overall Study||22
981817|NCT00384956|2378642|P1|STARTED|Overall Study||25
981818|NCT00385138|2378656|P2|NOT COMPLETED|Overall Study||28
981819|NCT00385138|2378657|P1|NOT COMPLETED|Overall Study||30
981820|NCT00385138|2378656|P2|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2641
981821|NCT00385138|2378657|P1|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2665
981822|NCT00385138|2378656|P2|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2650
981823|NCT00385138|2378657|P1|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2662
981824|NCT00385138|2378656|P2|Modified Intent-to-treat (mITT)|Overall Study|Excludes 24 patients who either did not received study drug or have PCI.|2645
981825|NCT00385138|2378657|P1|Modified Intent-to-treat (mITT)|Overall Study|Excludes 37 patients who either did not receive study drug or have PCI.|2656
981826|NCT00385138|2378656|P2|Intent-to-treat (ITT)|Overall Study||2669
981827|NCT00385138|2378657|P1|Intent-to-treat (ITT)|Overall Study|All patients randomized excluding two (2) who withdrew consent for using study data.|2693
981828|NCT00385138|2378656|P2|STARTED|Overall Study||2669
981829|NCT00385138|2378657|P1|STARTED|Overall Study||2695
981830|NCT00385203|2378703|P2|NOT COMPLETED|Overall Study||7
981831|NCT00385203|2378704|P1|NOT COMPLETED|Overall Study||26
981832|NCT00385203|2378703|P2|COMPLETED|Overall Study||3
981833|NCT00385203|2378704|P1|COMPLETED|Overall Study||0
981834|NCT00385203|2378703|P2|STARTED|Overall Study||10
981835|NCT00385203|2378704|P1|STARTED|Overall Study||26
981836|NCT00385216|2378722|P2|NOT COMPLETED|Second Intervention||0
981837|NCT00385216|2378723|P1|NOT COMPLETED|Second Intervention||0
981838|NCT00385216|2378722|P2|COMPLETED|Second Intervention||9
981839|NCT00385216|2378723|P1|COMPLETED|Second Intervention||11
981840|NCT00385216|2378722|P2|STARTED|Second Intervention||9
981841|NCT00385216|2378723|P1|STARTED|Second Intervention||11
981842|NCT00385216|2378722|P2|NOT COMPLETED|First Intervention||0
981843|NCT00385216|2378723|P1|NOT COMPLETED|First Intervention||0
981844|NCT00385216|2378722|P2|COMPLETED|First Intervention||9
981845|NCT00385216|2378723|P1|COMPLETED|First Intervention||11
981846|NCT00385216|2378722|P2|STARTED|First Intervention||9
981847|NCT00385216|2378723|P1|STARTED|First Intervention||11
981848|NCT00385268|2378737|P2|NOT COMPLETED|Overall Study||8
981849|NCT00385268|2378738|P1|NOT COMPLETED|Overall Study||16
981850|NCT00385268|2378737|P2|COMPLETED|Overall Study||18
981851|NCT00385268|2378738|P1|COMPLETED|Overall Study||18
981852|NCT00385268|2378737|P2|STARTED|Overall Study||26
981853|NCT00385268|2378738|P1|STARTED|Overall Study||34
981854|NCT00385515|2378746|P2|NOT COMPLETED|Overall Study||3
981855|NCT00385515|2378747|P1|NOT COMPLETED|Overall Study||4
981856|NCT00385515|2378746|P2|COMPLETED|Overall Study||21
981857|NCT00385515|2378747|P1|COMPLETED|Overall Study||53
981858|NCT00385515|2378746|P2|STARTED|Overall Study||24
981859|NCT00385515|2378747|P1|STARTED|Overall Study||57
981860|NCT00385541|2378755|P2|NOT COMPLETED|Overall Study||1
981861|NCT00385541|2378756|P1|NOT COMPLETED|Overall Study||0
981862|NCT00385541|2378755|P2|COMPLETED|Overall Study||24
981863|NCT00385541|2378756|P1|COMPLETED|Overall Study||25
981864|NCT00385541|2378755|P2|STARTED|Overall Study||25
981865|NCT00385541|2378756|P1|STARTED|Overall Study||25
981866|NCT00385580|2378772|P2|NOT COMPLETED|Overall Study||0
981867|NCT00385580|2378773|P1|NOT COMPLETED|Overall Study||0
981868|NCT00385580|2378772|P2|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|47
981869|NCT00385580|2378773|P1|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|48
981870|NCT00385580|2378772|P2|STARTED|Overall Study|Number of participants treated.|47
981871|NCT00385580|2378773|P1|STARTED|Overall Study|Number of participants treated.|48
981872|NCT00385593|2378864|P2|NOT COMPLETED|Overall Study||37
981873|NCT00385593|2378865|P1|NOT COMPLETED|Overall Study||58
981874|NCT00385593|2378864|P2|COMPLETED|Overall Study||289
981875|NCT00385593|2378865|P1|COMPLETED|Overall Study||270
981876|NCT00385593|2378864|P2|STARTED|Overall Study||326
981877|NCT00385593|2378865|P1|STARTED|Overall Study||328
981878|NCT00385671|2378884|P3|NOT COMPLETED|Overall Study||36
981879|NCT00385671|2378885|P2|NOT COMPLETED|Overall Study||51
981880|NCT00385671|2378886|P1|NOT COMPLETED|Overall Study||38
981881|NCT00385671|2378884|P3|COMPLETED|Overall Study||99
981882|NCT00385671|2378885|P2|COMPLETED|Overall Study||87
981883|NCT00385671|2378886|P1|COMPLETED|Overall Study||96
981884|NCT00385671|2378884|P3|STARTED|Overall Study||135
981885|NCT00385671|2378885|P2|STARTED|Overall Study||138
981886|NCT00385671|2378886|P1|STARTED|Overall Study||134
981887|NCT00385684|2379040|P2|NOT COMPLETED|PHASE B||0
981888|NCT00385684|2379041|P1|NOT COMPLETED|PHASE B||0
981889|NCT00385684|2379040|P2|COMPLETED|PHASE B||3
981890|NCT00385684|2379041|P1|COMPLETED|PHASE B||5
981891|NCT00385684|2379040|P2|STARTED|PHASE B||3
981892|NCT00385684|2379041|P1|STARTED|PHASE B||5
981893|NCT00385684|2379040|P2|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||2
981894|NCT00385684|2379041|P1|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||0
981895|NCT00385684|2379040|P2|COMPLETED|SECOND INTERVENTION OF PHASE A||3
981896|NCT00385684|2379041|P1|COMPLETED|SECOND INTERVENTION OF PHASE A||5
981897|NCT00385684|2379040|P2|STARTED|SECOND INTERVENTION OF PHASE A||5
981898|NCT00385684|2379041|P1|STARTED|SECOND INTERVENTION OF PHASE A||5
981899|NCT00385684|2379040|P2|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||0
981900|NCT00385684|2379041|P1|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||1
981901|NCT00385684|2379040|P2|COMPLETED|FIRST INTERVENTION OF PHASE A||5
981902|NCT00385684|2379041|P1|COMPLETED|FIRST INTERVENTION OF PHASE A||5
981903|NCT00385684|2379040|P2|STARTED|FIRST INTERVENTION OF PHASE A||5
981904|NCT00385684|2379041|P1|STARTED|FIRST INTERVENTION OF PHASE A||6
981905|NCT00385723|2379050|P3|NOT COMPLETED|Overall Study||2
981906|NCT00385723|2379051|P2|NOT COMPLETED|Overall Study||1
981907|NCT00385723|2379052|P1|NOT COMPLETED|Overall Study||2
981908|NCT00385723|2379050|P3|COMPLETED|Overall Study||44
981909|NCT00385723|2379051|P2|COMPLETED|Overall Study||45
981910|NCT00385723|2379052|P1|COMPLETED|Overall Study||44
981911|NCT00385723|2379050|P3|STARTED|Overall Study||46
981912|NCT00385723|2379051|P2|STARTED|Overall Study||46
981913|NCT00385723|2379052|P1|STARTED|Overall Study||46
981914|NCT00385736|2379069|P3|NOT COMPLETED|Safety Analysis Set||80
981915|NCT00385736|2379070|P2|NOT COMPLETED|Safety Analysis Set||44
981916|NCT00385736|2379071|P1|NOT COMPLETED|Safety Analysis Set||70
981917|NCT00385736|2379069|P3|COMPLETED|Safety Analysis Set||143
981918|NCT00385736|2379070|P2|COMPLETED|Safety Analysis Set||86
981919|NCT00385736|2379071|P1|COMPLETED|Safety Analysis Set||153
981920|NCT00385736|2379069|P3|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
981921|NCT00385736|2379070|P2|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|130
981922|NCT00385736|2379071|P1|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
981923|NCT00385736|2379069|P3|NOT COMPLETED|Efficacy Analysis Set - Maintenance||80
981924|NCT00385736|2379070|P2|NOT COMPLETED|Efficacy Analysis Set - Maintenance||44
981925|NCT00385736|2379071|P1|NOT COMPLETED|Efficacy Analysis Set - Maintenance||69
981926|NCT00385736|2379069|P3|COMPLETED|Efficacy Analysis Set - Maintenance||143
981927|NCT00385736|2379070|P2|COMPLETED|Efficacy Analysis Set - Maintenance||86
981928|NCT00385736|2379071|P1|COMPLETED|Efficacy Analysis Set - Maintenance||153
981929|NCT00385736|2379069|P3|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|223
981930|NCT00385736|2379070|P2|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|130
981931|NCT00385736|2379071|P1|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|222
981932|NCT00385736|2379069|P3|NOT COMPLETED|Efficacy Analysis Set - Induction||9
981933|NCT00385736|2379070|P2|NOT COMPLETED|Efficacy Analysis Set - Induction||12
981934|NCT00385736|2379071|P1|NOT COMPLETED|Efficacy Analysis Set - Induction||9
981935|NCT00385736|2379069|P3|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
981936|NCT00385736|2379070|P2|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|118
981937|NCT00385736|2379071|P1|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
981938|NCT00385736|2379069|P3|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
981939|NCT00385736|2379070|P2|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
981940|NCT00385736|2379071|P1|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
981941|NCT00385762|2379113|P1|NOT COMPLETED|Overall Study||2
981942|NCT00385762|2379113|P1|COMPLETED|Overall Study||33
981943|NCT00385762|2379113|P1|STARTED|Overall Study||35
981944|NCT00385801|2379122|P2|NOT COMPLETED|Overall Study||8
981945|NCT00385801|2379123|P1|NOT COMPLETED|Overall Study||9
981946|NCT00385801|2379122|P2|COMPLETED|Overall Study||8
981947|NCT00385801|2379123|P1|COMPLETED|Overall Study||6
981948|NCT00385801|2379122|P2|STARTED|Overall Study||16
981949|NCT00385801|2379123|P1|STARTED|Overall Study||15
981950|NCT00385827|2379138|P3|NOT COMPLETED|Part 2||48
981951|NCT00385827|2379139|P2|NOT COMPLETED|Part 2||33
981952|NCT00385827|2379140|P1|NOT COMPLETED|Part 2||0
981953|NCT00385827|2379138|P3|COMPLETED|Part 2||0
981954|NCT00385827|2379139|P2|COMPLETED|Part 2||16
981955|NCT00385827|2379140|P1|COMPLETED|Part 2||0
981956|NCT00385827|2379138|P3|Treated|Part 2||46
981957|NCT00385827|2379139|P2|Treated|Part 2||47
981958|NCT00385827|2379140|P1|Treated|Part 2||0
981959|NCT00385827|2379138|P3|STARTED|Part 2||48
981960|NCT00385827|2379139|P2|STARTED|Part 2||49
981961|NCT00385827|2379140|P1|STARTED|Part 2||0
981962|NCT00385827|2379138|P3|NOT COMPLETED|Part 1||0
981963|NCT00385827|2379139|P2|NOT COMPLETED|Part 1||0
981964|NCT00385827|2379140|P1|NOT COMPLETED|Part 1||9
981965|NCT00385827|2379138|P3|COMPLETED|Part 1||0
981966|NCT00385827|2379139|P2|COMPLETED|Part 1||0
981967|NCT00385827|2379140|P1|COMPLETED|Part 1||0
981968|NCT00385827|2379138|P3|Treated|Part 1||0
981969|NCT00385827|2379139|P2|Treated|Part 1||0
981970|NCT00385827|2379140|P1|Treated|Part 1||9
981971|NCT00385827|2379138|P3|STARTED|Part 1||0
981972|NCT00385827|2379139|P2|STARTED|Part 1||0
981973|NCT00385827|2379140|P1|STARTED|Part 1||9
981974|NCT00385840|2379162|P2|NOT COMPLETED|Overall Study||14
981975|NCT00385840|2379163|P1|NOT COMPLETED|Overall Study||4
981976|NCT00385840|2379162|P2|COMPLETED|Overall Study||531
981977|NCT00385840|2379163|P1|COMPLETED|Overall Study||129
981978|NCT00385840|2379162|P2|STARTED|Overall Study||545
981979|NCT00385840|2379163|P1|STARTED|Overall Study||133
981980|NCT00385918|2379185|P3|NOT COMPLETED|Intervention Phase After Randomization||0
981981|NCT00385918|2379186|P2|NOT COMPLETED|Intervention Phase After Randomization||0
981982|NCT00385918|2379187|P1|NOT COMPLETED|Intervention Phase After Randomization||3
981983|NCT00385918|2379185|P3|COMPLETED|Intervention Phase After Randomization||0
981984|NCT00385918|2379186|P2|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month home-base intervention|6
981985|NCT00385918|2379187|P1|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month training intervention|12
981986|NCT00385918|2379185|P3|STARTED|Intervention Phase After Randomization||0
981987|NCT00385918|2379186|P2|STARTED|Intervention Phase After Randomization|Participants successfully completed screening; this is the number in the home stretching arm.|6
981988|NCT00385918|2379187|P1|STARTED|Intervention Phase After Randomization|Participant successfully completed screening; this is the number in the Lokomat training arm.|15
981989|NCT00385918|2379185|P3|NOT COMPLETED|Feasibility & Baseline Measurement Phase||14
981990|NCT00385918|2379186|P2|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
981991|NCT00385918|2379187|P1|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
981992|NCT00385918|2379185|P3|COMPLETED|Feasibility & Baseline Measurement Phase||21
981993|NCT00385918|2379186|P2|COMPLETED|Feasibility & Baseline Measurement Phase||0
981994|NCT00385918|2379187|P1|COMPLETED|Feasibility & Baseline Measurement Phase||0
981995|NCT00385918|2379185|P3|Completed Baseline Tests|Feasibility & Baseline Measurement Phase|6 subjects did not complete all baseline tests.|21
981996|NCT00385918|2379186|P2|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
981997|NCT00385918|2379187|P1|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
981998|NCT00385918|2379185|P3|Number Eligible|Feasibility & Baseline Measurement Phase|8 subjects failed screening.|27
981999|NCT00385918|2379186|P2|Number Eligible|Feasibility & Baseline Measurement Phase||0
982000|NCT00385918|2379187|P1|Number Eligible|Feasibility & Baseline Measurement Phase||0
982001|NCT00385918|2379185|P3|STARTED|Feasibility & Baseline Measurement Phase|Total # of subjects screened.The screening occurred before randomization.|35
982002|NCT00385918|2379186|P2|STARTED|Feasibility & Baseline Measurement Phase||0
982003|NCT00385918|2379187|P1|STARTED|Feasibility & Baseline Measurement Phase||0
982004|NCT00385944|2379211|P3|NOT COMPLETED|2nd Maintenance Dose Period||0
982005|NCT00385944|2379212|P2|NOT COMPLETED|2nd Maintenance Dose Period||3
982006|NCT00385944|2379213|P1|NOT COMPLETED|2nd Maintenance Dose Period||2
982007|NCT00385944|2379211|P3|COMPLETED|2nd Maintenance Dose Period||0
982008|NCT00385944|2379212|P2|COMPLETED|2nd Maintenance Dose Period||19
982009|NCT00385944|2379213|P1|COMPLETED|2nd Maintenance Dose Period||22
982010|NCT00385944|2379211|P3|STARTED|2nd Maintenance Dose Period||0
982011|NCT00385944|2379212|P2|STARTED|2nd Maintenance Dose Period|2 patients discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|22
982012|NCT00385944|2379213|P1|STARTED|2nd Maintenance Dose Period|1 patient discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|24
982013|NCT00385944|2379211|P3|NOT COMPLETED|1st Maintenance Dose Period||0
982014|NCT00385944|2379212|P2|NOT COMPLETED|1st Maintenance Dose Period||1
982015|NCT00385944|2379213|P1|NOT COMPLETED|1st Maintenance Dose Period||4
982016|NCT00385944|2379211|P3|COMPLETED|1st Maintenance Dose Period||0
982017|NCT00385944|2379212|P2|COMPLETED|1st Maintenance Dose Period||24
982018|NCT00385944|2379213|P1|COMPLETED|1st Maintenance Dose Period||25
982019|NCT00385944|2379211|P3|STARTED|1st Maintenance Dose Period||0
982020|NCT00385944|2379212|P2|STARTED|1st Maintenance Dose Period|Two patients withdrew from the study after randomization but prior to receiving the 1st MD.|25
982021|NCT00385944|2379213|P1|STARTED|1st Maintenance Dose Period||29
982022|NCT00385944|2379211|P3|NOT COMPLETED|Loading Dose||0
982023|NCT00385944|2379212|P2|NOT COMPLETED|Loading Dose||0
982024|NCT00385944|2379213|P1|NOT COMPLETED|Loading Dose||0
982025|NCT00385944|2379211|P3|COMPLETED|Loading Dose||56
982026|NCT00385944|2379212|P2|COMPLETED|Loading Dose||0
982027|NCT00385944|2379213|P1|COMPLETED|Loading Dose||0
982028|NCT00385944|2379211|P3|STARTED|Loading Dose||56
982029|NCT00385944|2379212|P2|STARTED|Loading Dose||0
982030|NCT00385944|2379213|P1|STARTED|Loading Dose||0
982031|NCT00385996|2379254|P1|NOT COMPLETED|Overall Study||0
982032|NCT00385996|2379254|P1|COMPLETED|Overall Study||22
982033|NCT00385996|2379254|P1|STARTED|Overall Study||22
982034|NCT00386009|2379261|P2|NOT COMPLETED|Overall Study||10
982035|NCT00386009|2379262|P1|NOT COMPLETED|Overall Study||9
982036|NCT00386009|2379261|P2|COMPLETED|Overall Study||89
982037|NCT00386009|2379262|P1|COMPLETED|Overall Study||92
982038|NCT00386009|2379261|P2|STARTED|Overall Study||99
982039|NCT00386009|2379262|P1|STARTED|Overall Study||101
982040|NCT00386022|2379302|P2|NOT COMPLETED|Plus Estrogen||1
982041|NCT00386022|2379303|P1|NOT COMPLETED|Plus Estrogen||2
982042|NCT00386022|2379302|P2|COMPLETED|Plus Estrogen||8
982043|NCT00386022|2379303|P1|COMPLETED|Plus Estrogen||8
982044|NCT00386022|2379302|P2|All Doses GnRH|Plus Estrogen||8
982045|NCT00386022|2379303|P1|All Doses GnRH|Plus Estrogen||8
982046|NCT00386022|2379302|P2|Estrogen Patch|Plus Estrogen||9
982047|NCT00386022|2379303|P1|Estrogen Patch|Plus Estrogen||8
982048|NCT00386022|2379302|P2|STARTED|Plus Estrogen||9
982049|NCT00386022|2379303|P1|STARTED|Plus Estrogen||10
982050|NCT00386022|2379302|P2|NOT COMPLETED|Baseline||0
982051|NCT00386022|2379303|P1|NOT COMPLETED|Baseline||0
982052|NCT00386022|2379302|P2|COMPLETED|Baseline||9
982053|NCT00386022|2379303|P1|COMPLETED|Baseline||10
982054|NCT00386022|2379302|P2|All Doses of GnRH|Baseline||9
982055|NCT00386022|2379303|P1|All Doses of GnRH|Baseline||10
982056|NCT00386022|2379302|P2|STARTED|Baseline||9
982057|NCT00386022|2379303|P1|STARTED|Baseline||10
982058|NCT00386100|2379313|P2|NOT COMPLETED|Overall Study||131
982059|NCT00386100|2379314|P1|NOT COMPLETED|Overall Study||154
982060|NCT00386100|2379313|P2|COMPLETED|Overall Study||217
982061|NCT00386100|2379314|P1|COMPLETED|Overall Study||186
982062|NCT00386100|2379313|P2|STARTED|Overall Study||348
982063|NCT00386100|2379314|P1|STARTED|Overall Study||340
982064|NCT00386152|2379379|P3|NOT COMPLETED|Overall Study||33
982065|NCT00386152|2379380|P2|NOT COMPLETED|Overall Study||40
982066|NCT00386152|2379381|P1|NOT COMPLETED|Overall Study||44
982067|NCT00386152|2379379|P3|COMPLETED|Overall Study||42
982068|NCT00386152|2379380|P2|COMPLETED|Overall Study||37
982069|NCT00386152|2379381|P1|COMPLETED|Overall Study||31
982070|NCT00386152|2379379|P3|STARTED|Overall Study|number of subjects treated|75
982071|NCT00386152|2379380|P2|STARTED|Overall Study|number of subjects treated|77
982072|NCT00386152|2379381|P1|STARTED|Overall Study|number of subjects treated|75
982073|NCT00386243|2379400|P2|NOT COMPLETED|Overall Study||13
982074|NCT00386243|2379401|P1|NOT COMPLETED|Overall Study||7
982075|NCT00386243|2379400|P2|COMPLETED|Overall Study||108
982076|NCT00386243|2379401|P1|COMPLETED|Overall Study||114
982077|NCT00386243|2379400|P2|STARTED|Overall Study||121
982078|NCT00386243|2379401|P1|STARTED|Overall Study||121
982079|NCT00386256|2379413|P4|NOT COMPLETED|Overall Study||0
982080|NCT00386256|2379414|P3|NOT COMPLETED|Overall Study||0
982081|NCT00386256|2379415|P2|NOT COMPLETED|Overall Study||0
982082|NCT00386256|2379416|P1|NOT COMPLETED|Overall Study||0
982083|NCT00386256|2379413|P4|COMPLETED|Overall Study||3
982084|NCT00386256|2379414|P3|COMPLETED|Overall Study||4
982085|NCT00386256|2379415|P2|COMPLETED|Overall Study||15
982086|NCT00386256|2379416|P1|COMPLETED|Overall Study||16
982087|NCT00386256|2379413|P4|STARTED|Overall Study||3
982088|NCT00386256|2379414|P3|STARTED|Overall Study||4
982089|NCT00386256|2379415|P2|STARTED|Overall Study||15
982090|NCT00386256|2379416|P1|STARTED|Overall Study||16
982091|NCT00386308|2379432|P2|NOT COMPLETED|Overall Study||19
982092|NCT00386308|2379433|P1|NOT COMPLETED|Overall Study||29
982093|NCT00386308|2379432|P2|COMPLETED|Overall Study||54
982094|NCT00386308|2379433|P1|COMPLETED|Overall Study||94
982095|NCT00386308|2379432|P2|Modified Intent to Treat Population|Overall Study||72
982096|NCT00386308|2379433|P1|Modified Intent to Treat Population|Overall Study||115
982097|NCT00386308|2379432|P2|Intent to Treat Population|Overall Study||72
982098|NCT00386308|2379433|P1|Intent to Treat Population|Overall Study||117
982099|NCT00386308|2379432|P2|STARTED|Overall Study||73
982100|NCT00386308|2379433|P1|STARTED|Overall Study||123
982101|NCT00386334|2379447|P2|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||1
982102|NCT00386334|2379448|P1|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||3
982103|NCT00386334|2379447|P2|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||144
982104|NCT00386334|2379448|P1|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||143
982105|NCT00386334|2379447|P2|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|145
982106|NCT00386334|2379448|P1|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|146
982107|NCT00386334|2379447|P2|NOT COMPLETED|Double Blind Period||47
982108|NCT00386334|2379448|P1|NOT COMPLETED|Double Blind Period||46
982109|NCT00386334|2379447|P2|COMPLETED|Double Blind Period||147
982110|NCT00386334|2379448|P1|COMPLETED|Double Blind Period||148
982111|NCT00386334|2379447|P2|STARTED|Double Blind Period||194
982112|NCT00386334|2379448|P1|STARTED|Double Blind Period||194
982113|NCT00386360|2379592|P2|NOT COMPLETED|Overall Study||17
982114|NCT00386360|2379593|P1|NOT COMPLETED|Overall Study||9
982115|NCT00386360|2379592|P2|COMPLETED|Overall Study||95
982116|NCT00386360|2379593|P1|COMPLETED|Overall Study||40
982117|NCT00386360|2379592|P2|Primary Efficacy|Overall Study||77
982118|NCT00386360|2379593|P1|Primary Efficacy|Overall Study|Per-protocol patients with evaluable BVTV (trabecular bone volume/tissue volume) at baseline & M12.|36
982119|NCT00386360|2379592|P2|Intent to Treat Population (ITT)|Overall Study||110
982120|NCT00386360|2379593|P1|Intent to Treat Population (ITT)|Overall Study|Includes all patients randomized and took at least one dose of study drug.|49
982121|NCT00386360|2379592|P2|STARTED|Overall Study||112
982122|NCT00386360|2379593|P1|STARTED|Overall Study||49
982123|NCT00386425|2379628|P3|NOT COMPLETED|Overall Study||0
982124|NCT00386425|2379629|P2|NOT COMPLETED|Overall Study||1
982125|NCT00386425|2379630|P1|NOT COMPLETED|Overall Study||3
982126|NCT00386425|2379628|P3|COMPLETED|Overall Study||53
982127|NCT00386425|2379629|P2|COMPLETED|Overall Study|33 severe protein C deficiency; 172 moderate protein C deficiency|205
982128|NCT00386425|2379630|P1|COMPLETED|Overall Study|51 severe protein C deficiency; 173 moderate protein C deficiency|224
982129|NCT00386425|2379628|P3|Received Study Drug|Overall Study||53
982130|NCT00386425|2379629|P2|Received Study Drug|Overall Study||206
982131|NCT00386425|2379630|P1|Received Study Drug|Overall Study||227
982132|NCT00386425|2379628|P3|STARTED|Overall Study||53
982133|NCT00386425|2379629|P2|STARTED|Overall Study|33 severe protein C deficiency; 173 moderate protein C deficiency|206
982134|NCT00386425|2379630|P1|STARTED|Overall Study|51 severe protein C deficiency; 176 moderate protein C deficiency|227
982135|NCT00386477|2379656|P2|NOT COMPLETED|Overall Study||0
982136|NCT00386477|2379657|P1|NOT COMPLETED|Overall Study||0
982137|NCT00386477|2379656|P2|COMPLETED|Overall Study||145
982138|NCT00386477|2379657|P1|COMPLETED|Overall Study||155
982139|NCT00386477|2379656|P2|STARTED|Overall Study||145
982140|NCT00386477|2379657|P1|STARTED|Overall Study||155
982141|NCT00386607|2379663|P2|NOT COMPLETED|Extension||17
982142|NCT00386607|2379664|P1|NOT COMPLETED|Extension||0
982143|NCT00386607|2379663|P2|COMPLETED|Extension||145
982144|NCT00386607|2379664|P1|COMPLETED|Extension||0
982145|NCT00386607|2379663|P2|STARTED|Extension||162
982146|NCT00386607|2379664|P1|STARTED|Extension||0
982147|NCT00386607|2379663|P2|NOT COMPLETED|Core||0
982148|NCT00386607|2379664|P1|NOT COMPLETED|Core||115
982149|NCT00386607|2379663|P2|COMPLETED|Core||0
982150|NCT00386607|2379664|P1|COMPLETED|Core||486
982151|NCT00386607|2379663|P2|STARTED|Core||0
982152|NCT00386607|2379664|P1|STARTED|Core||601
982153|NCT00366899|2379682|P2|NOT COMPLETED|Toddler Dose||1
982154|NCT00366899|2379683|P1|NOT COMPLETED|Toddler Dose||2
982155|NCT00366899|2379682|P2|COMPLETED|Toddler Dose||281
982156|NCT00366899|2379683|P1|COMPLETED|Toddler Dose||285
982157|NCT00366899|2379682|P2|STARTED|Toddler Dose||282
982158|NCT00366899|2379683|P1|STARTED|Toddler Dose||287
982159|NCT00366899|2379682|P2|NOT COMPLETED|After Infant Series||9
982160|NCT00366899|2379683|P1|NOT COMPLETED|After Infant Series||7
982161|NCT00366899|2379682|P2|COMPLETED|After Infant Series||282
982162|NCT00366899|2379683|P1|COMPLETED|After Infant Series||287
982163|NCT00366899|2379682|P2|STARTED|After Infant Series||291
982164|NCT00366899|2379683|P1|STARTED|After Infant Series||294
982165|NCT00366899|2379682|P2|NOT COMPLETED|Infant Series||12
982166|NCT00366899|2379683|P1|NOT COMPLETED|Infant Series||9
982167|NCT00366899|2379682|P2|COMPLETED|Infant Series||291
982168|NCT00366899|2379683|P1|COMPLETED|Infant Series||294
982169|NCT00366899|2379682|P2|Vaccinated Dose 2|Infant Series||293
982170|NCT00366899|2379683|P1|Vaccinated Dose 2|Infant Series|1 participant randomized to 13vPnC, incorrectly received 7vPnC|296
982171|NCT00366899|2379682|P2|Vaccinated Dose 1|Infant Series||302
982172|NCT00366899|2379683|P1|Vaccinated Dose 1|Infant Series|2 participants randomized to 13vPnC, incorrectly received 7vPnC|302
982173|NCT00366899|2379682|P2|STARTED|Infant Series|1 participant randomized to 7vPnC but never vaccinated|303
982174|NCT00366899|2379683|P1|STARTED|Infant Series|1 participant was counted twice, 1 participant randomized to 13vPnC, incorrectly received 7vPnC|303
982175|NCT00367055|2379743|P2|NOT COMPLETED|Overall Study||11
982176|NCT00367055|2379744|P1|NOT COMPLETED|Overall Study||11
982177|NCT00367055|2379743|P2|COMPLETED|Overall Study||30
982178|NCT00367055|2379744|P1|COMPLETED|Overall Study||32
982179|NCT00367055|2379743|P2|STARTED|Overall Study||41
982180|NCT00367055|2379744|P1|STARTED|Overall Study||43
982181|NCT00367133|2379761|P3|NOT COMPLETED|3 Years||18
982182|NCT00367133|2379762|P2|NOT COMPLETED|3 Years||23
982183|NCT00367133|2379763|P1|NOT COMPLETED|3 Years||28
982184|NCT00367133|2379761|P3|COMPLETED|3 Years||98
982185|NCT00367133|2379762|P2|COMPLETED|3 Years||93
982186|NCT00367133|2379763|P1|COMPLETED|3 Years||115
982187|NCT00367133|2379761|P3|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
982188|NCT00367133|2379762|P2|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
982189|NCT00367133|2379763|P1|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|143
982190|NCT00367133|2379761|P3|NOT COMPLETED|2 Years||49
982191|NCT00367133|2379762|P2|NOT COMPLETED|2 Years||36
982192|NCT00367133|2379763|P1|NOT COMPLETED|2 Years||58
982193|NCT00367133|2379761|P3|COMPLETED|2 Years||205
982194|NCT00367133|2379762|P2|COMPLETED|2 Years||220
982195|NCT00367133|2379763|P1|COMPLETED|2 Years||272
982196|NCT00367133|2379761|P3|STARTED|2 Years|Number of Eyes|254
982197|NCT00367133|2379762|P2|STARTED|2 Years|Number of Eyes|256
982198|NCT00367133|2379763|P1|STARTED|2 Years|Number of Eyes|330
982199|NCT00377962|2379815|P2|NOT COMPLETED|Extension Study: 12-24 Months||4
982200|NCT00377962|2379816|P1|NOT COMPLETED|Extension Study: 12-24 Months||10
982201|NCT00377962|2379815|P2|COMPLETED|Extension Study: 12-24 Months||123
982202|NCT00377962|2379816|P1|COMPLETED|Extension Study: 12-24 Months||98
982203|NCT00377962|2379815|P2|STARTED|Extension Study: 12-24 Months||127
982204|NCT00377962|2379816|P1|STARTED|Extension Study: 12-24 Months||108
982205|NCT00377962|2379815|P2|NOT COMPLETED|Core Study: 0-12 Months||9
982206|NCT00377962|2379816|P1|NOT COMPLETED|Core Study: 0-12 Months||28
982207|NCT00377962|2379815|P2|COMPLETED|Core Study: 0-12 Months||133
982208|NCT00377962|2379816|P1|COMPLETED|Core Study: 0-12 Months||112
982209|NCT00377962|2379815|P2|STARTED|Core Study: 0-12 Months||142
982210|NCT00377962|2379816|P1|STARTED|Core Study: 0-12 Months||140
982211|NCT00386776|2379850|P1|NOT COMPLETED|Overall Study||8
982212|NCT00386776|2379850|P1|COMPLETED|Overall Study||32
982213|NCT00386776|2379850|P1|STARTED|Overall Study||40
982214|NCT00386880|2379860|P2|NOT COMPLETED|Overall Study||0
982215|NCT00386880|2379861|P1|NOT COMPLETED|Overall Study||0
982216|NCT00386880|2379860|P2|COMPLETED|Overall Study||8
982217|NCT00386880|2379861|P1|COMPLETED|Overall Study||30
982218|NCT00386880|2379860|P2|STARTED|Overall Study||8
982219|NCT00386880|2379861|P1|STARTED|Overall Study||30
982220|NCT00387010|2379866|P1|NOT COMPLETED|Treatment Period||11
982221|NCT00387010|2379866|P1|COMPLETED|Treatment Period||169
982222|NCT00387010|2379866|P1|Full Analysis Set|Treatment Period|FAS: treated patients with at least 1 paired baseline and post baseline efficacy assessment|175
982223|NCT00387010|2379866|P1|STARTED|Treatment Period||180
982224|NCT00387010|2379866|P1|NOT COMPLETED|Dose Titration Period||38
982225|NCT00387010|2379866|P1|COMPLETED|Dose Titration Period||180
982226|NCT00387010|2379866|P1|STARTED|Dose Titration Period||218
982227|NCT00387023|2379887|P1|NOT COMPLETED|Overall Study||0
982228|NCT00387023|2379887|P1|COMPLETED|Overall Study||12
982229|NCT00387023|2379887|P1|STARTED|Overall Study||12
982230|NCT00387036|2379891|P2|NOT COMPLETED|2-Week Crossover Second Intervention||0
982231|NCT00387036|2379892|P1|NOT COMPLETED|2-Week Crossover Second Intervention||0
982232|NCT00387036|2379891|P2|COMPLETED|2-Week Crossover Second Intervention||6
982233|NCT00387036|2379892|P1|COMPLETED|2-Week Crossover Second Intervention||6
982234|NCT00387036|2379891|P2|STARTED|2-Week Crossover Second Intervention||6
982235|NCT00387036|2379892|P1|STARTED|2-Week Crossover Second Intervention||6
982236|NCT00387036|2379891|P2|NOT COMPLETED|2-Week Placebo Washout||0
982237|NCT00387036|2379892|P1|NOT COMPLETED|2-Week Placebo Washout||0
982238|NCT00387036|2379891|P2|COMPLETED|2-Week Placebo Washout||6
982239|NCT00387036|2379892|P1|COMPLETED|2-Week Placebo Washout||6
982240|NCT00387036|2379891|P2|STARTED|2-Week Placebo Washout||6
982241|NCT00387036|2379892|P1|STARTED|2-Week Placebo Washout||6
982242|NCT00387036|2379891|P2|NOT COMPLETED|2-Week First Intervention||0
982243|NCT00387036|2379892|P1|NOT COMPLETED|2-Week First Intervention||0
982244|NCT00387036|2379891|P2|COMPLETED|2-Week First Intervention||6
982245|NCT00387036|2379892|P1|COMPLETED|2-Week First Intervention||6
982246|NCT00387036|2379891|P2|STARTED|2-Week First Intervention||6
982247|NCT00387036|2379892|P1|STARTED|2-Week First Intervention||6
982248|NCT00387088|2379902|P2|NOT COMPLETED|Overall Study||373
982249|NCT00387088|2379903|P1|NOT COMPLETED|Overall Study||318
982250|NCT00387088|2379902|P2|COMPLETED|Overall Study||1629
982251|NCT00387088|2379903|P1|COMPLETED|Overall Study||1671
982252|NCT00387088|2379902|P2|STARTED|Overall Study||2002
982253|NCT00387088|2379903|P1|STARTED|Overall Study||1989
982254|NCT00388947|2379947|P1|NOT COMPLETED|Overall Study||47
982255|NCT00388947|2379947|P1|COMPLETED|Overall Study|47 patients excluded because no AMS prolapse device was noted.|1543
982256|NCT00388947|2379947|P1|STARTED|Overall Study||1590
982257|NCT00388973|2379954|P2|NOT COMPLETED|Overall Study||58
982258|NCT00388973|2379955|P1|NOT COMPLETED|Overall Study||56
982259|NCT00388973|2379954|P2|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|114
982260|NCT00388973|2379955|P1|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|110
982261|NCT00388973|2379954|P2|Completed Study|Overall Study||114
982262|NCT00388973|2379955|P1|Completed Study|Overall Study||110
982263|NCT00388973|2379954|P2|STARTED|Overall Study|Randomized|172
982264|NCT00388973|2379955|P1|STARTED|Overall Study|Randomized|166
982265|NCT00389064|2379977|P2|NOT COMPLETED|Overall Study||59
982266|NCT00389064|2379978|P1|NOT COMPLETED|Overall Study||45
982267|NCT00389064|2379977|P2|COMPLETED|Overall Study||168
982268|NCT00389064|2379978|P1|COMPLETED|Overall Study||178
982269|NCT00389064|2379977|P2|STARTED|Overall Study||227
982270|NCT00389064|2379978|P1|STARTED|Overall Study||223
982271|NCT00389168|2380006|P2|NOT COMPLETED|Overall Study||5
982272|NCT00389168|2380007|P1|NOT COMPLETED|Overall Study||9
982273|NCT00389168|2380006|P2|COMPLETED|Overall Study||53
982274|NCT00389168|2380007|P1|COMPLETED|Overall Study||47
982275|NCT00389168|2380006|P2|STARTED|Overall Study||58
982276|NCT00389168|2380007|P1|STARTED|Overall Study||56
982277|NCT00389207|2380026|P3|NOT COMPLETED|Overall Study||41
982278|NCT00389207|2380027|P2|NOT COMPLETED|Overall Study||72
982279|NCT00389207|2380028|P1|NOT COMPLETED|Overall Study||63
982280|NCT00389207|2380026|P3|COMPLETED|Overall Study||152
982281|NCT00389207|2380027|P2|COMPLETED|Overall Study||116
982282|NCT00389207|2380028|P1|COMPLETED|Overall Study||125
982283|NCT00389207|2380026|P3|STARTED|Overall Study||193
982284|NCT00389207|2380027|P2|STARTED|Overall Study|4 patients were randomized to NVP BID but not treated and so are not part of the FAS|188
982285|NCT00389207|2380028|P1|STARTED|Overall Study|3 patients were randomized to NVP QD but not treated and so not part of the Full Analysis Set (FAS)|188
982286|NCT00389324|2380130|P1|NOT COMPLETED|Subcutaneous Phase||7
982287|NCT00389324|2380130|P1|COMPLETED|Subcutaneous Phase||25
982288|NCT00389324|2380130|P1|STARTED|Subcutaneous Phase||32
982289|NCT00389324|2380130|P1|NOT COMPLETED|Intravenous Phase||0
982290|NCT00389324|2380130|P1|COMPLETED|Intravenous Phase||32
982291|NCT00389324|2380130|P1|STARTED|Intravenous Phase|18 subjects entered from the Run-in Phase and 14 new participants entered directly|32
982292|NCT00389324|2380130|P1|NOT COMPLETED|Run-In Phase||3
982293|NCT00389324|2380130|P1|COMPLETED|Run-In Phase||18
982294|NCT00389324|2380130|P1|STARTED|Run-In Phase||21
982295|NCT00389441|2380137|P1|NOT COMPLETED|Overall Study||52
982296|NCT00389441|2380137|P1|COMPLETED|Overall Study||0
982297|NCT00389441|2380137|P1|STARTED|Overall Study||52
982298|NCT00389467|2380150|P4|NOT COMPLETED|Overall Study||0
982299|NCT00389467|2380151|P3|NOT COMPLETED|Overall Study||0
982300|NCT00389467|2380152|P2|NOT COMPLETED|Overall Study||0
982301|NCT00389467|2380153|P1|NOT COMPLETED|Overall Study||0
982302|NCT00389467|2380150|P4|COMPLETED|Overall Study||20
982303|NCT00389467|2380151|P3|COMPLETED|Overall Study||30
982304|NCT00389467|2380152|P2|COMPLETED|Overall Study||34
982305|NCT00389467|2380153|P1|COMPLETED|Overall Study||34
982306|NCT00389467|2380150|P4|STARTED|Overall Study||20
982307|NCT00389467|2380151|P3|STARTED|Overall Study||30
982308|NCT00389467|2380152|P2|STARTED|Overall Study||34
982309|NCT00389467|2380153|P1|STARTED|Overall Study||34
982310|NCT00389493|2380175|P3|NOT COMPLETED|Overall Study||3
982311|NCT00389493|2380176|P2|NOT COMPLETED|Overall Study||8
982312|NCT00389493|2380177|P1|NOT COMPLETED|Overall Study||3
982313|NCT00389493|2380175|P3|COMPLETED|Overall Study||17
982314|NCT00389493|2380176|P2|COMPLETED|Overall Study||32
982315|NCT00389493|2380177|P1|COMPLETED|Overall Study||37
982316|NCT00389493|2380175|P3|STARTED|Overall Study||20
982317|NCT00389493|2380176|P2|STARTED|Overall Study||40
982318|NCT00389493|2380177|P1|STARTED|Overall Study||40
982319|NCT00389519|2380201|P4|NOT COMPLETED|Treated||4
982320|NCT00389519|2380202|P3|NOT COMPLETED|Treated||0
982321|NCT00389519|2380203|P2|NOT COMPLETED|Treated||1
982322|NCT00389519|2380204|P1|NOT COMPLETED|Treated||2
982323|NCT00389519|2380201|P4|COMPLETED|Treated||76
982324|NCT00389519|2380202|P3|COMPLETED|Treated||40
982325|NCT00389519|2380203|P2|COMPLETED|Treated||40
982326|NCT00389519|2380204|P1|COMPLETED|Treated||79
982327|NCT00389519|2380201|P4|STARTED|Treated||80
982328|NCT00389519|2380202|P3|STARTED|Treated||40
982329|NCT00389519|2380203|P2|STARTED|Treated||41
982330|NCT00389519|2380204|P1|STARTED|Treated||81
982331|NCT00389519|2380201|P4|NOT COMPLETED|Randomized||0
982332|NCT00389519|2380202|P3|NOT COMPLETED|Randomized||0
982333|NCT00389519|2380203|P2|NOT COMPLETED|Randomized||0
982334|NCT00389519|2380204|P1|NOT COMPLETED|Randomized||2
982335|NCT00389519|2380201|P4|COMPLETED|Randomized||80
982336|NCT00389519|2380202|P3|COMPLETED|Randomized||40
982337|NCT00389519|2380203|P2|COMPLETED|Randomized||41
982338|NCT00389519|2380204|P1|COMPLETED|Randomized||81
982339|NCT00389519|2380201|P4|STARTED|Randomized||80
982340|NCT00389519|2380202|P3|STARTED|Randomized||40
982341|NCT00389519|2380203|P2|STARTED|Randomized||41
982342|NCT00389519|2380204|P1|STARTED|Randomized||83
982343|NCT00389519|2380201|P4|NOT COMPLETED|Placebo Run-In||0
982344|NCT00389519|2380202|P3|NOT COMPLETED|Placebo Run-In||0
982345|NCT00389519|2380203|P2|NOT COMPLETED|Placebo Run-In||0
982346|NCT00389519|2380204|P1|NOT COMPLETED|Placebo Run-In||178
982347|NCT00389519|2380201|P4|COMPLETED|Placebo Run-In||0
982348|NCT00389519|2380202|P3|COMPLETED|Placebo Run-In||0
982349|NCT00389519|2380203|P2|COMPLETED|Placebo Run-In||0
982350|NCT00389519|2380204|P1|COMPLETED|Placebo Run-In||244
982351|NCT00389519|2380201|P4|STARTED|Placebo Run-In||0
982352|NCT00389519|2380202|P3|STARTED|Placebo Run-In||0
982353|NCT00389519|2380203|P2|STARTED|Placebo Run-In||0
982354|NCT00389519|2380204|P1|STARTED|Placebo Run-In||422
982355|NCT00389532|2380232|P2|NOT COMPLETED|Overall Study||0
982356|NCT00389532|2380233|P1|NOT COMPLETED|Overall Study||0
982357|NCT00389532|2380232|P2|COMPLETED|Overall Study||56
982358|NCT00389532|2380233|P1|COMPLETED|Overall Study|3 of the participants did not have valid post-vaccination serological results|60
982359|NCT00389532|2380232|P2|STARTED|Overall Study||56
982360|NCT00389532|2380233|P1|STARTED|Overall Study||60
982361|NCT00389597|2380245|P4|NOT COMPLETED|Overall Study||6
982362|NCT00389597|2380246|P3|NOT COMPLETED|Overall Study||4
982363|NCT00389597|2380247|P2|NOT COMPLETED|Overall Study||6
982364|NCT00389597|2380248|P1|NOT COMPLETED|Overall Study||8
982365|NCT00389597|2380245|P4|COMPLETED|Overall Study||99
982366|NCT00389597|2380246|P3|COMPLETED|Overall Study||221
982367|NCT00389597|2380247|P2|COMPLETED|Overall Study||75
982368|NCT00389597|2380248|P1|COMPLETED|Overall Study||156
982369|NCT00389597|2380245|P4|24 mo|Overall Study||99
982370|NCT00389597|2380246|P3|24 mo|Overall Study||221
982371|NCT00389597|2380247|P2|24 mo|Overall Study||75
982372|NCT00389597|2380248|P1|24 mo|Overall Study||156
982373|NCT00389597|2380245|P4|STARTED|Overall Study||105
982374|NCT00389597|2380246|P3|STARTED|Overall Study||225
982375|NCT00389597|2380247|P2|STARTED|Overall Study||81
982376|NCT00389597|2380248|P1|STARTED|Overall Study||164
982377|NCT00389805|2380260|P2|NOT COMPLETED|Phase II||0
982378|NCT00389805|2380261|P1|NOT COMPLETED|Phase II||0
982379|NCT00389805|2380260|P2|COMPLETED|Phase II||0
982380|NCT00389805|2380261|P1|COMPLETED|Phase II||0
982381|NCT00389805|2380260|P2|STARTED|Phase II|The Phase II study was not conducted.|0
982382|NCT00389805|2380261|P1|STARTED|Phase II|The Phase II study was not conducted.|0
982383|NCT00389805|2380260|P2|NOT COMPLETED|Phase I||0
982384|NCT00389805|2380261|P1|NOT COMPLETED|Phase I||0
982385|NCT00389805|2380260|P2|COMPLETED|Phase I||12
982386|NCT00389805|2380261|P1|COMPLETED|Phase I||15
982387|NCT00389805|2380260|P2|STARTED|Phase I||12
982388|NCT00389805|2380261|P1|STARTED|Phase I||15
982389|NCT00389818|2380287|P1|NOT COMPLETED|Overall Study||3
982390|NCT00389818|2380287|P1|COMPLETED|Overall Study||40
982391|NCT00389818|2380287|P1|STARTED|Overall Study||43
982392|NCT00389831|2380293|P2|NOT COMPLETED|Overall Study||7
982393|NCT00389831|2380294|P1|NOT COMPLETED|Overall Study||0
982394|NCT00389831|2380293|P2|COMPLETED|Overall Study||27
982395|NCT00389831|2380294|P1|COMPLETED|Overall Study||10
982396|NCT00389831|2380293|P2|STARTED|Overall Study||34
982397|NCT00389831|2380294|P1|STARTED|Overall Study||10
982398|NCT00389857|2380322|P2|NOT COMPLETED|Overall Study||0
982399|NCT00389857|2380323|P1|NOT COMPLETED|Overall Study||0
982400|NCT00389857|2380322|P2|COMPLETED|Overall Study||17
982401|NCT00389857|2380323|P1|COMPLETED|Overall Study||14
982402|NCT00389857|2380322|P2|STARTED|Overall Study||17
982403|NCT00389857|2380323|P1|STARTED|Overall Study||14
982404|NCT00389974|2380333|P1|NOT COMPLETED|Overall Study||0
982405|NCT00389974|2380333|P1|COMPLETED|Overall Study||19
982406|NCT00389974|2380333|P1|STARTED|Overall Study||19
982407|NCT00390013|2380340|P4|NOT COMPLETED|Phase 2 Second Treatment||0
982408|NCT00390013|2380341|P3|NOT COMPLETED|Phase 2 Second Treatment||0
982409|NCT00390013|2380342|P2|NOT COMPLETED|Phase 2 Second Treatment||0
982410|NCT00390013|2380343|P1|NOT COMPLETED|Phase 2 Second Treatment||0
982411|NCT00390013|2380340|P4|COMPLETED|Phase 2 Second Treatment||0
982412|NCT00390013|2380341|P3|COMPLETED|Phase 2 Second Treatment||0
982413|NCT00390013|2380342|P2|COMPLETED|Phase 2 Second Treatment||1
982414|NCT00390013|2380343|P1|COMPLETED|Phase 2 Second Treatment||2
982415|NCT00390013|2380340|P4|STARTED|Phase 2 Second Treatment||0
982416|NCT00390013|2380341|P3|STARTED|Phase 2 Second Treatment||0
982417|NCT00390013|2380342|P2|STARTED|Phase 2 Second Treatment||1
982418|NCT00390013|2380343|P1|STARTED|Phase 2 Second Treatment||2
982419|NCT00390013|2380340|P4|NOT COMPLETED|Phase 2 First Treatment||0
982420|NCT00390013|2380341|P3|NOT COMPLETED|Phase 2 First Treatment||0
982421|NCT00390013|2380342|P2|NOT COMPLETED|Phase 2 First Treatment||1
982422|NCT00390013|2380343|P1|NOT COMPLETED|Phase 2 First Treatment||1
982423|NCT00390013|2380340|P4|COMPLETED|Phase 2 First Treatment||0
982424|NCT00390013|2380341|P3|COMPLETED|Phase 2 First Treatment||0
982425|NCT00390013|2380342|P2|COMPLETED|Phase 2 First Treatment||1
982426|NCT00390013|2380343|P1|COMPLETED|Phase 2 First Treatment||2
982427|NCT00390013|2380340|P4|STARTED|Phase 2 First Treatment||0
982428|NCT00390013|2380341|P3|STARTED|Phase 2 First Treatment||0
982429|NCT00390013|2380342|P2|STARTED|Phase 2 First Treatment||2
982430|NCT00390013|2380343|P1|STARTED|Phase 2 First Treatment||3
982431|NCT00390013|2380340|P4|NOT COMPLETED|Phase 1||1
982432|NCT00390013|2380341|P3|NOT COMPLETED|Phase 1||0
982433|NCT00390013|2380342|P2|NOT COMPLETED|Phase 1||0
982434|NCT00390013|2380343|P1|NOT COMPLETED|Phase 1||0
982435|NCT00390013|2380340|P4|COMPLETED|Phase 1||1
982436|NCT00390013|2380341|P3|COMPLETED|Phase 1||2
982437|NCT00390013|2380342|P2|COMPLETED|Phase 1||0
982438|NCT00390013|2380343|P1|COMPLETED|Phase 1||0
982439|NCT00390013|2380340|P4|STARTED|Phase 1||2
982440|NCT00390013|2380341|P3|STARTED|Phase 1||2
982441|NCT00390013|2380342|P2|STARTED|Phase 1||0
982442|NCT00390013|2380343|P1|STARTED|Phase 1||0
982443|NCT00390182|2380349|P1|NOT COMPLETED|Overall Study||5
982444|NCT00390182|2380349|P1|COMPLETED|Overall Study||33
982445|NCT00390182|2380349|P1|STARTED|Overall Study||38
982446|NCT00390221|2380358|P3|NOT COMPLETED|Overall Study||15
982447|NCT00390221|2380359|P2|NOT COMPLETED|Overall Study||20
982448|NCT00390221|2380360|P1|NOT COMPLETED|Overall Study||18
982449|NCT00390221|2380358|P3|COMPLETED|Overall Study||194
982450|NCT00390221|2380359|P2|COMPLETED|Overall Study||188
982451|NCT00390221|2380360|P1|COMPLETED|Overall Study||186
982452|NCT00390221|2380358|P3|STARTED|Overall Study||209
982453|NCT00390221|2380359|P2|STARTED|Overall Study||208
982454|NCT00390221|2380360|P1|STARTED|Overall Study||204
982455|NCT00390234|2380381|P1|NOT COMPLETED|Overall Study||0
982456|NCT00390234|2380381|P1|COMPLETED|Overall Study||63
982457|NCT00390234|2380381|P1|STARTED|Overall Study||63
982458|NCT00390364|2380389|P1|NOT COMPLETED|Overall Study||0
982459|NCT00390364|2380389|P1|COMPLETED|Overall Study||1
982460|NCT00390364|2380389|P1|STARTED|Overall Study||1
982461|NCT00390416|2380393|P1|NOT COMPLETED|Overall Study||4
982462|NCT00390416|2380393|P1|COMPLETED|Overall Study||44
982463|NCT00390416|2380393|P1|STARTED|Overall Study||48
982464|NCT00390455|2380401|P2|NOT COMPLETED|Overall Study||23
982465|NCT00390455|2380402|P1|NOT COMPLETED|Overall Study||32
982466|NCT00390455|2380401|P2|COMPLETED|Overall Study||124
982467|NCT00390455|2380402|P1|COMPLETED|Overall Study||116
982468|NCT00390455|2380401|P2|STARTED|Overall Study||147
982469|NCT00390455|2380402|P1|STARTED|Overall Study||148
982470|NCT00390468|2380420|P1|NOT COMPLETED|Overall Study||3
982471|NCT00390468|2380420|P1|COMPLETED|Overall Study||15
982472|NCT00390468|2380420|P1|STARTED|Overall Study||18
982473|NCT00390546|2380426|P2|NOT COMPLETED|Overall Study||5
982474|NCT00390546|2380427|P1|NOT COMPLETED|Overall Study||6
982475|NCT00390546|2380426|P2|COMPLETED|Overall Study||34
982476|NCT00390546|2380427|P1|COMPLETED|Overall Study||27
982477|NCT00390546|2380426|P2|STARTED|Overall Study||39
982478|NCT00390546|2380427|P1|STARTED|Overall Study||33
982479|NCT00390559|2380437|P1|NOT COMPLETED|Overall Study||44
982480|NCT00390559|2380437|P1|COMPLETED|Overall Study||80
982481|NCT00390559|2380437|P1|ActiveP/PlaceboC|Overall Study||90
982482|NCT00390559|2380437|P1|PlaceboP/PlaceboC|Overall Study||93
982483|NCT00390559|2380437|P1|ActiveP/ActiveC|Overall Study||87
982484|NCT00390559|2380437|P1|Received PlaceboP/Active C|Overall Study||93
982485|NCT00390559|2380437|P1|STARTED|Overall Study||124
982486|NCT00390572|2380449|P2|NOT COMPLETED|Overall Study||5
982487|NCT00390572|2380450|P1|NOT COMPLETED|Overall Study||8
982488|NCT00390572|2380449|P2|COMPLETED|Overall Study||64
982489|NCT00390572|2380450|P1|COMPLETED|Overall Study||60
982490|NCT00390572|2380449|P2|STARTED|Overall Study||69
982491|NCT00390572|2380450|P1|STARTED|Overall Study||68
982492|NCT00390611|2380466|P2|NOT COMPLETED|Maintenance Sorafenib to Month 12||0
982493|NCT00390611|2380467|P1|NOT COMPLETED|Maintenance Sorafenib to Month 12||10
982494|NCT00390611|2380466|P2|COMPLETED|Maintenance Sorafenib to Month 12||0
982495|NCT00390611|2380467|P1|COMPLETED|Maintenance Sorafenib to Month 12||13
982496|NCT00390611|2380466|P2|STARTED|Maintenance Sorafenib to Month 12|Patients in the Paclitaxel/carboplatin arm did not recieve maintenance sorafenib|0
982497|NCT00390611|2380467|P1|STARTED|Maintenance Sorafenib to Month 12|11 patients came off-study between the end of cycle 6 and the start of maintenance|23
982498|NCT00390611|2380466|P2|NOT COMPLETED|6 Cycles of Study Treatment||5
982499|NCT00390611|2380467|P1|NOT COMPLETED|6 Cycles of Study Treatment||9
982500|NCT00390611|2380466|P2|COMPLETED|6 Cycles of Study Treatment||37
982501|NCT00390611|2380467|P1|COMPLETED|6 Cycles of Study Treatment||34
982502|NCT00390611|2380466|P2|STARTED|6 Cycles of Study Treatment||42
982503|NCT00390611|2380467|P1|STARTED|6 Cycles of Study Treatment||43
982504|NCT00390689|2380482|P3|NOT COMPLETED|Overall Study||3
982505|NCT00390689|2380483|P2|NOT COMPLETED|Overall Study||5
982506|NCT00390689|2380484|P1|NOT COMPLETED|Overall Study||5
982507|NCT00390689|2380482|P3|COMPLETED|Overall Study||50
982508|NCT00390689|2380483|P2|COMPLETED|Overall Study||48
982509|NCT00390689|2380484|P1|COMPLETED|Overall Study||43
982510|NCT00390689|2380482|P3|STARTED|Overall Study||53
982511|NCT00390689|2380483|P2|STARTED|Overall Study||53
982512|NCT00390689|2380484|P1|STARTED|Overall Study||48
982513|NCT00390780|2380544|P2|NOT COMPLETED|Overall Study||27
982514|NCT00390780|2380545|P1|NOT COMPLETED|Overall Study||23
982515|NCT00390780|2380544|P2|COMPLETED|Overall Study||260
982516|NCT00390780|2380545|P1|COMPLETED|Overall Study||268
982517|NCT00390780|2380544|P2|Treatment|Overall Study||287
982518|NCT00390780|2380545|P1|Treatment|Overall Study|One patient randomized to miconazole lost study drug, never started treatment, and was discontinued.|290
982519|NCT00390780|2380544|P2|STARTED|Overall Study||287
982520|NCT00390780|2380545|P1|STARTED|Overall Study||291
982521|NCT00390806|2380577|P2|NOT COMPLETED|Overall Study||32
982522|NCT00390806|2380578|P1|NOT COMPLETED|Overall Study||30
982523|NCT00390806|2380577|P2|COMPLETED|Overall Study||204
982524|NCT00390806|2380578|P1|COMPLETED|Overall Study||206
982525|NCT00390806|2380577|P2|Ongoing|Overall Study||2
982526|NCT00390806|2380578|P1|Ongoing|Overall Study||4
982527|NCT00390806|2380577|P2|STARTED|Overall Study||236
982528|NCT00390806|2380578|P1|STARTED|Overall Study||236
982529|NCT00390858|2380646|P2|NOT COMPLETED|Overall Study||7
982530|NCT00390858|2380647|P1|NOT COMPLETED|Overall Study||9
982531|NCT00390858|2380646|P2|COMPLETED|Overall Study|13 Participants completed the Extension Study|13
982532|NCT00390858|2380647|P1|COMPLETED|Overall Study|11 participants Completed the Extension Study|11
982533|NCT00390858|2380646|P2|Completed Core & Entered Extension Study|Overall Study||20
982534|NCT00390858|2380647|P1|Completed Core & Entered Extension Study|Overall Study||19
982535|NCT00390858|2380646|P2|STARTED|Overall Study|20 Participants started the Core Study|20
982536|NCT00390858|2380647|P1|STARTED|Overall Study|20 participants started the Core Study|20
982537|NCT00390884|2380661|P2|NOT COMPLETED|Overall Study||2
982538|NCT00390884|2380662|P1|NOT COMPLETED|Overall Study||2
982539|NCT00390884|2380661|P2|COMPLETED|Overall Study||55
982540|NCT00390884|2380662|P1|COMPLETED|Overall Study||114
982541|NCT00390884|2380661|P2|STARTED|Overall Study||57
982542|NCT00390884|2380662|P1|STARTED|Overall Study||116
982543|NCT00391027|2380674|P2|NOT COMPLETED|Overall Study||12
982544|NCT00391027|2380675|P1|NOT COMPLETED|Overall Study||25
982545|NCT00391027|2380674|P2|COMPLETED|Overall Study||110
982546|NCT00391027|2380675|P1|COMPLETED|Overall Study||110
982547|NCT00391027|2380674|P2|STARTED|Overall Study|Full Analysis Set = 121; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|122
982548|NCT00391027|2380675|P1|STARTED|Overall Study|Full Analysis Set = 134; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|135
982549|NCT00391053|2380717|P4|NOT COMPLETED|Overall Study||10
982550|NCT00391053|2380718|P3|NOT COMPLETED|Overall Study||2
982551|NCT00391053|2380719|P2|NOT COMPLETED|Overall Study||1
982552|NCT00391053|2380720|P1|NOT COMPLETED|Overall Study||9
982553|NCT00391053|2380717|P4|COMPLETED|Overall Study||1252
982554|NCT00391053|2380718|P3|COMPLETED|Overall Study||868
982555|NCT00391053|2380719|P2|COMPLETED|Overall Study||847
982556|NCT00391053|2380720|P1|COMPLETED|Overall Study||848
982557|NCT00391053|2380717|P4|STARTED|Overall Study||1262
982558|NCT00391053|2380718|P3|STARTED|Overall Study||870
982559|NCT00391053|2380719|P2|STARTED|Overall Study||848
982560|NCT00391053|2380720|P1|STARTED|Overall Study||857
982561|NCT00391079|2380744|P2|NOT COMPLETED|Overall Study||16
982562|NCT00391079|2380745|P1|NOT COMPLETED|Overall Study||26
982563|NCT00391079|2380744|P2|COMPLETED|Overall Study||156
982564|NCT00391079|2380745|P1|COMPLETED|Overall Study||141
982565|NCT00391079|2380744|P2|STARTED|Overall Study||172
982566|NCT00391079|2380745|P1|STARTED|Overall Study||167
982567|NCT00391092|2380765|P2|NOT COMPLETED|Overall Study||216
982568|NCT00391092|2380766|P1|NOT COMPLETED|Overall Study||208
982569|NCT00391092|2380765|P2|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
982570|NCT00391092|2380766|P1|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
982571|NCT00391092|2380765|P2|Received Treatment|Overall Study||215
982572|NCT00391092|2380766|P1|Received Treatment|Overall Study||206
982573|NCT00391092|2380765|P2|STARTED|Overall Study||216
982574|NCT00391092|2380766|P1|STARTED|Overall Study||208
982575|NCT00391222|2380787|P4|NOT COMPLETED|Period III (Double-Blind Treatment)||0
982576|NCT00391222|2380788|P3|NOT COMPLETED|Period III (Double-Blind Treatment)||23
982577|NCT00391222|2380789|P2|NOT COMPLETED|Period III (Double-Blind Treatment)||22
982578|NCT00391222|2380790|P1|NOT COMPLETED|Period III (Double-Blind Treatment)||28
982579|NCT00391222|2380787|P4|COMPLETED|Period III (Double-Blind Treatment)||0
982580|NCT00391222|2380788|P3|COMPLETED|Period III (Double-Blind Treatment)||108
982581|NCT00391222|2380789|P2|COMPLETED|Period III (Double-Blind Treatment)||113
982582|NCT00391222|2380790|P1|COMPLETED|Period III (Double-Blind Treatment)||104
982583|NCT00391222|2380787|P4|STARTED|Period III (Double-Blind Treatment)||0
982584|NCT00391222|2380788|P3|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|131
982585|NCT00391222|2380789|P2|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|135
982586|NCT00391222|2380790|P1|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|132
982587|NCT00391222|2380787|P4|NOT COMPLETED|Period II (Open-label Risperidone LAI)||162
982588|NCT00391222|2380788|P3|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
982589|NCT00391222|2380789|P2|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
982590|NCT00391222|2380790|P1|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
982591|NCT00391222|2380787|P4|COMPLETED|Period II (Open-label Risperidone LAI)||398
982592|NCT00391222|2380788|P3|COMPLETED|Period II (Open-label Risperidone LAI)||0
982593|NCT00391222|2380789|P2|COMPLETED|Period II (Open-label Risperidone LAI)||0
982594|NCT00391222|2380790|P1|COMPLETED|Period II (Open-label Risperidone LAI)||0
982595|NCT00391222|2380787|P4|STARTED|Period II (Open-label Risperidone LAI)|The 25 patients at the site of Dr. Parikh were excluded from the analysis due to GCP non-compliance|560
982596|NCT00391222|2380788|P3|STARTED|Period II (Open-label Risperidone LAI)||0
982597|NCT00391222|2380789|P2|STARTED|Period II (Open-label Risperidone LAI)||0
982598|NCT00391222|2380790|P1|STARTED|Period II (Open-label Risperidone LAI)||0
982599|NCT00391274|2380816|P2|NOT COMPLETED|Overall Study||57
982600|NCT00391274|2380817|P1|NOT COMPLETED|Overall Study||61
982601|NCT00391274|2380816|P2|COMPLETED|Overall Study||47
982602|NCT00391274|2380817|P1|COMPLETED|Overall Study||46
982603|NCT00391274|2380816|P2|Received at Least One Dose of Study Drug|Overall Study||102
982604|NCT00391274|2380817|P1|Received at Least One Dose of Study Drug|Overall Study||106
982605|NCT00391274|2380816|P2|STARTED|Overall Study||104
982606|NCT00391274|2380817|P1|STARTED|Overall Study||107
982607|NCT00380861|2380835|P2|NOT COMPLETED|Overall Study||17
982608|NCT00380861|2380836|P1|NOT COMPLETED|Overall Study||18
982609|NCT00380861|2380835|P2|COMPLETED|Overall Study||74
982610|NCT00380861|2380836|P1|COMPLETED|Overall Study||75
982611|NCT00380861|2380835|P2|STARTED|Overall Study|Two subjects received the PFC Sigma RP-F device but not the RP and their results are not included.|91
982612|NCT00380861|2380836|P1|STARTED|Overall Study||93
982613|NCT00380874|2380844|P2|NOT COMPLETED|Overall Study||10
982614|NCT00380874|2380845|P1|NOT COMPLETED|Overall Study||13
982615|NCT00380874|2380844|P2|COMPLETED|Overall Study||19
982616|NCT00380874|2380845|P1|COMPLETED|Overall Study||19
982617|NCT00380874|2380844|P2|STARTED|Overall Study||29
982618|NCT00380874|2380845|P1|STARTED|Overall Study||32
982619|NCT00380978|2380863|P2|NOT COMPLETED|Overall Study||10
982620|NCT00380978|2380864|P1|NOT COMPLETED|Overall Study||2
982621|NCT00380978|2380863|P2|COMPLETED|Overall Study||400
982622|NCT00380978|2380864|P1|COMPLETED|Overall Study||406
982623|NCT00380978|2380863|P2|STARTED|Overall Study||410
982624|NCT00380978|2380864|P1|STARTED|Overall Study||408
982625|NCT00381004|2380884|P1|NOT COMPLETED|Overall Study||0
982626|NCT00381004|2380884|P1|COMPLETED|Overall Study||60
982627|NCT00381004|2380884|P1|STARTED|Overall Study||60
982628|NCT00381043|2380892|P2|NOT COMPLETED|Overall Study||8
982629|NCT00381043|2380893|P1|NOT COMPLETED|Overall Study||12
982630|NCT00381043|2380892|P2|COMPLETED|Overall Study||41
982631|NCT00381043|2380893|P1|COMPLETED|Overall Study||39
982632|NCT00381043|2380892|P2|STARTED|Overall Study||49
982633|NCT00381043|2380893|P1|STARTED|Overall Study||51
982634|NCT00381095|2380913|P2|NOT COMPLETED|Overall Study||21
982635|NCT00381095|2380914|P1|NOT COMPLETED|Overall Study||13
982636|NCT00381095|2380913|P2|COMPLETED|Overall Study||59
982637|NCT00381095|2380914|P1|COMPLETED|Overall Study||59
982638|NCT00381095|2380913|P2|STARTED|Overall Study||80
982639|NCT00381095|2380914|P1|STARTED|Overall Study||72
982640|NCT00381238|2380944|P1|NOT COMPLETED|Overall Study||12
982641|NCT00381238|2380944|P1|COMPLETED|Overall Study||21
982642|NCT00381238|2380944|P1|STARTED|Overall Study||33
982643|NCT00381303|2380960|P2|NOT COMPLETED|Overall Study||33
982644|NCT00381303|2380961|P1|NOT COMPLETED|Overall Study||94
982645|NCT00381303|2380960|P2|COMPLETED|Overall Study||109
982646|NCT00381303|2380961|P1|COMPLETED|Overall Study||193
982647|NCT00381303|2380960|P2|STARTED|Overall Study||142
982648|NCT00381303|2380961|P1|STARTED|Overall Study||287
982664|NCT00381810|2381099|P1|NOT COMPLETED|B Cell Follow-up||7
982665|NCT00381810|2381099|P1|COMPLETED|B Cell Follow-up||0
982666|NCT00381810|2381099|P1|STARTED|B Cell Follow-up|Participants only entered the B cell follow-up period if their peripheral B cells were depleted.|7
982667|NCT00381810|2381099|P1|NOT COMPLETED|Treatment and Safety Follow-up||15
982668|NCT00381810|2381099|P1|COMPLETED|Treatment and Safety Follow-up||16
982669|NCT00381810|2381099|P1|STARTED|Treatment and Safety Follow-up||31
982670|NCT00381849|2381105|P2|NOT COMPLETED|Open-label||0
982671|NCT00381849|2381106|P1|NOT COMPLETED|Open-label||0
982672|NCT00381849|2381105|P2|COMPLETED|Open-label||9
982673|NCT00381849|2381106|P1|COMPLETED|Open-label||10
982674|NCT00381849|2381105|P2|STARTED|Open-label||9
982675|NCT00381849|2381106|P1|STARTED|Open-label||10
982676|NCT00381849|2381105|P2|NOT COMPLETED|Second Intervention||0
982677|NCT00381849|2381106|P1|NOT COMPLETED|Second Intervention||0
982678|NCT00381849|2381105|P2|COMPLETED|Second Intervention||9
982679|NCT00381849|2381106|P1|COMPLETED|Second Intervention||10
982680|NCT00381849|2381105|P2|STARTED|Second Intervention||9
982681|NCT00381849|2381106|P1|STARTED|Second Intervention||10
982682|NCT00381849|2381105|P2|NOT COMPLETED|Wash Out||1
982683|NCT00381849|2381106|P1|NOT COMPLETED|Wash Out||0
982684|NCT00381849|2381105|P2|COMPLETED|Wash Out||9
982685|NCT00381849|2381106|P1|COMPLETED|Wash Out||10
982686|NCT00381849|2381105|P2|STARTED|Wash Out||10
982687|NCT00381849|2381106|P1|STARTED|Wash Out||10
982688|NCT00381849|2381105|P2|NOT COMPLETED|First Intervention||0
982689|NCT00381849|2381106|P1|NOT COMPLETED|First Intervention||0
982690|NCT00381849|2381105|P2|COMPLETED|First Intervention||10
982691|NCT00381849|2381106|P1|COMPLETED|First Intervention||10
982692|NCT00381849|2381105|P2|STARTED|First Intervention||10
982693|NCT00381849|2381106|P1|STARTED|First Intervention||10
982694|NCT00381862|2381124|P1|NOT COMPLETED|Overall Study||10
982695|NCT00381862|2381124|P1|COMPLETED|Overall Study||44
982696|NCT00381862|2381124|P1|STARTED|Overall Study||54
982697|NCT00381888|2381128|P1|NOT COMPLETED|Overall Study||17
982698|NCT00381888|2381128|P1|COMPLETED|Overall Study||27
982699|NCT00381888|2381128|P1|STARTED|Overall Study||44
982700|NCT00381940|2381133|P1|NOT COMPLETED|Overall Study||5
982701|NCT00381940|2381133|P1|COMPLETED|Overall Study||21
982702|NCT00381940|2381133|P1|STARTED|Overall Study||26
982703|NCT00382018|2381141|P4|NOT COMPLETED|Overall Study||59
982704|NCT00382018|2381142|P3|NOT COMPLETED|Overall Study||64
982705|NCT00382018|2381143|P2|NOT COMPLETED|Overall Study||165
982706|NCT00382018|2381144|P1|NOT COMPLETED|Overall Study||0
982707|NCT00382018|2381141|P4|COMPLETED|Overall Study||0
982708|NCT00382018|2381142|P3|COMPLETED|Overall Study||0
982709|NCT00382018|2381143|P2|COMPLETED|Overall Study||0
982710|NCT00382018|2381144|P1|COMPLETED|Overall Study|This group of patients did not receive protocol treatment.|276
982711|NCT00382018|2381141|P4|STARTED|Overall Study||59
982712|NCT00382018|2381142|P3|STARTED|Overall Study||64
982713|NCT00382018|2381143|P2|STARTED|Overall Study||165
982714|NCT00382018|2381144|P1|STARTED|Overall Study||276
982715|NCT00382031|2381164|P2|NOT COMPLETED|Overall Study||0
982716|NCT00382031|2381165|P1|NOT COMPLETED|Overall Study||0
982717|NCT00382031|2381164|P2|COMPLETED|Overall Study||95
982718|NCT00382031|2381165|P1|COMPLETED|Overall Study||191
982719|NCT00382031|2381164|P2|STARTED|Overall Study|Of the 95 randomized patients 94 attended Visit2.|95
982720|NCT00382031|2381165|P1|STARTED|Overall Study|Of the 191 randomized patients 189 received at least one infusion of zalutumumab|191
982721|NCT00382109|2381179|P2|NOT COMPLETED|Overall Study||4
982722|NCT00382109|2381180|P1|NOT COMPLETED|Overall Study||12
982723|NCT00382109|2381179|P2|COMPLETED|Overall Study||66
982724|NCT00382109|2381180|P1|COMPLETED|Overall Study||64
982725|NCT00382109|2381179|P2|STARTED|Overall Study||70
982726|NCT00382109|2381180|P1|STARTED|Overall Study||76
982727|NCT00382148|2381202|P2|NOT COMPLETED|Overall Study||0
982728|NCT00382148|2381203|P1|NOT COMPLETED|Overall Study||1
982729|NCT00382148|2381202|P2|COMPLETED|Overall Study||7
982730|NCT00382148|2381203|P1|COMPLETED|Overall Study||3
982731|NCT00382148|2381202|P2|STARTED|Overall Study||7
982732|NCT00382148|2381203|P1|STARTED|Overall Study||4
982733|NCT00382174|2381217|P3|NOT COMPLETED|Overall Study||21
982734|NCT00382174|2381218|P2|NOT COMPLETED|Overall Study||17
982735|NCT00382174|2381219|P1|NOT COMPLETED|Overall Study||4
982736|NCT00382174|2381217|P3|COMPLETED|Overall Study||51
982737|NCT00382174|2381218|P2|COMPLETED|Overall Study||37
982738|NCT00382174|2381219|P1|COMPLETED|Overall Study||14
982739|NCT00382174|2381217|P3|STARTED|Overall Study||72
982740|NCT00382174|2381218|P2|STARTED|Overall Study||54
982741|NCT00382174|2381219|P1|STARTED|Overall Study||18
982742|NCT00382291|2381233|P3|NOT COMPLETED|Overall Study||8
982743|NCT00382291|2381234|P2|NOT COMPLETED|Overall Study||7
982744|NCT00382291|2381235|P1|NOT COMPLETED|Overall Study||4
982745|NCT00382291|2381233|P3|COMPLETED|Overall Study||13
982746|NCT00382291|2381234|P2|COMPLETED|Overall Study||10
982747|NCT00382291|2381235|P1|COMPLETED|Overall Study||14
982748|NCT00382291|2381233|P3|STARTED|Overall Study||21
982749|NCT00382291|2381234|P2|STARTED|Overall Study||17
982750|NCT00382291|2381235|P1|STARTED|Overall Study||18
982751|NCT00382408|2381248|P2|NOT COMPLETED|Overall Study||54
982752|NCT00382408|2381249|P1|NOT COMPLETED|Overall Study||144
982753|NCT00382408|2381248|P2|COMPLETED|Overall Study||955
982754|NCT00382408|2381249|P1|COMPLETED|Overall Study||2887
982755|NCT00382408|2381248|P2|STARTED|Overall Study||1009
982756|NCT00382408|2381249|P1|STARTED|Overall Study||3031
982757|NCT00382590|2381275|P2|NOT COMPLETED|Overall Study||0
982758|NCT00382590|2381276|P1|NOT COMPLETED|Overall Study||0
982759|NCT00382590|2381275|P2|COMPLETED|Overall Study||6
982760|NCT00382590|2381276|P1|COMPLETED|Overall Study||4
982761|NCT00382590|2381275|P2|STARTED|Overall Study||6
982762|NCT00382590|2381276|P1|STARTED|Overall Study||4
982763|NCT00382720|2381285|P3|NOT COMPLETED|Overall Study||86
982764|NCT00382720|2381286|P2|NOT COMPLETED|Overall Study||89
982765|NCT00382720|2381287|P1|NOT COMPLETED|Overall Study||79
982766|NCT00382720|2381285|P3|COMPLETED|Overall Study||0
982767|NCT00382720|2381286|P2|COMPLETED|Overall Study||0
982768|NCT00382720|2381287|P1|COMPLETED|Overall Study||0
982769|NCT00382720|2381285|P3|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|82
982770|NCT00382720|2381286|P2|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|88
982771|NCT00382720|2381287|P1|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|78
982772|NCT00382720|2381285|P3|Administered Optimal Dose (Parts I & II)|Overall Study||82
982773|NCT00382720|2381286|P2|Administered Optimal Dose (Parts I & II)|Overall Study||88
982774|NCT00382720|2381287|P1|Administered Optimal Dose (Parts I & II)|Overall Study||78
982775|NCT00382720|2381285|P3|Administered Non-Optimal Dose (Part I)|Overall Study||0
982776|NCT00382720|2381286|P2|Administered Non-Optimal Dose (Part I)|Overall Study||11
982777|NCT00382720|2381287|P1|Administered Non-Optimal Dose (Part I)|Overall Study||10
982778|NCT00382720|2381285|P3|STARTED|Overall Study||86
982779|NCT00382720|2381286|P2|STARTED|Overall Study||89
982780|NCT00382720|2381287|P1|STARTED|Overall Study||79
982781|NCT00382733|2381301|P5|NOT COMPLETED|Overall Study||0
982782|NCT00382733|2381302|P4|NOT COMPLETED|Overall Study||0
982783|NCT00382733|2381303|P3|NOT COMPLETED|Overall Study||0
982784|NCT00382733|2381304|P2|NOT COMPLETED|Overall Study||1
982785|NCT00382733|2381305|P1|NOT COMPLETED|Overall Study||0
982786|NCT00382733|2381301|P5|COMPLETED|Overall Study||2
982787|NCT00382733|2381302|P4|COMPLETED|Overall Study||14
982788|NCT00382733|2381303|P3|COMPLETED|Overall Study||3
982789|NCT00382733|2381304|P2|COMPLETED|Overall Study|1 subject withdrew consent before completing Cycle 1 - that subject was replaced|3
982790|NCT00382733|2381305|P1|COMPLETED|Overall Study||3
982791|NCT00382733|2381301|P5|STARTED|Overall Study||2
982792|NCT00382733|2381302|P4|STARTED|Overall Study||14
982793|NCT00382733|2381303|P3|STARTED|Overall Study||3
982794|NCT00382733|2381304|P2|STARTED|Overall Study||4
982795|NCT00382733|2381305|P1|STARTED|Overall Study||3
982796|NCT00382785|2381325|P2|NOT COMPLETED|Overall Study||0
982797|NCT00382785|2381326|P1|NOT COMPLETED|Overall Study||0
982798|NCT00382785|2381325|P2|COMPLETED|Overall Study||26
982799|NCT00382785|2381326|P1|COMPLETED|Overall Study||25
982800|NCT00382785|2381325|P2|STARTED|Overall Study||26
982801|NCT00382785|2381326|P1|STARTED|Overall Study||25
982802|NCT00382863|2381338|P2|NOT COMPLETED|Overall Study||36
982803|NCT00382863|2381339|P1|NOT COMPLETED|Overall Study||15
982804|NCT00382863|2381338|P2|COMPLETED|Overall Study||78
982805|NCT00382863|2381339|P1|COMPLETED|Overall Study||81
982806|NCT00382863|2381338|P2|STARTED|Overall Study||114
982807|NCT00382863|2381339|P1|STARTED|Overall Study||96
982808|NCT00382928|2381395|P2|NOT COMPLETED|Overall Study||0
982809|NCT00382928|2381396|P1|NOT COMPLETED|Overall Study||0
982810|NCT00382928|2381395|P2|COMPLETED|Overall Study||95
982811|NCT00382928|2381396|P1|COMPLETED|Overall Study||97
982812|NCT00382928|2381395|P2|STARTED|Overall Study||95
982813|NCT00382928|2381396|P1|STARTED|Overall Study||97
982814|NCT00382967|2381410|P2|NOT COMPLETED|Overall Study||1
982815|NCT00382967|2381411|P1|NOT COMPLETED|Overall Study||1
982816|NCT00382967|2381410|P2|COMPLETED|Overall Study|Subject dosed in error, should not have received Datscan product|137
982817|NCT00382967|2381411|P1|COMPLETED|Overall Study|Patient lost to followup and the data was not recorded.|121
982818|NCT00382967|2381410|P2|STARTED|Overall Study||138
982819|NCT00382967|2381411|P1|STARTED|Overall Study|135 subjects enrolled at the start of the study, however, 13 subjects withdrew prior to dosing.|122
982820|NCT00382993|2381419|P2|NOT COMPLETED|Migraine Attack 2 (Period 2)||4
982821|NCT00382993|2381420|P1|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
982822|NCT00382993|2381419|P2|COMPLETED|Migraine Attack 2 (Period 2)||63
982823|NCT00382993|2381420|P1|COMPLETED|Migraine Attack 2 (Period 2)||68
982824|NCT00382993|2381419|P2|STARTED|Migraine Attack 2 (Period 2)||67
982825|NCT00382993|2381420|P1|STARTED|Migraine Attack 2 (Period 2)||70
982826|NCT00382993|2381419|P2|NOT COMPLETED|Migraine Attack 1 (Period 1)||18
982827|NCT00382993|2381420|P1|NOT COMPLETED|Migraine Attack 1 (Period 1)||14
982828|NCT00382993|2381419|P2|COMPLETED|Migraine Attack 1 (Period 1)||67
982829|NCT00382993|2381420|P1|COMPLETED|Migraine Attack 1 (Period 1)|Participant considered to have completed period if treated a migraine with investigational product.|70
982830|NCT00382993|2381419|P2|STARTED|Migraine Attack 1 (Period 1)||85
982831|NCT00382993|2381420|P1|STARTED|Migraine Attack 1 (Period 1)||84
982832|NCT00383019|2381464|P2|NOT COMPLETED|Overall Study||2
982833|NCT00383019|2381465|P1|NOT COMPLETED|Overall Study||5
982834|NCT00383019|2381464|P2|COMPLETED|Overall Study||143
982835|NCT00383019|2381465|P1|COMPLETED|Overall Study||139
982836|NCT00383019|2381464|P2|STARTED|Overall Study||145
982837|NCT00383019|2381465|P1|STARTED|Overall Study||144
982838|NCT00383071|2381491|P4|NOT COMPLETED|Overall Study||3
982839|NCT00383071|2381492|P3|NOT COMPLETED|Overall Study||7
982840|NCT00383071|2381493|P2|NOT COMPLETED|Overall Study||4
982841|NCT00383071|2381494|P1|NOT COMPLETED|Overall Study||0
982842|NCT00383071|2381491|P4|COMPLETED|Overall Study||22
982843|NCT00383071|2381492|P3|COMPLETED|Overall Study||44
982844|NCT00383071|2381493|P2|COMPLETED|Overall Study||21
982845|NCT00383071|2381494|P1|COMPLETED|Overall Study||25
982846|NCT00383071|2381491|P4|STARTED|Overall Study||25
982847|NCT00383071|2381492|P3|STARTED|Overall Study||51
982848|NCT00383071|2381493|P2|STARTED|Overall Study||25
982849|NCT00383071|2381494|P1|STARTED|Overall Study||25
982850|NCT00383084|2381506|P2|NOT COMPLETED|Overall Study||10
982851|NCT00383084|2381507|P1|NOT COMPLETED|Overall Study||12
982852|NCT00383084|2381506|P2|COMPLETED|Overall Study||28
982853|NCT00383084|2381507|P1|COMPLETED|Overall Study||34
982854|NCT00383084|2381506|P2|STARTED|Overall Study||38
982855|NCT00383084|2381507|P1|STARTED|Overall Study||46
982856|NCT00383110|2381521|P2|NOT COMPLETED|Overall Study||0
982857|NCT00383110|2381522|P1|NOT COMPLETED|Overall Study||0
982858|NCT00383110|2381521|P2|COMPLETED|Overall Study||150
982859|NCT00383110|2381522|P1|COMPLETED|Overall Study||150
982860|NCT00383110|2381521|P2|STARTED|Overall Study||150
982861|NCT00383110|2381522|P1|STARTED|Overall Study||150
982862|NCT00383123|2381540|P2|NOT COMPLETED|Overall Study||86
982863|NCT00383123|2381541|P1|NOT COMPLETED|Overall Study||111
982864|NCT00383123|2381540|P2|COMPLETED|Overall Study||1124
982865|NCT00383123|2381541|P1|COMPLETED|Overall Study||2004
982866|NCT00383123|2381540|P2|STARTED|Overall Study||1210
982867|NCT00383123|2381541|P1|STARTED|Overall Study||2115
982868|NCT00383149|2381561|P1|NOT COMPLETED|Overall Study||54
982869|NCT00383149|2381561|P1|COMPLETED|Overall Study||0
982870|NCT00383149|2381561|P1|STARTED|Overall Study||54
982871|NCT00383162|2381578|P2|NOT COMPLETED|Migraine Attack 2 (Period 2)||7
982872|NCT00383162|2381579|P1|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
982873|NCT00383162|2381578|P2|COMPLETED|Migraine Attack 2 (Period 2)||66
982874|NCT00383162|2381579|P1|COMPLETED|Migraine Attack 2 (Period 2)||65
982875|NCT00383162|2381578|P2|STARTED|Migraine Attack 2 (Period 2)||73
982876|NCT00383162|2381579|P1|STARTED|Migraine Attack 2 (Period 2)||67
982877|NCT00383162|2381578|P2|NOT COMPLETED|Migraine Attack 1 (Period 1)||13
982878|NCT00383162|2381579|P1|NOT COMPLETED|Migraine Attack 1 (Period 1)||20
982879|NCT00383162|2381578|P2|COMPLETED|Migraine Attack 1 (Period 1)|Participants not completing did not take investigational product.|73
982880|NCT00383162|2381579|P1|COMPLETED|Migraine Attack 1 (Period 1)|Participants completing a period treated a migraine with investigational product.|67
982881|NCT00383162|2381578|P2|STARTED|Migraine Attack 1 (Period 1)||86
982882|NCT00383162|2381579|P1|STARTED|Migraine Attack 1 (Period 1)||87
982883|NCT00383240|2381625|P4|NOT COMPLETED|Overall Study||77
982884|NCT00383240|2381626|P3|NOT COMPLETED|Overall Study||85
982885|NCT00383240|2381627|P2|NOT COMPLETED|Overall Study||33
982886|NCT00383240|2381628|P1|NOT COMPLETED|Overall Study||35
982887|NCT00383240|2381625|P4|COMPLETED|Overall Study||119
982888|NCT00383240|2381626|P3|COMPLETED|Overall Study||117
982889|NCT00383240|2381627|P2|COMPLETED|Overall Study||159
982890|NCT00383240|2381628|P1|COMPLETED|Overall Study||156
982891|NCT00383240|2381625|P4|STARTED|Overall Study||196
982892|NCT00383240|2381626|P3|STARTED|Overall Study||202
982893|NCT00383240|2381627|P2|STARTED|Overall Study||192
982894|NCT00383240|2381628|P1|STARTED|Overall Study||191
982895|NCT00383266|2381659|P1|NOT COMPLETED|Overall Study||0
982896|NCT00383266|2381659|P1|COMPLETED|Overall Study||9
982897|NCT00383266|2381659|P1|STARTED|Overall Study||9
982898|NCT00383331|2381670|P2|NOT COMPLETED|Overall Study||1
982899|NCT00383331|2381671|P1|NOT COMPLETED|Overall Study||0
982900|NCT00383331|2381670|P2|COMPLETED|Overall Study||8
982901|NCT00383331|2381671|P1|COMPLETED|Overall Study||10
982902|NCT00383331|2381670|P2|STARTED|Overall Study||9
982903|NCT00383331|2381671|P1|STARTED|Overall Study||10
982904|NCT00383435|2381692|P5|NOT COMPLETED|26-Week Treatment Safety Extension||3
982905|NCT00383435|2381693|P4|NOT COMPLETED|26-Week Treatment Safety Extension||15
982906|NCT00383435|2381694|P3|NOT COMPLETED|26-Week Treatment Safety Extension||16
982907|NCT00383435|2381695|P2|NOT COMPLETED|26-Week Treatment Safety Extension||9
982908|NCT00383435|2381696|P1|NOT COMPLETED|26-Week Treatment Safety Extension||14
982909|NCT00383435|2381692|P5|COMPLETED|26-Week Treatment Safety Extension||10
982910|NCT00383435|2381693|P4|COMPLETED|26-Week Treatment Safety Extension||116
982911|NCT00383435|2381694|P3|COMPLETED|26-Week Treatment Safety Extension||108
982912|NCT00383435|2381695|P2|COMPLETED|26-Week Treatment Safety Extension||121
982913|NCT00383435|2381696|P1|COMPLETED|26-Week Treatment Safety Extension||117
982914|NCT00383435|2381692|P5|STARTED|26-Week Treatment Safety Extension||13
982915|NCT00383435|2381693|P4|STARTED|26-Week Treatment Safety Extension||131
982916|NCT00383435|2381694|P3|STARTED|26-Week Treatment Safety Extension||124
982917|NCT00383435|2381695|P2|STARTED|26-Week Treatment Safety Extension||130
982918|NCT00383435|2381696|P1|STARTED|26-Week Treatment Safety Extension||131
982919|NCT00383435|2381692|P5|NOT COMPLETED|26-Week Double-Blind Treatment Period||53
982920|NCT00383435|2381693|P4|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
982921|NCT00383435|2381694|P3|NOT COMPLETED|26-Week Double-Blind Treatment Period||46
982922|NCT00383435|2381695|P2|NOT COMPLETED|26-Week Double-Blind Treatment Period||38
982923|NCT00383435|2381696|P1|NOT COMPLETED|26-Week Double-Blind Treatment Period||41
982924|NCT00383435|2381692|P5|COMPLETED|26-Week Double-Blind Treatment Period||159
982925|NCT00383435|2381693|P4|COMPLETED|26-Week Double-Blind Treatment Period||172
982926|NCT00383435|2381694|P3|COMPLETED|26-Week Double-Blind Treatment Period||164
982927|NCT00383435|2381695|P2|COMPLETED|26-Week Double-Blind Treatment Period||169
982928|NCT00383435|2381696|P1|COMPLETED|26-Week Double-Blind Treatment Period||176
982929|NCT00383435|2381692|P5|STARTED|26-Week Double-Blind Treatment Period||212
982930|NCT00383435|2381693|P4|STARTED|26-Week Double-Blind Treatment Period||209
982931|NCT00383435|2381694|P3|STARTED|26-Week Double-Blind Treatment Period||210
982932|NCT00383435|2381695|P2|STARTED|26-Week Double-Blind Treatment Period||207
982933|NCT00383435|2381696|P1|STARTED|26-Week Double-Blind Treatment Period||217
982934|NCT00383500|2381736|P3|NOT COMPLETED|Overall Study||2
982935|NCT00383500|2381737|P2|NOT COMPLETED|Overall Study||3
982936|NCT00383500|2381738|P1|NOT COMPLETED|Overall Study||8
982937|NCT00383500|2381736|P3|COMPLETED|Overall Study||22
982938|NCT00383500|2381737|P2|COMPLETED|Overall Study||21
982939|NCT00383500|2381738|P1|COMPLETED|Overall Study||19
982940|NCT00383500|2381736|P3|STARTED|Overall Study||24
982941|NCT00383500|2381737|P2|STARTED|Overall Study||24
982942|NCT00383500|2381738|P1|STARTED|Overall Study||27
982943|NCT00383552|2381753|P4|NOT COMPLETED|Overall Study||72
982944|NCT00383552|2381754|P3|NOT COMPLETED|Overall Study||61
982945|NCT00383552|2381755|P2|NOT COMPLETED|Overall Study||41
982946|NCT00383552|2381756|P1|NOT COMPLETED|Overall Study||36
982947|NCT00383552|2381753|P4|COMPLETED|Overall Study||116
982948|NCT00383552|2381754|P3|COMPLETED|Overall Study||127
982949|NCT00383552|2381755|P2|COMPLETED|Overall Study||147
982950|NCT00383552|2381756|P1|COMPLETED|Overall Study||146
982951|NCT00383552|2381753|P4|STARTED|Overall Study||188
982952|NCT00383552|2381754|P3|STARTED|Overall Study||188
982953|NCT00383552|2381755|P2|STARTED|Overall Study||188
982954|NCT00383552|2381756|P1|STARTED|Overall Study||182
982955|NCT00383565|2381795|P1|NOT COMPLETED|Overall Study||0
982956|NCT00383565|2381795|P1|COMPLETED|Overall Study||9
982957|NCT00383565|2381795|P1|STARTED|Overall Study||9
982958|NCT00383643|2381804|P3|NOT COMPLETED|Overall Study||1
982959|NCT00383643|2381805|P2|NOT COMPLETED|Overall Study||1
982960|NCT00383643|2381806|P1|NOT COMPLETED|Overall Study||1
982961|NCT00383643|2381804|P3|COMPLETED|Overall Study||13
982962|NCT00383643|2381805|P2|COMPLETED|Overall Study||15
982963|NCT00383643|2381806|P1|COMPLETED|Overall Study||17
982964|NCT00383643|2381804|P3|STARTED|Overall Study||14
982965|NCT00383643|2381805|P2|STARTED|Overall Study||16
982966|NCT00383643|2381806|P1|STARTED|Overall Study||18
982967|NCT00383721|2381831|P5|NOT COMPLETED|26-Week Treatment Safety Extension||0
982968|NCT00383721|2381832|P4|NOT COMPLETED|26-Week Treatment Safety Extension||17
982969|NCT00383721|2381833|P3|NOT COMPLETED|26-Week Treatment Safety Extension||23
982970|NCT00383721|2381834|P2|NOT COMPLETED|26-Week Treatment Safety Extension||17
982971|NCT00383721|2381835|P1|NOT COMPLETED|26-Week Treatment Safety Extension||19
982972|NCT00383721|2381831|P5|COMPLETED|26-Week Treatment Safety Extension||8
982973|NCT00383721|2381832|P4|COMPLETED|26-Week Treatment Safety Extension||131
982974|NCT00383721|2381833|P3|COMPLETED|26-Week Treatment Safety Extension||126
982975|NCT00383721|2381834|P2|COMPLETED|26-Week Treatment Safety Extension||136
982976|NCT00383721|2381835|P1|COMPLETED|26-Week Treatment Safety Extension||126
982977|NCT00383721|2381831|P5|STARTED|26-Week Treatment Safety Extension||8
982978|NCT00383721|2381832|P4|STARTED|26-Week Treatment Safety Extension||148
982979|NCT00383721|2381833|P3|STARTED|26-Week Treatment Safety Extension||149
982980|NCT00383721|2381834|P2|STARTED|26-Week Treatment Safety Extension||153
982981|NCT00383721|2381835|P1|STARTED|26-Week Treatment Safety Extension||145
982982|NCT00383721|2381831|P5|NOT COMPLETED|26-Week Double-Blind Treatment Period||67
982983|NCT00383721|2381832|P4|NOT COMPLETED|26-Week Double-Blind Treatment Period||50
982984|NCT00383721|2381833|P3|NOT COMPLETED|26-Week Double-Blind Treatment Period||51
982985|NCT00383721|2381834|P2|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
982986|NCT00383721|2381835|P1|NOT COMPLETED|26-Week Double-Blind Treatment Period||35
982987|NCT00383721|2381831|P5|COMPLETED|26-Week Double-Blind Treatment Period||169
982988|NCT00383721|2381832|P4|COMPLETED|26-Week Double-Blind Treatment Period||193
982989|NCT00383721|2381833|P3|COMPLETED|26-Week Double-Blind Treatment Period||202
982990|NCT00383721|2381834|P2|COMPLETED|26-Week Double-Blind Treatment Period||202
982991|NCT00383721|2381835|P1|COMPLETED|26-Week Double-Blind Treatment Period|1 participant listed as “ongoing” since the participant status could not be formally confirmed.|190
982992|NCT00383721|2381831|P5|STARTED|26-Week Double-Blind Treatment Period||236
982993|NCT00383721|2381832|P4|STARTED|26-Week Double-Blind Treatment Period||243
982994|NCT00383721|2381833|P3|STARTED|26-Week Double-Blind Treatment Period||253
982995|NCT00383721|2381834|P2|STARTED|26-Week Double-Blind Treatment Period||239
982996|NCT00383721|2381835|P1|STARTED|26-Week Double-Blind Treatment Period||225
982997|NCT00383747|2381874|P4|NOT COMPLETED|Visit 2||0
982998|NCT00383747|2381875|P3|NOT COMPLETED|Visit 2||0
982999|NCT00383747|2381876|P2|NOT COMPLETED|Visit 2||0
983000|NCT00383747|2381877|P1|NOT COMPLETED|Visit 2||0
983001|NCT00383747|2381874|P4|COMPLETED|Visit 2||16
983002|NCT00383747|2381875|P3|COMPLETED|Visit 2||16
983003|NCT00383747|2381876|P2|COMPLETED|Visit 2||14
983004|NCT00383747|2381877|P1|COMPLETED|Visit 2||14
983005|NCT00383747|2381874|P4|STARTED|Visit 2||16
983006|NCT00383747|2381875|P3|STARTED|Visit 2||16
983007|NCT00383747|2381876|P2|STARTED|Visit 2||14
983008|NCT00383747|2381877|P1|STARTED|Visit 2||14
983009|NCT00383747|2381874|P4|NOT COMPLETED|Visit 1||0
983010|NCT00383747|2381875|P3|NOT COMPLETED|Visit 1||0
983011|NCT00383747|2381876|P2|NOT COMPLETED|Visit 1||0
983012|NCT00383747|2381877|P1|NOT COMPLETED|Visit 1||0
983013|NCT00383747|2381874|P4|COMPLETED|Visit 1||16
983014|NCT00383747|2381875|P3|COMPLETED|Visit 1||16
983015|NCT00383747|2381876|P2|COMPLETED|Visit 1||14
983016|NCT00383747|2381877|P1|COMPLETED|Visit 1||14
983017|NCT00383747|2381874|P4|STARTED|Visit 1||16
983018|NCT00383747|2381875|P3|STARTED|Visit 1||16
983019|NCT00383747|2381876|P2|STARTED|Visit 1||14
983020|NCT00383747|2381877|P1|STARTED|Visit 1||14
983024|NCT00383786|2381913|P2|NOT COMPLETED|Overall Study||12
983025|NCT00383786|2381914|P1|NOT COMPLETED|Overall Study||4
983026|NCT00383786|2381913|P2|COMPLETED|Overall Study||13
983027|NCT00383786|2381914|P1|COMPLETED|Overall Study||18
983028|NCT00383786|2381913|P2|STARTED|Overall Study||25
983029|NCT00383786|2381914|P1|STARTED|Overall Study||22
983030|NCT00383942|2381922|P2|NOT COMPLETED|Overall Study||0
983031|NCT00383942|2381923|P1|NOT COMPLETED|Overall Study||0
983032|NCT00383942|2381922|P2|COMPLETED|Overall Study||40
983033|NCT00383942|2381923|P1|COMPLETED|Overall Study||40
983034|NCT00383942|2381922|P2|STARTED|Overall Study||40
983035|NCT00383942|2381923|P1|STARTED|Overall Study||40
983036|NCT00384033|2381933|P4|NOT COMPLETED|Overall Study||40
983037|NCT00384033|2381934|P3|NOT COMPLETED|Overall Study||43
983038|NCT00384033|2381935|P2|NOT COMPLETED|Overall Study||35
983039|NCT00384033|2381936|P1|NOT COMPLETED|Overall Study||41
983040|NCT00384033|2381933|P4|COMPLETED|Overall Study||119
983041|NCT00384033|2381934|P3|COMPLETED|Overall Study||117
983042|NCT00384033|2381935|P2|COMPLETED|Overall Study||120
983043|NCT00384033|2381936|P1|COMPLETED|Overall Study||123
983044|NCT00384033|2381933|P4|Treated|Overall Study||157
983045|NCT00384033|2381934|P3|Treated|Overall Study||150
983046|NCT00384033|2381935|P2|Treated|Overall Study||148
983047|NCT00384033|2381936|P1|Treated|Overall Study||161
983048|NCT00384033|2381933|P4|STARTED|Overall Study||159
983049|NCT00384033|2381934|P3|STARTED|Overall Study||160
983050|NCT00384033|2381935|P2|STARTED|Overall Study||155
983051|NCT00384033|2381936|P1|STARTED|Overall Study||164
983052|NCT00384059|2381980|P2|NOT COMPLETED|Toddler Dose||2
983053|NCT00384059|2381981|P1|NOT COMPLETED|Toddler Dose||1
983054|NCT00384059|2381980|P2|COMPLETED|Toddler Dose||120
983055|NCT00384059|2381981|P1|COMPLETED|Toddler Dose||130
983056|NCT00384059|2381980|P2|STARTED|Toddler Dose||122
983057|NCT00384059|2381981|P1|STARTED|Toddler Dose||131
983058|NCT00384059|2381980|P2|NOT COMPLETED|After Infant Series||10
983059|NCT00384059|2381981|P1|NOT COMPLETED|After Infant Series||4
983060|NCT00384059|2381980|P2|COMPLETED|After Infant Series||122
983061|NCT00384059|2381981|P1|COMPLETED|After Infant Series||131
983062|NCT00384059|2381980|P2|STARTED|After Infant Series||132
983063|NCT00384059|2381981|P1|STARTED|After Infant Series||135
983064|NCT00384059|2381980|P2|NOT COMPLETED|Infant Series||13
983065|NCT00384059|2381981|P1|NOT COMPLETED|Infant Series||6
983066|NCT00384059|2381980|P2|COMPLETED|Infant Series||132
983067|NCT00384059|2381981|P1|COMPLETED|Infant Series||135
983068|NCT00384059|2381980|P2|Vaccinated Dose 2|Infant Series||135
983069|NCT00384059|2381981|P1|Vaccinated Dose 2|Infant Series||136
983070|NCT00384059|2381980|P2|Vaccinated Dose 1|Infant Series||139
983071|NCT00384059|2381981|P1|Vaccinated Dose 1|Infant Series||139
983072|NCT00384059|2381980|P2|STARTED|Infant Series||145
983073|NCT00384059|2381981|P1|STARTED|Infant Series||141
983074|NCT00384085|2382030|P3|NOT COMPLETED|Overall Study||56
983075|NCT00384085|2382031|P2|NOT COMPLETED|Overall Study||46
983076|NCT00384085|2382032|P1|NOT COMPLETED|Overall Study||39
983077|NCT00384085|2382030|P3|COMPLETED|Overall Study|Based on the entire ITT population|141
983078|NCT00384085|2382031|P2|COMPLETED|Overall Study|Based on the entire ITT population|150
983079|NCT00384085|2382032|P1|COMPLETED|Overall Study|Based on the entire ITT population|156
983080|NCT00384085|2382030|P3|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||189
983081|NCT00384085|2382031|P2|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||186
983082|NCT00384085|2382032|P1|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||187
983083|NCT00384085|2382030|P3|Treated (Safety Population)|Overall Study||194
983084|NCT00384085|2382031|P2|Treated (Safety Population)|Overall Study||194
983085|NCT00384085|2382032|P1|Treated (Safety Population)|Overall Study||194
983086|NCT00384085|2382030|P3|Intent-To-Treat (ITT)|Overall Study||197
983087|NCT00384085|2382031|P2|Intent-To-Treat (ITT)|Overall Study||196
983088|NCT00384085|2382032|P1|Intent-To-Treat (ITT)|Overall Study||195
983089|NCT00384085|2382030|P3|STARTED|Overall Study|Randomized|197
983090|NCT00384085|2382031|P2|STARTED|Overall Study|Randomized|196
983091|NCT00384085|2382032|P1|STARTED|Overall Study|Randomized|195
983092|NCT00384176|2382059|P3|NOT COMPLETED|Overall Study||132
983093|NCT00384176|2382060|P2|NOT COMPLETED|Overall Study||319
983094|NCT00384176|2382061|P1|NOT COMPLETED|Overall Study||312
983095|NCT00384176|2382059|P3|COMPLETED|Overall Study||60
983096|NCT00384176|2382060|P2|COMPLETED|Overall Study||394
983097|NCT00384176|2382061|P1|COMPLETED|Overall Study||397
983098|NCT00384176|2382059|P3|STARTED|Overall Study||192
983099|NCT00384176|2382060|P2|STARTED|Overall Study||713
983100|NCT00384176|2382061|P1|STARTED|Overall Study||709
983101|NCT00384189|2382088|P4|NOT COMPLETED|Overall Study||40
983102|NCT00384189|2382089|P3|NOT COMPLETED|Overall Study||58
983103|NCT00384189|2382090|P2|NOT COMPLETED|Overall Study||57
983104|NCT00384189|2382091|P1|NOT COMPLETED|Overall Study||50
983105|NCT00384189|2382088|P4|COMPLETED|Overall Study||110
983106|NCT00384189|2382089|P3|COMPLETED|Overall Study||255
983107|NCT00384189|2382090|P2|COMPLETED|Overall Study||255
983108|NCT00384189|2382091|P1|COMPLETED|Overall Study||255
983109|NCT00384189|2382088|P4|Actual Treatment Received|Overall Study||146
983110|NCT00384189|2382089|P3|Actual Treatment Received|Overall Study|1 participants in the 160 μg arm actually received 40 μg and is moved to that arm.|310
983111|NCT00384189|2382090|P2|Actual Treatment Received|Overall Study||312
983112|NCT00384189|2382091|P1|Actual Treatment Received|Overall Study|1 participant randomized to 160 μg who actually received 40 μg is included.|305
983113|NCT00384189|2382088|P4|Randomized, Not Treated|Overall Study||4
983114|NCT00384189|2382089|P3|Randomized, Not Treated|Overall Study||2
983115|NCT00384189|2382090|P2|Randomized, Not Treated|Overall Study||0
983116|NCT00384189|2382091|P1|Randomized, Not Treated|Overall Study||1
983117|NCT00384189|2382088|P4|STARTED|Overall Study||150
983118|NCT00384189|2382089|P3|STARTED|Overall Study||313
983119|NCT00384189|2382090|P2|STARTED|Overall Study||312
983120|NCT00384189|2382091|P1|STARTED|Overall Study||305
983121|NCT00391365|2382151|P2|NOT COMPLETED|Overall Study||19
983122|NCT00391365|2382152|P1|NOT COMPLETED|Overall Study||25
983123|NCT00391365|2382151|P2|COMPLETED|Overall Study||151
983124|NCT00391365|2382152|P1|COMPLETED|Overall Study||78
983125|NCT00391365|2382151|P2|STARTED|Overall Study||170
983126|NCT00391365|2382152|P1|STARTED|Overall Study||103
983127|NCT00391391|2382166|P4|NOT COMPLETED|Overall Study||19
983128|NCT00391391|2382167|P3|NOT COMPLETED|Overall Study||23
983129|NCT00391391|2382168|P2|NOT COMPLETED|Overall Study||10
983130|NCT00391391|2382169|P1|NOT COMPLETED|Overall Study||9
983131|NCT00391391|2382166|P4|COMPLETED|Overall Study||145
983132|NCT00391391|2382167|P3|COMPLETED|Overall Study||138
983133|NCT00391391|2382168|P2|COMPLETED|Overall Study||87
983134|NCT00391391|2382169|P1|COMPLETED|Overall Study||89
983135|NCT00391391|2382166|P4|STARTED|Overall Study|1 participant was not vaccinated.|164
983136|NCT00391391|2382167|P3|STARTED|Overall Study|1 participant was not vaccinated.|161
983137|NCT00391391|2382168|P2|STARTED|Overall Study||97
983138|NCT00391391|2382169|P1|STARTED|Overall Study|1 participant was not vaccinated.|98
983139|NCT00391443|2382201|P2|NOT COMPLETED|Overall Study||0
983140|NCT00391443|2382202|P1|NOT COMPLETED|Overall Study||0
983141|NCT00391443|2382201|P2|COMPLETED|Overall Study||407
983142|NCT00391443|2382202|P1|COMPLETED|Overall Study||209
983143|NCT00391443|2382201|P2|STARTED|Overall Study||407
983144|NCT00391443|2382202|P1|STARTED|Overall Study|1 patient in the bosentan arm did not receive treatment & was excluded from the Safety Population.|209
983145|NCT00391469|2382214|P2|NOT COMPLETED|Overall Study||0
983146|NCT00391469|2382215|P1|NOT COMPLETED|Overall Study||0
983147|NCT00391469|2382214|P2|COMPLETED|Overall Study||671
983148|NCT00391469|2382215|P1|COMPLETED|Overall Study|5 patients were found to be incarcerated at time of randomization, thus data was not included|688
983149|NCT00391469|2382214|P2|STARTED|Overall Study||671
983150|NCT00391469|2382215|P1|STARTED|Overall Study||688
983151|NCT00391586|2382227|P1|NOT COMPLETED|Overall Study||24
983152|NCT00391586|2382227|P1|COMPLETED|Overall Study|These patients received at least 2 cycles of erlotinib|21
983153|NCT00391586|2382227|P1|Received Platinum-based Chemotherapy|Overall Study|Total number of patients who received platinum-based chemotherapy after erlotinib treatment|10
983154|NCT00391586|2382227|P1|Received First-line Erlotinib|Overall Study|These patients received at least one dose of on-study first-line erlotinib|43
983155|NCT00391586|2382227|P1|STARTED|Overall Study||45
983156|NCT00391599|2382234|P2|NOT COMPLETED|Overall Study||0
983157|NCT00391599|2382235|P1|NOT COMPLETED|Overall Study||0
983158|NCT00391599|2382234|P2|COMPLETED|Overall Study||65
983159|NCT00391599|2382235|P1|COMPLETED|Overall Study||65
983160|NCT00391599|2382234|P2|STARTED|Overall Study||65
983161|NCT00391599|2382235|P1|STARTED|Overall Study||65
983162|NCT00391625|2382245|P1|NOT COMPLETED|Month 84||0
983163|NCT00391625|2382245|P1|COMPLETED|Month 84||8
983164|NCT00391625|2382245|P1|STARTED|Month 84||8
983165|NCT00391625|2382245|P1|NOT COMPLETED|Month 50||1
983166|NCT00391625|2382245|P1|COMPLETED|Month 50||8
983167|NCT00391625|2382245|P1|STARTED|Month 50||9
983168|NCT00391625|2382245|P1|NOT COMPLETED|Month 14||1
983169|NCT00391625|2382245|P1|COMPLETED|Month 14||9
983170|NCT00391625|2382245|P1|STARTED|Month 14||10
983171|NCT00391625|2382245|P1|NOT COMPLETED|Baseline||0
983172|NCT00391625|2382245|P1|COMPLETED|Baseline||10
983173|NCT00391625|2382245|P1|STARTED|Baseline||10
983174|NCT00392288|2382288|P3|NOT COMPLETED|Overall Study||17
983175|NCT00392288|2382289|P2|NOT COMPLETED|Overall Study||22
983176|NCT00392288|2382290|P1|NOT COMPLETED|Overall Study||32
983177|NCT00392288|2382288|P3|COMPLETED|Overall Study|ITT set = 172 patients|159
983178|NCT00392288|2382289|P2|COMPLETED|Overall Study|ITT set = 166 patients|155
983179|NCT00392288|2382290|P1|COMPLETED|Overall Study|ITT set = 163 patients|143
983180|NCT00392288|2382288|P3|Treatment Period|Overall Study||175
983181|NCT00392288|2382289|P2|Treatment Period|Overall Study||174
983182|NCT00392288|2382290|P1|Treatment Period|Overall Study||172
983183|NCT00392288|2382288|P3|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|176
983184|NCT00392288|2382289|P2|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|177
983185|NCT00392288|2382290|P1|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|175
983186|NCT00392379|2382306|P2|NOT COMPLETED|Overall Study||38
983187|NCT00392379|2382307|P1|NOT COMPLETED|Overall Study||22
983188|NCT00392379|2382306|P2|COMPLETED|Overall Study|Medication period|96
983189|NCT00392379|2382307|P1|COMPLETED|Overall Study|Medication period|114
983190|NCT00392379|2382306|P2|STARTED|Overall Study|Medication period|134
983191|NCT00392379|2382307|P1|STARTED|Overall Study|Medication period|136
983192|NCT00392392|2382317|P1|NOT COMPLETED|Overall Study||20
983193|NCT00392392|2382317|P1|COMPLETED|Overall Study||9
983194|NCT00392392|2382317|P1|STARTED|Overall Study||29
983195|NCT00392444|2382321|P1|NOT COMPLETED|Overall Study||0
983196|NCT00392444|2382321|P1|COMPLETED|Overall Study||39
983197|NCT00392444|2382321|P1|STARTED|Overall Study||39
983198|NCT00392496|2382325|P1|NOT COMPLETED|Overall Study||0
983199|NCT00392496|2382325|P1|COMPLETED|Overall Study||19
983200|NCT00392496|2382325|P1|STARTED|Overall Study||19
983201|NCT00392665|2382331|P2|NOT COMPLETED|Overall Study||15
983202|NCT00392665|2382332|P1|NOT COMPLETED|Overall Study||17
983203|NCT00392665|2382331|P2|COMPLETED|Overall Study||3
983204|NCT00392665|2382332|P1|COMPLETED|Overall Study||1
983205|NCT00392665|2382331|P2|STARTED|Overall Study||18
983206|NCT00392665|2382332|P1|STARTED|Overall Study||18
983207|NCT00392678|2382348|P4|NOT COMPLETED|Overall Study||1
983208|NCT00392678|2382349|P3|NOT COMPLETED|Overall Study||2
983209|NCT00392678|2382350|P2|NOT COMPLETED|Overall Study||1
983210|NCT00392678|2382351|P1|NOT COMPLETED|Overall Study||0
983211|NCT00392678|2382348|P4|COMPLETED|Overall Study||26
983212|NCT00392678|2382349|P3|COMPLETED|Overall Study||25
983213|NCT00392678|2382350|P2|COMPLETED|Overall Study||26
983214|NCT00392678|2382351|P1|COMPLETED|Overall Study||27
983215|NCT00392678|2382348|P4|STARTED|Overall Study||27
983216|NCT00392678|2382349|P3|STARTED|Overall Study||27
983217|NCT00392678|2382350|P2|STARTED|Overall Study||27
983218|NCT00392678|2382351|P1|STARTED|Overall Study||27
983219|NCT00392704|2382385|P1|NOT COMPLETED|Combined Modality Therapy||5
983220|NCT00392704|2382385|P1|COMPLETED|Combined Modality Therapy||49
983221|NCT00392704|2382385|P1|STARTED|Combined Modality Therapy||54
983222|NCT00392704|2382385|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||6
983223|NCT00392704|2382385|P1|COMPLETED|Neoadjuvant Chemotherapy||54
983224|NCT00392704|2382385|P1|STARTED|Neoadjuvant Chemotherapy||60
983225|NCT00392769|2382390|P1|NOT COMPLETED|Overall Study||10
983226|NCT00392769|2382390|P1|COMPLETED|Overall Study||23
983227|NCT00392769|2382390|P1|STARTED|Overall Study||33
983228|NCT00392782|2382394|P1|NOT COMPLETED|Overall Study||0
983229|NCT00392782|2382394|P1|COMPLETED|Overall Study||24
983230|NCT00392782|2382394|P1|STARTED|Overall Study||24
983231|NCT00392808|2382408|P4|NOT COMPLETED|Overall Study||4
983232|NCT00392808|2382409|P3|NOT COMPLETED|Overall Study||2
983233|NCT00392808|2382410|P2|NOT COMPLETED|Overall Study||3
983234|NCT00392808|2382411|P1|NOT COMPLETED|Overall Study||6
983235|NCT00392808|2382408|P4|COMPLETED|Overall Study||100
983236|NCT00392808|2382409|P3|COMPLETED|Overall Study||107
983237|NCT00392808|2382410|P2|COMPLETED|Overall Study||86
983238|NCT00392808|2382411|P1|COMPLETED|Overall Study||81
983239|NCT00392808|2382408|P4|STARTED|Overall Study||104
983240|NCT00392808|2382409|P3|STARTED|Overall Study||109
983241|NCT00392808|2382410|P2|STARTED|Overall Study||89
983242|NCT00392808|2382411|P1|STARTED|Overall Study||87
983243|NCT00392821|2382425|P1|NOT COMPLETED|Overall Study||19
983244|NCT00392821|2382425|P1|COMPLETED|Overall Study||59
983245|NCT00392821|2382425|P1|STARTED|Overall Study||78
983246|NCT00392834|2382432|P2|NOT COMPLETED|Overall Study||0
983247|NCT00392834|2382433|P1|NOT COMPLETED|Overall Study||0
983248|NCT00392834|2382432|P2|COMPLETED|Overall Study||32
983249|NCT00392834|2382433|P1|COMPLETED|Overall Study||2
983250|NCT00392834|2382432|P2|STARTED|Overall Study||32
983251|NCT00392834|2382433|P1|STARTED|Overall Study||2
983252|NCT00392860|2382441|P3|NOT COMPLETED|Overall Study||0
983253|NCT00392860|2382442|P2|NOT COMPLETED|Overall Study||0
983254|NCT00392860|2382443|P1|NOT COMPLETED|Overall Study||0
983255|NCT00392860|2382441|P3|COMPLETED|Overall Study||1
983256|NCT00392860|2382442|P2|COMPLETED|Overall Study||0
983257|NCT00392860|2382443|P1|COMPLETED|Overall Study||3
983258|NCT00392860|2382441|P3|STARTED|Overall Study||1
983259|NCT00392860|2382442|P2|STARTED|Overall Study||0
983260|NCT00392860|2382443|P1|STARTED|Overall Study||3
983261|NCT00392925|2382453|P4|NOT COMPLETED|Randomization to Treatment Group Period||18
983262|NCT00392925|2382454|P3|NOT COMPLETED|Randomization to Treatment Group Period||19
983263|NCT00392925|2382455|P2|NOT COMPLETED|Randomization to Treatment Group Period||8
983264|NCT00392925|2382456|P1|NOT COMPLETED|Randomization to Treatment Group Period||0
983265|NCT00392925|2382453|P4|COMPLETED|Randomization to Treatment Group Period|At Week 20|38
983266|NCT00392925|2382454|P3|COMPLETED|Randomization to Treatment Group Period|At Week 20|37
983267|NCT00392925|2382455|P2|COMPLETED|Randomization to Treatment Group Period|AT Week 20|19
983268|NCT00392925|2382456|P1|COMPLETED|Randomization to Treatment Group Period||0
983269|NCT00392925|2382453|P4|STARTED|Randomization to Treatment Group Period||56
983270|NCT00392925|2382454|P3|STARTED|Randomization to Treatment Group Period||56
983271|NCT00392925|2382455|P2|STARTED|Randomization to Treatment Group Period||27
983272|NCT00392925|2382456|P1|STARTED|Randomization to Treatment Group Period||0
983273|NCT00392925|2382453|P4|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
983274|NCT00392925|2382454|P3|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
983275|NCT00392925|2382455|P2|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
983276|NCT00392925|2382456|P1|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||38
983277|NCT00392925|2382453|P4|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
983278|NCT00392925|2382454|P3|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
983279|NCT00392925|2382455|P2|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
983280|NCT00392925|2382456|P1|COMPLETED|4 Week Lead-In Period - Non-Randomized||139
983281|NCT00392925|2382453|P4|STARTED|4 Week Lead-In Period - Non-Randomized||0
983282|NCT00392925|2382454|P3|STARTED|4 Week Lead-In Period - Non-Randomized||0
983283|NCT00392925|2382455|P2|STARTED|4 Week Lead-In Period - Non-Randomized||0
983284|NCT00392925|2382456|P1|STARTED|4 Week Lead-In Period - Non-Randomized||177
983285|NCT00393029|2382544|P2|NOT COMPLETED|Overall Study||1
983286|NCT00393029|2382545|P1|NOT COMPLETED|Overall Study||0
983287|NCT00393029|2382544|P2|COMPLETED|Overall Study||9
983288|NCT00393029|2382545|P1|COMPLETED|Overall Study||2
983289|NCT00393029|2382544|P2|STARTED|Overall Study||10
983290|NCT00393029|2382545|P1|STARTED|Overall Study||2
983291|NCT00393042|2382554|P2|NOT COMPLETED|Second Intervetion||8
983292|NCT00393042|2382555|P1|NOT COMPLETED|Second Intervetion||2
983293|NCT00393042|2382554|P2|COMPLETED|Second Intervetion||19
983294|NCT00393042|2382555|P1|COMPLETED|Second Intervetion||24
983295|NCT00393042|2382554|P2|Completed 25/30 mg Dosage|Second Intervetion||20
983296|NCT00393042|2382555|P1|Completed 25/30 mg Dosage|Second Intervetion||24
983297|NCT00393042|2382554|P2|Completed the 20mg Dosage|Second Intervetion||21
983298|NCT00393042|2382555|P1|Completed the 20mg Dosage|Second Intervetion||24
983299|NCT00393042|2382554|P2|Completed 10 mg Dosage|Second Intervetion||24
983300|NCT00393042|2382555|P1|Completed 10 mg Dosage|Second Intervetion||26
983301|NCT00393042|2382554|P2|Completed Placebo Dosage|Second Intervetion||21
983302|NCT00393042|2382555|P1|Completed Placebo Dosage|Second Intervetion||25
983303|NCT00393042|2382554|P2|STARTED|Second Intervetion||27
983304|NCT00393042|2382555|P1|STARTED|Second Intervetion||26
983305|NCT00393042|2382554|P2|NOT COMPLETED|First Intervention||6
983306|NCT00393042|2382555|P1|NOT COMPLETED|First Intervention||5
983307|NCT00393042|2382554|P2|COMPLETED|First Intervention||27
983308|NCT00393042|2382555|P1|COMPLETED|First Intervention||26
983309|NCT00393042|2382554|P2|Completed 25/30mg Dosage|First Intervention||27
983310|NCT00393042|2382555|P1|Completed 25/30mg Dosage|First Intervention||27
983311|NCT00393042|2382554|P2|Completed 20 mg Dosage|First Intervention||28
983312|NCT00393042|2382555|P1|Completed 20 mg Dosage|First Intervention||26
983313|NCT00393042|2382554|P2|Completed 10mg Dosage|First Intervention||29
983314|NCT00393042|2382555|P1|Completed 10mg Dosage|First Intervention||29
983315|NCT00393042|2382554|P2|Completed the Placebo Dosage|First Intervention||29
983316|NCT00393042|2382555|P1|Completed the Placebo Dosage|First Intervention||27
983317|NCT00393042|2382554|P2|STARTED|First Intervention||33
983318|NCT00393042|2382555|P1|STARTED|First Intervention||31
983319|NCT00393068|2382625|P1|NOT COMPLETED|Overall Study||18
983320|NCT00393068|2382625|P1|COMPLETED|Overall Study||44
983321|NCT00393068|2382625|P1|STARTED|Overall Study||62
983322|NCT00393094|2382629|P1|NOT COMPLETED|Disease Progression After Trtmt: Onstudy||1
983323|NCT00393094|2382629|P1|COMPLETED|Disease Progression After Trtmt: Onstudy||29
983324|NCT00393094|2382629|P1|STARTED|Disease Progression After Trtmt: Onstudy||30
983325|NCT00393094|2382629|P1|NOT COMPLETED|Period1Bevacizumab & Irinotecan Patients||1
983326|NCT00393094|2382629|P1|COMPLETED|Period1Bevacizumab & Irinotecan Patients||30
983327|NCT00393094|2382629|P1|STARTED|Period1Bevacizumab & Irinotecan Patients||31
983328|NCT00393367|2382638|P2|NOT COMPLETED|Overall Study||7
983329|NCT00393367|2382639|P1|NOT COMPLETED|Overall Study||2
983330|NCT00393367|2382638|P2|COMPLETED|Overall Study||81
983331|NCT00393367|2382639|P1|COMPLETED|Overall Study||89
983332|NCT00393367|2382638|P2|STARTED|Overall Study||88
983333|NCT00393367|2382639|P1|STARTED|Overall Study||91
983334|NCT00393380|2382667|P1|NOT COMPLETED|Overall Study||0
983335|NCT00393380|2382667|P1|COMPLETED|Overall Study||13
983336|NCT00393380|2382667|P1|STARTED|Overall Study||13
983337|NCT00393458|2382682|P4|NOT COMPLETED|Overall Study||137
983338|NCT00393458|2382683|P3|NOT COMPLETED|Overall Study||112
983339|NCT00393458|2382684|P2|NOT COMPLETED|Overall Study||102
983340|NCT00393458|2382685|P1|NOT COMPLETED|Overall Study||99
983341|NCT00393458|2382682|P4|COMPLETED|Overall Study||295
983342|NCT00393458|2382683|P3|COMPLETED|Overall Study||323
983343|NCT00393458|2382684|P2|COMPLETED|Overall Study||326
983344|NCT00393458|2382685|P1|COMPLETED|Overall Study||338
983345|NCT00393458|2382682|P4|Exposed to Study Medication or Placebo|Overall Study||432
983346|NCT00393458|2382683|P3|Exposed to Study Medication or Placebo|Overall Study||434
983347|NCT00393458|2382684|P2|Exposed to Study Medication or Placebo|Overall Study||425
983348|NCT00393458|2382685|P1|Exposed to Study Medication or Placebo|Overall Study||437
983349|NCT00393458|2382682|P4|STARTED|Overall Study||432
983350|NCT00393458|2382683|P3|STARTED|Overall Study||435
983351|NCT00393458|2382684|P2|STARTED|Overall Study||428
983352|NCT00393458|2382685|P1|STARTED|Overall Study||437
983353|NCT00393484|2382701|P2|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||23
983354|NCT00393484|2382702|P1|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||8
983355|NCT00393484|2382701|P2|COMPLETED|Open-label Period (Weeks 96 to 240)||21
983356|NCT00393484|2382702|P1|COMPLETED|Open-label Period (Weeks 96 to 240)||40
983357|NCT00393484|2382701|P2|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|2
983358|NCT00393484|2382702|P1|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|0
983359|NCT00393484|2382701|P2|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
983360|NCT00393484|2382702|P1|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
983361|NCT00393484|2382701|P2|STARTED|Open-label Period (Weeks 96 to 240)||44
983362|NCT00393484|2382702|P1|STARTED|Open-label Period (Weeks 96 to 240)||48
983363|NCT00393484|2382701|P2|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||12
983364|NCT00393484|2382702|P1|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||2
983365|NCT00393484|2382701|P2|COMPLETED|Double-blind Period (Day 1 to Week 96)||52
983366|NCT00393484|2382702|P1|COMPLETED|Double-blind Period (Day 1 to Week 96)||54
983367|NCT00393484|2382701|P2|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
983368|NCT00393484|2382702|P1|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
983369|NCT00393484|2382701|P2|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|64
983370|NCT00393484|2382702|P1|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|56
983371|NCT00393510|2382736|P2|NOT COMPLETED|Overall Study||9
983372|NCT00393510|2382737|P1|NOT COMPLETED|Overall Study||3
983373|NCT00393510|2382736|P2|COMPLETED|Overall Study||31
983374|NCT00393510|2382737|P1|COMPLETED|Overall Study||37
983375|NCT00393510|2382736|P2|STARTED|Overall Study||40
983376|NCT00393510|2382737|P1|STARTED|Overall Study||40
983377|NCT00393523|2382752|P5|NOT COMPLETED|Overall Study||1
983378|NCT00393523|2382753|P4|NOT COMPLETED|Overall Study||6
983379|NCT00393523|2382754|P3|NOT COMPLETED|Overall Study||4
983380|NCT00393523|2382755|P2|NOT COMPLETED|Overall Study||9
983381|NCT00393523|2382756|P1|NOT COMPLETED|Overall Study||12
983382|NCT00393523|2382752|P5|COMPLETED|Overall Study||19
983383|NCT00393523|2382753|P4|COMPLETED|Overall Study||348
983384|NCT00393523|2382754|P3|COMPLETED|Overall Study||349
983385|NCT00393523|2382755|P2|COMPLETED|Overall Study||366
983386|NCT00393523|2382756|P1|COMPLETED|Overall Study||364
983387|NCT00393523|2382752|P5|Vaccination Visit 1|Overall Study||20
983388|NCT00393523|2382753|P4|Vaccination Visit 1|Overall Study||352
983389|NCT00393523|2382754|P3|Vaccination Visit 1|Overall Study||349
983390|NCT00393523|2382755|P2|Vaccination Visit 1|Overall Study||375
983391|NCT00393523|2382756|P1|Vaccination Visit 1|Overall Study||374
983392|NCT00393523|2382752|P5|STARTED|Overall Study||20
983393|NCT00393523|2382753|P4|STARTED|Overall Study||354
983394|NCT00393523|2382754|P3|STARTED|Overall Study||353
983395|NCT00393523|2382755|P2|STARTED|Overall Study||375
983396|NCT00393523|2382756|P1|STARTED|Overall Study||376
983397|NCT00393705|2382773|P2|NOT COMPLETED|Overall Study||23
983398|NCT00393705|2382774|P1|NOT COMPLETED|Overall Study||23
983399|NCT00393705|2382773|P2|COMPLETED|Overall Study||128
983400|NCT00393705|2382774|P1|COMPLETED|Overall Study||128
983401|NCT00393705|2382773|P2|Received at Least One Dose of Study Drug|Overall Study||139
983402|NCT00393705|2382774|P1|Received at Least One Dose of Study Drug|Overall Study||139
983403|NCT00393705|2382773|P2|STARTED|Overall Study||151
983404|NCT00393705|2382774|P1|STARTED|Overall Study||151
983405|NCT00393718|2382800|P2|NOT COMPLETED|Overall Study||22
983406|NCT00393718|2382801|P1|NOT COMPLETED|Overall Study||43
983407|NCT00393718|2382800|P2|COMPLETED|Overall Study||110
983408|NCT00393718|2382801|P1|COMPLETED|Overall Study||225
983409|NCT00393718|2382800|P2|STARTED|Overall Study||132
983410|NCT00393718|2382801|P1|STARTED|Overall Study||268
983411|NCT00393796|2382833|P2|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
983412|NCT00393796|2382834|P1|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
983413|NCT00393796|2382833|P2|COMPLETED|Open Label Period - Placebo to SUTENT||16
983414|NCT00393796|2382834|P1|COMPLETED|Open Label Period - Placebo to SUTENT||0
983415|NCT00393796|2382833|P2|STARTED|Open Label Period - Placebo to SUTENT||16
983416|NCT00393796|2382834|P1|STARTED|Open Label Period - Placebo to SUTENT||0
983417|NCT00393796|2382833|P2|NOT COMPLETED|Double Blind Period||0
983418|NCT00393796|2382834|P1|NOT COMPLETED|Double Blind Period||0
983419|NCT00393796|2382833|P2|COMPLETED|Double Blind Period||28
983420|NCT00393796|2382834|P1|COMPLETED|Double Blind Period||26
983421|NCT00393796|2382833|P2|STARTED|Double Blind Period||28
983422|NCT00393796|2382834|P1|STARTED|Double Blind Period||26
983423|NCT00393848|2382844|P4|NOT COMPLETED|Overall Study||1
983424|NCT00393848|2382845|P3|NOT COMPLETED|Overall Study||2
983425|NCT00393848|2382846|P2|NOT COMPLETED|Overall Study||0
983426|NCT00393848|2382847|P1|NOT COMPLETED|Overall Study||0
983427|NCT00393848|2382844|P4|COMPLETED|Overall Study||8
983428|NCT00393848|2382845|P3|COMPLETED|Overall Study||4
983429|NCT00393848|2382846|P2|COMPLETED|Overall Study||9
983430|NCT00393848|2382847|P1|COMPLETED|Overall Study||16
983431|NCT00393848|2382844|P4|STARTED|Overall Study||9
983432|NCT00393848|2382845|P3|STARTED|Overall Study||6
983433|NCT00393848|2382846|P2|STARTED|Overall Study||9
983434|NCT00393848|2382847|P1|STARTED|Overall Study||16
983435|NCT00393861|2382859|P1|NOT COMPLETED|Overall Study||26
983436|NCT00393861|2382859|P1|COMPLETED|Overall Study||3
983437|NCT00393861|2382859|P1|STARTED|Overall Study||29
983438|NCT00393874|2382869|P3|NOT COMPLETED|Overall Study||2
983439|NCT00393874|2382870|P2|NOT COMPLETED|Overall Study||4
983440|NCT00393874|2382871|P1|NOT COMPLETED|Overall Study||3
983441|NCT00393874|2382869|P3|COMPLETED|Overall Study||13
983442|NCT00393874|2382870|P2|COMPLETED|Overall Study||13
983443|NCT00393874|2382871|P1|COMPLETED|Overall Study||15
983444|NCT00393874|2382869|P3|STARTED|Overall Study||15
983445|NCT00393874|2382870|P2|STARTED|Overall Study||17
983446|NCT00393874|2382871|P1|STARTED|Overall Study||18
983447|NCT00393887|2382890|P2|NOT COMPLETED|Overall Study||9
983448|NCT00393887|2382891|P1|NOT COMPLETED|Overall Study||16
983449|NCT00393887|2382890|P2|COMPLETED|Overall Study||41
983450|NCT00393887|2382891|P1|COMPLETED|Overall Study||34
983451|NCT00393887|2382890|P2|1 Year|Overall Study||50
983452|NCT00393887|2382891|P1|1 Year|Overall Study||45
983453|NCT00393887|2382890|P2|STARTED|Overall Study||50
983454|NCT00393887|2382891|P1|STARTED|Overall Study||50
983455|NCT00393913|2382897|P1|NOT COMPLETED|CPAP Withdrawal||0
983456|NCT00393913|2382897|P1|COMPLETED|CPAP Withdrawal||42
983457|NCT00393913|2382897|P1|CPAP Compliance|CPAP Withdrawal|Only subjects with sufficient CPAP complaince (>4 hrs/night) were included.|42
983458|NCT00393913|2382897|P1|STARTED|CPAP Withdrawal|Includes only subjects with good CPAP adherence|42
983459|NCT00393913|2382897|P1|NOT COMPLETED|CPAP||7
983460|NCT00393913|2382897|P1|COMPLETED|CPAP||93
983461|NCT00393913|2382897|P1|STARTED|CPAP|Excludes normal volunteers without OSA|100
983462|NCT00393913|2382897|P1|NOT COMPLETED|Initial Assessment||37
983463|NCT00393913|2382897|P1|COMPLETED|Initial Assessment||107
983464|NCT00393913|2382897|P1|STARTED|Initial Assessment||144
983465|NCT00393939|2382905|P2|NOT COMPLETED|Overall Study||297
983466|NCT00393939|2382906|P1|NOT COMPLETED|Overall Study||296
983467|NCT00393939|2382905|P2|COMPLETED|Overall Study||0
983468|NCT00393939|2382906|P1|COMPLETED|Overall Study||0
983469|NCT00393939|2382905|P2|Treated|Overall Study||293
983470|NCT00393939|2382906|P1|Treated|Overall Study||295
983471|NCT00393939|2382905|P2|STARTED|Overall Study||297
983472|NCT00393939|2382906|P1|STARTED|Overall Study||296
983473|NCT00393978|2382926|P2|NOT COMPLETED|Overall Study||20
983474|NCT00393978|2382927|P1|NOT COMPLETED|Overall Study||16
983475|NCT00393978|2382926|P2|COMPLETED|Overall Study||18
983476|NCT00393978|2382927|P1|COMPLETED|Overall Study||21
983477|NCT00393978|2382926|P2|STARTED|Overall Study||38
983478|NCT00393978|2382927|P1|STARTED|Overall Study||37
983479|NCT00394082|2382935|P1|NOT COMPLETED|Overall Study||26
983480|NCT00394082|2382935|P1|COMPLETED|Overall Study|Treatment completed upon disease progression|24
983481|NCT00394082|2382935|P1|At Least One Response Assessment|Overall Study||43
983482|NCT00394082|2382935|P1|STARTED|Overall Study||50
983483|NCT00394095|2382946|P2|NOT COMPLETED|Overall Study||0
983484|NCT00394095|2382947|P1|NOT COMPLETED|Overall Study||1
983485|NCT00394095|2382946|P2|COMPLETED|Overall Study||14
983486|NCT00394095|2382947|P1|COMPLETED|Overall Study||16
983487|NCT00394095|2382946|P2|Screened|Overall Study||14
983488|NCT00394095|2382947|P1|Screened|Overall Study||17
983489|NCT00394095|2382946|P2|STARTED|Overall Study||14
983490|NCT00394095|2382947|P1|STARTED|Overall Study||17
983491|NCT00394212|2382957|P2|NOT COMPLETED|Overall Study||1
983492|NCT00394212|2382958|P1|NOT COMPLETED|Overall Study||7
983493|NCT00394212|2382957|P2|COMPLETED|Overall Study||26
983494|NCT00394212|2382958|P1|COMPLETED|Overall Study||43
983495|NCT00394212|2382957|P2|6 Month Follow-up|Overall Study||26
983496|NCT00394212|2382958|P1|6 Month Follow-up|Overall Study||43
983497|NCT00394212|2382957|P2|3 Month Follow-up|Overall Study||26
983498|NCT00394212|2382958|P1|3 Month Follow-up|Overall Study||45
983499|NCT00394212|2382957|P2|6 Week Follow-up|Overall Study||26
983500|NCT00394212|2382958|P1|6 Week Follow-up|Overall Study||45
983501|NCT00394212|2382957|P2|STARTED|Overall Study||27
983502|NCT00394212|2382958|P1|STARTED|Overall Study|2 subjects assigned to suturing underwent sham procedure, results based on Intent-To-Treat (ITT)|50
983503|NCT00394251|2382972|P2|NOT COMPLETED|Overall Study||38
983504|NCT00394251|2382973|P1|NOT COMPLETED|Overall Study||37
983505|NCT00394251|2382972|P2|COMPLETED|Overall Study||61
983506|NCT00394251|2382973|P1|COMPLETED|Overall Study||61
983507|NCT00394251|2382972|P2|At Least One Dose of Taxane|Overall Study||93
983508|NCT00394251|2382973|P1|At Least One Dose of Taxane|Overall Study||93
983509|NCT00394251|2382972|P2|STARTED|Overall Study||99
983510|NCT00394251|2382973|P1|STARTED|Overall Study||98
983511|NCT00394277|2383003|P4|NOT COMPLETED|Overall Study||125
983512|NCT00394277|2383004|P3|NOT COMPLETED|Overall Study||120
983513|NCT00394277|2383005|P2|NOT COMPLETED|Overall Study||60
983514|NCT00394277|2383006|P1|NOT COMPLETED|Overall Study||58
983515|NCT00394277|2383003|P4|COMPLETED|Overall Study||266
983516|NCT00394277|2383004|P3|COMPLETED|Overall Study||273
983517|NCT00394277|2383005|P2|COMPLETED|Overall Study||136
983518|NCT00394277|2383006|P1|COMPLETED|Overall Study||137
983519|NCT00394277|2383003|P4|STARTED|Overall Study||391
983520|NCT00394277|2383004|P3|STARTED|Overall Study||393
983521|NCT00394277|2383005|P2|STARTED|Overall Study||196
983522|NCT00394277|2383006|P1|STARTED|Overall Study||195
983523|NCT00394329|2383032|P4|NOT COMPLETED|Overall Study||24
983524|NCT00394329|2383033|P3|NOT COMPLETED|Overall Study||13
983525|NCT00394329|2383034|P2|NOT COMPLETED|Overall Study||9
983526|NCT00394329|2383035|P1|NOT COMPLETED|Overall Study||8
983527|NCT00394329|2383032|P4|COMPLETED|Overall Study||50
983528|NCT00394329|2383033|P3|COMPLETED|Overall Study||58
983529|NCT00394329|2383034|P2|COMPLETED|Overall Study||63
983530|NCT00394329|2383035|P1|COMPLETED|Overall Study||63
983531|NCT00394329|2383032|P4|STARTED|Overall Study||74
983532|NCT00394329|2383033|P3|STARTED|Overall Study||71
983533|NCT00394329|2383034|P2|STARTED|Overall Study||72
983534|NCT00394329|2383035|P1|STARTED|Overall Study||71
983535|NCT00394355|2383049|P4|NOT COMPLETED|Overall Study||31
983536|NCT00394355|2383050|P3|NOT COMPLETED|Overall Study||38
983537|NCT00394355|2383051|P2|NOT COMPLETED|Overall Study||34
983538|NCT00394355|2383052|P1|NOT COMPLETED|Overall Study||35
983539|NCT00394355|2383049|P4|COMPLETED|Overall Study||111
983540|NCT00394355|2383050|P3|COMPLETED|Overall Study||109
983541|NCT00394355|2383051|P2|COMPLETED|Overall Study||103
983542|NCT00394355|2383052|P1|COMPLETED|Overall Study||105
983543|NCT00394355|2383049|P4|STARTED|Overall Study||142
983544|NCT00394355|2383050|P3|STARTED|Overall Study||147
983545|NCT00394355|2383051|P2|STARTED|Overall Study||137
983546|NCT00394355|2383052|P1|STARTED|Overall Study||140
983547|NCT00394433|2383074|P1|NOT COMPLETED|Overall Study||3
983548|NCT00394433|2383074|P1|COMPLETED|Overall Study||35
983549|NCT00394433|2383074|P1|Evaluable and Treated|Overall Study||35
983550|NCT00394433|2383074|P1|STARTED|Overall Study||38
983551|NCT00394472|2383083|P2|NOT COMPLETED|Overall Study||11
983552|NCT00394472|2383084|P1|NOT COMPLETED|Overall Study||9
983553|NCT00394472|2383083|P2|COMPLETED|Overall Study||111
983554|NCT00394472|2383084|P1|COMPLETED|Overall Study||113
983555|NCT00394472|2383083|P2|STARTED|Overall Study||122
983556|NCT00394472|2383084|P1|STARTED|Overall Study||122
983557|NCT00394524|2383094|P2|NOT COMPLETED|Overall Study||10
983558|NCT00394524|2383095|P1|NOT COMPLETED|Overall Study||11
983559|NCT00394524|2383094|P2|COMPLETED|Overall Study||68
983560|NCT00394524|2383095|P1|COMPLETED|Overall Study||68
983561|NCT00394524|2383094|P2|STARTED|Overall Study||78
983562|NCT00394524|2383095|P1|STARTED|Overall Study||79
983563|NCT00394589|2383108|P3|NOT COMPLETED|Overall Study||7
983564|NCT00394589|2383109|P2|NOT COMPLETED|Overall Study||3
983565|NCT00394589|2383110|P1|NOT COMPLETED|Overall Study||8
983566|NCT00394589|2383108|P3|COMPLETED|Overall Study||11
983567|NCT00394589|2383109|P2|COMPLETED|Overall Study||8
983568|NCT00394589|2383110|P1|COMPLETED|Overall Study||6
983569|NCT00394589|2383108|P3|STARTED|Overall Study||18
983570|NCT00394589|2383109|P2|STARTED|Overall Study||11
983571|NCT00394589|2383110|P1|STARTED|Overall Study||14
983572|NCT00394654|2383120|P2|NOT COMPLETED|Overall Study||0
983573|NCT00394654|2383121|P1|NOT COMPLETED|Overall Study||2
983574|NCT00394654|2383120|P2|COMPLETED|Overall Study||15
983575|NCT00394654|2383121|P1|COMPLETED|Overall Study||13
983576|NCT00394654|2383120|P2|STARTED|Overall Study||15
983577|NCT00394654|2383121|P1|STARTED|Overall Study||15
983578|NCT00394706|2383191|P8|NOT COMPLETED|Overall Study||0
983579|NCT00394706|2383192|P7|NOT COMPLETED|Overall Study||3
983580|NCT00394706|2383193|P6|NOT COMPLETED|Overall Study||7
983581|NCT00394706|2383194|P5|NOT COMPLETED|Overall Study||2
983582|NCT00394706|2383195|P4|NOT COMPLETED|Overall Study||1
983583|NCT00394706|2383196|P3|NOT COMPLETED|Overall Study||9
983584|NCT00394706|2383197|P2|NOT COMPLETED|Overall Study||2
983585|NCT00394706|2383198|P1|NOT COMPLETED|Overall Study||4
983586|NCT00394706|2383191|P8|COMPLETED|Overall Study||851
983587|NCT00394706|2383192|P7|COMPLETED|Overall Study||926
983588|NCT00394706|2383193|P6|COMPLETED|Overall Study||1377
983589|NCT00394706|2383194|P5|COMPLETED|Overall Study||1634
983590|NCT00394706|2383195|P4|COMPLETED|Overall Study||1632
983591|NCT00394706|2383196|P3|COMPLETED|Overall Study||1615
983592|NCT00394706|2383197|P2|COMPLETED|Overall Study||1860
983593|NCT00394706|2383198|P1|COMPLETED|Overall Study||1815
983594|NCT00394706|2383191|P8|STARTED|Overall Study||851
983595|NCT00394706|2383192|P7|STARTED|Overall Study||929
983596|NCT00394706|2383193|P6|STARTED|Overall Study||1384
983597|NCT00394706|2383194|P5|STARTED|Overall Study||1636
983598|NCT00394706|2383195|P4|STARTED|Overall Study||1633
983599|NCT00394706|2383196|P3|STARTED|Overall Study||1624
983600|NCT00394706|2383197|P2|STARTED|Overall Study||1862
983601|NCT00394706|2383198|P1|STARTED|Overall Study||1819
983602|NCT00394771|2383220|P4|NOT COMPLETED|Overall Study||39
983603|NCT00394771|2383221|P3|NOT COMPLETED|Overall Study||47
983604|NCT00394771|2383222|P2|NOT COMPLETED|Overall Study||34
983605|NCT00394771|2383223|P1|NOT COMPLETED|Overall Study||41
983606|NCT00394771|2383220|P4|COMPLETED|Overall Study||109
983607|NCT00394771|2383221|P3|COMPLETED|Overall Study||96
983608|NCT00394771|2383222|P2|COMPLETED|Overall Study||102
983609|NCT00394771|2383223|P1|COMPLETED|Overall Study||99
983610|NCT00394771|2383220|P4|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|120
983611|NCT00394771|2383221|P3|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|108
983612|NCT00394771|2383222|P2|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
983613|NCT00394771|2383223|P1|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
983614|NCT00394771|2383220|P4|STARTED|Overall Study|Safety population of treated participants|148
983615|NCT00394771|2383221|P3|STARTED|Overall Study|Safety population of treated participants|143
983616|NCT00394771|2383222|P2|STARTED|Overall Study|Safety population of treated participants|136
983617|NCT00394771|2383223|P1|STARTED|Overall Study|Safety population of treated participants|140
983618|NCT00394836|2383287|P2|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||53
983619|NCT00394836|2383288|P1|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||20
983620|NCT00394836|2383287|P2|COMPLETED|Extended Follow-up Phase (2-5 Years)||5
983621|NCT00394836|2383288|P1|COMPLETED|Extended Follow-up Phase (2-5 Years)||0
983622|NCT00394836|2383287|P2|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|58
983623|NCT00394836|2383288|P1|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|20
983624|NCT00394836|2383287|P2|NOT COMPLETED|Teatment or Follow-up Phase||78
983625|NCT00394836|2383288|P1|NOT COMPLETED|Teatment or Follow-up Phase||28
983626|NCT00394836|2383287|P2|COMPLETED|Teatment or Follow-up Phase||8
983627|NCT00394836|2383288|P1|COMPLETED|Teatment or Follow-up Phase||2
983628|NCT00394836|2383287|P2|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|8
983629|NCT00394836|2383288|P1|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|4
983630|NCT00394836|2383287|P2|STARTED|Teatment or Follow-up Phase||86
983631|NCT00394836|2383288|P1|STARTED|Teatment or Follow-up Phase||30
983632|NCT00381381|2383330|P1|NOT COMPLETED|Overall Study||64
983633|NCT00381381|2383330|P1|COMPLETED|Overall Study||135
983634|NCT00381381|2383330|P1|STARTED|Overall Study||199
983635|NCT00381485|2383340|P4|NOT COMPLETED|Double-Blind Treatment Period||33
983636|NCT00381485|2383341|P3|NOT COMPLETED|Double-Blind Treatment Period||25
983637|NCT00381485|2383342|P2|NOT COMPLETED|Double-Blind Treatment Period||27
983638|NCT00381485|2383343|P1|NOT COMPLETED|Double-Blind Treatment Period||0
983639|NCT00381485|2383340|P4|COMPLETED|Double-Blind Treatment Period||207
983640|NCT00381485|2383341|P3|COMPLETED|Double-Blind Treatment Period||208
983641|NCT00381485|2383342|P2|COMPLETED|Double-Blind Treatment Period||228
983642|NCT00381485|2383343|P1|COMPLETED|Double-Blind Treatment Period||0
983643|NCT00381485|2383340|P4|STARTED|Double-Blind Treatment Period||240
983644|NCT00381485|2383341|P3|STARTED|Double-Blind Treatment Period||233
983645|NCT00381485|2383342|P2|STARTED|Double-Blind Treatment Period||255
983646|NCT00381485|2383343|P1|STARTED|Double-Blind Treatment Period||0
983647|NCT00381485|2383340|P4|NOT COMPLETED|Open-Label Run-In Period||0
983648|NCT00381485|2383341|P3|NOT COMPLETED|Open-Label Run-In Period||0
983649|NCT00381485|2383342|P2|NOT COMPLETED|Open-Label Run-In Period||0
983650|NCT00381485|2383343|P1|NOT COMPLETED|Open-Label Run-In Period||106
983651|NCT00381485|2383340|P4|COMPLETED|Open-Label Run-In Period||0
983652|NCT00381485|2383341|P3|COMPLETED|Open-Label Run-In Period||0
983653|NCT00381485|2383342|P2|COMPLETED|Open-Label Run-In Period||0
983654|NCT00381485|2383343|P1|COMPLETED|Open-Label Run-In Period||728
983655|NCT00381485|2383340|P4|STARTED|Open-Label Run-In Period||0
983656|NCT00381485|2383341|P3|STARTED|Open-Label Run-In Period||0
983657|NCT00381485|2383342|P2|STARTED|Open-Label Run-In Period||0
983658|NCT00381485|2383343|P1|STARTED|Open-Label Run-In Period||834
983659|NCT00381550|2383361|P1|NOT COMPLETED|Overall Study||0
983660|NCT00381550|2383361|P1|COMPLETED|Overall Study||35
983661|NCT00381550|2383361|P1|STARTED|Overall Study||35
983662|NCT00381563|2383368|P2|NOT COMPLETED|Overall Study||6
983663|NCT00381563|2383369|P1|NOT COMPLETED|Overall Study||7
983664|NCT00381563|2383368|P2|COMPLETED|Overall Study||33
983665|NCT00381563|2383369|P1|COMPLETED|Overall Study||34
983666|NCT00381563|2383368|P2|STARTED|Overall Study||39
983667|NCT00381563|2383369|P1|STARTED|Overall Study||41
983668|NCT00381615|2383380|P4|NOT COMPLETED|Overall Study||2
983669|NCT00381615|2383381|P3|NOT COMPLETED|Overall Study||1
983670|NCT00381615|2383382|P2|NOT COMPLETED|Overall Study||5
983671|NCT00381615|2383383|P1|NOT COMPLETED|Overall Study||4
983672|NCT00381615|2383380|P4|COMPLETED|Overall Study||22
983673|NCT00381615|2383381|P3|COMPLETED|Overall Study||24
983674|NCT00381615|2383382|P2|COMPLETED|Overall Study||45
983675|NCT00381615|2383383|P1|COMPLETED|Overall Study||44
983676|NCT00381615|2383380|P4|STARTED|Overall Study||24
983677|NCT00381615|2383381|P3|STARTED|Overall Study||25
983678|NCT00381615|2383382|P2|STARTED|Overall Study||50
983679|NCT00381615|2383383|P1|STARTED|Overall Study||48
983680|NCT00381628|2383437|P4|NOT COMPLETED|Overall Study||0
983681|NCT00381628|2383438|P3|NOT COMPLETED|Overall Study||0
983682|NCT00381628|2383439|P2|NOT COMPLETED|Overall Study||0
983683|NCT00381628|2383440|P1|NOT COMPLETED|Overall Study||0
983684|NCT00381628|2383437|P4|COMPLETED|Overall Study||14
983685|NCT00381628|2383438|P3|COMPLETED|Overall Study||0
983686|NCT00381628|2383439|P2|COMPLETED|Overall Study||27
983687|NCT00381628|2383440|P1|COMPLETED|Overall Study||18
983688|NCT00381628|2383437|P4|STARTED|Overall Study||14
983689|NCT00381628|2383438|P3|STARTED|Overall Study||0
983690|NCT00381628|2383439|P2|STARTED|Overall Study||27
983691|NCT00381628|2383440|P1|STARTED|Overall Study||18
983692|NCT00381641|2383452|P2|NOT COMPLETED|Overall Study||2
983693|NCT00381641|2383453|P1|NOT COMPLETED|Overall Study||0
983694|NCT00381641|2383452|P2|COMPLETED|Overall Study||23
983695|NCT00381641|2383453|P1|COMPLETED|Overall Study||38
983696|NCT00381641|2383452|P2|STARTED|Overall Study||25
983697|NCT00381641|2383453|P1|STARTED|Overall Study||38
983698|NCT00381680|2383467|P2|NOT COMPLETED|Overall Study||50
983699|NCT00381680|2383468|P1|NOT COMPLETED|Overall Study||125
983700|NCT00381680|2383467|P2|COMPLETED|Overall Study||19
983701|NCT00381680|2383468|P1|COMPLETED|Overall Study||81
983702|NCT00381680|2383467|P2|STARTED|Overall Study||69
983703|NCT00381680|2383468|P1|STARTED|Overall Study||206
983704|NCT00381693|2383483|P1|NOT COMPLETED|Overall Study||8
983705|NCT00381693|2383483|P1|COMPLETED|Overall Study||2
983706|NCT00381693|2383483|P1|STARTED|Overall Study||10
983707|NCT00381706|2383496|P3|NOT COMPLETED|Overall Study||1
983708|NCT00381706|2383497|P2|NOT COMPLETED|Overall Study||2
983709|NCT00381706|2383498|P1|NOT COMPLETED|Overall Study||7
983710|NCT00381706|2383496|P3|COMPLETED|Overall Study||79
983711|NCT00381706|2383497|P2|COMPLETED|Overall Study||81
983712|NCT00381706|2383498|P1|COMPLETED|Overall Study||75
983713|NCT00381706|2383496|P3|STARTED|Overall Study||80
983714|NCT00381706|2383497|P2|STARTED|Overall Study||83
983715|NCT00381706|2383498|P1|STARTED|Overall Study||82
983716|NCT00387127|2383523|P2|NOT COMPLETED|Overall Study||34
983717|NCT00387127|2383524|P1|NOT COMPLETED|Overall Study||33
983718|NCT00387127|2383523|P2|COMPLETED|Overall Study||0
983719|NCT00387127|2383524|P1|COMPLETED|Overall Study||0
983720|NCT00387127|2383523|P2|STARTED|Overall Study||34
983721|NCT00387127|2383524|P1|STARTED|Overall Study||33
983722|NCT00387153|2383564|P1|NOT COMPLETED|Overall Study||8
983723|NCT00387153|2383564|P1|COMPLETED|Overall Study||0
983724|NCT00387153|2383564|P1|STARTED|Overall Study||8
983725|NCT00387335|2383570|P2|NOT COMPLETED|Overall Study||0
983726|NCT00387335|2383571|P1|NOT COMPLETED|Overall Study||0
983727|NCT00387335|2383570|P2|COMPLETED|Overall Study||7
983728|NCT00387335|2383571|P1|COMPLETED|Overall Study||15
983729|NCT00387335|2383570|P2|STARTED|Overall Study||7
983730|NCT00387335|2383571|P1|STARTED|Overall Study||15
983731|NCT00387348|2383586|P3|NOT COMPLETED|Overall Study||4
983732|NCT00387348|2383587|P2|NOT COMPLETED|Overall Study||3
983733|NCT00387348|2383588|P1|NOT COMPLETED|Overall Study||3
983734|NCT00387348|2383586|P3|COMPLETED|Overall Study||7
983735|NCT00387348|2383587|P2|COMPLETED|Overall Study||2
983736|NCT00387348|2383588|P1|COMPLETED|Overall Study||5
983737|NCT00387348|2383586|P3|STARTED|Overall Study||11
983738|NCT00387348|2383587|P2|STARTED|Overall Study||5
983739|NCT00387348|2383588|P1|STARTED|Overall Study||8
983740|NCT00387426|2383602|P1|NOT COMPLETED|Overall Study||14
983741|NCT00387426|2383602|P1|COMPLETED|Overall Study||0
983742|NCT00387426|2383602|P1|STARTED|Overall Study||14
983743|NCT00387621|2383609|P2|NOT COMPLETED|Second Intervention||0
983744|NCT00387621|2383610|P1|NOT COMPLETED|Second Intervention||0
983745|NCT00387621|2383609|P2|COMPLETED|Second Intervention||29
983746|NCT00387621|2383610|P1|COMPLETED|Second Intervention||29
983747|NCT00387621|2383609|P2|STARTED|Second Intervention||29
983748|NCT00387621|2383610|P1|STARTED|Second Intervention||29
983749|NCT00387621|2383609|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
983750|NCT00387621|2383610|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
983751|NCT00387621|2383609|P2|COMPLETED|Washout Period of 2 Weeks||29
983752|NCT00387621|2383610|P1|COMPLETED|Washout Period of 2 Weeks||29
983753|NCT00387621|2383609|P2|STARTED|Washout Period of 2 Weeks||29
983754|NCT00387621|2383610|P1|STARTED|Washout Period of 2 Weeks||29
983755|NCT00387621|2383609|P2|NOT COMPLETED|First Intervention||0
983756|NCT00387621|2383610|P1|NOT COMPLETED|First Intervention||0
983757|NCT00387621|2383609|P2|COMPLETED|First Intervention||29
983758|NCT00387621|2383610|P1|COMPLETED|First Intervention||29
983759|NCT00387621|2383609|P2|STARTED|First Intervention||29
983760|NCT00387621|2383610|P1|STARTED|First Intervention||29
983761|NCT00387647|2383640|P1|NOT COMPLETED|Overall Study||18
983762|NCT00387647|2383640|P1|COMPLETED|Overall Study||6
983763|NCT00387647|2383640|P1|STARTED|Overall Study||24
983764|NCT00387660|2383648|P2|NOT COMPLETED|Overall Study||0
983765|NCT00387660|2383649|P1|NOT COMPLETED|Overall Study||0
983766|NCT00387660|2383648|P2|COMPLETED|Overall Study||40
983767|NCT00387660|2383649|P1|COMPLETED|Overall Study||40
983768|NCT00387660|2383648|P2|STARTED|Overall Study||40
983769|NCT00387660|2383649|P1|STARTED|Overall Study||40
983770|NCT00387673|2383659|P3|NOT COMPLETED|Overall Study||0
983771|NCT00387673|2383660|P2|NOT COMPLETED|Overall Study||0
983772|NCT00387673|2383661|P1|NOT COMPLETED|Overall Study||0
983773|NCT00387673|2383659|P3|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
983774|NCT00387673|2383660|P2|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
983775|NCT00387673|2383661|P1|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
983776|NCT00387673|2383659|P3|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
983777|NCT00387673|2383660|P2|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
983778|NCT00387673|2383661|P1|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
983779|NCT00387712|2383669|P2|NOT COMPLETED|Overall Study||36
983780|NCT00387712|2383670|P1|NOT COMPLETED|Overall Study||29
983781|NCT00387712|2383669|P2|COMPLETED|Overall Study||16
983782|NCT00387712|2383670|P1|COMPLETED|Overall Study||18
983783|NCT00387712|2383669|P2|STARTED|Overall Study||52
983784|NCT00387712|2383670|P1|STARTED|Overall Study||47
983785|NCT00387725|2383684|P4|NOT COMPLETED|Overall Study||2
983786|NCT00387725|2383685|P3|NOT COMPLETED|Overall Study||2
983787|NCT00387725|2383686|P2|NOT COMPLETED|Overall Study||1
983788|NCT00387725|2383687|P1|NOT COMPLETED|Overall Study||1
983789|NCT00387725|2383684|P4|COMPLETED|Overall Study||43
983790|NCT00387725|2383685|P3|COMPLETED|Overall Study||43
983791|NCT00387725|2383686|P2|COMPLETED|Overall Study||15
983792|NCT00387725|2383687|P1|COMPLETED|Overall Study||20
983793|NCT00387725|2383684|P4|STARTED|Overall Study||45
983794|NCT00387725|2383685|P3|STARTED|Overall Study||45
983795|NCT00387725|2383686|P2|STARTED|Overall Study||16
983796|NCT00387725|2383687|P1|STARTED|Overall Study||21
983797|NCT00387751|2383705|P1|NOT COMPLETED|Overall Study||0
983798|NCT00387751|2383705|P1|COMPLETED|Overall Study||14
983799|NCT00387751|2383705|P1|STARTED|Overall Study||14
983800|NCT00387764|2383709|P1|NOT COMPLETED|Overall Study||31
983801|NCT00387764|2383709|P1|COMPLETED|Overall Study|Participants completed treatment (until disease progression), but may not have completed the study.|49
983802|NCT00387764|2383709|P1|STARTED|Overall Study||80
983803|NCT00387790|2383727|P1|NOT COMPLETED|Overall Study||14
983804|NCT00387790|2383727|P1|COMPLETED|Overall Study||50
983805|NCT00387790|2383727|P1|STARTED|Overall Study||64
983806|NCT00387829|2383733|P2|NOT COMPLETED|Intent-to-treat Population||30
983807|NCT00387829|2383734|P1|NOT COMPLETED|Intent-to-treat Population||38
983808|NCT00387829|2383733|P2|COMPLETED|Intent-to-treat Population||136
983809|NCT00387829|2383734|P1|COMPLETED|Intent-to-treat Population||139
983810|NCT00387829|2383733|P2|STARTED|Intent-to-treat Population||166
983811|NCT00387829|2383734|P1|STARTED|Intent-to-treat Population||177
983812|NCT00387829|2383733|P2|NOT COMPLETED|Safety Population||33
983813|NCT00387829|2383734|P1|NOT COMPLETED|Safety Population||39
983814|NCT00387829|2383733|P2|COMPLETED|Safety Population||136
983815|NCT00387829|2383734|P1|COMPLETED|Safety Population||139
983816|NCT00387829|2383733|P2|STARTED|Safety Population||169
983817|NCT00387829|2383734|P1|STARTED|Safety Population||178
983818|NCT00387881|2383744|P2|NOT COMPLETED|Overall Study||102
983819|NCT00387881|2383745|P1|NOT COMPLETED|Overall Study||89
983820|NCT00387881|2383744|P2|COMPLETED|Overall Study||243
983821|NCT00387881|2383745|P1|COMPLETED|Overall Study||245
983822|NCT00387881|2383744|P2|STARTED|Overall Study||345
983823|NCT00387881|2383745|P1|STARTED|Overall Study||334
983824|NCT00387894|2383767|P1|NOT COMPLETED|Overall Study||1
983825|NCT00387894|2383767|P1|COMPLETED|Overall Study||5
983826|NCT00387894|2383767|P1|STARTED|Overall Study||6
983827|NCT00387959|2383772|P1|NOT COMPLETED|Overall Study||1
983828|NCT00387959|2383772|P1|COMPLETED|Overall Study||16
983829|NCT00387959|2383772|P1|STARTED|Overall Study||17
983830|NCT00388037|2383776|P1|NOT COMPLETED|Overall Study||1
983831|NCT00388037|2383776|P1|COMPLETED|Overall Study||30
983832|NCT00388037|2383776|P1|STARTED|Overall Study||31
983833|NCT00388154|2383780|P1|NOT COMPLETED|Overall Study||1
983834|NCT00388154|2383780|P1|COMPLETED|Overall Study||20
983835|NCT00388154|2383780|P1|STARTED|Overall Study||21
983836|NCT00388349|2383785|P2|NOT COMPLETED|Phase 2 Dose Expansion||0
983837|NCT00388349|2383786|P1|NOT COMPLETED|Phase 2 Dose Expansion||0
983838|NCT00388349|2383785|P2|COMPLETED|Phase 2 Dose Expansion||0
983839|NCT00388349|2383786|P1|COMPLETED|Phase 2 Dose Expansion||139
983840|NCT00388349|2383785|P2|STARTED|Phase 2 Dose Expansion|No participants were treated in Phase 2 at 1500 mg/m2 gemcitabine (MTD exceeded)|0
983841|NCT00388349|2383786|P1|STARTED|Phase 2 Dose Expansion|Includes the three phase 1 participants who received 1250 mg/m2 gemcitabine (MTD)|139
983842|NCT00388349|2383785|P2|NOT COMPLETED|Phase I Dose Escalation||3
983843|NCT00388349|2383786|P1|NOT COMPLETED|Phase I Dose Escalation||0
983844|NCT00388349|2383785|P2|COMPLETED|Phase I Dose Escalation||1
983845|NCT00388349|2383786|P1|COMPLETED|Phase I Dose Escalation||3
983846|NCT00388349|2383785|P2|STARTED|Phase I Dose Escalation||4
983847|NCT00388349|2383786|P1|STARTED|Phase I Dose Escalation||3
983848|NCT00388362|2383795|P1|NOT COMPLETED|Remained on Study Median of 514 Days||2
983849|NCT00388362|2383795|P1|COMPLETED|Remained on Study Median of 514 Days||21
983850|NCT00388362|2383795|P1|STARTED|Remained on Study Median of 514 Days||23
983851|NCT00388362|2383795|P1|NOT COMPLETED|Enrolled||13
983852|NCT00388362|2383795|P1|COMPLETED|Enrolled||23
983853|NCT00388362|2383795|P1|STARTED|Enrolled||36
983854|NCT00388453|2383803|P3|NOT COMPLETED|Overall Study||0
983855|NCT00388453|2383804|P2|NOT COMPLETED|Overall Study||0
983856|NCT00388453|2383805|P1|NOT COMPLETED|Overall Study||0
983857|NCT00388453|2383803|P3|COMPLETED|Overall Study||10
983858|NCT00388453|2383804|P2|COMPLETED|Overall Study||17
983859|NCT00388453|2383805|P1|COMPLETED|Overall Study||20
983860|NCT00388453|2383803|P3|STARTED|Overall Study||10
983861|NCT00388453|2383804|P2|STARTED|Overall Study||17
983862|NCT00388453|2383805|P1|STARTED|Overall Study||20
983863|NCT00388505|2383824|P2|NOT COMPLETED|Overall Study||38
983864|NCT00388505|2383825|P1|NOT COMPLETED|Overall Study||83
983865|NCT00388505|2383824|P2|COMPLETED|Overall Study||171
983866|NCT00388505|2383825|P1|COMPLETED|Overall Study||225
983867|NCT00388505|2383824|P2|STARTED|Overall Study|Randomized patients who received any amount of study medication|209
983868|NCT00388505|2383825|P1|STARTED|Overall Study|Randomized patients who received any amount of study medication|308
983869|NCT00388583|2383849|P2|NOT COMPLETED|Overall Study||4
983870|NCT00388583|2383850|P1|NOT COMPLETED|Overall Study||6
983871|NCT00388583|2383849|P2|COMPLETED|Overall Study||406
983872|NCT00388583|2383850|P1|COMPLETED|Overall Study||401
983873|NCT00388583|2383849|P2|STARTED|Overall Study||410
983874|NCT00388583|2383850|P1|STARTED|Overall Study||407
983875|NCT00388726|2383864|P2|NOT COMPLETED|Overall Study||244
983876|NCT00388726|2383865|P1|NOT COMPLETED|Overall Study||484
983877|NCT00388726|2383864|P2|COMPLETED|Overall Study||10
983878|NCT00388726|2383865|P1|COMPLETED|Overall Study||24
983879|NCT00388726|2383864|P2|STARTED|Overall Study||254
983880|NCT00388726|2383865|P1|STARTED|Overall Study||508
983881|NCT00388804|2383879|P2|NOT COMPLETED|Overall Study||0
983882|NCT00388804|2383880|P1|NOT COMPLETED|Overall Study||0
983883|NCT00388804|2383879|P2|COMPLETED|Overall Study||21
983884|NCT00388804|2383880|P1|COMPLETED|Overall Study||17
983885|NCT00388804|2383879|P2|STARTED|Overall Study||21
983886|NCT00388804|2383880|P1|STARTED|Overall Study||17
983887|NCT00394888|2383889|P3|NOT COMPLETED|Overall Study||0
983888|NCT00394888|2383890|P2|NOT COMPLETED|Overall Study||0
983889|NCT00394888|2383891|P1|NOT COMPLETED|Overall Study||0
983890|NCT00394888|2383889|P3|COMPLETED|Overall Study||201
983891|NCT00394888|2383890|P2|COMPLETED|Overall Study||48
983892|NCT00394888|2383891|P1|COMPLETED|Overall Study||108
983893|NCT00394888|2383889|P3|STARTED|Overall Study||201
983894|NCT00394888|2383890|P2|STARTED|Overall Study||48
983895|NCT00394888|2383891|P1|STARTED|Overall Study||108
983896|NCT00394901|2383906|P4|NOT COMPLETED|Double-blind Phase||27
983897|NCT00394901|2383907|P3|NOT COMPLETED|Double-blind Phase||18
983898|NCT00394901|2383908|P2|NOT COMPLETED|Double-blind Phase||14
983899|NCT00394901|2383909|P1|NOT COMPLETED|Double-blind Phase||15
983900|NCT00394901|2383906|P4|COMPLETED|Double-blind Phase||70
983901|NCT00394901|2383907|P3|COMPLETED|Double-blind Phase||71
983902|NCT00394901|2383908|P2|COMPLETED|Double-blind Phase||73
983903|NCT00394901|2383909|P1|COMPLETED|Double-blind Phase||83
983904|NCT00394901|2383906|P4|STARTED|Double-blind Phase|Subjects treated with the study drug.|97
983905|NCT00394901|2383907|P3|STARTED|Double-blind Phase|Subjects treated with the study drug.|89
983906|NCT00394901|2383908|P2|STARTED|Double-blind Phase|Subjects treated with the study drug.|87
983907|NCT00394901|2383909|P1|STARTED|Double-blind Phase|Subjects treated with the study drug.|98
983908|NCT00394901|2383906|P4|NOT COMPLETED|Baseline Phase||0
983909|NCT00394901|2383907|P3|NOT COMPLETED|Baseline Phase||1
983910|NCT00394901|2383908|P2|NOT COMPLETED|Baseline Phase||0
983911|NCT00394901|2383909|P1|NOT COMPLETED|Baseline Phase||0
983912|NCT00394901|2383906|P4|COMPLETED|Baseline Phase||97
983913|NCT00394901|2383907|P3|COMPLETED|Baseline Phase||89
983914|NCT00394901|2383908|P2|COMPLETED|Baseline Phase||87
983915|NCT00394901|2383909|P1|COMPLETED|Baseline Phase||98
983916|NCT00394901|2383906|P4|STARTED|Baseline Phase|Subjects randomized|97
983917|NCT00394901|2383907|P3|STARTED|Baseline Phase|Subjects randomized|90
983918|NCT00394901|2383908|P2|STARTED|Baseline Phase|Subjects randomized|87
983919|NCT00394901|2383909|P1|STARTED|Baseline Phase|Subjects randomized|98
983920|NCT00394914|2384136|P3|NOT COMPLETED|Treatment Period||6
983921|NCT00394914|2384137|P2|NOT COMPLETED|Treatment Period||10
983922|NCT00394914|2384138|P1|NOT COMPLETED|Treatment Period||0
983923|NCT00394914|2384136|P3|COMPLETED|Treatment Period||151
983924|NCT00394914|2384137|P2|COMPLETED|Treatment Period||144
983925|NCT00394914|2384138|P1|COMPLETED|Treatment Period||0
983926|NCT00394914|2384136|P3|STARTED|Treatment Period||157
983927|NCT00394914|2384137|P2|STARTED|Treatment Period||154
983928|NCT00394914|2384138|P1|STARTED|Treatment Period||0
983929|NCT00394914|2384136|P3|NOT COMPLETED|Pre-exposure Period||0
983930|NCT00394914|2384137|P2|NOT COMPLETED|Pre-exposure Period||0
983931|NCT00394914|2384138|P1|NOT COMPLETED|Pre-exposure Period||0
983932|NCT00394914|2384136|P3|COMPLETED|Pre-exposure Period||0
983933|NCT00394914|2384137|P2|COMPLETED|Pre-exposure Period||0
983934|NCT00394914|2384138|P1|COMPLETED|Pre-exposure Period||311
983935|NCT00394914|2384136|P3|STARTED|Pre-exposure Period||0
983936|NCT00394914|2384137|P2|STARTED|Pre-exposure Period||0
983937|NCT00394914|2384138|P1|STARTED|Pre-exposure Period||311
983938|NCT00394914|2384136|P3|NOT COMPLETED|Screening Period||0
983939|NCT00394914|2384137|P2|NOT COMPLETED|Screening Period||0
983940|NCT00394914|2384138|P1|NOT COMPLETED|Screening Period||0
983941|NCT00394914|2384136|P3|COMPLETED|Screening Period||0
983942|NCT00394914|2384137|P2|COMPLETED|Screening Period||0
983943|NCT00394914|2384138|P1|COMPLETED|Screening Period||311
983944|NCT00394914|2384136|P3|STARTED|Screening Period||0
983945|NCT00394914|2384137|P2|STARTED|Screening Period||0
983946|NCT00394914|2384138|P1|STARTED|Screening Period||311
983947|NCT00394953|2384164|P2|NOT COMPLETED|Second Treatment Period||74
983948|NCT00394953|2384165|P1|NOT COMPLETED|Second Treatment Period||29
983949|NCT00394953|2384164|P2|COMPLETED|Second Treatment Period||148
983950|NCT00394953|2384165|P1|COMPLETED|Second Treatment Period||187
983951|NCT00394953|2384164|P2|STARTED|Second Treatment Period||222
983952|NCT00394953|2384165|P1|STARTED|Second Treatment Period||216
983953|NCT00394953|2384164|P2|NOT COMPLETED|First Treatment Period||22
983954|NCT00394953|2384165|P1|NOT COMPLETED|First Treatment Period||29
983955|NCT00394953|2384164|P2|COMPLETED|First Treatment Period||222
983956|NCT00394953|2384165|P1|COMPLETED|First Treatment Period||216
983957|NCT00394953|2384164|P2|STARTED|First Treatment Period||244
983958|NCT00394953|2384165|P1|STARTED|First Treatment Period||245
983959|NCT00395018|2384181|P1|NOT COMPLETED|Off-Treatment Follow-up||4
983960|NCT00395018|2384181|P1|COMPLETED|Off-Treatment Follow-up|"Completed means completed the study"|1
983961|NCT00395018|2384181|P1|STARTED|Off-Treatment Follow-up|Treated participants who discontinued =<72 weeks and did not start other anti-HBV therapy|5
983962|NCT00395018|2384181|P1|NOT COMPLETED|On-Treatment||10
983963|NCT00395018|2384181|P1|COMPLETED|On-Treatment|"Completed means received treatment through Week 72"|55
983964|NCT00395018|2384181|P1|DISCONTINUED AT OR AFTER WEEK 72 VISIT|On-Treatment||0
983965|NCT00395018|2384181|P1|DISCONTINUED PRIOR TO WEEK 72 VISIT|On-Treatment||10
983966|NCT00395018|2384181|P1|STARTED|On-Treatment|Started = treated (participants who received at least 1 dose of study therapy)|65
983967|NCT00395044|2384202|P2|NOT COMPLETED|Overall Study||14
983968|NCT00395044|2384203|P1|NOT COMPLETED|Overall Study||18
983969|NCT00395044|2384202|P2|COMPLETED|Overall Study||11
983970|NCT00395044|2384203|P1|COMPLETED|Overall Study||7
983971|NCT00395044|2384202|P2|STARTED|Overall Study||25
983972|NCT00395044|2384203|P1|STARTED|Overall Study||25
983973|NCT00395057|2384225|P4|NOT COMPLETED|Overall Study||33
983974|NCT00395057|2384226|P3|NOT COMPLETED|Overall Study||33
983975|NCT00395057|2384227|P2|NOT COMPLETED|Overall Study||34
983976|NCT00395057|2384228|P1|NOT COMPLETED|Overall Study||32
983977|NCT00395057|2384225|P4|COMPLETED|Overall Study||1
983978|NCT00395057|2384226|P3|COMPLETED|Overall Study||2
983979|NCT00395057|2384227|P2|COMPLETED|Overall Study||1
983980|NCT00395057|2384228|P1|COMPLETED|Overall Study||2
983981|NCT00395057|2384225|P4|STARTED|Overall Study||34
983982|NCT00395057|2384226|P3|STARTED|Overall Study||35
983983|NCT00395057|2384227|P2|STARTED|Overall Study||35
983984|NCT00395057|2384228|P1|STARTED|Overall Study||34
983985|NCT00395083|2384256|P2|NOT COMPLETED|Overall Study||8
983986|NCT00395083|2384257|P1|NOT COMPLETED|Overall Study||10
983987|NCT00395083|2384256|P2|COMPLETED|Overall Study||201
983988|NCT00395083|2384257|P1|COMPLETED|Overall Study||207
983989|NCT00395083|2384256|P2|STARTED|Overall Study||209
983990|NCT00395083|2384257|P1|STARTED|Overall Study||217
984021|NCT00395161|2384293|P2|NOT COMPLETED|Overall Study||0
984022|NCT00395161|2384294|P1|NOT COMPLETED|Overall Study||0
984023|NCT00395161|2384293|P2|COMPLETED|Overall Study||144
984024|NCT00395161|2384294|P1|COMPLETED|Overall Study||149
984025|NCT00395161|2384293|P2|STARTED|Overall Study||144
984026|NCT00395161|2384294|P1|STARTED|Overall Study||149
984027|NCT00396084|2384314|P6|NOT COMPLETED|Overall Study||2
984028|NCT00396084|2384315|P5|NOT COMPLETED|Overall Study||1
984029|NCT00396084|2384316|P4|NOT COMPLETED|Overall Study||1
984030|NCT00396084|2384317|P3|NOT COMPLETED|Overall Study||0
984031|NCT00396084|2384318|P2|NOT COMPLETED|Overall Study||0
984032|NCT00396084|2384319|P1|NOT COMPLETED|Overall Study||0
984033|NCT00396084|2384314|P6|COMPLETED|Overall Study||18
984034|NCT00396084|2384315|P5|COMPLETED|Overall Study||9
984035|NCT00396084|2384316|P4|COMPLETED|Overall Study||9
984036|NCT00396084|2384317|P3|COMPLETED|Overall Study||10
984037|NCT00396084|2384318|P2|COMPLETED|Overall Study||10
984038|NCT00396084|2384319|P1|COMPLETED|Overall Study||10
984039|NCT00396084|2384314|P6|STARTED|Overall Study||20
984040|NCT00396084|2384315|P5|STARTED|Overall Study||10
984041|NCT00396084|2384316|P4|STARTED|Overall Study||10
984042|NCT00396084|2384317|P3|STARTED|Overall Study||10
984043|NCT00396084|2384318|P2|STARTED|Overall Study||10
984044|NCT00396084|2384319|P1|STARTED|Overall Study||10
984045|NCT00396097|2384394|P2|NOT COMPLETED|Overall Study||46
984046|NCT00396097|2384395|P1|NOT COMPLETED|Overall Study||26
984047|NCT00396097|2384394|P2|COMPLETED|Overall Study||156
984048|NCT00396097|2384395|P1|COMPLETED|Overall Study||88
984049|NCT00396097|2384394|P2|STARTED|Overall Study||202
984050|NCT00396097|2384395|P1|STARTED|Overall Study|4 participants randomized to Individualized Dose, received Standard Dose throughout the study.|114
984051|NCT00396136|2384417|P1|NOT COMPLETED|Overall Study||125
984052|NCT00396136|2384417|P1|COMPLETED|Overall Study||96
984053|NCT00396136|2384417|P1|STARTED|Overall Study||221
984054|NCT00396162|2384424|P2|NOT COMPLETED|Overall Study||3
984055|NCT00396162|2384425|P1|NOT COMPLETED|Overall Study||2
984056|NCT00396162|2384424|P2|COMPLETED|Overall Study||35
984057|NCT00396162|2384425|P1|COMPLETED|Overall Study||37
984058|NCT00396162|2384424|P2|STARTED|Overall Study||38
984059|NCT00396162|2384425|P1|STARTED|Overall Study||39
984060|NCT00396201|2384437|P1|NOT COMPLETED|Follow-up Period||0
984061|NCT00396201|2384437|P1|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|21
984062|NCT00396201|2384437|P1|STARTED|Follow-up Period|Participants who had transplants. One had insufficient collection of cells so no transplant.|21
984063|NCT00396201|2384437|P1|NOT COMPLETED|Treatment Period||0
984064|NCT00396201|2384437|P1|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|22
984065|NCT00396201|2384437|P1|STARTED|Treatment Period||22
984066|NCT00396253|2384454|P1|NOT COMPLETED|Overall Study||13
984067|NCT00396253|2384454|P1|COMPLETED|Overall Study||210
984068|NCT00396253|2384454|P1|STARTED|Overall Study||223
984069|NCT00396266|2384468|P2|NOT COMPLETED|Overall Study||0
984070|NCT00396266|2384469|P1|NOT COMPLETED|Overall Study||0
984071|NCT00396266|2384468|P2|COMPLETED|Overall Study||14
984072|NCT00396266|2384469|P1|COMPLETED|Overall Study||8
984073|NCT00396266|2384468|P2|STARTED|Overall Study||14
984074|NCT00396266|2384469|P1|STARTED|Overall Study||8
984075|NCT00396279|2384490|P1|NOT COMPLETED|Overall Study||30
984076|NCT00396279|2384490|P1|COMPLETED|Overall Study|Defined as participants with a complete resection|7
984077|NCT00396279|2384490|P1|STARTED|Overall Study||37
984078|NCT00396292|2384501|P2|NOT COMPLETED|Overall Study||16
984079|NCT00396292|2384502|P1|NOT COMPLETED|Overall Study||9
984080|NCT00396292|2384501|P2|COMPLETED|Overall Study||162
984081|NCT00396292|2384502|P1|COMPLETED|Overall Study||165
984082|NCT00396292|2384501|P2|STARTED|Overall Study||178
984083|NCT00396292|2384502|P1|STARTED|Overall Study||174
984084|NCT00396318|2384508|P1|NOT COMPLETED|7-Day Post-Treatment Contact||1
984085|NCT00396318|2384508|P1|COMPLETED|7-Day Post-Treatment Contact||240
984086|NCT00396318|2384508|P1|STARTED|7-Day Post-Treatment Contact||241
984087|NCT00396318|2384508|P1|NOT COMPLETED|48- to 96-Hour Follow-Up Period||5
984088|NCT00396318|2384508|P1|COMPLETED|48- to 96-Hour Follow-Up Period||241
984089|NCT00396318|2384508|P1|STARTED|48- to 96-Hour Follow-Up Period||246
984090|NCT00396318|2384508|P1|NOT COMPLETED|At Least One Dose of Tenecteplase (MITT)||5
984091|NCT00396318|2384508|P1|COMPLETED|At Least One Dose of Tenecteplase (MITT)||241
984092|NCT00396318|2384508|P1|STARTED|At Least One Dose of Tenecteplase (MITT)||246
984093|NCT00396331|2384523|P1|NOT COMPLETED|Overall Study||32
984094|NCT00396331|2384523|P1|COMPLETED|Overall Study||68
984095|NCT00396331|2384523|P1|Number of Participants Transplanted|Overall Study|7 participants had two transplants|87
984096|NCT00396331|2384523|P1|Number of Participants Treated|Overall Study||100
984097|NCT00396331|2384523|P1|STARTED|Overall Study||100
984098|NCT00396383|2384576|P1|NOT COMPLETED|Overall Study||3
984099|NCT00396383|2384576|P1|COMPLETED|Overall Study||6
984100|NCT00396383|2384576|P1|STARTED|Overall Study||9
984101|NCT00396409|2384587|P2|NOT COMPLETED|Period 2 - 2008||2
984102|NCT00396409|2384588|P1|NOT COMPLETED|Period 2 - 2008||7
984103|NCT00396409|2384587|P2|COMPLETED|Period 2 - 2008||53
984104|NCT00396409|2384588|P1|COMPLETED|Period 2 - 2008||52
984105|NCT00396409|2384587|P2|STARTED|Period 2 - 2008||55
984106|NCT00396409|2384588|P1|STARTED|Period 2 - 2008||59
984107|NCT00396409|2384587|P2|NOT COMPLETED|Between Period 1 and Period 2||2
984108|NCT00396409|2384588|P1|NOT COMPLETED|Between Period 1 and Period 2||3
984109|NCT00396409|2384587|P2|COMPLETED|Between Period 1 and Period 2||55
984110|NCT00396409|2384588|P1|COMPLETED|Between Period 1 and Period 2||59
984111|NCT00396409|2384587|P2|STARTED|Between Period 1 and Period 2||57
984112|NCT00396409|2384588|P1|STARTED|Between Period 1 and Period 2||62
984113|NCT00396409|2384587|P2|NOT COMPLETED|Period 1 - 2007||6
984114|NCT00396409|2384588|P1|NOT COMPLETED|Period 1 - 2007||3
984115|NCT00396409|2384587|P2|COMPLETED|Period 1 - 2007||57
984116|NCT00396409|2384588|P1|COMPLETED|Period 1 - 2007||62
984117|NCT00396409|2384587|P2|STARTED|Period 1 - 2007||63
984118|NCT00396409|2384588|P1|STARTED|Period 1 - 2007||65
984119|NCT00396565|2384621|P3|NOT COMPLETED|Overall Study||17
984120|NCT00396565|2384622|P2|NOT COMPLETED|Overall Study||91
984121|NCT00396565|2384623|P1|NOT COMPLETED|Overall Study||48
984122|NCT00396565|2384621|P3|COMPLETED|Overall Study||30
984123|NCT00396565|2384622|P2|COMPLETED|Overall Study||47
984124|NCT00396565|2384623|P1|COMPLETED|Overall Study||88
984125|NCT00396565|2384621|P3|STARTED|Overall Study||47
984126|NCT00396565|2384622|P2|STARTED|Overall Study||138
984127|NCT00396565|2384623|P1|STARTED|Overall Study||136
984128|NCT00396591|2384646|P1|NOT COMPLETED|Overall Study||16
984129|NCT00396591|2384646|P1|COMPLETED|Overall Study||0
984130|NCT00396591|2384646|P1|STARTED|Overall Study||16
984131|NCT00396630|2384658|P2|NOT COMPLETED|Overall Study||5
984132|NCT00396630|2384659|P1|NOT COMPLETED|Overall Study||5
984133|NCT00396630|2384658|P2|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
984134|NCT00396630|2384659|P1|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
984135|NCT00396630|2384658|P2|STARTED|Overall Study||100
984136|NCT00396630|2384659|P1|STARTED|Overall Study||100
984137|NCT00396656|2384676|P2|NOT COMPLETED|Second Treatment Period||1
984138|NCT00396656|2384677|P1|NOT COMPLETED|Second Treatment Period||0
984139|NCT00396656|2384676|P2|COMPLETED|Second Treatment Period||12
984140|NCT00396656|2384677|P1|COMPLETED|Second Treatment Period||15
984141|NCT00396656|2384676|P2|STARTED|Second Treatment Period||13
984142|NCT00396656|2384677|P1|STARTED|Second Treatment Period||15
984143|NCT00396656|2384676|P2|NOT COMPLETED|First Treatment Period||2
984144|NCT00396656|2384677|P1|NOT COMPLETED|First Treatment Period||0
984145|NCT00396656|2384676|P2|COMPLETED|First Treatment Period||13
984146|NCT00396656|2384677|P1|COMPLETED|First Treatment Period||15
984147|NCT00396656|2384676|P2|STARTED|First Treatment Period||15
984148|NCT00396656|2384677|P1|STARTED|First Treatment Period||15
984149|NCT00396812|2384693|P1|NOT COMPLETED|Overall Study||1
984150|NCT00396812|2384693|P1|COMPLETED|Overall Study|4 subjects completed treatment, but 1 subject terminated early due to disease progression|3
984151|NCT00396812|2384693|P1|STARTED|Overall Study||4
984152|NCT00396877|2384707|P2|NOT COMPLETED|Overall Study||8
984153|NCT00396877|2384708|P1|NOT COMPLETED|Overall Study||6
984154|NCT00396877|2384707|P2|COMPLETED|Overall Study|Completed follow-up|459
984155|NCT00396877|2384708|P1|COMPLETED|Overall Study|Completed follow-up|433
984156|NCT00396877|2384707|P2|Completed Treatment|Overall Study||352
984157|NCT00396877|2384708|P1|Completed Treatment|Overall Study||356
984158|NCT00396877|2384707|P2|Treated|Overall Study||464
984159|NCT00396877|2384708|P1|Treated|Overall Study||436
984160|NCT00396877|2384707|P2|STARTED|Overall Study|Randomized|467
984161|NCT00396877|2384708|P1|STARTED|Overall Study|Randomized|439
984162|NCT00396981|2384720|P2|NOT COMPLETED|Overall Study||9
984163|NCT00396981|2384721|P1|NOT COMPLETED|Overall Study||15
984164|NCT00396981|2384720|P2|COMPLETED|Overall Study||306
984165|NCT00396981|2384721|P1|COMPLETED|Overall Study||296
984166|NCT00396981|2384720|P2|STARTED|Overall Study||315
984167|NCT00396981|2384721|P1|STARTED|Overall Study||311
984168|NCT00397033|2384742|P3|NOT COMPLETED|Overall Study||23
984169|NCT00397033|2384743|P2|NOT COMPLETED|Overall Study||37
984170|NCT00397033|2384744|P1|NOT COMPLETED|Overall Study||44
984171|NCT00397033|2384742|P3|COMPLETED|Overall Study||77
984172|NCT00397033|2384743|P2|COMPLETED|Overall Study||72
984173|NCT00397033|2384744|P1|COMPLETED|Overall Study||63
984174|NCT00397033|2384742|P3|ITT Population|Overall Study||98
984175|NCT00397033|2384743|P2|ITT Population|Overall Study||105
984176|NCT00397033|2384744|P1|ITT Population|Overall Study||107
984177|NCT00397033|2384742|P3|Safety Population: >= 1 Dose of Drug|Overall Study||98
984178|NCT00397033|2384743|P2|Safety Population: >= 1 Dose of Drug|Overall Study||108
984179|NCT00397033|2384744|P1|Safety Population: >= 1 Dose of Drug|Overall Study||107
984180|NCT00397033|2384742|P3|STARTED|Overall Study||100
984181|NCT00397033|2384743|P2|STARTED|Overall Study||109
984182|NCT00397033|2384744|P1|STARTED|Overall Study||107
984183|NCT00397150|2384805|P2|NOT COMPLETED|Overall Study||145
984184|NCT00397150|2384806|P1|NOT COMPLETED|Overall Study||135
984185|NCT00397150|2384805|P2|COMPLETED|Overall Study||1111
984186|NCT00397150|2384806|P1|COMPLETED|Overall Study||1188
984187|NCT00397150|2384805|P2|STARTED|Overall Study||1256
984188|NCT00397150|2384806|P1|STARTED|Overall Study||1323
984189|NCT00397189|2384820|P2|NOT COMPLETED|Extension Period||43
984190|NCT00397189|2384821|P1|NOT COMPLETED|Extension Period||113
984191|NCT00397189|2384820|P2|COMPLETED|Extension Period||134
984192|NCT00397189|2384821|P1|COMPLETED|Extension Period||421
984193|NCT00397189|2384820|P2|STARTED|Extension Period|Please note randomization ratio in extension is 3:1|177
984194|NCT00397189|2384821|P1|STARTED|Extension Period|Not all completers continued to extension as only patients who wished to proceed were randomized.|534
984195|NCT00397189|2384820|P2|NOT COMPLETED|3 Weeks Period||22
984196|NCT00397189|2384821|P1|NOT COMPLETED|3 Weeks Period||21
984197|NCT00397189|2384820|P2|COMPLETED|3 Weeks Period|out of 373, 362 were included in the ITT population detailed in the Baseline Characteristics|373
984198|NCT00397189|2384821|P1|COMPLETED|3 Weeks Period|out of 373, 360 were included in the ITT population detailed in the Baseline Characteristics.|373
984199|NCT00397189|2384820|P2|STARTED|3 Weeks Period||395
984200|NCT00397189|2384821|P1|STARTED|3 Weeks Period||394
984201|NCT00397215|2384831|P4|NOT COMPLETED|Month 24 (Day 720)||0
984202|NCT00397215|2384832|P3|NOT COMPLETED|Month 24 (Day 720)||0
984203|NCT00397215|2384833|P2|NOT COMPLETED|Month 24 (Day 720)||0
984204|NCT00397215|2384834|P1|NOT COMPLETED|Month 24 (Day 720)||0
984205|NCT00397215|2384831|P4|COMPLETED|Month 24 (Day 720)||36
984206|NCT00397215|2384832|P3|COMPLETED|Month 24 (Day 720)||117
984207|NCT00397215|2384833|P2|COMPLETED|Month 24 (Day 720)||45
984208|NCT00397215|2384834|P1|COMPLETED|Month 24 (Day 720)||122
984209|NCT00397215|2384831|P4|STARTED|Month 24 (Day 720)||36
984210|NCT00397215|2384832|P3|STARTED|Month 24 (Day 720)||117
984211|NCT00397215|2384833|P2|STARTED|Month 24 (Day 720)||45
984212|NCT00397215|2384834|P1|STARTED|Month 24 (Day 720)||122
984213|NCT00397215|2384831|P4|NOT COMPLETED|Month 12 (Day 360)||0
984214|NCT00397215|2384832|P3|NOT COMPLETED|Month 12 (Day 360)||0
984215|NCT00397215|2384833|P2|NOT COMPLETED|Month 12 (Day 360)||0
984216|NCT00397215|2384834|P1|NOT COMPLETED|Month 12 (Day 360)||0
984217|NCT00397215|2384831|P4|COMPLETED|Month 12 (Day 360)||42
984218|NCT00397215|2384832|P3|COMPLETED|Month 12 (Day 360)||125
984219|NCT00397215|2384833|P2|COMPLETED|Month 12 (Day 360)||48
984220|NCT00397215|2384834|P1|COMPLETED|Month 12 (Day 360)||130
984221|NCT00397215|2384831|P4|STARTED|Month 12 (Day 360)||42
984222|NCT00397215|2384832|P3|STARTED|Month 12 (Day 360)||125
984223|NCT00397215|2384833|P2|STARTED|Month 12 (Day 360)||48
984224|NCT00397215|2384834|P1|STARTED|Month 12 (Day 360)||130
984225|NCT00397215|2384831|P4|NOT COMPLETED|Month 6 (Day 180)||0
984226|NCT00397215|2384832|P3|NOT COMPLETED|Month 6 (Day 180)||5
984227|NCT00397215|2384833|P2|NOT COMPLETED|Month 6 (Day 180)||3
984228|NCT00397215|2384834|P1|NOT COMPLETED|Month 6 (Day 180)||2
984229|NCT00397215|2384831|P4|COMPLETED|Month 6 (Day 180)||51
984230|NCT00397215|2384832|P3|COMPLETED|Month 6 (Day 180)||153
984231|NCT00397215|2384833|P2|COMPLETED|Month 6 (Day 180)||55
984232|NCT00397215|2384834|P1|COMPLETED|Month 6 (Day 180)||162
984233|NCT00397215|2384831|P4|STARTED|Month 6 (Day 180)||51
984234|NCT00397215|2384832|P3|STARTED|Month 6 (Day 180)||158
984235|NCT00397215|2384833|P2|STARTED|Month 6 (Day 180)||58
984236|NCT00397215|2384834|P1|STARTED|Month 6 (Day 180)||164
984237|NCT00397215|2384831|P4|NOT COMPLETED|Month 0 (Day 0)||4
984238|NCT00397215|2384832|P3|NOT COMPLETED|Month 0 (Day 0)||6
984239|NCT00397215|2384833|P2|NOT COMPLETED|Month 0 (Day 0)||5
984240|NCT00397215|2384834|P1|NOT COMPLETED|Month 0 (Day 0)||7
984241|NCT00397215|2384831|P4|COMPLETED|Month 0 (Day 0)||48
984242|NCT00397215|2384832|P3|COMPLETED|Month 0 (Day 0)||153
984243|NCT00397215|2384833|P2|COMPLETED|Month 0 (Day 0)||56
984244|NCT00397215|2384834|P1|COMPLETED|Month 0 (Day 0)||158
984245|NCT00397215|2384831|P4|STARTED|Month 0 (Day 0)||52
984246|NCT00397215|2384832|P3|STARTED|Month 0 (Day 0)||159
984247|NCT00397215|2384833|P2|STARTED|Month 0 (Day 0)||61
984248|NCT00397215|2384834|P1|STARTED|Month 0 (Day 0)||165
984249|NCT00397254|2384968|P2|NOT COMPLETED|Overall Study||2
984250|NCT00397254|2384969|P1|NOT COMPLETED|Overall Study||2
984251|NCT00397254|2384968|P2|COMPLETED|Overall Study||74
984252|NCT00397254|2384969|P1|COMPLETED|Overall Study||77
984253|NCT00397254|2384968|P2|STARTED|Overall Study||76
984254|NCT00397254|2384969|P1|STARTED|Overall Study||79
984255|NCT00397462|2384990|P3|NOT COMPLETED|Overall Study||0
984256|NCT00397462|2384991|P2|NOT COMPLETED|Overall Study||0
984257|NCT00397462|2384992|P1|NOT COMPLETED|Overall Study||0
984258|NCT00397462|2384990|P3|COMPLETED|Overall Study||15
984259|NCT00397462|2384991|P2|COMPLETED|Overall Study||13
984260|NCT00397462|2384992|P1|COMPLETED|Overall Study||16
984261|NCT00397462|2384990|P3|STARTED|Overall Study||15
984262|NCT00397462|2384991|P2|STARTED|Overall Study||13
984263|NCT00397462|2384992|P1|STARTED|Overall Study||16
984264|NCT00397488|2385003|P1|NOT COMPLETED|Overall Study||7
984265|NCT00397488|2385003|P1|COMPLETED|Overall Study||71
984266|NCT00397488|2385003|P1|STARTED|Overall Study||78
984267|NCT00397514|2385007|P1|NOT COMPLETED|Overall Study||9
984268|NCT00397514|2385007|P1|COMPLETED|Overall Study||25
984269|NCT00397514|2385007|P1|STARTED|Overall Study||34
984270|NCT00397540|2385019|P2|NOT COMPLETED|Overall Study||0
984271|NCT00397540|2385020|P1|NOT COMPLETED|Overall Study||1
984272|NCT00397540|2385019|P2|COMPLETED|Overall Study||85
984273|NCT00397540|2385020|P1|COMPLETED|Overall Study||59
984274|NCT00397540|2385019|P2|STARTED|Overall Study||85
984275|NCT00397540|2385020|P1|STARTED|Overall Study||60
984276|NCT00397631|2385028|P2|NOT COMPLETED|Overall Study||44
984277|NCT00397631|2385029|P1|NOT COMPLETED|Overall Study||30
984278|NCT00397631|2385028|P2|COMPLETED|Overall Study||215
984279|NCT00397631|2385029|P1|COMPLETED|Overall Study||231
984280|NCT00397631|2385028|P2|STARTED|Overall Study||259
984281|NCT00397631|2385029|P1|STARTED|Overall Study|Randomization ratio was 1:1|261
984282|NCT00397839|2385041|P2|NOT COMPLETED|Overall Study||18
984283|NCT00397839|2385042|P1|NOT COMPLETED|Overall Study||7
984284|NCT00397839|2385041|P2|COMPLETED|Overall Study||69
984285|NCT00397839|2385042|P1|COMPLETED|Overall Study||41
984286|NCT00397839|2385041|P2|STARTED|Overall Study||87
984287|NCT00397839|2385042|P1|STARTED|Overall Study||48
984288|NCT00397878|2385056|P1|NOT COMPLETED|Overall Study||0
984289|NCT00397878|2385056|P1|COMPLETED|Overall Study||10
984290|NCT00397878|2385056|P1|STARTED|Overall Study||10
984291|NCT00397891|2385065|P5|NOT COMPLETED|Overall Study||1
984292|NCT00397891|2385066|P4|NOT COMPLETED|Overall Study||0
984293|NCT00397891|2385067|P3|NOT COMPLETED|Overall Study||0
984294|NCT00397891|2385068|P2|NOT COMPLETED|Overall Study||0
984295|NCT00397891|2385069|P1|NOT COMPLETED|Overall Study||1
984296|NCT00397891|2385065|P5|COMPLETED|Overall Study||7
984297|NCT00397891|2385066|P4|COMPLETED|Overall Study||6
984298|NCT00397891|2385067|P3|COMPLETED|Overall Study||6
984299|NCT00397891|2385068|P2|COMPLETED|Overall Study||6
984300|NCT00397891|2385069|P1|COMPLETED|Overall Study||5
984301|NCT00397891|2385065|P5|STARTED|Overall Study||8
984302|NCT00397891|2385066|P4|STARTED|Overall Study||6
984303|NCT00397891|2385067|P3|STARTED|Overall Study||6
984304|NCT00397891|2385068|P2|STARTED|Overall Study||6
984305|NCT00397891|2385069|P1|STARTED|Overall Study||6
984306|NCT00397904|2385167|P1|NOT COMPLETED|Overall Study||0
984307|NCT00397904|2385167|P1|COMPLETED|Overall Study||16
984308|NCT00397904|2385167|P1|STARTED|Overall Study||16
984309|NCT00397930|2385173|P2|NOT COMPLETED|Overall Study||51
984310|NCT00397930|2385174|P1|NOT COMPLETED|Overall Study||38
984311|NCT00397930|2385173|P2|COMPLETED|Overall Study||153
984312|NCT00397930|2385174|P1|COMPLETED|Overall Study||168
984313|NCT00397930|2385173|P2|STARTED|Overall Study||204
984314|NCT00397930|2385174|P1|STARTED|Overall Study||206
984315|NCT00397982|2385180|P1|NOT COMPLETED|Overall Study||4
984316|NCT00397982|2385180|P1|COMPLETED|Overall Study||13
984317|NCT00397982|2385180|P1|STARTED|Overall Study||17
984318|NCT00398047|2385189|P1|NOT COMPLETED|Overall Study||3
984319|NCT00398047|2385189|P1|COMPLETED|Overall Study|all three patients progressed before completing|0
984320|NCT00398047|2385189|P1|STARTED|Overall Study||3
984321|NCT00398073|2385201|P2|NOT COMPLETED|Overall Study||0
984322|NCT00398073|2385202|P1|NOT COMPLETED|Overall Study||1
984323|NCT00398073|2385201|P2|COMPLETED|Overall Study||17
984324|NCT00398073|2385202|P1|COMPLETED|Overall Study||17
984325|NCT00398073|2385201|P2|STARTED|Overall Study||17
984326|NCT00398073|2385202|P1|STARTED|Overall Study||18
984327|NCT00398086|2385215|P3|NOT COMPLETED|Overall Study||2
984328|NCT00398086|2385216|P2|NOT COMPLETED|Overall Study||23
984329|NCT00398086|2385217|P1|NOT COMPLETED|Overall Study||9
984330|NCT00398086|2385215|P3|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|1
984331|NCT00398086|2385216|P2|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|21
984332|NCT00398086|2385217|P1|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|11
984333|NCT00398086|2385215|P3|Phase 1, Dose Escalation Population|Overall Study||3
984334|NCT00398086|2385216|P2|Phase 1, Dose Escalation Population|Overall Study||7
984335|NCT00398086|2385217|P1|Phase 1, Dose Escalation Population|Overall Study||20
984336|NCT00398086|2385215|P3|STARTED|Overall Study||3
984337|NCT00398086|2385216|P2|STARTED|Overall Study||44
984338|NCT00398086|2385217|P1|STARTED|Overall Study||20
984339|NCT00398112|2385249|P1|NOT COMPLETED|Overall Study||18
984340|NCT00398112|2385249|P1|COMPLETED|Overall Study||0
984341|NCT00398112|2385249|P1|STARTED|Overall Study||18
984342|NCT00398138|2385257|P1|NOT COMPLETED|Overall Study||2
984343|NCT00398138|2385257|P1|COMPLETED|Overall Study||10
984344|NCT00398138|2385257|P1|STARTED|Overall Study||12
984345|NCT00398216|2385267|P5|NOT COMPLETED|Overall Study||15
984346|NCT00398216|2385268|P4|NOT COMPLETED|Overall Study||22
984347|NCT00398216|2385269|P3|NOT COMPLETED|Overall Study||21
984348|NCT00398216|2385270|P2|NOT COMPLETED|Overall Study||19
984349|NCT00398216|2385271|P1|NOT COMPLETED|Overall Study||11
984350|NCT00398216|2385267|P5|COMPLETED|Overall Study||157
984351|NCT00398216|2385268|P4|COMPLETED|Overall Study||155
984352|NCT00398216|2385269|P3|COMPLETED|Overall Study||164
984353|NCT00398216|2385270|P2|COMPLETED|Overall Study||151
984354|NCT00398216|2385271|P1|COMPLETED|Overall Study||181
984355|NCT00398216|2385267|P5|STARTED|Overall Study||172
984356|NCT00398216|2385268|P4|STARTED|Overall Study||177
984357|NCT00398216|2385269|P3|STARTED|Overall Study||185
984358|NCT00398216|2385270|P2|STARTED|Overall Study||170
984359|NCT00398216|2385271|P1|STARTED|Overall Study||192
984360|NCT00398320|2385298|P1|NOT COMPLETED|Overall Study||6
984361|NCT00398320|2385298|P1|COMPLETED|Overall Study||34
984362|NCT00398320|2385298|P1|STARTED|Overall Study||40
984363|NCT00398398|2385306|P1|NOT COMPLETED|Overall Study||0
984364|NCT00398398|2385306|P1|COMPLETED|Overall Study||44
984365|NCT00398398|2385306|P1|STARTED|Overall Study||44
984366|NCT00398411|2385315|P2|NOT COMPLETED|Overall Study||1
984367|NCT00398411|2385316|P1|NOT COMPLETED|Overall Study||0
984368|NCT00398411|2385315|P2|COMPLETED|Overall Study||31
984369|NCT00398411|2385316|P1|COMPLETED|Overall Study||34
984370|NCT00398411|2385315|P2|STARTED|Overall Study||32
984371|NCT00398411|2385316|P1|STARTED|Overall Study||34
984372|NCT00391716|2385335|P3|NOT COMPLETED|Overall Study||19
984373|NCT00391716|2385336|P2|NOT COMPLETED|Overall Study||19
984374|NCT00391716|2385337|P1|NOT COMPLETED|Overall Study||27
984375|NCT00391716|2385335|P3|COMPLETED|Overall Study||30
984376|NCT00391716|2385336|P2|COMPLETED|Overall Study||28
984377|NCT00391716|2385337|P1|COMPLETED|Overall Study||27
984378|NCT00391716|2385335|P3|STARTED|Overall Study||49
984379|NCT00391716|2385336|P2|STARTED|Overall Study||47
984380|NCT00391716|2385337|P1|STARTED|Overall Study||54
984381|NCT00391768|2385361|P7|NOT COMPLETED|Overall Study||4
984382|NCT00391768|2385362|P6|NOT COMPLETED|Overall Study||3
984383|NCT00391768|2385363|P5|NOT COMPLETED|Overall Study||2
984384|NCT00391768|2385364|P4|NOT COMPLETED|Overall Study||1
984385|NCT00391768|2385365|P3|NOT COMPLETED|Overall Study||1
984386|NCT00391768|2385366|P2|NOT COMPLETED|Overall Study||0
984387|NCT00391768|2385367|P1|NOT COMPLETED|Overall Study||0
984388|NCT00391768|2385361|P7|COMPLETED|Overall Study||19
984389|NCT00391768|2385362|P6|COMPLETED|Overall Study||7
984390|NCT00391768|2385363|P5|COMPLETED|Overall Study||22
984391|NCT00391768|2385364|P4|COMPLETED|Overall Study||7
984392|NCT00391768|2385365|P3|COMPLETED|Overall Study||6
984393|NCT00391768|2385366|P2|COMPLETED|Overall Study||3
984394|NCT00391768|2385367|P1|COMPLETED|Overall Study||12
984395|NCT00391768|2385361|P7|STARTED|Overall Study||23
984396|NCT00391768|2385362|P6|STARTED|Overall Study||10
984397|NCT00391768|2385363|P5|STARTED|Overall Study||24
984398|NCT00391768|2385364|P4|STARTED|Overall Study||8
984399|NCT00391768|2385365|P3|STARTED|Overall Study||7
984400|NCT00391768|2385366|P2|STARTED|Overall Study||3
984401|NCT00391768|2385367|P1|STARTED|Overall Study||12
984402|NCT00391807|2385432|P1|NOT COMPLETED|Overall Study||715
984403|NCT00391807|2385432|P1|COMPLETED|Overall Study||968
984404|NCT00391807|2385432|P1|STARTED|Overall Study||1683
984405|NCT00391846|2385454|P2|NOT COMPLETED|Overall Study||7
984406|NCT00391846|2385455|P1|NOT COMPLETED|Overall Study||8
984407|NCT00391846|2385454|P2|COMPLETED|Overall Study|118 completed patients includes 5 CV related deaths|118
984408|NCT00391846|2385455|P1|COMPLETED|Overall Study|119 completed patients includes 4 CV related deaths|119
984409|NCT00391846|2385454|P2|STARTED|Overall Study|Of th 125 randomised patients 7 were discontinued|125
984410|NCT00391846|2385455|P1|STARTED|Overall Study|Of the 127 randomised patients 8 were discontinued|127
984411|NCT00391872|2385477|P2|NOT COMPLETED|Overall Study||255
984412|NCT00391872|2385478|P1|NOT COMPLETED|Overall Study||307
984413|NCT00391872|2385477|P2|COMPLETED|Overall Study||9036
984414|NCT00391872|2385478|P1|COMPLETED|Overall Study||9026
984415|NCT00391872|2385477|P2|STARTED|Overall Study||9291
984416|NCT00391872|2385478|P1|STARTED|Overall Study||9333
984417|NCT00391898|2385516|P2|NOT COMPLETED|Overall Study||10
984418|NCT00391898|2385517|P1|NOT COMPLETED|Overall Study||11
984419|NCT00391898|2385516|P2|COMPLETED|Overall Study||39
984420|NCT00391898|2385517|P1|COMPLETED|Overall Study||35
984421|NCT00391898|2385516|P2|STARTED|Overall Study||49
984422|NCT00391898|2385517|P1|STARTED|Overall Study|Safety population for Levodopa/carbidopa/entacapone is 45, for Levodopa/carbidopa, per randomized.|46
984423|NCT00391976|2385538|P3|NOT COMPLETED|Overall Study||35
984424|NCT00391976|2385539|P2|NOT COMPLETED|Overall Study||25
984425|NCT00391976|2385540|P1|NOT COMPLETED|Overall Study||27
984426|NCT00391976|2385538|P3|COMPLETED|Overall Study||0
984427|NCT00391976|2385539|P2|COMPLETED|Overall Study||18
984428|NCT00391976|2385540|P1|COMPLETED|Overall Study||18
984429|NCT00391976|2385538|P3|Safety Population|Overall Study||35
984430|NCT00391976|2385539|P2|Safety Population|Overall Study||43
984431|NCT00391976|2385540|P1|Safety Population|Overall Study|Patients who were enrolled and received at least one dose of study medication.|44
984432|NCT00391976|2385538|P3|Randomized|Overall Study||0
984433|NCT00391976|2385539|P2|Randomized|Overall Study||43
984434|NCT00391976|2385540|P1|Randomized|Overall Study|Randomization occurred after 28 days of treatment & negative antibody test aeruginosa antibody test|45
984435|NCT00391976|2385538|P3|STARTED|Overall Study||35
984436|NCT00391976|2385539|P2|STARTED|Overall Study||43
984437|NCT00391976|2385540|P1|STARTED|Overall Study|Started indicates all patients who were enrolled at Visit 1|45
984438|NCT00391989|2385562|P1|NOT COMPLETED|Overall Study||2
984439|NCT00391989|2385562|P1|COMPLETED|Overall Study||53
984440|NCT00391989|2385562|P1|STARTED|Overall Study||55
984441|NCT00392171|2385566|P1|NOT COMPLETED|Overall Study||105
984442|NCT00392171|2385566|P1|COMPLETED|Overall Study||15
984443|NCT00392171|2385566|P1|STARTED|Overall Study||120
984444|NCT00392197|2385572|P2|NOT COMPLETED|Overall Study||30
984445|NCT00392197|2385573|P1|NOT COMPLETED|Overall Study||21
984446|NCT00392197|2385572|P2|COMPLETED|Overall Study||33
984447|NCT00392197|2385573|P1|COMPLETED|Overall Study||27
984448|NCT00392197|2385572|P2|STARTED|Overall Study||63
984449|NCT00392197|2385573|P1|STARTED|Overall Study||48
984450|NCT00392210|2385583|P2|NOT COMPLETED|Second Voiding Trial||0
984451|NCT00392210|2385584|P1|NOT COMPLETED|Second Voiding Trial||0
984452|NCT00392210|2385583|P2|COMPLETED|Second Voiding Trial||31
984453|NCT00392210|2385584|P1|COMPLETED|Second Voiding Trial||34
984454|NCT00392210|2385583|P2|STARTED|Second Voiding Trial||31
984455|NCT00392210|2385584|P1|STARTED|Second Voiding Trial||34
984456|NCT00392210|2385583|P2|NOT COMPLETED|First Voiding Trial||2
984457|NCT00392210|2385584|P1|NOT COMPLETED|First Voiding Trial||2
984458|NCT00392210|2385583|P2|COMPLETED|First Voiding Trial||31
984459|NCT00392210|2385584|P1|COMPLETED|First Voiding Trial||34
984460|NCT00392210|2385583|P2|STARTED|First Voiding Trial||33
984461|NCT00392210|2385584|P1|STARTED|First Voiding Trial||36
984462|NCT00392223|2385592|P2|NOT COMPLETED|Overall Study||13
984463|NCT00392223|2385593|P1|NOT COMPLETED|Overall Study||9
984464|NCT00392223|2385592|P2|COMPLETED|Overall Study||47
984465|NCT00392223|2385593|P1|COMPLETED|Overall Study||49
984466|NCT00392223|2385592|P2|STARTED|Overall Study||60
984467|NCT00392223|2385593|P1|STARTED|Overall Study||58
984474|NCT00398632|2385618|P1|NOT COMPLETED|Overall Study||2
984475|NCT00398632|2385618|P1|COMPLETED|Overall Study|2/6 subjects withdrew at end of week 6; 1 for lack of efficacy, 1 because of time constraints.|4
984476|NCT00398632|2385618|P1|STARTED|Overall Study||6
984477|NCT00398866|2385625|P3|NOT COMPLETED|Overall Study||8
984478|NCT00398866|2385626|P2|NOT COMPLETED|Overall Study||8
984479|NCT00398866|2385627|P1|NOT COMPLETED|Overall Study||14
984480|NCT00398866|2385625|P3|COMPLETED|Overall Study||58
984481|NCT00398866|2385626|P2|COMPLETED|Overall Study||60
984482|NCT00398866|2385627|P1|COMPLETED|Overall Study||52
984483|NCT00398866|2385625|P3|STARTED|Overall Study||66
984484|NCT00398866|2385626|P2|STARTED|Overall Study||68
984485|NCT00398866|2385627|P1|STARTED|Overall Study||66
984486|NCT00398918|2385638|P1|NOT COMPLETED|Overall Study||0
984487|NCT00398918|2385638|P1|COMPLETED|Overall Study||10
984488|NCT00398918|2385638|P1|STARTED|Overall Study||10
984489|NCT00400569|2385643|P1|NOT COMPLETED|Overall Study||1
984490|NCT00400569|2385643|P1|COMPLETED|Overall Study||47
984491|NCT00400569|2385643|P1|STARTED|Overall Study||48
984492|NCT00400634|2385656|P2|NOT COMPLETED|Overall Study||1
984493|NCT00400634|2385657|P1|NOT COMPLETED|Overall Study||4
984494|NCT00400634|2385656|P2|COMPLETED|Overall Study||19
984495|NCT00400634|2385657|P1|COMPLETED|Overall Study||34
984496|NCT00400634|2385656|P2|STARTED|Overall Study||20
984497|NCT00400634|2385657|P1|STARTED|Overall Study||38
984498|NCT00400686|2385665|P1|NOT COMPLETED|Overall Study||0
984499|NCT00400686|2385665|P1|COMPLETED|Overall Study||31
984500|NCT00400686|2385665|P1|STARTED|Overall Study||31
984501|NCT00400712|2385673|P2|NOT COMPLETED|Overall Study||16
984502|NCT00400712|2385674|P1|NOT COMPLETED|Overall Study||17
984503|NCT00400712|2385673|P2|COMPLETED|Overall Study||35
984504|NCT00400712|2385674|P1|COMPLETED|Overall Study||35
984505|NCT00400712|2385673|P2|STARTED|Overall Study||51
984506|NCT00400712|2385674|P1|STARTED|Overall Study||52
984507|NCT00400764|2385697|P5|NOT COMPLETED|Phase II||11
984508|NCT00400764|2385698|P4|NOT COMPLETED|Phase II||26
984509|NCT00400764|2385699|P3|NOT COMPLETED|Phase II||23
984510|NCT00400764|2385700|P2|NOT COMPLETED|Phase II||0
984511|NCT00400764|2385701|P1|NOT COMPLETED|Phase II||0
984512|NCT00400764|2385697|P5|COMPLETED|Phase II||0
984513|NCT00400764|2385698|P4|COMPLETED|Phase II||0
984514|NCT00400764|2385699|P3|COMPLETED|Phase II||0
984515|NCT00400764|2385700|P2|COMPLETED|Phase II||0
984516|NCT00400764|2385701|P1|COMPLETED|Phase II||0
984517|NCT00400764|2385697|P5|Treated|Phase II||11
984518|NCT00400764|2385698|P4|Treated|Phase II||26
984519|NCT00400764|2385699|P3|Treated|Phase II|One patient in the Rituximab arm withdrew prior to treatment|22
984520|NCT00400764|2385700|P2|Treated|Phase II||0
984521|NCT00400764|2385701|P1|Treated|Phase II||0
984522|NCT00400764|2385697|P5|STARTED|Phase II||11
984523|NCT00400764|2385698|P4|STARTED|Phase II||26
984524|NCT00400764|2385699|P3|STARTED|Phase II||23
984525|NCT00400764|2385700|P2|STARTED|Phase II||0
984526|NCT00400764|2385701|P1|STARTED|Phase II||0
984527|NCT00400764|2385697|P5|NOT COMPLETED|Phase Ib||0
984528|NCT00400764|2385698|P4|NOT COMPLETED|Phase Ib||0
984529|NCT00400764|2385699|P3|NOT COMPLETED|Phase Ib||0
984530|NCT00400764|2385700|P2|NOT COMPLETED|Phase Ib||4
984531|NCT00400764|2385701|P1|NOT COMPLETED|Phase Ib||6
984532|NCT00400764|2385697|P5|COMPLETED|Phase Ib||0
984533|NCT00400764|2385698|P4|COMPLETED|Phase Ib||0
984534|NCT00400764|2385699|P3|COMPLETED|Phase Ib||0
984535|NCT00400764|2385700|P2|COMPLETED|Phase Ib||2
984536|NCT00400764|2385701|P1|COMPLETED|Phase Ib|One patient reported as discontinued due to an AE should have been reported as death.|0
984537|NCT00400764|2385697|P5|Treated|Phase Ib||0
984538|NCT00400764|2385698|P4|Treated|Phase Ib||0
984539|NCT00400764|2385699|P3|Treated|Phase Ib||0
984540|NCT00400764|2385700|P2|Treated|Phase Ib||6
984541|NCT00400764|2385701|P1|Treated|Phase Ib||6
984542|NCT00400764|2385697|P5|STARTED|Phase Ib||0
984543|NCT00400764|2385698|P4|STARTED|Phase Ib||0
984544|NCT00400764|2385699|P3|STARTED|Phase Ib||0
984545|NCT00400764|2385700|P2|STARTED|Phase Ib||6
984546|NCT00400764|2385701|P1|STARTED|Phase Ib||6
984547|NCT00400803|2385752|P1|NOT COMPLETED|Overall Study||0
984548|NCT00400803|2385752|P1|COMPLETED|Overall Study||35
984549|NCT00400803|2385752|P1|STARTED|Overall Study||35
984550|NCT00400829|2385763|P1|NOT COMPLETED|Overall Study||0
984551|NCT00400829|2385763|P1|COMPLETED|Overall Study||66
984552|NCT00400829|2385763|P1|STARTED|Overall Study||66
984553|NCT00400881|2385771|P2|NOT COMPLETED|Overall Study||0
984554|NCT00400881|2385772|P1|NOT COMPLETED|Overall Study||0
984555|NCT00400881|2385771|P2|COMPLETED|Overall Study||60
984556|NCT00400881|2385772|P1|COMPLETED|Overall Study||62
984557|NCT00400881|2385771|P2|STARTED|Overall Study||60
984558|NCT00400881|2385772|P1|STARTED|Overall Study||62
984559|NCT00400946|2385785|P5|NOT COMPLETED|Overall Study||38
984560|NCT00400946|2385786|P4|NOT COMPLETED|Overall Study||47
984561|NCT00400946|2385787|P3|NOT COMPLETED|Overall Study||2
984562|NCT00400946|2385788|P2|NOT COMPLETED|Overall Study||11
984563|NCT00400946|2385789|P1|NOT COMPLETED|Overall Study||14
984564|NCT00400946|2385785|P5|COMPLETED|Overall Study||206
984565|NCT00400946|2385786|P4|COMPLETED|Overall Study||4
984566|NCT00400946|2385787|P3|COMPLETED|Overall Study||40
984567|NCT00400946|2385788|P2|COMPLETED|Overall Study||221
984568|NCT00400946|2385789|P1|COMPLETED|Overall Study||217
984569|NCT00400946|2385785|P5|Eligible and Treated|Overall Study||243
984570|NCT00400946|2385786|P4|Eligible and Treated|Overall Study||46
984571|NCT00400946|2385787|P3|Eligible and Treated|Overall Study||42
984572|NCT00400946|2385788|P2|Eligible and Treated|Overall Study||232
984573|NCT00400946|2385789|P1|Eligible and Treated|Overall Study||231
984574|NCT00400946|2385785|P5|Evaluable for Day 32 MRD|Overall Study||168
984575|NCT00400946|2385786|P4|Evaluable for Day 32 MRD|Overall Study||12
984576|NCT00400946|2385787|P3|Evaluable for Day 32 MRD|Overall Study||33
984577|NCT00400946|2385788|P2|Evaluable for Day 32 MRD|Overall Study||167
984578|NCT00400946|2385789|P1|Evaluable for Day 32 MRD|Overall Study||166
984579|NCT00400946|2385785|P5|Evaluable for Day 18 Marrow Morphology|Overall Study||152
984580|NCT00400946|2385786|P4|Evaluable for Day 18 Marrow Morphology|Overall Study||13
984581|NCT00400946|2385787|P3|Evaluable for Day 18 Marrow Morphology|Overall Study||19
984582|NCT00400946|2385788|P2|Evaluable for Day 18 Marrow Morphology|Overall Study||161
984583|NCT00400946|2385789|P1|Evaluable for Day 18 Marrow Morphology|Overall Study||158
984584|NCT00400946|2385785|P5|Evaluable for CNS Directed-Treatment|Overall Study||227
984585|NCT00400946|2385786|P4|Evaluable for CNS Directed-Treatment|Overall Study||21
984586|NCT00400946|2385787|P3|Evaluable for CNS Directed-Treatment|Overall Study||42
984587|NCT00400946|2385788|P2|Evaluable for CNS Directed-Treatment|Overall Study||232
984588|NCT00400946|2385789|P1|Evaluable for CNS Directed-Treatment|Overall Study||231
984589|NCT00400946|2385785|P5|STARTED|Overall Study||244
984590|NCT00400946|2385786|P4|STARTED|Overall Study||51
984591|NCT00400946|2385787|P3|STARTED|Overall Study||42
984592|NCT00400946|2385788|P2|STARTED|Overall Study||232
984593|NCT00400946|2385789|P1|STARTED|Overall Study||231
984594|NCT00401102|2385815|P1|NOT COMPLETED|Overall Study||7
984595|NCT00401102|2385815|P1|COMPLETED|Overall Study||5
984596|NCT00401102|2385815|P1|STARTED|Overall Study||12
984597|NCT00401193|2385822|P3|NOT COMPLETED|Overall Study||6
984598|NCT00401193|2385823|P2|NOT COMPLETED|Overall Study||11
984599|NCT00401193|2385824|P1|NOT COMPLETED|Overall Study||15
984600|NCT00401193|2385822|P3|COMPLETED|Overall Study||63
984601|NCT00401193|2385823|P2|COMPLETED|Overall Study||106
984602|NCT00401193|2385824|P1|COMPLETED|Overall Study||103
984603|NCT00401193|2385822|P3|Modified Intent to Treat Population|Overall Study||67
984604|NCT00401193|2385823|P2|Modified Intent to Treat Population|Overall Study||115
984605|NCT00401193|2385824|P1|Modified Intent to Treat Population|Overall Study||112
984606|NCT00401193|2385822|P3|Intent to Treat Population|Overall Study||67
984607|NCT00401193|2385823|P2|Intent to Treat Population|Overall Study||115
984608|NCT00401193|2385824|P1|Intent to Treat Population|Overall Study||115
984609|NCT00401193|2385822|P3|STARTED|Overall Study||69
984610|NCT00401193|2385823|P2|STARTED|Overall Study||117
984611|NCT00401193|2385824|P1|STARTED|Overall Study||118
984612|NCT00401245|2385842|P8|NOT COMPLETED|Double Blind Tapering Phase||7
984613|NCT00401245|2385843|P7|NOT COMPLETED|Double Blind Tapering Phase||7
984614|NCT00401245|2385844|P6|NOT COMPLETED|Double Blind Tapering Phase||4
984615|NCT00401245|2385845|P5|NOT COMPLETED|Double Blind Tapering Phase||4
984616|NCT00401245|2385846|P4|NOT COMPLETED|Double Blind Tapering Phase||0
984617|NCT00401245|2385847|P3|NOT COMPLETED|Double Blind Tapering Phase||0
984618|NCT00401245|2385848|P2|NOT COMPLETED|Double Blind Tapering Phase||0
984619|NCT00401245|2385849|P1|NOT COMPLETED|Double Blind Tapering Phase||0
984620|NCT00401245|2385842|P8|COMPLETED|Double Blind Tapering Phase||95
984621|NCT00401245|2385843|P7|COMPLETED|Double Blind Tapering Phase||80
984622|NCT00401245|2385844|P6|COMPLETED|Double Blind Tapering Phase||90
984623|NCT00401245|2385845|P5|COMPLETED|Double Blind Tapering Phase||97
984624|NCT00401245|2385846|P4|COMPLETED|Double Blind Tapering Phase||0
984625|NCT00401245|2385847|P3|COMPLETED|Double Blind Tapering Phase||0
984626|NCT00401245|2385848|P2|COMPLETED|Double Blind Tapering Phase||0
984627|NCT00401245|2385849|P1|COMPLETED|Double Blind Tapering Phase||0
984628|NCT00401245|2385842|P8|STARTED|Double Blind Tapering Phase||102
984629|NCT00401245|2385843|P7|STARTED|Double Blind Tapering Phase||87
984630|NCT00401245|2385844|P6|STARTED|Double Blind Tapering Phase||94
984631|NCT00401245|2385845|P5|STARTED|Double Blind Tapering Phase||101
984632|NCT00401245|2385846|P4|STARTED|Double Blind Tapering Phase||0
984633|NCT00401245|2385847|P3|STARTED|Double Blind Tapering Phase||0
984634|NCT00401245|2385848|P2|STARTED|Double Blind Tapering Phase||0
984635|NCT00401245|2385849|P1|STARTED|Double Blind Tapering Phase||0
984636|NCT00401245|2385842|P8|NOT COMPLETED|Open Label Phase||0
984637|NCT00401245|2385843|P7|NOT COMPLETED|Open Label Phase||0
984638|NCT00401245|2385844|P6|NOT COMPLETED|Open Label Phase||0
984639|NCT00401245|2385845|P5|NOT COMPLETED|Open Label Phase||0
984640|NCT00401245|2385846|P4|NOT COMPLETED|Open Label Phase||21
984641|NCT00401245|2385847|P3|NOT COMPLETED|Open Label Phase||23
984642|NCT00401245|2385848|P2|NOT COMPLETED|Open Label Phase||35
984643|NCT00401245|2385849|P1|NOT COMPLETED|Open Label Phase||21
984644|NCT00401245|2385842|P8|COMPLETED|Open Label Phase||0
984645|NCT00401245|2385843|P7|COMPLETED|Open Label Phase||0
984646|NCT00401245|2385844|P6|COMPLETED|Open Label Phase||0
984647|NCT00401245|2385845|P5|COMPLETED|Open Label Phase||0
984648|NCT00401245|2385846|P4|COMPLETED|Open Label Phase||84
984649|NCT00401245|2385847|P3|COMPLETED|Open Label Phase||95
984650|NCT00401245|2385848|P2|COMPLETED|Open Label Phase||81
984651|NCT00401245|2385849|P1|COMPLETED|Open Label Phase||101
984652|NCT00401245|2385842|P8|STARTED|Open Label Phase||0
984653|NCT00401245|2385843|P7|STARTED|Open Label Phase||0
984654|NCT00401245|2385844|P6|STARTED|Open Label Phase||0
984655|NCT00401245|2385845|P5|STARTED|Open Label Phase||0
984656|NCT00401245|2385846|P4|STARTED|Open Label Phase||105
984657|NCT00401245|2385847|P3|STARTED|Open Label Phase||118
984658|NCT00401245|2385848|P2|STARTED|Open Label Phase||116
984659|NCT00401245|2385849|P1|STARTED|Open Label Phase||122
984660|NCT00401245|2385842|P8|NOT COMPLETED|Between Titration and Open Label Phase||0
984661|NCT00401245|2385843|P7|NOT COMPLETED|Between Titration and Open Label Phase||0
984662|NCT00401245|2385844|P6|NOT COMPLETED|Between Titration and Open Label Phase||0
984663|NCT00401245|2385845|P5|NOT COMPLETED|Between Titration and Open Label Phase||0
984664|NCT00401245|2385846|P4|NOT COMPLETED|Between Titration and Open Label Phase||2
984665|NCT00401245|2385847|P3|NOT COMPLETED|Between Titration and Open Label Phase||0
984666|NCT00401245|2385848|P2|NOT COMPLETED|Between Titration and Open Label Phase||2
984667|NCT00401245|2385849|P1|NOT COMPLETED|Between Titration and Open Label Phase||0
984668|NCT00401245|2385842|P8|COMPLETED|Between Titration and Open Label Phase||0
984669|NCT00401245|2385843|P7|COMPLETED|Between Titration and Open Label Phase||0
984670|NCT00401245|2385844|P6|COMPLETED|Between Titration and Open Label Phase||0
984671|NCT00401245|2385845|P5|COMPLETED|Between Titration and Open Label Phase||0
984672|NCT00401245|2385846|P4|COMPLETED|Between Titration and Open Label Phase||105
984673|NCT00401245|2385847|P3|COMPLETED|Between Titration and Open Label Phase||118
984674|NCT00401245|2385848|P2|COMPLETED|Between Titration and Open Label Phase||116
984675|NCT00401245|2385849|P1|COMPLETED|Between Titration and Open Label Phase||122
984676|NCT00401245|2385842|P8|STARTED|Between Titration and Open Label Phase||0
984677|NCT00401245|2385843|P7|STARTED|Between Titration and Open Label Phase||0
984678|NCT00401245|2385844|P6|STARTED|Between Titration and Open Label Phase||0
984679|NCT00401245|2385845|P5|STARTED|Between Titration and Open Label Phase||0
984680|NCT00401245|2385846|P4|STARTED|Between Titration and Open Label Phase||107
984681|NCT00401245|2385847|P3|STARTED|Between Titration and Open Label Phase||118
984682|NCT00401245|2385848|P2|STARTED|Between Titration and Open Label Phase||118
984683|NCT00401245|2385849|P1|STARTED|Between Titration and Open Label Phase||122
984684|NCT00401245|2385842|P8|NOT COMPLETED|Double Blind Titration Phase||0
984685|NCT00401245|2385843|P7|NOT COMPLETED|Double Blind Titration Phase||0
984686|NCT00401245|2385844|P6|NOT COMPLETED|Double Blind Titration Phase||0
984687|NCT00401245|2385845|P5|NOT COMPLETED|Double Blind Titration Phase||0
984688|NCT00401245|2385846|P4|NOT COMPLETED|Double Blind Titration Phase||15
984689|NCT00401245|2385847|P3|NOT COMPLETED|Double Blind Titration Phase||6
984690|NCT00401245|2385848|P2|NOT COMPLETED|Double Blind Titration Phase||3
984691|NCT00401245|2385849|P1|NOT COMPLETED|Double Blind Titration Phase||4
984692|NCT00401245|2385842|P8|COMPLETED|Double Blind Titration Phase||0
984693|NCT00401245|2385843|P7|COMPLETED|Double Blind Titration Phase||0
984694|NCT00401245|2385844|P6|COMPLETED|Double Blind Titration Phase||0
984695|NCT00401245|2385845|P5|COMPLETED|Double Blind Titration Phase||0
984696|NCT00401245|2385846|P4|COMPLETED|Double Blind Titration Phase||107
984697|NCT00401245|2385847|P3|COMPLETED|Double Blind Titration Phase||118
984698|NCT00401245|2385848|P2|COMPLETED|Double Blind Titration Phase||118
984699|NCT00401245|2385849|P1|COMPLETED|Double Blind Titration Phase||122
984700|NCT00401245|2385842|P8|STARTED|Double Blind Titration Phase||0
984701|NCT00401245|2385843|P7|STARTED|Double Blind Titration Phase||0
984702|NCT00401245|2385844|P6|STARTED|Double Blind Titration Phase||0
984703|NCT00401245|2385845|P5|STARTED|Double Blind Titration Phase||0
984704|NCT00401245|2385846|P4|STARTED|Double Blind Titration Phase||122
984705|NCT00401245|2385847|P3|STARTED|Double Blind Titration Phase||124
984706|NCT00401245|2385848|P2|STARTED|Double Blind Titration Phase||121
984707|NCT00401245|2385849|P1|STARTED|Double Blind Titration Phase||126
984708|NCT00401258|2385914|P1|NOT COMPLETED|Overall Study||7
984709|NCT00401258|2385914|P1|COMPLETED|Overall Study||8
984710|NCT00401258|2385914|P1|STARTED|Overall Study||15
984711|NCT00401401|2385922|P4|NOT COMPLETED|Overall Study||3
984712|NCT00401401|2385923|P3|NOT COMPLETED|Overall Study||1
984713|NCT00401401|2385924|P2|NOT COMPLETED|Overall Study||0
984714|NCT00401401|2385925|P1|NOT COMPLETED|Overall Study||0
984715|NCT00401401|2385922|P4|COMPLETED|Overall Study||9
984716|NCT00401401|2385923|P3|COMPLETED|Overall Study||5
984717|NCT00401401|2385924|P2|COMPLETED|Overall Study||6
984718|NCT00401401|2385925|P1|COMPLETED|Overall Study||6
984719|NCT00401401|2385922|P4|STARTED|Overall Study||12
984720|NCT00401401|2385923|P3|STARTED|Overall Study||6
984721|NCT00401401|2385924|P2|STARTED|Overall Study||6
984722|NCT00401401|2385925|P1|STARTED|Overall Study||6
984723|NCT00401414|2385950|P3|NOT COMPLETED|Overall Study||0
984724|NCT00401414|2385951|P2|NOT COMPLETED|Overall Study||0
984725|NCT00401414|2385952|P1|NOT COMPLETED|Overall Study||0
984726|NCT00401414|2385950|P3|COMPLETED|Overall Study||79
984727|NCT00401414|2385951|P2|COMPLETED|Overall Study||147
984728|NCT00401414|2385952|P1|COMPLETED|Overall Study||118
984729|NCT00401414|2385950|P3|STARTED|Overall Study||79
984730|NCT00401414|2385951|P2|STARTED|Overall Study||147
984731|NCT00401414|2385952|P1|STARTED|Overall Study||118
984732|NCT00401531|2385974|P2|NOT COMPLETED|Overall Study||10
984733|NCT00401531|2385975|P1|NOT COMPLETED|Overall Study||9
984734|NCT00401531|2385974|P2|COMPLETED|Overall Study||196
984735|NCT00401531|2385975|P1|COMPLETED|Overall Study||197
984736|NCT00401531|2385974|P2|STARTED|Overall Study||206
984737|NCT00401531|2385975|P1|STARTED|Overall Study||206
984738|NCT00401544|2385995|P4|NOT COMPLETED|Overall Study||16
984739|NCT00401544|2385996|P3|NOT COMPLETED|Overall Study||12
984740|NCT00401544|2385997|P2|NOT COMPLETED|Overall Study||18
984741|NCT00401544|2385998|P1|NOT COMPLETED|Overall Study||18
984742|NCT00401544|2385995|P4|COMPLETED|Overall Study||44
984743|NCT00401544|2385996|P3|COMPLETED|Overall Study||48
984744|NCT00401544|2385997|P2|COMPLETED|Overall Study||44
984745|NCT00401544|2385998|P1|COMPLETED|Overall Study||38
984746|NCT00401544|2385995|P4|STARTED|Overall Study|Randomized and treated|60
984747|NCT00401544|2385996|P3|STARTED|Overall Study|Randomized and treated|60
984748|NCT00401544|2385997|P2|STARTED|Overall Study|Randomized and treated|62
984749|NCT00401544|2385998|P1|STARTED|Overall Study|Randomized and treated|56
984750|NCT00401622|2386038|P2|NOT COMPLETED|Overall Study||43
984751|NCT00401622|2386039|P1|NOT COMPLETED|Overall Study||34
984752|NCT00401622|2386038|P2|COMPLETED|Overall Study||117
984753|NCT00401622|2386039|P1|COMPLETED|Overall Study||126
984754|NCT00401622|2386038|P2|STARTED|Overall Study||160
984755|NCT00401622|2386039|P1|STARTED|Overall Study||160
984756|NCT00401726|2386049|P2|NOT COMPLETED|Overall Study||112
984757|NCT00401726|2386050|P1|NOT COMPLETED|Overall Study||97
984758|NCT00401726|2386049|P2|COMPLETED|Overall Study||156
984759|NCT00401726|2386050|P1|COMPLETED|Overall Study||172
984760|NCT00401726|2386049|P2|STARTED|Overall Study||268
984761|NCT00401726|2386050|P1|STARTED|Overall Study||269
984762|NCT00401752|2386072|P2|NOT COMPLETED|Overall Study||18
984763|NCT00401752|2386073|P1|NOT COMPLETED|Overall Study||10
984764|NCT00401752|2386072|P2|COMPLETED|Overall Study||94
984765|NCT00401752|2386073|P1|COMPLETED|Overall Study||97
984766|NCT00401752|2386072|P2|Patients Included in Per-Protocol Popula|Overall Study||99
984767|NCT00401752|2386073|P1|Patients Included in Per-Protocol Popula|Overall Study||100
984768|NCT00401752|2386072|P2|Patients Included in Safety Population|Overall Study||110
984769|NCT00401752|2386073|P1|Patients Included in Safety Population|Overall Study||107
984770|NCT00401752|2386072|P2|Patients Included in ITT Population|Overall Study||111
984771|NCT00401752|2386073|P1|Patients Included in ITT Population|Overall Study||106
984772|NCT00401752|2386072|P2|Number of Patients Received Treatment|Overall Study||111
984773|NCT00401752|2386073|P1|Number of Patients Received Treatment|Overall Study||107
984774|NCT00401752|2386072|P2|STARTED|Overall Study||112
984775|NCT00401752|2386073|P1|STARTED|Overall Study||107
984776|NCT00401778|2386092|P3|NOT COMPLETED|Overall Study||1
984777|NCT00401778|2386093|P2|NOT COMPLETED|Overall Study||1
984778|NCT00401778|2386094|P1|NOT COMPLETED|Overall Study||1
984779|NCT00401778|2386092|P3|COMPLETED|Overall Study||10
984780|NCT00401778|2386093|P2|COMPLETED|Overall Study||11
984781|NCT00401778|2386094|P1|COMPLETED|Overall Study||9
984782|NCT00401778|2386092|P3|STARTED|Overall Study||11
984783|NCT00401778|2386093|P2|STARTED|Overall Study||12
984784|NCT00401778|2386094|P1|STARTED|Overall Study||10
984785|NCT00401830|2386108|P2|NOT COMPLETED|Overall Study||32
984786|NCT00401830|2386109|P1|NOT COMPLETED|Overall Study||31
984787|NCT00401830|2386108|P2|COMPLETED|Overall Study||46
984788|NCT00401830|2386109|P1|COMPLETED|Overall Study||50
984789|NCT00401830|2386108|P2|STARTED|Overall Study||78
984790|NCT00401830|2386109|P1|STARTED|Overall Study||81
984791|NCT00401843|2386144|P3|NOT COMPLETED|Overall Study||142
984792|NCT00401843|2386145|P2|NOT COMPLETED|Overall Study||144
984793|NCT00401843|2386146|P1|NOT COMPLETED|Overall Study||21
984794|NCT00401843|2386144|P3|COMPLETED|Overall Study||0
984795|NCT00401843|2386145|P2|COMPLETED|Overall Study||0
984796|NCT00401843|2386146|P1|COMPLETED|Overall Study||0
984797|NCT00401843|2386144|P3|Treated|Overall Study||139
984798|NCT00401843|2386145|P2|Treated|Overall Study||142
984799|NCT00401843|2386146|P1|Treated|Overall Study||21
984800|NCT00401843|2386144|P3|STARTED|Overall Study||142
984801|NCT00401843|2386145|P2|STARTED|Overall Study||144
984802|NCT00401843|2386146|P1|STARTED|Overall Study||21
984803|NCT00401882|2386164|P2|NOT COMPLETED|Overall Study||0
984804|NCT00401882|2386165|P1|NOT COMPLETED|Overall Study||0
984805|NCT00401882|2386164|P2|COMPLETED|Overall Study||5
984806|NCT00401882|2386165|P1|COMPLETED|Overall Study||2
984807|NCT00401882|2386164|P2|STARTED|Overall Study||5
984808|NCT00401882|2386165|P1|STARTED|Overall Study||2
984809|NCT00401960|2386183|P2|NOT COMPLETED|Overall Study||0
984810|NCT00401960|2386184|P1|NOT COMPLETED|Overall Study||5
984811|NCT00401960|2386183|P2|COMPLETED|Overall Study||1
984812|NCT00401960|2386184|P1|COMPLETED|Overall Study||0
984813|NCT00401960|2386183|P2|STARTED|Overall Study||1
984814|NCT00401960|2386184|P1|STARTED|Overall Study||5
984815|NCT00401973|2386195|P3|NOT COMPLETED|Overall Study||23
984816|NCT00401973|2386196|P2|NOT COMPLETED|Overall Study||26
984817|NCT00401973|2386197|P1|NOT COMPLETED|Overall Study||11
984818|NCT00401973|2386195|P3|COMPLETED|Overall Study||50
984819|NCT00401973|2386196|P2|COMPLETED|Overall Study||50
984820|NCT00401973|2386197|P1|COMPLETED|Overall Study||39
984821|NCT00401973|2386195|P3|STARTED|Overall Study||73
984822|NCT00401973|2386196|P2|STARTED|Overall Study||76
984823|NCT00401973|2386197|P1|STARTED|Overall Study||50
984824|NCT00402025|2386237|P3|NOT COMPLETED|Overall Study||10
984825|NCT00402025|2386238|P2|NOT COMPLETED|Overall Study||3
984826|NCT00402025|2386239|P1|NOT COMPLETED|Overall Study||2
984827|NCT00402025|2386237|P3|COMPLETED|Overall Study||0
984828|NCT00402025|2386238|P2|COMPLETED|Overall Study||1
984829|NCT00402025|2386239|P1|COMPLETED|Overall Study||1
984830|NCT00402025|2386237|P3|STARTED|Overall Study||10
984831|NCT00402025|2386238|P2|STARTED|Overall Study||4
984832|NCT00402025|2386239|P1|STARTED|Overall Study||3
984833|NCT00402051|2386264|P2|NOT COMPLETED|Overall Study||35
984834|NCT00402051|2386265|P1|NOT COMPLETED|Overall Study||38
984835|NCT00402051|2386264|P2|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|32
984836|NCT00402051|2386265|P1|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|28
984837|NCT00402051|2386264|P2|Received Treatment|Overall Study||65
984838|NCT00402051|2386265|P1|Received Treatment|Overall Study||65
984839|NCT00402051|2386264|P2|STARTED|Overall Study||67
984840|NCT00402051|2386265|P1|STARTED|Overall Study||66
984841|NCT00402103|2386281|P2|NOT COMPLETED|Overall Study||13
984842|NCT00402103|2386282|P1|NOT COMPLETED|Overall Study||91
984843|NCT00402103|2386281|P2|COMPLETED|Overall Study||73
984844|NCT00402103|2386282|P1|COMPLETED|Overall Study||379
984845|NCT00402103|2386281|P2|STARTED|Overall Study||86
984846|NCT00402103|2386282|P1|STARTED|Overall Study||470
984871|NCT00402194|2386356|P2|NOT COMPLETED|Overall Study||0
984872|NCT00402194|2386357|P1|NOT COMPLETED|Overall Study||0
984873|NCT00402194|2386356|P2|COMPLETED|Overall Study||8
984874|NCT00402194|2386357|P1|COMPLETED|Overall Study||9
984875|NCT00402194|2386356|P2|STARTED|Overall Study||8
984876|NCT00402194|2386357|P1|STARTED|Overall Study||9
984877|NCT00402233|2386369|P4|NOT COMPLETED|Overall Study||11
984878|NCT00402233|2386370|P3|NOT COMPLETED|Overall Study||11
984879|NCT00402233|2386371|P2|NOT COMPLETED|Overall Study||10
984880|NCT00402233|2386372|P1|NOT COMPLETED|Overall Study||5
984881|NCT00402233|2386369|P4|COMPLETED|Overall Study||62
984882|NCT00402233|2386370|P3|COMPLETED|Overall Study||70
984883|NCT00402233|2386371|P2|COMPLETED|Overall Study||70
984884|NCT00402233|2386372|P1|COMPLETED|Overall Study||72
984885|NCT00402233|2386369|P4|STARTED|Overall Study||73
984886|NCT00402233|2386370|P3|STARTED|Overall Study||81
984887|NCT00402233|2386371|P2|STARTED|Overall Study||80
984888|NCT00402233|2386372|P1|STARTED|Overall Study||77
984889|NCT00402246|2386396|P2|NOT COMPLETED|Overall Study||234
984890|NCT00402246|2386397|P1|NOT COMPLETED|Overall Study||220
984891|NCT00402246|2386396|P2|COMPLETED|Overall Study||749
984892|NCT00402246|2386397|P1|COMPLETED|Overall Study||794
984893|NCT00402246|2386396|P2|STARTED|Overall Study||983
984894|NCT00402246|2386397|P1|STARTED|Overall Study||1014
984895|NCT00402285|2386430|P3|NOT COMPLETED|Overall Study||2
984896|NCT00402285|2386431|P2|NOT COMPLETED|Overall Study||6
984897|NCT00402285|2386432|P1|NOT COMPLETED|Overall Study||7
984898|NCT00402285|2386430|P3|COMPLETED|Overall Study||26
984899|NCT00402285|2386431|P2|COMPLETED|Overall Study||21
984900|NCT00402285|2386432|P1|COMPLETED|Overall Study||22
984901|NCT00402285|2386430|P3|STARTED|Overall Study||28
984902|NCT00402285|2386431|P2|STARTED|Overall Study||27
984903|NCT00402285|2386432|P1|STARTED|Overall Study||29
984904|NCT00402324|2386440|P2|NOT COMPLETED|Overall Study||41
984905|NCT00402324|2386441|P1|NOT COMPLETED|Overall Study||43
984906|NCT00402324|2386440|P2|COMPLETED|Overall Study||60
984907|NCT00402324|2386441|P1|COMPLETED|Overall Study||58
984908|NCT00402324|2386440|P2|STARTED|Overall Study||101
984909|NCT00402324|2386441|P1|STARTED|Overall Study||101
984910|NCT00402337|2386476|P5|NOT COMPLETED|Overall Study||8
984911|NCT00402337|2386477|P4|NOT COMPLETED|Overall Study||12
984912|NCT00402337|2386478|P3|NOT COMPLETED|Overall Study||4
984913|NCT00402337|2386479|P2|NOT COMPLETED|Overall Study||6
984914|NCT00402337|2386480|P1|NOT COMPLETED|Overall Study||5
984915|NCT00402337|2386476|P5|COMPLETED|Overall Study||61
984916|NCT00402337|2386477|P4|COMPLETED|Overall Study||51
984917|NCT00402337|2386478|P3|COMPLETED|Overall Study||58
984918|NCT00402337|2386479|P2|COMPLETED|Overall Study||51
984919|NCT00402337|2386480|P1|COMPLETED|Overall Study||54
984920|NCT00402337|2386476|P5|STARTED|Overall Study||69
984921|NCT00402337|2386477|P4|STARTED|Overall Study||63
984922|NCT00402337|2386478|P3|STARTED|Overall Study||62
984923|NCT00402337|2386479|P2|STARTED|Overall Study||57
984924|NCT00402337|2386480|P1|STARTED|Overall Study||59
984925|NCT00402363|2386521|P4|NOT COMPLETED|Overall Study||10
984926|NCT00402363|2386522|P3|NOT COMPLETED|Overall Study||6
984927|NCT00402363|2386523|P2|NOT COMPLETED|Overall Study||30
984928|NCT00402363|2386524|P1|NOT COMPLETED|Overall Study||33
984929|NCT00402363|2386521|P4|COMPLETED|Overall Study||45
984930|NCT00402363|2386522|P3|COMPLETED|Overall Study||60
984931|NCT00402363|2386523|P2|COMPLETED|Overall Study||246
984932|NCT00402363|2386524|P1|COMPLETED|Overall Study||233
984933|NCT00402363|2386521|P4|STARTED|Overall Study||55
984934|NCT00402363|2386522|P3|STARTED|Overall Study||66
984935|NCT00402363|2386523|P2|STARTED|Overall Study||276
984936|NCT00402363|2386524|P1|STARTED|Overall Study||266
984937|NCT00402597|2386587|P5|NOT COMPLETED|Overall Study||124
984938|NCT00402597|2386588|P4|NOT COMPLETED|Overall Study||74
984939|NCT00402597|2386589|P3|NOT COMPLETED|Overall Study||212
984940|NCT00402597|2386590|P2|NOT COMPLETED|Overall Study||46
984941|NCT00402597|2386591|P1|NOT COMPLETED|Overall Study||191
984942|NCT00402597|2386587|P5|COMPLETED|Overall Study||479
984943|NCT00402597|2386588|P4|COMPLETED|Overall Study||279
984944|NCT00402597|2386589|P3|COMPLETED|Overall Study||834
984945|NCT00402597|2386590|P2|COMPLETED|Overall Study||261
984946|NCT00402597|2386591|P1|COMPLETED|Overall Study||962
984947|NCT00402597|2386587|P5|STARTED|Overall Study||603
984948|NCT00402597|2386588|P4|STARTED|Overall Study||353
984949|NCT00402597|2386589|P3|STARTED|Overall Study||1046
984950|NCT00402597|2386590|P2|STARTED|Overall Study||307
984951|NCT00402597|2386591|P1|STARTED|Overall Study||1153
984952|NCT00402649|2386628|P1|NOT COMPLETED|Overall Study||2
984953|NCT00402649|2386628|P1|COMPLETED|Overall Study||33
984954|NCT00402649|2386628|P1|STARTED|Overall Study||35
984955|NCT00402688|2386641|P3|NOT COMPLETED|Overall Study||15
984956|NCT00402688|2386642|P2|NOT COMPLETED|Overall Study||16
984957|NCT00402688|2386643|P1|NOT COMPLETED|Overall Study||21
984958|NCT00402688|2386641|P3|COMPLETED|Overall Study||65
984959|NCT00402688|2386642|P2|COMPLETED|Overall Study||65
984960|NCT00402688|2386643|P1|COMPLETED|Overall Study||60
984961|NCT00402688|2386641|P3|STARTED|Overall Study||80
984962|NCT00402688|2386642|P2|STARTED|Overall Study||81
984963|NCT00402688|2386643|P1|STARTED|Overall Study||81
984964|NCT00402714|2386668|P2|NOT COMPLETED|Overall Study||0
984965|NCT00402714|2386669|P1|NOT COMPLETED|Overall Study||0
984966|NCT00402714|2386668|P2|COMPLETED|Overall Study||11
984967|NCT00402714|2386669|P1|COMPLETED|Overall Study||3
984968|NCT00402714|2386668|P2|STARTED|Overall Study||11
984969|NCT00402714|2386669|P1|STARTED|Overall Study||3
984970|NCT00402727|2386679|P2|NOT COMPLETED|Overall Study||34
984971|NCT00402727|2386680|P1|NOT COMPLETED|Overall Study||42
984972|NCT00402727|2386679|P2|COMPLETED|Overall Study||347
984973|NCT00402727|2386680|P1|COMPLETED|Overall Study||390
984974|NCT00402727|2386679|P2|Achieving Test Of Cure (TOC)|Overall Study||347
984975|NCT00402727|2386680|P1|Achieving Test Of Cure (TOC)|Overall Study||390
984976|NCT00402727|2386679|P2|Achieving End Of Treatment (EOT)|Overall Study||355
984977|NCT00402727|2386680|P1|Achieving End Of Treatment (EOT)|Overall Study||408
984978|NCT00402727|2386679|P2|STARTED|Overall Study||381
984979|NCT00402727|2386680|P1|STARTED|Overall Study||432
984980|NCT00402740|2386708|P1|NOT COMPLETED|Overall Study||80
984981|NCT00402740|2386708|P1|COMPLETED|Overall Study||242
984982|NCT00402740|2386708|P1|STARTED|Overall Study||322
984983|NCT00402883|2386718|P1|NOT COMPLETED|Maintenance Therapy||0
984984|NCT00402883|2386718|P1|COMPLETED|Maintenance Therapy|All 5 patients received limited maintenance therapy due to early trial closure.|5
984985|NCT00402883|2386718|P1|STARTED|Maintenance Therapy||5
984986|NCT00402883|2386718|P1|NOT COMPLETED|Consolidation Therapy||0
984987|NCT00402883|2386718|P1|COMPLETED|Consolidation Therapy||5
984988|NCT00402883|2386718|P1|STARTED|Consolidation Therapy||5
984989|NCT00402883|2386718|P1|NOT COMPLETED|Induction Therapy||0
984990|NCT00402883|2386718|P1|COMPLETED|Induction Therapy||5
984991|NCT00402883|2386718|P1|STARTED|Induction Therapy||5
984992|NCT00402896|2386722|P1|NOT COMPLETED|Overall Study||0
984993|NCT00402896|2386722|P1|COMPLETED|Overall Study||20
984994|NCT00402896|2386722|P1|STARTED|Overall Study||20
984995|NCT00395226|2386728|P2|NOT COMPLETED|Overall Study||5
984996|NCT00395226|2386729|P1|NOT COMPLETED|Overall Study||4
984997|NCT00395226|2386728|P2|COMPLETED|Overall Study||22
984998|NCT00395226|2386729|P1|COMPLETED|Overall Study||22
984999|NCT00395226|2386728|P2|STARTED|Overall Study||27
985000|NCT00395226|2386729|P1|STARTED|Overall Study||26
985001|NCT00395291|2386735|P2|NOT COMPLETED|Second Intervention||0
985002|NCT00395291|2386736|P1|NOT COMPLETED|Second Intervention||0
985003|NCT00395291|2386735|P2|COMPLETED|Second Intervention||9
985004|NCT00395291|2386736|P1|COMPLETED|Second Intervention||13
985005|NCT00395291|2386735|P2|STARTED|Second Intervention||9
985006|NCT00395291|2386736|P1|STARTED|Second Intervention||13
985007|NCT00395291|2386735|P2|NOT COMPLETED|Washout Period for 30 Days||0
985008|NCT00395291|2386736|P1|NOT COMPLETED|Washout Period for 30 Days||2
985009|NCT00395291|2386735|P2|COMPLETED|Washout Period for 30 Days||9
985010|NCT00395291|2386736|P1|COMPLETED|Washout Period for 30 Days||13
985011|NCT00395291|2386735|P2|STARTED|Washout Period for 30 Days||9
985012|NCT00395291|2386736|P1|STARTED|Washout Period for 30 Days||15
985013|NCT00395291|2386735|P2|NOT COMPLETED|First Intervention||0
985014|NCT00395291|2386736|P1|NOT COMPLETED|First Intervention||2
985015|NCT00395291|2386735|P2|COMPLETED|First Intervention||9
985016|NCT00395291|2386736|P1|COMPLETED|First Intervention||15
985017|NCT00395291|2386735|P2|STARTED|First Intervention||9
985018|NCT00395291|2386736|P1|STARTED|First Intervention||17
985019|NCT00395304|2386766|P6|NOT COMPLETED|Treatment Period 3||1
985020|NCT00395304|2386767|P5|NOT COMPLETED|Treatment Period 3||0
985021|NCT00395304|2386768|P4|NOT COMPLETED|Treatment Period 3||2
985022|NCT00395304|2386769|P3|NOT COMPLETED|Treatment Period 3||0
985023|NCT00395304|2386770|P2|NOT COMPLETED|Treatment Period 3||2
985024|NCT00395304|2386771|P1|NOT COMPLETED|Treatment Period 3||1
985025|NCT00395304|2386766|P6|COMPLETED|Treatment Period 3||27
985026|NCT00395304|2386767|P5|COMPLETED|Treatment Period 3||27
985027|NCT00395304|2386768|P4|COMPLETED|Treatment Period 3||25
985028|NCT00395304|2386769|P3|COMPLETED|Treatment Period 3||29
985029|NCT00395304|2386770|P2|COMPLETED|Treatment Period 3||20
985030|NCT00395304|2386771|P1|COMPLETED|Treatment Period 3||29
985031|NCT00395304|2386766|P6|STARTED|Treatment Period 3||28
985032|NCT00395304|2386767|P5|STARTED|Treatment Period 3||27
985033|NCT00395304|2386768|P4|STARTED|Treatment Period 3||27
985034|NCT00395304|2386769|P3|STARTED|Treatment Period 3||29
985035|NCT00395304|2386770|P2|STARTED|Treatment Period 3||22
985036|NCT00395304|2386771|P1|STARTED|Treatment Period 3||30
985037|NCT00395304|2386766|P6|NOT COMPLETED|Treatment Period 2||2
985038|NCT00395304|2386767|P5|NOT COMPLETED|Treatment Period 2||0
985039|NCT00395304|2386768|P4|NOT COMPLETED|Treatment Period 2||1
985040|NCT00395304|2386769|P3|NOT COMPLETED|Treatment Period 2||1
985041|NCT00395304|2386770|P2|NOT COMPLETED|Treatment Period 2||4
985042|NCT00395304|2386771|P1|NOT COMPLETED|Treatment Period 2||0
985043|NCT00395304|2386766|P6|COMPLETED|Treatment Period 2||28
985044|NCT00395304|2386767|P5|COMPLETED|Treatment Period 2||27
985045|NCT00395304|2386768|P4|COMPLETED|Treatment Period 2||27
985046|NCT00395304|2386769|P3|COMPLETED|Treatment Period 2||29
985047|NCT00395304|2386770|P2|COMPLETED|Treatment Period 2||22
985048|NCT00395304|2386771|P1|COMPLETED|Treatment Period 2||30
985049|NCT00395304|2386766|P6|STARTED|Treatment Period 2||30
985050|NCT00395304|2386767|P5|STARTED|Treatment Period 2||27
985051|NCT00395304|2386768|P4|STARTED|Treatment Period 2||28
985052|NCT00395304|2386769|P3|STARTED|Treatment Period 2||30
985053|NCT00395304|2386770|P2|STARTED|Treatment Period 2||26
985054|NCT00395304|2386771|P1|STARTED|Treatment Period 2||30
985055|NCT00395304|2386766|P6|NOT COMPLETED|Treatment Period 1||2
985056|NCT00395304|2386767|P5|NOT COMPLETED|Treatment Period 1||1
985057|NCT00395304|2386768|P4|NOT COMPLETED|Treatment Period 1||3
985058|NCT00395304|2386769|P3|NOT COMPLETED|Treatment Period 1||0
985059|NCT00395304|2386770|P2|NOT COMPLETED|Treatment Period 1||4
985060|NCT00395304|2386771|P1|NOT COMPLETED|Treatment Period 1||1
985061|NCT00395304|2386766|P6|COMPLETED|Treatment Period 1||30
985062|NCT00395304|2386767|P5|COMPLETED|Treatment Period 1||27
985063|NCT00395304|2386768|P4|COMPLETED|Treatment Period 1||28
985064|NCT00395304|2386769|P3|COMPLETED|Treatment Period 1||30
985065|NCT00395304|2386770|P2|COMPLETED|Treatment Period 1||26
985066|NCT00395304|2386771|P1|COMPLETED|Treatment Period 1||30
985067|NCT00395304|2386766|P6|STARTED|Treatment Period 1||32
985068|NCT00395304|2386767|P5|STARTED|Treatment Period 1||28
985069|NCT00395304|2386768|P4|STARTED|Treatment Period 1||31
985070|NCT00395304|2386769|P3|STARTED|Treatment Period 1||30
985071|NCT00395304|2386770|P2|STARTED|Treatment Period 1||30
985072|NCT00395304|2386771|P1|STARTED|Treatment Period 1||31
985073|NCT00395343|2386777|P2|NOT COMPLETED|Overall Study||36
985074|NCT00395343|2386778|P1|NOT COMPLETED|Overall Study||41
985075|NCT00395343|2386777|P2|COMPLETED|Overall Study||283
985076|NCT00395343|2386778|P1|COMPLETED|Overall Study||281
985077|NCT00395343|2386777|P2|STARTED|Overall Study||319
985078|NCT00395343|2386778|P1|STARTED|Overall Study||322
985079|NCT00395447|2386798|P2|NOT COMPLETED|Overall Study||111
985080|NCT00395447|2386799|P1|NOT COMPLETED|Overall Study||121
985081|NCT00395447|2386798|P2|COMPLETED|Overall Study||602
985082|NCT00395447|2386799|P1|COMPLETED|Overall Study||910
985083|NCT00395447|2386798|P2|STARTED|Overall Study||713
985084|NCT00395447|2386799|P1|STARTED|Overall Study||1031
985085|NCT00395460|2386807|P2|NOT COMPLETED|Overall Study||0
985086|NCT00395460|2386808|P1|NOT COMPLETED|Overall Study||1
985087|NCT00395460|2386807|P2|COMPLETED|Overall Study||75
985088|NCT00395460|2386808|P1|COMPLETED|Overall Study||71
985089|NCT00395460|2386807|P2|Received Treatment|Overall Study||75
985090|NCT00395460|2386808|P1|Received Treatment|Overall Study|1 participant withdrew consent prior to study drug injection and did not receive any study drug.|71
985091|NCT00395460|2386807|P2|STARTED|Overall Study||75
985092|NCT00395460|2386808|P1|STARTED|Overall Study||72
985093|NCT00395486|2386832|P2|NOT COMPLETED|Overall Study||5
985094|NCT00395486|2386833|P1|NOT COMPLETED|Overall Study||6
985095|NCT00395486|2386832|P2|COMPLETED|Overall Study|Completed subjects|121
985096|NCT00395486|2386833|P1|COMPLETED|Overall Study|Completed subjects|126
985097|NCT00395486|2386832|P2|STARTED|Overall Study|Randomized subjects|126
985098|NCT00395486|2386833|P1|STARTED|Overall Study|Randomized subjects|132
985099|NCT00395512|2386865|P4|NOT COMPLETED|Overall Study||38
985100|NCT00395512|2386866|P3|NOT COMPLETED|Overall Study||28
985101|NCT00395512|2386867|P2|NOT COMPLETED|Overall Study||37
985102|NCT00395512|2386868|P1|NOT COMPLETED|Overall Study||38
985103|NCT00395512|2386865|P4|COMPLETED|Overall Study||126
985104|NCT00395512|2386866|P3|COMPLETED|Overall Study||136
985105|NCT00395512|2386867|P2|COMPLETED|Overall Study||126
985106|NCT00395512|2386868|P1|COMPLETED|Overall Study||126
985107|NCT00395512|2386865|P4|Safety Set|Overall Study|1 participant was lost to follow-up post visit 1. It is unknown if they took any study medication.|163
985108|NCT00395512|2386866|P3|Safety Set|Overall Study||164
985109|NCT00395512|2386867|P2|Safety Set|Overall Study||163
985110|NCT00395512|2386868|P1|Safety Set|Overall Study||164
985111|NCT00395512|2386865|P4|STARTED|Overall Study||164
985112|NCT00395512|2386866|P3|STARTED|Overall Study||164
985113|NCT00395512|2386867|P2|STARTED|Overall Study||163
985114|NCT00395512|2386868|P1|STARTED|Overall Study||164
985115|NCT00395629|2387041|P3|NOT COMPLETED|Extension Study||3
985116|NCT00395629|2387042|P2|NOT COMPLETED|Extension Study||0
985117|NCT00395629|2387043|P1|NOT COMPLETED|Extension Study||0
985118|NCT00395629|2387041|P3|COMPLETED|Extension Study||8
985119|NCT00395629|2387042|P2|COMPLETED|Extension Study||6
985120|NCT00395629|2387043|P1|COMPLETED|Extension Study||9
985121|NCT00395629|2387041|P3|STARTED|Extension Study||11
985122|NCT00395629|2387042|P2|STARTED|Extension Study||6
985123|NCT00395629|2387043|P1|STARTED|Extension Study||9
985124|NCT00395629|2387041|P3|NOT COMPLETED|Core Study||7
985125|NCT00395629|2387042|P2|NOT COMPLETED|Core Study||4
985126|NCT00395629|2387043|P1|NOT COMPLETED|Core Study||1
985127|NCT00395629|2387041|P3|COMPLETED|Core Study||16
985128|NCT00395629|2387042|P2|COMPLETED|Core Study||11
985129|NCT00395629|2387043|P1|COMPLETED|Core Study||10
985130|NCT00395629|2387041|P3|STARTED|Core Study||23
985131|NCT00395629|2387042|P2|STARTED|Core Study||15
985132|NCT00395629|2387043|P1|STARTED|Core Study||11
985133|NCT00395642|2387057|P1|NOT COMPLETED|Overall Study||13
985134|NCT00395642|2387057|P1|COMPLETED|Overall Study||53
985135|NCT00395642|2387057|P1|STARTED|Overall Study||66
985136|NCT00395694|2387063|P2|NOT COMPLETED|Continuation Phase||13
985137|NCT00395694|2387064|P1|NOT COMPLETED|Continuation Phase||15
985138|NCT00395694|2387063|P2|COMPLETED|Continuation Phase||35
985139|NCT00395694|2387064|P1|COMPLETED|Continuation Phase||34
985140|NCT00395694|2387063|P2|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|48
985141|NCT00395694|2387064|P1|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|49
985142|NCT00395694|2387063|P2|NOT COMPLETED|Escalation Phase + Maintenance Phase||2
985143|NCT00395694|2387064|P1|NOT COMPLETED|Escalation Phase + Maintenance Phase||1
985144|NCT00395694|2387063|P2|COMPLETED|Escalation Phase + Maintenance Phase||49
985145|NCT00395694|2387064|P1|COMPLETED|Escalation Phase + Maintenance Phase||50
985146|NCT00395694|2387063|P2|STARTED|Escalation Phase + Maintenance Phase||51
985147|NCT00395694|2387064|P1|STARTED|Escalation Phase + Maintenance Phase||51
985148|NCT00395733|2387097|P2|NOT COMPLETED|Period 2||5
985149|NCT00395733|2387098|P1|NOT COMPLETED|Period 2||2
985150|NCT00395733|2387097|P2|COMPLETED|Period 2||37
985151|NCT00395733|2387098|P1|COMPLETED|Period 2||39
985152|NCT00395733|2387097|P2|STARTED|Period 2||42
985153|NCT00395733|2387098|P1|STARTED|Period 2||41
985154|NCT00395733|2387097|P2|NOT COMPLETED|Period 1||0
985155|NCT00395733|2387098|P1|NOT COMPLETED|Period 1||0
985156|NCT00395733|2387097|P2|COMPLETED|Period 1||42
985157|NCT00395733|2387098|P1|COMPLETED|Period 1||41
985158|NCT00395733|2387097|P2|STARTED|Period 1||42
985159|NCT00395733|2387098|P1|STARTED|Period 1||41
985160|NCT00395746|2387123|P3|NOT COMPLETED|Overall Study||22
985161|NCT00395746|2387124|P2|NOT COMPLETED|Overall Study||4
985162|NCT00395746|2387125|P1|NOT COMPLETED|Overall Study||10
985163|NCT00395746|2387123|P3|COMPLETED|Overall Study|Completed 52 weeks treatment|66
985164|NCT00395746|2387124|P2|COMPLETED|Overall Study|Completed 52 weeks treatment|84
985165|NCT00395746|2387125|P1|COMPLETED|Overall Study|Completed 52 weeks treatment|78
985166|NCT00395746|2387123|P3|STARTED|Overall Study|Exposed to study drug|88
985167|NCT00395746|2387124|P2|STARTED|Overall Study|Exposed to study drug|88
985168|NCT00395746|2387125|P1|STARTED|Overall Study|Exposed to study drug|88
985169|NCT00395850|2387173|P4|NOT COMPLETED|Disulfiram/Placebo Treatment||13
985170|NCT00395850|2387174|P3|NOT COMPLETED|Disulfiram/Placebo Treatment||19
985171|NCT00395850|2387175|P2|NOT COMPLETED|Disulfiram/Placebo Treatment||14
985172|NCT00395850|2387176|P1|NOT COMPLETED|Disulfiram/Placebo Treatment||9
985173|NCT00395850|2387173|P4|COMPLETED|Disulfiram/Placebo Treatment||8
985174|NCT00395850|2387174|P3|COMPLETED|Disulfiram/Placebo Treatment||5
985175|NCT00395850|2387175|P2|COMPLETED|Disulfiram/Placebo Treatment||9
985176|NCT00395850|2387176|P1|COMPLETED|Disulfiram/Placebo Treatment||11
985177|NCT00395850|2387173|P4|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|21
985178|NCT00395850|2387174|P3|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|24
985179|NCT00395850|2387175|P2|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|23
985180|NCT00395850|2387176|P1|STARTED|Disulfiram/Placebo Treatment|Received >= 1 disulfiram dose. Two baseline/randomized subjects dropped out before receiving disulf|20
985181|NCT00395850|2387173|P4|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||4
985182|NCT00395850|2387174|P3|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||6
985183|NCT00395850|2387175|P2|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||2
985184|NCT00395850|2387176|P1|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||5
985185|NCT00395850|2387173|P4|COMPLETED|Randomization to Disulfiram/ Pre-admin||21
985186|NCT00395850|2387174|P3|COMPLETED|Randomization to Disulfiram/ Pre-admin||24
985187|NCT00395850|2387175|P2|COMPLETED|Randomization to Disulfiram/ Pre-admin||23
985188|NCT00395850|2387176|P1|COMPLETED|Randomization to Disulfiram/ Pre-admin||22
985189|NCT00395850|2387173|P4|STARTED|Randomization to Disulfiram/ Pre-admin||25
985190|NCT00395850|2387174|P3|STARTED|Randomization to Disulfiram/ Pre-admin||30
985191|NCT00395850|2387175|P2|STARTED|Randomization to Disulfiram/ Pre-admin||25
985192|NCT00395850|2387176|P1|STARTED|Randomization to Disulfiram/ Pre-admin||27
985193|NCT00395850|2387173|P4|NOT COMPLETED|Pre-randomization Baseline/Induction||0
985194|NCT00395850|2387174|P3|NOT COMPLETED|Pre-randomization Baseline/Induction||0
985195|NCT00395850|2387175|P2|NOT COMPLETED|Pre-randomization Baseline/Induction||0
985196|NCT00395850|2387176|P1|NOT COMPLETED|Pre-randomization Baseline/Induction||11
985197|NCT00395850|2387173|P4|COMPLETED|Pre-randomization Baseline/Induction||0
985198|NCT00395850|2387174|P3|COMPLETED|Pre-randomization Baseline/Induction||0
985199|NCT00395850|2387175|P2|COMPLETED|Pre-randomization Baseline/Induction||0
985200|NCT00395850|2387176|P1|COMPLETED|Pre-randomization Baseline/Induction||107
985201|NCT00395850|2387173|P4|STARTED|Pre-randomization Baseline/Induction||0
985202|NCT00395850|2387174|P3|STARTED|Pre-randomization Baseline/Induction||0
985203|NCT00395850|2387175|P2|STARTED|Pre-randomization Baseline/Induction||0
985204|NCT00395850|2387176|P1|STARTED|Pre-randomization Baseline/Induction|Pre-randomization and disulfiram (disulf) administration|118
985205|NCT00395863|2387192|P2|NOT COMPLETED|Overall Study||3
985206|NCT00395863|2387193|P1|NOT COMPLETED|Overall Study||2
985207|NCT00395863|2387192|P2|COMPLETED|Overall Study||20
985208|NCT00395863|2387193|P1|COMPLETED|Overall Study||21
985209|NCT00395863|2387192|P2|STARTED|Overall Study||23
985210|NCT00395863|2387193|P1|STARTED|Overall Study||23
985211|NCT00395876|2387226|P2|NOT COMPLETED|Overall Study||0
985212|NCT00395876|2387227|P1|NOT COMPLETED|Overall Study||3
985213|NCT00395876|2387226|P2|COMPLETED|Overall Study||50
985214|NCT00395876|2387227|P1|COMPLETED|Overall Study||47
985215|NCT00395876|2387226|P2|STARTED|Overall Study||50
985216|NCT00395876|2387227|P1|STARTED|Overall Study||50
985217|NCT00395967|2387253|P1|NOT COMPLETED|Follow-up Period||2
985218|NCT00395967|2387253|P1|COMPLETED|Follow-up Period||3
985219|NCT00395967|2387253|P1|STARTED|Follow-up Period|Participants who had transplants.|5
985220|NCT00395967|2387253|P1|NOT COMPLETED|Treatment Period||1
985221|NCT00395967|2387253|P1|COMPLETED|Treatment Period|Failed mobilization due to <2 fold yield after one day of plerixafor treatment|4
985222|NCT00395967|2387253|P1|STARTED|Treatment Period||5
985223|NCT00395993|2387264|P2|NOT COMPLETED|Overall Study||19
985224|NCT00395993|2387265|P1|NOT COMPLETED|Overall Study||35
985225|NCT00395993|2387264|P2|COMPLETED|Overall Study||212
985226|NCT00395993|2387265|P1|COMPLETED|Overall Study||211
985227|NCT00395993|2387264|P2|STARTED|Overall Study||231
985228|NCT00395993|2387265|P1|STARTED|Overall Study||246
985232|NCT00396032|2387288|P2|NOT COMPLETED|Overall Study||5
985233|NCT00396032|2387289|P1|NOT COMPLETED|Overall Study||4
985234|NCT00396032|2387288|P2|COMPLETED|Overall Study||71
985235|NCT00396032|2387289|P1|COMPLETED|Overall Study||70
985236|NCT00396032|2387288|P2|STARTED|Overall Study||76
985237|NCT00396032|2387289|P1|STARTED|Overall Study||74
985238|NCT00402987|2387307|P4|NOT COMPLETED|Overall Study||0
985239|NCT00402987|2387308|P3|NOT COMPLETED|Overall Study||1
985240|NCT00402987|2387309|P2|NOT COMPLETED|Overall Study||0
985241|NCT00402987|2387310|P1|NOT COMPLETED|Overall Study||0
985242|NCT00402987|2387307|P4|COMPLETED|Overall Study||89
985243|NCT00402987|2387308|P3|COMPLETED|Overall Study||44
985244|NCT00402987|2387309|P2|COMPLETED|Overall Study||45
985245|NCT00402987|2387310|P1|COMPLETED|Overall Study||90
985246|NCT00402987|2387307|P4|STARTED|Overall Study||89
985247|NCT00402987|2387308|P3|STARTED|Overall Study||45
985248|NCT00402987|2387309|P2|STARTED|Overall Study||45
985249|NCT00402987|2387310|P1|STARTED|Overall Study||90
985250|NCT00403130|2387472|P1|NOT COMPLETED|Overall Study||5
985251|NCT00403130|2387472|P1|COMPLETED|Overall Study||26
985252|NCT00403130|2387472|P1|STARTED|Overall Study||31
985253|NCT00403234|2387483|P4|NOT COMPLETED|Overall Study||0
985254|NCT00403234|2387484|P3|NOT COMPLETED|Overall Study||1
985255|NCT00403234|2387485|P2|NOT COMPLETED|Overall Study||1
985256|NCT00403234|2387486|P1|NOT COMPLETED|Overall Study||1
985257|NCT00403234|2387483|P4|COMPLETED|Overall Study||2
985258|NCT00403234|2387484|P3|COMPLETED|Overall Study||2
985259|NCT00403234|2387485|P2|COMPLETED|Overall Study||2
985260|NCT00403234|2387486|P1|COMPLETED|Overall Study||1
985261|NCT00403234|2387483|P4|STARTED|Overall Study||2
985262|NCT00403234|2387484|P3|STARTED|Overall Study||3
985263|NCT00403234|2387485|P2|STARTED|Overall Study||3
985264|NCT00403234|2387486|P1|STARTED|Overall Study||2
985265|NCT00403273|2387498|P2|NOT COMPLETED|Overall Study||4
985266|NCT00403273|2387499|P1|NOT COMPLETED|Overall Study||3
985267|NCT00403273|2387498|P2|COMPLETED|Overall Study||25
985268|NCT00403273|2387499|P1|COMPLETED|Overall Study||22
985269|NCT00403273|2387498|P2|STARTED|Overall Study||29
985270|NCT00403273|2387499|P1|STARTED|Overall Study||25
985271|NCT00403585|2387525|P1|NOT COMPLETED|Open-Label Phase; Extension Study||6
985272|NCT00403585|2387525|P1|COMPLETED|Open-Label Phase; Extension Study||74
985273|NCT00403585|2387525|P1|STARTED|Open-Label Phase; Extension Study|80 of 102 participants completing Study 103814 enrolled in extension (22 didn't continue medication)|80
985274|NCT00403585|2387525|P1|NOT COMPLETED|Initial Treatment Phase||2
985275|NCT00403585|2387525|P1|COMPLETED|Initial Treatment Phase||102
985276|NCT00403585|2387525|P1|STARTED|Initial Treatment Phase||104
985277|NCT00403754|2387534|P4|NOT COMPLETED|Open Label: Salmeterol||0
985278|NCT00403754|2387535|P3|NOT COMPLETED|Open Label: Salmeterol||0
985279|NCT00403754|2387536|P2|NOT COMPLETED|Open Label: Salmeterol||0
985280|NCT00403754|2387537|P1|NOT COMPLETED|Open Label: Salmeterol||0
985281|NCT00403754|2387534|P4|COMPLETED|Open Label: Salmeterol||11
985282|NCT00403754|2387535|P3|COMPLETED|Open Label: Salmeterol||8
985283|NCT00403754|2387536|P2|COMPLETED|Open Label: Salmeterol||9
985284|NCT00403754|2387537|P1|COMPLETED|Open Label: Salmeterol||11
985285|NCT00403754|2387534|P4|STARTED|Open Label: Salmeterol||11
985286|NCT00403754|2387535|P3|STARTED|Open Label: Salmeterol||8
985287|NCT00403754|2387536|P2|STARTED|Open Label: Salmeterol||9
985288|NCT00403754|2387537|P1|STARTED|Open Label: Salmeterol||11
985289|NCT00403754|2387534|P4|NOT COMPLETED|Core Treatment Period 4||0
985290|NCT00403754|2387535|P3|NOT COMPLETED|Core Treatment Period 4||0
985291|NCT00403754|2387536|P2|NOT COMPLETED|Core Treatment Period 4||0
985292|NCT00403754|2387537|P1|NOT COMPLETED|Core Treatment Period 4||0
985293|NCT00403754|2387534|P4|COMPLETED|Core Treatment Period 4||11
985294|NCT00403754|2387535|P3|COMPLETED|Core Treatment Period 4||8
985295|NCT00403754|2387536|P2|COMPLETED|Core Treatment Period 4||9
985296|NCT00403754|2387537|P1|COMPLETED|Core Treatment Period 4||11
985297|NCT00403754|2387534|P4|STARTED|Core Treatment Period 4||11
985298|NCT00403754|2387535|P3|STARTED|Core Treatment Period 4||8
985299|NCT00403754|2387536|P2|STARTED|Core Treatment Period 4||9
985300|NCT00403754|2387537|P1|STARTED|Core Treatment Period 4||11
985301|NCT00403754|2387534|P4|NOT COMPLETED|Core Treatment Period 3||0
985302|NCT00403754|2387535|P3|NOT COMPLETED|Core Treatment Period 3||0
985303|NCT00403754|2387536|P2|NOT COMPLETED|Core Treatment Period 3||0
985304|NCT00403754|2387537|P1|NOT COMPLETED|Core Treatment Period 3||0
985305|NCT00403754|2387534|P4|COMPLETED|Core Treatment Period 3||11
985306|NCT00403754|2387535|P3|COMPLETED|Core Treatment Period 3||8
985307|NCT00403754|2387536|P2|COMPLETED|Core Treatment Period 3||9
985308|NCT00403754|2387537|P1|COMPLETED|Core Treatment Period 3||11
985309|NCT00403754|2387534|P4|STARTED|Core Treatment Period 3||11
985310|NCT00403754|2387535|P3|STARTED|Core Treatment Period 3||8
985311|NCT00403754|2387536|P2|STARTED|Core Treatment Period 3||9
985312|NCT00403754|2387537|P1|STARTED|Core Treatment Period 3||11
985313|NCT00403754|2387534|P4|NOT COMPLETED|Core Treatment Period 2||0
985314|NCT00403754|2387535|P3|NOT COMPLETED|Core Treatment Period 2||1
985315|NCT00403754|2387536|P2|NOT COMPLETED|Core Treatment Period 2||0
985316|NCT00403754|2387537|P1|NOT COMPLETED|Core Treatment Period 2||0
985317|NCT00403754|2387534|P4|COMPLETED|Core Treatment Period 2||11
985318|NCT00403754|2387535|P3|COMPLETED|Core Treatment Period 2||8
985319|NCT00403754|2387536|P2|COMPLETED|Core Treatment Period 2||9
985320|NCT00403754|2387537|P1|COMPLETED|Core Treatment Period 2||11
985321|NCT00403754|2387534|P4|STARTED|Core Treatment Period 2||11
985322|NCT00403754|2387535|P3|STARTED|Core Treatment Period 2||9
985323|NCT00403754|2387536|P2|STARTED|Core Treatment Period 2||9
985324|NCT00403754|2387537|P1|STARTED|Core Treatment Period 2||11
985325|NCT00403754|2387534|P4|NOT COMPLETED|Core Treatment Period 1||0
985326|NCT00403754|2387535|P3|NOT COMPLETED|Core Treatment Period 1||0
985327|NCT00403754|2387536|P2|NOT COMPLETED|Core Treatment Period 1||1
985328|NCT00403754|2387537|P1|NOT COMPLETED|Core Treatment Period 1||0
985329|NCT00403754|2387534|P4|COMPLETED|Core Treatment Period 1||11
985330|NCT00403754|2387535|P3|COMPLETED|Core Treatment Period 1||9
985331|NCT00403754|2387536|P2|COMPLETED|Core Treatment Period 1||9
985332|NCT00403754|2387537|P1|COMPLETED|Core Treatment Period 1||11
985333|NCT00403754|2387534|P4|STARTED|Core Treatment Period 1||11
985334|NCT00403754|2387535|P3|STARTED|Core Treatment Period 1||9
985335|NCT00403754|2387536|P2|STARTED|Core Treatment Period 1||10
985336|NCT00403754|2387537|P1|STARTED|Core Treatment Period 1||11
985337|NCT00403767|2387566|P2|NOT COMPLETED|Overall Study||2468
985338|NCT00403767|2387567|P1|NOT COMPLETED|Overall Study||2520
985339|NCT00403767|2387566|P2|COMPLETED|Overall Study||4657
985340|NCT00403767|2387567|P1|COMPLETED|Overall Study||4591
985341|NCT00403767|2387566|P2|STARTED|Overall Study||7125
985342|NCT00403767|2387567|P1|STARTED|Overall Study||7111
985343|NCT00403845|2387591|P4|NOT COMPLETED|Treatment Period 4||0
985344|NCT00403845|2387592|P3|NOT COMPLETED|Treatment Period 4||0
985345|NCT00403845|2387593|P2|NOT COMPLETED|Treatment Period 4||0
985346|NCT00403845|2387594|P1|NOT COMPLETED|Treatment Period 4||0
985347|NCT00403845|2387591|P4|COMPLETED|Treatment Period 4||11
985348|NCT00403845|2387592|P3|COMPLETED|Treatment Period 4||11
985349|NCT00403845|2387593|P2|COMPLETED|Treatment Period 4||13
985350|NCT00403845|2387594|P1|COMPLETED|Treatment Period 4||10
985351|NCT00403845|2387591|P4|STARTED|Treatment Period 4||11
985352|NCT00403845|2387592|P3|STARTED|Treatment Period 4||11
985353|NCT00403845|2387593|P2|STARTED|Treatment Period 4||13
985354|NCT00403845|2387594|P1|STARTED|Treatment Period 4||10
985355|NCT00403845|2387591|P4|NOT COMPLETED|Treatment Period 3||2
985356|NCT00403845|2387592|P3|NOT COMPLETED|Treatment Period 3||0
985357|NCT00403845|2387593|P2|NOT COMPLETED|Treatment Period 3||0
985358|NCT00403845|2387594|P1|NOT COMPLETED|Treatment Period 3||0
985359|NCT00403845|2387591|P4|COMPLETED|Treatment Period 3||11
985360|NCT00403845|2387592|P3|COMPLETED|Treatment Period 3||11
985361|NCT00403845|2387593|P2|COMPLETED|Treatment Period 3||13
985362|NCT00403845|2387594|P1|COMPLETED|Treatment Period 3||10
985363|NCT00403845|2387591|P4|STARTED|Treatment Period 3||13
985364|NCT00403845|2387592|P3|STARTED|Treatment Period 3||11
985365|NCT00403845|2387593|P2|STARTED|Treatment Period 3||13
985366|NCT00403845|2387594|P1|STARTED|Treatment Period 3||10
985367|NCT00403845|2387591|P4|NOT COMPLETED|Treatment Period 2||0
985368|NCT00403845|2387592|P3|NOT COMPLETED|Treatment Period 2||0
985369|NCT00403845|2387593|P2|NOT COMPLETED|Treatment Period 2||0
985370|NCT00403845|2387594|P1|NOT COMPLETED|Treatment Period 2||1
985371|NCT00403845|2387591|P4|COMPLETED|Treatment Period 2||13
985372|NCT00403845|2387592|P3|COMPLETED|Treatment Period 2||11
985373|NCT00403845|2387593|P2|COMPLETED|Treatment Period 2||13
985374|NCT00403845|2387594|P1|COMPLETED|Treatment Period 2||10
985375|NCT00403845|2387591|P4|STARTED|Treatment Period 2||13
985376|NCT00403845|2387592|P3|STARTED|Treatment Period 2||11
985377|NCT00403845|2387593|P2|STARTED|Treatment Period 2||13
985378|NCT00403845|2387594|P1|STARTED|Treatment Period 2||11
985379|NCT00403845|2387591|P4|NOT COMPLETED|Treatment Period 1||1
985380|NCT00403845|2387592|P3|NOT COMPLETED|Treatment Period 1||0
985381|NCT00403845|2387593|P2|NOT COMPLETED|Treatment Period 1||0
985382|NCT00403845|2387594|P1|NOT COMPLETED|Treatment Period 1||1
985383|NCT00403845|2387591|P4|COMPLETED|Treatment Period 1||13
985384|NCT00403845|2387592|P3|COMPLETED|Treatment Period 1||11
985385|NCT00403845|2387593|P2|COMPLETED|Treatment Period 1||13
985386|NCT00403845|2387594|P1|COMPLETED|Treatment Period 1||11
985387|NCT00403845|2387591|P4|STARTED|Treatment Period 1||14
985388|NCT00403845|2387592|P3|STARTED|Treatment Period 1||11
985389|NCT00403845|2387593|P2|STARTED|Treatment Period 1||13
985390|NCT00403845|2387594|P1|STARTED|Treatment Period 1||12
985391|NCT00404079|2387618|P2|NOT COMPLETED|Overall Study||20
985392|NCT00404079|2387619|P1|NOT COMPLETED|Overall Study||22
985393|NCT00404079|2387618|P2|COMPLETED|Overall Study||105
985394|NCT00404079|2387619|P1|COMPLETED|Overall Study||103
985395|NCT00404079|2387618|P2|STARTED|Overall Study||125
985396|NCT00404079|2387619|P1|STARTED|Overall Study||125
985397|NCT00404092|2387629|P4|NOT COMPLETED|Overall Study||0
985398|NCT00404092|2387630|P3|NOT COMPLETED|Overall Study||1
985399|NCT00404092|2387631|P2|NOT COMPLETED|Overall Study||0
985400|NCT00404092|2387632|P1|NOT COMPLETED|Overall Study||1
985401|NCT00404092|2387629|P4|COMPLETED|Overall Study||20
985402|NCT00404092|2387630|P3|COMPLETED|Overall Study||8
985403|NCT00404092|2387631|P2|COMPLETED|Overall Study||8
985404|NCT00404092|2387632|P1|COMPLETED|Overall Study||8
985405|NCT00404092|2387629|P4|STARTED|Overall Study||20
985406|NCT00404092|2387630|P3|STARTED|Overall Study||9
985407|NCT00404092|2387631|P2|STARTED|Overall Study||8
985408|NCT00404092|2387632|P1|STARTED|Overall Study||9
985409|NCT00404248|2387649|P9|NOT COMPLETED|Overall Study||0
985410|NCT00404248|2387650|P8|NOT COMPLETED|Overall Study||0
985411|NCT00404248|2387651|P7|NOT COMPLETED|Overall Study||0
985412|NCT00404248|2387652|P6|NOT COMPLETED|Overall Study||0
985413|NCT00404248|2387653|P5|NOT COMPLETED|Overall Study||0
985414|NCT00404248|2387654|P4|NOT COMPLETED|Overall Study||0
985415|NCT00404248|2387655|P3|NOT COMPLETED|Overall Study||0
985416|NCT00404248|2387656|P2|NOT COMPLETED|Overall Study||1
985417|NCT00404248|2387657|P1|NOT COMPLETED|Overall Study||0
985418|NCT00404248|2387649|P9|COMPLETED|Overall Study||3
985419|NCT00404248|2387650|P8|COMPLETED|Overall Study||6
985420|NCT00404248|2387651|P7|COMPLETED|Overall Study||6
985421|NCT00404248|2387652|P6|COMPLETED|Overall Study||3
985422|NCT00404248|2387653|P5|COMPLETED|Overall Study||3
985423|NCT00404248|2387654|P4|COMPLETED|Overall Study||2
985424|NCT00404248|2387655|P3|COMPLETED|Overall Study||5
985425|NCT00404248|2387656|P2|COMPLETED|Overall Study||3
985426|NCT00404248|2387657|P1|COMPLETED|Overall Study||3
985427|NCT00404248|2387649|P9|STARTED|Overall Study||3
985428|NCT00404248|2387650|P8|STARTED|Overall Study||6
985429|NCT00404248|2387651|P7|STARTED|Overall Study||6
985430|NCT00404248|2387652|P6|STARTED|Overall Study||3
985431|NCT00404248|2387653|P5|STARTED|Overall Study||3
985432|NCT00404248|2387654|P4|STARTED|Overall Study||2
985433|NCT00404248|2387655|P3|STARTED|Overall Study||5
985434|NCT00404248|2387656|P2|STARTED|Overall Study||4
985435|NCT00404248|2387657|P1|STARTED|Overall Study||3
985436|NCT00404352|2387691|P9|NOT COMPLETED|Open Label Extension (up to 36 Months)||2
985437|NCT00404352|2387692|P8|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
985438|NCT00404352|2387693|P7|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
985439|NCT00404352|2387694|P6|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
985440|NCT00404352|2387695|P5|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
985441|NCT00404352|2387696|P4|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
985442|NCT00404352|2387697|P3|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
985443|NCT00404352|2387698|P2|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
985444|NCT00404352|2387699|P1|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
985445|NCT00404352|2387691|P9|COMPLETED|Open Label Extension (up to 36 Months)||9
985446|NCT00404352|2387692|P8|COMPLETED|Open Label Extension (up to 36 Months)||4
985447|NCT00404352|2387693|P7|COMPLETED|Open Label Extension (up to 36 Months)||3
985448|NCT00404352|2387694|P6|COMPLETED|Open Label Extension (up to 36 Months)||0
985449|NCT00404352|2387695|P5|COMPLETED|Open Label Extension (up to 36 Months)||0
985450|NCT00404352|2387696|P4|COMPLETED|Open Label Extension (up to 36 Months)||0
985451|NCT00404352|2387697|P3|COMPLETED|Open Label Extension (up to 36 Months)||0
985452|NCT00404352|2387698|P2|COMPLETED|Open Label Extension (up to 36 Months)||0
985453|NCT00404352|2387699|P1|COMPLETED|Open Label Extension (up to 36 Months)||0
985454|NCT00404352|2387691|P9|STARTED|Open Label Extension (up to 36 Months)|11 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|11
985455|NCT00404352|2387692|P8|STARTED|Open Label Extension (up to 36 Months)|5 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|5
985456|NCT00404352|2387693|P7|STARTED|Open Label Extension (up to 36 Months)|4 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|4
985457|NCT00404352|2387694|P6|STARTED|Open Label Extension (up to 36 Months)||0
985458|NCT00404352|2387695|P5|STARTED|Open Label Extension (up to 36 Months)||0
985459|NCT00404352|2387696|P4|STARTED|Open Label Extension (up to 36 Months)||0
985460|NCT00404352|2387697|P3|STARTED|Open Label Extension (up to 36 Months)||0
985461|NCT00404352|2387698|P2|STARTED|Open Label Extension (up to 36 Months)||0
985462|NCT00404352|2387699|P1|STARTED|Open Label Extension (up to 36 Months)||0
985463|NCT00404352|2387691|P9|NOT COMPLETED|Open Label (up to 24 Month)||0
985464|NCT00404352|2387692|P8|NOT COMPLETED|Open Label (up to 24 Month)||0
985465|NCT00404352|2387693|P7|NOT COMPLETED|Open Label (up to 24 Month)||0
985466|NCT00404352|2387694|P6|NOT COMPLETED|Open Label (up to 24 Month)||7
985467|NCT00404352|2387695|P5|NOT COMPLETED|Open Label (up to 24 Month)||2
985468|NCT00404352|2387696|P4|NOT COMPLETED|Open Label (up to 24 Month)||3
985469|NCT00404352|2387697|P3|NOT COMPLETED|Open Label (up to 24 Month)||0
985470|NCT00404352|2387698|P2|NOT COMPLETED|Open Label (up to 24 Month)||0
985471|NCT00404352|2387699|P1|NOT COMPLETED|Open Label (up to 24 Month)||0
985472|NCT00404352|2387691|P9|COMPLETED|Open Label (up to 24 Month)||0
985473|NCT00404352|2387692|P8|COMPLETED|Open Label (up to 24 Month)||0
985474|NCT00404352|2387693|P7|COMPLETED|Open Label (up to 24 Month)||0
985475|NCT00404352|2387694|P6|COMPLETED|Open Label (up to 24 Month)||52
985476|NCT00404352|2387695|P5|COMPLETED|Open Label (up to 24 Month)||28
985477|NCT00404352|2387696|P4|COMPLETED|Open Label (up to 24 Month)||28
985478|NCT00404352|2387697|P3|COMPLETED|Open Label (up to 24 Month)||0
985479|NCT00404352|2387698|P2|COMPLETED|Open Label (up to 24 Month)||0
985480|NCT00404352|2387699|P1|COMPLETED|Open Label (up to 24 Month)||0
985481|NCT00404352|2387691|P9|STARTED|Open Label (up to 24 Month)||0
985482|NCT00404352|2387692|P8|STARTED|Open Label (up to 24 Month)||0
985483|NCT00404352|2387693|P7|STARTED|Open Label (up to 24 Month)||0
985484|NCT00404352|2387694|P6|STARTED|Open Label (up to 24 Month)|From DB period, 59 participants converted to CDMS and switched to OL period in this study|59
985485|NCT00404352|2387695|P5|STARTED|Open Label (up to 24 Month)|From DB period, 30 participants converted to CDMS and switched to OL period in this study|30
985486|NCT00404352|2387696|P4|STARTED|Open Label (up to 24 Month)|From DB period, 31 participants converted to CDMS and switched to OL period in this study|31
985487|NCT00404352|2387697|P3|STARTED|Open Label (up to 24 Month)||0
985488|NCT00404352|2387698|P2|STARTED|Open Label (up to 24 Month)||0
985489|NCT00404352|2387699|P1|STARTED|Open Label (up to 24 Month)||0
985490|NCT00404352|2387691|P9|NOT COMPLETED|Double Blind (up to 24 Month)||0
985491|NCT00404352|2387692|P8|NOT COMPLETED|Double Blind (up to 24 Month)||0
985492|NCT00404352|2387693|P7|NOT COMPLETED|Double Blind (up to 24 Month)||0
985493|NCT00404352|2387694|P6|NOT COMPLETED|Double Blind (up to 24 Month)||0
985494|NCT00404352|2387695|P5|NOT COMPLETED|Double Blind (up to 24 Month)||0
985495|NCT00404352|2387696|P4|NOT COMPLETED|Double Blind (up to 24 Month)||0
985496|NCT00404352|2387697|P3|NOT COMPLETED|Double Blind (up to 24 Month)||79
985497|NCT00404352|2387698|P2|NOT COMPLETED|Double Blind (up to 24 Month)||47
985498|NCT00404352|2387699|P1|NOT COMPLETED|Double Blind (up to 24 Month)||52
985499|NCT00404352|2387691|P9|COMPLETED|Double Blind (up to 24 Month)||0
985500|NCT00404352|2387692|P8|COMPLETED|Double Blind (up to 24 Month)||0
985501|NCT00404352|2387693|P7|COMPLETED|Double Blind (up to 24 Month)||0
985502|NCT00404352|2387694|P6|COMPLETED|Double Blind (up to 24 Month)||0
985503|NCT00404352|2387695|P5|COMPLETED|Double Blind (up to 24 Month)||0
985504|NCT00404352|2387696|P4|COMPLETED|Double Blind (up to 24 Month)||0
985505|NCT00404352|2387697|P3|COMPLETED|Double Blind (up to 24 Month)||92
985506|NCT00404352|2387698|P2|COMPLETED|Double Blind (up to 24 Month)||128
985507|NCT00404352|2387699|P1|COMPLETED|Double Blind (up to 24 Month)||119
985508|NCT00404352|2387691|P9|Treated|Double Blind (up to 24 Month)||0
985509|NCT00404352|2387692|P8|Treated|Double Blind (up to 24 Month)||0
985510|NCT00404352|2387693|P7|Treated|Double Blind (up to 24 Month)||0
985511|NCT00404352|2387694|P6|Treated|Double Blind (up to 24 Month)||0
985512|NCT00404352|2387695|P5|Treated|Double Blind (up to 24 Month)||0
985513|NCT00404352|2387696|P4|Treated|Double Blind (up to 24 Month)||0
985514|NCT00404352|2387697|P3|Treated|Double Blind (up to 24 Month)||171
985515|NCT00404352|2387698|P2|Treated|Double Blind (up to 24 Month)||173
985516|NCT00404352|2387699|P1|Treated|Double Blind (up to 24 Month)||171
985517|NCT00404352|2387691|P9|STARTED|Double Blind (up to 24 Month)||0
985518|NCT00404352|2387692|P8|STARTED|Double Blind (up to 24 Month)||0
985519|NCT00404352|2387693|P7|STARTED|Double Blind (up to 24 Month)||0
985520|NCT00404352|2387694|P6|STARTED|Double Blind (up to 24 Month)||0
985521|NCT00404352|2387695|P5|STARTED|Double Blind (up to 24 Month)||0
985522|NCT00404352|2387696|P4|STARTED|Double Blind (up to 24 Month)||0
985523|NCT00404352|2387697|P3|STARTED|Double Blind (up to 24 Month)||171
985524|NCT00404352|2387698|P2|STARTED|Double Blind (up to 24 Month)||175
985525|NCT00404352|2387699|P1|STARTED|Double Blind (up to 24 Month)||171
985526|NCT00404495|2387733|P2|NOT COMPLETED|Overall Study||11
985527|NCT00404495|2387734|P1|NOT COMPLETED|Overall Study||44
985528|NCT00404495|2387733|P2|COMPLETED|Overall Study||6
985529|NCT00404495|2387734|P1|COMPLETED|Overall Study||22
985530|NCT00404495|2387733|P2|STARTED|Overall Study||17
985531|NCT00404495|2387734|P1|STARTED|Overall Study||66
985538|NCT00404651|2387765|P4|NOT COMPLETED|Overall Study||21
985539|NCT00404651|2387766|P3|NOT COMPLETED|Overall Study||45
985540|NCT00404651|2387767|P2|NOT COMPLETED|Overall Study||28
985541|NCT00404651|2387768|P1|NOT COMPLETED|Overall Study||39
985542|NCT00404651|2387765|P4|COMPLETED|Overall Study||146
985543|NCT00404651|2387766|P3|COMPLETED|Overall Study||294
985544|NCT00404651|2387767|P2|COMPLETED|Overall Study||315
985545|NCT00404651|2387768|P1|COMPLETED|Overall Study||301
985546|NCT00404651|2387765|P4|STARTED|Overall Study||167
985547|NCT00404651|2387766|P3|STARTED|Overall Study||339
985548|NCT00404651|2387767|P2|STARTED|Overall Study||343
985549|NCT00404651|2387768|P1|STARTED|Overall Study||340
985550|NCT00404820|2387796|P2|NOT COMPLETED|Overall Study||24
985551|NCT00404820|2387797|P1|NOT COMPLETED|Overall Study||19
985552|NCT00404820|2387796|P2|COMPLETED|Overall Study||172
985553|NCT00404820|2387797|P1|COMPLETED|Overall Study||389
985554|NCT00404820|2387796|P2|Started Treatment|Overall Study|The reason why 2 patients did not start treatment is unavailable.|194
985555|NCT00404820|2387797|P1|Started Treatment|Overall Study||408
985556|NCT00404820|2387796|P2|STARTED|Overall Study||196
985557|NCT00404820|2387797|P1|STARTED|Overall Study||408
985558|NCT00404924|2387817|P2|NOT COMPLETED|Overall Study||306
985559|NCT00404924|2387818|P1|NOT COMPLETED|Overall Study||603
985560|NCT00404924|2387817|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|1
985561|NCT00404924|2387818|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
985562|NCT00404924|2387817|P2|STARTED|Overall Study|randomised patients|307
985563|NCT00404924|2387818|P1|STARTED|Overall Study|randomised patients|617
985564|NCT00405067|2387837|P3|NOT COMPLETED|Overall Study||5
985565|NCT00405067|2387838|P2|NOT COMPLETED|Overall Study||9
985566|NCT00405067|2387839|P1|NOT COMPLETED|Overall Study||4
985567|NCT00405067|2387837|P3|COMPLETED|Overall Study||24
985568|NCT00405067|2387838|P2|COMPLETED|Overall Study||19
985569|NCT00405067|2387839|P1|COMPLETED|Overall Study||24
985570|NCT00405067|2387837|P3|STARTED|Overall Study||29
985571|NCT00405067|2387838|P2|STARTED|Overall Study||28
985572|NCT00405067|2387839|P1|STARTED|Overall Study||28
985573|NCT00405275|2387876|P2|NOT COMPLETED|Overall Study||19
985574|NCT00405275|2387877|P1|NOT COMPLETED|Overall Study||23
985575|NCT00405275|2387876|P2|COMPLETED|Overall Study||156
985576|NCT00405275|2387877|P1|COMPLETED|Overall Study||155
985577|NCT00405275|2387876|P2|24 Week (Switch)|Overall Study||44
985578|NCT00405275|2387877|P1|24 Week (Switch)|Overall Study||44
985579|NCT00405275|2387876|P2|24 Week (no Switch)|Overall Study||121
985580|NCT00405275|2387877|P1|24 Week (no Switch)|Overall Study||119
985581|NCT00405275|2387876|P2|24 Weeks (Total)|Overall Study||165
985582|NCT00405275|2387877|P1|24 Weeks (Total)|Overall Study||163
985583|NCT00405275|2387876|P2|STARTED|Overall Study||175
985584|NCT00405275|2387877|P1|STARTED|Overall Study||178
985585|NCT00405288|2387885|P2|NOT COMPLETED|Overall Study||0
985586|NCT00405288|2387886|P1|NOT COMPLETED|Overall Study||0
985587|NCT00405288|2387885|P2|COMPLETED|Overall Study||204
985588|NCT00405288|2387886|P1|COMPLETED|Overall Study||204
985589|NCT00405288|2387885|P2|STARTED|Overall Study||204
985590|NCT00405288|2387886|P1|STARTED|Overall Study||204
985591|NCT00405509|2387916|P2|NOT COMPLETED|Overall Study||0
985592|NCT00405509|2387917|P1|NOT COMPLETED|Overall Study||0
985593|NCT00405509|2387916|P2|COMPLETED|Overall Study||22
985594|NCT00405509|2387917|P1|COMPLETED|Overall Study||11
985595|NCT00405509|2387916|P2|STARTED|Overall Study||22
985596|NCT00405509|2387917|P1|STARTED|Overall Study||11
985597|NCT00405548|2387933|P2|NOT COMPLETED|Overall Study||1
985598|NCT00405548|2387934|P1|NOT COMPLETED|Overall Study||4
985599|NCT00405548|2387933|P2|COMPLETED|Overall Study||12
985600|NCT00405548|2387934|P1|COMPLETED|Overall Study||24
985601|NCT00405548|2387933|P2|STARTED|Overall Study||13
985602|NCT00405548|2387934|P1|STARTED|Overall Study||28
985603|NCT00405587|2387950|P4|NOT COMPLETED|Overall Study||20
985604|NCT00405587|2387951|P3|NOT COMPLETED|Overall Study||22
985605|NCT00405587|2387952|P2|NOT COMPLETED|Overall Study||28
985606|NCT00405587|2387953|P1|NOT COMPLETED|Overall Study||26
985607|NCT00405587|2387950|P4|COMPLETED|Overall Study||1
985608|NCT00405587|2387951|P3|COMPLETED|Overall Study||10
985609|NCT00405587|2387952|P2|COMPLETED|Overall Study||2
985610|NCT00405587|2387953|P1|COMPLETED|Overall Study||0
985611|NCT00405587|2387950|P4|STARTED|Overall Study||21
985612|NCT00405587|2387951|P3|STARTED|Overall Study||32
985613|NCT00405587|2387952|P2|STARTED|Overall Study||30
985614|NCT00405587|2387953|P1|STARTED|Overall Study||26
985615|NCT00405639|2388071|P2|NOT COMPLETED|Overall Study||0
985616|NCT00405639|2388072|P1|NOT COMPLETED|Overall Study||3
985617|NCT00405639|2388071|P2|COMPLETED|Overall Study||12
985618|NCT00405639|2388072|P1|COMPLETED|Overall Study||22
985619|NCT00405639|2388071|P2|STARTED|Overall Study||12
985620|NCT00405639|2388072|P1|STARTED|Overall Study||25
985621|NCT00405652|2388084|P1|NOT COMPLETED|Overall Study||4
985622|NCT00405652|2388084|P1|COMPLETED|Overall Study||30
985623|NCT00405652|2388084|P1|STARTED|Overall Study||34
985624|NCT00405704|2388091|P2|NOT COMPLETED|Overall Study||46
985625|NCT00405704|2388092|P1|NOT COMPLETED|Overall Study||41
985626|NCT00405704|2388091|P2|COMPLETED|Overall Study||259
985627|NCT00405704|2388092|P1|COMPLETED|Overall Study||261
985628|NCT00405704|2388091|P2|Recurrent UTI With TMP-SMZ Panel|Overall Study||69
985629|NCT00405704|2388092|P1|Recurrent UTI With TMP-SMZ Panel|Overall Study||38
985630|NCT00405704|2388091|P2|Recurrent UTI With E. Coli|Overall Study||57
985631|NCT00405704|2388092|P1|Recurrent UTI With E. Coli|Overall Study||30
985632|NCT00405704|2388091|P2|Outcome Stool Assessed|Overall Study||210
985633|NCT00405704|2388092|P1|Outcome Stool Assessed|Overall Study||203
985634|NCT00405704|2388091|P2|Completed Assessments for New Scarring|Overall Study||227
985635|NCT00405704|2388092|P1|Completed Assessments for New Scarring|Overall Study||220
985636|NCT00405704|2388091|P2|Completed Outcome Renal Scan|Overall Study||235
985637|NCT00405704|2388092|P1|Completed Outcome Renal Scan|Overall Study||227
985638|NCT00405704|2388091|P2|STARTED|Overall Study||305
985639|NCT00405704|2388092|P1|STARTED|Overall Study||302
985640|NCT00405756|2388115|P3|NOT COMPLETED|Follow-up||88
985641|NCT00405756|2388116|P2|NOT COMPLETED|Follow-up||90
985642|NCT00405756|2388117|P1|NOT COMPLETED|Follow-up||75
985643|NCT00405756|2388115|P3|COMPLETED|Follow-up||0
985644|NCT00405756|2388116|P2|COMPLETED|Follow-up||0
985645|NCT00405756|2388117|P1|COMPLETED|Follow-up||0
985646|NCT00405756|2388115|P3|STARTED|Follow-up|52 participants from the Double-blind and 36 from the Open Label Extension|88
985647|NCT00405756|2388116|P2|STARTED|Follow-up|65 participants from the Double-blind and 25 from the Open Label Extension|90
985648|NCT00405756|2388117|P1|STARTED|Follow-up|66 participants from Double-blind and 9 from the Open Label Extension|75
985649|NCT00405756|2388115|P3|NOT COMPLETED|Open-label Extension||72
985650|NCT00405756|2388116|P2|NOT COMPLETED|Open-label Extension||47
985651|NCT00405756|2388117|P1|NOT COMPLETED|Open-label Extension||19
985652|NCT00405756|2388115|P3|COMPLETED|Open-label Extension||0
985653|NCT00405756|2388116|P2|COMPLETED|Open-label Extension||0
985654|NCT00405756|2388117|P1|COMPLETED|Open-label Extension|Participants continue until disease progression or other reason for discontinuing.|0
985655|NCT00405756|2388115|P3|STARTED|Open-label Extension||72
985656|NCT00405756|2388116|P2|STARTED|Open-label Extension||47
985657|NCT00405756|2388117|P1|STARTED|Open-label Extension||19
985658|NCT00405756|2388115|P3|NOT COMPLETED|Double-blind Treatment||154
985659|NCT00405756|2388116|P2|NOT COMPLETED|Double-blind Treatment||153
985660|NCT00405756|2388117|P1|NOT COMPLETED|Double-blind Treatment||152
985661|NCT00405756|2388115|P3|COMPLETED|Double-blind Treatment||0
985662|NCT00405756|2388116|P2|COMPLETED|Double-blind Treatment||0
985663|NCT00405756|2388117|P1|COMPLETED|Double-blind Treatment|Double-blind Treatment Period had no defined completion.|0
985664|NCT00405756|2388115|P3|Safety Population|Double-blind Treatment||153
985665|NCT00405756|2388116|P2|Safety Population|Double-blind Treatment||152
985666|NCT00405756|2388117|P1|Safety Population|Double-blind Treatment|Participants who took at least one dose of study drug.|150
985667|NCT00405756|2388115|P3|STARTED|Double-blind Treatment||154
985668|NCT00405756|2388116|P2|STARTED|Double-blind Treatment||153
985669|NCT00405756|2388117|P1|STARTED|Double-blind Treatment|Intent to treat population of all randomized participants|152
985670|NCT00405821|2388207|P2|NOT COMPLETED|Overall Study||22
985671|NCT00405821|2388208|P1|NOT COMPLETED|Overall Study||22
985672|NCT00405821|2388207|P2|COMPLETED|Overall Study||198
985673|NCT00405821|2388208|P1|COMPLETED|Overall Study||198
985674|NCT00405821|2388207|P2|STARTED|Overall Study||220
985675|NCT00405821|2388208|P1|STARTED|Overall Study||220
985676|NCT00405912|2388221|P3|NOT COMPLETED|Overall Study||16
985677|NCT00405912|2388222|P2|NOT COMPLETED|Overall Study||19
985678|NCT00405912|2388223|P1|NOT COMPLETED|Overall Study||16
985679|NCT00405912|2388221|P3|COMPLETED|Overall Study||23
985680|NCT00405912|2388222|P2|COMPLETED|Overall Study||21
985681|NCT00405912|2388223|P1|COMPLETED|Overall Study||23
985682|NCT00405912|2388221|P3|STARTED|Overall Study||39
985683|NCT00405912|2388222|P2|STARTED|Overall Study||40
985684|NCT00405912|2388223|P1|STARTED|Overall Study||39
985685|NCT00405938|2388236|P2|NOT COMPLETED|Overall Study||0
985686|NCT00405938|2388237|P1|NOT COMPLETED|Overall Study||0
985687|NCT00405938|2388236|P2|COMPLETED|Overall Study||41
985688|NCT00405938|2388237|P1|COMPLETED|Overall Study||38
985689|NCT00405938|2388236|P2|STARTED|Overall Study||41
985690|NCT00405938|2388237|P1|STARTED|Overall Study||38
985691|NCT00405964|2388245|P2|NOT COMPLETED|Overall Study||95
985692|NCT00405964|2388246|P1|NOT COMPLETED|Overall Study||59
985693|NCT00405964|2388245|P2|COMPLETED|Overall Study||261
985694|NCT00405964|2388246|P1|COMPLETED|Overall Study||301
985695|NCT00405964|2388245|P2|STARTED|Overall Study||356
985696|NCT00405964|2388246|P1|STARTED|Overall Study||360
985697|NCT00406029|2388261|P5|NOT COMPLETED|Overall Study||8
985698|NCT00406029|2388262|P4|NOT COMPLETED|Overall Study||17
985699|NCT00406029|2388263|P3|NOT COMPLETED|Overall Study||10
985700|NCT00406029|2388264|P2|NOT COMPLETED|Overall Study||8
985701|NCT00406029|2388265|P1|NOT COMPLETED|Overall Study||16
985702|NCT00406029|2388261|P5|COMPLETED|Overall Study||41
985703|NCT00406029|2388262|P4|COMPLETED|Overall Study||40
985704|NCT00406029|2388263|P3|COMPLETED|Overall Study||39
985705|NCT00406029|2388264|P2|COMPLETED|Overall Study||41
985706|NCT00406029|2388265|P1|COMPLETED|Overall Study||33
985707|NCT00406029|2388261|P5|Treated|Overall Study||47
985708|NCT00406029|2388262|P4|Treated|Overall Study||54
985709|NCT00406029|2388263|P3|Treated|Overall Study||47
985710|NCT00406029|2388264|P2|Treated|Overall Study||49
985711|NCT00406029|2388265|P1|Treated|Overall Study||49
985712|NCT00406029|2388261|P5|STARTED|Overall Study||49
985713|NCT00406029|2388262|P4|STARTED|Overall Study||57
985714|NCT00406029|2388263|P3|STARTED|Overall Study||49
985715|NCT00406029|2388264|P2|STARTED|Overall Study||49
985716|NCT00406029|2388265|P1|STARTED|Overall Study||49
985717|NCT00398983|2388369|P2|NOT COMPLETED|Overall Study||0
985718|NCT00398983|2388370|P1|NOT COMPLETED|Overall Study||0
985719|NCT00398983|2388369|P2|COMPLETED|Overall Study||25
985720|NCT00398983|2388370|P1|COMPLETED|Overall Study||20
985721|NCT00398983|2388369|P2|STARTED|Overall Study||25
985722|NCT00398983|2388370|P1|STARTED|Overall Study||20
985723|NCT00399035|2388379|P3|NOT COMPLETED|Overall Study||252
985724|NCT00399035|2388380|P2|NOT COMPLETED|Overall Study||158
985725|NCT00399035|2388381|P1|NOT COMPLETED|Overall Study||313
985726|NCT00399035|2388379|P3|COMPLETED|Overall Study||106
985727|NCT00399035|2388380|P2|COMPLETED|Overall Study||58
985728|NCT00399035|2388381|P1|COMPLETED|Overall Study||189
985729|NCT00399035|2388379|P3|STARTED|Overall Study||358
985730|NCT00399035|2388380|P2|STARTED|Overall Study||216
985731|NCT00399035|2388381|P1|STARTED|Overall Study||502
985732|NCT00399308|2388403|P3|NOT COMPLETED|Overall Study||1
985733|NCT00399308|2388404|P2|NOT COMPLETED|Overall Study||0
985734|NCT00399308|2388405|P1|NOT COMPLETED|Overall Study||0
985735|NCT00399308|2388403|P3|COMPLETED|Overall Study|One patient withdrew: did not want to comply with study requirements|11
985736|NCT00399308|2388404|P2|COMPLETED|Overall Study||15
985737|NCT00399308|2388405|P1|COMPLETED|Overall Study||13
985738|NCT00399308|2388403|P3|STARTED|Overall Study||12
985739|NCT00399308|2388404|P2|STARTED|Overall Study||15
985740|NCT00399308|2388405|P1|STARTED|Overall Study||13
985741|NCT00399360|2388426|P4|NOT COMPLETED|Overall Study||6
985742|NCT00399360|2388427|P3|NOT COMPLETED|Overall Study||3
985743|NCT00399360|2388428|P2|NOT COMPLETED|Overall Study||3
985744|NCT00399360|2388429|P1|NOT COMPLETED|Overall Study||2
985745|NCT00399360|2388426|P4|COMPLETED|Overall Study||9
985746|NCT00399360|2388427|P3|COMPLETED|Overall Study||10
985747|NCT00399360|2388428|P2|COMPLETED|Overall Study||8
985748|NCT00399360|2388429|P1|COMPLETED|Overall Study||9
985749|NCT00399360|2388426|P4|STARTED|Overall Study||15
985750|NCT00399360|2388427|P3|STARTED|Overall Study||13
985751|NCT00399360|2388428|P2|STARTED|Overall Study||11
985752|NCT00399360|2388429|P1|STARTED|Overall Study||11
985753|NCT00399516|2388475|P1|NOT COMPLETED|Overall Study||2
985754|NCT00399516|2388475|P1|COMPLETED|Overall Study||19
985755|NCT00399516|2388475|P1|STARTED|Overall Study||21
985756|NCT00399542|2388481|P2|NOT COMPLETED|Overall Study||43
985757|NCT00399542|2388482|P1|NOT COMPLETED|Overall Study||84
985758|NCT00399542|2388481|P2|COMPLETED|Overall Study||151
985759|NCT00399542|2388482|P1|COMPLETED|Overall Study||303
985760|NCT00399542|2388481|P2|STARTED|Overall Study||194
985761|NCT00399542|2388482|P1|STARTED|Overall Study||387
985762|NCT00399568|2388546|P2|NOT COMPLETED|Overall Study||9
985763|NCT00399568|2388547|P1|NOT COMPLETED|Overall Study||12
985764|NCT00399568|2388546|P2|COMPLETED|Overall Study||156
985765|NCT00399568|2388547|P1|COMPLETED|Overall Study||154
985766|NCT00399568|2388546|P2|STARTED|Overall Study||165
985767|NCT00399568|2388547|P1|STARTED|Overall Study||166
985768|NCT00399763|2388561|P2|NOT COMPLETED|Overall Study||3
985769|NCT00399763|2388562|P1|NOT COMPLETED|Overall Study||2
985770|NCT00399763|2388561|P2|COMPLETED|Overall Study||32
985771|NCT00399763|2388562|P1|COMPLETED|Overall Study||33
985772|NCT00399763|2388561|P2|STARTED|Overall Study||35
985773|NCT00399763|2388562|P1|STARTED|Overall Study||35
985774|NCT00399880|2388574|P2|NOT COMPLETED|Overall Study||0
985775|NCT00399880|2388575|P1|NOT COMPLETED|Overall Study||0
985776|NCT00399880|2388574|P2|COMPLETED|Overall Study||65
985777|NCT00399880|2388575|P1|COMPLETED|Overall Study||65
985778|NCT00399880|2388574|P2|STARTED|Overall Study||65
985779|NCT00399880|2388575|P1|STARTED|Overall Study||65
985780|NCT00399893|2388585|P2|NOT COMPLETED|Overall Study||0
985781|NCT00399893|2388586|P1|NOT COMPLETED|Overall Study||1
985782|NCT00399893|2388585|P2|COMPLETED|Overall Study||3
985783|NCT00399893|2388586|P1|COMPLETED|Overall Study|Participant withdrew after 3 months but was included in results|1
985784|NCT00399893|2388585|P2|STARTED|Overall Study||3
985785|NCT00399893|2388586|P1|STARTED|Overall Study||2
985786|NCT00400153|2388615|P3|NOT COMPLETED|Overall Study||61
985787|NCT00400153|2388616|P2|NOT COMPLETED|Overall Study||55
985788|NCT00400153|2388617|P1|NOT COMPLETED|Overall Study||48
985789|NCT00400153|2388615|P3|COMPLETED|Overall Study||422
985790|NCT00400153|2388616|P2|COMPLETED|Overall Study||436
985791|NCT00400153|2388617|P1|COMPLETED|Overall Study||438
985792|NCT00400153|2388615|P3|STARTED|Overall Study||483
985793|NCT00400153|2388616|P2|STARTED|Overall Study||491
985794|NCT00400153|2388617|P1|STARTED|Overall Study||486
985795|NCT00400179|2388864|P2|NOT COMPLETED|Overall Study||18
985796|NCT00400179|2388865|P1|NOT COMPLETED|Overall Study||6
985797|NCT00400179|2388864|P2|COMPLETED|Overall Study||508
985798|NCT00400179|2388865|P1|COMPLETED|Overall Study|Received Treatment|521
985799|NCT00400179|2388864|P2|STARTED|Overall Study||526
985800|NCT00400179|2388865|P1|STARTED|Overall Study|Signed informed consent form and randomized|527
985801|NCT00400205|2388879|P1|NOT COMPLETED|Overall Study||5
985802|NCT00400205|2388879|P1|COMPLETED|Overall Study||9
985803|NCT00400205|2388879|P1|STARTED|Overall Study||14
985804|NCT00400400|2388885|P2|NOT COMPLETED|Overall Study||15
985805|NCT00400400|2388886|P1|NOT COMPLETED|Overall Study||14
985806|NCT00400400|2388885|P2|COMPLETED|Overall Study||185
985807|NCT00400400|2388886|P1|COMPLETED|Overall Study||186
985808|NCT00400400|2388885|P2|Intent-to-Treat Population|Overall Study||197
985809|NCT00400400|2388886|P1|Intent-to-Treat Population|Overall Study|Participants who received study drug.|199
985810|NCT00400400|2388885|P2|STARTED|Overall Study||200
985811|NCT00400400|2388886|P1|STARTED|Overall Study||200
985812|NCT00406107|2388906|P2|NOT COMPLETED|Overall Study||1
985813|NCT00406107|2388907|P1|NOT COMPLETED|Overall Study||1
985814|NCT00406107|2388906|P2|COMPLETED|Overall Study||4
985815|NCT00406107|2388907|P1|COMPLETED|Overall Study||14
985816|NCT00406107|2388906|P2|STARTED|Overall Study||5
985817|NCT00406107|2388907|P1|STARTED|Overall Study||15
985818|NCT00406133|2388921|P4|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
985819|NCT00406133|2388922|P3|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
985820|NCT00406133|2388923|P2|NOT COMPLETED|Phase 2 (Second 26 Week Period)||3
985821|NCT00406133|2388924|P1|NOT COMPLETED|Phase 2 (Second 26 Week Period)||2
985822|NCT00406133|2388921|P4|COMPLETED|Phase 2 (Second 26 Week Period)||60
985823|NCT00406133|2388922|P3|COMPLETED|Phase 2 (Second 26 Week Period)||67
985824|NCT00406133|2388923|P2|COMPLETED|Phase 2 (Second 26 Week Period)||152
985825|NCT00406133|2388924|P1|COMPLETED|Phase 2 (Second 26 Week Period)||157
985826|NCT00406133|2388921|P4|STARTED|Phase 2 (Second 26 Week Period)||60
985827|NCT00406133|2388922|P3|STARTED|Phase 2 (Second 26 Week Period)||67
985828|NCT00406133|2388923|P2|STARTED|Phase 2 (Second 26 Week Period)||155
985829|NCT00406133|2388924|P1|STARTED|Phase 2 (Second 26 Week Period)|3 subjects completed phase 1 but elected not to go into phase 2.|159
985830|NCT00406133|2388921|P4|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
985831|NCT00406133|2388922|P3|NOT COMPLETED|Phase 1 (First 26 Week Period)||0
985832|NCT00406133|2388923|P2|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
985833|NCT00406133|2388924|P1|NOT COMPLETED|Phase 1 (First 26 Week Period)||3
985834|NCT00406133|2388921|P4|COMPLETED|Phase 1 (First 26 Week Period)||60
985835|NCT00406133|2388922|P3|COMPLETED|Phase 1 (First 26 Week Period)||67
985836|NCT00406133|2388923|P2|COMPLETED|Phase 1 (First 26 Week Period)||155
985837|NCT00406133|2388924|P1|COMPLETED|Phase 1 (First 26 Week Period)||162
985838|NCT00406133|2388921|P4|STARTED|Phase 1 (First 26 Week Period)||62
985839|NCT00406133|2388922|P3|STARTED|Phase 1 (First 26 Week Period)||67
985840|NCT00406133|2388923|P2|STARTED|Phase 1 (First 26 Week Period)||157
985841|NCT00406133|2388924|P1|STARTED|Phase 1 (First 26 Week Period)||165
985842|NCT00406276|2388986|P1|NOT COMPLETED|Overall Study||4
985843|NCT00406276|2388986|P1|COMPLETED|Overall Study||24
985844|NCT00406276|2388986|P1|STARTED|Overall Study||28
985845|NCT00406315|2388991|P1|NOT COMPLETED|Overall Study||141
985846|NCT00406315|2388991|P1|COMPLETED|Overall Study||100
985847|NCT00406315|2388991|P1|STARTED|Overall Study|Started = Treated|241
985848|NCT00406354|2389012|P3|NOT COMPLETED|All Randomized and Treated Patients||22
985849|NCT00406354|2389013|P2|NOT COMPLETED|All Randomized and Treated Patients||13
985850|NCT00406354|2389014|P1|NOT COMPLETED|All Randomized and Treated Patients||16
985851|NCT00406354|2389012|P3|COMPLETED|All Randomized and Treated Patients||37
985852|NCT00406354|2389013|P2|COMPLETED|All Randomized and Treated Patients||48
985853|NCT00406354|2389014|P1|COMPLETED|All Randomized and Treated Patients||44
985854|NCT00406354|2389012|P3|STARTED|All Randomized and Treated Patients||59
985855|NCT00406354|2389013|P2|STARTED|All Randomized and Treated Patients||61
985856|NCT00406354|2389014|P1|STARTED|All Randomized and Treated Patients||60
985857|NCT00406354|2389012|P3|NOT COMPLETED|All Randomized Patients||1
985858|NCT00406354|2389013|P2|NOT COMPLETED|All Randomized Patients||0
985859|NCT00406354|2389014|P1|NOT COMPLETED|All Randomized Patients||0
985860|NCT00406354|2389012|P3|COMPLETED|All Randomized Patients|One patient was randomized but never received study treatment.|59
985861|NCT00406354|2389013|P2|COMPLETED|All Randomized Patients||61
985862|NCT00406354|2389014|P1|COMPLETED|All Randomized Patients||60
985863|NCT00406354|2389012|P3|STARTED|All Randomized Patients||60
985864|NCT00406354|2389013|P2|STARTED|All Randomized Patients||61
985865|NCT00406354|2389014|P1|STARTED|All Randomized Patients||60
985866|NCT00406367|2389087|P2|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
985867|NCT00406367|2389088|P1|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||20
985868|NCT00406367|2389087|P2|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
985869|NCT00406367|2389088|P1|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||82
985956|NCT00408499|2389344|P4|NOT COMPLETED|Phase II- MTD Expansion||0
985870|NCT00406367|2389087|P2|STARTED|Open-Label Ext. Period - up to 68 Weeks|In the Open-Label Extension Period no placebo treatment arm was given.|0
985871|NCT00406367|2389088|P1|STARTED|Open-Label Ext. Period - up to 68 Weeks||102
985872|NCT00406367|2389087|P2|NOT COMPLETED|Main Period - 6 to 20 Weeks||2
985873|NCT00406367|2389088|P1|NOT COMPLETED|Main Period - 6 to 20 Weeks||5
985874|NCT00406367|2389087|P2|COMPLETED|Main Period - 6 to 20 Weeks||32
985875|NCT00406367|2389088|P1|COMPLETED|Main Period - 6 to 20 Weeks||70
985876|NCT00406367|2389087|P2|STARTED|Main Period - 6 to 20 Weeks||34
985877|NCT00406367|2389088|P1|STARTED|Main Period - 6 to 20 Weeks||75
985878|NCT00406393|2389102|P2|NOT COMPLETED|Overall Study||1
985879|NCT00406393|2389103|P1|NOT COMPLETED|Overall Study||2
985880|NCT00406393|2389102|P2|COMPLETED|Overall Study||152
985881|NCT00406393|2389103|P1|COMPLETED|Overall Study||149
985882|NCT00406393|2389102|P2|STARTED|Overall Study||153
985883|NCT00406393|2389103|P1|STARTED|Overall Study||151
985884|NCT00407797|2389131|P1|NOT COMPLETED|Overall Study||18
985885|NCT00407797|2389131|P1|COMPLETED|Overall Study||118
985886|NCT00407797|2389131|P1|Full Analysis Set|Overall Study|At least 1 dose of study medication and had a baseline and at least 1 post-baseline measurement.|135
985887|NCT00407797|2389131|P1|STARTED|Overall Study||136
985888|NCT00407888|2389146|P1|NOT COMPLETED|Overall Study||0
985889|NCT00407888|2389146|P1|COMPLETED|Overall Study||60
985890|NCT00407888|2389146|P1|STARTED|Overall Study||60
985891|NCT00407966|2389154|P1|NOT COMPLETED|Overall Study||0
985892|NCT00407966|2389154|P1|COMPLETED|Overall Study||45
985893|NCT00407966|2389154|P1|CR|Overall Study||30
985894|NCT00407966|2389154|P1|STARTED|Overall Study||45
985895|NCT00408070|2389158|P1|NOT COMPLETED|Overall Study||0
985896|NCT00408070|2389158|P1|COMPLETED|Overall Study||5
985897|NCT00408070|2389158|P1|STARTED|Overall Study||5
985898|NCT00408200|2389164|P2|NOT COMPLETED|Overall Study||0
985899|NCT00408200|2389165|P1|NOT COMPLETED|Overall Study||0
985900|NCT00408200|2389164|P2|COMPLETED|Overall Study||53
985901|NCT00408200|2389165|P1|COMPLETED|Overall Study||57
985902|NCT00408200|2389164|P2|STARTED|Overall Study||53
985903|NCT00408200|2389165|P1|STARTED|Overall Study||57
985904|NCT00408317|2389173|P2|NOT COMPLETED|Second Intervention Period||2
985905|NCT00408317|2389174|P1|NOT COMPLETED|Second Intervention Period||2
985906|NCT00408317|2389173|P2|COMPLETED|Second Intervention Period||14
985907|NCT00408317|2389174|P1|COMPLETED|Second Intervention Period||12
985908|NCT00408317|2389173|P2|STARTED|Second Intervention Period||16
985909|NCT00408317|2389174|P1|STARTED|Second Intervention Period||14
985910|NCT00408317|2389173|P2|NOT COMPLETED|First Intervention Period||1
985911|NCT00408317|2389174|P1|NOT COMPLETED|First Intervention Period||0
985912|NCT00408317|2389173|P2|COMPLETED|First Intervention Period||16
985913|NCT00408317|2389174|P1|COMPLETED|First Intervention Period||14
985914|NCT00408317|2389173|P2|STARTED|First Intervention Period||17
985915|NCT00408317|2389174|P1|STARTED|First Intervention Period||14
985916|NCT00408408|2389192|P6|NOT COMPLETED|Overall Study||3
985917|NCT00408408|2389193|P5|NOT COMPLETED|Overall Study||5
985918|NCT00408408|2389194|P4|NOT COMPLETED|Overall Study||7
985919|NCT00408408|2389195|P3|NOT COMPLETED|Overall Study||0
985920|NCT00408408|2389196|P2|NOT COMPLETED|Overall Study||3
985921|NCT00408408|2389197|P1|NOT COMPLETED|Overall Study||2
985922|NCT00408408|2389192|P6|COMPLETED|Overall Study||201
985923|NCT00408408|2389193|P5|COMPLETED|Overall Study||192
985924|NCT00408408|2389194|P4|COMPLETED|Overall Study||194
985925|NCT00408408|2389195|P3|COMPLETED|Overall Study||204
985926|NCT00408408|2389196|P2|COMPLETED|Overall Study||196
985927|NCT00408408|2389197|P1|COMPLETED|Overall Study||199
985928|NCT00408408|2389192|P6|STARTED|Overall Study||204
985929|NCT00408408|2389193|P5|STARTED|Overall Study||197
985930|NCT00408408|2389194|P4|STARTED|Overall Study||201
985931|NCT00408408|2389195|P3|STARTED|Overall Study||204
985932|NCT00408408|2389196|P2|STARTED|Overall Study||199
985933|NCT00408408|2389197|P1|STARTED|Overall Study||201
985934|NCT00408421|2389261|P3|NOT COMPLETED|Treatment Re-Randomization||5
985935|NCT00408421|2389262|P2|NOT COMPLETED|Treatment Re-Randomization||7
985936|NCT00408421|2389263|P1|NOT COMPLETED|Treatment Re-Randomization||7
985937|NCT00408421|2389261|P3|COMPLETED|Treatment Re-Randomization||38
985938|NCT00408421|2389262|P2|COMPLETED|Treatment Re-Randomization||39
985939|NCT00408421|2389263|P1|COMPLETED|Treatment Re-Randomization||96
985940|NCT00408421|2389261|P3|STARTED|Treatment Re-Randomization||43
985941|NCT00408421|2389262|P2|STARTED|Treatment Re-Randomization||46
985942|NCT00408421|2389263|P1|STARTED|Treatment Re-Randomization||103
985943|NCT00408421|2389261|P3|NOT COMPLETED|Treatment Initial Randomization||0
985944|NCT00408421|2389262|P2|NOT COMPLETED|Treatment Initial Randomization||22
985945|NCT00408421|2389263|P1|NOT COMPLETED|Treatment Initial Randomization||17
985946|NCT00408421|2389261|P3|COMPLETED|Treatment Initial Randomization|Patients weren't randomized to Duloxetine 120 mg until Visit 4.|0
985947|NCT00408421|2389262|P2|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|89
985948|NCT00408421|2389263|P1|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|103
985949|NCT00408421|2389261|P3|STARTED|Treatment Initial Randomization||0
985950|NCT00408421|2389262|P2|STARTED|Treatment Initial Randomization||111
985951|NCT00408421|2389263|P1|STARTED|Treatment Initial Randomization||120
985952|NCT00408460|2389337|P1|NOT COMPLETED|Overall Study||0
985953|NCT00408460|2389337|P1|COMPLETED|Overall Study||34
985954|NCT00408460|2389337|P1|STARTED|Overall Study||34
985955|NCT00408499|2389343|P5|NOT COMPLETED|Phase II- MTD Expansion||20
985957|NCT00408499|2389345|P3|NOT COMPLETED|Phase II- MTD Expansion||0
985958|NCT00408499|2389346|P2|NOT COMPLETED|Phase II- MTD Expansion||0
985959|NCT00408499|2389347|P1|NOT COMPLETED|Phase II- MTD Expansion||0
985960|NCT00408499|2389343|P5|COMPLETED|Phase II- MTD Expansion||24
985961|NCT00408499|2389344|P4|COMPLETED|Phase II- MTD Expansion||0
985962|NCT00408499|2389345|P3|COMPLETED|Phase II- MTD Expansion||0
985963|NCT00408499|2389346|P2|COMPLETED|Phase II- MTD Expansion||0
985964|NCT00408499|2389347|P1|COMPLETED|Phase II- MTD Expansion||0
985965|NCT00408499|2389343|P5|STARTED|Phase II- MTD Expansion||44
985966|NCT00408499|2389344|P4|STARTED|Phase II- MTD Expansion||0
985967|NCT00408499|2389345|P3|STARTED|Phase II- MTD Expansion||0
985968|NCT00408499|2389346|P2|STARTED|Phase II- MTD Expansion||0
985969|NCT00408499|2389347|P1|STARTED|Phase II- MTD Expansion||0
985970|NCT00408499|2389343|P5|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
985971|NCT00408499|2389344|P4|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
985972|NCT00408499|2389345|P3|NOT COMPLETED|Phase 1: Dose Levels 1-4||1
985973|NCT00408499|2389346|P2|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
985974|NCT00408499|2389347|P1|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
985975|NCT00408499|2389343|P5|COMPLETED|Phase 1: Dose Levels 1-4||0
985976|NCT00408499|2389344|P4|COMPLETED|Phase 1: Dose Levels 1-4||6
985977|NCT00408499|2389345|P3|COMPLETED|Phase 1: Dose Levels 1-4||2
985978|NCT00408499|2389346|P2|COMPLETED|Phase 1: Dose Levels 1-4||5
985979|NCT00408499|2389347|P1|COMPLETED|Phase 1: Dose Levels 1-4||2
985980|NCT00408499|2389343|P5|STARTED|Phase 1: Dose Levels 1-4||0
985981|NCT00408499|2389344|P4|STARTED|Phase 1: Dose Levels 1-4||6
985982|NCT00408499|2389345|P3|STARTED|Phase 1: Dose Levels 1-4||3
985983|NCT00408499|2389346|P2|STARTED|Phase 1: Dose Levels 1-4||7
985984|NCT00408499|2389347|P1|STARTED|Phase 1: Dose Levels 1-4||4
985985|NCT00408590|2389358|P9|NOT COMPLETED|Overall Study||0
985986|NCT00408590|2389359|P8|NOT COMPLETED|Overall Study||0
985987|NCT00408590|2389360|P7|NOT COMPLETED|Overall Study||0
985988|NCT00408590|2389361|P6|NOT COMPLETED|Overall Study||0
985989|NCT00408590|2389362|P5|NOT COMPLETED|Overall Study||0
985990|NCT00408590|2389363|P4|NOT COMPLETED|Overall Study||0
985991|NCT00408590|2389364|P3|NOT COMPLETED|Overall Study||0
985992|NCT00408590|2389365|P2|NOT COMPLETED|Overall Study||0
985993|NCT00408590|2389366|P1|NOT COMPLETED|Overall Study||0
985994|NCT00408590|2389358|P9|COMPLETED|Overall Study||13
985995|NCT00408590|2389359|P8|COMPLETED|Overall Study||3
985996|NCT00408590|2389360|P7|COMPLETED|Overall Study||3
985997|NCT00408590|2389361|P6|COMPLETED|Overall Study||3
985998|NCT00408590|2389362|P5|COMPLETED|Overall Study||3
985999|NCT00408590|2389363|P4|COMPLETED|Overall Study||3
986000|NCT00408590|2389364|P3|COMPLETED|Overall Study||3
986001|NCT00408590|2389365|P2|COMPLETED|Overall Study||3
986002|NCT00408590|2389366|P1|COMPLETED|Overall Study||3
986003|NCT00408590|2389358|P9|STARTED|Overall Study||13
986004|NCT00408590|2389359|P8|STARTED|Overall Study||3
986005|NCT00408590|2389360|P7|STARTED|Overall Study||3
986006|NCT00408590|2389361|P6|STARTED|Overall Study||3
986007|NCT00408590|2389362|P5|STARTED|Overall Study||3
986008|NCT00408590|2389363|P4|STARTED|Overall Study||3
986009|NCT00408590|2389364|P3|STARTED|Overall Study||3
986010|NCT00408590|2389365|P2|STARTED|Overall Study||3
986011|NCT00408590|2389366|P1|STARTED|Overall Study||3
986012|NCT00408603|2389388|P3|NOT COMPLETED|Overall Study||40
986013|NCT00408603|2389389|P2|NOT COMPLETED|Overall Study||2
986014|NCT00408603|2389390|P1|NOT COMPLETED|Overall Study||4
986015|NCT00408603|2389388|P3|COMPLETED|Overall Study||35
986016|NCT00408603|2389389|P2|COMPLETED|Overall Study||37
986017|NCT00408603|2389390|P1|COMPLETED|Overall Study||65
986018|NCT00408603|2389388|P3|STARTED|Overall Study||75
986019|NCT00408603|2389389|P2|STARTED|Overall Study||39
986020|NCT00408603|2389390|P1|STARTED|Overall Study||69
986021|NCT00408629|2389406|P2|NOT COMPLETED|Overall Study||125
986022|NCT00408629|2389407|P1|NOT COMPLETED|Overall Study||97
986023|NCT00408629|2389406|P2|COMPLETED|Overall Study||135
986024|NCT00408629|2389407|P1|COMPLETED|Overall Study|1 ADA recipient did not receive study drug and discontinued due to other reasons.|161
986025|NCT00408629|2389406|P2|STARTED|Overall Study|14 PLB recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (246).|260
986026|NCT00408629|2389407|P1|STARTED|Overall Study|10 ADA recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (248).|258
986027|NCT00408681|2389446|P1|NOT COMPLETED|Overall Study||9
986028|NCT00408681|2389446|P1|COMPLETED|Overall Study|Completion was defined as administration of the study product for at least 28 days.|11
986029|NCT00408681|2389446|P1|STARTED|Overall Study||20
986030|NCT00408694|2389463|P1|NOT COMPLETED|Overall Study||2
986031|NCT00408694|2389463|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
986032|NCT00408694|2389463|P1|STARTED|Overall Study||46
986033|NCT00408876|2389471|P4|NOT COMPLETED|Overall Study||35
986034|NCT00408876|2389472|P3|NOT COMPLETED|Overall Study||50
986035|NCT00408876|2389473|P2|NOT COMPLETED|Overall Study||36
986036|NCT00408876|2389474|P1|NOT COMPLETED|Overall Study||16
986037|NCT00408876|2389471|P4|COMPLETED|Overall Study||82
986038|NCT00408876|2389472|P3|COMPLETED|Overall Study||62
986039|NCT00408876|2389473|P2|COMPLETED|Overall Study||80
986040|NCT00408876|2389474|P1|COMPLETED|Overall Study||43
986041|NCT00408876|2389471|P4|STARTED|Overall Study||117
986042|NCT00408876|2389472|P3|STARTED|Overall Study||112
986043|NCT00408876|2389473|P2|STARTED|Overall Study||116
986044|NCT00408876|2389474|P1|STARTED|Overall Study||59
986045|NCT00408902|2389724|P1|NOT COMPLETED|Overall Study||10
986046|NCT00408902|2389724|P1|COMPLETED|Overall Study||0
986047|NCT00408902|2389724|P1|STARTED|Overall Study||10
986048|NCT00408928|2389729|P1|NOT COMPLETED|Overall Study||3
986049|NCT00408928|2389729|P1|COMPLETED|Overall Study||8
986050|NCT00408928|2389729|P1|STARTED|Overall Study||11
986051|NCT00408993|2389736|P2|NOT COMPLETED|Overall Study||17
986052|NCT00408993|2389737|P1|NOT COMPLETED|Overall Study||19
986053|NCT00408993|2389736|P2|COMPLETED|Overall Study||92
986054|NCT00408993|2389737|P1|COMPLETED|Overall Study||87
986055|NCT00408993|2389736|P2|STARTED|Overall Study||109
986056|NCT00408993|2389737|P1|STARTED|Overall Study||106
986057|NCT00409006|2389771|P2|NOT COMPLETED|Overall Study||12
986058|NCT00409006|2389772|P1|NOT COMPLETED|Overall Study||20
986059|NCT00409006|2389771|P2|COMPLETED|Overall Study||19
986060|NCT00409006|2389772|P1|COMPLETED|Overall Study||19
986061|NCT00409006|2389771|P2|STARTED|Overall Study||31
986062|NCT00409006|2389772|P1|STARTED|Overall Study||39
986063|NCT00409175|2389788|P2|NOT COMPLETED|Overall Study||19
986064|NCT00409175|2389789|P1|NOT COMPLETED|Overall Study||18
986065|NCT00409175|2389788|P2|COMPLETED|Overall Study||44
986066|NCT00409175|2389789|P1|COMPLETED|Overall Study||47
986067|NCT00409175|2389788|P2|STARTED|Overall Study||63
986068|NCT00409175|2389789|P1|STARTED|Overall Study||65
986069|NCT00409188|2389815|P2|NOT COMPLETED|Overall Study||175
986070|NCT00409188|2389816|P1|NOT COMPLETED|Overall Study||383
986071|NCT00409188|2389815|P2|COMPLETED|Overall Study||332
986072|NCT00409188|2389816|P1|COMPLETED|Overall Study||623
986073|NCT00409188|2389815|P2|STARTED|Overall Study||507
986074|NCT00409188|2389816|P1|STARTED|Overall Study||1006
986075|NCT00409240|2389832|P2|NOT COMPLETED|Overall Study||1
986076|NCT00409240|2389833|P1|NOT COMPLETED|Overall Study||3
986077|NCT00409240|2389832|P2|COMPLETED|Overall Study||49
986078|NCT00409240|2389833|P1|COMPLETED|Overall Study||50
986079|NCT00409240|2389832|P2|STARTED|Overall Study||50
986080|NCT00409240|2389833|P1|STARTED|Overall Study||53
986081|NCT00409292|2389839|P1|NOT COMPLETED|Overall Study||0
986082|NCT00409292|2389839|P1|COMPLETED|Overall Study||33
986083|NCT00409292|2389839|P1|STARTED|Overall Study||33
986084|NCT00409331|2389846|P1|NOT COMPLETED|Overall Study||1
986085|NCT00409331|2389846|P1|COMPLETED|Overall Study||0
986086|NCT00409331|2389846|P1|STARTED|Overall Study||1
986087|NCT00409344|2389852|P2|NOT COMPLETED|Overall Study||0
986088|NCT00409344|2389853|P1|NOT COMPLETED|Overall Study||0
986089|NCT00409344|2389852|P2|COMPLETED|Overall Study|No participants were enrolled to completion|0
986090|NCT00409344|2389853|P1|COMPLETED|Overall Study|No participants were enrolled to completion|0
986091|NCT00409344|2389852|P2|STARTED|Overall Study|No participants enrolled|0
986092|NCT00409344|2389853|P1|STARTED|Overall Study|No participants enrolled|0
986093|NCT00409409|2389873|P2|NOT COMPLETED|Overall Study||4
986094|NCT00409409|2389874|P1|NOT COMPLETED|Overall Study||8
986095|NCT00409409|2389873|P2|COMPLETED|Overall Study||135
986096|NCT00409409|2389874|P1|COMPLETED|Overall Study||131
986097|NCT00409409|2389873|P2|STARTED|Overall Study||139
986098|NCT00409409|2389874|P1|STARTED|Overall Study||139
986118|NCT00409578|2389918|P4|NOT COMPLETED|Overall Study||67
986119|NCT00409578|2389919|P3|NOT COMPLETED|Overall Study||54
986120|NCT00409578|2389920|P2|NOT COMPLETED|Overall Study||70
986121|NCT00409578|2389921|P1|NOT COMPLETED|Overall Study||52
986122|NCT00409578|2389918|P4|COMPLETED|Overall Study||214
986123|NCT00409578|2389919|P3|COMPLETED|Overall Study||215
986124|NCT00409578|2389920|P2|COMPLETED|Overall Study||201
986125|NCT00409578|2389921|P1|COMPLETED|Overall Study||228
986126|NCT00409578|2389918|P4|STARTED|Overall Study||281
986127|NCT00409578|2389919|P3|STARTED|Overall Study||269
986128|NCT00409578|2389920|P2|STARTED|Overall Study||271
986129|NCT00409578|2389921|P1|STARTED|Overall Study||280
986130|NCT00409617|2389943|P1|NOT COMPLETED|Overall Study||160
986131|NCT00409617|2389943|P1|COMPLETED|Overall Study||785
986132|NCT00409617|2389943|P1|STARTED|Overall Study||945
986133|NCT00409682|2389958|P3|NOT COMPLETED|EOW Double-blind Maintenance Period||27
986134|NCT00409682|2389959|P2|NOT COMPLETED|EOW Double-blind Maintenance Period||37
986135|NCT00409682|2389960|P1|NOT COMPLETED|EOW Double-blind Maintenance Period||0
986136|NCT00409682|2389958|P3|COMPLETED|EOW Double-blind Maintenance Period||66
986137|NCT00409682|2389959|P2|COMPLETED|EOW Double-blind Maintenance Period||58
986383|NCT00410410|2390577|P7|COMPLETED|Maintenance Period (MP)||15
986138|NCT00409682|2389960|P1|COMPLETED|EOW Double-blind Maintenance Period||0
986139|NCT00409682|2389958|P3|STARTED|EOW Double-blind Maintenance Period||93
986140|NCT00409682|2389959|P2|STARTED|EOW Double-blind Maintenance Period||95
986141|NCT00409682|2389960|P1|STARTED|EOW Double-blind Maintenance Period||0
986142|NCT00409682|2389958|P3|NOT COMPLETED|Open-label Induction Period||0
986143|NCT00409682|2389959|P2|NOT COMPLETED|Open-label Induction Period||0
986144|NCT00409682|2389960|P1|NOT COMPLETED|Open-label Induction Period||4
986145|NCT00409682|2389958|P3|COMPLETED|Open-label Induction Period||0
986146|NCT00409682|2389959|P2|COMPLETED|Open-label Induction Period||0
986147|NCT00409682|2389960|P1|COMPLETED|Open-label Induction Period||188
986148|NCT00409682|2389958|P3|STARTED|Open-label Induction Period||0
986149|NCT00409682|2389959|P2|STARTED|Open-label Induction Period||0
986150|NCT00409682|2389960|P1|STARTED|Open-label Induction Period||192
986151|NCT00409708|2389979|P2|NOT COMPLETED|Washout||10
986152|NCT00409708|2389980|P1|NOT COMPLETED|Washout||21
986153|NCT00409708|2389979|P2|COMPLETED|Washout||29
986154|NCT00409708|2389980|P1|COMPLETED|Washout||17
986155|NCT00409708|2389979|P2|STARTED|Washout||39
986156|NCT00409708|2389980|P1|STARTED|Washout||38
986157|NCT00409708|2389979|P2|NOT COMPLETED|Treatment||17
986158|NCT00409708|2389980|P1|NOT COMPLETED|Treatment||15
986159|NCT00409708|2389979|P2|COMPLETED|Treatment||39
986160|NCT00409708|2389980|P1|COMPLETED|Treatment||38
986161|NCT00409708|2389979|P2|STARTED|Treatment||56
986162|NCT00409708|2389980|P1|STARTED|Treatment|A total of 142 participants were screened for the study but only 109 were randomized to treatment|53
986163|NCT00409747|2389998|P1|NOT COMPLETED|Overall Study||1
986164|NCT00409747|2389998|P1|COMPLETED|Overall Study||10
986165|NCT00409747|2389998|P1|STARTED|Overall Study||11
986166|NCT00409773|2390008|P5|NOT COMPLETED|Overall Study||10
986167|NCT00409773|2390009|P4|NOT COMPLETED|Overall Study||12
986168|NCT00409773|2390010|P3|NOT COMPLETED|Overall Study||9
986169|NCT00409773|2390011|P2|NOT COMPLETED|Overall Study||7
986170|NCT00409773|2390012|P1|NOT COMPLETED|Overall Study||9
986171|NCT00409773|2390008|P5|COMPLETED|Overall Study||218
986172|NCT00409773|2390009|P4|COMPLETED|Overall Study||216
986173|NCT00409773|2390010|P3|COMPLETED|Overall Study||220
986174|NCT00409773|2390011|P2|COMPLETED|Overall Study||222
986175|NCT00409773|2390012|P1|COMPLETED|Overall Study||220
986176|NCT00409773|2390008|P5|STARTED|Overall Study||228
986177|NCT00409773|2390009|P4|STARTED|Overall Study||228
986178|NCT00409773|2390010|P3|STARTED|Overall Study||229
986179|NCT00409773|2390011|P2|STARTED|Overall Study||229
986180|NCT00409773|2390012|P1|STARTED|Overall Study||229
986181|NCT00409786|2390094|P1|NOT COMPLETED|Overall Study||3
986182|NCT00409786|2390094|P1|COMPLETED|Overall Study||47
986183|NCT00409786|2390094|P1|STARTED|Overall Study||50
986184|NCT00409825|2390098|P1|NOT COMPLETED|Overall Study||0
986185|NCT00409825|2390098|P1|COMPLETED|Overall Study||61
986186|NCT00409825|2390098|P1|STARTED|Overall Study||61
986187|NCT00409838|2390104|P2|NOT COMPLETED|Long-term Extension Period||0
986188|NCT00409838|2390105|P1|NOT COMPLETED|Long-term Extension Period||18
986189|NCT00409838|2390104|P2|COMPLETED|Long-term Extension Period||0
986190|NCT00409838|2390105|P1|COMPLETED|Long-term Extension Period||87
986191|NCT00409838|2390104|P2|STARTED|Long-term Extension Period||0
986192|NCT00409838|2390105|P1|STARTED|Long-term Extension Period||105
986193|NCT00409838|2390104|P2|NOT COMPLETED|Short-term Period||5
986194|NCT00409838|2390105|P1|NOT COMPLETED|Short-term Period||3
986195|NCT00409838|2390104|P2|COMPLETED|Short-term Period|Participants who received placebo in this period received abatacept in next period.|52
986196|NCT00409838|2390105|P1|COMPLETED|Short-term Period||53
986197|NCT00409838|2390104|P2|Treated (Baseline) Population|Short-term Period||57
986198|NCT00409838|2390105|P1|Treated (Baseline) Population|Short-term Period||55
986199|NCT00409838|2390104|P2|STARTED|Short-term Period|Randomized|57
986200|NCT00409838|2390105|P1|STARTED|Short-term Period|Randomized|56
986201|NCT00410046|2390166|P1|NOT COMPLETED|Overall Study||5
986202|NCT00410046|2390166|P1|COMPLETED|Overall Study||79
986203|NCT00410046|2390166|P1|STARTED|Overall Study||84
986204|NCT00410059|2390195|P1|NOT COMPLETED|Overall Study||0
986205|NCT00410059|2390195|P1|COMPLETED|Overall Study||59
986206|NCT00410059|2390195|P1|STARTED|Overall Study||59
986207|NCT00410072|2390201|P2|NOT COMPLETED|After Week 48 to Week 96||11
986208|NCT00410072|2390202|P1|NOT COMPLETED|After Week 48 to Week 96||6
986209|NCT00410072|2390201|P2|COMPLETED|After Week 48 to Week 96||174
986210|NCT00410072|2390202|P1|COMPLETED|After Week 48 to Week 96||170
986211|NCT00410072|2390201|P2|STARTED|After Week 48 to Week 96||185
986212|NCT00410072|2390202|P1|STARTED|After Week 48 to Week 96||176
986213|NCT00410072|2390201|P2|NOT COMPLETED|Day 1 to Week 48||12
986214|NCT00410072|2390202|P1|NOT COMPLETED|Day 1 to Week 48||6
986215|NCT00410072|2390201|P2|COMPLETED|Day 1 to Week 48||185
986216|NCT00410072|2390202|P1|COMPLETED|Day 1 to Week 48||176
986217|NCT00410072|2390201|P2|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 1 more was randomized but not treated.|197
986218|NCT00410072|2390202|P1|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 4 more were randomized but not treated.|182
986219|NCT00410124|2390240|P2|NOT COMPLETED|Extension Phase - Open Label (45 Months)||111
986220|NCT00410124|2390241|P1|NOT COMPLETED|Extension Phase - Open Label (45 Months)||67
986221|NCT00410124|2390240|P2|COMPLETED|Extension Phase - Open Label (45 Months)||0
986222|NCT00410124|2390241|P1|COMPLETED|Extension Phase - Open Label (45 Months)||0
986223|NCT00410124|2390240|P2|STARTED|Extension Phase - Open Label (45 Months)|Patients on placebo in core received RAD001 in extension phase.|111
986224|NCT00410124|2390241|P1|STARTED|Extension Phase - Open Label (45 Months)||67
986225|NCT00410124|2390240|P2|NOT COMPLETED|Core Phase Double Blind (15 Months)||133
986226|NCT00410124|2390241|P1|NOT COMPLETED|Core Phase Double Blind (15 Months)||202
986227|NCT00410124|2390240|P2|COMPLETED|Core Phase Double Blind (15 Months)|All patients ongoing/completed/not completed in core had option to enter extension taking RAD001.|6
986228|NCT00410124|2390241|P1|COMPLETED|Core Phase Double Blind (15 Months)|Patients ongoing/completed double blind phase had option entering extension phase continuing RAD001.|75
986229|NCT00410124|2390240|P2|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||2
986230|NCT00410124|2390241|P1|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||62
986231|NCT00410124|2390240|P2|Ongoing|Core Phase Double Blind (15 Months)||4
986232|NCT00410124|2390241|P1|Ongoing|Core Phase Double Blind (15 Months)||13
986233|NCT00410124|2390240|P2|STARTED|Core Phase Double Blind (15 Months)||139
986234|NCT00410124|2390241|P1|STARTED|Core Phase Double Blind (15 Months)|Started indicates randomized (FAS) and treated|277
986235|NCT00410150|2390272|P2|NOT COMPLETED|Overall Study||3
986236|NCT00410150|2390273|P1|NOT COMPLETED|Overall Study||2
986237|NCT00410150|2390272|P2|COMPLETED|Overall Study|3 study withdrawals (analyzed by intention-to-treat0|17
986238|NCT00410150|2390273|P1|COMPLETED|Overall Study|2 study withdrawals (analyzed by intention-to-treat)|20
986239|NCT00410150|2390272|P2|STARTED|Overall Study||20
986240|NCT00410150|2390273|P1|STARTED|Overall Study||22
986241|NCT00410163|2390281|P2|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
986242|NCT00410163|2390282|P1|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
986243|NCT00410163|2390281|P2|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||11
986244|NCT00410163|2390282|P1|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
986245|NCT00410163|2390281|P2|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|21
986246|NCT00410163|2390282|P1|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|20
986247|NCT00410163|2390281|P2|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||11
986248|NCT00410163|2390282|P1|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||12
986249|NCT00410163|2390281|P2|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
986250|NCT00410163|2390282|P1|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
986251|NCT00410163|2390281|P2|STARTED|Treatment and Follow-up Phase (2 Years)||30
986252|NCT00410163|2390282|P1|STARTED|Treatment and Follow-up Phase (2 Years)||31
986253|NCT00410189|2390324|P1|NOT COMPLETED|Overall Study||0
986254|NCT00410189|2390324|P1|COMPLETED|Overall Study||54
986255|NCT00410189|2390324|P1|STARTED|Overall Study||54
986256|NCT00410202|2390332|P3|NOT COMPLETED|Off-treatment Follow up||12
986257|NCT00410202|2390333|P2|NOT COMPLETED|Off-treatment Follow up||8
986258|NCT00410202|2390334|P1|NOT COMPLETED|Off-treatment Follow up||14
986259|NCT00410202|2390332|P3|COMPLETED|Off-treatment Follow up||2
986260|NCT00410202|2390333|P2|COMPLETED|Off-treatment Follow up||0
986261|NCT00410202|2390334|P1|COMPLETED|Off-treatment Follow up||1
986262|NCT00410202|2390332|P3|STARTED|Off-treatment Follow up||14
986263|NCT00410202|2390333|P2|STARTED|Off-treatment Follow up||8
986264|NCT00410202|2390334|P1|STARTED|Off-treatment Follow up||15
986265|NCT00410202|2390332|P3|NOT COMPLETED|On-Treatment||71
986266|NCT00410202|2390333|P2|NOT COMPLETED|On-Treatment||79
986267|NCT00410202|2390334|P1|NOT COMPLETED|On-Treatment||75
986268|NCT00410202|2390332|P3|COMPLETED|On-Treatment|Completed the 100 week dosing|66
986269|NCT00410202|2390333|P2|COMPLETED|On-Treatment|Completed the 100 week dosing|61
986270|NCT00410202|2390334|P1|COMPLETED|On-Treatment|Completed the 100 week dosing|63
986271|NCT00410202|2390332|P3|Discontinued at or After Week 48 Visit|On-Treatment||3
986272|NCT00410202|2390333|P2|Discontinued at or After Week 48 Visit|On-Treatment||6
986273|NCT00410202|2390334|P1|Discontinued at or After Week 48 Visit|On-Treatment||2
986274|NCT00410202|2390332|P3|Discontinued Prior to Week 48 Visit|On-Treatment||2
986275|NCT00410202|2390333|P2|Discontinued Prior to Week 48 Visit|On-Treatment||2
986276|NCT00410202|2390334|P1|Discontinued Prior to Week 48 Visit|On-Treatment||4
986277|NCT00410202|2390332|P3|STARTED|On-Treatment||137
986278|NCT00410202|2390333|P2|STARTED|On-Treatment||140
986279|NCT00410202|2390334|P1|STARTED|On-Treatment||138
986280|NCT00410280|2390416|P2|NOT COMPLETED|Overall Study||0
986281|NCT00410280|2390417|P1|NOT COMPLETED|Overall Study||0
986282|NCT00410280|2390416|P2|COMPLETED|Overall Study||13
986283|NCT00410280|2390417|P1|COMPLETED|Overall Study||14
986284|NCT00410280|2390416|P2|STARTED|Overall Study||13
986285|NCT00410280|2390417|P1|STARTED|Overall Study||14
986286|NCT00403403|2390460|P2|NOT COMPLETED|Overall Study||0
986287|NCT00403403|2390461|P1|NOT COMPLETED|Overall Study||0
986288|NCT00403403|2390460|P2|COMPLETED|Overall Study||52
986289|NCT00403403|2390461|P1|COMPLETED|Overall Study||50
986290|NCT00403403|2390460|P2|Safety-Evaluable Patients|Overall Study||51
986291|NCT00403403|2390461|P1|Safety-Evaluable Patients|Overall Study||47
986292|NCT00403403|2390460|P2|STARTED|Overall Study||52
986293|NCT00403403|2390461|P1|STARTED|Overall Study||50
986294|NCT00403455|2390475|P1|NOT COMPLETED|Overall Study||1
986295|NCT00403455|2390475|P1|COMPLETED|Overall Study||37
986296|NCT00403455|2390475|P1|STARTED|Overall Study||38
986297|NCT00403481|2390479|P1|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||2
986298|NCT00403481|2390479|P1|COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||142
986299|NCT00403481|2390479|P1|STARTED|Olm 40 mg + Hydrochlorothiazide 25 mg|168 -24 met their blood pressure goal (remained on olmesartan 40 mg/hydrochlorothiazide 12.5mg)= 144|144
986300|NCT00403481|2390479|P1|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||5
986301|NCT00403481|2390479|P1|COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||168
986302|NCT00403481|2390479|P1|STARTED|Olm 40 mg + Hydrochlorothiazide 12.5 mg|177 -4 met their blood pressure goal (remained on olmesartan 40 mg)= 173|173
986303|NCT00403481|2390479|P1|NOT COMPLETED|Olm 40 mg||5
986304|NCT00403481|2390479|P1|COMPLETED|Olm 40 mg||177
986305|NCT00403481|2390479|P1|STARTED|Olm 40 mg|186 -4 met their blood pressure goal (remained on olmesartan 20 mg) = 182|182
986306|NCT00403481|2390479|P1|NOT COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||6
986307|NCT00403481|2390479|P1|COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||186
986308|NCT00403481|2390479|P1|STARTED|Olmesartan Medoxomil (Olm) 20 mg||192
986309|NCT00403546|2390496|P3|NOT COMPLETED|Randomized Trial||16
986310|NCT00403546|2390497|P2|NOT COMPLETED|Randomized Trial||17
986311|NCT00403546|2390498|P1|NOT COMPLETED|Randomized Trial||0
986312|NCT00403546|2390496|P3|COMPLETED|Randomized Trial||21
986313|NCT00403546|2390497|P2|COMPLETED|Randomized Trial||21
986314|NCT00403546|2390498|P1|COMPLETED|Randomized Trial||0
986315|NCT00403546|2390496|P3|STARTED|Randomized Trial||37
986316|NCT00403546|2390497|P2|STARTED|Randomized Trial||38
986317|NCT00403546|2390498|P1|STARTED|Randomized Trial|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|0
986318|NCT00403546|2390496|P3|NOT COMPLETED|Screening Phase||0
986319|NCT00403546|2390497|P2|NOT COMPLETED|Screening Phase||0
986320|NCT00403546|2390498|P1|NOT COMPLETED|Screening Phase||28
986321|NCT00403546|2390496|P3|COMPLETED|Screening Phase||0
986322|NCT00403546|2390497|P2|COMPLETED|Screening Phase||0
986323|NCT00403546|2390498|P1|COMPLETED|Screening Phase|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|75
986324|NCT00403546|2390496|P3|STARTED|Screening Phase||0
986325|NCT00403546|2390497|P2|STARTED|Screening Phase||0
986326|NCT00403546|2390498|P1|STARTED|Screening Phase||103
986327|NCT00403546|2390496|P3|NOT COMPLETED|Signed Informed Consent/Open-Label||0
986328|NCT00403546|2390497|P2|NOT COMPLETED|Signed Informed Consent/Open-Label||0
986329|NCT00403546|2390498|P1|NOT COMPLETED|Signed Informed Consent/Open-Label||28
986330|NCT00403546|2390496|P3|COMPLETED|Signed Informed Consent/Open-Label||0
986331|NCT00403546|2390497|P2|COMPLETED|Signed Informed Consent/Open-Label||0
986332|NCT00403546|2390498|P1|COMPLETED|Signed Informed Consent/Open-Label||103
986333|NCT00403546|2390496|P3|STARTED|Signed Informed Consent/Open-Label||0
986334|NCT00403546|2390497|P2|STARTED|Signed Informed Consent/Open-Label||0
986335|NCT00403546|2390498|P1|STARTED|Signed Informed Consent/Open-Label||131
986336|NCT00410384|2390541|P3|NOT COMPLETED|Overall Study||82
986337|NCT00410384|2390542|P2|NOT COMPLETED|Overall Study||72
986338|NCT00410384|2390543|P1|NOT COMPLETED|Overall Study||89
986339|NCT00410384|2390541|P3|COMPLETED|Overall Study||191
986340|NCT00410384|2390542|P2|COMPLETED|Overall Study||199
986341|NCT00410384|2390543|P1|COMPLETED|Overall Study||186
986342|NCT00410384|2390541|P3|STARTED|Overall Study||273
986343|NCT00410384|2390542|P2|STARTED|Overall Study||271
986344|NCT00410384|2390543|P1|STARTED|Overall Study||275
986345|NCT00410410|2390575|P9|NOT COMPLETED|Open-Label Period (OL)||349
986346|NCT00410410|2390576|P8|NOT COMPLETED|Open-Label Period (OL)||0
986347|NCT00410410|2390577|P7|NOT COMPLETED|Open-Label Period (OL)||0
986348|NCT00410410|2390578|P6|NOT COMPLETED|Open-Label Period (OL)||0
986349|NCT00410410|2390579|P5|NOT COMPLETED|Open-Label Period (OL)||0
986350|NCT00410410|2390580|P4|NOT COMPLETED|Open-Label Period (OL)||0
986351|NCT00410410|2390581|P3|NOT COMPLETED|Open-Label Period (OL)||0
986352|NCT00410410|2390582|P2|NOT COMPLETED|Open-Label Period (OL)||0
986353|NCT00410410|2390583|P1|NOT COMPLETED|Open-Label Period (OL)||0
986354|NCT00410410|2390575|P9|COMPLETED|Open-Label Period (OL)||0
986355|NCT00410410|2390576|P8|COMPLETED|Open-Label Period (OL)||0
986356|NCT00410410|2390577|P7|COMPLETED|Open-Label Period (OL)||0
986357|NCT00410410|2390578|P6|COMPLETED|Open-Label Period (OL)||0
986358|NCT00410410|2390579|P5|COMPLETED|Open-Label Period (OL)||0
986359|NCT00410410|2390580|P4|COMPLETED|Open-Label Period (OL)||0
986360|NCT00410410|2390581|P3|COMPLETED|Open-Label Period (OL)||0
986361|NCT00410410|2390582|P2|COMPLETED|Open-Label Period (OL)||0
986362|NCT00410410|2390583|P1|COMPLETED|Open-Label Period (OL)||0
986363|NCT00410410|2390575|P9|STARTED|Open-Label Period (OL)|349 entered OL (those who completed IP but failed response criteria, or completed/relapsed on MP).|349
986364|NCT00410410|2390576|P8|STARTED|Open-Label Period (OL)||0
986365|NCT00410410|2390577|P7|STARTED|Open-Label Period (OL)||0
986366|NCT00410410|2390578|P6|STARTED|Open-Label Period (OL)||0
986367|NCT00410410|2390579|P5|STARTED|Open-Label Period (OL)||0
986368|NCT00410410|2390580|P4|STARTED|Open-Label Period (OL)||0
986369|NCT00410410|2390581|P3|STARTED|Open-Label Period (OL)||0
986370|NCT00410410|2390582|P2|STARTED|Open-Label Period (OL)||0
986371|NCT00410410|2390583|P1|STARTED|Open-Label Period (OL)||0
986372|NCT00410410|2390575|P9|NOT COMPLETED|Maintenance Period (MP)||0
986373|NCT00410410|2390576|P8|NOT COMPLETED|Maintenance Period (MP)||55
986374|NCT00410410|2390577|P7|NOT COMPLETED|Maintenance Period (MP)||50
986375|NCT00410410|2390578|P6|NOT COMPLETED|Maintenance Period (MP)||0
986376|NCT00410410|2390579|P5|NOT COMPLETED|Maintenance Period (MP)||0
986377|NCT00410410|2390580|P4|NOT COMPLETED|Maintenance Period (MP)||0
986378|NCT00410410|2390581|P3|NOT COMPLETED|Maintenance Period (MP)||0
986379|NCT00410410|2390582|P2|NOT COMPLETED|Maintenance Period (MP)||0
986380|NCT00410410|2390583|P1|NOT COMPLETED|Maintenance Period (MP)||0
986381|NCT00410410|2390575|P9|COMPLETED|Maintenance Period (MP)||0
986382|NCT00410410|2390576|P8|COMPLETED|Maintenance Period (MP)||11
986384|NCT00410410|2390578|P6|COMPLETED|Maintenance Period (MP)||0
986385|NCT00410410|2390579|P5|COMPLETED|Maintenance Period (MP)||0
986386|NCT00410410|2390580|P4|COMPLETED|Maintenance Period (MP)||0
986387|NCT00410410|2390581|P3|COMPLETED|Maintenance Period (MP)||0
986388|NCT00410410|2390582|P2|COMPLETED|Maintenance Period (MP)||0
986389|NCT00410410|2390583|P1|COMPLETED|Maintenance Period (MP)||0
986390|NCT00410410|2390575|P9|STARTED|Maintenance Period (MP)||0
986391|NCT00410410|2390576|P8|STARTED|Maintenance Period (MP)|At end of IP, 66 participants met response criteria and were randomly assigned to placebo in MP.|66
986392|NCT00410410|2390577|P7|STARTED|Maintenance Period (MP)|At end of IP, 65 participants met response criteria and were randomly assigned to abatacept in MP.|65
986393|NCT00410410|2390578|P6|STARTED|Maintenance Period (MP)||0
986394|NCT00410410|2390579|P5|STARTED|Maintenance Period (MP)||0
986395|NCT00410410|2390580|P4|STARTED|Maintenance Period (MP)||0
986396|NCT00410410|2390581|P3|STARTED|Maintenance Period (MP)||0
986397|NCT00410410|2390582|P2|STARTED|Maintenance Period (MP)||0
986398|NCT00410410|2390583|P1|STARTED|Maintenance Period (MP)||0
986399|NCT00410410|2390575|P9|NOT COMPLETED|Induction Period (IP)||0
986400|NCT00410410|2390576|P8|NOT COMPLETED|Induction Period (IP)||0
986401|NCT00410410|2390577|P7|NOT COMPLETED|Induction Period (IP)||0
986402|NCT00410410|2390578|P6|NOT COMPLETED|Induction Period (IP)||29
986403|NCT00410410|2390579|P5|NOT COMPLETED|Induction Period (IP)||32
986404|NCT00410410|2390580|P4|NOT COMPLETED|Induction Period (IP)||20
986405|NCT00410410|2390581|P3|NOT COMPLETED|Induction Period (IP)||17
986406|NCT00410410|2390582|P2|NOT COMPLETED|Induction Period (IP)||35
986407|NCT00410410|2390583|P1|NOT COMPLETED|Induction Period (IP)||35
986408|NCT00410410|2390575|P9|COMPLETED|Induction Period (IP)||0
986409|NCT00410410|2390576|P8|COMPLETED|Induction Period (IP)||0
986410|NCT00410410|2390577|P7|COMPLETED|Induction Period (IP)||0
986411|NCT00410410|2390578|P6|COMPLETED|Induction Period (IP)||21
986412|NCT00410410|2390579|P5|COMPLETED|Induction Period (IP)||19
986413|NCT00410410|2390580|P4|COMPLETED|Induction Period (IP)||120
986414|NCT00410410|2390581|P3|COMPLETED|Induction Period (IP)||53
986415|NCT00410410|2390582|P2|COMPLETED|Induction Period (IP)||104
986416|NCT00410410|2390583|P1|COMPLETED|Induction Period (IP)||106
986417|NCT00410410|2390575|P9|STARTED|Induction Period (IP)||0
986418|NCT00410410|2390576|P8|STARTED|Induction Period (IP)||0
986419|NCT00410410|2390577|P7|STARTED|Induction Period (IP)||0
986420|NCT00410410|2390578|P6|STARTED|Induction Period (IP)||50
986421|NCT00410410|2390579|P5|STARTED|Induction Period (IP)||51
986422|NCT00410410|2390580|P4|STARTED|Induction Period (IP)||140
986423|NCT00410410|2390581|P3|STARTED|Induction Period (IP)||70
986424|NCT00410410|2390582|P2|STARTED|Induction Period (IP)||139
986425|NCT00410410|2390583|P1|STARTED|Induction Period (IP)||141
986426|NCT00410488|2390743|P2|NOT COMPLETED|Overall Study||0
986427|NCT00410488|2390744|P1|NOT COMPLETED|Overall Study||0
986428|NCT00410488|2390743|P2|COMPLETED|Overall Study||34
986429|NCT00410488|2390744|P1|COMPLETED|Overall Study||16
986430|NCT00410488|2390743|P2|STARTED|Overall Study||34
986431|NCT00410488|2390744|P1|STARTED|Overall Study||16
986432|NCT00410514|2390752|P3|NOT COMPLETED|Overall Study||7
986433|NCT00410514|2390753|P2|NOT COMPLETED|Overall Study||3
986434|NCT00410514|2390754|P1|NOT COMPLETED|Overall Study||2
986435|NCT00410514|2390752|P3|COMPLETED|Overall Study||58
986436|NCT00410514|2390753|P2|COMPLETED|Overall Study||67
986437|NCT00410514|2390754|P1|COMPLETED|Overall Study||63
986438|NCT00410514|2390752|P3|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|58
986439|NCT00410514|2390753|P2|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|64
986440|NCT00410514|2390754|P1|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|63
986441|NCT00410514|2390752|P3|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
986442|NCT00410514|2390753|P2|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|70
986443|NCT00410514|2390754|P1|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
986444|NCT00410514|2390752|P3|STARTED|Overall Study||65
986445|NCT00410514|2390753|P2|STARTED|Overall Study||70
986446|NCT00410514|2390754|P1|STARTED|Overall Study||65
986447|NCT00410605|2390813|P1|NOT COMPLETED|Overall Study||25
986448|NCT00410605|2390813|P1|COMPLETED|Overall Study||14
986449|NCT00410605|2390813|P1|STARTED|Overall Study||39
986450|NCT00410826|2390824|P2|NOT COMPLETED|Overall Study||4
986451|NCT00410826|2390825|P1|NOT COMPLETED|Overall Study||9
986452|NCT00410826|2390824|P2|COMPLETED|Overall Study||95
986453|NCT00410826|2390825|P1|COMPLETED|Overall Study||96
986454|NCT00410826|2390824|P2|STARTED|Overall Study||99
986455|NCT00410826|2390825|P1|STARTED|Overall Study||105
986456|NCT00410891|2390833|P1|NOT COMPLETED|Overall Study||0
986457|NCT00410891|2390833|P1|COMPLETED|Overall Study||129
986458|NCT00410891|2390833|P1|STARTED|Overall Study||129
986459|NCT00410904|2390839|P2|NOT COMPLETED|Overall Study||0
986460|NCT00410904|2390840|P1|NOT COMPLETED|Overall Study||0
986461|NCT00410904|2390839|P2|COMPLETED|Overall Study||20
986462|NCT00410904|2390840|P1|COMPLETED|Overall Study||40
986463|NCT00410904|2390839|P2|STARTED|Overall Study||20
986464|NCT00410904|2390840|P1|STARTED|Overall Study||40
986465|NCT00411151|2390846|P1|NOT COMPLETED|Overall Study||47
986466|NCT00411151|2390846|P1|COMPLETED|Overall Study||5
986467|NCT00411151|2390846|P1|STARTED|Overall Study||52
986468|NCT00411216|2390858|P2|NOT COMPLETED|Overall Study||2
986469|NCT00411216|2390859|P1|NOT COMPLETED|Overall Study||0
986470|NCT00411216|2390858|P2|COMPLETED|Overall Study||8
986471|NCT00411216|2390859|P1|COMPLETED|Overall Study||13
986472|NCT00411216|2390858|P2|STARTED|Overall Study||10
986473|NCT00411216|2390859|P1|STARTED|Overall Study||13
986474|NCT00411398|2390865|P1|NOT COMPLETED|Overall Study||5
986475|NCT00411398|2390865|P1|COMPLETED|Overall Study||10
986476|NCT00411398|2390865|P1|STARTED|Overall Study||15
986477|NCT00411411|2390871|P2|NOT COMPLETED|Overall Study||0
986478|NCT00411411|2390872|P1|NOT COMPLETED|Overall Study||0
986479|NCT00411411|2390871|P2|COMPLETED|Overall Study||25
986480|NCT00411411|2390872|P1|COMPLETED|Overall Study||24
986481|NCT00411411|2390871|P2|STARTED|Overall Study||25
986482|NCT00411411|2390872|P1|STARTED|Overall Study||24
986483|NCT00411450|2390880|P1|NOT COMPLETED|Overall Study||3
986484|NCT00411450|2390880|P1|COMPLETED|Overall Study|Ended second-line treatment|113
986485|NCT00411450|2390880|P1|Received Treatment|Overall Study||115
986486|NCT00411450|2390880|P1|STARTED|Overall Study||116
986487|NCT00411463|2390908|P2|NOT COMPLETED|Overall Study||3
986488|NCT00411463|2390909|P1|NOT COMPLETED|Overall Study||3
986489|NCT00411463|2390908|P2|COMPLETED|Overall Study||8
986490|NCT00411463|2390909|P1|COMPLETED|Overall Study||11
986491|NCT00411463|2390908|P2|STARTED|Overall Study||11
986492|NCT00411463|2390909|P1|STARTED|Overall Study||14
986493|NCT00411554|2390924|P2|NOT COMPLETED|Overall Study||9
986494|NCT00411554|2390925|P1|NOT COMPLETED|Overall Study||8
986495|NCT00411554|2390924|P2|COMPLETED|Overall Study||147
986496|NCT00411554|2390925|P1|COMPLETED|Overall Study||155
986497|NCT00411554|2390924|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|156
986498|NCT00411554|2390925|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|163
986499|NCT00411619|2390935|P1|NOT COMPLETED|Overall Study||6
986500|NCT00411619|2390935|P1|COMPLETED|Overall Study||22
986501|NCT00411619|2390935|P1|STARTED|Overall Study||28
986502|NCT00411645|2390942|P2|NOT COMPLETED|Overall Study||164
986503|NCT00411645|2390943|P1|NOT COMPLETED|Overall Study||81
986504|NCT00411645|2390942|P2|COMPLETED|Overall Study||290
986505|NCT00411645|2390943|P1|COMPLETED|Overall Study||146
986506|NCT00411645|2390942|P2|STARTED|Overall Study||454
986507|NCT00411645|2390943|P1|STARTED|Overall Study||227
986508|NCT00411671|2390967|P1|NOT COMPLETED|Overall Study||20
986509|NCT00411671|2390967|P1|COMPLETED|Overall Study||85
986510|NCT00411671|2390967|P1|STARTED|Overall Study||105
986511|NCT00411749|2390975|P2|NOT COMPLETED|Overall Study||0
986512|NCT00411749|2390976|P1|NOT COMPLETED|Overall Study||0
986513|NCT00411749|2390975|P2|COMPLETED|Overall Study|Completed at 1 month after vaccination series (Month 7). Subjects were followed until Month 7|25
986514|NCT00411749|2390976|P1|COMPLETED|Overall Study|Completed at 24 month after vaccination series (Month 30). Subjects were followed until Month 30|82
986515|NCT00411749|2390975|P2|Vaccinated|Overall Study||25
986516|NCT00411749|2390976|P1|Vaccinated|Overall Study||82
986517|NCT00411749|2390975|P2|STARTED|Overall Study||25
986518|NCT00411749|2390976|P1|STARTED|Overall Study||82
986519|NCT00411762|2390992|P1|NOT COMPLETED|Overall Study||5
986520|NCT00411762|2390992|P1|COMPLETED|Overall Study||20
986521|NCT00411762|2390992|P1|STARTED|Overall Study||25
986522|NCT00411788|2390997|P1|NOT COMPLETED|Overall Study||2
986523|NCT00411788|2390997|P1|COMPLETED|Overall Study||9
986524|NCT00411788|2390997|P1|STARTED|Overall Study||11
986525|NCT00412061|2391008|P2|NOT COMPLETED|Open Label Phase||170
986526|NCT00412061|2391009|P1|NOT COMPLETED|Open Label Phase||0
986527|NCT00412061|2391008|P2|COMPLETED|Open Label Phase||0
986528|NCT00412061|2391009|P1|COMPLETED|Open Label Phase||0
986529|NCT00412061|2391008|P2|STARTED|Open Label Phase||170
986530|NCT00412061|2391009|P1|STARTED|Open Label Phase||0
986531|NCT00412061|2391008|P2|NOT COMPLETED|Double Blind Phase||213
986532|NCT00412061|2391009|P1|NOT COMPLETED|Double Blind Phase||216
986533|NCT00412061|2391008|P2|COMPLETED|Double Blind Phase||0
986534|NCT00412061|2391009|P1|COMPLETED|Double Blind Phase||0
986535|NCT00412061|2391008|P2|Safety Set|Double Blind Phase|1 pt randomized never took drug Another randomized did not have valid post BL safety assessment|211
986536|NCT00412061|2391009|P1|Safety Set|Double Blind Phase|1 patient did not provide at laest one valid post baseline safety assessment.|215
986537|NCT00412061|2391008|P2|STARTED|Double Blind Phase||213
986538|NCT00412061|2391009|P1|STARTED|Double Blind Phase||216
986539|NCT00412074|2391030|P3|NOT COMPLETED|Overall Study||67
986540|NCT00412074|2391031|P2|NOT COMPLETED|Overall Study||22
986541|NCT00412074|2391032|P1|NOT COMPLETED|Overall Study||77
986542|NCT00412074|2391030|P3|COMPLETED|Overall Study||128
986543|NCT00412074|2391031|P2|COMPLETED|Overall Study||44
986544|NCT00412074|2391032|P1|COMPLETED|Overall Study||122
986545|NCT00412074|2391030|P3|STARTED|Overall Study||195
986546|NCT00412074|2391031|P2|STARTED|Overall Study||66
986547|NCT00412074|2391032|P1|STARTED|Overall Study||199
986548|NCT00412087|2391048|P2|NOT COMPLETED|Overall Study||65
986549|NCT00412087|2391049|P1|NOT COMPLETED|Overall Study||62
986550|NCT00412087|2391048|P2|COMPLETED|Overall Study||66
986551|NCT00412087|2391049|P1|COMPLETED|Overall Study||72
986552|NCT00412087|2391048|P2|STARTED|Overall Study||131
986553|NCT00412087|2391049|P1|STARTED|Overall Study||134
986554|NCT00412113|2391059|P2|NOT COMPLETED|Overall Study||15
986555|NCT00412113|2391060|P1|NOT COMPLETED|Overall Study||12
986556|NCT00412113|2391059|P2|COMPLETED|Overall Study|15-April-2008|107
986557|NCT00412113|2391060|P1|COMPLETED|Overall Study|15-April-2008|111
986558|NCT00412113|2391059|P2|Received Treatment|Overall Study||122
986559|NCT00412113|2391060|P1|Received Treatment|Overall Study|One subject assigned to Norvasc and TLC did not receive treatment and was excluded from all analyses|122
986560|NCT00412113|2391059|P2|STARTED|Overall Study|15-January-2007|122
986561|NCT00412113|2391060|P1|STARTED|Overall Study|15-January-2007|123
986562|NCT00412217|2391114|P2|NOT COMPLETED|Overall Study||48
986563|NCT00412217|2391115|P1|NOT COMPLETED|Overall Study||46
986564|NCT00412217|2391114|P2|COMPLETED|Overall Study||0
986565|NCT00412217|2391115|P1|COMPLETED|Overall Study||0
986566|NCT00412217|2391114|P2|STARTED|Overall Study||48
986567|NCT00412217|2391115|P1|STARTED|Overall Study||46
986568|NCT00412243|2391127|P1|NOT COMPLETED|Overall Study||0
986569|NCT00412243|2391127|P1|COMPLETED|Overall Study||50
986570|NCT00412243|2391127|P1|STARTED|Overall Study||50
986571|NCT00412360|2391133|P2|NOT COMPLETED|Overall Study||3
986572|NCT00412360|2391134|P1|NOT COMPLETED|Overall Study||1
986573|NCT00412360|2391133|P2|COMPLETED|Overall Study||108
986574|NCT00412360|2391134|P1|COMPLETED|Overall Study||112
986575|NCT00412360|2391133|P2|STARTED|Overall Study||111
986576|NCT00412360|2391134|P1|STARTED|Overall Study||113
986577|NCT00412373|2391160|P2|NOT COMPLETED|Overall Study||77
986578|NCT00412373|2391161|P1|NOT COMPLETED|Overall Study||41
986579|NCT00412373|2391160|P2|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment..|134
986580|NCT00412373|2391161|P1|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment.|52
986581|NCT00412373|2391160|P2|STARTED|Overall Study|Number of Subjects Intent-to-Treat Analysis Set.|211
986582|NCT00412373|2391161|P1|STARTED|Overall Study|Number of Subjects in Intent-to-Treat Analysis Set.|93
986583|NCT00412425|2391203|P2|NOT COMPLETED|Overall Study||0
986584|NCT00412425|2391204|P1|NOT COMPLETED|Overall Study||0
986585|NCT00412425|2391203|P2|COMPLETED|Overall Study||15
986586|NCT00412425|2391204|P1|COMPLETED|Overall Study||15
986587|NCT00412425|2391203|P2|STARTED|Overall Study||15
986588|NCT00412425|2391204|P1|STARTED|Overall Study||15
986589|NCT00412451|2391214|P4|NOT COMPLETED|Overall Study||2
986590|NCT00412451|2391215|P3|NOT COMPLETED|Overall Study||1
986591|NCT00412451|2391216|P2|NOT COMPLETED|Overall Study||0
986592|NCT00412451|2391217|P1|NOT COMPLETED|Overall Study||0
986593|NCT00412451|2391214|P4|COMPLETED|Overall Study||11
986594|NCT00412451|2391215|P3|COMPLETED|Overall Study||14
986595|NCT00412451|2391216|P2|COMPLETED|Overall Study||15
986596|NCT00412451|2391217|P1|COMPLETED|Overall Study||8
986597|NCT00412451|2391214|P4|STARTED|Overall Study||13
986598|NCT00412451|2391215|P3|STARTED|Overall Study||15
986599|NCT00412451|2391216|P2|STARTED|Overall Study||15
986600|NCT00412451|2391217|P1|STARTED|Overall Study||8
986601|NCT00412464|2391227|P1|NOT COMPLETED|Overall Study||0
986602|NCT00412464|2391227|P1|COMPLETED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
986603|NCT00412464|2391227|P1|STARTED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
986604|NCT00412516|2391238|P3|NOT COMPLETED|Overall Study||0
986605|NCT00412516|2391239|P2|NOT COMPLETED|Overall Study||0
986606|NCT00412516|2391240|P1|NOT COMPLETED|Overall Study||0
986607|NCT00412516|2391238|P3|COMPLETED|Overall Study||214
986608|NCT00412516|2391239|P2|COMPLETED|Overall Study||212
986609|NCT00412516|2391240|P1|COMPLETED|Overall Study||93
986610|NCT00412516|2391238|P3|STARTED|Overall Study||214
986611|NCT00412516|2391239|P2|STARTED|Overall Study||212
986612|NCT00412516|2391240|P1|STARTED|Overall Study||93
986613|NCT00412529|2391259|P2|NOT COMPLETED|Overall Study||0
986614|NCT00412529|2391260|P1|NOT COMPLETED|Overall Study||0
986615|NCT00412529|2391259|P2|COMPLETED|Overall Study||21
986616|NCT00412529|2391260|P1|COMPLETED|Overall Study||23
986617|NCT00412529|2391259|P2|STARTED|Overall Study||21
986618|NCT00412529|2391260|P1|STARTED|Overall Study||23
986619|NCT00412542|2391282|P2|NOT COMPLETED|Overall Study||3
986620|NCT00412542|2391283|P1|NOT COMPLETED|Overall Study||0
986621|NCT00412542|2391282|P2|COMPLETED|Overall Study||42
986622|NCT00412542|2391283|P1|COMPLETED|Overall Study||33
986623|NCT00412542|2391282|P2|STARTED|Overall Study||45
986624|NCT00412542|2391283|P1|STARTED|Overall Study||33
986625|NCT00412607|2391287|P1|NOT COMPLETED|Overall Study||104
986626|NCT00412607|2391287|P1|COMPLETED|Overall Study||145
986627|NCT00412607|2391287|P1|Started Study Catheter|Overall Study||233
986628|NCT00412607|2391287|P1|STARTED|Overall Study||249
986629|NCT00412737|2391300|P2|NOT COMPLETED|Overall Study||6
986630|NCT00412737|2391301|P1|NOT COMPLETED|Overall Study||16
986631|NCT00412737|2391300|P2|COMPLETED|Overall Study||232
986632|NCT00412737|2391301|P1|COMPLETED|Overall Study||221
986633|NCT00412737|2391300|P2|STARTED|Overall Study||238
986634|NCT00412737|2391301|P1|STARTED|Overall Study||237
986635|NCT00412750|2391322|P3|NOT COMPLETED|Overall Study||23
986636|NCT00412750|2391323|P2|NOT COMPLETED|Overall Study||21
986637|NCT00412750|2391324|P1|NOT COMPLETED|Overall Study||31
986638|NCT00412750|2391322|P3|COMPLETED|Overall Study||31
986639|NCT00412750|2391323|P2|COMPLETED|Overall Study||34
986640|NCT00412750|2391324|P1|COMPLETED|Overall Study||19
986641|NCT00412750|2391322|P3|STARTED|Overall Study||54
986642|NCT00412750|2391323|P2|STARTED|Overall Study||55
986643|NCT00412750|2391324|P1|STARTED|Overall Study||50
986644|NCT00412841|2391349|P2|NOT COMPLETED|Overall Study||5
986645|NCT00412841|2391350|P1|NOT COMPLETED|Overall Study||10
986646|NCT00412841|2391349|P2|COMPLETED|Overall Study||16
986647|NCT00412841|2391350|P1|COMPLETED|Overall Study||12
986648|NCT00412841|2391349|P2|STARTED|Overall Study||21
986649|NCT00412841|2391350|P1|STARTED|Overall Study||22
986650|NCT00412854|2391360|P2|NOT COMPLETED|Overall Study||16
986651|NCT00412854|2391361|P1|NOT COMPLETED|Overall Study||14
986652|NCT00412854|2391360|P2|COMPLETED|Overall Study||314
986653|NCT00412854|2391361|P1|COMPLETED|Overall Study||316
986654|NCT00412854|2391360|P2|STARTED|Overall Study||330
986655|NCT00412854|2391361|P1|STARTED|Overall Study||330
986656|NCT00412867|2391387|P1|NOT COMPLETED|Overall Study||0
986657|NCT00412867|2391387|P1|COMPLETED|Overall Study||58
986658|NCT00412867|2391387|P1|STARTED|Overall Study||58
986659|NCT00412893|2391396|P2|NOT COMPLETED|Overall Study||144
986660|NCT00412893|2391397|P1|NOT COMPLETED|Overall Study||145
986661|NCT00412893|2391396|P2|COMPLETED|Overall Study|Defined as completed treatment|120
986662|NCT00412893|2391397|P1|COMPLETED|Overall Study|Defined as completed treatment|118
986663|NCT00412893|2391396|P2|Received Treatment|Overall Study||258
986664|NCT00412893|2391397|P1|Received Treatment|Overall Study|One participant randomized to this group received voriconazole treatment for the first 7 days|258
986665|NCT00412893|2391396|P2|STARTED|Overall Study||264
986666|NCT00412893|2391397|P1|STARTED|Overall Study||263
986667|NCT00412932|2391423|P1|NOT COMPLETED|Olm+ Hydrochlorothiazide 25 mg||2
986668|NCT00412932|2391423|P1|COMPLETED|Olm+ Hydrochlorothiazide 25 mg||123
986669|NCT00412932|2391423|P1|STARTED|Olm+ Hydrochlorothiazide 25 mg|153 -28 met their blood pressure goal (stayed on olmesartan 40/hydrochlorothiazide 12.5) = 125|125
986670|NCT00412932|2391423|P1|NOT COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||6
986671|NCT00412932|2391423|P1|COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||153
986672|NCT00412932|2391423|P1|STARTED|Olm+Hydrochlorothiazide 12.5 mg|161 -2 met blood pressure goal (stayed on olmesartan 40) = 159|159
986673|NCT00412932|2391423|P1|NOT COMPLETED|Olmesartan 40 mg||8
986674|NCT00412932|2391423|P1|COMPLETED|Olmesartan 40 mg||161
986675|NCT00412932|2391423|P1|STARTED|Olmesartan 40 mg|171 -1 met blood pressure goal (stayed on olmesartan 20) -1 who erroneously skipped this step = 169.|169
986676|NCT00412932|2391423|P1|NOT COMPLETED|Olmesartan (Olm) 20 mg||7
986677|NCT00412932|2391423|P1|COMPLETED|Olmesartan (Olm) 20 mg||171
986678|NCT00412932|2391423|P1|STARTED|Olmesartan (Olm) 20 mg||178
986679|NCT00412958|2391436|P4|NOT COMPLETED|Overall Study||1
986680|NCT00412958|2391437|P3|NOT COMPLETED|Overall Study||0
986681|NCT00412958|2391438|P2|NOT COMPLETED|Overall Study||4
986682|NCT00412958|2391439|P1|NOT COMPLETED|Overall Study||3
986683|NCT00412958|2391436|P4|COMPLETED|Overall Study||30
986684|NCT00412958|2391437|P3|COMPLETED|Overall Study||32
986685|NCT00412958|2391438|P2|COMPLETED|Overall Study||29
986686|NCT00412958|2391439|P1|COMPLETED|Overall Study||26
986687|NCT00412958|2391436|P4|STARTED|Overall Study||31
986688|NCT00412958|2391437|P3|STARTED|Overall Study||32
986689|NCT00412958|2391438|P2|STARTED|Overall Study||33
986690|NCT00412958|2391439|P1|STARTED|Overall Study||29
986691|NCT00412971|2391451|P2|NOT COMPLETED|Overall Study||10
986692|NCT00412971|2391452|P1|NOT COMPLETED|Overall Study||30
986693|NCT00412971|2391451|P2|COMPLETED|Overall Study||108
986694|NCT00412971|2391452|P1|COMPLETED|Overall Study||85
986695|NCT00412971|2391451|P2|STARTED|Overall Study||118
986696|NCT00412971|2391452|P1|STARTED|Overall Study||115
986697|NCT00412984|2391463|P2|NOT COMPLETED|Overall Study||2493
986698|NCT00412984|2391464|P1|NOT COMPLETED|Overall Study||2310
986699|NCT00412984|2391463|P2|COMPLETED|Overall Study||6588
986700|NCT00412984|2391464|P1|COMPLETED|Overall Study||6810
986701|NCT00412984|2391463|P2|STARTED|Overall Study|Randomized participants|9081
986702|NCT00412984|2391464|P1|STARTED|Overall Study|Randomized participants|9120
986703|NCT00413010|2391508|P2|NOT COMPLETED|Overall Study||63
986704|NCT00413010|2391509|P1|NOT COMPLETED|Overall Study||72
986705|NCT00413010|2391508|P2|COMPLETED|Overall Study||113
986706|NCT00413010|2391509|P1|COMPLETED|Overall Study||108
986707|NCT00413010|2391508|P2|STARTED|Overall Study||176
986708|NCT00413010|2391509|P1|STARTED|Overall Study||180
986709|NCT00413036|2391529|P1|NOT COMPLETED|Overall Study||217
986710|NCT00413036|2391529|P1|COMPLETED|Overall Study|Participants remain on study drug until progressive disease or unacceptable adverse events develop.|0
986711|NCT00413036|2391529|P1|STARTED|Overall Study||217
986712|NCT00413049|2391539|P2|NOT COMPLETED|Overall Study||18
986713|NCT00413049|2391540|P1|NOT COMPLETED|Overall Study||24
986714|NCT00413049|2391539|P2|COMPLETED|Overall Study||331
986715|NCT00413049|2391540|P1|COMPLETED|Overall Study||325
986716|NCT00413049|2391539|P2|STARTED|Overall Study||349
986717|NCT00413049|2391540|P1|STARTED|Overall Study||349
986718|NCT00413062|2391558|P2|NOT COMPLETED|Overall Study||210
986719|NCT00413062|2391559|P1|NOT COMPLETED|Overall Study||678
986720|NCT00413062|2391558|P2|COMPLETED|Overall Study||344
986721|NCT00413062|2391559|P1|COMPLETED|Overall Study||988
986722|NCT00413062|2391558|P2|STARTED|Overall Study||554
986723|NCT00413062|2391559|P1|STARTED|Overall Study||1666
986724|NCT00413153|2391585|P2|NOT COMPLETED|Overall Study||1
986725|NCT00413153|2391586|P1|NOT COMPLETED|Overall Study||2
986726|NCT00413153|2391585|P2|COMPLETED|Overall Study||7
986727|NCT00413153|2391586|P1|COMPLETED|Overall Study||5
986728|NCT00413153|2391585|P2|STARTED|Overall Study||8
986729|NCT00413153|2391586|P1|STARTED|Overall Study||7
986730|NCT00413192|2391612|P4|NOT COMPLETED|Overall Study||32
986731|NCT00413192|2391613|P3|NOT COMPLETED|Overall Study||19
986732|NCT00413192|2391614|P2|NOT COMPLETED|Overall Study||40
986733|NCT00413192|2391615|P1|NOT COMPLETED|Overall Study||37
986734|NCT00413192|2391612|P4|COMPLETED|Overall Study||0
986735|NCT00413192|2391613|P3|COMPLETED|Overall Study||0
986736|NCT00413192|2391614|P2|COMPLETED|Overall Study||0
986737|NCT00413192|2391615|P1|COMPLETED|Overall Study||0
986738|NCT00413192|2391612|P4|STARTED|Overall Study||32
986739|NCT00413192|2391613|P3|STARTED|Overall Study||19
986740|NCT00413192|2391614|P2|STARTED|Overall Study||40
986741|NCT00413192|2391615|P1|STARTED|Overall Study||37
986742|NCT00413218|2391655|P2|NOT COMPLETED|Overall Study||96
986743|NCT00413218|2391656|P1|NOT COMPLETED|Overall Study||103
986744|NCT00413218|2391655|P2|COMPLETED|Overall Study||131
986745|NCT00413218|2391656|P1|COMPLETED|Overall Study||120
986746|NCT00413218|2391655|P2|Intent to Treat Population (ITT)|Overall Study||219
986747|NCT00413218|2391656|P1|Intent to Treat Population (ITT)|Overall Study||221
986748|NCT00413218|2391655|P2|STARTED|Overall Study||227
986749|NCT00413218|2391656|P1|STARTED|Overall Study||223
986750|NCT00413231|2391678|P1|NOT COMPLETED|365-day to 60-month Post Treatment||46
986751|NCT00413231|2391678|P1|COMPLETED|365-day to 60-month Post Treatment||93
986752|NCT00413231|2391678|P1|STARTED|365-day to 60-month Post Treatment||139
986753|NCT00413231|2391678|P1|NOT COMPLETED|30-day to 365-day Post Treatment||13
986754|NCT00413231|2391678|P1|COMPLETED|30-day to 365-day Post Treatment||139
986755|NCT00413231|2391678|P1|STARTED|30-day to 365-day Post Treatment||152
986756|NCT00413231|2391678|P1|NOT COMPLETED|0 to 30-day Post Treatment||8
986757|NCT00413231|2391678|P1|COMPLETED|0 to 30-day Post Treatment||152
986758|NCT00413231|2391678|P1|STARTED|0 to 30-day Post Treatment||160
986759|NCT00413244|2391710|P2|NOT COMPLETED|Overall Study||1
986760|NCT00413244|2391711|P1|NOT COMPLETED|Overall Study||10
986761|NCT00413244|2391710|P2|COMPLETED|Overall Study||19
986762|NCT00413244|2391711|P1|COMPLETED|Overall Study||21
986763|NCT00413244|2391710|P2|STARTED|Overall Study||20
986764|NCT00413244|2391711|P1|STARTED|Overall Study||31
986765|NCT00413283|2391743|P4|NOT COMPLETED|Overall Study||4
986766|NCT00413283|2391744|P3|NOT COMPLETED|Overall Study||2
986767|NCT00413283|2391745|P2|NOT COMPLETED|Overall Study||3
986768|NCT00413283|2391746|P1|NOT COMPLETED|Overall Study||1
986769|NCT00413283|2391743|P4|COMPLETED|Overall Study||13
986770|NCT00413283|2391744|P3|COMPLETED|Overall Study||16
986771|NCT00413283|2391745|P2|COMPLETED|Overall Study||13
986772|NCT00413283|2391746|P1|COMPLETED|Overall Study||11
986773|NCT00413283|2391743|P4|Received Study Drug|Overall Study||16
986774|NCT00413283|2391744|P3|Received Study Drug|Overall Study||18
986775|NCT00413283|2391745|P2|Received Study Drug|Overall Study||16
986776|NCT00413283|2391746|P1|Received Study Drug|Overall Study||12
986777|NCT00413283|2391743|P4|STARTED|Overall Study||17
986778|NCT00413283|2391744|P3|STARTED|Overall Study||18
986779|NCT00413283|2391745|P2|STARTED|Overall Study||16
986780|NCT00413283|2391746|P1|STARTED|Overall Study||12
986781|NCT00413335|2391778|P2|NOT COMPLETED|Overall Study||0
986782|NCT00413335|2391779|P1|NOT COMPLETED|Overall Study||0
986783|NCT00413335|2391778|P2|COMPLETED|Overall Study||9
986784|NCT00413335|2391779|P1|COMPLETED|Overall Study||12
986785|NCT00413335|2391778|P2|STARTED|Overall Study||9
986786|NCT00413335|2391779|P1|STARTED|Overall Study||12
986787|NCT00413374|2391793|P1|NOT COMPLETED|Overall Study||6
986788|NCT00413374|2391793|P1|COMPLETED|Overall Study||34
986789|NCT00413374|2391793|P1|STARTED|Overall Study||40
986790|NCT00413400|2391800|P2|NOT COMPLETED|Overall Study||4
986791|NCT00413400|2391801|P1|NOT COMPLETED|Overall Study||2
986792|NCT00413400|2391800|P2|COMPLETED|Overall Study||12
986793|NCT00413400|2391801|P1|COMPLETED|Overall Study||22
986794|NCT00413400|2391800|P2|3 Month Visit|Overall Study||12
986795|NCT00413400|2391801|P1|3 Month Visit|Overall Study||22
986796|NCT00413400|2391800|P2|STARTED|Overall Study||16
986797|NCT00413400|2391801|P1|STARTED|Overall Study||24
986798|NCT00413413|2391832|P3|NOT COMPLETED|Double-Blind||18
986799|NCT00413413|2391833|P2|NOT COMPLETED|Double-Blind||14
986800|NCT00413413|2391834|P1|NOT COMPLETED|Double-Blind||15
986801|NCT00413413|2391832|P3|COMPLETED|Double-Blind||285
986802|NCT00413413|2391833|P2|COMPLETED|Double-Blind||293
986803|NCT00413413|2391834|P1|COMPLETED|Double-Blind||293
986804|NCT00413413|2391832|P3|STARTED|Double-Blind||303
986805|NCT00413413|2391833|P2|STARTED|Double-Blind||307
986806|NCT00413413|2391834|P1|STARTED|Double-Blind||308
986807|NCT00413413|2391832|P3|NOT COMPLETED|Single-Blind||0
986808|NCT00413413|2391833|P2|NOT COMPLETED|Single-Blind||216
986809|NCT00413413|2391834|P1|NOT COMPLETED|Single-Blind||0
986810|NCT00413413|2391832|P3|COMPLETED|Single-Blind||0
986811|NCT00413413|2391833|P2|COMPLETED|Single-Blind||918
986812|NCT00413413|2391834|P1|COMPLETED|Single-Blind||0
986813|NCT00413413|2391832|P3|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
986814|NCT00413413|2391833|P2|STARTED|Single-Blind||1134
986815|NCT00413413|2391834|P1|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
986816|NCT00406640|2391856|P2|NOT COMPLETED|OL Extension Phase for Non-Responders||24
986817|NCT00406640|2391857|P1|NOT COMPLETED|OL Extension Phase for Non-Responders||22
986818|NCT00406640|2391856|P2|COMPLETED|OL Extension Phase for Non-Responders||36
986819|NCT00406640|2391857|P1|COMPLETED|OL Extension Phase for Non-Responders||47
986820|NCT00406640|2391856|P2|STARTED|OL Extension Phase for Non-Responders||60
986821|NCT00406640|2391857|P1|STARTED|OL Extension Phase for Non-Responders||69
986822|NCT00406640|2391856|P2|NOT COMPLETED|DB Continuation Phase for Responders||37
986823|NCT00406640|2391857|P1|NOT COMPLETED|DB Continuation Phase for Responders||33
986824|NCT00406640|2391856|P2|COMPLETED|DB Continuation Phase for Responders||151
986825|NCT00406640|2391857|P1|COMPLETED|DB Continuation Phase for Responders||139
986826|NCT00406640|2391856|P2|STARTED|DB Continuation Phase for Responders||188
986827|NCT00406640|2391857|P1|STARTED|DB Continuation Phase for Responders||172
986828|NCT00406640|2391856|P2|NOT COMPLETED|Acute Phase||43
986829|NCT00406640|2391857|P1|NOT COMPLETED|Acute Phase||51
986830|NCT00406640|2391856|P2|COMPLETED|Acute Phase||256
986831|NCT00406640|2391857|P1|COMPLETED|Acute Phase||245
986832|NCT00406640|2391856|P2|STARTED|Acute Phase||299
986833|NCT00406640|2391857|P1|STARTED|Acute Phase||296
986834|NCT00406653|2391891|P7|NOT COMPLETED|Open-Label Period||324
986835|NCT00406653|2391892|P6|NOT COMPLETED|Open-Label Period||0
986836|NCT00406653|2391893|P5|NOT COMPLETED|Open-Label Period||0
986837|NCT00406653|2391894|P4|NOT COMPLETED|Open-Label Period||0
986838|NCT00406653|2391895|P3|NOT COMPLETED|Open-Label Period||0
986839|NCT00406653|2391896|P2|NOT COMPLETED|Open-Label Period||0
986840|NCT00406653|2391897|P1|NOT COMPLETED|Open-Label Period||0
986841|NCT00406653|2391891|P7|COMPLETED|Open-Label Period||0
986842|NCT00406653|2391892|P6|COMPLETED|Open-Label Period||0
986843|NCT00406653|2391893|P5|COMPLETED|Open-Label Period||0
986844|NCT00406653|2391894|P4|COMPLETED|Open-Label Period||0
986845|NCT00406653|2391895|P3|COMPLETED|Open-Label Period||0
986846|NCT00406653|2391896|P2|COMPLETED|Open-Label Period||0
986847|NCT00406653|2391897|P1|COMPLETED|Open-Label Period||0
986848|NCT00406653|2391891|P7|STARTED|Open-Label Period|All completing IP but failing response criteria and those completing or relapsing on MP entered OL.|324
986849|NCT00406653|2391892|P6|STARTED|Open-Label Period||0
986850|NCT00406653|2391893|P5|STARTED|Open-Label Period||0
986851|NCT00406653|2391894|P4|STARTED|Open-Label Period||0
986852|NCT00406653|2391895|P3|STARTED|Open-Label Period||0
986853|NCT00406653|2391896|P2|STARTED|Open-Label Period||0
986854|NCT00406653|2391897|P1|STARTED|Open-Label Period||0
986855|NCT00406653|2391891|P7|NOT COMPLETED|Maintenance Period||0
986856|NCT00406653|2391892|P6|NOT COMPLETED|Maintenance Period||36
986857|NCT00406653|2391893|P5|NOT COMPLETED|Maintenance Period||30
986858|NCT00406653|2391894|P4|NOT COMPLETED|Maintenance Period||0
986859|NCT00406653|2391895|P3|NOT COMPLETED|Maintenance Period||0
986860|NCT00406653|2391896|P2|NOT COMPLETED|Maintenance Period||0
986861|NCT00406653|2391897|P1|NOT COMPLETED|Maintenance Period||0
986862|NCT00406653|2391891|P7|COMPLETED|Maintenance Period||0
986863|NCT00406653|2391892|P6|COMPLETED|Maintenance Period||10
986864|NCT00406653|2391893|P5|COMPLETED|Maintenance Period||14
986865|NCT00406653|2391894|P4|COMPLETED|Maintenance Period||0
986866|NCT00406653|2391895|P3|COMPLETED|Maintenance Period||0
986867|NCT00406653|2391896|P2|COMPLETED|Maintenance Period||0
986868|NCT00406653|2391897|P1|COMPLETED|Maintenance Period||0
986869|NCT00406653|2391891|P7|STARTED|Maintenance Period||0
986870|NCT00406653|2391892|P6|STARTED|Maintenance Period|At end of IP, 46 participants met response criteria and were randomly assigned to placebo in MP.|46
986871|NCT00406653|2391893|P5|STARTED|Maintenance Period|At end of IP, 44 participants met response criteria and were randomly assigned to abatacept in MP.|44
986872|NCT00406653|2391894|P4|STARTED|Maintenance Period||0
986873|NCT00406653|2391895|P3|STARTED|Maintenance Period||0
986874|NCT00406653|2391896|P2|STARTED|Maintenance Period||0
986875|NCT00406653|2391897|P1|STARTED|Maintenance Period||0
986876|NCT00406653|2391891|P7|NOT COMPLETED|Induction Period||0
986877|NCT00406653|2391892|P6|NOT COMPLETED|Induction Period||0
986878|NCT00406653|2391893|P5|NOT COMPLETED|Induction Period||0
986879|NCT00406653|2391894|P4|NOT COMPLETED|Induction Period||26
986880|NCT00406653|2391895|P3|NOT COMPLETED|Induction Period||18
986881|NCT00406653|2391896|P2|NOT COMPLETED|Induction Period||34
986882|NCT00406653|2391897|P1|NOT COMPLETED|Induction Period||15
986883|NCT00406653|2391891|P7|COMPLETED|Induction Period||0
986884|NCT00406653|2391892|P6|COMPLETED|Induction Period||0
986885|NCT00406653|2391893|P5|COMPLETED|Induction Period||0
986886|NCT00406653|2391894|P4|COMPLETED|Induction Period||102
986887|NCT00406653|2391895|P3|COMPLETED|Induction Period||112
986888|NCT00406653|2391896|P2|COMPLETED|Induction Period||94
986889|NCT00406653|2391897|P1|COMPLETED|Induction Period||50
986890|NCT00406653|2391891|P7|STARTED|Induction Period||0
986891|NCT00406653|2391892|P6|STARTED|Induction Period||0
986892|NCT00406653|2391893|P5|STARTED|Induction Period||0
986893|NCT00406653|2391894|P4|STARTED|Induction Period||128
986894|NCT00406653|2391895|P3|STARTED|Induction Period||130
986895|NCT00406653|2391896|P2|STARTED|Induction Period||128
986896|NCT00406653|2391897|P1|STARTED|Induction Period||65
986897|NCT00406692|2391976|P1|NOT COMPLETED|Overall Study||7
986898|NCT00406692|2391976|P1|COMPLETED|Overall Study||9
986899|NCT00406692|2391976|P1|STARTED|Overall Study||16
986900|NCT00406718|2391985|P3|NOT COMPLETED|Overall Study||8
986901|NCT00406718|2391986|P2|NOT COMPLETED|Overall Study||14
986902|NCT00406718|2391987|P1|NOT COMPLETED|Overall Study||4
986903|NCT00406718|2391985|P3|COMPLETED|Overall Study||39
986904|NCT00406718|2391986|P2|COMPLETED|Overall Study||34
986905|NCT00406718|2391987|P1|COMPLETED|Overall Study||43
986906|NCT00406718|2391985|P3|STARTED|Overall Study||47
986907|NCT00406718|2391986|P2|STARTED|Overall Study||48
986908|NCT00406718|2391987|P1|STARTED|Overall Study||47
986909|NCT00406783|2392003|P2|NOT COMPLETED|Overall Study||15
986910|NCT00406783|2392004|P1|NOT COMPLETED|Overall Study||14
986911|NCT00406783|2392003|P2|COMPLETED|Overall Study||256
986912|NCT00406783|2392004|P1|COMPLETED|Overall Study||262
986913|NCT00406783|2392003|P2|STARTED|Overall Study||271
986914|NCT00406783|2392004|P1|STARTED|Overall Study||276
986915|NCT00406848|2392018|P2|NOT COMPLETED|Overall Study||54
986916|NCT00406848|2392019|P1|NOT COMPLETED|Overall Study||93
986917|NCT00406848|2392018|P2|COMPLETED|Overall Study||67
986918|NCT00406848|2392019|P1|COMPLETED|Overall Study||156
986919|NCT00406848|2392018|P2|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=95.|121
986920|NCT00406848|2392019|P1|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=204.|249
986921|NCT00407030|2392084|P3|NOT COMPLETED|Extension Period - up to 68 Weeks||0
986922|NCT00407030|2392085|P2|NOT COMPLETED|Extension Period - up to 68 Weeks||29
986923|NCT00407030|2392086|P1|NOT COMPLETED|Extension Period - up to 68 Weeks||27
986924|NCT00407030|2392084|P3|COMPLETED|Extension Period - up to 68 Weeks||0
986925|NCT00407030|2392085|P2|COMPLETED|Extension Period - up to 68 Weeks||74
986926|NCT00407030|2392086|P1|COMPLETED|Extension Period - up to 68 Weeks||84
986927|NCT00407030|2392084|P3|STARTED|Extension Period - up to 68 Weeks|After the Main Period all patients were randomly assigned to the 2 active treatment arms.|0
986928|NCT00407030|2392085|P2|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|103
986929|NCT00407030|2392086|P1|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|111
986930|NCT00407030|2392084|P3|NOT COMPLETED|Main Period - 8 to 20 Weeks||6
986931|NCT00407030|2392085|P2|NOT COMPLETED|Main Period - 8 to 20 Weeks||3
986932|NCT00407030|2392086|P1|NOT COMPLETED|Main Period - 8 to 20 Weeks||5
986933|NCT00407030|2392084|P3|COMPLETED|Main Period - 8 to 20 Weeks||68
986934|NCT00407030|2392085|P2|COMPLETED|Main Period - 8 to 20 Weeks||75
986935|NCT00407030|2392086|P1|COMPLETED|Main Period - 8 to 20 Weeks||76
986936|NCT00407030|2392084|P3|STARTED|Main Period - 8 to 20 Weeks||74
986937|NCT00407030|2392085|P2|STARTED|Main Period - 8 to 20 Weeks||78
986938|NCT00407030|2392086|P1|STARTED|Main Period - 8 to 20 Weeks||81
986939|NCT00407355|2392114|P2|NOT COMPLETED|Overall Study||11
986940|NCT00407355|2392115|P1|NOT COMPLETED|Overall Study||10
986941|NCT00407355|2392114|P2|COMPLETED|Overall Study||9
986942|NCT00407355|2392115|P1|COMPLETED|Overall Study||10
986943|NCT00407355|2392114|P2|STARTED|Overall Study||20
986944|NCT00407355|2392115|P1|STARTED|Overall Study||20
986945|NCT00407381|2392126|P3|NOT COMPLETED|Overall Study||2
986946|NCT00407381|2392127|P2|NOT COMPLETED|Overall Study||4
986947|NCT00407381|2392128|P1|NOT COMPLETED|Overall Study||3
986948|NCT00407381|2392126|P3|COMPLETED|Overall Study||40
986949|NCT00407381|2392127|P2|COMPLETED|Overall Study||38
986950|NCT00407381|2392128|P1|COMPLETED|Overall Study||39
986951|NCT00407381|2392126|P3|STARTED|Overall Study||42
986952|NCT00407381|2392127|P2|STARTED|Overall Study||42
986953|NCT00407381|2392128|P1|STARTED|Overall Study||42
986954|NCT00407485|2392136|P1|NOT COMPLETED|Overall Study||0
986955|NCT00407485|2392136|P1|COMPLETED|Overall Study||22
986956|NCT00407485|2392136|P1|STARTED|Overall Study||22
986957|NCT00407511|2392141|P1|NOT COMPLETED|Overall Study||22
986958|NCT00407511|2392141|P1|COMPLETED|Overall Study||99
986959|NCT00407511|2392141|P1|STARTED|Overall Study||121
986960|NCT00407537|2392157|P2|NOT COMPLETED|Overall Study||44
986961|NCT00407537|2392158|P1|NOT COMPLETED|Overall Study||93
986962|NCT00407537|2392157|P2|COMPLETED|Overall Study||638
986963|NCT00407537|2392158|P1|COMPLETED|Overall Study||686
986964|NCT00407537|2392157|P2|Eligible for Efficacy Analysis|Overall Study||657
986965|NCT00407537|2392158|P1|Eligible for Efficacy Analysis|Overall Study||760
986966|NCT00407537|2392157|P2|STARTED|Overall Study|4 participants assigned to Caduet treatment received usual care only during the study|682
986967|NCT00407537|2392158|P1|STARTED|Overall Study||779
986968|NCT00407550|2392208|P2|NOT COMPLETED|Overall Study||4
986969|NCT00407550|2392209|P1|NOT COMPLETED|Overall Study||3
986970|NCT00407550|2392208|P2|COMPLETED|Overall Study||5
986971|NCT00407550|2392209|P1|COMPLETED|Overall Study||7
986972|NCT00407550|2392208|P2|STARTED|Overall Study||9
986973|NCT00407550|2392209|P1|STARTED|Overall Study||10
986974|NCT00407563|2392215|P1|NOT COMPLETED|Overall Study||1
986975|NCT00407563|2392215|P1|COMPLETED|Overall Study|One patient remains on study treatment.|47
986976|NCT00407563|2392215|P1|STARTED|Overall Study||48
986977|NCT00407654|2392223|P1|NOT COMPLETED|Overall Study||0
986978|NCT00407654|2392223|P1|COMPLETED|Overall Study||75
986979|NCT00407654|2392223|P1|STARTED|Overall Study||75
986980|NCT00407745|2392237|P2|NOT COMPLETED|Overall Study||17
986981|NCT00407745|2392238|P1|NOT COMPLETED|Overall Study||19
986982|NCT00407745|2392237|P2|COMPLETED|Overall Study||91
986983|NCT00407745|2392238|P1|COMPLETED|Overall Study||93
986984|NCT00407745|2392237|P2|Treated|Overall Study||107
986985|NCT00407745|2392238|P1|Treated|Overall Study||112
986986|NCT00407745|2392237|P2|STARTED|Overall Study||108
986987|NCT00407745|2392238|P1|STARTED|Overall Study||112
986988|NCT00413478|2392310|P1|NOT COMPLETED|Overall Study||0
986989|NCT00413478|2392310|P1|COMPLETED|Overall Study||9
986990|NCT00413478|2392310|P1|STARTED|Overall Study||9
986991|NCT00413582|2392316|P2|NOT COMPLETED|Overall Study||0
986992|NCT00413582|2392317|P1|NOT COMPLETED|Overall Study||0
986993|NCT00413582|2392316|P2|COMPLETED|Overall Study|all enrolled completed|55
986994|NCT00413582|2392317|P1|COMPLETED|Overall Study|all enrolled completed|55
986995|NCT00413582|2392316|P2|Completion of Study|Overall Study|all enrolled completed|55
986996|NCT00413582|2392317|P1|Completion of Study|Overall Study|all enrolled completed|55
986997|NCT00413582|2392316|P2|STARTED|Overall Study|all enrolled completed|55
986998|NCT00413582|2392317|P1|STARTED|Overall Study|all enrolled completed|55
986999|NCT00413634|2392327|P2|NOT COMPLETED|Overall Study||0
987000|NCT00413634|2392328|P1|NOT COMPLETED|Overall Study||0
987001|NCT00413634|2392327|P2|COMPLETED|Overall Study||12
987002|NCT00413634|2392328|P1|COMPLETED|Overall Study||12
987003|NCT00413634|2392327|P2|STARTED|Overall Study||12
987004|NCT00413634|2392328|P1|STARTED|Overall Study||12
987005|NCT00413660|2392371|P11|NOT COMPLETED|Post Week 12||1
987006|NCT00413660|2392372|P10|NOT COMPLETED|Post Week 12||1
987007|NCT00413660|2392373|P9|NOT COMPLETED|Post Week 12||0
987008|NCT00413660|2392374|P8|NOT COMPLETED|Post Week 12||0
987009|NCT00413660|2392375|P7|NOT COMPLETED|Post Week 12||3
987010|NCT00413660|2392376|P6|NOT COMPLETED|Post Week 12||3
987011|NCT00413660|2392377|P5|NOT COMPLETED|Post Week 12||6
987012|NCT00413660|2392378|P4|NOT COMPLETED|Post Week 12||1
987013|NCT00413660|2392379|P3|NOT COMPLETED|Post Week 12||8
987014|NCT00413660|2392380|P2|NOT COMPLETED|Post Week 12||4
987015|NCT00413660|2392381|P1|NOT COMPLETED|Post Week 12||3
987016|NCT00413660|2392371|P11|COMPLETED|Post Week 12||17
987017|NCT00413660|2392372|P10|COMPLETED|Post Week 12||12
987018|NCT00413660|2392373|P9|COMPLETED|Post Week 12||13
987019|NCT00413660|2392374|P8|COMPLETED|Post Week 12||21
987020|NCT00413660|2392375|P7|COMPLETED|Post Week 12||37
987021|NCT00413660|2392376|P6|COMPLETED|Post Week 12||54
987022|NCT00413660|2392377|P5|COMPLETED|Post Week 12||60
987023|NCT00413660|2392378|P4|COMPLETED|Post Week 12||66
987024|NCT00413660|2392379|P3|COMPLETED|Post Week 12||56
987025|NCT00413660|2392380|P2|COMPLETED|Post Week 12||44
987026|NCT00413660|2392381|P1|COMPLETED|Post Week 12||40
987027|NCT00413660|2392371|P11|STARTED|Post Week 12||18
987028|NCT00413660|2392372|P10|STARTED|Post Week 12||13
987029|NCT00413660|2392373|P9|STARTED|Post Week 12||13
987030|NCT00413660|2392374|P8|STARTED|Post Week 12||21
987031|NCT00413660|2392375|P7|STARTED|Post Week 12||40
987032|NCT00413660|2392376|P6|STARTED|Post Week 12||57
987033|NCT00413660|2392377|P5|STARTED|Post Week 12||66
987034|NCT00413660|2392378|P4|STARTED|Post Week 12||67
987035|NCT00413660|2392379|P3|STARTED|Post Week 12||64
987036|NCT00413660|2392380|P2|STARTED|Post Week 12||48
987037|NCT00413660|2392381|P1|STARTED|Post Week 12||43
987038|NCT00413660|2392371|P11|NOT COMPLETED|Up To Week 12||0
987039|NCT00413660|2392372|P10|NOT COMPLETED|Up To Week 12||0
987040|NCT00413660|2392373|P9|NOT COMPLETED|Up To Week 12||0
987041|NCT00413660|2392374|P8|NOT COMPLETED|Up To Week 12||0
987042|NCT00413660|2392375|P7|NOT COMPLETED|Up To Week 12||11
987043|NCT00413660|2392376|P6|NOT COMPLETED|Up To Week 12||10
987044|NCT00413660|2392377|P5|NOT COMPLETED|Up To Week 12||9
987045|NCT00413660|2392378|P4|NOT COMPLETED|Up To Week 12||8
987046|NCT00413660|2392379|P3|NOT COMPLETED|Up To Week 12||7
987047|NCT00413660|2392380|P2|NOT COMPLETED|Up To Week 12||7
987048|NCT00413660|2392381|P1|NOT COMPLETED|Up To Week 12||7
987049|NCT00413660|2392371|P11|COMPLETED|Up To Week 12||0
987050|NCT00413660|2392372|P10|COMPLETED|Up To Week 12||0
987051|NCT00413660|2392373|P9|COMPLETED|Up To Week 12||0
987052|NCT00413660|2392374|P8|COMPLETED|Up To Week 12||0
987053|NCT00413660|2392375|P7|COMPLETED|Up To Week 12||58
987054|NCT00413660|2392376|P6|COMPLETED|Up To Week 12||70
987055|NCT00413660|2392377|P5|COMPLETED|Up To Week 12||66
987056|NCT00413660|2392378|P4|COMPLETED|Up To Week 12||67
987057|NCT00413660|2392379|P3|COMPLETED|Up To Week 12||64
987058|NCT00413660|2392380|P2|COMPLETED|Up To Week 12||61
987059|NCT00413660|2392381|P1|COMPLETED|Up To Week 12||64
987060|NCT00413660|2392371|P11|Treated|Up To Week 12||0
987061|NCT00413660|2392372|P10|Treated|Up To Week 12||0
987062|NCT00413660|2392373|P9|Treated|Up To Week 12||0
987063|NCT00413660|2392374|P8|Treated|Up To Week 12||0
987064|NCT00413660|2392375|P7|Treated|Up To Week 12||69
987065|NCT00413660|2392376|P6|Treated|Up To Week 12||80
987066|NCT00413660|2392377|P5|Treated|Up To Week 12||75
987067|NCT00413660|2392378|P4|Treated|Up To Week 12||74
987068|NCT00413660|2392379|P3|Treated|Up To Week 12||71
987069|NCT00413660|2392380|P2|Treated|Up To Week 12||68
987070|NCT00413660|2392381|P1|Treated|Up To Week 12||70
987071|NCT00413660|2392371|P11|STARTED|Up To Week 12||0
987072|NCT00413660|2392372|P10|STARTED|Up To Week 12||0
987073|NCT00413660|2392373|P9|STARTED|Up To Week 12||0
987074|NCT00413660|2392374|P8|STARTED|Up To Week 12||0
987075|NCT00413660|2392375|P7|STARTED|Up To Week 12||69
987076|NCT00413660|2392376|P6|STARTED|Up To Week 12||80
987077|NCT00413660|2392377|P5|STARTED|Up To Week 12||75
987078|NCT00413660|2392378|P4|STARTED|Up To Week 12||75
987079|NCT00413660|2392379|P3|STARTED|Up To Week 12||71
987080|NCT00413660|2392380|P2|STARTED|Up To Week 12||68
987081|NCT00413660|2392381|P1|STARTED|Up To Week 12||71
987082|NCT00414518|2392729|P2|NOT COMPLETED|Overall Study||0
987083|NCT00414518|2392730|P1|NOT COMPLETED|Overall Study||0
987084|NCT00414518|2392729|P2|COMPLETED|Overall Study||9
987085|NCT00414518|2392730|P1|COMPLETED|Overall Study||7
987086|NCT00414518|2392729|P2|STARTED|Overall Study||9
987087|NCT00414518|2392730|P1|STARTED|Overall Study||7
987088|NCT00414544|2392740|P1|NOT COMPLETED|Overall Study||14
987089|NCT00414544|2392740|P1|COMPLETED|Overall Study||131
987090|NCT00414544|2392740|P1|STARTED|Overall Study||145
987091|NCT00414596|2392746|P1|NOT COMPLETED|Overall Study||2
987092|NCT00414596|2392746|P1|COMPLETED|Overall Study|April 2007|18
987093|NCT00414596|2392746|P1|STARTED|Overall Study|December 2006|20
987094|NCT00414609|2392757|P3|NOT COMPLETED|Extension Study||57
987095|NCT00414609|2392758|P2|NOT COMPLETED|Extension Study||0
987096|NCT00414609|2392759|P1|NOT COMPLETED|Extension Study||0
987097|NCT00414609|2392757|P3|COMPLETED|Extension Study||365
987098|NCT00414609|2392758|P2|COMPLETED|Extension Study||0
987099|NCT00414609|2392759|P1|COMPLETED|Extension Study||0
987100|NCT00414609|2392757|P3|Echocardiogram (ECHO) Analysis Set|Extension Study||400
987101|NCT00414609|2392758|P2|Echocardiogram (ECHO) Analysis Set|Extension Study||0
987102|NCT00414609|2392759|P1|Echocardiogram (ECHO) Analysis Set|Extension Study||0
987103|NCT00414609|2392757|P3|STARTED|Extension Study|Patients of both core arms who completed core study and signed informed consent form for extension.|422
987104|NCT00414609|2392758|P2|STARTED|Extension Study||0
987105|NCT00414609|2392759|P1|STARTED|Extension Study||0
987106|NCT00414609|2392757|P3|NOT COMPLETED|Core Study||0
987107|NCT00414609|2392758|P2|NOT COMPLETED|Core Study||45
987108|NCT00414609|2392759|P1|NOT COMPLETED|Core Study||34
987109|NCT00414609|2392757|P3|COMPLETED|Core Study||0
987110|NCT00414609|2392758|P2|COMPLETED|Core Study||378
987111|NCT00414609|2392759|P1|COMPLETED|Core Study||363
987112|NCT00414609|2392757|P3|Echocardiogram Evaluable Set|Core Study||0
987113|NCT00414609|2392758|P2|Echocardiogram Evaluable Set|Core Study||343
987114|NCT00414609|2392759|P1|Echocardiogram Evaluable Set|Core Study||330
987115|NCT00414609|2392757|P3|Received Study Drug|Core Study||0
987116|NCT00414609|2392758|P2|Received Study Drug|Core Study||422
987117|NCT00414609|2392759|P1|Received Study Drug|Core Study||397
987118|NCT00414609|2392757|P3|STARTED|Core Study||0
987119|NCT00414609|2392758|P2|STARTED|Core Study||423
987120|NCT00414609|2392759|P1|STARTED|Core Study||397
987121|NCT00414635|2392784|P2|NOT COMPLETED|Overall Study||2
987122|NCT00414635|2392785|P1|NOT COMPLETED|Overall Study||5
987123|NCT00414635|2392784|P2|COMPLETED|Overall Study||28
987124|NCT00414635|2392785|P1|COMPLETED|Overall Study||25
987125|NCT00414635|2392784|P2|STARTED|Overall Study||30
987126|NCT00414635|2392785|P1|STARTED|Overall Study||30
987127|NCT00414661|2392807|P4|NOT COMPLETED|Overall Study||3
987128|NCT00414661|2392808|P3|NOT COMPLETED|Overall Study||2
987129|NCT00414661|2392809|P2|NOT COMPLETED|Overall Study||14
987130|NCT00414661|2392810|P1|NOT COMPLETED|Overall Study||14
987131|NCT00414661|2392807|P4|COMPLETED|Overall Study||0
987132|NCT00414661|2392808|P3|COMPLETED|Overall Study||20
987133|NCT00414661|2392809|P2|COMPLETED|Overall Study||75
987134|NCT00414661|2392810|P1|COMPLETED|Overall Study||34
987135|NCT00414661|2392807|P4|STARTED|Overall Study||3
987136|NCT00414661|2392808|P3|STARTED|Overall Study||22
987137|NCT00414661|2392809|P2|STARTED|Overall Study||89
987138|NCT00414661|2392810|P1|STARTED|Overall Study||48
987139|NCT00414700|2392834|P2|NOT COMPLETED|Overall Study||3
987140|NCT00414700|2392835|P1|NOT COMPLETED|Overall Study||6
987141|NCT00414700|2392834|P2|COMPLETED|Overall Study||58
987142|NCT00414700|2392835|P1|COMPLETED|Overall Study||51
987143|NCT00414700|2392834|P2|STARTED|Overall Study||61
987144|NCT00414700|2392835|P1|STARTED|Overall Study||57
987151|NCT00414817|2392868|P2|NOT COMPLETED|Overall Study||3016
987152|NCT00414817|2392869|P1|NOT COMPLETED|Overall Study||3130
987153|NCT00414817|2392868|P2|COMPLETED|Overall Study|Qualified for primary analysis (3260 prior ICS users) or secondary analysis (755 new users) samples.|4015
987154|NCT00414817|2392869|P1|COMPLETED|Overall Study|Qualified for primary analysis (3171 prior ICS users) or secondary analysis (732 new users) samples.|3903
987155|NCT00414817|2392868|P2|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|184
987156|NCT00414817|2392869|P1|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|175
987157|NCT00414817|2392868|P2|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|123
987158|NCT00414817|2392869|P1|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|117
987159|NCT00414817|2392868|P2|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|900
987160|NCT00414817|2392869|P1|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|922
987161|NCT00414817|2392868|P2|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|417
987162|NCT00414817|2392869|P1|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|451
987163|NCT00414817|2392868|P2|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1392
987164|NCT00414817|2392869|P1|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1465
987165|NCT00414817|2392868|P2|STARTED|Overall Study||7031
987166|NCT00414817|2392869|P1|STARTED|Overall Study||7033
987167|NCT00414908|2392881|P2|NOT COMPLETED|Overall Study||1
987168|NCT00414908|2392882|P1|NOT COMPLETED|Overall Study||1
987169|NCT00414908|2392881|P2|COMPLETED|Overall Study||28
987170|NCT00414908|2392882|P1|COMPLETED|Overall Study||24
987171|NCT00414908|2392881|P2|STARTED|Overall Study||29
987172|NCT00414908|2392882|P1|STARTED|Overall Study||25
987173|NCT00414973|2392908|P4|NOT COMPLETED|Overall Study||0
987174|NCT00414973|2392909|P3|NOT COMPLETED|Overall Study||3
987175|NCT00414973|2392910|P2|NOT COMPLETED|Overall Study||10
987176|NCT00414973|2392911|P1|NOT COMPLETED|Overall Study||28
987177|NCT00414973|2392908|P4|COMPLETED|Overall Study||11
987178|NCT00414973|2392909|P3|COMPLETED|Overall Study||21
987179|NCT00414973|2392910|P2|COMPLETED|Overall Study||99
987180|NCT00414973|2392911|P1|COMPLETED|Overall Study||190
987181|NCT00414973|2392908|P4|STARTED|Overall Study||11
987182|NCT00414973|2392909|P3|STARTED|Overall Study||24
987183|NCT00414973|2392910|P2|STARTED|Overall Study||109
987184|NCT00414973|2392911|P1|STARTED|Overall Study||218
987185|NCT00415051|2392929|P1|NOT COMPLETED|Overall Study||1
987186|NCT00415051|2392929|P1|COMPLETED|Overall Study||19
987187|NCT00415051|2392929|P1|STARTED|Overall Study||20
987188|NCT00415168|2392936|P1|NOT COMPLETED|Overall Study||52
987189|NCT00415168|2392936|P1|COMPLETED|Overall Study||1
987190|NCT00415168|2392936|P1|Completed Treatment|Overall Study||15
987191|NCT00415168|2392936|P1|STARTED|Overall Study||53
987192|NCT00415194|2392948|P2|NOT COMPLETED|Overall Study||342
987193|NCT00415194|2392949|P1|NOT COMPLETED|Overall Study||328
987194|NCT00415194|2392948|P2|COMPLETED|Overall Study||55
987195|NCT00415194|2392949|P1|COMPLETED|Overall Study||70
987196|NCT00415194|2392948|P2|Received at Least 1 Dose of Study Drug|Overall Study||385
987197|NCT00415194|2392949|P1|Received at Least 1 Dose of Study Drug|Overall Study||392
987198|NCT00415194|2392948|P2|STARTED|Overall Study||397
987199|NCT00415194|2392949|P1|STARTED|Overall Study||398
987200|NCT00415493|2392967|P2|NOT COMPLETED|Overall Study||0
987201|NCT00415493|2392968|P1|NOT COMPLETED|Overall Study||0
987202|NCT00415493|2392967|P2|COMPLETED|Overall Study||12
987203|NCT00415493|2392968|P1|COMPLETED|Overall Study||12
987204|NCT00415493|2392967|P2|STARTED|Overall Study||12
987205|NCT00415493|2392968|P1|STARTED|Overall Study||12
987206|NCT00415506|2392976|P2|NOT COMPLETED|Overall Study||1
987207|NCT00415506|2392977|P1|NOT COMPLETED|Overall Study||3
987208|NCT00415506|2392976|P2|COMPLETED|Overall Study||9
987209|NCT00415506|2392977|P1|COMPLETED|Overall Study||9
987210|NCT00415506|2392976|P2|STARTED|Overall Study||10
987211|NCT00415506|2392977|P1|STARTED|Overall Study||12
987212|NCT00415532|2392987|P2|NOT COMPLETED|Safety Follow Up Period||12
987213|NCT00415532|2392988|P1|NOT COMPLETED|Safety Follow Up Period||9
987214|NCT00415532|2392987|P2|COMPLETED|Safety Follow Up Period||18
987215|NCT00415532|2392988|P1|COMPLETED|Safety Follow Up Period||34
987216|NCT00415532|2392987|P2|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|30
987217|NCT00415532|2392988|P1|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|43
987218|NCT00415532|2392987|P2|NOT COMPLETED|Treatment Period||15
987219|NCT00415532|2392988|P1|NOT COMPLETED|Treatment Period||17
987220|NCT00415532|2392987|P2|COMPLETED|Treatment Period||142
987221|NCT00415532|2392988|P1|COMPLETED|Treatment Period||60
987222|NCT00415532|2392987|P2|Switched to Romiplostim Group|Treatment Period||0
987223|NCT00415532|2392988|P1|Switched to Romiplostim Group|Treatment Period||2
987224|NCT00415532|2392987|P2|Received Treatment|Treatment Period||154
987225|NCT00415532|2392988|P1|Received Treatment|Treatment Period||75
987226|NCT00415532|2392987|P2|STARTED|Treatment Period||157
987227|NCT00415532|2392988|P1|STARTED|Treatment Period||77
987228|NCT00415597|2393008|P1|NOT COMPLETED|Treatment||305
987229|NCT00415597|2393008|P1|COMPLETED|Treatment||160
987230|NCT00415597|2393008|P1|STARTED|Treatment||465
987231|NCT00415597|2393008|P1|NOT COMPLETED|Enrollment||2
987232|NCT00415597|2393008|P1|COMPLETED|Enrollment||465
987233|NCT00415597|2393008|P1|STARTED|Enrollment||467
987234|NCT00415610|2393017|P3|NOT COMPLETED|Overall Study||5
987235|NCT00415610|2393018|P2|NOT COMPLETED|Overall Study||2
987236|NCT00415610|2393019|P1|NOT COMPLETED|Overall Study||3
987237|NCT00415610|2393017|P3|COMPLETED|Overall Study||17
987238|NCT00415610|2393018|P2|COMPLETED|Overall Study||18
987239|NCT00415610|2393019|P1|COMPLETED|Overall Study||15
987240|NCT00415610|2393017|P3|STARTED|Overall Study||22
987241|NCT00415610|2393018|P2|STARTED|Overall Study||20
987242|NCT00415610|2393019|P1|STARTED|Overall Study||18
987243|NCT00415623|2393035|P2|NOT COMPLETED|Overall Study||5
987244|NCT00415623|2393036|P1|NOT COMPLETED|Overall Study||5
987245|NCT00415623|2393035|P2|COMPLETED|Overall Study||146
987246|NCT00415623|2393036|P1|COMPLETED|Overall Study||149
987247|NCT00415623|2393035|P2|STARTED|Overall Study||151
987248|NCT00415623|2393036|P1|STARTED|Overall Study||154
987249|NCT00415857|2393062|P2|NOT COMPLETED|Overall Study||0
987250|NCT00415857|2393063|P1|NOT COMPLETED|Overall Study||0
987251|NCT00415857|2393062|P2|COMPLETED|Overall Study||3
987252|NCT00415857|2393063|P1|COMPLETED|Overall Study||2
987253|NCT00415857|2393062|P2|STARTED|Overall Study||3
987254|NCT00415857|2393063|P1|STARTED|Overall Study||2
987255|NCT00415870|2393073|P2|NOT COMPLETED|Overall Study||7
987256|NCT00415870|2393074|P1|NOT COMPLETED|Overall Study||6
987257|NCT00415870|2393073|P2|COMPLETED|Overall Study||26
987258|NCT00415870|2393074|P1|COMPLETED|Overall Study||26
987259|NCT00415870|2393073|P2|STARTED|Overall Study||33
987260|NCT00415870|2393074|P1|STARTED|Overall Study||32
987261|NCT00415909|2393080|P1|NOT COMPLETED|Overall Study||3
987262|NCT00415909|2393080|P1|COMPLETED|Overall Study||0
987263|NCT00415909|2393080|P1|STARTED|Overall Study||3
987264|NCT00416078|2393086|P2|NOT COMPLETED|Overall Study||8
987265|NCT00416078|2393087|P1|NOT COMPLETED|Overall Study||11
987266|NCT00416078|2393086|P2|COMPLETED|Overall Study||16
987267|NCT00416078|2393087|P1|COMPLETED|Overall Study||18
987268|NCT00416078|2393086|P2|STARTED|Overall Study||24
987269|NCT00416078|2393087|P1|STARTED|Overall Study||29
987270|NCT00416182|2393105|P2|NOT COMPLETED|Overall Study||2
987271|NCT00416182|2393106|P1|NOT COMPLETED|Overall Study||3
987272|NCT00416182|2393105|P2|COMPLETED|Overall Study||6
987273|NCT00416182|2393106|P1|COMPLETED|Overall Study||5
987274|NCT00416182|2393105|P2|STARTED|Overall Study||8
987275|NCT00416182|2393106|P1|STARTED|Overall Study||8
987276|NCT00416195|2393120|P2|NOT COMPLETED|Overall Study||4
987277|NCT00416195|2393121|P1|NOT COMPLETED|Overall Study||2
987278|NCT00416195|2393120|P2|COMPLETED|Overall Study||34
987279|NCT00416195|2393121|P1|COMPLETED|Overall Study||8
987280|NCT00416195|2393120|P2|STARTED|Overall Study||38
987281|NCT00416195|2393121|P1|STARTED|Overall Study||10
987282|NCT00416455|2393131|P2|NOT COMPLETED|Overall Study||8
987283|NCT00416455|2393132|P1|NOT COMPLETED|Overall Study||16
987284|NCT00416455|2393131|P2|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|207
987285|NCT00416455|2393132|P1|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|153
987286|NCT00416455|2393131|P2|STARTED|Overall Study|This is a diagnostic imaging study.|215
987287|NCT00416455|2393132|P1|STARTED|Overall Study|This is a diagnostic imaging study.|169
987288|NCT00416494|2393146|P2|NOT COMPLETED|Overall Study||0
987289|NCT00416494|2393147|P1|NOT COMPLETED|Overall Study||0
987290|NCT00416494|2393146|P2|COMPLETED|Overall Study||31
987291|NCT00416494|2393147|P1|COMPLETED|Overall Study||19
987292|NCT00416494|2393146|P2|STARTED|Overall Study||31
987293|NCT00416494|2393147|P1|STARTED|Overall Study||19
987294|NCT00416520|2393163|P4|NOT COMPLETED|Placebo-controlled Withdrawal Period||5
987295|NCT00416520|2393164|P3|NOT COMPLETED|Placebo-controlled Withdrawal Period||1
987296|NCT00416520|2393165|P2|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
987297|NCT00416520|2393166|P1|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
987298|NCT00416520|2393163|P4|COMPLETED|Placebo-controlled Withdrawal Period||49
987299|NCT00416520|2393164|P3|COMPLETED|Placebo-controlled Withdrawal Period||49
987300|NCT00416520|2393165|P2|COMPLETED|Placebo-controlled Withdrawal Period||0
987301|NCT00416520|2393166|P1|COMPLETED|Placebo-controlled Withdrawal Period||0
987302|NCT00416520|2393163|P4|STARTED|Placebo-controlled Withdrawal Period||54
987303|NCT00416520|2393164|P3|STARTED|Placebo-controlled Withdrawal Period||50
987304|NCT00416520|2393165|P2|STARTED|Placebo-controlled Withdrawal Period||0
987305|NCT00416520|2393166|P1|STARTED|Placebo-controlled Withdrawal Period||0
987306|NCT00416520|2393163|P4|NOT COMPLETED|Open-label Period||0
987307|NCT00416520|2393164|P3|NOT COMPLETED|Open-label Period||0
987308|NCT00416520|2393165|P2|NOT COMPLETED|Open-label Period||32
987309|NCT00416520|2393166|P1|NOT COMPLETED|Open-label Period||60
987310|NCT00416520|2393163|P4|COMPLETED|Open-label Period||0
987311|NCT00416520|2393164|P3|COMPLETED|Open-label Period||0
987312|NCT00416520|2393165|P2|COMPLETED|Open-label Period||139
987313|NCT00416520|2393166|P1|COMPLETED|Open-label Period||105
987314|NCT00416520|2393163|P4|STARTED|Open-label Period||0
987315|NCT00416520|2393164|P3|STARTED|Open-label Period||0
987316|NCT00416520|2393165|P2|STARTED|Open-label Period||171
987317|NCT00416520|2393166|P1|STARTED|Open-label Period||165
987318|NCT00416572|2393179|P3|NOT COMPLETED|Overall Study||8
987319|NCT00416572|2393180|P2|NOT COMPLETED|Overall Study||7
987320|NCT00416572|2393181|P1|NOT COMPLETED|Overall Study||13
987321|NCT00416572|2393179|P3|COMPLETED|Overall Study||76
987322|NCT00416572|2393180|P2|COMPLETED|Overall Study||78
987323|NCT00416572|2393181|P1|COMPLETED|Overall Study||70
987324|NCT00416572|2393179|P3|STARTED|Overall Study||84
987325|NCT00416572|2393180|P2|STARTED|Overall Study||85
987326|NCT00416572|2393181|P1|STARTED|Overall Study||83
987327|NCT00416598|2393195|P1|NOT COMPLETED|Decitabine Maintenance||72
987328|NCT00416598|2393195|P1|COMPLETED|Decitabine Maintenance||62
987329|NCT00416598|2393195|P1|STARTED|Decitabine Maintenance||134
987330|NCT00416598|2393195|P1|NOT COMPLETED|Induction & Intensification||412
987331|NCT00416598|2393195|P1|COMPLETED|Induction & Intensification||134
987332|NCT00416598|2393195|P1|STARTED|Induction & Intensification||546
987333|NCT00416624|2393204|P4|NOT COMPLETED|Overall Study||17
987334|NCT00416624|2393205|P3|NOT COMPLETED|Overall Study||18
987335|NCT00416624|2393206|P2|NOT COMPLETED|Overall Study||27
987336|NCT00416624|2393207|P1|NOT COMPLETED|Overall Study||22
987337|NCT00416624|2393204|P4|COMPLETED|Overall Study||40
987338|NCT00416624|2393205|P3|COMPLETED|Overall Study||40
987339|NCT00416624|2393206|P2|COMPLETED|Overall Study||33
987340|NCT00416624|2393207|P1|COMPLETED|Overall Study||39
987341|NCT00416624|2393204|P4|STARTED|Overall Study||57
987342|NCT00416624|2393205|P3|STARTED|Overall Study||58
987343|NCT00416624|2393206|P2|STARTED|Overall Study||60
987344|NCT00416624|2393207|P1|STARTED|Overall Study||61
987345|NCT00416715|2393261|P1|NOT COMPLETED|Overall Study||15
987346|NCT00416715|2393261|P1|COMPLETED|Overall Study||85
987347|NCT00416715|2393261|P1|STARTED|Overall Study||100
987348|NCT00416793|2393268|P1|NOT COMPLETED|Overall Study||0
987349|NCT00416793|2393268|P1|COMPLETED|Overall Study||9
987350|NCT00416793|2393268|P1|STARTED|Overall Study||9
987351|NCT00416884|2393272|P1|NOT COMPLETED|Overall Study||1
987352|NCT00416884|2393272|P1|COMPLETED|Overall Study||0
987353|NCT00416884|2393272|P1|STARTED|Overall Study||1
987354|NCT00417027|2393279|P3|NOT COMPLETED|Overall Study||5
987355|NCT00417027|2393280|P2|NOT COMPLETED|Overall Study||5
987356|NCT00417027|2393281|P1|NOT COMPLETED|Overall Study||0
987357|NCT00417027|2393279|P3|COMPLETED|Overall Study||54
987358|NCT00417027|2393280|P2|COMPLETED|Overall Study||60
987359|NCT00417027|2393281|P1|COMPLETED|Overall Study||66
987360|NCT00417027|2393279|P3|STARTED|Overall Study||59
987361|NCT00417027|2393280|P2|STARTED|Overall Study||65
987362|NCT00417027|2393281|P1|STARTED|Overall Study||66
987363|NCT00410761|2393309|P2|NOT COMPLETED|Overall Study||72
987364|NCT00410761|2393310|P1|NOT COMPLETED|Overall Study||120
987365|NCT00410761|2393309|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|28
987366|NCT00410761|2393310|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|111
987367|NCT00410761|2393309|P2|STARTED|Overall Study|randomised patients|100
987368|NCT00410761|2393310|P1|STARTED|Overall Study|randomised patients|231
987369|NCT00410813|2393332|P2|NOT COMPLETED|Overall Study||42
987370|NCT00410813|2393333|P1|NOT COMPLETED|Overall Study||43
987371|NCT00410813|2393332|P2|COMPLETED|Overall Study||0
987372|NCT00410813|2393333|P1|COMPLETED|Overall Study|Patients treated until progression.|0
987373|NCT00410813|2393332|P2|Eligible|Overall Study||38
987374|NCT00410813|2393333|P1|Eligible|Overall Study||41
987375|NCT00410813|2393332|P2|STARTED|Overall Study||42
987376|NCT00410813|2393333|P1|STARTED|Overall Study||43
987377|NCT00417079|2393370|P2|NOT COMPLETED|Overall Study||273
987378|NCT00417079|2393371|P1|NOT COMPLETED|Overall Study||331
987379|NCT00417079|2393370|P2|COMPLETED|Overall Study|Randomized patients|105
987380|NCT00417079|2393371|P1|COMPLETED|Overall Study|Randomized patients|46
987381|NCT00417079|2393370|P2|STARTED|Overall Study|Randomized patients|378
987382|NCT00417079|2393371|P1|STARTED|Overall Study|Randomized patients|377
987383|NCT00417170|2393393|P2|NOT COMPLETED|Overall Study||3
987384|NCT00417170|2393394|P1|NOT COMPLETED|Overall Study||2
987385|NCT00417170|2393393|P2|COMPLETED|Overall Study||22
987386|NCT00417170|2393394|P1|COMPLETED|Overall Study||21
987387|NCT00417170|2393393|P2|Pharmacodynamics Population|Overall Study||23
987388|NCT00417170|2393394|P1|Pharmacodynamics Population|Overall Study||21
987389|NCT00417170|2393393|P2|STARTED|Overall Study||25
987390|NCT00417170|2393394|P1|STARTED|Overall Study|"Started indicates Safety population."|23
987391|NCT00417248|2393408|P1|NOT COMPLETED|Overall Study||8
987392|NCT00417248|2393408|P1|COMPLETED|Overall Study||0
987393|NCT00417248|2393408|P1|STARTED|Overall Study||8
987394|NCT00417274|2393413|P1|NOT COMPLETED|Overall Study||0
987395|NCT00417274|2393413|P1|COMPLETED|Overall Study||31
987396|NCT00417274|2393413|P1|STARTED|Overall Study||31
987397|NCT00419926|2393419|P2|NOT COMPLETED|Overall Study||10
987398|NCT00419926|2393420|P1|NOT COMPLETED|Overall Study||14
987399|NCT00419926|2393419|P2|COMPLETED|Overall Study||148
987400|NCT00419926|2393420|P1|COMPLETED|Overall Study||141
987401|NCT00419926|2393419|P2|STARTED|Overall Study|Intention to treat population, 154 is safety population.|158
987402|NCT00419926|2393420|P1|STARTED|Overall Study|Intention to treat population, 150 is safety population.|155
987403|NCT00419952|2393436|P2|NOT COMPLETED|Overall Study||125
987404|NCT00419952|2393437|P1|NOT COMPLETED|Overall Study||149
987405|NCT00419952|2393436|P2|COMPLETED|Overall Study||240
987406|NCT00419952|2393437|P1|COMPLETED|Overall Study||228
987407|NCT00419952|2393436|P2|STARTED|Overall Study||365
987408|NCT00419952|2393437|P1|STARTED|Overall Study||377
987409|NCT00420017|2393471|P2|NOT COMPLETED|Overall Study||0
987410|NCT00420017|2393472|P1|NOT COMPLETED|Overall Study||2
987411|NCT00420017|2393471|P2|COMPLETED|Overall Study||40
987412|NCT00420017|2393472|P1|COMPLETED|Overall Study|40 completed analysis|38
987413|NCT00420017|2393471|P2|STARTED|Overall Study||40
987414|NCT00420017|2393472|P1|STARTED|Overall Study||40
987415|NCT00420056|2393484|P1|NOT COMPLETED|Overall Study||17
987416|NCT00420056|2393484|P1|COMPLETED|Overall Study||0
987417|NCT00420056|2393484|P1|STARTED|Overall Study||17
987418|NCT00420095|2393508|P2|NOT COMPLETED|Overall Study||1
987419|NCT00420095|2393509|P1|NOT COMPLETED|Overall Study||3
987420|NCT00420095|2393508|P2|COMPLETED|Overall Study||59
987421|NCT00420095|2393509|P1|COMPLETED|Overall Study||54
987422|NCT00420095|2393508|P2|STARTED|Overall Study||60
987423|NCT00420095|2393509|P1|STARTED|Overall Study||57
987424|NCT00420147|2393529|P2|NOT COMPLETED|Overall Study||0
987425|NCT00420147|2393530|P1|NOT COMPLETED|Overall Study||0
987426|NCT00420147|2393529|P2|COMPLETED|Overall Study||19
987427|NCT00420147|2393530|P1|COMPLETED|Overall Study||19
987428|NCT00420147|2393529|P2|STARTED|Overall Study||19
987429|NCT00420147|2393530|P1|STARTED|Overall Study||19
987430|NCT00420199|2393540|P2|NOT COMPLETED|Overall Study||0
987431|NCT00420199|2393541|P1|NOT COMPLETED|Overall Study||1
987432|NCT00420199|2393540|P2|COMPLETED|Overall Study||23
987433|NCT00420199|2393541|P1|COMPLETED|Overall Study||26
987434|NCT00420199|2393540|P2|STARTED|Overall Study||23
987435|NCT00420199|2393541|P1|STARTED|Overall Study||27
987436|NCT00420212|2393597|P3|NOT COMPLETED|Overall Study||96
987437|NCT00420212|2393598|P2|NOT COMPLETED|Overall Study||95
987438|NCT00420212|2393599|P1|NOT COMPLETED|Overall Study||91
987439|NCT00420212|2393597|P3|COMPLETED|Overall Study||320
987440|NCT00420212|2393598|P2|COMPLETED|Overall Study||315
987441|NCT00420212|2393599|P1|COMPLETED|Overall Study||317
987442|NCT00420212|2393597|P3|STARTED|Overall Study|416 participants were dosed; 416 participants were randomized|416
987443|NCT00420212|2393598|P2|STARTED|Overall Study|410 participants were dosed; 411 participants were randomized|410
987444|NCT00420212|2393599|P1|STARTED|Overall Study|408 participants were dosed; 410 participants were randomized|408
987445|NCT00420238|2393625|P2|NOT COMPLETED|12 Week Open-Label Treatment Period 2||1
987446|NCT00420238|2393626|P1|NOT COMPLETED|12 Week Open-Label Treatment Period 2||2
987447|NCT00420238|2393625|P2|COMPLETED|12 Week Open-Label Treatment Period 2||38
987448|NCT00420238|2393626|P1|COMPLETED|12 Week Open-Label Treatment Period 2||36
987449|NCT00420238|2393625|P2|STARTED|12 Week Open-Label Treatment Period 2||39
987450|NCT00420238|2393626|P1|STARTED|12 Week Open-Label Treatment Period 2||38
987451|NCT00420238|2393625|P2|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||4
987452|NCT00420238|2393626|P1|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||1
987453|NCT00420238|2393625|P2|COMPLETED|12 Week Double-Blind Treatment Period 1||39
987454|NCT00420238|2393626|P1|COMPLETED|12 Week Double-Blind Treatment Period 1||38
987455|NCT00420238|2393625|P2|STARTED|12 Week Double-Blind Treatment Period 1||43
987456|NCT00420238|2393626|P1|STARTED|12 Week Double-Blind Treatment Period 1||39
987457|NCT00420290|2393764|P2|NOT COMPLETED|Overall Study||4
987458|NCT00420290|2393765|P1|NOT COMPLETED|Overall Study||4
987459|NCT00420290|2393764|P2|COMPLETED|Overall Study||7
987460|NCT00420290|2393765|P1|COMPLETED|Overall Study||7
987461|NCT00420290|2393764|P2|STARTED|Overall Study||11
987462|NCT00420290|2393765|P1|STARTED|Overall Study||11
987463|NCT00420303|2393781|P2|NOT COMPLETED|Overall Study||4
987464|NCT00420303|2393782|P1|NOT COMPLETED|Overall Study||1
987465|NCT00420303|2393781|P2|COMPLETED|Overall Study||8
987466|NCT00420303|2393782|P1|COMPLETED|Overall Study||11
987467|NCT00420303|2393781|P2|STARTED|Overall Study||12
987468|NCT00420303|2393782|P1|STARTED|Overall Study||12
987469|NCT00420316|2393794|P2|NOT COMPLETED|Overall Study||9
987470|NCT00420316|2393795|P1|NOT COMPLETED|Overall Study||12
987471|NCT00420316|2393794|P2|COMPLETED|Overall Study||522
987472|NCT00420316|2393795|P1|COMPLETED|Overall Study||1070
987473|NCT00420316|2393794|P2|STARTED|Overall Study||531
987474|NCT00420316|2393795|P1|STARTED|Overall Study||1082
987475|NCT00420342|2393820|P3|NOT COMPLETED|Overall Study||1
987476|NCT00420342|2393821|P2|NOT COMPLETED|Overall Study||2
987477|NCT00420342|2393822|P1|NOT COMPLETED|Overall Study||1
987478|NCT00420342|2393820|P3|COMPLETED|Overall Study||28
987479|NCT00420342|2393821|P2|COMPLETED|Overall Study||31
987480|NCT00420342|2393822|P1|COMPLETED|Overall Study||29
987481|NCT00420342|2393820|P3|Received Treatment|Overall Study||29
987482|NCT00420342|2393821|P2|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|32
987483|NCT00420342|2393822|P1|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|29
987484|NCT00420342|2393820|P3|STARTED|Overall Study||29
987485|NCT00420342|2393821|P2|STARTED|Overall Study||33
987486|NCT00420342|2393822|P1|STARTED|Overall Study||30
987487|NCT00420407|2393865|P2|NOT COMPLETED|Overall Study||6
987488|NCT00420407|2393866|P1|NOT COMPLETED|Overall Study||4
987489|NCT00420407|2393865|P2|COMPLETED|Overall Study||34
987490|NCT00420407|2393866|P1|COMPLETED|Overall Study||37
987491|NCT00420407|2393865|P2|STARTED|Overall Study||40
987492|NCT00420407|2393866|P1|STARTED|Overall Study||41
987493|NCT00420420|2393874|P2|NOT COMPLETED|Overall Study||4
987494|NCT00420420|2393875|P1|NOT COMPLETED|Overall Study||8
987495|NCT00420420|2393874|P2|COMPLETED|Overall Study||67
987496|NCT00420420|2393875|P1|COMPLETED|Overall Study|One patient from the MK-0249 arm discontinued the trial due to an AE prior to receiving study drug.|65
987497|NCT00420420|2393874|P2|STARTED|Overall Study|Number of patients randomized.|71
987498|NCT00420420|2393875|P1|STARTED|Overall Study|Number of patients randomized.|73
987499|NCT00420459|2393891|P1|NOT COMPLETED|Overall Study||0
987500|NCT00420459|2393891|P1|COMPLETED|Overall Study||12
987501|NCT00420459|2393891|P1|STARTED|Overall Study||12
987502|NCT00420511|2393902|P2|NOT COMPLETED|Overall Study||1
987503|NCT00420511|2393903|P1|NOT COMPLETED|Overall Study||2
987504|NCT00420511|2393902|P2|COMPLETED|Overall Study||10
987505|NCT00420511|2393903|P1|COMPLETED|Overall Study||8
987506|NCT00420511|2393902|P2|STARTED|Overall Study||11
987507|NCT00420511|2393903|P1|STARTED|Overall Study||10
987508|NCT00420628|2393915|P2|NOT COMPLETED|Overall Study||4
987509|NCT00420628|2393916|P1|NOT COMPLETED|Overall Study||9
987510|NCT00420628|2393915|P2|COMPLETED|Overall Study||32
987511|NCT00420628|2393916|P1|COMPLETED|Overall Study||63
987512|NCT00420628|2393915|P2|STARTED|Overall Study||36
987513|NCT00420628|2393916|P1|STARTED|Overall Study||72
987514|NCT00420745|2393932|P2|NOT COMPLETED|Overall Study||6
987515|NCT00420745|2393933|P1|NOT COMPLETED|Overall Study||15
987516|NCT00420745|2393932|P2|COMPLETED|Overall Study||333
987517|NCT00420745|2393933|P1|COMPLETED|Overall Study||655
987518|NCT00420745|2393932|P2|STARTED|Overall Study||339
987519|NCT00420745|2393933|P1|STARTED|Overall Study||670
987520|NCT00420784|2393953|P4|NOT COMPLETED|Overall Study||78
987521|NCT00420784|2393954|P3|NOT COMPLETED|Overall Study||53
987522|NCT00420784|2393955|P2|NOT COMPLETED|Overall Study||58
987523|NCT00420784|2393956|P1|NOT COMPLETED|Overall Study||29
987524|NCT00420784|2393953|P4|COMPLETED|Overall Study||36
987525|NCT00420784|2393954|P3|COMPLETED|Overall Study||58
987526|NCT00420784|2393955|P2|COMPLETED|Overall Study||55
987527|NCT00420784|2393956|P1|COMPLETED|Overall Study||86
987528|NCT00420784|2393953|P4|STARTED|Overall Study||114
987529|NCT00420784|2393954|P3|STARTED|Overall Study||111
987530|NCT00420784|2393955|P2|STARTED|Overall Study||113
987531|NCT00420784|2393956|P1|STARTED|Overall Study||115
987532|NCT00420849|2393983|P1|NOT COMPLETED|Overall Study||331
987533|NCT00420849|2393983|P1|COMPLETED|Overall Study|Participants completed the study upon commercial availability of lenalidomide|256
987534|NCT00420849|2393983|P1|STARTED|Overall Study||587
987535|NCT00420927|2394055|P7|NOT COMPLETED|Period 2||53
987536|NCT00420927|2394056|P6|NOT COMPLETED|Period 2||15
987537|NCT00420927|2394057|P5|NOT COMPLETED|Period 2||43
987538|NCT00420927|2394058|P4|NOT COMPLETED|Period 2||10
987539|NCT00420927|2394059|P3|NOT COMPLETED|Period 2||13
987540|NCT00420927|2394060|P2|NOT COMPLETED|Period 2||0
987541|NCT00420927|2394061|P1|NOT COMPLETED|Period 2||0
987542|NCT00420927|2394055|P7|COMPLETED|Period 2||295
987543|NCT00420927|2394056|P6|COMPLETED|Period 2||97
987544|NCT00420927|2394057|P5|COMPLETED|Period 2||216
987545|NCT00420927|2394058|P4|COMPLETED|Period 2||95
987546|NCT00420927|2394059|P3|COMPLETED|Period 2||89
987547|NCT00420927|2394060|P2|COMPLETED|Period 2||0
987548|NCT00420927|2394061|P1|COMPLETED|Period 2||0
987549|NCT00420927|2394055|P7|STARTED|Period 2||348
987550|NCT00420927|2394056|P6|STARTED|Period 2||112
987551|NCT00420927|2394057|P5|STARTED|Period 2||259
987552|NCT00420927|2394058|P4|STARTED|Period 2||105
987553|NCT00420927|2394059|P3|STARTED|Period 2||102
987554|NCT00420927|2394060|P2|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
987555|NCT00420927|2394061|P1|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
987556|NCT00420927|2394055|P7|NOT COMPLETED|Period 1||0
987557|NCT00420927|2394056|P6|NOT COMPLETED|Period 1||0
987558|NCT00420927|2394057|P5|NOT COMPLETED|Period 1||0
987559|NCT00420927|2394058|P4|NOT COMPLETED|Period 1||0
987560|NCT00420927|2394059|P3|NOT COMPLETED|Period 1||0
987561|NCT00420927|2394060|P2|NOT COMPLETED|Period 1||57
987562|NCT00420927|2394061|P1|NOT COMPLETED|Period 1||49
987563|NCT00420927|2394055|P7|COMPLETED|Period 1||0
987564|NCT00420927|2394056|P6|COMPLETED|Period 1||0
987565|NCT00420927|2394057|P5|COMPLETED|Period 1||0
987566|NCT00420927|2394058|P4|COMPLETED|Period 1||0
987567|NCT00420927|2394059|P3|COMPLETED|Period 1||0
987568|NCT00420927|2394060|P2|COMPLETED|Period 1||460
987569|NCT00420927|2394061|P1|COMPLETED|Period 1||466
987570|NCT00420927|2394055|P7|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
987571|NCT00420927|2394056|P6|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
987572|NCT00420927|2394057|P5|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
987573|NCT00420927|2394058|P4|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
987574|NCT00420927|2394059|P3|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
987575|NCT00420927|2394060|P2|STARTED|Period 1||517
987576|NCT00420927|2394061|P1|STARTED|Period 1||515
987577|NCT00420992|2394167|P2|NOT COMPLETED|Maintenance Phase||75
987578|NCT00420992|2394168|P1|NOT COMPLETED|Maintenance Phase||61
987579|NCT00420992|2394167|P2|COMPLETED|Maintenance Phase||98
987580|NCT00420992|2394168|P1|COMPLETED|Maintenance Phase||110
987581|NCT00420992|2394167|P2|STARTED|Maintenance Phase||173
987582|NCT00420992|2394168|P1|STARTED|Maintenance Phase||171
987583|NCT00420992|2394167|P2|NOT COMPLETED|Titration Phase||0
987584|NCT00420992|2394168|P1|NOT COMPLETED|Titration Phase||203
987585|NCT00420992|2394167|P2|COMPLETED|Titration Phase||0
987586|NCT00420992|2394168|P1|COMPLETED|Titration Phase||344
987587|NCT00420992|2394167|P2|STARTED|Titration Phase||0
987588|NCT00420992|2394168|P1|STARTED|Titration Phase|All patients received ALO-01 during open-label titration phase|547
987589|NCT00421174|2394177|P2|NOT COMPLETED|Overall Study||1
987590|NCT00421174|2394178|P1|NOT COMPLETED|Overall Study||2
987591|NCT00421174|2394177|P2|COMPLETED|Overall Study||18
987592|NCT00421174|2394178|P1|COMPLETED|Overall Study||16
987593|NCT00421174|2394177|P2|STARTED|Overall Study||19
987594|NCT00421174|2394178|P1|STARTED|Overall Study||18
987595|NCT00421343|2394206|P1|NOT COMPLETED|Overall Study||6
987596|NCT00421343|2394206|P1|COMPLETED|Overall Study||23
987597|NCT00421343|2394206|P1|STARTED|Overall Study||29
987598|NCT00421408|2394212|P2|NOT COMPLETED|Overall Study||45
987599|NCT00421408|2394213|P1|NOT COMPLETED|Overall Study||42
987600|NCT00421408|2394212|P2|COMPLETED|Overall Study||61
987601|NCT00421408|2394213|P1|COMPLETED|Overall Study||60
987602|NCT00421408|2394212|P2|STARTED|Overall Study||106
987603|NCT00421408|2394213|P1|STARTED|Overall Study||102
987604|NCT00421603|2394233|P2|NOT COMPLETED|Overall Study||12
987605|NCT00421603|2394234|P1|NOT COMPLETED|Overall Study||11
987606|NCT00421603|2394233|P2|COMPLETED|Overall Study|Completed all 14 week sof trial|30
987607|NCT00421603|2394234|P1|COMPLETED|Overall Study|Completed all 14 week sof trial|28
987608|NCT00421603|2394233|P2|STARTED|Overall Study||42
987609|NCT00421603|2394234|P1|STARTED|Overall Study||39
987610|NCT00421733|2394243|P3|NOT COMPLETED|Overall Study||20
987611|NCT00421733|2394244|P2|NOT COMPLETED|Overall Study||26
987612|NCT00421733|2394245|P1|NOT COMPLETED|Overall Study||15
987613|NCT00421733|2394243|P3|COMPLETED|Overall Study||73
987614|NCT00421733|2394244|P2|COMPLETED|Overall Study||69
987615|NCT00421733|2394245|P1|COMPLETED|Overall Study||78
987616|NCT00421733|2394243|P3|STARTED|Overall Study||93
987617|NCT00421733|2394244|P2|STARTED|Overall Study||95
987618|NCT00421733|2394245|P1|STARTED|Overall Study||93
987619|NCT00421889|2394272|P9|NOT COMPLETED|Overall Study||11
987620|NCT00421889|2394273|P8|NOT COMPLETED|Overall Study||2
987621|NCT00421889|2394274|P7|NOT COMPLETED|Overall Study||4
987622|NCT00421889|2394275|P6|NOT COMPLETED|Overall Study||35
987623|NCT00421889|2394276|P5|NOT COMPLETED|Overall Study||6
987624|NCT00421889|2394277|P4|NOT COMPLETED|Overall Study||4
987625|NCT00421889|2394278|P3|NOT COMPLETED|Overall Study||3
987626|NCT00421889|2394279|P2|NOT COMPLETED|Overall Study||5
987627|NCT00421889|2394280|P1|NOT COMPLETED|Overall Study||5
987628|NCT00421889|2394272|P9|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 4.27|4
987629|NCT00421889|2394273|P8|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|1
987630|NCT00421889|2394274|P7|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.50|0
987631|NCT00421889|2394275|P6|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 7.69|0
987632|NCT00421889|2394276|P5|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.00|0
987633|NCT00421889|2394277|P4|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 9.25|0
987634|NCT00421889|2394278|P3|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|0
987635|NCT00421889|2394279|P2|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 8.20|0
987636|NCT00421889|2394280|P1|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.20|0
987637|NCT00421889|2394272|P9|STARTED|Overall Study||15
987638|NCT00421889|2394273|P8|STARTED|Overall Study||3
987639|NCT00421889|2394274|P7|STARTED|Overall Study||4
987640|NCT00421889|2394275|P6|STARTED|Overall Study||35
987641|NCT00421889|2394276|P5|STARTED|Overall Study||6
987642|NCT00421889|2394277|P4|STARTED|Overall Study||4
987643|NCT00421889|2394278|P3|STARTED|Overall Study||3
987644|NCT00421889|2394279|P2|STARTED|Overall Study||5
987645|NCT00421889|2394280|P1|STARTED|Overall Study||5
987646|NCT00421928|2394325|P3|NOT COMPLETED|Overall Study||134
987647|NCT00421928|2394326|P2|NOT COMPLETED|Overall Study||224
987648|NCT00421928|2394327|P1|NOT COMPLETED|Overall Study||163
987649|NCT00421928|2394325|P3|COMPLETED|Overall Study||203
987650|NCT00421928|2394326|P2|COMPLETED|Overall Study||118
987651|NCT00421928|2394327|P1|COMPLETED|Overall Study||181
987652|NCT00421928|2394325|P3|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|337
987653|NCT00421928|2394326|P2|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug. One subject was enrolled twice.|342
987654|NCT00421928|2394327|P1|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|344
987655|NCT00421954|2394353|P1|NOT COMPLETED|Overall Study||0
987656|NCT00421954|2394353|P1|COMPLETED|Overall Study||0
987657|NCT00421954|2394353|P1|STARTED|Overall Study||0
987658|NCT00421993|2394361|P4|NOT COMPLETED|Overall Study||57
987659|NCT00421993|2394362|P3|NOT COMPLETED|Overall Study||52
987660|NCT00421993|2394363|P2|NOT COMPLETED|Overall Study||49
987661|NCT00421993|2394364|P1|NOT COMPLETED|Overall Study||53
987662|NCT00421993|2394361|P4|COMPLETED|Overall Study||361
987663|NCT00421993|2394362|P3|COMPLETED|Overall Study||363
987664|NCT00421993|2394363|P2|COMPLETED|Overall Study||369
987665|NCT00421993|2394364|P1|COMPLETED|Overall Study||366
987666|NCT00421993|2394361|P4|STARTED|Overall Study||418
987667|NCT00421993|2394362|P3|STARTED|Overall Study||415
987668|NCT00421993|2394363|P2|STARTED|Overall Study||418
987669|NCT00421993|2394364|P1|STARTED|Overall Study||419
987670|NCT00422032|2394396|P2|NOT COMPLETED|Overall Study||0
987671|NCT00422032|2394397|P1|NOT COMPLETED|Overall Study||0
987672|NCT00422032|2394396|P2|COMPLETED|Overall Study||21
987673|NCT00422032|2394397|P1|COMPLETED|Overall Study||37
987674|NCT00422032|2394396|P2|STARTED|Overall Study||21
987675|NCT00422032|2394397|P1|STARTED|Overall Study||37
987718|NCT00422097|2394548|P8|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
987719|NCT00422097|2394549|P7|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
987720|NCT00422097|2394550|P6|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
987721|NCT00422097|2394551|P5|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
987722|NCT00422097|2394552|P4|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
987723|NCT00422097|2394553|P3|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
987724|NCT00422097|2394554|P2|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
987725|NCT00422097|2394555|P1|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
987726|NCT00422097|2394548|P8|COMPLETED|Ixabepilone With Famotidine or Food||7
987727|NCT00422097|2394549|P7|COMPLETED|Ixabepilone With Famotidine or Food||8
987728|NCT00422097|2394550|P6|COMPLETED|Ixabepilone With Famotidine or Food||0
987729|NCT00422097|2394551|P5|COMPLETED|Ixabepilone With Famotidine or Food||0
987730|NCT00422097|2394552|P4|COMPLETED|Ixabepilone With Famotidine or Food||0
987731|NCT00422097|2394553|P3|COMPLETED|Ixabepilone With Famotidine or Food||0
987732|NCT00422097|2394554|P2|COMPLETED|Ixabepilone With Famotidine or Food||0
987733|NCT00422097|2394555|P1|COMPLETED|Ixabepilone With Famotidine or Food||0
987734|NCT00422097|2394548|P8|STARTED|Ixabepilone With Famotidine or Food||7
987735|NCT00422097|2394549|P7|STARTED|Ixabepilone With Famotidine or Food||8
987736|NCT00422097|2394550|P6|STARTED|Ixabepilone With Famotidine or Food||0
987737|NCT00422097|2394551|P5|STARTED|Ixabepilone With Famotidine or Food||0
987738|NCT00422097|2394552|P4|STARTED|Ixabepilone With Famotidine or Food||0
987739|NCT00422097|2394553|P3|STARTED|Ixabepilone With Famotidine or Food||0
987740|NCT00422097|2394554|P2|STARTED|Ixabepilone With Famotidine or Food||0
987741|NCT00422097|2394555|P1|STARTED|Ixabepilone With Famotidine or Food||0
987742|NCT00422097|2394548|P8|NOT COMPLETED|Dose Level 6||0
987743|NCT00422097|2394549|P7|NOT COMPLETED|Dose Level 6||0
987744|NCT00422097|2394550|P6|NOT COMPLETED|Dose Level 6||0
987745|NCT00422097|2394551|P5|NOT COMPLETED|Dose Level 6||0
987746|NCT00422097|2394552|P4|NOT COMPLETED|Dose Level 6||0
987747|NCT00422097|2394553|P3|NOT COMPLETED|Dose Level 6||0
987748|NCT00422097|2394554|P2|NOT COMPLETED|Dose Level 6||0
987749|NCT00422097|2394555|P1|NOT COMPLETED|Dose Level 6||0
987750|NCT00422097|2394548|P8|COMPLETED|Dose Level 6||0
987751|NCT00422097|2394549|P7|COMPLETED|Dose Level 6||0
987752|NCT00422097|2394550|P6|COMPLETED|Dose Level 6||6
987753|NCT00422097|2394551|P5|COMPLETED|Dose Level 6||0
987754|NCT00422097|2394552|P4|COMPLETED|Dose Level 6||0
987755|NCT00422097|2394553|P3|COMPLETED|Dose Level 6||0
987756|NCT00422097|2394554|P2|COMPLETED|Dose Level 6||0
987757|NCT00422097|2394555|P1|COMPLETED|Dose Level 6||0
987758|NCT00422097|2394548|P8|STARTED|Dose Level 6||0
987759|NCT00422097|2394549|P7|STARTED|Dose Level 6||0
987760|NCT00422097|2394550|P6|STARTED|Dose Level 6||6
987761|NCT00422097|2394551|P5|STARTED|Dose Level 6||0
987762|NCT00422097|2394552|P4|STARTED|Dose Level 6||0
987763|NCT00422097|2394553|P3|STARTED|Dose Level 6||0
987764|NCT00422097|2394554|P2|STARTED|Dose Level 6||0
987765|NCT00422097|2394555|P1|STARTED|Dose Level 6||0
987766|NCT00422097|2394548|P8|NOT COMPLETED|Dose Level 5||0
987767|NCT00422097|2394549|P7|NOT COMPLETED|Dose Level 5||0
987768|NCT00422097|2394550|P6|NOT COMPLETED|Dose Level 5||0
987769|NCT00422097|2394551|P5|NOT COMPLETED|Dose Level 5||0
987770|NCT00422097|2394552|P4|NOT COMPLETED|Dose Level 5||0
987771|NCT00422097|2394553|P3|NOT COMPLETED|Dose Level 5||0
987772|NCT00422097|2394554|P2|NOT COMPLETED|Dose Level 5||0
987773|NCT00422097|2394555|P1|NOT COMPLETED|Dose Level 5||0
987774|NCT00422097|2394548|P8|COMPLETED|Dose Level 5||0
987775|NCT00422097|2394549|P7|COMPLETED|Dose Level 5||0
987776|NCT00422097|2394550|P6|COMPLETED|Dose Level 5||0
987777|NCT00422097|2394551|P5|COMPLETED|Dose Level 5||23
987778|NCT00422097|2394552|P4|COMPLETED|Dose Level 5||0
987779|NCT00422097|2394553|P3|COMPLETED|Dose Level 5||0
987780|NCT00422097|2394554|P2|COMPLETED|Dose Level 5||0
987781|NCT00422097|2394555|P1|COMPLETED|Dose Level 5||0
987782|NCT00422097|2394548|P8|STARTED|Dose Level 5||0
987783|NCT00422097|2394549|P7|STARTED|Dose Level 5||0
987784|NCT00422097|2394550|P6|STARTED|Dose Level 5||0
987785|NCT00422097|2394551|P5|STARTED|Dose Level 5||23
987786|NCT00422097|2394552|P4|STARTED|Dose Level 5||0
987787|NCT00422097|2394553|P3|STARTED|Dose Level 5||0
987788|NCT00422097|2394554|P2|STARTED|Dose Level 5||0
987789|NCT00422097|2394555|P1|STARTED|Dose Level 5||0
987790|NCT00422097|2394548|P8|NOT COMPLETED|Dose Level 4||0
987791|NCT00422097|2394549|P7|NOT COMPLETED|Dose Level 4||0
987792|NCT00422097|2394550|P6|NOT COMPLETED|Dose Level 4||0
987793|NCT00422097|2394551|P5|NOT COMPLETED|Dose Level 4||0
987794|NCT00422097|2394552|P4|NOT COMPLETED|Dose Level 4||0
987795|NCT00422097|2394553|P3|NOT COMPLETED|Dose Level 4||0
987796|NCT00422097|2394554|P2|NOT COMPLETED|Dose Level 4||0
987797|NCT00422097|2394555|P1|NOT COMPLETED|Dose Level 4||0
987798|NCT00422097|2394548|P8|COMPLETED|Dose Level 4||0
987799|NCT00422097|2394549|P7|COMPLETED|Dose Level 4||0
987800|NCT00422097|2394550|P6|COMPLETED|Dose Level 4||0
987801|NCT00422097|2394551|P5|COMPLETED|Dose Level 4||0
987802|NCT00422097|2394552|P4|COMPLETED|Dose Level 4||3
987803|NCT00422097|2394553|P3|COMPLETED|Dose Level 4||0
987804|NCT00422097|2394554|P2|COMPLETED|Dose Level 4||0
987805|NCT00422097|2394555|P1|COMPLETED|Dose Level 4||0
987806|NCT00422097|2394548|P8|STARTED|Dose Level 4||0
987807|NCT00422097|2394549|P7|STARTED|Dose Level 4||0
987808|NCT00422097|2394550|P6|STARTED|Dose Level 4||0
987809|NCT00422097|2394551|P5|STARTED|Dose Level 4||0
987810|NCT00422097|2394552|P4|STARTED|Dose Level 4||3
987811|NCT00422097|2394553|P3|STARTED|Dose Level 4||0
987812|NCT00422097|2394554|P2|STARTED|Dose Level 4||0
987813|NCT00422097|2394555|P1|STARTED|Dose Level 4||0
987814|NCT00422097|2394548|P8|NOT COMPLETED|Dose Level 3||0
987815|NCT00422097|2394549|P7|NOT COMPLETED|Dose Level 3||0
987816|NCT00422097|2394550|P6|NOT COMPLETED|Dose Level 3||0
987817|NCT00422097|2394551|P5|NOT COMPLETED|Dose Level 3||0
987818|NCT00422097|2394552|P4|NOT COMPLETED|Dose Level 3||0
987819|NCT00422097|2394553|P3|NOT COMPLETED|Dose Level 3||0
987820|NCT00422097|2394554|P2|NOT COMPLETED|Dose Level 3||0
987821|NCT00422097|2394555|P1|NOT COMPLETED|Dose Level 3||0
987822|NCT00422097|2394548|P8|COMPLETED|Dose Level 3||0
987823|NCT00422097|2394549|P7|COMPLETED|Dose Level 3||0
987824|NCT00422097|2394550|P6|COMPLETED|Dose Level 3||0
987825|NCT00422097|2394551|P5|COMPLETED|Dose Level 3||0
987826|NCT00422097|2394552|P4|COMPLETED|Dose Level 3||0
987827|NCT00422097|2394553|P3|COMPLETED|Dose Level 3||3
987828|NCT00422097|2394554|P2|COMPLETED|Dose Level 3||0
987829|NCT00422097|2394555|P1|COMPLETED|Dose Level 3||0
987830|NCT00422097|2394548|P8|STARTED|Dose Level 3||0
987831|NCT00422097|2394549|P7|STARTED|Dose Level 3||0
987832|NCT00422097|2394550|P6|STARTED|Dose Level 3||0
987833|NCT00422097|2394551|P5|STARTED|Dose Level 3||0
987834|NCT00422097|2394552|P4|STARTED|Dose Level 3||0
987835|NCT00422097|2394553|P3|STARTED|Dose Level 3||3
987836|NCT00422097|2394554|P2|STARTED|Dose Level 3||0
987837|NCT00422097|2394555|P1|STARTED|Dose Level 3||0
987838|NCT00422097|2394548|P8|NOT COMPLETED|Dose Level 2||0
987839|NCT00422097|2394549|P7|NOT COMPLETED|Dose Level 2||0
987840|NCT00422097|2394550|P6|NOT COMPLETED|Dose Level 2||0
987841|NCT00422097|2394551|P5|NOT COMPLETED|Dose Level 2||0
987842|NCT00422097|2394552|P4|NOT COMPLETED|Dose Level 2||0
987843|NCT00422097|2394553|P3|NOT COMPLETED|Dose Level 2||0
987844|NCT00422097|2394554|P2|NOT COMPLETED|Dose Level 2||1
987845|NCT00422097|2394555|P1|NOT COMPLETED|Dose Level 2||0
987846|NCT00422097|2394548|P8|COMPLETED|Dose Level 2||0
987847|NCT00422097|2394549|P7|COMPLETED|Dose Level 2||0
987848|NCT00422097|2394550|P6|COMPLETED|Dose Level 2||0
987849|NCT00422097|2394551|P5|COMPLETED|Dose Level 2||0
987850|NCT00422097|2394552|P4|COMPLETED|Dose Level 2||0
987851|NCT00422097|2394553|P3|COMPLETED|Dose Level 2||0
987852|NCT00422097|2394554|P2|COMPLETED|Dose Level 2||5
987853|NCT00422097|2394555|P1|COMPLETED|Dose Level 2||0
987854|NCT00422097|2394548|P8|STARTED|Dose Level 2||0
987855|NCT00422097|2394549|P7|STARTED|Dose Level 2||0
987856|NCT00422097|2394550|P6|STARTED|Dose Level 2||0
987857|NCT00422097|2394551|P5|STARTED|Dose Level 2||0
987858|NCT00422097|2394552|P4|STARTED|Dose Level 2||0
987859|NCT00422097|2394553|P3|STARTED|Dose Level 2||0
987860|NCT00422097|2394554|P2|STARTED|Dose Level 2||6
987861|NCT00422097|2394555|P1|STARTED|Dose Level 2||0
987862|NCT00422097|2394548|P8|NOT COMPLETED|Dose Level 1||0
987863|NCT00422097|2394549|P7|NOT COMPLETED|Dose Level 1||0
987864|NCT00422097|2394550|P6|NOT COMPLETED|Dose Level 1||0
987865|NCT00422097|2394551|P5|NOT COMPLETED|Dose Level 1||0
987866|NCT00422097|2394552|P4|NOT COMPLETED|Dose Level 1||0
987867|NCT00422097|2394553|P3|NOT COMPLETED|Dose Level 1||0
987868|NCT00422097|2394554|P2|NOT COMPLETED|Dose Level 1||0
987869|NCT00422097|2394555|P1|NOT COMPLETED|Dose Level 1||0
987870|NCT00422097|2394548|P8|COMPLETED|Dose Level 1||0
987871|NCT00422097|2394549|P7|COMPLETED|Dose Level 1||0
987872|NCT00422097|2394550|P6|COMPLETED|Dose Level 1||0
987873|NCT00422097|2394551|P5|COMPLETED|Dose Level 1||0
987874|NCT00422097|2394552|P4|COMPLETED|Dose Level 1||0
987875|NCT00422097|2394553|P3|COMPLETED|Dose Level 1||0
987876|NCT00422097|2394554|P2|COMPLETED|Dose Level 1||0
987877|NCT00422097|2394555|P1|COMPLETED|Dose Level 1||3
987878|NCT00422097|2394548|P8|STARTED|Dose Level 1||0
987879|NCT00422097|2394549|P7|STARTED|Dose Level 1||0
987880|NCT00422097|2394550|P6|STARTED|Dose Level 1||0
987881|NCT00422097|2394551|P5|STARTED|Dose Level 1||0
987882|NCT00422097|2394552|P4|STARTED|Dose Level 1||0
987883|NCT00422097|2394553|P3|STARTED|Dose Level 1||0
987884|NCT00422097|2394554|P2|STARTED|Dose Level 1||0
987885|NCT00422097|2394555|P1|STARTED|Dose Level 1||3
987886|NCT00422162|2394616|P2|NOT COMPLETED|Overall Study||30
987887|NCT00422162|2394617|P1|NOT COMPLETED|Overall Study||24
987888|NCT00422162|2394616|P2|COMPLETED|Overall Study||142
987889|NCT00422162|2394617|P1|COMPLETED|Overall Study||143
987890|NCT00422162|2394616|P2|Received Treatment|Overall Study||171
987891|NCT00422162|2394617|P1|Received Treatment|Overall Study||167
987892|NCT00422162|2394616|P2|STARTED|Overall Study||172
987893|NCT00422162|2394617|P1|STARTED|Overall Study||167
987894|NCT00422201|2394671|P1|NOT COMPLETED|Overall Study||11
987895|NCT00422201|2394671|P1|COMPLETED|Overall Study||7
987896|NCT00422201|2394671|P1|STARTED|Overall Study||18
987897|NCT00422227|2394677|P2|NOT COMPLETED|Overall Study||15
987898|NCT00422227|2394678|P1|NOT COMPLETED|Overall Study||4
987899|NCT00422227|2394677|P2|COMPLETED|Overall Study||88
987900|NCT00422227|2394678|P1|COMPLETED|Overall Study||193
987901|NCT00422227|2394677|P2|STARTED|Overall Study||103
987902|NCT00422227|2394678|P1|STARTED|Overall Study||197
987903|NCT00422279|2394704|P2|NOT COMPLETED|Overall Study||0
987904|NCT00422279|2394705|P1|NOT COMPLETED|Overall Study||0
987905|NCT00422279|2394704|P2|COMPLETED|Overall Study||2
987906|NCT00422279|2394705|P1|COMPLETED|Overall Study||2
987907|NCT00422279|2394704|P2|24 Month After Loading Period|Overall Study||2
987908|NCT00422279|2394705|P1|24 Month After Loading Period|Overall Study||2
987909|NCT00422279|2394704|P2|STARTED|Overall Study||2
987910|NCT00422279|2394705|P1|STARTED|Overall Study||2
987911|NCT00422292|2394717|P4|NOT COMPLETED|Overall Study||24
987912|NCT00422292|2394718|P3|NOT COMPLETED|Overall Study||22
987913|NCT00422292|2394719|P2|NOT COMPLETED|Overall Study||66
987914|NCT00422292|2394720|P1|NOT COMPLETED|Overall Study||18
987915|NCT00422292|2394717|P4|COMPLETED|Overall Study||452
987916|NCT00422292|2394718|P3|COMPLETED|Overall Study||224
987917|NCT00422292|2394719|P2|COMPLETED|Overall Study||598
987918|NCT00422292|2394720|P1|COMPLETED|Overall Study||239
987919|NCT00422292|2394717|P4|STARTED|Overall Study||476
987920|NCT00422292|2394718|P3|STARTED|Overall Study||246
987921|NCT00422292|2394719|P2|STARTED|Overall Study||664
987922|NCT00422292|2394720|P1|STARTED|Overall Study||257
987923|NCT00422383|2394751|P5|NOT COMPLETED|Overall Study||3
987924|NCT00422383|2394752|P4|NOT COMPLETED|Overall Study||2
987925|NCT00422383|2394753|P3|NOT COMPLETED|Overall Study||4
987926|NCT00422383|2394754|P2|NOT COMPLETED|Overall Study||14
987927|NCT00422383|2394755|P1|NOT COMPLETED|Overall Study||15
987928|NCT00422383|2394751|P5|COMPLETED|Overall Study||22
987929|NCT00422383|2394752|P4|COMPLETED|Overall Study||4
987930|NCT00422383|2394753|P3|COMPLETED|Overall Study||89
987931|NCT00422383|2394754|P2|COMPLETED|Overall Study||106
987932|NCT00422383|2394755|P1|COMPLETED|Overall Study||119
987933|NCT00422383|2394751|P5|STARTED|Overall Study||25
987934|NCT00422383|2394752|P4|STARTED|Overall Study||6
987935|NCT00422383|2394753|P3|STARTED|Overall Study||93
987936|NCT00422383|2394754|P2|STARTED|Overall Study||120
987937|NCT00422383|2394755|P1|STARTED|Overall Study||134
987938|NCT00413777|2394896|P2|NOT COMPLETED|Extension Period||0
987939|NCT00413777|2394897|P1|NOT COMPLETED|Extension Period||0
987940|NCT00413777|2394896|P2|COMPLETED|Extension Period||18
987941|NCT00413777|2394897|P1|COMPLETED|Extension Period||17
987942|NCT00413777|2394896|P2|STARTED|Extension Period||18
987943|NCT00413777|2394897|P1|STARTED|Extension Period||17
987944|NCT00413777|2394896|P2|NOT COMPLETED|Fixed-dose Period||3
987945|NCT00413777|2394897|P1|NOT COMPLETED|Fixed-dose Period||4
987946|NCT00413777|2394896|P2|COMPLETED|Fixed-dose Period||21
987947|NCT00413777|2394897|P1|COMPLETED|Fixed-dose Period||18
987948|NCT00413777|2394896|P2|STARTED|Fixed-dose Period||24
987949|NCT00413777|2394897|P1|STARTED|Fixed-dose Period||22
987950|NCT00413894|2394943|P1|NOT COMPLETED|Overall Study||80
987951|NCT00413894|2394943|P1|COMPLETED|Overall Study||344
987952|NCT00413894|2394943|P1|STARTED|Overall Study||424
987953|NCT00413920|2394960|P2|NOT COMPLETED|Overall Study||28
987954|NCT00413920|2394961|P1|NOT COMPLETED|Overall Study||28
987955|NCT00413920|2394960|P2|COMPLETED|Overall Study||82
987956|NCT00413920|2394961|P1|COMPLETED|Overall Study||84
987957|NCT00413920|2394960|P2|STARTED|Overall Study||110
987958|NCT00413920|2394961|P1|STARTED|Overall Study||112
987959|NCT00413959|2394976|P1|NOT COMPLETED|Overall Study||1
987960|NCT00413959|2394976|P1|COMPLETED|Overall Study||11
987961|NCT00413959|2394976|P1|STARTED|Overall Study||12
987962|NCT00413972|2394985|P4|NOT COMPLETED|Overall Study||3
987963|NCT00413972|2394986|P3|NOT COMPLETED|Overall Study||10
987964|NCT00413972|2394987|P2|NOT COMPLETED|Overall Study||8
987965|NCT00413972|2394988|P1|NOT COMPLETED|Overall Study||7
987966|NCT00413972|2394985|P4|COMPLETED|Overall Study||95
987967|NCT00413972|2394986|P3|COMPLETED|Overall Study||88
987968|NCT00413972|2394987|P2|COMPLETED|Overall Study||90
987969|NCT00413972|2394988|P1|COMPLETED|Overall Study||91
987970|NCT00413972|2394985|P4|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
987971|NCT00413972|2394986|P3|STARTED|Overall Study||98
987972|NCT00413972|2394987|P2|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
987973|NCT00413972|2394988|P1|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
987974|NCT00414011|2394998|P1|NOT COMPLETED|Overall Study||5
987975|NCT00414011|2394998|P1|COMPLETED|Overall Study||35
987976|NCT00414011|2394998|P1|STARTED|Overall Study||40
987977|NCT00414050|2395007|P4|NOT COMPLETED|Overall Study||8
987978|NCT00414050|2395008|P3|NOT COMPLETED|Overall Study||6
987979|NCT00414050|2395009|P2|NOT COMPLETED|Overall Study||8
987980|NCT00414050|2395010|P1|NOT COMPLETED|Overall Study||9
987981|NCT00414050|2395007|P4|COMPLETED|Overall Study||423
987982|NCT00414050|2395008|P3|COMPLETED|Overall Study||423
987983|NCT00414050|2395009|P2|COMPLETED|Overall Study||419
987984|NCT00414050|2395010|P1|COMPLETED|Overall Study||422
987985|NCT00414050|2395007|P4|Received Vaccination 3|Overall Study||424
987986|NCT00414050|2395008|P3|Received Vaccination 3|Overall Study||425
987987|NCT00414050|2395009|P2|Received Vaccination 3|Overall Study||419
987988|NCT00414050|2395010|P1|Received Vaccination 3|Overall Study||424
987989|NCT00414050|2395007|P4|Received Vaccination 2|Overall Study||425
987990|NCT00414050|2395008|P3|Received Vaccination 2|Overall Study||425
987991|NCT00414050|2395009|P2|Received Vaccination 2|Overall Study||421
987992|NCT00414050|2395010|P1|Received Vaccination 2|Overall Study||425
987993|NCT00414050|2395007|P4|Received Vaccination 1|Overall Study||431
987994|NCT00414050|2395008|P3|Received Vaccination 1|Overall Study||429
987995|NCT00414050|2395009|P2|Received Vaccination 1|Overall Study||426
987996|NCT00414050|2395010|P1|Received Vaccination 1|Overall Study||431
987997|NCT00414050|2395007|P4|STARTED|Overall Study||431
987998|NCT00414050|2395008|P3|STARTED|Overall Study||429
987999|NCT00414050|2395009|P2|STARTED|Overall Study||427
988000|NCT00414050|2395010|P1|STARTED|Overall Study||431
988001|NCT00414167|2395026|P2|NOT COMPLETED|Overall Study||3
988002|NCT00414167|2395027|P1|NOT COMPLETED|Overall Study||4
988003|NCT00414167|2395026|P2|COMPLETED|Overall Study||27
988004|NCT00414167|2395027|P1|COMPLETED|Overall Study||27
988005|NCT00414167|2395026|P2|STARTED|Overall Study||30
988006|NCT00414167|2395027|P1|STARTED|Overall Study||31
988007|NCT00414206|2395038|P3|NOT COMPLETED|Overall Study||55
988008|NCT00414206|2395039|P2|NOT COMPLETED|Overall Study||56
988009|NCT00414206|2395040|P1|NOT COMPLETED|Overall Study||58
988010|NCT00414206|2395038|P3|COMPLETED|Overall Study||59
988011|NCT00414206|2395039|P2|COMPLETED|Overall Study||58
988012|NCT00414206|2395040|P1|COMPLETED|Overall Study||57
988013|NCT00414206|2395038|P3|STARTED|Overall Study||114
988014|NCT00414206|2395039|P2|STARTED|Overall Study||114
988015|NCT00414206|2395040|P1|STARTED|Overall Study||115
988016|NCT00414310|2395050|P2|NOT COMPLETED|Overall Study||0
988017|NCT00414310|2395051|P1|NOT COMPLETED|Overall Study||1
988018|NCT00414310|2395050|P2|COMPLETED|Overall Study||79
988019|NCT00414310|2395051|P1|COMPLETED|Overall Study||70
988020|NCT00414310|2395050|P2|STARTED|Overall Study||79
988021|NCT00414310|2395051|P1|STARTED|Overall Study||71
988022|NCT00414388|2395057|P1|NOT COMPLETED|Overall Study||1
988023|NCT00414388|2395057|P1|COMPLETED|Overall Study||21
988024|NCT00414388|2395057|P1|STARTED|Overall Study||22
988025|NCT00414440|2395065|P2|NOT COMPLETED|Extension Period||140
988026|NCT00414440|2395066|P1|NOT COMPLETED|Extension Period||150
988027|NCT00414440|2395065|P2|COMPLETED|Extension Period|Extension|77
988028|NCT00414440|2395066|P1|COMPLETED|Extension Period|Extension|64
988029|NCT00414440|2395065|P2|STARTED|Extension Period|Extension|217
988030|NCT00414440|2395066|P1|STARTED|Extension Period|Extension|214
988031|NCT00414440|2395065|P2|NOT COMPLETED|Core Period||32
988032|NCT00414440|2395066|P1|NOT COMPLETED|Core Period||70
988033|NCT00414440|2395065|P2|COMPLETED|Core Period|Core period|185
988034|NCT00414440|2395066|P1|COMPLETED|Core Period|Core period|144
988035|NCT00414440|2395065|P2|STARTED|Core Period|Core period|217
988036|NCT00414440|2395066|P1|STARTED|Core Period|Core period|214
988037|NCT00414453|2395080|P1|NOT COMPLETED|Overall Study||16
988038|NCT00414453|2395080|P1|COMPLETED|Overall Study||3
988039|NCT00414453|2395080|P1|STARTED|Overall Study||19
988040|NCT00414466|2395130|P4|NOT COMPLETED|Overall Study||1
988041|NCT00414466|2395131|P3|NOT COMPLETED|Overall Study||1
988042|NCT00414466|2395132|P2|NOT COMPLETED|Overall Study||0
988043|NCT00414466|2395133|P1|NOT COMPLETED|Overall Study||2
988044|NCT00414466|2395130|P4|COMPLETED|Overall Study||42
988045|NCT00414466|2395131|P3|COMPLETED|Overall Study||40
988046|NCT00414466|2395132|P2|COMPLETED|Overall Study||42
988047|NCT00414466|2395133|P1|COMPLETED|Overall Study||42
988048|NCT00414466|2395130|P4|STARTED|Overall Study||43
988049|NCT00414466|2395131|P3|STARTED|Overall Study||41
988050|NCT00414466|2395132|P2|STARTED|Overall Study||42
988051|NCT00414466|2395133|P1|STARTED|Overall Study||44
988052|NCT00422422|2395151|P1|NOT COMPLETED|Overall Study||10
988053|NCT00422422|2395151|P1|COMPLETED|Overall Study||90
988054|NCT00422422|2395151|P1|STARTED|Overall Study||100
988055|NCT00422448|2395163|P1|NOT COMPLETED|Overall Study||0
988056|NCT00422448|2395163|P1|COMPLETED|Overall Study||43
988057|NCT00422448|2395163|P1|STARTED|Overall Study|22 prospectively enrolled during study period and 21 retrospectively enrolled|43
988058|NCT00422513|2395170|P2|NOT COMPLETED|Overall Study||106
988059|NCT00422513|2395171|P1|NOT COMPLETED|Overall Study||107
988060|NCT00422513|2395170|P2|COMPLETED|Overall Study||24
988061|NCT00422513|2395171|P1|COMPLETED|Overall Study||23
988062|NCT00422513|2395170|P2|STARTED|Overall Study||130
988063|NCT00422513|2395171|P1|STARTED|Overall Study||130
988064|NCT00422656|2395183|P1|NOT COMPLETED|Overall Study||0
988065|NCT00422656|2395183|P1|COMPLETED|Overall Study||37
988066|NCT00422656|2395183|P1|STARTED|Overall Study||37
988067|NCT00422669|2395190|P3|NOT COMPLETED|Overall Study||7
988068|NCT00422669|2395191|P2|NOT COMPLETED|Overall Study||100
988069|NCT00422669|2395192|P1|NOT COMPLETED|Overall Study||98
988070|NCT00422669|2395190|P3|COMPLETED|Overall Study||0
988071|NCT00422669|2395191|P2|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
988072|NCT00422669|2395192|P1|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
988073|NCT00422669|2395190|P3|STARTED|Overall Study||7
988074|NCT00422669|2395191|P2|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|100
988075|NCT00422669|2395192|P1|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|98
988076|NCT00422695|2395215|P2|NOT COMPLETED|Overall Study||0
988077|NCT00422695|2395216|P1|NOT COMPLETED|Overall Study||0
988078|NCT00422695|2395215|P2|COMPLETED|Overall Study||38
988079|NCT00422695|2395216|P1|COMPLETED|Overall Study||105
988080|NCT00422695|2395215|P2|STARTED|Overall Study||38
988081|NCT00422695|2395216|P1|STARTED|Overall Study||105
988082|NCT00422734|2395226|P2|NOT COMPLETED|Overall Study||21
988083|NCT00422734|2395227|P1|NOT COMPLETED|Overall Study||14
988084|NCT00422734|2395226|P2|COMPLETED|Overall Study||243
988085|NCT00422734|2395227|P1|COMPLETED|Overall Study||64
988086|NCT00422734|2395226|P2|STARTED|Overall Study||264
988087|NCT00422734|2395227|P1|STARTED|Overall Study||78
988088|NCT00423852|2395259|P1|NOT COMPLETED|Overall Study||3
988089|NCT00423852|2395259|P1|COMPLETED|Overall Study||23
988090|NCT00423852|2395259|P1|STARTED|Overall Study||26
988091|NCT00423878|2395266|P2|NOT COMPLETED|Overall Study||8
988092|NCT00423878|2395267|P1|NOT COMPLETED|Overall Study||20
988093|NCT00423878|2395266|P2|COMPLETED|Overall Study||98
988094|NCT00423878|2395267|P1|COMPLETED|Overall Study||89
988095|NCT00423878|2395266|P2|STARTED|Overall Study||106
988096|NCT00423878|2395267|P1|STARTED|Overall Study||109
988097|NCT00423891|2395278|P3|NOT COMPLETED|Post-Dosing Follow Up||1
988098|NCT00423891|2395279|P2|NOT COMPLETED|Post-Dosing Follow Up||17
988099|NCT00423891|2395280|P1|NOT COMPLETED|Post-Dosing Follow Up||2
988100|NCT00423891|2395278|P3|COMPLETED|Post-Dosing Follow Up||0
988101|NCT00423891|2395279|P2|COMPLETED|Post-Dosing Follow Up||1
988102|NCT00423891|2395280|P1|COMPLETED|Post-Dosing Follow Up||20
988103|NCT00423891|2395278|P3|STARTED|Post-Dosing Follow Up||1
988104|NCT00423891|2395279|P2|STARTED|Post-Dosing Follow Up|1 participant completed treatment but did not enter post dosing follow up period: Withdrew Consent.|18
988105|NCT00423891|2395280|P1|STARTED|Post-Dosing Follow Up||22
988106|NCT00423891|2395278|P3|NOT COMPLETED|Treatment||4
988107|NCT00423891|2395279|P2|NOT COMPLETED|Treatment||0
988108|NCT00423891|2395280|P1|NOT COMPLETED|Treatment||2
988109|NCT00423891|2395278|P3|COMPLETED|Treatment||1
988110|NCT00423891|2395279|P2|COMPLETED|Treatment||19
988111|NCT00423891|2395280|P1|COMPLETED|Treatment||22
988112|NCT00423891|2395278|P3|STARTED|Treatment||5
988113|NCT00423891|2395279|P2|STARTED|Treatment||19
988114|NCT00423891|2395280|P1|STARTED|Treatment||24
988115|NCT00423891|2395278|P3|NOT COMPLETED|Enrolled||3
988116|NCT00423891|2395279|P2|NOT COMPLETED|Enrolled||2
988117|NCT00423891|2395280|P1|NOT COMPLETED|Enrolled||11
988118|NCT00423891|2395278|P3|COMPLETED|Enrolled||5
988119|NCT00423891|2395279|P2|COMPLETED|Enrolled||19
988120|NCT00423891|2395280|P1|COMPLETED|Enrolled||24
988121|NCT00423891|2395278|P3|STARTED|Enrolled||8
988122|NCT00423891|2395279|P2|STARTED|Enrolled||21
988123|NCT00423891|2395280|P1|STARTED|Enrolled||35
988124|NCT00423917|2395347|P1|NOT COMPLETED|Overall Study||3
988125|NCT00423917|2395347|P1|COMPLETED|Overall Study||33
988126|NCT00423917|2395347|P1|STARTED|Overall Study||36
988127|NCT00423930|2395357|P1|NOT COMPLETED|Overall Study||2
988128|NCT00423930|2395357|P1|COMPLETED|Overall Study||42
988129|NCT00423930|2395357|P1|STARTED|Overall Study||44
988130|NCT00423943|2395364|P2|NOT COMPLETED|Overall Study||1
988131|NCT00423943|2395365|P1|NOT COMPLETED|Overall Study||3
988132|NCT00423943|2395364|P2|COMPLETED|Overall Study||13
988133|NCT00423943|2395365|P1|COMPLETED|Overall Study||16
988134|NCT00423943|2395364|P2|STARTED|Overall Study||14
988135|NCT00423943|2395365|P1|STARTED|Overall Study||19
988136|NCT00424008|2395381|P2|NOT COMPLETED|Overall Study||335
988137|NCT00424008|2395382|P1|NOT COMPLETED|Overall Study||349
988138|NCT00424008|2395381|P2|COMPLETED|Overall Study||16
988139|NCT00424008|2395382|P1|COMPLETED|Overall Study||22
988140|NCT00424008|2395381|P2|STARTED|Overall Study||351
988141|NCT00424008|2395382|P1|STARTED|Overall Study||371
988142|NCT00424021|2395399|P4|NOT COMPLETED|AMB-220-E Study Period||10
988143|NCT00424021|2395400|P3|NOT COMPLETED|AMB-220-E Study Period||5
988144|NCT00424021|2395401|P2|NOT COMPLETED|AMB-220-E Study Period||2
988145|NCT00424021|2395402|P1|NOT COMPLETED|AMB-220-E Study Period||1
988146|NCT00424021|2395399|P4|COMPLETED|AMB-220-E Study Period||16
988147|NCT00424021|2395400|P3|COMPLETED|AMB-220-E Study Period||14
988148|NCT00424021|2395401|P2|COMPLETED|AMB-220-E Study Period||5
988149|NCT00424021|2395402|P1|COMPLETED|AMB-220-E Study Period||1
988150|NCT00424021|2395399|P4|STARTED|AMB-220-E Study Period||26
988151|NCT00424021|2395400|P3|STARTED|AMB-220-E Study Period||19
988152|NCT00424021|2395401|P2|STARTED|AMB-220-E Study Period||7
988153|NCT00424021|2395402|P1|STARTED|AMB-220-E Study Period||2
988154|NCT00424021|2395399|P4|NOT COMPLETED|NCT00046319 Study Period||1
988155|NCT00424021|2395400|P3|NOT COMPLETED|NCT00046319 Study Period||1
988156|NCT00424021|2395401|P2|NOT COMPLETED|NCT00046319 Study Period||3
988157|NCT00424021|2395402|P1|NOT COMPLETED|NCT00046319 Study Period||1
988158|NCT00424021|2395399|P4|COMPLETED|NCT00046319 Study Period||12
988159|NCT00424021|2395400|P3|COMPLETED|NCT00046319 Study Period||15
988160|NCT00424021|2395401|P2|COMPLETED|NCT00046319 Study Period||16
988161|NCT00424021|2395402|P1|COMPLETED|NCT00046319 Study Period||15
988162|NCT00424021|2395399|P4|STARTED|NCT00046319 Study Period||13
988163|NCT00424021|2395400|P3|STARTED|NCT00046319 Study Period||16
988164|NCT00424021|2395401|P2|STARTED|NCT00046319 Study Period||19
988165|NCT00424021|2395402|P1|STARTED|NCT00046319 Study Period||16
988188|NCT00424177|2395474|P1|NOT COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||3
988189|NCT00424177|2395474|P1|COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||48
988190|NCT00424177|2395474|P1|STARTED|Cycle 3: Eltrombopag 50 or 75 mg||51
988191|NCT00424177|2395474|P1|NOT COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||4
988192|NCT00424177|2395474|P1|COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||51
988193|NCT00424177|2395474|P1|STARTED|Cycle 2: Eltrombopag 50 or 75 mg||55
988194|NCT00424177|2395474|P1|NOT COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||11
988195|NCT00424177|2395474|P1|COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||55
988196|NCT00424177|2395474|P1|STARTED|Cycle 1: Eltrombopag 50 mg Starting Dose||66
988197|NCT00424190|2395503|P2|NOT COMPLETED|Overall Study||30
988198|NCT00424190|2395504|P1|NOT COMPLETED|Overall Study||22
988199|NCT00424190|2395503|P2|COMPLETED|Overall Study||317
988200|NCT00424190|2395504|P1|COMPLETED|Overall Study||329
988201|NCT00424190|2395503|P2|STARTED|Overall Study||347
988202|NCT00424190|2395504|P1|STARTED|Overall Study||351
988203|NCT00424255|2395512|P2|NOT COMPLETED|Overall Study||346
988204|NCT00424255|2395513|P1|NOT COMPLETED|Overall Study||342
988205|NCT00424255|2395512|P2|COMPLETED|Overall Study||0
988206|NCT00424255|2395513|P1|COMPLETED|Overall Study||0
988207|NCT00424255|2395512|P2|STARTED|Overall Study||346
988208|NCT00424255|2395513|P1|STARTED|Overall Study||342
988209|NCT00424268|2395561|P2|NOT COMPLETED|Overall Study||39
988210|NCT00424268|2395562|P1|NOT COMPLETED|Overall Study||62
988211|NCT00424268|2395561|P2|COMPLETED|Overall Study||333
988212|NCT00424268|2395562|P1|COMPLETED|Overall Study||309
988213|NCT00424268|2395561|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|372
988214|NCT00424268|2395562|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|371
988215|NCT00424294|2395578|P2|NOT COMPLETED|Overall Study||15
988216|NCT00424294|2395579|P1|NOT COMPLETED|Overall Study||8
988217|NCT00424294|2395578|P2|COMPLETED|Overall Study||19
988218|NCT00424294|2395579|P1|COMPLETED|Overall Study||28
988219|NCT00424294|2395578|P2|Treated|Overall Study||34
988220|NCT00424294|2395579|P1|Treated|Overall Study||35
988221|NCT00424294|2395578|P2|STARTED|Overall Study||34
988222|NCT00424294|2395579|P1|STARTED|Overall Study||36
988223|NCT00424346|2395631|P4|NOT COMPLETED|Extension Phase||55
988224|NCT00424346|2395632|P3|NOT COMPLETED|Extension Phase||55
988225|NCT00424346|2395633|P2|NOT COMPLETED|Extension Phase||102
988226|NCT00424346|2395634|P1|NOT COMPLETED|Extension Phase||0
988227|NCT00424346|2395631|P4|COMPLETED|Extension Phase||3
988228|NCT00424346|2395632|P3|COMPLETED|Extension Phase||4
988229|NCT00424346|2395633|P2|COMPLETED|Extension Phase||8
988230|NCT00424346|2395634|P1|COMPLETED|Extension Phase||0
988231|NCT00424346|2395631|P4|STARTED|Extension Phase||58
988232|NCT00424346|2395632|P3|STARTED|Extension Phase||59
988233|NCT00424346|2395633|P2|STARTED|Extension Phase|Includes participants who completed the Core phase in the Canakinumab 600 mg IV + 300 mg q2wk group.|110
988234|NCT00424346|2395634|P1|STARTED|Extension Phase|Participants are represented in the Canakinumab 300 mg q2wk treatment group.|0
988235|NCT00424346|2395631|P4|NOT COMPLETED|Core Study||7
988236|NCT00424346|2395632|P3|NOT COMPLETED|Core Study||4
988237|NCT00424346|2395633|P2|NOT COMPLETED|Core Study||8
988238|NCT00424346|2395634|P1|NOT COMPLETED|Core Study||9
988239|NCT00424346|2395631|P4|COMPLETED|Core Study||63
988240|NCT00424346|2395632|P3|COMPLETED|Core Study||65
988241|NCT00424346|2395633|P2|COMPLETED|Core Study||56
988242|NCT00424346|2395634|P1|COMPLETED|Core Study||62
988243|NCT00424346|2395631|P4|STARTED|Core Study||70
988244|NCT00424346|2395632|P3|STARTED|Core Study||69
988245|NCT00424346|2395633|P2|STARTED|Core Study||64
988246|NCT00424346|2395634|P1|STARTED|Core Study||71
988247|NCT00424372|2395747|P1|NOT COMPLETED|Overall Study||31
988248|NCT00424372|2395747|P1|COMPLETED|Overall Study||95
988249|NCT00424372|2395747|P1|STARTED|Overall Study||126
988250|NCT00424385|2395755|P1|NOT COMPLETED|Cohort 1||1
988251|NCT00424385|2395755|P1|COMPLETED|Cohort 1||4
988252|NCT00424385|2395755|P1|STARTED|Cohort 1||5
988253|NCT00424385|2395755|P1|NOT COMPLETED|Cohort 0||6
988254|NCT00424385|2395755|P1|COMPLETED|Cohort 0||6
988255|NCT00424385|2395755|P1|STARTED|Cohort 0||12
988256|NCT00424398|2395765|P3|NOT COMPLETED|Overall Study||0
988257|NCT00424398|2395766|P2|NOT COMPLETED|Overall Study||1
988258|NCT00424398|2395767|P1|NOT COMPLETED|Overall Study||3
988259|NCT00424398|2395765|P3|COMPLETED|Overall Study||36
988260|NCT00424398|2395766|P2|COMPLETED|Overall Study||35
988261|NCT00424398|2395767|P1|COMPLETED|Overall Study||32
988262|NCT00424398|2395765|P3|STARTED|Overall Study||36
988263|NCT00424398|2395766|P2|STARTED|Overall Study||36
988264|NCT00424398|2395767|P1|STARTED|Overall Study||35
988265|NCT00424476|2395814|P3|NOT COMPLETED|Overall Study||49
988266|NCT00424476|2395815|P2|NOT COMPLETED|Overall Study||48
988267|NCT00424476|2395816|P1|NOT COMPLETED|Overall Study||61
988268|NCT00424476|2395814|P3|COMPLETED|Overall Study||241
988269|NCT00424476|2395815|P2|COMPLETED|Overall Study||240
988270|NCT00424476|2395816|P1|COMPLETED|Overall Study||226
988271|NCT00424476|2395814|P3|STARTED|Overall Study||290
988272|NCT00424476|2395815|P2|STARTED|Overall Study||288
988273|NCT00424476|2395816|P1|STARTED|Overall Study||287
988274|NCT00424502|2395839|P1|NOT COMPLETED|Overall Study||0
988275|NCT00424502|2395839|P1|COMPLETED|Overall Study||20
988276|NCT00424502|2395839|P1|STARTED|Overall Study||20
988277|NCT00424515|2395850|P2|NOT COMPLETED|Overall Study||13
988278|NCT00424515|2395851|P1|NOT COMPLETED|Overall Study||11
988279|NCT00424515|2395850|P2|COMPLETED|Overall Study||0
988280|NCT00424515|2395851|P1|COMPLETED|Overall Study||0
988281|NCT00424515|2395850|P2|STARTED|Overall Study||13
988282|NCT00424515|2395851|P1|STARTED|Overall Study||11
988283|NCT00424528|2395864|P3|NOT COMPLETED|Overall Study||4
988284|NCT00424528|2395865|P2|NOT COMPLETED|Overall Study||4
988285|NCT00424528|2395866|P1|NOT COMPLETED|Overall Study||5
988286|NCT00424528|2395864|P3|COMPLETED|Overall Study||74
988287|NCT00424528|2395865|P2|COMPLETED|Overall Study||76
988288|NCT00424528|2395866|P1|COMPLETED|Overall Study||71
988289|NCT00424528|2395864|P3|STARTED|Overall Study||78
988290|NCT00424528|2395865|P2|STARTED|Overall Study||80
988291|NCT00424528|2395866|P1|STARTED|Overall Study||76
988298|NCT00424593|2395938|P2|NOT COMPLETED|Dose-Blind Extension Period||0
988299|NCT00424593|2395939|P1|NOT COMPLETED|Dose-Blind Extension Period||64
988300|NCT00424593|2395938|P2|COMPLETED|Dose-Blind Extension Period||0
988301|NCT00424593|2395939|P1|COMPLETED|Dose-Blind Extension Period||117
988302|NCT00424593|2395938|P2|STARTED|Dose-Blind Extension Period|98 placebo patients from acute phase entered dose-blind period and received duloxetine.|0
988303|NCT00424593|2395939|P1|STARTED|Dose-Blind Extension Period|83 duloxetine patients from the acute phase entered the dose-blind period.|181
988304|NCT00424593|2395938|P2|NOT COMPLETED|Acute Double-Blind Period||23
988305|NCT00424593|2395939|P1|NOT COMPLETED|Acute Double-Blind Period||31
988306|NCT00424593|2395938|P2|COMPLETED|Acute Double-Blind Period||98
988307|NCT00424593|2395939|P1|COMPLETED|Acute Double-Blind Period||84
988308|NCT00424593|2395938|P2|STARTED|Acute Double-Blind Period||121
988309|NCT00424593|2395939|P1|STARTED|Acute Double-Blind Period||115
988310|NCT00424619|2395986|P3|NOT COMPLETED|3 Month||0
988311|NCT00424619|2395987|P2|NOT COMPLETED|3 Month||0
988312|NCT00424619|2395988|P1|NOT COMPLETED|3 Month||0
988313|NCT00424619|2395986|P3|COMPLETED|3 Month||17
988314|NCT00424619|2395987|P2|COMPLETED|3 Month||18
988315|NCT00424619|2395988|P1|COMPLETED|3 Month||12
988316|NCT00424619|2395986|P3|STARTED|3 Month||17
988317|NCT00424619|2395987|P2|STARTED|3 Month||18
988318|NCT00424619|2395988|P1|STARTED|3 Month||12
988319|NCT00424619|2395986|P3|NOT COMPLETED|4 Week||0
988320|NCT00424619|2395987|P2|NOT COMPLETED|4 Week||0
988321|NCT00424619|2395988|P1|NOT COMPLETED|4 Week||0
988322|NCT00424619|2395986|P3|COMPLETED|4 Week||17
988323|NCT00424619|2395987|P2|COMPLETED|4 Week||17
988324|NCT00424619|2395988|P1|COMPLETED|4 Week||18
988325|NCT00424619|2395986|P3|STARTED|4 Week||17
988326|NCT00424619|2395987|P2|STARTED|4 Week||17
988327|NCT00424619|2395988|P1|STARTED|4 Week||18
988328|NCT00424619|2395986|P3|NOT COMPLETED|Baseline||1
988329|NCT00424619|2395987|P2|NOT COMPLETED|Baseline||0
988330|NCT00424619|2395988|P1|NOT COMPLETED|Baseline||0
988331|NCT00424619|2395986|P3|COMPLETED|Baseline||20
988332|NCT00424619|2395987|P2|COMPLETED|Baseline||22
988333|NCT00424619|2395988|P1|COMPLETED|Baseline||22
988334|NCT00424619|2395986|P3|STARTED|Baseline|n=21 but one participant was lost as a screen failure|21
988335|NCT00424619|2395987|P2|STARTED|Baseline||22
988336|NCT00424619|2395988|P1|STARTED|Baseline||22
988337|NCT00424632|2396022|P10|NOT COMPLETED|Overall Study||6
988338|NCT00424632|2396023|P9|NOT COMPLETED|Overall Study||16
988339|NCT00424632|2396024|P8|NOT COMPLETED|Overall Study||3
988340|NCT00424632|2396025|P7|NOT COMPLETED|Overall Study||7
988341|NCT00424632|2396026|P6|NOT COMPLETED|Overall Study||15
988342|NCT00424632|2396027|P5|NOT COMPLETED|Overall Study||3
988343|NCT00424632|2396028|P4|NOT COMPLETED|Overall Study||4
988344|NCT00424632|2396029|P3|NOT COMPLETED|Overall Study||1
988345|NCT00424632|2396030|P2|NOT COMPLETED|Overall Study||1
988346|NCT00424632|2396031|P1|NOT COMPLETED|Overall Study||1
988347|NCT00424632|2396022|P10|COMPLETED|Overall Study||0
988348|NCT00424632|2396023|P9|COMPLETED|Overall Study||0
988349|NCT00424632|2396024|P8|COMPLETED|Overall Study||0
988350|NCT00424632|2396025|P7|COMPLETED|Overall Study||0
988351|NCT00424632|2396026|P6|COMPLETED|Overall Study||0
988352|NCT00424632|2396027|P5|COMPLETED|Overall Study||0
988353|NCT00424632|2396028|P4|COMPLETED|Overall Study||0
988354|NCT00424632|2396029|P3|COMPLETED|Overall Study||0
988355|NCT00424632|2396030|P2|COMPLETED|Overall Study||0
988356|NCT00424632|2396031|P1|COMPLETED|Overall Study||0
988357|NCT00424632|2396022|P10|STARTED|Overall Study||6
988358|NCT00424632|2396023|P9|STARTED|Overall Study||16
988359|NCT00424632|2396024|P8|STARTED|Overall Study||3
988360|NCT00424632|2396025|P7|STARTED|Overall Study||7
988361|NCT00424632|2396026|P6|STARTED|Overall Study||15
988362|NCT00424632|2396027|P5|STARTED|Overall Study||3
988363|NCT00424632|2396028|P4|STARTED|Overall Study||4
988364|NCT00424632|2396029|P3|STARTED|Overall Study||1
988365|NCT00424632|2396030|P2|STARTED|Overall Study||1
988366|NCT00424632|2396031|P1|STARTED|Overall Study||1
988367|NCT00424645|2396164|P2|NOT COMPLETED|Overall Study||0
988368|NCT00424645|2396165|P1|NOT COMPLETED|Overall Study||1
988369|NCT00424645|2396164|P2|COMPLETED|Overall Study||0
988370|NCT00424645|2396165|P1|COMPLETED|Overall Study||2
988371|NCT00424645|2396164|P2|STARTED|Overall Study||0
988372|NCT00424645|2396165|P1|STARTED|Overall Study||3
988373|NCT00424749|2396171|P1|NOT COMPLETED|Overall Study||1
988374|NCT00424749|2396171|P1|COMPLETED|Overall Study||3
988375|NCT00424749|2396171|P1|STARTED|Overall Study||4
988376|NCT00424762|2396178|P2|NOT COMPLETED|Overall Study||22
988377|NCT00424762|2396179|P1|NOT COMPLETED|Overall Study||20
988378|NCT00424762|2396178|P2|COMPLETED|Overall Study||54
988379|NCT00424762|2396179|P1|COMPLETED|Overall Study||54
988380|NCT00424762|2396178|P2|STARTED|Overall Study||76
988381|NCT00424762|2396179|P1|STARTED|Overall Study||74
988382|NCT00424775|2396189|P2|NOT COMPLETED|Overall Study||0
988383|NCT00424775|2396190|P1|NOT COMPLETED|Overall Study||3
988384|NCT00424775|2396189|P2|COMPLETED|Overall Study||0
988385|NCT00424775|2396190|P1|COMPLETED|Overall Study||0
988386|NCT00424775|2396189|P2|STARTED|Overall Study||0
988387|NCT00424775|2396190|P1|STARTED|Overall Study||3
988388|NCT00424827|2396198|P1|NOT COMPLETED|Overall Study||1
988389|NCT00424827|2396198|P1|COMPLETED|Overall Study||10
988390|NCT00424827|2396198|P1|STARTED|Overall Study||11
988391|NCT00425061|2396213|P7|NOT COMPLETED|Overall Study||19
988392|NCT00425061|2396214|P6|NOT COMPLETED|Overall Study||4
988393|NCT00425061|2396215|P5|NOT COMPLETED|Overall Study||26
988394|NCT00425061|2396216|P4|NOT COMPLETED|Overall Study||2
988395|NCT00425061|2396217|P3|NOT COMPLETED|Overall Study||0
988396|NCT00425061|2396218|P2|NOT COMPLETED|Overall Study||2
988397|NCT00425061|2396219|P1|NOT COMPLETED|Overall Study||2
988398|NCT00425061|2396213|P7|COMPLETED|Overall Study||26
988399|NCT00425061|2396214|P6|COMPLETED|Overall Study||0
988400|NCT00425061|2396215|P5|COMPLETED|Overall Study||19
988401|NCT00425061|2396216|P4|COMPLETED|Overall Study||14
988402|NCT00425061|2396217|P3|COMPLETED|Overall Study||16
988403|NCT00425061|2396218|P2|COMPLETED|Overall Study||15
988404|NCT00425061|2396219|P1|COMPLETED|Overall Study||14
988405|NCT00425061|2396213|P7|STARTED|Overall Study||45
988406|NCT00425061|2396214|P6|STARTED|Overall Study||4
988407|NCT00425061|2396215|P5|STARTED|Overall Study||45
988408|NCT00425061|2396216|P4|STARTED|Overall Study||16
988409|NCT00425061|2396217|P3|STARTED|Overall Study||16
988410|NCT00425061|2396218|P2|STARTED|Overall Study||17
988411|NCT00425061|2396219|P1|STARTED|Overall Study||16
988412|NCT00425100|2396335|P1|NOT COMPLETED|Overall Study||53
988413|NCT00425100|2396335|P1|COMPLETED|Overall Study||463
988414|NCT00425100|2396335|P1|STARTED|Overall Study||516
988415|NCT00425113|2396374|P2|NOT COMPLETED|Overall Study||2
988416|NCT00425113|2396375|P1|NOT COMPLETED|Overall Study||2
988417|NCT00425113|2396374|P2|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|16
988418|NCT00425113|2396375|P1|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|15
988419|NCT00425113|2396374|P2|Exposed to Study Drug|Overall Study||17
988420|NCT00425113|2396375|P1|Exposed to Study Drug|Overall Study||16
988421|NCT00425113|2396374|P2|STARTED|Overall Study||18
988422|NCT00425113|2396375|P1|STARTED|Overall Study||17
988423|NCT00425269|2396385|P2|NOT COMPLETED|Overall Study||20
988424|NCT00425269|2396386|P1|NOT COMPLETED|Overall Study||19
988425|NCT00425269|2396385|P2|COMPLETED|Overall Study||77
988426|NCT00425269|2396386|P1|COMPLETED|Overall Study||82
988427|NCT00425269|2396385|P2|STARTED|Overall Study||97
988428|NCT00425269|2396386|P1|STARTED|Overall Study||101
988429|NCT00425308|2396464|P2|NOT COMPLETED|Overall Study||1
988430|NCT00425308|2396465|P1|NOT COMPLETED|Overall Study||4
988431|NCT00425308|2396464|P2|COMPLETED|Overall Study||14
988432|NCT00425308|2396465|P1|COMPLETED|Overall Study||11
988433|NCT00425308|2396464|P2|STARTED|Overall Study||15
988434|NCT00425308|2396465|P1|STARTED|Overall Study||15
988435|NCT00425373|2396502|P9|NOT COMPLETED|Overall Study||18
988436|NCT00425373|2396503|P8|NOT COMPLETED|Overall Study||10
988437|NCT00425373|2396504|P7|NOT COMPLETED|Overall Study||7
988438|NCT00425373|2396505|P6|NOT COMPLETED|Overall Study||9
988439|NCT00425373|2396506|P5|NOT COMPLETED|Overall Study||10
988440|NCT00425373|2396507|P4|NOT COMPLETED|Overall Study||2
988441|NCT00425373|2396508|P3|NOT COMPLETED|Overall Study||3
988442|NCT00425373|2396509|P2|NOT COMPLETED|Overall Study||3
988443|NCT00425373|2396510|P1|NOT COMPLETED|Overall Study||5
988444|NCT00425373|2396502|P9|COMPLETED|Overall Study||148
988445|NCT00425373|2396503|P8|COMPLETED|Overall Study||151
988446|NCT00425373|2396504|P7|COMPLETED|Overall Study||154
988447|NCT00425373|2396505|P6|COMPLETED|Overall Study||154
988448|NCT00425373|2396506|P5|COMPLETED|Overall Study||159
988449|NCT00425373|2396507|P4|COMPLETED|Overall Study||160
988450|NCT00425373|2396508|P3|COMPLETED|Overall Study||157
988451|NCT00425373|2396509|P2|COMPLETED|Overall Study||164
988452|NCT00425373|2396510|P1|COMPLETED|Overall Study||154
988453|NCT00425373|2396502|P9|STARTED|Overall Study||166
988454|NCT00425373|2396503|P8|STARTED|Overall Study||161
988455|NCT00425373|2396504|P7|STARTED|Overall Study||161
988456|NCT00425373|2396505|P6|STARTED|Overall Study||163
988457|NCT00425373|2396506|P5|STARTED|Overall Study||169
988458|NCT00425373|2396507|P4|STARTED|Overall Study||162
988459|NCT00425373|2396508|P3|STARTED|Overall Study||160
988460|NCT00425373|2396509|P2|STARTED|Overall Study||167
988461|NCT00425373|2396510|P1|STARTED|Overall Study||159
988462|NCT00425386|2396566|P1|NOT COMPLETED|Overall Study||3
988463|NCT00425386|2396566|P1|COMPLETED|Overall Study||43
988464|NCT00425386|2396566|P1|STARTED|Overall Study||46
988465|NCT00425438|2396577|P2|NOT COMPLETED|Overall Study||27
988466|NCT00425438|2396578|P1|NOT COMPLETED|Overall Study||25
988467|NCT00425438|2396577|P2|COMPLETED|Overall Study||0
988468|NCT00425438|2396578|P1|COMPLETED|Overall Study||0
988469|NCT00425438|2396577|P2|STARTED|Overall Study||27
988470|NCT00425438|2396578|P1|STARTED|Overall Study||25
988471|NCT00425503|2396594|P1|NOT COMPLETED|Overall Study||3
988472|NCT00425503|2396594|P1|COMPLETED|Overall Study||37
988473|NCT00425503|2396594|P1|STARTED|Overall Study||40
988474|NCT00425607|2396598|P1|NOT COMPLETED|Overall Study||2
988475|NCT00425607|2396598|P1|COMPLETED|Overall Study||27
988476|NCT00425607|2396598|P1|Received Treatment|Overall Study||28
988477|NCT00425607|2396598|P1|STARTED|Overall Study||29
988478|NCT00425672|2396602|P1|NOT COMPLETED|Overall Study||1
988479|NCT00425672|2396602|P1|COMPLETED|Overall Study||14
988480|NCT00425672|2396602|P1|STARTED|Overall Study||15
988481|NCT00425698|2396613|P2|NOT COMPLETED|Overall Study||2
988482|NCT00425698|2396614|P1|NOT COMPLETED|Overall Study||3
988483|NCT00425698|2396613|P2|COMPLETED|Overall Study||42
988484|NCT00425698|2396614|P1|COMPLETED|Overall Study||41
988485|NCT00425698|2396613|P2|STARTED|Overall Study||44
988486|NCT00425698|2396614|P1|STARTED|Overall Study||44
988487|NCT00425750|2396620|P1|NOT COMPLETED|Overall Study||25
988488|NCT00425750|2396620|P1|COMPLETED|Overall Study||0
988489|NCT00425750|2396620|P1|STARTED|Overall Study||25
988490|NCT00425854|2396628|P2|NOT COMPLETED|Overall Study||21
988491|NCT00425854|2396629|P1|NOT COMPLETED|Overall Study||29
988492|NCT00425854|2396628|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
988493|NCT00425854|2396629|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
988494|NCT00425854|2396628|P2|STARTED|Overall Study|Treated|21
988495|NCT00425854|2396629|P1|STARTED|Overall Study|Treated|29
988496|NCT00425945|2396652|P2|NOT COMPLETED|Overall Study||5
988497|NCT00425945|2396653|P1|NOT COMPLETED|Overall Study||4
988498|NCT00425945|2396652|P2|COMPLETED|Overall Study||61
988499|NCT00425945|2396653|P1|COMPLETED|Overall Study||60
988500|NCT00425945|2396652|P2|STARTED|Overall Study||66
988501|NCT00425945|2396653|P1|STARTED|Overall Study||64
988502|NCT00426127|2396689|P1|NOT COMPLETED|Overall Study||2
988503|NCT00426127|2396689|P1|COMPLETED|Overall Study||0
988504|NCT00426127|2396689|P1|STARTED|Overall Study||2
988505|NCT00426153|2396697|P2|NOT COMPLETED|Overall Study||0
988506|NCT00426153|2396698|P1|NOT COMPLETED|Overall Study||0
988507|NCT00426153|2396697|P2|COMPLETED|Overall Study||14
988508|NCT00426153|2396698|P1|COMPLETED|Overall Study||28
988509|NCT00426153|2396697|P2|STARTED|Overall Study||14
988510|NCT00426153|2396698|P1|STARTED|Overall Study|Participants were randomized in a 2:1 ratio, Octreotide LAR depot: Placebo|28
988511|NCT00426231|2396712|P2|NOT COMPLETED|Overall Study||12
988512|NCT00426231|2396713|P1|NOT COMPLETED|Overall Study||9
988513|NCT00426231|2396712|P2|COMPLETED|Overall Study|For the 6-month endpoint|25
988514|NCT00426231|2396713|P1|COMPLETED|Overall Study|For the 6 month endpoint|27
988515|NCT00426231|2396712|P2|STARTED|Overall Study||37
988516|NCT00426231|2396713|P1|STARTED|Overall Study||36
988517|NCT00426270|2396721|P1|NOT COMPLETED|Overall Study||6
988518|NCT00426270|2396721|P1|COMPLETED|Overall Study||110
988519|NCT00426270|2396721|P1|STARTED|Overall Study||116
988520|NCT00426283|2396731|P2|NOT COMPLETED|Overall Study||1
988521|NCT00426283|2396732|P1|NOT COMPLETED|Overall Study||5
988522|NCT00426283|2396731|P2|COMPLETED|Overall Study||13
988523|NCT00426283|2396732|P1|COMPLETED|Overall Study||23
988524|NCT00426283|2396731|P2|STARTED|Overall Study||14
988525|NCT00426283|2396732|P1|STARTED|Overall Study||28
988526|NCT00426361|2396741|P3|NOT COMPLETED|Overall Study||5
988527|NCT00426361|2396742|P2|NOT COMPLETED|Overall Study||5
988528|NCT00426361|2396743|P1|NOT COMPLETED|Overall Study||4
988529|NCT00426361|2396741|P3|COMPLETED|Overall Study||243
988530|NCT00426361|2396742|P2|COMPLETED|Overall Study||250
988531|NCT00426361|2396743|P1|COMPLETED|Overall Study||244
988532|NCT00426361|2396741|P3|STARTED|Overall Study||248
988533|NCT00426361|2396742|P2|STARTED|Overall Study||255
988534|NCT00426361|2396743|P1|STARTED|Overall Study||248
988535|NCT00417482|2396796|P3|NOT COMPLETED|Phase B 2nd 16 Weeks||3
988536|NCT00417482|2396797|P2|NOT COMPLETED|Phase B 2nd 16 Weeks||13
988537|NCT00417482|2396798|P1|NOT COMPLETED|Phase B 2nd 16 Weeks||3
988538|NCT00417482|2396796|P3|COMPLETED|Phase B 2nd 16 Weeks||10
988539|NCT00417482|2396797|P2|COMPLETED|Phase B 2nd 16 Weeks||14
988540|NCT00417482|2396798|P1|COMPLETED|Phase B 2nd 16 Weeks||10
988541|NCT00417482|2396796|P3|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|13
988542|NCT00417482|2396797|P2|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|27
988543|NCT00417482|2396798|P1|STARTED|Phase B 2nd 16 Weeks|Risperidone for 16 weeks.|13
988544|NCT00417482|2396796|P3|NOT COMPLETED|Phase B 1st 16 Weeks||27
988545|NCT00417482|2396797|P2|NOT COMPLETED|Phase B 1st 16 Weeks||11
988546|NCT00417482|2396798|P1|NOT COMPLETED|Phase B 1st 16 Weeks||19
988547|NCT00417482|2396796|P3|COMPLETED|Phase B 1st 16 Weeks||13
988548|NCT00417482|2396797|P2|COMPLETED|Phase B 1st 16 Weeks||27
988549|NCT00417482|2396798|P1|COMPLETED|Phase B 1st 16 Weeks||13
988550|NCT00417482|2396796|P3|STARTED|Phase B 1st 16 Weeks|Placebo 16 weeks.|40
988551|NCT00417482|2396797|P2|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|38
988552|NCT00417482|2396798|P1|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|32
988553|NCT00417612|2396824|P2|NOT COMPLETED|Overall Study||3
988554|NCT00417612|2396825|P1|NOT COMPLETED|Overall Study||3
988555|NCT00417612|2396824|P2|COMPLETED|Overall Study||8
988556|NCT00417612|2396825|P1|COMPLETED|Overall Study||19
988557|NCT00417612|2396824|P2|STARTED|Overall Study||11
988558|NCT00417612|2396825|P1|STARTED|Overall Study||22
988559|NCT00417885|2396848|P1|NOT COMPLETED|Overall Study||6
988560|NCT00417885|2396848|P1|COMPLETED|Overall Study||0
988561|NCT00417885|2396848|P1|STARTED|Overall Study||6
988562|NCT00417963|2396857|P1|NOT COMPLETED|Overall Study||41
988563|NCT00417963|2396857|P1|COMPLETED|Overall Study|79 subjects completed in the roll-in cohort and 371 in the pivotal cohort.|445
988564|NCT00417963|2396857|P1|STARTED|Overall Study|79 participants were enrolled in the roll-in cohort and 407 in the pivotal cohort.|486
988565|NCT00417976|2396874|P1|NOT COMPLETED|Overall Study||3
988566|NCT00417976|2396874|P1|COMPLETED|Overall Study||39
988567|NCT00417976|2396874|P1|STARTED|Overall Study||42
988568|NCT00417989|2396881|P2|NOT COMPLETED|Overall Study||22
988569|NCT00417989|2396882|P1|NOT COMPLETED|Overall Study||20
988570|NCT00417989|2396881|P2|COMPLETED|Overall Study||219
988571|NCT00417989|2396882|P1|COMPLETED|Overall Study||224
988572|NCT00417989|2396881|P2|STARTED|Overall Study||241
988573|NCT00417989|2396882|P1|STARTED|Overall Study|Intent to Treat include safety population & subjects with baseline & 1 post baseline A1C measurement|244
988574|NCT00418015|2396906|P4|NOT COMPLETED|Overall Study||0
988575|NCT00418015|2396907|P3|NOT COMPLETED|Overall Study||0
988576|NCT00418015|2396908|P2|NOT COMPLETED|Overall Study||0
988577|NCT00418015|2396909|P1|NOT COMPLETED|Overall Study||0
988578|NCT00418015|2396906|P4|COMPLETED|Overall Study||25
988579|NCT00418015|2396907|P3|COMPLETED|Overall Study||78
988580|NCT00418015|2396908|P2|COMPLETED|Overall Study||46
988581|NCT00418015|2396909|P1|COMPLETED|Overall Study||144
988582|NCT00418015|2396906|P4|STARTED|Overall Study||25
988583|NCT00418015|2396907|P3|STARTED|Overall Study||78
988584|NCT00418015|2396908|P2|STARTED|Overall Study||46
988585|NCT00418015|2396909|P1|STARTED|Overall Study||144
988586|NCT00418093|2396935|P1|NOT COMPLETED|Overall Study||0
988587|NCT00418093|2396935|P1|COMPLETED|Overall Study||19
988588|NCT00418093|2396935|P1|Completed Study|Overall Study||19
988589|NCT00418093|2396935|P1|STARTED|Overall Study||19
988590|NCT00418145|2396942|P1|NOT COMPLETED|Overall Study||6
988591|NCT00418145|2396942|P1|COMPLETED|Overall Study||10
988592|NCT00418145|2396942|P1|STARTED|Overall Study||16
988593|NCT00418184|2396956|P2|NOT COMPLETED|Open-label Phase||5
988594|NCT00418184|2396957|P1|NOT COMPLETED|Open-label Phase||5
988595|NCT00418184|2396956|P2|COMPLETED|Open-label Phase|5 dropped out|43
988596|NCT00418184|2396957|P1|COMPLETED|Open-label Phase|5 dropped out|97
988597|NCT00418184|2396956|P2|STARTED|Open-label Phase|1 was not included due to low compliance in the double blind phase, 3 didn't want to participate.|48
988598|NCT00418184|2396957|P1|STARTED|Open-label Phase|3 were not included due to low compliance in the double blind phase, 5 didn't want to participate.|102
988599|NCT00418184|2396956|P2|NOT COMPLETED|Double-blind Phase||11
988600|NCT00418184|2396957|P1|NOT COMPLETED|Double-blind Phase||27
988601|NCT00418184|2396956|P2|COMPLETED|Double-blind Phase||52
988602|NCT00418184|2396957|P1|COMPLETED|Double-blind Phase||110
988603|NCT00418184|2396956|P2|STARTED|Double-blind Phase||63
988604|NCT00418184|2396957|P1|STARTED|Double-blind Phase||137
988605|NCT00418262|2396965|P1|NOT COMPLETED|Visits 8 Thru 10||5
988606|NCT00418262|2396965|P1|COMPLETED|Visits 8 Thru 10||11
988607|NCT00418262|2396965|P1|STARTED|Visits 8 Thru 10||16
988608|NCT00418262|2396965|P1|NOT COMPLETED|Visits 5 Thru 8||9
988609|NCT00418262|2396965|P1|COMPLETED|Visits 5 Thru 8||16
988610|NCT00418262|2396965|P1|STARTED|Visits 5 Thru 8||25
988611|NCT00418262|2396965|P1|NOT COMPLETED|Visits 1 (Baseline) Thru 5||2
988612|NCT00418262|2396965|P1|COMPLETED|Visits 1 (Baseline) Thru 5||25
988613|NCT00418262|2396965|P1|STARTED|Visits 1 (Baseline) Thru 5||27
988614|NCT00418314|2396985|P2|NOT COMPLETED|Overall Study||2
988615|NCT00418314|2396986|P1|NOT COMPLETED|Overall Study||1
988616|NCT00418314|2396985|P2|COMPLETED|Overall Study||828
988617|NCT00418314|2396986|P1|COMPLETED|Overall Study||816
988618|NCT00418314|2396985|P2|STARTED|Overall Study||830
988619|NCT00418314|2396986|P1|STARTED|Overall Study||817
988620|NCT00418379|2396999|P3|NOT COMPLETED|Year 5||3
988621|NCT00418379|2397000|P2|NOT COMPLETED|Year 5||5
988622|NCT00418379|2397001|P1|NOT COMPLETED|Year 5||2
988623|NCT00418379|2396999|P3|COMPLETED|Year 5||131
988624|NCT00418379|2397000|P2|COMPLETED|Year 5||115
988625|NCT00418379|2397001|P1|COMPLETED|Year 5||126
988626|NCT00418379|2396999|P3|STARTED|Year 5|20 patients withdrew between Year 4 and Year 5 study periods.|134
988627|NCT00418379|2397000|P2|STARTED|Year 5|16 patients withdrew between Year 4 and Year 5 study periods.|120
988628|NCT00418379|2397001|P1|STARTED|Year 5|14 patients withdrew between Year 4 and Year 5 study periods.|128
988629|NCT00418379|2396999|P3|NOT COMPLETED|Year 4||2
988630|NCT00418379|2397000|P2|NOT COMPLETED|Year 4||5
988631|NCT00418379|2397001|P1|NOT COMPLETED|Year 4||3
988632|NCT00418379|2396999|P3|COMPLETED|Year 4||154
988633|NCT00418379|2397000|P2|COMPLETED|Year 4||136
988634|NCT00418379|2397001|P1|COMPLETED|Year 4||142
988635|NCT00418379|2396999|P3|STARTED|Year 4|7 patients withdrew between Year 3 and Year 4 study periods.|156
988636|NCT00418379|2397000|P2|STARTED|Year 4|5 patients withdrew between Year 3 and Year 4 study periods.|141
988637|NCT00418379|2397001|P1|STARTED|Year 4|3 patients withdrew between Year 3 and Year 4 study periods.|145
988638|NCT00418379|2396999|P3|NOT COMPLETED|Year 3||3
988639|NCT00418379|2397000|P2|NOT COMPLETED|Year 3||2
988640|NCT00418379|2397001|P1|NOT COMPLETED|Year 3||3
988641|NCT00418379|2396999|P3|COMPLETED|Year 3||163
988642|NCT00418379|2397000|P2|COMPLETED|Year 3||146
988643|NCT00418379|2397001|P1|COMPLETED|Year 3||148
988644|NCT00418379|2396999|P3|STARTED|Year 3|6 patients withdrew between Year 2 and Year 3 treatment periods.|166
988645|NCT00418379|2397000|P2|STARTED|Year 3|7 patients withdrew between Year 2 and Year 3 treatment periods.|148
988646|NCT00418379|2397001|P1|STARTED|Year 3|8 patients withdrew between Year 2 and Year 3 treatment periods.|151
988647|NCT00418379|2396999|P3|NOT COMPLETED|Year 2||10
988648|NCT00418379|2397000|P2|NOT COMPLETED|Year 2||4
988649|NCT00418379|2397001|P1|NOT COMPLETED|Year 2||8
988650|NCT00418379|2396999|P3|COMPLETED|Year 2||172
988651|NCT00418379|2397000|P2|COMPLETED|Year 2||155
988652|NCT00418379|2397001|P1|COMPLETED|Year 2||159
988653|NCT00418379|2396999|P3|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|182
988654|NCT00418379|2397000|P2|STARTED|Year 2|20 patients withdrew between Year 1 and Year 2 treatment periods.|159
988655|NCT00418379|2397001|P1|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|167
988656|NCT00418379|2396999|P3|NOT COMPLETED|Year 1||15
988657|NCT00418379|2397000|P2|NOT COMPLETED|Year 1||28
988658|NCT00418379|2397001|P1|NOT COMPLETED|Year 1||18
988659|NCT00418379|2396999|P3|COMPLETED|Year 1||204
988660|NCT00418379|2397000|P2|COMPLETED|Year 1||179
988661|NCT00418379|2397001|P1|COMPLETED|Year 1||189
988662|NCT00418379|2396999|P3|STARTED|Year 1||219
988663|NCT00418379|2397000|P2|STARTED|Year 1||207
988664|NCT00418379|2397001|P1|STARTED|Year 1||207
988665|NCT00418522|2397011|P2|NOT COMPLETED|Overall Study||42
988666|NCT00418522|2397012|P1|NOT COMPLETED|Overall Study||83
988667|NCT00418522|2397011|P2|COMPLETED|Overall Study||152
988668|NCT00418522|2397012|P1|COMPLETED|Overall Study||136
988669|NCT00418522|2397011|P2|Received Treatment|Overall Study||190
988670|NCT00418522|2397012|P1|Received Treatment|Overall Study||212
988671|NCT00418522|2397011|P2|STARTED|Overall Study||194
988672|NCT00418522|2397012|P1|STARTED|Overall Study||219
988673|NCT00418561|2397059|P3|NOT COMPLETED|Overall Study||0
988674|NCT00418561|2397060|P2|NOT COMPLETED|Overall Study||1
988675|NCT00418561|2397061|P1|NOT COMPLETED|Overall Study||0
988676|NCT00418561|2397059|P3|COMPLETED|Overall Study||4
988677|NCT00418561|2397060|P2|COMPLETED|Overall Study||4
988678|NCT00418561|2397061|P1|COMPLETED|Overall Study||4
988679|NCT00418561|2397059|P3|STARTED|Overall Study||4
988680|NCT00418561|2397060|P2|STARTED|Overall Study||5
988681|NCT00418561|2397061|P1|STARTED|Overall Study||4
988682|NCT00418574|2397131|P2|NOT COMPLETED|Overall Study||23
988683|NCT00418574|2397132|P1|NOT COMPLETED|Overall Study||48
988684|NCT00418574|2397131|P2|COMPLETED|Overall Study||272
988685|NCT00418574|2397132|P1|COMPLETED|Overall Study||545
988686|NCT00418574|2397131|P2|TREATED|Overall Study||294
988687|NCT00418574|2397132|P1|TREATED|Overall Study||592
988688|NCT00418574|2397131|P2|STARTED|Overall Study||295
988689|NCT00418574|2397132|P1|STARTED|Overall Study||593
988690|NCT00418665|2397146|P3|NOT COMPLETED|Treatment Extension||2
988691|NCT00418665|2397147|P2|NOT COMPLETED|Treatment Extension||4
988692|NCT00418665|2397148|P1|NOT COMPLETED|Treatment Extension||6
988693|NCT00418665|2397146|P3|COMPLETED|Treatment Extension||7
988694|NCT00418665|2397147|P2|COMPLETED|Treatment Extension||4
988695|NCT00418665|2397148|P1|COMPLETED|Treatment Extension||1
988696|NCT00418665|2397146|P3|STARTED|Treatment Extension||9
988697|NCT00418665|2397147|P2|STARTED|Treatment Extension||8
988698|NCT00418665|2397148|P1|STARTED|Treatment Extension||7
988699|NCT00418665|2397146|P3|NOT COMPLETED|Treatment Period||4
988700|NCT00418665|2397147|P2|NOT COMPLETED|Treatment Period||6
988701|NCT00418665|2397148|P1|NOT COMPLETED|Treatment Period||5
988702|NCT00418665|2397146|P3|COMPLETED|Treatment Period||9
988703|NCT00418665|2397147|P2|COMPLETED|Treatment Period||8
988704|NCT00418665|2397148|P1|COMPLETED|Treatment Period||7
988705|NCT00418665|2397146|P3|Received Study Medication|Treatment Period||13
988706|NCT00418665|2397147|P2|Received Study Medication|Treatment Period||13
988707|NCT00418665|2397148|P1|Received Study Medication|Treatment Period||11
988708|NCT00418665|2397146|P3|STARTED|Treatment Period||13
988709|NCT00418665|2397147|P2|STARTED|Treatment Period||14
988710|NCT00418665|2397148|P1|STARTED|Treatment Period||12
988711|NCT00418691|2397168|P3|NOT COMPLETED|Overall Study||5
988712|NCT00418691|2397169|P2|NOT COMPLETED|Overall Study||2
988713|NCT00418691|2397170|P1|NOT COMPLETED|Overall Study||2
988714|NCT00418691|2397168|P3|COMPLETED|Overall Study||5
988715|NCT00418691|2397169|P2|COMPLETED|Overall Study||10
988716|NCT00418691|2397170|P1|COMPLETED|Overall Study||9
988717|NCT00418691|2397168|P3|STARTED|Overall Study||10
988718|NCT00418691|2397169|P2|STARTED|Overall Study||12
988719|NCT00418691|2397170|P1|STARTED|Overall Study||11
988720|NCT00418717|2397178|P1|NOT COMPLETED|Treatment Period B - Weeks 5-12||2
988721|NCT00418717|2397178|P1|COMPLETED|Treatment Period B - Weeks 5-12||39
988722|NCT00418717|2397178|P1|STARTED|Treatment Period B - Weeks 5-12||41
988723|NCT00418717|2397178|P1|NOT COMPLETED|Treatment Period A - Weeks 1-4||1
988724|NCT00418717|2397178|P1|COMPLETED|Treatment Period A - Weeks 1-4||41
988725|NCT00418717|2397178|P1|STARTED|Treatment Period A - Weeks 1-4||42
988726|NCT00418834|2397185|P2|NOT COMPLETED|Overall Study||20
988727|NCT00418834|2397186|P1|NOT COMPLETED|Overall Study||23
988728|NCT00418834|2397185|P2|COMPLETED|Overall Study||507
988729|NCT00418834|2397186|P1|COMPLETED|Overall Study||503
988730|NCT00418834|2397185|P2|STARTED|Overall Study||527
988731|NCT00418834|2397186|P1|STARTED|Overall Study||526
988732|NCT00418886|2397248|P2|NOT COMPLETED|Overall Study||255
988733|NCT00418886|2397249|P1|NOT COMPLETED|Overall Study||226
988734|NCT00418886|2397248|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|23
988735|NCT00418886|2397249|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|30
988736|NCT00418886|2397248|P2|STARTED|Overall Study|randomised patients|278
988737|NCT00418886|2397249|P1|STARTED|Overall Study|randomised patients|256
988738|NCT00418938|2397275|P2|NOT COMPLETED|Overall Study||23
988739|NCT00418938|2397276|P1|NOT COMPLETED|Overall Study||24
988740|NCT00418938|2397275|P2|COMPLETED|Overall Study||108
988741|NCT00418938|2397276|P1|COMPLETED|Overall Study||109
988742|NCT00418938|2397275|P2|STARTED|Overall Study||131
988743|NCT00418938|2397276|P1|STARTED|Overall Study||133
988744|NCT00418951|2397297|P3|NOT COMPLETED|Overall Study||0
988745|NCT00418951|2397298|P2|NOT COMPLETED|Overall Study||0
988746|NCT00418951|2397299|P1|NOT COMPLETED|Overall Study||0
988747|NCT00418951|2397297|P3|COMPLETED|Overall Study||40
988748|NCT00418951|2397298|P2|COMPLETED|Overall Study||33
988749|NCT00418951|2397299|P1|COMPLETED|Overall Study||39
988750|NCT00418951|2397297|P3|STARTED|Overall Study||40
988751|NCT00418951|2397298|P2|STARTED|Overall Study||33
988752|NCT00418951|2397299|P1|STARTED|Overall Study||39
988753|NCT00418964|2397310|P3|NOT COMPLETED|Overall Study||6
988754|NCT00418964|2397311|P2|NOT COMPLETED|Overall Study||3
988755|NCT00418964|2397312|P1|NOT COMPLETED|Overall Study||1
988756|NCT00418964|2397310|P3|COMPLETED|Overall Study||14
988757|NCT00418964|2397311|P2|COMPLETED|Overall Study||17
988758|NCT00418964|2397312|P1|COMPLETED|Overall Study||21
988759|NCT00418964|2397310|P3|STARTED|Overall Study||20
988760|NCT00418964|2397311|P2|STARTED|Overall Study||20
988761|NCT00418964|2397312|P1|STARTED|Overall Study||22
988762|NCT00418977|2397322|P2|NOT COMPLETED|Overall Study||3
988763|NCT00418977|2397323|P1|NOT COMPLETED|Overall Study||3
988764|NCT00418977|2397322|P2|COMPLETED|Overall Study||13
988765|NCT00418977|2397323|P1|COMPLETED|Overall Study||40
988766|NCT00418977|2397322|P2|STARTED|Overall Study||16
988767|NCT00418977|2397323|P1|STARTED|Overall Study||43
988768|NCT00419003|2397339|P2|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||0
988769|NCT00419003|2397340|P1|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||1
988770|NCT00419003|2397339|P2|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||8
988771|NCT00419003|2397340|P1|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||5
988772|NCT00419003|2397339|P2|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn’t split up evenly (same way as phase I) in the riluzole/placebo phase.|8
988773|NCT00419003|2397340|P1|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn’t split up evenly (same way as phase I) in the riluzole/placebo phase.|6
988774|NCT00419003|2397339|P2|NOT COMPLETED|Phase I, Ketamine Infusion||6
988775|NCT00419003|2397340|P1|NOT COMPLETED|Phase I, Ketamine Infusion||6
988776|NCT00419003|2397339|P2|COMPLETED|Phase I, Ketamine Infusion||7
988777|NCT00419003|2397340|P1|COMPLETED|Phase I, Ketamine Infusion||7
988778|NCT00419003|2397339|P2|STARTED|Phase I, Ketamine Infusion||13
988779|NCT00419003|2397340|P1|STARTED|Phase I, Ketamine Infusion||13
988780|NCT00419094|2397351|P2|NOT COMPLETED|Overall Study||30
988781|NCT00419094|2397352|P1|NOT COMPLETED|Overall Study||7
988782|NCT00419094|2397351|P2|COMPLETED|Overall Study||141
988783|NCT00419094|2397352|P1|COMPLETED|Overall Study||50
988784|NCT00419094|2397351|P2|STARTED|Overall Study||171
988785|NCT00419094|2397352|P1|STARTED|Overall Study|Number started refers to number randomized; 303 subjects were screened/enrolled and 228 randomized.|57
988786|NCT00419120|2397364|P1|NOT COMPLETED|Long Term Follow up Period||10
988787|NCT00419120|2397364|P1|COMPLETED|Long Term Follow up Period||0
988788|NCT00419120|2397364|P1|STARTED|Long Term Follow up Period|10 patients are being followed in long term follow up.|10
988789|NCT00419120|2397364|P1|NOT COMPLETED|Primary Study Period||0
988790|NCT00419120|2397364|P1|COMPLETED|Primary Study Period||10
988791|NCT00419120|2397364|P1|STARTED|Primary Study Period||10
988792|NCT00419159|2397371|P2|NOT COMPLETED|Overall Study||100
988793|NCT00419159|2397372|P1|NOT COMPLETED|Overall Study||99
988794|NCT00419159|2397371|P2|COMPLETED|Overall Study||0
988795|NCT00419159|2397372|P1|COMPLETED|Overall Study||0
988796|NCT00419159|2397371|P2|STARTED|Overall Study||100
988797|NCT00419159|2397372|P1|STARTED|Overall Study|Full Analysis Set|99
988798|NCT00419263|2397389|P3|NOT COMPLETED|Overall Study||3
988799|NCT00419263|2397390|P2|NOT COMPLETED|Overall Study||2
988800|NCT00419263|2397391|P1|NOT COMPLETED|Overall Study||3
988801|NCT00419263|2397389|P3|COMPLETED|Overall Study||112
988802|NCT00419263|2397390|P2|COMPLETED|Overall Study||112
988803|NCT00419263|2397391|P1|COMPLETED|Overall Study||112
988804|NCT00419263|2397389|P3|STARTED|Overall Study||115
988805|NCT00419263|2397390|P2|STARTED|Overall Study||114
988806|NCT00419263|2397391|P1|STARTED|Overall Study||115
988807|NCT00419315|2397420|P2|NOT COMPLETED|Overall Study||0
988808|NCT00419315|2397421|P1|NOT COMPLETED|Overall Study||0
988809|NCT00419315|2397420|P2|COMPLETED|Overall Study||78
988810|NCT00419315|2397421|P1|COMPLETED|Overall Study||85
988811|NCT00419315|2397420|P2|STARTED|Overall Study||78
988812|NCT00419315|2397421|P1|STARTED|Overall Study||85
988813|NCT00419341|2397429|P1|NOT COMPLETED|Efficacy Period||10
988814|NCT00419341|2397429|P1|COMPLETED|Efficacy Period||28
988815|NCT00419341|2397429|P1|STARTED|Efficacy Period||38
988816|NCT00419341|2397429|P1|NOT COMPLETED|Wash in/Wash Out Period||11
988817|NCT00419341|2397429|P1|COMPLETED|Wash in/Wash Out Period||38
988818|NCT00419341|2397429|P1|STARTED|Wash in/Wash Out Period||49
988819|NCT00419380|2397452|P2|NOT COMPLETED|Overall Study||10
988820|NCT00419380|2397453|P1|NOT COMPLETED|Overall Study||1
988821|NCT00419380|2397452|P2|COMPLETED|Overall Study||12
988822|NCT00419380|2397453|P1|COMPLETED|Overall Study||18
988823|NCT00419380|2397452|P2|STARTED|Overall Study||22
988824|NCT00419380|2397453|P1|STARTED|Overall Study||19
988825|NCT00419393|2397461|P1|NOT COMPLETED|Overall Study||24
988826|NCT00419393|2397461|P1|COMPLETED|Overall Study||166
988827|NCT00419393|2397461|P1|STARTED|Overall Study|One subject did not receive medication|190
988828|NCT00419445|2397472|P3|NOT COMPLETED|Overall Study||1
988829|NCT00419445|2397473|P2|NOT COMPLETED|Overall Study||2
988830|NCT00419445|2397474|P1|NOT COMPLETED|Overall Study||1
988831|NCT00419445|2397472|P3|COMPLETED|Overall Study||7
988832|NCT00419445|2397473|P2|COMPLETED|Overall Study||14
988833|NCT00419445|2397474|P1|COMPLETED|Overall Study||7
988834|NCT00419445|2397472|P3|STARTED|Overall Study||8
988835|NCT00419445|2397473|P2|STARTED|Overall Study||16
988836|NCT00419445|2397474|P1|STARTED|Overall Study||8
988837|NCT00419744|2397485|P3|NOT COMPLETED|Overall Study||133
988838|NCT00419744|2397486|P2|NOT COMPLETED|Overall Study||118
988839|NCT00419744|2397487|P1|NOT COMPLETED|Overall Study||117
988840|NCT00419744|2397485|P3|COMPLETED|Overall Study||271
988841|NCT00419744|2397486|P2|COMPLETED|Overall Study||290
988842|NCT00419744|2397487|P1|COMPLETED|Overall Study||290
988843|NCT00419744|2397485|P3|STARTED|Overall Study||404
988844|NCT00419744|2397486|P2|STARTED|Overall Study||408
988845|NCT00419744|2397487|P1|STARTED|Overall Study||407
988846|NCT00419757|2397518|P2|NOT COMPLETED|Overall Study||21
988847|NCT00419757|2397519|P1|NOT COMPLETED|Overall Study||18
988848|NCT00419757|2397518|P2|COMPLETED|Overall Study|Randomized patients|102
988849|NCT00419757|2397519|P1|COMPLETED|Overall Study|Randomized patients|109
988850|NCT00419757|2397518|P2|STARTED|Overall Study|Randomized patients|123
988851|NCT00419757|2397519|P1|STARTED|Overall Study|Randomized patients|127
988852|NCT00419770|2397557|P2|NOT COMPLETED|Overall Study||1
988853|NCT00419770|2397558|P1|NOT COMPLETED|Overall Study||5
988854|NCT00419770|2397557|P2|COMPLETED|Overall Study||8
988855|NCT00419770|2397558|P1|COMPLETED|Overall Study||6
988856|NCT00419770|2397557|P2|STARTED|Overall Study||9
988857|NCT00419770|2397558|P1|STARTED|Overall Study||11
988858|NCT00426556|2397568|P4|NOT COMPLETED|Phase II - Extension Phase||23
988859|NCT00426556|2397569|P3|NOT COMPLETED|Phase II - Extension Phase||0
988860|NCT00426556|2397570|P2|NOT COMPLETED|Phase II - Extension Phase||0
988861|NCT00426556|2397571|P1|NOT COMPLETED|Phase II - Extension Phase||0
988862|NCT00426556|2397568|P4|COMPLETED|Phase II - Extension Phase|Completed means 'Ongoing'|1
988863|NCT00426556|2397569|P3|COMPLETED|Phase II - Extension Phase||0
988864|NCT00426556|2397570|P2|COMPLETED|Phase II - Extension Phase||0
988865|NCT00426556|2397571|P1|COMPLETED|Phase II - Extension Phase||0
988866|NCT00426556|2397568|P4|STARTED|Phase II - Extension Phase|4 patients did not enter the Extension phase.|24
988867|NCT00426556|2397569|P3|STARTED|Phase II - Extension Phase||0
988868|NCT00426556|2397570|P2|STARTED|Phase II - Extension Phase||0
988869|NCT00426556|2397571|P1|STARTED|Phase II - Extension Phase||0
988870|NCT00426556|2397568|P4|NOT COMPLETED|Phase II - Core Phase||27
988871|NCT00426556|2397569|P3|NOT COMPLETED|Phase II - Core Phase||0
988872|NCT00426556|2397570|P2|NOT COMPLETED|Phase II - Core Phase||0
988873|NCT00426556|2397571|P1|NOT COMPLETED|Phase II - Core Phase||0
988874|NCT00426556|2397568|P4|COMPLETED|Phase II - Core Phase||28
988875|NCT00426556|2397569|P3|COMPLETED|Phase II - Core Phase||0
988876|NCT00426556|2397570|P2|COMPLETED|Phase II - Core Phase||0
988877|NCT00426556|2397571|P1|COMPLETED|Phase II - Core Phase||0
988878|NCT00426556|2397568|P4|STARTED|Phase II - Core Phase||55
988879|NCT00426556|2397569|P3|STARTED|Phase II - Core Phase||0
988880|NCT00426556|2397570|P2|STARTED|Phase II - Core Phase||0
988881|NCT00426556|2397571|P1|STARTED|Phase II - Core Phase||0
988882|NCT00426556|2397568|P4|NOT COMPLETED|Phase I - Extension Phase||0
988883|NCT00426556|2397569|P3|NOT COMPLETED|Phase I - Extension Phase||7
988884|NCT00426556|2397570|P2|NOT COMPLETED|Phase I - Extension Phase||6
988885|NCT00426556|2397571|P1|NOT COMPLETED|Phase I - Extension Phase||5
988886|NCT00426556|2397568|P4|COMPLETED|Phase I - Extension Phase||0
988887|NCT00426556|2397569|P3|COMPLETED|Phase I - Extension Phase||0
988888|NCT00426556|2397570|P2|COMPLETED|Phase I - Extension Phase||1
988889|NCT00426556|2397571|P1|COMPLETED|Phase I - Extension Phase||0
988890|NCT00426556|2397568|P4|STARTED|Phase I - Extension Phase||0
988891|NCT00426556|2397569|P3|STARTED|Phase I - Extension Phase||7
988892|NCT00426556|2397570|P2|STARTED|Phase I - Extension Phase||7
988893|NCT00426556|2397571|P1|STARTED|Phase I - Extension Phase||5
988894|NCT00426556|2397568|P4|NOT COMPLETED|Phase I - Core Phase||0
988895|NCT00426556|2397569|P3|NOT COMPLETED|Phase I - Core Phase||3
988896|NCT00426556|2397570|P2|NOT COMPLETED|Phase I - Core Phase||10
988897|NCT00426556|2397571|P1|NOT COMPLETED|Phase I - Core Phase||1
988898|NCT00426556|2397568|P4|COMPLETED|Phase I - Core Phase||0
988899|NCT00426556|2397569|P3|COMPLETED|Phase I - Core Phase||7
988900|NCT00426556|2397570|P2|COMPLETED|Phase I - Core Phase||7
988901|NCT00426556|2397571|P1|COMPLETED|Phase I - Core Phase||5
988902|NCT00426556|2397568|P4|STARTED|Phase I - Core Phase||0
988903|NCT00426556|2397569|P3|STARTED|Phase I - Core Phase||10
988904|NCT00426556|2397570|P2|STARTED|Phase I - Core Phase||17
988905|NCT00426556|2397571|P1|STARTED|Phase I - Core Phase||6
988906|NCT00426660|2397593|P1|NOT COMPLETED|Overall Study||131
988907|NCT00426660|2397593|P1|COMPLETED|Overall Study||916
988908|NCT00426660|2397593|P1|Safety Analysis Set|Overall Study||1032
988909|NCT00426660|2397593|P1|Treated|Overall Study||1032
988910|NCT00426660|2397593|P1|STARTED|Overall Study||1047
988911|NCT00426751|2397622|P2|NOT COMPLETED|Overall Study||20
988912|NCT00426751|2397623|P1|NOT COMPLETED|Overall Study||22
988913|NCT00426751|2397622|P2|COMPLETED|Overall Study||183
988914|NCT00426751|2397623|P1|COMPLETED|Overall Study||204
988915|NCT00426751|2397622|P2|STARTED|Overall Study||203
988916|NCT00426751|2397623|P1|STARTED|Overall Study||226
988917|NCT00427336|2397667|P1|NOT COMPLETED|Overall Study||0
988918|NCT00427336|2397667|P1|COMPLETED|Overall Study||9
988919|NCT00427336|2397667|P1|STARTED|Overall Study||9
988920|NCT00427349|2397671|P1|NOT COMPLETED|Overall Study||46
988921|NCT00427349|2397671|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity|0
988922|NCT00427349|2397671|P1|Eligible and Treated|Overall Study||44
988923|NCT00427349|2397671|P1|Treated|Overall Study||45
988924|NCT00427349|2397671|P1|Eligible|Overall Study||45
988925|NCT00427349|2397671|P1|STARTED|Overall Study||46
988926|NCT00427557|2397677|P1|NOT COMPLETED|Overall Study||0
988927|NCT00427557|2397677|P1|COMPLETED|Overall Study||30
988928|NCT00427557|2397677|P1|STARTED|Overall Study||30
988929|NCT00427635|2397683|P2|NOT COMPLETED|Study Completion to Safety Follow-up||1
988930|NCT00427635|2397684|P1|NOT COMPLETED|Study Completion to Safety Follow-up||0
988931|NCT00427635|2397683|P2|COMPLETED|Study Completion to Safety Follow-up|One participant lost to follow-up|25
988932|NCT00427635|2397684|P1|COMPLETED|Study Completion to Safety Follow-up||25
988933|NCT00427635|2397683|P2|STARTED|Study Completion to Safety Follow-up||26
988934|NCT00427635|2397684|P1|STARTED|Study Completion to Safety Follow-up||25
988935|NCT00427635|2397683|P2|NOT COMPLETED|Treatment Phase||0
988936|NCT00427635|2397684|P1|NOT COMPLETED|Treatment Phase||1
988937|NCT00427635|2397683|P2|COMPLETED|Treatment Phase|ITT population|26
988938|NCT00427635|2397684|P1|COMPLETED|Treatment Phase|ITT population. One voluntary discontinuation by parent/guardian|25
988939|NCT00427635|2397683|P2|STARTED|Treatment Phase|Randomised|26
988940|NCT00427635|2397684|P1|STARTED|Treatment Phase|Randomised|26
988941|NCT00427661|2397712|P1|NOT COMPLETED|Overall Study||0
988942|NCT00427661|2397712|P1|COMPLETED|Overall Study||8
988943|NCT00427661|2397712|P1|STARTED|Overall Study||8
988944|NCT00427700|2397720|P2|NOT COMPLETED|Overall Study||11
988945|NCT00427700|2397721|P1|NOT COMPLETED|Overall Study||3
988946|NCT00427700|2397720|P2|COMPLETED|Overall Study||31
988947|NCT00427700|2397721|P1|COMPLETED|Overall Study||37
988948|NCT00427700|2397720|P2|STARTED|Overall Study||42
988949|NCT00427700|2397721|P1|STARTED|Overall Study||40
988950|NCT00427765|2397729|P1|NOT COMPLETED|Overall Study||0
988951|NCT00427765|2397729|P1|COMPLETED|Overall Study||164
988952|NCT00427765|2397729|P1|STARTED|Overall Study||164
988953|NCT00427778|2397733|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
988954|NCT00427778|2397734|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
988955|NCT00427778|2397733|P2|COMPLETED|Second Intervention (4 Weeks)||14
988956|NCT00427778|2397734|P1|COMPLETED|Second Intervention (4 Weeks)||10
988957|NCT00427778|2397733|P2|STARTED|Second Intervention (4 Weeks)||14
988958|NCT00427778|2397734|P1|STARTED|Second Intervention (4 Weeks)||10
988959|NCT00427778|2397733|P2|NOT COMPLETED|Wash Out (2 Weeks)||0
988960|NCT00427778|2397734|P1|NOT COMPLETED|Wash Out (2 Weeks)||0
988961|NCT00427778|2397733|P2|COMPLETED|Wash Out (2 Weeks)||14
988962|NCT00427778|2397734|P1|COMPLETED|Wash Out (2 Weeks)||10
988963|NCT00427778|2397733|P2|STARTED|Wash Out (2 Weeks)||14
988964|NCT00427778|2397734|P1|STARTED|Wash Out (2 Weeks)||10
988965|NCT00427778|2397733|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
988966|NCT00427778|2397734|P1|NOT COMPLETED|First Intervention (4 Weeks)||4
988967|NCT00427778|2397733|P2|COMPLETED|First Intervention (4 Weeks)||14
988968|NCT00427778|2397734|P1|COMPLETED|First Intervention (4 Weeks)||10
988969|NCT00427778|2397733|P2|STARTED|First Intervention (4 Weeks)||15
988970|NCT00427778|2397734|P1|STARTED|First Intervention (4 Weeks)||14
988971|NCT00427791|2397755|P2|NOT COMPLETED|Overall Study||0
988972|NCT00427791|2397756|P1|NOT COMPLETED|Overall Study||0
988973|NCT00427791|2397755|P2|COMPLETED|Overall Study||13
988974|NCT00427791|2397756|P1|COMPLETED|Overall Study||10
988975|NCT00427791|2397755|P2|STARTED|Overall Study||13
988976|NCT00427791|2397756|P1|STARTED|Overall Study||10
988977|NCT00427804|2397766|P2|NOT COMPLETED|Overall Study||0
988978|NCT00427804|2397767|P1|NOT COMPLETED|Overall Study||0
988979|NCT00427804|2397766|P2|COMPLETED|Overall Study||5
988980|NCT00427804|2397767|P1|COMPLETED|Overall Study||4
988981|NCT00427804|2397766|P2|STARTED|Overall Study||5
988982|NCT00427804|2397767|P1|STARTED|Overall Study||4
988983|NCT00427895|2397777|P8|NOT COMPLETED|Vax 2/Year 3 to 4||2
988984|NCT00427895|2397778|P7|NOT COMPLETED|Vax 2/Year 3 to 4||0
988985|NCT00427895|2397779|P6|NOT COMPLETED|Vax 2/Year 3 to 4||0
988986|NCT00427895|2397780|P5|NOT COMPLETED|Vax 2/Year 3 to 4||1
988987|NCT00427895|2397781|P4|NOT COMPLETED|Vax 2/Year 3 to 4||0
988988|NCT00427895|2397782|P3|NOT COMPLETED|Vax 2/Year 3 to 4||0
988989|NCT00427895|2397783|P2|NOT COMPLETED|Vax 2/Year 3 to 4||0
988990|NCT00427895|2397784|P1|NOT COMPLETED|Vax 2/Year 3 to 4||0
988991|NCT00427895|2397777|P8|COMPLETED|Vax 2/Year 3 to 4||212
988992|NCT00427895|2397778|P7|COMPLETED|Vax 2/Year 3 to 4||189
988993|NCT00427895|2397779|P6|COMPLETED|Vax 2/Year 3 to 4||108
988994|NCT00427895|2397780|P5|COMPLETED|Vax 2/Year 3 to 4||107
988995|NCT00427895|2397781|P4|COMPLETED|Vax 2/Year 3 to 4||0
988996|NCT00427895|2397782|P3|COMPLETED|Vax 2/Year 3 to 4||0
988997|NCT00427895|2397783|P2|COMPLETED|Vax 2/Year 3 to 4||0
988998|NCT00427895|2397784|P1|COMPLETED|Vax 2/Year 3 to 4||0
988999|NCT00427895|2397777|P8|STARTED|Vax 2/Year 3 to 4||214
989000|NCT00427895|2397778|P7|STARTED|Vax 2/Year 3 to 4||189
989001|NCT00427895|2397779|P6|STARTED|Vax 2/Year 3 to 4||108
989002|NCT00427895|2397780|P5|STARTED|Vax 2/Year 3 to 4||108
989003|NCT00427895|2397781|P4|STARTED|Vax 2/Year 3 to 4||0
989004|NCT00427895|2397782|P3|STARTED|Vax 2/Year 3 to 4||0
989005|NCT00427895|2397783|P2|STARTED|Vax 2/Year 3 to 4||0
989006|NCT00427895|2397784|P1|STARTED|Vax 2/Year 3 to 4||0
989007|NCT00427895|2397777|P8|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
989008|NCT00427895|2397778|P7|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
989009|NCT00427895|2397779|P6|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
989010|NCT00427895|2397780|P5|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
989011|NCT00427895|2397781|P4|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||469
989012|NCT00427895|2397782|P3|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||159
989013|NCT00427895|2397783|P2|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||207
989014|NCT00427895|2397784|P1|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||188
989015|NCT00427895|2397777|P8|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
989016|NCT00427895|2397778|P7|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
989017|NCT00427895|2397779|P6|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
989018|NCT00427895|2397780|P5|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
989019|NCT00427895|2397781|P4|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
989020|NCT00427895|2397782|P3|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||214
989021|NCT00427895|2397783|P2|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||189
989022|NCT00427895|2397784|P1|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||216
989023|NCT00427895|2397777|P8|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
989024|NCT00427895|2397778|P7|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
989025|NCT00427895|2397779|P6|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
989026|NCT00427895|2397780|P5|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
989027|NCT00427895|2397781|P4|STARTED|Between Year 1 - Vax 2/Year 3 to 4||469
989028|NCT00427895|2397782|P3|STARTED|Between Year 1 - Vax 2/Year 3 to 4||373
989029|NCT00427895|2397783|P2|STARTED|Between Year 1 - Vax 2/Year 3 to 4||396
989030|NCT00427895|2397784|P1|STARTED|Between Year 1 - Vax 2/Year 3 to 4||404
989031|NCT00427895|2397777|P8|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
989032|NCT00427895|2397778|P7|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
989033|NCT00427895|2397779|P6|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
989034|NCT00427895|2397780|P5|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
989035|NCT00427895|2397781|P4|NOT COMPLETED|Vax 1/Year 1 Follow-up||33
989036|NCT00427895|2397782|P3|NOT COMPLETED|Vax 1/Year 1 Follow-up||19
989037|NCT00427895|2397783|P2|NOT COMPLETED|Vax 1/Year 1 Follow-up||15
989038|NCT00427895|2397784|P1|NOT COMPLETED|Vax 1/Year 1 Follow-up||7
989039|NCT00427895|2397777|P8|COMPLETED|Vax 1/Year 1 Follow-up||0
989040|NCT00427895|2397778|P7|COMPLETED|Vax 1/Year 1 Follow-up||0
989041|NCT00427895|2397779|P6|COMPLETED|Vax 1/Year 1 Follow-up||0
989042|NCT00427895|2397780|P5|COMPLETED|Vax 1/Year 1 Follow-up||0
989043|NCT00427895|2397781|P4|COMPLETED|Vax 1/Year 1 Follow-up||469
989044|NCT00427895|2397782|P3|COMPLETED|Vax 1/Year 1 Follow-up||373
989045|NCT00427895|2397783|P2|COMPLETED|Vax 1/Year 1 Follow-up||396
989046|NCT00427895|2397784|P1|COMPLETED|Vax 1/Year 1 Follow-up||404
989047|NCT00427895|2397777|P8|STARTED|Vax 1/Year 1 Follow-up||0
989048|NCT00427895|2397778|P7|STARTED|Vax 1/Year 1 Follow-up||0
989049|NCT00427895|2397779|P6|STARTED|Vax 1/Year 1 Follow-up||0
989050|NCT00427895|2397780|P5|STARTED|Vax 1/Year 1 Follow-up||0
989051|NCT00427895|2397781|P4|STARTED|Vax 1/Year 1 Follow-up||502
989052|NCT00427895|2397782|P3|STARTED|Vax 1/Year 1 Follow-up||392
989053|NCT00427895|2397783|P2|STARTED|Vax 1/Year 1 Follow-up||411
989054|NCT00427895|2397784|P1|STARTED|Vax 1/Year 1 Follow-up||411
989055|NCT00427895|2397777|P8|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
989056|NCT00427895|2397778|P7|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
989057|NCT00427895|2397779|P6|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
989058|NCT00427895|2397780|P5|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
989059|NCT00427895|2397781|P4|NOT COMPLETED|Between 6-Month Follow-up - Year 1||352
989060|NCT00427895|2397782|P3|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
989061|NCT00427895|2397783|P2|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
989062|NCT00427895|2397784|P1|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
989063|NCT00427895|2397777|P8|COMPLETED|Between 6-Month Follow-up - Year 1||0
989064|NCT00427895|2397778|P7|COMPLETED|Between 6-Month Follow-up - Year 1||0
989065|NCT00427895|2397779|P6|COMPLETED|Between 6-Month Follow-up - Year 1||0
989066|NCT00427895|2397780|P5|COMPLETED|Between 6-Month Follow-up - Year 1||0
989067|NCT00427895|2397781|P4|COMPLETED|Between 6-Month Follow-up - Year 1||502
989068|NCT00427895|2397782|P3|COMPLETED|Between 6-Month Follow-up - Year 1||392
989069|NCT00427895|2397783|P2|COMPLETED|Between 6-Month Follow-up - Year 1||411
989070|NCT00427895|2397784|P1|COMPLETED|Between 6-Month Follow-up - Year 1||411
989071|NCT00427895|2397777|P8|STARTED|Between 6-Month Follow-up - Year 1||0
989072|NCT00427895|2397778|P7|STARTED|Between 6-Month Follow-up - Year 1||0
989073|NCT00427895|2397779|P6|STARTED|Between 6-Month Follow-up - Year 1||0
989074|NCT00427895|2397780|P5|STARTED|Between 6-Month Follow-up - Year 1||0
989075|NCT00427895|2397781|P4|STARTED|Between 6-Month Follow-up - Year 1||854
989076|NCT00427895|2397782|P3|STARTED|Between 6-Month Follow-up - Year 1||392
989077|NCT00427895|2397783|P2|STARTED|Between 6-Month Follow-up - Year 1||411
989078|NCT00427895|2397784|P1|STARTED|Between 6-Month Follow-up - Year 1||411
989079|NCT00427895|2397777|P8|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
989080|NCT00427895|2397778|P7|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
989081|NCT00427895|2397779|P6|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
989082|NCT00427895|2397780|P5|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
989083|NCT00427895|2397781|P4|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||46
989084|NCT00427895|2397782|P3|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||14
989085|NCT00427895|2397783|P2|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||6
989086|NCT00427895|2397784|P1|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||7
989087|NCT00427895|2397777|P8|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
989088|NCT00427895|2397778|P7|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
989089|NCT00427895|2397779|P6|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
989090|NCT00427895|2397780|P5|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
989091|NCT00427895|2397781|P4|COMPLETED|Vax 1 Baseline/6-Month Follow-up||854
989092|NCT00427895|2397782|P3|COMPLETED|Vax 1 Baseline/6-Month Follow-up||392
989093|NCT00427895|2397783|P2|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
989094|NCT00427895|2397784|P1|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
989095|NCT00427895|2397777|P8|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
989096|NCT00427895|2397778|P7|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
989097|NCT00427895|2397779|P6|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
989098|NCT00427895|2397780|P5|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
989099|NCT00427895|2397781|P4|Vaccinated|Vax 1 Baseline/6-Month Follow-up||899
989100|NCT00427895|2397782|P3|Vaccinated|Vax 1 Baseline/6-Month Follow-up||404
989101|NCT00427895|2397783|P2|Vaccinated|Vax 1 Baseline/6-Month Follow-up||414
989102|NCT00427895|2397784|P1|Vaccinated|Vax 1 Baseline/6-Month Follow-up||417
989103|NCT00427895|2397777|P8|STARTED|Vax 1 Baseline/6-Month Follow-up||0
989104|NCT00427895|2397778|P7|STARTED|Vax 1 Baseline/6-Month Follow-up||0
989105|NCT00427895|2397779|P6|STARTED|Vax 1 Baseline/6-Month Follow-up||0
989106|NCT00427895|2397780|P5|STARTED|Vax 1 Baseline/6-Month Follow-up||0
989107|NCT00427895|2397781|P4|STARTED|Vax 1 Baseline/6-Month Follow-up||900
989108|NCT00427895|2397782|P3|STARTED|Vax 1 Baseline/6-Month Follow-up||406
989109|NCT00427895|2397783|P2|STARTED|Vax 1 Baseline/6-Month Follow-up||417
989110|NCT00427895|2397784|P1|STARTED|Vax 1 Baseline/6-Month Follow-up||418
989111|NCT00427921|2397839|P1|NOT COMPLETED|Overall Study||50
989112|NCT00427921|2397839|P1|COMPLETED|Overall Study||254
989113|NCT00427921|2397839|P1|STARTED|Overall Study||304
989114|NCT00427934|2397862|P4|NOT COMPLETED|Overall Study||15
989115|NCT00427934|2397863|P3|NOT COMPLETED|Overall Study||23
989116|NCT00427934|2397864|P2|NOT COMPLETED|Overall Study||0
989117|NCT00427934|2397865|P1|NOT COMPLETED|Overall Study||1
989118|NCT00427934|2397862|P4|COMPLETED|Overall Study||19
989119|NCT00427934|2397863|P3|COMPLETED|Overall Study||55
989120|NCT00427934|2397864|P2|COMPLETED|Overall Study||8
989121|NCT00427934|2397865|P1|COMPLETED|Overall Study||7
989122|NCT00427934|2397862|P4|Treated|Overall Study||33
989123|NCT00427934|2397863|P3|Treated|Overall Study||77
989124|NCT00427934|2397864|P2|Treated|Overall Study||8
989125|NCT00427934|2397865|P1|Treated|Overall Study||8
989126|NCT00427934|2397862|P4|STARTED|Overall Study||34
989127|NCT00427934|2397863|P3|STARTED|Overall Study||78
989128|NCT00427934|2397864|P2|STARTED|Overall Study||8
989129|NCT00427934|2397865|P1|STARTED|Overall Study||8
989130|NCT00427960|2397935|P2|NOT COMPLETED|Overall Study||4
989131|NCT00427960|2397936|P1|NOT COMPLETED|Overall Study||2
989132|NCT00427960|2397935|P2|COMPLETED|Overall Study||21
989133|NCT00427960|2397936|P1|COMPLETED|Overall Study||28
989134|NCT00427960|2397935|P2|STARTED|Overall Study||25
989135|NCT00427960|2397936|P1|STARTED|Overall Study||30
989136|NCT00427973|2397970|P1|NOT COMPLETED|Overall Study||0
989137|NCT00427973|2397970|P1|COMPLETED|Overall Study||17
989138|NCT00427973|2397970|P1|STARTED|Overall Study||17
989139|NCT00427999|2397977|P1|NOT COMPLETED|Overall Study||32
989140|NCT00427999|2397977|P1|COMPLETED|Overall Study||33
989141|NCT00427999|2397977|P1|Extension Follow-up|Overall Study||19
989142|NCT00427999|2397977|P1|Intent to Treat (ITT)|Overall Study||61
989143|NCT00427999|2397977|P1|STARTED|Overall Study||65
989144|NCT00428077|2397986|P1|NOT COMPLETED|Overall Study||0
989145|NCT00428077|2397986|P1|COMPLETED|Overall Study||4
989146|NCT00428077|2397986|P1|STARTED|Overall Study||4
989147|NCT00428090|2397994|P4|NOT COMPLETED|Overall Study||28
989148|NCT00428090|2397995|P3|NOT COMPLETED|Overall Study||38
989149|NCT00428090|2397996|P2|NOT COMPLETED|Overall Study||31
989150|NCT00428090|2397997|P1|NOT COMPLETED|Overall Study||34
989151|NCT00428090|2397994|P4|COMPLETED|Overall Study||55
989152|NCT00428090|2397995|P3|COMPLETED|Overall Study||127
989153|NCT00428090|2397996|P2|COMPLETED|Overall Study||135
989154|NCT00428090|2397997|P1|COMPLETED|Overall Study||131
989155|NCT00428090|2397994|P4|STARTED|Overall Study||83
989156|NCT00428090|2397995|P3|STARTED|Overall Study||165
989157|NCT00428090|2397996|P2|STARTED|Overall Study||166
989158|NCT00428090|2397997|P1|STARTED|Overall Study||165
989159|NCT00428116|2398113|P2|NOT COMPLETED|Overall Study||0
989160|NCT00428116|2398114|P1|NOT COMPLETED|Overall Study||3
989161|NCT00428116|2398113|P2|COMPLETED|Overall Study||21
989162|NCT00428116|2398114|P1|COMPLETED|Overall Study||18
989163|NCT00428116|2398113|P2|STARTED|Overall Study||21
989164|NCT00428116|2398114|P1|STARTED|Overall Study||21
989165|NCT00428207|2398122|P2|NOT COMPLETED|Overall Study||0
989166|NCT00428207|2398123|P1|NOT COMPLETED|Overall Study||0
989167|NCT00428207|2398122|P2|COMPLETED|Overall Study||2
989168|NCT00428207|2398123|P1|COMPLETED|Overall Study||2
989169|NCT00428207|2398122|P2|STARTED|Overall Study||2
989170|NCT00428207|2398123|P1|STARTED|Overall Study||2
989171|NCT00428220|2398129|P1|NOT COMPLETED|Overall Study||223
989172|NCT00428220|2398129|P1|COMPLETED|Overall Study||0
989173|NCT00428220|2398129|P1|STARTED|Overall Study||223
989174|NCT00428246|2398148|P3|NOT COMPLETED|Overall Study||1
989175|NCT00428246|2398149|P2|NOT COMPLETED|Overall Study||0
989176|NCT00428246|2398150|P1|NOT COMPLETED|Overall Study||1
989177|NCT00428246|2398148|P3|COMPLETED|Overall Study||7
989178|NCT00428246|2398149|P2|COMPLETED|Overall Study||8
989179|NCT00428246|2398150|P1|COMPLETED|Overall Study||7
989180|NCT00428246|2398148|P3|STARTED|Overall Study||8
989181|NCT00428246|2398149|P2|STARTED|Overall Study||8
989182|NCT00428246|2398150|P1|STARTED|Overall Study||8
989183|NCT00428298|2398160|P2|NOT COMPLETED|Overall Study||11
989184|NCT00428298|2398161|P1|NOT COMPLETED|Overall Study||14
989185|NCT00428298|2398160|P2|COMPLETED|Overall Study||19
989186|NCT00428298|2398161|P1|COMPLETED|Overall Study||16
989187|NCT00428298|2398160|P2|Second RBANS at Study Exit|Overall Study||3
989188|NCT00428298|2398161|P1|Second RBANS at Study Exit|Overall Study||3
989189|NCT00428298|2398160|P2|STARTED|Overall Study||30
989190|NCT00428298|2398161|P1|STARTED|Overall Study||30
989191|NCT00428389|2398173|P2|NOT COMPLETED|Extension Phase||26
989192|NCT00428389|2398174|P1|NOT COMPLETED|Extension Phase||32
989193|NCT00428389|2398173|P2|COMPLETED|Extension Phase||91
989194|NCT00428389|2398174|P1|COMPLETED|Extension Phase||85
989195|NCT00428389|2398173|P2|STARTED|Extension Phase||117
989196|NCT00428389|2398174|P1|STARTED|Extension Phase|Participants were required to sign a separate informed consent prior to entering the extension phase|117
989197|NCT00428389|2398173|P2|NOT COMPLETED|Core Phase||11
989198|NCT00428389|2398174|P1|NOT COMPLETED|Core Phase||11
989199|NCT00428389|2398173|P2|COMPLETED|Core Phase||120
989200|NCT00428389|2398174|P1|COMPLETED|Core Phase||120
989201|NCT00428389|2398173|P2|Intent-to-treat Population|Core Phase|1 patient was discontinued from the study the same day as randomization & excluded from all analyses|130
989202|NCT00428389|2398174|P1|Intent-to-treat Population|Core Phase||131
989203|NCT00428389|2398173|P2|STARTED|Core Phase||131
989204|NCT00428389|2398174|P1|STARTED|Core Phase||131
989205|NCT00428441|2398192|P1|NOT COMPLETED|Overall Study||1
989206|NCT00428441|2398192|P1|COMPLETED|Overall Study||74
989207|NCT00428441|2398192|P1|STARTED|Overall Study||75
989208|NCT00428584|2398198|P2|NOT COMPLETED|Extension Phase||29
989209|NCT00428584|2398199|P1|NOT COMPLETED|Extension Phase||21
989210|NCT00428584|2398198|P2|COMPLETED|Extension Phase||34
989211|NCT00428584|2398199|P1|COMPLETED|Extension Phase||35
989212|NCT00428584|2398198|P2|STARTED|Extension Phase||63
989213|NCT00428584|2398199|P1|STARTED|Extension Phase|Extension Phase - new formulation of rebif to new formulation of rebif|56
989214|NCT00428584|2398198|P2|NOT COMPLETED|Comparative Phase||1
989215|NCT00428584|2398199|P1|NOT COMPLETED|Comparative Phase||9
989216|NCT00428584|2398198|P2|COMPLETED|Comparative Phase||63
989217|NCT00428584|2398199|P1|COMPLETED|Comparative Phase|Comparator Phase - new formulation of rebif and Betaseron|56
989218|NCT00428584|2398198|P2|STARTED|Comparative Phase||64
989219|NCT00428584|2398199|P1|STARTED|Comparative Phase||65
989220|NCT00428597|2398225|P2|NOT COMPLETED|Overall Study||85
989221|NCT00428597|2398226|P1|NOT COMPLETED|Overall Study||86
989222|NCT00428597|2398225|P2|COMPLETED|Overall Study||0
989223|NCT00428597|2398226|P1|COMPLETED|Overall Study||0
989224|NCT00428597|2398225|P2|Received Treatment|Overall Study||82
989225|NCT00428597|2398226|P1|Received Treatment|Overall Study||83
989226|NCT00428597|2398225|P2|STARTED|Overall Study||85
989227|NCT00428597|2398226|P1|STARTED|Overall Study||86
989228|NCT00428792|2398268|P2|NOT COMPLETED|Overall Study||4
989229|NCT00428792|2398269|P1|NOT COMPLETED|Overall Study||1
989317|NCT00429364|2398453|P1|COMPLETED|Overall Study||271
989230|NCT00428792|2398268|P2|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|66
989231|NCT00428792|2398269|P1|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|79
989232|NCT00428792|2398268|P2|STARTED|Overall Study||70
989233|NCT00428792|2398269|P1|STARTED|Overall Study||80
989234|NCT00428844|2398296|P3|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
989235|NCT00428844|2398297|P2|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
989236|NCT00428844|2398298|P1|NOT COMPLETED|Completed Test of Cure (TOC) Visit||3
989237|NCT00428844|2398296|P3|COMPLETED|Completed Test of Cure (TOC) Visit||17
989238|NCT00428844|2398297|P2|COMPLETED|Completed Test of Cure (TOC) Visit||16
989239|NCT00428844|2398298|P1|COMPLETED|Completed Test of Cure (TOC) Visit||20
989240|NCT00428844|2398296|P3|STARTED|Completed Test of Cure (TOC) Visit||19
989241|NCT00428844|2398297|P2|STARTED|Completed Test of Cure (TOC) Visit||18
989242|NCT00428844|2398298|P1|STARTED|Completed Test of Cure (TOC) Visit||23
989243|NCT00428844|2398296|P3|NOT COMPLETED|Completed Study Drug Treatment||7
989244|NCT00428844|2398297|P2|NOT COMPLETED|Completed Study Drug Treatment||6
989245|NCT00428844|2398298|P1|NOT COMPLETED|Completed Study Drug Treatment||2
989246|NCT00428844|2398296|P3|COMPLETED|Completed Study Drug Treatment||19
989247|NCT00428844|2398297|P2|COMPLETED|Completed Study Drug Treatment||18
989248|NCT00428844|2398298|P1|COMPLETED|Completed Study Drug Treatment||23
989249|NCT00428844|2398296|P3|Received First Dose|Completed Study Drug Treatment||25
989250|NCT00428844|2398297|P2|Received First Dose|Completed Study Drug Treatment||24
989251|NCT00428844|2398298|P1|Received First Dose|Completed Study Drug Treatment||25
989252|NCT00428844|2398296|P3|STARTED|Completed Study Drug Treatment||26
989253|NCT00428844|2398297|P2|STARTED|Completed Study Drug Treatment||24
989254|NCT00428844|2398298|P1|STARTED|Completed Study Drug Treatment||25
989255|NCT00428922|2398319|P1|NOT COMPLETED|Overall Study||0
989256|NCT00428922|2398319|P1|COMPLETED|Overall Study||26
989257|NCT00428922|2398319|P1|STARTED|Overall Study||26
989258|NCT00428948|2398328|P2|NOT COMPLETED|Overall Study||67
989259|NCT00428948|2398329|P1|NOT COMPLETED|Overall Study||221
989260|NCT00428948|2398328|P2|COMPLETED|Overall Study||417
989261|NCT00428948|2398329|P1|COMPLETED|Overall Study||740
989262|NCT00428948|2398328|P2|Received Treatment|Overall Study||483
989263|NCT00428948|2398329|P1|Received Treatment|Overall Study||961
989264|NCT00428948|2398328|P2|STARTED|Overall Study||484
989265|NCT00428948|2398329|P1|STARTED|Overall Study||961
989266|NCT00428974|2398351|P4|NOT COMPLETED|Overall Study||3
989267|NCT00428974|2398352|P3|NOT COMPLETED|Overall Study||1
989268|NCT00428974|2398353|P2|NOT COMPLETED|Overall Study||0
989269|NCT00428974|2398354|P1|NOT COMPLETED|Overall Study||8
989270|NCT00428974|2398351|P4|COMPLETED|Overall Study||16
989271|NCT00428974|2398352|P3|COMPLETED|Overall Study||14
989272|NCT00428974|2398353|P2|COMPLETED|Overall Study||17
989273|NCT00428974|2398354|P1|COMPLETED|Overall Study||17
989274|NCT00428974|2398351|P4|STARTED|Overall Study||19
989275|NCT00428974|2398352|P3|STARTED|Overall Study||15
989276|NCT00428974|2398353|P2|STARTED|Overall Study||17
989277|NCT00428974|2398354|P1|STARTED|Overall Study|one patient was randomized but never received study treatment|25
989278|NCT00429026|2398368|P1|NOT COMPLETED|Overall Study||40
989279|NCT00429026|2398368|P1|COMPLETED|Overall Study||0
989280|NCT00429026|2398368|P1|STARTED|Overall Study||40
989281|NCT00429104|2398372|P1|NOT COMPLETED|Overall Study||1
989282|NCT00429104|2398372|P1|COMPLETED|Overall Study||17
989283|NCT00429104|2398372|P1|STARTED|Overall Study||18
989284|NCT00429143|2398377|P1|NOT COMPLETED|Overall Study||0
989285|NCT00429143|2398377|P1|COMPLETED|Overall Study||27
989286|NCT00429143|2398377|P1|STARTED|Overall Study||27
989287|NCT00429169|2398387|P2|NOT COMPLETED|Overall Study||2
989288|NCT00429169|2398388|P1|NOT COMPLETED|Overall Study||2
989289|NCT00429169|2398387|P2|COMPLETED|Overall Study|2 subjects excluded: re-diagnosis/ineligibility (1), and did not return after randomization (1).|38
989290|NCT00429169|2398388|P1|COMPLETED|Overall Study|2 subjects excluded due to re-diagnosis/ineligibility.|36
989291|NCT00429169|2398387|P2|STARTED|Overall Study||40
989292|NCT00429169|2398388|P1|STARTED|Overall Study||38
989293|NCT00429182|2398398|P1|NOT COMPLETED|Overall Study||7
989294|NCT00429182|2398398|P1|COMPLETED|Overall Study||25
989295|NCT00429182|2398398|P1|STARTED|Overall Study||32
989296|NCT00429273|2398406|P3|NOT COMPLETED|Overall Study||9
989297|NCT00429273|2398407|P2|NOT COMPLETED|Overall Study||8
989298|NCT00429273|2398408|P1|NOT COMPLETED|Overall Study||8
989299|NCT00429273|2398406|P3|COMPLETED|Overall Study||61
989300|NCT00429273|2398407|P2|COMPLETED|Overall Study||61
989301|NCT00429273|2398408|P1|COMPLETED|Overall Study||60
989302|NCT00429273|2398406|P3|STARTED|Overall Study||70
989303|NCT00429273|2398407|P2|STARTED|Overall Study||69
989304|NCT00429273|2398408|P1|STARTED|Overall Study||68
989305|NCT00429299|2398419|P3|NOT COMPLETED|Overall Study||4
989306|NCT00429299|2398420|P2|NOT COMPLETED|Overall Study||7
989307|NCT00429299|2398421|P1|NOT COMPLETED|Overall Study||4
989308|NCT00429299|2398419|P3|COMPLETED|Overall Study||42
989309|NCT00429299|2398420|P2|COMPLETED|Overall Study||32
989310|NCT00429299|2398421|P1|COMPLETED|Overall Study||32
989311|NCT00429299|2398419|P3|STARTED|Overall Study||46
989312|NCT00429299|2398420|P2|STARTED|Overall Study||39
989313|NCT00429299|2398421|P1|STARTED|Overall Study||36
989314|NCT00429364|2398452|P2|NOT COMPLETED|Overall Study||33
989315|NCT00429364|2398453|P1|NOT COMPLETED|Overall Study||32
989316|NCT00429364|2398452|P2|COMPLETED|Overall Study||272
989318|NCT00429364|2398452|P2|STARTED|Overall Study||305
989319|NCT00429364|2398453|P1|STARTED|Overall Study||303
989320|NCT00429403|2398511|P2|NOT COMPLETED|Overall Study||0
989321|NCT00429403|2398512|P1|NOT COMPLETED|Overall Study||0
989322|NCT00429403|2398511|P2|COMPLETED|Overall Study||0
989323|NCT00429403|2398512|P1|COMPLETED|Overall Study||1
989324|NCT00429403|2398511|P2|STARTED|Overall Study||0
989325|NCT00429403|2398512|P1|STARTED|Overall Study||1
989326|NCT00429416|2398518|P1|NOT COMPLETED|Overall Study||1
989327|NCT00429416|2398518|P1|COMPLETED|Overall Study||13
989328|NCT00429416|2398518|P1|STARTED|Overall Study||14
989329|NCT00429494|2398526|P1|NOT COMPLETED|Overall Study||15
989330|NCT00429494|2398526|P1|COMPLETED|Overall Study||44
989331|NCT00429494|2398526|P1|STARTED|Overall Study||59
989332|NCT00429507|2398530|P1|NOT COMPLETED|Overall Study||0
989333|NCT00429507|2398530|P1|COMPLETED|Overall Study||12
989334|NCT00429507|2398530|P1|STARTED|Overall Study||12
989335|NCT00429572|2398534|P1|NOT COMPLETED|Overall Study||1
989336|NCT00429572|2398534|P1|COMPLETED|Overall Study||18
989337|NCT00429572|2398534|P1|STARTED|Overall Study||19
989338|NCT00417417|2398544|P2|NOT COMPLETED|Overall Study||0
989339|NCT00417417|2398545|P1|NOT COMPLETED|Overall Study||0
989340|NCT00417417|2398544|P2|COMPLETED|Overall Study||6
989341|NCT00417417|2398545|P1|COMPLETED|Overall Study||4
989342|NCT00417417|2398544|P2|STARTED|Overall Study||6
989343|NCT00417417|2398545|P1|STARTED|Overall Study||4
989344|NCT00422903|2398555|P2|NOT COMPLETED|Overall Study||5
989345|NCT00422903|2398556|P1|NOT COMPLETED|Overall Study||4
989346|NCT00422903|2398555|P2|COMPLETED|Overall Study||38
989347|NCT00422903|2398556|P1|COMPLETED|Overall Study||45
989348|NCT00422903|2398555|P2|STARTED|Overall Study||43
989349|NCT00422903|2398556|P1|STARTED|Overall Study||49
989350|NCT00422942|2398580|P1|NOT COMPLETED|Overall Study||3
989351|NCT00422942|2398580|P1|COMPLETED|Overall Study||0
989352|NCT00422942|2398580|P1|STARTED|Overall Study||3
989353|NCT00423046|2398599|P2|NOT COMPLETED|Overall Study||345
989354|NCT00423046|2398600|P1|NOT COMPLETED|Overall Study||340
989355|NCT00423046|2398599|P2|COMPLETED|Overall Study|Completed until Month 60|208
989356|NCT00423046|2398600|P1|COMPLETED|Overall Study|Completed until Month 60|213
989357|NCT00423046|2398599|P2|STARTED|Overall Study||553
989358|NCT00423046|2398600|P1|STARTED|Overall Study||553
989359|NCT00423085|2398669|P4|NOT COMPLETED|52-Week Open-Label Extension Phase||163
989360|NCT00423085|2398670|P3|NOT COMPLETED|52-Week Open-Label Extension Phase||0
989361|NCT00423085|2398671|P2|NOT COMPLETED|52-Week Open-Label Extension Phase||0
989362|NCT00423085|2398672|P1|NOT COMPLETED|52-Week Open-Label Extension Phase||0
989363|NCT00423085|2398669|P4|COMPLETED|52-Week Open-Label Extension Phase||474
989364|NCT00423085|2398670|P3|COMPLETED|52-Week Open-Label Extension Phase||0
989365|NCT00423085|2398671|P2|COMPLETED|52-Week Open-Label Extension Phase||0
989366|NCT00423085|2398672|P1|COMPLETED|52-Week Open-Label Extension Phase||0
989367|NCT00423085|2398669|P4|STARTED|52-Week Open-Label Extension Phase|Patients who completed the 24-wk treatment phase were eligible to enroll in the open-label extension|637
989368|NCT00423085|2398670|P3|STARTED|52-Week Open-Label Extension Phase||0
989369|NCT00423085|2398671|P2|STARTED|52-Week Open-Label Extension Phase||0
989370|NCT00423085|2398672|P1|STARTED|52-Week Open-Label Extension Phase||0
989371|NCT00423085|2398669|P4|NOT COMPLETED|24-Week Double-Blind Treatment Phase||0
989372|NCT00423085|2398670|P3|NOT COMPLETED|24-Week Double-Blind Treatment Phase||59
989373|NCT00423085|2398671|P2|NOT COMPLETED|24-Week Double-Blind Treatment Phase||64
989374|NCT00423085|2398672|P1|NOT COMPLETED|24-Week Double-Blind Treatment Phase||46
989375|NCT00423085|2398669|P4|COMPLETED|24-Week Double-Blind Treatment Phase||0
989376|NCT00423085|2398670|P3|COMPLETED|24-Week Double-Blind Treatment Phase||228
989377|NCT00423085|2398671|P2|COMPLETED|24-Week Double-Blind Treatment Phase||220
989378|NCT00423085|2398672|P1|COMPLETED|24-Week Double-Blind Treatment Phase||242
989379|NCT00423085|2398669|P4|STARTED|24-Week Double-Blind Treatment Phase||0
989380|NCT00423085|2398670|P3|STARTED|24-Week Double-Blind Treatment Phase||287
989381|NCT00423085|2398671|P2|STARTED|24-Week Double-Blind Treatment Phase||284
989382|NCT00423085|2398672|P1|STARTED|24-Week Double-Blind Treatment Phase||288
989383|NCT00423098|2398701|P2|NOT COMPLETED|Overall Study||4
989384|NCT00423098|2398702|P1|NOT COMPLETED|Overall Study||3
989385|NCT00423098|2398701|P2|COMPLETED|Overall Study||35
989386|NCT00423098|2398702|P1|COMPLETED|Overall Study|Completed 24 weeks of study medication.|39
989387|NCT00423098|2398701|P2|STARTED|Overall Study||39
989388|NCT00423098|2398702|P1|STARTED|Overall Study|Total number of patients screened was 90, but the total number of randomized patients was 81.|42
989389|NCT00423150|2398726|P1|NOT COMPLETED|Overall Study||86
989390|NCT00423150|2398726|P1|COMPLETED|Overall Study||0
989391|NCT00423150|2398726|P1|STARTED|Overall Study||86
989392|NCT00423176|2398732|P2|NOT COMPLETED|Overall Study||29
989393|NCT00423176|2398733|P1|NOT COMPLETED|Overall Study||16
989394|NCT00423176|2398732|P2|COMPLETED|Overall Study||94
989395|NCT00423176|2398733|P1|COMPLETED|Overall Study||98
989396|NCT00423176|2398732|P2|STARTED|Overall Study||123
989397|NCT00423176|2398733|P1|STARTED|Overall Study||114
989398|NCT00423189|2398744|P3|NOT COMPLETED|Overall Study||0
989399|NCT00423189|2398745|P2|NOT COMPLETED|Overall Study||1
989400|NCT00423189|2398746|P1|NOT COMPLETED|Overall Study||0
989401|NCT00423189|2398744|P3|COMPLETED|Overall Study||2
989402|NCT00423189|2398745|P2|COMPLETED|Overall Study||2
989403|NCT00423189|2398746|P1|COMPLETED|Overall Study||2
989404|NCT00423189|2398744|P3|STARTED|Overall Study||2
989405|NCT00423189|2398745|P2|STARTED|Overall Study||3
989406|NCT00423189|2398746|P1|STARTED|Overall Study||2
989407|NCT00423267|2398768|P2|NOT COMPLETED|Period B||0
989408|NCT00423267|2398769|P1|NOT COMPLETED|Period B||0
989409|NCT00423267|2398768|P2|COMPLETED|Period B||0
989410|NCT00423267|2398769|P1|COMPLETED|Period B||12
989411|NCT00423267|2398768|P2|STARTED|Period B||0
989412|NCT00423267|2398769|P1|STARTED|Period B||12
989413|NCT00423267|2398768|P2|NOT COMPLETED|Period A||1
989414|NCT00423267|2398769|P1|NOT COMPLETED|Period A||2
989415|NCT00423267|2398768|P2|COMPLETED|Period A||6
989416|NCT00423267|2398769|P1|COMPLETED|Period A||7
989417|NCT00423267|2398768|P2|STARTED|Period A||7
989418|NCT00423267|2398769|P1|STARTED|Period A||9
989419|NCT00423293|2398786|P1|NOT COMPLETED|Overall Study||11
989420|NCT00423293|2398786|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
989421|NCT00423293|2398786|P1|STARTED|Overall Study||63
989422|NCT00423319|2398792|P2|NOT COMPLETED|Overall Study||252
989423|NCT00423319|2398793|P1|NOT COMPLETED|Overall Study||224
989424|NCT00423319|2398792|P2|COMPLETED|Overall Study||2447
989425|NCT00423319|2398793|P1|COMPLETED|Overall Study||2484
989426|NCT00423319|2398792|P2|Participants Who Received Treatment|Overall Study||2659
989427|NCT00423319|2398793|P1|Participants Who Received Treatment|Overall Study||2673
989428|NCT00423319|2398792|P2|STARTED|Overall Study|Randomized|2699
989429|NCT00423319|2398793|P1|STARTED|Overall Study|Randomized|2708
989430|NCT00423332|2398827|P2|NOT COMPLETED|Overall Study||7
989431|NCT00423332|2398828|P1|NOT COMPLETED|Overall Study||9
989432|NCT00423332|2398827|P2|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|11
989433|NCT00423332|2398828|P1|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|44
989434|NCT00423332|2398827|P2|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|4
989435|NCT00423332|2398828|P1|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|22
989436|NCT00423332|2398827|P2|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|14
989437|NCT00423332|2398828|P1|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|44
989438|NCT00423332|2398827|P2|STARTED|Overall Study|Number randomised|18
989439|NCT00423332|2398828|P1|STARTED|Overall Study|Randomised|53
989440|NCT00423358|2398847|P2|NOT COMPLETED|Overall Study||0
989441|NCT00423358|2398848|P1|NOT COMPLETED|Overall Study||0
989442|NCT00423358|2398847|P2|COMPLETED|Overall Study||11
989443|NCT00423358|2398848|P1|COMPLETED|Overall Study||11
989444|NCT00423358|2398847|P2|STARTED|Overall Study||11
989445|NCT00423358|2398848|P1|STARTED|Overall Study||11
989446|NCT00423436|2398860|P2|NOT COMPLETED|Overall Study||0
989447|NCT00423436|2398861|P1|NOT COMPLETED|Overall Study||0
989448|NCT00423436|2398860|P2|COMPLETED|Overall Study||33
989449|NCT00423436|2398861|P1|COMPLETED|Overall Study||35
989450|NCT00423436|2398860|P2|STARTED|Overall Study||33
989451|NCT00423436|2398861|P1|STARTED|Overall Study||35
989452|NCT00423449|2398867|P5|NOT COMPLETED|Overall Study||7
989453|NCT00423449|2398868|P4|NOT COMPLETED|Overall Study||22
989454|NCT00423449|2398869|P3|NOT COMPLETED|Overall Study||15
989455|NCT00423449|2398870|P2|NOT COMPLETED|Overall Study||4
989456|NCT00423449|2398871|P1|NOT COMPLETED|Overall Study||3
989457|NCT00423449|2398867|P5|COMPLETED|Overall Study||0
989458|NCT00423449|2398868|P4|COMPLETED|Overall Study||5
989459|NCT00423449|2398869|P3|COMPLETED|Overall Study||2
989460|NCT00423449|2398870|P2|COMPLETED|Overall Study||2
989461|NCT00423449|2398871|P1|COMPLETED|Overall Study||1
989462|NCT00423449|2398867|P5|STARTED|Overall Study||7
989463|NCT00423449|2398868|P4|STARTED|Overall Study||27
989464|NCT00423449|2398869|P3|STARTED|Overall Study||17
989465|NCT00423449|2398870|P2|STARTED|Overall Study||6
989466|NCT00423449|2398871|P1|STARTED|Overall Study||4
989467|NCT00423488|2398896|P2|NOT COMPLETED|Overall Study||1
989468|NCT00423488|2398897|P1|NOT COMPLETED|Overall Study||5
989469|NCT00423488|2398896|P2|COMPLETED|Overall Study||50
989470|NCT00423488|2398897|P1|COMPLETED|Overall Study||37
989471|NCT00423488|2398896|P2|STARTED|Overall Study||51
989472|NCT00423488|2398897|P1|STARTED|Overall Study||42
989473|NCT00423579|2398905|P2|NOT COMPLETED|Overall Study||4
989474|NCT00423579|2398906|P1|NOT COMPLETED|Overall Study||4
989475|NCT00423579|2398905|P2|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
989476|NCT00423579|2398906|P1|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
989477|NCT00423579|2398905|P2|STARTED|Overall Study||60
989478|NCT00423579|2398906|P1|STARTED|Overall Study|61 enrolled, however one subject was ineligible and was removed.|60
989479|NCT00423592|2398912|P1|NOT COMPLETED|Overall Study||7
989480|NCT00423592|2398912|P1|COMPLETED|Overall Study|Completed study|29
989481|NCT00423592|2398912|P1|Completed Preliminary Analysis Cut-off|Overall Study|Preliminary analysis cut-off at Week 12 for primary/secondary endpoint analysis|34
989482|NCT00423592|2398912|P1|STARTED|Overall Study|Enrolled|36
989483|NCT00423605|2398931|P1|NOT COMPLETED|Overall Study||241
989484|NCT00423605|2398931|P1|COMPLETED|Overall Study||319
989485|NCT00423605|2398931|P1|STARTED|Overall Study||560
989486|NCT00423657|2398937|P2|NOT COMPLETED|Overall Study||25
989487|NCT00423657|2398938|P1|NOT COMPLETED|Overall Study||26
989488|NCT00423657|2398937|P2|COMPLETED|Overall Study||313
989489|NCT00423657|2398938|P1|COMPLETED|Overall Study||316
989490|NCT00423657|2398937|P2|STARTED|Overall Study||338
989491|NCT00423657|2398938|P1|STARTED|Overall Study||342
989492|NCT00423670|2398951|P8|NOT COMPLETED|Follow-up Period||3
989493|NCT00423670|2398952|P7|NOT COMPLETED|Follow-up Period||9
989494|NCT00423670|2398953|P6|NOT COMPLETED|Follow-up Period||0
989495|NCT00423670|2398954|P5|NOT COMPLETED|Follow-up Period||2
989496|NCT00423670|2398955|P4|NOT COMPLETED|Follow-up Period||5
989497|NCT00423670|2398956|P3|NOT COMPLETED|Follow-up Period||11
989498|NCT00423670|2398957|P2|NOT COMPLETED|Follow-up Period||16
989499|NCT00423670|2398958|P1|NOT COMPLETED|Follow-up Period||3
989500|NCT00423670|2398951|P8|COMPLETED|Follow-up Period||32
989501|NCT00423670|2398952|P7|COMPLETED|Follow-up Period||41
989502|NCT00423670|2398953|P6|COMPLETED|Follow-up Period||14
989503|NCT00423670|2398954|P5|COMPLETED|Follow-up Period||89
989504|NCT00423670|2398955|P4|COMPLETED|Follow-up Period||91
989505|NCT00423670|2398956|P3|COMPLETED|Follow-up Period||85
989506|NCT00423670|2398957|P2|COMPLETED|Follow-up Period||84
989507|NCT00423670|2398958|P1|COMPLETED|Follow-up Period||94
989508|NCT00423670|2398951|P8|STARTED|Follow-up Period||35
989509|NCT00423670|2398952|P7|STARTED|Follow-up Period||50
989510|NCT00423670|2398953|P6|STARTED|Follow-up Period||14
989511|NCT00423670|2398954|P5|STARTED|Follow-up Period||91
989512|NCT00423670|2398955|P4|STARTED|Follow-up Period||96
989513|NCT00423670|2398956|P3|STARTED|Follow-up Period||96
989514|NCT00423670|2398957|P2|STARTED|Follow-up Period||100
989515|NCT00423670|2398958|P1|STARTED|Follow-up Period||97
989516|NCT00423670|2398951|P8|NOT COMPLETED|Treatment Period||21
989517|NCT00423670|2398952|P7|NOT COMPLETED|Treatment Period||31
989518|NCT00423670|2398953|P6|NOT COMPLETED|Treatment Period||8
989519|NCT00423670|2398954|P5|NOT COMPLETED|Treatment Period||27
989520|NCT00423670|2398955|P4|NOT COMPLETED|Treatment Period||40
989521|NCT00423670|2398956|P3|NOT COMPLETED|Treatment Period||27
989522|NCT00423670|2398957|P2|NOT COMPLETED|Treatment Period||30
989523|NCT00423670|2398958|P1|NOT COMPLETED|Treatment Period||52
989524|NCT00423670|2398951|P8|COMPLETED|Treatment Period||15
989525|NCT00423670|2398952|P7|COMPLETED|Treatment Period||28
989526|NCT00423670|2398953|P6|COMPLETED|Treatment Period||8
989527|NCT00423670|2398954|P5|COMPLETED|Treatment Period||76
989528|NCT00423670|2398955|P4|COMPLETED|Treatment Period||63
989529|NCT00423670|2398956|P3|COMPLETED|Treatment Period||76
989530|NCT00423670|2398957|P2|COMPLETED|Treatment Period||77
989531|NCT00423670|2398958|P1|COMPLETED|Treatment Period||52
989532|NCT00423670|2398951|P8|STARTED|Treatment Period|Arm 8 were Arm 1 participants that were positive for HCV-RNA at TW 24 and had the option to switch.|36
989533|NCT00423670|2398952|P7|STARTED|Treatment Period||59
989534|NCT00423670|2398953|P6|STARTED|Treatment Period||16
989535|NCT00423670|2398954|P5|STARTED|Treatment Period||103
989536|NCT00423670|2398955|P4|STARTED|Treatment Period||103
989537|NCT00423670|2398956|P3|STARTED|Treatment Period||103
989538|NCT00423670|2398957|P2|STARTED|Treatment Period||107
989539|NCT00423670|2398958|P1|STARTED|Treatment Period||104
989540|NCT00423683|2399016|P2|NOT COMPLETED|Overall Study||0
989541|NCT00423683|2399017|P1|NOT COMPLETED|Overall Study||1
989542|NCT00423683|2399016|P2|COMPLETED|Overall Study||33
989543|NCT00423683|2399017|P1|COMPLETED|Overall Study||30
989544|NCT00423683|2399016|P2|STARTED|Overall Study||33
989545|NCT00423683|2399017|P1|STARTED|Overall Study||31
989546|NCT00423722|2399031|P2|NOT COMPLETED|Overall Study||13
989547|NCT00423722|2399032|P1|NOT COMPLETED|Overall Study||14
989548|NCT00423722|2399031|P2|COMPLETED|Overall Study||53
989549|NCT00423722|2399032|P1|COMPLETED|Overall Study||49
989550|NCT00423722|2399031|P2|STARTED|Overall Study||66
989551|NCT00423722|2399032|P1|STARTED|Overall Study||63
989552|NCT00423735|2399055|P3|NOT COMPLETED|Overall Study||0
989553|NCT00423735|2399056|P2|NOT COMPLETED|Overall Study||6
989554|NCT00423735|2399057|P1|NOT COMPLETED|Overall Study||8
989555|NCT00423735|2399055|P3|COMPLETED|Overall Study||0
989556|NCT00423735|2399056|P2|COMPLETED|Overall Study||29
989557|NCT00423735|2399057|P1|COMPLETED|Overall Study||21
989558|NCT00423735|2399055|P3|STARTED|Overall Study||0
989559|NCT00423735|2399056|P2|STARTED|Overall Study||35
989560|NCT00423735|2399057|P1|STARTED|Overall Study||29
989561|NCT00423800|2399080|P2|NOT COMPLETED|Overall Study||1
989562|NCT00423800|2399081|P1|NOT COMPLETED|Overall Study||0
989563|NCT00423800|2399080|P2|COMPLETED|Overall Study||1
989564|NCT00423800|2399081|P1|COMPLETED|Overall Study||3
989565|NCT00423800|2399080|P2|STARTED|Overall Study||2
989566|NCT00423800|2399081|P1|STARTED|Overall Study||3
989567|NCT00423813|2399093|P3|NOT COMPLETED|Overall Study||74
989568|NCT00423813|2399094|P2|NOT COMPLETED|Overall Study||66
989569|NCT00423813|2399095|P1|NOT COMPLETED|Overall Study||57
989570|NCT00423813|2399093|P3|COMPLETED|Overall Study||116
989571|NCT00423813|2399094|P2|COMPLETED|Overall Study||129
989572|NCT00423813|2399095|P1|COMPLETED|Overall Study||131
989573|NCT00423813|2399093|P3|Treated|Overall Study||189
989574|NCT00423813|2399094|P2|Treated|Overall Study||194
989575|NCT00423813|2399095|P1|Treated|Overall Study||188
989576|NCT00423813|2399093|P3|STARTED|Overall Study||190
989577|NCT00423813|2399094|P2|STARTED|Overall Study||195
989578|NCT00423813|2399095|P1|STARTED|Overall Study||188
989579|NCT00429663|2399105|P2|NOT COMPLETED|Overall Study||39
989580|NCT00429663|2399106|P1|NOT COMPLETED|Overall Study||36
989581|NCT00429663|2399105|P2|COMPLETED|Overall Study||41
989582|NCT00429663|2399106|P1|COMPLETED|Overall Study||40
989583|NCT00429663|2399105|P2|STARTED|Overall Study||80
989584|NCT00429663|2399106|P1|STARTED|Overall Study||76
989585|NCT00429702|2399122|P2|NOT COMPLETED|Overall Study||0
989586|NCT00429702|2399123|P1|NOT COMPLETED|Overall Study||0
989587|NCT00429702|2399122|P2|COMPLETED|Overall Study||4
989588|NCT00429702|2399123|P1|COMPLETED|Overall Study||3
989589|NCT00429702|2399122|P2|STARTED|Overall Study||4
989590|NCT00429702|2399123|P1|STARTED|Overall Study||3
989591|NCT00429793|2399131|P1|NOT COMPLETED|Overall Study||6
989592|NCT00429793|2399131|P1|COMPLETED|Overall Study||54
989593|NCT00429793|2399131|P1|STARTED|Overall Study||60
989594|NCT00429923|2399141|P3|NOT COMPLETED|Overall Study||39
989595|NCT00429923|2399142|P2|NOT COMPLETED|Overall Study||4
989596|NCT00429923|2399143|P1|NOT COMPLETED|Overall Study||5
989597|NCT00429923|2399141|P3|COMPLETED|Overall Study||68
989598|NCT00429923|2399142|P2|COMPLETED|Overall Study||51
989599|NCT00429923|2399143|P1|COMPLETED|Overall Study||52
989600|NCT00429923|2399141|P3|STARTED|Overall Study||107
989601|NCT00429923|2399142|P2|STARTED|Overall Study||55
989602|NCT00429923|2399143|P1|STARTED|Overall Study||57
989603|NCT00429949|2399148|P1|NOT COMPLETED|Overall Study||0
989604|NCT00429949|2399148|P1|COMPLETED|Overall Study||21
989605|NCT00429949|2399148|P1|STARTED|Overall Study||21
989606|NCT00433914|2399160|P2|NOT COMPLETED|Overall Study||3
989607|NCT00433914|2399161|P1|NOT COMPLETED|Overall Study||0
989608|NCT00433914|2399160|P2|COMPLETED|Overall Study||27
989609|NCT00433914|2399161|P1|COMPLETED|Overall Study||30
989610|NCT00433914|2399160|P2|STARTED|Overall Study||30
989611|NCT00433914|2399161|P1|STARTED|Overall Study||30
989612|NCT00433992|2399181|P2|NOT COMPLETED|Overall Study||8
989613|NCT00433992|2399182|P1|NOT COMPLETED|Overall Study||9
989614|NCT00433992|2399181|P2|COMPLETED|Overall Study||20
989615|NCT00433992|2399182|P1|COMPLETED|Overall Study||19
989616|NCT00433992|2399181|P2|STARTED|Overall Study||28
989617|NCT00433992|2399182|P1|STARTED|Overall Study||28
989618|NCT00434018|2399194|P2|NOT COMPLETED|Overall Study||12
989619|NCT00434018|2399195|P1|NOT COMPLETED|Overall Study||17
989620|NCT00434018|2399194|P2|COMPLETED|Overall Study||57
989621|NCT00434018|2399195|P1|COMPLETED|Overall Study||52
989622|NCT00434018|2399194|P2|STARTED|Overall Study||69
989623|NCT00434018|2399195|P1|STARTED|Overall Study||69
989624|NCT00434057|2399211|P1|NOT COMPLETED|Overall Study||1
989625|NCT00434057|2399211|P1|COMPLETED|Overall Study|One patient withdrew from the study after signing the Informed Consent Form|1382
989626|NCT00434057|2399211|P1|STARTED|Overall Study||1383
989627|NCT00434109|2399215|P1|NOT COMPLETED|Overall Study||18
989628|NCT00434109|2399215|P1|COMPLETED|Overall Study|Patients completing the maximum eight cycles of sunitinib.|21
989629|NCT00434109|2399215|P1|STARTED|Overall Study||39
989630|NCT00434122|2399226|P2|NOT COMPLETED|Overall Study||7
989631|NCT00434122|2399227|P1|NOT COMPLETED|Overall Study||6
989632|NCT00434122|2399226|P2|COMPLETED|Overall Study||36
989633|NCT00434122|2399227|P1|COMPLETED|Overall Study||36
989634|NCT00434122|2399226|P2|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
989635|NCT00434122|2399227|P1|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
989636|NCT00434122|2399226|P2|STARTED|Overall Study|Randomised|43
989637|NCT00434122|2399227|P1|STARTED|Overall Study|Randomised|42
989638|NCT00434148|2399238|P2|NOT COMPLETED|Overall Study||73
989639|NCT00434148|2399239|P1|NOT COMPLETED|Overall Study||69
989640|NCT00434148|2399238|P2|COMPLETED|Overall Study||7
989641|NCT00434148|2399239|P1|COMPLETED|Overall Study||13
989642|NCT00434148|2399238|P2|Completed Month 12; Entered Extension|Overall Study||32
989643|NCT00434148|2399239|P1|Completed Month 12; Entered Extension|Overall Study||26
989644|NCT00434148|2399238|P2|Completed m. 12; Did Not Enter Extension|Overall Study||7
989645|NCT00434148|2399239|P1|Completed m. 12; Did Not Enter Extension|Overall Study||13
989646|NCT00434148|2399238|P2|Completed Month 12|Overall Study||39
989647|NCT00434148|2399239|P1|Completed Month 12|Overall Study||39
989648|NCT00434148|2399238|P2|STARTED|Overall Study||80
989649|NCT00434148|2399239|P1|STARTED|Overall Study|"Started indicates Full Analysis Set. Patients randomized and treated."|82
989650|NCT00434161|2399276|P3|NOT COMPLETED|Overall Study||11
989651|NCT00434161|2399277|P2|NOT COMPLETED|Overall Study||3
989652|NCT00434161|2399278|P1|NOT COMPLETED|Overall Study||10
989653|NCT00434161|2399276|P3|COMPLETED|Overall Study||104
989654|NCT00434161|2399277|P2|COMPLETED|Overall Study||54
989655|NCT00434161|2399278|P1|COMPLETED|Overall Study||99
989656|NCT00434161|2399276|P3|STARTED|Overall Study||115
989657|NCT00434161|2399277|P2|STARTED|Overall Study||57
989658|NCT00434161|2399278|P1|STARTED|Overall Study||109
989659|NCT00434213|2399320|P1|NOT COMPLETED|Overall Study||49
989660|NCT00434213|2399320|P1|COMPLETED|Overall Study||260
989661|NCT00434213|2399320|P1|STARTED|Overall Study||309
989662|NCT00434226|2399327|P2|NOT COMPLETED|Overall Study||26
989663|NCT00434226|2399328|P1|NOT COMPLETED|Overall Study||30
989664|NCT00434226|2399327|P2|COMPLETED|Overall Study||0
989665|NCT00434226|2399328|P1|COMPLETED|Overall Study||0
989666|NCT00434226|2399327|P2|STARTED|Overall Study||26
989667|NCT00434226|2399328|P1|STARTED|Overall Study||30
989668|NCT00434252|2399341|P2|NOT COMPLETED|Overall Study||131
989669|NCT00434252|2399342|P1|NOT COMPLETED|Overall Study||64
989670|NCT00434252|2399341|P2|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|12
989671|NCT00434252|2399342|P1|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|7
989672|NCT00434252|2399341|P2|Treated|Overall Study||143
989673|NCT00434252|2399342|P1|Treated|Overall Study|One patient died and one patient withdrew prior to receiving study treatment|69
989674|NCT00434252|2399341|P2|STARTED|Overall Study||143
989675|NCT00434252|2399342|P1|STARTED|Overall Study||71
989676|NCT00434278|2399364|P2|NOT COMPLETED|Overall Study||0
989677|NCT00434278|2399365|P1|NOT COMPLETED|Overall Study||2
989678|NCT00434278|2399364|P2|COMPLETED|Overall Study||13
989679|NCT00434278|2399365|P1|COMPLETED|Overall Study||12
989680|NCT00434278|2399364|P2|STARTED|Overall Study||13
989681|NCT00434278|2399365|P1|STARTED|Overall Study||14
989682|NCT00434304|2399373|P1|NOT COMPLETED|Overall Study||20
989683|NCT00434304|2399373|P1|COMPLETED|Overall Study||42
989684|NCT00434304|2399373|P1|STARTED|Overall Study||62
989685|NCT00434330|2399415|P6|NOT COMPLETED|Overall Study||1
989686|NCT00434330|2399416|P5|NOT COMPLETED|Overall Study||1
989687|NCT00434330|2399417|P4|NOT COMPLETED|Overall Study||2
989688|NCT00434330|2399418|P3|NOT COMPLETED|Overall Study||3
989689|NCT00434330|2399419|P2|NOT COMPLETED|Overall Study||0
989690|NCT00434330|2399420|P1|NOT COMPLETED|Overall Study||1
989691|NCT00434330|2399415|P6|COMPLETED|Overall Study||14
989692|NCT00434330|2399416|P5|COMPLETED|Overall Study||14
989693|NCT00434330|2399417|P4|COMPLETED|Overall Study||13
989694|NCT00434330|2399418|P3|COMPLETED|Overall Study||13
989695|NCT00434330|2399419|P2|COMPLETED|Overall Study||15
989696|NCT00434330|2399420|P1|COMPLETED|Overall Study||14
989697|NCT00434330|2399415|P6|STARTED|Overall Study||15
989698|NCT00434330|2399416|P5|STARTED|Overall Study||15
989699|NCT00434330|2399417|P4|STARTED|Overall Study||15
989700|NCT00434330|2399418|P3|STARTED|Overall Study||16
989701|NCT00434330|2399419|P2|STARTED|Overall Study||15
989702|NCT00434330|2399420|P1|STARTED|Overall Study||15
989703|NCT00434356|2399454|P2|NOT COMPLETED|Overall Study||23
989704|NCT00434356|2399455|P1|NOT COMPLETED|Overall Study||23
989705|NCT00434356|2399454|P2|COMPLETED|Overall Study||0
989706|NCT00434356|2399455|P1|COMPLETED|Overall Study||0
989707|NCT00434356|2399454|P2|STARTED|Overall Study||23
989708|NCT00434356|2399455|P1|STARTED|Overall Study||23
989709|NCT00434421|2399470|P1|NOT COMPLETED|Overall Study||2
989710|NCT00434421|2399470|P1|COMPLETED|Overall Study||26
989711|NCT00434421|2399470|P1|STARTED|Overall Study||28
989712|NCT00434434|2399477|P3|NOT COMPLETED|Overall Study||1
989713|NCT00434434|2399478|P2|NOT COMPLETED|Overall Study||0
989714|NCT00434434|2399479|P1|NOT COMPLETED|Overall Study||2
989715|NCT00434434|2399477|P3|COMPLETED|Overall Study||13
989716|NCT00434434|2399478|P2|COMPLETED|Overall Study||24
989717|NCT00434434|2399479|P1|COMPLETED|Overall Study||21
989718|NCT00434434|2399477|P3|STARTED|Overall Study||14
989719|NCT00434434|2399478|P2|STARTED|Overall Study||24
989720|NCT00434434|2399479|P1|STARTED|Overall Study||23
989721|NCT00434590|2399492|P2|NOT COMPLETED|Overall Study||5
989722|NCT00434590|2399493|P1|NOT COMPLETED|Overall Study||5
989723|NCT00434590|2399492|P2|COMPLETED|Overall Study||0
989724|NCT00434590|2399493|P1|COMPLETED|Overall Study|All patients randomized had study discontinued because of premature study termination.|0
989725|NCT00434590|2399492|P2|STARTED|Overall Study||5
989726|NCT00434590|2399493|P1|STARTED|Overall Study||5
989727|NCT00434642|2399501|P2|NOT COMPLETED|Open-label Treatment Phase||11
989728|NCT00434642|2399502|P1|NOT COMPLETED|Open-label Treatment Phase||0
989729|NCT00434642|2399501|P2|COMPLETED|Open-label Treatment Phase||1
989730|NCT00434642|2399502|P1|COMPLETED|Open-label Treatment Phase||0
989731|NCT00434642|2399501|P2|STARTED|Open-label Treatment Phase|One participant did not continue into the open-label treatment phase.|12
989732|NCT00434642|2399502|P1|STARTED|Open-label Treatment Phase||0
989733|NCT00434642|2399501|P2|NOT COMPLETED|Blinded Treatment Phase||229
989734|NCT00434642|2399502|P1|NOT COMPLETED|Blinded Treatment Phase||242
989735|NCT00434642|2399501|P2|COMPLETED|Blinded Treatment Phase||13
989736|NCT00434642|2399502|P1|COMPLETED|Blinded Treatment Phase||0
989737|NCT00434642|2399501|P2|STARTED|Blinded Treatment Phase||242
989738|NCT00434642|2399502|P1|STARTED|Blinded Treatment Phase||242
989739|NCT00434759|2399520|P2|NOT COMPLETED|Overall Study||5
989740|NCT00434759|2399521|P1|NOT COMPLETED|Overall Study||24
989741|NCT00434759|2399520|P2|COMPLETED|Overall Study||38
989742|NCT00434759|2399521|P1|COMPLETED|Overall Study||22
989743|NCT00434759|2399520|P2|STARTED|Overall Study||43
989744|NCT00434759|2399521|P1|STARTED|Overall Study||46
989745|NCT00434876|2399537|P2|NOT COMPLETED|Overall Study||1
989746|NCT00434876|2399538|P1|NOT COMPLETED|Overall Study||1
989747|NCT00434876|2399537|P2|COMPLETED|Overall Study||10
989748|NCT00434876|2399538|P1|COMPLETED|Overall Study||10
989749|NCT00434876|2399537|P2|STARTED|Overall Study||11
989750|NCT00434876|2399538|P1|STARTED|Overall Study||11
989751|NCT00434954|2399552|P2|NOT COMPLETED|Overall Study||71
989752|NCT00434954|2399553|P1|NOT COMPLETED|Overall Study||82
989753|NCT00434954|2399552|P2|COMPLETED|Overall Study||175
989754|NCT00434954|2399553|P1|COMPLETED|Overall Study||166
989755|NCT00434954|2399552|P2|Completed - Previous Treatment MET + SU|Overall Study||38
989756|NCT00434954|2399553|P1|Completed - Previous Treatment MET + SU|Overall Study||31
989757|NCT00434954|2399552|P2|Completed - Previous Treatment MET Only|Overall Study||137
989758|NCT00434954|2399553|P1|Completed - Previous Treatment MET Only|Overall Study||135
989759|NCT00434954|2399552|P2|FAS - Previous Treatment MET + SU|Overall Study||60
989760|NCT00434954|2399553|P1|FAS - Previous Treatment MET + SU|Overall Study||66
989761|NCT00434954|2399552|P2|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|173
989762|NCT00434954|2399553|P1|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|181
989763|NCT00434954|2399552|P2|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|233
989764|NCT00434954|2399553|P1|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|247
989765|NCT00434954|2399552|P2|Started - Previous Treatment MET + SU|Overall Study||65
989766|NCT00434954|2399553|P1|Started - Previous Treatment MET + SU|Overall Study||66
989767|NCT00434954|2399552|P2|Started - Previous Treatment MET Only|Overall Study||181
989768|NCT00434954|2399553|P1|Started - Previous Treatment MET Only|Overall Study||182
989769|NCT00434954|2399552|P2|STARTED|Overall Study||246
989770|NCT00434954|2399553|P1|STARTED|Overall Study||248
989771|NCT00434967|2399585|P4|NOT COMPLETED|Overall Study||14
989772|NCT00434967|2399586|P3|NOT COMPLETED|Overall Study||9
989773|NCT00434967|2399587|P2|NOT COMPLETED|Overall Study||8
989774|NCT00434967|2399588|P1|NOT COMPLETED|Overall Study||7
989775|NCT00434967|2399585|P4|COMPLETED|Overall Study||478
989776|NCT00434967|2399586|P3|COMPLETED|Overall Study||461
989777|NCT00434967|2399587|P2|COMPLETED|Overall Study||457
989778|NCT00434967|2399588|P1|COMPLETED|Overall Study||90
989779|NCT00434967|2399585|P4|STARTED|Overall Study||492
989780|NCT00434967|2399586|P3|STARTED|Overall Study||470
989781|NCT00434967|2399587|P2|STARTED|Overall Study||465
989782|NCT00434967|2399588|P1|STARTED|Overall Study||97
989783|NCT00434993|2399608|P2|NOT COMPLETED|Overall Study||0
989784|NCT00434993|2399609|P1|NOT COMPLETED|Overall Study||0
989785|NCT00434993|2399608|P2|COMPLETED|Overall Study||130
989786|NCT00434993|2399609|P1|COMPLETED|Overall Study||152
989787|NCT00434993|2399608|P2|STARTED|Overall Study||130
989788|NCT00434993|2399609|P1|STARTED|Overall Study||152
989789|NCT00435019|2399635|P2|NOT COMPLETED|Overall Study||10
989790|NCT00435019|2399636|P1|NOT COMPLETED|Overall Study||13
989791|NCT00435019|2399635|P2|COMPLETED|Overall Study||161
989792|NCT00435019|2399636|P1|COMPLETED|Overall Study||164
989793|NCT00435019|2399635|P2|Exposed to Study Drug|Overall Study|One subject withdrew before receiving study drug, and thus not included in the full analysis set.|170
989794|NCT00435019|2399636|P1|Exposed to Study Drug|Overall Study||177
989795|NCT00435019|2399635|P2|STARTED|Overall Study|Randomised|171
989796|NCT00435019|2399636|P1|STARTED|Overall Study|Randomised|177
989797|NCT00435045|2399648|P2|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||2
989798|NCT00435045|2399649|P1|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||5
989799|NCT00435045|2399648|P2|COMPLETED|Weeks 13-16 / 40mg Dose Level||111
989800|NCT00435045|2399649|P1|COMPLETED|Weeks 13-16 / 40mg Dose Level||108
989801|NCT00435045|2399648|P2|STARTED|Weeks 13-16 / 40mg Dose Level||113
989802|NCT00435045|2399649|P1|STARTED|Weeks 13-16 / 40mg Dose Level||113
989803|NCT00435045|2399648|P2|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
989804|NCT00435045|2399649|P1|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
989805|NCT00435045|2399648|P2|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
989806|NCT00435045|2399649|P1|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
989807|NCT00435045|2399648|P2|STARTED|Weeks 9-12 / 20mg Dose Level||118
989808|NCT00435045|2399649|P1|STARTED|Weeks 9-12 / 20mg Dose Level||118
989809|NCT00435045|2399648|P2|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||4
989810|NCT00435045|2399649|P1|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||5
989811|NCT00435045|2399648|P2|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
989812|NCT00435045|2399649|P1|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
989813|NCT00435045|2399648|P2|STARTED|Weeks 1-8 / 10 mg Dose Level||122
989814|NCT00435045|2399649|P1|STARTED|Weeks 1-8 / 10 mg Dose Level||123
989815|NCT00435162|2399706|P6|NOT COMPLETED|Period 2 (2 Weeks)||0
989816|NCT00435162|2399707|P5|NOT COMPLETED|Period 2 (2 Weeks)||0
989817|NCT00435162|2399708|P4|NOT COMPLETED|Period 2 (2 Weeks)||0
989818|NCT00435162|2399709|P3|NOT COMPLETED|Period 2 (2 Weeks)||0
989819|NCT00435162|2399710|P2|NOT COMPLETED|Period 2 (2 Weeks)||1
989820|NCT00435162|2399711|P1|NOT COMPLETED|Period 2 (2 Weeks)||0
989821|NCT00435162|2399706|P6|COMPLETED|Period 2 (2 Weeks)||15
989822|NCT00435162|2399707|P5|COMPLETED|Period 2 (2 Weeks)||15
989823|NCT00435162|2399708|P4|COMPLETED|Period 2 (2 Weeks)||8
989824|NCT00435162|2399709|P3|COMPLETED|Period 2 (2 Weeks)||6
989825|NCT00435162|2399710|P2|COMPLETED|Period 2 (2 Weeks)||14
989826|NCT00435162|2399711|P1|COMPLETED|Period 2 (2 Weeks)||15
989827|NCT00435162|2399706|P6|STARTED|Period 2 (2 Weeks)||15
989828|NCT00435162|2399707|P5|STARTED|Period 2 (2 Weeks)||15
989829|NCT00435162|2399708|P4|STARTED|Period 2 (2 Weeks)||8
989830|NCT00435162|2399709|P3|STARTED|Period 2 (2 Weeks)||6
989831|NCT00435162|2399710|P2|STARTED|Period 2 (2 Weeks)||15
989832|NCT00435162|2399711|P1|STARTED|Period 2 (2 Weeks)||15
989833|NCT00435162|2399706|P6|NOT COMPLETED|Period 1 (6 Weeks)||0
989834|NCT00435162|2399707|P5|NOT COMPLETED|Period 1 (6 Weeks)||0
989835|NCT00435162|2399708|P4|NOT COMPLETED|Period 1 (6 Weeks)||0
989836|NCT00435162|2399709|P3|NOT COMPLETED|Period 1 (6 Weeks)||0
989837|NCT00435162|2399710|P2|NOT COMPLETED|Period 1 (6 Weeks)||0
989838|NCT00435162|2399711|P1|NOT COMPLETED|Period 1 (6 Weeks)||0
989839|NCT00435162|2399706|P6|COMPLETED|Period 1 (6 Weeks)||15
989840|NCT00435162|2399707|P5|COMPLETED|Period 1 (6 Weeks)||15
989841|NCT00435162|2399708|P4|COMPLETED|Period 1 (6 Weeks)||8
989842|NCT00435162|2399709|P3|COMPLETED|Period 1 (6 Weeks)||6
989843|NCT00435162|2399710|P2|COMPLETED|Period 1 (6 Weeks)||15
989844|NCT00435162|2399711|P1|COMPLETED|Period 1 (6 Weeks)||15
989845|NCT00435162|2399706|P6|STARTED|Period 1 (6 Weeks)||15
989846|NCT00435162|2399707|P5|STARTED|Period 1 (6 Weeks)||15
989847|NCT00435162|2399708|P4|STARTED|Period 1 (6 Weeks)||8
989848|NCT00435162|2399709|P3|STARTED|Period 1 (6 Weeks)||6
989849|NCT00435162|2399710|P2|STARTED|Period 1 (6 Weeks)||15
989850|NCT00435162|2399711|P1|STARTED|Period 1 (6 Weeks)||15
989851|NCT00435188|2399731|P2|NOT COMPLETED|Overall Study||23
989852|NCT00435188|2399732|P1|NOT COMPLETED|Overall Study||22
989853|NCT00435188|2399731|P2|COMPLETED|Overall Study||176
989854|NCT00435188|2399732|P1|COMPLETED|Overall Study||177
989855|NCT00435188|2399731|P2|STARTED|Overall Study||199
989856|NCT00435188|2399732|P1|STARTED|Overall Study||199
989857|NCT00435370|2399774|P2|NOT COMPLETED|Overall Study||20
989858|NCT00435370|2399775|P1|NOT COMPLETED|Overall Study||22
989859|NCT00435370|2399774|P2|COMPLETED|Overall Study|The entire recruitment has been completed in December, 2011.|69
989860|NCT00435370|2399775|P1|COMPLETED|Overall Study||68
989861|NCT00435370|2399774|P2|STARTED|Overall Study|The recruitment restarted in August, 2010.|89
989862|NCT00435370|2399775|P1|STARTED|Overall Study||90
989863|NCT00435409|2399783|P3|NOT COMPLETED|Overall Study||78
989864|NCT00435409|2399784|P2|NOT COMPLETED|Overall Study||143
989865|NCT00435409|2399785|P1|NOT COMPLETED|Overall Study||221
989866|NCT00435409|2399783|P3|COMPLETED|Overall Study||0
989867|NCT00435409|2399784|P2|COMPLETED|Overall Study||0
989868|NCT00435409|2399785|P1|COMPLETED|Overall Study||0
989869|NCT00435409|2399783|P3|Treated|Overall Study||78
989870|NCT00435409|2399784|P2|Treated|Overall Study||139
989871|NCT00435409|2399785|P1|Treated|Overall Study||217
989872|NCT00435409|2399783|P3|STARTED|Overall Study||78
989873|NCT00435409|2399784|P2|STARTED|Overall Study||143
989874|NCT00435409|2399785|P1|STARTED|Overall Study||221
989875|NCT00435487|2399807|P2|NOT COMPLETED|Overall Study||15
989876|NCT00435487|2399808|P1|NOT COMPLETED|Overall Study||12
989877|NCT00435487|2399807|P2|COMPLETED|Overall Study||71
989878|NCT00435487|2399808|P1|COMPLETED|Overall Study||76
989879|NCT00435487|2399807|P2|TREATED|Overall Study|One subject was mistakenly treated with Dalteparin, two subjects withdrew consent before treatment.|83
989880|NCT00435487|2399808|P1|TREATED|Overall Study|One additional subject originally randomized to Unfractioned Heparin was treated with Dalteparin.|88
989881|NCT00435487|2399807|P2|STARTED|Overall Study||86
989882|NCT00435487|2399808|P1|STARTED|Overall Study|87 subjects were randomized however one additional subject originally randomized to UFH was treated.|88
989883|NCT00435539|2399829|P5|NOT COMPLETED|Overall Study||0
989884|NCT00435539|2399830|P4|NOT COMPLETED|Overall Study||0
989885|NCT00435539|2399831|P3|NOT COMPLETED|Overall Study||0
989886|NCT00435539|2399832|P2|NOT COMPLETED|Overall Study||0
989887|NCT00435539|2399833|P1|NOT COMPLETED|Overall Study||0
989888|NCT00435539|2399829|P5|COMPLETED|Overall Study||12
989889|NCT00435539|2399830|P4|COMPLETED|Overall Study||12
989890|NCT00435539|2399831|P3|COMPLETED|Overall Study||11
989891|NCT00435539|2399832|P2|COMPLETED|Overall Study||13
989892|NCT00435539|2399833|P1|COMPLETED|Overall Study||12
989893|NCT00435539|2399829|P5|STARTED|Overall Study||12
989894|NCT00435539|2399830|P4|STARTED|Overall Study||12
989895|NCT00435539|2399831|P3|STARTED|Overall Study||11
989896|NCT00435539|2399832|P2|STARTED|Overall Study||13
989897|NCT00435539|2399833|P1|STARTED|Overall Study||12
989898|NCT00435591|2399852|P4|NOT COMPLETED|Overall Study||11
989899|NCT00435591|2399853|P3|NOT COMPLETED|Overall Study||5
989900|NCT00435591|2399854|P2|NOT COMPLETED|Overall Study||4
989901|NCT00435591|2399855|P1|NOT COMPLETED|Overall Study||7
989902|NCT00435591|2399852|P4|COMPLETED|Overall Study||19
989903|NCT00435591|2399853|P3|COMPLETED|Overall Study||25
989904|NCT00435591|2399854|P2|COMPLETED|Overall Study||27
989905|NCT00435591|2399855|P1|COMPLETED|Overall Study||23
989906|NCT00435591|2399852|P4|End of Treatment|Overall Study||23
989907|NCT00435591|2399853|P3|End of Treatment|Overall Study||27
989908|NCT00435591|2399854|P2|End of Treatment|Overall Study||27
989909|NCT00435591|2399855|P1|End of Treatment|Overall Study||25
989910|NCT00435591|2399852|P4|Full Analysis Set|Overall Study||29
989911|NCT00435591|2399853|P3|Full Analysis Set|Overall Study||30
989912|NCT00435591|2399854|P2|Full Analysis Set|Overall Study||29
989913|NCT00435591|2399855|P1|Full Analysis Set|Overall Study||28
989914|NCT00435591|2399852|P4|Safety Analysis Set|Overall Study||29
989915|NCT00435591|2399853|P3|Safety Analysis Set|Overall Study||30
989916|NCT00435591|2399854|P2|Safety Analysis Set|Overall Study||30
989917|NCT00435591|2399855|P1|Safety Analysis Set|Overall Study||28
989918|NCT00435591|2399852|P4|STARTED|Overall Study||30
989919|NCT00435591|2399853|P3|STARTED|Overall Study||30
989920|NCT00435591|2399854|P2|STARTED|Overall Study||31
989921|NCT00435591|2399855|P1|STARTED|Overall Study||30
989922|NCT00435825|2399884|P4|NOT COMPLETED|Overall Study||16
989923|NCT00435825|2399885|P3|NOT COMPLETED|Overall Study||11
989924|NCT00435825|2399886|P2|NOT COMPLETED|Overall Study||12
989925|NCT00435825|2399887|P1|NOT COMPLETED|Overall Study||18
989926|NCT00435825|2399884|P4|COMPLETED|Overall Study||120
989927|NCT00435825|2399885|P3|COMPLETED|Overall Study||127
989928|NCT00435825|2399886|P2|COMPLETED|Overall Study||124
989929|NCT00435825|2399887|P1|COMPLETED|Overall Study|Completed is the number of participants who received study treatment and completed follow-up.|123
989930|NCT00435825|2399884|P4|Completed 48 Weeks Treatment|Overall Study||117
989931|NCT00435825|2399885|P3|Completed 48 Weeks Treatment|Overall Study||124
989932|NCT00435825|2399886|P2|Completed 48 Weeks Treatment|Overall Study||0
989933|NCT00435825|2399887|P1|Completed 48 Weeks Treatment|Overall Study||0
989934|NCT00435825|2399884|P4|Completed 24 Weeks Treatment|Overall Study||131
989935|NCT00435825|2399885|P3|Completed 24 Weeks Treatment|Overall Study||134
989936|NCT00435825|2399886|P2|Completed 24 Weeks Treatment|Overall Study||126
989937|NCT00435825|2399887|P1|Completed 24 Weeks Treatment|Overall Study||128
989938|NCT00435825|2399884|P4|Entered Follow-up|Overall Study||133
989939|NCT00435825|2399885|P3|Entered Follow-up|Overall Study||135
989940|NCT00435825|2399886|P2|Entered Follow-up|Overall Study||132
989941|NCT00435825|2399887|P1|Entered Follow-up|Overall Study||140
989942|NCT00435825|2399884|P4|Received Study Drug|Overall Study||136
989943|NCT00435825|2399885|P3|Received Study Drug|Overall Study||136
989944|NCT00435825|2399886|P2|Received Study Drug|Overall Study||136
989945|NCT00435825|2399887|P1|Received Study Drug|Overall Study||140
989946|NCT00435825|2399884|P4|STARTED|Overall Study||136
989947|NCT00435825|2399885|P3|STARTED|Overall Study||138
989948|NCT00435825|2399886|P2|STARTED|Overall Study||136
989949|NCT00435825|2399887|P1|STARTED|Overall Study||141
989950|NCT00435929|2399943|P2|NOT COMPLETED|Overall Study||0
989951|NCT00435929|2399944|P1|NOT COMPLETED|Overall Study||0
989952|NCT00435929|2399943|P2|COMPLETED|Overall Study||9
989953|NCT00435929|2399944|P1|COMPLETED|Overall Study||7
989954|NCT00435929|2399943|P2|STARTED|Overall Study||9
989955|NCT00435929|2399944|P1|STARTED|Overall Study||7
989956|NCT00435942|2399972|P2|NOT COMPLETED|Overall Study||27
989957|NCT00435942|2399973|P1|NOT COMPLETED|Overall Study||23
989958|NCT00435942|2399972|P2|COMPLETED|Overall Study||33
989959|NCT00435942|2399973|P1|COMPLETED|Overall Study||97
989960|NCT00435942|2399972|P2|STARTED|Overall Study||60
989961|NCT00435942|2399973|P1|STARTED|Overall Study||120
989962|NCT00435994|2399983|P3|NOT COMPLETED|Overall Study||0
989963|NCT00435994|2399984|P2|NOT COMPLETED|Overall Study||0
989964|NCT00435994|2399985|P1|NOT COMPLETED|Overall Study||7
989965|NCT00435994|2399983|P3|COMPLETED|Overall Study||12
989966|NCT00435994|2399984|P2|COMPLETED|Overall Study||25
989967|NCT00435994|2399985|P1|COMPLETED|Overall Study|7 of the subjects were consented and did not complete the study procedures.|15
989968|NCT00435994|2399983|P3|STARTED|Overall Study||12
989969|NCT00435994|2399984|P2|STARTED|Overall Study||25
989970|NCT00435994|2399985|P1|STARTED|Overall Study||22
989971|NCT00436007|2399997|P3|NOT COMPLETED|Overall Study||23
989972|NCT00436007|2399998|P2|NOT COMPLETED|Overall Study||14
989973|NCT00436007|2399999|P1|NOT COMPLETED|Overall Study||19
989974|NCT00436007|2399997|P3|COMPLETED|Overall Study||148
989975|NCT00436007|2399998|P2|COMPLETED|Overall Study||156
989976|NCT00436007|2399999|P1|COMPLETED|Overall Study||151
989977|NCT00436007|2399997|P3|STARTED|Overall Study||171
989978|NCT00436007|2399998|P2|STARTED|Overall Study||170
989979|NCT00436007|2399999|P1|STARTED|Overall Study||170
989980|NCT00436046|2400047|P3|NOT COMPLETED|Overall Study||0
989981|NCT00436046|2400048|P2|NOT COMPLETED|Overall Study||0
989982|NCT00436046|2400049|P1|NOT COMPLETED|Overall Study||0
989983|NCT00436046|2400047|P3|COMPLETED|Overall Study||31
989984|NCT00436046|2400048|P2|COMPLETED|Overall Study||32
989985|NCT00436046|2400049|P1|COMPLETED|Overall Study||32
989986|NCT00436046|2400047|P3|STARTED|Overall Study||31
989987|NCT00436046|2400048|P2|STARTED|Overall Study||32
989988|NCT00436046|2400049|P1|STARTED|Overall Study||32
989989|NCT00436163|2400078|P1|NOT COMPLETED|Overall Study||3
989990|NCT00436163|2400078|P1|COMPLETED|Overall Study||36
989991|NCT00436163|2400078|P1|STARTED|Overall Study||39
989992|NCT00436215|2400089|P1|NOT COMPLETED|Overall Study||4
989993|NCT00436215|2400089|P1|COMPLETED|Overall Study||51
989994|NCT00436215|2400089|P1|STARTED|Overall Study||55
989995|NCT00436332|2400095|P1|NOT COMPLETED|Overall Study||83
989996|NCT00436332|2400095|P1|COMPLETED|Overall Study||1
989997|NCT00436332|2400095|P1|Eligible and Began Protocol Therapy|Overall Study||79
989998|NCT00436332|2400095|P1|Eligible|Overall Study||82
989999|NCT00436332|2400095|P1|STARTED|Overall Study||84
990000|NCT00436345|2400104|P2|NOT COMPLETED|Overall Study||0
990001|NCT00436345|2400105|P1|NOT COMPLETED|Overall Study||3
990002|NCT00436345|2400104|P2|COMPLETED|Overall Study||18
990003|NCT00436345|2400105|P1|COMPLETED|Overall Study||18
990004|NCT00436345|2400104|P2|STARTED|Overall Study||18
990005|NCT00436345|2400105|P1|STARTED|Overall Study||21
990006|NCT00426764|2400158|P1|NOT COMPLETED|Overall Study||98
990007|NCT00426764|2400158|P1|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6 (data cutoff of October 31 2010).|33
990008|NCT00426764|2400158|P1|Received 6 or More Treatment Cycles|Overall Study||36
990009|NCT00426764|2400158|P1|Received 4 or More Treatment Cycles|Overall Study||50
990010|NCT00426764|2400158|P1|Histopathologically-Confirmed Population|Overall Study|Central histologic confirmation of peripheral T-cell lymphoma (PTCL).|130
990011|NCT00426764|2400158|P1|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|131
990012|NCT00426842|2400172|P1|NOT COMPLETED|Overall Study||1
990013|NCT00426842|2400172|P1|COMPLETED|Overall Study||10
990014|NCT00426842|2400172|P1|STARTED|Overall Study||11
990015|NCT00426855|2400178|P1|NOT COMPLETED|Overall Study||0
990016|NCT00426855|2400178|P1|COMPLETED|Overall Study||12
990017|NCT00426855|2400178|P1|STARTED|Overall Study||12
990018|NCT00427011|2400182|P1|NOT COMPLETED|Overall Study||25
990019|NCT00427011|2400182|P1|COMPLETED|Overall Study||0
990020|NCT00427011|2400182|P1|STARTED|Overall Study||25
990021|NCT00427037|2400195|P2|NOT COMPLETED|Overall Study||7
990022|NCT00427037|2400196|P1|NOT COMPLETED|Overall Study||7
990023|NCT00427037|2400195|P2|COMPLETED|Overall Study||10
990024|NCT00427037|2400196|P1|COMPLETED|Overall Study||10
990025|NCT00427037|2400195|P2|STARTED|Overall Study||17
990026|NCT00427037|2400196|P1|STARTED|Overall Study||17
990027|NCT00436436|2400204|P1|NOT COMPLETED|Overall Study||12
990028|NCT00436436|2400204|P1|COMPLETED|Overall Study||0
990029|NCT00436436|2400204|P1|STARTED|Overall Study||12
990030|NCT00436501|2400215|P2|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||3
990031|NCT00436501|2400216|P1|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
990032|NCT00436501|2400215|P2|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||46
990033|NCT00436501|2400216|P1|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
990034|NCT00436501|2400215|P2|STARTED|Phase 2: MTD VEGF Trap + Docetaxel|After toxicity observations Phase 2 opened June 4, 2008 and closed to entry September 27, 2010.|49
990035|NCT00436501|2400216|P1|STARTED|Phase 2: MTD VEGF Trap + Docetaxel||0
990036|NCT00436501|2400215|P2|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
990037|NCT00436501|2400216|P1|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
990038|NCT00436501|2400215|P2|COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
990039|NCT00436501|2400216|P1|COMPLETED|Phase 1: VEGF Trap Escalating Dose||9
990040|NCT00436501|2400215|P2|STARTED|Phase 1: VEGF Trap Escalating Dose|Participants registered in next period.|0
990041|NCT00436501|2400216|P1|STARTED|Phase 1: VEGF Trap Escalating Dose|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
990042|NCT00436501|2400215|P2|NOT COMPLETED|Complete Study Participation||0
990043|NCT00436501|2400216|P1|NOT COMPLETED|Complete Study Participation||0
990044|NCT00436501|2400215|P2|COMPLETED|Complete Study Participation||49
990045|NCT00436501|2400216|P1|COMPLETED|Complete Study Participation||9
990046|NCT00436501|2400215|P2|STARTED|Complete Study Participation|After toxicity observations, Phase 2 opened June 4, 2008 and closed September 27, 2010.|49
990047|NCT00436501|2400216|P1|STARTED|Complete Study Participation|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
990048|NCT00436553|2400230|P3|NOT COMPLETED|Overall Study||10
990049|NCT00436553|2400231|P2|NOT COMPLETED|Overall Study||12
990050|NCT00436553|2400232|P1|NOT COMPLETED|Overall Study||13
990051|NCT00436553|2400230|P3|COMPLETED|Overall Study||102
990052|NCT00436553|2400231|P2|COMPLETED|Overall Study||93
990053|NCT00436553|2400232|P1|COMPLETED|Overall Study|Completed the 12 month study phase.|91
990054|NCT00436553|2400230|P3|STARTED|Overall Study||112
990055|NCT00436553|2400231|P2|STARTED|Overall Study||105
990056|NCT00436553|2400232|P1|STARTED|Overall Study|"The table shows 12 month data. Started indicates Randomized set of population."|104
990057|NCT00436566|2400251|P1|NOT COMPLETED|Overall Study||3
990058|NCT00436566|2400251|P1|COMPLETED|Overall Study||109
990059|NCT00436566|2400251|P1|STARTED|Overall Study||112
990060|NCT00436605|2400255|P1|NOT COMPLETED|Overall Study||3
990061|NCT00436605|2400255|P1|COMPLETED|Overall Study||36
990062|NCT00436605|2400255|P1|STARTED|Overall Study||39
990063|NCT00436618|2400263|P3|NOT COMPLETED|Overall Study||61
990064|NCT00436618|2400264|P2|NOT COMPLETED|Overall Study||27
990065|NCT00436618|2400265|P1|NOT COMPLETED|Overall Study||30
990066|NCT00436618|2400263|P3|COMPLETED|Overall Study||46
990067|NCT00436618|2400264|P2|COMPLETED|Overall Study||28
990068|NCT00436618|2400265|P1|COMPLETED|Overall Study||84
990069|NCT00436618|2400263|P3|STARTED|Overall Study||107
990070|NCT00436618|2400264|P2|STARTED|Overall Study||55
990071|NCT00436618|2400265|P1|STARTED|Overall Study||114
990072|NCT00436644|2400282|P1|NOT COMPLETED|Overall Study||3
990073|NCT00436644|2400282|P1|COMPLETED|Overall Study||15
990074|NCT00436644|2400282|P1|STARTED|Overall Study||18
990075|NCT00437983|2400291|P2|NOT COMPLETED|Overall Study||13
990076|NCT00437983|2400292|P1|NOT COMPLETED|Overall Study||13
990077|NCT00437983|2400291|P2|COMPLETED|Overall Study||65
990078|NCT00437983|2400292|P1|COMPLETED|Overall Study||66
990079|NCT00437983|2400291|P2|STARTED|Overall Study||78
990080|NCT00437983|2400292|P1|STARTED|Overall Study||79
990081|NCT00438100|2400304|P2|NOT COMPLETED|Overall Study||4
990082|NCT00438100|2400305|P1|NOT COMPLETED|Overall Study||2
990083|NCT00438100|2400304|P2|COMPLETED|Overall Study||65
990084|NCT00438100|2400305|P1|COMPLETED|Overall Study||71
990085|NCT00438100|2400304|P2|STARTED|Overall Study||69
990086|NCT00438100|2400305|P1|STARTED|Overall Study||73
990087|NCT00438191|2400313|P2|NOT COMPLETED|Overall Study||14
990088|NCT00438191|2400314|P1|NOT COMPLETED|Overall Study||11
990089|NCT00438191|2400313|P2|COMPLETED|Overall Study||26
990090|NCT00438191|2400314|P1|COMPLETED|Overall Study||32
990091|NCT00438191|2400313|P2|STARTED|Overall Study||40
990092|NCT00438191|2400314|P1|STARTED|Overall Study||43
990093|NCT00438204|2400326|P1|NOT COMPLETED|Overall Study||0
990094|NCT00438204|2400326|P1|COMPLETED|Overall Study||39
990095|NCT00438204|2400326|P1|STARTED|Overall Study||39
990096|NCT00438360|2400332|P2|NOT COMPLETED|Overall Study||43
990097|NCT00438360|2400333|P1|NOT COMPLETED|Overall Study||72
990098|NCT00438360|2400332|P2|COMPLETED|Overall Study||38
990099|NCT00438360|2400333|P1|COMPLETED|Overall Study||90
990100|NCT00438360|2400332|P2|Intention to Treat (ITT) Population|Overall Study||79
990101|NCT00438360|2400333|P1|Intention to Treat (ITT) Population|Overall Study|These numbers are different from those started (randomized) as 2 pts from each arm never took drug.|160
990102|NCT00438360|2400332|P2|STARTED|Overall Study||81
990103|NCT00438360|2400333|P1|STARTED|Overall Study|"Started indicates randomized patients."|162
990104|NCT00438399|2400350|P6|NOT COMPLETED|Overall Study||6
990105|NCT00438399|2400351|P5|NOT COMPLETED|Overall Study||3
990106|NCT00438399|2400352|P4|NOT COMPLETED|Overall Study||4
990107|NCT00438399|2400353|P3|NOT COMPLETED|Overall Study||7
990108|NCT00438399|2400354|P2|NOT COMPLETED|Overall Study||8
990109|NCT00438399|2400355|P1|NOT COMPLETED|Overall Study||8
990110|NCT00438399|2400350|P6|COMPLETED|Overall Study||31
990111|NCT00438399|2400351|P5|COMPLETED|Overall Study||30
990112|NCT00438399|2400352|P4|COMPLETED|Overall Study||32
990113|NCT00438399|2400353|P3|COMPLETED|Overall Study||28
990114|NCT00438399|2400354|P2|COMPLETED|Overall Study||32
990115|NCT00438399|2400355|P1|COMPLETED|Overall Study||30
990116|NCT00438399|2400350|P6|TREATED & ANALYZED|Overall Study||31
990117|NCT00438399|2400351|P5|TREATED & ANALYZED|Overall Study||30
990118|NCT00438399|2400352|P4|TREATED & ANALYZED|Overall Study||32
990119|NCT00438399|2400353|P3|TREATED & ANALYZED|Overall Study||28
990120|NCT00438399|2400354|P2|TREATED & ANALYZED|Overall Study||32
990121|NCT00438399|2400355|P1|TREATED & ANALYZED|Overall Study||30
990122|NCT00438399|2400350|P6|STARTED|Overall Study||37
990123|NCT00438399|2400351|P5|STARTED|Overall Study||33
990124|NCT00438399|2400352|P4|STARTED|Overall Study||36
990125|NCT00438399|2400353|P3|STARTED|Overall Study||35
990126|NCT00438399|2400354|P2|STARTED|Overall Study||40
990127|NCT00438399|2400355|P1|STARTED|Overall Study||38
990128|NCT00438451|2400367|P3|NOT COMPLETED|Overall Study||53
990129|NCT00438451|2400368|P2|NOT COMPLETED|Overall Study||66
990130|NCT00438451|2400369|P1|NOT COMPLETED|Overall Study||47
990131|NCT00438451|2400367|P3|COMPLETED|Overall Study||65
990132|NCT00438451|2400368|P2|COMPLETED|Overall Study||55
990133|NCT00438451|2400369|P1|COMPLETED|Overall Study||75
990134|NCT00438451|2400367|P3|Maintenance Phase (Week 7-58)|Overall Study||93
990135|NCT00438451|2400368|P2|Maintenance Phase (Week 7-58)|Overall Study||89
990136|NCT00438451|2400369|P1|Maintenance Phase (Week 7-58)|Overall Study||93
990137|NCT00438451|2400367|P3|ITT Population|Overall Study||117
990138|NCT00438451|2400368|P2|ITT Population|Overall Study||120
990139|NCT00438451|2400369|P1|ITT Population|Overall Study||122
990140|NCT00438451|2400367|P3|Safety Population|Overall Study||117
990141|NCT00438451|2400368|P2|Safety Population|Overall Study||121
990142|NCT00438451|2400369|P1|Safety Population|Overall Study||122
990143|NCT00438451|2400367|P3|STARTED|Overall Study||118
990144|NCT00438451|2400368|P2|STARTED|Overall Study||121
990145|NCT00438451|2400369|P1|STARTED|Overall Study||122
990146|NCT00438464|2400412|P2|NOT COMPLETED|Overall Study||7
990147|NCT00438464|2400413|P1|NOT COMPLETED|Overall Study||14
990148|NCT00438464|2400412|P2|COMPLETED|Overall Study||94
990149|NCT00438464|2400413|P1|COMPLETED|Overall Study||89
990150|NCT00438464|2400412|P2|Received Assigned Intervention|Overall Study||94
990151|NCT00438464|2400413|P1|Received Assigned Intervention|Overall Study||89
990152|NCT00438464|2400412|P2|STARTED|Overall Study||101
990153|NCT00438464|2400413|P1|STARTED|Overall Study||103
990154|NCT00438490|2400467|P2|NOT COMPLETED|Overall Study||0
990155|NCT00438490|2400468|P1|NOT COMPLETED|Overall Study||0
990156|NCT00438490|2400467|P2|COMPLETED|Overall Study||9
990157|NCT00438490|2400468|P1|COMPLETED|Overall Study||12
990158|NCT00438490|2400467|P2|STARTED|Overall Study||9
990159|NCT00438490|2400468|P1|STARTED|Overall Study||12
990160|NCT00438659|2400476|P2|NOT COMPLETED|Overall Study||4
990161|NCT00438659|2400477|P1|NOT COMPLETED|Overall Study||6
990162|NCT00438659|2400476|P2|COMPLETED|Overall Study||82
990163|NCT00438659|2400477|P1|COMPLETED|Overall Study||84
990164|NCT00438659|2400476|P2|STARTED|Overall Study||86
990165|NCT00438659|2400477|P1|STARTED|Overall Study||90
990166|NCT00438672|2400501|P2|NOT COMPLETED|Overall Study||9
990167|NCT00438672|2400502|P1|NOT COMPLETED|Overall Study||7
990168|NCT00438672|2400501|P2|COMPLETED|Overall Study||24
990169|NCT00438672|2400502|P1|COMPLETED|Overall Study||24
990170|NCT00438672|2400501|P2|STARTED|Overall Study||33
990171|NCT00438672|2400502|P1|STARTED|Overall Study||31
990172|NCT00438750|2400512|P2|NOT COMPLETED|Overall Study||9
990173|NCT00438750|2400513|P1|NOT COMPLETED|Overall Study||9
990174|NCT00438750|2400512|P2|COMPLETED|Overall Study||37
990175|NCT00438750|2400513|P1|COMPLETED|Overall Study||39
990176|NCT00438750|2400512|P2|STARTED|Overall Study||46
990177|NCT00438750|2400513|P1|STARTED|Overall Study||48
990178|NCT00438802|2400534|P3|NOT COMPLETED|Overall Study||0
990179|NCT00438802|2400535|P2|NOT COMPLETED|Overall Study||0
990180|NCT00438802|2400536|P1|NOT COMPLETED|Overall Study||0
990181|NCT00438802|2400534|P3|COMPLETED|Overall Study||9
990182|NCT00438802|2400535|P2|COMPLETED|Overall Study||8
990183|NCT00438802|2400536|P1|COMPLETED|Overall Study||6
990184|NCT00438802|2400534|P3|STARTED|Overall Study||9
990185|NCT00438802|2400535|P2|STARTED|Overall Study||8
990186|NCT00438802|2400536|P1|STARTED|Overall Study||6
990187|NCT00438815|2400548|P1|NOT COMPLETED|Overall Study||70
990188|NCT00438815|2400548|P1|COMPLETED|Overall Study||43
990189|NCT00438815|2400548|P1|STARTED|Overall Study||113
990190|NCT00438854|2400558|P1|NOT COMPLETED|Overall Study||0
990191|NCT00438854|2400558|P1|COMPLETED|Overall Study||15
990192|NCT00438854|2400558|P1|STARTED|Overall Study||15
990193|NCT00438880|2400564|P2|NOT COMPLETED|Overall Study||0
990194|NCT00438880|2400565|P1|NOT COMPLETED|Overall Study||0
990195|NCT00438880|2400564|P2|COMPLETED|Overall Study||8
990196|NCT00438880|2400565|P1|COMPLETED|Overall Study||30
990197|NCT00438880|2400564|P2|STARTED|Overall Study||8
990198|NCT00438880|2400565|P1|STARTED|Overall Study||30
990199|NCT00438932|2400581|P4|NOT COMPLETED|Overall Study||0
990200|NCT00438932|2400582|P3|NOT COMPLETED|Overall Study||0
990201|NCT00438932|2400583|P2|NOT COMPLETED|Overall Study||0
990202|NCT00438932|2400584|P1|NOT COMPLETED|Overall Study||0
990203|NCT00438932|2400581|P4|COMPLETED|Overall Study||4
990204|NCT00438932|2400582|P3|COMPLETED|Overall Study||4
990205|NCT00438932|2400583|P2|COMPLETED|Overall Study||4
990206|NCT00438932|2400584|P1|COMPLETED|Overall Study||4
990207|NCT00438932|2400581|P4|STARTED|Overall Study||4
990208|NCT00438932|2400582|P3|STARTED|Overall Study||4
990209|NCT00438932|2400583|P2|STARTED|Overall Study||4
990210|NCT00438932|2400584|P1|STARTED|Overall Study||4
990211|NCT00438971|2400598|P1|NOT COMPLETED|Overall Study||2
990212|NCT00438971|2400598|P1|COMPLETED|Overall Study||15
990213|NCT00438971|2400598|P1|STARTED|Overall Study||17
990214|NCT00439140|2400612|P3|NOT COMPLETED|Treatment Cycle 2||0
990215|NCT00439140|2400613|P2|NOT COMPLETED|Treatment Cycle 2||1
990216|NCT00439140|2400614|P1|NOT COMPLETED|Treatment Cycle 2||2
990217|NCT00439140|2400612|P3|COMPLETED|Treatment Cycle 2||0
990218|NCT00439140|2400613|P2|COMPLETED|Treatment Cycle 2||6
990219|NCT00439140|2400614|P1|COMPLETED|Treatment Cycle 2||11
990220|NCT00439140|2400612|P3|STARTED|Treatment Cycle 2|No patients received placebo in Cycle 2.|0
990221|NCT00439140|2400613|P2|STARTED|Treatment Cycle 2|6 patients from the 300U arm plus 1 patient from the placebo arm in Cycle 1 entered Cycle 2.|7
990222|NCT00439140|2400614|P1|STARTED|Treatment Cycle 2|8 patients from the 200U arm plus 5 patients from the placebo arm in Cycle 1 entered Cycle 2.|13
990223|NCT00439140|2400612|P3|NOT COMPLETED|Treatment Cycle 1||1
990224|NCT00439140|2400613|P2|NOT COMPLETED|Treatment Cycle 1||4
990225|NCT00439140|2400614|P1|NOT COMPLETED|Treatment Cycle 1||1
990226|NCT00439140|2400612|P3|COMPLETED|Treatment Cycle 1|5 patients did not enter Cycle 2. 6 patients received botulinum toxin Type A in Cycle 2.|11
990227|NCT00439140|2400613|P2|COMPLETED|Treatment Cycle 1||10
990228|NCT00439140|2400614|P1|COMPLETED|Treatment Cycle 1||14
990229|NCT00439140|2400612|P3|STARTED|Treatment Cycle 1||12
990230|NCT00439140|2400613|P2|STARTED|Treatment Cycle 1||14
990231|NCT00439140|2400614|P1|STARTED|Treatment Cycle 1||15
990232|NCT00439179|2400647|P4|NOT COMPLETED|Overall Study||0
990233|NCT00439179|2400648|P3|NOT COMPLETED|Overall Study||0
990234|NCT00439179|2400649|P2|NOT COMPLETED|Overall Study||2
990235|NCT00439179|2400650|P1|NOT COMPLETED|Overall Study||0
990236|NCT00439179|2400647|P4|COMPLETED|Overall Study||5
990237|NCT00439179|2400648|P3|COMPLETED|Overall Study||6
990238|NCT00439179|2400649|P2|COMPLETED|Overall Study||11
990239|NCT00439179|2400650|P1|COMPLETED|Overall Study||3
990240|NCT00439179|2400647|P4|STARTED|Overall Study|2 with biliry|5
990241|NCT00439179|2400648|P3|STARTED|Overall Study|2 with biliary|6
990242|NCT00439179|2400649|P2|STARTED|Overall Study|2 with biliary|13
990243|NCT00439179|2400650|P1|STARTED|Overall Study|1 with biliary|3
990244|NCT00439218|2400664|P1|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||0
990245|NCT00439218|2400664|P1|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
990246|NCT00439218|2400664|P1|STARTED|Cohort 2 (500 mg/kg/Day)|One new subject was enrolled into the study after Cohort 1 completed the study.|1
990247|NCT00439218|2400664|P1|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||1
990248|NCT00439218|2400664|P1|COMPLETED|Cohort 1 (500 mg/kg/Day)|3 subjects completed the study in Cohort 1. Cohort 2 was then opened for new enrollments.|3
990249|NCT00439218|2400664|P1|STARTED|Cohort 1 (500 mg/kg/Day)||4
990250|NCT00439231|2400675|P1|NOT COMPLETED|Overall Study||28
990251|NCT00439231|2400675|P1|COMPLETED|Overall Study|5 subjects had a partial response, 0 complete response, 28 completed off study,|5
990252|NCT00439231|2400675|P1|STARTED|Overall Study||33
990253|NCT00439244|2400682|P3|NOT COMPLETED|Overall Study||7
990254|NCT00439244|2400683|P2|NOT COMPLETED|Overall Study||6
990255|NCT00439244|2400684|P1|NOT COMPLETED|Overall Study||11
990256|NCT00439244|2400682|P3|COMPLETED|Overall Study||131
990257|NCT00439244|2400683|P2|COMPLETED|Overall Study||131
990258|NCT00439244|2400684|P1|COMPLETED|Overall Study||126
990259|NCT00439244|2400682|P3|Safety Population|Overall Study||137
990260|NCT00439244|2400683|P2|Safety Population|Overall Study||137
990261|NCT00439244|2400684|P1|Safety Population|Overall Study|Total safety population is 411. One patient was randomized, but never received any study medication.|137
990262|NCT00439244|2400682|P3|STARTED|Overall Study||138
990263|NCT00439244|2400683|P2|STARTED|Overall Study||137
990264|NCT00439244|2400684|P1|STARTED|Overall Study|"Started indicates randomized as well as intent to treat (ITT) population enrolled to study."|137
990265|NCT00439270|2400709|P5|NOT COMPLETED|Phase 2 (51.6 Months)||0
990266|NCT00439270|2400710|P4|NOT COMPLETED|Phase 2 (51.6 Months)||34
990267|NCT00439270|2400711|P3|NOT COMPLETED|Phase 2 (51.6 Months)||0
990268|NCT00439270|2400712|P2|NOT COMPLETED|Phase 2 (51.6 Months)||0
990269|NCT00439270|2400713|P1|NOT COMPLETED|Phase 2 (51.6 Months)||0
990270|NCT00439270|2400709|P5|COMPLETED|Phase 2 (51.6 Months)||0
990271|NCT00439270|2400710|P4|COMPLETED|Phase 2 (51.6 Months)||0
990272|NCT00439270|2400711|P3|COMPLETED|Phase 2 (51.6 Months)||0
990273|NCT00439270|2400712|P2|COMPLETED|Phase 2 (51.6 Months)||0
990274|NCT00439270|2400713|P1|COMPLETED|Phase 2 (51.6 Months)||0
990275|NCT00439270|2400709|P5|STARTED|Phase 2 (51.6 Months)||0
990276|NCT00439270|2400710|P4|STARTED|Phase 2 (51.6 Months)|Includes 4 patients who completed Phase 1|34
990277|NCT00439270|2400711|P3|STARTED|Phase 2 (51.6 Months)||0
990278|NCT00439270|2400712|P2|STARTED|Phase 2 (51.6 Months)||0
990279|NCT00439270|2400713|P1|STARTED|Phase 2 (51.6 Months)||0
990280|NCT00439270|2400709|P5|NOT COMPLETED|Phase 1 (18.1 Months)||3
990281|NCT00439270|2400710|P4|NOT COMPLETED|Phase 1 (18.1 Months)||0
990282|NCT00439270|2400711|P3|NOT COMPLETED|Phase 1 (18.1 Months)||3
990283|NCT00439270|2400712|P2|NOT COMPLETED|Phase 1 (18.1 Months)||3
990284|NCT00439270|2400713|P1|NOT COMPLETED|Phase 1 (18.1 Months)||3
990285|NCT00439270|2400709|P5|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
990286|NCT00439270|2400710|P4|COMPLETED|Phase 1 (18.1 Months)|Remained on study|4
990287|NCT00439270|2400711|P3|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
990288|NCT00439270|2400712|P2|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
990289|NCT00439270|2400713|P1|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
990290|NCT00439270|2400709|P5|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
990291|NCT00439270|2400710|P4|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|4
990292|NCT00439270|2400711|P3|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
990293|NCT00439270|2400712|P2|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
990294|NCT00439270|2400713|P1|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
990295|NCT00439309|2400754|P2|NOT COMPLETED|Follow-Up||2
990296|NCT00439309|2400755|P1|NOT COMPLETED|Follow-Up||3
990297|NCT00439309|2400754|P2|COMPLETED|Follow-Up||13
990298|NCT00439309|2400755|P1|COMPLETED|Follow-Up||51
990299|NCT00439309|2400754|P2|STARTED|Follow-Up||15
990300|NCT00439309|2400755|P1|STARTED|Follow-Up||54
990301|NCT00439309|2400754|P2|NOT COMPLETED|Treatment||0
990302|NCT00439309|2400755|P1|NOT COMPLETED|Treatment||0
990303|NCT00439309|2400754|P2|COMPLETED|Treatment||15
990304|NCT00439309|2400755|P1|COMPLETED|Treatment||54
990305|NCT00439309|2400754|P2|STARTED|Treatment||15
990306|NCT00439309|2400755|P1|STARTED|Treatment||54
990307|NCT00439335|2400771|P2|NOT COMPLETED|Overall Study||0
990308|NCT00439335|2400772|P1|NOT COMPLETED|Overall Study||2
990309|NCT00439335|2400771|P2|COMPLETED|Overall Study||114
990310|NCT00439335|2400772|P1|COMPLETED|Overall Study||111
990311|NCT00439335|2400771|P2|STARTED|Overall Study||114
990312|NCT00439335|2400772|P1|STARTED|Overall Study||113
990313|NCT00439413|2400804|P2|NOT COMPLETED|Overall Study||37
990314|NCT00439413|2400805|P1|NOT COMPLETED|Overall Study||31
990315|NCT00439413|2400804|P2|COMPLETED|Overall Study||88
990316|NCT00439413|2400805|P1|COMPLETED|Overall Study||90
990317|NCT00439413|2400804|P2|STARTED|Overall Study||125
990318|NCT00439413|2400805|P1|STARTED|Overall Study||121
990319|NCT00439517|2400815|P2|NOT COMPLETED|Overall Study||0
990320|NCT00439517|2400816|P1|NOT COMPLETED|Overall Study||2
990321|NCT00439517|2400815|P2|COMPLETED|Overall Study||150
990322|NCT00439517|2400816|P1|COMPLETED|Overall Study||150
990323|NCT00439517|2400815|P2|STARTED|Overall Study||150
990324|NCT00439517|2400816|P1|STARTED|Overall Study||152
990325|NCT00439569|2400838|P1|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||1
990326|NCT00439569|2400838|P1|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
990327|NCT00439569|2400838|P1|STARTED|Cohort 2 (500 mg/kg/Day)|2 new subjects in Cohort 2 were enrolled into the study after Cohort 1 completed the study.|2
990328|NCT00439569|2400838|P1|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||4
990329|NCT00439569|2400838|P1|COMPLETED|Cohort 1 (500 mg/kg/Day)||3
990330|NCT00439569|2400838|P1|STARTED|Cohort 1 (500 mg/kg/Day)||7
990331|NCT00439608|2400849|P1|NOT COMPLETED|Overall Study||0
990332|NCT00439608|2400849|P1|COMPLETED|Overall Study||60
990333|NCT00439608|2400849|P1|STARTED|Overall Study||60
990334|NCT00439647|2400855|P2|NOT COMPLETED|Overall Study||71
990335|NCT00439647|2400856|P1|NOT COMPLETED|Overall Study||58
990336|NCT00439647|2400855|P2|COMPLETED|Overall Study||540
990337|NCT00439647|2400856|P1|COMPLETED|Overall Study||530
990338|NCT00439647|2400855|P2|Modified Intent to Treat (mITT)|Overall Study||574
990339|NCT00439647|2400856|P1|Modified Intent to Treat (mITT)|Overall Study||553
990340|NCT00439647|2400855|P2|STARTED|Overall Study||611
990341|NCT00439647|2400856|P1|STARTED|Overall Study|"Started indicates intent to treat (ITT) and safety set."|588
990342|NCT00439725|2400890|P2|NOT COMPLETED|Observational Period||7
990343|NCT00439725|2400891|P1|NOT COMPLETED|Observational Period||8
990344|NCT00439725|2400890|P2|COMPLETED|Observational Period||553
990345|NCT00439725|2400891|P1|COMPLETED|Observational Period||569
990346|NCT00439725|2400890|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|560
990347|NCT00439725|2400891|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|577
990348|NCT00439725|2400890|P2|NOT COMPLETED|Treatment Period||246
990349|NCT00439725|2400891|P1|NOT COMPLETED|Treatment Period||236
990350|NCT00439725|2400890|P2|COMPLETED|Treatment Period||349
990351|NCT00439725|2400891|P1|COMPLETED|Treatment Period||366
990352|NCT00439725|2400890|P2|Participants Received Treatment|Treatment Period|Safety population|590
990353|NCT00439725|2400891|P1|Participants Received Treatment|Treatment Period|Safety population|598
990354|NCT00439725|2400890|P2|STARTED|Treatment Period||595
990355|NCT00439725|2400891|P1|STARTED|Treatment Period||602
990356|NCT00439738|2400937|P2|NOT COMPLETED|Overall Study||28
990357|NCT00439738|2400938|P1|NOT COMPLETED|Overall Study||36
990358|NCT00439738|2400937|P2|COMPLETED|Overall Study||178
990359|NCT00439738|2400938|P1|COMPLETED|Overall Study||170
990360|NCT00439738|2400937|P2|STARTED|Overall Study||206
990361|NCT00439738|2400938|P1|STARTED|Overall Study||206
990362|NCT00439777|2400956|P2|NOT COMPLETED|Observational Period||41
990363|NCT00439777|2400957|P1|NOT COMPLETED|Observational Period||41
990364|NCT00439777|2400956|P2|COMPLETED|Observational Period||2156
990365|NCT00439777|2400957|P1|COMPLETED|Observational Period||2165
990366|NCT00439777|2400956|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2197
990367|NCT00439777|2400957|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2206
990368|NCT00439777|2400956|P2|NOT COMPLETED|Treatment Period||459
990369|NCT00439777|2400957|P1|NOT COMPLETED|Treatment Period||419
990370|NCT00439777|2400956|P2|COMPLETED|Treatment Period||1954
990371|NCT00439777|2400957|P1|COMPLETED|Treatment Period||2001
990372|NCT00439777|2400956|P2|Participants Received Treatment|Treatment Period||2405
990373|NCT00439777|2400957|P1|Participants Received Treatment|Treatment Period||2412
990374|NCT00439777|2400956|P2|STARTED|Treatment Period||2413
990375|NCT00439777|2400957|P1|STARTED|Treatment Period||2420
990376|NCT00439946|2400993|P1|NOT COMPLETED|Overall Study||0
990377|NCT00439946|2400993|P1|COMPLETED|Overall Study||8
990378|NCT00439946|2400993|P1|STARTED|Overall Study||8
990379|NCT00440011|2401012|P2|NOT COMPLETED|Overall Study||3
990380|NCT00440011|2401013|P1|NOT COMPLETED|Overall Study||4
990381|NCT00440011|2401012|P2|COMPLETED|Overall Study||132
990382|NCT00440011|2401013|P1|COMPLETED|Overall Study||127
990383|NCT00440011|2401012|P2|STARTED|Overall Study||135
990384|NCT00440011|2401013|P1|STARTED|Overall Study||131
990385|NCT00440050|2401023|P2|NOT COMPLETED|Overall Study||67
990386|NCT00440050|2401024|P1|NOT COMPLETED|Overall Study||40
990387|NCT00440050|2401023|P2|COMPLETED|Overall Study||171
990388|NCT00440050|2401024|P1|COMPLETED|Overall Study||124
990389|NCT00440050|2401023|P2|STARTED|Overall Study||238
990390|NCT00440050|2401024|P1|STARTED|Overall Study||164
990391|NCT00440115|2401039|P3|NOT COMPLETED|Overall Study||6
990392|NCT00440115|2401040|P2|NOT COMPLETED|Overall Study||11
990393|NCT00440115|2401041|P1|NOT COMPLETED|Overall Study||7
990394|NCT00440115|2401039|P3|COMPLETED|Overall Study||244
990395|NCT00440115|2401040|P2|COMPLETED|Overall Study||238
990396|NCT00440115|2401041|P1|COMPLETED|Overall Study||244
990397|NCT00440115|2401039|P3|STARTED|Overall Study||250
990398|NCT00440115|2401040|P2|STARTED|Overall Study||249
990399|NCT00440115|2401041|P1|STARTED|Overall Study||251
990400|NCT00440180|2401057|P2|NOT COMPLETED|Overall Study||0
990401|NCT00440180|2401058|P1|NOT COMPLETED|Overall Study||0
990402|NCT00440180|2401057|P2|COMPLETED|Overall Study||10
990403|NCT00440180|2401058|P1|COMPLETED|Overall Study||10
990404|NCT00440180|2401057|P2|STARTED|Overall Study||10
990405|NCT00440180|2401058|P1|STARTED|Overall Study||10
990406|NCT00440193|2401066|P2|NOT COMPLETED|Observational Period||38
990407|NCT00440193|2401067|P1|NOT COMPLETED|Observational Period||45
990408|NCT00440193|2401066|P2|COMPLETED|Observational Period||1369
990409|NCT00440193|2401067|P1|COMPLETED|Observational Period||1380
990410|NCT00440193|2401066|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1407
990411|NCT00440193|2401067|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1425
990412|NCT00440193|2401066|P2|NOT COMPLETED|Treatment Period||351
990413|NCT00440193|2401067|P1|NOT COMPLETED|Treatment Period||305
990414|NCT00440193|2401066|P2|COMPLETED|Treatment Period||1367
990415|NCT00440193|2401067|P1|COMPLETED|Treatment Period||1426
990416|NCT00440193|2401066|P2|Participants Received Treatment|Treatment Period||1711
990417|NCT00440193|2401067|P1|Participants Received Treatment|Treatment Period||1718
990418|NCT00440193|2401066|P2|STARTED|Treatment Period||1718
990419|NCT00440193|2401067|P1|STARTED|Treatment Period||1731
990420|NCT00431444|2401103|P2|NOT COMPLETED|Overall Study||7
990421|NCT00431444|2401104|P1|NOT COMPLETED|Overall Study||5
990422|NCT00431444|2401103|P2|COMPLETED|Overall Study||46
990423|NCT00431444|2401104|P1|COMPLETED|Overall Study||51
990424|NCT00431444|2401103|P2|STARTED|Overall Study|"Initially 110 randomized, 1 participant of Raloxifene group never took study drug."|53
990425|NCT00431444|2401104|P1|STARTED|Overall Study||56
990426|NCT00431496|2401128|P1|NOT COMPLETED|Overall Study||11
990427|NCT00431496|2401128|P1|COMPLETED|Overall Study||60
990428|NCT00431496|2401128|P1|STARTED|Overall Study||71
990429|NCT00431626|2401139|P2|NOT COMPLETED|Overall Study||0
990430|NCT00431626|2401140|P1|NOT COMPLETED|Overall Study||0
990431|NCT00431626|2401139|P2|COMPLETED|Overall Study||0
990432|NCT00431626|2401140|P1|COMPLETED|Overall Study||4
990433|NCT00431626|2401139|P2|STARTED|Overall Study||0
990434|NCT00431626|2401140|P1|STARTED|Overall Study||4
990435|NCT00431834|2401146|P1|NOT COMPLETED|Overall Study||13
990436|NCT00431834|2401146|P1|COMPLETED|Overall Study||62
990437|NCT00431834|2401146|P1|STARTED|Overall Study||75
990438|NCT00431847|2401157|P5|NOT COMPLETED|Overall Study||1
990439|NCT00431847|2401158|P4|NOT COMPLETED|Overall Study||14
990440|NCT00431847|2401159|P3|NOT COMPLETED|Overall Study||4
990441|NCT00431847|2401160|P2|NOT COMPLETED|Overall Study||3
990442|NCT00431847|2401161|P1|NOT COMPLETED|Overall Study||6
990443|NCT00431847|2401157|P5|COMPLETED|Overall Study||0
990444|NCT00431847|2401158|P4|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|170
990445|NCT00431847|2401159|P3|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|20
990446|NCT00431847|2401160|P2|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|42
990447|NCT00431847|2401161|P1|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|126
990448|NCT00431847|2401157|P5|STARTED|Overall Study||1
990449|NCT00431847|2401158|P4|STARTED|Overall Study||184
990450|NCT00431847|2401159|P3|STARTED|Overall Study||24
990451|NCT00431847|2401160|P2|STARTED|Overall Study||45
990452|NCT00431847|2401161|P1|STARTED|Overall Study||132
990453|NCT00431951|2401239|P4|NOT COMPLETED|Overall Study||2
990454|NCT00431951|2401240|P3|NOT COMPLETED|Overall Study||2
990455|NCT00431951|2401241|P2|NOT COMPLETED|Overall Study||2
990456|NCT00431951|2401242|P1|NOT COMPLETED|Overall Study||1
990457|NCT00431951|2401239|P4|COMPLETED|Overall Study||4
990458|NCT00431951|2401240|P3|COMPLETED|Overall Study||6
990459|NCT00431951|2401241|P2|COMPLETED|Overall Study||6
990460|NCT00431951|2401242|P1|COMPLETED|Overall Study||7
990461|NCT00431951|2401239|P4|STARTED|Overall Study||6
990462|NCT00431951|2401240|P3|STARTED|Overall Study||8
990463|NCT00431951|2401241|P2|STARTED|Overall Study||8
990464|NCT00431951|2401242|P1|STARTED|Overall Study||8
990465|NCT00431964|2401302|P2|NOT COMPLETED|Overall Study||8
990466|NCT00431964|2401303|P1|NOT COMPLETED|Overall Study||6
990467|NCT00431964|2401302|P2|COMPLETED|Overall Study||124
990468|NCT00431964|2401303|P1|COMPLETED|Overall Study||125
990469|NCT00431964|2401302|P2|Withdrew From Study|Overall Study||5
990470|NCT00431964|2401303|P1|Withdrew From Study|Overall Study||6
990471|NCT00431964|2401302|P2|Did Not Receive Drug|Overall Study||3
990472|NCT00431964|2401303|P1|Did Not Receive Drug|Overall Study||0
990473|NCT00431964|2401302|P2|Randomized/Received Drug|Overall Study||129
990474|NCT00431964|2401303|P1|Randomized/Received Drug|Overall Study||131
990475|NCT00431964|2401302|P2|STARTED|Overall Study||132
990476|NCT00431964|2401303|P1|STARTED|Overall Study||131
990492|NCT00432237|2401426|P4|NOT COMPLETED|Overall Study||124
990493|NCT00432237|2401427|P3|NOT COMPLETED|Overall Study||109
990494|NCT00432237|2401428|P2|NOT COMPLETED|Overall Study||101
990495|NCT00432237|2401429|P1|NOT COMPLETED|Overall Study||67
990496|NCT00432237|2401426|P4|COMPLETED|Overall Study||366
990497|NCT00432237|2401427|P3|COMPLETED|Overall Study||375
990498|NCT00432237|2401428|P2|COMPLETED|Overall Study||384
990499|NCT00432237|2401429|P1|COMPLETED|Overall Study||177
990500|NCT00432237|2401426|P4|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
990501|NCT00432237|2401427|P3|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|5
990502|NCT00432237|2401428|P2|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|3
990503|NCT00432237|2401429|P1|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
990504|NCT00432237|2401426|P4|Completed--With Data|Overall Study||365
990505|NCT00432237|2401427|P3|Completed--With Data|Overall Study||370
990506|NCT00432237|2401428|P2|Completed--With Data|Overall Study||381
990507|NCT00432237|2401429|P1|Completed--With Data|Overall Study||176
990508|NCT00432237|2401426|P4|STARTED|Overall Study||490
990509|NCT00432237|2401427|P3|STARTED|Overall Study|1 patient in the MK0974 300 mg group was treated but withdrew consent.|484
990510|NCT00432237|2401428|P2|STARTED|Overall Study||485
990511|NCT00432237|2401429|P1|STARTED|Overall Study|1 patient in the MK0974 50 mg group was treated but withdrew consent.|244
990512|NCT00432276|2401469|P2|NOT COMPLETED|Overall Study||156
990513|NCT00432276|2401470|P1|NOT COMPLETED|Overall Study||121
990514|NCT00432276|2401469|P2|COMPLETED|Overall Study||243
990515|NCT00432276|2401470|P1|COMPLETED|Overall Study||283
990516|NCT00432276|2401469|P2|Per Protocol Set|Overall Study||306
990517|NCT00432276|2401470|P1|Per Protocol Set|Overall Study|Patients who received at least 1 dose of study medication and who had no major protocol violations.|303
990518|NCT00432276|2401469|P2|STARTED|Overall Study||399
990519|NCT00432276|2401470|P1|STARTED|Overall Study||404
990520|NCT00432341|2401558|P2|NOT COMPLETED|Overall Study||0
990521|NCT00432341|2401559|P1|NOT COMPLETED|Overall Study||0
990522|NCT00432341|2401558|P2|COMPLETED|Overall Study||30
990523|NCT00432341|2401559|P1|COMPLETED|Overall Study||24
990524|NCT00432341|2401558|P2|STARTED|Overall Study||30
990525|NCT00432341|2401559|P1|STARTED|Overall Study||24
990526|NCT00432380|2401586|P3|NOT COMPLETED|Overall Study||1
990527|NCT00432380|2401587|P2|NOT COMPLETED|Overall Study||4
990528|NCT00432380|2401588|P1|NOT COMPLETED|Overall Study||4
990529|NCT00432380|2401586|P3|COMPLETED|Overall Study||74
990530|NCT00432380|2401587|P2|COMPLETED|Overall Study||146
990531|NCT00432380|2401588|P1|COMPLETED|Overall Study||146
990532|NCT00432380|2401586|P3|STARTED|Overall Study||75
990533|NCT00432380|2401587|P2|STARTED|Overall Study||150
990534|NCT00432380|2401588|P1|STARTED|Overall Study||150
990535|NCT00432445|2401612|P1|NOT COMPLETED|Overall Study||0
990536|NCT00432445|2401612|P1|COMPLETED|Overall Study||2
990537|NCT00432445|2401612|P1|STARTED|Overall Study||2
990538|NCT00432458|2401618|P2|NOT COMPLETED|Overall Study||1
990539|NCT00432458|2401619|P1|NOT COMPLETED|Overall Study||5
990540|NCT00432458|2401618|P2|COMPLETED|Overall Study||32
990541|NCT00432458|2401619|P1|COMPLETED|Overall Study||30
990542|NCT00432458|2401618|P2|STARTED|Overall Study||33
990543|NCT00432458|2401619|P1|STARTED|Overall Study||35
990544|NCT00432562|2401639|P2|NOT COMPLETED|Overall Study||0
990545|NCT00432562|2401640|P1|NOT COMPLETED|Overall Study||3
990546|NCT00432562|2401639|P2|COMPLETED|Overall Study||15
990547|NCT00432562|2401640|P1|COMPLETED|Overall Study||13
990548|NCT00432562|2401639|P2|STARTED|Overall Study||15
990549|NCT00432562|2401640|P1|STARTED|Overall Study||16
990550|NCT00432601|2401666|P2|NOT COMPLETED|Time 2 to Time 3||22
990551|NCT00432601|2401667|P1|NOT COMPLETED|Time 2 to Time 3||19
990552|NCT00432601|2401666|P2|COMPLETED|Time 2 to Time 3||122
990553|NCT00432601|2401667|P1|COMPLETED|Time 2 to Time 3||122
990554|NCT00432601|2401666|P2|STARTED|Time 2 to Time 3||144
990555|NCT00432601|2401667|P1|STARTED|Time 2 to Time 3||141
990556|NCT00432601|2401666|P2|NOT COMPLETED|Time 1 to Time 2||368
990557|NCT00432601|2401667|P1|NOT COMPLETED|Time 1 to Time 2||369
990558|NCT00432601|2401666|P2|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|144
990559|NCT00432601|2401667|P1|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|141
990560|NCT00432601|2401666|P2|STARTED|Time 1 to Time 2||512
990561|NCT00432601|2401667|P1|STARTED|Time 1 to Time 2||510
990562|NCT00432666|2401675|P2|NOT COMPLETED|Open-Label Extension Period||0
990563|NCT00432666|2401676|P1|NOT COMPLETED|Open-Label Extension Period||25
990564|NCT00432666|2401675|P2|COMPLETED|Open-Label Extension Period||0
990565|NCT00432666|2401676|P1|COMPLETED|Open-Label Extension Period||120
990566|NCT00432666|2401675|P2|STARTED|Open-Label Extension Period|In the Open-Label Extension Period no placebo treatment arm was given.|0
990567|NCT00432666|2401676|P1|STARTED|Open-Label Extension Period||145
990568|NCT00432666|2401675|P2|NOT COMPLETED|Main Period||1
990569|NCT00432666|2401676|P1|NOT COMPLETED|Main Period||2
990570|NCT00432666|2401675|P2|COMPLETED|Main Period||74
990571|NCT00432666|2401676|P1|COMPLETED|Main Period||71
990572|NCT00432666|2401675|P2|STARTED|Main Period||75
990573|NCT00432666|2401676|P1|STARTED|Main Period||73
990574|NCT00432744|2401840|P2|NOT COMPLETED|Months 7 - 12||1
990575|NCT00432744|2401841|P1|NOT COMPLETED|Months 7 - 12||1
990576|NCT00432744|2401840|P2|COMPLETED|Months 7 - 12||7
990577|NCT00432744|2401841|P1|COMPLETED|Months 7 - 12||6
990578|NCT00432744|2401840|P2|STARTED|Months 7 - 12||8
990579|NCT00432744|2401841|P1|STARTED|Months 7 - 12||7
990580|NCT00432744|2401840|P2|NOT COMPLETED|Months 0-6||4
990581|NCT00432744|2401841|P1|NOT COMPLETED|Months 0-6||5
990582|NCT00432744|2401840|P2|COMPLETED|Months 0-6|"One patient in period 1 other reason for loss became too disabled to complete the 6 month test."|8
990583|NCT00432744|2401841|P1|COMPLETED|Months 0-6||7
990584|NCT00432744|2401840|P2|STARTED|Months 0-6||12
990585|NCT00432744|2401841|P1|STARTED|Months 0-6||12
990586|NCT00432809|2401854|P3|NOT COMPLETED|2 Year Sub-study||1
990587|NCT00432809|2401855|P2|NOT COMPLETED|2 Year Sub-study||2
990588|NCT00432809|2401856|P1|NOT COMPLETED|2 Year Sub-study||3
990589|NCT00432809|2401854|P3|COMPLETED|2 Year Sub-study||19
990590|NCT00432809|2401855|P2|COMPLETED|2 Year Sub-study||18
990591|NCT00432809|2401856|P1|COMPLETED|2 Year Sub-study||17
990592|NCT00432809|2401854|P3|STARTED|2 Year Sub-study||20
990593|NCT00432809|2401855|P2|STARTED|2 Year Sub-study||20
990594|NCT00432809|2401856|P1|STARTED|2 Year Sub-study||20
990595|NCT00432809|2401854|P3|NOT COMPLETED|1 Year Follow-up||1
990596|NCT00432809|2401855|P2|NOT COMPLETED|1 Year Follow-up||0
990597|NCT00432809|2401856|P1|NOT COMPLETED|1 Year Follow-up||9
990598|NCT00432809|2401854|P3|COMPLETED|1 Year Follow-up||49
990599|NCT00432809|2401855|P2|COMPLETED|1 Year Follow-up||50
990600|NCT00432809|2401856|P1|COMPLETED|1 Year Follow-up||41
990601|NCT00432809|2401854|P3|STARTED|1 Year Follow-up||50
990602|NCT00432809|2401855|P2|STARTED|1 Year Follow-up||50
990603|NCT00432809|2401856|P1|STARTED|1 Year Follow-up||50
990604|NCT00432835|2401929|P2|NOT COMPLETED|Overall Study||7
990605|NCT00432835|2401930|P1|NOT COMPLETED|Overall Study||6
990606|NCT00432835|2401929|P2|COMPLETED|Overall Study|These 23 patients completed the entire 8 day protocol.|23
990607|NCT00432835|2401930|P1|COMPLETED|Overall Study|These 22 patients completed the entire 8 day protocol.|22
990608|NCT00432835|2401929|P2|Completed 2nd Intervention|Overall Study||23
990609|NCT00432835|2401930|P1|Completed 2nd Intervention|Overall Study||22
990610|NCT00432835|2401929|P2|Completed 1st Intervention|Overall Study||23
990611|NCT00432835|2401930|P1|Completed 1st Intervention|Overall Study||22
990612|NCT00432835|2401929|P2|STARTED|Overall Study||30
990613|NCT00432835|2401930|P1|STARTED|Overall Study||28
990614|NCT00432991|2401942|P2|NOT COMPLETED|Overall Study||12
990615|NCT00432991|2401943|P1|NOT COMPLETED|Overall Study||7
990616|NCT00432991|2401942|P2|COMPLETED|Overall Study||19
990617|NCT00432991|2401943|P1|COMPLETED|Overall Study||15
990618|NCT00432991|2401942|P2|STARTED|Overall Study||31
990619|NCT00432991|2401943|P1|STARTED|Overall Study||22
990620|NCT00433004|2401955|P2|NOT COMPLETED|Overall Study||7
990621|NCT00433004|2401956|P1|NOT COMPLETED|Overall Study||5
990622|NCT00433004|2401955|P2|COMPLETED|Overall Study||16
990623|NCT00433004|2401956|P1|COMPLETED|Overall Study||22
990624|NCT00433004|2401955|P2|STARTED|Overall Study||23
990625|NCT00433004|2401956|P1|STARTED|Overall Study||27
990626|NCT00433017|2401968|P2|NOT COMPLETED|Overall Study||101
990627|NCT00433017|2401969|P1|NOT COMPLETED|Overall Study||96
990628|NCT00433017|2401968|P2|COMPLETED|Overall Study||32
990629|NCT00433017|2401969|P1|COMPLETED|Overall Study||26
990630|NCT00433017|2401968|P2|Completed 12 Month Phase|Overall Study||126
990631|NCT00433017|2401969|P1|Completed 12 Month Phase|Overall Study||114
990632|NCT00433017|2401968|P2|STARTED|Overall Study||133
990633|NCT00433017|2401969|P1|STARTED|Overall Study||122
990634|NCT00433160|2401985|P2|NOT COMPLETED|104 Weeks, 28-Week OL Period||3
990635|NCT00433160|2401986|P1|NOT COMPLETED|104 Weeks, 28-Week OL Period||10
990636|NCT00433160|2401985|P2|COMPLETED|104 Weeks, 28-Week OL Period||47
990637|NCT00433160|2401986|P1|COMPLETED|104 Weeks, 28-Week OL Period||92
990638|NCT00433160|2401985|P2|Received Treatment|104 Weeks, 28-Week OL Period||50
990639|NCT00433160|2401986|P1|Received Treatment|104 Weeks, 28-Week OL Period||102
990640|NCT00433160|2401985|P2|STARTED|104 Weeks, 28-Week OL Period|Five participants withdrew at end of first OL period and did not continue on to second OL period.|50
990641|NCT00433160|2401986|P1|STARTED|104 Weeks, 28-Week OL Period|Eleven participants withdrew at end of first OL period and did not continue on to second OL period.|102
990642|NCT00433160|2401985|P2|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||4
990643|NCT00433160|2401986|P1|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||6
990644|NCT00433160|2401985|P2|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||55
990645|NCT00433160|2401986|P1|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||113
990646|NCT00433160|2401985|P2|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||59
990647|NCT00433160|2401986|P1|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||119
990648|NCT00433160|2401985|P2|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|59
990649|NCT00433160|2401986|P1|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|119
990650|NCT00433160|2401985|P2|NOT COMPLETED|52-Week Double-Blind (DB) Period||10
990651|NCT00433160|2401986|P1|NOT COMPLETED|52-Week Double-Blind (DB) Period||17
990652|NCT00433160|2401985|P2|COMPLETED|52-Week Double-Blind (DB) Period||60
990653|NCT00433160|2401986|P1|COMPLETED|52-Week Double-Blind (DB) Period||120
990654|NCT00433160|2401985|P2|Received Treatment|52-Week Double-Blind (DB) Period||68
990655|NCT00433160|2401986|P1|Received Treatment|52-Week Double-Blind (DB) Period||136
990656|NCT00433160|2401985|P2|STARTED|52-Week Double-Blind (DB) Period||70
990657|NCT00433160|2401986|P1|STARTED|52-Week Double-Blind (DB) Period||137
990658|NCT00433199|2402036|P2|NOT COMPLETED|Open-Label Period||34
990659|NCT00433199|2402037|P1|NOT COMPLETED|Open-Label Period||0
990660|NCT00433199|2402036|P2|COMPLETED|Open-Label Period||185
990661|NCT00433199|2402037|P1|COMPLETED|Open-Label Period||0
990662|NCT00433199|2402036|P2|STARTED|Open-Label Period||219
990663|NCT00433199|2402037|P1|STARTED|Open-Label Period||0
990664|NCT00433199|2402036|P2|NOT COMPLETED|Double-Blind Period||66
990665|NCT00433199|2402037|P1|NOT COMPLETED|Double-Blind Period||12
990666|NCT00433199|2402036|P2|COMPLETED|Double-Blind Period||168
990667|NCT00433199|2402037|P1|COMPLETED|Double-Blind Period||28
990668|NCT00433199|2402036|P2|STARTED|Double-Blind Period||234
990669|NCT00433199|2402037|P1|STARTED|Double-Blind Period||40
990670|NCT00433290|2402057|P2|NOT COMPLETED|Overall Study||17
990671|NCT00433290|2402058|P1|NOT COMPLETED|Overall Study||35
990672|NCT00433290|2402057|P2|COMPLETED|Overall Study||111
990673|NCT00433290|2402058|P1|COMPLETED|Overall Study||93
990674|NCT00433290|2402057|P2|STARTED|Overall Study||128
990675|NCT00433290|2402058|P1|STARTED|Overall Study||128
990676|NCT00433329|2402125|P1|NOT COMPLETED|Overall Study||21
990677|NCT00433329|2402125|P1|COMPLETED|Overall Study||79
990678|NCT00433329|2402125|P1|STARTED|Overall Study||100
990679|NCT00433381|2402131|P2|NOT COMPLETED|Overall Study||3
990680|NCT00433381|2402132|P1|NOT COMPLETED|Overall Study||5
990681|NCT00433381|2402131|P2|COMPLETED|Overall Study||57
990682|NCT00433381|2402132|P1|COMPLETED|Overall Study|Evaluated for 6-month progression-free survival. (Applies to both arms).|58
990683|NCT00433381|2402131|P2|STARTED|Overall Study||60
990684|NCT00433381|2402132|P1|STARTED|Overall Study||63
990685|NCT00433446|2402138|P1|NOT COMPLETED|Overall Study||61
990686|NCT00433446|2402138|P1|COMPLETED|Overall Study||1
990687|NCT00433446|2402138|P1|Eligible and Began Protocol Therapy|Overall Study||53
990688|NCT00433446|2402138|P1|Eligible|Overall Study||53
990689|NCT00433446|2402138|P1|STARTED|Overall Study||62
990690|NCT00433537|2402146|P3|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
990691|NCT00433537|2402147|P2|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
990692|NCT00433537|2402148|P1|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||16
990693|NCT00433537|2402146|P3|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
990694|NCT00433537|2402147|P2|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||22
990695|NCT00433537|2402148|P1|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||29
990696|NCT00433537|2402146|P3|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||0
990697|NCT00433537|2402147|P2|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||22
990698|NCT00433537|2402148|P1|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||44
990699|NCT00433537|2402146|P3|STARTED|Step 2 - Maintenance Rituximab or ASCT|One patient completed VcR-CVAD and then withdrew from the study.|0
990700|NCT00433537|2402147|P2|STARTED|Step 2 - Maintenance Rituximab or ASCT||22
990701|NCT00433537|2402148|P1|STARTED|Step 2 - Maintenance Rituximab or ASCT|This included all treated patients regardless of eligibility.|45
990702|NCT00433537|2402146|P3|NOT COMPLETED|Step 1 - VcR-CVAD Induction||9
990703|NCT00433537|2402147|P2|NOT COMPLETED|Step 1 - VcR-CVAD Induction||0
990704|NCT00433537|2402148|P1|NOT COMPLETED|Step 1 - VcR-CVAD Induction||1
990705|NCT00433537|2402146|P3|COMPLETED|Step 1 - VcR-CVAD Induction||1
990706|NCT00433537|2402147|P2|COMPLETED|Step 1 - VcR-CVAD Induction||22
990707|NCT00433537|2402148|P1|COMPLETED|Step 1 - VcR-CVAD Induction||44
990708|NCT00433537|2402146|P3|Eligible and Treated|Step 1 - VcR-CVAD Induction||9
990709|NCT00433537|2402147|P2|Eligible and Treated|Step 1 - VcR-CVAD Induction||22
990710|NCT00433537|2402148|P1|Eligible and Treated|Step 1 - VcR-CVAD Induction||44
990711|NCT00433537|2402146|P3|STARTED|Step 1 - VcR-CVAD Induction||10
990712|NCT00433537|2402147|P2|STARTED|Step 1 - VcR-CVAD Induction||22
990713|NCT00433537|2402148|P1|STARTED|Step 1 - VcR-CVAD Induction||45
990714|NCT00433550|2402160|P3|NOT COMPLETED|Overall Study||0
990715|NCT00433550|2402161|P2|NOT COMPLETED|Overall Study||0
990716|NCT00433550|2402162|P1|NOT COMPLETED|Overall Study||0
990717|NCT00433550|2402160|P3|COMPLETED|Overall Study||6
990718|NCT00433550|2402161|P2|COMPLETED|Overall Study||10
990719|NCT00433550|2402162|P1|COMPLETED|Overall Study||17
990720|NCT00433550|2402160|P3|STARTED|Overall Study||6
990721|NCT00433550|2402161|P2|STARTED|Overall Study||10
990722|NCT00433550|2402162|P1|STARTED|Overall Study||17
990723|NCT00433654|2402174|P2|NOT COMPLETED|Overall Study||5
990724|NCT00433654|2402175|P1|NOT COMPLETED|Overall Study||15
990725|NCT00433654|2402174|P2|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|201
990726|NCT00433654|2402175|P1|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|243
990727|NCT00433654|2402174|P2|STARTED|Overall Study||206
990728|NCT00433654|2402175|P1|STARTED|Overall Study||258
990729|NCT00433745|2402206|P1|NOT COMPLETED|Overall Study||0
990730|NCT00433745|2402206|P1|COMPLETED|Overall Study||4
990731|NCT00433745|2402206|P1|STARTED|Overall Study||4
990732|NCT00433771|2402211|P1|NOT COMPLETED|Overall Study||19
990733|NCT00433771|2402211|P1|COMPLETED|Overall Study|55 out of 58 patients were evaluable(had a stent placed and had at least 1 week of follow up)|55
990734|NCT00433771|2402211|P1|STARTED|Overall Study|74 enrolled patients(signed an Informed Consent Form)were screened.58 were eligible(intent to treat)|74
990735|NCT00433836|2402229|P2|NOT COMPLETED|Overall Study||6
990736|NCT00433836|2402230|P1|NOT COMPLETED|Overall Study||13
990737|NCT00433836|2402229|P2|COMPLETED|Overall Study||143
990738|NCT00433836|2402230|P1|COMPLETED|Overall Study||138
990739|NCT00433836|2402229|P2|STARTED|Overall Study||149
990740|NCT00433836|2402230|P1|STARTED|Overall Study||151
990741|NCT00440232|2402244|P2|NOT COMPLETED|Overall Study||4
990742|NCT00440232|2402245|P1|NOT COMPLETED|Overall Study||3
990743|NCT00440232|2402244|P2|COMPLETED|Overall Study||34
990744|NCT00440232|2402245|P1|COMPLETED|Overall Study||33
990745|NCT00440232|2402244|P2|STARTED|Overall Study||38
990746|NCT00440232|2402245|P1|STARTED|Overall Study||36
990747|NCT00440271|2402255|P2|NOT COMPLETED|Overall Study||15
990748|NCT00440271|2402256|P1|NOT COMPLETED|Overall Study||12
990749|NCT00440271|2402255|P2|COMPLETED|Overall Study||3
990750|NCT00440271|2402256|P1|COMPLETED|Overall Study||3
990751|NCT00440271|2402255|P2|STARTED|Overall Study||18
990752|NCT00440271|2402256|P1|STARTED|Overall Study||15
990753|NCT00440297|2402290|P2|NOT COMPLETED|Overall Study||18
990754|NCT00440297|2402291|P1|NOT COMPLETED|Overall Study||23
990755|NCT00440297|2402290|P2|COMPLETED|Overall Study||120
990756|NCT00440297|2402291|P1|COMPLETED|Overall Study||116
990757|NCT00440297|2402290|P2|Vaccination Visit 4|Overall Study||122
990758|NCT00440297|2402291|P1|Vaccination Visit 4|Overall Study||116
990759|NCT00440297|2402290|P2|Vaccination Visit 3|Overall Study||125
990760|NCT00440297|2402291|P1|Vaccination Visit 3|Overall Study||124
990761|NCT00440297|2402290|P2|Vaccination Visit 2|Overall Study||134
990762|NCT00440297|2402291|P1|Vaccination Visit 2|Overall Study||136
990763|NCT00440297|2402290|P2|Vaccination Visit 1|Overall Study||138
990764|NCT00440297|2402291|P1|Vaccination Visit 1|Overall Study||138
990765|NCT00440297|2402290|P2|STARTED|Overall Study||138
990766|NCT00440297|2402291|P1|STARTED|Overall Study||139
990767|NCT00440310|2402307|P2|NOT COMPLETED|Overall Study||30
990768|NCT00440310|2402308|P1|NOT COMPLETED|Overall Study||28
990769|NCT00440310|2402307|P2|COMPLETED|Overall Study||209
990770|NCT00440310|2402308|P1|COMPLETED|Overall Study||216
990771|NCT00440310|2402307|P2|Treated|Overall Study||232
990772|NCT00440310|2402308|P1|Treated|Overall Study||222
990773|NCT00440310|2402307|P2|STARTED|Overall Study||239
990774|NCT00440310|2402308|P1|STARTED|Overall Study||244
990775|NCT00440401|2402316|P2|NOT COMPLETED|Overall Study||6
990776|NCT00440401|2402317|P1|NOT COMPLETED|Overall Study||4
990777|NCT00440401|2402316|P2|COMPLETED|Overall Study||54
990778|NCT00440401|2402317|P1|COMPLETED|Overall Study||55
990779|NCT00440401|2402316|P2|STARTED|Overall Study||60
990780|NCT00440401|2402317|P1|STARTED|Overall Study||59
990781|NCT00440466|2402328|P3|NOT COMPLETED|Overall Study||41
990782|NCT00440466|2402329|P2|NOT COMPLETED|Overall Study||15
990783|NCT00440466|2402330|P1|NOT COMPLETED|Overall Study||13
990784|NCT00440466|2402328|P3|COMPLETED|Overall Study||174
990785|NCT00440466|2402329|P2|COMPLETED|Overall Study||92
990786|NCT00440466|2402330|P1|COMPLETED|Overall Study||95
990787|NCT00440466|2402328|P3|STARTED|Overall Study||215
990788|NCT00440466|2402329|P2|STARTED|Overall Study||107
990789|NCT00440466|2402330|P1|STARTED|Overall Study||108
990790|NCT00440505|2402362|P6|NOT COMPLETED|Third Intervention||0
990791|NCT00440505|2402363|P5|NOT COMPLETED|Third Intervention||0
990792|NCT00440505|2402364|P4|NOT COMPLETED|Third Intervention||1
990793|NCT00440505|2402365|P3|NOT COMPLETED|Third Intervention||0
990794|NCT00440505|2402366|P2|NOT COMPLETED|Third Intervention||0
990795|NCT00440505|2402367|P1|NOT COMPLETED|Third Intervention||0
990796|NCT00440505|2402362|P6|COMPLETED|Third Intervention||5
990797|NCT00440505|2402363|P5|COMPLETED|Third Intervention||5
990798|NCT00440505|2402364|P4|COMPLETED|Third Intervention||1
990799|NCT00440505|2402365|P3|COMPLETED|Third Intervention||1
990800|NCT00440505|2402366|P2|COMPLETED|Third Intervention||2
990801|NCT00440505|2402367|P1|COMPLETED|Third Intervention||5
990802|NCT00440505|2402362|P6|STARTED|Third Intervention||5
990803|NCT00440505|2402363|P5|STARTED|Third Intervention||5
990804|NCT00440505|2402364|P4|STARTED|Third Intervention||2
990805|NCT00440505|2402365|P3|STARTED|Third Intervention||1
990806|NCT00440505|2402366|P2|STARTED|Third Intervention||2
990807|NCT00440505|2402367|P1|STARTED|Third Intervention||5
990808|NCT00440505|2402362|P6|NOT COMPLETED|Second Intervention||0
990809|NCT00440505|2402363|P5|NOT COMPLETED|Second Intervention||0
990810|NCT00440505|2402364|P4|NOT COMPLETED|Second Intervention||0
990811|NCT00440505|2402365|P3|NOT COMPLETED|Second Intervention||0
990812|NCT00440505|2402366|P2|NOT COMPLETED|Second Intervention||0
990813|NCT00440505|2402367|P1|NOT COMPLETED|Second Intervention||0
990814|NCT00440505|2402362|P6|COMPLETED|Second Intervention||5
990815|NCT00440505|2402363|P5|COMPLETED|Second Intervention||5
990816|NCT00440505|2402364|P4|COMPLETED|Second Intervention||2
990817|NCT00440505|2402365|P3|COMPLETED|Second Intervention||1
990818|NCT00440505|2402366|P2|COMPLETED|Second Intervention||2
990819|NCT00440505|2402367|P1|COMPLETED|Second Intervention||5
990820|NCT00440505|2402362|P6|STARTED|Second Intervention||5
990821|NCT00440505|2402363|P5|STARTED|Second Intervention||5
990822|NCT00440505|2402364|P4|STARTED|Second Intervention||2
990823|NCT00440505|2402365|P3|STARTED|Second Intervention||1
990824|NCT00440505|2402366|P2|STARTED|Second Intervention||2
990825|NCT00440505|2402367|P1|STARTED|Second Intervention||5
990826|NCT00440505|2402362|P6|NOT COMPLETED|First Intervention||0
990827|NCT00440505|2402363|P5|NOT COMPLETED|First Intervention||0
990828|NCT00440505|2402364|P4|NOT COMPLETED|First Intervention||0
990829|NCT00440505|2402365|P3|NOT COMPLETED|First Intervention||0
990830|NCT00440505|2402366|P2|NOT COMPLETED|First Intervention||0
990831|NCT00440505|2402367|P1|NOT COMPLETED|First Intervention||0
990832|NCT00440505|2402362|P6|COMPLETED|First Intervention||5
990833|NCT00440505|2402363|P5|COMPLETED|First Intervention||5
990834|NCT00440505|2402364|P4|COMPLETED|First Intervention||2
990835|NCT00440505|2402365|P3|COMPLETED|First Intervention||1
990836|NCT00440505|2402366|P2|COMPLETED|First Intervention||2
990837|NCT00440505|2402367|P1|COMPLETED|First Intervention||5
990838|NCT00440505|2402362|P6|STARTED|First Intervention||5
990839|NCT00440505|2402363|P5|STARTED|First Intervention||5
990840|NCT00440505|2402364|P4|STARTED|First Intervention||2
990841|NCT00440505|2402365|P3|STARTED|First Intervention||1
990842|NCT00440505|2402366|P2|STARTED|First Intervention||2
990843|NCT00440505|2402367|P1|STARTED|First Intervention||5
990844|NCT00440518|2402387|P3|NOT COMPLETED|Maintenance and Safety Follow-up Periods||15
990845|NCT00440518|2402388|P2|NOT COMPLETED|Maintenance and Safety Follow-up Periods||12
990846|NCT00440518|2402389|P1|NOT COMPLETED|Maintenance and Safety Follow-up Periods||7
990847|NCT00440518|2402387|P3|COMPLETED|Maintenance and Safety Follow-up Periods||55
990848|NCT00440518|2402388|P2|COMPLETED|Maintenance and Safety Follow-up Periods||51
990849|NCT00440518|2402389|P1|COMPLETED|Maintenance and Safety Follow-up Periods||52
990850|NCT00440518|2402387|P3|STARTED|Maintenance and Safety Follow-up Periods||70
990851|NCT00440518|2402388|P2|STARTED|Maintenance and Safety Follow-up Periods||63
990852|NCT00440518|2402389|P1|STARTED|Maintenance and Safety Follow-up Periods||59
990853|NCT00440518|2402387|P3|NOT COMPLETED|Randomized /Titration Period||4
990854|NCT00440518|2402388|P2|NOT COMPLETED|Randomized /Titration Period||9
990855|NCT00440518|2402389|P1|NOT COMPLETED|Randomized /Titration Period||13
990856|NCT00440518|2402387|P3|COMPLETED|Randomized /Titration Period||70
990857|NCT00440518|2402388|P2|COMPLETED|Randomized /Titration Period||63
990858|NCT00440518|2402389|P1|COMPLETED|Randomized /Titration Period||59
990859|NCT00440518|2402387|P3|STARTED|Randomized /Titration Period||74
990860|NCT00440518|2402388|P2|STARTED|Randomized /Titration Period||72
990861|NCT00440518|2402389|P1|STARTED|Randomized /Titration Period||72
990862|NCT00440531|2402412|P3|NOT COMPLETED|Overall Study||7
990863|NCT00440531|2402413|P2|NOT COMPLETED|Overall Study||5
990864|NCT00440531|2402414|P1|NOT COMPLETED|Overall Study||10
990865|NCT00440531|2402412|P3|COMPLETED|Overall Study||165
990866|NCT00440531|2402413|P2|COMPLETED|Overall Study||178
990867|NCT00440531|2402414|P1|COMPLETED|Overall Study||175
990868|NCT00440531|2402412|P3|Vaccination 3|Overall Study||166
990869|NCT00440531|2402413|P2|Vaccination 3|Overall Study||178
990870|NCT00440531|2402414|P1|Vaccination 3|Overall Study||176
990871|NCT00440531|2402412|P3|Vaccination 2|Overall Study||171
990872|NCT00440531|2402413|P2|Vaccination 2|Overall Study||182
990873|NCT00440531|2402414|P1|Vaccination 2|Overall Study||181
990874|NCT00440531|2402412|P3|Vaccination 1|Overall Study||172
990875|NCT00440531|2402413|P2|Vaccination 1|Overall Study||183
990876|NCT00440531|2402414|P1|Vaccination 1|Overall Study||183
990877|NCT00440531|2402412|P3|STARTED|Overall Study||172
990878|NCT00440531|2402413|P2|STARTED|Overall Study||183
990879|NCT00440531|2402414|P1|STARTED|Overall Study||185
990880|NCT00441441|2402430|P2|NOT COMPLETED|Overall Study||14
990881|NCT00441441|2402431|P1|NOT COMPLETED|Overall Study||11
990882|NCT00441441|2402430|P2|COMPLETED|Overall Study||163
990883|NCT00441441|2402431|P1|COMPLETED|Overall Study||162
990884|NCT00441441|2402430|P2|STARTED|Overall Study||177
990885|NCT00441441|2402431|P1|STARTED|Overall Study||173
990886|NCT00441467|2402489|P1|NOT COMPLETED|Overall Study||18
990887|NCT00441467|2402489|P1|COMPLETED|Overall Study||4
990888|NCT00441467|2402489|P1|4 Cycles|Overall Study||7
990889|NCT00441467|2402489|P1|2 Cycles|Overall Study||17
990890|NCT00441467|2402489|P1|STARTED|Overall Study||22
990891|NCT00441480|2402497|P2|NOT COMPLETED|Overall Study||4
990892|NCT00441480|2402498|P1|NOT COMPLETED|Overall Study||3
990893|NCT00441480|2402497|P2|COMPLETED|Overall Study||41
990894|NCT00441480|2402498|P1|COMPLETED|Overall Study||43
990895|NCT00441480|2402497|P2|STARTED|Overall Study||45
990896|NCT00441480|2402498|P1|STARTED|Overall Study||46
990897|NCT00441545|2402530|P2|NOT COMPLETED|Second Intervention||7
990898|NCT00441545|2402531|P1|NOT COMPLETED|Second Intervention||12
990899|NCT00441545|2402530|P2|COMPLETED|Second Intervention||68
990900|NCT00441545|2402531|P1|COMPLETED|Second Intervention||65
990901|NCT00441545|2402530|P2|STARTED|Second Intervention||75
990902|NCT00441545|2402531|P1|STARTED|Second Intervention||77
990903|NCT00441545|2402530|P2|NOT COMPLETED|Washout||0
990904|NCT00441545|2402531|P1|NOT COMPLETED|Washout||0
990905|NCT00441545|2402530|P2|COMPLETED|Washout||75
990906|NCT00441545|2402531|P1|COMPLETED|Washout||77
990907|NCT00441545|2402530|P2|STARTED|Washout||75
990908|NCT00441545|2402531|P1|STARTED|Washout||77
990909|NCT00441545|2402530|P2|NOT COMPLETED|First Intervention||12
990910|NCT00441545|2402531|P1|NOT COMPLETED|First Intervention||18
990911|NCT00441545|2402530|P2|COMPLETED|First Intervention||75
990912|NCT00441545|2402531|P1|COMPLETED|First Intervention||77
990913|NCT00441545|2402530|P2|STARTED|First Intervention||87
990914|NCT00441545|2402531|P1|STARTED|First Intervention||95
990915|NCT00441558|2402543|P1|NOT COMPLETED|Overall Study||1056
990916|NCT00441558|2402543|P1|COMPLETED|Overall Study||667
990917|NCT00441558|2402543|P1|STARTED|Overall Study||1723
990918|NCT00441584|2402547|P1|NOT COMPLETED|Overall Study||105
990919|NCT00441584|2402547|P1|COMPLETED|Overall Study||12
990920|NCT00441584|2402547|P1|STARTED|Overall Study||117
990921|NCT00441701|2402561|P10|NOT COMPLETED|Overall Study||0
990922|NCT00441701|2402562|P9|NOT COMPLETED|Overall Study||0
990923|NCT00441701|2402563|P8|NOT COMPLETED|Overall Study||0
990924|NCT00441701|2402564|P7|NOT COMPLETED|Overall Study||0
990925|NCT00441701|2402565|P6|NOT COMPLETED|Overall Study||3
990926|NCT00441701|2402566|P5|NOT COMPLETED|Overall Study||2
990927|NCT00441701|2402567|P4|NOT COMPLETED|Overall Study||3
990928|NCT00441701|2402568|P3|NOT COMPLETED|Overall Study||4
990929|NCT00441701|2402569|P2|NOT COMPLETED|Overall Study||4
990930|NCT00441701|2402570|P1|NOT COMPLETED|Overall Study||5
990931|NCT00441701|2402561|P10|COMPLETED|Overall Study||0
990932|NCT00441701|2402562|P9|COMPLETED|Overall Study||0
990933|NCT00441701|2402563|P8|COMPLETED|Overall Study||0
990934|NCT00441701|2402564|P7|COMPLETED|Overall Study||0
990935|NCT00441701|2402565|P6|COMPLETED|Overall Study||8
990936|NCT00441701|2402566|P5|COMPLETED|Overall Study||20
990937|NCT00441701|2402567|P4|COMPLETED|Overall Study||8
990938|NCT00441701|2402568|P3|COMPLETED|Overall Study||18
990939|NCT00441701|2402569|P2|COMPLETED|Overall Study||7
990940|NCT00441701|2402570|P1|COMPLETED|Overall Study||17
990941|NCT00441701|2402561|P10|STARTED|Overall Study||0
990942|NCT00441701|2402562|P9|STARTED|Overall Study||0
990943|NCT00441701|2402563|P8|STARTED|Overall Study||0
990944|NCT00441701|2402564|P7|STARTED|Overall Study||0
990945|NCT00441701|2402565|P6|STARTED|Overall Study||11
990946|NCT00441701|2402566|P5|STARTED|Overall Study||22
990947|NCT00441701|2402567|P4|STARTED|Overall Study||11
990948|NCT00441701|2402568|P3|STARTED|Overall Study||22
990949|NCT00441701|2402569|P2|STARTED|Overall Study||11
990950|NCT00441701|2402570|P1|STARTED|Overall Study||22
990951|NCT00441727|2402655|P3|NOT COMPLETED|Overall Study||168
990952|NCT00441727|2402656|P2|NOT COMPLETED|Overall Study||118
990953|NCT00441727|2402657|P1|NOT COMPLETED|Overall Study||106
990954|NCT00441727|2402655|P3|COMPLETED|Overall Study|ITT/randomised|637
990955|NCT00441727|2402656|P2|COMPLETED|Overall Study|ITT/randomised|686
990956|NCT00441727|2402657|P1|COMPLETED|Overall Study|ITT/randomised|711
990957|NCT00441727|2402655|P3|STARTED|Overall Study|ITT/randomised|805
990958|NCT00441727|2402656|P2|STARTED|Overall Study|ITT/randomised|804
990959|NCT00441727|2402657|P1|STARTED|Overall Study|ITT/randomised|817
990960|NCT00441766|2402684|P4|NOT COMPLETED|Overall Study||6
990961|NCT00441766|2402685|P3|NOT COMPLETED|Overall Study||9
990962|NCT00441766|2402686|P2|NOT COMPLETED|Overall Study||7
990963|NCT00441766|2402687|P1|NOT COMPLETED|Overall Study||14
990964|NCT00441766|2402684|P4|COMPLETED|Overall Study||48
990965|NCT00441766|2402685|P3|COMPLETED|Overall Study||44
990966|NCT00441766|2402686|P2|COMPLETED|Overall Study||46
990967|NCT00441766|2402687|P1|COMPLETED|Overall Study||39
990968|NCT00441766|2402684|P4|STARTED|Overall Study||54
990969|NCT00441766|2402685|P3|STARTED|Overall Study||53
990970|NCT00441766|2402686|P2|STARTED|Overall Study||53
990971|NCT00441766|2402687|P1|STARTED|Overall Study||53
990972|NCT00441792|2402711|P2|NOT COMPLETED|Overall Study||2
990973|NCT00441792|2402712|P1|NOT COMPLETED|Overall Study||0
990974|NCT00441792|2402711|P2|COMPLETED|Overall Study|2 patients lost to follow up in Etomidate arm due to transfer to outside hospital.|61
990975|NCT00441792|2402712|P1|COMPLETED|Overall Study||59
990976|NCT00441792|2402711|P2|STARTED|Overall Study||63
990977|NCT00441792|2402712|P1|STARTED|Overall Study||59
990978|NCT00441974|2402720|P1|NOT COMPLETED|Overall Study||128
990979|NCT00441974|2402720|P1|COMPLETED|Overall Study||1342
990980|NCT00441974|2402720|P1|STARTED|Overall Study||1470
990981|NCT00442013|2402736|P2|NOT COMPLETED|Overall Study||17
990982|NCT00442013|2402737|P1|NOT COMPLETED|Overall Study||26
990983|NCT00442013|2402736|P2|COMPLETED|Overall Study||132
990984|NCT00442013|2402737|P1|COMPLETED|Overall Study||131
990985|NCT00442013|2402736|P2|STARTED|Overall Study||149
990986|NCT00442013|2402737|P1|STARTED|Overall Study||157
990987|NCT00442117|2402755|P2|NOT COMPLETED|Overall Study||38
990988|NCT00442117|2402756|P1|NOT COMPLETED|Overall Study||38
990989|NCT00442117|2402755|P2|COMPLETED|Overall Study||49
990990|NCT00442117|2402756|P1|COMPLETED|Overall Study||47
990991|NCT00442117|2402755|P2|STARTED|Overall Study||87
990992|NCT00442117|2402756|P1|STARTED|Overall Study||85
990993|NCT00442169|2402774|P6|NOT COMPLETED|Part 2||0
990994|NCT00442169|2402775|P5|NOT COMPLETED|Part 2||0
990995|NCT00442169|2402776|P4|NOT COMPLETED|Part 2||0
990996|NCT00442169|2402777|P3|NOT COMPLETED|Part 2||0
990997|NCT00442169|2402778|P2|NOT COMPLETED|Part 2||0
990998|NCT00442169|2402779|P1|NOT COMPLETED|Part 2||0
990999|NCT00442169|2402774|P6|COMPLETED|Part 2||57
991000|NCT00442169|2402775|P5|COMPLETED|Part 2||25
991001|NCT00442169|2402776|P4|COMPLETED|Part 2||0
991002|NCT00442169|2402777|P3|COMPLETED|Part 2||0
991003|NCT00442169|2402778|P2|COMPLETED|Part 2||0
991004|NCT00442169|2402779|P1|COMPLETED|Part 2||0
991005|NCT00442169|2402774|P6|STARTED|Part 2||57
991006|NCT00442169|2402775|P5|STARTED|Part 2||25
991007|NCT00442169|2402776|P4|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
991008|NCT00442169|2402777|P3|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
991009|NCT00442169|2402778|P2|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
991010|NCT00442169|2402779|P1|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
991011|NCT00442169|2402774|P6|NOT COMPLETED|Part 1||0
991012|NCT00442169|2402775|P5|NOT COMPLETED|Part 1||0
991013|NCT00442169|2402776|P4|NOT COMPLETED|Part 1||0
991014|NCT00442169|2402777|P3|NOT COMPLETED|Part 1||0
991015|NCT00442169|2402778|P2|NOT COMPLETED|Part 1||0
991016|NCT00442169|2402779|P1|NOT COMPLETED|Part 1||0
991017|NCT00442169|2402774|P6|COMPLETED|Part 1||0
991018|NCT00442169|2402775|P5|COMPLETED|Part 1||0
991019|NCT00442169|2402776|P4|COMPLETED|Part 1||31
991020|NCT00442169|2402777|P3|COMPLETED|Part 1||40
991021|NCT00442169|2402778|P2|COMPLETED|Part 1||24
991022|NCT00442169|2402779|P1|COMPLETED|Part 1||17
991023|NCT00442169|2402774|P6|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
991024|NCT00442169|2402775|P5|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
991025|NCT00442169|2402776|P4|STARTED|Part 1||31
991026|NCT00442169|2402777|P3|STARTED|Part 1||40
991027|NCT00442169|2402778|P2|STARTED|Part 1||24
991028|NCT00442169|2402779|P1|STARTED|Part 1||17
991029|NCT00442286|2402820|P2|NOT COMPLETED|Overall Study||2
991030|NCT00442286|2402821|P1|NOT COMPLETED|Overall Study||7
991031|NCT00442286|2402820|P2|COMPLETED|Overall Study||82
991032|NCT00442286|2402821|P1|COMPLETED|Overall Study||174
991033|NCT00442286|2402820|P2|12 Months|Overall Study||82
991034|NCT00442286|2402821|P1|12 Months|Overall Study||174
991035|NCT00442286|2402820|P2|6 Months|Overall Study||83
991036|NCT00442286|2402821|P1|6 Months|Overall Study||177
991037|NCT00442286|2402820|P2|STARTED|Overall Study||84
991038|NCT00442286|2402821|P1|STARTED|Overall Study||181
991039|NCT00442338|2402835|P3|NOT COMPLETED|Overall Study||0
991040|NCT00442338|2402836|P2|NOT COMPLETED|Overall Study||0
991041|NCT00442338|2402837|P1|NOT COMPLETED|Overall Study||0
991042|NCT00442338|2402835|P3|COMPLETED|Overall Study||31
991043|NCT00442338|2402836|P2|COMPLETED|Overall Study||30
991044|NCT00442338|2402837|P1|COMPLETED|Overall Study||30
991045|NCT00442338|2402835|P3|STARTED|Overall Study||31
991046|NCT00442338|2402836|P2|STARTED|Overall Study||30
991047|NCT00442338|2402837|P1|STARTED|Overall Study||30
991048|NCT00442351|2402847|P2|NOT COMPLETED|Overall Study||6
991049|NCT00442351|2402848|P1|NOT COMPLETED|Overall Study||7
991050|NCT00442351|2402847|P2|COMPLETED|Overall Study||3
991051|NCT00442351|2402848|P1|COMPLETED|Overall Study||10
991052|NCT00442351|2402847|P2|STARTED|Overall Study||9
991053|NCT00442351|2402848|P1|STARTED|Overall Study|Due to poor enrollment and a high screening failure rate, this study was terminated early.|17
991054|NCT00442364|2402854|P1|NOT COMPLETED|Overall Study||0
991055|NCT00442364|2402854|P1|COMPLETED|Overall Study||60
991056|NCT00442364|2402854|P1|STARTED|Overall Study||60
991057|NCT00442416|2402860|P2|NOT COMPLETED|Overall Study||39
991058|NCT00442416|2402861|P1|NOT COMPLETED|Overall Study||37
991059|NCT00442416|2402860|P2|COMPLETED|Overall Study||2
991060|NCT00442416|2402861|P1|COMPLETED|Overall Study||2
991061|NCT00442416|2402860|P2|STARTED|Overall Study||41
991062|NCT00442416|2402861|P1|STARTED|Overall Study||39
991063|NCT00442468|2402894|P1|NOT COMPLETED|Overall Study||183
991064|NCT00442468|2402894|P1|COMPLETED|Overall Study||1100
991065|NCT00442468|2402894|P1|STARTED|Overall Study||1283
991066|NCT00442507|2402922|P1|NOT COMPLETED|Overall Study||0
991067|NCT00442507|2402922|P1|COMPLETED|Overall Study||6
991068|NCT00442507|2402922|P1|STARTED|Overall Study||6
991069|NCT00442546|2402932|P3|NOT COMPLETED|Overall Study||33
991070|NCT00442546|2402933|P2|NOT COMPLETED|Overall Study||37
991071|NCT00442546|2402934|P1|NOT COMPLETED|Overall Study||26
991072|NCT00442546|2402932|P3|COMPLETED|Overall Study||71
991073|NCT00442546|2402933|P2|COMPLETED|Overall Study||63
991074|NCT00442546|2402934|P1|COMPLETED|Overall Study||77
991075|NCT00442546|2402932|P3|Received Treatment|Overall Study||98
991076|NCT00442546|2402933|P2|Received Treatment|Overall Study||96
991077|NCT00442546|2402934|P1|Received Treatment|Overall Study||98
991078|NCT00442546|2402932|P3|STARTED|Overall Study||104
991079|NCT00442546|2402933|P2|STARTED|Overall Study||100
991080|NCT00442546|2402934|P1|STARTED|Overall Study||103
991081|NCT00442559|2403058|P2|NOT COMPLETED|Overall Study||35
991082|NCT00442559|2403059|P1|NOT COMPLETED|Overall Study||34
991168|NCT00443040|2403274|P2|COMPLETED|Overall Study||11
991083|NCT00442559|2403058|P2|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|56
991084|NCT00442559|2403059|P1|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|66
991085|NCT00442559|2403058|P2|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|60
991086|NCT00442559|2403059|P1|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|68
991087|NCT00442559|2403058|P2|STARTED|Overall Study||91
991088|NCT00442559|2403059|P1|STARTED|Overall Study||100
991089|NCT00442572|2403073|P2|NOT COMPLETED|Overall Study||3
991090|NCT00442572|2403074|P1|NOT COMPLETED|Overall Study||8
991091|NCT00442572|2403073|P2|COMPLETED|Overall Study||1
991092|NCT00442572|2403074|P1|COMPLETED|Overall Study||9
991093|NCT00442572|2403073|P2|STARTED|Overall Study||4
991094|NCT00442572|2403074|P1|STARTED|Overall Study||17
991095|NCT00442598|2403115|P3|NOT COMPLETED|Overall Study||0
991096|NCT00442598|2403116|P2|NOT COMPLETED|Overall Study||8
991097|NCT00442598|2403117|P1|NOT COMPLETED|Overall Study||6
991098|NCT00442598|2403115|P3|COMPLETED|Overall Study||0
991099|NCT00442598|2403116|P2|COMPLETED|Overall Study||2
991100|NCT00442598|2403117|P1|COMPLETED|Overall Study||1
991101|NCT00442598|2403115|P3|Two Cycles|Overall Study||0
991102|NCT00442598|2403116|P2|Two Cycles|Overall Study||6
991103|NCT00442598|2403117|P1|Two Cycles|Overall Study||5
991104|NCT00442598|2403115|P3|STARTED|Overall Study||0
991105|NCT00442598|2403116|P2|STARTED|Overall Study||10
991106|NCT00442598|2403117|P1|STARTED|Overall Study||7
991113|NCT00442689|2403149|P3|NOT COMPLETED|Overall Study||9
991114|NCT00442689|2403150|P2|NOT COMPLETED|Overall Study||11
991115|NCT00442689|2403151|P1|NOT COMPLETED|Overall Study||10
991116|NCT00442689|2403149|P3|COMPLETED|Overall Study||13
991117|NCT00442689|2403150|P2|COMPLETED|Overall Study||13
991118|NCT00442689|2403151|P1|COMPLETED|Overall Study||11
991119|NCT00442689|2403149|P3|STARTED|Overall Study||22
991120|NCT00442689|2403150|P2|STARTED|Overall Study||24
991121|NCT00442689|2403151|P1|STARTED|Overall Study||21
991122|NCT00442702|2403179|P2|NOT COMPLETED|Evaluation Period||4
991123|NCT00442702|2403180|P1|NOT COMPLETED|Evaluation Period||5
991124|NCT00442702|2403179|P2|COMPLETED|Evaluation Period||107
991125|NCT00442702|2403180|P1|COMPLETED|Evaluation Period||97
991126|NCT00442702|2403179|P2|STARTED|Evaluation Period||111
991127|NCT00442702|2403180|P1|STARTED|Evaluation Period||102
991128|NCT00442702|2403179|P2|NOT COMPLETED|Titration Period||3
991129|NCT00442702|2403180|P1|NOT COMPLETED|Titration Period||12
991130|NCT00442702|2403179|P2|COMPLETED|Titration Period||111
991131|NCT00442702|2403180|P1|COMPLETED|Titration Period||102
991132|NCT00442702|2403179|P2|Safety Population|Titration Period||113
991133|NCT00442702|2403180|P1|Safety Population|Titration Period|One patient was randomized to darbepoetin alfa but treated by mistake with Mircera|115
991134|NCT00442702|2403179|P2|STARTED|Titration Period||114
991135|NCT00442702|2403180|P1|STARTED|Titration Period||114
991136|NCT00442897|2403194|P2|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
991137|NCT00442897|2403195|P1|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
991138|NCT00442897|2403194|P2|COMPLETED|24 Weeks Follow-up (3 Centers)||28
991139|NCT00442897|2403195|P1|COMPLETED|24 Weeks Follow-up (3 Centers)||29
991140|NCT00442897|2403194|P2|STARTED|24 Weeks Follow-up (3 Centers)|65 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|34
991141|NCT00442897|2403195|P1|STARTED|24 Weeks Follow-up (3 Centers)|66 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|35
991142|NCT00442897|2403194|P2|NOT COMPLETED|Base Study (12 Week Follow-up)||12
991143|NCT00442897|2403195|P1|NOT COMPLETED|Base Study (12 Week Follow-up)||17
991144|NCT00442897|2403194|P2|COMPLETED|Base Study (12 Week Follow-up)||99
991145|NCT00442897|2403195|P1|COMPLETED|Base Study (12 Week Follow-up)||101
991146|NCT00442897|2403194|P2|STARTED|Base Study (12 Week Follow-up)||111
991147|NCT00442897|2403195|P1|STARTED|Base Study (12 Week Follow-up)||118
991148|NCT00442936|2403207|P4|NOT COMPLETED|Overall Study||1
991149|NCT00442936|2403208|P3|NOT COMPLETED|Overall Study||1
991150|NCT00442936|2403209|P2|NOT COMPLETED|Overall Study||0
991151|NCT00442936|2403210|P1|NOT COMPLETED|Overall Study||1
991152|NCT00442936|2403207|P4|COMPLETED|Overall Study||347
991153|NCT00442936|2403208|P3|COMPLETED|Overall Study||344
991154|NCT00442936|2403209|P2|COMPLETED|Overall Study||354
991155|NCT00442936|2403210|P1|COMPLETED|Overall Study||332
991156|NCT00442936|2403207|P4|STARTED|Overall Study||348
991157|NCT00442936|2403208|P3|STARTED|Overall Study||345
991158|NCT00442936|2403209|P2|STARTED|Overall Study||354
991159|NCT00442936|2403210|P1|STARTED|Overall Study||333
991160|NCT00442962|2403256|P1|NOT COMPLETED|Overall Study||8
991161|NCT00442962|2403256|P1|COMPLETED|Overall Study|Completed 48 weeks of follow-up.|46
991162|NCT00442962|2403256|P1|Primary Outcome Evaluation|Overall Study|Primary outcome evaluation at week 24.|52
991163|NCT00442962|2403256|P1|STARTED|Overall Study||54
991164|NCT00443040|2403273|P3|NOT COMPLETED|Overall Study||1
991165|NCT00443040|2403274|P2|NOT COMPLETED|Overall Study||0
991166|NCT00443040|2403275|P1|NOT COMPLETED|Overall Study||4
991167|NCT00443040|2403273|P3|COMPLETED|Overall Study||9
991169|NCT00443040|2403275|P1|COMPLETED|Overall Study||10
991170|NCT00443040|2403273|P3|STARTED|Overall Study||10
991171|NCT00443040|2403274|P2|STARTED|Overall Study||11
991172|NCT00443040|2403275|P1|STARTED|Overall Study||14
991173|NCT00443053|2403285|P2|NOT COMPLETED|Overall Study||33
991174|NCT00443053|2403286|P1|NOT COMPLETED|Overall Study||21
991175|NCT00443053|2403285|P2|COMPLETED|Overall Study||1467
991176|NCT00443053|2403286|P1|COMPLETED|Overall Study||1481
991177|NCT00443053|2403285|P2|STARTED|Overall Study||1500
991178|NCT00443053|2403286|P1|STARTED|Overall Study||1502
991179|NCT00443118|2403307|P3|NOT COMPLETED|Overall Study||0
991180|NCT00443118|2403308|P2|NOT COMPLETED|Overall Study||1
991181|NCT00443118|2403309|P1|NOT COMPLETED|Overall Study||4
991182|NCT00443118|2403307|P3|COMPLETED|Overall Study||226
991183|NCT00443118|2403308|P2|COMPLETED|Overall Study||290
991184|NCT00443118|2403309|P1|COMPLETED|Overall Study||511
991185|NCT00443118|2403307|P3|STARTED|Overall Study||226
991186|NCT00443118|2403308|P2|STARTED|Overall Study||291
991187|NCT00443118|2403309|P1|STARTED|Overall Study||515
991188|NCT00443209|2403355|P2|NOT COMPLETED|Months 13 to 18 Treatment Period||47
991189|NCT00443209|2403356|P1|NOT COMPLETED|Months 13 to 18 Treatment Period||99
991190|NCT00443209|2403355|P2|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|39
991191|NCT00443209|2403356|P1|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|87
991192|NCT00443209|2403355|P2|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period was optional. 116 participants chose not to continue.|86
991193|NCT00443209|2403356|P1|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period.was optional. 181 participants chose not to continue.|186
991194|NCT00443209|2403355|P2|NOT COMPLETED|Months 1 to 12 Treatment Period||154
991195|NCT00443209|2403356|P1|NOT COMPLETED|Months 1 to 12 Treatment Period||345
991196|NCT00443209|2403355|P2|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|202
991197|NCT00443209|2403356|P1|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|367
991198|NCT00443209|2403355|P2|Treated|Months 1 to 12 Treatment Period||313
991199|NCT00443209|2403356|P1|Treated|Months 1 to 12 Treatment Period||641
991200|NCT00443209|2403355|P2|STARTED|Months 1 to 12 Treatment Period||356
991201|NCT00443209|2403356|P1|STARTED|Months 1 to 12 Treatment Period||712
991202|NCT00443261|2403370|P1|NOT COMPLETED|Overall Study||1
991203|NCT00443261|2403370|P1|COMPLETED|Overall Study|Study terminated due to poor accrual and only patient enrolled died|0
991204|NCT00443261|2403370|P1|Accrual in 10 Months|Overall Study|Patient died due to progressive disease after cycle 1 of treatment|1
991205|NCT00443261|2403370|P1|STARTED|Overall Study||1
991206|NCT00443352|2403374|P1|NOT COMPLETED|Overall Study||5
991207|NCT00443352|2403374|P1|COMPLETED|Overall Study||22
991208|NCT00443352|2403374|P1|STARTED|Overall Study||27
991209|NCT00443430|2403380|P2|NOT COMPLETED|Overall Study||4
991210|NCT00443430|2403381|P1|NOT COMPLETED|Overall Study||4
991211|NCT00443430|2403380|P2|COMPLETED|Overall Study||38
991212|NCT00443430|2403381|P1|COMPLETED|Overall Study||39
991213|NCT00443430|2403380|P2|STARTED|Overall Study||42
991214|NCT00443430|2403381|P1|STARTED|Overall Study||43
991215|NCT00443456|2403391|P1|NOT COMPLETED|Overall Study||18
991216|NCT00443456|2403391|P1|COMPLETED|Overall Study||116
991217|NCT00443456|2403391|P1|STARTED|Overall Study||134
991218|NCT00443534|2403424|P1|NOT COMPLETED|Overall Study||123
991219|NCT00443534|2403424|P1|COMPLETED|Overall Study||0
991220|NCT00443534|2403424|P1|Treated|Overall Study||122
991221|NCT00443534|2403424|P1|STARTED|Overall Study||123
991222|NCT00443560|2403433|P2|NOT COMPLETED|Overall Study||30
991223|NCT00443560|2403434|P1|NOT COMPLETED|Overall Study||60
991224|NCT00443560|2403433|P2|COMPLETED|Overall Study||1051
991225|NCT00443560|2403434|P1|COMPLETED|Overall Study||1021
991226|NCT00443560|2403433|P2|STARTED|Overall Study||1081
991227|NCT00443560|2403434|P1|STARTED|Overall Study||1081
991228|NCT00443599|2403446|P2|NOT COMPLETED|Overall Study||3
991229|NCT00443599|2403447|P1|NOT COMPLETED|Overall Study||6
991230|NCT00443599|2403446|P2|COMPLETED|Overall Study|Included in per-protocol analysis|490
991231|NCT00443599|2403447|P1|COMPLETED|Overall Study|Included in per-protocol analysis|490
991232|NCT00443599|2403446|P2|STARTED|Overall Study|Randomly Assigned to Standard Care|493
991233|NCT00443599|2403447|P1|STARTED|Overall Study|Randomly Assigned to Tight Glycemic Control|496
991234|NCT00443651|2403481|P2|NOT COMPLETED|Overall Study||58
991235|NCT00443651|2403482|P1|NOT COMPLETED|Overall Study||95
991236|NCT00443651|2403481|P2|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|118
991237|NCT00443651|2403482|P1|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|306
991238|NCT00443651|2403481|P2|Week 48|Overall Study||134
991239|NCT00443651|2403482|P1|Week 48|Overall Study||338
991240|NCT00443651|2403481|P2|Week 24|Overall Study||160
991241|NCT00443651|2403482|P1|Week 24|Overall Study||376
991242|NCT00443651|2403481|P2|STARTED|Overall Study||176
991243|NCT00443651|2403482|P1|STARTED|Overall Study||401
991244|NCT00443703|2403502|P2|NOT COMPLETED|Overall Study||18
991245|NCT00443703|2403503|P1|NOT COMPLETED|Overall Study||28
991246|NCT00443703|2403502|P2|COMPLETED|Overall Study||157
991247|NCT00443703|2403503|P1|COMPLETED|Overall Study||149
991248|NCT00443703|2403502|P2|Treated|Overall Study||174
991249|NCT00443703|2403503|P1|Treated|Overall Study||174
991250|NCT00443703|2403502|P2|STARTED|Overall Study||175
991251|NCT00443703|2403503|P1|STARTED|Overall Study||177
991252|NCT00443729|2403555|P2|NOT COMPLETED|Overall Study||7
991253|NCT00443729|2403556|P1|NOT COMPLETED|Overall Study||10
991254|NCT00443729|2403555|P2|COMPLETED|Overall Study||172
991255|NCT00443729|2403556|P1|COMPLETED|Overall Study||166
991256|NCT00443729|2403555|P2|Treated|Overall Study||178
991257|NCT00443729|2403556|P1|Treated|Overall Study||176
991258|NCT00443729|2403555|P2|STARTED|Overall Study||179
991259|NCT00443729|2403556|P1|STARTED|Overall Study||176
991260|NCT00443755|2403604|P2|NOT COMPLETED|Overall Study||1
991261|NCT00443755|2403605|P1|NOT COMPLETED|Overall Study||2
991262|NCT00443755|2403604|P2|COMPLETED|Overall Study||13
991263|NCT00443755|2403605|P1|COMPLETED|Overall Study||12
991264|NCT00443755|2403604|P2|STARTED|Overall Study||14
991265|NCT00443755|2403605|P1|STARTED|Overall Study||14
991269|NCT00443820|2403645|P4|NOT COMPLETED|Overall Study||17
991270|NCT00443820|2403646|P3|NOT COMPLETED|Overall Study||18
991271|NCT00443820|2403647|P2|NOT COMPLETED|Overall Study||19
991272|NCT00443820|2403648|P1|NOT COMPLETED|Overall Study||21
991273|NCT00443820|2403645|P4|COMPLETED|Overall Study||111
991274|NCT00443820|2403646|P3|COMPLETED|Overall Study||117
991275|NCT00443820|2403647|P2|COMPLETED|Overall Study|A participant from this gr. discont'ed due to renal failure, was counted as an AE and also as a SAE.|111
991276|NCT00443820|2403648|P1|COMPLETED|Overall Study||112
991277|NCT00443820|2403645|P4|Safety Population|Overall Study||126
991278|NCT00443820|2403646|P3|Safety Population|Overall Study||134
991279|NCT00443820|2403647|P2|Safety Population|Overall Study||129
991280|NCT00443820|2403648|P1|Safety Population|Overall Study|Participants who received study drug and had at least one post-baseline safety assessment.|131
991281|NCT00443820|2403645|P4|STARTED|Overall Study||128
991282|NCT00443820|2403646|P3|STARTED|Overall Study||135
991283|NCT00443820|2403647|P2|STARTED|Overall Study||130
991284|NCT00443820|2403648|P1|STARTED|Overall Study||133
991285|NCT00430027|2403670|P1|NOT COMPLETED|Overall Study||8
991286|NCT00430027|2403670|P1|COMPLETED|Overall Study||0
991287|NCT00430027|2403670|P1|STARTED|Overall Study||8
991288|NCT00430092|2403677|P3|NOT COMPLETED|Overall Study||57
991289|NCT00430092|2403678|P2|NOT COMPLETED|Overall Study||4
991290|NCT00430092|2403679|P1|NOT COMPLETED|Overall Study||6
991291|NCT00430092|2403677|P3|COMPLETED|Overall Study||56
991292|NCT00430092|2403678|P2|COMPLETED|Overall Study||48
991293|NCT00430092|2403679|P1|COMPLETED|Overall Study||48
991294|NCT00430092|2403677|P3|STARTED|Overall Study||113
991295|NCT00430092|2403678|P2|STARTED|Overall Study||52
991296|NCT00430092|2403679|P1|STARTED|Overall Study||54
991297|NCT00430248|2403687|P3|NOT COMPLETED|Overall Study||135
991298|NCT00430248|2403688|P2|NOT COMPLETED|Overall Study||158
991299|NCT00430248|2403689|P1|NOT COMPLETED|Overall Study||125
991300|NCT00430248|2403687|P3|COMPLETED|Overall Study||621
991301|NCT00430248|2403688|P2|COMPLETED|Overall Study||598
991302|NCT00430248|2403689|P1|COMPLETED|Overall Study||632
991303|NCT00430248|2403687|P3|STARTED|Overall Study||756
991304|NCT00430248|2403688|P2|STARTED|Overall Study||756
991305|NCT00430248|2403689|P1|STARTED|Overall Study||757
991306|NCT00430300|2403749|P4|NOT COMPLETED|Overall Study||2
991307|NCT00430300|2403750|P3|NOT COMPLETED|Overall Study||6
991308|NCT00430300|2403751|P2|NOT COMPLETED|Overall Study||2
991309|NCT00430300|2403752|P1|NOT COMPLETED|Overall Study||2
991310|NCT00430300|2403749|P4|COMPLETED|Overall Study||15
991311|NCT00430300|2403750|P3|COMPLETED|Overall Study||29
991312|NCT00430300|2403751|P2|COMPLETED|Overall Study||16
991313|NCT00430300|2403752|P1|COMPLETED|Overall Study||15
991314|NCT00430300|2403749|P4|STARTED|Overall Study||17
991315|NCT00430300|2403750|P3|STARTED|Overall Study||35
991316|NCT00430300|2403751|P2|STARTED|Overall Study||18
991317|NCT00430300|2403752|P1|STARTED|Overall Study||17
991318|NCT00430352|2403854|P1|NOT COMPLETED|Overall Study||138
991319|NCT00430352|2403854|P1|COMPLETED|Overall Study||407
991320|NCT00430352|2403854|P1|STARTED|Overall Study||545
991321|NCT00430495|2403872|P4|NOT COMPLETED|Overall Study||4
991322|NCT00430495|2403873|P3|NOT COMPLETED|Overall Study||13
991323|NCT00430495|2403874|P2|NOT COMPLETED|Overall Study||7
991324|NCT00430495|2403875|P1|NOT COMPLETED|Overall Study||14
991325|NCT00430495|2403872|P4|COMPLETED|Overall Study||60
991326|NCT00430495|2403873|P3|COMPLETED|Overall Study||49
991327|NCT00430495|2403874|P2|COMPLETED|Overall Study||59
991328|NCT00430495|2403875|P1|COMPLETED|Overall Study||50
991329|NCT00430495|2403872|P4|Treated|Overall Study||64
991330|NCT00430495|2403873|P3|Treated|Overall Study||62
991331|NCT00430495|2403874|P2|Treated|Overall Study||66
991332|NCT00430495|2403875|P1|Treated|Overall Study||62
991333|NCT00430495|2403872|P4|STARTED|Overall Study||64
991334|NCT00430495|2403873|P3|STARTED|Overall Study||62
991335|NCT00430495|2403874|P2|STARTED|Overall Study||66
991336|NCT00430495|2403875|P1|STARTED|Overall Study||64
991337|NCT00430508|2403917|P4|NOT COMPLETED|Overall Study||5
991338|NCT00430508|2403918|P3|NOT COMPLETED|Overall Study||13
991339|NCT00430508|2403919|P2|NOT COMPLETED|Overall Study||6
991340|NCT00430508|2403920|P1|NOT COMPLETED|Overall Study||3
991341|NCT00430508|2403917|P4|COMPLETED|Overall Study||269
991342|NCT00430508|2403918|P3|COMPLETED|Overall Study||266
991343|NCT00430508|2403919|P2|COMPLETED|Overall Study||272
991344|NCT00430508|2403920|P1|COMPLETED|Overall Study||137
991345|NCT00430508|2403917|P4|STARTED|Overall Study||274
991346|NCT00430508|2403918|P3|STARTED|Overall Study||279
991347|NCT00430508|2403919|P2|STARTED|Overall Study||278
991348|NCT00430508|2403920|P1|STARTED|Overall Study||140
991349|NCT00430625|2403956|P2|NOT COMPLETED|Overall Study||0
991350|NCT00430625|2403957|P1|NOT COMPLETED|Overall Study||0
991351|NCT00430625|2403956|P2|COMPLETED|Overall Study||12
991352|NCT00430625|2403957|P1|COMPLETED|Overall Study||13
991353|NCT00430625|2403956|P2|STARTED|Overall Study||12
991354|NCT00430625|2403957|P1|STARTED|Overall Study||13
991355|NCT00430638|2403975|P2|NOT COMPLETED|Overall Study||48
991356|NCT00430638|2403976|P1|NOT COMPLETED|Overall Study||78
991357|NCT00430638|2403975|P2|COMPLETED|Overall Study||92
991358|NCT00430638|2403976|P1|COMPLETED|Overall Study||60
991359|NCT00430638|2403975|P2|STARTED|Overall Study|2 participants were erroneously assigned to olmesartan 40 mg instead of 20 mg|140
991360|NCT00430638|2403976|P1|STARTED|Overall Study||138
991361|NCT00430677|2403995|P3|NOT COMPLETED|Long-term Extension Period||63
991362|NCT00430677|2403996|P2|NOT COMPLETED|Long-term Extension Period||58
991363|NCT00430677|2403997|P1|NOT COMPLETED|Long-term Extension Period||60
991364|NCT00430677|2403995|P3|COMPLETED|Long-term Extension Period|Completed the long-term extension period|11
991365|NCT00430677|2403996|P2|COMPLETED|Long-term Extension Period|Completed the long-term extension period|9
991366|NCT00430677|2403997|P1|COMPLETED|Long-term Extension Period|Completed the long-term extension period|10
991367|NCT00430677|2403995|P3|STARTED|Long-term Extension Period||74
991368|NCT00430677|2403996|P2|STARTED|Long-term Extension Period||67
991369|NCT00430677|2403997|P1|STARTED|Long-term Extension Period||70
991370|NCT00430677|2403995|P3|NOT COMPLETED|Short-term Period||22
991371|NCT00430677|2403996|P2|NOT COMPLETED|Short-term Period||25
991372|NCT00430677|2403997|P1|NOT COMPLETED|Short-term Period||23
991373|NCT00430677|2403995|P3|COMPLETED|Short-term Period|Completed the short-term period|78
991374|NCT00430677|2403996|P2|COMPLETED|Short-term Period|Completed the short-term period|74
991375|NCT00430677|2403997|P1|COMPLETED|Short-term Period|Completed the short-term period|76
991376|NCT00430677|2403995|P3|STARTED|Short-term Period||100
991377|NCT00430677|2403996|P2|STARTED|Short-term Period|1 participant took infliximab on day 1 and was discontinued before receiving study medication.|99
991378|NCT00430677|2403997|P1|STARTED|Short-term Period|1 participant died before receiving the first dose of study medication|99
991379|NCT00430716|2404121|P3|NOT COMPLETED|Open Label Phase||7
991380|NCT00430716|2404122|P2|NOT COMPLETED|Open Label Phase||7
991381|NCT00430716|2404123|P1|NOT COMPLETED|Open Label Phase||9
991382|NCT00430716|2404121|P3|COMPLETED|Open Label Phase||32
991383|NCT00430716|2404122|P2|COMPLETED|Open Label Phase||31
991384|NCT00430716|2404123|P1|COMPLETED|Open Label Phase||27
991385|NCT00430716|2404121|P3|STARTED|Open Label Phase||39
991386|NCT00430716|2404122|P2|STARTED|Open Label Phase||38
991387|NCT00430716|2404123|P1|STARTED|Open Label Phase||36
991388|NCT00430716|2404121|P3|NOT COMPLETED|Double Blind Phase||6
991389|NCT00430716|2404122|P2|NOT COMPLETED|Double Blind Phase||5
991390|NCT00430716|2404123|P1|NOT COMPLETED|Double Blind Phase||6
991391|NCT00430716|2404121|P3|COMPLETED|Double Blind Phase||39
991392|NCT00430716|2404122|P2|COMPLETED|Double Blind Phase||38
991393|NCT00430716|2404123|P1|COMPLETED|Double Blind Phase||36
991394|NCT00430716|2404121|P3|Treated|Double Blind Phase||45
991395|NCT00430716|2404122|P2|Treated|Double Blind Phase||43
991396|NCT00430716|2404123|P1|Treated|Double Blind Phase||41
991397|NCT00430716|2404121|P3|STARTED|Double Blind Phase||45
991398|NCT00430716|2404122|P2|STARTED|Double Blind Phase||43
991399|NCT00430716|2404123|P1|STARTED|Double Blind Phase||42
991400|NCT00430755|2404152|P1|NOT COMPLETED|Overall Study||53
991401|NCT00430755|2404152|P1|COMPLETED|Overall Study||45
991402|NCT00430755|2404152|P1|STARTED|Overall Study||98
991403|NCT00430768|2404159|P3|NOT COMPLETED|Overall Study||0
991404|NCT00430768|2404160|P2|NOT COMPLETED|Overall Study||0
991405|NCT00430768|2404161|P1|NOT COMPLETED|Overall Study||0
991406|NCT00430768|2404159|P3|COMPLETED|Overall Study||3
991407|NCT00430768|2404160|P2|COMPLETED|Overall Study||3
991408|NCT00430768|2404161|P1|COMPLETED|Overall Study||3
991409|NCT00430768|2404159|P3|STARTED|Overall Study||3
991410|NCT00430768|2404160|P2|STARTED|Overall Study||3
991411|NCT00430768|2404161|P1|STARTED|Overall Study||3
991412|NCT00430781|2404178|P3|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||20
991413|NCT00430781|2404179|P2|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||18
991414|NCT00430781|2404180|P1|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||24
991415|NCT00430781|2404178|P3|COMPLETED|End-of-Study Analysis; 28 July 2011||54
991416|NCT00430781|2404179|P2|COMPLETED|End-of-Study Analysis; 28 July 2011||59
991417|NCT00430781|2404180|P1|COMPLETED|End-of-Study Analysis; 28 July 2011||53
991418|NCT00430781|2404178|P3|STARTED|End-of-Study Analysis; 28 July 2011||74
991419|NCT00430781|2404179|P2|STARTED|End-of-Study Analysis; 28 July 2011|1 participant randomized to lapatinib (final analysis table) actually received combination therapy.|77
991420|NCT00430781|2404180|P1|STARTED|End-of-Study Analysis; 28 July 2011|Enrollment continued in this arm after data cut for Interim Analysis and before arm closed.|77
991421|NCT00430781|2404178|P3|NOT COMPLETED|Final Analysis; 31 July 2008||48
991422|NCT00430781|2404179|P2|NOT COMPLETED|Final Analysis; 31 July 2008||39
991423|NCT00430781|2404180|P1|NOT COMPLETED|Final Analysis; 31 July 2008||0
991424|NCT00430781|2404178|P3|COMPLETED|Final Analysis; 31 July 2008||26
991425|NCT00430781|2404179|P2|COMPLETED|Final Analysis; 31 July 2008||39
991426|NCT00430781|2404180|P1|COMPLETED|Final Analysis; 31 July 2008||0
991427|NCT00430781|2404178|P3|Ongoing|Final Analysis; 31 July 2008||32
991428|NCT00430781|2404179|P2|Ongoing|Final Analysis; 31 July 2008||29
991429|NCT00430781|2404180|P1|Ongoing|Final Analysis; 31 July 2008||0
991430|NCT00430781|2404178|P3|STARTED|Final Analysis; 31 July 2008||74
991431|NCT00430781|2404179|P2|STARTED|Final Analysis; 31 July 2008||78
991432|NCT00430781|2404180|P1|STARTED|Final Analysis; 31 July 2008||0
991433|NCT00430781|2404178|P3|NOT COMPLETED|Interim Analysis; 11 February 2008||60
991434|NCT00430781|2404179|P2|NOT COMPLETED|Interim Analysis; 11 February 2008||58
991435|NCT00430781|2404180|P1|NOT COMPLETED|Interim Analysis; 11 February 2008||59
991436|NCT00430781|2404178|P3|COMPLETED|Interim Analysis; 11 February 2008||0
991437|NCT00430781|2404179|P2|COMPLETED|Interim Analysis; 11 February 2008||0
991438|NCT00430781|2404180|P1|COMPLETED|Interim Analysis; 11 February 2008||0
991439|NCT00430781|2404178|P3|Ongoing|Interim Analysis; 11 February 2008||25
991440|NCT00430781|2404179|P2|Ongoing|Interim Analysis; 11 February 2008||20
991441|NCT00430781|2404180|P1|Ongoing|Interim Analysis; 11 February 2008||23
991442|NCT00430781|2404178|P3|STARTED|Interim Analysis; 11 February 2008||60
991443|NCT00430781|2404179|P2|STARTED|Interim Analysis; 11 February 2008||58
991444|NCT00430781|2404180|P1|STARTED|Interim Analysis; 11 February 2008||59
991445|NCT00430937|2404205|P2|NOT COMPLETED|Overall Study||28
991446|NCT00430937|2404206|P1|NOT COMPLETED|Overall Study||27
991447|NCT00430937|2404205|P2|COMPLETED|Overall Study||64
991448|NCT00430937|2404206|P1|COMPLETED|Overall Study||70
991449|NCT00430937|2404205|P2|STARTED|Overall Study||92
991450|NCT00430937|2404206|P1|STARTED|Overall Study|Additional 5 participants were randomized; however, they were not exposed to study drug by mistake.|97
991457|NCT00431041|2404233|P2|NOT COMPLETED|Overall Study||24
991458|NCT00431041|2404234|P1|NOT COMPLETED|Overall Study||16
991459|NCT00431041|2404233|P2|COMPLETED|Overall Study||40
991460|NCT00431041|2404234|P1|COMPLETED|Overall Study||52
991461|NCT00431041|2404233|P2|STARTED|Overall Study|Data represents ITT Population: All randomized subjects|64
991462|NCT00431041|2404234|P1|STARTED|Overall Study|Data represents Intention To Treat(ITT) Population: All randomized subjects|68
991463|NCT00431067|2404246|P1|NOT COMPLETED|Overall Study||41
991464|NCT00431067|2404246|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (22-Sep-2009)|0
991465|NCT00431067|2404246|P1|STARTED|Overall Study|52 patients screened, 41 treated|41
991466|NCT00431132|2404254|P1|NOT COMPLETED|Overall Study||44
991467|NCT00431132|2404254|P1|COMPLETED|Overall Study||292
991468|NCT00431132|2404254|P1|STARTED|Overall Study||336
991469|NCT00431184|2404261|P2|NOT COMPLETED|Second Intervention (Day 2)||0
991470|NCT00431184|2404262|P1|NOT COMPLETED|Second Intervention (Day 2)||0
991471|NCT00431184|2404261|P2|COMPLETED|Second Intervention (Day 2)||9
991472|NCT00431184|2404262|P1|COMPLETED|Second Intervention (Day 2)||10
991473|NCT00431184|2404261|P2|STARTED|Second Intervention (Day 2)||9
991474|NCT00431184|2404262|P1|STARTED|Second Intervention (Day 2)||10
991475|NCT00431184|2404261|P2|NOT COMPLETED|1st Intervention (Day 1)||0
991476|NCT00431184|2404262|P1|NOT COMPLETED|1st Intervention (Day 1)||0
991477|NCT00431184|2404261|P2|COMPLETED|1st Intervention (Day 1)||9
991478|NCT00431184|2404262|P1|COMPLETED|1st Intervention (Day 1)||10
991479|NCT00431184|2404261|P2|STARTED|1st Intervention (Day 1)||9
991480|NCT00431184|2404262|P1|STARTED|1st Intervention (Day 1)||10
991481|NCT00436748|2404272|P2|NOT COMPLETED|Overall Study||12
991482|NCT00436748|2404273|P1|NOT COMPLETED|Overall Study||11
991483|NCT00436748|2404272|P2|COMPLETED|Overall Study||45
991484|NCT00436748|2404273|P1|COMPLETED|Overall Study||48
991485|NCT00436748|2404272|P2|Received Treatment|Overall Study||56
991486|NCT00436748|2404273|P1|Received Treatment|Overall Study||58
991487|NCT00436748|2404272|P2|STARTED|Overall Study||57
991488|NCT00436748|2404273|P1|STARTED|Overall Study||59
991489|NCT00436826|2404309|P6|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||7
991490|NCT00436826|2404310|P5|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||51
991491|NCT00436826|2404311|P4|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
991492|NCT00436826|2404312|P3|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
991493|NCT00436826|2404313|P2|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
991494|NCT00436826|2404314|P1|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
991495|NCT00436826|2404309|P6|COMPLETED|Ext. Period (No Cladribine Treatment)||0
991496|NCT00436826|2404310|P5|COMPLETED|Ext. Period (No Cladribine Treatment)||1
991497|NCT00436826|2404311|P4|COMPLETED|Ext. Period (No Cladribine Treatment)||0
991498|NCT00436826|2404312|P3|COMPLETED|Ext. Period (No Cladribine Treatment)||0
991499|NCT00436826|2404313|P2|COMPLETED|Ext. Period (No Cladribine Treatment)||0
991500|NCT00436826|2404314|P1|COMPLETED|Ext. Period (No Cladribine Treatment)||0
991501|NCT00436826|2404309|P6|STARTED|Ext. Period (No Cladribine Treatment)||7
991502|NCT00436826|2404310|P5|STARTED|Ext. Period (No Cladribine Treatment)||52
991503|NCT00436826|2404311|P4|STARTED|Ext. Period (No Cladribine Treatment)||0
991504|NCT00436826|2404312|P3|STARTED|Ext. Period (No Cladribine Treatment)||0
991505|NCT00436826|2404313|P2|STARTED|Ext. Period (No Cladribine Treatment)||0
991506|NCT00436826|2404314|P1|STARTED|Ext. Period (No Cladribine Treatment)||0
991507|NCT00436826|2404309|P6|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
991508|NCT00436826|2404310|P5|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
991509|NCT00436826|2404311|P4|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||24
991510|NCT00436826|2404312|P3|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||44
991511|NCT00436826|2404313|P2|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
991512|NCT00436826|2404314|P1|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
991513|NCT00436826|2404309|P6|COMPLETED|Ext. Period (With Cladribine Treatment)||0
991514|NCT00436826|2404310|P5|COMPLETED|Ext. Period (With Cladribine Treatment)||0
991515|NCT00436826|2404311|P4|COMPLETED|Ext. Period (With Cladribine Treatment)||4
991516|NCT00436826|2404312|P3|COMPLETED|Ext. Period (With Cladribine Treatment)||3
991517|NCT00436826|2404313|P2|COMPLETED|Ext. Period (With Cladribine Treatment)||0
991518|NCT00436826|2404314|P1|COMPLETED|Ext. Period (With Cladribine Treatment)||0
991519|NCT00436826|2404309|P6|STARTED|Ext. Period (With Cladribine Treatment)||0
991520|NCT00436826|2404310|P5|STARTED|Ext. Period (With Cladribine Treatment)||0
991521|NCT00436826|2404311|P4|STARTED|Ext. Period (With Cladribine Treatment)||28
991522|NCT00436826|2404312|P3|STARTED|Ext. Period (With Cladribine Treatment)||47
991523|NCT00436826|2404313|P2|STARTED|Ext. Period (With Cladribine Treatment)||0
991524|NCT00436826|2404314|P1|STARTED|Ext. Period (With Cladribine Treatment)||0
991525|NCT00436826|2404309|P6|NOT COMPLETED|Double Blind Period||0
991526|NCT00436826|2404310|P5|NOT COMPLETED|Double Blind Period||0
991527|NCT00436826|2404311|P4|NOT COMPLETED|Double Blind Period||0
991528|NCT00436826|2404312|P3|NOT COMPLETED|Double Blind Period||0
991529|NCT00436826|2404313|P2|NOT COMPLETED|Double Blind Period||11
991530|NCT00436826|2404314|P1|NOT COMPLETED|Double Blind Period||13
991531|NCT00436826|2404309|P6|COMPLETED|Double Blind Period||0
991532|NCT00436826|2404310|P5|COMPLETED|Double Blind Period||0
991533|NCT00436826|2404311|P4|COMPLETED|Double Blind Period||0
991534|NCT00436826|2404312|P3|COMPLETED|Double Blind Period||0
991535|NCT00436826|2404313|P2|COMPLETED|Double Blind Period||37
991536|NCT00436826|2404314|P1|COMPLETED|Double Blind Period||111
991537|NCT00436826|2404309|P6|STARTED|Double Blind Period||0
991538|NCT00436826|2404310|P5|STARTED|Double Blind Period||0
991539|NCT00436826|2404311|P4|STARTED|Double Blind Period||0
991540|NCT00436826|2404312|P3|STARTED|Double Blind Period||0
991541|NCT00436826|2404313|P2|STARTED|Double Blind Period||48
991542|NCT00436826|2404314|P1|STARTED|Double Blind Period||124
991543|NCT00436852|2404336|P2|NOT COMPLETED|Overall Study||45
991544|NCT00436852|2404337|P1|NOT COMPLETED|Overall Study||35
991545|NCT00436852|2404336|P2|COMPLETED|Overall Study||2
991546|NCT00436852|2404337|P1|COMPLETED|Overall Study||10
991547|NCT00436852|2404336|P2|STARTED|Overall Study||47
991548|NCT00436852|2404337|P1|STARTED|Overall Study||45
991549|NCT00436904|2404345|P1|NOT COMPLETED|Overall Study||0
991550|NCT00436904|2404345|P1|COMPLETED|Overall Study||30
991551|NCT00436904|2404345|P1|STARTED|Overall Study||30
991552|NCT00436917|2404354|P1|NOT COMPLETED|Overall Study||54
991553|NCT00436917|2404354|P1|COMPLETED|Overall Study||0
991554|NCT00436917|2404354|P1|STARTED|Overall Study|6 participants with cancellation, protocol violation and ineligible were excluded from all analysis.|54
991555|NCT00436956|2404358|P2|NOT COMPLETED|Overall Study||0
991556|NCT00436956|2404359|P1|NOT COMPLETED|Overall Study||1
991557|NCT00436956|2404358|P2|COMPLETED|Overall Study||23
991558|NCT00436956|2404359|P1|COMPLETED|Overall Study|One pt was not evaluable due to a cord compression on day 2 of therapy; was removed from the trial.|35
991559|NCT00436956|2404358|P2|STARTED|Overall Study||23
991560|NCT00436956|2404359|P1|STARTED|Overall Study||36
991569|NCT00436982|2404421|P2|NOT COMPLETED|Overall Study||5
991570|NCT00436982|2404422|P1|NOT COMPLETED|Overall Study||5
991571|NCT00436982|2404421|P2|COMPLETED|Overall Study||25
991572|NCT00436982|2404422|P1|COMPLETED|Overall Study||25
991573|NCT00436982|2404421|P2|STARTED|Overall Study||30
991574|NCT00436982|2404422|P1|STARTED|Overall Study||30
991575|NCT00437034|2404428|P1|NOT COMPLETED|Overall Study||6
991576|NCT00437034|2404428|P1|COMPLETED|Overall Study||0
991577|NCT00437034|2404428|P1|STARTED|Overall Study||6
991578|NCT00437073|2404434|P2|NOT COMPLETED|Overall Study||1
991579|NCT00437073|2404435|P1|NOT COMPLETED|Overall Study||1
991580|NCT00437073|2404434|P2|COMPLETED|Overall Study||8
991581|NCT00437073|2404435|P1|COMPLETED|Overall Study||12
991582|NCT00437073|2404434|P2|STARTED|Overall Study||9
991583|NCT00437073|2404435|P1|STARTED|Overall Study||13
991584|NCT00437125|2404463|P1|NOT COMPLETED|Overall Study||32
991585|NCT00437125|2404463|P1|COMPLETED|Overall Study||119
991586|NCT00437125|2404463|P1|STARTED|Overall Study||151
991587|NCT00437203|2404492|P10|NOT COMPLETED|Overall Study||4
991588|NCT00437203|2404493|P9|NOT COMPLETED|Overall Study||3
991589|NCT00437203|2404494|P8|NOT COMPLETED|Overall Study||3
991590|NCT00437203|2404495|P7|NOT COMPLETED|Overall Study||7
991591|NCT00437203|2404496|P6|NOT COMPLETED|Overall Study||3
991592|NCT00437203|2404497|P5|NOT COMPLETED|Overall Study||3
991593|NCT00437203|2404498|P4|NOT COMPLETED|Overall Study||3
991594|NCT00437203|2404499|P3|NOT COMPLETED|Overall Study||3
991595|NCT00437203|2404500|P2|NOT COMPLETED|Overall Study||8
991596|NCT00437203|2404501|P1|NOT COMPLETED|Overall Study||6
991597|NCT00437203|2404492|P10|COMPLETED|Overall Study||0
991598|NCT00437203|2404493|P9|COMPLETED|Overall Study||0
991599|NCT00437203|2404494|P8|COMPLETED|Overall Study||0
991600|NCT00437203|2404495|P7|COMPLETED|Overall Study||0
991601|NCT00437203|2404496|P6|COMPLETED|Overall Study||0
991602|NCT00437203|2404497|P5|COMPLETED|Overall Study||0
991603|NCT00437203|2404498|P4|COMPLETED|Overall Study||0
991604|NCT00437203|2404499|P3|COMPLETED|Overall Study||0
991605|NCT00437203|2404500|P2|COMPLETED|Overall Study||0
991606|NCT00437203|2404501|P1|COMPLETED|Overall Study||0
991607|NCT00437203|2404492|P10|STARTED|Overall Study||4
991608|NCT00437203|2404493|P9|STARTED|Overall Study||3
991609|NCT00437203|2404494|P8|STARTED|Overall Study||3
991610|NCT00437203|2404495|P7|STARTED|Overall Study||7
991611|NCT00437203|2404496|P6|STARTED|Overall Study||3
991612|NCT00437203|2404497|P5|STARTED|Overall Study||3
991613|NCT00437203|2404498|P4|STARTED|Overall Study||3
991614|NCT00437203|2404499|P3|STARTED|Overall Study||3
991615|NCT00437203|2404500|P2|STARTED|Overall Study||8
991616|NCT00437203|2404501|P1|STARTED|Overall Study||6
991617|NCT00437281|2404625|P20|NOT COMPLETED|Overall Study||1
991618|NCT00437281|2404626|P19|NOT COMPLETED|Overall Study||1
991619|NCT00437281|2404627|P18|NOT COMPLETED|Overall Study||0
991620|NCT00437281|2404628|P17|NOT COMPLETED|Overall Study||0
991621|NCT00437281|2404629|P16|NOT COMPLETED|Overall Study||0
991622|NCT00437281|2404630|P15|NOT COMPLETED|Overall Study||1
991623|NCT00437281|2404631|P14|NOT COMPLETED|Overall Study||1
991624|NCT00437281|2404632|P13|NOT COMPLETED|Overall Study||0
991625|NCT00437281|2404633|P12|NOT COMPLETED|Overall Study||0
991626|NCT00437281|2404634|P11|NOT COMPLETED|Overall Study||0
991627|NCT00437281|2404635|P10|NOT COMPLETED|Overall Study||1
991628|NCT00437281|2404636|P9|NOT COMPLETED|Overall Study||0
991629|NCT00437281|2404637|P8|NOT COMPLETED|Overall Study||0
991630|NCT00437281|2404638|P7|NOT COMPLETED|Overall Study||0
991631|NCT00437281|2404639|P6|NOT COMPLETED|Overall Study||1
991632|NCT00437281|2404640|P5|NOT COMPLETED|Overall Study||0
991633|NCT00437281|2404641|P4|NOT COMPLETED|Overall Study||1
991634|NCT00437281|2404642|P3|NOT COMPLETED|Overall Study||0
991635|NCT00437281|2404643|P2|NOT COMPLETED|Overall Study||0
991636|NCT00437281|2404644|P1|NOT COMPLETED|Overall Study||0
991637|NCT00437281|2404625|P20|COMPLETED|Overall Study||2
991638|NCT00437281|2404626|P19|COMPLETED|Overall Study||1
991639|NCT00437281|2404627|P18|COMPLETED|Overall Study||4
991640|NCT00437281|2404628|P17|COMPLETED|Overall Study||3
991641|NCT00437281|2404629|P16|COMPLETED|Overall Study||3
991642|NCT00437281|2404630|P15|COMPLETED|Overall Study||4
991643|NCT00437281|2404631|P14|COMPLETED|Overall Study||2
991644|NCT00437281|2404632|P13|COMPLETED|Overall Study||2
991645|NCT00437281|2404633|P12|COMPLETED|Overall Study||3
991646|NCT00437281|2404634|P11|COMPLETED|Overall Study||3
991647|NCT00437281|2404635|P10|COMPLETED|Overall Study||4
991648|NCT00437281|2404636|P9|COMPLETED|Overall Study||3
991649|NCT00437281|2404637|P8|COMPLETED|Overall Study||3
991650|NCT00437281|2404638|P7|COMPLETED|Overall Study||3
991651|NCT00437281|2404639|P6|COMPLETED|Overall Study||3
991652|NCT00437281|2404640|P5|COMPLETED|Overall Study||4
991653|NCT00437281|2404641|P4|COMPLETED|Overall Study||2
991654|NCT00437281|2404642|P3|COMPLETED|Overall Study||3
991655|NCT00437281|2404643|P2|COMPLETED|Overall Study||3
991656|NCT00437281|2404644|P1|COMPLETED|Overall Study||3
991657|NCT00437281|2404625|P20|STARTED|Overall Study||3
991658|NCT00437281|2404626|P19|STARTED|Overall Study||2
991659|NCT00437281|2404627|P18|STARTED|Overall Study||4
991660|NCT00437281|2404628|P17|STARTED|Overall Study||3
991661|NCT00437281|2404629|P16|STARTED|Overall Study||3
991662|NCT00437281|2404630|P15|STARTED|Overall Study||5
991663|NCT00437281|2404631|P14|STARTED|Overall Study||3
991664|NCT00437281|2404632|P13|STARTED|Overall Study||2
991665|NCT00437281|2404633|P12|STARTED|Overall Study||3
991666|NCT00437281|2404634|P11|STARTED|Overall Study||3
991667|NCT00437281|2404635|P10|STARTED|Overall Study||5
991668|NCT00437281|2404636|P9|STARTED|Overall Study||3
991669|NCT00437281|2404637|P8|STARTED|Overall Study||3
991670|NCT00437281|2404638|P7|STARTED|Overall Study||3
991671|NCT00437281|2404639|P6|STARTED|Overall Study||4
991672|NCT00437281|2404640|P5|STARTED|Overall Study||4
991673|NCT00437281|2404641|P4|STARTED|Overall Study||3
991674|NCT00437281|2404642|P3|STARTED|Overall Study||3
991675|NCT00437281|2404643|P2|STARTED|Overall Study||3
991676|NCT00437281|2404644|P1|STARTED|Overall Study||3
991677|NCT00437398|2404938|P1|NOT COMPLETED|Overall Study||0
991678|NCT00437398|2404938|P1|COMPLETED|Overall Study||2
991679|NCT00437398|2404938|P1|STARTED|Overall Study||2
991680|NCT00437489|2404945|P2|NOT COMPLETED|Overall Study||22
991681|NCT00437489|2404946|P1|NOT COMPLETED|Overall Study||23
991682|NCT00437489|2404945|P2|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
991683|NCT00437489|2404946|P1|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
991684|NCT00437489|2404945|P2|STARTED|Overall Study||24
991685|NCT00437489|2404946|P1|STARTED|Overall Study||25
991686|NCT00437645|2404960|P2|NOT COMPLETED|Overall Study||115
991687|NCT00437645|2404961|P1|NOT COMPLETED|Overall Study||35
991688|NCT00437645|2404960|P2|COMPLETED|Overall Study||476
991689|NCT00437645|2404961|P1|COMPLETED|Overall Study||557
991690|NCT00437645|2404960|P2|STARTED|Overall Study||591
991691|NCT00437645|2404961|P1|STARTED|Overall Study||592
991692|NCT00443872|2404975|P1|NOT COMPLETED|Overall Study||17
991693|NCT00443872|2404975|P1|COMPLETED|Overall Study||60
991694|NCT00443872|2404975|P1|STARTED|Overall Study||77
991695|NCT00443898|2404992|P4|NOT COMPLETED|Overall Study||18
991696|NCT00443898|2404993|P3|NOT COMPLETED|Overall Study||29
991697|NCT00443898|2404994|P2|NOT COMPLETED|Overall Study||25
991698|NCT00443898|2404995|P1|NOT COMPLETED|Overall Study||24
991699|NCT00443898|2404992|P4|COMPLETED|Overall Study||110
991700|NCT00443898|2404993|P3|COMPLETED|Overall Study||107
991701|NCT00443898|2404994|P2|COMPLETED|Overall Study||103
991702|NCT00443898|2404995|P1|COMPLETED|Overall Study||102
991703|NCT00443898|2404992|P4|STARTED|Overall Study||128
991704|NCT00443898|2404993|P3|STARTED|Overall Study||136
991705|NCT00443898|2404994|P2|STARTED|Overall Study||128
991706|NCT00443898|2404995|P1|STARTED|Overall Study||126
991707|NCT00444067|2405019|P2|NOT COMPLETED|Overall Study||1
991708|NCT00444067|2405020|P1|NOT COMPLETED|Overall Study||0
991709|NCT00444067|2405019|P2|COMPLETED|Overall Study||23
991710|NCT00444067|2405020|P1|COMPLETED|Overall Study||74
991711|NCT00444067|2405019|P2|STARTED|Overall Study||24
991712|NCT00444067|2405020|P1|STARTED|Overall Study||74
991713|NCT00444106|2405033|P3|NOT COMPLETED|Overall Study||1
991714|NCT00444106|2405034|P2|NOT COMPLETED|Overall Study||1
991715|NCT00444106|2405035|P1|NOT COMPLETED|Overall Study||2
991716|NCT00444106|2405033|P3|COMPLETED|Overall Study||52
991717|NCT00444106|2405034|P2|COMPLETED|Overall Study||52
991718|NCT00444106|2405035|P1|COMPLETED|Overall Study||157
991719|NCT00444106|2405033|P3|Completed Treatment Period|Overall Study||53
991720|NCT00444106|2405034|P2|Completed Treatment Period|Overall Study||53
991721|NCT00444106|2405035|P1|Completed Treatment Period|Overall Study||159
991722|NCT00444106|2405033|P3|STARTED|Overall Study||53
991723|NCT00444106|2405034|P2|STARTED|Overall Study||53
991724|NCT00444106|2405035|P1|STARTED|Overall Study||159
991725|NCT00444145|2405050|P1|NOT COMPLETED|Overall Study||19
991726|NCT00444145|2405050|P1|COMPLETED|Overall Study||19
991727|NCT00444145|2405050|P1|STARTED|Overall Study||38
991728|NCT00446849|2405054|P1|NOT COMPLETED|Maintenance Phase||70
991729|NCT00446849|2405054|P1|COMPLETED|Maintenance Phase||138
991730|NCT00446849|2405054|P1|STARTED|Maintenance Phase||208
991731|NCT00446849|2405054|P1|NOT COMPLETED|Acute Phase||82
991732|NCT00446849|2405054|P1|COMPLETED|Acute Phase||56
991733|NCT00446849|2405054|P1|STARTED|Acute Phase||138
991734|NCT00446992|2405064|P1|NOT COMPLETED|Overall Study||16
991735|NCT00446992|2405064|P1|COMPLETED|Overall Study|Intervention Completion|14
991736|NCT00446992|2405064|P1|STARTED|Overall Study|Beginning of Intervention|30
991737|NCT00447005|2405076|P1|NOT COMPLETED|Overall Study||12
991738|NCT00447005|2405076|P1|COMPLETED|Overall Study||0
991739|NCT00447005|2405076|P1|STARTED|Overall Study||12
991740|NCT00447057|2405094|P4|NOT COMPLETED|Overall Study||26
991741|NCT00447057|2405095|P3|NOT COMPLETED|Overall Study||19
991742|NCT00447057|2405096|P2|NOT COMPLETED|Overall Study||73
991743|NCT00447057|2405097|P1|NOT COMPLETED|Overall Study||83
991744|NCT00447057|2405094|P4|COMPLETED|Overall Study||0
991745|NCT00447057|2405095|P3|COMPLETED|Overall Study||0
991746|NCT00447057|2405096|P2|COMPLETED|Overall Study||3
991747|NCT00447057|2405097|P1|COMPLETED|Overall Study||0
991748|NCT00447057|2405094|P4|STARTED|Overall Study||26
991749|NCT00447057|2405095|P3|STARTED|Overall Study||19
991750|NCT00447057|2405096|P2|STARTED|Overall Study||76
991751|NCT00447057|2405097|P1|STARTED|Overall Study||83
991752|NCT00447122|2405115|P1|NOT COMPLETED|Overall Study||2
991753|NCT00447122|2405115|P1|COMPLETED|Overall Study|29 evaluable thus 29 represented in efficacy and safety portion|29
991754|NCT00447122|2405115|P1|STARTED|Overall Study||31
991755|NCT00447226|2405119|P2|NOT COMPLETED|Double-blind Phase||3
991756|NCT00447226|2405120|P1|NOT COMPLETED|Double-blind Phase||4
991757|NCT00447226|2405119|P2|COMPLETED|Double-blind Phase||0
991758|NCT00447226|2405120|P1|COMPLETED|Double-blind Phase||0
991759|NCT00447226|2405119|P2|STARTED|Double-blind Phase||3
991760|NCT00447226|2405120|P1|STARTED|Double-blind Phase||4
991761|NCT00447226|2405119|P2|NOT COMPLETED|12-Week Open-label Phase||25
991762|NCT00447226|2405120|P1|NOT COMPLETED|12-Week Open-label Phase||0
991763|NCT00447226|2405119|P2|COMPLETED|12-Week Open-label Phase||7
991764|NCT00447226|2405120|P1|COMPLETED|12-Week Open-label Phase||0
991765|NCT00447226|2405119|P2|STARTED|12-Week Open-label Phase||32
991766|NCT00447226|2405120|P1|STARTED|12-Week Open-label Phase||0
991767|NCT00447265|2405138|P2|NOT COMPLETED|Overall Study||0
991768|NCT00447265|2405139|P1|NOT COMPLETED|Overall Study||1
991769|NCT00447265|2405138|P2|COMPLETED|Overall Study||0
991770|NCT00447265|2405139|P1|COMPLETED|Overall Study|The participant completed treatment and discontinued follow-up at week 39 after randomization|0
991771|NCT00447265|2405138|P2|STARTED|Overall Study||0
991772|NCT00447265|2405139|P1|STARTED|Overall Study||1
991773|NCT00447278|2405154|P2|NOT COMPLETED|Period III (Optional 6 Month Extension)||15
991774|NCT00447278|2405155|P1|NOT COMPLETED|Period III (Optional 6 Month Extension)||30
991775|NCT00447278|2405154|P2|COMPLETED|Period III (Optional 6 Month Extension)||140
991776|NCT00447278|2405155|P1|COMPLETED|Period III (Optional 6 Month Extension)||109
991777|NCT00447278|2405154|P2|STARTED|Period III (Optional 6 Month Extension)|16 choose not to enter this optional period.|155
991778|NCT00447278|2405155|P1|STARTED|Period III (Optional 6 Month Extension)|18 choose not to enter this optional period.|139
991779|NCT00447278|2405154|P2|NOT COMPLETED|Period II (6 Month Open-Label)||29
991780|NCT00447278|2405155|P1|NOT COMPLETED|Period II (6 Month Open-Label)||42
991781|NCT00447278|2405154|P2|COMPLETED|Period II (6 Month Open-Label)||171
991782|NCT00447278|2405155|P1|COMPLETED|Period II (6 Month Open-Label)||157
991783|NCT00447278|2405154|P2|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)|1 patient withdrew due to parent/guardian decision prior to receiving study drug.|199
991784|NCT00447278|2405155|P1|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)||199
991785|NCT00447278|2405154|P2|STARTED|Period II (6 Month Open-Label)||200
991786|NCT00447278|2405155|P1|STARTED|Period II (6 Month Open-Label)||199
991787|NCT00447330|2405176|P1|NOT COMPLETED|Overall Study||2
991788|NCT00447330|2405176|P1|COMPLETED|Overall Study||58
991789|NCT00447330|2405176|P1|STARTED|Overall Study|2 subjects signed the ICF, but were withdrawn from study prior to receiving any study drug|60
991790|NCT00447382|2405185|P2|NOT COMPLETED|Overall Study||6
991791|NCT00447382|2405186|P1|NOT COMPLETED|Overall Study||6
991792|NCT00447382|2405185|P2|COMPLETED|Overall Study||160
991793|NCT00447382|2405186|P1|COMPLETED|Overall Study||158
991794|NCT00447382|2405185|P2|STARTED|Overall Study||166
991795|NCT00447382|2405186|P1|STARTED|Overall Study||164
991796|NCT00447421|2405238|P1|NOT COMPLETED|Overall Study||6
991797|NCT00447421|2405238|P1|COMPLETED|Overall Study||3
991798|NCT00447421|2405238|P1|STARTED|Overall Study||9
991799|NCT00447499|2405248|P1|NOT COMPLETED|Overall Study||7
991800|NCT00447499|2405248|P1|COMPLETED|Overall Study||52
991801|NCT00447499|2405248|P1|STARTED|Overall Study||59
991802|NCT00447590|2405258|P1|NOT COMPLETED|Overall Study||60
991803|NCT00447590|2405258|P1|COMPLETED|Overall Study|Completing the study was defined as the number of participants in the study at month 60 (5 years).|93
991804|NCT00447590|2405258|P1|STARTED|Overall Study|153 participants were treated with the LAP-BAND System.|153
991805|NCT00447603|2405267|P3|NOT COMPLETED|Filter Period||15
991806|NCT00447603|2405268|P2|NOT COMPLETED|Filter Period||4
991807|NCT00447603|2405269|P1|NOT COMPLETED|Filter Period||0
991808|NCT00447603|2405267|P3|COMPLETED|Filter Period||0
991809|NCT00447603|2405268|P2|COMPLETED|Filter Period||0
991810|NCT00447603|2405269|P1|COMPLETED|Filter Period||0
991811|NCT00447603|2405267|P3|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|15
991812|NCT00447603|2405268|P2|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|4
991813|NCT00447603|2405269|P1|STARTED|Filter Period||0
991814|NCT00447603|2405267|P3|NOT COMPLETED|Screening||0
991815|NCT00447603|2405268|P2|NOT COMPLETED|Screening||0
991816|NCT00447603|2405269|P1|NOT COMPLETED|Screening||21
991817|NCT00447603|2405267|P3|COMPLETED|Screening||0
991818|NCT00447603|2405268|P2|COMPLETED|Screening||0
991819|NCT00447603|2405269|P1|COMPLETED|Screening||19
991820|NCT00447603|2405267|P3|STARTED|Screening||0
991821|NCT00447603|2405268|P2|STARTED|Screening||0
991822|NCT00447603|2405269|P1|STARTED|Screening||40
991823|NCT00447876|2405291|P2|NOT COMPLETED|Overall Study||4
991824|NCT00447876|2405292|P1|NOT COMPLETED|Overall Study||3
991825|NCT00447876|2405291|P2|COMPLETED|Overall Study||16
991826|NCT00447876|2405292|P1|COMPLETED|Overall Study||17
991827|NCT00447876|2405291|P2|STARTED|Overall Study||20
991828|NCT00447876|2405292|P1|STARTED|Overall Study||20
991829|NCT00447902|2405324|P2|NOT COMPLETED|Overall Study||6
991830|NCT00447902|2405325|P1|NOT COMPLETED|Overall Study||4
991831|NCT00447902|2405324|P2|COMPLETED|Overall Study||0
991832|NCT00447902|2405325|P1|COMPLETED|Overall Study||1
991833|NCT00447902|2405324|P2|STARTED|Overall Study||6
991834|NCT00447902|2405325|P1|STARTED|Overall Study||5
991835|NCT00448019|2405365|P1|NOT COMPLETED|Overall Study||7
991836|NCT00448019|2405365|P1|COMPLETED|Overall Study||57
991837|NCT00448019|2405365|P1|STARTED|Overall Study||64
991838|NCT00448123|2405373|P2|NOT COMPLETED|Overall Study||12
991839|NCT00448123|2405374|P1|NOT COMPLETED|Overall Study||15
991840|NCT00448123|2405373|P2|COMPLETED|Overall Study||53
991841|NCT00448123|2405374|P1|COMPLETED|Overall Study||47
991842|NCT00448123|2405373|P2|STARTED|Overall Study||65
991843|NCT00448123|2405374|P1|STARTED|Overall Study||62
991844|NCT00448136|2405386|P2|NOT COMPLETED|Overall Study||8
991845|NCT00448136|2405387|P1|NOT COMPLETED|Overall Study||4
991846|NCT00448136|2405386|P2|COMPLETED|Overall Study||41
991847|NCT00448136|2405387|P1|COMPLETED|Overall Study||30
991848|NCT00448136|2405386|P2|STARTED|Overall Study||49
991849|NCT00448136|2405387|P1|STARTED|Overall Study||34
991850|NCT00448175|2405425|P2|NOT COMPLETED|Continued PTNS Through 12 Months||0
991851|NCT00448175|2405426|P1|NOT COMPLETED|Continued PTNS Through 12 Months||10
991852|NCT00448175|2405425|P2|COMPLETED|Continued PTNS Through 12 Months||0
991853|NCT00448175|2405426|P1|COMPLETED|Continued PTNS Through 12 Months||25
991854|NCT00448175|2405425|P2|STARTED|Continued PTNS Through 12 Months||0
991855|NCT00448175|2405426|P1|STARTED|Continued PTNS Through 12 Months||35
991856|NCT00448175|2405425|P2|NOT COMPLETED|12 Weeks PTNS vs. Drug||7
991857|NCT00448175|2405426|P1|NOT COMPLETED|12 Weeks PTNS vs. Drug||9
991858|NCT00448175|2405425|P2|COMPLETED|12 Weeks PTNS vs. Drug||43
991859|NCT00448175|2405426|P1|COMPLETED|12 Weeks PTNS vs. Drug||41
991860|NCT00448175|2405425|P2|STARTED|12 Weeks PTNS vs. Drug||50
991861|NCT00448175|2405426|P1|STARTED|12 Weeks PTNS vs. Drug||50
991862|NCT00448201|2405432|P1|NOT COMPLETED|Overall Study||0
991863|NCT00448201|2405432|P1|COMPLETED|Overall Study||71
991864|NCT00448201|2405432|P1|STARTED|Overall Study||71
991865|NCT00448227|2405441|P1|NOT COMPLETED|Overall Study||0
991866|NCT00448227|2405441|P1|COMPLETED|Overall Study||18
991867|NCT00448227|2405441|P1|STARTED|Overall Study||18
991868|NCT00448279|2405470|P2|NOT COMPLETED|Overall Study||29
991869|NCT00448279|2405471|P1|NOT COMPLETED|Overall Study||29
991870|NCT00448279|2405470|P2|COMPLETED|Overall Study||0
991871|NCT00448279|2405471|P1|COMPLETED|Overall Study||0
991872|NCT00448279|2405470|P2|STARTED|Overall Study||29
991873|NCT00448279|2405471|P1|STARTED|Overall Study||29
991874|NCT00448344|2405489|P2|NOT COMPLETED|Overall Study||36
991875|NCT00448344|2405490|P1|NOT COMPLETED|Overall Study||30
991876|NCT00448344|2405489|P2|COMPLETED|Overall Study||200
991877|NCT00448344|2405490|P1|COMPLETED|Overall Study||205
991878|NCT00448344|2405489|P2|STARTED|Overall Study||236
991879|NCT00448344|2405490|P1|STARTED|Overall Study||235
991880|NCT00448357|2405498|P1|NOT COMPLETED|Overall Study||0
991881|NCT00448357|2405498|P1|COMPLETED|Overall Study||54
991882|NCT00448357|2405498|P1|STARTED|Overall Study||54
991883|NCT00448435|2405521|P2|NOT COMPLETED|Extension Period - 20 Weeks||0
991884|NCT00448435|2405522|P1|NOT COMPLETED|Extension Period - 20 Weeks||0
991885|NCT00448435|2405521|P2|COMPLETED|Extension Period - 20 Weeks||0
991886|NCT00448435|2405522|P1|COMPLETED|Extension Period - 20 Weeks||50
991887|NCT00448435|2405521|P2|STARTED|Extension Period - 20 Weeks||0
991888|NCT00448435|2405522|P1|STARTED|Extension Period - 20 Weeks||50
991889|NCT00448435|2405521|P2|NOT COMPLETED|Treatment Period II - 4 Weeks||0
991890|NCT00448435|2405522|P1|NOT COMPLETED|Treatment Period II - 4 Weeks||0
991891|NCT00448435|2405521|P2|COMPLETED|Treatment Period II - 4 Weeks||25
991892|NCT00448435|2405522|P1|COMPLETED|Treatment Period II - 4 Weeks||25
991893|NCT00448435|2405521|P2|STARTED|Treatment Period II - 4 Weeks||25
991894|NCT00448435|2405522|P1|STARTED|Treatment Period II - 4 Weeks||25
991895|NCT00448435|2405521|P2|NOT COMPLETED|Washout Period - 2 Weeks||0
991896|NCT00448435|2405522|P1|NOT COMPLETED|Washout Period - 2 Weeks||1
991897|NCT00448435|2405521|P2|COMPLETED|Washout Period - 2 Weeks||25
991898|NCT00448435|2405522|P1|COMPLETED|Washout Period - 2 Weeks||25
991899|NCT00448435|2405521|P2|STARTED|Washout Period - 2 Weeks||25
991900|NCT00448435|2405522|P1|STARTED|Washout Period - 2 Weeks||26
991901|NCT00448435|2405521|P2|NOT COMPLETED|Treatment Period I - 4 Weeks||0
991902|NCT00448435|2405522|P1|NOT COMPLETED|Treatment Period I - 4 Weeks||0
991903|NCT00448435|2405521|P2|COMPLETED|Treatment Period I - 4 Weeks||25
991904|NCT00448435|2405522|P1|COMPLETED|Treatment Period I - 4 Weeks||26
991905|NCT00448435|2405521|P2|STARTED|Treatment Period I - 4 Weeks||25
991906|NCT00448435|2405522|P1|STARTED|Treatment Period I - 4 Weeks||26
991907|NCT00448448|2405550|P2|NOT COMPLETED|Overall Study||41
991908|NCT00448448|2405551|P1|NOT COMPLETED|Overall Study||100
991909|NCT00448448|2405550|P2|COMPLETED|Overall Study||96
991910|NCT00448448|2405551|P1|COMPLETED|Overall Study||146
991911|NCT00448448|2405550|P2|STARTED|Overall Study||137
991912|NCT00448448|2405551|P1|STARTED|Overall Study||246
991913|NCT00448539|2405559|P2|NOT COMPLETED|Overall Study||152
991914|NCT00448539|2405560|P1|NOT COMPLETED|Overall Study||134
991915|NCT00448539|2405559|P2|COMPLETED|Overall Study||0
991916|NCT00448539|2405560|P1|COMPLETED|Overall Study||0
991917|NCT00448539|2405559|P2|STARTED|Overall Study||152
991918|NCT00448539|2405560|P1|STARTED|Overall Study||134
991919|NCT00448591|2405566|P1|NOT COMPLETED|Overall Study||2296
991920|NCT00448591|2405566|P1|COMPLETED|Overall Study||0
991921|NCT00448591|2405566|P1|STARTED|Overall Study||2296
991922|NCT00448630|2405575|P1|NOT COMPLETED|Overall Study||27
991923|NCT00448630|2405575|P1|COMPLETED|Overall Study|Number of patients who remained on same medication to end of study.|301
991924|NCT00448630|2405575|P1|STARTED|Overall Study||328
991925|NCT00448682|2405620|P1|NOT COMPLETED|Overall Study||0
991926|NCT00448682|2405620|P1|COMPLETED|Overall Study||25
991927|NCT00448682|2405620|P1|STARTED|Overall Study||25
991928|NCT00448708|2405628|P2|NOT COMPLETED|Overall Study||31
991929|NCT00448708|2405629|P1|NOT COMPLETED|Overall Study||35
991930|NCT00448708|2405628|P2|COMPLETED|Overall Study||79
991931|NCT00448708|2405629|P1|COMPLETED|Overall Study||77
991932|NCT00448708|2405628|P2|STARTED|Overall Study||110
991933|NCT00448708|2405629|P1|STARTED|Overall Study||112
991934|NCT00448760|2405637|P1|NOT COMPLETED|Overall Study||3
991935|NCT00448760|2405637|P1|COMPLETED|Overall Study||26
991936|NCT00448760|2405637|P1|STARTED|Overall Study||29
991937|NCT00448864|2405647|P3|NOT COMPLETED|Overall Study||1
991938|NCT00448864|2405648|P2|NOT COMPLETED|Overall Study||5
991939|NCT00448864|2405649|P1|NOT COMPLETED|Overall Study||5
991940|NCT00448864|2405647|P3|COMPLETED|Overall Study||18
991941|NCT00448864|2405648|P2|COMPLETED|Overall Study||24
991942|NCT00448864|2405649|P1|COMPLETED|Overall Study||22
991943|NCT00448864|2405647|P3|Completed Post-operative Period|Overall Study||18
991944|NCT00448864|2405648|P2|Completed Post-operative Period|Overall Study||25
991945|NCT00448864|2405649|P1|Completed Post-operative Period|Overall Study||26
991946|NCT00448864|2405647|P3|Started Post-operative Period|Overall Study||18
991947|NCT00448864|2405648|P2|Started Post-operative Period|Overall Study||25
991948|NCT00448864|2405649|P1|Started Post-operative Period|Overall Study||26
991949|NCT00448864|2405647|P3|Received at Least 1 Dose of Study Drug|Overall Study||18
991950|NCT00448864|2405648|P2|Received at Least 1 Dose of Study Drug|Overall Study||25
991951|NCT00448864|2405649|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
991952|NCT00448864|2405647|P3|STARTED|Overall Study||19
991953|NCT00448864|2405648|P2|STARTED|Overall Study||29
991954|NCT00448864|2405649|P1|STARTED|Overall Study||27
991955|NCT00448916|2405669|P4|NOT COMPLETED|Overall Study||6
991956|NCT00448916|2405670|P3|NOT COMPLETED|Overall Study||6
991957|NCT00448916|2405671|P2|NOT COMPLETED|Overall Study||6
991958|NCT00448916|2405672|P1|NOT COMPLETED|Overall Study||7
991959|NCT00448916|2405669|P4|COMPLETED|Overall Study||5
991960|NCT00448916|2405670|P3|COMPLETED|Overall Study||6
991961|NCT00448916|2405671|P2|COMPLETED|Overall Study||9
991962|NCT00448916|2405672|P1|COMPLETED|Overall Study||9
991963|NCT00448916|2405669|P4|STARTED|Overall Study||11
991964|NCT00448916|2405670|P3|STARTED|Overall Study||12
991965|NCT00448916|2405671|P2|STARTED|Overall Study||15
991966|NCT00448916|2405672|P1|STARTED|Overall Study||16
991967|NCT00449033|2405745|P2|NOT COMPLETED|Follow-up Period||434
991968|NCT00449033|2405746|P1|NOT COMPLETED|Follow-up Period||425
991969|NCT00449033|2405745|P2|COMPLETED|Follow-up Period||0
991970|NCT00449033|2405746|P1|COMPLETED|Follow-up Period||0
991971|NCT00449033|2405745|P2|STARTED|Follow-up Period|434 entered, comprising 452 randomized less 12 deaths, 2 lost to follow-up & 4 ongoing on treatment|434
991972|NCT00449033|2405746|P1|STARTED|Follow-up Period|425 entered, comprising 452 randomized less 21 deaths & 6 ongoing on treatment|425
991973|NCT00449033|2405745|P2|NOT COMPLETED|Treatment Period||452
991974|NCT00449033|2405746|P1|NOT COMPLETED|Treatment Period||452
991975|NCT00449033|2405745|P2|COMPLETED|Treatment Period||0
991976|NCT00449033|2405746|P1|COMPLETED|Treatment Period||0
991977|NCT00449033|2405745|P2|Received Treatment|Treatment Period||449
991978|NCT00449033|2405746|P1|Received Treatment|Treatment Period||452
991979|NCT00449033|2405745|P2|STARTED|Treatment Period|Reasons for not treated: Adverse event (N=1); Consent withdrawn (N=1); Reason missing (N=1)|452
991980|NCT00449033|2405746|P1|STARTED|Treatment Period||452
991981|NCT00449046|2405780|P1|NOT COMPLETED|Overall Study||0
991982|NCT00449046|2405780|P1|COMPLETED|Overall Study||40
991983|NCT00449046|2405780|P1|STARTED|Overall Study||40
991984|NCT00449072|2405793|P2|NOT COMPLETED|Overall Study||42
991985|NCT00449072|2405794|P1|NOT COMPLETED|Overall Study||41
991986|NCT00449072|2405793|P2|COMPLETED|Overall Study||109
991987|NCT00449072|2405794|P1|COMPLETED|Overall Study||107
991988|NCT00449072|2405793|P2|STARTED|Overall Study||151
991989|NCT00449072|2405794|P1|STARTED|Overall Study||148
991990|NCT00449150|2405821|P3|NOT COMPLETED|Overall Study||47
991991|NCT00449150|2405822|P2|NOT COMPLETED|Overall Study||53
991992|NCT00449150|2405823|P1|NOT COMPLETED|Overall Study||46
991993|NCT00449150|2405821|P3|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|171
991994|NCT00449150|2405822|P2|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|177
991995|NCT00449150|2405823|P1|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|173
991996|NCT00449150|2405821|P3|STARTED|Overall Study||218
991997|NCT00449150|2405822|P2|STARTED|Overall Study||230
991998|NCT00449150|2405823|P1|STARTED|Overall Study||219
991999|NCT00449163|2405831|P1|NOT COMPLETED|Overall Study||3
992000|NCT00449163|2405831|P1|COMPLETED|Overall Study||22
992001|NCT00449163|2405831|P1|STARTED|Overall Study||25
992002|NCT00449176|2405841|P3|NOT COMPLETED|Overall Study||167
992003|NCT00449176|2405842|P2|NOT COMPLETED|Overall Study||195
992004|NCT00449176|2405843|P1|NOT COMPLETED|Overall Study||152
992005|NCT00449176|2405841|P3|COMPLETED|Overall Study||152
992006|NCT00449176|2405842|P2|COMPLETED|Overall Study||133
992007|NCT00449176|2405843|P1|COMPLETED|Overall Study||166
992008|NCT00449176|2405841|P3|STARTED|Overall Study|5 randomly assigned to this group did not receive drug, 2 enrolled twice(of 326 subjects randomized)|319
992009|NCT00449176|2405842|P2|STARTED|Overall Study|6 randomly assigned to this treatment group did not take drug (of 334 subjects initially randomized)|328
992010|NCT00449176|2405843|P1|STARTED|Overall Study|3 randomly assigned to this treatment group did not take drug (of 321 subjects initially randomized)|318
992011|NCT00440557|2405872|P3|NOT COMPLETED|Overall Study||35
992012|NCT00440557|2405873|P2|NOT COMPLETED|Overall Study||29
992013|NCT00440557|2405874|P1|NOT COMPLETED|Overall Study||25
992014|NCT00440557|2405872|P3|COMPLETED|Overall Study||90
992015|NCT00440557|2405873|P2|COMPLETED|Overall Study||96
992016|NCT00440557|2405874|P1|COMPLETED|Overall Study||98
992017|NCT00440557|2405872|P3|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
992018|NCT00440557|2405873|P2|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
992019|NCT00440557|2405874|P1|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|123
992020|NCT00440700|2405906|P3|NOT COMPLETED|Overall Study||4
992021|NCT00440700|2405907|P2|NOT COMPLETED|Overall Study||8
992022|NCT00440700|2405908|P1|NOT COMPLETED|Overall Study||8
992023|NCT00440700|2405906|P3|COMPLETED|Overall Study||120
992024|NCT00440700|2405907|P2|COMPLETED|Overall Study||110
992025|NCT00440700|2405908|P1|COMPLETED|Overall Study||114
992026|NCT00440700|2405906|P3|STARTED|Overall Study||124
992027|NCT00440700|2405907|P2|STARTED|Overall Study||118
992028|NCT00440700|2405908|P1|STARTED|Overall Study||122
992029|NCT00440830|2405932|P4|NOT COMPLETED|Overall Study||0
992030|NCT00440830|2405933|P3|NOT COMPLETED|Overall Study||0
992031|NCT00440830|2405934|P2|NOT COMPLETED|Overall Study||0
992032|NCT00440830|2405935|P1|NOT COMPLETED|Overall Study||0
992033|NCT00440830|2405932|P4|COMPLETED|Overall Study||10
992034|NCT00440830|2405933|P3|COMPLETED|Overall Study||30
992035|NCT00440830|2405934|P2|COMPLETED|Overall Study||8
992036|NCT00440830|2405935|P1|COMPLETED|Overall Study||20
992037|NCT00440830|2405932|P4|STARTED|Overall Study||10
992038|NCT00440830|2405933|P3|STARTED|Overall Study||30
992039|NCT00440830|2405934|P2|STARTED|Overall Study||8
992040|NCT00440830|2405935|P1|STARTED|Overall Study||20
992041|NCT00440947|2405949|P5|NOT COMPLETED|Optional 60-Week Extension Phase||26
992042|NCT00440947|2405950|P4|NOT COMPLETED|Optional 60-Week Extension Phase||29
992043|NCT00440947|2405951|P3|NOT COMPLETED|Optional 60-Week Extension Phase||0
992044|NCT00440947|2405952|P2|NOT COMPLETED|Optional 60-Week Extension Phase||0
992045|NCT00440947|2405953|P1|NOT COMPLETED|Optional 60-Week Extension Phase||0
992046|NCT00440947|2405949|P5|COMPLETED|Optional 60-Week Extension Phase||154
992047|NCT00440947|2405950|P4|COMPLETED|Optional 60-Week Extension Phase||160
992048|NCT00440947|2405951|P3|COMPLETED|Optional 60-Week Extension Phase||0
992049|NCT00440947|2405952|P2|COMPLETED|Optional 60-Week Extension Phase||0
992050|NCT00440947|2405953|P1|COMPLETED|Optional 60-Week Extension Phase||0
992051|NCT00440947|2405949|P5|STARTED|Optional 60-Week Extension Phase||180
992052|NCT00440947|2405950|P4|STARTED|Optional 60-Week Extension Phase||189
992053|NCT00440947|2405951|P3|STARTED|Optional 60-Week Extension Phase||0
992054|NCT00440947|2405952|P2|STARTED|Optional 60-Week Extension Phase||0
992055|NCT00440947|2405953|P1|STARTED|Optional 60-Week Extension Phase||0
992056|NCT00440947|2405949|P5|NOT COMPLETED|48-Week Randomization Phase||0
992057|NCT00440947|2405950|P4|NOT COMPLETED|48-Week Randomization Phase||0
992058|NCT00440947|2405951|P3|NOT COMPLETED|48-Week Randomization Phase||24
992059|NCT00440947|2405952|P2|NOT COMPLETED|48-Week Randomization Phase||16
992060|NCT00440947|2405953|P1|NOT COMPLETED|48-Week Randomization Phase||0
992061|NCT00440947|2405949|P5|COMPLETED|48-Week Randomization Phase||0
992062|NCT00440947|2405950|P4|COMPLETED|48-Week Randomization Phase||0
992063|NCT00440947|2405951|P3|COMPLETED|48-Week Randomization Phase||185
992064|NCT00440947|2405952|P2|COMPLETED|48-Week Randomization Phase||194
992065|NCT00440947|2405953|P1|COMPLETED|48-Week Randomization Phase||0
992066|NCT00440947|2405949|P5|STARTED|48-Week Randomization Phase||0
992067|NCT00440947|2405950|P4|STARTED|48-Week Randomization Phase||0
992068|NCT00440947|2405951|P3|STARTED|48-Week Randomization Phase||209
992069|NCT00440947|2405952|P2|STARTED|48-Week Randomization Phase||210
992070|NCT00440947|2405953|P1|STARTED|48-Week Randomization Phase||0
992071|NCT00440947|2405949|P5|NOT COMPLETED|36-Week Induction Phase||0
992072|NCT00440947|2405950|P4|NOT COMPLETED|36-Week Induction Phase||0
992073|NCT00440947|2405951|P3|NOT COMPLETED|36-Week Induction Phase||0
992074|NCT00440947|2405952|P2|NOT COMPLETED|36-Week Induction Phase||0
992075|NCT00440947|2405953|P1|NOT COMPLETED|36-Week Induction Phase||73
992076|NCT00440947|2405949|P5|COMPLETED|36-Week Induction Phase||0
992077|NCT00440947|2405950|P4|COMPLETED|36-Week Induction Phase||0
992078|NCT00440947|2405951|P3|COMPLETED|36-Week Induction Phase||0
992079|NCT00440947|2405952|P2|COMPLETED|36-Week Induction Phase||0
992080|NCT00440947|2405953|P1|COMPLETED|36-Week Induction Phase|23 PAR without confirmed HIV-RNA<50c/mL prior to Wk 36 couldn’t be randomized but weren’t withdrawn.|442
992081|NCT00440947|2405949|P5|STARTED|36-Week Induction Phase||0
992082|NCT00440947|2405950|P4|STARTED|36-Week Induction Phase||0
992083|NCT00440947|2405951|P3|STARTED|36-Week Induction Phase||0
992084|NCT00440947|2405952|P2|STARTED|36-Week Induction Phase||0
992085|NCT00440947|2405953|P1|STARTED|36-Week Induction Phase||515
992086|NCT00441012|2406006|P2|NOT COMPLETED|Overall Study||13
992087|NCT00441012|2406007|P1|NOT COMPLETED|Overall Study||18
992088|NCT00441012|2406006|P2|COMPLETED|Overall Study||263
992089|NCT00441012|2406007|P1|COMPLETED|Overall Study||252
992090|NCT00441012|2406006|P2|Vaccination Visit 3|Overall Study||269
992091|NCT00441012|2406007|P1|Vaccination Visit 3|Overall Study||265
992092|NCT00441012|2406006|P2|Vaccination Visit 2|Overall Study||272
992093|NCT00441012|2406007|P1|Vaccination Visit 2|Overall Study||267
992094|NCT00441012|2406006|P2|Vaccination Visit 1|Overall Study|3 participants were vaccinated but were never randomized in the COMVAX™ group|276
992095|NCT00441012|2406007|P1|Vaccination Visit 1|Overall Study|1 participant was randomized but not vaccinated in the Modified Process Vaccine group|269
992096|NCT00441012|2406006|P2|STARTED|Overall Study||276
992097|NCT00441012|2406007|P1|STARTED|Overall Study||270
992098|NCT00441064|2406023|P2|NOT COMPLETED|Overall Study||7
992099|NCT00441064|2406024|P1|NOT COMPLETED|Overall Study||10
992100|NCT00441064|2406023|P2|COMPLETED|Overall Study||56
992101|NCT00441064|2406024|P1|COMPLETED|Overall Study||59
992102|NCT00441064|2406023|P2|Intent-to-treat (ITT) Population|Overall Study||57
992103|NCT00441064|2406024|P1|Intent-to-treat (ITT) Population|Overall Study||61
992104|NCT00441064|2406023|P2|Safety Population (SP)|Overall Study||63
992105|NCT00441064|2406024|P1|Safety Population (SP)|Overall Study||69
992106|NCT00441064|2406023|P2|STARTED|Overall Study||63
992107|NCT00441064|2406024|P1|STARTED|Overall Study||69
992108|NCT00441103|2406036|P2|NOT COMPLETED|Overall Study||4
992109|NCT00441103|2406037|P1|NOT COMPLETED|Overall Study||11
992110|NCT00441103|2406036|P2|COMPLETED|Overall Study||56
992111|NCT00441103|2406037|P1|COMPLETED|Overall Study||109
992112|NCT00441103|2406036|P2|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|60
992113|NCT00441103|2406037|P1|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|120
992114|NCT00441116|2406050|P2|NOT COMPLETED|Overall Study||2
992115|NCT00441116|2406051|P1|NOT COMPLETED|Overall Study||3
992116|NCT00441116|2406050|P2|COMPLETED|Overall Study||75
992117|NCT00441116|2406051|P1|COMPLETED|Overall Study||73
992118|NCT00441116|2406050|P2|STARTED|Overall Study||77
992119|NCT00441116|2406051|P1|STARTED|Overall Study||76
992120|NCT00441142|2406121|P4|NOT COMPLETED|Overall Study||68
992121|NCT00441142|2406122|P3|NOT COMPLETED|Overall Study||22
992122|NCT00441142|2406123|P2|NOT COMPLETED|Overall Study||7
992123|NCT00441142|2406124|P1|NOT COMPLETED|Overall Study||6
992124|NCT00441142|2406121|P4|COMPLETED|Overall Study||1
992125|NCT00441142|2406122|P3|COMPLETED|Overall Study||7
992126|NCT00441142|2406123|P2|COMPLETED|Overall Study||0
992127|NCT00441142|2406124|P1|COMPLETED|Overall Study||0
992128|NCT00441142|2406121|P4|STARTED|Overall Study||69
992129|NCT00441142|2406122|P3|STARTED|Overall Study||29
992130|NCT00441142|2406123|P2|STARTED|Overall Study||7
992131|NCT00441142|2406124|P1|STARTED|Overall Study||6
992132|NCT00441168|2406142|P2|NOT COMPLETED|Follow-up Period||9
992133|NCT00441168|2406143|P1|NOT COMPLETED|Follow-up Period||12
992134|NCT00441168|2406142|P2|COMPLETED|Follow-up Period||4
992135|NCT00441168|2406143|P1|COMPLETED|Follow-up Period||5
992136|NCT00441168|2406142|P2|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|13
992137|NCT00441168|2406143|P1|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|17
992138|NCT00441168|2406142|P2|NOT COMPLETED|Treatment Period||6
992139|NCT00441168|2406143|P1|NOT COMPLETED|Treatment Period||11
992140|NCT00441168|2406142|P2|COMPLETED|Treatment Period||7
992141|NCT00441168|2406143|P1|COMPLETED|Treatment Period||6
992142|NCT00441168|2406142|P2|TREATED|Treatment Period||13
992143|NCT00441168|2406143|P1|TREATED|Treatment Period||16
992144|NCT00441168|2406142|P2|STARTED|Treatment Period||13
992145|NCT00441168|2406143|P1|STARTED|Treatment Period||17
992146|NCT00441259|2406155|P2|NOT COMPLETED|Overall Study||0
992147|NCT00441259|2406156|P1|NOT COMPLETED|Overall Study||0
992148|NCT00441259|2406155|P2|COMPLETED|Overall Study||48
992149|NCT00441259|2406156|P1|COMPLETED|Overall Study||48
992150|NCT00441259|2406155|P2|STARTED|Overall Study||48
992151|NCT00441259|2406156|P1|STARTED|Overall Study||48
992152|NCT00441272|2406174|P2|NOT COMPLETED|Overall Study||25
992153|NCT00441272|2406175|P1|NOT COMPLETED|Overall Study||25
992154|NCT00441272|2406174|P2|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
992155|NCT00441272|2406175|P1|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
992156|NCT00441272|2406174|P2|STARTED|Overall Study||25
992157|NCT00441272|2406175|P1|STARTED|Overall Study||25
992158|NCT00441285|2406186|P5|NOT COMPLETED|Overall Study||0
992159|NCT00441285|2406187|P4|NOT COMPLETED|Overall Study||0
992160|NCT00441285|2406188|P3|NOT COMPLETED|Overall Study||0
992161|NCT00441285|2406189|P2|NOT COMPLETED|Overall Study||0
992162|NCT00441285|2406190|P1|NOT COMPLETED|Overall Study||0
992163|NCT00441285|2406186|P5|COMPLETED|Overall Study||43
992164|NCT00441285|2406187|P4|COMPLETED|Overall Study||40
992165|NCT00441285|2406188|P3|COMPLETED|Overall Study||41
992166|NCT00441285|2406189|P2|COMPLETED|Overall Study||16
992167|NCT00441285|2406190|P1|COMPLETED|Overall Study||16
992168|NCT00441285|2406186|P5|STARTED|Overall Study||43
992169|NCT00441285|2406187|P4|STARTED|Overall Study||40
992170|NCT00441285|2406188|P3|STARTED|Overall Study||41
992171|NCT00441285|2406189|P2|STARTED|Overall Study||16
992172|NCT00441285|2406190|P1|STARTED|Overall Study||16
992173|NCT00441337|2406218|P4|NOT COMPLETED|Overall Study||21
992174|NCT00441337|2406219|P3|NOT COMPLETED|Overall Study||6
992175|NCT00441337|2406220|P2|NOT COMPLETED|Overall Study||6
992176|NCT00441337|2406221|P1|NOT COMPLETED|Overall Study||6
992177|NCT00441337|2406218|P4|COMPLETED|Overall Study||0
992178|NCT00441337|2406219|P3|COMPLETED|Overall Study||0
992179|NCT00441337|2406220|P2|COMPLETED|Overall Study||0
992180|NCT00441337|2406221|P1|COMPLETED|Overall Study||0
992181|NCT00441337|2406218|P4|STARTED|Overall Study||21
992182|NCT00441337|2406219|P3|STARTED|Overall Study||6
992183|NCT00441337|2406220|P2|STARTED|Overall Study||6
992184|NCT00441337|2406221|P1|STARTED|Overall Study||6
992185|NCT00441363|2406301|P2|NOT COMPLETED|Overall Study||15
992186|NCT00441363|2406302|P1|NOT COMPLETED|Overall Study||17
992187|NCT00441363|2406301|P2|COMPLETED|Overall Study||19
992188|NCT00441363|2406302|P1|COMPLETED|Overall Study|no subject withdrew early since the trial was terminated|15
992189|NCT00441363|2406301|P2|STARTED|Overall Study||34
992190|NCT00441363|2406302|P1|STARTED|Overall Study||32
992191|NCT00449540|2406312|P3|NOT COMPLETED|Treatment Phase||17
992192|NCT00449540|2406313|P2|NOT COMPLETED|Treatment Phase||20
992193|NCT00449540|2406314|P1|NOT COMPLETED|Treatment Phase||0
992194|NCT00449540|2406312|P3|COMPLETED|Treatment Phase||82
992195|NCT00449540|2406313|P2|COMPLETED|Treatment Phase||82
992196|NCT00449540|2406314|P1|COMPLETED|Treatment Phase||0
992197|NCT00449540|2406312|P3|STARTED|Treatment Phase||99
992198|NCT00449540|2406313|P2|STARTED|Treatment Phase||102
992199|NCT00449540|2406314|P1|STARTED|Treatment Phase||0
992200|NCT00449540|2406312|P3|NOT COMPLETED|Pretreatment Phase||0
992201|NCT00449540|2406313|P2|NOT COMPLETED|Pretreatment Phase||0
992202|NCT00449540|2406314|P1|NOT COMPLETED|Pretreatment Phase||66
992203|NCT00449540|2406312|P3|COMPLETED|Pretreatment Phase||0
992204|NCT00449540|2406313|P2|COMPLETED|Pretreatment Phase||0
992205|NCT00449540|2406314|P1|COMPLETED|Pretreatment Phase||201
992206|NCT00449540|2406312|P3|STARTED|Pretreatment Phase||0
992207|NCT00449540|2406313|P2|STARTED|Pretreatment Phase||0
992208|NCT00449540|2406314|P1|STARTED|Pretreatment Phase||267
992209|NCT00449644|2406332|P4|NOT COMPLETED|Overall Study||32
992210|NCT00449644|2406333|P3|NOT COMPLETED|Overall Study||29
992211|NCT00449644|2406334|P2|NOT COMPLETED|Overall Study||13
992212|NCT00449644|2406335|P1|NOT COMPLETED|Overall Study||10
992213|NCT00449644|2406332|P4|COMPLETED|Overall Study|After Week 24, 1 patient rolled over to treatment with TMC207 and was not completed or discontinued.|49
992214|NCT00449644|2406333|P3|COMPLETED|Overall Study||50
992215|NCT00449644|2406334|P2|COMPLETED|Overall Study||11
992216|NCT00449644|2406335|P1|COMPLETED|Overall Study||13
992217|NCT00449644|2406332|P4|Rollover|Overall Study||1
992218|NCT00449644|2406333|P3|Rollover|Overall Study||0
992219|NCT00449644|2406334|P2|Rollover|Overall Study||0
992220|NCT00449644|2406335|P1|Rollover|Overall Study||0
992221|NCT00449644|2406332|P4|STARTED|Overall Study||81
992222|NCT00449644|2406333|P3|STARTED|Overall Study||79
992223|NCT00449644|2406334|P2|STARTED|Overall Study||24
992224|NCT00449644|2406335|P1|STARTED|Overall Study||23
992225|NCT00449696|2406355|P2|NOT COMPLETED|Overall Study||9
992226|NCT00449696|2406356|P1|NOT COMPLETED|Overall Study||20
992227|NCT00449696|2406355|P2|COMPLETED|Overall Study||119
992228|NCT00449696|2406356|P1|COMPLETED|Overall Study||231
992229|NCT00449696|2406355|P2|Analyzed Participants|Overall Study||128
992230|NCT00449696|2406356|P1|Analyzed Participants|Overall Study|2 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|247
992231|NCT00449696|2406355|P2|Received Injection|Overall Study||128
992232|NCT00449696|2406356|P1|Received Injection|Overall Study||249
992233|NCT00449696|2406355|P2|STARTED|Overall Study||128
992234|NCT00449696|2406356|P1|STARTED|Overall Study||251
992235|NCT00452673|2406382|P5|NOT COMPLETED|Dose Expansion Period||21
992236|NCT00452673|2406383|P4|NOT COMPLETED|Dose Expansion Period||0
992237|NCT00452673|2406384|P3|NOT COMPLETED|Dose Expansion Period||0
992238|NCT00452673|2406385|P2|NOT COMPLETED|Dose Expansion Period||0
992239|NCT00452673|2406386|P1|NOT COMPLETED|Dose Expansion Period||0
992240|NCT00452673|2406382|P5|COMPLETED|Dose Expansion Period||0
992241|NCT00452673|2406383|P4|COMPLETED|Dose Expansion Period||0
992242|NCT00452673|2406384|P3|COMPLETED|Dose Expansion Period||0
992243|NCT00452673|2406385|P2|COMPLETED|Dose Expansion Period||0
992244|NCT00452673|2406386|P1|COMPLETED|Dose Expansion Period||0
992245|NCT00452673|2406382|P5|STARTED|Dose Expansion Period|The last dose level arm in the escalation period was selected for the dose expansion period.|21
992246|NCT00452673|2406383|P4|STARTED|Dose Expansion Period||0
992247|NCT00452673|2406384|P3|STARTED|Dose Expansion Period||0
992248|NCT00452673|2406385|P2|STARTED|Dose Expansion Period||0
992249|NCT00452673|2406386|P1|STARTED|Dose Expansion Period||0
992250|NCT00452673|2406382|P5|NOT COMPLETED|Dose Escalation Period||0
992251|NCT00452673|2406383|P4|NOT COMPLETED|Dose Escalation Period||9
992252|NCT00452673|2406384|P3|NOT COMPLETED|Dose Escalation Period||6
992253|NCT00452673|2406385|P2|NOT COMPLETED|Dose Escalation Period||9
992254|NCT00452673|2406386|P1|NOT COMPLETED|Dose Escalation Period||7
992255|NCT00452673|2406382|P5|COMPLETED|Dose Escalation Period||0
992256|NCT00452673|2406383|P4|COMPLETED|Dose Escalation Period||0
992257|NCT00452673|2406384|P3|COMPLETED|Dose Escalation Period||0
992258|NCT00452673|2406385|P2|COMPLETED|Dose Escalation Period||0
992259|NCT00452673|2406386|P1|COMPLETED|Dose Escalation Period||0
992260|NCT00452673|2406382|P5|STARTED|Dose Escalation Period||0
992261|NCT00452673|2406383|P4|STARTED|Dose Escalation Period||9
992262|NCT00452673|2406384|P3|STARTED|Dose Escalation Period||6
992263|NCT00452673|2406385|P2|STARTED|Dose Escalation Period||9
992264|NCT00452673|2406386|P1|STARTED|Dose Escalation Period||7
992265|NCT00452699|2406418|P2|NOT COMPLETED|Overall Study||73
992266|NCT00452699|2406419|P1|NOT COMPLETED|Overall Study||81
992267|NCT00452699|2406418|P2|COMPLETED|Overall Study||242
992268|NCT00452699|2406419|P1|COMPLETED|Overall Study||225
992269|NCT00452699|2406418|P2|STARTED|Overall Study||315
992270|NCT00452699|2406419|P1|STARTED|Overall Study||306
992271|NCT00452790|2406433|P2|NOT COMPLETED|Toddler Dose||2
992272|NCT00452790|2406434|P1|NOT COMPLETED|Toddler Dose||0
992273|NCT00452790|2406433|P2|COMPLETED|Toddler Dose||198
992274|NCT00452790|2406434|P1|COMPLETED|Toddler Dose||198
992275|NCT00452790|2406433|P2|STARTED|Toddler Dose||200
992276|NCT00452790|2406434|P1|STARTED|Toddler Dose||198
992277|NCT00452790|2406433|P2|NOT COMPLETED|After Infant Series||14
992278|NCT00452790|2406434|P1|NOT COMPLETED|After Infant Series||21
992279|NCT00452790|2406433|P2|COMPLETED|After Infant Series||200
992280|NCT00452790|2406434|P1|COMPLETED|After Infant Series||198
992281|NCT00452790|2406433|P2|STARTED|After Infant Series||214
992282|NCT00452790|2406434|P1|STARTED|After Infant Series||219
992283|NCT00452790|2406433|P2|NOT COMPLETED|Infant Series||141
992284|NCT00452790|2406434|P1|NOT COMPLETED|Infant Series||135
992285|NCT00452790|2406433|P2|COMPLETED|Infant Series||214
992286|NCT00452790|2406434|P1|COMPLETED|Infant Series||219
992287|NCT00452790|2406433|P2|Vaccinated Dose 3|Infant Series||218
992288|NCT00452790|2406434|P1|Vaccinated Dose 3|Infant Series||221
992289|NCT00452790|2406433|P2|Vaccinated Dose 2|Infant Series||300
992290|NCT00452790|2406434|P1|Vaccinated Dose 2|Infant Series||300
992291|NCT00452790|2406433|P2|Vaccinated Dose 1|Infant Series||353
992292|NCT00452790|2406434|P1|Vaccinated Dose 1|Infant Series||353
992293|NCT00452790|2406433|P2|STARTED|Infant Series||355
992294|NCT00452790|2406434|P1|STARTED|Infant Series||354
992295|NCT00452868|2406468|P1|NOT COMPLETED|Overall Study||2
992296|NCT00452868|2406468|P1|COMPLETED|Overall Study||11
992297|NCT00452868|2406468|P1|STARTED|Overall Study||13
992298|NCT00453063|2406474|P2|NOT COMPLETED|Overall Study||3
992299|NCT00453063|2406475|P1|NOT COMPLETED|Overall Study||3
992300|NCT00453063|2406474|P2|COMPLETED|Overall Study||212
992301|NCT00453063|2406475|P1|COMPLETED|Overall Study||208
992302|NCT00453063|2406474|P2|STARTED|Overall Study||215
992303|NCT00453063|2406475|P1|STARTED|Overall Study||211
992304|NCT00453102|2406489|P1|NOT COMPLETED|Overall Study||2
992305|NCT00453102|2406489|P1|COMPLETED|Overall Study||16
992306|NCT00453102|2406489|P1|STARTED|Overall Study||18
992307|NCT00453154|2406501|P4|NOT COMPLETED|Open Label Sunitinib Crossover||0
992308|NCT00453154|2406502|P3|NOT COMPLETED|Open Label Sunitinib Crossover||0
992309|NCT00453154|2406503|P2|NOT COMPLETED|Open Label Sunitinib Crossover||0
992310|NCT00453154|2406504|P1|NOT COMPLETED|Open Label Sunitinib Crossover||0
992311|NCT00453154|2406501|P4|COMPLETED|Open Label Sunitinib Crossover||0
992312|NCT00453154|2406502|P3|COMPLETED|Open Label Sunitinib Crossover||18
992313|NCT00453154|2406503|P2|COMPLETED|Open Label Sunitinib Crossover||0
992314|NCT00453154|2406504|P1|COMPLETED|Open Label Sunitinib Crossover||0
992315|NCT00453154|2406501|P4|STARTED|Open Label Sunitinib Crossover||0
992316|NCT00453154|2406502|P3|STARTED|Open Label Sunitinib Crossover||18
992317|NCT00453154|2406503|P2|STARTED|Open Label Sunitinib Crossover||0
992318|NCT00453154|2406504|P1|STARTED|Open Label Sunitinib Crossover||0
992319|NCT00453154|2406501|P4|NOT COMPLETED|Double BIind Maintenance||49
992320|NCT00453154|2406502|P3|NOT COMPLETED|Double BIind Maintenance||46
992321|NCT00453154|2406503|P2|NOT COMPLETED|Double BIind Maintenance||0
992322|NCT00453154|2406504|P1|NOT COMPLETED|Double BIind Maintenance||0
992323|NCT00453154|2406501|P4|COMPLETED|Double BIind Maintenance||0
992324|NCT00453154|2406502|P3|COMPLETED|Double BIind Maintenance||0
992325|NCT00453154|2406503|P2|COMPLETED|Double BIind Maintenance||0
992326|NCT00453154|2406504|P1|COMPLETED|Double BIind Maintenance||0
992327|NCT00453154|2406501|P4|STARTED|Double BIind Maintenance||49
992328|NCT00453154|2406502|P3|STARTED|Double BIind Maintenance||46
992329|NCT00453154|2406503|P2|STARTED|Double BIind Maintenance||0
992330|NCT00453154|2406504|P1|STARTED|Double BIind Maintenance||0
992331|NCT00453154|2406501|P4|NOT COMPLETED|Combination Chemotherapy||0
992332|NCT00453154|2406502|P3|NOT COMPLETED|Combination Chemotherapy||0
992333|NCT00453154|2406503|P2|NOT COMPLETED|Combination Chemotherapy||49
992334|NCT00453154|2406504|P1|NOT COMPLETED|Combination Chemotherapy||0
992335|NCT00453154|2406501|P4|COMPLETED|Combination Chemotherapy||0
992336|NCT00453154|2406502|P3|COMPLETED|Combination Chemotherapy||0
992337|NCT00453154|2406503|P2|COMPLETED|Combination Chemotherapy||95
992338|NCT00453154|2406504|P1|COMPLETED|Combination Chemotherapy||12
992339|NCT00453154|2406501|P4|STARTED|Combination Chemotherapy||0
992340|NCT00453154|2406502|P3|STARTED|Combination Chemotherapy||0
992341|NCT00453154|2406503|P2|STARTED|Combination Chemotherapy||144
992342|NCT00453154|2406504|P1|STARTED|Combination Chemotherapy||12
992349|NCT00453193|2406536|P1|NOT COMPLETED|Overall Study||0
992350|NCT00453193|2406536|P1|COMPLETED|Overall Study||24
992351|NCT00453193|2406536|P1|STARTED|Overall Study||24
992352|NCT00453206|2406540|P1|NOT COMPLETED|Overall Study||1
992353|NCT00453206|2406540|P1|COMPLETED|Overall Study||65
992354|NCT00453206|2406540|P1|STARTED|Overall Study||66
992355|NCT00453310|2406544|P1|NOT COMPLETED|Overall Study||10
992356|NCT00453310|2406544|P1|COMPLETED|Overall Study||0
992357|NCT00453310|2406544|P1|STARTED|Overall Study||10
992358|NCT00453336|2406548|P1|NOT COMPLETED|Overall Study||0
992359|NCT00453336|2406548|P1|COMPLETED|Overall Study||45
992360|NCT00453336|2406548|P1|STARTED|Overall Study||45
992361|NCT00453349|2406555|P2|NOT COMPLETED|Completed Study||34
992362|NCT00453349|2406556|P1|NOT COMPLETED|Completed Study||27
992363|NCT00453349|2406555|P2|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|198
992364|NCT00453349|2406556|P1|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|201
992365|NCT00453349|2406555|P2|Completed Study Treatment|Completed Study|23 terminated prematurely|209
992366|NCT00453349|2406556|P1|Completed Study Treatment|Completed Study|25 terminated prematurely|203
992367|NCT00453349|2406555|P2|STARTED|Completed Study||232
992368|NCT00453349|2406556|P1|STARTED|Completed Study||228
992369|NCT00453349|2406555|P2|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||11
992370|NCT00453349|2406556|P1|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||10
992371|NCT00453349|2406555|P2|COMPLETED|Reaching of Primary Endpoint (TOC)||219
992372|NCT00453349|2406556|P1|COMPLETED|Reaching of Primary Endpoint (TOC)|All PP patients and ITT patients with a clinical response with no missing information|215
992373|NCT00453349|2406555|P2|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||190
992374|NCT00453349|2406556|P1|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||194
992375|NCT00453349|2406555|P2|STARTED|Reaching of Primary Endpoint (TOC)|i.e. the ITT population|230
992376|NCT00453349|2406556|P1|STARTED|Reaching of Primary Endpoint (TOC)|Subjects who attended the TOC visit or at least had a clinical evaluation at TOC|225
992377|NCT00453349|2406555|P2|NOT COMPLETED|Randomized||23
992378|NCT00453349|2406556|P1|NOT COMPLETED|Randomized||25
992379|NCT00453349|2406555|P2|COMPLETED|Randomized||209
992380|NCT00453349|2406556|P1|COMPLETED|Randomized||203
992381|NCT00453349|2406555|P2|STARTED|Randomized||232
992382|NCT00453349|2406556|P1|STARTED|Randomized||228
992383|NCT00453362|2406582|P1|NOT COMPLETED|Overall Study||87
992384|NCT00453362|2406582|P1|COMPLETED|Overall Study||1
992385|NCT00453362|2406582|P1|FLT-PET Evaluable|Overall Study|Participants who completed all FLT-PET scans through day 56.|50
992478|NCT00454324|2406940|P2|COMPLETED|Overall Study||13
992386|NCT00453362|2406582|P1|FDG-PET Evaluable|Overall Study|Participants who completed all FDG-PET scans through day 56.|51
992387|NCT00453362|2406582|P1|Treated With Erlotinib|Overall Study||74
992388|NCT00453362|2406582|P1|STARTED|Overall Study|14 participants consented but did not receive drug and are not represented in the baseline data|88
992389|NCT00453388|2406610|P4|NOT COMPLETED|Overall Study||0
992390|NCT00453388|2406611|P3|NOT COMPLETED|Overall Study||0
992391|NCT00453388|2406612|P2|NOT COMPLETED|Overall Study||0
992392|NCT00453388|2406613|P1|NOT COMPLETED|Overall Study||0
992393|NCT00453388|2406610|P4|COMPLETED|Overall Study||0
992394|NCT00453388|2406611|P3|COMPLETED|Overall Study||1
992395|NCT00453388|2406612|P2|COMPLETED|Overall Study||5
992396|NCT00453388|2406613|P1|COMPLETED|Overall Study||0
992397|NCT00453388|2406610|P4|STARTED|Overall Study||0
992398|NCT00453388|2406611|P3|STARTED|Overall Study||1
992399|NCT00453388|2406612|P2|STARTED|Overall Study||5
992400|NCT00453388|2406613|P1|STARTED|Overall Study||0
992401|NCT00453973|2406637|P2|NOT COMPLETED|Overall Study||48
992402|NCT00453973|2406638|P1|NOT COMPLETED|Overall Study||51
992403|NCT00453973|2406637|P2|COMPLETED|Overall Study||15
992404|NCT00453973|2406638|P1|COMPLETED|Overall Study||0
992405|NCT00453973|2406637|P2|STARTED|Overall Study||63
992406|NCT00453973|2406638|P1|STARTED|Overall Study||51
992407|NCT00453986|2406649|P5|NOT COMPLETED|Overall Study||0
992408|NCT00453986|2406650|P4|NOT COMPLETED|Overall Study||2
992409|NCT00453986|2406651|P3|NOT COMPLETED|Overall Study||6
992410|NCT00453986|2406652|P2|NOT COMPLETED|Overall Study||5
992411|NCT00453986|2406653|P1|NOT COMPLETED|Overall Study||6
992412|NCT00453986|2406649|P5|COMPLETED|Overall Study||105
992413|NCT00453986|2406650|P4|COMPLETED|Overall Study||310
992414|NCT00453986|2406651|P3|COMPLETED|Overall Study||307
992415|NCT00453986|2406652|P2|COMPLETED|Overall Study||306
992416|NCT00453986|2406653|P1|COMPLETED|Overall Study||305
992417|NCT00453986|2406649|P5|STARTED|Overall Study||105
992418|NCT00453986|2406650|P4|STARTED|Overall Study||312
992419|NCT00453986|2406651|P3|STARTED|Overall Study||313
992420|NCT00453986|2406652|P2|STARTED|Overall Study||311
992421|NCT00453986|2406653|P1|STARTED|Overall Study||311
992422|NCT00453999|2406749|P3|NOT COMPLETED|Overall Study||3
992423|NCT00453999|2406750|P2|NOT COMPLETED|Overall Study||5
992424|NCT00453999|2406751|P1|NOT COMPLETED|Overall Study||5
992425|NCT00453999|2406749|P3|COMPLETED|Overall Study||43
992426|NCT00453999|2406750|P2|COMPLETED|Overall Study||41
992427|NCT00453999|2406751|P1|COMPLETED|Overall Study||40
992428|NCT00453999|2406749|P3|STARTED|Overall Study||46
992429|NCT00453999|2406750|P2|STARTED|Overall Study||46
992430|NCT00453999|2406751|P1|STARTED|Overall Study||45
992431|NCT00454051|2406776|P2|NOT COMPLETED|Overall Study||3
992432|NCT00454051|2406777|P1|NOT COMPLETED|Overall Study||3
992433|NCT00454051|2406776|P2|COMPLETED|Overall Study||8
992434|NCT00454051|2406777|P1|COMPLETED|Overall Study||17
992435|NCT00454051|2406776|P2|STARTED|Overall Study||11
992436|NCT00454051|2406777|P1|STARTED|Overall Study||20
992437|NCT00454116|2406810|P3|NOT COMPLETED|Overall Study||28
992438|NCT00454116|2406811|P2|NOT COMPLETED|Overall Study||29
992439|NCT00454116|2406812|P1|NOT COMPLETED|Overall Study||27
992440|NCT00454116|2406810|P3|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
992441|NCT00454116|2406811|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
992442|NCT00454116|2406812|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|8
992443|NCT00454116|2406810|P3|STARTED|Overall Study|randomised patients|35
992444|NCT00454116|2406811|P2|STARTED|Overall Study|randomised patients|36
992445|NCT00454116|2406812|P1|STARTED|Overall Study|randomised patients|35
992446|NCT00454142|2406820|P1|NOT COMPLETED|Overall Study||1
992447|NCT00454142|2406820|P1|COMPLETED|Overall Study||32
992448|NCT00454142|2406820|P1|STARTED|Overall Study||33
992449|NCT00454181|2406837|P2|NOT COMPLETED|Overall Study||3
992450|NCT00454181|2406838|P1|NOT COMPLETED|Overall Study||15
992451|NCT00454181|2406837|P2|COMPLETED|Overall Study||11
992452|NCT00454181|2406838|P1|COMPLETED|Overall Study||30
992453|NCT00454181|2406837|P2|STARTED|Overall Study||14
992454|NCT00454181|2406838|P1|STARTED|Overall Study||45
992455|NCT00454194|2406856|P2|NOT COMPLETED|Overall Study||14
992456|NCT00454194|2406857|P1|NOT COMPLETED|Overall Study||22
992457|NCT00454194|2406856|P2|COMPLETED|Overall Study||37
992458|NCT00454194|2406857|P1|COMPLETED|Overall Study||25
992459|NCT00454194|2406856|P2|STARTED|Overall Study||51
992460|NCT00454194|2406857|P1|STARTED|Overall Study||47
992461|NCT00454207|2406875|P2|NOT COMPLETED|Overall Study||2
992462|NCT00454207|2406876|P1|NOT COMPLETED|Overall Study||4
992463|NCT00454207|2406875|P2|COMPLETED|Overall Study||21
992464|NCT00454207|2406876|P1|COMPLETED|Overall Study|19 participants completed Part I period. 17 of 19 participants continued from part I into Part II.|17
992465|NCT00454207|2406875|P2|STARTED|Overall Study||23
992466|NCT00454207|2406876|P1|STARTED|Overall Study||21
992467|NCT00454246|2406922|P3|NOT COMPLETED|Overall Study||9
992468|NCT00454246|2406923|P2|NOT COMPLETED|Overall Study||29
992469|NCT00454246|2406924|P1|NOT COMPLETED|Overall Study||73
992470|NCT00454246|2406922|P3|COMPLETED|Overall Study||0
992471|NCT00454246|2406923|P2|COMPLETED|Overall Study||0
992472|NCT00454246|2406924|P1|COMPLETED|Overall Study||0
992473|NCT00454246|2406922|P3|STARTED|Overall Study||9
992474|NCT00454246|2406923|P2|STARTED|Overall Study||29
992475|NCT00454246|2406924|P1|STARTED|Overall Study||73
992476|NCT00454324|2406940|P2|NOT COMPLETED|Overall Study||0
992477|NCT00454324|2406941|P1|NOT COMPLETED|Overall Study||0
992479|NCT00454324|2406941|P1|COMPLETED|Overall Study||14
992480|NCT00454324|2406940|P2|STARTED|Overall Study||13
992481|NCT00454324|2406941|P1|STARTED|Overall Study||14
992482|NCT00454363|2406955|P2|NOT COMPLETED|Overall Study||2
992483|NCT00454363|2406956|P1|NOT COMPLETED|Overall Study||5
992484|NCT00454363|2406955|P2|COMPLETED|Overall Study||29
992485|NCT00454363|2406956|P1|COMPLETED|Overall Study||15
992486|NCT00454363|2406955|P2|STARTED|Overall Study||31
992487|NCT00454363|2406956|P1|STARTED|Overall Study||20
992488|NCT00454532|2406967|P4|NOT COMPLETED|Overall Study||0
992489|NCT00454532|2406968|P3|NOT COMPLETED|Overall Study||0
992490|NCT00454532|2406969|P2|NOT COMPLETED|Overall Study||0
992491|NCT00454532|2406970|P1|NOT COMPLETED|Overall Study||0
992492|NCT00454532|2406967|P4|COMPLETED|Overall Study||7
992493|NCT00454532|2406968|P3|COMPLETED|Overall Study||3
992494|NCT00454532|2406969|P2|COMPLETED|Overall Study||6
992495|NCT00454532|2406970|P1|COMPLETED|Overall Study||11
992496|NCT00454532|2406967|P4|STARTED|Overall Study||7
992497|NCT00454532|2406968|P3|STARTED|Overall Study||3
992498|NCT00454532|2406969|P2|STARTED|Overall Study||6
992499|NCT00454532|2406970|P1|STARTED|Overall Study||11
992500|NCT00454571|2406990|P2|NOT COMPLETED|Overall Study||6
992501|NCT00454571|2406991|P1|NOT COMPLETED|Overall Study||13
992502|NCT00454571|2406990|P2|COMPLETED|Overall Study||13
992503|NCT00454571|2406991|P1|COMPLETED|Overall Study||5
992504|NCT00454571|2406990|P2|STARTED|Overall Study||19
992505|NCT00454571|2406991|P1|STARTED|Overall Study||18
992506|NCT00454584|2407002|P6|NOT COMPLETED|After Controlled Period||32
992507|NCT00454584|2407003|P5|NOT COMPLETED|After Controlled Period||12
992508|NCT00454584|2407004|P4|NOT COMPLETED|After Controlled Period||26
992509|NCT00454584|2407005|P3|NOT COMPLETED|After Controlled Period||0
992510|NCT00454584|2407006|P2|NOT COMPLETED|After Controlled Period||0
992511|NCT00454584|2407007|P1|NOT COMPLETED|After Controlled Period||0
992512|NCT00454584|2407002|P6|COMPLETED|After Controlled Period||310
992513|NCT00454584|2407003|P5|COMPLETED|After Controlled Period||189
992514|NCT00454584|2407004|P4|COMPLETED|After Controlled Period||310
992515|NCT00454584|2407005|P3|COMPLETED|After Controlled Period||0
992516|NCT00454584|2407006|P2|COMPLETED|After Controlled Period||0
992517|NCT00454584|2407007|P1|COMPLETED|After Controlled Period||0
992518|NCT00454584|2407002|P6|STARTED|After Controlled Period||342
992519|NCT00454584|2407003|P5|STARTED|After Controlled Period||201
992520|NCT00454584|2407004|P4|STARTED|After Controlled Period||336
992521|NCT00454584|2407005|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
992522|NCT00454584|2407006|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
992523|NCT00454584|2407007|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
992524|NCT00454584|2407002|P6|NOT COMPLETED|Controlled Period||0
992525|NCT00454584|2407003|P5|NOT COMPLETED|Controlled Period||0
992526|NCT00454584|2407004|P4|NOT COMPLETED|Controlled Period||0
992527|NCT00454584|2407005|P3|NOT COMPLETED|Controlled Period||5
992528|NCT00454584|2407006|P2|NOT COMPLETED|Controlled Period||8
992529|NCT00454584|2407007|P1|NOT COMPLETED|Controlled Period||11
992530|NCT00454584|2407002|P6|COMPLETED|Controlled Period||0
992531|NCT00454584|2407003|P5|COMPLETED|Controlled Period||0
992532|NCT00454584|2407004|P4|COMPLETED|Controlled Period||0
992533|NCT00454584|2407005|P3|COMPLETED|Controlled Period||342
992534|NCT00454584|2407006|P2|COMPLETED|Controlled Period||201
992535|NCT00454584|2407007|P1|COMPLETED|Controlled Period||336
992536|NCT00454584|2407002|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
992537|NCT00454584|2407003|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
992538|NCT00454584|2407004|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
992539|NCT00454584|2407005|P3|STARTED|Controlled Period||347
992540|NCT00454584|2407006|P2|STARTED|Controlled Period||209
992541|NCT00454584|2407007|P1|STARTED|Controlled Period||347
992542|NCT00454636|2407031|P4|NOT COMPLETED|Overall Study||32
992543|NCT00454636|2407032|P3|NOT COMPLETED|Overall Study||20
992544|NCT00454636|2407033|P2|NOT COMPLETED|Overall Study||23
992545|NCT00454636|2407034|P1|NOT COMPLETED|Overall Study||31
992546|NCT00454636|2407031|P4|COMPLETED|Overall Study||26
992547|NCT00454636|2407032|P3|COMPLETED|Overall Study||7
992548|NCT00454636|2407033|P2|COMPLETED|Overall Study||9
992549|NCT00454636|2407034|P1|COMPLETED|Overall Study||10
992550|NCT00454636|2407031|P4|STARTED|Overall Study||58
992551|NCT00454636|2407032|P3|STARTED|Overall Study||27
992552|NCT00454636|2407033|P2|STARTED|Overall Study||32
992553|NCT00454636|2407034|P1|STARTED|Overall Study||41
992554|NCT00454649|2407074|P10|NOT COMPLETED|Overall Study||5
992555|NCT00454649|2407075|P9|NOT COMPLETED|Overall Study||20
992556|NCT00454649|2407076|P8|NOT COMPLETED|Overall Study||19
992557|NCT00454649|2407077|P7|NOT COMPLETED|Overall Study||9
992558|NCT00454649|2407078|P6|NOT COMPLETED|Overall Study||7
992559|NCT00454649|2407079|P5|NOT COMPLETED|Overall Study||1
992560|NCT00454649|2407080|P4|NOT COMPLETED|Overall Study||6
992561|NCT00454649|2407081|P3|NOT COMPLETED|Overall Study||19
992562|NCT00454649|2407082|P2|NOT COMPLETED|Overall Study||4
992563|NCT00454649|2407083|P1|NOT COMPLETED|Overall Study||3
992564|NCT00454649|2407074|P10|COMPLETED|Overall Study||1
992565|NCT00454649|2407075|P9|COMPLETED|Overall Study||1
992566|NCT00454649|2407076|P8|COMPLETED|Overall Study||0
992567|NCT00454649|2407077|P7|COMPLETED|Overall Study||0
992568|NCT00454649|2407078|P6|COMPLETED|Overall Study||0
992569|NCT00454649|2407079|P5|COMPLETED|Overall Study||0
992570|NCT00454649|2407080|P4|COMPLETED|Overall Study||1
992571|NCT00454649|2407081|P3|COMPLETED|Overall Study||1
992572|NCT00454649|2407082|P2|COMPLETED|Overall Study||1
992573|NCT00454649|2407083|P1|COMPLETED|Overall Study||0
992574|NCT00454649|2407074|P10|STARTED|Overall Study||6
992575|NCT00454649|2407075|P9|STARTED|Overall Study||21
992576|NCT00454649|2407076|P8|STARTED|Overall Study||19
992577|NCT00454649|2407077|P7|STARTED|Overall Study||9
992578|NCT00454649|2407078|P6|STARTED|Overall Study||7
992579|NCT00454649|2407079|P5|STARTED|Overall Study||1
992580|NCT00454649|2407080|P4|STARTED|Overall Study||7
992581|NCT00454649|2407081|P3|STARTED|Overall Study||20
992582|NCT00454649|2407082|P2|STARTED|Overall Study||5
992583|NCT00454649|2407083|P1|STARTED|Overall Study||3
992584|NCT00454779|2407210|P2|NOT COMPLETED|Second-line Treatment Phase||3
992585|NCT00454779|2407211|P1|NOT COMPLETED|Second-line Treatment Phase||0
992586|NCT00454779|2407210|P2|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|27
992587|NCT00454779|2407211|P1|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|0
992588|NCT00454779|2407210|P2|STARTED|Second-line Treatment Phase|Second-line Panitumumab Monotherapy|30
992589|NCT00454779|2407211|P1|STARTED|Second-line Treatment Phase|Subjects in this arm do not have second-line treatment period|0
992590|NCT00454779|2407210|P2|NOT COMPLETED|First-line Treatment Phase||8
992591|NCT00454779|2407211|P1|NOT COMPLETED|First-line Treatment Phase||5
992592|NCT00454779|2407210|P2|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|49
992593|NCT00454779|2407211|P1|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|51
992594|NCT00454779|2407210|P2|Received Study Medication|First-line Treatment Phase||55
992595|NCT00454779|2407211|P1|Received Study Medication|First-line Treatment Phase||56
992596|NCT00454779|2407210|P2|STARTED|First-line Treatment Phase||57
992597|NCT00454779|2407211|P1|STARTED|First-line Treatment Phase||56
992598|NCT00454805|2407241|P2|NOT COMPLETED|Overall Study||23
992599|NCT00454805|2407242|P1|NOT COMPLETED|Overall Study||26
992600|NCT00454805|2407241|P2|COMPLETED|Overall Study|Ongoing at data cut-off|8
992601|NCT00454805|2407242|P1|COMPLETED|Overall Study|Ongoing at data cut-off|5
992602|NCT00454805|2407241|P2|STARTED|Overall Study|Randomised|31
992603|NCT00454805|2407242|P1|STARTED|Overall Study|Randomised|31
992604|NCT00454818|2407264|P5|NOT COMPLETED|Phase 2: Randomized Double-blind||4
992605|NCT00454818|2407265|P4|NOT COMPLETED|Phase 2: Randomized Double-blind||1
992606|NCT00454818|2407266|P3|NOT COMPLETED|Phase 2: Randomized Double-blind||3
992607|NCT00454818|2407267|P2|NOT COMPLETED|Phase 2: Randomized Double-blind||2
992608|NCT00454818|2407268|P1|NOT COMPLETED|Phase 2: Randomized Double-blind||0
992609|NCT00454818|2407264|P5|COMPLETED|Phase 2: Randomized Double-blind||10
992610|NCT00454818|2407265|P4|COMPLETED|Phase 2: Randomized Double-blind||8
992611|NCT00454818|2407266|P3|COMPLETED|Phase 2: Randomized Double-blind||5
992612|NCT00454818|2407267|P2|COMPLETED|Phase 2: Randomized Double-blind||6
992613|NCT00454818|2407268|P1|COMPLETED|Phase 2: Randomized Double-blind||0
992614|NCT00454818|2407264|P5|STARTED|Phase 2: Randomized Double-blind||14
992615|NCT00454818|2407265|P4|STARTED|Phase 2: Randomized Double-blind||9
992616|NCT00454818|2407266|P3|STARTED|Phase 2: Randomized Double-blind||8
992617|NCT00454818|2407267|P2|STARTED|Phase 2: Randomized Double-blind||8
992618|NCT00454818|2407268|P1|STARTED|Phase 2: Randomized Double-blind||0
992619|NCT00454818|2407264|P5|NOT COMPLETED|Phase I: Open-label Dose-escalation||0
992620|NCT00454818|2407265|P4|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
992621|NCT00454818|2407266|P3|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
992622|NCT00454818|2407267|P2|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
992623|NCT00454818|2407268|P1|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
992624|NCT00454818|2407264|P5|COMPLETED|Phase I: Open-label Dose-escalation||0
992625|NCT00454818|2407265|P4|COMPLETED|Phase I: Open-label Dose-escalation||2
992626|NCT00454818|2407266|P3|COMPLETED|Phase I: Open-label Dose-escalation||2
992627|NCT00454818|2407267|P2|COMPLETED|Phase I: Open-label Dose-escalation||2
992628|NCT00454818|2407268|P1|COMPLETED|Phase I: Open-label Dose-escalation||2
992629|NCT00454818|2407264|P5|STARTED|Phase I: Open-label Dose-escalation||0
992630|NCT00454818|2407265|P4|STARTED|Phase I: Open-label Dose-escalation||3
992631|NCT00454818|2407266|P3|STARTED|Phase I: Open-label Dose-escalation||3
992632|NCT00454818|2407267|P2|STARTED|Phase I: Open-label Dose-escalation||3
992633|NCT00454818|2407268|P1|STARTED|Phase I: Open-label Dose-escalation||3
992634|NCT00454857|2407345|P1|NOT COMPLETED|Overall Study||54
992635|NCT00454857|2407345|P1|COMPLETED|Overall Study||272
992636|NCT00454857|2407345|P1|Completed ≥1 Observational Study Visit|Overall Study||319
992637|NCT00454857|2407345|P1|Completed Retrospective Chart Review|Overall Study||324
992638|NCT00454857|2407345|P1|STARTED|Overall Study||326
992639|NCT00454909|2407365|P3|NOT COMPLETED|Overall Study||2
992640|NCT00454909|2407366|P2|NOT COMPLETED|Overall Study||3
992641|NCT00454909|2407367|P1|NOT COMPLETED|Overall Study||7
992642|NCT00454909|2407365|P3|COMPLETED|Overall Study||86
992643|NCT00454909|2407366|P2|COMPLETED|Overall Study||194
992644|NCT00454909|2407367|P1|COMPLETED|Overall Study||580
992645|NCT00454909|2407365|P3|STARTED|Overall Study||88
992646|NCT00454909|2407366|P2|STARTED|Overall Study||197
992647|NCT00454909|2407367|P1|STARTED|Overall Study||587
992648|NCT00454987|2407408|P3|NOT COMPLETED|Year 4||0
992649|NCT00454987|2407409|P2|NOT COMPLETED|Year 4||0
992650|NCT00454987|2407410|P1|NOT COMPLETED|Year 4||0
992651|NCT00454987|2407408|P3|COMPLETED|Year 4||0
992652|NCT00454987|2407409|P2|COMPLETED|Year 4||62
992653|NCT00454987|2407410|P1|COMPLETED|Year 4||206
992654|NCT00454987|2407408|P3|STARTED|Year 4||0
992655|NCT00454987|2407409|P2|STARTED|Year 4||62
992656|NCT00454987|2407410|P1|STARTED|Year 4||206
992657|NCT00454987|2407408|P3|NOT COMPLETED|Year 2||0
992658|NCT00454987|2407409|P2|NOT COMPLETED|Year 2||0
992659|NCT00454987|2407410|P1|NOT COMPLETED|Year 2||0
992660|NCT00454987|2407408|P3|COMPLETED|Year 2||74
992661|NCT00454987|2407409|P2|COMPLETED|Year 2||77
992662|NCT00454987|2407410|P1|COMPLETED|Year 2||235
992663|NCT00454987|2407408|P3|STARTED|Year 2||74
992664|NCT00454987|2407409|P2|STARTED|Year 2||77
992665|NCT00454987|2407410|P1|STARTED|Year 2||235
992666|NCT00454987|2407408|P3|NOT COMPLETED|Year 1||0
992667|NCT00454987|2407409|P2|NOT COMPLETED|Year 1||0
992668|NCT00454987|2407410|P1|NOT COMPLETED|Year 1||0
992669|NCT00454987|2407408|P3|COMPLETED|Year 1||0
992670|NCT00454987|2407409|P2|COMPLETED|Year 1||67
992671|NCT00454987|2407410|P1|COMPLETED|Year 1||221
992672|NCT00454987|2407408|P3|STARTED|Year 1||0
992673|NCT00454987|2407409|P2|STARTED|Year 1||67
992674|NCT00454987|2407410|P1|STARTED|Year 1||221
992675|NCT00454987|2407408|P3|NOT COMPLETED|Booster Period||0
992676|NCT00454987|2407409|P2|NOT COMPLETED|Booster Period||1
992677|NCT00454987|2407410|P1|NOT COMPLETED|Booster Period||2
992678|NCT00454987|2407408|P3|COMPLETED|Booster Period||0
992679|NCT00454987|2407409|P2|COMPLETED|Booster Period||116
992680|NCT00454987|2407410|P1|COMPLETED|Booster Period||357
992681|NCT00454987|2407408|P3|STARTED|Booster Period||0
992682|NCT00454987|2407409|P2|STARTED|Booster Period||117
992683|NCT00454987|2407410|P1|STARTED|Booster Period||359
992702|NCT00444457|2407555|P4|NOT COMPLETED|Toddler Dose||8
992703|NCT00444457|2407556|P3|NOT COMPLETED|Toddler Dose||4
992704|NCT00444457|2407557|P2|NOT COMPLETED|Toddler Dose||6
992705|NCT00444457|2407558|P1|NOT COMPLETED|Toddler Dose||7
992706|NCT00444457|2407555|P4|COMPLETED|Toddler Dose||200
992707|NCT00444457|2407556|P3|COMPLETED|Toddler Dose||404
992708|NCT00444457|2407557|P2|COMPLETED|Toddler Dose||391
992709|NCT00444457|2407558|P1|COMPLETED|Toddler Dose||408
992710|NCT00444457|2407555|P4|STARTED|Toddler Dose|Vaccinated toddler dose|208
992711|NCT00444457|2407556|P3|STARTED|Toddler Dose|Vaccinated toddler dose|408
992712|NCT00444457|2407557|P2|STARTED|Toddler Dose|Vaccinated toddler dose|397
992713|NCT00444457|2407558|P1|STARTED|Toddler Dose|Vaccinated toddler dose|415
992714|NCT00444457|2407555|P4|NOT COMPLETED|After Infant Series||10
992715|NCT00444457|2407556|P3|NOT COMPLETED|After Infant Series||19
992716|NCT00444457|2407557|P2|NOT COMPLETED|After Infant Series||30
992717|NCT00444457|2407558|P1|NOT COMPLETED|After Infant Series||20
992718|NCT00444457|2407555|P4|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|208
992719|NCT00444457|2407556|P3|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|408
992720|NCT00444457|2407557|P2|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|397
992721|NCT00444457|2407558|P1|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|415
992722|NCT00444457|2407555|P4|STARTED|After Infant Series||218
992723|NCT00444457|2407556|P3|STARTED|After Infant Series||427
992724|NCT00444457|2407557|P2|STARTED|After Infant Series||427
992725|NCT00444457|2407558|P1|STARTED|After Infant Series||435
992726|NCT00444457|2407555|P4|NOT COMPLETED|Infant Series||28
992727|NCT00444457|2407556|P3|NOT COMPLETED|Infant Series||61
992728|NCT00444457|2407557|P2|NOT COMPLETED|Infant Series||61
992729|NCT00444457|2407558|P1|NOT COMPLETED|Infant Series||54
992730|NCT00444457|2407555|P4|COMPLETED|Infant Series||218
992731|NCT00444457|2407556|P3|COMPLETED|Infant Series||428
992732|NCT00444457|2407557|P2|COMPLETED|Infant Series||427
992733|NCT00444457|2407558|P1|COMPLETED|Infant Series||435
992734|NCT00444457|2407555|P4|Vaccinated Dose 3|Infant Series||225
992735|NCT00444457|2407556|P3|Vaccinated Dose 3|Infant Series||438
992736|NCT00444457|2407557|P2|Vaccinated Dose 3|Infant Series||435
992737|NCT00444457|2407558|P1|Vaccinated Dose 3|Infant Series||442
992738|NCT00444457|2407555|P4|Vaccinated Dose 2|Infant Series||228
992739|NCT00444457|2407556|P3|Vaccinated Dose 2|Infant Series||455
992740|NCT00444457|2407557|P2|Vaccinated Dose 2|Infant Series||447
992741|NCT00444457|2407558|P1|Vaccinated Dose 2|Infant Series||455
992742|NCT00444457|2407555|P4|Vaccinated Dose 1|Infant Series||244
992743|NCT00444457|2407556|P3|Vaccinated Dose 1|Infant Series||485
992744|NCT00444457|2407557|P2|Vaccinated Dose 1|Infant Series||484
992745|NCT00444457|2407558|P1|Vaccinated Dose 1|Infant Series||486
992746|NCT00444457|2407555|P4|STARTED|Infant Series||246
992747|NCT00444457|2407556|P3|STARTED|Infant Series||489
992748|NCT00444457|2407557|P2|STARTED|Infant Series||488
992749|NCT00444457|2407558|P1|STARTED|Infant Series||489
992750|NCT00444535|2407620|P1|NOT COMPLETED|Overall Study||24
992751|NCT00444535|2407620|P1|COMPLETED|Overall Study||28
992752|NCT00444535|2407620|P1|STARTED|Overall Study||52
992753|NCT00444587|2407629|P2|NOT COMPLETED|Overall Study||15
992754|NCT00444587|2407630|P1|NOT COMPLETED|Overall Study||83
992755|NCT00444587|2407629|P2|COMPLETED|Overall Study||1
992756|NCT00444587|2407630|P1|COMPLETED|Overall Study||10
992757|NCT00444587|2407629|P2|STARTED|Overall Study||16
992758|NCT00444587|2407630|P1|STARTED|Overall Study||93
992759|NCT00444600|2407655|P4|NOT COMPLETED|Overall Study||10
992760|NCT00444600|2407656|P3|NOT COMPLETED|Overall Study||10
992761|NCT00444600|2407657|P2|NOT COMPLETED|Overall Study||16
992762|NCT00444600|2407658|P1|NOT COMPLETED|Overall Study||19
992763|NCT00444600|2407655|P4|COMPLETED|Overall Study|Number of eyes|176
992764|NCT00444600|2407656|P3|COMPLETED|Overall Study|Number of eyes|178
992765|NCT00444600|2407657|P2|COMPLETED|Overall Study|Number of eyes|171
992766|NCT00444600|2407658|P1|COMPLETED|Overall Study|Number of eyes|274
992767|NCT00444600|2407655|P4|STARTED|Overall Study|Number of eyes|186
992768|NCT00444600|2407656|P3|STARTED|Overall Study|Number of eyes|188
992769|NCT00444600|2407657|P2|STARTED|Overall Study|Number of eyes|187
992770|NCT00444600|2407658|P1|STARTED|Overall Study|Number of eyes|293
992771|NCT00444626|2407748|P1|NOT COMPLETED|Repeat Treatment Period||0
992772|NCT00444626|2407748|P1|COMPLETED|Repeat Treatment Period||105
992773|NCT00444626|2407748|P1|STARTED|Repeat Treatment Period|23 subjects withdrew after completing the Initial Treatment and did not enter the Repeat Treatment|105
992774|NCT00444626|2407748|P1|NOT COMPLETED|Initial Treatment Period||12
992775|NCT00444626|2407748|P1|COMPLETED|Initial Treatment Period||128
992776|NCT00444626|2407748|P1|STARTED|Initial Treatment Period||140
992777|NCT00444795|2407774|P1|NOT COMPLETED|Overall Study||3
992778|NCT00444795|2407774|P1|COMPLETED|Overall Study|Refer to the Safety Analysis Set.|617
992779|NCT00444795|2407774|P1|STARTED|Overall Study||620
992780|NCT00444912|2407781|P2|NOT COMPLETED|Overall Study||2
992781|NCT00444912|2407782|P1|NOT COMPLETED|Overall Study||3
992782|NCT00444912|2407781|P2|COMPLETED|Overall Study||13
992783|NCT00444912|2407782|P1|COMPLETED|Overall Study||12
992784|NCT00444912|2407781|P2|Received Transplant|Overall Study||14
992785|NCT00444912|2407782|P1|Received Transplant|Overall Study||14
992786|NCT00444912|2407781|P2|Received Plerixafor|Overall Study||15
992787|NCT00444912|2407782|P1|Received Plerixafor|Overall Study||15
992788|NCT00444912|2407781|P2|STARTED|Overall Study||15
992789|NCT00444912|2407782|P1|STARTED|Overall Study||15
992790|NCT00444925|2407813|P3|NOT COMPLETED|Double-blind Treatment Period||81
992791|NCT00444925|2407814|P2|NOT COMPLETED|Double-blind Treatment Period||56
992792|NCT00444925|2407815|P1|NOT COMPLETED|Double-blind Treatment Period||30
992793|NCT00444925|2407813|P3|COMPLETED|Double-blind Treatment Period||598
992794|NCT00444925|2407814|P2|COMPLETED|Double-blind Treatment Period||628
992795|NCT00444925|2407815|P1|COMPLETED|Double-blind Treatment Period||304
992796|NCT00444925|2407813|P3|STARTED|Double-blind Treatment Period||679
992797|NCT00444925|2407814|P2|STARTED|Double-blind Treatment Period||684
992798|NCT00444925|2407815|P1|STARTED|Double-blind Treatment Period||334
992799|NCT00444925|2407813|P3|NOT COMPLETED|Randomized to Double-blind Treatment||6
992800|NCT00444925|2407814|P2|NOT COMPLETED|Randomized to Double-blind Treatment||6
992801|NCT00444925|2407815|P1|NOT COMPLETED|Randomized to Double-blind Treatment||3
992802|NCT00444925|2407813|P3|COMPLETED|Randomized to Double-blind Treatment||679
992803|NCT00444925|2407814|P2|COMPLETED|Randomized to Double-blind Treatment||684
992804|NCT00444925|2407815|P1|COMPLETED|Randomized to Double-blind Treatment||334
992805|NCT00444925|2407813|P3|STARTED|Randomized to Double-blind Treatment||685
992806|NCT00444925|2407814|P2|STARTED|Randomized to Double-blind Treatment||690
992807|NCT00444925|2407815|P1|STARTED|Randomized to Double-blind Treatment||337
992808|NCT00444925|2407813|P3|NOT COMPLETED|Single-blind Placebo Run-In Period||0
992809|NCT00444925|2407814|P2|NOT COMPLETED|Single-blind Placebo Run-In Period||0
992810|NCT00444925|2407815|P1|NOT COMPLETED|Single-blind Placebo Run-In Period||734
992811|NCT00444925|2407813|P3|COMPLETED|Single-blind Placebo Run-In Period||0
992812|NCT00444925|2407814|P2|COMPLETED|Single-blind Placebo Run-In Period||0
992813|NCT00444925|2407815|P1|COMPLETED|Single-blind Placebo Run-In Period|progressed to randomization in double-blind treatment period|1712
992814|NCT00444925|2407813|P3|STARTED|Single-blind Placebo Run-In Period||0
992815|NCT00444925|2407814|P2|STARTED|Single-blind Placebo Run-In Period||0
992816|NCT00444925|2407815|P1|STARTED|Single-blind Placebo Run-In Period||2446
992817|NCT00444951|2407880|P3|NOT COMPLETED|Overall Study||3
992818|NCT00444951|2407881|P2|NOT COMPLETED|Overall Study||6
992819|NCT00444951|2407882|P1|NOT COMPLETED|Overall Study||5
992820|NCT00444951|2407880|P3|COMPLETED|Overall Study||160
992821|NCT00444951|2407881|P2|COMPLETED|Overall Study||136
992822|NCT00444951|2407882|P1|COMPLETED|Overall Study||140
992823|NCT00444951|2407880|P3|STARTED|Overall Study||163
992824|NCT00444951|2407881|P2|STARTED|Overall Study||142
992825|NCT00444951|2407882|P1|STARTED|Overall Study||145
992835|NCT00445146|2407930|P1|NOT COMPLETED|Overall Study||119
992836|NCT00445146|2407930|P1|COMPLETED|Overall Study||73
992837|NCT00445146|2407930|P1|STARTED|Overall Study||192
992838|NCT00445211|2407951|P2|NOT COMPLETED|Overall Study||0
992839|NCT00445211|2407952|P1|NOT COMPLETED|Overall Study||0
992840|NCT00445211|2407951|P2|COMPLETED|Overall Study||23
992841|NCT00445211|2407952|P1|COMPLETED|Overall Study||23
992842|NCT00445211|2407951|P2|STARTED|Overall Study||23
992843|NCT00445211|2407952|P1|STARTED|Overall Study||23
992844|NCT00445224|2407968|P2|NOT COMPLETED|Combined Exercises||0
992845|NCT00445224|2407969|P1|NOT COMPLETED|Combined Exercises||0
992846|NCT00445224|2407968|P2|COMPLETED|Combined Exercises||13
992847|NCT00445224|2407969|P1|COMPLETED|Combined Exercises||13
992848|NCT00445224|2407968|P2|STARTED|Combined Exercises||13
992849|NCT00445224|2407969|P1|STARTED|Combined Exercises||13
992850|NCT00445224|2407968|P2|NOT COMPLETED|Specific Exercises||3
992851|NCT00445224|2407969|P1|NOT COMPLETED|Specific Exercises||4
992852|NCT00445224|2407968|P2|COMPLETED|Specific Exercises|No adverse event occurred|13
992853|NCT00445224|2407969|P1|COMPLETED|Specific Exercises|No adverse event occurred|13
992854|NCT00445224|2407968|P2|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|13
992855|NCT00445224|2407969|P1|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|14
992856|NCT00445224|2407968|P2|Baseline|Specific Exercises||16
992857|NCT00445224|2407969|P1|Baseline|Specific Exercises||17
992858|NCT00445224|2407968|P2|STARTED|Specific Exercises||16
992859|NCT00445224|2407969|P1|STARTED|Specific Exercises||17
992860|NCT00445263|2407981|P2|NOT COMPLETED|Overall Study||1
992861|NCT00445263|2407982|P1|NOT COMPLETED|Overall Study||0
992862|NCT00445263|2407981|P2|COMPLETED|Overall Study||86
992863|NCT00445263|2407982|P1|COMPLETED|Overall Study||83
992864|NCT00445263|2407981|P2|STARTED|Overall Study||87
992865|NCT00445263|2407982|P1|STARTED|Overall Study||83
992866|NCT00445302|2407992|P4|NOT COMPLETED|Overall Study||0
992867|NCT00445302|2407993|P3|NOT COMPLETED|Overall Study||0
992868|NCT00445302|2407994|P2|NOT COMPLETED|Overall Study||0
992869|NCT00445302|2407995|P1|NOT COMPLETED|Overall Study||0
992870|NCT00445302|2407992|P4|COMPLETED|Overall Study||6
992871|NCT00445302|2407993|P3|COMPLETED|Overall Study||6
992872|NCT00445302|2407994|P2|COMPLETED|Overall Study||5
992873|NCT00445302|2407995|P1|COMPLETED|Overall Study||6
992874|NCT00445302|2407992|P4|STARTED|Overall Study||6
992875|NCT00445302|2407993|P3|STARTED|Overall Study||6
992876|NCT00445302|2407994|P2|STARTED|Overall Study||5
992877|NCT00445302|2407995|P1|STARTED|Overall Study||6
992878|NCT00445315|2408026|P5|NOT COMPLETED|Overall Study||0
992879|NCT00445315|2408027|P4|NOT COMPLETED|Overall Study||0
992880|NCT00445315|2408028|P3|NOT COMPLETED|Overall Study||0
992881|NCT00445315|2408029|P2|NOT COMPLETED|Overall Study||0
992882|NCT00445315|2408030|P1|NOT COMPLETED|Overall Study||0
992883|NCT00445315|2408026|P5|COMPLETED|Overall Study||8
992884|NCT00445315|2408027|P4|COMPLETED|Overall Study||6
992885|NCT00445315|2408028|P3|COMPLETED|Overall Study||6
992886|NCT00445315|2408029|P2|COMPLETED|Overall Study||6
992887|NCT00445315|2408030|P1|COMPLETED|Overall Study||6
992888|NCT00445315|2408026|P5|STARTED|Overall Study||8
992889|NCT00445315|2408027|P4|STARTED|Overall Study||6
992890|NCT00445315|2408028|P3|STARTED|Overall Study||6
992891|NCT00445315|2408029|P2|STARTED|Overall Study||6
992892|NCT00445315|2408030|P1|STARTED|Overall Study||6
992893|NCT00445328|2408122|P2|NOT COMPLETED|Overall Study||6
992894|NCT00445328|2408123|P1|NOT COMPLETED|Overall Study||3
992895|NCT00445328|2408122|P2|COMPLETED|Overall Study||36
992896|NCT00445328|2408123|P1|COMPLETED|Overall Study||39
992897|NCT00445328|2408122|P2|Received Treatment|Overall Study||42
992898|NCT00445328|2408123|P1|Received Treatment|Overall Study|1 subject discontinued after enrollment but prior to study treatment.|41
992899|NCT00445328|2408122|P2|STARTED|Overall Study||42
992900|NCT00445328|2408123|P1|STARTED|Overall Study||42
992901|NCT00445341|2408141|P1|NOT COMPLETED|Overall Study||2
992902|NCT00445341|2408141|P1|COMPLETED|Overall Study||26
992903|NCT00445341|2408141|P1|STARTED|Overall Study||28
992904|NCT00445432|2408149|P4|NOT COMPLETED|148 Weeks of Adalimumab Treatment||44
992905|NCT00445432|2408150|P3|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
992906|NCT00445432|2408151|P2|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
992907|NCT00445432|2408152|P1|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
992908|NCT00445432|2408149|P4|COMPLETED|148 Weeks of Adalimumab Treatment||35
992909|NCT00445432|2408150|P3|COMPLETED|148 Weeks of Adalimumab Treatment||0
992910|NCT00445432|2408151|P2|COMPLETED|148 Weeks of Adalimumab Treatment||0
992911|NCT00445432|2408152|P1|COMPLETED|148 Weeks of Adalimumab Treatment||0
992912|NCT00445432|2408149|P4|STARTED|148 Weeks of Adalimumab Treatment|3 participants discontinued while receiving double-blind placebo and never received any adalimumab|79
992913|NCT00445432|2408150|P3|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
992914|NCT00445432|2408151|P2|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
992915|NCT00445432|2408152|P1|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
992916|NCT00445432|2408149|P4|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
992917|NCT00445432|2408150|P3|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||11
992918|NCT00445432|2408151|P2|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||23
992919|NCT00445432|2408152|P1|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||15
992920|NCT00445432|2408149|P4|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
992921|NCT00445432|2408150|P3|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||21
992922|NCT00445432|2408151|P2|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||2
992923|NCT00445432|2408152|P1|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||10
992924|NCT00445432|2408149|P4|STARTED|Through Week 52 of NCT00445432 (M06-837)|This treatment group is not applicable for this period.|0
992925|NCT00445432|2408150|P3|STARTED|Through Week 52 of NCT00445432 (M06-837)||32
992926|NCT00445432|2408151|P2|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
992927|NCT00445432|2408152|P1|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
992928|NCT00445484|2408187|P2|NOT COMPLETED|Overall Study||1
992929|NCT00445484|2408188|P1|NOT COMPLETED|Overall Study||4
992930|NCT00445484|2408187|P2|COMPLETED|Overall Study||10
992931|NCT00445484|2408188|P1|COMPLETED|Overall Study||7
992932|NCT00445484|2408187|P2|STARTED|Overall Study||11
992933|NCT00445484|2408188|P1|STARTED|Overall Study||11
992934|NCT00445549|2408200|P1|NOT COMPLETED|Overall Study||12
992935|NCT00445549|2408200|P1|COMPLETED|Overall Study||0
992936|NCT00445549|2408200|P1|STARTED|Overall Study||12
992937|NCT00445588|2408205|P1|NOT COMPLETED|Overall Study||0
992938|NCT00445588|2408205|P1|COMPLETED|Overall Study||56
992939|NCT00445588|2408205|P1|STARTED|Overall Study||56
992940|NCT00445679|2408214|P4|NOT COMPLETED|Overall Study||47
992941|NCT00445679|2408215|P3|NOT COMPLETED|Overall Study||66
992942|NCT00445679|2408216|P2|NOT COMPLETED|Overall Study||46
992943|NCT00445679|2408217|P1|NOT COMPLETED|Overall Study||48
992944|NCT00445679|2408214|P4|COMPLETED|Overall Study||149
992945|NCT00445679|2408215|P3|COMPLETED|Overall Study||139
992946|NCT00445679|2408216|P2|COMPLETED|Overall Study||157
992947|NCT00445679|2408217|P1|COMPLETED|Overall Study||155
992948|NCT00445679|2408214|P4|STARTED|Overall Study||196
992949|NCT00445679|2408215|P3|STARTED|Overall Study||205
992950|NCT00445679|2408216|P2|STARTED|Overall Study||203
992951|NCT00445679|2408217|P1|STARTED|Overall Study||203
992952|NCT00445705|2408255|P4|NOT COMPLETED|Overall Study||14
992953|NCT00445705|2408256|P3|NOT COMPLETED|Overall Study||11
992954|NCT00445705|2408257|P2|NOT COMPLETED|Overall Study||11
992955|NCT00445705|2408258|P1|NOT COMPLETED|Overall Study||9
992956|NCT00445705|2408255|P4|COMPLETED|Overall Study||39
992957|NCT00445705|2408256|P3|COMPLETED|Overall Study||41
992958|NCT00445705|2408257|P2|COMPLETED|Overall Study||42
992959|NCT00445705|2408258|P1|COMPLETED|Overall Study||44
992960|NCT00445705|2408255|P4|STARTED|Overall Study||53
992961|NCT00445705|2408256|P3|STARTED|Overall Study||52
992962|NCT00445705|2408257|P2|STARTED|Overall Study||53
992963|NCT00445705|2408258|P1|STARTED|Overall Study||53
992964|NCT00445770|2408283|P3|NOT COMPLETED|Overall Study||31
992965|NCT00445770|2408284|P2|NOT COMPLETED|Overall Study||35
992966|NCT00445770|2408285|P1|NOT COMPLETED|Overall Study||53
992967|NCT00445770|2408283|P3|COMPLETED|Overall Study||151
992968|NCT00445770|2408284|P2|COMPLETED|Overall Study||157
992969|NCT00445770|2408285|P1|COMPLETED|Overall Study||123
992970|NCT00445770|2408283|P3|STARTED|Overall Study||182
992971|NCT00445770|2408284|P2|STARTED|Overall Study||192
992972|NCT00445770|2408285|P1|STARTED|Overall Study||176
992973|NCT00445848|2408352|P1|NOT COMPLETED|Overall Study||85
992974|NCT00445848|2408352|P1|COMPLETED|Overall Study||0
992975|NCT00445848|2408352|P1|STARTED|Overall Study||85
992976|NCT00445939|2408362|P4|NOT COMPLETED|Period B - Week 4 - Week 8||1
992977|NCT00445939|2408363|P3|NOT COMPLETED|Period B - Week 4 - Week 8||0
992978|NCT00445939|2408364|P2|NOT COMPLETED|Period B - Week 4 - Week 8||0
992979|NCT00445939|2408365|P1|NOT COMPLETED|Period B - Week 4 - Week 8||2
992980|NCT00445939|2408362|P4|COMPLETED|Period B - Week 4 - Week 8||20
992981|NCT00445939|2408363|P3|COMPLETED|Period B - Week 4 - Week 8||0
992982|NCT00445939|2408364|P2|COMPLETED|Period B - Week 4 - Week 8||0
992983|NCT00445939|2408365|P1|COMPLETED|Period B - Week 4 - Week 8||14
992984|NCT00445939|2408362|P4|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 160/80 and 80/40 subjects allocated to 40/40 group.|21
992985|NCT00445939|2408363|P3|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous placebo subjects allocated to 160/80 mg group.|0
992986|NCT00445939|2408364|P2|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 80/40 mg subjects allocated to 40/40 mg group.|0
992987|NCT00445939|2408365|P1|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 16 placebo subjects allocated to 160/80 mg group.|16
992988|NCT00445939|2408362|P4|NOT COMPLETED|Period A - Week 0 - Week 4||0
992989|NCT00445939|2408363|P3|NOT COMPLETED|Period A - Week 0 - Week 4||0
992990|NCT00445939|2408364|P2|NOT COMPLETED|Period A - Week 0 - Week 4||2
992991|NCT00445939|2408365|P1|NOT COMPLETED|Period A - Week 0 - Week 4||1
992992|NCT00445939|2408362|P4|COMPLETED|Period A - Week 0 - Week 4||0
992993|NCT00445939|2408363|P3|COMPLETED|Period A - Week 0 - Week 4|7 rated as responders and 16 rated as non-responders in evaluation on Week 4.|23
992994|NCT00445939|2408364|P2|COMPLETED|Period A - Week 0 - Week 4|20 rated as responders and 12 rated as non-responders in evaluation on Week 4.|32
992995|NCT00445939|2408365|P1|COMPLETED|Period A - Week 0 - Week 4|23 rated as responders and 9 rated as non-responders in evaluation on Week 4.|32
992996|NCT00445939|2408362|P4|STARTED|Period A - Week 0 - Week 4||0
992997|NCT00445939|2408363|P3|STARTED|Period A - Week 0 - Week 4||23
992998|NCT00445939|2408364|P2|STARTED|Period A - Week 0 - Week 4||34
992999|NCT00445939|2408365|P1|STARTED|Period A - Week 0 - Week 4||33
993000|NCT00446030|2408390|P2|NOT COMPLETED|FOLLOW-UP (up to 2-years)||9
993001|NCT00446030|2408391|P1|NOT COMPLETED|FOLLOW-UP (up to 2-years)||30
993002|NCT00446030|2408390|P2|COMPLETED|FOLLOW-UP (up to 2-years)||25
993003|NCT00446030|2408391|P1|COMPLETED|FOLLOW-UP (up to 2-years)||63
993004|NCT00446030|2408390|P2|STARTED|FOLLOW-UP (up to 2-years)||34
993005|NCT00446030|2408391|P1|STARTED|FOLLOW-UP (up to 2-years)|All participants, including those who discontinued treatment, continued to the follow-up period.|93
993006|NCT00446030|2408390|P2|NOT COMPLETED|TREATMENT (up to 52 Weeks)||9
993007|NCT00446030|2408391|P1|NOT COMPLETED|TREATMENT (up to 52 Weeks)||44
993008|NCT00446030|2408390|P2|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|25
993009|NCT00446030|2408391|P1|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|49
993010|NCT00446030|2408390|P2|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||34
993011|NCT00446030|2408391|P1|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||92
993012|NCT00446030|2408390|P2|STARTED|TREATMENT (up to 52 Weeks)||34
993013|NCT00446030|2408391|P1|STARTED|TREATMENT (up to 52 Weeks)||93
993014|NCT00446095|2408404|P5|NOT COMPLETED|Phase I (28 Days)||3
993015|NCT00446095|2408405|P4|NOT COMPLETED|Phase I (28 Days)||1
993016|NCT00446095|2408406|P3|NOT COMPLETED|Phase I (28 Days)||0
993017|NCT00446095|2408407|P2|NOT COMPLETED|Phase I (28 Days)||0
993018|NCT00446095|2408408|P1|NOT COMPLETED|Phase I (28 Days)||0
993019|NCT00446095|2408404|P5|COMPLETED|Phase I (28 Days)||4
993020|NCT00446095|2408405|P4|COMPLETED|Phase I (28 Days)||5
993021|NCT00446095|2408406|P3|COMPLETED|Phase I (28 Days)||0
993022|NCT00446095|2408407|P2|COMPLETED|Phase I (28 Days)||0
993023|NCT00446095|2408408|P1|COMPLETED|Phase I (28 Days)||0
993024|NCT00446095|2408404|P5|STARTED|Phase I (28 Days)||7
993025|NCT00446095|2408405|P4|STARTED|Phase I (28 Days)||6
993026|NCT00446095|2408406|P3|STARTED|Phase I (28 Days)||0
993027|NCT00446095|2408407|P2|STARTED|Phase I (28 Days)||0
993028|NCT00446095|2408408|P1|STARTED|Phase I (28 Days)||0
993029|NCT00446095|2408404|P5|NOT COMPLETED|Phase II (8 Weeks)||0
993030|NCT00446095|2408405|P4|NOT COMPLETED|Phase II (8 Weeks)||0
993031|NCT00446095|2408406|P3|NOT COMPLETED|Phase II (8 Weeks)||3
993032|NCT00446095|2408407|P2|NOT COMPLETED|Phase II (8 Weeks)||3
993033|NCT00446095|2408408|P1|NOT COMPLETED|Phase II (8 Weeks)||12
993034|NCT00446095|2408404|P5|COMPLETED|Phase II (8 Weeks)||0
993035|NCT00446095|2408405|P4|COMPLETED|Phase II (8 Weeks)||0
993036|NCT00446095|2408406|P3|COMPLETED|Phase II (8 Weeks)||21
993037|NCT00446095|2408407|P2|COMPLETED|Phase II (8 Weeks)||18
993038|NCT00446095|2408408|P1|COMPLETED|Phase II (8 Weeks)||11
993039|NCT00446095|2408404|P5|STARTED|Phase II (8 Weeks)||0
993040|NCT00446095|2408405|P4|STARTED|Phase II (8 Weeks)||0
993041|NCT00446095|2408406|P3|STARTED|Phase II (8 Weeks)||24
993042|NCT00446095|2408407|P2|STARTED|Phase II (8 Weeks)||21
993043|NCT00446095|2408408|P1|STARTED|Phase II (8 Weeks)||23
993044|NCT00446134|2408433|P4|NOT COMPLETED|Overall Study||45
993045|NCT00446134|2408434|P3|NOT COMPLETED|Overall Study||43
993046|NCT00446134|2408435|P2|NOT COMPLETED|Overall Study||45
993047|NCT00446134|2408436|P1|NOT COMPLETED|Overall Study||34
993048|NCT00446134|2408433|P4|COMPLETED|Overall Study||25
993049|NCT00446134|2408434|P3|COMPLETED|Overall Study||26
993050|NCT00446134|2408435|P2|COMPLETED|Overall Study||25
993051|NCT00446134|2408436|P1|COMPLETED|Overall Study||35
993052|NCT00446134|2408433|P4|STARTED|Overall Study||70
993053|NCT00446134|2408434|P3|STARTED|Overall Study|Includes 1 patient who did not receive study drug and was not included in any other analysis|69
993054|NCT00446134|2408435|P2|STARTED|Overall Study||70
993055|NCT00446134|2408436|P1|STARTED|Overall Study|Includes 2 patients who did not receive study drug and was not included in any other analysis|69
993056|NCT00446147|2408460|P2|NOT COMPLETED|Overall Study||14
993057|NCT00446147|2408461|P1|NOT COMPLETED|Overall Study||15
993058|NCT00446147|2408460|P2|COMPLETED|Overall Study||180
993059|NCT00446147|2408461|P1|COMPLETED|Overall Study||180
993060|NCT00446147|2408460|P2|STARTED|Overall Study||194
993061|NCT00446147|2408461|P1|STARTED|Overall Study||195
993062|NCT00446199|2408473|P4|NOT COMPLETED|Overall Study||30
993063|NCT00446199|2408474|P3|NOT COMPLETED|Overall Study||27
993064|NCT00446199|2408475|P2|NOT COMPLETED|Overall Study||20
993065|NCT00446199|2408476|P1|NOT COMPLETED|Overall Study||23
993066|NCT00446199|2408473|P4|COMPLETED|Overall Study||153
993067|NCT00446199|2408474|P3|COMPLETED|Overall Study||158
993068|NCT00446199|2408475|P2|COMPLETED|Overall Study||164
993069|NCT00446199|2408476|P1|COMPLETED|Overall Study||160
993070|NCT00446199|2408473|P4|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|176
993071|NCT00446199|2408474|P3|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|179
993072|NCT00446199|2408475|P2|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|177
993156|NCT00455429|2408787|P2|NOT COMPLETED|Overall Study||5
993073|NCT00446199|2408476|P1|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|178
993074|NCT00446199|2408473|P4|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|180
993075|NCT00446199|2408474|P3|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|182
993076|NCT00446199|2408475|P2|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|183
993077|NCT00446199|2408476|P1|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|181
993078|NCT00446199|2408473|P4|STARTED|Overall Study||183
993079|NCT00446199|2408474|P3|STARTED|Overall Study||185
993080|NCT00446199|2408475|P2|STARTED|Overall Study||184
993081|NCT00446199|2408476|P1|STARTED|Overall Study||183
993082|NCT00446251|2408554|P1|NOT COMPLETED|Overall Study||5
993083|NCT00446251|2408554|P1|COMPLETED|Overall Study||9
993084|NCT00446251|2408554|P1|STARTED|Overall Study|14 subjects were enrolled in this Rituximab-mycophenolic mofetil group.|14
993085|NCT00446264|2408560|P1|NOT COMPLETED|Overall Study||0
993086|NCT00446264|2408560|P1|COMPLETED|Overall Study||14
993087|NCT00446264|2408560|P1|STARTED|Overall Study||14
993088|NCT00446290|2408569|P1|NOT COMPLETED|Overall Study||0
993089|NCT00446290|2408569|P1|COMPLETED|Overall Study||22
993090|NCT00446290|2408569|P1|STARTED|Overall Study||22
993091|NCT00446446|2408573|P1|NOT COMPLETED|Overall Study||24
993092|NCT00446446|2408573|P1|COMPLETED|Overall Study|Participants who completed the 60-day safety visit|28
993093|NCT00446446|2408573|P1|STARTED|Overall Study||52
993094|NCT00446459|2408584|P1|NOT COMPLETED|12 Months||18
993095|NCT00446459|2408584|P1|COMPLETED|12 Months|4 subjects remained at month 12|4
993096|NCT00446459|2408584|P1|STARTED|12 Months|22 subjects remained on-study at month 8|22
993097|NCT00446459|2408584|P1|NOT COMPLETED|8 Months||12
993098|NCT00446459|2408584|P1|COMPLETED|8 Months|22 subjects were on study at month 8.|22
993099|NCT00446459|2408584|P1|STARTED|8 Months|34 subjects received any amount of MMF.|34
993100|NCT00446511|2408596|P4|NOT COMPLETED|Overall Study||6
993101|NCT00446511|2408597|P3|NOT COMPLETED|Overall Study||7
993102|NCT00446511|2408598|P2|NOT COMPLETED|Overall Study||2
993103|NCT00446511|2408599|P1|NOT COMPLETED|Overall Study||10
993104|NCT00446511|2408596|P4|COMPLETED|Overall Study||103
993105|NCT00446511|2408597|P3|COMPLETED|Overall Study||96
993106|NCT00446511|2408598|P2|COMPLETED|Overall Study||15
993107|NCT00446511|2408599|P1|COMPLETED|Overall Study||11
993108|NCT00446511|2408596|P4|STARTED|Overall Study||109
993109|NCT00446511|2408597|P3|STARTED|Overall Study||103
993110|NCT00446511|2408598|P2|STARTED|Overall Study||17
993111|NCT00446511|2408599|P1|STARTED|Overall Study||21
993112|NCT00446563|2408625|P2|NOT COMPLETED|Overall Study||9
993113|NCT00446563|2408626|P1|NOT COMPLETED|Overall Study||7
993114|NCT00446563|2408625|P2|COMPLETED|Overall Study||38
993115|NCT00446563|2408626|P1|COMPLETED|Overall Study||36
993116|NCT00446563|2408625|P2|STARTED|Overall Study||47
993117|NCT00446563|2408626|P1|STARTED|Overall Study||43
993118|NCT00446641|2408662|P2|NOT COMPLETED|Overall Study||10
993119|NCT00446641|2408663|P1|NOT COMPLETED|Overall Study||17
993120|NCT00446641|2408662|P2|COMPLETED|Overall Study||109
993121|NCT00446641|2408663|P1|COMPLETED|Overall Study||108
993122|NCT00446641|2408662|P2|STARTED|Overall Study||119
993123|NCT00446641|2408663|P1|STARTED|Overall Study||125
993124|NCT00446654|2408683|P2|NOT COMPLETED|Overall Study||0
993125|NCT00446654|2408684|P1|NOT COMPLETED|Overall Study||2
993126|NCT00446654|2408683|P2|COMPLETED|Overall Study||22
993127|NCT00446654|2408684|P1|COMPLETED|Overall Study||19
993128|NCT00446654|2408683|P2|STARTED|Overall Study||22
993129|NCT00446654|2408684|P1|STARTED|Overall Study||21
993130|NCT00446797|2408692|P2|NOT COMPLETED|Overall Study||12
993131|NCT00446797|2408693|P1|NOT COMPLETED|Overall Study||8
993132|NCT00446797|2408692|P2|COMPLETED|Overall Study||125
993133|NCT00446797|2408693|P1|COMPLETED|Overall Study||133
993134|NCT00446797|2408692|P2|STARTED|Overall Study||137
993135|NCT00446797|2408693|P1|STARTED|Overall Study||141
993136|NCT00455195|2408739|P2|NOT COMPLETED|Extension Study AGLU03206||0
993137|NCT00455195|2408740|P1|NOT COMPLETED|Extension Study AGLU03206||0
993138|NCT00455195|2408739|P2|COMPLETED|Extension Study AGLU03206||26
993139|NCT00455195|2408740|P1|COMPLETED|Extension Study AGLU03206||55
993140|NCT00455195|2408739|P2|STARTED|Extension Study AGLU03206|These 26 participants completed placebo double-blind treatment in the AGLU02704 (NCT00158600) study.|26
993141|NCT00455195|2408740|P1|STARTED|Extension Study AGLU03206||55
993142|NCT00455195|2408739|P2|NOT COMPLETED|Double-blind Study AGLU02704||4
993143|NCT00455195|2408740|P1|NOT COMPLETED|Double-blind Study AGLU02704||5
993144|NCT00455195|2408739|P2|COMPLETED|Double-blind Study AGLU02704||26
993145|NCT00455195|2408740|P1|COMPLETED|Double-blind Study AGLU02704||55
993146|NCT00455195|2408739|P2|STARTED|Double-blind Study AGLU02704|See study AGLU02704 (NCT00158600) for results while on placebo.|30
993147|NCT00455195|2408740|P1|STARTED|Double-blind Study AGLU02704|Patients randomized to alglucosidase alfa treatment group in AGLU02704 (NCT00158600).|60
993148|NCT00455312|2408756|P2|NOT COMPLETED|Overall Study||1
993149|NCT00455312|2408757|P1|NOT COMPLETED|Overall Study||0
993150|NCT00455312|2408756|P2|COMPLETED|Overall Study||20
993151|NCT00455312|2408757|P1|COMPLETED|Overall Study||15
993152|NCT00455312|2408756|P2|STARTED|Overall Study||21
993153|NCT00455312|2408757|P1|STARTED|Overall Study||15
993154|NCT00455429|2408785|P4|NOT COMPLETED|Overall Study||14
993155|NCT00455429|2408786|P3|NOT COMPLETED|Overall Study||1
993157|NCT00455429|2408788|P1|NOT COMPLETED|Overall Study||2
993158|NCT00455429|2408785|P4|COMPLETED|Overall Study||20
993159|NCT00455429|2408786|P3|COMPLETED|Overall Study||16
993160|NCT00455429|2408787|P2|COMPLETED|Overall Study||10
993161|NCT00455429|2408788|P1|COMPLETED|Overall Study||16
993162|NCT00455429|2408785|P4|Treated|Overall Study||32
993163|NCT00455429|2408786|P3|Treated|Overall Study||17
993164|NCT00455429|2408787|P2|Treated|Overall Study||15
993165|NCT00455429|2408788|P1|Treated|Overall Study||18
993166|NCT00455429|2408785|P4|STARTED|Overall Study||34
993167|NCT00455429|2408786|P3|STARTED|Overall Study||17
993168|NCT00455429|2408787|P2|STARTED|Overall Study||15
993169|NCT00455429|2408788|P1|STARTED|Overall Study||18
993170|NCT00455455|2408845|P2|NOT COMPLETED|Second Intervention||0
993171|NCT00455455|2408846|P1|NOT COMPLETED|Second Intervention||0
993172|NCT00455455|2408845|P2|COMPLETED|Second Intervention||24
993173|NCT00455455|2408846|P1|COMPLETED|Second Intervention||24
993174|NCT00455455|2408845|P2|STARTED|Second Intervention||24
993175|NCT00455455|2408846|P1|STARTED|Second Intervention||24
993176|NCT00455455|2408845|P2|NOT COMPLETED|Washout||0
993177|NCT00455455|2408846|P1|NOT COMPLETED|Washout||1
993178|NCT00455455|2408845|P2|COMPLETED|Washout||24
993179|NCT00455455|2408846|P1|COMPLETED|Washout||24
993180|NCT00455455|2408845|P2|STARTED|Washout||24
993181|NCT00455455|2408846|P1|STARTED|Washout||25
993182|NCT00455455|2408845|P2|NOT COMPLETED|First Intervention||0
993183|NCT00455455|2408846|P1|NOT COMPLETED|First Intervention||0
993184|NCT00455455|2408845|P2|COMPLETED|First Intervention||24
993185|NCT00455455|2408846|P1|COMPLETED|First Intervention||25
993186|NCT00455455|2408845|P2|STARTED|First Intervention||24
993187|NCT00455455|2408846|P1|STARTED|First Intervention||25
993188|NCT00455455|2408845|P2|NOT COMPLETED|Washout||1
993189|NCT00455455|2408846|P1|NOT COMPLETED|Washout||0
993190|NCT00455455|2408845|P2|COMPLETED|Washout||24
993191|NCT00455455|2408846|P1|COMPLETED|Washout||25
993192|NCT00455455|2408845|P2|STARTED|Washout||25
993193|NCT00455455|2408846|P1|STARTED|Washout||25
993194|NCT00455650|2408864|P6|NOT COMPLETED|Week 3||0
993195|NCT00455650|2408865|P5|NOT COMPLETED|Week 3||0
993196|NCT00455650|2408866|P4|NOT COMPLETED|Week 3||0
993197|NCT00455650|2408867|P3|NOT COMPLETED|Week 3||0
993198|NCT00455650|2408868|P2|NOT COMPLETED|Week 3||0
993199|NCT00455650|2408869|P1|NOT COMPLETED|Week 3||0
993200|NCT00455650|2408864|P6|COMPLETED|Week 3||13
993201|NCT00455650|2408865|P5|COMPLETED|Week 3||14
993202|NCT00455650|2408866|P4|COMPLETED|Week 3||14
993203|NCT00455650|2408867|P3|COMPLETED|Week 3||10
993204|NCT00455650|2408868|P2|COMPLETED|Week 3||10
993205|NCT00455650|2408869|P1|COMPLETED|Week 3||10
993206|NCT00455650|2408864|P6|STARTED|Week 3||13
993207|NCT00455650|2408865|P5|STARTED|Week 3||14
993208|NCT00455650|2408866|P4|STARTED|Week 3||14
993209|NCT00455650|2408867|P3|STARTED|Week 3||10
993210|NCT00455650|2408868|P2|STARTED|Week 3||10
993211|NCT00455650|2408869|P1|STARTED|Week 3||10
993212|NCT00455650|2408864|P6|NOT COMPLETED|Week 2||0
993213|NCT00455650|2408865|P5|NOT COMPLETED|Week 2||0
993214|NCT00455650|2408866|P4|NOT COMPLETED|Week 2||0
993215|NCT00455650|2408867|P3|NOT COMPLETED|Week 2||0
993216|NCT00455650|2408868|P2|NOT COMPLETED|Week 2||0
993217|NCT00455650|2408869|P1|NOT COMPLETED|Week 2||0
993218|NCT00455650|2408864|P6|COMPLETED|Week 2||13
993219|NCT00455650|2408865|P5|COMPLETED|Week 2||14
993220|NCT00455650|2408866|P4|COMPLETED|Week 2||14
993221|NCT00455650|2408867|P3|COMPLETED|Week 2||10
993222|NCT00455650|2408868|P2|COMPLETED|Week 2||10
993223|NCT00455650|2408869|P1|COMPLETED|Week 2||10
993224|NCT00455650|2408864|P6|STARTED|Week 2||13
993225|NCT00455650|2408865|P5|STARTED|Week 2||14
993226|NCT00455650|2408866|P4|STARTED|Week 2||14
993227|NCT00455650|2408867|P3|STARTED|Week 2||10
993228|NCT00455650|2408868|P2|STARTED|Week 2||10
993229|NCT00455650|2408869|P1|STARTED|Week 2||10
993230|NCT00455650|2408864|P6|NOT COMPLETED|Week 1||0
993231|NCT00455650|2408865|P5|NOT COMPLETED|Week 1||0
993232|NCT00455650|2408866|P4|NOT COMPLETED|Week 1||0
993233|NCT00455650|2408867|P3|NOT COMPLETED|Week 1||0
993234|NCT00455650|2408868|P2|NOT COMPLETED|Week 1||0
993235|NCT00455650|2408869|P1|NOT COMPLETED|Week 1||0
993236|NCT00455650|2408864|P6|COMPLETED|Week 1||13
993237|NCT00455650|2408865|P5|COMPLETED|Week 1||14
993238|NCT00455650|2408866|P4|COMPLETED|Week 1||14
993239|NCT00455650|2408867|P3|COMPLETED|Week 1||10
993240|NCT00455650|2408868|P2|COMPLETED|Week 1||10
993241|NCT00455650|2408869|P1|COMPLETED|Week 1||10
993242|NCT00455650|2408864|P6|STARTED|Week 1||13
993243|NCT00455650|2408865|P5|STARTED|Week 1||14
993244|NCT00455650|2408866|P4|STARTED|Week 1||14
993245|NCT00455650|2408867|P3|STARTED|Week 1||10
993246|NCT00455650|2408868|P2|STARTED|Week 1||10
993247|NCT00455650|2408869|P1|STARTED|Week 1||10
993248|NCT00455663|2408900|P3|NOT COMPLETED|Overall Study||3
993249|NCT00455663|2408901|P2|NOT COMPLETED|Overall Study||4
993250|NCT00455663|2408902|P1|NOT COMPLETED|Overall Study||3
993251|NCT00455663|2408900|P3|COMPLETED|Overall Study||29
993252|NCT00455663|2408901|P2|COMPLETED|Overall Study||32
993253|NCT00455663|2408902|P1|COMPLETED|Overall Study||34
993254|NCT00455663|2408900|P3|STARTED|Overall Study||32
993255|NCT00455663|2408901|P2|STARTED|Overall Study||36
993256|NCT00455663|2408902|P1|STARTED|Overall Study||37
993257|NCT00455702|2408921|P2|NOT COMPLETED|Overall Study||3
993258|NCT00455702|2408922|P1|NOT COMPLETED|Overall Study||3
993259|NCT00455702|2408921|P2|COMPLETED|Overall Study||16
993260|NCT00455702|2408922|P1|COMPLETED|Overall Study||16
993261|NCT00455702|2408921|P2|STARTED|Overall Study||19
993262|NCT00455702|2408922|P1|STARTED|Overall Study||19
993263|NCT00455858|2408930|P1|NOT COMPLETED|Overall Study||6
993264|NCT00455858|2408930|P1|COMPLETED|Overall Study||81
993265|NCT00455858|2408930|P1|STARTED|Overall Study|Enrolled in study and exposed to study drug|87
993266|NCT00455962|2408940|P2|NOT COMPLETED|Overall Study||0
993267|NCT00455962|2408941|P1|NOT COMPLETED|Overall Study||0
993268|NCT00455962|2408940|P2|COMPLETED|Overall Study||13
993269|NCT00455962|2408941|P1|COMPLETED|Overall Study||10
993270|NCT00455962|2408940|P2|STARTED|Overall Study||13
993271|NCT00455962|2408941|P1|STARTED|Overall Study||10
993272|NCT00455975|2408949|P2|NOT COMPLETED|Overall Study||21
993273|NCT00455975|2408950|P1|NOT COMPLETED|Overall Study||18
993274|NCT00455975|2408949|P2|COMPLETED|Overall Study||40
993275|NCT00455975|2408950|P1|COMPLETED|Overall Study||40
993276|NCT00455975|2408949|P2|STARTED|Overall Study||61
993277|NCT00455975|2408950|P1|STARTED|Overall Study||58
993278|NCT00456014|2408962|P1|NOT COMPLETED|Tricyclic Phase||3
993279|NCT00456014|2408962|P1|COMPLETED|Tricyclic Phase||1
993280|NCT00456014|2408962|P1|STARTED|Tricyclic Phase|Only non-remitters from phase 1 were eligible for phase 2, and not all those eligible continued.|4
993281|NCT00456014|2408962|P1|NOT COMPLETED|SSRI Phase||9
993282|NCT00456014|2408962|P1|COMPLETED|SSRI Phase||28
993283|NCT00456014|2408962|P1|STARTED|SSRI Phase||37
993284|NCT00456261|2408970|P2|NOT COMPLETED|Maintenance Therapy||0
993285|NCT00456261|2408971|P1|NOT COMPLETED|Maintenance Therapy||0
993286|NCT00456261|2408970|P2|COMPLETED|Maintenance Therapy||29
993287|NCT00456261|2408971|P1|COMPLETED|Maintenance Therapy||3
993288|NCT00456261|2408970|P2|STARTED|Maintenance Therapy||29
993289|NCT00456261|2408971|P1|STARTED|Maintenance Therapy||3
993290|NCT00456261|2408970|P2|NOT COMPLETED|Combination Therapy||26
993291|NCT00456261|2408971|P1|NOT COMPLETED|Combination Therapy||52
993292|NCT00456261|2408970|P2|COMPLETED|Combination Therapy||29
993293|NCT00456261|2408971|P1|COMPLETED|Combination Therapy||3
993294|NCT00456261|2408970|P2|STARTED|Combination Therapy||55
993295|NCT00456261|2408971|P1|STARTED|Combination Therapy||55
993296|NCT00456495|2408981|P1|NOT COMPLETED|Overall Study||2
993297|NCT00456495|2408981|P1|COMPLETED|Overall Study||3
993298|NCT00456495|2408981|P1|STARTED|Overall Study||5
993299|NCT00456508|2408986|P1|NOT COMPLETED|Overall Study||0
993300|NCT00456508|2408986|P1|COMPLETED|Overall Study||147
993301|NCT00456508|2408986|P1|STARTED|Overall Study||147
993302|NCT00456521|2408994|P2|NOT COMPLETED|Overall Study||84
993303|NCT00456521|2408995|P1|NOT COMPLETED|Overall Study||249
993304|NCT00456521|2408994|P2|COMPLETED|Overall Study||118
993305|NCT00456521|2408995|P1|COMPLETED|Overall Study||342
993306|NCT00456521|2408994|P2|STARTED|Overall Study||202
993307|NCT00456521|2408995|P1|STARTED|Overall Study||591
993308|NCT00456547|2409037|P2|NOT COMPLETED|Overall Study||0
993309|NCT00456547|2409038|P1|NOT COMPLETED|Overall Study||0
993310|NCT00456547|2409037|P2|COMPLETED|Overall Study||12
993311|NCT00456547|2409038|P1|COMPLETED|Overall Study||12
993312|NCT00456547|2409037|P2|STARTED|Overall Study||12
993313|NCT00456547|2409038|P1|STARTED|Overall Study||12
993314|NCT00456599|2409050|P1|NOT COMPLETED|Overall Study||3
993315|NCT00456599|2409050|P1|COMPLETED|Overall Study||68
993316|NCT00456599|2409050|P1|Completed 4th Cycle of Chemotherapy|Overall Study|24 patients (63%) completed a fourth cycle of chemotherapy.|24
993317|NCT00456599|2409050|P1|Post-Surgery Adjuvent Therapy|Overall Study|After resection, 26 patients (68%) initiated adjuvant therapy.|26
993318|NCT00456599|2409050|P1|Completed Resection|Overall Study|43 patients underwent resection.|43
993319|NCT00456599|2409050|P1|Completed Protocol Surgery|Overall Study|Forty-eight patients (71%) underwent laparotomy according to the protocol.|48
993320|NCT00456599|2409050|P1|Initiated Cycle 2|Overall Study|5 patients were removed from study prior to initiation of a second cycle.|61
993321|NCT00456599|2409050|P1|Completed Cycle 1|Overall Study|Of the 71 patients, 1 was removed for noncompliance; 2 withdrew; 2 did not complete cycle 1.|66
993322|NCT00456599|2409050|P1|STARTED|Overall Study||71
993323|NCT00456612|2409056|P1|NOT COMPLETED|Overall Study||3
993324|NCT00456612|2409056|P1|COMPLETED|Overall Study||1
993325|NCT00456612|2409056|P1|STARTED|Overall Study||4
993326|NCT00456625|2409061|P1|NOT COMPLETED|Overall Study||0
993327|NCT00456625|2409061|P1|COMPLETED|Overall Study||76
993328|NCT00456625|2409061|P1|STARTED|Overall Study||76
993329|NCT00456755|2409069|P2|NOT COMPLETED|Overall Study||1
993330|NCT00456755|2409070|P1|NOT COMPLETED|Overall Study||2
993331|NCT00456755|2409069|P2|COMPLETED|Overall Study||62
993332|NCT00456755|2409070|P1|COMPLETED|Overall Study||61
993333|NCT00456755|2409069|P2|STARTED|Overall Study||63
993334|NCT00456755|2409070|P1|STARTED|Overall Study||63
993335|NCT00456807|2409080|P2|NOT COMPLETED|Overall Study||0
993336|NCT00456807|2409081|P1|NOT COMPLETED|Overall Study||1
993337|NCT00456807|2409080|P2|COMPLETED|Overall Study||47
993338|NCT00456807|2409081|P1|COMPLETED|Overall Study||52
993339|NCT00456807|2409080|P2|STARTED|Overall Study||47
993340|NCT00456807|2409081|P1|STARTED|Overall Study||53
993341|NCT00456846|2409099|P2|NOT COMPLETED|Overall Study||28
993342|NCT00456846|2409100|P1|NOT COMPLETED|Overall Study||16
993343|NCT00456846|2409099|P2|COMPLETED|Overall Study|Treatment considered completed upon disease progression|48
993521|NCT00457977|2409475|P1|STARTED|Overall Study||90
993344|NCT00456846|2409100|P1|COMPLETED|Overall Study|Treatment considered completed upon disease progression|31
993345|NCT00456846|2409099|P2|STARTED|Overall Study||76
993346|NCT00456846|2409100|P1|STARTED|Overall Study||47
993347|NCT00456885|2409120|P2|NOT COMPLETED|Second Treatment Period, 16 Weeks||0
993348|NCT00456885|2409121|P1|NOT COMPLETED|Second Treatment Period, 16 Weeks||1
993349|NCT00456885|2409120|P2|COMPLETED|Second Treatment Period, 16 Weeks||17
993350|NCT00456885|2409121|P1|COMPLETED|Second Treatment Period, 16 Weeks||23
993351|NCT00456885|2409120|P2|STARTED|Second Treatment Period, 16 Weeks||17
993352|NCT00456885|2409121|P1|STARTED|Second Treatment Period, 16 Weeks||24
993353|NCT00456885|2409120|P2|NOT COMPLETED|Washout, 3 Weeks||0
993354|NCT00456885|2409121|P1|NOT COMPLETED|Washout, 3 Weeks||0
993355|NCT00456885|2409120|P2|COMPLETED|Washout, 3 Weeks||17
993356|NCT00456885|2409121|P1|COMPLETED|Washout, 3 Weeks||24
993357|NCT00456885|2409120|P2|STARTED|Washout, 3 Weeks||17
993358|NCT00456885|2409121|P1|STARTED|Washout, 3 Weeks||24
993359|NCT00456885|2409120|P2|NOT COMPLETED|First Treatment Period, 16 Weeks||0
993360|NCT00456885|2409121|P1|NOT COMPLETED|First Treatment Period, 16 Weeks||0
993361|NCT00456885|2409120|P2|COMPLETED|First Treatment Period, 16 Weeks||17
993362|NCT00456885|2409121|P1|COMPLETED|First Treatment Period, 16 Weeks||24
993363|NCT00456885|2409120|P2|STARTED|First Treatment Period, 16 Weeks||17
993364|NCT00456885|2409121|P1|STARTED|First Treatment Period, 16 Weeks||24
993365|NCT00456989|2409150|P1|NOT COMPLETED|Overall Study||0
993366|NCT00456989|2409150|P1|COMPLETED|Overall Study||39
993367|NCT00456989|2409150|P1|STARTED|Overall Study||39
993368|NCT00457002|2409156|P2|NOT COMPLETED|Overall Study||757
993369|NCT00457002|2409157|P1|NOT COMPLETED|Overall Study||813
993370|NCT00457002|2409156|P2|COMPLETED|Overall Study||2516
993371|NCT00457002|2409157|P1|COMPLETED|Overall Study||2442
993372|NCT00457002|2409156|P2|STARTED|Overall Study||3273
993373|NCT00457002|2409157|P1|STARTED|Overall Study||3255
993374|NCT00457015|2409227|P2|NOT COMPLETED|Overall Study||1
993375|NCT00457015|2409228|P1|NOT COMPLETED|Overall Study||0
993376|NCT00457015|2409227|P2|COMPLETED|Overall Study||47
993377|NCT00457015|2409228|P1|COMPLETED|Overall Study||48
993378|NCT00457015|2409227|P2|STARTED|Overall Study||48
993379|NCT00457015|2409228|P1|STARTED|Overall Study||48
993386|NCT00457249|2409269|P2|NOT COMPLETED|Overall Study||2
993387|NCT00457249|2409270|P1|NOT COMPLETED|Overall Study||12
993388|NCT00457249|2409269|P2|COMPLETED|Overall Study||389
993389|NCT00457249|2409270|P1|COMPLETED|Overall Study||1158
993390|NCT00457249|2409269|P2|STARTED|Overall Study||391
993391|NCT00457249|2409270|P1|STARTED|Overall Study||1170
993392|NCT00457301|2409284|P2|NOT COMPLETED|Overall Study||24
993393|NCT00457301|2409285|P1|NOT COMPLETED|Overall Study||23
993394|NCT00457301|2409284|P2|COMPLETED|Overall Study||84
993395|NCT00457301|2409285|P1|COMPLETED|Overall Study||82
993396|NCT00457301|2409284|P2|STARTED|Overall Study||108
993397|NCT00457301|2409285|P1|STARTED|Overall Study||105
993398|NCT00457392|2409299|P2|NOT COMPLETED|Overall Study||480
993399|NCT00457392|2409300|P1|NOT COMPLETED|Overall Study||480
993400|NCT00457392|2409299|P2|COMPLETED|Overall Study||0
993401|NCT00457392|2409300|P1|COMPLETED|Overall Study||0
993402|NCT00457392|2409299|P2|Treated|Overall Study||477
993403|NCT00457392|2409300|P1|Treated|Overall Study||473
993404|NCT00457392|2409299|P2|STARTED|Overall Study||480
993405|NCT00457392|2409300|P1|STARTED|Overall Study||480
993406|NCT00457418|2409316|P1|NOT COMPLETED|Post PK Maintenance||28
993407|NCT00457418|2409316|P1|COMPLETED|Post PK Maintenance||3
993408|NCT00457418|2409316|P1|STARTED|Post PK Maintenance|4 participants didn't complete the PK sampling phase but continued to post PK maintenance treatment.|31
993409|NCT00457418|2409316|P1|NOT COMPLETED|Pharmacokinetic (PK) Sampling Phase||5
993410|NCT00457418|2409316|P1|COMPLETED|Pharmacokinetic (PK) Sampling Phase||27
993411|NCT00457418|2409316|P1|STARTED|Pharmacokinetic (PK) Sampling Phase||32
993412|NCT00457691|2409328|P2|NOT COMPLETED|Overall Study||382
993413|NCT00457691|2409329|P1|NOT COMPLETED|Overall Study||386
993414|NCT00457691|2409328|P2|COMPLETED|Overall Study||0
993415|NCT00457691|2409329|P1|COMPLETED|Overall Study||0
993416|NCT00457691|2409328|P2|STARTED|Overall Study||382
993417|NCT00457691|2409329|P1|STARTED|Overall Study||386
993418|NCT00457730|2409351|P2|NOT COMPLETED|Overall Study||1
993419|NCT00457730|2409352|P1|NOT COMPLETED|Overall Study||4
993420|NCT00457730|2409351|P2|COMPLETED|Overall Study||19
993421|NCT00457730|2409352|P1|COMPLETED|Overall Study||14
993422|NCT00457730|2409351|P2|STARTED|Overall Study||20
993423|NCT00457730|2409352|P1|STARTED|Overall Study||18
993424|NCT00457743|2409365|P3|NOT COMPLETED|Overall Study||3
993425|NCT00457743|2409366|P2|NOT COMPLETED|Overall Study||27
993426|NCT00457743|2409367|P1|NOT COMPLETED|Overall Study||3
993427|NCT00457743|2409365|P3|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis(Intent-to treat population).|0
993428|NCT00457743|2409366|P2|COMPLETED|Overall Study|However, all 30 subjects enrolled were included in analysis(Intent-to treat population).|3
993429|NCT00457743|2409367|P1|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis (Intent-to treat population).|0
993430|NCT00457743|2409365|P3|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
993431|NCT00457743|2409366|P2|Enrolled in Phase 2|Overall Study|Six subjects who completed Phase 1 entered Phase 2, and 24 subjects were newly enrolled.|30
993432|NCT00457743|2409367|P1|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
993433|NCT00457743|2409365|P3|Completed Phase 1|Overall Study||3
993434|NCT00457743|2409366|P2|Completed Phase 1|Overall Study||6
993435|NCT00457743|2409367|P1|Completed Phase 1|Overall Study||3
993436|NCT00457743|2409365|P3|Enrolled in Phase 1|Overall Study||3
993437|NCT00457743|2409366|P2|Enrolled in Phase 1|Overall Study||6
993438|NCT00457743|2409367|P1|Enrolled in Phase 1|Overall Study||3
993439|NCT00457743|2409365|P3|STARTED|Overall Study|Overall study|3
993440|NCT00457743|2409366|P2|STARTED|Overall Study|Overall study|30
993441|NCT00457743|2409367|P1|STARTED|Overall Study|Overall study|3
993442|NCT00457795|2409409|P1|NOT COMPLETED|Overall Study||0
993443|NCT00457795|2409409|P1|COMPLETED|Overall Study||15
993444|NCT00457795|2409409|P1|STARTED|Overall Study||15
993445|NCT00457821|2409424|P8|NOT COMPLETED|Part 2||1
993446|NCT00457821|2409425|P7|NOT COMPLETED|Part 2||0
993447|NCT00457821|2409426|P6|NOT COMPLETED|Part 2||0
993448|NCT00457821|2409427|P5|NOT COMPLETED|Part 2||0
993449|NCT00457821|2409428|P4|NOT COMPLETED|Part 2||0
993450|NCT00457821|2409429|P3|NOT COMPLETED|Part 2||0
993451|NCT00457821|2409430|P2|NOT COMPLETED|Part 2||0
993452|NCT00457821|2409431|P1|NOT COMPLETED|Part 2||0
993453|NCT00457821|2409424|P8|COMPLETED|Part 2||4
993454|NCT00457821|2409425|P7|COMPLETED|Part 2||7
993455|NCT00457821|2409426|P6|COMPLETED|Part 2||8
993456|NCT00457821|2409427|P5|COMPLETED|Part 2||0
993457|NCT00457821|2409428|P4|COMPLETED|Part 2||0
993458|NCT00457821|2409429|P3|COMPLETED|Part 2||0
993459|NCT00457821|2409430|P2|COMPLETED|Part 2||0
993460|NCT00457821|2409431|P1|COMPLETED|Part 2||0
993461|NCT00457821|2409424|P8|Completed Study Drug Treatment|Part 2||4
993462|NCT00457821|2409425|P7|Completed Study Drug Treatment|Part 2|1 subject missed a 250-mg dose of ivacaftor on Day 28 of Part 2.|7
993463|NCT00457821|2409426|P6|Completed Study Drug Treatment|Part 2||8
993464|NCT00457821|2409427|P5|Completed Study Drug Treatment|Part 2||0
993465|NCT00457821|2409428|P4|Completed Study Drug Treatment|Part 2||0
993466|NCT00457821|2409429|P3|Completed Study Drug Treatment|Part 2||0
993467|NCT00457821|2409430|P2|Completed Study Drug Treatment|Part 2||0
993468|NCT00457821|2409431|P1|Completed Study Drug Treatment|Part 2||0
993469|NCT00457821|2409424|P8|STARTED|Part 2|All subjects who received at least 1 dose of study drug (placebo).|5
993470|NCT00457821|2409425|P7|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|7
993471|NCT00457821|2409426|P6|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|8
993472|NCT00457821|2409427|P5|STARTED|Part 2|Arm in Part 1 only|0
993473|NCT00457821|2409428|P4|STARTED|Part 2|Arm in Part 1 only|0
993474|NCT00457821|2409429|P3|STARTED|Part 2|Arm in Part 1 only|0
993475|NCT00457821|2409430|P2|STARTED|Part 2|Arm in Part 1 only|0
993476|NCT00457821|2409431|P1|STARTED|Part 2|Arm in Part 1 only|0
993477|NCT00457821|2409424|P8|NOT COMPLETED|Part 1||0
993478|NCT00457821|2409425|P7|NOT COMPLETED|Part 1||0
993479|NCT00457821|2409426|P6|NOT COMPLETED|Part 1||0
993480|NCT00457821|2409427|P5|NOT COMPLETED|Part 1||0
993481|NCT00457821|2409428|P4|NOT COMPLETED|Part 1||0
993482|NCT00457821|2409429|P3|NOT COMPLETED|Part 1||1
993483|NCT00457821|2409430|P2|NOT COMPLETED|Part 1||0
993484|NCT00457821|2409431|P1|NOT COMPLETED|Part 1||0
993485|NCT00457821|2409424|P8|COMPLETED|Part 1||0
993486|NCT00457821|2409425|P7|COMPLETED|Part 1||0
993487|NCT00457821|2409426|P6|COMPLETED|Part 1||0
993488|NCT00457821|2409427|P5|COMPLETED|Part 1||4
993489|NCT00457821|2409428|P4|COMPLETED|Part 1||4
993490|NCT00457821|2409429|P3|COMPLETED|Part 1||4
993491|NCT00457821|2409430|P2|COMPLETED|Part 1||4
993492|NCT00457821|2409431|P1|COMPLETED|Part 1||4
993493|NCT00457821|2409424|P8|STARTED|Part 1|Arm in Part 2 only|0
993494|NCT00457821|2409425|P7|STARTED|Part 1|Arm in Part 2 only|0
993495|NCT00457821|2409426|P6|STARTED|Part 1|Arm in Part 2 only|0
993496|NCT00457821|2409427|P5|STARTED|Part 1|Number of subjects randomized|4
993497|NCT00457821|2409428|P4|STARTED|Part 1|Number of subjects randomized|4
993498|NCT00457821|2409429|P3|STARTED|Part 1|Number of subjects randomized|5
993499|NCT00457821|2409430|P2|STARTED|Part 1|Number of subjects randomized|4
993500|NCT00457821|2409431|P1|STARTED|Part 1|Number of subjects randomized|4
993501|NCT00457951|2409463|P3|NOT COMPLETED|Overall Study||12
993502|NCT00457951|2409464|P2|NOT COMPLETED|Overall Study||16
993503|NCT00457951|2409465|P1|NOT COMPLETED|Overall Study||0
993504|NCT00457951|2409463|P3|COMPLETED|Overall Study||60
993505|NCT00457951|2409464|P2|COMPLETED|Overall Study||50
993506|NCT00457951|2409465|P1|COMPLETED|Overall Study||13
993507|NCT00457951|2409463|P3|STARTED|Overall Study||72
993508|NCT00457951|2409464|P2|STARTED|Overall Study||66
993509|NCT00457951|2409465|P1|STARTED|Overall Study||13
993510|NCT00457977|2409474|P2|NOT COMPLETED|Overall Study||25
993511|NCT00457977|2409475|P1|NOT COMPLETED|Overall Study||28
993512|NCT00457977|2409474|P2|COMPLETED|Overall Study||66
993513|NCT00457977|2409475|P1|COMPLETED|Overall Study||62
993514|NCT00457977|2409474|P2|2-Year|Overall Study||66
993515|NCT00457977|2409475|P1|2-Year|Overall Study||62
993516|NCT00457977|2409474|P2|1-Year|Overall Study||76
993517|NCT00457977|2409475|P1|1-Year|Overall Study||69
993518|NCT00457977|2409474|P2|1-Month|Overall Study||87
993519|NCT00457977|2409475|P1|1-Month|Overall Study||88
993520|NCT00457977|2409474|P2|STARTED|Overall Study||91
993522|NCT00444275|2409486|P5|NOT COMPLETED|Maintenance Treatment Phase||179
993523|NCT00444275|2409487|P4|NOT COMPLETED|Maintenance Treatment Phase||133
993524|NCT00444275|2409488|P3|NOT COMPLETED|Maintenance Treatment Phase||161
993525|NCT00444275|2409489|P2|NOT COMPLETED|Maintenance Treatment Phase||0
993526|NCT00444275|2409490|P1|NOT COMPLETED|Maintenance Treatment Phase||0
993527|NCT00444275|2409486|P5|COMPLETED|Maintenance Treatment Phase||701
993528|NCT00444275|2409487|P4|COMPLETED|Maintenance Treatment Phase||764
993529|NCT00444275|2409488|P3|COMPLETED|Maintenance Treatment Phase||747
993530|NCT00444275|2409489|P2|COMPLETED|Maintenance Treatment Phase||0
993531|NCT00444275|2409490|P1|COMPLETED|Maintenance Treatment Phase||0
993532|NCT00444275|2409486|P5|STARTED|Maintenance Treatment Phase||880
993533|NCT00444275|2409487|P4|STARTED|Maintenance Treatment Phase||897
993534|NCT00444275|2409488|P3|STARTED|Maintenance Treatment Phase||908
993535|NCT00444275|2409489|P2|STARTED|Maintenance Treatment Phase||0
993536|NCT00444275|2409490|P1|STARTED|Maintenance Treatment Phase||0
993537|NCT00444275|2409486|P5|NOT COMPLETED|Initial Treatment Phase||0
993538|NCT00444275|2409487|P4|NOT COMPLETED|Initial Treatment Phase||0
993539|NCT00444275|2409488|P3|NOT COMPLETED|Initial Treatment Phase||0
993540|NCT00444275|2409489|P2|NOT COMPLETED|Initial Treatment Phase||96
993541|NCT00444275|2409490|P1|NOT COMPLETED|Initial Treatment Phase||248
993542|NCT00444275|2409486|P5|COMPLETED|Initial Treatment Phase||0
993543|NCT00444275|2409487|P4|COMPLETED|Initial Treatment Phase||0
993544|NCT00444275|2409488|P3|COMPLETED|Initial Treatment Phase||0
993545|NCT00444275|2409489|P2|COMPLETED|Initial Treatment Phase||777
993546|NCT00444275|2409490|P1|COMPLETED|Initial Treatment Phase||1908
993547|NCT00444275|2409486|P5|STARTED|Initial Treatment Phase||0
993548|NCT00444275|2409487|P4|STARTED|Initial Treatment Phase||0
993549|NCT00444275|2409488|P3|STARTED|Initial Treatment Phase||0
993550|NCT00444275|2409489|P2|STARTED|Initial Treatment Phase||873
993551|NCT00444275|2409490|P1|STARTED|Initial Treatment Phase||2156
993552|NCT00449748|2409540|P1|NOT COMPLETED|Overall Study||0
993553|NCT00449748|2409540|P1|COMPLETED|Overall Study||10
993554|NCT00449748|2409540|P1|STARTED|Overall Study||10
993555|NCT00449787|2409546|P2|NOT COMPLETED|Overall Study||100
993556|NCT00449787|2409547|P1|NOT COMPLETED|Overall Study||105
993557|NCT00449787|2409546|P2|COMPLETED|Overall Study||98
993558|NCT00449787|2409547|P1|COMPLETED|Overall Study||98
993559|NCT00449787|2409546|P2|STARTED|Overall Study||198
993560|NCT00449787|2409547|P1|STARTED|Overall Study||203
993561|NCT00449865|2409559|P2|NOT COMPLETED|Overall Study||534
993562|NCT00449865|2409560|P1|NOT COMPLETED|Overall Study||522
993563|NCT00449865|2409559|P2|COMPLETED|Overall Study|477 Expected at Year 5|340
993564|NCT00449865|2409560|P1|COMPLETED|Overall Study|478 Expected at Year 5|345
993565|NCT00449865|2409559|P2|Completed Year 4|Overall Study|686 Expected at Year 4|523
993566|NCT00449865|2409560|P1|Completed Year 4|Overall Study|679 Expected at Year 4|521
993567|NCT00449865|2409559|P2|Completed Year 3|Overall Study|874 Expected at Year 3|715
993568|NCT00449865|2409560|P1|Completed Year 3|Overall Study|867 Expected at Year 3|719
993569|NCT00449865|2409559|P2|Completed Year 2|Overall Study|874 Expected at Year 2|766
993570|NCT00449865|2409560|P1|Completed Year 2|Overall Study|867 Expected at Year 2|768
993571|NCT00449865|2409559|P2|Completed Year 1|Overall Study|874 Expected at Year 1|822
993572|NCT00449865|2409560|P1|Completed Year 1|Overall Study|867 Expected at Year 1|802
993573|NCT00449865|2409559|P2|STARTED|Overall Study||874
993574|NCT00449865|2409560|P1|STARTED|Overall Study||867
993575|NCT00449930|2409568|P2|NOT COMPLETED|Overall Study||75
993576|NCT00449930|2409569|P1|NOT COMPLETED|Overall Study||61
993577|NCT00449930|2409568|P2|COMPLETED|Overall Study||447
993578|NCT00449930|2409569|P1|COMPLETED|Overall Study||467
993579|NCT00449930|2409568|P2|STARTED|Overall Study||522
993580|NCT00449930|2409569|P1|STARTED|Overall Study||528
993581|NCT00449956|2409586|P3|NOT COMPLETED|Overall Study||9
993582|NCT00449956|2409587|P2|NOT COMPLETED|Overall Study||4
993583|NCT00449956|2409588|P1|NOT COMPLETED|Overall Study||10
993584|NCT00449956|2409586|P3|COMPLETED|Overall Study||184
993585|NCT00449956|2409587|P2|COMPLETED|Overall Study||88
993586|NCT00449956|2409588|P1|COMPLETED|Overall Study||179
993587|NCT00449956|2409586|P3|STARTED|Overall Study||193
993588|NCT00449956|2409587|P2|STARTED|Overall Study||92
993589|NCT00449956|2409588|P1|STARTED|Overall Study||189
993590|NCT00450112|2409604|P2|NOT COMPLETED|Overall Study||6
993591|NCT00450112|2409605|P1|NOT COMPLETED|Overall Study||13
993592|NCT00450112|2409604|P2|COMPLETED|Overall Study||71
993593|NCT00450112|2409605|P1|COMPLETED|Overall Study||112
993594|NCT00450112|2409604|P2|Analyzed Participants|Overall Study||74
993595|NCT00450112|2409605|P1|Analyzed Participants|Overall Study|3 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|122
993596|NCT00450112|2409604|P2|Received Injection|Overall Study||74
993597|NCT00450112|2409605|P1|Received Injection|Overall Study||125
993598|NCT00450112|2409604|P2|STARTED|Overall Study||77
993599|NCT00450112|2409605|P1|STARTED|Overall Study||125
993600|NCT00450216|2409629|P2|NOT COMPLETED|Overall Study||129
993601|NCT00450216|2409630|P1|NOT COMPLETED|Overall Study||174
993602|NCT00450216|2409629|P2|COMPLETED|Overall Study||170
993603|NCT00450216|2409630|P1|COMPLETED|Overall Study||433
993604|NCT00450216|2409629|P2|STARTED|Overall Study||299
993605|NCT00450216|2409630|P1|STARTED|Overall Study||607
993606|NCT00450242|2409644|P2|NOT COMPLETED|Overall Study||1
993607|NCT00450242|2409645|P1|NOT COMPLETED|Overall Study||3
993608|NCT00450242|2409644|P2|COMPLETED|Overall Study||6
993609|NCT00450242|2409645|P1|COMPLETED|Overall Study||4
993610|NCT00450242|2409644|P2|STARTED|Overall Study||7
993611|NCT00450242|2409645|P1|STARTED|Overall Study||7
993612|NCT00450255|2409657|P1|NOT COMPLETED|Overall Study||1
993613|NCT00450255|2409657|P1|COMPLETED|Overall Study||40
993614|NCT00450255|2409657|P1|STARTED|Overall Study||41
993615|NCT00450294|2409663|P1|NOT COMPLETED|Overall Study||0
993616|NCT00450294|2409663|P1|COMPLETED|Overall Study||10
993617|NCT00450294|2409663|P1|STARTED|Overall Study||10
993618|NCT00450333|2409672|P4|NOT COMPLETED|Overall Study||28
993619|NCT00450333|2409673|P3|NOT COMPLETED|Overall Study||25
993620|NCT00450333|2409674|P2|NOT COMPLETED|Overall Study||63
993621|NCT00450333|2409675|P1|NOT COMPLETED|Overall Study||54
993622|NCT00450333|2409672|P4|COMPLETED|Overall Study||74
993623|NCT00450333|2409673|P3|COMPLETED|Overall Study||75
993624|NCT00450333|2409674|P2|COMPLETED|Overall Study||44
993625|NCT00450333|2409675|P1|COMPLETED|Overall Study||44
993626|NCT00450333|2409672|P4|STARTED|Overall Study||102
993627|NCT00450333|2409673|P3|STARTED|Overall Study||100
993628|NCT00450333|2409674|P2|STARTED|Overall Study||107
993629|NCT00450333|2409675|P1|STARTED|Overall Study||98
993630|NCT00450372|2409693|P1|NOT COMPLETED|Overall Study||1
993631|NCT00450372|2409693|P1|COMPLETED|Overall Study||37
993632|NCT00450372|2409693|P1|STARTED|Overall Study||38
993633|NCT00450385|2409702|P1|NOT COMPLETED|Overall Study||13
993634|NCT00450385|2409702|P1|COMPLETED|Overall Study||44
993635|NCT00450385|2409702|P1|STARTED|Overall Study||57
993636|NCT00450424|2409713|P2|NOT COMPLETED|Overall Study||11
993637|NCT00450424|2409714|P1|NOT COMPLETED|Overall Study||20
993638|NCT00450424|2409713|P2|COMPLETED|Overall Study||106
993639|NCT00450424|2409714|P1|COMPLETED|Overall Study||102
993640|NCT00450424|2409713|P2|STARTED|Overall Study||117
993641|NCT00450424|2409714|P1|STARTED|Overall Study||122
993642|NCT00450437|2409722|P4|NOT COMPLETED|Overall Study||11
993643|NCT00450437|2409723|P3|NOT COMPLETED|Overall Study||24
993644|NCT00450437|2409724|P2|NOT COMPLETED|Overall Study||16
993645|NCT00450437|2409725|P1|NOT COMPLETED|Overall Study||46
993646|NCT00450437|2409722|P4|COMPLETED|Overall Study||325
993647|NCT00450437|2409723|P3|COMPLETED|Overall Study||999
993648|NCT00450437|2409724|P2|COMPLETED|Overall Study||524
993649|NCT00450437|2409725|P1|COMPLETED|Overall Study||1594
993650|NCT00450437|2409722|P4|STARTED|Overall Study||336
993651|NCT00450437|2409723|P3|STARTED|Overall Study||1023
993652|NCT00450437|2409724|P2|STARTED|Overall Study||540
993653|NCT00450437|2409725|P1|STARTED|Overall Study||1640
993654|NCT00450450|2409749|P2|NOT COMPLETED|Overall Study||3
993655|NCT00450450|2409750|P1|NOT COMPLETED|Overall Study||5
993656|NCT00450450|2409749|P2|COMPLETED|Overall Study||11
993657|NCT00450450|2409750|P1|COMPLETED|Overall Study||8
993658|NCT00450450|2409749|P2|STARTED|Overall Study||14
993659|NCT00450450|2409750|P1|STARTED|Overall Study||13
993660|NCT00450580|2409774|P2|NOT COMPLETED|Overall Study||16
993661|NCT00450580|2409775|P1|NOT COMPLETED|Overall Study||16
993662|NCT00450580|2409774|P2|COMPLETED|Overall Study||90
993663|NCT00450580|2409775|P1|COMPLETED|Overall Study||90
993664|NCT00450580|2409774|P2|STARTED|Overall Study||106
993665|NCT00450580|2409775|P1|STARTED|Overall Study||106
993666|NCT00450619|2409795|P2|NOT COMPLETED|Overall Study||1
993667|NCT00450619|2409796|P1|NOT COMPLETED|Overall Study||4
993668|NCT00450619|2409795|P2|COMPLETED|Overall Study||21
993669|NCT00450619|2409796|P1|COMPLETED|Overall Study||18
993670|NCT00450619|2409795|P2|STARTED|Overall Study||22
993671|NCT00450619|2409796|P1|STARTED|Overall Study||22
993672|NCT00450658|2409822|P2|NOT COMPLETED|Overall Study||90
993673|NCT00450658|2409823|P1|NOT COMPLETED|Overall Study||143
993674|NCT00450658|2409822|P2|COMPLETED|Overall Study||122
993675|NCT00450658|2409823|P1|COMPLETED|Overall Study||272
993676|NCT00450658|2409822|P2|STARTED|Overall Study||212
993677|NCT00450658|2409823|P1|STARTED|Overall Study||415
993678|NCT00450723|2409835|P1|NOT COMPLETED|Overall Study||5
993679|NCT00450723|2409835|P1|COMPLETED|Overall Study||34
993680|NCT00450723|2409835|P1|STARTED|Overall Study||39
993681|NCT00450749|2409844|P3|NOT COMPLETED|Overall Study||2
993682|NCT00450749|2409845|P2|NOT COMPLETED|Overall Study||1
993683|NCT00450749|2409846|P1|NOT COMPLETED|Overall Study||0
993684|NCT00450749|2409844|P3|COMPLETED|Overall Study||2
993685|NCT00450749|2409845|P2|COMPLETED|Overall Study||2
993686|NCT00450749|2409846|P1|COMPLETED|Overall Study||3
993687|NCT00450749|2409844|P3|STARTED|Overall Study||4
993688|NCT00450749|2409845|P2|STARTED|Overall Study||3
993689|NCT00450749|2409846|P1|STARTED|Overall Study||3
993690|NCT00450801|2409854|P1|NOT COMPLETED|Overall Study||1
993691|NCT00450801|2409854|P1|COMPLETED|Overall Study||21
993692|NCT00450801|2409854|P1|STARTED|Overall Study||22
993693|NCT00450866|2409865|P2|NOT COMPLETED|Overall Study||3
993694|NCT00450866|2409866|P1|NOT COMPLETED|Overall Study||7
993695|NCT00450866|2409865|P2|COMPLETED|Overall Study||7
993696|NCT00450866|2409866|P1|COMPLETED|Overall Study||38
993697|NCT00450866|2409865|P2|STARTED|Overall Study||10
993698|NCT00450866|2409866|P1|STARTED|Overall Study||45
993699|NCT00450983|2409876|P1|NOT COMPLETED|Overall Study||0
993700|NCT00450983|2409876|P1|COMPLETED|Overall Study||1
993701|NCT00450983|2409876|P1|STARTED|Overall Study||1
993702|NCT00451048|2409888|P1|NOT COMPLETED|Overall Study||0
993703|NCT00451048|2409888|P1|COMPLETED|Overall Study||10
993704|NCT00451048|2409888|P1|STARTED|Overall Study||10
993705|NCT00451191|2409894|P2|NOT COMPLETED|Overall Study||11
993706|NCT00451191|2409895|P1|NOT COMPLETED|Overall Study||15
993707|NCT00451191|2409894|P2|COMPLETED|Overall Study||55
993708|NCT00451191|2409895|P1|COMPLETED|Overall Study||53
993709|NCT00451191|2409894|P2|STARTED|Overall Study||66
993710|NCT00451191|2409895|P1|STARTED|Overall Study||68
993711|NCT00451204|2409903|P2|NOT COMPLETED|Overall Study||20
993712|NCT00451204|2409904|P1|NOT COMPLETED|Overall Study||22
993713|NCT00451204|2409903|P2|COMPLETED|Overall Study||56
993714|NCT00451204|2409904|P1|COMPLETED|Overall Study|60 completed the study but 3 stopped study drug(s) early|60
993715|NCT00451204|2409903|P2|STARTED|Overall Study||76
993716|NCT00451204|2409904|P1|STARTED|Overall Study||82
993717|NCT00451282|2409922|P2|NOT COMPLETED|Overall Study||5
993718|NCT00451282|2409923|P1|NOT COMPLETED|Overall Study||6
993719|NCT00451282|2409922|P2|COMPLETED|Overall Study||34
993720|NCT00451282|2409923|P1|COMPLETED|Overall Study||40
993721|NCT00451282|2409922|P2|STARTED|Overall Study||39
993722|NCT00451282|2409923|P1|STARTED|Overall Study||46
993723|NCT00451451|2409939|P4|NOT COMPLETED|Overall Study||58
993724|NCT00451451|2409940|P3|NOT COMPLETED|Overall Study||72
993725|NCT00451451|2409941|P2|NOT COMPLETED|Overall Study||75
993726|NCT00451451|2409942|P1|NOT COMPLETED|Overall Study||85
993727|NCT00451451|2409939|P4|COMPLETED|Overall Study||292
993728|NCT00451451|2409940|P3|COMPLETED|Overall Study||273
993729|NCT00451451|2409941|P2|COMPLETED|Overall Study||284
993730|NCT00451451|2409942|P1|COMPLETED|Overall Study||278
993731|NCT00451451|2409939|P4|STARTED|Overall Study|350 participants were dosed; 360 participants were randomized|350
993732|NCT00451451|2409940|P3|STARTED|Overall Study|345 participants were dosed; 345 participants were randomized|345
993733|NCT00451451|2409941|P2|STARTED|Overall Study|359 participants were dosed; 362 participants were randomized|359
993734|NCT00451451|2409942|P1|STARTED|Overall Study|363 participants were dosed; 363 participants were randomized|363
993735|NCT00451698|2409971|P2|NOT COMPLETED|Overall Study||0
993736|NCT00451698|2409972|P1|NOT COMPLETED|Overall Study||0
993737|NCT00451698|2409971|P2|COMPLETED|Overall Study||6
993738|NCT00451698|2409972|P1|COMPLETED|Overall Study||3
993739|NCT00451698|2409971|P2|STARTED|Overall Study||6
993740|NCT00451698|2409972|P1|STARTED|Overall Study||3
993741|NCT00451906|2409980|P1|NOT COMPLETED|Overall Study||2239
993742|NCT00451906|2409980|P1|COMPLETED|Overall Study||13
993743|NCT00451906|2409980|P1|STARTED|Overall Study||2252
993744|NCT00451958|2409992|P5|NOT COMPLETED|CS21A (NCT00451958)||0
993745|NCT00451958|2409993|P4|NOT COMPLETED|CS21A (NCT00451958)||39
993746|NCT00451958|2409994|P3|NOT COMPLETED|CS21A (NCT00451958)||42
993747|NCT00451958|2409995|P2|NOT COMPLETED|CS21A (NCT00451958)||77
993748|NCT00451958|2409996|P1|NOT COMPLETED|CS21A (NCT00451958)||65
993749|NCT00451958|2409992|P5|COMPLETED|CS21A (NCT00451958)||0
993750|NCT00451958|2409993|P4|COMPLETED|CS21A (NCT00451958)||27
993751|NCT00451958|2409994|P3|COMPLETED|CS21A (NCT00451958)||27
993752|NCT00451958|2409995|P2|COMPLETED|CS21A (NCT00451958)||49
993753|NCT00451958|2409996|P1|COMPLETED|CS21A (NCT00451958)||60
993754|NCT00451958|2409992|P5|STARTED|CS21A (NCT00451958)|Participants were switched to the degarelix groups when CS21 was completed.|0
993755|NCT00451958|2409993|P4|STARTED|CS21A (NCT00451958)|One of the enrolled participants never received any treatment, i.e. the CS21A ITT population=65.|66
993756|NCT00451958|2409994|P3|STARTED|CS21A (NCT00451958)|CS21A ITT population.|69
993757|NCT00451958|2409995|P2|STARTED|CS21A (NCT00451958)|CS21A ITT population.|126
993758|NCT00451958|2409996|P1|STARTED|CS21A (NCT00451958)|CS21A intention-to-treat (ITT) population.|125
993759|NCT00451958|2409992|P5|NOT COMPLETED|CS21 (NCT00295750)||32
993760|NCT00451958|2409993|P4|NOT COMPLETED|CS21 (NCT00295750)||0
993761|NCT00451958|2409994|P3|NOT COMPLETED|CS21 (NCT00295750)||0
993762|NCT00451958|2409995|P2|NOT COMPLETED|CS21 (NCT00295750)||43
993763|NCT00451958|2409996|P1|NOT COMPLETED|CS21 (NCT00295750)||41
993764|NCT00451958|2409992|P5|COMPLETED|CS21 (NCT00295750)||172
993765|NCT00451958|2409993|P4|COMPLETED|CS21 (NCT00295750)||0
993766|NCT00451958|2409994|P3|COMPLETED|CS21 (NCT00295750)||0
993767|NCT00451958|2409995|P2|COMPLETED|CS21 (NCT00295750)||163
993768|NCT00451958|2409996|P1|COMPLETED|CS21 (NCT00295750)||169
993769|NCT00451958|2409992|P5|STARTED|CS21 (NCT00295750)||204
993770|NCT00451958|2409993|P4|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
993771|NCT00451958|2409994|P3|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
993772|NCT00451958|2409995|P2|STARTED|CS21 (NCT00295750)|CS21 ITT population.|206
993773|NCT00451958|2409996|P1|STARTED|CS21 (NCT00295750)|CS21 intention-to-treat (ITT) population.|210
993774|NCT00452114|2410028|P2|NOT COMPLETED|Overall Study||3
993775|NCT00452114|2410029|P1|NOT COMPLETED|Overall Study||3
993776|NCT00452114|2410028|P2|COMPLETED|Overall Study||10
993777|NCT00452114|2410029|P1|COMPLETED|Overall Study||12
993778|NCT00452114|2410028|P2|STARTED|Overall Study||13
993779|NCT00452114|2410029|P1|STARTED|Overall Study||15
993789|NCT00452348|2410077|P2|NOT COMPLETED|Overall Study||84
993790|NCT00452348|2410078|P1|NOT COMPLETED|Overall Study||79
993791|NCT00452348|2410077|P2|COMPLETED|Overall Study||234
993792|NCT00452348|2410078|P1|COMPLETED|Overall Study||231
993793|NCT00452348|2410077|P2|STARTED|Overall Study||318
993794|NCT00452348|2410078|P1|STARTED|Overall Study||310
993795|NCT00452361|2410092|P2|NOT COMPLETED|Overall Study||10
993796|NCT00452361|2410093|P1|NOT COMPLETED|Overall Study||21
993797|NCT00452361|2410092|P2|COMPLETED|Overall Study||0
993798|NCT00452361|2410093|P1|COMPLETED|Overall Study||0
993799|NCT00452361|2410092|P2|STARTED|Overall Study||10
993800|NCT00452361|2410093|P1|STARTED|Overall Study||21
993801|NCT00452374|2410135|P1|NOT COMPLETED|Overall Study||0
993802|NCT00452374|2410135|P1|COMPLETED|Overall Study||48
993803|NCT00452374|2410135|P1|STARTED|Overall Study||48
993804|NCT00452387|2410140|P1|NOT COMPLETED|Overall Study||0
993805|NCT00452387|2410140|P1|COMPLETED|Overall Study||22
993806|NCT00452387|2410140|P1|STARTED|Overall Study||22
993807|NCT00452400|2410153|P5|NOT COMPLETED|Overall Study||3
993808|NCT00452400|2410154|P4|NOT COMPLETED|Overall Study||1
993809|NCT00452400|2410155|P3|NOT COMPLETED|Overall Study||7
993810|NCT00452400|2410156|P2|NOT COMPLETED|Overall Study||1
993811|NCT00452400|2410157|P1|NOT COMPLETED|Overall Study||5
993812|NCT00452400|2410153|P5|COMPLETED|Overall Study||76
993813|NCT00452400|2410154|P4|COMPLETED|Overall Study||85
993814|NCT00452400|2410155|P3|COMPLETED|Overall Study||73
993815|NCT00452400|2410156|P2|COMPLETED|Overall Study||80
993816|NCT00452400|2410157|P1|COMPLETED|Overall Study||74
993817|NCT00452400|2410153|P5|STARTED|Overall Study||79
993818|NCT00452400|2410154|P4|STARTED|Overall Study||86
993819|NCT00452400|2410155|P3|STARTED|Overall Study||80
993820|NCT00452400|2410156|P2|STARTED|Overall Study||81
993821|NCT00452400|2410157|P1|STARTED|Overall Study||79
993822|NCT00452426|2410331|P2|NOT COMPLETED|Overall Study||11
993823|NCT00452426|2410332|P1|NOT COMPLETED|Overall Study||7
993824|NCT00452426|2410331|P2|COMPLETED|Overall Study||493
993825|NCT00452426|2410332|P1|COMPLETED|Overall Study||489
993826|NCT00452426|2410331|P2|STARTED|Overall Study||504
993827|NCT00452426|2410332|P1|STARTED|Overall Study||496
993828|NCT00452452|2410349|P3|NOT COMPLETED|Overall Study||1
993829|NCT00452452|2410350|P2|NOT COMPLETED|Overall Study||0
993830|NCT00452452|2410351|P1|NOT COMPLETED|Overall Study||2
993831|NCT00452452|2410349|P3|COMPLETED|Overall Study||152
993832|NCT00452452|2410350|P2|COMPLETED|Overall Study||112
993833|NCT00452452|2410351|P1|COMPLETED|Overall Study||88
993834|NCT00452452|2410349|P3|Vaccinated Dose 3|Overall Study||0
993835|NCT00452452|2410350|P2|Vaccinated Dose 3|Overall Study||0
993836|NCT00452452|2410351|P1|Vaccinated Dose 3|Overall Study||89
993837|NCT00452452|2410349|P3|Vaccinated Dose 2|Overall Study||0
993838|NCT00452452|2410350|P2|Vaccinated Dose 2|Overall Study||112
993839|NCT00452452|2410351|P1|Vaccinated Dose 2|Overall Study||90
993840|NCT00452452|2410349|P3|Vaccinated Dose 1|Overall Study||152
993841|NCT00452452|2410350|P2|Vaccinated Dose 1|Overall Study||112
993842|NCT00452452|2410351|P1|Vaccinated Dose 1|Overall Study||90
993843|NCT00452452|2410349|P3|STARTED|Overall Study||153
993844|NCT00452452|2410350|P2|STARTED|Overall Study||112
993845|NCT00452452|2410351|P1|STARTED|Overall Study||90
993846|NCT00452530|2410376|P2|NOT COMPLETED|Overall Study||136
993847|NCT00452530|2410377|P1|NOT COMPLETED|Overall Study||136
993848|NCT00452530|2410376|P2|COMPLETED|Overall Study||1393
993849|NCT00452530|2410377|P1|COMPLETED|Overall Study||1392
993850|NCT00452530|2410376|P2|Primary Participants|Overall Study||997
993851|NCT00452530|2410377|P1|Primary Participants|Overall Study||976
993852|NCT00452530|2410376|P2|Evaluable Participants|Overall Study||921
993853|NCT00452530|2410377|P1|Evaluable Participants|Overall Study||907
993854|NCT00452530|2410376|P2|Received Treatment|Overall Study||1508
993855|NCT00452530|2410377|P1|Received Treatment|Overall Study||1501
993856|NCT00452530|2410376|P2|STARTED|Overall Study|Randomized|1529
993857|NCT00452530|2410377|P1|STARTED|Overall Study|Randomized|1528
993858|NCT00452543|2410397|P2|NOT COMPLETED|Overall Study||6
993859|NCT00452543|2410398|P1|NOT COMPLETED|Overall Study||5
993860|NCT00452543|2410397|P2|COMPLETED|Overall Study||5
993861|NCT00452543|2410398|P1|COMPLETED|Overall Study||7
993862|NCT00452543|2410397|P2|STARTED|Overall Study||11
993863|NCT00452543|2410398|P1|STARTED|Overall Study||12
993864|NCT00458211|2410410|P1|NOT COMPLETED|Overall Study||16
993865|NCT00458211|2410410|P1|COMPLETED|Overall Study|12 early termination 2 protocol violation 2 ( from Rochester) withdrawn from further analysis|24
993866|NCT00458211|2410410|P1|STARTED|Overall Study||40
993867|NCT00458237|2410424|P3|NOT COMPLETED|Overall Study||0
993868|NCT00458237|2410425|P2|NOT COMPLETED|Overall Study||0
993869|NCT00458237|2410426|P1|NOT COMPLETED|Overall Study||0
993870|NCT00458237|2410424|P3|COMPLETED|Overall Study||5
993871|NCT00458237|2410425|P2|COMPLETED|Overall Study||3
993872|NCT00458237|2410426|P1|COMPLETED|Overall Study||3
993873|NCT00458237|2410424|P3|STARTED|Overall Study||5
993874|NCT00458237|2410425|P2|STARTED|Overall Study||3
993875|NCT00458237|2410426|P1|STARTED|Overall Study||3
993876|NCT00458302|2410437|P2|NOT COMPLETED|Overall Study||24
993877|NCT00458302|2410438|P1|NOT COMPLETED|Overall Study||20
993878|NCT00458302|2410437|P2|COMPLETED|Overall Study||103
993879|NCT00458302|2410438|P1|COMPLETED|Overall Study||109
993880|NCT00458302|2410437|P2|STARTED|Overall Study||127
993881|NCT00458302|2410438|P1|STARTED|Overall Study||129
993882|NCT00458406|2410471|P2|NOT COMPLETED|Month 3||0
993883|NCT00458406|2410472|P1|NOT COMPLETED|Month 3||0
993884|NCT00458406|2410471|P2|COMPLETED|Month 3||13
993885|NCT00458406|2410472|P1|COMPLETED|Month 3||43
993886|NCT00458406|2410471|P2|STARTED|Month 3||13
993887|NCT00458406|2410472|P1|STARTED|Month 3||43
993888|NCT00458406|2410471|P2|NOT COMPLETED|Month 1||0
993889|NCT00458406|2410472|P1|NOT COMPLETED|Month 1||0
993890|NCT00458406|2410471|P2|COMPLETED|Month 1||13
993891|NCT00458406|2410472|P1|COMPLETED|Month 1||43
993892|NCT00458406|2410471|P2|STARTED|Month 1||13
993893|NCT00458406|2410472|P1|STARTED|Month 1||43
993894|NCT00463437|2410494|P4|NOT COMPLETED|Overall Study||7
993895|NCT00463437|2410495|P3|NOT COMPLETED|Overall Study||6
993896|NCT00463437|2410496|P2|NOT COMPLETED|Overall Study||11
993897|NCT00463437|2410497|P1|NOT COMPLETED|Overall Study||4
993898|NCT00463437|2410494|P4|COMPLETED|Overall Study||350
993899|NCT00463437|2410495|P3|COMPLETED|Overall Study||352
993900|NCT00463437|2410496|P2|COMPLETED|Overall Study||352
993901|NCT00463437|2410497|P1|COMPLETED|Overall Study||355
993902|NCT00463437|2410494|P4|STARTED|Overall Study||357
993903|NCT00463437|2410495|P3|STARTED|Overall Study||358
993904|NCT00463437|2410496|P2|STARTED|Overall Study||363
993905|NCT00463437|2410497|P1|STARTED|Overall Study||359
993906|NCT00463567|2410566|P7|NOT COMPLETED|Overall Study||11
993907|NCT00463567|2410567|P6|NOT COMPLETED|Overall Study||21
993908|NCT00463567|2410568|P5|NOT COMPLETED|Overall Study||23
993909|NCT00463567|2410569|P4|NOT COMPLETED|Overall Study||131
993910|NCT00463567|2410570|P3|NOT COMPLETED|Overall Study||89
993911|NCT00463567|2410571|P2|NOT COMPLETED|Overall Study||77
993912|NCT00463567|2410572|P1|NOT COMPLETED|Overall Study||95
993913|NCT00463567|2410566|P7|COMPLETED|Overall Study||112
993914|NCT00463567|2410567|P6|COMPLETED|Overall Study||102
993915|NCT00463567|2410568|P5|COMPLETED|Overall Study||107
993916|NCT00463567|2410569|P4|COMPLETED|Overall Study||294
993917|NCT00463567|2410570|P3|COMPLETED|Overall Study||331
993918|NCT00463567|2410571|P2|COMPLETED|Overall Study||341
993919|NCT00463567|2410572|P1|COMPLETED|Overall Study||325
993920|NCT00463567|2410566|P7|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
993921|NCT00463567|2410567|P6|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
993922|NCT00463567|2410568|P5|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|127
993923|NCT00463567|2410569|P4|Safety Population: Received Study Drug|Overall Study||418
993924|NCT00463567|2410570|P3|Safety Population: Received Study Drug|Overall Study||415
993925|NCT00463567|2410571|P2|Safety Population: Received Study Drug|Overall Study||416
993926|NCT00463567|2410572|P1|Safety Population: Received Study Drug|Overall Study||416
993927|NCT00463567|2410566|P7|STARTED|Overall Study||123
993928|NCT00463567|2410567|P6|STARTED|Overall Study||123
993929|NCT00463567|2410568|P5|STARTED|Overall Study||130
993930|NCT00463567|2410569|P4|STARTED|Overall Study||425
993931|NCT00463567|2410570|P3|STARTED|Overall Study||420
993932|NCT00463567|2410571|P2|STARTED|Overall Study||418
993933|NCT00463567|2410572|P1|STARTED|Overall Study|Randomized Participants|420
993934|NCT00463580|2410605|P2|NOT COMPLETED|Overall Study||2
993935|NCT00463580|2410606|P1|NOT COMPLETED|Overall Study||3
993936|NCT00463580|2410605|P2|COMPLETED|Overall Study||28
993937|NCT00463580|2410606|P1|COMPLETED|Overall Study||27
993938|NCT00463580|2410605|P2|STARTED|Overall Study||30
993939|NCT00463580|2410606|P1|STARTED|Overall Study||30
993940|NCT00463606|2410617|P3|NOT COMPLETED|Overall Study||20
993941|NCT00463606|2410618|P2|NOT COMPLETED|Overall Study||34
993942|NCT00463606|2410619|P1|NOT COMPLETED|Overall Study||41
993943|NCT00463606|2410617|P3|COMPLETED|Overall Study||231
993944|NCT00463606|2410618|P2|COMPLETED|Overall Study||220
993945|NCT00463606|2410619|P1|COMPLETED|Overall Study||212
993946|NCT00463606|2410617|P3|STARTED|Overall Study||251
993947|NCT00463606|2410618|P2|STARTED|Overall Study||254
993948|NCT00463606|2410619|P1|STARTED|Overall Study||253
993949|NCT00463788|2410644|P2|NOT COMPLETED|Overall Study||54
993950|NCT00463788|2410645|P1|NOT COMPLETED|Overall Study||109
993951|NCT00463788|2410644|P2|COMPLETED|Overall Study||4
993952|NCT00463788|2410645|P1|COMPLETED|Overall Study||6
993953|NCT00463788|2410644|P2|Treated|Overall Study||57
993954|NCT00463788|2410645|P1|Treated|Overall Study||114
993955|NCT00463788|2410644|P2|STARTED|Overall Study||58
993956|NCT00463788|2410645|P1|STARTED|Overall Study||115
993957|NCT00463801|2410660|P1|NOT COMPLETED|Overall Study||13
993958|NCT00463801|2410660|P1|COMPLETED|Overall Study||39
993959|NCT00463801|2410660|P1|STARTED|Overall Study||52
993960|NCT00463840|2410664|P1|NOT COMPLETED|Overall Study||12
993961|NCT00463840|2410664|P1|COMPLETED|Overall Study||12
993962|NCT00463840|2410664|P1|STARTED|Overall Study||24
993963|NCT00463866|2410670|P2|NOT COMPLETED|Overall Study||340
993964|NCT00463866|2410671|P1|NOT COMPLETED|Overall Study||309
993965|NCT00463866|2410670|P2|COMPLETED|Overall Study||3705
993966|NCT00463866|2410671|P1|COMPLETED|Overall Study||3699
993967|NCT00463866|2410670|P2|STARTED|Overall Study|4221 participants randomised. Out of these, 176 had no efficacy data after randomisation.|4045
993968|NCT00463866|2410671|P1|STARTED|Overall Study|4203 participants randomised. Out of these, 195 had no efficacy data after randomisation.|4008
993969|NCT00464087|2410694|P3|NOT COMPLETED|Overall Study||29
993970|NCT00464087|2410695|P2|NOT COMPLETED|Overall Study||0
993971|NCT00464087|2410696|P1|NOT COMPLETED|Overall Study||0
993972|NCT00464087|2410694|P3|COMPLETED|Overall Study||0
993973|NCT00464087|2410695|P2|COMPLETED|Overall Study||51
993974|NCT00464087|2410696|P1|COMPLETED|Overall Study||49
993975|NCT00464087|2410694|P3|STARTED|Overall Study||29
993976|NCT00464087|2410695|P2|STARTED|Overall Study||51
993977|NCT00464087|2410696|P1|STARTED|Overall Study||49
993978|NCT00464204|2410714|P2|NOT COMPLETED|Overall Study||32
993979|NCT00464204|2410715|P1|NOT COMPLETED|Overall Study||49
993980|NCT00464204|2410714|P2|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|64
993981|NCT00464204|2410715|P1|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|51
993982|NCT00464204|2410714|P2|Withdrawal Due to Discharge From ICU|Overall Study||11
993983|NCT00464204|2410715|P1|Withdrawal Due to Discharge From ICU|Overall Study||18
993984|NCT00464204|2410714|P2|Day 90 Follow-up Performed|Overall Study||74
993985|NCT00464204|2410715|P1|Day 90 Follow-up Performed|Overall Study||69
993986|NCT00464204|2410714|P2|Day 30 Follow-up Performed|Overall Study||83
993987|NCT00464204|2410715|P1|Day 30 Follow-up Performed|Overall Study||89
993988|NCT00464204|2410714|P2|Completed Treatment|Overall Study||83
993989|NCT00464204|2410715|P1|Completed Treatment|Overall Study||81
993990|NCT00464204|2410714|P2|STARTED|Overall Study||96
993991|NCT00464204|2410715|P1|STARTED|Overall Study||100
993992|NCT00464269|2410753|P4|NOT COMPLETED|Overall Study||9
993993|NCT00464269|2410754|P3|NOT COMPLETED|Overall Study||7
993994|NCT00464269|2410755|P2|NOT COMPLETED|Overall Study||17
993995|NCT00464269|2410756|P1|NOT COMPLETED|Overall Study||6
993996|NCT00464269|2410753|P4|COMPLETED|Overall Study||93
993997|NCT00464269|2410754|P3|COMPLETED|Overall Study||93
993998|NCT00464269|2410755|P2|COMPLETED|Overall Study||82
993999|NCT00464269|2410756|P1|COMPLETED|Overall Study||93
994000|NCT00464269|2410753|P4|STARTED|Overall Study||102
994001|NCT00464269|2410754|P3|STARTED|Overall Study||100
994002|NCT00464269|2410755|P2|STARTED|Overall Study||99
994003|NCT00464269|2410756|P1|STARTED|Overall Study||99
994004|NCT00464308|2410857|P3|NOT COMPLETED|Overall Study||59
994005|NCT00464308|2410858|P2|NOT COMPLETED|Overall Study||63
994006|NCT00464308|2410859|P1|NOT COMPLETED|Overall Study||69
994007|NCT00464308|2410857|P3|COMPLETED|Overall Study||400
994008|NCT00464308|2410858|P2|COMPLETED|Overall Study||406
994009|NCT00464308|2410859|P1|COMPLETED|Overall Study||395
994010|NCT00464308|2410857|P3|STARTED|Overall Study||459
994011|NCT00464308|2410858|P2|STARTED|Overall Study||469
994012|NCT00464308|2410859|P1|STARTED|Overall Study||464
994013|NCT00464334|2410896|P11|NOT COMPLETED|Overall Study||4
994014|NCT00464334|2410897|P10|NOT COMPLETED|Overall Study||1
994015|NCT00464334|2410898|P9|NOT COMPLETED|Overall Study||6
994016|NCT00464334|2410899|P8|NOT COMPLETED|Overall Study||1
994017|NCT00464334|2410900|P7|NOT COMPLETED|Overall Study||3
994018|NCT00464334|2410901|P6|NOT COMPLETED|Overall Study||4
994019|NCT00464334|2410902|P5|NOT COMPLETED|Overall Study||4
994020|NCT00464334|2410903|P4|NOT COMPLETED|Overall Study||4
994021|NCT00464334|2410904|P3|NOT COMPLETED|Overall Study||5
994022|NCT00464334|2410905|P2|NOT COMPLETED|Overall Study||8
994023|NCT00464334|2410906|P1|NOT COMPLETED|Overall Study||1
994024|NCT00464334|2410896|P11|COMPLETED|Overall Study||4
994025|NCT00464334|2410897|P10|COMPLETED|Overall Study||4
994026|NCT00464334|2410898|P9|COMPLETED|Overall Study||2
994027|NCT00464334|2410899|P8|COMPLETED|Overall Study||7
994028|NCT00464334|2410900|P7|COMPLETED|Overall Study||6
994029|NCT00464334|2410901|P6|COMPLETED|Overall Study||3
994030|NCT00464334|2410902|P5|COMPLETED|Overall Study||3
994031|NCT00464334|2410903|P4|COMPLETED|Overall Study||4
994032|NCT00464334|2410904|P3|COMPLETED|Overall Study||3
994033|NCT00464334|2410905|P2|COMPLETED|Overall Study||5
994034|NCT00464334|2410906|P1|COMPLETED|Overall Study||4
994035|NCT00464334|2410896|P11|STARTED|Overall Study||8
994036|NCT00464334|2410897|P10|STARTED|Overall Study||5
994037|NCT00464334|2410898|P9|STARTED|Overall Study||8
994038|NCT00464334|2410899|P8|STARTED|Overall Study||8
994039|NCT00464334|2410900|P7|STARTED|Overall Study||9
994040|NCT00464334|2410901|P6|STARTED|Overall Study||7
994041|NCT00464334|2410902|P5|STARTED|Overall Study||7
994042|NCT00464334|2410903|P4|STARTED|Overall Study||8
994043|NCT00464334|2410904|P3|STARTED|Overall Study||8
994044|NCT00464334|2410905|P2|STARTED|Overall Study||13
994045|NCT00464334|2410906|P1|STARTED|Overall Study||5
994046|NCT00464438|2410965|P2|NOT COMPLETED|Overall Study||6
994047|NCT00464438|2410966|P1|NOT COMPLETED|Overall Study||2
994048|NCT00464438|2410965|P2|COMPLETED|Overall Study||80
994049|NCT00464438|2410966|P1|COMPLETED|Overall Study||83
994050|NCT00464438|2410965|P2|STARTED|Overall Study||86
994051|NCT00464438|2410966|P1|STARTED|Overall Study||85
994052|NCT00464464|2410980|P2|NOT COMPLETED|Overall Study||3
994053|NCT00464464|2410981|P1|NOT COMPLETED|Overall Study||5
994054|NCT00464464|2410980|P2|COMPLETED|Overall Study||36
994055|NCT00464464|2410981|P1|COMPLETED|Overall Study||36
994056|NCT00464464|2410980|P2|STARTED|Overall Study||39
994057|NCT00464464|2410981|P1|STARTED|Overall Study||41
994058|NCT00464490|2410995|P2|NOT COMPLETED|Overall Study||11
994059|NCT00464490|2410996|P1|NOT COMPLETED|Overall Study||11
994060|NCT00464490|2410995|P2|COMPLETED|Overall Study||10
994061|NCT00464490|2410996|P1|COMPLETED|Overall Study||10
994062|NCT00464490|2410995|P2|STARTED|Overall Study||21
994063|NCT00464490|2410996|P1|STARTED|Overall Study||21
994064|NCT00464542|2411002|P1|NOT COMPLETED|Post-treatment||0
994065|NCT00464542|2411002|P1|COMPLETED|Post-treatment||10
994066|NCT00464542|2411002|P1|STARTED|Post-treatment||10
994067|NCT00464542|2411002|P1|NOT COMPLETED|Pre-treatment||2
994068|NCT00464542|2411002|P1|COMPLETED|Pre-treatment||10
994069|NCT00464542|2411002|P1|STARTED|Pre-treatment||12
994073|NCT00464646|2411082|P2|NOT COMPLETED|Overall Study||0
994074|NCT00464646|2411083|P1|NOT COMPLETED|Overall Study||0
994075|NCT00464646|2411082|P2|COMPLETED|Overall Study||29
994076|NCT00464646|2411083|P1|COMPLETED|Overall Study||76
994077|NCT00464646|2411082|P2|STARTED|Overall Study||29
994078|NCT00464646|2411083|P1|STARTED|Overall Study||76
994079|NCT00464672|2411091|P6|NOT COMPLETED|Overall Study||4
994080|NCT00464672|2411092|P5|NOT COMPLETED|Overall Study||10
994081|NCT00464672|2411093|P4|NOT COMPLETED|Overall Study||1
994082|NCT00464672|2411094|P3|NOT COMPLETED|Overall Study||0
994083|NCT00464672|2411095|P2|NOT COMPLETED|Overall Study||10
994084|NCT00464672|2411096|P1|NOT COMPLETED|Overall Study||25
994085|NCT00464672|2411091|P6|COMPLETED|Overall Study||195
994086|NCT00464672|2411092|P5|COMPLETED|Overall Study||392
994087|NCT00464672|2411093|P4|COMPLETED|Overall Study||199
994088|NCT00464672|2411094|P3|COMPLETED|Overall Study||400
994089|NCT00464672|2411095|P2|COMPLETED|Overall Study||222
994090|NCT00464672|2411096|P1|COMPLETED|Overall Study||435
994091|NCT00464672|2411091|P6|STARTED|Overall Study||199
994092|NCT00464672|2411092|P5|STARTED|Overall Study||402
994093|NCT00464672|2411093|P4|STARTED|Overall Study||200
994094|NCT00464672|2411094|P3|STARTED|Overall Study||400
994095|NCT00464672|2411095|P2|STARTED|Overall Study||232
994096|NCT00464672|2411096|P1|STARTED|Overall Study||460
994097|NCT00464685|2411168|P2|NOT COMPLETED|Overall Study||33
994098|NCT00464685|2411169|P1|NOT COMPLETED|Overall Study||23
994099|NCT00464685|2411168|P2|COMPLETED|Overall Study||94
994100|NCT00464685|2411169|P1|COMPLETED|Overall Study||103
994101|NCT00464685|2411168|P2|STARTED|Overall Study||127
994102|NCT00464685|2411169|P1|STARTED|Overall Study||126
994103|NCT00464698|2411183|P1|NOT COMPLETED|Period 3: 120mg||2
994104|NCT00464698|2411183|P1|COMPLETED|Period 3: 120mg||12
994105|NCT00464698|2411183|P1|STARTED|Period 3: 120mg||14
994106|NCT00464698|2411183|P1|NOT COMPLETED|Period 2: 60 mg||0
994107|NCT00464698|2411183|P1|COMPLETED|Period 2: 60 mg||17
994108|NCT00464698|2411183|P1|STARTED|Period 2: 60 mg||17
994109|NCT00464698|2411183|P1|NOT COMPLETED|Period 1: 30 mg||3
994110|NCT00464698|2411183|P1|COMPLETED|Period 1: 30 mg||17
994111|NCT00464698|2411183|P1|STARTED|Period 1: 30 mg||20
994112|NCT00464711|2411193|P1|NOT COMPLETED|Overall Study||15
994113|NCT00464711|2411193|P1|COMPLETED|Overall Study||25
994114|NCT00464711|2411193|P1|STARTED|Overall Study||40
994115|NCT00464737|2411200|P3|NOT COMPLETED|Overall Study||55
994116|NCT00464737|2411201|P2|NOT COMPLETED|Overall Study||32
994117|NCT00464737|2411202|P1|NOT COMPLETED|Overall Study||32
994118|NCT00464737|2411200|P3|COMPLETED|Overall Study||19
994119|NCT00464737|2411201|P2|COMPLETED|Overall Study||42
994120|NCT00464737|2411202|P1|COMPLETED|Overall Study||50
994121|NCT00464737|2411200|P3|STARTED|Overall Study||74
994122|NCT00464737|2411201|P2|STARTED|Overall Study||74
994123|NCT00464737|2411202|P1|STARTED|Overall Study||82
994124|NCT00464945|2411251|P2|NOT COMPLETED|Toddler Dose||1
994125|NCT00464945|2411252|P1|NOT COMPLETED|Toddler Dose||0
994126|NCT00464945|2411251|P2|COMPLETED|Toddler Dose||130
994127|NCT00464945|2411252|P1|COMPLETED|Toddler Dose||131
994128|NCT00464945|2411251|P2|STARTED|Toddler Dose||131
994129|NCT00464945|2411252|P1|STARTED|Toddler Dose||131
994130|NCT00464945|2411251|P2|NOT COMPLETED|After Infant Series||2
994131|NCT00464945|2411252|P1|NOT COMPLETED|After Infant Series||0
994132|NCT00464945|2411251|P2|COMPLETED|After Infant Series||131
994133|NCT00464945|2411252|P1|COMPLETED|After Infant Series||131
994134|NCT00464945|2411251|P2|STARTED|After Infant Series||133
994135|NCT00464945|2411252|P1|STARTED|After Infant Series||131
994136|NCT00464945|2411251|P2|NOT COMPLETED|Infant Series||1
994137|NCT00464945|2411252|P1|NOT COMPLETED|Infant Series||4
994138|NCT00464945|2411251|P2|COMPLETED|Infant Series||133
994139|NCT00464945|2411252|P1|COMPLETED|Infant Series||131
994140|NCT00464945|2411251|P2|Vaccinated Dose 3|Infant Series||133
994141|NCT00464945|2411252|P1|Vaccinated Dose 3|Infant Series||132
994142|NCT00464945|2411251|P2|Vaccinated Dose 2|Infant Series||133
994143|NCT00464945|2411252|P1|Vaccinated Dose 2|Infant Series||132
994144|NCT00464945|2411251|P2|Vaccinated Dose 1|Infant Series||134
994145|NCT00464945|2411252|P1|Vaccinated Dose 1|Infant Series||134
994146|NCT00464945|2411251|P2|STARTED|Infant Series||134
994147|NCT00464945|2411252|P1|STARTED|Infant Series||135
994148|NCT00465088|2411282|P2|NOT COMPLETED|Overall Study||9
994149|NCT00465088|2411283|P1|NOT COMPLETED|Overall Study||32
994150|NCT00465088|2411282|P2|COMPLETED|Overall Study||70
994151|NCT00465088|2411283|P1|COMPLETED|Overall Study||82
994152|NCT00465088|2411282|P2|STARTED|Overall Study||79
994153|NCT00465088|2411283|P1|STARTED|Overall Study|For both arms, started means treated.|114
994154|NCT00465101|2411315|P1|NOT COMPLETED|Overall Study||59
994155|NCT00465101|2411315|P1|COMPLETED|Overall Study||91
994156|NCT00465101|2411315|P1|STARTED|Overall Study||150
994157|NCT00465179|2411348|P1|NOT COMPLETED|Overall Study||53
994158|NCT00465179|2411348|P1|COMPLETED|Overall Study||4
994159|NCT00465179|2411348|P1|STARTED|Overall Study||57
994160|NCT00465361|2411354|P1|NOT COMPLETED|Post-Intervention Assessment||0
994161|NCT00465361|2411354|P1|COMPLETED|Post-Intervention Assessment||3
994162|NCT00465361|2411354|P1|STARTED|Post-Intervention Assessment||3
994163|NCT00465361|2411354|P1|NOT COMPLETED|Baseline Assessment||4
994164|NCT00465361|2411354|P1|COMPLETED|Baseline Assessment||3
994165|NCT00465361|2411354|P1|STARTED|Baseline Assessment||7
994166|NCT00465530|2411360|P2|NOT COMPLETED|Overall Study||4
994167|NCT00465530|2411361|P1|NOT COMPLETED|Overall Study||2
994168|NCT00465530|2411360|P2|COMPLETED|Overall Study||15
994169|NCT00465530|2411361|P1|COMPLETED|Overall Study||19
994170|NCT00465530|2411360|P2|STARTED|Overall Study||19
994171|NCT00465530|2411361|P1|STARTED|Overall Study||21
994172|NCT00465569|2411373|P2|NOT COMPLETED|Overall Study||0
994173|NCT00465569|2411374|P1|NOT COMPLETED|Overall Study||1
994174|NCT00465569|2411373|P2|COMPLETED|Overall Study||7
994175|NCT00465569|2411374|P1|COMPLETED|Overall Study||12
994176|NCT00465569|2411373|P2|STARTED|Overall Study||7
994177|NCT00465569|2411374|P1|STARTED|Overall Study||13
994190|NCT00465738|2411416|P2|NOT COMPLETED|Overall Study||6
994191|NCT00465738|2411417|P1|NOT COMPLETED|Overall Study||6
994192|NCT00465738|2411416|P2|COMPLETED|Overall Study||89
994193|NCT00465738|2411417|P1|COMPLETED|Overall Study||91
994194|NCT00465738|2411416|P2|STARTED|Overall Study||95
994195|NCT00465738|2411417|P1|STARTED|Overall Study||97
994196|NCT00465816|2411510|P3|NOT COMPLETED|Overall Study||2
994197|NCT00465816|2411511|P2|NOT COMPLETED|Overall Study||0
994198|NCT00465816|2411512|P1|NOT COMPLETED|Overall Study||0
994199|NCT00465816|2411510|P3|COMPLETED|Overall Study||120
994200|NCT00465816|2411511|P2|COMPLETED|Overall Study||122
994201|NCT00465816|2411512|P1|COMPLETED|Overall Study||367
994202|NCT00465816|2411510|P3|STARTED|Overall Study||122
994203|NCT00465816|2411511|P2|STARTED|Overall Study||122
994204|NCT00465816|2411512|P1|STARTED|Overall Study||367
994205|NCT00465894|2411594|P2|NOT COMPLETED|Overall Study||3
994206|NCT00465894|2411595|P1|NOT COMPLETED|Overall Study||5
994207|NCT00465894|2411594|P2|COMPLETED|Overall Study||25
994208|NCT00465894|2411595|P1|COMPLETED|Overall Study||25
994209|NCT00465894|2411594|P2|STARTED|Overall Study||28
994210|NCT00465894|2411595|P1|STARTED|Overall Study||30
994211|NCT00450073|2411604|P3|NOT COMPLETED|Overall Study||1
994212|NCT00450073|2411605|P2|NOT COMPLETED|Overall Study||0
994213|NCT00450073|2411606|P1|NOT COMPLETED|Overall Study||1
994214|NCT00450073|2411604|P3|COMPLETED|Overall Study||9
994215|NCT00450073|2411605|P2|COMPLETED|Overall Study||10
994216|NCT00450073|2411606|P1|COMPLETED|Overall Study||9
994217|NCT00450073|2411604|P3|STARTED|Overall Study||10
994218|NCT00450073|2411605|P2|STARTED|Overall Study||10
994219|NCT00450073|2411606|P1|STARTED|Overall Study||10
994220|NCT00455520|2411616|P2|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||62
994221|NCT00455520|2411617|P1|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||63
994222|NCT00455520|2411616|P2|COMPLETED|Double Blind Tapentadol ER vs Placebo||131
994223|NCT00455520|2411617|P1|COMPLETED|Double Blind Tapentadol ER vs Placebo||133
994224|NCT00455520|2411616|P2|STARTED|Double Blind Tapentadol ER vs Placebo|1 subject enrolled two separate times in this study, 2 subjects did not receive study medication|193
994225|NCT00455520|2411617|P1|STARTED|Double Blind Tapentadol ER vs Placebo|2 subjects enrolled two separate times in this study, 1 subject did not receive study medication|196
994226|NCT00455520|2411616|P2|NOT COMPLETED|Open Label Tapentadol Extended Release||0
994227|NCT00455520|2411617|P1|NOT COMPLETED|Open Label Tapentadol Extended Release||196
994228|NCT00455520|2411616|P2|COMPLETED|Open Label Tapentadol Extended Release||0
994229|NCT00455520|2411617|P1|COMPLETED|Open Label Tapentadol Extended Release||395
994230|NCT00455520|2411616|P2|STARTED|Open Label Tapentadol Extended Release||0
994231|NCT00455520|2411617|P1|STARTED|Open Label Tapentadol Extended Release||591
994232|NCT00455533|2411635|P3|NOT COMPLETED|Period Two: Randomized Period||6
994233|NCT00455533|2411636|P2|NOT COMPLETED|Period Two: Randomized Period||6
994234|NCT00455533|2411637|P1|NOT COMPLETED|Period Two: Randomized Period||0
994235|NCT00455533|2411635|P3|COMPLETED|Period Two: Randomized Period||138
994236|NCT00455533|2411636|P2|COMPLETED|Period Two: Randomized Period||139
994237|NCT00455533|2411637|P1|COMPLETED|Period Two: Randomized Period||0
994238|NCT00455533|2411635|P3|STARTED|Period Two: Randomized Period|147 randomized, 144 randomized and treated with paclitaxel|144
994239|NCT00455533|2411636|P2|STARTED|Period Two: Randomized Period|148 randomized, 145 randomized and treated with ixabepilone|145
994240|NCT00455533|2411637|P1|STARTED|Period Two: Randomized Period||0
994241|NCT00455533|2411635|P3|NOT COMPLETED|Period One: Initial Chemotherapy||0
994242|NCT00455533|2411636|P2|NOT COMPLETED|Period One: Initial Chemotherapy||0
994243|NCT00455533|2411637|P1|NOT COMPLETED|Period One: Initial Chemotherapy||18
994244|NCT00455533|2411635|P3|COMPLETED|Period One: Initial Chemotherapy||0
994245|NCT00455533|2411636|P2|COMPLETED|Period One: Initial Chemotherapy||0
994246|NCT00455533|2411637|P1|COMPLETED|Period One: Initial Chemotherapy||295
994247|NCT00455533|2411635|P3|STARTED|Period One: Initial Chemotherapy||0
994248|NCT00455533|2411636|P2|STARTED|Period One: Initial Chemotherapy||0
994249|NCT00455533|2411637|P1|STARTED|Period One: Initial Chemotherapy||313
994250|NCT00465972|2411686|P2|NOT COMPLETED|Overall Study||1
994251|NCT00465972|2411687|P1|NOT COMPLETED|Overall Study||2
994252|NCT00465972|2411686|P2|COMPLETED|Overall Study||23
994253|NCT00465972|2411687|P1|COMPLETED|Overall Study||18
994254|NCT00465972|2411686|P2|STARTED|Overall Study||24
994255|NCT00465972|2411687|P1|STARTED|Overall Study||20
994256|NCT00465985|2411695|P2|NOT COMPLETED|Part III - Open-label Treatment Period||0
994257|NCT00465985|2411696|P1|NOT COMPLETED|Part III - Open-label Treatment Period||2
994258|NCT00465985|2411695|P2|COMPLETED|Part III - Open-label Treatment Period||0
994259|NCT00465985|2411696|P1|COMPLETED|Part III - Open-label Treatment Period||29
994260|NCT00465985|2411695|P2|STARTED|Part III - Open-label Treatment Period||0
994261|NCT00465985|2411696|P1|STARTED|Part III - Open-label Treatment Period|All patients received treatment with ACZ885 in Part III of the study.|31
994262|NCT00465985|2411695|P2|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||12
994263|NCT00465985|2411696|P1|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||0
994264|NCT00465985|2411695|P2|COMPLETED|Part II - 1:1 ACZ885:Placebo||4
994265|NCT00465985|2411696|P1|COMPLETED|Part II - 1:1 ACZ885:Placebo||15
994266|NCT00465985|2411695|P2|STARTED|Part II - 1:1 ACZ885:Placebo||16
994267|NCT00465985|2411696|P1|STARTED|Part II - 1:1 ACZ885:Placebo|Patients with complete response to treatment entered Part II and were randomized to ACZ885 ,placebo.|15
994268|NCT00465985|2411695|P2|NOT COMPLETED|Part I - Open-label Treatment Period||0
994269|NCT00465985|2411696|P1|NOT COMPLETED|Part I - Open-label Treatment Period||4
994270|NCT00465985|2411695|P2|COMPLETED|Part I - Open-label Treatment Period||0
994271|NCT00465985|2411696|P1|COMPLETED|Part I - Open-label Treatment Period|Only patients with a complete response completed Part I and entered Part II of the study.|31
994272|NCT00465985|2411695|P2|STARTED|Part I - Open-label Treatment Period||0
994273|NCT00465985|2411696|P1|STARTED|Part I - Open-label Treatment Period|All patients received treatment with ACZ885 in Part I of the study.|35
994274|NCT00465998|2411717|P1|NOT COMPLETED|Overall Study||0
994275|NCT00465998|2411717|P1|COMPLETED|Overall Study||275
994276|NCT00465998|2411717|P1|STARTED|Overall Study||275
994277|NCT00466167|2411725|P3|NOT COMPLETED|Overall Study||21
994278|NCT00466167|2411726|P2|NOT COMPLETED|Overall Study||12
994279|NCT00466167|2411727|P1|NOT COMPLETED|Overall Study||20
994280|NCT00466167|2411725|P3|COMPLETED|Overall Study||157
994281|NCT00466167|2411726|P2|COMPLETED|Overall Study||163
994282|NCT00466167|2411727|P1|COMPLETED|Overall Study||145
994283|NCT00466167|2411725|P3|STARTED|Overall Study||178
994284|NCT00466167|2411726|P2|STARTED|Overall Study||175
994285|NCT00466167|2411727|P1|STARTED|Overall Study||165
994286|NCT00466193|2411785|P2|NOT COMPLETED|Overall Study||8
994287|NCT00466193|2411786|P1|NOT COMPLETED|Overall Study||12
994288|NCT00466193|2411785|P2|COMPLETED|Overall Study|One patient did not report at least one Latency Sleep Onset following middle-of-the-night awakening.|137
994289|NCT00466193|2411786|P1|COMPLETED|Overall Study||138
994290|NCT00466193|2411785|P2|STARTED|Overall Study||145
994291|NCT00466193|2411786|P1|STARTED|Overall Study||150
994292|NCT00466206|2411810|P1|NOT COMPLETED|Overall Study||0
994293|NCT00466206|2411810|P1|COMPLETED|Overall Study|One of 10 patients withdrawn from study but completed treatment under Compassionate Use Designation|10
994294|NCT00466206|2411810|P1|STARTED|Overall Study||10
994295|NCT00466947|2411820|P2|NOT COMPLETED|Study End Analysis Period||2534
994296|NCT00466947|2411821|P1|NOT COMPLETED|Study End Analysis Period||2496
994297|NCT00466947|2411820|P2|COMPLETED|Study End Analysis Period||9265
994298|NCT00466947|2411821|P1|COMPLETED|Study End Analysis Period||9302
994299|NCT00466947|2411820|P2|STARTED|Study End Analysis Period||11799
994300|NCT00466947|2411821|P1|STARTED|Study End Analysis Period||11798
994301|NCT00466947|2411820|P2|NOT COMPLETED|Primary Outcome Analysis Period||11863
994302|NCT00466947|2411821|P1|NOT COMPLETED|Primary Outcome Analysis Period||11875
994303|NCT00466947|2411820|P2|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
994304|NCT00466947|2411821|P1|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
994305|NCT00466947|2411820|P2|Ongoing|Primary Outcome Analysis Period||11863
994306|NCT00466947|2411821|P1|Ongoing|Primary Outcome Analysis Period||11875
994307|NCT00466947|2411820|P2|STARTED|Primary Outcome Analysis Period||11863
994308|NCT00466947|2411821|P1|STARTED|Primary Outcome Analysis Period||11875
994309|NCT00466960|2411943|P1|NOT COMPLETED|Overall Study||0
994310|NCT00466960|2411943|P1|COMPLETED|Overall Study||21
994311|NCT00466960|2411943|P1|STARTED|Overall Study||21
994312|NCT00467038|2411954|P2|NOT COMPLETED|Overall Study||0
994313|NCT00467038|2411955|P1|NOT COMPLETED|Overall Study||0
994314|NCT00467038|2411954|P2|COMPLETED|Overall Study||11
994315|NCT00467038|2411955|P1|COMPLETED|Overall Study||11
994316|NCT00467038|2411954|P2|STARTED|Overall Study||11
994317|NCT00467038|2411955|P1|STARTED|Overall Study||11
994318|NCT00467051|2411963|P1|NOT COMPLETED|Overall Study||2
994319|NCT00467051|2411963|P1|COMPLETED|Overall Study||18
994320|NCT00467051|2411963|P1|STARTED|Overall Study||20
994321|NCT00467077|2411967|P1|NOT COMPLETED|Overall Study||0
994322|NCT00467077|2411967|P1|COMPLETED|Overall Study||21
994323|NCT00467077|2411967|P1|STARTED|Overall Study||21
994324|NCT00467259|2411976|P2|NOT COMPLETED|Overall Study||242
994325|NCT00467259|2411977|P1|NOT COMPLETED|Overall Study||75
994326|NCT00467259|2411976|P2|COMPLETED|Overall Study||778
994327|NCT00467259|2411977|P1|COMPLETED|Overall Study||176
994328|NCT00467259|2411976|P2|ITT Population|Overall Study|One subject did not take any study medication and was excluded from ITT population.|1019
994329|NCT00467259|2411977|P1|ITT Population|Overall Study||251
994330|NCT00467259|2411976|P2|STARTED|Overall Study||1020
994331|NCT00467259|2411977|P1|STARTED|Overall Study||251
994332|NCT00467285|2411989|P2|NOT COMPLETED|Overall Study||4
994333|NCT00467285|2411990|P1|NOT COMPLETED|Overall Study||4
994334|NCT00467285|2411989|P2|COMPLETED|Overall Study||60
994335|NCT00467285|2411990|P1|COMPLETED|Overall Study||28
994336|NCT00467285|2411989|P2|STARTED|Overall Study||64
994337|NCT00467285|2411990|P1|STARTED|Overall Study||32
994338|NCT00467363|2412010|P2|NOT COMPLETED|Overall Study||70
994339|NCT00467363|2412011|P1|NOT COMPLETED|Overall Study||80
994340|NCT00467363|2412010|P2|COMPLETED|Overall Study||543
994341|NCT00467363|2412011|P1|COMPLETED|Overall Study||535
994342|NCT00467363|2412010|P2|STARTED|Overall Study||613
994343|NCT00467363|2412011|P1|STARTED|Overall Study||615
994344|NCT00467389|2412045|P2|NOT COMPLETED|Overall Study||0
994345|NCT00467389|2412046|P1|NOT COMPLETED|Overall Study||0
994346|NCT00467389|2412045|P2|COMPLETED|Overall Study||6
994347|NCT00467389|2412046|P1|COMPLETED|Overall Study||6
994348|NCT00467389|2412045|P2|STARTED|Overall Study||6
994349|NCT00467389|2412046|P1|STARTED|Overall Study||6
994350|NCT00467519|2412058|P2|NOT COMPLETED|Overall Study||23
994351|NCT00467519|2412059|P1|NOT COMPLETED|Overall Study||14
994352|NCT00467519|2412058|P2|COMPLETED|Overall Study||488
994353|NCT00467519|2412059|P1|COMPLETED|Overall Study||517
994354|NCT00467519|2412058|P2|STARTED|Overall Study||511
994355|NCT00467519|2412059|P1|STARTED|Overall Study||531
994356|NCT00467558|2412077|P2|NOT COMPLETED|Overall Study||0
994357|NCT00467558|2412078|P1|NOT COMPLETED|Overall Study||2
994358|NCT00467558|2412077|P2|COMPLETED|Overall Study||3
994359|NCT00467558|2412078|P1|COMPLETED|Overall Study||2
994360|NCT00467558|2412077|P2|STARTED|Overall Study||3
994361|NCT00467558|2412078|P1|STARTED|Overall Study||4
994362|NCT00467584|2412089|P3|NOT COMPLETED|Overall Study||1
994363|NCT00467584|2412090|P2|NOT COMPLETED|Overall Study||5
994364|NCT00467584|2412091|P1|NOT COMPLETED|Overall Study||4
994365|NCT00467584|2412089|P3|COMPLETED|Overall Study||20
994366|NCT00467584|2412090|P2|COMPLETED|Overall Study||15
994367|NCT00467584|2412091|P1|COMPLETED|Overall Study||17
994368|NCT00467584|2412089|P3|STARTED|Overall Study||21
994369|NCT00467584|2412090|P2|STARTED|Overall Study||20
994370|NCT00467584|2412091|P1|STARTED|Overall Study||21
994371|NCT00467597|2412103|P2|NOT COMPLETED|Overall Study||0
994372|NCT00467597|2412104|P1|NOT COMPLETED|Overall Study||2
994373|NCT00467597|2412103|P2|COMPLETED|Overall Study||6
994374|NCT00467597|2412104|P1|COMPLETED|Overall Study||24
994375|NCT00467597|2412103|P2|STARTED|Overall Study||6
994376|NCT00467597|2412104|P1|STARTED|Overall Study||26
994377|NCT00467610|2412114|P1|NOT COMPLETED|Overall Study||1
994378|NCT00467610|2412114|P1|COMPLETED|Overall Study||5
994379|NCT00467610|2412114|P1|STARTED|Overall Study||6
994380|NCT00467649|2412123|P6|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||1
994381|NCT00467649|2412124|P5|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
994382|NCT00467649|2412125|P4|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||2
994383|NCT00467649|2412126|P3|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
994384|NCT00467649|2412127|P2|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
994385|NCT00467649|2412128|P1|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
994386|NCT00467649|2412123|P6|COMPLETED|Phase 2 (Intent-to-Treat Population)||35
994387|NCT00467649|2412124|P5|COMPLETED|Phase 2 (Intent-to-Treat Population)||14
994388|NCT00467649|2412125|P4|COMPLETED|Phase 2 (Intent-to-Treat Population)||29
994389|NCT00467649|2412126|P3|COMPLETED|Phase 2 (Intent-to-Treat Population)||17
994390|NCT00467649|2412127|P2|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
994391|NCT00467649|2412128|P1|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
994392|NCT00467649|2412123|P6|STARTED|Phase 2 (Intent-to-Treat Population)||36
994393|NCT00467649|2412124|P5|STARTED|Phase 2 (Intent-to-Treat Population)||14
994394|NCT00467649|2412125|P4|STARTED|Phase 2 (Intent-to-Treat Population)||31
994395|NCT00467649|2412126|P3|STARTED|Phase 2 (Intent-to-Treat Population)||17
994396|NCT00467649|2412127|P2|STARTED|Phase 2 (Intent-to-Treat Population)||0
994397|NCT00467649|2412128|P1|STARTED|Phase 2 (Intent-to-Treat Population)||0
994398|NCT00467649|2412123|P6|NOT COMPLETED|Phase 1 (Randomized Population)||0
994399|NCT00467649|2412124|P5|NOT COMPLETED|Phase 1 (Randomized Population)||0
994400|NCT00467649|2412125|P4|NOT COMPLETED|Phase 1 (Randomized Population)||0
994401|NCT00467649|2412126|P3|NOT COMPLETED|Phase 1 (Randomized Population)||0
994402|NCT00467649|2412127|P2|NOT COMPLETED|Phase 1 (Randomized Population)||6
994403|NCT00467649|2412128|P1|NOT COMPLETED|Phase 1 (Randomized Population)||9
994404|NCT00467649|2412123|P6|COMPLETED|Phase 1 (Randomized Population)||0
994405|NCT00467649|2412124|P5|COMPLETED|Phase 1 (Randomized Population)||0
994406|NCT00467649|2412125|P4|COMPLETED|Phase 1 (Randomized Population)||0
994407|NCT00467649|2412126|P3|COMPLETED|Phase 1 (Randomized Population)||0
994408|NCT00467649|2412127|P2|COMPLETED|Phase 1 (Randomized Population)||50
994409|NCT00467649|2412128|P1|COMPLETED|Phase 1 (Randomized Population)||48
994410|NCT00467649|2412123|P6|Intent to Treat|Phase 1 (Randomized Population)||0
994411|NCT00467649|2412124|P5|Intent to Treat|Phase 1 (Randomized Population)||0
994412|NCT00467649|2412125|P4|Intent to Treat|Phase 1 (Randomized Population)||0
994413|NCT00467649|2412126|P3|Intent to Treat|Phase 1 (Randomized Population)||0
994414|NCT00467649|2412127|P2|Intent to Treat|Phase 1 (Randomized Population)||56
994415|NCT00467649|2412128|P1|Intent to Treat|Phase 1 (Randomized Population)||56
994416|NCT00467649|2412123|P6|STARTED|Phase 1 (Randomized Population)||0
994417|NCT00467649|2412124|P5|STARTED|Phase 1 (Randomized Population)||0
994418|NCT00467649|2412125|P4|STARTED|Phase 1 (Randomized Population)||0
994419|NCT00467649|2412126|P3|STARTED|Phase 1 (Randomized Population)||0
994420|NCT00467649|2412127|P2|STARTED|Phase 1 (Randomized Population)||56
994421|NCT00467649|2412128|P1|STARTED|Phase 1 (Randomized Population)|One patient randomized to the SYMLIN group withdrew consent prior to receiving the first dose|57
994422|NCT00467740|2412173|P5|NOT COMPLETED|Overall Study||0
994423|NCT00467740|2412174|P4|NOT COMPLETED|Overall Study||1
994424|NCT00467740|2412175|P3|NOT COMPLETED|Overall Study||2
994425|NCT00467740|2412176|P2|NOT COMPLETED|Overall Study||3
994426|NCT00467740|2412177|P1|NOT COMPLETED|Overall Study||1
994427|NCT00467740|2412173|P5|COMPLETED|Overall Study||61
994428|NCT00467740|2412174|P4|COMPLETED|Overall Study||59
994429|NCT00467740|2412175|P3|COMPLETED|Overall Study||58
994430|NCT00467740|2412176|P2|COMPLETED|Overall Study||58
994431|NCT00467740|2412177|P1|COMPLETED|Overall Study||53
994432|NCT00467740|2412173|P5|STARTED|Overall Study||61
994433|NCT00467740|2412174|P4|STARTED|Overall Study||60
994434|NCT00467740|2412175|P3|STARTED|Overall Study||60
994435|NCT00467740|2412176|P2|STARTED|Overall Study||61
994436|NCT00467740|2412177|P1|STARTED|Overall Study||54
994437|NCT00467753|2412366|P2|NOT COMPLETED|Overall Study||2
994438|NCT00467753|2412367|P1|NOT COMPLETED|Overall Study||3
994439|NCT00467753|2412366|P2|COMPLETED|Overall Study||0
994440|NCT00467753|2412367|P1|COMPLETED|Overall Study||0
994441|NCT00467753|2412366|P2|STARTED|Overall Study||2
994442|NCT00467753|2412367|P1|STARTED|Overall Study||3
994443|NCT00467779|2412388|P15|NOT COMPLETED|Stage 3||17
994444|NCT00467779|2412389|P14|NOT COMPLETED|Stage 3||0
994445|NCT00467779|2412390|P13|NOT COMPLETED|Stage 3||0
994446|NCT00467779|2412391|P12|NOT COMPLETED|Stage 3||0
994447|NCT00467779|2412392|P11|NOT COMPLETED|Stage 3||0
994448|NCT00467779|2412393|P10|NOT COMPLETED|Stage 3||0
994449|NCT00467779|2412394|P9|NOT COMPLETED|Stage 3||0
994450|NCT00467779|2412395|P8|NOT COMPLETED|Stage 3||0
994451|NCT00467779|2412396|P7|NOT COMPLETED|Stage 3||0
994452|NCT00467779|2412397|P6|NOT COMPLETED|Stage 3||0
994453|NCT00467779|2412398|P5|NOT COMPLETED|Stage 3||0
994454|NCT00467779|2412399|P4|NOT COMPLETED|Stage 3||0
994455|NCT00467779|2412400|P3|NOT COMPLETED|Stage 3||0
994456|NCT00467779|2412401|P2|NOT COMPLETED|Stage 3||0
994457|NCT00467779|2412402|P1|NOT COMPLETED|Stage 3||0
994458|NCT00467779|2412388|P15|COMPLETED|Stage 3||3
994459|NCT00467779|2412389|P14|COMPLETED|Stage 3||0
994460|NCT00467779|2412390|P13|COMPLETED|Stage 3||0
994461|NCT00467779|2412391|P12|COMPLETED|Stage 3||0
994462|NCT00467779|2412392|P11|COMPLETED|Stage 3||0
994463|NCT00467779|2412393|P10|COMPLETED|Stage 3||0
994464|NCT00467779|2412394|P9|COMPLETED|Stage 3||0
994465|NCT00467779|2412395|P8|COMPLETED|Stage 3||0
994466|NCT00467779|2412396|P7|COMPLETED|Stage 3||0
994467|NCT00467779|2412397|P6|COMPLETED|Stage 3||0
994468|NCT00467779|2412398|P5|COMPLETED|Stage 3||0
994469|NCT00467779|2412399|P4|COMPLETED|Stage 3||0
994470|NCT00467779|2412400|P3|COMPLETED|Stage 3||0
994471|NCT00467779|2412401|P2|COMPLETED|Stage 3||0
994472|NCT00467779|2412402|P1|COMPLETED|Stage 3||0
994473|NCT00467779|2412388|P15|STARTED|Stage 3||20
994474|NCT00467779|2412389|P14|STARTED|Stage 3||0
994475|NCT00467779|2412390|P13|STARTED|Stage 3||0
994476|NCT00467779|2412391|P12|STARTED|Stage 3||0
994477|NCT00467779|2412392|P11|STARTED|Stage 3||0
994478|NCT00467779|2412393|P10|STARTED|Stage 3||0
994479|NCT00467779|2412394|P9|STARTED|Stage 3||0
994480|NCT00467779|2412395|P8|STARTED|Stage 3||0
994481|NCT00467779|2412396|P7|STARTED|Stage 3||0
994482|NCT00467779|2412397|P6|STARTED|Stage 3||0
994483|NCT00467779|2412398|P5|STARTED|Stage 3||0
994484|NCT00467779|2412399|P4|STARTED|Stage 3||0
994485|NCT00467779|2412400|P3|STARTED|Stage 3||0
994486|NCT00467779|2412401|P2|STARTED|Stage 3||0
994487|NCT00467779|2412402|P1|STARTED|Stage 3||0
994488|NCT00467779|2412388|P15|NOT COMPLETED|Stage 2A||0
994489|NCT00467779|2412389|P14|NOT COMPLETED|Stage 2A||21
994490|NCT00467779|2412390|P13|NOT COMPLETED|Stage 2A||0
994491|NCT00467779|2412391|P12|NOT COMPLETED|Stage 2A||0
994492|NCT00467779|2412392|P11|NOT COMPLETED|Stage 2A||0
994493|NCT00467779|2412393|P10|NOT COMPLETED|Stage 2A||0
994494|NCT00467779|2412394|P9|NOT COMPLETED|Stage 2A||0
994495|NCT00467779|2412395|P8|NOT COMPLETED|Stage 2A||0
994496|NCT00467779|2412396|P7|NOT COMPLETED|Stage 2A||0
994497|NCT00467779|2412397|P6|NOT COMPLETED|Stage 2A||0
994498|NCT00467779|2412398|P5|NOT COMPLETED|Stage 2A||0
994499|NCT00467779|2412399|P4|NOT COMPLETED|Stage 2A||0
994500|NCT00467779|2412400|P3|NOT COMPLETED|Stage 2A||0
994501|NCT00467779|2412401|P2|NOT COMPLETED|Stage 2A||0
994502|NCT00467779|2412402|P1|NOT COMPLETED|Stage 2A||0
994503|NCT00467779|2412388|P15|COMPLETED|Stage 2A||0
994504|NCT00467779|2412389|P14|COMPLETED|Stage 2A||1
994505|NCT00467779|2412390|P13|COMPLETED|Stage 2A||0
994506|NCT00467779|2412391|P12|COMPLETED|Stage 2A||0
994507|NCT00467779|2412392|P11|COMPLETED|Stage 2A||0
994508|NCT00467779|2412393|P10|COMPLETED|Stage 2A||0
994509|NCT00467779|2412394|P9|COMPLETED|Stage 2A||0
994510|NCT00467779|2412395|P8|COMPLETED|Stage 2A||0
994511|NCT00467779|2412396|P7|COMPLETED|Stage 2A||0
994512|NCT00467779|2412397|P6|COMPLETED|Stage 2A||0
994513|NCT00467779|2412398|P5|COMPLETED|Stage 2A||0
994514|NCT00467779|2412399|P4|COMPLETED|Stage 2A||0
994515|NCT00467779|2412400|P3|COMPLETED|Stage 2A||0
994516|NCT00467779|2412401|P2|COMPLETED|Stage 2A||0
994517|NCT00467779|2412402|P1|COMPLETED|Stage 2A||0
994518|NCT00467779|2412388|P15|STARTED|Stage 2A||0
994519|NCT00467779|2412389|P14|STARTED|Stage 2A||22
994520|NCT00467779|2412390|P13|STARTED|Stage 2A||0
994521|NCT00467779|2412391|P12|STARTED|Stage 2A||0
994522|NCT00467779|2412392|P11|STARTED|Stage 2A||0
994523|NCT00467779|2412393|P10|STARTED|Stage 2A||0
994524|NCT00467779|2412394|P9|STARTED|Stage 2A||0
994525|NCT00467779|2412395|P8|STARTED|Stage 2A||0
994526|NCT00467779|2412396|P7|STARTED|Stage 2A||0
994527|NCT00467779|2412397|P6|STARTED|Stage 2A||0
994528|NCT00467779|2412398|P5|STARTED|Stage 2A||0
994529|NCT00467779|2412399|P4|STARTED|Stage 2A||0
994530|NCT00467779|2412400|P3|STARTED|Stage 2A||0
994531|NCT00467779|2412401|P2|STARTED|Stage 2A||0
994532|NCT00467779|2412402|P1|STARTED|Stage 2A||0
994533|NCT00467779|2412388|P15|NOT COMPLETED|Stage 2||0
994534|NCT00467779|2412389|P14|NOT COMPLETED|Stage 2||0
994535|NCT00467779|2412390|P13|NOT COMPLETED|Stage 2||0
994536|NCT00467779|2412391|P12|NOT COMPLETED|Stage 2||0
994537|NCT00467779|2412392|P11|NOT COMPLETED|Stage 2||0
994538|NCT00467779|2412393|P10|NOT COMPLETED|Stage 2||0
994539|NCT00467779|2412394|P9|NOT COMPLETED|Stage 2||21
994540|NCT00467779|2412395|P8|NOT COMPLETED|Stage 2||0
994541|NCT00467779|2412396|P7|NOT COMPLETED|Stage 2||0
994542|NCT00467779|2412397|P6|NOT COMPLETED|Stage 2||0
994543|NCT00467779|2412398|P5|NOT COMPLETED|Stage 2||0
994544|NCT00467779|2412399|P4|NOT COMPLETED|Stage 2||0
994545|NCT00467779|2412400|P3|NOT COMPLETED|Stage 2||0
994546|NCT00467779|2412401|P2|NOT COMPLETED|Stage 2||0
994547|NCT00467779|2412402|P1|NOT COMPLETED|Stage 2||0
994548|NCT00467779|2412388|P15|COMPLETED|Stage 2||0
994549|NCT00467779|2412389|P14|COMPLETED|Stage 2||0
994550|NCT00467779|2412390|P13|COMPLETED|Stage 2||0
994551|NCT00467779|2412391|P12|COMPLETED|Stage 2||0
994552|NCT00467779|2412392|P11|COMPLETED|Stage 2||0
994553|NCT00467779|2412393|P10|COMPLETED|Stage 2||0
994554|NCT00467779|2412394|P9|COMPLETED|Stage 2||0
994555|NCT00467779|2412395|P8|COMPLETED|Stage 2||0
994556|NCT00467779|2412396|P7|COMPLETED|Stage 2||0
994557|NCT00467779|2412397|P6|COMPLETED|Stage 2||0
994558|NCT00467779|2412398|P5|COMPLETED|Stage 2||0
994559|NCT00467779|2412399|P4|COMPLETED|Stage 2||0
994560|NCT00467779|2412400|P3|COMPLETED|Stage 2||0
994561|NCT00467779|2412401|P2|COMPLETED|Stage 2||0
994562|NCT00467779|2412402|P1|COMPLETED|Stage 2||0
994563|NCT00467779|2412388|P15|STARTED|Stage 2||0
994564|NCT00467779|2412389|P14|STARTED|Stage 2||0
994565|NCT00467779|2412390|P13|STARTED|Stage 2||0
994566|NCT00467779|2412391|P12|STARTED|Stage 2||0
994567|NCT00467779|2412392|P11|STARTED|Stage 2||0
994568|NCT00467779|2412393|P10|STARTED|Stage 2||0
994569|NCT00467779|2412394|P9|STARTED|Stage 2||21
994570|NCT00467779|2412395|P8|STARTED|Stage 2||0
994571|NCT00467779|2412396|P7|STARTED|Stage 2||0
994572|NCT00467779|2412397|P6|STARTED|Stage 2||0
994573|NCT00467779|2412398|P5|STARTED|Stage 2||0
994574|NCT00467779|2412399|P4|STARTED|Stage 2||0
994575|NCT00467779|2412400|P3|STARTED|Stage 2||0
994576|NCT00467779|2412401|P2|STARTED|Stage 2||0
994577|NCT00467779|2412402|P1|STARTED|Stage 2||0
994578|NCT00467779|2412388|P15|NOT COMPLETED|Stage 1A||0
994579|NCT00467779|2412389|P14|NOT COMPLETED|Stage 1A||0
994580|NCT00467779|2412390|P13|NOT COMPLETED|Stage 1A||6
994581|NCT00467779|2412391|P12|NOT COMPLETED|Stage 1A||8
994582|NCT00467779|2412392|P11|NOT COMPLETED|Stage 1A||3
994583|NCT00467779|2412393|P10|NOT COMPLETED|Stage 1A||3
994584|NCT00467779|2412394|P9|NOT COMPLETED|Stage 1A||0
994585|NCT00467779|2412395|P8|NOT COMPLETED|Stage 1A||0
994586|NCT00467779|2412396|P7|NOT COMPLETED|Stage 1A||0
994587|NCT00467779|2412397|P6|NOT COMPLETED|Stage 1A||0
994588|NCT00467779|2412398|P5|NOT COMPLETED|Stage 1A||0
994589|NCT00467779|2412399|P4|NOT COMPLETED|Stage 1A||0
994590|NCT00467779|2412400|P3|NOT COMPLETED|Stage 1A||0
994591|NCT00467779|2412401|P2|NOT COMPLETED|Stage 1A||0
994592|NCT00467779|2412402|P1|NOT COMPLETED|Stage 1A||0
994593|NCT00467779|2412388|P15|COMPLETED|Stage 1A||0
994594|NCT00467779|2412389|P14|COMPLETED|Stage 1A||0
994595|NCT00467779|2412390|P13|COMPLETED|Stage 1A||0
994596|NCT00467779|2412391|P12|COMPLETED|Stage 1A||0
994597|NCT00467779|2412392|P11|COMPLETED|Stage 1A||0
994598|NCT00467779|2412393|P10|COMPLETED|Stage 1A||0
994599|NCT00467779|2412394|P9|COMPLETED|Stage 1A||0
994600|NCT00467779|2412395|P8|COMPLETED|Stage 1A||0
994601|NCT00467779|2412396|P7|COMPLETED|Stage 1A||0
994602|NCT00467779|2412397|P6|COMPLETED|Stage 1A||0
994603|NCT00467779|2412398|P5|COMPLETED|Stage 1A||0
994604|NCT00467779|2412399|P4|COMPLETED|Stage 1A||0
994605|NCT00467779|2412400|P3|COMPLETED|Stage 1A||0
994606|NCT00467779|2412401|P2|COMPLETED|Stage 1A||0
994607|NCT00467779|2412402|P1|COMPLETED|Stage 1A||0
994608|NCT00467779|2412388|P15|STARTED|Stage 1A||0
994609|NCT00467779|2412389|P14|STARTED|Stage 1A||0
994610|NCT00467779|2412390|P13|STARTED|Stage 1A||6
994611|NCT00467779|2412391|P12|STARTED|Stage 1A||8
994612|NCT00467779|2412392|P11|STARTED|Stage 1A||3
994613|NCT00467779|2412393|P10|STARTED|Stage 1A||3
994614|NCT00467779|2412394|P9|STARTED|Stage 1A||0
994615|NCT00467779|2412395|P8|STARTED|Stage 1A||0
994616|NCT00467779|2412396|P7|STARTED|Stage 1A||0
994617|NCT00467779|2412397|P6|STARTED|Stage 1A||0
994618|NCT00467779|2412398|P5|STARTED|Stage 1A||0
994619|NCT00467779|2412399|P4|STARTED|Stage 1A||0
994620|NCT00467779|2412400|P3|STARTED|Stage 1A||0
994621|NCT00467779|2412401|P2|STARTED|Stage 1A||0
994622|NCT00467779|2412402|P1|STARTED|Stage 1A||0
994623|NCT00467779|2412388|P15|NOT COMPLETED|Stage 1||0
994624|NCT00467779|2412389|P14|NOT COMPLETED|Stage 1||0
994625|NCT00467779|2412390|P13|NOT COMPLETED|Stage 1||0
994626|NCT00467779|2412391|P12|NOT COMPLETED|Stage 1||0
994627|NCT00467779|2412392|P11|NOT COMPLETED|Stage 1||0
994628|NCT00467779|2412393|P10|NOT COMPLETED|Stage 1||0
994629|NCT00467779|2412394|P9|NOT COMPLETED|Stage 1||0
994630|NCT00467779|2412395|P8|NOT COMPLETED|Stage 1||7
994631|NCT00467779|2412396|P7|NOT COMPLETED|Stage 1||7
994632|NCT00467779|2412397|P6|NOT COMPLETED|Stage 1||5
994633|NCT00467779|2412398|P5|NOT COMPLETED|Stage 1||3
994634|NCT00467779|2412399|P4|NOT COMPLETED|Stage 1||3
994635|NCT00467779|2412400|P3|NOT COMPLETED|Stage 1||3
994636|NCT00467779|2412401|P2|NOT COMPLETED|Stage 1||3
994637|NCT00467779|2412402|P1|NOT COMPLETED|Stage 1||4
994638|NCT00467779|2412388|P15|COMPLETED|Stage 1||0
994639|NCT00467779|2412389|P14|COMPLETED|Stage 1||0
994640|NCT00467779|2412390|P13|COMPLETED|Stage 1||0
994641|NCT00467779|2412391|P12|COMPLETED|Stage 1||0
994642|NCT00467779|2412392|P11|COMPLETED|Stage 1||0
994643|NCT00467779|2412393|P10|COMPLETED|Stage 1||0
994644|NCT00467779|2412394|P9|COMPLETED|Stage 1||0
994645|NCT00467779|2412395|P8|COMPLETED|Stage 1||0
994646|NCT00467779|2412396|P7|COMPLETED|Stage 1||0
994647|NCT00467779|2412397|P6|COMPLETED|Stage 1||1
994648|NCT00467779|2412398|P5|COMPLETED|Stage 1||0
994649|NCT00467779|2412399|P4|COMPLETED|Stage 1||0
994650|NCT00467779|2412400|P3|COMPLETED|Stage 1||0
994651|NCT00467779|2412401|P2|COMPLETED|Stage 1||0
994652|NCT00467779|2412402|P1|COMPLETED|Stage 1||0
994653|NCT00467779|2412388|P15|STARTED|Stage 1||0
994654|NCT00467779|2412389|P14|STARTED|Stage 1||0
994655|NCT00467779|2412390|P13|STARTED|Stage 1||0
994656|NCT00467779|2412391|P12|STARTED|Stage 1||0
994657|NCT00467779|2412392|P11|STARTED|Stage 1||0
994658|NCT00467779|2412393|P10|STARTED|Stage 1||0
994659|NCT00467779|2412394|P9|STARTED|Stage 1||0
994660|NCT00467779|2412395|P8|STARTED|Stage 1||7
994661|NCT00467779|2412396|P7|STARTED|Stage 1||7
994662|NCT00467779|2412397|P6|STARTED|Stage 1||6
994663|NCT00467779|2412398|P5|STARTED|Stage 1||3
994664|NCT00467779|2412399|P4|STARTED|Stage 1||3
994665|NCT00467779|2412400|P3|STARTED|Stage 1||3
994666|NCT00467779|2412401|P2|STARTED|Stage 1||3
994667|NCT00467779|2412402|P1|STARTED|Stage 1||4
994668|NCT00467831|2412574|P1|NOT COMPLETED|Overall Study||3
994669|NCT00467831|2412574|P1|COMPLETED|Overall Study||0
994670|NCT00467831|2412574|P1|STARTED|Overall Study||3
994671|NCT00467844|2412581|P3|NOT COMPLETED|Overall Study||14
994672|NCT00467844|2412582|P2|NOT COMPLETED|Overall Study||20
994673|NCT00467844|2412583|P1|NOT COMPLETED|Overall Study||19
994674|NCT00467844|2412581|P3|COMPLETED|Overall Study||38
994675|NCT00467844|2412582|P2|COMPLETED|Overall Study||34
994676|NCT00467844|2412583|P1|COMPLETED|Overall Study||34
994677|NCT00467844|2412581|P3|STARTED|Overall Study||52
994678|NCT00467844|2412582|P2|STARTED|Overall Study||54
994679|NCT00467844|2412583|P1|STARTED|Overall Study||53
994680|NCT00467857|2412596|P2|NOT COMPLETED|Overall Study||8
994681|NCT00467857|2412597|P1|NOT COMPLETED|Overall Study||3
994682|NCT00467857|2412596|P2|COMPLETED|Overall Study||139
994683|NCT00467857|2412597|P1|COMPLETED|Overall Study||143
994684|NCT00467857|2412596|P2|STARTED|Overall Study||147
994685|NCT00467857|2412597|P1|STARTED|Overall Study||146
994686|NCT00467870|2412635|P6|NOT COMPLETED|Overall Study||2
994687|NCT00467870|2412636|P5|NOT COMPLETED|Overall Study||37
994688|NCT00467870|2412637|P4|NOT COMPLETED|Overall Study||33
994689|NCT00467870|2412638|P3|NOT COMPLETED|Overall Study||4
994690|NCT00467870|2412639|P2|NOT COMPLETED|Overall Study||43
994691|NCT00467870|2412640|P1|NOT COMPLETED|Overall Study||45
994692|NCT00467870|2412635|P6|COMPLETED|Overall Study||21
994693|NCT00467870|2412636|P5|COMPLETED|Overall Study||93
994694|NCT00467870|2412637|P4|COMPLETED|Overall Study||79
994695|NCT00467870|2412638|P3|COMPLETED|Overall Study||18
994696|NCT00467870|2412639|P2|COMPLETED|Overall Study||74
994697|NCT00467870|2412640|P1|COMPLETED|Overall Study||75
994698|NCT00467870|2412635|P6|STARTED|Overall Study||23
994699|NCT00467870|2412636|P5|STARTED|Overall Study||130
994700|NCT00467870|2412637|P4|STARTED|Overall Study||112
994701|NCT00467870|2412638|P3|STARTED|Overall Study||22
994702|NCT00467870|2412639|P2|STARTED|Overall Study||117
994703|NCT00467870|2412640|P1|STARTED|Overall Study||120
994704|NCT00467896|2412681|P1|NOT COMPLETED|Overall Study||51
994705|NCT00467896|2412681|P1|COMPLETED|Overall Study||11
994706|NCT00467896|2412681|P1|STARTED|Overall Study||62
994707|NCT00467961|2412701|P1|NOT COMPLETED|Overall Study||7
994708|NCT00467961|2412701|P1|COMPLETED|Overall Study||24
994709|NCT00467961|2412701|P1|STARTED|Overall Study||31
994710|NCT00468052|2412707|P2|NOT COMPLETED|Overall Study||8
994711|NCT00468052|2412708|P1|NOT COMPLETED|Overall Study||7
994712|NCT00468052|2412707|P2|COMPLETED|Overall Study||61
994713|NCT00468052|2412708|P1|COMPLETED|Overall Study||61
994714|NCT00468052|2412707|P2|Target Enrollment|Overall Study||70
994715|NCT00468052|2412708|P1|Target Enrollment|Overall Study||70
994716|NCT00468052|2412707|P2|STARTED|Overall Study|One had an intraoperative complication and was withdrawn. 7 eliminated for a break in protocol.|69
994717|NCT00468052|2412708|P1|STARTED|Overall Study|1 subject withdrew consent.Surgery was cancelled for 2. 4 subjects eliminated for break in protocol|68
994718|NCT00468104|2412726|P2|NOT COMPLETED|Second Intervention||4
994719|NCT00468104|2412727|P1|NOT COMPLETED|Second Intervention||5
994720|NCT00468104|2412726|P2|COMPLETED|Second Intervention||37
994721|NCT00468104|2412727|P1|COMPLETED|Second Intervention||3
994722|NCT00468104|2412726|P2|STARTED|Second Intervention|4 patients responded to Placebo and did not go to the second intervention|41
994723|NCT00468104|2412727|P1|STARTED|Second Intervention|37 responded to Alteplase and did not go to the second intervention|8
994724|NCT00468104|2412726|P2|NOT COMPLETED|First Intervention||1
994725|NCT00468104|2412727|P1|NOT COMPLETED|First Intervention||9
994726|NCT00468104|2412726|P2|COMPLETED|First Intervention||45
994727|NCT00468104|2412727|P1|COMPLETED|First Intervention||45
994728|NCT00468104|2412726|P2|STARTED|First Intervention||46
994729|NCT00468104|2412727|P1|STARTED|First Intervention||54
994730|NCT00468143|2412742|P2|NOT COMPLETED|Second Intervention (3 Weeks)||3
994731|NCT00468143|2412743|P1|NOT COMPLETED|Second Intervention (3 Weeks)||3
994732|NCT00468143|2412742|P2|COMPLETED|Second Intervention (3 Weeks)||24
994733|NCT00468143|2412743|P1|COMPLETED|Second Intervention (3 Weeks)||25
994734|NCT00468143|2412742|P2|STARTED|Second Intervention (3 Weeks)||27
994735|NCT00468143|2412743|P1|STARTED|Second Intervention (3 Weeks)||28
994736|NCT00468143|2412742|P2|NOT COMPLETED|First Intervention (3 Weeks)||4
994737|NCT00468143|2412743|P1|NOT COMPLETED|First Intervention (3 Weeks)||3
994738|NCT00468143|2412742|P2|COMPLETED|First Intervention (3 Weeks)||27
994739|NCT00468143|2412743|P1|COMPLETED|First Intervention (3 Weeks)||28
994740|NCT00468143|2412742|P2|STARTED|First Intervention (3 Weeks)||31
994741|NCT00468143|2412743|P1|STARTED|First Intervention (3 Weeks)||31
994742|NCT00468208|2412757|P1|NOT COMPLETED|Overall Study||0
994743|NCT00468208|2412757|P1|COMPLETED|Overall Study|All patients reached common closing or early termination|20
994744|NCT00468208|2412757|P1|STARTED|Overall Study||20
994745|NCT00468286|2412767|P2|NOT COMPLETED|Overall Study||12
994746|NCT00468286|2412768|P1|NOT COMPLETED|Overall Study||7
994747|NCT00468286|2412767|P2|COMPLETED|Overall Study||54
994748|NCT00468286|2412768|P1|COMPLETED|Overall Study||60
994749|NCT00468286|2412767|P2|STARTED|Overall Study||66
994750|NCT00468286|2412768|P1|STARTED|Overall Study|Started=Intention to treat (ITT) population.|67
994751|NCT00468299|2412792|P2|NOT COMPLETED|Overall Study||1
994752|NCT00468299|2412793|P1|NOT COMPLETED|Overall Study||0
994753|NCT00468299|2412792|P2|COMPLETED|Overall Study||7
994754|NCT00468299|2412793|P1|COMPLETED|Overall Study||9
994755|NCT00468299|2412792|P2|STARTED|Overall Study||8
994756|NCT00468299|2412793|P1|STARTED|Overall Study||9
994757|NCT00468312|2412803|P2|NOT COMPLETED|Overall Study||5
994758|NCT00468312|2412804|P1|NOT COMPLETED|Overall Study||4
994759|NCT00468312|2412803|P2|COMPLETED|Overall Study||204
994760|NCT00468312|2412804|P1|COMPLETED|Overall Study||216
994761|NCT00468312|2412803|P2|STARTED|Overall Study||209
994762|NCT00468312|2412804|P1|STARTED|Overall Study||220
994763|NCT00468481|2412820|P2|NOT COMPLETED|Overall Study||24
994764|NCT00468481|2412821|P1|NOT COMPLETED|Overall Study||88
994765|NCT00468481|2412820|P2|COMPLETED|Overall Study||70
994766|NCT00468481|2412821|P1|COMPLETED|Overall Study||203
994767|NCT00468481|2412820|P2|Subjects Treated|Overall Study||94
994768|NCT00468481|2412821|P1|Subjects Treated|Overall Study||285
994769|NCT00468481|2412820|P2|STARTED|Overall Study||94
994770|NCT00468481|2412821|P1|STARTED|Overall Study|6 of these randomized subjects did not take any study medication|291
994771|NCT00468546|2412921|P2|NOT COMPLETED|Week 24 to Week 104 Analysis||225
994772|NCT00468546|2412922|P1|NOT COMPLETED|Week 24 to Week 104 Analysis||105
994773|NCT00468546|2412921|P2|COMPLETED|Week 24 to Week 104 Analysis||83
994774|NCT00468546|2412922|P1|COMPLETED|Week 24 to Week 104 Analysis||103
994775|NCT00468546|2412921|P2|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed W24 analysis were entered in W24 to W104 analysis.|308
994776|NCT00468546|2412922|P1|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed Week (W) 24 analysis were entered in W24 to W104 analysis.|208
994777|NCT00468546|2412921|P2|NOT COMPLETED|Week 24 Analysis||55
994778|NCT00468546|2412922|P1|NOT COMPLETED|Week 24 Analysis||97
994779|NCT00468546|2412921|P2|COMPLETED|Week 24 Analysis||253
994780|NCT00468546|2412922|P1|COMPLETED|Week 24 Analysis||111
994781|NCT00468546|2412921|P2|STARTED|Week 24 Analysis||308
994782|NCT00468546|2412922|P1|STARTED|Week 24 Analysis||208
994783|NCT00468559|2412952|P3|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||17
994784|NCT00468559|2412953|P2|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||10
994785|NCT00468559|2412954|P1|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||0
994786|NCT00468559|2412952|P3|COMPLETED|Double-blind, Treatment-withdrawal Phase||24
994787|NCT00468559|2412953|P2|COMPLETED|Double-blind, Treatment-withdrawal Phase||29
994788|NCT00468559|2412954|P1|COMPLETED|Double-blind, Treatment-withdrawal Phase||0
994789|NCT00468559|2412952|P3|STARTED|Double-blind, Treatment-withdrawal Phase||41
994790|NCT00468559|2412953|P2|STARTED|Double-blind, Treatment-withdrawal Phase||39
994791|NCT00468559|2412954|P1|STARTED|Double-blind, Treatment-withdrawal Phase||0
994792|NCT00468559|2412952|P3|NOT COMPLETED|Open-label Treatment Phase||0
994793|NCT00468559|2412953|P2|NOT COMPLETED|Open-label Treatment Phase||0
994794|NCT00468559|2412954|P1|NOT COMPLETED|Open-label Treatment Phase||18
994795|NCT00468559|2412952|P3|COMPLETED|Open-label Treatment Phase||0
994796|NCT00468559|2412953|P2|COMPLETED|Open-label Treatment Phase||0
994888|NCT00469079|2413442|P2|NOT COMPLETED|Overall Study||22
994797|NCT00468559|2412954|P1|COMPLETED|Open-label Treatment Phase|18 patients discontinued (were not randomized into the double-blind treatment withdrawal phase)|80
994798|NCT00468559|2412952|P3|STARTED|Open-label Treatment Phase||0
994799|NCT00468559|2412953|P2|STARTED|Open-label Treatment Phase||0
994800|NCT00468559|2412954|P1|STARTED|Open-label Treatment Phase|All participants received open-label esomeprazole during this phase of the study|98
994801|NCT00468585|2412984|P4|NOT COMPLETED|Overall Study||1
994802|NCT00468585|2412985|P3|NOT COMPLETED|Overall Study||5
994803|NCT00468585|2412986|P2|NOT COMPLETED|Overall Study||0
994804|NCT00468585|2412987|P1|NOT COMPLETED|Overall Study||1
994805|NCT00468585|2412984|P4|COMPLETED|Overall Study||5
994806|NCT00468585|2412985|P3|COMPLETED|Overall Study||45
994807|NCT00468585|2412986|P2|COMPLETED|Overall Study||3
994808|NCT00468585|2412987|P1|COMPLETED|Overall Study||3
994809|NCT00468585|2412984|P4|STARTED|Overall Study||6
994810|NCT00468585|2412985|P3|STARTED|Overall Study||50
994811|NCT00468585|2412986|P2|STARTED|Overall Study||3
994812|NCT00468585|2412987|P1|STARTED|Overall Study||4
994813|NCT00468650|2412997|P1|NOT COMPLETED|Overall Study||7
994814|NCT00468650|2412997|P1|COMPLETED|Overall Study||110
994815|NCT00468650|2412997|P1|STARTED|Overall Study||117
994816|NCT00468676|2413043|P2|NOT COMPLETED|Overall Study||12
994817|NCT00468676|2413044|P1|NOT COMPLETED|Overall Study||16
994818|NCT00468676|2413043|P2|COMPLETED|Overall Study||94
994819|NCT00468676|2413044|P1|COMPLETED|Overall Study||92
994820|NCT00468676|2413043|P2|STARTED|Overall Study||106
994821|NCT00468676|2413044|P1|STARTED|Overall Study||108
994822|NCT00468728|2413063|P2|NOT COMPLETED|Follow-up||31
994823|NCT00468728|2413064|P1|NOT COMPLETED|Follow-up||34
994824|NCT00468728|2413063|P2|COMPLETED|Follow-up||222
994825|NCT00468728|2413064|P1|COMPLETED|Follow-up||222
994826|NCT00468728|2413063|P2|STARTED|Follow-up||253
994827|NCT00468728|2413064|P1|STARTED|Follow-up||256
994828|NCT00468728|2413063|P2|NOT COMPLETED|Treatment||11
994829|NCT00468728|2413064|P1|NOT COMPLETED|Treatment||4
994830|NCT00468728|2413063|P2|COMPLETED|Treatment||253
994831|NCT00468728|2413064|P1|COMPLETED|Treatment||256
994832|NCT00468728|2413063|P2|STARTED|Treatment||264
994833|NCT00468728|2413064|P1|STARTED|Treatment||260
994834|NCT00468728|2413063|P2|NOT COMPLETED|Enrollment||7
994835|NCT00468728|2413064|P1|NOT COMPLETED|Enrollment||4
994836|NCT00468728|2413063|P2|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|264
994837|NCT00468728|2413064|P1|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|260
994838|NCT00468728|2413063|P2|STARTED|Enrollment||271
994839|NCT00468728|2413064|P1|STARTED|Enrollment||264
994840|NCT00468819|2413077|P3|NOT COMPLETED|Overall Study||2
994841|NCT00468819|2413078|P2|NOT COMPLETED|Overall Study||0
994842|NCT00468819|2413079|P1|NOT COMPLETED|Overall Study||6
994843|NCT00468819|2413077|P3|COMPLETED|Overall Study||46
994844|NCT00468819|2413078|P2|COMPLETED|Overall Study||44
994845|NCT00468819|2413079|P1|COMPLETED|Overall Study||42
994846|NCT00468819|2413077|P3|Treatment Received/ Safety Follow-up|Overall Study|FAS|48
994847|NCT00468819|2413078|P2|Treatment Received/ Safety Follow-up|Overall Study|FAS|44
994848|NCT00468819|2413079|P1|Treatment Received/ Safety Follow-up|Overall Study|FAS (Full Analysis Set)|46
994849|NCT00468819|2413077|P3|STARTED|Overall Study|Enrolled participants|48
994850|NCT00468819|2413078|P2|STARTED|Overall Study|Enrolled participants|44
994851|NCT00468819|2413079|P1|STARTED|Overall Study|Enrolled participants|48
994852|NCT00468845|2413160|P3|NOT COMPLETED|Overall Study||30
994853|NCT00468845|2413161|P2|NOT COMPLETED|Overall Study||34
994854|NCT00468845|2413162|P1|NOT COMPLETED|Overall Study||21
994855|NCT00468845|2413160|P3|COMPLETED|Overall Study||139
994856|NCT00468845|2413161|P2|COMPLETED|Overall Study||136
994857|NCT00468845|2413162|P1|COMPLETED|Overall Study||141
994858|NCT00468845|2413160|P3|Received Treatment|Overall Study||167
994859|NCT00468845|2413161|P2|Received Treatment|Overall Study||166
994860|NCT00468845|2413162|P1|Received Treatment|Overall Study||161
994861|NCT00468845|2413160|P3|STARTED|Overall Study||169
994862|NCT00468845|2413161|P2|STARTED|Overall Study||170
994863|NCT00468845|2413162|P1|STARTED|Overall Study||162
994864|NCT00468858|2413299|P3|NOT COMPLETED|Overall Study||14
994865|NCT00468858|2413300|P2|NOT COMPLETED|Overall Study||10
994866|NCT00468858|2413301|P1|NOT COMPLETED|Overall Study||9
994867|NCT00468858|2413299|P3|COMPLETED|Overall Study||199
994868|NCT00468858|2413300|P2|COMPLETED|Overall Study||202
994869|NCT00468858|2413301|P1|COMPLETED|Overall Study||202
994870|NCT00468858|2413299|P3|STARTED|Overall Study||213
994871|NCT00468858|2413300|P2|STARTED|Overall Study||212
994872|NCT00468858|2413301|P1|STARTED|Overall Study||211
994873|NCT00468910|2413421|P2|NOT COMPLETED|Overall Study||3
994874|NCT00468910|2413422|P1|NOT COMPLETED|Overall Study||4
994875|NCT00468910|2413421|P2|COMPLETED|Overall Study||36
994876|NCT00468910|2413422|P1|COMPLETED|Overall Study||36
994877|NCT00468910|2413421|P2|Follow-up|Overall Study||36
994878|NCT00468910|2413422|P1|Follow-up|Overall Study||36
994879|NCT00468910|2413421|P2|Post-Treatment Biopsy|Overall Study||36
994880|NCT00468910|2413422|P1|Post-Treatment Biopsy|Overall Study||36
994881|NCT00468910|2413421|P2|Treatment|Overall Study||36
994882|NCT00468910|2413422|P1|Treatment|Overall Study||36
994883|NCT00468910|2413421|P2|Randomization|Overall Study||39
994884|NCT00468910|2413422|P1|Randomization|Overall Study||40
994885|NCT00468910|2413421|P2|STARTED|Overall Study||39
994886|NCT00468910|2413422|P1|STARTED|Overall Study||40
994887|NCT00469079|2413441|P3|NOT COMPLETED|Overall Study||19
994889|NCT00469079|2413443|P1|NOT COMPLETED|Overall Study||9
994890|NCT00469079|2413441|P3|COMPLETED|Overall Study||32
994891|NCT00469079|2413442|P2|COMPLETED|Overall Study||30
994892|NCT00469079|2413443|P1|COMPLETED|Overall Study||18
994893|NCT00469079|2413441|P3|STARTED|Overall Study||51
994894|NCT00469079|2413442|P2|STARTED|Overall Study||52
994895|NCT00469079|2413443|P1|STARTED|Overall Study||27
994896|NCT00469092|2413462|P2|NOT COMPLETED|Overall Study||21
994897|NCT00469092|2413463|P1|NOT COMPLETED|Overall Study||26
994898|NCT00469092|2413462|P2|COMPLETED|Overall Study||220
994899|NCT00469092|2413463|P1|COMPLETED|Overall Study||213
994900|NCT00469092|2413462|P2|Exposed to Study Drug|Overall Study||238
994901|NCT00469092|2413463|P1|Exposed to Study Drug|Overall Study||231
994902|NCT00469092|2413462|P2|STARTED|Overall Study||241
994903|NCT00469092|2413463|P1|STARTED|Overall Study||239
994904|NCT00469209|2413482|P3|NOT COMPLETED|Overall Study||1
994905|NCT00469209|2413483|P2|NOT COMPLETED|Overall Study||0
994906|NCT00469209|2413484|P1|NOT COMPLETED|Overall Study||1
994907|NCT00469209|2413482|P3|COMPLETED|Overall Study||19
994908|NCT00469209|2413483|P2|COMPLETED|Overall Study||20
994909|NCT00469209|2413484|P1|COMPLETED|Overall Study||19
994910|NCT00469209|2413482|P3|STARTED|Overall Study||20
994911|NCT00469209|2413483|P2|STARTED|Overall Study||20
994912|NCT00469209|2413484|P1|STARTED|Overall Study||20
994913|NCT00469274|2413494|P2|NOT COMPLETED|Overall Study||0
994914|NCT00469274|2413495|P1|NOT COMPLETED|Overall Study||0
994915|NCT00469274|2413494|P2|COMPLETED|Overall Study||42
994916|NCT00469274|2413495|P1|COMPLETED|Overall Study||44
994917|NCT00469274|2413494|P2|STARTED|Overall Study||42
994918|NCT00469274|2413495|P1|STARTED|Overall Study||44
994919|NCT00469391|2413503|P2|NOT COMPLETED|Overall Study||5
994920|NCT00469391|2413504|P1|NOT COMPLETED|Overall Study||14
994921|NCT00469391|2413503|P2|COMPLETED|Overall Study||24
994922|NCT00469391|2413504|P1|COMPLETED|Overall Study||13
994923|NCT00469391|2413503|P2|Patient Preference|Overall Study||1
994924|NCT00469391|2413504|P1|Patient Preference|Overall Study||0
994925|NCT00469391|2413503|P2|Lost to Follow up|Overall Study||1
994926|NCT00469391|2413504|P1|Lost to Follow up|Overall Study||0
994927|NCT00469391|2413503|P2|Adverse Event|Overall Study||0
994928|NCT00469391|2413504|P1|Adverse Event|Overall Study||8
994929|NCT00469391|2413503|P2|Unsuccessful Implant Procedure|Overall Study||0
994930|NCT00469391|2413504|P1|Unsuccessful Implant Procedure|Overall Study||4
994931|NCT00469391|2413503|P2|Discontinued Prior to Procedure|Overall Study||3
994932|NCT00469391|2413504|P1|Discontinued Prior to Procedure|Overall Study||2
994933|NCT00469391|2413503|P2|STARTED|Overall Study||29
994934|NCT00469391|2413504|P1|STARTED|Overall Study||27
994935|NCT00458536|2413510|P1|NOT COMPLETED|Overall Study||19
994936|NCT00458536|2413510|P1|COMPLETED|Overall Study||19
994937|NCT00458536|2413510|P1|STARTED|Overall Study||38
994938|NCT00458705|2413514|P1|NOT COMPLETED|Overall Study||5
994939|NCT00458705|2413514|P1|COMPLETED|Overall Study||40
994940|NCT00458705|2413514|P1|STARTED|Overall Study||45
994941|NCT00458822|2413518|P1|NOT COMPLETED|Overall Study||0
994942|NCT00458822|2413518|P1|COMPLETED|Overall Study||40
994943|NCT00458822|2413518|P1|STARTED|Overall Study||40
994944|NCT00458952|2413524|P2|NOT COMPLETED|Overall Study||5
994945|NCT00458952|2413525|P1|NOT COMPLETED|Overall Study||2
994946|NCT00458952|2413524|P2|COMPLETED|Overall Study||9
994947|NCT00458952|2413525|P1|COMPLETED|Overall Study||5
994948|NCT00458952|2413524|P2|STARTED|Overall Study||14
994949|NCT00458952|2413525|P1|STARTED|Overall Study||7
994950|NCT00459043|2413531|P2|NOT COMPLETED|Overall Study||0
994951|NCT00459043|2413532|P1|NOT COMPLETED|Overall Study||1
994952|NCT00459043|2413531|P2|COMPLETED|Overall Study||15
994953|NCT00459043|2413532|P1|COMPLETED|Overall Study||14
994954|NCT00459043|2413531|P2|STARTED|Overall Study||15
994955|NCT00459043|2413532|P1|STARTED|Overall Study||15
994956|NCT00459056|2413544|P2|NOT COMPLETED|Second Intervention (Final Three Months)||0
994957|NCT00459056|2413545|P1|NOT COMPLETED|Second Intervention (Final Three Months)||0
994958|NCT00459056|2413544|P2|COMPLETED|Second Intervention (Final Three Months)||14
994959|NCT00459056|2413545|P1|COMPLETED|Second Intervention (Final Three Months)||9
994960|NCT00459056|2413544|P2|STARTED|Second Intervention (Final Three Months)||14
994961|NCT00459056|2413545|P1|STARTED|Second Intervention (Final Three Months)||9
994962|NCT00459056|2413544|P2|NOT COMPLETED|Washout (1 Month)||0
994963|NCT00459056|2413545|P1|NOT COMPLETED|Washout (1 Month)||0
994964|NCT00459056|2413544|P2|COMPLETED|Washout (1 Month)||14
994965|NCT00459056|2413545|P1|COMPLETED|Washout (1 Month)||9
994966|NCT00459056|2413544|P2|STARTED|Washout (1 Month)||14
994967|NCT00459056|2413545|P1|STARTED|Washout (1 Month)||9
994968|NCT00459056|2413544|P2|NOT COMPLETED|First Intervention (First Three Months)||1
994969|NCT00459056|2413545|P1|NOT COMPLETED|First Intervention (First Three Months)||1
994970|NCT00459056|2413544|P2|COMPLETED|First Intervention (First Three Months)||14
994971|NCT00459056|2413545|P1|COMPLETED|First Intervention (First Three Months)||9
994972|NCT00459056|2413544|P2|STARTED|First Intervention (First Three Months)||15
994973|NCT00459056|2413545|P1|STARTED|First Intervention (First Three Months)||10
994974|NCT00459108|2413551|P1|NOT COMPLETED|Overall Study||11
994975|NCT00459108|2413551|P1|COMPLETED|Overall Study||14
994976|NCT00459108|2413551|P1|STARTED|Overall Study||25
994977|NCT00459121|2413556|P1|NOT COMPLETED|Overall Study||0
994978|NCT00459121|2413556|P1|COMPLETED|Overall Study||2
994979|NCT00459121|2413556|P1|STARTED|Overall Study||2
994980|NCT00459134|2413562|P2|NOT COMPLETED|Overall Study||25
994981|NCT00459134|2413563|P1|NOT COMPLETED|Overall Study||23
994982|NCT00459134|2413562|P2|COMPLETED|Overall Study||67
994983|NCT00459134|2413563|P1|COMPLETED|Overall Study||71
994984|NCT00459134|2413562|P2|STARTED|Overall Study||92
994985|NCT00459134|2413563|P1|STARTED|Overall Study||94
994986|NCT00459186|2413571|P1|NOT COMPLETED|Combination RAD001 + Docetaxel||0
994987|NCT00459186|2413571|P1|COMPLETED|Combination RAD001 + Docetaxel||15
994988|NCT00459186|2413571|P1|STARTED|Combination RAD001 + Docetaxel||15
994989|NCT00459186|2413571|P1|NOT COMPLETED|PET Imaging and Assessment||3
994990|NCT00459186|2413571|P1|COMPLETED|PET Imaging and Assessment||15
994991|NCT00459186|2413571|P1|STARTED|PET Imaging and Assessment||18
994992|NCT00459186|2413571|P1|NOT COMPLETED|Single Agent RAD001||1
994993|NCT00459186|2413571|P1|COMPLETED|Single Agent RAD001||18
994994|NCT00459186|2413571|P1|STARTED|Single Agent RAD001||19
994995|NCT00459290|2413576|P1|NOT COMPLETED|Overall Study||5
994996|NCT00459290|2413576|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|19
994997|NCT00459290|2413576|P1|STARTED|Overall Study||24
994998|NCT00459303|2413590|P1|NOT COMPLETED|Overall Study||0
994999|NCT00459303|2413590|P1|COMPLETED|Overall Study||20
995000|NCT00459303|2413590|P1|STARTED|Overall Study||20
995001|NCT00459316|2413605|P3|NOT COMPLETED|Step 3||1
995002|NCT00459316|2413606|P2|NOT COMPLETED|Step 3||0
995003|NCT00459316|2413607|P1|NOT COMPLETED|Step 3||3
995004|NCT00459316|2413605|P3|COMPLETED|Step 3||39
995005|NCT00459316|2413606|P2|COMPLETED|Step 3||0
995006|NCT00459316|2413607|P1|COMPLETED|Step 3||149
995007|NCT00459316|2413605|P3|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|40
995008|NCT00459316|2413606|P2|STARTED|Step 3|Group 2 participants were not eligible for Step 3|0
995009|NCT00459316|2413607|P1|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|152
995010|NCT00459316|2413605|P3|NOT COMPLETED|Steps 1 & 2||2
995011|NCT00459316|2413606|P2|NOT COMPLETED|Steps 1 & 2||7
995012|NCT00459316|2413607|P1|NOT COMPLETED|Steps 1 & 2||21
995013|NCT00459316|2413605|P3|COMPLETED|Steps 1 & 2||57
995014|NCT00459316|2413606|P2|COMPLETED|Steps 1 & 2||32
995015|NCT00459316|2413607|P1|COMPLETED|Steps 1 & 2||259
995016|NCT00459316|2413605|P3|STARTED|Steps 1 & 2||59
995017|NCT00459316|2413606|P2|STARTED|Steps 1 & 2||39
995018|NCT00459316|2413607|P1|STARTED|Steps 1 & 2||280
995019|NCT00459342|2413661|P1|NOT COMPLETED|Overall Study||1
995020|NCT00459342|2413661|P1|COMPLETED|Overall Study||34
995021|NCT00459342|2413661|P1|STARTED|Overall Study||35
995022|NCT00459355|2413668|P2|NOT COMPLETED|Overall Study||18
995023|NCT00459355|2413669|P1|NOT COMPLETED|Overall Study||20
995024|NCT00459355|2413668|P2|COMPLETED|Overall Study|Includes 48 dyads, caregiver + care-recipient|96
995025|NCT00459355|2413669|P1|COMPLETED|Overall Study|Includes 60 dyads, caregiver + care-recipient|120
995026|NCT00459355|2413668|P2|STARTED|Overall Study|Includes 57 dyads, caregiver + care-recipient|114
995027|NCT00459355|2413669|P1|STARTED|Overall Study|Includes 70 dyads, caregiver/care-recipient|140
995028|NCT00459368|2413683|P2|NOT COMPLETED|Overall Study||329
995029|NCT00459368|2413684|P1|NOT COMPLETED|Overall Study||295
995030|NCT00459368|2413683|P2|COMPLETED|Overall Study||1034
995031|NCT00459368|2413684|P1|COMPLETED|Overall Study||1040
995032|NCT00459368|2413683|P2|STARTED|Overall Study||1363
995033|NCT00459368|2413684|P1|STARTED|Overall Study||1335
995034|NCT00459381|2413690|P1|NOT COMPLETED|Overall Study||0
995035|NCT00459381|2413690|P1|COMPLETED|Overall Study||35
995036|NCT00459381|2413690|P1|STARTED|Overall Study||35
995037|NCT00459537|2413702|P2|NOT COMPLETED|Overall Study||76
995038|NCT00459537|2413703|P1|NOT COMPLETED|Overall Study||66
995039|NCT00459537|2413702|P2|COMPLETED|Overall Study||446
995040|NCT00459537|2413703|P1|COMPLETED|Overall Study||441
995041|NCT00459537|2413702|P2|Safety Population|Overall Study||512
995042|NCT00459537|2413703|P1|Safety Population|Overall Study|Participants who had at least one dose of study drug and one post-baseline safety assessment.|493
995043|NCT00459537|2413702|P2|STARTED|Overall Study||522
995044|NCT00459537|2413703|P1|STARTED|Overall Study||507
995045|NCT00459667|2413720|P3|NOT COMPLETED|Overall Study||20
995046|NCT00459667|2413721|P2|NOT COMPLETED|Overall Study||47
995047|NCT00459667|2413722|P1|NOT COMPLETED|Overall Study||38
995048|NCT00459667|2413720|P3|COMPLETED|Overall Study||161
995049|NCT00459667|2413721|P2|COMPLETED|Overall Study||600
995050|NCT00459667|2413722|P1|COMPLETED|Overall Study||554
995051|NCT00459667|2413720|P3|Started Treatment|Overall Study||180
995052|NCT00459667|2413721|P2|Started Treatment|Overall Study||644
995053|NCT00459667|2413722|P1|Started Treatment|Overall Study||586
995054|NCT00459667|2413720|P3|Study Medication Dispensed|Overall Study||180
995055|NCT00459667|2413721|P2|Study Medication Dispensed|Overall Study||645
995056|NCT00459667|2413722|P1|Study Medication Dispensed|Overall Study||586
995057|NCT00459667|2413720|P3|STARTED|Overall Study||181
995058|NCT00459667|2413721|P2|STARTED|Overall Study||647
995059|NCT00459667|2413722|P1|STARTED|Overall Study||592
995060|NCT00459706|2413744|P2|NOT COMPLETED|Overall Study||21
995061|NCT00459706|2413745|P1|NOT COMPLETED|Overall Study||26
995062|NCT00459706|2413744|P2|COMPLETED|Overall Study||294
995063|NCT00459706|2413745|P1|COMPLETED|Overall Study||299
995064|NCT00459706|2413744|P2|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|2 participants withdrew consent before the first injection|313
995065|NCT00459706|2413745|P1|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|1 participant had no evaluation after the first injection|324
995066|NCT00459706|2413744|P2|STARTED|Overall Study||315
995067|NCT00459706|2413745|P1|STARTED|Overall Study||325
995068|NCT00459732|2413887|P2|NOT COMPLETED|Overall Study||3
995069|NCT00459732|2413888|P1|NOT COMPLETED|Overall Study||4
995070|NCT00459732|2413887|P2|COMPLETED|Overall Study|3 on placebo dropped: 1 pregnant after 12 mo, 1 lost to followup, one died after 12 month timepoint|14
995071|NCT00459732|2413888|P1|COMPLETED|Overall Study|4 on zn dropped: 1 pregnant and 1 nausea after baseline, 1 lost to followup, 1 exited after 12 month|19
995072|NCT00459732|2413887|P2|STARTED|Overall Study||17
995073|NCT00459732|2413888|P1|STARTED|Overall Study||23
995074|NCT00459810|2413898|P1|NOT COMPLETED|Overall Study||0
995075|NCT00459810|2413898|P1|COMPLETED|Overall Study||21
995076|NCT00459810|2413898|P1|STARTED|Overall Study||21
995077|NCT00459862|2413906|P1|NOT COMPLETED|Overall Study||0
995078|NCT00459862|2413906|P1|COMPLETED|Overall Study||34
995079|NCT00459862|2413906|P1|STARTED|Overall Study||34
995080|NCT00459875|2413915|P1|NOT COMPLETED|Overall Study||3
995081|NCT00459875|2413915|P1|COMPLETED|Overall Study||21
995082|NCT00459875|2413915|P1|STARTED|Overall Study||24
995083|NCT00459953|2413921|P2|NOT COMPLETED|Overall Study||1
995084|NCT00459953|2413922|P1|NOT COMPLETED|Overall Study||1
995085|NCT00459953|2413921|P2|COMPLETED|Overall Study||70
995086|NCT00459953|2413922|P1|COMPLETED|Overall Study||71
995087|NCT00459953|2413921|P2|STARTED|Overall Study||71
995088|NCT00459953|2413922|P1|STARTED|Overall Study||72
995089|NCT00459979|2413928|P1|NOT COMPLETED|Overall Study||2
995090|NCT00459979|2413928|P1|COMPLETED|Overall Study||28
995091|NCT00459979|2413928|P1|STARTED|Overall Study||30
995092|NCT00460031|2413938|P1|NOT COMPLETED|Overall Study||11
995093|NCT00460031|2413938|P1|COMPLETED|Overall Study||23
995094|NCT00460031|2413938|P1|STARTED|Overall Study||34
995095|NCT00460993|2413948|P2|NOT COMPLETED|Phase 2 (6 Days)||0
995096|NCT00460993|2413949|P1|NOT COMPLETED|Phase 2 (6 Days)||0
995097|NCT00460993|2413948|P2|COMPLETED|Phase 2 (6 Days)||17
995098|NCT00460993|2413949|P1|COMPLETED|Phase 2 (6 Days)||14
995099|NCT00460993|2413948|P2|STARTED|Phase 2 (6 Days)||17
995100|NCT00460993|2413949|P1|STARTED|Phase 2 (6 Days)||14
995101|NCT00460993|2413948|P2|NOT COMPLETED|Phase 1 (6 Days)||0
995102|NCT00460993|2413949|P1|NOT COMPLETED|Phase 1 (6 Days)||0
995103|NCT00460993|2413948|P2|COMPLETED|Phase 1 (6 Days)||17
995104|NCT00460993|2413949|P1|COMPLETED|Phase 1 (6 Days)||14
995105|NCT00460993|2413948|P2|STARTED|Phase 1 (6 Days)||17
995106|NCT00460993|2413949|P1|STARTED|Phase 1 (6 Days)||14
995107|NCT00461032|2413957|P2|NOT COMPLETED|Overall Study||44
995108|NCT00461032|2413958|P1|NOT COMPLETED|Overall Study||37
995109|NCT00461032|2413957|P2|COMPLETED|Overall Study||536
995110|NCT00461032|2413958|P1|COMPLETED|Overall Study||545
995111|NCT00461032|2413957|P2|STARTED|Overall Study||580
995112|NCT00461032|2413958|P1|STARTED|Overall Study||582
995113|NCT00461045|2413970|P1|NOT COMPLETED|Overall Study||0
995114|NCT00461045|2413970|P1|COMPLETED|Overall Study||15
995115|NCT00461045|2413970|P1|STARTED|Overall Study||15
995116|NCT00461097|2413982|P2|NOT COMPLETED|Overall Study||0
995117|NCT00461097|2413983|P1|NOT COMPLETED|Overall Study||0
995118|NCT00461097|2413982|P2|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure.|15
995119|NCT00461097|2413983|P1|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure and outcome measure #6.|40
995120|NCT00461097|2413982|P2|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||0
995121|NCT00461097|2413983|P1|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||7
995122|NCT00461097|2413982|P2|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||0
995123|NCT00461097|2413983|P1|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||16
995124|NCT00461097|2413982|P2|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||1
995125|NCT00461097|2413983|P1|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||34
995126|NCT00461097|2413982|P2|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||13
995127|NCT00461097|2413983|P1|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||35
995128|NCT00461097|2413982|P2|STARTED|Overall Study||15
995129|NCT00461097|2413983|P1|STARTED|Overall Study||40
995130|NCT00461123|2414001|P2|NOT COMPLETED|Overall Study||6
995131|NCT00461123|2414002|P1|NOT COMPLETED|Overall Study||6
995132|NCT00461123|2414001|P2|COMPLETED|Overall Study||19
995133|NCT00461123|2414002|P1|COMPLETED|Overall Study||19
995134|NCT00461123|2414001|P2|STARTED|Overall Study||25
995135|NCT00461123|2414002|P1|STARTED|Overall Study||25
995136|NCT00461175|2414018|P2|NOT COMPLETED|Overall Study||365
995137|NCT00461175|2414019|P1|NOT COMPLETED|Overall Study||522
995138|NCT00461175|2414018|P2|COMPLETED|Overall Study||18370
995139|NCT00461175|2414019|P1|COMPLETED|Overall Study||43078
995140|NCT00461175|2414018|P2|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|18735
995141|NCT00461175|2414019|P1|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|43600
995142|NCT00461253|2414029|P2|NOT COMPLETED|Overall Study||19798
995143|NCT00461253|2414030|P1|NOT COMPLETED|Overall Study||4980
995144|NCT00461253|2414029|P2|COMPLETED|Overall Study|Analyzed controls|20452
995145|NCT00461253|2414030|P1|COMPLETED|Overall Study|Analyzed cases|5113
995146|NCT00461253|2414029|P2|STARTED|Overall Study|Identified controls|40250
995147|NCT00461253|2414030|P1|STARTED|Overall Study|Identified cases|10093
995148|NCT00461292|2414039|P3|NOT COMPLETED|Treatment Cycle 2||0
995149|NCT00461292|2414040|P2|NOT COMPLETED|Treatment Cycle 2||2
995150|NCT00461292|2414041|P1|NOT COMPLETED|Treatment Cycle 2||5
995151|NCT00461292|2414039|P3|COMPLETED|Treatment Cycle 2||0
995152|NCT00461292|2414040|P2|COMPLETED|Treatment Cycle 2||72
995153|NCT00461292|2414041|P1|COMPLETED|Treatment Cycle 2||58
995154|NCT00461292|2414039|P3|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200 U in Cycle 2|0
995155|NCT00461292|2414040|P2|STARTED|Treatment Cycle 2|42 from the 200U group + 32 from the Placebo group entered Cycle 2|74
995156|NCT00461292|2414041|P1|STARTED|Treatment Cycle 2|32 from the 300U group + 31 from the Placebo group entered Cycle 2|63
995157|NCT00461292|2414039|P3|NOT COMPLETED|Treatment Cycle 1||11
995158|NCT00461292|2414040|P2|NOT COMPLETED|Treatment Cycle 1||12
995159|NCT00461292|2414041|P1|NOT COMPLETED|Treatment Cycle 1||15
995160|NCT00461292|2414039|P3|COMPLETED|Treatment Cycle 1||81
995161|NCT00461292|2414040|P2|COMPLETED|Treatment Cycle 1||80
995162|NCT00461292|2414041|P1|COMPLETED|Treatment Cycle 1||76
995163|NCT00461292|2414039|P3|STARTED|Treatment Cycle 1||92
995164|NCT00461292|2414040|P2|STARTED|Treatment Cycle 1||92
995165|NCT00461292|2414041|P1|STARTED|Treatment Cycle 1||91
995166|NCT00461305|2414060|P2|NOT COMPLETED|Continued Treatment||0
995167|NCT00461305|2414061|P1|NOT COMPLETED|Continued Treatment||95
995168|NCT00461305|2414060|P2|COMPLETED|Continued Treatment||0
995169|NCT00461305|2414061|P1|COMPLETED|Continued Treatment||254
995170|NCT00461305|2414060|P2|STARTED|Continued Treatment|no participants were treated with the DRSP 3 mg/EE 30 μg combination beyond 6 cycles|0
995171|NCT00461305|2414061|P1|STARTED|Continued Treatment|FAS, participants from previous treatment who were available to continue treatment|349
995172|NCT00461305|2414060|P2|NOT COMPLETED|Treatment||9
995173|NCT00461305|2414061|P1|NOT COMPLETED|Treatment||101
995174|NCT00461305|2414060|P2|COMPLETED|Treatment||56
995175|NCT00461305|2414061|P1|COMPLETED|Treatment||254
995176|NCT00461305|2414060|P2|Subjects Received Treatment|Treatment|FAS, safety population|65
995177|NCT00461305|2414061|P1|Subjects Received Treatment|Treatment|FAS, safety population|349
995178|NCT00461305|2414060|P2|Subjects Dispensed Drugs|Treatment||65
995179|NCT00461305|2414061|P1|Subjects Dispensed Drugs|Treatment||350
995180|NCT00461305|2414060|P2|STARTED|Treatment|Enrolled|65
995181|NCT00461305|2414061|P1|STARTED|Treatment|Enrolled|355
995182|NCT00461331|2414121|P2|NOT COMPLETED|Intervention 2||0
995183|NCT00461331|2414122|P1|NOT COMPLETED|Intervention 2||0
995184|NCT00461331|2414121|P2|COMPLETED|Intervention 2||10
995185|NCT00461331|2414122|P1|COMPLETED|Intervention 2||10
995186|NCT00461331|2414121|P2|STARTED|Intervention 2||10
995187|NCT00461331|2414122|P1|STARTED|Intervention 2||10
995188|NCT00461331|2414121|P2|NOT COMPLETED|Washout||0
995189|NCT00461331|2414122|P1|NOT COMPLETED|Washout||0
995190|NCT00461331|2414121|P2|COMPLETED|Washout||10
995191|NCT00461331|2414122|P1|COMPLETED|Washout||10
995192|NCT00461331|2414121|P2|STARTED|Washout||10
995193|NCT00461331|2414122|P1|STARTED|Washout||10
995194|NCT00461331|2414121|P2|NOT COMPLETED|Intervention 1||0
995195|NCT00461331|2414122|P1|NOT COMPLETED|Intervention 1||0
995196|NCT00461331|2414121|P2|COMPLETED|Intervention 1||10
995197|NCT00461331|2414122|P1|COMPLETED|Intervention 1||10
995198|NCT00461331|2414121|P2|STARTED|Intervention 1||10
995199|NCT00461331|2414122|P1|STARTED|Intervention 1||10
995200|NCT00461500|2414134|P2|NOT COMPLETED|Overall Study||6
995201|NCT00461500|2414135|P1|NOT COMPLETED|Overall Study||7
995202|NCT00461500|2414134|P2|COMPLETED|Overall Study||38
995203|NCT00461500|2414135|P1|COMPLETED|Overall Study||30
995204|NCT00461500|2414134|P2|STARTED|Overall Study||44
995205|NCT00461500|2414135|P1|STARTED|Overall Study||37
995206|NCT00461513|2414167|P2|NOT COMPLETED|Overall Study||27
995207|NCT00461513|2414168|P1|NOT COMPLETED|Overall Study||28
995208|NCT00461513|2414167|P2|COMPLETED|Overall Study||172
995209|NCT00461513|2414168|P1|COMPLETED|Overall Study||165
995210|NCT00461513|2414167|P2|STARTED|Overall Study||199
995211|NCT00461513|2414168|P1|STARTED|Overall Study||193
995218|NCT00461630|2414199|P2|NOT COMPLETED|Overall Study||827
995219|NCT00461630|2414200|P1|NOT COMPLETED|Overall Study||906
995220|NCT00461630|2414199|P2|COMPLETED|Overall Study||12008
995221|NCT00461630|2414200|P1|COMPLETED|Overall Study||11932
995222|NCT00461630|2414199|P2|STARTED|Overall Study||12835
995223|NCT00461630|2414200|P1|STARTED|Overall Study||12838
995224|NCT00461682|2414214|P1|NOT COMPLETED|Overall Study||1
995225|NCT00461682|2414214|P1|COMPLETED|Overall Study||0
995226|NCT00461682|2414214|P1|STARTED|Overall Study||1
995227|NCT00461708|2414242|P2|NOT COMPLETED|Overall Study||38
995228|NCT00461708|2414243|P1|NOT COMPLETED|Overall Study||115
995229|NCT00461708|2414242|P2|COMPLETED|Overall Study||0
995230|NCT00461708|2414243|P1|COMPLETED|Overall Study||0
995231|NCT00461708|2414242|P2|STARTED|Overall Study||38
995232|NCT00461708|2414243|P1|STARTED|Overall Study||115
995233|NCT00461734|2414271|P2|NOT COMPLETED|Overall Study||60
995234|NCT00461734|2414272|P1|NOT COMPLETED|Overall Study||58
995235|NCT00461734|2414271|P2|COMPLETED|Overall Study||60
995236|NCT00461734|2414272|P1|COMPLETED|Overall Study||62
995237|NCT00461734|2414271|P2|STARTED|Overall Study||120
995238|NCT00461734|2414272|P1|STARTED|Overall Study||120
995239|NCT00461786|2414304|P1|NOT COMPLETED|Overall Study||3
995240|NCT00461786|2414304|P1|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|48
995241|NCT00461786|2414304|P1|STARTED|Overall Study||51
995242|NCT00461812|2414312|P1|NOT COMPLETED|Overall Study||10
995243|NCT00461812|2414312|P1|COMPLETED|Overall Study||0
995244|NCT00461812|2414312|P1|STARTED|Overall Study||10
995245|NCT00461851|2414317|P1|NOT COMPLETED|Overall Study||2
995246|NCT00461851|2414317|P1|COMPLETED|Overall Study||17
995247|NCT00461851|2414317|P1|STARTED|Overall Study||19
995248|NCT00461981|2414323|P2|NOT COMPLETED|Overall Study||9
995249|NCT00461981|2414324|P1|NOT COMPLETED|Overall Study||11
995250|NCT00461981|2414323|P2|COMPLETED|Overall Study||42
995251|NCT00461981|2414324|P1|COMPLETED|Overall Study||39
995252|NCT00461981|2414323|P2|STARTED|Overall Study||51
995253|NCT00461981|2414324|P1|STARTED|Overall Study||50
995254|NCT00462020|2414436|P2|NOT COMPLETED|Overall Study||0
995255|NCT00462020|2414437|P1|NOT COMPLETED|Overall Study||0
995256|NCT00462020|2414436|P2|COMPLETED|Overall Study||50
995257|NCT00462020|2414437|P1|COMPLETED|Overall Study||52
995258|NCT00462020|2414436|P2|STARTED|Overall Study||50
995259|NCT00462020|2414437|P1|STARTED|Overall Study||52
995260|NCT00462072|2414446|P3|NOT COMPLETED|Week 10||0
995261|NCT00462072|2414447|P2|NOT COMPLETED|Week 10||0
995262|NCT00462072|2414448|P1|NOT COMPLETED|Week 10||0
995263|NCT00462072|2414446|P3|COMPLETED|Week 10||9
995264|NCT00462072|2414447|P2|COMPLETED|Week 10||12
995265|NCT00462072|2414448|P1|COMPLETED|Week 10||10
995266|NCT00462072|2414446|P3|STARTED|Week 10||9
995267|NCT00462072|2414447|P2|STARTED|Week 10||12
995268|NCT00462072|2414448|P1|STARTED|Week 10||10
995269|NCT00462072|2414446|P3|NOT COMPLETED|Baseline (Week 0)||0
995270|NCT00462072|2414447|P2|NOT COMPLETED|Baseline (Week 0)||0
995271|NCT00462072|2414448|P1|NOT COMPLETED|Baseline (Week 0)||0
995272|NCT00462072|2414446|P3|COMPLETED|Baseline (Week 0)||9
995273|NCT00462072|2414447|P2|COMPLETED|Baseline (Week 0)||12
995274|NCT00462072|2414448|P1|COMPLETED|Baseline (Week 0)||10
995275|NCT00462072|2414446|P3|STARTED|Baseline (Week 0)||9
995276|NCT00462072|2414447|P2|STARTED|Baseline (Week 0)||12
995277|NCT00462072|2414448|P1|STARTED|Baseline (Week 0)||10
995278|NCT00462228|2414462|P1|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
995279|NCT00462228|2414462|P1|COMPLETED|No Treatment (Washout) 4 Weeks||11
995280|NCT00462228|2414462|P1|STARTED|No Treatment (Washout) 4 Weeks||11
995281|NCT00462228|2414462|P1|NOT COMPLETED|Placebo or Memantine 12 Weeks||0
995282|NCT00462228|2414462|P1|COMPLETED|Placebo or Memantine 12 Weeks||11
995283|NCT00462228|2414462|P1|STARTED|Placebo or Memantine 12 Weeks||11
995284|NCT00462228|2414462|P1|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
995285|NCT00462228|2414462|P1|COMPLETED|No Treatment (Washout) 4 Weeks||11
995286|NCT00462228|2414462|P1|STARTED|No Treatment (Washout) 4 Weeks||11
995287|NCT00462228|2414462|P1|NOT COMPLETED|Memantine or Placebo 12 Weeks||0
995288|NCT00462228|2414462|P1|COMPLETED|Memantine or Placebo 12 Weeks||11
995289|NCT00462228|2414462|P1|STARTED|Memantine or Placebo 12 Weeks||11
995290|NCT00462280|2414487|P4|NOT COMPLETED|Overall Study||3
995291|NCT00462280|2414488|P3|NOT COMPLETED|Overall Study||0
995292|NCT00462280|2414489|P2|NOT COMPLETED|Overall Study||7
995293|NCT00462280|2414490|P1|NOT COMPLETED|Overall Study||10
995294|NCT00462280|2414487|P4|COMPLETED|Overall Study||4
995295|NCT00462280|2414488|P3|COMPLETED|Overall Study||7
995296|NCT00462280|2414489|P2|COMPLETED|Overall Study||25
995297|NCT00462280|2414490|P1|COMPLETED|Overall Study||24
995298|NCT00462280|2414487|P4|STARTED|Overall Study||7
995299|NCT00462280|2414488|P3|STARTED|Overall Study||7
995300|NCT00462280|2414489|P2|STARTED|Overall Study||32
995301|NCT00462280|2414490|P1|STARTED|Overall Study||34
995302|NCT00462306|2414552|P2|NOT COMPLETED|Overall Study||13
995303|NCT00462306|2414553|P1|NOT COMPLETED|Overall Study||0
995304|NCT00462306|2414552|P2|COMPLETED|Overall Study||490
995305|NCT00462306|2414553|P1|COMPLETED|Overall Study||4074
995306|NCT00462306|2414552|P2|STARTED|Overall Study||503
995307|NCT00462306|2414553|P1|STARTED|Overall Study||4074
995308|NCT00462332|2414563|P2|NOT COMPLETED|Overall Study||0
995309|NCT00462332|2414564|P1|NOT COMPLETED|Overall Study||0
995310|NCT00462332|2414563|P2|COMPLETED|Overall Study||41
995311|NCT00462332|2414564|P1|COMPLETED|Overall Study||45
995312|NCT00462332|2414563|P2|STARTED|Overall Study||41
995313|NCT00462332|2414564|P1|STARTED|Overall Study||45
995314|NCT00462345|2414572|P1|NOT COMPLETED|Overall Study||3
995315|NCT00462345|2414572|P1|COMPLETED|Overall Study||37
995316|NCT00462345|2414572|P1|Completed First Course|Overall Study||38
995317|NCT00462345|2414572|P1|STARTED|Overall Study||40
995318|NCT00462384|2414594|P1|NOT COMPLETED|Overall Study||9
995319|NCT00462384|2414594|P1|COMPLETED|Overall Study||30
995320|NCT00462384|2414594|P1|STARTED|Overall Study||39
995321|NCT00462423|2414602|P1|NOT COMPLETED|Overall Study||0
995322|NCT00462423|2414602|P1|COMPLETED|Overall Study||50
995323|NCT00462423|2414602|P1|STARTED|Overall Study||50
995324|NCT00462449|2414611|P2|NOT COMPLETED|Overall Study||0
995325|NCT00462449|2414612|P1|NOT COMPLETED|Overall Study||0
995326|NCT00462449|2414611|P2|COMPLETED|Overall Study||10
995327|NCT00462449|2414612|P1|COMPLETED|Overall Study||13
995328|NCT00462449|2414611|P2|STARTED|Overall Study||10
995329|NCT00462449|2414612|P1|STARTED|Overall Study||13
995330|NCT00462462|2414624|P2|NOT COMPLETED|Overall Study||1
995331|NCT00462462|2414625|P1|NOT COMPLETED|Overall Study||0
995332|NCT00462462|2414624|P2|COMPLETED|Overall Study||13
995333|NCT00462462|2414625|P1|COMPLETED|Overall Study||17
995334|NCT00462462|2414624|P2|STARTED|Overall Study||14
995335|NCT00462462|2414625|P1|STARTED|Overall Study||17
995336|NCT00462501|2414633|P1|NOT COMPLETED|Overall Study||5
995337|NCT00462501|2414633|P1|COMPLETED|Overall Study||30
995338|NCT00462501|2414633|P1|STARTED|Overall Study||35
995339|NCT00462605|2414637|P1|NOT COMPLETED|Overall Study||14
995340|NCT00462605|2414637|P1|COMPLETED|Overall Study||10
995341|NCT00462605|2414637|P1|STARTED|Overall Study||24
995342|NCT00462644|2414647|P2|NOT COMPLETED|Overall Study||0
995343|NCT00462644|2414648|P1|NOT COMPLETED|Overall Study||0
995344|NCT00462644|2414647|P2|COMPLETED|Overall Study||12
995345|NCT00462644|2414648|P1|COMPLETED|Overall Study||18
995346|NCT00462644|2414647|P2|STARTED|Overall Study||12
995347|NCT00462644|2414648|P1|STARTED|Overall Study||18
995348|NCT00462670|2414668|P2|NOT COMPLETED|Overall Study||7
995349|NCT00462670|2414669|P1|NOT COMPLETED|Overall Study||5
995350|NCT00462670|2414668|P2|COMPLETED|Overall Study||46
995351|NCT00462670|2414669|P1|COMPLETED|Overall Study||52
995352|NCT00462670|2414668|P2|STARTED|Overall Study||53
995353|NCT00462670|2414669|P1|STARTED|Overall Study||57
995354|NCT00462709|2414677|P1|NOT COMPLETED|Overall Study||67
995355|NCT00462709|2414677|P1|COMPLETED|Overall Study||79
995356|NCT00462709|2414677|P1|STARTED|Overall Study||146
995357|NCT00462722|2414687|P3|NOT COMPLETED|Overall Study||12
995358|NCT00462722|2414688|P2|NOT COMPLETED|Overall Study||4
995359|NCT00462722|2414689|P1|NOT COMPLETED|Overall Study||13
995360|NCT00462722|2414687|P3|COMPLETED|Overall Study||42
995361|NCT00462722|2414688|P2|COMPLETED|Overall Study||51
995362|NCT00462722|2414689|P1|COMPLETED|Overall Study||37
995363|NCT00462722|2414687|P3|STARTED|Overall Study||54
995364|NCT00462722|2414688|P2|STARTED|Overall Study||55
995365|NCT00462722|2414689|P1|STARTED|Overall Study||50
995366|NCT00462748|2414724|P3|NOT COMPLETED|Overall Study||11
995367|NCT00462748|2414725|P2|NOT COMPLETED|Overall Study||11
995368|NCT00462748|2414726|P1|NOT COMPLETED|Overall Study||12
995369|NCT00462748|2414724|P3|COMPLETED|Overall Study||251
995370|NCT00462748|2414725|P2|COMPLETED|Overall Study||252
995371|NCT00462748|2414726|P1|COMPLETED|Overall Study||249
995372|NCT00462748|2414724|P3|STARTED|Overall Study||262
995373|NCT00462748|2414725|P2|STARTED|Overall Study||263
995374|NCT00462748|2414726|P1|STARTED|Overall Study||261
995375|NCT00462826|2414734|P1|NOT COMPLETED|Overall Study||5
995376|NCT00462826|2414734|P1|COMPLETED|Overall Study||44
995377|NCT00462826|2414734|P1|STARTED|Overall Study||49
995378|NCT00462839|2414740|P2|NOT COMPLETED|Viewed Second||0
995379|NCT00462839|2414741|P1|NOT COMPLETED|Viewed Second||0
995380|NCT00462839|2414740|P2|COMPLETED|Viewed Second||53
995381|NCT00462839|2414741|P1|COMPLETED|Viewed Second||53
995382|NCT00462839|2414740|P2|STARTED|Viewed Second||53
995383|NCT00462839|2414741|P1|STARTED|Viewed Second||53
995384|NCT00462839|2414740|P2|NOT COMPLETED|Viewed First||0
995385|NCT00462839|2414741|P1|NOT COMPLETED|Viewed First||0
995386|NCT00462839|2414740|P2|COMPLETED|Viewed First||53
995387|NCT00462839|2414741|P1|COMPLETED|Viewed First||53
995388|NCT00462839|2414740|P2|STARTED|Viewed First||53
995389|NCT00462839|2414741|P1|STARTED|Viewed First||53
995390|NCT00462865|2414753|P1|NOT COMPLETED|Overall Study||1
995391|NCT00462865|2414753|P1|COMPLETED|Overall Study||17
995392|NCT00462865|2414753|P1|STARTED|Overall Study|18 pts enrolled,1 pt experienced a SAE infection normal ANC (gr 3) and did not begin study,see SAE|18
995393|NCT00462917|2414761|P4|NOT COMPLETED|Overall Study||11
995394|NCT00462917|2414762|P3|NOT COMPLETED|Overall Study||12
995395|NCT00462917|2414763|P2|NOT COMPLETED|Overall Study||10
995396|NCT00462917|2414764|P1|NOT COMPLETED|Overall Study||10
995397|NCT00462917|2414761|P4|COMPLETED|Overall Study||66
995398|NCT00462917|2414762|P3|COMPLETED|Overall Study||54
995399|NCT00462917|2414763|P2|COMPLETED|Overall Study||65
995400|NCT00462917|2414764|P1|COMPLETED|Overall Study||62
995401|NCT00462917|2414761|P4|Completed 6 Month Follow-up|Overall Study||66
995402|NCT00462917|2414762|P3|Completed 6 Month Follow-up|Overall Study||55
995403|NCT00462917|2414763|P2|Completed 6 Month Follow-up|Overall Study||68
995404|NCT00462917|2414764|P1|Completed 6 Month Follow-up|Overall Study||63
995405|NCT00462917|2414761|P4|Completed 6 Week Follow-up|Overall Study||68
995406|NCT00462917|2414762|P3|Completed 6 Week Follow-up|Overall Study||55
995407|NCT00462917|2414763|P2|Completed 6 Week Follow-up|Overall Study||70
995408|NCT00462917|2414764|P1|Completed 6 Week Follow-up|Overall Study||63
995409|NCT00462917|2414761|P4|Received Risk Information|Overall Study||68
995410|NCT00462917|2414762|P3|Received Risk Information|Overall Study||55
995411|NCT00462917|2414763|P2|Received Risk Information|Overall Study||70
995412|NCT00462917|2414764|P1|Received Risk Information|Overall Study||64
995413|NCT00462917|2414761|P4|Met With Genetic Counselor|Overall Study||71
995414|NCT00462917|2414762|P3|Met With Genetic Counselor|Overall Study||56
995415|NCT00462917|2414763|P2|Met With Genetic Counselor|Overall Study||71
995416|NCT00462917|2414764|P1|Met With Genetic Counselor|Overall Study||66
995417|NCT00462917|2414761|P4|STARTED|Overall Study||77
995418|NCT00462917|2414762|P3|STARTED|Overall Study||66
995419|NCT00462917|2414763|P2|STARTED|Overall Study||75
995420|NCT00462917|2414764|P1|STARTED|Overall Study||72
995430|NCT00462982|2414854|P1|NOT COMPLETED|Overall Study||3
995431|NCT00462982|2414854|P1|COMPLETED|Overall Study||5
995432|NCT00462982|2414854|P1|STARTED|Overall Study||8
995433|NCT00463047|2414858|P2|NOT COMPLETED|Double-Blind Treatment Period 2||2
995434|NCT00463047|2414859|P1|NOT COMPLETED|Double-Blind Treatment Period 2||1
995435|NCT00463047|2414858|P2|COMPLETED|Double-Blind Treatment Period 2||88
995436|NCT00463047|2414859|P1|COMPLETED|Double-Blind Treatment Period 2||92
995437|NCT00463047|2414858|P2|STARTED|Double-Blind Treatment Period 2||90
995438|NCT00463047|2414859|P1|STARTED|Double-Blind Treatment Period 2||93
995439|NCT00463047|2414858|P2|NOT COMPLETED|Double-Blind Treatment Period 1||4
995440|NCT00463047|2414859|P1|NOT COMPLETED|Double-Blind Treatment Period 1||3
995441|NCT00463047|2414858|P2|COMPLETED|Double-Blind Treatment Period 1||90
995442|NCT00463047|2414859|P1|COMPLETED|Double-Blind Treatment Period 1||93
995443|NCT00463047|2414858|P2|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|94
995444|NCT00463047|2414859|P1|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|96
995445|NCT00463047|2414858|P2|NOT COMPLETED|Titration Period 2||23
995446|NCT00463047|2414859|P1|NOT COMPLETED|Titration Period 2||30
995447|NCT00463047|2414858|P2|COMPLETED|Titration Period 2||98
995448|NCT00463047|2414859|P1|COMPLETED|Titration Period 2||93
995449|NCT00463047|2414858|P2|STARTED|Titration Period 2||121
995450|NCT00463047|2414859|P1|STARTED|Titration Period 2||123
995451|NCT00463047|2414858|P2|NOT COMPLETED|Titration Period 1||39
995452|NCT00463047|2414859|P1|NOT COMPLETED|Titration Period 1||37
995453|NCT00463047|2414858|P2|COMPLETED|Titration Period 1||121
995454|NCT00463047|2414859|P1|COMPLETED|Titration Period 1||123
995455|NCT00463047|2414858|P2|STARTED|Titration Period 1||160
995456|NCT00463047|2414859|P1|STARTED|Titration Period 1|323 subjects entered study period but 3 discontinued before being randomized to treatment|160
995457|NCT00463229|2414946|P2|NOT COMPLETED|Overall Study||10
995458|NCT00463229|2414947|P1|NOT COMPLETED|Overall Study||9
995459|NCT00463229|2414946|P2|COMPLETED|Overall Study||39
995460|NCT00463229|2414947|P1|COMPLETED|Overall Study||43
995461|NCT00463229|2414946|P2|STARTED|Overall Study||49
995462|NCT00463229|2414947|P1|STARTED|Overall Study||52
995463|NCT00463346|2414955|P2|NOT COMPLETED|Overall Study||3
995464|NCT00463346|2414956|P1|NOT COMPLETED|Overall Study||3
995465|NCT00463346|2414955|P2|COMPLETED|Overall Study||8
995466|NCT00463346|2414956|P1|COMPLETED|Overall Study||9
995467|NCT00463346|2414955|P2|STARTED|Overall Study||11
995468|NCT00463346|2414956|P1|STARTED|Overall Study||12
995469|NCT00463385|2414968|P4|NOT COMPLETED|Overall Study||22
995470|NCT00463385|2414969|P3|NOT COMPLETED|Overall Study||22
995471|NCT00463385|2414970|P2|NOT COMPLETED|Overall Study||22
995472|NCT00463385|2414971|P1|NOT COMPLETED|Overall Study||22
995473|NCT00463385|2414968|P4|COMPLETED|Overall Study||0
995474|NCT00463385|2414969|P3|COMPLETED|Overall Study||0
995475|NCT00463385|2414970|P2|COMPLETED|Overall Study||0
995476|NCT00463385|2414971|P1|COMPLETED|Overall Study||0
995477|NCT00463385|2414968|P4|Treated|Overall Study||22
995478|NCT00463385|2414969|P3|Treated|Overall Study||19
995479|NCT00463385|2414970|P2|Treated|Overall Study||22
995480|NCT00463385|2414971|P1|Treated|Overall Study||22
995481|NCT00463385|2414968|P4|STARTED|Overall Study||22
995482|NCT00463385|2414969|P3|STARTED|Overall Study||22
995483|NCT00463385|2414970|P2|STARTED|Overall Study||22
995484|NCT00463385|2414971|P1|STARTED|Overall Study||22
995485|NCT00469456|2415023|P2|NOT COMPLETED|Overall Study||4
995486|NCT00469456|2415024|P1|NOT COMPLETED|Overall Study||9
995487|NCT00469456|2415023|P2|COMPLETED|Overall Study||131
995488|NCT00469456|2415024|P1|COMPLETED|Overall Study||120
995489|NCT00469456|2415023|P2|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug.|135
995490|NCT00469456|2415024|P1|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|129
995491|NCT00469508|2415034|P2|NOT COMPLETED|Overall Study||24
995492|NCT00469508|2415035|P1|NOT COMPLETED|Overall Study||20
995493|NCT00469508|2415034|P2|COMPLETED|Overall Study||13
995494|NCT00469508|2415035|P1|COMPLETED|Overall Study||14
995495|NCT00469508|2415034|P2|STARTED|Overall Study||37
995496|NCT00469508|2415035|P1|STARTED|Overall Study||34
995497|NCT00470054|2415047|P1|NOT COMPLETED|Overall Study||1
995498|NCT00470054|2415047|P1|COMPLETED|Overall Study||43
995499|NCT00470054|2415047|P1|STARTED|Overall Study||44
995500|NCT00470067|2415055|P1|NOT COMPLETED|Overall Study||7
995501|NCT00470067|2415055|P1|COMPLETED|Overall Study||2
995502|NCT00470067|2415055|P1|STARTED|Overall Study||9
995503|NCT00470106|2415063|P4|NOT COMPLETED|Overall Study||2
995504|NCT00470106|2415064|P3|NOT COMPLETED|Overall Study||7
995505|NCT00470106|2415065|P2|NOT COMPLETED|Overall Study||5
995506|NCT00470106|2415066|P1|NOT COMPLETED|Overall Study||3
995507|NCT00470106|2415063|P4|COMPLETED|Overall Study||19
995508|NCT00470106|2415064|P3|COMPLETED|Overall Study||14
995509|NCT00470106|2415065|P2|COMPLETED|Overall Study||19
995510|NCT00470106|2415066|P1|COMPLETED|Overall Study||16
995511|NCT00470106|2415063|P4|STARTED|Overall Study||21
995512|NCT00470106|2415064|P3|STARTED|Overall Study||21
995513|NCT00470106|2415065|P2|STARTED|Overall Study||24
995514|NCT00470106|2415066|P1|STARTED|Overall Study||19
995515|NCT00470158|2415085|P5|NOT COMPLETED|Overall Study||6
995516|NCT00470158|2415086|P4|NOT COMPLETED|Overall Study||5
995517|NCT00470158|2415087|P3|NOT COMPLETED|Overall Study||8
995518|NCT00470158|2415088|P2|NOT COMPLETED|Overall Study||8
995519|NCT00470158|2415089|P1|NOT COMPLETED|Overall Study||8
995520|NCT00470158|2415085|P5|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|195
995521|NCT00470158|2415086|P4|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
995522|NCT00470158|2415087|P3|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
995523|NCT00470158|2415088|P2|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|191
995524|NCT00470158|2415089|P1|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
995525|NCT00470158|2415085|P5|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
995526|NCT00470158|2415086|P4|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|198
995527|NCT00470158|2415087|P3|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
995528|NCT00470158|2415088|P2|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|199
995529|NCT00470158|2415089|P1|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
995530|NCT00470184|2415101|P1|NOT COMPLETED|Overall Study||22
995531|NCT00470184|2415101|P1|COMPLETED|Overall Study||19
995532|NCT00470184|2415101|P1|Treated With Study Therapy|Overall Study||36
995533|NCT00470184|2415101|P1|STARTED|Overall Study||41
995534|NCT00470262|2415110|P2|NOT COMPLETED|Overall Study||0
995535|NCT00470262|2415111|P1|NOT COMPLETED|Overall Study||2
995536|NCT00470262|2415110|P2|COMPLETED|Overall Study||12
995537|NCT00470262|2415111|P1|COMPLETED|Overall Study||13
995538|NCT00470262|2415110|P2|STARTED|Overall Study||12
995539|NCT00470262|2415111|P1|STARTED|Overall Study||15
995540|NCT00470275|2415119|P1|NOT COMPLETED|Overall Study||10
995541|NCT00470275|2415119|P1|COMPLETED|Overall Study||0
995542|NCT00470275|2415119|P1|STARTED|Overall Study||10
995543|NCT00470301|2415123|P1|NOT COMPLETED|Overall Study||5
995544|NCT00470301|2415123|P1|COMPLETED|Overall Study||55
995545|NCT00470301|2415123|P1|STARTED|Overall Study||60
995546|NCT00470392|2415129|P2|NOT COMPLETED|Overall Study||0
995547|NCT00470392|2415130|P1|NOT COMPLETED|Overall Study||0
995548|NCT00470392|2415129|P2|COMPLETED|Overall Study||2
995549|NCT00470392|2415130|P1|COMPLETED|Overall Study||7
995550|NCT00470392|2415129|P2|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|2
995551|NCT00470392|2415130|P1|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|7
995552|NCT00470418|2415142|P2|NOT COMPLETED|Overall Study||0
995553|NCT00470418|2415143|P1|NOT COMPLETED|Overall Study||1
995554|NCT00470418|2415142|P2|COMPLETED|Overall Study||3
995555|NCT00470418|2415143|P1|COMPLETED|Overall Study||6
995556|NCT00470418|2415142|P2|STARTED|Overall Study||3
995557|NCT00470418|2415143|P1|STARTED|Overall Study||7
995558|NCT00470470|2415151|P1|NOT COMPLETED|Overall Study||5
995559|NCT00470470|2415151|P1|COMPLETED|Overall Study||25
995560|NCT00470470|2415151|P1|STARTED|Overall Study||30
995561|NCT00470535|2415156|P1|NOT COMPLETED|Overall Study||18
995562|NCT00470535|2415156|P1|COMPLETED|Overall Study||0
995563|NCT00470535|2415156|P1|STARTED|Overall Study||18
995564|NCT00470548|2415167|P4|NOT COMPLETED|Overall Study||0
995565|NCT00470548|2415168|P3|NOT COMPLETED|Overall Study||0
995566|NCT00470548|2415169|P2|NOT COMPLETED|Overall Study||0
995567|NCT00470548|2415170|P1|NOT COMPLETED|Overall Study||0
995568|NCT00470548|2415167|P4|COMPLETED|Overall Study||37
995569|NCT00470548|2415168|P3|COMPLETED|Overall Study||6
995570|NCT00470548|2415169|P2|COMPLETED|Overall Study||3
995571|NCT00470548|2415170|P1|COMPLETED|Overall Study||3
995572|NCT00470548|2415167|P4|STARTED|Overall Study||37
995573|NCT00470548|2415168|P3|STARTED|Overall Study||6
995574|NCT00470548|2415169|P2|STARTED|Overall Study||3
995575|NCT00470548|2415170|P1|STARTED|Overall Study||3
995576|NCT00470600|2415190|P2|NOT COMPLETED|Overall Study||0
995577|NCT00470600|2415191|P1|NOT COMPLETED|Overall Study||0
995578|NCT00470600|2415190|P2|COMPLETED|Overall Study|One subject was randomized to incorrect stratification categories (weight).|99
995579|NCT00470600|2415191|P1|COMPLETED|Overall Study|Two subjects were randomized to incorrect stratification categories (weight).|86
995580|NCT00470600|2415190|P2|STARTED|Overall Study||99
995581|NCT00470600|2415191|P1|STARTED|Overall Study||86
995582|NCT00470626|2415201|P1|NOT COMPLETED|Overall Study||17
995583|NCT00470626|2415201|P1|COMPLETED|Overall Study||112
995584|NCT00470626|2415201|P1|STARTED|Overall Study||129
995585|NCT00470834|2415209|P2|NOT COMPLETED|Extension Period (24 Months)||23
995586|NCT00470834|2415210|P1|NOT COMPLETED|Extension Period (24 Months)||15
995587|NCT00470834|2415209|P2|COMPLETED|Extension Period (24 Months)||7
995588|NCT00470834|2415210|P1|COMPLETED|Extension Period (24 Months)||11
995589|NCT00470834|2415209|P2|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|30
995590|NCT00470834|2415210|P1|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|26
995591|NCT00470834|2415209|P2|NOT COMPLETED|Treatment Period (18 Months)||31
995592|NCT00470834|2415210|P1|NOT COMPLETED|Treatment Period (18 Months)||38
995593|NCT00470834|2415209|P2|COMPLETED|Treatment Period (18 Months)||31
995594|NCT00470834|2415210|P1|COMPLETED|Treatment Period (18 Months)||27
995595|NCT00470834|2415209|P2|STARTED|Treatment Period (18 Months)||62
995596|NCT00470834|2415210|P1|STARTED|Treatment Period (18 Months)||65
995597|NCT00470847|2415224|P1|NOT COMPLETED|Overall Study||1
995598|NCT00470847|2415224|P1|COMPLETED|Overall Study||34
995599|NCT00470847|2415224|P1|STARTED|Overall Study||35
995600|NCT00471068|2415237|P2|NOT COMPLETED|Overall Study||1
995601|NCT00471068|2415238|P1|NOT COMPLETED|Overall Study||1
995602|NCT00471068|2415237|P2|COMPLETED|Overall Study||24
995603|NCT00471068|2415238|P1|COMPLETED|Overall Study||20
995604|NCT00471068|2415237|P2|STARTED|Overall Study||25
995605|NCT00471068|2415238|P1|STARTED|Overall Study||21
995606|NCT00471107|2415247|P3|NOT COMPLETED|Overall Study||3
995607|NCT00471107|2415248|P2|NOT COMPLETED|Overall Study||1
995608|NCT00471107|2415249|P1|NOT COMPLETED|Overall Study||3
995609|NCT00471107|2415247|P3|COMPLETED|Overall Study||12
995610|NCT00471107|2415248|P2|COMPLETED|Overall Study||14
995611|NCT00471107|2415249|P1|COMPLETED|Overall Study||12
995612|NCT00471107|2415247|P3|STARTED|Overall Study||15
995613|NCT00471107|2415248|P2|STARTED|Overall Study||15
995614|NCT00471107|2415249|P1|STARTED|Overall Study||15
995615|NCT00471146|2415259|P2|NOT COMPLETED|Overall Study||174
995616|NCT00471146|2415260|P1|NOT COMPLETED|Overall Study||172
995617|NCT00471146|2415259|P2|COMPLETED|Overall Study||142
995618|NCT00471146|2415260|P1|COMPLETED|Overall Study||142
995619|NCT00471146|2415259|P2|Treated|Overall Study||308
995620|NCT00471146|2415260|P1|Treated|Overall Study||305
995621|NCT00471146|2415259|P2|STARTED|Overall Study||316
995622|NCT00471146|2415260|P1|STARTED|Overall Study||314
995623|NCT00471237|2415289|P7|NOT COMPLETED|Overall Study||3
995624|NCT00471237|2415290|P6|NOT COMPLETED|Overall Study||39
995625|NCT00471237|2415291|P5|NOT COMPLETED|Overall Study||41
995626|NCT00471237|2415292|P4|NOT COMPLETED|Overall Study||45
995627|NCT00471237|2415293|P3|NOT COMPLETED|Overall Study||34
995628|NCT00471237|2415294|P2|NOT COMPLETED|Overall Study||42
995629|NCT00471237|2415295|P1|NOT COMPLETED|Overall Study||41
995630|NCT00471237|2415289|P7|COMPLETED|Overall Study||38
995631|NCT00471237|2415290|P6|COMPLETED|Overall Study||50
995632|NCT00471237|2415291|P5|COMPLETED|Overall Study||46
995633|NCT00471237|2415292|P4|COMPLETED|Overall Study||43
995634|NCT00471237|2415293|P3|COMPLETED|Overall Study||48
995635|NCT00471237|2415294|P2|COMPLETED|Overall Study||45
995636|NCT00471237|2415295|P1|COMPLETED|Overall Study||49
995637|NCT00471237|2415289|P7|STARTED|Overall Study||41
995638|NCT00471237|2415290|P6|STARTED|Overall Study||89
995639|NCT00471237|2415291|P5|STARTED|Overall Study||87
995640|NCT00471237|2415292|P4|STARTED|Overall Study||88
995641|NCT00471237|2415293|P3|STARTED|Overall Study||82
995642|NCT00471237|2415294|P2|STARTED|Overall Study||87
995643|NCT00471237|2415295|P1|STARTED|Overall Study||90
995644|NCT00471276|2415443|P1|NOT COMPLETED|Overall Study||83
995645|NCT00471276|2415443|P1|COMPLETED|Overall Study||0
995646|NCT00471276|2415443|P1|STARTED|Overall Study||83
995647|NCT00471315|2415466|P1|NOT COMPLETED|Overall Study||8
995648|NCT00471315|2415466|P1|COMPLETED|Overall Study||10
995649|NCT00471315|2415466|P1|STARTED|Overall Study||18
995650|NCT00471328|2415473|P2|NOT COMPLETED|Extension Phase||67
995651|NCT00471328|2415474|P1|NOT COMPLETED|Extension Phase||41
995652|NCT00471328|2415473|P2|COMPLETED|Extension Phase||0
995653|NCT00471328|2415474|P1|COMPLETED|Extension Phase||0
995654|NCT00471328|2415473|P2|Started:CrossOver During Extension|Extension Phase||10
995655|NCT00471328|2415474|P1|Started:CrossOver During Extension|Extension Phase||0
995656|NCT00471328|2415473|P2|Started:CrossOver After PrimaryAnalysis|Extension Phase||4
995657|NCT00471328|2415474|P1|Started:CrossOver After PrimaryAnalysis|Extension Phase||0
995658|NCT00471328|2415473|P2|Started:CrossOver Before PrimaryAnalysis|Extension Phase||53
995659|NCT00471328|2415474|P1|Started:CrossOver Before PrimaryAnalysis|Extension Phase||0
995660|NCT00471328|2415473|P2|STARTED|Extension Phase||67
995661|NCT00471328|2415474|P1|STARTED|Extension Phase|Out of 58 ongoing patients, 17 patients had progression or died before they could enter extension|41
995662|NCT00471328|2415473|P2|NOT COMPLETED|Core Phase||67
995663|NCT00471328|2415474|P1|NOT COMPLETED|Core Phase||107
995664|NCT00471328|2415473|P2|COMPLETED|Core Phase|Ongoing on treatment during completion of core|16
995665|NCT00471328|2415474|P1|COMPLETED|Core Phase|Ongoing on treatment during completion of core.|58
995666|NCT00471328|2415473|P2|Crossover to Nilotinib:Started Extension|Core Phase||53
995667|NCT00471328|2415474|P1|Crossover to Nilotinib:Started Extension|Core Phase||0
995668|NCT00471328|2415473|P2|STARTED|Core Phase||83
995669|NCT00471328|2415474|P1|STARTED|Core Phase||165
995670|NCT00471354|2415493|P1|NOT COMPLETED|Overall Study||52
995671|NCT00471354|2415493|P1|COMPLETED|Overall Study||176
995672|NCT00471354|2415493|P1|STARTED|Overall Study||228
995673|NCT00471380|2415503|P2|NOT COMPLETED|Third Intervention||2
995674|NCT00471380|2415504|P1|NOT COMPLETED|Third Intervention||1
995675|NCT00471380|2415503|P2|COMPLETED|Third Intervention||14
995676|NCT00471380|2415504|P1|COMPLETED|Third Intervention||17
995677|NCT00471380|2415503|P2|STARTED|Third Intervention||16
995678|NCT00471380|2415504|P1|STARTED|Third Intervention||18
995679|NCT00471380|2415503|P2|NOT COMPLETED|Second Intervention||4
995680|NCT00471380|2415504|P1|NOT COMPLETED|Second Intervention||0
995681|NCT00471380|2415503|P2|COMPLETED|Second Intervention||16
995682|NCT00471380|2415504|P1|COMPLETED|Second Intervention||18
995683|NCT00471380|2415503|P2|STARTED|Second Intervention||20
995684|NCT00471380|2415504|P1|STARTED|Second Intervention||18
995685|NCT00471380|2415503|P2|NOT COMPLETED|First Intervention||4
995686|NCT00471380|2415504|P1|NOT COMPLETED|First Intervention||4
995687|NCT00471380|2415503|P2|COMPLETED|First Intervention||20
995688|NCT00471380|2415504|P1|COMPLETED|First Intervention||18
995689|NCT00471380|2415503|P2|STARTED|First Intervention||24
995690|NCT00471380|2415504|P1|STARTED|First Intervention||22
995691|NCT00471445|2415512|P2|NOT COMPLETED|Overall Study||2
995692|NCT00471445|2415513|P1|NOT COMPLETED|Overall Study||2
995693|NCT00471445|2415512|P2|COMPLETED|Overall Study||231
995694|NCT00471445|2415513|P1|COMPLETED|Overall Study||227
995695|NCT00471445|2415512|P2|STARTED|Overall Study||233
995696|NCT00471445|2415513|P1|STARTED|Overall Study||229
995697|NCT00471497|2415522|P3|NOT COMPLETED|Overall Study||40
995698|NCT00471497|2415523|P2|NOT COMPLETED|Overall Study||35
995699|NCT00471497|2415524|P1|NOT COMPLETED|Overall Study||46
995700|NCT00471497|2415522|P3|COMPLETED|Overall Study|Completed means patient is on treatment in core phase of the study (ongoing) by data cut-off.|241
995701|NCT00471497|2415523|P2|COMPLETED|Overall Study|Completed means patient is on treatment in core phase of the study (ongoing) by data cut-off.|247
995702|NCT00471497|2415524|P1|COMPLETED|Overall Study|Completed means patient is on treatment in core phase of the study (ongoing) by data cut-off.|237
995703|NCT00471497|2415522|P3|SAFETY ANALYSIS SET|Overall Study|Safety set contained patients who received at least one dose of study medication.|277
995704|NCT00471497|2415523|P2|SAFETY ANALYSIS SET|Overall Study|Safety set contained patients who received at least one dose of study medication.|279
995705|NCT00471497|2415524|P1|SAFETY ANALYSIS SET|Overall Study|Safety set contained patients who received at least one dose of study medication.|280
995706|NCT00471497|2415522|P3|STARTED|Overall Study||281
995707|NCT00471497|2415523|P2|STARTED|Overall Study||282
995708|NCT00471497|2415524|P1|STARTED|Overall Study||283
995709|NCT00471536|2415532|P1|NOT COMPLETED|Overall Study||1
995710|NCT00471536|2415532|P1|COMPLETED|Overall Study||18
995711|NCT00471536|2415532|P1|STARTED|Overall Study||19
995712|NCT00471705|2415544|P3|NOT COMPLETED|Overall Study||15
995713|NCT00471705|2415545|P2|NOT COMPLETED|Overall Study||22
995714|NCT00471705|2415546|P1|NOT COMPLETED|Overall Study||24
995715|NCT00471705|2415544|P3|COMPLETED|Overall Study||134
995716|NCT00471705|2415545|P2|COMPLETED|Overall Study||121
995717|NCT00471705|2415546|P1|COMPLETED|Overall Study||121
995718|NCT00471705|2415544|P3|STARTED|Overall Study||149
995719|NCT00471705|2415545|P2|STARTED|Overall Study||143
995720|NCT00471705|2415546|P1|STARTED|Overall Study||145
995721|NCT00471718|2415560|P1|NOT COMPLETED|Overall Study||27
995722|NCT00471718|2415560|P1|COMPLETED|Overall Study||0
995723|NCT00471718|2415560|P1|STARTED|Overall Study||27
995724|NCT00471822|2415569|P1|NOT COMPLETED|Overall Study||2
995725|NCT00471822|2415569|P1|COMPLETED|Overall Study||9705
995726|NCT00471822|2415569|P1|Treated|Overall Study||9705
995727|NCT00471822|2415569|P1|STARTED|Overall Study||9707
995728|NCT00472030|2415579|P2|NOT COMPLETED|Overall Study||0
995729|NCT00472030|2415580|P1|NOT COMPLETED|Overall Study||1
995730|NCT00472030|2415579|P2|COMPLETED|Overall Study||0
995731|NCT00472030|2415580|P1|COMPLETED|Overall Study||1
995732|NCT00472030|2415579|P2|STARTED|Overall Study||0
995733|NCT00472030|2415580|P1|STARTED|Overall Study||2
995734|NCT00472056|2415600|P4|NOT COMPLETED|Overall Study||0
995735|NCT00472056|2415601|P3|NOT COMPLETED|Overall Study||0
995736|NCT00472056|2415602|P2|NOT COMPLETED|Overall Study||0
995737|NCT00472056|2415603|P1|NOT COMPLETED|Overall Study||0
995738|NCT00472056|2415600|P4|COMPLETED|Overall Study||17
995739|NCT00472056|2415601|P3|COMPLETED|Overall Study||32
995740|NCT00472056|2415602|P2|COMPLETED|Overall Study||19
995741|NCT00472056|2415603|P1|COMPLETED|Overall Study||25
995742|NCT00472056|2415600|P4|STARTED|Overall Study||17
995743|NCT00472056|2415601|P3|STARTED|Overall Study||32
995744|NCT00472056|2415602|P2|STARTED|Overall Study||19
995745|NCT00472056|2415603|P1|STARTED|Overall Study||25
995746|NCT00472082|2415611|P1|NOT COMPLETED|Overall Study||5
995747|NCT00472082|2415611|P1|COMPLETED|Overall Study||0
995748|NCT00472082|2415611|P1|STARTED|Overall Study||5
995749|NCT00472199|2415618|P2|NOT COMPLETED|Overall Study||60
995750|NCT00472199|2415619|P1|NOT COMPLETED|Overall Study||35
995751|NCT00472199|2415618|P2|COMPLETED|Overall Study||103
995752|NCT00472199|2415619|P1|COMPLETED|Overall Study||131
995753|NCT00472199|2415618|P2|STARTED|Overall Study||163
995754|NCT00472199|2415619|P1|STARTED|Overall Study||166
995755|NCT00472290|2415685|P1|NOT COMPLETED|Overall Study||72
995756|NCT00472290|2415685|P1|COMPLETED|Overall Study||0
995757|NCT00472290|2415685|P1|STARTED|Overall Study||72
995758|NCT00472303|2415697|P3|NOT COMPLETED|Maintenance Phase||17
995759|NCT00472303|2415698|P2|NOT COMPLETED|Maintenance Phase||16
995760|NCT00472303|2415699|P1|NOT COMPLETED|Maintenance Phase||17
995761|NCT00472303|2415697|P3|COMPLETED|Maintenance Phase||95
995762|NCT00472303|2415698|P2|COMPLETED|Maintenance Phase||93
995763|NCT00472303|2415699|P1|COMPLETED|Maintenance Phase||89
995764|NCT00472303|2415697|P3|STARTED|Maintenance Phase|112 of 218 participants in the tapentadol titration arm were re-randomized and treated.|112
995765|NCT00472303|2415698|P2|STARTED|Maintenance Phase||109
995766|NCT00472303|2415699|P1|STARTED|Maintenance Phase|106 of 218 participants in the tapentadol titration arm were re-randomized and treated.|106
995767|NCT00472303|2415697|P3|NOT COMPLETED|Discontinuations After Titration Phase||0
995768|NCT00472303|2415698|P2|NOT COMPLETED|Discontinuations After Titration Phase||20
995769|NCT00472303|2415699|P1|NOT COMPLETED|Discontinuations After Titration Phase||61
995770|NCT00472303|2415697|P3|COMPLETED|Discontinuations After Titration Phase||0
995771|NCT00472303|2415698|P2|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|109
995772|NCT00472303|2415699|P1|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|218
995773|NCT00472303|2415697|P3|STARTED|Discontinuations After Titration Phase||0
995774|NCT00472303|2415698|P2|STARTED|Discontinuations After Titration Phase||129
995775|NCT00472303|2415699|P1|STARTED|Discontinuations After Titration Phase||279
995776|NCT00472303|2415697|P3|NOT COMPLETED|Titration Phase||0
995777|NCT00472303|2415698|P2|NOT COMPLETED|Titration Phase||29
995778|NCT00472303|2415699|P1|NOT COMPLETED|Titration Phase||59
995779|NCT00472303|2415697|P3|COMPLETED|Titration Phase||0
995780|NCT00472303|2415698|P2|COMPLETED|Titration Phase||129
995781|NCT00472303|2415699|P1|COMPLETED|Titration Phase||279
995782|NCT00472303|2415697|P3|STARTED|Titration Phase|All participants in the titration phase were in the tapentadol arm during the titration phase.|0
995783|NCT00472303|2415698|P2|STARTED|Titration Phase||158
995784|NCT00472303|2415699|P1|STARTED|Titration Phase||338
995785|NCT00472420|2415762|P1|NOT COMPLETED|Follow-up Period||17
995786|NCT00472420|2415762|P1|COMPLETED|Follow-up Period||15
995787|NCT00472420|2415762|P1|STARTED|Follow-up Period||32
995788|NCT00472420|2415762|P1|NOT COMPLETED|Induction Treatment Period||16
995789|NCT00472420|2415762|P1|COMPLETED|Induction Treatment Period||32
995790|NCT00472420|2415762|P1|STARTED|Induction Treatment Period||48
995791|NCT00472446|2415772|P4|NOT COMPLETED|Overall Study||6
995792|NCT00472446|2415773|P3|NOT COMPLETED|Overall Study||7
995793|NCT00472446|2415774|P2|NOT COMPLETED|Overall Study||6
995794|NCT00472446|2415775|P1|NOT COMPLETED|Overall Study||5
995795|NCT00472446|2415772|P4|COMPLETED|Overall Study||39
995796|NCT00472446|2415773|P3|COMPLETED|Overall Study||38
995797|NCT00472446|2415774|P2|COMPLETED|Overall Study||41
995798|NCT00472446|2415775|P1|COMPLETED|Overall Study||41
995799|NCT00472446|2415772|P4|STARTED|Overall Study||45
995800|NCT00472446|2415773|P3|STARTED|Overall Study||45
995801|NCT00472446|2415774|P2|STARTED|Overall Study||47
995802|NCT00472446|2415775|P1|STARTED|Overall Study||46
995803|NCT00460109|2415805|P1|NOT COMPLETED|Overall Study||1
995804|NCT00460109|2415805|P1|COMPLETED|Overall Study||23
995805|NCT00460109|2415805|P1|STARTED|Overall Study||24
995806|NCT00460239|2415813|P9|NOT COMPLETED|Overall Study||0
995807|NCT00460239|2415814|P8|NOT COMPLETED|Overall Study||0
995808|NCT00460239|2415815|P7|NOT COMPLETED|Overall Study||0
995809|NCT00460239|2415816|P6|NOT COMPLETED|Overall Study||3
995810|NCT00460239|2415817|P5|NOT COMPLETED|Overall Study||0
995811|NCT00460239|2415818|P4|NOT COMPLETED|Overall Study||0
995812|NCT00460239|2415819|P3|NOT COMPLETED|Overall Study||0
995813|NCT00460239|2415820|P2|NOT COMPLETED|Overall Study||1
995814|NCT00460239|2415821|P1|NOT COMPLETED|Overall Study||0
995815|NCT00460239|2415813|P9|COMPLETED|Overall Study||1
995816|NCT00460239|2415814|P8|COMPLETED|Overall Study||1
995817|NCT00460239|2415815|P7|COMPLETED|Overall Study||1
995818|NCT00460239|2415816|P6|COMPLETED|Overall Study||1
995819|NCT00460239|2415817|P5|COMPLETED|Overall Study||1
995820|NCT00460239|2415818|P4|COMPLETED|Overall Study||0
995821|NCT00460239|2415819|P3|COMPLETED|Overall Study||1
995822|NCT00460239|2415820|P2|COMPLETED|Overall Study||2
995823|NCT00460239|2415821|P1|COMPLETED|Overall Study||0
995824|NCT00460239|2415813|P9|STARTED|Overall Study||1
995825|NCT00460239|2415814|P8|STARTED|Overall Study||1
995826|NCT00460239|2415815|P7|STARTED|Overall Study||1
995827|NCT00460239|2415816|P6|STARTED|Overall Study||4
995828|NCT00460239|2415817|P5|STARTED|Overall Study||1
995829|NCT00460239|2415818|P4|STARTED|Overall Study||0
995830|NCT00460239|2415819|P3|STARTED|Overall Study||1
995831|NCT00460239|2415820|P2|STARTED|Overall Study||3
995832|NCT00460239|2415821|P1|STARTED|Overall Study||0
995833|NCT00460265|2415892|P2|NOT COMPLETED|Overall Study||89
995834|NCT00460265|2415893|P1|NOT COMPLETED|Overall Study||85
995835|NCT00460265|2415892|P2|COMPLETED|Overall Study|Completed study=death|241
995836|NCT00460265|2415893|P1|COMPLETED|Overall Study|Completed study=death|243
995837|NCT00460265|2415892|P2|Received Study Medication|Overall Study||325
995838|NCT00460265|2415893|P1|Received Study Medication|Overall Study||325
995839|NCT00460265|2415892|P2|Randomized While Alive|Overall Study||330
995840|NCT00460265|2415893|P1|Randomized While Alive|Overall Study|1 subject was randomized by error after death|327
995841|NCT00460265|2415892|P2|STARTED|Overall Study||330
995842|NCT00460265|2415893|P1|STARTED|Overall Study||328
995843|NCT00460408|2415913|P4|NOT COMPLETED|Overall Study||0
995844|NCT00460408|2415914|P3|NOT COMPLETED|Overall Study||6
995845|NCT00460408|2415915|P2|NOT COMPLETED|Overall Study||3
995846|NCT00460408|2415916|P1|NOT COMPLETED|Overall Study||67
995847|NCT00460408|2415913|P4|COMPLETED|Overall Study||7
995848|NCT00460408|2415914|P3|COMPLETED|Overall Study||69
995849|NCT00460408|2415915|P2|COMPLETED|Overall Study||13
995850|NCT00460408|2415916|P1|COMPLETED|Overall Study||336
995851|NCT00460408|2415913|P4|STARTED|Overall Study||7
995852|NCT00460408|2415914|P3|STARTED|Overall Study||75
995853|NCT00460408|2415915|P2|STARTED|Overall Study||16
995854|NCT00460408|2415916|P1|STARTED|Overall Study||403
995855|NCT00460421|2415954|P3|NOT COMPLETED|Overall Study||0
995856|NCT00460421|2415955|P2|NOT COMPLETED|Overall Study||0
995857|NCT00460421|2415956|P1|NOT COMPLETED|Overall Study||0
995858|NCT00460421|2415954|P3|COMPLETED|Overall Study||9
995859|NCT00460421|2415955|P2|COMPLETED|Overall Study||9
995860|NCT00460421|2415956|P1|COMPLETED|Overall Study||9
995861|NCT00460421|2415954|P3|STARTED|Overall Study||9
995862|NCT00460421|2415955|P2|STARTED|Overall Study||9
995863|NCT00460421|2415956|P1|STARTED|Overall Study||9
995864|NCT00460434|2416002|P2|NOT COMPLETED|Overall Study||7
995865|NCT00460434|2416003|P1|NOT COMPLETED|Overall Study||3
995866|NCT00460434|2416002|P2|COMPLETED|Overall Study||165
995867|NCT00460434|2416003|P1|COMPLETED|Overall Study||162
995868|NCT00460434|2416002|P2|12 Months|Overall Study||165
995869|NCT00460434|2416003|P1|12 Months|Overall Study||162
995870|NCT00460434|2416002|P2|3 Months|Overall Study||171
995871|NCT00460434|2416003|P1|3 Months|Overall Study||163
995872|NCT00460434|2416002|P2|STARTED|Overall Study||172
995873|NCT00460434|2416003|P1|STARTED|Overall Study||165
995874|NCT00460525|2416031|P2|NOT COMPLETED|Overall Study||5
995875|NCT00460525|2416032|P1|NOT COMPLETED|Overall Study||11
995876|NCT00460525|2416031|P2|COMPLETED|Overall Study||194
995877|NCT00460525|2416032|P1|COMPLETED|Overall Study||190
995878|NCT00460525|2416031|P2|STARTED|Overall Study||199
995879|NCT00460525|2416032|P1|STARTED|Overall Study||201
995880|NCT00460551|2416072|P1|NOT COMPLETED|Overall Study||0
995881|NCT00460551|2416072|P1|COMPLETED|Overall Study|The trial was terminated after Period 1A. Only safety was measured.|13
995882|NCT00460551|2416072|P1|STARTED|Overall Study||13
995883|NCT00460564|2416081|P8|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
995884|NCT00460564|2416082|P7|NOT COMPLETED|Open-Label Phase (36 Weeks)||2
995885|NCT00460564|2416083|P6|NOT COMPLETED|Open-Label Phase (36 Weeks)||6
995886|NCT00460564|2416084|P5|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
995887|NCT00460564|2416085|P4|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
995888|NCT00460564|2416086|P3|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
995889|NCT00460564|2416087|P2|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
995890|NCT00460564|2416088|P1|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
995891|NCT00460564|2416081|P8|COMPLETED|Open-Label Phase (36 Weeks)||11
995892|NCT00460564|2416082|P7|COMPLETED|Open-Label Phase (36 Weeks)||19
995893|NCT00460564|2416083|P6|COMPLETED|Open-Label Phase (36 Weeks)||19
995894|NCT00460564|2416084|P5|COMPLETED|Open-Label Phase (36 Weeks)||38
995895|NCT00460564|2416085|P4|COMPLETED|Open-Label Phase (36 Weeks)||0
995896|NCT00460564|2416086|P3|COMPLETED|Open-Label Phase (36 Weeks)||0
995897|NCT00460564|2416087|P2|COMPLETED|Open-Label Phase (36 Weeks)||0
995898|NCT00460564|2416088|P1|COMPLETED|Open-Label Phase (36 Weeks)||0
995899|NCT00460564|2416081|P8|STARTED|Open-Label Phase (36 Weeks)||11
995900|NCT00460564|2416082|P7|STARTED|Open-Label Phase (36 Weeks)||21
995901|NCT00460564|2416083|P6|STARTED|Open-Label Phase (36 Weeks)||25
995902|NCT00460564|2416084|P5|STARTED|Open-Label Phase (36 Weeks)||47
995903|NCT00460564|2416085|P4|STARTED|Open-Label Phase (36 Weeks)||0
995904|NCT00460564|2416086|P3|STARTED|Open-Label Phase (36 Weeks)||0
995905|NCT00460564|2416087|P2|STARTED|Open-Label Phase (36 Weeks)||0
995906|NCT00460564|2416088|P1|STARTED|Open-Label Phase (36 Weeks)||0
995907|NCT00460564|2416081|P8|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
995908|NCT00460564|2416082|P7|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
995909|NCT00460564|2416083|P6|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
995910|NCT00460564|2416084|P5|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
995911|NCT00460564|2416085|P4|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
995912|NCT00460564|2416086|P3|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
995913|NCT00460564|2416087|P2|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
995914|NCT00460564|2416088|P1|NOT COMPLETED|Double-Blind Phase (12 Weeks)||4
995915|NCT00460564|2416081|P8|COMPLETED|Double-Blind Phase (12 Weeks)||0
995916|NCT00460564|2416082|P7|COMPLETED|Double-Blind Phase (12 Weeks)||0
995917|NCT00460564|2416083|P6|COMPLETED|Double-Blind Phase (12 Weeks)||0
995918|NCT00460564|2416084|P5|COMPLETED|Double-Blind Phase (12 Weeks)||0
995919|NCT00460564|2416085|P4|COMPLETED|Double-Blind Phase (12 Weeks)||11
995920|NCT00460564|2416086|P3|COMPLETED|Double-Blind Phase (12 Weeks)||21
995921|NCT00460564|2416087|P2|COMPLETED|Double-Blind Phase (12 Weeks)||25
995922|NCT00460564|2416088|P1|COMPLETED|Double-Blind Phase (12 Weeks)||47
995923|NCT00460564|2416081|P8|STARTED|Double-Blind Phase (12 Weeks)||0
995924|NCT00460564|2416082|P7|STARTED|Double-Blind Phase (12 Weeks)||0
995925|NCT00460564|2416083|P6|STARTED|Double-Blind Phase (12 Weeks)||0
995926|NCT00460564|2416084|P5|STARTED|Double-Blind Phase (12 Weeks)||0
995927|NCT00460564|2416085|P4|STARTED|Double-Blind Phase (12 Weeks)||11
995928|NCT00460564|2416086|P3|STARTED|Double-Blind Phase (12 Weeks)||21
995929|NCT00460564|2416087|P2|STARTED|Double-Blind Phase (12 Weeks)||26
995930|NCT00460564|2416088|P1|STARTED|Double-Blind Phase (12 Weeks)||51
995931|NCT00460577|2416184|P2|NOT COMPLETED|Overall Study||6
995932|NCT00460577|2416185|P1|NOT COMPLETED|Overall Study||2
995933|NCT00460577|2416184|P2|COMPLETED|Overall Study||24
995934|NCT00460577|2416185|P1|COMPLETED|Overall Study||28
995935|NCT00460577|2416184|P2|STARTED|Overall Study||30
995936|NCT00460577|2416185|P1|STARTED|Overall Study|148 patients were screened; however, 22 did not consent and 66 did not meet inclusion/exclusion.|30
995937|NCT00460603|2416211|P12|NOT COMPLETED|Phase 2||41
995938|NCT00460603|2416212|P11|NOT COMPLETED|Phase 2||43
995939|NCT00460603|2416213|P10|NOT COMPLETED|Phase 2||42
995940|NCT00460603|2416214|P9|NOT COMPLETED|Phase 2||0
995941|NCT00460603|2416215|P8|NOT COMPLETED|Phase 2||0
995942|NCT00460603|2416216|P7|NOT COMPLETED|Phase 2||0
995943|NCT00460603|2416217|P6|NOT COMPLETED|Phase 2||0
995944|NCT00460603|2416218|P5|NOT COMPLETED|Phase 2||0
995945|NCT00460603|2416219|P4|NOT COMPLETED|Phase 2||0
995946|NCT00460603|2416220|P3|NOT COMPLETED|Phase 2||0
995947|NCT00460603|2416221|P2|NOT COMPLETED|Phase 2||0
995948|NCT00460603|2416222|P1|NOT COMPLETED|Phase 2||0
995949|NCT00460603|2416211|P12|COMPLETED|Phase 2||0
995950|NCT00460603|2416212|P11|COMPLETED|Phase 2||0
995951|NCT00460603|2416213|P10|COMPLETED|Phase 2||0
995952|NCT00460603|2416214|P9|COMPLETED|Phase 2||0
995953|NCT00460603|2416215|P8|COMPLETED|Phase 2||0
995954|NCT00460603|2416216|P7|COMPLETED|Phase 2||0
995955|NCT00460603|2416217|P6|COMPLETED|Phase 2||0
995956|NCT00460603|2416218|P5|COMPLETED|Phase 2||0
995957|NCT00460603|2416219|P4|COMPLETED|Phase 2||0
995958|NCT00460603|2416220|P3|COMPLETED|Phase 2||0
995959|NCT00460603|2416221|P2|COMPLETED|Phase 2||0
995960|NCT00460603|2416222|P1|COMPLETED|Phase 2||0
995961|NCT00460603|2416211|P12|Treated|Phase 2||41
995962|NCT00460603|2416212|P11|Treated|Phase 2||43
995963|NCT00460603|2416213|P10|Treated|Phase 2||39
995964|NCT00460603|2416214|P9|Treated|Phase 2||0
995965|NCT00460603|2416215|P8|Treated|Phase 2||0
995966|NCT00460603|2416216|P7|Treated|Phase 2||0
995967|NCT00460603|2416217|P6|Treated|Phase 2||0
995968|NCT00460603|2416218|P5|Treated|Phase 2||0
995969|NCT00460603|2416219|P4|Treated|Phase 2||0
995970|NCT00460603|2416220|P3|Treated|Phase 2||0
995971|NCT00460603|2416221|P2|Treated|Phase 2||0
995972|NCT00460603|2416222|P1|Treated|Phase 2||0
995973|NCT00460603|2416211|P12|STARTED|Phase 2||41
995974|NCT00460603|2416212|P11|STARTED|Phase 2||43
995975|NCT00460603|2416213|P10|STARTED|Phase 2||42
995976|NCT00460603|2416214|P9|STARTED|Phase 2||0
995977|NCT00460603|2416215|P8|STARTED|Phase 2||0
995978|NCT00460603|2416216|P7|STARTED|Phase 2||0
995979|NCT00460603|2416217|P6|STARTED|Phase 2||0
995980|NCT00460603|2416218|P5|STARTED|Phase 2||0
995981|NCT00460603|2416219|P4|STARTED|Phase 2||0
995982|NCT00460603|2416220|P3|STARTED|Phase 2||0
995983|NCT00460603|2416221|P2|STARTED|Phase 2||0
995984|NCT00460603|2416222|P1|STARTED|Phase 2||0
995985|NCT00460603|2416211|P12|NOT COMPLETED|Phase 1||0
995986|NCT00460603|2416212|P11|NOT COMPLETED|Phase 1||0
995987|NCT00460603|2416213|P10|NOT COMPLETED|Phase 1||0
995988|NCT00460603|2416214|P9|NOT COMPLETED|Phase 1||18
995989|NCT00460603|2416215|P8|NOT COMPLETED|Phase 1||3
995990|NCT00460603|2416216|P7|NOT COMPLETED|Phase 1||6
995991|NCT00460603|2416217|P6|NOT COMPLETED|Phase 1||4
995992|NCT00460603|2416218|P5|NOT COMPLETED|Phase 1||6
995993|NCT00460603|2416219|P4|NOT COMPLETED|Phase 1||8
995994|NCT00460603|2416220|P3|NOT COMPLETED|Phase 1||4
995995|NCT00460603|2416221|P2|NOT COMPLETED|Phase 1||6
995996|NCT00460603|2416222|P1|NOT COMPLETED|Phase 1||6
995997|NCT00460603|2416211|P12|COMPLETED|Phase 1||0
995998|NCT00460603|2416212|P11|COMPLETED|Phase 1||0
995999|NCT00460603|2416213|P10|COMPLETED|Phase 1||0
996000|NCT00460603|2416214|P9|COMPLETED|Phase 1||0
996001|NCT00460603|2416215|P8|COMPLETED|Phase 1||0
996002|NCT00460603|2416216|P7|COMPLETED|Phase 1||0
996003|NCT00460603|2416217|P6|COMPLETED|Phase 1||0
996004|NCT00460603|2416218|P5|COMPLETED|Phase 1||0
996005|NCT00460603|2416219|P4|COMPLETED|Phase 1||0
996006|NCT00460603|2416220|P3|COMPLETED|Phase 1||0
996007|NCT00460603|2416221|P2|COMPLETED|Phase 1||0
996008|NCT00460603|2416222|P1|COMPLETED|Phase 1||0
996009|NCT00460603|2416211|P12|STARTED|Phase 1||0
996010|NCT00460603|2416212|P11|STARTED|Phase 1||0
996011|NCT00460603|2416213|P10|STARTED|Phase 1||0
996012|NCT00460603|2416214|P9|STARTED|Phase 1||18
996013|NCT00460603|2416215|P8|STARTED|Phase 1||3
996014|NCT00460603|2416216|P7|STARTED|Phase 1||6
996015|NCT00460603|2416217|P6|STARTED|Phase 1||4
996016|NCT00460603|2416218|P5|STARTED|Phase 1||6
996017|NCT00460603|2416219|P4|STARTED|Phase 1||8
996018|NCT00460603|2416220|P3|STARTED|Phase 1||4
996019|NCT00460603|2416221|P2|STARTED|Phase 1||6
996020|NCT00460603|2416222|P1|STARTED|Phase 1||6
996021|NCT00460655|2416316|P4|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
996022|NCT00460655|2416317|P3|NOT COMPLETED|Open-Label Phase (36 Weeks)||7
996023|NCT00460655|2416318|P2|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
996024|NCT00460655|2416319|P1|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
996025|NCT00460655|2416316|P4|COMPLETED|Open-Label Phase (36 Weeks)||52
996026|NCT00460655|2416317|P3|COMPLETED|Open-Label Phase (36 Weeks)||45
996027|NCT00460655|2416318|P2|COMPLETED|Open-Label Phase (36 Weeks)||0
996028|NCT00460655|2416319|P1|COMPLETED|Open-Label Phase (36 Weeks)||0
996029|NCT00460655|2416316|P4|STARTED|Open-Label Phase (36 Weeks)||61
996030|NCT00460655|2416317|P3|STARTED|Open-Label Phase (36 Weeks)||52
996031|NCT00460655|2416318|P2|STARTED|Open-Label Phase (36 Weeks)||0
996032|NCT00460655|2416319|P1|STARTED|Open-Label Phase (36 Weeks)||0
996033|NCT00460655|2416316|P4|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
996034|NCT00460655|2416317|P3|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
996035|NCT00460655|2416318|P2|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
996036|NCT00460655|2416319|P1|NOT COMPLETED|Double-Blind Phase (12 Weeks)||6
996037|NCT00460655|2416316|P4|COMPLETED|Double-Blind Phase (12 Weeks)||0
996038|NCT00460655|2416317|P3|COMPLETED|Double-Blind Phase (12 Weeks)||0
996039|NCT00460655|2416318|P2|COMPLETED|Double-Blind Phase (12 Weeks)||61
996040|NCT00460655|2416319|P1|COMPLETED|Double-Blind Phase (12 Weeks)||52
996041|NCT00460655|2416316|P4|STARTED|Double-Blind Phase (12 Weeks)||0
996042|NCT00460655|2416317|P3|STARTED|Double-Blind Phase (12 Weeks)||0
996043|NCT00460655|2416318|P2|STARTED|Double-Blind Phase (12 Weeks)||62
996044|NCT00460655|2416319|P1|STARTED|Double-Blind Phase (12 Weeks)||58
996045|NCT00460746|2416351|P1|NOT COMPLETED|Overall Study||2
996046|NCT00460746|2416351|P1|COMPLETED|Overall Study||8
996047|NCT00460746|2416351|P1|STARTED|Overall Study||10
996048|NCT00460798|2416364|P1|NOT COMPLETED|Overall Study||340
996049|NCT00460798|2416364|P1|COMPLETED|Overall Study||108
996050|NCT00460798|2416364|P1|Treated|Overall Study|Subjects with complete dosing information were recorded as 'Treated'|421
996051|NCT00460798|2416364|P1|STARTED|Overall Study||448
996052|NCT00460811|2416377|P5|NOT COMPLETED|Overall Study||20
996053|NCT00460811|2416378|P4|NOT COMPLETED|Overall Study||18
996054|NCT00460811|2416379|P3|NOT COMPLETED|Overall Study||14
996055|NCT00460811|2416380|P2|NOT COMPLETED|Overall Study||15
996056|NCT00460811|2416381|P1|NOT COMPLETED|Overall Study||16
996057|NCT00460811|2416377|P5|COMPLETED|Overall Study||65
996058|NCT00460811|2416378|P4|COMPLETED|Overall Study||71
996059|NCT00460811|2416379|P3|COMPLETED|Overall Study||71
996060|NCT00460811|2416380|P2|COMPLETED|Overall Study||67
996061|NCT00460811|2416381|P1|COMPLETED|Overall Study||63
996062|NCT00460811|2416377|P5|STARTED|Overall Study||85
996063|NCT00460811|2416378|P4|STARTED|Overall Study||89
996064|NCT00460811|2416379|P3|STARTED|Overall Study||85
996065|NCT00460811|2416380|P2|STARTED|Overall Study||82
996066|NCT00460811|2416381|P1|STARTED|Overall Study||79
996067|NCT00466310|2416426|P3|NOT COMPLETED|Overall Study||0
996068|NCT00466310|2416427|P2|NOT COMPLETED|Overall Study||0
996069|NCT00466310|2416428|P1|NOT COMPLETED|Overall Study||0
996070|NCT00466310|2416426|P3|COMPLETED|Overall Study||31
996071|NCT00466310|2416427|P2|COMPLETED|Overall Study||20
996072|NCT00466310|2416428|P1|COMPLETED|Overall Study||20
996073|NCT00466310|2416426|P3|STARTED|Overall Study||31
996074|NCT00466310|2416427|P2|STARTED|Overall Study||20
996075|NCT00466310|2416428|P1|STARTED|Overall Study||20
996076|NCT00466323|2416438|P2|NOT COMPLETED|Overall Study||23
996077|NCT00466323|2416439|P1|NOT COMPLETED|Overall Study||28
996078|NCT00466323|2416438|P2|COMPLETED|Overall Study||92
996079|NCT00466323|2416439|P1|COMPLETED|Overall Study||89
996080|NCT00466323|2416438|P2|STARTED|Overall Study||115
996081|NCT00466323|2416439|P1|STARTED|Overall Study||117
996082|NCT00466505|2416451|P1|NOT COMPLETED|Overall Study||17
996083|NCT00466505|2416451|P1|COMPLETED|Overall Study||0
996084|NCT00466505|2416451|P1|STARTED|Overall Study||17
996085|NCT00466687|2416463|P1|NOT COMPLETED|Overall Study||34
996086|NCT00466687|2416463|P1|COMPLETED|Overall Study||0
996087|NCT00466687|2416463|P1|STARTED|Overall Study||34
996094|NCT00466882|2416526|P1|NOT COMPLETED|Overall Study||0
996095|NCT00466882|2416526|P1|COMPLETED|Overall Study||3
996096|NCT00466882|2416526|P1|STARTED|Overall Study||3
996097|NCT00472576|2416532|P2|NOT COMPLETED|Second Intervention||0
996098|NCT00472576|2416533|P1|NOT COMPLETED|Second Intervention||0
996099|NCT00472576|2416532|P2|COMPLETED|Second Intervention||3
996100|NCT00472576|2416533|P1|COMPLETED|Second Intervention||2
996101|NCT00472576|2416532|P2|STARTED|Second Intervention||3
996102|NCT00472576|2416533|P1|STARTED|Second Intervention||2
996103|NCT00472576|2416532|P2|NOT COMPLETED|First Intervention||0
996104|NCT00472576|2416533|P1|NOT COMPLETED|First Intervention||0
996105|NCT00472576|2416532|P2|COMPLETED|First Intervention||3
996106|NCT00472576|2416533|P1|COMPLETED|First Intervention||2
996107|NCT00472576|2416532|P2|STARTED|First Intervention||3
996108|NCT00472576|2416533|P1|STARTED|First Intervention||2
996109|NCT00472641|2416541|P1|NOT COMPLETED|Overall Study||7
996110|NCT00472641|2416541|P1|COMPLETED|Overall Study||18
996111|NCT00472641|2416541|P1|STARTED|Overall Study||25
996112|NCT00472732|2416548|P2|NOT COMPLETED|Overall Study||0
996113|NCT00472732|2416549|P1|NOT COMPLETED|Overall Study||0
996114|NCT00472732|2416548|P2|COMPLETED|Overall Study||22
996115|NCT00472732|2416549|P1|COMPLETED|Overall Study||24
996116|NCT00472732|2416548|P2|STARTED|Overall Study||22
996117|NCT00472732|2416549|P1|STARTED|Overall Study||24
996118|NCT00472797|2416561|P2|NOT COMPLETED|Overall Study||1
996119|NCT00472797|2416562|P1|NOT COMPLETED|Overall Study||4
996120|NCT00472797|2416561|P2|COMPLETED|Overall Study||112
996121|NCT00472797|2416562|P1|COMPLETED|Overall Study||115
996122|NCT00472797|2416561|P2|STARTED|Overall Study||113
996123|NCT00472797|2416562|P1|STARTED|Overall Study||119
996124|NCT00472849|2416588|P2|NOT COMPLETED|Overall Study||0
996125|NCT00472849|2416589|P1|NOT COMPLETED|Overall Study||0
996126|NCT00472849|2416588|P2|COMPLETED|Overall Study||78
996127|NCT00472849|2416589|P1|COMPLETED|Overall Study||12
996128|NCT00472849|2416588|P2|STARTED|Overall Study||78
996129|NCT00472849|2416589|P1|STARTED|Overall Study||12
996130|NCT00474487|2416599|P4|NOT COMPLETED|Overall Study||0
996131|NCT00474487|2416600|P3|NOT COMPLETED|Overall Study||14
996132|NCT00474487|2416601|P2|NOT COMPLETED|Overall Study||2
996133|NCT00474487|2416602|P1|NOT COMPLETED|Overall Study||30
996134|NCT00474487|2416599|P4|COMPLETED|Overall Study||109
996135|NCT00474487|2416600|P3|COMPLETED|Overall Study||885
996136|NCT00474487|2416601|P2|COMPLETED|Overall Study||215
996137|NCT00474487|2416602|P1|COMPLETED|Overall Study||1576
996138|NCT00474487|2416599|P4|STARTED|Overall Study||109
996139|NCT00474487|2416600|P3|STARTED|Overall Study||899
996140|NCT00474487|2416601|P2|STARTED|Overall Study||217
996141|NCT00474487|2416602|P1|STARTED|Overall Study||1606
996193|NCT00474539|2416818|P2|NOT COMPLETED|Toddler Dose||0
996194|NCT00474539|2416819|P1|NOT COMPLETED|Toddler Dose||1
996195|NCT00474539|2416818|P2|COMPLETED|Toddler Dose||220
996196|NCT00474539|2416819|P1|COMPLETED|Toddler Dose||208
996197|NCT00474539|2416818|P2|STARTED|Toddler Dose||220
996198|NCT00474539|2416819|P1|STARTED|Toddler Dose||209
996199|NCT00474539|2416818|P2|NOT COMPLETED|After Infant Series||0
996200|NCT00474539|2416819|P1|NOT COMPLETED|After Infant Series||4
996201|NCT00474539|2416818|P2|COMPLETED|After Infant Series||220
996202|NCT00474539|2416819|P1|COMPLETED|After Infant Series||209
996203|NCT00474539|2416818|P2|STARTED|After Infant Series||220
996204|NCT00474539|2416819|P1|STARTED|After Infant Series||213
996205|NCT00474539|2416818|P2|NOT COMPLETED|Infant Series||6
996206|NCT00474539|2416819|P1|NOT COMPLETED|Infant Series||10
996207|NCT00474539|2416818|P2|COMPLETED|Infant Series||220
996208|NCT00474539|2416819|P1|COMPLETED|Infant Series||213
996209|NCT00474539|2416818|P2|Vaccinated Dose 3|Infant Series||221
996210|NCT00474539|2416819|P1|Vaccinated Dose 3|Infant Series||214
996211|NCT00474539|2416818|P2|Vaccinated Dose 2|Infant Series||222
996212|NCT00474539|2416819|P1|Vaccinated Dose 2|Infant Series||217
996213|NCT00474539|2416818|P2|Vaccinated Dose 1|Infant Series||226
996214|NCT00474539|2416819|P1|Vaccinated Dose 1|Infant Series||218
996215|NCT00474539|2416818|P2|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|226
996216|NCT00474539|2416819|P1|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|223
996217|NCT00474630|2416869|P2|NOT COMPLETED|Overall Study||70
996218|NCT00474630|2416870|P1|NOT COMPLETED|Overall Study||160
996219|NCT00474630|2416869|P2|COMPLETED|Overall Study||100
996220|NCT00474630|2416870|P1|COMPLETED|Overall Study||175
996221|NCT00474630|2416869|P2|STARTED|Overall Study||170
996222|NCT00474630|2416870|P1|STARTED|Overall Study||335
996223|NCT00474708|2416926|P2|NOT COMPLETED|Overall Study||25
996224|NCT00474708|2416927|P1|NOT COMPLETED|Overall Study||57
996225|NCT00474708|2416926|P2|COMPLETED|Overall Study||342
996226|NCT00474708|2416927|P1|COMPLETED|Overall Study||734
996227|NCT00474708|2416926|P2|STARTED|Overall Study||367
996228|NCT00474708|2416927|P1|STARTED|Overall Study||791
996229|NCT00474760|2416942|P7|NOT COMPLETED|Overall Study||10
996230|NCT00474760|2416943|P6|NOT COMPLETED|Overall Study||29
996231|NCT00474760|2416944|P5|NOT COMPLETED|Overall Study||12
996232|NCT00474760|2416945|P4|NOT COMPLETED|Overall Study||3
996233|NCT00474760|2416946|P3|NOT COMPLETED|Overall Study||3
996234|NCT00474760|2416947|P2|NOT COMPLETED|Overall Study||3
996235|NCT00474760|2416948|P1|NOT COMPLETED|Overall Study||3
996236|NCT00474760|2416942|P7|COMPLETED|Overall Study||1
996237|NCT00474760|2416943|P6|COMPLETED|Overall Study||0
996238|NCT00474760|2416944|P5|COMPLETED|Overall Study||1
996239|NCT00474760|2416945|P4|COMPLETED|Overall Study||0
996240|NCT00474760|2416946|P3|COMPLETED|Overall Study||0
996241|NCT00474760|2416947|P2|COMPLETED|Overall Study||0
996242|NCT00474760|2416948|P1|COMPLETED|Overall Study||0
996243|NCT00474760|2416942|P7|STARTED|Overall Study||11
996244|NCT00474760|2416943|P6|STARTED|Overall Study||29
996245|NCT00474760|2416944|P5|STARTED|Overall Study||13
996246|NCT00474760|2416945|P4|STARTED|Overall Study||3
996247|NCT00474760|2416946|P3|STARTED|Overall Study||3
996248|NCT00474760|2416947|P2|STARTED|Overall Study||3
996249|NCT00474760|2416948|P1|STARTED|Overall Study||3
996250|NCT00474786|2417055|P2|NOT COMPLETED|Overall Study||253
996251|NCT00474786|2417056|P1|NOT COMPLETED|Overall Study||259
996252|NCT00474786|2417055|P2|COMPLETED|Overall Study||0
996253|NCT00474786|2417056|P1|COMPLETED|Overall Study||0
996254|NCT00474786|2417055|P2|STARTED|Overall Study||253
996255|NCT00474786|2417056|P1|STARTED|Overall Study||259
996256|NCT00474812|2417074|P1|NOT COMPLETED|Overall Study||7
996257|NCT00474812|2417074|P1|COMPLETED|Overall Study||44
996258|NCT00474812|2417074|P1|STARTED|Overall Study||51
996259|NCT00474851|2417084|P2|NOT COMPLETED|Overall Study||11
996260|NCT00474851|2417085|P1|NOT COMPLETED|Overall Study||8
996261|NCT00474851|2417084|P2|COMPLETED|Overall Study||16
996262|NCT00474851|2417085|P1|COMPLETED|Overall Study||18
996263|NCT00474851|2417084|P2|Completed Baseline|Overall Study||26
996264|NCT00474851|2417085|P1|Completed Baseline|Overall Study||25
996265|NCT00474851|2417084|P2|STARTED|Overall Study||27
996266|NCT00474851|2417085|P1|STARTED|Overall Study||26
996267|NCT00474903|2417096|P3|NOT COMPLETED|Overall Study||2
996268|NCT00474903|2417097|P2|NOT COMPLETED|Overall Study||5
996269|NCT00474903|2417098|P1|NOT COMPLETED|Overall Study||1
996270|NCT00474903|2417096|P3|COMPLETED|Overall Study||43
996271|NCT00474903|2417097|P2|COMPLETED|Overall Study||42
996272|NCT00474903|2417098|P1|COMPLETED|Overall Study||29
996273|NCT00474903|2417096|P3|STARTED|Overall Study||45
996274|NCT00474903|2417097|P2|STARTED|Overall Study||47
996275|NCT00474903|2417098|P1|STARTED|Overall Study||30
996276|NCT00474929|2417114|P5|NOT COMPLETED|Overall Study||0
996277|NCT00474929|2417115|P4|NOT COMPLETED|Overall Study||2
996278|NCT00474929|2417116|P3|NOT COMPLETED|Overall Study||2
996279|NCT00474929|2417117|P2|NOT COMPLETED|Overall Study||1
996280|NCT00474929|2417118|P1|NOT COMPLETED|Overall Study||0
996281|NCT00474929|2417114|P5|COMPLETED|Overall Study||77
996282|NCT00474929|2417115|P4|COMPLETED|Overall Study||5
996283|NCT00474929|2417116|P3|COMPLETED|Overall Study||5
996284|NCT00474929|2417117|P2|COMPLETED|Overall Study||5
996285|NCT00474929|2417118|P1|COMPLETED|Overall Study||6
996286|NCT00474929|2417114|P5|STARTED|Overall Study||77
996287|NCT00474929|2417115|P4|STARTED|Overall Study||7
996288|NCT00474929|2417116|P3|STARTED|Overall Study||7
996289|NCT00474929|2417117|P2|STARTED|Overall Study||6
996290|NCT00474929|2417118|P1|STARTED|Overall Study||6
996291|NCT00474955|2417132|P1|NOT COMPLETED|Overall Study||8
996292|NCT00474955|2417132|P1|COMPLETED|Overall Study||19
996293|NCT00474955|2417132|P1|STARTED|Overall Study||27
996294|NCT00474968|2417145|P2|NOT COMPLETED|Overall Study||16
996295|NCT00474968|2417146|P1|NOT COMPLETED|Overall Study||18
996296|NCT00474968|2417145|P2|COMPLETED|Overall Study||355
996297|NCT00474968|2417146|P1|COMPLETED|Overall Study||348
996298|NCT00474968|2417145|P2|STARTED|Overall Study||371
996299|NCT00474968|2417146|P1|STARTED|Overall Study||366
996300|NCT00474994|2417156|P1|NOT COMPLETED|Overall Study||5
996301|NCT00474994|2417156|P1|COMPLETED|Overall Study||48
996302|NCT00474994|2417156|P1|STARTED|Overall Study||53
996303|NCT00475033|2417162|P2|NOT COMPLETED|Toddler Dose||0
996304|NCT00475033|2417163|P1|NOT COMPLETED|Toddler Dose||4
996305|NCT00475033|2417162|P2|COMPLETED|Toddler Dose||282
996306|NCT00475033|2417163|P1|COMPLETED|Toddler Dose||283
996307|NCT00475033|2417162|P2|STARTED|Toddler Dose|Vaccinated Toddler Dose|282
996308|NCT00475033|2417163|P1|STARTED|Toddler Dose|Vaccinated Toddler Dose|287
996309|NCT00475033|2417162|P2|NOT COMPLETED|After the Infant Series||8
996310|NCT00475033|2417163|P1|NOT COMPLETED|After the Infant Series||6
996311|NCT00475033|2417162|P2|COMPLETED|After the Infant Series||282
996312|NCT00475033|2417163|P1|COMPLETED|After the Infant Series||287
996313|NCT00475033|2417162|P2|Withdrawn After Infant Series|After the Infant Series||8
996314|NCT00475033|2417163|P1|Withdrawn After Infant Series|After the Infant Series||6
996315|NCT00475033|2417162|P2|STARTED|After the Infant Series||290
996316|NCT00475033|2417163|P1|STARTED|After the Infant Series||293
996317|NCT00475033|2417162|P2|NOT COMPLETED|Infant Series||13
996318|NCT00475033|2417163|P1|NOT COMPLETED|Infant Series||7
996319|NCT00475033|2417162|P2|COMPLETED|Infant Series||290
996320|NCT00475033|2417163|P1|COMPLETED|Infant Series||293
996321|NCT00475033|2417162|P2|Vaccinated Dose 3|Infant Series||294
996322|NCT00475033|2417163|P1|Vaccinated Dose 3|Infant Series||293
996323|NCT00475033|2417162|P2|Vaccinated Dose 2|Infant Series||296
996324|NCT00475033|2417163|P1|Vaccinated Dose 2|Infant Series||297
996325|NCT00475033|2417162|P2|Vaccinated Dose 1|Infant Series||303
996326|NCT00475033|2417163|P1|Vaccinated Dose 1|Infant Series||300
996327|NCT00475033|2417162|P2|STARTED|Infant Series||303
996328|NCT00475033|2417163|P1|STARTED|Infant Series||300
996329|NCT00475085|2417215|P4|NOT COMPLETED|Overall Study||20
996330|NCT00475085|2417216|P3|NOT COMPLETED|Overall Study||19
996331|NCT00475085|2417217|P2|NOT COMPLETED|Overall Study||20
996332|NCT00475085|2417218|P1|NOT COMPLETED|Overall Study||18
996333|NCT00475085|2417215|P4|COMPLETED|Overall Study||234
996334|NCT00475085|2417216|P3|COMPLETED|Overall Study||241
996335|NCT00475085|2417217|P2|COMPLETED|Overall Study||234
996336|NCT00475085|2417218|P1|COMPLETED|Overall Study||235
996337|NCT00475085|2417215|P4|STARTED|Overall Study||254
996338|NCT00475085|2417216|P3|STARTED|Overall Study||260
996339|NCT00475085|2417217|P2|STARTED|Overall Study||254
996340|NCT00475085|2417218|P1|STARTED|Overall Study||253
996341|NCT00475150|2417230|P2|NOT COMPLETED|Overall Study||0
996342|NCT00475150|2417231|P1|NOT COMPLETED|Overall Study||0
996343|NCT00475150|2417230|P2|COMPLETED|Overall Study||16
996344|NCT00475150|2417231|P1|COMPLETED|Overall Study||23
996345|NCT00475150|2417230|P2|STARTED|Overall Study||16
996346|NCT00475150|2417231|P1|STARTED|Overall Study||23
996347|NCT00475176|2417244|P1|NOT COMPLETED|Overall Study||4
996348|NCT00475176|2417244|P1|COMPLETED|Overall Study||20
996349|NCT00475176|2417244|P1|STARTED|Overall Study||24
996350|NCT00475228|2417251|P2|NOT COMPLETED|Overall Study||17
996351|NCT00475228|2417252|P1|NOT COMPLETED|Overall Study||17
996352|NCT00475228|2417251|P2|COMPLETED|Overall Study||27
996353|NCT00475228|2417252|P1|COMPLETED|Overall Study||27
996354|NCT00475228|2417251|P2|STARTED|Overall Study||44
996355|NCT00475228|2417252|P1|STARTED|Overall Study||44
996356|NCT00475241|2417264|P2|NOT COMPLETED|Overall Study||3
996357|NCT00475241|2417265|P1|NOT COMPLETED|Overall Study||7
996358|NCT00475241|2417264|P2|COMPLETED|Overall Study||15
996359|NCT00475241|2417265|P1|COMPLETED|Overall Study||11
996360|NCT00475241|2417264|P2|STARTED|Overall Study||18
996361|NCT00475241|2417265|P1|STARTED|Overall Study||18
996362|NCT00475306|2417275|P4|NOT COMPLETED|Overall Study||1
996363|NCT00475306|2417276|P3|NOT COMPLETED|Overall Study||0
996364|NCT00475306|2417277|P2|NOT COMPLETED|Overall Study||1
996365|NCT00475306|2417278|P1|NOT COMPLETED|Overall Study||1
996366|NCT00475306|2417275|P4|COMPLETED|Overall Study|1 patient's intravenous line infiltrated.|71
996367|NCT00475306|2417276|P3|COMPLETED|Overall Study||72
996368|NCT00475306|2417277|P2|COMPLETED|Overall Study|For 1 patient, data collection was incomplete and results could not be analyzed|71
996369|NCT00475306|2417278|P1|COMPLETED|Overall Study|1 patient had resolution of nausea prior and did not receive the investigational medication|72
996370|NCT00475306|2417275|P4|STARTED|Overall Study||72
996371|NCT00475306|2417276|P3|STARTED|Overall Study||72
996372|NCT00475306|2417277|P2|STARTED|Overall Study||72
996373|NCT00475306|2417278|P1|STARTED|Overall Study||73
996374|NCT00475319|2417295|P3|NOT COMPLETED|Overall Study||4
996375|NCT00475319|2417296|P2|NOT COMPLETED|Overall Study||1
996376|NCT00475319|2417297|P1|NOT COMPLETED|Overall Study||2
996377|NCT00475319|2417295|P3|COMPLETED|Overall Study||99
996378|NCT00475319|2417296|P2|COMPLETED|Overall Study||101
996379|NCT00475319|2417297|P1|COMPLETED|Overall Study||101
996380|NCT00475319|2417295|P3|STARTED|Overall Study||103
996381|NCT00475319|2417296|P2|STARTED|Overall Study||102
996382|NCT00475319|2417297|P1|STARTED|Overall Study||103
996383|NCT00475332|2417308|P1|NOT COMPLETED|Overall Study||0
996384|NCT00475332|2417308|P1|COMPLETED|Overall Study||2
996385|NCT00475332|2417308|P1|STARTED|Overall Study||2
996386|NCT00475423|2417313|P1|NOT COMPLETED|Overall Study||32
996387|NCT00475423|2417313|P1|COMPLETED|Overall Study||90
996388|NCT00475423|2417313|P1|STARTED|Overall Study||122
996389|NCT00475501|2417338|P4|NOT COMPLETED|Overall Study||4
996390|NCT00475501|2417339|P3|NOT COMPLETED|Overall Study||4
996391|NCT00475501|2417340|P2|NOT COMPLETED|Overall Study||5
996392|NCT00475501|2417341|P1|NOT COMPLETED|Overall Study||7
996393|NCT00475501|2417338|P4|COMPLETED|Overall Study||12
996394|NCT00475501|2417339|P3|COMPLETED|Overall Study||13
996395|NCT00475501|2417340|P2|COMPLETED|Overall Study||8
996396|NCT00475501|2417341|P1|COMPLETED|Overall Study||7
996397|NCT00475501|2417338|P4|STARTED|Overall Study||16
996398|NCT00475501|2417339|P3|STARTED|Overall Study||17
996399|NCT00475501|2417340|P2|STARTED|Overall Study||13
996400|NCT00475501|2417341|P1|STARTED|Overall Study||14
996401|NCT00475657|2417391|P1|NOT COMPLETED|Overall Study||4
996402|NCT00475657|2417391|P1|COMPLETED|Overall Study||1
996403|NCT00475657|2417391|P1|STARTED|Overall Study||5
996404|NCT00475670|2417401|P2|NOT COMPLETED|Overall Study||41
996405|NCT00475670|2417402|P1|NOT COMPLETED|Overall Study||3
996406|NCT00475670|2417401|P2|COMPLETED|Overall Study||0
996407|NCT00475670|2417402|P1|COMPLETED|Overall Study|This cohort was closed prematurely (with only 3 participants) because of enrollment difficulties.|0
996408|NCT00475670|2417401|P2|STARTED|Overall Study||41
996409|NCT00475670|2417402|P1|STARTED|Overall Study||3
996410|NCT00475709|2417426|P1|NOT COMPLETED|Overall Study||76
996411|NCT00475709|2417426|P1|COMPLETED|Overall Study||946
996412|NCT00475709|2417426|P1|Eligible of Analysis|Overall Study|Excludes eight ineligible subjects|1014
996413|NCT00475709|2417426|P1|STARTED|Overall Study||1022
996414|NCT00475722|2417434|P2|NOT COMPLETED|Overall Study||12
996415|NCT00475722|2417435|P1|NOT COMPLETED|Overall Study||15
996416|NCT00475722|2417434|P2|COMPLETED|Overall Study||47
996417|NCT00475722|2417435|P1|COMPLETED|Overall Study||46
996418|NCT00475722|2417434|P2|STARTED|Overall Study||59
996419|NCT00475722|2417435|P1|STARTED|Overall Study||61
996420|NCT00475735|2417447|P6|NOT COMPLETED|Treatment Period 2||1
996421|NCT00475735|2417448|P5|NOT COMPLETED|Treatment Period 2||1
996422|NCT00475735|2417449|P4|NOT COMPLETED|Treatment Period 2||2
996423|NCT00475735|2417450|P3|NOT COMPLETED|Treatment Period 2||0
996424|NCT00475735|2417451|P2|NOT COMPLETED|Treatment Period 2||1
996425|NCT00475735|2417452|P1|NOT COMPLETED|Treatment Period 2||0
996426|NCT00475735|2417447|P6|COMPLETED|Treatment Period 2||13
996427|NCT00475735|2417448|P5|COMPLETED|Treatment Period 2||15
996428|NCT00475735|2417449|P4|COMPLETED|Treatment Period 2||4
996429|NCT00475735|2417450|P3|COMPLETED|Treatment Period 2||7
996430|NCT00475735|2417451|P2|COMPLETED|Treatment Period 2||9
996431|NCT00475735|2417452|P1|COMPLETED|Treatment Period 2||10
996432|NCT00475735|2417447|P6|STARTED|Treatment Period 2||14
996433|NCT00475735|2417448|P5|STARTED|Treatment Period 2||16
996434|NCT00475735|2417449|P4|STARTED|Treatment Period 2||6
996435|NCT00475735|2417450|P3|STARTED|Treatment Period 2||7
996436|NCT00475735|2417451|P2|STARTED|Treatment Period 2||10
996437|NCT00475735|2417452|P1|STARTED|Treatment Period 2||10
996438|NCT00475735|2417447|P6|NOT COMPLETED|Treatment Washout||0
996439|NCT00475735|2417448|P5|NOT COMPLETED|Treatment Washout||0
996440|NCT00475735|2417449|P4|NOT COMPLETED|Treatment Washout||0
996441|NCT00475735|2417450|P3|NOT COMPLETED|Treatment Washout||0
996442|NCT00475735|2417451|P2|NOT COMPLETED|Treatment Washout||2
996443|NCT00475735|2417452|P1|NOT COMPLETED|Treatment Washout||0
996444|NCT00475735|2417447|P6|COMPLETED|Treatment Washout||14
996445|NCT00475735|2417448|P5|COMPLETED|Treatment Washout||16
996446|NCT00475735|2417449|P4|COMPLETED|Treatment Washout||6
996447|NCT00475735|2417450|P3|COMPLETED|Treatment Washout||7
996448|NCT00475735|2417451|P2|COMPLETED|Treatment Washout||10
996449|NCT00475735|2417452|P1|COMPLETED|Treatment Washout||10
996450|NCT00475735|2417447|P6|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|14
996451|NCT00475735|2417448|P5|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|16
996452|NCT00475735|2417449|P4|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|6
996453|NCT00475735|2417450|P3|STARTED|Treatment Washout||7
996454|NCT00475735|2417451|P2|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|12
996455|NCT00475735|2417452|P1|STARTED|Treatment Washout||10
996456|NCT00475735|2417447|P6|NOT COMPLETED|Treatment Period 1||3
996457|NCT00475735|2417448|P5|NOT COMPLETED|Treatment Period 1||2
996458|NCT00475735|2417449|P4|NOT COMPLETED|Treatment Period 1||2
996459|NCT00475735|2417450|P3|NOT COMPLETED|Treatment Period 1||0
996460|NCT00475735|2417451|P2|NOT COMPLETED|Treatment Period 1||2
996461|NCT00475735|2417452|P1|NOT COMPLETED|Treatment Period 1||4
996462|NCT00475735|2417447|P6|COMPLETED|Treatment Period 1||12
996463|NCT00475735|2417448|P5|COMPLETED|Treatment Period 1||14
996464|NCT00475735|2417449|P4|COMPLETED|Treatment Period 1||5
996465|NCT00475735|2417450|P3|COMPLETED|Treatment Period 1||7
996466|NCT00475735|2417451|P2|COMPLETED|Treatment Period 1||11
996467|NCT00475735|2417452|P1|COMPLETED|Treatment Period 1||10
996468|NCT00475735|2417447|P6|STARTED|Treatment Period 1||15
996469|NCT00475735|2417448|P5|STARTED|Treatment Period 1||16
996470|NCT00475735|2417449|P4|STARTED|Treatment Period 1||7
996471|NCT00475735|2417450|P3|STARTED|Treatment Period 1||7
996472|NCT00475735|2417451|P2|STARTED|Treatment Period 1||13
996473|NCT00475735|2417452|P1|STARTED|Treatment Period 1||14
996474|NCT00475787|2417465|P2|NOT COMPLETED|Overall Study||7
996475|NCT00475787|2417466|P1|NOT COMPLETED|Overall Study||8
996476|NCT00475787|2417465|P2|COMPLETED|Overall Study||60
996477|NCT00475787|2417466|P1|COMPLETED|Overall Study||61
996478|NCT00475787|2417465|P2|STARTED|Overall Study||67
996479|NCT00475787|2417466|P1|STARTED|Overall Study||69
996480|NCT00475852|2417482|P2|NOT COMPLETED|Overall Study||548
996481|NCT00475852|2417483|P1|NOT COMPLETED|Overall Study||517
996482|NCT00475852|2417482|P2|COMPLETED|Overall Study||3029
996483|NCT00475852|2417483|P1|COMPLETED|Overall Study||3047
996484|NCT00475852|2417482|P2|STARTED|Overall Study||3577
996485|NCT00475852|2417483|P1|STARTED|Overall Study||3564
996486|NCT00475865|2417514|P3|NOT COMPLETED|Overall Study||6
996487|NCT00475865|2417515|P2|NOT COMPLETED|Overall Study||5
996488|NCT00475865|2417516|P1|NOT COMPLETED|Overall Study||2
996489|NCT00475865|2417514|P3|COMPLETED|Overall Study|completed treatment period|34
996490|NCT00475865|2417515|P2|COMPLETED|Overall Study|completed treatment period|37
996491|NCT00475865|2417516|P1|COMPLETED|Overall Study||39
996492|NCT00475865|2417514|P3|Treated|Overall Study||40
996493|NCT00475865|2417515|P2|Treated|Overall Study||42
996494|NCT00475865|2417516|P1|Treated|Overall Study|completed treatment period|41
996495|NCT00475865|2417514|P3|STARTED|Overall Study|randomized|40
996496|NCT00475865|2417515|P2|STARTED|Overall Study|randomized|42
996497|NCT00475865|2417516|P1|STARTED|Overall Study|randomized|41
996498|NCT00475878|2417546|P2|NOT COMPLETED|Overall Study||0
996499|NCT00475878|2417547|P1|NOT COMPLETED|Overall Study||0
996500|NCT00475878|2417546|P2|COMPLETED|Overall Study||72
996501|NCT00475878|2417547|P1|COMPLETED|Overall Study||75
996502|NCT00475878|2417546|P2|STARTED|Overall Study||72
996503|NCT00475878|2417547|P1|STARTED|Overall Study||75
996504|NCT00475904|2417558|P3|NOT COMPLETED|Overall Study||4
996505|NCT00475904|2417559|P2|NOT COMPLETED|Overall Study||13
996506|NCT00475904|2417560|P1|NOT COMPLETED|Overall Study||15
996507|NCT00475904|2417558|P3|COMPLETED|Overall Study||72
996508|NCT00475904|2417559|P2|COMPLETED|Overall Study||131
996509|NCT00475904|2417560|P1|COMPLETED|Overall Study||125
996510|NCT00475904|2417558|P3|STARTED|Overall Study||76
996511|NCT00475904|2417559|P2|STARTED|Overall Study||144
996512|NCT00475904|2417560|P1|STARTED|Overall Study||140
996513|NCT00476008|2417573|P2|NOT COMPLETED|Overall Study||8
996514|NCT00476008|2417574|P1|NOT COMPLETED|Overall Study||9
996515|NCT00476008|2417573|P2|COMPLETED|Overall Study||13
996516|NCT00476008|2417574|P1|COMPLETED|Overall Study||13
996517|NCT00476008|2417573|P2|6 Month Testing|Overall Study||14
996518|NCT00476008|2417574|P1|6 Month Testing|Overall Study||15
996519|NCT00476008|2417573|P2|STARTED|Overall Study||21
996520|NCT00476008|2417574|P1|STARTED|Overall Study||22
996521|NCT00476021|2417600|P2|NOT COMPLETED|Overall Study||0
996522|NCT00476021|2417601|P1|NOT COMPLETED|Overall Study||0
996523|NCT00476021|2417600|P2|COMPLETED|Overall Study||51
996524|NCT00476021|2417601|P1|COMPLETED|Overall Study||51
996525|NCT00476021|2417600|P2|STARTED|Overall Study||51
996526|NCT00476021|2417601|P1|STARTED|Overall Study||51
996527|NCT00476086|2417615|P1|NOT COMPLETED|Overall Study||5
996528|NCT00476086|2417615|P1|COMPLETED|Overall Study||15
996529|NCT00476086|2417615|P1|Received Radiation|Overall Study||15
996530|NCT00476086|2417615|P1|Received Chemotherapy|Overall Study||19
996531|NCT00476086|2417615|P1|STARTED|Overall Study||20
996532|NCT00476151|2417623|P2|NOT COMPLETED|Overall Study||7
996533|NCT00476151|2417624|P1|NOT COMPLETED|Overall Study||3
996534|NCT00476151|2417623|P2|COMPLETED|Overall Study||107
996535|NCT00476151|2417624|P1|COMPLETED|Overall Study||109
996536|NCT00476151|2417623|P2|STARTED|Overall Study||114
996537|NCT00476151|2417624|P1|STARTED|Overall Study||112
996538|NCT00476229|2417630|P1|NOT COMPLETED|Overall Study||1
996539|NCT00476229|2417630|P1|COMPLETED|Overall Study||19
996540|NCT00476229|2417630|P1|STARTED|Overall Study||20
996541|NCT00476242|2417636|P2|NOT COMPLETED|Overall Study||16
996542|NCT00476242|2417637|P1|NOT COMPLETED|Overall Study||8
996543|NCT00476242|2417636|P2|COMPLETED|Overall Study||12
996544|NCT00476242|2417637|P1|COMPLETED|Overall Study||19
996545|NCT00476242|2417636|P2|STARTED|Overall Study||28
996546|NCT00476242|2417637|P1|STARTED|Overall Study||27
996547|NCT00476476|2417647|P2|NOT COMPLETED|Overall Study||24
996548|NCT00476476|2417648|P1|NOT COMPLETED|Overall Study||2
996549|NCT00476476|2417647|P2|COMPLETED|Overall Study|Treatment was not of fixed duration and thus pts are not considered to have 'Completed' treatment.|0
996550|NCT00476476|2417648|P1|COMPLETED|Overall Study||15
996551|NCT00476476|2417647|P2|Response Evaluable|Overall Study|One woman was unevaluable due to an allergic reaction that developed after the 2nd dose.|23
996552|NCT00476476|2417648|P1|Response Evaluable|Overall Study||17
996553|NCT00476476|2417647|P2|STARTED|Overall Study||24
996554|NCT00476476|2417648|P1|STARTED|Overall Study||17
996555|NCT00476593|2417657|P4|NOT COMPLETED|Overall Study||22
996556|NCT00476593|2417658|P3|NOT COMPLETED|Overall Study||8
996557|NCT00476593|2417659|P2|NOT COMPLETED|Overall Study||2
996558|NCT00476593|2417660|P1|NOT COMPLETED|Overall Study||10
996559|NCT00476593|2417657|P4|COMPLETED|Overall Study||107
996560|NCT00476593|2417658|P3|COMPLETED|Overall Study||30
996561|NCT00476593|2417659|P2|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 17 cases|17
996562|NCT00476593|2417660|P1|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 22 cases|22
996563|NCT00476593|2417657|P4|STARTED|Overall Study||129
996564|NCT00476593|2417658|P3|STARTED|Overall Study||38
996565|NCT00476593|2417659|P2|STARTED|Overall Study||19
996566|NCT00476593|2417660|P1|STARTED|Overall Study||32
996567|NCT00476645|2417670|P1|NOT COMPLETED|Overall Study||0
996568|NCT00476645|2417670|P1|COMPLETED|Overall Study||10
996569|NCT00476645|2417670|P1|STARTED|Overall Study||10
996570|NCT00476788|2417676|P1|NOT COMPLETED|Overall Study||3
996571|NCT00476788|2417676|P1|COMPLETED|Overall Study||11
996572|NCT00476788|2417676|P1|STARTED|Overall Study||14
996573|NCT00476827|2417687|P6|NOT COMPLETED|Overall Study||0
996574|NCT00476827|2417688|P5|NOT COMPLETED|Overall Study||0
996575|NCT00476827|2417689|P4|NOT COMPLETED|Overall Study||0
996576|NCT00476827|2417690|P3|NOT COMPLETED|Overall Study||0
996577|NCT00476827|2417691|P2|NOT COMPLETED|Overall Study||0
996578|NCT00476827|2417692|P1|NOT COMPLETED|Overall Study||0
996579|NCT00476827|2417687|P6|COMPLETED|Overall Study||2
996580|NCT00476827|2417688|P5|COMPLETED|Overall Study||2
996581|NCT00476827|2417689|P4|COMPLETED|Overall Study||0
996582|NCT00476827|2417690|P3|COMPLETED|Overall Study||1
996583|NCT00476827|2417691|P2|COMPLETED|Overall Study||0
996584|NCT00476827|2417692|P1|COMPLETED|Overall Study||3
996585|NCT00476827|2417687|P6|STARTED|Overall Study||2
996586|NCT00476827|2417688|P5|STARTED|Overall Study||2
996587|NCT00476827|2417689|P4|STARTED|Overall Study||0
996588|NCT00476827|2417690|P3|STARTED|Overall Study||1
996589|NCT00476827|2417691|P2|STARTED|Overall Study||0
996590|NCT00476827|2417692|P1|STARTED|Overall Study||3
996591|NCT00476957|2417724|P2|NOT COMPLETED|Overall Study||193
996592|NCT00476957|2417725|P1|NOT COMPLETED|Overall Study||176
996593|NCT00476957|2417724|P2|COMPLETED|Overall Study||4159
996594|NCT00476957|2417725|P1|COMPLETED|Overall Study||4181
996595|NCT00476957|2417724|P2|STARTED|Overall Study||4352
996596|NCT00476957|2417725|P1|STARTED|Overall Study||4357
996597|NCT00469833|2417733|P1|NOT COMPLETED|Overall Study||2
996598|NCT00469833|2417733|P1|COMPLETED|Overall Study||15
996599|NCT00469833|2417733|P1|STARTED|Overall Study|17 subjects met inclusion criteria and consented for the study|17
996600|NCT00469859|2417745|P2|NOT COMPLETED|Overall Study||2
996601|NCT00469859|2417746|P1|NOT COMPLETED|Overall Study||0
996602|NCT00469859|2417745|P2|COMPLETED|Overall Study||6
996603|NCT00469859|2417746|P1|COMPLETED|Overall Study||6
996604|NCT00469859|2417745|P2|STARTED|Overall Study||8
996605|NCT00469859|2417746|P1|STARTED|Overall Study||6
996606|NCT00469898|2417754|P1|NOT COMPLETED|Overall Study||25
996607|NCT00469898|2417754|P1|COMPLETED|Overall Study||25
996608|NCT00469898|2417754|P1|STARTED|Overall Study||50
996609|NCT00477152|2417761|P1|NOT COMPLETED|Overall Study||3
996610|NCT00477152|2417761|P1|COMPLETED|Overall Study|Two patients treated, but assessments incomplete. All available data included in analyses for these.|49
996611|NCT00477152|2417761|P1|STARTED|Overall Study|One patient withdrawn prior to treatment, so not included in analyses.|52
996612|NCT00477165|2417770|P2|NOT COMPLETED|Overall Study||2
996613|NCT00477165|2417771|P1|NOT COMPLETED|Overall Study||7
996614|NCT00477165|2417770|P2|COMPLETED|Overall Study||25
996615|NCT00477165|2417771|P1|COMPLETED|Overall Study||20
996616|NCT00477165|2417770|P2|STARTED|Overall Study||27
996617|NCT00477165|2417771|P1|STARTED|Overall Study||27
996618|NCT00477191|2417783|P1|NOT COMPLETED|Overall Study||5
996619|NCT00477191|2417783|P1|COMPLETED|Overall Study||13
996620|NCT00477191|2417783|P1|STARTED|Overall Study||18
996621|NCT00477204|2417792|P2|NOT COMPLETED|Overall Study||0
996622|NCT00477204|2417793|P1|NOT COMPLETED|Overall Study||0
996623|NCT00477204|2417792|P2|COMPLETED|Overall Study||5
996624|NCT00477204|2417793|P1|COMPLETED|Overall Study||4
996625|NCT00477204|2417792|P2|STARTED|Overall Study||5
996626|NCT00477204|2417793|P1|STARTED|Overall Study||4
996627|NCT00477230|2417801|P2|NOT COMPLETED|Overall Study||31
996628|NCT00477230|2417802|P1|NOT COMPLETED|Overall Study||20
996629|NCT00477230|2417801|P2|COMPLETED|Overall Study||1
996630|NCT00477230|2417802|P1|COMPLETED|Overall Study||12
996631|NCT00477230|2417801|P2|STARTED|Overall Study||32
996632|NCT00477230|2417802|P1|STARTED|Overall Study||32
996633|NCT00477269|2417810|P3|NOT COMPLETED|Open Label Extension||13
996634|NCT00477269|2417811|P2|NOT COMPLETED|Open Label Extension||0
996635|NCT00477269|2417812|P1|NOT COMPLETED|Open Label Extension||0
996636|NCT00477269|2417810|P3|COMPLETED|Open Label Extension||9
996637|NCT00477269|2417811|P2|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
996638|NCT00477269|2417812|P1|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
996639|NCT00477269|2417810|P3|STARTED|Open Label Extension||22
996640|NCT00477269|2417811|P2|STARTED|Open Label Extension|Arm in the Core study not extension|0
996641|NCT00477269|2417812|P1|STARTED|Open Label Extension|Arm in the Core study not extension|0
996642|NCT00477269|2417810|P3|NOT COMPLETED|Core Study||0
996643|NCT00477269|2417811|P2|NOT COMPLETED|Core Study||8
996644|NCT00477269|2417812|P1|NOT COMPLETED|Core Study||9
996645|NCT00477269|2417810|P3|COMPLETED|Core Study||0
996646|NCT00477269|2417811|P2|COMPLETED|Core Study||23
996647|NCT00477269|2417812|P1|COMPLETED|Core Study||19
996648|NCT00477269|2417810|P3|STARTED|Core Study||0
996649|NCT00477269|2417811|P2|STARTED|Core Study||31
996650|NCT00477269|2417812|P1|STARTED|Core Study||28
996651|NCT00477295|2417866|P2|NOT COMPLETED|Overall Study||109
996652|NCT00477295|2417867|P1|NOT COMPLETED|Overall Study||121
996653|NCT00477295|2417866|P2|COMPLETED|Overall Study||192
996654|NCT00477295|2417867|P1|COMPLETED|Overall Study||161
996655|NCT00477295|2417866|P2|STARTED|Overall Study||301
996656|NCT00477295|2417867|P1|STARTED|Overall Study||282
996657|NCT00477594|2417895|P2|NOT COMPLETED|Follow-up Period||1
996658|NCT00477594|2417896|P1|NOT COMPLETED|Follow-up Period||3
996659|NCT00477594|2417895|P2|COMPLETED|Follow-up Period||4
996660|NCT00477594|2417896|P1|COMPLETED|Follow-up Period||13
996661|NCT00477594|2417895|P2|STARTED|Follow-up Period||5
996662|NCT00477594|2417896|P1|STARTED|Follow-up Period||16
996663|NCT00477594|2417895|P2|NOT COMPLETED|Year 3||0
996664|NCT00477594|2417896|P1|NOT COMPLETED|Year 3||2
996665|NCT00477594|2417895|P2|COMPLETED|Year 3||0
996666|NCT00477594|2417896|P1|COMPLETED|Year 3||2
996667|NCT00477594|2417895|P2|STARTED|Year 3||0
996668|NCT00477594|2417896|P1|STARTED|Year 3||4
996669|NCT00477594|2417895|P2|NOT COMPLETED|Year 1 and Year 2||4
996670|NCT00477594|2417896|P1|NOT COMPLETED|Year 1 and Year 2||9
996671|NCT00477594|2417895|P2|COMPLETED|Year 1 and Year 2||1
996672|NCT00477594|2417896|P1|COMPLETED|Year 1 and Year 2||7
996673|NCT00477594|2417895|P2|STARTED|Year 1 and Year 2||5
996674|NCT00477594|2417896|P1|STARTED|Year 1 and Year 2||16
996675|NCT00477607|2417954|P2|NOT COMPLETED|Overall Study||7
996676|NCT00477607|2417955|P1|NOT COMPLETED|Overall Study||7
996677|NCT00477607|2417954|P2|COMPLETED|Overall Study||13
996678|NCT00477607|2417955|P1|COMPLETED|Overall Study||12
996679|NCT00477607|2417954|P2|STARTED|Overall Study||20
996680|NCT00477607|2417955|P1|STARTED|Overall Study||19
996681|NCT00477633|2417965|P1|NOT COMPLETED|Overall Study||709
996682|NCT00477633|2417965|P1|COMPLETED|Overall Study||991
996683|NCT00477633|2417965|P1|STARTED|Overall Study||1700
996684|NCT00477672|2417974|P3|NOT COMPLETED|Overall Study||16
996685|NCT00477672|2417975|P2|NOT COMPLETED|Overall Study||16
996686|NCT00477672|2417976|P1|NOT COMPLETED|Overall Study||7
996687|NCT00477672|2417974|P3|COMPLETED|Overall Study||83
996688|NCT00477672|2417975|P2|COMPLETED|Overall Study||85
996689|NCT00477672|2417976|P1|COMPLETED|Overall Study||91
996690|NCT00477672|2417974|P3|STARTED|Overall Study||99
996691|NCT00477672|2417975|P2|STARTED|Overall Study||101
996692|NCT00477672|2417976|P1|STARTED|Overall Study||98
996693|NCT00477685|2417987|P1|NOT COMPLETED|Overall Study||0
996694|NCT00477685|2417987|P1|COMPLETED|Overall Study||10
996695|NCT00477685|2417987|P1|STARTED|Overall Study||10
996696|NCT00477750|2417992|P1|NOT COMPLETED|Overall Study||11
996697|NCT00477750|2417992|P1|COMPLETED|Overall Study||15
996698|NCT00477750|2417992|P1|STARTED|Overall Study||26
996699|NCT00477971|2417998|P2|NOT COMPLETED|Overall Study||6
996700|NCT00477971|2417999|P1|NOT COMPLETED|Overall Study||17
996701|NCT00477971|2417998|P2|COMPLETED|Overall Study||49
996702|NCT00477971|2417999|P1|COMPLETED|Overall Study||17
996703|NCT00477971|2417998|P2|STARTED|Overall Study||55
996704|NCT00477971|2417999|P1|STARTED|Overall Study||34
996705|NCT00478023|2418016|P5|NOT COMPLETED|Overall Study||55
996706|NCT00478023|2418017|P4|NOT COMPLETED|Overall Study||30
996707|NCT00478023|2418018|P3|NOT COMPLETED|Overall Study||20
996708|NCT00478023|2418019|P2|NOT COMPLETED|Overall Study||24
996709|NCT00478023|2418020|P1|NOT COMPLETED|Overall Study||35
996710|NCT00478023|2418016|P5|COMPLETED|Overall Study||114
996711|NCT00478023|2418017|P4|COMPLETED|Overall Study||146
996712|NCT00478023|2418018|P3|COMPLETED|Overall Study||151
996713|NCT00478023|2418019|P2|COMPLETED|Overall Study||144
996714|NCT00478023|2418020|P1|COMPLETED|Overall Study||135
996715|NCT00478023|2418016|P5|STARTED|Overall Study||169
996716|NCT00478023|2418017|P4|STARTED|Overall Study||176
996717|NCT00478023|2418018|P3|STARTED|Overall Study||171
996718|NCT00478023|2418019|P2|STARTED|Overall Study||168
996719|NCT00478023|2418020|P1|STARTED|Overall Study||170
996720|NCT00478036|2418040|P3|NOT COMPLETED|Overall Study||0
996721|NCT00478036|2418041|P2|NOT COMPLETED|Overall Study||0
996722|NCT00478036|2418042|P1|NOT COMPLETED|Overall Study||0
996723|NCT00478036|2418040|P3|COMPLETED|Overall Study||14
996724|NCT00478036|2418041|P2|COMPLETED|Overall Study||7
996725|NCT00478036|2418042|P1|COMPLETED|Overall Study||10
996726|NCT00478036|2418040|P3|STARTED|Overall Study||14
996727|NCT00478036|2418041|P2|STARTED|Overall Study||7
996728|NCT00478036|2418042|P1|STARTED|Overall Study||10
996729|NCT00478140|2418050|P1|NOT COMPLETED|Overall Study||3
996730|NCT00478140|2418050|P1|COMPLETED|Overall Study||1
996731|NCT00478140|2418050|P1|STARTED|Overall Study||4
996732|NCT00478192|2418057|P3|NOT COMPLETED|Overall Study||2
996733|NCT00478192|2418058|P2|NOT COMPLETED|Overall Study||5
996734|NCT00478192|2418059|P1|NOT COMPLETED|Overall Study||4
996735|NCT00478192|2418057|P3|COMPLETED|Overall Study||8
996736|NCT00478192|2418058|P2|COMPLETED|Overall Study||15
996737|NCT00478192|2418059|P1|COMPLETED|Overall Study||16
996738|NCT00478192|2418057|P3|End of Treatment|Overall Study||8
996739|NCT00478192|2418058|P2|End of Treatment|Overall Study||16
996740|NCT00478192|2418059|P1|End of Treatment|Overall Study||18
996741|NCT00478192|2418057|P3|Full Analysis Set / Safety Analysis Set|Overall Study||9
996742|NCT00478192|2418058|P2|Full Analysis Set / Safety Analysis Set|Overall Study||20
996743|NCT00478192|2418059|P1|Full Analysis Set / Safety Analysis Set|Overall Study||20
996744|NCT00478192|2418057|P3|STARTED|Overall Study||10
996745|NCT00478192|2418058|P2|STARTED|Overall Study||20
996746|NCT00478192|2418059|P1|STARTED|Overall Study||20
996747|NCT00478205|2418088|P2|NOT COMPLETED|Overall Study||87
996748|NCT00478205|2418089|P1|NOT COMPLETED|Overall Study||296
996749|NCT00478205|2418088|P2|COMPLETED|Overall Study||399
996750|NCT00478205|2418089|P1|COMPLETED|Overall Study||685
996751|NCT00478205|2418088|P2|STARTED|Overall Study||486
996752|NCT00478205|2418089|P1|STARTED|Overall Study||981
996753|NCT00478218|2418103|P2|NOT COMPLETED|Overall Study||0
996754|NCT00478218|2418104|P1|NOT COMPLETED|Overall Study||0
996755|NCT00478218|2418103|P2|COMPLETED|Overall Study||19
996756|NCT00478218|2418104|P1|COMPLETED|Overall Study||34
996757|NCT00478218|2418103|P2|STARTED|Overall Study||19
996758|NCT00478218|2418104|P1|STARTED|Overall Study||34
996759|NCT00478231|2418116|P1|NOT COMPLETED|Overall Study||84
996760|NCT00478231|2418116|P1|COMPLETED|Overall Study||125
996761|NCT00478231|2418116|P1|Treated|Overall Study||206
996762|NCT00478231|2418116|P1|STARTED|Overall Study||209
996763|NCT00478244|2418135|P1|NOT COMPLETED|Overall Study||1
996764|NCT00478244|2418135|P1|COMPLETED|Overall Study||6
996765|NCT00478244|2418135|P1|STARTED|Overall Study||7
996766|NCT00478257|2418150|P2|NOT COMPLETED|Overall Study||3
996767|NCT00478257|2418151|P1|NOT COMPLETED|Overall Study||8
996768|NCT00478257|2418150|P2|COMPLETED|Overall Study||13
996769|NCT00478257|2418151|P1|COMPLETED|Overall Study||15
996770|NCT00478257|2418150|P2|STARTED|Overall Study||16
996771|NCT00478257|2418151|P1|STARTED|Overall Study||23
996772|NCT00478556|2418159|P2|NOT COMPLETED|Overall Study||0
996773|NCT00478556|2418160|P1|NOT COMPLETED|Overall Study||0
996774|NCT00478556|2418159|P2|COMPLETED|Overall Study||149
996775|NCT00478556|2418160|P1|COMPLETED|Overall Study||151
996776|NCT00478556|2418159|P2|STARTED|Overall Study||149
996777|NCT00478556|2418160|P1|STARTED|Overall Study||151
996778|NCT00478569|2418168|P1|NOT COMPLETED|Overall Study||409
996779|NCT00478569|2418168|P1|COMPLETED|Overall Study||761
996780|NCT00478569|2418168|P1|STARTED|Overall Study||1170
996781|NCT00478608|2418182|P1|NOT COMPLETED|Overall Study||20
996782|NCT00478608|2418182|P1|COMPLETED|Overall Study||59
996783|NCT00478608|2418182|P1|STARTED|Overall Study||79
996784|NCT00478647|2418190|P1|NOT COMPLETED|Overall Study||2
996785|NCT00478647|2418190|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT)=participants who have received at least 1 full or partial dose of study drug.|38
996786|NCT00478647|2418190|P1|STARTED|Overall Study||40
996787|NCT00478673|2418198|P1|NOT COMPLETED|12-Months Post-Procedure||64
996788|NCT00478673|2418198|P1|COMPLETED|12-Months Post-Procedure||231
996789|NCT00478673|2418198|P1|STARTED|12-Months Post-Procedure|3 participants who did not complete Period 1 due to death (2) and withdrawal (1) are not included.|295
996790|NCT00478673|2418198|P1|NOT COMPLETED|30-Days Post-Procedure||10
996791|NCT00478673|2418198|P1|COMPLETED|30-Days Post-Procedure|"7 participants who did not complete this Period due to Missed Visit still continued on to Period 2"|288
996792|NCT00478673|2418198|P1|STARTED|30-Days Post-Procedure||298
996793|NCT00478777|2418203|P1|NOT COMPLETED|Overall Study||77
996794|NCT00478777|2418203|P1|COMPLETED|Overall Study|10 participants had >= 6 months and 63 participants < 6 months treatment prior to study termination.|73
996795|NCT00478777|2418203|P1|Safety and Full Analysis Set (FAS)|Overall Study|6 enrolled participants did not receive lenalidomide.|144
996796|NCT00478777|2418203|P1|STARTED|Overall Study||150
996797|NCT00478881|2418212|P2|NOT COMPLETED|Overall Study||22
996798|NCT00478881|2418213|P1|NOT COMPLETED|Overall Study||39
996799|NCT00478881|2418212|P2|COMPLETED|Overall Study||176
996800|NCT00478881|2418213|P1|COMPLETED|Overall Study||160
996801|NCT00478881|2418212|P2|Received Medication|Overall Study||198
996802|NCT00478881|2418213|P1|Received Medication|Overall Study||198
996803|NCT00478881|2418212|P2|STARTED|Overall Study||198
996804|NCT00478881|2418213|P1|STARTED|Overall Study||199
996805|NCT00479037|2418239|P2|NOT COMPLETED|Overall Study||6
996806|NCT00479037|2418240|P1|NOT COMPLETED|Overall Study||3
996807|NCT00479037|2418239|P2|COMPLETED|Overall Study||34
996808|NCT00479037|2418240|P1|COMPLETED|Overall Study||38
996809|NCT00479037|2418239|P2|STARTED|Overall Study||40
996810|NCT00479037|2418240|P1|STARTED|Overall Study||41
996811|NCT00479089|2418252|P2|NOT COMPLETED|Overall Study||0
996812|NCT00479089|2418253|P1|NOT COMPLETED|Overall Study||0
996813|NCT00479089|2418252|P2|COMPLETED|Overall Study||25
996814|NCT00479089|2418253|P1|COMPLETED|Overall Study||25
996815|NCT00479089|2418252|P2|STARTED|Overall Study||25
996816|NCT00479089|2418253|P1|STARTED|Overall Study||25
996817|NCT00479154|2418265|P2|NOT COMPLETED|Overall Study||0
996818|NCT00479154|2418266|P1|NOT COMPLETED|Overall Study||0
996819|NCT00479154|2418265|P2|COMPLETED|Overall Study||3
996820|NCT00479154|2418266|P1|COMPLETED|Overall Study||3
996821|NCT00479154|2418265|P2|STARTED|Overall Study||3
996822|NCT00479154|2418266|P1|STARTED|Overall Study||3
996823|NCT00479232|2418274|P6|NOT COMPLETED|Overall Study||30
996824|NCT00479232|2418275|P5|NOT COMPLETED|Overall Study||4
996825|NCT00479232|2418276|P4|NOT COMPLETED|Overall Study||3
996826|NCT00479232|2418277|P3|NOT COMPLETED|Overall Study||28
996827|NCT00479232|2418278|P2|NOT COMPLETED|Overall Study||3
996828|NCT00479232|2418279|P1|NOT COMPLETED|Overall Study||3
996829|NCT00479232|2418274|P6|COMPLETED|Overall Study||0
996830|NCT00479232|2418275|P5|COMPLETED|Overall Study||0
996831|NCT00479232|2418276|P4|COMPLETED|Overall Study||0
996832|NCT00479232|2418277|P3|COMPLETED|Overall Study||0
996833|NCT00479232|2418278|P2|COMPLETED|Overall Study||0
996834|NCT00479232|2418279|P1|COMPLETED|Overall Study||0
996835|NCT00479232|2418274|P6|STARTED|Overall Study||30
996836|NCT00479232|2418275|P5|STARTED|Overall Study||4
996837|NCT00479232|2418276|P4|STARTED|Overall Study||3
996838|NCT00479232|2418277|P3|STARTED|Overall Study||28
996839|NCT00479232|2418278|P2|STARTED|Overall Study||3
996840|NCT00479232|2418279|P1|STARTED|Overall Study||3
996841|NCT00479258|2418299|P2|NOT COMPLETED|Overall Study||0
996842|NCT00479258|2418300|P1|NOT COMPLETED|Overall Study||0
996843|NCT00479258|2418299|P2|COMPLETED|Overall Study||0
996844|NCT00479258|2418300|P1|COMPLETED|Overall Study||0
996845|NCT00479258|2418299|P2|STARTED|Overall Study||0
996846|NCT00479258|2418300|P1|STARTED|Overall Study||0
996847|NCT00479336|2418308|P4|NOT COMPLETED|Overall Study||5
996848|NCT00479336|2418309|P3|NOT COMPLETED|Overall Study||1
996849|NCT00479336|2418310|P2|NOT COMPLETED|Overall Study||6
996850|NCT00479336|2418311|P1|NOT COMPLETED|Overall Study||4
996851|NCT00479336|2418308|P4|COMPLETED|Overall Study||21
996852|NCT00479336|2418309|P3|COMPLETED|Overall Study||24
996853|NCT00479336|2418310|P2|COMPLETED|Overall Study||20
996854|NCT00479336|2418311|P1|COMPLETED|Overall Study||23
996855|NCT00479336|2418308|P4|STARTED|Overall Study||26
996856|NCT00479336|2418309|P3|STARTED|Overall Study||25
996857|NCT00479336|2418310|P2|STARTED|Overall Study||26
996858|NCT00479336|2418311|P1|STARTED|Overall Study||27
996859|NCT00479388|2418327|P2|NOT COMPLETED|Overall Study||73
996860|NCT00479388|2418328|P1|NOT COMPLETED|Overall Study||132
996861|NCT00479388|2418327|P2|COMPLETED|Overall Study||537
996862|NCT00479388|2418328|P1|COMPLETED|Overall Study||474
996863|NCT00479388|2418327|P2|STARTED|Overall Study||610
996864|NCT00479388|2418328|P1|STARTED|Overall Study||606
996865|NCT00479401|2418341|P3|NOT COMPLETED|Overall Study||12
996866|NCT00479401|2418342|P2|NOT COMPLETED|Overall Study||37
996867|NCT00479401|2418343|P1|NOT COMPLETED|Overall Study||49
996868|NCT00479401|2418341|P3|COMPLETED|Overall Study||91
996869|NCT00479401|2418342|P2|COMPLETED|Overall Study||176
996870|NCT00479401|2418343|P1|COMPLETED|Overall Study||174
996871|NCT00479401|2418341|P3|STARTED|Overall Study||103
996872|NCT00479401|2418342|P2|STARTED|Overall Study||213
996873|NCT00479401|2418343|P1|STARTED|Overall Study||223
996874|NCT00479466|2418402|P6|NOT COMPLETED|Overall Study||4
996875|NCT00479466|2418403|P5|NOT COMPLETED|Overall Study||8
996876|NCT00479466|2418404|P4|NOT COMPLETED|Overall Study||3
996877|NCT00479466|2418405|P3|NOT COMPLETED|Overall Study||3
996878|NCT00479466|2418406|P2|NOT COMPLETED|Overall Study||8
996879|NCT00479466|2418407|P1|NOT COMPLETED|Overall Study||13
996880|NCT00479466|2418402|P6|COMPLETED|Overall Study||53
996881|NCT00479466|2418403|P5|COMPLETED|Overall Study||48
996882|NCT00479466|2418404|P4|COMPLETED|Overall Study||55
996883|NCT00479466|2418405|P3|COMPLETED|Overall Study||54
996884|NCT00479466|2418406|P2|COMPLETED|Overall Study||49
996885|NCT00479466|2418407|P1|COMPLETED|Overall Study||44
996886|NCT00479466|2418402|P6|STARTED|Overall Study||57
996887|NCT00479466|2418403|P5|STARTED|Overall Study||56
996888|NCT00479466|2418404|P4|STARTED|Overall Study||58
996889|NCT00479466|2418405|P3|STARTED|Overall Study||57
996890|NCT00479466|2418406|P2|STARTED|Overall Study||57
996891|NCT00479466|2418407|P1|STARTED|Overall Study||57
996892|NCT00479557|2418440|P7|NOT COMPLETED|Overall Study||2
996893|NCT00479557|2418441|P6|NOT COMPLETED|Overall Study||13
996894|NCT00479557|2418442|P5|NOT COMPLETED|Overall Study||4
996895|NCT00479557|2418443|P4|NOT COMPLETED|Overall Study||5
996896|NCT00479557|2418444|P3|NOT COMPLETED|Overall Study||8
996897|NCT00479557|2418445|P2|NOT COMPLETED|Overall Study||10
996898|NCT00479557|2418446|P1|NOT COMPLETED|Overall Study||10
996899|NCT00479557|2418440|P7|COMPLETED|Overall Study||15
996900|NCT00479557|2418441|P6|COMPLETED|Overall Study||31
996901|NCT00479557|2418442|P5|COMPLETED|Overall Study||8
996902|NCT00479557|2418443|P4|COMPLETED|Overall Study||30
996903|NCT00479557|2418444|P3|COMPLETED|Overall Study||32
996904|NCT00479557|2418445|P2|COMPLETED|Overall Study||51
996905|NCT00479557|2418446|P1|COMPLETED|Overall Study||26
996906|NCT00479557|2418440|P7|Treated|Overall Study||17
996907|NCT00479557|2418441|P6|Treated|Overall Study||44
996908|NCT00479557|2418442|P5|Treated|Overall Study||12
996909|NCT00479557|2418443|P4|Treated|Overall Study||35
996910|NCT00479557|2418444|P3|Treated|Overall Study||40
996911|NCT00479557|2418445|P2|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
996912|NCT00479557|2418446|P1|Treated|Overall Study||36
996913|NCT00479557|2418440|P7|STARTED|Overall Study||17
996914|NCT00479557|2418441|P6|STARTED|Overall Study||44
996915|NCT00479557|2418442|P5|STARTED|Overall Study||12
996916|NCT00479557|2418443|P4|STARTED|Overall Study||35
996917|NCT00479557|2418444|P3|STARTED|Overall Study||40
996918|NCT00479557|2418445|P2|STARTED|Overall Study||61
996919|NCT00479557|2418446|P1|STARTED|Overall Study||36
996920|NCT00479674|2418483|P1|NOT COMPLETED|Overall Study||41
996921|NCT00479674|2418483|P1|COMPLETED|Overall Study||0
996922|NCT00479674|2418483|P1|STARTED|Overall Study||41
996923|NCT00479713|2418493|P2|NOT COMPLETED|Overall Study||9
996924|NCT00479713|2418494|P1|NOT COMPLETED|Overall Study||13
996925|NCT00479713|2418493|P2|COMPLETED|Overall Study||295
996926|NCT00479713|2418494|P1|COMPLETED|Overall Study||301
996927|NCT00479713|2418493|P2|STARTED|Overall Study||304
996928|NCT00479713|2418494|P1|STARTED|Overall Study||314
996929|NCT00479765|2418518|P1|NOT COMPLETED|Overall Study||4
996930|NCT00479765|2418518|P1|COMPLETED|Overall Study||0
996931|NCT00479765|2418518|P1|STARTED|Overall Study||4
996932|NCT00479856|2418522|P1|NOT COMPLETED|Overall Study||3
996933|NCT00479856|2418522|P1|COMPLETED|Overall Study||6
996934|NCT00479856|2418522|P1|STARTED|Overall Study||9
996935|NCT00479882|2418535|P4|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||18
996936|NCT00479882|2418536|P3|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||20
996937|NCT00479882|2418537|P2|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||21
996938|NCT00479882|2418538|P1|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||25
996939|NCT00479882|2418535|P4|COMPLETED|Crossover: Period III (Weeks 13-20)||447
996940|NCT00479882|2418536|P3|COMPLETED|Crossover: Period III (Weeks 13-20)||420
996941|NCT00479882|2418537|P2|COMPLETED|Crossover: Period III (Weeks 13-20)||419
996942|NCT00479882|2418538|P1|COMPLETED|Crossover: Period III (Weeks 13-20)||447
996943|NCT00479882|2418535|P4|STARTED|Crossover: Period III (Weeks 13-20)||465
996944|NCT00479882|2418536|P3|STARTED|Crossover: Period III (Weeks 13-20)||440
996945|NCT00479882|2418537|P2|STARTED|Crossover: Period III (Weeks 13-20)||440
996946|NCT00479882|2418538|P1|STARTED|Crossover: Period III (Weeks 13-20)||472
996947|NCT00479882|2418535|P4|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||140
996948|NCT00479882|2418536|P3|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||157
996949|NCT00479882|2418537|P2|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||162
996950|NCT00479882|2418538|P1|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||138
996951|NCT00479882|2418535|P4|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||465
996952|NCT00479882|2418536|P3|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
996953|NCT00479882|2418537|P2|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
996954|NCT00479882|2418538|P1|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||472
996955|NCT00479882|2418535|P4|STARTED|Precrossover: Periods I/II (Weeks 1-12)||605
996956|NCT00479882|2418536|P3|STARTED|Precrossover: Periods I/II (Weeks 1-12)||597
996957|NCT00479882|2418537|P2|STARTED|Precrossover: Periods I/II (Weeks 1-12)||602
996958|NCT00479882|2418538|P1|STARTED|Precrossover: Periods I/II (Weeks 1-12)||610
996959|NCT00473083|2418671|P3|NOT COMPLETED|Overall Study||0
996960|NCT00473083|2418672|P2|NOT COMPLETED|Overall Study||0
996961|NCT00473083|2418673|P1|NOT COMPLETED|Overall Study||1
996962|NCT00473083|2418671|P3|COMPLETED|Overall Study||50
996963|NCT00473083|2418672|P2|COMPLETED|Overall Study||50
996964|NCT00473083|2418673|P1|COMPLETED|Overall Study|One patient (2%) from treatment arm 1 discontinued the study drug as a result of a TEAE (dizziness)|49
996965|NCT00473083|2418671|P3|STARTED|Overall Study||50
996966|NCT00473083|2418672|P2|STARTED|Overall Study||50
996967|NCT00473083|2418673|P1|STARTED|Overall Study||50
996968|NCT00473265|2418699|P1|NOT COMPLETED|Overall Study||20
996969|NCT00473265|2418699|P1|COMPLETED|Overall Study||48
996970|NCT00473265|2418699|P1|STARTED|Overall Study||68
996971|NCT00473330|2418711|P3|NOT COMPLETED|Open-label Extension Through Month 60||77
996972|NCT00473330|2418712|P2|NOT COMPLETED|Open-label Extension Through Month 60||78
996973|NCT00473330|2418713|P1|NOT COMPLETED|Open-label Extension Through Month 60||88
996974|NCT00473330|2418711|P3|COMPLETED|Open-label Extension Through Month 60||0
996975|NCT00473330|2418712|P2|COMPLETED|Open-label Extension Through Month 60||1
996976|NCT00473330|2418713|P1|COMPLETED|Open-label Extension Through Month 60||1
996977|NCT00473330|2418711|P3|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|77
996978|NCT00473330|2418712|P2|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|79
996979|NCT00473330|2418713|P1|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|89
996980|NCT00473330|2418711|P3|NOT COMPLETED|Open-label Extension Through Month 48||27
996981|NCT00473330|2418712|P2|NOT COMPLETED|Open-label Extension Through Month 48||20
996982|NCT00473330|2418713|P1|NOT COMPLETED|Open-label Extension Through Month 48||26
996983|NCT00473330|2418711|P3|COMPLETED|Open-label Extension Through Month 48||50
996984|NCT00473330|2418712|P2|COMPLETED|Open-label Extension Through Month 48||59
996985|NCT00473330|2418713|P1|COMPLETED|Open-label Extension Through Month 48||63
996986|NCT00473330|2418711|P3|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|77
996987|NCT00473330|2418712|P2|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|79
996988|NCT00473330|2418713|P1|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|89
996989|NCT00473330|2418711|P3|NOT COMPLETED|Core Study||41
996990|NCT00473330|2418712|P2|NOT COMPLETED|Core Study||25
996991|NCT00473330|2418713|P1|NOT COMPLETED|Core Study||27
996992|NCT00473330|2418711|P3|COMPLETED|Core Study||86
996993|NCT00473330|2418712|P2|COMPLETED|Core Study||100
996994|NCT00473330|2418713|P1|COMPLETED|Core Study||98
996995|NCT00473330|2418711|P3|STARTED|Core Study||127
996996|NCT00473330|2418712|P2|STARTED|Core Study||125
996997|NCT00473330|2418713|P1|STARTED|Core Study||125
996998|NCT00473382|2418771|P3|NOT COMPLETED|Open-label Extension Through Month 60||82
996999|NCT00473382|2418772|P2|NOT COMPLETED|Open-label Extension Through Month 60||82
997000|NCT00473382|2418773|P1|NOT COMPLETED|Open-label Extension Through Month 60||86
997001|NCT00473382|2418771|P3|COMPLETED|Open-label Extension Through Month 60||2
997002|NCT00473382|2418772|P2|COMPLETED|Open-label Extension Through Month 60||1
997003|NCT00473382|2418773|P1|COMPLETED|Open-label Extension Through Month 60||2
997004|NCT00473382|2418771|P3|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|84
997005|NCT00473382|2418772|P2|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|83
997006|NCT00473382|2418773|P1|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|88
997007|NCT00473382|2418771|P3|NOT COMPLETED|Open-label Extension Through Month 48||47
997008|NCT00473382|2418772|P2|NOT COMPLETED|Open-label Extension Through Month 48||41
997009|NCT00473382|2418773|P1|NOT COMPLETED|Open-label Extension Through Month 48||50
997010|NCT00473382|2418771|P3|COMPLETED|Open-label Extension Through Month 48||37
997011|NCT00473382|2418772|P2|COMPLETED|Open-label Extension Through Month 48||42
997012|NCT00473382|2418773|P1|COMPLETED|Open-label Extension Through Month 48||38
997013|NCT00473382|2418771|P3|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|84
997014|NCT00473382|2418772|P2|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|83
997015|NCT00473382|2418773|P1|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|88
997016|NCT00473382|2418771|P3|NOT COMPLETED|Core Study||29
997017|NCT00473382|2418772|P2|NOT COMPLETED|Core Study||27
997018|NCT00473382|2418773|P1|NOT COMPLETED|Core Study||28
997019|NCT00473382|2418771|P3|COMPLETED|Core Study||98
997020|NCT00473382|2418772|P2|COMPLETED|Core Study||98
997021|NCT00473382|2418773|P1|COMPLETED|Core Study||102
997022|NCT00473382|2418771|P3|STARTED|Core Study||127
997023|NCT00473382|2418772|P2|STARTED|Core Study||125
997024|NCT00473382|2418773|P1|STARTED|Core Study||130
997025|NCT00473434|2418828|P1|NOT COMPLETED|Overall Study||32
997026|NCT00473434|2418828|P1|COMPLETED|Overall Study||32
997027|NCT00473434|2418828|P1|STARTED|Overall Study||64
997028|NCT00473512|2418895|P5|NOT COMPLETED|Period 2 (Phase 2)||2
997029|NCT00473512|2418896|P4|NOT COMPLETED|Period 2 (Phase 2)||23
997030|NCT00473512|2418897|P3|NOT COMPLETED|Period 2 (Phase 2)||2
997031|NCT00473512|2418898|P2|NOT COMPLETED|Period 2 (Phase 2)||2
997032|NCT00473512|2418899|P1|NOT COMPLETED|Period 2 (Phase 2)||1
997033|NCT00473512|2418895|P5|COMPLETED|Period 2 (Phase 2)||0
997034|NCT00473512|2418896|P4|COMPLETED|Period 2 (Phase 2)||0
997035|NCT00473512|2418897|P3|COMPLETED|Period 2 (Phase 2)||0
997036|NCT00473512|2418898|P2|COMPLETED|Period 2 (Phase 2)||0
997037|NCT00473512|2418899|P1|COMPLETED|Period 2 (Phase 2)||0
997038|NCT00473512|2418895|P5|STARTED|Period 2 (Phase 2)||2
997039|NCT00473512|2418896|P4|STARTED|Period 2 (Phase 2)|2 participants did not continue to Phase 2 of the study.|23
997040|NCT00473512|2418897|P3|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|2
997041|NCT00473512|2418898|P2|STARTED|Period 2 (Phase 2)||2
997042|NCT00473512|2418899|P1|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|1
997043|NCT00473512|2418895|P5|NOT COMPLETED|Period 1 (Phase 1)||1
997044|NCT00473512|2418896|P4|NOT COMPLETED|Period 1 (Phase 1)||17
997045|NCT00473512|2418897|P3|NOT COMPLETED|Period 1 (Phase 1)||0
997046|NCT00473512|2418898|P2|NOT COMPLETED|Period 1 (Phase 1)||1
997047|NCT00473512|2418899|P1|NOT COMPLETED|Period 1 (Phase 1)||1
997048|NCT00473512|2418895|P5|COMPLETED|Period 1 (Phase 1)||2
997049|NCT00473512|2418896|P4|COMPLETED|Period 1 (Phase 1)||25
997050|NCT00473512|2418897|P3|COMPLETED|Period 1 (Phase 1)||3
997051|NCT00473512|2418898|P2|COMPLETED|Period 1 (Phase 1)||2
997052|NCT00473512|2418899|P1|COMPLETED|Period 1 (Phase 1)||2
997053|NCT00473512|2418895|P5|STARTED|Period 1 (Phase 1)||3
997054|NCT00473512|2418896|P4|STARTED|Period 1 (Phase 1)||42
997055|NCT00473512|2418897|P3|STARTED|Period 1 (Phase 1)||3
997056|NCT00473512|2418898|P2|STARTED|Period 1 (Phase 1)||3
997057|NCT00473512|2418899|P1|STARTED|Period 1 (Phase 1)||3
997058|NCT00473564|2418957|P1|NOT COMPLETED|Overall Study||23
997059|NCT00473564|2418957|P1|COMPLETED|Overall Study||147
997060|NCT00473564|2418957|P1|STARTED|Overall Study||170
997061|NCT00473590|2418964|P2|NOT COMPLETED|Overall Study||38
997062|NCT00473590|2418965|P1|NOT COMPLETED|Overall Study||45
997063|NCT00473590|2418964|P2|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|11
997064|NCT00473590|2418965|P1|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|8
997065|NCT00473590|2418964|P2|Safety Population|Overall Study||50
997066|NCT00473590|2418965|P1|Safety Population|Overall Study|2 patients received at least 1 bevacizumab dose & were analyzed as bevacizumab-treated patients|50
997067|NCT00473590|2418964|P2|Treated|Overall Study||48
997068|NCT00473590|2418965|P1|Treated|Overall Study||52
997069|NCT00473590|2418964|P2|STARTED|Overall Study||49
997070|NCT00473590|2418965|P1|STARTED|Overall Study||53
997071|NCT00473642|2418984|P3|NOT COMPLETED|Overall Study||2
997072|NCT00473642|2418985|P2|NOT COMPLETED|Overall Study||1
997073|NCT00473642|2418986|P1|NOT COMPLETED|Overall Study||2
997074|NCT00473642|2418984|P3|COMPLETED|Overall Study||8
997075|NCT00473642|2418985|P2|COMPLETED|Overall Study||10
997076|NCT00473642|2418986|P1|COMPLETED|Overall Study||8
997077|NCT00473642|2418984|P3|STARTED|Overall Study||10
997078|NCT00473642|2418985|P2|STARTED|Overall Study||11
997079|NCT00473642|2418986|P1|STARTED|Overall Study||10
997080|NCT00473655|2418997|P3|NOT COMPLETED|Overall Study||8
997081|NCT00473655|2418998|P2|NOT COMPLETED|Overall Study||5
997082|NCT00473655|2418999|P1|NOT COMPLETED|Overall Study||9
997083|NCT00473655|2418997|P3|COMPLETED|Overall Study|8 participants were lost of follow up|103
997084|NCT00473655|2418998|P2|COMPLETED|Overall Study|5 participants were lost of follow up|107
997085|NCT00473655|2418999|P1|COMPLETED|Overall Study|9 participants were lost of follow up|102
997086|NCT00473655|2418997|P3|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
997087|NCT00473655|2418998|P2|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|112
997088|NCT00473655|2418999|P1|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
997089|NCT00473668|2419034|P3|NOT COMPLETED|Overall Study||10
997090|NCT00473668|2419035|P2|NOT COMPLETED|Overall Study||11
997091|NCT00473668|2419036|P1|NOT COMPLETED|Overall Study||5
997092|NCT00473668|2419034|P3|COMPLETED|Overall Study||89
997093|NCT00473668|2419035|P2|COMPLETED|Overall Study||89
997094|NCT00473668|2419036|P1|COMPLETED|Overall Study||95
997095|NCT00473668|2419034|P3|STARTED|Overall Study||99
997096|NCT00473668|2419035|P2|STARTED|Overall Study||100
997097|NCT00473668|2419036|P1|STARTED|Overall Study||100
997098|NCT00473746|2419091|P5|NOT COMPLETED|Period 2 (Phase 2)||27
997099|NCT00473746|2419092|P4|NOT COMPLETED|Period 2 (Phase 2)||0
997100|NCT00473746|2419093|P3|NOT COMPLETED|Period 2 (Phase 2)||0
997101|NCT00473746|2419094|P2|NOT COMPLETED|Period 2 (Phase 2)||0
997102|NCT00473746|2419095|P1|NOT COMPLETED|Period 2 (Phase 2)||0
997103|NCT00473746|2419091|P5|COMPLETED|Period 2 (Phase 2)||6
997104|NCT00473746|2419092|P4|COMPLETED|Period 2 (Phase 2)||0
997105|NCT00473746|2419093|P3|COMPLETED|Period 2 (Phase 2)||0
997106|NCT00473746|2419094|P2|COMPLETED|Period 2 (Phase 2)||0
997107|NCT00473746|2419095|P1|COMPLETED|Period 2 (Phase 2)||0
997108|NCT00473746|2419091|P5|STARTED|Period 2 (Phase 2)||33
997109|NCT00473746|2419092|P4|STARTED|Period 2 (Phase 2)||0
997110|NCT00473746|2419093|P3|STARTED|Period 2 (Phase 2)||0
997111|NCT00473746|2419094|P2|STARTED|Period 2 (Phase 2)||0
997112|NCT00473746|2419095|P1|STARTED|Period 2 (Phase 2)||0
997113|NCT00473746|2419091|P5|NOT COMPLETED|Period 1 (Phase 1)||0
997114|NCT00473746|2419092|P4|NOT COMPLETED|Period 1 (Phase 1)||10
997115|NCT00473746|2419093|P3|NOT COMPLETED|Period 1 (Phase 1)||6
997116|NCT00473746|2419094|P2|NOT COMPLETED|Period 1 (Phase 1)||9
997117|NCT00473746|2419095|P1|NOT COMPLETED|Period 1 (Phase 1)||6
997118|NCT00473746|2419091|P5|COMPLETED|Period 1 (Phase 1)||0
997119|NCT00473746|2419092|P4|COMPLETED|Period 1 (Phase 1)|Treatment ongoing|2
997120|NCT00473746|2419093|P3|COMPLETED|Period 1 (Phase 1)||0
997121|NCT00473746|2419094|P2|COMPLETED|Period 1 (Phase 1)||0
997122|NCT00473746|2419095|P1|COMPLETED|Period 1 (Phase 1)||0
997123|NCT00473746|2419091|P5|STARTED|Period 1 (Phase 1)||0
997124|NCT00473746|2419092|P4|STARTED|Period 1 (Phase 1)||12
997125|NCT00473746|2419093|P3|STARTED|Period 1 (Phase 1)||6
997126|NCT00473746|2419094|P2|STARTED|Period 1 (Phase 1)||9
997127|NCT00473746|2419095|P1|STARTED|Period 1 (Phase 1)||6
997128|NCT00473824|2419142|P2|NOT COMPLETED|Overall Study||0
997129|NCT00473824|2419143|P1|NOT COMPLETED|Overall Study||5
997130|NCT00473824|2419142|P2|COMPLETED|Overall Study|Study Completion/Early Termination Date|2
997131|NCT00473824|2419143|P1|COMPLETED|Overall Study|Study Completion/Early Termination Date|0
997132|NCT00473824|2419142|P2|STARTED|Overall Study||2
997133|NCT00473824|2419143|P1|STARTED|Overall Study||5
997134|NCT00473837|2419151|P2|NOT COMPLETED|Overall Study||3
997135|NCT00473837|2419152|P1|NOT COMPLETED|Overall Study||1
997136|NCT00473837|2419151|P2|COMPLETED|Overall Study||43
997137|NCT00473837|2419152|P1|COMPLETED|Overall Study||49
997138|NCT00473837|2419151|P2|STARTED|Overall Study||46
997139|NCT00473837|2419152|P1|STARTED|Overall Study||50
997140|NCT00473876|2419160|P2|NOT COMPLETED|Overall Study||1
997141|NCT00473876|2419161|P1|NOT COMPLETED|Overall Study||3
997142|NCT00473876|2419160|P2|COMPLETED|Overall Study||22
997143|NCT00473876|2419161|P1|COMPLETED|Overall Study||36
997144|NCT00473876|2419160|P2|STARTED|Overall Study||23
997145|NCT00473876|2419161|P1|STARTED|Overall Study||39
997146|NCT00473889|2419171|P2|NOT COMPLETED|Overall Study||64
997147|NCT00473889|2419172|P1|NOT COMPLETED|Overall Study||83
997148|NCT00473889|2419171|P2|COMPLETED|Overall Study||63
997149|NCT00473889|2419172|P1|COMPLETED|Overall Study||43
997150|NCT00473889|2419171|P2|STARTED|Overall Study||127
997151|NCT00473889|2419172|P1|STARTED|Overall Study||126
997152|NCT00474045|2419184|P2|NOT COMPLETED|Overall Study||101
997153|NCT00474045|2419185|P1|NOT COMPLETED|Overall Study||106
997154|NCT00474045|2419184|P2|COMPLETED|Overall Study||136
997155|NCT00474045|2419185|P1|COMPLETED|Overall Study||127
997156|NCT00474045|2419184|P2|Pregnancies (for Exposed-pregnant)|Overall Study|2 subjects had spontaneous abortion and became pregnant again|160
997157|NCT00474045|2419185|P1|Pregnancies (for Exposed-pregnant)|Overall Study||152
997158|NCT00474045|2419184|P2|Exposed-Pregnant Subjects|Overall Study|3 withdrawn before treatment initiation|158
997159|NCT00474045|2419185|P1|Exposed-Pregnant Subjects|Overall Study||152
997160|NCT00474045|2419184|P2|Exposed-All Subjects|Overall Study|5 withdrawn before treatment initiation|232
997161|NCT00474045|2419185|P1|Exposed-All Subjects|Overall Study||233
997162|NCT00474045|2419184|P2|STARTED|Overall Study||237
997163|NCT00474045|2419185|P1|STARTED|Overall Study||233
997164|NCT00474058|2419285|P2|NOT COMPLETED|Overall Study||17
997165|NCT00474058|2419286|P1|NOT COMPLETED|Overall Study||24
997166|NCT00474058|2419285|P2|COMPLETED|Overall Study||80
997167|NCT00474058|2419286|P1|COMPLETED|Overall Study||166
997168|NCT00474058|2419285|P2|STARTED|Overall Study||97
997169|NCT00474058|2419286|P1|STARTED|Overall Study||190
997170|NCT00474123|2419300|P2|NOT COMPLETED|Overall Study||0
997171|NCT00474123|2419301|P1|NOT COMPLETED|Overall Study||0
997172|NCT00474123|2419300|P2|COMPLETED|Overall Study||40
997173|NCT00474123|2419301|P1|COMPLETED|Overall Study||38
997174|NCT00474123|2419300|P2|STARTED|Overall Study||40
997175|NCT00474123|2419301|P1|STARTED|Overall Study||38
997176|NCT00474175|2419328|P3|NOT COMPLETED|Overall Study||4
997177|NCT00474175|2419329|P2|NOT COMPLETED|Overall Study||7
997178|NCT00474175|2419330|P1|NOT COMPLETED|Overall Study||1
997179|NCT00474175|2419328|P3|COMPLETED|Overall Study||225
997180|NCT00474175|2419329|P2|COMPLETED|Overall Study||226
997181|NCT00474175|2419330|P1|COMPLETED|Overall Study||114
997182|NCT00474175|2419328|P3|Treated|Overall Study||228
997183|NCT00474175|2419329|P2|Treated|Overall Study||233
997184|NCT00474175|2419330|P1|Treated|Overall Study||115
997185|NCT00474175|2419328|P3|STARTED|Overall Study||229
997186|NCT00474175|2419329|P2|STARTED|Overall Study||233
997187|NCT00474175|2419330|P1|STARTED|Overall Study||115
997188|NCT00474188|2419365|P1|NOT COMPLETED|Overall Study||6
997189|NCT00474188|2419365|P1|COMPLETED|Overall Study|Disease progression=15, adverse event=4, death=1|20
997190|NCT00474188|2419365|P1|STARTED|Overall Study||26
997191|NCT00474201|2419372|P1|NOT COMPLETED|Overall Study||0
997192|NCT00474201|2419372|P1|COMPLETED|Overall Study||15
997193|NCT00474201|2419372|P1|STARTED|Overall Study||15
997194|NCT00474240|2419383|P6|NOT COMPLETED|Overall Study||18
997195|NCT00474240|2419384|P5|NOT COMPLETED|Overall Study||8
997196|NCT00474240|2419385|P4|NOT COMPLETED|Overall Study||16
997197|NCT00474240|2419386|P3|NOT COMPLETED|Overall Study||9
997198|NCT00474240|2419387|P2|NOT COMPLETED|Overall Study||1
997199|NCT00474240|2419388|P1|NOT COMPLETED|Overall Study||1
997200|NCT00474240|2419383|P6|COMPLETED|Overall Study||8
997201|NCT00474240|2419384|P5|COMPLETED|Overall Study||18
997202|NCT00474240|2419385|P4|COMPLETED|Overall Study||10
997203|NCT00474240|2419386|P3|COMPLETED|Overall Study||17
997204|NCT00474240|2419387|P2|COMPLETED|Overall Study||25
997205|NCT00474240|2419388|P1|COMPLETED|Overall Study||26
997206|NCT00474240|2419383|P6|STARTED|Overall Study||26
997207|NCT00474240|2419384|P5|STARTED|Overall Study||26
997208|NCT00474240|2419385|P4|STARTED|Overall Study||26
997209|NCT00474240|2419386|P3|STARTED|Overall Study||26
997210|NCT00474240|2419387|P2|STARTED|Overall Study||26
997211|NCT00474240|2419388|P1|STARTED|Overall Study||27
997212|NCT00474383|2419408|P2|NOT COMPLETED|Extension||5
997213|NCT00474383|2419409|P1|NOT COMPLETED|Extension||0
997214|NCT00474383|2419408|P2|COMPLETED|Extension||0
997215|NCT00474383|2419409|P1|COMPLETED|Extension||0
997216|NCT00474383|2419408|P2|STARTED|Extension||5
997217|NCT00474383|2419409|P1|STARTED|Extension||0
997218|NCT00474383|2419408|P2|NOT COMPLETED|Between Main Study and Extension||0
997219|NCT00474383|2419409|P1|NOT COMPLETED|Between Main Study and Extension||6
997220|NCT00474383|2419408|P2|COMPLETED|Between Main Study and Extension||0
997221|NCT00474383|2419409|P1|COMPLETED|Between Main Study and Extension||5
997222|NCT00474383|2419408|P2|STARTED|Between Main Study and Extension||0
997223|NCT00474383|2419409|P1|STARTED|Between Main Study and Extension||11
997224|NCT00474383|2419408|P2|NOT COMPLETED|Main Study||0
997225|NCT00474383|2419409|P1|NOT COMPLETED|Main Study||36
997226|NCT00474383|2419408|P2|COMPLETED|Main Study||0
997227|NCT00474383|2419409|P1|COMPLETED|Main Study||11
997228|NCT00474383|2419408|P2|STARTED|Main Study||0
997229|NCT00474383|2419409|P1|STARTED|Main Study||47
997230|NCT00480324|2419422|P2|NOT COMPLETED|Overall Study||16
997231|NCT00480324|2419423|P1|NOT COMPLETED|Overall Study||32
997232|NCT00480324|2419422|P2|COMPLETED|Overall Study||241
997233|NCT00480324|2419423|P1|COMPLETED|Overall Study||476
997234|NCT00480324|2419422|P2|STARTED|Overall Study||257
997235|NCT00480324|2419423|P1|STARTED|Overall Study||508
997236|NCT00480493|2419451|P2|NOT COMPLETED|Overall Study||7
997237|NCT00480493|2419452|P1|NOT COMPLETED|Overall Study||2
997238|NCT00480493|2419451|P2|COMPLETED|Overall Study||21
997239|NCT00480493|2419452|P1|COMPLETED|Overall Study||30
997240|NCT00480493|2419451|P2|Randomized|Overall Study||28
997241|NCT00480493|2419452|P1|Randomized|Overall Study||32
997242|NCT00480493|2419451|P2|STARTED|Overall Study||28
997243|NCT00480493|2419452|P1|STARTED|Overall Study||32
997244|NCT00480857|2419462|P1|NOT COMPLETED|Overall Study||2
997245|NCT00480857|2419462|P1|COMPLETED|Overall Study||17
997246|NCT00480857|2419462|P1|STARTED|Overall Study||19
997247|NCT00480987|2419470|P1|NOT COMPLETED|Overall Study||0
997248|NCT00480987|2419470|P1|COMPLETED|Overall Study||27
997249|NCT00480987|2419470|P1|STARTED|Overall Study||27
997250|NCT00481065|2419482|P8|NOT COMPLETED|Overall Study||19
997251|NCT00481065|2419483|P7|NOT COMPLETED|Overall Study||16
997252|NCT00481065|2419484|P6|NOT COMPLETED|Overall Study||24
997253|NCT00481065|2419485|P5|NOT COMPLETED|Overall Study||23
997254|NCT00481065|2419486|P4|NOT COMPLETED|Overall Study||15
997255|NCT00481065|2419487|P3|NOT COMPLETED|Overall Study||19
997256|NCT00481065|2419488|P2|NOT COMPLETED|Overall Study||17
997257|NCT00481065|2419489|P1|NOT COMPLETED|Overall Study||22
997258|NCT00481065|2419482|P8|COMPLETED|Overall Study||30
997259|NCT00481065|2419483|P7|COMPLETED|Overall Study||34
997260|NCT00481065|2419484|P6|COMPLETED|Overall Study||27
997261|NCT00481065|2419485|P5|COMPLETED|Overall Study||28
997262|NCT00481065|2419486|P4|COMPLETED|Overall Study||37
997263|NCT00481065|2419487|P3|COMPLETED|Overall Study||32
997264|NCT00481065|2419488|P2|COMPLETED|Overall Study||33
997265|NCT00481065|2419489|P1|COMPLETED|Overall Study||29
997266|NCT00481065|2419482|P8|STARTED|Overall Study||49
997267|NCT00481065|2419483|P7|STARTED|Overall Study||50
997268|NCT00481065|2419484|P6|STARTED|Overall Study||51
997269|NCT00481065|2419485|P5|STARTED|Overall Study||51
997270|NCT00481065|2419486|P4|STARTED|Overall Study||52
997271|NCT00481065|2419487|P3|STARTED|Overall Study||51
997272|NCT00481065|2419488|P2|STARTED|Overall Study||50
997273|NCT00481065|2419489|P1|STARTED|Overall Study||51
997274|NCT00481078|2419577|P2|NOT COMPLETED|Overall Study||20
997275|NCT00481078|2419578|P1|NOT COMPLETED|Overall Study||42
997276|NCT00481078|2419577|P2|COMPLETED|Overall Study||12
997277|NCT00481078|2419578|P1|COMPLETED|Overall Study||20
997278|NCT00481078|2419577|P2|STARTED|Overall Study||32
997279|NCT00481078|2419578|P1|STARTED|Overall Study||62
997280|NCT00481195|2419590|P2|NOT COMPLETED|Overall Study||39
997281|NCT00481195|2419591|P1|NOT COMPLETED|Overall Study||39
997282|NCT00481195|2419590|P2|COMPLETED|Overall Study||90
997283|NCT00481195|2419591|P1|COMPLETED|Overall Study||89
997284|NCT00481195|2419590|P2|STARTED|Overall Study|Four of these subjects were randomized but never received study medication.|129
997285|NCT00481195|2419591|P1|STARTED|Overall Study|Two of these subjects were randomized but never received study medication.|128
997286|NCT00481247|2419677|P2|NOT COMPLETED|Overall Study||260
997287|NCT00481247|2419678|P1|NOT COMPLETED|Overall Study||259
997288|NCT00481247|2419677|P2|COMPLETED|Overall Study||0
997289|NCT00481247|2419678|P1|COMPLETED|Overall Study||0
997290|NCT00481247|2419677|P2|Received Treatment|Overall Study||258
997291|NCT00481247|2419678|P1|Received Treatment|Overall Study||258
997292|NCT00481247|2419677|P2|STARTED|Overall Study|Randomized|260
997293|NCT00481247|2419678|P1|STARTED|Overall Study|Randomized|259
997294|NCT00481351|2419702|P2|NOT COMPLETED|Overall Study||0
997295|NCT00481351|2419703|P1|NOT COMPLETED|Overall Study||0
997296|NCT00481351|2419702|P2|COMPLETED|Overall Study||12
997297|NCT00481351|2419703|P1|COMPLETED|Overall Study||13
997298|NCT00481351|2419702|P2|STARTED|Overall Study||12
997299|NCT00481351|2419703|P1|STARTED|Overall Study||13
997300|NCT00481507|2419719|P2|NOT COMPLETED|Overall Study||0
997301|NCT00481507|2419720|P1|NOT COMPLETED|Overall Study||0
997302|NCT00481507|2419719|P2|COMPLETED|Overall Study||61
997303|NCT00481507|2419720|P1|COMPLETED|Overall Study||64
997304|NCT00481507|2419719|P2|STARTED|Overall Study||61
997305|NCT00481507|2419720|P1|STARTED|Overall Study||64
997306|NCT00481676|2419728|P2|NOT COMPLETED|Overall Study||5
997307|NCT00481676|2419729|P1|NOT COMPLETED|Overall Study||2
997308|NCT00481676|2419728|P2|COMPLETED|Overall Study||17
997309|NCT00481676|2419729|P1|COMPLETED|Overall Study||25
997310|NCT00481676|2419728|P2|STARTED|Overall Study||22
997311|NCT00481676|2419729|P1|STARTED|Overall Study||27
997312|NCT00481767|2419753|P2|NOT COMPLETED|Overall Study||21
997313|NCT00481767|2419754|P1|NOT COMPLETED|Overall Study||32
997314|NCT00481767|2419753|P2|COMPLETED|Overall Study||205
997315|NCT00481767|2419754|P1|COMPLETED|Overall Study||418
997316|NCT00481767|2419753|P2|STARTED|Overall Study||226
997317|NCT00481767|2419754|P1|STARTED|Overall Study||450
997318|NCT00481845|2419786|P2|NOT COMPLETED|Overall Study||0
997319|NCT00481845|2419787|P1|NOT COMPLETED|Overall Study||0
997320|NCT00481845|2419786|P2|COMPLETED|Overall Study||0
997321|NCT00481845|2419787|P1|COMPLETED|Overall Study||1
997322|NCT00481845|2419786|P2|STARTED|Overall Study||0
997323|NCT00481845|2419787|P1|STARTED|Overall Study||1
997324|NCT00481871|2419800|P5|NOT COMPLETED|Overall Study||0
997325|NCT00481871|2419801|P4|NOT COMPLETED|Overall Study||0
997326|NCT00481871|2419802|P3|NOT COMPLETED|Overall Study||1
997327|NCT00481871|2419803|P2|NOT COMPLETED|Overall Study||0
997328|NCT00481871|2419804|P1|NOT COMPLETED|Overall Study||0
997329|NCT00481871|2419800|P5|COMPLETED|Overall Study||34
997330|NCT00481871|2419801|P4|COMPLETED|Overall Study||38
997331|NCT00481871|2419802|P3|COMPLETED|Overall Study||17
997332|NCT00481871|2419803|P2|COMPLETED|Overall Study||10
997333|NCT00481871|2419804|P1|COMPLETED|Overall Study||7
997334|NCT00481871|2419800|P5|STARTED|Overall Study||34
997335|NCT00481871|2419801|P4|STARTED|Overall Study||38
997336|NCT00481871|2419802|P3|STARTED|Overall Study||18
997337|NCT00481871|2419803|P2|STARTED|Overall Study||10
997338|NCT00481871|2419804|P1|STARTED|Overall Study||7
997339|NCT00481988|2419820|P2|NOT COMPLETED|Overall Study||1
997340|NCT00481988|2419821|P1|NOT COMPLETED|Overall Study||1
997341|NCT00481988|2419820|P2|COMPLETED|Overall Study||8
997342|NCT00481988|2419821|P1|COMPLETED|Overall Study||11
997343|NCT00481988|2419820|P2|Crossover|Overall Study|patient dropped out of study after 5 sessions to illness unrelated to study|8
997344|NCT00481988|2419821|P1|Crossover|Overall Study|patient dropped out of study after 5 sessions to pursue other treatment options|11
997345|NCT00481988|2419820|P2|STARTED|Overall Study|one patient was dropped from the study before randomization|9
997346|NCT00481988|2419821|P1|STARTED|Overall Study||12
997347|NCT00482014|2419833|P4|NOT COMPLETED|Overall Study||23
997348|NCT00482014|2419834|P3|NOT COMPLETED|Overall Study||11
997349|NCT00482014|2419835|P2|NOT COMPLETED|Overall Study||6
997350|NCT00482014|2419836|P1|NOT COMPLETED|Overall Study||7
997351|NCT00482014|2419833|P4|COMPLETED|Overall Study||29
997352|NCT00482014|2419834|P3|COMPLETED|Overall Study||35
997353|NCT00482014|2419835|P2|COMPLETED|Overall Study||7
997354|NCT00482014|2419836|P1|COMPLETED|Overall Study||2
997355|NCT00482014|2419833|P4|STARTED|Overall Study||52
997356|NCT00482014|2419834|P3|STARTED|Overall Study||46
997357|NCT00482014|2419835|P2|STARTED|Overall Study||13
997358|NCT00482014|2419836|P1|STARTED|Overall Study||9
997359|NCT00482170|2419860|P2|NOT COMPLETED|Overall Study||20
997360|NCT00482170|2419861|P1|NOT COMPLETED|Overall Study||15
997361|NCT00482170|2419860|P2|COMPLETED|Overall Study||194
997362|NCT00482170|2419861|P1|COMPLETED|Overall Study||192
997363|NCT00482170|2419860|P2|Treated|Overall Study||211
997364|NCT00482170|2419861|P1|Treated|Overall Study||207
997365|NCT00482170|2419860|P2|STARTED|Overall Study||214
997366|NCT00482170|2419861|P1|STARTED|Overall Study||207
997367|NCT00482274|2419979|P1|NOT COMPLETED|Overall Study||1
997368|NCT00482274|2419979|P1|COMPLETED|Overall Study||2
997369|NCT00482274|2419979|P1|STARTED|Overall Study||3
997370|NCT00482391|2419987|P1|NOT COMPLETED|Overall Study||3
997371|NCT00482391|2419987|P1|COMPLETED|Overall Study||92
997372|NCT00482391|2419987|P1|STARTED|Overall Study||95
997373|NCT00482547|2419994|P2|NOT COMPLETED|Overall Study||161
997374|NCT00482547|2419995|P1|NOT COMPLETED|Overall Study||173
997375|NCT00482547|2419994|P2|COMPLETED|Overall Study||428
997376|NCT00482547|2419995|P1|COMPLETED|Overall Study||426
997377|NCT00482547|2419994|P2|48 Hour Evaluation|Overall Study|428 went on to be included in the Silicone-coated 48 hour efficacy evaluable population.|428
997378|NCT00482547|2419995|P1|48 Hour Evaluation|Overall Study|426 went on to be included in the Silver-coated 48 hour efficacy evaluable population.|426
997379|NCT00482547|2419994|P2|Successful Catheterization|Overall Study|Out of the 589 SiCS catheter subjects 568 (96.4%) had a successful catheterization.|568
997380|NCT00482547|2419995|P1|Successful Catheterization|Overall Study|Out of the 599 AgCS subjects 565 (94.3%) had a successful catheterization.|565
997381|NCT00482547|2419994|P2|STARTED|Overall Study|589 subjects were enrolled in the silicone-coated catheter group.|589
997382|NCT00482547|2419995|P1|STARTED|Overall Study|599 subjects were enrolled in the silver-coated catheter group.|599
997383|NCT00482612|2420019|P4|NOT COMPLETED|Follow-up Period||8
997384|NCT00482612|2420020|P3|NOT COMPLETED|Follow-up Period||22
997385|NCT00482612|2420021|P2|NOT COMPLETED|Follow-up Period||18
997386|NCT00482612|2420022|P1|NOT COMPLETED|Follow-up Period||14
997387|NCT00482612|2420019|P4|COMPLETED|Follow-up Period||127
997388|NCT00482612|2420020|P3|COMPLETED|Follow-up Period||106
997389|NCT00482612|2420021|P2|COMPLETED|Follow-up Period||107
997390|NCT00482612|2420022|P1|COMPLETED|Follow-up Period||123
997391|NCT00482612|2420019|P4|STARTED|Follow-up Period||135
997392|NCT00482612|2420020|P3|STARTED|Follow-up Period||128
997393|NCT00482612|2420021|P2|STARTED|Follow-up Period||125
997394|NCT00482612|2420022|P1|STARTED|Follow-up Period||137
997395|NCT00482612|2420019|P4|NOT COMPLETED|In-treatment Period||0
997396|NCT00482612|2420020|P3|NOT COMPLETED|In-treatment Period||1
997397|NCT00482612|2420021|P2|NOT COMPLETED|In-treatment Period||0
997398|NCT00482612|2420022|P1|NOT COMPLETED|In-treatment Period||0
997399|NCT00482612|2420019|P4|COMPLETED|In-treatment Period||135
997400|NCT00482612|2420020|P3|COMPLETED|In-treatment Period||128
997401|NCT00482612|2420021|P2|COMPLETED|In-treatment Period||125
997402|NCT00482612|2420022|P1|COMPLETED|In-treatment Period||137
997403|NCT00482612|2420019|P4|Treated|In-treatment Period||135
997404|NCT00482612|2420020|P3|Treated|In-treatment Period||128
997405|NCT00482612|2420021|P2|Treated|In-treatment Period||125
997406|NCT00482612|2420022|P1|Treated|In-treatment Period||137
997407|NCT00482612|2420019|P4|STARTED|In-treatment Period||135
997408|NCT00482612|2420020|P3|STARTED|In-treatment Period||129
997409|NCT00482612|2420021|P2|STARTED|In-treatment Period||125
997410|NCT00482612|2420022|P1|STARTED|In-treatment Period||137
997411|NCT00482625|2420048|P1|NOT COMPLETED|Overall Study||0
997412|NCT00482625|2420048|P1|COMPLETED|Overall Study||6
997413|NCT00482625|2420048|P1|STARTED|Overall Study||6
997414|NCT00482703|2420059|P2|NOT COMPLETED|Overall Study||0
997415|NCT00482703|2420060|P1|NOT COMPLETED|Overall Study||1
997416|NCT00482703|2420059|P2|COMPLETED|Overall Study||12
997417|NCT00482703|2420060|P1|COMPLETED|Overall Study||10
997418|NCT00482703|2420059|P2|STARTED|Overall Study|number enrolled, randomized and treated|12
997419|NCT00482703|2420060|P1|STARTED|Overall Study|number enrolled, randomized and treated|11
997420|NCT00482729|2420107|P2|NOT COMPLETED|Overall Study||218
997421|NCT00482729|2420108|P1|NOT COMPLETED|Overall Study||217
997422|NCT00482729|2420107|P2|COMPLETED|Overall Study||406
997423|NCT00482729|2420108|P1|COMPLETED|Overall Study||409
997424|NCT00482729|2420107|P2|Completed Phase B|Overall Study||406
997425|NCT00482729|2420108|P1|Completed Phase B|Overall Study||409
997426|NCT00482729|2420107|P2|Completed Phase A|Overall Study||482
997427|NCT00482729|2420108|P1|Completed Phase A|Overall Study||484
997428|NCT00482729|2420107|P2|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 3 patients were excluded from all analysis|624
997429|NCT00482729|2420108|P1|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 1 patient was excluded from all analysis|626
997430|NCT00482911|2420124|P2|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
997431|NCT00482911|2420125|P1|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
997432|NCT00482911|2420124|P2|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun|5 stopped at Dose D-QOD, 2 stopped at Dose D-QD (1 after first increasing to Dose E-QD)|7
997433|NCT00482911|2420125|P1|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
997434|NCT00482911|2420124|P2|STARTED|Dosing Schedule 2: Len, Cyc, & Sun|All received Dose D-QD in cycle 1|7
997435|NCT00482911|2420125|P1|STARTED|Dosing Schedule 2: Len, Cyc, & Sun||0
997436|NCT00482911|2420124|P2|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
997437|NCT00482911|2420125|P1|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
997438|NCT00482911|2420124|P2|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QOD|2
997439|NCT00482911|2420125|P1|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QD, 1 stopped at Dose C-QOD|3
997440|NCT00482911|2420124|P2|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 1|2
997441|NCT00482911|2420125|P1|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 2|3
997442|NCT00482911|2420124|P2|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
997443|NCT00482911|2420125|P1|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
997444|NCT00482911|2420124|P2|COMPLETED|Dosing Schedule 1: Len & Cyc||0
997445|NCT00482911|2420125|P1|COMPLETED|Dosing Schedule 1: Len & Cyc||3
997446|NCT00482911|2420124|P2|STARTED|Dosing Schedule 1: Len & Cyc||0
997447|NCT00482911|2420125|P1|STARTED|Dosing Schedule 1: Len & Cyc|All received Dose A-QD in cycle 1|3
997448|NCT00483002|2420139|P1|NOT COMPLETED|Overall Study||2554
997449|NCT00483002|2420139|P1|COMPLETED|Overall Study||1165
997450|NCT00483002|2420139|P1|STARTED|Overall Study||3719
997451|NCT00483041|2420147|P2|NOT COMPLETED|Overall Study||1
997452|NCT00483041|2420148|P1|NOT COMPLETED|Overall Study||0
997453|NCT00483041|2420147|P2|COMPLETED|Overall Study||5
997454|NCT00483041|2420148|P1|COMPLETED|Overall Study||5
997455|NCT00483041|2420147|P2|STARTED|Overall Study||6
997456|NCT00483041|2420148|P1|STARTED|Overall Study||5
997457|NCT00483119|2420180|P2|NOT COMPLETED|Overall Study||1
997458|NCT00483119|2420181|P1|NOT COMPLETED|Overall Study||1
997459|NCT00483119|2420180|P2|COMPLETED|Overall Study||3
997460|NCT00483119|2420181|P1|COMPLETED|Overall Study||4
997461|NCT00483119|2420180|P2|STARTED|Overall Study||4
997462|NCT00483119|2420181|P1|STARTED|Overall Study||5
997463|NCT00483184|2420196|P3|NOT COMPLETED|Overall Study||3
997464|NCT00483184|2420197|P2|NOT COMPLETED|Overall Study||4
997465|NCT00483184|2420198|P1|NOT COMPLETED|Overall Study||5
997466|NCT00483184|2420196|P3|COMPLETED|Overall Study||23
997467|NCT00483184|2420197|P2|COMPLETED|Overall Study||27
997468|NCT00483184|2420198|P1|COMPLETED|Overall Study||22
997469|NCT00483184|2420196|P3|STARTED|Overall Study||26
997470|NCT00483184|2420197|P2|STARTED|Overall Study||31
997471|NCT00483184|2420198|P1|STARTED|Overall Study||27
997472|NCT00483223|2420206|P1|NOT COMPLETED|Overall Study||0
997473|NCT00483223|2420206|P1|COMPLETED|Overall Study||86
997474|NCT00483223|2420206|P1|STARTED|Overall Study||86
997475|NCT00483262|2420215|P2|NOT COMPLETED|Overall Study||0
997476|NCT00483262|2420216|P1|NOT COMPLETED|Overall Study||0
997477|NCT00483262|2420215|P2|COMPLETED|Overall Study||43
997478|NCT00483262|2420216|P1|COMPLETED|Overall Study||20
997479|NCT00483262|2420215|P2|STARTED|Overall Study||43
997480|NCT00483262|2420216|P1|STARTED|Overall Study||20
997481|NCT00483327|2420226|P1|NOT COMPLETED|Overall Study||10
997482|NCT00483327|2420226|P1|COMPLETED|Overall Study||20
997483|NCT00483327|2420226|P1|STARTED|Overall Study||30
997484|NCT00477334|2420235|P2|NOT COMPLETED|Overall Study||76
997485|NCT00477334|2420236|P1|NOT COMPLETED|Overall Study||170
997486|NCT00477334|2420235|P2|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|75
997739|NCT00489970|2420746|P2|COMPLETED|Persistence Year 3||486
997487|NCT00477334|2420236|P1|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|142
997488|NCT00477334|2420235|P2|Modified Intent to Treat Population|Overall Study||78
997489|NCT00477334|2420236|P1|Modified Intent to Treat Population|Overall Study||152
997490|NCT00477334|2420235|P2|Participants Completing First Recurrence|Overall Study||92
997491|NCT00477334|2420236|P1|Participants Completing First Recurrence|Overall Study||187
997492|NCT00477334|2420235|P2|Intent to Treat Population|Overall Study||98
997493|NCT00477334|2420236|P1|Intent to Treat Population|Overall Study||201
997494|NCT00477334|2420235|P2|Randomized and Took Study Drug|Overall Study||98
997495|NCT00477334|2420236|P1|Randomized and Took Study Drug|Overall Study||206
997496|NCT00477334|2420235|P2|STARTED|Overall Study||151
997497|NCT00477334|2420236|P1|STARTED|Overall Study||312
997498|NCT00477386|2420262|P2|NOT COMPLETED|Overall Study||17
997499|NCT00477386|2420263|P1|NOT COMPLETED|Overall Study||11
997500|NCT00477386|2420262|P2|COMPLETED|Overall Study||0
997501|NCT00477386|2420263|P1|COMPLETED|Overall Study||0
997502|NCT00477386|2420262|P2|STARTED|Overall Study||17
997503|NCT00477386|2420263|P1|STARTED|Overall Study||11
997504|NCT00477451|2420275|P4|NOT COMPLETED|Overall Study||0
997505|NCT00477451|2420276|P3|NOT COMPLETED|Overall Study||0
997506|NCT00477451|2420277|P2|NOT COMPLETED|Overall Study||0
997507|NCT00477451|2420278|P1|NOT COMPLETED|Overall Study||0
997508|NCT00477451|2420275|P4|COMPLETED|Overall Study||2
997509|NCT00477451|2420276|P3|COMPLETED|Overall Study||7
997510|NCT00477451|2420277|P2|COMPLETED|Overall Study||20
997511|NCT00477451|2420278|P1|COMPLETED|Overall Study||20
997512|NCT00477451|2420275|P4|STARTED|Overall Study||2
997513|NCT00477451|2420276|P3|STARTED|Overall Study||7
997514|NCT00477451|2420277|P2|STARTED|Overall Study||20
997515|NCT00477451|2420278|P1|STARTED|Overall Study||20
997516|NCT00477464|2420290|P1|NOT COMPLETED|Overall Study||51
997517|NCT00477464|2420290|P1|COMPLETED|Overall Study||0
997518|NCT00477464|2420290|P1|STARTED|Overall Study||51
997519|NCT00477490|2420318|P9|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||8
997520|NCT00477490|2420319|P8|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
997521|NCT00477490|2420320|P7|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
997522|NCT00477490|2420321|P6|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||6
997523|NCT00477490|2420322|P5|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||20
997524|NCT00477490|2420323|P4|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||12
997525|NCT00477490|2420324|P3|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||15
997526|NCT00477490|2420325|P2|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||28
997527|NCT00477490|2420326|P1|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||0
997528|NCT00477490|2420318|P9|COMPLETED|Part II: Extension Week 5 up to Day 169||26
997529|NCT00477490|2420319|P8|COMPLETED|Part II: Extension Week 5 up to Day 169||29
997530|NCT00477490|2420320|P7|COMPLETED|Part II: Extension Week 5 up to Day 169||32
997531|NCT00477490|2420321|P6|COMPLETED|Part II: Extension Week 5 up to Day 169||25
997532|NCT00477490|2420322|P5|COMPLETED|Part II: Extension Week 5 up to Day 169||107
997533|NCT00477490|2420323|P4|COMPLETED|Part II: Extension Week 5 up to Day 169||120
997534|NCT00477490|2420324|P3|COMPLETED|Part II: Extension Week 5 up to Day 169||120
997535|NCT00477490|2420325|P2|COMPLETED|Part II: Extension Week 5 up to Day 169||107
997536|NCT00477490|2420326|P1|COMPLETED|Part II: Extension Week 5 up to Day 169||0
997537|NCT00477490|2420318|P9|STARTED|Part II: Extension Week 5 up to Day 169||34
997538|NCT00477490|2420319|P8|STARTED|Part II: Extension Week 5 up to Day 169||34
997539|NCT00477490|2420320|P7|STARTED|Part II: Extension Week 5 up to Day 169||37
997540|NCT00477490|2420321|P6|STARTED|Part II: Extension Week 5 up to Day 169||31
997541|NCT00477490|2420322|P5|STARTED|Part II: Extension Week 5 up to Day 169||127
997542|NCT00477490|2420323|P4|STARTED|Part II: Extension Week 5 up to Day 169||132
997543|NCT00477490|2420324|P3|STARTED|Part II: Extension Week 5 up to Day 169||135
997544|NCT00477490|2420325|P2|STARTED|Part II: Extension Week 5 up to Day 169||135
997545|NCT00477490|2420326|P1|STARTED|Part II: Extension Week 5 up to Day 169||0
997546|NCT00477490|2420318|P9|NOT COMPLETED|Part I: 4 Week Efficacy||0
997547|NCT00477490|2420319|P8|NOT COMPLETED|Part I: 4 Week Efficacy||0
997548|NCT00477490|2420320|P7|NOT COMPLETED|Part I: 4 Week Efficacy||0
997549|NCT00477490|2420321|P6|NOT COMPLETED|Part I: 4 Week Efficacy||0
997550|NCT00477490|2420322|P5|NOT COMPLETED|Part I: 4 Week Efficacy||25
997551|NCT00477490|2420323|P4|NOT COMPLETED|Part I: 4 Week Efficacy||20
997552|NCT00477490|2420324|P3|NOT COMPLETED|Part I: 4 Week Efficacy||10
997553|NCT00477490|2420325|P2|NOT COMPLETED|Part I: 4 Week Efficacy||19
997554|NCT00477490|2420326|P1|NOT COMPLETED|Part I: 4 Week Efficacy||15
997555|NCT00477490|2420318|P9|COMPLETED|Part I: 4 Week Efficacy||0
997556|NCT00477490|2420319|P8|COMPLETED|Part I: 4 Week Efficacy||0
997557|NCT00477490|2420320|P7|COMPLETED|Part I: 4 Week Efficacy||0
997558|NCT00477490|2420321|P6|COMPLETED|Part I: 4 Week Efficacy||0
997559|NCT00477490|2420322|P5|COMPLETED|Part I: 4 Week Efficacy||135
997560|NCT00477490|2420323|P4|COMPLETED|Part I: 4 Week Efficacy||138
997561|NCT00477490|2420324|P3|COMPLETED|Part I: 4 Week Efficacy||148
997562|NCT00477490|2420325|P2|COMPLETED|Part I: 4 Week Efficacy||144
997563|NCT00477490|2420326|P1|COMPLETED|Part I: 4 Week Efficacy||145
997564|NCT00477490|2420318|P9|ITT Population|Part I: 4 Week Efficacy||0
997565|NCT00477490|2420319|P8|ITT Population|Part I: 4 Week Efficacy||0
997566|NCT00477490|2420320|P7|ITT Population|Part I: 4 Week Efficacy||0
997567|NCT00477490|2420321|P6|ITT Population|Part I: 4 Week Efficacy||0
997740|NCT00489970|2420747|P1|COMPLETED|Persistence Year 3||1019
997568|NCT00477490|2420322|P5|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|146
997569|NCT00477490|2420323|P4|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|148
997570|NCT00477490|2420324|P3|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|152
997571|NCT00477490|2420325|P2|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|155
997572|NCT00477490|2420326|P1|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|156
997573|NCT00477490|2420318|P9|STARTED|Part I: 4 Week Efficacy||0
997574|NCT00477490|2420319|P8|STARTED|Part I: 4 Week Efficacy||0
997575|NCT00477490|2420320|P7|STARTED|Part I: 4 Week Efficacy||0
997576|NCT00477490|2420321|P6|STARTED|Part I: 4 Week Efficacy||0
997577|NCT00477490|2420322|P5|STARTED|Part I: 4 Week Efficacy||160
997578|NCT00477490|2420323|P4|STARTED|Part I: 4 Week Efficacy||158
997579|NCT00477490|2420324|P3|STARTED|Part I: 4 Week Efficacy||158
997580|NCT00477490|2420325|P2|STARTED|Part I: 4 Week Efficacy||163
997581|NCT00477490|2420326|P1|STARTED|Part I: 4 Week Efficacy||160
997582|NCT00483379|2420412|P2|NOT COMPLETED|Extension Period||0
997583|NCT00483379|2420413|P1|NOT COMPLETED|Extension Period||0
997584|NCT00483379|2420412|P2|COMPLETED|Extension Period||2
997585|NCT00483379|2420413|P1|COMPLETED|Extension Period||1
997586|NCT00483379|2420412|P2|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|2
997587|NCT00483379|2420413|P1|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|1
997588|NCT00483379|2420412|P2|NOT COMPLETED|Treatment Period||0
997589|NCT00483379|2420413|P1|NOT COMPLETED|Treatment Period||2
997590|NCT00483379|2420412|P2|COMPLETED|Treatment Period||7
997591|NCT00483379|2420413|P1|COMPLETED|Treatment Period||4
997592|NCT00483379|2420412|P2|STARTED|Treatment Period||7
997593|NCT00483379|2420413|P1|STARTED|Treatment Period||6
997594|NCT00483405|2420449|P1|NOT COMPLETED|Overall Study||28
997595|NCT00483405|2420449|P1|COMPLETED|Overall Study||0
997596|NCT00483405|2420449|P1|STARTED|Overall Study||28
997600|NCT00483548|2420469|P2|NOT COMPLETED|Overall Study||46
997601|NCT00483548|2420470|P1|NOT COMPLETED|Overall Study||60
997602|NCT00483548|2420469|P2|COMPLETED|Overall Study||104
997603|NCT00483548|2420470|P1|COMPLETED|Overall Study||88
997604|NCT00483548|2420469|P2|Received Study Treatment|Overall Study|3 subjects randomized but not treated.|147
997605|NCT00483548|2420470|P1|Received Study Treatment|Overall Study|1 subject randomized but lost to follow up; no treatment data.|147
997606|NCT00483548|2420469|P2|STARTED|Overall Study||150
997607|NCT00483548|2420470|P1|STARTED|Overall Study||148
997608|NCT00483574|2420510|P2|NOT COMPLETED|Overall Study||13
997609|NCT00483574|2420511|P1|NOT COMPLETED|Overall Study||102
997610|NCT00483574|2420510|P2|COMPLETED|Overall Study||308
997611|NCT00483574|2420511|P1|COMPLETED|Overall Study||951
997612|NCT00483574|2420510|P2|STARTED|Overall Study||321
997613|NCT00483574|2420511|P1|STARTED|Overall Study||1053
997614|NCT00483652|2420521|P2|NOT COMPLETED|Post-study Follow-up||0
997615|NCT00483652|2420522|P1|NOT COMPLETED|Post-study Follow-up||0
997616|NCT00483652|2420521|P2|COMPLETED|Post-study Follow-up||114
997617|NCT00483652|2420522|P1|COMPLETED|Post-study Follow-up||113
997618|NCT00483652|2420521|P2|STARTED|Post-study Follow-up||114
997619|NCT00483652|2420522|P1|STARTED|Post-study Follow-up||113
997620|NCT00483652|2420521|P2|NOT COMPLETED|Double-blind Treatment Period||5
997621|NCT00483652|2420522|P1|NOT COMPLETED|Double-blind Treatment Period||7
997622|NCT00483652|2420521|P2|COMPLETED|Double-blind Treatment Period||114
997623|NCT00483652|2420522|P1|COMPLETED|Double-blind Treatment Period||113
997624|NCT00483652|2420521|P2|STARTED|Double-blind Treatment Period||119
997625|NCT00483652|2420522|P1|STARTED|Double-blind Treatment Period||120
997626|NCT00489476|2420534|P4|NOT COMPLETED|Overall Study||0
997627|NCT00489476|2420535|P3|NOT COMPLETED|Overall Study||0
997628|NCT00489476|2420536|P2|NOT COMPLETED|Overall Study||1
997629|NCT00489476|2420537|P1|NOT COMPLETED|Overall Study||0
997630|NCT00489476|2420534|P4|COMPLETED|Overall Study||43
997631|NCT00489476|2420535|P3|COMPLETED|Overall Study||43
997632|NCT00489476|2420536|P2|COMPLETED|Overall Study||42
997633|NCT00489476|2420537|P1|COMPLETED|Overall Study||39
997634|NCT00489476|2420534|P4|STARTED|Overall Study||43
997635|NCT00489476|2420535|P3|STARTED|Overall Study||43
997636|NCT00489476|2420536|P2|STARTED|Overall Study||43
997637|NCT00489476|2420537|P1|STARTED|Overall Study||39
997638|NCT00489489|2420558|P3|NOT COMPLETED|Overall Study||3
997639|NCT00489489|2420559|P2|NOT COMPLETED|Overall Study||5
997640|NCT00489489|2420560|P1|NOT COMPLETED|Overall Study||3
997641|NCT00489489|2420558|P3|COMPLETED|Overall Study|completed treatment period|37
997642|NCT00489489|2420559|P2|COMPLETED|Overall Study|completed treatment period|32
997643|NCT00489489|2420560|P1|COMPLETED|Overall Study|completed treatment period|38
997644|NCT00489489|2420558|P3|Treated|Overall Study|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|39
997645|NCT00489489|2420559|P2|Treated|Overall Study||36
997646|NCT00489489|2420560|P1|Treated|Overall Study||41
997647|NCT00489489|2420558|P3|STARTED|Overall Study|randomized|40
997648|NCT00489489|2420559|P2|STARTED|Overall Study|randomized|37
997649|NCT00489489|2420560|P1|STARTED|Overall Study|randomized|41
997650|NCT00489541|2420590|P2|NOT COMPLETED|9-Month Angiographic Follow-up||17
997651|NCT00489541|2420591|P1|NOT COMPLETED|9-Month Angiographic Follow-up||27
997652|NCT00489541|2420590|P2|COMPLETED|9-Month Angiographic Follow-up||108
997653|NCT00489541|2420591|P1|COMPLETED|9-Month Angiographic Follow-up||197
997654|NCT00489541|2420590|P2|STARTED|9-Month Angiographic Follow-up||125
997655|NCT00489541|2420591|P1|STARTED|9-Month Angiographic Follow-up||224
997656|NCT00489541|2420590|P2|NOT COMPLETED|12-Month Clinical Follow-up||5
997657|NCT00489541|2420591|P1|NOT COMPLETED|12-Month Clinical Follow-up||9
997658|NCT00489541|2420590|P2|COMPLETED|12-Month Clinical Follow-up||120
997659|NCT00489541|2420591|P1|COMPLETED|12-Month Clinical Follow-up||215
997660|NCT00489541|2420590|P2|STARTED|12-Month Clinical Follow-up||125
997661|NCT00489541|2420591|P1|STARTED|12-Month Clinical Follow-up||224
997662|NCT00489554|2420599|P1|NOT COMPLETED|Overall Study||4
997663|NCT00489554|2420599|P1|COMPLETED|Overall Study||226
997664|NCT00489554|2420599|P1|STARTED|Overall Study||230
997665|NCT00489736|2420619|P2|NOT COMPLETED|Overall Study||69
997666|NCT00489736|2420620|P1|NOT COMPLETED|Overall Study||96
997667|NCT00489736|2420619|P2|COMPLETED|Overall Study|completed study drug period|186
997668|NCT00489736|2420620|P1|COMPLETED|Overall Study|completed study drug period|153
997669|NCT00489736|2420619|P2|STARTED|Overall Study|Randomized and treated patients|255
997670|NCT00489736|2420620|P1|STARTED|Overall Study|Randomized and treated patients|249
997671|NCT00489853|2420630|P3|NOT COMPLETED|Follow-up Period||0
997672|NCT00489853|2420631|P2|NOT COMPLETED|Follow-up Period||0
997673|NCT00489853|2420632|P1|NOT COMPLETED|Follow-up Period||0
997674|NCT00489853|2420630|P3|COMPLETED|Follow-up Period||33
997675|NCT00489853|2420631|P2|COMPLETED|Follow-up Period||29
997676|NCT00489853|2420632|P1|COMPLETED|Follow-up Period||29
997677|NCT00489853|2420630|P3|STARTED|Follow-up Period||33
997678|NCT00489853|2420631|P2|STARTED|Follow-up Period||29
997679|NCT00489853|2420632|P1|STARTED|Follow-up Period||29
997680|NCT00489853|2420630|P3|NOT COMPLETED|Treatment Period 3||0
997681|NCT00489853|2420631|P2|NOT COMPLETED|Treatment Period 3||1
997682|NCT00489853|2420632|P1|NOT COMPLETED|Treatment Period 3||0
997683|NCT00489853|2420630|P3|COMPLETED|Treatment Period 3||33
997684|NCT00489853|2420631|P2|COMPLETED|Treatment Period 3||29
997685|NCT00489853|2420632|P1|COMPLETED|Treatment Period 3||29
997686|NCT00489853|2420630|P3|STARTED|Treatment Period 3||33
997687|NCT00489853|2420631|P2|STARTED|Treatment Period 3||30
997688|NCT00489853|2420632|P1|STARTED|Treatment Period 3||29
997689|NCT00489853|2420630|P3|NOT COMPLETED|Wash-out Period 2||2
997690|NCT00489853|2420631|P2|NOT COMPLETED|Wash-out Period 2||3
997691|NCT00489853|2420632|P1|NOT COMPLETED|Wash-out Period 2||4
997692|NCT00489853|2420630|P3|COMPLETED|Wash-out Period 2||31
997693|NCT00489853|2420631|P2|COMPLETED|Wash-out Period 2||32
997694|NCT00489853|2420632|P1|COMPLETED|Wash-out Period 2||29
997695|NCT00489853|2420630|P3|STARTED|Wash-out Period 2||33
997696|NCT00489853|2420631|P2|STARTED|Wash-out Period 2||35
997697|NCT00489853|2420632|P1|STARTED|Wash-out Period 2||33
997698|NCT00489853|2420630|P3|NOT COMPLETED|Treatment Period 2||0
997699|NCT00489853|2420631|P2|NOT COMPLETED|Treatment Period 2||0
997700|NCT00489853|2420632|P1|NOT COMPLETED|Treatment Period 2||0
997701|NCT00489853|2420630|P3|COMPLETED|Treatment Period 2||33
997702|NCT00489853|2420631|P2|COMPLETED|Treatment Period 2||35
997703|NCT00489853|2420632|P1|COMPLETED|Treatment Period 2||33
997704|NCT00489853|2420630|P3|STARTED|Treatment Period 2||33
997705|NCT00489853|2420631|P2|STARTED|Treatment Period 2||35
997706|NCT00489853|2420632|P1|STARTED|Treatment Period 2||33
997707|NCT00489853|2420630|P3|NOT COMPLETED|Wash-out Period 1||6
997708|NCT00489853|2420631|P2|NOT COMPLETED|Wash-out Period 1||3
997709|NCT00489853|2420632|P1|NOT COMPLETED|Wash-out Period 1||1
997710|NCT00489853|2420630|P3|COMPLETED|Wash-out Period 1||32
997711|NCT00489853|2420631|P2|COMPLETED|Wash-out Period 1||34
997712|NCT00489853|2420632|P1|COMPLETED|Wash-out Period 1||35
997713|NCT00489853|2420630|P3|STARTED|Wash-out Period 1||38
997714|NCT00489853|2420631|P2|STARTED|Wash-out Period 1||37
997715|NCT00489853|2420632|P1|STARTED|Wash-out Period 1||36
997716|NCT00489853|2420630|P3|NOT COMPLETED|Treatment Period 1||0
997717|NCT00489853|2420631|P2|NOT COMPLETED|Treatment Period 1||0
997718|NCT00489853|2420632|P1|NOT COMPLETED|Treatment Period 1||0
997719|NCT00489853|2420630|P3|COMPLETED|Treatment Period 1||38
997720|NCT00489853|2420631|P2|COMPLETED|Treatment Period 1||37
997721|NCT00489853|2420632|P1|COMPLETED|Treatment Period 1||36
997722|NCT00489853|2420630|P3|STARTED|Treatment Period 1||38
997723|NCT00489853|2420631|P2|STARTED|Treatment Period 1||37
997724|NCT00489853|2420632|P1|STARTED|Treatment Period 1||36
997725|NCT00489866|2420729|P2|NOT COMPLETED|Overall Study||0
997726|NCT00489866|2420730|P1|NOT COMPLETED|Overall Study||2
997727|NCT00489866|2420729|P2|COMPLETED|Overall Study||7
997728|NCT00489866|2420730|P1|COMPLETED|Overall Study||5
997729|NCT00489866|2420729|P2|STARTED|Overall Study||7
997730|NCT00489866|2420730|P1|STARTED|Overall Study||7
997731|NCT00489970|2420746|P2|NOT COMPLETED|Persistence Year 5||0
997732|NCT00489970|2420747|P1|NOT COMPLETED|Persistence Year 5||0
997733|NCT00489970|2420746|P2|COMPLETED|Persistence Year 5||401
997734|NCT00489970|2420747|P1|COMPLETED|Persistence Year 5||856
997735|NCT00489970|2420746|P2|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|401
997736|NCT00489970|2420747|P1|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|856
997737|NCT00489970|2420746|P2|NOT COMPLETED|Persistence Year 3||0
997738|NCT00489970|2420747|P1|NOT COMPLETED|Persistence Year 3||0
997741|NCT00489970|2420746|P2|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|486
997742|NCT00489970|2420747|P1|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|1019
997743|NCT00489970|2420746|P2|NOT COMPLETED|Persistence Year 1||0
997744|NCT00489970|2420747|P1|NOT COMPLETED|Persistence Year 1||0
997745|NCT00489970|2420746|P2|COMPLETED|Persistence Year 1||523
997746|NCT00489970|2420747|P1|COMPLETED|Persistence Year 1||1069
997747|NCT00489970|2420746|P2|STARTED|Persistence Year 1||523
997748|NCT00489970|2420747|P1|STARTED|Persistence Year 1||1069
997749|NCT00490009|2420771|P1|NOT COMPLETED|Overall Study||0
997750|NCT00490009|2420771|P1|COMPLETED|Overall Study||9
997751|NCT00490009|2420771|P1|STARTED|Overall Study||9
997752|NCT00490022|2420779|P2|NOT COMPLETED|Overall Study||3
997753|NCT00490022|2420780|P1|NOT COMPLETED|Overall Study||1
997754|NCT00490022|2420779|P2|COMPLETED|Overall Study||12
997755|NCT00490022|2420780|P1|COMPLETED|Overall Study||15
997756|NCT00490022|2420779|P2|STARTED|Overall Study||15
997757|NCT00490022|2420780|P1|STARTED|Overall Study||16
997758|NCT00490035|2420792|P4|NOT COMPLETED|Overall Study||6
997759|NCT00490035|2420793|P3|NOT COMPLETED|Overall Study||12
997760|NCT00490035|2420794|P2|NOT COMPLETED|Overall Study||6
997761|NCT00490035|2420795|P1|NOT COMPLETED|Overall Study||8
997762|NCT00490035|2420792|P4|COMPLETED|Overall Study||94
997763|NCT00490035|2420793|P3|COMPLETED|Overall Study||88
997764|NCT00490035|2420794|P2|COMPLETED|Overall Study||93
997765|NCT00490035|2420795|P1|COMPLETED|Overall Study||92
997766|NCT00490035|2420792|P4|STARTED|Overall Study||100
997767|NCT00490035|2420793|P3|STARTED|Overall Study||100
997768|NCT00490035|2420794|P2|STARTED|Overall Study||99
997769|NCT00490035|2420795|P1|STARTED|Overall Study||100
997770|NCT00490061|2420893|P1|NOT COMPLETED|Overall Study||1
997771|NCT00490061|2420893|P1|COMPLETED|Overall Study||16
997772|NCT00490061|2420893|P1|STARTED|Overall Study||17
997773|NCT00490100|2420898|P1|NOT COMPLETED|Overall Study||3
997774|NCT00490100|2420898|P1|COMPLETED|Overall Study||3
997775|NCT00490100|2420898|P1|STARTED|Overall Study||6
997776|NCT00490139|2420907|P4|NOT COMPLETED|Overall Study||307
997777|NCT00490139|2420908|P3|NOT COMPLETED|Overall Study||434
997778|NCT00490139|2420909|P2|NOT COMPLETED|Overall Study||275
997779|NCT00490139|2420910|P1|NOT COMPLETED|Overall Study||308
997780|NCT00490139|2420907|P4|COMPLETED|Overall Study||1790
997781|NCT00490139|2420908|P3|COMPLETED|Overall Study||1666
997782|NCT00490139|2420909|P2|COMPLETED|Overall Study||1816
997783|NCT00490139|2420910|P1|COMPLETED|Overall Study||1785
997784|NCT00490139|2420907|P4|STARTED|Overall Study||2097
997785|NCT00490139|2420908|P3|STARTED|Overall Study||2100
997786|NCT00490139|2420909|P2|STARTED|Overall Study||2091
997787|NCT00490139|2420910|P1|STARTED|Overall Study||2093
997788|NCT00490256|2420942|P2|NOT COMPLETED|Overall Study||0
997789|NCT00490256|2420943|P1|NOT COMPLETED|Overall Study||0
997790|NCT00490256|2420942|P2|COMPLETED|Overall Study||7
997791|NCT00490256|2420943|P1|COMPLETED|Overall Study||7
997792|NCT00490256|2420942|P2|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
997793|NCT00490256|2420943|P1|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
997794|NCT00490256|2420942|P2|STARTED|Overall Study||7
997795|NCT00490256|2420943|P1|STARTED|Overall Study||7
997796|NCT00490269|2420951|P2|NOT COMPLETED|Placebo Then Dronabinol||0
997797|NCT00490269|2420952|P1|NOT COMPLETED|Placebo Then Dronabinol||0
997798|NCT00490269|2420951|P2|COMPLETED|Placebo Then Dronabinol||6
997799|NCT00490269|2420952|P1|COMPLETED|Placebo Then Dronabinol||6
997800|NCT00490269|2420951|P2|STARTED|Placebo Then Dronabinol||6
997801|NCT00490269|2420952|P1|STARTED|Placebo Then Dronabinol||6
997802|NCT00490269|2420951|P2|NOT COMPLETED|Dronabinol Then Placebo||0
997803|NCT00490269|2420952|P1|NOT COMPLETED|Dronabinol Then Placebo||0
997804|NCT00490269|2420951|P2|COMPLETED|Dronabinol Then Placebo||6
997805|NCT00490269|2420952|P1|COMPLETED|Dronabinol Then Placebo||6
997806|NCT00490269|2420951|P2|STARTED|Dronabinol Then Placebo||6
997807|NCT00490269|2420952|P1|STARTED|Dronabinol Then Placebo||6
997808|NCT00490477|2420960|P2|NOT COMPLETED|Overall Study||0
997809|NCT00490477|2420961|P1|NOT COMPLETED|Overall Study||0
997810|NCT00490477|2420960|P2|COMPLETED|Overall Study||8
997811|NCT00490477|2420961|P1|COMPLETED|Overall Study||8
997812|NCT00490477|2420960|P2|STARTED|Overall Study||8
997813|NCT00490477|2420961|P1|STARTED|Overall Study||8
997814|NCT00490490|2420967|P1|NOT COMPLETED|Completed Assessment for TTP||3
997815|NCT00490490|2420967|P1|COMPLETED|Completed Assessment for TTP||5
997816|NCT00490490|2420967|P1|STARTED|Completed Assessment for TTP||8
997817|NCT00490490|2420967|P1|NOT COMPLETED|Completed Assessment for CR||0
997818|NCT00490490|2420967|P1|COMPLETED|Completed Assessment for CR||8
997819|NCT00490490|2420967|P1|STARTED|Completed Assessment for CR||8
997820|NCT00490542|2420975|P2|NOT COMPLETED|Overall Study||4
997821|NCT00490542|2420976|P1|NOT COMPLETED|Overall Study||7
997822|NCT00490542|2420975|P2|COMPLETED|Overall Study||31
997823|NCT00490542|2420976|P1|COMPLETED|Overall Study||31
997824|NCT00490542|2420975|P2|STARTED|Overall Study||35
997825|NCT00490542|2420976|P1|STARTED|Overall Study||38
997826|NCT00490555|2420986|P4|NOT COMPLETED|Overall Study||0
997827|NCT00490555|2420987|P3|NOT COMPLETED|Overall Study||2
997828|NCT00490555|2420988|P2|NOT COMPLETED|Overall Study||0
997829|NCT00490555|2420989|P1|NOT COMPLETED|Overall Study||0
997830|NCT00490555|2420986|P4|COMPLETED|Overall Study||7
997831|NCT00490555|2420987|P3|COMPLETED|Overall Study||7
997832|NCT00490555|2420988|P2|COMPLETED|Overall Study||8
997833|NCT00490555|2420989|P1|COMPLETED|Overall Study||8
997834|NCT00490555|2420986|P4|STARTED|Overall Study||7
997835|NCT00490555|2420987|P3|STARTED|Overall Study||9
997836|NCT00490555|2420988|P2|STARTED|Overall Study||8
997837|NCT00490555|2420989|P1|STARTED|Overall Study||8
997838|NCT00490646|2421017|P2|NOT COMPLETED|Overall Study||2
997839|NCT00490646|2421018|P1|NOT COMPLETED|Overall Study||2
997840|NCT00490646|2421017|P2|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=13; study drug toxicity=1)|23
997841|NCT00490646|2421018|P1|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=14; study drug toxicity=4)|23
997842|NCT00490646|2421017|P2|Treated|Overall Study||24
997843|NCT00490646|2421018|P1|Treated|Overall Study||24
997844|NCT00490646|2421017|P2|STARTED|Overall Study||25
997845|NCT00490646|2421018|P1|STARTED|Overall Study||25
997846|NCT00490698|2421038|P1|NOT COMPLETED|Overall Study||10
997847|NCT00490698|2421038|P1|COMPLETED|Overall Study||1
997848|NCT00490698|2421038|P1|STARTED|Overall Study||11
997849|NCT00490724|2421045|P3|NOT COMPLETED|Period II||3
997850|NCT00490724|2421046|P2|NOT COMPLETED|Period II||1
997851|NCT00490724|2421047|P1|NOT COMPLETED|Period II||3
997852|NCT00490724|2421045|P3|COMPLETED|Period II||16
997853|NCT00490724|2421046|P2|COMPLETED|Period II||19
997854|NCT00490724|2421047|P1|COMPLETED|Period II||18
997855|NCT00490724|2421045|P3|STARTED|Period II||19
997856|NCT00490724|2421046|P2|STARTED|Period II||20
997857|NCT00490724|2421047|P1|STARTED|Period II||21
997858|NCT00490724|2421045|P3|NOT COMPLETED|Period I||1
997859|NCT00490724|2421046|P2|NOT COMPLETED|Period I||0
997860|NCT00490724|2421047|P1|NOT COMPLETED|Period I||0
997861|NCT00490724|2421045|P3|COMPLETED|Period I||19
997862|NCT00490724|2421046|P2|COMPLETED|Period I||20
997863|NCT00490724|2421047|P1|COMPLETED|Period I||21
997864|NCT00490724|2421045|P3|STARTED|Period I||20
997865|NCT00490724|2421046|P2|STARTED|Period I||20
997866|NCT00490724|2421047|P1|STARTED|Period I||21
997867|NCT00490802|2421114|P2|NOT COMPLETED|Overall Study||2
997868|NCT00490802|2421115|P1|NOT COMPLETED|Overall Study||1
997869|NCT00490802|2421114|P2|COMPLETED|Overall Study||7
997870|NCT00490802|2421115|P1|COMPLETED|Overall Study||9
997871|NCT00490802|2421114|P2|STARTED|Overall Study||9
997872|NCT00490802|2421115|P1|STARTED|Overall Study||10
997873|NCT00490815|2421131|P2|NOT COMPLETED|Overall Study||9
997874|NCT00490815|2421132|P1|NOT COMPLETED|Overall Study||8
997875|NCT00490815|2421131|P2|COMPLETED|Overall Study||8
997876|NCT00490815|2421132|P1|COMPLETED|Overall Study||12
997877|NCT00490815|2421131|P2|STARTED|Overall Study||17
997878|NCT00490815|2421132|P1|STARTED|Overall Study||20
997879|NCT00490841|2421140|P1|NOT COMPLETED|Overall Study||13
997880|NCT00490841|2421140|P1|COMPLETED|Overall Study||189
997881|NCT00490841|2421140|P1|STARTED|Overall Study||202
997882|NCT00490919|2421162|P3|NOT COMPLETED|Double-blind Phase||84
997883|NCT00490919|2421163|P2|NOT COMPLETED|Double-blind Phase||86
997884|NCT00490919|2421164|P1|NOT COMPLETED|Double-blind Phase||0
997885|NCT00490919|2421162|P3|COMPLETED|Double-blind Phase||199
997886|NCT00490919|2421163|P2|COMPLETED|Double-blind Phase||170
997887|NCT00490919|2421164|P1|COMPLETED|Double-blind Phase||0
997888|NCT00490919|2421162|P3|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|283
997889|NCT00490919|2421163|P2|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|256
997890|NCT00490919|2421164|P1|STARTED|Double-blind Phase||0
997891|NCT00490919|2421162|P3|NOT COMPLETED|Open-label Run-in Period||0
997892|NCT00490919|2421163|P2|NOT COMPLETED|Open-label Run-in Period||0
997893|NCT00490919|2421164|P1|NOT COMPLETED|Open-label Run-in Period||483
997894|NCT00490919|2421162|P3|COMPLETED|Open-label Run-in Period||0
997895|NCT00490919|2421163|P2|COMPLETED|Open-label Run-in Period||0
997896|NCT00490919|2421164|P1|COMPLETED|Open-label Run-in Period|Completed run-in and randomized; however 2 had no safety data after randomization visit (N = 539)|541
997897|NCT00490919|2421162|P3|STARTED|Open-label Run-in Period||0
997898|NCT00490919|2421163|P2|STARTED|Open-label Run-in Period||0
997899|NCT00490919|2421164|P1|STARTED|Open-label Run-in Period||1024
997900|NCT00490945|2421180|P5|NOT COMPLETED|Overall Study||0
997901|NCT00490945|2421181|P4|NOT COMPLETED|Overall Study||0
997902|NCT00490945|2421182|P3|NOT COMPLETED|Overall Study||0
997903|NCT00490945|2421183|P2|NOT COMPLETED|Overall Study||1
997904|NCT00490945|2421184|P1|NOT COMPLETED|Overall Study||0
997905|NCT00490945|2421180|P5|COMPLETED|Overall Study||7
997906|NCT00490945|2421181|P4|COMPLETED|Overall Study||7
997907|NCT00490945|2421182|P3|COMPLETED|Overall Study||8
997908|NCT00490945|2421183|P2|COMPLETED|Overall Study||8
997909|NCT00490945|2421184|P1|COMPLETED|Overall Study||8
997910|NCT00490945|2421180|P5|STARTED|Overall Study||7
997911|NCT00490945|2421181|P4|STARTED|Overall Study||7
997912|NCT00490945|2421182|P3|STARTED|Overall Study||8
997913|NCT00490945|2421183|P2|STARTED|Overall Study||9
997914|NCT00490945|2421184|P1|STARTED|Overall Study||8
997915|NCT00490971|2421220|P5|NOT COMPLETED|Maintenance||39
997916|NCT00490971|2421221|P4|NOT COMPLETED|Maintenance||53
997917|NCT00490971|2421222|P3|NOT COMPLETED|Maintenance||51
997918|NCT00490971|2421223|P2|NOT COMPLETED|Maintenance||0
997919|NCT00490971|2421224|P1|NOT COMPLETED|Maintenance||0
997920|NCT00490971|2421220|P5|COMPLETED|Maintenance||44
997921|NCT00490971|2421221|P4|COMPLETED|Maintenance||96
997922|NCT00490971|2421222|P3|COMPLETED|Maintenance||96
997923|NCT00490971|2421223|P2|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
997924|NCT00490971|2421224|P1|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
997925|NCT00490971|2421220|P5|STARTED|Maintenance||83
997926|NCT00490971|2421221|P4|STARTED|Maintenance|152 participants were assigned to pali/pali, out of which 149 took the study medication.|149
997927|NCT00490971|2421222|P3|STARTED|Maintenance|148 participants were assigned to pali/placebo, out of which 147 took the study medication.|147
997928|NCT00490971|2421223|P2|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
997929|NCT00490971|2421224|P1|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
997930|NCT00490971|2421220|P5|NOT COMPLETED|Acute/Continuation||0
997931|NCT00490971|2421221|P4|NOT COMPLETED|Acute/Continuation||0
997932|NCT00490971|2421222|P3|NOT COMPLETED|Acute/Continuation||0
997933|NCT00490971|2421223|P2|NOT COMPLETED|Acute/Continuation||62
997934|NCT00490971|2421224|P1|NOT COMPLETED|Acute/Continuation||306
997935|NCT00490971|2421220|P5|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
997936|NCT00490971|2421221|P4|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
997937|NCT00490971|2421222|P3|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
997938|NCT00490971|2421223|P2|COMPLETED|Acute/Continuation||86
997939|NCT00490971|2421224|P1|COMPLETED|Acute/Continuation||308
997940|NCT00490971|2421220|P5|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
997941|NCT00490971|2421221|P4|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
997942|NCT00490971|2421222|P3|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
997943|NCT00490971|2421223|P2|STARTED|Acute/Continuation|149 participants were assigned to paliperidone, out of which 148 took the study medication.|148
997944|NCT00490971|2421224|P1|STARTED|Acute/Continuation|617 participants were assigned to paliperidone, out of which 614 took the study medication.|614
997945|NCT00491075|2421266|P1|NOT COMPLETED|Overall Study||2
997946|NCT00491075|2421266|P1|COMPLETED|Overall Study||14
997947|NCT00491075|2421266|P1|STARTED|Overall Study||16
997948|NCT00491179|2421272|P2|NOT COMPLETED|Overall Study||2
997949|NCT00491179|2421273|P1|NOT COMPLETED|Overall Study||7
997950|NCT00491179|2421272|P2|COMPLETED|Overall Study||8
997951|NCT00491179|2421273|P1|COMPLETED|Overall Study||18
997952|NCT00491179|2421272|P2|STARTED|Overall Study||10
997953|NCT00491179|2421273|P1|STARTED|Overall Study||25
997954|NCT00491244|2421283|P2|NOT COMPLETED|Overall Study||20
997955|NCT00491244|2421284|P1|NOT COMPLETED|Overall Study||27
997956|NCT00491244|2421283|P2|COMPLETED|Overall Study||168
997957|NCT00491244|2421284|P1|COMPLETED|Overall Study||162
997958|NCT00491244|2421283|P2|STARTED|Overall Study||188
997959|NCT00491244|2421284|P1|STARTED|Overall Study||189
997960|NCT00491374|2421294|P2|NOT COMPLETED|Overall Study||0
997961|NCT00491374|2421295|P1|NOT COMPLETED|Overall Study||0
997962|NCT00491374|2421294|P2|COMPLETED|Overall Study||0
997963|NCT00491374|2421295|P1|COMPLETED|Overall Study||0
997964|NCT00491374|2421294|P2|STARTED|Overall Study||0
997965|NCT00491374|2421295|P1|STARTED|Overall Study||0
997966|NCT00491387|2421301|P1|NOT COMPLETED|Overall Study||0
997967|NCT00491387|2421301|P1|COMPLETED|Overall Study||24
997968|NCT00491387|2421301|P1|Study Enrollment|Overall Study||24
997969|NCT00491387|2421301|P1|STARTED|Overall Study||24
997970|NCT00491400|2421307|P2|NOT COMPLETED|Overall Study||4
997971|NCT00491400|2421308|P1|NOT COMPLETED|Overall Study||5
997972|NCT00491400|2421307|P2|COMPLETED|Overall Study||9
997973|NCT00491400|2421308|P1|COMPLETED|Overall Study||10
997974|NCT00491400|2421307|P2|Finished Second Treatment|Overall Study|None withdrew during fenofibrate treatment (second treatment)|9
997975|NCT00491400|2421308|P1|Finished Second Treatment|Overall Study|2 withdrew during atorvastatin treatment (second treatment)|10
997976|NCT00491400|2421307|P2|Started Second Treatment|Overall Study|None withdrew during the washout period|9
997977|NCT00491400|2421308|P1|Started Second Treatment|Overall Study|2 withdrew during washout period|12
997978|NCT00491400|2421307|P2|Completed First Treatment|Overall Study|4 withdrew during atorvastatin treatment (first treatment)|9
997979|NCT00491400|2421308|P1|Completed First Treatment|Overall Study|None withdrew during fenofibrate treatment (first treatment)|14
997980|NCT00491400|2421307|P2|Started First Treatment|Overall Study|None withdrew prior to starting atorvastatin|13
997981|NCT00491400|2421308|P1|Started First Treatment|Overall Study|1 withdrew prior to starting fenofibrate|14
997982|NCT00491400|2421307|P2|STARTED|Overall Study||13
997983|NCT00491400|2421308|P1|STARTED|Overall Study||15
997984|NCT00491504|2421320|P4|NOT COMPLETED|Overall Study||4
997985|NCT00491504|2421321|P3|NOT COMPLETED|Overall Study||4
997986|NCT00491504|2421322|P2|NOT COMPLETED|Overall Study||1
997987|NCT00491504|2421323|P1|NOT COMPLETED|Overall Study||0
997988|NCT00491504|2421320|P4|COMPLETED|Overall Study||73
997989|NCT00491504|2421321|P3|COMPLETED|Overall Study||74
997990|NCT00491504|2421322|P2|COMPLETED|Overall Study||77
997991|NCT00491504|2421323|P1|COMPLETED|Overall Study||77
997992|NCT00491504|2421320|P4|STARTED|Overall Study|All subjects who received placebo on Day 1 through Day 7|77
997993|NCT00491504|2421321|P3|STARTED|Overall Study|All subjects who received MFNS on Day 1 through Day 7|78
997994|NCT00491504|2421322|P2|STARTED|Overall Study|All subjects who received placebo only on Day 1|78
997995|NCT00491504|2421323|P1|STARTED|Overall Study|All subjects who received MFNS only on Day 1|77
997996|NCT00491530|2421334|P3|NOT COMPLETED|Overall Study||5
997997|NCT00491530|2421335|P2|NOT COMPLETED|Overall Study||6
997998|NCT00491530|2421336|P1|NOT COMPLETED|Overall Study||12
997999|NCT00491530|2421334|P3|COMPLETED|Overall Study||81
998000|NCT00491530|2421335|P2|COMPLETED|Overall Study||44
998001|NCT00491530|2421336|P1|COMPLETED|Overall Study||162
998002|NCT00491530|2421334|P3|STARTED|Overall Study||86
998003|NCT00491530|2421335|P2|STARTED|Overall Study||50
998004|NCT00491530|2421336|P1|STARTED|Overall Study||174
998005|NCT00491556|2421364|P2|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||5
998006|NCT00491556|2421365|P1|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||24
998007|NCT00491556|2421364|P2|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||22
998008|NCT00491556|2421365|P1|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||25
998009|NCT00491556|2421364|P2|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||27
998010|NCT00491556|2421365|P1|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||49
998011|NCT00491556|2421364|P2|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||0
998012|NCT00491556|2421365|P1|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||26
998013|NCT00491556|2421364|P2|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||27
998014|NCT00491556|2421365|P1|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||49
998015|NCT00491556|2421364|P2|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||27
998016|NCT00491556|2421365|P1|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||53
998017|NCT00491556|2421364|P2|STARTED|Entry-Week (WK) 48: EXP/Standard Care||27
998018|NCT00491556|2421365|P1|STARTED|Entry-Week (WK) 48: EXP/Standard Care||75
998019|NCT00491608|2421421|P1|NOT COMPLETED|Overall Study||3
998020|NCT00491608|2421421|P1|COMPLETED|Overall Study||206
998021|NCT00491608|2421421|P1|STARTED|Overall Study|Participants who received treatment|209
998022|NCT00491738|2421432|P2|NOT COMPLETED|Overall Study||0
998023|NCT00491738|2421433|P1|NOT COMPLETED|Overall Study||0
998024|NCT00491738|2421432|P2|COMPLETED|Overall Study||9
998025|NCT00491738|2421433|P1|COMPLETED|Overall Study||7
998026|NCT00491738|2421432|P2|STARTED|Overall Study||9
998027|NCT00491738|2421433|P1|STARTED|Overall Study||7
998028|NCT00491764|2421443|P6|NOT COMPLETED|Overall Study||9
998029|NCT00491764|2421444|P5|NOT COMPLETED|Overall Study||3
998030|NCT00491764|2421445|P4|NOT COMPLETED|Overall Study||8
998031|NCT00491764|2421446|P3|NOT COMPLETED|Overall Study||8
998032|NCT00491764|2421447|P2|NOT COMPLETED|Overall Study||7
998033|NCT00491764|2421448|P1|NOT COMPLETED|Overall Study||5
998034|NCT00491764|2421443|P6|COMPLETED|Overall Study||27
998035|NCT00491764|2421444|P5|COMPLETED|Overall Study||33
998036|NCT00491764|2421445|P4|COMPLETED|Overall Study||28
998037|NCT00491764|2421446|P3|COMPLETED|Overall Study||28
998038|NCT00491764|2421447|P2|COMPLETED|Overall Study||30
998039|NCT00491764|2421448|P1|COMPLETED|Overall Study||32
998040|NCT00491764|2421443|P6|STARTED|Overall Study||36
998041|NCT00491764|2421444|P5|STARTED|Overall Study||36
998042|NCT00491764|2421445|P4|STARTED|Overall Study||36
998043|NCT00491764|2421446|P3|STARTED|Overall Study||36
998044|NCT00491764|2421447|P2|STARTED|Overall Study||37
998045|NCT00491764|2421448|P1|STARTED|Overall Study||37
998046|NCT00491829|2421477|P3|NOT COMPLETED|Overall Study||75
998047|NCT00491829|2421478|P2|NOT COMPLETED|Overall Study||114
998048|NCT00491829|2421479|P1|NOT COMPLETED|Overall Study||95
998049|NCT00491829|2421477|P3|COMPLETED|Overall Study||243
998050|NCT00491829|2421478|P2|COMPLETED|Overall Study||202
998051|NCT00491829|2421479|P1|COMPLETED|Overall Study||216
998052|NCT00491829|2421477|P3|STARTED|Overall Study||318
998053|NCT00491829|2421478|P2|STARTED|Overall Study||316
998054|NCT00491829|2421479|P1|STARTED|Overall Study||311
998055|NCT00491894|2421487|P1|NOT COMPLETED|Overall Study||34
998056|NCT00491894|2421487|P1|COMPLETED|Overall Study||103
998057|NCT00491894|2421487|P1|STARTED|Overall Study||137
998058|NCT00480532|2421499|P4|NOT COMPLETED|Overall Study||1
998059|NCT00480532|2421500|P3|NOT COMPLETED|Overall Study||4
998060|NCT00480532|2421501|P2|NOT COMPLETED|Overall Study||4
998061|NCT00480532|2421502|P1|NOT COMPLETED|Overall Study||2
998062|NCT00480532|2421499|P4|COMPLETED|Overall Study||31
998063|NCT00480532|2421500|P3|COMPLETED|Overall Study||29
998064|NCT00480532|2421501|P2|COMPLETED|Overall Study||29
998065|NCT00480532|2421502|P1|COMPLETED|Overall Study||31
998066|NCT00480532|2421499|P4|STARTED|Overall Study||32
998067|NCT00480532|2421500|P3|STARTED|Overall Study||33
998068|NCT00480532|2421501|P2|STARTED|Overall Study||33
998069|NCT00480532|2421502|P1|STARTED|Overall Study||33
998070|NCT00480636|2421520|P1|NOT COMPLETED|Overall Study||19
998071|NCT00480636|2421520|P1|COMPLETED|Overall Study||83
998072|NCT00480636|2421520|P1|STARTED|Overall Study||102
998073|NCT00480740|2421531|P3|NOT COMPLETED|Overall Study||0
998074|NCT00480740|2421532|P2|NOT COMPLETED|Overall Study||0
998075|NCT00480740|2421533|P1|NOT COMPLETED|Overall Study||0
998076|NCT00480740|2421531|P3|COMPLETED|Overall Study||6
998077|NCT00480740|2421532|P2|COMPLETED|Overall Study||9
998078|NCT00480740|2421533|P1|COMPLETED|Overall Study||26
998079|NCT00480740|2421531|P3|STARTED|Overall Study||6
998080|NCT00480740|2421532|P2|STARTED|Overall Study||9
998081|NCT00480740|2421533|P1|STARTED|Overall Study||26
998082|NCT00480779|2421543|P2|NOT COMPLETED|Overall Study||3
998083|NCT00480779|2421544|P1|NOT COMPLETED|Overall Study||2
998084|NCT00480779|2421543|P2|COMPLETED|Overall Study||19
998085|NCT00480779|2421544|P1|COMPLETED|Overall Study||24
998086|NCT00480779|2421543|P2|STARTED|Overall Study||22
998087|NCT00480779|2421544|P1|STARTED|Overall Study||26
998088|NCT00492024|2421570|P2|NOT COMPLETED|Follow up||2
998089|NCT00492024|2421571|P1|NOT COMPLETED|Follow up||1
998090|NCT00492024|2421570|P2|COMPLETED|Follow up||99
998091|NCT00492024|2421571|P1|COMPLETED|Follow up||221
998092|NCT00492024|2421570|P2|STARTED|Follow up||101
998093|NCT00492024|2421571|P1|STARTED|Follow up||222
998094|NCT00492024|2421570|P2|NOT COMPLETED|Treatment||22
998095|NCT00492024|2421571|P1|NOT COMPLETED|Treatment||29
998096|NCT00492024|2421570|P2|COMPLETED|Treatment||101
998097|NCT00492024|2421571|P1|COMPLETED|Treatment||222
998098|NCT00492024|2421570|P2|STARTED|Treatment||123
998099|NCT00492024|2421571|P1|STARTED|Treatment||251
998100|NCT00492063|2421591|P4|NOT COMPLETED|Overall Study||10
998101|NCT00492063|2421592|P3|NOT COMPLETED|Overall Study||11
998102|NCT00492063|2421593|P2|NOT COMPLETED|Overall Study||14
998103|NCT00492063|2421594|P1|NOT COMPLETED|Overall Study||10
998104|NCT00492063|2421591|P4|COMPLETED|Overall Study||666
998105|NCT00492063|2421592|P3|COMPLETED|Overall Study||667
998106|NCT00492063|2421593|P2|COMPLETED|Overall Study||634
998107|NCT00492063|2421594|P1|COMPLETED|Overall Study||642
998108|NCT00492063|2421591|P4|STARTED|Overall Study||676
998109|NCT00492063|2421592|P3|STARTED|Overall Study||678
998110|NCT00492063|2421593|P2|STARTED|Overall Study||648
998111|NCT00492063|2421594|P1|STARTED|Overall Study||652
998112|NCT00492089|2421618|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
998113|NCT00492089|2421619|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
998114|NCT00492089|2421618|P2|COMPLETED|Second Intervention (6 Weeks)||6
998115|NCT00492089|2421619|P1|COMPLETED|Second Intervention (6 Weeks)||5
998116|NCT00492089|2421618|P2|STARTED|Second Intervention (6 Weeks)||6
998117|NCT00492089|2421619|P1|STARTED|Second Intervention (6 Weeks)||5
998118|NCT00492089|2421618|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
998119|NCT00492089|2421619|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
998120|NCT00492089|2421618|P2|COMPLETED|First Intervention (6 Weeks)||6
998121|NCT00492089|2421619|P1|COMPLETED|First Intervention (6 Weeks)||5
998122|NCT00492089|2421618|P2|STARTED|First Intervention (6 Weeks)||6
998123|NCT00492089|2421619|P1|STARTED|First Intervention (6 Weeks)||5
998124|NCT00492206|2421625|P1|NOT COMPLETED|Overall Study||0
998125|NCT00492206|2421625|P1|COMPLETED|Overall Study||40
998126|NCT00492206|2421625|P1|STARTED|Overall Study||40
998127|NCT00492232|2421634|P2|NOT COMPLETED|Open-Label Treatment||0
998128|NCT00492232|2421635|P1|NOT COMPLETED|Open-Label Treatment||1
998129|NCT00492232|2421634|P2|COMPLETED|Open-Label Treatment||0
998130|NCT00492232|2421635|P1|COMPLETED|Open-Label Treatment||88
998131|NCT00492232|2421634|P2|STARTED|Open-Label Treatment|All subjects received ramelteon in the OLTP.|0
998132|NCT00492232|2421635|P1|STARTED|Open-Label Treatment|In the previous DBTP, 45 and 44 subjects were randomized to ramelteon and placebo, respectively.|89
998133|NCT00492232|2421634|P2|NOT COMPLETED|Double-Blind Treatment||25
998134|NCT00492232|2421635|P1|NOT COMPLETED|Double-Blind Treatment||18
998135|NCT00492232|2421634|P2|COMPLETED|Double-Blind Treatment||45
998136|NCT00492232|2421635|P1|COMPLETED|Double-Blind Treatment||47
998137|NCT00492232|2421634|P2|STARTED|Double-Blind Treatment||70
998138|NCT00492232|2421635|P1|STARTED|Double-Blind Treatment||65
998139|NCT00492232|2421634|P2|NOT COMPLETED|Placebo Run-in||70
998140|NCT00492232|2421635|P1|NOT COMPLETED|Placebo Run-in||0
998141|NCT00492232|2421634|P2|COMPLETED|Placebo Run-in|These subjects successfully completed the placebo run-in period and were randomized to the DBTP.|135
998142|NCT00492232|2421635|P1|COMPLETED|Placebo Run-in||0
998143|NCT00492232|2421634|P2|STARTED|Placebo Run-in|All subjects received placebo in the placebo run-in period.|205
998144|NCT00492232|2421635|P1|STARTED|Placebo Run-in||0
998145|NCT00492973|2421669|P2|NOT COMPLETED|Overall Study||1
998146|NCT00492973|2421670|P1|NOT COMPLETED|Overall Study||0
998147|NCT00492973|2421669|P2|COMPLETED|Overall Study|One patient died of complications related to deep joint sepsis in the early postoperative period.|38
998148|NCT00492973|2421670|P1|COMPLETED|Overall Study||37
998149|NCT00492973|2421669|P2|STARTED|Overall Study||39
998150|NCT00492973|2421670|P1|STARTED|Overall Study||37
998151|NCT00493012|2421686|P2|NOT COMPLETED|Overall Study||17
998152|NCT00493012|2421687|P1|NOT COMPLETED|Overall Study||18
998153|NCT00493012|2421686|P2|COMPLETED|Overall Study||83
998154|NCT00493012|2421687|P1|COMPLETED|Overall Study||82
998155|NCT00493012|2421686|P2|STARTED|Overall Study||100
998156|NCT00493012|2421687|P1|STARTED|Overall Study||100
998157|NCT00493038|2421715|P2|NOT COMPLETED|Follow-up||0
998158|NCT00493038|2421716|P1|NOT COMPLETED|Follow-up||1
998159|NCT00493038|2421715|P2|COMPLETED|Follow-up||126
998160|NCT00493038|2421716|P1|COMPLETED|Follow-up||122
998161|NCT00493038|2421715|P2|STARTED|Follow-up||126
998162|NCT00493038|2421716|P1|STARTED|Follow-up||123
998163|NCT00493038|2421715|P2|NOT COMPLETED|Treatment||20
998164|NCT00493038|2421716|P1|NOT COMPLETED|Treatment||24
998165|NCT00493038|2421715|P2|COMPLETED|Treatment||126
998166|NCT00493038|2421716|P1|COMPLETED|Treatment||123
998167|NCT00493038|2421715|P2|Test-of-Cure Visit|Treatment||126
998168|NCT00493038|2421716|P1|Test-of-Cure Visit|Treatment||123
998169|NCT00493038|2421715|P2|Treated With Study Medication|Treatment||142
998170|NCT00493038|2421716|P1|Treated With Study Medication|Treatment||145
998171|NCT00493038|2421715|P2|Randomization|Treatment||146
998172|NCT00493038|2421716|P1|Randomization|Treatment||147
998173|NCT00493038|2421715|P2|STARTED|Treatment||146
998174|NCT00493038|2421716|P1|STARTED|Treatment||147
998175|NCT00493181|2421730|P1|NOT COMPLETED|Overall Study||0
998176|NCT00493181|2421730|P1|COMPLETED|Overall Study||8
998177|NCT00493181|2421730|P1|STARTED|Overall Study||8
998178|NCT00493220|2421740|P6|NOT COMPLETED|Final 7-Day Safety Follow-up||0
998179|NCT00493220|2421741|P5|NOT COMPLETED|Final 7-Day Safety Follow-up||0
998180|NCT00493220|2421742|P4|NOT COMPLETED|Final 7-Day Safety Follow-up||0
998181|NCT00493220|2421743|P3|NOT COMPLETED|Final 7-Day Safety Follow-up||0
998182|NCT00493220|2421744|P2|NOT COMPLETED|Final 7-Day Safety Follow-up||0
998183|NCT00493220|2421745|P1|NOT COMPLETED|Final 7-Day Safety Follow-up||0
998184|NCT00493220|2421740|P6|COMPLETED|Final 7-Day Safety Follow-up||5
998185|NCT00493220|2421741|P5|COMPLETED|Final 7-Day Safety Follow-up||5
998186|NCT00493220|2421742|P4|COMPLETED|Final 7-Day Safety Follow-up||5
998187|NCT00493220|2421743|P3|COMPLETED|Final 7-Day Safety Follow-up||5
998188|NCT00493220|2421744|P2|COMPLETED|Final 7-Day Safety Follow-up||5
998189|NCT00493220|2421745|P1|COMPLETED|Final 7-Day Safety Follow-up||4
998190|NCT00493220|2421740|P6|STARTED|Final 7-Day Safety Follow-up||5
998191|NCT00493220|2421741|P5|STARTED|Final 7-Day Safety Follow-up||5
998192|NCT00493220|2421742|P4|STARTED|Final 7-Day Safety Follow-up||5
998193|NCT00493220|2421743|P3|STARTED|Final 7-Day Safety Follow-up||5
998194|NCT00493220|2421744|P2|STARTED|Final 7-Day Safety Follow-up||5
998195|NCT00493220|2421745|P1|STARTED|Final 7-Day Safety Follow-up||4
998196|NCT00493220|2421740|P6|NOT COMPLETED|Third Intervention||0
998197|NCT00493220|2421741|P5|NOT COMPLETED|Third Intervention||0
998198|NCT00493220|2421742|P4|NOT COMPLETED|Third Intervention||0
998199|NCT00493220|2421743|P3|NOT COMPLETED|Third Intervention||0
998200|NCT00493220|2421744|P2|NOT COMPLETED|Third Intervention||0
998201|NCT00493220|2421745|P1|NOT COMPLETED|Third Intervention||1
998202|NCT00493220|2421740|P6|COMPLETED|Third Intervention||5
998203|NCT00493220|2421741|P5|COMPLETED|Third Intervention||5
998204|NCT00493220|2421742|P4|COMPLETED|Third Intervention||5
998205|NCT00493220|2421743|P3|COMPLETED|Third Intervention||5
998206|NCT00493220|2421744|P2|COMPLETED|Third Intervention||5
998207|NCT00493220|2421745|P1|COMPLETED|Third Intervention||4
998208|NCT00493220|2421740|P6|STARTED|Third Intervention||5
998209|NCT00493220|2421741|P5|STARTED|Third Intervention||5
998210|NCT00493220|2421742|P4|STARTED|Third Intervention||5
998211|NCT00493220|2421743|P3|STARTED|Third Intervention||5
998212|NCT00493220|2421744|P2|STARTED|Third Intervention||5
998213|NCT00493220|2421745|P1|STARTED|Third Intervention||5
998214|NCT00493220|2421740|P6|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
998215|NCT00493220|2421741|P5|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
998216|NCT00493220|2421742|P4|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
998217|NCT00493220|2421743|P3|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
998218|NCT00493220|2421744|P2|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
998219|NCT00493220|2421745|P1|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
998220|NCT00493220|2421740|P6|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
998221|NCT00493220|2421741|P5|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
998222|NCT00493220|2421742|P4|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
998223|NCT00493220|2421743|P3|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
998224|NCT00493220|2421744|P2|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
998225|NCT00493220|2421745|P1|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
998226|NCT00493220|2421740|P6|STARTED|Second 7-Day Washout & Safety Follow-up||5
998227|NCT00493220|2421741|P5|STARTED|Second 7-Day Washout & Safety Follow-up||5
998228|NCT00493220|2421742|P4|STARTED|Second 7-Day Washout & Safety Follow-up||5
998229|NCT00493220|2421743|P3|STARTED|Second 7-Day Washout & Safety Follow-up||5
998230|NCT00493220|2421744|P2|STARTED|Second 7-Day Washout & Safety Follow-up||5
998231|NCT00493220|2421745|P1|STARTED|Second 7-Day Washout & Safety Follow-up||5
998232|NCT00493220|2421740|P6|NOT COMPLETED|Second Intervention||0
998233|NCT00493220|2421741|P5|NOT COMPLETED|Second Intervention||0
998234|NCT00493220|2421742|P4|NOT COMPLETED|Second Intervention||0
998235|NCT00493220|2421743|P3|NOT COMPLETED|Second Intervention||0
998236|NCT00493220|2421744|P2|NOT COMPLETED|Second Intervention||0
998237|NCT00493220|2421745|P1|NOT COMPLETED|Second Intervention||0
998238|NCT00493220|2421740|P6|COMPLETED|Second Intervention||5
998239|NCT00493220|2421741|P5|COMPLETED|Second Intervention||5
998240|NCT00493220|2421742|P4|COMPLETED|Second Intervention||5
998241|NCT00493220|2421743|P3|COMPLETED|Second Intervention||5
998242|NCT00493220|2421744|P2|COMPLETED|Second Intervention||5
998243|NCT00493220|2421745|P1|COMPLETED|Second Intervention||5
998244|NCT00493220|2421740|P6|STARTED|Second Intervention||5
998245|NCT00493220|2421741|P5|STARTED|Second Intervention||5
998246|NCT00493220|2421742|P4|STARTED|Second Intervention||5
998247|NCT00493220|2421743|P3|STARTED|Second Intervention||5
998248|NCT00493220|2421744|P2|STARTED|Second Intervention||5
998249|NCT00493220|2421745|P1|STARTED|Second Intervention||5
998250|NCT00493220|2421740|P6|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
998251|NCT00493220|2421741|P5|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
998252|NCT00493220|2421742|P4|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
998253|NCT00493220|2421743|P3|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
998254|NCT00493220|2421744|P2|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
998255|NCT00493220|2421745|P1|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
998256|NCT00493220|2421740|P6|COMPLETED|First 7-Day Washout & Safety Follow-up||5
998257|NCT00493220|2421741|P5|COMPLETED|First 7-Day Washout & Safety Follow-up||5
998258|NCT00493220|2421742|P4|COMPLETED|First 7-Day Washout & Safety Follow-up||5
998259|NCT00493220|2421743|P3|COMPLETED|First 7-Day Washout & Safety Follow-up||5
998260|NCT00493220|2421744|P2|COMPLETED|First 7-Day Washout & Safety Follow-up||5
998261|NCT00493220|2421745|P1|COMPLETED|First 7-Day Washout & Safety Follow-up||5
998262|NCT00493220|2421740|P6|STARTED|First 7-Day Washout & Safety Follow-up||5
998263|NCT00493220|2421741|P5|STARTED|First 7-Day Washout & Safety Follow-up||5
998264|NCT00493220|2421742|P4|STARTED|First 7-Day Washout & Safety Follow-up||5
998265|NCT00493220|2421743|P3|STARTED|First 7-Day Washout & Safety Follow-up||5
998266|NCT00493220|2421744|P2|STARTED|First 7-Day Washout & Safety Follow-up||5
998267|NCT00493220|2421745|P1|STARTED|First 7-Day Washout & Safety Follow-up||5
998268|NCT00493220|2421740|P6|NOT COMPLETED|First Intervention||0
998269|NCT00493220|2421741|P5|NOT COMPLETED|First Intervention||0
998270|NCT00493220|2421742|P4|NOT COMPLETED|First Intervention||0
998271|NCT00493220|2421743|P3|NOT COMPLETED|First Intervention||0
998272|NCT00493220|2421744|P2|NOT COMPLETED|First Intervention||0
998273|NCT00493220|2421745|P1|NOT COMPLETED|First Intervention||0
998274|NCT00493220|2421740|P6|COMPLETED|First Intervention||5
998275|NCT00493220|2421741|P5|COMPLETED|First Intervention||5
998276|NCT00493220|2421742|P4|COMPLETED|First Intervention||5
998277|NCT00493220|2421743|P3|COMPLETED|First Intervention||5
998278|NCT00493220|2421744|P2|COMPLETED|First Intervention||5
998279|NCT00493220|2421745|P1|COMPLETED|First Intervention||5
998280|NCT00493220|2421740|P6|STARTED|First Intervention||5
998281|NCT00493220|2421741|P5|STARTED|First Intervention||5
998282|NCT00493220|2421742|P4|STARTED|First Intervention||5
998283|NCT00493220|2421743|P3|STARTED|First Intervention||5
998284|NCT00493220|2421744|P2|STARTED|First Intervention||5
998285|NCT00493220|2421745|P1|STARTED|First Intervention||5
998286|NCT00493246|2421770|P8|NOT COMPLETED|Overall Study||0
998287|NCT00493246|2421771|P7|NOT COMPLETED|Overall Study||1
998288|NCT00493246|2421772|P6|NOT COMPLETED|Overall Study||1
998289|NCT00493246|2421773|P5|NOT COMPLETED|Overall Study||1
998290|NCT00493246|2421774|P4|NOT COMPLETED|Overall Study||0
998291|NCT00493246|2421775|P3|NOT COMPLETED|Overall Study||0
998292|NCT00493246|2421776|P2|NOT COMPLETED|Overall Study||0
998293|NCT00493246|2421777|P1|NOT COMPLETED|Overall Study||0
998294|NCT00493246|2421770|P8|COMPLETED|Overall Study|Completed study 30 days after the last dose|10
998295|NCT00493246|2421771|P7|COMPLETED|Overall Study|Completed study 30 days after the last dose|11
998296|NCT00493246|2421772|P6|COMPLETED|Overall Study|Completed study 30 days after the last dose|15
998297|NCT00493246|2421773|P5|COMPLETED|Overall Study|Completed study 30 days after the last dose|8
998298|NCT00493246|2421774|P4|COMPLETED|Overall Study|Completed study 30 days after the last dose|13
998299|NCT00493246|2421775|P3|COMPLETED|Overall Study|Completed study 30 days after the last dose|12
998300|NCT00493246|2421776|P2|COMPLETED|Overall Study|Completed study 30 days after the last dose|1
998301|NCT00493246|2421777|P1|COMPLETED|Overall Study|Completed study 30 days after the last dose|2
998302|NCT00493246|2421770|P8|STARTED|Overall Study|All subjects who were randomized.|10
998303|NCT00493246|2421771|P7|STARTED|Overall Study|All subjects who were randomized.|12
998304|NCT00493246|2421772|P6|STARTED|Overall Study|All subjects who were randomized.|16
998305|NCT00493246|2421773|P5|STARTED|Overall Study|All subjects who were randomized.Excludes 1 subject who was randomized in error.|9
998306|NCT00493246|2421774|P4|STARTED|Overall Study||13
998307|NCT00493246|2421775|P3|STARTED|Overall Study||12
998308|NCT00493246|2421776|P2|STARTED|Overall Study||1
998309|NCT00493246|2421777|P1|STARTED|Overall Study||2
998310|NCT00493285|2421841|P6|NOT COMPLETED|Overall Study||0
998311|NCT00493285|2421842|P5|NOT COMPLETED|Overall Study||1
998312|NCT00493285|2421843|P4|NOT COMPLETED|Overall Study||0
998313|NCT00493285|2421844|P3|NOT COMPLETED|Overall Study||0
998314|NCT00493285|2421845|P2|NOT COMPLETED|Overall Study||0
998315|NCT00493285|2421846|P1|NOT COMPLETED|Overall Study||0
998316|NCT00493285|2421841|P6|COMPLETED|Overall Study||5
998317|NCT00493285|2421842|P5|COMPLETED|Overall Study||9
998318|NCT00493285|2421843|P4|COMPLETED|Overall Study||6
998319|NCT00493285|2421844|P3|COMPLETED|Overall Study||9
998320|NCT00493285|2421845|P2|COMPLETED|Overall Study||6
998321|NCT00493285|2421846|P1|COMPLETED|Overall Study||13
998322|NCT00493285|2421841|P6|STARTED|Overall Study||5
998323|NCT00493285|2421842|P5|STARTED|Overall Study||10
998324|NCT00493285|2421843|P4|STARTED|Overall Study||6
998325|NCT00493285|2421844|P3|STARTED|Overall Study||9
998326|NCT00493285|2421845|P2|STARTED|Overall Study||6
998327|NCT00493285|2421846|P1|STARTED|Overall Study||13
998328|NCT00493311|2422072|P2|NOT COMPLETED|Overall Study||2
998329|NCT00493311|2422073|P1|NOT COMPLETED|Overall Study||2
998330|NCT00493311|2422072|P2|COMPLETED|Overall Study||29
998331|NCT00493311|2422073|P1|COMPLETED|Overall Study||27
998332|NCT00493311|2422072|P2|STARTED|Overall Study||31
998333|NCT00493311|2422073|P1|STARTED|Overall Study||29
998334|NCT00493454|2422087|P1|NOT COMPLETED|Overall Study||1
998335|NCT00493454|2422087|P1|COMPLETED|Overall Study||5
998336|NCT00493454|2422087|P1|STARTED|Overall Study||6
998337|NCT00493636|2422093|P2|NOT COMPLETED|Overall Study||2
998338|NCT00493636|2422094|P1|NOT COMPLETED|Overall Study||2
998339|NCT00493636|2422093|P2|COMPLETED|Overall Study||77
998340|NCT00493636|2422094|P1|COMPLETED|Overall Study||79
998341|NCT00493636|2422093|P2|STARTED|Overall Study||79
998342|NCT00493636|2422094|P1|STARTED|Overall Study||81
998343|NCT00493649|2422108|P1|NOT COMPLETED|Overall Study||82
998344|NCT00493649|2422108|P1|COMPLETED|Overall Study||411
998345|NCT00493649|2422108|P1|STARTED|Overall Study||493
998346|NCT00493779|2422119|P1|NOT COMPLETED|Overall Study||1
998347|NCT00493779|2422119|P1|COMPLETED|Overall Study|Completed follow-up phase|97
998348|NCT00493779|2422119|P1|STARTED|Overall Study|Number of subjects who had discontinued clopidogrel treatment and entered follow-up phase|98
998349|NCT00493805|2422126|P2|NOT COMPLETED|Overall Study||0
998350|NCT00493805|2422127|P1|NOT COMPLETED|Overall Study||0
998351|NCT00493805|2422126|P2|COMPLETED|Overall Study||42
998352|NCT00493805|2422127|P1|COMPLETED|Overall Study||17
998353|NCT00493805|2422126|P2|STARTED|Overall Study||42
998354|NCT00493805|2422127|P1|STARTED|Overall Study||17
998355|NCT00493974|2422137|P2|NOT COMPLETED|Overall Study||14
998356|NCT00493974|2422138|P1|NOT COMPLETED|Overall Study||13
998357|NCT00493974|2422137|P2|COMPLETED|Overall Study||45
998358|NCT00493974|2422138|P1|COMPLETED|Overall Study||47
998359|NCT00493974|2422137|P2|STARTED|Overall Study||59
998360|NCT00493974|2422138|P1|STARTED|Overall Study||60
998361|NCT00494013|2422158|P2|NOT COMPLETED|Overall Study||36
998362|NCT00494013|2422159|P1|NOT COMPLETED|Overall Study||30
998363|NCT00494013|2422158|P2|COMPLETED|Overall Study||183
998364|NCT00494013|2422159|P1|COMPLETED|Overall Study||193
998365|NCT00494013|2422158|P2|Full Analysis Set (Intent to Treat)|Overall Study||210
998366|NCT00494013|2422159|P1|Full Analysis Set (Intent to Treat)|Overall Study||219
998367|NCT00494013|2422158|P2|STARTED|Overall Study||219
998368|NCT00494013|2422159|P1|STARTED|Overall Study||223
998369|NCT00494026|2422187|P1|NOT COMPLETED|Overall Study||4
998370|NCT00494026|2422187|P1|COMPLETED|Overall Study|2 patients did receive the full study treatment prior to the study being terminated.|0
998371|NCT00494026|2422187|P1|STARTED|Overall Study||4
998372|NCT00494091|2422197|P2|NOT COMPLETED|Overall Study||76
998373|NCT00494091|2422198|P1|NOT COMPLETED|Overall Study||6
998374|NCT00494091|2422197|P2|COMPLETED|Overall Study||0
998375|NCT00494091|2422198|P1|COMPLETED|Overall Study||0
998376|NCT00494091|2422197|P2|STARTED|Overall Study||76
998377|NCT00494091|2422198|P1|STARTED|Overall Study||6
998378|NCT00494143|2422220|P6|NOT COMPLETED|Overall Study||0
998379|NCT00494143|2422221|P5|NOT COMPLETED|Overall Study||0
998380|NCT00494143|2422222|P4|NOT COMPLETED|Overall Study||0
998381|NCT00494143|2422223|P3|NOT COMPLETED|Overall Study||0
998382|NCT00494143|2422224|P2|NOT COMPLETED|Overall Study||0
998383|NCT00494143|2422225|P1|NOT COMPLETED|Overall Study||0
998384|NCT00494143|2422220|P6|COMPLETED|Overall Study||0
998385|NCT00494143|2422221|P5|COMPLETED|Overall Study||1
998386|NCT00494143|2422222|P4|COMPLETED|Overall Study||0
998387|NCT00494143|2422223|P3|COMPLETED|Overall Study||3
998388|NCT00494143|2422224|P2|COMPLETED|Overall Study||2
998389|NCT00494143|2422225|P1|COMPLETED|Overall Study||1
998390|NCT00494143|2422220|P6|STARTED|Overall Study||0
998391|NCT00494143|2422221|P5|STARTED|Overall Study||1
998392|NCT00494143|2422222|P4|STARTED|Overall Study||0
998393|NCT00494143|2422223|P3|STARTED|Overall Study||3
998394|NCT00494143|2422224|P2|STARTED|Overall Study||2
998395|NCT00494143|2422225|P1|STARTED|Overall Study||1
998396|NCT00494221|2422242|P3|NOT COMPLETED|Overall Study||14
998397|NCT00494221|2422243|P2|NOT COMPLETED|Overall Study||11
998398|NCT00494221|2422244|P1|NOT COMPLETED|Overall Study||16
998399|NCT00494221|2422242|P3|COMPLETED|Overall Study||44
998400|NCT00494221|2422243|P2|COMPLETED|Overall Study||45
998401|NCT00494221|2422244|P1|COMPLETED|Overall Study||42
998402|NCT00494221|2422242|P3|STARTED|Overall Study||58
998403|NCT00494221|2422243|P2|STARTED|Overall Study||56
998404|NCT00494221|2422244|P1|STARTED|Overall Study||58
998405|NCT00494234|2422266|P2|NOT COMPLETED|Overall Study||10
998406|NCT00494234|2422267|P1|NOT COMPLETED|Overall Study||15
998407|NCT00494234|2422266|P2|COMPLETED|Overall Study||17
998408|NCT00494234|2422267|P1|COMPLETED|Overall Study||12
998409|NCT00494234|2422266|P2|STARTED|Overall Study||27
998410|NCT00494234|2422267|P1|STARTED|Overall Study||27
998411|NCT00494299|2422285|P2|NOT COMPLETED|Overall Study||229
998412|NCT00494299|2422286|P1|NOT COMPLETED|Overall Study||229
998413|NCT00494299|2422285|P2|COMPLETED|Overall Study||0
998414|NCT00494299|2422286|P1|COMPLETED|Overall Study||0
998415|NCT00494299|2422285|P2|Received Treatment|Overall Study||227
998416|NCT00494299|2422286|P1|Received Treatment|Overall Study||229
998417|NCT00494299|2422285|P2|STARTED|Overall Study||229
998418|NCT00494299|2422286|P1|STARTED|Overall Study||229
998425|NCT00494481|2422315|P2|NOT COMPLETED|Overall Study||24
998426|NCT00494481|2422316|P1|NOT COMPLETED|Overall Study||29
998427|NCT00494481|2422315|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
998428|NCT00494481|2422316|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|6
998429|NCT00494481|2422315|P2|STARTED|Overall Study|randomised patients|29
998430|NCT00494481|2422316|P1|STARTED|Overall Study|randomised patients|35
998431|NCT00494494|2422324|P2|NOT COMPLETED|Overall Study||0
998432|NCT00494494|2422325|P1|NOT COMPLETED|Overall Study||0
998433|NCT00494494|2422324|P2|COMPLETED|Overall Study||39
998434|NCT00494494|2422325|P1|COMPLETED|Overall Study||40
998435|NCT00494494|2422324|P2|STARTED|Overall Study||39
998436|NCT00494494|2422325|P1|STARTED|Overall Study||40
998437|NCT00494507|2422343|P4|NOT COMPLETED|Open-Label Phase||5
998438|NCT00494507|2422344|P3|NOT COMPLETED|Open-Label Phase||5
998439|NCT00494507|2422345|P2|NOT COMPLETED|Open-Label Phase||1
998440|NCT00494507|2422346|P1|NOT COMPLETED|Open-Label Phase||0
998441|NCT00494507|2422343|P4|COMPLETED|Open-Label Phase||14
998442|NCT00494507|2422344|P3|COMPLETED|Open-Label Phase||17
998443|NCT00494507|2422345|P2|COMPLETED|Open-Label Phase||7
998444|NCT00494507|2422346|P1|COMPLETED|Open-Label Phase||9
998445|NCT00494507|2422343|P4|STARTED|Open-Label Phase||19
998446|NCT00494507|2422344|P3|STARTED|Open-Label Phase||22
998447|NCT00494507|2422345|P2|STARTED|Open-Label Phase|1 subject randomized to Acetazolamide in this phase is not included-drug arm was removed from trial.|8
998448|NCT00494507|2422346|P1|STARTED|Open-Label Phase||9
998449|NCT00494507|2422343|P4|NOT COMPLETED|Double-Blind Phase||1
998450|NCT00494507|2422344|P3|NOT COMPLETED|Double-Blind Phase||2
998451|NCT00494507|2422345|P2|NOT COMPLETED|Double-Blind Phase||0
998452|NCT00494507|2422346|P1|NOT COMPLETED|Double-Blind Phase||3
998453|NCT00494507|2422343|P4|COMPLETED|Double-Blind Phase||19
998454|NCT00494507|2422344|P3|COMPLETED|Double-Blind Phase||22
998455|NCT00494507|2422345|P2|COMPLETED|Double-Blind Phase||9
998456|NCT00494507|2422346|P1|COMPLETED|Double-Blind Phase||9
998457|NCT00494507|2422343|P4|Reached Endpoint of Acute Worsening|Double-Blind Phase||5
998458|NCT00494507|2422344|P3|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
998459|NCT00494507|2422345|P2|Reached Endpoint of Acute Worsening|Double-Blind Phase||2
998460|NCT00494507|2422346|P1|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
998461|NCT00494507|2422343|P4|STARTED|Double-Blind Phase||20
998462|NCT00494507|2422344|P3|STARTED|Double-Blind Phase||24
998463|NCT00494507|2422345|P2|STARTED|Double-Blind Phase||9
998464|NCT00494507|2422346|P1|STARTED|Double-Blind Phase||12
998465|NCT00494585|2422394|P1|NOT COMPLETED|Overall Study||0
998466|NCT00494585|2422394|P1|COMPLETED|Overall Study||22
998467|NCT00494585|2422394|P1|STARTED|Overall Study||22
998468|NCT00494676|2422398|P2|NOT COMPLETED|Second Intervention||1
998469|NCT00494676|2422399|P1|NOT COMPLETED|Second Intervention||1
998470|NCT00494676|2422398|P2|COMPLETED|Second Intervention||28
998471|NCT00494676|2422399|P1|COMPLETED|Second Intervention||33
998472|NCT00494676|2422398|P2|STARTED|Second Intervention||29
998473|NCT00494676|2422399|P1|STARTED|Second Intervention||34
998474|NCT00494676|2422398|P2|NOT COMPLETED|First Intervention||3
998475|NCT00494676|2422399|P1|NOT COMPLETED|First Intervention||1
998476|NCT00494676|2422398|P2|COMPLETED|First Intervention||29
998477|NCT00494676|2422399|P1|COMPLETED|First Intervention||34
998478|NCT00494676|2422398|P2|STARTED|First Intervention||32
998479|NCT00494676|2422399|P1|STARTED|First Intervention||35
998480|NCT00494676|2422398|P2|NOT COMPLETED|Allocation||4
998481|NCT00494676|2422399|P1|NOT COMPLETED|Allocation||2
998482|NCT00494676|2422398|P2|COMPLETED|Allocation||32
998483|NCT00494676|2422399|P1|COMPLETED|Allocation||35
998484|NCT00494676|2422398|P2|STARTED|Allocation||36
998485|NCT00494676|2422399|P1|STARTED|Allocation||37
998486|NCT00494780|2422408|P2|NOT COMPLETED|Overall Study||13
998487|NCT00494780|2422409|P1|NOT COMPLETED|Overall Study||11
998488|NCT00494780|2422408|P2|COMPLETED|Overall Study||17
998489|NCT00494780|2422409|P1|COMPLETED|Overall Study||18
998490|NCT00494780|2422408|P2|STARTED|Overall Study||30
998491|NCT00494780|2422409|P1|STARTED|Overall Study||29
998492|NCT00494806|2422449|P2|NOT COMPLETED|Overall Study||0
998493|NCT00494806|2422450|P1|NOT COMPLETED|Overall Study||0
998494|NCT00494806|2422449|P2|COMPLETED|Overall Study||32
998495|NCT00494806|2422450|P1|COMPLETED|Overall Study||34
998496|NCT00494806|2422449|P2|STARTED|Overall Study||32
998497|NCT00494806|2422450|P1|STARTED|Overall Study||34
998498|NCT00494871|2422458|P2|NOT COMPLETED|Follow-up (FU) Period||23
998499|NCT00494871|2422459|P1|NOT COMPLETED|Follow-up (FU) Period||29
998500|NCT00494871|2422458|P2|COMPLETED|Follow-up (FU) Period||616
998501|NCT00494871|2422459|P1|COMPLETED|Follow-up (FU) Period||610
998502|NCT00494871|2422458|P2|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|630
998503|NCT00494871|2422459|P1|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|628
998504|NCT00494871|2422458|P2|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
998505|NCT00494871|2422459|P1|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
998506|NCT00494871|2422458|P2|NOT COMPLETED|Double-blind (DB) Treatment Period||172
998507|NCT00494871|2422459|P1|NOT COMPLETED|Double-blind (DB) Treatment Period||160
998508|NCT00494871|2422458|P2|COMPLETED|Double-blind (DB) Treatment Period||468
998509|NCT00494871|2422459|P1|COMPLETED|Double-blind (DB) Treatment Period||480
998510|NCT00494871|2422458|P2|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
998511|NCT00494871|2422459|P1|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
998512|NCT00494871|2422458|P2|STARTED|Double-blind (DB) Treatment Period||640
998513|NCT00494871|2422459|P1|STARTED|Double-blind (DB) Treatment Period||640
998514|NCT00494975|2422491|P2|NOT COMPLETED|Overall Study||1
998515|NCT00494975|2422492|P1|NOT COMPLETED|Overall Study||2
998516|NCT00494975|2422491|P2|COMPLETED|Overall Study||10
998517|NCT00494975|2422492|P1|COMPLETED|Overall Study||8
998518|NCT00494975|2422491|P2|STARTED|Overall Study||11
998519|NCT00494975|2422492|P1|STARTED|Overall Study||10
998520|NCT00495079|2422498|P1|NOT COMPLETED|Overall Study||0
998521|NCT00495079|2422498|P1|COMPLETED|Overall Study||65
998522|NCT00495079|2422498|P1|STARTED|Overall Study||65
998523|NCT00495131|2422507|P2|NOT COMPLETED|Overall Study||6
998524|NCT00495131|2422508|P1|NOT COMPLETED|Overall Study||7
998525|NCT00495131|2422507|P2|COMPLETED|Overall Study||148
998526|NCT00495131|2422508|P1|COMPLETED|Overall Study||147
998527|NCT00495131|2422507|P2|STARTED|Overall Study||154
998528|NCT00495131|2422508|P1|STARTED|Overall Study||154
998529|NCT00495157|2422521|P3|NOT COMPLETED|Overall Study||13
998530|NCT00495157|2422522|P2|NOT COMPLETED|Overall Study||23
998531|NCT00495157|2422523|P1|NOT COMPLETED|Overall Study||16
998532|NCT00495157|2422521|P3|COMPLETED|Overall Study||101
998533|NCT00495157|2422522|P2|COMPLETED|Overall Study||92
998534|NCT00495157|2422523|P1|COMPLETED|Overall Study||97
998535|NCT00495157|2422521|P3|STARTED|Overall Study||114
998536|NCT00495157|2422522|P2|STARTED|Overall Study||115
998537|NCT00495157|2422523|P1|STARTED|Overall Study||113
998538|NCT00495222|2422531|P1|NOT COMPLETED|Overall Study||0
998539|NCT00495222|2422531|P1|COMPLETED|Overall Study||9
998540|NCT00495222|2422531|P1|STARTED|Overall Study||9
998541|NCT00495391|2422536|P2|NOT COMPLETED|Overall Study||21
998542|NCT00495391|2422537|P1|NOT COMPLETED|Overall Study||36
998543|NCT00495391|2422536|P2|COMPLETED|Overall Study||1
998544|NCT00495391|2422537|P1|COMPLETED|Overall Study||6
998545|NCT00495391|2422536|P2|From Baseline to End of Follow up|Overall Study||1
998546|NCT00495391|2422537|P1|From Baseline to End of Follow up|Overall Study||6
998547|NCT00495391|2422536|P2|From Baseline to End of Treatment|Overall Study||1
998548|NCT00495391|2422537|P1|From Baseline to End of Treatment|Overall Study||6
998549|NCT00495391|2422536|P2|From Baseline to Week 16|Overall Study||11
998550|NCT00495391|2422537|P1|From Baseline to Week 16|Overall Study||24
998551|NCT00495391|2422536|P2|From Baseline to Week 8|Overall Study||20
998552|NCT00495391|2422537|P1|From Baseline to Week 8|Overall Study||31
998553|NCT00495391|2422536|P2|STARTED|Overall Study||22
998554|NCT00495391|2422537|P1|STARTED|Overall Study||42
998555|NCT00483704|2422560|P3|NOT COMPLETED|Treatment||156
998556|NCT00483704|2422561|P2|NOT COMPLETED|Treatment||129
998557|NCT00483704|2422562|P1|NOT COMPLETED|Treatment||129
998558|NCT00483704|2422560|P3|COMPLETED|Treatment||399
998559|NCT00483704|2422561|P2|COMPLETED|Treatment||420
998560|NCT00483704|2422562|P1|COMPLETED|Treatment||444
998561|NCT00483704|2422560|P3|STARTED|Treatment||555
998562|NCT00483704|2422561|P2|STARTED|Treatment||549
998563|NCT00483704|2422562|P1|STARTED|Treatment||573
998564|NCT00483704|2422560|P3|NOT COMPLETED|Randomization||91
998565|NCT00483704|2422561|P2|NOT COMPLETED|Randomization||96
998566|NCT00483704|2422562|P1|NOT COMPLETED|Randomization||71
998567|NCT00483704|2422560|P3|COMPLETED|Randomization||555
998568|NCT00483704|2422561|P2|COMPLETED|Randomization||549
998569|NCT00483704|2422562|P1|COMPLETED|Randomization||573
998570|NCT00483704|2422560|P3|STARTED|Randomization||646
998571|NCT00483704|2422561|P2|STARTED|Randomization||645
998572|NCT00483704|2422562|P1|STARTED|Randomization||644
998573|NCT00483717|2422608|P2|NOT COMPLETED|Overall Study||21
998574|NCT00483717|2422609|P1|NOT COMPLETED|Overall Study||24
998575|NCT00483717|2422608|P2|COMPLETED|Overall Study||65
998576|NCT00483717|2422609|P1|COMPLETED|Overall Study||63
998577|NCT00483717|2422608|P2|STARTED|Overall Study||86
998578|NCT00483717|2422609|P1|STARTED|Overall Study||87
998579|NCT00483756|2422632|P3|NOT COMPLETED|Overall Study||52
998580|NCT00483756|2422633|P2|NOT COMPLETED|Overall Study||50
998581|NCT00483756|2422634|P1|NOT COMPLETED|Overall Study||33
998582|NCT00483756|2422632|P3|COMPLETED|Overall Study||59
998583|NCT00483756|2422633|P2|COMPLETED|Overall Study||60
998584|NCT00483756|2422634|P1|COMPLETED|Overall Study||77
998585|NCT00483756|2422632|P3|Treated|Overall Study||107
998586|NCT00483756|2422633|P2|Treated|Overall Study||106
998587|NCT00483756|2422634|P1|Treated|Overall Study||109
998588|NCT00483756|2422632|P3|STARTED|Overall Study||111
998589|NCT00483756|2422633|P2|STARTED|Overall Study||110
998590|NCT00483756|2422634|P1|STARTED|Overall Study||110
998591|NCT00483938|2422703|P7|NOT COMPLETED|Overall Study||40
998592|NCT00483938|2422704|P6|NOT COMPLETED|Overall Study||8
998593|NCT00483938|2422705|P5|NOT COMPLETED|Overall Study||2
998594|NCT00483938|2422706|P4|NOT COMPLETED|Overall Study||6
998595|NCT00483938|2422707|P3|NOT COMPLETED|Overall Study||0
998596|NCT00483938|2422708|P2|NOT COMPLETED|Overall Study||19
998597|NCT00483938|2422709|P1|NOT COMPLETED|Overall Study||5
998598|NCT00483938|2422703|P7|COMPLETED|Overall Study||0
998599|NCT00483938|2422704|P6|COMPLETED|Overall Study||18
998600|NCT00483938|2422705|P5|COMPLETED|Overall Study||23
998601|NCT00483938|2422706|P4|COMPLETED|Overall Study||25
998602|NCT00483938|2422707|P3|COMPLETED|Overall Study||30
998603|NCT00483938|2422708|P2|COMPLETED|Overall Study||24
998604|NCT00483938|2422709|P1|COMPLETED|Overall Study||36
998605|NCT00483938|2422703|P7|STARTED|Overall Study||40
998606|NCT00483938|2422704|P6|STARTED|Overall Study||26
998607|NCT00483938|2422705|P5|STARTED|Overall Study||25
998608|NCT00483938|2422706|P4|STARTED|Overall Study||31
998609|NCT00483938|2422707|P3|STARTED|Overall Study||30
998610|NCT00483938|2422708|P2|STARTED|Overall Study||43
998611|NCT00483938|2422709|P1|STARTED|Overall Study||41
998612|NCT00484094|2422730|P1|NOT COMPLETED|Overall Study||42
998613|NCT00484094|2422730|P1|COMPLETED|Overall Study||167
998614|NCT00484094|2422730|P1|STARTED|Overall Study||209
998615|NCT00484159|2422742|P3|NOT COMPLETED|Overall Study||0
998616|NCT00484159|2422743|P2|NOT COMPLETED|Overall Study||1
998617|NCT00484159|2422744|P1|NOT COMPLETED|Overall Study||1
998618|NCT00484159|2422742|P3|COMPLETED|Overall Study||51
998619|NCT00484159|2422743|P2|COMPLETED|Overall Study||49
998620|NCT00484159|2422744|P1|COMPLETED|Overall Study||49
998621|NCT00484159|2422742|P3|STARTED|Overall Study||51
998622|NCT00484159|2422743|P2|STARTED|Overall Study||50
998623|NCT00484159|2422744|P1|STARTED|Overall Study||50
998624|NCT00484185|2422755|P1|NOT COMPLETED|Overall Study||71
998625|NCT00484185|2422755|P1|COMPLETED|Overall Study||112
998626|NCT00484185|2422755|P1|Treated|Overall Study||178
998627|NCT00484185|2422755|P1|STARTED|Overall Study||183
998628|NCT00484289|2422777|P3|NOT COMPLETED|Post Marketing Phase||0
998629|NCT00484289|2422778|P2|NOT COMPLETED|Post Marketing Phase||1
998630|NCT00484289|2422779|P1|NOT COMPLETED|Post Marketing Phase||0
998631|NCT00484289|2422777|P3|COMPLETED|Post Marketing Phase||10
998632|NCT00484289|2422778|P2|COMPLETED|Post Marketing Phase||141
998633|NCT00484289|2422779|P1|COMPLETED|Post Marketing Phase||10
998634|NCT00484289|2422777|P3|STARTED|Post Marketing Phase||10
998635|NCT00484289|2422778|P2|STARTED|Post Marketing Phase||142
998636|NCT00484289|2422779|P1|STARTED|Post Marketing Phase||10
998637|NCT00484289|2422777|P3|NOT COMPLETED|Long Term Phase||16
998638|NCT00484289|2422778|P2|NOT COMPLETED|Long Term Phase||36
998639|NCT00484289|2422779|P1|NOT COMPLETED|Long Term Phase||3
998640|NCT00484289|2422777|P3|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
998641|NCT00484289|2422778|P2|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|142
998642|NCT00484289|2422779|P1|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
998643|NCT00484289|2422777|P3|STARTED|Long Term Phase||26
998644|NCT00484289|2422778|P2|STARTED|Long Term Phase||178
998645|NCT00484289|2422779|P1|STARTED|Long Term Phase||13
998646|NCT00484315|2422853|P2|NOT COMPLETED|9-Month Angiographic Follow-up||13
998647|NCT00484315|2422854|P1|NOT COMPLETED|9-Month Angiographic Follow-up||28
998648|NCT00484315|2422853|P2|COMPLETED|9-Month Angiographic Follow-up||61
998649|NCT00484315|2422854|P1|COMPLETED|9-Month Angiographic Follow-up||228
998650|NCT00484315|2422853|P2|STARTED|9-Month Angiographic Follow-up||74
998651|NCT00484315|2422854|P1|STARTED|9-Month Angiographic Follow-up||256
998652|NCT00484315|2422853|P2|NOT COMPLETED|12-Month Clinical Follow-up||9
998653|NCT00484315|2422854|P1|NOT COMPLETED|12-Month Clinical Follow-up||28
998654|NCT00484315|2422853|P2|COMPLETED|12-Month Clinical Follow-up||311
998655|NCT00484315|2422854|P1|COMPLETED|12-Month Clinical Follow-up||914
998656|NCT00484315|2422853|P2|STARTED|12-Month Clinical Follow-up||320
998657|NCT00484315|2422854|P1|STARTED|12-Month Clinical Follow-up||942
998658|NCT00484393|2422864|P2|NOT COMPLETED|Overall Study||0
998659|NCT00484393|2422865|P1|NOT COMPLETED|Overall Study||0
998660|NCT00484393|2422864|P2|COMPLETED|Overall Study||3
998661|NCT00484393|2422865|P1|COMPLETED|Overall Study||4
998662|NCT00484393|2422864|P2|STARTED|Overall Study||3
998663|NCT00484393|2422865|P1|STARTED|Overall Study||4
998664|NCT00484419|2422874|P3|NOT COMPLETED|Overall Study||11
998665|NCT00484419|2422875|P2|NOT COMPLETED|Overall Study||5
998666|NCT00484419|2422876|P1|NOT COMPLETED|Overall Study||12
998667|NCT00484419|2422874|P3|COMPLETED|Overall Study||45
998668|NCT00484419|2422875|P2|COMPLETED|Overall Study||51
998669|NCT00484419|2422876|P1|COMPLETED|Overall Study||45
998670|NCT00484419|2422874|P3|STARTED|Overall Study||56
998671|NCT00484419|2422875|P2|STARTED|Overall Study||56
998672|NCT00484419|2422876|P1|STARTED|Overall Study||57
998673|NCT00484679|2422932|P1|NOT COMPLETED|Overall Study||3
998674|NCT00484679|2422932|P1|COMPLETED|Overall Study||15
998675|NCT00484679|2422932|P1|STARTED|Overall Study||18
998676|NCT00484939|2422938|P2|NOT COMPLETED|Overall Study||140
998677|NCT00484939|2422939|P1|NOT COMPLETED|Overall Study||140
998678|NCT00484939|2422938|P2|COMPLETED|Overall Study||0
998679|NCT00484939|2422939|P1|COMPLETED|Overall Study||0
998680|NCT00484939|2422938|P2|STARTED|Overall Study||140
998681|NCT00484939|2422939|P1|STARTED|Overall Study||140
998682|NCT00485069|2422961|P2|NOT COMPLETED|Overall Study||12
998683|NCT00485069|2422962|P1|NOT COMPLETED|Overall Study||18
998684|NCT00485069|2422961|P2|COMPLETED|Overall Study||46
998685|NCT00485069|2422962|P1|COMPLETED|Overall Study||47
998686|NCT00485069|2422961|P2|STARTED|Overall Study||58
998687|NCT00485069|2422962|P1|STARTED|Overall Study||65
998688|NCT00485134|2423013|P8|NOT COMPLETED|Overall Study||1
998689|NCT00485134|2423014|P7|NOT COMPLETED|Overall Study||3
998690|NCT00485134|2423015|P6|NOT COMPLETED|Overall Study||4
998691|NCT00485134|2423016|P5|NOT COMPLETED|Overall Study||3
998692|NCT00485134|2423017|P4|NOT COMPLETED|Overall Study||1
998693|NCT00485134|2423018|P3|NOT COMPLETED|Overall Study||3
998694|NCT00485134|2423019|P2|NOT COMPLETED|Overall Study||2
998695|NCT00485134|2423020|P1|NOT COMPLETED|Overall Study||1
998696|NCT00485134|2423013|P8|COMPLETED|Overall Study||20
998697|NCT00485134|2423014|P7|COMPLETED|Overall Study||28
998698|NCT00485134|2423015|P6|COMPLETED|Overall Study||3
998699|NCT00485134|2423016|P5|COMPLETED|Overall Study||7
998700|NCT00485134|2423017|P4|COMPLETED|Overall Study||7
998701|NCT00485134|2423018|P3|COMPLETED|Overall Study||9
998702|NCT00485134|2423019|P2|COMPLETED|Overall Study||10
998703|NCT00485134|2423020|P1|COMPLETED|Overall Study||11
998704|NCT00485134|2423013|P8|STARTED|Overall Study||21
998705|NCT00485134|2423014|P7|STARTED|Overall Study||31
998706|NCT00485134|2423015|P6|STARTED|Overall Study||7
998707|NCT00485134|2423016|P5|STARTED|Overall Study||10
998708|NCT00485134|2423017|P4|STARTED|Overall Study||8
998709|NCT00485134|2423018|P3|STARTED|Overall Study||12
998710|NCT00485134|2423019|P2|STARTED|Overall Study||12
998711|NCT00485134|2423020|P1|STARTED|Overall Study||12
998712|NCT00485173|2423042|P2|NOT COMPLETED|Overall Study||64
998713|NCT00485173|2423043|P1|NOT COMPLETED|Overall Study||36
998714|NCT00485173|2423042|P2|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|422
998715|NCT00485173|2423043|P1|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|188
998716|NCT00485173|2423042|P2|STARTED|Overall Study||486
998717|NCT00485173|2423043|P1|STARTED|Overall Study||224
998718|NCT00485264|2423089|P6|NOT COMPLETED|Overall Study||0
998719|NCT00485264|2423090|P5|NOT COMPLETED|Overall Study||0
998720|NCT00485264|2423091|P4|NOT COMPLETED|Overall Study||10
998721|NCT00485264|2423092|P3|NOT COMPLETED|Overall Study||0
998722|NCT00485264|2423093|P2|NOT COMPLETED|Overall Study||1
998723|NCT00485264|2423094|P1|NOT COMPLETED|Overall Study||6
998724|NCT00485264|2423089|P6|COMPLETED|Overall Study|Not included in this interim analysis|0
998725|NCT00485264|2423090|P5|COMPLETED|Overall Study|Not included in this interim analysis|0
998726|NCT00485264|2423091|P4|COMPLETED|Overall Study|Completed week 48|11
998727|NCT00485264|2423092|P3|COMPLETED|Overall Study|Completed week 48|18
998728|NCT00485264|2423093|P2|COMPLETED|Overall Study|Completed week 48|15
998729|NCT00485264|2423094|P1|COMPLETED|Overall Study|Completed week 48|65
998730|NCT00485264|2423089|P6|Completed Week 24|Overall Study||0
998731|NCT00485264|2423090|P5|Completed Week 24|Overall Study||0
998732|NCT00485264|2423091|P4|Completed Week 24|Overall Study||21
998733|NCT00485264|2423092|P3|Completed Week 24|Overall Study||18
998734|NCT00485264|2423093|P2|Completed Week 24|Overall Study||16
998735|NCT00485264|2423094|P1|Completed Week 24|Overall Study||67
998736|NCT00485264|2423089|P6|STARTED|Overall Study|Not included in this interim analysis|0
998737|NCT00485264|2423090|P5|STARTED|Overall Study|Not included in this interim analysis|0
998738|NCT00485264|2423091|P4|STARTED|Overall Study||21
998739|NCT00485264|2423092|P3|STARTED|Overall Study||18
998740|NCT00485264|2423093|P2|STARTED|Overall Study||16
998741|NCT00485264|2423094|P1|STARTED|Overall Study||71
998742|NCT00485303|2423178|P1|NOT COMPLETED|Overall Study||56
998743|NCT00485303|2423178|P1|COMPLETED|Overall Study||2
998744|NCT00485303|2423178|P1|STARTED|Overall Study||58
998745|NCT00485433|2423194|P4|NOT COMPLETED|Overall Study||0
998746|NCT00485433|2423195|P3|NOT COMPLETED|Overall Study||0
998747|NCT00485433|2423196|P2|NOT COMPLETED|Overall Study||0
998748|NCT00485433|2423197|P1|NOT COMPLETED|Overall Study||0
998749|NCT00485433|2423194|P4|COMPLETED|Overall Study||25
998750|NCT00485433|2423195|P3|COMPLETED|Overall Study||24
998751|NCT00485433|2423196|P2|COMPLETED|Overall Study||25
998752|NCT00485433|2423197|P1|COMPLETED|Overall Study||24
998753|NCT00485433|2423194|P4|STARTED|Overall Study||25
998754|NCT00485433|2423195|P3|STARTED|Overall Study||24
998755|NCT00485433|2423196|P2|STARTED|Overall Study||25
998756|NCT00485433|2423197|P1|STARTED|Overall Study||24
998757|NCT00485472|2423207|P2|NOT COMPLETED|Overall Study||12
998758|NCT00485472|2423208|P1|NOT COMPLETED|Overall Study||16
998759|NCT00485472|2423207|P2|COMPLETED|Overall Study||64
998760|NCT00485472|2423208|P1|COMPLETED|Overall Study||57
998761|NCT00485472|2423207|P2|Entered Maintenance Phase|Overall Study||67
998762|NCT00485472|2423208|P1|Entered Maintenance Phase|Overall Study||65
998763|NCT00485472|2423207|P2|STARTED|Overall Study||76
998764|NCT00485472|2423208|P1|STARTED|Overall Study||73
998765|NCT00485485|2423230|P1|NOT COMPLETED|Overall Study||0
998766|NCT00485485|2423230|P1|COMPLETED|Overall Study||7
998767|NCT00485485|2423230|P1|STARTED|Overall Study||7
998768|NCT00486954|2423238|P5|NOT COMPLETED|Randomized Part||14
998769|NCT00486954|2423239|P4|NOT COMPLETED|Randomized Part||20
998770|NCT00486954|2423240|P3|NOT COMPLETED|Randomized Part||0
998771|NCT00486954|2423241|P2|NOT COMPLETED|Randomized Part||0
998772|NCT00486954|2423242|P1|NOT COMPLETED|Randomized Part||0
998773|NCT00486954|2423238|P5|COMPLETED|Randomized Part||115
998774|NCT00486954|2423239|P4|COMPLETED|Randomized Part||112
998775|NCT00486954|2423240|P3|COMPLETED|Randomized Part||0
998776|NCT00486954|2423241|P2|COMPLETED|Randomized Part||0
998777|NCT00486954|2423242|P1|COMPLETED|Randomized Part||0
998778|NCT00486954|2423238|P5|STARTED|Randomized Part||129
998779|NCT00486954|2423239|P4|STARTED|Randomized Part||132
998780|NCT00486954|2423240|P3|STARTED|Randomized Part||0
998781|NCT00486954|2423241|P2|STARTED|Randomized Part||0
998782|NCT00486954|2423242|P1|STARTED|Randomized Part||0
998783|NCT00486954|2423238|P5|NOT COMPLETED|Pilot Part||0
998784|NCT00486954|2423239|P4|NOT COMPLETED|Pilot Part||0
998785|NCT00486954|2423240|P3|NOT COMPLETED|Pilot Part||6
998786|NCT00486954|2423241|P2|NOT COMPLETED|Pilot Part||0
998787|NCT00486954|2423242|P1|NOT COMPLETED|Pilot Part||6
998788|NCT00486954|2423238|P5|COMPLETED|Pilot Part||0
998789|NCT00486954|2423239|P4|COMPLETED|Pilot Part||0
998790|NCT00486954|2423240|P3|COMPLETED|Pilot Part||0
998791|NCT00486954|2423241|P2|COMPLETED|Pilot Part||0
998792|NCT00486954|2423242|P1|COMPLETED|Pilot Part||0
998793|NCT00486954|2423238|P5|STARTED|Pilot Part||0
998794|NCT00486954|2423239|P4|STARTED|Pilot Part||0
998795|NCT00486954|2423240|P3|STARTED|Pilot Part||6
998796|NCT00486954|2423241|P2|STARTED|Pilot Part||0
998797|NCT00486954|2423242|P1|STARTED|Pilot Part||6
998798|NCT00487084|2423341|P3|NOT COMPLETED|Overall Study||5
998799|NCT00487084|2423342|P2|NOT COMPLETED|Overall Study||3
998800|NCT00487084|2423343|P1|NOT COMPLETED|Overall Study||4
998801|NCT00487084|2423341|P3|COMPLETED|Overall Study||28
998802|NCT00487084|2423342|P2|COMPLETED|Overall Study||30
998803|NCT00487084|2423343|P1|COMPLETED|Overall Study||29
998804|NCT00487084|2423341|P3|STARTED|Overall Study||33
998805|NCT00487084|2423342|P2|STARTED|Overall Study||33
998806|NCT00487084|2423343|P1|STARTED|Overall Study||33
998807|NCT00487162|2423362|P2|NOT COMPLETED|Overall Study||5
998808|NCT00487162|2423363|P1|NOT COMPLETED|Overall Study||2
998809|NCT00487162|2423362|P2|COMPLETED|Overall Study||21
998810|NCT00487162|2423363|P1|COMPLETED|Overall Study||28
998811|NCT00487162|2423362|P2|STARTED|Overall Study||26
998812|NCT00487162|2423363|P1|STARTED|Overall Study||30
998813|NCT00487188|2423373|P3|NOT COMPLETED|Maintenance Phase||1
998814|NCT00487188|2423374|P2|NOT COMPLETED|Maintenance Phase||0
998815|NCT00487188|2423375|P1|NOT COMPLETED|Maintenance Phase||3
998816|NCT00487188|2423373|P3|COMPLETED|Maintenance Phase||8
998817|NCT00487188|2423374|P2|COMPLETED|Maintenance Phase||8
998818|NCT00487188|2423375|P1|COMPLETED|Maintenance Phase||7
998819|NCT00487188|2423373|P3|STARTED|Maintenance Phase||9
998820|NCT00487188|2423374|P2|STARTED|Maintenance Phase||8
998821|NCT00487188|2423375|P1|STARTED|Maintenance Phase||10
998822|NCT00487188|2423373|P3|NOT COMPLETED|Induction Phase||0
998823|NCT00487188|2423374|P2|NOT COMPLETED|Induction Phase||7
998824|NCT00487188|2423375|P1|NOT COMPLETED|Induction Phase||9
998825|NCT00487188|2423373|P3|COMPLETED|Induction Phase||0
998826|NCT00487188|2423374|P2|COMPLETED|Induction Phase||9
998827|NCT00487188|2423375|P1|COMPLETED|Induction Phase||22
998828|NCT00487188|2423373|P3|Safety Population|Induction Phase||0
998829|NCT00487188|2423374|P2|Safety Population|Induction Phase|2 patients randomized to ENF + HARRT only received treatment with HAART|18
998830|NCT00487188|2423375|P1|Safety Population|Induction Phase||29
998831|NCT00487188|2423373|P3|STARTED|Induction Phase|Participants were only randomized to this treatment arm in the Maintenance Phase|0
998832|NCT00487188|2423374|P2|STARTED|Induction Phase||16
998833|NCT00487188|2423375|P1|STARTED|Induction Phase||31
998834|NCT00487240|2423414|P2|NOT COMPLETED|Overall Study||26
998835|NCT00487240|2423415|P1|NOT COMPLETED|Overall Study||31
998836|NCT00487240|2423414|P2|COMPLETED|Overall Study||166
998837|NCT00487240|2423415|P1|COMPLETED|Overall Study||164
998838|NCT00487240|2423414|P2|Full Analysis Set (ITT Population)|Overall Study||189
998839|NCT00487240|2423415|P1|Full Analysis Set (ITT Population)|Overall Study||192
998840|NCT00487240|2423414|P2|STARTED|Overall Study||192
998841|NCT00487240|2423415|P1|STARTED|Overall Study||195
998842|NCT00487279|2423443|P2|NOT COMPLETED|Overall Study||2
998843|NCT00487279|2423444|P1|NOT COMPLETED|Overall Study||1
998844|NCT00487279|2423443|P2|COMPLETED|Overall Study||35
998845|NCT00487279|2423444|P1|COMPLETED|Overall Study||43
998846|NCT00487279|2423443|P2|STARTED|Overall Study||37
998847|NCT00487279|2423444|P1|STARTED|Overall Study||44
998848|NCT00487396|2423452|P1|NOT COMPLETED|Overall Study||3
998849|NCT00487396|2423452|P1|COMPLETED|Overall Study||95
998850|NCT00487396|2423452|P1|STARTED|Overall Study||98
998851|NCT00487435|2423458|P1|NOT COMPLETED|Overall Study||485
998852|NCT00487435|2423458|P1|COMPLETED|Overall Study||669
998853|NCT00487435|2423458|P1|STARTED|Overall Study|Patients who received at least one dose of Tapentadol (CG5503) Extended Release (ER)|1154
998854|NCT00487461|2423466|P3|NOT COMPLETED|Overall Study||4
998855|NCT00487461|2423467|P2|NOT COMPLETED|Overall Study||2
998856|NCT00487461|2423468|P1|NOT COMPLETED|Overall Study||0
998857|NCT00487461|2423466|P3|COMPLETED|Overall Study||7
998858|NCT00487461|2423467|P2|COMPLETED|Overall Study||10
998859|NCT00487461|2423468|P1|COMPLETED|Overall Study||2
998860|NCT00487461|2423466|P3|STARTED|Overall Study||11
998861|NCT00487461|2423467|P2|STARTED|Overall Study||12
998862|NCT00487461|2423468|P1|STARTED|Overall Study||2
998875|NCT00487552|2423504|P1|NOT COMPLETED|Overall Study||6
998876|NCT00487552|2423504|P1|COMPLETED|Overall Study||12
998877|NCT00487552|2423504|P1|STARTED|Overall Study||18
998878|NCT00487565|2423509|P1|NOT COMPLETED|Overall Study||28
998879|NCT00487565|2423509|P1|COMPLETED|Overall Study||182
998880|NCT00487565|2423509|P1|STARTED|Overall Study||210
998881|NCT00487578|2423515|P2|NOT COMPLETED|Overall Study||4
998882|NCT00487578|2423516|P1|NOT COMPLETED|Overall Study||1
998883|NCT00487578|2423515|P2|COMPLETED|Overall Study||5
998884|NCT00487578|2423516|P1|COMPLETED|Overall Study||2
998885|NCT00487578|2423515|P2|STARTED|Overall Study||9
998886|NCT00487578|2423516|P1|STARTED|Overall Study||3
998887|NCT00487669|2423532|P1|NOT COMPLETED|Overall Study||0
998888|NCT00487669|2423532|P1|COMPLETED|Overall Study||12
998889|NCT00487669|2423532|P1|STARTED|Overall Study||12
998890|NCT00487695|2423542|P2|NOT COMPLETED|Second Procedure||3
998891|NCT00487695|2423543|P1|NOT COMPLETED|Second Procedure||1
998892|NCT00487695|2423542|P2|COMPLETED|Second Procedure||20
998893|NCT00487695|2423543|P1|COMPLETED|Second Procedure||19
998894|NCT00487695|2423542|P2|STARTED|Second Procedure||23
998895|NCT00487695|2423543|P1|STARTED|Second Procedure||20
998896|NCT00487695|2423542|P2|NOT COMPLETED|First Procedure||0
998897|NCT00487695|2423543|P1|NOT COMPLETED|First Procedure||3
998898|NCT00487695|2423542|P2|COMPLETED|First Procedure||23
998899|NCT00487695|2423543|P1|COMPLETED|First Procedure||20
998900|NCT00487695|2423542|P2|STARTED|First Procedure||23
998901|NCT00487695|2423543|P1|STARTED|First Procedure||23
998902|NCT00487721|2423561|P2|NOT COMPLETED|Overall Study||0
998903|NCT00487721|2423562|P1|NOT COMPLETED|Overall Study||0
998904|NCT00487721|2423561|P2|COMPLETED|Overall Study||6
998905|NCT00487721|2423562|P1|COMPLETED|Overall Study||6
998906|NCT00487721|2423561|P2|STARTED|Overall Study||6
998907|NCT00487721|2423562|P1|STARTED|Overall Study||6
998908|NCT00487747|2423567|P1|NOT COMPLETED|Overall Study||11
998909|NCT00487747|2423567|P1|COMPLETED|Overall Study||7
998910|NCT00487747|2423567|P1|STARTED|Overall Study||18
998911|NCT00487825|2423578|P2|NOT COMPLETED|Overall Study||5
998912|NCT00487825|2423579|P1|NOT COMPLETED|Overall Study||6
998913|NCT00487825|2423578|P2|COMPLETED|Overall Study||21
998914|NCT00487825|2423579|P1|COMPLETED|Overall Study||46
998915|NCT00487825|2423578|P2|STARTED|Overall Study||26
998916|NCT00487825|2423579|P1|STARTED|Overall Study|"Started indicates Intent-to-treat population (ITT)"|52
998917|NCT00487942|2423595|P4|NOT COMPLETED|Overall Study||2
998918|NCT00487942|2423596|P3|NOT COMPLETED|Overall Study||3
998919|NCT00487942|2423597|P2|NOT COMPLETED|Overall Study||3
998920|NCT00487942|2423598|P1|NOT COMPLETED|Overall Study||3
998921|NCT00487942|2423595|P4|COMPLETED|Overall Study||13
998922|NCT00487942|2423596|P3|COMPLETED|Overall Study||12
998923|NCT00487942|2423597|P2|COMPLETED|Overall Study||12
998924|NCT00487942|2423598|P1|COMPLETED|Overall Study||12
998925|NCT00487942|2423595|P4|STARTED|Overall Study|One subject randomized to placebo discontinued prior to receiving any study drug, leaving 14.|15
998926|NCT00487942|2423596|P3|STARTED|Overall Study||15
998927|NCT00487942|2423597|P2|STARTED|Overall Study||15
998928|NCT00487942|2423598|P1|STARTED|Overall Study||15
998929|NCT00487981|2423980|P1|NOT COMPLETED|Overall Study||1
998930|NCT00487981|2423980|P1|COMPLETED|Overall Study||0
998931|NCT00487981|2423980|P1|STARTED|Overall Study||1
998932|NCT00488033|2423986|P2|NOT COMPLETED|Overall Study||0
998933|NCT00488033|2423987|P1|NOT COMPLETED|Overall Study||1
998934|NCT00488033|2423986|P2|COMPLETED|Overall Study||452
998935|NCT00488033|2423987|P1|COMPLETED|Overall Study||447
998936|NCT00488033|2423986|P2|STARTED|Overall Study||452
998937|NCT00488033|2423987|P1|STARTED|Overall Study||448
998938|NCT00488059|2424003|P3|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||4
998939|NCT00488059|2424004|P2|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
998940|NCT00488059|2424005|P1|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
998941|NCT00488059|2424003|P3|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||1
998942|NCT00488059|2424004|P2|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
998943|NCT00488059|2424005|P1|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
998944|NCT00488059|2424003|P3|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||5
998945|NCT00488059|2424004|P2|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
998946|NCT00488059|2424005|P1|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
998947|NCT00488059|2424003|P3|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
998948|NCT00488059|2424004|P2|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||2
998949|NCT00488059|2424005|P1|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
998950|NCT00488059|2424003|P3|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
998951|NCT00488059|2424004|P2|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||7
998952|NCT00488059|2424005|P1|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
998953|NCT00488059|2424003|P3|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
998954|NCT00488059|2424004|P2|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||9
998955|NCT00488059|2424005|P1|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
998956|NCT00488059|2424003|P3|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
998957|NCT00488059|2424004|P2|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
998958|NCT00488059|2424005|P1|NOT COMPLETED|Phase I: ENF 90mg SC BID||15
998959|NCT00488059|2424003|P3|COMPLETED|Phase I: ENF 90mg SC BID||0
998960|NCT00488059|2424004|P2|COMPLETED|Phase I: ENF 90mg SC BID||0
998961|NCT00488059|2424005|P1|COMPLETED|Phase I: ENF 90mg SC BID||14
998962|NCT00488059|2424003|P3|STARTED|Phase I: ENF 90mg SC BID||0
998963|NCT00488059|2424004|P2|STARTED|Phase I: ENF 90mg SC BID||0
998964|NCT00488059|2424005|P1|STARTED|Phase I: ENF 90mg SC BID||29
998965|NCT00488293|2424024|P2|NOT COMPLETED|Overall Study||30
998966|NCT00488293|2424025|P1|NOT COMPLETED|Overall Study||36
998967|NCT00488293|2424024|P2|COMPLETED|Overall Study||166
998968|NCT00488293|2424025|P1|COMPLETED|Overall Study||160
998969|NCT00488293|2424024|P2|STARTED|Overall Study||196
998970|NCT00488293|2424025|P1|STARTED|Overall Study||196
998971|NCT00488319|2424052|P3|NOT COMPLETED|Overall Study||122
998972|NCT00488319|2424053|P2|NOT COMPLETED|Overall Study||43
998973|NCT00488319|2424054|P1|NOT COMPLETED|Overall Study||15
998974|NCT00488319|2424052|P3|COMPLETED|Overall Study||121
998975|NCT00488319|2424053|P2|COMPLETED|Overall Study||75
998976|NCT00488319|2424054|P1|COMPLETED|Overall Study||24
998977|NCT00488319|2424052|P3|STARTED|Overall Study||243
998978|NCT00488319|2424053|P2|STARTED|Overall Study||118
998979|NCT00488319|2424054|P1|STARTED|Overall Study||39
998980|NCT00488345|2424142|P3|NOT COMPLETED|Overall Study||3
998981|NCT00488345|2424143|P2|NOT COMPLETED|Overall Study||4
998982|NCT00488345|2424144|P1|NOT COMPLETED|Overall Study||0
998983|NCT00488345|2424142|P3|COMPLETED|Overall Study||17
998984|NCT00488345|2424143|P2|COMPLETED|Overall Study||17
998985|NCT00488345|2424144|P1|COMPLETED|Overall Study||17
998986|NCT00488345|2424142|P3|STARTED|Overall Study||20
998987|NCT00488345|2424143|P2|STARTED|Overall Study||21
998988|NCT00488345|2424144|P1|STARTED|Overall Study||17
998989|NCT00488475|2424167|P1|NOT COMPLETED|Overall Study||1754
998990|NCT00488475|2424167|P1|COMPLETED|Overall Study||3191
998991|NCT00488475|2424167|P1|STARTED|Overall Study||4945
998992|NCT00488488|2424193|P1|NOT COMPLETED|Overall Study||268
998993|NCT00488488|2424193|P1|COMPLETED|Overall Study|Excludes 4 participants with missing information.|760
998994|NCT00488488|2424193|P1|Analyzed|Overall Study|3 participants were not analyzed due to retrospective documentation.|1025
998995|NCT00488488|2424193|P1|STARTED|Overall Study||1028
998996|NCT00488514|2424208|P1|NOT COMPLETED|Overall Study||293
998997|NCT00488514|2424208|P1|COMPLETED|Overall Study||363
998998|NCT00488514|2424208|P1|STARTED|Overall Study||656
998999|NCT00488592|2424281|P1|NOT COMPLETED|Overall Study||3
999000|NCT00488592|2424281|P1|COMPLETED|Overall Study|7 completed the initial series of 6 vaccinations|7
999001|NCT00488592|2424281|P1|STARTED|Overall Study|10 subjects were accrued|10
999002|NCT00488618|2424287|P2|NOT COMPLETED|Overall Study||43
999003|NCT00488618|2424288|P1|NOT COMPLETED|Overall Study||47
999004|NCT00488618|2424287|P2|COMPLETED|Overall Study||75
999005|NCT00488618|2424288|P1|COMPLETED|Overall Study||73
999006|NCT00488618|2424287|P2|Safety Population: Received Study Drug|Overall Study||118
999007|NCT00488618|2424288|P1|Safety Population: Received Study Drug|Overall Study||118
999008|NCT00488618|2424287|P2|STARTED|Overall Study||118
999009|NCT00488618|2424288|P1|STARTED|Overall Study||120
999010|NCT00488631|2424302|P10|NOT COMPLETED|Open Label Study Extension (Week 54-228)||3
999011|NCT00488631|2424303|P9|NOT COMPLETED|Open Label Study Extension (Week 54-228)||182
999012|NCT00488631|2424304|P8|NOT COMPLETED|Open Label Study Extension (Week 54-228)||27
999013|NCT00488631|2424305|P7|NOT COMPLETED|Open Label Study Extension (Week 54-228)||80
999014|NCT00488631|2424306|P6|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
999015|NCT00488631|2424307|P5|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
999016|NCT00488631|2424308|P4|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
999017|NCT00488631|2424309|P3|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
999018|NCT00488631|2424310|P2|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
999019|NCT00488631|2424311|P1|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
999020|NCT00488631|2424302|P10|COMPLETED|Open Label Study Extension (Week 54-228)||4
999021|NCT00488631|2424303|P9|COMPLETED|Open Label Study Extension (Week 54-228)||288
999022|NCT00488631|2424304|P8|COMPLETED|Open Label Study Extension (Week 54-228)||66
999023|NCT00488631|2424305|P7|COMPLETED|Open Label Study Extension (Week 54-228)||16
999024|NCT00488631|2424306|P6|COMPLETED|Open Label Study Extension (Week 54-228)||0
999025|NCT00488631|2424307|P5|COMPLETED|Open Label Study Extension (Week 54-228)||0
999026|NCT00488631|2424308|P4|COMPLETED|Open Label Study Extension (Week 54-228)||0
999027|NCT00488631|2424309|P3|COMPLETED|Open Label Study Extension (Week 54-228)||0
999028|NCT00488631|2424310|P2|COMPLETED|Open Label Study Extension (Week 54-228)||0
999029|NCT00488631|2424311|P1|COMPLETED|Open Label Study Extension (Week 54-228)||0
999030|NCT00488631|2424302|P10|STARTED|Open Label Study Extension (Week 54-228)||7
999031|NCT00488631|2424303|P9|STARTED|Open Label Study Extension (Week 54-228)||470
999032|NCT00488631|2424304|P8|STARTED|Open Label Study Extension (Week 54-228)||93
999033|NCT00488631|2424305|P7|STARTED|Open Label Study Extension (Week 54-228)||96
999034|NCT00488631|2424306|P6|STARTED|Open Label Study Extension (Week 54-228)||0
999035|NCT00488631|2424307|P5|STARTED|Open Label Study Extension (Week 54-228)||0
999036|NCT00488631|2424308|P4|STARTED|Open Label Study Extension (Week 54-228)||0
999037|NCT00488631|2424309|P3|STARTED|Open Label Study Extension (Week 54-228)||0
999038|NCT00488631|2424310|P2|STARTED|Open Label Study Extension (Week 54-228)||0
999039|NCT00488631|2424311|P1|STARTED|Open Label Study Extension (Week 54-228)||0
999040|NCT00488631|2424302|P10|NOT COMPLETED|Double Blind Period (Week 0-54)||0
999041|NCT00488631|2424303|P9|NOT COMPLETED|Double Blind Period (Week 0-54)||0
999042|NCT00488631|2424304|P8|NOT COMPLETED|Double Blind Period (Week 0-54)||0
999043|NCT00488631|2424305|P7|NOT COMPLETED|Double Blind Period (Week 0-54)||0
999044|NCT00488631|2424306|P6|NOT COMPLETED|Double Blind Period (Week 0-54)||216
999045|NCT00488631|2424307|P5|NOT COMPLETED|Double Blind Period (Week 0-54)||103
999046|NCT00488631|2424308|P4|NOT COMPLETED|Double Blind Period (Week 0-54)||41
999047|NCT00488631|2424309|P3|NOT COMPLETED|Double Blind Period (Week 0-54)||45
999048|NCT00488631|2424310|P2|NOT COMPLETED|Double Blind Period (Week 0-54)||43
999049|NCT00488631|2424311|P1|NOT COMPLETED|Double Blind Period (Week 0-54)||43
999050|NCT00488631|2424302|P10|COMPLETED|Double Blind Period (Week 0-54)||0
999051|NCT00488631|2424303|P9|COMPLETED|Double Blind Period (Week 0-54)||0
999052|NCT00488631|2424304|P8|COMPLETED|Double Blind Period (Week 0-54)||0
999053|NCT00488631|2424305|P7|COMPLETED|Double Blind Period (Week 0-54)||0
999054|NCT00488631|2424306|P6|COMPLETED|Double Blind Period (Week 0-54)||189
999055|NCT00488631|2424307|P5|COMPLETED|Double Blind Period (Week 0-54)||127
999056|NCT00488631|2424308|P4|COMPLETED|Double Blind Period (Week 0-54)||88
999057|NCT00488631|2424309|P3|COMPLETED|Double Blind Period (Week 0-54)||109
999058|NCT00488631|2424310|P2|COMPLETED|Double Blind Period (Week 0-54)||111
999059|NCT00488631|2424311|P1|COMPLETED|Double Blind Period (Week 0-54)||113
999060|NCT00488631|2424302|P10|STARTED|Double Blind Period (Week 0-54)||0
999061|NCT00488631|2424303|P9|STARTED|Double Blind Period (Week 0-54)||0
999062|NCT00488631|2424304|P8|STARTED|Double Blind Period (Week 0-54)||0
999063|NCT00488631|2424305|P7|STARTED|Double Blind Period (Week 0-54)||0
999064|NCT00488631|2424306|P6|STARTED|Double Blind Period (Week 0-54)||405
999065|NCT00488631|2424307|P5|STARTED|Double Blind Period (Week 0-54)||230
999066|NCT00488631|2424308|P4|STARTED|Double Blind Period (Week 0-54)||129
999067|NCT00488631|2424309|P3|STARTED|Double Blind Period (Week 0-54)||154
999068|NCT00488631|2424310|P2|STARTED|Double Blind Period (Week 0-54)||154
999069|NCT00488631|2424311|P1|STARTED|Double Blind Period (Week 0-54)||156
999070|NCT00488644|2424346|P1|NOT COMPLETED|Overall Study||2
999071|NCT00488644|2424346|P1|COMPLETED|Overall Study||10
999072|NCT00488644|2424346|P1|STARTED|Overall Study||12
999094|NCT00488826|2424438|P3|NOT COMPLETED|Overall Study||26
999095|NCT00488826|2424439|P2|NOT COMPLETED|Overall Study||52
999096|NCT00488826|2424440|P1|NOT COMPLETED|Overall Study||56
999097|NCT00488826|2424438|P3|COMPLETED|Overall Study||178
999098|NCT00488826|2424439|P2|COMPLETED|Overall Study||244
999099|NCT00488826|2424440|P1|COMPLETED|Overall Study||244
999100|NCT00488826|2424438|P3|STARTED|Overall Study||204
999101|NCT00488826|2424439|P2|STARTED|Overall Study||296
999102|NCT00488826|2424440|P1|STARTED|Overall Study||300
999103|NCT00488865|2424451|P1|NOT COMPLETED|Overall Study||0
999104|NCT00488865|2424451|P1|COMPLETED|Overall Study||100
999105|NCT00488865|2424451|P1|STARTED|Overall Study||100
999106|NCT00489086|2424457|P1|NOT COMPLETED|Overall Study||23
999107|NCT00489086|2424457|P1|COMPLETED|Overall Study|23 subjects completed 18 months|13
999108|NCT00489086|2424457|P1|STARTED|Overall Study||36
999109|NCT00489216|2424461|P1|NOT COMPLETED|Overall Study||1
999110|NCT00489216|2424461|P1|COMPLETED|Overall Study||1
999111|NCT00489216|2424461|P1|STARTED|Overall Study||2
999112|NCT00489255|2424472|P2|NOT COMPLETED|Period 3: Days 57 to 84||4
999113|NCT00489255|2424473|P1|NOT COMPLETED|Period 3: Days 57 to 84||4
999114|NCT00489255|2424472|P2|COMPLETED|Period 3: Days 57 to 84|Re-randomized participants is 27.Sample sizes differed due to withdrawal&re-randomization design.|78
999115|NCT00489255|2424473|P1|COMPLETED|Period 3: Days 57 to 84||24
999116|NCT00489255|2424472|P2|STARTED|Period 3: Days 57 to 84|Re-randomized participants is 30.Sample sizes differed due to withdrawal&re-randomization design.|82
999117|NCT00489255|2424473|P1|STARTED|Period 3: Days 57 to 84||28
999118|NCT00489255|2424472|P2|NOT COMPLETED|Period 2: Days 29 to 56||4
999119|NCT00489255|2424473|P1|NOT COMPLETED|Period 2: Days 29 to 56||3
999120|NCT00489255|2424472|P2|COMPLETED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|55
999121|NCT00489255|2424473|P1|COMPLETED|Period 2: Days 29 to 56||61
999122|NCT00489255|2424472|P2|Completed But Discontinued Study|Period 2: Days 29 to 56|Re-randomized participants is 2.Sample sizes differed due to withdrawal&re-randomization design.|3
999123|NCT00489255|2424473|P1|Completed But Discontinued Study|Period 2: Days 29 to 56||3
999124|NCT00489255|2424472|P2|Completed and Follow Period 3|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|52
999125|NCT00489255|2424473|P1|Completed and Follow Period 3|Period 2: Days 29 to 56||58
999126|NCT00489255|2424472|P2|STARTED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|59
999127|NCT00489255|2424473|P1|STARTED|Period 2: Days 29 to 56||64
999128|NCT00489255|2424472|P2|NOT COMPLETED|Period 1: Days 1 to 28||12
999129|NCT00489255|2424473|P1|NOT COMPLETED|Period 1: Days 1 to 28||29
999130|NCT00489255|2424472|P2|COMPLETED|Period 1: Days 1 to 28||34
999131|NCT00489255|2424473|P1|COMPLETED|Period 1: Days 1 to 28||107
999132|NCT00489255|2424472|P2|Completed But Discontinued Study|Period 1: Days 1 to 28||5
999133|NCT00489255|2424473|P1|Completed But Discontinued Study|Period 1: Days 1 to 28||13
999134|NCT00489255|2424472|P2|Completed and Follow Period 2|Period 1: Days 1 to 28||29
999135|NCT00489255|2424473|P1|Completed and Follow Period 2|Period 1: Days 1 to 28||94
999136|NCT00489255|2424472|P2|STARTED|Period 1: Days 1 to 28||46
999137|NCT00489255|2424473|P1|STARTED|Period 1: Days 1 to 28||136
999138|NCT00489255|2424472|P2|NOT COMPLETED|Screening and Initial Randomization||3
999139|NCT00489255|2424473|P1|NOT COMPLETED|Screening and Initial Randomization||9
999140|NCT00489255|2424472|P2|COMPLETED|Screening and Initial Randomization||46
999141|NCT00489255|2424473|P1|COMPLETED|Screening and Initial Randomization||136
999142|NCT00489255|2424472|P2|STARTED|Screening and Initial Randomization|Total randomized subjects to receive placebo|49
999143|NCT00489255|2424473|P1|STARTED|Screening and Initial Randomization|Total randomized subjects to receive Tigan|145
999144|NCT00489268|2424526|P5|NOT COMPLETED|Overall Study||20
999145|NCT00489268|2424527|P4|NOT COMPLETED|Overall Study||0
999146|NCT00489268|2424528|P3|NOT COMPLETED|Overall Study||1
999147|NCT00489268|2424529|P2|NOT COMPLETED|Overall Study||0
999148|NCT00489268|2424530|P1|NOT COMPLETED|Overall Study||0
999149|NCT00489268|2424526|P5|COMPLETED|Overall Study||50
999150|NCT00489268|2424527|P4|COMPLETED|Overall Study||11
999151|NCT00489268|2424528|P3|COMPLETED|Overall Study||9
999152|NCT00489268|2424529|P2|COMPLETED|Overall Study||10
999153|NCT00489268|2424530|P1|COMPLETED|Overall Study||1
999154|NCT00489268|2424526|P5|STARTED|Overall Study||70
999155|NCT00489268|2424527|P4|STARTED|Overall Study||11
999156|NCT00489268|2424528|P3|STARTED|Overall Study||10
999157|NCT00489268|2424529|P2|STARTED|Overall Study||10
999158|NCT00489268|2424530|P1|STARTED|Overall Study||1
999159|NCT00489359|2424559|P2|NOT COMPLETED|Overall Study||29
999160|NCT00489359|2424560|P1|NOT COMPLETED|Overall Study||7
999161|NCT00489359|2424559|P2|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|37
999162|NCT00489359|2424560|P1|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|13
999163|NCT00489359|2424559|P2|STARTED|Overall Study||66
999164|NCT00489359|2424560|P1|STARTED|Overall Study||20
999165|NCT00489411|2424585|P2|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||19
999166|NCT00489411|2424586|P1|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||18
999167|NCT00489411|2424585|P2|COMPLETED|Crossover Treatment Period (Weeks 8-12)||74
999168|NCT00489411|2424586|P1|COMPLETED|Crossover Treatment Period (Weeks 8-12)||67
999169|NCT00489411|2424585|P2|STARTED|Crossover Treatment Period (Weeks 8-12)||93
999170|NCT00489411|2424586|P1|STARTED|Crossover Treatment Period (Weeks 8-12)||85
999171|NCT00489411|2424585|P2|NOT COMPLETED|Washout Period (Weeks 6-7)||1
999172|NCT00489411|2424586|P1|NOT COMPLETED|Washout Period (Weeks 6-7)||2
999173|NCT00489411|2424585|P2|COMPLETED|Washout Period (Weeks 6-7)||93
999174|NCT00489411|2424586|P1|COMPLETED|Washout Period (Weeks 6-7)||85
999175|NCT00489411|2424585|P2|STARTED|Washout Period (Weeks 6-7)||94
999176|NCT00489411|2424586|P1|STARTED|Washout Period (Weeks 6-7)||87
999177|NCT00489411|2424585|P2|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||22
999178|NCT00489411|2424586|P1|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||28
999179|NCT00489411|2424585|P2|COMPLETED|Initial Treatment Period (Weeks 1-5)||94
999180|NCT00489411|2424586|P1|COMPLETED|Initial Treatment Period (Weeks 1-5)||87
999181|NCT00489411|2424585|P2|STARTED|Initial Treatment Period (Weeks 1-5)||116
999182|NCT00489411|2424586|P1|STARTED|Initial Treatment Period (Weeks 1-5)||115
999183|NCT00489424|2424601|P3|NOT COMPLETED|Overall Study||5
999184|NCT00489424|2424602|P2|NOT COMPLETED|Overall Study||5
999185|NCT00489424|2424603|P1|NOT COMPLETED|Overall Study||4
999186|NCT00489424|2424601|P3|COMPLETED|Overall Study||257
999187|NCT00489424|2424602|P2|COMPLETED|Overall Study||259
999188|NCT00489424|2424603|P1|COMPLETED|Overall Study||263
999189|NCT00489424|2424601|P3|STARTED|Overall Study||262
999190|NCT00489424|2424602|P2|STARTED|Overall Study||264
999191|NCT00489424|2424603|P1|STARTED|Overall Study||267
999192|NCT00495495|2424632|P1|NOT COMPLETED|Overall Study||99
999193|NCT00495495|2424632|P1|COMPLETED|Overall Study||295
999194|NCT00495495|2424632|P1|STARTED|Overall Study||394
999195|NCT00495521|2424647|P2|NOT COMPLETED|Overall Study||1
999196|NCT00495521|2424648|P1|NOT COMPLETED|Overall Study||0
999197|NCT00495521|2424647|P2|COMPLETED|Overall Study||0
999198|NCT00495521|2424648|P1|COMPLETED|Overall Study||1
999199|NCT00495521|2424647|P2|STARTED|Overall Study||1
999200|NCT00495521|2424648|P1|STARTED|Overall Study||1
999201|NCT00495586|2424680|P2|NOT COMPLETED|Overall Study||4
999202|NCT00495586|2424681|P1|NOT COMPLETED|Overall Study||4
999203|NCT00495586|2424680|P2|COMPLETED|Overall Study||158
999204|NCT00495586|2424681|P1|COMPLETED|Overall Study||152
999205|NCT00495586|2424680|P2|STARTED|Overall Study||162
999206|NCT00495586|2424681|P1|STARTED|Overall Study||156
999207|NCT00495612|2424691|P2|NOT COMPLETED|Overall Study||0
999208|NCT00495612|2424692|P1|NOT COMPLETED|Overall Study||4
999209|NCT00495612|2424691|P2|COMPLETED|Overall Study||33
999210|NCT00495612|2424692|P1|COMPLETED|Overall Study||32
999211|NCT00495612|2424691|P2|STARTED|Overall Study||33
999212|NCT00495612|2424692|P1|STARTED|Overall Study||36
999213|NCT00495625|2424708|P1|NOT COMPLETED|Overall Study||10
999214|NCT00495625|2424708|P1|COMPLETED|Overall Study||23
999215|NCT00495625|2424708|P1|STARTED|Overall Study||33
999216|NCT00495677|2424724|P7|NOT COMPLETED|Stage 2 (25 Days)||0
999217|NCT00495677|2424725|P6|NOT COMPLETED|Stage 2 (25 Days)||0
999218|NCT00495677|2424726|P5|NOT COMPLETED|Stage 2 (25 Days)||0
999219|NCT00495677|2424727|P4|NOT COMPLETED|Stage 2 (25 Days)||0
999220|NCT00495677|2424728|P3|NOT COMPLETED|Stage 2 (25 Days)||0
999221|NCT00495677|2424729|P2|NOT COMPLETED|Stage 2 (25 Days)||0
999222|NCT00495677|2424730|P1|NOT COMPLETED|Stage 2 (25 Days)||0
999223|NCT00495677|2424724|P7|COMPLETED|Stage 2 (25 Days)||7
999224|NCT00495677|2424725|P6|COMPLETED|Stage 2 (25 Days)||8
999225|NCT00495677|2424726|P5|COMPLETED|Stage 2 (25 Days)||8
999226|NCT00495677|2424727|P4|COMPLETED|Stage 2 (25 Days)||0
999227|NCT00495677|2424728|P3|COMPLETED|Stage 2 (25 Days)||0
999228|NCT00495677|2424729|P2|COMPLETED|Stage 2 (25 Days)||0
999229|NCT00495677|2424730|P1|COMPLETED|Stage 2 (25 Days)||0
999230|NCT00495677|2424724|P7|STARTED|Stage 2 (25 Days)||7
999231|NCT00495677|2424725|P6|STARTED|Stage 2 (25 Days)||8
999232|NCT00495677|2424726|P5|STARTED|Stage 2 (25 Days)||8
999233|NCT00495677|2424727|P4|STARTED|Stage 2 (25 Days)||0
999234|NCT00495677|2424728|P3|STARTED|Stage 2 (25 Days)||0
999235|NCT00495677|2424729|P2|STARTED|Stage 2 (25 Days)||0
999236|NCT00495677|2424730|P1|STARTED|Stage 2 (25 Days)||0
999237|NCT00495677|2424724|P7|NOT COMPLETED|Stage 1 (25 Days)||0
999238|NCT00495677|2424725|P6|NOT COMPLETED|Stage 1 (25 Days)||0
999239|NCT00495677|2424726|P5|NOT COMPLETED|Stage 1 (25 Days)||0
999240|NCT00495677|2424727|P4|NOT COMPLETED|Stage 1 (25 Days)||0
999241|NCT00495677|2424728|P3|NOT COMPLETED|Stage 1 (25 Days)||1
999242|NCT00495677|2424729|P2|NOT COMPLETED|Stage 1 (25 Days)||0
999243|NCT00495677|2424730|P1|NOT COMPLETED|Stage 1 (25 Days)||0
999244|NCT00495677|2424724|P7|COMPLETED|Stage 1 (25 Days)||0
999245|NCT00495677|2424725|P6|COMPLETED|Stage 1 (25 Days)||0
999246|NCT00495677|2424726|P5|COMPLETED|Stage 1 (25 Days)||0
999247|NCT00495677|2424727|P4|COMPLETED|Stage 1 (25 Days)||6
999248|NCT00495677|2424728|P3|COMPLETED|Stage 1 (25 Days)||5
999249|NCT00495677|2424729|P2|COMPLETED|Stage 1 (25 Days)||6
999250|NCT00495677|2424730|P1|COMPLETED|Stage 1 (25 Days)||2
999251|NCT00495677|2424724|P7|STARTED|Stage 1 (25 Days)||0
999252|NCT00495677|2424725|P6|STARTED|Stage 1 (25 Days)||0
999253|NCT00495677|2424726|P5|STARTED|Stage 1 (25 Days)||0
999254|NCT00495677|2424727|P4|STARTED|Stage 1 (25 Days)||6
999255|NCT00495677|2424728|P3|STARTED|Stage 1 (25 Days)||6
999256|NCT00495677|2424729|P2|STARTED|Stage 1 (25 Days)||6
999257|NCT00495677|2424730|P1|STARTED|Stage 1 (25 Days)||2
999258|NCT00495755|2424785|P1|NOT COMPLETED|Overall Study||3
999259|NCT00495755|2424785|P1|COMPLETED|Overall Study||10
999260|NCT00495755|2424785|P1|STARTED|Overall Study||13
999261|NCT00495794|2424792|P2|NOT COMPLETED|Overall Study||0
999262|NCT00495794|2424793|P1|NOT COMPLETED|Overall Study||522
999263|NCT00495794|2424792|P2|COMPLETED|Overall Study||2303
999264|NCT00495794|2424793|P1|COMPLETED|Overall Study||1797
999265|NCT00495794|2424792|P2|STARTED|Overall Study||2303
999266|NCT00495794|2424793|P1|STARTED|Overall Study||2319
999267|NCT00496054|2424803|P1|NOT COMPLETED|Overall Study||8
999268|NCT00496054|2424803|P1|COMPLETED|Overall Study||102
999269|NCT00496054|2424803|P1|STARTED|Overall Study||110
999270|NCT00496080|2424830|P1|NOT COMPLETED|Overall Study||27
999271|NCT00496080|2424830|P1|COMPLETED|Overall Study||60
999272|NCT00496080|2424830|P1|STARTED|Overall Study||87
999273|NCT00496197|2424840|P1|NOT COMPLETED|Overall Study||122
999274|NCT00496197|2424840|P1|COMPLETED|Overall Study||160
999275|NCT00496197|2424840|P1|STARTED|Overall Study||282
999276|NCT00496262|2424867|P1|NOT COMPLETED|Overall Study||0
999277|NCT00496262|2424867|P1|COMPLETED|Overall Study||15
999278|NCT00496262|2424867|P1|STARTED|Overall Study||15
999279|NCT00496340|2424880|P1|NOT COMPLETED|Overall Study||0
999280|NCT00496340|2424880|P1|COMPLETED|Overall Study||42
999281|NCT00496340|2424880|P1|STARTED|Overall Study||42
999282|NCT00496366|2424893|P1|NOT COMPLETED|Overall Study||1
999283|NCT00496366|2424893|P1|COMPLETED|Overall Study||10
999284|NCT00496366|2424893|P1|STARTED|Overall Study||11
999285|NCT00496379|2424898|P1|NOT COMPLETED|Overall Study||0
999286|NCT00496379|2424898|P1|COMPLETED|Overall Study||15
999287|NCT00496379|2424898|P1|STARTED|Overall Study||15
999288|NCT00496470|2424908|P2|NOT COMPLETED|Overall Study||29
999289|NCT00496470|2424909|P1|NOT COMPLETED|Overall Study||26
999290|NCT00496470|2424908|P2|COMPLETED|Overall Study||302
999291|NCT00496470|2424909|P1|COMPLETED|Overall Study||303
999292|NCT00496470|2424908|P2|Received Study Medication|Overall Study||330
999293|NCT00496470|2424909|P1|Received Study Medication|Overall Study||329
999294|NCT00496470|2424908|P2|STARTED|Overall Study||331
999295|NCT00496470|2424909|P1|STARTED|Overall Study||329
999296|NCT00496483|2424987|P1|NOT COMPLETED|Overall Study||12
999297|NCT00496483|2424987|P1|COMPLETED|Overall Study||48
999298|NCT00496483|2424987|P1|Dosed|Overall Study||51
999299|NCT00496483|2424987|P1|STARTED|Overall Study||60
999300|NCT00496587|2425002|P1|NOT COMPLETED|Overall Study||31
999301|NCT00496587|2425002|P1|COMPLETED|Overall Study||3
999302|NCT00496587|2425002|P1|STARTED|Overall Study||34
999303|NCT00496626|2425010|P2|NOT COMPLETED|Overall Study||6
999304|NCT00496626|2425011|P1|NOT COMPLETED|Overall Study||6
999305|NCT00496626|2425010|P2|COMPLETED|Overall Study||292
999306|NCT00496626|2425011|P1|COMPLETED|Overall Study||296
999307|NCT00496626|2425010|P2|STARTED|Overall Study||298
999308|NCT00496626|2425011|P1|STARTED|Overall Study||302
999309|NCT00496730|2425025|P2|NOT COMPLETED|Overall Study||5
999310|NCT00496730|2425026|P1|NOT COMPLETED|Overall Study||6
999311|NCT00496730|2425025|P2|COMPLETED|Overall Study||121
999312|NCT00496730|2425026|P1|COMPLETED|Overall Study||124
999313|NCT00496730|2425025|P2|STARTED|Overall Study||126
999314|NCT00496730|2425026|P1|STARTED|Overall Study||130
999323|NCT00496782|2425063|P2|NOT COMPLETED|Overall Study||2
999324|NCT00496782|2425064|P1|NOT COMPLETED|Overall Study||1
999325|NCT00496782|2425063|P2|COMPLETED|Overall Study||5
999326|NCT00496782|2425064|P1|COMPLETED|Overall Study||8
999327|NCT00496782|2425063|P2|STARTED|Overall Study||7
999328|NCT00496782|2425064|P1|STARTED|Overall Study||9
999329|NCT00496808|2425096|P1|NOT COMPLETED|Overall Study||0
999330|NCT00496808|2425096|P1|COMPLETED|Overall Study||69
999331|NCT00496808|2425096|P1|STARTED|Overall Study||69
999332|NCT00496834|2425103|P2|NOT COMPLETED|Overall Study||13
999333|NCT00496834|2425104|P1|NOT COMPLETED|Overall Study||18
999334|NCT00496834|2425103|P2|COMPLETED|Overall Study||87
999335|NCT00496834|2425104|P1|COMPLETED|Overall Study||83
999336|NCT00496834|2425103|P2|STARTED|Overall Study||100
999337|NCT00496834|2425104|P1|STARTED|Overall Study||101
999338|NCT00496860|2425119|P3|NOT COMPLETED|Overall Study||0
999339|NCT00496860|2425120|P2|NOT COMPLETED|Overall Study||1
999340|NCT00496860|2425121|P1|NOT COMPLETED|Overall Study||1
999341|NCT00496860|2425119|P3|COMPLETED|Overall Study||6
999342|NCT00496860|2425120|P2|COMPLETED|Overall Study||15
999343|NCT00496860|2425121|P1|COMPLETED|Overall Study||3
999344|NCT00496860|2425119|P3|STARTED|Overall Study||6
999345|NCT00496860|2425120|P2|STARTED|Overall Study||16
999346|NCT00496860|2425121|P1|STARTED|Overall Study||4
999347|NCT00496873|2425141|P1|NOT COMPLETED|Overall Study||7
999348|NCT00496873|2425141|P1|COMPLETED|Overall Study||78
999349|NCT00496873|2425141|P1|STARTED|Overall Study||85
999356|NCT00497055|2425160|P2|NOT COMPLETED|Overall Study||5
999357|NCT00497055|2425161|P1|NOT COMPLETED|Overall Study||10
999358|NCT00497055|2425160|P2|COMPLETED|Overall Study||40
999359|NCT00497055|2425161|P1|COMPLETED|Overall Study||35
999360|NCT00497055|2425160|P2|STARTED|Overall Study||45
999361|NCT00497055|2425161|P1|STARTED|Overall Study||45
999362|NCT00497081|2425173|P2|NOT COMPLETED|Overall Study||2
999363|NCT00497081|2425174|P1|NOT COMPLETED|Overall Study||2
999364|NCT00497081|2425173|P2|COMPLETED|Overall Study||28
999365|NCT00497081|2425174|P1|COMPLETED|Overall Study||28
999366|NCT00497081|2425173|P2|STARTED|Overall Study||30
999367|NCT00497081|2425174|P1|STARTED|Overall Study||30
999368|NCT00497146|2425186|P2|NOT COMPLETED|Long-term Follow-up Period||6
999369|NCT00497146|2425187|P1|NOT COMPLETED|Long-term Follow-up Period||15
999370|NCT00497146|2425186|P2|COMPLETED|Long-term Follow-up Period||66
999371|NCT00497146|2425187|P1|COMPLETED|Long-term Follow-up Period||50
999372|NCT00497146|2425186|P2|STARTED|Long-term Follow-up Period||72
999373|NCT00497146|2425187|P1|STARTED|Long-term Follow-up Period||65
999374|NCT00497146|2425186|P2|NOT COMPLETED|Treatment Period||21
999375|NCT00497146|2425187|P1|NOT COMPLETED|Treatment Period||27
999376|NCT00497146|2425186|P2|COMPLETED|Treatment Period||91
999377|NCT00497146|2425187|P1|COMPLETED|Treatment Period||88
999378|NCT00497146|2425186|P2|STARTED|Treatment Period||112
999379|NCT00497146|2425187|P1|STARTED|Treatment Period||115
999380|NCT00497198|2425229|P2|NOT COMPLETED|Overall Study||5
999381|NCT00497198|2425230|P1|NOT COMPLETED|Overall Study||5
999382|NCT00497198|2425229|P2|COMPLETED|Overall Study||86
999383|NCT00497198|2425230|P1|COMPLETED|Overall Study||87
999384|NCT00497198|2425229|P2|STARTED|Overall Study||91
999385|NCT00497198|2425230|P1|STARTED|Overall Study||92
999386|NCT00497770|2425248|P4|NOT COMPLETED|Overall Study||0
999387|NCT00497770|2425249|P3|NOT COMPLETED|Overall Study||0
999388|NCT00497770|2425250|P2|NOT COMPLETED|Overall Study||0
999389|NCT00497770|2425251|P1|NOT COMPLETED|Overall Study||0
999390|NCT00497770|2425248|P4|COMPLETED|Overall Study||28
999391|NCT00497770|2425249|P3|COMPLETED|Overall Study||37
999392|NCT00497770|2425250|P2|COMPLETED|Overall Study||65
999393|NCT00497770|2425251|P1|COMPLETED|Overall Study||304
999394|NCT00497770|2425248|P4|STARTED|Overall Study||28
999395|NCT00497770|2425249|P3|STARTED|Overall Study||37
999396|NCT00497770|2425250|P2|STARTED|Overall Study||65
999397|NCT00497770|2425251|P1|STARTED|Overall Study||304
999398|NCT00497796|2425303|P2|NOT COMPLETED|Overall Study||59
999399|NCT00497796|2425304|P1|NOT COMPLETED|Overall Study||85
999400|NCT00497796|2425303|P2|COMPLETED|Overall Study||101
999401|NCT00497796|2425304|P1|COMPLETED|Overall Study||62
999402|NCT00497796|2425303|P2|STARTED|Overall Study||160
999403|NCT00497796|2425304|P1|STARTED|Overall Study||147
999404|NCT00497874|2425334|P2|NOT COMPLETED|Overall Study||116
999405|NCT00497874|2425335|P1|NOT COMPLETED|Overall Study||147
999406|NCT00497874|2425334|P2|COMPLETED|Overall Study||343
999407|NCT00497874|2425335|P1|COMPLETED|Overall Study||296
999408|NCT00497874|2425334|P2|STARTED|Overall Study||459
999409|NCT00497874|2425335|P1|STARTED|Overall Study||443
999410|NCT00498173|2425353|P3|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
999411|NCT00498173|2425354|P2|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
999412|NCT00498173|2425355|P1|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
999413|NCT00498173|2425353|P3|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
999414|NCT00498173|2425354|P2|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
999415|NCT00498173|2425355|P1|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
999416|NCT00498173|2425353|P3|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
999417|NCT00498173|2425354|P2|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
999418|NCT00498173|2425355|P1|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
999419|NCT00498173|2425353|P3|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
999420|NCT00498173|2425354|P2|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||1
999421|NCT00498173|2425355|P1|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||2
999422|NCT00498173|2425353|P3|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
999423|NCT00498173|2425354|P2|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||30
999424|NCT00498173|2425355|P1|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||27
999425|NCT00498173|2425353|P3|STARTED|Phase 1-Blinded Randomization (8 Weeks)||0
999426|NCT00498173|2425354|P2|STARTED|Phase 1-Blinded Randomization (8 Weeks)||31
999427|NCT00498173|2425355|P1|STARTED|Phase 1-Blinded Randomization (8 Weeks)||29
999428|NCT00498186|2425383|P1|NOT COMPLETED|Overall Study||173
999429|NCT00498186|2425383|P1|COMPLETED|Overall Study||122
999430|NCT00498186|2425383|P1|STARTED|Overall Study||295
999431|NCT00498355|2425388|P1|NOT COMPLETED|Overall Study||1
999432|NCT00498355|2425388|P1|COMPLETED|Overall Study||6
999433|NCT00498355|2425388|P1|STARTED|Overall Study||7
999434|NCT00498368|2425394|P2|NOT COMPLETED|Overall Study||2
999435|NCT00498368|2425395|P1|NOT COMPLETED|Overall Study||3
999436|NCT00498368|2425394|P2|COMPLETED|Overall Study||15
999437|NCT00498368|2425395|P1|COMPLETED|Overall Study||14
999438|NCT00498368|2425394|P2|STARTED|Overall Study||17
999439|NCT00498368|2425395|P1|STARTED|Overall Study||17
999440|NCT00498433|2425410|P3|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
999441|NCT00498433|2425411|P2|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
999442|NCT00498433|2425412|P1|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
999443|NCT00498433|2425410|P3|COMPLETED|Part 2: Double Blind (12 Weeks)||8
999444|NCT00498433|2425411|P2|COMPLETED|Part 2: Double Blind (12 Weeks)||8
999445|NCT00498433|2425412|P1|COMPLETED|Part 2: Double Blind (12 Weeks)||0
999446|NCT00498433|2425410|P3|STARTED|Part 2: Double Blind (12 Weeks)||8
999447|NCT00498433|2425411|P2|STARTED|Part 2: Double Blind (12 Weeks)||8
999448|NCT00498433|2425412|P1|STARTED|Part 2: Double Blind (12 Weeks)||0
999449|NCT00498433|2425410|P3|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
999450|NCT00498433|2425411|P2|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
999451|NCT00498433|2425412|P1|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||20
999452|NCT00498433|2425410|P3|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
999453|NCT00498433|2425411|P2|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
999454|NCT00498433|2425412|P1|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||16
999455|NCT00498433|2425410|P3|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
999456|NCT00498433|2425411|P2|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
999457|NCT00498433|2425412|P1|STARTED|Part 2: Placebo Run-in (2 Weeks)||36
999458|NCT00498433|2425410|P3|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
999459|NCT00498433|2425411|P2|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
999460|NCT00498433|2425412|P1|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
999461|NCT00498433|2425410|P3|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
999462|NCT00498433|2425411|P2|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
999463|NCT00498433|2425412|P1|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
999464|NCT00498433|2425410|P3|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
999465|NCT00498433|2425411|P2|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
999466|NCT00498433|2425412|P1|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
999467|NCT00498433|2425410|P3|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
999468|NCT00498433|2425411|P2|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
999469|NCT00498433|2425412|P1|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
999470|NCT00498433|2425410|P3|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
999471|NCT00498433|2425411|P2|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||10
999472|NCT00498433|2425412|P1|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
999473|NCT00498433|2425410|P3|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
999474|NCT00498433|2425411|P2|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||10
999475|NCT00498433|2425412|P1|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
999476|NCT00498433|2425410|P3|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
999477|NCT00498433|2425411|P2|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
999478|NCT00498433|2425412|P1|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
999479|NCT00498433|2425410|P3|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
999480|NCT00498433|2425411|P2|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
999481|NCT00498433|2425412|P1|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
999482|NCT00498433|2425410|P3|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
999483|NCT00498433|2425411|P2|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
999484|NCT00498433|2425412|P1|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
999485|NCT00498485|2425457|P2|NOT COMPLETED|Overall Study||5
999486|NCT00498485|2425458|P1|NOT COMPLETED|Overall Study||1
999487|NCT00498485|2425457|P2|COMPLETED|Overall Study||5
999488|NCT00498485|2425458|P1|COMPLETED|Overall Study||6
999489|NCT00498485|2425457|P2|STARTED|Overall Study||10
999490|NCT00498485|2425458|P1|STARTED|Overall Study||7
999491|NCT00485693|2425468|P2|NOT COMPLETED|Overall Study||0
999492|NCT00485693|2425469|P1|NOT COMPLETED|Overall Study||0
999493|NCT00485693|2425468|P2|COMPLETED|Overall Study||104
999494|NCT00485693|2425469|P1|COMPLETED|Overall Study||34
999495|NCT00485693|2425468|P2|STARTED|Overall Study||104
999496|NCT00485693|2425469|P1|STARTED|Overall Study||34
999497|NCT00485732|2425480|P2|NOT COMPLETED|Overall Study||9
999498|NCT00485732|2425481|P1|NOT COMPLETED|Overall Study||8
999499|NCT00485732|2425480|P2|COMPLETED|Overall Study||67
999500|NCT00485732|2425481|P1|COMPLETED|Overall Study||141
999501|NCT00485732|2425480|P2|STARTED|Overall Study||76
999502|NCT00485732|2425481|P1|STARTED|Overall Study||149
999503|NCT00485758|2425503|P2|NOT COMPLETED|Overall Study||65
999504|NCT00485758|2425504|P1|NOT COMPLETED|Overall Study||156
999505|NCT00485758|2425503|P2|COMPLETED|Overall Study||277
999506|NCT00485758|2425504|P1|COMPLETED|Overall Study||298
999507|NCT00485758|2425503|P2|STARTED|Overall Study||342
999508|NCT00485758|2425504|P1|STARTED|Overall Study||454
999509|NCT00485836|2425517|P3|NOT COMPLETED|Overall Study||11
999510|NCT00485836|2425518|P2|NOT COMPLETED|Overall Study||3
999511|NCT00485836|2425519|P1|NOT COMPLETED|Overall Study||15
999512|NCT00485836|2425517|P3|COMPLETED|Overall Study||119
999513|NCT00485836|2425518|P2|COMPLETED|Overall Study||129
999514|NCT00485836|2425519|P1|COMPLETED|Overall Study||115
999515|NCT00485836|2425517|P3|Received Study Drug (Safety Population)|Overall Study||129
999516|NCT00485836|2425518|P2|Received Study Drug (Safety Population)|Overall Study||132
999517|NCT00485836|2425519|P1|Received Study Drug (Safety Population)|Overall Study||129
999518|NCT00485836|2425517|P3|STARTED|Overall Study||130
999519|NCT00485836|2425518|P2|STARTED|Overall Study||132
999520|NCT00485836|2425519|P1|STARTED|Overall Study||130
999527|NCT00486018|2425557|P3|NOT COMPLETED|Overall Study||6
999528|NCT00486018|2425558|P2|NOT COMPLETED|Overall Study||6
999529|NCT00486018|2425559|P1|NOT COMPLETED|Overall Study||9
999530|NCT00486018|2425557|P3|COMPLETED|Overall Study||125
999531|NCT00486018|2425558|P2|COMPLETED|Overall Study||128
999532|NCT00486018|2425559|P1|COMPLETED|Overall Study||123
999533|NCT00486018|2425557|P3|Received Drug (Safety Population)|Overall Study||130
999534|NCT00486018|2425558|P2|Received Drug (Safety Population)|Overall Study||134
999535|NCT00486018|2425559|P1|Received Drug (Safety Population)|Overall Study||131
999536|NCT00486018|2425557|P3|STARTED|Overall Study||131
999537|NCT00486018|2425558|P2|STARTED|Overall Study||134
999538|NCT00486018|2425559|P1|STARTED|Overall Study||132
999539|NCT00486044|2425587|P2|NOT COMPLETED|Overall Study||3
999540|NCT00486044|2425588|P1|NOT COMPLETED|Overall Study||2
999541|NCT00486044|2425587|P2|COMPLETED|Overall Study|21 completed MRI sub-study|46
999542|NCT00486044|2425588|P1|COMPLETED|Overall Study|27 completed MRI sub-study|49
999543|NCT00486044|2425587|P2|STARTED|Overall Study|23 in MRI sub-study|49
999544|NCT00486044|2425588|P1|STARTED|Overall Study|50 received assigned intervention (1 withdrew during baseline) 27 in MRI sub-study|51
999545|NCT00486226|2425600|P1|NOT COMPLETED|Overall Study||13
999546|NCT00486226|2425600|P1|COMPLETED|Overall Study||92
999547|NCT00486226|2425600|P1|STARTED|Overall Study||105
999548|NCT00486252|2425608|P1|NOT COMPLETED|Overall Study||58
999549|NCT00486252|2425608|P1|COMPLETED|Overall Study||938
999550|NCT00486252|2425608|P1|STARTED|Overall Study||996
999551|NCT00486265|2425623|P1|NOT COMPLETED|Overall Study||9
999552|NCT00486265|2425623|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met|0
999553|NCT00486265|2425623|P1|STARTED|Overall Study|Partipants dosed on day 1.|9
999554|NCT00486278|2425627|P1|NOT COMPLETED|Overall Study||9
999555|NCT00486278|2425627|P1|COMPLETED|Overall Study||42
999556|NCT00486278|2425627|P1|STARTED|Overall Study|96 bleeds by 51 subjects, 77 were treated with vatreptacog alfa and 19 with rFVIIa|51
999557|NCT00486291|2425763|P2|NOT COMPLETED|Overall Study||29
999558|NCT00486291|2425764|P1|NOT COMPLETED|Overall Study||16
999559|NCT00486291|2425763|P2|COMPLETED|Overall Study||76
999560|NCT00486291|2425764|P1|COMPLETED|Overall Study||89
999561|NCT00486291|2425763|P2|STARTED|Overall Study|1 subject discontinued prior to first dose|105
999562|NCT00486291|2425764|P1|STARTED|Overall Study|3 subjects discontinued prior to first dose|105
999563|NCT00486330|2425772|P1|NOT COMPLETED|Overall Study||2
999564|NCT00486330|2425772|P1|COMPLETED|Overall Study|Of the 12 subjects treated, two developed adverse events leading to study drug discontinuation.|10
999565|NCT00486330|2425772|P1|STARTED|Overall Study|Twelve subjects met inclusion/exclusion criteria|12
999566|NCT00486434|2425778|P2|NOT COMPLETED|Overall Study||134
999567|NCT00486434|2425779|P1|NOT COMPLETED|Overall Study||194
999568|NCT00486434|2425778|P2|COMPLETED|Overall Study||454
999569|NCT00486434|2425779|P1|COMPLETED|Overall Study||394
999570|NCT00486434|2425778|P2|STARTED|Overall Study||588
999571|NCT00486434|2425779|P1|STARTED|Overall Study||588
999572|NCT00486447|2425789|P1|NOT COMPLETED|Overall Study||0
999573|NCT00486447|2425789|P1|COMPLETED|Overall Study||249
999574|NCT00486447|2425789|P1|STARTED|Overall Study||249
999575|NCT00486525|2425796|P2|NOT COMPLETED|Overall Study||13
999576|NCT00486525|2425797|P1|NOT COMPLETED|Overall Study||6
999577|NCT00486525|2425796|P2|COMPLETED|Overall Study||87
999578|NCT00486525|2425797|P1|COMPLETED|Overall Study||94
999579|NCT00486525|2425796|P2|STARTED|Overall Study||100
999580|NCT00486525|2425797|P1|STARTED|Overall Study||100
999581|NCT00486642|2425815|P2|NOT COMPLETED|Overall Study||0
999582|NCT00486642|2425816|P1|NOT COMPLETED|Overall Study||0
999583|NCT00486642|2425815|P2|COMPLETED|Overall Study||13
999584|NCT00486642|2425816|P1|COMPLETED|Overall Study||10
999585|NCT00486642|2425815|P2|STARTED|Overall Study||13
999586|NCT00486642|2425816|P1|STARTED|Overall Study||10
999587|NCT00486720|2425840|P2|NOT COMPLETED|Overall Study||12
999588|NCT00486720|2425841|P1|NOT COMPLETED|Overall Study||10
999589|NCT00486720|2425840|P2|COMPLETED|Overall Study||0
999590|NCT00486720|2425841|P1|COMPLETED|Overall Study||0
999591|NCT00486720|2425840|P2|STARTED|Overall Study||12
999592|NCT00486720|2425841|P1|STARTED|Overall Study|1 randomized patient was discontinued before receiving treatment due to a protocol violation|10
999593|NCT00486759|2425851|P2|NOT COMPLETED|Safety Follow-up||118
999594|NCT00486759|2425852|P1|NOT COMPLETED|Safety Follow-up||139
999595|NCT00486759|2425851|P2|COMPLETED|Safety Follow-up||142
999596|NCT00486759|2425852|P1|COMPLETED|Safety Follow-up||64
999597|NCT00486759|2425851|P2|STARTED|Safety Follow-up||260
999598|NCT00486759|2425852|P1|STARTED|Safety Follow-up||203
999599|NCT00486759|2425851|P2|NOT COMPLETED|Treatment||137
999600|NCT00486759|2425852|P1|NOT COMPLETED|Treatment||187
999601|NCT00486759|2425851|P2|COMPLETED|Treatment||260
999602|NCT00486759|2425852|P1|COMPLETED|Treatment||203
999603|NCT00486759|2425851|P2|STARTED|Treatment||397
999604|NCT00486759|2425852|P1|STARTED|Treatment||390
999605|NCT00486811|2425865|P3|NOT COMPLETED|Overall Study||214
999606|NCT00486811|2425866|P2|NOT COMPLETED|Overall Study||141
999607|NCT00486811|2425867|P1|NOT COMPLETED|Overall Study||122
999608|NCT00486811|2425865|P3|COMPLETED|Overall Study||119
999609|NCT00486811|2425866|P2|COMPLETED|Overall Study||179
999610|NCT00486811|2425867|P1|COMPLETED|Overall Study||215
999611|NCT00486811|2425865|P3|STARTED|Overall Study|Two participants were not eligible to be dosed.|333
999612|NCT00486811|2425866|P2|STARTED|Overall Study|One participant was not eligible to be dosed.|320
999613|NCT00486811|2425867|P1|STARTED|Overall Study||337
999614|NCT00486837|2425910|P2|NOT COMPLETED|Overall Study||7
999615|NCT00486837|2425911|P1|NOT COMPLETED|Overall Study||9
999616|NCT00486837|2425910|P2|COMPLETED|Overall Study||28
999617|NCT00486837|2425911|P1|COMPLETED|Overall Study||28
999618|NCT00486837|2425910|P2|STARTED|Overall Study||35
999619|NCT00486837|2425911|P1|STARTED|Overall Study||37
999620|NCT00486863|2425929|P2|NOT COMPLETED|Overall Study||3
999621|NCT00486863|2425930|P1|NOT COMPLETED|Overall Study||1
999622|NCT00486863|2425929|P2|COMPLETED|Overall Study||183
999623|NCT00486863|2425930|P1|COMPLETED|Overall Study||183
999624|NCT00486863|2425929|P2|STARTED|Overall Study||186
999625|NCT00486863|2425930|P1|STARTED|Overall Study||184
999626|NCT00486902|2425974|P2|NOT COMPLETED|Overall Study||5
999627|NCT00486902|2425975|P1|NOT COMPLETED|Overall Study||9
999628|NCT00486902|2425974|P2|COMPLETED|Overall Study||89
999629|NCT00486902|2425975|P1|COMPLETED|Overall Study||85
999630|NCT00486902|2425974|P2|STARTED|Overall Study||94
999631|NCT00486902|2425975|P1|STARTED|Overall Study||94
999632|NCT00492284|2425999|P4|NOT COMPLETED|Overall Study||10
999633|NCT00492284|2426000|P3|NOT COMPLETED|Overall Study||6
999634|NCT00492284|2426001|P2|NOT COMPLETED|Overall Study||4
999635|NCT00492284|2426002|P1|NOT COMPLETED|Overall Study||1
999636|NCT00492284|2425999|P4|COMPLETED|Overall Study||31
999637|NCT00492284|2426000|P3|COMPLETED|Overall Study||37
999638|NCT00492284|2426001|P2|COMPLETED|Overall Study||35
999639|NCT00492284|2426002|P1|COMPLETED|Overall Study||38
999640|NCT00492284|2425999|P4|STARTED|Overall Study||41
999641|NCT00492284|2426000|P3|STARTED|Overall Study||43
999642|NCT00492284|2426001|P2|STARTED|Overall Study||39
999643|NCT00492284|2426002|P1|STARTED|Overall Study||39
999644|NCT00492297|2426044|P1|NOT COMPLETED|Survival Only Follow-up||59
999645|NCT00492297|2426044|P1|COMPLETED|Survival Only Follow-up||0
999646|NCT00492297|2426044|P1|STARTED|Survival Only Follow-up||59
999647|NCT00492297|2426044|P1|NOT COMPLETED|Active Follow-up 30(+4) Days Duration||19
999648|NCT00492297|2426044|P1|COMPLETED|Active Follow-up 30(+4) Days Duration||59
999649|NCT00492297|2426044|P1|STARTED|Active Follow-up 30(+4) Days Duration|AFU is 30(+4) days duration for subjects withdrawn from sorafenib due to PD.|78
999650|NCT00492297|2426044|P1|NOT COMPLETED|Treatment||5
999651|NCT00492297|2426044|P1|COMPLETED|Treatment||78
999652|NCT00492297|2426044|P1|Second Stage of Simon Optimal Design|Treatment|Recruitment continued into the second stage. 51 of 83 subjects were treated in the second stage.|51
999653|NCT00492297|2426044|P1|First Stage of Simon Optimal Design|Treatment|32 subjects of 83 subjects enrolled were treated in first stage.|32
999654|NCT00492297|2426044|P1|STARTED|Treatment||83
999655|NCT00492336|2426060|P2|NOT COMPLETED|Overall Study||6
999656|NCT00492336|2426061|P1|NOT COMPLETED|Overall Study||2
999657|NCT00492336|2426060|P2|COMPLETED|Overall Study||23
999658|NCT00492336|2426061|P1|COMPLETED|Overall Study||26
999659|NCT00492336|2426060|P2|STARTED|Overall Study||29
999660|NCT00492336|2426061|P1|STARTED|Overall Study||28
999661|NCT00492401|2426067|P1|NOT COMPLETED|Overall Study||0
999662|NCT00492401|2426067|P1|COMPLETED|Overall Study||55
999663|NCT00492401|2426067|P1|STARTED|Overall Study||55
999664|NCT00492531|2426078|P2|NOT COMPLETED|Overall Study||23
999665|NCT00492531|2426079|P1|NOT COMPLETED|Overall Study||22
999666|NCT00492531|2426078|P2|COMPLETED|Overall Study|Of 14 subjects who completed study, 13 were enrolled in Open label.|14
999667|NCT00492531|2426079|P1|COMPLETED|Overall Study|Of 15 subjects who completed study, 13 were enrolled in Open label.|15
999668|NCT00492531|2426078|P2|STARTED|Overall Study||37
999669|NCT00492531|2426079|P1|STARTED|Overall Study||37
999670|NCT00492544|2426091|P1|NOT COMPLETED|Overall Study||0
999671|NCT00492544|2426091|P1|COMPLETED|Overall Study||100
999672|NCT00492544|2426091|P1|STARTED|Overall Study||100
999673|NCT00492557|2426105|P2|NOT COMPLETED|Overall Study||23
999674|NCT00492557|2426106|P1|NOT COMPLETED|Overall Study||24
999675|NCT00492557|2426105|P2|COMPLETED|Overall Study||557
999676|NCT00492557|2426106|P1|COMPLETED|Overall Study||556
999677|NCT00492557|2426105|P2|Vaccinated Dose 2|Overall Study||558
999678|NCT00492557|2426106|P1|Vaccinated Dose 2|Overall Study||560
999679|NCT00492557|2426105|P2|Vaccinated Dose 1|Overall Study||575
999680|NCT00492557|2426106|P1|Vaccinated Dose 1|Overall Study||577
999681|NCT00492557|2426105|P2|STARTED|Overall Study||580
999682|NCT00492557|2426106|P1|STARTED|Overall Study||580
999683|NCT00492583|2426124|P2|NOT COMPLETED|Overall Study||0
999684|NCT00492583|2426125|P1|NOT COMPLETED|Overall Study||0
999685|NCT00492583|2426124|P2|COMPLETED|Overall Study||87
999686|NCT00492583|2426125|P1|COMPLETED|Overall Study||95
999687|NCT00492583|2426124|P2|STARTED|Overall Study||87
999688|NCT00492583|2426125|P1|STARTED|Overall Study||95
999689|NCT00492622|2426131|P1|NOT COMPLETED|Overall Study||0
999690|NCT00492622|2426131|P1|COMPLETED|Overall Study||12
999691|NCT00492622|2426131|P1|STARTED|Overall Study|all subjects received the immediate release formulation|12
999692|NCT00492726|2426143|P2|NOT COMPLETED|Overall Study||36
999693|NCT00492726|2426144|P1|NOT COMPLETED|Overall Study||50
999694|NCT00492726|2426143|P2|COMPLETED|Overall Study||358
999695|NCT00492726|2426144|P1|COMPLETED|Overall Study||360
999696|NCT00492726|2426143|P2|End of Study|Overall Study||358
999697|NCT00492726|2426144|P1|End of Study|Overall Study||360
999698|NCT00492726|2426143|P2|End of Treatment (EOT, Day 5 to 14)|Overall Study||377
999699|NCT00492726|2426144|P1|End of Treatment (EOT, Day 5 to 14)|Overall Study||387
999700|NCT00492726|2426143|P2|STARTED|Overall Study||394
999701|NCT00492726|2426144|P1|STARTED|Overall Study||410
999702|NCT00492752|2426170|P4|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||6
999703|NCT00492752|2426171|P3|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||47
999704|NCT00492752|2426172|P2|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||16
999705|NCT00492752|2426173|P1|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||86
999706|NCT00492752|2426170|P4|COMPLETED|Follow-up and/or Open Label Sorafenib||0
999707|NCT00492752|2426171|P3|COMPLETED|Follow-up and/or Open Label Sorafenib|20 participants were followed up until the end of this trial|20
999708|NCT00492752|2426172|P2|COMPLETED|Follow-up and/or Open Label Sorafenib||0
999709|NCT00492752|2426173|P1|COMPLETED|Follow-up and/or Open Label Sorafenib|1 participant completed all assessments, 33 were followed up until the end of this trial|34
999710|NCT00492752|2426170|P4|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||6
999711|NCT00492752|2426171|P3|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
999712|NCT00492752|2426172|P2|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||16
999713|NCT00492752|2426173|P1|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
999714|NCT00492752|2426170|P4|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
999715|NCT00492752|2426171|P3|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||67
999716|NCT00492752|2426172|P2|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
999717|NCT00492752|2426173|P1|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||120
999718|NCT00492752|2426170|P4|STARTED|Follow-up and/or Open Label Sorafenib||6
999719|NCT00492752|2426171|P3|STARTED|Follow-up and/or Open Label Sorafenib||67
999720|NCT00492752|2426172|P2|STARTED|Follow-up and/or Open Label Sorafenib||16
999721|NCT00492752|2426173|P1|STARTED|Follow-up and/or Open Label Sorafenib||120
999722|NCT00492752|2426170|P4|NOT COMPLETED|Double Blind Treatment||0
999723|NCT00492752|2426171|P3|NOT COMPLETED|Double Blind Treatment||3
999724|NCT00492752|2426172|P2|NOT COMPLETED|Double Blind Treatment||0
999725|NCT00492752|2426173|P1|NOT COMPLETED|Double Blind Treatment||14
999726|NCT00492752|2426170|P4|COMPLETED|Double Blind Treatment||6
999727|NCT00492752|2426171|P3|COMPLETED|Double Blind Treatment||67
999728|NCT00492752|2426172|P2|COMPLETED|Double Blind Treatment||16
999729|NCT00492752|2426173|P1|COMPLETED|Double Blind Treatment||120
999730|NCT00492752|2426170|P4|Received Treatment|Double Blind Treatment|Safety Population|6
999731|NCT00492752|2426171|P3|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to protocol violation.|69
999732|NCT00492752|2426172|P2|Received Treatment|Double Blind Treatment|Safety Population|16
999733|NCT00492752|2426173|P1|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to an Adverse Event.|133
999734|NCT00492752|2426170|P4|STARTED|Double Blind Treatment||6
999735|NCT00492752|2426171|P3|STARTED|Double Blind Treatment||70
999736|NCT00492752|2426172|P2|STARTED|Double Blind Treatment||16
999737|NCT00492752|2426173|P1|STARTED|Double Blind Treatment||134
999738|NCT00492856|2426206|P4|NOT COMPLETED|Post-consolidation||1
999739|NCT00492856|2426207|P3|NOT COMPLETED|Post-consolidation||27
999740|NCT00492856|2426208|P2|NOT COMPLETED|Post-consolidation||12
999741|NCT00492856|2426209|P1|NOT COMPLETED|Post-consolidation||0
999742|NCT00492856|2426206|P4|COMPLETED|Post-consolidation||0
999743|NCT00492856|2426207|P3|COMPLETED|Post-consolidation||0
999744|NCT00492856|2426208|P2|COMPLETED|Post-consolidation||29
999745|NCT00492856|2426209|P1|COMPLETED|Post-consolidation||0
999746|NCT00492856|2426206|P4|STARTED|Post-consolidation||1
999747|NCT00492856|2426207|P3|STARTED|Post-consolidation||27
999748|NCT00492856|2426208|P2|STARTED|Post-consolidation||41
999749|NCT00492856|2426209|P1|STARTED|Post-consolidation|Patients who achieve CRm, are randomized to the treatment arm, and are eligible.|0
999750|NCT00492856|2426206|P4|NOT COMPLETED|Consolidation||0
999751|NCT00492856|2426207|P3|NOT COMPLETED|Consolidation||0
999752|NCT00492856|2426208|P2|NOT COMPLETED|Consolidation||0
999753|NCT00492856|2426209|P1|NOT COMPLETED|Consolidation||9
999754|NCT00492856|2426206|P4|COMPLETED|Consolidation||0
999755|NCT00492856|2426207|P3|COMPLETED|Consolidation||0
999756|NCT00492856|2426208|P2|COMPLETED|Consolidation||0
999757|NCT00492856|2426209|P1|COMPLETED|Consolidation||83
999758|NCT00492856|2426206|P4|STARTED|Consolidation||0
999759|NCT00492856|2426207|P3|STARTED|Consolidation||0
999760|NCT00492856|2426208|P2|STARTED|Consolidation||0
999761|NCT00492856|2426209|P1|STARTED|Consolidation|Patients in CR (CRm), CRi, or PR after induction, register for consolidation and are eligible.|92
999762|NCT00492856|2426206|P4|NOT COMPLETED|Induction||0
999763|NCT00492856|2426207|P3|NOT COMPLETED|Induction||0
999764|NCT00492856|2426208|P2|NOT COMPLETED|Induction||0
999765|NCT00492856|2426209|P1|NOT COMPLETED|Induction||6
999766|NCT00492856|2426206|P4|COMPLETED|Induction||0
999767|NCT00492856|2426207|P3|COMPLETED|Induction||0
999768|NCT00492856|2426208|P2|COMPLETED|Induction||0
999769|NCT00492856|2426209|P1|COMPLETED|Induction||99
999770|NCT00492856|2426206|P4|STARTED|Induction||0
999771|NCT00492856|2426207|P3|STARTED|Induction||0
999772|NCT00492856|2426208|P2|STARTED|Induction||0
999773|NCT00492856|2426209|P1|STARTED|Induction||105
999774|NCT00498550|2426223|P2|NOT COMPLETED|Overall Study||1
999775|NCT00498550|2426224|P1|NOT COMPLETED|Overall Study||0
999776|NCT00498550|2426223|P2|COMPLETED|Overall Study||15
999777|NCT00498550|2426224|P1|COMPLETED|Overall Study|13 of 15 received clozapine all 12 visits, two discontinued clozapine early but remained in study.|15
999778|NCT00498550|2426223|P2|STARTED|Overall Study||16
999779|NCT00498550|2426224|P1|STARTED|Overall Study||15
999780|NCT00498602|2426237|P7|NOT COMPLETED|Overall Study||2
999781|NCT00498602|2426238|P6|NOT COMPLETED|Overall Study||13
999782|NCT00498602|2426239|P5|NOT COMPLETED|Overall Study||4
999783|NCT00498602|2426240|P4|NOT COMPLETED|Overall Study||5
999784|NCT00498602|2426241|P3|NOT COMPLETED|Overall Study||8
999785|NCT00498602|2426242|P2|NOT COMPLETED|Overall Study||10
999786|NCT00498602|2426243|P1|NOT COMPLETED|Overall Study||10
999787|NCT00498602|2426237|P7|COMPLETED|Overall Study||15
999788|NCT00498602|2426238|P6|COMPLETED|Overall Study||31
999789|NCT00498602|2426239|P5|COMPLETED|Overall Study||8
999790|NCT00498602|2426240|P4|COMPLETED|Overall Study||30
999791|NCT00498602|2426241|P3|COMPLETED|Overall Study||32
999792|NCT00498602|2426242|P2|COMPLETED|Overall Study||51
999793|NCT00498602|2426243|P1|COMPLETED|Overall Study||26
999794|NCT00498602|2426237|P7|Treated|Overall Study||17
999795|NCT00498602|2426238|P6|Treated|Overall Study||44
999796|NCT00498602|2426239|P5|Treated|Overall Study||12
999797|NCT00498602|2426240|P4|Treated|Overall Study||35
999798|NCT00498602|2426241|P3|Treated|Overall Study||40
999799|NCT00498602|2426242|P2|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
999800|NCT00498602|2426243|P1|Treated|Overall Study||36
999801|NCT00498602|2426237|P7|STARTED|Overall Study||17
999802|NCT00498602|2426238|P6|STARTED|Overall Study||44
999803|NCT00498602|2426239|P5|STARTED|Overall Study||12
999804|NCT00498602|2426240|P4|STARTED|Overall Study||35
999805|NCT00498602|2426241|P3|STARTED|Overall Study||40
999806|NCT00498602|2426242|P2|STARTED|Overall Study||61
999807|NCT00498602|2426243|P1|STARTED|Overall Study||36
999808|NCT00498615|2426280|P6|NOT COMPLETED|Placebo||0
999809|NCT00498615|2426281|P5|NOT COMPLETED|Placebo||0
999810|NCT00498615|2426282|P4|NOT COMPLETED|Placebo||0
999811|NCT00498615|2426283|P3|NOT COMPLETED|Placebo||0
999812|NCT00498615|2426284|P2|NOT COMPLETED|Placebo||0
999813|NCT00498615|2426285|P1|NOT COMPLETED|Placebo||0
999814|NCT00498615|2426280|P6|COMPLETED|Placebo||3
999815|NCT00498615|2426281|P5|COMPLETED|Placebo||3
999816|NCT00498615|2426282|P4|COMPLETED|Placebo||2
999817|NCT00498615|2426283|P3|COMPLETED|Placebo||3
999818|NCT00498615|2426284|P2|COMPLETED|Placebo||4
999819|NCT00498615|2426285|P1|COMPLETED|Placebo||2
999820|NCT00498615|2426280|P6|STARTED|Placebo||3
999821|NCT00498615|2426281|P5|STARTED|Placebo||3
999822|NCT00498615|2426282|P4|STARTED|Placebo||2
999823|NCT00498615|2426283|P3|STARTED|Placebo||3
999824|NCT00498615|2426284|P2|STARTED|Placebo||4
999825|NCT00498615|2426285|P1|STARTED|Placebo||2
999826|NCT00498615|2426280|P6|NOT COMPLETED|Fasudil 40mg||0
999827|NCT00498615|2426281|P5|NOT COMPLETED|Fasudil 40mg||0
999828|NCT00498615|2426282|P4|NOT COMPLETED|Fasudil 40mg||0
999829|NCT00498615|2426283|P3|NOT COMPLETED|Fasudil 40mg||0
999830|NCT00498615|2426284|P2|NOT COMPLETED|Fasudil 40mg||0
999831|NCT00498615|2426285|P1|NOT COMPLETED|Fasudil 40mg||0
999832|NCT00498615|2426280|P6|COMPLETED|Fasudil 40mg||3
999833|NCT00498615|2426281|P5|COMPLETED|Fasudil 40mg||3
999834|NCT00498615|2426282|P4|COMPLETED|Fasudil 40mg||2
999835|NCT00498615|2426283|P3|COMPLETED|Fasudil 40mg||3
999836|NCT00498615|2426284|P2|COMPLETED|Fasudil 40mg||4
999837|NCT00498615|2426285|P1|COMPLETED|Fasudil 40mg||2
999838|NCT00498615|2426280|P6|STARTED|Fasudil 40mg||3
999839|NCT00498615|2426281|P5|STARTED|Fasudil 40mg||3
999840|NCT00498615|2426282|P4|STARTED|Fasudil 40mg||2
999841|NCT00498615|2426283|P3|STARTED|Fasudil 40mg||3
999842|NCT00498615|2426284|P2|STARTED|Fasudil 40mg||4
999843|NCT00498615|2426285|P1|STARTED|Fasudil 40mg||2
999844|NCT00498615|2426280|P6|NOT COMPLETED|Fasudil 80mg||0
999845|NCT00498615|2426281|P5|NOT COMPLETED|Fasudil 80mg||0
999846|NCT00498615|2426282|P4|NOT COMPLETED|Fasudil 80mg||0
999847|NCT00498615|2426283|P3|NOT COMPLETED|Fasudil 80mg||0
999848|NCT00498615|2426284|P2|NOT COMPLETED|Fasudil 80mg||0
999849|NCT00498615|2426285|P1|NOT COMPLETED|Fasudil 80mg||0
999850|NCT00498615|2426280|P6|COMPLETED|Fasudil 80mg||3
999851|NCT00498615|2426281|P5|COMPLETED|Fasudil 80mg||3
999852|NCT00498615|2426282|P4|COMPLETED|Fasudil 80mg||2
999853|NCT00498615|2426283|P3|COMPLETED|Fasudil 80mg||3
999854|NCT00498615|2426284|P2|COMPLETED|Fasudil 80mg||4
999855|NCT00498615|2426285|P1|COMPLETED|Fasudil 80mg||2
999856|NCT00498615|2426280|P6|STARTED|Fasudil 80mg||3
999857|NCT00498615|2426281|P5|STARTED|Fasudil 80mg||3
999858|NCT00498615|2426282|P4|STARTED|Fasudil 80mg||2
999859|NCT00498615|2426283|P3|STARTED|Fasudil 80mg||3
999860|NCT00498615|2426284|P2|STARTED|Fasudil 80mg||4
999861|NCT00498615|2426285|P1|STARTED|Fasudil 80mg||2
999868|NCT00498706|2426310|P2|NOT COMPLETED|Overall Study||0
999869|NCT00498706|2426311|P1|NOT COMPLETED|Overall Study||0
999870|NCT00498706|2426310|P2|COMPLETED|Overall Study||162
999871|NCT00498706|2426311|P1|COMPLETED|Overall Study||163
999872|NCT00498706|2426310|P2|Post Treatment Week 18|Overall Study||162
999873|NCT00498706|2426311|P1|Post Treatment Week 18|Overall Study||163
999874|NCT00498706|2426310|P2|STARTED|Overall Study||162
999875|NCT00498706|2426311|P1|STARTED|Overall Study||163
999876|NCT00498797|2426325|P2|NOT COMPLETED|Overall Study||29
999877|NCT00498797|2426326|P1|NOT COMPLETED|Overall Study||38
999878|NCT00498797|2426325|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
999879|NCT00498797|2426326|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
999880|NCT00498797|2426325|P2|STARTED|Overall Study|randomised patients|43
999881|NCT00498797|2426326|P1|STARTED|Overall Study|randomised patients|43
999882|NCT00499252|2426334|P1|NOT COMPLETED|Overall Study||12
999883|NCT00499252|2426334|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|39
999884|NCT00499252|2426334|P1|STARTED|Overall Study||51
999885|NCT00499343|2426342|P2|NOT COMPLETED|Overall Study||0
999886|NCT00499343|2426343|P1|NOT COMPLETED|Overall Study||0
999887|NCT00499343|2426342|P2|COMPLETED|Overall Study||43
999888|NCT00499343|2426343|P1|COMPLETED|Overall Study||41
999889|NCT00499343|2426342|P2|STARTED|Overall Study||43
999890|NCT00499343|2426343|P1|STARTED|Overall Study||41
999891|NCT00499369|2426354|P5|NOT COMPLETED|Overall Study||12
999892|NCT00499369|2426355|P4|NOT COMPLETED|Overall Study||9
999893|NCT00499369|2426356|P3|NOT COMPLETED|Overall Study||17
999894|NCT00499369|2426357|P2|NOT COMPLETED|Overall Study||18
999895|NCT00499369|2426358|P1|NOT COMPLETED|Overall Study||16
999896|NCT00499369|2426354|P5|COMPLETED|Overall Study||0
999897|NCT00499369|2426355|P4|COMPLETED|Overall Study||0
999898|NCT00499369|2426356|P3|COMPLETED|Overall Study||0
999899|NCT00499369|2426357|P2|COMPLETED|Overall Study||0
999900|NCT00499369|2426358|P1|COMPLETED|Overall Study||0
999901|NCT00499369|2426354|P5|Eligible|Overall Study||12
999902|NCT00499369|2426355|P4|Eligible|Overall Study||8
999903|NCT00499369|2426356|P3|Eligible|Overall Study||16
999904|NCT00499369|2426357|P2|Eligible|Overall Study||16
999905|NCT00499369|2426358|P1|Eligible|Overall Study||14
999906|NCT00499369|2426354|P5|STARTED|Overall Study||12
999907|NCT00499369|2426355|P4|STARTED|Overall Study||9
999908|NCT00499369|2426356|P3|STARTED|Overall Study||17
999909|NCT00499369|2426357|P2|STARTED|Overall Study||18
999910|NCT00499369|2426358|P1|STARTED|Overall Study||16
999911|NCT00499408|2426385|P1|NOT COMPLETED|Overall Study||0
999912|NCT00499408|2426385|P1|COMPLETED|Overall Study|Three patients did not have adequate testing to be evaluable for a response.|26
999913|NCT00499408|2426385|P1|STARTED|Overall Study||26
999914|NCT00499447|2426389|P1|NOT COMPLETED|Overall Study||0
999915|NCT00499447|2426389|P1|COMPLETED|Overall Study||13
999916|NCT00499447|2426389|P1|STARTED|Overall Study||13
999917|NCT00499460|2426395|P2|NOT COMPLETED|Intervention 2 (30 Days)||1
999918|NCT00499460|2426396|P1|NOT COMPLETED|Intervention 2 (30 Days)||0
999919|NCT00499460|2426395|P2|COMPLETED|Intervention 2 (30 Days)||6
999920|NCT00499460|2426396|P1|COMPLETED|Intervention 2 (30 Days)||6
999921|NCT00499460|2426395|P2|STARTED|Intervention 2 (30 Days)||7
999922|NCT00499460|2426396|P1|STARTED|Intervention 2 (30 Days)||6
999923|NCT00499460|2426395|P2|NOT COMPLETED|Intervention 1 (30 Days)||0
999924|NCT00499460|2426396|P1|NOT COMPLETED|Intervention 1 (30 Days)||2
999925|NCT00499460|2426395|P2|COMPLETED|Intervention 1 (30 Days)||7
999926|NCT00499460|2426396|P1|COMPLETED|Intervention 1 (30 Days)||6
999927|NCT00499460|2426395|P2|STARTED|Intervention 1 (30 Days)||7
999928|NCT00499460|2426396|P1|STARTED|Intervention 1 (30 Days)||8
999929|NCT00499473|2426414|P2|NOT COMPLETED|Overall Study||0
999930|NCT00499473|2426415|P1|NOT COMPLETED|Overall Study||6
999931|NCT00499473|2426414|P2|COMPLETED|Overall Study||4
999932|NCT00499473|2426415|P1|COMPLETED|Overall Study|Patients evaluable|21
999933|NCT00499473|2426414|P2|STARTED|Overall Study||4
999934|NCT00499473|2426415|P1|STARTED|Overall Study||27
999935|NCT00499486|2426431|P1|NOT COMPLETED|Overall Study||16
999936|NCT00499486|2426431|P1|COMPLETED|Overall Study||31
999937|NCT00499486|2426431|P1|STARTED|Overall Study||47
999938|NCT00499590|2426440|P3|NOT COMPLETED|Overall Study||113
999939|NCT00499590|2426441|P2|NOT COMPLETED|Overall Study||112
999940|NCT00499590|2426442|P1|NOT COMPLETED|Overall Study||113
999941|NCT00499590|2426440|P3|COMPLETED|Overall Study||0
999942|NCT00499590|2426441|P2|COMPLETED|Overall Study||0
999943|NCT00499590|2426442|P1|COMPLETED|Overall Study||0
999944|NCT00499590|2426440|P3|STARTED|Overall Study||113
999945|NCT00499590|2426441|P2|STARTED|Overall Study||112
999946|NCT00499590|2426442|P1|STARTED|Overall Study||113
999947|NCT00499603|2426455|P2|NOT COMPLETED|Overall Study||1
999948|NCT00499603|2426456|P1|NOT COMPLETED|Overall Study||0
999949|NCT00499603|2426455|P2|COMPLETED|Overall Study||22
999950|NCT00499603|2426456|P1|COMPLETED|Overall Study||27
999951|NCT00499603|2426455|P2|STARTED|Overall Study||23
999952|NCT00499603|2426456|P1|STARTED|Overall Study||27
999953|NCT00499616|2426470|P4|NOT COMPLETED|Overall Study||57
999954|NCT00499616|2426471|P3|NOT COMPLETED|Overall Study||36
999955|NCT00499616|2426472|P2|NOT COMPLETED|Overall Study||28
999956|NCT00499616|2426473|P1|NOT COMPLETED|Overall Study||15
999957|NCT00499616|2426470|P4|COMPLETED|Overall Study||0
999958|NCT00499616|2426471|P3|COMPLETED|Overall Study||53
999959|NCT00499616|2426472|P2|COMPLETED|Overall Study||114
999960|NCT00499616|2426473|P1|COMPLETED|Overall Study||161
999961|NCT00499616|2426470|P4|STARTED|Overall Study||57
999962|NCT00499616|2426471|P3|STARTED|Overall Study||89
999963|NCT00499616|2426472|P2|STARTED|Overall Study||142
999964|NCT00499616|2426473|P1|STARTED|Overall Study||176
999965|NCT00499655|2426510|P2|NOT COMPLETED|Overall Study||0
999966|NCT00499655|2426511|P1|NOT COMPLETED|Overall Study||0
999967|NCT00499655|2426510|P2|COMPLETED|Overall Study||54
999968|NCT00499655|2426511|P1|COMPLETED|Overall Study||53
999969|NCT00499655|2426510|P2|STARTED|Overall Study||54
999970|NCT00499655|2426511|P1|STARTED|Overall Study||53
999971|NCT00499681|2426527|P2|NOT COMPLETED|Overall Study||2
999972|NCT00499681|2426528|P1|NOT COMPLETED|Overall Study||0
999973|NCT00499681|2426527|P2|COMPLETED|Overall Study||0
999974|NCT00499681|2426528|P1|COMPLETED|Overall Study||4
999975|NCT00499681|2426527|P2|STARTED|Overall Study||2
999976|NCT00499681|2426528|P1|STARTED|Overall Study||4
999977|NCT00499694|2426534|P1|NOT COMPLETED|Overall Study||1
999978|NCT00499694|2426534|P1|COMPLETED|Overall Study||30
999979|NCT00499694|2426534|P1|STARTED|Overall Study||31
999980|NCT00499863|2426540|P2|NOT COMPLETED|Overall Study||43
999981|NCT00499863|2426541|P1|NOT COMPLETED|Overall Study||50
999982|NCT00499863|2426540|P2|COMPLETED|Overall Study||29
999983|NCT00499863|2426541|P1|COMPLETED|Overall Study||95
999984|NCT00499863|2426540|P2|STARTED|Overall Study||72
999985|NCT00499863|2426541|P1|STARTED|Overall Study||145
999986|NCT00499889|2426569|P1|NOT COMPLETED|Overall Study||1
999987|NCT00499889|2426569|P1|COMPLETED|Overall Study||41
999988|NCT00499889|2426569|P1|STARTED|Overall Study||42
999989|NCT00499915|2426577|P2|NOT COMPLETED|Overall Study||6
999990|NCT00499915|2426578|P1|NOT COMPLETED|Overall Study||15
999991|NCT00499915|2426577|P2|COMPLETED|Overall Study||76
999992|NCT00499915|2426578|P1|COMPLETED|Overall Study||68
999993|NCT00499915|2426577|P2|STARTED|Overall Study||82
999994|NCT00499915|2426578|P1|STARTED|Overall Study||83
999995|NCT00500071|2426584|P1|NOT COMPLETED|30-day Safety Follow-up||17
999996|NCT00500071|2426584|P1|COMPLETED|30-day Safety Follow-up||278
999997|NCT00500071|2426584|P1|STARTED|30-day Safety Follow-up||295
999998|NCT00500071|2426584|P1|NOT COMPLETED|Dose-optimization and Maintenance Phase||22
999999|NCT00500071|2426584|P1|COMPLETED|Dose-optimization and Maintenance Phase||295
1000000|NCT00500071|2426584|P1|STARTED|Dose-optimization and Maintenance Phase|Safety population (i.e., received at least one dose of study medication)|317
1000001|NCT00500071|2426584|P1|NOT COMPLETED|Screening and Washout Phase||1
1000002|NCT00500071|2426584|P1|COMPLETED|Screening and Washout Phase||317
1000003|NCT00500071|2426584|P1|STARTED|Screening and Washout Phase||318
1000004|NCT00500110|2426593|P1|NOT COMPLETED|Overall Study||3
1000005|NCT00500110|2426593|P1|COMPLETED|Overall Study||36
1000006|NCT00500110|2426593|P1|STARTED|Overall Study||39
1000007|NCT00500149|2426597|P2|NOT COMPLETED|Second Intervention (Cross-over Phase)||0
1000008|NCT00500149|2426598|P1|NOT COMPLETED|Second Intervention (Cross-over Phase)||2
1000009|NCT00500149|2426597|P2|COMPLETED|Second Intervention (Cross-over Phase)||57
1000010|NCT00500149|2426598|P1|COMPLETED|Second Intervention (Cross-over Phase)||54
1000011|NCT00500149|2426597|P2|STARTED|Second Intervention (Cross-over Phase)||57
1000012|NCT00500149|2426598|P1|STARTED|Second Intervention (Cross-over Phase)||56
1000013|NCT00500149|2426597|P2|NOT COMPLETED|First Intervention (Cross-over Phase)||2
1000014|NCT00500149|2426598|P1|NOT COMPLETED|First Intervention (Cross-over Phase)||2
1000015|NCT00500149|2426597|P2|COMPLETED|First Intervention (Cross-over Phase)||57
1000016|NCT00500149|2426598|P1|COMPLETED|First Intervention (Cross-over Phase)||56
1000017|NCT00500149|2426597|P2|STARTED|First Intervention (Cross-over Phase)||59
1000018|NCT00500149|2426598|P1|STARTED|First Intervention (Cross-over Phase)||58
1000019|NCT00500149|2426597|P2|NOT COMPLETED|Enrolled (Dose-optimization Phase)||0
1000020|NCT00500149|2426598|P1|NOT COMPLETED|Enrolled (Dose-optimization Phase)||12
1000021|NCT00500149|2426597|P2|COMPLETED|Enrolled (Dose-optimization Phase)||0
1000022|NCT00500149|2426598|P1|COMPLETED|Enrolled (Dose-optimization Phase)||117
1000023|NCT00500149|2426597|P2|STARTED|Enrolled (Dose-optimization Phase)||0
1000024|NCT00500149|2426598|P1|STARTED|Enrolled (Dose-optimization Phase)||129
1000025|NCT00500240|2426608|P2|NOT COMPLETED|Overall Study||0
1000026|NCT00500240|2426609|P1|NOT COMPLETED|Overall Study||0
1000027|NCT00500240|2426608|P2|COMPLETED|Overall Study||26
1000028|NCT00500240|2426609|P1|COMPLETED|Overall Study||25
1000029|NCT00500240|2426608|P2|STARTED|Overall Study||26
1000030|NCT00500240|2426609|P1|STARTED|Overall Study||25
1000031|NCT00500266|2426619|P1|NOT COMPLETED|Overall Study||13
1000032|NCT00500266|2426619|P1|COMPLETED|Overall Study||1040
1000033|NCT00500266|2426619|P1|Treated|Overall Study||1049
1000034|NCT00500266|2426619|P1|STARTED|Overall Study||1053
1000035|NCT00500292|2426629|P3|NOT COMPLETED|Overall Study||27
1000036|NCT00500292|2426630|P2|NOT COMPLETED|Overall Study||31
1000037|NCT00500292|2426631|P1|NOT COMPLETED|Overall Study||25
1000038|NCT00500292|2426629|P3|COMPLETED|Overall Study|ongoing study treatment at data cut-off|10
1000039|NCT00500292|2426630|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|4
1000040|NCT00500292|2426631|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
1000041|NCT00500292|2426629|P3|STARTED|Overall Study|randomised patients|37
1000042|NCT00500292|2426630|P2|STARTED|Overall Study|randomised patients|35
1000043|NCT00500292|2426631|P1|STARTED|Overall Study|randomised patients|32
1000044|NCT00500318|2426641|P2|NOT COMPLETED|Overall Study||17
1000045|NCT00500318|2426642|P1|NOT COMPLETED|Overall Study||5
1000046|NCT00500318|2426641|P2|COMPLETED|Overall Study||78
1000047|NCT00500318|2426642|P1|COMPLETED|Overall Study||81
1000048|NCT00500318|2426641|P2|STARTED|Overall Study||95
1000049|NCT00500318|2426642|P1|STARTED|Overall Study||86
1000050|NCT00500357|2426656|P1|NOT COMPLETED|Overall Study||1
1000051|NCT00500357|2426656|P1|COMPLETED|Overall Study||104
1000052|NCT00500357|2426656|P1|Evaluable Immunogenicity Population|Overall Study|Administered Vax 1 and Vax 2 in study 6115A1-500; Vax 3 and at least 1 assay result in 6115A1-3009.|98
1000053|NCT00500357|2426656|P1|Received 13vPnC (Vax 3)|Overall Study||105
1000054|NCT00500357|2426656|P1|STARTED|Overall Study||105
1000055|NCT00500370|2426677|P2|NOT COMPLETED|Overall Study||34
1000056|NCT00500370|2426678|P1|NOT COMPLETED|Overall Study||33
1000057|NCT00500370|2426677|P2|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|49
1000058|NCT00500370|2426678|P1|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|47
1000059|NCT00500370|2426677|P2|Treatment Complete (Week 24)|Overall Study||54
1000060|NCT00500370|2426678|P1|Treatment Complete (Week 24)|Overall Study||48
1000061|NCT00500370|2426677|P2|Treatment Start-Baseline (Week 0)|Overall Study||79
1000062|NCT00500370|2426678|P1|Treatment Start-Baseline (Week 0)|Overall Study||73
1000063|NCT00500370|2426677|P2|STARTED|Overall Study||83
1000064|NCT00500370|2426678|P1|STARTED|Overall Study||80
1000065|NCT00500448|2426716|P2|NOT COMPLETED|Overall Study||0
1000066|NCT00500448|2426717|P1|NOT COMPLETED|Overall Study||0
1000067|NCT00500448|2426716|P2|COMPLETED|Overall Study||16
1000068|NCT00500448|2426717|P1|COMPLETED|Overall Study||14
1000069|NCT00500448|2426716|P2|STARTED|Overall Study||16
1000070|NCT00500448|2426717|P1|STARTED|Overall Study||14
1000071|NCT00500539|2426731|P1|NOT COMPLETED|Follow-up Period (16 Weeks)||12
1000072|NCT00500539|2426731|P1|COMPLETED|Follow-up Period (16 Weeks)||136
1000073|NCT00500539|2426731|P1|STARTED|Follow-up Period (16 Weeks)|Participants could discontinue study drug and still enter the follow-up period.|148
1000074|NCT00500539|2426731|P1|NOT COMPLETED|Treatment Period (24 Weeks)||15
1000075|NCT00500539|2426731|P1|COMPLETED|Treatment Period (24 Weeks)||140
1000076|NCT00500539|2426731|P1|STARTED|Treatment Period (24 Weeks)||155
1000077|NCT00500578|2426740|P2|NOT COMPLETED|Overall Study||0
1000078|NCT00500578|2426741|P1|NOT COMPLETED|Overall Study||0
1000079|NCT00500578|2426740|P2|COMPLETED|Overall Study|All completed|32
1000080|NCT00500578|2426741|P1|COMPLETED|Overall Study|All completed|18
1000081|NCT00500578|2426740|P2|STARTED|Overall Study||32
1000082|NCT00500578|2426741|P1|STARTED|Overall Study||18
1000083|NCT00500656|2426751|P4|NOT COMPLETED|Open Label Extension (OLE) Phase||2
1000084|NCT00500656|2426752|P3|NOT COMPLETED|Open Label Extension (OLE) Phase||1
1000085|NCT00500656|2426753|P2|NOT COMPLETED|Open Label Extension (OLE) Phase||12
1000086|NCT00500656|2426754|P1|NOT COMPLETED|Open Label Extension (OLE) Phase||7
1000087|NCT00500656|2426751|P4|COMPLETED|Open Label Extension (OLE) Phase||6
1000088|NCT00500656|2426752|P3|COMPLETED|Open Label Extension (OLE) Phase||1
1000089|NCT00500656|2426753|P2|COMPLETED|Open Label Extension (OLE) Phase||9
1000090|NCT00500656|2426754|P1|COMPLETED|Open Label Extension (OLE) Phase||16
1000091|NCT00500656|2426751|P4|STARTED|Open Label Extension (OLE) Phase|Subjects did not experience an angioedema attack during the controlled phase|8
1000092|NCT00500656|2426752|P3|STARTED|Open Label Extension (OLE) Phase||2
1000093|NCT00500656|2426753|P2|STARTED|Open Label Extension (OLE) Phase|7 Subjects did not experience an angioedema attack after their first attack in the controlled phase|21
1000094|NCT00500656|2426754|P1|STARTED|Open Label Extension (OLE) Phase|3 Subjects did not experience an angioedema attack after their first attack in the controlled phase|23
1000095|NCT00500656|2426751|P4|NOT COMPLETED|Controlled Phase||8
1000096|NCT00500656|2426752|P3|NOT COMPLETED|Controlled Phase||1
1000097|NCT00500656|2426753|P2|NOT COMPLETED|Controlled Phase||10
1000098|NCT00500656|2426754|P1|NOT COMPLETED|Controlled Phase||10
1000099|NCT00500656|2426751|P4|COMPLETED|Controlled Phase||0
1000100|NCT00500656|2426752|P3|COMPLETED|Controlled Phase||2
1000101|NCT00500656|2426753|P2|COMPLETED|Controlled Phase||28
1000102|NCT00500656|2426754|P1|COMPLETED|Controlled Phase||26
1000103|NCT00500656|2426751|P4|STARTED|Controlled Phase||8
1000104|NCT00500656|2426752|P3|STARTED|Controlled Phase||3
1000105|NCT00500656|2426753|P2|STARTED|Controlled Phase||38
1000106|NCT00500656|2426754|P1|STARTED|Controlled Phase||36
1000113|NCT00500760|2426777|P2|NOT COMPLETED|Overall Study||24
1000114|NCT00500760|2426778|P1|NOT COMPLETED|Overall Study||43
1000115|NCT00500760|2426777|P2|COMPLETED|Overall Study||40
1000116|NCT00500760|2426778|P1|COMPLETED|Overall Study||46
1000117|NCT00500760|2426777|P2|Received Treatment|Overall Study||63
1000118|NCT00500760|2426778|P1|Received Treatment|Overall Study||87
1000119|NCT00500760|2426777|P2|STARTED|Overall Study||64
1000120|NCT00500760|2426778|P1|STARTED|Overall Study||89
1000121|NCT00501007|2426796|P2|NOT COMPLETED|Overall Study||25
1000122|NCT00501007|2426797|P1|NOT COMPLETED|Overall Study||29
1000123|NCT00501007|2426796|P2|COMPLETED|Overall Study||78
1000124|NCT00501007|2426797|P1|COMPLETED|Overall Study||71
1000125|NCT00501007|2426796|P2|STARTED|Overall Study||103
1000126|NCT00501007|2426797|P1|STARTED|Overall Study||100
1000133|NCT00501085|2426812|P1|NOT COMPLETED|Overall Study||432
1000134|NCT00501085|2426812|P1|COMPLETED|Overall Study|Number of participants completing 5 year follow-up visit.|83
1000135|NCT00501085|2426812|P1|STARTED|Overall Study|Number of participants who were treated with the LAP-BAND System.|515
1000136|NCT00501228|2426820|P1|NOT COMPLETED|Overall Study||1
1000137|NCT00501228|2426820|P1|COMPLETED|Overall Study||1
1000138|NCT00501228|2426820|P1|STARTED|Overall Study||2
1000139|NCT00501293|2426826|P2|NOT COMPLETED|Maintenance Period||28
1000140|NCT00501293|2426827|P1|NOT COMPLETED|Maintenance Period||46
1000141|NCT00501293|2426826|P2|COMPLETED|Maintenance Period||25
1000142|NCT00501293|2426827|P1|COMPLETED|Maintenance Period||63
1000143|NCT00501293|2426826|P2|STARTED|Maintenance Period||53
1000144|NCT00501293|2426827|P1|STARTED|Maintenance Period||109
1000145|NCT00501293|2426826|P2|NOT COMPLETED|Optimization Period||0
1000146|NCT00501293|2426827|P1|NOT COMPLETED|Optimization Period||1
1000147|NCT00501293|2426826|P2|COMPLETED|Optimization Period||53
1000148|NCT00501293|2426827|P1|COMPLETED|Optimization Period||109
1000149|NCT00501293|2426826|P2|STARTED|Optimization Period||53
1000150|NCT00501293|2426827|P1|STARTED|Optimization Period||110
1000151|NCT00501345|2426854|P1|NOT COMPLETED|Overall Study||0
1000152|NCT00501345|2426854|P1|COMPLETED|Overall Study||5
1000153|NCT00501345|2426854|P1|STARTED|Overall Study||5
1000154|NCT00501540|2426858|P1|NOT COMPLETED|Overall Study||5
1000155|NCT00501540|2426858|P1|COMPLETED|Overall Study||10
1000156|NCT00501540|2426858|P1|STARTED|Overall Study||15
1000157|NCT00501592|2426867|P3|NOT COMPLETED|Overall Study||3
1000158|NCT00501592|2426868|P2|NOT COMPLETED|Overall Study||5
1000159|NCT00501592|2426869|P1|NOT COMPLETED|Overall Study||0
1000160|NCT00501592|2426867|P3|COMPLETED|Overall Study||20
1000161|NCT00501592|2426868|P2|COMPLETED|Overall Study||16
1000162|NCT00501592|2426869|P1|COMPLETED|Overall Study||20
1000163|NCT00501592|2426867|P3|STARTED|Overall Study||23
1000164|NCT00501592|2426868|P2|STARTED|Overall Study||21
1000165|NCT00501592|2426869|P1|STARTED|Overall Study||20
1000166|NCT00501631|2426882|P2|NOT COMPLETED|Part B (Open-label Period)||51
1000167|NCT00501631|2426883|P1|NOT COMPLETED|Part B (Open-label Period)||53
1000168|NCT00501631|2426882|P2|COMPLETED|Part B (Open-label Period)||48
1000169|NCT00501631|2426883|P1|COMPLETED|Part B (Open-label Period)||37
1000170|NCT00501631|2426882|P2|STARTED|Part B (Open-label Period)||99
1000171|NCT00501631|2426883|P1|STARTED|Part B (Open-label Period)||90
1000172|NCT00501631|2426882|P2|NOT COMPLETED|Part A (Double-blind Period)||49
1000173|NCT00501631|2426883|P1|NOT COMPLETED|Part A (Double-blind Period)||62
1000174|NCT00501631|2426882|P2|COMPLETED|Part A (Double-blind Period)||99
1000175|NCT00501631|2426883|P1|COMPLETED|Part A (Double-blind Period)||90
1000176|NCT00501631|2426882|P2|STARTED|Part A (Double-blind Period)||148
1000177|NCT00501631|2426883|P1|STARTED|Part A (Double-blind Period)||152
1000178|NCT00501644|2426889|P1|NOT COMPLETED|Overall Study||5
1000179|NCT00501644|2426889|P1|COMPLETED|Overall Study||54
1000180|NCT00501644|2426889|P1|STARTED|Overall Study||59
1000181|NCT00495820|2426895|P2|NOT COMPLETED|Overall Study||1
1000182|NCT00495820|2426896|P1|NOT COMPLETED|Overall Study||1
1000183|NCT00495820|2426895|P2|COMPLETED|Overall Study||29
1000184|NCT00495820|2426896|P1|COMPLETED|Overall Study||29
1000185|NCT00495820|2426895|P2|STARTED|Overall Study||30
1000186|NCT00495820|2426896|P1|STARTED|Overall Study||30
1000187|NCT00501852|2426906|P1|NOT COMPLETED|Overall Study||5
1000188|NCT00501852|2426906|P1|COMPLETED|Overall Study||78
1000189|NCT00501852|2426906|P1|Tiotropium|Overall Study||55
1000190|NCT00501852|2426906|P1|Placebo|Overall Study||55
1000191|NCT00501852|2426906|P1|NVA237 100µg|Overall Study||54
1000192|NCT00501852|2426906|P1|NVA237 50µg|Overall Study||53
1000193|NCT00501852|2426906|P1|NVA237 25µg|Overall Study||51
1000194|NCT00501852|2426906|P1|NVA237 12.5µg|Overall Study||55
1000195|NCT00501852|2426906|P1|STARTED|Overall Study||83
1000196|NCT00501891|2426926|P1|NOT COMPLETED|Overall Study||0
1000197|NCT00501891|2426926|P1|COMPLETED|Overall Study||32
1000198|NCT00501891|2426926|P1|STARTED|Overall Study||32
1000199|NCT00501943|2426935|P2|NOT COMPLETED|Overall Study||3
1000200|NCT00501943|2426936|P1|NOT COMPLETED|Overall Study||2
1000201|NCT00501943|2426935|P2|COMPLETED|Overall Study||18
1000202|NCT00501943|2426936|P1|COMPLETED|Overall Study||20
1000203|NCT00501943|2426935|P2|STARTED|Overall Study||21
1000204|NCT00501943|2426936|P1|STARTED|Overall Study||22
1000205|NCT00501969|2426952|P1|NOT COMPLETED|Overall Study||206
1000206|NCT00501969|2426952|P1|COMPLETED|Overall Study||189
1000207|NCT00501969|2426952|P1|STARTED|Overall Study||395
1000208|NCT00501995|2426958|P1|NOT COMPLETED|Overall Study||1
1000209|NCT00501995|2426958|P1|COMPLETED|Overall Study||5
1000210|NCT00501995|2426958|P1|STARTED|Overall Study||6
1000211|NCT00504231|2426967|P4|NOT COMPLETED|Overall Study||0
1000212|NCT00504231|2426968|P3|NOT COMPLETED|Overall Study||1
1000213|NCT00504231|2426969|P2|NOT COMPLETED|Overall Study||0
1000214|NCT00504231|2426970|P1|NOT COMPLETED|Overall Study||0
1000215|NCT00504231|2426967|P4|COMPLETED|Overall Study||65
1000216|NCT00504231|2426968|P3|COMPLETED|Overall Study||63
1000217|NCT00504231|2426969|P2|COMPLETED|Overall Study||64
1000218|NCT00504231|2426970|P1|COMPLETED|Overall Study||65
1000219|NCT00504231|2426967|P4|STARTED|Overall Study||65
1000220|NCT00504231|2426968|P3|STARTED|Overall Study||64
1000221|NCT00504231|2426969|P2|STARTED|Overall Study||64
1000222|NCT00504231|2426970|P1|STARTED|Overall Study||65
1000223|NCT00504257|2426988|P1|NOT COMPLETED|Overall Study||4
1000224|NCT00504257|2426988|P1|COMPLETED|Overall Study||41
1000225|NCT00504257|2426988|P1|STARTED|Overall Study||45
1000226|NCT00504426|2427000|P4|NOT COMPLETED|Overall Study||0
1000227|NCT00504426|2427001|P3|NOT COMPLETED|Overall Study||4
1000228|NCT00504426|2427002|P2|NOT COMPLETED|Overall Study||1
1000229|NCT00504426|2427003|P1|NOT COMPLETED|Overall Study||3
1000230|NCT00504426|2427000|P4|COMPLETED|Overall Study||24
1000231|NCT00504426|2427001|P3|COMPLETED|Overall Study||18
1000232|NCT00504426|2427002|P2|COMPLETED|Overall Study||22
1000233|NCT00504426|2427003|P1|COMPLETED|Overall Study||29
1000234|NCT00504426|2427000|P4|STARTED|Overall Study||24
1000235|NCT00504426|2427001|P3|STARTED|Overall Study||22
1000236|NCT00504426|2427002|P2|STARTED|Overall Study||23
1000237|NCT00504426|2427003|P1|STARTED|Overall Study||32
1000238|NCT00504504|2427017|P1|NOT COMPLETED|Overall Study||0
1000239|NCT00504504|2427017|P1|COMPLETED|Overall Study||82
1000240|NCT00504504|2427017|P1|STARTED|Overall Study||82
1000241|NCT00504556|2427026|P5|NOT COMPLETED|Overall Study||25
1000242|NCT00504556|2427027|P4|NOT COMPLETED|Overall Study||128
1000243|NCT00504556|2427028|P3|NOT COMPLETED|Overall Study||31
1000244|NCT00504556|2427029|P2|NOT COMPLETED|Overall Study||38
1000245|NCT00504556|2427030|P1|NOT COMPLETED|Overall Study||35
1000246|NCT00504556|2427026|P5|COMPLETED|Overall Study||226
1000247|NCT00504556|2427027|P4|COMPLETED|Overall Study||52
1000248|NCT00504556|2427028|P3|COMPLETED|Overall Study||204
1000249|NCT00504556|2427029|P2|COMPLETED|Overall Study||207
1000250|NCT00504556|2427030|P1|COMPLETED|Overall Study||200
1000251|NCT00504556|2427026|P5|Pharmacodynamic Analysis Set|Overall Study||244
1000252|NCT00504556|2427027|P4|Pharmacodynamic Analysis Set|Overall Study||170
1000253|NCT00504556|2427028|P3|Pharmacodynamic Analysis Set|Overall Study||228
1000254|NCT00504556|2427029|P2|Pharmacodynamic Analysis Set|Overall Study||236
1000255|NCT00504556|2427030|P1|Pharmacodynamic Analysis Set|Overall Study||230
1000256|NCT00504556|2427026|P5|Per Protocol Analysis Set|Overall Study||250
1000257|NCT00504556|2427027|P4|Per Protocol Analysis Set|Overall Study||180
1000258|NCT00504556|2427028|P3|Per Protocol Analysis Set|Overall Study||234
1000259|NCT00504556|2427029|P2|Per Protocol Analysis Set|Overall Study||243
1000260|NCT00504556|2427030|P1|Per Protocol Analysis Set|Overall Study||235
1000261|NCT00504556|2427026|P5|Safety Analysis Set|Overall Study||250
1000262|NCT00504556|2427027|P4|Safety Analysis Set|Overall Study||180
1000263|NCT00504556|2427028|P3|Safety Analysis Set|Overall Study||234
1000264|NCT00504556|2427029|P2|Safety Analysis Set|Overall Study||244
1000265|NCT00504556|2427030|P1|Safety Analysis Set|Overall Study||235
1000266|NCT00504556|2427026|P5|STARTED|Overall Study||251
1000267|NCT00504556|2427027|P4|STARTED|Overall Study||180
1000268|NCT00504556|2427028|P3|STARTED|Overall Study||235
1000269|NCT00504556|2427029|P2|STARTED|Overall Study||245
1000270|NCT00504556|2427030|P1|STARTED|Overall Study||235
1000271|NCT00504595|2427094|P4|NOT COMPLETED|Overall Study||0
1000272|NCT00504595|2427095|P3|NOT COMPLETED|Overall Study||2
1000273|NCT00504595|2427096|P2|NOT COMPLETED|Overall Study||0
1000274|NCT00504595|2427097|P1|NOT COMPLETED|Overall Study||1
1000275|NCT00504595|2427094|P4|COMPLETED|Overall Study||10
1000276|NCT00504595|2427095|P3|COMPLETED|Overall Study||8
1000277|NCT00504595|2427096|P2|COMPLETED|Overall Study||10
1000278|NCT00504595|2427097|P1|COMPLETED|Overall Study||49
1000279|NCT00504595|2427094|P4|STARTED|Overall Study||10
1000280|NCT00504595|2427095|P3|STARTED|Overall Study||10
1000281|NCT00504595|2427096|P2|STARTED|Overall Study||10
1000282|NCT00504595|2427097|P1|STARTED|Overall Study||50
1000283|NCT00504660|2427111|P2|NOT COMPLETED|Overall Study||0
1000284|NCT00504660|2427112|P1|NOT COMPLETED|Overall Study||0
1000285|NCT00504660|2427111|P2|COMPLETED|Overall Study||43
1000286|NCT00504660|2427112|P1|COMPLETED|Overall Study||31
1000287|NCT00504660|2427111|P2|STARTED|Overall Study||43
1000288|NCT00504660|2427112|P1|STARTED|Overall Study||31
1000289|NCT00504725|2427120|P2|NOT COMPLETED|Overall Study||0
1000290|NCT00504725|2427121|P1|NOT COMPLETED|Overall Study||1
1000291|NCT00504725|2427120|P2|COMPLETED|Overall Study||20
1000292|NCT00504725|2427121|P1|COMPLETED|Overall Study|Prior to unblinding, one subject was discontinued due to elevated CRP levels at baseline.|20
1000293|NCT00504725|2427120|P2|STARTED|Overall Study||20
1000294|NCT00504725|2427121|P1|STARTED|Overall Study||21
1000295|NCT00504751|2427131|P1|NOT COMPLETED|Overall Study||0
1000296|NCT00504751|2427131|P1|COMPLETED|Overall Study||15
1000297|NCT00504751|2427131|P1|STARTED|Overall Study||15
1000298|NCT00504777|2427135|P1|NOT COMPLETED|Overall Study||1
1000299|NCT00504777|2427135|P1|COMPLETED|Overall Study||35
1000300|NCT00504777|2427135|P1|STARTED|Overall Study||36
1000301|NCT00504881|2427144|P2|NOT COMPLETED|Overall Study||36
1000302|NCT00504881|2427145|P1|NOT COMPLETED|Overall Study||10
1000303|NCT00504881|2427144|P2|COMPLETED|Overall Study||323
1000304|NCT00504881|2427145|P1|COMPLETED|Overall Study||111
1000305|NCT00504881|2427144|P2|STARTED|Overall Study||359
1000306|NCT00504881|2427145|P1|STARTED|Overall Study||121
1000307|NCT00504894|2427197|P2|NOT COMPLETED|Overall Study||0
1000308|NCT00504894|2427198|P1|NOT COMPLETED|Overall Study||0
1000309|NCT00504894|2427197|P2|COMPLETED|Overall Study||18
1000310|NCT00504894|2427198|P1|COMPLETED|Overall Study||17
1000311|NCT00504894|2427197|P2|STARTED|Overall Study||18
1000312|NCT00504894|2427198|P1|STARTED|Overall Study||17
1000313|NCT00504985|2427204|P1|NOT COMPLETED|Overall Study||0
1000314|NCT00504985|2427204|P1|COMPLETED|Overall Study||14
1000315|NCT00504985|2427204|P1|STARTED|Overall Study||14
1000316|NCT00505076|2427211|P3|NOT COMPLETED|Overall Study||5
1000317|NCT00505076|2427212|P2|NOT COMPLETED|Overall Study||2
1000318|NCT00505076|2427213|P1|NOT COMPLETED|Overall Study||3
1000319|NCT00505076|2427211|P3|COMPLETED|Overall Study||17
1000320|NCT00505076|2427212|P2|COMPLETED|Overall Study||17
1000321|NCT00505076|2427213|P1|COMPLETED|Overall Study||19
1000322|NCT00505076|2427211|P3|STARTED|Overall Study||22
1000323|NCT00505076|2427212|P2|STARTED|Overall Study||19
1000324|NCT00505076|2427213|P1|STARTED|Overall Study||22
1000325|NCT00505284|2427232|P5|NOT COMPLETED|Overall Study||33
1000326|NCT00505284|2427233|P4|NOT COMPLETED|Overall Study||19
1000327|NCT00505284|2427234|P3|NOT COMPLETED|Overall Study||12
1000328|NCT00505284|2427235|P2|NOT COMPLETED|Overall Study||16
1000329|NCT00505284|2427236|P1|NOT COMPLETED|Overall Study||10
1000330|NCT00505284|2427232|P5|COMPLETED|Overall Study||37
1000331|NCT00505284|2427233|P4|COMPLETED|Overall Study||49
1000332|NCT00505284|2427234|P3|COMPLETED|Overall Study||57
1000333|NCT00505284|2427235|P2|COMPLETED|Overall Study||56
1000334|NCT00505284|2427236|P1|COMPLETED|Overall Study||63
1000335|NCT00505284|2427232|P5|STARTED|Overall Study||70
1000336|NCT00505284|2427233|P4|STARTED|Overall Study||68
1000337|NCT00505284|2427234|P3|STARTED|Overall Study||69
1000338|NCT00505284|2427235|P2|STARTED|Overall Study||72
1000339|NCT00505284|2427236|P1|STARTED|Overall Study||73
1000340|NCT00505362|2427305|P2|NOT COMPLETED|Overall Study||0
1000341|NCT00505362|2427306|P1|NOT COMPLETED|Overall Study||0
1000342|NCT00505362|2427305|P2|COMPLETED|Overall Study||28
1000343|NCT00505362|2427306|P1|COMPLETED|Overall Study||35
1000344|NCT00505362|2427305|P2|STARTED|Overall Study||28
1000345|NCT00505362|2427306|P1|STARTED|Overall Study||35
1000346|NCT00505375|2427316|P2|NOT COMPLETED|Overall Study||5
1000347|NCT00505375|2427317|P1|NOT COMPLETED|Overall Study||4
1000348|NCT00505375|2427316|P2|COMPLETED|Overall Study||30
1000349|NCT00505375|2427317|P1|COMPLETED|Overall Study||73
1000350|NCT00505375|2427316|P2|STARTED|Overall Study||35
1000351|NCT00505375|2427317|P1|STARTED|Overall Study||77
1000352|NCT00505414|2427325|P5|NOT COMPLETED|Maintenance Phase||0
1000353|NCT00505414|2427326|P4|NOT COMPLETED|Maintenance Phase||0
1000354|NCT00505414|2427327|P3|NOT COMPLETED|Maintenance Phase||8
1000355|NCT00505414|2427328|P2|NOT COMPLETED|Maintenance Phase||5
1000356|NCT00505414|2427329|P1|NOT COMPLETED|Maintenance Phase||6
1000357|NCT00505414|2427325|P5|COMPLETED|Maintenance Phase||0
1000358|NCT00505414|2427326|P4|COMPLETED|Maintenance Phase||0
1000359|NCT00505414|2427327|P3|COMPLETED|Maintenance Phase||6
1000360|NCT00505414|2427328|P2|COMPLETED|Maintenance Phase||10
1000361|NCT00505414|2427329|P1|COMPLETED|Maintenance Phase||12
1000362|NCT00505414|2427325|P5|Did Not Qualify for Maintenance Phase|Maintenance Phase||1
1000363|NCT00505414|2427326|P4|Did Not Qualify for Maintenance Phase|Maintenance Phase||3
1000364|NCT00505414|2427327|P3|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
1000365|NCT00505414|2427328|P2|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
1000366|NCT00505414|2427329|P1|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
1000367|NCT00505414|2427325|P5|STARTED|Maintenance Phase|18 of 19 participants completing the morphine titration phase were continued on morphine.|0
1000368|NCT00505414|2427326|P4|STARTED|Maintenance Phase|29 of 32 participants were treated in the maintenance phase either with placebo or tapentadol|0
1000369|NCT00505414|2427327|P3|STARTED|Maintenance Phase|14 of 32 tapentadol titration participants were treated with placebo in the maintenance phase.|14
1000370|NCT00505414|2427328|P2|STARTED|Maintenance Phase|15 of 32 tapentadol titration participants continued with tapentadol in the maintenance phase|15
1000371|NCT00505414|2427329|P1|STARTED|Maintenance Phase|18 of the 19 morphine participants continued with morphine in the maintenance phase.|18
1000372|NCT00505414|2427325|P5|NOT COMPLETED|Titration Phase||12
1000373|NCT00505414|2427326|P4|NOT COMPLETED|Titration Phase||30
1000374|NCT00505414|2427327|P3|NOT COMPLETED|Titration Phase||0
1000375|NCT00505414|2427328|P2|NOT COMPLETED|Titration Phase||0
1000376|NCT00505414|2427329|P1|NOT COMPLETED|Titration Phase||0
1000377|NCT00505414|2427325|P5|COMPLETED|Titration Phase||19
1000378|NCT00505414|2427326|P4|COMPLETED|Titration Phase||32
1000379|NCT00505414|2427327|P3|COMPLETED|Titration Phase||0
1000380|NCT00505414|2427328|P2|COMPLETED|Titration Phase||0
1000381|NCT00505414|2427329|P1|COMPLETED|Titration Phase||0
1000382|NCT00505414|2427325|P5|STARTED|Titration Phase||31
1000383|NCT00505414|2427326|P4|STARTED|Titration Phase||62
1000384|NCT00505414|2427327|P3|STARTED|Titration Phase||0
1000385|NCT00505414|2427328|P2|STARTED|Titration Phase||0
1000386|NCT00505414|2427329|P1|STARTED|Titration Phase||0
1000387|NCT00505518|2427344|P1|NOT COMPLETED|Overall Study||0
1000388|NCT00505518|2427344|P1|COMPLETED|Overall Study||9
1000389|NCT00505518|2427344|P1|STARTED|Overall Study||9
1000390|NCT00505622|2427353|P3|NOT COMPLETED|Overall Study||96
1000391|NCT00505622|2427354|P2|NOT COMPLETED|Overall Study||108
1000392|NCT00505622|2427355|P1|NOT COMPLETED|Overall Study||121
1000393|NCT00505622|2427353|P3|COMPLETED|Overall Study||0
1000394|NCT00505622|2427354|P2|COMPLETED|Overall Study||0
1000395|NCT00505622|2427355|P1|COMPLETED|Overall Study||0
1000396|NCT00505622|2427353|P3|STARTED|Overall Study||96
1000397|NCT00505622|2427354|P2|STARTED|Overall Study||108
1000398|NCT00505622|2427355|P1|STARTED|Overall Study||121
1000399|NCT00505635|2427372|P1|NOT COMPLETED|Overall Study||0
1000400|NCT00505635|2427372|P1|COMPLETED|Overall Study||5
1000401|NCT00505635|2427372|P1|STARTED|Overall Study||5
1000402|NCT00505661|2427376|P1|NOT COMPLETED|Overall Study||4
1000403|NCT00505661|2427376|P1|COMPLETED|Overall Study||12
1000404|NCT00505661|2427376|P1|STARTED|Overall Study||16
1000405|NCT00505687|2427380|P1|NOT COMPLETED|Overall Study||95
1000406|NCT00505687|2427380|P1|COMPLETED|Overall Study||91
1000407|NCT00505687|2427380|P1|STARTED|Overall Study||186
1000408|NCT00505752|2427390|P4|NOT COMPLETED|Overall Study||6
1000409|NCT00505752|2427391|P3|NOT COMPLETED|Overall Study||8
1000410|NCT00505752|2427392|P2|NOT COMPLETED|Overall Study||9
1000411|NCT00505752|2427393|P1|NOT COMPLETED|Overall Study||6
1000412|NCT00505752|2427390|P4|COMPLETED|Overall Study||126
1000413|NCT00505752|2427391|P3|COMPLETED|Overall Study||120
1000414|NCT00505752|2427392|P2|COMPLETED|Overall Study||119
1000415|NCT00505752|2427393|P1|COMPLETED|Overall Study||126
1000416|NCT00505752|2427390|P4|STARTED|Overall Study||132
1000417|NCT00505752|2427391|P3|STARTED|Overall Study||128
1000418|NCT00505752|2427392|P2|STARTED|Overall Study||128
1000419|NCT00505752|2427393|P1|STARTED|Overall Study||132
1000420|NCT00505765|2427410|P3|NOT COMPLETED|Overall Study||3
1000421|NCT00505765|2427411|P2|NOT COMPLETED|Overall Study||3
1000422|NCT00505765|2427412|P1|NOT COMPLETED|Overall Study||2
1000423|NCT00505765|2427410|P3|COMPLETED|Overall Study||19
1000424|NCT00505765|2427411|P2|COMPLETED|Overall Study||17
1000425|NCT00505765|2427412|P1|COMPLETED|Overall Study||19
1000426|NCT00505765|2427410|P3|Mid-Point Assessment|Overall Study||21
1000427|NCT00505765|2427411|P2|Mid-Point Assessment|Overall Study||19
1000428|NCT00505765|2427412|P1|Mid-Point Assessment|Overall Study||20
1000429|NCT00505765|2427410|P3|STARTED|Overall Study||22
1000430|NCT00505765|2427411|P2|STARTED|Overall Study||20
1000431|NCT00505765|2427412|P1|STARTED|Overall Study||21
1000432|NCT00505778|2427437|P2|NOT COMPLETED|Overall Study||135
1000433|NCT00505778|2427438|P1|NOT COMPLETED|Overall Study||134
1000434|NCT00505778|2427437|P2|COMPLETED|Overall Study||378
1000435|NCT00505778|2427438|P1|COMPLETED|Overall Study||380
1000436|NCT00505778|2427437|P2|Intent to Treat (ITT) Population|Overall Study||511
1000437|NCT00505778|2427438|P1|Intent to Treat (ITT) Population|Overall Study||512
1000438|NCT00505778|2427437|P2|STARTED|Overall Study||513
1000439|NCT00505778|2427438|P1|STARTED|Overall Study||514
1000440|NCT00505895|2427456|P2|NOT COMPLETED|Overall Study||0
1000441|NCT00505895|2427457|P1|NOT COMPLETED|Overall Study||0
1000442|NCT00505895|2427456|P2|COMPLETED|Overall Study||23
1000443|NCT00505895|2427457|P1|COMPLETED|Overall Study||27
1000444|NCT00505895|2427456|P2|STARTED|Overall Study||23
1000445|NCT00505895|2427457|P1|STARTED|Overall Study||27
1000446|NCT00505921|2427465|P1|NOT COMPLETED|Overall Study||9
1000447|NCT00505921|2427465|P1|COMPLETED|Overall Study||18
1000448|NCT00505921|2427465|P1|STARTED|Overall Study||27
1000449|NCT00505934|2427469|P1|NOT COMPLETED|Overall Study||3
1000450|NCT00505934|2427469|P1|COMPLETED|Overall Study||16
1000451|NCT00505934|2427469|P1|STARTED|Overall Study|Of the 23 subjects screened, 19 were enrolled into the study and received levetiracetam IV (LEV IV).|19
1000452|NCT00506025|2427478|P3|NOT COMPLETED|Overall Study||0
1000453|NCT00506025|2427479|P2|NOT COMPLETED|Overall Study||0
1000454|NCT00506025|2427480|P1|NOT COMPLETED|Overall Study||0
1000455|NCT00506025|2427478|P3|COMPLETED|Overall Study||8
1000456|NCT00506025|2427479|P2|COMPLETED|Overall Study||9
1000457|NCT00506025|2427480|P1|COMPLETED|Overall Study||10
1000458|NCT00506025|2427478|P3|STARTED|Overall Study||8
1000459|NCT00506025|2427479|P2|STARTED|Overall Study||9
1000460|NCT00506025|2427480|P1|STARTED|Overall Study||10
1000461|NCT00506064|2427490|P2|NOT COMPLETED|Overall Study||0
1000462|NCT00506064|2427491|P1|NOT COMPLETED|Overall Study||0
1000463|NCT00506064|2427490|P2|COMPLETED|Overall Study||0
1000464|NCT00506064|2427491|P1|COMPLETED|Overall Study||1
1000465|NCT00506064|2427490|P2|STARTED|Overall Study||0
1000466|NCT00506064|2427491|P1|STARTED|Overall Study||1
1000467|NCT00506077|2427499|P2|NOT COMPLETED|Treatment Period 2||1
1000468|NCT00506077|2427500|P1|NOT COMPLETED|Treatment Period 2||1
1000469|NCT00506077|2427499|P2|COMPLETED|Treatment Period 2||23
1000470|NCT00506077|2427500|P1|COMPLETED|Treatment Period 2||23
1000471|NCT00506077|2427499|P2|STARTED|Treatment Period 2||24
1000472|NCT00506077|2427500|P1|STARTED|Treatment Period 2||24
1000473|NCT00506077|2427499|P2|NOT COMPLETED|Washout||0
1000474|NCT00506077|2427500|P1|NOT COMPLETED|Washout||0
1000475|NCT00506077|2427499|P2|COMPLETED|Washout||24
1000476|NCT00506077|2427500|P1|COMPLETED|Washout||24
1000477|NCT00506077|2427499|P2|STARTED|Washout||24
1000478|NCT00506077|2427500|P1|STARTED|Washout||24
1000479|NCT00506077|2427499|P2|NOT COMPLETED|Treatment Period 1||3
1000480|NCT00506077|2427500|P1|NOT COMPLETED|Treatment Period 1||4
1000481|NCT00506077|2427499|P2|COMPLETED|Treatment Period 1||24
1000482|NCT00506077|2427500|P1|COMPLETED|Treatment Period 1||24
1000483|NCT00506077|2427499|P2|STARTED|Treatment Period 1||27
1000484|NCT00506077|2427500|P1|STARTED|Treatment Period 1||28
1000485|NCT00506155|2427520|P1|NOT COMPLETED|Overall Study||0
1000486|NCT00506155|2427520|P1|COMPLETED|Overall Study||60
1000487|NCT00506155|2427520|P1|STARTED|Overall Study||60
1000488|NCT00506285|2427527|P2|NOT COMPLETED|6-month Open Label Phase||12
1000489|NCT00506285|2427528|P1|NOT COMPLETED|6-month Open Label Phase||10
1000490|NCT00506285|2427527|P2|COMPLETED|6-month Open Label Phase||19
1000491|NCT00506285|2427528|P1|COMPLETED|6-month Open Label Phase||10
1000492|NCT00506285|2427527|P2|STARTED|6-month Open Label Phase||31
1000493|NCT00506285|2427528|P1|STARTED|6-month Open Label Phase||20
1000494|NCT00506285|2427527|P2|NOT COMPLETED|Double Blind Cross-Over Phase||5
1000495|NCT00506285|2427528|P1|NOT COMPLETED|Double Blind Cross-Over Phase||9
1000496|NCT00506285|2427527|P2|COMPLETED|Double Blind Cross-Over Phase||31
1000497|NCT00506285|2427528|P1|COMPLETED|Double Blind Cross-Over Phase||20
1000498|NCT00506285|2427527|P2|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||31
1000499|NCT00506285|2427528|P1|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||29
1000500|NCT00506285|2427527|P2|STARTED|Double Blind Cross-Over Phase||36
1000501|NCT00506285|2427528|P1|STARTED|Double Blind Cross-Over Phase||29
1000502|NCT00506285|2427527|P2|NOT COMPLETED|3 Week Screening Phase||10
1000503|NCT00506285|2427528|P1|NOT COMPLETED|3 Week Screening Phase||17
1000504|NCT00506285|2427527|P2|COMPLETED|3 Week Screening Phase||36
1000505|NCT00506285|2427528|P1|COMPLETED|3 Week Screening Phase||29
1000506|NCT00506285|2427527|P2|STARTED|3 Week Screening Phase||46
1000507|NCT00506285|2427528|P1|STARTED|3 Week Screening Phase||46
1000508|NCT00506350|2427545|P9|NOT COMPLETED|Overall Study||5
1000509|NCT00506350|2427546|P8|NOT COMPLETED|Overall Study||5
1000510|NCT00506350|2427547|P7|NOT COMPLETED|Overall Study||2
1000511|NCT00506350|2427548|P6|NOT COMPLETED|Overall Study||2
1000512|NCT00506350|2427549|P5|NOT COMPLETED|Overall Study||10
1000513|NCT00506350|2427550|P4|NOT COMPLETED|Overall Study||2
1000514|NCT00506350|2427551|P3|NOT COMPLETED|Overall Study||6
1000515|NCT00506350|2427552|P2|NOT COMPLETED|Overall Study||3
1000516|NCT00506350|2427553|P1|NOT COMPLETED|Overall Study||3
1000517|NCT00506350|2427545|P9|COMPLETED|Overall Study||30
1000518|NCT00506350|2427546|P8|COMPLETED|Overall Study||36
1000519|NCT00506350|2427547|P7|COMPLETED|Overall Study||33
1000520|NCT00506350|2427548|P6|COMPLETED|Overall Study||38
1000521|NCT00506350|2427549|P5|COMPLETED|Overall Study||40
1000522|NCT00506350|2427550|P4|COMPLETED|Overall Study||34
1000523|NCT00506350|2427551|P3|COMPLETED|Overall Study||31
1000524|NCT00506350|2427552|P2|COMPLETED|Overall Study||37
1000525|NCT00506350|2427553|P1|COMPLETED|Overall Study||33
1000526|NCT00506350|2427545|P9|STARTED|Overall Study||35
1000527|NCT00506350|2427546|P8|STARTED|Overall Study||41
1000528|NCT00506350|2427547|P7|STARTED|Overall Study||35
1000529|NCT00506350|2427548|P6|STARTED|Overall Study||40
1000530|NCT00506350|2427549|P5|STARTED|Overall Study||50
1000531|NCT00506350|2427550|P4|STARTED|Overall Study||36
1000532|NCT00506350|2427551|P3|STARTED|Overall Study||37
1000533|NCT00506350|2427552|P2|STARTED|Overall Study||40
1000534|NCT00506350|2427553|P1|STARTED|Overall Study||36
1000535|NCT00506389|2427701|P3|NOT COMPLETED|Follow-up Period||0
1000536|NCT00506389|2427702|P2|NOT COMPLETED|Follow-up Period||0
1000537|NCT00506389|2427703|P1|NOT COMPLETED|Follow-up Period||0
1000538|NCT00506389|2427701|P3|COMPLETED|Follow-up Period||136
1000539|NCT00506389|2427702|P2|COMPLETED|Follow-up Period||138
1000540|NCT00506389|2427703|P1|COMPLETED|Follow-up Period||139
1000541|NCT00506389|2427701|P3|STARTED|Follow-up Period|11 participants who discontinued treatment entered the Follow-up Period.|136
1000542|NCT00506389|2427702|P2|STARTED|Follow-up Period|14 participants who discontinued treatment entered the Follow-up Period.|138
1000543|NCT00506389|2427703|P1|STARTED|Follow-up Period|22 participants who discontinued treatment entered the Follow-up Period.|139
1000544|NCT00506389|2427701|P3|NOT COMPLETED|In-treatment Period||12
1000545|NCT00506389|2427702|P2|NOT COMPLETED|In-treatment Period||15
1000546|NCT00506389|2427703|P1|NOT COMPLETED|In-treatment Period||26
1000547|NCT00506389|2427701|P3|COMPLETED|In-treatment Period||125
1000548|NCT00506389|2427702|P2|COMPLETED|In-treatment Period||124
1000549|NCT00506389|2427703|P1|COMPLETED|In-treatment Period||117
1000550|NCT00506389|2427701|P3|All Participants Treated|In-treatment Period||136
1000551|NCT00506389|2427702|P2|All Participants Treated|In-treatment Period||138
1000552|NCT00506389|2427703|P1|All Participants Treated|In-treatment Period||139
1000553|NCT00506389|2427701|P3|STARTED|In-treatment Period||137
1000554|NCT00506389|2427702|P2|STARTED|In-treatment Period||139
1000555|NCT00506389|2427703|P1|STARTED|In-treatment Period||143
1000556|NCT00506415|2427720|P4|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||62
1000557|NCT00506415|2427721|P3|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
1000558|NCT00506415|2427722|P2|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
1000559|NCT00506415|2427723|P1|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
1000560|NCT00506415|2427720|P4|COMPLETED|Extended Open Label (Maximum 48 Weeks)||395
1000561|NCT00506415|2427721|P3|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
1000562|NCT00506415|2427722|P2|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
1000563|NCT00506415|2427723|P1|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
1000564|NCT00506415|2427720|P4|STARTED|Extended Open Label (Maximum 48 Weeks)|Two participants did not receive study drug, hence excluded from this arm.|457
1000565|NCT00506415|2427721|P3|STARTED|Extended Open Label (Maximum 48 Weeks)||0
1000566|NCT00506415|2427722|P2|STARTED|Extended Open Label (Maximum 48 Weeks)||0
1000567|NCT00506415|2427723|P1|STARTED|Extended Open Label (Maximum 48 Weeks)||0
1000568|NCT00506415|2427720|P4|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
1000569|NCT00506415|2427721|P3|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||73
1000570|NCT00506415|2427722|P2|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||83
1000571|NCT00506415|2427723|P1|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
1000572|NCT00506415|2427720|P4|COMPLETED|Double Blind (Maximum 48 Weeks )||0
1000573|NCT00506415|2427721|P3|COMPLETED|Double Blind (Maximum 48 Weeks )||207
1000574|NCT00506415|2427722|P2|COMPLETED|Double Blind (Maximum 48 Weeks )||203
1000575|NCT00506415|2427723|P1|COMPLETED|Double Blind (Maximum 48 Weeks )||0
1000576|NCT00506415|2427720|P4|STARTED|Double Blind (Maximum 48 Weeks )||0
1000577|NCT00506415|2427721|P3|STARTED|Double Blind (Maximum 48 Weeks )||280
1000578|NCT00506415|2427722|P2|STARTED|Double Blind (Maximum 48 Weeks )|1 patient was randomized in error and did not receive study drug, hence excluded from this arm.|286
1000579|NCT00506415|2427723|P1|STARTED|Double Blind (Maximum 48 Weeks )||0
1000580|NCT00506415|2427720|P4|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
1000581|NCT00506415|2427721|P3|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
1000582|NCT00506415|2427722|P2|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
1000583|NCT00506415|2427723|P1|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||499
1000584|NCT00506415|2427720|P4|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
1000585|NCT00506415|2427721|P3|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
1000586|NCT00506415|2427722|P2|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
1000587|NCT00506415|2427723|P1|COMPLETED|Initial Open Label (Maximum 48 Weeks)||1085
1000588|NCT00506415|2427720|P4|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
1000589|NCT00506415|2427721|P3|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
1000590|NCT00506415|2427722|P2|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
1000591|NCT00506415|2427723|P1|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||1582
1000592|NCT00506415|2427720|P4|STARTED|Initial Open Label (Maximum 48 Weeks)||0
1000593|NCT00506415|2427721|P3|STARTED|Initial Open Label (Maximum 48 Weeks)||0
1000594|NCT00506415|2427722|P2|STARTED|Initial Open Label (Maximum 48 Weeks)||0
1000595|NCT00506415|2427723|P1|STARTED|Initial Open Label (Maximum 48 Weeks)|Enrolled patients.|1584
1000596|NCT00506441|2427745|P2|NOT COMPLETED|Period 2; Double-blind Period||5
1000597|NCT00506441|2427746|P1|NOT COMPLETED|Period 2; Double-blind Period||3
1000598|NCT00506441|2427745|P2|COMPLETED|Period 2; Double-blind Period||79
1000599|NCT00506441|2427746|P1|COMPLETED|Period 2; Double-blind Period||82
1000600|NCT00506441|2427745|P2|STARTED|Period 2; Double-blind Period||84
1000601|NCT00506441|2427746|P1|STARTED|Period 2; Double-blind Period||85
1000602|NCT00506441|2427745|P2|NOT COMPLETED|Period 1; Open-label Period||0
1000603|NCT00506441|2427746|P1|NOT COMPLETED|Period 1; Open-label Period||76
1000604|NCT00506441|2427745|P2|COMPLETED|Period 1; Open-label Period||0
1000605|NCT00506441|2427746|P1|COMPLETED|Period 1; Open-label Period||169
1000606|NCT00506441|2427745|P2|STARTED|Period 1; Open-label Period||0
1000607|NCT00506441|2427746|P1|STARTED|Period 1; Open-label Period||245
1000608|NCT00506454|2427756|P2|NOT COMPLETED|Overall Study||1
1000609|NCT00506454|2427757|P1|NOT COMPLETED|Overall Study||1
1000610|NCT00506454|2427756|P2|COMPLETED|Overall Study||10
1000611|NCT00506454|2427757|P1|COMPLETED|Overall Study||10
1000612|NCT00506454|2427756|P2|STARTED|Overall Study||11
1000613|NCT00506454|2427757|P1|STARTED|Overall Study||11
1000614|NCT00506493|2427763|P1|NOT COMPLETED|Overall Study||11
1000615|NCT00506493|2427763|P1|COMPLETED|Overall Study||64
1000616|NCT00506493|2427763|P1|STARTED|Overall Study||75
1000617|NCT00506597|2427770|P1|NOT COMPLETED|Overall Study||0
1000618|NCT00506597|2427770|P1|COMPLETED|Overall Study||33
1000619|NCT00506597|2427770|P1|STARTED|Overall Study||33
1000620|NCT00506662|2427776|P2|NOT COMPLETED|Overall Study||28
1000621|NCT00506662|2427777|P1|NOT COMPLETED|Overall Study||17
1000622|NCT00506662|2427776|P2|COMPLETED|Overall Study||20
1000623|NCT00506662|2427777|P1|COMPLETED|Overall Study||21
1000624|NCT00506662|2427776|P2|STARTED|Overall Study||48
1000625|NCT00506662|2427777|P1|STARTED|Overall Study||38
1000626|NCT00506675|2427809|P2|NOT COMPLETED|Overall Study||0
1000627|NCT00506675|2427810|P1|NOT COMPLETED|Overall Study||0
1000628|NCT00506675|2427809|P2|COMPLETED|Overall Study||28
1000629|NCT00506675|2427810|P1|COMPLETED|Overall Study||27
1000630|NCT00506675|2427809|P2|STARTED|Overall Study||28
1000631|NCT00506675|2427810|P1|STARTED|Overall Study||27
1000632|NCT00506714|2427824|P2|NOT COMPLETED|Overall Study||0
1000633|NCT00506714|2427825|P1|NOT COMPLETED|Overall Study||0
1000634|NCT00506714|2427824|P2|COMPLETED|Overall Study||13
1000635|NCT00506714|2427825|P1|COMPLETED|Overall Study||13
1000636|NCT00506714|2427824|P2|STARTED|Overall Study||13
1000637|NCT00506714|2427825|P1|STARTED|Overall Study||13
1000638|NCT00498927|2427833|P1|NOT COMPLETED|Overall Study||0
1000639|NCT00498927|2427833|P1|COMPLETED|Overall Study||47
1000640|NCT00498927|2427833|P1|STARTED|Overall Study||47
1000641|NCT00498940|2427840|P2|NOT COMPLETED|Overall Study||0
1000642|NCT00498940|2427841|P1|NOT COMPLETED|Overall Study||0
1000643|NCT00498940|2427840|P2|COMPLETED|Overall Study||31
1000644|NCT00498940|2427841|P1|COMPLETED|Overall Study||30
1000645|NCT00498940|2427840|P2|STARTED|Overall Study||31
1000646|NCT00498940|2427841|P1|STARTED|Overall Study||30
1000647|NCT00499031|2427847|P1|NOT COMPLETED|Overall Study||3
1000648|NCT00499031|2427847|P1|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|35
1000649|NCT00499031|2427847|P1|STARTED|Overall Study|Total number participants enrolled on study|38
1000650|NCT00499096|2427854|P2|NOT COMPLETED|Overall Study||20
1000651|NCT00499096|2427855|P1|NOT COMPLETED|Overall Study||23
1000652|NCT00499096|2427854|P2|COMPLETED|Overall Study||40
1000653|NCT00499096|2427855|P1|COMPLETED|Overall Study||35
1000654|NCT00499096|2427854|P2|STARTED|Overall Study||60
1000655|NCT00499096|2427855|P1|STARTED|Overall Study||58
1000656|NCT00499109|2427875|P2|NOT COMPLETED|Overall Study||7
1000657|NCT00499109|2427876|P1|NOT COMPLETED|Overall Study||18
1000658|NCT00499109|2427875|P2|COMPLETED|Overall Study||85
1000659|NCT00499109|2427876|P1|COMPLETED|Overall Study||165
1000660|NCT00499109|2427875|P2|STARTED|Overall Study||92
1000661|NCT00499109|2427876|P1|STARTED|Overall Study||183
1000662|NCT00499122|2427889|P1|NOT COMPLETED|Overall Study||2
1000663|NCT00499122|2427889|P1|COMPLETED|Overall Study||39
1000664|NCT00499122|2427889|P1|STARTED|Overall Study||41
1000665|NCT00506831|2427894|P1|NOT COMPLETED|Overall Study||2
1000666|NCT00506831|2427894|P1|COMPLETED|Overall Study||7
1000667|NCT00506831|2427894|P1|STARTED|Overall Study||9
1000668|NCT00506857|2427898|P1|NOT COMPLETED|Overall Study||0
1000669|NCT00506857|2427898|P1|COMPLETED|Overall Study||80
1000670|NCT00506857|2427898|P1|STARTED|Overall Study||80
1000671|NCT00506883|2427906|P3|NOT COMPLETED|Overall Study||4
1000672|NCT00506883|2427907|P2|NOT COMPLETED|Overall Study||3
1000673|NCT00506883|2427908|P1|NOT COMPLETED|Overall Study||7
1000674|NCT00506883|2427906|P3|COMPLETED|Overall Study||55
1000675|NCT00506883|2427907|P2|COMPLETED|Overall Study||71
1000676|NCT00506883|2427908|P1|COMPLETED|Overall Study||45
1000677|NCT00506883|2427906|P3|STARTED|Overall Study||59
1000678|NCT00506883|2427907|P2|STARTED|Overall Study||74
1000679|NCT00506883|2427908|P1|STARTED|Overall Study||52
1000680|NCT00506922|2427921|P5|NOT COMPLETED|Overall Study||1
1000681|NCT00506922|2427922|P4|NOT COMPLETED|Overall Study||2
1000682|NCT00506922|2427923|P3|NOT COMPLETED|Overall Study||0
1000683|NCT00506922|2427924|P2|NOT COMPLETED|Overall Study||0
1000684|NCT00506922|2427925|P1|NOT COMPLETED|Overall Study||0
1000685|NCT00506922|2427921|P5|COMPLETED|Overall Study||10
1000686|NCT00506922|2427922|P4|COMPLETED|Overall Study||61
1000687|NCT00506922|2427923|P3|COMPLETED|Overall Study||29
1000688|NCT00506922|2427924|P2|COMPLETED|Overall Study||10
1000689|NCT00506922|2427925|P1|COMPLETED|Overall Study||37
1000690|NCT00506922|2427921|P5|STARTED|Overall Study||11
1000691|NCT00506922|2427922|P4|STARTED|Overall Study||63
1000692|NCT00506922|2427923|P3|STARTED|Overall Study||29
1000693|NCT00506922|2427924|P2|STARTED|Overall Study||10
1000694|NCT00506922|2427925|P1|STARTED|Overall Study||37
1000695|NCT00506948|2427933|P1|NOT COMPLETED|Overall Study||10
1000696|NCT00506948|2427933|P1|COMPLETED|Overall Study||0
1000697|NCT00506948|2427933|P1|STARTED|Overall Study||10
1000698|NCT00507416|2427940|P3|NOT COMPLETED|Overall Study||114
1000699|NCT00507416|2427941|P2|NOT COMPLETED|Overall Study||125
1000700|NCT00507416|2427942|P1|NOT COMPLETED|Overall Study||118
1000701|NCT00507416|2427940|P3|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|53
1000702|NCT00507416|2427941|P2|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|42
1000703|NCT00507416|2427942|P1|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|50
1000704|NCT00507416|2427940|P3|Completed 8 Treatment Cycles|Overall Study||69
1000705|NCT00507416|2427941|P2|Completed 8 Treatment Cycles|Overall Study||60
1000706|NCT00507416|2427942|P1|Completed 8 Treatment Cycles|Overall Study||82
1000707|NCT00507416|2427940|P3|Treated (Safety Population)|Overall Study||163
1000708|NCT00507416|2427941|P2|Treated (Safety Population)|Overall Study||158
1000709|NCT00507416|2427942|P1|Treated (Safety Population)|Overall Study||165
1000710|NCT00507416|2427940|P3|STARTED|Overall Study||167
1000711|NCT00507416|2427941|P2|STARTED|Overall Study||167
1000712|NCT00507416|2427942|P1|STARTED|Overall Study||168
1000713|NCT00507429|2427973|P2|NOT COMPLETED|Maintenance Phase||0
1000714|NCT00507429|2427974|P1|NOT COMPLETED|Maintenance Phase||14
1000715|NCT00507429|2427973|P2|COMPLETED|Maintenance Phase||0
1000716|NCT00507429|2427974|P1|COMPLETED|Maintenance Phase|14 subjects were withdrawn due to progressive disease, 2 subjects continued beyond data cut-off|2
1000717|NCT00507429|2427973|P2|STARTED|Maintenance Phase|Control arm subjects followed for survival only; not enrolled in Maintenance period|0
1000718|NCT00507429|2427974|P1|STARTED|Maintenance Phase|2 subjects did not enter maintenance: 1/18 progressive disease; 1/18 lost to follow-up.|16
1000719|NCT00507429|2427973|P2|NOT COMPLETED|Treatment Phase||18
1000720|NCT00507429|2427974|P1|NOT COMPLETED|Treatment Phase||37
1000721|NCT00507429|2427973|P2|COMPLETED|Treatment Phase||7
1000722|NCT00507429|2427974|P1|COMPLETED|Treatment Phase||18
1000723|NCT00507429|2427973|P2|STARTED|Treatment Phase|Randomized|25
1000724|NCT00507429|2427974|P1|STARTED|Treatment Phase|Randomized|55
1000725|NCT00507442|2427986|P4|NOT COMPLETED|Overall Study||5
1000726|NCT00507442|2427987|P3|NOT COMPLETED|Overall Study||15
1000727|NCT00507442|2427988|P2|NOT COMPLETED|Overall Study||27
1000728|NCT00507442|2427989|P1|NOT COMPLETED|Overall Study||16
1000729|NCT00507442|2427986|P4|COMPLETED|Overall Study||12
1000730|NCT00507442|2427987|P3|COMPLETED|Overall Study||18
1000731|NCT00507442|2427988|P2|COMPLETED|Overall Study||39
1000732|NCT00507442|2427989|P1|COMPLETED|Overall Study||26
1000733|NCT00507442|2427986|P4|STARTED|Overall Study||17
1000734|NCT00507442|2427987|P3|STARTED|Overall Study||33
1000735|NCT00507442|2427988|P2|STARTED|Overall Study||66
1000736|NCT00507442|2427989|P1|STARTED|Overall Study||42
1000737|NCT00507455|2428042|P3|NOT COMPLETED|Overall Study||12
1000738|NCT00507455|2428043|P2|NOT COMPLETED|Overall Study||6
1000739|NCT00507455|2428044|P1|NOT COMPLETED|Overall Study||12
1000740|NCT00507455|2428042|P3|COMPLETED|Overall Study||62
1000741|NCT00507455|2428043|P2|COMPLETED|Overall Study||68
1000742|NCT00507455|2428044|P1|COMPLETED|Overall Study||62
1000743|NCT00507455|2428042|P3|STARTED|Overall Study||74
1000744|NCT00507455|2428043|P2|STARTED|Overall Study||74
1000745|NCT00507455|2428044|P1|STARTED|Overall Study||74
1000746|NCT00507507|2428105|P2|NOT COMPLETED|24-week Treatment-free Follow-up Period||17
1000747|NCT00507507|2428106|P1|NOT COMPLETED|24-week Treatment-free Follow-up Period||10
1000748|NCT00507507|2428105|P2|COMPLETED|24-week Treatment-free Follow-up Period||12
1000749|NCT00507507|2428106|P1|COMPLETED|24-week Treatment-free Follow-up Period||16
1000750|NCT00507507|2428105|P2|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|29
1000751|NCT00507507|2428106|P1|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|26
1000752|NCT00507507|2428105|P2|NOT COMPLETED|Treatment Period||53
1000753|NCT00507507|2428106|P1|NOT COMPLETED|Treatment Period||52
1000754|NCT00507507|2428105|P2|COMPLETED|Treatment Period||9
1000755|NCT00507507|2428106|P1|COMPLETED|Treatment Period||12
1000756|NCT00507507|2428105|P2|Completed 192 Weeks of Treatment|Treatment Period||52
1000757|NCT00507507|2428106|P1|Completed 192 Weeks of Treatment|Treatment Period||52
1000758|NCT00507507|2428105|P2|STARTED|Treatment Period||62
1000759|NCT00507507|2428106|P1|STARTED|Treatment Period||64
1000760|NCT00507546|2428140|P2|NOT COMPLETED|Overall Study||1
1000761|NCT00507546|2428141|P1|NOT COMPLETED|Overall Study||2
1000762|NCT00507546|2428140|P2|COMPLETED|Overall Study||3
1000763|NCT00507546|2428141|P1|COMPLETED|Overall Study||2
1000764|NCT00507546|2428140|P2|STARTED|Overall Study||4
1000765|NCT00507546|2428141|P1|STARTED|Overall Study||4
1000766|NCT00507559|2428149|P1|NOT COMPLETED|Overall Study||71
1000767|NCT00507559|2428149|P1|COMPLETED|Overall Study||84
1000768|NCT00507559|2428149|P1|STARTED|Overall Study||155
1000769|NCT00507689|2428165|P2|NOT COMPLETED|Randomized Period||2
1000770|NCT00507689|2428166|P1|NOT COMPLETED|Randomized Period||1
1000771|NCT00507689|2428165|P2|COMPLETED|Randomized Period||16
1000772|NCT00507689|2428166|P1|COMPLETED|Randomized Period||18
1000773|NCT00507689|2428165|P2|STARTED|Randomized Period|18 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF.|18
1000774|NCT00507689|2428166|P1|STARTED|Randomized Period|19 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF+HBIg.|19
1000775|NCT00507689|2428165|P2|NOT COMPLETED|Pre-Randomization Period||0
1000776|NCT00507689|2428166|P1|NOT COMPLETED|Pre-Randomization Period||3
1000777|NCT00507689|2428165|P2|COMPLETED|Pre-Randomization Period||0
1000778|NCT00507689|2428166|P1|COMPLETED|Pre-Randomization Period||37
1000779|NCT00507689|2428165|P2|STARTED|Pre-Randomization Period||0
1000780|NCT00507689|2428166|P1|STARTED|Pre-Randomization Period||40
1000781|NCT00507767|2428183|P1|NOT COMPLETED|Overall Study||0
1000782|NCT00507767|2428183|P1|COMPLETED|Overall Study||15
1000783|NCT00507767|2428183|P1|STARTED|Overall Study||15
1000784|NCT00507819|2428187|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
1000785|NCT00507819|2428188|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
1000786|NCT00507819|2428187|P2|COMPLETED|Second Intervention (6 Weeks)||14
1000787|NCT00507819|2428188|P1|COMPLETED|Second Intervention (6 Weeks)||13
1000788|NCT00507819|2428187|P2|STARTED|Second Intervention (6 Weeks)||14
1000789|NCT00507819|2428188|P1|STARTED|Second Intervention (6 Weeks)||13
1000790|NCT00507819|2428187|P2|NOT COMPLETED|Washout (6 Weeks)||0
1000791|NCT00507819|2428188|P1|NOT COMPLETED|Washout (6 Weeks)||1
1000792|NCT00507819|2428187|P2|COMPLETED|Washout (6 Weeks)||14
1000793|NCT00507819|2428188|P1|COMPLETED|Washout (6 Weeks)||13
1000794|NCT00507819|2428187|P2|STARTED|Washout (6 Weeks)||14
1000795|NCT00507819|2428188|P1|STARTED|Washout (6 Weeks)||14
1000796|NCT00507819|2428187|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
1000797|NCT00507819|2428188|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
1000798|NCT00507819|2428187|P2|COMPLETED|First Intervention (6 Weeks)||14
1000799|NCT00507819|2428188|P1|COMPLETED|First Intervention (6 Weeks)||14
1000800|NCT00507819|2428187|P2|STARTED|First Intervention (6 Weeks)||14
1000801|NCT00507819|2428188|P1|STARTED|First Intervention (6 Weeks)||14
1000802|NCT00508001|2428203|P3|NOT COMPLETED|Overall Study||7
1000803|NCT00508001|2428204|P2|NOT COMPLETED|Overall Study||12
1000804|NCT00508001|2428205|P1|NOT COMPLETED|Overall Study||19
1000805|NCT00508001|2428203|P3|COMPLETED|Overall Study||16
1000806|NCT00508001|2428204|P2|COMPLETED|Overall Study||13
1000807|NCT00508001|2428205|P1|COMPLETED|Overall Study||0
1000808|NCT00508001|2428203|P3|Secondary Treatment Phase|Overall Study||16
1000809|NCT00508001|2428204|P2|Secondary Treatment Phase|Overall Study||13
1000810|NCT00508001|2428205|P1|Secondary Treatment Phase|Overall Study||0
1000811|NCT00508001|2428203|P3|STARTED|Overall Study||23
1000812|NCT00508001|2428204|P2|STARTED|Overall Study||25
1000813|NCT00508001|2428205|P1|STARTED|Overall Study||19
1000814|NCT00508027|2428222|P1|NOT COMPLETED|Dose Level 3||0
1000815|NCT00508027|2428222|P1|COMPLETED|Dose Level 3||2
1000816|NCT00508027|2428222|P1|STARTED|Dose Level 3|enrollment discontinued due to FDA recommendations regarding high dose (80mg/day) simvastatin|2
1000817|NCT00508027|2428222|P1|NOT COMPLETED|Dose Level 2||4
1000818|NCT00508027|2428222|P1|COMPLETED|Dose Level 2||16
1000905|NCT00508716|2428492|P1|COMPLETED|Overall Study||61
1000819|NCT00508027|2428222|P1|STARTED|Dose Level 2|The participants starting each dose period is a new cohort of subjects. 20 new subjects in dose 2|20
1000820|NCT00508027|2428222|P1|NOT COMPLETED|Dose Level 1||8
1000821|NCT00508027|2428222|P1|COMPLETED|Dose Level 1||12
1000822|NCT00508027|2428222|P1|STARTED|Dose Level 1|The participants starting each dose period is a new cohort of subjects. 20 subjects started dose 1|20
1000823|NCT00508118|2428262|P2|NOT COMPLETED|Overall Study||0
1000824|NCT00508118|2428263|P1|NOT COMPLETED|Overall Study||0
1000825|NCT00508118|2428262|P2|COMPLETED|Overall Study||4
1000826|NCT00508118|2428263|P1|COMPLETED|Overall Study||3
1000827|NCT00508118|2428262|P2|STARTED|Overall Study|Documentation is not available for the 7th subject and treatment arm.|4
1000828|NCT00508118|2428263|P1|STARTED|Overall Study||3
1000829|NCT00508144|2428282|P1|NOT COMPLETED|Overall Study||11
1000830|NCT00508144|2428282|P1|COMPLETED|Overall Study||53
1000831|NCT00508144|2428282|P1|STARTED|Overall Study||64
1000832|NCT00508157|2428288|P2|NOT COMPLETED|Overall Study||3
1000833|NCT00508157|2428289|P1|NOT COMPLETED|Overall Study||2
1000834|NCT00508157|2428288|P2|COMPLETED|Overall Study||23
1000835|NCT00508157|2428289|P1|COMPLETED|Overall Study||24
1000836|NCT00508157|2428288|P2|Safety Sample|Overall Study|1 participant was withdrawn from study prior to receiving study drug & excluded from safety sample.|25
1000837|NCT00508157|2428289|P1|Safety Sample|Overall Study||26
1000838|NCT00508157|2428288|P2|Randomized Sample|Overall Study||26
1000839|NCT00508157|2428289|P1|Randomized Sample|Overall Study||26
1000840|NCT00508157|2428288|P2|STARTED|Overall Study||26
1000841|NCT00508157|2428289|P1|STARTED|Overall Study||26
1000842|NCT00508274|2428311|P1|NOT COMPLETED|Overall Study||2
1000843|NCT00508274|2428311|P1|COMPLETED|Overall Study||50
1000844|NCT00508274|2428311|P1|STARTED|Overall Study||52
1000845|NCT00508391|2428322|P2|NOT COMPLETED|Second Treatment||0
1000846|NCT00508391|2428323|P1|NOT COMPLETED|Second Treatment||2
1000847|NCT00508391|2428322|P2|COMPLETED|Second Treatment||59
1000848|NCT00508391|2428323|P1|COMPLETED|Second Treatment||52
1000849|NCT00508391|2428322|P2|STARTED|Second Treatment||59
1000850|NCT00508391|2428323|P1|STARTED|Second Treatment||54
1000851|NCT00508391|2428322|P2|NOT COMPLETED|First Treatment||3
1000852|NCT00508391|2428323|P1|NOT COMPLETED|First Treatment||6
1000853|NCT00508391|2428322|P2|COMPLETED|First Treatment||59
1000854|NCT00508391|2428323|P1|COMPLETED|First Treatment||54
1000855|NCT00508391|2428322|P2|STARTED|First Treatment||62
1000856|NCT00508391|2428323|P1|STARTED|First Treatment||60
1000857|NCT00508404|2428334|P1|NOT COMPLETED|Overall Study||42
1000858|NCT00508404|2428334|P1|COMPLETED|Overall Study|Completion of safety follow-up visit conducted 8 weeks after last dose|112
1000859|NCT00508404|2428334|P1|STARTED|Overall Study||154
1000860|NCT00508469|2428361|P2|NOT COMPLETED|Overall Study||10
1000861|NCT00508469|2428362|P1|NOT COMPLETED|Overall Study||17
1000862|NCT00508469|2428361|P2|COMPLETED|Overall Study||40
1000863|NCT00508469|2428362|P1|COMPLETED|Overall Study||35
1000864|NCT00508469|2428361|P2|STARTED|Overall Study||50
1000865|NCT00508469|2428362|P1|STARTED|Overall Study||52
1000866|NCT00508482|2428371|P3|NOT COMPLETED|at the 12th Week of Follow-up||0
1000867|NCT00508482|2428372|P2|NOT COMPLETED|at the 12th Week of Follow-up||0
1000868|NCT00508482|2428373|P1|NOT COMPLETED|at the 12th Week of Follow-up||0
1000869|NCT00508482|2428371|P3|COMPLETED|at the 12th Week of Follow-up||98
1000870|NCT00508482|2428372|P2|COMPLETED|at the 12th Week of Follow-up||96
1000871|NCT00508482|2428373|P1|COMPLETED|at the 12th Week of Follow-up||196
1000872|NCT00508482|2428371|P3|STARTED|at the 12th Week of Follow-up||98
1000873|NCT00508482|2428372|P2|STARTED|at the 12th Week of Follow-up||96
1000874|NCT00508482|2428373|P1|STARTED|at the 12th Week of Follow-up||196
1000875|NCT00508482|2428371|P3|NOT COMPLETED|at the 4th Week of Follow-up||1
1000876|NCT00508482|2428372|P2|NOT COMPLETED|at the 4th Week of Follow-up||6
1000877|NCT00508482|2428373|P1|NOT COMPLETED|at the 4th Week of Follow-up||20
1000878|NCT00508482|2428371|P3|COMPLETED|at the 4th Week of Follow-up||98
1000879|NCT00508482|2428372|P2|COMPLETED|at the 4th Week of Follow-up||96
1000880|NCT00508482|2428373|P1|COMPLETED|at the 4th Week of Follow-up||196
1000881|NCT00508482|2428371|P3|STARTED|at the 4th Week of Follow-up||99
1000882|NCT00508482|2428372|P2|STARTED|at the 4th Week of Follow-up||102
1000883|NCT00508482|2428373|P1|STARTED|at the 4th Week of Follow-up||216
1000884|NCT00508482|2428371|P3|NOT COMPLETED|Over 4 Weeks of Treatment||20
1000885|NCT00508482|2428372|P2|NOT COMPLETED|Over 4 Weeks of Treatment||17
1000886|NCT00508482|2428373|P1|NOT COMPLETED|Over 4 Weeks of Treatment||21
1000887|NCT00508482|2428371|P3|COMPLETED|Over 4 Weeks of Treatment||99
1000888|NCT00508482|2428372|P2|COMPLETED|Over 4 Weeks of Treatment||102
1000889|NCT00508482|2428373|P1|COMPLETED|Over 4 Weeks of Treatment||216
1000890|NCT00508482|2428371|P3|STARTED|Over 4 Weeks of Treatment||119
1000891|NCT00508482|2428372|P2|STARTED|Over 4 Weeks of Treatment||119
1000892|NCT00508482|2428373|P1|STARTED|Over 4 Weeks of Treatment||237
1000893|NCT00508521|2428408|P1|NOT COMPLETED|Overall Study||0
1000894|NCT00508521|2428408|P1|COMPLETED|Overall Study||4
1000895|NCT00508521|2428408|P1|STARTED|Overall Study||4
1000896|NCT00508651|2428414|P2|NOT COMPLETED|Overall Study||2
1000897|NCT00508651|2428415|P1|NOT COMPLETED|Overall Study||4
1000898|NCT00508651|2428414|P2|COMPLETED|Overall Study||8
1000899|NCT00508651|2428415|P1|COMPLETED|Overall Study||16
1000900|NCT00508651|2428414|P2|STARTED|Overall Study||10
1000901|NCT00508651|2428415|P1|STARTED|Overall Study||20
1000902|NCT00508716|2428491|P2|NOT COMPLETED|Overall Study||0
1000903|NCT00508716|2428492|P1|NOT COMPLETED|Overall Study||0
1000904|NCT00508716|2428491|P2|COMPLETED|Overall Study||63
1000906|NCT00508716|2428491|P2|STARTED|Overall Study||63
1000907|NCT00508716|2428492|P1|STARTED|Overall Study||61
1000908|NCT00508742|2428500|P2|NOT COMPLETED|Period 3: Toddler Dose||15
1000909|NCT00508742|2428501|P1|NOT COMPLETED|Period 3: Toddler Dose||25
1000910|NCT00508742|2428500|P2|COMPLETED|Period 3: Toddler Dose||863
1000911|NCT00508742|2428501|P1|COMPLETED|Period 3: Toddler Dose||858
1000912|NCT00508742|2428500|P2|STARTED|Period 3: Toddler Dose||878
1000913|NCT00508742|2428501|P1|STARTED|Period 3: Toddler Dose||883
1000914|NCT00508742|2428500|P2|NOT COMPLETED|Period 2: After Infant Series||11
1000915|NCT00508742|2428501|P1|NOT COMPLETED|Period 2: After Infant Series||7
1000916|NCT00508742|2428500|P2|COMPLETED|Period 2: After Infant Series||878
1000917|NCT00508742|2428501|P1|COMPLETED|Period 2: After Infant Series||883
1000918|NCT00508742|2428500|P2|STARTED|Period 2: After Infant Series||889
1000919|NCT00508742|2428501|P1|STARTED|Period 2: After Infant Series||890
1000920|NCT00508742|2428500|P2|NOT COMPLETED|Period 1: Infant Series||45
1000921|NCT00508742|2428501|P1|NOT COMPLETED|Period 1: Infant Series||42
1000922|NCT00508742|2428500|P2|COMPLETED|Period 1: Infant Series||889
1000923|NCT00508742|2428501|P1|COMPLETED|Period 1: Infant Series||890
1000924|NCT00508742|2428500|P2|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||892
1000925|NCT00508742|2428501|P1|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||898
1000926|NCT00508742|2428500|P2|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||902
1000927|NCT00508742|2428501|P1|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||904
1000928|NCT00508742|2428500|P2|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||933
1000929|NCT00508742|2428501|P1|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||930
1000930|NCT00508742|2428500|P2|STARTED|Period 1: Infant Series||934
1000931|NCT00508742|2428501|P1|STARTED|Period 1: Infant Series||932
1000932|NCT00508755|2428515|P1|NOT COMPLETED|Overall Study||1
1000933|NCT00508755|2428515|P1|COMPLETED|Overall Study||5
1000934|NCT00508755|2428515|P1|STARTED|Overall Study||6
1000935|NCT00508820|2428523|P2|NOT COMPLETED|Overall Study||64
1000936|NCT00508820|2428524|P1|NOT COMPLETED|Overall Study||55
1000937|NCT00508820|2428523|P2|COMPLETED|Overall Study||175
1000938|NCT00508820|2428524|P1|COMPLETED|Overall Study||113
1000939|NCT00508820|2428523|P2|STARTED|Overall Study||239
1000940|NCT00508820|2428524|P1|STARTED|Overall Study||168
1000941|NCT00508872|2428534|P1|NOT COMPLETED|Overall Study||2
1000942|NCT00508872|2428534|P1|COMPLETED|Overall Study||0
1000943|NCT00508872|2428534|P1|STARTED|Overall Study||2
1000944|NCT00508924|2428542|P4|NOT COMPLETED|Overall Study||1
1000945|NCT00508924|2428543|P3|NOT COMPLETED|Overall Study||1
1000946|NCT00508924|2428544|P2|NOT COMPLETED|Overall Study||0
1000947|NCT00508924|2428545|P1|NOT COMPLETED|Overall Study||0
1000948|NCT00508924|2428542|P4|COMPLETED|Overall Study||33
1000949|NCT00508924|2428543|P3|COMPLETED|Overall Study||31
1000950|NCT00508924|2428544|P2|COMPLETED|Overall Study||38
1000951|NCT00508924|2428545|P1|COMPLETED|Overall Study||36
1000952|NCT00508924|2428542|P4|STARTED|Overall Study||34
1000953|NCT00508924|2428543|P3|STARTED|Overall Study||32
1000954|NCT00508924|2428544|P2|STARTED|Overall Study||38
1000955|NCT00508924|2428545|P1|STARTED|Overall Study||36
1000956|NCT00509028|2428561|P2|NOT COMPLETED|Overall Study||7
1000957|NCT00509028|2428562|P1|NOT COMPLETED|Overall Study||12
1000958|NCT00509028|2428561|P2|COMPLETED|Overall Study||113
1000959|NCT00509028|2428562|P1|COMPLETED|Overall Study||109
1000960|NCT00509028|2428561|P2|STARTED|Overall Study||120
1000961|NCT00509028|2428562|P1|STARTED|Overall Study||121
1000962|NCT00509041|2428594|P1|NOT COMPLETED|Overall Study||0
1000963|NCT00509041|2428594|P1|COMPLETED|Overall Study||43
1000964|NCT00509041|2428594|P1|STARTED|Overall Study||43
1000965|NCT00509067|2428603|P2|NOT COMPLETED|Overall Study||5
1000966|NCT00509067|2428604|P1|NOT COMPLETED|Overall Study||4
1000967|NCT00509067|2428603|P2|COMPLETED|Overall Study||19
1000968|NCT00509067|2428604|P1|COMPLETED|Overall Study||15
1000969|NCT00509067|2428603|P2|STARTED|Overall Study||24
1000970|NCT00509067|2428604|P1|STARTED|Overall Study||19
1000971|NCT00509106|2428612|P2|NOT COMPLETED|Overall Study||29
1000972|NCT00509106|2428613|P1|NOT COMPLETED|Overall Study||31
1000973|NCT00509106|2428612|P2|COMPLETED|Overall Study||278
1000974|NCT00509106|2428613|P1|COMPLETED|Overall Study||284
1000975|NCT00509106|2428612|P2|STARTED|Overall Study||307
1000976|NCT00509106|2428613|P1|STARTED|Overall Study||315
1000977|NCT00509197|2428621|P2|NOT COMPLETED|Overall Study||0
1000978|NCT00509197|2428622|P1|NOT COMPLETED|Overall Study||0
1000979|NCT00509197|2428621|P2|COMPLETED|Overall Study||6
1000980|NCT00509197|2428622|P1|COMPLETED|Overall Study||6
1000981|NCT00509197|2428621|P2|STARTED|Overall Study||6
1000982|NCT00509197|2428622|P1|STARTED|Overall Study||6
1000983|NCT00509223|2428636|P2|NOT COMPLETED|Overall Study||72
1000984|NCT00509223|2428637|P1|NOT COMPLETED|Overall Study||88
1000985|NCT00509223|2428636|P2|COMPLETED|Overall Study||137
1000986|NCT00509223|2428637|P1|COMPLETED|Overall Study||119
1000987|NCT00509223|2428636|P2|STARTED|Overall Study||209
1000988|NCT00509223|2428637|P1|STARTED|Overall Study||207
1000989|NCT00509236|2428645|P2|NOT COMPLETED|Overall Study||20
1000990|NCT00509236|2428646|P1|NOT COMPLETED|Overall Study||17
1000991|NCT00509236|2428645|P2|COMPLETED|Overall Study||45
1000992|NCT00509236|2428646|P1|COMPLETED|Overall Study||47
1000993|NCT00509236|2428645|P2|STARTED|Overall Study||65
1000994|NCT00509236|2428646|P1|STARTED|Overall Study||64
1000995|NCT00509249|2428659|P1|NOT COMPLETED|Overall Study||0
1000996|NCT00509249|2428659|P1|COMPLETED|Overall Study||18
1000997|NCT00509249|2428659|P1|STARTED|Overall Study||18
1000998|NCT00509262|2428665|P2|NOT COMPLETED|Overall Study||42
1000999|NCT00509262|2428666|P1|NOT COMPLETED|Overall Study||47
1001000|NCT00509262|2428665|P2|COMPLETED|Overall Study||170
1001001|NCT00509262|2428666|P1|COMPLETED|Overall Study||164
1001002|NCT00509262|2428665|P2|STARTED|Overall Study||212
1001003|NCT00509262|2428666|P1|STARTED|Overall Study||211
1001004|NCT00509288|2428680|P2|NOT COMPLETED|Overall Study||0
1001005|NCT00509288|2428681|P1|NOT COMPLETED|Overall Study||0
1001006|NCT00509288|2428680|P2|COMPLETED|Overall Study||3
1001007|NCT00509288|2428681|P1|COMPLETED|Overall Study||21
1001008|NCT00509288|2428680|P2|STARTED|Overall Study||3
1001009|NCT00509288|2428681|P1|STARTED|Overall Study||21
1001010|NCT00509366|2428694|P5|NOT COMPLETED|Overall Study||0
1001011|NCT00509366|2428695|P4|NOT COMPLETED|Overall Study||0
1001012|NCT00509366|2428696|P3|NOT COMPLETED|Overall Study||1
1001013|NCT00509366|2428697|P2|NOT COMPLETED|Overall Study||1
1001014|NCT00509366|2428698|P1|NOT COMPLETED|Overall Study||1
1001015|NCT00509366|2428694|P5|COMPLETED|Overall Study|Patients who were neither assigned nor treated with protocol-based therapy.|51
1001016|NCT00509366|2428695|P4|COMPLETED|Overall Study|Patients assigned to treatment and treated with docetaxel/gemcitabine treatment combination.|2
1001017|NCT00509366|2428696|P3|COMPLETED|Overall Study|Patients assigned to treatment and treated with pemetrexed/gemcitabine treatment combination.|21
1001018|NCT00509366|2428697|P2|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/pemetrexed treatment combination.|7
1001019|NCT00509366|2428698|P1|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/gemcitabine treatment combination.|17
1001020|NCT00509366|2428694|P5|Assigned Treatment|Overall Study||0
1001021|NCT00509366|2428695|P4|Assigned Treatment|Overall Study|Patients who were assigned to docetaxel/gemcitabine treatment arm.|2
1001022|NCT00509366|2428696|P3|Assigned Treatment|Overall Study|Patients who were assigned to pemetrexed/gemcitabine treatment arm.|22
1001023|NCT00509366|2428697|P2|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/pemetrexed treatment arm.|8
1001024|NCT00509366|2428698|P1|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/gemcitabine treatment arm.|18
1001025|NCT00509366|2428694|P5|STARTED|Overall Study|Registered patients who were neither assigned nor treated with protocol-based therapy.|51
1001026|NCT00509366|2428695|P4|STARTED|Overall Study|Registered patients who were assigned docetaxel/gemcitabine treatment.|2
1001027|NCT00509366|2428696|P3|STARTED|Overall Study|Registered patients who were assigned pemetrexed/gemcitabine treatment.|22
1001028|NCT00509366|2428697|P2|STARTED|Overall Study|Registered patients who were assigned cisplatin/pemetrexed treatment.|8
1001029|NCT00509366|2428698|P1|STARTED|Overall Study|Registered patients who were assigned cisplatin/gemcitabine treatment.|18
1001030|NCT00509392|2428711|P3|NOT COMPLETED|Overall Study||0
1001031|NCT00509392|2428712|P2|NOT COMPLETED|Overall Study||0
1001032|NCT00509392|2428713|P1|NOT COMPLETED|Overall Study||0
1001033|NCT00509392|2428711|P3|COMPLETED|Overall Study||4
1001034|NCT00509392|2428712|P2|COMPLETED|Overall Study||33
1001035|NCT00509392|2428713|P1|COMPLETED|Overall Study||32
1001036|NCT00509392|2428711|P3|STARTED|Overall Study||4
1001037|NCT00509392|2428712|P2|STARTED|Overall Study||33
1001038|NCT00509392|2428713|P1|STARTED|Overall Study||32
1001039|NCT00509496|2428761|P2|NOT COMPLETED|Overall Study||0
1001040|NCT00509496|2428762|P1|NOT COMPLETED|Overall Study||0
1001041|NCT00509496|2428761|P2|COMPLETED|Overall Study||2
1001042|NCT00509496|2428762|P1|COMPLETED|Overall Study||19
1001043|NCT00509496|2428761|P2|STARTED|Overall Study||2
1001044|NCT00509496|2428762|P1|STARTED|Overall Study||19
1001045|NCT00509587|2428770|P1|NOT COMPLETED|Overall Study||0
1001046|NCT00509587|2428770|P1|COMPLETED|Overall Study||21
1001047|NCT00509587|2428770|P1|STARTED|Overall Study||21
1001048|NCT00509600|2428778|P1|NOT COMPLETED|Overall Study||1
1001049|NCT00509600|2428778|P1|COMPLETED|Overall Study||0
1001050|NCT00509600|2428778|P1|STARTED|Overall Study||1
1001051|NCT00509769|2428782|P1|NOT COMPLETED|Overall Study||91
1001052|NCT00509769|2428782|P1|COMPLETED|Overall Study||21
1001053|NCT00509769|2428782|P1|STARTED|Overall Study||112
1001054|NCT00509795|2428795|P4|NOT COMPLETED|Overall Study||27
1001055|NCT00509795|2428796|P3|NOT COMPLETED|Overall Study||27
1001056|NCT00509795|2428797|P2|NOT COMPLETED|Overall Study||11
1001057|NCT00509795|2428798|P1|NOT COMPLETED|Overall Study||22
1001058|NCT00509795|2428795|P4|COMPLETED|Overall Study||276
1001059|NCT00509795|2428796|P3|COMPLETED|Overall Study||277
1001060|NCT00509795|2428797|P2|COMPLETED|Overall Study||293
1001061|NCT00509795|2428798|P1|COMPLETED|Overall Study||284
1001062|NCT00509795|2428795|P4|Per Protocol Set (PPS) Population|Overall Study||265
1001063|NCT00509795|2428796|P3|Per Protocol Set (PPS) Population|Overall Study||270
1001064|NCT00509795|2428797|P2|Per Protocol Set (PPS) Population|Overall Study||285
1001065|NCT00509795|2428798|P1|Per Protocol Set (PPS) Population|Overall Study||269
1001066|NCT00509795|2428795|P4|Full Analysis Set (FAS) Population|Overall Study||301
1001067|NCT00509795|2428796|P3|Full Analysis Set (FAS) Population|Overall Study||301
1001068|NCT00509795|2428797|P2|Full Analysis Set (FAS) Population|Overall Study||304
1001069|NCT00509795|2428798|P1|Full Analysis Set (FAS) Population|Overall Study||304
1001070|NCT00509795|2428795|P4|Patients Received Treatment (SAF)|Overall Study||303
1001071|NCT00509795|2428796|P3|Patients Received Treatment (SAF)|Overall Study||304
1001072|NCT00509795|2428797|P2|Patients Received Treatment (SAF)|Overall Study||304
1001073|NCT00509795|2428798|P1|Patients Received Treatment (SAF)|Overall Study||304
1001074|NCT00509795|2428795|P4|STARTED|Overall Study||303
1001075|NCT00509795|2428796|P3|STARTED|Overall Study||304
1001076|NCT00509795|2428797|P2|STARTED|Overall Study||304
1001077|NCT00509795|2428798|P1|STARTED|Overall Study||306
1001078|NCT00502203|2428829|P1|NOT COMPLETED|Overall Study||1
1001079|NCT00502203|2428829|P1|COMPLETED|Overall Study||22
1001080|NCT00502203|2428829|P1|STARTED|Overall Study||23
1001081|NCT00502216|2428835|P2|NOT COMPLETED|Overall Study||0
1001082|NCT00502216|2428836|P1|NOT COMPLETED|Overall Study||0
1001083|NCT00502216|2428835|P2|COMPLETED|Overall Study||19
1001084|NCT00502216|2428836|P1|COMPLETED|Overall Study||21
1001085|NCT00502216|2428835|P2|STARTED|Overall Study||19
1001086|NCT00502216|2428836|P1|STARTED|Overall Study||21
1001087|NCT00502242|2428844|P2|NOT COMPLETED|Overall Study||56
1001088|NCT00502242|2428845|P1|NOT COMPLETED|Overall Study||51
1001089|NCT00502242|2428844|P2|COMPLETED|Overall Study||84
1001090|NCT00502242|2428845|P1|COMPLETED|Overall Study||104
1001091|NCT00502242|2428844|P2|STARTED|Overall Study||140
1001092|NCT00502242|2428845|P1|STARTED|Overall Study||155
1001093|NCT00502320|2428898|P2|NOT COMPLETED|Overall Study||7
1001094|NCT00502320|2428899|P1|NOT COMPLETED|Overall Study||6
1001095|NCT00502320|2428898|P2|COMPLETED|Overall Study||18
1001096|NCT00502320|2428899|P1|COMPLETED|Overall Study||19
1001097|NCT00502320|2428898|P2|Screening Visit|Overall Study|Participant signed informed consent but was a screen failure because she was nursing at the time.|24
1001098|NCT00502320|2428899|P1|Screening Visit|Overall Study||25
1001099|NCT00502320|2428898|P2|STARTED|Overall Study||25
1001100|NCT00502320|2428899|P1|STARTED|Overall Study||25
1001101|NCT00502593|2428921|P12|NOT COMPLETED|Overall Study||0
1001102|NCT00502593|2428922|P11|NOT COMPLETED|Overall Study||2
1001103|NCT00502593|2428923|P10|NOT COMPLETED|Overall Study||0
1001104|NCT00502593|2428924|P9|NOT COMPLETED|Overall Study||6
1001105|NCT00502593|2428925|P8|NOT COMPLETED|Overall Study||0
1001106|NCT00502593|2428926|P7|NOT COMPLETED|Overall Study||5
1001107|NCT00502593|2428927|P6|NOT COMPLETED|Overall Study||0
1001108|NCT00502593|2428928|P5|NOT COMPLETED|Overall Study||4
1001109|NCT00502593|2428929|P4|NOT COMPLETED|Overall Study||4
1001110|NCT00502593|2428930|P3|NOT COMPLETED|Overall Study||10
1001111|NCT00502593|2428931|P2|NOT COMPLETED|Overall Study||2
1001112|NCT00502593|2428932|P1|NOT COMPLETED|Overall Study||3
1001113|NCT00502593|2428921|P12|COMPLETED|Overall Study||18
1001114|NCT00502593|2428922|P11|COMPLETED|Overall Study||47
1001115|NCT00502593|2428923|P10|COMPLETED|Overall Study||17
1001116|NCT00502593|2428924|P9|COMPLETED|Overall Study||43
1001117|NCT00502593|2428925|P8|COMPLETED|Overall Study||17
1001118|NCT00502593|2428926|P7|COMPLETED|Overall Study||44
1001119|NCT00502593|2428927|P6|COMPLETED|Overall Study||17
1001120|NCT00502593|2428928|P5|COMPLETED|Overall Study||47
1001121|NCT00502593|2428929|P4|COMPLETED|Overall Study||14
1001122|NCT00502593|2428930|P3|COMPLETED|Overall Study||41
1001123|NCT00502593|2428931|P2|COMPLETED|Overall Study||16
1001124|NCT00502593|2428932|P1|COMPLETED|Overall Study||48
1001125|NCT00502593|2428921|P12|STARTED|Overall Study||18
1001126|NCT00502593|2428922|P11|STARTED|Overall Study||49
1001127|NCT00502593|2428923|P10|STARTED|Overall Study||17
1001128|NCT00502593|2428924|P9|STARTED|Overall Study||49
1001129|NCT00502593|2428925|P8|STARTED|Overall Study||17
1001130|NCT00502593|2428926|P7|STARTED|Overall Study||49
1001131|NCT00502593|2428927|P6|STARTED|Overall Study||17
1001132|NCT00502593|2428928|P5|STARTED|Overall Study||51
1001133|NCT00502593|2428929|P4|STARTED|Overall Study||18
1001134|NCT00502593|2428930|P3|STARTED|Overall Study||51
1001135|NCT00502593|2428931|P2|STARTED|Overall Study||18
1001136|NCT00502593|2428932|P1|STARTED|Overall Study||51
1001137|NCT00502671|2429446|P1|NOT COMPLETED|Overall Study||77
1001138|NCT00502671|2429446|P1|COMPLETED|Overall Study||151
1001139|NCT00502671|2429446|P1|STARTED|Overall Study||228
1001140|NCT00502697|2429453|P2|NOT COMPLETED|Overall Study||12
1001141|NCT00502697|2429454|P1|NOT COMPLETED|Overall Study||13
1001142|NCT00502697|2429453|P2|COMPLETED|Overall Study||102
1001143|NCT00502697|2429454|P1|COMPLETED|Overall Study||109
1001144|NCT00502697|2429453|P2|STARTED|Overall Study||114
1001145|NCT00502697|2429454|P1|STARTED|Overall Study||122
1001146|NCT00502775|2429465|P3|NOT COMPLETED|Overall Study||13
1001147|NCT00502775|2429466|P2|NOT COMPLETED|Overall Study||15
1001148|NCT00502775|2429467|P1|NOT COMPLETED|Overall Study||10
1001149|NCT00502775|2429465|P3|COMPLETED|Overall Study||214
1001150|NCT00502775|2429466|P2|COMPLETED|Overall Study||209
1001151|NCT00502775|2429467|P1|COMPLETED|Overall Study||219
1001152|NCT00502775|2429465|P3|STARTED|Overall Study||227
1001153|NCT00502775|2429466|P2|STARTED|Overall Study||224
1001154|NCT00502775|2429467|P1|STARTED|Overall Study||229
1001155|NCT00502801|2429508|P1|NOT COMPLETED|End of Therapy to Test of Cure||8
1001156|NCT00502801|2429508|P1|COMPLETED|End of Therapy to Test of Cure||121
1001157|NCT00502801|2429508|P1|STARTED|End of Therapy to Test of Cure||129
1001158|NCT00502801|2429508|P1|NOT COMPLETED|Treatment Period||54
1001159|NCT00502801|2429508|P1|COMPLETED|Treatment Period||129
1001160|NCT00502801|2429508|P1|STARTED|Treatment Period||183
1001161|NCT00502840|2429513|P1|NOT COMPLETED|Overall Study||100
1001162|NCT00502840|2429513|P1|COMPLETED|Overall Study||93
1001163|NCT00502840|2429513|P1|STARTED|Overall Study||193
1001164|NCT00502853|2429541|P1|NOT COMPLETED|Overall Study||0
1001165|NCT00502853|2429541|P1|COMPLETED|Overall Study||10
1001166|NCT00502853|2429541|P1|STARTED|Overall Study||10
1001167|NCT00502905|2429566|P1|NOT COMPLETED|Overall Study||0
1001168|NCT00502905|2429566|P1|COMPLETED|Overall Study||196
1001169|NCT00502905|2429566|P1|STARTED|Overall Study||196
1001170|NCT00502944|2429572|P2|NOT COMPLETED|Overall Study||1766
1001171|NCT00502944|2429573|P1|NOT COMPLETED|Overall Study||1064
1001172|NCT00502944|2429572|P2|COMPLETED|Overall Study||643
1001173|NCT00502944|2429573|P1|COMPLETED|Overall Study||1382
1001174|NCT00502944|2429572|P2|STARTED|Overall Study||2409
1001175|NCT00502944|2429573|P1|STARTED|Overall Study||2446
1001176|NCT00502996|2429585|P1|NOT COMPLETED|Overall Study||44
1001177|NCT00502996|2429585|P1|COMPLETED|Overall Study||188
1001178|NCT00502996|2429585|P1|STARTED|Overall Study||232
1001179|NCT00503009|2429612|P3|NOT COMPLETED|Overall Study||3
1001180|NCT00503009|2429613|P2|NOT COMPLETED|Overall Study||2
1001181|NCT00503009|2429614|P1|NOT COMPLETED|Overall Study||1
1001182|NCT00503009|2429612|P3|COMPLETED|Overall Study||3
1001183|NCT00503009|2429613|P2|COMPLETED|Overall Study||3
1001184|NCT00503009|2429614|P1|COMPLETED|Overall Study||4
1001185|NCT00503009|2429612|P3|STARTED|Overall Study||6
1001186|NCT00503009|2429613|P2|STARTED|Overall Study||5
1001187|NCT00503009|2429614|P1|STARTED|Overall Study||5
1001188|NCT00503113|2429634|P3|NOT COMPLETED|Overall Study||28
1001189|NCT00503113|2429635|P2|NOT COMPLETED|Overall Study||28
1001190|NCT00503113|2429636|P1|NOT COMPLETED|Overall Study||33
1001191|NCT00503113|2429634|P3|COMPLETED|Overall Study||241
1001192|NCT00503113|2429635|P2|COMPLETED|Overall Study||236
1001193|NCT00503113|2429636|P1|COMPLETED|Overall Study||235
1001194|NCT00503113|2429634|P3|Safety Population|Overall Study||267
1001195|NCT00503113|2429635|P2|Safety Population|Overall Study||263
1001196|NCT00503113|2429636|P1|Safety Population|Overall Study||263
1001197|NCT00503113|2429634|P3|Per Protocol Population (PP)|Overall Study||241
1001198|NCT00503113|2429635|P2|Per Protocol Population (PP)|Overall Study||243
1001199|NCT00503113|2429636|P1|Per Protocol Population (PP)|Overall Study||246
1001200|NCT00503113|2429634|P3|Intent to Treat Population (ITT)|Overall Study||268
1001201|NCT00503113|2429635|P2|Intent to Treat Population (ITT)|Overall Study||261
1001202|NCT00503113|2429636|P1|Intent to Treat Population (ITT)|Overall Study||262
1001203|NCT00503113|2429634|P3|STARTED|Overall Study||269
1001204|NCT00503113|2429635|P2|STARTED|Overall Study||264
1001205|NCT00503113|2429636|P1|STARTED|Overall Study||268
1001206|NCT00503139|2429665|P1|NOT COMPLETED|Overall Study||8
1001207|NCT00503139|2429665|P1|COMPLETED|Overall Study||676
1001208|NCT00503139|2429665|P1|STARTED|Overall Study||684
1001209|NCT00503308|2429678|P2|NOT COMPLETED|Overall Study||1
1001210|NCT00503308|2429679|P1|NOT COMPLETED|Overall Study||2
1001211|NCT00503308|2429678|P2|COMPLETED|Overall Study||134
1001212|NCT00503308|2429679|P1|COMPLETED|Overall Study||144
1001213|NCT00503308|2429678|P2|STARTED|Overall Study||135
1001214|NCT00503308|2429679|P1|STARTED|Overall Study||146
1001215|NCT00503399|2429687|P2|NOT COMPLETED|Overall Study||8
1001216|NCT00503399|2429688|P1|NOT COMPLETED|Overall Study||7
1001217|NCT00503399|2429687|P2|COMPLETED|Overall Study||39
1001218|NCT00503399|2429688|P1|COMPLETED|Overall Study||38
1001219|NCT00503399|2429687|P2|STARTED|Overall Study||47
1001220|NCT00503399|2429688|P1|STARTED|Overall Study||45
1001221|NCT00503425|2429710|P1|NOT COMPLETED|Overall Study||54
1001222|NCT00503425|2429710|P1|COMPLETED|Overall Study||161
1001223|NCT00503425|2429710|P1|STARTED|Overall Study||215
1001224|NCT00503698|2429720|P2|NOT COMPLETED|Overall Study||355
1001225|NCT00503698|2429721|P1|NOT COMPLETED|Overall Study||357
1001226|NCT00503698|2429720|P2|COMPLETED|Overall Study|Trial prematurely terminated|0
1001227|NCT00503698|2429721|P1|COMPLETED|Overall Study|Trial prematurely terminated|0
1001228|NCT00503698|2429720|P2|Exposed to Trial Drug|Overall Study|6 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|349
1001229|NCT00503698|2429721|P1|Exposed to Trial Drug|Overall Study|11 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|346
1001230|NCT00503698|2429720|P2|STARTED|Overall Study|Randomised|355
1001231|NCT00503698|2429721|P1|STARTED|Overall Study|Randomised|357
1001232|NCT00503750|2429735|P1|NOT COMPLETED|Overall Study||0
1001233|NCT00503750|2429735|P1|COMPLETED|Overall Study||27
1001234|NCT00503750|2429735|P1|STARTED|Overall Study||27
1001235|NCT00503776|2429744|P4|NOT COMPLETED|Overall Study||2
1001236|NCT00503776|2429745|P3|NOT COMPLETED|Overall Study||2
1001237|NCT00503776|2429746|P2|NOT COMPLETED|Overall Study||0
1001238|NCT00503776|2429747|P1|NOT COMPLETED|Overall Study||1
1001239|NCT00503776|2429744|P4|COMPLETED|Overall Study||8
1001240|NCT00503776|2429745|P3|COMPLETED|Overall Study||10
1001241|NCT00503776|2429746|P2|COMPLETED|Overall Study||12
1001242|NCT00503776|2429747|P1|COMPLETED|Overall Study||7
1001243|NCT00503776|2429744|P4|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|10
1001244|NCT00503776|2429745|P3|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|12
1001245|NCT00503776|2429746|P2|STARTED|Overall Study||12
1001246|NCT00503776|2429747|P1|STARTED|Overall Study||8
1001247|NCT00503841|2429773|P1|NOT COMPLETED|Overall Study||44
1001248|NCT00503841|2429773|P1|COMPLETED|Overall Study||0
1001249|NCT00503841|2429773|P1|STARTED|Overall Study||44
1001250|NCT00503906|2429777|P1|NOT COMPLETED|Overall Study||1
1001251|NCT00503906|2429777|P1|COMPLETED|Overall Study||29
1001252|NCT00503906|2429777|P1|STARTED|Overall Study||30
1001253|NCT00503984|2429788|P6|NOT COMPLETED|Overall Study||0
1001254|NCT00503984|2429789|P5|NOT COMPLETED|Overall Study||1
1001255|NCT00503984|2429790|P4|NOT COMPLETED|Overall Study||0
1001256|NCT00503984|2429791|P3|NOT COMPLETED|Overall Study||0
1001257|NCT00503984|2429792|P2|NOT COMPLETED|Overall Study||2
1001258|NCT00503984|2429793|P1|NOT COMPLETED|Overall Study||0
1001259|NCT00503984|2429788|P6|COMPLETED|Overall Study||1
1001260|NCT00503984|2429789|P5|COMPLETED|Overall Study||5
1001261|NCT00503984|2429790|P4|COMPLETED|Overall Study||6
1001262|NCT00503984|2429791|P3|COMPLETED|Overall Study||3
1001263|NCT00503984|2429792|P2|COMPLETED|Overall Study||1
1001264|NCT00503984|2429793|P1|COMPLETED|Overall Study||3
1001265|NCT00503984|2429788|P6|STARTED|Overall Study||1
1001266|NCT00503984|2429789|P5|STARTED|Overall Study||6
1001267|NCT00503984|2429790|P4|STARTED|Overall Study||6
1001268|NCT00503984|2429791|P3|STARTED|Overall Study||3
1001269|NCT00503984|2429792|P2|STARTED|Overall Study||3
1001270|NCT00503984|2429793|P1|STARTED|Overall Study||3
1001271|NCT00503997|2429819|P1|NOT COMPLETED|Overall Study||8
1001272|NCT00503997|2429819|P1|COMPLETED|Overall Study||34
1001273|NCT00503997|2429819|P1|STARTED|Overall Study||42
1001274|NCT00504075|2429823|P1|NOT COMPLETED|Overall Study||8
1001275|NCT00504075|2429823|P1|COMPLETED|Overall Study||27
1001276|NCT00504075|2429823|P1|STARTED|Overall Study||35
1001277|NCT00504153|2429829|P1|NOT COMPLETED|Overall Study||6
1001278|NCT00504153|2429829|P1|COMPLETED|Overall Study||13
1001279|NCT00504153|2429829|P1|STARTED|Overall Study||19
1001280|NCT00504166|2429839|P2|NOT COMPLETED|Overall Study||14
1001281|NCT00504166|2429840|P1|NOT COMPLETED|Overall Study||6
1001282|NCT00504166|2429839|P2|COMPLETED|Overall Study||13
1001283|NCT00504166|2429840|P1|COMPLETED|Overall Study||20
1001284|NCT00504166|2429839|P2|STARTED|Overall Study||27
1001285|NCT00504166|2429840|P1|STARTED|Overall Study||26
1001286|NCT00509873|2429848|P2|NOT COMPLETED|Overall Study||15
1001287|NCT00509873|2429849|P1|NOT COMPLETED|Overall Study||11
1001288|NCT00509873|2429848|P2|COMPLETED|Overall Study||276
1001289|NCT00509873|2429849|P1|COMPLETED|Overall Study||276
1001290|NCT00509873|2429848|P2|STARTED|Overall Study||291
1001291|NCT00509873|2429849|P1|STARTED|Overall Study||287
1001292|NCT00509899|2429871|P8|NOT COMPLETED|Overall Study||1
1001293|NCT00509899|2429872|P7|NOT COMPLETED|Overall Study||1
1001294|NCT00509899|2429873|P6|NOT COMPLETED|Overall Study||10
1001295|NCT00509899|2429874|P5|NOT COMPLETED|Overall Study||5
1001296|NCT00509899|2429875|P4|NOT COMPLETED|Overall Study||4
1001297|NCT00509899|2429876|P3|NOT COMPLETED|Overall Study||20
1001298|NCT00509899|2429877|P2|NOT COMPLETED|Overall Study||9
1001299|NCT00509899|2429878|P1|NOT COMPLETED|Overall Study||16
1001300|NCT00509899|2429871|P8|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|2
1001301|NCT00509899|2429872|P7|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|5
1001302|NCT00509899|2429873|P6|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|12
1001303|NCT00509899|2429874|P5|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
1001304|NCT00509899|2429875|P4|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
1001305|NCT00509899|2429876|P3|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|27
1001306|NCT00509899|2429877|P2|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|26
1001307|NCT00509899|2429878|P1|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|14
1001308|NCT00509899|2429871|P8|STARTED|Overall Study||3
1001309|NCT00509899|2429872|P7|STARTED|Overall Study||6
1001310|NCT00509899|2429873|P6|STARTED|Overall Study||22
1001311|NCT00509899|2429874|P5|STARTED|Overall Study||6
1001312|NCT00509899|2429875|P4|STARTED|Overall Study||5
1001313|NCT00509899|2429876|P3|STARTED|Overall Study||47
1001314|NCT00509899|2429877|P2|STARTED|Overall Study||35
1001315|NCT00509899|2429878|P1|STARTED|Overall Study||30
1001316|NCT00509925|2429916|P2|NOT COMPLETED|Overall Study||1
1001317|NCT00509925|2429917|P1|NOT COMPLETED|Overall Study||0
1001318|NCT00509925|2429916|P2|COMPLETED|Overall Study||10
1001319|NCT00509925|2429917|P1|COMPLETED|Overall Study||12
1001320|NCT00509925|2429916|P2|STARTED|Overall Study||11
1001321|NCT00509925|2429917|P1|STARTED|Overall Study||12
1001322|NCT00510068|2429959|P2|NOT COMPLETED|Open-label Period||0
1001323|NCT00510068|2429960|P1|NOT COMPLETED|Open-label Period||225
1001324|NCT00510068|2429959|P2|COMPLETED|Open-label Period||0
1001325|NCT00510068|2429960|P1|COMPLETED|Open-label Period||0
1001326|NCT00510068|2429959|P2|STARTED|Open-label Period||0
1001327|NCT00510068|2429960|P1|STARTED|Open-label Period|172 patients switched over from placebo & 53 who were initially randomized to Everolimus arm.|225
1001328|NCT00510068|2429959|P2|NOT COMPLETED|Double-blind Period||203
1001329|NCT00510068|2429960|P1|NOT COMPLETED|Double-blind Period||207
1001330|NCT00510068|2429959|P2|COMPLETED|Double-blind Period||0
1001331|NCT00510068|2429960|P1|COMPLETED|Double-blind Period||0
1001332|NCT00510068|2429959|P2|Safety Population|Double-blind Period||203
1001333|NCT00510068|2429960|P1|Safety Population|Double-blind Period||204
1001334|NCT00510068|2429959|P2|STARTED|Double-blind Period||203
1001335|NCT00510068|2429960|P1|STARTED|Double-blind Period||207
1001336|NCT00510146|2430003|P2|NOT COMPLETED|Open-Label Treatment||26
1001337|NCT00510146|2430004|P1|NOT COMPLETED|Open-Label Treatment||71
1001338|NCT00510146|2430003|P2|COMPLETED|Open-Label Treatment||96
1001339|NCT00510146|2430004|P1|COMPLETED|Open-Label Treatment||196
1001340|NCT00510146|2430003|P2|STARTED|Open-Label Treatment||122
1001341|NCT00510146|2430004|P1|STARTED|Open-Label Treatment||267
1001342|NCT00510146|2430003|P2|NOT COMPLETED|Double-Blind Treatment||49
1001343|NCT00510146|2430004|P1|NOT COMPLETED|Double-Blind Treatment||76
1001344|NCT00510146|2430003|P2|COMPLETED|Double-Blind Treatment||122
1001345|NCT00510146|2430004|P1|COMPLETED|Double-Blind Treatment||267
1001346|NCT00510146|2430003|P2|STARTED|Double-Blind Treatment||171
1001347|NCT00510146|2430004|P1|STARTED|Double-Blind Treatment||343
1001348|NCT00510484|2430093|P2|NOT COMPLETED|Period 2||0
1001349|NCT00510484|2430094|P1|NOT COMPLETED|Period 2||0
1001350|NCT00510484|2430093|P2|COMPLETED|Period 2||15
1001351|NCT00510484|2430094|P1|COMPLETED|Period 2||16
1001352|NCT00510484|2430093|P2|STARTED|Period 2||15
1001353|NCT00510484|2430094|P1|STARTED|Period 2||16
1001354|NCT00510484|2430093|P2|NOT COMPLETED|Wash-out Period||1
1001355|NCT00510484|2430094|P1|NOT COMPLETED|Wash-out Period||0
1001356|NCT00510484|2430093|P2|COMPLETED|Wash-out Period||15
1001357|NCT00510484|2430094|P1|COMPLETED|Wash-out Period||16
1001358|NCT00510484|2430093|P2|STARTED|Wash-out Period||16
1001359|NCT00510484|2430094|P1|STARTED|Wash-out Period||16
1001360|NCT00510484|2430093|P2|NOT COMPLETED|Period 1||0
1001361|NCT00510484|2430094|P1|NOT COMPLETED|Period 1||0
1001362|NCT00510484|2430093|P2|COMPLETED|Period 1||16
1001363|NCT00510484|2430094|P1|COMPLETED|Period 1||16
1001364|NCT00510484|2430093|P2|STARTED|Period 1||16
1001365|NCT00510484|2430094|P1|STARTED|Period 1||16
1001366|NCT00510497|2430114|P1|NOT COMPLETED|Overall Study||3
1001367|NCT00510497|2430114|P1|COMPLETED|Overall Study||8
1001368|NCT00510497|2430114|P1|STARTED|Overall Study||11
1001369|NCT00510510|2430122|P3|NOT COMPLETED|Overall Study||17
1001370|NCT00510510|2430123|P2|NOT COMPLETED|Overall Study||9
1001371|NCT00510510|2430124|P1|NOT COMPLETED|Overall Study||5
1001372|NCT00510510|2430122|P3|COMPLETED|Overall Study||74
1001373|NCT00510510|2430123|P2|COMPLETED|Overall Study||89
1001374|NCT00510510|2430124|P1|COMPLETED|Overall Study||87
1001375|NCT00510510|2430122|P3|STARTED|Overall Study||91
1001376|NCT00510510|2430123|P2|STARTED|Overall Study||98
1001377|NCT00510510|2430124|P1|STARTED|Overall Study||92
1001378|NCT00510653|2430135|P1|NOT COMPLETED|Overall Study||11
1001379|NCT00510653|2430135|P1|COMPLETED|Overall Study||13
1001380|NCT00510653|2430135|P1|STARTED|Overall Study||24
1001381|NCT00510692|2430141|P2|NOT COMPLETED|Overall Study||3
1001382|NCT00510692|2430142|P1|NOT COMPLETED|Overall Study||2
1001383|NCT00510692|2430141|P2|COMPLETED|Overall Study||26
1001384|NCT00510692|2430142|P1|COMPLETED|Overall Study||27
1001385|NCT00510692|2430141|P2|STARTED|Overall Study||29
1001386|NCT00510692|2430142|P1|STARTED|Overall Study||29
1001387|NCT00510744|2430156|P1|NOT COMPLETED|Overall Study||0
1001388|NCT00510744|2430156|P1|COMPLETED|Overall Study||5
1001389|NCT00510744|2430156|P1|STARTED|Overall Study||5
1001390|NCT00510783|2430162|P2|NOT COMPLETED|Overall Study||29
1001391|NCT00510783|2430163|P1|NOT COMPLETED|Overall Study||31
1001392|NCT00510783|2430162|P2|COMPLETED|Overall Study||47
1001393|NCT00510783|2430163|P1|COMPLETED|Overall Study||51
1001394|NCT00510783|2430162|P2|STARTED|Overall Study||76
1001395|NCT00510783|2430163|P1|STARTED|Overall Study||82
1001396|NCT00510809|2430172|P3|NOT COMPLETED|Overall Study||0
1001397|NCT00510809|2430173|P2|NOT COMPLETED|Overall Study||0
1001398|NCT00510809|2430174|P1|NOT COMPLETED|Overall Study||0
1001399|NCT00510809|2430172|P3|COMPLETED|Overall Study||18
1001400|NCT00510809|2430173|P2|COMPLETED|Overall Study||18
1001401|NCT00510809|2430174|P1|COMPLETED|Overall Study||18
1001402|NCT00510809|2430172|P3|STARTED|Overall Study||18
1001403|NCT00510809|2430173|P2|STARTED|Overall Study||18
1001404|NCT00510809|2430174|P1|STARTED|Overall Study||18
1001405|NCT00510835|2430188|P3|NOT COMPLETED|Overall Study||2
1001406|NCT00510835|2430189|P2|NOT COMPLETED|Overall Study||2
1001407|NCT00510835|2430190|P1|NOT COMPLETED|Overall Study||6
1001408|NCT00510835|2430188|P3|COMPLETED|Overall Study||456
1001409|NCT00510835|2430189|P2|COMPLETED|Overall Study||446
1001410|NCT00510835|2430190|P1|COMPLETED|Overall Study||439
1001411|NCT00510835|2430188|P3|STARTED|Overall Study||458
1001412|NCT00510835|2430189|P2|STARTED|Overall Study||448
1001413|NCT00510835|2430190|P1|STARTED|Overall Study||445
1001414|NCT00510874|2430205|P7|NOT COMPLETED|Overall Study||1
1001415|NCT00510874|2430206|P6|NOT COMPLETED|Overall Study||0
1001416|NCT00510874|2430207|P5|NOT COMPLETED|Overall Study||7
1001417|NCT00510874|2430208|P4|NOT COMPLETED|Overall Study||3
1001418|NCT00510874|2430209|P3|NOT COMPLETED|Overall Study||1
1001419|NCT00510874|2430210|P2|NOT COMPLETED|Overall Study||4
1001420|NCT00510874|2430211|P1|NOT COMPLETED|Overall Study||3
1001421|NCT00510874|2430205|P7|COMPLETED|Overall Study|Upto Day 182|49
1001422|NCT00510874|2430206|P6|COMPLETED|Overall Study|Upto Day 182|50
1001423|NCT00510874|2430207|P5|COMPLETED|Overall Study|Upto Day 182|141
1001424|NCT00510874|2430208|P4|COMPLETED|Overall Study|Upto Day 182|148
1001425|NCT00510874|2430209|P3|COMPLETED|Overall Study|Upto Day 182|150
1001426|NCT00510874|2430210|P2|COMPLETED|Overall Study|Upto Day 182|148
1001427|NCT00510874|2430211|P1|COMPLETED|Overall Study|Upto Day 182|75
1001428|NCT00510874|2430205|P7|STARTED|Overall Study||50
1001429|NCT00510874|2430206|P6|STARTED|Overall Study||50
1001430|NCT00510874|2430207|P5|STARTED|Overall Study||148
1001431|NCT00510874|2430208|P4|STARTED|Overall Study||151
1001432|NCT00510874|2430209|P3|STARTED|Overall Study||151
1001433|NCT00510874|2430210|P2|STARTED|Overall Study||152
1001434|NCT00510874|2430211|P1|STARTED|Overall Study||78
1001435|NCT00510887|2430311|P1|NOT COMPLETED|Overall Study||1
1001436|NCT00510887|2430311|P1|COMPLETED|Overall Study||11
1001437|NCT00510887|2430311|P1|STARTED|Overall Study||12
1001438|NCT00510952|2430322|P2|NOT COMPLETED|Overall Study||16
1001439|NCT00510952|2430323|P1|NOT COMPLETED|Overall Study||26
1001440|NCT00510952|2430322|P2|COMPLETED|Overall Study||220
1001441|NCT00510952|2430323|P1|COMPLETED|Overall Study||209
1001442|NCT00510952|2430322|P2|Full Analysis Set (Intent to Treat)|Overall Study||229
1001443|NCT00510952|2430323|P1|Full Analysis Set (Intent to Treat)|Overall Study||229
1001444|NCT00510952|2430322|P2|STARTED|Overall Study||236
1001445|NCT00510952|2430323|P1|STARTED|Overall Study||235
1001446|NCT00511004|2430352|P3|NOT COMPLETED|Overall Study||4
1001447|NCT00511004|2430353|P2|NOT COMPLETED|Overall Study||0
1001448|NCT00511004|2430354|P1|NOT COMPLETED|Overall Study||0
1001449|NCT00511004|2430352|P3|COMPLETED|Overall Study||10
1001450|NCT00511004|2430353|P2|COMPLETED|Overall Study||13
1001451|NCT00511004|2430354|P1|COMPLETED|Overall Study||13
1001452|NCT00511004|2430352|P3|STARTED|Overall Study||14
1001453|NCT00511004|2430353|P2|STARTED|Overall Study||13
1001454|NCT00511004|2430354|P1|STARTED|Overall Study||13
1001455|NCT00511095|2430371|P1|NOT COMPLETED|Overall Study||11
1001456|NCT00511095|2430371|P1|COMPLETED|Overall Study||196
1001457|NCT00511095|2430371|P1|STARTED|Overall Study||207
1001458|NCT00511108|2430381|P4|NOT COMPLETED|Overall Study||5
1001459|NCT00511108|2430382|P3|NOT COMPLETED|Overall Study||5
1001460|NCT00511108|2430383|P2|NOT COMPLETED|Overall Study||2
1001461|NCT00511108|2430384|P1|NOT COMPLETED|Overall Study||6
1001462|NCT00511108|2430381|P4|COMPLETED|Overall Study||48
1001463|NCT00511108|2430382|P3|COMPLETED|Overall Study||47
1001464|NCT00511108|2430383|P2|COMPLETED|Overall Study||52
1001465|NCT00511108|2430384|P1|COMPLETED|Overall Study||46
1001466|NCT00511108|2430381|P4|STARTED|Overall Study||53
1001467|NCT00511108|2430382|P3|STARTED|Overall Study||52
1001468|NCT00511108|2430383|P2|STARTED|Overall Study||54
1001469|NCT00511108|2430384|P1|STARTED|Overall Study||52
1001470|NCT00511134|2430404|P2|NOT COMPLETED|Overall Study||2
1001471|NCT00511134|2430405|P1|NOT COMPLETED|Overall Study||0
1001472|NCT00511134|2430404|P2|COMPLETED|Overall Study||1
1001473|NCT00511134|2430405|P1|COMPLETED|Overall Study||1
1001474|NCT00511134|2430404|P2|STARTED|Overall Study||3
1001475|NCT00511134|2430405|P1|STARTED|Overall Study||1
1001476|NCT00511147|2430413|P1|NOT COMPLETED|Overall Study||7
1001477|NCT00511147|2430413|P1|COMPLETED|Overall Study||57
1001478|NCT00511147|2430413|P1|STARTED|Overall Study||64
1001479|NCT00511173|2430420|P1|NOT COMPLETED|Overall Study||0
1001480|NCT00511173|2430420|P1|COMPLETED|Overall Study||102
1001481|NCT00511173|2430420|P1|STARTED|Overall Study||102
1001482|NCT00511199|2430427|P2|NOT COMPLETED|Overall Study||125
1001483|NCT00511199|2430428|P1|NOT COMPLETED|Overall Study||449
1001484|NCT00511199|2430427|P2|COMPLETED|Overall Study||410
1001485|NCT00511199|2430428|P1|COMPLETED|Overall Study||1142
1001486|NCT00511199|2430427|P2|STARTED|Overall Study||535
1001487|NCT00511199|2430428|P1|STARTED|Overall Study||1591
1001488|NCT00511238|2430454|P2|NOT COMPLETED|Overall Study||226
1001489|NCT00511238|2430455|P1|NOT COMPLETED|Overall Study||42
1001490|NCT00511238|2430454|P2|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|40
1001491|NCT00511238|2430455|P1|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|4
1001492|NCT00511238|2430454|P2|STARTED|Overall Study||266
1001493|NCT00511238|2430455|P1|STARTED|Overall Study||46
1001494|NCT00511342|2430474|P2|NOT COMPLETED|Overall Study||22
1001495|NCT00511342|2430475|P1|NOT COMPLETED|Overall Study||13
1001496|NCT00511342|2430474|P2|COMPLETED|Overall Study||32
1001497|NCT00511342|2430475|P1|COMPLETED|Overall Study||43
1001498|NCT00511342|2430474|P2|STARTED|Overall Study||54
1001499|NCT00511342|2430475|P1|STARTED|Overall Study||56
1001500|NCT00511355|2430501|P2|NOT COMPLETED|Overall Study||9
1001501|NCT00511355|2430502|P1|NOT COMPLETED|Overall Study||7
1001502|NCT00511355|2430501|P2|COMPLETED|Overall Study||52
1001503|NCT00511355|2430502|P1|COMPLETED|Overall Study||53
1001504|NCT00511355|2430501|P2|STARTED|Overall Study||61
1001505|NCT00511355|2430502|P1|STARTED|Overall Study||60
1001506|NCT00511433|2430602|P2|NOT COMPLETED|Overall Study||1
1001507|NCT00511433|2430603|P1|NOT COMPLETED|Overall Study||6
1001508|NCT00511433|2430602|P2|COMPLETED|Overall Study||15
1001509|NCT00511433|2430603|P1|COMPLETED|Overall Study||26
1001510|NCT00511433|2430602|P2|STARTED|Overall Study||16
1001511|NCT00511433|2430603|P1|STARTED|Overall Study||32
1001512|NCT00511472|2430643|P2|NOT COMPLETED|Overall Study||6
1001513|NCT00511472|2430644|P1|NOT COMPLETED|Overall Study||3
1001514|NCT00511472|2430643|P2|COMPLETED|Overall Study||17
1001515|NCT00511472|2430644|P1|COMPLETED|Overall Study||44
1001516|NCT00511472|2430643|P2|STARTED|Overall Study||23
1001517|NCT00511472|2430644|P1|STARTED|Overall Study||47
1001518|NCT00511667|2430663|P2|NOT COMPLETED|Overall Study||3
1001519|NCT00511667|2430664|P1|NOT COMPLETED|Overall Study||12
1001520|NCT00511667|2430663|P2|COMPLETED|Overall Study||15
1001521|NCT00511667|2430664|P1|COMPLETED|Overall Study||40
1001522|NCT00511667|2430663|P2|STARTED|Overall Study||18
1001523|NCT00511667|2430664|P1|STARTED|Overall Study||52
1001524|NCT00511706|2430699|P2|NOT COMPLETED|Overall Study||5
1001525|NCT00511706|2430700|P1|NOT COMPLETED|Overall Study||8
1001526|NCT00511706|2430699|P2|COMPLETED|Overall Study||115
1001527|NCT00511706|2430700|P1|COMPLETED|Overall Study||115
1001528|NCT00511706|2430699|P2|STARTED|Overall Study||120
1001529|NCT00511706|2430700|P1|STARTED|Overall Study||123
1001530|NCT00511797|2430716|P4|NOT COMPLETED|Overall Study||15
1001531|NCT00511797|2430717|P3|NOT COMPLETED|Overall Study||11
1001532|NCT00511797|2430718|P2|NOT COMPLETED|Overall Study||8
1001533|NCT00511797|2430719|P1|NOT COMPLETED|Overall Study||7
1001534|NCT00511797|2430716|P4|COMPLETED|Overall Study||47
1001535|NCT00511797|2430717|P3|COMPLETED|Overall Study||51
1001536|NCT00511797|2430718|P2|COMPLETED|Overall Study||55
1001537|NCT00511797|2430719|P1|COMPLETED|Overall Study||55
1001538|NCT00511797|2430716|P4|Subjects Received Treatment|Overall Study|FAS|58
1001539|NCT00511797|2430717|P3|Subjects Received Treatment|Overall Study|FAS|61
1001540|NCT00511797|2430718|P2|Subjects Received Treatment|Overall Study|FAS|62
1001541|NCT00511797|2430719|P1|Subjects Received Treatment|Overall Study|FAS|61
1001542|NCT00511797|2430716|P4|Subjects Dispensed Drugs|Overall Study||59
1001543|NCT00511797|2430717|P3|Subjects Dispensed Drugs|Overall Study||61
1001544|NCT00511797|2430718|P2|Subjects Dispensed Drugs|Overall Study||63
1001545|NCT00511797|2430719|P1|Subjects Dispensed Drugs|Overall Study||61
1001546|NCT00511797|2430716|P4|STARTED|Overall Study||62
1001547|NCT00511797|2430717|P3|STARTED|Overall Study||62
1001548|NCT00511797|2430718|P2|STARTED|Overall Study||63
1001549|NCT00511797|2430719|P1|STARTED|Overall Study||62
1001550|NCT00511810|2430823|P2|NOT COMPLETED|Overall Study||5
1001551|NCT00511810|2430824|P1|NOT COMPLETED|Overall Study||1
1001552|NCT00511810|2430823|P2|COMPLETED|Overall Study|2 terminated for worsening symptoms;1 refused a scan;2 lost to follow up (could not be contacted)|7
1001553|NCT00511810|2430824|P1|COMPLETED|Overall Study||7
1001554|NCT00511810|2430823|P2|STARTED|Overall Study||12
1001555|NCT00511810|2430824|P1|STARTED|Overall Study||8
1001556|NCT00511836|2430832|P2|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||0
1001557|NCT00511836|2430833|P1|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||16
1001558|NCT00511836|2430832|P2|COMPLETED|Optional Open-label VIVITROL (2 Months)||0
1001559|NCT00511836|2430833|P1|COMPLETED|Optional Open-label VIVITROL (2 Months)||6
1001560|NCT00511836|2430832|P2|STARTED|Optional Open-label VIVITROL (2 Months)|Not all subjects from the double-blind phase entered the optional open-label extension.|0
1001561|NCT00511836|2430833|P1|STARTED|Optional Open-label VIVITROL (2 Months)|Subjects who received placebo during Month 1 switched to VIVITROL for the optional extension phase.|22
1001562|NCT00511836|2430832|P2|NOT COMPLETED|Double-blind Period||0
1001563|NCT00511836|2430833|P1|NOT COMPLETED|Double-blind Period||1
1001564|NCT00511836|2430832|P2|COMPLETED|Double-blind Period||15
1001565|NCT00511836|2430833|P1|COMPLETED|Double-blind Period||15
1001566|NCT00511836|2430832|P2|STARTED|Double-blind Period||15
1001567|NCT00511836|2430833|P1|STARTED|Double-blind Period||16
1001568|NCT00511862|2430851|P3|NOT COMPLETED|Overall Study||0
1001569|NCT00511862|2430852|P2|NOT COMPLETED|Overall Study||0
1001570|NCT00511862|2430853|P1|NOT COMPLETED|Overall Study||0
1001571|NCT00511862|2430851|P3|COMPLETED|Overall Study||47
1001572|NCT00511862|2430852|P2|COMPLETED|Overall Study||43
1001573|NCT00511862|2430853|P1|COMPLETED|Overall Study||61
1001574|NCT00511862|2430851|P3|STARTED|Overall Study||47
1001575|NCT00511862|2430852|P2|STARTED|Overall Study||43
1001576|NCT00511862|2430853|P1|STARTED|Overall Study||61
1001577|NCT00511901|2430866|P2|NOT COMPLETED|Overall Study||3
1001578|NCT00511901|2430867|P1|NOT COMPLETED|Overall Study||1
1001579|NCT00511901|2430866|P2|COMPLETED|Overall Study||8
1001580|NCT00511901|2430867|P1|COMPLETED|Overall Study||10
1001581|NCT00511901|2430866|P2|STARTED|Overall Study||11
1001582|NCT00511901|2430867|P1|STARTED|Overall Study||11
1001583|NCT00511914|2430889|P2|NOT COMPLETED|Overall Study||0
1001584|NCT00511914|2430890|P1|NOT COMPLETED|Overall Study||0
1001585|NCT00511914|2430889|P2|COMPLETED|Overall Study||67
1001586|NCT00511914|2430890|P1|COMPLETED|Overall Study||68
1001587|NCT00511914|2430889|P2|STARTED|Overall Study||67
1001588|NCT00511914|2430890|P1|STARTED|Overall Study||68
1001589|NCT00511992|2430904|P1|NOT COMPLETED|Overall Study||7
1001590|NCT00511992|2430904|P1|COMPLETED|Overall Study||13
1001591|NCT00511992|2430904|P1|STARTED|Overall Study||20
1001592|NCT00512096|2430909|P1|NOT COMPLETED|Overall Study||7
1001593|NCT00512096|2430909|P1|COMPLETED|Overall Study||23
1001594|NCT00512096|2430909|P1|STARTED|Overall Study||30
1001595|NCT00512148|2430913|P1|NOT COMPLETED|Long Term Follow Up Period||6
1001596|NCT00512148|2430913|P1|COMPLETED|Long Term Follow Up Period|6 patients are being followed in long term follow up|0
1001597|NCT00512148|2430913|P1|STARTED|Long Term Follow Up Period||6
1001598|NCT00512148|2430913|P1|NOT COMPLETED|Primay Study Period||1
1001599|NCT00512148|2430913|P1|COMPLETED|Primay Study Period||6
1001600|NCT00512148|2430913|P1|STARTED|Primay Study Period||7
1001601|NCT00512252|2430921|P3|NOT COMPLETED|Overall Study||3
1001602|NCT00512252|2430922|P2|NOT COMPLETED|Overall Study||0
1001603|NCT00512252|2430923|P1|NOT COMPLETED|Overall Study||0
1001604|NCT00512252|2430921|P3|COMPLETED|Overall Study||43
1001605|NCT00512252|2430922|P2|COMPLETED|Overall Study||3
1001606|NCT00512252|2430923|P1|COMPLETED|Overall Study||3
1001607|NCT00512252|2430921|P3|STARTED|Overall Study||46
1001608|NCT00512252|2430922|P2|STARTED|Overall Study||3
1001609|NCT00512252|2430923|P1|STARTED|Overall Study||3
1001610|NCT00512278|2430953|P2|NOT COMPLETED|Overall Study||17
1001611|NCT00512278|2430954|P1|NOT COMPLETED|Overall Study||28
1001612|NCT00512278|2430953|P2|COMPLETED|Overall Study||56
1001613|NCT00512278|2430954|P1|COMPLETED|Overall Study||45
1001614|NCT00512278|2430953|P2|STARTED|Overall Study||73
1001615|NCT00512278|2430954|P1|STARTED|Overall Study||73
1001616|NCT00512707|2430970|P2|NOT COMPLETED|Overall Study||12
1001617|NCT00512707|2430971|P1|NOT COMPLETED|Overall Study||10
1001618|NCT00512707|2430970|P2|COMPLETED|Overall Study||58
1001619|NCT00512707|2430971|P1|COMPLETED|Overall Study||60
1001620|NCT00512707|2430970|P2|STARTED|Overall Study||70
1001621|NCT00512707|2430971|P1|STARTED|Overall Study||70
1001622|NCT00507130|2431005|P4|NOT COMPLETED|Overall Study||1
1001623|NCT00507130|2431006|P3|NOT COMPLETED|Overall Study||1
1001624|NCT00507130|2431007|P2|NOT COMPLETED|Overall Study||0
1001625|NCT00507130|2431008|P1|NOT COMPLETED|Overall Study||1
1001626|NCT00507130|2431005|P4|COMPLETED|Overall Study||8
1001627|NCT00507130|2431006|P3|COMPLETED|Overall Study||8
1001628|NCT00507130|2431007|P2|COMPLETED|Overall Study||9
1001629|NCT00507130|2431008|P1|COMPLETED|Overall Study||8
1001630|NCT00507130|2431005|P4|STARTED|Overall Study||9
1001631|NCT00507130|2431006|P3|STARTED|Overall Study||9
1001632|NCT00507130|2431007|P2|STARTED|Overall Study||9
1001633|NCT00507130|2431008|P1|STARTED|Overall Study||9
1001634|NCT00507208|2431052|P2|NOT COMPLETED|Overall Study||0
1001635|NCT00507208|2431053|P1|NOT COMPLETED|Overall Study||0
1001636|NCT00507208|2431052|P2|COMPLETED|Overall Study||26
1001637|NCT00507208|2431053|P1|COMPLETED|Overall Study||27
1001638|NCT00507208|2431052|P2|Received Dynasplint in Crossover|Overall Study||3
1001639|NCT00507208|2431053|P1|Received Dynasplint in Crossover|Overall Study||0
1001640|NCT00507208|2431052|P2|STARTED|Overall Study||26
1001641|NCT00507208|2431053|P1|STARTED|Overall Study||27
1001642|NCT00512798|2431061|P2|NOT COMPLETED|Overall Study||27
1001643|NCT00512798|2431062|P1|NOT COMPLETED|Overall Study||19
1001644|NCT00512798|2431061|P2|COMPLETED|Overall Study||1
1001645|NCT00512798|2431062|P1|COMPLETED|Overall Study||0
1001646|NCT00512798|2431061|P2|STARTED|Overall Study||28
1001647|NCT00512798|2431062|P1|STARTED|Overall Study||19
1001648|NCT00512876|2431071|P1|NOT COMPLETED|Overall Study||4
1001649|NCT00512876|2431071|P1|COMPLETED|Overall Study||20
1001650|NCT00512876|2431071|P1|STARTED|Overall Study||24
1001651|NCT00512902|2431076|P1|NOT COMPLETED|Overall Study||8
1001652|NCT00512902|2431076|P1|COMPLETED|Overall Study||12
1001653|NCT00512902|2431076|P1|STARTED|Overall Study||20
1001654|NCT00513019|2431086|P2|NOT COMPLETED|Overall Study||5
1001655|NCT00513019|2431087|P1|NOT COMPLETED|Overall Study||5
1001656|NCT00513019|2431086|P2|COMPLETED|Overall Study||13
1001657|NCT00513019|2431087|P1|COMPLETED|Overall Study||12
1001658|NCT00513019|2431086|P2|STARTED|Overall Study||18
1001659|NCT00513019|2431087|P1|STARTED|Overall Study||17
1001660|NCT00513071|2431093|P1|NOT COMPLETED|Overall Study||5
1001661|NCT00513071|2431093|P1|COMPLETED|Overall Study||23
1001662|NCT00513071|2431093|P1|STARTED|Overall Study||28
1001663|NCT00514501|2431098|P1|NOT COMPLETED|Overall Study||3
1001664|NCT00514501|2431098|P1|COMPLETED|Overall Study||507
1001665|NCT00514501|2431098|P1|STARTED|Overall Study||510
1001666|NCT00514514|2431107|P3|NOT COMPLETED|Extension - 4 Years||21
1001667|NCT00514514|2431108|P2|NOT COMPLETED|Extension - 4 Years||22
1001668|NCT00514514|2431109|P1|NOT COMPLETED|Extension - 4 Years||37
1001669|NCT00514514|2431107|P3|COMPLETED|Extension - 4 Years||113
1001670|NCT00514514|2431108|P2|COMPLETED|Extension - 4 Years||117
1001671|NCT00514514|2431109|P1|COMPLETED|Extension - 4 Years||108
1001672|NCT00514514|2431107|P3|Non-randomized (Followed)|Extension - 4 Years||0
1001673|NCT00514514|2431108|P2|Non-randomized (Followed)|Extension - 4 Years||0
1001674|NCT00514514|2431109|P1|Non-randomized (Followed)|Extension - 4 Years|Patients were not randomized but continued on standard regimen and entered follow up.|95
1001675|NCT00514514|2431107|P3|STARTED|Extension - 4 Years||134
1001676|NCT00514514|2431108|P2|STARTED|Extension - 4 Years||139
1001677|NCT00514514|2431109|P1|STARTED|Extension - 4 Years||145
1001678|NCT00514514|2431107|P3|NOT COMPLETED|Randomized - 9 Month||38
1001679|NCT00514514|2431108|P2|NOT COMPLETED|Randomized - 9 Month||61
1001680|NCT00514514|2431109|P1|NOT COMPLETED|Randomized - 9 Month||39
1001681|NCT00514514|2431107|P3|COMPLETED|Randomized - 9 Month||124
1001682|NCT00514514|2431108|P2|COMPLETED|Randomized - 9 Month||110
1001683|NCT00514514|2431109|P1|COMPLETED|Randomized - 9 Month||127
1001684|NCT00514514|2431107|P3|Randomized - Received Treatment|Randomized - 9 Month||161
1001685|NCT00514514|2431108|P2|Randomized - Received Treatment|Randomized - 9 Month||171
1001686|NCT00514514|2431109|P1|Randomized - Received Treatment|Randomized - 9 Month||165
1001687|NCT00514514|2431107|P3|STARTED|Randomized - 9 Month||162
1001688|NCT00514514|2431108|P2|STARTED|Randomized - 9 Month||171
1001689|NCT00514514|2431109|P1|STARTED|Randomized - 9 Month||166
1001690|NCT00514514|2431107|P3|NOT COMPLETED|Pre-phase||0
1001691|NCT00514514|2431108|P2|NOT COMPLETED|Pre-phase||0
1001692|NCT00514514|2431109|P1|NOT COMPLETED|Pre-phase||303
1001693|NCT00514514|2431107|P3|COMPLETED|Pre-phase||0
1001694|NCT00514514|2431108|P2|COMPLETED|Pre-phase||0
1001695|NCT00514514|2431109|P1|COMPLETED|Pre-phase||499
1001696|NCT00514514|2431107|P3|STARTED|Pre-phase||0
1001697|NCT00514514|2431108|P2|STARTED|Pre-phase||0
1001698|NCT00514514|2431109|P1|STARTED|Pre-phase|All enrolled patients received standard regimen for 3 months|802
1001699|NCT00514592|2431153|P1|NOT COMPLETED|Overall Study||0
1001700|NCT00514592|2431153|P1|COMPLETED|Overall Study||230
1001701|NCT00514592|2431153|P1|STARTED|Overall Study||230
1001702|NCT00514683|2431163|P5|NOT COMPLETED|Overall Study||33
1001703|NCT00514683|2431164|P4|NOT COMPLETED|Overall Study||14
1001704|NCT00514683|2431165|P3|NOT COMPLETED|Overall Study||18
1001705|NCT00514683|2431166|P2|NOT COMPLETED|Overall Study||25
1001706|NCT00514683|2431167|P1|NOT COMPLETED|Overall Study||26
1001707|NCT00514683|2431163|P5|COMPLETED|Overall Study||53
1001708|NCT00514683|2431164|P4|COMPLETED|Overall Study||72
1001709|NCT00514683|2431165|P3|COMPLETED|Overall Study||68
1001710|NCT00514683|2431166|P2|COMPLETED|Overall Study||62
1001711|NCT00514683|2431167|P1|COMPLETED|Overall Study||61
1001712|NCT00514683|2431163|P5|STARTED|Overall Study|Randomised|86
1001713|NCT00514683|2431164|P4|STARTED|Overall Study|Randomised|86
1001714|NCT00514683|2431165|P3|STARTED|Overall Study|Randomised|86
1001715|NCT00514683|2431166|P2|STARTED|Overall Study|Randomised|87
1001716|NCT00514683|2431167|P1|STARTED|Overall Study|Randomised|87
1001717|NCT00514709|2431360|P2|NOT COMPLETED|Overall Study||0
1001718|NCT00514709|2431361|P1|NOT COMPLETED|Overall Study||0
1001719|NCT00514709|2431360|P2|COMPLETED|Overall Study||613
1001720|NCT00514709|2431361|P1|COMPLETED|Overall Study||1230
1001721|NCT00514709|2431360|P2|STARTED|Overall Study||613
1001722|NCT00514709|2431361|P1|STARTED|Overall Study||1230
1001723|NCT00514735|2431373|P2|NOT COMPLETED|Overall Study||6
1001724|NCT00514735|2431374|P1|NOT COMPLETED|Overall Study||14
1001725|NCT00514735|2431373|P2|COMPLETED|Overall Study||66
1001726|NCT00514735|2431374|P1|COMPLETED|Overall Study||124
1001727|NCT00514735|2431373|P2|STARTED|Overall Study||72
1001728|NCT00514735|2431374|P1|STARTED|Overall Study||138
1001729|NCT00514813|2431396|P4|NOT COMPLETED|Overall Study||4
1001730|NCT00514813|2431397|P3|NOT COMPLETED|Overall Study||47
1001731|NCT00514813|2431398|P2|NOT COMPLETED|Overall Study||86
1001732|NCT00514813|2431399|P1|NOT COMPLETED|Overall Study||15
1001733|NCT00514813|2431396|P4|COMPLETED|Overall Study||0
1001734|NCT00514813|2431397|P3|COMPLETED|Overall Study||0
1001735|NCT00514813|2431398|P2|COMPLETED|Overall Study||0
1001736|NCT00514813|2431399|P1|COMPLETED|Overall Study||0
1001737|NCT00514813|2431396|P4|STARTED|Overall Study||4
1001738|NCT00514813|2431397|P3|STARTED|Overall Study||47
1001739|NCT00514813|2431398|P2|STARTED|Overall Study||86
1001740|NCT00514813|2431399|P1|STARTED|Overall Study||15
1001741|NCT00514852|2431419|P2|NOT COMPLETED|Overall Study||5
1001742|NCT00514852|2431420|P1|NOT COMPLETED|Overall Study||5
1001743|NCT00514852|2431419|P2|COMPLETED|Overall Study||154
1001744|NCT00514852|2431420|P1|COMPLETED|Overall Study||152
1001745|NCT00514852|2431419|P2|STARTED|Overall Study||159
1001746|NCT00514852|2431420|P1|STARTED|Overall Study||157
1001747|NCT00514904|2431446|P2|NOT COMPLETED|Overall Study||5
1001748|NCT00514904|2431447|P1|NOT COMPLETED|Overall Study||24
1001749|NCT00514904|2431446|P2|COMPLETED|Overall Study||371
1001750|NCT00514904|2431447|P1|COMPLETED|Overall Study||1101
1001751|NCT00514904|2431446|P2|STARTED|Overall Study||376
1001752|NCT00514904|2431447|P1|STARTED|Overall Study||1125
1001753|NCT00514917|2431483|P2|NOT COMPLETED|Overall Study||115
1001754|NCT00514917|2431484|P1|NOT COMPLETED|Overall Study||126
1001755|NCT00514917|2431483|P2|COMPLETED|Overall Study||91
1001756|NCT00514917|2431484|P1|COMPLETED|Overall Study||81
1001757|NCT00514917|2431483|P2|Testosterone-Specific Evaluable|Overall Study||124
1001758|NCT00514917|2431484|P1|Testosterone-Specific Evaluable|Overall Study||122
1001759|NCT00514917|2431483|P2|Completed Study Treatment|Overall Study||182
1001760|NCT00514917|2431484|P1|Completed Study Treatment|Overall Study||170
1001761|NCT00514917|2431483|P2|Treated|Overall Study||204
1001762|NCT00514917|2431484|P1|Treated|Overall Study||196
1001763|NCT00514917|2431483|P2|STARTED|Overall Study||206
1001764|NCT00514917|2431484|P1|STARTED|Overall Study||207
1001765|NCT00514943|2431512|P2|NOT COMPLETED|Stage 2||36
1001766|NCT00514943|2431513|P1|NOT COMPLETED|Stage 2||32
1001767|NCT00514943|2431512|P2|COMPLETED|Stage 2||0
1001768|NCT00514943|2431513|P1|COMPLETED|Stage 2||0
1001769|NCT00514943|2431512|P2|STARTED|Stage 2||36
1001770|NCT00514943|2431513|P1|STARTED|Stage 2||32
1001771|NCT00514943|2431512|P2|NOT COMPLETED|Stage 1||26
1001772|NCT00514943|2431513|P1|NOT COMPLETED|Stage 1||30
1001773|NCT00514943|2431512|P2|COMPLETED|Stage 1||36
1001774|NCT00514943|2431513|P1|COMPLETED|Stage 1||32
1001775|NCT00514943|2431512|P2|STARTED|Stage 1|2 randomized patients were not treated|62
1001776|NCT00514943|2431513|P1|STARTED|Stage 1|1 randomized patient was not treated|62
1001777|NCT00515008|2431571|P2|NOT COMPLETED|Overall Study||4
1001778|NCT00515008|2431572|P1|NOT COMPLETED|Overall Study||3
1001779|NCT00515008|2431571|P2|COMPLETED|Overall Study||29
1001780|NCT00515008|2431572|P1|COMPLETED|Overall Study||30
1001781|NCT00515008|2431571|P2|Completed 12 Week Evaluation|Overall Study||29
1001782|NCT00515008|2431572|P1|Completed 12 Week Evaluation|Overall Study||32
1001783|NCT00515008|2431571|P2|STARTED|Overall Study||33
1001784|NCT00515008|2431572|P1|STARTED|Overall Study||33
1001785|NCT00515034|2431598|P4|NOT COMPLETED|Overall Study||5
1001786|NCT00515034|2431599|P3|NOT COMPLETED|Overall Study||8
1001787|NCT00515034|2431600|P2|NOT COMPLETED|Overall Study||2
1001788|NCT00515034|2431601|P1|NOT COMPLETED|Overall Study||8
1001789|NCT00515034|2431598|P4|COMPLETED|Overall Study||15
1001790|NCT00515034|2431599|P3|COMPLETED|Overall Study||54
1001791|NCT00515034|2431600|P2|COMPLETED|Overall Study||13
1001792|NCT00515034|2431601|P1|COMPLETED|Overall Study||41
1001793|NCT00515034|2431598|P4|TREATED|Overall Study||19
1001794|NCT00515034|2431599|P3|TREATED|Overall Study||61
1001795|NCT00515034|2431600|P2|TREATED|Overall Study||15
1001796|NCT00515034|2431601|P1|TREATED|Overall Study||48
1001797|NCT00515034|2431598|P4|STARTED|Overall Study||20
1001798|NCT00515034|2431599|P3|STARTED|Overall Study||62
1001799|NCT00515034|2431600|P2|STARTED|Overall Study||15
1001800|NCT00515034|2431601|P1|STARTED|Overall Study||49
1001801|NCT00515073|2431619|P1|NOT COMPLETED|Overall Study||2
1001802|NCT00515073|2431619|P1|COMPLETED|Overall Study||28
1001803|NCT00515073|2431619|P1|STARTED|Overall Study||30
1001804|NCT00515086|2431627|P4|NOT COMPLETED|Overall Study||6
1001805|NCT00515086|2431628|P3|NOT COMPLETED|Overall Study||5
1001806|NCT00515086|2431629|P2|NOT COMPLETED|Overall Study||6
1001807|NCT00515086|2431630|P1|NOT COMPLETED|Overall Study||24
1001808|NCT00515086|2431627|P4|COMPLETED|Overall Study||0
1001809|NCT00515086|2431628|P3|COMPLETED|Overall Study||0
1001810|NCT00515086|2431629|P2|COMPLETED|Overall Study||0
1001811|NCT00515086|2431630|P1|COMPLETED|Overall Study||0
1001812|NCT00515086|2431627|P4|STARTED|Overall Study||6
1001813|NCT00515086|2431628|P3|STARTED|Overall Study||5
1001814|NCT00515086|2431629|P2|STARTED|Overall Study||6
1001815|NCT00515086|2431630|P1|STARTED|Overall Study||24
1001816|NCT00515099|2431659|P2|NOT COMPLETED|Overall Study||4
1001817|NCT00515099|2431660|P1|NOT COMPLETED|Overall Study||3
1001818|NCT00515099|2431659|P2|COMPLETED|Overall Study||16
1001819|NCT00515099|2431660|P1|COMPLETED|Overall Study||35
1001820|NCT00515099|2431659|P2|STARTED|Overall Study||20
1001821|NCT00515099|2431660|P1|STARTED|Overall Study||38
1001822|NCT00515112|2431680|P2|NOT COMPLETED|Overall Study||3
1001823|NCT00515112|2431681|P1|NOT COMPLETED|Overall Study||3
1001824|NCT00515112|2431680|P2|COMPLETED|Overall Study||0
1001825|NCT00515112|2431681|P1|COMPLETED|Overall Study||0
1001826|NCT00515112|2431680|P2|STARTED|Overall Study||3
1001827|NCT00515112|2431681|P1|STARTED|Overall Study||3
1001828|NCT00515177|2431691|P2|NOT COMPLETED|Overall Study||1
1001829|NCT00515177|2431692|P1|NOT COMPLETED|Overall Study||2
1001830|NCT00515177|2431691|P2|COMPLETED|Overall Study||9
1001831|NCT00515177|2431692|P1|COMPLETED|Overall Study||18
1001832|NCT00515177|2431691|P2|STARTED|Overall Study||10
1001833|NCT00515177|2431692|P1|STARTED|Overall Study||20
1001834|NCT00515203|2431710|P2|NOT COMPLETED|Overall Study||0
1001835|NCT00515203|2431711|P1|NOT COMPLETED|Overall Study||0
1001836|NCT00515203|2431710|P2|COMPLETED|Overall Study||5
1001837|NCT00515203|2431711|P1|COMPLETED|Overall Study||17
1001838|NCT00515203|2431710|P2|STARTED|Overall Study||5
1001839|NCT00515203|2431711|P1|STARTED|Overall Study||17
1001840|NCT00515216|2431727|P1|NOT COMPLETED|Overall Study||1
1001841|NCT00515216|2431727|P1|COMPLETED|Overall Study||25
1001842|NCT00515216|2431727|P1|STARTED|Overall Study||26
1001843|NCT00515294|2431753|P4|NOT COMPLETED|Overall Study||4
1001844|NCT00515294|2431754|P3|NOT COMPLETED|Overall Study||11
1001845|NCT00515294|2431755|P2|NOT COMPLETED|Overall Study||3
1001846|NCT00515294|2431756|P1|NOT COMPLETED|Overall Study||9
1001847|NCT00515294|2431753|P4|COMPLETED|Overall Study||35
1001848|NCT00515294|2431754|P3|COMPLETED|Overall Study||27
1001849|NCT00515294|2431755|P2|COMPLETED|Overall Study||36
1001850|NCT00515294|2431756|P1|COMPLETED|Overall Study||29
1001851|NCT00515294|2431753|P4|STARTED|Overall Study||39
1001852|NCT00515294|2431754|P3|STARTED|Overall Study||38
1001853|NCT00515294|2431755|P2|STARTED|Overall Study||39
1001854|NCT00515294|2431756|P1|STARTED|Overall Study||38
1001855|NCT00515437|2431774|P4|NOT COMPLETED|Overall Study||1
1001856|NCT00515437|2431775|P3|NOT COMPLETED|Overall Study||0
1001857|NCT00515437|2431776|P2|NOT COMPLETED|Overall Study||0
1001858|NCT00515437|2431777|P1|NOT COMPLETED|Overall Study||0
1001859|NCT00515437|2431774|P4|COMPLETED|Overall Study||14
1001860|NCT00515437|2431775|P3|COMPLETED|Overall Study||13
1001861|NCT00515437|2431776|P2|COMPLETED|Overall Study||12
1001862|NCT00515437|2431777|P1|COMPLETED|Overall Study||14
1001863|NCT00515437|2431774|P4|STARTED|Overall Study||15
1001864|NCT00515437|2431775|P3|STARTED|Overall Study||13
1001865|NCT00515437|2431776|P2|STARTED|Overall Study||12
1001866|NCT00515437|2431777|P1|STARTED|Overall Study||14
1001867|NCT00515463|2431801|P2|NOT COMPLETED|Overall Study||14
1001868|NCT00515463|2431802|P1|NOT COMPLETED|Overall Study||14
1001869|NCT00515463|2431801|P2|COMPLETED|Overall Study||142
1001870|NCT00515463|2431802|P1|COMPLETED|Overall Study||141
1001871|NCT00515463|2431801|P2|Received Study Medication|Overall Study||156
1001872|NCT00515463|2431802|P1|Received Study Medication|Overall Study||154
1001873|NCT00515463|2431801|P2|STARTED|Overall Study||156
1001874|NCT00515463|2431802|P1|STARTED|Overall Study||155
1001875|NCT00515502|2431952|P12|NOT COMPLETED|Treatment Period 4||0
1001876|NCT00515502|2431953|P11|NOT COMPLETED|Treatment Period 4||0
1001877|NCT00515502|2431954|P10|NOT COMPLETED|Treatment Period 4||0
1001878|NCT00515502|2431955|P9|NOT COMPLETED|Treatment Period 4||0
1001879|NCT00515502|2431956|P8|NOT COMPLETED|Treatment Period 4||0
1001880|NCT00515502|2431957|P7|NOT COMPLETED|Treatment Period 4||0
1001881|NCT00515502|2431958|P6|NOT COMPLETED|Treatment Period 4||0
1001882|NCT00515502|2431959|P5|NOT COMPLETED|Treatment Period 4||0
1001883|NCT00515502|2431960|P4|NOT COMPLETED|Treatment Period 4||0
1001884|NCT00515502|2431961|P3|NOT COMPLETED|Treatment Period 4||0
1001885|NCT00515502|2431962|P2|NOT COMPLETED|Treatment Period 4||0
1001886|NCT00515502|2431963|P1|NOT COMPLETED|Treatment Period 4||0
1001887|NCT00515502|2431952|P12|COMPLETED|Treatment Period 4||0
1001888|NCT00515502|2431953|P11|COMPLETED|Treatment Period 4||1
1001889|NCT00515502|2431954|P10|COMPLETED|Treatment Period 4||2
1001890|NCT00515502|2431955|P9|COMPLETED|Treatment Period 4||0
1001891|NCT00515502|2431956|P8|COMPLETED|Treatment Period 4||1
1001892|NCT00515502|2431957|P7|COMPLETED|Treatment Period 4||1
1001893|NCT00515502|2431958|P6|COMPLETED|Treatment Period 4||1
1001894|NCT00515502|2431959|P5|COMPLETED|Treatment Period 4||3
1001895|NCT00515502|2431960|P4|COMPLETED|Treatment Period 4||3
1001896|NCT00515502|2431961|P3|COMPLETED|Treatment Period 4||4
1001897|NCT00515502|2431962|P2|COMPLETED|Treatment Period 4||3
1001898|NCT00515502|2431963|P1|COMPLETED|Treatment Period 4||1
1001899|NCT00515502|2431952|P12|STARTED|Treatment Period 4||0
1001900|NCT00515502|2431953|P11|STARTED|Treatment Period 4||1
1001901|NCT00515502|2431954|P10|STARTED|Treatment Period 4||2
1001902|NCT00515502|2431955|P9|STARTED|Treatment Period 4||0
1001903|NCT00515502|2431956|P8|STARTED|Treatment Period 4||1
1001904|NCT00515502|2431957|P7|STARTED|Treatment Period 4||1
1001905|NCT00515502|2431958|P6|STARTED|Treatment Period 4||1
1001906|NCT00515502|2431959|P5|STARTED|Treatment Period 4||3
1001907|NCT00515502|2431960|P4|STARTED|Treatment Period 4||3
1001908|NCT00515502|2431961|P3|STARTED|Treatment Period 4||4
1001909|NCT00515502|2431962|P2|STARTED|Treatment Period 4||3
1001910|NCT00515502|2431963|P1|STARTED|Treatment Period 4||1
1001911|NCT00515502|2431952|P12|NOT COMPLETED|Washout Period 3||0
1001912|NCT00515502|2431953|P11|NOT COMPLETED|Washout Period 3||0
1001913|NCT00515502|2431954|P10|NOT COMPLETED|Washout Period 3||0
1001914|NCT00515502|2431955|P9|NOT COMPLETED|Washout Period 3||0
1001915|NCT00515502|2431956|P8|NOT COMPLETED|Washout Period 3||0
1001916|NCT00515502|2431957|P7|NOT COMPLETED|Washout Period 3||0
1001917|NCT00515502|2431958|P6|NOT COMPLETED|Washout Period 3||0
1001918|NCT00515502|2431959|P5|NOT COMPLETED|Washout Period 3||0
1001919|NCT00515502|2431960|P4|NOT COMPLETED|Washout Period 3||0
1001920|NCT00515502|2431961|P3|NOT COMPLETED|Washout Period 3||0
1001921|NCT00515502|2431962|P2|NOT COMPLETED|Washout Period 3||0
1001922|NCT00515502|2431963|P1|NOT COMPLETED|Washout Period 3||0
1001923|NCT00515502|2431952|P12|COMPLETED|Washout Period 3||0
1001924|NCT00515502|2431953|P11|COMPLETED|Washout Period 3||1
1001925|NCT00515502|2431954|P10|COMPLETED|Washout Period 3||2
1001926|NCT00515502|2431955|P9|COMPLETED|Washout Period 3||0
1001927|NCT00515502|2431956|P8|COMPLETED|Washout Period 3||1
1001928|NCT00515502|2431957|P7|COMPLETED|Washout Period 3||1
1001929|NCT00515502|2431958|P6|COMPLETED|Washout Period 3||1
1001930|NCT00515502|2431959|P5|COMPLETED|Washout Period 3||3
1001931|NCT00515502|2431960|P4|COMPLETED|Washout Period 3||3
1001932|NCT00515502|2431961|P3|COMPLETED|Washout Period 3||4
1001933|NCT00515502|2431962|P2|COMPLETED|Washout Period 3||3
1001934|NCT00515502|2431963|P1|COMPLETED|Washout Period 3||1
1001935|NCT00515502|2431952|P12|STARTED|Washout Period 3||0
1001936|NCT00515502|2431953|P11|STARTED|Washout Period 3||1
1001937|NCT00515502|2431954|P10|STARTED|Washout Period 3||2
1001938|NCT00515502|2431955|P9|STARTED|Washout Period 3||0
1001939|NCT00515502|2431956|P8|STARTED|Washout Period 3||1
1001940|NCT00515502|2431957|P7|STARTED|Washout Period 3||1
1001941|NCT00515502|2431958|P6|STARTED|Washout Period 3||1
1001942|NCT00515502|2431959|P5|STARTED|Washout Period 3||3
1001943|NCT00515502|2431960|P4|STARTED|Washout Period 3||3
1001944|NCT00515502|2431961|P3|STARTED|Washout Period 3||4
1001945|NCT00515502|2431962|P2|STARTED|Washout Period 3||3
1001946|NCT00515502|2431963|P1|STARTED|Washout Period 3||1
1001947|NCT00515502|2431952|P12|NOT COMPLETED|Treatment Period 3||0
1001948|NCT00515502|2431953|P11|NOT COMPLETED|Treatment Period 3||0
1001949|NCT00515502|2431954|P10|NOT COMPLETED|Treatment Period 3||0
1001950|NCT00515502|2431955|P9|NOT COMPLETED|Treatment Period 3||0
1001951|NCT00515502|2431956|P8|NOT COMPLETED|Treatment Period 3||0
1001952|NCT00515502|2431957|P7|NOT COMPLETED|Treatment Period 3||0
1001953|NCT00515502|2431958|P6|NOT COMPLETED|Treatment Period 3||0
1001954|NCT00515502|2431959|P5|NOT COMPLETED|Treatment Period 3||0
1001955|NCT00515502|2431960|P4|NOT COMPLETED|Treatment Period 3||0
1001956|NCT00515502|2431961|P3|NOT COMPLETED|Treatment Period 3||0
1001957|NCT00515502|2431962|P2|NOT COMPLETED|Treatment Period 3||0
1001958|NCT00515502|2431963|P1|NOT COMPLETED|Treatment Period 3||0
1001959|NCT00515502|2431952|P12|COMPLETED|Treatment Period 3||0
1001960|NCT00515502|2431953|P11|COMPLETED|Treatment Period 3||1
1001961|NCT00515502|2431954|P10|COMPLETED|Treatment Period 3||2
1001962|NCT00515502|2431955|P9|COMPLETED|Treatment Period 3||0
1001963|NCT00515502|2431956|P8|COMPLETED|Treatment Period 3||1
1001964|NCT00515502|2431957|P7|COMPLETED|Treatment Period 3||1
1001965|NCT00515502|2431958|P6|COMPLETED|Treatment Period 3||1
1001966|NCT00515502|2431959|P5|COMPLETED|Treatment Period 3||3
1001967|NCT00515502|2431960|P4|COMPLETED|Treatment Period 3||3
1001968|NCT00515502|2431961|P3|COMPLETED|Treatment Period 3||4
1001969|NCT00515502|2431962|P2|COMPLETED|Treatment Period 3||3
1001970|NCT00515502|2431963|P1|COMPLETED|Treatment Period 3||1
1001971|NCT00515502|2431952|P12|STARTED|Treatment Period 3||0
1001972|NCT00515502|2431953|P11|STARTED|Treatment Period 3||1
1001973|NCT00515502|2431954|P10|STARTED|Treatment Period 3||2
1001974|NCT00515502|2431955|P9|STARTED|Treatment Period 3||0
1001975|NCT00515502|2431956|P8|STARTED|Treatment Period 3||1
1001976|NCT00515502|2431957|P7|STARTED|Treatment Period 3||1
1001977|NCT00515502|2431958|P6|STARTED|Treatment Period 3||1
1001978|NCT00515502|2431959|P5|STARTED|Treatment Period 3||3
1001979|NCT00515502|2431960|P4|STARTED|Treatment Period 3||3
1001980|NCT00515502|2431961|P3|STARTED|Treatment Period 3||4
1001981|NCT00515502|2431962|P2|STARTED|Treatment Period 3||3
1001982|NCT00515502|2431963|P1|STARTED|Treatment Period 3||1
1001983|NCT00515502|2431952|P12|NOT COMPLETED|Washout Period 2||0
1001984|NCT00515502|2431953|P11|NOT COMPLETED|Washout Period 2||0
1001985|NCT00515502|2431954|P10|NOT COMPLETED|Washout Period 2||0
1001986|NCT00515502|2431955|P9|NOT COMPLETED|Washout Period 2||0
1001987|NCT00515502|2431956|P8|NOT COMPLETED|Washout Period 2||0
1001988|NCT00515502|2431957|P7|NOT COMPLETED|Washout Period 2||0
1001989|NCT00515502|2431958|P6|NOT COMPLETED|Washout Period 2||0
1001990|NCT00515502|2431959|P5|NOT COMPLETED|Washout Period 2||0
1001991|NCT00515502|2431960|P4|NOT COMPLETED|Washout Period 2||0
1001992|NCT00515502|2431961|P3|NOT COMPLETED|Washout Period 2||0
1001993|NCT00515502|2431962|P2|NOT COMPLETED|Washout Period 2||0
1001994|NCT00515502|2431963|P1|NOT COMPLETED|Washout Period 2||0
1001995|NCT00515502|2431952|P12|COMPLETED|Washout Period 2||0
1001996|NCT00515502|2431953|P11|COMPLETED|Washout Period 2||1
1001997|NCT00515502|2431954|P10|COMPLETED|Washout Period 2||2
1001998|NCT00515502|2431955|P9|COMPLETED|Washout Period 2||0
1001999|NCT00515502|2431956|P8|COMPLETED|Washout Period 2||1
1002000|NCT00515502|2431957|P7|COMPLETED|Washout Period 2||1
1002001|NCT00515502|2431958|P6|COMPLETED|Washout Period 2||1
1002002|NCT00515502|2431959|P5|COMPLETED|Washout Period 2||3
1002003|NCT00515502|2431960|P4|COMPLETED|Washout Period 2||3
1002004|NCT00515502|2431961|P3|COMPLETED|Washout Period 2||4
1002005|NCT00515502|2431962|P2|COMPLETED|Washout Period 2||3
1002006|NCT00515502|2431963|P1|COMPLETED|Washout Period 2||1
1002007|NCT00515502|2431952|P12|STARTED|Washout Period 2||0
1002008|NCT00515502|2431953|P11|STARTED|Washout Period 2||1
1002009|NCT00515502|2431954|P10|STARTED|Washout Period 2||2
1002010|NCT00515502|2431955|P9|STARTED|Washout Period 2||0
1002011|NCT00515502|2431956|P8|STARTED|Washout Period 2||1
1002012|NCT00515502|2431957|P7|STARTED|Washout Period 2||1
1002013|NCT00515502|2431958|P6|STARTED|Washout Period 2||1
1002014|NCT00515502|2431959|P5|STARTED|Washout Period 2||3
1002015|NCT00515502|2431960|P4|STARTED|Washout Period 2||3
1002016|NCT00515502|2431961|P3|STARTED|Washout Period 2||4
1002017|NCT00515502|2431962|P2|STARTED|Washout Period 2||3
1002018|NCT00515502|2431963|P1|STARTED|Washout Period 2||1
1002019|NCT00515502|2431952|P12|NOT COMPLETED|Treatment Period 2||0
1002020|NCT00515502|2431953|P11|NOT COMPLETED|Treatment Period 2||0
1002021|NCT00515502|2431954|P10|NOT COMPLETED|Treatment Period 2||0
1002022|NCT00515502|2431955|P9|NOT COMPLETED|Treatment Period 2||0
1002023|NCT00515502|2431956|P8|NOT COMPLETED|Treatment Period 2||0
1002024|NCT00515502|2431957|P7|NOT COMPLETED|Treatment Period 2||0
1002025|NCT00515502|2431958|P6|NOT COMPLETED|Treatment Period 2||0
1002026|NCT00515502|2431959|P5|NOT COMPLETED|Treatment Period 2||0
1002027|NCT00515502|2431960|P4|NOT COMPLETED|Treatment Period 2||0
1002028|NCT00515502|2431961|P3|NOT COMPLETED|Treatment Period 2||0
1002029|NCT00515502|2431962|P2|NOT COMPLETED|Treatment Period 2||1
1002030|NCT00515502|2431963|P1|NOT COMPLETED|Treatment Period 2||0
1002031|NCT00515502|2431952|P12|COMPLETED|Treatment Period 2||0
1002032|NCT00515502|2431953|P11|COMPLETED|Treatment Period 2||1
1002033|NCT00515502|2431954|P10|COMPLETED|Treatment Period 2||2
1002034|NCT00515502|2431955|P9|COMPLETED|Treatment Period 2||0
1002035|NCT00515502|2431956|P8|COMPLETED|Treatment Period 2||1
1002036|NCT00515502|2431957|P7|COMPLETED|Treatment Period 2||1
1002037|NCT00515502|2431958|P6|COMPLETED|Treatment Period 2||1
1002038|NCT00515502|2431959|P5|COMPLETED|Treatment Period 2||3
1002039|NCT00515502|2431960|P4|COMPLETED|Treatment Period 2||3
1002040|NCT00515502|2431961|P3|COMPLETED|Treatment Period 2||4
1002041|NCT00515502|2431962|P2|COMPLETED|Treatment Period 2||3
1002042|NCT00515502|2431963|P1|COMPLETED|Treatment Period 2||1
1002043|NCT00515502|2431952|P12|STARTED|Treatment Period 2||0
1002044|NCT00515502|2431953|P11|STARTED|Treatment Period 2||1
1002045|NCT00515502|2431954|P10|STARTED|Treatment Period 2||2
1002046|NCT00515502|2431955|P9|STARTED|Treatment Period 2||0
1002047|NCT00515502|2431956|P8|STARTED|Treatment Period 2||1
1002048|NCT00515502|2431957|P7|STARTED|Treatment Period 2||1
1002049|NCT00515502|2431958|P6|STARTED|Treatment Period 2||1
1002050|NCT00515502|2431959|P5|STARTED|Treatment Period 2||3
1002051|NCT00515502|2431960|P4|STARTED|Treatment Period 2||3
1002052|NCT00515502|2431961|P3|STARTED|Treatment Period 2||4
1002053|NCT00515502|2431962|P2|STARTED|Treatment Period 2||4
1002054|NCT00515502|2431963|P1|STARTED|Treatment Period 2||1
1002055|NCT00515502|2431952|P12|NOT COMPLETED|Washout Period 1||0
1002056|NCT00515502|2431953|P11|NOT COMPLETED|Washout Period 1||0
1002057|NCT00515502|2431954|P10|NOT COMPLETED|Washout Period 1||0
1002058|NCT00515502|2431955|P9|NOT COMPLETED|Washout Period 1||0
1002059|NCT00515502|2431956|P8|NOT COMPLETED|Washout Period 1||0
1002060|NCT00515502|2431957|P7|NOT COMPLETED|Washout Period 1||0
1002061|NCT00515502|2431958|P6|NOT COMPLETED|Washout Period 1||0
1002062|NCT00515502|2431959|P5|NOT COMPLETED|Washout Period 1||0
1002063|NCT00515502|2431960|P4|NOT COMPLETED|Washout Period 1||0
1002064|NCT00515502|2431961|P3|NOT COMPLETED|Washout Period 1||0
1002065|NCT00515502|2431962|P2|NOT COMPLETED|Washout Period 1||0
1002066|NCT00515502|2431963|P1|NOT COMPLETED|Washout Period 1||0
1002067|NCT00515502|2431952|P12|COMPLETED|Washout Period 1||0
1002068|NCT00515502|2431953|P11|COMPLETED|Washout Period 1||1
1002069|NCT00515502|2431954|P10|COMPLETED|Washout Period 1||2
1002070|NCT00515502|2431955|P9|COMPLETED|Washout Period 1||0
1002071|NCT00515502|2431956|P8|COMPLETED|Washout Period 1||1
1002072|NCT00515502|2431957|P7|COMPLETED|Washout Period 1||1
1002073|NCT00515502|2431958|P6|COMPLETED|Washout Period 1||1
1002074|NCT00515502|2431959|P5|COMPLETED|Washout Period 1||3
1002075|NCT00515502|2431960|P4|COMPLETED|Washout Period 1||3
1002076|NCT00515502|2431961|P3|COMPLETED|Washout Period 1||4
1002077|NCT00515502|2431962|P2|COMPLETED|Washout Period 1||4
1002078|NCT00515502|2431963|P1|COMPLETED|Washout Period 1||1
1002079|NCT00515502|2431952|P12|STARTED|Washout Period 1||0
1002080|NCT00515502|2431953|P11|STARTED|Washout Period 1||1
1002081|NCT00515502|2431954|P10|STARTED|Washout Period 1||2
1002082|NCT00515502|2431955|P9|STARTED|Washout Period 1||0
1002083|NCT00515502|2431956|P8|STARTED|Washout Period 1||1
1002084|NCT00515502|2431957|P7|STARTED|Washout Period 1||1
1002085|NCT00515502|2431958|P6|STARTED|Washout Period 1||1
1002086|NCT00515502|2431959|P5|STARTED|Washout Period 1||3
1002087|NCT00515502|2431960|P4|STARTED|Washout Period 1||3
1002088|NCT00515502|2431961|P3|STARTED|Washout Period 1||4
1002089|NCT00515502|2431962|P2|STARTED|Washout Period 1||4
1002090|NCT00515502|2431963|P1|STARTED|Washout Period 1||1
1002091|NCT00515502|2431952|P12|NOT COMPLETED|Treatment Period 1||1
1002092|NCT00515502|2431953|P11|NOT COMPLETED|Treatment Period 1||0
1002093|NCT00515502|2431954|P10|NOT COMPLETED|Treatment Period 1||0
1002094|NCT00515502|2431955|P9|NOT COMPLETED|Treatment Period 1||1
1002095|NCT00515502|2431956|P8|NOT COMPLETED|Treatment Period 1||0
1002096|NCT00515502|2431957|P7|NOT COMPLETED|Treatment Period 1||1
1002097|NCT00515502|2431958|P6|NOT COMPLETED|Treatment Period 1||0
1002098|NCT00515502|2431959|P5|NOT COMPLETED|Treatment Period 1||0
1002099|NCT00515502|2431960|P4|NOT COMPLETED|Treatment Period 1||0
1002100|NCT00515502|2431961|P3|NOT COMPLETED|Treatment Period 1||0
1002101|NCT00515502|2431962|P2|NOT COMPLETED|Treatment Period 1||0
1002102|NCT00515502|2431963|P1|NOT COMPLETED|Treatment Period 1||0
1002103|NCT00515502|2431952|P12|COMPLETED|Treatment Period 1||0
1002104|NCT00515502|2431953|P11|COMPLETED|Treatment Period 1||1
1002105|NCT00515502|2431954|P10|COMPLETED|Treatment Period 1||2
1002106|NCT00515502|2431955|P9|COMPLETED|Treatment Period 1||0
1002107|NCT00515502|2431956|P8|COMPLETED|Treatment Period 1||1
1002108|NCT00515502|2431957|P7|COMPLETED|Treatment Period 1||1
1002109|NCT00515502|2431958|P6|COMPLETED|Treatment Period 1||1
1002110|NCT00515502|2431959|P5|COMPLETED|Treatment Period 1||3
1002111|NCT00515502|2431960|P4|COMPLETED|Treatment Period 1||3
1002112|NCT00515502|2431961|P3|COMPLETED|Treatment Period 1||4
1002113|NCT00515502|2431962|P2|COMPLETED|Treatment Period 1||4
1002114|NCT00515502|2431963|P1|COMPLETED|Treatment Period 1||1
1002115|NCT00515502|2431952|P12|STARTED|Treatment Period 1||1
1002116|NCT00515502|2431953|P11|STARTED|Treatment Period 1||1
1002117|NCT00515502|2431954|P10|STARTED|Treatment Period 1||2
1002118|NCT00515502|2431955|P9|STARTED|Treatment Period 1||1
1002119|NCT00515502|2431956|P8|STARTED|Treatment Period 1||1
1002120|NCT00515502|2431957|P7|STARTED|Treatment Period 1||2
1002121|NCT00515502|2431958|P6|STARTED|Treatment Period 1||1
1002122|NCT00515502|2431959|P5|STARTED|Treatment Period 1||3
1002123|NCT00515502|2431960|P4|STARTED|Treatment Period 1||3
1002124|NCT00515502|2431961|P3|STARTED|Treatment Period 1||4
1002125|NCT00515502|2431962|P2|STARTED|Treatment Period 1||4
1002126|NCT00515502|2431963|P1|STARTED|Treatment Period 1||1
1002127|NCT00515541|2432125|P4|NOT COMPLETED|Overall Study||5
1002128|NCT00515541|2432126|P3|NOT COMPLETED|Overall Study||0
1002129|NCT00515541|2432127|P2|NOT COMPLETED|Overall Study||5
1002130|NCT00515541|2432128|P1|NOT COMPLETED|Overall Study||0
1002131|NCT00515541|2432125|P4|COMPLETED|Overall Study||6
1002132|NCT00515541|2432126|P3|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
1002133|NCT00515541|2432127|P2|COMPLETED|Overall Study||7
1002134|NCT00515541|2432128|P1|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
1002135|NCT00515541|2432125|P4|24 Weeks (8 gm Lovaza)|Overall Study|Three subjects withdrew after 18 weeks (1 GI problem, 1 undefined medical problem, 1 no show)|6
1002136|NCT00515541|2432126|P3|24 Weeks (8 gm Lovaza)|Overall Study||10
1002137|NCT00515541|2432127|P2|24 Weeks (8 gm Lovaza)|Overall Study|Two subjects withdrew at 20 and 21 weeks due to nausea. Subjects were closed out early.|7
1002138|NCT00515541|2432128|P1|24 Weeks (8 gm Lovaza)|Overall Study||10
1002139|NCT00515541|2432125|P4|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 14 weeks with GI problems.|9
1002140|NCT00515541|2432126|P3|18 Weeks (4 gm Lovaza)|Overall Study||10
1002141|NCT00515541|2432127|P2|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 12 weeks due to acquired bleeding disorder present before enrolling.|9
1002142|NCT00515541|2432128|P1|18 Weeks (4 gm Lovaza)|Overall Study||10
1002143|NCT00515541|2432125|P4|12 Weeks (2 gm Lovaza)|Overall Study||10
1002144|NCT00515541|2432126|P3|12 Weeks (2 gm Lovaza)|Overall Study||10
1002145|NCT00515541|2432127|P2|12 Weeks (2 gm Lovaza)|Overall Study||10
1002146|NCT00515541|2432128|P1|12 Weeks (2 gm Lovaza)|Overall Study||10
1002147|NCT00515541|2432125|P4|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled due to no show for appt. after baseline.|10
1002148|NCT00515541|2432126|P3|6 Weeks (1 gm Lovaza)|Overall Study||10
1002149|NCT00515541|2432127|P2|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled after baseline. One subject pulled due to no show for appt.after baseline|10
1002150|NCT00515541|2432128|P1|6 Weeks (1 gm Lovaza)|Overall Study||10
1002151|NCT00515541|2432125|P4|STARTED|Overall Study||11
1002152|NCT00515541|2432126|P3|STARTED|Overall Study||10
1002153|NCT00515541|2432127|P2|STARTED|Overall Study||12
1002154|NCT00515541|2432128|P1|STARTED|Overall Study||10
1002155|NCT00515619|2432150|P1|NOT COMPLETED|Overall Study||216
1002156|NCT00515619|2432150|P1|COMPLETED|Overall Study||160
1002157|NCT00515619|2432150|P1|Safety Set|Overall Study||376
1002158|NCT00515619|2432150|P1|STARTED|Overall Study||376
1002159|NCT00515671|2432160|P2|NOT COMPLETED|Overall Study||17
1002160|NCT00515671|2432161|P1|NOT COMPLETED|Overall Study||17
1002161|NCT00515671|2432160|P2|COMPLETED|Overall Study||41
1002162|NCT00515671|2432161|P1|COMPLETED|Overall Study||43
1002163|NCT00515671|2432160|P2|STARTED|Overall Study||58
1002164|NCT00515671|2432161|P1|STARTED|Overall Study||60
1002165|NCT00515697|2432169|P1|NOT COMPLETED|Overall Study||0
1002166|NCT00515697|2432169|P1|COMPLETED|Overall Study||39
1002167|NCT00515697|2432169|P1|Received at Least 1 Dose of Study Drug|Overall Study||39
1002168|NCT00515697|2432169|P1|STARTED|Overall Study||39
1002169|NCT00515827|2432182|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
1002170|NCT00515827|2432183|P1|NOT COMPLETED|Second Intervention (12 Weeks)||1
1002171|NCT00515827|2432182|P2|COMPLETED|Second Intervention (12 Weeks)||25
1002172|NCT00515827|2432183|P1|COMPLETED|Second Intervention (12 Weeks)||25
1002173|NCT00515827|2432182|P2|STARTED|Second Intervention (12 Weeks)||25
1002174|NCT00515827|2432183|P1|STARTED|Second Intervention (12 Weeks)||26
1002175|NCT00515827|2432182|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
1002176|NCT00515827|2432183|P1|NOT COMPLETED|First Intervention (12 Weeks)||1
1002177|NCT00515827|2432182|P2|COMPLETED|First Intervention (12 Weeks)||25
1002178|NCT00515827|2432183|P1|COMPLETED|First Intervention (12 Weeks)||26
1002179|NCT00515827|2432182|P2|STARTED|First Intervention (12 Weeks)||26
1002180|NCT00515827|2432183|P1|STARTED|First Intervention (12 Weeks)||27
1002181|NCT00515879|2432207|P2|NOT COMPLETED|Overall Study||20
1002182|NCT00515879|2432208|P1|NOT COMPLETED|Overall Study||25
1002183|NCT00515879|2432207|P2|COMPLETED|Overall Study||62
1002184|NCT00515879|2432208|P1|COMPLETED|Overall Study||62
1002185|NCT00515879|2432207|P2|STARTED|Overall Study||82
1002186|NCT00515879|2432208|P1|STARTED|Overall Study||87
1002187|NCT00516048|2432218|P3|NOT COMPLETED|Overall Study||1
1002188|NCT00516048|2432219|P2|NOT COMPLETED|Overall Study||2
1002189|NCT00516048|2432220|P1|NOT COMPLETED|Overall Study||0
1002190|NCT00516048|2432218|P3|COMPLETED|Overall Study||0
1002191|NCT00516048|2432219|P2|COMPLETED|Overall Study||40
1002192|NCT00516048|2432220|P1|COMPLETED|Overall Study||15
1002193|NCT00516048|2432218|P3|STARTED|Overall Study||1
1002194|NCT00516048|2432219|P2|STARTED|Overall Study||42
1002195|NCT00516048|2432220|P1|STARTED|Overall Study||15
1002196|NCT00516074|2432236|P2|NOT COMPLETED|Overall Study||3
1002197|NCT00516074|2432237|P1|NOT COMPLETED|Overall Study||6
1002198|NCT00516074|2432236|P2|COMPLETED|Overall Study||23
1002199|NCT00516074|2432237|P1|COMPLETED|Overall Study||22
1002200|NCT00516074|2432236|P2|STARTED|Overall Study||26
1002201|NCT00516074|2432237|P1|STARTED|Overall Study||28
1002202|NCT00516139|2432253|P1|NOT COMPLETED|Overall Study||38
1002203|NCT00516139|2432253|P1|COMPLETED|Overall Study|Study completers completed Escalation, AM, and either AO or both Conversion and Monotherapy Phases.|84
1002204|NCT00516139|2432253|P1|STARTED|Overall Study||122
1002205|NCT00516165|2432282|P1|NOT COMPLETED|Overall Study||0
1002206|NCT00516165|2432282|P1|COMPLETED|Overall Study||28
1002207|NCT00516165|2432282|P1|STARTED|Overall Study||28
1002208|NCT00516217|2432291|P1|NOT COMPLETED|Overall Study||0
1002209|NCT00516217|2432291|P1|COMPLETED|Overall Study||29
1002210|NCT00516217|2432291|P1|STARTED|Overall Study||29
1002211|NCT00516269|2432299|P2|NOT COMPLETED|Overall Study||3
1002212|NCT00516269|2432300|P1|NOT COMPLETED|Overall Study||2
1002213|NCT00516269|2432299|P2|COMPLETED|Overall Study|2 patients did not complete the study and 1 randomized to placebo twice.|16
1002214|NCT00516269|2432300|P1|COMPLETED|Overall Study|2 patients had an early termination|17
1002215|NCT00516269|2432299|P2|STARTED|Overall Study||19
1002216|NCT00516269|2432300|P1|STARTED|Overall Study||19
1002217|NCT00516295|2432309|P3|NOT COMPLETED|Overall Study||0
1002218|NCT00516295|2432310|P2|NOT COMPLETED|Overall Study||0
1002219|NCT00516295|2432311|P1|NOT COMPLETED|Overall Study||3
1002220|NCT00516295|2432309|P3|COMPLETED|Overall Study||0
1002221|NCT00516295|2432310|P2|COMPLETED|Overall Study||0
1002222|NCT00516295|2432311|P1|COMPLETED|Overall Study||4
1002223|NCT00516295|2432309|P3|STARTED|Overall Study||0
1002224|NCT00516295|2432310|P2|STARTED|Overall Study||0
1002225|NCT00516295|2432311|P1|STARTED|Overall Study||7
1002226|NCT00516321|2432324|P3|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||54
1002227|NCT00516321|2432325|P2|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||35
1002228|NCT00516321|2432326|P1|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||0
1002229|NCT00516321|2432324|P3|COMPLETED|Double-blind (DB) Antiviral Treatment||396
1002230|NCT00516321|2432325|P2|COMPLETED|Double-blind (DB) Antiviral Treatment||197
1002231|NCT00516321|2432326|P1|COMPLETED|Double-blind (DB) Antiviral Treatment||0
1002232|NCT00516321|2432324|P3|STARTED|Double-blind (DB) Antiviral Treatment||450
1002233|NCT00516321|2432325|P2|STARTED|Double-blind (DB) Antiviral Treatment||232
1002234|NCT00516321|2432326|P1|STARTED|Double-blind (DB) Antiviral Treatment||0
1002235|NCT00516321|2432324|P3|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
1002236|NCT00516321|2432325|P2|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
1002237|NCT00516321|2432326|P1|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||33
1002238|NCT00516321|2432324|P3|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
1002239|NCT00516321|2432325|P2|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
1002240|NCT00516321|2432326|P1|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||682
1002241|NCT00516321|2432324|P3|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
1002242|NCT00516321|2432325|P2|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
1002243|NCT00516321|2432326|P1|STARTED|Open-label (OL) Pre-Antiviral Treatment||715
1002244|NCT00516386|2432374|P1|NOT COMPLETED|Overall Study||6
1002245|NCT00516386|2432374|P1|COMPLETED|Overall Study||10
1002246|NCT00516386|2432374|P1|STARTED|Overall Study||16
1002247|NCT00516503|2432381|P2|NOT COMPLETED|Overall Study||0
1002248|NCT00516503|2432382|P1|NOT COMPLETED|Overall Study||0
1002249|NCT00516503|2432381|P2|COMPLETED|Overall Study||102
1002250|NCT00516503|2432382|P1|COMPLETED|Overall Study||101
1002251|NCT00516503|2432381|P2|STARTED|Overall Study||102
1002252|NCT00516503|2432382|P1|STARTED|Overall Study||101
1002253|NCT00516737|2432402|P2|NOT COMPLETED|Overall Study||8
1002254|NCT00516737|2432403|P1|NOT COMPLETED|Overall Study||11
1002255|NCT00516737|2432402|P2|COMPLETED|Overall Study||96
1002256|NCT00516737|2432403|P1|COMPLETED|Overall Study||92
1002257|NCT00516737|2432402|P2|STARTED|Overall Study||104
1002258|NCT00516737|2432403|P1|STARTED|Overall Study||103
1002259|NCT00516893|2432421|P1|NOT COMPLETED|Overall Study||21
1002260|NCT00516893|2432421|P1|COMPLETED|Overall Study||92
1002261|NCT00516893|2432421|P1|Received Study Treatment|Overall Study||112
1002262|NCT00516893|2432421|P1|STARTED|Overall Study||113
1002263|NCT00510224|2432428|P1|NOT COMPLETED|Overall Study||3
1002264|NCT00510224|2432428|P1|COMPLETED|Overall Study||10
1002265|NCT00510224|2432428|P1|STARTED|Overall Study||13
1002266|NCT00510276|2432437|P2|NOT COMPLETED|Extension Open-Label Phase||48
1002267|NCT00510276|2432438|P1|NOT COMPLETED|Extension Open-Label Phase||33
1002268|NCT00510276|2432437|P2|COMPLETED|Extension Open-Label Phase||81
1002269|NCT00510276|2432438|P1|COMPLETED|Extension Open-Label Phase||78
1002270|NCT00510276|2432437|P2|STARTED|Extension Open-Label Phase|1 patient who completed acute phase did not participate in the optional atometine extension phase|129
1002271|NCT00510276|2432438|P1|STARTED|Extension Open-Label Phase|4 patients who completed acute phase did not participate in the optional atomoxetine extension phase|111
1002272|NCT00510276|2432437|P2|NOT COMPLETED|Acute Double-Blind Phase||95
1002273|NCT00510276|2432438|P1|NOT COMPLETED|Acute Double-Blind Phase||105
1002274|NCT00510276|2432437|P2|COMPLETED|Acute Double-Blind Phase||130
1002275|NCT00510276|2432438|P1|COMPLETED|Acute Double-Blind Phase||115
1002276|NCT00510276|2432437|P2|STARTED|Acute Double-Blind Phase||225
1002277|NCT00510276|2432438|P1|STARTED|Acute Double-Blind Phase||220
1002278|NCT00510289|2432523|P1|NOT COMPLETED|Overall Study||12
1002279|NCT00510289|2432523|P1|COMPLETED|Overall Study|Completed at least one cycle of study drug and had disease assessments|7
1002280|NCT00510289|2432523|P1|Started Study Drug|Overall Study|3 patients progressed prior to starting study drug|16
1002281|NCT00510289|2432523|P1|STARTED|Overall Study|All patients who consented|19
1002282|NCT00516906|2432533|P2|NOT COMPLETED|Overall Study||2
1002283|NCT00516906|2432534|P1|NOT COMPLETED|Overall Study||6
1002284|NCT00516906|2432533|P2|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
1002285|NCT00516906|2432534|P1|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
1002286|NCT00516906|2432533|P2|STARTED|Overall Study|33 patients were randomized but one patient was discharged prior to treatment.|32
1002287|NCT00516906|2432534|P1|STARTED|Overall Study||36
1002288|NCT00516919|2432544|P2|NOT COMPLETED|Overall Study||7
1002289|NCT00516919|2432545|P1|NOT COMPLETED|Overall Study||10
1002290|NCT00516919|2432544|P2|COMPLETED|Overall Study||32
1002291|NCT00516919|2432545|P1|COMPLETED|Overall Study||30
1002292|NCT00516919|2432544|P2|STARTED|Overall Study||39
1002293|NCT00516919|2432545|P1|STARTED|Overall Study||40
1002294|NCT00517010|2432551|P1|NOT COMPLETED|Overall Study||1
1002295|NCT00517010|2432551|P1|COMPLETED|Overall Study||5
1002296|NCT00517010|2432551|P1|STARTED|Overall Study||6
1002297|NCT00517075|2432560|P4|NOT COMPLETED|Overall Study||0
1002298|NCT00517075|2432561|P3|NOT COMPLETED|Overall Study||0
1002299|NCT00517075|2432562|P2|NOT COMPLETED|Overall Study||0
1002300|NCT00517075|2432563|P1|NOT COMPLETED|Overall Study||0
1002301|NCT00517075|2432560|P4|COMPLETED|Overall Study||0
1002302|NCT00517075|2432561|P3|COMPLETED|Overall Study||0
1002303|NCT00517075|2432562|P2|COMPLETED|Overall Study||0
1002304|NCT00517075|2432563|P1|COMPLETED|Overall Study||0
1002305|NCT00517075|2432560|P4|STARTED|Overall Study||0
1002306|NCT00517075|2432561|P3|STARTED|Overall Study||0
1002307|NCT00517075|2432562|P2|STARTED|Overall Study||0
1002308|NCT00517075|2432563|P1|STARTED|Overall Study||0
1002309|NCT00517192|2432603|P2|NOT COMPLETED|Overall Study||20
1002310|NCT00517192|2432604|P1|NOT COMPLETED|Overall Study||19
1002311|NCT00517192|2432603|P2|COMPLETED|Overall Study||0
1002312|NCT00517192|2432604|P1|COMPLETED|Overall Study||0
1002313|NCT00517192|2432603|P2|STARTED|Overall Study||20
1002314|NCT00517192|2432604|P1|STARTED|Overall Study||19
1002315|NCT00518284|2432656|P4|NOT COMPLETED|Overall Study||2
1002316|NCT00518284|2432657|P3|NOT COMPLETED|Overall Study||1
1002317|NCT00518284|2432658|P2|NOT COMPLETED|Overall Study||3
1002318|NCT00518284|2432659|P1|NOT COMPLETED|Overall Study||0
1002319|NCT00518284|2432656|P4|COMPLETED|Overall Study||0
1002320|NCT00518284|2432657|P3|COMPLETED|Overall Study||0
1002321|NCT00518284|2432658|P2|COMPLETED|Overall Study||0
1002322|NCT00518284|2432659|P1|COMPLETED|Overall Study||0
1002323|NCT00518284|2432656|P4|STARTED|Overall Study||2
1002324|NCT00518284|2432657|P3|STARTED|Overall Study||1
1002325|NCT00518284|2432658|P2|STARTED|Overall Study||3
1002326|NCT00518284|2432659|P1|STARTED|Overall Study||0
1002327|NCT00518323|2432717|P4|NOT COMPLETED|Overall Study||25
1002328|NCT00518323|2432718|P3|NOT COMPLETED|Overall Study||11
1002329|NCT00518323|2432719|P2|NOT COMPLETED|Overall Study||8
1002330|NCT00518323|2432720|P1|NOT COMPLETED|Overall Study||19
1002331|NCT00518323|2432717|P4|COMPLETED|Overall Study||26
1002332|NCT00518323|2432718|P3|COMPLETED|Overall Study||37
1002333|NCT00518323|2432719|P2|COMPLETED|Overall Study||40
1002334|NCT00518323|2432720|P1|COMPLETED|Overall Study||35
1002335|NCT00518323|2432717|P4|STARTED|Overall Study||51
1002336|NCT00518323|2432718|P3|STARTED|Overall Study||48
1002337|NCT00518323|2432719|P2|STARTED|Overall Study||48
1002338|NCT00518323|2432720|P1|STARTED|Overall Study||54
1002339|NCT00518336|2432748|P2|NOT COMPLETED|Year 9||1
1002340|NCT00518336|2432749|P1|NOT COMPLETED|Year 9||5
1002341|NCT00518336|2432748|P2|COMPLETED|Year 9||212
1002342|NCT00518336|2432749|P1|COMPLETED|Year 9||219
1002343|NCT00518336|2432748|P2|STARTED|Year 9||213
1002344|NCT00518336|2432749|P1|STARTED|Year 9|1 subject did not particpate at the previous timepoint, came back and was added in the Total cohort|224
1002345|NCT00518336|2432748|P2|NOT COMPLETED|Year 8||2
1002346|NCT00518336|2432749|P1|NOT COMPLETED|Year 8||1
1002347|NCT00518336|2432748|P2|COMPLETED|Year 8||211
1002348|NCT00518336|2432749|P1|COMPLETED|Year 8||222
1002433|NCT00518713|2433008|P4|STARTED|Overall Study||59
1002434|NCT00518713|2433009|P3|STARTED|Overall Study||59
1002349|NCT00518336|2432748|P2|STARTED|Year 8|2 subjects withdrawn at Year 7 came back and were therefore no longer considered as withdrawn.|213
1002350|NCT00518336|2432749|P1|STARTED|Year 8|1 subject withdrawn at Year 7 came back and was therefore no longer considered as withdrawn.|223
1002351|NCT00518336|2432748|P2|NOT COMPLETED|Year 7||3
1002352|NCT00518336|2432749|P1|NOT COMPLETED|Year 7||2
1002353|NCT00518336|2432748|P2|COMPLETED|Year 7||208
1002354|NCT00518336|2432749|P1|COMPLETED|Year 7||220
1002355|NCT00518336|2432748|P2|STARTED|Year 7||211
1002356|NCT00518336|2432749|P1|STARTED|Year 7||222
1002357|NCT00518531|2432913|P2|NOT COMPLETED|Treatment Period 2||20
1002358|NCT00518531|2432914|P1|NOT COMPLETED|Treatment Period 2||3
1002359|NCT00518531|2432913|P2|COMPLETED|Treatment Period 2||95
1002360|NCT00518531|2432914|P1|COMPLETED|Treatment Period 2||103
1002361|NCT00518531|2432913|P2|Received Treatment|Treatment Period 2||110
1002362|NCT00518531|2432914|P1|Received Treatment|Treatment Period 2||106
1002363|NCT00518531|2432913|P2|STARTED|Treatment Period 2|Participants can start Treatment Period 2 without completing Treatment Period 1.|115
1002364|NCT00518531|2432914|P1|STARTED|Treatment Period 2||106
1002365|NCT00518531|2432913|P2|NOT COMPLETED|Treatment Period 1||12
1002366|NCT00518531|2432914|P1|NOT COMPLETED|Treatment Period 1||18
1002367|NCT00518531|2432913|P2|COMPLETED|Treatment Period 1|Participants who completed Treatment Period 1 may choose not to start Treatment Period 2|114
1002368|NCT00518531|2432914|P1|COMPLETED|Treatment Period 1||106
1002369|NCT00518531|2432913|P2|Received Treatment|Treatment Period 1||124
1002370|NCT00518531|2432914|P1|Received Treatment|Treatment Period 1||119
1002371|NCT00518531|2432913|P2|STARTED|Treatment Period 1||126
1002372|NCT00518531|2432914|P1|STARTED|Treatment Period 1||124
1002373|NCT00518622|2432956|P8|NOT COMPLETED|Overall Study||0
1002374|NCT00518622|2432957|P7|NOT COMPLETED|Overall Study||0
1002375|NCT00518622|2432958|P6|NOT COMPLETED|Overall Study||0
1002376|NCT00518622|2432959|P5|NOT COMPLETED|Overall Study||0
1002377|NCT00518622|2432960|P4|NOT COMPLETED|Overall Study||0
1002378|NCT00518622|2432961|P3|NOT COMPLETED|Overall Study||1
1002379|NCT00518622|2432962|P2|NOT COMPLETED|Overall Study||1
1002380|NCT00518622|2432963|P1|NOT COMPLETED|Overall Study||0
1002381|NCT00518622|2432956|P8|COMPLETED|Overall Study||5
1002382|NCT00518622|2432957|P7|COMPLETED|Overall Study||4
1002383|NCT00518622|2432958|P6|COMPLETED|Overall Study||5
1002384|NCT00518622|2432959|P5|COMPLETED|Overall Study||6
1002385|NCT00518622|2432960|P4|COMPLETED|Overall Study||5
1002386|NCT00518622|2432961|P3|COMPLETED|Overall Study||5
1002387|NCT00518622|2432962|P2|COMPLETED|Overall Study||5
1002388|NCT00518622|2432963|P1|COMPLETED|Overall Study||3
1002389|NCT00518622|2432956|P8|Discontinued Therapy|Overall Study||0
1002390|NCT00518622|2432957|P7|Discontinued Therapy|Overall Study||0
1002391|NCT00518622|2432958|P6|Discontinued Therapy|Overall Study||0
1002392|NCT00518622|2432959|P5|Discontinued Therapy|Overall Study||0
1002393|NCT00518622|2432960|P4|Discontinued Therapy|Overall Study||0
1002394|NCT00518622|2432961|P3|Discontinued Therapy|Overall Study||0
1002395|NCT00518622|2432962|P2|Discontinued Therapy|Overall Study||1
1002396|NCT00518622|2432963|P1|Discontinued Therapy|Overall Study|Discontinued therapy defined if participant has not taken 8 days of medication per the protocol.|0
1002397|NCT00518622|2432956|P8|Completed Therapy|Overall Study||5
1002398|NCT00518622|2432957|P7|Completed Therapy|Overall Study||4
1002399|NCT00518622|2432958|P6|Completed Therapy|Overall Study||5
1002400|NCT00518622|2432959|P5|Completed Therapy|Overall Study||6
1002401|NCT00518622|2432960|P4|Completed Therapy|Overall Study||5
1002402|NCT00518622|2432961|P3|Completed Therapy|Overall Study||6
1002403|NCT00518622|2432962|P2|Completed Therapy|Overall Study||5
1002404|NCT00518622|2432963|P1|Completed Therapy|Overall Study|Completed therapy defined if participant has taken 8 days of study medication per the protocol.|3
1002405|NCT00518622|2432956|P8|STARTED|Overall Study||5
1002406|NCT00518622|2432957|P7|STARTED|Overall Study||4
1002407|NCT00518622|2432958|P6|STARTED|Overall Study||5
1002408|NCT00518622|2432959|P5|STARTED|Overall Study||6
1002409|NCT00518622|2432960|P4|STARTED|Overall Study||5
1002410|NCT00518622|2432961|P3|STARTED|Overall Study||6
1002411|NCT00518622|2432962|P2|STARTED|Overall Study||6
1002412|NCT00518622|2432963|P1|STARTED|Overall Study||3
1002413|NCT00518687|2432991|P2|NOT COMPLETED|Overall Study||1420
1002414|NCT00518687|2432992|P1|NOT COMPLETED|Overall Study||1437
1002415|NCT00518687|2432991|P2|COMPLETED|Overall Study||2585
1002416|NCT00518687|2432992|P1|COMPLETED|Overall Study||2568
1002417|NCT00518687|2432991|P2|Vaccinated|Overall Study||3982
1002418|NCT00518687|2432992|P1|Vaccinated|Overall Study||3981
1002419|NCT00518687|2432991|P2|STARTED|Overall Study|An additional 11 participants were not analyzed because of questionable clinical practices at 1 site|4005
1002420|NCT00518687|2432992|P1|STARTED|Overall Study|An additional 10 participants were not analyzed because of questionable clinical practices at 1 site|4005
1002421|NCT00518713|2433008|P4|NOT COMPLETED|Overall Study||18
1002422|NCT00518713|2433009|P3|NOT COMPLETED|Overall Study||18
1002423|NCT00518713|2433010|P2|NOT COMPLETED|Overall Study||17
1002424|NCT00518713|2433011|P1|NOT COMPLETED|Overall Study||8
1002425|NCT00518713|2433008|P4|COMPLETED|Overall Study||41
1002426|NCT00518713|2433009|P3|COMPLETED|Overall Study||41
1002427|NCT00518713|2433010|P2|COMPLETED|Overall Study||45
1002428|NCT00518713|2433011|P1|COMPLETED|Overall Study||50
1002429|NCT00518713|2433008|P4|Modified Intent-to-Treat Population|Overall Study||57
1002430|NCT00518713|2433009|P3|Modified Intent-to-Treat Population|Overall Study||49
1002431|NCT00518713|2433010|P2|Modified Intent-to-Treat Population|Overall Study||58
1002432|NCT00518713|2433011|P1|Modified Intent-to-Treat Population|Overall Study||53
1002435|NCT00518713|2433010|P2|STARTED|Overall Study||62
1002436|NCT00518713|2433011|P1|STARTED|Overall Study||58
1002437|NCT00518882|2433071|P2|NOT COMPLETED|Open-Label Extension, Week 26-78||49
1002438|NCT00518882|2433072|P1|NOT COMPLETED|Open-Label Extension, Week 26-78||41
1002439|NCT00518882|2433071|P2|COMPLETED|Open-Label Extension, Week 26-78||138
1002440|NCT00518882|2433072|P1|COMPLETED|Open-Label Extension, Week 26-78||161
1002441|NCT00518882|2433071|P2|STARTED|Open-Label Extension, Week 26-78||187
1002442|NCT00518882|2433072|P1|STARTED|Open-Label Extension, Week 26-78||202
1002443|NCT00518882|2433071|P2|NOT COMPLETED|Double-Blind, Week 0-26||45
1002444|NCT00518882|2433072|P1|NOT COMPLETED|Double-Blind, Week 0-26||33
1002445|NCT00518882|2433071|P2|COMPLETED|Double-Blind, Week 0-26||187
1002446|NCT00518882|2433072|P1|COMPLETED|Double-Blind, Week 0-26||202
1002447|NCT00518882|2433071|P2|Randomised|Double-Blind, Week 0-26||231
1002448|NCT00518882|2433072|P1|Randomised|Double-Blind, Week 0-26||233
1002449|NCT00518882|2433071|P2|STARTED|Double-Blind, Week 0-26|1 subject exposed to study drug before randomisation. Subject only included in safety analysis set|232
1002450|NCT00518882|2433072|P1|STARTED|Double-Blind, Week 0-26|2 subjects exposed to study drug before randomisation. Subjects only included in safety analysis set|235
1002451|NCT00518986|2433188|P2|NOT COMPLETED|Overall Study||26
1002452|NCT00518986|2433189|P1|NOT COMPLETED|Overall Study||26
1002453|NCT00518986|2433188|P2|COMPLETED|Overall Study||98
1002454|NCT00518986|2433189|P1|COMPLETED|Overall Study||99
1002455|NCT00518986|2433188|P2|STARTED|Overall Study||124
1002456|NCT00518986|2433189|P1|STARTED|Overall Study|One subject discontinued before treatment, only 124 subjects in each treatment group were dosed.|125
1002457|NCT00519077|2433313|P1|NOT COMPLETED|Overall Study||8
1002458|NCT00519077|2433313|P1|COMPLETED|Overall Study||36
1002459|NCT00519077|2433313|P1|STARTED|Overall Study||44
1002460|NCT00519090|2433320|P2|NOT COMPLETED|Overall Study||0
1002461|NCT00519090|2433321|P1|NOT COMPLETED|Overall Study||0
1002462|NCT00519090|2433320|P2|COMPLETED|Overall Study||4
1002463|NCT00519090|2433321|P1|COMPLETED|Overall Study||2
1002464|NCT00519090|2433320|P2|STARTED|Overall Study||4
1002465|NCT00519090|2433321|P1|STARTED|Overall Study||2
1002466|NCT00519194|2433329|P1|NOT COMPLETED|Overall Study||21
1002467|NCT00519194|2433329|P1|COMPLETED|Overall Study||91
1002468|NCT00519194|2433329|P1|STARTED|Overall Study||112
1002469|NCT00519285|2433335|P2|NOT COMPLETED|Overall Study||612
1002470|NCT00519285|2433336|P1|NOT COMPLETED|Overall Study||612
1002471|NCT00519285|2433335|P2|COMPLETED|Overall Study||0
1002472|NCT00519285|2433336|P1|COMPLETED|Overall Study|Participants were treated until progressive disease, unacceptable toxicity, or refusal of treatment|0
1002473|NCT00519285|2433335|P2|Still Treated at Cut-off Date|Overall Study||2
1002474|NCT00519285|2433336|P1|Still Treated at Cut-off Date|Overall Study|The cut-off date for analysis was defined as 07 February 2012, date at which 873 deaths has occurred|1
1002475|NCT00519285|2433335|P2|TREATED|Overall Study|Received at least part of one dose of aflibercept|605
1002476|NCT00519285|2433336|P1|TREATED|Overall Study|Received at least part of one dose of placebo|604
1002477|NCT00519285|2433335|P2|STARTED|Overall Study|Randomized|612
1002478|NCT00519285|2433336|P1|STARTED|Overall Study|Randomized|612
1002479|NCT00519376|2433362|P16|NOT COMPLETED|Treatment Period 4||0
1002480|NCT00519376|2433363|P15|NOT COMPLETED|Treatment Period 4||0
1002481|NCT00519376|2433364|P14|NOT COMPLETED|Treatment Period 4||0
1002482|NCT00519376|2433365|P13|NOT COMPLETED|Treatment Period 4||0
1002483|NCT00519376|2433366|P12|NOT COMPLETED|Treatment Period 4||0
1002484|NCT00519376|2433367|P11|NOT COMPLETED|Treatment Period 4||0
1002485|NCT00519376|2433368|P10|NOT COMPLETED|Treatment Period 4||0
1002486|NCT00519376|2433369|P9|NOT COMPLETED|Treatment Period 4||0
1002487|NCT00519376|2433370|P8|NOT COMPLETED|Treatment Period 4||0
1002488|NCT00519376|2433371|P7|NOT COMPLETED|Treatment Period 4||0
1002489|NCT00519376|2433372|P6|NOT COMPLETED|Treatment Period 4||0
1002490|NCT00519376|2433373|P5|NOT COMPLETED|Treatment Period 4||0
1002491|NCT00519376|2433374|P4|NOT COMPLETED|Treatment Period 4||0
1002492|NCT00519376|2433375|P3|NOT COMPLETED|Treatment Period 4||1
1002493|NCT00519376|2433376|P2|NOT COMPLETED|Treatment Period 4||0
1002494|NCT00519376|2433377|P1|NOT COMPLETED|Treatment Period 4||0
1002495|NCT00519376|2433362|P16|COMPLETED|Treatment Period 4||1
1002496|NCT00519376|2433363|P15|COMPLETED|Treatment Period 4||1
1002497|NCT00519376|2433364|P14|COMPLETED|Treatment Period 4||1
1002498|NCT00519376|2433365|P13|COMPLETED|Treatment Period 4||0
1002499|NCT00519376|2433366|P12|COMPLETED|Treatment Period 4||1
1002500|NCT00519376|2433367|P11|COMPLETED|Treatment Period 4||1
1002501|NCT00519376|2433368|P10|COMPLETED|Treatment Period 4||1
1002502|NCT00519376|2433369|P9|COMPLETED|Treatment Period 4||1
1002503|NCT00519376|2433370|P8|COMPLETED|Treatment Period 4||1
1002504|NCT00519376|2433371|P7|COMPLETED|Treatment Period 4||1
1002505|NCT00519376|2433372|P6|COMPLETED|Treatment Period 4||1
1002506|NCT00519376|2433373|P5|COMPLETED|Treatment Period 4||1
1002507|NCT00519376|2433374|P4|COMPLETED|Treatment Period 4||2
1002508|NCT00519376|2433375|P3|COMPLETED|Treatment Period 4||1
1002509|NCT00519376|2433376|P2|COMPLETED|Treatment Period 4||2
1002510|NCT00519376|2433377|P1|COMPLETED|Treatment Period 4||2
1002511|NCT00519376|2433362|P16|STARTED|Treatment Period 4||1
1002512|NCT00519376|2433363|P15|STARTED|Treatment Period 4||1
1002513|NCT00519376|2433364|P14|STARTED|Treatment Period 4||1
1002514|NCT00519376|2433365|P13|STARTED|Treatment Period 4||0
1002515|NCT00519376|2433366|P12|STARTED|Treatment Period 4||1
1002516|NCT00519376|2433367|P11|STARTED|Treatment Period 4||1
1002517|NCT00519376|2433368|P10|STARTED|Treatment Period 4||1
1002518|NCT00519376|2433369|P9|STARTED|Treatment Period 4||1
1002519|NCT00519376|2433370|P8|STARTED|Treatment Period 4||1
1002520|NCT00519376|2433371|P7|STARTED|Treatment Period 4||1
1002521|NCT00519376|2433372|P6|STARTED|Treatment Period 4||1
1002522|NCT00519376|2433373|P5|STARTED|Treatment Period 4||1
1002523|NCT00519376|2433374|P4|STARTED|Treatment Period 4||2
1002524|NCT00519376|2433375|P3|STARTED|Treatment Period 4||2
1002525|NCT00519376|2433376|P2|STARTED|Treatment Period 4||2
1002526|NCT00519376|2433377|P1|STARTED|Treatment Period 4||2
1002527|NCT00519376|2433362|P16|NOT COMPLETED|Washout Period 3||0
1002528|NCT00519376|2433363|P15|NOT COMPLETED|Washout Period 3||0
1002529|NCT00519376|2433364|P14|NOT COMPLETED|Washout Period 3||0
1002530|NCT00519376|2433365|P13|NOT COMPLETED|Washout Period 3||0
1002531|NCT00519376|2433366|P12|NOT COMPLETED|Washout Period 3||0
1002532|NCT00519376|2433367|P11|NOT COMPLETED|Washout Period 3||0
1002533|NCT00519376|2433368|P10|NOT COMPLETED|Washout Period 3||0
1002534|NCT00519376|2433369|P9|NOT COMPLETED|Washout Period 3||0
1002535|NCT00519376|2433370|P8|NOT COMPLETED|Washout Period 3||0
1002536|NCT00519376|2433371|P7|NOT COMPLETED|Washout Period 3||0
1002537|NCT00519376|2433372|P6|NOT COMPLETED|Washout Period 3||0
1002538|NCT00519376|2433373|P5|NOT COMPLETED|Washout Period 3||0
1002539|NCT00519376|2433374|P4|NOT COMPLETED|Washout Period 3||0
1002540|NCT00519376|2433375|P3|NOT COMPLETED|Washout Period 3||0
1002541|NCT00519376|2433376|P2|NOT COMPLETED|Washout Period 3||0
1002542|NCT00519376|2433377|P1|NOT COMPLETED|Washout Period 3||0
1002543|NCT00519376|2433362|P16|COMPLETED|Washout Period 3||1
1002544|NCT00519376|2433363|P15|COMPLETED|Washout Period 3||1
1002545|NCT00519376|2433364|P14|COMPLETED|Washout Period 3||1
1002546|NCT00519376|2433365|P13|COMPLETED|Washout Period 3||0
1002547|NCT00519376|2433366|P12|COMPLETED|Washout Period 3||1
1002548|NCT00519376|2433367|P11|COMPLETED|Washout Period 3||1
1002549|NCT00519376|2433368|P10|COMPLETED|Washout Period 3||1
1002550|NCT00519376|2433369|P9|COMPLETED|Washout Period 3||1
1002551|NCT00519376|2433370|P8|COMPLETED|Washout Period 3||1
1002552|NCT00519376|2433371|P7|COMPLETED|Washout Period 3||1
1002553|NCT00519376|2433372|P6|COMPLETED|Washout Period 3||1
1002554|NCT00519376|2433373|P5|COMPLETED|Washout Period 3||1
1002555|NCT00519376|2433374|P4|COMPLETED|Washout Period 3||2
1002556|NCT00519376|2433375|P3|COMPLETED|Washout Period 3||2
1002557|NCT00519376|2433376|P2|COMPLETED|Washout Period 3||2
1002558|NCT00519376|2433377|P1|COMPLETED|Washout Period 3||2
1002559|NCT00519376|2433362|P16|STARTED|Washout Period 3||1
1002560|NCT00519376|2433363|P15|STARTED|Washout Period 3||1
1002561|NCT00519376|2433364|P14|STARTED|Washout Period 3||1
1002562|NCT00519376|2433365|P13|STARTED|Washout Period 3||0
1002563|NCT00519376|2433366|P12|STARTED|Washout Period 3||1
1002564|NCT00519376|2433367|P11|STARTED|Washout Period 3||1
1002565|NCT00519376|2433368|P10|STARTED|Washout Period 3||1
1002566|NCT00519376|2433369|P9|STARTED|Washout Period 3||1
1002567|NCT00519376|2433370|P8|STARTED|Washout Period 3||1
1002568|NCT00519376|2433371|P7|STARTED|Washout Period 3||1
1002569|NCT00519376|2433372|P6|STARTED|Washout Period 3||1
1002570|NCT00519376|2433373|P5|STARTED|Washout Period 3||1
1002571|NCT00519376|2433374|P4|STARTED|Washout Period 3||2
1002572|NCT00519376|2433375|P3|STARTED|Washout Period 3||2
1002573|NCT00519376|2433376|P2|STARTED|Washout Period 3||2
1002574|NCT00519376|2433377|P1|STARTED|Washout Period 3||2
1002575|NCT00519376|2433362|P16|NOT COMPLETED|Treatment Period 3||0
1002576|NCT00519376|2433363|P15|NOT COMPLETED|Treatment Period 3||0
1002577|NCT00519376|2433364|P14|NOT COMPLETED|Treatment Period 3||0
1002578|NCT00519376|2433365|P13|NOT COMPLETED|Treatment Period 3||0
1002579|NCT00519376|2433366|P12|NOT COMPLETED|Treatment Period 3||0
1002580|NCT00519376|2433367|P11|NOT COMPLETED|Treatment Period 3||0
1002581|NCT00519376|2433368|P10|NOT COMPLETED|Treatment Period 3||0
1002582|NCT00519376|2433369|P9|NOT COMPLETED|Treatment Period 3||0
1002583|NCT00519376|2433370|P8|NOT COMPLETED|Treatment Period 3||0
1002584|NCT00519376|2433371|P7|NOT COMPLETED|Treatment Period 3||0
1002585|NCT00519376|2433372|P6|NOT COMPLETED|Treatment Period 3||0
1002586|NCT00519376|2433373|P5|NOT COMPLETED|Treatment Period 3||0
1002587|NCT00519376|2433374|P4|NOT COMPLETED|Treatment Period 3||0
1002588|NCT00519376|2433375|P3|NOT COMPLETED|Treatment Period 3||0
1002589|NCT00519376|2433376|P2|NOT COMPLETED|Treatment Period 3||0
1002590|NCT00519376|2433377|P1|NOT COMPLETED|Treatment Period 3||0
1002591|NCT00519376|2433362|P16|COMPLETED|Treatment Period 3||1
1002592|NCT00519376|2433363|P15|COMPLETED|Treatment Period 3||1
1002593|NCT00519376|2433364|P14|COMPLETED|Treatment Period 3||1
1002594|NCT00519376|2433365|P13|COMPLETED|Treatment Period 3||0
1002595|NCT00519376|2433366|P12|COMPLETED|Treatment Period 3||1
1002596|NCT00519376|2433367|P11|COMPLETED|Treatment Period 3||1
1002597|NCT00519376|2433368|P10|COMPLETED|Treatment Period 3||1
1002598|NCT00519376|2433369|P9|COMPLETED|Treatment Period 3||1
1002599|NCT00519376|2433370|P8|COMPLETED|Treatment Period 3||1
1002600|NCT00519376|2433371|P7|COMPLETED|Treatment Period 3||1
1002601|NCT00519376|2433372|P6|COMPLETED|Treatment Period 3||1
1002602|NCT00519376|2433373|P5|COMPLETED|Treatment Period 3||1
1002603|NCT00519376|2433374|P4|COMPLETED|Treatment Period 3||2
1002604|NCT00519376|2433375|P3|COMPLETED|Treatment Period 3||2
1002605|NCT00519376|2433376|P2|COMPLETED|Treatment Period 3||2
1002606|NCT00519376|2433377|P1|COMPLETED|Treatment Period 3||2
1002607|NCT00519376|2433362|P16|STARTED|Treatment Period 3||1
1002608|NCT00519376|2433363|P15|STARTED|Treatment Period 3||1
1002609|NCT00519376|2433364|P14|STARTED|Treatment Period 3||1
1002610|NCT00519376|2433365|P13|STARTED|Treatment Period 3||0
1002611|NCT00519376|2433366|P12|STARTED|Treatment Period 3||1
1002612|NCT00519376|2433367|P11|STARTED|Treatment Period 3||1
1002613|NCT00519376|2433368|P10|STARTED|Treatment Period 3||1
1002614|NCT00519376|2433369|P9|STARTED|Treatment Period 3||1
1002615|NCT00519376|2433370|P8|STARTED|Treatment Period 3||1
1002616|NCT00519376|2433371|P7|STARTED|Treatment Period 3||1
1002617|NCT00519376|2433372|P6|STARTED|Treatment Period 3||1
1002618|NCT00519376|2433373|P5|STARTED|Treatment Period 3||1
1002619|NCT00519376|2433374|P4|STARTED|Treatment Period 3||2
1002620|NCT00519376|2433375|P3|STARTED|Treatment Period 3||2
1002621|NCT00519376|2433376|P2|STARTED|Treatment Period 3||2
1002622|NCT00519376|2433377|P1|STARTED|Treatment Period 3||2
1002623|NCT00519376|2433362|P16|NOT COMPLETED|Washout Period 2||0
1002624|NCT00519376|2433363|P15|NOT COMPLETED|Washout Period 2||0
1002625|NCT00519376|2433364|P14|NOT COMPLETED|Washout Period 2||0
1002626|NCT00519376|2433365|P13|NOT COMPLETED|Washout Period 2||0
1002627|NCT00519376|2433366|P12|NOT COMPLETED|Washout Period 2||0
1002628|NCT00519376|2433367|P11|NOT COMPLETED|Washout Period 2||0
1002629|NCT00519376|2433368|P10|NOT COMPLETED|Washout Period 2||0
1002630|NCT00519376|2433369|P9|NOT COMPLETED|Washout Period 2||0
1002631|NCT00519376|2433370|P8|NOT COMPLETED|Washout Period 2||0
1002632|NCT00519376|2433371|P7|NOT COMPLETED|Washout Period 2||0
1002633|NCT00519376|2433372|P6|NOT COMPLETED|Washout Period 2||0
1002634|NCT00519376|2433373|P5|NOT COMPLETED|Washout Period 2||0
1002635|NCT00519376|2433374|P4|NOT COMPLETED|Washout Period 2||0
1002636|NCT00519376|2433375|P3|NOT COMPLETED|Washout Period 2||0
1002637|NCT00519376|2433376|P2|NOT COMPLETED|Washout Period 2||0
1002638|NCT00519376|2433377|P1|NOT COMPLETED|Washout Period 2||0
1002639|NCT00519376|2433362|P16|COMPLETED|Washout Period 2||1
1002640|NCT00519376|2433363|P15|COMPLETED|Washout Period 2||1
1002641|NCT00519376|2433364|P14|COMPLETED|Washout Period 2||1
1002642|NCT00519376|2433365|P13|COMPLETED|Washout Period 2||0
1002643|NCT00519376|2433366|P12|COMPLETED|Washout Period 2||1
1002644|NCT00519376|2433367|P11|COMPLETED|Washout Period 2||1
1002645|NCT00519376|2433368|P10|COMPLETED|Washout Period 2||1
1002646|NCT00519376|2433369|P9|COMPLETED|Washout Period 2||1
1002647|NCT00519376|2433370|P8|COMPLETED|Washout Period 2||1
1002648|NCT00519376|2433371|P7|COMPLETED|Washout Period 2||1
1002649|NCT00519376|2433372|P6|COMPLETED|Washout Period 2||1
1002650|NCT00519376|2433373|P5|COMPLETED|Washout Period 2||1
1002651|NCT00519376|2433374|P4|COMPLETED|Washout Period 2||2
1002652|NCT00519376|2433375|P3|COMPLETED|Washout Period 2||2
1002653|NCT00519376|2433376|P2|COMPLETED|Washout Period 2||2
1002654|NCT00519376|2433377|P1|COMPLETED|Washout Period 2||2
1002655|NCT00519376|2433362|P16|STARTED|Washout Period 2||1
1002656|NCT00519376|2433363|P15|STARTED|Washout Period 2||1
1002657|NCT00519376|2433364|P14|STARTED|Washout Period 2||1
1002658|NCT00519376|2433365|P13|STARTED|Washout Period 2||0
1002659|NCT00519376|2433366|P12|STARTED|Washout Period 2||1
1002660|NCT00519376|2433367|P11|STARTED|Washout Period 2||1
1002661|NCT00519376|2433368|P10|STARTED|Washout Period 2||1
1002662|NCT00519376|2433369|P9|STARTED|Washout Period 2||1
1002663|NCT00519376|2433370|P8|STARTED|Washout Period 2||1
1002664|NCT00519376|2433371|P7|STARTED|Washout Period 2||1
1002665|NCT00519376|2433372|P6|STARTED|Washout Period 2||1
1002666|NCT00519376|2433373|P5|STARTED|Washout Period 2||1
1002667|NCT00519376|2433374|P4|STARTED|Washout Period 2||2
1002668|NCT00519376|2433375|P3|STARTED|Washout Period 2||2
1002669|NCT00519376|2433376|P2|STARTED|Washout Period 2||2
1002670|NCT00519376|2433377|P1|STARTED|Washout Period 2||2
1002671|NCT00519376|2433362|P16|NOT COMPLETED|Treatment Period 2||0
1002672|NCT00519376|2433363|P15|NOT COMPLETED|Treatment Period 2||0
1002673|NCT00519376|2433364|P14|NOT COMPLETED|Treatment Period 2||0
1002674|NCT00519376|2433365|P13|NOT COMPLETED|Treatment Period 2||1
1002675|NCT00519376|2433366|P12|NOT COMPLETED|Treatment Period 2||0
1002676|NCT00519376|2433367|P11|NOT COMPLETED|Treatment Period 2||0
1002677|NCT00519376|2433368|P10|NOT COMPLETED|Treatment Period 2||0
1002678|NCT00519376|2433369|P9|NOT COMPLETED|Treatment Period 2||0
1002679|NCT00519376|2433370|P8|NOT COMPLETED|Treatment Period 2||0
1002680|NCT00519376|2433371|P7|NOT COMPLETED|Treatment Period 2||0
1002681|NCT00519376|2433372|P6|NOT COMPLETED|Treatment Period 2||0
1002682|NCT00519376|2433373|P5|NOT COMPLETED|Treatment Period 2||0
1002683|NCT00519376|2433374|P4|NOT COMPLETED|Treatment Period 2||0
1002684|NCT00519376|2433375|P3|NOT COMPLETED|Treatment Period 2||0
1002685|NCT00519376|2433376|P2|NOT COMPLETED|Treatment Period 2||0
1002686|NCT00519376|2433377|P1|NOT COMPLETED|Treatment Period 2||0
1002687|NCT00519376|2433362|P16|COMPLETED|Treatment Period 2||1
1002688|NCT00519376|2433363|P15|COMPLETED|Treatment Period 2||1
1002689|NCT00519376|2433364|P14|COMPLETED|Treatment Period 2||1
1002690|NCT00519376|2433365|P13|COMPLETED|Treatment Period 2||0
1002691|NCT00519376|2433366|P12|COMPLETED|Treatment Period 2||1
1002692|NCT00519376|2433367|P11|COMPLETED|Treatment Period 2||1
1002693|NCT00519376|2433368|P10|COMPLETED|Treatment Period 2||1
1002694|NCT00519376|2433369|P9|COMPLETED|Treatment Period 2||1
1002695|NCT00519376|2433370|P8|COMPLETED|Treatment Period 2||1
1002696|NCT00519376|2433371|P7|COMPLETED|Treatment Period 2||1
1002697|NCT00519376|2433372|P6|COMPLETED|Treatment Period 2||1
1002698|NCT00519376|2433373|P5|COMPLETED|Treatment Period 2||1
1002699|NCT00519376|2433374|P4|COMPLETED|Treatment Period 2||2
1002700|NCT00519376|2433375|P3|COMPLETED|Treatment Period 2||2
1002701|NCT00519376|2433376|P2|COMPLETED|Treatment Period 2||2
1002702|NCT00519376|2433377|P1|COMPLETED|Treatment Period 2||2
1002703|NCT00519376|2433362|P16|STARTED|Treatment Period 2||1
1002704|NCT00519376|2433363|P15|STARTED|Treatment Period 2||1
1002705|NCT00519376|2433364|P14|STARTED|Treatment Period 2||1
1002706|NCT00519376|2433365|P13|STARTED|Treatment Period 2||1
1002707|NCT00519376|2433366|P12|STARTED|Treatment Period 2||1
1002708|NCT00519376|2433367|P11|STARTED|Treatment Period 2||1
1002709|NCT00519376|2433368|P10|STARTED|Treatment Period 2||1
1002710|NCT00519376|2433369|P9|STARTED|Treatment Period 2||1
1002711|NCT00519376|2433370|P8|STARTED|Treatment Period 2||1
1002712|NCT00519376|2433371|P7|STARTED|Treatment Period 2||1
1002713|NCT00519376|2433372|P6|STARTED|Treatment Period 2||1
1002714|NCT00519376|2433373|P5|STARTED|Treatment Period 2||1
1002715|NCT00519376|2433374|P4|STARTED|Treatment Period 2||2
1002716|NCT00519376|2433375|P3|STARTED|Treatment Period 2||2
1002717|NCT00519376|2433376|P2|STARTED|Treatment Period 2||2
1002718|NCT00519376|2433377|P1|STARTED|Treatment Period 2||2
1002719|NCT00519376|2433362|P16|NOT COMPLETED|Washout Period 1||0
1002720|NCT00519376|2433363|P15|NOT COMPLETED|Washout Period 1||0
1002721|NCT00519376|2433364|P14|NOT COMPLETED|Washout Period 1||0
1002722|NCT00519376|2433365|P13|NOT COMPLETED|Washout Period 1||0
1002723|NCT00519376|2433366|P12|NOT COMPLETED|Washout Period 1||0
1002724|NCT00519376|2433367|P11|NOT COMPLETED|Washout Period 1||0
1002725|NCT00519376|2433368|P10|NOT COMPLETED|Washout Period 1||0
1002726|NCT00519376|2433369|P9|NOT COMPLETED|Washout Period 1||0
1002727|NCT00519376|2433370|P8|NOT COMPLETED|Washout Period 1||0
1002728|NCT00519376|2433371|P7|NOT COMPLETED|Washout Period 1||0
1002729|NCT00519376|2433372|P6|NOT COMPLETED|Washout Period 1||0
1002730|NCT00519376|2433373|P5|NOT COMPLETED|Washout Period 1||0
1002731|NCT00519376|2433374|P4|NOT COMPLETED|Washout Period 1||0
1002732|NCT00519376|2433375|P3|NOT COMPLETED|Washout Period 1||0
1002733|NCT00519376|2433376|P2|NOT COMPLETED|Washout Period 1||0
1002734|NCT00519376|2433377|P1|NOT COMPLETED|Washout Period 1||0
1002735|NCT00519376|2433362|P16|COMPLETED|Washout Period 1||1
1002736|NCT00519376|2433363|P15|COMPLETED|Washout Period 1||1
1002737|NCT00519376|2433364|P14|COMPLETED|Washout Period 1||1
1002738|NCT00519376|2433365|P13|COMPLETED|Washout Period 1||1
1002739|NCT00519376|2433366|P12|COMPLETED|Washout Period 1||1
1002740|NCT00519376|2433367|P11|COMPLETED|Washout Period 1||1
1002741|NCT00519376|2433368|P10|COMPLETED|Washout Period 1||1
1002742|NCT00519376|2433369|P9|COMPLETED|Washout Period 1||1
1002743|NCT00519376|2433370|P8|COMPLETED|Washout Period 1||1
1002744|NCT00519376|2433371|P7|COMPLETED|Washout Period 1||1
1002745|NCT00519376|2433372|P6|COMPLETED|Washout Period 1||1
1002746|NCT00519376|2433373|P5|COMPLETED|Washout Period 1||1
1002747|NCT00519376|2433374|P4|COMPLETED|Washout Period 1||2
1002748|NCT00519376|2433375|P3|COMPLETED|Washout Period 1||2
1002749|NCT00519376|2433376|P2|COMPLETED|Washout Period 1||2
1002750|NCT00519376|2433377|P1|COMPLETED|Washout Period 1||2
1002751|NCT00519376|2433362|P16|STARTED|Washout Period 1||1
1002752|NCT00519376|2433363|P15|STARTED|Washout Period 1||1
1002753|NCT00519376|2433364|P14|STARTED|Washout Period 1||1
1002754|NCT00519376|2433365|P13|STARTED|Washout Period 1||1
1002755|NCT00519376|2433366|P12|STARTED|Washout Period 1||1
1002756|NCT00519376|2433367|P11|STARTED|Washout Period 1||1
1002757|NCT00519376|2433368|P10|STARTED|Washout Period 1||1
1002758|NCT00519376|2433369|P9|STARTED|Washout Period 1||1
1002759|NCT00519376|2433370|P8|STARTED|Washout Period 1||1
1002760|NCT00519376|2433371|P7|STARTED|Washout Period 1||1
1002761|NCT00519376|2433372|P6|STARTED|Washout Period 1||1
1002762|NCT00519376|2433373|P5|STARTED|Washout Period 1||1
1002763|NCT00519376|2433374|P4|STARTED|Washout Period 1||2
1002764|NCT00519376|2433375|P3|STARTED|Washout Period 1||2
1002765|NCT00519376|2433376|P2|STARTED|Washout Period 1||2
1002766|NCT00519376|2433377|P1|STARTED|Washout Period 1||2
1002767|NCT00519376|2433362|P16|NOT COMPLETED|Treatment Period 1||0
1002768|NCT00519376|2433363|P15|NOT COMPLETED|Treatment Period 1||0
1002769|NCT00519376|2433364|P14|NOT COMPLETED|Treatment Period 1||0
1002770|NCT00519376|2433365|P13|NOT COMPLETED|Treatment Period 1||0
1002771|NCT00519376|2433366|P12|NOT COMPLETED|Treatment Period 1||0
1002772|NCT00519376|2433367|P11|NOT COMPLETED|Treatment Period 1||0
1002773|NCT00519376|2433368|P10|NOT COMPLETED|Treatment Period 1||0
1002774|NCT00519376|2433369|P9|NOT COMPLETED|Treatment Period 1||0
1002775|NCT00519376|2433370|P8|NOT COMPLETED|Treatment Period 1||0
1002776|NCT00519376|2433371|P7|NOT COMPLETED|Treatment Period 1||0
1002777|NCT00519376|2433372|P6|NOT COMPLETED|Treatment Period 1||0
1002778|NCT00519376|2433373|P5|NOT COMPLETED|Treatment Period 1||0
1002779|NCT00519376|2433374|P4|NOT COMPLETED|Treatment Period 1||0
1002780|NCT00519376|2433375|P3|NOT COMPLETED|Treatment Period 1||0
1002781|NCT00519376|2433376|P2|NOT COMPLETED|Treatment Period 1||0
1002782|NCT00519376|2433377|P1|NOT COMPLETED|Treatment Period 1||0
1002783|NCT00519376|2433362|P16|COMPLETED|Treatment Period 1||1
1002784|NCT00519376|2433363|P15|COMPLETED|Treatment Period 1||1
1002785|NCT00519376|2433364|P14|COMPLETED|Treatment Period 1||1
1002786|NCT00519376|2433365|P13|COMPLETED|Treatment Period 1||1
1002787|NCT00519376|2433366|P12|COMPLETED|Treatment Period 1||1
1002788|NCT00519376|2433367|P11|COMPLETED|Treatment Period 1||1
1002789|NCT00519376|2433368|P10|COMPLETED|Treatment Period 1||1
1002790|NCT00519376|2433369|P9|COMPLETED|Treatment Period 1||1
1002791|NCT00519376|2433370|P8|COMPLETED|Treatment Period 1||1
1002792|NCT00519376|2433371|P7|COMPLETED|Treatment Period 1||1
1002793|NCT00519376|2433372|P6|COMPLETED|Treatment Period 1||1
1002794|NCT00519376|2433373|P5|COMPLETED|Treatment Period 1||1
1002795|NCT00519376|2433374|P4|COMPLETED|Treatment Period 1||2
1002796|NCT00519376|2433375|P3|COMPLETED|Treatment Period 1||2
1002797|NCT00519376|2433376|P2|COMPLETED|Treatment Period 1||2
1002798|NCT00519376|2433377|P1|COMPLETED|Treatment Period 1||2
1002799|NCT00519376|2433362|P16|STARTED|Treatment Period 1||1
1002800|NCT00519376|2433363|P15|STARTED|Treatment Period 1||1
1002801|NCT00519376|2433364|P14|STARTED|Treatment Period 1||1
1002802|NCT00519376|2433365|P13|STARTED|Treatment Period 1||1
1002803|NCT00519376|2433366|P12|STARTED|Treatment Period 1||1
1002804|NCT00519376|2433367|P11|STARTED|Treatment Period 1||1
1002805|NCT00519376|2433368|P10|STARTED|Treatment Period 1||1
1002806|NCT00519376|2433369|P9|STARTED|Treatment Period 1||1
1002807|NCT00519376|2433370|P8|STARTED|Treatment Period 1||1
1002808|NCT00519376|2433371|P7|STARTED|Treatment Period 1||1
1002809|NCT00519376|2433372|P6|STARTED|Treatment Period 1||1
1002810|NCT00519376|2433373|P5|STARTED|Treatment Period 1||1
1002811|NCT00519376|2433374|P4|STARTED|Treatment Period 1||2
1002812|NCT00519376|2433375|P3|STARTED|Treatment Period 1||2
1002813|NCT00519376|2433376|P2|STARTED|Treatment Period 1||2
1002814|NCT00519376|2433377|P1|STARTED|Treatment Period 1||2
1002815|NCT00519428|2433502|P3|NOT COMPLETED|Overall Study||25
1002816|NCT00519428|2433503|P2|NOT COMPLETED|Overall Study||15
1002817|NCT00519428|2433504|P1|NOT COMPLETED|Overall Study||21
1002818|NCT00519428|2433502|P3|COMPLETED|Overall Study||58
1002819|NCT00519428|2433503|P2|COMPLETED|Overall Study||69
1002820|NCT00519428|2433504|P1|COMPLETED|Overall Study||57
1002821|NCT00519428|2433502|P3|STARTED|Overall Study||83
1002822|NCT00519428|2433503|P2|STARTED|Overall Study||84
1002823|NCT00519428|2433504|P1|STARTED|Overall Study||78
1002824|NCT00519532|2433524|P1|NOT COMPLETED|Overall Study||18
1002825|NCT00519532|2433524|P1|COMPLETED|Overall Study||66
1002826|NCT00519532|2433524|P1|STARTED|Overall Study||84
1002827|NCT00519584|2433535|P4|NOT COMPLETED|Overall Study||0
1002828|NCT00519584|2433536|P3|NOT COMPLETED|Overall Study||0
1002829|NCT00519584|2433537|P2|NOT COMPLETED|Overall Study||0
1002830|NCT00519584|2433538|P1|NOT COMPLETED|Overall Study||0
1002831|NCT00519584|2433535|P4|COMPLETED|Overall Study||56
1002832|NCT00519584|2433536|P3|COMPLETED|Overall Study||54
1002833|NCT00519584|2433537|P2|COMPLETED|Overall Study||54
1002834|NCT00519584|2433538|P1|COMPLETED|Overall Study||54
1002835|NCT00519584|2433535|P4|STARTED|Overall Study||56
1002836|NCT00519584|2433536|P3|STARTED|Overall Study||54
1002837|NCT00519584|2433537|P2|STARTED|Overall Study||54
1002838|NCT00519584|2433538|P1|STARTED|Overall Study||54
1002839|NCT00519623|2433560|P1|NOT COMPLETED|Overall Study||1
1002840|NCT00519623|2433560|P1|COMPLETED|Overall Study||8
1002841|NCT00519623|2433560|P1|STARTED|Overall Study||9
1002842|NCT00519636|2433569|P4|NOT COMPLETED|Post Study Period||1
1002843|NCT00519636|2433570|P3|NOT COMPLETED|Post Study Period||0
1002844|NCT00519636|2433571|P2|NOT COMPLETED|Post Study Period||0
1002845|NCT00519636|2433572|P1|NOT COMPLETED|Post Study Period||0
1002846|NCT00519636|2433569|P4|COMPLETED|Post Study Period||85
1002847|NCT00519636|2433570|P3|COMPLETED|Post Study Period||74
1002848|NCT00519636|2433571|P2|COMPLETED|Post Study Period||71
1002849|NCT00519636|2433572|P1|COMPLETED|Post Study Period||69
1002850|NCT00519636|2433569|P4|STARTED|Post Study Period||86
1002851|NCT00519636|2433570|P3|STARTED|Post Study Period||74
1002852|NCT00519636|2433571|P2|STARTED|Post Study Period||71
1002853|NCT00519636|2433572|P1|STARTED|Post Study Period||69
1002854|NCT00519636|2433569|P4|NOT COMPLETED|Treatment Period 2||2
1002855|NCT00519636|2433570|P3|NOT COMPLETED|Treatment Period 2||1
1002856|NCT00519636|2433571|P2|NOT COMPLETED|Treatment Period 2||1
1002857|NCT00519636|2433572|P1|NOT COMPLETED|Treatment Period 2||0
1002858|NCT00519636|2433569|P4|COMPLETED|Treatment Period 2||86
1002859|NCT00519636|2433570|P3|COMPLETED|Treatment Period 2||74
1002860|NCT00519636|2433571|P2|COMPLETED|Treatment Period 2||71
1002861|NCT00519636|2433572|P1|COMPLETED|Treatment Period 2||69
1002862|NCT00519636|2433569|P4|STARTED|Treatment Period 2||88
1002863|NCT00519636|2433570|P3|STARTED|Treatment Period 2||75
1002864|NCT00519636|2433571|P2|STARTED|Treatment Period 2||72
1002865|NCT00519636|2433572|P1|STARTED|Treatment Period 2||69
1002866|NCT00519636|2433569|P4|NOT COMPLETED|Washout Period||5
1002867|NCT00519636|2433570|P3|NOT COMPLETED|Washout Period||14
1002868|NCT00519636|2433571|P2|NOT COMPLETED|Washout Period||14
1002869|NCT00519636|2433572|P1|NOT COMPLETED|Washout Period||20
1002870|NCT00519636|2433569|P4|COMPLETED|Washout Period||88
1002871|NCT00519636|2433570|P3|COMPLETED|Washout Period||75
1002872|NCT00519636|2433571|P2|COMPLETED|Washout Period||72
1002873|NCT00519636|2433572|P1|COMPLETED|Washout Period||69
1002874|NCT00519636|2433569|P4|STARTED|Washout Period||93
1002875|NCT00519636|2433570|P3|STARTED|Washout Period||89
1002876|NCT00519636|2433571|P2|STARTED|Washout Period||86
1002877|NCT00519636|2433572|P1|STARTED|Washout Period||89
1002878|NCT00519636|2433569|P4|NOT COMPLETED|Treatment Period 1||0
1002879|NCT00519636|2433570|P3|NOT COMPLETED|Treatment Period 1||1
1002880|NCT00519636|2433571|P2|NOT COMPLETED|Treatment Period 1||0
1002881|NCT00519636|2433572|P1|NOT COMPLETED|Treatment Period 1||2
1002882|NCT00519636|2433569|P4|COMPLETED|Treatment Period 1||93
1002883|NCT00519636|2433570|P3|COMPLETED|Treatment Period 1||89
1002884|NCT00519636|2433571|P2|COMPLETED|Treatment Period 1||86
1002885|NCT00519636|2433572|P1|COMPLETED|Treatment Period 1||89
1002886|NCT00519636|2433569|P4|STARTED|Treatment Period 1||93
1002887|NCT00519636|2433570|P3|STARTED|Treatment Period 1||90
1002888|NCT00519636|2433571|P2|STARTED|Treatment Period 1||86
1002889|NCT00519636|2433572|P1|STARTED|Treatment Period 1||91
1002890|NCT00519649|2433602|P1|NOT COMPLETED|Overall Study||1
1002891|NCT00519649|2433602|P1|COMPLETED|Overall Study||299
1002892|NCT00519649|2433602|P1|STARTED|Overall Study||300
1002893|NCT00519779|2433613|P2|NOT COMPLETED|Overall Study||1
1002894|NCT00519779|2433614|P1|NOT COMPLETED|Overall Study||0
1002895|NCT00519779|2433613|P2|COMPLETED|Overall Study||33
1002896|NCT00519779|2433614|P1|COMPLETED|Overall Study||34
1002897|NCT00519779|2433613|P2|STARTED|Overall Study||34
1002898|NCT00519779|2433614|P1|STARTED|Overall Study||34
1002899|NCT00519818|2433630|P1|NOT COMPLETED|Overall Study||0
1002900|NCT00519818|2433630|P1|COMPLETED|Overall Study||14
1002901|NCT00519818|2433630|P1|STARTED|Overall Study||14
1002902|NCT00519831|2433638|P1|NOT COMPLETED|Overall Study||3
1002903|NCT00519831|2433638|P1|COMPLETED|Overall Study||13
1002904|NCT00519831|2433638|P1|STARTED|Overall Study||16
1002905|NCT00519896|2433645|P1|NOT COMPLETED|Overall Study||2
1002906|NCT00519896|2433645|P1|COMPLETED|Overall Study||33
1002907|NCT00519896|2433645|P1|STARTED|Overall Study||35
1002908|NCT00520013|2433654|P3|NOT COMPLETED|Overall Study||11
1002909|NCT00520013|2433655|P2|NOT COMPLETED|Overall Study||15
1002910|NCT00520013|2433656|P1|NOT COMPLETED|Overall Study||12
1002911|NCT00520013|2433654|P3|COMPLETED|Overall Study||0
1002912|NCT00520013|2433655|P2|COMPLETED|Overall Study||10
1002913|NCT00520013|2433656|P1|COMPLETED|Overall Study||11
1002914|NCT00520013|2433654|P3|Treated|Overall Study||11
1002915|NCT00520013|2433655|P2|Treated|Overall Study||25
1002916|NCT00520013|2433656|P1|Treated|Overall Study||23
1002917|NCT00520013|2433654|P3|STARTED|Overall Study|Excludes a pt who went off-study (on reg day) due to consent that may not have been informed (ESL).|11
1002918|NCT00520013|2433655|P2|STARTED|Overall Study||25
1002919|NCT00520013|2433656|P1|STARTED|Overall Study||23
1002920|NCT00520130|2433668|P2|NOT COMPLETED|Overall Study||1
1002921|NCT00520130|2433669|P1|NOT COMPLETED|Overall Study||5
1002922|NCT00520130|2433668|P2|COMPLETED|Overall Study||44
1002923|NCT00520130|2433669|P1|COMPLETED|Overall Study||39
1002924|NCT00520130|2433668|P2|STARTED|Overall Study||45
1002925|NCT00520130|2433669|P1|STARTED|Overall Study||44
1002926|NCT00520234|2433711|P2|NOT COMPLETED|Overall Study||2
1002927|NCT00520234|2433712|P1|NOT COMPLETED|Overall Study||1
1002928|NCT00520234|2433711|P2|COMPLETED|Overall Study||102
1002929|NCT00520234|2433712|P1|COMPLETED|Overall Study||117
1002930|NCT00520234|2433711|P2|STARTED|Overall Study||104
1002931|NCT00520234|2433712|P1|STARTED|Overall Study||118
1002932|NCT00520286|2433724|P2|NOT COMPLETED|Overall Study||32
1002933|NCT00520286|2433725|P1|NOT COMPLETED|Overall Study||66
1002934|NCT00520286|2433724|P2|COMPLETED|Overall Study||36
1002935|NCT00520286|2433725|P1|COMPLETED|Overall Study||76
1002936|NCT00520286|2433724|P2|STARTED|Overall Study||68
1002937|NCT00520286|2433725|P1|STARTED|Overall Study||142
1002938|NCT00520299|2433736|P3|NOT COMPLETED|Overall Study||6
1002939|NCT00520299|2433737|P2|NOT COMPLETED|Overall Study||3
1002940|NCT00520299|2433738|P1|NOT COMPLETED|Overall Study||0
1002941|NCT00520299|2433736|P3|COMPLETED|Overall Study||13
1002942|NCT00520299|2433737|P2|COMPLETED|Overall Study||3
1002943|NCT00520299|2433738|P1|COMPLETED|Overall Study|Defined as completion of 1 treatment cycle|6
1002944|NCT00520299|2433736|P3|STARTED|Overall Study||19
1002945|NCT00520299|2433737|P2|STARTED|Overall Study||6
1002946|NCT00520299|2433738|P1|STARTED|Overall Study||6
1002947|NCT00520351|2433769|P2|NOT COMPLETED|Second Intervention||0
1002948|NCT00520351|2433770|P1|NOT COMPLETED|Second Intervention||0
1002949|NCT00520351|2433769|P2|COMPLETED|Second Intervention||14
1002950|NCT00520351|2433770|P1|COMPLETED|Second Intervention||14
1002951|NCT00520351|2433769|P2|STARTED|Second Intervention||14
1002952|NCT00520351|2433770|P1|STARTED|Second Intervention||14
1002953|NCT00520351|2433769|P2|NOT COMPLETED|First Intervention||1
1002954|NCT00520351|2433770|P1|NOT COMPLETED|First Intervention||1
1002955|NCT00520351|2433769|P2|COMPLETED|First Intervention|End date is Feb.25, 2008|14
1002956|NCT00520351|2433770|P1|COMPLETED|First Intervention|End date is Feb.25, 2008|14
1002957|NCT00520351|2433769|P2|STARTED|First Intervention|Start date is Sep.06, 2007|15
1002958|NCT00520351|2433770|P1|STARTED|First Intervention|Start date is Sep.06, 2007|15
1002959|NCT00520403|2433782|P1|NOT COMPLETED|Bevacizumab Monotherapy||2
1002960|NCT00520403|2433782|P1|COMPLETED|Bevacizumab Monotherapy||0
1002961|NCT00520403|2433782|P1|STARTED|Bevacizumab Monotherapy|2 of 7 participants completing Bevacizumab+IFN/vinblastine cycles initiated bevacizumab monotherapy|2
1002962|NCT00520403|2433782|P1|NOT COMPLETED|Bevacizumab + IFN/Vinblastine||18
1002963|NCT00520403|2433782|P1|COMPLETED|Bevacizumab + IFN/Vinblastine||7
1002964|NCT00520403|2433782|P1|STARTED|Bevacizumab + IFN/Vinblastine||25
1002965|NCT00520468|2433789|P1|NOT COMPLETED|Overall Study||0
1002966|NCT00520468|2433789|P1|COMPLETED|Overall Study||14
1002967|NCT00520468|2433789|P1|STARTED|Overall Study||14
1002968|NCT00520494|2433793|P1|NOT COMPLETED|Overall Study||1
1002969|NCT00520494|2433793|P1|COMPLETED|Overall Study||17
1002970|NCT00520494|2433793|P1|STARTED|Overall Study||18
1002971|NCT00520546|2433816|P1|NOT COMPLETED|Overall Study||6
1002972|NCT00520546|2433816|P1|COMPLETED|Overall Study||38
1002973|NCT00520546|2433816|P1|STARTED|Overall Study||44
1002974|NCT00520572|2433837|P6|NOT COMPLETED|Overall Study||2
1002975|NCT00520572|2433838|P5|NOT COMPLETED|Overall Study||12
1002976|NCT00520572|2433839|P4|NOT COMPLETED|Overall Study||14
1002977|NCT00520572|2433840|P3|NOT COMPLETED|Overall Study||15
1002978|NCT00520572|2433841|P2|NOT COMPLETED|Overall Study||14
1002979|NCT00520572|2433842|P1|NOT COMPLETED|Overall Study||12
1002980|NCT00520572|2433837|P6|COMPLETED|Overall Study|Participants completed the study.|62
1002981|NCT00520572|2433838|P5|COMPLETED|Overall Study|Participants completed the study.|53
1002982|NCT00520572|2433839|P4|COMPLETED|Overall Study|Participants completed the study.|50
1002983|NCT00520572|2433840|P3|COMPLETED|Overall Study|Participants completed the study.|49
1002984|NCT00520572|2433841|P2|COMPLETED|Overall Study|Participants completed the study.|50
1002985|NCT00520572|2433842|P1|COMPLETED|Overall Study|Participants completed the study.|52
1002986|NCT00520572|2433837|P6|STARTED|Overall Study|Participants randomised.|64
1002987|NCT00520572|2433838|P5|STARTED|Overall Study|Participants randomised.|65
1002988|NCT00520572|2433839|P4|STARTED|Overall Study|Participants randomised.|64
1002989|NCT00520572|2433840|P3|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
1002990|NCT00520572|2433841|P2|STARTED|Overall Study|Participants randomised.|64
1002991|NCT00520572|2433842|P1|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
1002992|NCT00520676|2433882|P2|NOT COMPLETED|Overall Study||103
1002993|NCT00520676|2433883|P1|NOT COMPLETED|Overall Study||101
1002994|NCT00520676|2433882|P2|COMPLETED|Overall Study||29
1002995|NCT00520676|2433883|P1|COMPLETED|Overall Study||27
1002996|NCT00520676|2433882|P2|Qualified Intent-to-treat (Q-ITT)|Overall Study||105
1002997|NCT00520676|2433883|P1|Qualified Intent-to-treat (Q-ITT)|Overall Study||106
1002998|NCT00520676|2433882|P2|Received at Least 1 Dose of Study Drug|Overall Study||127
1002999|NCT00520676|2433883|P1|Received at Least 1 Dose of Study Drug|Overall Study||118
1003000|NCT00520676|2433882|P2|STARTED|Overall Study||132
1003001|NCT00520676|2433883|P1|STARTED|Overall Study||128
1003002|NCT00513240|2433905|P2|NOT COMPLETED|Overall Study||7
1003003|NCT00513240|2433906|P1|NOT COMPLETED|Overall Study||13
1003004|NCT00513240|2433905|P2|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|20
1003005|NCT00513240|2433906|P1|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|22
1003006|NCT00513240|2433905|P2|Clinical Data Collection &Pre/Postop MRI|Overall Study||27
1003007|NCT00513240|2433906|P1|Clinical Data Collection &Pre/Postop MRI|Overall Study|3 not having intended surgery are subtracted from original 35 subjects, leaving 32|32
1003008|NCT00513240|2433905|P2|STARTED|Overall Study|25 had 3 doses; 1 had 1 dose due to rash; 1 had 2 doses and 1 dose of EPO due to pharmacy error|27
1003009|NCT00513240|2433906|P1|STARTED|Overall Study|3 did not have intended surgery; 28 had all 3 doses; 4 had 1 dose but no more due to delayed surgery|35
1003010|NCT00513292|2433915|P2|NOT COMPLETED|Overall Study||0
1003011|NCT00513292|2433916|P1|NOT COMPLETED|Overall Study||0
1003012|NCT00513292|2433915|P2|COMPLETED|Overall Study||142
1003013|NCT00513292|2433916|P1|COMPLETED|Overall Study||138
1003014|NCT00513292|2433915|P2|STARTED|Overall Study||142
1003015|NCT00513292|2433916|P1|STARTED|Overall Study||138
1003016|NCT00513305|2433934|P2|NOT COMPLETED|Overall Study||27
1003017|NCT00513305|2433935|P1|NOT COMPLETED|Overall Study||28
1003018|NCT00513305|2433934|P2|COMPLETED|Overall Study||7
1003019|NCT00513305|2433935|P1|COMPLETED|Overall Study||5
1003020|NCT00513305|2433934|P2|STARTED|Overall Study|One subject withdrew prior to receiving study medication|34
1003021|NCT00513305|2433935|P1|STARTED|Overall Study||33
1003022|NCT00513344|2433951|P1|NOT COMPLETED|3rd Intervention 1 Day||0
1003023|NCT00513344|2433951|P1|COMPLETED|3rd Intervention 1 Day||5
1003024|NCT00513344|2433951|P1|STARTED|3rd Intervention 1 Day||5
1003025|NCT00513344|2433951|P1|NOT COMPLETED|Washout Period 3 Days||0
1003026|NCT00513344|2433951|P1|COMPLETED|Washout Period 3 Days||5
1003027|NCT00513344|2433951|P1|STARTED|Washout Period 3 Days||5
1003028|NCT00513344|2433951|P1|NOT COMPLETED|2nd Intervention 1 Day||0
1003029|NCT00513344|2433951|P1|COMPLETED|2nd Intervention 1 Day||5
1003030|NCT00513344|2433951|P1|STARTED|2nd Intervention 1 Day||5
1003031|NCT00513344|2433951|P1|NOT COMPLETED|Washout Period 3 Days||0
1003032|NCT00513344|2433951|P1|COMPLETED|Washout Period 3 Days||5
1003033|NCT00513344|2433951|P1|STARTED|Washout Period 3 Days||5
1003034|NCT00513344|2433951|P1|NOT COMPLETED|1st Intervention 1 Day||0
1003035|NCT00513344|2433951|P1|COMPLETED|1st Intervention 1 Day||5
1003036|NCT00513344|2433951|P1|STARTED|1st Intervention 1 Day||5
1003037|NCT00513344|2433951|P1|NOT COMPLETED|Diet Restriction (3 Days)||0
1003038|NCT00513344|2433951|P1|COMPLETED|Diet Restriction (3 Days)||5
1003039|NCT00513344|2433951|P1|STARTED|Diet Restriction (3 Days)||5
1003040|NCT00513357|2433964|P2|NOT COMPLETED|Overall Study||10
1003041|NCT00513357|2433965|P1|NOT COMPLETED|Overall Study||15
1003042|NCT00513357|2433964|P2|COMPLETED|Overall Study||25
1003043|NCT00513357|2433965|P1|COMPLETED|Overall Study||23
1003044|NCT00513357|2433964|P2|STARTED|Overall Study||35
1003045|NCT00513357|2433965|P1|STARTED|Overall Study||38
1003046|NCT00513370|2433971|P1|NOT COMPLETED|Overall Study||24
1003047|NCT00513370|2433971|P1|COMPLETED|Overall Study||179
1003048|NCT00513370|2433971|P1|STARTED|Overall Study||203
1003049|NCT00513409|2434001|P2|NOT COMPLETED|Overall Study||6
1003050|NCT00513409|2434002|P1|NOT COMPLETED|Overall Study||2
1003051|NCT00513409|2434001|P2|COMPLETED|Overall Study||73
1003052|NCT00513409|2434002|P1|COMPLETED|Overall Study||82
1003053|NCT00513409|2434001|P2|STARTED|Overall Study||79
1003054|NCT00513409|2434002|P1|STARTED|Overall Study||84
1003055|NCT00513435|2434028|P1|NOT COMPLETED|Overall Study||0
1003056|NCT00513435|2434028|P1|COMPLETED|Overall Study||9
1003057|NCT00513435|2434028|P1|STARTED|Overall Study||9
1003058|NCT00513474|2434035|P2|NOT COMPLETED|Overall Study||9
1003059|NCT00513474|2434036|P1|NOT COMPLETED|Overall Study||7
1003060|NCT00513474|2434035|P2|COMPLETED|Overall Study||12
1003061|NCT00513474|2434036|P1|COMPLETED|Overall Study||18
1003062|NCT00513474|2434035|P2|Received Rasburicase Per Protocol|Overall Study||0
1003063|NCT00513474|2434036|P1|Received Rasburicase Per Protocol|Overall Study||24
1003064|NCT00513474|2434035|P2|STARTED|Overall Study||21
1003065|NCT00513474|2434036|P1|STARTED|Overall Study||25
1003066|NCT00513500|2434050|P2|NOT COMPLETED|Overall Study||54
1003067|NCT00513500|2434051|P1|NOT COMPLETED|Overall Study||41
1003068|NCT00513500|2434050|P2|COMPLETED|Overall Study||2054
1003069|NCT00513500|2434051|P1|COMPLETED|Overall Study||976
1003070|NCT00513500|2434050|P2|STARTED|Overall Study||2108
1003071|NCT00513500|2434051|P1|STARTED|Overall Study||1017
1003072|NCT00513526|2434061|P1|NOT COMPLETED|Overall Study||17
1003073|NCT00513526|2434061|P1|COMPLETED|Overall Study||92
1003074|NCT00513526|2434061|P1|STARTED|Overall Study||109
1003075|NCT00513604|2434081|P5|NOT COMPLETED|Overall Study||0
1003076|NCT00513604|2434082|P4|NOT COMPLETED|Overall Study||0
1003077|NCT00513604|2434083|P3|NOT COMPLETED|Overall Study||3
1003078|NCT00513604|2434084|P2|NOT COMPLETED|Overall Study||3
1003079|NCT00513604|2434085|P1|NOT COMPLETED|Overall Study||2
1003080|NCT00513604|2434081|P5|COMPLETED|Overall Study||35
1003081|NCT00513604|2434082|P4|COMPLETED|Overall Study||34
1003082|NCT00513604|2434083|P3|COMPLETED|Overall Study||21
1003083|NCT00513604|2434084|P2|COMPLETED|Overall Study||36
1003084|NCT00513604|2434085|P1|COMPLETED|Overall Study||24
1003085|NCT00513604|2434081|P5|STARTED|Overall Study|Cohort 5 = CD4+ depleted TIL-it is the SAME as cohort 2|35
1003086|NCT00513604|2434082|P4|STARTED|Overall Study|Cohort 4 = unselected TIL - it is the SAME as cohort 1|34
1003087|NCT00513604|2434083|P3|STARTED|Overall Study|Cohort 3 = CD4+ depleted (selected) TIL + 600Gy radiation|24
1003088|NCT00513604|2434084|P2|STARTED|Overall Study|Cohort 2 = CD4+ depleted (selected) TIL|39
1003089|NCT00513604|2434085|P1|STARTED|Overall Study|Cohort 1 = unselected TIL|26
1003090|NCT00513617|2434105|P3|NOT COMPLETED|Overall Study||8
1003091|NCT00513617|2434106|P2|NOT COMPLETED|Overall Study||10
1003092|NCT00513617|2434107|P1|NOT COMPLETED|Overall Study||11
1003093|NCT00513617|2434105|P3|COMPLETED|Overall Study||30
1003094|NCT00513617|2434106|P2|COMPLETED|Overall Study||25
1003095|NCT00513617|2434107|P1|COMPLETED|Overall Study||25
1003096|NCT00513617|2434105|P3|STARTED|Overall Study||38
1003097|NCT00513617|2434106|P2|STARTED|Overall Study||35
1003098|NCT00513617|2434107|P1|STARTED|Overall Study||36
1003099|NCT00513682|2434118|P1|NOT COMPLETED|Treatment Phase||0
1003100|NCT00513682|2434118|P1|COMPLETED|Treatment Phase||7
1003101|NCT00513682|2434118|P1|STARTED|Treatment Phase||7
1003102|NCT00513682|2434118|P1|NOT COMPLETED|Washout Phase||2
1003103|NCT00513682|2434118|P1|COMPLETED|Washout Phase||7
1003104|NCT00513682|2434118|P1|STARTED|Washout Phase||9
1003105|NCT00513682|2434118|P1|NOT COMPLETED|Screening Phase||0
1003106|NCT00513682|2434118|P1|COMPLETED|Screening Phase||9
1003107|NCT00513682|2434118|P1|STARTED|Screening Phase||9
1003108|NCT00513695|2434127|P1|NOT COMPLETED|Overall Study||5
1003109|NCT00513695|2434127|P1|COMPLETED|Overall Study||63
1003110|NCT00513695|2434127|P1|STARTED|Overall Study||68
1003111|NCT00513708|2434139|P3|NOT COMPLETED|Overall Study||4
1003112|NCT00513708|2434140|P2|NOT COMPLETED|Overall Study||4
1003113|NCT00513708|2434141|P1|NOT COMPLETED|Overall Study||4
1003114|NCT00513708|2434139|P3|COMPLETED|Overall Study||46
1003115|NCT00513708|2434140|P2|COMPLETED|Overall Study||46
1003116|NCT00513708|2434141|P1|COMPLETED|Overall Study||46
1003117|NCT00513708|2434139|P3|STARTED|Overall Study||50
1003118|NCT00513708|2434140|P2|STARTED|Overall Study||50
1003119|NCT00513708|2434141|P1|STARTED|Overall Study||50
1003120|NCT00513799|2434159|P4|NOT COMPLETED|Four-Month Follow-Up||3
1003121|NCT00513799|2434160|P3|NOT COMPLETED|Four-Month Follow-Up||7
1003122|NCT00513799|2434161|P2|NOT COMPLETED|Four-Month Follow-Up||5
1003123|NCT00513799|2434162|P1|NOT COMPLETED|Four-Month Follow-Up||0
1003124|NCT00513799|2434159|P4|COMPLETED|Four-Month Follow-Up||51
1003125|NCT00513799|2434160|P3|COMPLETED|Four-Month Follow-Up||57
1003126|NCT00513799|2434161|P2|COMPLETED|Four-Month Follow-Up||57
1003127|NCT00513799|2434162|P1|COMPLETED|Four-Month Follow-Up||64
1003128|NCT00513799|2434159|P4|STARTED|Four-Month Follow-Up||54
1003129|NCT00513799|2434160|P3|STARTED|Four-Month Follow-Up||64
1003130|NCT00513799|2434161|P2|STARTED|Four-Month Follow-Up||62
1003131|NCT00513799|2434162|P1|STARTED|Four-Month Follow-Up||64
1003132|NCT00513799|2434159|P4|NOT COMPLETED|One-Month Follow-Up||21
1003133|NCT00513799|2434160|P3|NOT COMPLETED|One-Month Follow-Up||11
1003134|NCT00513799|2434161|P2|NOT COMPLETED|One-Month Follow-Up||13
1003135|NCT00513799|2434162|P1|NOT COMPLETED|One-Month Follow-Up||11
1003136|NCT00513799|2434159|P4|COMPLETED|One-Month Follow-Up||54
1003137|NCT00513799|2434160|P3|COMPLETED|One-Month Follow-Up||64
1003138|NCT00513799|2434161|P2|COMPLETED|One-Month Follow-Up||62
1003139|NCT00513799|2434162|P1|COMPLETED|One-Month Follow-Up||64
1003140|NCT00513799|2434159|P4|STARTED|One-Month Follow-Up||75
1003141|NCT00513799|2434160|P3|STARTED|One-Month Follow-Up||75
1003142|NCT00513799|2434161|P2|STARTED|One-Month Follow-Up||75
1003143|NCT00513799|2434162|P1|STARTED|One-Month Follow-Up||75
1003144|NCT00514020|2434180|P1|NOT COMPLETED|Overall Study||28
1003145|NCT00514020|2434180|P1|COMPLETED|Overall Study||5
1003146|NCT00514020|2434180|P1|STARTED|Overall Study|two patients withdrew before treatment; one withdrew after treatment|33
1003147|NCT00514137|2434184|P1|NOT COMPLETED|Overall Study||0
1003148|NCT00514137|2434184|P1|COMPLETED|Overall Study||13
1003149|NCT00514137|2434184|P1|STARTED|Overall Study||13
1003150|NCT00514215|2434191|P1|NOT COMPLETED|Overall Study||0
1003151|NCT00514215|2434191|P1|COMPLETED|Overall Study||8
1003152|NCT00514215|2434191|P1|STARTED|Overall Study||8
1003153|NCT00520741|2434197|P2|NOT COMPLETED|Overall Study||125
1003154|NCT00520741|2434198|P1|NOT COMPLETED|Overall Study||37
1003155|NCT00520741|2434197|P2|COMPLETED|Overall Study||194
1003156|NCT00520741|2434198|P1|COMPLETED|Overall Study||69
1003157|NCT00520741|2434197|P2|STARTED|Overall Study|One subject was randomized at 2 sites and excluded from the Safety Set.|319
1003158|NCT00520741|2434198|P1|STARTED|Overall Study||106
1003159|NCT00520767|2434214|P1|NOT COMPLETED|Overall Study||2
1003160|NCT00520767|2434214|P1|COMPLETED|Overall Study||33
1003161|NCT00520767|2434214|P1|STARTED|Overall Study||35
1003162|NCT00520845|2434218|P1|NOT COMPLETED|Overall Study||22
1003163|NCT00520845|2434218|P1|COMPLETED|Overall Study||1
1003164|NCT00520845|2434218|P1|STARTED|Overall Study||23
1003165|NCT00520936|2434234|P8|NOT COMPLETED|Overall Study||1
1003166|NCT00520936|2434235|P7|NOT COMPLETED|Overall Study||4
1003167|NCT00520936|2434236|P6|NOT COMPLETED|Overall Study||0
1003168|NCT00520936|2434237|P5|NOT COMPLETED|Overall Study||1
1003169|NCT00520936|2434238|P4|NOT COMPLETED|Overall Study||0
1003170|NCT00520936|2434239|P3|NOT COMPLETED|Overall Study||2
1003171|NCT00520936|2434240|P2|NOT COMPLETED|Overall Study||4
1003172|NCT00520936|2434241|P1|NOT COMPLETED|Overall Study||0
1003173|NCT00520936|2434234|P8|COMPLETED|Overall Study||9
1003174|NCT00520936|2434235|P7|COMPLETED|Overall Study||7
1003175|NCT00520936|2434236|P6|COMPLETED|Overall Study||10
1003176|NCT00520936|2434237|P5|COMPLETED|Overall Study||5
1003177|NCT00520936|2434238|P4|COMPLETED|Overall Study||5
1003178|NCT00520936|2434239|P3|COMPLETED|Overall Study||7
1003179|NCT00520936|2434240|P2|COMPLETED|Overall Study||7
1003180|NCT00520936|2434241|P1|COMPLETED|Overall Study|Study completion defined as treated until disease progression. Completed=progressive disease.|10
1003181|NCT00520936|2434234|P8|STARTED|Overall Study||10
1003182|NCT00520936|2434235|P7|STARTED|Overall Study||11
1003183|NCT00520936|2434236|P6|STARTED|Overall Study||10
1003184|NCT00520936|2434237|P5|STARTED|Overall Study||6
1003185|NCT00520936|2434238|P4|STARTED|Overall Study||5
1003186|NCT00520936|2434239|P3|STARTED|Overall Study||9
1003187|NCT00520936|2434240|P2|STARTED|Overall Study||11
1003188|NCT00520936|2434241|P1|STARTED|Overall Study|75 participants entered the study and 72 were enrolled and received study drug.|10
1003189|NCT00520975|2434270|P2|NOT COMPLETED|Overall Study||48
1003190|NCT00520975|2434271|P1|NOT COMPLETED|Overall Study||48
1003191|NCT00520975|2434270|P2|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
1003192|NCT00520975|2434271|P1|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
1003193|NCT00520975|2434270|P2|Treated and Reported Adverse Events Data|Overall Study||45
1003194|NCT00520975|2434271|P1|Treated and Reported Adverse Events Data|Overall Study||47
1003195|NCT00520975|2434270|P2|STARTED|Overall Study||48
1003196|NCT00520975|2434271|P1|STARTED|Overall Study||48
1003197|NCT00521001|2434295|P1|NOT COMPLETED|Overall Study||1
1003198|NCT00521001|2434295|P1|COMPLETED|Overall Study||48
1003199|NCT00521001|2434295|P1|STARTED|Overall Study||49
1003200|NCT00521014|2434302|P1|NOT COMPLETED|Overall Study||1
1003201|NCT00521014|2434302|P1|COMPLETED|Overall Study||13
1003202|NCT00521014|2434302|P1|STARTED|Overall Study||14
1003203|NCT00521339|2434306|P3|NOT COMPLETED|Observational Follow Up Phase||0
1003204|NCT00521339|2434307|P2|NOT COMPLETED|Observational Follow Up Phase||0
1003205|NCT00521339|2434308|P1|NOT COMPLETED|Observational Follow Up Phase||0
1003206|NCT00521339|2434306|P3|COMPLETED|Observational Follow Up Phase||4
1003207|NCT00521339|2434307|P2|COMPLETED|Observational Follow Up Phase||4
1003208|NCT00521339|2434308|P1|COMPLETED|Observational Follow Up Phase||14
1003209|NCT00521339|2434306|P3|STARTED|Observational Follow Up Phase||4
1003210|NCT00521339|2434307|P2|STARTED|Observational Follow Up Phase||4
1003211|NCT00521339|2434308|P1|STARTED|Observational Follow Up Phase||14
1003212|NCT00521339|2434306|P3|NOT COMPLETED|Treatment Extension Phase||3
1003213|NCT00521339|2434307|P2|NOT COMPLETED|Treatment Extension Phase||0
1003214|NCT00521339|2434308|P1|NOT COMPLETED|Treatment Extension Phase||0
1003215|NCT00521339|2434306|P3|COMPLETED|Treatment Extension Phase||4
1003216|NCT00521339|2434307|P2|COMPLETED|Treatment Extension Phase||4
1003217|NCT00521339|2434308|P1|COMPLETED|Treatment Extension Phase||0
1003218|NCT00521339|2434306|P3|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|7
1003219|NCT00521339|2434307|P2|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|4
1003220|NCT00521339|2434308|P1|STARTED|Treatment Extension Phase||0
1003221|NCT00521339|2434306|P3|NOT COMPLETED|Treatment Phase||0
1003222|NCT00521339|2434307|P2|NOT COMPLETED|Treatment Phase||0
1003223|NCT00521339|2434308|P1|NOT COMPLETED|Treatment Phase||12
1003224|NCT00521339|2434306|P3|COMPLETED|Treatment Phase||0
1003225|NCT00521339|2434307|P2|COMPLETED|Treatment Phase||0
1003226|NCT00521339|2434308|P1|COMPLETED|Treatment Phase||19
1003227|NCT00521339|2434306|P3|Received Apremilast|Treatment Phase||0
1003228|NCT00521339|2434307|P2|Received Apremilast|Treatment Phase||0
1003229|NCT00521339|2434308|P1|Received Apremilast|Treatment Phase|1 participant withdrew consent prior to first visit and was excluded from safety population|30
1003230|NCT00521339|2434306|P3|STARTED|Treatment Phase||0
1003231|NCT00521339|2434307|P2|STARTED|Treatment Phase||0
1003232|NCT00521339|2434308|P1|STARTED|Treatment Phase||31
1003233|NCT00521352|2434373|P2|NOT COMPLETED|Overall Study||3
1003234|NCT00521352|2434374|P1|NOT COMPLETED|Overall Study||1
1003235|NCT00521352|2434373|P2|COMPLETED|Overall Study||10
1003236|NCT00521352|2434374|P1|COMPLETED|Overall Study||11
1003237|NCT00521352|2434373|P2|STARTED|Overall Study||13
1003238|NCT00521352|2434374|P1|STARTED|Overall Study||12
1003239|NCT00521365|2434384|P1|NOT COMPLETED|Overall Study||20
1003240|NCT00521365|2434384|P1|COMPLETED|Overall Study|68 participants completed the study and 68 completed without protocol deviations|68
1003241|NCT00521365|2434384|P1|Safety Analysis Set|Overall Study|All participants who received study treatment|88
1003242|NCT00521365|2434384|P1|Per Protocol (PP) Population|Overall Study|All participants without protocol deviations|68
1003243|NCT00521365|2434384|P1|Modified Intention to Treat (mITT)|Overall Study|Participants who have an YMRS assessment at inclusion, and at least one assessment after inclusion|88
1003244|NCT00521365|2434384|P1|STARTED|Overall Study|98 participants were screened and obtain 88 patients who receive study treatment|88
1003245|NCT00521456|2434403|P2|NOT COMPLETED|Overall Study||28
1003246|NCT00521456|2434404|P1|NOT COMPLETED|Overall Study||13
1003247|NCT00521456|2434403|P2|COMPLETED|Overall Study||59
1003248|NCT00521456|2434404|P1|COMPLETED|Overall Study||163
1003249|NCT00521456|2434403|P2|STARTED|Overall Study||87
1003250|NCT00521456|2434404|P1|STARTED|Overall Study||176
1003251|NCT00521586|2434418|P2|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||12
1003252|NCT00521586|2434419|P1|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||3
1003253|NCT00521586|2434418|P2|COMPLETED|Revaccination With 13vPnC (Year 5)||351
1003254|NCT00521586|2434419|P1|COMPLETED|Revaccination With 13vPnC (Year 5)||361
1003255|NCT00521586|2434418|P2|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||351
1003256|NCT00521586|2434419|P1|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||361
1003257|NCT00521586|2434418|P2|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||359
1003258|NCT00521586|2434419|P1|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||363
1003259|NCT00521586|2434418|P2|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||363
1003260|NCT00521586|2434419|P1|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||364
1003261|NCT00521586|2434418|P2|STARTED|Revaccination With 13vPnC (Year 5)||363
1003262|NCT00521586|2434419|P1|STARTED|Revaccination With 13vPnC (Year 5)||364
1003263|NCT00521586|2434418|P2|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||170
1003264|NCT00521586|2434419|P1|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||169
1003265|NCT00521586|2434418|P2|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||363
1003266|NCT00521586|2434419|P1|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||364
1003267|NCT00521586|2434418|P2|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
1003268|NCT00521586|2434419|P1|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
1003269|NCT00521586|2434418|P2|NOT COMPLETED|Initial Vaccination (Year 0)||29
1003270|NCT00521586|2434419|P1|NOT COMPLETED|Initial Vaccination (Year 0)||21
1003271|NCT00521586|2434418|P2|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
1003272|NCT00521586|2434419|P1|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
1003273|NCT00521586|2434418|P2|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|529
1003274|NCT00521586|2434419|P1|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|531
1003275|NCT00521586|2434418|P2|Vaccinated Dose 2|Initial Vaccination (Year 0)||543
1003276|NCT00521586|2434419|P1|Vaccinated Dose 2|Initial Vaccination (Year 0)||538
1003277|NCT00521586|2434418|P2|Vaccinated Dose 1|Initial Vaccination (Year 0)||560
1003278|NCT00521586|2434419|P1|Vaccinated Dose 1|Initial Vaccination (Year 0)||551
1003279|NCT00521586|2434418|P2|STARTED|Initial Vaccination (Year 0)||562
1003280|NCT00521586|2434419|P1|STARTED|Initial Vaccination (Year 0)||554
1003281|NCT00521599|2434480|P3|NOT COMPLETED|Overall Study||36
1003282|NCT00521599|2434481|P2|NOT COMPLETED|Overall Study||29
1003283|NCT00521599|2434482|P1|NOT COMPLETED|Overall Study||25
1003284|NCT00521599|2434480|P3|COMPLETED|Overall Study||100
1003285|NCT00521599|2434481|P2|COMPLETED|Overall Study||239
1003286|NCT00521599|2434482|P1|COMPLETED|Overall Study||243
1003287|NCT00521599|2434480|P3|STARTED|Overall Study||136
1003288|NCT00521599|2434481|P2|STARTED|Overall Study||268
1003289|NCT00521599|2434482|P1|STARTED|Overall Study||268
1003290|NCT00521924|2434493|P2|NOT COMPLETED|Overall Study||4
1003291|NCT00521924|2434494|P1|NOT COMPLETED|Overall Study||4
1003292|NCT00521924|2434493|P2|COMPLETED|Overall Study|At Early Termination, 3 patients completed Week 6 and 1 completed Week 22.|0
1003293|NCT00521924|2434494|P1|COMPLETED|Overall Study|At Early Termination, 1 patient completed Week 2 and 2 patients completed Week 6.|0
1003294|NCT00521924|2434493|P2|STARTED|Overall Study|Subjects randomized|4
1003295|NCT00521924|2434494|P1|STARTED|Overall Study|Subjects randomized|4
1003296|NCT00521976|2434500|P1|NOT COMPLETED|Overall Study||0
1003297|NCT00521976|2434500|P1|COMPLETED|Overall Study||871
1003298|NCT00521976|2434500|P1|STARTED|Overall Study||871
1003299|NCT00521989|2434510|P5|NOT COMPLETED|Overall Study||23
1003300|NCT00521989|2434511|P4|NOT COMPLETED|Overall Study||12
1003301|NCT00521989|2434512|P3|NOT COMPLETED|Overall Study||16
1003302|NCT00521989|2434513|P2|NOT COMPLETED|Overall Study||17
1003303|NCT00521989|2434514|P1|NOT COMPLETED|Overall Study||20
1003304|NCT00521989|2434510|P5|COMPLETED|Overall Study||35
1003305|NCT00521989|2434511|P4|COMPLETED|Overall Study||42
1003306|NCT00521989|2434512|P3|COMPLETED|Overall Study||41
1003307|NCT00521989|2434513|P2|COMPLETED|Overall Study||37
1003308|NCT00521989|2434514|P1|COMPLETED|Overall Study||36
1003309|NCT00521989|2434510|P5|STARTED|Overall Study||58
1003310|NCT00521989|2434511|P4|STARTED|Overall Study||54
1003311|NCT00521989|2434512|P3|STARTED|Overall Study||57
1003312|NCT00521989|2434513|P2|STARTED|Overall Study||54
1003313|NCT00521989|2434514|P1|STARTED|Overall Study||56
1003314|NCT00522041|2434528|P2|NOT COMPLETED|Overall Study||12
1003315|NCT00522041|2434529|P1|NOT COMPLETED|Overall Study||17
1003316|NCT00522041|2434528|P2|COMPLETED|Overall Study||113
1003317|NCT00522041|2434529|P1|COMPLETED|Overall Study||106
1003318|NCT00522041|2434528|P2|Received Treatment|Overall Study||124
1003319|NCT00522041|2434529|P1|Received Treatment|Overall Study||123
1003320|NCT00522041|2434528|P2|STARTED|Overall Study||125
1003321|NCT00522041|2434529|P1|STARTED|Overall Study||123
1003322|NCT00522171|2434541|P2|NOT COMPLETED|Overall Study||0
1003323|NCT00522171|2434542|P1|NOT COMPLETED|Overall Study||0
1003324|NCT00522171|2434541|P2|COMPLETED|Overall Study||15
1003325|NCT00522171|2434542|P1|COMPLETED|Overall Study||15
1003326|NCT00522171|2434541|P2|STARTED|Overall Study||15
1003327|NCT00522171|2434542|P1|STARTED|Overall Study||15
1003328|NCT00522275|2434550|P1|NOT COMPLETED|Overall Study||170
1003329|NCT00522275|2434550|P1|COMPLETED|Overall Study||138
1003330|NCT00522275|2434550|P1|STARTED|Overall Study||308
1003331|NCT00522301|2434558|P1|NOT COMPLETED|Overall Study||6
1003332|NCT00522301|2434558|P1|COMPLETED|Overall Study||0
1003333|NCT00522301|2434558|P1|STARTED|Overall Study||6
1003334|NCT00522379|2434567|P5|NOT COMPLETED|Overall Study||27
1003335|NCT00522379|2434568|P4|NOT COMPLETED|Overall Study||14
1003336|NCT00522379|2434569|P3|NOT COMPLETED|Overall Study||22
1003337|NCT00522379|2434570|P2|NOT COMPLETED|Overall Study||23
1003338|NCT00522379|2434571|P1|NOT COMPLETED|Overall Study||22
1003339|NCT00522379|2434567|P5|COMPLETED|Overall Study||81
1003340|NCT00522379|2434568|P4|COMPLETED|Overall Study||80
1003341|NCT00522379|2434569|P3|COMPLETED|Overall Study||82
1003342|NCT00522379|2434570|P2|COMPLETED|Overall Study||84
1003343|NCT00522379|2434571|P1|COMPLETED|Overall Study||79
1003344|NCT00522379|2434567|P5|STARTED|Overall Study||108
1003345|NCT00522379|2434568|P4|STARTED|Overall Study||94
1003346|NCT00522379|2434569|P3|STARTED|Overall Study||104
1003347|NCT00522379|2434570|P2|STARTED|Overall Study||107
1003348|NCT00522379|2434571|P1|STARTED|Overall Study||101
1003349|NCT00522392|2434675|P2|NOT COMPLETED|Overall Study||13
1003350|NCT00522392|2434676|P1|NOT COMPLETED|Overall Study||8
1003351|NCT00522392|2434675|P2|COMPLETED|Overall Study||12
1003352|NCT00522392|2434676|P1|COMPLETED|Overall Study||15
1003353|NCT00522392|2434675|P2|Pts w/ QOL Assessments Complete|Overall Study||8
1003354|NCT00522392|2434676|P1|Pts w/ QOL Assessments Complete|Overall Study||12
1003355|NCT00522392|2434675|P2|Pts w/ Measurable Disease at Baseline|Overall Study||16
1003356|NCT00522392|2434676|P1|Pts w/ Measurable Disease at Baseline|Overall Study||16
1003357|NCT00522392|2434675|P2|STARTED|Overall Study||25
1003358|NCT00522392|2434676|P1|STARTED|Overall Study||23
1003359|NCT00522418|2434690|P2|NOT COMPLETED|Overall Study||58
1003360|NCT00522418|2434691|P1|NOT COMPLETED|Overall Study||57
1003361|NCT00522418|2434690|P2|COMPLETED|Overall Study|Completed 2-year follow-up|5
1003362|NCT00522418|2434691|P1|COMPLETED|Overall Study|Completed 2-year follow-up|2
1003363|NCT00522418|2434690|P2|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|29
1003364|NCT00522418|2434691|P1|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|31
1003365|NCT00522418|2434690|P2|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|35
1003366|NCT00522418|2434691|P1|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|33
1003367|NCT00522418|2434690|P2|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|45
1003368|NCT00522418|2434691|P1|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|38
1003369|NCT00522418|2434690|P2|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
1003370|NCT00522418|2434691|P1|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
1003371|NCT00522418|2434690|P2|Efficacy Set|Overall Study|10 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
1003372|NCT00522418|2434691|P1|Efficacy Set|Overall Study|6 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
1003373|NCT00522418|2434690|P2|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site’s local ethics committee.|58
1003374|NCT00522418|2434691|P1|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site’s local ethics committee.|54
1003375|NCT00522418|2434690|P2|STARTED|Overall Study||63
1003376|NCT00522418|2434691|P1|STARTED|Overall Study||59
1003377|NCT00522431|2434737|P1|NOT COMPLETED|Overall Study||11
1003378|NCT00522431|2434737|P1|COMPLETED|Overall Study||138
1003379|NCT00522431|2434737|P1|STARTED|Overall Study||149
1003380|NCT00522457|2434742|P1|NOT COMPLETED|Overall Study||18
1003381|NCT00522457|2434742|P1|COMPLETED|Overall Study||1
1003382|NCT00522457|2434742|P1|STARTED|Overall Study||19
1003383|NCT00522626|2434748|P1|NOT COMPLETED|Overall Study||7
1003384|NCT00522626|2434748|P1|COMPLETED|Overall Study||12
1003385|NCT00522626|2434748|P1|STARTED|Overall Study||19
1003386|NCT00522795|2434752|P1|NOT COMPLETED|Overall Study||0
1003387|NCT00522795|2434752|P1|COMPLETED|Overall Study||40
1003388|NCT00522795|2434752|P1|STARTED|Overall Study||40
1003389|NCT00522873|2434758|P2|NOT COMPLETED|Overall Study||44
1003390|NCT00522873|2434759|P1|NOT COMPLETED|Overall Study||96
1003391|NCT00522873|2434758|P2|COMPLETED|Overall Study|128 women completed study medication. 129 women completed the study.|128
1003392|NCT00522873|2434759|P1|COMPLETED|Overall Study|394 women completed study medication. 398 women completed the study.|394
1003393|NCT00522873|2434758|P2|Received Treatment|Overall Study||172
1003394|NCT00522873|2434759|P1|Received Treatment|Overall Study||489
1003395|NCT00522873|2434758|P2|STARTED|Overall Study||172
1003396|NCT00522873|2434759|P1|STARTED|Overall Study||490
1003397|NCT00522925|2434771|P3|NOT COMPLETED|Overall Study||2
1003398|NCT00522925|2434772|P2|NOT COMPLETED|Overall Study||1
1003399|NCT00522925|2434773|P1|NOT COMPLETED|Overall Study||8
1003400|NCT00522925|2434771|P3|COMPLETED|Overall Study||36
1003401|NCT00522925|2434772|P2|COMPLETED|Overall Study||38
1003402|NCT00522925|2434773|P1|COMPLETED|Overall Study||28
1003403|NCT00522925|2434771|P3|STARTED|Overall Study||38
1003404|NCT00522925|2434772|P2|STARTED|Overall Study||39
1003405|NCT00522925|2434773|P1|STARTED|Overall Study||36
1003406|NCT00522951|2434781|P2|NOT COMPLETED|Period 2||1
1003407|NCT00522951|2434782|P1|NOT COMPLETED|Period 2||2
1003408|NCT00522951|2434781|P2|COMPLETED|Period 2||75
1003409|NCT00522951|2434782|P1|COMPLETED|Period 2||84
1003410|NCT00522951|2434781|P2|Subjects Received Treatment|Period 2||75
1003411|NCT00522951|2434782|P1|Subjects Received Treatment|Period 2||84
1003412|NCT00522951|2434781|P2|STARTED|Period 2||76
1003413|NCT00522951|2434782|P1|STARTED|Period 2||86
1003414|NCT00522951|2434781|P2|NOT COMPLETED|Washout Period||2
1003415|NCT00522951|2434782|P1|NOT COMPLETED|Washout Period||0
1003416|NCT00522951|2434781|P2|COMPLETED|Washout Period||76
1003417|NCT00522951|2434782|P1|COMPLETED|Washout Period||86
1003418|NCT00522951|2434781|P2|STARTED|Washout Period||78
1003419|NCT00522951|2434782|P1|STARTED|Washout Period||86
1003420|NCT00522951|2434781|P2|NOT COMPLETED|Period 1||1
1003421|NCT00522951|2434782|P1|NOT COMPLETED|Period 1||0
1003422|NCT00522951|2434781|P2|COMPLETED|Period 1||78
1003423|NCT00522951|2434782|P1|COMPLETED|Period 1||86
1003424|NCT00522951|2434781|P2|Received Treatment|Period 1||78
1003425|NCT00522951|2434782|P1|Received Treatment|Period 1||86
1003426|NCT00522951|2434781|P2|STARTED|Period 1||79
1003427|NCT00522951|2434782|P1|STARTED|Period 1||86
1003428|NCT00523237|2434822|P1|NOT COMPLETED|Overall Study||0
1003429|NCT00523237|2434822|P1|COMPLETED|Overall Study||14
1003430|NCT00523237|2434822|P1|STARTED|Overall Study||14
1003431|NCT00523341|2434828|P2|NOT COMPLETED|Overall Study||1000
1003432|NCT00523341|2434829|P1|NOT COMPLETED|Overall Study||924
1003433|NCT00523341|2434828|P2|COMPLETED|Overall Study||1343
1003434|NCT00523341|2434829|P1|COMPLETED|Overall Study||1283
1003435|NCT00523341|2434828|P2|Received Treatment|Overall Study||2343
1003436|NCT00523341|2434829|P1|Received Treatment|Overall Study||2206
1003437|NCT00523341|2434828|P2|STARTED|Overall Study||2343
1003438|NCT00523341|2434829|P1|STARTED|Overall Study||2207
1003439|NCT00523367|2434929|P1|NOT COMPLETED|Overall Study||23
1003440|NCT00523367|2434929|P1|COMPLETED|Overall Study||2
1003441|NCT00523367|2434929|P1|STARTED|Overall Study||25
1003442|NCT00523419|2434933|P1|NOT COMPLETED|Overall Study||32
1003443|NCT00523419|2434933|P1|COMPLETED|Overall Study||0
1003444|NCT00523419|2434933|P1|STARTED|Overall Study||32
1003445|NCT00523549|2434945|P2|NOT COMPLETED|Overall Study||16
1003446|NCT00523549|2434946|P1|NOT COMPLETED|Overall Study||19
1003447|NCT00523549|2434945|P2|COMPLETED|Overall Study||99
1003448|NCT00523549|2434946|P1|COMPLETED|Overall Study||95
1003449|NCT00523549|2434945|P2|STARTED|Overall Study||115
1003450|NCT00523549|2434946|P1|STARTED|Overall Study||114
1003451|NCT00523614|2434966|P2|NOT COMPLETED|Overall Study||0
1003452|NCT00523614|2434967|P1|NOT COMPLETED|Overall Study||0
1003453|NCT00523614|2434966|P2|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
1003454|NCT00523614|2434967|P1|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
1003455|NCT00523614|2434966|P2|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
1003456|NCT00523614|2434967|P1|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
1003457|NCT00523640|2434973|P1|NOT COMPLETED|Overall Study||1
1003458|NCT00523640|2434973|P1|COMPLETED|Overall Study|1 patient died before starting treatment|29
1003459|NCT00523640|2434973|P1|STARTED|Overall Study||30
1003460|NCT00523705|2434981|P2|NOT COMPLETED|Overall Study||1
1003461|NCT00523705|2434982|P1|NOT COMPLETED|Overall Study||0
1003462|NCT00523705|2434981|P2|COMPLETED|Overall Study|1 withdrew due to no time|3
1003463|NCT00523705|2434982|P1|COMPLETED|Overall Study||7
1003464|NCT00523705|2434981|P2|STARTED|Overall Study||4
1003465|NCT00523705|2434982|P1|STARTED|Overall Study||7
1003466|NCT00523718|2434996|P2|NOT COMPLETED|Overall Study||0
1003467|NCT00523718|2434997|P1|NOT COMPLETED|Overall Study||3
1003468|NCT00523718|2434996|P2|COMPLETED|Overall Study||18
1003469|NCT00523718|2434997|P1|COMPLETED|Overall Study||17
1003470|NCT00523718|2434996|P2|STARTED|Overall Study||18
1003471|NCT00523718|2434997|P1|STARTED|Overall Study||20
1003472|NCT00523744|2435009|P1|NOT COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||0
1003473|NCT00523744|2435009|P1|COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||91
1003474|NCT00523744|2435009|P1|STARTED|Phase 3 - Amlodipine+Valsartan+HCTZ|Only patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg at the end of Phase 2.|91
1003475|NCT00523744|2435009|P1|NOT COMPLETED|Phase 2 - Amlodipine+Valsartan||3
1003476|NCT00523744|2435009|P1|COMPLETED|Phase 2 - Amlodipine+Valsartan||173
1003477|NCT00523744|2435009|P1|STARTED|Phase 2 - Amlodipine+Valsartan|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|176
1003478|NCT00523744|2435009|P1|NOT COMPLETED|Phase 1 - Amlodipine+Olmesartan||6
1003479|NCT00523744|2435009|P1|COMPLETED|Phase 1 - Amlodipine+Olmesartan||251
1003480|NCT00523744|2435009|P1|STARTED|Phase 1 - Amlodipine+Olmesartan||257
1003481|NCT00517296|2435028|P2|NOT COMPLETED|Overall Study||0
1003482|NCT00517296|2435029|P1|NOT COMPLETED|Overall Study||1
1003483|NCT00517296|2435028|P2|COMPLETED|Overall Study||11
1003484|NCT00517296|2435029|P1|COMPLETED|Overall Study||9
1003485|NCT00517296|2435028|P2|STARTED|Overall Study||11
1003486|NCT00517296|2435029|P1|STARTED|Overall Study||10
1003487|NCT00517361|2435039|P1|NOT COMPLETED|Overall Study||11
1003488|NCT00517361|2435039|P1|COMPLETED|Overall Study|This study has been terminated due to poor accrual.|0
1003489|NCT00517361|2435039|P1|STARTED|Overall Study||11
1003490|NCT00517413|2435046|P1|NOT COMPLETED|Overall Study||61
1003491|NCT00517413|2435046|P1|COMPLETED|Overall Study||102
1003492|NCT00517413|2435046|P1|STARTED|Overall Study||163
1003493|NCT00517530|2435074|P7|NOT COMPLETED|Overall Study||19
1003494|NCT00517530|2435075|P6|NOT COMPLETED|Overall Study||19
1003495|NCT00517530|2435076|P5|NOT COMPLETED|Overall Study||20
1003496|NCT00517530|2435077|P4|NOT COMPLETED|Overall Study||21
1003497|NCT00517530|2435078|P3|NOT COMPLETED|Overall Study||18
1003498|NCT00517530|2435079|P2|NOT COMPLETED|Overall Study||13
1003499|NCT00517530|2435080|P1|NOT COMPLETED|Overall Study||19
1003500|NCT00517530|2435074|P7|COMPLETED|Overall Study||1
1003501|NCT00517530|2435075|P6|COMPLETED|Overall Study||0
1003502|NCT00517530|2435076|P5|COMPLETED|Overall Study||1
1003503|NCT00517530|2435077|P4|COMPLETED|Overall Study||1
1003504|NCT00517530|2435078|P3|COMPLETED|Overall Study||0
1003505|NCT00517530|2435079|P2|COMPLETED|Overall Study||0
1003506|NCT00517530|2435080|P1|COMPLETED|Overall Study||2
1003507|NCT00517530|2435074|P7|Retreated Population|Overall Study||0
1003508|NCT00517530|2435075|P6|Retreated Population|Overall Study||2
1003509|NCT00517530|2435076|P5|Retreated Population|Overall Study||2
1003510|NCT00517530|2435077|P4|Retreated Population|Overall Study||4
1003511|NCT00517530|2435078|P3|Retreated Population|Overall Study||1
1003512|NCT00517530|2435079|P2|Retreated Population|Overall Study||2
1003513|NCT00517530|2435080|P1|Retreated Population|Overall Study||2
1003514|NCT00517530|2435074|P7|Completed Follow-up|Overall Study||1
1003515|NCT00517530|2435075|P6|Completed Follow-up|Overall Study||0
1003516|NCT00517530|2435076|P5|Completed Follow-up|Overall Study||0
1003517|NCT00517530|2435077|P4|Completed Follow-up|Overall Study||1
1003518|NCT00517530|2435078|P3|Completed Follow-up|Overall Study||0
1003519|NCT00517530|2435079|P2|Completed Follow-up|Overall Study||0
1003520|NCT00517530|2435080|P1|Completed Follow-up|Overall Study||2
1003521|NCT00517530|2435074|P7|Started Follow-up|Overall Study||19
1003522|NCT00517530|2435075|P6|Started Follow-up|Overall Study||16
1003523|NCT00517530|2435076|P5|Started Follow-up|Overall Study||17
1003524|NCT00517530|2435077|P4|Started Follow-up|Overall Study||21
1003525|NCT00517530|2435078|P3|Started Follow-up|Overall Study||17
1003526|NCT00517530|2435079|P2|Started Follow-up|Overall Study||13
1003527|NCT00517530|2435080|P1|Started Follow-up|Overall Study||20
1003528|NCT00517530|2435074|P7|Completed Treatment|Overall Study||13
1003529|NCT00517530|2435075|P6|Completed Treatment|Overall Study||9
1003530|NCT00517530|2435076|P5|Completed Treatment|Overall Study||9
1003531|NCT00517530|2435077|P4|Completed Treatment|Overall Study||18
1003532|NCT00517530|2435078|P3|Completed Treatment|Overall Study||13
1003533|NCT00517530|2435079|P2|Completed Treatment|Overall Study||13
1003534|NCT00517530|2435080|P1|Completed Treatment|Overall Study||11
1003535|NCT00517530|2435074|P7|STARTED|Overall Study||20
1003536|NCT00517530|2435075|P6|STARTED|Overall Study||19
1003537|NCT00517530|2435076|P5|STARTED|Overall Study||21
1003538|NCT00517530|2435077|P4|STARTED|Overall Study||22
1003539|NCT00517530|2435078|P3|STARTED|Overall Study||18
1003540|NCT00517530|2435079|P2|STARTED|Overall Study||13
1003541|NCT00517530|2435080|P1|STARTED|Overall Study||21
1003542|NCT00517556|2435142|P2|NOT COMPLETED|Overall Study||5
1003543|NCT00517556|2435143|P1|NOT COMPLETED|Overall Study||4
1003544|NCT00517556|2435142|P2|COMPLETED|Overall Study||14
1003545|NCT00517556|2435143|P1|COMPLETED|Overall Study||15
1003546|NCT00517556|2435142|P2|STARTED|Overall Study||19
1003547|NCT00517556|2435143|P1|STARTED|Overall Study||19
1003548|NCT00517595|2435149|P1|NOT COMPLETED|Overall Study||0
1003549|NCT00517595|2435149|P1|COMPLETED|Overall Study||48
1003550|NCT00517595|2435149|P1|STARTED|Overall Study||48
1003551|NCT00517634|2435158|P6|NOT COMPLETED|Third Treatment Period||0
1003552|NCT00517634|2435159|P5|NOT COMPLETED|Third Treatment Period||0
1003553|NCT00517634|2435160|P4|NOT COMPLETED|Third Treatment Period||0
1003554|NCT00517634|2435161|P3|NOT COMPLETED|Third Treatment Period||0
1003555|NCT00517634|2435162|P2|NOT COMPLETED|Third Treatment Period||0
1003556|NCT00517634|2435163|P1|NOT COMPLETED|Third Treatment Period||0
1003557|NCT00517634|2435158|P6|COMPLETED|Third Treatment Period||4
1003558|NCT00517634|2435159|P5|COMPLETED|Third Treatment Period||3
1003559|NCT00517634|2435160|P4|COMPLETED|Third Treatment Period||3
1003560|NCT00517634|2435161|P3|COMPLETED|Third Treatment Period||4
1003561|NCT00517634|2435162|P2|COMPLETED|Third Treatment Period||4
1003562|NCT00517634|2435163|P1|COMPLETED|Third Treatment Period||4
1003563|NCT00517634|2435158|P6|STARTED|Third Treatment Period||4
1003564|NCT00517634|2435159|P5|STARTED|Third Treatment Period||3
1003565|NCT00517634|2435160|P4|STARTED|Third Treatment Period||3
1003566|NCT00517634|2435161|P3|STARTED|Third Treatment Period||4
1003567|NCT00517634|2435162|P2|STARTED|Third Treatment Period||4
1003568|NCT00517634|2435163|P1|STARTED|Third Treatment Period||4
1003569|NCT00517634|2435158|P6|NOT COMPLETED|Second Treatment Period||0
1003570|NCT00517634|2435159|P5|NOT COMPLETED|Second Treatment Period||1
1003571|NCT00517634|2435160|P4|NOT COMPLETED|Second Treatment Period||0
1003572|NCT00517634|2435161|P3|NOT COMPLETED|Second Treatment Period||0
1003573|NCT00517634|2435162|P2|NOT COMPLETED|Second Treatment Period||0
1003574|NCT00517634|2435163|P1|NOT COMPLETED|Second Treatment Period||0
1003575|NCT00517634|2435158|P6|COMPLETED|Second Treatment Period||4
1003576|NCT00517634|2435159|P5|COMPLETED|Second Treatment Period||3
1003577|NCT00517634|2435160|P4|COMPLETED|Second Treatment Period||3
1003578|NCT00517634|2435161|P3|COMPLETED|Second Treatment Period||4
1003579|NCT00517634|2435162|P2|COMPLETED|Second Treatment Period||4
1003580|NCT00517634|2435163|P1|COMPLETED|Second Treatment Period||4
1003581|NCT00517634|2435158|P6|STARTED|Second Treatment Period||4
1003582|NCT00517634|2435159|P5|STARTED|Second Treatment Period||4
1003583|NCT00517634|2435160|P4|STARTED|Second Treatment Period||3
1003584|NCT00517634|2435161|P3|STARTED|Second Treatment Period||4
1003585|NCT00517634|2435162|P2|STARTED|Second Treatment Period||4
1003586|NCT00517634|2435163|P1|STARTED|Second Treatment Period||4
1003587|NCT00517634|2435158|P6|NOT COMPLETED|First Treatment Period||0
1003588|NCT00517634|2435159|P5|NOT COMPLETED|First Treatment Period||0
1003589|NCT00517634|2435160|P4|NOT COMPLETED|First Treatment Period||0
1003590|NCT00517634|2435161|P3|NOT COMPLETED|First Treatment Period||0
1003591|NCT00517634|2435162|P2|NOT COMPLETED|First Treatment Period||0
1003592|NCT00517634|2435163|P1|NOT COMPLETED|First Treatment Period||0
1003593|NCT00517634|2435158|P6|COMPLETED|First Treatment Period||4
1003594|NCT00517634|2435159|P5|COMPLETED|First Treatment Period||4
1003595|NCT00517634|2435160|P4|COMPLETED|First Treatment Period||3
1003596|NCT00517634|2435161|P3|COMPLETED|First Treatment Period||4
1003597|NCT00517634|2435162|P2|COMPLETED|First Treatment Period||4
1003598|NCT00517634|2435163|P1|COMPLETED|First Treatment Period||4
1003599|NCT00517634|2435158|P6|STARTED|First Treatment Period||4
1003600|NCT00517634|2435159|P5|STARTED|First Treatment Period||4
1003601|NCT00517634|2435160|P4|STARTED|First Treatment Period||3
1003602|NCT00517634|2435161|P3|STARTED|First Treatment Period||4
1003603|NCT00517634|2435162|P2|STARTED|First Treatment Period||4
1003604|NCT00517634|2435163|P1|STARTED|First Treatment Period||4
1003605|NCT00517699|2435174|P1|NOT COMPLETED|Overall Study||5
1003606|NCT00517699|2435174|P1|COMPLETED|Overall Study||0
1003607|NCT00517699|2435174|P1|STARTED|Overall Study||5
1003608|NCT00517751|2435182|P1|NOT COMPLETED|Overall Study||129
1003609|NCT00517751|2435182|P1|COMPLETED|Overall Study||33
1003610|NCT00517751|2435182|P1|STARTED|Overall Study||162
1003611|NCT00517829|2435207|P2|NOT COMPLETED|Overall Study||75
1003612|NCT00517829|2435208|P1|NOT COMPLETED|Overall Study||75
1003613|NCT00517829|2435207|P2|COMPLETED|Overall Study||0
1003614|NCT00517829|2435208|P1|COMPLETED|Overall Study||0
1003615|NCT00517829|2435207|P2|STARTED|Overall Study||75
1003616|NCT00517829|2435208|P1|STARTED|Overall Study||75
1003617|NCT00517881|2435222|P1|NOT COMPLETED|Overall Study||5
1003618|NCT00517881|2435222|P1|COMPLETED|Overall Study||24
1003619|NCT00517881|2435222|P1|STARTED|Overall Study||29
1003620|NCT00517933|2435234|P2|NOT COMPLETED|Period 2||13
1003621|NCT00517933|2435235|P1|NOT COMPLETED|Period 2||6
1003622|NCT00517933|2435234|P2|COMPLETED|Period 2||70
1003623|NCT00517933|2435235|P1|COMPLETED|Period 2||73
1003624|NCT00517933|2435234|P2|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|83
1003625|NCT00517933|2435235|P1|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|79
1003626|NCT00517933|2435234|P2|NOT COMPLETED|Period 1||6
1003627|NCT00517933|2435235|P1|NOT COMPLETED|Period 1||8
1003628|NCT00517933|2435234|P2|COMPLETED|Period 1||85
1003629|NCT00517933|2435235|P1|COMPLETED|Period 1||81
1003630|NCT00517933|2435234|P2|STARTED|Period 1|Patients decreased due to death, adverse event and other (see below)|91
1003631|NCT00517933|2435235|P1|STARTED|Period 1|Patients decreased due to death, adverse event, lost to follow up and other (see below)|89
1003632|NCT00518011|2435301|P2|NOT COMPLETED|Overall Study||8
1003633|NCT00518011|2435302|P1|NOT COMPLETED|Overall Study||9
1003634|NCT00518011|2435301|P2|COMPLETED|Overall Study||0
1003635|NCT00518011|2435302|P1|COMPLETED|Overall Study||0
1003636|NCT00518011|2435301|P2|STARTED|Overall Study||8
1003637|NCT00518011|2435302|P1|STARTED|Overall Study||9
1003638|NCT00518089|2435324|P2|NOT COMPLETED|Overall Study||31
1003639|NCT00518089|2435325|P1|NOT COMPLETED|Overall Study||28
1003640|NCT00518089|2435324|P2|COMPLETED|Overall Study||398
1003641|NCT00518089|2435325|P1|COMPLETED|Overall Study||402
1003642|NCT00518089|2435324|P2|STARTED|Overall Study||429
1003643|NCT00518089|2435325|P1|STARTED|Overall Study||430
1003644|NCT00518115|2435349|P10|NOT COMPLETED|Overall Study||15
1003645|NCT00518115|2435350|P9|NOT COMPLETED|Overall Study||5
1003646|NCT00518115|2435351|P8|NOT COMPLETED|Overall Study||15
1003647|NCT00518115|2435352|P7|NOT COMPLETED|Overall Study||8
1003648|NCT00518115|2435353|P6|NOT COMPLETED|Overall Study||15
1003649|NCT00518115|2435354|P5|NOT COMPLETED|Overall Study||10
1003650|NCT00518115|2435355|P4|NOT COMPLETED|Overall Study||11
1003651|NCT00518115|2435356|P3|NOT COMPLETED|Overall Study||17
1003652|NCT00518115|2435357|P2|NOT COMPLETED|Overall Study||6
1003653|NCT00518115|2435358|P1|NOT COMPLETED|Overall Study||12
1003654|NCT00518115|2435349|P10|COMPLETED|Overall Study||20
1003655|NCT00518115|2435350|P9|COMPLETED|Overall Study||30
1003656|NCT00518115|2435351|P8|COMPLETED|Overall Study||20
1003657|NCT00518115|2435352|P7|COMPLETED|Overall Study||25
1003658|NCT00518115|2435353|P6|COMPLETED|Overall Study||19
1003659|NCT00518115|2435354|P5|COMPLETED|Overall Study||21
1003660|NCT00518115|2435355|P4|COMPLETED|Overall Study||24
1003661|NCT00518115|2435356|P3|COMPLETED|Overall Study||19
1003662|NCT00518115|2435357|P2|COMPLETED|Overall Study||29
1003663|NCT00518115|2435358|P1|COMPLETED|Overall Study||40
1003664|NCT00518115|2435349|P10|Safety Population|Overall Study|These participants received at least one dose of study drug.|34
1003665|NCT00518115|2435350|P9|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
1003666|NCT00518115|2435351|P8|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
1003667|NCT00518115|2435352|P7|Safety Population|Overall Study|These participants received at least one dose of study drug.|32
1003668|NCT00518115|2435353|P6|Safety Population|Overall Study|These participants received at least one dose of study drug.|33
1003669|NCT00518115|2435354|P5|Safety Population|Overall Study|These participants received at least one dose of study drug.|31
1003670|NCT00518115|2435355|P4|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
1003671|NCT00518115|2435356|P3|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
1003672|NCT00518115|2435357|P2|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
1003673|NCT00518115|2435358|P1|Safety Population|Overall Study|These participants received at least one dose of study drug.|51
1003674|NCT00518115|2435349|P10|STARTED|Overall Study||35
1003675|NCT00518115|2435350|P9|STARTED|Overall Study||35
1003676|NCT00518115|2435351|P8|STARTED|Overall Study||35
1003677|NCT00518115|2435352|P7|STARTED|Overall Study||33
1003678|NCT00518115|2435353|P6|STARTED|Overall Study||34
1003679|NCT00518115|2435354|P5|STARTED|Overall Study||31
1003680|NCT00518115|2435355|P4|STARTED|Overall Study||35
1003681|NCT00518115|2435356|P3|STARTED|Overall Study||36
1003682|NCT00518115|2435357|P2|STARTED|Overall Study||35
1003683|NCT00518115|2435358|P1|STARTED|Overall Study||52
1003684|NCT00518180|2435517|P3|NOT COMPLETED|Overall Study||82
1003685|NCT00518180|2435518|P2|NOT COMPLETED|Overall Study||69
1003686|NCT00518180|2435519|P1|NOT COMPLETED|Overall Study||65
1003687|NCT00518180|2435517|P3|COMPLETED|Overall Study||457
1003688|NCT00518180|2435518|P2|COMPLETED|Overall Study||472
1003689|NCT00518180|2435519|P1|COMPLETED|Overall Study||475
1003690|NCT00518180|2435517|P3|STARTED|Overall Study||539
1003691|NCT00518180|2435518|P2|STARTED|Overall Study||541
1003692|NCT00518180|2435519|P1|STARTED|Overall Study||540
1003693|NCT00518206|2435563|P2|NOT COMPLETED|Overall Study||6
1003694|NCT00518206|2435564|P1|NOT COMPLETED|Overall Study||11
1003695|NCT00518206|2435563|P2|COMPLETED|Overall Study||13
1003696|NCT00518206|2435564|P1|COMPLETED|Overall Study||16
1003697|NCT00518206|2435563|P2|STARTED|Overall Study||19
1003698|NCT00518206|2435564|P1|STARTED|Overall Study||27
1003699|NCT00523809|2435578|P1|NOT COMPLETED|Overall Study||0
1003700|NCT00523809|2435578|P1|COMPLETED|Overall Study||5
1003701|NCT00523809|2435578|P1|STARTED|Overall Study||5
1003702|NCT00523848|2435582|P1|NOT COMPLETED|Overall Study||24
1003703|NCT00523848|2435582|P1|COMPLETED|Overall Study||22
1003704|NCT00523848|2435582|P1|Treated With Study Therapy|Overall Study||44
1003705|NCT00523848|2435582|P1|STARTED|Overall Study||46
1003706|NCT00523939|2435590|P2|NOT COMPLETED|Overall Study||0
1003707|NCT00523939|2435591|P1|NOT COMPLETED|Overall Study||0
1003708|NCT00523939|2435590|P2|COMPLETED|Overall Study||2
1003709|NCT00523939|2435591|P1|COMPLETED|Overall Study||2
1003710|NCT00523939|2435590|P2|STARTED|Overall Study||2
1003711|NCT00523939|2435591|P1|STARTED|Overall Study||2
1003712|NCT00523978|2435600|P2|NOT COMPLETED|Overall Study||8
1003713|NCT00523978|2435601|P1|NOT COMPLETED|Overall Study||9
1003714|NCT00523978|2435600|P2|COMPLETED|Overall Study||79
1003715|NCT00523978|2435601|P1|COMPLETED|Overall Study||162
1003716|NCT00523978|2435600|P2|STARTED|Overall Study||87
1003717|NCT00523978|2435601|P1|STARTED|Overall Study||171
1003718|NCT00523991|2435615|P2|NOT COMPLETED|Overall Study||27
1003719|NCT00523991|2435616|P1|NOT COMPLETED|Overall Study||21
1003720|NCT00523991|2435615|P2|COMPLETED|Overall Study||211
1003721|NCT00523991|2435616|P1|COMPLETED|Overall Study||198
1003722|NCT00523991|2435615|P2|STARTED|Overall Study||238
1003723|NCT00523991|2435616|P1|STARTED|Overall Study||219
1003724|NCT00524030|2435896|P2|NOT COMPLETED|Overall Study||59
1003725|NCT00524030|2435897|P1|NOT COMPLETED|Overall Study||17
1003726|NCT00524030|2435896|P2|COMPLETED|Overall Study||70
1003727|NCT00524030|2435897|P1|COMPLETED|Overall Study||15
1003728|NCT00524030|2435896|P2|Completed Taper/Titration Phase|Overall Study||70
1003729|NCT00524030|2435897|P1|Completed Taper/Titration Phase|Overall Study||15
1003730|NCT00524030|2435896|P2|Completed Double-Blind Treatment Phase|Overall Study||70
1003731|NCT00524030|2435897|P1|Completed Double-Blind Treatment Phase|Overall Study||15
1003732|NCT00524030|2435896|P2|STARTED|Overall Study||129
1003733|NCT00524030|2435897|P1|STARTED|Overall Study||32
1003734|NCT00524043|2435916|P3|NOT COMPLETED|Overall Study||31
1003735|NCT00524043|2435917|P2|NOT COMPLETED|Overall Study||28
1003736|NCT00524043|2435918|P1|NOT COMPLETED|Overall Study||30
1003737|NCT00524043|2435916|P3|COMPLETED|Overall Study||35
1003738|NCT00524043|2435917|P2|COMPLETED|Overall Study||42
1003739|NCT00524043|2435918|P1|COMPLETED|Overall Study||34
1003740|NCT00524043|2435916|P3|STARTED|Overall Study||66
1003741|NCT00524043|2435917|P2|STARTED|Overall Study||70
1003742|NCT00524043|2435918|P1|STARTED|Overall Study|One patient was randomly assigned to treatment but did not receive placebo.|64
1003743|NCT00524121|2435938|P1|NOT COMPLETED|Overall Study||19
1003744|NCT00524121|2435938|P1|COMPLETED|Overall Study||3
1003745|NCT00524121|2435938|P1|STARTED|Overall Study||22
1003746|NCT00525525|2435957|P2|NOT COMPLETED|Overall Study||0
1003747|NCT00525525|2435958|P1|NOT COMPLETED|Overall Study||0
1003748|NCT00525525|2435957|P2|COMPLETED|Overall Study||15
1003749|NCT00525525|2435958|P1|COMPLETED|Overall Study||59
1003750|NCT00525525|2435957|P2|STARTED|Overall Study||15
1003751|NCT00525525|2435958|P1|STARTED|Overall Study||59
1003752|NCT00525603|2435965|P1|NOT COMPLETED|Overall Study||0
1003753|NCT00525603|2435965|P1|COMPLETED|Overall Study||60
1003754|NCT00525603|2435965|P1|STARTED|Overall Study||60
1003755|NCT00525629|2435971|P2|NOT COMPLETED|Overall Study||5
1003756|NCT00525629|2435972|P1|NOT COMPLETED|Overall Study||5
1003757|NCT00525629|2435971|P2|COMPLETED|Overall Study||15
1003758|NCT00525629|2435972|P1|COMPLETED|Overall Study||15
1003759|NCT00525629|2435971|P2|STARTED|Overall Study||20
1003760|NCT00525629|2435972|P1|STARTED|Overall Study||20
1003761|NCT00525733|2435980|P2|NOT COMPLETED|Overall Study||3
1003762|NCT00525733|2435981|P1|NOT COMPLETED|Overall Study||3
1003763|NCT00525733|2435980|P2|COMPLETED|Overall Study||23
1003764|NCT00525733|2435981|P1|COMPLETED|Overall Study||11
1003765|NCT00525733|2435980|P2|STARTED|Overall Study||26
1003766|NCT00525733|2435981|P1|STARTED|Overall Study||14
1003767|NCT00525798|2435989|P2|NOT COMPLETED|Overall Study||599
1003768|NCT00525798|2435990|P1|NOT COMPLETED|Overall Study||756
1003769|NCT00525798|2435989|P2|COMPLETED|Overall Study||1732
1003770|NCT00525798|2435990|P1|COMPLETED|Overall Study||1578
1003771|NCT00525798|2435989|P2|STARTED|Overall Study||2331
1003772|NCT00525798|2435990|P1|STARTED|Overall Study||2334
1003773|NCT00525824|2436002|P4|NOT COMPLETED|Overall Study||15
1003774|NCT00525824|2436003|P3|NOT COMPLETED|Overall Study||19
1003775|NCT00525824|2436004|P2|NOT COMPLETED|Overall Study||28
1003776|NCT00525824|2436005|P1|NOT COMPLETED|Overall Study||19
1003777|NCT00525824|2436002|P4|COMPLETED|Overall Study||188
1003778|NCT00525824|2436003|P3|COMPLETED|Overall Study||183
1003779|NCT00525824|2436004|P2|COMPLETED|Overall Study||186
1003780|NCT00525824|2436005|P1|COMPLETED|Overall Study||195
1003781|NCT00525824|2436002|P4|STARTED|Overall Study|Randomized population|203
1003782|NCT00525824|2436003|P3|STARTED|Overall Study|Randomized population|202
1003783|NCT00525824|2436004|P2|STARTED|Overall Study|Randomized population|214
1003784|NCT00525824|2436005|P1|STARTED|Overall Study|Randomized population|214
1003785|NCT00525837|2436067|P1|NOT COMPLETED|Overall Study||4
1003786|NCT00525837|2436067|P1|COMPLETED|Overall Study||14
1003787|NCT00525837|2436067|P1|STARTED|Overall Study||18
1003788|NCT00525876|2436073|P2|NOT COMPLETED|Overall Study||0
1003789|NCT00525876|2436074|P1|NOT COMPLETED|Overall Study||0
1003790|NCT00525876|2436073|P2|COMPLETED|Overall Study||20
1003791|NCT00525876|2436074|P1|COMPLETED|Overall Study||16
1003792|NCT00525876|2436073|P2|STARTED|Overall Study||20
1003793|NCT00525876|2436074|P1|STARTED|Overall Study||16
1003794|NCT00525902|2436080|P1|NOT COMPLETED|Overall Study||1
1003795|NCT00525902|2436080|P1|COMPLETED|Overall Study||30
1003796|NCT00525902|2436080|P1|50 Weeks|Overall Study||12
1003797|NCT00525902|2436080|P1|10 Weeks|Overall Study||30
1003798|NCT00525902|2436080|P1|STARTED|Overall Study||31
1003799|NCT00525915|2436087|P2|NOT COMPLETED|Overall Study||9
1003800|NCT00525915|2436088|P1|NOT COMPLETED|Overall Study||8
1003801|NCT00525915|2436087|P2|COMPLETED|Overall Study||54
1003802|NCT00525915|2436088|P1|COMPLETED|Overall Study|Participants who underwent surgery.|55
1003803|NCT00525915|2436087|P2|STARTED|Overall Study||63
1003804|NCT00525915|2436088|P1|STARTED|Overall Study||63
1003805|NCT00526058|2436096|P2|NOT COMPLETED|Period: Second Intervention||0
1003806|NCT00526058|2436097|P1|NOT COMPLETED|Period: Second Intervention||0
1003807|NCT00526058|2436096|P2|COMPLETED|Period: Second Intervention||9
1003808|NCT00526058|2436097|P1|COMPLETED|Period: Second Intervention||9
1003809|NCT00526058|2436096|P2|STARTED|Period: Second Intervention||9
1003810|NCT00526058|2436097|P1|STARTED|Period: Second Intervention||9
1003811|NCT00526058|2436096|P2|NOT COMPLETED|Period: First Intervention||0
1003812|NCT00526058|2436097|P1|NOT COMPLETED|Period: First Intervention||0
1003813|NCT00526058|2436096|P2|COMPLETED|Period: First Intervention||9
1003814|NCT00526058|2436097|P1|COMPLETED|Period: First Intervention||9
1003815|NCT00526058|2436096|P2|STARTED|Period: First Intervention||9
1003816|NCT00526058|2436097|P1|STARTED|Period: First Intervention||9
1003817|NCT00526097|2436105|P2|NOT COMPLETED|Overall Study||56
1003818|NCT00526097|2436106|P1|NOT COMPLETED|Overall Study||15
1003819|NCT00526097|2436105|P2|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|191
1003820|NCT00526097|2436106|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|106
1003821|NCT00526097|2436105|P2|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|247
1003822|NCT00526097|2436106|P1|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|121
1003823|NCT00526110|2436284|P2|NOT COMPLETED|Overall Study||41
1003824|NCT00526110|2436285|P1|NOT COMPLETED|Overall Study||2
1003825|NCT00526110|2436284|P2|COMPLETED|Overall Study||4
1003826|NCT00526110|2436285|P1|COMPLETED|Overall Study||51
1003827|NCT00526110|2436284|P2|STARTED|Overall Study||45
1003828|NCT00526110|2436285|P1|STARTED|Overall Study||53
1003829|NCT00526123|2436294|P2|NOT COMPLETED|Overall Study||246
1003830|NCT00526123|2436295|P1|NOT COMPLETED|Overall Study||264
1003831|NCT00526123|2436294|P2|COMPLETED|Overall Study||50
1003832|NCT00526123|2436295|P1|COMPLETED|Overall Study||39
1003833|NCT00526123|2436294|P2|STARTED|Overall Study|Intent-to-Treat population|296
1003834|NCT00526123|2436295|P1|STARTED|Overall Study|Intent-to-Treat population|303
1003835|NCT00526162|2436315|P1|NOT COMPLETED|Overall Study||3
1003836|NCT00526162|2436315|P1|COMPLETED|Overall Study||80
1003837|NCT00526162|2436315|P1|STARTED|Overall Study||83
1003838|NCT00526188|2436320|P1|NOT COMPLETED|Overall Study||0
1003839|NCT00526188|2436320|P1|COMPLETED|Overall Study||234
1003840|NCT00526188|2436320|P1|STARTED|Overall Study||234
1003841|NCT00526227|2436326|P1|NOT COMPLETED|Overall Study||2
1003842|NCT00526227|2436326|P1|COMPLETED|Overall Study||79
1003843|NCT00526227|2436326|P1|STARTED|Overall Study||81
1003844|NCT00526292|2436331|P1|NOT COMPLETED|Overall Study||0
1003845|NCT00526292|2436331|P1|COMPLETED|Overall Study||6
1003846|NCT00526292|2436331|P1|STARTED|Overall Study||6
1003847|NCT00526331|2436335|P1|NOT COMPLETED|Overall Study||55
1003848|NCT00526331|2436335|P1|COMPLETED|Overall Study||0
1003849|NCT00526331|2436335|P1|STARTED|Overall Study||55
1003850|NCT00526474|2436341|P2|NOT COMPLETED|Overall Study||272
1003851|NCT00526474|2436342|P1|NOT COMPLETED|Overall Study||292
1003852|NCT00526474|2436341|P2|COMPLETED|Overall Study||12953
1003853|NCT00526474|2436342|P1|COMPLETED|Overall Study||12932
1003854|NCT00526474|2436341|P2|Received Study Drug|Overall Study||13186
1003855|NCT00526474|2436342|P1|Received Study Drug|Overall Study||13166
1003856|NCT00526474|2436341|P2|STARTED|Overall Study||13225
1003857|NCT00526474|2436342|P1|STARTED|Overall Study||13224
1003858|NCT00526630|2436410|P2|NOT COMPLETED|Second Intervention Period - 12 Weeks||1
1003859|NCT00526630|2436411|P1|NOT COMPLETED|Second Intervention Period - 12 Weeks||2
1003860|NCT00526630|2436410|P2|COMPLETED|Second Intervention Period - 12 Weeks||7
1003861|NCT00526630|2436411|P1|COMPLETED|Second Intervention Period - 12 Weeks||10
1003862|NCT00526630|2436410|P2|STARTED|Second Intervention Period - 12 Weeks||8
1003863|NCT00526630|2436411|P1|STARTED|Second Intervention Period - 12 Weeks||12
1003864|NCT00526630|2436410|P2|NOT COMPLETED|First Intervention Period - 12 Weeks||3
1003865|NCT00526630|2436411|P1|NOT COMPLETED|First Intervention Period - 12 Weeks||0
1003866|NCT00526630|2436410|P2|COMPLETED|First Intervention Period - 12 Weeks||8
1003867|NCT00526630|2436411|P1|COMPLETED|First Intervention Period - 12 Weeks||12
1003868|NCT00526630|2436410|P2|STARTED|First Intervention Period - 12 Weeks||11
1003869|NCT00526630|2436411|P1|STARTED|First Intervention Period - 12 Weeks||12
1003870|NCT00526669|2436439|P2|NOT COMPLETED|Combined Treatment Phase||8
1003871|NCT00526669|2436440|P1|NOT COMPLETED|Combined Treatment Phase||0
1003872|NCT00526669|2436439|P2|COMPLETED|Combined Treatment Phase||59
1003873|NCT00526669|2436440|P1|COMPLETED|Combined Treatment Phase||0
1003874|NCT00526669|2436439|P2|STARTED|Combined Treatment Phase||67
1003875|NCT00526669|2436440|P1|STARTED|Combined Treatment Phase||0
1003876|NCT00526669|2436439|P2|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
1003877|NCT00526669|2436440|P1|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
1003878|NCT00526669|2436439|P2|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
1003879|NCT00526669|2436440|P1|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||67
1003880|NCT00526669|2436439|P2|STARTED|7-Day Run-in Monotherapy Treatment Phase||0
1003881|NCT00526669|2436440|P1|STARTED|7-Day Run-in Monotherapy Treatment Phase||67
1003882|NCT00526799|2436471|P2|NOT COMPLETED|Overall Study||1
1003883|NCT00526799|2436472|P1|NOT COMPLETED|Overall Study||1
1003884|NCT00526799|2436471|P2|COMPLETED|Overall Study||13
1003885|NCT00526799|2436472|P1|COMPLETED|Overall Study||15
1003886|NCT00526799|2436471|P2|STARTED|Overall Study||14
1003887|NCT00526799|2436472|P1|STARTED|Overall Study||16
1003891|NCT00526994|2436492|P3|NOT COMPLETED|Overall Study||107
1003892|NCT00526994|2436493|P2|NOT COMPLETED|Overall Study||121
1003893|NCT00526994|2436494|P1|NOT COMPLETED|Overall Study||108
1003894|NCT00526994|2436492|P3|COMPLETED|Overall Study||791
1003895|NCT00526994|2436493|P2|COMPLETED|Overall Study||772
1003896|NCT00526994|2436494|P1|COMPLETED|Overall Study||801
1003897|NCT00526994|2436492|P3|STARTED|Overall Study||898
1003898|NCT00526994|2436493|P2|STARTED|Overall Study||893
1003899|NCT00526994|2436494|P1|STARTED|Overall Study||909
1003900|NCT00527072|2436511|P1|NOT COMPLETED|Overall Study||36
1003901|NCT00527072|2436511|P1|COMPLETED|Overall Study||179
1003902|NCT00527072|2436511|P1|STARTED|Overall Study||215
1003903|NCT00527098|2436519|P2|NOT COMPLETED|Overall Study||0
1003904|NCT00527098|2436520|P1|NOT COMPLETED|Overall Study||0
1003905|NCT00527098|2436519|P2|COMPLETED|Overall Study||83
1003906|NCT00527098|2436520|P1|COMPLETED|Overall Study||36
1003907|NCT00527098|2436519|P2|STARTED|Overall Study||83
1003908|NCT00527098|2436520|P1|STARTED|Overall Study||36
1003909|NCT00527111|2436527|P2|NOT COMPLETED|Overall Study||22
1003910|NCT00527111|2436528|P1|NOT COMPLETED|Overall Study||20
1003911|NCT00527111|2436527|P2|COMPLETED|Overall Study||47
1003912|NCT00527111|2436528|P1|COMPLETED|Overall Study||50
1003913|NCT00527111|2436527|P2|STARTED|Overall Study||69
1003914|NCT00527111|2436528|P1|STARTED|Overall Study||70
1003915|NCT00527124|2436544|P2|NOT COMPLETED|Overall Study||0
1003916|NCT00527124|2436545|P1|NOT COMPLETED|Overall Study||0
1003917|NCT00527124|2436544|P2|COMPLETED|Overall Study||28
1003918|NCT00527124|2436545|P1|COMPLETED|Overall Study||29
1003919|NCT00527124|2436544|P2|STARTED|Overall Study||28
1003920|NCT00527124|2436545|P1|STARTED|Overall Study||29
1003921|NCT00527319|2436554|P3|NOT COMPLETED|Overall Study||6
1003922|NCT00527319|2436555|P2|NOT COMPLETED|Overall Study||4
1003923|NCT00527319|2436556|P1|NOT COMPLETED|Overall Study||6
1003924|NCT00527319|2436554|P3|COMPLETED|Overall Study||7
1003925|NCT00527319|2436555|P2|COMPLETED|Overall Study||8
1003926|NCT00527319|2436556|P1|COMPLETED|Overall Study||6
1003927|NCT00527319|2436554|P3|STARTED|Overall Study||13
1003928|NCT00527319|2436555|P2|STARTED|Overall Study||12
1003929|NCT00527319|2436556|P1|STARTED|Overall Study||12
1003930|NCT00527332|2436569|P2|NOT COMPLETED|Overall Study||9
1003931|NCT00527332|2436570|P1|NOT COMPLETED|Overall Study||9
1003932|NCT00527332|2436569|P2|COMPLETED|Overall Study||80
1003933|NCT00527332|2436570|P1|COMPLETED|Overall Study||82
1003934|NCT00527332|2436569|P2|STARTED|Overall Study||89
1003935|NCT00527332|2436570|P1|STARTED|Overall Study||91
1003936|NCT00527397|2436576|P1|NOT COMPLETED|Overall Study||24
1003937|NCT00527397|2436576|P1|COMPLETED|Overall Study||0
1003938|NCT00527397|2436576|P1|STARTED|Overall Study||24
1003939|NCT00527423|2436600|P1|NOT COMPLETED|Overall Study||37
1003940|NCT00527423|2436600|P1|COMPLETED|Overall Study||120
1003941|NCT00527423|2436600|P1|STARTED|Overall Study||157
1003942|NCT00527475|2436608|P2|NOT COMPLETED|Overall Study||1
1003943|NCT00527475|2436609|P1|NOT COMPLETED|Overall Study||3
1003944|NCT00527475|2436608|P2|COMPLETED|Overall Study||29
1003945|NCT00527475|2436609|P1|COMPLETED|Overall Study||27
1003946|NCT00527475|2436608|P2|STARTED|Overall Study||30
1003947|NCT00527475|2436609|P1|STARTED|Overall Study||30
1003960|NCT00527514|2436696|P1|NOT COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||2
1003961|NCT00527514|2436696|P1|COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||132
1003962|NCT00527514|2436696|P1|STARTED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|158 -24 who met blood pressure goal = 134|134
1003963|NCT00527514|2436696|P1|NOT COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||3
1003964|NCT00527514|2436696|P1|COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||158
1003965|NCT00527514|2436696|P1|STARTED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|178 -19 who met blood pressure goal + 2 who were mis-titrated = 161|161
1003966|NCT00527514|2436696|P1|NOT COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||2
1003967|NCT00527514|2436696|P1|COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||178
1003968|NCT00527514|2436696|P1|STARTED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|184 -2 who were mis-titrated -2 who met blood pressure goal = 180|180
1003969|NCT00527514|2436696|P1|NOT COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg||1
1003970|NCT00527514|2436696|P1|COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg|1 participant dropped out. 2 participants were subsequently mis-titrated to the third regimen.|184
1003971|NCT00527514|2436696|P1|STARTED|Weeks 1-3: Amlodipine (Aml) 5mg||185
1003972|NCT00527566|2436708|P1|NOT COMPLETED|Overall Study||0
1003973|NCT00527566|2436708|P1|COMPLETED|Overall Study||10
1003974|NCT00527566|2436708|P1|STARTED|Overall Study||10
1003975|NCT00527592|2436717|P1|NOT COMPLETED|Overall Study||0
1003976|NCT00527592|2436717|P1|COMPLETED|Overall Study||54
1003977|NCT00527592|2436717|P1|STARTED|Overall Study||54
1003978|NCT00527605|2436725|P2|NOT COMPLETED|Overall Study||11
1003979|NCT00527605|2436726|P1|NOT COMPLETED|Overall Study||13
1003980|NCT00527605|2436725|P2|COMPLETED|Overall Study||116
1003981|NCT00527605|2436726|P1|COMPLETED|Overall Study||113
1003982|NCT00527605|2436725|P2|STARTED|Overall Study||127
1003983|NCT00527605|2436726|P1|STARTED|Overall Study||126
1003984|NCT00527618|2436762|P2|NOT COMPLETED|Week 15-18 (Second Intervention)||3
1003985|NCT00527618|2436763|P1|NOT COMPLETED|Week 15-18 (Second Intervention)||0
1003986|NCT00527618|2436762|P2|COMPLETED|Week 15-18 (Second Intervention)|Acyclovir|13
1003987|NCT00527618|2436763|P1|COMPLETED|Week 15-18 (Second Intervention)|Valacyclovir|12
1003988|NCT00527618|2436762|P2|STARTED|Week 15-18 (Second Intervention)|Acyclovir|16
1003989|NCT00527618|2436763|P1|STARTED|Week 15-18 (Second Intervention)|Valacyclovir|12
1003990|NCT00527618|2436762|P2|NOT COMPLETED|Week 13-14 (Washout)||0
1003991|NCT00527618|2436763|P1|NOT COMPLETED|Week 13-14 (Washout)||1
1003992|NCT00527618|2436762|P2|COMPLETED|Week 13-14 (Washout)||16
1003993|NCT00527618|2436763|P1|COMPLETED|Week 13-14 (Washout)||12
1003994|NCT00527618|2436762|P2|STARTED|Week 13-14 (Washout)||16
1003995|NCT00527618|2436763|P1|STARTED|Week 13-14 (Washout)||13
1003996|NCT00527618|2436762|P2|NOT COMPLETED|Week 1-12 (First Intervention)||2
1003997|NCT00527618|2436763|P1|NOT COMPLETED|Week 1-12 (First Intervention)||3
1003998|NCT00527618|2436762|P2|COMPLETED|Week 1-12 (First Intervention)|Valacyclovir|16
1003999|NCT00527618|2436763|P1|COMPLETED|Week 1-12 (First Intervention)|Acyclovir|13
1004000|NCT00527618|2436762|P2|STARTED|Week 1-12 (First Intervention)|Valacyclovir; one participant was removed from the study due to urticaria after 2.5 weeks|18
1004001|NCT00527618|2436763|P1|STARTED|Week 1-12 (First Intervention)|Acyclovir|16
1004002|NCT00527722|2436778|P2|NOT COMPLETED|Overall Study||0
1004003|NCT00527722|2436779|P1|NOT COMPLETED|Overall Study||0
1004004|NCT00527722|2436778|P2|COMPLETED|Overall Study||25
1004005|NCT00527722|2436779|P1|COMPLETED|Overall Study||22
1004006|NCT00527722|2436778|P2|STARTED|Overall Study||25
1004007|NCT00527722|2436779|P1|STARTED|Overall Study||22
1004017|NCT00527748|2436862|P1|NOT COMPLETED|Overall Study||3
1004018|NCT00527748|2436862|P1|COMPLETED|Overall Study||23
1004019|NCT00527748|2436862|P1|STARTED|Overall Study||26
1004020|NCT00527787|2436868|P2|NOT COMPLETED|Overall Study||63
1004021|NCT00527787|2436869|P1|NOT COMPLETED|Overall Study||38
1004022|NCT00527787|2436868|P2|COMPLETED|Overall Study||153
1004023|NCT00527787|2436869|P1|COMPLETED|Overall Study||180
1004024|NCT00527787|2436868|P2|STARTED|Overall Study|Safety and Intent-to-treat population (>=1 dose drug + no baseline ulcer) N=216|216
1004025|NCT00527787|2436869|P1|STARTED|Overall Study||218
1004026|NCT00527826|2436893|P2|NOT COMPLETED|Overall Study||26
1004027|NCT00527826|2436894|P1|NOT COMPLETED|Overall Study||21
1004028|NCT00527826|2436893|P2|COMPLETED|Overall Study||80
1004029|NCT00527826|2436894|P1|COMPLETED|Overall Study||87
1004030|NCT00527826|2436893|P2|STARTED|Overall Study||106
1004031|NCT00527826|2436894|P1|STARTED|Overall Study|All Patients Population was used for Participant Flow section.|108
1004032|NCT00527878|2436941|P2|NOT COMPLETED|Intervention 2||0
1004033|NCT00527878|2436942|P1|NOT COMPLETED|Intervention 2||0
1004034|NCT00527878|2436941|P2|COMPLETED|Intervention 2||4
1004035|NCT00527878|2436942|P1|COMPLETED|Intervention 2||5
1004036|NCT00527878|2436941|P2|STARTED|Intervention 2||4
1004037|NCT00527878|2436942|P1|STARTED|Intervention 2||5
1004038|NCT00527878|2436941|P2|NOT COMPLETED|Intervention 1||3
1004039|NCT00527878|2436942|P1|NOT COMPLETED|Intervention 1||2
1004040|NCT00527878|2436941|P2|COMPLETED|Intervention 1||4
1004041|NCT00527878|2436942|P1|COMPLETED|Intervention 1||5
1004042|NCT00527878|2436941|P2|STARTED|Intervention 1||7
1004043|NCT00527878|2436942|P1|STARTED|Intervention 1||7
1004044|NCT00527904|2436954|P1|NOT COMPLETED|Overall Study||96
1004045|NCT00527904|2436954|P1|COMPLETED|Overall Study||143
1004046|NCT00527904|2436954|P1|STARTED|Overall Study||239
1004047|NCT00527943|2436960|P2|NOT COMPLETED|Overall Study||146
1004048|NCT00527943|2436961|P1|NOT COMPLETED|Overall Study||160
1004049|NCT00527943|2436960|P2|COMPLETED|Overall Study||6327
1004050|NCT00527943|2436961|P1|COMPLETED|Overall Study||6311
1004051|NCT00527943|2436960|P2|Received Treatment|Overall Study||6446
1004052|NCT00527943|2436961|P1|Received Treatment|Overall Study||6441
1004053|NCT00527943|2436960|P2|STARTED|Overall Study||6473
1004054|NCT00527943|2436961|P1|STARTED|Overall Study||6471
1004055|NCT00527982|2436995|P2|NOT COMPLETED|Overall Study||0
1004056|NCT00527982|2436996|P1|NOT COMPLETED|Overall Study||1
1004057|NCT00527982|2436995|P2|COMPLETED|Overall Study||0
1004058|NCT00527982|2436996|P1|COMPLETED|Overall Study||0
1004059|NCT00527982|2436995|P2|STARTED|Overall Study||0
1004060|NCT00527982|2436996|P1|STARTED|Overall Study||1
1004061|NCT00528021|2437006|P4|NOT COMPLETED|Overall Study||9
1004062|NCT00528021|2437007|P3|NOT COMPLETED|Overall Study||7
1004063|NCT00528021|2437008|P2|NOT COMPLETED|Overall Study||13
1004064|NCT00528021|2437009|P1|NOT COMPLETED|Overall Study||17
1004065|NCT00528021|2437006|P4|COMPLETED|Overall Study||47
1004066|NCT00528021|2437007|P3|COMPLETED|Overall Study||49
1004067|NCT00528021|2437008|P2|COMPLETED|Overall Study||46
1004068|NCT00528021|2437009|P1|COMPLETED|Overall Study||42
1004069|NCT00528021|2437006|P4|STARTED|Overall Study||56
1004070|NCT00528021|2437007|P3|STARTED|Overall Study||56
1004071|NCT00528021|2437008|P2|STARTED|Overall Study||59
1004072|NCT00528021|2437009|P1|STARTED|Overall Study||59
1004073|NCT00521053|2437019|P1|NOT COMPLETED|Observation Phase||68
1004074|NCT00521053|2437019|P1|COMPLETED|Observation Phase||12
1004075|NCT00521053|2437019|P1|STARTED|Observation Phase||80
1004076|NCT00521053|2437019|P1|NOT COMPLETED|Treatment Phase||0
1004077|NCT00521053|2437019|P1|COMPLETED|Treatment Phase||80
1004078|NCT00521053|2437019|P1|Received 4 Cycles of PV-10|Treatment Phase||3
1004079|NCT00521053|2437019|P1|Received 3 Cycles of PV-10|Treatment Phase||16
1004080|NCT00521053|2437019|P1|Received 2 Cycles of PV-10|Treatment Phase||26
1004081|NCT00521053|2437019|P1|Received 1 Cycle of PV-10|Treatment Phase||35
1004082|NCT00521053|2437019|P1|STARTED|Treatment Phase||80
1004083|NCT00521079|2437031|P2|NOT COMPLETED|Overall Study||5
1004084|NCT00521079|2437032|P1|NOT COMPLETED|Overall Study||14
1004085|NCT00521079|2437031|P2|COMPLETED|Overall Study||97
1004086|NCT00521079|2437032|P1|COMPLETED|Overall Study||178
1004087|NCT00521079|2437031|P2|Surgical Roll-In|Overall Study||5
1004088|NCT00521079|2437032|P1|Surgical Roll-In|Overall Study||9
1004089|NCT00521079|2437031|P2|STARTED|Overall Study||102
1004090|NCT00521079|2437032|P1|STARTED|Overall Study||192
1004091|NCT00521144|2437047|P5|NOT COMPLETED|Overall Study||7
1004092|NCT00521144|2437048|P4|NOT COMPLETED|Overall Study||1
1004093|NCT00521144|2437049|P3|NOT COMPLETED|Overall Study||2
1004094|NCT00521144|2437050|P2|NOT COMPLETED|Overall Study||3
1004095|NCT00521144|2437051|P1|NOT COMPLETED|Overall Study||4
1004096|NCT00521144|2437047|P5|COMPLETED|Overall Study||0
1004097|NCT00521144|2437048|P4|COMPLETED|Overall Study||0
1004098|NCT00521144|2437049|P3|COMPLETED|Overall Study||1
1004099|NCT00521144|2437050|P2|COMPLETED|Overall Study||2
1004100|NCT00521144|2437051|P1|COMPLETED|Overall Study||2
1004101|NCT00521144|2437047|P5|STARTED|Overall Study||7
1004102|NCT00521144|2437048|P4|STARTED|Overall Study||1
1004103|NCT00521144|2437049|P3|STARTED|Overall Study||3
1004104|NCT00521144|2437050|P2|STARTED|Overall Study||5
1004105|NCT00521144|2437051|P1|STARTED|Overall Study||6
1004106|NCT00528112|2437065|P2|NOT COMPLETED|Extension Phase||157
1004107|NCT00528112|2437066|P1|NOT COMPLETED|Extension Phase||0
1004108|NCT00528112|2437065|P2|COMPLETED|Extension Phase||550
1004109|NCT00528112|2437066|P1|COMPLETED|Extension Phase||0
1004110|NCT00528112|2437065|P2|STARTED|Extension Phase||707
1004111|NCT00528112|2437066|P1|STARTED|Extension Phase|Only subjects in the LCS16 groups could participate in the extension phase|0
1004112|NCT00528112|2437065|P2|NOT COMPLETED|Treatment up to 3 Years||583
1004113|NCT00528112|2437066|P1|NOT COMPLETED|Treatment up to 3 Years||613
1004114|NCT00528112|2437065|P2|COMPLETED|Treatment up to 3 Years||870
1004115|NCT00528112|2437066|P1|COMPLETED|Treatment up to 3 Years||819
1004116|NCT00528112|2437065|P2|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1452
1004117|NCT00528112|2437066|P1|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1432
1004118|NCT00528112|2437065|P2|STARTED|Treatment up to 3 Years||1453
1004119|NCT00528112|2437066|P1|STARTED|Treatment up to 3 Years||1432
1004120|NCT00528190|2437122|P2|NOT COMPLETED|Overall Study||1
1004121|NCT00528190|2437123|P1|NOT COMPLETED|Overall Study||0
1004122|NCT00528190|2437122|P2|COMPLETED|Overall Study||16
1004123|NCT00528190|2437123|P1|COMPLETED|Overall Study||18
1004124|NCT00528190|2437122|P2|STARTED|Overall Study||17
1004125|NCT00528190|2437123|P1|STARTED|Overall Study||18
1004126|NCT00528268|2437131|P2|NOT COMPLETED|Overall Study||1
1004127|NCT00528268|2437132|P1|NOT COMPLETED|Overall Study||1
1004128|NCT00528268|2437131|P2|COMPLETED|Overall Study||7
1004129|NCT00528268|2437132|P1|COMPLETED|Overall Study||5
1004130|NCT00528268|2437131|P2|STARTED|Overall Study||8
1004131|NCT00528268|2437132|P1|STARTED|Overall Study||6
1004132|NCT00528931|2437138|P1|NOT COMPLETED|Overall Study||1
1004133|NCT00528931|2437138|P1|COMPLETED|Overall Study||15
1004134|NCT00528931|2437138|P1|STARTED|Overall Study||16
1004135|NCT00528957|2437148|P2|NOT COMPLETED|Second Extension (Week 144 to Week 240)||40
1004136|NCT00528957|2437149|P1|NOT COMPLETED|Second Extension (Week 144 to Week 240)||34
1004137|NCT00528957|2437148|P2|COMPLETED|Second Extension (Week 144 to Week 240)|Study is ongoing, therefore no participants have completed the study.|0
1004138|NCT00528957|2437149|P1|COMPLETED|Second Extension (Week 144 to Week 240)|Study is ongoing, therefore no participants have completed the study.|0
1004139|NCT00528957|2437148|P2|STARTED|Second Extension (Week 144 to Week 240)||40
1004140|NCT00528957|2437149|P1|STARTED|Second Extension (Week 144 to Week 240)|One participant completed the first extension and did not enroll in the second extension.|34
1004141|NCT00528957|2437148|P2|NOT COMPLETED|First Extension (Week 48 to Week 144)||1
1004142|NCT00528957|2437149|P1|NOT COMPLETED|First Extension (Week 48 to Week 144)||3
1004143|NCT00528957|2437148|P2|COMPLETED|First Extension (Week 48 to Week 144)||40
1004144|NCT00528957|2437149|P1|COMPLETED|First Extension (Week 48 to Week 144)||35
1004145|NCT00528957|2437148|P2|STARTED|First Extension (Week 48 to Week 144)|Seven participants completed the 48-week randomized phase and did not enroll in the first extension.|41
1004146|NCT00528957|2437149|P1|STARTED|First Extension (Week 48 to Week 144)|Six participants completed the 48-week randomized phase and did not enroll in the first extension.|38
1004147|NCT00528957|2437148|P2|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||1
1004148|NCT00528957|2437149|P1|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||4
1004149|NCT00528957|2437148|P2|COMPLETED|Randomized Phase (Baseline to Week 48)||48
1004150|NCT00528957|2437149|P1|COMPLETED|Randomized Phase (Baseline to Week 48)||44
1004151|NCT00528957|2437148|P2|STARTED|Randomized Phase (Baseline to Week 48)||49
1004152|NCT00528957|2437149|P1|STARTED|Randomized Phase (Baseline to Week 48)||48
1004153|NCT00529035|2437192|P1|NOT COMPLETED|Overall Study||1
1004154|NCT00529035|2437192|P1|COMPLETED|Overall Study|28 evaluable, 1 patient withdrew participation and was not evaluable|28
1004155|NCT00529035|2437192|P1|STARTED|Overall Study|29 enrolled|29
1004156|NCT00529087|2437206|P3|NOT COMPLETED|Overall Study||16
1004157|NCT00529087|2437207|P2|NOT COMPLETED|Overall Study||28
1004158|NCT00529087|2437208|P1|NOT COMPLETED|Overall Study||28
1004159|NCT00529087|2437206|P3|COMPLETED|Overall Study||146
1004160|NCT00529087|2437207|P2|COMPLETED|Overall Study||120
1004161|NCT00529087|2437208|P1|COMPLETED|Overall Study||122
1004162|NCT00529087|2437206|P3|STARTED|Overall Study||162
1004163|NCT00529087|2437207|P2|STARTED|Overall Study||148
1004164|NCT00529087|2437208|P1|STARTED|Overall Study||150
1004165|NCT00529100|2437275|P2|NOT COMPLETED|Overall Study||9
1004166|NCT00529100|2437276|P1|NOT COMPLETED|Overall Study||0
1004167|NCT00529100|2437275|P2|COMPLETED|Overall Study||24
1004168|NCT00529100|2437276|P1|COMPLETED|Overall Study||16
1004169|NCT00529100|2437275|P2|Received at Least 1 Dose of Study Drug|Overall Study||33
1004170|NCT00529100|2437276|P1|Received at Least 1 Dose of Study Drug|Overall Study||16
1004171|NCT00529100|2437275|P2|STARTED|Overall Study||33
1004172|NCT00529100|2437276|P1|STARTED|Overall Study||16
1004173|NCT00529126|2437294|P4|NOT COMPLETED|Overall Study||0
1004174|NCT00529126|2437295|P3|NOT COMPLETED|Overall Study||0
1004175|NCT00529126|2437296|P2|NOT COMPLETED|Overall Study||0
1004176|NCT00529126|2437297|P1|NOT COMPLETED|Overall Study||0
1004177|NCT00529126|2437294|P4|COMPLETED|Overall Study||26
1004178|NCT00529126|2437295|P3|COMPLETED|Overall Study||24
1004179|NCT00529126|2437296|P2|COMPLETED|Overall Study||25
1004180|NCT00529126|2437297|P1|COMPLETED|Overall Study||25
1004181|NCT00529126|2437294|P4|STARTED|Overall Study||26
1004182|NCT00529126|2437295|P3|STARTED|Overall Study||24
1004183|NCT00529126|2437296|P2|STARTED|Overall Study||25
1004184|NCT00529126|2437297|P1|STARTED|Overall Study||25
1004185|NCT00529152|2437307|P1|NOT COMPLETED|Overall Study||5
1004186|NCT00529152|2437307|P1|COMPLETED|Overall Study||95
1004187|NCT00529152|2437307|P1|STARTED|Overall Study||100
1004188|NCT00529191|2437313|P2|NOT COMPLETED|Overall Study||0
1004189|NCT00529191|2437314|P1|NOT COMPLETED|Overall Study||3
1004190|NCT00529191|2437313|P2|COMPLETED|Overall Study||13
1004191|NCT00529191|2437314|P1|COMPLETED|Overall Study||24
1004192|NCT00529191|2437313|P2|STARTED|Overall Study||13
1004193|NCT00529191|2437314|P1|STARTED|Overall Study||27
1004194|NCT00529204|2437336|P1|NOT COMPLETED|Overall Study||0
1004195|NCT00529204|2437336|P1|COMPLETED|Overall Study||1
1004196|NCT00529204|2437336|P1|STARTED|Overall Study||1
1004197|NCT00529217|2437342|P1|NOT COMPLETED|Overall Study||4
1004198|NCT00529217|2437342|P1|COMPLETED|Overall Study||8
1004199|NCT00529217|2437342|P1|STARTED|Overall Study||12
1004200|NCT00529243|2437347|P1|NOT COMPLETED|Overall Study||3
1004201|NCT00529243|2437347|P1|COMPLETED|Overall Study||49
1004202|NCT00529243|2437347|P1|STARTED|Overall Study||52
1004203|NCT00529282|2437354|P2|NOT COMPLETED|Overall Study||0
1004204|NCT00529282|2437355|P1|NOT COMPLETED|Overall Study||0
1004205|NCT00529282|2437354|P2|COMPLETED|Overall Study||2
1004206|NCT00529282|2437355|P1|COMPLETED|Overall Study||0
1004207|NCT00529282|2437354|P2|STARTED|Overall Study||2
1004208|NCT00529282|2437355|P1|STARTED|Overall Study||0
1004209|NCT00529308|2437369|P2|NOT COMPLETED|Overall Study||1
1004210|NCT00529308|2437370|P1|NOT COMPLETED|Overall Study||1
1004211|NCT00529308|2437369|P2|COMPLETED|Overall Study||10
1004212|NCT00529308|2437370|P1|COMPLETED|Overall Study||8
1004213|NCT00529308|2437369|P2|STARTED|Overall Study||11
1004214|NCT00529308|2437370|P1|STARTED|Overall Study||9
1004215|NCT00529399|2437387|P3|NOT COMPLETED|Overall Study||2
1004216|NCT00529399|2437388|P2|NOT COMPLETED|Overall Study||1
1004217|NCT00529399|2437389|P1|NOT COMPLETED|Overall Study||2
1004218|NCT00529399|2437387|P3|COMPLETED|Overall Study||46
1004219|NCT00529399|2437388|P2|COMPLETED|Overall Study||48
1004220|NCT00529399|2437389|P1|COMPLETED|Overall Study||46
1004221|NCT00529399|2437387|P3|STARTED|Overall Study||48
1004222|NCT00529399|2437388|P2|STARTED|Overall Study||49
1004223|NCT00529399|2437389|P1|STARTED|Overall Study||48
1004224|NCT00529451|2437401|P4|NOT COMPLETED|Overall Study||31
1004225|NCT00529451|2437402|P3|NOT COMPLETED|Overall Study||40
1004226|NCT00529451|2437403|P2|NOT COMPLETED|Overall Study||48
1004227|NCT00529451|2437404|P1|NOT COMPLETED|Overall Study||37
1004228|NCT00529451|2437401|P4|COMPLETED|Overall Study||299
1004229|NCT00529451|2437402|P3|COMPLETED|Overall Study||292
1004230|NCT00529451|2437403|P2|COMPLETED|Overall Study||275
1004231|NCT00529451|2437404|P1|COMPLETED|Overall Study||294
1004232|NCT00529451|2437401|P4|STARTED|Overall Study||330
1004233|NCT00529451|2437402|P3|STARTED|Overall Study||332
1004234|NCT00529451|2437403|P2|STARTED|Overall Study||323
1004235|NCT00529451|2437404|P1|STARTED|Overall Study||331
1004236|NCT00529464|2437431|P3|NOT COMPLETED|Overall Study||0
1004237|NCT00529464|2437432|P2|NOT COMPLETED|Overall Study||0
1004238|NCT00529464|2437433|P1|NOT COMPLETED|Overall Study||0
1004239|NCT00529464|2437431|P3|COMPLETED|Overall Study||0
1004240|NCT00529464|2437432|P2|COMPLETED|Overall Study||0
1004241|NCT00529464|2437433|P1|COMPLETED|Overall Study||0
1004242|NCT00529464|2437431|P3|STARTED|Overall Study||0
1004243|NCT00529464|2437432|P2|STARTED|Overall Study||0
1004244|NCT00529464|2437433|P1|STARTED|Overall Study||0
1004245|NCT00529516|2437444|P3|NOT COMPLETED|Overall Study||1
1004246|NCT00529516|2437445|P2|NOT COMPLETED|Overall Study||2
1004247|NCT00529516|2437446|P1|NOT COMPLETED|Overall Study||3
1004248|NCT00529516|2437444|P3|COMPLETED|Overall Study||288
1004249|NCT00529516|2437445|P2|COMPLETED|Overall Study||486
1004250|NCT00529516|2437446|P1|COMPLETED|Overall Study||472
1004251|NCT00529516|2437444|P3|STARTED|Overall Study||289
1004252|NCT00529516|2437445|P2|STARTED|Overall Study||488
1004253|NCT00529516|2437446|P1|STARTED|Overall Study||475
1004254|NCT00529529|2437517|P3|NOT COMPLETED|Overall Study||31
1004255|NCT00529529|2437518|P2|NOT COMPLETED|Overall Study||43
1004256|NCT00529529|2437519|P1|NOT COMPLETED|Overall Study||43
1004257|NCT00529529|2437517|P3|COMPLETED|Overall Study||238
1004258|NCT00529529|2437518|P2|COMPLETED|Overall Study||225
1004259|NCT00529529|2437519|P1|COMPLETED|Overall Study||225
1004260|NCT00529529|2437517|P3|STARTED|Overall Study||269
1004261|NCT00529529|2437518|P2|STARTED|Overall Study||268
1004262|NCT00529529|2437519|P1|STARTED|Overall Study||268
1004263|NCT00529542|2437577|P2|NOT COMPLETED|Overall Study||1
1004264|NCT00529542|2437578|P1|NOT COMPLETED|Overall Study||1
1004265|NCT00529542|2437577|P2|COMPLETED|Overall Study||10
1004266|NCT00529542|2437578|P1|COMPLETED|Overall Study||8
1004267|NCT00529542|2437577|P2|STARTED|Overall Study||11
1004268|NCT00529542|2437578|P1|STARTED|Overall Study||9
1004269|NCT00529555|2437621|P3|NOT COMPLETED|Overall Study||26
1004270|NCT00529555|2437622|P2|NOT COMPLETED|Overall Study||30
1004271|NCT00529555|2437623|P1|NOT COMPLETED|Overall Study||29
1004272|NCT00529555|2437621|P3|COMPLETED|Overall Study||174
1004273|NCT00529555|2437622|P2|COMPLETED|Overall Study||172
1004274|NCT00529555|2437623|P1|COMPLETED|Overall Study||171
1004275|NCT00529555|2437621|P3|STARTED|Overall Study||200
1004276|NCT00529555|2437622|P2|STARTED|Overall Study||202
1004277|NCT00529555|2437623|P1|STARTED|Overall Study||200
1004278|NCT00529568|2437633|P3|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||102
1004279|NCT00529568|2437634|P2|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||48
1004280|NCT00529568|2437635|P1|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||0
1004281|NCT00529568|2437633|P3|COMPLETED|Double-bilnd Antiviral Treatment Phase||404
1004282|NCT00529568|2437634|P2|COMPLETED|Double-bilnd Antiviral Treatment Phase||205
1004283|NCT00529568|2437635|P1|COMPLETED|Double-bilnd Antiviral Treatment Phase||0
1004284|NCT00529568|2437633|P3|STARTED|Double-bilnd Antiviral Treatment Phase||506
1004285|NCT00529568|2437634|P2|STARTED|Double-bilnd Antiviral Treatment Phase||253
1004286|NCT00529568|2437635|P1|STARTED|Double-bilnd Antiviral Treatment Phase||0
1004287|NCT00529568|2437633|P3|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
1004288|NCT00529568|2437634|P2|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
1004289|NCT00529568|2437635|P1|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||46
1004290|NCT00529568|2437633|P3|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
1004291|NCT00529568|2437634|P2|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
1004292|NCT00529568|2437635|P1|COMPLETED|Open-label Pre-Antiviral Treatment Phase||759
1004293|NCT00529568|2437633|P3|STARTED|Open-label Pre-Antiviral Treatment Phase||0
1004294|NCT00529568|2437634|P2|STARTED|Open-label Pre-Antiviral Treatment Phase||0
1004295|NCT00529568|2437635|P1|STARTED|Open-label Pre-Antiviral Treatment Phase||805
1004296|NCT00529633|2437685|P2|NOT COMPLETED|Overall Study||1
1004297|NCT00529633|2437686|P1|NOT COMPLETED|Overall Study||1
1004298|NCT00529633|2437685|P2|COMPLETED|Overall Study||1
1004299|NCT00529633|2437686|P1|COMPLETED|Overall Study||1
1004300|NCT00529633|2437685|P2|STARTED|Overall Study||2
1004301|NCT00529633|2437686|P1|STARTED|Overall Study||2
1004302|NCT00529659|2437698|P2|NOT COMPLETED|Overall Study||23
1004303|NCT00529659|2437699|P1|NOT COMPLETED|Overall Study||11
1004304|NCT00529659|2437698|P2|COMPLETED|Overall Study||66
1004305|NCT00529659|2437699|P1|COMPLETED|Overall Study||70
1004306|NCT00529659|2437698|P2|STARTED|Overall Study||89
1004307|NCT00529659|2437699|P1|STARTED|Overall Study||81
1004308|NCT00529763|2437718|P3|NOT COMPLETED|Overall Study||7
1004309|NCT00529763|2437719|P2|NOT COMPLETED|Overall Study||33
1004310|NCT00529763|2437720|P1|NOT COMPLETED|Overall Study||10
1004311|NCT00529763|2437718|P3|COMPLETED|Overall Study|52 participants still on treatment; not completed = off treatment (n=7)|52
1004312|NCT00529763|2437719|P2|COMPLETED|Overall Study|4 participants still on treatment; not completed = off treatment (n=33)|4
1004313|NCT00529763|2437720|P1|COMPLETED|Overall Study|15 participants still on treatment; not completed = off treatment (n=10)|15
1004314|NCT00529763|2437718|P3|STARTED|Overall Study||59
1004315|NCT00529763|2437719|P2|STARTED|Overall Study|38 participants were enrolled; 37 were treated in this cohort|37
1004316|NCT00529763|2437720|P1|STARTED|Overall Study||25
1004317|NCT00529789|2437756|P1|NOT COMPLETED|Study Period IV||6
1004318|NCT00529789|2437756|P1|COMPLETED|Study Period IV|Includes 1 patient who withdrew at last visit; didn't enter Taper; however received 30 weeks of drug|42
1004319|NCT00529789|2437756|P1|STARTED|Study Period IV||48
1004320|NCT00529789|2437756|P1|NOT COMPLETED|Study Period II/III||24
1004321|NCT00529789|2437756|P1|COMPLETED|Study Period II/III||48
1004322|NCT00529789|2437756|P1|STARTED|Study Period II/III||72
1004323|NCT00530023|2437780|P2|NOT COMPLETED|Overall Study||1
1004324|NCT00530023|2437781|P1|NOT COMPLETED|Overall Study||0
1004325|NCT00530023|2437780|P2|COMPLETED|Overall Study||14
1004326|NCT00530023|2437781|P1|COMPLETED|Overall Study||14
1004327|NCT00530023|2437780|P2|STARTED|Overall Study||15
1004328|NCT00530023|2437781|P1|STARTED|Overall Study||14
1004329|NCT00530075|2437795|P1|NOT COMPLETED|Overall Study||7
1004330|NCT00530075|2437795|P1|COMPLETED|Overall Study||38
1004331|NCT00530075|2437795|P1|STARTED|Overall Study||45
1004332|NCT00530088|2437806|P1|NOT COMPLETED|Overall Study||10
1004333|NCT00530088|2437806|P1|COMPLETED|Overall Study||20
1004334|NCT00530088|2437806|P1|STARTED|Overall Study||30
1004335|NCT00530257|2437811|P1|NOT COMPLETED|Overall Study||1
1004336|NCT00530257|2437811|P1|COMPLETED|Overall Study||30
1004337|NCT00530257|2437811|P1|STARTED|Overall Study||31
1004338|NCT00530270|2437841|P2|NOT COMPLETED|Overall Study||0
1004339|NCT00530270|2437842|P1|NOT COMPLETED|Overall Study||1
1004340|NCT00530270|2437841|P2|COMPLETED|Overall Study||6
1004341|NCT00530270|2437842|P1|COMPLETED|Overall Study||5
1004342|NCT00530270|2437841|P2|STARTED|Overall Study||6
1004343|NCT00530270|2437842|P1|STARTED|Overall Study||6
1004344|NCT00530335|2437856|P1|NOT COMPLETED|Overall Study||6
1004345|NCT00530335|2437856|P1|COMPLETED|Overall Study||39
1004346|NCT00530335|2437856|P1|STARTED|Overall Study||45
1004347|NCT00530348|2437873|P2|NOT COMPLETED|Overall Study||19
1004348|NCT00530348|2437874|P1|NOT COMPLETED|Overall Study||22
1004349|NCT00530348|2437873|P2|COMPLETED|Overall Study||367
1004350|NCT00530348|2437874|P1|COMPLETED|Overall Study||173
1004351|NCT00530348|2437873|P2|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|376
1004352|NCT00530348|2437874|P1|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|187
1004353|NCT00530348|2437873|P2|STARTED|Overall Study|Randomized.|386
1004354|NCT00530348|2437874|P1|STARTED|Overall Study|Randomized.|195
1004355|NCT00530439|2437892|P2|NOT COMPLETED|Overall Study||26
1004356|NCT00530439|2437893|P1|NOT COMPLETED|Overall Study||30
1004357|NCT00530439|2437892|P2|COMPLETED|Overall Study||154
1004358|NCT00530439|2437893|P1|COMPLETED|Overall Study||150
1004359|NCT00530439|2437892|P2|STARTED|Overall Study||180
1004360|NCT00530439|2437893|P1|STARTED|Overall Study||180
1004361|NCT00530504|2437899|P1|NOT COMPLETED|Overall Study||152
1004362|NCT00530504|2437899|P1|COMPLETED|Overall Study||1348
1004363|NCT00530504|2437899|P1|STARTED|Overall Study||1500
1004364|NCT00530634|2437903|P1|NOT COMPLETED|Overall Study||0
1004365|NCT00530634|2437903|P1|COMPLETED|Overall Study||3
1004366|NCT00530634|2437903|P1|STARTED|Overall Study||3
1004367|NCT00530712|2437907|P1|NOT COMPLETED|12 Month Follow-up Visit||24
1004461|NCT00530946|2438269|P2|STARTED|Overall Study||41
1004368|NCT00530712|2437907|P1|COMPLETED|12 Month Follow-up Visit|Subjects that Completed 12-Month Follow-up Visit|263
1004369|NCT00530712|2437907|P1|STARTED|12 Month Follow-up Visit|Subjects Expected for 12 Month Visit|287
1004370|NCT00530712|2437907|P1|NOT COMPLETED|6 Month Follow-up Visit||12
1004371|NCT00530712|2437907|P1|COMPLETED|6 Month Follow-up Visit|Subjects that Completed 6-Month Follow-up Visit|275
1004372|NCT00530712|2437907|P1|STARTED|6 Month Follow-up Visit|Subjects Expected for 6-Month Visit|287
1004373|NCT00530712|2437907|P1|NOT COMPLETED|30 Day Follow-up Visit||7
1004374|NCT00530712|2437907|P1|COMPLETED|30 Day Follow-up Visit|Subjects that Completed 30-Day Follow-up Visit|280
1004375|NCT00530712|2437907|P1|STARTED|30 Day Follow-up Visit|Subjects Expected for 30-Day Visit|287
1004376|NCT00530712|2437907|P1|NOT COMPLETED|Enrollment||0
1004377|NCT00530712|2437907|P1|COMPLETED|Enrollment|Subjects Available at Discharge|287
1004378|NCT00530712|2437907|P1|STARTED|Enrollment|Total Enrolled Subjects|287
1004379|NCT00530764|2437926|P4|NOT COMPLETED|Overall Study||25
1004380|NCT00530764|2437927|P3|NOT COMPLETED|Overall Study||20
1004381|NCT00530764|2437928|P2|NOT COMPLETED|Overall Study||21
1004382|NCT00530764|2437929|P1|NOT COMPLETED|Overall Study||31
1004383|NCT00530764|2437926|P4|COMPLETED|Overall Study||66
1004384|NCT00530764|2437927|P3|COMPLETED|Overall Study||71
1004385|NCT00530764|2437928|P2|COMPLETED|Overall Study||67
1004386|NCT00530764|2437929|P1|COMPLETED|Overall Study||59
1004387|NCT00530764|2437926|P4|STARTED|Overall Study||91
1004388|NCT00530764|2437927|P3|STARTED|Overall Study||91
1004389|NCT00530764|2437928|P2|STARTED|Overall Study||88
1004390|NCT00530764|2437929|P1|STARTED|Overall Study||90
1004391|NCT00530777|2437973|P2|NOT COMPLETED|Overall Study||5
1004392|NCT00530777|2437974|P1|NOT COMPLETED|Overall Study||7
1004393|NCT00530777|2437973|P2|COMPLETED|Overall Study||69
1004394|NCT00530777|2437974|P1|COMPLETED|Overall Study||67
1004395|NCT00530777|2437973|P2|STARTED|Overall Study||74
1004396|NCT00530777|2437974|P1|STARTED|Overall Study||74
1004397|NCT00530790|2437982|P1|NOT COMPLETED|Overall Study||5
1004398|NCT00530790|2437982|P1|COMPLETED|Overall Study||30
1004399|NCT00530790|2437982|P1|STARTED|Overall Study||35
1004400|NCT00530816|2438005|P3|NOT COMPLETED|Overall Study||41
1004401|NCT00530816|2438006|P2|NOT COMPLETED|Overall Study||42
1004402|NCT00530816|2438007|P1|NOT COMPLETED|Overall Study||26
1004403|NCT00530816|2438005|P3|COMPLETED|Overall Study||29
1004404|NCT00530816|2438006|P2|COMPLETED|Overall Study||17
1004405|NCT00530816|2438007|P1|COMPLETED|Overall Study||9
1004406|NCT00530816|2438005|P3|STARTED|Overall Study||70
1004407|NCT00530816|2438006|P2|STARTED|Overall Study||59
1004408|NCT00530816|2438007|P1|STARTED|Overall Study||35
1004409|NCT00530842|2438035|P2|NOT COMPLETED|Period 2||9
1004410|NCT00530842|2438036|P1|NOT COMPLETED|Period 2||8
1004411|NCT00530842|2438035|P2|COMPLETED|Period 2||151
1004412|NCT00530842|2438036|P1|COMPLETED|Period 2||149
1004413|NCT00530842|2438035|P2|STARTED|Period 2||160
1004414|NCT00530842|2438036|P1|STARTED|Period 2||157
1004415|NCT00530842|2438035|P2|NOT COMPLETED|Period 1||11
1004416|NCT00530842|2438036|P1|NOT COMPLETED|Period 1||14
1004417|NCT00530842|2438035|P2|COMPLETED|Period 1||161
1004418|NCT00530842|2438036|P1|COMPLETED|Period 1||158
1004419|NCT00530842|2438035|P2|STARTED|Period 1||172
1004420|NCT00530842|2438036|P1|STARTED|Period 1||172
1004421|NCT00530842|2438035|P2|NOT COMPLETED|Overall Study||21
1004422|NCT00530842|2438036|P1|NOT COMPLETED|Overall Study||23
1004423|NCT00530842|2438035|P2|COMPLETED|Overall Study||151
1004424|NCT00530842|2438036|P1|COMPLETED|Overall Study||149
1004425|NCT00530842|2438035|P2|STARTED|Overall Study||172
1004426|NCT00530842|2438036|P1|STARTED|Overall Study||172
1004427|NCT00530855|2438160|P1|NOT COMPLETED|Overall Study||112
1004428|NCT00530855|2438160|P1|COMPLETED|Overall Study||210
1004429|NCT00530855|2438160|P1|STARTED|Overall Study||322
1004430|NCT00530894|2438171|P4|NOT COMPLETED|Overall Study||94
1004431|NCT00530894|2438172|P3|NOT COMPLETED|Overall Study||55
1004432|NCT00530894|2438173|P2|NOT COMPLETED|Overall Study||115
1004433|NCT00530894|2438174|P1|NOT COMPLETED|Overall Study||88
1004434|NCT00530894|2438171|P4|COMPLETED|Overall Study||85
1004435|NCT00530894|2438172|P3|COMPLETED|Overall Study||124
1004436|NCT00530894|2438173|P2|COMPLETED|Overall Study||236
1004437|NCT00530894|2438174|P1|COMPLETED|Overall Study||260
1004438|NCT00530894|2438171|P4|STARTED|Overall Study||179
1004439|NCT00530894|2438172|P3|STARTED|Overall Study||179
1004440|NCT00530894|2438173|P2|STARTED|Overall Study||351
1004441|NCT00530894|2438174|P1|STARTED|Overall Study||348
1004442|NCT00530920|2438205|P3|NOT COMPLETED|Overall Study||4
1004443|NCT00530920|2438206|P2|NOT COMPLETED|Overall Study||2
1004444|NCT00530920|2438207|P1|NOT COMPLETED|Overall Study||0
1004445|NCT00530920|2438205|P3|COMPLETED|Overall Study||24
1004446|NCT00530920|2438206|P2|COMPLETED|Overall Study||25
1004447|NCT00530920|2438207|P1|COMPLETED|Overall Study||30
1004448|NCT00530920|2438205|P3|STARTED|Overall Study||28
1004449|NCT00530920|2438206|P2|STARTED|Overall Study||27
1004450|NCT00530920|2438207|P1|STARTED|Overall Study||30
1004451|NCT00530946|2438267|P4|NOT COMPLETED|Overall Study||2
1004452|NCT00530946|2438268|P3|NOT COMPLETED|Overall Study||1
1004453|NCT00530946|2438269|P2|NOT COMPLETED|Overall Study||2
1004454|NCT00530946|2438270|P1|NOT COMPLETED|Overall Study||2
1004455|NCT00530946|2438267|P4|COMPLETED|Overall Study||38
1004456|NCT00530946|2438268|P3|COMPLETED|Overall Study||40
1004457|NCT00530946|2438269|P2|COMPLETED|Overall Study||39
1004458|NCT00530946|2438270|P1|COMPLETED|Overall Study||41
1004459|NCT00530946|2438267|P4|STARTED|Overall Study||40
1004460|NCT00530946|2438268|P3|STARTED|Overall Study||41
1004462|NCT00530946|2438270|P1|STARTED|Overall Study||43
1004463|NCT00531011|2438322|P2|NOT COMPLETED|Overall Study||7
1004464|NCT00531011|2438323|P1|NOT COMPLETED|Overall Study||4
1004465|NCT00531011|2438322|P2|COMPLETED|Overall Study||90
1004466|NCT00531011|2438323|P1|COMPLETED|Overall Study||99
1004467|NCT00531011|2438322|P2|STARTED|Overall Study||97
1004468|NCT00531011|2438323|P1|STARTED|Overall Study||103
1004469|NCT00531050|2438371|P6|NOT COMPLETED|Part 2: Period 3||1
1004470|NCT00531050|2438372|P5|NOT COMPLETED|Part 2: Period 3||0
1004471|NCT00531050|2438373|P4|NOT COMPLETED|Part 2: Period 3||0
1004472|NCT00531050|2438374|P3|NOT COMPLETED|Part 2: Period 3||0
1004473|NCT00531050|2438375|P2|NOT COMPLETED|Part 2: Period 3||0
1004474|NCT00531050|2438376|P1|NOT COMPLETED|Part 2: Period 3||1
1004475|NCT00531050|2438371|P6|COMPLETED|Part 2: Period 3||3
1004476|NCT00531050|2438372|P5|COMPLETED|Part 2: Period 3||4
1004477|NCT00531050|2438373|P4|COMPLETED|Part 2: Period 3||4
1004478|NCT00531050|2438374|P3|COMPLETED|Part 2: Period 3||4
1004479|NCT00531050|2438375|P2|COMPLETED|Part 2: Period 3||4
1004480|NCT00531050|2438376|P1|COMPLETED|Part 2: Period 3||2
1004481|NCT00531050|2438371|P6|STARTED|Part 2: Period 3||4
1004482|NCT00531050|2438372|P5|STARTED|Part 2: Period 3||4
1004483|NCT00531050|2438373|P4|STARTED|Part 2: Period 3||4
1004484|NCT00531050|2438374|P3|STARTED|Part 2: Period 3||4
1004485|NCT00531050|2438375|P2|STARTED|Part 2: Period 3||4
1004486|NCT00531050|2438376|P1|STARTED|Part 2: Period 3||3
1004487|NCT00531050|2438371|P6|NOT COMPLETED|Part 2: Period 2||0
1004488|NCT00531050|2438372|P5|NOT COMPLETED|Part 2: Period 2||0
1004489|NCT00531050|2438373|P4|NOT COMPLETED|Part 2: Period 2||0
1004490|NCT00531050|2438374|P3|NOT COMPLETED|Part 2: Period 2||0
1004491|NCT00531050|2438375|P2|NOT COMPLETED|Part 2: Period 2||0
1004492|NCT00531050|2438376|P1|NOT COMPLETED|Part 2: Period 2||0
1004493|NCT00531050|2438371|P6|COMPLETED|Part 2: Period 2||4
1004494|NCT00531050|2438372|P5|COMPLETED|Part 2: Period 2||4
1004495|NCT00531050|2438373|P4|COMPLETED|Part 2: Period 2||4
1004496|NCT00531050|2438374|P3|COMPLETED|Part 2: Period 2||4
1004497|NCT00531050|2438375|P2|COMPLETED|Part 2: Period 2||4
1004498|NCT00531050|2438376|P1|COMPLETED|Part 2: Period 2||3
1004499|NCT00531050|2438371|P6|STARTED|Part 2: Period 2||4
1004500|NCT00531050|2438372|P5|STARTED|Part 2: Period 2||4
1004501|NCT00531050|2438373|P4|STARTED|Part 2: Period 2||4
1004502|NCT00531050|2438374|P3|STARTED|Part 2: Period 2||4
1004503|NCT00531050|2438375|P2|STARTED|Part 2: Period 2||4
1004504|NCT00531050|2438376|P1|STARTED|Part 2: Period 2||3
1004505|NCT00531050|2438371|P6|NOT COMPLETED|Part 2: Period 1||1
1004506|NCT00531050|2438372|P5|NOT COMPLETED|Part 2: Period 1||0
1004507|NCT00531050|2438373|P4|NOT COMPLETED|Part 2: Period 1||0
1004508|NCT00531050|2438374|P3|NOT COMPLETED|Part 2: Period 1||0
1004509|NCT00531050|2438375|P2|NOT COMPLETED|Part 2: Period 1||0
1004510|NCT00531050|2438376|P1|NOT COMPLETED|Part 2: Period 1||0
1004511|NCT00531050|2438371|P6|COMPLETED|Part 2: Period 1||4
1004512|NCT00531050|2438372|P5|COMPLETED|Part 2: Period 1||4
1004513|NCT00531050|2438373|P4|COMPLETED|Part 2: Period 1||4
1004514|NCT00531050|2438374|P3|COMPLETED|Part 2: Period 1||4
1004515|NCT00531050|2438375|P2|COMPLETED|Part 2: Period 1||4
1004516|NCT00531050|2438376|P1|COMPLETED|Part 2: Period 1||3
1004517|NCT00531050|2438371|P6|STARTED|Part 2: Period 1||5
1004518|NCT00531050|2438372|P5|STARTED|Part 2: Period 1||4
1004519|NCT00531050|2438373|P4|STARTED|Part 2: Period 1||4
1004520|NCT00531050|2438374|P3|STARTED|Part 2: Period 1||4
1004521|NCT00531050|2438375|P2|STARTED|Part 2: Period 1||4
1004522|NCT00531050|2438376|P1|STARTED|Part 2: Period 1||3
1004523|NCT00531050|2438371|P6|NOT COMPLETED|Part 1: Period 3||0
1004524|NCT00531050|2438372|P5|NOT COMPLETED|Part 1: Period 3||0
1004525|NCT00531050|2438373|P4|NOT COMPLETED|Part 1: Period 3||0
1004526|NCT00531050|2438374|P3|NOT COMPLETED|Part 1: Period 3||0
1004527|NCT00531050|2438375|P2|NOT COMPLETED|Part 1: Period 3||0
1004528|NCT00531050|2438376|P1|NOT COMPLETED|Part 1: Period 3||1
1004529|NCT00531050|2438371|P6|COMPLETED|Part 1: Period 3||5
1004530|NCT00531050|2438372|P5|COMPLETED|Part 1: Period 3||4
1004531|NCT00531050|2438373|P4|COMPLETED|Part 1: Period 3||4
1004532|NCT00531050|2438374|P3|COMPLETED|Part 1: Period 3||4
1004533|NCT00531050|2438375|P2|COMPLETED|Part 1: Period 3||4
1004534|NCT00531050|2438376|P1|COMPLETED|Part 1: Period 3||3
1004535|NCT00531050|2438371|P6|STARTED|Part 1: Period 3||5
1004536|NCT00531050|2438372|P5|STARTED|Part 1: Period 3||4
1004537|NCT00531050|2438373|P4|STARTED|Part 1: Period 3||4
1004538|NCT00531050|2438374|P3|STARTED|Part 1: Period 3||4
1004539|NCT00531050|2438375|P2|STARTED|Part 1: Period 3||4
1004540|NCT00531050|2438376|P1|STARTED|Part 1: Period 3||4
1004541|NCT00531050|2438371|P6|NOT COMPLETED|Part 1: Period 2||0
1004542|NCT00531050|2438372|P5|NOT COMPLETED|Part 1: Period 2||0
1004543|NCT00531050|2438373|P4|NOT COMPLETED|Part 1: Period 2||0
1004544|NCT00531050|2438374|P3|NOT COMPLETED|Part 1: Period 2||0
1004545|NCT00531050|2438375|P2|NOT COMPLETED|Part 1: Period 2||0
1004546|NCT00531050|2438376|P1|NOT COMPLETED|Part 1: Period 2||0
1004547|NCT00531050|2438371|P6|COMPLETED|Part 1: Period 2||5
1004548|NCT00531050|2438372|P5|COMPLETED|Part 1: Period 2||4
1004549|NCT00531050|2438373|P4|COMPLETED|Part 1: Period 2||4
1004550|NCT00531050|2438374|P3|COMPLETED|Part 1: Period 2||4
1004551|NCT00531050|2438375|P2|COMPLETED|Part 1: Period 2||4
1004552|NCT00531050|2438376|P1|COMPLETED|Part 1: Period 2||4
1004553|NCT00531050|2438371|P6|STARTED|Part 1: Period 2||5
1004554|NCT00531050|2438372|P5|STARTED|Part 1: Period 2||4
1004555|NCT00531050|2438373|P4|STARTED|Part 1: Period 2||4
1004556|NCT00531050|2438374|P3|STARTED|Part 1: Period 2||4
1004557|NCT00531050|2438375|P2|STARTED|Part 1: Period 2||4
1004558|NCT00531050|2438376|P1|STARTED|Part 1: Period 2||4
1004559|NCT00531050|2438371|P6|NOT COMPLETED|Part 1: Period 1||0
1004560|NCT00531050|2438372|P5|NOT COMPLETED|Part 1: Period 1||0
1004561|NCT00531050|2438373|P4|NOT COMPLETED|Part 1: Period 1||1
1004562|NCT00531050|2438374|P3|NOT COMPLETED|Part 1: Period 1||0
1004563|NCT00531050|2438375|P2|NOT COMPLETED|Part 1: Period 1||1
1004564|NCT00531050|2438376|P1|NOT COMPLETED|Part 1: Period 1||0
1004565|NCT00531050|2438371|P6|COMPLETED|Part 1: Period 1||5
1004566|NCT00531050|2438372|P5|COMPLETED|Part 1: Period 1||4
1004567|NCT00531050|2438373|P4|COMPLETED|Part 1: Period 1||4
1004568|NCT00531050|2438374|P3|COMPLETED|Part 1: Period 1||4
1004569|NCT00531050|2438375|P2|COMPLETED|Part 1: Period 1||4
1004570|NCT00531050|2438376|P1|COMPLETED|Part 1: Period 1||4
1004571|NCT00531050|2438371|P6|STARTED|Part 1: Period 1||5
1004572|NCT00531050|2438372|P5|STARTED|Part 1: Period 1||4
1004573|NCT00531050|2438373|P4|STARTED|Part 1: Period 1||5
1004574|NCT00531050|2438374|P3|STARTED|Part 1: Period 1||4
1004575|NCT00531050|2438375|P2|STARTED|Part 1: Period 1||5
1004576|NCT00531050|2438376|P1|STARTED|Part 1: Period 1||4
1004577|NCT00531206|2438403|P1|NOT COMPLETED|Overall Study||20
1004578|NCT00531206|2438403|P1|COMPLETED|Overall Study||45
1004579|NCT00531206|2438403|P1|STARTED|Overall Study||65
1004580|NCT00531284|2438444|P17|NOT COMPLETED|Overall Study||8
1004581|NCT00531284|2438445|P16|NOT COMPLETED|Overall Study||12
1004582|NCT00531284|2438446|P15|NOT COMPLETED|Overall Study||4
1004583|NCT00531284|2438447|P14|NOT COMPLETED|Overall Study||3
1004584|NCT00531284|2438448|P13|NOT COMPLETED|Overall Study||2
1004585|NCT00531284|2438449|P12|NOT COMPLETED|Overall Study||24
1004586|NCT00531284|2438450|P11|NOT COMPLETED|Overall Study||3
1004587|NCT00531284|2438451|P10|NOT COMPLETED|Overall Study||4
1004588|NCT00531284|2438452|P9|NOT COMPLETED|Overall Study||11
1004589|NCT00531284|2438453|P8|NOT COMPLETED|Overall Study||10
1004590|NCT00531284|2438454|P7|NOT COMPLETED|Overall Study||6
1004591|NCT00531284|2438455|P6|NOT COMPLETED|Overall Study||7
1004592|NCT00531284|2438456|P5|NOT COMPLETED|Overall Study||6
1004593|NCT00531284|2438457|P4|NOT COMPLETED|Overall Study||63
1004594|NCT00531284|2438458|P3|NOT COMPLETED|Overall Study||6
1004595|NCT00531284|2438459|P2|NOT COMPLETED|Overall Study||4
1004596|NCT00531284|2438460|P1|NOT COMPLETED|Overall Study||3
1004597|NCT00531284|2438444|P17|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
1004598|NCT00531284|2438445|P16|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|2
1004599|NCT00531284|2438446|P15|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|3
1004600|NCT00531284|2438447|P14|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
1004601|NCT00531284|2438448|P13|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
1004602|NCT00531284|2438449|P12|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
1004603|NCT00531284|2438450|P11|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
1004604|NCT00531284|2438451|P10|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
1004605|NCT00531284|2438452|P9|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
1004606|NCT00531284|2438453|P8|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
1004607|NCT00531284|2438454|P7|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
1004608|NCT00531284|2438455|P6|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
1004609|NCT00531284|2438456|P5|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
1004610|NCT00531284|2438457|P4|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|2
1004611|NCT00531284|2438458|P3|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|1
1004612|NCT00531284|2438459|P2|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
1004613|NCT00531284|2438460|P1|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
1004614|NCT00531284|2438444|P17|STARTED|Overall Study||8
1004615|NCT00531284|2438445|P16|STARTED|Overall Study||14
1004616|NCT00531284|2438446|P15|STARTED|Overall Study||7
1004617|NCT00531284|2438447|P14|STARTED|Overall Study||3
1004618|NCT00531284|2438448|P13|STARTED|Overall Study||2
1004619|NCT00531284|2438449|P12|STARTED|Overall Study||24
1004620|NCT00531284|2438450|P11|STARTED|Overall Study||3
1004621|NCT00531284|2438451|P10|STARTED|Overall Study||4
1004622|NCT00531284|2438452|P9|STARTED|Overall Study||11
1004623|NCT00531284|2438453|P8|STARTED|Overall Study||10
1004624|NCT00531284|2438454|P7|STARTED|Overall Study||6
1004625|NCT00531284|2438455|P6|STARTED|Overall Study||7
1004626|NCT00531284|2438456|P5|STARTED|Overall Study||6
1004627|NCT00531284|2438457|P4|STARTED|Overall Study||65
1004628|NCT00531284|2438458|P3|STARTED|Overall Study||7
1004629|NCT00531284|2438459|P2|STARTED|Overall Study||4
1004630|NCT00531284|2438460|P1|STARTED|Overall Study||3
1004631|NCT00531427|2438612|P2|NOT COMPLETED|Overall Study||94
1004632|NCT00531427|2438613|P1|NOT COMPLETED|Overall Study||73
1004633|NCT00531427|2438612|P2|COMPLETED|Overall Study||191
1004634|NCT00531427|2438613|P1|COMPLETED|Overall Study||209
1004635|NCT00531427|2438612|P2|STARTED|Overall Study||285
1004636|NCT00531427|2438613|P1|STARTED|Overall Study||282
1004637|NCT00524134|2438624|P1|NOT COMPLETED|Overall Study||2
1004638|NCT00524134|2438624|P1|COMPLETED|Overall Study||4
1004639|NCT00524134|2438624|P1|STARTED|Overall Study||6
1004640|NCT00524225|2438631|P1|NOT COMPLETED|Overall Study||0
1004641|NCT00524225|2438631|P1|COMPLETED|Overall Study||3
1004642|NCT00524225|2438631|P1|STARTED|Overall Study||3
1004643|NCT00524264|2438638|P2|NOT COMPLETED|Overall Study||27
1004644|NCT00524264|2438639|P1|NOT COMPLETED|Overall Study||20
1004645|NCT00524264|2438638|P2|COMPLETED|Overall Study||57
1004646|NCT00524264|2438639|P1|COMPLETED|Overall Study||144
1004647|NCT00524264|2438638|P2|STARTED|Overall Study||84
1004648|NCT00524264|2438639|P1|STARTED|Overall Study||164
1004649|NCT00524303|2438654|P3|NOT COMPLETED|Overall Study||18
1004650|NCT00524303|2438655|P2|NOT COMPLETED|Overall Study||10
1004651|NCT00524303|2438656|P1|NOT COMPLETED|Overall Study||12
1004652|NCT00524303|2438654|P3|COMPLETED|Overall Study||15
1004653|NCT00524303|2438655|P2|COMPLETED|Overall Study||24
1004654|NCT00524303|2438656|P1|COMPLETED|Overall Study||21
1004655|NCT00524303|2438654|P3|STARTED|Overall Study||33
1004656|NCT00524303|2438655|P2|STARTED|Overall Study||34
1004657|NCT00524303|2438656|P1|STARTED|Overall Study||33
1004658|NCT00524316|2438684|P1|NOT COMPLETED|Overall Study||16
1004659|NCT00524316|2438684|P1|COMPLETED|Overall Study||0
1004660|NCT00524316|2438684|P1|STARTED|Overall Study||16
1004661|NCT00524342|2438693|P1|NOT COMPLETED|Overall Study||0
1004662|NCT00524342|2438693|P1|COMPLETED|Overall Study||7
1004663|NCT00524342|2438693|P1|STARTED|Overall Study||7
1004664|NCT00524368|2438700|P2|NOT COMPLETED|Overall Study||48
1004665|NCT00524368|2438701|P1|NOT COMPLETED|Overall Study||41
1004666|NCT00524368|2438700|P2|COMPLETED|Overall Study||248
1004667|NCT00524368|2438701|P1|COMPLETED|Overall Study||253
1004668|NCT00524368|2438700|P2|STARTED|Overall Study||296
1004669|NCT00524368|2438701|P1|STARTED|Overall Study||294
1004670|NCT00524394|2438729|P1|NOT COMPLETED|Overall Study||1
1004671|NCT00524394|2438729|P1|COMPLETED|Overall Study||1
1004672|NCT00524394|2438729|P1|STARTED|Overall Study||2
1004673|NCT00524420|2438735|P2|NOT COMPLETED|Overall Study||0
1004674|NCT00524420|2438736|P1|NOT COMPLETED|Overall Study||1
1004675|NCT00524420|2438735|P2|COMPLETED|Overall Study||11
1004676|NCT00524420|2438736|P1|COMPLETED|Overall Study|1 dropped out after treatment 10 because of poor response and was included in the efficacy analyses.|7
1004677|NCT00524420|2438735|P2|STARTED|Overall Study||11
1004678|NCT00524420|2438736|P1|STARTED|Overall Study|One was incorrectly randomized;she did not have a BIRS of >7. Was excluded from efficacy analysis.|8
1004679|NCT00524459|2438748|P1|NOT COMPLETED|Overall Study||2
1004680|NCT00524459|2438748|P1|COMPLETED|Overall Study||4
1004681|NCT00524459|2438748|P1|STARTED|Overall Study||6
1004682|NCT00524485|2438756|P1|NOT COMPLETED|Overall Study||5
1004683|NCT00524485|2438756|P1|COMPLETED|Overall Study||7
1004684|NCT00524485|2438756|P1|STARTED|Overall Study||12
1004685|NCT00524511|2438768|P2|NOT COMPLETED|Overall Study||7
1004686|NCT00524511|2438769|P1|NOT COMPLETED|Overall Study||4
1004687|NCT00524511|2438768|P2|COMPLETED|Overall Study||61
1004688|NCT00524511|2438769|P1|COMPLETED|Overall Study||64
1004689|NCT00524511|2438768|P2|STARTED|Overall Study||68
1004690|NCT00524511|2438769|P1|STARTED|Overall Study||68
1004691|NCT00524537|2438777|P1|NOT COMPLETED|Overall Study||2574
1004692|NCT00524537|2438777|P1|COMPLETED|Overall Study|Still enrolled in study at the end of study|2451
1004693|NCT00524537|2438777|P1|Discontinued After Re-enrollment|Overall Study|Discontinued from study after re-enrollment|102
1004694|NCT00524537|2438777|P1|Re-enrolled|Overall Study|Discontinued from study and later re-enrolled in study|339
1004695|NCT00524537|2438777|P1|Discontinued|Overall Study|Discontinued from study|2811
1004696|NCT00524537|2438777|P1|STARTED|Overall Study|All Treated Population: All participants who received at least 1 injection of Humira in the registry|5025
1004697|NCT00524576|2438793|P2|NOT COMPLETED|Overall Study||0
1004698|NCT00524576|2438794|P1|NOT COMPLETED|Overall Study||0
1004699|NCT00524576|2438793|P2|COMPLETED|Overall Study||47
1004700|NCT00524576|2438794|P1|COMPLETED|Overall Study||97
1004701|NCT00524576|2438793|P2|STARTED|Overall Study||47
1004702|NCT00524576|2438794|P1|STARTED|Overall Study||97
1004706|NCT00524680|2438820|P4|NOT COMPLETED|Overall Study||6
1004707|NCT00524680|2438821|P3|NOT COMPLETED|Overall Study||3
1004708|NCT00524680|2438822|P2|NOT COMPLETED|Overall Study||1
1004709|NCT00524680|2438823|P1|NOT COMPLETED|Overall Study||3
1004710|NCT00524680|2438820|P4|COMPLETED|Overall Study||34
1004711|NCT00524680|2438821|P3|COMPLETED|Overall Study||33
1004712|NCT00524680|2438822|P2|COMPLETED|Overall Study||34
1004713|NCT00524680|2438823|P1|COMPLETED|Overall Study||34
1004714|NCT00524680|2438820|P4|STARTED|Overall Study||40
1004715|NCT00524680|2438821|P3|STARTED|Overall Study||36
1004716|NCT00524680|2438822|P2|STARTED|Overall Study||35
1004717|NCT00524680|2438823|P1|STARTED|Overall Study||37
1004718|NCT00524745|2438849|P4|NOT COMPLETED|Overall Study||22
1004719|NCT00524745|2438850|P3|NOT COMPLETED|Overall Study||29
1004720|NCT00524745|2438851|P2|NOT COMPLETED|Overall Study||13
1004721|NCT00524745|2438852|P1|NOT COMPLETED|Overall Study||34
1004722|NCT00524745|2438849|P4|COMPLETED|Overall Study||205
1004723|NCT00524745|2438850|P3|COMPLETED|Overall Study||212
1004724|NCT00524745|2438851|P2|COMPLETED|Overall Study||193
1004725|NCT00524745|2438852|P1|COMPLETED|Overall Study||195
1004726|NCT00524745|2438849|P4|STARTED|Overall Study||227
1004727|NCT00524745|2438850|P3|STARTED|Overall Study||241
1004728|NCT00524745|2438851|P2|STARTED|Overall Study||206
1004729|NCT00524745|2438852|P1|STARTED|Overall Study||229
1004730|NCT00524771|2438876|P2|NOT COMPLETED|Overall Study||585
1004731|NCT00524771|2438877|P1|NOT COMPLETED|Overall Study||220
1004732|NCT00524771|2438876|P2|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16431
1004733|NCT00524771|2438877|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16864
1004734|NCT00524771|2438876|P2|STARTED|Overall Study||17016
1004735|NCT00524771|2438877|P1|STARTED|Overall Study||17084
1004736|NCT00524940|2438887|P1|NOT COMPLETED|Overall Study||0
1004737|NCT00524940|2438887|P1|COMPLETED|Overall Study||124
1004738|NCT00524940|2438887|P1|STARTED|Overall Study||124
1004739|NCT00525031|2438894|P2|NOT COMPLETED|Overall Study||1
1004740|NCT00525031|2438895|P1|NOT COMPLETED|Overall Study||1
1004741|NCT00525031|2438894|P2|COMPLETED|Overall Study||24
1004742|NCT00525031|2438895|P1|COMPLETED|Overall Study||26
1004743|NCT00525031|2438894|P2|STARTED|Overall Study||25
1004744|NCT00525031|2438895|P1|STARTED|Overall Study||27
1004745|NCT00525135|2438902|P1|NOT COMPLETED|Overall Study||0
1004746|NCT00525135|2438902|P1|COMPLETED|Overall Study||5
1004747|NCT00525135|2438902|P1|STARTED|Overall Study||5
1004748|NCT00525148|2438914|P4|NOT COMPLETED|Overall Study||61
1004749|NCT00525148|2438915|P3|NOT COMPLETED|Overall Study||7
1004750|NCT00525148|2438916|P2|NOT COMPLETED|Overall Study||38
1004751|NCT00525148|2438917|P1|NOT COMPLETED|Overall Study||23
1004752|NCT00525148|2438914|P4|COMPLETED|Overall Study||0
1004753|NCT00525148|2438915|P3|COMPLETED|Overall Study||0
1004754|NCT00525148|2438916|P2|COMPLETED|Overall Study||0
1004755|NCT00525148|2438917|P1|COMPLETED|Overall Study||0
1004756|NCT00525148|2438914|P4|STARTED|Overall Study|entered and treated|61
1004757|NCT00525148|2438915|P3|STARTED|Overall Study|entered and treated|7
1004758|NCT00525148|2438916|P2|STARTED|Overall Study|entered and treated|38
1004759|NCT00525148|2438917|P1|STARTED|Overall Study|entered and treated|23
1004760|NCT00525161|2438935|P1|NOT COMPLETED|Overall Study||1
1004761|NCT00525161|2438935|P1|COMPLETED|Overall Study||10
1004762|NCT00525161|2438935|P1|STARTED|Overall Study||11
1004763|NCT00525174|2438943|P2|NOT COMPLETED|Overall Study||8
1004764|NCT00525174|2438944|P1|NOT COMPLETED|Overall Study||9
1004765|NCT00525174|2438943|P2|COMPLETED|Overall Study||81
1004766|NCT00525174|2438944|P1|COMPLETED|Overall Study||88
1004767|NCT00525174|2438943|P2|STARTED|Overall Study||89
1004768|NCT00525174|2438944|P1|STARTED|Overall Study||97
1004769|NCT00525265|2438994|P2|NOT COMPLETED|Overall Study||0
1004770|NCT00525265|2438995|P1|NOT COMPLETED|Overall Study||1
1004771|NCT00525265|2438994|P2|COMPLETED|Overall Study||10
1004772|NCT00525265|2438995|P1|COMPLETED|Overall Study||9
1004773|NCT00525265|2438994|P2|STARTED|Overall Study||10
1004774|NCT00525265|2438995|P1|STARTED|Overall Study||10
1004775|NCT00525421|2439003|P2|NOT COMPLETED|Overall Study||0
1004776|NCT00525421|2439004|P1|NOT COMPLETED|Overall Study||0
1004777|NCT00525421|2439003|P2|COMPLETED|Overall Study||10
1004778|NCT00525421|2439004|P1|COMPLETED|Overall Study||10
1004779|NCT00525421|2439003|P2|STARTED|Overall Study||10
1004780|NCT00525421|2439004|P1|STARTED|Overall Study|Enrollment started october 2007|10
1004781|NCT00525499|2439016|P4|NOT COMPLETED|Overall Study||7
1004782|NCT00525499|2439017|P3|NOT COMPLETED|Overall Study||7
1004783|NCT00525499|2439018|P2|NOT COMPLETED|Overall Study||7
1004784|NCT00525499|2439019|P1|NOT COMPLETED|Overall Study||7
1004785|NCT00525499|2439016|P4|COMPLETED|Overall Study||39
1004786|NCT00525499|2439017|P3|COMPLETED|Overall Study||40
1004787|NCT00525499|2439018|P2|COMPLETED|Overall Study||39
1004788|NCT00525499|2439019|P1|COMPLETED|Overall Study||40
1004789|NCT00525499|2439016|P4|STARTED|Overall Study||46
1004790|NCT00525499|2439017|P3|STARTED|Overall Study||47
1004791|NCT00525499|2439018|P2|STARTED|Overall Study||46
1004792|NCT00525499|2439019|P1|STARTED|Overall Study||47
1004793|NCT00525512|2439035|P4|NOT COMPLETED|Open-Label Phase||5
1004794|NCT00525512|2439036|P3|NOT COMPLETED|Open-Label Phase||6
1004795|NCT00525512|2439037|P2|NOT COMPLETED|Open-Label Phase||0
1004796|NCT00525512|2439038|P1|NOT COMPLETED|Open-Label Phase||0
1004797|NCT00525512|2439035|P4|COMPLETED|Open-Label Phase||189
1004798|NCT00525512|2439036|P3|COMPLETED|Open-Label Phase||158
1004799|NCT00525512|2439037|P2|COMPLETED|Open-Label Phase||0
1004800|NCT00525512|2439038|P1|COMPLETED|Open-Label Phase||0
1004801|NCT00525512|2439035|P4|STARTED|Open-Label Phase||194
1004802|NCT00525512|2439036|P3|STARTED|Open-Label Phase||164
1004803|NCT00525512|2439037|P2|STARTED|Open-Label Phase||0
1004804|NCT00525512|2439038|P1|STARTED|Open-Label Phase||0
1004805|NCT00525512|2439035|P4|NOT COMPLETED|Double-Blind Phase||0
1004806|NCT00525512|2439036|P3|NOT COMPLETED|Double-Blind Phase||0
1004807|NCT00525512|2439037|P2|NOT COMPLETED|Double-Blind Phase||66
1004808|NCT00525512|2439038|P1|NOT COMPLETED|Double-Blind Phase||96
1004809|NCT00525512|2439035|P4|COMPLETED|Double-Blind Phase||0
1004810|NCT00525512|2439036|P3|COMPLETED|Double-Blind Phase||0
1004811|NCT00525512|2439037|P2|COMPLETED|Double-Blind Phase||194
1004812|NCT00525512|2439038|P1|COMPLETED|Double-Blind Phase||163
1004813|NCT00525512|2439035|P4|STARTED|Double-Blind Phase||0
1004814|NCT00525512|2439036|P3|STARTED|Double-Blind Phase||0
1004815|NCT00525512|2439037|P2|STARTED|Double-Blind Phase||260
1004816|NCT00525512|2439038|P1|STARTED|Double-Blind Phase||259
1004817|NCT00531453|2439178|P2|NOT COMPLETED|Overall Study||0
1004818|NCT00531453|2439179|P1|NOT COMPLETED|Overall Study||0
1004819|NCT00531453|2439178|P2|COMPLETED|Overall Study|10 April 2009|49
1004820|NCT00531453|2439179|P1|COMPLETED|Overall Study|10 April 2009|49
1004821|NCT00531453|2439178|P2|STARTED|Overall Study|02 October 2007|49
1004822|NCT00531453|2439179|P1|STARTED|Overall Study|02 October 2007|49
1004823|NCT00531479|2439189|P2|NOT COMPLETED|Overall Study||83
1004824|NCT00531479|2439190|P1|NOT COMPLETED|Overall Study||76
1004825|NCT00531479|2439189|P2|COMPLETED|Overall Study||146
1004826|NCT00531479|2439190|P1|COMPLETED|Overall Study||154
1004827|NCT00531479|2439189|P2|Treated|Overall Study||226
1004828|NCT00531479|2439190|P1|Treated|Overall Study||228
1004829|NCT00531479|2439189|P2|STARTED|Overall Study||229
1004830|NCT00531479|2439190|P1|STARTED|Overall Study||230
1004831|NCT00531518|2439210|P2|NOT COMPLETED|Overall Study||71
1004832|NCT00531518|2439211|P1|NOT COMPLETED|Overall Study||32
1004833|NCT00531518|2439210|P2|COMPLETED|Overall Study||134
1004834|NCT00531518|2439211|P1|COMPLETED|Overall Study||55
1004835|NCT00531518|2439210|P2|STARTED|Overall Study||205
1004836|NCT00531518|2439211|P1|STARTED|Overall Study||87
1004837|NCT00531661|2439219|P2|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||57
1004838|NCT00531661|2439220|P1|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||58
1004839|NCT00531661|2439219|P2|COMPLETED|Study Duration: 15 Months Avg. Follow-up||197
1004840|NCT00531661|2439220|P1|COMPLETED|Study Duration: 15 Months Avg. Follow-up||186
1004841|NCT00531661|2439219|P2|STARTED|Study Duration: 15 Months Avg. Follow-up||254
1004842|NCT00531661|2439220|P1|STARTED|Study Duration: 15 Months Avg. Follow-up||244
1004843|NCT00531661|2439219|P2|NOT COMPLETED|6 Months||26
1004844|NCT00531661|2439220|P1|NOT COMPLETED|6 Months||26
1004845|NCT00531661|2439219|P2|COMPLETED|6 Months||254
1004846|NCT00531661|2439220|P1|COMPLETED|6 Months||244
1004847|NCT00531661|2439219|P2|STARTED|6 Months||280
1004848|NCT00531661|2439220|P1|STARTED|6 Months||270
1004849|NCT00531752|2439244|P4|NOT COMPLETED|Second Double-blind Intervention Period||2
1004850|NCT00531752|2439245|P3|NOT COMPLETED|Second Double-blind Intervention Period||0
1004851|NCT00531752|2439246|P2|NOT COMPLETED|Second Double-blind Intervention Period||2
1004852|NCT00531752|2439247|P1|NOT COMPLETED|Second Double-blind Intervention Period||2
1004853|NCT00531752|2439244|P4|COMPLETED|Second Double-blind Intervention Period||11
1004854|NCT00531752|2439245|P3|COMPLETED|Second Double-blind Intervention Period||9
1004855|NCT00531752|2439246|P2|COMPLETED|Second Double-blind Intervention Period||11
1004856|NCT00531752|2439247|P1|COMPLETED|Second Double-blind Intervention Period||9
1004857|NCT00531752|2439244|P4|STARTED|Second Double-blind Intervention Period||13
1004858|NCT00531752|2439245|P3|STARTED|Second Double-blind Intervention Period||9
1004859|NCT00531752|2439246|P2|STARTED|Second Double-blind Intervention Period||13
1004860|NCT00531752|2439247|P1|STARTED|Second Double-blind Intervention Period||11
1004861|NCT00531752|2439244|P4|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
1004862|NCT00531752|2439245|P3|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
1004863|NCT00531752|2439246|P2|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
1004864|NCT00531752|2439247|P1|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
1004865|NCT00531752|2439244|P4|COMPLETED|Wash-out Period (at Least 7 Days)||13
1004866|NCT00531752|2439245|P3|COMPLETED|Wash-out Period (at Least 7 Days)||9
1004867|NCT00531752|2439246|P2|COMPLETED|Wash-out Period (at Least 7 Days)||13
1004868|NCT00531752|2439247|P1|COMPLETED|Wash-out Period (at Least 7 Days)||11
1004869|NCT00531752|2439244|P4|STARTED|Wash-out Period (at Least 7 Days)||13
1004870|NCT00531752|2439245|P3|STARTED|Wash-out Period (at Least 7 Days)||9
1004871|NCT00531752|2439246|P2|STARTED|Wash-out Period (at Least 7 Days)||13
1004872|NCT00531752|2439247|P1|STARTED|Wash-out Period (at Least 7 Days)||11
1004873|NCT00531752|2439244|P4|NOT COMPLETED|First Double-blind Intervention Period||3
1004874|NCT00531752|2439245|P3|NOT COMPLETED|First Double-blind Intervention Period||7
1004875|NCT00531752|2439246|P2|NOT COMPLETED|First Double-blind Intervention Period||4
1004876|NCT00531752|2439247|P1|NOT COMPLETED|First Double-blind Intervention Period||6
1004877|NCT00531752|2439244|P4|COMPLETED|First Double-blind Intervention Period||13
1004878|NCT00531752|2439245|P3|COMPLETED|First Double-blind Intervention Period||9
1004879|NCT00531752|2439246|P2|COMPLETED|First Double-blind Intervention Period||13
1004880|NCT00531752|2439247|P1|COMPLETED|First Double-blind Intervention Period||11
1004881|NCT00531752|2439244|P4|Treated|First Double-blind Intervention Period||16
1004882|NCT00531752|2439245|P3|Treated|First Double-blind Intervention Period||16
1004883|NCT00531752|2439246|P2|Treated|First Double-blind Intervention Period||17
1004884|NCT00531752|2439247|P1|Treated|First Double-blind Intervention Period||16
1004885|NCT00531752|2439244|P4|STARTED|First Double-blind Intervention Period||16
1004886|NCT00531752|2439245|P3|STARTED|First Double-blind Intervention Period||16
1004887|NCT00531752|2439246|P2|STARTED|First Double-blind Intervention Period||17
1004888|NCT00531752|2439247|P1|STARTED|First Double-blind Intervention Period||17
1004889|NCT00532129|2439324|P1|NOT COMPLETED|Follow-up Period||65
1004890|NCT00532129|2439324|P1|COMPLETED|Follow-up Period||33
1004891|NCT00532129|2439324|P1|STARTED|Follow-up Period||98
1004892|NCT00532129|2439324|P1|NOT COMPLETED|Treatment Period||49
1004893|NCT00532129|2439324|P1|COMPLETED|Treatment Period||51
1004894|NCT00532129|2439324|P1|STARTED|Treatment Period||100
1004895|NCT00532155|2439344|P2|NOT COMPLETED|Overall Study||456
1004896|NCT00532155|2439345|P1|NOT COMPLETED|Overall Study||457
1004897|NCT00532155|2439344|P2|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
1004898|NCT00532155|2439345|P1|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
1004899|NCT00532155|2439344|P2|SAFETY POPULATION|Overall Study||450
1004900|NCT00532155|2439345|P1|SAFETY POPULATION|Overall Study||455
1004901|NCT00532155|2439344|P2|STARTED|Overall Study||456
1004902|NCT00532155|2439345|P1|STARTED|Overall Study||457
1004903|NCT00532259|2439359|P1|NOT COMPLETED|Overall Study||32
1004904|NCT00532259|2439359|P1|COMPLETED|Overall Study||40
1004905|NCT00532259|2439359|P1|STARTED|Overall Study||72
1004906|NCT00532298|2439370|P6|NOT COMPLETED|Overall Study||2
1004907|NCT00532298|2439371|P5|NOT COMPLETED|Overall Study||1
1004908|NCT00532298|2439372|P4|NOT COMPLETED|Overall Study||0
1004909|NCT00532298|2439373|P3|NOT COMPLETED|Overall Study||1
1004910|NCT00532298|2439374|P2|NOT COMPLETED|Overall Study||1
1004911|NCT00532298|2439375|P1|NOT COMPLETED|Overall Study||2
1004912|NCT00532298|2439370|P6|COMPLETED|Overall Study||261
1004913|NCT00532298|2439371|P5|COMPLETED|Overall Study||267
1004914|NCT00532298|2439372|P4|COMPLETED|Overall Study||264
1004915|NCT00532298|2439373|P3|COMPLETED|Overall Study||263
1004916|NCT00532298|2439374|P2|COMPLETED|Overall Study||265
1004917|NCT00532298|2439375|P1|COMPLETED|Overall Study||267
1004918|NCT00532298|2439370|P6|STARTED|Overall Study||263
1004919|NCT00532298|2439371|P5|STARTED|Overall Study||268
1004920|NCT00532298|2439372|P4|STARTED|Overall Study||264
1004921|NCT00532298|2439373|P3|STARTED|Overall Study||264
1004922|NCT00532298|2439374|P2|STARTED|Overall Study||266
1004923|NCT00532298|2439375|P1|STARTED|Overall Study||269
1004924|NCT00532441|2439455|P2|NOT COMPLETED|Overall Study||0
1004925|NCT00532441|2439456|P1|NOT COMPLETED|Overall Study||1
1004926|NCT00532441|2439455|P2|COMPLETED|Overall Study||11
1004927|NCT00532441|2439456|P1|COMPLETED|Overall Study||13
1004928|NCT00532441|2439455|P2|STARTED|Overall Study||11
1004929|NCT00532441|2439456|P1|STARTED|Overall Study||14
1004930|NCT00532480|2439465|P1|NOT COMPLETED|Overall Study||3
1004931|NCT00532480|2439465|P1|COMPLETED|Overall Study||7
1004932|NCT00532480|2439465|P1|STARTED|Overall Study||10
1004933|NCT00532493|2439471|P2|NOT COMPLETED|Overall Study||29
1004934|NCT00532493|2439472|P1|NOT COMPLETED|Overall Study||30
1004935|NCT00532493|2439471|P2|COMPLETED|Overall Study||123
1004936|NCT00532493|2439472|P1|COMPLETED|Overall Study||122
1004937|NCT00532493|2439471|P2|STARTED|Overall Study||152
1004938|NCT00532493|2439472|P1|STARTED|Overall Study||152
1004939|NCT00532779|2439505|P3|NOT COMPLETED|Overall Study||291
1004940|NCT00532779|2439506|P2|NOT COMPLETED|Overall Study||287
1004941|NCT00532779|2439507|P1|NOT COMPLETED|Overall Study||294
1004942|NCT00532779|2439505|P3|COMPLETED|Overall Study||290
1004943|NCT00532779|2439506|P2|COMPLETED|Overall Study||296
1004944|NCT00532779|2439507|P1|COMPLETED|Overall Study||284
1004945|NCT00532779|2439505|P3|STARTED|Overall Study||581
1004946|NCT00532779|2439506|P2|STARTED|Overall Study||583
1004947|NCT00532779|2439507|P1|STARTED|Overall Study||578
1004948|NCT00532883|2439570|P4|NOT COMPLETED|Overall Study||5
1004949|NCT00532883|2439571|P3|NOT COMPLETED|Overall Study||4
1004950|NCT00532883|2439572|P2|NOT COMPLETED|Overall Study||7
1004951|NCT00532883|2439573|P1|NOT COMPLETED|Overall Study||6
1004952|NCT00532883|2439570|P4|COMPLETED|Overall Study|Study terminated early.|6
1004953|NCT00532883|2439571|P3|COMPLETED|Overall Study|Study terminated early.|6
1004954|NCT00532883|2439572|P2|COMPLETED|Overall Study|Study terminated early.|5
1004955|NCT00532883|2439573|P1|COMPLETED|Overall Study|Study terminated early.|5
1004956|NCT00532883|2439570|P4|STARTED|Overall Study||11
1004957|NCT00532883|2439571|P3|STARTED|Overall Study||10
1004958|NCT00532883|2439572|P2|STARTED|Overall Study||12
1004959|NCT00532883|2439573|P1|STARTED|Overall Study||11
1004960|NCT00532935|2439585|P2|NOT COMPLETED|Overall Study||52
1004961|NCT00532935|2439586|P1|NOT COMPLETED|Overall Study||51
1004962|NCT00532935|2439585|P2|COMPLETED|Overall Study||204
1004963|NCT00532935|2439586|P1|COMPLETED|Overall Study||210
1004964|NCT00532935|2439585|P2|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|256
1004965|NCT00532935|2439586|P1|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|261
1004966|NCT00532948|2439603|P3|NOT COMPLETED|Overall Study||4
1004967|NCT00532948|2439604|P2|NOT COMPLETED|Overall Study||5
1004968|NCT00532948|2439605|P1|NOT COMPLETED|Overall Study||4
1004969|NCT00532948|2439603|P3|COMPLETED|Overall Study||2
1004970|NCT00532948|2439604|P2|COMPLETED|Overall Study||9
1004971|NCT00532948|2439605|P1|COMPLETED|Overall Study||0
1004972|NCT00532948|2439603|P3|STARTED|Overall Study||6
1004973|NCT00532948|2439604|P2|STARTED|Overall Study||14
1004974|NCT00532948|2439605|P1|STARTED|Overall Study||4
1004975|NCT00533117|2439639|P4|NOT COMPLETED|Overall Study||5
1004976|NCT00533117|2439640|P3|NOT COMPLETED|Overall Study||6
1004977|NCT00533117|2439641|P2|NOT COMPLETED|Overall Study||5
1004978|NCT00533117|2439642|P1|NOT COMPLETED|Overall Study||4
1004979|NCT00533117|2439639|P4|COMPLETED|Overall Study||13
1004980|NCT00533117|2439640|P3|COMPLETED|Overall Study||14
1004981|NCT00533117|2439641|P2|COMPLETED|Overall Study||14
1004982|NCT00533117|2439642|P1|COMPLETED|Overall Study||14
1004983|NCT00533117|2439639|P4|STARTED|Overall Study||18
1004984|NCT00533117|2439640|P3|STARTED|Overall Study||20
1004985|NCT00533117|2439641|P2|STARTED|Overall Study||19
1004986|NCT00533117|2439642|P1|STARTED|Overall Study||18
1004987|NCT00533273|2439652|P2|NOT COMPLETED|Open-label||0
1004988|NCT00533273|2439653|P1|NOT COMPLETED|Open-label||6
1004989|NCT00533273|2439652|P2|COMPLETED|Open-label||0
1004990|NCT00533273|2439653|P1|COMPLETED|Open-label||58
1004991|NCT00533273|2439652|P2|STARTED|Open-label|no placebo - this phase was open label|0
1004992|NCT00533273|2439653|P1|STARTED|Open-label|open-label was extension of double-blind; 64 of 66 patients continued into open-label|64
1004993|NCT00533273|2439652|P2|NOT COMPLETED|Double-blind||2
1004994|NCT00533273|2439653|P1|NOT COMPLETED|Double-blind||0
1004995|NCT00533273|2439652|P2|COMPLETED|Double-blind||19
1004996|NCT00533273|2439653|P1|COMPLETED|Double-blind||45
1004997|NCT00533273|2439652|P2|STARTED|Double-blind||21
1004998|NCT00533273|2439653|P1|STARTED|Double-blind||45
1004999|NCT00533351|2439661|P2|NOT COMPLETED|Period 3||0
1005000|NCT00533351|2439662|P1|NOT COMPLETED|Period 3||0
1005001|NCT00533351|2439661|P2|COMPLETED|Period 3||0
1005002|NCT00533351|2439662|P1|COMPLETED|Period 3||3
1005003|NCT00533351|2439661|P2|STARTED|Period 3|No patients continued to Period 3|0
1005004|NCT00533351|2439662|P1|STARTED|Period 3|Three out of the five patients who completed Period 2 continued to Period 3|3
1005005|NCT00533351|2439661|P2|NOT COMPLETED|Period 2||0
1005006|NCT00533351|2439662|P1|NOT COMPLETED|Period 2||0
1005007|NCT00533351|2439661|P2|COMPLETED|Period 2||1
1005008|NCT00533351|2439662|P1|COMPLETED|Period 2||5
1005009|NCT00533351|2439661|P2|STARTED|Period 2||1
1005010|NCT00533351|2439662|P1|STARTED|Period 2||5
1005011|NCT00533351|2439661|P2|NOT COMPLETED|Period 1||1
1005012|NCT00533351|2439662|P1|NOT COMPLETED|Period 1||2
1005013|NCT00533351|2439661|P2|COMPLETED|Period 1||1
1005014|NCT00533351|2439662|P1|COMPLETED|Period 1||5
1005015|NCT00533351|2439661|P2|STARTED|Period 1||2
1005016|NCT00533351|2439662|P1|STARTED|Period 1||7
1005017|NCT00533442|2439672|P2|NOT COMPLETED|Follow-up||10
1005018|NCT00533442|2439673|P1|NOT COMPLETED|Follow-up||9
1005019|NCT00533442|2439672|P2|COMPLETED|Follow-up||74
1005020|NCT00533442|2439673|P1|COMPLETED|Follow-up||77
1005021|NCT00533442|2439672|P2|STARTED|Follow-up|Ongoing Follow-up at 17-124 months (N=74); Lost to Follow-up (N=10, at 5-67 months).|84
1005022|NCT00533442|2439673|P1|STARTED|Follow-up|Ongoing Follow-up at 13-123 months (N=77); Lost to Follow-up (N=9, at 5-100 months).|86
1005023|NCT00533442|2439672|P2|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
1005024|NCT00533442|2439673|P1|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
1005025|NCT00533442|2439672|P2|COMPLETED|Allocation and Intent to Treat Analysis||84
1005026|NCT00533442|2439673|P1|COMPLETED|Allocation and Intent to Treat Analysis||86
1005027|NCT00533442|2439672|P2|STARTED|Allocation and Intent to Treat Analysis||84
1005028|NCT00533442|2439673|P1|STARTED|Allocation and Intent to Treat Analysis||86
1005029|NCT00533507|2439683|P1|NOT COMPLETED|Overall Study||1
1005030|NCT00533507|2439683|P1|COMPLETED|Overall Study||229
1005031|NCT00533507|2439683|P1|STARTED|Overall Study||230
1005032|NCT00533546|2439702|P1|NOT COMPLETED|Overall Study||0
1005033|NCT00533546|2439702|P1|COMPLETED|Overall Study||12
1005034|NCT00533546|2439702|P1|STARTED|Overall Study||12
1005035|NCT00533702|2439711|P2|NOT COMPLETED|Overall Study||2
1005036|NCT00533702|2439712|P1|NOT COMPLETED|Overall Study||5
1005037|NCT00533702|2439711|P2|COMPLETED|Overall Study||50
1005038|NCT00533702|2439712|P1|COMPLETED|Overall Study||49
1005039|NCT00533702|2439711|P2|Received Any Quantity of Study Drug|Overall Study||50
1005040|NCT00533702|2439712|P1|Received Any Quantity of Study Drug|Overall Study||52
1005041|NCT00533702|2439711|P2|STARTED|Overall Study||52
1005042|NCT00533702|2439712|P1|STARTED|Overall Study||54
1005043|NCT00533897|2439739|P8|NOT COMPLETED|Long Term Extension (LTE)||25
1005044|NCT00533897|2439740|P7|NOT COMPLETED|Long Term Extension (LTE)||13
1005045|NCT00533897|2439741|P6|NOT COMPLETED|Long Term Extension (LTE)||0
1005046|NCT00533897|2439742|P5|NOT COMPLETED|Long Term Extension (LTE)||0
1005047|NCT00533897|2439743|P4|NOT COMPLETED|Long Term Extension (LTE)||0
1005048|NCT00533897|2439744|P3|NOT COMPLETED|Long Term Extension (LTE)||0
1005049|NCT00533897|2439745|P2|NOT COMPLETED|Long Term Extension (LTE)||0
1005050|NCT00533897|2439746|P1|NOT COMPLETED|Long Term Extension (LTE)||0
1005051|NCT00533897|2439739|P8|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|88
1005052|NCT00533897|2439740|P7|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|24
1005053|NCT00533897|2439741|P6|COMPLETED|Long Term Extension (LTE)||0
1005054|NCT00533897|2439742|P5|COMPLETED|Long Term Extension (LTE)||0
1005055|NCT00533897|2439743|P4|COMPLETED|Long Term Extension (LTE)||0
1005056|NCT00533897|2439744|P3|COMPLETED|Long Term Extension (LTE)||0
1005057|NCT00533897|2439745|P2|COMPLETED|Long Term Extension (LTE)||0
1005058|NCT00533897|2439746|P1|COMPLETED|Long Term Extension (LTE)||0
1005059|NCT00533897|2439739|P8|STARTED|Long Term Extension (LTE)|117 completed RI but 4 did not enter LTE: 1 lack of efficacy and 3 had their site closed.|113
1005060|NCT00533897|2439740|P7|STARTED|Long Term Extension (LTE)|37 non-responders in Lead-In entered the LTE directly and didn't participate in DBW or RI Periods.|37
1005061|NCT00533897|2439741|P6|STARTED|Long Term Extension (LTE)||0
1005062|NCT00533897|2439742|P5|STARTED|Long Term Extension (LTE)||0
1005063|NCT00533897|2439743|P4|STARTED|Long Term Extension (LTE)||0
1005064|NCT00533897|2439744|P3|STARTED|Long Term Extension (LTE)||0
1005065|NCT00533897|2439745|P2|STARTED|Long Term Extension (LTE)||0
1005066|NCT00533897|2439746|P1|STARTED|Long Term Extension (LTE)||0
1005067|NCT00533897|2439739|P8|NOT COMPLETED|Re-introduction (RI) Period 3||0
1005068|NCT00533897|2439740|P7|NOT COMPLETED|Re-introduction (RI) Period 3||0
1005069|NCT00533897|2439741|P6|NOT COMPLETED|Re-introduction (RI) Period 3||2
1005070|NCT00533897|2439742|P5|NOT COMPLETED|Re-introduction (RI) Period 3||0
1005071|NCT00533897|2439743|P4|NOT COMPLETED|Re-introduction (RI) Period 3||0
1005072|NCT00533897|2439744|P3|NOT COMPLETED|Re-introduction (RI) Period 3||0
1005073|NCT00533897|2439745|P2|NOT COMPLETED|Re-introduction (RI) Period 3||0
1005074|NCT00533897|2439746|P1|NOT COMPLETED|Re-introduction (RI) Period 3||0
1005075|NCT00533897|2439739|P8|COMPLETED|Re-introduction (RI) Period 3||0
1005076|NCT00533897|2439740|P7|COMPLETED|Re-introduction (RI) Period 3||0
1005077|NCT00533897|2439741|P6|COMPLETED|Re-introduction (RI) Period 3||42
1005078|NCT00533897|2439742|P5|COMPLETED|Re-introduction (RI) Period 3||35
1005079|NCT00533897|2439743|P4|COMPLETED|Re-introduction (RI) Period 3||40
1005080|NCT00533897|2439744|P3|COMPLETED|Re-introduction (RI) Period 3||0
1005081|NCT00533897|2439745|P2|COMPLETED|Re-introduction (RI) Period 3||0
1005082|NCT00533897|2439746|P1|COMPLETED|Re-introduction (RI) Period 3||0
1005083|NCT00533897|2439739|P8|STARTED|Re-introduction (RI) Period 3||0
1005084|NCT00533897|2439740|P7|STARTED|Re-introduction (RI) Period 3||0
1005085|NCT00533897|2439741|P6|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|44
1005086|NCT00533897|2439742|P5|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|35
1005087|NCT00533897|2439743|P4|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|40
1005088|NCT00533897|2439744|P3|STARTED|Re-introduction (RI) Period 3||0
1005089|NCT00533897|2439745|P2|STARTED|Re-introduction (RI) Period 3||0
1005090|NCT00533897|2439746|P1|STARTED|Re-introduction (RI) Period 3||0
1005091|NCT00533897|2439739|P8|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
1005092|NCT00533897|2439740|P7|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
1005093|NCT00533897|2439741|P6|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
1005094|NCT00533897|2439742|P5|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
1005095|NCT00533897|2439743|P4|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
1005096|NCT00533897|2439744|P3|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||3
1005097|NCT00533897|2439745|P2|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||1
1005098|NCT00533897|2439746|P1|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
1005099|NCT00533897|2439739|P8|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
1005100|NCT00533897|2439740|P7|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
1005101|NCT00533897|2439741|P6|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
1005102|NCT00533897|2439742|P5|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
1005103|NCT00533897|2439743|P4|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
1005104|NCT00533897|2439744|P3|COMPLETED|Double-blind Withdrawal (DBW) Period 2|Two participants discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|77
1005105|NCT00533897|2439745|P2|COMPLETED|Double-blind Withdrawal (DBW) Period 2|One participant discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|39
1005106|NCT00533897|2439746|P1|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
1005107|NCT00533897|2439739|P8|STARTED|Double-blind Withdrawal (DBW) Period 2||0
1005108|NCT00533897|2439740|P7|STARTED|Double-blind Withdrawal (DBW) Period 2||0
1005109|NCT00533897|2439741|P6|STARTED|Double-blind Withdrawal (DBW) Period 2||0
1005110|NCT00533897|2439742|P5|STARTED|Double-blind Withdrawal (DBW) Period 2||0
1005111|NCT00533897|2439743|P4|STARTED|Double-blind Withdrawal (DBW) Period 2||0
1005112|NCT00533897|2439744|P3|STARTED|Double-blind Withdrawal (DBW) Period 2||80
1005113|NCT00533897|2439745|P2|STARTED|Double-blind Withdrawal (DBW) Period 2||40
1005114|NCT00533897|2439746|P1|STARTED|Double-blind Withdrawal (DBW) Period 2||0
1005115|NCT00533897|2439739|P8|NOT COMPLETED|Lead-in (LI) Period 1||0
1005116|NCT00533897|2439740|P7|NOT COMPLETED|Lead-in (LI) Period 1||0
1005117|NCT00533897|2439741|P6|NOT COMPLETED|Lead-in (LI) Period 1||0
1005118|NCT00533897|2439742|P5|NOT COMPLETED|Lead-in (LI) Period 1||0
1005119|NCT00533897|2439743|P4|NOT COMPLETED|Lead-in (LI) Period 1||0
1005120|NCT00533897|2439744|P3|NOT COMPLETED|Lead-in (LI) Period 1||0
1005121|NCT00533897|2439745|P2|NOT COMPLETED|Lead-in (LI) Period 1||0
1005122|NCT00533897|2439746|P1|NOT COMPLETED|Lead-in (LI) Period 1||10
1005123|NCT00533897|2439739|P8|COMPLETED|Lead-in (LI) Period 1||0
1005124|NCT00533897|2439740|P7|COMPLETED|Lead-in (LI) Period 1||0
1005125|NCT00533897|2439741|P6|COMPLETED|Lead-in (LI) Period 1||0
1005126|NCT00533897|2439742|P5|COMPLETED|Lead-in (LI) Period 1||0
1005127|NCT00533897|2439743|P4|COMPLETED|Lead-in (LI) Period 1||0
1005128|NCT00533897|2439744|P3|COMPLETED|Lead-in (LI) Period 1||0
1005129|NCT00533897|2439745|P2|COMPLETED|Lead-in (LI) Period 1||0
1005130|NCT00533897|2439746|P1|COMPLETED|Lead-in (LI) Period 1|37 participants entered the LTE directly and did not enter the DBW Period nor receive DBW treatment.|157
1005131|NCT00533897|2439739|P8|STARTED|Lead-in (LI) Period 1||0
1005132|NCT00533897|2439740|P7|STARTED|Lead-in (LI) Period 1||0
1005133|NCT00533897|2439741|P6|STARTED|Lead-in (LI) Period 1||0
1005134|NCT00533897|2439742|P5|STARTED|Lead-in (LI) Period 1||0
1005135|NCT00533897|2439743|P4|STARTED|Lead-in (LI) Period 1||0
1005136|NCT00533897|2439744|P3|STARTED|Lead-in (LI) Period 1||0
1005137|NCT00533897|2439745|P2|STARTED|Lead-in (LI) Period 1||0
1005138|NCT00533897|2439746|P1|STARTED|Lead-in (LI) Period 1||167
1005139|NCT00533949|2439888|P4|NOT COMPLETED|Overall Study||10
1005140|NCT00533949|2439889|P3|NOT COMPLETED|Overall Study||10
1005141|NCT00533949|2439890|P2|NOT COMPLETED|Overall Study||14
1005142|NCT00533949|2439891|P1|NOT COMPLETED|Overall Study||15
1005143|NCT00533949|2439888|P4|COMPLETED|Overall Study||100
1005144|NCT00533949|2439889|P3|COMPLETED|Overall Study||137
1005145|NCT00533949|2439890|P2|COMPLETED|Overall Study||107
1005146|NCT00533949|2439891|P1|COMPLETED|Overall Study||151
1005147|NCT00533949|2439888|P4|STARTED|Overall Study||110
1005148|NCT00533949|2439889|P3|STARTED|Overall Study||147
1005149|NCT00533949|2439890|P2|STARTED|Overall Study||121
1005238|NCT00534404|2440150|P1|3-month Follow up Completed|Overall Study||682
1005150|NCT00533949|2439891|P1|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|166
1005151|NCT00534001|2439921|P2|NOT COMPLETED|Overall Study||4
1005152|NCT00534001|2439922|P1|NOT COMPLETED|Overall Study||5
1005153|NCT00534001|2439921|P2|COMPLETED|Overall Study||43
1005154|NCT00534001|2439922|P1|COMPLETED|Overall Study||43
1005155|NCT00534001|2439921|P2|STARTED|Overall Study||47
1005156|NCT00534001|2439922|P1|STARTED|Overall Study||48
1005157|NCT00534092|2439932|P2|NOT COMPLETED|Overall Study||0
1005158|NCT00534092|2439933|P1|NOT COMPLETED|Overall Study||2
1005159|NCT00534092|2439932|P2|COMPLETED|Overall Study||14
1005160|NCT00534092|2439933|P1|COMPLETED|Overall Study||53
1005161|NCT00534092|2439932|P2|STARTED|Overall Study||14
1005162|NCT00534092|2439933|P1|STARTED|Overall Study||55
1005163|NCT00534105|2439958|P2|NOT COMPLETED|Overall Study||39
1005164|NCT00534105|2439959|P1|NOT COMPLETED|Overall Study||23
1005165|NCT00534105|2439958|P2|COMPLETED|Overall Study||20
1005166|NCT00534105|2439959|P1|COMPLETED|Overall Study||24
1005167|NCT00534105|2439958|P2|STARTED|Overall Study||59
1005168|NCT00534105|2439959|P1|STARTED|Overall Study||47
1005172|NCT00534248|2439977|P2|NOT COMPLETED|Overall Study||673
1005173|NCT00534248|2439978|P1|NOT COMPLETED|Overall Study||661
1005174|NCT00534248|2439977|P2|COMPLETED|Overall Study||10555
1005175|NCT00534248|2439978|P1|COMPLETED|Overall Study||10550
1005176|NCT00534248|2439977|P2|VACCINATED|Overall Study||11210
1005177|NCT00534248|2439978|P1|VACCINATED|Overall Study||11186
1005178|NCT00534248|2439977|P2|STARTED|Overall Study||11228
1005179|NCT00534248|2439978|P1|STARTED|Overall Study||11211
1005180|NCT00534313|2439992|P4|NOT COMPLETED|Long-term Period||33
1005181|NCT00534313|2439993|P3|NOT COMPLETED|Long-term Period||43
1005182|NCT00534313|2439994|P2|NOT COMPLETED|Long-term Period||34
1005183|NCT00534313|2439995|P1|NOT COMPLETED|Long-term Period||37
1005184|NCT00534313|2439992|P4|COMPLETED|Long-term Period||0
1005185|NCT00534313|2439993|P3|COMPLETED|Long-term Period||0
1005186|NCT00534313|2439994|P2|COMPLETED|Long-term Period||0
1005187|NCT00534313|2439995|P1|COMPLETED|Long-term Period||0
1005188|NCT00534313|2439992|P4|STARTED|Long-term Period||33
1005189|NCT00534313|2439993|P3|STARTED|Long-term Period||43
1005190|NCT00534313|2439994|P2|STARTED|Long-term Period||34
1005191|NCT00534313|2439995|P1|STARTED|Long-term Period||37
1005192|NCT00534313|2439992|P4|NOT COMPLETED|Short-term Period||9
1005193|NCT00534313|2439993|P3|NOT COMPLETED|Short-term Period||2
1005194|NCT00534313|2439994|P2|NOT COMPLETED|Short-term Period||6
1005195|NCT00534313|2439995|P1|NOT COMPLETED|Short-term Period||6
1005196|NCT00534313|2439992|P4|COMPLETED|Short-term Period|Completed the short-term study|33
1005197|NCT00534313|2439993|P3|COMPLETED|Short-term Period|Completed the short-term study|43
1005198|NCT00534313|2439994|P2|COMPLETED|Short-term Period|Completed the short-term study|34
1005199|NCT00534313|2439995|P1|COMPLETED|Short-term Period|Completed the short-term study|37
1005200|NCT00534313|2439992|P4|STARTED|Short-term Period||42
1005201|NCT00534313|2439993|P3|STARTED|Short-term Period||45
1005202|NCT00534313|2439994|P2|STARTED|Short-term Period||40
1005203|NCT00534313|2439995|P1|STARTED|Short-term Period||43
1005204|NCT00534352|2440088|P1|NOT COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||4
1005205|NCT00534352|2440088|P1|COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||14
1005206|NCT00534352|2440088|P1|STARTED|Optional Extension: DRV/Rtv + TDF/FTC||18
1005207|NCT00534352|2440088|P1|NOT COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||1
1005208|NCT00534352|2440088|P1|COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||20
1005209|NCT00534352|2440088|P1|STARTED|Treatment C: DRV/Rtv + TDF/FTC||21
1005210|NCT00534352|2440088|P1|NOT COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||0
1005211|NCT00534352|2440088|P1|COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
1005212|NCT00534352|2440088|P1|STARTED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
1005213|NCT00534352|2440088|P1|NOT COMPLETED|Treatment A: TMC125 + TDF/FTC||2
1005214|NCT00534352|2440088|P1|COMPLETED|Treatment A: TMC125 + TDF/FTC||21
1005215|NCT00534352|2440088|P1|STARTED|Treatment A: TMC125 + TDF/FTC||23
1005216|NCT00534365|2440130|P2|NOT COMPLETED|Overall Study||7
1005217|NCT00534365|2440131|P1|NOT COMPLETED|Overall Study||0
1005218|NCT00534365|2440130|P2|COMPLETED|Overall Study||129
1005219|NCT00534365|2440131|P1|COMPLETED|Overall Study||127
1005220|NCT00534365|2440130|P2|Included in Intent to Treat Analysis|Overall Study||136
1005221|NCT00534365|2440131|P1|Included in Intent to Treat Analysis|Overall Study||127
1005222|NCT00534365|2440130|P2|Follow up at 12 Months or More|Overall Study||128
1005223|NCT00534365|2440131|P1|Follow up at 12 Months or More|Overall Study||119
1005224|NCT00534365|2440130|P2|Any Follow up|Overall Study||135
1005225|NCT00534365|2440131|P1|Any Follow up|Overall Study||126
1005226|NCT00534365|2440130|P2|Received Procedure|Overall Study|7 patients excluded due to receipt of sling other than mini-sling|129
1005227|NCT00534365|2440131|P1|Received Procedure|Overall Study||127
1005228|NCT00534365|2440130|P2|STARTED|Overall Study||136
1005229|NCT00534365|2440131|P1|STARTED|Overall Study||127
1005230|NCT00534404|2440148|P3|NOT COMPLETED|Overall Study||242
1005231|NCT00534404|2440149|P2|NOT COMPLETED|Overall Study||143
1005232|NCT00534404|2440150|P1|NOT COMPLETED|Overall Study||180
1005233|NCT00534404|2440148|P3|COMPLETED|Overall Study||586
1005234|NCT00534404|2440149|P2|COMPLETED|Overall Study||687
1005235|NCT00534404|2440150|P1|COMPLETED|Overall Study||647
1005236|NCT00534404|2440148|P3|3-month Follow up Completed|Overall Study||593
1005237|NCT00534404|2440149|P2|3-month Follow up Completed|Overall Study||731
1005239|NCT00534404|2440148|P3|1-month Follow up Completed|Overall Study||626
1005240|NCT00534404|2440149|P2|1-month Follow up Completed|Overall Study||781
1005241|NCT00534404|2440150|P1|1-month Follow up Completed|Overall Study||742
1005242|NCT00534404|2440148|P3|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
1005243|NCT00534404|2440149|P2|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
1005244|NCT00534404|2440150|P1|Completed at Least 1 Counseling Call|Overall Study||813
1005245|NCT00534404|2440148|P3|Completed Second NRT Order|Overall Study|NRT not available for this arm.|0
1005246|NCT00534404|2440149|P2|Completed Second NRT Order|Overall Study||789
1005247|NCT00534404|2440150|P1|Completed Second NRT Order|Overall Study||640
1005248|NCT00534404|2440148|P3|Completed First NRT Order|Overall Study|NRT was not available for this arm|0
1005249|NCT00534404|2440149|P2|Completed First NRT Order|Overall Study|Participants could order NRT without completing a web session|821
1005250|NCT00534404|2440150|P1|Completed First NRT Order|Overall Study||765
1005251|NCT00534404|2440148|P3|Completed at Least 1 Online Session|Overall Study||658
1005252|NCT00534404|2440149|P2|Completed at Least 1 Online Session|Overall Study||813
1005253|NCT00534404|2440150|P1|Completed at Least 1 Online Session|Overall Study||781
1005254|NCT00534404|2440148|P3|STARTED|Overall Study||828
1005255|NCT00534404|2440149|P2|STARTED|Overall Study||830
1005256|NCT00534404|2440150|P1|STARTED|Overall Study||827
1005257|NCT00534417|2440164|P1|NOT COMPLETED|Overall Study||0
1005258|NCT00534417|2440164|P1|COMPLETED|Overall Study||41
1005259|NCT00534417|2440164|P1|STARTED|Overall Study||41
1005260|NCT00534495|2440178|P3|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||11
1005261|NCT00534495|2440179|P2|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
1005262|NCT00534495|2440180|P1|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
1005263|NCT00534495|2440178|P3|COMPLETED|Long Term Ext. Phase Week 24-month 21||29
1005264|NCT00534495|2440179|P2|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
1005265|NCT00534495|2440180|P1|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
1005266|NCT00534495|2440178|P3|STARTED|Long Term Ext. Phase Week 24-month 21||40
1005267|NCT00534495|2440179|P2|STARTED|Long Term Ext. Phase Week 24-month 21||0
1005268|NCT00534495|2440180|P1|STARTED|Long Term Ext. Phase Week 24-month 21||0
1005269|NCT00534495|2440178|P3|NOT COMPLETED|All Active Treatment Phase Week 4-24||0
1005270|NCT00534495|2440179|P2|NOT COMPLETED|All Active Treatment Phase Week 4-24||9
1005271|NCT00534495|2440180|P1|NOT COMPLETED|All Active Treatment Phase Week 4-24||4
1005272|NCT00534495|2440178|P3|COMPLETED|All Active Treatment Phase Week 4-24||0
1005273|NCT00534495|2440179|P2|COMPLETED|All Active Treatment Phase Week 4-24||25
1005274|NCT00534495|2440180|P1|COMPLETED|All Active Treatment Phase Week 4-24||32
1005275|NCT00534495|2440178|P3|STARTED|All Active Treatment Phase Week 4-24||0
1005276|NCT00534495|2440179|P2|STARTED|All Active Treatment Phase Week 4-24||34
1005277|NCT00534495|2440180|P1|STARTED|All Active Treatment Phase Week 4-24||36
1005278|NCT00534495|2440178|P3|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
1005279|NCT00534495|2440179|P2|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||1
1005280|NCT00534495|2440180|P1|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
1005281|NCT00534495|2440178|P3|COMPLETED|Double Blind Placebo Phase Week 0-4||0
1005282|NCT00534495|2440179|P2|COMPLETED|Double Blind Placebo Phase Week 0-4||34
1005283|NCT00534495|2440180|P1|COMPLETED|Double Blind Placebo Phase Week 0-4||36
1005284|NCT00534495|2440178|P3|STARTED|Double Blind Placebo Phase Week 0-4||0
1005285|NCT00534495|2440179|P2|STARTED|Double Blind Placebo Phase Week 0-4||35
1005286|NCT00534495|2440180|P1|STARTED|Double Blind Placebo Phase Week 0-4||36
1005287|NCT00528372|2440212|P9|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
1005288|NCT00528372|2440213|P8|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
1005289|NCT00528372|2440214|P7|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||17
1005290|NCT00528372|2440215|P6|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||15
1005291|NCT00528372|2440216|P5|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||21
1005292|NCT00528372|2440217|P4|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||14
1005293|NCT00528372|2440218|P3|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||8
1005294|NCT00528372|2440219|P2|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||19
1005295|NCT00528372|2440220|P1|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||20
1005296|NCT00528372|2440212|P9|COMPLETED|Long-term (LT) Period (Weeks 24-102)||27
1005297|NCT00528372|2440213|P8|COMPLETED|Long-term (LT) Period (Weeks 24-102)||22
1005298|NCT00528372|2440214|P7|COMPLETED|Long-term (LT) Period (Weeks 24-102)||48
1005299|NCT00528372|2440215|P6|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
1005300|NCT00528372|2440216|P5|COMPLETED|Long-term (LT) Period (Weeks 24-102)||37
1005301|NCT00528372|2440217|P4|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
1005302|NCT00528372|2440218|P3|COMPLETED|Long-term (LT) Period (Weeks 24-102)||43
1005303|NCT00528372|2440219|P2|COMPLETED|Long-term (LT) Period (Weeks 24-102)||40
1005304|NCT00528372|2440220|P1|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
1005305|NCT00528372|2440212|P9|STARTED|Long-term (LT) Period (Weeks 24-102)|1 patient completed ST phase but withdrew for sponsor administrative reason before start of LT phase|33
1005306|NCT00528372|2440213|P8|STARTED|Long-term (LT) Period (Weeks 24-102)||28
1005307|NCT00528372|2440214|P7|STARTED|Long-term (LT) Period (Weeks 24-102)||65
1005308|NCT00528372|2440215|P6|STARTED|Long-term (LT) Period (Weeks 24-102)||57
1005309|NCT00528372|2440216|P5|STARTED|Long-term (LT) Period (Weeks 24-102)||58
1005310|NCT00528372|2440217|P4|STARTED|Long-term (LT) Period (Weeks 24-102)||56
1005311|NCT00528372|2440218|P3|STARTED|Long-term (LT) Period (Weeks 24-102)||51
1005312|NCT00528372|2440219|P2|STARTED|Long-term (LT) Period (Weeks 24-102)||59
1005313|NCT00528372|2440220|P1|STARTED|Long-term (LT) Period (Weeks 24-102)||62
1005314|NCT00528372|2440212|P9|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
1005315|NCT00528372|2440213|P8|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||6
1005316|NCT00528372|2440214|P7|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
1005317|NCT00528372|2440215|P6|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
1005318|NCT00528372|2440216|P5|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||9
1005319|NCT00528372|2440217|P4|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||13
1005320|NCT00528372|2440218|P3|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
1005321|NCT00528372|2440219|P2|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
1005322|NCT00528372|2440220|P1|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
1005323|NCT00528372|2440212|P9|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||34
1005324|NCT00528372|2440213|P8|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||28
1005325|NCT00528372|2440214|P7|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||65
1005326|NCT00528372|2440215|P6|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
1005327|NCT00528372|2440216|P5|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||58
1005328|NCT00528372|2440217|P4|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
1005329|NCT00528372|2440218|P3|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||52
1005330|NCT00528372|2440219|P2|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||60
1005331|NCT00528372|2440220|P1|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||63
1005332|NCT00528372|2440212|P9|STARTED|Short-term (ST) Period (Day 1-Week 24)||39
1005333|NCT00528372|2440213|P8|STARTED|Short-term (ST) Period (Day 1-Week 24)||34
1005334|NCT00528372|2440214|P7|STARTED|Short-term (ST) Period (Day 1-Week 24)||76
1005335|NCT00528372|2440215|P6|STARTED|Short-term (ST) Period (Day 1-Week 24)||68
1005336|NCT00528372|2440216|P5|STARTED|Short-term (ST) Period (Day 1-Week 24)||67
1005337|NCT00528372|2440217|P4|STARTED|Short-term (ST) Period (Day 1-Week 24)||70
1005338|NCT00528372|2440218|P3|STARTED|Short-term (ST) Period (Day 1-Week 24)||64
1005339|NCT00528372|2440219|P2|STARTED|Short-term (ST) Period (Day 1-Week 24)||65
1005340|NCT00528372|2440220|P1|STARTED|Short-term (ST) Period (Day 1-Week 24)||75
1005341|NCT00528398|2440332|P1|NOT COMPLETED|Overall Study||0
1005342|NCT00528398|2440332|P1|COMPLETED|Overall Study||111
1005343|NCT00528398|2440332|P1|STARTED|Overall Study||111
1005344|NCT00528411|2440340|P3|NOT COMPLETED|Overall Study||1
1005345|NCT00528411|2440341|P2|NOT COMPLETED|Overall Study||3
1005346|NCT00528411|2440342|P1|NOT COMPLETED|Overall Study||5
1005347|NCT00528411|2440340|P3|COMPLETED|Overall Study||11
1005348|NCT00528411|2440341|P2|COMPLETED|Overall Study||51
1005349|NCT00528411|2440342|P1|COMPLETED|Overall Study||52
1005350|NCT00528411|2440340|P3|STARTED|Overall Study||12
1005351|NCT00528411|2440341|P2|STARTED|Overall Study||54
1005352|NCT00528411|2440342|P1|STARTED|Overall Study||57
1005353|NCT00528424|2440465|P1|NOT COMPLETED|Overall Study||29
1005354|NCT00528424|2440465|P1|COMPLETED|Overall Study||257
1005355|NCT00528424|2440465|P1|STARTED|Overall Study||286
1005356|NCT00528450|2440469|P1|NOT COMPLETED|Overall Study||0
1005357|NCT00528450|2440469|P1|COMPLETED|Overall Study||1
1005358|NCT00528450|2440469|P1|STARTED|Overall Study||1
1005359|NCT00528528|2440477|P4|NOT COMPLETED|Overall Study||3
1005360|NCT00528528|2440478|P3|NOT COMPLETED|Overall Study||3
1005361|NCT00528528|2440479|P2|NOT COMPLETED|Overall Study||3
1005362|NCT00528528|2440480|P1|NOT COMPLETED|Overall Study||3
1005363|NCT00528528|2440477|P4|COMPLETED|Overall Study||36
1005364|NCT00528528|2440478|P3|COMPLETED|Overall Study||37
1005365|NCT00528528|2440479|P2|COMPLETED|Overall Study||39
1005366|NCT00528528|2440480|P1|COMPLETED|Overall Study||37
1005367|NCT00528528|2440477|P4|Ongoing at Time of Cut-off|Overall Study||0
1005368|NCT00528528|2440478|P3|Ongoing at Time of Cut-off|Overall Study||1
1005369|NCT00528528|2440479|P2|Ongoing at Time of Cut-off|Overall Study||0
1005370|NCT00528528|2440480|P1|Ongoing at Time of Cut-off|Overall Study||0
1005371|NCT00528528|2440477|P4|STARTED|Overall Study||39
1005372|NCT00528528|2440478|P3|STARTED|Overall Study||40
1005373|NCT00528528|2440479|P2|STARTED|Overall Study||42
1005374|NCT00528528|2440480|P1|STARTED|Overall Study||40
1005375|NCT00528541|2440516|P2|NOT COMPLETED|Overall Study||1
1005376|NCT00528541|2440517|P1|NOT COMPLETED|Overall Study||2
1005377|NCT00528541|2440516|P2|COMPLETED|Overall Study||69
1005378|NCT00528541|2440517|P1|COMPLETED|Overall Study||73
1005379|NCT00528541|2440516|P2|STARTED|Overall Study||70
1005380|NCT00528541|2440517|P1|STARTED|Overall Study||75
1005381|NCT00528567|2440541|P2|NOT COMPLETED|Overall Study||308
1005382|NCT00528567|2440542|P1|NOT COMPLETED|Overall Study||431
1005383|NCT00528567|2440541|P2|COMPLETED|Overall Study||982
1005384|NCT00528567|2440542|P1|COMPLETED|Overall Study||870
1005385|NCT00528567|2440541|P2|Safety Population|Overall Study||1271
1005386|NCT00528567|2440542|P1|Safety Population|Overall Study||1288
1005387|NCT00528567|2440541|P2|Intention to Treat|Overall Study||1290
1005388|NCT00528567|2440542|P1|Intention to Treat|Overall Study||1301
1005389|NCT00528567|2440541|P2|STARTED|Overall Study||1290
1005390|NCT00528567|2440542|P1|STARTED|Overall Study||1301
1005391|NCT00528606|2440582|P2|NOT COMPLETED|Overall Study||4
1005392|NCT00528606|2440583|P1|NOT COMPLETED|Overall Study||13
1005393|NCT00528606|2440582|P2|COMPLETED|Overall Study||100
1005394|NCT00528606|2440583|P1|COMPLETED|Overall Study||191
1005395|NCT00528606|2440582|P2|STARTED|Overall Study||104
1005396|NCT00528606|2440583|P1|STARTED|Overall Study||204
1005397|NCT00528645|2440589|P1|NOT COMPLETED|Overall Study||3
1005398|NCT00528645|2440589|P1|COMPLETED|Overall Study||20
1005399|NCT00528645|2440589|P1|STARTED|Overall Study||23
1005400|NCT00528775|2440593|P1|NOT COMPLETED|Overall Study||1
1005401|NCT00528775|2440593|P1|COMPLETED|Overall Study||5
1005402|NCT00528775|2440593|P1|STARTED|Overall Study||6
1005403|NCT00528788|2440601|P1|NOT COMPLETED|Overall Study||4
1005404|NCT00528788|2440601|P1|COMPLETED|Overall Study||20
1005405|NCT00528788|2440601|P1|STARTED|Overall Study||24
1005406|NCT00528801|2440607|P2|NOT COMPLETED|Overall Study||11
1005407|NCT00528801|2440608|P1|NOT COMPLETED|Overall Study||27
1005408|NCT00528801|2440607|P2|COMPLETED|Overall Study||41
1005409|NCT00528801|2440608|P1|COMPLETED|Overall Study||133
1005410|NCT00528801|2440607|P2|STARTED|Overall Study||52
1005411|NCT00528801|2440608|P1|STARTED|Overall Study||160
1005412|NCT00528840|2440618|P1|NOT COMPLETED|Overall Study||33
1005413|NCT00528840|2440618|P1|COMPLETED|Overall Study||168
1005414|NCT00528840|2440618|P1|STARTED|Overall Study||201
1005415|NCT00528866|2440622|P1|NOT COMPLETED|Overall Study||6
1005416|NCT00528866|2440622|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|74
1005417|NCT00528866|2440622|P1|STARTED|Overall Study||80
1005418|NCT00528879|2440638|P4|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||24
1005419|NCT00528879|2440639|P3|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||33
1005420|NCT00528879|2440640|P2|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||38
1005421|NCT00528879|2440641|P1|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||42
1005422|NCT00528879|2440638|P4|COMPLETED|Long-term Period (Weeks 24 to 102)||95
1005423|NCT00528879|2440639|P3|COMPLETED|Long-term Period (Weeks 24 to 102)||89
1005424|NCT00528879|2440640|P2|COMPLETED|Long-term Period (Weeks 24 to 102)||82
1005425|NCT00528879|2440641|P1|COMPLETED|Long-term Period (Weeks 24 to 102)||73
1005426|NCT00528879|2440638|P4|STARTED|Long-term Period (Weeks 24 to 102)||119
1005427|NCT00528879|2440639|P3|STARTED|Long-term Period (Weeks 24 to 102)||122
1005428|NCT00528879|2440640|P2|STARTED|Long-term Period (Weeks 24 to 102)||120
1005429|NCT00528879|2440641|P1|STARTED|Long-term Period (Weeks 24 to 102)||115
1005430|NCT00528879|2440638|P4|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||16
1005431|NCT00528879|2440639|P3|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||15
1005432|NCT00528879|2440640|P2|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||17
1005433|NCT00528879|2440641|P1|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||22
1005434|NCT00528879|2440638|P4|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|119
1005435|NCT00528879|2440639|P3|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|122
1005436|NCT00528879|2440640|P2|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|120
1005437|NCT00528879|2440641|P1|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|115
1005438|NCT00528879|2440638|P4|Completed the Period|Short-term Period (Day 1 to Week 24)||121
1005439|NCT00528879|2440639|P3|Completed the Period|Short-term Period (Day 1 to Week 24)||122
1005440|NCT00528879|2440640|P2|Completed the Period|Short-term Period (Day 1 to Week 24)||121
1005441|NCT00528879|2440641|P1|Completed the Period|Short-term Period (Day 1 to Week 24)||119
1005442|NCT00528879|2440638|P4|STARTED|Short-term Period (Day 1 to Week 24)||135
1005443|NCT00528879|2440639|P3|STARTED|Short-term Period (Day 1 to Week 24)||137
1005444|NCT00528879|2440640|P2|STARTED|Short-term Period (Day 1 to Week 24)||137
1005445|NCT00528879|2440641|P1|STARTED|Short-term Period (Day 1 to Week 24)||137
1005446|NCT00534599|2440709|P2|NOT COMPLETED|Overall Study||32
1005447|NCT00534599|2440710|P1|NOT COMPLETED|Overall Study||57
1005448|NCT00534599|2440709|P2|COMPLETED|Overall Study||168
1005449|NCT00534599|2440710|P1|COMPLETED|Overall Study||152
1005450|NCT00534599|2440709|P2|STARTED|Overall Study|Randomized|200
1005451|NCT00534599|2440710|P1|STARTED|Overall Study|Randomized|209
1005452|NCT00534638|2440746|P2|NOT COMPLETED|Overall Study||11791
1005453|NCT00534638|2440747|P1|NOT COMPLETED|Overall Study||6491
1005454|NCT00534638|2440746|P2|COMPLETED|Overall Study||5547
1005455|NCT00534638|2440747|P1|COMPLETED|Overall Study||8346
1005456|NCT00534638|2440746|P2|STARTED|Overall Study||17338
1005457|NCT00534638|2440747|P1|STARTED|Overall Study||14837
1005458|NCT00534794|2440782|P2|NOT COMPLETED|Overall Study||0
1005459|NCT00534794|2440783|P1|NOT COMPLETED|Overall Study||0
1005460|NCT00534794|2440782|P2|COMPLETED|Overall Study||39
1005461|NCT00534794|2440783|P1|COMPLETED|Overall Study||40
1005462|NCT00534794|2440782|P2|STARTED|Overall Study||39
1005463|NCT00534794|2440783|P1|STARTED|Overall Study||40
1005464|NCT00534833|2440793|P2|NOT COMPLETED|Overall Study||0
1005465|NCT00534833|2440794|P1|NOT COMPLETED|Overall Study||0
1005466|NCT00534833|2440793|P2|COMPLETED|Overall Study||180
1005467|NCT00534833|2440794|P1|COMPLETED|Overall Study||182
1005468|NCT00534833|2440793|P2|STARTED|Overall Study||180
1005469|NCT00534833|2440794|P1|STARTED|Overall Study||182
1005470|NCT00536263|2440807|P3|NOT COMPLETED|Overall Study||21
1005471|NCT00536263|2440808|P2|NOT COMPLETED|Overall Study||14
1005472|NCT00536263|2440809|P1|NOT COMPLETED|Overall Study||11
1005473|NCT00536263|2440807|P3|COMPLETED|Overall Study||204
1005474|NCT00536263|2440808|P2|COMPLETED|Overall Study||207
1005475|NCT00536263|2440809|P1|COMPLETED|Overall Study||214
1005476|NCT00536263|2440807|P3|STARTED|Overall Study|One (1) participant withdrawn from study for non-compliance.|225
1005477|NCT00536263|2440808|P2|STARTED|Overall Study||221
1005478|NCT00536263|2440809|P1|STARTED|Overall Study||225
1005479|NCT00536341|2440849|P2|NOT COMPLETED|Overall Study||11
1005480|NCT00536341|2440850|P1|NOT COMPLETED|Overall Study||5
1005481|NCT00536341|2440849|P2|COMPLETED|Overall Study||43
1005482|NCT00536341|2440850|P1|COMPLETED|Overall Study||5
1005483|NCT00536341|2440849|P2|STARTED|Overall Study||54
1005484|NCT00536341|2440850|P1|STARTED|Overall Study||10
1005485|NCT00536380|2440863|P3|NOT COMPLETED|Overall Study||10
1005486|NCT00536380|2440864|P2|NOT COMPLETED|Overall Study||9
1005487|NCT00536380|2440865|P1|NOT COMPLETED|Overall Study||12
1005488|NCT00536380|2440863|P3|COMPLETED|Overall Study||94
1005489|NCT00536380|2440864|P2|COMPLETED|Overall Study||95
1005490|NCT00536380|2440865|P1|COMPLETED|Overall Study||94
1005491|NCT00536380|2440863|P3|STARTED|Overall Study||104
1005492|NCT00536380|2440864|P2|STARTED|Overall Study||104
1005493|NCT00536380|2440865|P1|STARTED|Overall Study||106
1005494|NCT00536471|2440877|P4|NOT COMPLETED|Overall Study||74
1005495|NCT00536471|2440878|P3|NOT COMPLETED|Overall Study||139
1005496|NCT00536471|2440879|P2|NOT COMPLETED|Overall Study||84
1005497|NCT00536471|2440880|P1|NOT COMPLETED|Overall Study||156
1005498|NCT00536471|2440877|P4|COMPLETED|Overall Study||57
1005499|NCT00536471|2440878|P3|COMPLETED|Overall Study||122
1005500|NCT00536471|2440879|P2|COMPLETED|Overall Study||43
1005501|NCT00536471|2440880|P1|COMPLETED|Overall Study||101
1005502|NCT00536471|2440877|P4|STARTED|Overall Study||131
1005503|NCT00536471|2440878|P3|STARTED|Overall Study||261
1005504|NCT00536471|2440879|P2|STARTED|Overall Study||127
1005505|NCT00536471|2440880|P1|STARTED|Overall Study||257
1005506|NCT00536484|2441124|P2|NOT COMPLETED|Overall Study||56
1005507|NCT00536484|2441125|P1|NOT COMPLETED|Overall Study||60
1005508|NCT00536484|2441124|P2|COMPLETED|Overall Study|134 completed on 4mg dose and 248 on 8mg dose|382
1005509|NCT00536484|2441125|P1|COMPLETED|Overall Study|88 completed on matched 4mg dose and 297 on matched 8mg dose|385
1005510|NCT00536484|2441124|P2|STARTED|Overall Study|448 participants randomised; 10 not treated|438
1005511|NCT00536484|2441125|P1|STARTED|Overall Study|448 participants randomised; 3 not treated|445
1005512|NCT00536510|2441157|P2|NOT COMPLETED|Overall Study||29
1005513|NCT00536510|2441158|P1|NOT COMPLETED|Overall Study||82
1005514|NCT00536510|2441157|P2|COMPLETED|Overall Study||295
1005515|NCT00536510|2441158|P1|COMPLETED|Overall Study||240
1005516|NCT00536510|2441157|P2|STARTED|Overall Study||324
1005517|NCT00536510|2441158|P1|STARTED|Overall Study||322
1005518|NCT00536575|2441166|P1|NOT COMPLETED|Overall Study||2
1005519|NCT00536575|2441166|P1|COMPLETED|Overall Study||11
1005520|NCT00536575|2441166|P1|STARTED|Overall Study||13
1005521|NCT00536731|2441173|P3|NOT COMPLETED|Overall Study||5
1005522|NCT00536731|2441174|P2|NOT COMPLETED|Overall Study||5
1005523|NCT00536731|2441175|P1|NOT COMPLETED|Overall Study||4
1005524|NCT00536731|2441173|P3|COMPLETED|Overall Study||238
1005525|NCT00536731|2441174|P2|COMPLETED|Overall Study||241
1005526|NCT00536731|2441175|P1|COMPLETED|Overall Study||249
1005527|NCT00536731|2441173|P3|STARTED|Overall Study||243
1005528|NCT00536731|2441174|P2|STARTED|Overall Study||246
1005529|NCT00536731|2441175|P1|STARTED|Overall Study||253
1005530|NCT00536744|2441221|P2|NOT COMPLETED|Overall Study||28
1005531|NCT00536744|2441222|P1|NOT COMPLETED|Overall Study||29
1005532|NCT00536744|2441221|P2|COMPLETED|Overall Study||71
1005533|NCT00536744|2441222|P1|COMPLETED|Overall Study||78
1005534|NCT00536744|2441221|P2|STARTED|Overall Study||99
1005535|NCT00536744|2441222|P1|STARTED|Overall Study||107
1005536|NCT00536809|2441228|P1|NOT COMPLETED|Phase II||2
1005537|NCT00536809|2441228|P1|COMPLETED|Phase II||0
1005538|NCT00536809|2441228|P1|STARTED|Phase II||2
1005539|NCT00536809|2441228|P1|NOT COMPLETED|Phase I (Dose-finding Phase)||0
1005540|NCT00536809|2441228|P1|COMPLETED|Phase I (Dose-finding Phase)||10
1005541|NCT00536809|2441228|P1|STARTED|Phase I (Dose-finding Phase)||10
1005542|NCT00536874|2441249|P1|NOT COMPLETED|Overall Study||4
1005543|NCT00536874|2441249|P1|COMPLETED|Overall Study||35
1005544|NCT00536874|2441249|P1|STARTED|Overall Study||39
1005545|NCT00536913|2441261|P2|NOT COMPLETED|Overall Study||0
1005546|NCT00536913|2441262|P1|NOT COMPLETED|Overall Study||0
1005547|NCT00536913|2441261|P2|COMPLETED|Overall Study||52
1005548|NCT00536913|2441262|P1|COMPLETED|Overall Study||55
1005549|NCT00536913|2441261|P2|STARTED|Overall Study||52
1005550|NCT00536913|2441262|P1|STARTED|Overall Study||55
1005551|NCT00536978|2441284|P1|NOT COMPLETED|Overall Study||22
1005552|NCT00536978|2441284|P1|COMPLETED|Overall Study||0
1005553|NCT00536978|2441284|P1|STARTED|Overall Study||22
1005554|NCT00536991|2441288|P1|NOT COMPLETED|Overall Study||13
1005555|NCT00536991|2441288|P1|COMPLETED|Overall Study||38
1005556|NCT00536991|2441288|P1|STARTED|Overall Study||51
1005557|NCT00537017|2441295|P1|NOT COMPLETED|Follow-up Phase||9
1005558|NCT00537017|2441295|P1|COMPLETED|Follow-up Phase||126
1005559|NCT00537017|2441295|P1|STARTED|Follow-up Phase|All TP participants were eligible for FUP entry. 5 participants completing TP did not enter FUP.|135
1005560|NCT00537017|2441295|P1|NOT COMPLETED|Treatment Phase||34
1005561|NCT00537017|2441295|P1|COMPLETED|Treatment Phase||106
1005562|NCT00537017|2441295|P1|STARTED|Treatment Phase||140
1005563|NCT00537030|2441306|P1|NOT COMPLETED|Overall Study||16
1005564|NCT00537030|2441306|P1|COMPLETED|Overall Study||43
1005565|NCT00537030|2441306|P1|STARTED|Overall Study||59
1005566|NCT00537056|2441310|P1|NOT COMPLETED|12-month Follow-up||0
1005567|NCT00537056|2441310|P1|COMPLETED|12-month Follow-up||17
1005568|NCT00537056|2441310|P1|STARTED|12-month Follow-up||17
1005569|NCT00537056|2441310|P1|NOT COMPLETED|Interim PET/CT||5
1005570|NCT00537056|2441310|P1|COMPLETED|Interim PET/CT||12
1005571|NCT00537056|2441310|P1|STARTED|Interim PET/CT||17
1005572|NCT00537056|2441310|P1|NOT COMPLETED|Baseline PET/CT||0
1005573|NCT00537056|2441310|P1|COMPLETED|Baseline PET/CT||17
1005574|NCT00537056|2441310|P1|STARTED|Baseline PET/CT||17
1005575|NCT00537082|2441325|P3|NOT COMPLETED|Overall Study||6
1005576|NCT00537082|2441326|P2|NOT COMPLETED|Overall Study||9
1005577|NCT00537082|2441327|P1|NOT COMPLETED|Overall Study||9
1005578|NCT00537082|2441325|P3|COMPLETED|Overall Study||51
1005579|NCT00537082|2441326|P2|COMPLETED|Overall Study||48
1005580|NCT00537082|2441327|P1|COMPLETED|Overall Study||48
1005581|NCT00537082|2441325|P3|STARTED|Overall Study||57
1005582|NCT00537082|2441326|P2|STARTED|Overall Study||57
1005583|NCT00537082|2441327|P1|STARTED|Overall Study||57
1005584|NCT00537095|2441346|P2|NOT COMPLETED|Overall Study||57
1005585|NCT00537095|2441347|P1|NOT COMPLETED|Overall Study||51
1005586|NCT00537095|2441346|P2|COMPLETED|Overall Study||16
1005587|NCT00537095|2441347|P1|COMPLETED|Overall Study||21
1005588|NCT00537095|2441346|P2|STARTED|Overall Study||73
1005589|NCT00537095|2441347|P1|STARTED|Overall Study||72
1005590|NCT00537199|2441359|P1|NOT COMPLETED|Overall Study||1
1005591|NCT00537199|2441359|P1|COMPLETED|Overall Study||0
1005592|NCT00537199|2441359|P1|STARTED|Overall Study||1
1005593|NCT00537238|2441365|P2|NOT COMPLETED|Overall Study||173
1005594|NCT00537238|2441366|P1|NOT COMPLETED|Overall Study||174
1005595|NCT00537238|2441365|P2|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|82
1005596|NCT00537238|2441366|P1|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|80
1005597|NCT00537238|2441365|P2|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|195
1005598|NCT00537238|2441366|P1|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|185
1005599|NCT00537238|2441365|P2|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|210
1005600|NCT00537238|2441366|P1|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|208
1005601|NCT00537238|2441365|P2|Completed Titration Phase|Overall Study||236
1005602|NCT00537238|2441366|P1|Completed Titration Phase|Overall Study||226
1005603|NCT00537238|2441365|P2|STARTED|Overall Study||255
1005604|NCT00537238|2441366|P1|STARTED|Overall Study||254
1005605|NCT00537277|2441386|P1|NOT COMPLETED|Overall Study||49
1005606|NCT00537277|2441386|P1|COMPLETED|Overall Study||112
1005607|NCT00537277|2441386|P1|Exposed to Trial Drug|Overall Study|One subject not exposed to trial drug, and thus not included in full analysis set (FAS)|160
1005608|NCT00537277|2441386|P1|STARTED|Overall Study||161
1005609|NCT00537303|2441397|P2|NOT COMPLETED|Overall Study||25
1005610|NCT00537303|2441398|P1|NOT COMPLETED|Overall Study||26
1005611|NCT00537303|2441397|P2|COMPLETED|Overall Study||125
1005612|NCT00537303|2441398|P1|COMPLETED|Overall Study||120
1005613|NCT00537303|2441397|P2|STARTED|Overall Study||150
1005614|NCT00537303|2441398|P1|STARTED|Overall Study||146
1005657|NCT00537329|2441451|P1|NOT COMPLETED|Overall Study||26
1005658|NCT00537329|2441451|P1|COMPLETED|Overall Study||17
1005659|NCT00537329|2441451|P1|STARTED|Overall Study||43
1005660|NCT00537381|2441467|P2|NOT COMPLETED|Overall Study||62
1005661|NCT00537381|2441468|P1|NOT COMPLETED|Overall Study||56
1005662|NCT00537381|2441467|P2|COMPLETED|Overall Study||4
1005663|NCT00537381|2441468|P1|COMPLETED|Overall Study||9
1005664|NCT00537381|2441467|P2|STARTED|Overall Study||66
1005665|NCT00537381|2441468|P1|STARTED|Overall Study|11 Participants after disease progression switched to intetumumab alone (2) or D+P+ Intetumumab (9).|65
1005666|NCT00537394|2441491|P3|NOT COMPLETED|2nd Year of Follow-up||6
1005667|NCT00537394|2441492|P2|NOT COMPLETED|2nd Year of Follow-up||9
1005668|NCT00537394|2441493|P1|NOT COMPLETED|2nd Year of Follow-up||11
1005669|NCT00537394|2441491|P3|COMPLETED|2nd Year of Follow-up||44
1005670|NCT00537394|2441492|P2|COMPLETED|2nd Year of Follow-up||159
1005671|NCT00537394|2441493|P1|COMPLETED|2nd Year of Follow-up||158
1005672|NCT00537394|2441491|P3|STARTED|2nd Year of Follow-up||50
1005673|NCT00537394|2441492|P2|STARTED|2nd Year of Follow-up||168
1005674|NCT00537394|2441493|P1|STARTED|2nd Year of Follow-up||169
1005675|NCT00537394|2441491|P3|NOT COMPLETED|First Year of Follow-up||3
1005676|NCT00537394|2441492|P2|NOT COMPLETED|First Year of Follow-up||11
1005677|NCT00537394|2441493|P1|NOT COMPLETED|First Year of Follow-up||12
1005678|NCT00537394|2441491|P3|COMPLETED|First Year of Follow-up||50
1005679|NCT00537394|2441492|P2|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|168
1005680|NCT00537394|2441493|P1|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|169
1005681|NCT00537394|2441491|P3|STARTED|First Year of Follow-up||53
1005682|NCT00537394|2441492|P2|STARTED|First Year of Follow-up||179
1005683|NCT00537394|2441493|P1|STARTED|First Year of Follow-up||181
1005684|NCT00537407|2441532|P5|NOT COMPLETED|Part 2 Weeks 5-48 or 72||7
1005685|NCT00537407|2441533|P4|NOT COMPLETED|Part 2 Weeks 5-48 or 72||6
1005686|NCT00537407|2441534|P3|NOT COMPLETED|Part 2 Weeks 5-48 or 72||9
1005687|NCT00537407|2441535|P2|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
1005688|NCT00537407|2441536|P1|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
1005689|NCT00537407|2441532|P5|COMPLETED|Part 2 Weeks 5-48 or 72||3
1005690|NCT00537407|2441533|P4|COMPLETED|Part 2 Weeks 5-48 or 72||4
1005691|NCT00537407|2441534|P3|COMPLETED|Part 2 Weeks 5-48 or 72||2
1005692|NCT00537407|2441535|P2|COMPLETED|Part 2 Weeks 5-48 or 72||1
1005693|NCT00537407|2441536|P1|COMPLETED|Part 2 Weeks 5-48 or 72||2
1005694|NCT00537407|2441532|P5|STARTED|Part 2 Weeks 5-48 or 72||10
1005695|NCT00537407|2441533|P4|STARTED|Part 2 Weeks 5-48 or 72||10
1005696|NCT00537407|2441534|P3|STARTED|Part 2 Weeks 5-48 or 72||11
1005697|NCT00537407|2441535|P2|STARTED|Part 2 Weeks 5-48 or 72||9
1005698|NCT00537407|2441536|P1|STARTED|Part 2 Weeks 5-48 or 72||10
1005699|NCT00537407|2441532|P5|NOT COMPLETED|Part 1 Weeks 1-4||0
1005700|NCT00537407|2441533|P4|NOT COMPLETED|Part 1 Weeks 1-4||0
1005701|NCT00537407|2441534|P3|NOT COMPLETED|Part 1 Weeks 1-4||0
1005702|NCT00537407|2441535|P2|NOT COMPLETED|Part 1 Weeks 1-4||0
1005703|NCT00537407|2441536|P1|NOT COMPLETED|Part 1 Weeks 1-4||0
1005704|NCT00537407|2441532|P5|COMPLETED|Part 1 Weeks 1-4||10
1005705|NCT00537407|2441533|P4|COMPLETED|Part 1 Weeks 1-4||10
1005706|NCT00537407|2441534|P3|COMPLETED|Part 1 Weeks 1-4||11
1005707|NCT00537407|2441535|P2|COMPLETED|Part 1 Weeks 1-4||9
1005708|NCT00537407|2441536|P1|COMPLETED|Part 1 Weeks 1-4||10
1005709|NCT00537407|2441532|P5|STARTED|Part 1 Weeks 1-4||10
1005710|NCT00537407|2441533|P4|STARTED|Part 1 Weeks 1-4||10
1005711|NCT00537407|2441534|P3|STARTED|Part 1 Weeks 1-4||11
1005712|NCT00537407|2441535|P2|STARTED|Part 1 Weeks 1-4||9
1005713|NCT00537407|2441536|P1|STARTED|Part 1 Weeks 1-4||10
1005714|NCT00537485|2441575|P2|NOT COMPLETED|Overall Study||10
1005715|NCT00537485|2441576|P1|NOT COMPLETED|Overall Study||15
1005716|NCT00537485|2441575|P2|COMPLETED|Overall Study||80
1005717|NCT00537485|2441576|P1|COMPLETED|Overall Study||75
1005718|NCT00537485|2441575|P2|STARTED|Overall Study||90
1005719|NCT00537485|2441576|P1|STARTED|Overall Study||90
1005720|NCT00537511|2441600|P1|NOT COMPLETED|Maintenance Phase (Monotherapy)||8
1005721|NCT00537511|2441600|P1|COMPLETED|Maintenance Phase (Monotherapy)||0
1005722|NCT00537511|2441600|P1|STARTED|Maintenance Phase (Monotherapy)||8
1005723|NCT00537511|2441600|P1|NOT COMPLETED|Recovery Period (Monotherapy)||8
1005724|NCT00537511|2441600|P1|COMPLETED|Recovery Period (Monotherapy)||3
1005725|NCT00537511|2441600|P1|STARTED|Recovery Period (Monotherapy)||11
1005726|NCT00537511|2441600|P1|NOT COMPLETED|Extension Period (Combination)||6
1005727|NCT00537511|2441600|P1|COMPLETED|Extension Period (Combination)||11
1005728|NCT00537511|2441600|P1|STARTED|Extension Period (Combination)||17
1005729|NCT00537511|2441600|P1|NOT COMPLETED|Treatment Period (Combination)||5
1005730|NCT00537511|2441600|P1|COMPLETED|Treatment Period (Combination)||17
1005731|NCT00537511|2441600|P1|Safety Population|Treatment Period (Combination)|Safety = All participants who took ≥1 dose of study treatment.|22
1005732|NCT00537511|2441600|P1|Intent-to-Treat (ITT) Populaton|Treatment Period (Combination)|ITT = all participants enrolled in the study.|22
1005733|NCT00537511|2441600|P1|STARTED|Treatment Period (Combination)||22
1005734|NCT00537680|2441628|P3|NOT COMPLETED|Overall Study||0
1005735|NCT00537680|2441629|P2|NOT COMPLETED|Overall Study||2
1005736|NCT00537680|2441630|P1|NOT COMPLETED|Overall Study||0
1005737|NCT00537680|2441628|P3|COMPLETED|Overall Study||24
1005738|NCT00537680|2441629|P2|COMPLETED|Overall Study||22
1005739|NCT00537680|2441630|P1|COMPLETED|Overall Study||22
1005740|NCT00537680|2441628|P3|STARTED|Overall Study||24
1005741|NCT00537680|2441629|P2|STARTED|Overall Study||24
1005742|NCT00537680|2441630|P1|STARTED|Overall Study||22
1005743|NCT00537745|2441638|P1|NOT COMPLETED|Overall Study||5
1005744|NCT00537745|2441638|P1|COMPLETED|Overall Study||9
1005745|NCT00537745|2441638|P1|Began Intervention|Overall Study||11
1005746|NCT00537745|2441638|P1|STARTED|Overall Study|There were three screen fails and two early terminations.|14
1005747|NCT00537771|2441645|P2|NOT COMPLETED|Overall Study||61
1005748|NCT00537771|2441646|P1|NOT COMPLETED|Overall Study||29
1005749|NCT00537771|2441645|P2|COMPLETED|Overall Study||114
1005750|NCT00537771|2441646|P1|COMPLETED|Overall Study||149
1005751|NCT00537771|2441645|P2|STARTED|Overall Study||175
1005752|NCT00537771|2441646|P1|STARTED|Overall Study||178
1005753|NCT00537810|2441660|P4|NOT COMPLETED|Overall Study||4
1005754|NCT00537810|2441661|P3|NOT COMPLETED|Overall Study||4
1005755|NCT00537810|2441662|P2|NOT COMPLETED|Overall Study||13
1005756|NCT00537810|2441663|P1|NOT COMPLETED|Overall Study||6
1005757|NCT00537810|2441660|P4|COMPLETED|Overall Study||22
1005758|NCT00537810|2441661|P3|COMPLETED|Overall Study||21
1005759|NCT00537810|2441662|P2|COMPLETED|Overall Study||14
1005760|NCT00537810|2441663|P1|COMPLETED|Overall Study||20
1005761|NCT00537810|2441660|P4|STARTED|Overall Study||26
1005762|NCT00537810|2441661|P3|STARTED|Overall Study||25
1005763|NCT00537810|2441662|P2|STARTED|Overall Study||27
1005764|NCT00537810|2441663|P1|STARTED|Overall Study||26
1005765|NCT00537823|2441679|P2|NOT COMPLETED|Overall Study||0
1005766|NCT00537823|2441680|P1|NOT COMPLETED|Overall Study||2
1005767|NCT00537823|2441679|P2|COMPLETED|Overall Study||2
1005768|NCT00537823|2441680|P1|COMPLETED|Overall Study||5
1005769|NCT00537823|2441679|P2|STARTED|Overall Study||2
1005770|NCT00537823|2441680|P1|STARTED|Overall Study||7
1005771|NCT00537940|2441704|P2|NOT COMPLETED|Overall Study||179
1005772|NCT00537940|2441705|P1|NOT COMPLETED|Overall Study||183
1005773|NCT00537940|2441704|P2|COMPLETED|Overall Study||62
1005774|NCT00537940|2441705|P1|COMPLETED|Overall Study|2 participants had both treatment related and non-treatment related AE leading to discontinuation.|58
1005775|NCT00537940|2441704|P2|Entered Opt Blinded Continuation Phase|Overall Study||139
1005776|NCT00537940|2441705|P1|Entered Opt Blinded Continuation Phase|Overall Study||140
1005777|NCT00537940|2441704|P2|Completed Maintenance Phase|Overall Study||172
1005778|NCT00537940|2441705|P1|Completed Maintenance Phase|Overall Study||187
1005779|NCT00537940|2441704|P2|Completed Titration Phase|Overall Study||210
1005780|NCT00537940|2441705|P1|Completed Titration Phase|Overall Study||213
1005781|NCT00537940|2441704|P2|STARTED|Overall Study||241
1005782|NCT00537940|2441705|P1|STARTED|Overall Study||241
1005783|NCT00537979|2441729|P2|NOT COMPLETED|Overall Study||20
1005784|NCT00537979|2441730|P1|NOT COMPLETED|Overall Study||6
1005785|NCT00537979|2441729|P2|COMPLETED|Overall Study||89
1005786|NCT00537979|2441730|P1|COMPLETED|Overall Study||32
1005787|NCT00537979|2441729|P2|STARTED|Overall Study||109
1005788|NCT00537979|2441730|P1|STARTED|Overall Study||38
1005789|NCT00538213|2441747|P3|NOT COMPLETED|Overall Study||0
1005790|NCT00538213|2441748|P2|NOT COMPLETED|Overall Study||0
1005791|NCT00538213|2441749|P1|NOT COMPLETED|Overall Study||0
1005792|NCT00538213|2441747|P3|COMPLETED|Overall Study||38
1005793|NCT00538213|2441748|P2|COMPLETED|Overall Study||40
1005794|NCT00538213|2441749|P1|COMPLETED|Overall Study||55
1005795|NCT00538213|2441747|P3|STARTED|Overall Study||38
1005796|NCT00538213|2441748|P2|STARTED|Overall Study||40
1005797|NCT00538213|2441749|P1|STARTED|Overall Study||55
1005798|NCT00538291|2441796|P1|NOT COMPLETED|Overall Study||3
1005799|NCT00538291|2441796|P1|COMPLETED|Overall Study||10
1005800|NCT00538291|2441796|P1|STARTED|Overall Study||13
1005801|NCT00538304|2441802|P2|NOT COMPLETED|Overall Study||5
1005802|NCT00538304|2441803|P1|NOT COMPLETED|Overall Study||7
1005803|NCT00538304|2441802|P2|COMPLETED|Overall Study||66
1005804|NCT00538304|2441803|P1|COMPLETED|Overall Study||144
1005805|NCT00538304|2441802|P2|STARTED|Overall Study||71
1005806|NCT00538304|2441803|P1|STARTED|Overall Study||151
1005807|NCT00538434|2441823|P4|NOT COMPLETED|Overall Study||6
1005808|NCT00538434|2441824|P3|NOT COMPLETED|Overall Study||7
1005809|NCT00538434|2441825|P2|NOT COMPLETED|Overall Study||11
1005810|NCT00538434|2441826|P1|NOT COMPLETED|Overall Study||9
1005811|NCT00538434|2441823|P4|COMPLETED|Overall Study|Completed all scheduled study visits|51
1005812|NCT00538434|2441824|P3|COMPLETED|Overall Study|Completed all scheduled study visits|50
1005813|NCT00538434|2441825|P2|COMPLETED|Overall Study|Completed all scheduled study visits|46
1005814|NCT00538434|2441826|P1|COMPLETED|Overall Study|Completed all scheduled study visits|47
1005815|NCT00538434|2441823|P4|Intent-to-treat (ITT) Population|Overall Study||57
1005816|NCT00538434|2441824|P3|Intent-to-treat (ITT) Population|Overall Study||57
1005817|NCT00538434|2441825|P2|Intent-to-treat (ITT) Population|Overall Study||57
1005818|NCT00538434|2441826|P1|Intent-to-treat (ITT) Population|Overall Study|1 participant was randomized but not treated|55
1005819|NCT00538434|2441823|P4|STARTED|Overall Study||57
1005820|NCT00538434|2441824|P3|STARTED|Overall Study||57
1005821|NCT00538434|2441825|P2|STARTED|Overall Study||57
1005822|NCT00538434|2441826|P1|STARTED|Overall Study||56
1005823|NCT00538473|2441850|P2|NOT COMPLETED|Overall Study||0
1005824|NCT00538473|2441851|P1|NOT COMPLETED|Overall Study||1
1005825|NCT00538473|2441850|P2|COMPLETED|Overall Study||35
1005826|NCT00538473|2441851|P1|COMPLETED|Overall Study||32
1005827|NCT00538473|2441850|P2|STARTED|Overall Study||35
1005828|NCT00538473|2441851|P1|STARTED|Overall Study||33
1005829|NCT00538512|2441886|P3|NOT COMPLETED|Overall Study||13
1005830|NCT00538512|2441887|P2|NOT COMPLETED|Overall Study||30
1005831|NCT00538512|2441888|P1|NOT COMPLETED|Overall Study||27
1005832|NCT00538512|2441886|P3|COMPLETED|Overall Study||312
1005833|NCT00538512|2441887|P2|COMPLETED|Overall Study||783
1005834|NCT00538512|2441888|P1|COMPLETED|Overall Study||787
1005835|NCT00538512|2441886|P3|STARTED|Overall Study||325
1005836|NCT00538512|2441887|P2|STARTED|Overall Study||813
1005837|NCT00538512|2441888|P1|STARTED|Overall Study||814
1005838|NCT00538590|2441898|P2|NOT COMPLETED|Overall Study||0
1005839|NCT00538590|2441899|P1|NOT COMPLETED|Overall Study||1
1005840|NCT00538590|2441898|P2|COMPLETED|Overall Study||10
1005841|NCT00538590|2441899|P1|COMPLETED|Overall Study|Deceased 8 months after surgery due to known cardiovascular co-morbidity.|9
1005842|NCT00538590|2441898|P2|STARTED|Overall Study||10
1005843|NCT00538590|2441899|P1|STARTED|Overall Study||10
1005844|NCT00538616|2441915|P2|NOT COMPLETED|Overall Study||0
1005845|NCT00538616|2441916|P1|NOT COMPLETED|Overall Study||0
1005846|NCT00538616|2441915|P2|COMPLETED|Overall Study||3
1005847|NCT00538616|2441916|P1|COMPLETED|Overall Study||5
1005848|NCT00538616|2441915|P2|STARTED|Overall Study||3
1005849|NCT00538616|2441916|P1|STARTED|Overall Study||5
1005850|NCT00538629|2441922|P1|NOT COMPLETED|Overall Study||22
1005851|NCT00538629|2441922|P1|COMPLETED|Overall Study||449
1005852|NCT00538629|2441922|P1|STARTED|Overall Study||471
1005853|NCT00538642|2441969|P2|NOT COMPLETED|Overall Study||5
1005854|NCT00538642|2441970|P1|NOT COMPLETED|Overall Study||1
1005855|NCT00538642|2441969|P2|COMPLETED|Overall Study||9
1005856|NCT00538642|2441970|P1|COMPLETED|Overall Study||9
1005857|NCT00538642|2441969|P2|STARTED|Overall Study||14
1005858|NCT00538642|2441970|P1|STARTED|Overall Study||10
1005859|NCT00531817|2442012|P2|NOT COMPLETED|Entered Extended Treatment Period||57
1005860|NCT00531817|2442013|P1|NOT COMPLETED|Entered Extended Treatment Period||137
1005861|NCT00531817|2442012|P2|COMPLETED|Entered Extended Treatment Period||113
1005862|NCT00531817|2442013|P1|COMPLETED|Entered Extended Treatment Period||206
1005863|NCT00531817|2442012|P2|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator’s discretion.|170
1005864|NCT00531817|2442013|P1|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator’s discretion.|343
1005865|NCT00531817|2442012|P2|NOT COMPLETED|Randomized||34
1005866|NCT00531817|2442013|P1|NOT COMPLETED|Randomized||59
1005867|NCT00531817|2442012|P2|COMPLETED|Randomized||173
1005868|NCT00531817|2442013|P1|COMPLETED|Randomized||353
1005869|NCT00531817|2442012|P2|Received Study Drug in Core Study|Randomized|2 patients did not receive any study medication. Intent-to-treat population = 205.|205
1005870|NCT00531817|2442013|P1|Received Study Drug in Core Study|Randomized|3 patients did not receive any study medication. Intent-to-treat population = 409.|409
1005871|NCT00531817|2442012|P2|STARTED|Randomized||207
1005872|NCT00531817|2442013|P1|STARTED|Randomized||412
1005873|NCT00531843|2442042|P2|NOT COMPLETED|Overall Study||0
1005874|NCT00531843|2442043|P1|NOT COMPLETED|Overall Study||0
1005875|NCT00531843|2442042|P2|COMPLETED|Overall Study||6
1005876|NCT00531843|2442043|P1|COMPLETED|Overall Study||81
1005877|NCT00531843|2442042|P2|STARTED|Overall Study||6
1005878|NCT00531843|2442043|P1|STARTED|Overall Study||81
1005879|NCT00531882|2442056|P3|NOT COMPLETED|Overall Study||0
1005880|NCT00531882|2442057|P2|NOT COMPLETED|Overall Study||0
1005881|NCT00531882|2442058|P1|NOT COMPLETED|Overall Study||0
1005882|NCT00531882|2442056|P3|COMPLETED|Overall Study||5
1005883|NCT00531882|2442057|P2|COMPLETED|Overall Study||10
1005884|NCT00531882|2442058|P1|COMPLETED|Overall Study||10
1005885|NCT00531882|2442056|P3|STARTED|Overall Study||5
1005886|NCT00531882|2442057|P2|STARTED|Overall Study||10
1005887|NCT00531882|2442058|P1|STARTED|Overall Study||10
1005888|NCT00531934|2442068|P2|NOT COMPLETED|Overall Study||63
1005889|NCT00531934|2442069|P1|NOT COMPLETED|Overall Study||66
1005890|NCT00531934|2442068|P2|COMPLETED|Overall Study||11
1005891|NCT00531934|2442069|P1|COMPLETED|Overall Study||7
1005892|NCT00531934|2442068|P2|STARTED|Overall Study||74
1005893|NCT00531934|2442069|P1|STARTED|Overall Study||73
1005894|NCT00531947|2442139|P2|NOT COMPLETED|Overall Study||51
1005895|NCT00531947|2442140|P1|NOT COMPLETED|Overall Study||42
1005896|NCT00531947|2442139|P2|COMPLETED|Overall Study||101
1005897|NCT00531947|2442140|P1|COMPLETED|Overall Study||114
1005898|NCT00531947|2442139|P2|STARTED|Overall Study|all randomized subjects who received at least one dose of EMSAM study medication|152
1005899|NCT00531947|2442140|P1|STARTED|Overall Study|all randomized subjects who received at least one dose of placebo study medication|156
1005900|NCT00531960|2442184|P2|NOT COMPLETED|Overall Study||63
1005901|NCT00531960|2442185|P1|NOT COMPLETED|Overall Study||61
1005902|NCT00531960|2442184|P2|COMPLETED|Overall Study||0
1005903|NCT00531960|2442185|P1|COMPLETED|Overall Study||0
1005904|NCT00531960|2442184|P2|STARTED|Overall Study||63
1005905|NCT00531960|2442185|P1|STARTED|Overall Study||61
1005906|NCT00538733|2442201|P1|NOT COMPLETED|Overall Study||12
1005907|NCT00538733|2442201|P1|COMPLETED|Overall Study||14
1005908|NCT00538733|2442201|P1|Removed to Pursue Alternative Theray|Overall Study||2
1005909|NCT00538733|2442201|P1|Removed to Pursue a Stem Cell Transplant|Overall Study||11
1005910|NCT00538733|2442201|P1|Removed Due to Progression of Disease|Overall Study||1
1005911|NCT00538733|2442201|P1|STARTED|Overall Study||26
1005912|NCT00538785|2442210|P2|NOT COMPLETED|Overall Study||17
1005913|NCT00538785|2442211|P1|NOT COMPLETED|Overall Study||19
1005914|NCT00538785|2442210|P2|COMPLETED|Overall Study||595
1005915|NCT00538785|2442211|P1|COMPLETED|Overall Study||604
1005916|NCT00538785|2442210|P2|STARTED|Overall Study||612
1005917|NCT00538785|2442211|P1|STARTED|Overall Study|A subject was randomized without appropriate consent in France and is not included in the results.|623
1005918|NCT00538824|2442232|P1|NOT COMPLETED|Overall Study||0
1005919|NCT00538824|2442232|P1|COMPLETED|Overall Study||5
1005920|NCT00538824|2442232|P1|Progression of Disease|Overall Study||2
1005921|NCT00538824|2442232|P1|STARTED|Overall Study||5
1005922|NCT00538850|2442236|P3|NOT COMPLETED|Placebo - Double-blind||3
1005923|NCT00538850|2442237|P2|NOT COMPLETED|Placebo - Double-blind||0
1005924|NCT00538850|2442238|P1|NOT COMPLETED|Placebo - Double-blind||0
1005925|NCT00538850|2442236|P3|COMPLETED|Placebo - Double-blind||95
1005926|NCT00538850|2442237|P2|COMPLETED|Placebo - Double-blind||0
1005927|NCT00538850|2442238|P1|COMPLETED|Placebo - Double-blind||0
1005928|NCT00538850|2442236|P3|STARTED|Placebo - Double-blind||98
1005929|NCT00538850|2442237|P2|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
1005930|NCT00538850|2442238|P1|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
1005931|NCT00538850|2442236|P3|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
1005932|NCT00538850|2442237|P2|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||3
1005933|NCT00538850|2442238|P1|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
1005934|NCT00538850|2442236|P3|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
1005935|NCT00538850|2442237|P2|COMPLETED|Fentanyl Sublingual Spray - Double-blind||95
1005936|NCT00538850|2442238|P1|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
1005937|NCT00538850|2442236|P3|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
1005938|NCT00538850|2442237|P2|STARTED|Fentanyl Sublingual Spray - Double-blind||98
1005939|NCT00538850|2442238|P1|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
1005940|NCT00538850|2442236|P3|NOT COMPLETED|Titration Period||0
1005941|NCT00538850|2442237|P2|NOT COMPLETED|Titration Period||0
1005942|NCT00538850|2442238|P1|NOT COMPLETED|Titration Period||32
1005943|NCT00538850|2442236|P3|COMPLETED|Titration Period||0
1005944|NCT00538850|2442237|P2|COMPLETED|Titration Period||0
1005945|NCT00538850|2442238|P1|COMPLETED|Titration Period||98
1005946|NCT00538850|2442236|P3|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
1005947|NCT00538850|2442237|P2|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
1005948|NCT00538850|2442238|P1|STARTED|Titration Period||130
1005949|NCT00538863|2442250|P1|NOT COMPLETED|Open-label Maintenance||106
1005950|NCT00538863|2442250|P1|COMPLETED|Open-label Maintenance||163
1005951|NCT00538863|2442250|P1|STARTED|Open-label Maintenance|Five participants who completed the titration period did not start the maintenance period.|269
1005952|NCT00538863|2442250|P1|NOT COMPLETED|Open-label Titration||45
1005953|NCT00538863|2442250|P1|COMPLETED|Open-label Titration||184
1005954|NCT00538863|2442250|P1|STARTED|Open-label Titration||229
1005955|NCT00538902|2442259|P3|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
1005956|NCT00538902|2442260|P2|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
1005957|NCT00538902|2442261|P1|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||36
1005958|NCT00538902|2442259|P3|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||52
1005959|NCT00538902|2442260|P2|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||55
1005960|NCT00538902|2442261|P1|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||23
1005961|NCT00538902|2442259|P3|STARTED|OL Wk 24 to End (Primary D/C Reasons)||116
1005962|NCT00538902|2442260|P2|STARTED|OL Wk 24 to End (Primary D/C Reasons)||119
1005963|NCT00538902|2442261|P1|STARTED|OL Wk 24 to End (Primary D/C Reasons)||59
1005964|NCT00538902|2442259|P3|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||5
1005965|NCT00538902|2442260|P2|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||2
1005966|NCT00538902|2442261|P1|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||1
1005967|NCT00538902|2442259|P3|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||116
1005968|NCT00538902|2442260|P2|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||119
1005969|NCT00538902|2442261|P1|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||59
1005970|NCT00538902|2442259|P3|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
1005971|NCT00538902|2442260|P2|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
1005972|NCT00538902|2442261|P1|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||60
1005973|NCT00538915|2442296|P1|NOT COMPLETED|Overall Study||11
1005974|NCT00538915|2442296|P1|COMPLETED|Overall Study||52
1005975|NCT00538915|2442296|P1|STARTED|Overall Study||63
1005976|NCT00538980|2442300|P1|NOT COMPLETED|Overall Study||10
1005977|NCT00538980|2442300|P1|COMPLETED|Overall Study||0
1005978|NCT00538980|2442300|P1|STARTED|Overall Study||10
1005979|NCT00539006|2442312|P4|NOT COMPLETED|Post-Study||0
1005980|NCT00539006|2442313|P3|NOT COMPLETED|Post-Study||0
1005981|NCT00539006|2442314|P2|NOT COMPLETED|Post-Study||0
1005982|NCT00539006|2442315|P1|NOT COMPLETED|Post-Study||0
1005983|NCT00539006|2442312|P4|COMPLETED|Post-Study||81
1005984|NCT00539006|2442313|P3|COMPLETED|Post-Study||77
1005985|NCT00539006|2442314|P2|COMPLETED|Post-Study||83
1005986|NCT00539006|2442315|P1|COMPLETED|Post-Study||75
1005987|NCT00539006|2442312|P4|STARTED|Post-Study||81
1005988|NCT00539006|2442313|P3|STARTED|Post-Study||77
1005989|NCT00539006|2442314|P2|STARTED|Post-Study||83
1005990|NCT00539006|2442315|P1|STARTED|Post-Study||75
1005991|NCT00539006|2442312|P4|NOT COMPLETED|Treatment Period 2||0
1005992|NCT00539006|2442313|P3|NOT COMPLETED|Treatment Period 2||0
1005993|NCT00539006|2442314|P2|NOT COMPLETED|Treatment Period 2||1
1005994|NCT00539006|2442315|P1|NOT COMPLETED|Treatment Period 2||1
1005995|NCT00539006|2442312|P4|COMPLETED|Treatment Period 2||81
1005996|NCT00539006|2442313|P3|COMPLETED|Treatment Period 2||77
1005997|NCT00539006|2442314|P2|COMPLETED|Treatment Period 2||83
1005998|NCT00539006|2442315|P1|COMPLETED|Treatment Period 2||75
1005999|NCT00539006|2442312|P4|STARTED|Treatment Period 2||81
1006000|NCT00539006|2442313|P3|STARTED|Treatment Period 2||77
1006001|NCT00539006|2442314|P2|STARTED|Treatment Period 2||84
1006002|NCT00539006|2442315|P1|STARTED|Treatment Period 2||76
1006003|NCT00539006|2442312|P4|NOT COMPLETED|Washout||9
1006004|NCT00539006|2442313|P3|NOT COMPLETED|Washout||16
1006005|NCT00539006|2442314|P2|NOT COMPLETED|Washout||10
1006006|NCT00539006|2442315|P1|NOT COMPLETED|Washout||20
1006007|NCT00539006|2442312|P4|COMPLETED|Washout||81
1006008|NCT00539006|2442313|P3|COMPLETED|Washout||77
1006009|NCT00539006|2442314|P2|COMPLETED|Washout||84
1006010|NCT00539006|2442315|P1|COMPLETED|Washout||76
1006011|NCT00539006|2442312|P4|STARTED|Washout||90
1006012|NCT00539006|2442313|P3|STARTED|Washout||93
1006013|NCT00539006|2442314|P2|STARTED|Washout||94
1006014|NCT00539006|2442315|P1|STARTED|Washout||96
1006015|NCT00539006|2442312|P4|NOT COMPLETED|Treatment Period 1||1
1006016|NCT00539006|2442313|P3|NOT COMPLETED|Treatment Period 1||2
1006017|NCT00539006|2442314|P2|NOT COMPLETED|Treatment Period 1||0
1006018|NCT00539006|2442315|P1|NOT COMPLETED|Treatment Period 1||0
1006019|NCT00539006|2442312|P4|COMPLETED|Treatment Period 1||90
1006020|NCT00539006|2442313|P3|COMPLETED|Treatment Period 1||93
1006021|NCT00539006|2442314|P2|COMPLETED|Treatment Period 1||94
1006022|NCT00539006|2442315|P1|COMPLETED|Treatment Period 1||96
1006023|NCT00539006|2442312|P4|STARTED|Treatment Period 1||91
1006024|NCT00539006|2442313|P3|STARTED|Treatment Period 1||95
1006025|NCT00539006|2442314|P2|STARTED|Treatment Period 1||94
1006026|NCT00539006|2442315|P1|STARTED|Treatment Period 1||96
1006027|NCT00539006|2442312|P4|NOT COMPLETED|Pre-treatment||0
1006028|NCT00539006|2442313|P3|NOT COMPLETED|Pre-treatment||0
1006029|NCT00539006|2442314|P2|NOT COMPLETED|Pre-treatment||1
1006030|NCT00539006|2442315|P1|NOT COMPLETED|Pre-treatment||0
1006031|NCT00539006|2442312|P4|COMPLETED|Pre-treatment||91
1006032|NCT00539006|2442313|P3|COMPLETED|Pre-treatment||95
1006033|NCT00539006|2442314|P2|COMPLETED|Pre-treatment||94
1006034|NCT00539006|2442315|P1|COMPLETED|Pre-treatment||96
1006035|NCT00539006|2442312|P4|STARTED|Pre-treatment||91
1006036|NCT00539006|2442313|P3|STARTED|Pre-treatment||95
1006037|NCT00539006|2442314|P2|STARTED|Pre-treatment||95
1006038|NCT00539006|2442315|P1|STARTED|Pre-treatment||96
1006039|NCT00539032|2442347|P2|NOT COMPLETED|Overall Study||1
1006040|NCT00539032|2442348|P1|NOT COMPLETED|Overall Study||2
1006041|NCT00539032|2442347|P2|COMPLETED|Overall Study||84
1006042|NCT00539032|2442348|P1|COMPLETED|Overall Study||151
1006043|NCT00539032|2442347|P2|STARTED|Overall Study||85
1006044|NCT00539032|2442348|P1|STARTED|Overall Study||153
1006045|NCT00539864|2442360|P2|NOT COMPLETED|Overall Study||2
1006046|NCT00539864|2442361|P1|NOT COMPLETED|Overall Study||1
1006047|NCT00539864|2442360|P2|COMPLETED|Overall Study||300
1006048|NCT00539864|2442361|P1|COMPLETED|Overall Study||299
1006049|NCT00539864|2442360|P2|STARTED|Overall Study||302
1006050|NCT00539864|2442361|P1|STARTED|Overall Study||300
1006051|NCT00539942|2442375|P2|NOT COMPLETED|Overall Study||0
1006052|NCT00539942|2442376|P1|NOT COMPLETED|Overall Study||0
1006053|NCT00539942|2442375|P2|COMPLETED|Overall Study||3
1006054|NCT00539942|2442376|P1|COMPLETED|Overall Study||4
1006055|NCT00539942|2442375|P2|STARTED|Overall Study||3
1006056|NCT00539942|2442376|P1|STARTED|Overall Study||4
1006057|NCT00539994|2442387|P3|NOT COMPLETED|Overall Study||2
1006058|NCT00539994|2442388|P2|NOT COMPLETED|Overall Study||1
1006059|NCT00539994|2442389|P1|NOT COMPLETED|Overall Study||3
1006060|NCT00539994|2442387|P3|COMPLETED|Overall Study||13
1006061|NCT00539994|2442388|P2|COMPLETED|Overall Study||18
1006062|NCT00539994|2442389|P1|COMPLETED|Overall Study||20
1006063|NCT00539994|2442387|P3|STARTED|Overall Study||15
1006064|NCT00539994|2442388|P2|STARTED|Overall Study||19
1006065|NCT00539994|2442389|P1|STARTED|Overall Study||23
1006066|NCT00540046|2442428|P2|NOT COMPLETED|Overall Study||23
1006067|NCT00540046|2442429|P1|NOT COMPLETED|Overall Study||33
1006068|NCT00540046|2442428|P2|COMPLETED|Overall Study||88
1006069|NCT00540046|2442429|P1|COMPLETED|Overall Study||71
1006070|NCT00540046|2442428|P2|STARTED|Overall Study||111
1006071|NCT00540046|2442429|P1|STARTED|Overall Study||104
1006072|NCT00540124|2442440|P3|NOT COMPLETED|Overall Study||1
1006073|NCT00540124|2442441|P2|NOT COMPLETED|Overall Study||3
1006074|NCT00540124|2442442|P1|NOT COMPLETED|Overall Study||4
1006075|NCT00540124|2442440|P3|COMPLETED|Overall Study||48
1006076|NCT00540124|2442441|P2|COMPLETED|Overall Study||48
1006077|NCT00540124|2442442|P1|COMPLETED|Overall Study||47
1006078|NCT00540124|2442440|P3|STARTED|Overall Study||49
1006079|NCT00540124|2442441|P2|STARTED|Overall Study||51
1006080|NCT00540124|2442442|P1|STARTED|Overall Study||51
1006081|NCT00540228|2442491|P5|NOT COMPLETED|Overall Study||0
1006082|NCT00540228|2442492|P4|NOT COMPLETED|Overall Study||0
1006083|NCT00540228|2442493|P3|NOT COMPLETED|Overall Study||0
1006084|NCT00540228|2442494|P2|NOT COMPLETED|Overall Study||1
1006085|NCT00540228|2442495|P1|NOT COMPLETED|Overall Study||3
1006086|NCT00540228|2442491|P5|COMPLETED|Overall Study||202
1006087|NCT00540228|2442492|P4|COMPLETED|Overall Study||202
1006088|NCT00540228|2442493|P3|COMPLETED|Overall Study||204
1006089|NCT00540228|2442494|P2|COMPLETED|Overall Study||197
1006090|NCT00540228|2442495|P1|COMPLETED|Overall Study||197
1006091|NCT00540228|2442491|P5|STARTED|Overall Study||202
1006092|NCT00540228|2442492|P4|STARTED|Overall Study||202
1006093|NCT00540228|2442493|P3|STARTED|Overall Study||204
1006094|NCT00540228|2442494|P2|STARTED|Overall Study||198
1006095|NCT00540228|2442495|P1|STARTED|Overall Study||200
1006096|NCT00540293|2442562|P1|NOT COMPLETED|Overall Study||35
1006097|NCT00540293|2442562|P1|COMPLETED|Overall Study||390
1006098|NCT00540293|2442562|P1|STARTED|Overall Study||425
1006099|NCT00540423|2442607|P3|NOT COMPLETED|Open-Label Treatment Period||2
1006100|NCT00540423|2442608|P2|NOT COMPLETED|Open-Label Treatment Period||0
1006101|NCT00540423|2442609|P1|NOT COMPLETED|Open-Label Treatment Period||0
1006102|NCT00540423|2442607|P3|COMPLETED|Open-Label Treatment Period||20
1006103|NCT00540423|2442608|P2|COMPLETED|Open-Label Treatment Period||0
1006104|NCT00540423|2442609|P1|COMPLETED|Open-Label Treatment Period||0
1006105|NCT00540423|2442607|P3|STARTED|Open-Label Treatment Period||22
1006106|NCT00540423|2442608|P2|STARTED|Open-Label Treatment Period||0
1006107|NCT00540423|2442609|P1|STARTED|Open-Label Treatment Period||0
1006108|NCT00540423|2442607|P3|NOT COMPLETED|Double-Blind Treatment Period||0
1006109|NCT00540423|2442608|P2|NOT COMPLETED|Double-Blind Treatment Period||1
1006110|NCT00540423|2442609|P1|NOT COMPLETED|Double-Blind Treatment Period||0
1006111|NCT00540423|2442607|P3|COMPLETED|Double-Blind Treatment Period||0
1006112|NCT00540423|2442608|P2|COMPLETED|Double-Blind Treatment Period||14
1006113|NCT00540423|2442609|P1|COMPLETED|Double-Blind Treatment Period||8
1006114|NCT00540423|2442607|P3|STARTED|Double-Blind Treatment Period||0
1006115|NCT00540423|2442608|P2|STARTED|Double-Blind Treatment Period||15
1006116|NCT00540423|2442609|P1|STARTED|Double-Blind Treatment Period||8
1006117|NCT00540436|2442659|P1|NOT COMPLETED|Second 12-Week Treatment Period||1
1006118|NCT00540436|2442659|P1|COMPLETED|Second 12-Week Treatment Period||21
1006119|NCT00540436|2442659|P1|STARTED|Second 12-Week Treatment Period||22
1006120|NCT00540436|2442659|P1|NOT COMPLETED|First 12-Week Treatment Period||3
1006121|NCT00540436|2442659|P1|COMPLETED|First 12-Week Treatment Period||22
1006122|NCT00540436|2442659|P1|STARTED|First 12-Week Treatment Period||25
1006123|NCT00540449|2442674|P2|NOT COMPLETED|Overall Study||78
1006124|NCT00540449|2442675|P1|NOT COMPLETED|Overall Study||84
1006125|NCT00540449|2442674|P2|COMPLETED|Overall Study||266
1006126|NCT00540449|2442675|P1|COMPLETED|Overall Study||262
1006127|NCT00540449|2442674|P2|STARTED|Overall Study||344
1006128|NCT00540449|2442675|P1|STARTED|Overall Study||346
1006129|NCT00540514|2442699|P2|NOT COMPLETED|Overall Study||266
1006130|NCT00540514|2442700|P1|NOT COMPLETED|Overall Study||246
1006131|NCT00540514|2442699|P2|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|265
1006132|NCT00540514|2442700|P1|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|275
1006133|NCT00540514|2442699|P2|Biomarker Population|Overall Study||36
1006134|NCT00540514|2442700|P1|Biomarker Population|Overall Study||35
1006135|NCT00540514|2442699|P2|Treated|Overall Study||524
1006136|NCT00540514|2442700|P1|Treated|Overall Study||514
1006137|NCT00540514|2442699|P2|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|531
1006138|NCT00540514|2442700|P1|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|521
1006139|NCT00540579|2442730|P1|NOT COMPLETED|Overall Study||0
1006140|NCT00540579|2442730|P1|COMPLETED|Overall Study||23
1006141|NCT00540579|2442730|P1|STARTED|Overall Study||23
1006142|NCT00540592|2442745|P10|NOT COMPLETED|Overall Study||2
1006143|NCT00540592|2442746|P9|NOT COMPLETED|Overall Study||1
1006144|NCT00540592|2442747|P8|NOT COMPLETED|Overall Study||1
1006145|NCT00540592|2442748|P7|NOT COMPLETED|Overall Study||0
1006146|NCT00540592|2442749|P6|NOT COMPLETED|Overall Study||0
1006147|NCT00540592|2442750|P5|NOT COMPLETED|Overall Study||1
1006148|NCT00540592|2442751|P4|NOT COMPLETED|Overall Study||1
1006149|NCT00540592|2442752|P3|NOT COMPLETED|Overall Study||1
1006150|NCT00540592|2442753|P2|NOT COMPLETED|Overall Study||1
1006151|NCT00540592|2442754|P1|NOT COMPLETED|Overall Study||2
1006152|NCT00540592|2442745|P10|COMPLETED|Overall Study||201
1006153|NCT00540592|2442746|P9|COMPLETED|Overall Study||199
1006154|NCT00540592|2442747|P8|COMPLETED|Overall Study||198
1006155|NCT00540592|2442748|P7|COMPLETED|Overall Study||198
1006156|NCT00540592|2442749|P6|COMPLETED|Overall Study||198
1006157|NCT00540592|2442750|P5|COMPLETED|Overall Study||198
1006158|NCT00540592|2442751|P4|COMPLETED|Overall Study||201
1006159|NCT00540592|2442752|P3|COMPLETED|Overall Study||201
1006160|NCT00540592|2442753|P2|COMPLETED|Overall Study||201
1006161|NCT00540592|2442754|P1|COMPLETED|Overall Study||202
1006162|NCT00540592|2442745|P10|Completed at Day 180|Overall Study||189
1006163|NCT00540592|2442746|P9|Completed at Day 180|Overall Study||198
1006164|NCT00540592|2442747|P8|Completed at Day 180|Overall Study||193
1006165|NCT00540592|2442748|P7|Completed at Day 180|Overall Study||196
1006166|NCT00540592|2442749|P6|Completed at Day 180|Overall Study||198
1006167|NCT00540592|2442750|P5|Completed at Day 180|Overall Study||195
1006168|NCT00540592|2442751|P4|Completed at Day 180|Overall Study||197
1006169|NCT00540592|2442752|P3|Completed at Day 180|Overall Study||197
1006170|NCT00540592|2442753|P2|Completed at Day 180|Overall Study||201
1006171|NCT00540592|2442754|P1|Completed at Day 180|Overall Study||200
1006172|NCT00540592|2442745|P10|STARTED|Overall Study||203
1006173|NCT00540592|2442746|P9|STARTED|Overall Study||200
1006174|NCT00540592|2442747|P8|STARTED|Overall Study||199
1006175|NCT00540592|2442748|P7|STARTED|Overall Study||198
1006176|NCT00540592|2442749|P6|STARTED|Overall Study||198
1006177|NCT00540592|2442750|P5|STARTED|Overall Study||199
1006178|NCT00540592|2442751|P4|STARTED|Overall Study||202
1006179|NCT00540592|2442752|P3|STARTED|Overall Study||202
1006180|NCT00540592|2442753|P2|STARTED|Overall Study||202
1006181|NCT00540592|2442754|P1|STARTED|Overall Study||204
1006182|NCT00540644|2442988|P2|NOT COMPLETED|Overall Study||9
1006183|NCT00540644|2442989|P1|NOT COMPLETED|Overall Study||9
1006184|NCT00540644|2442988|P2|COMPLETED|Overall Study||13
1006185|NCT00540644|2442989|P1|COMPLETED|Overall Study||39
1006186|NCT00540644|2442988|P2|STARTED|Overall Study||22
1006187|NCT00540644|2442989|P1|STARTED|Overall Study||48
1006188|NCT00540722|2442999|P1|NOT COMPLETED|Overall Study||0
1006189|NCT00540722|2442999|P1|COMPLETED|Overall Study||56
1006190|NCT00540722|2442999|P1|STARTED|Overall Study||56
1006191|NCT00540969|2443009|P2|NOT COMPLETED|Overall Study||0
1006192|NCT00540969|2443010|P1|NOT COMPLETED|Overall Study||0
1006193|NCT00540969|2443009|P2|COMPLETED|Overall Study||1
1006194|NCT00540969|2443010|P1|COMPLETED|Overall Study||2
1006195|NCT00540969|2443009|P2|STARTED|Overall Study||1
1006196|NCT00540969|2443010|P1|STARTED|Overall Study||2
1006197|NCT00541034|2443020|P1|NOT COMPLETED|Overall Study||3
1006198|NCT00541034|2443020|P1|COMPLETED|Overall Study||46
1006199|NCT00541034|2443020|P1|STARTED|Overall Study||49
1006200|NCT00541099|2443024|P1|NOT COMPLETED|Overall Study||3
1006201|NCT00541099|2443024|P1|COMPLETED|Overall Study||8
1006202|NCT00541099|2443024|P1|STARTED|Overall Study||11
1006203|NCT00541190|2443030|P2|NOT COMPLETED|Overall Study||0
1006204|NCT00541190|2443031|P1|NOT COMPLETED|Overall Study||0
1006205|NCT00541190|2443030|P2|COMPLETED|Overall Study||11
1006206|NCT00541190|2443031|P1|COMPLETED|Overall Study||10
1006207|NCT00541190|2443030|P2|STARTED|Overall Study||11
1006208|NCT00541190|2443031|P1|STARTED|Overall Study||10
1006209|NCT00541229|2443045|P6|NOT COMPLETED|Treatment Period III (Week 11)||1
1006210|NCT00541229|2443046|P5|NOT COMPLETED|Treatment Period III (Week 11)||1
1006211|NCT00541229|2443047|P4|NOT COMPLETED|Treatment Period III (Week 11)||0
1006212|NCT00541229|2443048|P3|NOT COMPLETED|Treatment Period III (Week 11)||1
1006213|NCT00541229|2443049|P2|NOT COMPLETED|Treatment Period III (Week 11)||0
1006214|NCT00541229|2443050|P1|NOT COMPLETED|Treatment Period III (Week 11)||0
1006215|NCT00541229|2443045|P6|COMPLETED|Treatment Period III (Week 11)||4
1006216|NCT00541229|2443046|P5|COMPLETED|Treatment Period III (Week 11)||6
1006217|NCT00541229|2443047|P4|COMPLETED|Treatment Period III (Week 11)||8
1006218|NCT00541229|2443048|P3|COMPLETED|Treatment Period III (Week 11)||9
1006219|NCT00541229|2443049|P2|COMPLETED|Treatment Period III (Week 11)||8
1006220|NCT00541229|2443050|P1|COMPLETED|Treatment Period III (Week 11)||7
1006221|NCT00541229|2443045|P6|STARTED|Treatment Period III (Week 11)||5
1006222|NCT00541229|2443046|P5|STARTED|Treatment Period III (Week 11)||7
1006223|NCT00541229|2443047|P4|STARTED|Treatment Period III (Week 11)||8
1006224|NCT00541229|2443048|P3|STARTED|Treatment Period III (Week 11)||10
1006225|NCT00541229|2443049|P2|STARTED|Treatment Period III (Week 11)||8
1006226|NCT00541229|2443050|P1|STARTED|Treatment Period III (Week 11)||7
1006227|NCT00541229|2443045|P6|NOT COMPLETED|Washout Period II (Week 7-10)||3
1006228|NCT00541229|2443046|P5|NOT COMPLETED|Washout Period II (Week 7-10)||4
1006229|NCT00541229|2443047|P4|NOT COMPLETED|Washout Period II (Week 7-10)||4
1006230|NCT00541229|2443048|P3|NOT COMPLETED|Washout Period II (Week 7-10)||2
1006231|NCT00541229|2443049|P2|NOT COMPLETED|Washout Period II (Week 7-10)||4
1006232|NCT00541229|2443050|P1|NOT COMPLETED|Washout Period II (Week 7-10)||4
1006233|NCT00541229|2443045|P6|COMPLETED|Washout Period II (Week 7-10)||5
1006234|NCT00541229|2443046|P5|COMPLETED|Washout Period II (Week 7-10)||7
1006235|NCT00541229|2443047|P4|COMPLETED|Washout Period II (Week 7-10)||8
1006236|NCT00541229|2443048|P3|COMPLETED|Washout Period II (Week 7-10)||10
1006237|NCT00541229|2443049|P2|COMPLETED|Washout Period II (Week 7-10)||8
1006238|NCT00541229|2443050|P1|COMPLETED|Washout Period II (Week 7-10)||7
1006239|NCT00541229|2443045|P6|STARTED|Washout Period II (Week 7-10)||8
1006240|NCT00541229|2443046|P5|STARTED|Washout Period II (Week 7-10)||11
1006241|NCT00541229|2443047|P4|STARTED|Washout Period II (Week 7-10)||12
1006242|NCT00541229|2443048|P3|STARTED|Washout Period II (Week 7-10)||12
1006243|NCT00541229|2443049|P2|STARTED|Washout Period II (Week 7-10)||12
1006244|NCT00541229|2443050|P1|STARTED|Washout Period II (Week 7-10)||11
1006245|NCT00541229|2443045|P6|NOT COMPLETED|Treatment Period II (Week 6)||3
1006246|NCT00541229|2443046|P5|NOT COMPLETED|Treatment Period II (Week 6)||2
1006247|NCT00541229|2443047|P4|NOT COMPLETED|Treatment Period II (Week 6)||1
1006248|NCT00541229|2443048|P3|NOT COMPLETED|Treatment Period II (Week 6)||1
1006249|NCT00541229|2443049|P2|NOT COMPLETED|Treatment Period II (Week 6)||1
1006250|NCT00541229|2443050|P1|NOT COMPLETED|Treatment Period II (Week 6)||2
1006251|NCT00541229|2443045|P6|COMPLETED|Treatment Period II (Week 6)||8
1006252|NCT00541229|2443046|P5|COMPLETED|Treatment Period II (Week 6)||11
1006253|NCT00541229|2443047|P4|COMPLETED|Treatment Period II (Week 6)||12
1006254|NCT00541229|2443048|P3|COMPLETED|Treatment Period II (Week 6)||12
1006255|NCT00541229|2443049|P2|COMPLETED|Treatment Period II (Week 6)||12
1006256|NCT00541229|2443050|P1|COMPLETED|Treatment Period II (Week 6)||11
1006257|NCT00541229|2443045|P6|STARTED|Treatment Period II (Week 6)||11
1006258|NCT00541229|2443046|P5|STARTED|Treatment Period II (Week 6)||13
1006259|NCT00541229|2443047|P4|STARTED|Treatment Period II (Week 6)||13
1006260|NCT00541229|2443048|P3|STARTED|Treatment Period II (Week 6)||13
1006261|NCT00541229|2443049|P2|STARTED|Treatment Period II (Week 6)||13
1006262|NCT00541229|2443050|P1|STARTED|Treatment Period II (Week 6)||13
1006263|NCT00541229|2443045|P6|NOT COMPLETED|Washout Period I (Week 2-5)||5
1006264|NCT00541229|2443046|P5|NOT COMPLETED|Washout Period I (Week 2-5)||1
1006265|NCT00541229|2443047|P4|NOT COMPLETED|Washout Period I (Week 2-5)||4
1006266|NCT00541229|2443048|P3|NOT COMPLETED|Washout Period I (Week 2-5)||4
1006267|NCT00541229|2443049|P2|NOT COMPLETED|Washout Period I (Week 2-5)||2
1006268|NCT00541229|2443050|P1|NOT COMPLETED|Washout Period I (Week 2-5)||4
1006269|NCT00541229|2443045|P6|COMPLETED|Washout Period I (Week 2-5)||11
1006270|NCT00541229|2443046|P5|COMPLETED|Washout Period I (Week 2-5)||13
1006271|NCT00541229|2443047|P4|COMPLETED|Washout Period I (Week 2-5)||13
1006272|NCT00541229|2443048|P3|COMPLETED|Washout Period I (Week 2-5)||13
1006273|NCT00541229|2443049|P2|COMPLETED|Washout Period I (Week 2-5)||13
1006274|NCT00541229|2443050|P1|COMPLETED|Washout Period I (Week 2-5)||13
1006275|NCT00541229|2443045|P6|STARTED|Washout Period I (Week 2-5)||16
1006276|NCT00541229|2443046|P5|STARTED|Washout Period I (Week 2-5)||14
1006277|NCT00541229|2443047|P4|STARTED|Washout Period I (Week 2-5)||17
1006278|NCT00541229|2443048|P3|STARTED|Washout Period I (Week 2-5)||17
1006279|NCT00541229|2443049|P2|STARTED|Washout Period I (Week 2-5)||15
1006280|NCT00541229|2443050|P1|STARTED|Washout Period I (Week 2-5)||17
1006281|NCT00541229|2443045|P6|NOT COMPLETED|Treatment Period I (Week 1)||2
1006282|NCT00541229|2443046|P5|NOT COMPLETED|Treatment Period I (Week 1)||0
1006283|NCT00541229|2443047|P4|NOT COMPLETED|Treatment Period I (Week 1)||1
1006284|NCT00541229|2443048|P3|NOT COMPLETED|Treatment Period I (Week 1)||3
1006285|NCT00541229|2443049|P2|NOT COMPLETED|Treatment Period I (Week 1)||1
1006286|NCT00541229|2443050|P1|NOT COMPLETED|Treatment Period I (Week 1)||0
1006287|NCT00541229|2443045|P6|COMPLETED|Treatment Period I (Week 1)||16
1006288|NCT00541229|2443046|P5|COMPLETED|Treatment Period I (Week 1)||14
1006289|NCT00541229|2443047|P4|COMPLETED|Treatment Period I (Week 1)||17
1006290|NCT00541229|2443048|P3|COMPLETED|Treatment Period I (Week 1)||17
1006291|NCT00541229|2443049|P2|COMPLETED|Treatment Period I (Week 1)||15
1006292|NCT00541229|2443050|P1|COMPLETED|Treatment Period I (Week 1)||17
1006293|NCT00541229|2443045|P6|STARTED|Treatment Period I (Week 1)||18
1006294|NCT00541229|2443046|P5|STARTED|Treatment Period I (Week 1)||14
1006295|NCT00541229|2443047|P4|STARTED|Treatment Period I (Week 1)||18
1006296|NCT00541229|2443048|P3|STARTED|Treatment Period I (Week 1)||20
1006297|NCT00541229|2443049|P2|STARTED|Treatment Period I (Week 1)||16
1006298|NCT00541229|2443050|P1|STARTED|Treatment Period I (Week 1)||17
1006299|NCT00541242|2443060|P2|NOT COMPLETED|Treatment Period 2||7
1006300|NCT00541242|2443061|P1|NOT COMPLETED|Treatment Period 2||9
1006301|NCT00541242|2443060|P2|COMPLETED|Treatment Period 2||266
1006302|NCT00541242|2443061|P1|COMPLETED|Treatment Period 2||261
1006303|NCT00541242|2443060|P2|STARTED|Treatment Period 2||273
1006304|NCT00541242|2443061|P1|STARTED|Treatment Period 2||270
1006305|NCT00541242|2443060|P2|NOT COMPLETED|Treatment Period 1||0
1006306|NCT00541242|2443061|P1|NOT COMPLETED|Treatment Period 1||0
1006307|NCT00541242|2443060|P2|COMPLETED|Treatment Period 1|43 of the 586 patients did not enter Treatment Period 2 (Randomized at Week 6)|586
1006308|NCT00541242|2443061|P1|COMPLETED|Treatment Period 1||0
1006309|NCT00541242|2443060|P2|STARTED|Treatment Period 1|586 patients were enrolled and received open-label latanoprost for 6 weeks|586
1006310|NCT00541242|2443061|P1|STARTED|Treatment Period 1||0
1006311|NCT00541307|2443069|P1|NOT COMPLETED|Overall Study||24
1006312|NCT00541307|2443069|P1|COMPLETED|Overall Study||95
1006313|NCT00541307|2443069|P1|STARTED|Overall Study||119
1006314|NCT00541346|2443077|P1|NOT COMPLETED|Follow-up||1
1006315|NCT00541346|2443077|P1|COMPLETED|Follow-up||15
1006316|NCT00541346|2443077|P1|STARTED|Follow-up||16
1006317|NCT00541346|2443077|P1|NOT COMPLETED|Baseline||0
1006318|NCT00541346|2443077|P1|COMPLETED|Baseline||16
1006319|NCT00541346|2443077|P1|STARTED|Baseline||16
1006320|NCT00541450|2443093|P2|NOT COMPLETED|Phase B||31
1006321|NCT00541450|2443094|P1|NOT COMPLETED|Phase B||37
1006322|NCT00541450|2443093|P2|COMPLETED|Phase B||200
1006323|NCT00541450|2443094|P1|COMPLETED|Phase B||187
1006324|NCT00541450|2443093|P2|STARTED|Phase B||231
1006325|NCT00541450|2443094|P1|STARTED|Phase B||224
1006326|NCT00541450|2443093|P2|NOT COMPLETED|Phase A||17
1006327|NCT00541450|2443094|P1|NOT COMPLETED|Phase A||20
1006328|NCT00541450|2443093|P2|COMPLETED|Phase A||231
1006329|NCT00541450|2443094|P1|COMPLETED|Phase A||224
1006330|NCT00541450|2443093|P2|STARTED|Phase A||248
1006331|NCT00541450|2443094|P1|STARTED|Phase A||244
1006332|NCT00541593|2443112|P1|NOT COMPLETED|Overall Study||0
1006333|NCT00541593|2443112|P1|COMPLETED|Overall Study||5
1006334|NCT00541593|2443112|P1|STARTED|Overall Study||5
1006335|NCT00541658|2443119|P3|NOT COMPLETED|Overall Study||68
1006336|NCT00541658|2443120|P2|NOT COMPLETED|Overall Study||73
1006337|NCT00541658|2443121|P1|NOT COMPLETED|Overall Study||60
1006338|NCT00541658|2443119|P3|COMPLETED|Overall Study||240
1006339|NCT00541658|2443120|P2|COMPLETED|Overall Study||234
1006340|NCT00541658|2443121|P1|COMPLETED|Overall Study||248
1006341|NCT00541658|2443119|P3|ITT Population|Overall Study||308
1006342|NCT00541658|2443120|P2|ITT Population|Overall Study||307
1006343|NCT00541658|2443121|P1|ITT Population|Overall Study||307
1006344|NCT00541658|2443119|P3|STARTED|Overall Study||308
1006345|NCT00541658|2443120|P2|STARTED|Overall Study||307
1006346|NCT00541658|2443121|P1|STARTED|Overall Study||308
1006347|NCT00541671|2443280|P2|NOT COMPLETED|Overall Study||0
1006348|NCT00541671|2443281|P1|NOT COMPLETED|Overall Study||0
1006349|NCT00541671|2443280|P2|COMPLETED|Overall Study||12
1006350|NCT00541671|2443281|P1|COMPLETED|Overall Study||13
1006351|NCT00541671|2443280|P2|STARTED|Overall Study||12
1006352|NCT00541671|2443281|P1|STARTED|Overall Study||13
1006353|NCT00541775|2443290|P3|NOT COMPLETED|Overall Study||8
1006354|NCT00541775|2443291|P2|NOT COMPLETED|Overall Study||2
1006355|NCT00541775|2443292|P1|NOT COMPLETED|Overall Study||9
1006356|NCT00541775|2443290|P3|COMPLETED|Overall Study||84
1006357|NCT00541775|2443291|P2|COMPLETED|Overall Study||85
1006358|NCT00541775|2443292|P1|COMPLETED|Overall Study||85
1006359|NCT00541775|2443290|P3|STARTED|Overall Study||92
1006360|NCT00541775|2443291|P2|STARTED|Overall Study||87
1006361|NCT00541775|2443292|P1|STARTED|Overall Study||94
1006362|NCT00541970|2443310|P4|NOT COMPLETED|Month 60||72
1006363|NCT00541970|2443311|P3|NOT COMPLETED|Month 60||82
1006364|NCT00541970|2443312|P2|NOT COMPLETED|Month 60||77
1006365|NCT00541970|2443313|P1|NOT COMPLETED|Month 60||78
1006366|NCT00541970|2443310|P4|COMPLETED|Month 60||167
1006367|NCT00541970|2443311|P3|COMPLETED|Month 60||158
1006368|NCT00541970|2443312|P2|COMPLETED|Month 60||164
1006369|NCT00541970|2443313|P1|COMPLETED|Month 60||162
1006370|NCT00541970|2443310|P4|STARTED|Month 60||239
1006371|NCT00541970|2443311|P3|STARTED|Month 60||240
1006372|NCT00541970|2443312|P2|STARTED|Month 60||241
1006373|NCT00541970|2443313|P1|STARTED|Month 60||240
1006374|NCT00541970|2443310|P4|NOT COMPLETED|Month 48||75
1006375|NCT00541970|2443311|P3|NOT COMPLETED|Month 48||73
1006376|NCT00541970|2443312|P2|NOT COMPLETED|Month 48||73
1006377|NCT00541970|2443313|P1|NOT COMPLETED|Month 48||71
1006378|NCT00541970|2443310|P4|COMPLETED|Month 48||164
1006379|NCT00541970|2443311|P3|COMPLETED|Month 48||167
1006380|NCT00541970|2443312|P2|COMPLETED|Month 48||168
1006381|NCT00541970|2443313|P1|COMPLETED|Month 48||169
1006382|NCT00541970|2443310|P4|STARTED|Month 48||239
1006383|NCT00541970|2443311|P3|STARTED|Month 48||240
1006384|NCT00541970|2443312|P2|STARTED|Month 48||241
1006385|NCT00541970|2443313|P1|STARTED|Month 48||240
1006386|NCT00541970|2443310|P4|NOT COMPLETED|Month 36||60
1006387|NCT00541970|2443311|P3|NOT COMPLETED|Month 36||66
1006388|NCT00541970|2443312|P2|NOT COMPLETED|Month 36||66
1006389|NCT00541970|2443313|P1|NOT COMPLETED|Month 36||61
1006390|NCT00541970|2443310|P4|COMPLETED|Month 36||179
1006391|NCT00541970|2443311|P3|COMPLETED|Month 36||174
1006392|NCT00541970|2443312|P2|COMPLETED|Month 36||175
1006393|NCT00541970|2443313|P1|COMPLETED|Month 36||179
1006394|NCT00541970|2443310|P4|STARTED|Month 36||239
1006395|NCT00541970|2443311|P3|STARTED|Month 36||240
1006396|NCT00541970|2443312|P2|STARTED|Month 36||241
1006397|NCT00541970|2443313|P1|STARTED|Month 36||240
1006398|NCT00541970|2443310|P4|NOT COMPLETED|Month 24||22
1006399|NCT00541970|2443311|P3|NOT COMPLETED|Month 24||32
1006400|NCT00541970|2443312|P2|NOT COMPLETED|Month 24||32
1006401|NCT00541970|2443313|P1|NOT COMPLETED|Month 24||29
1006402|NCT00541970|2443310|P4|COMPLETED|Month 24||217
1006403|NCT00541970|2443311|P3|COMPLETED|Month 24||208
1006404|NCT00541970|2443312|P2|COMPLETED|Month 24||209
1006405|NCT00541970|2443313|P1|COMPLETED|Month 24||211
1006406|NCT00541970|2443310|P4|STARTED|Month 24||239
1006407|NCT00541970|2443311|P3|STARTED|Month 24||240
1006408|NCT00541970|2443312|P2|STARTED|Month 24||241
1006409|NCT00541970|2443313|P1|STARTED|Month 24||240
1006410|NCT00541970|2443310|P4|NOT COMPLETED|Month 18||17
1006411|NCT00541970|2443311|P3|NOT COMPLETED|Month 18||25
1006412|NCT00541970|2443312|P2|NOT COMPLETED|Month 18||24
1006413|NCT00541970|2443313|P1|NOT COMPLETED|Month 18||14
1006414|NCT00541970|2443310|P4|COMPLETED|Month 18||222
1006415|NCT00541970|2443311|P3|COMPLETED|Month 18||215
1006416|NCT00541970|2443312|P2|COMPLETED|Month 18||217
1006417|NCT00541970|2443313|P1|COMPLETED|Month 18||226
1006418|NCT00541970|2443310|P4|STARTED|Month 18||239
1006419|NCT00541970|2443311|P3|STARTED|Month 18||240
1006420|NCT00541970|2443312|P2|STARTED|Month 18||241
1006421|NCT00541970|2443313|P1|STARTED|Month 18||240
1006422|NCT00541970|2443310|P4|NOT COMPLETED|Month 12||16
1006423|NCT00541970|2443311|P3|NOT COMPLETED|Month 12||21
1006424|NCT00541970|2443312|P2|NOT COMPLETED|Month 12||22
1006425|NCT00541970|2443313|P1|NOT COMPLETED|Month 12||12
1006426|NCT00541970|2443310|P4|COMPLETED|Month 12||223
1006427|NCT00541970|2443311|P3|COMPLETED|Month 12||219
1006428|NCT00541970|2443312|P2|COMPLETED|Month 12||219
1006429|NCT00541970|2443313|P1|COMPLETED|Month 12||228
1006430|NCT00541970|2443310|P4|STARTED|Month 12||239
1006431|NCT00541970|2443311|P3|STARTED|Month 12||240
1006432|NCT00541970|2443312|P2|STARTED|Month 12||241
1006433|NCT00541970|2443313|P1|STARTED|Month 12||240
1006434|NCT00541970|2443310|P4|NOT COMPLETED|Month 7||5
1006435|NCT00541970|2443311|P3|NOT COMPLETED|Month 7||11
1006436|NCT00541970|2443312|P2|NOT COMPLETED|Month 7||13
1006437|NCT00541970|2443313|P1|NOT COMPLETED|Month 7||9
1006438|NCT00541970|2443310|P4|COMPLETED|Month 7||234
1006439|NCT00541970|2443311|P3|COMPLETED|Month 7||229
1006440|NCT00541970|2443312|P2|COMPLETED|Month 7||228
1006441|NCT00541970|2443313|P1|COMPLETED|Month 7||231
1006442|NCT00541970|2443310|P4|STARTED|Month 7||239
1006443|NCT00541970|2443311|P3|STARTED|Month 7||240
1006444|NCT00541970|2443312|P2|STARTED|Month 7||241
1006445|NCT00541970|2443313|P1|STARTED|Month 7||240
1006446|NCT00542178|2443468|P8|NOT COMPLETED|Overall Study||85
1006447|NCT00542178|2443469|P7|NOT COMPLETED|Overall Study||87
1006448|NCT00542178|2443470|P6|NOT COMPLETED|Overall Study||89
1006449|NCT00542178|2443471|P5|NOT COMPLETED|Overall Study||64
1006450|NCT00542178|2443472|P4|NOT COMPLETED|Overall Study||62
1006451|NCT00542178|2443473|P3|NOT COMPLETED|Overall Study||74
1006452|NCT00542178|2443474|P2|NOT COMPLETED|Overall Study||80
1006453|NCT00542178|2443475|P1|NOT COMPLETED|Overall Study||75
1006454|NCT00542178|2443468|P8|COMPLETED|Overall Study||381
1006455|NCT00542178|2443469|P7|COMPLETED|Overall Study||406
1006456|NCT00542178|2443470|P6|COMPLETED|Overall Study||406
1006457|NCT00542178|2443471|P5|COMPLETED|Overall Study||400
1006458|NCT00542178|2443472|P4|COMPLETED|Overall Study||308
1006459|NCT00542178|2443473|P3|COMPLETED|Overall Study||308
1006460|NCT00542178|2443474|P2|COMPLETED|Overall Study||332
1006461|NCT00542178|2443475|P1|COMPLETED|Overall Study||315
1006462|NCT00542178|2443468|P8|STARTED|Overall Study||466
1006463|NCT00542178|2443469|P7|STARTED|Overall Study||493
1006464|NCT00542178|2443470|P6|STARTED|Overall Study||495
1006465|NCT00542178|2443471|P5|STARTED|Overall Study||464
1006466|NCT00542178|2443472|P4|STARTED|Overall Study||370
1006467|NCT00542178|2443473|P3|STARTED|Overall Study||382
1006468|NCT00542178|2443474|P2|STARTED|Overall Study||412
1006469|NCT00542178|2443475|P1|STARTED|Overall Study||390
1006470|NCT00534937|2443491|P2|NOT COMPLETED|Overall Study||12
1006471|NCT00534937|2443492|P1|NOT COMPLETED|Overall Study||8
1006472|NCT00534937|2443491|P2|COMPLETED|Overall Study||35
1006473|NCT00534937|2443492|P1|COMPLETED|Overall Study||34
1006474|NCT00534937|2443491|P2|STARTED|Overall Study||47
1006475|NCT00534937|2443492|P1|STARTED|Overall Study||42
1006476|NCT00534976|2443506|P2|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||0
1006477|NCT00534976|2443507|P1|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||2
1006478|NCT00534976|2443506|P2|COMPLETED|Period 3: Crossover Placebo/ Montelukast||32
1006479|NCT00534976|2443507|P1|COMPLETED|Period 3: Crossover Placebo/ Montelukast||31
1006480|NCT00534976|2443506|P2|STARTED|Period 3: Crossover Placebo/ Montelukast||32
1006481|NCT00534976|2443507|P1|STARTED|Period 3: Crossover Placebo/ Montelukast||33
1006482|NCT00534976|2443506|P2|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||1
1006483|NCT00534976|2443507|P1|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||0
1006484|NCT00534976|2443506|P2|COMPLETED|Period 2: Treatment Montelukast/ Placebo||32
1006485|NCT00534976|2443507|P1|COMPLETED|Period 2: Treatment Montelukast/ Placebo||33
1006486|NCT00534976|2443506|P2|STARTED|Period 2: Treatment Montelukast/ Placebo||33
1006487|NCT00534976|2443507|P1|STARTED|Period 2: Treatment Montelukast/ Placebo||33
1006488|NCT00534976|2443506|P2|NOT COMPLETED|Period 1: Placebo Run-in||0
1006489|NCT00534976|2443507|P1|NOT COMPLETED|Period 1: Placebo Run-in||0
1006490|NCT00534976|2443506|P2|COMPLETED|Period 1: Placebo Run-in||33
1006491|NCT00534976|2443507|P1|COMPLETED|Period 1: Placebo Run-in||33
1006492|NCT00534976|2443506|P2|STARTED|Period 1: Placebo Run-in||33
1006493|NCT00534976|2443507|P1|STARTED|Period 1: Placebo Run-in||33
1006494|NCT00535002|2443535|P8|NOT COMPLETED|Overall Study||0
1006495|NCT00535002|2443536|P7|NOT COMPLETED|Overall Study||0
1006496|NCT00535002|2443537|P6|NOT COMPLETED|Overall Study||0
1006497|NCT00535002|2443538|P5|NOT COMPLETED|Overall Study||0
1006498|NCT00535002|2443539|P4|NOT COMPLETED|Overall Study||0
1006499|NCT00535002|2443540|P3|NOT COMPLETED|Overall Study||0
1006500|NCT00535002|2443541|P2|NOT COMPLETED|Overall Study||0
1006501|NCT00535002|2443542|P1|NOT COMPLETED|Overall Study||0
1006502|NCT00535002|2443535|P8|COMPLETED|Overall Study||16
1006503|NCT00535002|2443536|P7|COMPLETED|Overall Study||12
1006504|NCT00535002|2443537|P6|COMPLETED|Overall Study||17
1006505|NCT00535002|2443538|P5|COMPLETED|Overall Study||9
1006506|NCT00535002|2443539|P4|COMPLETED|Overall Study||14
1006507|NCT00535002|2443540|P3|COMPLETED|Overall Study||13
1006508|NCT00535002|2443541|P2|COMPLETED|Overall Study||12
1006509|NCT00535002|2443542|P1|COMPLETED|Overall Study||19
1006510|NCT00535002|2443535|P8|STARTED|Overall Study||16
1006511|NCT00535002|2443536|P7|STARTED|Overall Study||12
1006512|NCT00535002|2443537|P6|STARTED|Overall Study||17
1006513|NCT00535002|2443538|P5|STARTED|Overall Study||9
1006514|NCT00535002|2443539|P4|STARTED|Overall Study||14
1006515|NCT00535002|2443540|P3|STARTED|Overall Study||13
1006516|NCT00535002|2443541|P2|STARTED|Overall Study||12
1006517|NCT00535002|2443542|P1|STARTED|Overall Study||19
1006518|NCT00535132|2443558|P2|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
1006519|NCT00535132|2443559|P1|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
1006520|NCT00535132|2443558|P2|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|96
1006521|NCT00535132|2443559|P1|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|95
1006522|NCT00535132|2443558|P2|STARTED|Intent-to-Treat (ITT) Analysis Set||99
1006523|NCT00535132|2443559|P1|STARTED|Intent-to-Treat (ITT) Analysis Set||98
1006524|NCT00535132|2443558|P2|NOT COMPLETED|Safety Analysis Set||2
1006525|NCT00535132|2443559|P1|NOT COMPLETED|Safety Analysis Set||2
1006526|NCT00535132|2443558|P2|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|99
1006527|NCT00535132|2443559|P1|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|98
1006528|NCT00535132|2443558|P2|STARTED|Safety Analysis Set||101
1006529|NCT00535132|2443559|P1|STARTED|Safety Analysis Set||100
1006530|NCT00535132|2443558|P2|NOT COMPLETED|Randomized Population||0
1006531|NCT00535132|2443559|P1|NOT COMPLETED|Randomized Population||0
1006532|NCT00535132|2443558|P2|COMPLETED|Randomized Population||101
1006533|NCT00535132|2443559|P1|COMPLETED|Randomized Population||100
1006534|NCT00535132|2443558|P2|STARTED|Randomized Population|Number of Subjects Randomized|101
1006535|NCT00535132|2443559|P1|STARTED|Randomized Population|Number of Subjects Randomized|100
1006536|NCT00535145|2443609|P1|NOT COMPLETED|Phase II||15
1006537|NCT00535145|2443609|P1|COMPLETED|Phase II||69
1006538|NCT00535145|2443609|P1|STARTED|Phase II|Of the 85 participants who completed Phase 1, 84 met the criteria to enroll into Phase 2|84
1006539|NCT00535145|2443609|P1|NOT COMPLETED|Phase I||29
1006540|NCT00535145|2443609|P1|COMPLETED|Phase I||85
1006541|NCT00535145|2443609|P1|STARTED|Phase I||114
1006542|NCT00535223|2443621|P2|NOT COMPLETED|Overall Study||1
1006543|NCT00535223|2443622|P1|NOT COMPLETED|Overall Study||4
1006544|NCT00535223|2443621|P2|COMPLETED|Overall Study||39
1006545|NCT00535223|2443622|P1|COMPLETED|Overall Study||37
1006546|NCT00535223|2443621|P2|STARTED|Overall Study|Patients were randomized in cohorts of ten.|40
1006547|NCT00535223|2443622|P1|STARTED|Overall Study|Patients were randomized in cohorts of ten.|41
1006548|NCT00535262|2443630|P1|NOT COMPLETED|Overall Study||3
1006549|NCT00535262|2443630|P1|COMPLETED|Overall Study|Pharmaceutical company withdrew supply of EmSam prematurely before protocol was complete.|0
1006550|NCT00535262|2443630|P1|STARTED|Overall Study|3 patients were enrolled in the study. Data was collected for only two weeks before funding expired.|3
1006551|NCT00535288|2443639|P5|NOT COMPLETED|Overall Study||42
1006552|NCT00535288|2443640|P4|NOT COMPLETED|Overall Study||29
1006553|NCT00535288|2443641|P3|NOT COMPLETED|Overall Study||33
1006554|NCT00535288|2443642|P2|NOT COMPLETED|Overall Study||32
1006555|NCT00535288|2443643|P1|NOT COMPLETED|Overall Study||54
1006556|NCT00535288|2443639|P5|COMPLETED|Overall Study||116
1006557|NCT00535288|2443640|P4|COMPLETED|Overall Study||122
1006558|NCT00535288|2443641|P3|COMPLETED|Overall Study||127
1006559|NCT00535288|2443642|P2|COMPLETED|Overall Study||130
1006560|NCT00535288|2443643|P1|COMPLETED|Overall Study||260
1006561|NCT00535288|2443639|P5|STARTED|Overall Study|One participant randomized to receive placebo received esmirtazapine 18 mg.|158
1006562|NCT00535288|2443640|P4|STARTED|Overall Study||151
1006563|NCT00535288|2443641|P3|STARTED|Overall Study||160
1006564|NCT00535288|2443642|P2|STARTED|Overall Study||162
1006565|NCT00535288|2443643|P1|STARTED|Overall Study|2 participants randomized to receive placebo did not receive placebo|314
1006566|NCT00535301|2443722|P2|NOT COMPLETED|Overall Study||5
1006567|NCT00535301|2443723|P1|NOT COMPLETED|Overall Study||5
1006568|NCT00535301|2443722|P2|COMPLETED|Overall Study||33
1006569|NCT00535301|2443723|P1|COMPLETED|Overall Study||33
1006570|NCT00535301|2443722|P2|STARTED|Overall Study||38
1006571|NCT00535301|2443723|P1|STARTED|Overall Study||38
1006572|NCT00535392|2443733|P1|NOT COMPLETED|Overall Study||0
1006573|NCT00535392|2443733|P1|COMPLETED|Overall Study||33
1006574|NCT00535392|2443733|P1|STARTED|Overall Study||33
1006575|NCT00535405|2443744|P5|NOT COMPLETED|Overall Study||16
1006576|NCT00535405|2443745|P4|NOT COMPLETED|Overall Study||22
1006577|NCT00535405|2443746|P3|NOT COMPLETED|Overall Study||18
1006578|NCT00535405|2443747|P2|NOT COMPLETED|Overall Study||26
1006579|NCT00535405|2443748|P1|NOT COMPLETED|Overall Study||17
1006580|NCT00535405|2443744|P5|COMPLETED|Overall Study||241
1006581|NCT00535405|2443745|P4|COMPLETED|Overall Study||235
1006582|NCT00535405|2443746|P3|COMPLETED|Overall Study||241
1006583|NCT00535405|2443747|P2|COMPLETED|Overall Study||233
1006584|NCT00535405|2443748|P1|COMPLETED|Overall Study||240
1006585|NCT00535405|2443744|P5|STARTED|Overall Study||257
1006586|NCT00535405|2443745|P4|STARTED|Overall Study||257
1006587|NCT00535405|2443746|P3|STARTED|Overall Study||259
1006588|NCT00535405|2443747|P2|STARTED|Overall Study||259
1006589|NCT00535405|2443748|P1|STARTED|Overall Study||257
1006590|NCT00535496|2443787|P4|NOT COMPLETED|Overall Study||0
1006591|NCT00535496|2443788|P3|NOT COMPLETED|Overall Study||0
1006592|NCT00535496|2443789|P2|NOT COMPLETED|Overall Study||2
1006593|NCT00535496|2443790|P1|NOT COMPLETED|Overall Study||0
1006594|NCT00535496|2443787|P4|COMPLETED|Overall Study||31
1006595|NCT00535496|2443788|P3|COMPLETED|Overall Study||30
1006596|NCT00535496|2443789|P2|COMPLETED|Overall Study||13
1006597|NCT00535496|2443790|P1|COMPLETED|Overall Study||15
1006598|NCT00535496|2443787|P4|All-Subjects-Treated (AST) Group|Overall Study||31
1006599|NCT00535496|2443788|P3|All-Subjects-Treated (AST) Group|Overall Study||30
1006600|NCT00535496|2443789|P2|All-Subjects-Treated (AST) Group|Overall Study||14
1006601|NCT00535496|2443790|P1|All-Subjects-Treated (AST) Group|Overall Study||15
1006602|NCT00535496|2443787|P4|STARTED|Overall Study||31
1006603|NCT00535496|2443788|P3|STARTED|Overall Study||30
1006604|NCT00535496|2443789|P2|STARTED|Overall Study||15
1006605|NCT00535496|2443790|P1|STARTED|Overall Study||15
1006606|NCT00535587|2443809|P4|NOT COMPLETED|Overall Study||13
1006607|NCT00535587|2443810|P3|NOT COMPLETED|Overall Study||8
1006608|NCT00535587|2443811|P2|NOT COMPLETED|Overall Study||11
1006609|NCT00535587|2443812|P1|NOT COMPLETED|Overall Study||10
1006610|NCT00535587|2443809|P4|COMPLETED|Overall Study||41
1006611|NCT00535587|2443810|P3|COMPLETED|Overall Study||39
1006612|NCT00535587|2443811|P2|COMPLETED|Overall Study||42
1006613|NCT00535587|2443812|P1|COMPLETED|Overall Study||43
1006614|NCT00535587|2443809|P4|STARTED|Overall Study||54
1006615|NCT00535587|2443810|P3|STARTED|Overall Study||47
1006616|NCT00535587|2443811|P2|STARTED|Overall Study||53
1006617|NCT00535587|2443812|P1|STARTED|Overall Study||53
1006618|NCT00535652|2443820|P1|NOT COMPLETED|Overall Study||3
1006619|NCT00535652|2443820|P1|COMPLETED|Overall Study||20
1006620|NCT00535652|2443820|P1|STARTED|Overall Study||23
1006621|NCT00535730|2443826|P2|NOT COMPLETED|Overall Study||7
1006622|NCT00535730|2443827|P1|NOT COMPLETED|Overall Study||2
1006623|NCT00535730|2443826|P2|COMPLETED|Overall Study||230
1006624|NCT00535730|2443827|P1|COMPLETED|Overall Study||234
1006625|NCT00535730|2443826|P2|STARTED|Overall Study|Two subjects were allocated but not vaccinated making the number of subjects vaccinated 235|237
1006626|NCT00535730|2443827|P1|STARTED|Overall Study||236
1006627|NCT00535769|2443846|P2|NOT COMPLETED|Overall Study||0
1006628|NCT00535769|2443847|P1|NOT COMPLETED|Overall Study||0
1006629|NCT00535769|2443846|P2|COMPLETED|Overall Study||35
1006630|NCT00535769|2443847|P1|COMPLETED|Overall Study||35
1006631|NCT00535769|2443846|P2|STARTED|Overall Study||35
1006632|NCT00535769|2443847|P1|STARTED|Overall Study||35
1006633|NCT00535782|2443858|P3|NOT COMPLETED|Part 2: 80-Week Open-label Period||26
1006634|NCT00535782|2443859|P2|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
1006635|NCT00535782|2443860|P1|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
1006636|NCT00535782|2443858|P3|COMPLETED|Part 2: 80-Week Open-label Period||98
1006637|NCT00535782|2443859|P2|COMPLETED|Part 2: 80-Week Open-label Period||0
1006638|NCT00535782|2443860|P1|COMPLETED|Part 2: 80-Week Open-label Period||0
1006639|NCT00535782|2443858|P3|STARTED|Part 2: 80-Week Open-label Period||124
1006640|NCT00535782|2443859|P2|STARTED|Part 2: 80-Week Open-label Period||0
1006641|NCT00535782|2443860|P1|STARTED|Part 2: 80-Week Open-label Period||0
1006642|NCT00535782|2443858|P3|NOT COMPLETED|Part 1: 24-Week Double-blind Period||0
1006643|NCT00535782|2443859|P2|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
1006644|NCT00535782|2443860|P1|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
1006645|NCT00535782|2443858|P3|COMPLETED|Part 1: 24-Week Double-blind Period||0
1006646|NCT00535782|2443859|P2|COMPLETED|Part 1: 24-Week Double-blind Period||59
1006647|NCT00535782|2443860|P1|COMPLETED|Part 1: 24-Week Double-blind Period||65
1006648|NCT00535782|2443858|P3|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
1006649|NCT00535782|2443859|P2|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||62
1006650|NCT00535782|2443860|P1|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
1006651|NCT00535782|2443858|P3|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||0
1006652|NCT00535782|2443859|P2|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period|1 misrandomized patient received the TCZ in error, and 1 patient received TCZ as rescue therapy.|2
1006653|NCT00535782|2443860|P1|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||69
1006654|NCT00535782|2443858|P3|STARTED|Part 1: 24-Week Double-blind Period||0
1006655|NCT00535782|2443859|P2|STARTED|Part 1: 24-Week Double-blind Period||63
1006656|NCT00535782|2443860|P1|STARTED|Part 1: 24-Week Double-blind Period||69
1006657|NCT00535821|2443877|P2|NOT COMPLETED|Overall Study||0
1006658|NCT00535821|2443878|P1|NOT COMPLETED|Overall Study||0
1006659|NCT00535821|2443877|P2|COMPLETED|Overall Study||3
1006660|NCT00535821|2443878|P1|COMPLETED|Overall Study||2
1006661|NCT00535821|2443877|P2|STARTED|Overall Study||3
1006662|NCT00535821|2443878|P1|STARTED|Overall Study||2
1006663|NCT00535847|2443887|P3|NOT COMPLETED|Overall Study||2
1006664|NCT00535847|2443888|P2|NOT COMPLETED|Overall Study||14
1006665|NCT00535847|2443889|P1|NOT COMPLETED|Overall Study||22
1006666|NCT00535847|2443887|P3|COMPLETED|Overall Study||0
1006667|NCT00535847|2443888|P2|COMPLETED|Overall Study||20
1006668|NCT00535847|2443889|P1|COMPLETED|Overall Study||59
1006669|NCT00535847|2443887|P3|STARTED|Overall Study||2
1006670|NCT00535847|2443888|P2|STARTED|Overall Study||34
1006671|NCT00535847|2443889|P1|STARTED|Overall Study||81
1006672|NCT00535873|2443913|P1|NOT COMPLETED|Overall Study||0
1006673|NCT00535873|2443913|P1|COMPLETED|Overall Study||60
1006674|NCT00535873|2443913|P1|STARTED|Overall Study||60
1006675|NCT00535938|2443919|P2|NOT COMPLETED|Overall Study||462
1006676|NCT00535938|2443920|P1|NOT COMPLETED|Overall Study||391
1006677|NCT00535938|2443919|P2|COMPLETED|Overall Study||404
1006678|NCT00535938|2443920|P1|COMPLETED|Overall Study||115
1006679|NCT00535938|2443919|P2|STARTED|Overall Study||866
1006680|NCT00535938|2443920|P1|STARTED|Overall Study||506
1006681|NCT00536107|2443958|P2|NOT COMPLETED|Overall Study||6
1006682|NCT00536107|2443959|P1|NOT COMPLETED|Overall Study||8
1006683|NCT00536107|2443958|P2|COMPLETED|Overall Study||0
1006684|NCT00536107|2443959|P1|COMPLETED|Overall Study||0
1006685|NCT00536107|2443958|P2|STARTED|Overall Study||6
1006686|NCT00536107|2443959|P1|STARTED|Overall Study||8
1006687|NCT00536120|2443969|P2|NOT COMPLETED|Overall Study||3
1006688|NCT00536120|2443970|P1|NOT COMPLETED|Overall Study||6
1006689|NCT00536120|2443969|P2|COMPLETED|Overall Study||27
1006690|NCT00536120|2443970|P1|COMPLETED|Overall Study||24
1006691|NCT00536120|2443969|P2|STARTED|Overall Study||30
1006692|NCT00536120|2443970|P1|STARTED|Overall Study||30
1006693|NCT00536172|2443984|P2|NOT COMPLETED|Overall Study||9
1006694|NCT00536172|2443985|P1|NOT COMPLETED|Overall Study||14
1006695|NCT00536172|2443984|P2|COMPLETED|Overall Study||65
1006696|NCT00536172|2443985|P1|COMPLETED|Overall Study||60
1006697|NCT00536172|2443984|P2|STARTED|Overall Study||74
1006698|NCT00536172|2443985|P1|STARTED|Overall Study||74
1006699|NCT00536198|2443993|P2|NOT COMPLETED|Overall Study||39
1006700|NCT00536198|2443994|P1|NOT COMPLETED|Overall Study||37
1006701|NCT00536198|2443993|P2|COMPLETED|Overall Study||88
1006702|NCT00536198|2443994|P1|COMPLETED|Overall Study||88
1006703|NCT00536198|2443993|P2|Cycle 6|Overall Study||88
1006704|NCT00536198|2443994|P1|Cycle 6|Overall Study||88
1006705|NCT00536198|2443993|P2|Cycle 5|Overall Study||85
1006706|NCT00536198|2443994|P1|Cycle 5|Overall Study||88
1006707|NCT00536198|2443993|P2|Cycle 4|Overall Study||98
1006708|NCT00536198|2443994|P1|Cycle 4|Overall Study||95
1006709|NCT00536198|2443993|P2|Cycle 3|Overall Study||101
1006710|NCT00536198|2443994|P1|Cycle 3|Overall Study||100
1006711|NCT00536198|2443993|P2|Cycle 2|Overall Study||112
1006712|NCT00536198|2443994|P1|Cycle 2|Overall Study||104
1006713|NCT00536198|2443993|P2|Cycle 1|Overall Study||123
1006714|NCT00536198|2443994|P1|Cycle 1|Overall Study||110
1006715|NCT00536198|2443993|P2|STARTED|Overall Study||127
1006716|NCT00536198|2443994|P1|STARTED|Overall Study||125
1006717|NCT00542269|2444025|P3|NOT COMPLETED|Overall Study||6
1006718|NCT00542269|2444026|P2|NOT COMPLETED|Overall Study||6
1006719|NCT00542269|2444027|P1|NOT COMPLETED|Overall Study||13
1006720|NCT00542269|2444025|P3|COMPLETED|Overall Study||51
1006721|NCT00542269|2444026|P2|COMPLETED|Overall Study||54
1006722|NCT00542269|2444027|P1|COMPLETED|Overall Study||48
1006723|NCT00542269|2444025|P3|STARTED|Overall Study||57
1006724|NCT00542269|2444026|P2|STARTED|Overall Study||60
1006725|NCT00542269|2444027|P1|STARTED|Overall Study||61
1006726|NCT00542308|2444056|P1|NOT COMPLETED|Overall Study||0
1006727|NCT00542308|2444056|P1|COMPLETED|Overall Study||90
1006728|NCT00542308|2444056|P1|STARTED|Overall Study||90
1006729|NCT00542321|2444063|P2|NOT COMPLETED|Overall Study||1
1006730|NCT00542321|2444064|P1|NOT COMPLETED|Overall Study||0
1006731|NCT00542321|2444063|P2|COMPLETED|Overall Study||7
1006732|NCT00542321|2444064|P1|COMPLETED|Overall Study||8
1006733|NCT00542321|2444063|P2|STARTED|Overall Study||8
1006734|NCT00542321|2444064|P1|STARTED|Overall Study||8
1006735|NCT00542386|2444084|P6|NOT COMPLETED|Overall Study||50
1006736|NCT00542386|2444085|P5|NOT COMPLETED|Overall Study||40
1006737|NCT00542386|2444086|P4|NOT COMPLETED|Overall Study||38
1006738|NCT00542386|2444087|P3|NOT COMPLETED|Overall Study||33
1006739|NCT00542386|2444088|P2|NOT COMPLETED|Overall Study||28
1006740|NCT00542386|2444089|P1|NOT COMPLETED|Overall Study||43
1006741|NCT00542386|2444084|P6|COMPLETED|Overall Study||82
1006742|NCT00542386|2444085|P5|COMPLETED|Overall Study||62
1006743|NCT00542386|2444086|P4|COMPLETED|Overall Study||65
1006744|NCT00542386|2444087|P3|COMPLETED|Overall Study||66
1006745|NCT00542386|2444088|P2|COMPLETED|Overall Study||74
1006746|NCT00542386|2444089|P1|COMPLETED|Overall Study||61
1006747|NCT00542386|2444084|P6|STARTED|Overall Study||132
1006748|NCT00542386|2444085|P5|STARTED|Overall Study||102
1006749|NCT00542386|2444086|P4|STARTED|Overall Study||103
1006750|NCT00542386|2444087|P3|STARTED|Overall Study||99
1006751|NCT00542386|2444088|P2|STARTED|Overall Study||102
1006752|NCT00542386|2444089|P1|STARTED|Overall Study||104
1006783|NCT00542490|2444150|P1|NOT COMPLETED|Overall Study||2
1006784|NCT00542490|2444150|P1|COMPLETED|Overall Study||21
1006785|NCT00542490|2444150|P1|STARTED|Overall Study||23
1006786|NCT00542542|2444157|P2|NOT COMPLETED|Overall Study||0
1006787|NCT00542542|2444158|P1|NOT COMPLETED|Overall Study||0
1006788|NCT00542542|2444157|P2|COMPLETED|Overall Study||44
1006789|NCT00542542|2444158|P1|COMPLETED|Overall Study||44
1006790|NCT00542542|2444157|P2|STARTED|Overall Study||44
1006791|NCT00542542|2444158|P1|STARTED|Overall Study||44
1006792|NCT00542880|2444166|P2|NOT COMPLETED|Period 3||2
1006793|NCT00542880|2444167|P1|NOT COMPLETED|Period 3||0
1006794|NCT00542880|2444166|P2|COMPLETED|Period 3||201
1006795|NCT00542880|2444167|P1|COMPLETED|Period 3||204
1006796|NCT00542880|2444166|P2|STARTED|Period 3||203
1006797|NCT00542880|2444167|P1|STARTED|Period 3||204
1006798|NCT00542880|2444166|P2|NOT COMPLETED|Period 2||10
1006799|NCT00542880|2444167|P1|NOT COMPLETED|Period 2||7
1006800|NCT00542880|2444166|P2|COMPLETED|Period 2||203
1006801|NCT00542880|2444167|P1|COMPLETED|Period 2||204
1006802|NCT00542880|2444166|P2|STARTED|Period 2||213
1006803|NCT00542880|2444167|P1|STARTED|Period 2||211
1006804|NCT00542880|2444166|P2|NOT COMPLETED|Period 1||12
1006805|NCT00542880|2444167|P1|NOT COMPLETED|Period 1||6
1006806|NCT00542880|2444166|P2|COMPLETED|Period 1||213
1006807|NCT00542880|2444167|P1|COMPLETED|Period 1||211
1006808|NCT00542880|2444166|P2|STARTED|Period 1||225
1006809|NCT00542880|2444167|P1|STARTED|Period 1|This was a cross-over study|217
1006810|NCT00542971|2444203|P1|NOT COMPLETED|Overall Study||0
1006811|NCT00542971|2444203|P1|COMPLETED|Overall Study||75
1006812|NCT00542971|2444203|P1|STARTED|Overall Study||75
1006813|NCT00542997|2444208|P1|NOT COMPLETED|Efficacy Period||3
1006814|NCT00542997|2444208|P1|COMPLETED|Efficacy Period||43
1006815|NCT00542997|2444208|P1|STARTED|Efficacy Period||46
1006816|NCT00542997|2444208|P1|NOT COMPLETED|Wash in / Wash Out Period||5
1006817|NCT00542997|2444208|P1|COMPLETED|Wash in / Wash Out Period||46
1006818|NCT00542997|2444208|P1|STARTED|Wash in / Wash Out Period||51
1006819|NCT00543101|2444225|P2|NOT COMPLETED|Overall Study||0
1006820|NCT00543101|2444226|P1|NOT COMPLETED|Overall Study||0
1006821|NCT00543101|2444225|P2|COMPLETED|Overall Study||12
1006822|NCT00543101|2444226|P1|COMPLETED|Overall Study||12
1006823|NCT00543101|2444225|P2|STARTED|Overall Study||12
1006824|NCT00543101|2444226|P1|STARTED|Overall Study||12
1006825|NCT00543140|2444238|P1|NOT COMPLETED|Overall Study||72
1006826|NCT00543140|2444238|P1|COMPLETED|Overall Study||231
1006827|NCT00543140|2444238|P1|STARTED|Overall Study||303
1006828|NCT00543296|2444246|P1|NOT COMPLETED|Overall Study||7
1006829|NCT00543296|2444246|P1|COMPLETED|Overall Study||14
1006830|NCT00543296|2444246|P1|STARTED|Overall Study||21
1006831|NCT00543543|2444257|P4|NOT COMPLETED|Extension Study||226
1006832|NCT00543543|2444258|P3|NOT COMPLETED|Extension Study||0
1006833|NCT00543543|2444259|P2|NOT COMPLETED|Extension Study||0
1006834|NCT00543543|2444260|P1|NOT COMPLETED|Extension Study||0
1006835|NCT00543543|2444257|P4|COMPLETED|Extension Study||2824
1006836|NCT00543543|2444258|P3|COMPLETED|Extension Study||0
1006837|NCT00543543|2444259|P2|COMPLETED|Extension Study||150
1006838|NCT00543543|2444260|P1|COMPLETED|Extension Study||0
1006839|NCT00543543|2444257|P4|STARTED|Extension Study|Cohort 2|3050
1006840|NCT00543543|2444258|P3|STARTED|Extension Study|This group did not participate in the Extension Study|0
1006841|NCT00543543|2444259|P2|STARTED|Extension Study|Cohort 1|150
1006842|NCT00543543|2444260|P1|STARTED|Extension Study|This group did not participate in the Extension Study|0
1006843|NCT00543543|2444257|P4|NOT COMPLETED|Base Study||1222
1006844|NCT00543543|2444258|P3|NOT COMPLETED|Base Study||14
1006845|NCT00543543|2444259|P2|NOT COMPLETED|Base Study||1252
1006846|NCT00543543|2444260|P1|NOT COMPLETED|Base Study||20
1006847|NCT00543543|2444257|P4|COMPLETED|Base Study|Follow-up was up to 54 months|5887
1006848|NCT00543543|2444258|P3|COMPLETED|Base Study|Follow-up was up to 7 months|296
1006849|NCT00543543|2444259|P2|COMPLETED|Base Study|Follow-up was up to 54 months|5854
1006850|NCT00543543|2444260|P1|COMPLETED|Base Study|Follow-up was up to 7 months|295
1006851|NCT00543543|2444257|P4|Completed 3 Vaccinations|Base Study||6934
1006852|NCT00543543|2444258|P3|Completed 3 Vaccinations|Base Study||297
1006853|NCT00543543|2444259|P2|Completed 3 Vaccinations|Base Study||6928
1006854|NCT00543543|2444260|P1|Completed 3 Vaccinations|Base Study||300
1006855|NCT00543543|2444257|P4|STARTED|Base Study||7109
1006856|NCT00543543|2444258|P3|STARTED|Base Study||310
1006857|NCT00543543|2444259|P2|STARTED|Base Study||7106
1006858|NCT00543543|2444260|P1|STARTED|Base Study||315
1006859|NCT00543569|2444305|P4|NOT COMPLETED|Overall Study||9
1006860|NCT00543569|2444306|P3|NOT COMPLETED|Overall Study||20
1006861|NCT00543569|2444307|P2|NOT COMPLETED|Overall Study||8
1006862|NCT00543569|2444308|P1|NOT COMPLETED|Overall Study||12
1006863|NCT00543569|2444305|P4|COMPLETED|Overall Study||72
1006864|NCT00543569|2444306|P3|COMPLETED|Overall Study||60
1006865|NCT00543569|2444307|P2|COMPLETED|Overall Study||72
1006866|NCT00543569|2444308|P1|COMPLETED|Overall Study||70
1006867|NCT00543569|2444305|P4|Received Treatment|Overall Study||78
1006868|NCT00543569|2444306|P3|Received Treatment|Overall Study||75
1006869|NCT00543569|2444307|P2|Received Treatment|Overall Study||77
1006870|NCT00543569|2444308|P1|Received Treatment|Overall Study||79
1006871|NCT00543569|2444305|P4|STARTED|Overall Study||81
1006872|NCT00543569|2444306|P3|STARTED|Overall Study||80
1006873|NCT00543569|2444307|P2|STARTED|Overall Study||80
1006874|NCT00543569|2444308|P1|STARTED|Overall Study||82
1006875|NCT00543725|2444412|P2|NOT COMPLETED|Overall Study||74
1006876|NCT00543725|2444413|P1|NOT COMPLETED|Overall Study||68
1006877|NCT00543725|2444412|P2|COMPLETED|Overall Study||264
1006878|NCT00543725|2444413|P1|COMPLETED|Overall Study||272
1006879|NCT00543725|2444412|P2|STARTED|Overall Study||338
1006880|NCT00543725|2444413|P1|STARTED|Overall Study||340
1006881|NCT00543764|2444437|P2|NOT COMPLETED|Overall Study||0
1006882|NCT00543764|2444438|P1|NOT COMPLETED|Overall Study||0
1006883|NCT00543764|2444437|P2|COMPLETED|Overall Study||50
1006884|NCT00543764|2444438|P1|COMPLETED|Overall Study||100
1006885|NCT00543764|2444437|P2|STARTED|Overall Study||50
1006886|NCT00543764|2444438|P1|STARTED|Overall Study||100
1006887|NCT00543803|2444444|P1|NOT COMPLETED|Overall Study||142
1006888|NCT00543803|2444444|P1|COMPLETED|Overall Study||192
1006889|NCT00543803|2444444|P1|STARTED|Overall Study||334
1006890|NCT00543855|2444465|P4|NOT COMPLETED|Overall Study||4
1006891|NCT00543855|2444466|P3|NOT COMPLETED|Overall Study||6
1006892|NCT00543855|2444467|P2|NOT COMPLETED|Overall Study||2
1006893|NCT00543855|2444468|P1|NOT COMPLETED|Overall Study||4
1006894|NCT00543855|2444465|P4|COMPLETED|Overall Study||30
1006895|NCT00543855|2444466|P3|COMPLETED|Overall Study||31
1006896|NCT00543855|2444467|P2|COMPLETED|Overall Study||31
1006897|NCT00543855|2444468|P1|COMPLETED|Overall Study||31
1006898|NCT00543855|2444465|P4|STARTED|Overall Study||34
1006899|NCT00543855|2444466|P3|STARTED|Overall Study||37
1006900|NCT00543855|2444467|P2|STARTED|Overall Study||33
1006901|NCT00543855|2444468|P1|STARTED|Overall Study||35
1006902|NCT00543985|2444490|P1|NOT COMPLETED|Overall Study||4
1006903|NCT00543985|2444490|P1|COMPLETED|Overall Study||32
1006904|NCT00543985|2444490|P1|STARTED|Overall Study||36
1006905|NCT00544167|2444497|P1|NOT COMPLETED|Overall Study||29
1006906|NCT00544167|2444497|P1|COMPLETED|Overall Study||16
1006907|NCT00544167|2444497|P1|STARTED|Overall Study||45
1006908|NCT00544440|2444501|P1|NOT COMPLETED|Overall Study||57
1006909|NCT00544440|2444501|P1|COMPLETED|Overall Study||0
1006910|NCT00544440|2444501|P1|STARTED|Overall Study||57
1006911|NCT00544544|2444508|P1|NOT COMPLETED|Overall Study||3
1006912|NCT00544544|2444508|P1|COMPLETED|Overall Study||11
1006913|NCT00544544|2444508|P1|STARTED|Overall Study||14
1006914|NCT00544557|2444512|P1|NOT COMPLETED|Overall Study||434
1006915|NCT00544557|2444512|P1|COMPLETED|Overall Study||1251
1006916|NCT00544557|2444512|P1|STARTED|Overall Study||1685
1006917|NCT00544648|2444545|P2|NOT COMPLETED|Overall Study||1
1006918|NCT00544648|2444546|P1|NOT COMPLETED|Overall Study||3
1006919|NCT00544648|2444545|P2|COMPLETED|Overall Study||1
1006920|NCT00544648|2444546|P1|COMPLETED|Overall Study||8
1006921|NCT00544648|2444545|P2|STARTED|Overall Study||2
1006922|NCT00544648|2444546|P1|STARTED|Overall Study||11
1006923|NCT00544674|2444560|P1|NOT COMPLETED|Overall Study||1
1006924|NCT00544674|2444560|P1|COMPLETED|Overall Study||4
1006925|NCT00544674|2444560|P1|STARTED|Overall Study|1 subject registered and expired prior to dosing|5
1006926|NCT00544713|2444566|P2|NOT COMPLETED|Overall Study||5
1006927|NCT00544713|2444567|P1|NOT COMPLETED|Overall Study||3
1006928|NCT00544713|2444566|P2|COMPLETED|Overall Study||109
1006929|NCT00544713|2444567|P1|COMPLETED|Overall Study||111
1006930|NCT00544713|2444566|P2|STARTED|Overall Study||114
1006931|NCT00544713|2444567|P1|STARTED|Overall Study||114
1006932|NCT00544778|2444597|P1|NOT COMPLETED|Overall Study||0
1006933|NCT00544778|2444597|P1|COMPLETED|Overall Study||7
1006934|NCT00544778|2444597|P1|STARTED|Overall Study||7
1006935|NCT00544817|2444601|P1|NOT COMPLETED|Follow-up Systemic Therapy||19
1006936|NCT00544817|2444601|P1|COMPLETED|Follow-up Systemic Therapy||9
1006937|NCT00544817|2444601|P1|STARTED|Follow-up Systemic Therapy||28
1006938|NCT00544817|2444601|P1|NOT COMPLETED|No Treatment Interval||12
1006939|NCT00544817|2444601|P1|COMPLETED|No Treatment Interval||28
1006940|NCT00544817|2444601|P1|STARTED|No Treatment Interval||40
1006941|NCT00544817|2444601|P1|NOT COMPLETED|Combined Modality||7
1006942|NCT00544817|2444601|P1|COMPLETED|Combined Modality||40
1006943|NCT00544817|2444601|P1|STARTED|Combined Modality||47
1006944|NCT00544869|2444610|P3|NOT COMPLETED|Overall Study||0
1006945|NCT00544869|2444611|P2|NOT COMPLETED|Overall Study||2
1006946|NCT00544869|2444612|P1|NOT COMPLETED|Overall Study||12
1006947|NCT00544869|2444610|P3|COMPLETED|Overall Study||2
1006948|NCT00544869|2444611|P2|COMPLETED|Overall Study||12
1006949|NCT00544869|2444612|P1|COMPLETED|Overall Study||24
1006950|NCT00544869|2444610|P3|STARTED|Overall Study||2
1006951|NCT00544869|2444611|P2|STARTED|Overall Study||14
1006952|NCT00544869|2444612|P1|STARTED|Overall Study||36
1006953|NCT00544882|2444622|P3|NOT COMPLETED|Cycle 3: Follow-up||0
1006954|NCT00544882|2444623|P2|NOT COMPLETED|Cycle 3: Follow-up||2
1006955|NCT00544882|2444624|P1|NOT COMPLETED|Cycle 3: Follow-up||0
1006956|NCT00544882|2444622|P3|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|28
1006957|NCT00544882|2444623|P2|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|26
1006958|NCT00544882|2444624|P1|COMPLETED|Cycle 3: Follow-up||0
1006959|NCT00544882|2444622|P3|STARTED|Cycle 3: Follow-up||28
1006960|NCT00544882|2444623|P2|STARTED|Cycle 3: Follow-up||28
1006961|NCT00544882|2444624|P1|STARTED|Cycle 3: Follow-up||0
1006962|NCT00544882|2444622|P3|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
1006963|NCT00544882|2444623|P2|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
1006964|NCT00544882|2444624|P1|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||0
1006965|NCT00544882|2444622|P3|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
1006966|NCT00544882|2444623|P2|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
1006967|NCT00544882|2444624|P1|COMPLETED|Cycle 2: Randomized Treatment Cycle||0
1006968|NCT00544882|2444622|P3|Treated|Cycle 2: Randomized Treatment Cycle|One participant was dropped from the study due to noncompliance prior to treatment.|28
1006969|NCT00544882|2444623|P2|Treated|Cycle 2: Randomized Treatment Cycle|One participant withdrew prior to treatment|28
1006970|NCT00544882|2444624|P1|Treated|Cycle 2: Randomized Treatment Cycle||0
1006971|NCT00544882|2444622|P3|STARTED|Cycle 2: Randomized Treatment Cycle||29
1006972|NCT00544882|2444623|P2|STARTED|Cycle 2: Randomized Treatment Cycle||29
1006973|NCT00544882|2444624|P1|STARTED|Cycle 2: Randomized Treatment Cycle||0
1006974|NCT00544882|2444622|P3|NOT COMPLETED|Cycle 1: Run-in Cycle||0
1006975|NCT00544882|2444623|P2|NOT COMPLETED|Cycle 1: Run-in Cycle||0
1006976|NCT00544882|2444624|P1|NOT COMPLETED|Cycle 1: Run-in Cycle||3
1006977|NCT00544882|2444622|P3|COMPLETED|Cycle 1: Run-in Cycle||0
1006978|NCT00544882|2444623|P2|COMPLETED|Cycle 1: Run-in Cycle||0
1006979|NCT00544882|2444624|P1|COMPLETED|Cycle 1: Run-in Cycle||58
1006980|NCT00544882|2444622|P3|STARTED|Cycle 1: Run-in Cycle||0
1006981|NCT00544882|2444623|P2|STARTED|Cycle 1: Run-in Cycle||0
1006982|NCT00544882|2444624|P1|STARTED|Cycle 1: Run-in Cycle||61
1006983|NCT00544908|2444646|P1|NOT COMPLETED|Overall Study||0
1006984|NCT00544908|2444646|P1|COMPLETED|Overall Study||7
1006985|NCT00544908|2444646|P1|STARTED|Overall Study||7
1006986|NCT00545025|2444653|P2|NOT COMPLETED|Overall Study||0
1006987|NCT00545025|2444654|P1|NOT COMPLETED|Overall Study||0
1006988|NCT00545025|2444653|P2|COMPLETED|Overall Study||83
1006989|NCT00545025|2444654|P1|COMPLETED|Overall Study||160
1006990|NCT00545025|2444653|P2|STARTED|Overall Study||83
1006991|NCT00545025|2444654|P1|STARTED|Overall Study||160
1006992|NCT00545051|2444676|P2|NOT COMPLETED|Overall Study||7
1006993|NCT00545051|2444677|P1|NOT COMPLETED|Overall Study||9
1006994|NCT00545051|2444676|P2|COMPLETED|Overall Study||65
1006995|NCT00545051|2444677|P1|COMPLETED|Overall Study||59
1006996|NCT00545051|2444676|P2|STARTED|Overall Study||72
1006997|NCT00545051|2444677|P1|STARTED|Overall Study||68
1006998|NCT00545064|2444691|P1|NOT COMPLETED|Overall Study||8
1006999|NCT00545064|2444691|P1|COMPLETED|Overall Study||170
1007000|NCT00545064|2444691|P1|Visit 3 (Week 8)|Overall Study|8 patients didn’t complete the 8-week period. 6 were retrieved and considered as Visit 3 (Week 8)|176
1007001|NCT00545064|2444691|P1|Visit 2 (Week 4)|Overall Study||169
1007002|NCT00545064|2444691|P1|Visit 1 (Baseline)|Overall Study||178
1007003|NCT00545064|2444691|P1|STARTED|Overall Study||178
1007004|NCT00545103|2444704|P4|NOT COMPLETED|Overall Study||70
1007005|NCT00545103|2444705|P3|NOT COMPLETED|Overall Study||76
1007006|NCT00545103|2444706|P2|NOT COMPLETED|Overall Study||78
1007007|NCT00545103|2444707|P1|NOT COMPLETED|Overall Study||75
1007008|NCT00545103|2444704|P4|COMPLETED|Overall Study||76
1007009|NCT00545103|2444705|P3|COMPLETED|Overall Study||74
1007010|NCT00545103|2444706|P2|COMPLETED|Overall Study||70
1007011|NCT00545103|2444707|P1|COMPLETED|Overall Study||73
1007012|NCT00545103|2444704|P4|STARTED|Overall Study||146
1007013|NCT00545103|2444705|P3|STARTED|Overall Study||150
1007014|NCT00545103|2444706|P2|STARTED|Overall Study||148
1007015|NCT00545103|2444707|P1|STARTED|Overall Study||148
1007016|NCT00545155|2444741|P1|NOT COMPLETED|Overall Study||0
1007017|NCT00545155|2444741|P1|COMPLETED|Overall Study||187
1007018|NCT00545155|2444741|P1|STARTED|Overall Study||187
1007019|NCT00545168|2444757|P3|NOT COMPLETED|Overall Study||21
1007020|NCT00545168|2444758|P2|NOT COMPLETED|Overall Study||5
1007021|NCT00545168|2444759|P1|NOT COMPLETED|Overall Study||16
1007022|NCT00545168|2444757|P3|COMPLETED|Overall Study||193
1007023|NCT00545168|2444758|P2|COMPLETED|Overall Study||58
1007024|NCT00545168|2444759|P1|COMPLETED|Overall Study||187
1007025|NCT00545168|2444757|P3|STARTED|Overall Study||214
1007026|NCT00545168|2444758|P2|STARTED|Overall Study||63
1007027|NCT00545168|2444759|P1|STARTED|Overall Study||203
1007028|NCT00545181|2444770|P2|NOT COMPLETED|Overall Study||0
1007029|NCT00545181|2444771|P1|NOT COMPLETED|Overall Study||0
1007030|NCT00545181|2444770|P2|COMPLETED|Overall Study||25
1007031|NCT00545181|2444771|P1|COMPLETED|Overall Study||29
1007032|NCT00545181|2444770|P2|STARTED|Overall Study||25
1007033|NCT00545181|2444771|P1|STARTED|Overall Study||29
1007034|NCT00545233|2444779|P2|NOT COMPLETED|Overall Study||35
1007035|NCT00545233|2444780|P1|NOT COMPLETED|Overall Study||46
1007036|NCT00545233|2444779|P2|COMPLETED|Overall Study||41
1007037|NCT00545233|2444780|P1|COMPLETED|Overall Study||33
1007038|NCT00545233|2444779|P2|Intent-to-Treat (ITT)|Overall Study||73
1007039|NCT00545233|2444780|P1|Intent-to-Treat (ITT)|Overall Study||77
1007040|NCT00545233|2444779|P2|Safety Set|Overall Study||75
1007041|NCT00545233|2444780|P1|Safety Set|Overall Study||77
1007042|NCT00545233|2444779|P2|STARTED|Overall Study||76
1007043|NCT00545233|2444780|P1|STARTED|Overall Study||79
1007044|NCT00545272|2444833|P6|NOT COMPLETED|Overall Study||3
1007045|NCT00545272|2444834|P5|NOT COMPLETED|Overall Study||2
1007046|NCT00545272|2444835|P4|NOT COMPLETED|Overall Study||1
1007047|NCT00545272|2444836|P3|NOT COMPLETED|Overall Study||1
1007048|NCT00545272|2444837|P2|NOT COMPLETED|Overall Study||1
1007049|NCT00545272|2444838|P1|NOT COMPLETED|Overall Study||0
1007050|NCT00545272|2444833|P6|COMPLETED|Overall Study||59
1007051|NCT00545272|2444834|P5|COMPLETED|Overall Study||62
1007052|NCT00545272|2444835|P4|COMPLETED|Overall Study||71
1007053|NCT00545272|2444836|P3|COMPLETED|Overall Study||64
1007054|NCT00545272|2444837|P2|COMPLETED|Overall Study||67
1007055|NCT00545272|2444838|P1|COMPLETED|Overall Study||61
1007056|NCT00545272|2444833|P6|STARTED|Overall Study||62
1007057|NCT00545272|2444834|P5|STARTED|Overall Study||64
1007058|NCT00545272|2444835|P4|STARTED|Overall Study||72
1007059|NCT00545272|2444836|P3|STARTED|Overall Study||65
1007060|NCT00545272|2444837|P2|STARTED|Overall Study||68
1007061|NCT00545272|2444838|P1|STARTED|Overall Study||61
1007062|NCT00545298|2444891|P3|NOT COMPLETED|Overall Study||1
1007063|NCT00545298|2444892|P2|NOT COMPLETED|Overall Study||0
1007064|NCT00545298|2444893|P1|NOT COMPLETED|Overall Study||2
1007065|NCT00545298|2444891|P3|COMPLETED|Overall Study||0
1007066|NCT00545298|2444892|P2|COMPLETED|Overall Study||1
1007067|NCT00545298|2444893|P1|COMPLETED|Overall Study||0
1007068|NCT00545298|2444891|P3|STARTED|Overall Study||1
1007069|NCT00545298|2444892|P2|STARTED|Overall Study||1
1007070|NCT00545298|2444893|P1|STARTED|Overall Study||2
1007071|NCT00545363|2444906|P2|NOT COMPLETED|Overall Study||15
1007072|NCT00545363|2444907|P1|NOT COMPLETED|Overall Study||19
1007073|NCT00545363|2444906|P2|COMPLETED|Overall Study||343
1007074|NCT00545363|2444907|P1|COMPLETED|Overall Study||339
1007075|NCT00545363|2444906|P2|Treated|Overall Study||357
1007076|NCT00545363|2444907|P1|Treated|Overall Study||354
1007077|NCT00545363|2444906|P2|STARTED|Overall Study||358
1007078|NCT00545363|2444907|P1|STARTED|Overall Study||358
1007079|NCT00539110|2444921|P2|NOT COMPLETED|Overall Study||0
1007080|NCT00539110|2444922|P1|NOT COMPLETED|Overall Study||0
1007081|NCT00539110|2444921|P2|COMPLETED|Overall Study||5
1007082|NCT00539110|2444922|P1|COMPLETED|Overall Study||5
1007083|NCT00539110|2444921|P2|STARTED|Overall Study||5
1007084|NCT00539110|2444922|P1|STARTED|Overall Study||5
1007085|NCT00539188|2444930|P2|NOT COMPLETED|Overall Study||1
1007086|NCT00539188|2444931|P1|NOT COMPLETED|Overall Study||3
1007087|NCT00539188|2444930|P2|COMPLETED|Overall Study||1
1007088|NCT00539188|2444931|P1|COMPLETED|Overall Study||1
1007089|NCT00539188|2444930|P2|Received Allocated Intervention|Overall Study||2
1007090|NCT00539188|2444931|P1|Received Allocated Intervention|Overall Study||3
1007091|NCT00539188|2444930|P2|STARTED|Overall Study||2
1007092|NCT00539188|2444931|P1|STARTED|Overall Study||4
1007093|NCT00539240|2444946|P3|NOT COMPLETED|Overall Study||15
1007094|NCT00539240|2444947|P2|NOT COMPLETED|Overall Study||7
1007095|NCT00539240|2444948|P1|NOT COMPLETED|Overall Study||6
1007096|NCT00539240|2444946|P3|COMPLETED|Overall Study||39
1007097|NCT00539240|2444947|P2|COMPLETED|Overall Study||48
1007098|NCT00539240|2444948|P1|COMPLETED|Overall Study||53
1007099|NCT00539240|2444946|P3|STARTED|Overall Study||54
1007100|NCT00539240|2444947|P2|STARTED|Overall Study||55
1007101|NCT00539240|2444948|P1|STARTED|Overall Study||59
1007102|NCT00539253|2444965|P1|NOT COMPLETED|Overall Study||26
1007103|NCT00539253|2444965|P1|COMPLETED|Overall Study||19
1007104|NCT00539253|2444965|P1|STARTED|Overall Study||45
1007105|NCT00539279|2444972|P2|NOT COMPLETED|6-Month Follow-Up Assessment||7
1007106|NCT00539279|2444973|P1|NOT COMPLETED|6-Month Follow-Up Assessment||1
1007107|NCT00539279|2444972|P2|COMPLETED|6-Month Follow-Up Assessment||22
1007108|NCT00539279|2444973|P1|COMPLETED|6-Month Follow-Up Assessment||17
1007109|NCT00539279|2444972|P2|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to RT)|29
1007110|NCT00539279|2444973|P1|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to PE)|18
1007111|NCT00539279|2444972|P2|NOT COMPLETED|Post-Treatment Assessment||9
1007112|NCT00539279|2444973|P1|NOT COMPLETED|Post-Treatment Assessment||12
1007113|NCT00539279|2444972|P2|COMPLETED|Post-Treatment Assessment||29
1007114|NCT00539279|2444973|P1|COMPLETED|Post-Treatment Assessment||18
1007115|NCT00539279|2444972|P2|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to RT)|38
1007116|NCT00539279|2444973|P1|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to PE)|30
1007117|NCT00539279|2444972|P2|NOT COMPLETED|Treatment||8
1007118|NCT00539279|2444973|P1|NOT COMPLETED|Treatment||11
1007119|NCT00539279|2444972|P2|COMPLETED|Treatment||38
1007120|NCT00539279|2444973|P1|COMPLETED|Treatment||30
1007121|NCT00539279|2444972|P2|STARTED|Treatment||46
1007122|NCT00539279|2444973|P1|STARTED|Treatment||41
1007123|NCT00539305|2444993|P2|NOT COMPLETED|Overall Study||2
1007124|NCT00539305|2444994|P1|NOT COMPLETED|Overall Study||1
1007125|NCT00539305|2444993|P2|COMPLETED|Overall Study||10
1007126|NCT00539305|2444994|P1|COMPLETED|Overall Study||9
1007127|NCT00539305|2444993|P2|STARTED|Overall Study||12
1007128|NCT00539305|2444994|P1|STARTED|Overall Study||10
1007129|NCT00539513|2445008|P2|NOT COMPLETED|Overall Study||2
1007130|NCT00539513|2445009|P1|NOT COMPLETED|Overall Study||2
1007131|NCT00539513|2445008|P2|COMPLETED|Overall Study||3
1007132|NCT00539513|2445009|P1|COMPLETED|Overall Study||3
1007133|NCT00539513|2445008|P2|Received Allocated Intervention|Overall Study||4
1007134|NCT00539513|2445009|P1|Received Allocated Intervention|Overall Study||3
1007135|NCT00539513|2445008|P2|STARTED|Overall Study||5
1007136|NCT00539513|2445009|P1|STARTED|Overall Study||5
1007137|NCT00539526|2445024|P3|NOT COMPLETED|Overall Study||2
1007138|NCT00539526|2445025|P2|NOT COMPLETED|Overall Study||2
1007139|NCT00539526|2445026|P1|NOT COMPLETED|Overall Study||3
1007140|NCT00539526|2445024|P3|COMPLETED|Overall Study||36
1007141|NCT00539526|2445025|P2|COMPLETED|Overall Study||31
1007142|NCT00539526|2445026|P1|COMPLETED|Overall Study||32
1007143|NCT00539526|2445024|P3|STARTED|Overall Study||38
1007144|NCT00539526|2445025|P2|STARTED|Overall Study||33
1007145|NCT00539526|2445026|P1|STARTED|Overall Study||35
1007146|NCT00539539|2445042|P2|NOT COMPLETED|Overall Study||0
1007147|NCT00539539|2445043|P1|NOT COMPLETED|Overall Study||0
1007148|NCT00539539|2445042|P2|COMPLETED|Overall Study||771
1007149|NCT00539539|2445043|P1|COMPLETED|Overall Study||815
1007150|NCT00539539|2445042|P2|STARTED|Overall Study||771
1007151|NCT00539539|2445043|P1|STARTED|Overall Study||815
1007152|NCT00539591|2445066|P3|NOT COMPLETED|Overall Study||3
1007153|NCT00539591|2445067|P2|NOT COMPLETED|Overall Study||2
1007154|NCT00539591|2445068|P1|NOT COMPLETED|Overall Study||5
1007155|NCT00539591|2445066|P3|COMPLETED|Overall Study||1
1007156|NCT00539591|2445067|P2|COMPLETED|Overall Study||0
1007157|NCT00539591|2445068|P1|COMPLETED|Overall Study||18
1007158|NCT00539591|2445066|P3|STARTED|Overall Study||4
1007159|NCT00539591|2445067|P2|STARTED|Overall Study||2
1007160|NCT00539591|2445068|P1|STARTED|Overall Study||23
1007161|NCT00539617|2445176|P1|NOT COMPLETED|Treatment Period||0
1007162|NCT00539617|2445176|P1|COMPLETED|Treatment Period||3
1007163|NCT00539617|2445176|P1|STARTED|Treatment Period||3
1007164|NCT00539617|2445176|P1|NOT COMPLETED|Run-In Period||1
1007165|NCT00539617|2445176|P1|COMPLETED|Run-In Period||3
1007166|NCT00539617|2445176|P1|STARTED|Run-In Period||4
1007167|NCT00539617|2445176|P1|NOT COMPLETED|Pre-screening Period||3
1007168|NCT00539617|2445176|P1|COMPLETED|Pre-screening Period||4
1007169|NCT00539617|2445176|P1|STARTED|Pre-screening Period||7
1007170|NCT00539695|2445181|P1|NOT COMPLETED|Overall Study||13
1007171|NCT00539695|2445181|P1|COMPLETED|Overall Study||12
1007172|NCT00539695|2445181|P1|Evaluable Patients|Overall Study|Patients who received IL-2.|22
1007173|NCT00539695|2445181|P1|STARTED|Overall Study||25
1007174|NCT00539734|2445185|P1|NOT COMPLETED|Overall Study||1
1007175|NCT00539734|2445185|P1|COMPLETED|Overall Study||25
1007176|NCT00539734|2445185|P1|STARTED|Overall Study||26
1007177|NCT00545402|2445192|P2|NOT COMPLETED|Overall Study||29
1007178|NCT00545402|2445193|P1|NOT COMPLETED|Overall Study||34
1007179|NCT00545402|2445192|P2|COMPLETED|Overall Study||61
1007180|NCT00545402|2445193|P1|COMPLETED|Overall Study||56
1007181|NCT00545402|2445192|P2|STARTED|Overall Study||90
1007182|NCT00545402|2445193|P1|STARTED|Overall Study||90
1007183|NCT00545441|2445211|P2|NOT COMPLETED|Overall Study||16
1007184|NCT00545441|2445212|P1|NOT COMPLETED|Overall Study||18
1007185|NCT00545441|2445211|P2|COMPLETED|Overall Study||26
1007186|NCT00545441|2445212|P1|COMPLETED|Overall Study||26
1007187|NCT00545441|2445211|P2|STARTED|Overall Study||42
1007188|NCT00545441|2445212|P1|STARTED|Overall Study||44
1007189|NCT00545506|2445220|P2|NOT COMPLETED|Overall Study||0
1007190|NCT00545506|2445221|P1|NOT COMPLETED|Overall Study||0
1007191|NCT00545506|2445220|P2|COMPLETED|Overall Study||3
1007192|NCT00545506|2445221|P1|COMPLETED|Overall Study||3
1007193|NCT00545506|2445220|P2|STARTED|Overall Study||3
1007194|NCT00545506|2445221|P1|STARTED|Overall Study||3
1007195|NCT00545571|2445227|P1|NOT COMPLETED|Overall Study||67
1007196|NCT00545571|2445227|P1|COMPLETED|Overall Study||53
1007197|NCT00545571|2445227|P1|STARTED|Overall Study||120
1007207|NCT00545623|2445260|P4|NOT COMPLETED|Overall Study||11
1007208|NCT00545623|2445261|P3|NOT COMPLETED|Overall Study||13
1007209|NCT00545623|2445262|P2|NOT COMPLETED|Overall Study||10
1007210|NCT00545623|2445263|P1|NOT COMPLETED|Overall Study||7
1007211|NCT00545623|2445260|P4|COMPLETED|Overall Study||23
1007212|NCT00545623|2445261|P3|COMPLETED|Overall Study||20
1007213|NCT00545623|2445262|P2|COMPLETED|Overall Study||21
1007214|NCT00545623|2445263|P1|COMPLETED|Overall Study||25
1007215|NCT00545623|2445260|P4|STARTED|Overall Study||34
1007216|NCT00545623|2445261|P3|STARTED|Overall Study||33
1007217|NCT00545623|2445262|P2|STARTED|Overall Study||31
1007218|NCT00545623|2445263|P1|STARTED|Overall Study||32
1007219|NCT00545662|2445275|P2|NOT COMPLETED|Overall Study||79
1007220|NCT00545662|2445276|P1|NOT COMPLETED|Overall Study||85
1007221|NCT00545662|2445275|P2|COMPLETED|Overall Study||528
1007222|NCT00545662|2445276|P1|COMPLETED|Overall Study||521
1007223|NCT00545662|2445275|P2|STARTED|Overall Study||607
1007224|NCT00545662|2445276|P1|STARTED|Overall Study||606
1007225|NCT00545688|2445286|P4|NOT COMPLETED|Follow-Up Period||27
1007226|NCT00545688|2445287|P3|NOT COMPLETED|Follow-Up Period||20
1007227|NCT00545688|2445288|P2|NOT COMPLETED|Follow-Up Period||19
1007228|NCT00545688|2445289|P1|NOT COMPLETED|Follow-Up Period||21
1007229|NCT00545688|2445286|P4|COMPLETED|Follow-Up Period||60
1007230|NCT00545688|2445287|P3|COMPLETED|Follow-Up Period||78
1007231|NCT00545688|2445288|P2|COMPLETED|Follow-Up Period||83
1007232|NCT00545688|2445289|P1|COMPLETED|Follow-Up Period||77
1007233|NCT00545688|2445286|P4|STARTED|Follow-Up Period||87
1007234|NCT00545688|2445287|P3|STARTED|Follow-Up Period||98
1007235|NCT00545688|2445288|P2|STARTED|Follow-Up Period||102
1007236|NCT00545688|2445289|P1|STARTED|Follow-Up Period||98
1007237|NCT00545688|2445286|P4|NOT COMPLETED|Adjuvant Treatment Period||14
1007238|NCT00545688|2445287|P3|NOT COMPLETED|Adjuvant Treatment Period||4
1007239|NCT00545688|2445288|P2|NOT COMPLETED|Adjuvant Treatment Period||8
1007240|NCT00545688|2445289|P1|NOT COMPLETED|Adjuvant Treatment Period||5
1007241|NCT00545688|2445286|P4|COMPLETED|Adjuvant Treatment Period||74
1007242|NCT00545688|2445287|P3|COMPLETED|Adjuvant Treatment Period||90
1007243|NCT00545688|2445288|P2|COMPLETED|Adjuvant Treatment Period||94
1007244|NCT00545688|2445289|P1|COMPLETED|Adjuvant Treatment Period||98
1007245|NCT00545688|2445286|P4|STARTED|Adjuvant Treatment Period||88
1007246|NCT00545688|2445287|P3|STARTED|Adjuvant Treatment Period||94
1007247|NCT00545688|2445288|P2|STARTED|Adjuvant Treatment Period||102
1007248|NCT00545688|2445289|P1|STARTED|Adjuvant Treatment Period||103
1007249|NCT00545688|2445286|P4|NOT COMPLETED|Neo-Adjuvant Treatment Period||6
1007250|NCT00545688|2445287|P3|NOT COMPLETED|Neo-Adjuvant Treatment Period||14
1007251|NCT00545688|2445288|P2|NOT COMPLETED|Neo-Adjuvant Treatment Period||5
1007252|NCT00545688|2445289|P1|NOT COMPLETED|Neo-Adjuvant Treatment Period||4
1007253|NCT00545688|2445286|P4|COMPLETED|Neo-Adjuvant Treatment Period||88
1007254|NCT00545688|2445287|P3|COMPLETED|Neo-Adjuvant Treatment Period||94
1007255|NCT00545688|2445288|P2|COMPLETED|Neo-Adjuvant Treatment Period||102
1007256|NCT00545688|2445289|P1|COMPLETED|Neo-Adjuvant Treatment Period||103
1007257|NCT00545688|2445286|P4|STARTED|Neo-Adjuvant Treatment Period||94
1007258|NCT00545688|2445287|P3|STARTED|Neo-Adjuvant Treatment Period||108
1007259|NCT00545688|2445288|P2|STARTED|Neo-Adjuvant Treatment Period||107
1007260|NCT00545688|2445289|P1|STARTED|Neo-Adjuvant Treatment Period||107
1007261|NCT00546715|2445363|P4|NOT COMPLETED|Overall Study||0
1007262|NCT00546715|2445364|P3|NOT COMPLETED|Overall Study||0
1007263|NCT00546715|2445365|P2|NOT COMPLETED|Overall Study||1
1007264|NCT00546715|2445366|P1|NOT COMPLETED|Overall Study||0
1007265|NCT00546715|2445363|P4|COMPLETED|Overall Study||2
1007266|NCT00546715|2445364|P3|COMPLETED|Overall Study||5
1007267|NCT00546715|2445365|P2|COMPLETED|Overall Study||4
1007268|NCT00546715|2445366|P1|COMPLETED|Overall Study||6
1007269|NCT00546715|2445363|P4|STARTED|Overall Study||2
1007270|NCT00546715|2445364|P3|STARTED|Overall Study||5
1007271|NCT00546715|2445365|P2|STARTED|Overall Study||5
1007272|NCT00546715|2445366|P1|STARTED|Overall Study||6
1007273|NCT00546728|2445421|P2|NOT COMPLETED|Overall Study||0
1007274|NCT00546728|2445422|P1|NOT COMPLETED|Overall Study||0
1007275|NCT00546728|2445421|P2|COMPLETED|Overall Study||25
1007276|NCT00546728|2445422|P1|COMPLETED|Overall Study||25
1007277|NCT00546728|2445421|P2|STARTED|Overall Study||25
1007278|NCT00546728|2445422|P1|STARTED|Overall Study||25
1007279|NCT00546754|2445430|P2|NOT COMPLETED|Overall Study||49
1007280|NCT00546754|2445431|P1|NOT COMPLETED|Overall Study||50
1007281|NCT00546754|2445430|P2|COMPLETED|Overall Study||334
1007282|NCT00546754|2445431|P1|COMPLETED|Overall Study||375
1007283|NCT00546754|2445430|P2|Week 12|Overall Study||334
1007284|NCT00546754|2445431|P1|Week 12|Overall Study||375
1007285|NCT00546754|2445430|P2|Week 6|Overall Study||347
1007286|NCT00546754|2445431|P1|Week 6|Overall Study||396
1007287|NCT00546754|2445430|P2|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|373
1007288|NCT00546754|2445431|P1|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|416
1007289|NCT00546754|2445430|P2|STARTED|Overall Study|Number of patients enrolled and randomized|383
1007290|NCT00546754|2445431|P1|STARTED|Overall Study|Number of patients enrolled and randomized|425
1007291|NCT00546819|2445463|P2|NOT COMPLETED|Overall Study||6
1007292|NCT00546819|2445464|P1|NOT COMPLETED|Overall Study||8
1007293|NCT00546819|2445463|P2|COMPLETED|Overall Study||96
1007294|NCT00546819|2445464|P1|COMPLETED|Overall Study||199
1007295|NCT00546819|2445463|P2|VACCINATED|Overall Study||100
1007296|NCT00546819|2445464|P1|VACCINATED|Overall Study||206
1007297|NCT00546819|2445463|P2|STARTED|Overall Study||102
1007298|NCT00546819|2445464|P1|STARTED|Overall Study||207
1007299|NCT00546871|2445474|P2|NOT COMPLETED|Study Extension Period||1
1007300|NCT00546871|2445475|P1|NOT COMPLETED|Study Extension Period||1
1007301|NCT00546871|2445474|P2|COMPLETED|Study Extension Period||25
1007302|NCT00546871|2445475|P1|COMPLETED|Study Extension Period||9
1007303|NCT00546871|2445474|P2|STARTED|Study Extension Period|6 withdrawn after Part 3b|26
1007304|NCT00546871|2445475|P1|STARTED|Study Extension Period|2 withdrawn after Part 3b|10
1007305|NCT00546871|2445474|P2|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
1007306|NCT00546871|2445475|P1|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
1007307|NCT00546871|2445474|P2|COMPLETED|Part 3b - SC IGIV 12 Weeks||32
1007308|NCT00546871|2445475|P1|COMPLETED|Part 3b - SC IGIV 12 Weeks||12
1007309|NCT00546871|2445474|P2|STARTED|Part 3b - SC IGIV 12 Weeks||32
1007310|NCT00546871|2445475|P1|STARTED|Part 3b - SC IGIV 12 Weeks||12
1007311|NCT00546871|2445474|P2|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
1007312|NCT00546871|2445475|P1|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
1007313|NCT00546871|2445474|P2|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
1007314|NCT00546871|2445475|P1|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
1007315|NCT00546871|2445474|P2|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
1007316|NCT00546871|2445475|P1|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
1007317|NCT00546871|2445474|P2|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||3
1007318|NCT00546871|2445475|P1|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||1
1007319|NCT00546871|2445474|P2|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||32
1007320|NCT00546871|2445475|P1|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||12
1007321|NCT00546871|2445474|P2|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||35
1007322|NCT00546871|2445475|P1|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||13
1007323|NCT00546871|2445474|P2|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||0
1007324|NCT00546871|2445475|P1|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||1
1007325|NCT00546871|2445474|P2|COMPLETED|Part 1 - IV Infusions of IGIV, PK||35
1007326|NCT00546871|2445475|P1|COMPLETED|Part 1 - IV Infusions of IGIV, PK||13
1007327|NCT00546871|2445474|P2|STARTED|Part 1 - IV Infusions of IGIV, PK||35
1007328|NCT00546871|2445475|P1|STARTED|Part 1 - IV Infusions of IGIV, PK||14
1007329|NCT00546884|2445580|P2|NOT COMPLETED|Overall Study||0
1007330|NCT00546884|2445581|P1|NOT COMPLETED|Overall Study||0
1007331|NCT00546884|2445580|P2|COMPLETED|Overall Study||117
1007332|NCT00546884|2445581|P1|COMPLETED|Overall Study||145
1007333|NCT00546884|2445580|P2|STARTED|Overall Study||117
1007334|NCT00546884|2445581|P1|STARTED|Overall Study||145
1007335|NCT00546897|2445589|P2|NOT COMPLETED|Overall Study||0
1007336|NCT00546897|2445590|P1|NOT COMPLETED|Overall Study||0
1007337|NCT00546897|2445589|P2|COMPLETED|Overall Study||33
1007338|NCT00546897|2445590|P1|COMPLETED|Overall Study||15
1007339|NCT00546897|2445589|P2|STARTED|Overall Study||33
1007340|NCT00546897|2445590|P1|STARTED|Overall Study||15
1007341|NCT00546910|2445628|P2|NOT COMPLETED|Overall Study||11
1007342|NCT00546910|2445629|P1|NOT COMPLETED|Overall Study||9
1007343|NCT00546910|2445628|P2|COMPLETED|Overall Study||51
1007344|NCT00546910|2445629|P1|COMPLETED|Overall Study||54
1007345|NCT00546910|2445628|P2|STARTED|Overall Study||62
1007346|NCT00546910|2445629|P1|STARTED|Overall Study||63
1007347|NCT00547118|2445649|P2|NOT COMPLETED|Overall Study||2
1007348|NCT00547118|2445650|P1|NOT COMPLETED|Overall Study||1
1007349|NCT00547118|2445649|P2|COMPLETED|Overall Study||7
1007350|NCT00547118|2445650|P1|COMPLETED|Overall Study||7
1007351|NCT00547118|2445649|P2|STARTED|Overall Study||9
1007352|NCT00547118|2445650|P1|STARTED|Overall Study||8
1007353|NCT00547157|2445658|P2|NOT COMPLETED|Overall Study||23
1007354|NCT00547157|2445659|P1|NOT COMPLETED|Overall Study||49
1007355|NCT00547157|2445658|P2|COMPLETED|Overall Study||39
1007356|NCT00547157|2445659|P1|COMPLETED|Overall Study||41
1007357|NCT00547157|2445658|P2|STARTED|Overall Study||62
1007358|NCT00547157|2445659|P1|STARTED|Overall Study||90
1007359|NCT00547365|2445675|P1|NOT COMPLETED|Overall Study||8
1007360|NCT00547365|2445675|P1|COMPLETED|Overall Study||2
1007361|NCT00547365|2445675|P1|STARTED|Overall Study||10
1007362|NCT00547456|2445680|P1|NOT COMPLETED|Overall Study||0
1007363|NCT00547456|2445680|P1|COMPLETED|Overall Study||20
1007364|NCT00547456|2445680|P1|STARTED|Overall Study||20
1007365|NCT00547521|2445686|P2|NOT COMPLETED|Long Term Extension (LTE) Study||31
1007366|NCT00547521|2445687|P1|NOT COMPLETED|Long Term Extension (LTE) Study||0
1007367|NCT00547521|2445686|P2|COMPLETED|Long Term Extension (LTE) Study||59
1007368|NCT00547521|2445687|P1|COMPLETED|Long Term Extension (LTE) Study||0
1007369|NCT00547521|2445686|P2|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|90
1007370|NCT00547521|2445687|P1|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|0
1007371|NCT00547521|2445686|P2|NOT COMPLETED|Short Term Study (4 Months)||4
1007372|NCT00547521|2445687|P1|NOT COMPLETED|Short Term Study (4 Months)||1
1007373|NCT00547521|2445686|P2|COMPLETED|Short Term Study (4 Months)||45
1007374|NCT00547521|2445687|P1|COMPLETED|Short Term Study (4 Months)||50
1007375|NCT00547521|2445686|P2|STARTED|Short Term Study (4 Months)|Number of participants treated.|49
1007376|NCT00547521|2445687|P1|STARTED|Short Term Study (4 Months)|Number of participants treated.|51
1007377|NCT00547534|2445757|P1|NOT COMPLETED|Overall Study||11
1007378|NCT00547534|2445757|P1|COMPLETED|Overall Study|25 patients received at least 4 cycles. 29 patients were evaluable for response.|19
1007379|NCT00547534|2445757|P1|STARTED|Overall Study|31 patients enrolled; one patient was determined to be ineligible, and did not receive any therapy.|30
1007380|NCT00547638|2445765|P2|NOT COMPLETED|Overall Study||14
1007381|NCT00547638|2445766|P1|NOT COMPLETED|Overall Study||24
1007382|NCT00547638|2445765|P2|COMPLETED|Overall Study||59
1007383|NCT00547638|2445766|P1|COMPLETED|Overall Study||119
1007384|NCT00547638|2445765|P2|STARTED|Overall Study||73
1007385|NCT00547638|2445766|P1|STARTED|Overall Study||143
1007386|NCT00547703|2445784|P2|NOT COMPLETED|Overall Study||0
1007387|NCT00547703|2445785|P1|NOT COMPLETED|Overall Study||1
1007388|NCT00547703|2445784|P2|COMPLETED|Overall Study||1
1007389|NCT00547703|2445785|P1|COMPLETED|Overall Study||3
1007390|NCT00547703|2445784|P2|STARTED|Overall Study||1
1007391|NCT00547703|2445785|P1|STARTED|Overall Study||4
1007392|NCT00547911|2445795|P6|NOT COMPLETED|Overall Study||0
1007393|NCT00547911|2445796|P5|NOT COMPLETED|Overall Study||0
1007394|NCT00547911|2445797|P4|NOT COMPLETED|Overall Study||1
1007395|NCT00547911|2445798|P3|NOT COMPLETED|Overall Study||0
1007396|NCT00547911|2445799|P2|NOT COMPLETED|Overall Study||0
1007397|NCT00547911|2445800|P1|NOT COMPLETED|Overall Study||0
1007398|NCT00547911|2445795|P6|COMPLETED|Overall Study||3
1007399|NCT00547911|2445796|P5|COMPLETED|Overall Study||3
1007400|NCT00547911|2445797|P4|COMPLETED|Overall Study||1
1007401|NCT00547911|2445798|P3|COMPLETED|Overall Study||2
1007402|NCT00547911|2445799|P2|COMPLETED|Overall Study||2
1007403|NCT00547911|2445800|P1|COMPLETED|Overall Study||2
1007404|NCT00547911|2445795|P6|STARTED|Overall Study||3
1007405|NCT00547911|2445796|P5|STARTED|Overall Study||3
1007406|NCT00547911|2445797|P4|STARTED|Overall Study||2
1007407|NCT00547911|2445798|P3|STARTED|Overall Study||2
1007408|NCT00547911|2445799|P2|STARTED|Overall Study||2
1007409|NCT00547911|2445800|P1|STARTED|Overall Study||2
1007410|NCT00548041|2445829|P1|NOT COMPLETED|Overall Study||0
1007411|NCT00548041|2445829|P1|COMPLETED|Overall Study||100
1007412|NCT00548041|2445829|P1|STARTED|Overall Study||100
1007413|NCT00548132|2445835|P2|NOT COMPLETED|Overall Study||0
1007414|NCT00548132|2445836|P1|NOT COMPLETED|Overall Study||0
1007415|NCT00548132|2445835|P2|COMPLETED|Overall Study||554
1007416|NCT00548132|2445836|P1|COMPLETED|Overall Study||534
1007417|NCT00548132|2445835|P2|Consented to Study|Overall Study||554
1007418|NCT00548132|2445836|P1|Consented to Study|Overall Study||534
1007419|NCT00548132|2445835|P2|STARTED|Overall Study||554
1007420|NCT00548132|2445836|P1|STARTED|Overall Study||534
1007421|NCT00548145|2445846|P2|NOT COMPLETED|Overall Study||4
1007422|NCT00548145|2445847|P1|NOT COMPLETED|Overall Study||1
1007423|NCT00548145|2445846|P2|COMPLETED|Overall Study||16
1007424|NCT00548145|2445847|P1|COMPLETED|Overall Study||17
1007425|NCT00548145|2445846|P2|STARTED|Overall Study||20
1007426|NCT00548145|2445847|P1|STARTED|Overall Study||18
1007427|NCT00548184|2445853|P1|NOT COMPLETED|Overall Study||5
1007428|NCT00548184|2445853|P1|COMPLETED|Overall Study|65 patients were on treatment. 5 did not complete due to adverse events or other reasons.|60
1007429|NCT00548184|2445853|P1|STARTED|Overall Study||65
1007430|NCT00548249|2445862|P5|NOT COMPLETED|Overall Study||21
1007431|NCT00548249|2445863|P4|NOT COMPLETED|Overall Study||13
1007432|NCT00548249|2445864|P3|NOT COMPLETED|Overall Study||20
1007433|NCT00548249|2445865|P2|NOT COMPLETED|Overall Study||13
1007434|NCT00548249|2445866|P1|NOT COMPLETED|Overall Study||16
1007435|NCT00548249|2445862|P5|COMPLETED|Overall Study||7
1007436|NCT00548249|2445863|P4|COMPLETED|Overall Study||9
1007437|NCT00548249|2445864|P3|COMPLETED|Overall Study||9
1007438|NCT00548249|2445865|P2|COMPLETED|Overall Study||13
1007439|NCT00548249|2445866|P1|COMPLETED|Overall Study||10
1007440|NCT00548249|2445862|P5|STARTED|Overall Study||28
1007441|NCT00548249|2445863|P4|STARTED|Overall Study||22
1007442|NCT00548249|2445864|P3|STARTED|Overall Study||29
1007443|NCT00548249|2445865|P2|STARTED|Overall Study||26
1007444|NCT00548249|2445866|P1|STARTED|Overall Study||26
1007445|NCT00548262|2445903|P1|NOT COMPLETED|Overall Study||32
1007446|NCT00548262|2445903|P1|COMPLETED|Overall Study|1 N had D/C recorded as died and as lack of efficacy; reported as lack of efficacy in reason for D/C|22
1007447|NCT00548262|2445903|P1|STARTED|Overall Study|1 participant (N) had death recorded twice; reported as 1 death in reason for discontinuation (D/C)|54
1007448|NCT00548327|2445930|P2|NOT COMPLETED|Overall Study||1
1007449|NCT00548327|2445931|P1|NOT COMPLETED|Overall Study||0
1007450|NCT00548327|2445930|P2|COMPLETED|Overall Study|Patient randomized to receive placebo first. While on placebo, Adverse Event lead to discontinuation|4
1007451|NCT00548327|2445931|P1|COMPLETED|Overall Study||6
1007452|NCT00548327|2445930|P2|STARTED|Overall Study||5
1007453|NCT00548327|2445931|P1|STARTED|Overall Study||6
1007454|NCT00548340|2445952|P3|NOT COMPLETED|Overall Study||9
1007455|NCT00548340|2445953|P2|NOT COMPLETED|Overall Study||11
1007456|NCT00548340|2445954|P1|NOT COMPLETED|Overall Study||8
1007457|NCT00548340|2445952|P3|COMPLETED|Overall Study||95
1007458|NCT00548340|2445953|P2|COMPLETED|Overall Study||98
1007459|NCT00548340|2445954|P1|COMPLETED|Overall Study||101
1007460|NCT00548340|2445952|P3|STARTED|Overall Study||104
1007461|NCT00548340|2445953|P2|STARTED|Overall Study||109
1007462|NCT00548340|2445954|P1|STARTED|Overall Study||109
1007463|NCT00548405|2445974|P3|NOT COMPLETED|Overall Study||9
1007464|NCT00548405|2445975|P2|NOT COMPLETED|Overall Study||20
1007465|NCT00548405|2445976|P1|NOT COMPLETED|Overall Study||56
1007466|NCT00548405|2445974|P3|COMPLETED|Overall Study||164
1007467|NCT00548405|2445975|P2|COMPLETED|Overall Study||416
1007468|NCT00548405|2445976|P1|COMPLETED|Overall Study||175
1007469|NCT00548405|2445974|P3|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|170
1007470|NCT00548405|2445975|P2|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|426
1007471|NCT00548405|2445976|P1|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|202
1007472|NCT00548405|2445974|P3|STARTED|Overall Study|Randomized.|173
1007473|NCT00548405|2445975|P2|STARTED|Overall Study|Randomized.|436
1007474|NCT00548405|2445976|P1|STARTED|Overall Study|Randomized.|231
1007475|NCT00548418|2445994|P1|NOT COMPLETED|Overall Study||0
1007476|NCT00548418|2445994|P1|COMPLETED|Overall Study||27
1007477|NCT00548418|2445994|P1|STARTED|Overall Study||27
1007478|NCT00548431|2446002|P1|NOT COMPLETED|Overall Study||0
1007479|NCT00548431|2446002|P1|COMPLETED|Overall Study||38
1007480|NCT00548431|2446002|P1|STARTED|Overall Study||38
1007481|NCT00548470|2446006|P1|NOT COMPLETED|Overall Study||2
1007482|NCT00548470|2446006|P1|COMPLETED|Overall Study||12
1007483|NCT00548470|2446006|P1|STARTED|Overall Study||14
1007484|NCT00548548|2446016|P2|NOT COMPLETED|Overall Study||366
1007485|NCT00548548|2446017|P1|NOT COMPLETED|Overall Study||362
1007486|NCT00548548|2446016|P2|COMPLETED|Overall Study||21
1007487|NCT00548548|2446017|P1|COMPLETED|Overall Study|Completed treatment discontinuation form was not completed; patient was counted alive on treatment.|25
1007488|NCT00548548|2446016|P2|Safety Population|Overall Study||381
1007489|NCT00548548|2446017|P1|Safety Population|Overall Study|Four patients randomized to placebo received single doses of bevacizumab in error.|386
1007490|NCT00548548|2446016|P2|Treated|Overall Study||384
1007491|NCT00548548|2446017|P1|Treated|Overall Study||383
1007492|NCT00548548|2446016|P2|STARTED|Overall Study||387
1007493|NCT00548548|2446017|P1|STARTED|Overall Study||387
1007494|NCT00548691|2446039|P2|NOT COMPLETED|Overall Study||9
1007495|NCT00548691|2446040|P1|NOT COMPLETED|Overall Study||7
1007496|NCT00548691|2446039|P2|COMPLETED|Overall Study||250
1007497|NCT00548691|2446040|P1|COMPLETED|Overall Study||251
1007498|NCT00548691|2446039|P2|STARTED|Overall Study||259
1007499|NCT00548691|2446040|P1|STARTED|Overall Study||258
1007500|NCT00548717|2446048|P2|NOT COMPLETED|Overall Study||2
1007501|NCT00548717|2446049|P1|NOT COMPLETED|Overall Study||9
1007502|NCT00548717|2446048|P2|COMPLETED|Overall Study||0
1007503|NCT00548717|2446049|P1|COMPLETED|Overall Study||4
1007504|NCT00548717|2446048|P2|STARTED|Overall Study||2
1007505|NCT00548717|2446049|P1|STARTED|Overall Study||13
1007506|NCT00548808|2446068|P2|NOT COMPLETED|Overall Study||26
1007507|NCT00548808|2446069|P1|NOT COMPLETED|Overall Study||42
1007508|NCT00548808|2446068|P2|COMPLETED|Overall Study||186
1007509|NCT00548808|2446069|P1|COMPLETED|Overall Study||172
1007510|NCT00548808|2446068|P2|Per-Protocol Set|Overall Study||184
1007511|NCT00548808|2446069|P1|Per-Protocol Set|Overall Study||177
1007512|NCT00548808|2446068|P2|Full Analysis Set|Overall Study||212
1007513|NCT00548808|2446069|P1|Full Analysis Set|Overall Study||211
1007514|NCT00548808|2446068|P2|STARTED|Overall Study||212
1007515|NCT00548808|2446069|P1|STARTED|Overall Study||214
1007516|NCT00548847|2446091|P1|NOT COMPLETED|Overall Study||7
1007517|NCT00548847|2446091|P1|COMPLETED|Overall Study||8
1007518|NCT00548847|2446091|P1|STARTED|Overall Study||15
1007519|NCT00548860|2446098|P2|NOT COMPLETED|Overall Study||175
1007520|NCT00548860|2446099|P1|NOT COMPLETED|Overall Study||136
1007521|NCT00548860|2446098|P2|COMPLETED|Overall Study||847
1007522|NCT00548860|2446099|P1|COMPLETED|Overall Study||860
1007523|NCT00548860|2446098|P2|STARTED|Overall Study||1022
1007524|NCT00548860|2446099|P1|STARTED|Overall Study||996
1007525|NCT00548886|2446105|P1|NOT COMPLETED|Overall Study||0
1007526|NCT00548886|2446105|P1|COMPLETED|Overall Study||7
1007527|NCT00548886|2446105|P1|STARTED|Overall Study||7
1007528|NCT00549055|2446109|P1|NOT COMPLETED|Overall Study||35
1007529|NCT00549055|2446109|P1|COMPLETED|Overall Study||3
1007530|NCT00549055|2446109|P1|STARTED|Overall Study||38
1007531|NCT00549172|2446121|P2|NOT COMPLETED|Overall Study||0
1007532|NCT00549172|2446122|P1|NOT COMPLETED|Overall Study||0
1007533|NCT00549172|2446121|P2|COMPLETED|Overall Study||76
1007534|NCT00549172|2446122|P1|COMPLETED|Overall Study||70
1007535|NCT00549172|2446121|P2|STARTED|Overall Study||76
1007536|NCT00549172|2446122|P1|STARTED|Overall Study||70
1007537|NCT00549198|2446138|P2|NOT COMPLETED|Overall Study||63
1007538|NCT00549198|2446139|P1|NOT COMPLETED|Overall Study||80
1007539|NCT00549198|2446138|P2|COMPLETED|Overall Study||134
1007540|NCT00549198|2446139|P1|COMPLETED|Overall Study||115
1007541|NCT00549198|2446138|P2|STARTED|Overall Study|Four participants were randomized but were not exposed to study drug (TDF/FTC).|197
1007542|NCT00549198|2446139|P1|STARTED|Overall Study|Three participants were randomized but were not exposed to study drug (ABC/3TC).|195
1007543|NCT00542620|2446261|P2|NOT COMPLETED|Overall Study||0
1007544|NCT00542620|2446262|P1|NOT COMPLETED|Overall Study||0
1007545|NCT00542620|2446261|P2|COMPLETED|Overall Study||12
1007546|NCT00542620|2446262|P1|COMPLETED|Overall Study||13
1007547|NCT00542620|2446261|P2|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|13
1007548|NCT00542620|2446262|P1|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|12
1007549|NCT00542620|2446261|P2|STARTED|Overall Study||12
1007550|NCT00542620|2446262|P1|STARTED|Overall Study||13
1007551|NCT00542789|2446328|P2|NOT COMPLETED|Overall Study||78
1007552|NCT00542789|2446329|P1|NOT COMPLETED|Overall Study||41
1007553|NCT00542789|2446328|P2|COMPLETED|Overall Study||90
1007554|NCT00542789|2446329|P1|COMPLETED|Overall Study||134
1007555|NCT00542789|2446328|P2|STARTED|Overall Study|Randomised|168
1007556|NCT00542789|2446329|P1|STARTED|Overall Study|Randomised|175
1007557|NCT00542815|2446342|P3|NOT COMPLETED|Overall Study||32
1007558|NCT00542815|2446343|P2|NOT COMPLETED|Overall Study||32
1007559|NCT00542815|2446344|P1|NOT COMPLETED|Overall Study||106
1007560|NCT00542815|2446342|P3|COMPLETED|Overall Study||92
1007561|NCT00542815|2446343|P2|COMPLETED|Overall Study||44
1007562|NCT00542815|2446344|P1|COMPLETED|Overall Study||326
1007563|NCT00542815|2446342|P3|STARTED|Overall Study||124
1007564|NCT00542815|2446343|P2|STARTED|Overall Study||76
1007565|NCT00542815|2446344|P1|STARTED|Overall Study||432
1007566|NCT00542828|2446355|P1|NOT COMPLETED|Overall Study||13
1007567|NCT00542828|2446355|P1|COMPLETED|Overall Study|Number of participants who completed the 12-month study period.|3
1007568|NCT00542828|2446355|P1|STARTED|Overall Study|Number of participants enrolled in the study; of the 16 enrolled, 14 received study treatment.|16
1007569|NCT00549302|2446372|P3|NOT COMPLETED|Open-Label||69
1007570|NCT00549302|2446373|P2|NOT COMPLETED|Open-Label||0
1007571|NCT00549302|2446374|P1|NOT COMPLETED|Open-Label||0
1007572|NCT00549302|2446372|P3|COMPLETED|Open-Label|Another death occurred during the 30-day follow-up period after study drug discontinuation|217
1007573|NCT00549302|2446373|P2|COMPLETED|Open-Label||0
1007574|NCT00549302|2446374|P1|COMPLETED|Open-Label||0
1007575|NCT00549302|2446372|P3|STARTED|Open-Label|7 participants who completed the Double-Blind Period did not enter the Open-Label Period.|286
1007576|NCT00549302|2446373|P2|STARTED|Open-Label||0
1007577|NCT00549302|2446374|P1|STARTED|Open-Label||0
1007578|NCT00549302|2446372|P3|NOT COMPLETED|Double-Blind||0
1007579|NCT00549302|2446373|P2|NOT COMPLETED|Double-Blind||53
1007580|NCT00549302|2446374|P1|NOT COMPLETED|Double-Blind||11
1007581|NCT00549302|2446372|P3|COMPLETED|Double-Blind||0
1007582|NCT00549302|2446373|P2|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|241
1007583|NCT00549302|2446374|P1|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|52
1007584|NCT00549302|2446372|P3|Received at Least One Dose of Study Drug|Double-Blind||0
1007585|NCT00549302|2446373|P2|Received at Least One Dose of Study Drug|Double-Blind||294
1007586|NCT00549302|2446374|P1|Received at Least One Dose of Study Drug|Double-Blind||63
1007587|NCT00549302|2446372|P3|STARTED|Double-Blind||0
1007588|NCT00549302|2446373|P2|STARTED|Double-Blind||294
1007589|NCT00549302|2446374|P1|STARTED|Double-Blind||63
1007590|NCT00549328|2446384|P1|NOT COMPLETED|Overall Study||14
1007591|NCT00549328|2446384|P1|COMPLETED|Overall Study||0
1007592|NCT00549328|2446384|P1|STARTED|Overall Study||14
1007593|NCT00549393|2446395|P2|NOT COMPLETED|Period 3 (6 Months)||0
1007594|NCT00549393|2446396|P1|NOT COMPLETED|Period 3 (6 Months)||0
1007595|NCT00549393|2446395|P2|COMPLETED|Period 3 (6 Months)||1326
1007596|NCT00549393|2446396|P1|COMPLETED|Period 3 (6 Months)||1103
1007597|NCT00549393|2446395|P2|Per Protocol|Period 3 (6 Months)||1326
1007598|NCT00549393|2446396|P1|Per Protocol|Period 3 (6 Months)||667
1007599|NCT00549393|2446395|P2|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1326
1007600|NCT00549393|2446396|P1|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1103
1007601|NCT00549393|2446395|P2|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
1007602|NCT00549393|2446396|P1|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
1007603|NCT00549393|2446395|P2|COMPLETED|Period 2 Washout (2 Weeks)||0
1007604|NCT00549393|2446396|P1|COMPLETED|Period 2 Washout (2 Weeks)||0
1007605|NCT00549393|2446395|P2|STARTED|Period 2 Washout (2 Weeks)||0
1007606|NCT00549393|2446396|P1|STARTED|Period 2 Washout (2 Weeks)||0
1007607|NCT00549393|2446395|P2|NOT COMPLETED|Period 1 (6 Months)||0
1007608|NCT00549393|2446396|P1|NOT COMPLETED|Period 1 (6 Months)||0
1007609|NCT00549393|2446395|P2|COMPLETED|Period 1 (6 Months)||1199
1007610|NCT00549393|2446396|P1|COMPLETED|Period 1 (6 Months)||1319
1007611|NCT00549393|2446395|P2|Per Protocol|Period 1 (6 Months)||1199
1007612|NCT00549393|2446396|P1|Per Protocol|Period 1 (6 Months)||880
1007613|NCT00549393|2446395|P2|STARTED|Period 1 (6 Months)|ITT|1199
1007614|NCT00549393|2446396|P1|STARTED|Period 1 (6 Months)|intention to treat (ITT)|1319
1007615|NCT00549445|2446408|P2|NOT COMPLETED|Overall Study||17
1007616|NCT00549445|2446409|P1|NOT COMPLETED|Overall Study||15
1007617|NCT00549445|2446408|P2|COMPLETED|Overall Study||13
1007618|NCT00549445|2446409|P1|COMPLETED|Overall Study||8
1007619|NCT00549445|2446408|P2|STARTED|Overall Study||30
1007620|NCT00549445|2446409|P1|STARTED|Overall Study||23
1007621|NCT00549549|2446419|P4|NOT COMPLETED|Overall Study||25
1007622|NCT00549549|2446420|P3|NOT COMPLETED|Overall Study||17
1007623|NCT00549549|2446421|P2|NOT COMPLETED|Overall Study||22
1007624|NCT00549549|2446422|P1|NOT COMPLETED|Overall Study||24
1007625|NCT00549549|2446419|P4|COMPLETED|Overall Study||78
1007626|NCT00549549|2446420|P3|COMPLETED|Overall Study||82
1007627|NCT00549549|2446421|P2|COMPLETED|Overall Study||77
1007628|NCT00549549|2446422|P1|COMPLETED|Overall Study||77
1007629|NCT00549549|2446419|P4|Treated|Overall Study||102
1007630|NCT00549549|2446420|P3|Treated|Overall Study||98
1007631|NCT00549549|2446421|P2|Treated|Overall Study||99
1007632|NCT00549549|2446422|P1|Treated|Overall Study||101
1007633|NCT00549549|2446419|P4|STARTED|Overall Study||103
1007634|NCT00549549|2446420|P3|STARTED|Overall Study||99
1007635|NCT00549549|2446421|P2|STARTED|Overall Study||99
1007636|NCT00549549|2446422|P1|STARTED|Overall Study||101
1007637|NCT00549562|2446488|P1|NOT COMPLETED|Overall Study||2
1007638|NCT00549562|2446488|P1|COMPLETED|Overall Study||23
1007639|NCT00549562|2446488|P1|STARTED|Overall Study||25
1007640|NCT00550953|2446498|P2|NOT COMPLETED|Overall Study||6
1007641|NCT00550953|2446499|P1|NOT COMPLETED|Overall Study||6
1007642|NCT00550953|2446498|P2|COMPLETED|Overall Study||152
1007643|NCT00550953|2446499|P1|COMPLETED|Overall Study||150
1007644|NCT00550953|2446498|P2|STARTED|Overall Study||158
1007645|NCT00550953|2446499|P1|STARTED|Overall Study||156
1007646|NCT00551031|2446524|P5|NOT COMPLETED|Overall Study||1
1007647|NCT00551031|2446525|P4|NOT COMPLETED|Overall Study||3
1007648|NCT00551031|2446526|P3|NOT COMPLETED|Overall Study||2
1007649|NCT00551031|2446527|P2|NOT COMPLETED|Overall Study||11
1007650|NCT00551031|2446528|P1|NOT COMPLETED|Overall Study||2
1007651|NCT00551031|2446524|P5|COMPLETED|Overall Study||185
1007652|NCT00551031|2446525|P4|COMPLETED|Overall Study||317
1007653|NCT00551031|2446526|P3|COMPLETED|Overall Study||317
1007654|NCT00551031|2446527|P2|COMPLETED|Overall Study||625
1007655|NCT00551031|2446528|P1|COMPLETED|Overall Study||635
1007656|NCT00551031|2446524|P5|STARTED|Overall Study||186
1007657|NCT00551031|2446525|P4|STARTED|Overall Study||320
1007658|NCT00551031|2446526|P3|STARTED|Overall Study||319
1007659|NCT00551031|2446527|P2|STARTED|Overall Study||636
1007660|NCT00551031|2446528|P1|STARTED|Overall Study||637
1007661|NCT00551070|2446555|P1|NOT COMPLETED|Overall Study||0
1007662|NCT00551070|2446555|P1|COMPLETED|Overall Study||52
1007663|NCT00551070|2446555|P1|STARTED|Overall Study||52
1007664|NCT00551135|2446569|P4|NOT COMPLETED|Overall Study||5
1007665|NCT00551135|2446570|P3|NOT COMPLETED|Overall Study||5
1007666|NCT00551135|2446571|P2|NOT COMPLETED|Overall Study||2
1007667|NCT00551135|2446572|P1|NOT COMPLETED|Overall Study||5
1007668|NCT00551135|2446569|P4|COMPLETED|Overall Study||103
1007669|NCT00551135|2446570|P3|COMPLETED|Overall Study||98
1007670|NCT00551135|2446571|P2|COMPLETED|Overall Study||104
1007671|NCT00551135|2446572|P1|COMPLETED|Overall Study||103
1007672|NCT00551135|2446569|P4|STARTED|Overall Study||108
1007673|NCT00551135|2446570|P3|STARTED|Overall Study||103
1007674|NCT00551135|2446571|P2|STARTED|Overall Study||106
1007675|NCT00551135|2446572|P1|STARTED|Overall Study||108
1007676|NCT00551161|2446686|P1|NOT COMPLETED|Overall Study||1
1007677|NCT00551161|2446686|P1|COMPLETED|Overall Study||11
1007678|NCT00551161|2446686|P1|STARTED|Overall Study||12
1007679|NCT00551174|2446692|P2|NOT COMPLETED|Overall Study||6
1007680|NCT00551174|2446693|P1|NOT COMPLETED|Overall Study||19
1007681|NCT00551174|2446692|P2|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|394
1007682|NCT00551174|2446693|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|362
1007683|NCT00551174|2446692|P2|STARTED|Overall Study||400
1007684|NCT00551174|2446693|P1|STARTED|Overall Study||381
1007685|NCT00551200|2446705|P1|NOT COMPLETED|Overall Study||4
1007686|NCT00551200|2446705|P1|COMPLETED|Overall Study||10
1007687|NCT00551200|2446705|P1|STARTED|Overall Study||14
1007688|NCT00551213|2446720|P2|NOT COMPLETED|Overall Study||17
1007689|NCT00551213|2446721|P1|NOT COMPLETED|Overall Study||50
1007690|NCT00551213|2446720|P2|COMPLETED|Overall Study||0
1007691|NCT00551213|2446721|P1|COMPLETED|Overall Study||0
1007692|NCT00551213|2446720|P2|Treated|Overall Study||15
1007693|NCT00551213|2446721|P1|Treated|Overall Study||49
1007694|NCT00551213|2446720|P2|STARTED|Overall Study||17
1007695|NCT00551213|2446721|P1|STARTED|Overall Study||50
1007696|NCT00551291|2446737|P1|NOT COMPLETED|Overall Study||1
1007697|NCT00551291|2446737|P1|COMPLETED|Overall Study||9
1007698|NCT00551291|2446737|P1|STARTED|Overall Study||10
1007699|NCT00551369|2446743|P1|NOT COMPLETED|Overall Study||7
1007700|NCT00551369|2446743|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|26
1007701|NCT00551369|2446743|P1|STARTED|Overall Study||33
1007702|NCT00551421|2446750|P1|NOT COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||1
1007703|NCT00551421|2446750|P1|COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||13
1007704|NCT00551421|2446750|P1|STARTED|Amended Protocol (Cetuximab-refr. mCRC)||14
1007705|NCT00551421|2446750|P1|NOT COMPLETED|Original Protocol, Dose Level 1||0
1007706|NCT00551421|2446750|P1|COMPLETED|Original Protocol, Dose Level 1|1 subject developed Grade 3 diarrhea, all 3 subjects experienced significant skin toxicity.|3
1007707|NCT00551421|2446750|P1|STARTED|Original Protocol, Dose Level 1||3
1007708|NCT00551525|2446757|P1|NOT COMPLETED|Overall Study||5
1007709|NCT00551525|2446757|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study|62
1007710|NCT00551525|2446757|P1|STARTED|Overall Study||67
1007711|NCT00551642|2446768|P2|NOT COMPLETED|Overall Study||63
1007712|NCT00551642|2446769|P1|NOT COMPLETED|Overall Study||61
1007713|NCT00551642|2446768|P2|COMPLETED|Overall Study||338
1007714|NCT00551642|2446769|P1|COMPLETED|Overall Study||338
1007715|NCT00551642|2446768|P2|STARTED|Overall Study||401
1007716|NCT00551642|2446769|P1|STARTED|Overall Study||399
1007717|NCT00551707|2446780|P5|NOT COMPLETED|Overall Study||1
1007718|NCT00551707|2446781|P4|NOT COMPLETED|Overall Study||4
1007719|NCT00551707|2446782|P3|NOT COMPLETED|Overall Study||3
1007720|NCT00551707|2446783|P2|NOT COMPLETED|Overall Study||6
1007721|NCT00551707|2446784|P1|NOT COMPLETED|Overall Study||0
1007722|NCT00551707|2446780|P5|COMPLETED|Overall Study||3
1007723|NCT00551707|2446781|P4|COMPLETED|Overall Study||4
1007724|NCT00551707|2446782|P3|COMPLETED|Overall Study||10
1007725|NCT00551707|2446783|P2|COMPLETED|Overall Study||16
1007726|NCT00551707|2446784|P1|COMPLETED|Overall Study||4
1007727|NCT00551707|2446780|P5|STARTED|Overall Study||4
1007728|NCT00551707|2446781|P4|STARTED|Overall Study||8
1007729|NCT00551707|2446782|P3|STARTED|Overall Study||13
1007730|NCT00551707|2446783|P2|STARTED|Overall Study||22
1007731|NCT00551707|2446784|P1|STARTED|Overall Study||4
1007732|NCT00551746|2446803|P2|NOT COMPLETED|Overall Study||8
1007733|NCT00551746|2446804|P1|NOT COMPLETED|Overall Study||11
1007734|NCT00551746|2446803|P2|COMPLETED|Overall Study||26
1007735|NCT00551746|2446804|P1|COMPLETED|Overall Study||25
1007736|NCT00551746|2446803|P2|STARTED|Overall Study||34
1007737|NCT00551746|2446804|P1|STARTED|Overall Study||36
1007738|NCT00551759|2446810|P1|NOT COMPLETED|Overall Study||13
1007739|NCT00551759|2446810|P1|COMPLETED|Overall Study||9
1007740|NCT00551759|2446810|P1|Received Adjuvant Therapy|Overall Study||12
1007741|NCT00551759|2446810|P1|Underwent Surgery|Overall Study||17
1007742|NCT00551759|2446810|P1|Eligible and Began Treatment|Overall Study||21
1007743|NCT00551759|2446810|P1|STARTED|Overall Study||22
1007750|NCT00552058|2446863|P2|NOT COMPLETED|Overall Study||24
1007751|NCT00552058|2446864|P1|NOT COMPLETED|Overall Study||16
1007752|NCT00552058|2446863|P2|COMPLETED|Overall Study||192
1007753|NCT00552058|2446864|P1|COMPLETED|Overall Study||207
1007754|NCT00552058|2446863|P2|STARTED|Overall Study||216
1007755|NCT00552058|2446864|P1|STARTED|Overall Study||223
1007756|NCT00552084|2446904|P2|NOT COMPLETED|Overall Study||9
1007757|NCT00552084|2446905|P1|NOT COMPLETED|Overall Study||8
1007758|NCT00552084|2446904|P2|COMPLETED|Overall Study||55
1007759|NCT00552084|2446905|P1|COMPLETED|Overall Study||118
1007760|NCT00552084|2446904|P2|STARTED|Overall Study||64
1007761|NCT00552084|2446905|P1|STARTED|Overall Study||126
1007762|NCT00552110|2446916|P5|NOT COMPLETED|Overall Study||9
1007763|NCT00552110|2446917|P4|NOT COMPLETED|Overall Study||8
1007764|NCT00552110|2446918|P3|NOT COMPLETED|Overall Study||2
1007765|NCT00552110|2446919|P2|NOT COMPLETED|Overall Study||5
1007766|NCT00552110|2446920|P1|NOT COMPLETED|Overall Study||4
1007767|NCT00552110|2446916|P5|COMPLETED|Overall Study||133
1007768|NCT00552110|2446917|P4|COMPLETED|Overall Study||133
1007769|NCT00552110|2446918|P3|COMPLETED|Overall Study||137
1007770|NCT00552110|2446919|P2|COMPLETED|Overall Study||134
1007771|NCT00552110|2446920|P1|COMPLETED|Overall Study||142
1007772|NCT00552110|2446916|P5|STARTED|Overall Study||142
1007773|NCT00552110|2446917|P4|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|141
1007774|NCT00552110|2446918|P3|STARTED|Overall Study||139
1007775|NCT00552110|2446919|P2|STARTED|Overall Study||139
1007776|NCT00552110|2446920|P1|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|146
1007777|NCT00552175|2446940|P3|NOT COMPLETED|Overall Study||14
1007778|NCT00552175|2446941|P2|NOT COMPLETED|Overall Study||13
1007779|NCT00552175|2446942|P1|NOT COMPLETED|Overall Study||17
1007780|NCT00552175|2446940|P3|COMPLETED|Overall Study||72
1007781|NCT00552175|2446941|P2|COMPLETED|Overall Study||73
1007782|NCT00552175|2446942|P1|COMPLETED|Overall Study||150
1007783|NCT00552175|2446940|P3|Full Analysis Set Population|Overall Study||86
1007784|NCT00552175|2446941|P2|Full Analysis Set Population|Overall Study||85
1007785|NCT00552175|2446942|P1|Full Analysis Set Population|Overall Study||167
1007786|NCT00552175|2446940|P3|STARTED|Overall Study||86
1007787|NCT00552175|2446941|P2|STARTED|Overall Study||86
1007788|NCT00552175|2446942|P1|STARTED|Overall Study||167
1007789|NCT00552188|2446979|P2|NOT COMPLETED|Overall Study||5
1007790|NCT00552188|2446980|P1|NOT COMPLETED|Overall Study||2
1007791|NCT00552188|2446979|P2|COMPLETED|Overall Study||21
1007792|NCT00552188|2446980|P1|COMPLETED|Overall Study||24
1007793|NCT00552188|2446979|P2|STARTED|Overall Study||26
1007794|NCT00552188|2446980|P1|STARTED|Overall Study||26
1007795|NCT00552240|2446990|P2|NOT COMPLETED|Overall Study||18
1007796|NCT00552240|2446991|P1|NOT COMPLETED|Overall Study||24
1007797|NCT00552240|2446990|P2|COMPLETED|Overall Study||59
1007798|NCT00552240|2446991|P1|COMPLETED|Overall Study||51
1007799|NCT00552240|2446990|P2|STARTED|Overall Study|Number in Full Analysis Set (FAS)|77
1007800|NCT00552240|2446991|P1|STARTED|Overall Study|Number in Full Analysis Set (FAS)|75
1007801|NCT00552279|2447093|P2|NOT COMPLETED|Overall Study||3
1007802|NCT00552279|2447094|P1|NOT COMPLETED|Overall Study||14
1007803|NCT00552279|2447093|P2|COMPLETED|Overall Study||398
1007804|NCT00552279|2447094|P1|COMPLETED|Overall Study||389
1007805|NCT00552279|2447093|P2|STARTED|Overall Study||401
1007806|NCT00552279|2447094|P1|STARTED|Overall Study||403
1007807|NCT00552305|2447118|P1|NOT COMPLETED|Overall Study||250
1007808|NCT00552305|2447118|P1|COMPLETED|Overall Study||120
1007809|NCT00552305|2447118|P1|STARTED|Overall Study||370
1007810|NCT00552344|2447126|P1|NOT COMPLETED|Overall Study||315
1007811|NCT00552344|2447126|P1|COMPLETED|Overall Study||87
1007812|NCT00552344|2447126|P1|STARTED|Overall Study||402
1007813|NCT00552396|2447142|P7|NOT COMPLETED|Overall Study||9
1007814|NCT00552396|2447143|P6|NOT COMPLETED|Overall Study||3
1007815|NCT00552396|2447144|P5|NOT COMPLETED|Overall Study||3
1007816|NCT00552396|2447145|P4|NOT COMPLETED|Overall Study||6
1007817|NCT00552396|2447146|P3|NOT COMPLETED|Overall Study||3
1007818|NCT00552396|2447147|P2|NOT COMPLETED|Overall Study||3
1007819|NCT00552396|2447148|P1|NOT COMPLETED|Overall Study||3
1007820|NCT00552396|2447142|P7|COMPLETED|Overall Study||1
1007821|NCT00552396|2447143|P6|COMPLETED|Overall Study||0
1007822|NCT00552396|2447144|P5|COMPLETED|Overall Study||0
1007823|NCT00552396|2447145|P4|COMPLETED|Overall Study||0
1007824|NCT00552396|2447146|P3|COMPLETED|Overall Study||0
1007825|NCT00552396|2447147|P2|COMPLETED|Overall Study||0
1007826|NCT00552396|2447148|P1|COMPLETED|Overall Study||1
1007827|NCT00552396|2447142|P7|STARTED|Overall Study||10
1007828|NCT00552396|2447143|P6|STARTED|Overall Study||3
1007829|NCT00552396|2447144|P5|STARTED|Overall Study||3
1007830|NCT00552396|2447145|P4|STARTED|Overall Study||6
1007831|NCT00552396|2447146|P3|STARTED|Overall Study||3
1007832|NCT00552396|2447147|P2|STARTED|Overall Study||3
1007833|NCT00552396|2447148|P1|STARTED|Overall Study||4
1007834|NCT00552409|2447187|P2|NOT COMPLETED|Overall Study||2
1007835|NCT00552409|2447188|P1|NOT COMPLETED|Overall Study||1
1007836|NCT00552409|2447187|P2|COMPLETED|Overall Study||9
1007837|NCT00552409|2447188|P1|COMPLETED|Overall Study||10
1007838|NCT00552409|2447187|P2|STARTED|Overall Study||11
1007839|NCT00552409|2447188|P1|STARTED|Overall Study||11
1007840|NCT00552422|2447194|P1|NOT COMPLETED|Overall Study||0
1007841|NCT00552422|2447194|P1|COMPLETED|Overall Study||6
1007842|NCT00552422|2447194|P1|STARTED|Overall Study||6
1007843|NCT00552448|2447200|P2|NOT COMPLETED|Overall Study||0
1007844|NCT00552448|2447201|P1|NOT COMPLETED|Overall Study||1
1007845|NCT00552448|2447200|P2|COMPLETED|Overall Study||16
1007846|NCT00552448|2447201|P1|COMPLETED|Overall Study||19
1007847|NCT00552448|2447200|P2|STARTED|Overall Study||16
1007848|NCT00552448|2447201|P1|STARTED|Overall Study||20
1007849|NCT00552513|2447215|P2|NOT COMPLETED|Overall Study||1
1007850|NCT00552513|2447216|P1|NOT COMPLETED|Overall Study||5
1007851|NCT00552513|2447215|P2|COMPLETED|Overall Study||1437
1007852|NCT00552513|2447216|P1|COMPLETED|Overall Study||1588
1007853|NCT00552513|2447215|P2|STARTED|Overall Study||1438
1007854|NCT00552513|2447216|P1|STARTED|Overall Study||1593
1007855|NCT00552578|2447228|P2|NOT COMPLETED|Overall Study||1
1007856|NCT00552578|2447229|P1|NOT COMPLETED|Overall Study||1
1007857|NCT00552578|2447228|P2|COMPLETED|Overall Study||5
1007858|NCT00552578|2447229|P1|COMPLETED|Overall Study||5
1007859|NCT00552578|2447228|P2|STARTED|Overall Study||6
1007860|NCT00552578|2447229|P1|STARTED|Overall Study||6
1007861|NCT00552669|2447241|P2|NOT COMPLETED|Overall Study||7
1007862|NCT00552669|2447242|P1|NOT COMPLETED|Overall Study||3
1007863|NCT00552669|2447241|P2|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|93
1007864|NCT00552669|2447242|P1|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|97
1007865|NCT00552669|2447241|P2|STARTED|Overall Study|patients|100
1007866|NCT00552669|2447242|P1|STARTED|Overall Study|patients|100
1007867|NCT00552695|2447254|P2|NOT COMPLETED|Overall Study||0
1007868|NCT00552695|2447255|P1|NOT COMPLETED|Overall Study||0
1007869|NCT00552695|2447254|P2|COMPLETED|Overall Study|September 2007|23
1007870|NCT00552695|2447255|P1|COMPLETED|Overall Study|September 2007|22
1007871|NCT00552695|2447254|P2|STARTED|Overall Study|August 2007|23
1007872|NCT00552695|2447255|P1|STARTED|Overall Study|August 2007|22
1007873|NCT00552760|2447265|P2|NOT COMPLETED|Overall Study||33
1007874|NCT00552760|2447266|P1|NOT COMPLETED|Overall Study||26
1007875|NCT00552760|2447265|P2|COMPLETED|Overall Study||8
1007876|NCT00552760|2447266|P1|COMPLETED|Overall Study||16
1007877|NCT00552760|2447265|P2|STARTED|Overall Study||41
1007878|NCT00552760|2447266|P1|STARTED|Overall Study||42
1007879|NCT00552786|2447282|P2|NOT COMPLETED|Second Intervention||0
1007880|NCT00552786|2447283|P1|NOT COMPLETED|Second Intervention||0
1007881|NCT00552786|2447282|P2|COMPLETED|Second Intervention||28
1007882|NCT00552786|2447283|P1|COMPLETED|Second Intervention||25
1007883|NCT00552786|2447282|P2|STARTED|Second Intervention||28
1007884|NCT00552786|2447283|P1|STARTED|Second Intervention||25
1007885|NCT00552786|2447282|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
1007886|NCT00552786|2447283|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
1007887|NCT00552786|2447282|P2|COMPLETED|Washout Period of 2 Weeks||28
1007888|NCT00552786|2447283|P1|COMPLETED|Washout Period of 2 Weeks||25
1007889|NCT00552786|2447282|P2|STARTED|Washout Period of 2 Weeks||28
1007890|NCT00552786|2447283|P1|STARTED|Washout Period of 2 Weeks||25
1007891|NCT00552786|2447282|P2|NOT COMPLETED|First Intervention||0
1007892|NCT00552786|2447283|P1|NOT COMPLETED|First Intervention||0
1007893|NCT00552786|2447282|P2|COMPLETED|First Intervention||28
1007894|NCT00552786|2447283|P1|COMPLETED|First Intervention||25
1007895|NCT00552786|2447282|P2|Medication and Hearing Evaluation|First Intervention||28
1007896|NCT00552786|2447283|P1|Medication and Hearing Evaluation|First Intervention||25
1007897|NCT00552786|2447282|P2|STARTED|First Intervention||28
1007898|NCT00552786|2447283|P1|STARTED|First Intervention||25
1007899|NCT00552812|2447291|P1|NOT COMPLETED|Overall Study||20
1007900|NCT00552812|2447291|P1|COMPLETED|Overall Study|Some still remain inside the 2 year follow up window. 2 year follow up data is not yet complete.|85
1007901|NCT00552812|2447291|P1|STARTED|Overall Study|168 consents, 57 failed cath criteria, 5 met criteria but received covered stent, 1 withdrew consent|105
1007902|NCT00553098|2447297|P1|NOT COMPLETED|Overall Study||1
1007903|NCT00553098|2447297|P1|COMPLETED|Overall Study||28
1007904|NCT00553098|2447297|P1|STARTED|Overall Study||29
1007905|NCT00553150|2447313|P4|NOT COMPLETED|Overall Study||4
1007906|NCT00553150|2447314|P3|NOT COMPLETED|Overall Study||0
1007907|NCT00553150|2447315|P2|NOT COMPLETED|Overall Study||0
1007908|NCT00553150|2447316|P1|NOT COMPLETED|Overall Study||0
1007909|NCT00553150|2447313|P4|COMPLETED|Overall Study||100
1007910|NCT00553150|2447314|P3|COMPLETED|Overall Study||6
1007911|NCT00553150|2447315|P2|COMPLETED|Overall Study||6
1007912|NCT00553150|2447316|P1|COMPLETED|Overall Study||6
1007913|NCT00553150|2447313|P4|STARTED|Overall Study||104
1007914|NCT00553150|2447314|P3|STARTED|Overall Study||6
1007915|NCT00553150|2447315|P2|STARTED|Overall Study||6
1007916|NCT00553150|2447316|P1|STARTED|Overall Study||6
1007917|NCT00553202|2447328|P1|NOT COMPLETED|Overall Study||68
1007918|NCT00553202|2447328|P1|COMPLETED|Overall Study||90
1007919|NCT00553202|2447328|P1|STARTED|Overall Study||158
1007920|NCT00553267|2447339|P3|NOT COMPLETED|Overall Study||10
1007921|NCT00553267|2447340|P2|NOT COMPLETED|Overall Study||18
1007922|NCT00553267|2447341|P1|NOT COMPLETED|Overall Study||14
1007923|NCT00553267|2447339|P3|COMPLETED|Overall Study||307
1007924|NCT00553267|2447340|P2|COMPLETED|Overall Study||297
1007925|NCT00553267|2447341|P1|COMPLETED|Overall Study||301
1007926|NCT00553267|2447339|P3|STARTED|Overall Study||317
1007927|NCT00553267|2447340|P2|STARTED|Overall Study||315
1007928|NCT00553267|2447341|P1|STARTED|Overall Study||315
1007929|NCT00553280|2447376|P1|NOT COMPLETED|Overall Study||26
1007930|NCT00553280|2447376|P1|COMPLETED|Overall Study||97
1007931|NCT00553280|2447376|P1|STARTED|Overall Study||123
1007932|NCT00553319|2447388|P3|NOT COMPLETED|Overall Study||9
1007933|NCT00553319|2447389|P2|NOT COMPLETED|Overall Study||10
1007934|NCT00553319|2447390|P1|NOT COMPLETED|Overall Study||14
1007935|NCT00553319|2447388|P3|COMPLETED|Overall Study||34
1007936|NCT00553319|2447389|P2|COMPLETED|Overall Study||30
1007937|NCT00553319|2447390|P1|COMPLETED|Overall Study||29
1007938|NCT00553319|2447388|P3|STARTED|Overall Study||43
1007939|NCT00553319|2447389|P2|STARTED|Overall Study||40
1007940|NCT00553319|2447390|P1|STARTED|Overall Study||43
1007941|NCT00553332|2447401|P1|NOT COMPLETED|Overall Study||1
1007942|NCT00553332|2447401|P1|COMPLETED|Overall Study|evaluable for response|28
1007943|NCT00553332|2447401|P1|STARTED|Overall Study||29
1007944|NCT00553358|2447413|P3|NOT COMPLETED|Overall Study||60
1007945|NCT00553358|2447414|P2|NOT COMPLETED|Overall Study||12
1007946|NCT00553358|2447415|P1|NOT COMPLETED|Overall Study||53
1007947|NCT00553358|2447413|P3|COMPLETED|Overall Study||92
1007948|NCT00553358|2447414|P2|COMPLETED|Overall Study||137
1007949|NCT00553358|2447415|P1|COMPLETED|Overall Study||101
1007950|NCT00553358|2447413|P3|STARTED|Overall Study||152
1007951|NCT00553358|2447414|P2|STARTED|Overall Study||149
1007952|NCT00553358|2447415|P1|STARTED|Overall Study||154
1007953|NCT00545740|2447445|P4|NOT COMPLETED|Overall Study||71
1007954|NCT00545740|2447446|P3|NOT COMPLETED|Overall Study||96
1007955|NCT00545740|2447447|P2|NOT COMPLETED|Overall Study||83
1007956|NCT00545740|2447448|P1|NOT COMPLETED|Overall Study||75
1007957|NCT00545740|2447445|P4|COMPLETED|Overall Study||78
1007958|NCT00545740|2447446|P3|COMPLETED|Overall Study||55
1007959|NCT00545740|2447447|P2|COMPLETED|Overall Study||62
1007960|NCT00545740|2447448|P1|COMPLETED|Overall Study||70
1007961|NCT00545740|2447445|P4|STARTED|Overall Study||149
1007962|NCT00545740|2447446|P3|STARTED|Overall Study||151
1007963|NCT00545740|2447447|P2|STARTED|Overall Study||145
1007964|NCT00545740|2447448|P1|STARTED|Overall Study||145
1007965|NCT00545753|2447485|P3|NOT COMPLETED|Overall Study||26
1007966|NCT00545753|2447486|P2|NOT COMPLETED|Overall Study||5
1007967|NCT00545753|2447487|P1|NOT COMPLETED|Overall Study||16
1007968|NCT00545753|2447485|P3|COMPLETED|Overall Study||230
1007969|NCT00545753|2447486|P2|COMPLETED|Overall Study||54
1007970|NCT00545753|2447487|P1|COMPLETED|Overall Study||227
1007971|NCT00545753|2447485|P3|STARTED|Overall Study||256
1007972|NCT00545753|2447486|P2|STARTED|Overall Study||59
1007973|NCT00545753|2447487|P1|STARTED|Overall Study||243
1007974|NCT00545766|2447496|P1|NOT COMPLETED|Overall Study||5
1007975|NCT00545766|2447496|P1|COMPLETED|Overall Study||36
1007976|NCT00545766|2447496|P1|STARTED|Overall Study||41
1007977|NCT00545779|2447500|P1|NOT COMPLETED|Overall Study||44
1007978|NCT00545779|2447500|P1|COMPLETED|Overall Study||633
1007979|NCT00545779|2447500|P1|STARTED|Overall Study||677
1007980|NCT00545792|2447513|P1|NOT COMPLETED|Overall Study||1
1007981|NCT00545792|2447513|P1|COMPLETED|Overall Study||20
1007982|NCT00545792|2447513|P1|STARTED|Overall Study||21
1007986|NCT00545948|2447535|P3|NOT COMPLETED|Overall Study||7
1007987|NCT00545948|2447536|P2|NOT COMPLETED|Overall Study||1
1007988|NCT00545948|2447537|P1|NOT COMPLETED|Overall Study||1
1007989|NCT00545948|2447535|P3|COMPLETED|Overall Study||0
1007990|NCT00545948|2447536|P2|COMPLETED|Overall Study|Patients who received pemetrexed + cisplatin protocol therapy.|14
1007991|NCT00545948|2447537|P1|COMPLETED|Overall Study|Patients who received vinorelbine + cisplatin protocol therapy.|8
1007992|NCT00545948|2447535|P3|Assigned Treatment|Overall Study||0
1007993|NCT00545948|2447536|P2|Assigned Treatment|Overall Study||15
1007994|NCT00545948|2447537|P1|Assigned Treatment|Overall Study||9
1007995|NCT00545948|2447535|P3|STARTED|Overall Study|Registered patients who were not assigned to receive protocol therapy.|7
1007996|NCT00545948|2447536|P2|STARTED|Overall Study|Registered patients assigned to receive pemetrexed + cisplatin protocol therapy.|15
1007997|NCT00545948|2447537|P1|STARTED|Overall Study|Registered patients assigned to receive vinorelbine + cisplatin protocol therapy.|9
1007998|NCT00545974|2447549|P2|NOT COMPLETED|Overall Study||3
1007999|NCT00545974|2447550|P1|NOT COMPLETED|Overall Study||2
1008000|NCT00545974|2447549|P2|COMPLETED|Overall Study|subjects completed 26 weeks treatment in placebo cohort|39
1008001|NCT00545974|2447550|P1|COMPLETED|Overall Study|subjects completed 26 weeks treatment in memantine cohort|37
1008002|NCT00545974|2447549|P2|STARTED|Overall Study|subjects randomized to placebo cohort|42
1008003|NCT00545974|2447550|P1|STARTED|Overall Study|subjects randomized to memantine cohort|39
1008004|NCT00546000|2447558|P1|NOT COMPLETED|Overall Study||4
1008005|NCT00546000|2447558|P1|COMPLETED|Overall Study||52
1008006|NCT00546000|2447558|P1|STARTED|Overall Study||56
1008007|NCT00546052|2447563|P1|NOT COMPLETED|Overall Study||227
1008008|NCT00546052|2447563|P1|COMPLETED|Overall Study||1511
1008009|NCT00546052|2447563|P1|Week 52|Overall Study||1511
1008010|NCT00546052|2447563|P1|Week 32|Overall Study||1583
1008011|NCT00546052|2447563|P1|Week 12|Overall Study||1650
1008012|NCT00546052|2447563|P1|Week 8|Overall Study||1680
1008013|NCT00546052|2447563|P1|Week 4|Overall Study||1714
1008014|NCT00546052|2447563|P1|STARTED|Overall Study||1738
1008015|NCT00546078|2447583|P2|NOT COMPLETED|Overall Study||7
1008016|NCT00546078|2447584|P1|NOT COMPLETED|Overall Study||4
1008017|NCT00546078|2447583|P2|COMPLETED|Overall Study||43
1008018|NCT00546078|2447584|P1|COMPLETED|Overall Study||61
1008019|NCT00546078|2447583|P2|Month 18|Overall Study||45
1008020|NCT00546078|2447584|P1|Month 18|Overall Study||61
1008021|NCT00546078|2447583|P2|STARTED|Overall Study||50
1008022|NCT00546078|2447584|P1|STARTED|Overall Study||65
1008023|NCT00546104|2447622|P1|NOT COMPLETED|Overall Study||0
1008024|NCT00546104|2447622|P1|COMPLETED|Overall Study||31
1008025|NCT00546104|2447622|P1|STARTED|Overall Study||31
1008026|NCT00546117|2447633|P2|NOT COMPLETED|Overall Study||0
1008027|NCT00546117|2447634|P1|NOT COMPLETED|Overall Study||4
1008028|NCT00546117|2447633|P2|COMPLETED|Overall Study||7
1008029|NCT00546117|2447634|P1|COMPLETED|Overall Study||5
1008030|NCT00546117|2447633|P2|STARTED|Overall Study||7
1008031|NCT00546117|2447634|P1|STARTED|Overall Study||9
1008032|NCT00546156|2447644|P2|NOT COMPLETED|Overall Study||1
1008033|NCT00546156|2447645|P1|NOT COMPLETED|Overall Study||14
1008034|NCT00546156|2447644|P2|COMPLETED|Overall Study||19
1008035|NCT00546156|2447645|P1|COMPLETED|Overall Study||70
1008036|NCT00546156|2447644|P2|STARTED|Overall Study||20
1008037|NCT00546156|2447645|P1|STARTED|Overall Study||84
1008038|NCT00546260|2447654|P2|NOT COMPLETED|Overall Study||2
1008039|NCT00546260|2447655|P1|NOT COMPLETED|Overall Study||8
1008040|NCT00546260|2447654|P2|COMPLETED|Overall Study||32
1008041|NCT00546260|2447655|P1|COMPLETED|Overall Study||28
1008042|NCT00546260|2447654|P2|STARTED|Overall Study||34
1008043|NCT00546260|2447655|P1|STARTED|Overall Study||36
1008044|NCT00546273|2447670|P5|NOT COMPLETED|IV||0
1008045|NCT00546273|2447671|P4|NOT COMPLETED|IV||0
1008046|NCT00546273|2447672|P3|NOT COMPLETED|IV||0
1008047|NCT00546273|2447673|P2|NOT COMPLETED|IV||0
1008048|NCT00546273|2447674|P1|NOT COMPLETED|IV||0
1008049|NCT00546273|2447670|P5|COMPLETED|IV||2
1008050|NCT00546273|2447671|P4|COMPLETED|IV||4
1008051|NCT00546273|2447672|P3|COMPLETED|IV||0
1008052|NCT00546273|2447673|P2|COMPLETED|IV||0
1008053|NCT00546273|2447674|P1|COMPLETED|IV||0
1008054|NCT00546273|2447670|P5|STARTED|IV||2
1008055|NCT00546273|2447671|P4|STARTED|IV||4
1008056|NCT00546273|2447672|P3|STARTED|IV||0
1008057|NCT00546273|2447673|P2|STARTED|IV||0
1008058|NCT00546273|2447674|P1|STARTED|IV||0
1008059|NCT00546273|2447670|P5|NOT COMPLETED|III||0
1008060|NCT00546273|2447671|P4|NOT COMPLETED|III||0
1008061|NCT00546273|2447672|P3|NOT COMPLETED|III||0
1008062|NCT00546273|2447673|P2|NOT COMPLETED|III||0
1008063|NCT00546273|2447674|P1|NOT COMPLETED|III||0
1008064|NCT00546273|2447670|P5|COMPLETED|III||2
1008065|NCT00546273|2447671|P4|COMPLETED|III||0
1008066|NCT00546273|2447672|P3|COMPLETED|III||4
1008067|NCT00546273|2447673|P2|COMPLETED|III||0
1008068|NCT00546273|2447674|P1|COMPLETED|III||0
1008069|NCT00546273|2447670|P5|STARTED|III||2
1008070|NCT00546273|2447671|P4|STARTED|III||0
1008071|NCT00546273|2447672|P3|STARTED|III||4
1008072|NCT00546273|2447673|P2|STARTED|III||0
1008073|NCT00546273|2447674|P1|STARTED|III||0
1008074|NCT00546273|2447670|P5|NOT COMPLETED|II||0
1008075|NCT00546273|2447671|P4|NOT COMPLETED|II||0
1008076|NCT00546273|2447672|P3|NOT COMPLETED|II||0
1008077|NCT00546273|2447673|P2|NOT COMPLETED|II||0
1008078|NCT00546273|2447674|P1|NOT COMPLETED|II||0
1008079|NCT00546273|2447670|P5|COMPLETED|II||2
1008080|NCT00546273|2447671|P4|COMPLETED|II||0
1008081|NCT00546273|2447672|P3|COMPLETED|II||0
1008082|NCT00546273|2447673|P2|COMPLETED|II||4
1008083|NCT00546273|2447674|P1|COMPLETED|II||0
1008084|NCT00546273|2447670|P5|STARTED|II||2
1008085|NCT00546273|2447671|P4|STARTED|II||0
1008086|NCT00546273|2447672|P3|STARTED|II||0
1008087|NCT00546273|2447673|P2|STARTED|II||4
1008088|NCT00546273|2447674|P1|STARTED|II||0
1008089|NCT00546273|2447670|P5|NOT COMPLETED|I||0
1008090|NCT00546273|2447671|P4|NOT COMPLETED|I||0
1008091|NCT00546273|2447672|P3|NOT COMPLETED|I||0
1008092|NCT00546273|2447673|P2|NOT COMPLETED|I||0
1008093|NCT00546273|2447674|P1|NOT COMPLETED|I||0
1008094|NCT00546273|2447670|P5|COMPLETED|I||2
1008095|NCT00546273|2447671|P4|COMPLETED|I||0
1008096|NCT00546273|2447672|P3|COMPLETED|I||0
1008097|NCT00546273|2447673|P2|COMPLETED|I||0
1008098|NCT00546273|2447674|P1|COMPLETED|I||4
1008099|NCT00546273|2447670|P5|STARTED|I||2
1008100|NCT00546273|2447671|P4|STARTED|I||0
1008101|NCT00546273|2447672|P3|STARTED|I||0
1008102|NCT00546273|2447673|P2|STARTED|I||0
1008103|NCT00546273|2447674|P1|STARTED|I||4
1008104|NCT00546351|2447681|P1|NOT COMPLETED|Overall Study||236
1008105|NCT00546351|2447681|P1|COMPLETED|Overall Study||385
1008106|NCT00546351|2447681|P1|STARTED|Overall Study||621
1008107|NCT00546364|2447712|P3|NOT COMPLETED|Overall Study||17
1008108|NCT00546364|2447713|P2|NOT COMPLETED|Overall Study||18
1008109|NCT00546364|2447714|P1|NOT COMPLETED|Overall Study||17
1008110|NCT00546364|2447712|P3|COMPLETED|Overall Study|Still on treatment|3
1008111|NCT00546364|2447713|P2|COMPLETED|Overall Study|Still on treatment|4
1008112|NCT00546364|2447714|P1|COMPLETED|Overall Study|Still on treatment|3
1008113|NCT00546364|2447712|P3|Never Treated|Overall Study||0
1008114|NCT00546364|2447713|P2|Never Treated|Overall Study||0
1008115|NCT00546364|2447714|P1|Never Treated|Overall Study||0
1008116|NCT00546364|2447712|P3|STARTED|Overall Study||20
1008117|NCT00546364|2447713|P2|STARTED|Overall Study||22
1008118|NCT00546364|2447714|P1|STARTED|Overall Study||20
1008119|NCT00546377|2447749|P1|NOT COMPLETED|Overall Study||7
1008120|NCT00546377|2447749|P1|COMPLETED|Overall Study||43
1008121|NCT00546377|2447749|P1|STARTED|Overall Study||50
1008122|NCT00546429|2447754|P1|NOT COMPLETED|Overall Study||30
1008123|NCT00546429|2447754|P1|COMPLETED|Overall Study||32
1008124|NCT00546429|2447754|P1|STARTED|Overall Study|2 subjects did not have a preoperative Merle D'Aubigne score.|62
1008125|NCT00546481|2447760|P3|NOT COMPLETED|Maintenance Phase (CERA)||4
1008126|NCT00546481|2447761|P2|NOT COMPLETED|Maintenance Phase (CERA)||0
1008127|NCT00546481|2447762|P1|NOT COMPLETED|Maintenance Phase (CERA)||0
1008128|NCT00546481|2447760|P3|COMPLETED|Maintenance Phase (CERA)||50
1008129|NCT00546481|2447761|P2|COMPLETED|Maintenance Phase (CERA)||0
1008130|NCT00546481|2447762|P1|COMPLETED|Maintenance Phase (CERA)||0
1008131|NCT00546481|2447760|P3|STARTED|Maintenance Phase (CERA)||54
1008132|NCT00546481|2447761|P2|STARTED|Maintenance Phase (CERA)||0
1008133|NCT00546481|2447762|P1|STARTED|Maintenance Phase (CERA)||0
1008134|NCT00546481|2447760|P3|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
1008135|NCT00546481|2447761|P2|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||5
1008136|NCT00546481|2447762|P1|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||6
1008137|NCT00546481|2447760|P3|COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
1008138|NCT00546481|2447761|P2|COMPLETED|Correction Phase (CERA or Epoetin Beta)||36
1008139|NCT00546481|2447762|P1|COMPLETED|Correction Phase (CERA or Epoetin Beta)||33
1008140|NCT00546481|2447760|P3|STARTED|Correction Phase (CERA or Epoetin Beta)||0
1008141|NCT00546481|2447761|P2|STARTED|Correction Phase (CERA or Epoetin Beta)||41
1008142|NCT00546481|2447762|P1|STARTED|Correction Phase (CERA or Epoetin Beta)||39
1008143|NCT00546572|2447787|P2|NOT COMPLETED|Vax 2 / Year 1||2
1008144|NCT00546572|2447788|P1|NOT COMPLETED|Vax 2 / Year 1||4
1008145|NCT00546572|2447787|P2|COMPLETED|Vax 2 / Year 1||402
1008146|NCT00546572|2447788|P1|COMPLETED|Vax 2 / Year 1||387
1008147|NCT00546572|2447787|P2|Received Vax 2|Vax 2 / Year 1||404
1008148|NCT00546572|2447788|P1|Received Vax 2|Vax 2 / Year 1||391
1008149|NCT00546572|2447787|P2|STARTED|Vax 2 / Year 1||404
1008150|NCT00546572|2447788|P1|STARTED|Vax 2 / Year 1||391
1008151|NCT00546572|2447787|P2|NOT COMPLETED|Vax 1 / Year 0||70
1008152|NCT00546572|2447788|P1|NOT COMPLETED|Vax 1 / Year 0||73
1008153|NCT00546572|2447787|P2|COMPLETED|Vax 1 / Year 0||404
1008154|NCT00546572|2447788|P1|COMPLETED|Vax 1 / Year 0||391
1008155|NCT00546572|2447787|P2|Received Vax 1|Vax 1 / Year 0||473
1008156|NCT00546572|2447788|P1|Received Vax 1|Vax 1 / Year 0||463
1008157|NCT00546572|2447787|P2|STARTED|Vax 1 / Year 0||474
1008158|NCT00546572|2447788|P1|STARTED|Vax 1 / Year 0||464
1008159|NCT00546637|2447832|P2|NOT COMPLETED|Overall Study||49
1008160|NCT00546637|2447833|P1|NOT COMPLETED|Overall Study||73
1008161|NCT00546637|2447832|P2|COMPLETED|Overall Study||424
1008162|NCT00546637|2447833|P1|COMPLETED|Overall Study||401
1008163|NCT00546637|2447832|P2|Received Treatment|Overall Study||472
1008164|NCT00546637|2447833|P1|Received Treatment|Overall Study||471
1008165|NCT00546637|2447832|P2|STARTED|Overall Study||473
1008166|NCT00546637|2447833|P1|STARTED|Overall Study||474
1008167|NCT00553436|2447905|P1|NOT COMPLETED|Overall Study||1
1008168|NCT00553436|2447905|P1|COMPLETED|Overall Study|09 April 2009|6
1008169|NCT00553436|2447905|P1|STARTED|Overall Study|20 August 2007|7
1008170|NCT00553462|2447911|P1|NOT COMPLETED|Overall Study||14
1008171|NCT00553462|2447911|P1|COMPLETED|Overall Study||61
1008172|NCT00553462|2447911|P1|STARTED|Overall Study||75
1008173|NCT00553475|2447920|P3|NOT COMPLETED|Overall Study||13
1008174|NCT00553475|2447921|P2|NOT COMPLETED|Overall Study||20
1008175|NCT00553475|2447922|P1|NOT COMPLETED|Overall Study||16
1008176|NCT00553475|2447920|P3|COMPLETED|Overall Study||32
1008177|NCT00553475|2447921|P2|COMPLETED|Overall Study||114
1008178|NCT00553475|2447922|P1|COMPLETED|Overall Study||119
1008179|NCT00553475|2447920|P3|STARTED|Overall Study||45
1008180|NCT00553475|2447921|P2|STARTED|Overall Study||134
1008181|NCT00553475|2447922|P1|STARTED|Overall Study||135
1008182|NCT00553501|2448044|P1|NOT COMPLETED|Overall Study||4
1008183|NCT00553501|2448044|P1|COMPLETED|Overall Study||55
1008184|NCT00553501|2448044|P1|STARTED|Overall Study||59
1008185|NCT00553514|2448055|P5|NOT COMPLETED|Overall Study||7
1008186|NCT00553514|2448056|P4|NOT COMPLETED|Overall Study||7
1008187|NCT00553514|2448057|P3|NOT COMPLETED|Overall Study||6
1008188|NCT00553514|2448058|P2|NOT COMPLETED|Overall Study||8
1008189|NCT00553514|2448059|P1|NOT COMPLETED|Overall Study||8
1008190|NCT00553514|2448055|P5|COMPLETED|Overall Study||8
1008191|NCT00553514|2448056|P4|COMPLETED|Overall Study||6
1008192|NCT00553514|2448057|P3|COMPLETED|Overall Study||9
1008193|NCT00553514|2448058|P2|COMPLETED|Overall Study||6
1008194|NCT00553514|2448059|P1|COMPLETED|Overall Study||6
1008195|NCT00553514|2448055|P5|STARTED|Overall Study||15
1008196|NCT00553514|2448056|P4|STARTED|Overall Study||13
1008197|NCT00553514|2448057|P3|STARTED|Overall Study||15
1008198|NCT00553514|2448058|P2|STARTED|Overall Study||14
1008199|NCT00553514|2448059|P1|STARTED|Overall Study||14
1008200|NCT00553605|2448098|P2|NOT COMPLETED|Overall Study||3
1008201|NCT00553605|2448099|P1|NOT COMPLETED|Overall Study||4
1008202|NCT00553605|2448098|P2|COMPLETED|Overall Study||161
1008203|NCT00553605|2448099|P1|COMPLETED|Overall Study||172
1008204|NCT00553605|2448098|P2|Treated|Overall Study||164
1008205|NCT00553605|2448099|P1|Treated|Overall Study||174
1008206|NCT00553605|2448098|P2|STARTED|Overall Study||164
1008207|NCT00553605|2448099|P1|STARTED|Overall Study||176
1008208|NCT00553631|2448125|P2|NOT COMPLETED|Overall Study||1
1008209|NCT00553631|2448126|P1|NOT COMPLETED|Overall Study||1
1008210|NCT00553631|2448125|P2|COMPLETED|Overall Study||16
1008211|NCT00553631|2448126|P1|COMPLETED|Overall Study||16
1008212|NCT00553631|2448125|P2|STARTED|Overall Study|Intent-to-treat (ITT) population|17
1008213|NCT00553631|2448126|P1|STARTED|Overall Study|Intent-to-treat (ITT) population|17
1008214|NCT00553644|2448146|P1|NOT COMPLETED|Overall Study||28
1008215|NCT00553644|2448146|P1|COMPLETED|Overall Study||25
1008216|NCT00553644|2448146|P1|STARTED|Overall Study||53
1008217|NCT00553696|2448157|P4|NOT COMPLETED|Overall Study||1
1008218|NCT00553696|2448158|P3|NOT COMPLETED|Overall Study||6
1008219|NCT00553696|2448159|P2|NOT COMPLETED|Overall Study||16
1008220|NCT00553696|2448160|P1|NOT COMPLETED|Overall Study||4
1008221|NCT00553696|2448157|P4|COMPLETED|Overall Study||0
1008222|NCT00553696|2448158|P3|COMPLETED|Overall Study||0
1008223|NCT00553696|2448159|P2|COMPLETED|Overall Study||0
1008224|NCT00553696|2448160|P1|COMPLETED|Overall Study||0
1008225|NCT00553696|2448157|P4|STARTED|Overall Study||1
1008226|NCT00553696|2448158|P3|STARTED|Overall Study||6
1008227|NCT00553696|2448159|P2|STARTED|Overall Study||16
1008228|NCT00553696|2448160|P1|STARTED|Overall Study||4
1008229|NCT00553969|2448202|P4|NOT COMPLETED|Overall Study||1
1008230|NCT00553969|2448203|P3|NOT COMPLETED|Overall Study||1
1008231|NCT00553969|2448204|P2|NOT COMPLETED|Overall Study||0
1008232|NCT00553969|2448205|P1|NOT COMPLETED|Overall Study||8
1008233|NCT00553969|2448202|P4|COMPLETED|Overall Study||23
1008234|NCT00553969|2448203|P3|COMPLETED|Overall Study||21
1008235|NCT00553969|2448204|P2|COMPLETED|Overall Study||24
1008236|NCT00553969|2448205|P1|COMPLETED|Overall Study||23
1008237|NCT00553969|2448202|P4|STARTED|Overall Study||24
1008238|NCT00553969|2448203|P3|STARTED|Overall Study||22
1008239|NCT00553969|2448204|P2|STARTED|Overall Study||24
1008240|NCT00553969|2448205|P1|STARTED|Overall Study||31
1008241|NCT00554099|2448218|P3|NOT COMPLETED|Non-Treatment Phase (9 Months)||3
1008242|NCT00554099|2448219|P2|NOT COMPLETED|Non-Treatment Phase (9 Months)||5
1008243|NCT00554099|2448220|P1|NOT COMPLETED|Non-Treatment Phase (9 Months)||7
1008244|NCT00554099|2448218|P3|COMPLETED|Non-Treatment Phase (9 Months)||24
1008245|NCT00554099|2448219|P2|COMPLETED|Non-Treatment Phase (9 Months)||27
1008246|NCT00554099|2448220|P1|COMPLETED|Non-Treatment Phase (9 Months)||22
1008247|NCT00554099|2448218|P3|STARTED|Non-Treatment Phase (9 Months)||27
1008248|NCT00554099|2448219|P2|STARTED|Non-Treatment Phase (9 Months)||32
1008249|NCT00554099|2448220|P1|STARTED|Non-Treatment Phase (9 Months)||29
1008250|NCT00554099|2448218|P3|NOT COMPLETED|Treatment Period (12 Weeks)||9
1008251|NCT00554099|2448219|P2|NOT COMPLETED|Treatment Period (12 Weeks)||8
1008252|NCT00554099|2448220|P1|NOT COMPLETED|Treatment Period (12 Weeks)||12
1008253|NCT00554099|2448218|P3|COMPLETED|Treatment Period (12 Weeks)||27
1008254|NCT00554099|2448219|P2|COMPLETED|Treatment Period (12 Weeks)||32
1008255|NCT00554099|2448220|P1|COMPLETED|Treatment Period (12 Weeks)||29
1008256|NCT00554099|2448218|P3|STARTED|Treatment Period (12 Weeks)||36
1008257|NCT00554099|2448219|P2|STARTED|Treatment Period (12 Weeks)||40
1008258|NCT00554099|2448220|P1|STARTED|Treatment Period (12 Weeks)||41
1008259|NCT00554190|2448249|P1|NOT COMPLETED|Overall Study||10
1008260|NCT00554190|2448249|P1|COMPLETED|Overall Study|10 subjects did not complete the Termination Study Forms|19
1008261|NCT00554190|2448249|P1|STARTED|Overall Study|29 subjects treated.|29
1008262|NCT00554216|2448258|P3|NOT COMPLETED|Overall Study||172
1008263|NCT00554216|2448259|P2|NOT COMPLETED|Overall Study||94
1008264|NCT00554216|2448260|P1|NOT COMPLETED|Overall Study||242
1008265|NCT00554216|2448258|P3|COMPLETED|Overall Study||340
1008266|NCT00554216|2448259|P2|COMPLETED|Overall Study||147
1008267|NCT00554216|2448260|P1|COMPLETED|Overall Study||272
1008268|NCT00554216|2448258|P3|STARTED|Overall Study||512
1008269|NCT00554216|2448259|P2|STARTED|Overall Study||241
1008270|NCT00554216|2448260|P1|STARTED|Overall Study||514
1008271|NCT00554229|2448273|P2|NOT COMPLETED|Overall Study||225
1008272|NCT00554229|2448274|P1|NOT COMPLETED|Overall Study||226
1008273|NCT00554229|2448273|P2|COMPLETED|Overall Study||70
1008274|NCT00554229|2448274|P1|COMPLETED|Overall Study||73
1008275|NCT00554229|2448273|P2|Patients Who Received Treatment|Overall Study||295
1008276|NCT00554229|2448274|P1|Patients Who Received Treatment|Overall Study||298
1008277|NCT00554229|2448273|P2|STARTED|Overall Study||295
1008278|NCT00554229|2448274|P1|STARTED|Overall Study||299
1008279|NCT00554294|2448298|P2|NOT COMPLETED|Overall Study||80
1008280|NCT00554294|2448299|P1|NOT COMPLETED|Overall Study||160
1008281|NCT00554294|2448298|P2|COMPLETED|Overall Study||1641
1008282|NCT00554294|2448299|P1|COMPLETED|Overall Study||1309
1008283|NCT00554294|2448298|P2|STARTED|Overall Study||1721
1008284|NCT00554294|2448299|P1|STARTED|Overall Study||1469
1008285|NCT00554372|2448305|P2|NOT COMPLETED|Overall Study||0
1008286|NCT00554372|2448306|P1|NOT COMPLETED|Overall Study||0
1008287|NCT00554372|2448305|P2|COMPLETED|Overall Study||16
1008288|NCT00554372|2448306|P1|COMPLETED|Overall Study||14
1008289|NCT00554372|2448305|P2|STARTED|Overall Study||16
1008290|NCT00554372|2448306|P1|STARTED|Overall Study||14
1008291|NCT00554463|2448318|P1|NOT COMPLETED|Overall Study||0
1008292|NCT00554463|2448318|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|5
1008293|NCT00554463|2448318|P1|STARTED|Overall Study||5
1008298|NCT00554619|2448351|P1|NOT COMPLETED|Overall Study||3
1008299|NCT00554619|2448351|P1|COMPLETED|Overall Study||18
1008300|NCT00554619|2448351|P1|STARTED|Overall Study||21
1008301|NCT00554671|2448365|P2|NOT COMPLETED|Overall Study||16
1008302|NCT00554671|2448366|P1|NOT COMPLETED|Overall Study||20
1008303|NCT00554671|2448365|P2|COMPLETED|Overall Study||117
1008304|NCT00554671|2448366|P1|COMPLETED|Overall Study||97
1008305|NCT00554671|2448365|P2|STARTED|Overall Study||133
1008306|NCT00554671|2448366|P1|STARTED|Overall Study||117
1008307|NCT00554749|2448374|P1|NOT COMPLETED|Overall Study||0
1008308|NCT00554749|2448374|P1|COMPLETED|Overall Study||7
1008309|NCT00554749|2448374|P1|STARTED|Overall Study||7
1008310|NCT00554801|2448381|P2|NOT COMPLETED|Overall Study||0
1008311|NCT00554801|2448382|P1|NOT COMPLETED|Overall Study||19
1008312|NCT00554801|2448381|P2|COMPLETED|Overall Study||29
1008313|NCT00554801|2448382|P1|COMPLETED|Overall Study||36
1008314|NCT00554801|2448381|P2|STARTED|Overall Study||29
1008315|NCT00554801|2448382|P1|STARTED|Overall Study||55
1008316|NCT00554840|2448390|P2|NOT COMPLETED|Overall Study||1
1008317|NCT00554840|2448391|P1|NOT COMPLETED|Overall Study||0
1008318|NCT00554840|2448390|P2|COMPLETED|Overall Study||4
1008319|NCT00554840|2448391|P1|COMPLETED|Overall Study||4
1008320|NCT00554840|2448390|P2|STARTED|Overall Study||5
1008321|NCT00554840|2448391|P1|STARTED|Overall Study||4
1008322|NCT00554853|2448409|P2|NOT COMPLETED|Crossover Arm (3 Months)||2
1008323|NCT00554853|2448410|P1|NOT COMPLETED|Crossover Arm (3 Months)||3
1008324|NCT00554853|2448409|P2|COMPLETED|Crossover Arm (3 Months)||55
1008325|NCT00554853|2448410|P1|COMPLETED|Crossover Arm (3 Months)||53
1008326|NCT00554853|2448409|P2|STARTED|Crossover Arm (3 Months)||57
1008327|NCT00554853|2448410|P1|STARTED|Crossover Arm (3 Months)||56
1008328|NCT00554853|2448409|P2|NOT COMPLETED|Washout Period (2 Weeks)||7
1008329|NCT00554853|2448410|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
1008330|NCT00554853|2448409|P2|COMPLETED|Washout Period (2 Weeks)||57
1008331|NCT00554853|2448410|P1|COMPLETED|Washout Period (2 Weeks)||56
1008332|NCT00554853|2448409|P2|STARTED|Washout Period (2 Weeks)||64
1008333|NCT00554853|2448410|P1|STARTED|Washout Period (2 Weeks)||56
1008334|NCT00554853|2448409|P2|NOT COMPLETED|First Arm of Study||7
1008335|NCT00554853|2448410|P1|NOT COMPLETED|First Arm of Study||16
1008336|NCT00554853|2448409|P2|COMPLETED|First Arm of Study||64
1008337|NCT00554853|2448410|P1|COMPLETED|First Arm of Study||56
1008338|NCT00554853|2448409|P2|STARTED|First Arm of Study||71
1008339|NCT00554853|2448410|P1|STARTED|First Arm of Study||72
1008340|NCT00554970|2448426|P4|NOT COMPLETED|Period 2||0
1008341|NCT00554970|2448427|P3|NOT COMPLETED|Period 2||1
1008342|NCT00554970|2448428|P2|NOT COMPLETED|Period 2||0
1008343|NCT00554970|2448429|P1|NOT COMPLETED|Period 2||0
1008344|NCT00554970|2448426|P4|COMPLETED|Period 2||8
1008345|NCT00554970|2448427|P3|COMPLETED|Period 2||7
1008346|NCT00554970|2448428|P2|COMPLETED|Period 2||8
1008347|NCT00554970|2448429|P1|COMPLETED|Period 2||7
1008348|NCT00554970|2448426|P4|STARTED|Period 2||8
1008349|NCT00554970|2448427|P3|STARTED|Period 2||8
1008350|NCT00554970|2448428|P2|STARTED|Period 2||8
1008351|NCT00554970|2448429|P1|STARTED|Period 2||7
1008352|NCT00554970|2448426|P4|NOT COMPLETED|Period 1||0
1008353|NCT00554970|2448427|P3|NOT COMPLETED|Period 1||0
1008354|NCT00554970|2448428|P2|NOT COMPLETED|Period 1||0
1008355|NCT00554970|2448429|P1|NOT COMPLETED|Period 1||1
1008356|NCT00554970|2448426|P4|COMPLETED|Period 1||8
1008357|NCT00554970|2448427|P3|COMPLETED|Period 1||8
1008358|NCT00554970|2448428|P2|COMPLETED|Period 1||8
1008359|NCT00554970|2448429|P1|COMPLETED|Period 1||7
1008360|NCT00554970|2448426|P4|STARTED|Period 1||8
1008361|NCT00554970|2448427|P3|STARTED|Period 1||8
1008362|NCT00554970|2448428|P2|STARTED|Period 1||8
1008363|NCT00554970|2448429|P1|STARTED|Period 1||8
1008364|NCT00554996|2448459|P1|NOT COMPLETED|Overall Study||0
1008365|NCT00554996|2448459|P1|COMPLETED|Overall Study||10
1008366|NCT00554996|2448459|P1|STARTED|Overall Study||10
1008367|NCT00555009|2448465|P2|NOT COMPLETED|Overall Study||6
1008368|NCT00555009|2448466|P1|NOT COMPLETED|Overall Study||2
1008369|NCT00555009|2448465|P2|COMPLETED|Overall Study||0
1008370|NCT00555009|2448466|P1|COMPLETED|Overall Study||2
1008371|NCT00555009|2448465|P2|STARTED|Overall Study||6
1008372|NCT00555009|2448466|P1|STARTED|Overall Study||4
1008373|NCT00555048|2448488|P1|NOT COMPLETED|Overall Study||0
1008374|NCT00555048|2448488|P1|COMPLETED|Overall Study||1
1008375|NCT00555048|2448488|P1|STARTED|Overall Study||1
1008376|NCT00555061|2448498|P1|NOT COMPLETED|Overall Study||9
1008377|NCT00555061|2448498|P1|COMPLETED|Overall Study||78
1008378|NCT00555061|2448498|P1|STARTED|Overall Study|One participant did not receive study medication and was not included in the analysis population.|87
1008379|NCT00555152|2448509|P4|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
1008380|NCT00555152|2448510|P3|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
1008381|NCT00555152|2448511|P2|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
1008382|NCT00555152|2448512|P1|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
1008383|NCT00555152|2448509|P4|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||9
1008384|NCT00555152|2448510|P3|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
1008385|NCT00555152|2448511|P2|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||10
1008386|NCT00555152|2448512|P1|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
1008387|NCT00555152|2448509|P4|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||9
1008388|NCT00555152|2448510|P3|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||0
1008389|NCT00555152|2448511|P2|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||10
1008390|NCT00555152|2448512|P1|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14|Participants in initial and second study registration periods reported separately.|0
1008391|NCT00555152|2448509|P4|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
1008392|NCT00555152|2448510|P3|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
1008393|NCT00555152|2448511|P2|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
1008394|NCT00555152|2448512|P1|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
1008395|NCT00555152|2448509|P4|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||1
1008396|NCT00555152|2448510|P3|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
1008397|NCT00555152|2448511|P2|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
1008398|NCT00555152|2448512|P1|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||2
1008399|NCT00555152|2448509|P4|STARTED|Period Open at BCM: 1/17/08-3/8/10||1
1008400|NCT00555152|2448510|P3|STARTED|Period Open at BCM: 1/17/08-3/8/10||0
1008401|NCT00555152|2448511|P2|STARTED|Period Open at BCM: 1/17/08-3/8/10|Participants in initial and second study registration periods reported separately.|0
1008402|NCT00555152|2448512|P1|STARTED|Period Open at BCM: 1/17/08-3/8/10||2
1008403|NCT00555217|2448536|P2|NOT COMPLETED|Overall Study||68
1008404|NCT00555217|2448537|P1|NOT COMPLETED|Overall Study||75
1008405|NCT00555217|2448536|P2|COMPLETED|Overall Study||656
1008406|NCT00555217|2448537|P1|COMPLETED|Overall Study||649
1008407|NCT00555217|2448536|P2|STARTED|Overall Study||724
1008408|NCT00555217|2448537|P1|STARTED|Overall Study||724
1008444|NCT00555360|2448858|P2|NOT COMPLETED|Overall Study||36
1008445|NCT00555360|2448859|P1|NOT COMPLETED|Overall Study||27
1008446|NCT00555360|2448858|P2|COMPLETED|Overall Study||153
1008447|NCT00555360|2448859|P1|COMPLETED|Overall Study||156
1008448|NCT00555360|2448858|P2|STARTED|Overall Study||189
1008449|NCT00555360|2448859|P1|STARTED|Overall Study||183
1008450|NCT00555425|2448871|P2|NOT COMPLETED|Overall Study||19
1008451|NCT00555425|2448872|P1|NOT COMPLETED|Overall Study||51
1008452|NCT00555425|2448871|P2|COMPLETED|Overall Study||37
1008453|NCT00555425|2448872|P1|COMPLETED|Overall Study||6
1008454|NCT00555425|2448871|P2|STARTED|Overall Study||56
1008455|NCT00555425|2448872|P1|STARTED|Overall Study||57
1008456|NCT00555438|2448890|P1|NOT COMPLETED|Between 10 Days and 30 Days Postoperativ||5
1008457|NCT00555438|2448890|P1|COMPLETED|Between 10 Days and 30 Days Postoperativ||433
1008458|NCT00555438|2448890|P1|STARTED|Between 10 Days and 30 Days Postoperativ||438
1008459|NCT00555438|2448890|P1|NOT COMPLETED|10 Days Post-operative||4
1008460|NCT00555438|2448890|P1|COMPLETED|10 Days Post-operative|438 patients attended the day 10 visit (four patients died during hospitalization)|438
1008461|NCT00555438|2448890|P1|STARTED|10 Days Post-operative||442
1008462|NCT00555464|2448900|P2|NOT COMPLETED|Overall Study||3
1008463|NCT00555464|2448901|P1|NOT COMPLETED|Overall Study||0
1008464|NCT00555464|2448900|P2|COMPLETED|Overall Study||1
1008465|NCT00555464|2448901|P1|COMPLETED|Overall Study||4
1008466|NCT00555464|2448900|P2|STARTED|Overall Study||4
1008467|NCT00555464|2448901|P1|STARTED|Overall Study||4
1008468|NCT00555477|2448911|P2|NOT COMPLETED|Overall Study||13
1008469|NCT00555477|2448912|P1|NOT COMPLETED|Overall Study||2
1008470|NCT00555477|2448911|P2|COMPLETED|Overall Study||32
1008471|NCT00555477|2448912|P1|COMPLETED|Overall Study||12
1008472|NCT00555477|2448911|P2|STARTED|Overall Study||45
1008473|NCT00555477|2448912|P1|STARTED|Overall Study||14
1008474|NCT00555568|2448920|P3|NOT COMPLETED|Overall Study||16
1008475|NCT00555568|2448921|P2|NOT COMPLETED|Overall Study||16
1008476|NCT00555568|2448922|P1|NOT COMPLETED|Overall Study||26
1008477|NCT00555568|2448920|P3|COMPLETED|Overall Study||84
1008478|NCT00555568|2448921|P2|COMPLETED|Overall Study||82
1008479|NCT00555568|2448922|P1|COMPLETED|Overall Study||74
1008480|NCT00555568|2448920|P3|STARTED|Overall Study||100
1008481|NCT00555568|2448921|P2|STARTED|Overall Study||98
1008482|NCT00555568|2448922|P1|STARTED|Overall Study||100
1008483|NCT00555620|2448948|P6|NOT COMPLETED|Overall Study||22
1008484|NCT00555620|2448949|P5|NOT COMPLETED|Overall Study||3
1008485|NCT00555620|2448950|P4|NOT COMPLETED|Overall Study||23
1008486|NCT00555620|2448951|P3|NOT COMPLETED|Overall Study||15
1008487|NCT00555620|2448952|P2|NOT COMPLETED|Overall Study||7
1008488|NCT00555620|2448953|P1|NOT COMPLETED|Overall Study||6
1008489|NCT00555620|2448948|P6|COMPLETED|Overall Study||0
1008490|NCT00555620|2448949|P5|COMPLETED|Overall Study||0
1008491|NCT00555620|2448950|P4|COMPLETED|Overall Study||0
1008492|NCT00555620|2448951|P3|COMPLETED|Overall Study||0
1008493|NCT00555620|2448952|P2|COMPLETED|Overall Study||0
1008494|NCT00555620|2448953|P1|COMPLETED|Overall Study||0
1008495|NCT00555620|2448948|P6|STARTED|Overall Study||22
1008496|NCT00555620|2448949|P5|STARTED|Overall Study||3
1008497|NCT00555620|2448950|P4|STARTED|Overall Study||23
1008498|NCT00555620|2448951|P3|STARTED|Overall Study||15
1008499|NCT00555620|2448952|P2|STARTED|Overall Study||7
1008500|NCT00555620|2448953|P1|STARTED|Overall Study||6
1008501|NCT00555672|2449067|P2|NOT COMPLETED|Overall Study||10
1008502|NCT00555672|2449068|P1|NOT COMPLETED|Overall Study||24
1008503|NCT00555672|2449067|P2|COMPLETED|Overall Study||0
1008504|NCT00555672|2449068|P1|COMPLETED|Overall Study||0
1008505|NCT00555672|2449067|P2|STARTED|Overall Study||10
1008506|NCT00555672|2449068|P1|STARTED|Overall Study||24
1008507|NCT00555750|2449089|P2|NOT COMPLETED|Overall Study||0
1008508|NCT00555750|2449090|P1|NOT COMPLETED|Overall Study||0
1008509|NCT00555750|2449089|P2|COMPLETED|Overall Study||10
1008510|NCT00555750|2449090|P1|COMPLETED|Overall Study||10
1008511|NCT00555750|2449089|P2|STARTED|Overall Study||10
1008512|NCT00555750|2449090|P1|STARTED|Overall Study||10
1008513|NCT00555880|2449122|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1008514|NCT00555880|2449123|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1008515|NCT00555880|2449122|P2|COMPLETED|Treatment Period 2 (1 Day)||11
1008516|NCT00555880|2449123|P1|COMPLETED|Treatment Period 2 (1 Day)||13
1008517|NCT00555880|2449122|P2|STARTED|Treatment Period 2 (1 Day)||11
1008518|NCT00555880|2449123|P1|STARTED|Treatment Period 2 (1 Day)||13
1008519|NCT00555880|2449122|P2|NOT COMPLETED|Washout (1 Day)||0
1008520|NCT00555880|2449123|P1|NOT COMPLETED|Washout (1 Day)||0
1008521|NCT00555880|2449122|P2|COMPLETED|Washout (1 Day)||11
1008522|NCT00555880|2449123|P1|COMPLETED|Washout (1 Day)||13
1008523|NCT00555880|2449122|P2|STARTED|Washout (1 Day)||11
1008524|NCT00555880|2449123|P1|STARTED|Washout (1 Day)||13
1008525|NCT00555880|2449122|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1008526|NCT00555880|2449123|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1008527|NCT00555880|2449122|P2|COMPLETED|Treatment Period 1 (1 Day)||11
1008528|NCT00555880|2449123|P1|COMPLETED|Treatment Period 1 (1 Day)||13
1008529|NCT00555880|2449122|P2|STARTED|Treatment Period 1 (1 Day)||11
1008530|NCT00555880|2449123|P1|STARTED|Treatment Period 1 (1 Day)||13
1008539|NCT00555906|2449174|P5|NOT COMPLETED|Phase 2||32
1008540|NCT00555906|2449175|P4|NOT COMPLETED|Phase 2||0
1008541|NCT00555906|2449176|P3|NOT COMPLETED|Phase 2||0
1008542|NCT00555906|2449177|P2|NOT COMPLETED|Phase 2||0
1008543|NCT00555906|2449178|P1|NOT COMPLETED|Phase 2||0
1008544|NCT00555906|2449174|P5|COMPLETED|Phase 2||0
1008545|NCT00555906|2449175|P4|COMPLETED|Phase 2||0
1008546|NCT00555906|2449176|P3|COMPLETED|Phase 2||0
1008547|NCT00555906|2449177|P2|COMPLETED|Phase 2||0
1008548|NCT00555906|2449178|P1|COMPLETED|Phase 2||0
1008549|NCT00555906|2449174|P5|Treated|Phase 2||30
1008550|NCT00555906|2449175|P4|Treated|Phase 2||0
1008551|NCT00555906|2449176|P3|Treated|Phase 2||0
1008552|NCT00555906|2449177|P2|Treated|Phase 2||0
1008553|NCT00555906|2449178|P1|Treated|Phase 2||0
1008554|NCT00555906|2449174|P5|STARTED|Phase 2||32
1008555|NCT00555906|2449175|P4|STARTED|Phase 2||0
1008556|NCT00555906|2449176|P3|STARTED|Phase 2||0
1008557|NCT00555906|2449177|P2|STARTED|Phase 2||0
1008558|NCT00555906|2449178|P1|STARTED|Phase 2||0
1008559|NCT00555906|2449174|P5|NOT COMPLETED|Phase 1||0
1008560|NCT00555906|2449175|P4|NOT COMPLETED|Phase 1||5
1008561|NCT00555906|2449176|P3|NOT COMPLETED|Phase 1||7
1008562|NCT00555906|2449177|P2|NOT COMPLETED|Phase 1||6
1008563|NCT00555906|2449178|P1|NOT COMPLETED|Phase 1||3
1008564|NCT00555906|2449174|P5|COMPLETED|Phase 1||0
1008565|NCT00555906|2449175|P4|COMPLETED|Phase 1||0
1008566|NCT00555906|2449176|P3|COMPLETED|Phase 1||0
1008567|NCT00555906|2449177|P2|COMPLETED|Phase 1||0
1008568|NCT00555906|2449178|P1|COMPLETED|Phase 1||0
1008569|NCT00555906|2449174|P5|STARTED|Phase 1||0
1008570|NCT00555906|2449175|P4|STARTED|Phase 1||5
1008571|NCT00555906|2449176|P3|STARTED|Phase 1||7
1008572|NCT00555906|2449177|P2|STARTED|Phase 1||6
1008573|NCT00555906|2449178|P1|STARTED|Phase 1||3
1008574|NCT00555997|2449211|P4|NOT COMPLETED|Phase 2 SPCD||3
1008575|NCT00555997|2449212|P3|NOT COMPLETED|Phase 2 SPCD||7
1008576|NCT00555997|2449213|P2|NOT COMPLETED|Phase 2 SPCD||0
1008577|NCT00555997|2449214|P1|NOT COMPLETED|Phase 2 SPCD||0
1008578|NCT00555997|2449211|P4|COMPLETED|Phase 2 SPCD||22
1008579|NCT00555997|2449212|P3|COMPLETED|Phase 2 SPCD||31
1008580|NCT00555997|2449213|P2|COMPLETED|Phase 2 SPCD||0
1008581|NCT00555997|2449214|P1|COMPLETED|Phase 2 SPCD||0
1008582|NCT00555997|2449211|P4|STARTED|Phase 2 SPCD||25
1008583|NCT00555997|2449212|P3|STARTED|Phase 2 SPCD||38
1008584|NCT00555997|2449213|P2|STARTED|Phase 2 SPCD||0
1008585|NCT00555997|2449214|P1|STARTED|Phase 2 SPCD||0
1008586|NCT00555997|2449211|P4|NOT COMPLETED|Phase 1 SPCD||0
1008587|NCT00555997|2449212|P3|NOT COMPLETED|Phase 1 SPCD||0
1008588|NCT00555997|2449213|P2|NOT COMPLETED|Phase 1 SPCD||15
1008589|NCT00555997|2449214|P1|NOT COMPLETED|Phase 1 SPCD||12
1008590|NCT00555997|2449211|P4|COMPLETED|Phase 1 SPCD||0
1008591|NCT00555997|2449212|P3|COMPLETED|Phase 1 SPCD||0
1008592|NCT00555997|2449213|P2|COMPLETED|Phase 1 SPCD||76
1008593|NCT00555997|2449214|P1|COMPLETED|Phase 1 SPCD||17
1008594|NCT00555997|2449211|P4|STARTED|Phase 1 SPCD||0
1008595|NCT00555997|2449212|P3|STARTED|Phase 1 SPCD||0
1008596|NCT00555997|2449213|P2|STARTED|Phase 1 SPCD||91
1008597|NCT00555997|2449214|P1|STARTED|Phase 1 SPCD||29
1008598|NCT00556049|2449230|P1|NOT COMPLETED|Overall Study||0
1008599|NCT00556049|2449230|P1|COMPLETED|Overall Study||72
1008600|NCT00556049|2449230|P1|STARTED|Overall Study||72
1008601|NCT00556075|2449237|P3|NOT COMPLETED|Overall Study||8
1008602|NCT00556075|2449238|P2|NOT COMPLETED|Overall Study||9
1008603|NCT00556075|2449239|P1|NOT COMPLETED|Overall Study||13
1008604|NCT00556075|2449237|P3|COMPLETED|Overall Study||15
1008605|NCT00556075|2449238|P2|COMPLETED|Overall Study||13
1008606|NCT00556075|2449239|P1|COMPLETED|Overall Study||9
1008607|NCT00556075|2449237|P3|STARTED|Overall Study||23
1008608|NCT00556075|2449238|P2|STARTED|Overall Study||22
1008609|NCT00556075|2449239|P1|STARTED|Overall Study||22
1008610|NCT00556140|2449262|P1|NOT COMPLETED|Overall Study||3
1008611|NCT00556140|2449262|P1|COMPLETED|Overall Study||13
1008612|NCT00556140|2449262|P1|STARTED|Overall Study||16
1008613|NCT00556166|2449267|P1|NOT COMPLETED|Overall Study||1
1008614|NCT00556166|2449267|P1|COMPLETED|Overall Study||3
1008615|NCT00556166|2449267|P1|STARTED|Overall Study||4
1008616|NCT00556322|2449274|P2|NOT COMPLETED|Overall Study||203
1008617|NCT00556322|2449275|P1|NOT COMPLETED|Overall Study||221
1008618|NCT00556322|2449274|P2|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
1008619|NCT00556322|2449275|P1|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
1008620|NCT00556322|2449274|P2|STARTED|Overall Study||203
1008621|NCT00556322|2449275|P1|STARTED|Overall Study||221
1008630|NCT00556400|2449344|P2|NOT COMPLETED|Overall Study||0
1008631|NCT00556400|2449345|P1|NOT COMPLETED|Overall Study||0
1008632|NCT00556400|2449344|P2|COMPLETED|Overall Study||0
1008633|NCT00556400|2449345|P1|COMPLETED|Overall Study||1
1008634|NCT00556400|2449344|P2|STARTED|Overall Study||0
1008635|NCT00556400|2449345|P1|STARTED|Overall Study||1
1008636|NCT00556426|2449354|P1|NOT COMPLETED|Overall Study||9
1008637|NCT00556426|2449354|P1|COMPLETED|Overall Study||91
1008638|NCT00556426|2449354|P1|STARTED|Overall Study||100
1008639|NCT00549601|2449365|P3|NOT COMPLETED|Received Study Drug||4
1008640|NCT00549601|2449366|P2|NOT COMPLETED|Received Study Drug||11
1008641|NCT00549601|2449367|P1|NOT COMPLETED|Received Study Drug||7
1008642|NCT00549601|2449365|P3|COMPLETED|Received Study Drug||45
1008643|NCT00549601|2449366|P2|COMPLETED|Received Study Drug||36
1008644|NCT00549601|2449367|P1|COMPLETED|Received Study Drug||36
1008645|NCT00549601|2449365|P3|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|49
1008646|NCT00549601|2449366|P2|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|47
1008647|NCT00549601|2449367|P1|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|43
1008648|NCT00549601|2449365|P3|NOT COMPLETED|Randomized||2
1008649|NCT00549601|2449366|P2|NOT COMPLETED|Randomized||1
1008650|NCT00549601|2449367|P1|NOT COMPLETED|Randomized||0
1008651|NCT00549601|2449365|P3|COMPLETED|Randomized||49
1008652|NCT00549601|2449366|P2|COMPLETED|Randomized||47
1008653|NCT00549601|2449367|P1|COMPLETED|Randomized||43
1008654|NCT00549601|2449365|P3|STARTED|Randomized||51
1008655|NCT00549601|2449366|P2|STARTED|Randomized||48
1008656|NCT00549601|2449367|P1|STARTED|Randomized||43
1008657|NCT00549640|2449391|P2|NOT COMPLETED|Overall Study||16
1008658|NCT00549640|2449392|P1|NOT COMPLETED|Overall Study||18
1008659|NCT00549640|2449391|P2|COMPLETED|Overall Study||24
1008660|NCT00549640|2449392|P1|COMPLETED|Overall Study|For the primary endpoint, subjects who discontinued participation were assumed to be smoking.|22
1008661|NCT00549640|2449391|P2|STARTED|Overall Study||40
1008662|NCT00549640|2449392|P1|STARTED|Overall Study||40
1008663|NCT00549718|2449406|P4|NOT COMPLETED|Overall Study||55
1008664|NCT00549718|2449407|P3|NOT COMPLETED|Overall Study||39
1008665|NCT00549718|2449408|P2|NOT COMPLETED|Overall Study||37
1008666|NCT00549718|2449409|P1|NOT COMPLETED|Overall Study||41
1008667|NCT00549718|2449406|P4|COMPLETED|Overall Study||73
1008668|NCT00549718|2449407|P3|COMPLETED|Overall Study||85
1008669|NCT00549718|2449408|P2|COMPLETED|Overall Study||86
1008670|NCT00549718|2449409|P1|COMPLETED|Overall Study||84
1008671|NCT00549718|2449406|P4|STARTED|Overall Study||128
1008672|NCT00549718|2449407|P3|STARTED|Overall Study||124
1008673|NCT00549718|2449408|P2|STARTED|Overall Study||123
1008674|NCT00549718|2449409|P1|STARTED|Overall Study||125
1008675|NCT00549757|2449425|P2|NOT COMPLETED|Extension Period (in Average 9 Months)||635
1008676|NCT00549757|2449426|P1|NOT COMPLETED|Extension Period (in Average 9 Months)||625
1008677|NCT00549757|2449425|P2|COMPLETED|Extension Period (in Average 9 Months)||3182
1008678|NCT00549757|2449426|P1|COMPLETED|Extension Period (in Average 9 Months)||3148
1008679|NCT00549757|2449425|P2|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3817
1008680|NCT00549757|2449426|P1|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3773
1008681|NCT00549757|2449425|P2|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4310
1008682|NCT00549757|2449426|P1|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4296
1008683|NCT00549757|2449425|P2|COMPLETED|Active Treatment Phase: Max. 50 Months||0
1008684|NCT00549757|2449426|P1|COMPLETED|Active Treatment Phase: Max. 50 Months||0
1008685|NCT00549757|2449425|P2|Safety Set|Active Treatment Phase: Max. 50 Months||4285
1008686|NCT00549757|2449426|P1|Safety Set|Active Treatment Phase: Max. 50 Months||4272
1008687|NCT00549757|2449425|P2|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4287
1008688|NCT00549757|2449426|P1|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4274
1008689|NCT00549757|2449425|P2|STARTED|Active Treatment Phase: Max. 50 Months||4310
1008690|NCT00549757|2449426|P1|STARTED|Active Treatment Phase: Max. 50 Months|"Started indicates randomized patients."|4296
1008691|NCT00549770|2449492|P8|NOT COMPLETED|Overall Study||25
1008692|NCT00549770|2449493|P7|NOT COMPLETED|Overall Study||14
1008693|NCT00549770|2449494|P6|NOT COMPLETED|Overall Study||13
1008694|NCT00549770|2449495|P5|NOT COMPLETED|Overall Study||17
1008695|NCT00549770|2449496|P4|NOT COMPLETED|Overall Study||16
1008696|NCT00549770|2449497|P3|NOT COMPLETED|Overall Study||10
1008697|NCT00549770|2449498|P2|NOT COMPLETED|Overall Study||11
1008698|NCT00549770|2449499|P1|NOT COMPLETED|Overall Study||7
1008699|NCT00549770|2449492|P8|COMPLETED|Overall Study||148
1008700|NCT00549770|2449493|P7|COMPLETED|Overall Study||151
1008701|NCT00549770|2449494|P6|COMPLETED|Overall Study||151
1008702|NCT00549770|2449495|P5|COMPLETED|Overall Study||149
1008703|NCT00549770|2449496|P4|COMPLETED|Overall Study||147
1008704|NCT00549770|2449497|P3|COMPLETED|Overall Study||162
1008705|NCT00549770|2449498|P2|COMPLETED|Overall Study||158
1008706|NCT00549770|2449499|P1|COMPLETED|Overall Study||149
1008707|NCT00549770|2449492|P8|Ambulatory Blood Pressure Monitoring|Overall Study||57
1008708|NCT00549770|2449493|P7|Ambulatory Blood Pressure Monitoring|Overall Study||50
1008709|NCT00549770|2449494|P6|Ambulatory Blood Pressure Monitoring|Overall Study||54
1008710|NCT00549770|2449495|P5|Ambulatory Blood Pressure Monitoring|Overall Study||49
1008711|NCT00549770|2449496|P4|Ambulatory Blood Pressure Monitoring|Overall Study||55
1008712|NCT00549770|2449497|P3|Ambulatory Blood Pressure Monitoring|Overall Study||53
1008713|NCT00549770|2449498|P2|Ambulatory Blood Pressure Monitoring|Overall Study||61
1008714|NCT00549770|2449499|P1|Ambulatory Blood Pressure Monitoring|Overall Study||48
1008715|NCT00549770|2449492|P8|Intent-to-treat Population|Overall Study||172
1008716|NCT00549770|2449493|P7|Intent-to-treat Population|Overall Study||164
1008717|NCT00549770|2449494|P6|Intent-to-treat Population|Overall Study||163
1008718|NCT00549770|2449495|P5|Intent-to-treat Population|Overall Study||163
1008719|NCT00549770|2449496|P4|Intent-to-treat Population|Overall Study||163
1008720|NCT00549770|2449497|P3|Intent-to-treat Population|Overall Study||170
1008721|NCT00549770|2449498|P2|Intent-to-treat Population|Overall Study||168
1008722|NCT00549770|2449499|P1|Intent-to-treat Population|Overall Study||154
1008723|NCT00549770|2449492|P8|STARTED|Overall Study||173
1008724|NCT00549770|2449493|P7|STARTED|Overall Study||165
1008725|NCT00549770|2449494|P6|STARTED|Overall Study||164
1008726|NCT00549770|2449495|P5|STARTED|Overall Study||166
1008727|NCT00549770|2449496|P4|STARTED|Overall Study||163
1008728|NCT00549770|2449497|P3|STARTED|Overall Study||172
1008729|NCT00549770|2449498|P2|STARTED|Overall Study||169
1008730|NCT00549770|2449499|P1|STARTED|Overall Study||156
1008731|NCT00549783|2449583|P2|NOT COMPLETED|Overall Study||13
1008732|NCT00549783|2449584|P1|NOT COMPLETED|Overall Study||8
1008733|NCT00549783|2449583|P2|COMPLETED|Overall Study||122
1008734|NCT00549783|2449584|P1|COMPLETED|Overall Study||131
1008735|NCT00549783|2449583|P2|STARTED|Overall Study||135
1008736|NCT00549783|2449584|P1|STARTED|Overall Study||139
1008737|NCT00549822|2449614|P1|NOT COMPLETED|Overall Study||0
1008738|NCT00549822|2449614|P1|COMPLETED|Overall Study||3
1008739|NCT00549822|2449614|P1|STARTED|Overall Study||3
1008740|NCT00549900|2449620|P1|NOT COMPLETED|Overall Study||1
1008741|NCT00549900|2449620|P1|COMPLETED|Overall Study||29
1008742|NCT00549900|2449620|P1|STARTED|Overall Study||30
1008743|NCT00549939|2449632|P3|NOT COMPLETED|40-week Open Label Treatment Period||5
1008744|NCT00549939|2449633|P2|NOT COMPLETED|40-week Open Label Treatment Period||5
1008745|NCT00549939|2449634|P1|NOT COMPLETED|40-week Open Label Treatment Period||0
1008746|NCT00549939|2449632|P3|COMPLETED|40-week Open Label Treatment Period||78
1008747|NCT00549939|2449633|P2|COMPLETED|40-week Open Label Treatment Period||75
1008748|NCT00549939|2449634|P1|COMPLETED|40-week Open Label Treatment Period||0
1008749|NCT00549939|2449632|P3|STARTED|40-week Open Label Treatment Period|55 patients continued Alfuzosin 0.2 mg/kg/day and 28 patients started Alfuzosin 0.2 mg/kg/day.|83
1008750|NCT00549939|2449633|P2|STARTED|40-week Open Label Treatment Period|54 patients continued Alfuzosin 0.1 mg/kg/day and 26 patients started Alfuzosin 0.1 mg/kg/day.|80
1008751|NCT00549939|2449634|P1|STARTED|40-week Open Label Treatment Period|54 patients continued and switched to Alfuzosin: 26 to 0.1 mg/kg/day and 28 to 0.2 mg/kg/day.|0
1008752|NCT00549939|2449632|P3|NOT COMPLETED|12-week Double Blind Treatment Period||2
1008753|NCT00549939|2449633|P2|NOT COMPLETED|12-week Double Blind Treatment Period||2
1008754|NCT00549939|2449634|P1|NOT COMPLETED|12-week Double Blind Treatment Period||1
1008755|NCT00549939|2449632|P3|COMPLETED|12-week Double Blind Treatment Period||56
1008756|NCT00549939|2449633|P2|COMPLETED|12-week Double Blind Treatment Period||55
1008757|NCT00549939|2449634|P1|COMPLETED|12-week Double Blind Treatment Period||56
1008758|NCT00549939|2449632|P3|STARTED|12-week Double Blind Treatment Period||58
1008759|NCT00549939|2449633|P2|STARTED|12-week Double Blind Treatment Period||57
1008760|NCT00549939|2449634|P1|STARTED|12-week Double Blind Treatment Period|29 (Alfuzosin 0.1 mg/kg/day matching placebo) + 28 (Alfuzosin 0.2 mg/kg/day matching placebo)|57
1008761|NCT00550043|2449666|P5|NOT COMPLETED|Overall Study||1
1008762|NCT00550043|2449667|P4|NOT COMPLETED|Overall Study||2
1008763|NCT00550043|2449668|P3|NOT COMPLETED|Overall Study||1
1008764|NCT00550043|2449669|P2|NOT COMPLETED|Overall Study||3
1008765|NCT00550043|2449670|P1|NOT COMPLETED|Overall Study||0
1008766|NCT00550043|2449666|P5|COMPLETED|Overall Study||9
1008767|NCT00550043|2449667|P4|COMPLETED|Overall Study||8
1008768|NCT00550043|2449668|P3|COMPLETED|Overall Study||8
1008769|NCT00550043|2449669|P2|COMPLETED|Overall Study||9
1008770|NCT00550043|2449670|P1|COMPLETED|Overall Study||9
1008771|NCT00550043|2449666|P5|STARTED|Overall Study||10
1008772|NCT00550043|2449667|P4|STARTED|Overall Study||10
1008773|NCT00550043|2449668|P3|STARTED|Overall Study||9
1008774|NCT00550043|2449669|P2|STARTED|Overall Study||12
1008775|NCT00550043|2449670|P1|STARTED|Overall Study||9
1008776|NCT00550147|2449722|P1|NOT COMPLETED|Quetiapine Addition Treatment Period||6
1008777|NCT00550147|2449722|P1|COMPLETED|Quetiapine Addition Treatment Period||18
1008778|NCT00550147|2449722|P1|STARTED|Quetiapine Addition Treatment Period||24
1008779|NCT00550147|2449722|P1|NOT COMPLETED|OROS Methylphenidate Monotherapy||6
1008780|NCT00550147|2449722|P1|COMPLETED|OROS Methylphenidate Monotherapy||24
1008781|NCT00550147|2449722|P1|STARTED|OROS Methylphenidate Monotherapy||30
1008782|NCT00550173|2449743|P3|NOT COMPLETED|Overall Study||73
1008783|NCT00550173|2449744|P2|NOT COMPLETED|Overall Study||63
1008784|NCT00550173|2449745|P1|NOT COMPLETED|Overall Study||72
1008785|NCT00550173|2449743|P3|COMPLETED|Overall Study||11
1008786|NCT00550173|2449744|P2|COMPLETED|Overall Study||19
1008787|NCT00550173|2449745|P1|COMPLETED|Overall Study||9
1008788|NCT00550173|2449743|P3|Not Discontinued at 18 Months|Overall Study||11
1008789|NCT00550173|2449744|P2|Not Discontinued at 18 Months|Overall Study||19
1008790|NCT00550173|2449745|P1|Not Discontinued at 18 Months|Overall Study||9
1008791|NCT00550173|2449743|P3|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|80
1008792|NCT00550173|2449744|P2|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|82
1008793|NCT00550173|2449745|P1|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|78
1008794|NCT00550173|2449743|P3|STARTED|Overall Study||84
1008795|NCT00550173|2449744|P2|STARTED|Overall Study||82
1008796|NCT00550173|2449745|P1|STARTED|Overall Study||81
1008797|NCT00550277|2449774|P1|NOT COMPLETED|Overall Study||9
1008798|NCT00550277|2449774|P1|COMPLETED|Overall Study||11
1008799|NCT00550277|2449774|P1|STARTED|Overall Study||20
1008800|NCT00550368|2449780|P2|NOT COMPLETED|Overall Study||0
1008801|NCT00550368|2449781|P1|NOT COMPLETED|Overall Study||0
1008802|NCT00550368|2449780|P2|COMPLETED|Overall Study||19
1008803|NCT00550368|2449781|P1|COMPLETED|Overall Study||26
1008804|NCT00550368|2449780|P2|STARTED|Overall Study||19
1008805|NCT00550368|2449781|P1|STARTED|Overall Study||26
1008806|NCT00550394|2449791|P2|NOT COMPLETED|Overall Study||13
1008807|NCT00550394|2449792|P1|NOT COMPLETED|Overall Study||12
1008808|NCT00550394|2449791|P2|COMPLETED|Overall Study||5
1008809|NCT00550394|2449792|P1|COMPLETED|Overall Study||9
1008810|NCT00550394|2449791|P2|STARTED|Overall Study||18
1008811|NCT00550394|2449792|P1|STARTED|Overall Study||21
1008812|NCT00550407|2449806|P3|NOT COMPLETED|26-Week Randomized Phase||24
1008813|NCT00550407|2449807|P2|NOT COMPLETED|26-Week Randomized Phase||43
1008814|NCT00550407|2449808|P1|NOT COMPLETED|26-Week Randomized Phase||0
1008815|NCT00550407|2449806|P3|COMPLETED|26-Week Randomized Phase||21
1008816|NCT00550407|2449807|P2|COMPLETED|26-Week Randomized Phase||15
1008817|NCT00550407|2449808|P1|COMPLETED|26-Week Randomized Phase||0
1008818|NCT00550407|2449806|P3|STARTED|26-Week Randomized Phase||45
1008819|NCT00550407|2449807|P2|STARTED|26-Week Randomized Phase||58
1008820|NCT00550407|2449808|P1|STARTED|26-Week Randomized Phase||0
1008821|NCT00550407|2449806|P3|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
1008822|NCT00550407|2449807|P2|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
1008823|NCT00550407|2449808|P1|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||112
1008824|NCT00550407|2449806|P3|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
1008825|NCT00550407|2449807|P2|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
1008826|NCT00550407|2449808|P1|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||103
1008827|NCT00550407|2449806|P3|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
1008828|NCT00550407|2449807|P2|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
1008829|NCT00550407|2449808|P1|STARTED|8-16 Week Preliminary (Open-Label) Phase||215
1008830|NCT00550446|2449848|P11|NOT COMPLETED|Post Week 12||1
1008831|NCT00550446|2449849|P10|NOT COMPLETED|Post Week 12||7
1008832|NCT00550446|2449850|P9|NOT COMPLETED|Post Week 12||2
1008833|NCT00550446|2449851|P8|NOT COMPLETED|Post Week 12||1
1008834|NCT00550446|2449852|P7|NOT COMPLETED|Post Week 12||2
1008835|NCT00550446|2449853|P6|NOT COMPLETED|Post Week 12||1
1008836|NCT00550446|2449854|P5|NOT COMPLETED|Post Week 12||2
1008837|NCT00550446|2449855|P4|NOT COMPLETED|Post Week 12||3
1008838|NCT00550446|2449856|P3|NOT COMPLETED|Post Week 12||3
1008839|NCT00550446|2449857|P2|NOT COMPLETED|Post Week 12||2
1008840|NCT00550446|2449858|P1|NOT COMPLETED|Post Week 12||3
1008841|NCT00550446|2449848|P11|COMPLETED|Post Week 12||24
1008842|NCT00550446|2449849|P10|COMPLETED|Post Week 12||37
1008843|NCT00550446|2449850|P9|COMPLETED|Post Week 12||15
1008844|NCT00550446|2449851|P8|COMPLETED|Post Week 12||16
1008845|NCT00550446|2449852|P7|COMPLETED|Post Week 12||19
1008846|NCT00550446|2449853|P6|COMPLETED|Post Week 12||0
1008847|NCT00550446|2449854|P5|COMPLETED|Post Week 12||52
1008848|NCT00550446|2449855|P4|COMPLETED|Post Week 12||55
1008849|NCT00550446|2449856|P3|COMPLETED|Post Week 12||43
1008850|NCT00550446|2449857|P2|COMPLETED|Post Week 12||28
1008851|NCT00550446|2449858|P1|COMPLETED|Post Week 12||24
1008852|NCT00550446|2449848|P11|STARTED|Post Week 12||25
1008853|NCT00550446|2449849|P10|STARTED|Post Week 12||44
1008854|NCT00550446|2449850|P9|STARTED|Post Week 12||17
1008855|NCT00550446|2449851|P8|STARTED|Post Week 12||17
1008856|NCT00550446|2449852|P7|STARTED|Post Week 12||21
1008857|NCT00550446|2449853|P6|STARTED|Post Week 12||1
1008858|NCT00550446|2449854|P5|STARTED|Post Week 12||54
1008859|NCT00550446|2449855|P4|STARTED|Post Week 12||58
1008860|NCT00550446|2449856|P3|STARTED|Post Week 12||46
1008861|NCT00550446|2449857|P2|STARTED|Post Week 12||30
1008862|NCT00550446|2449858|P1|STARTED|Post Week 12||27
1008863|NCT00550446|2449848|P11|NOT COMPLETED|Up To Week 12||0
1008864|NCT00550446|2449849|P10|NOT COMPLETED|Up To Week 12||0
1008865|NCT00550446|2449850|P9|NOT COMPLETED|Up To Week 12||0
1008866|NCT00550446|2449851|P8|NOT COMPLETED|Up To Week 12||0
1008867|NCT00550446|2449852|P7|NOT COMPLETED|Up To Week 12||13
1008868|NCT00550446|2449853|P6|NOT COMPLETED|Up To Week 12||8
1008869|NCT00550446|2449854|P5|NOT COMPLETED|Up To Week 12||3
1008870|NCT00550446|2449855|P4|NOT COMPLETED|Up To Week 12||3
1008871|NCT00550446|2449856|P3|NOT COMPLETED|Up To Week 12||4
1008872|NCT00550446|2449857|P2|NOT COMPLETED|Up To Week 12||5
1008873|NCT00550446|2449858|P1|NOT COMPLETED|Up To Week 12||10
1008874|NCT00550446|2449848|P11|COMPLETED|Up To Week 12||0
1008875|NCT00550446|2449849|P10|COMPLETED|Up To Week 12||0
1008876|NCT00550446|2449850|P9|COMPLETED|Up To Week 12||0
1008877|NCT00550446|2449851|P8|COMPLETED|Up To Week 12||0
1008878|NCT00550446|2449852|P7|COMPLETED|Up To Week 12||46
1008879|NCT00550446|2449853|P6|COMPLETED|Up To Week 12||45
1008880|NCT00550446|2449854|P5|COMPLETED|Up To Week 12||54
1008881|NCT00550446|2449855|P4|COMPLETED|Up To Week 12||58
1008882|NCT00550446|2449856|P3|COMPLETED|Up To Week 12||46
1008883|NCT00550446|2449857|P2|COMPLETED|Up To Week 12||47
1008884|NCT00550446|2449858|P1|COMPLETED|Up To Week 12||44
1008885|NCT00550446|2449848|P11|Treated|Up To Week 12||0
1008886|NCT00550446|2449849|P10|Treated|Up To Week 12||0
1008887|NCT00550446|2449850|P9|Treated|Up To Week 12||0
1008888|NCT00550446|2449851|P8|Treated|Up To Week 12||0
1008889|NCT00550446|2449852|P7|Treated|Up To Week 12||59
1008890|NCT00550446|2449853|P6|Treated|Up To Week 12||53
1008891|NCT00550446|2449854|P5|Treated|Up To Week 12||57
1008892|NCT00550446|2449855|P4|Treated|Up To Week 12||61
1008893|NCT00550446|2449856|P3|Treated|Up To Week 12||49
1008894|NCT00550446|2449857|P2|Treated|Up To Week 12||51
1008895|NCT00550446|2449858|P1|Treated|Up To Week 12||54
1008896|NCT00550446|2449848|P11|STARTED|Up To Week 12||0
1008897|NCT00550446|2449849|P10|STARTED|Up To Week 12||0
1008898|NCT00550446|2449850|P9|STARTED|Up To Week 12||0
1008899|NCT00550446|2449851|P8|STARTED|Up To Week 12||0
1008900|NCT00550446|2449852|P7|STARTED|Up To Week 12||59
1008901|NCT00550446|2449853|P6|STARTED|Up To Week 12||53
1008902|NCT00550446|2449854|P5|STARTED|Up To Week 12||57
1008903|NCT00550446|2449855|P4|STARTED|Up To Week 12||61
1008904|NCT00550446|2449856|P3|STARTED|Up To Week 12||50
1008905|NCT00550446|2449857|P2|STARTED|Up To Week 12||52
1008906|NCT00550446|2449858|P1|STARTED|Up To Week 12||54
1008913|NCT00550537|2450355|P1|NOT COMPLETED|Overall Study||104
1008914|NCT00550537|2450355|P1|COMPLETED|Overall Study||12
1008915|NCT00550537|2450355|P1|STARTED|Overall Study||116
1008916|NCT00550550|2450372|P2|NOT COMPLETED|Overall Study||29
1008917|NCT00550550|2450373|P1|NOT COMPLETED|Overall Study||34
1008918|NCT00550550|2450372|P2|COMPLETED|Overall Study||140
1008919|NCT00550550|2450373|P1|COMPLETED|Overall Study||142
1008920|NCT00550550|2450372|P2|Number Treated|Overall Study||169
1008921|NCT00550550|2450373|P1|Number Treated|Overall Study||175
1008922|NCT00550550|2450372|P2|STARTED|Overall Study||169
1008923|NCT00550550|2450373|P1|STARTED|Overall Study||176
1008927|NCT00550654|2450396|P1|NOT COMPLETED|Overall Study||0
1008928|NCT00550654|2450396|P1|COMPLETED|Overall Study||1
1008929|NCT00550654|2450396|P1|STARTED|Overall Study||1
1008930|NCT00550680|2450406|P1|NOT COMPLETED|Overall Study||56
1008931|NCT00550680|2450406|P1|COMPLETED|Overall Study||152
1008932|NCT00550680|2450406|P1|STARTED|Overall Study||208
1008933|NCT00550732|2450415|P1|NOT COMPLETED|Overall Study||11
1008934|NCT00550732|2450415|P1|COMPLETED|Overall Study||29
1008935|NCT00550732|2450415|P1|STARTED|Overall Study||40
1008936|NCT00550745|2450428|P2|NOT COMPLETED|Overall Study||60
1008937|NCT00550745|2450429|P1|NOT COMPLETED|Overall Study||87
1008938|NCT00550745|2450428|P2|COMPLETED|Overall Study||5939
1008939|NCT00550745|2450429|P1|COMPLETED|Overall Study||5913
1008940|NCT00550745|2450428|P2|STARTED|Overall Study||5999
1008941|NCT00550745|2450429|P1|STARTED|Overall Study||6000
1008942|NCT00550771|2450439|P2|NOT COMPLETED|Overall Study||10
1008943|NCT00550771|2450440|P1|NOT COMPLETED|Overall Study||17
1008944|NCT00550771|2450439|P2|COMPLETED|Overall Study||50
1008945|NCT00550771|2450440|P1|COMPLETED|Overall Study||104
1008946|NCT00550771|2450439|P2|STARTED|Overall Study||60
1008947|NCT00550771|2450440|P1|STARTED|Overall Study||121
1008948|NCT00550836|2450454|P2|NOT COMPLETED|Overall Study||9
1008949|NCT00550836|2450455|P1|NOT COMPLETED|Overall Study||3
1008950|NCT00550836|2450454|P2|COMPLETED|Overall Study||46
1008951|NCT00550836|2450455|P1|COMPLETED|Overall Study||46
1008952|NCT00550836|2450454|P2|STARTED|Overall Study||55
1008953|NCT00550836|2450455|P1|STARTED|Overall Study||49
1008954|NCT00550862|2450473|P4|NOT COMPLETED|Overall Study||1
1008955|NCT00550862|2450474|P3|NOT COMPLETED|Overall Study||16
1008956|NCT00550862|2450475|P2|NOT COMPLETED|Overall Study||6
1008957|NCT00550862|2450476|P1|NOT COMPLETED|Overall Study||6
1008958|NCT00550862|2450473|P4|COMPLETED|Overall Study||37
1008959|NCT00550862|2450474|P3|COMPLETED|Overall Study||25
1008960|NCT00550862|2450475|P2|COMPLETED|Overall Study||42
1008961|NCT00550862|2450476|P1|COMPLETED|Overall Study||32
1008962|NCT00550862|2450473|P4|STARTED|Overall Study||38
1008963|NCT00550862|2450474|P3|STARTED|Overall Study||41
1008964|NCT00550862|2450475|P2|STARTED|Overall Study||48
1008965|NCT00550862|2450476|P1|STARTED|Overall Study||38
1008966|NCT00556452|2450497|P3|NOT COMPLETED|Overall Study||0
1008967|NCT00556452|2450498|P2|NOT COMPLETED|Overall Study||0
1008968|NCT00556452|2450499|P1|NOT COMPLETED|Overall Study||0
1008969|NCT00556452|2450497|P3|COMPLETED|Overall Study||19
1008970|NCT00556452|2450498|P2|COMPLETED|Overall Study||21
1008971|NCT00556452|2450499|P1|COMPLETED|Overall Study||6
1008972|NCT00556452|2450497|P3|STARTED|Overall Study||19
1008973|NCT00556452|2450498|P2|STARTED|Overall Study||21
1008974|NCT00556452|2450499|P1|STARTED|Overall Study||6
1008975|NCT00556478|2450507|P2|NOT COMPLETED|Open-Label Phase||10
1008976|NCT00556478|2450508|P1|NOT COMPLETED|Open-Label Phase||14
1008977|NCT00556478|2450507|P2|COMPLETED|Open-Label Phase||67
1008978|NCT00556478|2450508|P1|COMPLETED|Open-Label Phase||132
1008979|NCT00556478|2450507|P2|Treated in Open-label|Open-Label Phase||71
1008980|NCT00556478|2450508|P1|Treated in Open-label|Open-Label Phase||142
1008981|NCT00556478|2450507|P2|STARTED|Open-Label Phase||77
1008982|NCT00556478|2450508|P1|STARTED|Open-Label Phase||146
1008983|NCT00556478|2450507|P2|NOT COMPLETED|Double-blind Phase||8
1008984|NCT00556478|2450508|P1|NOT COMPLETED|Double-blind Phase||21
1008985|NCT00556478|2450507|P2|COMPLETED|Double-blind Phase||77
1008986|NCT00556478|2450508|P1|COMPLETED|Double-blind Phase||150
1008987|NCT00556478|2450507|P2|ITT|Double-blind Phase||82
1008988|NCT00556478|2450508|P1|ITT|Double-blind Phase||167
1008989|NCT00556478|2450507|P2|STARTED|Double-blind Phase||85
1008990|NCT00556478|2450508|P1|STARTED|Double-blind Phase||171
1008991|NCT00556491|2450535|P2|NOT COMPLETED|Overall Study||1
1008992|NCT00556491|2450536|P1|NOT COMPLETED|Overall Study||1
1008993|NCT00556491|2450535|P2|COMPLETED|Overall Study||19
1008994|NCT00556491|2450536|P1|COMPLETED|Overall Study||19
1008995|NCT00556491|2450535|P2|STARTED|Overall Study||20
1008996|NCT00556491|2450536|P1|STARTED|Overall Study|January 2008|20
1008997|NCT00556504|2450544|P2|NOT COMPLETED|Overall Study||9
1008998|NCT00556504|2450545|P1|NOT COMPLETED|Overall Study||8
1008999|NCT00556504|2450544|P2|COMPLETED|Overall Study||33
1009000|NCT00556504|2450545|P1|COMPLETED|Overall Study||34
1009001|NCT00556504|2450544|P2|Safety Population|Overall Study||42
1009002|NCT00556504|2450545|P1|Safety Population|Overall Study||41
1009003|NCT00556504|2450544|P2|Intend-to Treat Population|Overall Study||42
1009004|NCT00556504|2450545|P1|Intend-to Treat Population|Overall Study||42
1009005|NCT00556504|2450544|P2|STARTED|Overall Study||42
1009006|NCT00556504|2450545|P1|STARTED|Overall Study||42
1009007|NCT00556543|2450563|P1|NOT COMPLETED|Overall Study||0
1009008|NCT00556543|2450563|P1|COMPLETED|Overall Study|Subjects completed 180 days of study enrollment|10
1009009|NCT00556543|2450563|P1|STARTED|Overall Study||10
1009010|NCT00556673|2450581|P2|NOT COMPLETED|Overall Study||2
1009011|NCT00556673|2450582|P1|NOT COMPLETED|Overall Study||3
1009012|NCT00556673|2450581|P2|COMPLETED|Overall Study||13
1009013|NCT00556673|2450582|P1|COMPLETED|Overall Study||13
1009014|NCT00556673|2450581|P2|Pharmacodynamic (PD) Population|Overall Study|3 patients inadvertently unblinded were not included in PD analysis population.|12
1009015|NCT00556673|2450582|P1|Pharmacodynamic (PD) Population|Overall Study|4 patients inadvertently unblinded were not included in PD analysis population.|12
1009016|NCT00556673|2450581|P2|STARTED|Overall Study||15
1009017|NCT00556673|2450582|P1|STARTED|Overall Study||16
1009018|NCT00556712|2450620|P2|NOT COMPLETED|Overall Study||438
1009019|NCT00556712|2450621|P1|NOT COMPLETED|Overall Study||451
1009020|NCT00556712|2450620|P2|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
1009021|NCT00556712|2450621|P1|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
1009022|NCT00556712|2450620|P2|STARTED|Overall Study||438
1009023|NCT00556712|2450621|P1|STARTED|Overall Study||451
1009024|NCT00558285|2450702|P5|NOT COMPLETED|Overall Study||4
1009025|NCT00558285|2450703|P4|NOT COMPLETED|Overall Study||4
1009026|NCT00558285|2450704|P3|NOT COMPLETED|Overall Study||5
1009027|NCT00558285|2450705|P2|NOT COMPLETED|Overall Study||3
1009028|NCT00558285|2450706|P1|NOT COMPLETED|Overall Study||6
1009029|NCT00558285|2450702|P5|COMPLETED|Overall Study||49
1009030|NCT00558285|2450703|P4|COMPLETED|Overall Study||48
1009031|NCT00558285|2450704|P3|COMPLETED|Overall Study||46
1009032|NCT00558285|2450705|P2|COMPLETED|Overall Study||48
1009033|NCT00558285|2450706|P1|COMPLETED|Overall Study||44
1009034|NCT00558285|2450702|P5|Safety: Received Study Drug|Overall Study||53
1009035|NCT00558285|2450703|P4|Safety: Received Study Drug|Overall Study||51
1009036|NCT00558285|2450704|P3|Safety: Received Study Drug|Overall Study||51
1009037|NCT00558285|2450705|P2|Safety: Received Study Drug|Overall Study||51
1009038|NCT00558285|2450706|P1|Safety: Received Study Drug|Overall Study||49
1009039|NCT00558285|2450702|P5|STARTED|Overall Study||53
1009040|NCT00558285|2450703|P4|STARTED|Overall Study||52
1009041|NCT00558285|2450704|P3|STARTED|Overall Study||51
1009042|NCT00558285|2450705|P2|STARTED|Overall Study||51
1009043|NCT00558285|2450706|P1|STARTED|Overall Study||50
1009044|NCT00558363|2450750|P2|NOT COMPLETED|Overall Study||36
1009045|NCT00558363|2450751|P1|NOT COMPLETED|Overall Study||71
1009046|NCT00558363|2450750|P2|COMPLETED|Overall Study||111
1009047|NCT00558363|2450751|P1|COMPLETED|Overall Study||76
1009048|NCT00558363|2450750|P2|STARTED|Overall Study||147
1009049|NCT00558363|2450751|P1|STARTED|Overall Study||147
1009050|NCT00558428|2450805|P4|NOT COMPLETED|Overall Study||11
1009051|NCT00558428|2450806|P3|NOT COMPLETED|Overall Study||4
1009052|NCT00558428|2450807|P2|NOT COMPLETED|Overall Study||24
1009053|NCT00558428|2450808|P1|NOT COMPLETED|Overall Study||12
1009054|NCT00558428|2450805|P4|COMPLETED|Overall Study||266
1009055|NCT00558428|2450806|P3|COMPLETED|Overall Study||273
1009056|NCT00558428|2450807|P2|COMPLETED|Overall Study||252
1009057|NCT00558428|2450808|P1|COMPLETED|Overall Study||255
1009058|NCT00558428|2450805|P4|STARTED|Overall Study||277
1009059|NCT00558428|2450806|P3|STARTED|Overall Study||277
1009060|NCT00558428|2450807|P2|STARTED|Overall Study||276
1009061|NCT00558428|2450808|P1|STARTED|Overall Study||267
1009062|NCT00558467|2450848|P2|NOT COMPLETED|Overall Study||4
1009063|NCT00558467|2450849|P1|NOT COMPLETED|Overall Study||1
1009064|NCT00558467|2450848|P2|COMPLETED|Overall Study||39
1009065|NCT00558467|2450849|P1|COMPLETED|Overall Study||19
1009066|NCT00558467|2450848|P2|STARTED|Overall Study||43
1009067|NCT00558467|2450849|P1|STARTED|Overall Study||20
1009068|NCT00558558|2450905|P1|NOT COMPLETED|Overall Study||6
1009069|NCT00558558|2450905|P1|COMPLETED|Overall Study||0
1009070|NCT00558558|2450905|P1|STARTED|Overall Study||6
1009071|NCT00558571|2450913|P4|NOT COMPLETED|Overall Study||0
1009072|NCT00558571|2450914|P3|NOT COMPLETED|Overall Study||0
1009073|NCT00558571|2450915|P2|NOT COMPLETED|Overall Study||0
1009074|NCT00558571|2450916|P1|NOT COMPLETED|Overall Study||0
1009075|NCT00558571|2450913|P4|COMPLETED|Overall Study||30
1009076|NCT00558571|2450914|P3|COMPLETED|Overall Study||16
1009077|NCT00558571|2450915|P2|COMPLETED|Overall Study||16
1009078|NCT00558571|2450916|P1|COMPLETED|Overall Study||16
1009079|NCT00558571|2450913|P4|STARTED|Overall Study||30
1009080|NCT00558571|2450914|P3|STARTED|Overall Study||16
1009081|NCT00558571|2450915|P2|STARTED|Overall Study||16
1009082|NCT00558571|2450916|P1|STARTED|Overall Study||16
1009083|NCT00558636|2450993|P2|NOT COMPLETED|Follow-up||7
1009084|NCT00558636|2450994|P1|NOT COMPLETED|Follow-up||12
1009085|NCT00558636|2450993|P2|COMPLETED|Follow-up|Study was prematurely terminated|0
1009086|NCT00558636|2450994|P1|COMPLETED|Follow-up|Study was prematurely terminated|0
1009087|NCT00558636|2450993|P2|STARTED|Follow-up|7 subjects entered Follow-up phase before they completed the treatment phase|7
1009088|NCT00558636|2450994|P1|STARTED|Follow-up|12 subjects entered Follow-up phase before they completed the treatment phase|12
1009089|NCT00558636|2450993|P2|NOT COMPLETED|Treatment||44
1009090|NCT00558636|2450994|P1|NOT COMPLETED|Treatment||47
1009091|NCT00558636|2450993|P2|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
1009092|NCT00558636|2450994|P1|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
1009093|NCT00558636|2450993|P2|Start of Maintenance Monotherapy|Treatment|Placebo taken as the single agent in the Maintenance Phase|2
1009094|NCT00558636|2450994|P1|Start of Maintenance Monotherapy|Treatment|Sorafenib taken as the single agent in the Maintenance Phase|2
1009095|NCT00558636|2450993|P2|STARTED|Treatment||44
1009096|NCT00558636|2450994|P1|STARTED|Treatment|up to 6 cycles of combination therapy|47
1009097|NCT00558701|2451014|P2|NOT COMPLETED|Overall Study||4
1009098|NCT00558701|2451015|P1|NOT COMPLETED|Overall Study||1
1009099|NCT00558701|2451014|P2|COMPLETED|Overall Study||11
1009100|NCT00558701|2451015|P1|COMPLETED|Overall Study||14
1009101|NCT00558701|2451014|P2|STARTED|Overall Study||15
1009102|NCT00558701|2451015|P1|STARTED|Overall Study||15
1009103|NCT00558753|2451023|P2|NOT COMPLETED|Overall Study||7
1009104|NCT00558753|2451024|P1|NOT COMPLETED|Overall Study||5
1009105|NCT00558753|2451023|P2|COMPLETED|Overall Study||113
1009106|NCT00558753|2451024|P1|COMPLETED|Overall Study||115
1009107|NCT00558753|2451023|P2|STARTED|Overall Study||120
1009108|NCT00558753|2451024|P1|STARTED|Overall Study||120
1009109|NCT00558792|2451037|P3|NOT COMPLETED|Overall Study||0
1009110|NCT00558792|2451038|P2|NOT COMPLETED|Overall Study||0
1009111|NCT00558792|2451039|P1|NOT COMPLETED|Overall Study||0
1009112|NCT00558792|2451037|P3|COMPLETED|Overall Study||60
1009113|NCT00558792|2451038|P2|COMPLETED|Overall Study||63
1009114|NCT00558792|2451039|P1|COMPLETED|Overall Study||68
1009115|NCT00558792|2451037|P3|STARTED|Overall Study||60
1009116|NCT00558792|2451038|P2|STARTED|Overall Study||63
1009117|NCT00558792|2451039|P1|STARTED|Overall Study||68
1009118|NCT00558831|2451083|P1|NOT COMPLETED|Overall Study||1
1009119|NCT00558831|2451083|P1|COMPLETED|Overall Study||10
1009120|NCT00558831|2451083|P1|STARTED|Overall Study||11
1009121|NCT00558870|2451091|P2|NOT COMPLETED|Overall Study||0
1009122|NCT00558870|2451092|P1|NOT COMPLETED|Overall Study||0
1009123|NCT00558870|2451091|P2|COMPLETED|Overall Study||2
1009124|NCT00558870|2451092|P1|COMPLETED|Overall Study||2
1009125|NCT00558870|2451091|P2|STARTED|Overall Study||2
1009126|NCT00558870|2451092|P1|STARTED|Overall Study||2
1009127|NCT00558896|2451107|P7|NOT COMPLETED|Overall Study||24
1009128|NCT00558896|2451108|P6|NOT COMPLETED|Overall Study||52
1009129|NCT00558896|2451109|P5|NOT COMPLETED|Overall Study||23
1009130|NCT00558896|2451110|P4|NOT COMPLETED|Overall Study||12
1009131|NCT00558896|2451111|P3|NOT COMPLETED|Overall Study||5
1009132|NCT00558896|2451112|P2|NOT COMPLETED|Overall Study||7
1009133|NCT00558896|2451113|P1|NOT COMPLETED|Overall Study||21
1009134|NCT00558896|2451107|P7|COMPLETED|Overall Study||9
1009135|NCT00558896|2451108|P6|COMPLETED|Overall Study||68
1009136|NCT00558896|2451109|P5|COMPLETED|Overall Study||37
1009137|NCT00558896|2451110|P4|COMPLETED|Overall Study||23
1009138|NCT00558896|2451111|P3|COMPLETED|Overall Study||30
1009139|NCT00558896|2451112|P2|COMPLETED|Overall Study||27
1009140|NCT00558896|2451113|P1|COMPLETED|Overall Study||39
1009141|NCT00558896|2451107|P7|STARTED|Overall Study||33
1009142|NCT00558896|2451108|P6|STARTED|Overall Study||120
1009143|NCT00558896|2451109|P5|STARTED|Overall Study||60
1009144|NCT00558896|2451110|P4|STARTED|Overall Study||35
1009145|NCT00558896|2451111|P3|STARTED|Overall Study||35
1009146|NCT00558896|2451112|P2|STARTED|Overall Study||34
1009147|NCT00558896|2451113|P1|STARTED|Overall Study||60
1009148|NCT00559013|2451143|P1|NOT COMPLETED|Overall Study||0
1009149|NCT00559013|2451143|P1|COMPLETED|Overall Study||38
1009150|NCT00559013|2451143|P1|STARTED|Overall Study||38
1009151|NCT00559104|2451149|P2|NOT COMPLETED|Overall Study||0
1009152|NCT00559104|2451150|P1|NOT COMPLETED|Overall Study||9
1009153|NCT00559104|2451149|P2|COMPLETED|Overall Study||5
1009154|NCT00559104|2451150|P1|COMPLETED|Overall Study|Progression was the reason for off-treatment for 9 of 9 patients who went off of treatment.|46
1009155|NCT00559104|2451149|P2|STARTED|Overall Study||5
1009156|NCT00559104|2451150|P1|STARTED|Overall Study||55
1009157|NCT00559273|2451162|P2|NOT COMPLETED|Evaluation Period (8 Weeks)||5
1009158|NCT00559273|2451163|P1|NOT COMPLETED|Evaluation Period (8 Weeks)||3
1009159|NCT00559273|2451162|P2|COMPLETED|Evaluation Period (8 Weeks)||137
1009160|NCT00559273|2451163|P1|COMPLETED|Evaluation Period (8 Weeks)||141
1009161|NCT00559273|2451162|P2|STARTED|Evaluation Period (8 Weeks)||142
1009162|NCT00559273|2451163|P1|STARTED|Evaluation Period (8 Weeks)||144
1009163|NCT00559273|2451162|P2|NOT COMPLETED|Correction Period (20 Weeks)||12
1009164|NCT00559273|2451163|P1|NOT COMPLETED|Correction Period (20 Weeks)||9
1009165|NCT00559273|2451162|P2|COMPLETED|Correction Period (20 Weeks)||142
1009166|NCT00559273|2451163|P1|COMPLETED|Correction Period (20 Weeks)||144
1009167|NCT00559273|2451162|P2|Treated|Correction Period (20 Weeks)||154
1009168|NCT00559273|2451163|P1|Treated|Correction Period (20 Weeks)||151
1009169|NCT00559273|2451162|P2|STARTED|Correction Period (20 Weeks)||154
1009170|NCT00559273|2451163|P1|STARTED|Correction Period (20 Weeks)||153
1009171|NCT00559364|2451185|P2|NOT COMPLETED|Overall Study||0
1009172|NCT00559364|2451186|P1|NOT COMPLETED|Overall Study||1
1009173|NCT00559364|2451185|P2|COMPLETED|Overall Study||20
1009174|NCT00559364|2451186|P1|COMPLETED|Overall Study||29
1009175|NCT00559364|2451185|P2|STARTED|Overall Study||20
1009176|NCT00559364|2451186|P1|STARTED|Overall Study||30
1009177|NCT00559377|2451196|P1|NOT COMPLETED|Overall Study||9
1009178|NCT00559377|2451196|P1|COMPLETED|Overall Study||7
1009179|NCT00559377|2451196|P1|STARTED|Overall Study||16
1009180|NCT00559507|2451204|P1|NOT COMPLETED|Overall Study||3
1009181|NCT00559507|2451204|P1|COMPLETED|Overall Study||9
1009182|NCT00559507|2451204|P1|STARTED|Overall Study||12
1009183|NCT00559585|2451212|P2|NOT COMPLETED|Open Label LT Period Main + Sub-Study||0
1009184|NCT00559585|2451213|P1|NOT COMPLETED|Open Label LT Period Main + Sub-Study||428
1009185|NCT00559585|2451212|P2|COMPLETED|Open Label LT Period Main + Sub-Study||0
1009186|NCT00559585|2451213|P1|COMPLETED|Open Label LT Period Main + Sub-Study||945
1009187|NCT00559585|2451212|P2|STARTED|Open Label LT Period Main + Sub-Study|IV administration was discontinued and abatacept was only administered SC during LT Period.|0
1009188|NCT00559585|2451213|P1|STARTED|Open Label LT Period Main + Sub-Study|1373 includes 15 participants from ST Period Sub-Study who rolled over into LT Period (6 SC + 9 IV).|1373
1009189|NCT00559585|2451212|P2|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
1009190|NCT00559585|2451213|P1|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
1009191|NCT00559585|2451212|P2|COMPLETED|Anti-TNF Sub-Study in ST Period||9
1009192|NCT00559585|2451213|P1|COMPLETED|Anti-TNF Sub-Study in ST Period||7
1009193|NCT00559585|2451212|P2|STARTED|Anti-TNF Sub-Study in ST Period|9 completed Sub-Study ST Period and 9 chose to over into the LT Period.|10
1009194|NCT00559585|2451213|P1|STARTED|Anti-TNF Sub-Study in ST Period|7 completed Sub-Study ST period and 6 chose to roll over into LT Period.|8
1009195|NCT00559585|2451212|P2|NOT COMPLETED|Double Blind ST Period Main Study||45
1009196|NCT00559585|2451213|P1|NOT COMPLETED|Double Blind ST Period Main Study||43
1009197|NCT00559585|2451212|P2|COMPLETED|Double Blind ST Period Main Study||676
1009198|NCT00559585|2451213|P1|COMPLETED|Double Blind ST Period Main Study||693
1009199|NCT00559585|2451212|P2|STARTED|Double Blind ST Period Main Study|Randomized and treated|721
1009200|NCT00559585|2451213|P1|STARTED|Double Blind ST Period Main Study|Randomized and treated|736
1009201|NCT00559637|2451273|P1|NOT COMPLETED|Overall Study||54
1009202|NCT00559637|2451273|P1|COMPLETED|Overall Study||130
1009203|NCT00559637|2451273|P1|STARTED|Overall Study||184
1009204|NCT00559754|2451284|P1|NOT COMPLETED|Overall Study||11
1009205|NCT00559754|2451284|P1|COMPLETED|Overall Study||61
1009206|NCT00559754|2451284|P1|STARTED|Overall Study||72
1009207|NCT00559897|2451308|P1|NOT COMPLETED|Overall Study||0
1009208|NCT00559897|2451308|P1|COMPLETED|Overall Study||6
1009209|NCT00559897|2451308|P1|STARTED|Overall Study||6
1009210|NCT00559936|2451312|P1|NOT COMPLETED|Overall Study||4
1009211|NCT00559936|2451312|P1|COMPLETED|Overall Study||20
1009212|NCT00559936|2451312|P1|STARTED|Overall Study||24
1009213|NCT00559949|2451317|P1|NOT COMPLETED|Overall Study||7
1009214|NCT00559949|2451317|P1|COMPLETED|Overall Study||32
1009215|NCT00559949|2451317|P1|STARTED|Overall Study||39
1009216|NCT00559962|2451332|P8|NOT COMPLETED|Overall Study||4
1009217|NCT00559962|2451333|P7|NOT COMPLETED|Overall Study||5
1009218|NCT00559962|2451334|P6|NOT COMPLETED|Overall Study||5
1009219|NCT00559962|2451335|P5|NOT COMPLETED|Overall Study||14
1009220|NCT00559962|2451336|P4|NOT COMPLETED|Overall Study||5
1009221|NCT00559962|2451337|P3|NOT COMPLETED|Overall Study||10
1009222|NCT00559962|2451338|P2|NOT COMPLETED|Overall Study||9
1009223|NCT00559962|2451339|P1|NOT COMPLETED|Overall Study||2
1009224|NCT00559962|2451332|P8|COMPLETED|Overall Study||25
1009225|NCT00559962|2451333|P7|COMPLETED|Overall Study||28
1009226|NCT00559962|2451334|P6|COMPLETED|Overall Study||23
1009227|NCT00559962|2451335|P5|COMPLETED|Overall Study||21
1009228|NCT00559962|2451336|P4|COMPLETED|Overall Study||29
1009229|NCT00559962|2451337|P3|COMPLETED|Overall Study||24
1009230|NCT00559962|2451338|P2|COMPLETED|Overall Study||25
1009231|NCT00559962|2451339|P1|COMPLETED|Overall Study||31
1009232|NCT00559962|2451332|P8|STARTED|Overall Study||29
1009233|NCT00559962|2451333|P7|STARTED|Overall Study||33
1009234|NCT00559962|2451334|P6|STARTED|Overall Study||28
1009235|NCT00559962|2451335|P5|STARTED|Overall Study||35
1009236|NCT00559962|2451336|P4|STARTED|Overall Study||34
1009237|NCT00559962|2451337|P3|STARTED|Overall Study||34
1009238|NCT00559962|2451338|P2|STARTED|Overall Study||34
1009239|NCT00559962|2451339|P1|STARTED|Overall Study||33
1009240|NCT00559988|2451361|P2|NOT COMPLETED|Overall Study||352
1009241|NCT00559988|2451362|P1|NOT COMPLETED|Overall Study||351
1009242|NCT00559988|2451361|P2|COMPLETED|Overall Study||1009
1009243|NCT00559988|2451362|P1|COMPLETED|Overall Study||1006
1009244|NCT00559988|2451361|P2|STARTED|Overall Study||1361
1009245|NCT00559988|2451362|P1|STARTED|Overall Study||1357
1009246|NCT00560066|2451370|P2|NOT COMPLETED|Overall Study||22
1009247|NCT00560066|2451371|P1|NOT COMPLETED|Overall Study||6
1009248|NCT00560066|2451370|P2|COMPLETED|Overall Study||980
1009249|NCT00560066|2451371|P1|COMPLETED|Overall Study||390
1009250|NCT00560066|2451370|P2|STARTED|Overall Study||1002
1009251|NCT00560066|2451371|P1|STARTED|Overall Study||396
1009252|NCT00560105|2451403|P2|NOT COMPLETED|Overall Study||2
1009253|NCT00560105|2451404|P1|NOT COMPLETED|Overall Study||1
1009254|NCT00560105|2451403|P2|COMPLETED|Overall Study||18
1009255|NCT00560105|2451404|P1|COMPLETED|Overall Study||19
1009256|NCT00560105|2451403|P2|STARTED|Overall Study||20
1009257|NCT00560105|2451404|P1|STARTED|Overall Study||20
1009258|NCT00560235|2451419|P3|NOT COMPLETED|Phase 2||97
1009259|NCT00560235|2451420|P2|NOT COMPLETED|Phase 2||0
1009260|NCT00560235|2451421|P1|NOT COMPLETED|Phase 2||0
1009261|NCT00560235|2451419|P3|COMPLETED|Phase 2||10
1009262|NCT00560235|2451420|P2|COMPLETED|Phase 2||0
1009263|NCT00560235|2451421|P1|COMPLETED|Phase 2||0
1009264|NCT00560235|2451419|P3|STARTED|Phase 2||107
1009265|NCT00560235|2451420|P2|STARTED|Phase 2||0
1009266|NCT00560235|2451421|P1|STARTED|Phase 2||0
1009267|NCT00560235|2451419|P3|NOT COMPLETED|Phase 1B||0
1009268|NCT00560235|2451420|P2|NOT COMPLETED|Phase 1B||19
1009269|NCT00560235|2451421|P1|NOT COMPLETED|Phase 1B||0
1009270|NCT00560235|2451419|P3|COMPLETED|Phase 1B||0
1009271|NCT00560235|2451420|P2|COMPLETED|Phase 1B||2
1009272|NCT00560235|2451421|P1|COMPLETED|Phase 1B||0
1009273|NCT00560235|2451419|P3|STARTED|Phase 1B||0
1009274|NCT00560235|2451420|P2|STARTED|Phase 1B||21
1009275|NCT00560235|2451421|P1|STARTED|Phase 1B||0
1009276|NCT00560235|2451419|P3|NOT COMPLETED|Phase 1||0
1009277|NCT00560235|2451420|P2|NOT COMPLETED|Phase 1||0
1009278|NCT00560235|2451421|P1|NOT COMPLETED|Phase 1||8
1009279|NCT00560235|2451419|P3|COMPLETED|Phase 1||0
1009280|NCT00560235|2451420|P2|COMPLETED|Phase 1||0
1009281|NCT00560235|2451421|P1|COMPLETED|Phase 1||2
1009282|NCT00560235|2451419|P3|STARTED|Phase 1||0
1009283|NCT00560235|2451420|P2|STARTED|Phase 1||0
1009284|NCT00560235|2451421|P1|STARTED|Phase 1||10
1009285|NCT00560313|2451450|P1|NOT COMPLETED|Overall Study||6
1009286|NCT00560313|2451450|P1|COMPLETED|Overall Study||48
1009287|NCT00560313|2451450|P1|STARTED|Overall Study||54
1009288|NCT00560352|2451477|P3|NOT COMPLETED|Overall Study||4
1009289|NCT00560352|2451478|P2|NOT COMPLETED|Overall Study||3
1009290|NCT00560352|2451479|P1|NOT COMPLETED|Overall Study||7
1009291|NCT00560352|2451477|P3|COMPLETED|Overall Study||0
1009292|NCT00560352|2451478|P2|COMPLETED|Overall Study||0
1009293|NCT00560352|2451479|P1|COMPLETED|Overall Study||0
1009294|NCT00560352|2451477|P3|STARTED|Overall Study||4
1009295|NCT00560352|2451478|P2|STARTED|Overall Study||3
1009296|NCT00560352|2451479|P1|STARTED|Overall Study||7
1009297|NCT00560391|2451501|P5|NOT COMPLETED|Overall Study||2
1009298|NCT00560391|2451502|P4|NOT COMPLETED|Overall Study||1
1009299|NCT00560391|2451503|P3|NOT COMPLETED|Overall Study||0
1009300|NCT00560391|2451504|P2|NOT COMPLETED|Overall Study||0
1009301|NCT00560391|2451505|P1|NOT COMPLETED|Overall Study||0
1009302|NCT00560391|2451501|P5|COMPLETED|Overall Study|Completed=offtreatment;Disease progression-6;Study drug toxicity-7; Unrelated AE-1,Subject request-1|15
1009303|NCT00560391|2451502|P4|COMPLETED|Overall Study|Completed=off treatment; Disease progression-2; Unrelated AE 1 and Subject request 2|5
1009304|NCT00560391|2451503|P3|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Maximum clinical benefit-1; Unrelated AE-1|3
1009305|NCT00560391|2451504|P2|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Death-1; Unrelated AE-1|3
1009306|NCT00560391|2451505|P1|COMPLETED|Overall Study|Completed=off treatment;Disease progression-1;Death-1;Max. clinical benefit-2;Study drug toxicity-2|6
1009307|NCT00560391|2451501|P5|STARTED|Overall Study|Participants who received treatment|17
1009308|NCT00560391|2451502|P4|STARTED|Overall Study|Participants who received treatment|6
1009309|NCT00560391|2451503|P3|STARTED|Overall Study|Participants who received treatment|3
1009310|NCT00560391|2451504|P2|STARTED|Overall Study|Participants who received treatment|3
1009311|NCT00560391|2451505|P1|STARTED|Overall Study|Participants who received treatment|6
1009312|NCT00560404|2451560|P2|NOT COMPLETED|Overall Study||21
1009313|NCT00560404|2451561|P1|NOT COMPLETED|Overall Study||36
1009314|NCT00560404|2451560|P2|COMPLETED|Overall Study||100
1009315|NCT00560404|2451561|P1|COMPLETED|Overall Study||76
1009316|NCT00560404|2451560|P2|STARTED|Overall Study||121
1009317|NCT00560404|2451561|P1|STARTED|Overall Study||112
1009318|NCT00560417|2451605|P2|NOT COMPLETED|Overall Study||17
1009319|NCT00560417|2451606|P1|NOT COMPLETED|Overall Study||17
1009320|NCT00560417|2451605|P2|COMPLETED|Overall Study||151
1009321|NCT00560417|2451606|P1|COMPLETED|Overall Study||154
1009322|NCT00560417|2451605|P2|Intention to Treat (ITT) Population|Overall Study||167
1009323|NCT00560417|2451606|P1|Intention to Treat (ITT) Population|Overall Study||170
1009324|NCT00560417|2451605|P2|STARTED|Overall Study||168
1009325|NCT00560417|2451606|P1|STARTED|Overall Study||171
1009326|NCT00560508|2451634|P2|NOT COMPLETED|52-week Open-label Period Pramipexole ER||11
1009327|NCT00560508|2451635|P1|NOT COMPLETED|52-week Open-label Period Pramipexole ER||8
1009328|NCT00560508|2451634|P2|COMPLETED|52-week Open-label Period Pramipexole ER||42
1009329|NCT00560508|2451635|P1|COMPLETED|52-week Open-label Period Pramipexole ER||43
1009330|NCT00560508|2451634|P2|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|53
1009331|NCT00560508|2451635|P1|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|51
1009332|NCT00560508|2451634|P2|NOT COMPLETED|12 Week Double-blind Period||3
1009333|NCT00560508|2451635|P1|NOT COMPLETED|12 Week Double-blind Period||5
1009334|NCT00560508|2451634|P2|COMPLETED|12 Week Double-blind Period||53
1009335|NCT00560508|2451635|P1|COMPLETED|12 Week Double-blind Period||51
1009336|NCT00560508|2451634|P2|STARTED|12 Week Double-blind Period||56
1009337|NCT00560508|2451635|P1|STARTED|12 Week Double-blind Period||56
1009338|NCT00560560|2451694|P2|NOT COMPLETED|Overall Study||83
1009339|NCT00560560|2451695|P1|NOT COMPLETED|Overall Study||85
1009340|NCT00560560|2451694|P2|COMPLETED|Overall Study||0
1009341|NCT00560560|2451695|P1|COMPLETED|Overall Study||0
1009342|NCT00560560|2451694|P2|STARTED|Overall Study||83
1009343|NCT00560560|2451695|P1|STARTED|Overall Study||85
1009344|NCT00560573|2451715|P6|NOT COMPLETED|Overall Study||13
1009345|NCT00560573|2451716|P5|NOT COMPLETED|Overall Study||7
1009346|NCT00560573|2451717|P4|NOT COMPLETED|Overall Study||10
1009347|NCT00560573|2451718|P3|NOT COMPLETED|Overall Study||6
1009348|NCT00560573|2451719|P2|NOT COMPLETED|Overall Study||3
1009349|NCT00560573|2451720|P1|NOT COMPLETED|Overall Study||6
1009350|NCT00560573|2451715|P6|COMPLETED|Overall Study||0
1009351|NCT00560573|2451716|P5|COMPLETED|Overall Study||1
1009352|NCT00560573|2451717|P4|COMPLETED|Overall Study||0
1009353|NCT00560573|2451718|P3|COMPLETED|Overall Study||0
1009354|NCT00560573|2451719|P2|COMPLETED|Overall Study||0
1009355|NCT00560573|2451720|P1|COMPLETED|Overall Study||0
1009356|NCT00560573|2451715|P6|Treated|Overall Study||13
1009357|NCT00560573|2451716|P5|Treated|Overall Study||7
1009358|NCT00560573|2451717|P4|Treated|Overall Study||10
1009359|NCT00560573|2451718|P3|Treated|Overall Study||6
1009360|NCT00560573|2451719|P2|Treated|Overall Study||3
1009361|NCT00560573|2451720|P1|Treated|Overall Study||6
1009362|NCT00560573|2451715|P6|STARTED|Overall Study||13
1009363|NCT00560573|2451716|P5|STARTED|Overall Study||8
1009364|NCT00560573|2451717|P4|STARTED|Overall Study||10
1009365|NCT00560573|2451718|P3|STARTED|Overall Study||6
1009366|NCT00560573|2451719|P2|STARTED|Overall Study||3
1009367|NCT00560573|2451720|P1|STARTED|Overall Study||6
1009368|NCT00560612|2451774|P2|NOT COMPLETED|Overall Study||0
1009369|NCT00560612|2451775|P1|NOT COMPLETED|Overall Study||0
1009370|NCT00560612|2451774|P2|COMPLETED|Overall Study||7
1009371|NCT00560612|2451775|P1|COMPLETED|Overall Study||5
1009372|NCT00560612|2451774|P2|STARTED|Overall Study||7
1009373|NCT00560612|2451775|P1|STARTED|Overall Study||5
1009374|NCT00560703|2451783|P2|NOT COMPLETED|Overall Study||6
1009375|NCT00560703|2451784|P1|NOT COMPLETED|Overall Study||0
1009376|NCT00560703|2451783|P2|COMPLETED|Overall Study||18
1009377|NCT00560703|2451784|P1|COMPLETED|Overall Study||46
1009378|NCT00560703|2451783|P2|STARTED|Overall Study||24
1009379|NCT00560703|2451784|P1|STARTED|Overall Study||46
1009380|NCT00560794|2451792|P1|NOT COMPLETED|Overall Study||11
1009381|NCT00560794|2451792|P1|COMPLETED|Overall Study||10
1009382|NCT00560794|2451792|P1|Completed 1 Treatment Cycle|Overall Study||20
1009383|NCT00560794|2451792|P1|STARTED|Overall Study||21
1009384|NCT00560833|2451814|P5|NOT COMPLETED|Overall Study||42
1009385|NCT00560833|2451815|P4|NOT COMPLETED|Overall Study||31
1009386|NCT00560833|2451816|P3|NOT COMPLETED|Overall Study||39
1009387|NCT00560833|2451817|P2|NOT COMPLETED|Overall Study||26
1009388|NCT00560833|2451818|P1|NOT COMPLETED|Overall Study||44
1009389|NCT00560833|2451814|P5|COMPLETED|Overall Study||114
1009390|NCT00560833|2451815|P4|COMPLETED|Overall Study||124
1009391|NCT00560833|2451816|P3|COMPLETED|Overall Study||121
1009392|NCT00560833|2451817|P2|COMPLETED|Overall Study||129
1009393|NCT00560833|2451818|P1|COMPLETED|Overall Study||273
1009394|NCT00560833|2451814|P5|Treated|Overall Study|One participant was randomized but not treated|155
1009395|NCT00560833|2451815|P4|Treated|Overall Study||155
1009396|NCT00560833|2451816|P3|Treated|Overall Study||160
1009397|NCT00560833|2451817|P2|Treated|Overall Study|One participant was randomized but not treated|154
1009398|NCT00560833|2451818|P1|Treated|Overall Study|One participant was not randomized but was treated with placebo|317
1009399|NCT00560833|2451814|P5|STARTED|Overall Study||156
1009400|NCT00560833|2451815|P4|STARTED|Overall Study||155
1009401|NCT00560833|2451816|P3|STARTED|Overall Study||160
1009402|NCT00560833|2451817|P2|STARTED|Overall Study||155
1009403|NCT00560833|2451818|P1|STARTED|Overall Study||317
1009404|NCT00553735|2451850|P1|NOT COMPLETED|Overall Study||7
1009405|NCT00553735|2451850|P1|COMPLETED|Overall Study||1
1009406|NCT00553735|2451850|P1|STARTED|Overall Study||8
1009407|NCT00553787|2451870|P3|NOT COMPLETED|Overall Study||262
1009408|NCT00553787|2451871|P2|NOT COMPLETED|Overall Study||124
1009409|NCT00553787|2451872|P1|NOT COMPLETED|Overall Study||378
1009410|NCT00553787|2451870|P3|COMPLETED|Overall Study||733
1009411|NCT00553787|2451871|P2|COMPLETED|Overall Study||374
1009412|NCT00553787|2451872|P1|COMPLETED|Overall Study||616
1009413|NCT00553787|2451870|P3|STARTED|Overall Study||995
1009414|NCT00553787|2451871|P2|STARTED|Overall Study||498
1009415|NCT00553787|2451872|P1|STARTED|Overall Study||994
1009416|NCT00553839|2451883|P1|NOT COMPLETED|Overall Study||0
1009417|NCT00553839|2451883|P1|COMPLETED|Overall Study||21
1009418|NCT00553839|2451883|P1|STARTED|Overall Study||21
1009419|NCT00560859|2451891|P2|NOT COMPLETED|Overall Study||24
1009420|NCT00560859|2451892|P1|NOT COMPLETED|Overall Study||32
1009421|NCT00560859|2451891|P2|COMPLETED|Overall Study||203
1009422|NCT00560859|2451892|P1|COMPLETED|Overall Study||194
1009423|NCT00560859|2451891|P2|STARTED|Overall Study||227
1009424|NCT00560859|2451892|P1|STARTED|Overall Study||226
1009425|NCT00560885|2451902|P1|NOT COMPLETED|Overall Study||8
1009426|NCT00560885|2451902|P1|COMPLETED|Overall Study||47
1009427|NCT00560885|2451902|P1|2 Year Follow-up|Overall Study||47
1009428|NCT00560885|2451902|P1|12 Month Follow-up|Overall Study|48 pts available for 12 month follow-up, 46 pts assessed|48
1009429|NCT00560885|2451902|P1|6 Month Follow-up|Overall Study|50 pts available for 6 month follow-up, 50 pts assessed|50
1009430|NCT00560885|2451902|P1|3 Month Follow-up|Overall Study|51 pts available for 3 month follow-up, 48 pts assessed.|51
1009431|NCT00560885|2451902|P1|30 Day Follow-up|Overall Study|53 pts available for 30 day follow-up, 52 pts assessed|53
1009432|NCT00560885|2451902|P1|STARTED|Overall Study||55
1009433|NCT00560937|2451911|P2|NOT COMPLETED|Overall Study||2
1009434|NCT00560937|2451912|P1|NOT COMPLETED|Overall Study||1
1009435|NCT00560937|2451911|P2|COMPLETED|Overall Study||9
1009436|NCT00560937|2451912|P1|COMPLETED|Overall Study|One participant was withdrawn after 6 weeks and data were carried forward|9
1009437|NCT00560937|2451911|P2|STARTED|Overall Study||11
1009438|NCT00560937|2451912|P1|STARTED|Overall Study||10
1009439|NCT00560950|2451930|P2|NOT COMPLETED|Overall Study||0
1009440|NCT00560950|2451931|P1|NOT COMPLETED|Overall Study||1
1009441|NCT00560950|2451930|P2|COMPLETED|Overall Study||71
1009442|NCT00560950|2451931|P1|COMPLETED|Overall Study||71
1009443|NCT00560950|2451930|P2|STARTED|Overall Study||71
1009444|NCT00560950|2451931|P1|STARTED|Overall Study||72
1009445|NCT00561002|2451969|P2|NOT COMPLETED|Overall Study||0
1009446|NCT00561002|2451970|P1|NOT COMPLETED|Overall Study||0
1009447|NCT00561002|2451969|P2|COMPLETED|Overall Study||9
1009448|NCT00561002|2451970|P1|COMPLETED|Overall Study||23
1009449|NCT00561002|2451969|P2|STARTED|Overall Study||9
1009450|NCT00561002|2451970|P1|STARTED|Overall Study||23
1009451|NCT00561015|2451988|P6|NOT COMPLETED|Overall Study||3
1009452|NCT00561015|2451989|P5|NOT COMPLETED|Overall Study||1
1009453|NCT00561015|2451990|P4|NOT COMPLETED|Overall Study||1
1009454|NCT00561015|2451991|P3|NOT COMPLETED|Overall Study||0
1009455|NCT00561015|2451992|P2|NOT COMPLETED|Overall Study||0
1009456|NCT00561015|2451993|P1|NOT COMPLETED|Overall Study||4
1009457|NCT00561015|2451988|P6|COMPLETED|Overall Study||6
1009458|NCT00561015|2451989|P5|COMPLETED|Overall Study||8
1009459|NCT00561015|2451990|P4|COMPLETED|Overall Study||7
1009460|NCT00561015|2451991|P3|COMPLETED|Overall Study||9
1009461|NCT00561015|2451992|P2|COMPLETED|Overall Study||5
1009462|NCT00561015|2451993|P1|COMPLETED|Overall Study||5
1009463|NCT00561015|2451988|P6|STARTED|Overall Study||9
1009464|NCT00561015|2451989|P5|STARTED|Overall Study||9
1009465|NCT00561015|2451990|P4|STARTED|Overall Study||8
1009466|NCT00561015|2451991|P3|STARTED|Overall Study||9
1009467|NCT00561015|2451992|P2|STARTED|Overall Study||5
1009468|NCT00561015|2451993|P1|STARTED|Overall Study||9
1009469|NCT00561145|2452069|P2|NOT COMPLETED|Overall Study||0
1009470|NCT00561145|2452070|P1|NOT COMPLETED|Overall Study||0
1009471|NCT00561145|2452069|P2|COMPLETED|Overall Study||17
1009472|NCT00561145|2452070|P1|COMPLETED|Overall Study||15
1009473|NCT00561145|2452069|P2|STARTED|Overall Study||17
1009474|NCT00561145|2452070|P1|STARTED|Overall Study||15
1009475|NCT00561834|2452076|P1|NOT COMPLETED|Overall Study||0
1009476|NCT00561834|2452076|P1|COMPLETED|Overall Study||2
1009477|NCT00561834|2452076|P1|STARTED|Overall Study||2
1009478|NCT00561912|2452080|P1|NOT COMPLETED|Overall Study||1
1009479|NCT00561912|2452080|P1|COMPLETED|Overall Study||1
1009480|NCT00561912|2452080|P1|STARTED|Overall Study||2
1009481|NCT00561925|2452087|P5|NOT COMPLETED|Open-Label Extension Period||50
1009482|NCT00561925|2452088|P4|NOT COMPLETED|Open-Label Extension Period||43
1009483|NCT00561925|2452089|P3|NOT COMPLETED|Open-Label Extension Period||0
1009484|NCT00561925|2452090|P2|NOT COMPLETED|Open-Label Extension Period||0
1009485|NCT00561925|2452091|P1|NOT COMPLETED|Open-Label Extension Period||0
1009486|NCT00561925|2452087|P5|COMPLETED|Open-Label Extension Period||328
1009487|NCT00561925|2452088|P4|COMPLETED|Open-Label Extension Period||315
1009488|NCT00561925|2452089|P3|COMPLETED|Open-Label Extension Period||0
1009489|NCT00561925|2452090|P2|COMPLETED|Open-Label Extension Period||1
1009490|NCT00561925|2452091|P1|COMPLETED|Open-Label Extension Period||0
1009491|NCT00561925|2452087|P5|STARTED|Open-Label Extension Period||378
1009492|NCT00561925|2452088|P4|STARTED|Open-Label Extension Period||358
1009493|NCT00561925|2452089|P3|STARTED|Open-Label Extension Period||0
1009494|NCT00561925|2452090|P2|STARTED|Open-Label Extension Period||1
1009495|NCT00561925|2452091|P1|STARTED|Open-Label Extension Period||0
1009496|NCT00561925|2452087|P5|NOT COMPLETED|144-week Double-blind, Double-dummy||0
1009497|NCT00561925|2452088|P4|NOT COMPLETED|144-week Double-blind, Double-dummy||0
1009498|NCT00561925|2452089|P3|NOT COMPLETED|144-week Double-blind, Double-dummy||127
1009499|NCT00561925|2452090|P2|NOT COMPLETED|144-week Double-blind, Double-dummy||150
1009500|NCT00561925|2452091|P1|NOT COMPLETED|144-week Double-blind, Double-dummy||0
1009501|NCT00561925|2452087|P5|COMPLETED|144-week Double-blind, Double-dummy||0
1009502|NCT00561925|2452088|P4|COMPLETED|144-week Double-blind, Double-dummy||0
1009503|NCT00561925|2452089|P3|COMPLETED|144-week Double-blind, Double-dummy||378
1009504|NCT00561925|2452090|P2|COMPLETED|144-week Double-blind, Double-dummy||358
1009505|NCT00561925|2452091|P1|COMPLETED|144-week Double-blind, Double-dummy||0
1009506|NCT00561925|2452087|P5|STARTED|144-week Double-blind, Double-dummy||0
1009507|NCT00561925|2452088|P4|STARTED|144-week Double-blind, Double-dummy||0
1009508|NCT00561925|2452089|P3|STARTED|144-week Double-blind, Double-dummy||505
1009509|NCT00561925|2452090|P2|STARTED|144-week Double-blind, Double-dummy||508
1009510|NCT00561925|2452091|P1|STARTED|144-week Double-blind, Double-dummy||0
1009511|NCT00561925|2452087|P5|NOT COMPLETED|14 Day Lead-In Period||0
1009512|NCT00561925|2452088|P4|NOT COMPLETED|14 Day Lead-In Period||0
1009513|NCT00561925|2452089|P3|NOT COMPLETED|14 Day Lead-In Period||0
1009514|NCT00561925|2452090|P2|NOT COMPLETED|14 Day Lead-In Period||0
1009515|NCT00561925|2452091|P1|NOT COMPLETED|14 Day Lead-In Period||55
1009516|NCT00561925|2452087|P5|COMPLETED|14 Day Lead-In Period||0
1009517|NCT00561925|2452088|P4|COMPLETED|14 Day Lead-In Period||0
1009518|NCT00561925|2452089|P3|COMPLETED|14 Day Lead-In Period||0
1009519|NCT00561925|2452090|P2|COMPLETED|14 Day Lead-In Period||0
1009520|NCT00561925|2452091|P1|COMPLETED|14 Day Lead-In Period||1013
1009521|NCT00561925|2452087|P5|STARTED|14 Day Lead-In Period||0
1009522|NCT00561925|2452088|P4|STARTED|14 Day Lead-In Period||0
1009523|NCT00561925|2452089|P3|STARTED|14 Day Lead-In Period||0
1009524|NCT00561925|2452090|P2|STARTED|14 Day Lead-In Period||0
1009525|NCT00561925|2452091|P1|STARTED|14 Day Lead-In Period||1068
1009526|NCT00561951|2452143|P3|NOT COMPLETED|Overall Study||32
1009527|NCT00561951|2452144|P2|NOT COMPLETED|Overall Study||34
1009528|NCT00561951|2452145|P1|NOT COMPLETED|Overall Study||33
1009529|NCT00561951|2452143|P3|COMPLETED|Overall Study||281
1009530|NCT00561951|2452144|P2|COMPLETED|Overall Study||286
1009531|NCT00561951|2452145|P1|COMPLETED|Overall Study||285
1009532|NCT00561951|2452143|P3|STARTED|Overall Study||313
1009533|NCT00561951|2452144|P2|STARTED|Overall Study||320
1009534|NCT00561951|2452145|P1|STARTED|Overall Study||318
1009535|NCT00561977|2452201|P3|NOT COMPLETED|Overall Study||2
1009536|NCT00561977|2452202|P2|NOT COMPLETED|Overall Study||3
1009537|NCT00561977|2452203|P1|NOT COMPLETED|Overall Study||0
1009538|NCT00561977|2452201|P3|COMPLETED|Overall Study||10
1009539|NCT00561977|2452202|P2|COMPLETED|Overall Study||9
1009540|NCT00561977|2452203|P1|COMPLETED|Overall Study||12
1009541|NCT00561977|2452201|P3|STARTED|Overall Study||12
1009542|NCT00561977|2452202|P2|STARTED|Overall Study||12
1009543|NCT00561977|2452203|P1|STARTED|Overall Study||12
1009544|NCT00562094|2452226|P1|NOT COMPLETED|Overall Study||62
1009545|NCT00562094|2452226|P1|COMPLETED|Overall Study||8554
1009546|NCT00562094|2452226|P1|STARTED|Overall Study||8616
1009547|NCT00562120|2452238|P4|NOT COMPLETED|Fourth Intervention Period||0
1009548|NCT00562120|2452239|P3|NOT COMPLETED|Fourth Intervention Period||0
1009549|NCT00562120|2452240|P2|NOT COMPLETED|Fourth Intervention Period||0
1009550|NCT00562120|2452241|P1|NOT COMPLETED|Fourth Intervention Period||0
1009551|NCT00562120|2452238|P4|COMPLETED|Fourth Intervention Period||5
1009552|NCT00562120|2452239|P3|COMPLETED|Fourth Intervention Period||5
1009553|NCT00562120|2452240|P2|COMPLETED|Fourth Intervention Period||5
1009554|NCT00562120|2452241|P1|COMPLETED|Fourth Intervention Period||4
1009555|NCT00562120|2452238|P4|STARTED|Fourth Intervention Period||5
1009556|NCT00562120|2452239|P3|STARTED|Fourth Intervention Period||5
1009557|NCT00562120|2452240|P2|STARTED|Fourth Intervention Period||5
1009558|NCT00562120|2452241|P1|STARTED|Fourth Intervention Period||4
1009559|NCT00562120|2452238|P4|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
1009560|NCT00562120|2452239|P3|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
1009561|NCT00562120|2452240|P2|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
1009562|NCT00562120|2452241|P1|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
1009563|NCT00562120|2452238|P4|COMPLETED|Washout Period 3 (At Least 14 Days)||5
1009564|NCT00562120|2452239|P3|COMPLETED|Washout Period 3 (At Least 14 Days)||5
1009565|NCT00562120|2452240|P2|COMPLETED|Washout Period 3 (At Least 14 Days)||5
1009566|NCT00562120|2452241|P1|COMPLETED|Washout Period 3 (At Least 14 Days)||4
1009567|NCT00562120|2452238|P4|STARTED|Washout Period 3 (At Least 14 Days)||5
1009568|NCT00562120|2452239|P3|STARTED|Washout Period 3 (At Least 14 Days)||5
1009569|NCT00562120|2452240|P2|STARTED|Washout Period 3 (At Least 14 Days)||5
1009570|NCT00562120|2452241|P1|STARTED|Washout Period 3 (At Least 14 Days)||4
1009571|NCT00562120|2452238|P4|NOT COMPLETED|Third Intervention Period||0
1009572|NCT00562120|2452239|P3|NOT COMPLETED|Third Intervention Period||0
1009573|NCT00562120|2452240|P2|NOT COMPLETED|Third Intervention Period||0
1009574|NCT00562120|2452241|P1|NOT COMPLETED|Third Intervention Period||0
1009575|NCT00562120|2452238|P4|COMPLETED|Third Intervention Period||5
1009576|NCT00562120|2452239|P3|COMPLETED|Third Intervention Period||5
1009577|NCT00562120|2452240|P2|COMPLETED|Third Intervention Period||5
1009578|NCT00562120|2452241|P1|COMPLETED|Third Intervention Period||4
1009579|NCT00562120|2452238|P4|STARTED|Third Intervention Period||5
1009580|NCT00562120|2452239|P3|STARTED|Third Intervention Period||5
1009581|NCT00562120|2452240|P2|STARTED|Third Intervention Period||5
1009582|NCT00562120|2452241|P1|STARTED|Third Intervention Period||4
1009583|NCT00562120|2452238|P4|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
1009584|NCT00562120|2452239|P3|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
1009585|NCT00562120|2452240|P2|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
1009586|NCT00562120|2452241|P1|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
1009587|NCT00562120|2452238|P4|COMPLETED|Washout Period 2 (At Least 14 Days)||5
1009588|NCT00562120|2452239|P3|COMPLETED|Washout Period 2 (At Least 14 Days)||5
1009589|NCT00562120|2452240|P2|COMPLETED|Washout Period 2 (At Least 14 Days)||5
1009590|NCT00562120|2452241|P1|COMPLETED|Washout Period 2 (At Least 14 Days)||4
1009591|NCT00562120|2452238|P4|STARTED|Washout Period 2 (At Least 14 Days)||5
1009592|NCT00562120|2452239|P3|STARTED|Washout Period 2 (At Least 14 Days)||5
1009593|NCT00562120|2452240|P2|STARTED|Washout Period 2 (At Least 14 Days)||5
1009594|NCT00562120|2452241|P1|STARTED|Washout Period 2 (At Least 14 Days)||4
1009595|NCT00562120|2452238|P4|NOT COMPLETED|Second Intervention Period||0
1009596|NCT00562120|2452239|P3|NOT COMPLETED|Second Intervention Period||0
1009597|NCT00562120|2452240|P2|NOT COMPLETED|Second Intervention Period||0
1009598|NCT00562120|2452241|P1|NOT COMPLETED|Second Intervention Period||0
1009599|NCT00562120|2452238|P4|COMPLETED|Second Intervention Period||5
1009600|NCT00562120|2452239|P3|COMPLETED|Second Intervention Period||5
1009601|NCT00562120|2452240|P2|COMPLETED|Second Intervention Period||5
1009602|NCT00562120|2452241|P1|COMPLETED|Second Intervention Period||4
1009603|NCT00562120|2452238|P4|STARTED|Second Intervention Period||5
1009604|NCT00562120|2452239|P3|STARTED|Second Intervention Period||5
1009605|NCT00562120|2452240|P2|STARTED|Second Intervention Period||5
1009606|NCT00562120|2452241|P1|STARTED|Second Intervention Period||4
1009607|NCT00562120|2452238|P4|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
1009608|NCT00562120|2452239|P3|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
1009609|NCT00562120|2452240|P2|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
1009610|NCT00562120|2452241|P1|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
1009611|NCT00562120|2452238|P4|COMPLETED|Washout Period 1 (At Least 14 Days)||5
1009612|NCT00562120|2452239|P3|COMPLETED|Washout Period 1 (At Least 14 Days)||5
1009613|NCT00562120|2452240|P2|COMPLETED|Washout Period 1 (At Least 14 Days)||5
1009614|NCT00562120|2452241|P1|COMPLETED|Washout Period 1 (At Least 14 Days)||4
1009615|NCT00562120|2452238|P4|STARTED|Washout Period 1 (At Least 14 Days)||5
1009616|NCT00562120|2452239|P3|STARTED|Washout Period 1 (At Least 14 Days)||5
1009617|NCT00562120|2452240|P2|STARTED|Washout Period 1 (At Least 14 Days)||5
1009618|NCT00562120|2452241|P1|STARTED|Washout Period 1 (At Least 14 Days)||4
1009619|NCT00562120|2452238|P4|NOT COMPLETED|First Intervention Period||0
1009620|NCT00562120|2452239|P3|NOT COMPLETED|First Intervention Period||0
1009621|NCT00562120|2452240|P2|NOT COMPLETED|First Intervention Period||0
1009622|NCT00562120|2452241|P1|NOT COMPLETED|First Intervention Period||2
1009623|NCT00562120|2452238|P4|COMPLETED|First Intervention Period||5
1009624|NCT00562120|2452239|P3|COMPLETED|First Intervention Period||5
1009625|NCT00562120|2452240|P2|COMPLETED|First Intervention Period||5
1009626|NCT00562120|2452241|P1|COMPLETED|First Intervention Period||4
1009627|NCT00562120|2452238|P4|Treated|First Intervention Period||5
1009628|NCT00562120|2452239|P3|Treated|First Intervention Period||5
1009629|NCT00562120|2452240|P2|Treated|First Intervention Period||5
1009630|NCT00562120|2452241|P1|Treated|First Intervention Period||5
1009631|NCT00562120|2452238|P4|STARTED|First Intervention Period||5
1009632|NCT00562120|2452239|P3|STARTED|First Intervention Period||5
1009633|NCT00562120|2452240|P2|STARTED|First Intervention Period||5
1009634|NCT00562120|2452241|P1|STARTED|First Intervention Period||6
1009635|NCT00562159|2452275|P2|NOT COMPLETED|Overall Study||33
1009636|NCT00562159|2452276|P1|NOT COMPLETED|Overall Study||38
1009637|NCT00562159|2452275|P2|COMPLETED|Overall Study||192
1009638|NCT00562159|2452276|P1|COMPLETED|Overall Study||175
1009639|NCT00562159|2452275|P2|STARTED|Overall Study||225
1009640|NCT00562159|2452276|P1|STARTED|Overall Study||213
1009641|NCT00562302|2452290|P2|NOT COMPLETED|Overall Study||32
1009642|NCT00562302|2452291|P1|NOT COMPLETED|Overall Study||20
1009643|NCT00562302|2452290|P2|COMPLETED|Overall Study||137
1009644|NCT00562302|2452291|P1|COMPLETED|Overall Study||150
1009645|NCT00562302|2452290|P2|STARTED|Overall Study||169
1009646|NCT00562302|2452291|P1|STARTED|Overall Study||170
1009647|NCT00562315|2452311|P1|NOT COMPLETED|Overall Study||0
1009648|NCT00562315|2452311|P1|COMPLETED|Overall Study||93
1009649|NCT00562315|2452311|P1|STARTED|Overall Study||93
1009650|NCT00562328|2452326|P1|NOT COMPLETED|Overall Study||0
1009651|NCT00562328|2452326|P1|COMPLETED|Overall Study||33
1009652|NCT00562328|2452326|P1|STARTED|Overall Study||33
1009653|NCT00562354|2452332|P2|NOT COMPLETED|Overall Study||2
1009654|NCT00562354|2452333|P1|NOT COMPLETED|Overall Study||0
1009655|NCT00562354|2452332|P2|COMPLETED|Overall Study||135
1009656|NCT00562354|2452333|P1|COMPLETED|Overall Study||134
1009657|NCT00562354|2452332|P2|Evaluable Immunogenicity Population|Overall Study||134
1009658|NCT00562354|2452333|P1|Evaluable Immunogenicity Population|Overall Study||134
1009659|NCT00562354|2452332|P2|Received Study Treatment|Overall Study||136
1009660|NCT00562354|2452333|P1|Received Study Treatment|Overall Study||134
1009661|NCT00562354|2452332|P2|STARTED|Overall Study||137
1009662|NCT00562354|2452333|P1|STARTED|Overall Study||134
1009663|NCT00562484|2452376|P2|NOT COMPLETED|Overall Study||104
1009664|NCT00562484|2452377|P1|NOT COMPLETED|Overall Study||206
1009665|NCT00562484|2452376|P2|COMPLETED|Overall Study||4907
1009666|NCT00562484|2452377|P1|COMPLETED|Overall Study||9827
1009667|NCT00562484|2452376|P2|STARTED|Overall Study||5011
1009668|NCT00562484|2452377|P1|STARTED|Overall Study||10033
1009669|NCT00562588|2452409|P2|NOT COMPLETED|Overall Study||99
1009670|NCT00562588|2452410|P1|NOT COMPLETED|Overall Study||92
1009671|NCT00562588|2452409|P2|COMPLETED|Overall Study||184
1009672|NCT00562588|2452410|P1|COMPLETED|Overall Study||168
1009673|NCT00562588|2452409|P2|STARTED|Overall Study||283
1009674|NCT00562588|2452410|P1|STARTED|Overall Study||260
1009675|NCT00562627|2452441|P3|NOT COMPLETED|Overall Study||1
1009676|NCT00562627|2452442|P2|NOT COMPLETED|Overall Study||1
1009677|NCT00562627|2452443|P1|NOT COMPLETED|Overall Study||1
1009678|NCT00562627|2452441|P3|COMPLETED|Overall Study||33
1009679|NCT00562627|2452442|P2|COMPLETED|Overall Study||33
1009680|NCT00562627|2452443|P1|COMPLETED|Overall Study||33
1009681|NCT00562627|2452441|P3|STARTED|Overall Study||34
1009682|NCT00562627|2452442|P2|STARTED|Overall Study||34
1009683|NCT00562627|2452443|P1|STARTED|Overall Study||34
1009684|NCT00562861|2452459|P2|NOT COMPLETED|Overall Study||11
1009685|NCT00562861|2452460|P1|NOT COMPLETED|Overall Study||20
1009686|NCT00562861|2452459|P2|COMPLETED|Overall Study||48
1009687|NCT00562861|2452460|P1|COMPLETED|Overall Study||40
1009688|NCT00562861|2452459|P2|STARTED|Overall Study||59
1009689|NCT00562861|2452460|P1|STARTED|Overall Study||60
1009690|NCT00563290|2452468|P2|NOT COMPLETED|Overall Study||0
1009691|NCT00563290|2452469|P1|NOT COMPLETED|Overall Study||0
1009692|NCT00563290|2452468|P2|COMPLETED|Overall Study||4
1009693|NCT00563290|2452469|P1|COMPLETED|Overall Study||3
1009694|NCT00563290|2452468|P2|STARTED|Overall Study||4
1009695|NCT00563290|2452469|P1|STARTED|Overall Study||3
1009696|NCT00563316|2452478|P1|NOT COMPLETED|Overall Study||12
1009697|NCT00563316|2452478|P1|COMPLETED|Overall Study||16
1009698|NCT00563316|2452478|P1|Received Investigational Product|Overall Study||27
1009699|NCT00563316|2452478|P1|STARTED|Overall Study||28
1009700|NCT00563368|2452496|P7|NOT COMPLETED|Overall Study||33
1009701|NCT00563368|2452497|P6|NOT COMPLETED|Overall Study||30
1009702|NCT00563368|2452498|P5|NOT COMPLETED|Overall Study||28
1009703|NCT00563368|2452499|P4|NOT COMPLETED|Overall Study||29
1009704|NCT00563368|2452500|P3|NOT COMPLETED|Overall Study||30
1009705|NCT00563368|2452501|P2|NOT COMPLETED|Overall Study||30
1009706|NCT00563368|2452502|P1|NOT COMPLETED|Overall Study||35
1009707|NCT00563368|2452496|P7|COMPLETED|Overall Study||75
1009708|NCT00563368|2452497|P6|COMPLETED|Overall Study||77
1009709|NCT00563368|2452498|P5|COMPLETED|Overall Study||80
1009710|NCT00563368|2452499|P4|COMPLETED|Overall Study||78
1009711|NCT00563368|2452500|P3|COMPLETED|Overall Study||78
1009712|NCT00563368|2452501|P2|COMPLETED|Overall Study||79
1009713|NCT00563368|2452502|P1|COMPLETED|Overall Study||74
1009714|NCT00563368|2452496|P7|STARTED|Overall Study||108
1009715|NCT00563368|2452497|P6|STARTED|Overall Study||107
1009716|NCT00563368|2452498|P5|STARTED|Overall Study||108
1009717|NCT00563368|2452499|P4|STARTED|Overall Study||107
1009718|NCT00563368|2452500|P3|STARTED|Overall Study||108
1009719|NCT00563368|2452501|P2|STARTED|Overall Study||109
1009720|NCT00563368|2452502|P1|STARTED|Overall Study||109
1009721|NCT00563381|2452527|P2|NOT COMPLETED|Overall Study||648
1009722|NCT00563381|2452528|P1|NOT COMPLETED|Overall Study||585
1009723|NCT00563381|2452527|P2|COMPLETED|Overall Study|Completed treatment|3021
1009724|NCT00563381|2452528|P1|COMPLETED|Overall Study|Completed treatment|3122
1009725|NCT00563381|2452527|P2|STARTED|Overall Study|Started treatment|3669
1009726|NCT00563381|2452528|P1|STARTED|Overall Study|Started treatment|3707
1009727|NCT00563576|2452596|P2|NOT COMPLETED|Overall Study||14
1009728|NCT00563576|2452597|P1|NOT COMPLETED|Overall Study||14
1009729|NCT00563576|2452596|P2|COMPLETED|Overall Study||22
1009730|NCT00563576|2452597|P1|COMPLETED|Overall Study||21
1009731|NCT00563576|2452596|P2|STARTED|Overall Study||36
1009732|NCT00563576|2452597|P1|STARTED|Overall Study||35
1009733|NCT00563706|2452616|P9|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
1009734|NCT00563706|2452617|P8|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
1009735|NCT00563706|2452618|P7|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
1009736|NCT00563706|2452619|P6|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
1009737|NCT00563706|2452620|P5|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
1009738|NCT00563706|2452621|P4|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
1009739|NCT00563706|2452622|P3|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
1009740|NCT00563706|2452623|P2|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
1009741|NCT00563706|2452624|P1|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
1009742|NCT00563706|2452616|P9|COMPLETED|Taper Phase (Day 29 up to Day 35)||32
1009743|NCT00563706|2452617|P8|COMPLETED|Taper Phase (Day 29 up to Day 35)||16
1009744|NCT00563706|2452618|P7|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
1009745|NCT00563706|2452619|P6|COMPLETED|Taper Phase (Day 29 up to Day 35)||14
1009746|NCT00563706|2452620|P5|COMPLETED|Taper Phase (Day 29 up to Day 35)||11
1009747|NCT00563706|2452621|P4|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
1009748|NCT00563706|2452622|P3|COMPLETED|Taper Phase (Day 29 up to Day 35)||3
1009749|NCT00563706|2452623|P2|COMPLETED|Taper Phase (Day 29 up to Day 35)||13
1009750|NCT00563706|2452624|P1|COMPLETED|Taper Phase (Day 29 up to Day 35)||20
1009751|NCT00563706|2452616|P9|STARTED|Taper Phase (Day 29 up to Day 35)||32
1009752|NCT00563706|2452617|P8|STARTED|Taper Phase (Day 29 up to Day 35)||16
1009753|NCT00563706|2452618|P7|STARTED|Taper Phase (Day 29 up to Day 35)||9
1009754|NCT00563706|2452619|P6|STARTED|Taper Phase (Day 29 up to Day 35)||14
1009755|NCT00563706|2452620|P5|STARTED|Taper Phase (Day 29 up to Day 35)||11
1009756|NCT00563706|2452621|P4|STARTED|Taper Phase (Day 29 up to Day 35)||9
1009757|NCT00563706|2452622|P3|STARTED|Taper Phase (Day 29 up to Day 35)||3
1009758|NCT00563706|2452623|P2|STARTED|Taper Phase (Day 29 up to Day 35)||13
1009759|NCT00563706|2452624|P1|STARTED|Taper Phase (Day 29 up to Day 35)||20
1009760|NCT00563706|2452616|P9|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
1009761|NCT00563706|2452617|P8|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
1009762|NCT00563706|2452618|P7|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
1009763|NCT00563706|2452619|P6|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
1009764|NCT00563706|2452620|P5|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
1009765|NCT00563706|2452621|P4|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||10
1009766|NCT00563706|2452622|P3|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
1009767|NCT00563706|2452623|P2|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
1009768|NCT00563706|2452624|P1|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||17
1009769|NCT00563706|2452616|P9|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||32
1009770|NCT00563706|2452617|P8|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||16
1009771|NCT00563706|2452618|P7|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
1009772|NCT00563706|2452619|P6|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
1009773|NCT00563706|2452620|P5|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
1009774|NCT00563706|2452621|P4|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
1009775|NCT00563706|2452622|P3|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
1009776|NCT00563706|2452623|P2|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||13
1009777|NCT00563706|2452624|P1|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||20
1009862|NCT00557245|2452883|P2|COMPLETED|Overall Study||1571
1009778|NCT00563706|2452616|P9|STARTED|DB Treatment Period (Day 1 up to Day 28)||43
1009779|NCT00563706|2452617|P8|STARTED|DB Treatment Period (Day 1 up to Day 28)||30
1009780|NCT00563706|2452618|P7|STARTED|DB Treatment Period (Day 1 up to Day 28)||12
1009781|NCT00563706|2452619|P6|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
1009782|NCT00563706|2452620|P5|STARTED|DB Treatment Period (Day 1 up to Day 28)||16
1009783|NCT00563706|2452621|P4|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
1009784|NCT00563706|2452622|P3|STARTED|DB Treatment Period (Day 1 up to Day 28)||8
1009785|NCT00563706|2452623|P2|STARTED|DB Treatment Period (Day 1 up to Day 28)||18
1009786|NCT00563706|2452624|P1|STARTED|DB Treatment Period (Day 1 up to Day 28)||37
1009787|NCT00563797|2452727|P2|NOT COMPLETED|Overall Study||2
1009788|NCT00563797|2452728|P1|NOT COMPLETED|Overall Study||7
1009789|NCT00563797|2452727|P2|COMPLETED|Overall Study||8
1009790|NCT00563797|2452728|P1|COMPLETED|Overall Study||4
1009791|NCT00563797|2452727|P2|Follow-Up|Overall Study||10
1009792|NCT00563797|2452728|P1|Follow-Up|Overall Study||11
1009793|NCT00563797|2452727|P2|Received Allocated Intervention|Overall Study||10
1009794|NCT00563797|2452728|P1|Received Allocated Intervention|Overall Study||11
1009795|NCT00563797|2452727|P2|STARTED|Overall Study||10
1009796|NCT00563797|2452728|P1|STARTED|Overall Study||11
1009797|NCT00564265|2452740|P1|NOT COMPLETED|Overall Study||0
1009798|NCT00564265|2452740|P1|COMPLETED|Overall Study||24
1009799|NCT00564265|2452740|P1|STARTED|Overall Study||24
1009800|NCT00564278|2452746|P2|NOT COMPLETED|Overall Study||42
1009801|NCT00564278|2452747|P1|NOT COMPLETED|Overall Study||47
1009802|NCT00564278|2452746|P2|COMPLETED|Overall Study||56
1009803|NCT00564278|2452747|P1|COMPLETED|Overall Study||50
1009804|NCT00564278|2452746|P2|STARTED|Overall Study||98
1009805|NCT00564278|2452747|P1|STARTED|Overall Study||97
1009806|NCT00556894|2452766|P3|NOT COMPLETED|Overall Study||19
1009807|NCT00556894|2452767|P2|NOT COMPLETED|Overall Study||19
1009808|NCT00556894|2452768|P1|NOT COMPLETED|Overall Study||16
1009809|NCT00556894|2452766|P3|COMPLETED|Overall Study||65
1009810|NCT00556894|2452767|P2|COMPLETED|Overall Study||68
1009811|NCT00556894|2452768|P1|COMPLETED|Overall Study||66
1009812|NCT00556894|2452766|P3|STARTED|Overall Study||84
1009813|NCT00556894|2452767|P2|STARTED|Overall Study||87
1009814|NCT00556894|2452768|P1|STARTED|Overall Study||82
1009815|NCT00556933|2452780|P4|NOT COMPLETED|CNI Withdrawal vs. Minimization||2
1009816|NCT00556933|2452781|P3|NOT COMPLETED|CNI Withdrawal vs. Minimization||3
1009817|NCT00556933|2452782|P2|NOT COMPLETED|CNI Withdrawal vs. Minimization||4
1009818|NCT00556933|2452783|P1|NOT COMPLETED|CNI Withdrawal vs. Minimization||1
1009819|NCT00556933|2452780|P4|COMPLETED|CNI Withdrawal vs. Minimization||41
1009820|NCT00556933|2452781|P3|COMPLETED|CNI Withdrawal vs. Minimization||36
1009821|NCT00556933|2452782|P2|COMPLETED|CNI Withdrawal vs. Minimization||33
1009822|NCT00556933|2452783|P1|COMPLETED|CNI Withdrawal vs. Minimization||42
1009823|NCT00556933|2452780|P4|STARTED|CNI Withdrawal vs. Minimization||43
1009824|NCT00556933|2452781|P3|STARTED|CNI Withdrawal vs. Minimization||39
1009825|NCT00556933|2452782|P2|STARTED|CNI Withdrawal vs. Minimization||37
1009826|NCT00556933|2452783|P1|STARTED|CNI Withdrawal vs. Minimization||43
1009827|NCT00556933|2452780|P4|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
1009828|NCT00556933|2452781|P3|NOT COMPLETED|Single vs. Divided-dose rATG Induction||6
1009829|NCT00556933|2452782|P2|NOT COMPLETED|Single vs. Divided-dose rATG Induction||8
1009830|NCT00556933|2452783|P1|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
1009831|NCT00556933|2452780|P4|COMPLETED|Single vs. Divided-dose rATG Induction||43
1009832|NCT00556933|2452781|P3|COMPLETED|Single vs. Divided-dose rATG Induction||39
1009833|NCT00556933|2452782|P2|COMPLETED|Single vs. Divided-dose rATG Induction||37
1009834|NCT00556933|2452783|P1|COMPLETED|Single vs. Divided-dose rATG Induction||43
1009835|NCT00556933|2452780|P4|STARTED|Single vs. Divided-dose rATG Induction||45
1009836|NCT00556933|2452781|P3|STARTED|Single vs. Divided-dose rATG Induction||45
1009837|NCT00556933|2452782|P2|STARTED|Single vs. Divided-dose rATG Induction||45
1009838|NCT00556933|2452783|P1|STARTED|Single vs. Divided-dose rATG Induction||45
1009839|NCT00556946|2452837|P1|NOT COMPLETED|Overall Study||1
1009840|NCT00556946|2452837|P1|COMPLETED|Overall Study||16
1009841|NCT00556946|2452837|P1|STARTED|Overall Study||17
1009842|NCT00556972|2452841|P1|NOT COMPLETED|Overall Study||0
1009843|NCT00556972|2452841|P1|COMPLETED|Overall Study||4
1009844|NCT00556972|2452841|P1|STARTED|Overall Study||4
1009845|NCT00556998|2452848|P1|NOT COMPLETED|Voriconazole Oral||2
1009846|NCT00556998|2452848|P1|COMPLETED|Voriconazole Oral||20
1009847|NCT00556998|2452848|P1|STARTED|Voriconazole Oral|One participant received voriconazole 150 mg every 12 hours during oral phase.|22
1009848|NCT00556998|2452848|P1|NOT COMPLETED|Voriconazole Intravenous (IV)||5
1009849|NCT00556998|2452848|P1|COMPLETED|Voriconazole Intravenous (IV)|One participant received 2 days of oral; then received IV again before discontinuing from study.|21
1009850|NCT00556998|2452848|P1|Treated|Voriconazole Intravenous (IV)||26
1009851|NCT00556998|2452848|P1|STARTED|Voriconazole Intravenous (IV)||26
1009852|NCT00557076|2452870|P2|NOT COMPLETED|Overall Study||1
1009853|NCT00557076|2452871|P1|NOT COMPLETED|Overall Study||0
1009854|NCT00557076|2452870|P2|COMPLETED|Overall Study|One participant was withdrawn due to unblinding|7
1009855|NCT00557076|2452871|P1|COMPLETED|Overall Study||8
1009856|NCT00557076|2452870|P2|STARTED|Overall Study||8
1009857|NCT00557076|2452871|P1|STARTED|Overall Study||8
1009858|NCT00557245|2452882|P3|NOT COMPLETED|Overall Study||12
1009859|NCT00557245|2452883|P2|NOT COMPLETED|Overall Study||12
1009860|NCT00557245|2452884|P1|NOT COMPLETED|Overall Study||12
1009861|NCT00557245|2452882|P3|COMPLETED|Overall Study||1574
1009863|NCT00557245|2452884|P1|COMPLETED|Overall Study||1577
1009864|NCT00557245|2452882|P3|STARTED|Overall Study||1586
1009865|NCT00557245|2452883|P2|STARTED|Overall Study||1583
1009866|NCT00557245|2452884|P1|STARTED|Overall Study||1589
1009867|NCT00557284|2452924|P2|NOT COMPLETED|Overall Study||0
1009868|NCT00557284|2452925|P1|NOT COMPLETED|Overall Study||0
1009869|NCT00557284|2452924|P2|COMPLETED|Overall Study||11
1009870|NCT00557284|2452925|P1|COMPLETED|Overall Study||9
1009871|NCT00557284|2452924|P2|STARTED|Overall Study||11
1009872|NCT00557284|2452925|P1|STARTED|Overall Study||9
1009873|NCT00557310|2452945|P1|NOT COMPLETED|Extension Phase (18 - 24 Months)||5
1009874|NCT00557310|2452945|P1|COMPLETED|Extension Phase (18 - 24 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|25
1009875|NCT00557310|2452945|P1|STARTED|Extension Phase (18 - 24 Months)||30
1009876|NCT00557310|2452945|P1|NOT COMPLETED|Main Study (0 - 18 Months)||5
1009877|NCT00557310|2452945|P1|COMPLETED|Main Study (0 - 18 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|30
1009878|NCT00557310|2452945|P1|STARTED|Main Study (0 - 18 Months)||35
1009879|NCT00557323|2452965|P1|NOT COMPLETED|Overall Study||7
1009880|NCT00557323|2452965|P1|COMPLETED|Overall Study||27
1009881|NCT00557323|2452965|P1|STARTED|Overall Study||34
1009882|NCT00557349|2452972|P2|NOT COMPLETED|Overall Study||5
1009883|NCT00557349|2452973|P1|NOT COMPLETED|Overall Study||5
1009884|NCT00557349|2452972|P2|COMPLETED|Overall Study||13
1009885|NCT00557349|2452973|P1|COMPLETED|Overall Study||17
1009886|NCT00557349|2452972|P2|STARTED|Overall Study||18
1009887|NCT00557349|2452973|P1|STARTED|Overall Study|omeprazole/bicarb|22
1009888|NCT00557362|2452985|P4|NOT COMPLETED|Overall Study||3
1009889|NCT00557362|2452986|P3|NOT COMPLETED|Overall Study||4
1009890|NCT00557362|2452987|P2|NOT COMPLETED|Overall Study||2
1009891|NCT00557362|2452988|P1|NOT COMPLETED|Overall Study||2
1009892|NCT00557362|2452985|P4|COMPLETED|Overall Study||27
1009893|NCT00557362|2452986|P3|COMPLETED|Overall Study||26
1009894|NCT00557362|2452987|P2|COMPLETED|Overall Study||28
1009895|NCT00557362|2452988|P1|COMPLETED|Overall Study||28
1009896|NCT00557362|2452985|P4|STARTED|Overall Study||30
1009897|NCT00557362|2452986|P3|STARTED|Overall Study||30
1009898|NCT00557362|2452987|P2|STARTED|Overall Study||30
1009899|NCT00557362|2452988|P1|STARTED|Overall Study||30
1009900|NCT00557440|2453007|P3|NOT COMPLETED|Treatment Period 3||0
1009901|NCT00557440|2453008|P2|NOT COMPLETED|Treatment Period 3||0
1009902|NCT00557440|2453009|P1|NOT COMPLETED|Treatment Period 3||0
1009903|NCT00557440|2453007|P3|COMPLETED|Treatment Period 3||12
1009904|NCT00557440|2453008|P2|COMPLETED|Treatment Period 3||12
1009905|NCT00557440|2453009|P1|COMPLETED|Treatment Period 3||12
1009906|NCT00557440|2453007|P3|STARTED|Treatment Period 3||12
1009907|NCT00557440|2453008|P2|STARTED|Treatment Period 3||12
1009908|NCT00557440|2453009|P1|STARTED|Treatment Period 3||12
1009909|NCT00557440|2453007|P3|NOT COMPLETED|Treatment Period 2||0
1009910|NCT00557440|2453008|P2|NOT COMPLETED|Treatment Period 2||0
1009911|NCT00557440|2453009|P1|NOT COMPLETED|Treatment Period 2||0
1009912|NCT00557440|2453007|P3|COMPLETED|Treatment Period 2||12
1009913|NCT00557440|2453008|P2|COMPLETED|Treatment Period 2||12
1009914|NCT00557440|2453009|P1|COMPLETED|Treatment Period 2||12
1009915|NCT00557440|2453007|P3|STARTED|Treatment Period 2||12
1009916|NCT00557440|2453008|P2|STARTED|Treatment Period 2||12
1009917|NCT00557440|2453009|P1|STARTED|Treatment Period 2||12
1009918|NCT00557440|2453007|P3|NOT COMPLETED|Treatment Period 1||1
1009919|NCT00557440|2453008|P2|NOT COMPLETED|Treatment Period 1||0
1009920|NCT00557440|2453009|P1|NOT COMPLETED|Treatment Period 1||0
1009921|NCT00557440|2453007|P3|COMPLETED|Treatment Period 1||12
1009922|NCT00557440|2453008|P2|COMPLETED|Treatment Period 1||12
1009923|NCT00557440|2453009|P1|COMPLETED|Treatment Period 1||12
1009924|NCT00557440|2453007|P3|STARTED|Treatment Period 1||13
1009925|NCT00557440|2453008|P2|STARTED|Treatment Period 1||12
1009926|NCT00557440|2453009|P1|STARTED|Treatment Period 1||12
1009927|NCT00557466|2453035|P6|NOT COMPLETED|Overall Study||6
1009928|NCT00557466|2453036|P5|NOT COMPLETED|Overall Study||3
1009929|NCT00557466|2453037|P4|NOT COMPLETED|Overall Study||4
1009930|NCT00557466|2453038|P3|NOT COMPLETED|Overall Study||6
1009931|NCT00557466|2453039|P2|NOT COMPLETED|Overall Study||5
1009932|NCT00557466|2453040|P1|NOT COMPLETED|Overall Study||4
1009933|NCT00557466|2453035|P6|COMPLETED|Overall Study||85
1009934|NCT00557466|2453036|P5|COMPLETED|Overall Study||87
1009935|NCT00557466|2453037|P4|COMPLETED|Overall Study||92
1009936|NCT00557466|2453038|P3|COMPLETED|Overall Study||95
1009937|NCT00557466|2453039|P2|COMPLETED|Overall Study||87
1009938|NCT00557466|2453040|P1|COMPLETED|Overall Study||94
1009939|NCT00557466|2453035|P6|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|89
1009940|NCT00557466|2453036|P5|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|87
1009941|NCT00557466|2453037|P4|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|93
1009942|NCT00557466|2453038|P3|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
1009943|NCT00557466|2453039|P2|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|91
1009944|NCT00557466|2453040|P1|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
1009945|NCT00557466|2453035|P6|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|91
1009946|NCT00557466|2453036|P5|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|90
1009947|NCT00557466|2453037|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|96
1009948|NCT00557466|2453038|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|101
1009949|NCT00557466|2453039|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|92
1009950|NCT00557466|2453040|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|98
1009951|NCT00557466|2453035|P6|STARTED|Overall Study||91
1009952|NCT00557466|2453036|P5|STARTED|Overall Study||90
1009953|NCT00557466|2453037|P4|STARTED|Overall Study||96
1009954|NCT00557466|2453038|P3|STARTED|Overall Study||101
1009955|NCT00557466|2453039|P2|STARTED|Overall Study||92
1009956|NCT00557466|2453040|P1|STARTED|Overall Study||98
1009957|NCT00557492|2453090|P1|NOT COMPLETED|Overall Study||1
1009958|NCT00557492|2453090|P1|COMPLETED|Overall Study|Evaluable for outcomes|58
1009959|NCT00557492|2453090|P1|STARTED|Overall Study||59
1009960|NCT00557505|2453111|P9|NOT COMPLETED|Overall Study||17
1009961|NCT00557505|2453112|P8|NOT COMPLETED|Overall Study||5
1009962|NCT00557505|2453113|P7|NOT COMPLETED|Overall Study||3
1009963|NCT00557505|2453114|P6|NOT COMPLETED|Overall Study||3
1009964|NCT00557505|2453115|P5|NOT COMPLETED|Overall Study||2
1009965|NCT00557505|2453116|P4|NOT COMPLETED|Overall Study||3
1009966|NCT00557505|2453117|P3|NOT COMPLETED|Overall Study||4
1009967|NCT00557505|2453118|P2|NOT COMPLETED|Overall Study||3
1009968|NCT00557505|2453119|P1|NOT COMPLETED|Overall Study||3
1009969|NCT00557505|2453111|P9|COMPLETED|Overall Study||0
1009970|NCT00557505|2453112|P8|COMPLETED|Overall Study||0
1009971|NCT00557505|2453113|P7|COMPLETED|Overall Study||0
1009972|NCT00557505|2453114|P6|COMPLETED|Overall Study||0
1009973|NCT00557505|2453115|P5|COMPLETED|Overall Study||0
1009974|NCT00557505|2453116|P4|COMPLETED|Overall Study||0
1009975|NCT00557505|2453117|P3|COMPLETED|Overall Study||0
1009976|NCT00557505|2453118|P2|COMPLETED|Overall Study||0
1009977|NCT00557505|2453119|P1|COMPLETED|Overall Study||0
1009978|NCT00557505|2453111|P9|STARTED|Overall Study||17
1009979|NCT00557505|2453112|P8|STARTED|Overall Study||5
1009980|NCT00557505|2453113|P7|STARTED|Overall Study||3
1009981|NCT00557505|2453114|P6|STARTED|Overall Study||3
1009982|NCT00557505|2453115|P5|STARTED|Overall Study||2
1009983|NCT00557505|2453116|P4|STARTED|Overall Study||3
1009984|NCT00557505|2453117|P3|STARTED|Overall Study||4
1009985|NCT00557505|2453118|P2|STARTED|Overall Study||3
1009986|NCT00557505|2453119|P1|STARTED|Overall Study||3
1009987|NCT00557622|2453285|P2|NOT COMPLETED|12-Week Treatment Phase||1
1009988|NCT00557622|2453286|P1|NOT COMPLETED|12-Week Treatment Phase||0
1009989|NCT00557622|2453285|P2|COMPLETED|12-Week Treatment Phase||1
1009990|NCT00557622|2453286|P1|COMPLETED|12-Week Treatment Phase||1
1009991|NCT00557622|2453285|P2|STARTED|12-Week Treatment Phase||2
1009992|NCT00557622|2453286|P1|STARTED|12-Week Treatment Phase||1
1009993|NCT00557622|2453285|P2|NOT COMPLETED|4-Week Run-in Phase||0
1009994|NCT00557622|2453286|P1|NOT COMPLETED|4-Week Run-in Phase||2
1009995|NCT00557622|2453285|P2|COMPLETED|4-Week Run-in Phase||0
1009996|NCT00557622|2453286|P1|COMPLETED|4-Week Run-in Phase||3
1009997|NCT00557622|2453285|P2|STARTED|4-Week Run-in Phase||0
1009998|NCT00557622|2453286|P1|STARTED|4-Week Run-in Phase||5
1009999|NCT00557830|2453309|P3|NOT COMPLETED|Treatment Phase||0
1010000|NCT00557830|2453310|P2|NOT COMPLETED|Treatment Phase||0
1010001|NCT00557830|2453311|P1|NOT COMPLETED|Treatment Phase||0
1010002|NCT00557830|2453309|P3|COMPLETED|Treatment Phase||2
1010003|NCT00557830|2453310|P2|COMPLETED|Treatment Phase||4
1010004|NCT00557830|2453311|P1|COMPLETED|Treatment Phase||0
1010005|NCT00557830|2453309|P3|STARTED|Treatment Phase||2
1010006|NCT00557830|2453310|P2|STARTED|Treatment Phase||4
1010007|NCT00557830|2453311|P1|STARTED|Treatment Phase||0
1010008|NCT00557830|2453309|P3|NOT COMPLETED|Screening Treatment Phase||0
1010009|NCT00557830|2453310|P2|NOT COMPLETED|Screening Treatment Phase||0
1010010|NCT00557830|2453311|P1|NOT COMPLETED|Screening Treatment Phase||6
1010011|NCT00557830|2453309|P3|COMPLETED|Screening Treatment Phase||0
1010012|NCT00557830|2453310|P2|COMPLETED|Screening Treatment Phase||0
1010013|NCT00557830|2453311|P1|COMPLETED|Screening Treatment Phase||6
1010014|NCT00557830|2453309|P3|STARTED|Screening Treatment Phase||0
1010015|NCT00557830|2453310|P2|STARTED|Screening Treatment Phase||0
1010016|NCT00557830|2453311|P1|STARTED|Screening Treatment Phase||12
1010017|NCT00557856|2453331|P9|NOT COMPLETED|Part 2: Exploratory Phase||24
1010018|NCT00557856|2453332|P8|NOT COMPLETED|Part 2: Exploratory Phase||0
1010019|NCT00557856|2453333|P7|NOT COMPLETED|Part 2: Exploratory Phase||0
1010020|NCT00557856|2453334|P6|NOT COMPLETED|Part 2: Exploratory Phase||0
1010021|NCT00557856|2453335|P5|NOT COMPLETED|Part 2: Exploratory Phase||0
1010022|NCT00557856|2453336|P4|NOT COMPLETED|Part 2: Exploratory Phase||0
1010023|NCT00557856|2453337|P3|NOT COMPLETED|Part 2: Exploratory Phase||0
1010024|NCT00557856|2453338|P2|NOT COMPLETED|Part 2: Exploratory Phase||0
1010025|NCT00557856|2453339|P1|NOT COMPLETED|Part 2: Exploratory Phase||0
1010026|NCT00557856|2453331|P9|COMPLETED|Part 2: Exploratory Phase||0
1010027|NCT00557856|2453332|P8|COMPLETED|Part 2: Exploratory Phase||0
1010028|NCT00557856|2453333|P7|COMPLETED|Part 2: Exploratory Phase||0
1010029|NCT00557856|2453334|P6|COMPLETED|Part 2: Exploratory Phase||0
1010030|NCT00557856|2453335|P5|COMPLETED|Part 2: Exploratory Phase||0
1010031|NCT00557856|2453336|P4|COMPLETED|Part 2: Exploratory Phase||0
1010032|NCT00557856|2453337|P3|COMPLETED|Part 2: Exploratory Phase||0
1010033|NCT00557856|2453338|P2|COMPLETED|Part 2: Exploratory Phase||0
1010034|NCT00557856|2453339|P1|COMPLETED|Part 2: Exploratory Phase||0
1010035|NCT00557856|2453331|P9|STARTED|Part 2: Exploratory Phase||24
1010036|NCT00557856|2453332|P8|STARTED|Part 2: Exploratory Phase||0
1010037|NCT00557856|2453333|P7|STARTED|Part 2: Exploratory Phase||0
1010038|NCT00557856|2453334|P6|STARTED|Part 2: Exploratory Phase||0
1010039|NCT00557856|2453335|P5|STARTED|Part 2: Exploratory Phase||0
1010040|NCT00557856|2453336|P4|STARTED|Part 2: Exploratory Phase||0
1010041|NCT00557856|2453337|P3|STARTED|Part 2: Exploratory Phase||0
1010042|NCT00557856|2453338|P2|STARTED|Part 2: Exploratory Phase||0
1010043|NCT00557856|2453339|P1|STARTED|Part 2: Exploratory Phase||0
1010044|NCT00557856|2453331|P9|NOT COMPLETED|Part 1: Dose Escalation Phase||0
1010045|NCT00557856|2453332|P8|NOT COMPLETED|Part 1: Dose Escalation Phase||6
1010046|NCT00557856|2453333|P7|NOT COMPLETED|Part 1: Dose Escalation Phase||7
1010047|NCT00557856|2453334|P6|NOT COMPLETED|Part 1: Dose Escalation Phase||8
1010048|NCT00557856|2453335|P5|NOT COMPLETED|Part 1: Dose Escalation Phase||4
1010049|NCT00557856|2453336|P4|NOT COMPLETED|Part 1: Dose Escalation Phase||3
1010050|NCT00557856|2453337|P3|NOT COMPLETED|Part 1: Dose Escalation Phase||6
1010051|NCT00557856|2453338|P2|NOT COMPLETED|Part 1: Dose Escalation Phase||5
1010052|NCT00557856|2453339|P1|NOT COMPLETED|Part 1: Dose Escalation Phase||7
1010053|NCT00557856|2453331|P9|COMPLETED|Part 1: Dose Escalation Phase||0
1010054|NCT00557856|2453332|P8|COMPLETED|Part 1: Dose Escalation Phase||0
1010055|NCT00557856|2453333|P7|COMPLETED|Part 1: Dose Escalation Phase||0
1010056|NCT00557856|2453334|P6|COMPLETED|Part 1: Dose Escalation Phase||0
1010057|NCT00557856|2453335|P5|COMPLETED|Part 1: Dose Escalation Phase||0
1010058|NCT00557856|2453336|P4|COMPLETED|Part 1: Dose Escalation Phase||0
1010059|NCT00557856|2453337|P3|COMPLETED|Part 1: Dose Escalation Phase||0
1010060|NCT00557856|2453338|P2|COMPLETED|Part 1: Dose Escalation Phase||0
1010061|NCT00557856|2453339|P1|COMPLETED|Part 1: Dose Escalation Phase||0
1010062|NCT00557856|2453331|P9|Treated|Part 1: Dose Escalation Phase||0
1010063|NCT00557856|2453332|P8|Treated|Part 1: Dose Escalation Phase||6
1010064|NCT00557856|2453333|P7|Treated|Part 1: Dose Escalation Phase||7
1010065|NCT00557856|2453334|P6|Treated|Part 1: Dose Escalation Phase||8
1010066|NCT00557856|2453335|P5|Treated|Part 1: Dose Escalation Phase||4
1010067|NCT00557856|2453336|P4|Treated|Part 1: Dose Escalation Phase||3
1010068|NCT00557856|2453337|P3|Treated|Part 1: Dose Escalation Phase||6
1010069|NCT00557856|2453338|P2|Treated|Part 1: Dose Escalation Phase||5
1010070|NCT00557856|2453339|P1|Treated|Part 1: Dose Escalation Phase||5
1010071|NCT00557856|2453331|P9|STARTED|Part 1: Dose Escalation Phase||0
1010072|NCT00557856|2453332|P8|STARTED|Part 1: Dose Escalation Phase||6
1010073|NCT00557856|2453333|P7|STARTED|Part 1: Dose Escalation Phase||7
1010074|NCT00557856|2453334|P6|STARTED|Part 1: Dose Escalation Phase||8
1010075|NCT00557856|2453335|P5|STARTED|Part 1: Dose Escalation Phase||4
1010076|NCT00557856|2453336|P4|STARTED|Part 1: Dose Escalation Phase||3
1010077|NCT00557856|2453337|P3|STARTED|Part 1: Dose Escalation Phase||6
1010078|NCT00557856|2453338|P2|STARTED|Part 1: Dose Escalation Phase||5
1010079|NCT00557856|2453339|P1|STARTED|Part 1: Dose Escalation Phase||7
1010080|NCT00557947|2453535|P1|NOT COMPLETED|Overall Study||0
1010081|NCT00557947|2453535|P1|COMPLETED|Overall Study||83
1010082|NCT00557947|2453535|P1|STARTED|Overall Study||83
1010083|NCT00558012|2453553|P2|NOT COMPLETED|Overall Study||18
1010084|NCT00558012|2453554|P1|NOT COMPLETED|Overall Study||25
1010085|NCT00558012|2453553|P2|COMPLETED|Overall Study||74
1010086|NCT00558012|2453554|P1|COMPLETED|Overall Study||64
1010087|NCT00558012|2453553|P2|STARTED|Overall Study||92
1010088|NCT00558012|2453554|P1|STARTED|Overall Study||89
1010089|NCT00558025|2453562|P2|NOT COMPLETED|Overall Study||3
1010090|NCT00558025|2453563|P1|NOT COMPLETED|Overall Study||4
1010091|NCT00558025|2453562|P2|COMPLETED|Overall Study||49
1010092|NCT00558025|2453563|P1|COMPLETED|Overall Study||100
1010093|NCT00558025|2453562|P2|STARTED|Overall Study||52
1010094|NCT00558025|2453563|P1|STARTED|Overall Study||104
1010095|NCT00558064|2453587|P2|NOT COMPLETED|Overall Study||5
1010096|NCT00558064|2453588|P1|NOT COMPLETED|Overall Study||5
1010097|NCT00558064|2453587|P2|COMPLETED|Overall Study||257
1010098|NCT00558064|2453588|P1|COMPLETED|Overall Study||264
1010099|NCT00558064|2453587|P2|STARTED|Overall Study||262
1010100|NCT00558064|2453588|P1|STARTED|Overall Study||269
1010101|NCT00558103|2453613|P6|NOT COMPLETED|Monotherapy Extension Phase||9
1010102|NCT00558103|2453614|P5|NOT COMPLETED|Monotherapy Extension Phase||0
1010103|NCT00558103|2453615|P4|NOT COMPLETED|Monotherapy Extension Phase||0
1010104|NCT00558103|2453616|P3|NOT COMPLETED|Monotherapy Extension Phase||0
1010105|NCT00558103|2453617|P2|NOT COMPLETED|Monotherapy Extension Phase||0
1010106|NCT00558103|2453618|P1|NOT COMPLETED|Monotherapy Extension Phase||0
1010107|NCT00558103|2453613|P6|COMPLETED|Monotherapy Extension Phase||0
1010108|NCT00558103|2453614|P5|COMPLETED|Monotherapy Extension Phase||0
1010109|NCT00558103|2453615|P4|COMPLETED|Monotherapy Extension Phase||0
1010110|NCT00558103|2453616|P3|COMPLETED|Monotherapy Extension Phase||0
1010111|NCT00558103|2453617|P2|COMPLETED|Monotherapy Extension Phase||0
1010112|NCT00558103|2453618|P1|COMPLETED|Monotherapy Extension Phase||0
1010113|NCT00558103|2453613|P6|STARTED|Monotherapy Extension Phase|9/11 participants completing pazopanib monotherapy elected to receive lapatinib monotherapy.|9
1010114|NCT00558103|2453614|P5|STARTED|Monotherapy Extension Phase||0
1010115|NCT00558103|2453615|P4|STARTED|Monotherapy Extension Phase||0
1010116|NCT00558103|2453616|P3|STARTED|Monotherapy Extension Phase||0
1010117|NCT00558103|2453617|P2|STARTED|Monotherapy Extension Phase||0
1010118|NCT00558103|2453618|P1|STARTED|Monotherapy Extension Phase||0
1010119|NCT00558103|2453613|P6|NOT COMPLETED|Randomized Treatment Phase||0
1010120|NCT00558103|2453614|P5|NOT COMPLETED|Randomized Treatment Phase||5
1010121|NCT00558103|2453615|P4|NOT COMPLETED|Randomized Treatment Phase||2
1010122|NCT00558103|2453616|P3|NOT COMPLETED|Randomized Treatment Phase||3
1010123|NCT00558103|2453617|P2|NOT COMPLETED|Randomized Treatment Phase||4
1010124|NCT00558103|2453618|P1|NOT COMPLETED|Randomized Treatment Phase||5
1010125|NCT00558103|2453613|P6|COMPLETED|Randomized Treatment Phase||0
1010126|NCT00558103|2453614|P5|COMPLETED|Randomized Treatment Phase||33
1010127|NCT00558103|2453615|P4|COMPLETED|Randomized Treatment Phase||11
1010128|NCT00558103|2453616|P3|COMPLETED|Randomized Treatment Phase||33
1010129|NCT00558103|2453617|P2|COMPLETED|Randomized Treatment Phase||34
1010130|NCT00558103|2453618|P1|COMPLETED|Randomized Treatment Phase||33
1010131|NCT00558103|2453613|P6|STARTED|Randomized Treatment Phase||0
1010132|NCT00558103|2453614|P5|STARTED|Randomized Treatment Phase||38
1010133|NCT00558103|2453615|P4|STARTED|Randomized Treatment Phase||13
1010134|NCT00558103|2453616|P3|STARTED|Randomized Treatment Phase||36
1010135|NCT00558103|2453617|P2|STARTED|Randomized Treatment Phase||38
1010136|NCT00558103|2453618|P1|STARTED|Randomized Treatment Phase||38
1010137|NCT00558246|2453646|P1|NOT COMPLETED|Overall Study||0
1010138|NCT00558246|2453646|P1|COMPLETED|Overall Study||79
1010139|NCT00558246|2453646|P1|STARTED|Overall Study||79
1010140|NCT00558259|2453663|P2|NOT COMPLETED|Overall Study||99
1010141|NCT00558259|2453664|P1|NOT COMPLETED|Overall Study||71
1010142|NCT00558259|2453663|P2|COMPLETED|Overall Study|Completed treatment.|563
1010143|NCT00558259|2453664|P1|COMPLETED|Overall Study|Completed treatment.|610
1010144|NCT00558259|2453663|P2|STARTED|Overall Study|Number who started treatment. There were 6 patients randomised to placebo and not treated.|662
1010145|NCT00558259|2453664|P1|STARTED|Overall Study|Number who started treatment. There were 4 patients randomised to Dabigatran and not treated.|681
1010146|NCT00558272|2453686|P2|NOT COMPLETED|Overall Study||2
1010147|NCT00558272|2453687|P1|NOT COMPLETED|Overall Study||13
1010148|NCT00558272|2453686|P2|COMPLETED|Overall Study|4-week treatment period|68
1010149|NCT00558272|2453687|P1|COMPLETED|Overall Study|4-week treatment period|56
1010150|NCT00558272|2453686|P2|30 Days Follow-up|Overall Study|30 days after last dose|67
1010151|NCT00558272|2453687|P1|30 Days Follow-up|Overall Study|30 days after last dose|41
1010152|NCT00558272|2453686|P2|STARTED|Overall Study|Randomised|70
1010153|NCT00558272|2453687|P1|STARTED|Overall Study|Randomised|69
1010154|NCT00564447|2453733|P8|NOT COMPLETED|Overall Study||0
1010155|NCT00564447|2453734|P7|NOT COMPLETED|Overall Study||0
1010156|NCT00564447|2453735|P6|NOT COMPLETED|Overall Study||0
1010157|NCT00564447|2453736|P5|NOT COMPLETED|Overall Study||0
1010158|NCT00564447|2453737|P4|NOT COMPLETED|Overall Study||0
1010159|NCT00564447|2453738|P3|NOT COMPLETED|Overall Study||0
1010160|NCT00564447|2453739|P2|NOT COMPLETED|Overall Study||0
1010161|NCT00564447|2453740|P1|NOT COMPLETED|Overall Study||0
1010162|NCT00564447|2453733|P8|COMPLETED|Overall Study||6
1010163|NCT00564447|2453734|P7|COMPLETED|Overall Study||6
1010164|NCT00564447|2453735|P6|COMPLETED|Overall Study||6
1010165|NCT00564447|2453736|P5|COMPLETED|Overall Study||6
1010166|NCT00564447|2453737|P4|COMPLETED|Overall Study||6
1010167|NCT00564447|2453738|P3|COMPLETED|Overall Study||6
1010168|NCT00564447|2453739|P2|COMPLETED|Overall Study||6
1010169|NCT00564447|2453740|P1|COMPLETED|Overall Study||6
1010170|NCT00564447|2453733|P8|STARTED|Overall Study||6
1010171|NCT00564447|2453734|P7|STARTED|Overall Study||6
1010172|NCT00564447|2453735|P6|STARTED|Overall Study||6
1010173|NCT00564447|2453736|P5|STARTED|Overall Study||6
1010174|NCT00564447|2453737|P4|STARTED|Overall Study||6
1010175|NCT00564447|2453738|P3|STARTED|Overall Study||6
1010176|NCT00564447|2453739|P2|STARTED|Overall Study||6
1010177|NCT00564447|2453740|P1|STARTED|Overall Study||6
1010178|NCT00564486|2453761|P4|NOT COMPLETED|Overall Study||7
1010179|NCT00564486|2453762|P3|NOT COMPLETED|Overall Study||3
1010180|NCT00564486|2453763|P2|NOT COMPLETED|Overall Study||1
1010181|NCT00564486|2453764|P1|NOT COMPLETED|Overall Study||7
1010182|NCT00564486|2453761|P4|COMPLETED|Overall Study||60
1010183|NCT00564486|2453762|P3|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|39
1010184|NCT00564486|2453763|P2|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|91
1010185|NCT00564486|2453764|P1|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|36
1010186|NCT00564486|2453761|P4|STARTED|Overall Study||67
1010187|NCT00564486|2453762|P3|STARTED|Overall Study|One subject randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|42
1010188|NCT00564486|2453763|P2|STARTED|Overall Study|One subject was randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|92
1010189|NCT00564486|2453764|P1|STARTED|Overall Study||43
1010190|NCT00564629|2453782|P2|NOT COMPLETED|Overall Study||9
1010191|NCT00564629|2453783|P1|NOT COMPLETED|Overall Study||15
1010192|NCT00564629|2453782|P2|COMPLETED|Overall Study||45
1010193|NCT00564629|2453783|P1|COMPLETED|Overall Study||36
1010194|NCT00564629|2453782|P2|STARTED|Overall Study||54
1010195|NCT00564629|2453783|P1|STARTED|Overall Study||51
1010196|NCT00567840|2453810|P5|NOT COMPLETED|Overall Study||0
1010197|NCT00567840|2453811|P4|NOT COMPLETED|Overall Study||1
1010198|NCT00567840|2453812|P3|NOT COMPLETED|Overall Study||1
1010199|NCT00567840|2453813|P2|NOT COMPLETED|Overall Study||0
1010200|NCT00567840|2453814|P1|NOT COMPLETED|Overall Study||2
1010201|NCT00567840|2453810|P5|COMPLETED|Overall Study||8
1010202|NCT00567840|2453811|P4|COMPLETED|Overall Study||14
1010203|NCT00567840|2453812|P3|COMPLETED|Overall Study||15
1010204|NCT00567840|2453813|P2|COMPLETED|Overall Study||15
1010205|NCT00567840|2453814|P1|COMPLETED|Overall Study||13
1010206|NCT00567840|2453810|P5|STARTED|Overall Study||8
1010207|NCT00567840|2453811|P4|STARTED|Overall Study||15
1010208|NCT00567840|2453812|P3|STARTED|Overall Study||16
1010209|NCT00567840|2453813|P2|STARTED|Overall Study||15
1010210|NCT00567840|2453814|P1|STARTED|Overall Study||15
1010211|NCT00567879|2453857|P6|NOT COMPLETED|Overall Study||3
1010212|NCT00567879|2453858|P5|NOT COMPLETED|Overall Study||12
1010213|NCT00567879|2453859|P4|NOT COMPLETED|Overall Study||6
1010214|NCT00567879|2453860|P3|NOT COMPLETED|Overall Study||21
1010215|NCT00567879|2453861|P2|NOT COMPLETED|Overall Study||7
1010216|NCT00567879|2453862|P1|NOT COMPLETED|Overall Study||7
1010217|NCT00567879|2453857|P6|COMPLETED|Overall Study||0
1010218|NCT00567879|2453858|P5|COMPLETED|Overall Study||0
1010219|NCT00567879|2453859|P4|COMPLETED|Overall Study||0
1010220|NCT00567879|2453860|P3|COMPLETED|Overall Study||0
1010221|NCT00567879|2453861|P2|COMPLETED|Overall Study||0
1010222|NCT00567879|2453862|P1|COMPLETED|Overall Study||0
1010223|NCT00567879|2453857|P6|Maximum Tolerated Dose Determining Set|Overall Study||3
1010224|NCT00567879|2453858|P5|Maximum Tolerated Dose Determining Set|Overall Study||12
1010225|NCT00567879|2453859|P4|Maximum Tolerated Dose Determining Set|Overall Study||6
1010226|NCT00567879|2453860|P3|Maximum Tolerated Dose Determining Set|Overall Study|6 participants belonged to the dose expansion group at 20mg/m2 i.v.|18
1010227|NCT00567879|2453861|P2|Maximum Tolerated Dose Determining Set|Overall Study||7
1010228|NCT00567879|2453862|P1|Maximum Tolerated Dose Determining Set|Overall Study||5
1010229|NCT00567879|2453857|P6|STARTED|Overall Study||3
1010230|NCT00567879|2453858|P5|STARTED|Overall Study||12
1010231|NCT00567879|2453859|P4|STARTED|Overall Study||6
1010232|NCT00567879|2453860|P3|STARTED|Overall Study|7 participants belonged to the dose expansion group at 20mg/m2 i.v.|21
1010233|NCT00567879|2453861|P2|STARTED|Overall Study||7
1010234|NCT00567879|2453862|P1|STARTED|Overall Study||7
1010235|NCT00567892|2453885|P4|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||1
1010236|NCT00567892|2453886|P3|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
1010237|NCT00567892|2453887|P2|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
1010238|NCT00567892|2453888|P1|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
1010239|NCT00567892|2453885|P4|COMPLETED|Second Treatment (2 or 4 Weeks)||5
1010240|NCT00567892|2453886|P3|COMPLETED|Second Treatment (2 or 4 Weeks)||9
1010241|NCT00567892|2453887|P2|COMPLETED|Second Treatment (2 or 4 Weeks)||7
1010242|NCT00567892|2453888|P1|COMPLETED|Second Treatment (2 or 4 Weeks)||7
1010243|NCT00567892|2453885|P4|STARTED|Second Treatment (2 or 4 Weeks)||6
1010244|NCT00567892|2453886|P3|STARTED|Second Treatment (2 or 4 Weeks)||9
1010245|NCT00567892|2453887|P2|STARTED|Second Treatment (2 or 4 Weeks)||7
1010246|NCT00567892|2453888|P1|STARTED|Second Treatment (2 or 4 Weeks)||7
1010247|NCT00567892|2453885|P4|NOT COMPLETED|Washout (2 Weeks)||0
1010248|NCT00567892|2453886|P3|NOT COMPLETED|Washout (2 Weeks)||0
1010249|NCT00567892|2453887|P2|NOT COMPLETED|Washout (2 Weeks)||0
1010250|NCT00567892|2453888|P1|NOT COMPLETED|Washout (2 Weeks)||0
1010251|NCT00567892|2453885|P4|COMPLETED|Washout (2 Weeks)||6
1010252|NCT00567892|2453886|P3|COMPLETED|Washout (2 Weeks)||9
1010253|NCT00567892|2453887|P2|COMPLETED|Washout (2 Weeks)||7
1010254|NCT00567892|2453888|P1|COMPLETED|Washout (2 Weeks)||7
1010255|NCT00567892|2453885|P4|STARTED|Washout (2 Weeks)||6
1010256|NCT00567892|2453886|P3|STARTED|Washout (2 Weeks)||9
1010257|NCT00567892|2453887|P2|STARTED|Washout (2 Weeks)||7
1010258|NCT00567892|2453888|P1|STARTED|Washout (2 Weeks)||7
1010259|NCT00567892|2453885|P4|NOT COMPLETED|First Treatment (2 or 4 Weeks)||4
1010260|NCT00567892|2453886|P3|NOT COMPLETED|First Treatment (2 or 4 Weeks)||1
1010261|NCT00567892|2453887|P2|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
1010262|NCT00567892|2453888|P1|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
1010263|NCT00567892|2453885|P4|COMPLETED|First Treatment (2 or 4 Weeks)||6
1010264|NCT00567892|2453886|P3|COMPLETED|First Treatment (2 or 4 Weeks)||9
1010265|NCT00567892|2453887|P2|COMPLETED|First Treatment (2 or 4 Weeks)||7
1010266|NCT00567892|2453888|P1|COMPLETED|First Treatment (2 or 4 Weeks)||7
1010267|NCT00567892|2453885|P4|STARTED|First Treatment (2 or 4 Weeks)||10
1010268|NCT00567892|2453886|P3|STARTED|First Treatment (2 or 4 Weeks)||10
1010269|NCT00567892|2453887|P2|STARTED|First Treatment (2 or 4 Weeks)||7
1010270|NCT00567892|2453888|P1|STARTED|First Treatment (2 or 4 Weeks)||7
1010271|NCT00567996|2453903|P3|NOT COMPLETED|Overall Study||70
1010272|NCT00567996|2453904|P2|NOT COMPLETED|Overall Study||50
1010273|NCT00567996|2453905|P1|NOT COMPLETED|Overall Study||44
1010274|NCT00567996|2453903|P3|COMPLETED|Overall Study||265
1010275|NCT00567996|2453904|P2|COMPLETED|Overall Study||284
1010276|NCT00567996|2453905|P1|COMPLETED|Overall Study||289
1010277|NCT00567996|2453903|P3|Intent-to-treat: Received Study Drug|Overall Study||335
1010278|NCT00567996|2453904|P2|Intent-to-treat: Received Study Drug|Overall Study||333
1010279|NCT00567996|2453905|P1|Intent-to-treat: Received Study Drug|Overall Study||330
1010280|NCT00567996|2453903|P3|STARTED|Overall Study||335
1010281|NCT00567996|2453904|P2|STARTED|Overall Study||334
1010282|NCT00567996|2453905|P1|STARTED|Overall Study|Randomized participants|333
1010283|NCT00568022|2453922|P3|NOT COMPLETED|Overall Study||0
1010284|NCT00568022|2453923|P2|NOT COMPLETED|Overall Study||0
1010285|NCT00568022|2453924|P1|NOT COMPLETED|Overall Study||0
1010286|NCT00568022|2453922|P3|COMPLETED|Overall Study||3
1010287|NCT00568022|2453923|P2|COMPLETED|Overall Study||3
1010288|NCT00568022|2453924|P1|COMPLETED|Overall Study||3
1010289|NCT00568022|2453922|P3|STARTED|Overall Study||3
1010290|NCT00568022|2453923|P2|STARTED|Overall Study||3
1010291|NCT00568022|2453924|P1|STARTED|Overall Study||3
1010292|NCT00568061|2453956|P2|NOT COMPLETED|Overall Study||2
1010293|NCT00568061|2453957|P1|NOT COMPLETED|Overall Study||5
1010294|NCT00568061|2453956|P2|COMPLETED|Overall Study||14
1010295|NCT00568061|2453957|P1|COMPLETED|Overall Study||8
1010296|NCT00568061|2453956|P2|STARTED|Overall Study||16
1010297|NCT00568061|2453957|P1|STARTED|Overall Study||13
1010298|NCT00568087|2453965|P2|NOT COMPLETED|Overall Study||7
1010299|NCT00568087|2453966|P1|NOT COMPLETED|Overall Study||7
1010300|NCT00568087|2453965|P2|COMPLETED|Overall Study||17
1010301|NCT00568087|2453966|P1|COMPLETED|Overall Study||15
1010302|NCT00568087|2453965|P2|Received Intervention|Overall Study||23
1010303|NCT00568087|2453966|P1|Received Intervention|Overall Study||21
1010304|NCT00568087|2453965|P2|STARTED|Overall Study||24
1010305|NCT00568087|2453966|P1|STARTED|Overall Study||22
1010342|NCT00568334|2454001|P2|NOT COMPLETED|Overall Study||1
1010343|NCT00568334|2454002|P1|NOT COMPLETED|Overall Study||1
1010344|NCT00568334|2454001|P2|COMPLETED|Overall Study||121
1010345|NCT00568334|2454002|P1|COMPLETED|Overall Study||121
1010346|NCT00568334|2454001|P2|STARTED|Overall Study||122
1010347|NCT00568334|2454002|P1|STARTED|Overall Study||122
1010348|NCT00568386|2454028|P2|NOT COMPLETED|Overall Study||0
1010349|NCT00568386|2454029|P1|NOT COMPLETED|Overall Study||0
1010350|NCT00568386|2454028|P2|COMPLETED|Overall Study||20
1010351|NCT00568386|2454029|P1|COMPLETED|Overall Study||20
1010352|NCT00568386|2454028|P2|STARTED|Overall Study||20
1010353|NCT00568386|2454029|P1|STARTED|Overall Study||20
1010354|NCT00568399|2454035|P1|NOT COMPLETED|Overall Study||15
1010355|NCT00568399|2454035|P1|COMPLETED|Overall Study|Of 48 subject enrolled, 37 initiated sodium thiosulfate treatment. 22 completed the entire protocol|22
1010356|NCT00568399|2454035|P1|STARTED|Overall Study||37
1010357|NCT00568451|2454043|P4|NOT COMPLETED|Overall Study||7
1010358|NCT00568451|2454044|P3|NOT COMPLETED|Overall Study||2
1010359|NCT00568451|2454045|P2|NOT COMPLETED|Overall Study||0
1010360|NCT00568451|2454046|P1|NOT COMPLETED|Overall Study||0
1010361|NCT00568451|2454043|P4|COMPLETED|Overall Study||2
1010362|NCT00568451|2454044|P3|COMPLETED|Overall Study||0
1010363|NCT00568451|2454045|P2|COMPLETED|Overall Study||0
1010364|NCT00568451|2454046|P1|COMPLETED|Overall Study||0
1010365|NCT00568451|2454043|P4|STARTED|Overall Study||9
1010366|NCT00568451|2454044|P3|STARTED|Overall Study||2
1010367|NCT00568451|2454045|P2|STARTED|Overall Study||0
1010368|NCT00568451|2454046|P1|STARTED|Overall Study||0
1010369|NCT00568555|2454064|P2|NOT COMPLETED|Overall Study||1
1010370|NCT00568555|2454065|P1|NOT COMPLETED|Overall Study||1
1010371|NCT00568555|2454064|P2|COMPLETED|Overall Study||14
1010372|NCT00568555|2454065|P1|COMPLETED|Overall Study||15
1010373|NCT00568555|2454064|P2|STARTED|Overall Study||15
1010374|NCT00568555|2454065|P1|STARTED|Overall Study||16
1010375|NCT00568685|2454082|P3|NOT COMPLETED|Overall Study||5
1010376|NCT00568685|2454083|P2|NOT COMPLETED|Overall Study||5
1010377|NCT00568685|2454084|P1|NOT COMPLETED|Overall Study||10
1010378|NCT00568685|2454082|P3|COMPLETED|Overall Study||46
1010379|NCT00568685|2454083|P2|COMPLETED|Overall Study||46
1010380|NCT00568685|2454084|P1|COMPLETED|Overall Study||41
1010381|NCT00568685|2454082|P3|STARTED|Overall Study||51
1010382|NCT00568685|2454083|P2|STARTED|Overall Study||51
1010383|NCT00568685|2454084|P1|STARTED|Overall Study||51
1010384|NCT00568776|2454120|P4|NOT COMPLETED|Overall Study||72
1010385|NCT00568776|2454121|P3|NOT COMPLETED|Overall Study||74
1010386|NCT00568776|2454122|P2|NOT COMPLETED|Overall Study||36
1010387|NCT00568776|2454123|P1|NOT COMPLETED|Overall Study||30
1010388|NCT00568776|2454120|P4|COMPLETED|Overall Study||19
1010389|NCT00568776|2454121|P3|COMPLETED|Overall Study||15
1010390|NCT00568776|2454122|P2|COMPLETED|Overall Study||52
1010391|NCT00568776|2454123|P1|COMPLETED|Overall Study||53
1010392|NCT00568776|2454120|P4|STARTED|Overall Study|42 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|91
1010393|NCT00568776|2454121|P3|STARTED|Overall Study|41 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|89
1010394|NCT00568776|2454122|P2|STARTED|Overall Study|One randomized patient withdrew consent and did not receive ELND005 250 mg BID|88
1010395|NCT00568776|2454123|P1|STARTED|Overall Study|One randomized patient withdrew consent and did not receive placebo|83
1010396|NCT00568854|2454159|P2|NOT COMPLETED|Overall Study||0
1010397|NCT00568854|2454160|P1|NOT COMPLETED|Overall Study||0
1010398|NCT00568854|2454159|P2|COMPLETED|Overall Study||4
1010399|NCT00568854|2454160|P1|COMPLETED|Overall Study||6
1010400|NCT00568854|2454159|P2|STARTED|Overall Study||4
1010401|NCT00568854|2454160|P1|STARTED|Overall Study||6
1010402|NCT00568958|2454170|P2|NOT COMPLETED|Follow-Up||4
1010403|NCT00568958|2454171|P1|NOT COMPLETED|Follow-Up||8
1010404|NCT00568958|2454170|P2|COMPLETED|Follow-Up||63
1010405|NCT00568958|2454171|P1|COMPLETED|Follow-Up||53
1010406|NCT00568958|2454170|P2|STARTED|Follow-Up||67
1010407|NCT00568958|2454171|P1|STARTED|Follow-Up||61
1010408|NCT00568958|2454170|P2|NOT COMPLETED|Allocation||3
1010409|NCT00568958|2454171|P1|NOT COMPLETED|Allocation||9
1010410|NCT00568958|2454170|P2|COMPLETED|Allocation||67
1010411|NCT00568958|2454171|P1|COMPLETED|Allocation||61
1010412|NCT00568958|2454170|P2|STARTED|Allocation||70
1010413|NCT00568958|2454171|P1|STARTED|Allocation||70
1010414|NCT00569010|2454193|P4|NOT COMPLETED|Overall Study||0
1010415|NCT00569010|2454194|P3|NOT COMPLETED|Overall Study||0
1010416|NCT00569010|2454195|P2|NOT COMPLETED|Overall Study||0
1010417|NCT00569010|2454196|P1|NOT COMPLETED|Overall Study||0
1010418|NCT00569010|2454193|P4|COMPLETED|Overall Study||11
1010419|NCT00569010|2454194|P3|COMPLETED|Overall Study||11
1010420|NCT00569010|2454195|P2|COMPLETED|Overall Study||6
1010421|NCT00569010|2454196|P1|COMPLETED|Overall Study||6
1010422|NCT00569010|2454193|P4|STARTED|Overall Study||11
1010423|NCT00569010|2454194|P3|STARTED|Overall Study||11
1010424|NCT00569010|2454195|P2|STARTED|Overall Study||6
1010425|NCT00569010|2454196|P1|STARTED|Overall Study||6
1010426|NCT00569127|2454208|P2|NOT COMPLETED|Overall Study||213
1010427|NCT00569127|2454209|P1|NOT COMPLETED|Overall Study||214
1010428|NCT00569127|2454208|P2|COMPLETED|Overall Study||0
1010429|NCT00569127|2454209|P1|COMPLETED|Overall Study||0
1010430|NCT00569127|2454208|P2|Eligible|Overall Study||202
1010431|NCT00569127|2454209|P1|Eligible|Overall Study||200
1010432|NCT00569127|2454208|P2|STARTED|Overall Study||213
1010433|NCT00569127|2454209|P1|STARTED|Overall Study||214
1010434|NCT00569166|2454228|P3|NOT COMPLETED|Overall Study||4
1010435|NCT00569166|2454229|P2|NOT COMPLETED|Overall Study||6
1010436|NCT00569166|2454230|P1|NOT COMPLETED|Overall Study||9
1010437|NCT00569166|2454228|P3|COMPLETED|Overall Study||27
1010438|NCT00569166|2454229|P2|COMPLETED|Overall Study||25
1010439|NCT00569166|2454230|P1|COMPLETED|Overall Study||21
1010440|NCT00569166|2454228|P3|STARTED|Overall Study||31
1010441|NCT00569166|2454229|P2|STARTED|Overall Study||31
1010442|NCT00569166|2454230|P1|STARTED|Overall Study||30
1010443|NCT00569192|2454265|P3|NOT COMPLETED|Overall Study||25
1010444|NCT00569192|2454266|P2|NOT COMPLETED|Overall Study||20
1010445|NCT00569192|2454267|P1|NOT COMPLETED|Overall Study||23
1010446|NCT00569192|2454265|P3|COMPLETED|Overall Study||99
1010447|NCT00569192|2454266|P2|COMPLETED|Overall Study||105
1010448|NCT00569192|2454267|P1|COMPLETED|Overall Study||88
1010449|NCT00569192|2454265|P3|STARTED|Overall Study||124
1010450|NCT00569192|2454266|P2|STARTED|Overall Study||125
1010451|NCT00569192|2454267|P1|STARTED|Overall Study||111
1010452|NCT00569231|2454290|P1|NOT COMPLETED|Overall Study||7
1010453|NCT00569231|2454290|P1|COMPLETED|Overall Study||11
1010454|NCT00569231|2454290|P1|STARTED|Overall Study||18
1010455|NCT00569270|2454297|P2|NOT COMPLETED|Period: Second Intervention||0
1010456|NCT00569270|2454298|P1|NOT COMPLETED|Period: Second Intervention||0
1010457|NCT00569270|2454297|P2|COMPLETED|Period: Second Intervention||14
1010458|NCT00569270|2454298|P1|COMPLETED|Period: Second Intervention||15
1010459|NCT00569270|2454297|P2|29 Days|Period: Second Intervention||14
1010460|NCT00569270|2454298|P1|29 Days|Period: Second Intervention||15
1010461|NCT00569270|2454297|P2|STARTED|Period: Second Intervention||14
1010462|NCT00569270|2454298|P1|STARTED|Period: Second Intervention||15
1010463|NCT00569270|2454297|P2|NOT COMPLETED|Period: First Intervention||1
1010464|NCT00569270|2454298|P1|NOT COMPLETED|Period: First Intervention||0
1010465|NCT00569270|2454297|P2|COMPLETED|Period: First Intervention||14
1010466|NCT00569270|2454298|P1|COMPLETED|Period: First Intervention||15
1010467|NCT00569270|2454297|P2|STARTED|Period: First Intervention||15
1010468|NCT00569270|2454298|P1|STARTED|Period: First Intervention|randomized cross over study|15
1010469|NCT00569374|2454333|P1|NOT COMPLETED|Overall Study||4
1010470|NCT00569374|2454333|P1|COMPLETED|Overall Study||4
1010471|NCT00569374|2454333|P1|STARTED|Overall Study||8
1010472|NCT00569530|2454345|P2|NOT COMPLETED|Overall Study||0
1010473|NCT00569530|2454346|P1|NOT COMPLETED|Overall Study||0
1010474|NCT00569530|2454345|P2|COMPLETED|Overall Study||42
1010475|NCT00569530|2454346|P1|COMPLETED|Overall Study||43
1010476|NCT00569530|2454345|P2|STARTED|Overall Study||42
1010477|NCT00569530|2454346|P1|STARTED|Overall Study||43
1010478|NCT00569582|2454354|P1|NOT COMPLETED|Overall Study||16
1010479|NCT00569582|2454354|P1|COMPLETED|Overall Study||34
1010480|NCT00569582|2454354|P1|STARTED|Overall Study||50
1010481|NCT00569660|2454359|P1|NOT COMPLETED|Overall Study||0
1010482|NCT00569660|2454359|P1|COMPLETED|Overall Study||34
1010483|NCT00569660|2454359|P1|STARTED|Overall Study||34
1010484|NCT00569673|2454363|P1|NOT COMPLETED|Overall Study||0
1010485|NCT00569673|2454363|P1|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|71
1010486|NCT00569673|2454363|P1|STARTED|Overall Study|Total number participants enrolled on study|71
1010487|NCT00569777|2454369|P2|NOT COMPLETED|Overall Study||3
1010488|NCT00569777|2454370|P1|NOT COMPLETED|Overall Study||10
1010489|NCT00569777|2454369|P2|COMPLETED|Overall Study||101
1010490|NCT00569777|2454370|P1|COMPLETED|Overall Study||196
1010491|NCT00569777|2454369|P2|STARTED|Overall Study||104
1010492|NCT00569777|2454370|P1|STARTED|Overall Study||206
1010493|NCT00569803|2454420|P8|NOT COMPLETED|Overall Study||1
1010494|NCT00569803|2454421|P7|NOT COMPLETED|Overall Study||0
1010495|NCT00569803|2454422|P6|NOT COMPLETED|Overall Study||0
1010496|NCT00569803|2454423|P5|NOT COMPLETED|Overall Study||0
1010497|NCT00569803|2454424|P4|NOT COMPLETED|Overall Study||1
1010498|NCT00569803|2454425|P3|NOT COMPLETED|Overall Study||0
1010499|NCT00569803|2454426|P2|NOT COMPLETED|Overall Study||0
1010500|NCT00569803|2454427|P1|NOT COMPLETED|Overall Study||1
1010501|NCT00569803|2454420|P8|COMPLETED|Overall Study||5
1010502|NCT00569803|2454421|P7|COMPLETED|Overall Study||10
1010503|NCT00569803|2454422|P6|COMPLETED|Overall Study||5
1010504|NCT00569803|2454423|P5|COMPLETED|Overall Study||5
1010505|NCT00569803|2454424|P4|COMPLETED|Overall Study||5
1010506|NCT00569803|2454425|P3|COMPLETED|Overall Study||5
1010507|NCT00569803|2454426|P2|COMPLETED|Overall Study||5
1010508|NCT00569803|2454427|P1|COMPLETED|Overall Study||4
1010509|NCT00569803|2454420|P8|STARTED|Overall Study||6
1010510|NCT00569803|2454421|P7|STARTED|Overall Study||10
1010511|NCT00569803|2454422|P6|STARTED|Overall Study||5
1010512|NCT00569803|2454423|P5|STARTED|Overall Study||5
1010513|NCT00569803|2454424|P4|STARTED|Overall Study||6
1010514|NCT00569803|2454425|P3|STARTED|Overall Study||5
1010515|NCT00569803|2454426|P2|STARTED|Overall Study||5
1010516|NCT00569803|2454427|P1|STARTED|Overall Study||5
1010517|NCT00569855|2454552|P1|NOT COMPLETED|Overall Study||0
1010518|NCT00569855|2454552|P1|COMPLETED|Overall Study|785 subjects treated with study drug|785
1010519|NCT00569855|2454552|P1|STARTED|Overall Study|832 subjects enrolled; however, study records only available for analysis from 2004 =446 subjects|785
1010520|NCT00569868|2454556|P1|NOT COMPLETED|Overall Study||0
1010521|NCT00569868|2454556|P1|COMPLETED|Overall Study||11
1010522|NCT00569868|2454556|P1|STARTED|Overall Study||11
1010523|NCT00569946|2454560|P1|NOT COMPLETED|Overall Study||59
1010524|NCT00569946|2454560|P1|COMPLETED|Overall Study||5
1010525|NCT00569946|2454560|P1|STARTED|Overall Study||64
1010526|NCT00570037|2454578|P2|NOT COMPLETED|Overall Study||69
1010527|NCT00570037|2454579|P1|NOT COMPLETED|Overall Study||44
1010528|NCT00570037|2454578|P2|COMPLETED|Overall Study||237
1010529|NCT00570037|2454579|P1|COMPLETED|Overall Study||194
1010530|NCT00570037|2454578|P2|STARTED|Overall Study||306
1010531|NCT00570037|2454579|P1|STARTED|Overall Study||238
1010544|NCT00570141|2454598|P1|NOT COMPLETED|Overall Study||3
1010545|NCT00570141|2454598|P1|COMPLETED|Overall Study||10
1010546|NCT00570141|2454598|P1|STARTED|Overall Study||13
1010547|NCT00561340|2454605|P2|NOT COMPLETED|Overall Study||0
1010548|NCT00561340|2454606|P1|NOT COMPLETED|Overall Study||6
1010549|NCT00561340|2454605|P2|COMPLETED|Overall Study||16
1010550|NCT00561340|2454606|P1|COMPLETED|Overall Study||7
1010551|NCT00561340|2454605|P2|STARTED|Overall Study||16
1010552|NCT00561340|2454606|P1|STARTED|Overall Study||13
1010553|NCT00561353|2454624|P10|NOT COMPLETED|Overall Study||2
1010554|NCT00561353|2454625|P9|NOT COMPLETED|Overall Study||7
1010555|NCT00561353|2454626|P8|NOT COMPLETED|Overall Study||4
1010556|NCT00561353|2454627|P7|NOT COMPLETED|Overall Study||6
1010557|NCT00561353|2454628|P6|NOT COMPLETED|Overall Study||6
1010558|NCT00561353|2454629|P5|NOT COMPLETED|Overall Study||1
1010559|NCT00561353|2454630|P4|NOT COMPLETED|Overall Study||6
1010560|NCT00561353|2454631|P3|NOT COMPLETED|Overall Study||3
1010561|NCT00561353|2454632|P2|NOT COMPLETED|Overall Study||3
1010562|NCT00561353|2454633|P1|NOT COMPLETED|Overall Study||5
1010563|NCT00561353|2454624|P10|COMPLETED|Overall Study||3
1010564|NCT00561353|2454625|P9|COMPLETED|Overall Study||2
1010565|NCT00561353|2454626|P8|COMPLETED|Overall Study||6
1010566|NCT00561353|2454627|P7|COMPLETED|Overall Study||3
1010567|NCT00561353|2454628|P6|COMPLETED|Overall Study||3
1010568|NCT00561353|2454629|P5|COMPLETED|Overall Study||5
1010569|NCT00561353|2454630|P4|COMPLETED|Overall Study||12
1010570|NCT00561353|2454631|P3|COMPLETED|Overall Study||10
1010571|NCT00561353|2454632|P2|COMPLETED|Overall Study||16
1010572|NCT00561353|2454633|P1|COMPLETED|Overall Study||13
1010573|NCT00561353|2454624|P10|STARTED|Overall Study||5
1010574|NCT00561353|2454625|P9|STARTED|Overall Study||9
1010575|NCT00561353|2454626|P8|STARTED|Overall Study||10
1010576|NCT00561353|2454627|P7|STARTED|Overall Study||9
1010577|NCT00561353|2454628|P6|STARTED|Overall Study||9
1010578|NCT00561353|2454629|P5|STARTED|Overall Study||6
1010579|NCT00561353|2454630|P4|STARTED|Overall Study||18
1010580|NCT00561353|2454631|P3|STARTED|Overall Study||13
1010581|NCT00561353|2454632|P2|STARTED|Overall Study||19
1010582|NCT00561353|2454633|P1|STARTED|Overall Study||18
1010583|NCT00561392|2454786|P1|NOT COMPLETED|Overall Study||53
1010584|NCT00561392|2454786|P1|COMPLETED|Overall Study||155
1010585|NCT00561392|2454786|P1|STARTED|Overall Study||208
1010586|NCT00561418|2454798|P1|NOT COMPLETED|Overall Study||0
1010587|NCT00561418|2454798|P1|COMPLETED|Overall Study||23
1010588|NCT00561418|2454798|P1|STARTED|Overall Study||23
1010589|NCT00561431|2454807|P2|NOT COMPLETED|Overall Study||0
1010590|NCT00561431|2454808|P1|NOT COMPLETED|Overall Study||0
1010591|NCT00561431|2454807|P2|COMPLETED|Overall Study||100
1010592|NCT00561431|2454808|P1|COMPLETED|Overall Study||100
1010593|NCT00561431|2454807|P2|STARTED|Overall Study||100
1010594|NCT00561431|2454808|P1|STARTED|Overall Study||100
1010595|NCT00561457|2454816|P1|NOT COMPLETED|Overall Study||24
1010596|NCT00561457|2454816|P1|COMPLETED|Overall Study||110
1010597|NCT00561457|2454816|P1|STARTED|Overall Study||134
1010598|NCT00561470|2454822|P2|NOT COMPLETED|Overall Study||612
1010599|NCT00561470|2454823|P1|NOT COMPLETED|Overall Study||614
1010600|NCT00561470|2454822|P2|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
1010601|NCT00561470|2454823|P1|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
1010602|NCT00561470|2454822|P2|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|14
1010603|NCT00561470|2454823|P1|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|11
1010604|NCT00561470|2454822|P2|SAFETY POPULATION|Overall Study|Treated participants including 4 from Placebo/FOLFIRI who received at least 1 dose of Aflibercept|611
1010605|NCT00561470|2454823|P1|SAFETY POPULATION|Overall Study|Treated participants excluding 4 who received at least 1 dose of Aflibercept|605
1010606|NCT00561470|2454822|P2|TREATED|Overall Study||607
1010607|NCT00561470|2454823|P1|TREATED|Overall Study||609
1010608|NCT00561470|2454822|P2|STARTED|Overall Study||612
1010609|NCT00561470|2454823|P1|STARTED|Overall Study||614
1010610|NCT00561574|2454839|P2|NOT COMPLETED|Overall Study||58
1010611|NCT00561574|2454840|P1|NOT COMPLETED|Overall Study||48
1010612|NCT00561574|2454839|P2|COMPLETED|Overall Study||73
1010613|NCT00561574|2454840|P1|COMPLETED|Overall Study||80
1010614|NCT00561574|2454839|P2|STARTED|Overall Study||131
1010615|NCT00561574|2454840|P1|STARTED|Overall Study||128
1010616|NCT00561600|2454866|P2|NOT COMPLETED|Overall Study||16
1010617|NCT00561600|2454867|P1|NOT COMPLETED|Overall Study||18
1010618|NCT00561600|2454866|P2|COMPLETED|Overall Study||119
1010619|NCT00561600|2454867|P1|COMPLETED|Overall Study||112
1010620|NCT00561600|2454866|P2|STARTED|Overall Study||135
1010621|NCT00561600|2454867|P1|STARTED|Overall Study||130
1010622|NCT00561652|2454929|P2|NOT COMPLETED|Overall Study||1
1010623|NCT00561652|2454930|P1|NOT COMPLETED|Overall Study||0
1010624|NCT00561652|2454929|P2|COMPLETED|Overall Study||19
1010625|NCT00561652|2454930|P1|COMPLETED|Overall Study||10
1010626|NCT00561652|2454929|P2|STARTED|Overall Study||20
1010627|NCT00561652|2454930|P1|STARTED|Overall Study||10
1010628|NCT00561678|2454950|P2|NOT COMPLETED|Overall Study||6
1010629|NCT00561678|2454951|P1|NOT COMPLETED|Overall Study||8
1010630|NCT00561678|2454950|P2|COMPLETED|Overall Study||201
1010631|NCT00561678|2454951|P1|COMPLETED|Overall Study||189
1010632|NCT00561678|2454950|P2|STARTED|Overall Study||207
1010633|NCT00561678|2454951|P1|STARTED|Overall Study||197
1010634|NCT00561730|2454967|P1|NOT COMPLETED|Overall Study||9
1010635|NCT00561730|2454967|P1|COMPLETED|Overall Study||1986
1010636|NCT00561730|2454967|P1|STARTED|Overall Study||1995
1010637|NCT00561795|2454983|P4|NOT COMPLETED|Overall Study||0
1010638|NCT00561795|2454984|P3|NOT COMPLETED|Overall Study||0
1010639|NCT00561795|2454985|P2|NOT COMPLETED|Overall Study||6
1010640|NCT00561795|2454986|P1|NOT COMPLETED|Overall Study||4
1010641|NCT00561795|2454983|P4|COMPLETED|Overall Study||0
1010642|NCT00561795|2454984|P3|COMPLETED|Overall Study||0
1010643|NCT00561795|2454985|P2|COMPLETED|Overall Study||0
1010644|NCT00561795|2454986|P1|COMPLETED|Overall Study||2
1010645|NCT00561795|2454983|P4|STARTED|Overall Study||0
1010646|NCT00561795|2454984|P3|STARTED|Overall Study||0
1010647|NCT00561795|2454985|P2|STARTED|Overall Study||6
1010648|NCT00561795|2454986|P1|STARTED|Overall Study||6
1010649|NCT00561821|2455010|P4|NOT COMPLETED|Overall Study||3
1010650|NCT00561821|2455011|P3|NOT COMPLETED|Overall Study||2
1010651|NCT00561821|2455012|P2|NOT COMPLETED|Overall Study||6
1010652|NCT00561821|2455013|P1|NOT COMPLETED|Overall Study||5
1010653|NCT00561821|2455010|P4|COMPLETED|Overall Study||133
1010654|NCT00561821|2455011|P3|COMPLETED|Overall Study||132
1010655|NCT00561821|2455012|P2|COMPLETED|Overall Study||130
1010656|NCT00561821|2455013|P1|COMPLETED|Overall Study||127
1010657|NCT00561821|2455010|P4|Treated|Overall Study||136
1010658|NCT00561821|2455011|P3|Treated|Overall Study||133
1010659|NCT00561821|2455012|P2|Treated|Overall Study||136
1010660|NCT00561821|2455013|P1|Treated|Overall Study||132
1010661|NCT00561821|2455010|P4|STARTED|Overall Study||136
1010662|NCT00561821|2455011|P3|STARTED|Overall Study||134
1010663|NCT00561821|2455012|P2|STARTED|Overall Study||136
1010664|NCT00561821|2455013|P1|STARTED|Overall Study||132
1010665|NCT00570232|2455087|P1|NOT COMPLETED|Overall Study||23
1010666|NCT00570232|2455087|P1|COMPLETED|Overall Study||8
1010667|NCT00570232|2455087|P1|STARTED|Overall Study||31
1010668|NCT00570310|2455095|P2|NOT COMPLETED|Overall Study||6
1010669|NCT00570310|2455096|P1|NOT COMPLETED|Overall Study||2
1010670|NCT00570310|2455095|P2|COMPLETED|Overall Study||45
1010671|NCT00570310|2455096|P1|COMPLETED|Overall Study||51
1010672|NCT00570310|2455095|P2|STARTED|Overall Study||51
1010673|NCT00570310|2455096|P1|STARTED|Overall Study||53
1010674|NCT00570349|2455107|P3|NOT COMPLETED|Overall Study||0
1010675|NCT00570349|2455108|P2|NOT COMPLETED|Overall Study||0
1010676|NCT00570349|2455109|P1|NOT COMPLETED|Overall Study||0
1010677|NCT00570349|2455107|P3|COMPLETED|Overall Study||6
1010678|NCT00570349|2455108|P2|COMPLETED|Overall Study||6
1010679|NCT00570349|2455109|P1|COMPLETED|Overall Study||6
1010680|NCT00570349|2455107|P3|STARTED|Overall Study||6
1010681|NCT00570349|2455108|P2|STARTED|Overall Study||6
1010682|NCT00570349|2455109|P1|STARTED|Overall Study||6
1010683|NCT00570362|2455125|P2|NOT COMPLETED|Overall Study||0
1010684|NCT00570362|2455126|P1|NOT COMPLETED|Overall Study||0
1010685|NCT00570362|2455125|P2|COMPLETED|Overall Study||30
1010686|NCT00570362|2455126|P1|COMPLETED|Overall Study||19
1010687|NCT00570362|2455125|P2|STARTED|Overall Study||30
1010688|NCT00570362|2455126|P1|STARTED|Overall Study||19
1010689|NCT00570401|2455132|P1|NOT COMPLETED|Overall Study||2
1010690|NCT00570401|2455132|P1|COMPLETED|Overall Study||19
1010691|NCT00570401|2455132|P1|STARTED|Overall Study||21
1010692|NCT00570492|2455138|P3|NOT COMPLETED|52-week Double-blind Treatment Period||51
1010693|NCT00570492|2455139|P2|NOT COMPLETED|52-week Double-blind Treatment Period||50
1010694|NCT00570492|2455140|P1|NOT COMPLETED|52-week Double-blind Treatment Period||0
1010695|NCT00570492|2455138|P3|COMPLETED|52-week Double-blind Treatment Period||186
1010696|NCT00570492|2455139|P2|COMPLETED|52-week Double-blind Treatment Period||187
1010697|NCT00570492|2455140|P1|COMPLETED|52-week Double-blind Treatment Period||0
1010698|NCT00570492|2455138|P3|STARTED|52-week Double-blind Treatment Period||237
1010699|NCT00570492|2455139|P2|STARTED|52-week Double-blind Treatment Period||237
1010700|NCT00570492|2455140|P1|STARTED|52-week Double-blind Treatment Period||0
1010701|NCT00570492|2455138|P3|NOT COMPLETED|16-week Single-blind Baseline Period||0
1010702|NCT00570492|2455139|P2|NOT COMPLETED|16-week Single-blind Baseline Period||0
1010703|NCT00570492|2455140|P1|NOT COMPLETED|16-week Single-blind Baseline Period||436
1010704|NCT00570492|2455138|P3|COMPLETED|16-week Single-blind Baseline Period||0
1010705|NCT00570492|2455139|P2|COMPLETED|16-week Single-blind Baseline Period||0
1010706|NCT00570492|2455140|P1|COMPLETED|16-week Single-blind Baseline Period||474
1010707|NCT00570492|2455138|P3|STARTED|16-week Single-blind Baseline Period||0
1010708|NCT00570492|2455139|P2|STARTED|16-week Single-blind Baseline Period||0
1010709|NCT00570492|2455140|P1|STARTED|16-week Single-blind Baseline Period||910
1010710|NCT00570505|2455178|P1|NOT COMPLETED|Overall Study||41
1010711|NCT00570505|2455178|P1|COMPLETED|Overall Study|The number of subjects completing the 60-month study|108
1010712|NCT00570505|2455178|P1|STARTED|Overall Study||149
1010713|NCT00571103|2455189|P1|NOT COMPLETED|Overall Study||2
1010714|NCT00571103|2455189|P1|COMPLETED|Overall Study|Of the 28 participants, 1 subject withdrew and 1 was lost to follow-up after their baseline visit.|26
1010715|NCT00571103|2455189|P1|STARTED|Overall Study||28
1010716|NCT00571194|2455194|P1|NOT COMPLETED|Overall Study||0
1010717|NCT00571194|2455194|P1|COMPLETED|Overall Study||7
1010718|NCT00571194|2455194|P1|STARTED|Overall Study||7
1010731|NCT00571428|2455213|P2|NOT COMPLETED|Overall Study||0
1010732|NCT00571428|2455214|P1|NOT COMPLETED|Overall Study||0
1010733|NCT00571428|2455213|P2|COMPLETED|Overall Study||18
1010734|NCT00571428|2455214|P1|COMPLETED|Overall Study||15
1010735|NCT00571428|2455213|P2|STARTED|Overall Study||18
1010736|NCT00571428|2455214|P1|STARTED|Overall Study||15
1010737|NCT00571649|2455248|P2|NOT COMPLETED|Follow-up Period||528
1010738|NCT00571649|2455249|P1|NOT COMPLETED|Follow-up Period||545
1010739|NCT00571649|2455248|P2|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3107
1010740|NCT00571649|2455249|P1|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3038
1010741|NCT00571649|2455248|P2|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3635
1010742|NCT00571649|2455249|P1|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3583
1010743|NCT00571649|2455248|P2|NOT COMPLETED|Treatment Period||1004
1010744|NCT00571649|2455249|P1|NOT COMPLETED|Treatment Period||1092
1010745|NCT00571649|2455248|P2|COMPLETED|Treatment Period||3047
1010746|NCT00571649|2455249|P1|COMPLETED|Treatment Period||2958
1010747|NCT00571649|2455248|P2|Day 35|Treatment Period||3115
1010748|NCT00571649|2455249|P1|Day 35|Treatment Period||3033
1010749|NCT00571649|2455248|P2|Day 10|Treatment Period||3499
1010750|NCT00571649|2455249|P1|Day 10|Treatment Period||3454
1010751|NCT00571649|2455248|P2|Participants Received Treatment|Treatment Period||4001
1010752|NCT00571649|2455249|P1|Participants Received Treatment|Treatment Period||3997
1010753|NCT00571649|2455248|P2|STARTED|Treatment Period||4051
1010754|NCT00571649|2455249|P1|STARTED|Treatment Period||4050
1010755|NCT00571662|2455281|P1|NOT COMPLETED|Overall Study||8
1010756|NCT00571662|2455281|P1|COMPLETED|Overall Study||68
1010757|NCT00571662|2455281|P1|STARTED|Overall Study||76
1010758|NCT00571688|2455289|P2|NOT COMPLETED|Overall Study||6
1010759|NCT00571688|2455290|P1|NOT COMPLETED|Overall Study||5
1010760|NCT00571688|2455289|P2|COMPLETED|Overall Study||19
1010761|NCT00571688|2455290|P1|COMPLETED|Overall Study||20
1010762|NCT00571688|2455289|P2|STARTED|Overall Study||25
1010763|NCT00571688|2455290|P1|STARTED|Overall Study||25
1010764|NCT00571701|2455298|P2|NOT COMPLETED|Second Intervention 12 Months||1
1010765|NCT00571701|2455299|P1|NOT COMPLETED|Second Intervention 12 Months||3
1010766|NCT00571701|2455298|P2|COMPLETED|Second Intervention 12 Months||20
1010767|NCT00571701|2455299|P1|COMPLETED|Second Intervention 12 Months||13
1010768|NCT00571701|2455298|P2|STARTED|Second Intervention 12 Months||21
1010769|NCT00571701|2455299|P1|STARTED|Second Intervention 12 Months||16
1010770|NCT00571701|2455298|P2|NOT COMPLETED|First Intervention 12 Months||1
1010771|NCT00571701|2455299|P1|NOT COMPLETED|First Intervention 12 Months||3
1010772|NCT00571701|2455298|P2|COMPLETED|First Intervention 12 Months||21
1010773|NCT00571701|2455299|P1|COMPLETED|First Intervention 12 Months||16
1010774|NCT00571701|2455298|P2|STARTED|First Intervention 12 Months||22
1010775|NCT00571701|2455299|P1|STARTED|First Intervention 12 Months||19
1010776|NCT00571922|2455325|P2|NOT COMPLETED|Overall Study||36
1010777|NCT00571922|2455326|P1|NOT COMPLETED|Overall Study||36
1010778|NCT00571922|2455325|P2|COMPLETED|Overall Study||0
1010779|NCT00571922|2455326|P1|COMPLETED|Overall Study||0
1010780|NCT00571922|2455325|P2|STARTED|Overall Study||36
1010781|NCT00571922|2455326|P1|STARTED|Overall Study||36
1010782|NCT00571948|2455336|P2|NOT COMPLETED|Overall Study||14
1010783|NCT00571948|2455337|P1|NOT COMPLETED|Overall Study||11
1010784|NCT00571948|2455336|P2|COMPLETED|Overall Study|Excluded n = 3) Reasons: diet record < 75 % of days (n = 2); blood analysis failed (n= 1)|52
1010785|NCT00571948|2455337|P1|COMPLETED|Overall Study|Excluded from analysis (n = 2) Reason: diet record for less than 75 % of days (n = 2)|55
1010786|NCT00571948|2455336|P2|STARTED|Overall Study||66
1010787|NCT00571948|2455337|P1|STARTED|Overall Study||66
1010788|NCT00571961|2455343|P1|NOT COMPLETED|Overall Study||0
1010789|NCT00571961|2455343|P1|COMPLETED|Overall Study||12
1010790|NCT00571961|2455343|P1|STARTED|Overall Study||12
1010791|NCT00571974|2455349|P2|NOT COMPLETED|Phase II||4
1010792|NCT00571974|2455350|P1|NOT COMPLETED|Phase II||0
1010793|NCT00571974|2455349|P2|COMPLETED|Phase II||17
1010794|NCT00571974|2455350|P1|COMPLETED|Phase II||0
1010795|NCT00571974|2455349|P2|STARTED|Phase II|3 participants are from phase I|21
1010796|NCT00571974|2455350|P1|STARTED|Phase II||0
1010797|NCT00571974|2455349|P2|NOT COMPLETED|Phase I||0
1010798|NCT00571974|2455350|P1|NOT COMPLETED|Phase I||0
1010799|NCT00571974|2455349|P2|COMPLETED|Phase I||0
1010800|NCT00571974|2455350|P1|COMPLETED|Phase I||9
1010801|NCT00571974|2455349|P2|STARTED|Phase I||0
1010802|NCT00571974|2455350|P1|STARTED|Phase I||9
1010803|NCT00571987|2455356|P1|NOT COMPLETED|Overall Study||7
1010804|NCT00571987|2455356|P1|COMPLETED|Overall Study||100
1010805|NCT00571987|2455356|P1|STARTED|Overall Study||107
1010806|NCT00572039|2455363|P2|NOT COMPLETED|Overall Study||10
1010807|NCT00572039|2455364|P1|NOT COMPLETED|Overall Study||16
1010808|NCT00572039|2455363|P2|COMPLETED|Overall Study||110
1010809|NCT00572039|2455364|P1|COMPLETED|Overall Study||105
1010810|NCT00572039|2455363|P2|STARTED|Overall Study||120
1010811|NCT00572039|2455364|P1|STARTED|Overall Study||121
1010812|NCT00572117|2455378|P2|NOT COMPLETED|Overall Study||2
1010813|NCT00572117|2455379|P1|NOT COMPLETED|Overall Study||2
1010814|NCT00572117|2455378|P2|COMPLETED|Overall Study||5
1010815|NCT00572117|2455379|P1|COMPLETED|Overall Study||3
1010816|NCT00572117|2455378|P2|STARTED|Overall Study||7
1010817|NCT00572117|2455379|P1|STARTED|Overall Study||5
1010818|NCT00572156|2455391|P4|NOT COMPLETED|Overall Study||25
1010819|NCT00572156|2455392|P3|NOT COMPLETED|Overall Study||27
1010820|NCT00572156|2455393|P2|NOT COMPLETED|Overall Study||26
1010821|NCT00572156|2455394|P1|NOT COMPLETED|Overall Study||26
1010822|NCT00572156|2455391|P4|COMPLETED|Overall Study||1
1010823|NCT00572156|2455392|P3|COMPLETED|Overall Study||0
1010824|NCT00572156|2455393|P2|COMPLETED|Overall Study||1
1010825|NCT00572156|2455394|P1|COMPLETED|Overall Study||0
1010826|NCT00572156|2455391|P4|STARTED|Overall Study||26
1010827|NCT00572156|2455392|P3|STARTED|Overall Study||27
1010828|NCT00572156|2455393|P2|STARTED|Overall Study||27
1010829|NCT00572156|2455394|P1|STARTED|Overall Study||26
1010830|NCT00572260|2455452|P1|NOT COMPLETED|Overall Study||0
1010831|NCT00572260|2455452|P1|COMPLETED|Overall Study||11
1010832|NCT00572260|2455452|P1|STARTED|Overall Study||11
1010833|NCT00572468|2455458|P2|NOT COMPLETED|Overall Study||4
1010834|NCT00572468|2455459|P1|NOT COMPLETED|Overall Study||2
1010835|NCT00572468|2455458|P2|COMPLETED|Overall Study||16
1010836|NCT00572468|2455459|P1|COMPLETED|Overall Study||20
1010837|NCT00572468|2455458|P2|STARTED|Overall Study||20
1010838|NCT00572468|2455459|P1|STARTED|Overall Study||22
1010839|NCT00572533|2455469|P2|NOT COMPLETED|Overall Study||3
1010840|NCT00572533|2455470|P1|NOT COMPLETED|Overall Study||7
1010841|NCT00572533|2455469|P2|COMPLETED|Overall Study||28
1010842|NCT00572533|2455470|P1|COMPLETED|Overall Study||24
1010843|NCT00572533|2455469|P2|STARTED|Overall Study||31
1010844|NCT00572533|2455470|P1|STARTED|Overall Study||31
1010845|NCT00572572|2455492|P2|NOT COMPLETED|Overall Study||6
1010846|NCT00572572|2455493|P1|NOT COMPLETED|Overall Study||3
1010847|NCT00572572|2455492|P2|COMPLETED|Overall Study||28
1010848|NCT00572572|2455493|P1|COMPLETED|Overall Study||32
1010849|NCT00572572|2455492|P2|STARTED|Overall Study||34
1010850|NCT00572572|2455493|P1|STARTED|Overall Study||35
1010851|NCT00572624|2455511|P2|NOT COMPLETED|Overall Study||4
1010852|NCT00572624|2455512|P1|NOT COMPLETED|Overall Study||17
1010853|NCT00572624|2455511|P2|COMPLETED|Overall Study||10
1010854|NCT00572624|2455512|P1|COMPLETED|Overall Study||20
1010855|NCT00572624|2455511|P2|STARTED|Overall Study||14
1010856|NCT00572624|2455512|P1|STARTED|Overall Study||37
1010857|NCT00572728|2455538|P1|NOT COMPLETED|Overall Study||39
1010858|NCT00572728|2455538|P1|COMPLETED|Overall Study|51 patients eligible for primary objective analysis|51
1010859|NCT00572728|2455538|P1|RCB Evaluation|Overall Study|Secondary: histopathology was available in 35 patients for RCB evaluation|35
1010860|NCT00572728|2455538|P1|LN Evaluation After NAC|Overall Study|Secondary:38 patients were available for histopathological LN evaluation after NAC|38
1010861|NCT00572728|2455538|P1|Completed FLT3 Scan|Overall Study|Secondary analysis milestone: 43 pts had FLT-3 performed.|43
1010862|NCT00572728|2455538|P1|Pathology Complete|Overall Study||51
1010863|NCT00572728|2455538|P1|Second Chemotherapy Initiated After FLT2|Overall Study||52
1010864|NCT00572728|2455538|P1|Second Chemotherapy Initiated|Overall Study||59
1010865|NCT00572728|2455538|P1|Completed FLT2 Scan|Overall Study||60
1010866|NCT00572728|2455538|P1|First Therapy Initiated|Overall Study||65
1010867|NCT00572728|2455538|P1|Completed FLT1 Scan|Overall Study||67
1010868|NCT00572728|2455538|P1|On Study|Overall Study||71
1010869|NCT00572728|2455538|P1|Did Not Withdraw|Overall Study||72
1010870|NCT00572728|2455538|P1|Enrolled Under Amendment 5 or Later|Overall Study||82
1010871|NCT00572728|2455538|P1|Eligible|Overall Study||87
1010872|NCT00572728|2455538|P1|STARTED|Overall Study|Registered|90
1010873|NCT00572832|2455552|P2|NOT COMPLETED|Overall Study||12
1010874|NCT00572832|2455553|P1|NOT COMPLETED|Overall Study||0
1010875|NCT00572832|2455552|P2|COMPLETED|Overall Study||88
1010876|NCT00572832|2455553|P1|COMPLETED|Overall Study||100
1010877|NCT00572832|2455552|P2|STARTED|Overall Study||100
1010878|NCT00572832|2455553|P1|STARTED|Overall Study||100
1010879|NCT00572897|2455561|P2|NOT COMPLETED|Overall Study||0
1010880|NCT00572897|2455562|P1|NOT COMPLETED|Overall Study||0
1010881|NCT00572897|2455561|P2|COMPLETED|Overall Study||34
1010882|NCT00572897|2455562|P1|COMPLETED|Overall Study||32
1010883|NCT00572897|2455561|P2|STARTED|Overall Study||34
1010884|NCT00572897|2455562|P1|STARTED|Overall Study||32
1010885|NCT00572910|2455584|P11|NOT COMPLETED|Overall Study||3
1010886|NCT00572910|2455585|P10|NOT COMPLETED|Overall Study||6
1010887|NCT00572910|2455586|P9|NOT COMPLETED|Overall Study||3
1010888|NCT00572910|2455587|P8|NOT COMPLETED|Overall Study||4
1010889|NCT00572910|2455588|P7|NOT COMPLETED|Overall Study||4
1010890|NCT00572910|2455589|P6|NOT COMPLETED|Overall Study||3
1010891|NCT00572910|2455590|P5|NOT COMPLETED|Overall Study||2
1010892|NCT00572910|2455591|P4|NOT COMPLETED|Overall Study||4
1010893|NCT00572910|2455592|P3|NOT COMPLETED|Overall Study||2
1010894|NCT00572910|2455593|P2|NOT COMPLETED|Overall Study||3
1010895|NCT00572910|2455594|P1|NOT COMPLETED|Overall Study||4
1010896|NCT00572910|2455584|P11|COMPLETED|Overall Study||15
1010897|NCT00572910|2455585|P10|COMPLETED|Overall Study||13
1010898|NCT00572910|2455586|P9|COMPLETED|Overall Study||16
1010899|NCT00572910|2455587|P8|COMPLETED|Overall Study||15
1010900|NCT00572910|2455588|P7|COMPLETED|Overall Study||15
1010901|NCT00572910|2455589|P6|COMPLETED|Overall Study||16
1010902|NCT00572910|2455590|P5|COMPLETED|Overall Study||17
1010903|NCT00572910|2455591|P4|COMPLETED|Overall Study||14
1010904|NCT00572910|2455592|P3|COMPLETED|Overall Study||17
1010905|NCT00572910|2455593|P2|COMPLETED|Overall Study||15
1010906|NCT00572910|2455594|P1|COMPLETED|Overall Study||15
1010907|NCT00572910|2455584|P11|STARTED|Overall Study||18
1010908|NCT00572910|2455585|P10|STARTED|Overall Study||19
1010909|NCT00572910|2455586|P9|STARTED|Overall Study||19
1010910|NCT00572910|2455587|P8|STARTED|Overall Study||19
1010911|NCT00572910|2455588|P7|STARTED|Overall Study||19
1010912|NCT00572910|2455589|P6|STARTED|Overall Study||19
1010913|NCT00572910|2455590|P5|STARTED|Overall Study||19
1010914|NCT00572910|2455591|P4|STARTED|Overall Study||18
1010915|NCT00572910|2455592|P3|STARTED|Overall Study||19
1010916|NCT00572910|2455593|P2|STARTED|Overall Study||18
1010917|NCT00572910|2455594|P1|STARTED|Overall Study||19
1010918|NCT00573066|2455640|P1|NOT COMPLETED|Overall Study||20
1010919|NCT00573066|2455640|P1|COMPLETED|Overall Study||36
1010920|NCT00573066|2455640|P1|STARTED|Overall Study||56
1010921|NCT00573131|2455646|P2|NOT COMPLETED|Overall Study||8
1010922|NCT00573131|2455647|P1|NOT COMPLETED|Overall Study||10
1010923|NCT00573131|2455646|P2|COMPLETED|Overall Study||57
1010924|NCT00573131|2455647|P1|COMPLETED|Overall Study||62
1010925|NCT00573131|2455646|P2|STARTED|Overall Study||65
1010926|NCT00573131|2455647|P1|STARTED|Overall Study||72
1010927|NCT00573144|2455655|P2|NOT COMPLETED|Overall Study||3
1010928|NCT00573144|2455656|P1|NOT COMPLETED|Overall Study||2
1010929|NCT00573144|2455655|P2|COMPLETED|Overall Study||25
1010930|NCT00573144|2455656|P1|COMPLETED|Overall Study||28
1010931|NCT00573144|2455655|P2|STARTED|Overall Study||28
1010932|NCT00573144|2455656|P1|STARTED|Overall Study||30
1010933|NCT00573157|2455668|P2|NOT COMPLETED|Overall Study||2
1010934|NCT00573157|2455669|P1|NOT COMPLETED|Overall Study||4
1010935|NCT00573157|2455668|P2|COMPLETED|Overall Study||0
1010936|NCT00573157|2455669|P1|COMPLETED|Overall Study||0
1010937|NCT00573157|2455668|P2|STARTED|Overall Study||2
1010938|NCT00573157|2455669|P1|STARTED|Overall Study||4
1010939|NCT00573170|2455679|P6|NOT COMPLETED|Third Treatment Period||2
1010940|NCT00573170|2455680|P5|NOT COMPLETED|Third Treatment Period||0
1010941|NCT00573170|2455681|P4|NOT COMPLETED|Third Treatment Period||0
1010942|NCT00573170|2455682|P3|NOT COMPLETED|Third Treatment Period||0
1010943|NCT00573170|2455683|P2|NOT COMPLETED|Third Treatment Period||0
1010944|NCT00573170|2455684|P1|NOT COMPLETED|Third Treatment Period||1
1010945|NCT00573170|2455679|P6|COMPLETED|Third Treatment Period||51
1010946|NCT00573170|2455680|P5|COMPLETED|Third Treatment Period||51
1010947|NCT00573170|2455681|P4|COMPLETED|Third Treatment Period||56
1010948|NCT00573170|2455682|P3|COMPLETED|Third Treatment Period||55
1010949|NCT00573170|2455683|P2|COMPLETED|Third Treatment Period||54
1010950|NCT00573170|2455684|P1|COMPLETED|Third Treatment Period||50
1010951|NCT00573170|2455679|P6|STARTED|Third Treatment Period||53
1010952|NCT00573170|2455680|P5|STARTED|Third Treatment Period||51
1010953|NCT00573170|2455681|P4|STARTED|Third Treatment Period||56
1010954|NCT00573170|2455682|P3|STARTED|Third Treatment Period||55
1010955|NCT00573170|2455683|P2|STARTED|Third Treatment Period||54
1010956|NCT00573170|2455684|P1|STARTED|Third Treatment Period||51
1010957|NCT00573170|2455679|P6|NOT COMPLETED|Second Washout Period||2
1010958|NCT00573170|2455680|P5|NOT COMPLETED|Second Washout Period||8
1010959|NCT00573170|2455681|P4|NOT COMPLETED|Second Washout Period||5
1010960|NCT00573170|2455682|P3|NOT COMPLETED|Second Washout Period||4
1010961|NCT00573170|2455683|P2|NOT COMPLETED|Second Washout Period||4
1010962|NCT00573170|2455684|P1|NOT COMPLETED|Second Washout Period||5
1010963|NCT00573170|2455679|P6|COMPLETED|Second Washout Period||53
1010964|NCT00573170|2455680|P5|COMPLETED|Second Washout Period||51
1010965|NCT00573170|2455681|P4|COMPLETED|Second Washout Period||56
1010966|NCT00573170|2455682|P3|COMPLETED|Second Washout Period||55
1010967|NCT00573170|2455683|P2|COMPLETED|Second Washout Period||54
1010968|NCT00573170|2455684|P1|COMPLETED|Second Washout Period||51
1010969|NCT00573170|2455679|P6|STARTED|Second Washout Period||55
1010970|NCT00573170|2455680|P5|STARTED|Second Washout Period||59
1010971|NCT00573170|2455681|P4|STARTED|Second Washout Period||61
1010972|NCT00573170|2455682|P3|STARTED|Second Washout Period||59
1010973|NCT00573170|2455683|P2|STARTED|Second Washout Period||58
1010974|NCT00573170|2455684|P1|STARTED|Second Washout Period||56
1010975|NCT00573170|2455679|P6|NOT COMPLETED|Second Treatment Period||0
1010976|NCT00573170|2455680|P5|NOT COMPLETED|Second Treatment Period||0
1010977|NCT00573170|2455681|P4|NOT COMPLETED|Second Treatment Period||0
1010978|NCT00573170|2455682|P3|NOT COMPLETED|Second Treatment Period||0
1010979|NCT00573170|2455683|P2|NOT COMPLETED|Second Treatment Period||0
1010980|NCT00573170|2455684|P1|NOT COMPLETED|Second Treatment Period||0
1010981|NCT00573170|2455679|P6|COMPLETED|Second Treatment Period||55
1010982|NCT00573170|2455680|P5|COMPLETED|Second Treatment Period||59
1010983|NCT00573170|2455681|P4|COMPLETED|Second Treatment Period||61
1010984|NCT00573170|2455682|P3|COMPLETED|Second Treatment Period||59
1010985|NCT00573170|2455683|P2|COMPLETED|Second Treatment Period||58
1010986|NCT00573170|2455684|P1|COMPLETED|Second Treatment Period||56
1010987|NCT00573170|2455679|P6|STARTED|Second Treatment Period||55
1010988|NCT00573170|2455680|P5|STARTED|Second Treatment Period||59
1010989|NCT00573170|2455681|P4|STARTED|Second Treatment Period||61
1010990|NCT00573170|2455682|P3|STARTED|Second Treatment Period||59
1010991|NCT00573170|2455683|P2|STARTED|Second Treatment Period||58
1010992|NCT00573170|2455684|P1|STARTED|Second Treatment Period||56
1010993|NCT00573170|2455679|P6|NOT COMPLETED|First Washout Period||7
1010994|NCT00573170|2455680|P5|NOT COMPLETED|First Washout Period||3
1010995|NCT00573170|2455681|P4|NOT COMPLETED|First Washout Period||5
1010996|NCT00573170|2455682|P3|NOT COMPLETED|First Washout Period||1
1010997|NCT00573170|2455683|P2|NOT COMPLETED|First Washout Period||2
1010998|NCT00573170|2455684|P1|NOT COMPLETED|First Washout Period||8
1010999|NCT00573170|2455679|P6|COMPLETED|First Washout Period||55
1011000|NCT00573170|2455680|P5|COMPLETED|First Washout Period|Source data list 4 noncompleters; per number starting next period, there were only 3 noncompleters.|59
1011001|NCT00573170|2455681|P4|COMPLETED|First Washout Period||61
1011002|NCT00573170|2455682|P3|COMPLETED|First Washout Period||59
1011003|NCT00573170|2455683|P2|COMPLETED|First Washout Period||58
1011004|NCT00573170|2455684|P1|COMPLETED|First Washout Period||56
1011005|NCT00573170|2455679|P6|STARTED|First Washout Period||62
1011006|NCT00573170|2455680|P5|STARTED|First Washout Period||62
1011007|NCT00573170|2455681|P4|STARTED|First Washout Period||66
1011008|NCT00573170|2455682|P3|STARTED|First Washout Period||60
1011009|NCT00573170|2455683|P2|STARTED|First Washout Period||60
1011010|NCT00573170|2455684|P1|STARTED|First Washout Period||64
1011011|NCT00573170|2455679|P6|NOT COMPLETED|First Treatment Period||0
1011012|NCT00573170|2455680|P5|NOT COMPLETED|First Treatment Period||1
1011013|NCT00573170|2455681|P4|NOT COMPLETED|First Treatment Period||0
1011014|NCT00573170|2455682|P3|NOT COMPLETED|First Treatment Period||0
1011015|NCT00573170|2455683|P2|NOT COMPLETED|First Treatment Period||0
1011016|NCT00573170|2455684|P1|NOT COMPLETED|First Treatment Period||0
1011017|NCT00573170|2455679|P6|COMPLETED|First Treatment Period||62
1011018|NCT00573170|2455680|P5|COMPLETED|First Treatment Period||62
1011019|NCT00573170|2455681|P4|COMPLETED|First Treatment Period||66
1011020|NCT00573170|2455682|P3|COMPLETED|First Treatment Period||60
1011021|NCT00573170|2455683|P2|COMPLETED|First Treatment Period||60
1011022|NCT00573170|2455684|P1|COMPLETED|First Treatment Period||64
1011023|NCT00573170|2455679|P6|STARTED|First Treatment Period||62
1011024|NCT00573170|2455680|P5|STARTED|First Treatment Period||63
1011025|NCT00573170|2455681|P4|STARTED|First Treatment Period||66
1011026|NCT00573170|2455682|P3|STARTED|First Treatment Period||60
1011027|NCT00573170|2455683|P2|STARTED|First Treatment Period||60
1011028|NCT00573170|2455684|P1|STARTED|First Treatment Period||64
1011029|NCT00573183|2455760|P2|NOT COMPLETED|Overall Study||63
1011030|NCT00573183|2455761|P1|NOT COMPLETED|Overall Study||72
1011031|NCT00573183|2455760|P2|COMPLETED|Overall Study||174
1011032|NCT00573183|2455761|P1|COMPLETED|Overall Study||162
1011033|NCT00573183|2455760|P2|STARTED|Overall Study||237
1011034|NCT00573183|2455761|P1|STARTED|Overall Study||234
1011035|NCT00573248|2455771|P2|NOT COMPLETED|Overall Study||11
1011036|NCT00573248|2455772|P1|NOT COMPLETED|Overall Study||15
1011037|NCT00573248|2455771|P2|COMPLETED|Overall Study||27
1011038|NCT00573248|2455772|P1|COMPLETED|Overall Study||25
1011039|NCT00573248|2455771|P2|Nicotine Patches and Placebo Patches|Overall Study||27
1011040|NCT00573248|2455772|P1|Nicotine Patches and Placebo Patches|Overall Study||25
1011041|NCT00573248|2455771|P2|STARTED|Overall Study||38
1011042|NCT00573248|2455772|P1|STARTED|Overall Study||40
1011043|NCT00573261|2455786|P2|NOT COMPLETED|Overall Study||5
1011044|NCT00573261|2455787|P1|NOT COMPLETED|Overall Study||6
1011045|NCT00573261|2455786|P2|COMPLETED|Overall Study||15
1011046|NCT00573261|2455787|P1|COMPLETED|Overall Study||14
1011047|NCT00573261|2455786|P2|STARTED|Overall Study||20
1011048|NCT00573261|2455787|P1|STARTED|Overall Study||20
1011049|NCT00573287|2455815|P2|NOT COMPLETED|Overall Study||3
1011050|NCT00573287|2455816|P1|NOT COMPLETED|Overall Study||4
1011051|NCT00573287|2455815|P2|COMPLETED|Overall Study||4
1011052|NCT00573287|2455816|P1|COMPLETED|Overall Study||3
1011053|NCT00573287|2455815|P2|STARTED|Overall Study||7
1011054|NCT00573287|2455816|P1|STARTED|Overall Study||7
1011055|NCT00573313|2455826|P4|NOT COMPLETED|Overall Study||0
1011056|NCT00573313|2455827|P3|NOT COMPLETED|Overall Study||6
1011057|NCT00573313|2455828|P2|NOT COMPLETED|Overall Study||0
1011058|NCT00573313|2455829|P1|NOT COMPLETED|Overall Study||5
1011059|NCT00573313|2455826|P4|COMPLETED|Overall Study||26
1011060|NCT00573313|2455827|P3|COMPLETED|Overall Study||13
1011061|NCT00573313|2455828|P2|COMPLETED|Overall Study||28
1011062|NCT00573313|2455829|P1|COMPLETED|Overall Study||13
1011063|NCT00573313|2455826|P4|STARTED|Overall Study||26
1011064|NCT00573313|2455827|P3|STARTED|Overall Study|Nineteen recruited to start.|19
1011065|NCT00573313|2455828|P2|STARTED|Overall Study||28
1011066|NCT00573313|2455829|P1|STARTED|Overall Study|Eighteen participants recruited to start.|18
1011067|NCT00573391|2455839|P2|NOT COMPLETED|Overall Study||2
1011068|NCT00573391|2455840|P1|NOT COMPLETED|Overall Study||3
1011069|NCT00573391|2455839|P2|COMPLETED|Overall Study||0
1011070|NCT00573391|2455840|P1|COMPLETED|Overall Study||0
1011071|NCT00573391|2455839|P2|STARTED|Overall Study||2
1011072|NCT00573391|2455840|P1|STARTED|Overall Study||3
1011073|NCT00573430|2455849|P3|NOT COMPLETED|Overall Study||10
1011074|NCT00573430|2455850|P2|NOT COMPLETED|Overall Study||5
1011075|NCT00573430|2455851|P1|NOT COMPLETED|Overall Study||1
1011076|NCT00573430|2455849|P3|COMPLETED|Overall Study||33
1011077|NCT00573430|2455850|P2|COMPLETED|Overall Study||40
1011078|NCT00573430|2455851|P1|COMPLETED|Overall Study||39
1011079|NCT00573430|2455849|P3|STARTED|Overall Study|randomized|43
1011080|NCT00573430|2455850|P2|STARTED|Overall Study|randomized|45
1011081|NCT00573430|2455851|P1|STARTED|Overall Study|randomized|40
1011082|NCT00573443|2455874|P3|NOT COMPLETED|Open-Label Extension Phase||0
1011083|NCT00573443|2455875|P2|NOT COMPLETED|Open-Label Extension Phase||0
1011084|NCT00573443|2455876|P1|NOT COMPLETED|Open-Label Extension Phase||18
1011085|NCT00573443|2455874|P3|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
1011086|NCT00573443|2455875|P2|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
1011087|NCT00573443|2455876|P1|COMPLETED|Open-Label Extension Phase||235
1011088|NCT00573443|2455874|P3|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
1011089|NCT00573443|2455875|P2|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
1011090|NCT00573443|2455876|P1|Subjects With PBA Secondary to MS|Open-Label Extension Phase||107
1011091|NCT00573443|2455874|P3|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
1011092|NCT00573443|2455875|P2|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
1011093|NCT00573443|2455876|P1|Subjects With PBA Secondary to ALS|Open-Label Extension Phase||146
1011178|NCT00565266|2456016|P1|STARTED|Overall Study||210
1011094|NCT00573443|2455874|P3|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
1011095|NCT00573443|2455875|P2|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
1011096|NCT00573443|2455876|P1|STARTED|Open-Label Extension Phase|Subjects who completed any of the arms in the DB phase had the option to enroll in this OLE phase|253
1011097|NCT00573443|2455874|P3|NOT COMPLETED|Double-Blind Phase||15
1011098|NCT00573443|2455875|P2|NOT COMPLETED|Double-Blind Phase||19
1011099|NCT00573443|2455876|P1|NOT COMPLETED|Double-Blind Phase||9
1011100|NCT00573443|2455874|P3|COMPLETED|Double-Blind Phase||94
1011101|NCT00573443|2455875|P2|COMPLETED|Double-Blind Phase||88
1011102|NCT00573443|2455876|P1|COMPLETED|Double-Blind Phase||101
1011103|NCT00573443|2455874|P3|Subjects With PBA Secondary to MS|Double-Blind Phase||45
1011104|NCT00573443|2455875|P2|Subjects With PBA Secondary to MS|Double-Blind Phase||39
1011105|NCT00573443|2455876|P1|Subjects With PBA Secondary to MS|Double-Blind Phase||45
1011106|NCT00573443|2455874|P3|Subjects With PBA Secondary to ALS|Double-Blind Phase||64
1011107|NCT00573443|2455875|P2|Subjects With PBA Secondary to ALS|Double-Blind Phase||68
1011108|NCT00573443|2455876|P1|Subjects With PBA Secondary to ALS|Double-Blind Phase||65
1011109|NCT00573443|2455874|P3|STARTED|Double-Blind Phase||109
1011110|NCT00573443|2455875|P2|STARTED|Double-Blind Phase||107
1011111|NCT00573443|2455876|P1|STARTED|Double-Blind Phase||110
1011112|NCT00573469|2455906|P3|NOT COMPLETED|Overall Study||4
1011113|NCT00573469|2455907|P2|NOT COMPLETED|Overall Study||4
1011114|NCT00573469|2455908|P1|NOT COMPLETED|Overall Study||6
1011115|NCT00573469|2455906|P3|COMPLETED|Overall Study||22
1011116|NCT00573469|2455907|P2|COMPLETED|Overall Study||21
1011117|NCT00573469|2455908|P1|COMPLETED|Overall Study||20
1011118|NCT00573469|2455906|P3|STARTED|Overall Study||26
1011119|NCT00573469|2455907|P2|STARTED|Overall Study||25
1011120|NCT00573469|2455908|P1|STARTED|Overall Study||26
1011121|NCT00573508|2455930|P2|NOT COMPLETED|Overall Study||41
1011122|NCT00573508|2455931|P1|NOT COMPLETED|Overall Study||64
1011123|NCT00573508|2455930|P2|COMPLETED|Overall Study||345
1011124|NCT00573508|2455931|P1|COMPLETED|Overall Study||318
1011125|NCT00573508|2455930|P2|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|377
1011126|NCT00573508|2455931|P1|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|374
1011127|NCT00573508|2455930|P2|STARTED|Overall Study||386
1011128|NCT00573508|2455931|P1|STARTED|Overall Study||382
1011129|NCT00573534|2455961|P1|NOT COMPLETED|Overall Study||3
1011130|NCT00573534|2455961|P1|COMPLETED|Overall Study||5
1011131|NCT00573534|2455961|P1|STARTED|Overall Study||8
1011132|NCT00565058|2455968|P2|NOT COMPLETED|Overall Study||0
1011133|NCT00565058|2455969|P1|NOT COMPLETED|Overall Study||1
1011134|NCT00565058|2455968|P2|COMPLETED|Overall Study||15
1011135|NCT00565058|2455969|P1|COMPLETED|Overall Study||9
1011136|NCT00565058|2455968|P2|STARTED|Overall Study||15
1011137|NCT00565058|2455969|P1|STARTED|Overall Study||10
1011138|NCT00565084|2455977|P3|NOT COMPLETED|Third Treatment Period||0
1011139|NCT00565084|2455978|P2|NOT COMPLETED|Third Treatment Period||0
1011140|NCT00565084|2455979|P1|NOT COMPLETED|Third Treatment Period||0
1011141|NCT00565084|2455977|P3|COMPLETED|Third Treatment Period||11
1011142|NCT00565084|2455978|P2|COMPLETED|Third Treatment Period||11
1011143|NCT00565084|2455979|P1|COMPLETED|Third Treatment Period||11
1011144|NCT00565084|2455977|P3|STARTED|Third Treatment Period||11
1011145|NCT00565084|2455978|P2|STARTED|Third Treatment Period||11
1011146|NCT00565084|2455979|P1|STARTED|Third Treatment Period||11
1011147|NCT00565084|2455977|P3|NOT COMPLETED|Second Treatment Period||0
1011148|NCT00565084|2455978|P2|NOT COMPLETED|Second Treatment Period||0
1011149|NCT00565084|2455979|P1|NOT COMPLETED|Second Treatment Period||0
1011150|NCT00565084|2455977|P3|COMPLETED|Second Treatment Period||11
1011151|NCT00565084|2455978|P2|COMPLETED|Second Treatment Period||11
1011152|NCT00565084|2455979|P1|COMPLETED|Second Treatment Period||11
1011153|NCT00565084|2455977|P3|STARTED|Second Treatment Period||11
1011154|NCT00565084|2455978|P2|STARTED|Second Treatment Period||11
1011155|NCT00565084|2455979|P1|STARTED|Second Treatment Period||11
1011156|NCT00565084|2455977|P3|NOT COMPLETED|First Treatment Period||0
1011157|NCT00565084|2455978|P2|NOT COMPLETED|First Treatment Period||0
1011158|NCT00565084|2455979|P1|NOT COMPLETED|First Treatment Period||0
1011159|NCT00565084|2455977|P3|COMPLETED|First Treatment Period||11
1011160|NCT00565084|2455978|P2|COMPLETED|First Treatment Period||11
1011161|NCT00565084|2455979|P1|COMPLETED|First Treatment Period||11
1011162|NCT00565084|2455977|P3|STARTED|First Treatment Period||11
1011163|NCT00565084|2455978|P2|STARTED|First Treatment Period||11
1011164|NCT00565084|2455979|P1|STARTED|First Treatment Period||11
1011165|NCT00565110|2455989|P2|NOT COMPLETED|Overall Study||131
1011166|NCT00565110|2455990|P1|NOT COMPLETED|Overall Study||131
1011167|NCT00565110|2455989|P2|COMPLETED|Overall Study||111
1011168|NCT00565110|2455990|P1|COMPLETED|Overall Study||99
1011169|NCT00565110|2455989|P2|12-Month|Overall Study||144
1011170|NCT00565110|2455990|P1|12-Month|Overall Study||114
1011171|NCT00565110|2455989|P2|STARTED|Overall Study||242
1011172|NCT00565110|2455990|P1|STARTED|Overall Study||230
1011173|NCT00565136|2455998|P1|NOT COMPLETED|Overall Study||3
1011174|NCT00565136|2455998|P1|COMPLETED|Overall Study||26
1011175|NCT00565136|2455998|P1|STARTED|Overall Study||29
1011176|NCT00565266|2456016|P1|NOT COMPLETED|Overall Study||36
1011177|NCT00565266|2456016|P1|COMPLETED|Overall Study||174
1011179|NCT00565370|2456024|P1|NOT COMPLETED|Overall Study||0
1011180|NCT00565370|2456024|P1|COMPLETED|Overall Study||21
1011181|NCT00565370|2456024|P1|STARTED|Overall Study||21
1011182|NCT00565409|2456032|P4|NOT COMPLETED|Period 2 Double-Blind||59
1011183|NCT00565409|2456033|P3|NOT COMPLETED|Period 2 Double-Blind||27
1011184|NCT00565409|2456034|P2|NOT COMPLETED|Period 2 Double-Blind||21
1011185|NCT00565409|2456035|P1|NOT COMPLETED|Period 2 Double-Blind||0
1011186|NCT00565409|2456032|P4|COMPLETED|Period 2 Double-Blind||141
1011187|NCT00565409|2456033|P3|COMPLETED|Period 2 Double-Blind||175
1011188|NCT00565409|2456034|P2|COMPLETED|Period 2 Double-Blind||181
1011189|NCT00565409|2456035|P1|COMPLETED|Period 2 Double-Blind||0
1011190|NCT00565409|2456032|P4|STARTED|Period 2 Double-Blind||200
1011191|NCT00565409|2456033|P3|STARTED|Period 2 Double-Blind||202
1011192|NCT00565409|2456034|P2|STARTED|Period 2 Double-Blind||202
1011193|NCT00565409|2456035|P1|STARTED|Period 2 Double-Blind||0
1011194|NCT00565409|2456032|P4|NOT COMPLETED|After Period 1, Prior to Period 2||0
1011195|NCT00565409|2456033|P3|NOT COMPLETED|After Period 1, Prior to Period 2||0
1011196|NCT00565409|2456034|P2|NOT COMPLETED|After Period 1, Prior to Period 2||0
1011197|NCT00565409|2456035|P1|NOT COMPLETED|After Period 1, Prior to Period 2||152
1011198|NCT00565409|2456032|P4|COMPLETED|After Period 1, Prior to Period 2||0
1011199|NCT00565409|2456033|P3|COMPLETED|After Period 1, Prior to Period 2||0
1011200|NCT00565409|2456034|P2|COMPLETED|After Period 1, Prior to Period 2||0
1011201|NCT00565409|2456035|P1|COMPLETED|After Period 1, Prior to Period 2||604
1011202|NCT00565409|2456032|P4|STARTED|After Period 1, Prior to Period 2||0
1011203|NCT00565409|2456033|P3|STARTED|After Period 1, Prior to Period 2||0
1011204|NCT00565409|2456034|P2|STARTED|After Period 1, Prior to Period 2||0
1011205|NCT00565409|2456035|P1|STARTED|After Period 1, Prior to Period 2||756
1011206|NCT00565409|2456032|P4|NOT COMPLETED|Period 1 Open Label||0
1011207|NCT00565409|2456033|P3|NOT COMPLETED|Period 1 Open Label||0
1011208|NCT00565409|2456034|P2|NOT COMPLETED|Period 1 Open Label||0
1011209|NCT00565409|2456035|P1|NOT COMPLETED|Period 1 Open Label||78
1011210|NCT00565409|2456032|P4|COMPLETED|Period 1 Open Label||0
1011211|NCT00565409|2456033|P3|COMPLETED|Period 1 Open Label||0
1011212|NCT00565409|2456034|P2|COMPLETED|Period 1 Open Label||0
1011213|NCT00565409|2456035|P1|COMPLETED|Period 1 Open Label||756
1011214|NCT00565409|2456032|P4|STARTED|Period 1 Open Label||0
1011215|NCT00565409|2456033|P3|STARTED|Period 1 Open Label||0
1011216|NCT00565409|2456034|P2|STARTED|Period 1 Open Label||0
1011217|NCT00565409|2456035|P1|STARTED|Period 1 Open Label||834
1011218|NCT00565448|2456139|P2|NOT COMPLETED|Overall Study||2
1011219|NCT00565448|2456140|P1|NOT COMPLETED|Overall Study||3
1011220|NCT00565448|2456139|P2|COMPLETED|Overall Study|Completed induction period as per protocol.|23
1011221|NCT00565448|2456140|P1|COMPLETED|Overall Study|Completed induction period as per protocol.|47
1011222|NCT00565448|2456139|P2|STARTED|Overall Study|ITT population: all randomized participants. All were treated.|25
1011223|NCT00565448|2456140|P1|STARTED|Overall Study|Intent to treat (ITT) population: all randomized participants. All were treated.|50
1011224|NCT00565461|2456155|P4|NOT COMPLETED|Overall Study||3
1011225|NCT00565461|2456156|P3|NOT COMPLETED|Overall Study||1
1011226|NCT00565461|2456157|P2|NOT COMPLETED|Overall Study||1
1011227|NCT00565461|2456158|P1|NOT COMPLETED|Overall Study||0
1011228|NCT00565461|2456155|P4|COMPLETED|Overall Study||37
1011229|NCT00565461|2456156|P3|COMPLETED|Overall Study||39
1011230|NCT00565461|2456157|P2|COMPLETED|Overall Study||39
1011231|NCT00565461|2456158|P1|COMPLETED|Overall Study||40
1011232|NCT00565461|2456155|P4|STARTED|Overall Study||40
1011233|NCT00565461|2456156|P3|STARTED|Overall Study||40
1011234|NCT00565461|2456157|P2|STARTED|Overall Study||40
1011235|NCT00565461|2456158|P1|STARTED|Overall Study||40
1011236|NCT00565604|2456170|P1|NOT COMPLETED|Overall Study||4
1011237|NCT00565604|2456170|P1|COMPLETED|Overall Study||39
1011238|NCT00565604|2456170|P1|6 Month|Overall Study||39
1011239|NCT00565604|2456170|P1|6 Week|Overall Study||39
1011240|NCT00565604|2456170|P1|2 Week|Overall Study||41
1011241|NCT00565604|2456170|P1|7 Day|Overall Study||41
1011242|NCT00565604|2456170|P1|STARTED|Overall Study||43
1011243|NCT00565617|2456177|P1|NOT COMPLETED|Overall Study||1
1011244|NCT00565617|2456177|P1|COMPLETED|Overall Study||5
1011245|NCT00565617|2456177|P1|STARTED|Overall Study||6
1011246|NCT00565643|2456183|P2|NOT COMPLETED|Overall Study||0
1011247|NCT00565643|2456184|P1|NOT COMPLETED|Overall Study||0
1011248|NCT00565643|2456183|P2|COMPLETED|Overall Study||373
1011249|NCT00565643|2456184|P1|COMPLETED|Overall Study||380
1011250|NCT00565643|2456183|P2|Primary Outcome (Subsequent Cesarean)|Overall Study||92
1011251|NCT00565643|2456184|P1|Primary Outcome (Subsequent Cesarean)|Overall Study||80
1011252|NCT00565643|2456183|P2|Safety Data|Overall Study||373
1011253|NCT00565643|2456184|P1|Safety Data|Overall Study||380
1011254|NCT00565643|2456183|P2|STARTED|Overall Study||373
1011255|NCT00565643|2456184|P1|STARTED|Overall Study||380
1011256|NCT00565721|2456202|P1|NOT COMPLETED|Overall Study||17
1011257|NCT00565721|2456202|P1|COMPLETED|Overall Study||16
1011258|NCT00565721|2456202|P1|STARTED|Overall Study||33
1011259|NCT00565747|2456223|P2|NOT COMPLETED|Overall Study||73
1011260|NCT00565747|2456224|P1|NOT COMPLETED|Overall Study||67
1011261|NCT00565747|2456223|P2|COMPLETED|Overall Study|Completed with an embryo transfer|605
1011262|NCT00565747|2456224|P1|COMPLETED|Overall Study|Completed with an embryo transfer|587
1011263|NCT00565747|2456223|P2|STARTED|Overall Study||678
1011264|NCT00565747|2456224|P1|STARTED|Overall Study||654
1011265|NCT00565812|2456237|P3|NOT COMPLETED|Overall Study||130
1011266|NCT00565812|2456238|P2|NOT COMPLETED|Overall Study||135
1011267|NCT00565812|2456239|P1|NOT COMPLETED|Overall Study||144
1011268|NCT00565812|2456237|P3|COMPLETED|Overall Study||356
1011269|NCT00565812|2456238|P2|COMPLETED|Overall Study||351
1011270|NCT00565812|2456239|P1|COMPLETED|Overall Study||341
1011271|NCT00565812|2456237|P3|STARTED|Overall Study||486
1011272|NCT00565812|2456238|P2|STARTED|Overall Study||486
1011273|NCT00565812|2456239|P1|STARTED|Overall Study||485
1011274|NCT00566020|2456376|P2|NOT COMPLETED|46-week Long-term Administration Phase||17
1011275|NCT00566020|2456377|P1|NOT COMPLETED|46-week Long-term Administration Phase||0
1011276|NCT00566020|2456376|P2|COMPLETED|46-week Long-term Administration Phase||68
1011277|NCT00566020|2456377|P1|COMPLETED|46-week Long-term Administration Phase||0
1011278|NCT00566020|2456376|P2|STARTED|46-week Long-term Administration Phase||85
1011279|NCT00566020|2456377|P1|STARTED|46-week Long-term Administration Phase||0
1011280|NCT00566020|2456376|P2|NOT COMPLETED|6-week Dosage Adjustment Phase||0
1011281|NCT00566020|2456377|P1|NOT COMPLETED|6-week Dosage Adjustment Phase||7
1011282|NCT00566020|2456376|P2|COMPLETED|6-week Dosage Adjustment Phase||0
1011283|NCT00566020|2456377|P1|COMPLETED|6-week Dosage Adjustment Phase||85
1011284|NCT00566020|2456376|P2|STARTED|6-week Dosage Adjustment Phase||0
1011285|NCT00566020|2456377|P1|STARTED|6-week Dosage Adjustment Phase||92
1011286|NCT00566111|2456404|P2|NOT COMPLETED|Overall Study||2
1011287|NCT00566111|2456405|P1|NOT COMPLETED|Overall Study||0
1011288|NCT00566111|2456404|P2|COMPLETED|Overall Study||1
1011289|NCT00566111|2456405|P1|COMPLETED|Overall Study||2
1011290|NCT00566111|2456404|P2|STARTED|Overall Study||3
1011291|NCT00566111|2456405|P1|STARTED|Overall Study||2
1011292|NCT00566150|2456421|P2|NOT COMPLETED|Overall Study||5
1011293|NCT00566150|2456422|P1|NOT COMPLETED|Overall Study||9
1011294|NCT00566150|2456421|P2|COMPLETED|Overall Study||11
1011295|NCT00566150|2456422|P1|COMPLETED|Overall Study||10
1011296|NCT00566150|2456421|P2|STARTED|Overall Study||16
1011297|NCT00566150|2456422|P1|STARTED|Overall Study||19
1011298|NCT00566254|2456436|P2|NOT COMPLETED|Overall Study||14
1011299|NCT00566254|2456437|P1|NOT COMPLETED|Overall Study||10
1011300|NCT00566254|2456436|P2|COMPLETED|Overall Study||93
1011301|NCT00566254|2456437|P1|COMPLETED|Overall Study||90
1011302|NCT00566254|2456436|P2|STARTED|Overall Study||107
1011303|NCT00566254|2456437|P1|STARTED|Overall Study||100
1011304|NCT00566462|2456451|P2|NOT COMPLETED|Overall Study||0
1011305|NCT00566462|2456452|P1|NOT COMPLETED|Overall Study||0
1011306|NCT00566462|2456451|P2|COMPLETED|Overall Study||0
1011307|NCT00566462|2456452|P1|COMPLETED|Overall Study||1
1011308|NCT00566462|2456451|P2|STARTED|Overall Study||0
1011309|NCT00566462|2456452|P1|STARTED|Overall Study||1
1011310|NCT00566501|2456462|P2|NOT COMPLETED|Overall Study||126
1011311|NCT00566501|2456463|P1|NOT COMPLETED|Overall Study||156
1011312|NCT00566501|2456462|P2|COMPLETED|Overall Study||210
1011313|NCT00566501|2456463|P1|COMPLETED|Overall Study||423
1011314|NCT00566501|2456462|P2|Not Determined|Overall Study||0
1011315|NCT00566501|2456463|P1|Not Determined|Overall Study||1
1011316|NCT00566501|2456462|P2|Other ( Not Specified)|Overall Study||21
1011317|NCT00566501|2456463|P1|Other ( Not Specified)|Overall Study||24
1011318|NCT00566501|2456462|P2|Medication Non-compliance|Overall Study||0
1011319|NCT00566501|2456463|P1|Medication Non-compliance|Overall Study||5
1011320|NCT00566501|2456462|P2|Protocol Violation|Overall Study||2
1011321|NCT00566501|2456463|P1|Protocol Violation|Overall Study||2
1011322|NCT00566501|2456462|P2|Request of Investigator or Sponsor|Overall Study||7
1011323|NCT00566501|2456463|P1|Request of Investigator or Sponsor|Overall Study||6
1011324|NCT00566501|2456462|P2|Withdraw of Consent by Subject|Overall Study||30
1011325|NCT00566501|2456463|P1|Withdraw of Consent by Subject|Overall Study||33
1011326|NCT00566501|2456462|P2|Lack of Efficacy|Overall Study||3
1011327|NCT00566501|2456463|P1|Lack of Efficacy|Overall Study||8
1011328|NCT00566501|2456462|P2|Adverse Event|Overall Study||59
1011329|NCT00566501|2456463|P1|Adverse Event|Overall Study||68
1011330|NCT00566501|2456462|P2|Discontinued|Overall Study||122
1011331|NCT00566501|2456463|P1|Discontinued|Overall Study||146
1011332|NCT00566501|2456462|P2|Safety Population|Overall Study||332
1011333|NCT00566501|2456463|P1|Safety Population|Overall Study||570
1011334|NCT00566501|2456462|P2|STARTED|Overall Study||336
1011335|NCT00566501|2456463|P1|STARTED|Overall Study||579
1011336|NCT00566579|2456471|P2|NOT COMPLETED|Overall Study||0
1011337|NCT00566579|2456472|P1|NOT COMPLETED|Overall Study||0
1011338|NCT00566579|2456471|P2|COMPLETED|Overall Study||31
1011339|NCT00566579|2456472|P1|COMPLETED|Overall Study||29
1011340|NCT00566579|2456471|P2|STARTED|Overall Study||31
1011341|NCT00566579|2456472|P1|STARTED|Overall Study||29
1011342|NCT00566631|2456478|P1|NOT COMPLETED|Part 2: Extension Phase||82
1011343|NCT00566631|2456478|P1|COMPLETED|Part 2: Extension Phase||57
1011344|NCT00566631|2456478|P1|STARTED|Part 2: Extension Phase||139
1011345|NCT00566631|2456478|P1|NOT COMPLETED|Between Treatment and Extension Phase||95
1011346|NCT00566631|2456478|P1|COMPLETED|Between Treatment and Extension Phase||139
1011347|NCT00566631|2456478|P1|STARTED|Between Treatment and Extension Phase||234
1011348|NCT00566631|2456478|P1|NOT COMPLETED|Part 1: Core Treatment Phase||60
1011349|NCT00566631|2456478|P1|COMPLETED|Part 1: Core Treatment Phase||234
1011350|NCT00566631|2456478|P1|STARTED|Part 1: Core Treatment Phase||294
1011351|NCT00566696|2456493|P1|NOT COMPLETED|Overall Study||42
1011352|NCT00566696|2456493|P1|COMPLETED|Overall Study||31
1011353|NCT00566696|2456493|P1|STARTED|Overall Study||73
1011354|NCT00566709|2456503|P2|NOT COMPLETED|Overall Study||0
1011355|NCT00566709|2456504|P1|NOT COMPLETED|Overall Study||5
1011356|NCT00566709|2456503|P2|COMPLETED|Overall Study||51
1011357|NCT00566709|2456504|P1|COMPLETED|Overall Study||46
1011358|NCT00566709|2456503|P2|STARTED|Overall Study||51
1011359|NCT00566709|2456504|P1|STARTED|Overall Study||51
1011360|NCT00566722|2456523|P3|NOT COMPLETED|Overall Study||9
1011361|NCT00566722|2456524|P2|NOT COMPLETED|Overall Study||5
1011362|NCT00566722|2456525|P1|NOT COMPLETED|Overall Study||2
1011363|NCT00566722|2456523|P3|COMPLETED|Overall Study||73
1011364|NCT00566722|2456524|P2|COMPLETED|Overall Study||24
1011365|NCT00566722|2456525|P1|COMPLETED|Overall Study||39
1011366|NCT00566722|2456523|P3|STARTED|Overall Study||82
1011367|NCT00566722|2456524|P2|STARTED|Overall Study||29
1011368|NCT00566722|2456525|P1|STARTED|Overall Study||41
1011369|NCT00566735|2456571|P2|NOT COMPLETED|Overall Study||7
1011370|NCT00566735|2456572|P1|NOT COMPLETED|Overall Study||2
1011371|NCT00566735|2456571|P2|COMPLETED|Overall Study|7 participants withdrew before baselines. Therefore, 12 participants will be included in baselines.|12
1011372|NCT00566735|2456572|P1|COMPLETED|Overall Study|2 participants withdrew before baselines. Therefore, 18 participants will be included in baselines.|18
1011373|NCT00566735|2456571|P2|Withdrew Before Baseline Measures|Overall Study||7
1011374|NCT00566735|2456572|P1|Withdrew Before Baseline Measures|Overall Study||2
1011375|NCT00566735|2456571|P2|STARTED|Overall Study||19
1011376|NCT00566735|2456572|P1|STARTED|Overall Study||20
1011377|NCT00566852|2456584|P2|NOT COMPLETED|Overall Study||198
1011378|NCT00566852|2456585|P1|NOT COMPLETED|Overall Study||207
1011379|NCT00566852|2456584|P2|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|78
1011380|NCT00566852|2456585|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|71
1011381|NCT00566852|2456584|P2|STARTED|Overall Study||276
1011382|NCT00566852|2456585|P1|STARTED|Overall Study||278
1011383|NCT00566930|2456604|P3|NOT COMPLETED|Overall Study||1
1011384|NCT00566930|2456605|P2|NOT COMPLETED|Overall Study||4
1011385|NCT00566930|2456606|P1|NOT COMPLETED|Overall Study||2
1011386|NCT00566930|2456604|P3|COMPLETED|Overall Study||32
1011387|NCT00566930|2456605|P2|COMPLETED|Overall Study||32
1011388|NCT00566930|2456606|P1|COMPLETED|Overall Study||27
1011389|NCT00566930|2456604|P3|STARTED|Overall Study||33
1011390|NCT00566930|2456605|P2|STARTED|Overall Study||36
1011391|NCT00566930|2456606|P1|STARTED|Overall Study||29
1011392|NCT00566943|2456616|P2|NOT COMPLETED|Overall Study||0
1011393|NCT00566943|2456617|P1|NOT COMPLETED|Overall Study||0
1011394|NCT00566943|2456616|P2|COMPLETED|Overall Study||49
1011395|NCT00566943|2456617|P1|COMPLETED|Overall Study||52
1011396|NCT00566943|2456616|P2|STARTED|Overall Study||49
1011397|NCT00566943|2456617|P1|STARTED|Overall Study||52
1011398|NCT00566969|2456632|P3|NOT COMPLETED|Overall Study||12
1011399|NCT00566969|2456633|P2|NOT COMPLETED|Overall Study||9
1011400|NCT00566969|2456634|P1|NOT COMPLETED|Overall Study||15
1011401|NCT00566969|2456632|P3|COMPLETED|Overall Study||23
1011402|NCT00566969|2456633|P2|COMPLETED|Overall Study||28
1011403|NCT00566969|2456634|P1|COMPLETED|Overall Study||19
1011404|NCT00566969|2456632|P3|STARTED|Overall Study||35
1011405|NCT00566969|2456633|P2|STARTED|Overall Study||37
1011406|NCT00566969|2456634|P1|STARTED|Overall Study||34
1011407|NCT00566982|2456644|P2|NOT COMPLETED|Overall Study||69
1011408|NCT00566982|2456645|P1|NOT COMPLETED|Overall Study||8
1011409|NCT00566982|2456644|P2|COMPLETED|Overall Study||294
1011410|NCT00566982|2456645|P1|COMPLETED|Overall Study||55
1011411|NCT00566982|2456644|P2|STARTED|Overall Study||363
1011412|NCT00566982|2456645|P1|STARTED|Overall Study||63
1011413|NCT00566995|2456667|P1|NOT COMPLETED|Overall Study||8
1011414|NCT00566995|2456667|P1|COMPLETED|Overall Study||29
1011415|NCT00566995|2456667|P1|STARTED|Overall Study||37
1011416|NCT00567008|2456674|P2|NOT COMPLETED|Overall Study||1
1011417|NCT00567008|2456675|P1|NOT COMPLETED|Overall Study||1
1011418|NCT00567008|2456674|P2|COMPLETED|Overall Study||18
1011419|NCT00567008|2456675|P1|COMPLETED|Overall Study||17
1011420|NCT00567008|2456674|P2|STARTED|Overall Study||19
1011421|NCT00567008|2456675|P1|STARTED|Overall Study||18
1011422|NCT00567112|2456681|P3|NOT COMPLETED|Treatment Period 4 (3 Days)||0
1011423|NCT00567112|2456682|P2|NOT COMPLETED|Treatment Period 4 (3 Days)||0
1011424|NCT00567112|2456683|P1|NOT COMPLETED|Treatment Period 4 (3 Days)||0
1011425|NCT00567112|2456681|P3|COMPLETED|Treatment Period 4 (3 Days)||3
1011426|NCT00567112|2456682|P2|COMPLETED|Treatment Period 4 (3 Days)||7
1011427|NCT00567112|2456683|P1|COMPLETED|Treatment Period 4 (3 Days)||4
1011428|NCT00567112|2456681|P3|STARTED|Treatment Period 4 (3 Days)||3
1011429|NCT00567112|2456682|P2|STARTED|Treatment Period 4 (3 Days)||7
1011430|NCT00567112|2456683|P1|STARTED|Treatment Period 4 (3 Days)||4
1011431|NCT00567112|2456681|P3|NOT COMPLETED|Washout Period 3 (3 Days)||0
1011432|NCT00567112|2456682|P2|NOT COMPLETED|Washout Period 3 (3 Days)||0
1011433|NCT00567112|2456683|P1|NOT COMPLETED|Washout Period 3 (3 Days)||3
1011434|NCT00567112|2456681|P3|COMPLETED|Washout Period 3 (3 Days)||3
1011435|NCT00567112|2456682|P2|COMPLETED|Washout Period 3 (3 Days)||7
1011436|NCT00567112|2456683|P1|COMPLETED|Washout Period 3 (3 Days)||4
1011437|NCT00567112|2456681|P3|STARTED|Washout Period 3 (3 Days)||3
1011438|NCT00567112|2456682|P2|STARTED|Washout Period 3 (3 Days)||7
1011439|NCT00567112|2456683|P1|STARTED|Washout Period 3 (3 Days)||7
1011440|NCT00567112|2456681|P3|NOT COMPLETED|Treatment Period 3 (3 Days)||0
1011441|NCT00567112|2456682|P2|NOT COMPLETED|Treatment Period 3 (3 Days)||0
1011442|NCT00567112|2456683|P1|NOT COMPLETED|Treatment Period 3 (3 Days)||0
1011443|NCT00567112|2456681|P3|COMPLETED|Treatment Period 3 (3 Days)||3
1011444|NCT00567112|2456682|P2|COMPLETED|Treatment Period 3 (3 Days)||7
1011445|NCT00567112|2456683|P1|COMPLETED|Treatment Period 3 (3 Days)||7
1011446|NCT00567112|2456681|P3|STARTED|Treatment Period 3 (3 Days)||3
1011447|NCT00567112|2456682|P2|STARTED|Treatment Period 3 (3 Days)||7
1011448|NCT00567112|2456683|P1|STARTED|Treatment Period 3 (3 Days)||7
1011449|NCT00567112|2456681|P3|NOT COMPLETED|Washout Period 2 (3 Days)||0
1011450|NCT00567112|2456682|P2|NOT COMPLETED|Washout Period 2 (3 Days)||0
1011451|NCT00567112|2456683|P1|NOT COMPLETED|Washout Period 2 (3 Days)||0
1011452|NCT00567112|2456681|P3|COMPLETED|Washout Period 2 (3 Days)||3
1011453|NCT00567112|2456682|P2|COMPLETED|Washout Period 2 (3 Days)||7
1011454|NCT00567112|2456683|P1|COMPLETED|Washout Period 2 (3 Days)||7
1011455|NCT00567112|2456681|P3|STARTED|Washout Period 2 (3 Days)||3
1011456|NCT00567112|2456682|P2|STARTED|Washout Period 2 (3 Days)||7
1011457|NCT00567112|2456683|P1|STARTED|Washout Period 2 (3 Days)||7
1011458|NCT00567112|2456681|P3|NOT COMPLETED|Treatment Period 2 (3 Days)||0
1011459|NCT00567112|2456682|P2|NOT COMPLETED|Treatment Period 2 (3 Days)||1
1011460|NCT00567112|2456683|P1|NOT COMPLETED|Treatment Period 2 (3 Days)||0
1011461|NCT00567112|2456681|P3|COMPLETED|Treatment Period 2 (3 Days)||3
1011462|NCT00567112|2456682|P2|COMPLETED|Treatment Period 2 (3 Days)||7
1011463|NCT00567112|2456683|P1|COMPLETED|Treatment Period 2 (3 Days)||7
1011464|NCT00567112|2456681|P3|STARTED|Treatment Period 2 (3 Days)|3 new participants added to Treatment Group ABCD & received treatment sequence BCD for Periods 2-4|3
1011465|NCT00567112|2456682|P2|STARTED|Treatment Period 2 (3 Days)||8
1011466|NCT00567112|2456683|P1|STARTED|Treatment Period 2 (3 Days)||7
1011467|NCT00567112|2456681|P3|NOT COMPLETED|Washout Period 1 (3 Days)||0
1011468|NCT00567112|2456682|P2|NOT COMPLETED|Washout Period 1 (3 Days)||0
1011469|NCT00567112|2456683|P1|NOT COMPLETED|Washout Period 1 (3 Days)||0
1011470|NCT00567112|2456681|P3|COMPLETED|Washout Period 1 (3 Days)||0
1011471|NCT00567112|2456682|P2|COMPLETED|Washout Period 1 (3 Days)||8
1011472|NCT00567112|2456683|P1|COMPLETED|Washout Period 1 (3 Days)||7
1011473|NCT00567112|2456681|P3|STARTED|Washout Period 1 (3 Days)||0
1011474|NCT00567112|2456682|P2|STARTED|Washout Period 1 (3 Days)||8
1011475|NCT00567112|2456683|P1|STARTED|Washout Period 1 (3 Days)||7
1011476|NCT00567112|2456681|P3|NOT COMPLETED|Treatment Period 1 (3 Days)||0
1011477|NCT00567112|2456682|P2|NOT COMPLETED|Treatment Period 1 (3 Days)||0
1011478|NCT00567112|2456683|P1|NOT COMPLETED|Treatment Period 1 (3 Days)||0
1011479|NCT00567112|2456681|P3|COMPLETED|Treatment Period 1 (3 Days)||0
1011480|NCT00567112|2456682|P2|COMPLETED|Treatment Period 1 (3 Days)||8
1011481|NCT00567112|2456683|P1|COMPLETED|Treatment Period 1 (3 Days)||7
1011482|NCT00567112|2456681|P3|STARTED|Treatment Period 1 (3 Days)||0
1011483|NCT00567112|2456682|P2|STARTED|Treatment Period 1 (3 Days)||8
1011484|NCT00567112|2456683|P1|STARTED|Treatment Period 1 (3 Days)||7
1011485|NCT00567164|2456708|P3|NOT COMPLETED|Overall Study||72
1011486|NCT00567164|2456709|P2|NOT COMPLETED|Overall Study||73
1011487|NCT00567164|2456710|P1|NOT COMPLETED|Overall Study||546
1011488|NCT00567164|2456708|P3|COMPLETED|Overall Study||160
1011489|NCT00567164|2456709|P2|COMPLETED|Overall Study||161
1011490|NCT00567164|2456710|P1|COMPLETED|Overall Study||875
1011491|NCT00567164|2456708|P3|Subjects Received Treatment|Overall Study|Full Analysis Set|226
1011492|NCT00567164|2456709|P2|Subjects Received Treatment|Overall Study|Full Analysis Set|232
1011493|NCT00567164|2456710|P1|Subjects Received Treatment|Overall Study|Full Analysis Set|1406
1011494|NCT00567164|2456708|P3|STARTED|Overall Study||232
1011495|NCT00567164|2456709|P2|STARTED|Overall Study||234
1011496|NCT00567164|2456710|P1|STARTED|Overall Study||1421
1011497|NCT00567190|2456784|P2|NOT COMPLETED|Overall Study||264
1011498|NCT00567190|2456785|P1|NOT COMPLETED|Overall Study||210
1011499|NCT00567190|2456784|P2|COMPLETED|Overall Study|On 11 February 2014, 37 were alive and on study treatment; 105 were alive and in survival follow-up|142
1011500|NCT00567190|2456785|P1|COMPLETED|Overall Study|On 11 February 2014, 67 were alive and on study treatment; 125 were alive and in survival follow-up|192
1011501|NCT00567190|2456784|P2|STARTED|Overall Study|All randomized patients (Intent-to-Treat [ITT]) population|406
1011502|NCT00567190|2456785|P1|STARTED|Overall Study|All randomized patients (Intent-to-Treat [ITT]) population|402
1011503|NCT00567229|2456802|P1|NOT COMPLETED|Overall Study||0
1011504|NCT00567229|2456802|P1|COMPLETED|Overall Study||3
1011505|NCT00567229|2456802|P1|STARTED|Overall Study||3
1011506|NCT00567242|2456808|P2|NOT COMPLETED|Overall Study||0
1011507|NCT00567242|2456809|P1|NOT COMPLETED|Overall Study||0
1011508|NCT00567242|2456808|P2|COMPLETED|Overall Study||7
1011509|NCT00567242|2456809|P1|COMPLETED|Overall Study||7
1011510|NCT00567242|2456808|P2|STARTED|Overall Study||7
1011511|NCT00567242|2456809|P1|STARTED|Overall Study||7
1011512|NCT00567255|2456821|P2|NOT COMPLETED|Overall Study||228
1011513|NCT00567255|2456822|P1|NOT COMPLETED|Overall Study||463
1011514|NCT00567255|2456821|P2|COMPLETED|Overall Study||267
1011515|NCT00567255|2456822|P1|COMPLETED|Overall Study||538
1011516|NCT00567255|2456821|P2|STARTED|Overall Study||495
1011517|NCT00567255|2456822|P1|STARTED|Overall Study||1001
1011518|NCT00567268|2456866|P1|NOT COMPLETED|Overall Study||50
1011519|NCT00567268|2456866|P1|COMPLETED|Overall Study||1144
1011520|NCT00567268|2456866|P1|STARTED|Overall Study||1194
1011521|NCT00567307|2456917|P2|NOT COMPLETED|Overall Study||1
1011522|NCT00567307|2456918|P1|NOT COMPLETED|Overall Study||12
1011523|NCT00567307|2456917|P2|COMPLETED|Overall Study||104
1011524|NCT00567307|2456918|P1|COMPLETED|Overall Study||99
1011525|NCT00567307|2456917|P2|STARTED|Overall Study||105
1011526|NCT00567307|2456918|P1|STARTED|Overall Study||111
1011527|NCT00567320|2456926|P2|NOT COMPLETED|Overall Study||0
1011528|NCT00567320|2456927|P1|NOT COMPLETED|Overall Study||0
1011529|NCT00567320|2456926|P2|COMPLETED|Overall Study||18
1011530|NCT00567320|2456927|P1|COMPLETED|Overall Study||13
1011531|NCT00567320|2456926|P2|STARTED|Overall Study||18
1011532|NCT00567320|2456927|P1|STARTED|Overall Study||13
1011533|NCT00567476|2456935|P2|NOT COMPLETED|Overall Study||4
1011534|NCT00567476|2456936|P1|NOT COMPLETED|Overall Study||8
1011535|NCT00567476|2456935|P2|COMPLETED|Overall Study||34
1011536|NCT00567476|2456936|P1|COMPLETED|Overall Study||70
1011537|NCT00567476|2456935|P2|STARTED|Overall Study||38
1011538|NCT00567476|2456936|P1|STARTED|Overall Study||78
1011539|NCT00567502|2456964|P4|NOT COMPLETED|Overall Study||87
1011540|NCT00567502|2456965|P3|NOT COMPLETED|Overall Study||908
1011541|NCT00567502|2456966|P2|NOT COMPLETED|Overall Study||33
1011542|NCT00567502|2456967|P1|NOT COMPLETED|Overall Study||241
1011543|NCT00567502|2456964|P4|COMPLETED|Overall Study||23
1011544|NCT00567502|2456965|P3|COMPLETED|Overall Study||1758
1011545|NCT00567502|2456966|P2|COMPLETED|Overall Study||108
1011546|NCT00567502|2456967|P1|COMPLETED|Overall Study||563
1011547|NCT00567502|2456964|P4|Initiated Treatment|Overall Study||38
1011548|NCT00567502|2456965|P3|Initiated Treatment|Overall Study||2666
1011549|NCT00567502|2456966|P2|Initiated Treatment|Overall Study||141
1011550|NCT00567502|2456967|P1|Initiated Treatment|Overall Study||804
1011551|NCT00567502|2456964|P4|STARTED|Overall Study||110
1011552|NCT00567502|2456965|P3|STARTED|Overall Study||2666
1011553|NCT00567502|2456966|P2|STARTED|Overall Study||141
1011554|NCT00567502|2456967|P1|STARTED|Overall Study||804
1011555|NCT00567541|2457004|P2|NOT COMPLETED|Overall Study||1
1011556|NCT00567541|2457005|P1|NOT COMPLETED|Overall Study||0
1011557|NCT00567541|2457004|P2|COMPLETED|Overall Study||8
1011558|NCT00567541|2457005|P1|COMPLETED|Overall Study||7
1011559|NCT00567541|2457004|P2|STARTED|Overall Study||9
1011560|NCT00567541|2457005|P1|STARTED|Overall Study||7
1011561|NCT00567567|2457014|P3|NOT COMPLETED|Overall Study||278
1011562|NCT00567567|2457015|P2|NOT COMPLETED|Overall Study||134
1011563|NCT00567567|2457016|P1|NOT COMPLETED|Overall Study||152
1011564|NCT00567567|2457014|P3|COMPLETED|Overall Study||1
1011565|NCT00567567|2457015|P2|COMPLETED|Overall Study||42
1011566|NCT00567567|2457016|P1|COMPLETED|Overall Study||58
1011567|NCT00567567|2457014|P3|STARTED|Overall Study||279
1011568|NCT00567567|2457015|P2|STARTED|Overall Study||176
1011569|NCT00567567|2457016|P1|STARTED|Overall Study||210
1011570|NCT00567593|2457040|P1|NOT COMPLETED|Overall Study||2
1011571|NCT00567593|2457040|P1|COMPLETED|Overall Study||10
1011572|NCT00567593|2457040|P1|STARTED|Overall Study||12
1011573|NCT00573755|2457046|P2|NOT COMPLETED|Overall Study||0
1011574|NCT00573755|2457047|P1|NOT COMPLETED|Overall Study||1
1011575|NCT00573755|2457046|P2|COMPLETED|Overall Study||2
1011576|NCT00573755|2457047|P1|COMPLETED|Overall Study||1
1011577|NCT00573755|2457046|P2|STARTED|Overall Study||2
1011578|NCT00573755|2457047|P1|STARTED|Overall Study||2
1011579|NCT00573768|2457066|P3|NOT COMPLETED|Overall Study||4
1011580|NCT00573768|2457067|P2|NOT COMPLETED|Overall Study||2
1011581|NCT00573768|2457068|P1|NOT COMPLETED|Overall Study||2
1011582|NCT00573768|2457066|P3|COMPLETED|Overall Study||87
1011583|NCT00573768|2457067|P2|COMPLETED|Overall Study||89
1011584|NCT00573768|2457068|P1|COMPLETED|Overall Study||87
1011585|NCT00573768|2457066|P3|STARTED|Overall Study||91
1011586|NCT00573768|2457067|P2|STARTED|Overall Study||91
1011587|NCT00573768|2457068|P1|STARTED|Overall Study||89
1011588|NCT00573859|2457076|P1|NOT COMPLETED|Smoking Versus Abstinence||12
1011589|NCT00573859|2457076|P1|COMPLETED|Smoking Versus Abstinence||15
1011590|NCT00573859|2457076|P1|STARTED|Smoking Versus Abstinence||27
1011591|NCT00573859|2457076|P1|NOT COMPLETED|Medication Versus Placebo||12
1011592|NCT00573859|2457076|P1|COMPLETED|Medication Versus Placebo||15
1011593|NCT00573859|2457076|P1|STARTED|Medication Versus Placebo||27
1011594|NCT00573937|2457084|P2|NOT COMPLETED|Overall Study||1
1011595|NCT00573937|2457085|P1|NOT COMPLETED|Overall Study||0
1011596|NCT00573937|2457084|P2|COMPLETED|Overall Study||0
1011597|NCT00573937|2457085|P1|COMPLETED|Overall Study||0
1011598|NCT00573937|2457084|P2|STARTED|Overall Study||1
1011599|NCT00573937|2457085|P1|STARTED|Overall Study||0
1011600|NCT00575367|2457095|P2|NOT COMPLETED|Overall Study||0
1011601|NCT00575367|2457096|P1|NOT COMPLETED|Overall Study||0
1011602|NCT00575367|2457095|P2|COMPLETED|Overall Study||18
1011603|NCT00575367|2457096|P1|COMPLETED|Overall Study||19
1011604|NCT00575367|2457095|P2|STARTED|Overall Study||18
1011605|NCT00575367|2457096|P1|STARTED|Overall Study||19
1011606|NCT00575380|2457104|P2|NOT COMPLETED|Overall Study||3
1011607|NCT00575380|2457105|P1|NOT COMPLETED|Overall Study||1
1011608|NCT00575380|2457104|P2|COMPLETED|Overall Study||55
1011609|NCT00575380|2457105|P1|COMPLETED|Overall Study||57
1011610|NCT00575380|2457104|P2|STARTED|Overall Study||58
1011611|NCT00575380|2457105|P1|STARTED|Overall Study||58
1011612|NCT00575510|2457116|P3|NOT COMPLETED|Overall Study||17
1011613|NCT00575510|2457117|P2|NOT COMPLETED|Overall Study||13
1011614|NCT00575510|2457118|P1|NOT COMPLETED|Overall Study||12
1011615|NCT00575510|2457116|P3|COMPLETED|Overall Study||96
1011616|NCT00575510|2457117|P2|COMPLETED|Overall Study||101
1011617|NCT00575510|2457118|P1|COMPLETED|Overall Study||102
1011618|NCT00575510|2457116|P3|STARTED|Overall Study||113
1011619|NCT00575510|2457117|P2|STARTED|Overall Study||114
1011620|NCT00575510|2457118|P1|STARTED|Overall Study||114
1011621|NCT00575588|2457131|P2|NOT COMPLETED|Overall Study||283
1011622|NCT00575588|2457132|P1|NOT COMPLETED|Overall Study||263
1011623|NCT00575588|2457131|P2|COMPLETED|Overall Study|Completed 104 weeks of treatment|147
1011624|NCT00575588|2457132|P1|COMPLETED|Overall Study|Completed 104 weeks of treatment|165
1011625|NCT00575588|2457131|P2|STARTED|Overall Study|Randomized and treated|430
1011626|NCT00575588|2457132|P1|STARTED|Overall Study|Randomized and treated|428
1011627|NCT00575666|2457154|P2|NOT COMPLETED|Overall Study||3
1011628|NCT00575666|2457155|P1|NOT COMPLETED|Overall Study||4
1011629|NCT00575666|2457154|P2|COMPLETED|Overall Study||21
1011630|NCT00575666|2457155|P1|COMPLETED|Overall Study||17
1011631|NCT00575666|2457154|P2|STARTED|Overall Study||24
1011632|NCT00575666|2457155|P1|STARTED|Overall Study||21
1011633|NCT00575887|2457193|P1|NOT COMPLETED|Overall Study||0
1011634|NCT00575887|2457193|P1|COMPLETED|Overall Study||25
1011635|NCT00575887|2457193|P1|STARTED|Overall Study||25
1011636|NCT00575965|2457197|P1|NOT COMPLETED|Overall Study||0
1011637|NCT00575965|2457197|P1|COMPLETED|Overall Study||18
1011638|NCT00575965|2457197|P1|STARTED|Overall Study||18
1011639|NCT00576056|2457202|P1|NOT COMPLETED|Overall Study||14
1011640|NCT00576056|2457202|P1|COMPLETED|Overall Study||5
1011641|NCT00576056|2457202|P1|STARTED|Overall Study||19
1011642|NCT00576147|2457207|P1|NOT COMPLETED|Overall Study||0
1011643|NCT00576147|2457207|P1|COMPLETED|Overall Study||431
1011644|NCT00576147|2457207|P1|STARTED|Overall Study||431
1011645|NCT00576199|2457211|P1|NOT COMPLETED|Overall Study||30
1011646|NCT00576199|2457211|P1|COMPLETED|Overall Study||0
1011647|NCT00576199|2457211|P1|STARTED|Overall Study||30
1011648|NCT00576251|2457222|P2|NOT COMPLETED|Overall Study||1
1011649|NCT00576251|2457223|P1|NOT COMPLETED|Overall Study||1
1011650|NCT00576251|2457222|P2|COMPLETED|Overall Study||111
1011651|NCT00576251|2457223|P1|COMPLETED|Overall Study||108
1011652|NCT00576251|2457222|P2|STARTED|Overall Study||112
1011653|NCT00576251|2457223|P1|STARTED|Overall Study||109
1011654|NCT00576303|2457229|P1|NOT COMPLETED|Long Term Safety Period||16
1011655|NCT00576303|2457229|P1|COMPLETED|Long Term Safety Period||162
1011656|NCT00576303|2457229|P1|STARTED|Long Term Safety Period||178
1011657|NCT00576303|2457229|P1|NOT COMPLETED|Efficacy Evaluation Period||5
1011658|NCT00576303|2457229|P1|COMPLETED|Efficacy Evaluation Period||178
1011659|NCT00576303|2457229|P1|STARTED|Efficacy Evaluation Period||183
1011660|NCT00576303|2457229|P1|NOT COMPLETED|Dose Titration Period||17
1011661|NCT00576303|2457229|P1|COMPLETED|Dose Titration Period||183
1011662|NCT00576303|2457229|P1|STARTED|Dose Titration Period||200
1011663|NCT00576316|2457238|P1|NOT COMPLETED|Overall Study||20
1011664|NCT00576316|2457238|P1|COMPLETED|Overall Study|Number of patients who completed study|181
1011665|NCT00576316|2457238|P1|STARTED|Overall Study|Number of patients recruited|201
1011666|NCT00576381|2457243|P1|NOT COMPLETED|Overall Study||7
1011667|NCT00576381|2457243|P1|COMPLETED|Overall Study||23
1011668|NCT00576381|2457243|P1|STARTED|Overall Study||30
1011669|NCT00576420|2457250|P3|NOT COMPLETED|Overall Study||1
1011670|NCT00576420|2457251|P2|NOT COMPLETED|Overall Study||0
1011671|NCT00576420|2457252|P1|NOT COMPLETED|Overall Study||0
1011672|NCT00576420|2457250|P3|COMPLETED|Overall Study||22
1011673|NCT00576420|2457251|P2|COMPLETED|Overall Study||24
1011674|NCT00576420|2457252|P1|COMPLETED|Overall Study||26
1011675|NCT00576420|2457250|P3|STARTED|Overall Study||23
1011676|NCT00576420|2457251|P2|STARTED|Overall Study||24
1011677|NCT00576420|2457252|P1|STARTED|Overall Study||26
1011678|NCT00576472|2457432|P15|NOT COMPLETED|MPH Home Maintenance Phase||23
1011679|NCT00576472|2457433|P14|NOT COMPLETED|MPH Home Maintenance Phase||27
1011680|NCT00576472|2457434|P13|NOT COMPLETED|MPH Home Maintenance Phase||0
1011681|NCT00576472|2457435|P12|NOT COMPLETED|MPH Home Maintenance Phase||0
1011682|NCT00576472|2457436|P11|NOT COMPLETED|MPH Home Maintenance Phase||0
1011683|NCT00576472|2457437|P10|NOT COMPLETED|MPH Home Maintenance Phase||0
1011684|NCT00576472|2457438|P9|NOT COMPLETED|MPH Home Maintenance Phase||0
1011685|NCT00576472|2457439|P8|NOT COMPLETED|MPH Home Maintenance Phase||0
1011686|NCT00576472|2457440|P7|NOT COMPLETED|MPH Home Maintenance Phase||0
1011687|NCT00576472|2457441|P6|NOT COMPLETED|MPH Home Maintenance Phase||0
1011688|NCT00576472|2457442|P5|NOT COMPLETED|MPH Home Maintenance Phase||0
1011689|NCT00576472|2457443|P4|NOT COMPLETED|MPH Home Maintenance Phase||0
1011690|NCT00576472|2457444|P3|NOT COMPLETED|MPH Home Maintenance Phase||0
1011691|NCT00576472|2457445|P2|NOT COMPLETED|MPH Home Maintenance Phase||0
1011692|NCT00576472|2457446|P1|NOT COMPLETED|MPH Home Maintenance Phase||0
1011693|NCT00576472|2457432|P15|COMPLETED|MPH Home Maintenance Phase||68
1011694|NCT00576472|2457433|P14|COMPLETED|MPH Home Maintenance Phase||0
1011695|NCT00576472|2457434|P13|COMPLETED|MPH Home Maintenance Phase||0
1011696|NCT00576472|2457435|P12|COMPLETED|MPH Home Maintenance Phase||0
1011697|NCT00576472|2457436|P11|COMPLETED|MPH Home Maintenance Phase||0
1011698|NCT00576472|2457437|P10|COMPLETED|MPH Home Maintenance Phase||0
1011699|NCT00576472|2457438|P9|COMPLETED|MPH Home Maintenance Phase||0
1011700|NCT00576472|2457439|P8|COMPLETED|MPH Home Maintenance Phase||0
1011701|NCT00576472|2457440|P7|COMPLETED|MPH Home Maintenance Phase||0
1011702|NCT00576472|2457441|P6|COMPLETED|MPH Home Maintenance Phase||0
1011703|NCT00576472|2457442|P5|COMPLETED|MPH Home Maintenance Phase||0
1011704|NCT00576472|2457443|P4|COMPLETED|MPH Home Maintenance Phase||0
1011705|NCT00576472|2457444|P3|COMPLETED|MPH Home Maintenance Phase||0
1011706|NCT00576472|2457445|P2|COMPLETED|MPH Home Maintenance Phase||0
1011707|NCT00576472|2457446|P1|COMPLETED|MPH Home Maintenance Phase||0
1011708|NCT00576472|2457432|P15|STARTED|MPH Home Maintenance Phase||91
1011709|NCT00576472|2457433|P14|STARTED|MPH Home Maintenance Phase||27
1011710|NCT00576472|2457434|P13|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1011711|NCT00576472|2457435|P12|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1011712|NCT00576472|2457436|P11|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1011713|NCT00576472|2457437|P10|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1011714|NCT00576472|2457438|P9|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1011715|NCT00576472|2457439|P8|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1011716|NCT00576472|2457440|P7|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1011717|NCT00576472|2457441|P6|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1011718|NCT00576472|2457442|P5|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1011719|NCT00576472|2457443|P4|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1011720|NCT00576472|2457444|P3|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1011721|NCT00576472|2457445|P2|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1011722|NCT00576472|2457446|P1|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
1011723|NCT00576472|2457432|P15|NOT COMPLETED|MPH Cross Over Phase||0
1011724|NCT00576472|2457433|P14|NOT COMPLETED|MPH Cross Over Phase||0
1011725|NCT00576472|2457434|P13|NOT COMPLETED|MPH Cross Over Phase||0
1011726|NCT00576472|2457435|P12|NOT COMPLETED|MPH Cross Over Phase||1
1011727|NCT00576472|2457436|P11|NOT COMPLETED|MPH Cross Over Phase||1
1011728|NCT00576472|2457437|P10|NOT COMPLETED|MPH Cross Over Phase||0
1011729|NCT00576472|2457438|P9|NOT COMPLETED|MPH Cross Over Phase||2
1011730|NCT00576472|2457439|P8|NOT COMPLETED|MPH Cross Over Phase||0
1011731|NCT00576472|2457440|P7|NOT COMPLETED|MPH Cross Over Phase||12
1011732|NCT00576472|2457441|P6|NOT COMPLETED|MPH Cross Over Phase||0
1011733|NCT00576472|2457442|P5|NOT COMPLETED|MPH Cross Over Phase||0
1011734|NCT00576472|2457443|P4|NOT COMPLETED|MPH Cross Over Phase||0
1011735|NCT00576472|2457444|P3|NOT COMPLETED|MPH Cross Over Phase||0
1011736|NCT00576472|2457445|P2|NOT COMPLETED|MPH Cross Over Phase||0
1011737|NCT00576472|2457446|P1|NOT COMPLETED|MPH Cross Over Phase||0
1011738|NCT00576472|2457432|P15|COMPLETED|MPH Cross Over Phase||0
1011739|NCT00576472|2457433|P14|COMPLETED|MPH Cross Over Phase||0
1011740|NCT00576472|2457434|P13|COMPLETED|MPH Cross Over Phase||21
1011741|NCT00576472|2457435|P12|COMPLETED|MPH Cross Over Phase||17
1011742|NCT00576472|2457436|P11|COMPLETED|MPH Cross Over Phase||22
1011743|NCT00576472|2457437|P10|COMPLETED|MPH Cross Over Phase||22
1011744|NCT00576472|2457438|P9|COMPLETED|MPH Cross Over Phase||16
1011745|NCT00576472|2457439|P8|COMPLETED|MPH Cross Over Phase||20
1011746|NCT00576472|2457440|P7|COMPLETED|MPH Cross Over Phase||0
1011747|NCT00576472|2457441|P6|COMPLETED|MPH Cross Over Phase||0
1011748|NCT00576472|2457442|P5|COMPLETED|MPH Cross Over Phase||0
1011749|NCT00576472|2457443|P4|COMPLETED|MPH Cross Over Phase||0
1011750|NCT00576472|2457444|P3|COMPLETED|MPH Cross Over Phase||0
1011751|NCT00576472|2457445|P2|COMPLETED|MPH Cross Over Phase||0
1011752|NCT00576472|2457446|P1|COMPLETED|MPH Cross Over Phase||0
1011753|NCT00576472|2457432|P15|STARTED|MPH Cross Over Phase||0
1011754|NCT00576472|2457433|P14|STARTED|MPH Cross Over Phase||0
1011755|NCT00576472|2457434|P13|STARTED|MPH Cross Over Phase||21
1011756|NCT00576472|2457435|P12|STARTED|MPH Cross Over Phase||18
1011757|NCT00576472|2457436|P11|STARTED|MPH Cross Over Phase||23
1011758|NCT00576472|2457437|P10|STARTED|MPH Cross Over Phase||22
1011759|NCT00576472|2457438|P9|STARTED|MPH Cross Over Phase||18
1011760|NCT00576472|2457439|P8|STARTED|MPH Cross Over Phase||20
1011761|NCT00576472|2457440|P7|STARTED|MPH Cross Over Phase||12
1011762|NCT00576472|2457441|P6|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
1011763|NCT00576472|2457442|P5|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
1011764|NCT00576472|2457443|P4|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
1011765|NCT00576472|2457444|P3|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
1011766|NCT00576472|2457445|P2|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
1011767|NCT00576472|2457446|P1|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
1011768|NCT00576472|2457432|P15|NOT COMPLETED|MPH In-Lab Phase||0
1011769|NCT00576472|2457433|P14|NOT COMPLETED|MPH In-Lab Phase||0
1011770|NCT00576472|2457434|P13|NOT COMPLETED|MPH In-Lab Phase||0
1011771|NCT00576472|2457435|P12|NOT COMPLETED|MPH In-Lab Phase||0
1011772|NCT00576472|2457436|P11|NOT COMPLETED|MPH In-Lab Phase||0
1011773|NCT00576472|2457437|P10|NOT COMPLETED|MPH In-Lab Phase||0
1011774|NCT00576472|2457438|P9|NOT COMPLETED|MPH In-Lab Phase||0
1011775|NCT00576472|2457439|P8|NOT COMPLETED|MPH In-Lab Phase||0
1011776|NCT00576472|2457440|P7|NOT COMPLETED|MPH In-Lab Phase||0
1011777|NCT00576472|2457441|P6|NOT COMPLETED|MPH In-Lab Phase||0
1011778|NCT00576472|2457442|P5|NOT COMPLETED|MPH In-Lab Phase||0
1011779|NCT00576472|2457443|P4|NOT COMPLETED|MPH In-Lab Phase||335
1011780|NCT00576472|2457444|P3|NOT COMPLETED|MPH In-Lab Phase||0
1011781|NCT00576472|2457445|P2|NOT COMPLETED|MPH In-Lab Phase||0
1011782|NCT00576472|2457446|P1|NOT COMPLETED|MPH In-Lab Phase||0
1011783|NCT00576472|2457432|P15|COMPLETED|MPH In-Lab Phase||0
1011784|NCT00576472|2457433|P14|COMPLETED|MPH In-Lab Phase||0
1011785|NCT00576472|2457434|P13|COMPLETED|MPH In-Lab Phase||0
1011786|NCT00576472|2457435|P12|COMPLETED|MPH In-Lab Phase||0
1011787|NCT00576472|2457436|P11|COMPLETED|MPH In-Lab Phase||0
1011788|NCT00576472|2457437|P10|COMPLETED|MPH In-Lab Phase||0
1011789|NCT00576472|2457438|P9|COMPLETED|MPH In-Lab Phase||0
1011790|NCT00576472|2457439|P8|COMPLETED|MPH In-Lab Phase||0
1011791|NCT00576472|2457440|P7|COMPLETED|MPH In-Lab Phase||0
1011792|NCT00576472|2457441|P6|COMPLETED|MPH In-Lab Phase||67
1011793|NCT00576472|2457442|P5|COMPLETED|MPH In-Lab Phase||67
1011794|NCT00576472|2457443|P4|COMPLETED|MPH In-Lab Phase||0
1011795|NCT00576472|2457444|P3|COMPLETED|MPH In-Lab Phase||0
1011796|NCT00576472|2457445|P2|COMPLETED|MPH In-Lab Phase||0
1011797|NCT00576472|2457446|P1|COMPLETED|MPH In-Lab Phase||0
1011798|NCT00576472|2457432|P15|STARTED|MPH In-Lab Phase||0
1011799|NCT00576472|2457433|P14|STARTED|MPH In-Lab Phase||0
1011800|NCT00576472|2457434|P13|STARTED|MPH In-Lab Phase||0
1011801|NCT00576472|2457435|P12|STARTED|MPH In-Lab Phase||0
1011802|NCT00576472|2457436|P11|STARTED|MPH In-Lab Phase||0
1011803|NCT00576472|2457437|P10|STARTED|MPH In-Lab Phase||0
1011804|NCT00576472|2457438|P9|STARTED|MPH In-Lab Phase||0
1011805|NCT00576472|2457439|P8|STARTED|MPH In-Lab Phase||0
1011806|NCT00576472|2457440|P7|STARTED|MPH In-Lab Phase||0
1011807|NCT00576472|2457441|P6|STARTED|MPH In-Lab Phase||67
1011808|NCT00576472|2457442|P5|STARTED|MPH In-Lab Phase||67
1011809|NCT00576472|2457443|P4|STARTED|MPH In-Lab Phase||335
1011810|NCT00576472|2457444|P3|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
1011811|NCT00576472|2457445|P2|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
1011812|NCT00576472|2457446|P1|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
1011813|NCT00576472|2457432|P15|NOT COMPLETED|Initial Screening||0
1011814|NCT00576472|2457433|P14|NOT COMPLETED|Initial Screening||0
1011815|NCT00576472|2457434|P13|NOT COMPLETED|Initial Screening||0
1011816|NCT00576472|2457435|P12|NOT COMPLETED|Initial Screening||0
1011817|NCT00576472|2457436|P11|NOT COMPLETED|Initial Screening||0
1011818|NCT00576472|2457437|P10|NOT COMPLETED|Initial Screening||0
1011819|NCT00576472|2457438|P9|NOT COMPLETED|Initial Screening||0
1011820|NCT00576472|2457439|P8|NOT COMPLETED|Initial Screening||0
1011821|NCT00576472|2457440|P7|NOT COMPLETED|Initial Screening||0
1011822|NCT00576472|2457441|P6|NOT COMPLETED|Initial Screening||0
1011823|NCT00576472|2457442|P5|NOT COMPLETED|Initial Screening||0
1011824|NCT00576472|2457443|P4|NOT COMPLETED|Initial Screening||0
1011825|NCT00576472|2457444|P3|NOT COMPLETED|Initial Screening||0
1011826|NCT00576472|2457445|P2|NOT COMPLETED|Initial Screening||0
1011827|NCT00576472|2457446|P1|NOT COMPLETED|Initial Screening||0
1011828|NCT00576472|2457432|P15|COMPLETED|Initial Screening||0
1011829|NCT00576472|2457433|P14|COMPLETED|Initial Screening||0
1011830|NCT00576472|2457434|P13|COMPLETED|Initial Screening||0
1011831|NCT00576472|2457435|P12|COMPLETED|Initial Screening||0
1011832|NCT00576472|2457436|P11|COMPLETED|Initial Screening||0
1011833|NCT00576472|2457437|P10|COMPLETED|Initial Screening||0
1011834|NCT00576472|2457438|P9|COMPLETED|Initial Screening||0
1011835|NCT00576472|2457439|P8|COMPLETED|Initial Screening||0
1011836|NCT00576472|2457440|P7|COMPLETED|Initial Screening||0
1011837|NCT00576472|2457441|P6|COMPLETED|Initial Screening||0
1011838|NCT00576472|2457442|P5|COMPLETED|Initial Screening||0
1011839|NCT00576472|2457443|P4|COMPLETED|Initial Screening||0
1011840|NCT00576472|2457444|P3|COMPLETED|Initial Screening||199
1011841|NCT00576472|2457445|P2|COMPLETED|Initial Screening||40
1011842|NCT00576472|2457446|P1|COMPLETED|Initial Screening||230
1011843|NCT00576472|2457432|P15|STARTED|Initial Screening||0
1011844|NCT00576472|2457433|P14|STARTED|Initial Screening||0
1011845|NCT00576472|2457434|P13|STARTED|Initial Screening||0
1011846|NCT00576472|2457435|P12|STARTED|Initial Screening||0
1011847|NCT00576472|2457436|P11|STARTED|Initial Screening||0
1011848|NCT00576472|2457437|P10|STARTED|Initial Screening||0
1011849|NCT00576472|2457438|P9|STARTED|Initial Screening||0
1011850|NCT00576472|2457439|P8|STARTED|Initial Screening||0
1011851|NCT00576472|2457440|P7|STARTED|Initial Screening||0
1011852|NCT00576472|2457441|P6|STARTED|Initial Screening||0
1011853|NCT00576472|2457442|P5|STARTED|Initial Screening||0
1011854|NCT00576472|2457443|P4|STARTED|Initial Screening||0
1011855|NCT00576472|2457444|P3|STARTED|Initial Screening||199
1011856|NCT00576472|2457445|P2|STARTED|Initial Screening||40
1011857|NCT00576472|2457446|P1|STARTED|Initial Screening||230
1011858|NCT00576524|2457538|P2|NOT COMPLETED|Overall Study||0
1011859|NCT00576524|2457539|P1|NOT COMPLETED|Overall Study||0
1011860|NCT00576524|2457538|P2|COMPLETED|Overall Study||0
1011861|NCT00576524|2457539|P1|COMPLETED|Overall Study||2
1011862|NCT00576524|2457538|P2|STARTED|Overall Study||0
1011863|NCT00576524|2457539|P1|STARTED|Overall Study||2
1011864|NCT00576576|2457549|P1|NOT COMPLETED|Overall Study||7
1011865|NCT00576576|2457549|P1|COMPLETED|Overall Study||20
1011866|NCT00576576|2457549|P1|STARTED|Overall Study||27
1011867|NCT00576628|2457555|P1|NOT COMPLETED|Overall Study||43
1011868|NCT00576628|2457555|P1|COMPLETED|Overall Study||82
1011869|NCT00576628|2457555|P1|STARTED|Overall Study||125
1011870|NCT00576693|2457577|P2|NOT COMPLETED|Overall Study||24
1011871|NCT00576693|2457578|P1|NOT COMPLETED|Overall Study||10
1011872|NCT00576693|2457577|P2|COMPLETED|Overall Study||203
1011873|NCT00576693|2457578|P1|COMPLETED|Overall Study||214
1011874|NCT00576693|2457577|P2|STARTED|Overall Study||227
1011875|NCT00576693|2457578|P1|STARTED|Overall Study||224
1011876|NCT00576732|2457587|P6|NOT COMPLETED|OPEN LABEL||8
1011877|NCT00576732|2457588|P5|NOT COMPLETED|OPEN LABEL||4
1011878|NCT00576732|2457589|P4|NOT COMPLETED|OPEN LABEL||11
1011879|NCT00576732|2457590|P3|NOT COMPLETED|OPEN LABEL||0
1011880|NCT00576732|2457591|P2|NOT COMPLETED|OPEN LABEL||0
1011881|NCT00576732|2457592|P1|NOT COMPLETED|OPEN LABEL||0
1011882|NCT00576732|2457587|P6|COMPLETED|OPEN LABEL||17
1011883|NCT00576732|2457588|P5|COMPLETED|OPEN LABEL||20
1011884|NCT00576732|2457589|P4|COMPLETED|OPEN LABEL||19
1011885|NCT00576732|2457590|P3|COMPLETED|OPEN LABEL||0
1011886|NCT00576732|2457591|P2|COMPLETED|OPEN LABEL||0
1011887|NCT00576732|2457592|P1|COMPLETED|OPEN LABEL||0
1011888|NCT00576732|2457587|P6|STARTED|OPEN LABEL|All 25 double-blind RIS high dose completers and 0 RIS high dose non-completers entered open-label.|25
1011889|NCT00576732|2457588|P5|STARTED|OPEN LABEL|24 of 25 double-blind RIS low dose completers and 0 RIS low dose non-completers entered open-label.|24
1011890|NCT00576732|2457589|P4|STARTED|OPEN LABEL|26 of 27 double-blind placebo completers and 4 of 8 placebo non-completers entered open-label.|30
1011891|NCT00576732|2457590|P3|STARTED|OPEN LABEL||0
1011892|NCT00576732|2457591|P2|STARTED|OPEN LABEL||0
1011893|NCT00576732|2457592|P1|STARTED|OPEN LABEL||0
1011894|NCT00576732|2457587|P6|NOT COMPLETED|DOUBLE BLIND||0
1011895|NCT00576732|2457588|P5|NOT COMPLETED|DOUBLE BLIND||0
1011896|NCT00576732|2457589|P4|NOT COMPLETED|DOUBLE BLIND||0
1011897|NCT00576732|2457590|P3|NOT COMPLETED|DOUBLE BLIND||6
1011898|NCT00576732|2457591|P2|NOT COMPLETED|DOUBLE BLIND||5
1011899|NCT00576732|2457592|P1|NOT COMPLETED|DOUBLE BLIND||8
1011900|NCT00576732|2457587|P6|COMPLETED|DOUBLE BLIND||0
1011901|NCT00576732|2457588|P5|COMPLETED|DOUBLE BLIND||0
1011902|NCT00576732|2457589|P4|COMPLETED|DOUBLE BLIND||0
1011903|NCT00576732|2457590|P3|COMPLETED|DOUBLE BLIND||25
1011904|NCT00576732|2457591|P2|COMPLETED|DOUBLE BLIND||25
1011905|NCT00576732|2457592|P1|COMPLETED|DOUBLE BLIND||27
1011906|NCT00576732|2457587|P6|STARTED|DOUBLE BLIND||0
1011907|NCT00576732|2457588|P5|STARTED|DOUBLE BLIND||0
1011908|NCT00576732|2457589|P4|STARTED|DOUBLE BLIND||0
1011909|NCT00576732|2457590|P3|STARTED|DOUBLE BLIND||31
1011910|NCT00576732|2457591|P2|STARTED|DOUBLE BLIND||30
1011911|NCT00576732|2457592|P1|STARTED|DOUBLE BLIND||35
1011912|NCT00576758|2457624|P2|NOT COMPLETED|Follow-up Period||17
1011913|NCT00576758|2457625|P1|NOT COMPLETED|Follow-up Period||27
1011914|NCT00576758|2457624|P2|COMPLETED|Follow-up Period||34
1011915|NCT00576758|2457625|P1|COMPLETED|Follow-up Period||28
1011916|NCT00576758|2457624|P2|STARTED|Follow-up Period|Includes 21 pts who entered follow-up after induction and didn't enter the extended treatment phase.|51
1011917|NCT00576758|2457625|P1|STARTED|Follow-up Period|Includes 23 pts who entered follow-up after induction and didn't enter the extended treatment phase.|55
1011918|NCT00576758|2457624|P2|NOT COMPLETED|Extension Treatment Period||43
1011919|NCT00576758|2457625|P1|NOT COMPLETED|Extension Treatment Period||42
1011920|NCT00576758|2457624|P2|COMPLETED|Extension Treatment Period||30
1011921|NCT00576758|2457625|P1|COMPLETED|Extension Treatment Period|+ 2 patients (pts) who withdrew prior to receiving study drug.|30
1011922|NCT00576758|2457624|P2|STARTED|Extension Treatment Period|8 patients did not enter extended treatment phase/follow-up phase + 2 patients entered follow-up.|73
1011923|NCT00576758|2457625|P1|STARTED|Extension Treatment Period|6 patients did not enter extended treatment phase/follow-up + 1 patient entered follow-up.|72
1011924|NCT00576758|2457624|P2|NOT COMPLETED|Induction Treatment Period||5
1011925|NCT00576758|2457625|P1|NOT COMPLETED|Induction Treatment Period||8
1011926|NCT00576758|2457624|P2|COMPLETED|Induction Treatment Period||83
1011927|NCT00576758|2457625|P1|COMPLETED|Induction Treatment Period||79
1011928|NCT00576758|2457624|P2|Received Treatment|Induction Treatment Period||87
1011929|NCT00576758|2457625|P1|Received Treatment|Induction Treatment Period||86
1011930|NCT00576758|2457624|P2|STARTED|Induction Treatment Period||88
1011931|NCT00576758|2457625|P1|STARTED|Induction Treatment Period||87
1011932|NCT00576823|2457671|P3|NOT COMPLETED|40-week Safety Extension Phase||0
1011933|NCT00576823|2457672|P2|NOT COMPLETED|40-week Safety Extension Phase||0
1011934|NCT00576823|2457673|P1|NOT COMPLETED|40-week Safety Extension Phase||1
1011935|NCT00576823|2457671|P3|COMPLETED|40-week Safety Extension Phase||6
1011936|NCT00576823|2457672|P2|COMPLETED|40-week Safety Extension Phase||6
1011937|NCT00576823|2457673|P1|COMPLETED|40-week Safety Extension Phase||10
1011938|NCT00576823|2457671|P3|STARTED|40-week Safety Extension Phase|One patient refused to continue in the extension phase.|6
1011939|NCT00576823|2457672|P2|STARTED|40-week Safety Extension Phase||6
1011940|NCT00576823|2457673|P1|STARTED|40-week Safety Extension Phase||11
1011941|NCT00576823|2457671|P3|NOT COMPLETED|12-week Efficacy Phase||0
1011942|NCT00576823|2457672|P2|NOT COMPLETED|12-week Efficacy Phase||0
1011943|NCT00576823|2457673|P1|NOT COMPLETED|12-week Efficacy Phase||1
1011944|NCT00576823|2457671|P3|COMPLETED|12-week Efficacy Phase||7
1011945|NCT00576823|2457672|P2|COMPLETED|12-week Efficacy Phase||6
1011946|NCT00576823|2457673|P1|COMPLETED|12-week Efficacy Phase||11
1011947|NCT00576823|2457671|P3|STARTED|12-week Efficacy Phase||7
1011948|NCT00576823|2457672|P2|STARTED|12-week Efficacy Phase||6
1011949|NCT00576823|2457673|P1|STARTED|12-week Efficacy Phase||12
1011950|NCT00576901|2457687|P1|NOT COMPLETED|Overall Study||3
1011951|NCT00576901|2457687|P1|COMPLETED|Overall Study||20
1011952|NCT00576901|2457687|P1|STARTED|Overall Study||23
1011953|NCT00576927|2457697|P1|NOT COMPLETED|Randomization 1:1 Placebo or Active Drug||0
1011954|NCT00576927|2457697|P1|COMPLETED|Randomization 1:1 Placebo or Active Drug||22
1011955|NCT00576927|2457697|P1|STARTED|Randomization 1:1 Placebo or Active Drug||22
1011956|NCT00576927|2457697|P1|NOT COMPLETED|Sleep Hygiene With Study Drug||0
1011957|NCT00576927|2457697|P1|COMPLETED|Sleep Hygiene With Study Drug||22
1011958|NCT00576927|2457697|P1|STARTED|Sleep Hygiene With Study Drug||22
1011959|NCT00576927|2457697|P1|NOT COMPLETED|Sleep Hygiene With the Placebo||1
1011960|NCT00576927|2457697|P1|COMPLETED|Sleep Hygiene With the Placebo||22
1011961|NCT00576927|2457697|P1|STARTED|Sleep Hygiene With the Placebo||23
1011962|NCT00576927|2457697|P1|NOT COMPLETED|Sleep Hygiene Behavioral Intervention||7
1011963|NCT00576927|2457697|P1|COMPLETED|Sleep Hygiene Behavioral Intervention||23
1011964|NCT00576927|2457697|P1|STARTED|Sleep Hygiene Behavioral Intervention||30
1011965|NCT00576927|2457697|P1|NOT COMPLETED|Baseline||13
1011966|NCT00576927|2457697|P1|COMPLETED|Baseline||30
1011967|NCT00576927|2457697|P1|STARTED|Baseline||43
1011968|NCT00576927|2457697|P1|NOT COMPLETED|Clinical Assessment||36
1011969|NCT00576927|2457697|P1|COMPLETED|Clinical Assessment||43
1011970|NCT00576927|2457697|P1|STARTED|Clinical Assessment||79
1011971|NCT00577005|2457711|P2|NOT COMPLETED|Overall Study||3
1011972|NCT00577005|2457712|P1|NOT COMPLETED|Overall Study||5
1011973|NCT00577005|2457711|P2|COMPLETED|Overall Study||9
1011974|NCT00577005|2457712|P1|COMPLETED|Overall Study||11
1011975|NCT00577005|2457711|P2|STARTED|Overall Study||12
1011976|NCT00577005|2457712|P1|STARTED|Overall Study||16
1011977|NCT00577031|2457724|P1|NOT COMPLETED|Overall Study||205
1011978|NCT00577031|2457724|P1|COMPLETED|Overall Study||0
1011979|NCT00577031|2457724|P1|STARTED|Overall Study||205
1011980|NCT00577083|2457745|P2|NOT COMPLETED|Second Intervention (14days)||0
1011981|NCT00577083|2457746|P1|NOT COMPLETED|Second Intervention (14days)||0
1011982|NCT00577083|2457745|P2|COMPLETED|Second Intervention (14days)||52
1011983|NCT00577083|2457746|P1|COMPLETED|Second Intervention (14days)||48
1011984|NCT00577083|2457745|P2|STARTED|Second Intervention (14days)||52
1011985|NCT00577083|2457746|P1|STARTED|Second Intervention (14days)||48
1011986|NCT00577083|2457745|P2|NOT COMPLETED|Washout (14 Days)||0
1011987|NCT00577083|2457746|P1|NOT COMPLETED|Washout (14 Days)||0
1011988|NCT00577083|2457745|P2|COMPLETED|Washout (14 Days)||52
1011989|NCT00577083|2457746|P1|COMPLETED|Washout (14 Days)||48
1011990|NCT00577083|2457745|P2|STARTED|Washout (14 Days)||52
1011991|NCT00577083|2457746|P1|STARTED|Washout (14 Days)||48
1011992|NCT00577083|2457745|P2|NOT COMPLETED|First Intervention (14 Days)||0
1011993|NCT00577083|2457746|P1|NOT COMPLETED|First Intervention (14 Days)||0
1011994|NCT00577083|2457745|P2|COMPLETED|First Intervention (14 Days)||52
1011995|NCT00577083|2457746|P1|COMPLETED|First Intervention (14 Days)||48
1011996|NCT00577083|2457745|P2|STARTED|First Intervention (14 Days)||52
1011997|NCT00577083|2457746|P1|STARTED|First Intervention (14 Days)||48
1011998|NCT00577096|2457754|P2|NOT COMPLETED|Long Term Participation||0
1011999|NCT00577096|2457755|P1|NOT COMPLETED|Long Term Participation||0
1012000|NCT00577096|2457754|P2|COMPLETED|Long Term Participation|Sub-set of patients (n=69) who completed short term (n=120) continued in long term participation.|35
1012001|NCT00577096|2457755|P1|COMPLETED|Long Term Participation||34
1012002|NCT00577096|2457754|P2|STARTED|Long Term Participation|Only 35 patients who met long-term eligibility (response to EPO) were enrolled.|35
1012003|NCT00577096|2457755|P1|STARTED|Long Term Participation|Only the first 34 patients who met long-term eligibility (response to EPO) were enrolled.|34
1012004|NCT00577096|2457754|P2|NOT COMPLETED|Short Term Participation||8
1012005|NCT00577096|2457755|P1|NOT COMPLETED|Short Term Participation||7
1012006|NCT00577096|2457754|P2|COMPLETED|Short Term Participation||58
1012007|NCT00577096|2457755|P1|COMPLETED|Short Term Participation||62
1012008|NCT00577096|2457754|P2|STARTED|Short Term Participation||66
1012009|NCT00577096|2457755|P1|STARTED|Short Term Participation||69
1012010|NCT00577122|2457781|P2|NOT COMPLETED|Overall Study||16
1012011|NCT00577122|2457782|P1|NOT COMPLETED|Overall Study||14
1012012|NCT00577122|2457781|P2|COMPLETED|Overall Study||0
1012013|NCT00577122|2457782|P1|COMPLETED|Overall Study||0
1012014|NCT00577122|2457781|P2|STARTED|Overall Study||16
1012015|NCT00577122|2457782|P1|STARTED|Overall Study||14
1012016|NCT00577135|2457798|P4|NOT COMPLETED|Overall Study||0
1012017|NCT00577135|2457799|P3|NOT COMPLETED|Overall Study||0
1012018|NCT00577135|2457800|P2|NOT COMPLETED|Overall Study||0
1012019|NCT00577135|2457801|P1|NOT COMPLETED|Overall Study||0
1012020|NCT00577135|2457798|P4|COMPLETED|Overall Study||75
1012021|NCT00577135|2457799|P3|COMPLETED|Overall Study||77
1012022|NCT00577135|2457800|P2|COMPLETED|Overall Study||82
1012023|NCT00577135|2457801|P1|COMPLETED|Overall Study||74
1012024|NCT00577135|2457798|P4|STARTED|Overall Study||75
1012025|NCT00577135|2457799|P3|STARTED|Overall Study||77
1012026|NCT00577135|2457800|P2|STARTED|Overall Study||82
1012027|NCT00577135|2457801|P1|STARTED|Overall Study||74
1012028|NCT00577356|2457919|P1|NOT COMPLETED|Overall Study||0
1012029|NCT00577356|2457919|P1|COMPLETED|Overall Study||6
1012030|NCT00577356|2457919|P1|STARTED|Overall Study||6
1012031|NCT00577382|2457925|P2|NOT COMPLETED|Overall Study||31
1012032|NCT00577382|2457926|P1|NOT COMPLETED|Overall Study||21
1012033|NCT00577382|2457925|P2|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
1012034|NCT00577382|2457926|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
1012035|NCT00577382|2457925|P2|STARTED|Overall Study||31
1012036|NCT00577382|2457926|P1|STARTED|Overall Study||21
1012037|NCT00577395|2457940|P2|NOT COMPLETED|Overall Study||6
1012038|NCT00577395|2457941|P1|NOT COMPLETED|Overall Study||7
1012039|NCT00577395|2457940|P2|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
1012040|NCT00577395|2457941|P1|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
1012041|NCT00577395|2457940|P2|STARTED|Overall Study|67 were planned for Treatment 1, but due to enrollment difficulties this was not met.|6
1012042|NCT00577395|2457941|P1|STARTED|Overall Study|67 planned for Treatment 2, but due to enrollment difficulties this was not met.|7
1012043|NCT00577408|2457951|P2|NOT COMPLETED|Overall Study||23
1012044|NCT00577408|2457952|P1|NOT COMPLETED|Overall Study||12
1012045|NCT00577408|2457951|P2|COMPLETED|Overall Study||9
1012046|NCT00577408|2457952|P1|COMPLETED|Overall Study||16
1012047|NCT00577408|2457951|P2|STARTED|Overall Study||32
1012048|NCT00577408|2457952|P1|STARTED|Overall Study||28
1012049|NCT00577460|2457961|P3|NOT COMPLETED|Overall Study||27
1012050|NCT00577460|2457962|P2|NOT COMPLETED|Overall Study||19
1012051|NCT00577460|2457963|P1|NOT COMPLETED|Overall Study||16
1012052|NCT00577460|2457961|P3|COMPLETED|Overall Study||112
1012053|NCT00577460|2457962|P2|COMPLETED|Overall Study||104
1012054|NCT00577460|2457963|P1|COMPLETED|Overall Study||113
1012055|NCT00577460|2457961|P3|STARTED|Overall Study||139
1012056|NCT00577460|2457962|P2|STARTED|Overall Study||123
1012057|NCT00577460|2457963|P1|STARTED|Overall Study||129
1012058|NCT00577473|2458072|P2|NOT COMPLETED|Overall Study||24
1012059|NCT00577473|2458073|P1|NOT COMPLETED|Overall Study||21
1012060|NCT00577473|2458072|P2|COMPLETED|Overall Study||123
1012061|NCT00577473|2458073|P1|COMPLETED|Overall Study||133
1012062|NCT00577473|2458072|P2|ITT Population|Overall Study||136
1012063|NCT00577473|2458073|P1|ITT Population|Overall Study||150
1012064|NCT00577473|2458072|P2|STARTED|Overall Study||147
1012065|NCT00577473|2458073|P1|STARTED|Overall Study||154
1012069|NCT00577629|2458105|P1|NOT COMPLETED|Long Term Follow-Up||25
1012070|NCT00577629|2458105|P1|COMPLETED|Long Term Follow-Up||13
1012071|NCT00577629|2458105|P1|STARTED|Long Term Follow-Up||38
1012072|NCT00577629|2458105|P1|NOT COMPLETED|Treatment Period||1
1012073|NCT00577629|2458105|P1|COMPLETED|Treatment Period||38
1012074|NCT00577629|2458105|P1|STARTED|Treatment Period||39
1012075|NCT00577642|2458113|P1|NOT COMPLETED|Overall Study||1
1012076|NCT00577642|2458113|P1|COMPLETED|Overall Study||28
1012077|NCT00577642|2458113|P1|STARTED|Overall Study||29
1012078|NCT00577655|2458119|P2|NOT COMPLETED|Overall Study||4
1012079|NCT00577655|2458120|P1|NOT COMPLETED|Overall Study||1
1012080|NCT00577655|2458119|P2|COMPLETED|Overall Study||47
1012081|NCT00577655|2458120|P1|COMPLETED|Overall Study||51
1012082|NCT00577655|2458119|P2|STARTED|Overall Study|This number represents the number of participants randomized.|51
1012083|NCT00577655|2458120|P1|STARTED|Overall Study|This number represents the number of participants randomized.|52
1012084|NCT00577707|2458158|P1|NOT COMPLETED|Overall Study||3
1012085|NCT00577707|2458158|P1|COMPLETED|Overall Study||6
1012086|NCT00577707|2458158|P1|STARTED|Overall Study||9
1012087|NCT00577720|2458166|P4|NOT COMPLETED|Overall Study||7
1012088|NCT00577720|2458167|P3|NOT COMPLETED|Overall Study||1
1012089|NCT00577720|2458168|P2|NOT COMPLETED|Overall Study||1
1012090|NCT00577720|2458169|P1|NOT COMPLETED|Overall Study||4
1012091|NCT00577720|2458166|P4|COMPLETED|Overall Study||65
1012092|NCT00577720|2458167|P3|COMPLETED|Overall Study||35
1012093|NCT00577720|2458168|P2|COMPLETED|Overall Study||35
1012094|NCT00577720|2458169|P1|COMPLETED|Overall Study||33
1012095|NCT00577720|2458166|P4|ITT (Intent to Treat) Population|Overall Study||65
1012096|NCT00577720|2458167|P3|ITT (Intent to Treat) Population|Overall Study||35
1012097|NCT00577720|2458168|P2|ITT (Intent to Treat) Population|Overall Study||35
1012098|NCT00577720|2458169|P1|ITT (Intent to Treat) Population|Overall Study||34
1012099|NCT00577720|2458166|P4|STARTED|Overall Study||72
1012100|NCT00577720|2458167|P3|STARTED|Overall Study||36
1012101|NCT00577720|2458168|P2|STARTED|Overall Study||36
1012102|NCT00577720|2458169|P1|STARTED|Overall Study||37
1012103|NCT00577772|2458189|P2|NOT COMPLETED|Overall Study||1
1012104|NCT00577772|2458190|P1|NOT COMPLETED|Overall Study||0
1012105|NCT00577772|2458189|P2|COMPLETED|Overall Study||6
1012106|NCT00577772|2458190|P1|COMPLETED|Overall Study||10
1012107|NCT00577772|2458189|P2|STARTED|Overall Study||7
1012108|NCT00577772|2458190|P1|STARTED|Overall Study||10
1012109|NCT00577824|2458199|P3|NOT COMPLETED|Overall Study||2
1012110|NCT00577824|2458200|P2|NOT COMPLETED|Overall Study||20
1012111|NCT00577824|2458201|P1|NOT COMPLETED|Overall Study||7
1012112|NCT00577824|2458199|P3|COMPLETED|Overall Study||34
1012113|NCT00577824|2458200|P2|COMPLETED|Overall Study||53
1012114|NCT00577824|2458201|P1|COMPLETED|Overall Study||65
1012115|NCT00577824|2458199|P3|Full Analysis Set|Overall Study||35
1012116|NCT00577824|2458200|P2|Full Analysis Set|Overall Study||72
1012117|NCT00577824|2458201|P1|Full Analysis Set|Overall Study|Full Analysis Set=subject received at least one dose of study medication (active or placebo)|72
1012118|NCT00577824|2458199|P3|STARTED|Overall Study||36
1012119|NCT00577824|2458200|P2|STARTED|Overall Study||73
1012120|NCT00577824|2458201|P1|STARTED|Overall Study|Started=Randomized|72
1012121|NCT00577863|2458259|P2|NOT COMPLETED|Overall Study||14
1012122|NCT00577863|2458260|P1|NOT COMPLETED|Overall Study||10
1012123|NCT00577863|2458259|P2|COMPLETED|Overall Study||94
1012124|NCT00577863|2458260|P1|COMPLETED|Overall Study||82
1012125|NCT00577863|2458259|P2|Received at Least One Injection|Overall Study||107
1012126|NCT00577863|2458260|P1|Received at Least One Injection|Overall Study||92
1012127|NCT00577863|2458259|P2|STARTED|Overall Study||108
1012128|NCT00577863|2458260|P1|STARTED|Overall Study||92
1012129|NCT00564681|2458303|P4|NOT COMPLETED|Overall Study||2
1012130|NCT00564681|2458304|P3|NOT COMPLETED|Overall Study||3
1012131|NCT00564681|2458305|P2|NOT COMPLETED|Overall Study||3
1012132|NCT00564681|2458306|P1|NOT COMPLETED|Overall Study||11
1012133|NCT00564681|2458303|P4|COMPLETED|Overall Study||19
1012134|NCT00564681|2458304|P3|COMPLETED|Overall Study||40
1012135|NCT00564681|2458305|P2|COMPLETED|Overall Study||58
1012136|NCT00564681|2458306|P1|COMPLETED|Overall Study||106
1012137|NCT00564681|2458303|P4|STARTED|Overall Study||21
1012138|NCT00564681|2458304|P3|STARTED|Overall Study||43
1012139|NCT00564681|2458305|P2|STARTED|Overall Study||61
1012140|NCT00564681|2458306|P1|STARTED|Overall Study||117
1012141|NCT00564733|2458327|P1|NOT COMPLETED|Overall Study||9
1012142|NCT00564733|2458327|P1|COMPLETED|Overall Study||46
1012143|NCT00564733|2458327|P1|STARTED|Overall Study||55
1012144|NCT00564850|2458331|P1|NOT COMPLETED|Overall Study||2
1012145|NCT00564850|2458331|P1|COMPLETED|Overall Study||35
1012146|NCT00564850|2458331|P1|STARTED|Overall Study||37
1012147|NCT00564876|2458349|P1|NOT COMPLETED|Overall Study||0
1012148|NCT00564876|2458349|P1|COMPLETED|Overall Study||2
1012149|NCT00564876|2458349|P1|STARTED|Overall Study||2
1012150|NCT00564889|2458356|P1|NOT COMPLETED|Overall Study||29
1012151|NCT00564889|2458356|P1|COMPLETED|Overall Study||6
1012152|NCT00564889|2458356|P1|STARTED|Overall Study||35
1012153|NCT00564902|2458367|P3|NOT COMPLETED|Overall Study||4
1012154|NCT00564902|2458368|P2|NOT COMPLETED|Overall Study||4
1012155|NCT00564902|2458369|P1|NOT COMPLETED|Overall Study||1
1012156|NCT00564902|2458367|P3|COMPLETED|Overall Study||21
1012157|NCT00564902|2458368|P2|COMPLETED|Overall Study||21
1012158|NCT00564902|2458369|P1|COMPLETED|Overall Study||9
1012159|NCT00564902|2458367|P3|12 Months|Overall Study||21
1012160|NCT00564902|2458368|P2|12 Months|Overall Study||21
1012161|NCT00564902|2458369|P1|12 Months|Overall Study||9
1012162|NCT00564902|2458367|P3|8 Months|Overall Study||21
1012163|NCT00564902|2458368|P2|8 Months|Overall Study||22
1012164|NCT00564902|2458369|P1|8 Months|Overall Study||9
1012165|NCT00564902|2458367|P3|4 Months|Overall Study||23
1012166|NCT00564902|2458368|P2|4 Months|Overall Study||24
1012167|NCT00564902|2458369|P1|4 Months|Overall Study||9
1012168|NCT00564902|2458367|P3|STARTED|Overall Study||25
1012169|NCT00564902|2458368|P2|STARTED|Overall Study||25
1012170|NCT00564902|2458369|P1|STARTED|Overall Study||10
1012171|NCT00564954|2458403|P2|NOT COMPLETED|Period 2- 1 Week||0
1012172|NCT00564954|2458404|P1|NOT COMPLETED|Period 2- 1 Week||0
1012173|NCT00564954|2458403|P2|COMPLETED|Period 2- 1 Week||42
1012174|NCT00564954|2458404|P1|COMPLETED|Period 2- 1 Week||44
1012175|NCT00564954|2458403|P2|STARTED|Period 2- 1 Week||42
1012176|NCT00564954|2458404|P1|STARTED|Period 2- 1 Week||44
1012177|NCT00564954|2458403|P2|NOT COMPLETED|Period 1- 1 Week||0
1012178|NCT00564954|2458404|P1|NOT COMPLETED|Period 1- 1 Week||0
1012179|NCT00564954|2458403|P2|COMPLETED|Period 1- 1 Week||42
1012180|NCT00564954|2458404|P1|COMPLETED|Period 1- 1 Week||44
1012181|NCT00564954|2458403|P2|STARTED|Period 1- 1 Week||42
1012182|NCT00564954|2458404|P1|STARTED|Period 1- 1 Week||44
1012183|NCT00565045|2458422|P2|NOT COMPLETED|Overall Study||3
1012184|NCT00565045|2458423|P1|NOT COMPLETED|Overall Study||1
1012185|NCT00565045|2458422|P2|COMPLETED|Overall Study||8
1012186|NCT00565045|2458423|P1|COMPLETED|Overall Study||9
1012187|NCT00565045|2458422|P2|STARTED|Overall Study||11
1012188|NCT00565045|2458423|P1|STARTED|Overall Study||10
1012189|NCT00570531|2458437|P1|NOT COMPLETED|Overall Study||0
1012190|NCT00570531|2458437|P1|COMPLETED|Overall Study||6
1012191|NCT00570531|2458437|P1|STARTED|Overall Study||6
1012192|NCT00570674|2458443|P7|NOT COMPLETED|Overall Study||0
1012193|NCT00570674|2458444|P6|NOT COMPLETED|Overall Study||0
1012194|NCT00570674|2458445|P5|NOT COMPLETED|Overall Study||0
1012195|NCT00570674|2458446|P4|NOT COMPLETED|Overall Study||0
1012196|NCT00570674|2458447|P3|NOT COMPLETED|Overall Study||1
1012197|NCT00570674|2458448|P2|NOT COMPLETED|Overall Study||0
1012198|NCT00570674|2458449|P1|NOT COMPLETED|Overall Study||0
1012199|NCT00570674|2458443|P7|COMPLETED|Overall Study||0
1012200|NCT00570674|2458444|P6|COMPLETED|Overall Study||10
1012201|NCT00570674|2458445|P5|COMPLETED|Overall Study||3
1012202|NCT00570674|2458446|P4|COMPLETED|Overall Study||3
1012203|NCT00570674|2458447|P3|COMPLETED|Overall Study||3
1012204|NCT00570674|2458448|P2|COMPLETED|Overall Study||3
1012205|NCT00570674|2458449|P1|COMPLETED|Overall Study||6
1012206|NCT00570674|2458443|P7|PEG Evaluable|Overall Study||0
1012207|NCT00570674|2458444|P6|PEG Evaluable|Overall Study||10
1012208|NCT00570674|2458445|P5|PEG Evaluable|Overall Study||2
1012209|NCT00570674|2458446|P4|PEG Evaluable|Overall Study||3
1012210|NCT00570674|2458447|P3|PEG Evaluable|Overall Study||3
1012211|NCT00570674|2458448|P2|PEG Evaluable|Overall Study||3
1012212|NCT00570674|2458449|P1|PEG Evaluable|Overall Study||6
1012213|NCT00570674|2458443|P7|Treated|Overall Study||0
1012214|NCT00570674|2458444|P6|Treated|Overall Study||10
1012215|NCT00570674|2458445|P5|Treated|Overall Study||3
1012216|NCT00570674|2458446|P4|Treated|Overall Study||3
1012217|NCT00570674|2458447|P3|Treated|Overall Study||3
1012218|NCT00570674|2458448|P2|Treated|Overall Study||3
1012219|NCT00570674|2458449|P1|Treated|Overall Study||6
1012220|NCT00570674|2458443|P7|STARTED|Overall Study|The study did not continue beyond phase I.|0
1012221|NCT00570674|2458444|P6|STARTED|Overall Study||10
1012222|NCT00570674|2458445|P5|STARTED|Overall Study||3
1012223|NCT00570674|2458446|P4|STARTED|Overall Study||3
1012224|NCT00570674|2458447|P3|STARTED|Overall Study||4
1012225|NCT00570674|2458448|P2|STARTED|Overall Study||3
1012226|NCT00570674|2458449|P1|STARTED|Overall Study||6
1012227|NCT00570687|2458464|P10|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1012228|NCT00570687|2458465|P9|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1012229|NCT00570687|2458466|P8|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1012230|NCT00570687|2458467|P7|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1012231|NCT00570687|2458468|P6|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1012232|NCT00570687|2458469|P5|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1012233|NCT00570687|2458470|P4|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1012234|NCT00570687|2458471|P3|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1012235|NCT00570687|2458472|P2|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1012236|NCT00570687|2458473|P1|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1012237|NCT00570687|2458464|P10|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1012238|NCT00570687|2458465|P9|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1012239|NCT00570687|2458466|P8|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1012240|NCT00570687|2458467|P7|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1012241|NCT00570687|2458468|P6|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1012242|NCT00570687|2458469|P5|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
1012243|NCT00570687|2458470|P4|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
1012244|NCT00570687|2458471|P3|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
1012245|NCT00570687|2458472|P2|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
1012246|NCT00570687|2458473|P1|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
1012247|NCT00570687|2458464|P10|STARTED|Clamp 2 (1 Day) - Amendment 1||0
1012248|NCT00570687|2458465|P9|STARTED|Clamp 2 (1 Day) - Amendment 1||0
1012249|NCT00570687|2458466|P8|STARTED|Clamp 2 (1 Day) - Amendment 1||0
1012250|NCT00570687|2458467|P7|STARTED|Clamp 2 (1 Day) - Amendment 1||0
1012251|NCT00570687|2458468|P6|STARTED|Clamp 2 (1 Day) - Amendment 1||0
1012252|NCT00570687|2458469|P5|STARTED|Clamp 2 (1 Day) - Amendment 1||0
1012253|NCT00570687|2458470|P4|STARTED|Clamp 2 (1 Day) - Amendment 1||4
1012254|NCT00570687|2458471|P3|STARTED|Clamp 2 (1 Day) - Amendment 1||2
1012255|NCT00570687|2458472|P2|STARTED|Clamp 2 (1 Day) - Amendment 1||2
1012256|NCT00570687|2458473|P1|STARTED|Clamp 2 (1 Day) - Amendment 1||4
1012257|NCT00570687|2458464|P10|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1012258|NCT00570687|2458465|P9|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1012259|NCT00570687|2458466|P8|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1012260|NCT00570687|2458467|P7|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1012261|NCT00570687|2458468|P6|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1012262|NCT00570687|2458469|P5|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1012263|NCT00570687|2458470|P4|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1012264|NCT00570687|2458471|P3|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1012265|NCT00570687|2458472|P2|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1012266|NCT00570687|2458473|P1|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1012267|NCT00570687|2458464|P10|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1012268|NCT00570687|2458465|P9|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1012269|NCT00570687|2458466|P8|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1012270|NCT00570687|2458467|P7|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1012271|NCT00570687|2458468|P6|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1012272|NCT00570687|2458469|P5|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
1012273|NCT00570687|2458470|P4|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
1012274|NCT00570687|2458471|P3|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
1012275|NCT00570687|2458472|P2|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
1012276|NCT00570687|2458473|P1|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
1012277|NCT00570687|2458464|P10|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
1012278|NCT00570687|2458465|P9|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
1012279|NCT00570687|2458466|P8|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
1012280|NCT00570687|2458467|P7|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
1012281|NCT00570687|2458468|P6|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
1012282|NCT00570687|2458469|P5|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
1012283|NCT00570687|2458470|P4|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
1012284|NCT00570687|2458471|P3|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
1012285|NCT00570687|2458472|P2|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
1012286|NCT00570687|2458473|P1|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
1012287|NCT00570687|2458464|P10|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1012288|NCT00570687|2458465|P9|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1012289|NCT00570687|2458466|P8|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1012290|NCT00570687|2458467|P7|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1012291|NCT00570687|2458468|P6|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1012292|NCT00570687|2458469|P5|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1012293|NCT00570687|2458470|P4|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1012294|NCT00570687|2458471|P3|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1012295|NCT00570687|2458472|P2|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1012296|NCT00570687|2458473|P1|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1012297|NCT00570687|2458464|P10|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1012298|NCT00570687|2458465|P9|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1012299|NCT00570687|2458466|P8|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1012300|NCT00570687|2458467|P7|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1012301|NCT00570687|2458468|P6|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1012302|NCT00570687|2458469|P5|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
1012303|NCT00570687|2458470|P4|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
1012304|NCT00570687|2458471|P3|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
1012305|NCT00570687|2458472|P2|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
1012306|NCT00570687|2458473|P1|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
1012307|NCT00570687|2458464|P10|STARTED|Clamp 1 (1 Day) - Amendment 1||0
1012308|NCT00570687|2458465|P9|STARTED|Clamp 1 (1 Day) - Amendment 1||0
1012309|NCT00570687|2458466|P8|STARTED|Clamp 1 (1 Day) - Amendment 1||0
1012310|NCT00570687|2458467|P7|STARTED|Clamp 1 (1 Day) - Amendment 1||0
1012311|NCT00570687|2458468|P6|STARTED|Clamp 1 (1 Day) - Amendment 1||0
1012312|NCT00570687|2458469|P5|STARTED|Clamp 1 (1 Day) - Amendment 1||0
1012313|NCT00570687|2458470|P4|STARTED|Clamp 1 (1 Day) - Amendment 1||4
1012314|NCT00570687|2458471|P3|STARTED|Clamp 1 (1 Day) - Amendment 1||2
1012315|NCT00570687|2458472|P2|STARTED|Clamp 1 (1 Day) - Amendment 1||2
1012316|NCT00570687|2458473|P1|STARTED|Clamp 1 (1 Day) - Amendment 1||4
1012317|NCT00570687|2458464|P10|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1012318|NCT00570687|2458465|P9|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1012319|NCT00570687|2458466|P8|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1012320|NCT00570687|2458467|P7|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1012321|NCT00570687|2458468|P6|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1012322|NCT00570687|2458469|P5|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1012323|NCT00570687|2458470|P4|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1012324|NCT00570687|2458471|P3|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1012325|NCT00570687|2458472|P2|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1012326|NCT00570687|2458473|P1|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1012327|NCT00570687|2458464|P10|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1012328|NCT00570687|2458465|P9|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1012329|NCT00570687|2458466|P8|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1012330|NCT00570687|2458467|P7|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1012331|NCT00570687|2458468|P6|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1012332|NCT00570687|2458469|P5|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
1012333|NCT00570687|2458470|P4|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
1012334|NCT00570687|2458471|P3|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
1012335|NCT00570687|2458472|P2|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
1012336|NCT00570687|2458473|P1|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
1012337|NCT00570687|2458464|P10|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
1012338|NCT00570687|2458465|P9|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
1012339|NCT00570687|2458466|P8|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
1012340|NCT00570687|2458467|P7|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
1012341|NCT00570687|2458468|P6|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
1012342|NCT00570687|2458469|P5|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
1012343|NCT00570687|2458470|P4|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
1012344|NCT00570687|2458471|P3|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
1012345|NCT00570687|2458472|P2|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
1012346|NCT00570687|2458473|P1|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
1012347|NCT00570687|2458464|P10|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1012348|NCT00570687|2458465|P9|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1012349|NCT00570687|2458466|P8|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1012350|NCT00570687|2458467|P7|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1012351|NCT00570687|2458468|P6|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1012352|NCT00570687|2458469|P5|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1012353|NCT00570687|2458470|P4|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1012354|NCT00570687|2458471|P3|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1012355|NCT00570687|2458472|P2|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1012356|NCT00570687|2458473|P1|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1012357|NCT00570687|2458464|P10|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1012358|NCT00570687|2458465|P9|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1012359|NCT00570687|2458466|P8|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1012360|NCT00570687|2458467|P7|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1012361|NCT00570687|2458468|P6|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1012362|NCT00570687|2458469|P5|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
1012363|NCT00570687|2458470|P4|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
1012364|NCT00570687|2458471|P3|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
1012365|NCT00570687|2458472|P2|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
1012366|NCT00570687|2458473|P1|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
1012367|NCT00570687|2458464|P10|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
1012368|NCT00570687|2458465|P9|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
1012369|NCT00570687|2458466|P8|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
1012370|NCT00570687|2458467|P7|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
1012371|NCT00570687|2458468|P6|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
1012372|NCT00570687|2458469|P5|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
1012373|NCT00570687|2458470|P4|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
1012374|NCT00570687|2458471|P3|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
1012375|NCT00570687|2458472|P2|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
1012376|NCT00570687|2458473|P1|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
1012377|NCT00570687|2458464|P10|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1012378|NCT00570687|2458465|P9|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1012379|NCT00570687|2458466|P8|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1012380|NCT00570687|2458467|P7|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1012381|NCT00570687|2458468|P6|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1012382|NCT00570687|2458469|P5|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1012383|NCT00570687|2458470|P4|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1012384|NCT00570687|2458471|P3|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1012385|NCT00570687|2458472|P2|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1012386|NCT00570687|2458473|P1|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1012387|NCT00570687|2458464|P10|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1012388|NCT00570687|2458465|P9|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1012389|NCT00570687|2458466|P8|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1012390|NCT00570687|2458467|P7|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1012391|NCT00570687|2458468|P6|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1012392|NCT00570687|2458469|P5|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
1012393|NCT00570687|2458470|P4|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
1012394|NCT00570687|2458471|P3|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
1012395|NCT00570687|2458472|P2|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
1012396|NCT00570687|2458473|P1|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
1012397|NCT00570687|2458464|P10|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
1012398|NCT00570687|2458465|P9|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
1012399|NCT00570687|2458466|P8|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
1012400|NCT00570687|2458467|P7|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
1012401|NCT00570687|2458468|P6|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
1012402|NCT00570687|2458469|P5|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
1012403|NCT00570687|2458470|P4|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
1012404|NCT00570687|2458471|P3|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
1012405|NCT00570687|2458472|P2|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
1012406|NCT00570687|2458473|P1|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
1012407|NCT00570687|2458464|P10|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1012408|NCT00570687|2458465|P9|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1012409|NCT00570687|2458466|P8|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1012410|NCT00570687|2458467|P7|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1012411|NCT00570687|2458468|P6|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1012412|NCT00570687|2458469|P5|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1012413|NCT00570687|2458470|P4|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1012414|NCT00570687|2458471|P3|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1012415|NCT00570687|2458472|P2|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1012416|NCT00570687|2458473|P1|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1012417|NCT00570687|2458464|P10|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1012418|NCT00570687|2458465|P9|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1012419|NCT00570687|2458466|P8|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1012420|NCT00570687|2458467|P7|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1012421|NCT00570687|2458468|P6|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1012422|NCT00570687|2458469|P5|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
1012423|NCT00570687|2458470|P4|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
1012424|NCT00570687|2458471|P3|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
1012425|NCT00570687|2458472|P2|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
1012426|NCT00570687|2458473|P1|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
1012427|NCT00570687|2458464|P10|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
1012428|NCT00570687|2458465|P9|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
1012429|NCT00570687|2458466|P8|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
1012430|NCT00570687|2458467|P7|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
1012431|NCT00570687|2458468|P6|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
1012432|NCT00570687|2458469|P5|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
1012433|NCT00570687|2458470|P4|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
1012434|NCT00570687|2458471|P3|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
1012435|NCT00570687|2458472|P2|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
1012436|NCT00570687|2458473|P1|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
1012437|NCT00570687|2458464|P10|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1012438|NCT00570687|2458465|P9|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1012439|NCT00570687|2458466|P8|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1012440|NCT00570687|2458467|P7|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||1
1012441|NCT00570687|2458468|P6|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1012442|NCT00570687|2458469|P5|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1012443|NCT00570687|2458470|P4|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1012444|NCT00570687|2458471|P3|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1012445|NCT00570687|2458472|P2|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1012446|NCT00570687|2458473|P1|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1012447|NCT00570687|2458464|P10|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1012448|NCT00570687|2458465|P9|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1012449|NCT00570687|2458466|P8|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1012450|NCT00570687|2458467|P7|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1012451|NCT00570687|2458468|P6|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1012452|NCT00570687|2458469|P5|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1012453|NCT00570687|2458470|P4|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1012454|NCT00570687|2458471|P3|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1012455|NCT00570687|2458472|P2|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1012456|NCT00570687|2458473|P1|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
1012457|NCT00570687|2458464|P10|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
1012458|NCT00570687|2458465|P9|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
1012459|NCT00570687|2458466|P8|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
1012460|NCT00570687|2458467|P7|STARTED|Washout 5 (7-21 Days) - Orig Protocol||1
1012461|NCT00570687|2458468|P6|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
1012462|NCT00570687|2458469|P5|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
1012463|NCT00570687|2458470|P4|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
1012464|NCT00570687|2458471|P3|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
1012465|NCT00570687|2458472|P2|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
1012466|NCT00570687|2458473|P1|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
1012467|NCT00570687|2458464|P10|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1012468|NCT00570687|2458465|P9|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1012469|NCT00570687|2458466|P8|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1012470|NCT00570687|2458467|P7|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1012471|NCT00570687|2458468|P6|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1012472|NCT00570687|2458469|P5|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1012473|NCT00570687|2458470|P4|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1012474|NCT00570687|2458471|P3|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1012475|NCT00570687|2458472|P2|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1012476|NCT00570687|2458473|P1|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1012477|NCT00570687|2458464|P10|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1012478|NCT00570687|2458465|P9|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1012479|NCT00570687|2458466|P8|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1012480|NCT00570687|2458467|P7|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||1
1012481|NCT00570687|2458468|P6|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1012482|NCT00570687|2458469|P5|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1012483|NCT00570687|2458470|P4|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1012484|NCT00570687|2458471|P3|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1012485|NCT00570687|2458472|P2|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1012486|NCT00570687|2458473|P1|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
1012487|NCT00570687|2458464|P10|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
1012488|NCT00570687|2458465|P9|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
1012489|NCT00570687|2458466|P8|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
1012490|NCT00570687|2458467|P7|STARTED|Clamp 2 (1 Day) - Orig Protocol||1
1012491|NCT00570687|2458468|P6|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
1012492|NCT00570687|2458469|P5|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
1012493|NCT00570687|2458470|P4|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
1012494|NCT00570687|2458471|P3|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
1012495|NCT00570687|2458472|P2|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
1012496|NCT00570687|2458473|P1|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
1012497|NCT00570687|2458464|P10|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1012498|NCT00570687|2458465|P9|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
1012499|NCT00570687|2458466|P8|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1012500|NCT00570687|2458467|P7|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1012501|NCT00570687|2458468|P6|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1012502|NCT00570687|2458469|P5|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1012503|NCT00570687|2458470|P4|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1012504|NCT00570687|2458471|P3|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1012505|NCT00570687|2458472|P2|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1012506|NCT00570687|2458473|P1|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1012507|NCT00570687|2458464|P10|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1012508|NCT00570687|2458465|P9|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1012509|NCT00570687|2458466|P8|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1012510|NCT00570687|2458467|P7|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
1012511|NCT00570687|2458468|P6|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1012512|NCT00570687|2458469|P5|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1012513|NCT00570687|2458470|P4|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1012514|NCT00570687|2458471|P3|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1012515|NCT00570687|2458472|P2|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1012516|NCT00570687|2458473|P1|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
1012517|NCT00570687|2458464|P10|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
1012518|NCT00570687|2458465|P9|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
1012519|NCT00570687|2458466|P8|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
1012520|NCT00570687|2458467|P7|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
1012521|NCT00570687|2458468|P6|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
1012522|NCT00570687|2458469|P5|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
1012523|NCT00570687|2458470|P4|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
1012524|NCT00570687|2458471|P3|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
1012525|NCT00570687|2458472|P2|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
1012526|NCT00570687|2458473|P1|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
1012527|NCT00570687|2458464|P10|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1012528|NCT00570687|2458465|P9|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1012529|NCT00570687|2458466|P8|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1012530|NCT00570687|2458467|P7|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1012531|NCT00570687|2458468|P6|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1012532|NCT00570687|2458469|P5|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1012533|NCT00570687|2458470|P4|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1012534|NCT00570687|2458471|P3|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1012535|NCT00570687|2458472|P2|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1012536|NCT00570687|2458473|P1|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1012537|NCT00570687|2458464|P10|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1012538|NCT00570687|2458465|P9|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
1012539|NCT00570687|2458466|P8|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1012540|NCT00570687|2458467|P7|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
1012541|NCT00570687|2458468|P6|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1012542|NCT00570687|2458469|P5|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1012543|NCT00570687|2458470|P4|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1012544|NCT00570687|2458471|P3|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1012545|NCT00570687|2458472|P2|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1012546|NCT00570687|2458473|P1|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
1012547|NCT00570687|2458464|P10|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
1012548|NCT00570687|2458465|P9|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
1012549|NCT00570687|2458466|P8|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
1012550|NCT00570687|2458467|P7|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
1012551|NCT00570687|2458468|P6|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
1012552|NCT00570687|2458469|P5|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
1012553|NCT00570687|2458470|P4|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
1012554|NCT00570687|2458471|P3|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
1012555|NCT00570687|2458472|P2|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
1012556|NCT00570687|2458473|P1|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
1012557|NCT00570687|2458464|P10|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
1012558|NCT00570687|2458465|P9|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
1012559|NCT00570687|2458466|P8|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
1012560|NCT00570687|2458467|P7|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
1012561|NCT00570687|2458468|P6|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
1012562|NCT00570687|2458469|P5|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
1012563|NCT00570687|2458470|P4|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
1012564|NCT00570687|2458471|P3|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
1012565|NCT00570687|2458472|P2|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
1012566|NCT00570687|2458473|P1|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
1012567|NCT00570687|2458464|P10|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
1012568|NCT00570687|2458465|P9|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
1012569|NCT00570687|2458466|P8|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
1012570|NCT00570687|2458467|P7|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
1012571|NCT00570687|2458468|P6|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
1012572|NCT00570687|2458469|P5|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
1012573|NCT00570687|2458470|P4|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
1012574|NCT00570687|2458471|P3|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
1012575|NCT00570687|2458472|P2|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
1012576|NCT00570687|2458473|P1|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
1012577|NCT00570687|2458464|P10|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
1012578|NCT00570687|2458465|P9|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
1012579|NCT00570687|2458466|P8|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
1012580|NCT00570687|2458467|P7|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
1012581|NCT00570687|2458468|P6|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
1012582|NCT00570687|2458469|P5|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
1012583|NCT00570687|2458470|P4|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
1012584|NCT00570687|2458471|P3|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
1012585|NCT00570687|2458472|P2|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
1012586|NCT00570687|2458473|P1|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
1012587|NCT00570687|2458464|P10|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1012588|NCT00570687|2458465|P9|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1012589|NCT00570687|2458466|P8|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1012590|NCT00570687|2458467|P7|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1012591|NCT00570687|2458468|P6|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1012592|NCT00570687|2458469|P5|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1012593|NCT00570687|2458470|P4|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1012594|NCT00570687|2458471|P3|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1012595|NCT00570687|2458472|P2|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1012596|NCT00570687|2458473|P1|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1012597|NCT00570687|2458464|P10|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
1012598|NCT00570687|2458465|P9|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
1012599|NCT00570687|2458466|P8|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
1012600|NCT00570687|2458467|P7|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
1012601|NCT00570687|2458468|P6|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
1012602|NCT00570687|2458469|P5|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
1012603|NCT00570687|2458470|P4|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1012604|NCT00570687|2458471|P3|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1012605|NCT00570687|2458472|P2|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1012606|NCT00570687|2458473|P1|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1012607|NCT00570687|2458464|P10|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
1012608|NCT00570687|2458465|P9|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
1012609|NCT00570687|2458466|P8|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
1012610|NCT00570687|2458467|P7|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
1012611|NCT00570687|2458468|P6|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
1012612|NCT00570687|2458469|P5|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
1012613|NCT00570687|2458470|P4|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1012614|NCT00570687|2458471|P3|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1012615|NCT00570687|2458472|P2|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1012616|NCT00570687|2458473|P1|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
1012617|NCT00570687|2458464|P10|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1012618|NCT00570687|2458465|P9|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1012619|NCT00570687|2458466|P8|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1012620|NCT00570687|2458467|P7|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1012621|NCT00570687|2458468|P6|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1012622|NCT00570687|2458469|P5|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1012623|NCT00570687|2458470|P4|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1012624|NCT00570687|2458471|P3|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1012625|NCT00570687|2458472|P2|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1012626|NCT00570687|2458473|P1|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1012627|NCT00570687|2458464|P10|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
1012628|NCT00570687|2458465|P9|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
1012629|NCT00570687|2458466|P8|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
1012630|NCT00570687|2458467|P7|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
1012631|NCT00570687|2458468|P6|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
1012632|NCT00570687|2458469|P5|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
1012633|NCT00570687|2458470|P4|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1012634|NCT00570687|2458471|P3|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1012635|NCT00570687|2458472|P2|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1012636|NCT00570687|2458473|P1|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
1012637|NCT00570687|2458464|P10|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
1012638|NCT00570687|2458465|P9|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
1012639|NCT00570687|2458466|P8|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
1012640|NCT00570687|2458467|P7|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
1012641|NCT00570687|2458468|P6|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
1012642|NCT00570687|2458469|P5|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
1012643|NCT00570687|2458470|P4|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
1012644|NCT00570687|2458471|P3|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
1012645|NCT00570687|2458472|P2|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
1012646|NCT00570687|2458473|P1|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
1012647|NCT00570687|2458464|P10|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1012648|NCT00570687|2458465|P9|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1012649|NCT00570687|2458466|P8|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1012650|NCT00570687|2458467|P7|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1012651|NCT00570687|2458468|P6|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1012652|NCT00570687|2458469|P5|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1012653|NCT00570687|2458470|P4|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1012654|NCT00570687|2458471|P3|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1012655|NCT00570687|2458472|P2|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1012656|NCT00570687|2458473|P1|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1012657|NCT00570687|2458464|P10|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
1012658|NCT00570687|2458465|P9|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
1012659|NCT00570687|2458466|P8|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
1012660|NCT00570687|2458467|P7|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
1012661|NCT00570687|2458468|P6|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
1012662|NCT00570687|2458469|P5|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
1012663|NCT00570687|2458470|P4|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1012664|NCT00570687|2458471|P3|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1012665|NCT00570687|2458472|P2|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1012666|NCT00570687|2458473|P1|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1012667|NCT00570687|2458464|P10|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
1012668|NCT00570687|2458465|P9|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
1012669|NCT00570687|2458466|P8|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
1012670|NCT00570687|2458467|P7|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
1012671|NCT00570687|2458468|P6|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
1012672|NCT00570687|2458469|P5|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
1012673|NCT00570687|2458470|P4|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1012674|NCT00570687|2458471|P3|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1012675|NCT00570687|2458472|P2|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1012676|NCT00570687|2458473|P1|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
1012677|NCT00570687|2458464|P10|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1012678|NCT00570687|2458465|P9|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1012679|NCT00570687|2458466|P8|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1012680|NCT00570687|2458467|P7|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1012681|NCT00570687|2458468|P6|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1012682|NCT00570687|2458469|P5|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1012683|NCT00570687|2458470|P4|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1012684|NCT00570687|2458471|P3|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1012685|NCT00570687|2458472|P2|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1012686|NCT00570687|2458473|P1|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1012687|NCT00570687|2458464|P10|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
1012688|NCT00570687|2458465|P9|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
1012689|NCT00570687|2458466|P8|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
1012690|NCT00570687|2458467|P7|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
1012691|NCT00570687|2458468|P6|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
1012692|NCT00570687|2458469|P5|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
1012693|NCT00570687|2458470|P4|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1012694|NCT00570687|2458471|P3|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1012695|NCT00570687|2458472|P2|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1012696|NCT00570687|2458473|P1|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
1012697|NCT00570687|2458464|P10|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
1012698|NCT00570687|2458465|P9|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
1012699|NCT00570687|2458466|P8|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
1012700|NCT00570687|2458467|P7|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
1012701|NCT00570687|2458468|P6|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
1012702|NCT00570687|2458469|P5|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
1012703|NCT00570687|2458470|P4|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
1012704|NCT00570687|2458471|P3|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
1012705|NCT00570687|2458472|P2|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
1012706|NCT00570687|2458473|P1|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
1012707|NCT00570687|2458464|P10|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1012708|NCT00570687|2458465|P9|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1012709|NCT00570687|2458466|P8|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1012710|NCT00570687|2458467|P7|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1012711|NCT00570687|2458468|P6|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1012712|NCT00570687|2458469|P5|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1012713|NCT00570687|2458470|P4|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1012714|NCT00570687|2458471|P3|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1012715|NCT00570687|2458472|P2|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1012716|NCT00570687|2458473|P1|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1012717|NCT00570687|2458464|P10|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
1012718|NCT00570687|2458465|P9|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
1012719|NCT00570687|2458466|P8|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
1012720|NCT00570687|2458467|P7|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
1012721|NCT00570687|2458468|P6|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
1012722|NCT00570687|2458469|P5|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
1012723|NCT00570687|2458470|P4|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1012724|NCT00570687|2458471|P3|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1012725|NCT00570687|2458472|P2|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1012726|NCT00570687|2458473|P1|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1012727|NCT00570687|2458464|P10|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
1012728|NCT00570687|2458465|P9|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
1012729|NCT00570687|2458466|P8|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
1012730|NCT00570687|2458467|P7|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
1012731|NCT00570687|2458468|P6|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
1012732|NCT00570687|2458469|P5|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
1012733|NCT00570687|2458470|P4|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1012734|NCT00570687|2458471|P3|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1012735|NCT00570687|2458472|P2|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1012736|NCT00570687|2458473|P1|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
1012737|NCT00570713|2458501|P2|NOT COMPLETED|Overall Study||77
1012738|NCT00570713|2458502|P1|NOT COMPLETED|Overall Study||78
1012739|NCT00570713|2458501|P2|COMPLETED|Overall Study||0
1012740|NCT00570713|2458502|P1|COMPLETED|Overall Study||0
1012741|NCT00570713|2458501|P2|STARTED|Overall Study||77
1012742|NCT00570713|2458502|P1|STARTED|Overall Study||78
1012743|NCT00570739|2458516|P4|NOT COMPLETED|Overall Study||12
1012744|NCT00570739|2458517|P3|NOT COMPLETED|Overall Study||16
1012745|NCT00570739|2458518|P2|NOT COMPLETED|Overall Study||21
1012746|NCT00570739|2458519|P1|NOT COMPLETED|Overall Study||21
1012747|NCT00570739|2458516|P4|COMPLETED|Overall Study||96
1012748|NCT00570739|2458517|P3|COMPLETED|Overall Study||92
1012749|NCT00570739|2458518|P2|COMPLETED|Overall Study||124
1012750|NCT00570739|2458519|P1|COMPLETED|Overall Study||120
1012751|NCT00570739|2458516|P4|STARTED|Overall Study||108
1012752|NCT00570739|2458517|P3|STARTED|Overall Study||108
1012753|NCT00570739|2458518|P2|STARTED|Overall Study||145
1012754|NCT00570739|2458519|P1|STARTED|Overall Study||141
1012755|NCT00570765|2458672|P3|NOT COMPLETED|Overall Study||0
1012756|NCT00570765|2458673|P2|NOT COMPLETED|Overall Study||7
1012757|NCT00570765|2458674|P1|NOT COMPLETED|Overall Study||4
1012758|NCT00570765|2458672|P3|COMPLETED|Overall Study||23
1012759|NCT00570765|2458673|P2|COMPLETED|Overall Study||9
1012760|NCT00570765|2458674|P1|COMPLETED|Overall Study||16
1012761|NCT00570765|2458672|P3|STARTED|Overall Study||23
1012762|NCT00570765|2458673|P2|STARTED|Overall Study||16
1012763|NCT00570765|2458674|P1|STARTED|Overall Study||20
1012764|NCT00570778|2458688|P4|NOT COMPLETED|Overall Study||4
1012765|NCT00570778|2458689|P3|NOT COMPLETED|Overall Study||7
1012766|NCT00570778|2458690|P2|NOT COMPLETED|Overall Study||4
1012767|NCT00570778|2458691|P1|NOT COMPLETED|Overall Study||4
1012768|NCT00570778|2458688|P4|COMPLETED|Overall Study||34
1012769|NCT00570778|2458689|P3|COMPLETED|Overall Study||30
1012770|NCT00570778|2458690|P2|COMPLETED|Overall Study||34
1012771|NCT00570778|2458691|P1|COMPLETED|Overall Study||37
1012772|NCT00570778|2458688|P4|Modified Intent-to-treat Population|Overall Study||37
1012773|NCT00570778|2458689|P3|Modified Intent-to-treat Population|Overall Study||35
1012774|NCT00570778|2458690|P2|Modified Intent-to-treat Population|Overall Study||37
1012775|NCT00570778|2458691|P1|Modified Intent-to-treat Population|Overall Study||40
1012776|NCT00570778|2458688|P4|Safety Population: Received Study Drug|Overall Study||38
1012777|NCT00570778|2458689|P3|Safety Population: Received Study Drug|Overall Study||36
1012778|NCT00570778|2458690|P2|Safety Population: Received Study Drug|Overall Study||38
1012779|NCT00570778|2458691|P1|Safety Population: Received Study Drug|Overall Study|Safety Population included all participants who received at least 1 dose of any study drug.|41
1012780|NCT00570778|2458688|P4|STARTED|Overall Study||38
1012781|NCT00570778|2458689|P3|STARTED|Overall Study||37
1012782|NCT00570778|2458690|P2|STARTED|Overall Study||38
1012783|NCT00570778|2458691|P1|STARTED|Overall Study||41
1012784|NCT00570908|2458709|P1|NOT COMPLETED|Overall Study||7
1012785|NCT00570908|2458709|P1|COMPLETED|Overall Study|5 patients progressed during the study treatment|5
1012786|NCT00570908|2458709|P1|STARTED|Overall Study||12
1012787|NCT00570921|2458713|P1|NOT COMPLETED|Overall Study||2
1012788|NCT00570921|2458713|P1|COMPLETED|Overall Study||31
1012789|NCT00570921|2458713|P1|STARTED|Overall Study||33
1012790|NCT00570960|2458721|P2|NOT COMPLETED|Overall Study||0
1012791|NCT00570960|2458722|P1|NOT COMPLETED|Overall Study||0
1012792|NCT00570960|2458721|P2|COMPLETED|Overall Study||4
1012793|NCT00570960|2458722|P1|COMPLETED|Overall Study||4
1012794|NCT00570960|2458721|P2|STARTED|Overall Study||4
1012795|NCT00570960|2458722|P1|STARTED|Overall Study||4
1012796|NCT00571038|2458730|P2|NOT COMPLETED|Overall Study||14
1012797|NCT00571038|2458731|P1|NOT COMPLETED|Overall Study||11
1012798|NCT00571038|2458730|P2|COMPLETED|Overall Study|5 died 2 moved 3 asked to be withdrawn 4 unable to reach|171
1012799|NCT00571038|2458731|P1|COMPLETED|Overall Study|"7 died 2 moved
1 asked to be withdrawn
1 unable to reach"|208
1012800|NCT00571038|2458730|P2|18 Month Survey Only|Overall Study||163
1012801|NCT00571038|2458731|P1|18 Month Survey Only|Overall Study||199
1012802|NCT00571038|2458730|P2|6 Month Follow up|Overall Study||176
1012803|NCT00571038|2458731|P1|6 Month Follow up|Overall Study||208
1012804|NCT00571038|2458730|P2|STARTED|Overall Study||185
1012805|NCT00571038|2458731|P1|STARTED|Overall Study||219
1012806|NCT00577889|2458780|P3|NOT COMPLETED|Overall Study||0
1012807|NCT00577889|2458781|P2|NOT COMPLETED|Overall Study||0
1012808|NCT00577889|2458782|P1|NOT COMPLETED|Overall Study||1
1012809|NCT00577889|2458780|P3|COMPLETED|Overall Study||6
1012810|NCT00577889|2458781|P2|COMPLETED|Overall Study||6
1012811|NCT00577889|2458782|P1|COMPLETED|Overall Study||8
1012812|NCT00577889|2458780|P3|STARTED|Overall Study||6
1012813|NCT00577889|2458781|P2|STARTED|Overall Study||6
1012814|NCT00577889|2458782|P1|STARTED|Overall Study||9
1012815|NCT00578071|2458799|P1|NOT COMPLETED|Overall Study||0
1012816|NCT00578071|2458799|P1|COMPLETED|Overall Study||29
1012817|NCT00578071|2458799|P1|STARTED|Overall Study||29
1012818|NCT00578136|2458808|P2|NOT COMPLETED|Overall Study||1
1012819|NCT00578136|2458809|P1|NOT COMPLETED|Overall Study||1
1012820|NCT00578136|2458808|P2|COMPLETED|Overall Study||26
1012821|NCT00578136|2458809|P1|COMPLETED|Overall Study||26
1012822|NCT00578136|2458808|P2|STARTED|Overall Study||27
1012823|NCT00578136|2458809|P1|STARTED|Overall Study||27
1012824|NCT00578175|2458820|P3|NOT COMPLETED|Overall Study||24
1012825|NCT00578175|2458821|P2|NOT COMPLETED|Overall Study||43
1012826|NCT00578175|2458822|P1|NOT COMPLETED|Overall Study||70
1012827|NCT00578175|2458820|P3|COMPLETED|Overall Study||365
1012828|NCT00578175|2458821|P2|COMPLETED|Overall Study||646
1012829|NCT00578175|2458822|P1|COMPLETED|Overall Study||635
1012830|NCT00578175|2458820|P3|STARTED|Overall Study||389
1012831|NCT00578175|2458821|P2|STARTED|Overall Study||689
1012832|NCT00578175|2458822|P1|STARTED|Overall Study||705
1012833|NCT00578214|2458902|P3|NOT COMPLETED|Overall Study||0
1012834|NCT00578214|2458903|P2|NOT COMPLETED|Overall Study||0
1012835|NCT00578214|2458904|P1|NOT COMPLETED|Overall Study||0
1012836|NCT00578214|2458902|P3|COMPLETED|Overall Study||31
1012837|NCT00578214|2458903|P2|COMPLETED|Overall Study||22
1012838|NCT00578214|2458904|P1|COMPLETED|Overall Study||22
1012839|NCT00578214|2458902|P3|STARTED|Overall Study||31
1012840|NCT00578214|2458903|P2|STARTED|Overall Study||22
1012841|NCT00578214|2458904|P1|STARTED|Overall Study||22
1012842|NCT00578227|2458954|P3|NOT COMPLETED|Overall Study||4
1012843|NCT00578227|2458955|P2|NOT COMPLETED|Overall Study||2
1012844|NCT00578227|2458956|P1|NOT COMPLETED|Overall Study||5
1012845|NCT00578227|2458954|P3|COMPLETED|Overall Study||267
1012846|NCT00578227|2458955|P2|COMPLETED|Overall Study||268
1012847|NCT00578227|2458956|P1|COMPLETED|Overall Study||267
1012848|NCT00578227|2458954|P3|STARTED|Overall Study||271
1012849|NCT00578227|2458955|P2|STARTED|Overall Study||270
1012850|NCT00578227|2458956|P1|STARTED|Overall Study||272
1012851|NCT00578864|2459028|P2|NOT COMPLETED|Overall Study||0
1012852|NCT00578864|2459029|P1|NOT COMPLETED|Overall Study||1
1012853|NCT00578864|2459028|P2|COMPLETED|Overall Study||6
1012854|NCT00578864|2459029|P1|COMPLETED|Overall Study|died of complications of surgery after 2 cycles|6
1012855|NCT00578864|2459028|P2|STARTED|Overall Study||6
1012856|NCT00578864|2459029|P1|STARTED|Overall Study||7
1012857|NCT00578877|2459045|P2|NOT COMPLETED|Overall Study||128
1012858|NCT00578877|2459046|P1|NOT COMPLETED|Overall Study||81
1012859|NCT00578877|2459045|P2|COMPLETED|Overall Study||172
1012860|NCT00578877|2459046|P1|COMPLETED|Overall Study||69
1012861|NCT00578877|2459045|P2|STARTED|Overall Study||300
1012862|NCT00578877|2459046|P1|STARTED|Overall Study||150
1012863|NCT00578903|2459052|P1|NOT COMPLETED|Overall Study||0
1012864|NCT00578903|2459052|P1|COMPLETED|Overall Study||22
1012865|NCT00578903|2459052|P1|STARTED|Overall Study||22
1012866|NCT00578929|2459065|P4|NOT COMPLETED|Randomized Period||14
1012867|NCT00578929|2459066|P3|NOT COMPLETED|Randomized Period||8
1012868|NCT00578929|2459067|P2|NOT COMPLETED|Randomized Period||14
1012869|NCT00578929|2459068|P1|NOT COMPLETED|Randomized Period||17
1012870|NCT00578929|2459065|P4|COMPLETED|Randomized Period||283
1012871|NCT00578929|2459066|P3|COMPLETED|Randomized Period||288
1012872|NCT00578929|2459067|P2|COMPLETED|Randomized Period||283
1012873|NCT00578929|2459068|P1|COMPLETED|Randomized Period||281
1012874|NCT00578929|2459065|P4|STARTED|Randomized Period||297
1012875|NCT00578929|2459066|P3|STARTED|Randomized Period||296
1012876|NCT00578929|2459067|P2|STARTED|Randomized Period||297
1012877|NCT00578929|2459068|P1|STARTED|Randomized Period||298
1012878|NCT00578929|2459065|P4|NOT COMPLETED|Vehicle Run-In Period||0
1012879|NCT00578929|2459066|P3|NOT COMPLETED|Vehicle Run-In Period||0
1012880|NCT00578929|2459067|P2|NOT COMPLETED|Vehicle Run-In Period||0
1012881|NCT00578929|2459068|P1|NOT COMPLETED|Vehicle Run-In Period||0
1012882|NCT00578929|2459065|P4|COMPLETED|Vehicle Run-In Period||0
1012883|NCT00578929|2459066|P3|COMPLETED|Vehicle Run-In Period||0
1012884|NCT00578929|2459067|P2|COMPLETED|Vehicle Run-In Period||2388
1012885|NCT00578929|2459068|P1|COMPLETED|Vehicle Run-In Period||0
1012886|NCT00578929|2459065|P4|STARTED|Vehicle Run-In Period||0
1012887|NCT00578929|2459066|P3|STARTED|Vehicle Run-In Period||0
1012888|NCT00578929|2459067|P2|STARTED|Vehicle Run-In Period||2388
1012889|NCT00578929|2459068|P1|STARTED|Vehicle Run-In Period||0
1012890|NCT00578942|2459083|P1|NOT COMPLETED|Overall Study||1
1012891|NCT00578942|2459083|P1|COMPLETED|Overall Study||47
1012892|NCT00578942|2459083|P1|STARTED|Overall Study||48
1012893|NCT00578968|2459092|P3|NOT COMPLETED|Intervention||0
1012894|NCT00578968|2459093|P2|NOT COMPLETED|Intervention||0
1012895|NCT00578968|2459094|P1|NOT COMPLETED|Intervention||0
1012896|NCT00578968|2459092|P3|COMPLETED|Intervention||0
1012897|NCT00578968|2459093|P2|COMPLETED|Intervention||12
1012898|NCT00578968|2459094|P1|COMPLETED|Intervention||12
1012899|NCT00578968|2459092|P3|STARTED|Intervention||0
1012900|NCT00578968|2459093|P2|STARTED|Intervention||12
1012901|NCT00578968|2459094|P1|STARTED|Intervention||12
1012902|NCT00578968|2459092|P3|NOT COMPLETED|Baseline (Prior to Intervention)||0
1012903|NCT00578968|2459093|P2|NOT COMPLETED|Baseline (Prior to Intervention)||0
1012904|NCT00578968|2459094|P1|NOT COMPLETED|Baseline (Prior to Intervention)||0
1012905|NCT00578968|2459092|P3|COMPLETED|Baseline (Prior to Intervention)||12
1012906|NCT00578968|2459093|P2|COMPLETED|Baseline (Prior to Intervention)||12
1012907|NCT00578968|2459094|P1|COMPLETED|Baseline (Prior to Intervention)||12
1012908|NCT00578968|2459092|P3|STARTED|Baseline (Prior to Intervention)||12
1012909|NCT00578968|2459093|P2|STARTED|Baseline (Prior to Intervention)||12
1012910|NCT00578968|2459094|P1|STARTED|Baseline (Prior to Intervention)||12
1012911|NCT00579059|2459157|P2|NOT COMPLETED|Overall Study||10
1012912|NCT00579059|2459158|P1|NOT COMPLETED|Overall Study||21
1012913|NCT00579059|2459157|P2|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
1012914|NCT00579059|2459158|P1|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
1012915|NCT00579059|2459157|P2|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
1012916|NCT00579059|2459158|P1|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
1012917|NCT00579059|2459157|P2|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
1012918|NCT00579059|2459158|P1|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
1012919|NCT00579059|2459157|P2|1 Year|Overall Study|7 patients didn't return for follow-up.|3
1012920|NCT00579059|2459158|P1|1 Year|Overall Study|13 patients didn't return for follow-up.|8
1012921|NCT00579059|2459157|P2|6 Months|Overall Study|6 patients didn't return for follow-up.|4
1012922|NCT00579059|2459158|P1|6 Months|Overall Study|10 Patients didn't return for follow-up.|11
1012923|NCT00579059|2459157|P2|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|9
1012924|NCT00579059|2459158|P1|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|20
1012925|NCT00579059|2459157|P2|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|10
1012926|NCT00579059|2459158|P1|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|21
1012927|NCT00579098|2459168|P2|NOT COMPLETED|Overall Study||8
1012928|NCT00579098|2459169|P1|NOT COMPLETED|Overall Study||9
1012929|NCT00579098|2459168|P2|COMPLETED|Overall Study||55
1012930|NCT00579098|2459169|P1|COMPLETED|Overall Study||53
1012931|NCT00579098|2459168|P2|STARTED|Overall Study||63
1012932|NCT00579098|2459169|P1|STARTED|Overall Study||62
1012933|NCT00579111|2459185|P2|NOT COMPLETED|Overall Study||1
1012934|NCT00579111|2459186|P1|NOT COMPLETED|Overall Study||2
1012935|NCT00579111|2459185|P2|COMPLETED|Overall Study||0
1012936|NCT00579111|2459186|P1|COMPLETED|Overall Study||1
1012937|NCT00579111|2459185|P2|STARTED|Overall Study||1
1012938|NCT00579111|2459186|P1|STARTED|Overall Study||3
1012939|NCT00579137|2459194|P1|NOT COMPLETED|Overall Study||0
1012940|NCT00579137|2459194|P1|COMPLETED|Overall Study||3
1012941|NCT00579137|2459194|P1|STARTED|Overall Study||3
1012942|NCT00579254|2459201|P1|NOT COMPLETED|Overall Study||112
1012943|NCT00579254|2459201|P1|COMPLETED|Overall Study||0
1012944|NCT00579254|2459201|P1|STARTED|Overall Study||112
1012945|NCT00579345|2459213|P8|NOT COMPLETED|Overall Study||2
1012946|NCT00579345|2459214|P7|NOT COMPLETED|Overall Study||0
1012947|NCT00579345|2459215|P6|NOT COMPLETED|Overall Study||0
1012948|NCT00579345|2459216|P5|NOT COMPLETED|Overall Study||0
1012949|NCT00579345|2459217|P4|NOT COMPLETED|Overall Study||1
1012950|NCT00579345|2459218|P3|NOT COMPLETED|Overall Study||2
1012951|NCT00579345|2459219|P2|NOT COMPLETED|Overall Study||1
1012952|NCT00579345|2459220|P1|NOT COMPLETED|Overall Study||5
1012953|NCT00579345|2459213|P8|COMPLETED|Overall Study||42
1012954|NCT00579345|2459214|P7|COMPLETED|Overall Study||57
1012955|NCT00579345|2459215|P6|COMPLETED|Overall Study||78
1012956|NCT00579345|2459216|P5|COMPLETED|Overall Study||90
1012957|NCT00579345|2459217|P4|COMPLETED|Overall Study||143
1012958|NCT00579345|2459218|P3|COMPLETED|Overall Study||389
1012959|NCT00579345|2459219|P2|COMPLETED|Overall Study||168
1012960|NCT00579345|2459220|P1|COMPLETED|Overall Study||544
1012961|NCT00579345|2459213|P8|STARTED|Overall Study||44
1012962|NCT00579345|2459214|P7|STARTED|Overall Study||57
1012963|NCT00579345|2459215|P6|STARTED|Overall Study||78
1012964|NCT00579345|2459216|P5|STARTED|Overall Study||90
1012965|NCT00579345|2459217|P4|STARTED|Overall Study||144
1012966|NCT00579345|2459218|P3|STARTED|Overall Study||391
1012967|NCT00579345|2459219|P2|STARTED|Overall Study||169
1012968|NCT00579345|2459220|P1|STARTED|Overall Study||549
1012969|NCT00579501|2459252|P1|NOT COMPLETED|Overall Study||29
1012970|NCT00579501|2459252|P1|COMPLETED|Overall Study||0
1012971|NCT00579501|2459252|P1|STARTED|Overall Study||29
1012972|NCT00579670|2459262|P5|NOT COMPLETED|Overall Study||0
1012973|NCT00579670|2459263|P4|NOT COMPLETED|Overall Study||22
1012974|NCT00579670|2459264|P3|NOT COMPLETED|Overall Study||4
1012975|NCT00579670|2459265|P2|NOT COMPLETED|Overall Study||1
1012976|NCT00579670|2459266|P1|NOT COMPLETED|Overall Study||2
1012977|NCT00579670|2459262|P5|COMPLETED|Overall Study||5
1012978|NCT00579670|2459263|P4|COMPLETED|Overall Study||263
1012979|NCT00579670|2459264|P3|COMPLETED|Overall Study||84
1012980|NCT00579670|2459265|P2|COMPLETED|Overall Study||56
1012981|NCT00579670|2459266|P1|COMPLETED|Overall Study||13
1012982|NCT00579670|2459262|P5|Population: Within SmPC (Completed)|Overall Study||0
1012983|NCT00579670|2459263|P4|Population: Within SmPC (Completed)|Overall Study|DC: AE N=2; Lack of efficacy N=5; LTFU N=3; Other unspecified N=2|147
1012984|NCT00579670|2459264|P3|Population: Within SmPC (Completed)|Overall Study|DC: AE N=1; Lack of efficacy N=1; Other unspecified N=1; Withdrawal by subject N=1|79
1012985|NCT00579670|2459265|P2|Population: Within SmPC (Completed)|Overall Study|DC: Lost to follow-up (LTFU) N=1|55
1012986|NCT00579670|2459266|P1|Population: Within SmPC (Completed)|Overall Study|Not Completed (DC): Subject died N=1; Adverse Event (AE) N=1|13
1012987|NCT00579670|2459262|P5|Population: Within SmPC (Started)|Overall Study|"Ziprasidone Unknown reporting group is not applicable to the Within SmPC population"|0
1012988|NCT00579670|2459263|P4|Population: Within SmPC (Started)|Overall Study||159
1012989|NCT00579670|2459264|P3|Population: Within SmPC (Started)|Overall Study||83
1012990|NCT00579670|2459265|P2|Population: Within SmPC (Started)|Overall Study||56
1012991|NCT00579670|2459266|P1|Population: Within SmPC (Started)|Overall Study|"Within summary of product characteristics (SmPC): FAS subjects who received all doses Within SmPC"|15
1012992|NCT00579670|2459262|P5|STARTED|Overall Study||5
1012993|NCT00579670|2459263|P4|STARTED|Overall Study||285
1012994|NCT00579670|2459264|P3|STARTED|Overall Study||88
1012995|NCT00579670|2459265|P2|STARTED|Overall Study||57
1012996|NCT00579670|2459266|P1|STARTED|Overall Study|Full Analysis Set (FAS): at least 1 dose study medication and at least 1 efficacy measurement|15
1012997|NCT00579813|2459480|P2|NOT COMPLETED|Overall Study||0
1012998|NCT00579813|2459481|P1|NOT COMPLETED|Overall Study||0
1012999|NCT00579813|2459480|P2|COMPLETED|Overall Study||10
1013000|NCT00579813|2459481|P1|COMPLETED|Overall Study||60
1013001|NCT00579813|2459480|P2|STARTED|Overall Study||10
1013002|NCT00579813|2459481|P1|STARTED|Overall Study||60
1013003|NCT00579826|2459499|P2|NOT COMPLETED|Overall Study||3
1013004|NCT00579826|2459500|P1|NOT COMPLETED|Overall Study||5
1013005|NCT00579826|2459499|P2|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|23
1013006|NCT00579826|2459500|P1|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|24
1013007|NCT00579826|2459499|P2|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|25
1013008|NCT00579826|2459500|P1|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|28
1013009|NCT00579826|2459499|P2|STARTED|Overall Study||26
1013010|NCT00579826|2459500|P1|STARTED|Overall Study||29
1013011|NCT00579982|2459510|P1|NOT COMPLETED|Overall Study||8
1013012|NCT00579982|2459510|P1|COMPLETED|Overall Study||89
1013013|NCT00579982|2459510|P1|STARTED|Overall Study||97
1013014|NCT00580034|2459529|P2|NOT COMPLETED|Overall Study||0
1013015|NCT00580034|2459530|P1|NOT COMPLETED|Overall Study||10
1013016|NCT00580034|2459529|P2|COMPLETED|Overall Study||88
1013017|NCT00580034|2459530|P1|COMPLETED|Overall Study||78
1013018|NCT00580034|2459529|P2|STARTED|Overall Study||88
1013019|NCT00580034|2459530|P1|STARTED|Overall Study||88
1013020|NCT00580073|2459536|P1|NOT COMPLETED|Overall Study||0
1013021|NCT00580073|2459536|P1|COMPLETED|Overall Study||6
1013022|NCT00580073|2459536|P1|STARTED|Overall Study||6
1013023|NCT00580138|2459542|P1|NOT COMPLETED|Overall Study||0
1013024|NCT00580138|2459542|P1|COMPLETED|Overall Study||30
1013025|NCT00580138|2459542|P1|STARTED|Overall Study||30
1013026|NCT00580151|2459548|P2|NOT COMPLETED|Overall Study||0
1013027|NCT00580151|2459549|P1|NOT COMPLETED|Overall Study||0
1013028|NCT00580151|2459548|P2|COMPLETED|Overall Study||0
1013029|NCT00580151|2459549|P1|COMPLETED|Overall Study||9
1013030|NCT00580151|2459548|P2|STARTED|Overall Study||0
1013031|NCT00580151|2459549|P1|STARTED|Overall Study||9
1013032|NCT00580229|2459557|P1|NOT COMPLETED|Overall Study||0
1013033|NCT00580229|2459557|P1|COMPLETED|Overall Study||50
1013034|NCT00580229|2459557|P1|STARTED|Overall Study||50
1013035|NCT00580294|2459561|P1|NOT COMPLETED|Overall Study||0
1013036|NCT00580294|2459561|P1|COMPLETED|Overall Study||12
1013037|NCT00580294|2459561|P1|STARTED|Overall Study||12
1013038|NCT00580333|2459565|P1|NOT COMPLETED|Overall Study||0
1013039|NCT00580333|2459565|P1|COMPLETED|Overall Study||51
1013040|NCT00580333|2459565|P1|STARTED|Overall Study||51
1013041|NCT00580372|2459572|P1|NOT COMPLETED|Overall Study||0
1013042|NCT00580372|2459572|P1|COMPLETED|Overall Study||231
1013043|NCT00580372|2459572|P1|STARTED|Overall Study||231
1013044|NCT00580398|2459578|P2|NOT COMPLETED|Overall Study||0
1013045|NCT00580398|2459579|P1|NOT COMPLETED|Overall Study||0
1013046|NCT00580398|2459578|P2|COMPLETED|Overall Study||32
1013047|NCT00580398|2459579|P1|COMPLETED|Overall Study||17
1013048|NCT00580398|2459578|P2|STARTED|Overall Study||32
1013049|NCT00580398|2459579|P1|STARTED|Overall Study||17
1013050|NCT00580502|2459587|P1|NOT COMPLETED|Overall Study||0
1013051|NCT00580502|2459587|P1|COMPLETED|Overall Study||50
1013052|NCT00580502|2459587|P1|STARTED|Overall Study||50
1013077|NCT00580671|2459618|P3|NOT COMPLETED|Overall Study||17
1013078|NCT00580671|2459619|P2|NOT COMPLETED|Overall Study||16
1013079|NCT00580671|2459620|P1|NOT COMPLETED|Overall Study||16
1013080|NCT00580671|2459618|P3|COMPLETED|Overall Study||34
1013081|NCT00580671|2459619|P2|COMPLETED|Overall Study||35
1013082|NCT00580671|2459620|P1|COMPLETED|Overall Study||35
1013083|NCT00580671|2459618|P3|STARTED|Overall Study||51
1013084|NCT00580671|2459619|P2|STARTED|Overall Study||51
1013085|NCT00580671|2459620|P1|STARTED|Overall Study||51
1013086|NCT00580723|2459634|P1|NOT COMPLETED|Overall Study||8
1013087|NCT00580723|2459634|P1|COMPLETED|Overall Study||16
1013088|NCT00580723|2459634|P1|STARTED|Overall Study||24
1013089|NCT00580788|2459644|P4|NOT COMPLETED|Overall Study||1
1013090|NCT00580788|2459645|P3|NOT COMPLETED|Overall Study||0
1013091|NCT00580788|2459646|P2|NOT COMPLETED|Overall Study||0
1013092|NCT00580788|2459647|P1|NOT COMPLETED|Overall Study||0
1013093|NCT00580788|2459644|P4|COMPLETED|Overall Study|One subject was stopped early for hypertension. One subject completed but was not analyzed.|1
1013094|NCT00580788|2459645|P3|COMPLETED|Overall Study||3
1013095|NCT00580788|2459646|P2|COMPLETED|Overall Study||6
1013096|NCT00580788|2459647|P1|COMPLETED|Overall Study||3
1013097|NCT00580788|2459644|P4|STARTED|Overall Study||2
1013098|NCT00580788|2459645|P3|STARTED|Overall Study||3
1013099|NCT00580788|2459646|P2|STARTED|Overall Study||6
1013100|NCT00580788|2459647|P1|STARTED|Overall Study||3
1013101|NCT00580801|2459708|P3|NOT COMPLETED|Overall Study||3
1013102|NCT00580801|2459709|P2|NOT COMPLETED|Overall Study||1
1013103|NCT00580801|2459710|P1|NOT COMPLETED|Overall Study||6
1013104|NCT00580801|2459708|P3|COMPLETED|Overall Study||5
1013105|NCT00580801|2459709|P2|COMPLETED|Overall Study||7
1013106|NCT00580801|2459710|P1|COMPLETED|Overall Study||2
1013107|NCT00580801|2459708|P3|STARTED|Overall Study||8
1013108|NCT00580801|2459709|P2|STARTED|Overall Study||8
1013109|NCT00580801|2459710|P1|STARTED|Overall Study||8
1013110|NCT00580840|2459745|P4|NOT COMPLETED|Double-Blind||15
1013111|NCT00580840|2459746|P3|NOT COMPLETED|Double-Blind||9
1013112|NCT00580840|2459747|P2|NOT COMPLETED|Double-Blind||7
1013113|NCT00580840|2459748|P1|NOT COMPLETED|Double-Blind||0
1013114|NCT00580840|2459745|P4|COMPLETED|Double-Blind||54
1013115|NCT00580840|2459746|P3|COMPLETED|Double-Blind||61
1013116|NCT00580840|2459747|P2|COMPLETED|Double-Blind||63
1013117|NCT00580840|2459748|P1|COMPLETED|Double-Blind||0
1013118|NCT00580840|2459745|P4|STARTED|Double-Blind||69
1013119|NCT00580840|2459746|P3|STARTED|Double-Blind||70
1013120|NCT00580840|2459747|P2|STARTED|Double-Blind||70
1013121|NCT00580840|2459748|P1|STARTED|Double-Blind||0
1013122|NCT00580840|2459745|P4|NOT COMPLETED|Run-in||0
1013123|NCT00580840|2459746|P3|NOT COMPLETED|Run-in||0
1013124|NCT00580840|2459747|P2|NOT COMPLETED|Run-in||0
1013125|NCT00580840|2459748|P1|NOT COMPLETED|Run-in||124
1013126|NCT00580840|2459745|P4|COMPLETED|Run-in||0
1013127|NCT00580840|2459746|P3|COMPLETED|Run-in||0
1013128|NCT00580840|2459747|P2|COMPLETED|Run-in||0
1013129|NCT00580840|2459748|P1|COMPLETED|Run-in|Of the 209 randomized participants, 208 are in the Full Analysis Set (FAS).|209
1013130|NCT00580840|2459745|P4|STARTED|Run-in||0
1013131|NCT00580840|2459746|P3|STARTED|Run-in||0
1013132|NCT00580840|2459747|P2|STARTED|Run-in||0
1013133|NCT00580840|2459748|P1|STARTED|Run-in|620 subjects were screened for the study with 333 being enrolled.|333
1013134|NCT00580853|2459856|P3|NOT COMPLETED|Overall Study||0
1013135|NCT00580853|2459857|P2|NOT COMPLETED|Overall Study||0
1013136|NCT00580853|2459858|P1|NOT COMPLETED|Overall Study||0
1013137|NCT00580853|2459856|P3|COMPLETED|Overall Study||21
1013138|NCT00580853|2459857|P2|COMPLETED|Overall Study||21
1013139|NCT00580853|2459858|P1|COMPLETED|Overall Study||20
1013140|NCT00580853|2459856|P3|STARTED|Overall Study||21
1013141|NCT00580853|2459857|P2|STARTED|Overall Study||21
1013142|NCT00580853|2459858|P1|STARTED|Overall Study||20
1013143|NCT00580866|2459871|P2|NOT COMPLETED|Overall Study||2
1013144|NCT00580866|2459872|P1|NOT COMPLETED|Overall Study||2
1013145|NCT00580866|2459871|P2|COMPLETED|Overall Study||5
1013146|NCT00580866|2459872|P1|COMPLETED|Overall Study||8
1013147|NCT00580866|2459871|P2|STARTED|Overall Study||7
1013148|NCT00580866|2459872|P1|STARTED|Overall Study||10
1013149|NCT00580957|2459882|P2|NOT COMPLETED|Overall Study||7
1013150|NCT00580957|2459883|P1|NOT COMPLETED|Overall Study||7
1013151|NCT00580957|2459882|P2|COMPLETED|Overall Study||21
1013152|NCT00580957|2459883|P1|COMPLETED|Overall Study||21
1013153|NCT00580957|2459882|P2|STARTED|Overall Study||28
1013154|NCT00580957|2459883|P1|STARTED|Overall Study||28
1013155|NCT00580970|2459891|P1|NOT COMPLETED|Treatment (Lovastatin)||19
1013156|NCT00580970|2459891|P1|COMPLETED|Treatment (Lovastatin)||53
1013157|NCT00580970|2459891|P1|6 Months of Treatment|Treatment (Lovastatin)|Subjects evaluable for analysis|53
1013158|NCT00580970|2459891|P1|STARTED|Treatment (Lovastatin)||72
1013159|NCT00580970|2459891|P1|NOT COMPLETED|Pre-treatment||1
1013160|NCT00580970|2459891|P1|COMPLETED|Pre-treatment||72
1013161|NCT00580970|2459891|P1|STARTED|Pre-treatment||73
1013162|NCT00580983|2459895|P1|NOT COMPLETED|Overall Study||7
1013163|NCT00580983|2459895|P1|COMPLETED|Overall Study||73
1013164|NCT00580983|2459895|P1|STARTED|Overall Study||80
1013165|NCT00581061|2459900|P1|NOT COMPLETED|Overall Study||0
1013166|NCT00581061|2459900|P1|COMPLETED|Overall Study||13
1013167|NCT00581061|2459900|P1|STARTED|Overall Study||13
1013168|NCT00581100|2459908|P2|NOT COMPLETED|Overall Study||5
1013169|NCT00581100|2459909|P1|NOT COMPLETED|Overall Study||7
1013170|NCT00581100|2459908|P2|COMPLETED|Overall Study||29
1013171|NCT00581100|2459909|P1|COMPLETED|Overall Study||31
1013172|NCT00581100|2459908|P2|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|33
1013173|NCT00581100|2459909|P1|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|36
1013174|NCT00581100|2459908|P2|STARTED|Overall Study||34
1013175|NCT00581100|2459909|P1|STARTED|Overall Study||38
1013176|NCT00581113|2459947|P2|NOT COMPLETED|Overall Study||1
1013177|NCT00581113|2459948|P1|NOT COMPLETED|Overall Study||0
1013178|NCT00581113|2459947|P2|COMPLETED|Overall Study||3
1013179|NCT00581113|2459948|P1|COMPLETED|Overall Study||4
1013180|NCT00581113|2459947|P2|STARTED|Overall Study||4
1013181|NCT00581113|2459948|P1|STARTED|Overall Study||4
1013182|NCT00581230|2459956|P1|NOT COMPLETED|Overall Study||0
1013183|NCT00581230|2459956|P1|COMPLETED|Overall Study||51
1013184|NCT00581230|2459956|P1|Laryngoscopy With RAMP|Overall Study||51
1013185|NCT00581230|2459956|P1|Laryngoscopy Without RAMP|Overall Study||51
1013186|NCT00581230|2459956|P1|STARTED|Overall Study||51
1013205|NCT00574067|2459990|P4|NOT COMPLETED|Overall Study||0
1013206|NCT00574067|2459991|P3|NOT COMPLETED|Overall Study||0
1013207|NCT00574067|2459992|P2|NOT COMPLETED|Overall Study||1
1013208|NCT00574067|2459993|P1|NOT COMPLETED|Overall Study||1
1013209|NCT00574067|2459990|P4|COMPLETED|Overall Study||53
1013210|NCT00574067|2459991|P3|COMPLETED|Overall Study||54
1013211|NCT00574067|2459992|P2|COMPLETED|Overall Study||52
1013212|NCT00574067|2459993|P1|COMPLETED|Overall Study||52
1013213|NCT00574067|2459990|P4|STARTED|Overall Study||53
1013214|NCT00574067|2459991|P3|STARTED|Overall Study||54
1013215|NCT00574067|2459992|P2|STARTED|Overall Study||53
1013216|NCT00574067|2459993|P1|STARTED|Overall Study||53
1013223|NCT00574145|2460037|P2|NOT COMPLETED|Overall Study||1
1013224|NCT00574145|2460038|P1|NOT COMPLETED|Overall Study||2
1013225|NCT00574145|2460037|P2|COMPLETED|Overall Study||21
1013226|NCT00574145|2460038|P1|COMPLETED|Overall Study||20
1013227|NCT00574145|2460037|P2|STARTED|Overall Study||22
1013228|NCT00574145|2460038|P1|STARTED|Overall Study||22
1013229|NCT00574171|2460048|P1|NOT COMPLETED|Overall Study||0
1013230|NCT00574171|2460048|P1|COMPLETED|Overall Study||29
1013231|NCT00574171|2460048|P1|STARTED|Overall Study||29
1013232|NCT00574249|2460054|P2|NOT COMPLETED|Overall Study||28
1013233|NCT00574249|2460055|P1|NOT COMPLETED|Overall Study||26
1013234|NCT00574249|2460054|P2|COMPLETED|Overall Study||338
1013235|NCT00574249|2460055|P1|COMPLETED|Overall Study||338
1013236|NCT00574249|2460054|P2|STARTED|Overall Study||366
1013237|NCT00574249|2460055|P1|STARTED|Overall Study||364
1013238|NCT00574275|2460097|P2|NOT COMPLETED|Overall Study||271
1013239|NCT00574275|2460098|P1|NOT COMPLETED|Overall Study||275
1013240|NCT00574275|2460097|P2|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
1013241|NCT00574275|2460098|P1|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
1013242|NCT00574275|2460097|P2|SAFETY POPULATION|Overall Study|Includes 2 participants from the Placebo and Gemcitabine arm who received 1 dose of Aflibercept|270
1013243|NCT00574275|2460098|P1|SAFETY POPULATION|Overall Study|Excludes 2 participants who received 1 dose of Aflibercept|271
1013244|NCT00574275|2460097|P2|TREATED|Overall Study||268
1013245|NCT00574275|2460098|P1|TREATED|Overall Study||273
1013246|NCT00574275|2460097|P2|STARTED|Overall Study||271
1013247|NCT00574275|2460098|P1|STARTED|Overall Study||275
1013248|NCT00574288|2460121|P7|NOT COMPLETED|Overall Study||42
1013249|NCT00574288|2460122|P6|NOT COMPLETED|Overall Study||30
1013250|NCT00574288|2460123|P5|NOT COMPLETED|Overall Study||1
1013251|NCT00574288|2460124|P4|NOT COMPLETED|Overall Study||2
1013252|NCT00574288|2460125|P3|NOT COMPLETED|Overall Study||0
1013253|NCT00574288|2460126|P2|NOT COMPLETED|Overall Study||1
1013254|NCT00574288|2460127|P1|NOT COMPLETED|Overall Study||13
1013255|NCT00574288|2460121|P7|COMPLETED|Overall Study||0
1013256|NCT00574288|2460122|P6|COMPLETED|Overall Study||0
1013257|NCT00574288|2460123|P5|COMPLETED|Overall Study||2
1013258|NCT00574288|2460124|P4|COMPLETED|Overall Study||1
1013259|NCT00574288|2460125|P3|COMPLETED|Overall Study||3
1013260|NCT00574288|2460126|P2|COMPLETED|Overall Study||2
1013261|NCT00574288|2460127|P1|COMPLETED|Overall Study||7
1013262|NCT00574288|2460121|P7|STARTED|Overall Study||42
1013263|NCT00574288|2460122|P6|STARTED|Overall Study||30
1013264|NCT00574288|2460123|P5|STARTED|Overall Study||3
1013265|NCT00574288|2460124|P4|STARTED|Overall Study||3
1013266|NCT00574288|2460125|P3|STARTED|Overall Study||3
1013267|NCT00574288|2460126|P2|STARTED|Overall Study||3
1013268|NCT00574288|2460127|P1|STARTED|Overall Study||20
1013269|NCT00574340|2460163|P2|NOT COMPLETED|Study 2 (2 Days)||0
1013270|NCT00574340|2460164|P1|NOT COMPLETED|Study 2 (2 Days)||0
1013271|NCT00574340|2460163|P2|COMPLETED|Study 2 (2 Days)||6
1013272|NCT00574340|2460164|P1|COMPLETED|Study 2 (2 Days)||6
1013273|NCT00574340|2460163|P2|STARTED|Study 2 (2 Days)||6
1013274|NCT00574340|2460164|P1|STARTED|Study 2 (2 Days)||6
1013275|NCT00574340|2460163|P2|NOT COMPLETED|Study 1 (2 Days)||0
1013276|NCT00574340|2460164|P1|NOT COMPLETED|Study 1 (2 Days)||0
1013277|NCT00574340|2460163|P2|COMPLETED|Study 1 (2 Days)||10
1013278|NCT00574340|2460164|P1|COMPLETED|Study 1 (2 Days)||10
1013279|NCT00574340|2460163|P2|STARTED|Study 1 (2 Days)||10
1013280|NCT00574340|2460164|P1|STARTED|Study 1 (2 Days)||10
1013281|NCT00574405|2460172|P2|NOT COMPLETED|Overall Study||2
1013282|NCT00574405|2460173|P1|NOT COMPLETED|Overall Study||3
1013283|NCT00574405|2460172|P2|COMPLETED|Overall Study||10
1013284|NCT00574405|2460173|P1|COMPLETED|Overall Study||9
1013285|NCT00574405|2460172|P2|STARTED|Overall Study||12
1013286|NCT00574405|2460173|P1|STARTED|Overall Study||12
1013287|NCT00574548|2460181|P2|NOT COMPLETED|Overall Study||16
1013288|NCT00574548|2460182|P1|NOT COMPLETED|Overall Study||61
1013289|NCT00574548|2460181|P2|COMPLETED|Overall Study||222
1013290|NCT00574548|2460182|P1|COMPLETED|Overall Study||421
1013291|NCT00574548|2460181|P2|Completed Vax 2 (6 Month Contact)|Overall Study||222
1013292|NCT00574548|2460182|P1|Completed Vax 2 (6 Month Contact)|Overall Study||421
1013293|NCT00574548|2460181|P2|Received Vax 2|Overall Study||223
1013294|NCT00574548|2460182|P1|Received Vax 2|Overall Study||427
1013295|NCT00574548|2460181|P2|Withdrawn Before Vax 2|Overall Study||11
1013296|NCT00574548|2460182|P1|Withdrawn Before Vax 2|Overall Study||41
1013297|NCT00574548|2460181|P2|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||3
1013298|NCT00574548|2460182|P1|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||7
1013299|NCT00574548|2460181|P2|Completed Vax 1 (6 Month Contact)|Overall Study||234
1013300|NCT00574548|2460182|P1|Completed Vax 1 (6 Month Contact)|Overall Study||468
1013301|NCT00574548|2460181|P2|Received Vaccination 1 (Vax 1)|Overall Study||237
1013302|NCT00574548|2460182|P1|Received Vaccination 1 (Vax 1)|Overall Study||478
1013303|NCT00574548|2460181|P2|STARTED|Overall Study||238
1013304|NCT00574548|2460182|P1|STARTED|Overall Study||482
1013305|NCT00574704|2460230|P4|NOT COMPLETED|Overall Study||0
1013306|NCT00574704|2460231|P3|NOT COMPLETED|Overall Study||1
1013307|NCT00574704|2460232|P2|NOT COMPLETED|Overall Study||0
1013308|NCT00574704|2460233|P1|NOT COMPLETED|Overall Study||0
1013309|NCT00574704|2460230|P4|COMPLETED|Overall Study||10
1013310|NCT00574704|2460231|P3|COMPLETED|Overall Study||9
1013311|NCT00574704|2460232|P2|COMPLETED|Overall Study||10
1013312|NCT00574704|2460233|P1|COMPLETED|Overall Study||10
1013313|NCT00574704|2460230|P4|STARTED|Overall Study||10
1013314|NCT00574704|2460231|P3|STARTED|Overall Study||10
1013315|NCT00574704|2460232|P2|STARTED|Overall Study||10
1013316|NCT00574704|2460233|P1|STARTED|Overall Study||10
1013317|NCT00574795|2460243|P1|NOT COMPLETED|Toddler Dose||1
1013318|NCT00574795|2460243|P1|COMPLETED|Toddler Dose||184
1013319|NCT00574795|2460243|P1|STARTED|Toddler Dose||185
1013320|NCT00574795|2460243|P1|NOT COMPLETED|After Infant Series||3
1013321|NCT00574795|2460243|P1|COMPLETED|After Infant Series||185
1013322|NCT00574795|2460243|P1|STARTED|After Infant Series||188
1013323|NCT00574795|2460243|P1|NOT COMPLETED|Infant Series||5
1013324|NCT00574795|2460243|P1|COMPLETED|Infant Series||188
1013325|NCT00574795|2460243|P1|Vaccinated Dose 3|Infant Series||190
1013326|NCT00574795|2460243|P1|Vaccinated Dose 2|Infant Series||190
1013327|NCT00574795|2460243|P1|Vaccinated Dose 1|Infant Series||193
1013328|NCT00574795|2460243|P1|STARTED|Infant Series||193
1013329|NCT00574834|2460263|P3|NOT COMPLETED|Overall Study||0
1013330|NCT00574834|2460264|P2|NOT COMPLETED|Overall Study||0
1013331|NCT00574834|2460265|P1|NOT COMPLETED|Overall Study||0
1013332|NCT00574834|2460263|P3|COMPLETED|Overall Study||4
1013333|NCT00574834|2460264|P2|COMPLETED|Overall Study||4
1013334|NCT00574834|2460265|P1|COMPLETED|Overall Study||9
1013335|NCT00574834|2460263|P3|STARTED|Overall Study||4
1013336|NCT00574834|2460264|P2|STARTED|Overall Study||4
1013337|NCT00574834|2460265|P1|STARTED|Overall Study||9
1013338|NCT00574847|2460275|P2|NOT COMPLETED|Overall Study||7
1013339|NCT00574847|2460276|P1|NOT COMPLETED|Overall Study||8
1013340|NCT00574847|2460275|P2|COMPLETED|Overall Study||56
1013341|NCT00574847|2460276|P1|COMPLETED|Overall Study||56
1013342|NCT00574847|2460275|P2|STARTED|Overall Study||63
1013343|NCT00574847|2460276|P1|STARTED|Overall Study||64
1013344|NCT00574873|2460310|P2|NOT COMPLETED|Overall Study||251
1013345|NCT00574873|2460311|P1|NOT COMPLETED|Overall Study||238
1013346|NCT00574873|2460310|P2|COMPLETED|Overall Study||1
1013347|NCT00574873|2460311|P1|COMPLETED|Overall Study||12
1013348|NCT00574873|2460310|P2|Treated|Overall Study||251
1013349|NCT00574873|2460311|P1|Treated|Overall Study||248
1013350|NCT00574873|2460310|P2|STARTED|Overall Study||252
1013351|NCT00574873|2460311|P1|STARTED|Overall Study||250
1013352|NCT00574912|2460327|P1|NOT COMPLETED|Overall Study||8
1013353|NCT00574912|2460327|P1|COMPLETED|Overall Study||12
1013354|NCT00574912|2460327|P1|Completed 2.0|Overall Study||12
1013355|NCT00574912|2460327|P1|Completed 1.5|Overall Study||12
1013356|NCT00574912|2460327|P1|Completed 1.0|Overall Study||12
1013357|NCT00574912|2460327|P1|Completed 0.5|Overall Study||12
1013358|NCT00574912|2460327|P1|Completed Placebo|Overall Study|12 original participants started the trial.|12
1013359|NCT00574912|2460327|P1|STARTED|Overall Study||20
1013360|NCT00574990|2460342|P3|NOT COMPLETED|Overall Study||0
1013361|NCT00574990|2460343|P2|NOT COMPLETED|Overall Study||0
1013362|NCT00574990|2460344|P1|NOT COMPLETED|Overall Study||0
1013363|NCT00574990|2460342|P3|COMPLETED|Overall Study||8
1013364|NCT00574990|2460343|P2|COMPLETED|Overall Study||19
1013365|NCT00574990|2460344|P1|COMPLETED|Overall Study||12
1013366|NCT00574990|2460342|P3|STARTED|Overall Study||8
1013367|NCT00574990|2460343|P2|STARTED|Overall Study||19
1013368|NCT00574990|2460344|P1|STARTED|Overall Study||12
1013369|NCT00575016|2460359|P4|NOT COMPLETED|Treatment Cycle 2||0
1013370|NCT00575016|2460360|P3|NOT COMPLETED|Treatment Cycle 2||0
1013371|NCT00575016|2460361|P2|NOT COMPLETED|Treatment Cycle 2||0
1013372|NCT00575016|2460362|P1|NOT COMPLETED|Treatment Cycle 2||1
1013373|NCT00575016|2460359|P4|COMPLETED|Treatment Cycle 2||0
1013374|NCT00575016|2460360|P3|COMPLETED|Treatment Cycle 2||0
1013375|NCT00575016|2460361|P2|COMPLETED|Treatment Cycle 2||0
1013376|NCT00575016|2460362|P1|COMPLETED|Treatment Cycle 2||30
1013377|NCT00575016|2460359|P4|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
1013378|NCT00575016|2460360|P3|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
1013379|NCT00575016|2460361|P2|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
1013380|NCT00575016|2460362|P1|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|31
1013381|NCT00575016|2460359|P4|NOT COMPLETED|Treatment Cycle 1||5
1013382|NCT00575016|2460360|P3|NOT COMPLETED|Treatment Cycle 1||4
1013383|NCT00575016|2460361|P2|NOT COMPLETED|Treatment Cycle 1||5
1013384|NCT00575016|2460362|P1|NOT COMPLETED|Treatment Cycle 1||9
1013385|NCT00575016|2460359|P4|COMPLETED|Treatment Cycle 1|9 pts from Placebo group entered Cycle 2|12
1013386|NCT00575016|2460360|P3|COMPLETED|Treatment Cycle 1|8 pts from 50U group entered Cycle 2|15
1013387|NCT00575016|2460361|P2|COMPLETED|Treatment Cycle 1|11 pts from 100U group entered Cycle 2|16
1013388|NCT00575016|2460362|P1|COMPLETED|Treatment Cycle 1|3 pts from 200U group entered Cycle 2|8
1013389|NCT00575016|2460359|P4|STARTED|Treatment Cycle 1|1 pt randomized to Placebo never received treatment|17
1013390|NCT00575016|2460360|P3|STARTED|Treatment Cycle 1||19
1013391|NCT00575016|2460361|P2|STARTED|Treatment Cycle 1||21
1013392|NCT00575016|2460362|P1|STARTED|Treatment Cycle 1||17
1013393|NCT00575029|2460380|P1|NOT COMPLETED|Overall Study||0
1013394|NCT00575029|2460380|P1|COMPLETED|Overall Study||7
1013395|NCT00575029|2460380|P1|STARTED|Overall Study||7
1013399|NCT00575094|2460390|P1|NOT COMPLETED|Overall Study||3
1013400|NCT00575094|2460390|P1|COMPLETED|Overall Study||6
1013401|NCT00575094|2460390|P1|STARTED|Overall Study||9
1013402|NCT00575146|2460394|P1|NOT COMPLETED|Overall Study||3
1013403|NCT00575146|2460394|P1|COMPLETED|Overall Study||17
1013404|NCT00575146|2460394|P1|STARTED|Overall Study||20
1013408|NCT00575185|2460510|P2|NOT COMPLETED|Overall Study||0
1013409|NCT00575185|2460511|P1|NOT COMPLETED|Overall Study||0
1013410|NCT00575185|2460510|P2|COMPLETED|Overall Study||11
1013411|NCT00575185|2460511|P1|COMPLETED|Overall Study||12
1013412|NCT00575185|2460510|P2|STARTED|Overall Study||11
1013413|NCT00575185|2460511|P1|STARTED|Overall Study||12
1013414|NCT00581347|2460521|P2|NOT COMPLETED|Overall Study||0
1013415|NCT00581347|2460522|P1|NOT COMPLETED|Overall Study||0
1013416|NCT00581347|2460521|P2|COMPLETED|Overall Study||3707
1013417|NCT00581347|2460522|P1|COMPLETED|Overall Study||3839
1013418|NCT00581347|2460521|P2|STARTED|Overall Study||3707
1013419|NCT00581347|2460522|P1|STARTED|Overall Study||3839
1013420|NCT00581360|2460530|P1|NOT COMPLETED|Overall Study||1
1013421|NCT00581360|2460530|P1|COMPLETED|Overall Study||9
1013422|NCT00581360|2460530|P1|STARTED|Overall Study||10
1013423|NCT00581386|2460541|P3|NOT COMPLETED|Overall Study||0
1013424|NCT00581386|2460542|P2|NOT COMPLETED|Overall Study||0
1013425|NCT00581386|2460543|P1|NOT COMPLETED|Overall Study||0
1013426|NCT00581386|2460541|P3|COMPLETED|Overall Study|04/15/2009|72
1013427|NCT00581386|2460542|P2|COMPLETED|Overall Study|04/15/2009|73
1013428|NCT00581386|2460543|P1|COMPLETED|Overall Study|04/15/2009|73
1013429|NCT00581386|2460541|P3|STARTED|Overall Study|05/30/2007|72
1013430|NCT00581386|2460542|P2|STARTED|Overall Study|05/30/2007|73
1013431|NCT00581386|2460543|P1|STARTED|Overall Study|05/30/2007|73
1013432|NCT00581399|2460568|P2|NOT COMPLETED|Overall Study||0
1013433|NCT00581399|2460569|P1|NOT COMPLETED|Overall Study||0
1013434|NCT00581399|2460568|P2|COMPLETED|Overall Study||48
1013435|NCT00581399|2460569|P1|COMPLETED|Overall Study||46
1013436|NCT00581399|2460568|P2|STARTED|Overall Study||48
1013437|NCT00581399|2460569|P1|STARTED|Overall Study||46
1013441|NCT00581542|2460584|P2|NOT COMPLETED|Overall Study||23
1013442|NCT00581542|2460585|P1|NOT COMPLETED|Overall Study||11
1013443|NCT00581542|2460584|P2|COMPLETED|Overall Study||39
1013444|NCT00581542|2460585|P1|COMPLETED|Overall Study||51
1013445|NCT00581542|2460584|P2|STARTED|Overall Study||62
1013446|NCT00581542|2460585|P1|STARTED|Overall Study||62
1013447|NCT00581555|2460595|P2|NOT COMPLETED|Overall Study||20
1013448|NCT00581555|2460596|P1|NOT COMPLETED|Overall Study||43
1013449|NCT00581555|2460595|P2|COMPLETED|Overall Study||38
1013450|NCT00581555|2460596|P1|COMPLETED|Overall Study||19
1013451|NCT00581555|2460595|P2|STARTED|Overall Study||58
1013452|NCT00581555|2460596|P1|STARTED|Overall Study||62
1013453|NCT00581581|2460620|P2|NOT COMPLETED|Overall Study||0
1013454|NCT00581581|2460621|P1|NOT COMPLETED|Overall Study||0
1013455|NCT00581581|2460620|P2|COMPLETED|Overall Study||30
1013456|NCT00581581|2460621|P1|COMPLETED|Overall Study||32
1013457|NCT00581581|2460620|P2|STARTED|Overall Study||30
1013458|NCT00581581|2460621|P1|STARTED|Overall Study||32
1013459|NCT00582660|2460629|P2|NOT COMPLETED|Overall Study||0
1013460|NCT00582660|2460630|P1|NOT COMPLETED|Overall Study||0
1013461|NCT00582660|2460629|P2|COMPLETED|Overall Study||20
1013462|NCT00582660|2460630|P1|COMPLETED|Overall Study||20
1013463|NCT00582660|2460629|P2|STARTED|Overall Study||20
1013464|NCT00582660|2460630|P1|STARTED|Overall Study||20
1013465|NCT00582712|2460638|P1|NOT COMPLETED|Overall Study||4
1013466|NCT00582712|2460638|P1|COMPLETED|Overall Study||1
1013467|NCT00582712|2460638|P1|STARTED|Overall Study||5
1013468|NCT00582738|2460644|P2|NOT COMPLETED|Overall Study||18
1013469|NCT00582738|2460645|P1|NOT COMPLETED|Overall Study||9
1013470|NCT00582738|2460644|P2|COMPLETED|Overall Study||4
1013471|NCT00582738|2460645|P1|COMPLETED|Overall Study||12
1013472|NCT00582738|2460644|P2|STARTED|Overall Study||22
1013473|NCT00582738|2460645|P1|STARTED|Overall Study||21
1013477|NCT00582816|2460676|P1|NOT COMPLETED|Overall Study||3
1013478|NCT00582816|2460676|P1|COMPLETED|Overall Study|"Completed here means patients stably engrafted with donor cells."|6
1013479|NCT00582816|2460676|P1|STARTED|Overall Study||9
1013480|NCT00582894|2460686|P1|NOT COMPLETED|Overall Study||0
1013481|NCT00582894|2460686|P1|COMPLETED|Overall Study||17
1013482|NCT00582894|2460686|P1|Day 100 Post Transplant|Overall Study||17
1013483|NCT00582894|2460686|P1|STARTED|Overall Study||17
1013484|NCT00582907|2460693|P4|NOT COMPLETED|4th Course||0
1013485|NCT00582907|2460694|P3|NOT COMPLETED|4th Course||0
1013486|NCT00582907|2460695|P2|NOT COMPLETED|4th Course||0
1013487|NCT00582907|2460696|P1|NOT COMPLETED|4th Course||0
1013488|NCT00582907|2460693|P4|COMPLETED|4th Course||3
1013489|NCT00582907|2460694|P3|COMPLETED|4th Course||3
1013490|NCT00582907|2460695|P2|COMPLETED|4th Course||3
1013491|NCT00582907|2460696|P1|COMPLETED|4th Course||2
1013492|NCT00582907|2460693|P4|STARTED|4th Course||3
1013493|NCT00582907|2460694|P3|STARTED|4th Course||3
1013494|NCT00582907|2460695|P2|STARTED|4th Course||3
1013495|NCT00582907|2460696|P1|STARTED|4th Course||2
1013496|NCT00582907|2460693|P4|NOT COMPLETED|3rd Course||0
1013497|NCT00582907|2460694|P3|NOT COMPLETED|3rd Course||0
1013498|NCT00582907|2460695|P2|NOT COMPLETED|3rd Course||0
1013499|NCT00582907|2460696|P1|NOT COMPLETED|3rd Course||0
1013500|NCT00582907|2460693|P4|COMPLETED|3rd Course||3
1013501|NCT00582907|2460694|P3|COMPLETED|3rd Course||3
1013502|NCT00582907|2460695|P2|COMPLETED|3rd Course||3
1013503|NCT00582907|2460696|P1|COMPLETED|3rd Course||2
1013504|NCT00582907|2460693|P4|STARTED|3rd Course||3
1013505|NCT00582907|2460694|P3|STARTED|3rd Course||3
1013506|NCT00582907|2460695|P2|STARTED|3rd Course||3
1013507|NCT00582907|2460696|P1|STARTED|3rd Course||2
1013508|NCT00582907|2460693|P4|NOT COMPLETED|2nd Course||0
1013509|NCT00582907|2460694|P3|NOT COMPLETED|2nd Course||0
1013510|NCT00582907|2460695|P2|NOT COMPLETED|2nd Course||0
1013511|NCT00582907|2460696|P1|NOT COMPLETED|2nd Course||1
1013512|NCT00582907|2460693|P4|COMPLETED|2nd Course||3
1013513|NCT00582907|2460694|P3|COMPLETED|2nd Course||3
1013514|NCT00582907|2460695|P2|COMPLETED|2nd Course||3
1013515|NCT00582907|2460696|P1|COMPLETED|2nd Course||2
1013516|NCT00582907|2460693|P4|STARTED|2nd Course||3
1013517|NCT00582907|2460694|P3|STARTED|2nd Course||3
1013518|NCT00582907|2460695|P2|STARTED|2nd Course||3
1013519|NCT00582907|2460696|P1|STARTED|2nd Course||3
1013520|NCT00582907|2460693|P4|NOT COMPLETED|1st Course||1
1013521|NCT00582907|2460694|P3|NOT COMPLETED|1st Course||0
1013522|NCT00582907|2460695|P2|NOT COMPLETED|1st Course||0
1013523|NCT00582907|2460696|P1|NOT COMPLETED|1st Course||1
1013524|NCT00582907|2460693|P4|COMPLETED|1st Course|Patient lost to follow-up towards end of 1st course|3
1013525|NCT00582907|2460694|P3|COMPLETED|1st Course||3
1013526|NCT00582907|2460695|P2|COMPLETED|1st Course||3
1013527|NCT00582907|2460696|P1|COMPLETED|1st Course|1 left after 1st course (transportation issues)|3
1013528|NCT00582907|2460693|P4|STARTED|1st Course||4
1013529|NCT00582907|2460694|P3|STARTED|1st Course||3
1013530|NCT00582907|2460695|P2|STARTED|1st Course||3
1013531|NCT00582907|2460696|P1|STARTED|1st Course||4
1013532|NCT00582933|2460728|P1|NOT COMPLETED|Overall Study||3
1013533|NCT00582933|2460728|P1|COMPLETED|Overall Study||92
1013534|NCT00582933|2460728|P1|STARTED|Overall Study||95
1013535|NCT00582946|2460732|P1|NOT COMPLETED|Overall Study||0
1013536|NCT00582946|2460732|P1|COMPLETED|Overall Study||16
1013537|NCT00582946|2460732|P1|STARTED|Overall Study||16
1013538|NCT00582972|2460736|P1|NOT COMPLETED|Overall Study||2
1013539|NCT00582972|2460736|P1|COMPLETED|Overall Study||21
1013540|NCT00582972|2460736|P1|STARTED|Overall Study||23
1013541|NCT00583115|2460741|P1|NOT COMPLETED|Overall Study||1
1013542|NCT00583115|2460741|P1|COMPLETED|Overall Study||0
1013543|NCT00583115|2460741|P1|STARTED|Overall Study||1
1013544|NCT00583219|2460746|P1|NOT COMPLETED|Phase 2||1
1013545|NCT00583219|2460746|P1|COMPLETED|Phase 2||21
1013546|NCT00583219|2460746|P1|STARTED|Phase 2|6 subjects from P1 continued in P2; plus 16 new subjects. All subjects in P2 got 300 units Botox.|22
1013547|NCT00583219|2460746|P1|NOT COMPLETED|Phase 1||0
1013548|NCT00583219|2460746|P1|COMPLETED|Phase 1||9
1013549|NCT00583219|2460746|P1|STARTED|Phase 1|First 3 subjects in Phase 1 received 200 units Botox. The remaining subjects got 300 units Botox.|9
1013550|NCT00583362|2460763|P1|NOT COMPLETED|Overall Study||202
1013551|NCT00583362|2460763|P1|COMPLETED|Overall Study||96
1013552|NCT00583362|2460763|P1|STARTED|Overall Study||298
1013553|NCT00583453|2460789|P2|NOT COMPLETED|Overall Study||2
1013554|NCT00583453|2460790|P1|NOT COMPLETED|Overall Study||0
1013555|NCT00583453|2460789|P2|COMPLETED|Overall Study||6
1013556|NCT00583453|2460790|P1|COMPLETED|Overall Study||9
1013557|NCT00583453|2460789|P2|STARTED|Overall Study||8
1013558|NCT00583453|2460790|P1|STARTED|Overall Study||9
1013559|NCT00583466|2460804|P1|NOT COMPLETED|Overall Study||0
1013560|NCT00583466|2460804|P1|COMPLETED|Overall Study||18
1013561|NCT00583466|2460804|P1|STARTED|Overall Study||18
1013562|NCT00583492|2460812|P2|NOT COMPLETED|Overall Study||0
1013563|NCT00583492|2460813|P1|NOT COMPLETED|Overall Study||0
1013564|NCT00583492|2460812|P2|COMPLETED|Overall Study||23
1013565|NCT00583492|2460813|P1|COMPLETED|Overall Study||21
1013566|NCT00583492|2460812|P2|STARTED|Overall Study||23
1013567|NCT00583492|2460813|P1|STARTED|Overall Study||21
1013568|NCT00583557|2460829|P1|NOT COMPLETED|Overall Study||70
1013569|NCT00583557|2460829|P1|COMPLETED|Overall Study|Completer defined as subjects whose reason for discontinuation was sponsor discontinuation of study|85
1013570|NCT00583557|2460829|P1|Received at Least 1 Dose Belimumab|Overall Study||153
1013571|NCT00583557|2460829|P1|STARTED|Overall Study||155
1013572|NCT00583596|2460833|P1|NOT COMPLETED|Overall Study||284
1013573|NCT00583596|2460833|P1|COMPLETED|Overall Study||152
1013574|NCT00583596|2460833|P1|STARTED|Overall Study|Subjects in Phase 2 clinical trial who received the AMPLATZER Duct Occluder.|436
1013575|NCT00583622|2460838|P1|NOT COMPLETED|Overall Study||0
1013576|NCT00583622|2460838|P1|COMPLETED|Overall Study||12
1013577|NCT00583622|2460838|P1|STARTED|Overall Study||12
1013578|NCT00583661|2460843|P1|NOT COMPLETED|Overall Study||0
1013579|NCT00583661|2460843|P1|COMPLETED|Overall Study||48
1013580|NCT00583661|2460843|P1|STARTED|Overall Study||48
1013581|NCT00583700|2460852|P2|NOT COMPLETED|Overall Study||4
1013582|NCT00583700|2460853|P1|NOT COMPLETED|Overall Study||3
1013583|NCT00583700|2460852|P2|COMPLETED|Overall Study||23
1013584|NCT00583700|2460853|P1|COMPLETED|Overall Study||24
1013585|NCT00583700|2460852|P2|STARTED|Overall Study||27
1013586|NCT00583700|2460853|P1|STARTED|Overall Study||27
1013587|NCT00583713|2460864|P3|NOT COMPLETED|Overall Study||0
1013588|NCT00583713|2460865|P2|NOT COMPLETED|Overall Study||0
1013589|NCT00583713|2460866|P1|NOT COMPLETED|Overall Study||0
1013590|NCT00583713|2460864|P3|COMPLETED|Overall Study||6
1013591|NCT00583713|2460865|P2|COMPLETED|Overall Study||6
1013592|NCT00583713|2460866|P1|COMPLETED|Overall Study||6
1013593|NCT00583713|2460864|P3|STARTED|Overall Study||6
1013594|NCT00583713|2460865|P2|STARTED|Overall Study||6
1013595|NCT00583713|2460866|P1|STARTED|Overall Study||6
1013596|NCT00583908|2460889|P12|NOT COMPLETED|Period 4 - Fourth Intervention||0
1013597|NCT00583908|2460890|P11|NOT COMPLETED|Period 4 - Fourth Intervention||0
1013598|NCT00583908|2460891|P10|NOT COMPLETED|Period 4 - Fourth Intervention||0
1013599|NCT00583908|2460892|P9|NOT COMPLETED|Period 4 - Fourth Intervention||0
1013600|NCT00583908|2460893|P8|NOT COMPLETED|Period 4 - Fourth Intervention||0
1013601|NCT00583908|2460894|P7|NOT COMPLETED|Period 4 - Fourth Intervention||0
1013602|NCT00583908|2460895|P6|NOT COMPLETED|Period 4 - Fourth Intervention||0
1013603|NCT00583908|2460896|P5|NOT COMPLETED|Period 4 - Fourth Intervention||0
1013604|NCT00583908|2460897|P4|NOT COMPLETED|Period 4 - Fourth Intervention||0
1013605|NCT00583908|2460898|P3|NOT COMPLETED|Period 4 - Fourth Intervention||0
1013606|NCT00583908|2460899|P2|NOT COMPLETED|Period 4 - Fourth Intervention||0
1013607|NCT00583908|2460900|P1|NOT COMPLETED|Period 4 - Fourth Intervention||0
1013608|NCT00583908|2460889|P12|COMPLETED|Period 4 - Fourth Intervention||1
1013609|NCT00583908|2460890|P11|COMPLETED|Period 4 - Fourth Intervention||1
1013610|NCT00583908|2460891|P10|COMPLETED|Period 4 - Fourth Intervention||1
1013611|NCT00583908|2460892|P9|COMPLETED|Period 4 - Fourth Intervention||1
1013612|NCT00583908|2460893|P8|COMPLETED|Period 4 - Fourth Intervention||1
1013613|NCT00583908|2460894|P7|COMPLETED|Period 4 - Fourth Intervention||1
1013614|NCT00583908|2460895|P6|COMPLETED|Period 4 - Fourth Intervention||1
1013615|NCT00583908|2460896|P5|COMPLETED|Period 4 - Fourth Intervention||2
1013616|NCT00583908|2460897|P4|COMPLETED|Period 4 - Fourth Intervention||1
1013617|NCT00583908|2460898|P3|COMPLETED|Period 4 - Fourth Intervention||1
1013618|NCT00583908|2460899|P2|COMPLETED|Period 4 - Fourth Intervention||2
1013619|NCT00583908|2460900|P1|COMPLETED|Period 4 - Fourth Intervention||1
1013620|NCT00583908|2460889|P12|STARTED|Period 4 - Fourth Intervention||1
1013621|NCT00583908|2460890|P11|STARTED|Period 4 - Fourth Intervention||1
1013622|NCT00583908|2460891|P10|STARTED|Period 4 - Fourth Intervention||1
1013623|NCT00583908|2460892|P9|STARTED|Period 4 - Fourth Intervention||1
1013624|NCT00583908|2460893|P8|STARTED|Period 4 - Fourth Intervention||1
1013625|NCT00583908|2460894|P7|STARTED|Period 4 - Fourth Intervention||1
1013626|NCT00583908|2460895|P6|STARTED|Period 4 - Fourth Intervention||1
1013627|NCT00583908|2460896|P5|STARTED|Period 4 - Fourth Intervention||2
1013628|NCT00583908|2460897|P4|STARTED|Period 4 - Fourth Intervention||1
1013629|NCT00583908|2460898|P3|STARTED|Period 4 - Fourth Intervention||1
1013630|NCT00583908|2460899|P2|STARTED|Period 4 - Fourth Intervention||2
1013631|NCT00583908|2460900|P1|STARTED|Period 4 - Fourth Intervention||1
1013632|NCT00583908|2460889|P12|NOT COMPLETED|Period 3 - Third Intervention||0
1013633|NCT00583908|2460890|P11|NOT COMPLETED|Period 3 - Third Intervention||0
1013634|NCT00583908|2460891|P10|NOT COMPLETED|Period 3 - Third Intervention||0
1013635|NCT00583908|2460892|P9|NOT COMPLETED|Period 3 - Third Intervention||0
1013636|NCT00583908|2460893|P8|NOT COMPLETED|Period 3 - Third Intervention||0
1013637|NCT00583908|2460894|P7|NOT COMPLETED|Period 3 - Third Intervention||0
1013638|NCT00583908|2460895|P6|NOT COMPLETED|Period 3 - Third Intervention||0
1013639|NCT00583908|2460896|P5|NOT COMPLETED|Period 3 - Third Intervention||0
1013640|NCT00583908|2460897|P4|NOT COMPLETED|Period 3 - Third Intervention||0
1013641|NCT00583908|2460898|P3|NOT COMPLETED|Period 3 - Third Intervention||0
1013642|NCT00583908|2460899|P2|NOT COMPLETED|Period 3 - Third Intervention||0
1013643|NCT00583908|2460900|P1|NOT COMPLETED|Period 3 - Third Intervention||0
1013644|NCT00583908|2460889|P12|COMPLETED|Period 3 - Third Intervention||1
1013645|NCT00583908|2460890|P11|COMPLETED|Period 3 - Third Intervention||1
1013646|NCT00583908|2460891|P10|COMPLETED|Period 3 - Third Intervention||1
1013647|NCT00583908|2460892|P9|COMPLETED|Period 3 - Third Intervention||1
1013648|NCT00583908|2460893|P8|COMPLETED|Period 3 - Third Intervention||1
1013649|NCT00583908|2460894|P7|COMPLETED|Period 3 - Third Intervention||1
1013650|NCT00583908|2460895|P6|COMPLETED|Period 3 - Third Intervention||1
1013651|NCT00583908|2460896|P5|COMPLETED|Period 3 - Third Intervention||2
1013652|NCT00583908|2460897|P4|COMPLETED|Period 3 - Third Intervention||1
1013653|NCT00583908|2460898|P3|COMPLETED|Period 3 - Third Intervention||1
1013654|NCT00583908|2460899|P2|COMPLETED|Period 3 - Third Intervention||2
1013655|NCT00583908|2460900|P1|COMPLETED|Period 3 - Third Intervention||1
1013656|NCT00583908|2460889|P12|STARTED|Period 3 - Third Intervention||1
1013657|NCT00583908|2460890|P11|STARTED|Period 3 - Third Intervention||1
1013658|NCT00583908|2460891|P10|STARTED|Period 3 - Third Intervention||1
1013659|NCT00583908|2460892|P9|STARTED|Period 3 - Third Intervention||1
1013660|NCT00583908|2460893|P8|STARTED|Period 3 - Third Intervention||1
1013661|NCT00583908|2460894|P7|STARTED|Period 3 - Third Intervention||1
1013662|NCT00583908|2460895|P6|STARTED|Period 3 - Third Intervention||1
1013663|NCT00583908|2460896|P5|STARTED|Period 3 - Third Intervention||2
1013664|NCT00583908|2460897|P4|STARTED|Period 3 - Third Intervention||1
1013665|NCT00583908|2460898|P3|STARTED|Period 3 - Third Intervention||1
1013666|NCT00583908|2460899|P2|STARTED|Period 3 - Third Intervention||2
1013667|NCT00583908|2460900|P1|STARTED|Period 3 - Third Intervention||1
1013668|NCT00583908|2460889|P12|NOT COMPLETED|Period 2 - Second Intervention||0
1013669|NCT00583908|2460890|P11|NOT COMPLETED|Period 2 - Second Intervention||0
1013670|NCT00583908|2460891|P10|NOT COMPLETED|Period 2 - Second Intervention||0
1013671|NCT00583908|2460892|P9|NOT COMPLETED|Period 2 - Second Intervention||0
1013672|NCT00583908|2460893|P8|NOT COMPLETED|Period 2 - Second Intervention||0
1013673|NCT00583908|2460894|P7|NOT COMPLETED|Period 2 - Second Intervention||0
1013674|NCT00583908|2460895|P6|NOT COMPLETED|Period 2 - Second Intervention||0
1013675|NCT00583908|2460896|P5|NOT COMPLETED|Period 2 - Second Intervention||0
1013676|NCT00583908|2460897|P4|NOT COMPLETED|Period 2 - Second Intervention||0
1013677|NCT00583908|2460898|P3|NOT COMPLETED|Period 2 - Second Intervention||0
1013678|NCT00583908|2460899|P2|NOT COMPLETED|Period 2 - Second Intervention||0
1013679|NCT00583908|2460900|P1|NOT COMPLETED|Period 2 - Second Intervention||0
1013680|NCT00583908|2460889|P12|COMPLETED|Period 2 - Second Intervention||1
1013681|NCT00583908|2460890|P11|COMPLETED|Period 2 - Second Intervention||1
1013682|NCT00583908|2460891|P10|COMPLETED|Period 2 - Second Intervention||1
1013683|NCT00583908|2460892|P9|COMPLETED|Period 2 - Second Intervention||1
1013684|NCT00583908|2460893|P8|COMPLETED|Period 2 - Second Intervention||1
1013685|NCT00583908|2460894|P7|COMPLETED|Period 2 - Second Intervention||1
1013686|NCT00583908|2460895|P6|COMPLETED|Period 2 - Second Intervention||1
1013687|NCT00583908|2460896|P5|COMPLETED|Period 2 - Second Intervention||2
1013688|NCT00583908|2460897|P4|COMPLETED|Period 2 - Second Intervention||1
1013689|NCT00583908|2460898|P3|COMPLETED|Period 2 - Second Intervention||1
1013690|NCT00583908|2460899|P2|COMPLETED|Period 2 - Second Intervention||2
1013691|NCT00583908|2460900|P1|COMPLETED|Period 2 - Second Intervention||1
1013692|NCT00583908|2460889|P12|STARTED|Period 2 - Second Intervention||1
1013693|NCT00583908|2460890|P11|STARTED|Period 2 - Second Intervention||1
1013694|NCT00583908|2460891|P10|STARTED|Period 2 - Second Intervention||1
1013695|NCT00583908|2460892|P9|STARTED|Period 2 - Second Intervention||1
1013696|NCT00583908|2460893|P8|STARTED|Period 2 - Second Intervention||1
1013697|NCT00583908|2460894|P7|STARTED|Period 2 - Second Intervention||1
1013698|NCT00583908|2460895|P6|STARTED|Period 2 - Second Intervention||1
1013699|NCT00583908|2460896|P5|STARTED|Period 2 - Second Intervention||2
1013700|NCT00583908|2460897|P4|STARTED|Period 2 - Second Intervention||1
1013701|NCT00583908|2460898|P3|STARTED|Period 2 - Second Intervention||1
1013702|NCT00583908|2460899|P2|STARTED|Period 2 - Second Intervention||2
1013703|NCT00583908|2460900|P1|STARTED|Period 2 - Second Intervention||1
1013704|NCT00583908|2460889|P12|NOT COMPLETED|Period 1 - First Intervention||0
1013705|NCT00583908|2460890|P11|NOT COMPLETED|Period 1 - First Intervention||0
1013706|NCT00583908|2460891|P10|NOT COMPLETED|Period 1 - First Intervention||0
1013707|NCT00583908|2460892|P9|NOT COMPLETED|Period 1 - First Intervention||0
1013708|NCT00583908|2460893|P8|NOT COMPLETED|Period 1 - First Intervention||0
1013709|NCT00583908|2460894|P7|NOT COMPLETED|Period 1 - First Intervention||0
1013710|NCT00583908|2460895|P6|NOT COMPLETED|Period 1 - First Intervention||0
1013711|NCT00583908|2460896|P5|NOT COMPLETED|Period 1 - First Intervention||0
1013712|NCT00583908|2460897|P4|NOT COMPLETED|Period 1 - First Intervention||0
1013713|NCT00583908|2460898|P3|NOT COMPLETED|Period 1 - First Intervention||0
1013714|NCT00583908|2460899|P2|NOT COMPLETED|Period 1 - First Intervention||0
1013715|NCT00583908|2460900|P1|NOT COMPLETED|Period 1 - First Intervention||0
1013716|NCT00583908|2460889|P12|COMPLETED|Period 1 - First Intervention||1
1013717|NCT00583908|2460890|P11|COMPLETED|Period 1 - First Intervention||1
1013718|NCT00583908|2460891|P10|COMPLETED|Period 1 - First Intervention||1
1013719|NCT00583908|2460892|P9|COMPLETED|Period 1 - First Intervention||1
1013720|NCT00583908|2460893|P8|COMPLETED|Period 1 - First Intervention||1
1013721|NCT00583908|2460894|P7|COMPLETED|Period 1 - First Intervention||1
1013722|NCT00583908|2460895|P6|COMPLETED|Period 1 - First Intervention||1
1013723|NCT00583908|2460896|P5|COMPLETED|Period 1 - First Intervention||2
1013724|NCT00583908|2460897|P4|COMPLETED|Period 1 - First Intervention||1
1013725|NCT00583908|2460898|P3|COMPLETED|Period 1 - First Intervention||1
1013726|NCT00583908|2460899|P2|COMPLETED|Period 1 - First Intervention||2
1013727|NCT00583908|2460900|P1|COMPLETED|Period 1 - First Intervention||1
1013728|NCT00583908|2460889|P12|STARTED|Period 1 - First Intervention||1
1013729|NCT00583908|2460890|P11|STARTED|Period 1 - First Intervention||1
1013730|NCT00583908|2460891|P10|STARTED|Period 1 - First Intervention||1
1013731|NCT00583908|2460892|P9|STARTED|Period 1 - First Intervention||1
1013732|NCT00583908|2460893|P8|STARTED|Period 1 - First Intervention||1
1013733|NCT00583908|2460894|P7|STARTED|Period 1 - First Intervention||1
1013734|NCT00583908|2460895|P6|STARTED|Period 1 - First Intervention||1
1013735|NCT00583908|2460896|P5|STARTED|Period 1 - First Intervention||2
1013736|NCT00583908|2460897|P4|STARTED|Period 1 - First Intervention||1
1013737|NCT00583908|2460898|P3|STARTED|Period 1 - First Intervention||1
1013738|NCT00583908|2460899|P2|STARTED|Period 1 - First Intervention||2
1013739|NCT00583908|2460900|P1|STARTED|Period 1 - First Intervention||1
1013740|NCT00583947|2460956|P2|NOT COMPLETED|Open Label Period||0
1013741|NCT00583947|2460957|P1|NOT COMPLETED|Open Label Period||0
1013742|NCT00583947|2460956|P2|COMPLETED|Open Label Period||24
1013743|NCT00583947|2460957|P1|COMPLETED|Open Label Period||22
1013744|NCT00583947|2460956|P2|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|24
1013745|NCT00583947|2460957|P1|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|22
1013746|NCT00583947|2460956|P2|NOT COMPLETED|Washout||0
1013747|NCT00583947|2460957|P1|NOT COMPLETED|Washout||0
1013748|NCT00583947|2460956|P2|COMPLETED|Washout||24
1013749|NCT00583947|2460957|P1|COMPLETED|Washout||22
1013750|NCT00583947|2460956|P2|STARTED|Washout||24
1013751|NCT00583947|2460957|P1|STARTED|Washout||22
1013752|NCT00583947|2460956|P2|NOT COMPLETED|Cross-over Period||2
1013753|NCT00583947|2460957|P1|NOT COMPLETED|Cross-over Period||5
1013754|NCT00583947|2460956|P2|COMPLETED|Cross-over Period||24
1013755|NCT00583947|2460957|P1|COMPLETED|Cross-over Period||22
1013756|NCT00583947|2460956|P2|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|26
1013757|NCT00583947|2460957|P1|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|27
1013758|NCT00584077|2461007|P1|NOT COMPLETED|Overall Study||0
1013759|NCT00584077|2461007|P1|COMPLETED|Overall Study||15
1013760|NCT00584077|2461007|P1|STARTED|Overall Study||15
1013761|NCT00584194|2461011|P1|NOT COMPLETED|Overall Study||135
1013762|NCT00584194|2461011|P1|COMPLETED|Overall Study||143
1013763|NCT00584194|2461011|P1|STARTED|Overall Study||278
1013764|NCT00584220|2461019|P2|NOT COMPLETED|Second Period||0
1013765|NCT00584220|2461020|P1|NOT COMPLETED|Second Period||0
1013766|NCT00584220|2461019|P2|COMPLETED|Second Period||39
1013767|NCT00584220|2461020|P1|COMPLETED|Second Period||48
1013768|NCT00584220|2461019|P2|STARTED|Second Period||39
1013769|NCT00584220|2461020|P1|STARTED|Second Period||48
1013770|NCT00584220|2461019|P2|NOT COMPLETED|First Period||0
1013771|NCT00584220|2461020|P1|NOT COMPLETED|First Period||0
1013772|NCT00584220|2461019|P2|COMPLETED|First Period||39
1013773|NCT00584220|2461020|P1|COMPLETED|First Period||48
1013774|NCT00584220|2461019|P2|STARTED|First Period||39
1013775|NCT00584220|2461020|P1|STARTED|First Period||48
1013776|NCT00584402|2461028|P1|NOT COMPLETED|Overall Study||0
1013777|NCT00584402|2461028|P1|COMPLETED|Overall Study||8
1013778|NCT00584402|2461028|P1|STARTED|Overall Study||8
1013779|NCT00584415|2461033|P1|NOT COMPLETED|Overall Study||7
1013780|NCT00584415|2461033|P1|COMPLETED|Overall Study||112
1013781|NCT00584415|2461033|P1|STARTED|Overall Study|A total of 119 enrolled and 112 underwent the ablation procedure;|119
1013782|NCT00584454|2461038|P1|NOT COMPLETED|Overall Study||4
1013783|NCT00584454|2461038|P1|COMPLETED|Overall Study||6
1013784|NCT00584454|2461038|P1|STARTED|Overall Study||10
1013785|NCT00584480|2461042|P1|NOT COMPLETED|Second 8 Weeks (40 Treatments)||0
1013786|NCT00584480|2461042|P1|COMPLETED|Second 8 Weeks (40 Treatments)||10
1013787|NCT00584480|2461042|P1|STARTED|Second 8 Weeks (40 Treatments)||10
1013788|NCT00584480|2461042|P1|NOT COMPLETED|4-Week Break From Treatment||0
1013789|NCT00584480|2461042|P1|COMPLETED|4-Week Break From Treatment||10
1013790|NCT00584480|2461042|P1|STARTED|4-Week Break From Treatment||10
1013791|NCT00584480|2461042|P1|NOT COMPLETED|First 8 Weeks (40 Treatments)||0
1013792|NCT00584480|2461042|P1|COMPLETED|First 8 Weeks (40 Treatments)||10
1013793|NCT00584480|2461042|P1|STARTED|First 8 Weeks (40 Treatments)||10
1013794|NCT00584558|2461046|P1|NOT COMPLETED|Overall Study||0
1013795|NCT00584558|2461046|P1|COMPLETED|Overall Study||2420
1013796|NCT00584558|2461046|P1|STARTED|Overall Study||2420
1013797|NCT00584701|2461051|P1|NOT COMPLETED|Follow-up||12
1013798|NCT00584701|2461051|P1|COMPLETED|Follow-up||34
1013799|NCT00584701|2461051|P1|STARTED|Follow-up||46
1013800|NCT00584701|2461051|P1|NOT COMPLETED|Active Risperidone||3
1013801|NCT00584701|2461051|P1|COMPLETED|Active Risperidone||46
1013802|NCT00584701|2461051|P1|STARTED|Active Risperidone||49
1013803|NCT00584727|2461056|P6|NOT COMPLETED|Third Intervention||2
1013804|NCT00584727|2461057|P5|NOT COMPLETED|Third Intervention||4
1013805|NCT00584727|2461058|P4|NOT COMPLETED|Third Intervention||0
1013806|NCT00584727|2461059|P3|NOT COMPLETED|Third Intervention||1
1013807|NCT00584727|2461060|P2|NOT COMPLETED|Third Intervention||0
1013808|NCT00584727|2461061|P1|NOT COMPLETED|Third Intervention||0
1013809|NCT00584727|2461056|P6|COMPLETED|Third Intervention||14
1013810|NCT00584727|2461057|P5|COMPLETED|Third Intervention||12
1013811|NCT00584727|2461058|P4|COMPLETED|Third Intervention||14
1013812|NCT00584727|2461059|P3|COMPLETED|Third Intervention||14
1013813|NCT00584727|2461060|P2|COMPLETED|Third Intervention||17
1013814|NCT00584727|2461061|P1|COMPLETED|Third Intervention||17
1013815|NCT00584727|2461056|P6|STARTED|Third Intervention||16
1013816|NCT00584727|2461057|P5|STARTED|Third Intervention||16
1013817|NCT00584727|2461058|P4|STARTED|Third Intervention||14
1013818|NCT00584727|2461059|P3|STARTED|Third Intervention||15
1013819|NCT00584727|2461060|P2|STARTED|Third Intervention||17
1013820|NCT00584727|2461061|P1|STARTED|Third Intervention||17
1013821|NCT00584727|2461056|P6|NOT COMPLETED|Second Intervention||0
1013822|NCT00584727|2461057|P5|NOT COMPLETED|Second Intervention||0
1013823|NCT00584727|2461058|P4|NOT COMPLETED|Second Intervention||0
1013824|NCT00584727|2461059|P3|NOT COMPLETED|Second Intervention||0
1013825|NCT00584727|2461060|P2|NOT COMPLETED|Second Intervention||0
1013826|NCT00584727|2461061|P1|NOT COMPLETED|Second Intervention||0
1013827|NCT00584727|2461056|P6|COMPLETED|Second Intervention||16
1013828|NCT00584727|2461057|P5|COMPLETED|Second Intervention||16
1013829|NCT00584727|2461058|P4|COMPLETED|Second Intervention||14
1013830|NCT00584727|2461059|P3|COMPLETED|Second Intervention||15
1013831|NCT00584727|2461060|P2|COMPLETED|Second Intervention||17
1013832|NCT00584727|2461061|P1|COMPLETED|Second Intervention||17
1013833|NCT00584727|2461056|P6|STARTED|Second Intervention||16
1013834|NCT00584727|2461057|P5|STARTED|Second Intervention||16
1013835|NCT00584727|2461058|P4|STARTED|Second Intervention||14
1013836|NCT00584727|2461059|P3|STARTED|Second Intervention||15
1013837|NCT00584727|2461060|P2|STARTED|Second Intervention||17
1013838|NCT00584727|2461061|P1|STARTED|Second Intervention||17
1013839|NCT00584727|2461056|P6|NOT COMPLETED|First Intervention||0
1013840|NCT00584727|2461057|P5|NOT COMPLETED|First Intervention||0
1013841|NCT00584727|2461058|P4|NOT COMPLETED|First Intervention||0
1013842|NCT00584727|2461059|P3|NOT COMPLETED|First Intervention||1
1013843|NCT00584727|2461060|P2|NOT COMPLETED|First Intervention||0
1013844|NCT00584727|2461061|P1|NOT COMPLETED|First Intervention||0
1013845|NCT00584727|2461056|P6|COMPLETED|First Intervention||16
1013846|NCT00584727|2461057|P5|COMPLETED|First Intervention||16
1013847|NCT00584727|2461058|P4|COMPLETED|First Intervention||14
1013848|NCT00584727|2461059|P3|COMPLETED|First Intervention||15
1013849|NCT00584727|2461060|P2|COMPLETED|First Intervention||17
1013850|NCT00584727|2461061|P1|COMPLETED|First Intervention||17
1013851|NCT00584727|2461056|P6|STARTED|First Intervention||16
1013852|NCT00584727|2461057|P5|STARTED|First Intervention||16
1013853|NCT00584727|2461058|P4|STARTED|First Intervention||14
1013854|NCT00584727|2461059|P3|STARTED|First Intervention||16
1013855|NCT00584727|2461060|P2|STARTED|First Intervention||17
1013856|NCT00584727|2461061|P1|STARTED|First Intervention||17
1013857|NCT00584740|2461087|P2|NOT COMPLETED|Overall Study||6
1013858|NCT00584740|2461088|P1|NOT COMPLETED|Overall Study||12
1013859|NCT00584740|2461087|P2|COMPLETED|Overall Study||14
1013860|NCT00584740|2461088|P1|COMPLETED|Overall Study||27
1013861|NCT00584740|2461087|P2|STARTED|Overall Study||20
1013862|NCT00584740|2461088|P1|STARTED|Overall Study||39
1013863|NCT00584831|2461106|P19|NOT COMPLETED|Intervention 4||0
1013864|NCT00584831|2461107|P18|NOT COMPLETED|Intervention 4||0
1013865|NCT00584831|2461108|P17|NOT COMPLETED|Intervention 4||0
1013866|NCT00584831|2461109|P16|NOT COMPLETED|Intervention 4||0
1013867|NCT00584831|2461110|P15|NOT COMPLETED|Intervention 4||0
1013868|NCT00584831|2461111|P14|NOT COMPLETED|Intervention 4||0
1013869|NCT00584831|2461112|P13|NOT COMPLETED|Intervention 4||0
1013870|NCT00584831|2461113|P12|NOT COMPLETED|Intervention 4||0
1013871|NCT00584831|2461114|P11|NOT COMPLETED|Intervention 4||0
1013872|NCT00584831|2461115|P10|NOT COMPLETED|Intervention 4||0
1013873|NCT00584831|2461116|P9|NOT COMPLETED|Intervention 4||0
1013874|NCT00584831|2461117|P8|NOT COMPLETED|Intervention 4||0
1013875|NCT00584831|2461118|P7|NOT COMPLETED|Intervention 4||0
1013876|NCT00584831|2461119|P6|NOT COMPLETED|Intervention 4||0
1013877|NCT00584831|2461120|P5|NOT COMPLETED|Intervention 4||0
1013878|NCT00584831|2461121|P4|NOT COMPLETED|Intervention 4||0
1013879|NCT00584831|2461122|P3|NOT COMPLETED|Intervention 4||0
1013880|NCT00584831|2461123|P2|NOT COMPLETED|Intervention 4||0
1013881|NCT00584831|2461124|P1|NOT COMPLETED|Intervention 4||0
1013882|NCT00584831|2461106|P19|COMPLETED|Intervention 4||1
1013883|NCT00584831|2461107|P18|COMPLETED|Intervention 4||1
1013884|NCT00584831|2461108|P17|COMPLETED|Intervention 4||4
1013885|NCT00584831|2461109|P16|COMPLETED|Intervention 4||1
1013886|NCT00584831|2461110|P15|COMPLETED|Intervention 4||2
1013887|NCT00584831|2461111|P14|COMPLETED|Intervention 4||1
1013888|NCT00584831|2461112|P13|COMPLETED|Intervention 4||2
1013889|NCT00584831|2461113|P12|COMPLETED|Intervention 4||1
1013890|NCT00584831|2461114|P11|COMPLETED|Intervention 4||2
1013891|NCT00584831|2461115|P10|COMPLETED|Intervention 4||2
1013892|NCT00584831|2461116|P9|COMPLETED|Intervention 4||3
1013893|NCT00584831|2461117|P8|COMPLETED|Intervention 4||2
1013894|NCT00584831|2461118|P7|COMPLETED|Intervention 4||6
1013895|NCT00584831|2461119|P6|COMPLETED|Intervention 4||1
1013896|NCT00584831|2461120|P5|COMPLETED|Intervention 4||2
1013897|NCT00584831|2461121|P4|COMPLETED|Intervention 4||1
1013898|NCT00584831|2461122|P3|COMPLETED|Intervention 4||2
1013899|NCT00584831|2461123|P2|COMPLETED|Intervention 4||3
1013900|NCT00584831|2461124|P1|COMPLETED|Intervention 4||1
1013901|NCT00584831|2461106|P19|STARTED|Intervention 4||1
1013902|NCT00584831|2461107|P18|STARTED|Intervention 4||1
1013903|NCT00584831|2461108|P17|STARTED|Intervention 4||4
1013904|NCT00584831|2461109|P16|STARTED|Intervention 4||1
1013905|NCT00584831|2461110|P15|STARTED|Intervention 4||2
1013906|NCT00584831|2461111|P14|STARTED|Intervention 4||1
1013907|NCT00584831|2461112|P13|STARTED|Intervention 4||2
1013908|NCT00584831|2461113|P12|STARTED|Intervention 4||1
1013909|NCT00584831|2461114|P11|STARTED|Intervention 4||2
1013910|NCT00584831|2461115|P10|STARTED|Intervention 4||2
1013911|NCT00584831|2461116|P9|STARTED|Intervention 4||3
1013912|NCT00584831|2461117|P8|STARTED|Intervention 4||2
1013913|NCT00584831|2461118|P7|STARTED|Intervention 4||6
1013914|NCT00584831|2461119|P6|STARTED|Intervention 4||1
1013915|NCT00584831|2461120|P5|STARTED|Intervention 4||2
1013916|NCT00584831|2461121|P4|STARTED|Intervention 4||1
1013917|NCT00584831|2461122|P3|STARTED|Intervention 4||2
1013918|NCT00584831|2461123|P2|STARTED|Intervention 4||3
1013919|NCT00584831|2461124|P1|STARTED|Intervention 4||1
1013920|NCT00584831|2461106|P19|NOT COMPLETED|Intervention 3||0
1013921|NCT00584831|2461107|P18|NOT COMPLETED|Intervention 3||0
1013922|NCT00584831|2461108|P17|NOT COMPLETED|Intervention 3||0
1013923|NCT00584831|2461109|P16|NOT COMPLETED|Intervention 3||0
1013924|NCT00584831|2461110|P15|NOT COMPLETED|Intervention 3||0
1013925|NCT00584831|2461111|P14|NOT COMPLETED|Intervention 3||0
1013926|NCT00584831|2461112|P13|NOT COMPLETED|Intervention 3||0
1013927|NCT00584831|2461113|P12|NOT COMPLETED|Intervention 3||0
1013928|NCT00584831|2461114|P11|NOT COMPLETED|Intervention 3||0
1013929|NCT00584831|2461115|P10|NOT COMPLETED|Intervention 3||0
1013930|NCT00584831|2461116|P9|NOT COMPLETED|Intervention 3||0
1013931|NCT00584831|2461117|P8|NOT COMPLETED|Intervention 3||0
1013932|NCT00584831|2461118|P7|NOT COMPLETED|Intervention 3||0
1013933|NCT00584831|2461119|P6|NOT COMPLETED|Intervention 3||0
1013934|NCT00584831|2461120|P5|NOT COMPLETED|Intervention 3||0
1013935|NCT00584831|2461121|P4|NOT COMPLETED|Intervention 3||0
1013936|NCT00584831|2461122|P3|NOT COMPLETED|Intervention 3||0
1013937|NCT00584831|2461123|P2|NOT COMPLETED|Intervention 3||0
1013938|NCT00584831|2461124|P1|NOT COMPLETED|Intervention 3||0
1013939|NCT00584831|2461106|P19|COMPLETED|Intervention 3||1
1013940|NCT00584831|2461107|P18|COMPLETED|Intervention 3||1
1013941|NCT00584831|2461108|P17|COMPLETED|Intervention 3||4
1013942|NCT00584831|2461109|P16|COMPLETED|Intervention 3||1
1013943|NCT00584831|2461110|P15|COMPLETED|Intervention 3||3
1013944|NCT00584831|2461111|P14|COMPLETED|Intervention 3||1
1013945|NCT00584831|2461112|P13|COMPLETED|Intervention 3||2
1013946|NCT00584831|2461113|P12|COMPLETED|Intervention 3||1
1013947|NCT00584831|2461114|P11|COMPLETED|Intervention 3||2
1013948|NCT00584831|2461115|P10|COMPLETED|Intervention 3||2
1013949|NCT00584831|2461116|P9|COMPLETED|Intervention 3||4
1013950|NCT00584831|2461117|P8|COMPLETED|Intervention 3||2
1013951|NCT00584831|2461118|P7|COMPLETED|Intervention 3||6
1013952|NCT00584831|2461119|P6|COMPLETED|Intervention 3||1
1013953|NCT00584831|2461120|P5|COMPLETED|Intervention 3||2
1013954|NCT00584831|2461121|P4|COMPLETED|Intervention 3||1
1013955|NCT00584831|2461122|P3|COMPLETED|Intervention 3||2
1013956|NCT00584831|2461123|P2|COMPLETED|Intervention 3||3
1013957|NCT00584831|2461124|P1|COMPLETED|Intervention 3||1
1013958|NCT00584831|2461106|P19|STARTED|Intervention 3||1
1013959|NCT00584831|2461107|P18|STARTED|Intervention 3||1
1013960|NCT00584831|2461108|P17|STARTED|Intervention 3||4
1013961|NCT00584831|2461109|P16|STARTED|Intervention 3||1
1013962|NCT00584831|2461110|P15|STARTED|Intervention 3||3
1013963|NCT00584831|2461111|P14|STARTED|Intervention 3||1
1013964|NCT00584831|2461112|P13|STARTED|Intervention 3||2
1013965|NCT00584831|2461113|P12|STARTED|Intervention 3||1
1013966|NCT00584831|2461114|P11|STARTED|Intervention 3||2
1013967|NCT00584831|2461115|P10|STARTED|Intervention 3||2
1013968|NCT00584831|2461116|P9|STARTED|Intervention 3||4
1013969|NCT00584831|2461117|P8|STARTED|Intervention 3||2
1013970|NCT00584831|2461118|P7|STARTED|Intervention 3||6
1013971|NCT00584831|2461119|P6|STARTED|Intervention 3||1
1013972|NCT00584831|2461120|P5|STARTED|Intervention 3||2
1013973|NCT00584831|2461121|P4|STARTED|Intervention 3||1
1013974|NCT00584831|2461122|P3|STARTED|Intervention 3||2
1013975|NCT00584831|2461123|P2|STARTED|Intervention 3||3
1013976|NCT00584831|2461124|P1|STARTED|Intervention 3||1
1013977|NCT00584831|2461106|P19|NOT COMPLETED|Intervention 2||0
1013978|NCT00584831|2461107|P18|NOT COMPLETED|Intervention 2||0
1013979|NCT00584831|2461108|P17|NOT COMPLETED|Intervention 2||0
1013980|NCT00584831|2461109|P16|NOT COMPLETED|Intervention 2||0
1013981|NCT00584831|2461110|P15|NOT COMPLETED|Intervention 2||0
1013982|NCT00584831|2461111|P14|NOT COMPLETED|Intervention 2||0
1013983|NCT00584831|2461112|P13|NOT COMPLETED|Intervention 2||0
1013984|NCT00584831|2461113|P12|NOT COMPLETED|Intervention 2||0
1013985|NCT00584831|2461114|P11|NOT COMPLETED|Intervention 2||0
1013986|NCT00584831|2461115|P10|NOT COMPLETED|Intervention 2||0
1013987|NCT00584831|2461116|P9|NOT COMPLETED|Intervention 2||0
1013988|NCT00584831|2461117|P8|NOT COMPLETED|Intervention 2||0
1013989|NCT00584831|2461118|P7|NOT COMPLETED|Intervention 2||0
1013990|NCT00584831|2461119|P6|NOT COMPLETED|Intervention 2||0
1013991|NCT00584831|2461120|P5|NOT COMPLETED|Intervention 2||0
1013992|NCT00584831|2461121|P4|NOT COMPLETED|Intervention 2||0
1013993|NCT00584831|2461122|P3|NOT COMPLETED|Intervention 2||0
1013994|NCT00584831|2461123|P2|NOT COMPLETED|Intervention 2||0
1013995|NCT00584831|2461124|P1|NOT COMPLETED|Intervention 2||0
1013996|NCT00584831|2461106|P19|COMPLETED|Intervention 2||1
1013997|NCT00584831|2461107|P18|COMPLETED|Intervention 2||1
1013998|NCT00584831|2461108|P17|COMPLETED|Intervention 2||4
1013999|NCT00584831|2461109|P16|COMPLETED|Intervention 2||1
1014000|NCT00584831|2461110|P15|COMPLETED|Intervention 2||3
1014001|NCT00584831|2461111|P14|COMPLETED|Intervention 2||1
1014002|NCT00584831|2461112|P13|COMPLETED|Intervention 2||2
1014003|NCT00584831|2461113|P12|COMPLETED|Intervention 2||1
1014004|NCT00584831|2461114|P11|COMPLETED|Intervention 2||2
1014005|NCT00584831|2461115|P10|COMPLETED|Intervention 2||2
1014006|NCT00584831|2461116|P9|COMPLETED|Intervention 2||4
1014007|NCT00584831|2461117|P8|COMPLETED|Intervention 2||2
1014008|NCT00584831|2461118|P7|COMPLETED|Intervention 2||6
1014009|NCT00584831|2461119|P6|COMPLETED|Intervention 2||1
1014010|NCT00584831|2461120|P5|COMPLETED|Intervention 2||2
1014011|NCT00584831|2461121|P4|COMPLETED|Intervention 2||1
1014012|NCT00584831|2461122|P3|COMPLETED|Intervention 2||2
1014013|NCT00584831|2461123|P2|COMPLETED|Intervention 2||3
1014014|NCT00584831|2461124|P1|COMPLETED|Intervention 2||1
1014015|NCT00584831|2461106|P19|STARTED|Intervention 2||1
1014016|NCT00584831|2461107|P18|STARTED|Intervention 2||1
1014017|NCT00584831|2461108|P17|STARTED|Intervention 2||4
1014018|NCT00584831|2461109|P16|STARTED|Intervention 2||1
1014019|NCT00584831|2461110|P15|STARTED|Intervention 2||3
1014020|NCT00584831|2461111|P14|STARTED|Intervention 2||1
1014021|NCT00584831|2461112|P13|STARTED|Intervention 2||2
1014022|NCT00584831|2461113|P12|STARTED|Intervention 2||1
1014023|NCT00584831|2461114|P11|STARTED|Intervention 2||2
1014024|NCT00584831|2461115|P10|STARTED|Intervention 2||2
1014025|NCT00584831|2461116|P9|STARTED|Intervention 2||4
1014026|NCT00584831|2461117|P8|STARTED|Intervention 2||2
1014027|NCT00584831|2461118|P7|STARTED|Intervention 2||6
1014028|NCT00584831|2461119|P6|STARTED|Intervention 2||1
1014029|NCT00584831|2461120|P5|STARTED|Intervention 2||2
1014030|NCT00584831|2461121|P4|STARTED|Intervention 2||1
1014031|NCT00584831|2461122|P3|STARTED|Intervention 2||2
1014032|NCT00584831|2461123|P2|STARTED|Intervention 2||3
1014033|NCT00584831|2461124|P1|STARTED|Intervention 2||1
1014034|NCT00584831|2461106|P19|NOT COMPLETED|Intervention 1||0
1014035|NCT00584831|2461107|P18|NOT COMPLETED|Intervention 1||0
1014036|NCT00584831|2461108|P17|NOT COMPLETED|Intervention 1||0
1014037|NCT00584831|2461109|P16|NOT COMPLETED|Intervention 1||0
1014038|NCT00584831|2461110|P15|NOT COMPLETED|Intervention 1||0
1014039|NCT00584831|2461111|P14|NOT COMPLETED|Intervention 1||0
1014040|NCT00584831|2461112|P13|NOT COMPLETED|Intervention 1||0
1014041|NCT00584831|2461113|P12|NOT COMPLETED|Intervention 1||0
1014042|NCT00584831|2461114|P11|NOT COMPLETED|Intervention 1||0
1014043|NCT00584831|2461115|P10|NOT COMPLETED|Intervention 1||0
1014044|NCT00584831|2461116|P9|NOT COMPLETED|Intervention 1||0
1014045|NCT00584831|2461117|P8|NOT COMPLETED|Intervention 1||0
1014046|NCT00584831|2461118|P7|NOT COMPLETED|Intervention 1||0
1014047|NCT00584831|2461119|P6|NOT COMPLETED|Intervention 1||0
1014048|NCT00584831|2461120|P5|NOT COMPLETED|Intervention 1||0
1014049|NCT00584831|2461121|P4|NOT COMPLETED|Intervention 1||0
1014050|NCT00584831|2461122|P3|NOT COMPLETED|Intervention 1||0
1014051|NCT00584831|2461123|P2|NOT COMPLETED|Intervention 1||0
1014052|NCT00584831|2461124|P1|NOT COMPLETED|Intervention 1||0
1014053|NCT00584831|2461106|P19|COMPLETED|Intervention 1||1
1014054|NCT00584831|2461107|P18|COMPLETED|Intervention 1||1
1014055|NCT00584831|2461108|P17|COMPLETED|Intervention 1||4
1014056|NCT00584831|2461109|P16|COMPLETED|Intervention 1||1
1014057|NCT00584831|2461110|P15|COMPLETED|Intervention 1||3
1014058|NCT00584831|2461111|P14|COMPLETED|Intervention 1||1
1014059|NCT00584831|2461112|P13|COMPLETED|Intervention 1||2
1014060|NCT00584831|2461113|P12|COMPLETED|Intervention 1||1
1014061|NCT00584831|2461114|P11|COMPLETED|Intervention 1||2
1014062|NCT00584831|2461115|P10|COMPLETED|Intervention 1||2
1014063|NCT00584831|2461116|P9|COMPLETED|Intervention 1||4
1014064|NCT00584831|2461117|P8|COMPLETED|Intervention 1||2
1014065|NCT00584831|2461118|P7|COMPLETED|Intervention 1||6
1014066|NCT00584831|2461119|P6|COMPLETED|Intervention 1||1
1014067|NCT00584831|2461120|P5|COMPLETED|Intervention 1||2
1014068|NCT00584831|2461121|P4|COMPLETED|Intervention 1||1
1014069|NCT00584831|2461122|P3|COMPLETED|Intervention 1||2
1014070|NCT00584831|2461123|P2|COMPLETED|Intervention 1||3
1014071|NCT00584831|2461124|P1|COMPLETED|Intervention 1||1
1014072|NCT00584831|2461106|P19|STARTED|Intervention 1||1
1014073|NCT00584831|2461107|P18|STARTED|Intervention 1||1
1014074|NCT00584831|2461108|P17|STARTED|Intervention 1||4
1014075|NCT00584831|2461109|P16|STARTED|Intervention 1||1
1014076|NCT00584831|2461110|P15|STARTED|Intervention 1||3
1014077|NCT00584831|2461111|P14|STARTED|Intervention 1||1
1014078|NCT00584831|2461112|P13|STARTED|Intervention 1||2
1014079|NCT00584831|2461113|P12|STARTED|Intervention 1||1
1014080|NCT00584831|2461114|P11|STARTED|Intervention 1||2
1014081|NCT00584831|2461115|P10|STARTED|Intervention 1||2
1014082|NCT00584831|2461116|P9|STARTED|Intervention 1||4
1014083|NCT00584831|2461117|P8|STARTED|Intervention 1||2
1014084|NCT00584831|2461118|P7|STARTED|Intervention 1||6
1014085|NCT00584831|2461119|P6|STARTED|Intervention 1||1
1014086|NCT00584831|2461120|P5|STARTED|Intervention 1||2
1014087|NCT00584831|2461121|P4|STARTED|Intervention 1||1
1014088|NCT00584831|2461122|P3|STARTED|Intervention 1||2
1014089|NCT00584831|2461123|P2|STARTED|Intervention 1||3
1014090|NCT00584831|2461124|P1|STARTED|Intervention 1||1
1014091|NCT00584844|2461146|P1|NOT COMPLETED|Overall Study||79
1014092|NCT00584844|2461146|P1|COMPLETED|Overall Study||405
1014093|NCT00584844|2461146|P1|STARTED|Overall Study||484
1014094|NCT00584857|2461156|P1|NOT COMPLETED|Overall Study||0
1014095|NCT00584857|2461156|P1|COMPLETED|Overall Study||30
1014096|NCT00584857|2461156|P1|STARTED|Overall Study||30
1014097|NCT00584909|2461161|P1|NOT COMPLETED|Overall Study||4
1014098|NCT00584909|2461161|P1|COMPLETED|Overall Study||9
1014099|NCT00584909|2461161|P1|STARTED|Overall Study||13
1014100|NCT00584935|2461166|P1|NOT COMPLETED|Overall Study||0
1014101|NCT00584935|2461166|P1|COMPLETED|Overall Study||3
1014102|NCT00584935|2461166|P1|STARTED|Overall Study||3
1014103|NCT00584948|2461172|P2|NOT COMPLETED|Overall Study||11
1014104|NCT00584948|2461173|P1|NOT COMPLETED|Overall Study||13
1014105|NCT00584948|2461172|P2|COMPLETED|Overall Study||36
1014106|NCT00584948|2461173|P1|COMPLETED|Overall Study||34
1014107|NCT00584948|2461172|P2|STARTED|Overall Study||47
1014108|NCT00584948|2461173|P1|STARTED|Overall Study||47
1014109|NCT00584987|2461185|P4|NOT COMPLETED|Overall Study||1
1014110|NCT00584987|2461186|P3|NOT COMPLETED|Overall Study||1
1014111|NCT00584987|2461187|P2|NOT COMPLETED|Overall Study||1
1014112|NCT00584987|2461188|P1|NOT COMPLETED|Overall Study||1
1014113|NCT00584987|2461185|P4|COMPLETED|Overall Study||15
1014114|NCT00584987|2461186|P3|COMPLETED|Overall Study||16
1014115|NCT00584987|2461187|P2|COMPLETED|Overall Study||15
1014116|NCT00584987|2461188|P1|COMPLETED|Overall Study||14
1014117|NCT00584987|2461185|P4|STARTED|Overall Study||16
1014118|NCT00584987|2461186|P3|STARTED|Overall Study||17
1014119|NCT00584987|2461187|P2|STARTED|Overall Study||16
1014120|NCT00584987|2461188|P1|STARTED|Overall Study||15
1014121|NCT00585013|2461220|P2|NOT COMPLETED|Overall Study||0
1014122|NCT00585013|2461221|P1|NOT COMPLETED|Overall Study||0
1014123|NCT00585013|2461220|P2|COMPLETED|Overall Study||8
1014124|NCT00585013|2461221|P1|COMPLETED|Overall Study||8
1014125|NCT00585013|2461220|P2|STARTED|Overall Study||8
1014126|NCT00585013|2461221|P1|STARTED|Overall Study||8
1014127|NCT00585039|2461237|P2|NOT COMPLETED|Overall Study||0
1014128|NCT00585039|2461238|P1|NOT COMPLETED|Overall Study||2
1014129|NCT00585039|2461237|P2|COMPLETED|Overall Study||44
1014130|NCT00585039|2461238|P1|COMPLETED|Overall Study||55
1014131|NCT00585039|2461237|P2|STARTED|Overall Study||44
1014132|NCT00585039|2461238|P1|STARTED|Overall Study||57
1014133|NCT00585078|2461246|P1|NOT COMPLETED|Overall Study||40
1014134|NCT00585078|2461246|P1|COMPLETED|Overall Study||0
1014135|NCT00585078|2461246|P1|Response Evaluable|Overall Study||24
1014136|NCT00585078|2461246|P1|Toxicity Evaluable|Overall Study||36
1014137|NCT00585078|2461246|P1|Treated|Overall Study||37
1014138|NCT00585078|2461246|P1|STARTED|Overall Study||40
1014139|NCT00585104|2461253|P1|NOT COMPLETED|Overall Study||4
1014140|NCT00585104|2461253|P1|COMPLETED|Overall Study||6
1014141|NCT00585104|2461253|P1|STARTED|Overall Study||10
1014142|NCT00578279|2461259|P2|NOT COMPLETED|Overall Study||0
1014143|NCT00578279|2461260|P1|NOT COMPLETED|Overall Study||0
1014144|NCT00578279|2461259|P2|COMPLETED|Overall Study||10
1014145|NCT00578279|2461260|P1|COMPLETED|Overall Study||10
1014146|NCT00578279|2461259|P2|STARTED|Overall Study||10
1014147|NCT00578279|2461260|P1|STARTED|Overall Study||10
1014148|NCT00578305|2461269|P3|NOT COMPLETED|Safety Follow-up Phase||46
1014149|NCT00578305|2461270|P2|NOT COMPLETED|Safety Follow-up Phase||45
1014150|NCT00578305|2461271|P1|NOT COMPLETED|Safety Follow-up Phase||46
1014151|NCT00578305|2461269|P3|COMPLETED|Safety Follow-up Phase||8
1014152|NCT00578305|2461270|P2|COMPLETED|Safety Follow-up Phase||9
1014153|NCT00578305|2461271|P1|COMPLETED|Safety Follow-up Phase||11
1014154|NCT00578305|2461269|P3|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
1014155|NCT00578305|2461270|P2|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
1014156|NCT00578305|2461271|P1|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|57
1014157|NCT00578305|2461269|P3|NOT COMPLETED|Extension Phase||3
1014158|NCT00578305|2461270|P2|NOT COMPLETED|Extension Phase||1
1014159|NCT00578305|2461271|P1|NOT COMPLETED|Extension Phase||4
1014160|NCT00578305|2461269|P3|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|40
1014161|NCT00578305|2461270|P2|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
1014162|NCT00578305|2461271|P1|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
1014163|NCT00578305|2461269|P3|STARTED|Extension Phase||43
1014164|NCT00578305|2461270|P2|STARTED|Extension Phase||50
1014165|NCT00578305|2461271|P1|STARTED|Extension Phase||53
1014166|NCT00578305|2461269|P3|NOT COMPLETED|Double-blind Treatment Phase||14
1014167|NCT00578305|2461270|P2|NOT COMPLETED|Double-blind Treatment Phase||4
1014168|NCT00578305|2461271|P1|NOT COMPLETED|Double-blind Treatment Phase||3
1014169|NCT00578305|2461269|P3|COMPLETED|Double-blind Treatment Phase||49
1014170|NCT00578305|2461270|P2|COMPLETED|Double-blind Treatment Phase||56
1014171|NCT00578305|2461271|P1|COMPLETED|Double-blind Treatment Phase||59
1014172|NCT00578305|2461269|P3|Treated|Double-blind Treatment Phase||63
1014173|NCT00578305|2461270|P2|Treated|Double-blind Treatment Phase||60
1014174|NCT00578305|2461271|P1|Treated|Double-blind Treatment Phase||62
1014175|NCT00578305|2461269|P3|STARTED|Double-blind Treatment Phase||63
1014176|NCT00578305|2461270|P2|STARTED|Double-blind Treatment Phase||60
1014177|NCT00578305|2461271|P1|STARTED|Double-blind Treatment Phase||62
1014178|NCT00578318|2461332|P2|NOT COMPLETED|Overall Study||0
1014179|NCT00578318|2461333|P1|NOT COMPLETED|Overall Study||3
1014180|NCT00578318|2461332|P2|COMPLETED|Overall Study||8
1014181|NCT00578318|2461333|P1|COMPLETED|Overall Study||5
1014182|NCT00578318|2461332|P2|STARTED|Overall Study||8
1014183|NCT00578318|2461333|P1|STARTED|Overall Study||8
1014190|NCT00578383|2461354|P4|NOT COMPLETED|Overall Study||6
1014191|NCT00578383|2461355|P3|NOT COMPLETED|Overall Study||6
1014192|NCT00578383|2461356|P2|NOT COMPLETED|Overall Study||16
1014193|NCT00578383|2461357|P1|NOT COMPLETED|Overall Study||16
1014194|NCT00578383|2461354|P4|COMPLETED|Overall Study||9
1014195|NCT00578383|2461355|P3|COMPLETED|Overall Study||13
1014196|NCT00578383|2461356|P2|COMPLETED|Overall Study||20
1014197|NCT00578383|2461357|P1|COMPLETED|Overall Study||21
1014198|NCT00578383|2461354|P4|STARTED|Overall Study||15
1014199|NCT00578383|2461355|P3|STARTED|Overall Study||19
1014200|NCT00578383|2461356|P2|STARTED|Overall Study||36
1014201|NCT00578383|2461357|P1|STARTED|Overall Study||37
1014208|NCT00578461|2461401|P1|NOT COMPLETED|Overall Study||0
1014209|NCT00578461|2461401|P1|COMPLETED|Overall Study||26
1014210|NCT00578461|2461401|P1|STARTED|Overall Study||26
1014211|NCT00578539|2461405|P1|NOT COMPLETED|Overall Study||0
1014212|NCT00578539|2461405|P1|COMPLETED|Overall Study||24
1014213|NCT00578539|2461405|P1|STARTED|Overall Study||24
1014214|NCT00578552|2461412|P3|NOT COMPLETED|Overall Study||15
1014215|NCT00578552|2461413|P2|NOT COMPLETED|Overall Study||14
1014216|NCT00578552|2461414|P1|NOT COMPLETED|Overall Study||15
1014217|NCT00578552|2461412|P3|COMPLETED|Overall Study||11
1014218|NCT00578552|2461413|P2|COMPLETED|Overall Study||13
1014219|NCT00578552|2461414|P1|COMPLETED|Overall Study||12
1014220|NCT00578552|2461412|P3|STARTED|Overall Study||26
1014221|NCT00578552|2461413|P2|STARTED|Overall Study||27
1014222|NCT00578552|2461414|P1|STARTED|Overall Study||27
1014223|NCT00578565|2461422|P1|NOT COMPLETED|Overall Study||3
1014224|NCT00578565|2461422|P1|COMPLETED|Overall Study||7
1014225|NCT00578565|2461422|P1|STARTED|Overall Study||10
1014226|NCT00578617|2461433|P2|NOT COMPLETED|Overall Study||0
1014227|NCT00578617|2461434|P1|NOT COMPLETED|Overall Study||0
1014228|NCT00578617|2461433|P2|COMPLETED|Overall Study||29
1014229|NCT00578617|2461434|P1|COMPLETED|Overall Study||31
1014230|NCT00578617|2461433|P2|STARTED|Overall Study||29
1014231|NCT00578617|2461434|P1|STARTED|Overall Study||31
1014232|NCT00578734|2461442|P2|NOT COMPLETED|Overall Study||0
1014233|NCT00578734|2461443|P1|NOT COMPLETED|Overall Study||0
1014234|NCT00578734|2461442|P2|COMPLETED|Overall Study||81
1014235|NCT00578734|2461443|P1|COMPLETED|Overall Study||84
1014236|NCT00578734|2461442|P2|STARTED|Overall Study||81
1014237|NCT00578734|2461443|P1|STARTED|Overall Study||84
1014238|NCT00578786|2461454|P3|NOT COMPLETED|Overall Study||30
1014239|NCT00578786|2461455|P2|NOT COMPLETED|Overall Study||66
1014240|NCT00578786|2461456|P1|NOT COMPLETED|Overall Study||39
1014241|NCT00578786|2461454|P3|COMPLETED|Overall Study||67
1014242|NCT00578786|2461455|P2|COMPLETED|Overall Study||124
1014243|NCT00578786|2461456|P1|COMPLETED|Overall Study||57
1014244|NCT00578786|2461454|P3|STARTED|Overall Study||97
1014245|NCT00578786|2461455|P2|STARTED|Overall Study||190
1014246|NCT00578786|2461456|P1|STARTED|Overall Study||96
1014247|NCT00578812|2461537|P2|NOT COMPLETED|Overall Study||7
1014248|NCT00578812|2461538|P1|NOT COMPLETED|Overall Study||6
1014249|NCT00578812|2461537|P2|COMPLETED|Overall Study||185
1014250|NCT00578812|2461538|P1|COMPLETED|Overall Study|Modified Intent-to-Treat (treated patients; analyzed as randomized).|218
1014251|NCT00578812|2461537|P2|STARTED|Overall Study||192
1014252|NCT00578812|2461538|P1|STARTED|Overall Study|Does not include investigational training patients (78 STARTED, 76 COMPLETED, 2 Not Treated).|224
1014253|NCT00585169|2461574|P1|NOT COMPLETED|Overall Study||1
1014254|NCT00585169|2461574|P1|COMPLETED|Overall Study||28
1014255|NCT00585169|2461574|P1|STARTED|Overall Study||29
1014256|NCT00585182|2461580|P1|NOT COMPLETED|Overall Study||0
1014257|NCT00585182|2461580|P1|COMPLETED|Overall Study||28
1014258|NCT00585182|2461580|P1|STARTED|Overall Study||28
1014259|NCT00585221|2461585|P1|NOT COMPLETED|Overall Study||8
1014260|NCT00585221|2461585|P1|COMPLETED|Overall Study||0
1014261|NCT00585221|2461585|P1|STARTED|Overall Study||8
1014262|NCT00585286|2461590|P1|NOT COMPLETED|Overall Study||1
1014263|NCT00585286|2461590|P1|COMPLETED|Overall Study||14
1014264|NCT00585286|2461590|P1|STARTED|Overall Study||15
1014265|NCT00585312|2461599|P2|NOT COMPLETED|Overall Study||44
1014266|NCT00585312|2461600|P1|NOT COMPLETED|Overall Study||51
1014267|NCT00585312|2461599|P2|COMPLETED|Overall Study||7
1014268|NCT00585312|2461600|P1|COMPLETED|Overall Study||4
1014269|NCT00585312|2461599|P2|Treated|Overall Study||48
1014270|NCT00585312|2461600|P1|Treated|Overall Study||53
1014271|NCT00585312|2461599|P2|STARTED|Overall Study|STARTED=Randomized|51
1014272|NCT00585312|2461600|P1|STARTED|Overall Study|STARTED=Randomized|55
1014273|NCT00585351|2461618|P8|NOT COMPLETED|Enrollment Period (Intervention)||1
1014274|NCT00585351|2461619|P7|NOT COMPLETED|Enrollment Period (Intervention)||2
1014275|NCT00585351|2461620|P6|NOT COMPLETED|Enrollment Period (Intervention)||2
1014276|NCT00585351|2461621|P5|NOT COMPLETED|Enrollment Period (Intervention)||2
1014277|NCT00585351|2461622|P4|NOT COMPLETED|Enrollment Period (Intervention)||0
1014278|NCT00585351|2461623|P3|NOT COMPLETED|Enrollment Period (Intervention)||0
1014279|NCT00585351|2461624|P2|NOT COMPLETED|Enrollment Period (Intervention)||0
1014280|NCT00585351|2461625|P1|NOT COMPLETED|Enrollment Period (Intervention)||0
1014281|NCT00585351|2461618|P8|COMPLETED|Enrollment Period (Intervention)||2
1014282|NCT00585351|2461619|P7|COMPLETED|Enrollment Period (Intervention)||5
1014283|NCT00585351|2461620|P6|COMPLETED|Enrollment Period (Intervention)||5
1014284|NCT00585351|2461621|P5|COMPLETED|Enrollment Period (Intervention)||3
1014285|NCT00585351|2461622|P4|COMPLETED|Enrollment Period (Intervention)||15
1014286|NCT00585351|2461623|P3|COMPLETED|Enrollment Period (Intervention)||15
1014287|NCT00585351|2461624|P2|COMPLETED|Enrollment Period (Intervention)||0
1014288|NCT00585351|2461625|P1|COMPLETED|Enrollment Period (Intervention)||0
1014289|NCT00585351|2461618|P8|STARTED|Enrollment Period (Intervention)||3
1014290|NCT00585351|2461619|P7|STARTED|Enrollment Period (Intervention)||7
1014291|NCT00585351|2461620|P6|STARTED|Enrollment Period (Intervention)||7
1014292|NCT00585351|2461621|P5|STARTED|Enrollment Period (Intervention)||5
1014293|NCT00585351|2461622|P4|STARTED|Enrollment Period (Intervention)||15
1014294|NCT00585351|2461623|P3|STARTED|Enrollment Period (Intervention)||15
1014295|NCT00585351|2461624|P2|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in No Advanced Notification group for this period."|0
1014296|NCT00585351|2461625|P1|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in Advanced Notification group for this period."|0
1014297|NCT00585351|2461618|P8|NOT COMPLETED|Notification Period (Informed Consent)||0
1014298|NCT00585351|2461619|P7|NOT COMPLETED|Notification Period (Informed Consent)||0
1014299|NCT00585351|2461620|P6|NOT COMPLETED|Notification Period (Informed Consent)||0
1014300|NCT00585351|2461621|P5|NOT COMPLETED|Notification Period (Informed Consent)||0
1014301|NCT00585351|2461622|P4|NOT COMPLETED|Notification Period (Informed Consent)||0
1014302|NCT00585351|2461623|P3|NOT COMPLETED|Notification Period (Informed Consent)||0
1014303|NCT00585351|2461624|P2|NOT COMPLETED|Notification Period (Informed Consent)||25
1014304|NCT00585351|2461625|P1|NOT COMPLETED|Notification Period (Informed Consent)||23
1014305|NCT00585351|2461618|P8|COMPLETED|Notification Period (Informed Consent)||0
1014306|NCT00585351|2461619|P7|COMPLETED|Notification Period (Informed Consent)||0
1014307|NCT00585351|2461620|P6|COMPLETED|Notification Period (Informed Consent)||0
1014308|NCT00585351|2461621|P5|COMPLETED|Notification Period (Informed Consent)||0
1014309|NCT00585351|2461622|P4|COMPLETED|Notification Period (Informed Consent)||0
1014310|NCT00585351|2461623|P3|COMPLETED|Notification Period (Informed Consent)||0
1014311|NCT00585351|2461624|P2|COMPLETED|Notification Period (Informed Consent)||25
1014312|NCT00585351|2461625|P1|COMPLETED|Notification Period (Informed Consent)||27
1014313|NCT00585351|2461618|P8|STARTED|Notification Period (Informed Consent)||0
1014314|NCT00585351|2461619|P7|STARTED|Notification Period (Informed Consent)||0
1014315|NCT00585351|2461620|P6|STARTED|Notification Period (Informed Consent)||0
1014316|NCT00585351|2461621|P5|STARTED|Notification Period (Informed Consent)||0
1014317|NCT00585351|2461622|P4|STARTED|Notification Period (Informed Consent)||0
1014318|NCT00585351|2461623|P3|STARTED|Notification Period (Informed Consent)||0
1014319|NCT00585351|2461624|P2|STARTED|Notification Period (Informed Consent)||50
1014320|NCT00585351|2461625|P1|STARTED|Notification Period (Informed Consent)||50
1014321|NCT00585377|2461639|P1|NOT COMPLETED|Overall Study||0
1014322|NCT00585377|2461639|P1|COMPLETED|Overall Study||50
1014323|NCT00585377|2461639|P1|STARTED|Overall Study||50
1014324|NCT00585468|2461645|P2|NOT COMPLETED|Second Intervention||0
1014325|NCT00585468|2461646|P1|NOT COMPLETED|Second Intervention||0
1014326|NCT00585468|2461645|P2|COMPLETED|Second Intervention||10
1014327|NCT00585468|2461646|P1|COMPLETED|Second Intervention||9
1014328|NCT00585468|2461645|P2|STARTED|Second Intervention||10
1014329|NCT00585468|2461646|P1|STARTED|Second Intervention||9
1014330|NCT00585468|2461645|P2|NOT COMPLETED|First Intervention||1
1014331|NCT00585468|2461646|P1|NOT COMPLETED|First Intervention||1
1014332|NCT00585468|2461645|P2|COMPLETED|First Intervention||10
1014333|NCT00585468|2461646|P1|COMPLETED|First Intervention||9
1014334|NCT00585468|2461645|P2|STARTED|First Intervention||11
1014335|NCT00585468|2461646|P1|STARTED|First Intervention||10
1014336|NCT00585910|2461666|P1|NOT COMPLETED|ATMX + Osmotic-Release Methylphenidate||9
1014337|NCT00585910|2461666|P1|COMPLETED|ATMX + Osmotic-Release Methylphenidate||41
1014338|NCT00585910|2461666|P1|STARTED|ATMX + Osmotic-Release Methylphenidate|Number of participants to add OROS MPH to their ATMX regimen|50
1014339|NCT00585910|2461666|P1|NOT COMPLETED|Atomoxetine (ATMX) Alone||17
1014340|NCT00585910|2461666|P1|COMPLETED|Atomoxetine (ATMX) Alone|Number of subjects who completed Phase I. 15 completed only Phase I. 40 proceeded onto Phase II.|55
1014341|NCT00585910|2461666|P1|STARTED|Atomoxetine (ATMX) Alone|This is the number of subjects who were exposed to ATMX in Phase I of the study.|72
1014342|NCT00585923|2461674|P2|NOT COMPLETED|Overall Study||33
1014343|NCT00585923|2461675|P1|NOT COMPLETED|Overall Study||31
1014344|NCT00585923|2461674|P2|COMPLETED|Overall Study||26
1014345|NCT00585923|2461675|P1|COMPLETED|Overall Study||25
1014346|NCT00585923|2461674|P2|STARTED|Overall Study||59
1014347|NCT00585923|2461675|P1|STARTED|Overall Study||56
1014348|NCT00585975|2461691|P2|NOT COMPLETED|Overall Study||13
1014349|NCT00585975|2461692|P1|NOT COMPLETED|Overall Study||15
1014350|NCT00585975|2461691|P2|COMPLETED|Overall Study||278
1014351|NCT00585975|2461692|P1|COMPLETED|Overall Study||262
1014352|NCT00585975|2461691|P2|STARTED|Overall Study||291
1014353|NCT00585975|2461692|P1|STARTED|Overall Study||277
1014354|NCT00586066|2461702|P2|NOT COMPLETED|Overall Study||10
1014355|NCT00586066|2461703|P1|NOT COMPLETED|Overall Study||18
1014356|NCT00586066|2461702|P2|COMPLETED|Overall Study||14
1014357|NCT00586066|2461703|P1|COMPLETED|Overall Study||30
1014358|NCT00586066|2461702|P2|STARTED|Overall Study||24
1014359|NCT00586066|2461703|P1|STARTED|Overall Study||48
1014360|NCT00586105|2461713|P1|NOT COMPLETED|Overall Study||39
1014361|NCT00586105|2461713|P1|COMPLETED|Overall Study||0
1014362|NCT00586105|2461713|P1|STARTED|Overall Study||39
1014363|NCT00586157|2461726|P2|NOT COMPLETED|Second Intervention||1
1014364|NCT00586157|2461727|P1|NOT COMPLETED|Second Intervention||2
1014365|NCT00586157|2461726|P2|COMPLETED|Second Intervention||14
1014366|NCT00586157|2461727|P1|COMPLETED|Second Intervention||12
1014367|NCT00586157|2461726|P2|STARTED|Second Intervention||15
1014368|NCT00586157|2461727|P1|STARTED|Second Intervention||14
1014369|NCT00586157|2461726|P2|NOT COMPLETED|First Intervention||0
1014370|NCT00586157|2461727|P1|NOT COMPLETED|First Intervention||1
1014371|NCT00586157|2461726|P2|COMPLETED|First Intervention||15
1014372|NCT00586157|2461727|P1|COMPLETED|First Intervention||14
1014373|NCT00586157|2461726|P2|STARTED|First Intervention||15
1014374|NCT00586157|2461727|P1|STARTED|First Intervention||15
1014375|NCT00586170|2461739|P2|NOT COMPLETED|Overall Study||0
1014376|NCT00586170|2461740|P1|NOT COMPLETED|Overall Study||0
1014377|NCT00586170|2461739|P2|COMPLETED|Overall Study||3
1014378|NCT00586170|2461740|P1|COMPLETED|Overall Study||5
1014379|NCT00586170|2461739|P2|STARTED|Overall Study|Initially enrollment was listed as 9. 1 placebo patient withdrew prior to surgery, so enrollment=8.|3
1014380|NCT00586170|2461740|P1|STARTED|Overall Study||5
1014381|NCT00586196|2461750|P2|NOT COMPLETED|Overall Study||0
1014382|NCT00586196|2461751|P1|NOT COMPLETED|Overall Study||0
1014383|NCT00586196|2461750|P2|COMPLETED|Overall Study||9
1014384|NCT00586196|2461751|P1|COMPLETED|Overall Study||7
1014385|NCT00586196|2461750|P2|STARTED|Overall Study||9
1014386|NCT00586196|2461751|P1|STARTED|Overall Study||7
1014387|NCT00586261|2461761|P2|NOT COMPLETED|Overall Study||0
1014388|NCT00586261|2461762|P1|NOT COMPLETED|Overall Study||0
1014389|NCT00586261|2461761|P2|COMPLETED|Overall Study||19
1014390|NCT00586261|2461762|P1|COMPLETED|Overall Study||17
1014391|NCT00586261|2461761|P2|STARTED|Overall Study||19
1014392|NCT00586261|2461762|P1|STARTED|Overall Study||17
1014393|NCT00586313|2461768|P1|NOT COMPLETED|Overall Study||2
1014394|NCT00586313|2461768|P1|COMPLETED|Overall Study||19
1014395|NCT00586313|2461768|P1|STARTED|Overall Study||21
1014396|NCT00586326|2461773|P1|NOT COMPLETED|Treated Through 5-yr Follow Up-Treated||26
1014397|NCT00586326|2461773|P1|COMPLETED|Treated Through 5-yr Follow Up-Treated||74
1014398|NCT00586326|2461773|P1|STARTED|Treated Through 5-yr Follow Up-Treated||100
1014399|NCT00586326|2461773|P1|NOT COMPLETED|Device Placed toTreatment-ITT||18
1014400|NCT00586326|2461773|P1|COMPLETED|Device Placed toTreatment-ITT||100
1014401|NCT00586326|2461773|P1|STARTED|Device Placed toTreatment-ITT||118
1014402|NCT00586326|2461773|P1|NOT COMPLETED|Enrollment to Device Placement-Enrolled||15
1014403|NCT00586326|2461773|P1|COMPLETED|Enrollment to Device Placement-Enrolled||118
1014404|NCT00586326|2461773|P1|STARTED|Enrollment to Device Placement-Enrolled||133
1014414|NCT00586469|2461883|P2|NOT COMPLETED|Overall Study||1
1014415|NCT00586469|2461884|P1|NOT COMPLETED|Overall Study||0
1014416|NCT00586469|2461883|P2|COMPLETED|Overall Study||499
1014417|NCT00586469|2461884|P1|COMPLETED|Overall Study||500
1014418|NCT00586469|2461883|P2|STARTED|Overall Study||500
1014419|NCT00586469|2461884|P1|STARTED|Overall Study||500
1014420|NCT00586482|2461910|P2|NOT COMPLETED|Overall Study||0
1014421|NCT00586482|2461911|P1|NOT COMPLETED|Overall Study||0
1014422|NCT00586482|2461910|P2|COMPLETED|Overall Study||24
1014423|NCT00586482|2461911|P1|COMPLETED|Overall Study||22
1014424|NCT00586482|2461910|P2|STARTED|Overall Study||24
1014425|NCT00586482|2461911|P1|STARTED|Overall Study||22
1014426|NCT00586495|2461925|P1|NOT COMPLETED|Follow-up||92
1014427|NCT00586495|2461925|P1|COMPLETED|Follow-up||0
1014428|NCT00586495|2461925|P1|STARTED|Follow-up||92
1014429|NCT00586495|2461925|P1|NOT COMPLETED|Treatment Period||95
1014430|NCT00586495|2461925|P1|COMPLETED|Treatment Period||0
1014431|NCT00586495|2461925|P1|STARTED|Treatment Period||95
1014432|NCT00586521|2461935|P1|NOT COMPLETED|Prophylactic Treatment (Months 8-13)||0
1014433|NCT00586521|2461935|P1|COMPLETED|Prophylactic Treatment (Months 8-13)||19
1014434|NCT00586521|2461935|P1|STARTED|Prophylactic Treatment (Months 8-13)||19
1014435|NCT00586521|2461935|P1|NOT COMPLETED|On Demand Treatment (Months 1-6)||1
1014436|NCT00586521|2461935|P1|COMPLETED|On Demand Treatment (Months 1-6)||19
1014437|NCT00586521|2461935|P1|STARTED|On Demand Treatment (Months 1-6)||20
1014438|NCT00586573|2461942|P1|NOT COMPLETED|Overall Study||6
1014439|NCT00586573|2461942|P1|COMPLETED|Overall Study||28
1014440|NCT00586573|2461942|P1|STARTED|Overall Study||34
1014441|NCT00586612|2461948|P2|NOT COMPLETED|Booster Phase||1
1014442|NCT00586612|2461949|P1|NOT COMPLETED|Booster Phase||3
1014443|NCT00586612|2461948|P2|COMPLETED|Booster Phase||143
1014444|NCT00586612|2461949|P1|COMPLETED|Booster Phase||151
1014445|NCT00586612|2461948|P2|STARTED|Booster Phase||144
1014446|NCT00586612|2461949|P1|STARTED|Booster Phase||154
1014447|NCT00586612|2461948|P2|NOT COMPLETED|Primary Phase||3
1014448|NCT00586612|2461949|P1|NOT COMPLETED|Primary Phase||1
1014449|NCT00586612|2461948|P2|COMPLETED|Primary Phase||147
1014450|NCT00586612|2461949|P1|COMPLETED|Primary Phase||162
1014451|NCT00586612|2461948|P2|STARTED|Primary Phase||150
1014452|NCT00586612|2461949|P1|STARTED|Primary Phase||163
1014453|NCT00586625|2462017|P2|NOT COMPLETED|Overall Study||17
1014454|NCT00586625|2462018|P1|NOT COMPLETED|Overall Study||43
1014455|NCT00586625|2462017|P2|COMPLETED|Overall Study||269
1014456|NCT00586625|2462018|P1|COMPLETED|Overall Study||532
1014457|NCT00586625|2462017|P2|STARTED|Overall Study||286
1014458|NCT00586625|2462018|P1|STARTED|Overall Study||575
1014459|NCT00586664|2462027|P3|NOT COMPLETED|Overall Study||1
1014460|NCT00586664|2462028|P2|NOT COMPLETED|Overall Study||7
1014461|NCT00586664|2462029|P1|NOT COMPLETED|Overall Study||5
1014462|NCT00586664|2462027|P3|COMPLETED|Overall Study||43
1014463|NCT00586664|2462028|P2|COMPLETED|Overall Study||36
1014464|NCT00586664|2462029|P1|COMPLETED|Overall Study||38
1014465|NCT00586664|2462027|P3|STARTED|Overall Study||44
1014466|NCT00586664|2462028|P2|STARTED|Overall Study||43
1014467|NCT00586664|2462029|P1|STARTED|Overall Study||43
1014468|NCT00586690|2462075|P2|NOT COMPLETED|Overall Study||0
1014469|NCT00586690|2462076|P1|NOT COMPLETED|Overall Study||16
1014470|NCT00586690|2462075|P2|COMPLETED|Overall Study||22
1014471|NCT00586690|2462076|P1|COMPLETED|Overall Study||5
1014472|NCT00586690|2462075|P2|STARTED|Overall Study||22
1014473|NCT00586690|2462076|P1|STARTED|Overall Study|Four consented subjects were screen failures.|21
1014474|NCT00586703|2462083|P1|NOT COMPLETED|Overall Study||12
1014475|NCT00586703|2462083|P1|COMPLETED|Overall Study||4
1014476|NCT00586703|2462083|P1|STARTED|Overall Study||16
1014477|NCT00586716|2462090|P2|NOT COMPLETED|Overall Study||0
1014478|NCT00586716|2462091|P1|NOT COMPLETED|Overall Study||0
1014479|NCT00586716|2462090|P2|COMPLETED|Overall Study||8
1014480|NCT00586716|2462091|P1|COMPLETED|Overall Study||14
1014481|NCT00586716|2462090|P2|STARTED|Overall Study||8
1014482|NCT00586716|2462091|P1|STARTED|Overall Study||14
1014483|NCT00586729|2462100|P2|NOT COMPLETED|Overall Study||1
1014484|NCT00586729|2462101|P1|NOT COMPLETED|Overall Study||3
1014485|NCT00586729|2462100|P2|COMPLETED|Overall Study||8
1014486|NCT00586729|2462101|P1|COMPLETED|Overall Study||11
1014487|NCT00586729|2462100|P2|STARTED|Overall Study||9
1014488|NCT00586729|2462101|P1|STARTED|Overall Study||14
1014489|NCT00586820|2462113|P2|NOT COMPLETED|Overall Study||0
1014490|NCT00586820|2462114|P1|NOT COMPLETED|Overall Study||1
1014491|NCT00586820|2462113|P2|COMPLETED|Overall Study||11
1014492|NCT00586820|2462114|P1|COMPLETED|Overall Study||11
1014493|NCT00586820|2462113|P2|STARTED|Overall Study||11
1014494|NCT00586820|2462114|P1|STARTED|Overall Study||12
1014495|NCT00586846|2462122|P1|NOT COMPLETED|Overall Study||6
1014496|NCT00586846|2462122|P1|COMPLETED|Overall Study||34
1014497|NCT00586846|2462122|P1|STARTED|Overall Study||40
1014498|NCT00586898|2462126|P1|NOT COMPLETED|Overall Study||7
1014499|NCT00586898|2462126|P1|COMPLETED|Overall Study||29
1014500|NCT00586898|2462126|P1|STARTED|Overall Study||36
1014501|NCT00587041|2462133|P3|NOT COMPLETED|Overall Study||0
1014502|NCT00587041|2462134|P2|NOT COMPLETED|Overall Study||0
1014503|NCT00587041|2462135|P1|NOT COMPLETED|Overall Study||0
1014504|NCT00587041|2462133|P3|COMPLETED|Overall Study||14
1014505|NCT00587041|2462134|P2|COMPLETED|Overall Study||14
1014506|NCT00587041|2462135|P1|COMPLETED|Overall Study||12
1014507|NCT00587041|2462133|P3|STARTED|Overall Study||14
1014508|NCT00587041|2462134|P2|STARTED|Overall Study||14
1014509|NCT00587041|2462135|P1|STARTED|Overall Study||12
1014510|NCT00587054|2462146|P1|NOT COMPLETED|Overall Study||9
1014511|NCT00587054|2462146|P1|COMPLETED|Overall Study||120
1014512|NCT00587054|2462146|P1|STARTED|Overall Study||129
1014513|NCT00587067|2462150|P1|NOT COMPLETED|Overall Study||0
1014514|NCT00587067|2462150|P1|COMPLETED|Overall Study||34
1014515|NCT00587067|2462150|P1|STARTED|Overall Study||34
1014516|NCT00587132|2462160|P4|NOT COMPLETED|Overall Study||0
1014517|NCT00587132|2462161|P3|NOT COMPLETED|Overall Study||0
1014518|NCT00587132|2462162|P2|NOT COMPLETED|Overall Study||0
1014519|NCT00587132|2462163|P1|NOT COMPLETED|Overall Study||0
1014520|NCT00587132|2462160|P4|COMPLETED|Overall Study||0
1014521|NCT00587132|2462161|P3|COMPLETED|Overall Study||0
1014522|NCT00587132|2462162|P2|COMPLETED|Overall Study||0
1014523|NCT00587132|2462163|P1|COMPLETED|Overall Study||4
1014524|NCT00587132|2462160|P4|STARTED|Overall Study||0
1014525|NCT00587132|2462161|P3|STARTED|Overall Study||0
1014526|NCT00587132|2462162|P2|STARTED|Overall Study||0
1014527|NCT00587132|2462163|P1|STARTED|Overall Study||4
1014528|NCT00587158|2462175|P2|NOT COMPLETED|Overall Study||8
1014529|NCT00587158|2462176|P1|NOT COMPLETED|Overall Study||5
1014530|NCT00587158|2462175|P2|COMPLETED|Overall Study||43
1014531|NCT00587158|2462176|P1|COMPLETED|Overall Study||44
1014532|NCT00587158|2462175|P2|Continued in Study|Overall Study||46
1014533|NCT00587158|2462176|P1|Continued in Study|Overall Study||45
1014534|NCT00587158|2462175|P2|STARTED|Overall Study||51
1014535|NCT00587158|2462176|P1|STARTED|Overall Study||49
1014536|NCT00587171|2462208|P2|NOT COMPLETED|Overall Study||1
1014537|NCT00587171|2462209|P1|NOT COMPLETED|Overall Study||1
1014538|NCT00587171|2462208|P2|COMPLETED|Overall Study||9
1014539|NCT00587171|2462209|P1|COMPLETED|Overall Study||8
1014540|NCT00587171|2462208|P2|STARTED|Overall Study||10
1014541|NCT00587171|2462209|P1|STARTED|Overall Study||9
1014542|NCT00587223|2462237|P1|NOT COMPLETED|Overall Study||1
1014543|NCT00587223|2462237|P1|COMPLETED|Overall Study|Subject withdrawn from study at Day 7.|0
1014544|NCT00587223|2462237|P1|STARTED|Overall Study|Study design was within-subject control. Only 1 subject was enrolled in the study.|1
1014545|NCT00587288|2462254|P2|NOT COMPLETED|Overall Study||9
1014546|NCT00587288|2462255|P1|NOT COMPLETED|Overall Study||3
1014547|NCT00587288|2462254|P2|COMPLETED|Overall Study||44
1014548|NCT00587288|2462255|P1|COMPLETED|Overall Study||50
1014549|NCT00587288|2462254|P2|STARTED|Overall Study||53
1014550|NCT00587288|2462255|P1|STARTED|Overall Study||53
1014551|NCT00587431|2462275|P2|NOT COMPLETED|Overall Study||1
1014552|NCT00587431|2462276|P1|NOT COMPLETED|Overall Study||1
1014553|NCT00587431|2462275|P2|COMPLETED|Overall Study||38
1014554|NCT00587431|2462276|P1|COMPLETED|Overall Study||62
1014555|NCT00587431|2462275|P2|STARTED|Overall Study||39
1014556|NCT00587431|2462276|P1|STARTED|Overall Study||63
1014557|NCT00587457|2462288|P3|NOT COMPLETED|Overall Study||5
1014558|NCT00587457|2462289|P2|NOT COMPLETED|Overall Study||3
1014559|NCT00587457|2462290|P1|NOT COMPLETED|Overall Study||3
1014560|NCT00587457|2462288|P3|COMPLETED|Overall Study||0
1014561|NCT00587457|2462289|P2|COMPLETED|Overall Study||0
1014562|NCT00587457|2462290|P1|COMPLETED|Overall Study||0
1014563|NCT00587457|2462288|P3|STARTED|Overall Study||5
1014564|NCT00587457|2462289|P2|STARTED|Overall Study||3
1014565|NCT00587457|2462290|P1|STARTED|Overall Study||3
1014566|NCT00587483|2462328|P3|NOT COMPLETED|Overall Study||0
1014567|NCT00587483|2462329|P2|NOT COMPLETED|Overall Study||0
1014568|NCT00587483|2462330|P1|NOT COMPLETED|Overall Study||0
1014569|NCT00587483|2462328|P3|COMPLETED|Overall Study||112
1014570|NCT00587483|2462329|P2|COMPLETED|Overall Study||115
1014571|NCT00587483|2462330|P1|COMPLETED|Overall Study||115
1014572|NCT00587483|2462328|P3|STARTED|Overall Study||112
1014573|NCT00587483|2462329|P2|STARTED|Overall Study||115
1014574|NCT00587483|2462330|P1|STARTED|Overall Study||115
1014575|NCT00587587|2462358|P2|NOT COMPLETED|Overall Study||1
1014576|NCT00587587|2462359|P1|NOT COMPLETED|Overall Study||6
1014577|NCT00587587|2462358|P2|COMPLETED|Overall Study||12
1014578|NCT00587587|2462359|P1|COMPLETED|Overall Study||11
1014579|NCT00587587|2462358|P2|STARTED|Overall Study||13
1014580|NCT00587587|2462359|P1|STARTED|Overall Study||17
1014581|NCT00587639|2462379|P1|NOT COMPLETED|Overall Study||1
1014582|NCT00587639|2462379|P1|COMPLETED|Overall Study||7
1014583|NCT00587639|2462379|P1|STARTED|Overall Study||8
1014584|NCT00587678|2462387|P3|NOT COMPLETED|Overall Study||8
1014585|NCT00587678|2462388|P2|NOT COMPLETED|Overall Study||4
1014586|NCT00587678|2462389|P1|NOT COMPLETED|Overall Study||6
1014587|NCT00587678|2462387|P3|COMPLETED|Overall Study||33
1014588|NCT00587678|2462388|P2|COMPLETED|Overall Study||18
1014589|NCT00587678|2462389|P1|COMPLETED|Overall Study||16
1014590|NCT00587678|2462387|P3|STARTED|Overall Study||41
1014591|NCT00587678|2462388|P2|STARTED|Overall Study||22
1014592|NCT00587678|2462389|P1|STARTED|Overall Study||22
1014593|NCT00587769|2462427|P1|NOT COMPLETED|Overall Study||0
1014594|NCT00587769|2462427|P1|COMPLETED|Overall Study||38
1014595|NCT00587769|2462427|P1|STARTED|Overall Study||38
1014596|NCT00587795|2462434|P2|NOT COMPLETED|Overall Study||0
1014597|NCT00587795|2462435|P1|NOT COMPLETED|Overall Study||1
1014598|NCT00587795|2462434|P2|COMPLETED|Overall Study||0
1014599|NCT00587795|2462435|P1|COMPLETED|Overall Study||0
1014600|NCT00587795|2462434|P2|STARTED|Overall Study||0
1014601|NCT00587795|2462435|P1|STARTED|Overall Study||1
1014602|NCT00587834|2462441|P1|NOT COMPLETED|Overall Study||0
1014603|NCT00587834|2462441|P1|COMPLETED|Overall Study||96
1014604|NCT00587834|2462441|P1|STARTED|Overall Study||96
1014605|NCT00587847|2462457|P1|NOT COMPLETED|Overall Study||7
1014606|NCT00587847|2462457|P1|COMPLETED|Overall Study||5
1014607|NCT00587847|2462457|P1|STARTED|Overall Study||12
1014608|NCT00587860|2462464|P2|NOT COMPLETED|Overall Study||5
1014609|NCT00587860|2462465|P1|NOT COMPLETED|Overall Study||5
1014610|NCT00587860|2462464|P2|COMPLETED|Overall Study||30
1014611|NCT00587860|2462465|P1|COMPLETED|Overall Study||30
1014612|NCT00587860|2462464|P2|STARTED|Overall Study||35
1014613|NCT00587860|2462465|P1|STARTED|Overall Study||35
1014614|NCT00587964|2462485|P1|NOT COMPLETED|Overall Study||12
1014615|NCT00587964|2462485|P1|COMPLETED|Overall Study||39
1014616|NCT00587964|2462485|P1|STARTED|Overall Study||51
1014617|NCT00587990|2462492|P3|NOT COMPLETED|Overall Study||0
1014618|NCT00587990|2462493|P2|NOT COMPLETED|Overall Study||0
1014619|NCT00587990|2462494|P1|NOT COMPLETED|Overall Study||0
1014620|NCT00587990|2462492|P3|COMPLETED|Overall Study||3
1014621|NCT00587990|2462493|P2|COMPLETED|Overall Study||4
1014622|NCT00587990|2462494|P1|COMPLETED|Overall Study||2
1014623|NCT00587990|2462492|P3|STARTED|Overall Study||3
1014624|NCT00587990|2462493|P2|STARTED|Overall Study||4
1014625|NCT00587990|2462494|P1|STARTED|Overall Study||2
1014626|NCT00588094|2462502|P1|NOT COMPLETED|Overall Study||5
1014627|NCT00588094|2462502|P1|COMPLETED|Overall Study||15
1014628|NCT00588094|2462502|P1|STARTED|Overall Study||20
1014629|NCT00588146|2462506|P2|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
1014630|NCT00588146|2462507|P1|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
1014631|NCT00588146|2462506|P2|COMPLETED|Second Intervention (6 Months to 1 Year)||2
1014632|NCT00588146|2462507|P1|COMPLETED|Second Intervention (6 Months to 1 Year)||1
1014633|NCT00588146|2462506|P2|STARTED|Second Intervention (6 Months to 1 Year)||2
1014634|NCT00588146|2462507|P1|STARTED|Second Intervention (6 Months to 1 Year)||1
1014635|NCT00588146|2462506|P2|NOT COMPLETED|First Intervention (Baseline to 6 mo)||3
1014636|NCT00588146|2462507|P1|NOT COMPLETED|First Intervention (Baseline to 6 mo)||4
1014637|NCT00588146|2462506|P2|COMPLETED|First Intervention (Baseline to 6 mo)||2
1014638|NCT00588146|2462507|P1|COMPLETED|First Intervention (Baseline to 6 mo)||1
1014639|NCT00588146|2462506|P2|STARTED|First Intervention (Baseline to 6 mo)||5
1014640|NCT00588146|2462507|P1|STARTED|First Intervention (Baseline to 6 mo)||5
1014641|NCT00588159|2462515|P2|NOT COMPLETED|Overall Study||11
1014642|NCT00588159|2462516|P1|NOT COMPLETED|Overall Study||15
1014643|NCT00588159|2462515|P2|COMPLETED|Overall Study||63
1014644|NCT00588159|2462516|P1|COMPLETED|Overall Study||57
1014645|NCT00588159|2462515|P2|STARTED|Overall Study||74
1014646|NCT00588159|2462516|P1|STARTED|Overall Study||72
1014647|NCT00588237|2462532|P1|NOT COMPLETED|Overall Study||4
1014648|NCT00588237|2462532|P1|COMPLETED|Overall Study||38
1014649|NCT00588237|2462532|P1|STARTED|Overall Study||42
1014650|NCT00588341|2462536|P1|NOT COMPLETED|Overall Study||5
1014651|NCT00588341|2462536|P1|COMPLETED|Overall Study||19
1014652|NCT00588341|2462536|P1|STARTED|Overall Study||24
1014653|NCT00588354|2462542|P2|NOT COMPLETED|Baseline to 4 Weeks||1
1014654|NCT00588354|2462543|P1|NOT COMPLETED|Baseline to 4 Weeks||0
1014655|NCT00588354|2462542|P2|COMPLETED|Baseline to 4 Weeks||14
1014656|NCT00588354|2462543|P1|COMPLETED|Baseline to 4 Weeks||9
1014657|NCT00588354|2462542|P2|STARTED|Baseline to 4 Weeks||15
1014658|NCT00588354|2462543|P1|STARTED|Baseline to 4 Weeks||9
1014659|NCT00588354|2462542|P2|NOT COMPLETED|Baseline to 2 Weeks||0
1014660|NCT00588354|2462543|P1|NOT COMPLETED|Baseline to 2 Weeks||2
1014661|NCT00588354|2462542|P2|COMPLETED|Baseline to 2 Weeks||15
1014662|NCT00588354|2462543|P1|COMPLETED|Baseline to 2 Weeks||9
1014663|NCT00588354|2462542|P2|STARTED|Baseline to 2 Weeks||15
1014664|NCT00588354|2462543|P1|STARTED|Baseline to 2 Weeks||11
1014665|NCT00581776|2462563|P1|NOT COMPLETED|Overall Study||3
1014666|NCT00581776|2462563|P1|COMPLETED|Overall Study|3 subjects did not complete the planned induction chemotherapy.|27
1014667|NCT00581776|2462563|P1|STARTED|Overall Study||30
1014668|NCT00581828|2462570|P1|NOT COMPLETED|Overall Study||1
1014669|NCT00581828|2462570|P1|COMPLETED|Overall Study||18
1014670|NCT00581828|2462570|P1|STARTED|Overall Study||19
1014671|NCT00581854|2462574|P1|NOT COMPLETED|Overall Study||0
1014672|NCT00581854|2462574|P1|COMPLETED|Overall Study||22
1014673|NCT00581854|2462574|P1|STARTED|Overall Study||22
1014674|NCT00581867|2462578|P2|NOT COMPLETED|Second Intervention||0
1014675|NCT00581867|2462579|P1|NOT COMPLETED|Second Intervention||0
1014676|NCT00581867|2462578|P2|COMPLETED|Second Intervention||14
1014677|NCT00581867|2462579|P1|COMPLETED|Second Intervention||15
1014678|NCT00581867|2462578|P2|STARTED|Second Intervention|1 individual completed period 1 (Intranasal Insulin) but did not complete period 2 (Placebo).|14
1014679|NCT00581867|2462579|P1|STARTED|Second Intervention|n=1 completed period 1 (placebo) but not period 2 (insulin). This individuals died between periods.|15
1014680|NCT00581867|2462578|P2|NOT COMPLETED|First Intervention||0
1014681|NCT00581867|2462579|P1|NOT COMPLETED|First Intervention||0
1014682|NCT00581867|2462578|P2|COMPLETED|First Intervention||15
1014683|NCT00581867|2462579|P1|COMPLETED|First Intervention||16
1014684|NCT00581867|2462578|P2|STARTED|First Intervention||15
1014685|NCT00581867|2462579|P1|STARTED|First Intervention||16
1014686|NCT00581919|2462587|P1|NOT COMPLETED|Overall Study||24
1014687|NCT00581919|2462587|P1|COMPLETED|Overall Study||8
1014688|NCT00581919|2462587|P1|STARTED|Overall Study||32
1014689|NCT00581945|2462595|P2|NOT COMPLETED|Overall Study||10
1014690|NCT00581945|2462596|P1|NOT COMPLETED|Overall Study||9
1014691|NCT00581945|2462595|P2|COMPLETED|Overall Study||63
1014692|NCT00581945|2462596|P1|COMPLETED|Overall Study||65
1014693|NCT00581945|2462595|P2|STARTED|Overall Study||73
1014694|NCT00581945|2462596|P1|STARTED|Overall Study||74
1014695|NCT00581971|2462612|P1|NOT COMPLETED|Overall Study||0
1014696|NCT00581971|2462612|P1|COMPLETED|Overall Study||30
1014697|NCT00581971|2462612|P1|STARTED|Overall Study||30
1014704|NCT00582036|2462644|P2|NOT COMPLETED|Overall Study||1
1014705|NCT00582036|2462645|P1|NOT COMPLETED|Overall Study||0
1014706|NCT00582036|2462644|P2|COMPLETED|Overall Study|One patient withdrew consent|5
1014707|NCT00582036|2462645|P1|COMPLETED|Overall Study||5
1014708|NCT00582036|2462644|P2|STARTED|Overall Study||6
1014709|NCT00582036|2462645|P1|STARTED|Overall Study||5
1014710|NCT00582075|2462651|P1|NOT COMPLETED|Overall Study||0
1014711|NCT00582075|2462651|P1|COMPLETED|Overall Study||25
1014712|NCT00582075|2462651|P1|STARTED|Overall Study||25
1014713|NCT00582114|2462658|P2|NOT COMPLETED|Overall Study||54
1014714|NCT00582114|2462659|P1|NOT COMPLETED|Overall Study||42
1014715|NCT00582114|2462658|P2|COMPLETED|Overall Study||46
1014716|NCT00582114|2462659|P1|COMPLETED|Overall Study||58
1014717|NCT00582114|2462658|P2|STARTED|Overall Study||100
1014718|NCT00582114|2462659|P1|STARTED|Overall Study||100
1014719|NCT00582205|2462667|P1|NOT COMPLETED|Overall Study||10
1014720|NCT00582205|2462667|P1|COMPLETED|Overall Study||11
1014721|NCT00582205|2462667|P1|STARTED|Overall Study||21
1014722|NCT00582309|2462675|P3|NOT COMPLETED|Overall Study||2
1014723|NCT00582309|2462676|P2|NOT COMPLETED|Overall Study||0
1014724|NCT00582309|2462677|P1|NOT COMPLETED|Overall Study||0
1014725|NCT00582309|2462675|P3|COMPLETED|Overall Study|2 did not have enough data collected to be used|44
1014726|NCT00582309|2462676|P2|COMPLETED|Overall Study||49
1014727|NCT00582309|2462677|P1|COMPLETED|Overall Study||56
1014728|NCT00582309|2462675|P3|STARTED|Overall Study||46
1014729|NCT00582309|2462676|P2|STARTED|Overall Study||49
1014730|NCT00582309|2462677|P1|STARTED|Overall Study||56
1014731|NCT00582361|2462687|P2|NOT COMPLETED|Overall Study||0
1014732|NCT00582361|2462688|P1|NOT COMPLETED|Overall Study||0
1014733|NCT00582361|2462687|P2|COMPLETED|Overall Study||38
1014734|NCT00582361|2462688|P1|COMPLETED|Overall Study||25
1014735|NCT00582361|2462687|P2|STARTED|Overall Study||38
1014736|NCT00582361|2462688|P1|STARTED|Overall Study||25
1014737|NCT00582400|2462696|P1|NOT COMPLETED|Overall Study||3
1014738|NCT00582400|2462696|P1|COMPLETED|Overall Study||6
1014739|NCT00582400|2462696|P1|STARTED|Overall Study||9
1014740|NCT00582426|2462705|P2|NOT COMPLETED|Overall Study||13
1014741|NCT00582426|2462706|P1|NOT COMPLETED|Overall Study||20
1014742|NCT00582426|2462705|P2|COMPLETED|Overall Study||58
1014743|NCT00582426|2462706|P1|COMPLETED|Overall Study||48
1014744|NCT00582426|2462705|P2|STARTED|Overall Study||71
1014745|NCT00582426|2462706|P1|STARTED|Overall Study|"Patient in both arms belongs to started indicates safety and intent to treat (ITT) populations."|68
1014746|NCT00582491|2462734|P2|NOT COMPLETED|Overall Study||0
1014747|NCT00582491|2462735|P1|NOT COMPLETED|Overall Study||1
1014748|NCT00582491|2462734|P2|COMPLETED|Overall Study||10
1014749|NCT00582491|2462735|P1|COMPLETED|Overall Study||10
1014750|NCT00582491|2462734|P2|STARTED|Overall Study||10
1014751|NCT00582491|2462735|P1|STARTED|Overall Study||11
1014752|NCT00582517|2462759|P2|NOT COMPLETED|Overall Study||0
1014753|NCT00582517|2462760|P1|NOT COMPLETED|Overall Study||0
1014754|NCT00582517|2462759|P2|COMPLETED|Overall Study||55
1014755|NCT00582517|2462760|P1|COMPLETED|Overall Study||45
1014756|NCT00582517|2462759|P2|STARTED|Overall Study||55
1014757|NCT00582517|2462760|P1|STARTED|Overall Study||45
1014758|NCT00582556|2462769|P3|NOT COMPLETED|Overall Study||2
1014759|NCT00582556|2462770|P2|NOT COMPLETED|Overall Study||1
1014760|NCT00582556|2462771|P1|NOT COMPLETED|Overall Study||0
1014761|NCT00582556|2462769|P3|COMPLETED|Overall Study||12
1014762|NCT00582556|2462770|P2|COMPLETED|Overall Study||14
1014763|NCT00582556|2462771|P1|COMPLETED|Overall Study||14
1014764|NCT00582556|2462769|P3|STARTED|Overall Study||14
1014765|NCT00582556|2462770|P2|STARTED|Overall Study||15
1014766|NCT00582556|2462771|P1|STARTED|Overall Study||14
1014767|NCT00582608|2462788|P1|NOT COMPLETED|Overall Study||12
1014768|NCT00582608|2462788|P1|COMPLETED|Overall Study||0
1014769|NCT00582608|2462788|P1|STARTED|Overall Study||12
1014770|NCT00588380|2462792|P1|NOT COMPLETED|Overall Study||0
1014771|NCT00588380|2462792|P1|COMPLETED|Overall Study||88
1014772|NCT00588380|2462792|P1|STARTED|Overall Study||88
1014773|NCT00588406|2462799|P2|NOT COMPLETED|Overall Study||0
1014774|NCT00588406|2462800|P1|NOT COMPLETED|Overall Study||0
1014775|NCT00588406|2462799|P2|COMPLETED|Overall Study||49
1014776|NCT00588406|2462800|P1|COMPLETED|Overall Study||46
1014777|NCT00588406|2462799|P2|STARTED|Overall Study||49
1014778|NCT00588406|2462800|P1|STARTED|Overall Study||46
1014779|NCT00588445|2462808|P1|NOT COMPLETED|Overall Study||15
1014780|NCT00588445|2462808|P1|COMPLETED|Overall Study||50
1014781|NCT00588445|2462808|P1|STARTED|Overall Study||65
1014782|NCT00588471|2462816|P2|NOT COMPLETED|Overall Study||0
1014783|NCT00588471|2462817|P1|NOT COMPLETED|Overall Study||0
1014784|NCT00588471|2462816|P2|COMPLETED|Overall Study||29
1014785|NCT00588471|2462817|P1|COMPLETED|Overall Study||28
1014786|NCT00588471|2462816|P2|STARTED|Overall Study||29
1014787|NCT00588471|2462817|P1|STARTED|Overall Study||28
1014788|NCT00588536|2462825|P1|NOT COMPLETED|Overall Study||0
1014789|NCT00588536|2462825|P1|COMPLETED|Overall Study||5
1014790|NCT00588536|2462825|P1|STARTED|Overall Study||5
1014791|NCT00588640|2462829|P1|NOT COMPLETED|Overall Study||2
1014792|NCT00588640|2462829|P1|COMPLETED|Overall Study||8
1014793|NCT00588640|2462829|P1|STARTED|Overall Study||10
1014794|NCT00588666|2462833|P1|NOT COMPLETED|Overall Study||4
1014795|NCT00588666|2462833|P1|COMPLETED|Overall Study||47
1014796|NCT00588666|2462833|P1|STARTED|Overall Study||51
1014797|NCT00588692|2462840|P2|NOT COMPLETED|Overall Study||3
1014798|NCT00588692|2462841|P1|NOT COMPLETED|Overall Study||7
1014799|NCT00588692|2462840|P2|COMPLETED|Overall Study||27
1014800|NCT00588692|2462841|P1|COMPLETED|Overall Study||23
1014801|NCT00588692|2462840|P2|STARTED|Overall Study||30
1014802|NCT00588692|2462841|P1|STARTED|Overall Study||30
1014803|NCT00592007|2462877|P1|NOT COMPLETED|Overall Study||2
1014804|NCT00592007|2462877|P1|COMPLETED|Overall Study||5
1014805|NCT00592007|2462877|P1|STARTED|Overall Study||7
1014806|NCT00592072|2462882|P2|NOT COMPLETED|Second Sequence||0
1014807|NCT00592072|2462883|P1|NOT COMPLETED|Second Sequence||0
1014808|NCT00592072|2462882|P2|COMPLETED|Second Sequence||5
1014809|NCT00592072|2462883|P1|COMPLETED|Second Sequence||5
1014810|NCT00592072|2462882|P2|STARTED|Second Sequence||5
1014811|NCT00592072|2462883|P1|STARTED|Second Sequence||5
1014812|NCT00592072|2462882|P2|NOT COMPLETED|Wash Out Period||1
1014813|NCT00592072|2462883|P1|NOT COMPLETED|Wash Out Period||1
1014814|NCT00592072|2462882|P2|COMPLETED|Wash Out Period||5
1014815|NCT00592072|2462883|P1|COMPLETED|Wash Out Period||5
1014816|NCT00592072|2462882|P2|STARTED|Wash Out Period||6
1014817|NCT00592072|2462883|P1|STARTED|Wash Out Period||6
1014818|NCT00592072|2462882|P2|NOT COMPLETED|First Sequence||0
1014819|NCT00592072|2462883|P1|NOT COMPLETED|First Sequence||0
1014820|NCT00592072|2462882|P2|COMPLETED|First Sequence||6
1014821|NCT00592072|2462883|P1|COMPLETED|First Sequence||6
1014822|NCT00592072|2462882|P2|STARTED|First Sequence||6
1014823|NCT00592072|2462883|P1|STARTED|First Sequence||6
1014824|NCT00592124|2462911|P6|NOT COMPLETED|Overall Study||3
1014825|NCT00592124|2462912|P5|NOT COMPLETED|Overall Study||3
1014826|NCT00592124|2462913|P4|NOT COMPLETED|Overall Study||3
1014827|NCT00592124|2462914|P3|NOT COMPLETED|Overall Study||6
1014828|NCT00592124|2462915|P2|NOT COMPLETED|Overall Study||5
1014829|NCT00592124|2462916|P1|NOT COMPLETED|Overall Study||4
1014830|NCT00592124|2462911|P6|COMPLETED|Overall Study||24
1014831|NCT00592124|2462912|P5|COMPLETED|Overall Study||24
1014832|NCT00592124|2462913|P4|COMPLETED|Overall Study||24
1014833|NCT00592124|2462914|P3|COMPLETED|Overall Study||24
1014834|NCT00592124|2462915|P2|COMPLETED|Overall Study||24
1014835|NCT00592124|2462916|P1|COMPLETED|Overall Study||24
1014836|NCT00592124|2462911|P6|STARTED|Overall Study||27
1014837|NCT00592124|2462912|P5|STARTED|Overall Study||27
1014838|NCT00592124|2462913|P4|STARTED|Overall Study||27
1014839|NCT00592124|2462914|P3|STARTED|Overall Study||30
1014840|NCT00592124|2462915|P2|STARTED|Overall Study||29
1014841|NCT00592124|2462916|P1|STARTED|Overall Study||28
1014842|NCT00592176|2462967|P1|NOT COMPLETED|Overall Study||0
1014843|NCT00592176|2462967|P1|COMPLETED|Overall Study||5
1014844|NCT00592176|2462967|P1|STARTED|Overall Study||5
1014845|NCT00592319|2462974|P2|NOT COMPLETED|Overall Study||3
1014846|NCT00592319|2462975|P1|NOT COMPLETED|Overall Study||0
1014847|NCT00592319|2462974|P2|COMPLETED|Overall Study||5
1014848|NCT00592319|2462975|P1|COMPLETED|Overall Study||2
1014849|NCT00592319|2462974|P2|STARTED|Overall Study||8
1014850|NCT00592319|2462975|P1|STARTED|Overall Study||2
1014851|NCT00592358|2462983|P1|NOT COMPLETED|Overall Study||6
1014852|NCT00592358|2462983|P1|COMPLETED|Overall Study||11
1014853|NCT00592358|2462983|P1|STARTED|Overall Study||17
1014854|NCT00592384|2462990|P2|NOT COMPLETED|Overall Study||6
1014855|NCT00592384|2462991|P1|NOT COMPLETED|Overall Study||5
1014856|NCT00592384|2462990|P2|COMPLETED|Overall Study||63
1014857|NCT00592384|2462991|P1|COMPLETED|Overall Study||59
1014858|NCT00592384|2462990|P2|STARTED|Overall Study||69
1014859|NCT00592384|2462991|P1|STARTED|Overall Study||64
1014860|NCT00592475|2463002|P3|NOT COMPLETED|Overall Study||0
1014861|NCT00592475|2463003|P2|NOT COMPLETED|Overall Study||0
1014862|NCT00592475|2463004|P1|NOT COMPLETED|Overall Study||0
1014863|NCT00592475|2463002|P3|COMPLETED|Overall Study||5
1014864|NCT00592475|2463003|P2|COMPLETED|Overall Study||9
1014865|NCT00592475|2463004|P1|COMPLETED|Overall Study||6
1014866|NCT00592475|2463002|P3|STARTED|Overall Study||5
1014867|NCT00592475|2463003|P2|STARTED|Overall Study||9
1014868|NCT00592475|2463004|P1|STARTED|Overall Study||6
1014869|NCT00592488|2463029|P2|NOT COMPLETED|Overall Study||0
1014870|NCT00592488|2463030|P1|NOT COMPLETED|Overall Study||0
1014871|NCT00592488|2463029|P2|COMPLETED|Overall Study||7
1014872|NCT00592488|2463030|P1|COMPLETED|Overall Study||6
1014873|NCT00592488|2463029|P2|STARTED|Overall Study||7
1014874|NCT00592488|2463030|P1|STARTED|Overall Study||6
1014875|NCT00592631|2463038|P2|NOT COMPLETED|Overall Study||2
1014876|NCT00592631|2463039|P1|NOT COMPLETED|Overall Study||0
1014877|NCT00592631|2463038|P2|COMPLETED|Overall Study||9
1014878|NCT00592631|2463039|P1|COMPLETED|Overall Study||16
1014879|NCT00592631|2463038|P2|STARTED|Overall Study||11
1014880|NCT00592631|2463039|P1|STARTED|Overall Study||16
1014881|NCT00592683|2463047|P2|NOT COMPLETED|Overall Study||4
1014882|NCT00592683|2463048|P1|NOT COMPLETED|Overall Study||4
1014883|NCT00592683|2463047|P2|COMPLETED|Overall Study||6
1014884|NCT00592683|2463048|P1|COMPLETED|Overall Study||6
1014885|NCT00592683|2463047|P2|STARTED|Overall Study||10
1014886|NCT00592683|2463048|P1|STARTED|Overall Study||10
1014887|NCT00592761|2463056|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
1014888|NCT00592761|2463057|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
1014889|NCT00592761|2463056|P2|COMPLETED|Second Intervention (2 Weeks)||9
1014890|NCT00592761|2463057|P1|COMPLETED|Second Intervention (2 Weeks)||9
1014891|NCT00592761|2463056|P2|STARTED|Second Intervention (2 Weeks)||9
1014892|NCT00592761|2463057|P1|STARTED|Second Intervention (2 Weeks)||9
1014893|NCT00592761|2463056|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
1014894|NCT00592761|2463057|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
1014895|NCT00592761|2463056|P2|COMPLETED|First Intervention (2 Weeks)||9
1014896|NCT00592761|2463057|P1|COMPLETED|First Intervention (2 Weeks)||9
1014897|NCT00592761|2463056|P2|STARTED|First Intervention (2 Weeks)||9
1014898|NCT00592761|2463057|P1|STARTED|First Intervention (2 Weeks)||9
1014899|NCT00592774|2463074|P5|NOT COMPLETED|Overall Study||14
1014900|NCT00592774|2463075|P4|NOT COMPLETED|Overall Study||14
1014901|NCT00592774|2463076|P3|NOT COMPLETED|Overall Study||4
1014902|NCT00592774|2463077|P2|NOT COMPLETED|Overall Study||32
1014903|NCT00592774|2463078|P1|NOT COMPLETED|Overall Study||11
1014904|NCT00592774|2463074|P5|COMPLETED|Overall Study||9
1014905|NCT00592774|2463075|P4|COMPLETED|Overall Study||8
1014906|NCT00592774|2463076|P3|COMPLETED|Overall Study||18
1014907|NCT00592774|2463077|P2|COMPLETED|Overall Study||21
1014908|NCT00592774|2463078|P1|COMPLETED|Overall Study||15
1014909|NCT00592774|2463074|P5|STARTED|Overall Study||23
1014910|NCT00592774|2463075|P4|STARTED|Overall Study||22
1014911|NCT00592774|2463076|P3|STARTED|Overall Study||22
1014912|NCT00592774|2463077|P2|STARTED|Overall Study||53
1014913|NCT00592774|2463078|P1|STARTED|Overall Study||26
1014914|NCT00592839|2463138|P3|NOT COMPLETED|Overall Study||6
1014915|NCT00592839|2463139|P2|NOT COMPLETED|Overall Study||4
1014916|NCT00592839|2463140|P1|NOT COMPLETED|Overall Study||2
1014917|NCT00592839|2463138|P3|COMPLETED|Overall Study||46
1014918|NCT00592839|2463139|P2|COMPLETED|Overall Study||48
1014919|NCT00592839|2463140|P1|COMPLETED|Overall Study||51
1014920|NCT00592839|2463138|P3|STARTED|Overall Study||52
1014921|NCT00592839|2463139|P2|STARTED|Overall Study||52
1014922|NCT00592839|2463140|P1|STARTED|Overall Study||53
1014923|NCT00592852|2463163|P1|NOT COMPLETED|Overall Study||6
1014924|NCT00592852|2463163|P1|COMPLETED|Overall Study||7
1014925|NCT00592852|2463163|P1|STARTED|Overall Study||13
1014926|NCT00592904|2463172|P4|NOT COMPLETED|Overall Study||11
1014927|NCT00592904|2463173|P3|NOT COMPLETED|Overall Study||17
1014928|NCT00592904|2463174|P2|NOT COMPLETED|Overall Study||55
1014929|NCT00592904|2463175|P1|NOT COMPLETED|Overall Study||25
1014930|NCT00592904|2463172|P4|COMPLETED|Overall Study||19
1014931|NCT00592904|2463173|P3|COMPLETED|Overall Study||10
1014932|NCT00592904|2463174|P2|COMPLETED|Overall Study||93
1014933|NCT00592904|2463175|P1|COMPLETED|Overall Study||32
1014934|NCT00592904|2463172|P4|STARTED|Overall Study||30
1014935|NCT00592904|2463173|P3|STARTED|Overall Study||27
1014936|NCT00592904|2463174|P2|STARTED|Overall Study||148
1014937|NCT00592904|2463175|P1|STARTED|Overall Study||57
1014938|NCT00592943|2463203|P2|NOT COMPLETED|Overall Study||0
1014939|NCT00592943|2463204|P1|NOT COMPLETED|Overall Study||0
1014940|NCT00592943|2463203|P2|COMPLETED|Overall Study||6
1014941|NCT00592943|2463204|P1|COMPLETED|Overall Study||6
1014942|NCT00592943|2463203|P2|STARTED|Overall Study||6
1014943|NCT00592943|2463204|P1|STARTED|Overall Study||6
1014944|NCT00593112|2463216|P2|NOT COMPLETED|Overall Study||0
1014945|NCT00593112|2463217|P1|NOT COMPLETED|Overall Study||10
1014946|NCT00593112|2463216|P2|COMPLETED|Overall Study||12
1014947|NCT00593112|2463217|P1|COMPLETED|Overall Study||17
1014948|NCT00593112|2463216|P2|STARTED|Overall Study||12
1014949|NCT00593112|2463217|P1|STARTED|Overall Study||27
1014950|NCT00593320|2463229|P2|NOT COMPLETED|Overall Study||0
1014951|NCT00593320|2463230|P1|NOT COMPLETED|Overall Study||0
1014952|NCT00593320|2463229|P2|COMPLETED|Overall Study||1
1014953|NCT00593320|2463230|P1|COMPLETED|Overall Study||1
1014954|NCT00593320|2463229|P2|STARTED|Overall Study||1
1014955|NCT00593320|2463230|P1|STARTED|Overall Study||1
1014956|NCT00593333|2463244|P2|NOT COMPLETED|Overall Study||11
1014957|NCT00593333|2463245|P1|NOT COMPLETED|Overall Study||10
1014958|NCT00593333|2463244|P2|COMPLETED|Overall Study||45
1014959|NCT00593333|2463245|P1|COMPLETED|Overall Study||44
1014960|NCT00593333|2463244|P2|STARTED|Overall Study||56
1014961|NCT00593333|2463245|P1|STARTED|Overall Study||54
1014962|NCT00593346|2463251|P1|NOT COMPLETED|Overall Study||0
1014963|NCT00593346|2463251|P1|COMPLETED|Overall Study||151
1014964|NCT00593346|2463251|P1|STARTED|Overall Study||151
1014965|NCT00593372|2463268|P2|NOT COMPLETED|Overall Study||0
1014966|NCT00593372|2463269|P1|NOT COMPLETED|Overall Study||0
1014967|NCT00593372|2463268|P2|COMPLETED|Overall Study|Three evaluated and completed protocol.|3
1014968|NCT00593372|2463269|P1|COMPLETED|Overall Study|Eight completed behavioral treatment.|8
1014969|NCT00593372|2463268|P2|STARTED|Overall Study|Three evaluated but only maintained medical treatment.|3
1014970|NCT00593372|2463269|P1|STARTED|Overall Study|Eight enrolled in behavioral treatment.|8
1014971|NCT00593450|2463279|P4|NOT COMPLETED|Overall Study||29
1014972|NCT00593450|2463280|P3|NOT COMPLETED|Overall Study||13
1014973|NCT00593450|2463281|P2|NOT COMPLETED|Overall Study||21
1014974|NCT00593450|2463282|P1|NOT COMPLETED|Overall Study||17
1014975|NCT00593450|2463279|P4|COMPLETED|Overall Study||271
1014976|NCT00593450|2463280|P3|COMPLETED|Overall Study||285
1014977|NCT00593450|2463281|P2|COMPLETED|Overall Study||265
1014978|NCT00593450|2463282|P1|COMPLETED|Overall Study||284
1014979|NCT00593450|2463279|P4|STARTED|Overall Study||300
1014980|NCT00593450|2463280|P3|STARTED|Overall Study||298
1014981|NCT00593450|2463281|P2|STARTED|Overall Study||286
1014982|NCT00593450|2463282|P1|STARTED|Overall Study||301
1014983|NCT00593606|2463352|P1|NOT COMPLETED|Overall Study||27
1014984|NCT00593606|2463352|P1|COMPLETED|Overall Study||97
1014985|NCT00593606|2463352|P1|Treatment Period Completed|Overall Study||99
1014986|NCT00593606|2463352|P1|Full Analysis Set|Overall Study||114
1014987|NCT00593606|2463352|P1|Start of Treatment - Safety Set|Overall Study||116
1014988|NCT00593606|2463352|P1|STARTED|Overall Study||124
1014989|NCT00593645|2463448|P1|NOT COMPLETED|Overall Study||0
1014990|NCT00593645|2463448|P1|COMPLETED|Overall Study||7
1014991|NCT00593645|2463448|P1|STARTED|Overall Study||7
1014992|NCT00593684|2463464|P2|NOT COMPLETED|Overall Study||1
1014993|NCT00593684|2463465|P1|NOT COMPLETED|Overall Study||2
1014994|NCT00593684|2463464|P2|COMPLETED|Overall Study||24
1014995|NCT00593684|2463465|P1|COMPLETED|Overall Study||23
1014996|NCT00593684|2463464|P2|STARTED|Overall Study||25
1014997|NCT00593684|2463465|P1|STARTED|Overall Study||25
1014998|NCT00593736|2463481|P4|NOT COMPLETED|Treatment Period and Placebo Run-out||4
1014999|NCT00593736|2463482|P3|NOT COMPLETED|Treatment Period and Placebo Run-out||5
1015000|NCT00593736|2463483|P2|NOT COMPLETED|Treatment Period and Placebo Run-out||2
1015001|NCT00593736|2463484|P1|NOT COMPLETED|Treatment Period and Placebo Run-out||3
1015002|NCT00593736|2463481|P4|COMPLETED|Treatment Period and Placebo Run-out||28
1015003|NCT00593736|2463482|P3|COMPLETED|Treatment Period and Placebo Run-out||30
1015004|NCT00593736|2463483|P2|COMPLETED|Treatment Period and Placebo Run-out||31
1015005|NCT00593736|2463484|P1|COMPLETED|Treatment Period and Placebo Run-out||29
1015006|NCT00593736|2463481|P4|STARTED|Treatment Period and Placebo Run-out||32
1015007|NCT00593736|2463482|P3|STARTED|Treatment Period and Placebo Run-out||35
1015008|NCT00593736|2463483|P2|STARTED|Treatment Period and Placebo Run-out||33
1015009|NCT00593736|2463484|P1|STARTED|Treatment Period and Placebo Run-out||32
1015010|NCT00593736|2463481|P4|NOT COMPLETED|Screening Period and Placebo Run-in||417
1015011|NCT00593736|2463482|P3|NOT COMPLETED|Screening Period and Placebo Run-in||0
1015012|NCT00593736|2463483|P2|NOT COMPLETED|Screening Period and Placebo Run-in||0
1015013|NCT00593736|2463484|P1|NOT COMPLETED|Screening Period and Placebo Run-in||0
1015014|NCT00593736|2463481|P4|COMPLETED|Screening Period and Placebo Run-in||132
1015015|NCT00593736|2463482|P3|COMPLETED|Screening Period and Placebo Run-in||0
1015016|NCT00593736|2463483|P2|COMPLETED|Screening Period and Placebo Run-in||0
1015017|NCT00593736|2463484|P1|COMPLETED|Screening Period and Placebo Run-in||0
1015018|NCT00593736|2463481|P4|STARTED|Screening Period and Placebo Run-in||549
1015019|NCT00593736|2463482|P3|STARTED|Screening Period and Placebo Run-in||0
1015020|NCT00593736|2463483|P2|STARTED|Screening Period and Placebo Run-in||0
1015021|NCT00593736|2463484|P1|STARTED|Screening Period and Placebo Run-in||0
1015022|NCT00593814|2463732|P2|NOT COMPLETED|Overall Study||0
1015023|NCT00593814|2463733|P1|NOT COMPLETED|Overall Study||24
1015024|NCT00593814|2463732|P2|COMPLETED|Overall Study||120
1015025|NCT00593814|2463733|P1|COMPLETED|Overall Study||115
1015026|NCT00593814|2463732|P2|STARTED|Overall Study||120
1015027|NCT00593814|2463733|P1|STARTED|Overall Study||139
1015028|NCT00593827|2463741|P2|NOT COMPLETED|Overall Study||2
1015029|NCT00593827|2463742|P1|NOT COMPLETED|Overall Study||0
1015030|NCT00593827|2463741|P2|COMPLETED|Overall Study|Completed=off-study (Major reasons: AEs=30; disease progression=55; not treated=2).|89
1015031|NCT00593827|2463742|P1|COMPLETED|Overall Study|Completed=off-study (Major reasons: Adverse events (AE)=15; disease progression=76; not treated=3).|85
1015032|NCT00593827|2463741|P2|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|89
1015033|NCT00593827|2463742|P1|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|79
1015034|NCT00593827|2463741|P2|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|89
1015035|NCT00593827|2463742|P1|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|82
1015036|NCT00593827|2463741|P2|STARTED|Overall Study|ITT Population: Participants who were randomized (eligible and ineligible).|91
1015037|NCT00593827|2463742|P1|STARTED|Overall Study|Intent-to-Treat (ITT) Population: Participants who were randomized (eligible and ineligible).|85
1015038|NCT00593840|2463764|P1|NOT COMPLETED|Overall Study||1
1015039|NCT00593840|2463764|P1|COMPLETED|Overall Study||72
1015040|NCT00593840|2463764|P1|STARTED|Overall Study||73
1015041|NCT00593866|2463774|P1|NOT COMPLETED|Overall Study||0
1015042|NCT00593866|2463774|P1|COMPLETED|Overall Study||50
1015043|NCT00593866|2463774|P1|STARTED|Overall Study||50
1015044|NCT00593918|2463781|P2|NOT COMPLETED|Overall Study||24
1015045|NCT00593918|2463782|P1|NOT COMPLETED|Overall Study||5
1015046|NCT00593918|2463781|P2|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|50
1015047|NCT00593918|2463782|P1|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|12
1015048|NCT00593918|2463781|P2|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/AG and AA genotypes|74
1015049|NCT00593918|2463782|P1|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/GG Genotype|17
1015050|NCT00593957|2463793|P3|NOT COMPLETED|Overall Study||2
1015051|NCT00593957|2463794|P2|NOT COMPLETED|Overall Study||1
1015052|NCT00593957|2463795|P1|NOT COMPLETED|Overall Study||0
1015053|NCT00593957|2463793|P3|COMPLETED|Overall Study||10
1015054|NCT00593957|2463794|P2|COMPLETED|Overall Study||12
1015055|NCT00593957|2463795|P1|COMPLETED|Overall Study||13
1015056|NCT00593957|2463793|P3|STARTED|Overall Study||12
1015057|NCT00593957|2463794|P2|STARTED|Overall Study||13
1015058|NCT00593957|2463795|P1|STARTED|Overall Study||13
1015059|NCT00594022|2463819|P2|NOT COMPLETED|Overall Study||0
1015060|NCT00594022|2463820|P1|NOT COMPLETED|Overall Study||0
1015061|NCT00594022|2463819|P2|COMPLETED|Overall Study||173
1015062|NCT00594022|2463820|P1|COMPLETED|Overall Study||176
1015063|NCT00594022|2463819|P2|STARTED|Overall Study||173
1015064|NCT00594022|2463820|P1|STARTED|Overall Study||176
1015065|NCT00594035|2463836|P2|NOT COMPLETED|Overall Study||3
1015066|NCT00594035|2463837|P1|NOT COMPLETED|Overall Study||2
1015067|NCT00594035|2463836|P2|COMPLETED|Overall Study|53 control group subjects were evaluable at the 90-day visit|53
1015068|NCT00594035|2463837|P1|COMPLETED|Overall Study|100 Spinal Sealant subjects were evaluable at the 90-day visit|100
1015069|NCT00594035|2463836|P2|STARTED|Overall Study|56 subjects were randomized to the control group (standard of care)|56
1015070|NCT00594035|2463837|P1|STARTED|Overall Study|102 subjects were randomized to Spinal Sealant|102
1015071|NCT00594100|2463843|P1|NOT COMPLETED|Follow-up Through 30 Days Post Procedure||12
1015072|NCT00594100|2463843|P1|COMPLETED|Follow-up Through 30 Days Post Procedure||224
1015073|NCT00594100|2463843|P1|STARTED|Follow-up Through 30 Days Post Procedure||236
1015074|NCT00594100|2463843|P1|NOT COMPLETED|Procedure||9
1015075|NCT00594100|2463843|P1|COMPLETED|Procedure||236
1015076|NCT00594100|2463843|P1|STARTED|Procedure||245
1015077|NCT00594165|2463852|P1|NOT COMPLETED|Overall Study||217
1015078|NCT00594165|2463852|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
1015079|NCT00594165|2463852|P1|STARTED|Overall Study||217
1015080|NCT00594178|2463858|P1|NOT COMPLETED|Overall Study||5
1015081|NCT00594178|2463858|P1|COMPLETED|Overall Study||12
1015082|NCT00594178|2463858|P1|STARTED|Overall Study||17
1015083|NCT00594204|2463865|P2|NOT COMPLETED|Overall Study||45
1015084|NCT00594204|2463866|P1|NOT COMPLETED|Overall Study||58
1015085|NCT00594204|2463865|P2|COMPLETED|Overall Study||154
1015086|NCT00594204|2463866|P1|COMPLETED|Overall Study||336
1015087|NCT00594204|2463865|P2|Received Treatment|Overall Study||198
1015088|NCT00594204|2463866|P1|Received Treatment|Overall Study||390
1015089|NCT00594204|2463865|P2|STARTED|Overall Study||199
1015090|NCT00594204|2463866|P1|STARTED|Overall Study||394
1015091|NCT00594230|2463878|P2|NOT COMPLETED|Overall Study||9
1015092|NCT00594230|2463879|P1|NOT COMPLETED|Overall Study||15
1015093|NCT00594230|2463878|P2|COMPLETED|Overall Study||1
1015094|NCT00594230|2463879|P1|COMPLETED|Overall Study||1
1015095|NCT00594230|2463878|P2|STARTED|Overall Study||10
1015096|NCT00594230|2463879|P1|STARTED|Overall Study||16
1015097|NCT00594256|2463885|P1|NOT COMPLETED|Overall Study||0
1015098|NCT00594256|2463885|P1|COMPLETED|Overall Study||8
1015099|NCT00594256|2463885|P1|STARTED|Overall Study||8
1015100|NCT00594308|2463893|P1|NOT COMPLETED|Overall Study||0
1015101|NCT00594308|2463893|P1|COMPLETED|Overall Study||10
1015102|NCT00594308|2463893|P1|STARTED|Overall Study||10
1015103|NCT00594386|2463901|P1|NOT COMPLETED|Overall Study||258
1015104|NCT00594386|2463901|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
1015105|NCT00594386|2463901|P1|STARTED|Overall Study||258
1015106|NCT00594399|2463909|P3|NOT COMPLETED|Rerandomization Arm 1 Only||0
1015107|NCT00594399|2463910|P2|NOT COMPLETED|Rerandomization Arm 1 Only||4
1015108|NCT00594399|2463911|P1|NOT COMPLETED|Rerandomization Arm 1 Only||2
1015109|NCT00594399|2463909|P3|COMPLETED|Rerandomization Arm 1 Only||82
1015110|NCT00594399|2463910|P2|COMPLETED|Rerandomization Arm 1 Only||114
1015111|NCT00594399|2463911|P1|COMPLETED|Rerandomization Arm 1 Only||79
1015112|NCT00594399|2463909|P3|Rerandomization|Rerandomization Arm 1 Only||82
1015113|NCT00594399|2463910|P2|Rerandomization|Rerandomization Arm 1 Only||114
1015114|NCT00594399|2463911|P1|Rerandomization|Rerandomization Arm 1 Only|Rerandomized to continue to receive telephone calls every 2 weeks or at a reduced dose of 1/ month|81
1015115|NCT00594399|2463909|P3|STARTED|Rerandomization Arm 1 Only|This sample reflects newly randomized study Arm|82
1015116|NCT00594399|2463910|P2|STARTED|Rerandomization Arm 1 Only||118
1015117|NCT00594399|2463911|P1|STARTED|Rerandomization Arm 1 Only|Total sample in Arm 1 was rerandomized and allocated to remain in Arm 1 or assigned to Arm 3|81
1015118|NCT00594399|2463909|P3|NOT COMPLETED|Initial 3 Month Counseling||0
1015119|NCT00594399|2463910|P2|NOT COMPLETED|Initial 3 Month Counseling||4
1015120|NCT00594399|2463911|P1|NOT COMPLETED|Initial 3 Month Counseling||17
1015121|NCT00594399|2463909|P3|COMPLETED|Initial 3 Month Counseling||0
1015122|NCT00594399|2463910|P2|COMPLETED|Initial 3 Month Counseling||118
1015123|NCT00594399|2463911|P1|COMPLETED|Initial 3 Month Counseling||163
1015124|NCT00594399|2463909|P3|STARTED|Initial 3 Month Counseling||0
1015125|NCT00594399|2463910|P2|STARTED|Initial 3 Month Counseling||122
1015126|NCT00594399|2463911|P1|STARTED|Initial 3 Month Counseling||180
1015127|NCT00594425|2463936|P3|NOT COMPLETED|Overall Study||10
1015128|NCT00594425|2463937|P2|NOT COMPLETED|Overall Study||14
1015129|NCT00594425|2463938|P1|NOT COMPLETED|Overall Study||7
1015130|NCT00594425|2463936|P3|COMPLETED|Overall Study||42
1015131|NCT00594425|2463937|P2|COMPLETED|Overall Study||34
1015132|NCT00594425|2463938|P1|COMPLETED|Overall Study||43
1015133|NCT00594425|2463936|P3|STARTED|Overall Study||52
1015134|NCT00594425|2463937|P2|STARTED|Overall Study||48
1015135|NCT00594425|2463938|P1|STARTED|Overall Study||50
1015136|NCT00594464|2464048|P1|NOT COMPLETED|Overall Study||3
1015137|NCT00594464|2464048|P1|COMPLETED|Overall Study||11
1015138|NCT00594464|2464048|P1|STARTED|Overall Study||14
1015139|NCT00585494|2464060|P1|NOT COMPLETED|Overall Study||56
1015140|NCT00585494|2464060|P1|COMPLETED|Overall Study||244
1015141|NCT00585494|2464060|P1|STARTED|Overall Study||300
1015142|NCT00585533|2464064|P1|NOT COMPLETED|Overall Study||9
1015143|NCT00585533|2464064|P1|COMPLETED|Overall Study||31
1015144|NCT00585533|2464064|P1|STARTED|Overall Study||40
1015145|NCT00585585|2464069|P1|NOT COMPLETED|Overall Study||1
1015146|NCT00585585|2464069|P1|COMPLETED|Overall Study||0
1015147|NCT00585585|2464069|P1|Patients Receiving Drug|Overall Study||1
1015148|NCT00585585|2464069|P1|STARTED|Overall Study||1
1015149|NCT00585637|2464077|P4|NOT COMPLETED|6-month Time Point||6
1015150|NCT00585637|2464078|P3|NOT COMPLETED|6-month Time Point||11
1015151|NCT00585637|2464079|P2|NOT COMPLETED|6-month Time Point||13
1015152|NCT00585637|2464080|P1|NOT COMPLETED|6-month Time Point||6
1015153|NCT00585637|2464077|P4|COMPLETED|6-month Time Point||77
1015154|NCT00585637|2464078|P3|COMPLETED|6-month Time Point||72
1015155|NCT00585637|2464079|P2|COMPLETED|6-month Time Point||68
1015156|NCT00585637|2464080|P1|COMPLETED|6-month Time Point||75
1015157|NCT00585637|2464077|P4|STARTED|6-month Time Point||83
1015158|NCT00585637|2464078|P3|STARTED|6-month Time Point||83
1015159|NCT00585637|2464079|P2|STARTED|6-month Time Point||81
1015160|NCT00585637|2464080|P1|STARTED|6-month Time Point||81
1015161|NCT00585637|2464077|P4|NOT COMPLETED|3-month Time Point||5
1015162|NCT00585637|2464078|P3|NOT COMPLETED|3-month Time Point||7
1015163|NCT00585637|2464079|P2|NOT COMPLETED|3-month Time Point||14
1015164|NCT00585637|2464080|P1|NOT COMPLETED|3-month Time Point||10
1015165|NCT00585637|2464077|P4|COMPLETED|3-month Time Point||78
1015166|NCT00585637|2464078|P3|COMPLETED|3-month Time Point||76
1015167|NCT00585637|2464079|P2|COMPLETED|3-month Time Point||67
1015168|NCT00585637|2464080|P1|COMPLETED|3-month Time Point||71
1015169|NCT00585637|2464077|P4|STARTED|3-month Time Point||83
1015170|NCT00585637|2464078|P3|STARTED|3-month Time Point||83
1015171|NCT00585637|2464079|P2|STARTED|3-month Time Point||81
1015172|NCT00585637|2464080|P1|STARTED|3-month Time Point||81
1015173|NCT00585637|2464077|P4|NOT COMPLETED|Baseline||0
1015174|NCT00585637|2464078|P3|NOT COMPLETED|Baseline||0
1015175|NCT00585637|2464079|P2|NOT COMPLETED|Baseline||0
1015176|NCT00585637|2464080|P1|NOT COMPLETED|Baseline||0
1015177|NCT00585637|2464077|P4|COMPLETED|Baseline||83
1015178|NCT00585637|2464078|P3|COMPLETED|Baseline||83
1015179|NCT00585637|2464079|P2|COMPLETED|Baseline||81
1015180|NCT00585637|2464080|P1|COMPLETED|Baseline||81
1015181|NCT00585637|2464077|P4|STARTED|Baseline||83
1015182|NCT00585637|2464078|P3|STARTED|Baseline||83
1015183|NCT00585637|2464079|P2|STARTED|Baseline||81
1015184|NCT00585637|2464080|P1|STARTED|Baseline||81
1015185|NCT00585650|2464108|P2|NOT COMPLETED|Overall Study||0
1015186|NCT00585650|2464109|P1|NOT COMPLETED|Overall Study||0
1015187|NCT00585650|2464108|P2|COMPLETED|Overall Study||12
1015188|NCT00585650|2464109|P1|COMPLETED|Overall Study||8
1015189|NCT00585650|2464108|P2|STARTED|Overall Study||12
1015190|NCT00585650|2464109|P1|STARTED|Overall Study||8
1015191|NCT00585689|2464115|P1|NOT COMPLETED|Overall Study||7
1015192|NCT00585689|2464115|P1|COMPLETED|Overall Study||22
1015193|NCT00585689|2464115|P1|STARTED|Overall Study||29
1015194|NCT00585715|2464121|P2|NOT COMPLETED|Overall Study||0
1015195|NCT00585715|2464122|P1|NOT COMPLETED|Overall Study||3
1015196|NCT00585715|2464121|P2|COMPLETED|Overall Study||11
1015197|NCT00585715|2464122|P1|COMPLETED|Overall Study||8
1015198|NCT00585715|2464121|P2|STARTED|Overall Study||11
1015199|NCT00585715|2464122|P1|STARTED|Overall Study||11
1015200|NCT00594516|2464130|P3|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||8
1015201|NCT00594516|2464131|P2|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||7
1015202|NCT00594516|2464132|P1|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
1015203|NCT00594516|2464130|P3|COMPLETED|DB: Tapentadol IR to ER & ER to IR||35
1015204|NCT00594516|2464131|P2|COMPLETED|DB: Tapentadol IR to ER & ER to IR||37
1015205|NCT00594516|2464132|P1|COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
1015206|NCT00594516|2464130|P3|STARTED|DB: Tapentadol IR to ER & ER to IR||43
1015207|NCT00594516|2464131|P2|STARTED|DB: Tapentadol IR to ER & ER to IR||44
1015208|NCT00594516|2464132|P1|STARTED|DB: Tapentadol IR to ER & ER to IR||0
1015209|NCT00594516|2464130|P3|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
1015210|NCT00594516|2464131|P2|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
1015211|NCT00594516|2464132|P1|NOT COMPLETED|Open Label (OL): Tapentadol IR||29
1015212|NCT00594516|2464130|P3|COMPLETED|Open Label (OL): Tapentadol IR||0
1015213|NCT00594516|2464131|P2|COMPLETED|Open Label (OL): Tapentadol IR||0
1015214|NCT00594516|2464132|P1|COMPLETED|Open Label (OL): Tapentadol IR||87
1015215|NCT00594516|2464130|P3|STARTED|Open Label (OL): Tapentadol IR||0
1015216|NCT00594516|2464131|P2|STARTED|Open Label (OL): Tapentadol IR||0
1015217|NCT00594516|2464132|P1|STARTED|Open Label (OL): Tapentadol IR|one patient was enrolled but lost to follow up at the start of open label therefore was not included|116
1015218|NCT00594568|2464143|P3|NOT COMPLETED|Safety Follow Up (SFU)-Optional||42
1015219|NCT00594568|2464144|P2|NOT COMPLETED|Safety Follow Up (SFU)-Optional||55
1015220|NCT00594568|2464145|P1|NOT COMPLETED|Safety Follow Up (SFU)-Optional||61
1015221|NCT00594568|2464143|P3|COMPLETED|Safety Follow Up (SFU)-Optional||172
1015222|NCT00594568|2464144|P2|COMPLETED|Safety Follow Up (SFU)-Optional||168
1015223|NCT00594568|2464145|P1|COMPLETED|Safety Follow Up (SFU)-Optional||229
1015224|NCT00594568|2464143|P3|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional, pts entered from initial treatment and delayed start or did not enter SFU.|214
1015225|NCT00594568|2464144|P2|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|223
1015226|NCT00594568|2464145|P1|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|290
1015227|NCT00594568|2464143|P3|NOT COMPLETED|Delayed Start||66
1015228|NCT00594568|2464144|P2|NOT COMPLETED|Delayed Start||77
1015229|NCT00594568|2464145|P1|NOT COMPLETED|Delayed Start||98
1015230|NCT00594568|2464143|P3|COMPLETED|Delayed Start||55
1015231|NCT00594568|2464144|P2|COMPLETED|Delayed Start||76
1015232|NCT00594568|2464145|P1|COMPLETED|Delayed Start||91
1015233|NCT00594568|2464143|P3|STARTED|Delayed Start||121
1015234|NCT00594568|2464144|P2|STARTED|Delayed Start||153
1015235|NCT00594568|2464145|P1|STARTED|Delayed Start||189
1015236|NCT00594568|2464143|P3|NOT COMPLETED|Initial Treatment||408
1015237|NCT00594568|2464144|P2|NOT COMPLETED|Initial Treatment||354
1015238|NCT00594568|2464145|P1|NOT COMPLETED|Initial Treatment||312
1015239|NCT00594568|2464143|P3|COMPLETED|Initial Treatment||121
1015240|NCT00594568|2464144|P2|COMPLETED|Initial Treatment||153
1015241|NCT00594568|2464145|P1|COMPLETED|Initial Treatment||189
1015242|NCT00594568|2464143|P3|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|527
1015243|NCT00594568|2464144|P2|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|506
1015244|NCT00594568|2464145|P1|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants (pts) who had at least 1 dose of study drug.|501
1015245|NCT00594568|2464143|P3|STARTED|Initial Treatment||529
1015246|NCT00594568|2464144|P2|STARTED|Initial Treatment||507
1015247|NCT00594568|2464145|P1|STARTED|Initial Treatment||501
1015248|NCT00594646|2464233|P1|NOT COMPLETED|Overall Study||16
1015249|NCT00594646|2464233|P1|COMPLETED|Overall Study||84
1015250|NCT00594646|2464233|P1|STARTED|Overall Study||100
1015251|NCT00594659|2464241|P3|NOT COMPLETED|Overall Study||7
1015252|NCT00594659|2464242|P2|NOT COMPLETED|Overall Study||9
1015253|NCT00594659|2464243|P1|NOT COMPLETED|Overall Study||13
1015254|NCT00594659|2464241|P3|COMPLETED|Overall Study||9
1015255|NCT00594659|2464242|P2|COMPLETED|Overall Study||21
1015256|NCT00594659|2464243|P1|COMPLETED|Overall Study||16
1015257|NCT00594659|2464241|P3|STARTED|Overall Study||16
1015258|NCT00594659|2464242|P2|STARTED|Overall Study||30
1015259|NCT00594659|2464243|P1|STARTED|Overall Study||29
1015260|NCT00594685|2464254|P1|NOT COMPLETED|Overall Study||0
1015261|NCT00594685|2464254|P1|COMPLETED|Overall Study||10
1015262|NCT00594685|2464254|P1|STARTED|Overall Study||10
1015263|NCT00594815|2464271|P1|NOT COMPLETED|Overall Study||9
1015264|NCT00594815|2464271|P1|COMPLETED|Overall Study||43
1015265|NCT00594815|2464271|P1|STARTED|Overall Study||52
1015266|NCT00597519|2464276|P1|NOT COMPLETED|Overall Study||1
1015267|NCT00597519|2464276|P1|COMPLETED|Overall Study||27
1015268|NCT00597519|2464276|P1|STARTED|Overall Study||28
1015269|NCT00597545|2464282|P2|NOT COMPLETED|Overall Study||0
1015270|NCT00597545|2464283|P1|NOT COMPLETED|Overall Study||0
1015271|NCT00597545|2464282|P2|COMPLETED|Overall Study||6
1015272|NCT00597545|2464283|P1|COMPLETED|Overall Study||4
1015273|NCT00597545|2464282|P2|STARTED|Overall Study||6
1015274|NCT00597545|2464283|P1|STARTED|Overall Study||4
1015275|NCT00597558|2464289|P1|NOT COMPLETED|Overall Study||4
1015276|NCT00597558|2464289|P1|COMPLETED|Overall Study||9
1015277|NCT00597558|2464289|P1|STARTED|Overall Study||13
1015278|NCT00597584|2464297|P2|NOT COMPLETED|Overall Study||63
1015279|NCT00597584|2464298|P1|NOT COMPLETED|Overall Study||128
1015280|NCT00597584|2464297|P2|COMPLETED|Overall Study||211
1015281|NCT00597584|2464298|P1|COMPLETED|Overall Study||421
1015282|NCT00597584|2464297|P2|STARTED|Overall Study||274
1015283|NCT00597584|2464298|P1|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin|549
1015284|NCT00597675|2464310|P2|NOT COMPLETED|Open Label Phase||0
1015285|NCT00597675|2464311|P1|NOT COMPLETED|Open Label Phase||0
1015286|NCT00597675|2464310|P2|COMPLETED|Open Label Phase||5
1015287|NCT00597675|2464311|P1|COMPLETED|Open Label Phase||2
1015288|NCT00597675|2464310|P2|STARTED|Open Label Phase||5
1015289|NCT00597675|2464311|P1|STARTED|Open Label Phase|Patients previously on placebo were crossed over onto open label peanut OIT|2
1015290|NCT00597675|2464310|P2|NOT COMPLETED|Blinded Phase||1
1015291|NCT00597675|2464311|P1|NOT COMPLETED|Blinded Phase||2
1015292|NCT00597675|2464310|P2|COMPLETED|Blinded Phase||5
1015293|NCT00597675|2464311|P1|COMPLETED|Blinded Phase||2
1015294|NCT00597675|2464310|P2|STARTED|Blinded Phase||6
1015295|NCT00597675|2464311|P1|STARTED|Blinded Phase||4
1015296|NCT00597701|2464324|P2|NOT COMPLETED|Overall Study||8
1015297|NCT00597701|2464325|P1|NOT COMPLETED|Overall Study||7
1015298|NCT00597701|2464324|P2|COMPLETED|Overall Study||13
1015299|NCT00597701|2464325|P1|COMPLETED|Overall Study||18
1015300|NCT00597701|2464324|P2|STARTED|Overall Study||21
1015301|NCT00597701|2464325|P1|STARTED|Overall Study||25
1015302|NCT00597714|2464333|P3|NOT COMPLETED|Overall Study||10
1015303|NCT00597714|2464334|P2|NOT COMPLETED|Overall Study||46
1015304|NCT00597714|2464335|P1|NOT COMPLETED|Overall Study||56
1015305|NCT00597714|2464333|P3|COMPLETED|Overall Study||84
1015306|NCT00597714|2464334|P2|COMPLETED|Overall Study||11
1015307|NCT00597714|2464335|P1|COMPLETED|Overall Study||24
1015308|NCT00597714|2464333|P3|STARTED|Overall Study||94
1015309|NCT00597714|2464334|P2|STARTED|Overall Study||57
1015310|NCT00597714|2464335|P1|STARTED|Overall Study||80
1015311|NCT00597727|2464349|P5|NOT COMPLETED|Open-label Extended Maintenance Phase||2
1015312|NCT00597727|2464350|P4|NOT COMPLETED|Open-label Extended Maintenance Phase||3
1015313|NCT00597727|2464351|P3|NOT COMPLETED|Open-label Extended Maintenance Phase||6
1015314|NCT00597727|2464352|P2|NOT COMPLETED|Open-label Extended Maintenance Phase||0
1015315|NCT00597727|2464353|P1|NOT COMPLETED|Open-label Extended Maintenance Phase||0
1015316|NCT00597727|2464349|P5|COMPLETED|Open-label Extended Maintenance Phase||1
1015317|NCT00597727|2464350|P4|COMPLETED|Open-label Extended Maintenance Phase||14
1015318|NCT00597727|2464351|P3|COMPLETED|Open-label Extended Maintenance Phase||23
1015319|NCT00597727|2464352|P2|COMPLETED|Open-label Extended Maintenance Phase||0
1015320|NCT00597727|2464353|P1|COMPLETED|Open-label Extended Maintenance Phase||0
1015321|NCT00597727|2464349|P5|STARTED|Open-label Extended Maintenance Phase||3
1015322|NCT00597727|2464350|P4|STARTED|Open-label Extended Maintenance Phase||17
1015323|NCT00597727|2464351|P3|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding.|29
1015324|NCT00597727|2464352|P2|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
1015325|NCT00597727|2464353|P1|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
1015326|NCT00597727|2464349|P5|NOT COMPLETED|12 Month Blinded Phase||1
1015327|NCT00597727|2464350|P4|NOT COMPLETED|12 Month Blinded Phase||10
1015328|NCT00597727|2464351|P3|NOT COMPLETED|12 Month Blinded Phase||0
1015329|NCT00597727|2464352|P2|NOT COMPLETED|12 Month Blinded Phase||0
1015330|NCT00597727|2464353|P1|NOT COMPLETED|12 Month Blinded Phase||0
1015331|NCT00597727|2464349|P5|COMPLETED|12 Month Blinded Phase||3
1015332|NCT00597727|2464350|P4|COMPLETED|12 Month Blinded Phase||17
1015333|NCT00597727|2464351|P3|COMPLETED|12 Month Blinded Phase||0
1015334|NCT00597727|2464352|P2|COMPLETED|12 Month Blinded Phase||15
1015335|NCT00597727|2464353|P1|COMPLETED|12 Month Blinded Phase||14
1015336|NCT00597727|2464349|P5|STARTED|12 Month Blinded Phase||4
1015337|NCT00597727|2464350|P4|STARTED|12 Month Blinded Phase||27
1015338|NCT00597727|2464351|P3|STARTED|12 Month Blinded Phase||0
1015339|NCT00597727|2464352|P2|STARTED|12 Month Blinded Phase||15
1015340|NCT00597727|2464353|P1|STARTED|12 Month Blinded Phase||14
1015341|NCT00597753|2464369|P2|NOT COMPLETED|Overall Study||69
1015342|NCT00597753|2464370|P1|NOT COMPLETED|Overall Study||166
1015343|NCT00597753|2464369|P2|COMPLETED|Overall Study||202
1015344|NCT00597753|2464370|P1|COMPLETED|Overall Study||366
1015345|NCT00597753|2464369|P2|STARTED|Overall Study||271
1015346|NCT00597753|2464370|P1|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin alfa|532
1015347|NCT00597896|2464382|P2|NOT COMPLETED|Overall Study||2
1015348|NCT00597896|2464383|P1|NOT COMPLETED|Overall Study||3
1015349|NCT00597896|2464382|P2|COMPLETED|Overall Study||24
1015350|NCT00597896|2464383|P1|COMPLETED|Overall Study||21
1015351|NCT00597896|2464382|P2|STARTED|Overall Study||26
1015352|NCT00597896|2464383|P1|STARTED|Overall Study||24
1015353|NCT00597909|2464412|P3|NOT COMPLETED|Overall Study||0
1015354|NCT00597909|2464413|P2|NOT COMPLETED|Overall Study||0
1015355|NCT00597909|2464414|P1|NOT COMPLETED|Overall Study||0
1015356|NCT00597909|2464412|P3|COMPLETED|Overall Study||0
1015357|NCT00597909|2464413|P2|COMPLETED|Overall Study||0
1015358|NCT00597909|2464414|P1|COMPLETED|Overall Study||0
1015359|NCT00597909|2464412|P3|STARTED|Overall Study||0
1015360|NCT00597909|2464413|P2|STARTED|Overall Study||0
1015361|NCT00597909|2464414|P1|STARTED|Overall Study||0
1015362|NCT00598078|2464422|P2|NOT COMPLETED|Period 3 (Day 3)||0
1015363|NCT00598078|2464423|P1|NOT COMPLETED|Period 3 (Day 3)||0
1015364|NCT00598078|2464422|P2|COMPLETED|Period 3 (Day 3)||10
1015365|NCT00598078|2464423|P1|COMPLETED|Period 3 (Day 3)||9
1015366|NCT00598078|2464422|P2|STARTED|Period 3 (Day 3)||10
1015367|NCT00598078|2464423|P1|STARTED|Period 3 (Day 3)||9
1015368|NCT00598078|2464422|P2|NOT COMPLETED|Period 2 (Day 2)||0
1015369|NCT00598078|2464423|P1|NOT COMPLETED|Period 2 (Day 2)||1
1015370|NCT00598078|2464422|P2|COMPLETED|Period 2 (Day 2)||10
1015371|NCT00598078|2464423|P1|COMPLETED|Period 2 (Day 2)||9
1015372|NCT00598078|2464422|P2|STARTED|Period 2 (Day 2)||10
1015373|NCT00598078|2464423|P1|STARTED|Period 2 (Day 2)||10
1015374|NCT00598078|2464422|P2|NOT COMPLETED|Period 1 (Day 1)||0
1015375|NCT00598078|2464423|P1|NOT COMPLETED|Period 1 (Day 1)||0
1015376|NCT00598078|2464422|P2|COMPLETED|Period 1 (Day 1)||10
1015377|NCT00598078|2464423|P1|COMPLETED|Period 1 (Day 1)||10
1015378|NCT00598078|2464422|P2|STARTED|Period 1 (Day 1)||10
1015379|NCT00598078|2464423|P1|STARTED|Period 1 (Day 1)||10
1015380|NCT00598273|2464434|P3|NOT COMPLETED|Overall Study||39
1015381|NCT00598273|2464435|P2|NOT COMPLETED|Overall Study||38
1015382|NCT00598273|2464436|P1|NOT COMPLETED|Overall Study||41
1015383|NCT00598273|2464434|P3|COMPLETED|Overall Study||125
1015384|NCT00598273|2464435|P2|COMPLETED|Overall Study||127
1015385|NCT00598273|2464436|P1|COMPLETED|Overall Study||120
1015386|NCT00598273|2464434|P3|STARTED|Overall Study||164
1015387|NCT00598273|2464435|P2|STARTED|Overall Study||165
1015388|NCT00598273|2464436|P1|STARTED|Overall Study||161
1015389|NCT00598442|2464453|P3|NOT COMPLETED|Overall Study||24
1015390|NCT00598442|2464454|P2|NOT COMPLETED|Overall Study||39
1015391|NCT00598442|2464455|P1|NOT COMPLETED|Overall Study||43
1015392|NCT00598442|2464453|P3|COMPLETED|Overall Study||139
1015393|NCT00598442|2464454|P2|COMPLETED|Overall Study||124
1015394|NCT00598442|2464455|P1|COMPLETED|Overall Study||124
1015395|NCT00598442|2464453|P3|STARTED|Overall Study||163
1015396|NCT00598442|2464454|P2|STARTED|Overall Study||163
1015397|NCT00598442|2464455|P1|STARTED|Overall Study||167
1015398|NCT00598507|2464469|P1|NOT COMPLETED|Overall Study||0
1015399|NCT00598507|2464469|P1|COMPLETED|Overall Study||35
1015400|NCT00598507|2464469|P1|STARTED|Overall Study||35
1015401|NCT00598559|2464479|P3|NOT COMPLETED|Overall Study||3
1015402|NCT00598559|2464480|P2|NOT COMPLETED|Overall Study||28
1015403|NCT00598559|2464481|P1|NOT COMPLETED|Overall Study||27
1015404|NCT00598559|2464479|P3|COMPLETED|Overall Study|Subjects completed 5 days of treatment|27
1015405|NCT00598559|2464480|P2|COMPLETED|Overall Study|Subjects completed 5 days of treatment|63
1015406|NCT00598559|2464481|P1|COMPLETED|Overall Study|Subjects completed 5 days of treatment|65
1015407|NCT00598559|2464479|P3|STARTED|Overall Study||30
1015408|NCT00598559|2464480|P2|STARTED|Overall Study||91
1015409|NCT00598559|2464481|P1|STARTED|Overall Study||92
1015410|NCT00598585|2464500|P2|NOT COMPLETED|Overall Study||0
1015411|NCT00598585|2464501|P1|NOT COMPLETED|Overall Study||1
1015412|NCT00598585|2464500|P2|COMPLETED|Overall Study||6
1015413|NCT00598585|2464501|P1|COMPLETED|Overall Study||5
1015414|NCT00598585|2464500|P2|STARTED|Overall Study||6
1015415|NCT00598585|2464501|P1|STARTED|Overall Study||6
1015416|NCT00598650|2464507|P1|NOT COMPLETED|Overall Study||27
1015417|NCT00598650|2464507|P1|COMPLETED|Overall Study|5 subjects withdrew for multiple reasons|81
1015418|NCT00598650|2464507|P1|STARTED|Overall Study||108
1015419|NCT00598689|2464516|P2|NOT COMPLETED|Overall Study||0
1015420|NCT00598689|2464517|P1|NOT COMPLETED|Overall Study||0
1015421|NCT00598689|2464516|P2|COMPLETED|Overall Study||40
1015422|NCT00598689|2464517|P1|COMPLETED|Overall Study||40
1015423|NCT00598689|2464516|P2|STARTED|Overall Study||40
1015424|NCT00598689|2464517|P1|STARTED|Overall Study||40
1015425|NCT00598702|2464535|P8|NOT COMPLETED|Overall Study||0
1015426|NCT00598702|2464536|P7|NOT COMPLETED|Overall Study||1
1015427|NCT00598702|2464537|P6|NOT COMPLETED|Overall Study||12
1015428|NCT00598702|2464538|P5|NOT COMPLETED|Overall Study||3
1015429|NCT00598702|2464539|P4|NOT COMPLETED|Overall Study||8
1015430|NCT00598702|2464540|P3|NOT COMPLETED|Overall Study||2
1015431|NCT00598702|2464541|P2|NOT COMPLETED|Overall Study||2
1015432|NCT00598702|2464542|P1|NOT COMPLETED|Overall Study||0
1015433|NCT00598702|2464535|P8|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|4
1015434|NCT00598702|2464536|P7|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|0
1015435|NCT00598702|2464537|P6|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|30
1015436|NCT00598702|2464538|P5|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|6
1015437|NCT00598702|2464539|P4|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|25
1015438|NCT00598702|2464540|P3|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|5
1015439|NCT00598702|2464541|P2|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
1015440|NCT00598702|2464542|P1|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
1015441|NCT00598702|2464535|P8|STARTED|Overall Study||4
1015442|NCT00598702|2464536|P7|STARTED|Overall Study||1
1015443|NCT00598702|2464537|P6|STARTED|Overall Study||42
1015444|NCT00598702|2464538|P5|STARTED|Overall Study||9
1015445|NCT00598702|2464539|P4|STARTED|Overall Study||33
1015446|NCT00598702|2464540|P3|STARTED|Overall Study||7
1015447|NCT00598702|2464541|P2|STARTED|Overall Study||3
1015448|NCT00598702|2464542|P1|STARTED|Overall Study||1
1015455|NCT00598819|2464607|P1|NOT COMPLETED|Overall Study||0
1015456|NCT00598819|2464607|P1|COMPLETED|Overall Study||14
1015457|NCT00598819|2464607|P1|STARTED|Overall Study||14
1015458|NCT00598832|2464617|P2|NOT COMPLETED|Overall Study||82
1015459|NCT00598832|2464618|P1|NOT COMPLETED|Overall Study||62
1015460|NCT00598832|2464617|P2|COMPLETED|Overall Study||460
1015461|NCT00598832|2464618|P1|COMPLETED|Overall Study||471
1015462|NCT00598832|2464617|P2|STARTED|Overall Study||542
1015463|NCT00598832|2464618|P1|STARTED|Overall Study||533
1015464|NCT00598871|2464634|P2|NOT COMPLETED|Overall Study||1
1015465|NCT00598871|2464635|P1|NOT COMPLETED|Overall Study||0
1015466|NCT00598871|2464634|P2|COMPLETED|Overall Study||8
1015467|NCT00598871|2464635|P1|COMPLETED|Overall Study||3
1015468|NCT00598871|2464634|P2|STARTED|Overall Study||9
1015469|NCT00598871|2464635|P1|STARTED|Overall Study||3
1015470|NCT00599014|2464643|P1|NOT COMPLETED|Overall Study||0
1015471|NCT00599014|2464643|P1|COMPLETED|Overall Study||335
1015472|NCT00599014|2464643|P1|STARTED|Overall Study||335
1015473|NCT00599027|2464650|P2|NOT COMPLETED|Overall Study||3
1015474|NCT00599027|2464651|P1|NOT COMPLETED|Overall Study||1
1015475|NCT00599027|2464650|P2|COMPLETED|Overall Study||22
1015476|NCT00599027|2464651|P1|COMPLETED|Overall Study||25
1015477|NCT00599027|2464650|P2|STARTED|Overall Study||25
1015478|NCT00599027|2464651|P1|STARTED|Overall Study||26
1015479|NCT00599053|2464659|P2|NOT COMPLETED|Overall Study||0
1015480|NCT00599053|2464660|P1|NOT COMPLETED|Overall Study||0
1015481|NCT00599053|2464659|P2|COMPLETED|Overall Study||2
1015482|NCT00599053|2464660|P1|COMPLETED|Overall Study||5
1015483|NCT00599053|2464659|P2|STARTED|Overall Study||2
1015484|NCT00599053|2464660|P1|STARTED|Overall Study||5
1015485|NCT00599131|2464672|P1|NOT COMPLETED|Overall Study||0
1015486|NCT00599131|2464672|P1|COMPLETED|Overall Study||4
1015487|NCT00599131|2464672|P1|STARTED|Overall Study||4
1015488|NCT00599196|2464680|P1|NOT COMPLETED|Overall Study||381
1015489|NCT00599196|2464680|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
1015490|NCT00599196|2464680|P1|STARTED|Overall Study||381
1015491|NCT00599248|2464688|P4|NOT COMPLETED|Overall Study||0
1015492|NCT00599248|2464689|P3|NOT COMPLETED|Overall Study||0
1015493|NCT00599248|2464690|P2|NOT COMPLETED|Overall Study||0
1015494|NCT00599248|2464691|P1|NOT COMPLETED|Overall Study||0
1015495|NCT00599248|2464688|P4|COMPLETED|Overall Study||3
1015496|NCT00599248|2464689|P3|COMPLETED|Overall Study||3
1015497|NCT00599248|2464690|P2|COMPLETED|Overall Study||3
1015498|NCT00599248|2464691|P1|COMPLETED|Overall Study||3
1015499|NCT00599248|2464688|P4|STARTED|Overall Study||3
1015500|NCT00599248|2464689|P3|STARTED|Overall Study||3
1015501|NCT00599248|2464690|P2|STARTED|Overall Study||3
1015502|NCT00599248|2464691|P1|STARTED|Overall Study||3
1015503|NCT00599313|2464719|P1|NOT COMPLETED|Overall Study||36
1015504|NCT00599313|2464719|P1|COMPLETED|Overall Study||0
1015505|NCT00599313|2464719|P1|STARTED|Overall Study||36
1015506|NCT00599326|2464728|P1|NOT COMPLETED|Overall Study||2
1015507|NCT00599326|2464728|P1|COMPLETED|Overall Study||8
1015508|NCT00599326|2464728|P1|STARTED|Overall Study||10
1015509|NCT00599339|2464733|P1|NOT COMPLETED|Overall Study||664
1015510|NCT00599339|2464733|P1|COMPLETED|Overall Study||1531
1015511|NCT00599339|2464733|P1|Safety Set|Overall Study||2179
1015512|NCT00599339|2464733|P1|STARTED|Overall Study||2195
1015513|NCT00599521|2464837|P2|NOT COMPLETED|Overall Study||69
1015514|NCT00599521|2464838|P1|NOT COMPLETED|Overall Study||60
1015515|NCT00599521|2464837|P2|COMPLETED|Overall Study||462
1015516|NCT00599521|2464838|P1|COMPLETED|Overall Study||475
1015517|NCT00599521|2464837|P2|STARTED|Overall Study||531
1015518|NCT00599521|2464838|P1|STARTED|Overall Study||535
1015519|NCT00599755|2464852|P1|NOT COMPLETED|Overall Study||19
1015520|NCT00599755|2464852|P1|COMPLETED|Overall Study||49
1015521|NCT00599755|2464852|P1|STARTED|Overall Study||68
1015522|NCT00599872|2464863|P2|NOT COMPLETED|Overall Study||33
1015523|NCT00599872|2464864|P1|NOT COMPLETED|Overall Study||49
1015524|NCT00599872|2464863|P2|COMPLETED|Overall Study||181
1015525|NCT00599872|2464864|P1|COMPLETED|Overall Study||167
1015526|NCT00599872|2464863|P2|STARTED|Overall Study||214
1015527|NCT00599872|2464864|P1|STARTED|Overall Study||216
1015528|NCT00599924|2464887|P7|NOT COMPLETED|Overall Study||5
1015529|NCT00599924|2464888|P6|NOT COMPLETED|Overall Study||4
1015530|NCT00599924|2464889|P5|NOT COMPLETED|Overall Study||6
1015531|NCT00599924|2464890|P4|NOT COMPLETED|Overall Study||8
1015532|NCT00599924|2464891|P3|NOT COMPLETED|Overall Study||2
1015533|NCT00599924|2464892|P2|NOT COMPLETED|Overall Study||5
1015534|NCT00599924|2464893|P1|NOT COMPLETED|Overall Study||3
1015535|NCT00599924|2464887|P7|COMPLETED|Overall Study||3
1015536|NCT00599924|2464888|P6|COMPLETED|Overall Study||2
1015537|NCT00599924|2464889|P5|COMPLETED|Overall Study||3
1015538|NCT00599924|2464890|P4|COMPLETED|Overall Study||4
1015539|NCT00599924|2464891|P3|COMPLETED|Overall Study||3
1015540|NCT00599924|2464892|P2|COMPLETED|Overall Study||4
1015541|NCT00599924|2464893|P1|COMPLETED|Overall Study||1
1015542|NCT00599924|2464887|P7|STARTED|Overall Study||8
1015543|NCT00599924|2464888|P6|STARTED|Overall Study||6
1015544|NCT00599924|2464889|P5|STARTED|Overall Study||9
1015545|NCT00599924|2464890|P4|STARTED|Overall Study||12
1015546|NCT00599924|2464891|P3|STARTED|Overall Study||5
1015547|NCT00599924|2464892|P2|STARTED|Overall Study||9
1015548|NCT00599924|2464893|P1|STARTED|Overall Study||4
1015549|NCT00600015|2464980|P2|NOT COMPLETED|Overall Study||35
1015550|NCT00600015|2464981|P1|NOT COMPLETED|Overall Study||60
1015551|NCT00600015|2464980|P2|COMPLETED|Overall Study|Completed >=2 cycles|20
1015552|NCT00600015|2464981|P1|COMPLETED|Overall Study|Completed >=2 cycles|51
1015553|NCT00600015|2464980|P2|STARTED|Overall Study||55
1015554|NCT00600015|2464981|P1|STARTED|Overall Study||111
1015555|NCT00600028|2464991|P2|NOT COMPLETED|Second Intervention (12 Weeks)||2
1015556|NCT00600028|2464992|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
1015557|NCT00600028|2464991|P2|COMPLETED|Second Intervention (12 Weeks)||8
1015558|NCT00600028|2464992|P1|COMPLETED|Second Intervention (12 Weeks)||12
1015559|NCT00600028|2464991|P2|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|10
1015560|NCT00600028|2464992|P1|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|12
1015561|NCT00600028|2464991|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
1015562|NCT00600028|2464992|P1|NOT COMPLETED|First Intervention (12 Weeks)||1
1015563|NCT00600028|2464991|P2|COMPLETED|First Intervention (12 Weeks)||10
1015564|NCT00600028|2464992|P1|COMPLETED|First Intervention (12 Weeks)||12
1015565|NCT00600028|2464991|P2|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|11
1015566|NCT00600028|2464992|P1|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|13
1015567|NCT00588731|2465006|P2|NOT COMPLETED|Overall Study||2
1015568|NCT00588731|2465007|P1|NOT COMPLETED|Overall Study||3
1015569|NCT00588731|2465006|P2|COMPLETED|Overall Study||18
1015570|NCT00588731|2465007|P1|COMPLETED|Overall Study||18
1015571|NCT00588731|2465006|P2|STARTED|Overall Study||20
1015572|NCT00588731|2465007|P1|STARTED|Overall Study||21
1015573|NCT00588809|2465015|P1|NOT COMPLETED|Overall Study||0
1015574|NCT00588809|2465015|P1|COMPLETED|Overall Study||47
1015575|NCT00588809|2465015|P1|STARTED|Overall Study||47
1015576|NCT00588822|2465024|P1|NOT COMPLETED|Overall Study||8
1015577|NCT00588822|2465024|P1|COMPLETED|Overall Study||13
1015578|NCT00588822|2465024|P1|STARTED|Overall Study||21
1015579|NCT00588848|2465035|P2|NOT COMPLETED|Overall Study||0
1015580|NCT00588848|2465036|P1|NOT COMPLETED|Overall Study||0
1015581|NCT00588848|2465035|P2|COMPLETED|Overall Study||8
1015582|NCT00588848|2465036|P1|COMPLETED|Overall Study||3
1015583|NCT00588848|2465035|P2|STARTED|Overall Study||8
1015584|NCT00588848|2465036|P1|STARTED|Overall Study||3
1015585|NCT00588861|2465046|P2|NOT COMPLETED|10 Years||114
1015586|NCT00588861|2465047|P1|NOT COMPLETED|10 Years||107
1015587|NCT00588861|2465046|P2|COMPLETED|10 Years||0
1015588|NCT00588861|2465047|P1|COMPLETED|10 Years||0
1015589|NCT00588861|2465046|P2|STARTED|10 Years|114 cases were due at 10 Years, however no patients returned for follow-up.|114
1015590|NCT00588861|2465047|P1|STARTED|10 Years|107 cases were due at 10 Years, however no patients returned for follow-up.|107
1015591|NCT00588861|2465046|P2|NOT COMPLETED|8 Years||114
1015592|NCT00588861|2465047|P1|NOT COMPLETED|8 Years||105
1015593|NCT00588861|2465046|P2|COMPLETED|8 Years||0
1015594|NCT00588861|2465047|P1|COMPLETED|8 Years||2
1015595|NCT00588861|2465046|P2|STARTED|8 Years|114 cases were due at 8 Years, however no patients returned for follow-up.|114
1015596|NCT00588861|2465047|P1|STARTED|8 Years|107 cases were due at 8 Years, however only 2 returned for follow-up.|107
1015597|NCT00588861|2465046|P2|NOT COMPLETED|6 Years||109
1015598|NCT00588861|2465047|P1|NOT COMPLETED|6 Years||104
1015599|NCT00588861|2465046|P2|COMPLETED|6 Years||5
1015600|NCT00588861|2465047|P1|COMPLETED|6 Years||3
1015601|NCT00588861|2465046|P2|STARTED|6 Years|114 cases were due at 6 Years, however only 5 returned for follow-up.|114
1015602|NCT00588861|2465047|P1|STARTED|6 Years|107 cases were due at 6 Years, however only 3 returned for follow-up.|107
1015603|NCT00588861|2465046|P2|NOT COMPLETED|4 Years||103
1015604|NCT00588861|2465047|P1|NOT COMPLETED|4 Years||91
1015605|NCT00588861|2465046|P2|COMPLETED|4 Years||11
1015606|NCT00588861|2465047|P1|COMPLETED|4 Years||16
1015607|NCT00588861|2465046|P2|STARTED|4 Years|114 cases were due at 4 Years, however only 11 returned for follow-up.|114
1015608|NCT00588861|2465047|P1|STARTED|4 Years|107 cases were due at 4 Years, however only 16 returned for follow-up.|107
1015609|NCT00588861|2465046|P2|NOT COMPLETED|2 Years||87
1015610|NCT00588861|2465047|P1|NOT COMPLETED|2 Years||92
1015611|NCT00588861|2465046|P2|COMPLETED|2 Years||27
1015612|NCT00588861|2465047|P1|COMPLETED|2 Years||15
1015613|NCT00588861|2465046|P2|STARTED|2 Years|114 cases were due at 2 Years, however only 27 returned for follow-up.|114
1015614|NCT00588861|2465047|P1|STARTED|2 Years|107 cases were due at 2 Years, however only 15 returned for follow-up.|107
1015615|NCT00588861|2465046|P2|NOT COMPLETED|1 Year||82
1015616|NCT00588861|2465047|P1|NOT COMPLETED|1 Year||89
1015617|NCT00588861|2465046|P2|COMPLETED|1 Year||32
1015618|NCT00588861|2465047|P1|COMPLETED|1 Year||18
1015619|NCT00588861|2465046|P2|STARTED|1 Year|114 cases were due at 1 Year, however only 32 returned for follow-up.|114
1015620|NCT00588861|2465047|P1|STARTED|1 Year|107 cases were due at 1 Year, however only 18 returned for follow-up.|107
1015621|NCT00588861|2465046|P2|NOT COMPLETED|6 Months||73
1015622|NCT00588861|2465047|P1|NOT COMPLETED|6 Months||98
1015623|NCT00588861|2465046|P2|COMPLETED|6 Months||41
1015624|NCT00588861|2465047|P1|COMPLETED|6 Months||9
1015625|NCT00588861|2465046|P2|STARTED|6 Months|114 cases were due at 6 Months, however only 41 returned for follow-up.|114
1015626|NCT00588861|2465047|P1|STARTED|6 Months|107 cases were due at 6 Months, however only 9 returned for follow-up.|107
1015627|NCT00588861|2465046|P2|NOT COMPLETED|Pre-Operative||86
1015628|NCT00588861|2465047|P1|NOT COMPLETED|Pre-Operative||95
1015629|NCT00588861|2465046|P2|COMPLETED|Pre-Operative||114
1015630|NCT00588861|2465047|P1|COMPLETED|Pre-Operative||107
1015631|NCT00588861|2465046|P2|STARTED|Pre-Operative|200 patients were enrolled, however only 114 contributed preop data.|200
1015632|NCT00588861|2465047|P1|STARTED|Pre-Operative|202 Patients were enrolled, however only 107 contributed preop data.|202
1015633|NCT00588900|2465055|P1|NOT COMPLETED|Overall Study||0
1015634|NCT00588900|2465055|P1|COMPLETED|Overall Study||5
1015635|NCT00588900|2465055|P1|STARTED|Overall Study||5
1015636|NCT00588952|2465063|P2|NOT COMPLETED|Overall Study||7
1015637|NCT00588952|2465064|P1|NOT COMPLETED|Overall Study||3
1015638|NCT00588952|2465063|P2|COMPLETED|Overall Study||63
1015639|NCT00588952|2465064|P1|COMPLETED|Overall Study||26
1015640|NCT00588952|2465063|P2|STARTED|Overall Study||70
1015641|NCT00588952|2465064|P1|STARTED|Overall Study||29
1015642|NCT00588965|2465084|P1|NOT COMPLETED|Overall Study||0
1015643|NCT00588965|2465084|P1|COMPLETED|Overall Study||35
1015644|NCT00588965|2465084|P1|STARTED|Overall Study||35
1015645|NCT00589108|2465095|P3|NOT COMPLETED|Overall Study||5
1015646|NCT00589108|2465096|P2|NOT COMPLETED|Overall Study||4
1015647|NCT00589108|2465097|P1|NOT COMPLETED|Overall Study||4
1015648|NCT00589108|2465095|P3|COMPLETED|Overall Study||75
1015649|NCT00589108|2465096|P2|COMPLETED|Overall Study||76
1015650|NCT00589108|2465097|P1|COMPLETED|Overall Study||76
1015651|NCT00589108|2465095|P3|STARTED|Overall Study||80
1015652|NCT00589108|2465096|P2|STARTED|Overall Study||80
1015653|NCT00589108|2465097|P1|STARTED|Overall Study||80
1015654|NCT00589472|2465117|P1|NOT COMPLETED|Overall Study||1
1015655|NCT00589472|2465117|P1|COMPLETED|Overall Study||18
1015656|NCT00589472|2465117|P1|STARTED|Overall Study||19
1015657|NCT00589550|2465127|P1|NOT COMPLETED|Overall Study||1
1015658|NCT00589550|2465127|P1|COMPLETED|Overall Study||0
1015659|NCT00589550|2465127|P1|Withdrew From Study|Overall Study||1
1015660|NCT00589550|2465127|P1|STARTED|Overall Study||1
1015661|NCT00589563|2465137|P1|NOT COMPLETED|Overall Study||0
1015662|NCT00589563|2465137|P1|COMPLETED|Overall Study||32
1015663|NCT00589563|2465137|P1|STARTED|Overall Study||32
1015664|NCT00589602|2465154|P1|NOT COMPLETED|Overall Study||1
1015665|NCT00589602|2465154|P1|COMPLETED|Overall Study||12
1015666|NCT00589602|2465154|P1|STARTED|Overall Study||13
1015667|NCT00589628|2465164|P2|NOT COMPLETED|Overall Study||1
1015668|NCT00589628|2465165|P1|NOT COMPLETED|Overall Study||0
1015669|NCT00589628|2465164|P2|COMPLETED|Overall Study||5
1015670|NCT00589628|2465165|P1|COMPLETED|Overall Study||7
1015671|NCT00589628|2465164|P2|STARTED|Overall Study||6
1015672|NCT00589628|2465165|P1|STARTED|Overall Study||7
1015673|NCT00589667|2465171|P1|NOT COMPLETED|Overall Study||3
1015674|NCT00589667|2465171|P1|COMPLETED|Overall Study||23
1015675|NCT00589667|2465171|P1|STARTED|Overall Study||26
1015676|NCT00589693|2465178|P2|NOT COMPLETED|Overall Study||29
1015677|NCT00589693|2465179|P1|NOT COMPLETED|Overall Study||44
1015678|NCT00589693|2465178|P2|COMPLETED|Overall Study||83
1015679|NCT00589693|2465179|P1|COMPLETED|Overall Study||71
1015680|NCT00589693|2465178|P2|STARTED|Overall Study||112
1015681|NCT00589693|2465179|P1|STARTED|Overall Study||115
1015682|NCT00589784|2465195|P2|NOT COMPLETED|Overall Study||10
1015683|NCT00589784|2465196|P1|NOT COMPLETED|Overall Study||1
1015684|NCT00589784|2465195|P2|COMPLETED|Overall Study||4
1015685|NCT00589784|2465196|P1|COMPLETED|Overall Study||35
1015686|NCT00589784|2465195|P2|STARTED|Overall Study||14
1015687|NCT00589784|2465196|P1|STARTED|Overall Study||36
1015688|NCT00589849|2465201|P1|NOT COMPLETED|Overall Study||0
1015689|NCT00589849|2465201|P1|COMPLETED|Overall Study||32
1015690|NCT00589849|2465201|P1|STARTED|Overall Study||32
1015691|NCT00589888|2465205|P5|NOT COMPLETED|64-gram Oral Fat Load||0
1015692|NCT00589888|2465206|P4|NOT COMPLETED|64-gram Oral Fat Load||0
1015693|NCT00589888|2465207|P3|NOT COMPLETED|64-gram Oral Fat Load||0
1015694|NCT00589888|2465208|P2|NOT COMPLETED|64-gram Oral Fat Load||0
1015695|NCT00589888|2465209|P1|NOT COMPLETED|64-gram Oral Fat Load||0
1015696|NCT00589888|2465205|P5|COMPLETED|64-gram Oral Fat Load||13
1015697|NCT00589888|2465206|P4|COMPLETED|64-gram Oral Fat Load||0
1015698|NCT00589888|2465207|P3|COMPLETED|64-gram Oral Fat Load||0
1015699|NCT00589888|2465208|P2|COMPLETED|64-gram Oral Fat Load||0
1015700|NCT00589888|2465209|P1|COMPLETED|64-gram Oral Fat Load||0
1015701|NCT00589888|2465205|P5|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
1015702|NCT00589888|2465206|P4|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
1015703|NCT00589888|2465207|P3|STARTED|64-gram Oral Fat Load||0
1015704|NCT00589888|2465208|P2|STARTED|64-gram Oral Fat Load||0
1015705|NCT00589888|2465209|P1|STARTED|64-gram Oral Fat Load||0
1015706|NCT00589888|2465205|P5|NOT COMPLETED|32-gram Oral Fat Load||0
1015707|NCT00589888|2465206|P4|NOT COMPLETED|32-gram Oral Fat Load||0
1015708|NCT00589888|2465207|P3|NOT COMPLETED|32-gram Oral Fat Load||0
1015709|NCT00589888|2465208|P2|NOT COMPLETED|32-gram Oral Fat Load||0
1015710|NCT00589888|2465209|P1|NOT COMPLETED|32-gram Oral Fat Load||0
1015711|NCT00589888|2465205|P5|COMPLETED|32-gram Oral Fat Load||0
1015712|NCT00589888|2465206|P4|COMPLETED|32-gram Oral Fat Load||13
1015713|NCT00589888|2465207|P3|COMPLETED|32-gram Oral Fat Load||0
1015714|NCT00589888|2465208|P2|COMPLETED|32-gram Oral Fat Load||0
1015715|NCT00589888|2465209|P1|COMPLETED|32-gram Oral Fat Load||0
1015716|NCT00589888|2465205|P5|STARTED|32-gram Oral Fat Load||0
1015717|NCT00589888|2465206|P4|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
1015718|NCT00589888|2465207|P3|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
1015719|NCT00589888|2465208|P2|STARTED|32-gram Oral Fat Load||0
1015720|NCT00589888|2465209|P1|STARTED|32-gram Oral Fat Load||0
1015721|NCT00589888|2465205|P5|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
1015722|NCT00589888|2465206|P4|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
1015723|NCT00589888|2465207|P3|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
1015724|NCT00589888|2465208|P2|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
1015725|NCT00589888|2465209|P1|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
1015726|NCT00589888|2465205|P5|COMPLETED|Intralipid 20% @ 40cc/Hour||0
1015727|NCT00589888|2465206|P4|COMPLETED|Intralipid 20% @ 40cc/Hour||0
1015728|NCT00589888|2465207|P3|COMPLETED|Intralipid 20% @ 40cc/Hour||13
1015729|NCT00589888|2465208|P2|COMPLETED|Intralipid 20% @ 40cc/Hour||0
1015730|NCT00589888|2465209|P1|COMPLETED|Intralipid 20% @ 40cc/Hour||0
1015731|NCT00589888|2465205|P5|STARTED|Intralipid 20% @ 40cc/Hour||0
1015732|NCT00589888|2465206|P4|STARTED|Intralipid 20% @ 40cc/Hour||0
1015733|NCT00589888|2465207|P3|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
1015734|NCT00589888|2465208|P2|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|0
1015735|NCT00589888|2465209|P1|STARTED|Intralipid 20% @ 40cc/Hour||0
1015736|NCT00589888|2465205|P5|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
1015737|NCT00589888|2465206|P4|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
1015738|NCT00589888|2465207|P3|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
1015739|NCT00589888|2465208|P2|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
1015740|NCT00589888|2465209|P1|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
1015741|NCT00589888|2465205|P5|COMPLETED|Intralipid 20% @ 20cc/hr||0
1015742|NCT00589888|2465206|P4|COMPLETED|Intralipid 20% @ 20cc/hr||0
1015743|NCT00589888|2465207|P3|COMPLETED|Intralipid 20% @ 20cc/hr||0
1015744|NCT00589888|2465208|P2|COMPLETED|Intralipid 20% @ 20cc/hr||13
1015745|NCT00589888|2465209|P1|COMPLETED|Intralipid 20% @ 20cc/hr||0
1015746|NCT00589888|2465205|P5|STARTED|Intralipid 20% @ 20cc/hr||0
1015747|NCT00589888|2465206|P4|STARTED|Intralipid 20% @ 20cc/hr||0
1015748|NCT00589888|2465207|P3|STARTED|Intralipid 20% @ 20cc/hr||0
1015749|NCT00589888|2465208|P2|STARTED|Intralipid 20% @ 20cc/hr||13
1015750|NCT00589888|2465209|P1|STARTED|Intralipid 20% @ 20cc/hr|the same 13 patients did each of the 5 arms at 5 different visits|0
1015751|NCT00589888|2465205|P5|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
1015752|NCT00589888|2465206|P4|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
1015753|NCT00589888|2465207|P3|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
1015754|NCT00589888|2465208|P2|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
1015755|NCT00589888|2465209|P1|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
1015756|NCT00589888|2465205|P5|COMPLETED|Normal Saline @ 40cc/Hour||0
1015757|NCT00589888|2465206|P4|COMPLETED|Normal Saline @ 40cc/Hour||0
1015758|NCT00589888|2465207|P3|COMPLETED|Normal Saline @ 40cc/Hour||0
1015759|NCT00589888|2465208|P2|COMPLETED|Normal Saline @ 40cc/Hour||0
1015760|NCT00589888|2465209|P1|COMPLETED|Normal Saline @ 40cc/Hour||13
1015761|NCT00589888|2465205|P5|STARTED|Normal Saline @ 40cc/Hour||0
1015762|NCT00589888|2465206|P4|STARTED|Normal Saline @ 40cc/Hour||0
1015763|NCT00589888|2465207|P3|STARTED|Normal Saline @ 40cc/Hour||0
1015764|NCT00589888|2465208|P2|STARTED|Normal Saline @ 40cc/Hour||0
1015765|NCT00589888|2465209|P1|STARTED|Normal Saline @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
1015766|NCT00589914|2465223|P2|NOT COMPLETED|Overall Study||137
1015767|NCT00589914|2465224|P1|NOT COMPLETED|Overall Study||150
1015768|NCT00589914|2465223|P2|COMPLETED|Overall Study||471
1015769|NCT00589914|2465224|P1|COMPLETED|Overall Study||456
1015770|NCT00589914|2465223|P2|STARTED|Overall Study||608
1015771|NCT00589914|2465224|P1|STARTED|Overall Study||606
1015772|NCT00589979|2465236|P3|NOT COMPLETED|Double-Blind Treatment Period 3||1
1015773|NCT00589979|2465237|P2|NOT COMPLETED|Double-Blind Treatment Period 3||1
1015774|NCT00589979|2465238|P1|NOT COMPLETED|Double-Blind Treatment Period 3||0
1015775|NCT00589979|2465236|P3|COMPLETED|Double-Blind Treatment Period 3||38
1015776|NCT00589979|2465237|P2|COMPLETED|Double-Blind Treatment Period 3||46
1015777|NCT00589979|2465238|P1|COMPLETED|Double-Blind Treatment Period 3||0
1015778|NCT00589979|2465236|P3|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|39
1015779|NCT00589979|2465237|P2|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|47
1015780|NCT00589979|2465238|P1|STARTED|Double-Blind Treatment Period 3||0
1015781|NCT00589979|2465236|P3|NOT COMPLETED|Double-Blind Treatment Period 2||2
1015782|NCT00589979|2465237|P2|NOT COMPLETED|Double-Blind Treatment Period 2||1
1015783|NCT00589979|2465238|P1|NOT COMPLETED|Double-Blind Treatment Period 2||0
1015784|NCT00589979|2465236|P3|COMPLETED|Double-Blind Treatment Period 2||39
1015785|NCT00589979|2465237|P2|COMPLETED|Double-Blind Treatment Period 2||47
1015786|NCT00589979|2465238|P1|COMPLETED|Double-Blind Treatment Period 2||0
1015787|NCT00589979|2465236|P3|STARTED|Double-Blind Treatment Period 2|N=20 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|41
1015788|NCT00589979|2465237|P2|STARTED|Double-Blind Treatment Period 2|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|48
1015789|NCT00589979|2465238|P1|STARTED|Double-Blind Treatment Period 2||0
1015790|NCT00589979|2465236|P3|NOT COMPLETED|Double-Blind Treatment Period 1||2
1015791|NCT00589979|2465237|P2|NOT COMPLETED|Double-Blind Treatment Period 1||2
1015792|NCT00589979|2465238|P1|NOT COMPLETED|Double-Blind Treatment Period 1||0
1015793|NCT00589979|2465236|P3|COMPLETED|Double-Blind Treatment Period 1||41
1015794|NCT00589979|2465237|P2|COMPLETED|Double-Blind Treatment Period 1||48
1015795|NCT00589979|2465238|P1|COMPLETED|Double-Blind Treatment Period 1||0
1015796|NCT00589979|2465236|P3|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|43
1015797|NCT00589979|2465237|P2|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|50
1015798|NCT00589979|2465238|P1|STARTED|Double-Blind Treatment Period 1|Participants completing the Run-in Period were then randomized to two different treatment sequences.|0
1015799|NCT00589979|2465236|P3|NOT COMPLETED|Run-In Period||0
1015800|NCT00589979|2465237|P2|NOT COMPLETED|Run-In Period||0
1015801|NCT00589979|2465238|P1|NOT COMPLETED|Run-In Period||76
1015802|NCT00589979|2465236|P3|COMPLETED|Run-In Period||0
1015803|NCT00589979|2465237|P2|COMPLETED|Run-In Period||0
1015804|NCT00589979|2465238|P1|COMPLETED|Run-In Period||93
1015805|NCT00589979|2465236|P3|STARTED|Run-In Period||0
1015806|NCT00589979|2465237|P2|STARTED|Run-In Period||0
1015807|NCT00589979|2465238|P1|STARTED|Run-In Period||169
1015808|NCT00590005|2465275|P2|NOT COMPLETED|Overall Study||0
1015809|NCT00590005|2465276|P1|NOT COMPLETED|Overall Study||0
1015810|NCT00590005|2465275|P2|COMPLETED|Overall Study||119
1015811|NCT00590005|2465276|P1|COMPLETED|Overall Study||106
1015812|NCT00590005|2465275|P2|STARTED|Overall Study||119
1015813|NCT00590005|2465276|P1|STARTED|Overall Study||106
1015814|NCT00590018|2465286|P2|NOT COMPLETED|Overall Study||0
1015815|NCT00590018|2465287|P1|NOT COMPLETED|Overall Study||0
1015816|NCT00590018|2465286|P2|COMPLETED|Overall Study||9
1015817|NCT00590018|2465287|P1|COMPLETED|Overall Study||9
1015818|NCT00590018|2465286|P2|STARTED|Overall Study||9
1015819|NCT00590018|2465287|P1|STARTED|Overall Study||9
1015820|NCT00590031|2465295|P1|NOT COMPLETED|Overall Study||6
1015821|NCT00590031|2465295|P1|COMPLETED|Overall Study||55
1015822|NCT00590031|2465295|P1|STARTED|Overall Study||61
1015823|NCT00590044|2465302|P2|NOT COMPLETED|Overall Study||2
1015824|NCT00590044|2465303|P1|NOT COMPLETED|Overall Study||4
1015825|NCT00590044|2465302|P2|COMPLETED|Overall Study||34
1015826|NCT00590044|2465303|P1|COMPLETED|Overall Study||34
1015827|NCT00590044|2465302|P2|STARTED|Overall Study||36
1015828|NCT00590044|2465303|P1|STARTED|Overall Study||38
1015829|NCT00590135|2465309|P1|NOT COMPLETED|Overall Study||59
1015830|NCT00590135|2465309|P1|COMPLETED|Overall Study||0
1015831|NCT00590135|2465309|P1|STARTED|Overall Study||59
1015832|NCT00590161|2465319|P2|NOT COMPLETED|Overall Study||3
1015833|NCT00590161|2465320|P1|NOT COMPLETED|Overall Study||3
1015834|NCT00590161|2465319|P2|COMPLETED|Overall Study||26
1015835|NCT00590161|2465320|P1|COMPLETED|Overall Study||23
1015836|NCT00590161|2465319|P2|STARTED|Overall Study||29
1015837|NCT00590161|2465320|P1|STARTED|Overall Study||26
1015838|NCT00590226|2465328|P2|NOT COMPLETED|Overall Study||0
1015839|NCT00590226|2465329|P1|NOT COMPLETED|Overall Study||0
1015840|NCT00590226|2465328|P2|COMPLETED|Overall Study||63
1015841|NCT00590226|2465329|P1|COMPLETED|Overall Study||67
1015842|NCT00590226|2465328|P2|STARTED|Overall Study||63
1015843|NCT00590226|2465329|P1|STARTED|Overall Study||67
1015844|NCT00590317|2465339|P2|NOT COMPLETED|Overall Study||5
1015845|NCT00590317|2465340|P1|NOT COMPLETED|Overall Study||1
1015846|NCT00590317|2465339|P2|COMPLETED|Overall Study||27
1015847|NCT00590317|2465340|P1|COMPLETED|Overall Study||31
1015848|NCT00590317|2465339|P2|STARTED|Overall Study||32
1015849|NCT00590317|2465340|P1|STARTED|Overall Study||32
1015850|NCT00590369|2465352|P2|NOT COMPLETED|Overall Study||0
1015851|NCT00590369|2465353|P1|NOT COMPLETED|Overall Study||0
1015852|NCT00590369|2465352|P2|COMPLETED|Overall Study||5
1015853|NCT00590369|2465353|P1|COMPLETED|Overall Study|Study stopped early due to difficulty recruiting subjects|6
1015854|NCT00590369|2465352|P2|STARTED|Overall Study||5
1015855|NCT00590369|2465353|P1|STARTED|Overall Study||6
1015856|NCT00590460|2465369|P1|NOT COMPLETED|Overall Study||0
1015857|NCT00590460|2465369|P1|COMPLETED|Overall Study||5
1015858|NCT00590460|2465369|P1|STARTED|Overall Study||5
1015859|NCT00590538|2465381|P1|NOT COMPLETED|Overall Study||2
1015860|NCT00590538|2465381|P1|COMPLETED|Overall Study||7
1015861|NCT00590538|2465381|P1|STARTED|Overall Study|STUDY NOT UNBLINDED AT TIME OF TERMINATION; THEREFORE NUMBER ASSIGNED TO EACH GROUP IS NOT KNOWN.|9
1015862|NCT00590564|2465389|P1|NOT COMPLETED|Overall Study||18
1015863|NCT00590564|2465389|P1|COMPLETED|Overall Study||24
1015864|NCT00590564|2465389|P1|STARTED|Overall Study||42
1015865|NCT00590577|2465397|P4|NOT COMPLETED|Overall Study||93
1015866|NCT00590577|2465398|P3|NOT COMPLETED|Overall Study||73
1015867|NCT00590577|2465399|P2|NOT COMPLETED|Overall Study||76
1015868|NCT00590577|2465400|P1|NOT COMPLETED|Overall Study||77
1015869|NCT00590577|2465397|P4|COMPLETED|Overall Study||71
1015870|NCT00590577|2465398|P3|COMPLETED|Overall Study||90
1015871|NCT00590577|2465399|P2|COMPLETED|Overall Study||89
1015872|NCT00590577|2465400|P1|COMPLETED|Overall Study||83
1015873|NCT00590577|2465397|P4|STARTED|Overall Study||164
1015874|NCT00590577|2465398|P3|STARTED|Overall Study||163
1015875|NCT00590577|2465399|P2|STARTED|Overall Study||165
1015876|NCT00590577|2465400|P1|STARTED|Overall Study||160
1015877|NCT00590590|2465421|P3|NOT COMPLETED|Overall Study||6
1015878|NCT00590590|2465422|P2|NOT COMPLETED|Overall Study||6
1015879|NCT00590590|2465423|P1|NOT COMPLETED|Overall Study||7
1015880|NCT00590590|2465421|P3|COMPLETED|Overall Study||21
1015881|NCT00590590|2465422|P2|COMPLETED|Overall Study||33
1015882|NCT00590590|2465423|P1|COMPLETED|Overall Study||32
1015883|NCT00590590|2465421|P3|STARTED|Overall Study||27
1015884|NCT00590590|2465422|P2|STARTED|Overall Study||39
1015885|NCT00590590|2465423|P1|STARTED|Overall Study||39
1015886|NCT00590720|2465448|P2|NOT COMPLETED|Overall Study||1
1015887|NCT00590720|2465449|P1|NOT COMPLETED|Overall Study||1
1015888|NCT00590720|2465448|P2|COMPLETED|Overall Study||6
1015889|NCT00590720|2465449|P1|COMPLETED|Overall Study||3
1015890|NCT00590720|2465448|P2|STARTED|Overall Study||7
1015891|NCT00590720|2465449|P1|STARTED|Overall Study||4
1015892|NCT00590759|2465491|P1|NOT COMPLETED|Overall Study||80
1015893|NCT00590759|2465491|P1|COMPLETED|Overall Study||70
1015894|NCT00590759|2465491|P1|STARTED|Overall Study||150
1015895|NCT00590772|2465496|P1|NOT COMPLETED|Overall Study||0
1015896|NCT00590772|2465496|P1|COMPLETED|Overall Study||31
1015897|NCT00590772|2465496|P1|STARTED|Overall Study||31
1015898|NCT00590863|2465505|P3|NOT COMPLETED|Overall Study||78
1015899|NCT00590863|2465506|P2|NOT COMPLETED|Overall Study||82
1015900|NCT00590863|2465507|P1|NOT COMPLETED|Overall Study||84
1015901|NCT00590863|2465505|P3|COMPLETED|Overall Study||146
1015902|NCT00590863|2465506|P2|COMPLETED|Overall Study||138
1015903|NCT00590863|2465507|P1|COMPLETED|Overall Study||137
1015904|NCT00590863|2465505|P3|STARTED|Overall Study||224
1015905|NCT00590863|2465506|P2|STARTED|Overall Study||220
1015906|NCT00590863|2465507|P1|STARTED|Overall Study||221
1015907|NCT00590889|2465520|P2|NOT COMPLETED|Overall Study||299
1015908|NCT00590889|2465521|P1|NOT COMPLETED|Overall Study||286
1015909|NCT00590889|2465520|P2|COMPLETED|Overall Study||104
1015910|NCT00590889|2465521|P1|COMPLETED|Overall Study||118
1015911|NCT00590889|2465520|P2|STARTED|Overall Study||403
1015912|NCT00590889|2465521|P1|STARTED|Overall Study||404
1015913|NCT00590902|2465527|P1|NOT COMPLETED|Overall Study||1
1015914|NCT00590902|2465527|P1|COMPLETED|Overall Study||80
1015915|NCT00590902|2465527|P1|STARTED|Overall Study||81
1015916|NCT00590967|2465533|P2|NOT COMPLETED|Overall Study||5
1015917|NCT00590967|2465534|P1|NOT COMPLETED|Overall Study||3
1015918|NCT00590967|2465533|P2|COMPLETED|Overall Study||20
1015919|NCT00590967|2465534|P1|COMPLETED|Overall Study||41
1015920|NCT00590967|2465533|P2|STARTED|Overall Study||25
1015921|NCT00590967|2465534|P1|STARTED|Overall Study||44
1015922|NCT00591006|2465546|P24|NOT COMPLETED|Overall Study||1
1015923|NCT00591006|2465547|P23|NOT COMPLETED|Overall Study||1
1015924|NCT00591006|2465548|P22|NOT COMPLETED|Overall Study||0
1015925|NCT00591006|2465549|P21|NOT COMPLETED|Overall Study||0
1015926|NCT00591006|2465550|P20|NOT COMPLETED|Overall Study||0
1015927|NCT00591006|2465551|P19|NOT COMPLETED|Overall Study||0
1015928|NCT00591006|2465552|P18|NOT COMPLETED|Overall Study||0
1015929|NCT00591006|2465553|P17|NOT COMPLETED|Overall Study||0
1015930|NCT00591006|2465554|P16|NOT COMPLETED|Overall Study||1
1015931|NCT00591006|2465555|P15|NOT COMPLETED|Overall Study||0
1015932|NCT00591006|2465556|P14|NOT COMPLETED|Overall Study||0
1015933|NCT00591006|2465557|P13|NOT COMPLETED|Overall Study||0
1015934|NCT00591006|2465558|P12|NOT COMPLETED|Overall Study||0
1015935|NCT00591006|2465559|P11|NOT COMPLETED|Overall Study||0
1015936|NCT00591006|2465560|P10|NOT COMPLETED|Overall Study||0
1015937|NCT00591006|2465561|P9|NOT COMPLETED|Overall Study||0
1015938|NCT00591006|2465562|P8|NOT COMPLETED|Overall Study||0
1015939|NCT00591006|2465563|P7|NOT COMPLETED|Overall Study||0
1015940|NCT00591006|2465564|P6|NOT COMPLETED|Overall Study||0
1015941|NCT00591006|2465565|P5|NOT COMPLETED|Overall Study||0
1015942|NCT00591006|2465566|P4|NOT COMPLETED|Overall Study||0
1015943|NCT00591006|2465567|P3|NOT COMPLETED|Overall Study||0
1015944|NCT00591006|2465568|P2|NOT COMPLETED|Overall Study||0
1015945|NCT00591006|2465569|P1|NOT COMPLETED|Overall Study||0
1015946|NCT00591006|2465546|P24|COMPLETED|Overall Study||0
1015947|NCT00591006|2465547|P23|COMPLETED|Overall Study||0
1015948|NCT00591006|2465548|P22|COMPLETED|Overall Study||1
1015949|NCT00591006|2465549|P21|COMPLETED|Overall Study||0
1015950|NCT00591006|2465550|P20|COMPLETED|Overall Study||1
1015951|NCT00591006|2465551|P19|COMPLETED|Overall Study||0
1015952|NCT00591006|2465552|P18|COMPLETED|Overall Study||1
1015953|NCT00591006|2465553|P17|COMPLETED|Overall Study||0
1015954|NCT00591006|2465554|P16|COMPLETED|Overall Study||0
1015955|NCT00591006|2465555|P15|COMPLETED|Overall Study||0
1015956|NCT00591006|2465556|P14|COMPLETED|Overall Study||2
1015957|NCT00591006|2465557|P13|COMPLETED|Overall Study||1
1015958|NCT00591006|2465558|P12|COMPLETED|Overall Study||1
1015959|NCT00591006|2465559|P11|COMPLETED|Overall Study||0
1015960|NCT00591006|2465560|P10|COMPLETED|Overall Study||1
1015961|NCT00591006|2465561|P9|COMPLETED|Overall Study||1
1015962|NCT00591006|2465562|P8|COMPLETED|Overall Study||0
1015963|NCT00591006|2465563|P7|COMPLETED|Overall Study||1
1015964|NCT00591006|2465564|P6|COMPLETED|Overall Study||0
1015965|NCT00591006|2465565|P5|COMPLETED|Overall Study||1
1015966|NCT00591006|2465566|P4|COMPLETED|Overall Study||1
1015967|NCT00591006|2465567|P3|COMPLETED|Overall Study||1
1015968|NCT00591006|2465568|P2|COMPLETED|Overall Study||0
1015969|NCT00591006|2465569|P1|COMPLETED|Overall Study||1
1015970|NCT00591006|2465546|P24|Treatment #4|Overall Study||0
1015971|NCT00591006|2465547|P23|Treatment #4|Overall Study||0
1015972|NCT00591006|2465548|P22|Treatment #4|Overall Study||1
1015973|NCT00591006|2465549|P21|Treatment #4|Overall Study||0
1015974|NCT00591006|2465550|P20|Treatment #4|Overall Study||1
1015975|NCT00591006|2465551|P19|Treatment #4|Overall Study||0
1015976|NCT00591006|2465552|P18|Treatment #4|Overall Study||1
1015977|NCT00591006|2465553|P17|Treatment #4|Overall Study||0
1015978|NCT00591006|2465554|P16|Treatment #4|Overall Study||0
1015979|NCT00591006|2465555|P15|Treatment #4|Overall Study||0
1015980|NCT00591006|2465556|P14|Treatment #4|Overall Study||2
1015981|NCT00591006|2465557|P13|Treatment #4|Overall Study||1
1015982|NCT00591006|2465558|P12|Treatment #4|Overall Study||1
1015983|NCT00591006|2465559|P11|Treatment #4|Overall Study||0
1015984|NCT00591006|2465560|P10|Treatment #4|Overall Study||1
1015985|NCT00591006|2465561|P9|Treatment #4|Overall Study||1
1015986|NCT00591006|2465562|P8|Treatment #4|Overall Study||0
1015987|NCT00591006|2465563|P7|Treatment #4|Overall Study||1
1015988|NCT00591006|2465564|P6|Treatment #4|Overall Study||0
1015989|NCT00591006|2465565|P5|Treatment #4|Overall Study||1
1015990|NCT00591006|2465566|P4|Treatment #4|Overall Study||1
1015991|NCT00591006|2465567|P3|Treatment #4|Overall Study||1
1015992|NCT00591006|2465568|P2|Treatment #4|Overall Study||0
1015993|NCT00591006|2465569|P1|Treatment #4|Overall Study||1
1015994|NCT00591006|2465546|P24|Treatment #3|Overall Study||1
1015995|NCT00591006|2465547|P23|Treatment #3|Overall Study||1
1015996|NCT00591006|2465548|P22|Treatment #3|Overall Study||1
1015997|NCT00591006|2465549|P21|Treatment #3|Overall Study||0
1015998|NCT00591006|2465550|P20|Treatment #3|Overall Study||1
1015999|NCT00591006|2465551|P19|Treatment #3|Overall Study||0
1016000|NCT00591006|2465552|P18|Treatment #3|Overall Study||1
1016001|NCT00591006|2465553|P17|Treatment #3|Overall Study||0
1016002|NCT00591006|2465554|P16|Treatment #3|Overall Study||0
1016003|NCT00591006|2465555|P15|Treatment #3|Overall Study||0
1016004|NCT00591006|2465556|P14|Treatment #3|Overall Study||2
1016005|NCT00591006|2465557|P13|Treatment #3|Overall Study||1
1016006|NCT00591006|2465558|P12|Treatment #3|Overall Study||1
1016007|NCT00591006|2465559|P11|Treatment #3|Overall Study||0
1016008|NCT00591006|2465560|P10|Treatment #3|Overall Study||1
1016009|NCT00591006|2465561|P9|Treatment #3|Overall Study||1
1016010|NCT00591006|2465562|P8|Treatment #3|Overall Study||0
1016011|NCT00591006|2465563|P7|Treatment #3|Overall Study||1
1016012|NCT00591006|2465564|P6|Treatment #3|Overall Study||0
1016013|NCT00591006|2465565|P5|Treatment #3|Overall Study||1
1016014|NCT00591006|2465566|P4|Treatment #3|Overall Study||1
1016015|NCT00591006|2465567|P3|Treatment #3|Overall Study||1
1016016|NCT00591006|2465568|P2|Treatment #3|Overall Study||0
1016017|NCT00591006|2465569|P1|Treatment #3|Overall Study||1
1016018|NCT00591006|2465546|P24|Treatment #2|Overall Study||1
1016019|NCT00591006|2465547|P23|Treatment #2|Overall Study||1
1016020|NCT00591006|2465548|P22|Treatment #2|Overall Study||1
1016021|NCT00591006|2465549|P21|Treatment #2|Overall Study||0
1016022|NCT00591006|2465550|P20|Treatment #2|Overall Study||1
1016023|NCT00591006|2465551|P19|Treatment #2|Overall Study||0
1016024|NCT00591006|2465552|P18|Treatment #2|Overall Study||1
1016025|NCT00591006|2465553|P17|Treatment #2|Overall Study||0
1016026|NCT00591006|2465554|P16|Treatment #2|Overall Study||0
1016027|NCT00591006|2465555|P15|Treatment #2|Overall Study||0
1016028|NCT00591006|2465556|P14|Treatment #2|Overall Study||2
1016029|NCT00591006|2465557|P13|Treatment #2|Overall Study||1
1016030|NCT00591006|2465558|P12|Treatment #2|Overall Study||1
1016031|NCT00591006|2465559|P11|Treatment #2|Overall Study||0
1016032|NCT00591006|2465560|P10|Treatment #2|Overall Study||1
1016033|NCT00591006|2465561|P9|Treatment #2|Overall Study||1
1016034|NCT00591006|2465562|P8|Treatment #2|Overall Study||0
1016035|NCT00591006|2465563|P7|Treatment #2|Overall Study||1
1016036|NCT00591006|2465564|P6|Treatment #2|Overall Study||0
1016037|NCT00591006|2465565|P5|Treatment #2|Overall Study||1
1016038|NCT00591006|2465566|P4|Treatment #2|Overall Study||1
1016039|NCT00591006|2465567|P3|Treatment #2|Overall Study||1
1016040|NCT00591006|2465568|P2|Treatment #2|Overall Study||0
1016041|NCT00591006|2465569|P1|Treatment #2|Overall Study||1
1016042|NCT00591006|2465546|P24|STARTED|Overall Study||1
1016043|NCT00591006|2465547|P23|STARTED|Overall Study||1
1016044|NCT00591006|2465548|P22|STARTED|Overall Study||1
1016045|NCT00591006|2465549|P21|STARTED|Overall Study||0
1016046|NCT00591006|2465550|P20|STARTED|Overall Study||1
1016047|NCT00591006|2465551|P19|STARTED|Overall Study||0
1016048|NCT00591006|2465552|P18|STARTED|Overall Study||1
1016049|NCT00591006|2465553|P17|STARTED|Overall Study||0
1016050|NCT00591006|2465554|P16|STARTED|Overall Study||1
1016051|NCT00591006|2465555|P15|STARTED|Overall Study||0
1016052|NCT00591006|2465556|P14|STARTED|Overall Study||2
1016053|NCT00591006|2465557|P13|STARTED|Overall Study||1
1016054|NCT00591006|2465558|P12|STARTED|Overall Study||1
1016055|NCT00591006|2465559|P11|STARTED|Overall Study||0
1016056|NCT00591006|2465560|P10|STARTED|Overall Study||1
1016057|NCT00591006|2465561|P9|STARTED|Overall Study||1
1016058|NCT00591006|2465562|P8|STARTED|Overall Study||0
1016059|NCT00591006|2465563|P7|STARTED|Overall Study||1
1016060|NCT00591006|2465564|P6|STARTED|Overall Study||0
1016061|NCT00591006|2465565|P5|STARTED|Overall Study||1
1016062|NCT00591006|2465566|P4|STARTED|Overall Study||1
1016063|NCT00591006|2465567|P3|STARTED|Overall Study||1
1016064|NCT00591006|2465568|P2|STARTED|Overall Study||0
1016065|NCT00591006|2465569|P1|STARTED|Overall Study||1
1016066|NCT00591019|2465587|P2|NOT COMPLETED|Intevention 2 (14 Days)||0
1016067|NCT00591019|2465588|P1|NOT COMPLETED|Intevention 2 (14 Days)||0
1016068|NCT00591019|2465587|P2|COMPLETED|Intevention 2 (14 Days)||3
1016069|NCT00591019|2465588|P1|COMPLETED|Intevention 2 (14 Days)||2
1016070|NCT00591019|2465587|P2|STARTED|Intevention 2 (14 Days)||3
1016071|NCT00591019|2465588|P1|STARTED|Intevention 2 (14 Days)||2
1016072|NCT00591019|2465587|P2|NOT COMPLETED|Intervention 1 (14 Days)||0
1016073|NCT00591019|2465588|P1|NOT COMPLETED|Intervention 1 (14 Days)||0
1016074|NCT00591019|2465587|P2|COMPLETED|Intervention 1 (14 Days)||3
1016075|NCT00591019|2465588|P1|COMPLETED|Intervention 1 (14 Days)||2
1016076|NCT00591019|2465587|P2|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|3
1016077|NCT00591019|2465588|P1|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|2
1016078|NCT00591019|2465587|P2|NOT COMPLETED|Baseline (1 Day)||0
1016079|NCT00591019|2465588|P1|NOT COMPLETED|Baseline (1 Day)||0
1016080|NCT00591019|2465587|P2|COMPLETED|Baseline (1 Day)||4
1016081|NCT00591019|2465588|P1|COMPLETED|Baseline (1 Day)||3
1016082|NCT00591019|2465587|P2|STARTED|Baseline (1 Day)||4
1016083|NCT00591019|2465588|P1|STARTED|Baseline (1 Day)||3
1016084|NCT00591149|2465599|P1|NOT COMPLETED|Overall Study||5
1016085|NCT00591149|2465599|P1|COMPLETED|Overall Study||11
1016086|NCT00591149|2465599|P1|STARTED|Overall Study||16
1016087|NCT00591214|2465603|P1|NOT COMPLETED|Overall Study||8
1016088|NCT00591214|2465603|P1|COMPLETED|Overall Study||2
1016089|NCT00591214|2465603|P1|STARTED|Overall Study||10
1016090|NCT00591227|2465614|P2|NOT COMPLETED|Overall Study||0
1016091|NCT00591227|2465615|P1|NOT COMPLETED|Overall Study||0
1016092|NCT00591227|2465614|P2|COMPLETED|Overall Study||87
1016093|NCT00591227|2465615|P1|COMPLETED|Overall Study||89
1016094|NCT00591227|2465614|P2|STARTED|Overall Study||87
1016095|NCT00591227|2465615|P1|STARTED|Overall Study||89
1016096|NCT00591240|2465623|P2|NOT COMPLETED|Overall Study||0
1016097|NCT00591240|2465624|P1|NOT COMPLETED|Overall Study||0
1016098|NCT00591240|2465623|P2|COMPLETED|Overall Study||222
1016099|NCT00591240|2465624|P1|COMPLETED|Overall Study||116
1016100|NCT00591240|2465623|P2|STARTED|Overall Study||222
1016101|NCT00591240|2465624|P1|STARTED|Overall Study||116
1016102|NCT00591253|2465633|P3|NOT COMPLETED|Overall Study||15
1016103|NCT00591253|2465634|P2|NOT COMPLETED|Overall Study||21
1016104|NCT00591253|2465635|P1|NOT COMPLETED|Overall Study||14
1016105|NCT00591253|2465633|P3|COMPLETED|Overall Study||123
1016106|NCT00591253|2465634|P2|COMPLETED|Overall Study||116
1016107|NCT00591253|2465635|P1|COMPLETED|Overall Study||126
1016108|NCT00591253|2465633|P3|STARTED|Overall Study|Randomized or Treated|138
1016109|NCT00591253|2465634|P2|STARTED|Overall Study|Randomized or Treated|137
1016110|NCT00591253|2465635|P1|STARTED|Overall Study|Randomized or Treated|140
1016111|NCT00591266|2465688|P3|NOT COMPLETED|Overall Study||14
1016112|NCT00591266|2465689|P2|NOT COMPLETED|Overall Study||11
1016113|NCT00591266|2465690|P1|NOT COMPLETED|Overall Study||9
1016114|NCT00591266|2465688|P3|COMPLETED|Overall Study||175
1016115|NCT00591266|2465689|P2|COMPLETED|Overall Study||177
1016116|NCT00591266|2465690|P1|COMPLETED|Overall Study||180
1016117|NCT00591266|2465688|P3|STARTED|Overall Study|Randomized only|189
1016118|NCT00591266|2465689|P2|STARTED|Overall Study|Randomized only|188
1016119|NCT00591266|2465690|P1|STARTED|Overall Study|Randomized only|189
1016120|NCT00591305|2465742|P2|NOT COMPLETED|Overall Study||0
1016121|NCT00591305|2465743|P1|NOT COMPLETED|Overall Study||0
1016122|NCT00591305|2465742|P2|COMPLETED|Overall Study||0
1016123|NCT00591305|2465743|P1|COMPLETED|Overall Study||1
1016124|NCT00591305|2465742|P2|1st Follow-up in 2 Wks After Surgery|Overall Study||0
1016125|NCT00591305|2465743|P1|1st Follow-up in 2 Wks After Surgery|Overall Study||1
1016126|NCT00591305|2465742|P2|STARTED|Overall Study||0
1016127|NCT00591305|2465743|P1|STARTED|Overall Study||1
1016128|NCT00591344|2465755|P2|NOT COMPLETED|Overall Study||8
1016129|NCT00591344|2465756|P1|NOT COMPLETED|Overall Study||5
1016130|NCT00591344|2465755|P2|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|18
1016131|NCT00591344|2465756|P1|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|20
1016132|NCT00591344|2465755|P2|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
1016133|NCT00591344|2465756|P1|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
1016134|NCT00591344|2465755|P2|STARTED|Overall Study|26 randomized, 2 withdrew before the 6 month test and were replaced, 24 completed 6 month test|26
1016135|NCT00591344|2465756|P1|STARTED|Overall Study|25 randomized, 1 withdrew before the 6 month test and was replaced; 24 completed the 6 month test|25
1016136|NCT00591370|2465766|P1|NOT COMPLETED|Overall Study||2
1016137|NCT00591370|2465766|P1|COMPLETED|Overall Study||49
1016138|NCT00591370|2465766|P1|STARTED|Overall Study||51
1016139|NCT00591565|2465772|P1|NOT COMPLETED|Overall Study||5
1016140|NCT00591565|2465772|P1|COMPLETED|Overall Study||8
1016141|NCT00591565|2465772|P1|STARTED|Overall Study||13
1016142|NCT00591578|2465779|P3|NOT COMPLETED|Open-Label Extension Phase||0
1016143|NCT00591578|2465780|P2|NOT COMPLETED|Open-Label Extension Phase||10
1016144|NCT00591578|2465781|P1|NOT COMPLETED|Open-Label Extension Phase||6
1016145|NCT00591578|2465779|P3|COMPLETED|Open-Label Extension Phase||0
1016146|NCT00591578|2465780|P2|COMPLETED|Open-Label Extension Phase||105
1016147|NCT00591578|2465781|P1|COMPLETED|Open-Label Extension Phase||49
1016148|NCT00591578|2465779|P3|STARTED|Open-Label Extension Phase||0
1016149|NCT00591578|2465780|P2|STARTED|Open-Label Extension Phase||115
1016150|NCT00591578|2465781|P1|STARTED|Open-Label Extension Phase||55
1016151|NCT00591578|2465779|P3|NOT COMPLETED|Double-Blind Treatment Phase||84
1016152|NCT00591578|2465780|P2|NOT COMPLETED|Double-Blind Treatment Phase||80
1016153|NCT00591578|2465781|P1|NOT COMPLETED|Double-Blind Treatment Phase||78
1016154|NCT00591578|2465779|P3|COMPLETED|Double-Blind Treatment Phase||244
1016155|NCT00591578|2465780|P2|COMPLETED|Double-Blind Treatment Phase||249
1016156|NCT00591578|2465781|P1|COMPLETED|Double-Blind Treatment Phase||249
1016157|NCT00591578|2465779|P3|STARTED|Double-Blind Treatment Phase|Two participants randomized but not treated.|328
1016158|NCT00591578|2465780|P2|STARTED|Double-Blind Treatment Phase||329
1016159|NCT00591578|2465781|P1|STARTED|Double-Blind Treatment Phase||327
1016160|NCT00591591|2465834|P2|NOT COMPLETED|Overall Study||39
1016161|NCT00591591|2465835|P1|NOT COMPLETED|Overall Study||11
1016162|NCT00591591|2465834|P2|COMPLETED|Overall Study||94
1016163|NCT00591591|2465835|P1|COMPLETED|Overall Study||165
1016164|NCT00591591|2465834|P2|STARTED|Overall Study||133
1016165|NCT00591591|2465835|P1|STARTED|Overall Study||176
1016166|NCT00591721|2465851|P2|NOT COMPLETED|Overall Study||22
1016167|NCT00591721|2465852|P1|NOT COMPLETED|Overall Study||21
1016168|NCT00591721|2465851|P2|COMPLETED|Overall Study||70
1016169|NCT00591721|2465852|P1|COMPLETED|Overall Study||68
1016170|NCT00591721|2465851|P2|STARTED|Overall Study||92
1016171|NCT00591721|2465852|P1|STARTED|Overall Study||89
1016172|NCT00591734|2465858|P1|NOT COMPLETED|Overall Study||53
1016173|NCT00591734|2465858|P1|COMPLETED|Overall Study||4
1016174|NCT00591734|2465858|P1|STARTED|Overall Study||57
1016175|NCT00591760|2465864|P2|NOT COMPLETED|Overall Study||0
1016176|NCT00591760|2465865|P1|NOT COMPLETED|Overall Study||0
1016177|NCT00591760|2465864|P2|COMPLETED|Overall Study||28
1016178|NCT00591760|2465865|P1|COMPLETED|Overall Study||28
1016179|NCT00591760|2465864|P2|STARTED|Overall Study||28
1016180|NCT00591760|2465865|P1|STARTED|Overall Study||28
1016181|NCT00591773|2465874|P3|NOT COMPLETED|Overall Study||16
1016182|NCT00591773|2465875|P2|NOT COMPLETED|Overall Study||24
1016183|NCT00591773|2465876|P1|NOT COMPLETED|Overall Study||16
1016184|NCT00591773|2465874|P3|COMPLETED|Overall Study||168
1016185|NCT00591773|2465875|P2|COMPLETED|Overall Study||158
1016186|NCT00591773|2465876|P1|COMPLETED|Overall Study||169
1016187|NCT00591773|2465874|P3|STARTED|Overall Study||184
1016188|NCT00591773|2465875|P2|STARTED|Overall Study||182
1016189|NCT00591773|2465876|P1|STARTED|Overall Study||185
1016190|NCT00591825|2465930|P4|NOT COMPLETED|Overall Study||0
1016191|NCT00591825|2465931|P3|NOT COMPLETED|Overall Study||0
1016192|NCT00591825|2465932|P2|NOT COMPLETED|Overall Study||0
1016193|NCT00591825|2465933|P1|NOT COMPLETED|Overall Study||0
1016194|NCT00591825|2465930|P4|COMPLETED|Overall Study||14
1016195|NCT00591825|2465931|P3|COMPLETED|Overall Study||13
1016196|NCT00591825|2465932|P2|COMPLETED|Overall Study||13
1016197|NCT00591825|2465933|P1|COMPLETED|Overall Study||14
1016198|NCT00591825|2465930|P4|STARTED|Overall Study||14
1016199|NCT00591825|2465931|P3|STARTED|Overall Study||13
1016200|NCT00591825|2465932|P2|STARTED|Overall Study||13
1016201|NCT00591825|2465933|P1|STARTED|Overall Study||14
1016202|NCT00591851|2465959|P1|NOT COMPLETED|Overall Study||6
1016203|NCT00591851|2465959|P1|COMPLETED|Overall Study||64
1016204|NCT00591851|2465959|P1|STARTED|Overall Study||70
1016205|NCT00591864|2465963|P1|NOT COMPLETED|Overall Study||5
1016206|NCT00591864|2465963|P1|COMPLETED|Overall Study||84
1016207|NCT00591864|2465963|P1|STARTED|Overall Study||89
1016208|NCT00600067|2465971|P2|NOT COMPLETED|Overall Study||7
1016209|NCT00600067|2465972|P1|NOT COMPLETED|Overall Study||3
1016210|NCT00600067|2465971|P2|COMPLETED|Overall Study||68
1016211|NCT00600067|2465972|P1|COMPLETED|Overall Study||52
1016212|NCT00600067|2465971|P2|STARTED|Overall Study||75
1016213|NCT00600067|2465972|P1|STARTED|Overall Study||55
1016214|NCT00600080|2465980|P2|NOT COMPLETED|Period 2: One-week to Two-weeks||0
1016215|NCT00600080|2465981|P1|NOT COMPLETED|Period 2: One-week to Two-weeks||0
1016216|NCT00600080|2465980|P2|COMPLETED|Period 2: One-week to Two-weeks||32
1016217|NCT00600080|2465981|P1|COMPLETED|Period 2: One-week to Two-weeks||28
1016218|NCT00600080|2465980|P2|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|32
1016219|NCT00600080|2465981|P1|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|28
1016220|NCT00600080|2465980|P2|NOT COMPLETED|Period 1: Baseline to One-week||0
1016221|NCT00600080|2465981|P1|NOT COMPLETED|Period 1: Baseline to One-week||0
1016222|NCT00600080|2465980|P2|COMPLETED|Period 1: Baseline to One-week||32
1016223|NCT00600080|2465981|P1|COMPLETED|Period 1: Baseline to One-week||28
1016224|NCT00600080|2465980|P2|STARTED|Period 1: Baseline to One-week||32
1016225|NCT00600080|2465981|P1|STARTED|Period 1: Baseline to One-week||28
1016226|NCT00600119|2465999|P6|NOT COMPLETED|Follow-up Period||1
1016227|NCT00600119|2466000|P5|NOT COMPLETED|Follow-up Period||0
1016228|NCT00600119|2466001|P4|NOT COMPLETED|Follow-up Period||0
1016229|NCT00600119|2466002|P3|NOT COMPLETED|Follow-up Period||0
1016230|NCT00600119|2466003|P2|NOT COMPLETED|Follow-up Period||0
1016231|NCT00600119|2466004|P1|NOT COMPLETED|Follow-up Period||1
1016232|NCT00600119|2465999|P6|COMPLETED|Follow-up Period||20
1016233|NCT00600119|2466000|P5|COMPLETED|Follow-up Period||31
1016234|NCT00600119|2466001|P4|COMPLETED|Follow-up Period||28
1016235|NCT00600119|2466002|P3|COMPLETED|Follow-up Period||27
1016236|NCT00600119|2466003|P2|COMPLETED|Follow-up Period||28
1016237|NCT00600119|2466004|P1|COMPLETED|Follow-up Period||26
1016238|NCT00600119|2465999|P6|STARTED|Follow-up Period||21
1016239|NCT00600119|2466000|P5|STARTED|Follow-up Period||31
1016240|NCT00600119|2466001|P4|STARTED|Follow-up Period||28
1016241|NCT00600119|2466002|P3|STARTED|Follow-up Period||27
1016242|NCT00600119|2466003|P2|STARTED|Follow-up Period||28
1016243|NCT00600119|2466004|P1|STARTED|Follow-up Period||27
1016244|NCT00600119|2465999|P6|NOT COMPLETED|Double-blind Treatment Period||14
1016245|NCT00600119|2466000|P5|NOT COMPLETED|Double-blind Treatment Period||6
1016246|NCT00600119|2466001|P4|NOT COMPLETED|Double-blind Treatment Period||2
1016247|NCT00600119|2466002|P3|NOT COMPLETED|Double-blind Treatment Period||0
1016248|NCT00600119|2466003|P2|NOT COMPLETED|Double-blind Treatment Period||5
1016249|NCT00600119|2466004|P1|NOT COMPLETED|Double-blind Treatment Period||5
1016250|NCT00600119|2465999|P6|COMPLETED|Double-blind Treatment Period||21
1016251|NCT00600119|2466000|P5|COMPLETED|Double-blind Treatment Period||31
1016252|NCT00600119|2466001|P4|COMPLETED|Double-blind Treatment Period||28
1016253|NCT00600119|2466002|P3|COMPLETED|Double-blind Treatment Period||27
1016254|NCT00600119|2466003|P2|COMPLETED|Double-blind Treatment Period||28
1016255|NCT00600119|2466004|P1|COMPLETED|Double-blind Treatment Period||27
1016256|NCT00600119|2465999|P6|STARTED|Double-blind Treatment Period||35
1016257|NCT00600119|2466000|P5|STARTED|Double-blind Treatment Period||37
1016258|NCT00600119|2466001|P4|STARTED|Double-blind Treatment Period||30
1016259|NCT00600119|2466002|P3|STARTED|Double-blind Treatment Period||27
1016260|NCT00600119|2466003|P2|STARTED|Double-blind Treatment Period||33
1016261|NCT00600119|2466004|P1|STARTED|Double-blind Treatment Period||32
1016262|NCT00600119|2465999|P6|NOT COMPLETED|Single-blind Placebo run-in Period||2
1016263|NCT00600119|2466000|P5|NOT COMPLETED|Single-blind Placebo run-in Period||2
1016264|NCT00600119|2466001|P4|NOT COMPLETED|Single-blind Placebo run-in Period||1
1016265|NCT00600119|2466002|P3|NOT COMPLETED|Single-blind Placebo run-in Period||2
1016266|NCT00600119|2466003|P2|NOT COMPLETED|Single-blind Placebo run-in Period||2
1016267|NCT00600119|2466004|P1|NOT COMPLETED|Single-blind Placebo run-in Period||4
1016268|NCT00600119|2465999|P6|COMPLETED|Single-blind Placebo run-in Period||35
1016269|NCT00600119|2466000|P5|COMPLETED|Single-blind Placebo run-in Period||37
1016270|NCT00600119|2466001|P4|COMPLETED|Single-blind Placebo run-in Period||30
1016271|NCT00600119|2466002|P3|COMPLETED|Single-blind Placebo run-in Period||27
1016272|NCT00600119|2466003|P2|COMPLETED|Single-blind Placebo run-in Period||33
1016273|NCT00600119|2466004|P1|COMPLETED|Single-blind Placebo run-in Period||32
1016274|NCT00600119|2465999|P6|STARTED|Single-blind Placebo run-in Period||37
1016275|NCT00600119|2466000|P5|STARTED|Single-blind Placebo run-in Period||39
1016276|NCT00600119|2466001|P4|STARTED|Single-blind Placebo run-in Period||31
1016277|NCT00600119|2466002|P3|STARTED|Single-blind Placebo run-in Period||29
1016278|NCT00600119|2466003|P2|STARTED|Single-blind Placebo run-in Period||35
1016279|NCT00600119|2466004|P1|STARTED|Single-blind Placebo run-in Period||36
1016280|NCT00600171|2466042|P6|NOT COMPLETED|Overall Study||5
1016281|NCT00600171|2466043|P5|NOT COMPLETED|Overall Study||8
1016282|NCT00600171|2466044|P4|NOT COMPLETED|Overall Study||12
1016283|NCT00600171|2466045|P3|NOT COMPLETED|Overall Study||10
1016284|NCT00600171|2466046|P2|NOT COMPLETED|Overall Study||17
1016285|NCT00600171|2466047|P1|NOT COMPLETED|Overall Study||16
1016286|NCT00600171|2466042|P6|COMPLETED|Overall Study||97
1016287|NCT00600171|2466043|P5|COMPLETED|Overall Study||93
1016288|NCT00600171|2466044|P4|COMPLETED|Overall Study||88
1016289|NCT00600171|2466045|P3|COMPLETED|Overall Study||91
1016290|NCT00600171|2466046|P2|COMPLETED|Overall Study||84
1016291|NCT00600171|2466047|P1|COMPLETED|Overall Study||86
1016292|NCT00600171|2466042|P6|STARTED|Overall Study||102
1016293|NCT00600171|2466043|P5|STARTED|Overall Study||101
1016294|NCT00600171|2466044|P4|STARTED|Overall Study||100
1016295|NCT00600171|2466045|P3|STARTED|Overall Study||101
1016296|NCT00600171|2466046|P2|STARTED|Overall Study||101
1016297|NCT00600171|2466047|P1|STARTED|Overall Study||102
1016298|NCT00600353|2466117|P2|NOT COMPLETED|Overall Study||1
1016299|NCT00600353|2466118|P1|NOT COMPLETED|Overall Study||1
1016300|NCT00600353|2466117|P2|COMPLETED|Overall Study||9
1016301|NCT00600353|2466118|P1|COMPLETED|Overall Study||9
1016302|NCT00600353|2466117|P2|STARTED|Overall Study||10
1016303|NCT00600353|2466118|P1|STARTED|Overall Study||10
1016304|NCT00600821|2466132|P2|NOT COMPLETED|Overall Study||60
1016305|NCT00600821|2466133|P1|NOT COMPLETED|Overall Study||58
1016306|NCT00600821|2466132|P2|COMPLETED|Overall Study||0
1016307|NCT00600821|2466133|P1|COMPLETED|Overall Study||0
1016308|NCT00600821|2466132|P2|Treated|Overall Study||59
1016309|NCT00600821|2466133|P1|Treated|Overall Study||58
1016310|NCT00600821|2466132|P2|STARTED|Overall Study||60
1016311|NCT00600821|2466133|P1|STARTED|Overall Study||58
1016312|NCT00600886|2466161|P2|NOT COMPLETED|Extension - After Crossover (CAS)||13
1016313|NCT00600886|2466162|P1|NOT COMPLETED|Extension - After Crossover (CAS)||62
1016314|NCT00600886|2466161|P2|COMPLETED|Extension - After Crossover (CAS)|Completed the study|25
1016315|NCT00600886|2466162|P1|COMPLETED|Extension - After Crossover (CAS)|Completed after month 26: transferred to a roll-over protocol or commercial supply of Pas.LAR|19
1016316|NCT00600886|2466161|P2|Discontinued After M26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|0
1016317|NCT00600886|2466162|P1|Discontinued After M26|Extension - After Crossover (CAS)||31
1016318|NCT00600886|2466161|P2|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||13
1016319|NCT00600886|2466162|P1|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||31
1016320|NCT00600886|2466161|P2|Completed After Month 26|Extension - After Crossover (CAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in study after M26|0
1016321|NCT00600886|2466162|P1|Completed After Month 26|Extension - After Crossover (CAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|19
1016322|NCT00600886|2466161|P2|Completed Study at Month 26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|25
1016323|NCT00600886|2466162|P1|Completed Study at Month 26|Extension - After Crossover (CAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
1016324|NCT00600886|2466161|P2|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Octreotide LAR|38
1016325|NCT00600886|2466162|P1|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Pasireotide LAR|81
1016326|NCT00600886|2466161|P2|NOT COMPLETED|Extension - Same Treatment (FAS)||11
1016327|NCT00600886|2466162|P1|NOT COMPLETED|Extension - Same Treatment (FAS)||46
1016328|NCT00600886|2466161|P2|COMPLETED|Extension - Same Treatment (FAS)|Completed = completed the study|35
1016329|NCT00600886|2466162|P1|COMPLETED|Extension - Same Treatment (FAS)|Completed= completed after M26, switched to commercial pasireotide LAR or entered roll-over protocol|28
1016330|NCT00600886|2466161|P2|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||10
1016331|NCT00600886|2466162|P1|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||23
1016332|NCT00600886|2466161|P2|Discontinued After Month 26|Extension - Same Treatment (FAS)|Received treatment and discontinued after M26: Recorded as protocol deviation|1
1016333|NCT00600886|2466162|P1|Discontinued After Month 26|Extension - Same Treatment (FAS)||23
1016334|NCT00600886|2466161|P2|Completed Study After Month 26|Extension - Same Treatment (FAS)|Received treatment and completed after M26: Recorded as protocol deviation|4
1016335|NCT00600886|2466162|P1|Completed Study After Month 26|Extension - Same Treatment (FAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|28
1016336|NCT00600886|2466161|P2|Completed Study at Month 26|Extension - Same Treatment (FAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in the study after M26|31
1016337|NCT00600886|2466162|P1|Completed Study at Month 26|Extension - Same Treatment (FAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
1016338|NCT00600886|2466161|P2|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Octreotide LAR|46
1016339|NCT00600886|2466162|P1|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Pasireotide LAR|74
1016340|NCT00600886|2466161|P2|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||26
1016341|NCT00600886|2466162|P1|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||35
1016342|NCT00600886|2466161|P2|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|156
1016343|NCT00600886|2466162|P1|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|141
1016344|NCT00600886|2466161|P2|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||46
1016345|NCT00600886|2466162|P1|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||74
1016346|NCT00600886|2466161|P2|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||81
1016347|NCT00600886|2466162|P1|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||38
1016348|NCT00600886|2466161|P2|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
1016349|NCT00600886|2466162|P1|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
1016350|NCT00600886|2466161|P2|STARTED|Core Phase - Full Analysis Set (FAS)||182
1016351|NCT00600886|2466162|P1|STARTED|Core Phase - Full Analysis Set (FAS)||176
1016352|NCT00600938|2466226|P4|NOT COMPLETED|Extension Study||1
1016353|NCT00600938|2466227|P3|NOT COMPLETED|Extension Study||9
1016354|NCT00600938|2466228|P2|NOT COMPLETED|Extension Study||5
1016355|NCT00600938|2466229|P1|NOT COMPLETED|Extension Study||9
1016356|NCT00600938|2466226|P4|COMPLETED|Extension Study||0
1016357|NCT00600938|2466227|P3|COMPLETED|Extension Study||33
1016358|NCT00600938|2466228|P2|COMPLETED|Extension Study||24
1016359|NCT00600938|2466229|P1|COMPLETED|Extension Study||65
1016360|NCT00600938|2466226|P4|Extension Safety Set|Extension Study||1
1016361|NCT00600938|2466227|P3|Extension Safety Set|Extension Study||42
1016362|NCT00600938|2466228|P2|Extension Safety Set|Extension Study||29
1016363|NCT00600938|2466229|P1|Extension Safety Set|Extension Study|1 patient did not receive drug in the ext. phase but received drug in the core phase|73
1016364|NCT00600938|2466226|P4|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|1
1016365|NCT00600938|2466227|P3|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|42
1016366|NCT00600938|2466228|P2|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|29
1016367|NCT00600938|2466229|P1|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|74
1016368|NCT00600938|2466226|P4|NOT COMPLETED|Core Study||0
1016369|NCT00600938|2466227|P3|NOT COMPLETED|Core Study||0
1016370|NCT00600938|2466228|P2|NOT COMPLETED|Core Study||21
1016371|NCT00600938|2466229|P1|NOT COMPLETED|Core Study||16
1016372|NCT00600938|2466226|P4|COMPLETED|Core Study||0
1016373|NCT00600938|2466227|P3|COMPLETED|Core Study||0
1016374|NCT00600938|2466228|P2|COMPLETED|Core Study||78
1016375|NCT00600938|2466229|P1|COMPLETED|Core Study||82
1016376|NCT00600938|2466226|P4|Per Protocol Set (PPS)|Core Study||0
1016377|NCT00600938|2466227|P3|Per Protocol Set (PPS)|Core Study||0
1016378|NCT00600938|2466228|P2|Per Protocol Set (PPS)|Core Study||81
1016379|NCT00600938|2466229|P1|Per Protocol Set (PPS)|Core Study||91
1016380|NCT00600938|2466226|P4|Core Safety Set|Core Study||0
1016381|NCT00600938|2466227|P3|Core Safety Set|Core Study||0
1016382|NCT00600938|2466228|P2|Core Safety Set|Core Study||91
1016383|NCT00600938|2466229|P1|Core Safety Set|Core Study||96
1016384|NCT00600938|2466226|P4|STARTED|Core Study||0
1016385|NCT00600938|2466227|P3|STARTED|Core Study||0
1016386|NCT00600938|2466228|P2|STARTED|Core Study||99
1016387|NCT00600938|2466229|P1|STARTED|Core Study||98
1016388|NCT00601107|2466295|P4|NOT COMPLETED|Overall Study||12
1016389|NCT00601107|2466296|P3|NOT COMPLETED|Overall Study||12
1016390|NCT00601107|2466297|P2|NOT COMPLETED|Overall Study||9
1016391|NCT00601107|2466298|P1|NOT COMPLETED|Overall Study||13
1016392|NCT00601107|2466295|P4|COMPLETED|Overall Study||13
1016393|NCT00601107|2466296|P3|COMPLETED|Overall Study||16
1016394|NCT00601107|2466297|P2|COMPLETED|Overall Study||22
1016395|NCT00601107|2466298|P1|COMPLETED|Overall Study||14
1016396|NCT00601107|2466295|P4|Treated|Overall Study||25
1016397|NCT00601107|2466296|P3|Treated|Overall Study||28
1016398|NCT00601107|2466297|P2|Treated|Overall Study||31
1016399|NCT00601107|2466298|P1|Treated|Overall Study||27
1016400|NCT00601107|2466295|P4|STARTED|Overall Study||25
1016401|NCT00601107|2466296|P3|STARTED|Overall Study||28
1016402|NCT00601107|2466297|P2|STARTED|Overall Study||31
1016403|NCT00601107|2466298|P1|STARTED|Overall Study|Randomized.|27
1016404|NCT00601146|2466316|P1|NOT COMPLETED|Overall Study||161
1016405|NCT00601146|2466316|P1|COMPLETED|Overall Study||39
1016406|NCT00601146|2466316|P1|STARTED|Overall Study||200
1016407|NCT00601250|2466322|P2|NOT COMPLETED|Overall Study||39
1016408|NCT00601250|2466323|P1|NOT COMPLETED|Overall Study||14
1016409|NCT00601250|2466322|P2|COMPLETED|Overall Study|number who completed treatment|484
1016410|NCT00601250|2466323|P1|COMPLETED|Overall Study|number who completed treatment|163
1016411|NCT00601250|2466322|P2|STARTED|Overall Study|number who started treatment. One additional patient was randomised but not treated.|523
1016412|NCT00601250|2466323|P1|STARTED|Overall Study|number who started treatment|177
1016413|NCT00601354|2466359|P2|NOT COMPLETED|Overall Study||5
1016414|NCT00601354|2466360|P1|NOT COMPLETED|Overall Study||4
1016415|NCT00601354|2466359|P2|COMPLETED|Overall Study||4
1016416|NCT00601354|2466360|P1|COMPLETED|Overall Study||4
1016417|NCT00601354|2466359|P2|STARTED|Overall Study||9
1016418|NCT00601354|2466360|P1|STARTED|Overall Study||8
1016419|NCT00601367|2466370|P1|NOT COMPLETED|Overall Study||187
1016420|NCT00601367|2466370|P1|COMPLETED|Overall Study||293
1016421|NCT00601367|2466370|P1|STARTED|Overall Study||480
1016422|NCT00601419|2466374|P1|NOT COMPLETED|Overall Study||4
1016423|NCT00601419|2466374|P1|COMPLETED|Overall Study||226
1016424|NCT00601419|2466374|P1|STARTED|Overall Study||230
1016425|NCT00601458|2466401|P3|NOT COMPLETED|Overall Study||2
1016426|NCT00601458|2466402|P2|NOT COMPLETED|Overall Study||5
1016427|NCT00601458|2466403|P1|NOT COMPLETED|Overall Study||4
1016428|NCT00601458|2466401|P3|COMPLETED|Overall Study||28
1016429|NCT00601458|2466402|P2|COMPLETED|Overall Study||29
1016430|NCT00601458|2466403|P1|COMPLETED|Overall Study||32
1016431|NCT00601458|2466401|P3|STARTED|Overall Study||30
1016432|NCT00601458|2466402|P2|STARTED|Overall Study||34
1016433|NCT00601458|2466403|P1|STARTED|Overall Study||36
1016434|NCT00601523|2466416|P2|NOT COMPLETED|Overall Study||26
1016435|NCT00601523|2466417|P1|NOT COMPLETED|Overall Study||77
1016436|NCT00601523|2466416|P2|COMPLETED|Overall Study||117
1016437|NCT00601523|2466417|P1|COMPLETED|Overall Study||291
1016438|NCT00601523|2466416|P2|STARTED|Overall Study||143
1016439|NCT00601523|2466417|P1|STARTED|Overall Study||368
1016440|NCT00601627|2466449|P1|NOT COMPLETED|Overall Study||0
1016441|NCT00601627|2466449|P1|COMPLETED|Overall Study||51
1016442|NCT00601627|2466449|P1|STARTED|Overall Study||51
1016443|NCT00601640|2466461|P3|NOT COMPLETED|Overall Study||10
1016444|NCT00601640|2466462|P2|NOT COMPLETED|Overall Study||5
1016445|NCT00601640|2466463|P1|NOT COMPLETED|Overall Study||5
1016446|NCT00601640|2466461|P3|COMPLETED|Overall Study||42
1016447|NCT00601640|2466462|P2|COMPLETED|Overall Study||47
1016448|NCT00601640|2466463|P1|COMPLETED|Overall Study||47
1016449|NCT00601640|2466461|P3|STARTED|Overall Study||52
1016450|NCT00601640|2466462|P2|STARTED|Overall Study||52
1016451|NCT00601640|2466463|P1|STARTED|Overall Study||52
1016452|NCT00601718|2466477|P1|NOT COMPLETED|Overall Study||0
1016453|NCT00601718|2466477|P1|COMPLETED|Overall Study||29
1016454|NCT00601718|2466477|P1|STARTED|Overall Study||29
1016455|NCT00601731|2466496|P4|NOT COMPLETED|Overall Study||1
1016456|NCT00601731|2466497|P3|NOT COMPLETED|Overall Study||15
1016457|NCT00601731|2466498|P2|NOT COMPLETED|Overall Study||0
1016458|NCT00601731|2466499|P1|NOT COMPLETED|Overall Study||23
1016459|NCT00601731|2466496|P4|COMPLETED|Overall Study||29
1016460|NCT00601731|2466497|P3|COMPLETED|Overall Study||151
1016461|NCT00601731|2466498|P2|COMPLETED|Overall Study||43
1016462|NCT00601731|2466499|P1|COMPLETED|Overall Study||120
1016463|NCT00601731|2466496|P4|STARTED|Overall Study||30
1016464|NCT00601731|2466497|P3|STARTED|Overall Study||166
1016465|NCT00601731|2466498|P2|STARTED|Overall Study||43
1016466|NCT00601731|2466499|P1|STARTED|Overall Study||143
1016467|NCT00601796|2466549|P1|NOT COMPLETED|Overall Study||0
1016468|NCT00601796|2466549|P1|COMPLETED|Overall Study||24
1016469|NCT00601796|2466549|P1|STARTED|Overall Study||24
1016470|NCT00601835|2466558|P2|NOT COMPLETED|Overall Study||14
1016471|NCT00601835|2466559|P1|NOT COMPLETED|Overall Study||60
1016472|NCT00601835|2466558|P2|COMPLETED|Overall Study||686
1016473|NCT00601835|2466559|P1|COMPLETED|Overall Study||2890
1016474|NCT00601835|2466558|P2|STARTED|Overall Study||700
1016475|NCT00601835|2466559|P1|STARTED|Overall Study||2950
1016482|NCT00601926|2466586|P1|NOT COMPLETED|Overall Study||0
1016483|NCT00601926|2466586|P1|COMPLETED|Overall Study||5
1016484|NCT00601926|2466586|P1|STARTED|Overall Study||5
1016485|NCT00601952|2466594|P2|NOT COMPLETED|Overall Study||0
1016486|NCT00601952|2466595|P1|NOT COMPLETED|Overall Study||2
1016487|NCT00601952|2466594|P2|COMPLETED|Overall Study||17
1016488|NCT00601952|2466595|P1|COMPLETED|Overall Study||12
1016489|NCT00601952|2466594|P2|STARTED|Overall Study||17
1016490|NCT00601952|2466595|P1|STARTED|Overall Study||14
1016491|NCT00601965|2466605|P4|NOT COMPLETED|Overall Study||1
1016492|NCT00601965|2466606|P3|NOT COMPLETED|Overall Study||0
1016493|NCT00601965|2466607|P2|NOT COMPLETED|Overall Study||2
1016494|NCT00601965|2466608|P1|NOT COMPLETED|Overall Study||0
1016495|NCT00601965|2466605|P4|COMPLETED|Overall Study||17
1016496|NCT00601965|2466606|P3|COMPLETED|Overall Study||19
1016497|NCT00601965|2466607|P2|COMPLETED|Overall Study||16
1016498|NCT00601965|2466608|P1|COMPLETED|Overall Study||18
1016499|NCT00601965|2466605|P4|STARTED|Overall Study||18
1016500|NCT00601965|2466606|P3|STARTED|Overall Study||19
1016501|NCT00601965|2466607|P2|STARTED|Overall Study||18
1016502|NCT00601965|2466608|P1|STARTED|Overall Study||18
1016503|NCT00602043|2466622|P1|NOT COMPLETED|Overall Study||5
1016504|NCT00602043|2466622|P1|COMPLETED|Overall Study||15
1016505|NCT00602043|2466622|P1|STARTED|Overall Study||20
1016506|NCT00602225|2466627|P1|NOT COMPLETED|Overall Study||0
1016507|NCT00602225|2466627|P1|COMPLETED|Overall Study||50
1016508|NCT00602225|2466627|P1|STARTED|Overall Study||50
1016509|NCT00602290|2466640|P3|NOT COMPLETED|Overall Study||1
1016510|NCT00602290|2466641|P2|NOT COMPLETED|Overall Study||2
1016511|NCT00602290|2466642|P1|NOT COMPLETED|Overall Study||2
1016512|NCT00602290|2466640|P3|COMPLETED|Overall Study||46
1016513|NCT00602290|2466641|P2|COMPLETED|Overall Study||46
1016514|NCT00602290|2466642|P1|COMPLETED|Overall Study||46
1016515|NCT00602290|2466640|P3|STARTED|Overall Study||47
1016516|NCT00602290|2466641|P2|STARTED|Overall Study||48
1016517|NCT00602290|2466642|P1|STARTED|Overall Study||48
1016518|NCT00602355|2466653|P3|NOT COMPLETED|Overall Study||10
1016519|NCT00602355|2466654|P2|NOT COMPLETED|Overall Study||18
1016520|NCT00602355|2466655|P1|NOT COMPLETED|Overall Study||9
1016521|NCT00602355|2466653|P3|COMPLETED|Overall Study||43
1016522|NCT00602355|2466654|P2|COMPLETED|Overall Study||38
1016523|NCT00602355|2466655|P1|COMPLETED|Overall Study||44
1016524|NCT00602355|2466653|P3|STARTED|Overall Study||53
1016525|NCT00602355|2466654|P2|STARTED|Overall Study||56
1016526|NCT00602355|2466655|P1|STARTED|Overall Study||53
1016527|NCT00602420|2466677|P2|NOT COMPLETED|Overall Study||24
1016528|NCT00602420|2466678|P1|NOT COMPLETED|Overall Study||25
1016529|NCT00602420|2466677|P2|COMPLETED|Overall Study||229
1016530|NCT00602420|2466678|P1|COMPLETED|Overall Study||232
1016531|NCT00602420|2466677|P2|STARTED|Overall Study||253
1016532|NCT00602420|2466678|P1|STARTED|Overall Study||257
1016533|NCT00602446|2466684|P1|NOT COMPLETED|Overall Study||0
1016534|NCT00602446|2466684|P1|COMPLETED|Overall Study||3
1016535|NCT00602446|2466684|P1|STARTED|Overall Study||3
1016536|NCT00602459|2466693|P4|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
1016537|NCT00602459|2466694|P3|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
1016538|NCT00602459|2466695|P2|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
1016539|NCT00602459|2466696|P1|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
1016540|NCT00602459|2466693|P4|COMPLETED|Re-assignment After Del(11q22.3) Testing||31
1016541|NCT00602459|2466694|P3|COMPLETED|Re-assignment After Del(11q22.3) Testing||137
1016542|NCT00602459|2466695|P2|COMPLETED|Re-assignment After Del(11q22.3) Testing||109
1016543|NCT00602459|2466696|P1|COMPLETED|Re-assignment After Del(11q22.3) Testing||123
1016544|NCT00602459|2466693|P4|STARTED|Re-assignment After Del(11q22.3) Testing||31
1016545|NCT00602459|2466694|P3|STARTED|Re-assignment After Del(11q22.3) Testing||137
1016546|NCT00602459|2466695|P2|STARTED|Re-assignment After Del(11q22.3) Testing||109
1016547|NCT00602459|2466696|P1|STARTED|Re-assignment After Del(11q22.3) Testing||123
1016548|NCT00602459|2466693|P4|NOT COMPLETED|Initial Registration/Randomization||0
1016549|NCT00602459|2466694|P3|NOT COMPLETED|Initial Registration/Randomization||3
1016550|NCT00602459|2466695|P2|NOT COMPLETED|Initial Registration/Randomization||10
1016551|NCT00602459|2466696|P1|NOT COMPLETED|Initial Registration/Randomization||5
1016552|NCT00602459|2466693|P4|COMPLETED|Initial Registration/Randomization||0
1016553|NCT00602459|2466694|P3|COMPLETED|Initial Registration/Randomization||137
1016554|NCT00602459|2466695|P2|COMPLETED|Initial Registration/Randomization||130
1016555|NCT00602459|2466696|P1|COMPLETED|Initial Registration/Randomization||133
1016556|NCT00602459|2466693|P4|STARTED|Initial Registration/Randomization||0
1016557|NCT00602459|2466694|P3|STARTED|Initial Registration/Randomization||140
1016558|NCT00602459|2466695|P2|STARTED|Initial Registration/Randomization||140
1016559|NCT00602459|2466696|P1|STARTED|Initial Registration/Randomization||138
1016560|NCT00602472|2466714|P2|NOT COMPLETED|Overall Study||58
1016561|NCT00602472|2466715|P1|NOT COMPLETED|Overall Study||21
1016562|NCT00602472|2466714|P2|COMPLETED|Overall Study|number who completed treatment|734
1016563|NCT00602472|2466715|P1|COMPLETED|Overall Study|number who completed treatment|242
1016564|NCT00602472|2466714|P2|STARTED|Overall Study|3 randomised patients never took medication.|792
1016565|NCT00602472|2466715|P1|STARTED|Overall Study|3 randomised patients never took medication.|263
1016566|NCT00602537|2466747|P2|NOT COMPLETED|Follow Up Study Comparison||3
1016567|NCT00602537|2466748|P1|NOT COMPLETED|Follow Up Study Comparison||11
1016568|NCT00602537|2466747|P2|COMPLETED|Follow Up Study Comparison||14
1016569|NCT00602537|2466748|P1|COMPLETED|Follow Up Study Comparison||31
1016570|NCT00602537|2466747|P2|STARTED|Follow Up Study Comparison||17
1016571|NCT00602537|2466748|P1|STARTED|Follow Up Study Comparison||42
1016572|NCT00602537|2466747|P2|NOT COMPLETED|12 Week Double Blind Comparison||47
1016573|NCT00602537|2466748|P1|NOT COMPLETED|12 Week Double Blind Comparison||23
1016574|NCT00602537|2466747|P2|COMPLETED|12 Week Double Blind Comparison||17
1016575|NCT00602537|2466748|P1|COMPLETED|12 Week Double Blind Comparison||42
1016576|NCT00602537|2466747|P2|Responded|12 Week Double Blind Comparison||22
1016577|NCT00602537|2466748|P1|Responded|12 Week Double Blind Comparison||44
1016578|NCT00602537|2466747|P2|STARTED|12 Week Double Blind Comparison||64
1016579|NCT00602537|2466748|P1|STARTED|12 Week Double Blind Comparison||65
1016580|NCT00602641|2466758|P2|NOT COMPLETED|Overall Study||152
1016581|NCT00602641|2466759|P1|NOT COMPLETED|Overall Study||154
1016582|NCT00602641|2466758|P2|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
1016583|NCT00602641|2466759|P1|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
1016584|NCT00602641|2466758|P2|Started Protocol Therapy|Overall Study||150
1016585|NCT00602641|2466759|P1|Started Protocol Therapy|Overall Study||148
1016586|NCT00602641|2466758|P2|STARTED|Overall Study||152
1016587|NCT00602641|2466759|P1|STARTED|Overall Study||154
1016588|NCT00602771|2466773|P2|NOT COMPLETED|Overall Study||0
1016589|NCT00602771|2466774|P1|NOT COMPLETED|Overall Study||1
1016590|NCT00602771|2466773|P2|COMPLETED|Overall Study||21
1016591|NCT00602771|2466774|P1|COMPLETED|Overall Study||62
1016592|NCT00602771|2466773|P2|STARTED|Overall Study||21
1016593|NCT00602771|2466774|P1|STARTED|Overall Study||63
1016597|NCT00602927|2466786|P2|NOT COMPLETED|Period 3: 13 Days||3
1016598|NCT00602927|2466787|P1|NOT COMPLETED|Period 3: 13 Days||2
1016599|NCT00602927|2466786|P2|COMPLETED|Period 3: 13 Days||9
1016600|NCT00602927|2466787|P1|COMPLETED|Period 3: 13 Days||13
1016601|NCT00602927|2466786|P2|STARTED|Period 3: 13 Days||12
1016602|NCT00602927|2466787|P1|STARTED|Period 3: 13 Days||15
1016603|NCT00602927|2466786|P2|NOT COMPLETED|Period 2: 14 Days||2
1016604|NCT00602927|2466787|P1|NOT COMPLETED|Period 2: 14 Days||0
1016605|NCT00602927|2466786|P2|COMPLETED|Period 2: 14 Days||12
1016606|NCT00602927|2466787|P1|COMPLETED|Period 2: 14 Days||15
1016607|NCT00602927|2466786|P2|STARTED|Period 2: 14 Days||14
1016608|NCT00602927|2466787|P1|STARTED|Period 2: 14 Days||15
1016609|NCT00602927|2466786|P2|NOT COMPLETED|Period 1: 13 Days||5
1016610|NCT00602927|2466787|P1|NOT COMPLETED|Period 1: 13 Days||4
1016611|NCT00602927|2466786|P2|COMPLETED|Period 1: 13 Days||14
1016612|NCT00602927|2466787|P1|COMPLETED|Period 1: 13 Days||15
1016613|NCT00602927|2466786|P2|STARTED|Period 1: 13 Days||19
1016614|NCT00602927|2466787|P1|STARTED|Period 1: 13 Days||19
1016615|NCT00602979|2466800|P5|NOT COMPLETED|Overall Study||3
1016616|NCT00602979|2466801|P4|NOT COMPLETED|Overall Study||3
1016617|NCT00602979|2466802|P3|NOT COMPLETED|Overall Study||3
1016618|NCT00602979|2466803|P2|NOT COMPLETED|Overall Study||3
1016619|NCT00602979|2466804|P1|NOT COMPLETED|Overall Study||3
1016620|NCT00602979|2466800|P5|COMPLETED|Overall Study||45
1016621|NCT00602979|2466801|P4|COMPLETED|Overall Study||45
1016622|NCT00602979|2466802|P3|COMPLETED|Overall Study||45
1016623|NCT00602979|2466803|P2|COMPLETED|Overall Study||45
1016624|NCT00602979|2466804|P1|COMPLETED|Overall Study||45
1016625|NCT00602979|2466800|P5|STARTED|Overall Study||48
1016626|NCT00602979|2466801|P4|STARTED|Overall Study||48
1016627|NCT00602979|2466802|P3|STARTED|Overall Study||48
1016628|NCT00602979|2466803|P2|STARTED|Overall Study||48
1016629|NCT00602979|2466804|P1|STARTED|Overall Study||48
1016630|NCT00603018|2466816|P1|NOT COMPLETED|Overall Study||0
1016631|NCT00603018|2466816|P1|COMPLETED|Overall Study||23
1016632|NCT00603018|2466816|P1|STARTED|Overall Study||23
1016633|NCT00603044|2466823|P2|NOT COMPLETED|Overall Study||0
1016634|NCT00603044|2466824|P1|NOT COMPLETED|Overall Study||0
1016635|NCT00603044|2466823|P2|COMPLETED|Overall Study||13
1016636|NCT00603044|2466824|P1|COMPLETED|Overall Study||11
1016637|NCT00603044|2466823|P2|STARTED|Overall Study||13
1016638|NCT00603044|2466824|P1|STARTED|Overall Study||11
1016639|NCT00603187|2466840|P1|NOT COMPLETED|Overall Study||0
1016640|NCT00603187|2466840|P1|COMPLETED|Overall Study||4
1016641|NCT00603187|2466840|P1|STARTED|Overall Study||4
1016642|NCT00603239|2466848|P2|NOT COMPLETED|Overall Study||4
1016643|NCT00603239|2466849|P1|NOT COMPLETED|Overall Study||15
1016644|NCT00603239|2466848|P2|COMPLETED|Overall Study||50
1016645|NCT00603239|2466849|P1|COMPLETED|Overall Study||96
1016646|NCT00603239|2466848|P2|STARTED|Overall Study||54
1016647|NCT00603239|2466849|P1|STARTED|Overall Study||111
1016648|NCT00603265|2466878|P3|NOT COMPLETED|Overall Study||5
1016649|NCT00603265|2466879|P2|NOT COMPLETED|Overall Study||16
1016650|NCT00603265|2466880|P1|NOT COMPLETED|Overall Study||7
1016651|NCT00603265|2466878|P3|COMPLETED|Overall Study||67
1016652|NCT00603265|2466879|P2|COMPLETED|Overall Study||62
1016653|NCT00603265|2466880|P1|COMPLETED|Overall Study||69
1016654|NCT00603265|2466878|P3|Received at Least 1 Dose of Study Drug|Overall Study||72
1016655|NCT00603265|2466879|P2|Received at Least 1 Dose of Study Drug|Overall Study||78
1016656|NCT00603265|2466880|P1|Received at Least 1 Dose of Study Drug|Overall Study||75
1016657|NCT00603265|2466878|P3|STARTED|Overall Study||72
1016658|NCT00603265|2466879|P2|STARTED|Overall Study||78
1016659|NCT00603265|2466880|P1|STARTED|Overall Study|1 participant was randomized in error and did not receive study medication|76
1016660|NCT00603278|2466912|P6|NOT COMPLETED|Overall Study||19
1016661|NCT00603278|2466913|P5|NOT COMPLETED|Overall Study||13
1016662|NCT00603278|2466914|P4|NOT COMPLETED|Overall Study||11
1016663|NCT00603278|2466915|P3|NOT COMPLETED|Overall Study||14
1016664|NCT00603278|2466916|P2|NOT COMPLETED|Overall Study||17
1016665|NCT00603278|2466917|P1|NOT COMPLETED|Overall Study||41
1016666|NCT00603278|2466912|P6|COMPLETED|Overall Study||81
1016667|NCT00603278|2466913|P5|COMPLETED|Overall Study||86
1016668|NCT00603278|2466914|P4|COMPLETED|Overall Study||92
1016669|NCT00603278|2466915|P3|COMPLETED|Overall Study||87
1016670|NCT00603278|2466916|P2|COMPLETED|Overall Study||88
1016671|NCT00603278|2466917|P1|COMPLETED|Overall Study||66
1016672|NCT00603278|2466912|P6|STARTED|Overall Study||100
1016673|NCT00603278|2466913|P5|STARTED|Overall Study||99
1016674|NCT00603278|2466914|P4|STARTED|Overall Study||103
1016675|NCT00603278|2466915|P3|STARTED|Overall Study||101
1016676|NCT00603278|2466916|P2|STARTED|Overall Study||105
1016677|NCT00603278|2466917|P1|STARTED|Overall Study||107
1016687|NCT00603304|2467081|P2|NOT COMPLETED|Overall Study||31
1016688|NCT00603304|2467082|P1|NOT COMPLETED|Overall Study||32
1016689|NCT00603304|2467081|P2|COMPLETED|Overall Study||155
1016690|NCT00603304|2467082|P1|COMPLETED|Overall Study||151
1016691|NCT00603304|2467081|P2|STARTED|Overall Study||186
1016692|NCT00603304|2467082|P1|STARTED|Overall Study||183
1016693|NCT00603382|2467122|P6|NOT COMPLETED|Overall Study||18
1016694|NCT00603382|2467123|P5|NOT COMPLETED|Overall Study||9
1016695|NCT00603382|2467124|P4|NOT COMPLETED|Overall Study||12
1016696|NCT00603382|2467125|P3|NOT COMPLETED|Overall Study||9
1016697|NCT00603382|2467126|P2|NOT COMPLETED|Overall Study||14
1016698|NCT00603382|2467127|P1|NOT COMPLETED|Overall Study||18
1016699|NCT00603382|2467122|P6|COMPLETED|Overall Study||84
1016700|NCT00603382|2467123|P5|COMPLETED|Overall Study||86
1016701|NCT00603382|2467124|P4|COMPLETED|Overall Study||98
1016702|NCT00603382|2467125|P3|COMPLETED|Overall Study||91
1016703|NCT00603382|2467126|P2|COMPLETED|Overall Study||83
1016704|NCT00603382|2467127|P1|COMPLETED|Overall Study||76
1016705|NCT00603382|2467122|P6|STARTED|Overall Study||102
1016706|NCT00603382|2467123|P5|STARTED|Overall Study||95
1016707|NCT00603382|2467124|P4|STARTED|Overall Study||110
1016708|NCT00603382|2467125|P3|STARTED|Overall Study||100
1016709|NCT00603382|2467126|P2|STARTED|Overall Study||97
1016710|NCT00603382|2467127|P1|STARTED|Overall Study||94
1016711|NCT00594958|2467276|P3|NOT COMPLETED|Overall Study||10
1016712|NCT00594958|2467277|P2|NOT COMPLETED|Overall Study||3
1016713|NCT00594958|2467278|P1|NOT COMPLETED|Overall Study||14
1016714|NCT00594958|2467276|P3|COMPLETED|Overall Study||202
1016715|NCT00594958|2467277|P2|COMPLETED|Overall Study||210
1016716|NCT00594958|2467278|P1|COMPLETED|Overall Study||200
1016717|NCT00594958|2467276|P3|Randomized and at Least 1 Vaccination|Overall Study||211
1016718|NCT00594958|2467277|P2|Randomized and at Least 1 Vaccination|Overall Study||213
1016719|NCT00594958|2467278|P1|Randomized and at Least 1 Vaccination|Overall Study||212
1016720|NCT00594958|2467276|P3|STARTED|Overall Study||212
1016721|NCT00594958|2467277|P2|STARTED|Overall Study||213
1016722|NCT00594958|2467278|P1|STARTED|Overall Study||214
1016723|NCT00595075|2467288|P2|NOT COMPLETED|Overall Study||0
1016724|NCT00595075|2467289|P1|NOT COMPLETED|Overall Study||1
1016725|NCT00595075|2467288|P2|COMPLETED|Overall Study||5
1016726|NCT00595075|2467289|P1|COMPLETED|Overall Study||5
1016727|NCT00595075|2467288|P2|STARTED|Overall Study||5
1016728|NCT00595075|2467289|P1|STARTED|Overall Study||6
1016729|NCT00595088|2467307|P1|NOT COMPLETED|Overall Study||40
1016730|NCT00595088|2467307|P1|COMPLETED|Overall Study|5 patients ongoing, 7 completed the study (week 46)and 35 withdrew prematurely|7
1016731|NCT00595088|2467307|P1|STARTED|Overall Study||47
1016732|NCT00595114|2467316|P2|NOT COMPLETED|Overall Study||0
1016733|NCT00595114|2467317|P1|NOT COMPLETED|Overall Study||0
1016734|NCT00595114|2467316|P2|COMPLETED|Overall Study||19
1016735|NCT00595114|2467317|P1|COMPLETED|Overall Study||24
1016736|NCT00595114|2467316|P2|STARTED|Overall Study||19
1016737|NCT00595114|2467317|P1|STARTED|Overall Study||24
1016738|NCT00595127|2467323|P1|NOT COMPLETED|Overall Study||10
1016739|NCT00595127|2467323|P1|COMPLETED|Overall Study||11
1016740|NCT00595127|2467323|P1|STARTED|Overall Study||21
1016741|NCT00595153|2467330|P3|NOT COMPLETED|Overall Study||25
1016742|NCT00595153|2467331|P2|NOT COMPLETED|Overall Study||16
1016743|NCT00595153|2467332|P1|NOT COMPLETED|Overall Study||4
1016744|NCT00595153|2467330|P3|COMPLETED|Overall Study||36
1016745|NCT00595153|2467331|P2|COMPLETED|Overall Study||26
1016746|NCT00595153|2467332|P1|COMPLETED|Overall Study||20
1016747|NCT00595153|2467330|P3|STARTED|Overall Study||61
1016748|NCT00595153|2467331|P2|STARTED|Overall Study||42
1016749|NCT00595153|2467332|P1|STARTED|Overall Study||24
1016750|NCT00595270|2467343|P3|NOT COMPLETED|Overall Study||8
1016751|NCT00595270|2467344|P2|NOT COMPLETED|Overall Study||10
1016752|NCT00595270|2467345|P1|NOT COMPLETED|Overall Study||6
1016753|NCT00595270|2467343|P3|COMPLETED|Overall Study||108
1016754|NCT00595270|2467344|P2|COMPLETED|Overall Study||107
1016755|NCT00595270|2467345|P1|COMPLETED|Overall Study||110
1016756|NCT00595270|2467343|P3|STARTED|Overall Study||116
1016757|NCT00595270|2467344|P2|STARTED|Overall Study||117
1016758|NCT00595270|2467345|P1|STARTED|Overall Study||116
1016759|NCT00595309|2467353|P1|NOT COMPLETED|Overall Study||4
1016760|NCT00595309|2467353|P1|COMPLETED|Overall Study||194
1016761|NCT00595309|2467353|P1|STARTED|Overall Study||198
1016762|NCT00595335|2467359|P2|NOT COMPLETED|Six Months to Twelve Months||1
1016763|NCT00595335|2467360|P1|NOT COMPLETED|Six Months to Twelve Months||1
1016764|NCT00595335|2467359|P2|COMPLETED|Six Months to Twelve Months||9
1016765|NCT00595335|2467360|P1|COMPLETED|Six Months to Twelve Months||10
1016766|NCT00595335|2467359|P2|STARTED|Six Months to Twelve Months||10
1016767|NCT00595335|2467360|P1|STARTED|Six Months to Twelve Months||11
1016768|NCT00595335|2467359|P2|NOT COMPLETED|Baseline to Six Months||2
1016769|NCT00595335|2467360|P1|NOT COMPLETED|Baseline to Six Months||2
1016770|NCT00595335|2467359|P2|COMPLETED|Baseline to Six Months||10
1016771|NCT00595335|2467360|P1|COMPLETED|Baseline to Six Months||11
1016772|NCT00595335|2467359|P2|STARTED|Baseline to Six Months||12
1016773|NCT00595335|2467360|P1|STARTED|Baseline to Six Months||13
1016774|NCT00595361|2467382|P2|NOT COMPLETED|Overall Study||0
1016775|NCT00595361|2467383|P1|NOT COMPLETED|Overall Study||0
1016776|NCT00595361|2467382|P2|COMPLETED|Overall Study||18
1016777|NCT00595361|2467383|P1|COMPLETED|Overall Study||12
1016778|NCT00595361|2467382|P2|STARTED|Overall Study||18
1016779|NCT00595361|2467383|P1|STARTED|Overall Study||12
1016780|NCT00595413|2467397|P4|NOT COMPLETED|Overall Study||4
1016781|NCT00595413|2467398|P3|NOT COMPLETED|Overall Study||8
1016782|NCT00595413|2467399|P2|NOT COMPLETED|Overall Study||5
1016783|NCT00595413|2467400|P1|NOT COMPLETED|Overall Study||7
1016784|NCT00595413|2467397|P4|COMPLETED|Overall Study||75
1016785|NCT00595413|2467398|P3|COMPLETED|Overall Study||70
1016786|NCT00595413|2467399|P2|COMPLETED|Overall Study||73
1016787|NCT00595413|2467400|P1|COMPLETED|Overall Study||69
1016788|NCT00595413|2467397|P4|STARTED|Overall Study||79
1016789|NCT00595413|2467398|P3|STARTED|Overall Study||78
1016790|NCT00595413|2467399|P2|STARTED|Overall Study||78
1016791|NCT00595413|2467400|P1|STARTED|Overall Study||76
1016792|NCT00595465|2467429|P3|NOT COMPLETED|Overall Study||7
1016793|NCT00595465|2467430|P2|NOT COMPLETED|Overall Study||4
1016794|NCT00595465|2467431|P1|NOT COMPLETED|Overall Study||6
1016795|NCT00595465|2467429|P3|COMPLETED|Overall Study||121
1016796|NCT00595465|2467430|P2|COMPLETED|Overall Study||125
1016797|NCT00595465|2467431|P1|COMPLETED|Overall Study||124
1016798|NCT00595465|2467429|P3|STARTED|Overall Study||128
1016799|NCT00595465|2467430|P2|STARTED|Overall Study||129
1016800|NCT00595465|2467431|P1|STARTED|Overall Study||130
1016801|NCT00595504|2467441|P2|NOT COMPLETED|Overall Study||3
1016802|NCT00595504|2467442|P1|NOT COMPLETED|Overall Study||2
1016803|NCT00595504|2467441|P2|COMPLETED|Overall Study||6
1016804|NCT00595504|2467442|P1|COMPLETED|Overall Study||14
1016805|NCT00595504|2467441|P2|STARTED|Overall Study||9
1016806|NCT00595504|2467442|P1|STARTED|Overall Study||16
1016807|NCT00595517|2467452|P1|NOT COMPLETED|Overall Study||19
1016808|NCT00595517|2467452|P1|COMPLETED|Overall Study||111
1016809|NCT00595517|2467452|P1|STARTED|Overall Study||130
1016810|NCT00595530|2467459|P1|NOT COMPLETED|Overall Study||0
1016811|NCT00595530|2467459|P1|COMPLETED|Overall Study||3
1016812|NCT00595530|2467459|P1|STARTED|Overall Study||3
1016813|NCT00595556|2467465|P2|NOT COMPLETED|Overall Study||1
1016814|NCT00595556|2467466|P1|NOT COMPLETED|Overall Study||3
1016815|NCT00595556|2467465|P2|COMPLETED|Overall Study||19
1016816|NCT00595556|2467466|P1|COMPLETED|Overall Study||17
1016817|NCT00595556|2467465|P2|STARTED|Overall Study||20
1016818|NCT00595556|2467466|P1|STARTED|Overall Study||20
1016819|NCT00595582|2467480|P1|NOT COMPLETED|Overall Study||10
1016820|NCT00595582|2467480|P1|COMPLETED|Overall Study||0
1016821|NCT00595582|2467480|P1|STARTED|Overall Study||10
1016822|NCT00595764|2467486|P2|NOT COMPLETED|Overall Study||43
1016823|NCT00595764|2467487|P1|NOT COMPLETED|Overall Study||39
1016824|NCT00595764|2467486|P2|COMPLETED|Overall Study||27
1016825|NCT00595764|2467487|P1|COMPLETED|Overall Study||32
1016826|NCT00595764|2467486|P2|STARTED|Overall Study||70
1016827|NCT00595764|2467487|P1|STARTED|Overall Study||71
1016828|NCT00595790|2467504|P3|NOT COMPLETED|Overall Study||3
1016829|NCT00595790|2467505|P2|NOT COMPLETED|Overall Study||1
1016830|NCT00595790|2467506|P1|NOT COMPLETED|Overall Study||2
1016831|NCT00595790|2467504|P3|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|122
1016832|NCT00595790|2467505|P2|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
1016833|NCT00595790|2467506|P1|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
1016834|NCT00595790|2467504|P3|STARTED|Overall Study|125 subjects randomized to this group, 124 subjects received 1x6 mcg.(Safety Population: N=124)|125
1016927|NCT00596635|2467695|P3|NOT COMPLETED|Overall Study||8
1016835|NCT00595790|2467505|P2|STARTED|Overall Study|124 subjects randomized to this group, 125 subjects received 1x12 mcg.(Safety Population: N=125)|124
1016836|NCT00595790|2467506|P1|STARTED|Overall Study||125
1016837|NCT00595868|2467516|P2|NOT COMPLETED|Overall Study||50
1016838|NCT00595868|2467517|P1|NOT COMPLETED|Overall Study||45
1016839|NCT00595868|2467516|P2|COMPLETED|Overall Study||61
1016840|NCT00595868|2467517|P1|COMPLETED|Overall Study||62
1016841|NCT00595868|2467516|P2|STARTED|Overall Study||111
1016842|NCT00595868|2467517|P1|STARTED|Overall Study||107
1016843|NCT00595881|2467525|P1|NOT COMPLETED|Overall Study||0
1016844|NCT00595881|2467525|P1|COMPLETED|Overall Study||420
1016845|NCT00595881|2467525|P1|STARTED|Overall Study||420
1016846|NCT00595920|2467530|P1|NOT COMPLETED|Overall Study||116
1016847|NCT00595920|2467530|P1|COMPLETED|Overall Study||0
1016848|NCT00595920|2467530|P1|Patients Dosed|Overall Study|116 patients enrolled; however, only 38 received at least 1 dose.|38
1016849|NCT00595920|2467530|P1|STARTED|Overall Study||116
1016850|NCT00595946|2467536|P2|NOT COMPLETED|Overall Study||69
1016851|NCT00595946|2467537|P1|NOT COMPLETED|Overall Study||64
1016852|NCT00595946|2467536|P2|COMPLETED|Overall Study||152
1016853|NCT00595946|2467537|P1|COMPLETED|Overall Study||154
1016854|NCT00595946|2467536|P2|STARTED|Overall Study||221
1016855|NCT00595946|2467537|P1|STARTED|Overall Study||218
1016856|NCT00595959|2467553|P1|NOT COMPLETED|Overall Study||2
1016857|NCT00595959|2467553|P1|COMPLETED|Overall Study||63
1016858|NCT00595959|2467553|P1|STARTED|Overall Study||65
1016865|NCT00596102|2467590|P3|NOT COMPLETED|Up to Month 60||637
1016866|NCT00596102|2467591|P2|NOT COMPLETED|Up to Month 60||338
1016867|NCT00596102|2467592|P1|NOT COMPLETED|Up to Month 60||2181
1016868|NCT00596102|2467590|P3|COMPLETED|Up to Month 60||0
1016869|NCT00596102|2467591|P2|COMPLETED|Up to Month 60||0
1016870|NCT00596102|2467592|P1|COMPLETED|Up to Month 60|"long-term safety follow-up beyond Month 6 for a sub-set of subjects in IC51 group only"|102
1016871|NCT00596102|2467590|P3|STARTED|Up to Month 60||637
1016872|NCT00596102|2467591|P2|STARTED|Up to Month 60||338
1016873|NCT00596102|2467592|P1|STARTED|Up to Month 60||2283
1016874|NCT00596102|2467590|P3|NOT COMPLETED|Up to Month 6||0
1016875|NCT00596102|2467591|P2|NOT COMPLETED|Up to Month 6||0
1016876|NCT00596102|2467592|P1|NOT COMPLETED|Up to Month 6||0
1016877|NCT00596102|2467590|P3|COMPLETED|Up to Month 6||637
1016878|NCT00596102|2467591|P2|COMPLETED|Up to Month 6||338
1016879|NCT00596102|2467592|P1|COMPLETED|Up to Month 6||2283
1016880|NCT00596102|2467590|P3|STARTED|Up to Month 6||637
1016881|NCT00596102|2467591|P2|STARTED|Up to Month 6||338
1016882|NCT00596102|2467592|P1|STARTED|Up to Month 6||2283
1016883|NCT00596167|2467599|P1|NOT COMPLETED|Overall Study||0
1016884|NCT00596167|2467599|P1|COMPLETED|Overall Study||6
1016885|NCT00596167|2467599|P1|STARTED|Overall Study|All recruited subjects completed the study.|6
1016886|NCT00596271|2467606|P3|NOT COMPLETED|Overall Study||1
1016887|NCT00596271|2467607|P2|NOT COMPLETED|Overall Study||6
1016888|NCT00596271|2467608|P1|NOT COMPLETED|Overall Study||5
1016889|NCT00596271|2467606|P3|COMPLETED|Overall Study||61
1016890|NCT00596271|2467607|P2|COMPLETED|Overall Study||59
1016891|NCT00596271|2467608|P1|COMPLETED|Overall Study||60
1016892|NCT00596271|2467606|P3|STARTED|Overall Study||62
1016893|NCT00596271|2467607|P2|STARTED|Overall Study||65
1016894|NCT00596271|2467608|P1|STARTED|Overall Study||65
1016895|NCT00596362|2467617|P1|NOT COMPLETED|Overall Study||1
1016896|NCT00596362|2467617|P1|COMPLETED|Overall Study||0
1016897|NCT00596362|2467617|P1|STARTED|Overall Study||1
1016898|NCT00596427|2467623|P2|NOT COMPLETED|Overall Study||2
1016899|NCT00596427|2467624|P1|NOT COMPLETED|Overall Study||4
1016900|NCT00596427|2467623|P2|COMPLETED|Overall Study||28
1016901|NCT00596427|2467624|P1|COMPLETED|Overall Study||26
1016902|NCT00596427|2467623|P2|STARTED|Overall Study||30
1016903|NCT00596427|2467624|P1|STARTED|Overall Study||30
1016904|NCT00596440|2467654|P2|NOT COMPLETED|Overall Study||80
1016905|NCT00596440|2467655|P1|NOT COMPLETED|Overall Study||65
1016906|NCT00596440|2467654|P2|COMPLETED|Overall Study||41
1016907|NCT00596440|2467655|P1|COMPLETED|Overall Study||48
1016908|NCT00596440|2467654|P2|Showed to First Treatment Session|Overall Study||52
1016909|NCT00596440|2467655|P1|Showed to First Treatment Session|Overall Study||61
1016910|NCT00596440|2467654|P2|Showed to Eligibility Visit|Overall Study||72
1016911|NCT00596440|2467655|P1|Showed to Eligibility Visit|Overall Study||85
1016912|NCT00596440|2467654|P2|STARTED|Overall Study||121
1016913|NCT00596440|2467655|P1|STARTED|Overall Study||113
1016914|NCT00596453|2467667|P2|NOT COMPLETED|Overall Study||3
1016915|NCT00596453|2467668|P1|NOT COMPLETED|Overall Study||1
1016916|NCT00596453|2467667|P2|COMPLETED|Overall Study||12
1016917|NCT00596453|2467668|P1|COMPLETED|Overall Study||12
1016918|NCT00596453|2467667|P2|STARTED|Overall Study||15
1016919|NCT00596453|2467668|P1|STARTED|Overall Study||13
1016920|NCT00596466|2467674|P1|NOT COMPLETED|Overall Study||17
1016921|NCT00596466|2467674|P1|COMPLETED|Overall Study||58
1016922|NCT00596466|2467674|P1|Enrolled, Treated|Overall Study||73
1016923|NCT00596466|2467674|P1|STARTED|Overall Study||75
1016924|NCT00596622|2467683|P1|NOT COMPLETED|Overall Study||13
1016925|NCT00596622|2467683|P1|COMPLETED|Overall Study||33
1016926|NCT00596622|2467683|P1|STARTED|Overall Study||46
1016928|NCT00596635|2467696|P2|NOT COMPLETED|Overall Study||13
1016929|NCT00596635|2467697|P1|NOT COMPLETED|Overall Study||7
1016930|NCT00596635|2467695|P3|COMPLETED|Overall Study||11
1016931|NCT00596635|2467696|P2|COMPLETED|Overall Study||7
1016932|NCT00596635|2467697|P1|COMPLETED|Overall Study||10
1016933|NCT00596635|2467695|P3|STARTED|Overall Study||19
1016934|NCT00596635|2467696|P2|STARTED|Overall Study||20
1016935|NCT00596635|2467697|P1|STARTED|Overall Study||17
1016936|NCT00596687|2467713|P2|NOT COMPLETED|Overall Study||9
1016937|NCT00596687|2467714|P1|NOT COMPLETED|Overall Study||14
1016938|NCT00596687|2467713|P2|COMPLETED|Overall Study||107
1016939|NCT00596687|2467714|P1|COMPLETED|Overall Study||104
1016940|NCT00596687|2467713|P2|STARTED|Overall Study||116
1016941|NCT00596687|2467714|P1|STARTED|Overall Study||118
1016942|NCT00596752|2467724|P2|NOT COMPLETED|Overall Study||143
1016943|NCT00596752|2467725|P1|NOT COMPLETED|Overall Study||126
1016944|NCT00596752|2467724|P2|COMPLETED|Overall Study||282
1016945|NCT00596752|2467725|P1|COMPLETED|Overall Study||289
1016946|NCT00596752|2467724|P2|Randomized and Treated|Overall Study||424
1016947|NCT00596752|2467725|P1|Randomized and Treated|Overall Study||415
1016948|NCT00596752|2467724|P2|STARTED|Overall Study||425
1016949|NCT00596752|2467725|P1|STARTED|Overall Study||415
1016950|NCT00596817|2467756|P2|NOT COMPLETED|Double-blind Period||79
1016951|NCT00596817|2467757|P1|NOT COMPLETED|Double-blind Period||88
1016952|NCT00596817|2467756|P2|COMPLETED|Double-blind Period||125
1016953|NCT00596817|2467757|P1|COMPLETED|Double-blind Period||104
1016954|NCT00596817|2467756|P2|STARTED|Double-blind Period|206 patients were randomised. 2 did not receive study medication. 204 is FAS.|204
1016955|NCT00596817|2467757|P1|STARTED|Double-blind Period|194 patients were randomised. 2 did not receive study medication. 192 is full-analysis set (FAS).|192
1016956|NCT00596817|2467756|P2|NOT COMPLETED|Open-label Period to Double-blind Period||92
1016957|NCT00596817|2467757|P1|NOT COMPLETED|Open-label Period to Double-blind Period||0
1016958|NCT00596817|2467756|P2|COMPLETED|Open-label Period to Double-blind Period||400
1016959|NCT00596817|2467757|P1|COMPLETED|Open-label Period to Double-blind Period||0
1016960|NCT00596817|2467756|P2|STARTED|Open-label Period to Double-blind Period||492
1016961|NCT00596817|2467757|P1|STARTED|Open-label Period to Double-blind Period||0
1016962|NCT00596817|2467756|P2|NOT COMPLETED|Open-label Period||147
1016963|NCT00596817|2467757|P1|NOT COMPLETED|Open-label Period||0
1016964|NCT00596817|2467756|P2|COMPLETED|Open-label Period||492
1016965|NCT00596817|2467757|P1|COMPLETED|Open-label Period||0
1016966|NCT00596817|2467756|P2|STARTED|Open-label Period||639
1016967|NCT00596817|2467757|P1|STARTED|Open-label Period||0
1016968|NCT00596830|2467782|P2|NOT COMPLETED|Overall Study||339
1016969|NCT00596830|2467783|P1|NOT COMPLETED|Overall Study||342
1016970|NCT00596830|2467782|P2|COMPLETED|Overall Study||0
1016971|NCT00596830|2467783|P1|COMPLETED|Overall Study||0
1016972|NCT00596830|2467782|P2|Treated|Overall Study||332
1016973|NCT00596830|2467783|P1|Treated|Overall Study|1 participant in this group only received chemo and did not complete due to death.|339
1016974|NCT00596830|2467782|P2|STARTED|Overall Study||339
1016975|NCT00596830|2467783|P1|STARTED|Overall Study|1 participant in this group only received paclitaxel and carboplatin (chemo).|342
1016976|NCT00596934|2467806|P1|NOT COMPLETED|Overall Study||2
1016977|NCT00596934|2467806|P1|COMPLETED|Overall Study||7
1016978|NCT00596934|2467806|P1|STARTED|Overall Study||9
1016979|NCT00596947|2467819|P2|NOT COMPLETED|Overall Study||3
1016980|NCT00596947|2467820|P1|NOT COMPLETED|Overall Study||6
1016981|NCT00596947|2467819|P2|COMPLETED|Overall Study||6
1016982|NCT00596947|2467820|P1|COMPLETED|Overall Study||3
1016983|NCT00596947|2467819|P2|STARTED|Overall Study||9
1016984|NCT00596947|2467820|P1|STARTED|Overall Study||9
1016985|NCT00596960|2467862|P2|NOT COMPLETED|Overall Study||9
1016986|NCT00596960|2467863|P1|NOT COMPLETED|Overall Study||11
1016987|NCT00596960|2467862|P2|COMPLETED|Overall Study||60
1016988|NCT00596960|2467863|P1|COMPLETED|Overall Study||59
1016989|NCT00596960|2467862|P2|STARTED|Overall Study|One subject did not have any alcohol use data and thus was excluded from the statistical analysis|69
1016990|NCT00596960|2467863|P1|STARTED|Overall Study||70
1016991|NCT00597012|2467875|P2|NOT COMPLETED|Overall Study||8
1016992|NCT00597012|2467876|P1|NOT COMPLETED|Overall Study||13
1016993|NCT00597012|2467875|P2|COMPLETED|Overall Study||169
1016994|NCT00597012|2467876|P1|COMPLETED|Overall Study||161
1016995|NCT00597012|2467875|P2|STARTED|Overall Study||177
1016996|NCT00597012|2467876|P1|STARTED|Overall Study||174
1016997|NCT00597038|2467888|P2|NOT COMPLETED|Overall Study||4
1016998|NCT00597038|2467889|P1|NOT COMPLETED|Overall Study||2
1016999|NCT00597038|2467888|P2|COMPLETED|Overall Study|Two patients withdrew, one did not complete due to progressive disease, one patient died.|30
1017000|NCT00597038|2467889|P1|COMPLETED|Overall Study|One did not complete due to PI decision, one did not complete due to progressive disease.|14
1017001|NCT00597038|2467888|P2|STARTED|Overall Study||34
1017002|NCT00597038|2467889|P1|STARTED|Overall Study||16
1017003|NCT00597116|2467900|P2|NOT COMPLETED|Overall Study||11
1017004|NCT00597116|2467901|P1|NOT COMPLETED|Overall Study||14
1017005|NCT00597116|2467900|P2|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
1017006|NCT00597116|2467901|P1|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
1017007|NCT00597116|2467900|P2|STARTED|Overall Study||11
1017008|NCT00597116|2467901|P1|STARTED|Overall Study||14
1017009|NCT00597207|2467915|P2|NOT COMPLETED|Overall Study||7
1017010|NCT00597207|2467916|P1|NOT COMPLETED|Overall Study||5
1017011|NCT00597207|2467915|P2|COMPLETED|Overall Study||2125
1017012|NCT00597207|2467916|P1|COMPLETED|Overall Study||2094
1017013|NCT00597207|2467915|P2|STARTED|Overall Study||2132
1017014|NCT00597207|2467916|P1|STARTED|Overall Study||2099
1017015|NCT00597272|2467929|P7|NOT COMPLETED|Overall Study||0
1017016|NCT00597272|2467930|P6|NOT COMPLETED|Overall Study||0
1017017|NCT00597272|2467931|P5|NOT COMPLETED|Overall Study||0
1017018|NCT00597272|2467932|P4|NOT COMPLETED|Overall Study||0
1017019|NCT00597272|2467933|P3|NOT COMPLETED|Overall Study||0
1017020|NCT00597272|2467934|P2|NOT COMPLETED|Overall Study||0
1017021|NCT00597272|2467935|P1|NOT COMPLETED|Overall Study||0
1017022|NCT00597272|2467929|P7|COMPLETED|Overall Study||10
1017023|NCT00597272|2467930|P6|COMPLETED|Overall Study||10
1017024|NCT00597272|2467931|P5|COMPLETED|Overall Study||1
1017025|NCT00597272|2467932|P4|COMPLETED|Overall Study||1
1017026|NCT00597272|2467933|P3|COMPLETED|Overall Study||10
1017027|NCT00597272|2467934|P2|COMPLETED|Overall Study||1
1017028|NCT00597272|2467935|P1|COMPLETED|Overall Study||1
1017029|NCT00597272|2467929|P7|STARTED|Overall Study||10
1017030|NCT00597272|2467930|P6|STARTED|Overall Study||10
1017031|NCT00597272|2467931|P5|STARTED|Overall Study||1
1017032|NCT00597272|2467932|P4|STARTED|Overall Study||1
1017033|NCT00597272|2467933|P3|STARTED|Overall Study||10
1017034|NCT00597272|2467934|P2|STARTED|Overall Study||1
1017035|NCT00597272|2467935|P1|STARTED|Overall Study||1
1017036|NCT00597376|2467953|P2|NOT COMPLETED|Overall Study||4
1017037|NCT00597376|2467954|P1|NOT COMPLETED|Overall Study||8
1017038|NCT00597376|2467953|P2|COMPLETED|Overall Study|All participants started (53) were included in primary analyses.|49
1017039|NCT00597376|2467954|P1|COMPLETED|Overall Study|All participants started (51) were included in primary analyses.|43
1017040|NCT00597376|2467953|P2|STARTED|Overall Study||53
1017041|NCT00597376|2467954|P1|STARTED|Overall Study||51
1017042|NCT00597402|2467964|P1|NOT COMPLETED|Overall Study||0
1017043|NCT00597402|2467964|P1|COMPLETED|Overall Study||125
1017044|NCT00597402|2467964|P1|STARTED|Overall Study||125
1017045|NCT00597428|2467973|P2|NOT COMPLETED|Overall Study||71
1017046|NCT00597428|2467974|P1|NOT COMPLETED|Overall Study||61
1017047|NCT00597428|2467973|P2|COMPLETED|Overall Study||152
1017048|NCT00597428|2467974|P1|COMPLETED|Overall Study||153
1017049|NCT00597428|2467973|P2|STARTED|Overall Study||223
1017050|NCT00597428|2467974|P1|STARTED|Overall Study||214
1017051|NCT00597493|2467990|P1|NOT COMPLETED|Overall Study||0
1017052|NCT00597493|2467990|P1|COMPLETED|Overall Study||32
1017053|NCT00597493|2467990|P1|STARTED|Overall Study||32
1017054|NCT00597506|2468007|P1|NOT COMPLETED|Overall Study||1
1017055|NCT00597506|2468007|P1|COMPLETED|Overall Study||49
1017056|NCT00597506|2468007|P1|STARTED|Overall Study||50
1017057|NCT00603408|2468012|P1|NOT COMPLETED|Overall Study||0
1017058|NCT00603408|2468012|P1|COMPLETED|Overall Study||5
1017059|NCT00603408|2468012|P1|STARTED|Overall Study||5
1017060|NCT00603447|2468030|P7|NOT COMPLETED|Overall Study||24
1017061|NCT00603447|2468031|P6|NOT COMPLETED|Overall Study||2
1017062|NCT00603447|2468032|P5|NOT COMPLETED|Overall Study||5
1017063|NCT00603447|2468033|P4|NOT COMPLETED|Overall Study||2
1017064|NCT00603447|2468034|P3|NOT COMPLETED|Overall Study||2
1017065|NCT00603447|2468035|P2|NOT COMPLETED|Overall Study||3
1017066|NCT00603447|2468036|P1|NOT COMPLETED|Overall Study||0
1017067|NCT00603447|2468030|P7|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|20
1017068|NCT00603447|2468031|P6|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
1017069|NCT00603447|2468032|P5|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|1
1017070|NCT00603447|2468033|P4|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|4
1017071|NCT00603447|2468034|P3|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
1017072|NCT00603447|2468035|P2|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|3
1017073|NCT00603447|2468036|P1|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
1017074|NCT00603447|2468030|P7|STARTED|Overall Study||44
1017075|NCT00603447|2468031|P6|STARTED|Overall Study||8
1017076|NCT00603447|2468032|P5|STARTED|Overall Study||6
1017077|NCT00603447|2468033|P4|STARTED|Overall Study||6
1017078|NCT00603447|2468034|P3|STARTED|Overall Study||8
1017079|NCT00603447|2468035|P2|STARTED|Overall Study||6
1017080|NCT00603447|2468036|P1|STARTED|Overall Study||6
1017081|NCT00603473|2468058|P1|NOT COMPLETED|Overall Study||9
1017082|NCT00603473|2468058|P1|COMPLETED|Overall Study||80
1017083|NCT00603473|2468058|P1|STARTED|Overall Study||89
1017084|NCT00603512|2468069|P5|NOT COMPLETED|Overall Study||5
1017085|NCT00603512|2468070|P4|NOT COMPLETED|Overall Study||7
1017086|NCT00603512|2468071|P3|NOT COMPLETED|Overall Study||5
1017087|NCT00603512|2468072|P2|NOT COMPLETED|Overall Study||5
1017088|NCT00603512|2468073|P1|NOT COMPLETED|Overall Study||2
1017089|NCT00603512|2468069|P5|COMPLETED|Overall Study||23
1017090|NCT00603512|2468070|P4|COMPLETED|Overall Study||21
1017091|NCT00603512|2468071|P3|COMPLETED|Overall Study||23
1017092|NCT00603512|2468072|P2|COMPLETED|Overall Study||23
1017093|NCT00603512|2468073|P1|COMPLETED|Overall Study||26
1017094|NCT00603512|2468069|P5|Treated|Overall Study||28
1017095|NCT00603512|2468070|P4|Treated|Overall Study||26
1017096|NCT00603512|2468071|P3|Treated|Overall Study||27
1017097|NCT00603512|2468072|P2|Treated|Overall Study||27
1017098|NCT00603512|2468073|P1|Treated|Overall Study||28
1017099|NCT00603512|2468069|P5|STARTED|Overall Study||28
1017100|NCT00603512|2468070|P4|STARTED|Overall Study||28
1017101|NCT00603512|2468071|P3|STARTED|Overall Study||28
1017102|NCT00603512|2468072|P2|STARTED|Overall Study||28
1017103|NCT00603512|2468073|P1|STARTED|Overall Study||28
1017104|NCT00603525|2468217|P3|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||111
1017105|NCT00603525|2468218|P2|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
1017106|NCT00603525|2468219|P1|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
1017107|NCT00603525|2468217|P3|COMPLETED|Follow-up Period (Approximately 2 Years)||13
1017108|NCT00603525|2468218|P2|COMPLETED|Follow-up Period (Approximately 2 Years)||0
1017109|NCT00603525|2468219|P1|COMPLETED|Follow-up Period (Approximately 2 Years)||0
1017110|NCT00603525|2468217|P3|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)|As par. were not on active drug during the Follow-up Period, withdrawal reasons were not collected.|111
1017111|NCT00603525|2468218|P2|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
1017112|NCT00603525|2468219|P1|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
1017113|NCT00603525|2468217|P3|STARTED|Follow-up Period (Approximately 2 Years)|124 participants (par) completing/withdrawing from the DB or OL Periods attended >=1 follow-up visit|124
1017114|NCT00603525|2468218|P2|STARTED|Follow-up Period (Approximately 2 Years)||0
1017115|NCT00603525|2468219|P1|STARTED|Follow-up Period (Approximately 2 Years)||0
1017116|NCT00603525|2468217|P3|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
1017117|NCT00603525|2468218|P2|NOT COMPLETED|OL Treatment Period (120 Weeks)||112
1017118|NCT00603525|2468219|P1|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
1017119|NCT00603525|2468217|P3|COMPLETED|OL Treatment Period (120 Weeks)||0
1017120|NCT00603525|2468218|P2|COMPLETED|OL Treatment Period (120 Weeks)||13
1017121|NCT00603525|2468219|P1|COMPLETED|OL Treatment Period (120 Weeks)||0
1017122|NCT00603525|2468217|P3|STARTED|OL Treatment Period (120 Weeks)||0
1017123|NCT00603525|2468218|P2|STARTED|OL Treatment Period (120 Weeks)|61 participants received OFA during the DB Period; 64 received placebo during the DB Period.|125
1017124|NCT00603525|2468219|P1|STARTED|OL Treatment Period (120 Weeks)||0
1017125|NCT00603525|2468217|P3|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
1017126|NCT00603525|2468218|P2|NOT COMPLETED|DB Treatment Period (24 Weeks)||22
1017127|NCT00603525|2468219|P1|NOT COMPLETED|DB Treatment Period (24 Weeks)||17
1017128|NCT00603525|2468217|P3|COMPLETED|DB Treatment Period (24 Weeks)||0
1017129|NCT00603525|2468218|P2|COMPLETED|DB Treatment Period (24 Weeks)||63
1017130|NCT00603525|2468219|P1|COMPLETED|DB Treatment Period (24 Weeks)||67
1017131|NCT00603525|2468217|P3|STARTED|DB Treatment Period (24 Weeks)||0
1017132|NCT00603525|2468218|P2|STARTED|DB Treatment Period (24 Weeks)||85
1017133|NCT00603525|2468219|P1|STARTED|DB Treatment Period (24 Weeks)||84
1017134|NCT00603538|2468349|P3|NOT COMPLETED|Overall Study||2
1017135|NCT00603538|2468350|P2|NOT COMPLETED|Overall Study||4
1017136|NCT00603538|2468351|P1|NOT COMPLETED|Overall Study||3
1017137|NCT00603538|2468349|P3|COMPLETED|Overall Study||4
1017138|NCT00603538|2468350|P2|COMPLETED|Overall Study||3
1017139|NCT00603538|2468351|P1|COMPLETED|Overall Study||3
1017140|NCT00603538|2468349|P3|STARTED|Overall Study||6
1017141|NCT00603538|2468350|P2|STARTED|Overall Study|Including one participant who discontinued from the study prior to CP-751,871 administration.|7
1017142|NCT00603538|2468351|P1|STARTED|Overall Study||6
1017143|NCT00603564|2468391|P2|NOT COMPLETED|Overall Study||0
1017144|NCT00603564|2468392|P1|NOT COMPLETED|Overall Study||0
1017145|NCT00603564|2468391|P2|COMPLETED|Overall Study|February 2008|27
1017146|NCT00603564|2468392|P1|COMPLETED|Overall Study|February 2008|20
1017147|NCT00603564|2468391|P2|STARTED|Overall Study|January 2006|27
1017148|NCT00603564|2468392|P1|STARTED|Overall Study|January 2006|20
1017149|NCT00603590|2468402|P2|NOT COMPLETED|Overall Study||51
1017150|NCT00603590|2468403|P1|NOT COMPLETED|Overall Study||76
1017151|NCT00603590|2468402|P2|COMPLETED|Overall Study||183
1017152|NCT00603590|2468403|P1|COMPLETED|Overall Study||165
1017153|NCT00603590|2468402|P2|Eight Months|Overall Study||194
1017154|NCT00603590|2468403|P1|Eight Months|Overall Study||178
1017155|NCT00603590|2468402|P2|Four Months|Overall Study||200
1017156|NCT00603590|2468403|P1|Four Months|Overall Study||187
1017157|NCT00603590|2468402|P2|One Month|Overall Study||212
1017158|NCT00603590|2468403|P1|One Month|Overall Study||204
1017159|NCT00603590|2468402|P2|STARTED|Overall Study||234
1017160|NCT00603590|2468403|P1|STARTED|Overall Study||241
1017161|NCT00603642|2468415|P2|NOT COMPLETED|Overall Study||0
1017162|NCT00603642|2468416|P1|NOT COMPLETED|Overall Study||0
1017163|NCT00603642|2468415|P2|COMPLETED|Overall Study||22
1017164|NCT00603642|2468416|P1|COMPLETED|Overall Study||12
1017165|NCT00603642|2468415|P2|STARTED|Overall Study||22
1017166|NCT00603642|2468416|P1|STARTED|Overall Study||12
1017167|NCT00603993|2468430|P1|NOT COMPLETED|Overall Study||20
1017168|NCT00603993|2468430|P1|COMPLETED|Overall Study||68
1017169|NCT00603993|2468430|P1|STARTED|Overall Study||88
1017170|NCT00604019|2468445|P2|NOT COMPLETED|Overall Study||0
1017171|NCT00604019|2468446|P1|NOT COMPLETED|Overall Study||0
1017172|NCT00604019|2468445|P2|COMPLETED|Overall Study||118
1017173|NCT00604019|2468446|P1|COMPLETED|Overall Study||134
1017174|NCT00604019|2468445|P2|STARTED|Overall Study||118
1017175|NCT00604019|2468446|P1|STARTED|Overall Study||134
1017176|NCT00604045|2468454|P2|NOT COMPLETED|Overall Study||1
1017177|NCT00604045|2468455|P1|NOT COMPLETED|Overall Study||1
1017178|NCT00604045|2468454|P2|COMPLETED|Overall Study||9
1017179|NCT00604045|2468455|P1|COMPLETED|Overall Study||14
1017180|NCT00604045|2468454|P2|STARTED|Overall Study||10
1017181|NCT00604045|2468455|P1|STARTED|Overall Study||15
1017182|NCT00604162|2468461|P1|NOT COMPLETED|Overall Study||4
1017183|NCT00604162|2468461|P1|COMPLETED|Overall Study||328
1017184|NCT00604162|2468461|P1|STARTED|Overall Study||332
1017203|NCT00604188|2468532|P2|NOT COMPLETED|Overall Study||25
1017204|NCT00604188|2468533|P1|NOT COMPLETED|Overall Study||27
1017205|NCT00604188|2468532|P2|COMPLETED|Overall Study||70
1017206|NCT00604188|2468533|P1|COMPLETED|Overall Study||66
1017207|NCT00604188|2468532|P2|STARTED|Overall Study|The ITT population for Subutex-to-Suboxone Induction is 94 participants|95
1017208|NCT00604188|2468533|P1|STARTED|Overall Study||93
1017209|NCT00604214|2468555|P2|NOT COMPLETED|Day 91 to Day 180||32
1017210|NCT00604214|2468556|P1|NOT COMPLETED|Day 91 to Day 180||26
1017211|NCT00604214|2468555|P2|COMPLETED|Day 91 to Day 180||521
1017212|NCT00604214|2468556|P1|COMPLETED|Day 91 to Day 180||529
1017213|NCT00604214|2468555|P2|STARTED|Day 91 to Day 180||553
1017214|NCT00604214|2468556|P1|STARTED|Day 91 to Day 180||555
1017215|NCT00604214|2468555|P2|NOT COMPLETED|Day 29 to Day 90||79
1017216|NCT00604214|2468556|P1|NOT COMPLETED|Day 29 to Day 90||68
1017217|NCT00604214|2468555|P2|COMPLETED|Day 29 to Day 90||553
1017218|NCT00604214|2468556|P1|COMPLETED|Day 29 to Day 90||555
1017219|NCT00604214|2468555|P2|STARTED|Day 29 to Day 90||632
1017220|NCT00604214|2468556|P1|STARTED|Day 29 to Day 90||623
1017221|NCT00604214|2468555|P2|NOT COMPLETED|Baseline to Day 28||213
1017222|NCT00604214|2468556|P1|NOT COMPLETED|Baseline to Day 28||228
1017223|NCT00604214|2468555|P2|COMPLETED|Baseline to Day 28||632
1017224|NCT00604214|2468556|P1|COMPLETED|Baseline to Day 28||623
1017225|NCT00604214|2468555|P2|Received Study Drug|Baseline to Day 28||833
1017226|NCT00604214|2468556|P1|Received Study Drug|Baseline to Day 28||833
1017227|NCT00604214|2468555|P2|STARTED|Baseline to Day 28||845
1017228|NCT00604214|2468556|P1|STARTED|Baseline to Day 28||851
1017229|NCT00604279|2468588|P2|NOT COMPLETED|Overall Study||38
1017230|NCT00604279|2468589|P1|NOT COMPLETED|Overall Study||64
1017231|NCT00604279|2468588|P2|COMPLETED|Overall Study||185
1017232|NCT00604279|2468589|P1|COMPLETED|Overall Study||165
1017233|NCT00604279|2468588|P2|STARTED|Overall Study||223
1017234|NCT00604279|2468589|P1|STARTED|Overall Study||229
1017235|NCT00604383|2468605|P2|NOT COMPLETED|Overall Study||84
1017236|NCT00604383|2468606|P1|NOT COMPLETED|Overall Study||87
1017237|NCT00604383|2468605|P2|COMPLETED|Overall Study||256
1017238|NCT00604383|2468606|P1|COMPLETED|Overall Study||258
1017239|NCT00604383|2468605|P2|Received Extended Treatment|Overall Study||141
1017240|NCT00604383|2468606|P1|Received Extended Treatment|Overall Study||136
1017241|NCT00604383|2468605|P2|Received at Least 1 Dose of Study Drug|Overall Study||340
1017242|NCT00604383|2468606|P1|Received at Least 1 Dose of Study Drug|Overall Study||345
1017243|NCT00604383|2468605|P2|STARTED|Overall Study||340
1017244|NCT00604383|2468606|P1|STARTED|Overall Study||345
1017245|NCT00604461|2468620|P1|NOT COMPLETED|Overall Study||1
1017246|NCT00604461|2468620|P1|COMPLETED|Overall Study|Death within 30 days of treatment occurred in 1 patient.|12
1017247|NCT00604461|2468620|P1|STARTED|Overall Study||13
1017248|NCT00604500|2468625|P1|NOT COMPLETED|Overall Study||11
1017249|NCT00604500|2468625|P1|COMPLETED|Overall Study|There were 233 participants who took at least 90% of the labeled actuations (Completer Population).|261
1017250|NCT00604500|2468625|P1|STARTED|Overall Study||272
1017251|NCT00604552|2468634|P2|NOT COMPLETED|Overall Study||0
1017252|NCT00604552|2468635|P1|NOT COMPLETED|Overall Study||0
1017253|NCT00604552|2468634|P2|COMPLETED|Overall Study||160
1017254|NCT00604552|2468635|P1|COMPLETED|Overall Study||189
1017255|NCT00604552|2468634|P2|STARTED|Overall Study||160
1017256|NCT00604552|2468635|P1|STARTED|Overall Study||189
1017257|NCT00604565|2468643|P2|NOT COMPLETED|Overall Study||3
1017258|NCT00604565|2468644|P1|NOT COMPLETED|Overall Study||0
1017259|NCT00604565|2468643|P2|COMPLETED|Overall Study||4
1017260|NCT00604565|2468644|P1|COMPLETED|Overall Study||4
1017261|NCT00604565|2468643|P2|STARTED|Overall Study||7
1017262|NCT00604565|2468644|P1|STARTED|Overall Study||4
1017263|NCT00604669|2468652|P1|NOT COMPLETED|Overall Study||7
1017264|NCT00604669|2468652|P1|COMPLETED|Overall Study||163
1017265|NCT00604669|2468652|P1|STARTED|Overall Study||170
1017266|NCT00604695|2468658|P2|NOT COMPLETED|Overall Study||4
1017267|NCT00604695|2468659|P1|NOT COMPLETED|Overall Study||0
1017268|NCT00604695|2468658|P2|COMPLETED|Overall Study||16
1017269|NCT00604695|2468659|P1|COMPLETED|Overall Study||20
1017270|NCT00604695|2468658|P2|STARTED|Overall Study||20
1017271|NCT00604695|2468659|P1|STARTED|Overall Study||20
1017272|NCT00604708|2468683|P2|NOT COMPLETED|Overall Study||40
1017273|NCT00604708|2468684|P1|NOT COMPLETED|Overall Study||31
1017274|NCT00604708|2468683|P2|COMPLETED|Overall Study||397
1017275|NCT00604708|2468684|P1|COMPLETED|Overall Study||399
1017276|NCT00604708|2468683|P2|STARTED|Overall Study||437
1017277|NCT00604708|2468684|P1|STARTED|Overall Study||430
1017278|NCT00604721|2468692|P1|NOT COMPLETED|Overall Study||2
1017279|NCT00604721|2468692|P1|COMPLETED|Overall Study|2 patients failed to complete a full cycle of therapy.|17
1017280|NCT00604721|2468692|P1|STARTED|Overall Study||19
1017281|NCT00604786|2468700|P2|NOT COMPLETED|Overall Study||0
1017282|NCT00604786|2468701|P1|NOT COMPLETED|Overall Study||2
1017283|NCT00604786|2468700|P2|COMPLETED|Overall Study||4
1017284|NCT00604786|2468701|P1|COMPLETED|Overall Study||12
1017285|NCT00604786|2468700|P2|STARTED|Overall Study||4
1017286|NCT00604786|2468701|P1|STARTED|Overall Study||14
1017287|NCT00604812|2468710|P6|NOT COMPLETED|Overall Study||0
1017288|NCT00604812|2468711|P5|NOT COMPLETED|Overall Study||0
1017289|NCT00604812|2468712|P4|NOT COMPLETED|Overall Study||0
1017290|NCT00604812|2468713|P3|NOT COMPLETED|Overall Study||0
1017291|NCT00604812|2468714|P2|NOT COMPLETED|Overall Study||0
1017292|NCT00604812|2468715|P1|NOT COMPLETED|Overall Study||0
1017293|NCT00604812|2468710|P6|COMPLETED|Overall Study||1
1017294|NCT00604812|2468711|P5|COMPLETED|Overall Study||5
1017295|NCT00604812|2468712|P4|COMPLETED|Overall Study||3
1017296|NCT00604812|2468713|P3|COMPLETED|Overall Study||10
1017297|NCT00604812|2468714|P2|COMPLETED|Overall Study||3
1017298|NCT00604812|2468715|P1|COMPLETED|Overall Study||9
1017299|NCT00604812|2468710|P6|STARTED|Overall Study||1
1017300|NCT00604812|2468711|P5|STARTED|Overall Study||5
1017301|NCT00604812|2468712|P4|STARTED|Overall Study||3
1017302|NCT00604812|2468713|P3|STARTED|Overall Study||10
1017303|NCT00604812|2468714|P2|STARTED|Overall Study||3
1017304|NCT00604812|2468715|P1|STARTED|Overall Study||9
1017305|NCT00604825|2468739|P4|NOT COMPLETED|Overall Study||11
1017306|NCT00604825|2468740|P3|NOT COMPLETED|Overall Study||16
1017307|NCT00604825|2468741|P2|NOT COMPLETED|Overall Study||15
1017308|NCT00604825|2468742|P1|NOT COMPLETED|Overall Study||9
1017309|NCT00604825|2468739|P4|COMPLETED|Overall Study||79
1017310|NCT00604825|2468740|P3|COMPLETED|Overall Study||73
1017311|NCT00604825|2468741|P2|COMPLETED|Overall Study||72
1017312|NCT00604825|2468742|P1|COMPLETED|Overall Study||81
1017313|NCT00604825|2468739|P4|STARTED|Overall Study||90
1017314|NCT00604825|2468740|P3|STARTED|Overall Study||89
1017315|NCT00604825|2468741|P2|STARTED|Overall Study||87
1017316|NCT00604825|2468742|P1|STARTED|Overall Study||90
1017317|NCT00604851|2468942|P2|NOT COMPLETED|Overall Study||26
1017318|NCT00604851|2468943|P1|NOT COMPLETED|Overall Study||17
1017319|NCT00604851|2468942|P2|COMPLETED|Overall Study||131
1017320|NCT00604851|2468943|P1|COMPLETED|Overall Study||132
1017321|NCT00604851|2468942|P2|STARTED|Overall Study||157
1017322|NCT00604851|2468943|P1|STARTED|Overall Study||149
1017323|NCT00604968|2468949|P1|NOT COMPLETED|Overall Study||0
1017324|NCT00604968|2468949|P1|COMPLETED|Overall Study|Due to the nature of study, all subjects receiving drug were considered to have completed.|25
1017325|NCT00604968|2468949|P1|STARTED|Overall Study||25
1017326|NCT00605033|2468964|P2|NOT COMPLETED|Overall Study||8
1017327|NCT00605033|2468965|P1|NOT COMPLETED|Overall Study||7
1017328|NCT00605033|2468964|P2|COMPLETED|Overall Study||90
1017329|NCT00605033|2468965|P1|COMPLETED|Overall Study||136
1017330|NCT00605033|2468964|P2|STARTED|Overall Study|One participant was randomized but withdrew before taking any study medication (treated n=97).|98
1017331|NCT00605033|2468965|P1|STARTED|Overall Study||143
1017332|NCT00605072|2468974|P3|NOT COMPLETED|Overall Study||4
1017333|NCT00605072|2468975|P2|NOT COMPLETED|Overall Study||11
1017334|NCT00605072|2468976|P1|NOT COMPLETED|Overall Study||7
1017335|NCT00605072|2468974|P3|COMPLETED|Overall Study||11
1017336|NCT00605072|2468975|P2|COMPLETED|Overall Study||9
1017337|NCT00605072|2468976|P1|COMPLETED|Overall Study||11
1017338|NCT00605072|2468974|P3|STARTED|Overall Study||15
1017339|NCT00605072|2468975|P2|STARTED|Overall Study||20
1017340|NCT00605072|2468976|P1|STARTED|Overall Study||18
1017341|NCT00605085|2468998|P2|NOT COMPLETED|Overall Study||25
1017342|NCT00605085|2468999|P1|NOT COMPLETED|Overall Study||50
1017343|NCT00605085|2468998|P2|COMPLETED|Overall Study||638
1017344|NCT00605085|2468999|P1|COMPLETED|Overall Study||1962
1017345|NCT00605085|2468998|P2|STARTED|Overall Study||663
1017346|NCT00605085|2468999|P1|STARTED|Overall Study||2012
1017347|NCT00605150|2469005|P1|NOT COMPLETED|Overall Study||1
1017348|NCT00605150|2469005|P1|COMPLETED|Overall Study||10
1017349|NCT00605150|2469005|P1|STARTED|Overall Study|11 started|11
1017350|NCT00605176|2469012|P3|NOT COMPLETED|Overall Study||9
1017351|NCT00605176|2469013|P2|NOT COMPLETED|Overall Study||6
1017352|NCT00605176|2469014|P1|NOT COMPLETED|Overall Study||11
1017353|NCT00605176|2469012|P3|COMPLETED|Overall Study||150
1017354|NCT00605176|2469013|P2|COMPLETED|Overall Study||154
1017355|NCT00605176|2469014|P1|COMPLETED|Overall Study||149
1017356|NCT00605176|2469012|P3|STARTED|Overall Study||159
1017357|NCT00605176|2469013|P2|STARTED|Overall Study||160
1017358|NCT00605176|2469014|P1|STARTED|Overall Study||160
1017359|NCT00605202|2469031|P2|NOT COMPLETED|Second Intervention||0
1017360|NCT00605202|2469032|P1|NOT COMPLETED|Second Intervention||0
1017361|NCT00605202|2469031|P2|COMPLETED|Second Intervention||5
1017362|NCT00605202|2469032|P1|COMPLETED|Second Intervention||5
1017363|NCT00605202|2469031|P2|STARTED|Second Intervention||5
1017364|NCT00605202|2469032|P1|STARTED|Second Intervention||5
1017365|NCT00605202|2469031|P2|NOT COMPLETED|Washout Period of 3 Weeks||0
1017366|NCT00605202|2469032|P1|NOT COMPLETED|Washout Period of 3 Weeks||0
1017367|NCT00605202|2469031|P2|COMPLETED|Washout Period of 3 Weeks||5
1017368|NCT00605202|2469032|P1|COMPLETED|Washout Period of 3 Weeks||5
1017369|NCT00605202|2469031|P2|STARTED|Washout Period of 3 Weeks||5
1017370|NCT00605202|2469032|P1|STARTED|Washout Period of 3 Weeks||5
1017371|NCT00605202|2469031|P2|NOT COMPLETED|First Intervention||0
1017372|NCT00605202|2469032|P1|NOT COMPLETED|First Intervention||0
1017373|NCT00605202|2469031|P2|COMPLETED|First Intervention||5
1017374|NCT00605202|2469032|P1|COMPLETED|First Intervention||5
1017375|NCT00605202|2469031|P2|STARTED|First Intervention||5
1017376|NCT00605202|2469032|P1|STARTED|First Intervention||5
1017377|NCT00605267|2469040|P2|NOT COMPLETED|Overall Study||9
1017378|NCT00605267|2469041|P1|NOT COMPLETED|Overall Study||3
1017379|NCT00605267|2469040|P2|COMPLETED|Overall Study|Breast surgery performed|90
1017380|NCT00605267|2469041|P1|COMPLETED|Overall Study|Breast surgery performed|95
1017381|NCT00605267|2469040|P2|STARTED|Overall Study||99
1017382|NCT00605267|2469041|P1|STARTED|Overall Study||98
1017383|NCT00605280|2469083|P4|NOT COMPLETED|Year 3 Extension||9
1017384|NCT00605280|2469084|P3|NOT COMPLETED|Year 3 Extension||0
1017385|NCT00605280|2469085|P2|NOT COMPLETED|Year 3 Extension||0
1017386|NCT00605280|2469086|P1|NOT COMPLETED|Year 3 Extension||8
1017387|NCT00605280|2469083|P4|COMPLETED|Year 3 Extension||45
1017388|NCT00605280|2469084|P3|COMPLETED|Year 3 Extension||0
1017389|NCT00605280|2469085|P2|COMPLETED|Year 3 Extension||0
1017390|NCT00605280|2469086|P1|COMPLETED|Year 3 Extension||38
1017391|NCT00605280|2469083|P4|Received 0.3 mg Treatment|Year 3 Extension||54
1017392|NCT00605280|2469084|P3|Received 0.3 mg Treatment|Year 3 Extension||0
1017393|NCT00605280|2469085|P2|Received 0.3 mg Treatment|Year 3 Extension||0
1017394|NCT00605280|2469086|P1|Received 0.3 mg Treatment|Year 3 Extension||46
1017395|NCT00605280|2469083|P4|STARTED|Year 3 Extension||54
1017396|NCT00605280|2469084|P3|STARTED|Year 3 Extension||0
1017397|NCT00605280|2469085|P2|STARTED|Year 3 Extension||0
1017398|NCT00605280|2469086|P1|STARTED|Year 3 Extension||46
1017399|NCT00605280|2469083|P4|NOT COMPLETED|Year 2||22
1017400|NCT00605280|2469084|P3|NOT COMPLETED|Year 2||6
1017401|NCT00605280|2469085|P2|NOT COMPLETED|Year 2||6
1017402|NCT00605280|2469086|P1|NOT COMPLETED|Year 2||24
1017403|NCT00605280|2469083|P4|COMPLETED|Year 2||102
1017404|NCT00605280|2469084|P3|COMPLETED|Year 2||0
1017405|NCT00605280|2469085|P2|COMPLETED|Year 2||5
1017406|NCT00605280|2469086|P1|COMPLETED|Year 2||102
1017407|NCT00605280|2469083|P4|Received 0.3 mg Treatment|Year 2||0
1017408|NCT00605280|2469084|P3|Received 0.3 mg Treatment|Year 2||2
1017409|NCT00605280|2469085|P2|Received 0.3 mg Treatment|Year 2||3
1017410|NCT00605280|2469086|P1|Received 0.3 mg Treatment|Year 2||126
1017411|NCT00605280|2469083|P4|STARTED|Year 2||124
1017412|NCT00605280|2469084|P3|STARTED|Year 2||6
1017413|NCT00605280|2469085|P2|STARTED|Year 2||11
1017414|NCT00605280|2469086|P1|STARTED|Year 2||126
1017415|NCT00605280|2469083|P4|NOT COMPLETED|Year 1||19
1017416|NCT00605280|2469084|P3|NOT COMPLETED|Year 1||1
1017417|NCT00605280|2469085|P2|NOT COMPLETED|Year 1||11
1017418|NCT00605280|2469086|P1|NOT COMPLETED|Year 1||19
1017419|NCT00605280|2469083|P4|COMPLETED|Year 1||124
1017420|NCT00605280|2469084|P3|COMPLETED|Year 1||6
1017421|NCT00605280|2469085|P2|COMPLETED|Year 1||11
1017422|NCT00605280|2469086|P1|COMPLETED|Year 1||126
1017423|NCT00605280|2469083|P4|Received 0.3 mg Treatment|Year 1||0
1017424|NCT00605280|2469084|P3|Received 0.3 mg Treatment|Year 1||3
1017425|NCT00605280|2469085|P2|Received 0.3 mg Treatment|Year 1||13
1017426|NCT00605280|2469086|P1|Received 0.3 mg Treatment|Year 1||144
1017427|NCT00605280|2469083|P4|STARTED|Year 1||143
1017428|NCT00605280|2469084|P3|STARTED|Year 1||7
1017429|NCT00605280|2469085|P2|STARTED|Year 1||22
1017430|NCT00605280|2469086|P1|STARTED|Year 1||145
1017431|NCT00605293|2469120|P2|NOT COMPLETED|Overall Study||5
1017432|NCT00605293|2469121|P1|NOT COMPLETED|Overall Study||17
1017433|NCT00605293|2469120|P2|COMPLETED|Overall Study||31
1017434|NCT00605293|2469121|P1|COMPLETED|Overall Study||48
1017435|NCT00605293|2469120|P2|STARTED|Overall Study||36
1017436|NCT00605293|2469121|P1|STARTED|Overall Study||65
1017437|NCT00605306|2469139|P2|NOT COMPLETED|Overall Study||1
1017438|NCT00605306|2469140|P1|NOT COMPLETED|Overall Study||0
1017439|NCT00605306|2469139|P2|COMPLETED|Overall Study||13
1017440|NCT00605306|2469140|P1|COMPLETED|Overall Study||14
1017441|NCT00605306|2469139|P2|STARTED|Overall Study||14
1017442|NCT00605306|2469140|P1|STARTED|Overall Study||14
1017443|NCT00605345|2469154|P2|NOT COMPLETED|Overall Study||3
1017444|NCT00605345|2469155|P1|NOT COMPLETED|Overall Study||1
1017445|NCT00605345|2469154|P2|COMPLETED|Overall Study||22
1017446|NCT00605345|2469155|P1|COMPLETED|Overall Study||45
1017447|NCT00605345|2469154|P2|STARTED|Overall Study||25
1017448|NCT00605345|2469155|P1|STARTED|Overall Study||46
1017449|NCT00605358|2469173|P2|NOT COMPLETED|Overall Study||0
1017450|NCT00605358|2469174|P1|NOT COMPLETED|Overall Study||0
1017451|NCT00605358|2469173|P2|COMPLETED|Overall Study||80
1017452|NCT00605358|2469174|P1|COMPLETED|Overall Study||81
1017453|NCT00605358|2469173|P2|STARTED|Overall Study||80
1017454|NCT00605358|2469174|P1|STARTED|Overall Study||81
1017455|NCT00605384|2469182|P2|NOT COMPLETED|Overall Study||1
1017456|NCT00605384|2469183|P1|NOT COMPLETED|Overall Study||1
1017457|NCT00605384|2469182|P2|COMPLETED|Overall Study|study terminated early|0
1017458|NCT00605384|2469183|P1|COMPLETED|Overall Study|study terminated early|0
1017459|NCT00605384|2469182|P2|STARTED|Overall Study||1
1017460|NCT00605384|2469183|P1|STARTED|Overall Study||1
1017461|NCT00605423|2469213|P2|NOT COMPLETED|Overall Study||0
1017462|NCT00605423|2469214|P1|NOT COMPLETED|Overall Study||0
1017463|NCT00605423|2469213|P2|COMPLETED|Overall Study||2
1017464|NCT00605423|2469214|P1|COMPLETED|Overall Study||4
1017465|NCT00605423|2469213|P2|STARTED|Overall Study||2
1017466|NCT00605423|2469214|P1|STARTED|Overall Study||4
1017467|NCT00605475|2469234|P10|NOT COMPLETED|Overall Study||2
1017468|NCT00605475|2469235|P9|NOT COMPLETED|Overall Study||2
1017469|NCT00605475|2469236|P8|NOT COMPLETED|Overall Study||0
1017470|NCT00605475|2469237|P7|NOT COMPLETED|Overall Study||1
1017471|NCT00605475|2469238|P6|NOT COMPLETED|Overall Study||2
1017472|NCT00605475|2469239|P5|NOT COMPLETED|Overall Study||1
1017473|NCT00605475|2469240|P4|NOT COMPLETED|Overall Study||0
1017474|NCT00605475|2469241|P3|NOT COMPLETED|Overall Study||0
1017475|NCT00605475|2469242|P2|NOT COMPLETED|Overall Study||0
1017476|NCT00605475|2469243|P1|NOT COMPLETED|Overall Study||0
1017477|NCT00605475|2469234|P10|COMPLETED|Overall Study||8
1017478|NCT00605475|2469235|P9|COMPLETED|Overall Study||18
1017479|NCT00605475|2469236|P8|COMPLETED|Overall Study||24
1017480|NCT00605475|2469237|P7|COMPLETED|Overall Study||22
1017481|NCT00605475|2469238|P6|COMPLETED|Overall Study||22
1017482|NCT00605475|2469239|P5|COMPLETED|Overall Study||24
1017483|NCT00605475|2469240|P4|COMPLETED|Overall Study||45
1017484|NCT00605475|2469241|P3|COMPLETED|Overall Study||45
1017485|NCT00605475|2469242|P2|COMPLETED|Overall Study||5
1017486|NCT00605475|2469243|P1|COMPLETED|Overall Study||10
1017487|NCT00605475|2469234|P10|STARTED|Overall Study||10
1017488|NCT00605475|2469235|P9|STARTED|Overall Study||20
1017489|NCT00605475|2469236|P8|STARTED|Overall Study||24
1017490|NCT00605475|2469237|P7|STARTED|Overall Study||23
1017491|NCT00605475|2469238|P6|STARTED|Overall Study||24
1017492|NCT00605475|2469239|P5|STARTED|Overall Study||25
1017493|NCT00605475|2469240|P4|STARTED|Overall Study||45
1017494|NCT00605475|2469241|P3|STARTED|Overall Study||45
1017495|NCT00605475|2469242|P2|STARTED|Overall Study||5
1017496|NCT00605475|2469243|P1|STARTED|Overall Study||10
1017497|NCT00605540|2469365|P1|NOT COMPLETED|Overall Study||38
1017498|NCT00605540|2469365|P1|COMPLETED|Overall Study||95
1017499|NCT00605540|2469365|P1|STARTED|Overall Study||133
1017500|NCT00605657|2469373|P1|NOT COMPLETED|Overall Study||2
1017501|NCT00605657|2469373|P1|COMPLETED|Overall Study||3
1017502|NCT00605657|2469373|P1|STARTED|Overall Study||5
1017503|NCT00605696|2469380|P2|NOT COMPLETED|Overall Study||0
1017504|NCT00605696|2469381|P1|NOT COMPLETED|Overall Study||0
1017505|NCT00605696|2469380|P2|COMPLETED|Overall Study||11
1017506|NCT00605696|2469381|P1|COMPLETED|Overall Study||7
1017507|NCT00605696|2469380|P2|STARTED|Overall Study||11
1017508|NCT00605696|2469381|P1|STARTED|Overall Study||7
1017509|NCT00605722|2469389|P1|NOT COMPLETED|Overall Study||51
1017510|NCT00605722|2469389|P1|COMPLETED|Overall Study|Completed=Completed Treatment.|0
1017511|NCT00605722|2469389|P1|STARTED|Overall Study||51
1017512|NCT00605813|2469399|P1|NOT COMPLETED|Overall Study||25
1017513|NCT00605813|2469399|P1|COMPLETED|Overall Study||517
1017514|NCT00605813|2469399|P1|STARTED|Overall Study||542
1017524|NCT00605865|2469425|P1|NOT COMPLETED|Overall Study||115
1017525|NCT00605865|2469425|P1|COMPLETED|Overall Study||2157
1017526|NCT00605865|2469425|P1|STARTED|Overall Study||2272
1017527|NCT00605904|2469466|P2|NOT COMPLETED|Infusion Sessions||3
1017528|NCT00605904|2469467|P1|NOT COMPLETED|Infusion Sessions||1
1017529|NCT00605904|2469466|P2|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|13
1017530|NCT00605904|2469467|P1|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|12
1017531|NCT00605904|2469466|P2|Yohimbine Infusion|Infusion Sessions|Milestones (infusions) were not received in the same order for each subjects so are not consecutive.|15
1017532|NCT00605904|2469467|P1|Yohimbine Infusion|Infusion Sessions||12
1017533|NCT00605904|2469466|P2|mCPP Infusion|Infusion Sessions||13
1017534|NCT00605904|2469467|P1|mCPP Infusion|Infusion Sessions||12
1017535|NCT00605904|2469466|P2|Saline Infusion|Infusion Sessions||14
1017536|NCT00605904|2469467|P1|Saline Infusion|Infusion Sessions||13
1017537|NCT00605904|2469466|P2|STARTED|Infusion Sessions||16
1017538|NCT00605904|2469467|P1|STARTED|Infusion Sessions||13
1017539|NCT00605904|2469466|P2|NOT COMPLETED|Baseline Data Collection and Dosing||5
1017540|NCT00605904|2469467|P1|NOT COMPLETED|Baseline Data Collection and Dosing||0
1017541|NCT00605904|2469466|P2|COMPLETED|Baseline Data Collection and Dosing||16
1017542|NCT00605904|2469467|P1|COMPLETED|Baseline Data Collection and Dosing||13
1017543|NCT00605904|2469466|P2|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|21
1017544|NCT00605904|2469467|P1|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|13
1017545|NCT00605917|2469477|P1|NOT COMPLETED|Overall Study||79
1017546|NCT00605917|2469477|P1|COMPLETED|Overall Study||908
1017547|NCT00605917|2469477|P1|STARTED|Overall Study||987
1017548|NCT00606008|2469516|P1|NOT COMPLETED|Overall Study||5
1017549|NCT00606008|2469516|P1|COMPLETED|Overall Study||25
1017550|NCT00606008|2469516|P1|STARTED|Overall Study||30
1017551|NCT00606021|2469532|P3|NOT COMPLETED|Maintenance Phase||17
1017552|NCT00606021|2469533|P2|NOT COMPLETED|Maintenance Phase||23
1017553|NCT00606021|2469534|P1|NOT COMPLETED|Maintenance Phase||0
1017554|NCT00606021|2469532|P3|COMPLETED|Maintenance Phase||10
1017555|NCT00606021|2469533|P2|COMPLETED|Maintenance Phase||5
1017556|NCT00606021|2469534|P1|COMPLETED|Maintenance Phase||0
1017557|NCT00606021|2469532|P3|STARTED|Maintenance Phase||27
1017558|NCT00606021|2469533|P2|STARTED|Maintenance Phase||28
1017559|NCT00606021|2469534|P1|STARTED|Maintenance Phase||0
1017560|NCT00606021|2469532|P3|NOT COMPLETED|Induction Phase||0
1017561|NCT00606021|2469533|P2|NOT COMPLETED|Induction Phase||0
1017562|NCT00606021|2469534|P1|NOT COMPLETED|Induction Phase||87
1017563|NCT00606021|2469532|P3|COMPLETED|Induction Phase||0
1017564|NCT00606021|2469533|P2|COMPLETED|Induction Phase||0
1017565|NCT00606021|2469534|P1|COMPLETED|Induction Phase||19
1017566|NCT00606021|2469532|P3|STARTED|Induction Phase||0
1017567|NCT00606021|2469533|P2|STARTED|Induction Phase||0
1017568|NCT00606021|2469534|P1|STARTED|Induction Phase||106
1017569|NCT00606034|2469552|P1|NOT COMPLETED|Overall Study||1
1017570|NCT00606034|2469552|P1|COMPLETED|Overall Study||20
1017571|NCT00606034|2469552|P1|STARTED|Overall Study||21
1017572|NCT00606086|2469560|P2|NOT COMPLETED|Overall Study||15
1017573|NCT00606086|2469561|P1|NOT COMPLETED|Overall Study||12
1017574|NCT00606086|2469560|P2|COMPLETED|Overall Study||53
1017575|NCT00606086|2469561|P1|COMPLETED|Overall Study||60
1017576|NCT00606086|2469560|P2|STARTED|Overall Study||68
1017577|NCT00606086|2469561|P1|STARTED|Overall Study||72
1017578|NCT00606138|2469569|P2|NOT COMPLETED|Overall Study||0
1017579|NCT00606138|2469570|P1|NOT COMPLETED|Overall Study||0
1017580|NCT00606138|2469569|P2|COMPLETED|Overall Study||2
1017581|NCT00606138|2469570|P1|COMPLETED|Overall Study||6
1017582|NCT00606138|2469569|P2|STARTED|Overall Study||2
1017583|NCT00606138|2469570|P1|STARTED|Overall Study||6
1017584|NCT00606177|2469586|P2|NOT COMPLETED|Overall Study||25
1017585|NCT00606177|2469587|P1|NOT COMPLETED|Overall Study||27
1017586|NCT00606177|2469586|P2|COMPLETED|Overall Study||19
1017587|NCT00606177|2469587|P1|COMPLETED|Overall Study||28
1017588|NCT00606177|2469586|P2|STARTED|Overall Study||44
1017589|NCT00606177|2469587|P1|STARTED|Overall Study||55
1017590|NCT00606229|2469595|P1|NOT COMPLETED|Overall Study||22
1017591|NCT00606229|2469595|P1|COMPLETED|Overall Study||19
1017592|NCT00606229|2469595|P1|STARTED|Overall Study||41
1017593|NCT00606281|2469602|P2|NOT COMPLETED|Overall Study||66
1017594|NCT00606281|2469603|P1|NOT COMPLETED|Overall Study||56
1017595|NCT00606281|2469602|P2|COMPLETED|Overall Study||64
1017596|NCT00606281|2469603|P1|COMPLETED|Overall Study||72
1017597|NCT00606281|2469602|P2|STARTED|Overall Study||130
1017598|NCT00606281|2469603|P1|STARTED|Overall Study||128
1017599|NCT00606320|2469611|P1|NOT COMPLETED|Overall Study||37
1017600|NCT00606320|2469611|P1|COMPLETED|Overall Study||22
1017601|NCT00606320|2469611|P1|STARTED|Overall Study||59
1017602|NCT00606489|2469618|P2|NOT COMPLETED|Overall Study||0
1017603|NCT00606489|2469619|P1|NOT COMPLETED|Overall Study||0
1017604|NCT00606489|2469618|P2|COMPLETED|Overall Study||40
1017605|NCT00606489|2469619|P1|COMPLETED|Overall Study||21
1017606|NCT00606489|2469618|P2|STARTED|Overall Study||40
1017607|NCT00606489|2469619|P1|STARTED|Overall Study||21
1017608|NCT00589121|2469627|P2|NOT COMPLETED|Overall Study||7
1017609|NCT00589121|2469628|P1|NOT COMPLETED|Overall Study||2
1017610|NCT00589121|2469627|P2|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|79
1017611|NCT00589121|2469628|P1|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|10
1017612|NCT00589121|2469627|P2|STARTED|Overall Study||86
1017613|NCT00589121|2469628|P1|STARTED|Overall Study||12
1017614|NCT00589277|2469647|P2|NOT COMPLETED|Overall Study||286
1017615|NCT00589277|2469648|P1|NOT COMPLETED|Overall Study||460
1017616|NCT00589277|2469647|P2|COMPLETED|Overall Study||524
1017617|NCT00589277|2469648|P1|COMPLETED|Overall Study||762
1017618|NCT00589277|2469647|P2|Completed 3 Month Follow Up|Overall Study||524
1017619|NCT00589277|2469648|P1|Completed 3 Month Follow Up|Overall Study||762
1017620|NCT00589277|2469647|P2|Completed 2 Week Follow Up|Overall Study||424
1017621|NCT00589277|2469648|P1|Completed 2 Week Follow Up|Overall Study||603
1017622|NCT00589277|2469647|P2|STARTED|Overall Study||810
1017623|NCT00589277|2469648|P1|STARTED|Overall Study||1222
1017624|NCT00589290|2469658|P1|NOT COMPLETED|Overall Study||1
1017625|NCT00589290|2469658|P1|COMPLETED|Overall Study||40
1017626|NCT00589290|2469658|P1|STARTED|Overall Study||41
1017627|NCT00589303|2469668|P2|NOT COMPLETED|Overall Study||1
1017628|NCT00589303|2469669|P1|NOT COMPLETED|Overall Study||2
1017629|NCT00589303|2469668|P2|COMPLETED|Overall Study||12
1017630|NCT00589303|2469669|P1|COMPLETED|Overall Study||12
1017631|NCT00589303|2469668|P2|STARTED|Overall Study||13
1017632|NCT00589303|2469669|P1|STARTED|Overall Study||14
1017633|NCT00594854|2469677|P2|NOT COMPLETED|Overall Study||10
1017634|NCT00594854|2469678|P1|NOT COMPLETED|Overall Study||7
1017635|NCT00594854|2469677|P2|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|1
1017636|NCT00594854|2469678|P1|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|2
1017637|NCT00594854|2469677|P2|STARTED|Overall Study||11
1017638|NCT00594854|2469678|P1|STARTED|Overall Study||9
1017639|NCT00594880|2469690|P2|NOT COMPLETED|Overall Study||1
1017640|NCT00594880|2469691|P1|NOT COMPLETED|Overall Study||2
1017641|NCT00594880|2469690|P2|COMPLETED|Overall Study||10
1017642|NCT00594880|2469691|P1|COMPLETED|Overall Study||10
1017643|NCT00594880|2469690|P2|STARTED|Overall Study||11
1017644|NCT00594880|2469691|P1|STARTED|Overall Study||12
1017645|NCT00594906|2469703|P2|NOT COMPLETED|Overall Study||2
1017646|NCT00594906|2469704|P1|NOT COMPLETED|Overall Study||1
1017647|NCT00594906|2469703|P2|COMPLETED|Overall Study||1
1017648|NCT00594906|2469704|P1|COMPLETED|Overall Study||6
1017649|NCT00594906|2469703|P2|STARTED|Overall Study||3
1017650|NCT00594906|2469704|P1|STARTED|Overall Study||7
1017651|NCT00594945|2469713|P3|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
1017652|NCT00594945|2469714|P2|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
1017653|NCT00594945|2469715|P1|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
1017654|NCT00594945|2469713|P3|COMPLETED|Cohort 2 / Treatment Period 2||2
1017655|NCT00594945|2469714|P2|COMPLETED|Cohort 2 / Treatment Period 2||3
1017656|NCT00594945|2469715|P1|COMPLETED|Cohort 2 / Treatment Period 2||0
1017657|NCT00594945|2469713|P3|STARTED|Cohort 2 / Treatment Period 2||2
1017658|NCT00594945|2469714|P2|STARTED|Cohort 2 / Treatment Period 2||3
1017659|NCT00594945|2469715|P1|STARTED|Cohort 2 / Treatment Period 2||0
1017660|NCT00594945|2469713|P3|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
1017661|NCT00594945|2469714|P2|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
1017662|NCT00594945|2469715|P1|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
1017663|NCT00594945|2469713|P3|COMPLETED|Cohort 1 / Treatment Period 1||2
1017664|NCT00594945|2469714|P2|COMPLETED|Cohort 1 / Treatment Period 1||0
1017665|NCT00594945|2469715|P1|COMPLETED|Cohort 1 / Treatment Period 1||4
1017666|NCT00594945|2469713|P3|STARTED|Cohort 1 / Treatment Period 1||2
1017667|NCT00594945|2469714|P2|STARTED|Cohort 1 / Treatment Period 1||0
1017668|NCT00594945|2469715|P1|STARTED|Cohort 1 / Treatment Period 1||4
1017669|NCT00600613|2469721|P1|NOT COMPLETED|Overall Study||1
1017670|NCT00600613|2469721|P1|COMPLETED|Overall Study||5
1017671|NCT00600613|2469721|P1|STARTED|Overall Study||6
1017672|NCT00600704|2469727|P2|NOT COMPLETED|Overall Study||0
1017673|NCT00600704|2469728|P1|NOT COMPLETED|Overall Study||0
1017674|NCT00600704|2469727|P2|COMPLETED|Overall Study||92
1017675|NCT00600704|2469728|P1|COMPLETED|Overall Study||100
1017676|NCT00600704|2469727|P2|STARTED|Overall Study||92
1017677|NCT00600704|2469728|P1|STARTED|Overall Study||100
1017678|NCT00600743|2469738|P4|NOT COMPLETED|Overall Study||0
1017679|NCT00600743|2469739|P3|NOT COMPLETED|Overall Study||0
1017680|NCT00600743|2469740|P2|NOT COMPLETED|Overall Study||0
1017681|NCT00600743|2469741|P1|NOT COMPLETED|Overall Study||0
1017682|NCT00600743|2469738|P4|COMPLETED|Overall Study||7
1017683|NCT00600743|2469739|P3|COMPLETED|Overall Study||8
1017684|NCT00600743|2469740|P2|COMPLETED|Overall Study||4
1017685|NCT00600743|2469741|P1|COMPLETED|Overall Study||4
1017686|NCT00600743|2469738|P4|STARTED|Overall Study||7
1017687|NCT00600743|2469739|P3|STARTED|Overall Study||8
1017688|NCT00600743|2469740|P2|STARTED|Overall Study||4
1017689|NCT00600743|2469741|P1|STARTED|Overall Study||4
1017690|NCT00600756|2469770|P2|NOT COMPLETED|Overall Study Analysis After 12 Months||176
1017691|NCT00600756|2469771|P1|NOT COMPLETED|Overall Study Analysis After 12 Months||183
1017692|NCT00600756|2469770|P2|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|227
1017693|NCT00600756|2469771|P1|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|212
1017694|NCT00600756|2469770|P2|ITT Analysis|Overall Study Analysis After 12 Months||392
1017695|NCT00600756|2469771|P1|ITT Analysis|Overall Study Analysis After 12 Months||379
1017696|NCT00600756|2469770|P2|Safety Analysis|Overall Study Analysis After 12 Months||402
1017697|NCT00600756|2469771|P1|Safety Analysis|Overall Study Analysis After 12 Months||391
1017698|NCT00600756|2469770|P2|Randomized Analysis|Overall Study Analysis After 12 Months||403
1017699|NCT00600756|2469771|P1|Randomized Analysis|Overall Study Analysis After 12 Months||395
1017700|NCT00600756|2469770|P2|STARTED|Overall Study Analysis After 12 Months||403
1017701|NCT00600756|2469771|P1|STARTED|Overall Study Analysis After 12 Months||395
1017702|NCT00600756|2469770|P2|NOT COMPLETED|Analysis After 6 Months||120
1017703|NCT00600756|2469771|P1|NOT COMPLETED|Analysis After 6 Months||131
1017704|NCT00600756|2469770|P2|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|283
1017705|NCT00600756|2469771|P1|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|264
1017706|NCT00600756|2469770|P2|STARTED|Analysis After 6 Months||403
1017707|NCT00600756|2469771|P1|STARTED|Analysis After 6 Months||395
1017708|NCT00606502|2469839|P2|NOT COMPLETED|Treatment||3
1017709|NCT00606502|2469840|P1|NOT COMPLETED|Treatment||0
1017710|NCT00606502|2469839|P2|COMPLETED|Treatment||98
1017711|NCT00606502|2469840|P1|COMPLETED|Treatment||97
1017712|NCT00606502|2469839|P2|STARTED|Treatment||101
1017713|NCT00606502|2469840|P1|STARTED|Treatment||97
1017714|NCT00606502|2469839|P2|NOT COMPLETED|Randomization||0
1017715|NCT00606502|2469840|P1|NOT COMPLETED|Randomization||3
1017716|NCT00606502|2469839|P2|COMPLETED|Randomization||101
1017717|NCT00606502|2469840|P1|COMPLETED|Randomization||97
1017718|NCT00606502|2469839|P2|STARTED|Randomization||101
1017719|NCT00606502|2469840|P1|STARTED|Randomization||100
1017720|NCT00606554|2469854|P2|NOT COMPLETED|Overall Study||0
1017721|NCT00606554|2469855|P1|NOT COMPLETED|Overall Study||0
1017722|NCT00606554|2469854|P2|COMPLETED|Overall Study||18
1017723|NCT00606554|2469855|P1|COMPLETED|Overall Study||15
1017724|NCT00606554|2469854|P2|STARTED|Overall Study||18
1017725|NCT00606554|2469855|P1|STARTED|Overall Study||15
1017726|NCT00606580|2469868|P3|NOT COMPLETED|Overall Study||22
1017727|NCT00606580|2469869|P2|NOT COMPLETED|Overall Study||3
1017728|NCT00606580|2469870|P1|NOT COMPLETED|Overall Study||2
1017729|NCT00606580|2469868|P3|COMPLETED|Overall Study||103
1017730|NCT00606580|2469869|P2|COMPLETED|Overall Study||122
1017731|NCT00606580|2469870|P1|COMPLETED|Overall Study||123
1017732|NCT00606580|2469868|P3|STARTED|Overall Study||125
1017733|NCT00606580|2469869|P2|STARTED|Overall Study||125
1017734|NCT00606580|2469870|P1|STARTED|Overall Study||125
1017735|NCT00606593|2469911|P10|NOT COMPLETED|Overall Study||0
1017736|NCT00606593|2469912|P9|NOT COMPLETED|Overall Study||1
1017737|NCT00606593|2469913|P8|NOT COMPLETED|Overall Study||2
1017738|NCT00606593|2469914|P7|NOT COMPLETED|Overall Study||1
1017739|NCT00606593|2469915|P6|NOT COMPLETED|Overall Study||0
1017740|NCT00606593|2469916|P5|NOT COMPLETED|Overall Study||1
1017741|NCT00606593|2469917|P4|NOT COMPLETED|Overall Study||1
1017742|NCT00606593|2469918|P3|NOT COMPLETED|Overall Study||2
1017743|NCT00606593|2469919|P2|NOT COMPLETED|Overall Study||0
1017744|NCT00606593|2469920|P1|NOT COMPLETED|Overall Study||1
1017745|NCT00606593|2469911|P10|COMPLETED|Overall Study||11
1017746|NCT00606593|2469912|P9|COMPLETED|Overall Study||11
1017747|NCT00606593|2469913|P8|COMPLETED|Overall Study||9
1017748|NCT00606593|2469914|P7|COMPLETED|Overall Study||10
1017749|NCT00606593|2469915|P6|COMPLETED|Overall Study||11
1017750|NCT00606593|2469916|P5|COMPLETED|Overall Study||11
1017751|NCT00606593|2469917|P4|COMPLETED|Overall Study||10
1017752|NCT00606593|2469918|P3|COMPLETED|Overall Study||9
1017753|NCT00606593|2469919|P2|COMPLETED|Overall Study||11
1017754|NCT00606593|2469920|P1|COMPLETED|Overall Study||10
1017755|NCT00606593|2469911|P10|5th Double-blind Treatment|Overall Study||11
1017756|NCT00606593|2469912|P9|5th Double-blind Treatment|Overall Study||11
1017757|NCT00606593|2469913|P8|5th Double-blind Treatment|Overall Study||9
1017758|NCT00606593|2469914|P7|5th Double-blind Treatment|Overall Study||10
1017759|NCT00606593|2469915|P6|5th Double-blind Treatment|Overall Study||11
1017760|NCT00606593|2469916|P5|5th Double-blind Treatment|Overall Study||11
1017761|NCT00606593|2469917|P4|5th Double-blind Treatment|Overall Study||10
1017762|NCT00606593|2469918|P3|5th Double-blind Treatment|Overall Study||9
1017763|NCT00606593|2469919|P2|5th Double-blind Treatment|Overall Study||11
1017764|NCT00606593|2469920|P1|5th Double-blind Treatment|Overall Study||10
1017765|NCT00606593|2469911|P10|4th Double-blind Treatment|Overall Study||11
1017766|NCT00606593|2469912|P9|4th Double-blind Treatment|Overall Study||11
1017767|NCT00606593|2469913|P8|4th Double-blind Treatment|Overall Study||9
1017768|NCT00606593|2469914|P7|4th Double-blind Treatment|Overall Study||10
1017769|NCT00606593|2469915|P6|4th Double-blind Treatment|Overall Study||11
1017770|NCT00606593|2469916|P5|4th Double-blind Treatment|Overall Study||11
1017771|NCT00606593|2469917|P4|4th Double-blind Treatment|Overall Study||10
1017772|NCT00606593|2469918|P3|4th Double-blind Treatment|Overall Study||10
1017773|NCT00606593|2469919|P2|4th Double-blind Treatment|Overall Study||11
1017774|NCT00606593|2469920|P1|4th Double-blind Treatment|Overall Study||10
1017775|NCT00606593|2469911|P10|3rd Double-blind Treatment|Overall Study||11
1017776|NCT00606593|2469912|P9|3rd Double-blind Treatment|Overall Study||12
1017777|NCT00606593|2469913|P8|3rd Double-blind Treatment|Overall Study||9
1017778|NCT00606593|2469914|P7|3rd Double-blind Treatment|Overall Study||10
1017779|NCT00606593|2469915|P6|3rd Double-blind Treatment|Overall Study||11
1017780|NCT00606593|2469916|P5|3rd Double-blind Treatment|Overall Study||11
1017781|NCT00606593|2469917|P4|3rd Double-blind Treatment|Overall Study||10
1017782|NCT00606593|2469918|P3|3rd Double-blind Treatment|Overall Study||10
1017783|NCT00606593|2469919|P2|3rd Double-blind Treatment|Overall Study||11
1017784|NCT00606593|2469920|P1|3rd Double-blind Treatment|Overall Study||11
1017785|NCT00606593|2469911|P10|2nd Double-blind Treatment|Overall Study||11
1017786|NCT00606593|2469912|P9|2nd Double-blind Treatment|Overall Study||12
1017787|NCT00606593|2469913|P8|2nd Double-blind Treatment|Overall Study||9
1017788|NCT00606593|2469914|P7|2nd Double-blind Treatment|Overall Study||10
1017789|NCT00606593|2469915|P6|2nd Double-blind Treatment|Overall Study||11
1017790|NCT00606593|2469916|P5|2nd Double-blind Treatment|Overall Study||12
1017791|NCT00606593|2469917|P4|2nd Double-blind Treatment|Overall Study||10
1017792|NCT00606593|2469918|P3|2nd Double-blind Treatment|Overall Study||11
1017793|NCT00606593|2469919|P2|2nd Double-blind Treatment|Overall Study||11
1017794|NCT00606593|2469920|P1|2nd Double-blind Treatment|Overall Study||11
1017795|NCT00606593|2469911|P10|1st Double-blind Treatment|Overall Study||11
1017796|NCT00606593|2469912|P9|1st Double-blind Treatment|Overall Study||12
1017797|NCT00606593|2469913|P8|1st Double-blind Treatment|Overall Study||11
1017798|NCT00606593|2469914|P7|1st Double-blind Treatment|Overall Study||11
1017799|NCT00606593|2469915|P6|1st Double-blind Treatment|Overall Study||11
1017800|NCT00606593|2469916|P5|1st Double-blind Treatment|Overall Study||12
1017801|NCT00606593|2469917|P4|1st Double-blind Treatment|Overall Study||11
1017802|NCT00606593|2469918|P3|1st Double-blind Treatment|Overall Study||11
1017803|NCT00606593|2469919|P2|1st Double-blind Treatment|Overall Study||11
1017804|NCT00606593|2469920|P1|1st Double-blind Treatment|Overall Study||11
1017805|NCT00606593|2469911|P10|STARTED|Overall Study|Randomized participants|11
1017806|NCT00606593|2469912|P9|STARTED|Overall Study|Randomized participants|12
1017807|NCT00606593|2469913|P8|STARTED|Overall Study|Randomized participants. One participant actually received the treatment sequence 200/P/100/ 50/25|11
1017808|NCT00606593|2469914|P7|STARTED|Overall Study|Randomized participants|11
1017809|NCT00606593|2469915|P6|STARTED|Overall Study|Randomized participants|11
1017810|NCT00606593|2469916|P5|STARTED|Overall Study|Randomized participants|12
1017811|NCT00606593|2469917|P4|STARTED|Overall Study|Randomized participants|11
1017812|NCT00606593|2469918|P3|STARTED|Overall Study|Randomized participants|11
1017813|NCT00606593|2469919|P2|STARTED|Overall Study|Randomized participants|11
1017814|NCT00606593|2469920|P1|STARTED|Overall Study|Randomized participants|11
1017815|NCT00606632|2469938|P1|NOT COMPLETED|Overall Study||22
1017816|NCT00606632|2469938|P1|COMPLETED|Overall Study||204
1017817|NCT00606632|2469938|P1|STARTED|Overall Study||226
1017818|NCT00606684|2469951|P7|NOT COMPLETED|Double-Blind Treatment Period||8
1017819|NCT00606684|2469952|P6|NOT COMPLETED|Double-Blind Treatment Period||9
1017820|NCT00606684|2469953|P5|NOT COMPLETED|Double-Blind Treatment Period||9
1017821|NCT00606684|2469954|P4|NOT COMPLETED|Double-Blind Treatment Period||10
1017822|NCT00606684|2469955|P3|NOT COMPLETED|Double-Blind Treatment Period||11
1017823|NCT00606684|2469956|P2|NOT COMPLETED|Double-Blind Treatment Period||16
1017824|NCT00606684|2469957|P1|NOT COMPLETED|Double-Blind Treatment Period||0
1017825|NCT00606684|2469951|P7|COMPLETED|Double-Blind Treatment Period||91
1017826|NCT00606684|2469952|P6|COMPLETED|Double-Blind Treatment Period||92
1017827|NCT00606684|2469953|P5|COMPLETED|Double-Blind Treatment Period||92
1017828|NCT00606684|2469954|P4|COMPLETED|Double-Blind Treatment Period||91
1017829|NCT00606684|2469955|P3|COMPLETED|Double-Blind Treatment Period||88
1017830|NCT00606684|2469956|P2|COMPLETED|Double-Blind Treatment Period||85
1017831|NCT00606684|2469957|P1|COMPLETED|Double-Blind Treatment Period||0
1017832|NCT00606684|2469951|P7|STARTED|Double-Blind Treatment Period||99
1017833|NCT00606684|2469952|P6|STARTED|Double-Blind Treatment Period||101
1017834|NCT00606684|2469953|P5|STARTED|Double-Blind Treatment Period||101
1017835|NCT00606684|2469954|P4|STARTED|Double-Blind Treatment Period||101
1017836|NCT00606684|2469955|P3|STARTED|Double-Blind Treatment Period||99
1017837|NCT00606684|2469956|P2|STARTED|Double-Blind Treatment Period||101
1017838|NCT00606684|2469957|P1|STARTED|Double-Blind Treatment Period||0
1017839|NCT00606684|2469951|P7|NOT COMPLETED|2-week Single-Blind Run-in Period||0
1017840|NCT00606684|2469952|P6|NOT COMPLETED|2-week Single-Blind Run-in Period||0
1017841|NCT00606684|2469953|P5|NOT COMPLETED|2-week Single-Blind Run-in Period||0
1017842|NCT00606684|2469954|P4|NOT COMPLETED|2-week Single-Blind Run-in Period||0
1017843|NCT00606684|2469955|P3|NOT COMPLETED|2-week Single-Blind Run-in Period||0
1017844|NCT00606684|2469956|P2|NOT COMPLETED|2-week Single-Blind Run-in Period||0
1017845|NCT00606684|2469957|P1|NOT COMPLETED|2-week Single-Blind Run-in Period||246
1017846|NCT00606684|2469951|P7|COMPLETED|2-week Single-Blind Run-in Period||0
1017847|NCT00606684|2469952|P6|COMPLETED|2-week Single-Blind Run-in Period||0
1017848|NCT00606684|2469953|P5|COMPLETED|2-week Single-Blind Run-in Period||0
1017849|NCT00606684|2469954|P4|COMPLETED|2-week Single-Blind Run-in Period||0
1017850|NCT00606684|2469955|P3|COMPLETED|2-week Single-Blind Run-in Period||0
1017851|NCT00606684|2469956|P2|COMPLETED|2-week Single-Blind Run-in Period||0
1017852|NCT00606684|2469957|P1|COMPLETED|2-week Single-Blind Run-in Period||605
1017853|NCT00606684|2469951|P7|STARTED|2-week Single-Blind Run-in Period||0
1017854|NCT00606684|2469952|P6|STARTED|2-week Single-Blind Run-in Period||0
1017855|NCT00606684|2469953|P5|STARTED|2-week Single-Blind Run-in Period||0
1017856|NCT00606684|2469954|P4|STARTED|2-week Single-Blind Run-in Period||0
1017857|NCT00606684|2469955|P3|STARTED|2-week Single-Blind Run-in Period||0
1017858|NCT00606684|2469956|P2|STARTED|2-week Single-Blind Run-in Period||0
1017859|NCT00606684|2469957|P1|STARTED|2-week Single-Blind Run-in Period||851
1017860|NCT00606801|2469991|P2|NOT COMPLETED|Intervention||3
1017861|NCT00606801|2469992|P1|NOT COMPLETED|Intervention||3
1017862|NCT00606801|2469991|P2|COMPLETED|Intervention||14
1017863|NCT00606801|2469992|P1|COMPLETED|Intervention||14
1017864|NCT00606801|2469991|P2|STARTED|Intervention||17
1017865|NCT00606801|2469992|P1|STARTED|Intervention||17
1017866|NCT00606801|2469991|P2|NOT COMPLETED|Adaptation||0
1017867|NCT00606801|2469992|P1|NOT COMPLETED|Adaptation||0
1017868|NCT00606801|2469991|P2|COMPLETED|Adaptation||17
1017869|NCT00606801|2469992|P1|COMPLETED|Adaptation||17
1017870|NCT00606801|2469991|P2|STARTED|Adaptation||17
1017871|NCT00606801|2469992|P1|STARTED|Adaptation||17
1017872|NCT00607321|2470014|P1|NOT COMPLETED|Overall Study||0
1017873|NCT00607321|2470014|P1|COMPLETED|Overall Study||60
1017874|NCT00607321|2470014|P1|STARTED|Overall Study||60
1017875|NCT00607373|2470024|P2|NOT COMPLETED|Follow-up Period||5
1017876|NCT00607373|2470025|P1|NOT COMPLETED|Follow-up Period||1
1017877|NCT00607373|2470024|P2|COMPLETED|Follow-up Period||6
1017878|NCT00607373|2470025|P1|COMPLETED|Follow-up Period||0
1017879|NCT00607373|2470024|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|11
1017880|NCT00607373|2470025|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|1
1017881|NCT00607373|2470024|P2|NOT COMPLETED|Treatment Period||6
1017882|NCT00607373|2470025|P1|NOT COMPLETED|Treatment Period||0
1017883|NCT00607373|2470024|P2|COMPLETED|Treatment Period|23 enrolled in open-label extension study NCT00694109|28
1017884|NCT00607373|2470025|P1|COMPLETED|Treatment Period|16 enrolled in open-label extension study NCT00694109|17
1017885|NCT00607373|2470024|P2|STARTED|Treatment Period||34
1017886|NCT00607373|2470025|P1|STARTED|Treatment Period||17
1017887|NCT00607386|2470069|P1|NOT COMPLETED|Overall Study||1
1017888|NCT00607386|2470069|P1|COMPLETED|Overall Study||27
1017889|NCT00607386|2470069|P1|STARTED|Overall Study||28
1017890|NCT00607477|2470084|P2|NOT COMPLETED|Overall Study||0
1017891|NCT00607477|2470085|P1|NOT COMPLETED|Overall Study||0
1017892|NCT00607477|2470084|P2|COMPLETED|Overall Study||2
1017893|NCT00607477|2470085|P1|COMPLETED|Overall Study||0
1017894|NCT00607477|2470084|P2|STARTED|Overall Study||2
1017895|NCT00607477|2470085|P1|STARTED|Overall Study||0
1017896|NCT00607594|2470091|P1|NOT COMPLETED|Overall Study||0
1017897|NCT00607594|2470091|P1|COMPLETED|Overall Study||21
1017898|NCT00607594|2470091|P1|STARTED|Overall Study||21
1017899|NCT00607672|2470101|P3|NOT COMPLETED|Overall Study||5
1017900|NCT00607672|2470102|P2|NOT COMPLETED|Overall Study||3
1017901|NCT00607672|2470103|P1|NOT COMPLETED|Overall Study||4
1017902|NCT00607672|2470101|P3|COMPLETED|Overall Study||22
1017903|NCT00607672|2470102|P2|COMPLETED|Overall Study||24
1017904|NCT00607672|2470103|P1|COMPLETED|Overall Study||28
1017905|NCT00607672|2470101|P3|STARTED|Overall Study||27
1017906|NCT00607672|2470102|P2|STARTED|Overall Study||27
1017907|NCT00607672|2470103|P1|STARTED|Overall Study||32
1017908|NCT00607724|2470154|P7|NOT COMPLETED|Stage 2: Expanded Cohort||11
1017909|NCT00607724|2470155|P6|NOT COMPLETED|Stage 2: Expanded Cohort||12
1017910|NCT00607724|2470156|P5|NOT COMPLETED|Stage 2: Expanded Cohort||9
1017911|NCT00607724|2470157|P4|NOT COMPLETED|Stage 2: Expanded Cohort||5
1017912|NCT00607724|2470158|P3|NOT COMPLETED|Stage 2: Expanded Cohort||0
1017913|NCT00607724|2470159|P2|NOT COMPLETED|Stage 2: Expanded Cohort||0
1017914|NCT00607724|2470160|P1|NOT COMPLETED|Stage 2: Expanded Cohort||0
1017915|NCT00607724|2470154|P7|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered ‘completers’.|5
1017916|NCT00607724|2470155|P6|COMPLETED|Stage 2: Expanded Cohort||0
1017917|NCT00607724|2470156|P5|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered ‘completers’.|5
1017918|NCT00607724|2470157|P4|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered ‘completers’.|1
1017919|NCT00607724|2470158|P3|COMPLETED|Stage 2: Expanded Cohort||0
1017920|NCT00607724|2470159|P2|COMPLETED|Stage 2: Expanded Cohort||0
1017921|NCT00607724|2470160|P1|COMPLETED|Stage 2: Expanded Cohort||0
1017922|NCT00607724|2470154|P7|STARTED|Stage 2: Expanded Cohort||16
1017923|NCT00607724|2470155|P6|STARTED|Stage 2: Expanded Cohort||12
1017924|NCT00607724|2470156|P5|STARTED|Stage 2: Expanded Cohort||14
1017925|NCT00607724|2470157|P4|STARTED|Stage 2: Expanded Cohort||6
1017926|NCT00607724|2470158|P3|STARTED|Stage 2: Expanded Cohort||0
1017927|NCT00607724|2470159|P2|STARTED|Stage 2: Expanded Cohort||0
1017928|NCT00607724|2470160|P1|STARTED|Stage 2: Expanded Cohort||0
1017929|NCT00607724|2470154|P7|NOT COMPLETED|Stage 1: Dose Escalation||0
1017930|NCT00607724|2470155|P6|NOT COMPLETED|Stage 1: Dose Escalation||0
1017931|NCT00607724|2470156|P5|NOT COMPLETED|Stage 1: Dose Escalation||0
1017932|NCT00607724|2470157|P4|NOT COMPLETED|Stage 1: Dose Escalation||0
1017933|NCT00607724|2470158|P3|NOT COMPLETED|Stage 1: Dose Escalation||4
1017934|NCT00607724|2470159|P2|NOT COMPLETED|Stage 1: Dose Escalation||8
1017935|NCT00607724|2470160|P1|NOT COMPLETED|Stage 1: Dose Escalation||7
1017936|NCT00607724|2470154|P7|COMPLETED|Stage 1: Dose Escalation||0
1017937|NCT00607724|2470155|P6|COMPLETED|Stage 1: Dose Escalation||0
1017938|NCT00607724|2470156|P5|COMPLETED|Stage 1: Dose Escalation||0
1017939|NCT00607724|2470157|P4|COMPLETED|Stage 1: Dose Escalation||0
1017940|NCT00607724|2470158|P3|COMPLETED|Stage 1: Dose Escalation||0
1017941|NCT00607724|2470159|P2|COMPLETED|Stage 1: Dose Escalation|Participants still on treatment at time of study closure were considered ‘completers’.|1
1017942|NCT00607724|2470160|P1|COMPLETED|Stage 1: Dose Escalation||0
1017943|NCT00607724|2470154|P7|STARTED|Stage 1: Dose Escalation||0
1017944|NCT00607724|2470155|P6|STARTED|Stage 1: Dose Escalation||0
1017945|NCT00607724|2470156|P5|STARTED|Stage 1: Dose Escalation||0
1017946|NCT00607724|2470157|P4|STARTED|Stage 1: Dose Escalation||0
1017947|NCT00607724|2470158|P3|STARTED|Stage 1: Dose Escalation||4
1017948|NCT00607724|2470159|P2|STARTED|Stage 1: Dose Escalation||9
1017949|NCT00607724|2470160|P1|STARTED|Stage 1: Dose Escalation||7
1017950|NCT00607789|2470238|P2|NOT COMPLETED|Overall Study||6
1017951|NCT00607789|2470239|P1|NOT COMPLETED|Overall Study||7
1017952|NCT00607789|2470238|P2|COMPLETED|Overall Study||14
1017953|NCT00607789|2470239|P1|COMPLETED|Overall Study||13
1017954|NCT00607789|2470238|P2|STARTED|Overall Study||20
1017955|NCT00607789|2470239|P1|STARTED|Overall Study|20 participants were randomized in each group|20
1017956|NCT00607815|2470249|P2|NOT COMPLETED|Overall Study||11
1017957|NCT00607815|2470250|P1|NOT COMPLETED|Overall Study||23
1017958|NCT00607815|2470249|P2|COMPLETED|Overall Study||25
1017959|NCT00607815|2470250|P1|COMPLETED|Overall Study||20
1017960|NCT00607815|2470249|P2|STARTED|Overall Study||36
1017961|NCT00607815|2470250|P1|STARTED|Overall Study||43
1017962|NCT00607867|2470266|P2|NOT COMPLETED|Overall Study||0
1017963|NCT00607867|2470267|P1|NOT COMPLETED|Overall Study||0
1017964|NCT00607867|2470266|P2|COMPLETED|Overall Study||7
1017965|NCT00607867|2470267|P1|COMPLETED|Overall Study||7
1017966|NCT00607867|2470266|P2|STARTED|Overall Study||7
1017967|NCT00607867|2470267|P1|STARTED|Overall Study||7
1017968|NCT00607880|2470285|P2|NOT COMPLETED|Overall Study||0
1017969|NCT00607880|2470286|P1|NOT COMPLETED|Overall Study||1
1017970|NCT00607880|2470285|P2|COMPLETED|Overall Study||50
1017971|NCT00607880|2470286|P1|COMPLETED|Overall Study||49
1017972|NCT00607880|2470285|P2|STARTED|Overall Study||50
1017973|NCT00607880|2470286|P1|STARTED|Overall Study||50
1017974|NCT00607893|2470300|P2|NOT COMPLETED|Overall Study||4
1017975|NCT00607893|2470301|P1|NOT COMPLETED|Overall Study||6
1017976|NCT00607893|2470300|P2|COMPLETED|Overall Study||72
1017977|NCT00607893|2470301|P1|COMPLETED|Overall Study||71
1017978|NCT00607893|2470300|P2|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|29
1017979|NCT00607893|2470301|P1|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|0
1017980|NCT00607893|2470300|P2|Completed 8 Week Visit|Overall Study||72
1017981|NCT00607893|2470301|P1|Completed 8 Week Visit|Overall Study||71
1017982|NCT00607893|2470300|P2|Completed Baseline Visit|Overall Study||75
1017983|NCT00607893|2470301|P1|Completed Baseline Visit|Overall Study||74
1017984|NCT00607893|2470300|P2|STARTED|Overall Study||76
1017985|NCT00607893|2470301|P1|STARTED|Overall Study||77
1017986|NCT00607919|2470329|P2|NOT COMPLETED|Open-Label Phase||12
1017987|NCT00607919|2470330|P1|NOT COMPLETED|Open-Label Phase||10
1017988|NCT00607919|2470329|P2|COMPLETED|Open-Label Phase||59
1017989|NCT00607919|2470330|P1|COMPLETED|Open-Label Phase||74
1017990|NCT00607919|2470329|P2|STARTED|Open-Label Phase||71
1017991|NCT00607919|2470330|P1|STARTED|Open-Label Phase||84
1017992|NCT00607919|2470329|P2|NOT COMPLETED|Acute Phase||16
1017993|NCT00607919|2470330|P1|NOT COMPLETED|Acute Phase||34
1017994|NCT00607919|2470329|P2|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|73
1017995|NCT00607919|2470330|P1|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|86
1017996|NCT00607919|2470329|P2|STARTED|Acute Phase||89
1017997|NCT00607919|2470330|P1|STARTED|Acute Phase||120
1017998|NCT00607997|2470390|P4|NOT COMPLETED|Overall Study||16
1017999|NCT00607997|2470391|P3|NOT COMPLETED|Overall Study||24
1018000|NCT00607997|2470392|P2|NOT COMPLETED|Overall Study||27
1018001|NCT00607997|2470393|P1|NOT COMPLETED|Overall Study||27
1018002|NCT00607997|2470390|P4|COMPLETED|Overall Study||4
1018003|NCT00607997|2470391|P3|COMPLETED|Overall Study||5
1018004|NCT00607997|2470392|P2|COMPLETED|Overall Study||8
1018005|NCT00607997|2470393|P1|COMPLETED|Overall Study||2
1018006|NCT00607997|2470390|P4|STARTED|Overall Study||20
1018007|NCT00607997|2470391|P3|STARTED|Overall Study||29
1018008|NCT00607997|2470392|P2|STARTED|Overall Study||35
1018009|NCT00607997|2470393|P1|STARTED|Overall Study||29
1018010|NCT00608023|2470452|P3|NOT COMPLETED|Overall Study||14
1018011|NCT00608023|2470453|P2|NOT COMPLETED|Overall Study||22
1018012|NCT00608023|2470454|P1|NOT COMPLETED|Overall Study||12
1018013|NCT00608023|2470452|P3|COMPLETED|Overall Study||72
1018014|NCT00608023|2470453|P2|COMPLETED|Overall Study||63
1018015|NCT00608023|2470454|P1|COMPLETED|Overall Study||80
1018016|NCT00608023|2470452|P3|STARTED|Overall Study||86
1018017|NCT00608023|2470453|P2|STARTED|Overall Study||85
1018018|NCT00608023|2470454|P1|STARTED|Overall Study||92
1018019|NCT00608140|2470476|P2|NOT COMPLETED|Overall Study||1
1018020|NCT00608140|2470477|P1|NOT COMPLETED|Overall Study||1
1018021|NCT00608140|2470476|P2|COMPLETED|Overall Study|Study ended early due to low enrollment|0
1018022|NCT00608140|2470477|P1|COMPLETED|Overall Study|Study ended early due to low enrollment|0
1018023|NCT00608140|2470476|P2|STARTED|Overall Study||1
1018024|NCT00608140|2470477|P1|STARTED|Overall Study||1
1018025|NCT00608205|2470487|P2|NOT COMPLETED|Overall Study||3
1018026|NCT00608205|2470488|P1|NOT COMPLETED|Overall Study||3
1018027|NCT00608205|2470487|P2|COMPLETED|Overall Study||31
1018028|NCT00608205|2470488|P1|COMPLETED|Overall Study||32
1018029|NCT00608205|2470487|P2|STARTED|Overall Study||34
1018030|NCT00608205|2470488|P1|STARTED|Overall Study||35
1018031|NCT00608244|2470576|P1|NOT COMPLETED|Overall Study||2
1018032|NCT00608244|2470576|P1|COMPLETED|Overall Study||57
1018033|NCT00608244|2470576|P1|STARTED|Overall Study||59
1018034|NCT00608322|2470587|P2|NOT COMPLETED|Overall Study||1
1018035|NCT00608322|2470588|P1|NOT COMPLETED|Overall Study||2
1018036|NCT00608322|2470587|P2|COMPLETED|Overall Study||22
1018037|NCT00608322|2470588|P1|COMPLETED|Overall Study||24
1018038|NCT00608322|2470587|P2|STARTED|Overall Study||23
1018039|NCT00608322|2470588|P1|STARTED|Overall Study||26
1018040|NCT00608426|2470596|P2|NOT COMPLETED|Overall Study||905
1018041|NCT00608426|2470597|P1|NOT COMPLETED|Overall Study||836
1018042|NCT00608426|2470596|P2|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1614
1018043|NCT00608426|2470597|P1|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1768
1018044|NCT00608426|2470596|P2|STARTED|Overall Study||2519
1018045|NCT00608426|2470597|P1|STARTED|Overall Study||2604
1018046|NCT00608465|2470607|P1|NOT COMPLETED|Overall Study||0
1018047|NCT00608465|2470607|P1|COMPLETED|Overall Study||4
1018048|NCT00608465|2470607|P1|STARTED|Overall Study||4
1018049|NCT00608491|2470614|P2|NOT COMPLETED|Overall Study||22
1018050|NCT00608491|2470615|P1|NOT COMPLETED|Overall Study||21
1018051|NCT00608491|2470614|P2|COMPLETED|Overall Study||72
1018052|NCT00608491|2470615|P1|COMPLETED|Overall Study||73
1018053|NCT00608491|2470614|P2|STARTED|Overall Study||94
1018054|NCT00608491|2470615|P1|STARTED|Overall Study||94
1018055|NCT00608517|2470762|P3|NOT COMPLETED|Overall Study||0
1018056|NCT00608517|2470763|P2|NOT COMPLETED|Overall Study||0
1018057|NCT00608517|2470764|P1|NOT COMPLETED|Overall Study||1
1018058|NCT00608517|2470762|P3|COMPLETED|Overall Study||1
1018059|NCT00608517|2470763|P2|COMPLETED|Overall Study||3
1018060|NCT00608517|2470764|P1|COMPLETED|Overall Study||1
1018061|NCT00608517|2470762|P3|STARTED|Overall Study||1
1018062|NCT00608517|2470763|P2|STARTED|Overall Study||3
1018063|NCT00608517|2470764|P1|STARTED|Overall Study||2
1018064|NCT00608530|2470792|P2|NOT COMPLETED|Overall Study||5
1018065|NCT00608530|2470793|P1|NOT COMPLETED|Overall Study||11
1018066|NCT00608530|2470792|P2|COMPLETED|Overall Study||28
1018067|NCT00608530|2470793|P1|COMPLETED|Overall Study||22
1018068|NCT00608530|2470792|P2|Attended > 0 Treatment Sessions|Overall Study||31
1018069|NCT00608530|2470793|P1|Attended > 0 Treatment Sessions|Overall Study||28
1018070|NCT00608530|2470792|P2|STARTED|Overall Study|Randomized|33
1018071|NCT00608530|2470793|P1|STARTED|Overall Study|Randomized|33
1018072|NCT00608543|2470803|P1|NOT COMPLETED|Overall Study||4
1018073|NCT00608543|2470803|P1|COMPLETED|Overall Study||13
1018074|NCT00608543|2470803|P1|STARTED|Overall Study||17
1018075|NCT00608569|2470814|P2|NOT COMPLETED|Overall Study||9
1018076|NCT00608569|2470815|P1|NOT COMPLETED|Overall Study||10
1018077|NCT00608569|2470814|P2|COMPLETED|Overall Study||119
1018078|NCT00608569|2470815|P1|COMPLETED|Overall Study||119
1018079|NCT00608569|2470814|P2|STARTED|Overall Study||128
1018080|NCT00608569|2470815|P1|STARTED|Overall Study||129
1018081|NCT00608582|2470837|P2|NOT COMPLETED|Overall Study||4
1018082|NCT00608582|2470838|P1|NOT COMPLETED|Overall Study||4
1018083|NCT00608582|2470837|P2|COMPLETED|Overall Study||7
1018084|NCT00608582|2470838|P1|COMPLETED|Overall Study||10
1018085|NCT00608582|2470837|P2|STARTED|Overall Study||11
1018086|NCT00608582|2470838|P1|STARTED|Overall Study||14
1018087|NCT00608634|2470849|P3|NOT COMPLETED|Overall Study||1
1018088|NCT00608634|2470850|P2|NOT COMPLETED|Overall Study||1
1018089|NCT00608634|2470851|P1|NOT COMPLETED|Overall Study||2
1018090|NCT00608634|2470849|P3|COMPLETED|Overall Study||27
1018091|NCT00608634|2470850|P2|COMPLETED|Overall Study||26
1018092|NCT00608634|2470851|P1|COMPLETED|Overall Study||26
1018093|NCT00608634|2470849|P3|STARTED|Overall Study||28
1018094|NCT00608634|2470850|P2|STARTED|Overall Study||27
1018095|NCT00608634|2470851|P1|STARTED|Overall Study||28
1018096|NCT00608777|2470862|P1|NOT COMPLETED|Overall Study||0
1018097|NCT00608777|2470862|P1|COMPLETED|Overall Study||6
1018098|NCT00608777|2470862|P1|STARTED|Overall Study||6
1018099|NCT00608829|2470866|P1|NOT COMPLETED|Overall Study||15
1018100|NCT00608829|2470866|P1|COMPLETED|Overall Study||8
1018101|NCT00608829|2470866|P1|STARTED|Overall Study||23
1018102|NCT00608842|2470874|P4|NOT COMPLETED|Overall Study||1
1018103|NCT00608842|2470875|P3|NOT COMPLETED|Overall Study||2
1018104|NCT00608842|2470876|P2|NOT COMPLETED|Overall Study||1
1018105|NCT00608842|2470877|P1|NOT COMPLETED|Overall Study||1
1018106|NCT00608842|2470874|P4|COMPLETED|Overall Study||16
1018107|NCT00608842|2470875|P3|COMPLETED|Overall Study||13
1018108|NCT00608842|2470876|P2|COMPLETED|Overall Study||14
1018109|NCT00608842|2470877|P1|COMPLETED|Overall Study||14
1018110|NCT00608842|2470874|P4|STARTED|Overall Study||17
1018111|NCT00608842|2470875|P3|STARTED|Overall Study||15
1018112|NCT00608842|2470876|P2|STARTED|Overall Study||15
1018113|NCT00608842|2470877|P1|STARTED|Overall Study||15
1018114|NCT00608868|2470911|P1|NOT COMPLETED|Overall Study||15
1018115|NCT00608868|2470911|P1|COMPLETED|Overall Study||141
1018116|NCT00608868|2470911|P1|Per Protocol (PP) Population|Overall Study||121
1018117|NCT00608868|2470911|P1|Intention to Treat (ITT) Population|Overall Study|8 patients who had no target lesion and 8 who had no tumor assessment after baseline were excluded|138
1018118|NCT00608868|2470911|P1|Treatment Completed|Overall Study||141
1018119|NCT00608868|2470911|P1|Safety Population|Overall Study|2 patients who received no study treatment were excluded|154
1018120|NCT00608868|2470911|P1|Enrolled|Overall Study||156
1018121|NCT00608868|2470911|P1|STARTED|Overall Study||156
1018122|NCT00608881|2470920|P2|NOT COMPLETED|Overall Study||66
1018123|NCT00608881|2470921|P1|NOT COMPLETED|Overall Study||79
1018124|NCT00608881|2470920|P2|COMPLETED|Overall Study||240
1018125|NCT00608881|2470921|P1|COMPLETED|Overall Study||224
1018126|NCT00608881|2470920|P2|STARTED|Overall Study||306
1018127|NCT00608881|2470921|P1|STARTED|Overall Study||303
1018128|NCT00608907|2470958|P3|NOT COMPLETED|Overall Study||1
1018129|NCT00608907|2470959|P2|NOT COMPLETED|Overall Study||0
1018130|NCT00608907|2470960|P1|NOT COMPLETED|Overall Study||12
1018131|NCT00608907|2470958|P3|COMPLETED|Overall Study||17
1018132|NCT00608907|2470959|P2|COMPLETED|Overall Study||13
1018133|NCT00608907|2470960|P1|COMPLETED|Overall Study||18
1018134|NCT00608907|2470958|P3|STARTED|Overall Study||18
1018135|NCT00608907|2470959|P2|STARTED|Overall Study||13
1018136|NCT00608907|2470960|P1|STARTED|Overall Study||30
1018137|NCT00608959|2470970|P1|NOT COMPLETED|Part 2||0
1018138|NCT00608959|2470970|P1|COMPLETED|Part 2||25
1018139|NCT00608959|2470970|P1|STARTED|Part 2|20 Part 1 subjects also participated in Part 2.Five more subjects were enrolled for a total of 25.|25
1018140|NCT00608959|2470970|P1|NOT COMPLETED|Part 1||1
1018141|NCT00608959|2470970|P1|COMPLETED|Part 1||24
1018142|NCT00608959|2470970|P1|STARTED|Part 1|25 subjects each participated in Parts 1 and 2 .A total of 20 subjects participated in both parts.|25
1018143|NCT00608985|2470984|P4|NOT COMPLETED|Overall Study||9
1018144|NCT00608985|2470985|P3|NOT COMPLETED|Overall Study||6
1018145|NCT00608985|2470986|P2|NOT COMPLETED|Overall Study||13
1018146|NCT00608985|2470987|P1|NOT COMPLETED|Overall Study||16
1018147|NCT00608985|2470984|P4|COMPLETED|Overall Study|Completed follow-up|159
1018148|NCT00608985|2470985|P3|COMPLETED|Overall Study|Completed follow-up|170
1018149|NCT00608985|2470986|P2|COMPLETED|Overall Study|Completed follow-up|173
1018150|NCT00608985|2470987|P1|COMPLETED|Overall Study|Completed follow-up|161
1018151|NCT00608985|2470984|P4|Completed Double-blind Treatment|Overall Study||161
1018152|NCT00608985|2470985|P3|Completed Double-blind Treatment|Overall Study||171
1018153|NCT00608985|2470986|P2|Completed Double-blind Treatment|Overall Study||174
1018154|NCT00608985|2470987|P1|Completed Double-blind Treatment|Overall Study||163
1018155|NCT00608985|2470984|P4|STARTED|Overall Study|Randomized and started double-blind treatment|168
1018156|NCT00608985|2470985|P3|STARTED|Overall Study|Randomized and started double-blind treatment|176
1018157|NCT00608985|2470986|P2|STARTED|Overall Study|Randomized and started double-blind treatment|186
1018158|NCT00608985|2470987|P1|STARTED|Overall Study|Randomized and started double-blind treatment|177
1018159|NCT00609167|2471019|P2|NOT COMPLETED|Overall Study||7
1018160|NCT00609167|2471020|P1|NOT COMPLETED|Overall Study||8
1018161|NCT00609167|2471019|P2|COMPLETED|Overall Study||23
1018162|NCT00609167|2471020|P1|COMPLETED|Overall Study||25
1018163|NCT00609167|2471019|P2|STARTED|Overall Study||30
1018164|NCT00609167|2471020|P1|STARTED|Overall Study||33
1018165|NCT00609245|2471042|P1|NOT COMPLETED|Overall Study||1
1018166|NCT00609245|2471042|P1|COMPLETED|Overall Study||12
1018167|NCT00609245|2471042|P1|STARTED|Overall Study||13
1018168|NCT00609336|2471048|P1|NOT COMPLETED|Overall Study||13
1018169|NCT00609336|2471048|P1|COMPLETED|Overall Study||22
1018170|NCT00609336|2471048|P1|Surgery|Overall Study||22
1018171|NCT00609336|2471048|P1|STARTED|Overall Study||35
1018172|NCT00609362|2471062|P2|NOT COMPLETED|Overall Study||1
1018173|NCT00609362|2471063|P1|NOT COMPLETED|Overall Study||3
1018174|NCT00609362|2471062|P2|COMPLETED|Overall Study||27
1018175|NCT00609362|2471063|P1|COMPLETED|Overall Study||26
1018176|NCT00609362|2471062|P2|STARTED|Overall Study||28
1018177|NCT00609362|2471063|P1|STARTED|Overall Study||29
1018178|NCT00609466|2471076|P3|NOT COMPLETED|Overall Study||4
1018179|NCT00609466|2471077|P2|NOT COMPLETED|Overall Study||6
1018180|NCT00609466|2471078|P1|NOT COMPLETED|Overall Study||2
1018181|NCT00609466|2471076|P3|COMPLETED|Overall Study||95
1018182|NCT00609466|2471077|P2|COMPLETED|Overall Study||90
1018183|NCT00609466|2471078|P1|COMPLETED|Overall Study||94
1018184|NCT00609466|2471076|P3|STARTED|Overall Study||99
1018185|NCT00609466|2471077|P2|STARTED|Overall Study||96
1018186|NCT00609466|2471078|P1|STARTED|Overall Study||96
1018187|NCT00609492|2471107|P3|NOT COMPLETED|Overall Study||7
1018188|NCT00609492|2471108|P2|NOT COMPLETED|Overall Study||3
1018189|NCT00609492|2471109|P1|NOT COMPLETED|Overall Study||1
1018190|NCT00609492|2471107|P3|COMPLETED|Overall Study||122
1018191|NCT00609492|2471108|P2|COMPLETED|Overall Study||69
1018192|NCT00609492|2471109|P1|COMPLETED|Overall Study||43
1018193|NCT00609492|2471107|P3|STARTED|Overall Study||129
1018194|NCT00609492|2471108|P2|STARTED|Overall Study||72
1018195|NCT00609492|2471109|P1|STARTED|Overall Study||44
1018196|NCT00609518|2471193|P2|NOT COMPLETED|Overall Study||40
1018197|NCT00609518|2471194|P1|NOT COMPLETED|Overall Study||43
1018198|NCT00609518|2471193|P2|COMPLETED|Overall Study||17
1018199|NCT00609518|2471194|P1|COMPLETED|Overall Study||11
1018200|NCT00609518|2471193|P2|Completed 6 Treatment Cycles|Overall Study||22
1018201|NCT00609518|2471194|P1|Completed 6 Treatment Cycles|Overall Study||19
1018202|NCT00609518|2471193|P2|STARTED|Overall Study||57
1018203|NCT00609518|2471194|P1|STARTED|Overall Study||54
1018204|NCT00609622|2471208|P2|NOT COMPLETED|Overall Study||95
1018205|NCT00609622|2471209|P1|NOT COMPLETED|Overall Study||96
1018206|NCT00609622|2471208|P2|COMPLETED|Overall Study||0
1018207|NCT00609622|2471209|P1|COMPLETED|Overall Study||0
1018208|NCT00609622|2471208|P2|STARTED|Overall Study||95
1018209|NCT00609622|2471209|P1|STARTED|Overall Study||96
1018210|NCT00609674|2471231|P2|NOT COMPLETED|Overall Study||7
1018211|NCT00609674|2471232|P1|NOT COMPLETED|Overall Study||7
1018212|NCT00609674|2471231|P2|COMPLETED|Overall Study||153
1018213|NCT00609674|2471232|P1|COMPLETED|Overall Study||148
1018214|NCT00609674|2471231|P2|STARTED|Overall Study||160
1018215|NCT00609674|2471232|P1|STARTED|Overall Study||155
1018216|NCT00609739|2471266|P1|NOT COMPLETED|Overall Study||0
1018217|NCT00609739|2471266|P1|COMPLETED|Overall Study||1
1018218|NCT00609739|2471266|P1|STARTED|Overall Study||1
1018219|NCT00609765|2471273|P1|NOT COMPLETED|Overall Study||1
1018220|NCT00609765|2471273|P1|COMPLETED|Overall Study||0
1018221|NCT00609765|2471273|P1|STARTED|Overall Study||1
1018222|NCT00609804|2471280|P2|NOT COMPLETED|Overall Study||28
1018223|NCT00609804|2471281|P1|NOT COMPLETED|Overall Study||25
1018224|NCT00609804|2471280|P2|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
1018225|NCT00609804|2471281|P1|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
1018226|NCT00609804|2471280|P2|STARTED|Overall Study||28
1018227|NCT00609804|2471281|P1|STARTED|Overall Study||25
1018228|NCT00609869|2471291|P1|NOT COMPLETED|Overall Study||11
1018229|NCT00609869|2471291|P1|COMPLETED|Overall Study||18
1018230|NCT00609869|2471291|P1|STARTED|Overall Study||29
1018231|NCT00609947|2471297|P1|NOT COMPLETED|Overall Study||1
1018232|NCT00609947|2471297|P1|COMPLETED|Overall Study|One death due to automobile accident.|240
1018233|NCT00609947|2471297|P1|STARTED|Overall Study||241
1018234|NCT00603733|2471304|P2|NOT COMPLETED|Maintenance Phase ITT||16
1018235|NCT00603733|2471305|P1|NOT COMPLETED|Maintenance Phase ITT||10
1018236|NCT00603733|2471304|P2|COMPLETED|Maintenance Phase ITT||66
1018237|NCT00603733|2471305|P1|COMPLETED|Maintenance Phase ITT||61
1018238|NCT00603733|2471304|P2|STARTED|Maintenance Phase ITT||82
1018239|NCT00603733|2471305|P1|STARTED|Maintenance Phase ITT|Note:82 subjects randomized at Active phase & 71 at Run-In phase progressed to the maintenance phase|71
1018240|NCT00603733|2471304|P2|NOT COMPLETED|Run-In Phase - 4 Weeks||13
1018241|NCT00603733|2471305|P1|NOT COMPLETED|Run-In Phase - 4 Weeks||14
1018242|NCT00603733|2471304|P2|COMPLETED|Run-In Phase - 4 Weeks||36
1018243|NCT00603733|2471305|P1|COMPLETED|Run-In Phase - 4 Weeks||35
1018244|NCT00603733|2471304|P2|STARTED|Run-In Phase - 4 Weeks||49
1018245|NCT00603733|2471305|P1|STARTED|Run-In Phase - 4 Weeks|Note: Of the 98 subjects randomized at Run-In, 71 progressed into the maintenance phase.|49
1018246|NCT00603733|2471304|P2|NOT COMPLETED|Active Phase ITT||17
1018247|NCT00603733|2471305|P1|NOT COMPLETED|Active Phase ITT||11
1018248|NCT00603733|2471304|P2|COMPLETED|Active Phase ITT||78
1018249|NCT00603733|2471305|P1|COMPLETED|Active Phase ITT||84
1018250|NCT00603733|2471304|P2|STARTED|Active Phase ITT||95
1018251|NCT00603733|2471305|P1|STARTED|Active Phase ITT|Note: a total of 190 new participants were enrolled and randomized in the Active Phase|95
1018252|NCT00603746|2471321|P6|NOT COMPLETED|Overall Study||13
1018253|NCT00603746|2471322|P5|NOT COMPLETED|Overall Study||17
1018254|NCT00603746|2471323|P4|NOT COMPLETED|Overall Study||13
1018255|NCT00603746|2471324|P3|NOT COMPLETED|Overall Study||8
1018256|NCT00603746|2471325|P2|NOT COMPLETED|Overall Study||18
1018257|NCT00603746|2471326|P1|NOT COMPLETED|Overall Study||38
1018258|NCT00603746|2471321|P6|COMPLETED|Overall Study||97
1018259|NCT00603746|2471322|P5|COMPLETED|Overall Study||85
1018260|NCT00603746|2471323|P4|COMPLETED|Overall Study||94
1018261|NCT00603746|2471324|P3|COMPLETED|Overall Study||93
1018262|NCT00603746|2471325|P2|COMPLETED|Overall Study||81
1018263|NCT00603746|2471326|P1|COMPLETED|Overall Study||65
1018264|NCT00603746|2471321|P6|STARTED|Overall Study||110
1018265|NCT00603746|2471322|P5|STARTED|Overall Study||102
1018266|NCT00603746|2471323|P4|STARTED|Overall Study||107
1018267|NCT00603746|2471324|P3|STARTED|Overall Study||101
1018268|NCT00603746|2471325|P2|STARTED|Overall Study||99
1018269|NCT00603746|2471326|P1|STARTED|Overall Study||103
1018270|NCT00603798|2471475|P3|NOT COMPLETED|Overall Study||10
1018271|NCT00603798|2471476|P2|NOT COMPLETED|Overall Study||7
1018272|NCT00603798|2471477|P1|NOT COMPLETED|Overall Study||10
1018273|NCT00603798|2471475|P3|COMPLETED|Overall Study||154
1018274|NCT00603798|2471476|P2|COMPLETED|Overall Study||157
1018275|NCT00603798|2471477|P1|COMPLETED|Overall Study||152
1018276|NCT00603798|2471475|P3|STARTED|Overall Study||164
1018277|NCT00603798|2471476|P2|STARTED|Overall Study||164
1018278|NCT00603798|2471477|P1|STARTED|Overall Study||162
1018279|NCT00603837|2471496|P2|NOT COMPLETED|Overall Study||0
1018280|NCT00603837|2471497|P1|NOT COMPLETED|Overall Study||3
1018281|NCT00603837|2471496|P2|COMPLETED|Overall Study||19
1018282|NCT00603837|2471497|P1|COMPLETED|Overall Study||17
1018283|NCT00603837|2471496|P2|STARTED|Overall Study||19
1018284|NCT00603837|2471497|P1|STARTED|Overall Study||20
1018285|NCT00603889|2471503|P1|NOT COMPLETED|Overall Study||0
1018286|NCT00603889|2471503|P1|COMPLETED|Overall Study||12
1018287|NCT00603889|2471503|P1|STARTED|Overall Study||12
1018297|NCT00603915|2471526|P1|NOT COMPLETED|Overall Study||1
1018298|NCT00603915|2471526|P1|COMPLETED|Overall Study||19
1018299|NCT00603915|2471526|P1|STARTED|Overall Study||20
1018300|NCT00609973|2471533|P2|NOT COMPLETED|Overall Study||6
1018301|NCT00609973|2471534|P1|NOT COMPLETED|Overall Study||8
1018302|NCT00609973|2471533|P2|COMPLETED|Overall Study||10
1018303|NCT00609973|2471534|P1|COMPLETED|Overall Study||9
1018304|NCT00609973|2471533|P2|STARTED|Overall Study||16
1018305|NCT00609973|2471534|P1|STARTED|Overall Study||17
1018306|NCT00609986|2471544|P2|NOT COMPLETED|Overall Study||3
1018307|NCT00609986|2471545|P1|NOT COMPLETED|Overall Study||8
1018308|NCT00609986|2471544|P2|COMPLETED|Overall Study||49
1018309|NCT00609986|2471545|P1|COMPLETED|Overall Study||44
1018310|NCT00609986|2471544|P2|Received Transplant|Overall Study||49
1018311|NCT00609986|2471545|P1|Received Transplant|Overall Study||44
1018312|NCT00609986|2471544|P2|STARTED|Overall Study||52
1018313|NCT00609986|2471545|P1|STARTED|Overall Study||52
1018314|NCT00610129|2471557|P1|NOT COMPLETED|Overall Study||3
1018315|NCT00610129|2471557|P1|COMPLETED|Overall Study||25
1018316|NCT00610129|2471557|P1|STARTED|Overall Study||28
1018317|NCT00610155|2471561|P6|NOT COMPLETED|Period 3||0
1018318|NCT00610155|2471562|P5|NOT COMPLETED|Period 3||0
1018319|NCT00610155|2471563|P4|NOT COMPLETED|Period 3||0
1018320|NCT00610155|2471564|P3|NOT COMPLETED|Period 3||0
1018321|NCT00610155|2471565|P2|NOT COMPLETED|Period 3||0
1018322|NCT00610155|2471566|P1|NOT COMPLETED|Period 3||1
1018323|NCT00610155|2471561|P6|COMPLETED|Period 3||1
1018324|NCT00610155|2471562|P5|COMPLETED|Period 3||3
1018325|NCT00610155|2471563|P4|COMPLETED|Period 3||3
1018326|NCT00610155|2471564|P3|COMPLETED|Period 3||3
1018327|NCT00610155|2471565|P2|COMPLETED|Period 3||3
1018328|NCT00610155|2471566|P1|COMPLETED|Period 3||3
1018329|NCT00610155|2471561|P6|STARTED|Period 3||1
1018330|NCT00610155|2471562|P5|STARTED|Period 3||3
1018331|NCT00610155|2471563|P4|STARTED|Period 3||3
1018332|NCT00610155|2471564|P3|STARTED|Period 3||3
1018333|NCT00610155|2471565|P2|STARTED|Period 3||3
1018334|NCT00610155|2471566|P1|STARTED|Period 3||4
1018335|NCT00610155|2471561|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
1018336|NCT00610155|2471562|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
1018337|NCT00610155|2471563|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
1018338|NCT00610155|2471564|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
1018339|NCT00610155|2471565|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
1018340|NCT00610155|2471566|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
1018341|NCT00610155|2471561|P6|COMPLETED|Washout Period 2 (7 Days)||1
1018342|NCT00610155|2471562|P5|COMPLETED|Washout Period 2 (7 Days)||3
1018343|NCT00610155|2471563|P4|COMPLETED|Washout Period 2 (7 Days)||3
1018344|NCT00610155|2471564|P3|COMPLETED|Washout Period 2 (7 Days)||3
1018345|NCT00610155|2471565|P2|COMPLETED|Washout Period 2 (7 Days)||3
1018346|NCT00610155|2471566|P1|COMPLETED|Washout Period 2 (7 Days)||4
1018347|NCT00610155|2471561|P6|STARTED|Washout Period 2 (7 Days)||1
1018348|NCT00610155|2471562|P5|STARTED|Washout Period 2 (7 Days)||3
1018349|NCT00610155|2471563|P4|STARTED|Washout Period 2 (7 Days)||3
1018350|NCT00610155|2471564|P3|STARTED|Washout Period 2 (7 Days)||3
1018351|NCT00610155|2471565|P2|STARTED|Washout Period 2 (7 Days)||3
1018352|NCT00610155|2471566|P1|STARTED|Washout Period 2 (7 Days)||4
1018353|NCT00610155|2471561|P6|NOT COMPLETED|Period 2||0
1018354|NCT00610155|2471562|P5|NOT COMPLETED|Period 2||0
1018355|NCT00610155|2471563|P4|NOT COMPLETED|Period 2||0
1018356|NCT00610155|2471564|P3|NOT COMPLETED|Period 2||0
1018357|NCT00610155|2471565|P2|NOT COMPLETED|Period 2||0
1018358|NCT00610155|2471566|P1|NOT COMPLETED|Period 2||0
1018359|NCT00610155|2471561|P6|COMPLETED|Period 2||1
1018360|NCT00610155|2471562|P5|COMPLETED|Period 2||3
1018361|NCT00610155|2471563|P4|COMPLETED|Period 2||3
1018362|NCT00610155|2471564|P3|COMPLETED|Period 2||3
1018363|NCT00610155|2471565|P2|COMPLETED|Period 2||3
1018364|NCT00610155|2471566|P1|COMPLETED|Period 2||4
1018365|NCT00610155|2471561|P6|STARTED|Period 2||1
1018366|NCT00610155|2471562|P5|STARTED|Period 2||3
1018367|NCT00610155|2471563|P4|STARTED|Period 2||3
1018368|NCT00610155|2471564|P3|STARTED|Period 2||3
1018369|NCT00610155|2471565|P2|STARTED|Period 2||3
1018370|NCT00610155|2471566|P1|STARTED|Period 2||4
1018371|NCT00610155|2471561|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
1018372|NCT00610155|2471562|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
1018373|NCT00610155|2471563|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
1018374|NCT00610155|2471564|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
1018375|NCT00610155|2471565|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
1018376|NCT00610155|2471566|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
1018377|NCT00610155|2471561|P6|COMPLETED|Washout Period 1 (7 Days)||1
1018378|NCT00610155|2471562|P5|COMPLETED|Washout Period 1 (7 Days)||3
1018379|NCT00610155|2471563|P4|COMPLETED|Washout Period 1 (7 Days)||3
1018380|NCT00610155|2471564|P3|COMPLETED|Washout Period 1 (7 Days)||3
1018381|NCT00610155|2471565|P2|COMPLETED|Washout Period 1 (7 Days)||3
1018382|NCT00610155|2471566|P1|COMPLETED|Washout Period 1 (7 Days)||4
1018383|NCT00610155|2471561|P6|STARTED|Washout Period 1 (7 Days)||1
1018384|NCT00610155|2471562|P5|STARTED|Washout Period 1 (7 Days)||3
1018385|NCT00610155|2471563|P4|STARTED|Washout Period 1 (7 Days)||3
1018386|NCT00610155|2471564|P3|STARTED|Washout Period 1 (7 Days)||3
1018387|NCT00610155|2471565|P2|STARTED|Washout Period 1 (7 Days)||3
1018388|NCT00610155|2471566|P1|STARTED|Washout Period 1 (7 Days)||4
1018389|NCT00610155|2471561|P6|NOT COMPLETED|Period 1||0
1018390|NCT00610155|2471562|P5|NOT COMPLETED|Period 1||0
1018391|NCT00610155|2471563|P4|NOT COMPLETED|Period 1||0
1018392|NCT00610155|2471564|P3|NOT COMPLETED|Period 1||1
1018393|NCT00610155|2471565|P2|NOT COMPLETED|Period 1||0
1018394|NCT00610155|2471566|P1|NOT COMPLETED|Period 1||0
1018395|NCT00610155|2471561|P6|COMPLETED|Period 1||1
1018396|NCT00610155|2471562|P5|COMPLETED|Period 1||3
1018397|NCT00610155|2471563|P4|COMPLETED|Period 1||3
1018398|NCT00610155|2471564|P3|COMPLETED|Period 1||3
1018399|NCT00610155|2471565|P2|COMPLETED|Period 1||3
1018400|NCT00610155|2471566|P1|COMPLETED|Period 1||4
1018401|NCT00610155|2471561|P6|STARTED|Period 1||1
1018402|NCT00610155|2471562|P5|STARTED|Period 1||3
1018403|NCT00610155|2471563|P4|STARTED|Period 1||3
1018404|NCT00610155|2471564|P3|STARTED|Period 1||4
1018405|NCT00610155|2471565|P2|STARTED|Period 1||3
1018406|NCT00610155|2471566|P1|STARTED|Period 1||4
1018407|NCT00610168|2471615|P2|NOT COMPLETED|Overall Study||0
1018408|NCT00610168|2471616|P1|NOT COMPLETED|Overall Study||2
1018409|NCT00610168|2471615|P2|COMPLETED|Overall Study||7
1018410|NCT00610168|2471616|P1|COMPLETED|Overall Study||73
1018411|NCT00610168|2471615|P2|STARTED|Overall Study||7
1018412|NCT00610168|2471616|P1|STARTED|Overall Study||75
1018413|NCT00610207|2471635|P1|NOT COMPLETED|Overall Study||3
1018414|NCT00610207|2471635|P1|COMPLETED|Overall Study||18
1018415|NCT00610207|2471635|P1|STARTED|Overall Study||21
1018416|NCT00611247|2471642|P2|NOT COMPLETED|Overall Study||21
1018417|NCT00611247|2471643|P1|NOT COMPLETED|Overall Study||2
1018418|NCT00611247|2471642|P2|COMPLETED|Overall Study||10
1018419|NCT00611247|2471643|P1|COMPLETED|Overall Study||3
1018420|NCT00611247|2471642|P2|STARTED|Overall Study||31
1018421|NCT00611247|2471643|P1|STARTED|Overall Study||5
1018422|NCT00611325|2471655|P2|NOT COMPLETED|Overall Study||0
1018423|NCT00611325|2471656|P1|NOT COMPLETED|Overall Study||0
1018424|NCT00611325|2471655|P2|COMPLETED|Overall Study||28
1018425|NCT00611325|2471656|P1|COMPLETED|Overall Study||28
1018426|NCT00611325|2471655|P2|STARTED|Overall Study||28
1018427|NCT00611325|2471656|P1|STARTED|Overall Study||28
1018428|NCT00611403|2471672|P2|NOT COMPLETED|Post Treatment Extension Phase||1
1018429|NCT00611403|2471673|P1|NOT COMPLETED|Post Treatment Extension Phase||4
1018430|NCT00611403|2471672|P2|COMPLETED|Post Treatment Extension Phase||24
1018431|NCT00611403|2471673|P1|COMPLETED|Post Treatment Extension Phase||22
1018432|NCT00611403|2471672|P2|STARTED|Post Treatment Extension Phase|25 of 69 pts who received ENDURA® in the Treatment Phase entered the Post Treatment Extension Phase|25
1018433|NCT00611403|2471673|P1|STARTED|Post Treatment Extension Phase|26 of 68 pts who received RESTASIS® in the Treatment Phase entered the Post Treatment Ext. Phase|26
1018434|NCT00611403|2471672|P2|NOT COMPLETED|Treatment Phase||11
1018435|NCT00611403|2471673|P1|NOT COMPLETED|Treatment Phase||6
1018436|NCT00611403|2471672|P2|COMPLETED|Treatment Phase||58
1018437|NCT00611403|2471673|P1|COMPLETED|Treatment Phase||62
1018438|NCT00611403|2471672|P2|STARTED|Treatment Phase||69
1018439|NCT00611403|2471673|P1|STARTED|Treatment Phase||68
1018440|NCT00611442|2471685|P2|NOT COMPLETED|Overall Study||2
1018441|NCT00611442|2471686|P1|NOT COMPLETED|Overall Study||1
1018442|NCT00611442|2471685|P2|COMPLETED|Overall Study||94
1018443|NCT00611442|2471686|P1|COMPLETED|Overall Study||94
1018444|NCT00611442|2471685|P2|STARTED|Overall Study||96
1018445|NCT00611442|2471686|P1|STARTED|Overall Study||95
1018446|NCT00611455|2471700|P3|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||211
1018447|NCT00611455|2471701|P2|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
1018448|NCT00611455|2471702|P1|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
1018449|NCT00611455|2471700|P3|COMPLETED|Follow-up Period (Approximately 2 Years)||49
1018450|NCT00611455|2471701|P2|COMPLETED|Follow-up Period (Approximately 2 Years)||0
1018451|NCT00611455|2471702|P1|COMPLETED|Follow-up Period (Approximately 2 Years)||0
1018452|NCT00611455|2471700|P3|STARTED|Follow-up Period (Approximately 2 Years)|These participants received at least one infusion of placebo or ofatumumab.|260
1018453|NCT00611455|2471701|P2|STARTED|Follow-up Period (Approximately 2 Years)||0
1018454|NCT00611455|2471702|P1|STARTED|Follow-up Period (Approximately 2 Years)||0
1018455|NCT00611455|2471700|P3|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
1018456|NCT00611455|2471701|P2|NOT COMPLETED|OL Treatment Period (120 Weeks)||179
1018457|NCT00611455|2471702|P1|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
1018458|NCT00611455|2471700|P3|COMPLETED|OL Treatment Period (120 Weeks)||0
1018459|NCT00611455|2471701|P2|COMPLETED|OL Treatment Period (120 Weeks)||52
1018460|NCT00611455|2471702|P1|COMPLETED|OL Treatment Period (120 Weeks)||0
1018461|NCT00611455|2471700|P3|STARTED|OL Treatment Period (120 Weeks)||0
1018462|NCT00611455|2471701|P2|STARTED|OL Treatment Period (120 Weeks)|118 participants received OFA during the DB Period; 113 received placebo during the DB Period.|231
1018463|NCT00611455|2471702|P1|STARTED|OL Treatment Period (120 Weeks)||0
1018464|NCT00611455|2471700|P3|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
1018465|NCT00611455|2471701|P2|NOT COMPLETED|DB Treatment Period (24 Weeks)||14
1018466|NCT00611455|2471702|P1|NOT COMPLETED|DB Treatment Period (24 Weeks)||13
1018467|NCT00611455|2471700|P3|COMPLETED|DB Treatment Period (24 Weeks)||0
1018468|NCT00611455|2471701|P2|COMPLETED|DB Treatment Period (24 Weeks)||117
1018469|NCT00611455|2471702|P1|COMPLETED|DB Treatment Period (24 Weeks)||121
1018470|NCT00611455|2471700|P3|STARTED|DB Treatment Period (24 Weeks)||0
1018471|NCT00611455|2471701|P2|STARTED|DB Treatment Period (24 Weeks)||131
1018472|NCT00611455|2471702|P1|STARTED|DB Treatment Period (24 Weeks)||134
1018473|NCT00611468|2471828|P4|NOT COMPLETED|Overall Study||0
1018474|NCT00611468|2471829|P3|NOT COMPLETED|Overall Study||0
1018475|NCT00611468|2471830|P2|NOT COMPLETED|Overall Study||1
1018476|NCT00611468|2471831|P1|NOT COMPLETED|Overall Study||0
1018477|NCT00611468|2471828|P4|COMPLETED|Overall Study||13
1018478|NCT00611468|2471829|P3|COMPLETED|Overall Study||6
1018479|NCT00611468|2471830|P2|COMPLETED|Overall Study|One subject did not complete Cycle 1 of treatment and was replaced.|6
1018480|NCT00611468|2471831|P1|COMPLETED|Overall Study||3
1018481|NCT00611468|2471828|P4|STARTED|Overall Study||13
1018482|NCT00611468|2471829|P3|STARTED|Overall Study||6
1018483|NCT00611468|2471830|P2|STARTED|Overall Study||7
1018484|NCT00611468|2471831|P1|STARTED|Overall Study||3
1018485|NCT00611533|2471841|P2|NOT COMPLETED|Second Intervention (6 Weeks)||2
1018486|NCT00611533|2471842|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
1018487|NCT00611533|2471841|P2|COMPLETED|Second Intervention (6 Weeks)||4
1018488|NCT00611533|2471842|P1|COMPLETED|Second Intervention (6 Weeks)||8
1018489|NCT00611533|2471841|P2|STARTED|Second Intervention (6 Weeks)||6
1018490|NCT00611533|2471842|P1|STARTED|Second Intervention (6 Weeks)||8
1018491|NCT00611533|2471841|P2|NOT COMPLETED|First Intervention (6 Weeks)||2
1018492|NCT00611533|2471842|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
1018493|NCT00611533|2471841|P2|COMPLETED|First Intervention (6 Weeks)||6
1018494|NCT00611533|2471842|P1|COMPLETED|First Intervention (6 Weeks)||8
1018495|NCT00611533|2471841|P2|STARTED|First Intervention (6 Weeks)||8
1018496|NCT00611533|2471842|P1|STARTED|First Intervention (6 Weeks)||8
1018497|NCT00611559|2471864|P3|NOT COMPLETED|Overall Study||1
1018498|NCT00611559|2471865|P2|NOT COMPLETED|Overall Study||1
1018499|NCT00611559|2471866|P1|NOT COMPLETED|Overall Study||1
1018500|NCT00611559|2471864|P3|COMPLETED|Overall Study||56
1018501|NCT00611559|2471865|P2|COMPLETED|Overall Study||114
1018502|NCT00611559|2471866|P1|COMPLETED|Overall Study||110
1018503|NCT00611559|2471864|P3|STARTED|Overall Study||57
1018504|NCT00611559|2471865|P2|STARTED|Overall Study||115
1018505|NCT00611559|2471866|P1|STARTED|Overall Study||111
1018506|NCT00611624|2471925|P1|NOT COMPLETED|Overall Study||0
1018507|NCT00611624|2471925|P1|COMPLETED|Overall Study||28
1018508|NCT00611624|2471925|P1|STARTED|Overall Study||28
1018509|NCT00611715|2471932|P2|NOT COMPLETED|Overall Study||6
1018510|NCT00611715|2471933|P1|NOT COMPLETED|Overall Study||41
1018511|NCT00611715|2471932|P2|COMPLETED|Overall Study||0
1018512|NCT00611715|2471933|P1|COMPLETED|Overall Study|"2 pts in Arm 1 remain on-tx. They are not accounted for in off-tx reasonor completed data fields"|1
1018513|NCT00611715|2471932|P2|STARTED|Overall Study||6
1018514|NCT00611715|2471933|P1|STARTED|Overall Study||42
1018515|NCT00611767|2471947|P2|NOT COMPLETED|Overall Study||2
1018516|NCT00611767|2471948|P1|NOT COMPLETED|Overall Study||9
1018517|NCT00611767|2471947|P2|COMPLETED|Overall Study||22
1018518|NCT00611767|2471948|P1|COMPLETED|Overall Study||40
1018519|NCT00611767|2471947|P2|Placebo Test Day|Overall Study||1
1018520|NCT00611767|2471948|P1|Placebo Test Day|Overall Study||6
1018521|NCT00611767|2471947|P2|Thiopental Test Day|Overall Study||1
1018522|NCT00611767|2471948|P1|Thiopental Test Day|Overall Study||3
1018523|NCT00611767|2471947|P2|STARTED|Overall Study||24
1018524|NCT00611767|2471948|P1|STARTED|Overall Study||49
1018525|NCT00611806|2472110|P2|NOT COMPLETED|Overall Study||3
1018526|NCT00611806|2472111|P1|NOT COMPLETED|Overall Study||16
1018527|NCT00611806|2472110|P2|COMPLETED|Overall Study||43
1018528|NCT00611806|2472111|P1|COMPLETED|Overall Study||78
1018529|NCT00611806|2472110|P2|STARTED|Overall Study||46
1018530|NCT00611806|2472111|P1|STARTED|Overall Study||94
1018531|NCT00611884|2472127|P4|NOT COMPLETED|Overall Study||6
1018532|NCT00611884|2472128|P3|NOT COMPLETED|Overall Study||4
1018533|NCT00611884|2472129|P2|NOT COMPLETED|Overall Study||9
1018534|NCT00611884|2472130|P1|NOT COMPLETED|Overall Study||9
1018535|NCT00611884|2472127|P4|COMPLETED|Overall Study||56
1018536|NCT00611884|2472128|P3|COMPLETED|Overall Study||58
1018537|NCT00611884|2472129|P2|COMPLETED|Overall Study||51
1018538|NCT00611884|2472130|P1|COMPLETED|Overall Study||52
1018539|NCT00611884|2472127|P4|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
1018540|NCT00611884|2472128|P3|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
1018541|NCT00611884|2472129|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|59
1018542|NCT00611884|2472130|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|58
1018543|NCT00611884|2472127|P4|STARTED|Overall Study||62
1018544|NCT00611884|2472128|P3|STARTED|Overall Study||62
1018545|NCT00611884|2472129|P2|STARTED|Overall Study||60
1018546|NCT00611884|2472130|P1|STARTED|Overall Study||61
1018547|NCT00611897|2472184|P2|NOT COMPLETED|Day 2: Crossover Treatment||0
1018548|NCT00611897|2472185|P1|NOT COMPLETED|Day 2: Crossover Treatment||0
1018549|NCT00611897|2472184|P2|COMPLETED|Day 2: Crossover Treatment||8
1018550|NCT00611897|2472185|P1|COMPLETED|Day 2: Crossover Treatment||8
1018551|NCT00611897|2472184|P2|STARTED|Day 2: Crossover Treatment||8
1018552|NCT00611897|2472185|P1|STARTED|Day 2: Crossover Treatment||8
1018553|NCT00611897|2472184|P2|NOT COMPLETED|Day 1: Initial Treatment||0
1018554|NCT00611897|2472185|P1|NOT COMPLETED|Day 1: Initial Treatment||0
1018555|NCT00611897|2472184|P2|COMPLETED|Day 1: Initial Treatment||8
1018556|NCT00611897|2472185|P1|COMPLETED|Day 1: Initial Treatment||8
1018557|NCT00611897|2472184|P2|STARTED|Day 1: Initial Treatment||8
1018558|NCT00611897|2472185|P1|STARTED|Day 1: Initial Treatment||8
1018559|NCT00612040|2472212|P3|NOT COMPLETED|Overall Study||7
1018560|NCT00612040|2472213|P2|NOT COMPLETED|Overall Study||7
1018561|NCT00612040|2472214|P1|NOT COMPLETED|Overall Study||5
1018562|NCT00612040|2472212|P3|COMPLETED|Overall Study||52
1018563|NCT00612040|2472213|P2|COMPLETED|Overall Study||52
1018564|NCT00612040|2472214|P1|COMPLETED|Overall Study||55
1018565|NCT00612040|2472212|P3|Exposed|Overall Study||59
1018566|NCT00612040|2472213|P2|Exposed|Overall Study||59
1018567|NCT00612040|2472214|P1|Exposed|Overall Study||60
1018568|NCT00612040|2472212|P3|STARTED|Overall Study||59
1018569|NCT00612040|2472213|P2|STARTED|Overall Study||59
1018570|NCT00612040|2472214|P1|STARTED|Overall Study||60
1018571|NCT00612066|2472258|P1|NOT COMPLETED|Overall Study||1
1018572|NCT00612066|2472258|P1|COMPLETED|Overall Study||1
1018573|NCT00612066|2472258|P1|STARTED|Overall Study||2
1018574|NCT00612105|2472264|P2|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||0
1018575|NCT00612105|2472265|P1|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||1
1018576|NCT00612105|2472264|P2|COMPLETED|Period Title 3: 3-Week Taper Phase||58
1018577|NCT00612105|2472265|P1|COMPLETED|Period Title 3: 3-Week Taper Phase||85
1018578|NCT00612105|2472264|P2|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|58
1018579|NCT00612105|2472265|P1|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|86
1018580|NCT00612105|2472264|P2|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||2
1018581|NCT00612105|2472265|P1|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||11
1018582|NCT00612105|2472264|P2|COMPLETED|Period Title 2: 4-Week Maintenance Phase||55
1018583|NCT00612105|2472265|P1|COMPLETED|Period Title 2: 4-Week Maintenance Phase||78
1018584|NCT00612105|2472264|P2|STARTED|Period Title 2: 4-Week Maintenance Phase||57
1018585|NCT00612105|2472265|P1|STARTED|Period Title 2: 4-Week Maintenance Phase||89
1018586|NCT00612105|2472264|P2|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||5
1018587|NCT00612105|2472265|P1|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||36
1018588|NCT00612105|2472264|P2|COMPLETED|Period Title 1: 6-Week Titration Phase||57
1018589|NCT00612105|2472265|P1|COMPLETED|Period Title 1: 6-Week Titration Phase||89
1018590|NCT00612105|2472264|P2|STARTED|Period Title 1: 6-Week Titration Phase||62
1018591|NCT00612105|2472265|P1|STARTED|Period Title 1: 6-Week Titration Phase||125
1018592|NCT00612222|2472315|P1|NOT COMPLETED|Overall Study||0
1018593|NCT00612222|2472315|P1|COMPLETED|Overall Study||4
1018594|NCT00612222|2472315|P1|STARTED|Overall Study||4
1018595|NCT00612313|2472323|P2|NOT COMPLETED|Overall Study||13
1018596|NCT00612313|2472324|P1|NOT COMPLETED|Overall Study||17
1018597|NCT00612313|2472323|P2|COMPLETED|Overall Study||62
1018598|NCT00612313|2472324|P1|COMPLETED|Overall Study||52
1018599|NCT00612313|2472323|P2|STARTED|Overall Study||75
1018600|NCT00612313|2472324|P1|STARTED|Overall Study||69
1018601|NCT00612339|2472340|P1|NOT COMPLETED|Overall Study||0
1018602|NCT00612339|2472340|P1|COMPLETED|Overall Study||41
1018603|NCT00612339|2472340|P1|STARTED|Overall Study||41
1018604|NCT00612352|2472346|P2|NOT COMPLETED|Overall Study||6
1018605|NCT00612352|2472347|P1|NOT COMPLETED|Overall Study||9
1018606|NCT00612352|2472346|P2|COMPLETED|Overall Study||109
1018607|NCT00612352|2472347|P1|COMPLETED|Overall Study||56
1018608|NCT00612352|2472346|P2|Placebo|Overall Study||4
1018609|NCT00612352|2472347|P1|Placebo|Overall Study||4
1018610|NCT00612352|2472346|P2|40%mg|Overall Study||0
1018611|NCT00612352|2472347|P1|40%mg|Overall Study||1
1018612|NCT00612352|2472346|P2|100%mg|Overall Study||1
1018613|NCT00612352|2472347|P1|100%mg|Overall Study||2
1018614|NCT00612352|2472346|P2|Placebo & 100%mg|Overall Study||0
1018615|NCT00612352|2472347|P1|Placebo & 100%mg|Overall Study||1
1018616|NCT00612352|2472346|P2|40%mg & 100%mg|Overall Study||1
1018617|NCT00612352|2472347|P1|40%mg & 100%mg|Overall Study||1
1018618|NCT00612352|2472346|P2|STARTED|Overall Study||115
1018619|NCT00612352|2472347|P1|STARTED|Overall Study||65
1018620|NCT00612430|2472463|P2|NOT COMPLETED|Overall Study||0
1018621|NCT00612430|2472464|P1|NOT COMPLETED|Overall Study||0
1018622|NCT00612430|2472463|P2|COMPLETED|Overall Study||27
1018623|NCT00612430|2472464|P1|COMPLETED|Overall Study||32
1018624|NCT00612430|2472463|P2|STARTED|Overall Study||27
1018625|NCT00612430|2472464|P1|STARTED|Overall Study||32
1018626|NCT00612456|2472481|P3|NOT COMPLETED|Overall Study||0
1018627|NCT00612456|2472482|P2|NOT COMPLETED|Overall Study||2
1018628|NCT00612456|2472483|P1|NOT COMPLETED|Overall Study||2
1018629|NCT00612456|2472481|P3|COMPLETED|Overall Study||16
1018630|NCT00612456|2472482|P2|COMPLETED|Overall Study||25
1018631|NCT00612456|2472483|P1|COMPLETED|Overall Study||25
1018632|NCT00612456|2472481|P3|STARTED|Overall Study||16
1018633|NCT00612456|2472482|P2|STARTED|Overall Study||27
1018634|NCT00612456|2472483|P1|STARTED|Overall Study||27
1018635|NCT00612508|2472529|P2|NOT COMPLETED|Overall Study||4
1018636|NCT00612508|2472530|P1|NOT COMPLETED|Overall Study||3
1018637|NCT00612508|2472529|P2|COMPLETED|Overall Study|6 nuvaring users returned for the 84 day biopsy|3
1018638|NCT00612508|2472530|P1|COMPLETED|Overall Study|5 desogen users returned for the 84 day biopsy|4
1018639|NCT00612508|2472529|P2|STARTED|Overall Study||7
1018640|NCT00612508|2472530|P1|STARTED|Overall Study||7
1018641|NCT00612534|2472542|P4|NOT COMPLETED|Overall Study||17
1018642|NCT00612534|2472543|P3|NOT COMPLETED|Overall Study||7
1018643|NCT00612534|2472544|P2|NOT COMPLETED|Overall Study||17
1018644|NCT00612534|2472545|P1|NOT COMPLETED|Overall Study||13
1018645|NCT00612534|2472542|P4|COMPLETED|Overall Study||7
1018646|NCT00612534|2472543|P3|COMPLETED|Overall Study||13
1018647|NCT00612534|2472544|P2|COMPLETED|Overall Study||9
1018648|NCT00612534|2472545|P1|COMPLETED|Overall Study||11
1018649|NCT00612534|2472542|P4|STARTED|Overall Study||24
1018650|NCT00612534|2472543|P3|STARTED|Overall Study||20
1018651|NCT00612534|2472544|P2|STARTED|Overall Study||26
1018652|NCT00612534|2472545|P1|STARTED|Overall Study||24
1018665|NCT00612573|2472588|P4|NOT COMPLETED|Overall Study||13
1018666|NCT00612573|2472589|P3|NOT COMPLETED|Overall Study||9
1018667|NCT00612573|2472590|P2|NOT COMPLETED|Overall Study||14
1018668|NCT00612573|2472591|P1|NOT COMPLETED|Overall Study||12
1018669|NCT00612573|2472588|P4|COMPLETED|Overall Study||54
1018670|NCT00612573|2472589|P3|COMPLETED|Overall Study||52
1018671|NCT00612573|2472590|P2|COMPLETED|Overall Study||51
1018672|NCT00612573|2472591|P1|COMPLETED|Overall Study||52
1018673|NCT00612573|2472588|P4|STARTED|Overall Study||67
1018674|NCT00612573|2472589|P3|STARTED|Overall Study||61
1018675|NCT00612573|2472590|P2|STARTED|Overall Study||65
1018676|NCT00612573|2472591|P1|STARTED|Overall Study||64
1018677|NCT00612677|2472613|P1|NOT COMPLETED|Overall Study||1
1018678|NCT00612677|2472613|P1|COMPLETED|Overall Study||0
1018679|NCT00612677|2472613|P1|STARTED|Overall Study||1
1018680|NCT00612690|2472621|P2|NOT COMPLETED|Overall Study||118
1018681|NCT00612690|2472622|P1|NOT COMPLETED|Overall Study||115
1018682|NCT00612690|2472621|P2|COMPLETED|Overall Study||89
1018683|NCT00612690|2472622|P1|COMPLETED|Overall Study||160
1018684|NCT00612690|2472621|P2|STARTED|Overall Study||207
1018685|NCT00612690|2472622|P1|STARTED|Overall Study||275
1018686|NCT00612807|2472632|P2|NOT COMPLETED|Overall Study||0
1018687|NCT00612807|2472633|P1|NOT COMPLETED|Overall Study||2
1018688|NCT00612807|2472632|P2|COMPLETED|Overall Study||28
1018689|NCT00612807|2472633|P1|COMPLETED|Overall Study||12
1018690|NCT00612807|2472632|P2|STARTED|Overall Study||28
1018691|NCT00612807|2472633|P1|STARTED|Overall Study||14
1018698|NCT00613015|2472661|P6|NOT COMPLETED|Overall Study||3
1018699|NCT00613015|2472662|P5|NOT COMPLETED|Overall Study||2
1018700|NCT00613015|2472663|P4|NOT COMPLETED|Overall Study||3
1018701|NCT00613015|2472664|P3|NOT COMPLETED|Overall Study||3
1018702|NCT00613015|2472665|P2|NOT COMPLETED|Overall Study||1
1018703|NCT00613015|2472666|P1|NOT COMPLETED|Overall Study||0
1018704|NCT00613015|2472661|P6|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|16
1018705|NCT00613015|2472662|P5|COMPLETED|Overall Study|Two participants did not complete one-week follow-up visit.|13
1018706|NCT00613015|2472663|P4|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|21
1018707|NCT00613015|2472664|P3|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|23
1018708|NCT00613015|2472665|P2|COMPLETED|Overall Study|One participant did not complete the one-week follow-up visit.|11
1018709|NCT00613015|2472666|P1|COMPLETED|Overall Study||13
1018710|NCT00613015|2472661|P6|STARTED|Overall Study||19
1018711|NCT00613015|2472662|P5|STARTED|Overall Study||15
1018712|NCT00613015|2472663|P4|STARTED|Overall Study||24
1018713|NCT00613015|2472664|P3|STARTED|Overall Study||26
1018714|NCT00613015|2472665|P2|STARTED|Overall Study||12
1018715|NCT00613015|2472666|P1|STARTED|Overall Study||13
1018716|NCT00613028|2472688|P2|NOT COMPLETED|Overall Study||1
1018717|NCT00613028|2472689|P1|NOT COMPLETED|Overall Study||0
1018718|NCT00613028|2472688|P2|COMPLETED|Overall Study||12
1018719|NCT00613028|2472689|P1|COMPLETED|Overall Study||10
1018720|NCT00613028|2472688|P2|STARTED|Overall Study||13
1018721|NCT00613028|2472689|P1|STARTED|Overall Study||10
1018722|NCT00613080|2472703|P1|NOT COMPLETED|Overall Study||11
1018723|NCT00613080|2472703|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|68
1018724|NCT00613080|2472703|P1|STARTED|Overall Study||79
1018725|NCT00613106|2472709|P2|NOT COMPLETED|Overall Study||9
1018726|NCT00613106|2472710|P1|NOT COMPLETED|Overall Study||20
1018727|NCT00613106|2472709|P2|COMPLETED|Overall Study||38
1018728|NCT00613106|2472710|P1|COMPLETED|Overall Study||112
1018729|NCT00613106|2472709|P2|STARTED|Overall Study||47
1018730|NCT00613106|2472710|P1|STARTED|Overall Study||132
1018731|NCT00613301|2472716|P1|NOT COMPLETED|Overall Study||228
1018732|NCT00613301|2472716|P1|COMPLETED|Overall Study||188
1018733|NCT00613301|2472716|P1|STARTED|Overall Study||416
1018734|NCT00613314|2472723|P1|NOT COMPLETED|Overall Study||155
1018735|NCT00613314|2472723|P1|COMPLETED|Overall Study||15113
1018736|NCT00613314|2472723|P1|STARTED|Overall Study||15268
1018737|NCT00613327|2472731|P1|NOT COMPLETED|Overall Study||101
1018738|NCT00613327|2472731|P1|COMPLETED|Overall Study||244
1018739|NCT00613327|2472731|P1|STARTED|Overall Study||345
1018740|NCT00613366|2472752|P2|NOT COMPLETED|Overall Study||2
1018741|NCT00613366|2472753|P1|NOT COMPLETED|Overall Study||3
1018742|NCT00613366|2472752|P2|COMPLETED|Overall Study||18
1018743|NCT00613366|2472753|P1|COMPLETED|Overall Study||17
1018744|NCT00613366|2472752|P2|STARTED|Overall Study||20
1018745|NCT00613366|2472753|P1|STARTED|Overall Study||20
1018746|NCT00613379|2472764|P3|NOT COMPLETED|Overall Study||0
1018747|NCT00613379|2472765|P2|NOT COMPLETED|Overall Study||0
1018748|NCT00613379|2472766|P1|NOT COMPLETED|Overall Study||0
1018749|NCT00613379|2472764|P3|COMPLETED|Overall Study||11
1018750|NCT00613379|2472765|P2|COMPLETED|Overall Study||10
1018751|NCT00613379|2472766|P1|COMPLETED|Overall Study||10
1018752|NCT00613379|2472764|P3|STARTED|Overall Study||11
1018753|NCT00613379|2472765|P2|STARTED|Overall Study||10
1018754|NCT00613379|2472766|P1|STARTED|Overall Study||10
1018755|NCT00613405|2472776|P2|NOT COMPLETED|Overall Study||0
1018756|NCT00613405|2472777|P1|NOT COMPLETED|Overall Study||0
1018757|NCT00613405|2472776|P2|COMPLETED|Overall Study||42
1018758|NCT00613405|2472777|P1|COMPLETED|Overall Study||45
1018759|NCT00613405|2472776|P2|STARTED|Overall Study||42
1018760|NCT00613405|2472777|P1|STARTED|Overall Study||45
1018761|NCT00613509|2472785|P2|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
1018762|NCT00613509|2472786|P1|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
1018763|NCT00613509|2472785|P2|COMPLETED|Cycle 2 (Group 2 = Crossover)||4
1018764|NCT00613509|2472786|P1|COMPLETED|Cycle 2 (Group 2 = Crossover)||11
1018765|NCT00613509|2472785|P2|STARTED|Cycle 2 (Group 2 = Crossover)||4
1018766|NCT00613509|2472786|P1|STARTED|Cycle 2 (Group 2 = Crossover)||11
1018767|NCT00613509|2472785|P2|NOT COMPLETED|Cycle 1||8
1018768|NCT00613509|2472786|P1|NOT COMPLETED|Cycle 1||5
1018769|NCT00613509|2472785|P2|COMPLETED|Cycle 1|Completion of Cycle 1. 12 participants were deemed evaluable|4
1018770|NCT00613509|2472786|P1|COMPLETED|Cycle 1|Completion of Cycle 1. 9 participants were deemed evaluable|6
1018771|NCT00613509|2472785|P2|STARTED|Cycle 1||12
1018772|NCT00613509|2472786|P1|STARTED|Cycle 1||11
1018773|NCT00613574|2472808|P1|NOT COMPLETED|Overall Study||6
1018774|NCT00613574|2472808|P1|COMPLETED|Overall Study||401
1018775|NCT00613574|2472808|P1|STARTED|Overall Study||407
1018776|NCT00613626|2472821|P3|NOT COMPLETED|Overall Study||0
1018777|NCT00613626|2472822|P2|NOT COMPLETED|Overall Study||1
1018778|NCT00613626|2472823|P1|NOT COMPLETED|Overall Study||0
1018779|NCT00613626|2472821|P3|COMPLETED|Overall Study||7
1018780|NCT00613626|2472822|P2|COMPLETED|Overall Study||33
1018781|NCT00613626|2472823|P1|COMPLETED|Overall Study||33
1018782|NCT00613626|2472821|P3|1st Dose ZD6474|Overall Study||7
1018783|NCT00613626|2472822|P2|1st Dose ZD6474|Overall Study||34
1018784|NCT00613626|2472823|P1|1st Dose ZD6474|Overall Study||33
1018785|NCT00613626|2472821|P3|STARTED|Overall Study|These participants provided the toxicity data to determine if ZD6474+Etopiside+Cisplatin was safe.|7
1018786|NCT00613626|2472822|P2|STARTED|Overall Study||34
1018787|NCT00613626|2472823|P1|STARTED|Overall Study||33
1018788|NCT00606892|2472839|P2|NOT COMPLETED|Second Intervention||0
1018789|NCT00606892|2472840|P1|NOT COMPLETED|Second Intervention||0
1018790|NCT00606892|2472839|P2|COMPLETED|Second Intervention||4
1018791|NCT00606892|2472840|P1|COMPLETED|Second Intervention||8
1018792|NCT00606892|2472839|P2|STARTED|Second Intervention||4
1018793|NCT00606892|2472840|P1|STARTED|Second Intervention||8
1018794|NCT00606892|2472839|P2|NOT COMPLETED|Washout Period||0
1018795|NCT00606892|2472840|P1|NOT COMPLETED|Washout Period||0
1018796|NCT00606892|2472839|P2|COMPLETED|Washout Period||4
1018797|NCT00606892|2472840|P1|COMPLETED|Washout Period||8
1018798|NCT00606892|2472839|P2|STARTED|Washout Period||4
1018799|NCT00606892|2472840|P1|STARTED|Washout Period||8
1018800|NCT00606892|2472839|P2|NOT COMPLETED|First Intervention||4
1018801|NCT00606892|2472840|P1|NOT COMPLETED|First Intervention||1
1018802|NCT00606892|2472839|P2|COMPLETED|First Intervention||4
1018803|NCT00606892|2472840|P1|COMPLETED|First Intervention||8
1018804|NCT00606892|2472839|P2|STARTED|First Intervention||8
1018805|NCT00606892|2472840|P1|STARTED|First Intervention||9
1018806|NCT00606892|2472839|P2|NOT COMPLETED|Adaptation||0
1018807|NCT00606892|2472840|P1|NOT COMPLETED|Adaptation||0
1018808|NCT00606892|2472839|P2|COMPLETED|Adaptation||8
1018809|NCT00606892|2472840|P1|COMPLETED|Adaptation||9
1018810|NCT00606892|2472839|P2|STARTED|Adaptation||8
1018811|NCT00606892|2472840|P1|STARTED|Adaptation||9
1018812|NCT00606905|2472874|P2|NOT COMPLETED|Overall Study||15
1018813|NCT00606905|2472875|P1|NOT COMPLETED|Overall Study||15
1018814|NCT00606905|2472874|P2|COMPLETED|Overall Study||24
1018815|NCT00606905|2472875|P1|COMPLETED|Overall Study||23
1018816|NCT00606905|2472874|P2|Pregnancy|Overall Study||33
1018817|NCT00606905|2472875|P1|Pregnancy|Overall Study||29
1018818|NCT00606905|2472874|P2|STARTED|Overall Study||39
1018819|NCT00606905|2472875|P1|STARTED|Overall Study||38
1018820|NCT00606931|2472881|P1|NOT COMPLETED|Overall Study||3
1018821|NCT00606931|2472881|P1|COMPLETED|Overall Study||19
1018822|NCT00606931|2472881|P1|STARTED|Overall Study||22
1018823|NCT00606944|2472889|P2|NOT COMPLETED|Overall Study||0
1018824|NCT00606944|2472890|P1|NOT COMPLETED|Overall Study||0
1018825|NCT00606944|2472889|P2|COMPLETED|Overall Study||100
1018826|NCT00606944|2472890|P1|COMPLETED|Overall Study||98
1018827|NCT00606944|2472889|P2|STARTED|Overall Study||100
1018828|NCT00606944|2472890|P1|STARTED|Overall Study||98
1018829|NCT00607048|2472898|P6|NOT COMPLETED|Overall Study||5
1018830|NCT00607048|2472899|P5|NOT COMPLETED|Overall Study||6
1018831|NCT00607048|2472900|P4|NOT COMPLETED|Overall Study||3
1018832|NCT00607048|2472901|P3|NOT COMPLETED|Overall Study||4
1018833|NCT00607048|2472902|P2|NOT COMPLETED|Overall Study||4
1018834|NCT00607048|2472903|P1|NOT COMPLETED|Overall Study||3
1018835|NCT00607048|2472898|P6|COMPLETED|Overall Study||2
1018836|NCT00607048|2472899|P5|COMPLETED|Overall Study||0
1018837|NCT00607048|2472900|P4|COMPLETED|Overall Study||0
1018838|NCT00607048|2472901|P3|COMPLETED|Overall Study||3
1018839|NCT00607048|2472902|P2|COMPLETED|Overall Study||2
1018840|NCT00607048|2472903|P1|COMPLETED|Overall Study||0
1018841|NCT00607048|2472898|P6|STARTED|Overall Study||7
1018842|NCT00607048|2472899|P5|STARTED|Overall Study||6
1018843|NCT00607048|2472900|P4|STARTED|Overall Study||3
1018844|NCT00607048|2472901|P3|STARTED|Overall Study||7
1018845|NCT00607048|2472902|P2|STARTED|Overall Study||6
1018846|NCT00607048|2472903|P1|STARTED|Overall Study||3
1018847|NCT00607087|2472988|P3|NOT COMPLETED|Period 3||0
1018848|NCT00607087|2472989|P2|NOT COMPLETED|Period 3||2
1018849|NCT00607087|2472990|P1|NOT COMPLETED|Period 3||2
1018850|NCT00607087|2472988|P3|COMPLETED|Period 3||84
1018851|NCT00607087|2472989|P2|COMPLETED|Period 3||84
1018852|NCT00607087|2472990|P1|COMPLETED|Period 3||84
1018853|NCT00607087|2472988|P3|STARTED|Period 3||84
1018854|NCT00607087|2472989|P2|STARTED|Period 3||86
1018855|NCT00607087|2472990|P1|STARTED|Period 3||86
1018856|NCT00607087|2472988|P3|NOT COMPLETED|Period 2||5
1018857|NCT00607087|2472989|P2|NOT COMPLETED|Period 2||3
1018858|NCT00607087|2472990|P1|NOT COMPLETED|Period 2||1
1018859|NCT00607087|2472988|P3|COMPLETED|Period 2||84
1018860|NCT00607087|2472989|P2|COMPLETED|Period 2||86
1018861|NCT00607087|2472990|P1|COMPLETED|Period 2||86
1018862|NCT00607087|2472988|P3|STARTED|Period 2||89
1018863|NCT00607087|2472989|P2|STARTED|Period 2||89
1018864|NCT00607087|2472990|P1|STARTED|Period 2||87
1018865|NCT00607087|2472988|P3|NOT COMPLETED|Period 1||5
1018866|NCT00607087|2472989|P2|NOT COMPLETED|Period 1||6
1018867|NCT00607087|2472990|P1|NOT COMPLETED|Period 1||12
1018868|NCT00607087|2472988|P3|COMPLETED|Period 1||89
1018869|NCT00607087|2472989|P2|COMPLETED|Period 1||89
1018870|NCT00607087|2472990|P1|COMPLETED|Period 1||87
1018871|NCT00607087|2472988|P3|STARTED|Period 1||94
1018872|NCT00607087|2472989|P2|STARTED|Period 1||95
1018873|NCT00607087|2472990|P1|STARTED|Period 1||99
1018874|NCT00607087|2472988|P3|NOT COMPLETED|Overall Study||10
1018875|NCT00607087|2472989|P2|NOT COMPLETED|Overall Study||11
1018876|NCT00607087|2472990|P1|NOT COMPLETED|Overall Study||15
1018877|NCT00607087|2472988|P3|COMPLETED|Overall Study||84
1018878|NCT00607087|2472989|P2|COMPLETED|Overall Study||84
1018879|NCT00607087|2472990|P1|COMPLETED|Overall Study||84
1018880|NCT00607087|2472988|P3|STARTED|Overall Study||94
1018881|NCT00607087|2472989|P2|STARTED|Overall Study||95
1018882|NCT00607087|2472990|P1|STARTED|Overall Study||99
1018883|NCT00607113|2473048|P2|NOT COMPLETED|Overall Study||0
1018884|NCT00607113|2473049|P1|NOT COMPLETED|Overall Study||0
1018885|NCT00607113|2473048|P2|COMPLETED|Overall Study||20
1018886|NCT00607113|2473049|P1|COMPLETED|Overall Study||19
1018887|NCT00607113|2473048|P2|STARTED|Overall Study||20
1018888|NCT00607113|2473049|P1|STARTED|Overall Study||19
1018895|NCT00607243|2473071|P2|NOT COMPLETED|Telephone Safety Assessment Period||2
1018896|NCT00607243|2473072|P1|NOT COMPLETED|Telephone Safety Assessment Period||5
1018897|NCT00607243|2473071|P2|COMPLETED|Telephone Safety Assessment Period|40 Available for 3 months 39 Available for 6 months|39
1018898|NCT00607243|2473072|P1|COMPLETED|Telephone Safety Assessment Period|80 Available for 3 months 77 Available for 6 months|77
1018899|NCT00607243|2473071|P2|STARTED|Telephone Safety Assessment Period||41
1018900|NCT00607243|2473072|P1|STARTED|Telephone Safety Assessment Period||82
1018901|NCT00607243|2473071|P2|NOT COMPLETED|Initial Post-vaccination Period||0
1018902|NCT00607243|2473072|P1|NOT COMPLETED|Initial Post-vaccination Period||0
1018903|NCT00607243|2473071|P2|COMPLETED|Initial Post-vaccination Period||41
1018904|NCT00607243|2473072|P1|COMPLETED|Initial Post-vaccination Period||82
1018905|NCT00607243|2473071|P2|STARTED|Initial Post-vaccination Period||41
1018906|NCT00607243|2473072|P1|STARTED|Initial Post-vaccination Period||82
1018907|NCT00607269|2473080|P2|NOT COMPLETED|Overall Study||0
1018908|NCT00607269|2473081|P1|NOT COMPLETED|Overall Study||0
1018909|NCT00607269|2473080|P2|COMPLETED|Overall Study||64
1018910|NCT00607269|2473081|P1|COMPLETED|Overall Study||67
1018911|NCT00607269|2473080|P2|STARTED|Overall Study||64
1018912|NCT00607269|2473081|P1|STARTED|Overall Study||67
1018913|NCT00613730|2473093|P1|NOT COMPLETED|Overall Study||3
1018914|NCT00613730|2473093|P1|COMPLETED|Overall Study||0
1018915|NCT00613730|2473093|P1|STARTED|Overall Study||3
1018916|NCT00613821|2473101|P2|NOT COMPLETED|Overall Study||1
1018917|NCT00613821|2473102|P1|NOT COMPLETED|Overall Study||2
1018918|NCT00613821|2473101|P2|COMPLETED|Overall Study||39
1018919|NCT00613821|2473102|P1|COMPLETED|Overall Study||38
1018920|NCT00613821|2473101|P2|STARTED|Overall Study||40
1018921|NCT00613821|2473102|P1|STARTED|Overall Study||40
1018922|NCT00613925|2473110|P2|NOT COMPLETED|Overall Study||1
1018923|NCT00613925|2473111|P1|NOT COMPLETED|Overall Study||0
1018924|NCT00613925|2473110|P2|COMPLETED|Overall Study||32
1018925|NCT00613925|2473111|P1|COMPLETED|Overall Study||37
1018926|NCT00613925|2473110|P2|STARTED|Overall Study||33
1018927|NCT00613925|2473111|P1|STARTED|Overall Study||37
1018928|NCT00613938|2473123|P4|NOT COMPLETED|Overall Study||26
1018929|NCT00613938|2473124|P3|NOT COMPLETED|Overall Study||23
1018930|NCT00613938|2473125|P2|NOT COMPLETED|Overall Study||28
1018931|NCT00613938|2473126|P1|NOT COMPLETED|Overall Study||20
1018932|NCT00613938|2473123|P4|COMPLETED|Overall Study||253
1018933|NCT00613938|2473124|P3|COMPLETED|Overall Study||255
1018934|NCT00613938|2473125|P2|COMPLETED|Overall Study||247
1018935|NCT00613938|2473126|P1|COMPLETED|Overall Study||49
1018936|NCT00613938|2473123|P4|STARTED|Overall Study|one patient did not have a valid baseline score therefore excluded from above|279
1018937|NCT00613938|2473124|P3|STARTED|Overall Study||278
1018938|NCT00613938|2473125|P2|STARTED|Overall Study||275
1018939|NCT00613938|2473126|P1|STARTED|Overall Study||69
1018940|NCT00613951|2473159|P3|NOT COMPLETED|Overall Study||5
1018941|NCT00613951|2473160|P2|NOT COMPLETED|Overall Study||5
1018942|NCT00613951|2473161|P1|NOT COMPLETED|Overall Study||7
1018943|NCT00613951|2473159|P3|COMPLETED|Overall Study||57
1018944|NCT00613951|2473160|P2|COMPLETED|Overall Study||54
1018945|NCT00613951|2473161|P1|COMPLETED|Overall Study||54
1018946|NCT00613951|2473159|P3|Exposed|Overall Study||62
1018947|NCT00613951|2473160|P2|Exposed|Overall Study||59
1018948|NCT00613951|2473161|P1|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|60
1018949|NCT00613951|2473159|P3|STARTED|Overall Study||62
1018950|NCT00613951|2473160|P2|STARTED|Overall Study||59
1018951|NCT00613951|2473161|P1|STARTED|Overall Study||61
1018952|NCT00615719|2473202|P1|NOT COMPLETED|Overall Study||5
1018953|NCT00615719|2473202|P1|COMPLETED|Overall Study||30
1018954|NCT00615719|2473202|P1|STARTED|Overall Study||35
1018955|NCT00615836|2473210|P5|NOT COMPLETED|Extension Study (FE992026 CS31)||0
1018956|NCT00615836|2473211|P4|NOT COMPLETED|Extension Study (FE992026 CS31)||84
1018957|NCT00615836|2473212|P3|NOT COMPLETED|Extension Study (FE992026 CS31)||73
1018958|NCT00615836|2473213|P2|NOT COMPLETED|Extension Study (FE992026 CS31)||86
1018959|NCT00615836|2473214|P1|NOT COMPLETED|Extension Study (FE992026 CS31)||141
1018960|NCT00615836|2473210|P5|COMPLETED|Extension Study (FE992026 CS31)||0
1018961|NCT00615836|2473211|P4|COMPLETED|Extension Study (FE992026 CS31)||53
1018962|NCT00615836|2473212|P3|COMPLETED|Extension Study (FE992026 CS31)||59
1018963|NCT00615836|2473213|P2|COMPLETED|Extension Study (FE992026 CS31)||58
1018964|NCT00615836|2473214|P1|COMPLETED|Extension Study (FE992026 CS31)||0
1018965|NCT00615836|2473210|P5|STARTED|Extension Study (FE992026 CS31)||0
1018966|NCT00615836|2473211|P4|STARTED|Extension Study (FE992026 CS31)||137
1018967|NCT00615836|2473212|P3|STARTED|Extension Study (FE992026 CS31)||132
1018968|NCT00615836|2473213|P2|STARTED|Extension Study (FE992026 CS31)||144
1018969|NCT00615836|2473214|P1|STARTED|Extension Study (FE992026 CS31)||141
1018970|NCT00615836|2473210|P5|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||15
1018971|NCT00615836|2473211|P4|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||25
1018972|NCT00615836|2473212|P3|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||20
1018973|NCT00615836|2473213|P2|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||10
1018974|NCT00615836|2473214|P1|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||19
1018975|NCT00615836|2473210|P5|COMPLETED|Part I of Core Study (FE992026 CS29)||145
1018976|NCT00615836|2473211|P4|COMPLETED|Part I of Core Study (FE992026 CS29)||135
1018977|NCT00615836|2473212|P3|COMPLETED|Part I of Core Study (FE992026 CS29)||138
1018978|NCT00615836|2473213|P2|COMPLETED|Part I of Core Study (FE992026 CS29)||148
1018979|NCT00615836|2473214|P1|COMPLETED|Part I of Core Study (FE992026 CS29)||144
1018980|NCT00615836|2473210|P5|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|156
1018981|NCT00615836|2473211|P4|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|146
1018982|NCT00615836|2473212|P3|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|148
1018983|NCT00615836|2473213|P2|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|152
1018984|NCT00615836|2473214|P1|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|155
1018985|NCT00615836|2473210|P5|STARTED|Part I of Core Study (FE992026 CS29)||160
1018986|NCT00615836|2473211|P4|STARTED|Part I of Core Study (FE992026 CS29)||160
1018987|NCT00615836|2473212|P3|STARTED|Part I of Core Study (FE992026 CS29)||158
1018988|NCT00615836|2473213|P2|STARTED|Part I of Core Study (FE992026 CS29)||158
1018989|NCT00615836|2473214|P1|STARTED|Part I of Core Study (FE992026 CS29)||163
1018990|NCT00615901|2473274|P1|NOT COMPLETED|Overall Study||9
1018991|NCT00615901|2473274|P1|COMPLETED|Overall Study||29
1018992|NCT00615901|2473274|P1|STARTED|Overall Study||38
1018993|NCT00615914|2473278|P1|NOT COMPLETED|Overall Study||637
1018994|NCT00615914|2473278|P1|COMPLETED|Overall Study||1008
1018995|NCT00615914|2473278|P1|STARTED|Overall Study|The number of patients enrolled|1645
1018996|NCT00615927|2473287|P2|NOT COMPLETED|Overall Study||0
1018997|NCT00615927|2473288|P1|NOT COMPLETED|Overall Study||0
1018998|NCT00615927|2473287|P2|COMPLETED|Overall Study||32
1018999|NCT00615927|2473288|P1|COMPLETED|Overall Study||32
1019000|NCT00615927|2473287|P2|STARTED|Overall Study||32
1019001|NCT00615927|2473288|P1|STARTED|Overall Study||32
1019002|NCT00615992|2473302|P1|NOT COMPLETED|Overall Study||67
1019003|NCT00615992|2473302|P1|COMPLETED|Overall Study||687
1019004|NCT00615992|2473302|P1|STARTED|Overall Study||754
1019005|NCT00616018|2473311|P1|NOT COMPLETED|Overall Study||3
1019006|NCT00616018|2473311|P1|COMPLETED|Overall Study||24
1019007|NCT00616018|2473311|P1|STARTED|Overall Study||27
1019008|NCT00616109|2473316|P1|NOT COMPLETED|Overall Study||0
1019009|NCT00616109|2473316|P1|COMPLETED|Overall Study||16
1019010|NCT00616109|2473316|P1|STARTED|Overall Study||16
1019011|NCT00616122|2473323|P1|NOT COMPLETED|Overall Study||7
1019012|NCT00616122|2473323|P1|COMPLETED|Overall Study||25
1019013|NCT00616122|2473323|P1|STARTED|Overall Study||32
1019020|NCT00616239|2473336|P1|NOT COMPLETED|Overall Study||2
1019021|NCT00616239|2473336|P1|COMPLETED|Overall Study||18
1019022|NCT00616239|2473336|P1|STARTED|Overall Study||20
1019023|NCT00616343|2473340|P1|NOT COMPLETED|Overall Study||0
1019024|NCT00616343|2473340|P1|COMPLETED|Overall Study||9
1019025|NCT00616343|2473340|P1|STARTED|Overall Study||9
1019026|NCT00616421|2473347|P3|NOT COMPLETED|Overall Study||41
1019027|NCT00616421|2473348|P2|NOT COMPLETED|Overall Study||38
1019028|NCT00616421|2473349|P1|NOT COMPLETED|Overall Study||26
1019029|NCT00616421|2473347|P3|COMPLETED|Overall Study||1229
1019030|NCT00616421|2473348|P2|COMPLETED|Overall Study||1240
1019031|NCT00616421|2473349|P1|COMPLETED|Overall Study||333
1019032|NCT00616421|2473347|P3|STARTED|Overall Study||1270
1019033|NCT00616421|2473348|P2|STARTED|Overall Study||1278
1019034|NCT00616421|2473349|P1|STARTED|Overall Study||359
1019035|NCT00616434|2473388|P2|NOT COMPLETED|Overall Study||8
1019036|NCT00616434|2473389|P1|NOT COMPLETED|Overall Study||6
1019037|NCT00616434|2473388|P2|COMPLETED|Overall Study||53
1019038|NCT00616434|2473389|P1|COMPLETED|Overall Study||56
1019039|NCT00616434|2473388|P2|STARTED|Overall Study||61
1019040|NCT00616434|2473389|P1|STARTED|Overall Study||62
1019041|NCT00616577|2473402|P3|NOT COMPLETED|Overall Study||0
1019042|NCT00616577|2473403|P2|NOT COMPLETED|Overall Study||0
1019043|NCT00616577|2473404|P1|NOT COMPLETED|Overall Study||0
1019044|NCT00616577|2473402|P3|COMPLETED|Overall Study||7
1019045|NCT00616577|2473403|P2|COMPLETED|Overall Study||9
1019046|NCT00616577|2473404|P1|COMPLETED|Overall Study||6
1019047|NCT00616577|2473402|P3|STARTED|Overall Study||7
1019048|NCT00616577|2473403|P2|STARTED|Overall Study||9
1019049|NCT00616577|2473404|P1|STARTED|Overall Study||6
1019050|NCT00616603|2473415|P3|NOT COMPLETED|Overall Study||2
1019051|NCT00616603|2473416|P2|NOT COMPLETED|Overall Study||0
1019052|NCT00616603|2473417|P1|NOT COMPLETED|Overall Study||2
1019053|NCT00616603|2473415|P3|COMPLETED|Overall Study||13
1019054|NCT00616603|2473416|P2|COMPLETED|Overall Study||14
1019055|NCT00616603|2473417|P1|COMPLETED|Overall Study||12
1019056|NCT00616603|2473415|P3|STARTED|Overall Study||15
1019057|NCT00616603|2473416|P2|STARTED|Overall Study||14
1019058|NCT00616603|2473417|P1|STARTED|Overall Study||14
1019059|NCT00616629|2473430|P5|NOT COMPLETED|Overall Study||0
1019060|NCT00616629|2473431|P4|NOT COMPLETED|Overall Study||0
1019061|NCT00616629|2473432|P3|NOT COMPLETED|Overall Study||1
1019062|NCT00616629|2473433|P2|NOT COMPLETED|Overall Study||2
1019063|NCT00616629|2473434|P1|NOT COMPLETED|Overall Study||2
1019064|NCT00616629|2473430|P5|COMPLETED|Overall Study||12
1019065|NCT00616629|2473431|P4|COMPLETED|Overall Study||2
1019066|NCT00616629|2473432|P3|COMPLETED|Overall Study||13
1019067|NCT00616629|2473433|P2|COMPLETED|Overall Study||12
1019068|NCT00616629|2473434|P1|COMPLETED|Overall Study||11
1019069|NCT00616629|2473430|P5|STARTED|Overall Study||12
1019070|NCT00616629|2473431|P4|STARTED|Overall Study||2
1019071|NCT00616629|2473432|P3|STARTED|Overall Study|One patient never received study drug|14
1019072|NCT00616629|2473433|P2|STARTED|Overall Study|Two patients never received study drug|14
1019073|NCT00616629|2473434|P1|STARTED|Overall Study|Two patients never received study drug|13
1019074|NCT00616642|2473478|P2|NOT COMPLETED|Overall Study||1
1019075|NCT00616642|2473479|P1|NOT COMPLETED|Overall Study||0
1019076|NCT00616642|2473478|P2|COMPLETED|Overall Study||0
1019077|NCT00616642|2473479|P1|COMPLETED|Overall Study||0
1019078|NCT00616642|2473478|P2|STARTED|Overall Study||1
1019079|NCT00616642|2473479|P1|STARTED|Overall Study||0
1019080|NCT00616655|2473488|P3|NOT COMPLETED|Overall Study||48
1019081|NCT00616655|2473489|P2|NOT COMPLETED|Overall Study||41
1019082|NCT00616655|2473490|P1|NOT COMPLETED|Overall Study||35
1019083|NCT00616655|2473488|P3|COMPLETED|Overall Study||103
1019084|NCT00616655|2473489|P2|COMPLETED|Overall Study||112
1019085|NCT00616655|2473490|P1|COMPLETED|Overall Study||117
1019086|NCT00616655|2473488|P3|STARTED|Overall Study||151
1019087|NCT00616655|2473489|P2|STARTED|Overall Study||153
1019088|NCT00616655|2473490|P1|STARTED|Overall Study||152
1019095|NCT00616772|2473539|P2|NOT COMPLETED|Overall Study||102
1019096|NCT00616772|2473540|P1|NOT COMPLETED|Overall Study||115
1019097|NCT00616772|2473539|P2|COMPLETED|Overall Study||240
1019098|NCT00616772|2473540|P1|COMPLETED|Overall Study||225
1019099|NCT00616772|2473539|P2|Treated|Overall Study||339
1019100|NCT00616772|2473540|P1|Treated|Overall Study||337
1019101|NCT00616772|2473539|P2|STARTED|Overall Study||342
1019102|NCT00616772|2473540|P1|STARTED|Overall Study||340
1019103|NCT00616902|2473556|P2|NOT COMPLETED|Overall Study||6
1019104|NCT00616902|2473557|P1|NOT COMPLETED|Overall Study||6
1019105|NCT00616902|2473556|P2|COMPLETED|Overall Study||0
1019106|NCT00616902|2473557|P1|COMPLETED|Overall Study||0
1019107|NCT00616902|2473556|P2|STARTED|Overall Study||6
1019108|NCT00616902|2473557|P1|STARTED|Overall Study||6
1019109|NCT00616928|2473585|P4|NOT COMPLETED|Overall Study||7
1019110|NCT00616928|2473586|P3|NOT COMPLETED|Overall Study||17
1019111|NCT00616928|2473587|P2|NOT COMPLETED|Overall Study||18
1019112|NCT00616928|2473588|P1|NOT COMPLETED|Overall Study||62
1019113|NCT00616928|2473585|P4|COMPLETED|Overall Study||364
1019114|NCT00616928|2473586|P3|COMPLETED|Overall Study||1101
1019115|NCT00616928|2473587|P2|COMPLETED|Overall Study||750
1019116|NCT00616928|2473588|P1|COMPLETED|Overall Study||2242
1019117|NCT00616928|2473585|P4|STARTED|Overall Study||371
1019118|NCT00616928|2473586|P3|STARTED|Overall Study||1118
1019119|NCT00616928|2473587|P2|STARTED|Overall Study||768
1019120|NCT00616928|2473588|P1|STARTED|Overall Study||2304
1019121|NCT00616967|2473652|P3|NOT COMPLETED|Overall Study||1
1019122|NCT00616967|2473653|P2|NOT COMPLETED|Overall Study||0
1019123|NCT00616967|2473654|P1|NOT COMPLETED|Overall Study||0
1019124|NCT00616967|2473652|P3|COMPLETED|Overall Study||30
1019125|NCT00616967|2473653|P2|COMPLETED|Overall Study||31
1019126|NCT00616967|2473654|P1|COMPLETED|Overall Study||6
1019127|NCT00616967|2473652|P3|STARTED|Overall Study||31
1019128|NCT00616967|2473653|P2|STARTED|Overall Study||31
1019129|NCT00616967|2473654|P1|STARTED|Overall Study||6
1019130|NCT00617058|2473666|P3|NOT COMPLETED|Overall Study||0
1019131|NCT00617058|2473667|P2|NOT COMPLETED|Overall Study||0
1019132|NCT00617058|2473668|P1|NOT COMPLETED|Overall Study||0
1019133|NCT00617058|2473666|P3|COMPLETED|Overall Study||0
1019134|NCT00617058|2473667|P2|COMPLETED|Overall Study||0
1019135|NCT00617058|2473668|P1|COMPLETED|Overall Study||1
1019136|NCT00617058|2473666|P3|STARTED|Overall Study||0
1019137|NCT00617058|2473667|P2|STARTED|Overall Study||0
1019138|NCT00617058|2473668|P1|STARTED|Overall Study||1
1019139|NCT00617084|2473708|P2|NOT COMPLETED|Overall Study||26
1019140|NCT00617084|2473709|P1|NOT COMPLETED|Overall Study||21
1019141|NCT00617084|2473708|P2|COMPLETED|Overall Study||1126
1019142|NCT00617084|2473709|P1|COMPLETED|Overall Study||1119
1019143|NCT00617084|2473708|P2|STARTED|Overall Study||1152
1019144|NCT00617084|2473709|P1|STARTED|Overall Study||1140
1019145|NCT00617097|2473719|P2|NOT COMPLETED|Overall Study||0
1019146|NCT00617097|2473720|P1|NOT COMPLETED|Overall Study||0
1019147|NCT00617097|2473719|P2|COMPLETED|Overall Study||25
1019148|NCT00617097|2473720|P1|COMPLETED|Overall Study||25
1019149|NCT00617097|2473719|P2|STARTED|Overall Study||25
1019150|NCT00617097|2473720|P1|STARTED|Overall Study||25
1019151|NCT00617123|2473734|P2|NOT COMPLETED|Study Treatment Period||16
1019152|NCT00617123|2473735|P1|NOT COMPLETED|Study Treatment Period||17
1019153|NCT00617123|2473734|P2|COMPLETED|Study Treatment Period||79
1019154|NCT00617123|2473735|P1|COMPLETED|Study Treatment Period||81
1019155|NCT00617123|2473734|P2|Treated|Study Treatment Period||95
1019156|NCT00617123|2473735|P1|Treated|Study Treatment Period|1 participant was not treated|97
1019157|NCT00617123|2473734|P2|STARTED|Study Treatment Period||95
1019158|NCT00617123|2473735|P1|STARTED|Study Treatment Period||98
1019159|NCT00617123|2473734|P2|NOT COMPLETED|Referral Screening Period||26
1019160|NCT00617123|2473735|P1|NOT COMPLETED|Referral Screening Period||39
1019161|NCT00617123|2473734|P2|COMPLETED|Referral Screening Period||95
1019162|NCT00617123|2473735|P1|COMPLETED|Referral Screening Period||98
1019163|NCT00617123|2473734|P2|STARTED|Referral Screening Period||121
1019164|NCT00617123|2473735|P1|STARTED|Referral Screening Period||137
1019165|NCT00617175|2473751|P2|NOT COMPLETED|Overall Study||0
1019166|NCT00617175|2473752|P1|NOT COMPLETED|Overall Study||0
1019167|NCT00617175|2473751|P2|COMPLETED|Overall Study||948
1019168|NCT00617175|2473752|P1|COMPLETED|Overall Study||954
1019169|NCT00617175|2473751|P2|STARTED|Overall Study||948
1019170|NCT00617175|2473752|P1|STARTED|Overall Study||954
1019171|NCT00617188|2473758|P1|NOT COMPLETED|Overall Study||0
1019172|NCT00617188|2473758|P1|COMPLETED|Overall Study||26
1019173|NCT00617188|2473758|P1|STARTED|Overall Study||26
1019174|NCT00617201|2473769|P2|NOT COMPLETED|Overall Study||13
1019175|NCT00617201|2473770|P1|NOT COMPLETED|Overall Study||9
1019176|NCT00617201|2473769|P2|COMPLETED|Overall Study||12
1019177|NCT00617201|2473770|P1|COMPLETED|Overall Study||16
1019178|NCT00617201|2473769|P2|STARTED|Overall Study||25
1019179|NCT00617201|2473770|P1|STARTED|Overall Study||25
1019180|NCT00617240|2473780|P2|NOT COMPLETED|Overall Study||0
1019181|NCT00617240|2473781|P1|NOT COMPLETED|Overall Study||1
1019182|NCT00617240|2473780|P2|COMPLETED|Overall Study||4
1019183|NCT00617240|2473781|P1|COMPLETED|Overall Study||4
1019184|NCT00617240|2473780|P2|STARTED|Overall Study||4
1019185|NCT00617240|2473781|P1|STARTED|Overall Study||5
1019186|NCT00617279|2473801|P2|NOT COMPLETED|Overall Study||17
1019187|NCT00617279|2473802|P1|NOT COMPLETED|Overall Study||14
1019188|NCT00617279|2473801|P2|COMPLETED|Overall Study||0
1019189|NCT00617279|2473802|P1|COMPLETED|Overall Study||0
1019190|NCT00617279|2473801|P2|STARTED|Overall Study||17
1019191|NCT00617279|2473802|P1|STARTED|Overall Study||14
1019192|NCT00617305|2473859|P3|NOT COMPLETED|Overall Study||1
1019193|NCT00617305|2473860|P2|NOT COMPLETED|Overall Study||0
1019194|NCT00617305|2473861|P1|NOT COMPLETED|Overall Study||8
1019195|NCT00617305|2473859|P3|COMPLETED|Overall Study||0
1019196|NCT00617305|2473860|P2|COMPLETED|Overall Study||4
1019197|NCT00617305|2473861|P1|COMPLETED|Overall Study||25
1019198|NCT00617305|2473859|P3|Completed 24-week Primary Analysis|Overall Study||0
1019199|NCT00617305|2473860|P2|Completed 24-week Primary Analysis|Overall Study||4
1019200|NCT00617305|2473861|P1|Completed 24-week Primary Analysis|Overall Study||31
1019201|NCT00617305|2473859|P3|STARTED|Overall Study||1
1019202|NCT00617305|2473860|P2|STARTED|Overall Study||4
1019203|NCT00617305|2473861|P1|STARTED|Overall Study||33
1019204|NCT00617357|2473915|P1|NOT COMPLETED|Overall Study||16
1019205|NCT00617357|2473915|P1|COMPLETED|Overall Study|67 subjects completed study; 7 completed early, 60 completed 24 month visit|67
1019206|NCT00617357|2473915|P1|STARTED|Overall Study|83 subjects enrolled, 80 subjects received Strattice reinforcement of hernia repair|83
1019207|NCT00617396|2473925|P1|NOT COMPLETED|Overall Study||0
1019208|NCT00617396|2473925|P1|COMPLETED|Overall Study||25
1019209|NCT00617396|2473925|P1|STARTED|Overall Study||25
1019210|NCT00617409|2473932|P3|NOT COMPLETED|Overall Study||27
1019211|NCT00617409|2473933|P2|NOT COMPLETED|Overall Study||18
1019212|NCT00617409|2473934|P1|NOT COMPLETED|Overall Study||16
1019213|NCT00617409|2473932|P3|COMPLETED|Overall Study||4
1019214|NCT00617409|2473933|P2|COMPLETED|Overall Study||2
1019215|NCT00617409|2473934|P1|COMPLETED|Overall Study||2
1019216|NCT00617409|2473932|P3|STARTED|Overall Study||31
1019217|NCT00617409|2473933|P2|STARTED|Overall Study||20
1019218|NCT00617409|2473934|P1|STARTED|Overall Study||18
1019219|NCT00617461|2473945|P2|NOT COMPLETED|6-Day Down-Titration Period||2
1019220|NCT00617461|2473946|P1|NOT COMPLETED|6-Day Down-Titration Period||2
1019221|NCT00617461|2473945|P2|COMPLETED|6-Day Down-Titration Period||35
1019222|NCT00617461|2473946|P1|COMPLETED|6-Day Down-Titration Period||39
1019223|NCT00617461|2473945|P2|STARTED|6-Day Down-Titration Period||37
1019224|NCT00617461|2473946|P1|STARTED|6-Day Down-Titration Period||41
1019225|NCT00617461|2473945|P2|NOT COMPLETED|Second Treatment Intervention Period||4
1019226|NCT00617461|2473946|P1|NOT COMPLETED|Second Treatment Intervention Period||0
1019227|NCT00617461|2473945|P2|COMPLETED|Second Treatment Intervention Period||37
1019228|NCT00617461|2473946|P1|COMPLETED|Second Treatment Intervention Period||41
1019229|NCT00617461|2473945|P2|STARTED|Second Treatment Intervention Period||41
1019230|NCT00617461|2473946|P1|STARTED|Second Treatment Intervention Period||41
1019231|NCT00617461|2473945|P2|NOT COMPLETED|4-Day Crossover Period||0
1019232|NCT00617461|2473946|P1|NOT COMPLETED|4-Day Crossover Period||1
1019233|NCT00617461|2473945|P2|COMPLETED|4-Day Crossover Period||40
1019234|NCT00617461|2473946|P1|COMPLETED|4-Day Crossover Period||41
1019235|NCT00617461|2473945|P2|STARTED|4-Day Crossover Period|One 3600:1200 participant skipped the Crossover period, going directly to second Treatment Period.|40
1019236|NCT00617461|2473946|P1|STARTED|4-Day Crossover Period||42
1019237|NCT00617461|2473945|P2|NOT COMPLETED|First Treatment Intervention Period||3
1019238|NCT00617461|2473946|P1|NOT COMPLETED|First Treatment Intervention Period||10
1019239|NCT00617461|2473945|P2|COMPLETED|First Treatment Intervention Period||41
1019240|NCT00617461|2473946|P1|COMPLETED|First Treatment Intervention Period||42
1019241|NCT00617461|2473945|P2|STARTED|First Treatment Intervention Period||44
1019242|NCT00617461|2473946|P1|STARTED|First Treatment Intervention Period|2 par. (1 withdrawal due to inv. discretion, 1 withdrawal by subject) did not take study drug.|52
1019243|NCT00617591|2473999|P1|NOT COMPLETED|Overall Study||10
1019244|NCT00617591|2473999|P1|COMPLETED|Overall Study||47
1019245|NCT00617591|2473999|P1|STARTED|Overall Study||57
1019246|NCT00617604|2474009|P2|NOT COMPLETED|Overall Study||20
1019247|NCT00617604|2474010|P1|NOT COMPLETED|Overall Study||18
1019248|NCT00617604|2474009|P2|COMPLETED|Overall Study|Completed Month 6 assessment|88
1019249|NCT00617604|2474010|P1|COMPLETED|Overall Study|Completed Month 6 assessment|92
1019250|NCT00617604|2474009|P2|Completed 12 Weeks of Treatment|Overall Study||83
1019251|NCT00617604|2474010|P1|Completed 12 Weeks of Treatment|Overall Study||89
1019252|NCT00617604|2474009|P2|Received Treatment|Overall Study||105
1019253|NCT00617604|2474010|P1|Received Treatment|Overall Study||107
1019254|NCT00617604|2474009|P2|STARTED|Overall Study||108
1019255|NCT00617604|2474010|P1|STARTED|Overall Study||110
1019256|NCT00617669|2474056|P2|NOT COMPLETED|Overall Study||451
1019257|NCT00617669|2474057|P1|NOT COMPLETED|Overall Study||430
1019258|NCT00617669|2474056|P2|COMPLETED|Overall Study|Patients receiving placebo at data cut-off|77
1019259|NCT00617669|2474057|P1|COMPLETED|Overall Study|Patients receiving ZD4054 10 mg at data cut-off|94
1019260|NCT00617669|2474056|P2|Patients Who Received IP|Overall Study||525
1019261|NCT00617669|2474057|P1|Patients Who Received IP|Overall Study||522
1019262|NCT00617669|2474056|P2|STARTED|Overall Study||528
1019263|NCT00617669|2474057|P1|STARTED|Overall Study||524
1019264|NCT00617708|2474080|P3|NOT COMPLETED|Overall Study||64
1019265|NCT00617708|2474081|P2|NOT COMPLETED|Overall Study||60
1019266|NCT00617708|2474082|P1|NOT COMPLETED|Overall Study||10
1019267|NCT00617708|2474080|P3|COMPLETED|Overall Study||0
1019268|NCT00617708|2474081|P2|COMPLETED|Overall Study||0
1019269|NCT00617708|2474082|P1|COMPLETED|Overall Study||0
1019270|NCT00617708|2474080|P3|Eligible and Began Protocol Therapy|Overall Study||59
1019271|NCT00617708|2474081|P2|Eligible and Began Protocol Therapy|Overall Study||57
1019272|NCT00617708|2474082|P1|Eligible and Began Protocol Therapy|Overall Study||9
1019273|NCT00617708|2474080|P3|STARTED|Overall Study||64
1019274|NCT00617708|2474081|P2|STARTED|Overall Study||60
1019275|NCT00617708|2474082|P1|STARTED|Overall Study||10
1019276|NCT00617773|2474097|P1|NOT COMPLETED|Overall Study||24
1019277|NCT00617773|2474097|P1|COMPLETED|Overall Study|Patients COMPLETED were evaluated as having no disease progression at the end of cycle 3.|7
1019278|NCT00617773|2474097|P1|STARTED|Overall Study||31
1019279|NCT00617851|2474116|P4|NOT COMPLETED|Overall Study||25
1019280|NCT00617851|2474117|P3|NOT COMPLETED|Overall Study||45
1019281|NCT00617851|2474118|P2|NOT COMPLETED|Overall Study||40
1019282|NCT00617851|2474119|P1|NOT COMPLETED|Overall Study||47
1019283|NCT00617851|2474116|P4|COMPLETED|Overall Study||192
1019284|NCT00617851|2474117|P3|COMPLETED|Overall Study||384
1019285|NCT00617851|2474118|P2|COMPLETED|Overall Study||391
1019286|NCT00617851|2474119|P1|COMPLETED|Overall Study||383
1019287|NCT00617851|2474116|P4|STARTED|Overall Study||217
1019288|NCT00617851|2474117|P3|STARTED|Overall Study||429
1019289|NCT00617851|2474118|P2|STARTED|Overall Study||431
1019290|NCT00617851|2474119|P1|STARTED|Overall Study||430
1019291|NCT00617890|2474161|P4|NOT COMPLETED|Overall Study||115
1019292|NCT00617890|2474162|P3|NOT COMPLETED|Overall Study||35
1019293|NCT00617890|2474163|P2|NOT COMPLETED|Overall Study||28
1019294|NCT00617890|2474164|P1|NOT COMPLETED|Overall Study||31
1019295|NCT00617890|2474161|P4|COMPLETED|Overall Study||1
1019296|NCT00617890|2474162|P3|COMPLETED|Overall Study||0
1019297|NCT00617890|2474163|P2|COMPLETED|Overall Study||5
1019298|NCT00617890|2474164|P1|COMPLETED|Overall Study||4
1019299|NCT00617890|2474161|P4|Received Treatment|Overall Study||115
1019300|NCT00617890|2474162|P3|Received Treatment|Overall Study||34
1019301|NCT00617890|2474163|P2|Received Treatment|Overall Study||33
1019302|NCT00617890|2474164|P1|Received Treatment|Overall Study||34
1019303|NCT00617890|2474161|P4|STARTED|Overall Study||116
1019304|NCT00617890|2474162|P3|STARTED|Overall Study||35
1019305|NCT00617890|2474163|P2|STARTED|Overall Study||33
1019306|NCT00617890|2474164|P1|STARTED|Overall Study||35
1019307|NCT00617903|2474198|P2|NOT COMPLETED|Overall Study||7
1019308|NCT00617903|2474199|P1|NOT COMPLETED|Overall Study||3
1019309|NCT00617903|2474198|P2|COMPLETED|Overall Study||35
1019310|NCT00617903|2474199|P1|COMPLETED|Overall Study||38
1019311|NCT00617903|2474198|P2|STARTED|Overall Study||42
1019312|NCT00617903|2474199|P1|STARTED|Overall Study||41
1019313|NCT00617929|2474241|P1|NOT COMPLETED|Overall Study||1
1019314|NCT00617929|2474241|P1|COMPLETED|Overall Study||11
1019315|NCT00617929|2474241|P1|STARTED|Overall Study||12
1019316|NCT00617942|2474253|P2|NOT COMPLETED|Overall Study||4
1019317|NCT00617942|2474254|P1|NOT COMPLETED|Overall Study||8
1019318|NCT00617942|2474253|P2|COMPLETED|Overall Study||19
1019319|NCT00617942|2474254|P1|COMPLETED|Overall Study||29
1019320|NCT00617942|2474253|P2|STARTED|Overall Study||23
1019321|NCT00617942|2474254|P1|STARTED|Overall Study||37
1019322|NCT00617981|2474268|P2|NOT COMPLETED|Overall Study||102
1019323|NCT00617981|2474269|P1|NOT COMPLETED|Overall Study||110
1019324|NCT00617981|2474268|P2|COMPLETED|Overall Study||245
1019325|NCT00617981|2474269|P1|COMPLETED|Overall Study||244
1019326|NCT00617981|2474268|P2|STARTED|Overall Study||347
1019327|NCT00617981|2474269|P1|STARTED|Overall Study||354
1019328|NCT00618072|2474278|P3|NOT COMPLETED|Overall Study||4
1019329|NCT00618072|2474279|P2|NOT COMPLETED|Overall Study||1
1019330|NCT00618072|2474280|P1|NOT COMPLETED|Overall Study||2
1019331|NCT00618072|2474278|P3|COMPLETED|Overall Study||11
1019332|NCT00618072|2474279|P2|COMPLETED|Overall Study||14
1019333|NCT00618072|2474280|P1|COMPLETED|Overall Study||14
1019334|NCT00618072|2474278|P3|STARTED|Overall Study||15
1019335|NCT00618072|2474279|P2|STARTED|Overall Study||15
1019336|NCT00618072|2474280|P1|STARTED|Overall Study||16
1019337|NCT00610311|2474312|P1|NOT COMPLETED|Overall Study||0
1019338|NCT00610311|2474312|P1|COMPLETED|Overall Study||3
1019339|NCT00610311|2474312|P1|STARTED|Overall Study||3
1019340|NCT00610363|2474321|P2|NOT COMPLETED|Overall Study||3
1019341|NCT00610363|2474322|P1|NOT COMPLETED|Overall Study||11
1019342|NCT00610363|2474321|P2|COMPLETED|Overall Study||38
1019343|NCT00610363|2474322|P1|COMPLETED|Overall Study||31
1019344|NCT00610363|2474321|P2|STARTED|Overall Study||41
1019345|NCT00610363|2474322|P1|STARTED|Overall Study||42
1019346|NCT00610441|2474344|P4|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
1019347|NCT00610441|2474345|P3|NOT COMPLETED|Treatment Period 2 - 3 Weeks||0
1019348|NCT00610441|2474346|P2|NOT COMPLETED|Treatment Period 2 - 3 Weeks||1
1019349|NCT00610441|2474347|P1|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
1019350|NCT00610441|2474344|P4|COMPLETED|Treatment Period 2 - 3 Weeks||14
1019351|NCT00610441|2474345|P3|COMPLETED|Treatment Period 2 - 3 Weeks||9
1019352|NCT00610441|2474346|P2|COMPLETED|Treatment Period 2 - 3 Weeks||12
1019353|NCT00610441|2474347|P1|COMPLETED|Treatment Period 2 - 3 Weeks||10
1019354|NCT00610441|2474344|P4|STARTED|Treatment Period 2 - 3 Weeks||16
1019355|NCT00610441|2474345|P3|STARTED|Treatment Period 2 - 3 Weeks||9
1019356|NCT00610441|2474346|P2|STARTED|Treatment Period 2 - 3 Weeks||13
1019357|NCT00610441|2474347|P1|STARTED|Treatment Period 2 - 3 Weeks||12
1019358|NCT00610441|2474344|P4|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
1019359|NCT00610441|2474345|P3|NOT COMPLETED|Placebo Washout Period - 2 Weeks||2
1019360|NCT00610441|2474346|P2|NOT COMPLETED|Placebo Washout Period - 2 Weeks||1
1019361|NCT00610441|2474347|P1|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
1019362|NCT00610441|2474344|P4|COMPLETED|Placebo Washout Period - 2 Weeks||16
1019363|NCT00610441|2474345|P3|COMPLETED|Placebo Washout Period - 2 Weeks||9
1019364|NCT00610441|2474346|P2|COMPLETED|Placebo Washout Period - 2 Weeks||13
1019365|NCT00610441|2474347|P1|COMPLETED|Placebo Washout Period - 2 Weeks||12
1019366|NCT00610441|2474344|P4|STARTED|Placebo Washout Period - 2 Weeks||16
1019367|NCT00610441|2474345|P3|STARTED|Placebo Washout Period - 2 Weeks||11
1019368|NCT00610441|2474346|P2|STARTED|Placebo Washout Period - 2 Weeks||14
1019369|NCT00610441|2474347|P1|STARTED|Placebo Washout Period - 2 Weeks||12
1019370|NCT00610441|2474344|P4|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
1019371|NCT00610441|2474345|P3|NOT COMPLETED|Treatment Period 1 - 3 Weeks||7
1019372|NCT00610441|2474346|P2|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
1019373|NCT00610441|2474347|P1|NOT COMPLETED|Treatment Period 1 - 3 Weeks||3
1019374|NCT00610441|2474344|P4|COMPLETED|Treatment Period 1 - 3 Weeks||16
1019375|NCT00610441|2474345|P3|COMPLETED|Treatment Period 1 - 3 Weeks||11
1019376|NCT00610441|2474346|P2|COMPLETED|Treatment Period 1 - 3 Weeks||14
1019377|NCT00610441|2474347|P1|COMPLETED|Treatment Period 1 - 3 Weeks||12
1019378|NCT00610441|2474344|P4|STARTED|Treatment Period 1 - 3 Weeks||18
1019379|NCT00610441|2474345|P3|STARTED|Treatment Period 1 - 3 Weeks||18
1019380|NCT00610441|2474346|P2|STARTED|Treatment Period 1 - 3 Weeks||16
1019381|NCT00610441|2474347|P1|STARTED|Treatment Period 1 - 3 Weeks||15
1019382|NCT00610532|2474438|P1|NOT COMPLETED|Intravenous Phenytoin Plus Probenecid||0
1019383|NCT00610532|2474438|P1|COMPLETED|Intravenous Phenytoin Plus Probenecid||7
1019384|NCT00610532|2474438|P1|STARTED|Intravenous Phenytoin Plus Probenecid|one participant dropped out between periods|7
1019385|NCT00610532|2474438|P1|NOT COMPLETED|Intravenous Phenytoin Alone||0
1019386|NCT00610532|2474438|P1|COMPLETED|Intravenous Phenytoin Alone||8
1019387|NCT00610532|2474438|P1|STARTED|Intravenous Phenytoin Alone||8
1019388|NCT00610649|2474455|P11|NOT COMPLETED|Overall Study||1
1019389|NCT00610649|2474456|P10|NOT COMPLETED|Overall Study||1
1019390|NCT00610649|2474457|P9|NOT COMPLETED|Overall Study||0
1019391|NCT00610649|2474458|P8|NOT COMPLETED|Overall Study||0
1019392|NCT00610649|2474459|P7|NOT COMPLETED|Overall Study||0
1019393|NCT00610649|2474460|P6|NOT COMPLETED|Overall Study||0
1019394|NCT00610649|2474461|P5|NOT COMPLETED|Overall Study||0
1019395|NCT00610649|2474462|P4|NOT COMPLETED|Overall Study||0
1019396|NCT00610649|2474463|P3|NOT COMPLETED|Overall Study||0
1019397|NCT00610649|2474464|P2|NOT COMPLETED|Overall Study||1
1019398|NCT00610649|2474465|P1|NOT COMPLETED|Overall Study||1
1019399|NCT00610649|2474455|P11|COMPLETED|Overall Study||9
1019400|NCT00610649|2474456|P10|COMPLETED|Overall Study||9
1019401|NCT00610649|2474457|P9|COMPLETED|Overall Study||10
1019402|NCT00610649|2474458|P8|COMPLETED|Overall Study||2
1019403|NCT00610649|2474459|P7|COMPLETED|Overall Study||4
1019404|NCT00610649|2474460|P6|COMPLETED|Overall Study||2
1019405|NCT00610649|2474461|P5|COMPLETED|Overall Study||4
1019406|NCT00610649|2474462|P4|COMPLETED|Overall Study||2
1019407|NCT00610649|2474463|P3|COMPLETED|Overall Study||4
1019408|NCT00610649|2474464|P2|COMPLETED|Overall Study||1
1019409|NCT00610649|2474465|P1|COMPLETED|Overall Study||3
1019410|NCT00610649|2474455|P11|STARTED|Overall Study||10
1019411|NCT00610649|2474456|P10|STARTED|Overall Study||10
1019412|NCT00610649|2474457|P9|STARTED|Overall Study||10
1019413|NCT00610649|2474458|P8|STARTED|Overall Study||2
1019414|NCT00610649|2474459|P7|STARTED|Overall Study||4
1019415|NCT00610649|2474460|P6|STARTED|Overall Study||2
1019416|NCT00610649|2474461|P5|STARTED|Overall Study||4
1019417|NCT00610649|2474462|P4|STARTED|Overall Study||2
1019418|NCT00610649|2474463|P3|STARTED|Overall Study||4
1019419|NCT00610649|2474464|P2|STARTED|Overall Study||2
1019420|NCT00610649|2474465|P1|STARTED|Overall Study||4
1019421|NCT00610675|2474519|P1|NOT COMPLETED|Overall Study||220
1019422|NCT00610675|2474519|P1|COMPLETED|Overall Study||126
1019423|NCT00610675|2474519|P1|Treated|Overall Study||342
1019424|NCT00610675|2474519|P1|STARTED|Overall Study||346
1019425|NCT00610688|2474533|P3|NOT COMPLETED|Overall Study||8
1019426|NCT00610688|2474534|P2|NOT COMPLETED|Overall Study||13
1019427|NCT00610688|2474535|P1|NOT COMPLETED|Overall Study||9
1019428|NCT00610688|2474533|P3|COMPLETED|Overall Study||55
1019429|NCT00610688|2474534|P2|COMPLETED|Overall Study||52
1019430|NCT00610688|2474535|P1|COMPLETED|Overall Study||55
1019431|NCT00610688|2474533|P3|STARTED|Overall Study||63
1019432|NCT00610688|2474534|P2|STARTED|Overall Study||65
1019433|NCT00610688|2474535|P1|STARTED|Overall Study||64
1019434|NCT00610701|2474551|P2|NOT COMPLETED|Overall Study||11
1019435|NCT00610701|2474552|P1|NOT COMPLETED|Overall Study||10
1019436|NCT00610701|2474551|P2|COMPLETED|Overall Study||9
1019437|NCT00610701|2474552|P1|COMPLETED|Overall Study||5
1019438|NCT00610701|2474551|P2|STARTED|Overall Study||20
1019439|NCT00610701|2474552|P1|STARTED|Overall Study||15
1019440|NCT00610714|2474560|P2|NOT COMPLETED|Overall Study||24
1019441|NCT00610714|2474561|P1|NOT COMPLETED|Overall Study||26
1019442|NCT00610714|2474560|P2|COMPLETED|Overall Study||82
1019443|NCT00610714|2474561|P1|COMPLETED|Overall Study||79
1019444|NCT00610714|2474560|P2|STARTED|Overall Study||106
1019445|NCT00610714|2474561|P1|STARTED|Overall Study||105
1019446|NCT00610740|2474571|P1|NOT COMPLETED|Overall Study||0
1019447|NCT00610740|2474571|P1|COMPLETED|Overall Study||18
1019448|NCT00610740|2474571|P1|STARTED|Overall Study||18
1019449|NCT00610857|2474577|P1|NOT COMPLETED|Overall Study||2
1019450|NCT00610857|2474577|P1|COMPLETED|Overall Study||35
1019451|NCT00610857|2474577|P1|STARTED|Overall Study||37
1019452|NCT00610883|2474584|P1|NOT COMPLETED|Overall Study||0
1019453|NCT00610883|2474584|P1|COMPLETED|Overall Study||17
1019454|NCT00610883|2474584|P1|STARTED|Overall Study||17
1019455|NCT00610987|2474590|P2|NOT COMPLETED|Overall Study||0
1019456|NCT00610987|2474591|P1|NOT COMPLETED|Overall Study||0
1019457|NCT00610987|2474590|P2|COMPLETED|Overall Study||71
1019458|NCT00610987|2474591|P1|COMPLETED|Overall Study||75
1019459|NCT00610987|2474590|P2|STARTED|Overall Study||71
1019460|NCT00610987|2474591|P1|STARTED|Overall Study||75
1019461|NCT00611026|2474600|P3|NOT COMPLETED|Double-blind Treatment Period||98
1019462|NCT00611026|2474601|P2|NOT COMPLETED|Double-blind Treatment Period||88
1019463|NCT00611026|2474602|P1|NOT COMPLETED|Double-blind Treatment Period||47
1019464|NCT00611026|2474600|P3|COMPLETED|Double-blind Treatment Period||862
1019465|NCT00611026|2474601|P2|COMPLETED|Double-blind Treatment Period||885
1019466|NCT00611026|2474602|P1|COMPLETED|Double-blind Treatment Period||431
1019467|NCT00611026|2474600|P3|STARTED|Double-blind Treatment Period||960
1019468|NCT00611026|2474601|P2|STARTED|Double-blind Treatment Period||973
1019469|NCT00611026|2474602|P1|STARTED|Double-blind Treatment Period||478
1019470|NCT00611026|2474600|P3|NOT COMPLETED|Randomized to Double-blind Treatment||3
1019471|NCT00611026|2474601|P2|NOT COMPLETED|Randomized to Double-blind Treatment||1
1019472|NCT00611026|2474602|P1|NOT COMPLETED|Randomized to Double-blind Treatment||2
1019473|NCT00611026|2474600|P3|COMPLETED|Randomized to Double-blind Treatment||960
1019474|NCT00611026|2474601|P2|COMPLETED|Randomized to Double-blind Treatment||973
1019475|NCT00611026|2474602|P1|COMPLETED|Randomized to Double-blind Treatment||478
1019476|NCT00611026|2474600|P3|STARTED|Randomized to Double-blind Treatment||963
1019477|NCT00611026|2474601|P2|STARTED|Randomized to Double-blind Treatment||974
1019478|NCT00611026|2474602|P1|STARTED|Randomized to Double-blind Treatment||480
1019487|NCT00618332|2474678|P2|NOT COMPLETED|Overall Study||0
1019488|NCT00618332|2474679|P1|NOT COMPLETED|Overall Study||0
1019489|NCT00618332|2474678|P2|COMPLETED|Overall Study||20
1019490|NCT00618332|2474679|P1|COMPLETED|Overall Study||20
1019491|NCT00618332|2474678|P2|STARTED|Overall Study||20
1019492|NCT00618332|2474679|P1|STARTED|Overall Study||20
1019493|NCT00618371|2474701|P1|NOT COMPLETED|Overall Study||2
1019494|NCT00618371|2474701|P1|COMPLETED|Overall Study||10
1019495|NCT00618371|2474701|P1|STARTED|Overall Study||12
1019496|NCT00618410|2474706|P2|NOT COMPLETED|Second Intervention||0
1019497|NCT00618410|2474707|P1|NOT COMPLETED|Second Intervention||0
1019498|NCT00618410|2474706|P2|COMPLETED|Second Intervention||5
1019499|NCT00618410|2474707|P1|COMPLETED|Second Intervention||7
1019500|NCT00618410|2474706|P2|STARTED|Second Intervention||5
1019501|NCT00618410|2474707|P1|STARTED|Second Intervention||7
1019502|NCT00618410|2474706|P2|NOT COMPLETED|Washout Period (2 Weeks)||1
1019503|NCT00618410|2474707|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
1019504|NCT00618410|2474706|P2|COMPLETED|Washout Period (2 Weeks)||5
1019505|NCT00618410|2474707|P1|COMPLETED|Washout Period (2 Weeks)||7
1019506|NCT00618410|2474706|P2|STARTED|Washout Period (2 Weeks)||6
1019507|NCT00618410|2474707|P1|STARTED|Washout Period (2 Weeks)||7
1019508|NCT00618410|2474706|P2|NOT COMPLETED|First Intervention||0
1019509|NCT00618410|2474707|P1|NOT COMPLETED|First Intervention||0
1019510|NCT00618410|2474706|P2|COMPLETED|First Intervention||6
1019511|NCT00618410|2474707|P1|COMPLETED|First Intervention||7
1019512|NCT00618410|2474706|P2|STARTED|First Intervention||6
1019513|NCT00618410|2474707|P1|STARTED|First Intervention||7
1019514|NCT00618436|2474725|P2|NOT COMPLETED|Overall Study||0
1019515|NCT00618436|2474726|P1|NOT COMPLETED|Overall Study||0
1019516|NCT00618436|2474725|P2|COMPLETED|Overall Study||18
1019517|NCT00618436|2474726|P1|COMPLETED|Overall Study||34
1019518|NCT00618436|2474725|P2|STARTED|Overall Study||18
1019519|NCT00618436|2474726|P1|STARTED|Overall Study||34
1019520|NCT00618449|2474738|P2|NOT COMPLETED|Overall Study||110
1019521|NCT00618449|2474739|P1|NOT COMPLETED|Overall Study||98
1019522|NCT00618449|2474738|P2|COMPLETED|Overall Study||558
1019523|NCT00618449|2474739|P1|COMPLETED|Overall Study||581
1019524|NCT00618449|2474738|P2|1-year, Post-treatment|Overall Study||558
1019525|NCT00618449|2474739|P1|1-year, Post-treatment|Overall Study||581
1019526|NCT00618449|2474738|P2|1-month, Post-treatment|Overall Study||656
1019527|NCT00618449|2474739|P1|1-month, Post-treatment|Overall Study||666
1019528|NCT00618449|2474738|P2|STARTED|Overall Study||668
1019529|NCT00618449|2474739|P1|STARTED|Overall Study||679
1019530|NCT00618514|2474747|P3|NOT COMPLETED|Overall Study||4
1019531|NCT00618514|2474748|P2|NOT COMPLETED|Overall Study||12
1019532|NCT00618514|2474749|P1|NOT COMPLETED|Overall Study||11
1019533|NCT00618514|2474747|P3|COMPLETED|Overall Study||12
1019534|NCT00618514|2474748|P2|COMPLETED|Overall Study||26
1019535|NCT00618514|2474749|P1|COMPLETED|Overall Study||25
1019536|NCT00618514|2474747|P3|STARTED|Overall Study||16
1019537|NCT00618514|2474748|P2|STARTED|Overall Study||38
1019538|NCT00618514|2474749|P1|STARTED|Overall Study||36
1019539|NCT00618540|2474767|P1|NOT COMPLETED|Overall Study||0
1019540|NCT00618540|2474767|P1|COMPLETED|Overall Study||1
1019541|NCT00618540|2474767|P1|STARTED|Overall Study||1
1019542|NCT00618618|2474782|P4|NOT COMPLETED|Overall Study||1
1019543|NCT00618618|2474783|P3|NOT COMPLETED|Overall Study||3
1019544|NCT00618618|2474784|P2|NOT COMPLETED|Overall Study||3
1019545|NCT00618618|2474785|P1|NOT COMPLETED|Overall Study||4
1019546|NCT00618618|2474782|P4|COMPLETED|Overall Study||13
1019547|NCT00618618|2474783|P3|COMPLETED|Overall Study||18
1019548|NCT00618618|2474784|P2|COMPLETED|Overall Study||11
1019549|NCT00618618|2474785|P1|COMPLETED|Overall Study||20
1019550|NCT00618618|2474782|P4|Received Treatment|Overall Study||14
1019551|NCT00618618|2474783|P3|Received Treatment|Overall Study||20
1019552|NCT00618618|2474784|P2|Received Treatment|Overall Study||13
1019553|NCT00618618|2474785|P1|Received Treatment|Overall Study||24
1019554|NCT00618618|2474782|P4|STARTED|Overall Study||14
1019555|NCT00618618|2474783|P3|STARTED|Overall Study||21
1019556|NCT00618618|2474784|P2|STARTED|Overall Study||14
1019557|NCT00618618|2474785|P1|STARTED|Overall Study||24
1019558|NCT00618722|2474835|P4|NOT COMPLETED|Overall Study||4
1019559|NCT00618722|2474836|P3|NOT COMPLETED|Overall Study||3
1019560|NCT00618722|2474837|P2|NOT COMPLETED|Overall Study||2
1019561|NCT00618722|2474838|P1|NOT COMPLETED|Overall Study||3
1019562|NCT00618722|2474835|P4|COMPLETED|Overall Study||18
1019563|NCT00618722|2474836|P3|COMPLETED|Overall Study||19
1019564|NCT00618722|2474837|P2|COMPLETED|Overall Study||18
1019565|NCT00618722|2474838|P1|COMPLETED|Overall Study||18
1019566|NCT00618722|2474835|P4|Received Treatment|Overall Study||22
1019567|NCT00618722|2474836|P3|Received Treatment|Overall Study||22
1019568|NCT00618722|2474837|P2|Received Treatment|Overall Study||20
1019569|NCT00618722|2474838|P1|Received Treatment|Overall Study||20
1019570|NCT00618722|2474835|P4|STARTED|Overall Study||22
1019571|NCT00618722|2474836|P3|STARTED|Overall Study||22
1019572|NCT00618722|2474837|P2|STARTED|Overall Study||20
1019573|NCT00618722|2474838|P1|STARTED|Overall Study||21
1019574|NCT00618748|2474875|P3|NOT COMPLETED|Overall Study||14
1019575|NCT00618748|2474876|P2|NOT COMPLETED|Overall Study||5
1019576|NCT00618748|2474877|P1|NOT COMPLETED|Overall Study||11
1019577|NCT00618748|2474875|P3|COMPLETED|Overall Study||6
1019578|NCT00618748|2474876|P2|COMPLETED|Overall Study||20
1019579|NCT00618748|2474877|P1|COMPLETED|Overall Study||45
1019580|NCT00618748|2474875|P3|STARTED|Overall Study||20
1019581|NCT00618748|2474876|P2|STARTED|Overall Study||25
1019582|NCT00618748|2474877|P1|STARTED|Overall Study||56
1019583|NCT00618774|2474920|P2|NOT COMPLETED|Overall Study||3
1019584|NCT00618774|2474921|P1|NOT COMPLETED|Overall Study||6
1019585|NCT00618774|2474920|P2|COMPLETED|Overall Study||45
1019586|NCT00618774|2474921|P1|COMPLETED|Overall Study||205
1019587|NCT00618774|2474920|P2|STARTED|Overall Study||48
1019588|NCT00618774|2474921|P1|STARTED|Overall Study||211
1019589|NCT00618787|2474953|P2|NOT COMPLETED|Overall Study||2
1019590|NCT00618787|2474954|P1|NOT COMPLETED|Overall Study||3
1019591|NCT00618787|2474953|P2|COMPLETED|Overall Study||21
1019592|NCT00618787|2474954|P1|COMPLETED|Overall Study||19
1019593|NCT00618787|2474953|P2|STARTED|Overall Study||23
1019594|NCT00618787|2474954|P1|STARTED|Overall Study||22
1019595|NCT00618813|2474960|P1|NOT COMPLETED|Overall Study||4
1019596|NCT00618813|2474960|P1|COMPLETED|Overall Study||31
1019597|NCT00618813|2474960|P1|Completed Week 29 to Week 37 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|33
1019598|NCT00618813|2474960|P1|Completed Week 23 to Week 28 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
1019599|NCT00618813|2474960|P1|Completed Week 13 to Week 22 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
1019600|NCT00618813|2474960|P1|Completed Enrollment - Week 12 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|35
1019601|NCT00618813|2474960|P1|STARTED|Overall Study||35
1019602|NCT00618826|2474968|P1|NOT COMPLETED|Overall Study||1
1019603|NCT00618826|2474968|P1|COMPLETED|Overall Study||13
1019604|NCT00618826|2474968|P1|STARTED|Overall Study||14
1019605|NCT00618839|2474973|P1|NOT COMPLETED|Overall Study||0
1019606|NCT00618839|2474973|P1|COMPLETED|Overall Study||15
1019607|NCT00618839|2474973|P1|STARTED|Overall Study||15
1019608|NCT00618956|2474984|P2|NOT COMPLETED|Overall Study||50
1019609|NCT00618956|2474985|P1|NOT COMPLETED|Overall Study||25
1019610|NCT00618956|2474984|P2|COMPLETED|Overall Study||160
1019611|NCT00618956|2474985|P1|COMPLETED|Overall Study||86
1019612|NCT00618956|2474984|P2|STARTED|Overall Study||210
1019613|NCT00618956|2474985|P1|STARTED|Overall Study||111
1019614|NCT00618982|2475001|P1|NOT COMPLETED|Overall Study||50
1019615|NCT00618982|2475001|P1|COMPLETED|Overall Study||33
1019616|NCT00618982|2475001|P1|STARTED|Overall Study||83
1019617|NCT00618995|2475022|P4|NOT COMPLETED|Period 4||0
1019618|NCT00618995|2475023|P3|NOT COMPLETED|Period 4||0
1019619|NCT00618995|2475024|P2|NOT COMPLETED|Period 4||0
1019620|NCT00618995|2475025|P1|NOT COMPLETED|Period 4||1
1019621|NCT00618995|2475022|P4|COMPLETED|Period 4||6
1019622|NCT00618995|2475023|P3|COMPLETED|Period 4||4
1019623|NCT00618995|2475024|P2|COMPLETED|Period 4||6
1019624|NCT00618995|2475025|P1|COMPLETED|Period 4||5
1019625|NCT00618995|2475022|P4|STARTED|Period 4||6
1019626|NCT00618995|2475023|P3|STARTED|Period 4||4
1019627|NCT00618995|2475024|P2|STARTED|Period 4||6
1019628|NCT00618995|2475025|P1|STARTED|Period 4||6
1019629|NCT00618995|2475022|P4|NOT COMPLETED|Period 3||0
1019630|NCT00618995|2475023|P3|NOT COMPLETED|Period 3||0
1019631|NCT00618995|2475024|P2|NOT COMPLETED|Period 3||0
1019632|NCT00618995|2475025|P1|NOT COMPLETED|Period 3||0
1019633|NCT00618995|2475022|P4|COMPLETED|Period 3||6
1019634|NCT00618995|2475023|P3|COMPLETED|Period 3||4
1019635|NCT00618995|2475024|P2|COMPLETED|Period 3||6
1019636|NCT00618995|2475025|P1|COMPLETED|Period 3||6
1019637|NCT00618995|2475022|P4|STARTED|Period 3||6
1019638|NCT00618995|2475023|P3|STARTED|Period 3||4
1019639|NCT00618995|2475024|P2|STARTED|Period 3||6
1019640|NCT00618995|2475025|P1|STARTED|Period 3||6
1019641|NCT00618995|2475022|P4|NOT COMPLETED|Period 2||0
1019642|NCT00618995|2475023|P3|NOT COMPLETED|Period 2||1
1019643|NCT00618995|2475024|P2|NOT COMPLETED|Period 2||0
1019644|NCT00618995|2475025|P1|NOT COMPLETED|Period 2||0
1019645|NCT00618995|2475022|P4|COMPLETED|Period 2||6
1019646|NCT00618995|2475023|P3|COMPLETED|Period 2||4
1019647|NCT00618995|2475024|P2|COMPLETED|Period 2||6
1019648|NCT00618995|2475025|P1|COMPLETED|Period 2||6
1019649|NCT00618995|2475022|P4|STARTED|Period 2||6
1019650|NCT00618995|2475023|P3|STARTED|Period 2||5
1019651|NCT00618995|2475024|P2|STARTED|Period 2||6
1019652|NCT00618995|2475025|P1|STARTED|Period 2||6
1019653|NCT00618995|2475022|P4|NOT COMPLETED|Period 1||0
1019654|NCT00618995|2475023|P3|NOT COMPLETED|Period 1||2
1019655|NCT00618995|2475024|P2|NOT COMPLETED|Period 1||1
1019656|NCT00618995|2475025|P1|NOT COMPLETED|Period 1||0
1019657|NCT00618995|2475022|P4|COMPLETED|Period 1||6
1019658|NCT00618995|2475023|P3|COMPLETED|Period 1||5
1019659|NCT00618995|2475024|P2|COMPLETED|Period 1||6
1019660|NCT00618995|2475025|P1|COMPLETED|Period 1||6
1019661|NCT00618995|2475022|P4|STARTED|Period 1||6
1019662|NCT00618995|2475023|P3|STARTED|Period 1||7
1019663|NCT00618995|2475024|P2|STARTED|Period 1||7
1019664|NCT00618995|2475025|P1|STARTED|Period 1||6
1019665|NCT00619060|2475039|P2|NOT COMPLETED|Overall Study||0
1019666|NCT00619060|2475040|P1|NOT COMPLETED|Overall Study||0
1019667|NCT00619060|2475039|P2|COMPLETED|Overall Study||12
1019668|NCT00619060|2475040|P1|COMPLETED|Overall Study||10
1019669|NCT00619060|2475039|P2|STARTED|Overall Study||12
1019670|NCT00619060|2475040|P1|STARTED|Overall Study||10
1019671|NCT00619073|2475048|P2|NOT COMPLETED|Second Intervention - 60 Days||0
1019672|NCT00619073|2475049|P1|NOT COMPLETED|Second Intervention - 60 Days||0
1019673|NCT00619073|2475048|P2|COMPLETED|Second Intervention - 60 Days||8
1019674|NCT00619073|2475049|P1|COMPLETED|Second Intervention - 60 Days||8
1019675|NCT00619073|2475048|P2|STARTED|Second Intervention - 60 Days||8
1019676|NCT00619073|2475049|P1|STARTED|Second Intervention - 60 Days||8
1019677|NCT00619073|2475048|P2|NOT COMPLETED|Washout Period (30 Days)||0
1019678|NCT00619073|2475049|P1|NOT COMPLETED|Washout Period (30 Days)||0
1019679|NCT00619073|2475048|P2|COMPLETED|Washout Period (30 Days)||8
1019680|NCT00619073|2475049|P1|COMPLETED|Washout Period (30 Days)||8
1019681|NCT00619073|2475048|P2|STARTED|Washout Period (30 Days)||8
1019682|NCT00619073|2475049|P1|STARTED|Washout Period (30 Days)||8
1019683|NCT00619073|2475048|P2|NOT COMPLETED|First Intervention - 60 Days||0
1019684|NCT00619073|2475049|P1|NOT COMPLETED|First Intervention - 60 Days||0
1019685|NCT00619073|2475048|P2|COMPLETED|First Intervention - 60 Days||8
1019686|NCT00619073|2475049|P1|COMPLETED|First Intervention - 60 Days||8
1019687|NCT00619073|2475048|P2|STARTED|First Intervention - 60 Days||8
1019688|NCT00619073|2475049|P1|STARTED|First Intervention - 60 Days||8
1019689|NCT00619099|2475057|P2|NOT COMPLETED|Overall Study||19
1019690|NCT00619099|2475058|P1|NOT COMPLETED|Overall Study||33
1019691|NCT00619099|2475057|P2|COMPLETED|Overall Study||4
1019692|NCT00619099|2475058|P1|COMPLETED|Overall Study||11
1019693|NCT00619099|2475057|P2|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|22
1019694|NCT00619099|2475058|P1|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|43
1019695|NCT00619099|2475057|P2|STARTED|Overall Study|All randomized subjects|23
1019696|NCT00619099|2475058|P1|STARTED|Overall Study|All randomized subjects|44
1019700|NCT00619151|2475070|P2|NOT COMPLETED|Overall Study||0
1019701|NCT00619151|2475071|P1|NOT COMPLETED|Overall Study||1
1019702|NCT00619151|2475070|P2|COMPLETED|Overall Study||0
1019703|NCT00619151|2475071|P1|COMPLETED|Overall Study||1
1019704|NCT00619151|2475070|P2|STARTED|Overall Study||0
1019705|NCT00619151|2475071|P1|STARTED|Overall Study||2
1019706|NCT00619177|2475079|P1|NOT COMPLETED|Overall Study||508
1019707|NCT00619177|2475079|P1|COMPLETED|Overall Study|"Due to some missing termination information, the number of completed may be larger than 3061."|3061
1019708|NCT00619177|2475079|P1|STARTED|Overall Study|treated set = 3569 (treated with Movalis)|3569
1019709|NCT00619190|2475089|P2|NOT COMPLETED|Overall Study||0
1019710|NCT00619190|2475090|P1|NOT COMPLETED|Overall Study||1
1019711|NCT00619190|2475089|P2|COMPLETED|Overall Study||9
1019712|NCT00619190|2475090|P1|COMPLETED|Overall Study||20
1019713|NCT00619190|2475089|P2|STARTED|Overall Study||9
1019714|NCT00619190|2475090|P1|STARTED|Overall Study||21
1019715|NCT00619229|2475102|P2|NOT COMPLETED|Overall Study||2
1019716|NCT00619229|2475103|P1|NOT COMPLETED|Overall Study||4
1019717|NCT00619229|2475102|P2|COMPLETED|Overall Study||16
1019718|NCT00619229|2475103|P1|COMPLETED|Overall Study||14
1019719|NCT00619229|2475102|P2|Full Analysis Set (FAS)|Overall Study||17
1019720|NCT00619229|2475103|P1|Full Analysis Set (FAS)|Overall Study||16
1019721|NCT00619229|2475102|P2|STARTED|Overall Study||18
1019722|NCT00619229|2475103|P1|STARTED|Overall Study||18
1019723|NCT00619242|2475129|P1|NOT COMPLETED|Overall Study||0
1019724|NCT00619242|2475129|P1|COMPLETED|Overall Study||3
1019725|NCT00619242|2475129|P1|STARTED|Overall Study||3
1019726|NCT00619307|2475135|P2|NOT COMPLETED|Overall Study||4
1019727|NCT00619307|2475136|P1|NOT COMPLETED|Overall Study||4
1019728|NCT00619307|2475135|P2|COMPLETED|Overall Study||53
1019729|NCT00619307|2475136|P1|COMPLETED|Overall Study||56
1019730|NCT00619307|2475135|P2|STARTED|Overall Study||57
1019731|NCT00619307|2475136|P1|STARTED|Overall Study||60
1019732|NCT00619359|2475152|P2|NOT COMPLETED|Overall Study||81
1019733|NCT00619359|2475153|P1|NOT COMPLETED|Overall Study||67
1019734|NCT00619359|2475152|P2|COMPLETED|Overall Study||1094
1019735|NCT00619359|2475153|P1|COMPLETED|Overall Study||1080
1019736|NCT00619359|2475152|P2|STARTED|Overall Study||1175
1019737|NCT00619359|2475153|P1|STARTED|Overall Study||1147
1019738|NCT00619385|2475166|P3|NOT COMPLETED|Overall Study||4
1019739|NCT00619385|2475167|P2|NOT COMPLETED|Overall Study||2
1019740|NCT00619385|2475168|P1|NOT COMPLETED|Overall Study||1
1019741|NCT00619385|2475166|P3|COMPLETED|Overall Study||6
1019742|NCT00619385|2475167|P2|COMPLETED|Overall Study||6
1019743|NCT00619385|2475168|P1|COMPLETED|Overall Study||6
1019744|NCT00619385|2475166|P3|STARTED|Overall Study||10
1019745|NCT00619385|2475167|P2|STARTED|Overall Study||8
1019746|NCT00619385|2475168|P1|STARTED|Overall Study||7
1019747|NCT00619476|2475185|P4|NOT COMPLETED|Overall Study||34
1019748|NCT00619476|2475186|P3|NOT COMPLETED|Overall Study||24
1019749|NCT00619476|2475187|P2|NOT COMPLETED|Overall Study||22
1019750|NCT00619476|2475188|P1|NOT COMPLETED|Overall Study||31
1019751|NCT00619476|2475185|P4|COMPLETED|Overall Study||56
1019752|NCT00619476|2475186|P3|COMPLETED|Overall Study||60
1019753|NCT00619476|2475187|P2|COMPLETED|Overall Study||85
1019754|NCT00619476|2475188|P1|COMPLETED|Overall Study||64
1019755|NCT00619476|2475185|P4|Safety Population|Overall Study||87
1019756|NCT00619476|2475186|P3|Safety Population|Overall Study||82
1019757|NCT00619476|2475187|P2|Safety Population|Overall Study||107
1019758|NCT00619476|2475188|P1|Safety Population|Overall Study||95
1019759|NCT00619476|2475185|P4|Intent-to-Treat Population|Overall Study||87
1019760|NCT00619476|2475186|P3|Intent-to-Treat Population|Overall Study||82
1019761|NCT00619476|2475187|P2|Intent-to-Treat Population|Overall Study||107
1019762|NCT00619476|2475188|P1|Intent-to-Treat Population|Overall Study||95
1019763|NCT00619476|2475185|P4|STARTED|Overall Study||90
1019764|NCT00619476|2475186|P3|STARTED|Overall Study||84
1019765|NCT00619476|2475187|P2|STARTED|Overall Study||107
1019766|NCT00619476|2475188|P1|STARTED|Overall Study||95
1019767|NCT00619489|2475272|P2|NOT COMPLETED|Overall Study||34
1019768|NCT00619489|2475273|P1|NOT COMPLETED|Overall Study||23
1019769|NCT00619489|2475272|P2|COMPLETED|Overall Study||1
1019770|NCT00619489|2475273|P1|COMPLETED|Overall Study||14
1019771|NCT00619489|2475272|P2|STARTED|Overall Study||35
1019772|NCT00619489|2475273|P1|STARTED|Overall Study||37
1019773|NCT00619502|2475293|P2|NOT COMPLETED|Overall Study||10
1019774|NCT00619502|2475294|P1|NOT COMPLETED|Overall Study||8
1019775|NCT00619502|2475293|P2|COMPLETED|Overall Study||114
1019776|NCT00619502|2475294|P1|COMPLETED|Overall Study||122
1019777|NCT00619502|2475293|P2|STARTED|Overall Study||124
1019778|NCT00619502|2475294|P1|STARTED|Overall Study||130
1019779|NCT00619619|2475312|P8|NOT COMPLETED|Overall Study||3
1019780|NCT00619619|2475313|P7|NOT COMPLETED|Overall Study||1
1019781|NCT00619619|2475314|P6|NOT COMPLETED|Overall Study||0
1019782|NCT00619619|2475315|P5|NOT COMPLETED|Overall Study||2
1019783|NCT00619619|2475316|P4|NOT COMPLETED|Overall Study||1
1019784|NCT00619619|2475317|P3|NOT COMPLETED|Overall Study||1
1019785|NCT00619619|2475318|P2|NOT COMPLETED|Overall Study||0
1019786|NCT00619619|2475319|P1|NOT COMPLETED|Overall Study||0
1019787|NCT00619619|2475312|P8|COMPLETED|Overall Study||5
1019788|NCT00619619|2475313|P7|COMPLETED|Overall Study||7
1019789|NCT00619619|2475314|P6|COMPLETED|Overall Study||7
1019790|NCT00619619|2475315|P5|COMPLETED|Overall Study||5
1019791|NCT00619619|2475316|P4|COMPLETED|Overall Study||6
1019792|NCT00619619|2475317|P3|COMPLETED|Overall Study||8
1019793|NCT00619619|2475318|P2|COMPLETED|Overall Study||7
1019794|NCT00619619|2475319|P1|COMPLETED|Overall Study|Completed=conclusion of Test Article (treatment) phase for all treatment groups in 3151A6-2000.|6
1019795|NCT00619619|2475312|P8|Entered the Extension Study|Overall Study||7
1019796|NCT00619619|2475313|P7|Entered the Extension Study|Overall Study||6
1019797|NCT00619619|2475314|P6|Entered the Extension Study|Overall Study||6
1019798|NCT00619619|2475315|P5|Entered the Extension Study|Overall Study||7
1019799|NCT00619619|2475316|P4|Entered the Extension Study|Overall Study||3
1019800|NCT00619619|2475317|P3|Entered the Extension Study|Overall Study||8
1019801|NCT00619619|2475318|P2|Entered the Extension Study|Overall Study||5
1019802|NCT00619619|2475319|P1|Entered the Extension Study|Overall Study|Extension study: 3151A6-2001 (NCT00669110)|6
1019803|NCT00619619|2475312|P8|STARTED|Overall Study||8
1019804|NCT00619619|2475313|P7|STARTED|Overall Study||8
1019805|NCT00619619|2475314|P6|STARTED|Overall Study||7
1019806|NCT00619619|2475315|P5|STARTED|Overall Study||7
1019807|NCT00619619|2475316|P4|STARTED|Overall Study||7
1019808|NCT00619619|2475317|P3|STARTED|Overall Study||9
1019809|NCT00619619|2475318|P2|STARTED|Overall Study||7
1019810|NCT00619619|2475319|P1|STARTED|Overall Study||6
1019811|NCT00619645|2475404|P1|NOT COMPLETED|Overall Study||1
1019812|NCT00619645|2475404|P1|COMPLETED|Overall Study||7
1019813|NCT00619645|2475404|P1|STARTED|Overall Study||8
1019814|NCT00619684|2475410|P1|NOT COMPLETED|Overall Study||0
1019815|NCT00619684|2475410|P1|COMPLETED|Overall Study||18
1019816|NCT00619684|2475410|P1|STARTED|Overall Study||18
1019817|NCT00619762|2475419|P1|NOT COMPLETED|Overall Study||3
1019818|NCT00619762|2475419|P1|COMPLETED|Overall Study|(25 breasts) last patient visit 11/09/2009|14
1019819|NCT00619762|2475419|P1|STARTED|Overall Study|(29 breasts) First patient implanted 10/23/2007|17
1019820|NCT00619801|2475426|P2|NOT COMPLETED|Overall Study||3
1019821|NCT00619801|2475427|P1|NOT COMPLETED|Overall Study||1
1019822|NCT00619801|2475426|P2|COMPLETED|Overall Study||111
1019823|NCT00619801|2475427|P1|COMPLETED|Overall Study||58
1019824|NCT00619801|2475426|P2|Safety Population|Overall Study||114
1019825|NCT00619801|2475427|P1|Safety Population|Overall Study||59
1019826|NCT00619801|2475426|P2|STARTED|Overall Study||114
1019827|NCT00619801|2475427|P1|STARTED|Overall Study||59
1019828|NCT00619827|2475459|P2|NOT COMPLETED|Overall Study||4
1019829|NCT00619827|2475460|P1|NOT COMPLETED|Overall Study||3
1019830|NCT00619827|2475459|P2|COMPLETED|Overall Study||40
1019831|NCT00619827|2475460|P1|COMPLETED|Overall Study||42
1019832|NCT00619827|2475459|P2|STARTED|Overall Study||44
1019833|NCT00619827|2475460|P1|STARTED|Overall Study||45
1019834|NCT00619892|2475468|P2|NOT COMPLETED|Overall Study||2
1019835|NCT00619892|2475469|P1|NOT COMPLETED|Overall Study||3
1019836|NCT00619892|2475468|P2|COMPLETED|Overall Study||11
1019837|NCT00619892|2475469|P1|COMPLETED|Overall Study||10
1019838|NCT00619892|2475468|P2|STARTED|Overall Study||13
1019839|NCT00619892|2475469|P1|STARTED|Overall Study||13
1019840|NCT00619918|2475479|P2|NOT COMPLETED|Overall Study||22
1019841|NCT00619918|2475480|P1|NOT COMPLETED|Overall Study||20
1019842|NCT00619918|2475479|P2|COMPLETED|Overall Study||195
1019843|NCT00619918|2475480|P1|COMPLETED|Overall Study||210
1019844|NCT00619918|2475479|P2|STARTED|Overall Study||217
1019845|NCT00619918|2475480|P1|STARTED|Overall Study||230
1019846|NCT00619957|2475490|P2|NOT COMPLETED|Month 48 Open-Label||17
1019847|NCT00619957|2475491|P1|NOT COMPLETED|Month 48 Open-Label||12
1019848|NCT00619957|2475490|P2|COMPLETED|Month 48 Open-Label||134
1019849|NCT00619957|2475491|P1|COMPLETED|Month 48 Open-Label||55
1019850|NCT00619957|2475490|P2|STARTED|Month 48 Open-Label||151
1019851|NCT00619957|2475491|P1|STARTED|Month 48 Open-Label||67
1019852|NCT00619957|2475490|P2|NOT COMPLETED|Month 24 Double-Blind||17
1019853|NCT00619957|2475491|P1|NOT COMPLETED|Month 24 Double-Blind||18
1019854|NCT00619957|2475490|P2|COMPLETED|Month 24 Double-Blind||175
1019855|NCT00619957|2475491|P1|COMPLETED|Month 24 Double-Blind||75
1019856|NCT00619957|2475490|P2|Intent to Treat (ITT Population)|Month 24 Double-Blind|One subject did not take any study medication.|191
1019857|NCT00619957|2475491|P1|Intent to Treat (ITT Population)|Month 24 Double-Blind||93
1019858|NCT00619957|2475490|P2|STARTED|Month 24 Double-Blind||192
1019859|NCT00619957|2475491|P1|STARTED|Month 24 Double-Blind||93
1019860|NCT00619970|2475574|P3|NOT COMPLETED|Overall Study||2
1019861|NCT00619970|2475575|P2|NOT COMPLETED|Overall Study||3
1019862|NCT00619970|2475576|P1|NOT COMPLETED|Overall Study||0
1019863|NCT00619970|2475574|P3|COMPLETED|Overall Study||24
1019864|NCT00619970|2475575|P2|COMPLETED|Overall Study||46
1019865|NCT00619970|2475576|P1|COMPLETED|Overall Study||40
1019866|NCT00619970|2475574|P3|STARTED|Overall Study||26
1019867|NCT00619970|2475575|P2|STARTED|Overall Study||49
1019868|NCT00619970|2475576|P1|STARTED|Overall Study||40
1019905|NCT00620022|2475603|P2|NOT COMPLETED|Treatment Period 2||2
1019906|NCT00620022|2475604|P1|NOT COMPLETED|Treatment Period 2||2
1019907|NCT00620022|2475603|P2|COMPLETED|Treatment Period 2||35
1019908|NCT00620022|2475604|P1|COMPLETED|Treatment Period 2||39
1019909|NCT00620022|2475603|P2|STARTED|Treatment Period 2||37
1019910|NCT00620022|2475604|P1|STARTED|Treatment Period 2||41
1019911|NCT00620022|2475603|P2|NOT COMPLETED|Treatment Period 1||6
1019912|NCT00620022|2475604|P1|NOT COMPLETED|Treatment Period 1||5
1019913|NCT00620022|2475603|P2|COMPLETED|Treatment Period 1||37
1019914|NCT00620022|2475604|P1|COMPLETED|Treatment Period 1||41
1019915|NCT00620022|2475603|P2|STARTED|Treatment Period 1|Of 44 randomized patients, 1 patient discontinued before receiving any study treatment.|43
1019916|NCT00620022|2475604|P1|STARTED|Treatment Period 1||46
1019917|NCT00620035|2475612|P1|NOT COMPLETED|Overall Study||145
1019918|NCT00620035|2475612|P1|COMPLETED|Overall Study||156
1019919|NCT00620035|2475612|P1|STARTED|Overall Study||301
1019920|NCT00620074|2475622|P1|NOT COMPLETED|Overall Study||1
1019921|NCT00620074|2475622|P1|COMPLETED|Overall Study||5
1019922|NCT00620074|2475622|P1|STARTED|Overall Study||6
1019923|NCT00620113|2475634|P4|NOT COMPLETED|Overall Study||10
1019924|NCT00620113|2475635|P3|NOT COMPLETED|Overall Study||5
1019925|NCT00620113|2475636|P2|NOT COMPLETED|Overall Study||7
1019926|NCT00620113|2475637|P1|NOT COMPLETED|Overall Study||13
1019927|NCT00620113|2475634|P4|COMPLETED|Overall Study||59
1019928|NCT00620113|2475635|P3|COMPLETED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|66
1019929|NCT00620113|2475636|P2|COMPLETED|Overall Study||67
1019930|NCT00620113|2475637|P1|COMPLETED|Overall Study||60
1019931|NCT00620113|2475634|P4|Efficacy/Safety Population|Overall Study||69
1019932|NCT00620113|2475635|P3|Efficacy/Safety Population|Overall Study||70
1019933|NCT00620113|2475636|P2|Efficacy/Safety Population|Overall Study||74
1019934|NCT00620113|2475637|P1|Efficacy/Safety Population|Overall Study||73
1019935|NCT00620113|2475634|P4|STARTED|Overall Study||69
1019936|NCT00620113|2475635|P3|STARTED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|71
1019937|NCT00620113|2475636|P2|STARTED|Overall Study||74
1019938|NCT00620113|2475637|P1|STARTED|Overall Study||73
1019939|NCT00620126|2475689|P2|NOT COMPLETED|Overall Study||5
1019940|NCT00620126|2475690|P1|NOT COMPLETED|Overall Study||11
1019941|NCT00620126|2475689|P2|COMPLETED|Overall Study||17
1019942|NCT00620126|2475690|P1|COMPLETED|Overall Study||14
1019943|NCT00620126|2475689|P2|STARTED|Overall Study||22
1019944|NCT00620126|2475690|P1|STARTED|Overall Study||25
1019945|NCT00620282|2475703|P3|NOT COMPLETED|Overall Study||1
1019946|NCT00620282|2475704|P2|NOT COMPLETED|Overall Study||2
1019947|NCT00620282|2475705|P1|NOT COMPLETED|Overall Study||0
1019948|NCT00620282|2475703|P3|COMPLETED|Overall Study||16
1019949|NCT00620282|2475704|P2|COMPLETED|Overall Study||14
1019950|NCT00620282|2475705|P1|COMPLETED|Overall Study||16
1019951|NCT00620282|2475703|P3|STARTED|Overall Study||17
1019952|NCT00620282|2475704|P2|STARTED|Overall Study||16
1019953|NCT00620282|2475705|P1|STARTED|Overall Study||16
1019954|NCT00620373|2475752|P1|NOT COMPLETED|Overall Study||33
1019955|NCT00620373|2475752|P1|COMPLETED|Overall Study||936
1019956|NCT00620373|2475752|P1|STARTED|Overall Study||969
1019957|NCT00620425|2475768|P1|NOT COMPLETED|Overall Study||0
1019958|NCT00620425|2475768|P1|COMPLETED|Overall Study||18
1019959|NCT00620425|2475768|P1|STARTED|Overall Study||18
1019960|NCT00620464|2475781|P2|NOT COMPLETED|Overall Study||24
1019961|NCT00620464|2475782|P1|NOT COMPLETED|Overall Study||20
1019962|NCT00620464|2475781|P2|COMPLETED|Overall Study||32
1019963|NCT00620464|2475782|P1|COMPLETED|Overall Study||32
1019964|NCT00620464|2475781|P2|STARTED|Overall Study||56
1019965|NCT00620464|2475782|P1|STARTED|Overall Study||52
1019966|NCT00620542|2475792|P4|NOT COMPLETED|Part B (2 Year Core Study)||144
1019967|NCT00620542|2475793|P3|NOT COMPLETED|Part B (2 Year Core Study)||148
1019968|NCT00620542|2475794|P2|NOT COMPLETED|Part B (2 Year Core Study)||0
1019969|NCT00620542|2475795|P1|NOT COMPLETED|Part B (2 Year Core Study)||0
1019970|NCT00620542|2475792|P4|COMPLETED|Part B (2 Year Core Study)||547
1019971|NCT00620542|2475793|P3|COMPLETED|Part B (2 Year Core Study)||546
1019972|NCT00620542|2475794|P2|COMPLETED|Part B (2 Year Core Study)||0
1019973|NCT00620542|2475795|P1|COMPLETED|Part B (2 Year Core Study)||0
1019974|NCT00620542|2475792|P4|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|519
1019975|NCT00620542|2475793|P3|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|520
1019976|NCT00620542|2475794|P2|Intent-to-treat Population|Part B (2 Year Core Study)||0
1019977|NCT00620542|2475795|P1|Intent-to-treat Population|Part B (2 Year Core Study)||0
1019978|NCT00620542|2475792|P4|Received Treatment|Part B (2 Year Core Study)||689
1019979|NCT00620542|2475793|P3|Received Treatment|Part B (2 Year Core Study)||691
1019980|NCT00620542|2475794|P2|Received Treatment|Part B (2 Year Core Study)||0
1019981|NCT00620542|2475795|P1|Received Treatment|Part B (2 Year Core Study)||0
1019982|NCT00620542|2475792|P4|STARTED|Part B (2 Year Core Study)|Of 691 patients randomized, N=689 received treatment.|691
1019983|NCT00620542|2475793|P3|STARTED|Part B (2 Year Core Study)|Of 694 patients randomized, N=691 received treatment.|694
1019984|NCT00620542|2475794|P2|STARTED|Part B (2 Year Core Study)||0
1019985|NCT00620542|2475795|P1|STARTED|Part B (2 Year Core Study)||0
1019986|NCT00620542|2475792|P4|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
1019987|NCT00620542|2475793|P3|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
1019988|NCT00620542|2475794|P2|NOT COMPLETED|Part A (Run-in - 2 Weeks)||476
1019989|NCT00620542|2475795|P1|NOT COMPLETED|Part A (Run-in - 2 Weeks)||472
1019990|NCT00620542|2475792|P4|COMPLETED|Part A (Run-in - 2 Weeks)||0
1019991|NCT00620542|2475793|P3|COMPLETED|Part A (Run-in - 2 Weeks)||0
1019992|NCT00620542|2475794|P2|COMPLETED|Part A (Run-in - 2 Weeks)||690
1019993|NCT00620542|2475795|P1|COMPLETED|Part A (Run-in - 2 Weeks)||695
1019994|NCT00620542|2475792|P4|Received Treatment|Part A (Run-in - 2 Weeks)||0
1019995|NCT00620542|2475793|P3|Received Treatment|Part A (Run-in - 2 Weeks)||0
1019996|NCT00620542|2475794|P2|Received Treatment|Part A (Run-in - 2 Weeks)||795
1019997|NCT00620542|2475795|P1|Received Treatment|Part A (Run-in - 2 Weeks)||783
1019998|NCT00620542|2475792|P4|STARTED|Part A (Run-in - 2 Weeks)||0
1019999|NCT00620542|2475793|P3|STARTED|Part A (Run-in - 2 Weeks)||0
1020000|NCT00620542|2475794|P2|STARTED|Part A (Run-in - 2 Weeks)|Of 1166 randomized, N=795 received treatment.|1166
1020001|NCT00620542|2475795|P1|STARTED|Part A (Run-in - 2 Weeks)|Of 1167 randomized, N=783 received treatment.|1167
1020002|NCT00620555|2475833|P1|NOT COMPLETED|Overall Study||21
1020003|NCT00620555|2475833|P1|COMPLETED|Overall Study||44
1020004|NCT00620555|2475833|P1|STARTED|Overall Study||65
1020005|NCT00620659|2475840|P6|NOT COMPLETED|Treatment Period 3||0
1020006|NCT00620659|2475841|P5|NOT COMPLETED|Treatment Period 3||0
1020007|NCT00620659|2475842|P4|NOT COMPLETED|Treatment Period 3||1
1020008|NCT00620659|2475843|P3|NOT COMPLETED|Treatment Period 3||0
1020009|NCT00620659|2475844|P2|NOT COMPLETED|Treatment Period 3||2
1020010|NCT00620659|2475845|P1|NOT COMPLETED|Treatment Period 3||0
1020011|NCT00620659|2475840|P6|COMPLETED|Treatment Period 3||20
1020012|NCT00620659|2475841|P5|COMPLETED|Treatment Period 3||15
1020013|NCT00620659|2475842|P4|COMPLETED|Treatment Period 3||17
1020014|NCT00620659|2475843|P3|COMPLETED|Treatment Period 3||19
1020015|NCT00620659|2475844|P2|COMPLETED|Treatment Period 3||16
1020016|NCT00620659|2475845|P1|COMPLETED|Treatment Period 3||16
1020017|NCT00620659|2475840|P6|STARTED|Treatment Period 3||20
1020018|NCT00620659|2475841|P5|STARTED|Treatment Period 3||15
1020019|NCT00620659|2475842|P4|STARTED|Treatment Period 3||18
1020020|NCT00620659|2475843|P3|STARTED|Treatment Period 3||19
1020021|NCT00620659|2475844|P2|STARTED|Treatment Period 3||18
1020022|NCT00620659|2475845|P1|STARTED|Treatment Period 3||16
1020023|NCT00620659|2475840|P6|NOT COMPLETED|Placebo Washout Period 2||0
1020024|NCT00620659|2475841|P5|NOT COMPLETED|Placebo Washout Period 2||0
1020025|NCT00620659|2475842|P4|NOT COMPLETED|Placebo Washout Period 2||0
1020026|NCT00620659|2475843|P3|NOT COMPLETED|Placebo Washout Period 2||0
1020027|NCT00620659|2475844|P2|NOT COMPLETED|Placebo Washout Period 2||0
1020028|NCT00620659|2475845|P1|NOT COMPLETED|Placebo Washout Period 2||2
1020029|NCT00620659|2475840|P6|COMPLETED|Placebo Washout Period 2||20
1020030|NCT00620659|2475841|P5|COMPLETED|Placebo Washout Period 2||15
1020031|NCT00620659|2475842|P4|COMPLETED|Placebo Washout Period 2||18
1020032|NCT00620659|2475843|P3|COMPLETED|Placebo Washout Period 2||19
1020033|NCT00620659|2475844|P2|COMPLETED|Placebo Washout Period 2||18
1020034|NCT00620659|2475845|P1|COMPLETED|Placebo Washout Period 2||16
1020035|NCT00620659|2475840|P6|STARTED|Placebo Washout Period 2||20
1020036|NCT00620659|2475841|P5|STARTED|Placebo Washout Period 2||15
1020037|NCT00620659|2475842|P4|STARTED|Placebo Washout Period 2||18
1020038|NCT00620659|2475843|P3|STARTED|Placebo Washout Period 2||19
1020039|NCT00620659|2475844|P2|STARTED|Placebo Washout Period 2||18
1020040|NCT00620659|2475845|P1|STARTED|Placebo Washout Period 2||18
1020041|NCT00620659|2475840|P6|NOT COMPLETED|Treatment Period 2||0
1020042|NCT00620659|2475841|P5|NOT COMPLETED|Treatment Period 2||5
1020043|NCT00620659|2475842|P4|NOT COMPLETED|Treatment Period 2||0
1020044|NCT00620659|2475843|P3|NOT COMPLETED|Treatment Period 2||1
1020045|NCT00620659|2475844|P2|NOT COMPLETED|Treatment Period 2||3
1020046|NCT00620659|2475845|P1|NOT COMPLETED|Treatment Period 2||0
1020047|NCT00620659|2475840|P6|COMPLETED|Treatment Period 2||20
1020048|NCT00620659|2475841|P5|COMPLETED|Treatment Period 2||15
1020049|NCT00620659|2475842|P4|COMPLETED|Treatment Period 2||18
1020050|NCT00620659|2475843|P3|COMPLETED|Treatment Period 2||19
1020051|NCT00620659|2475844|P2|COMPLETED|Treatment Period 2||18
1020052|NCT00620659|2475845|P1|COMPLETED|Treatment Period 2||18
1020053|NCT00620659|2475840|P6|STARTED|Treatment Period 2||20
1020054|NCT00620659|2475841|P5|STARTED|Treatment Period 2||20
1020055|NCT00620659|2475842|P4|STARTED|Treatment Period 2||18
1020056|NCT00620659|2475843|P3|STARTED|Treatment Period 2||20
1020057|NCT00620659|2475844|P2|STARTED|Treatment Period 2||21
1020058|NCT00620659|2475845|P1|STARTED|Treatment Period 2||18
1020059|NCT00620659|2475840|P6|NOT COMPLETED|Placebo Washout Period 1||0
1020060|NCT00620659|2475841|P5|NOT COMPLETED|Placebo Washout Period 1||0
1020061|NCT00620659|2475842|P4|NOT COMPLETED|Placebo Washout Period 1||1
1020062|NCT00620659|2475843|P3|NOT COMPLETED|Placebo Washout Period 1||0
1020063|NCT00620659|2475844|P2|NOT COMPLETED|Placebo Washout Period 1||0
1020064|NCT00620659|2475845|P1|NOT COMPLETED|Placebo Washout Period 1||0
1020065|NCT00620659|2475840|P6|COMPLETED|Placebo Washout Period 1||20
1020066|NCT00620659|2475841|P5|COMPLETED|Placebo Washout Period 1||20
1020067|NCT00620659|2475842|P4|COMPLETED|Placebo Washout Period 1||18
1020068|NCT00620659|2475843|P3|COMPLETED|Placebo Washout Period 1||20
1020069|NCT00620659|2475844|P2|COMPLETED|Placebo Washout Period 1||21
1020070|NCT00620659|2475845|P1|COMPLETED|Placebo Washout Period 1||18
1020071|NCT00620659|2475840|P6|STARTED|Placebo Washout Period 1||20
1020072|NCT00620659|2475841|P5|STARTED|Placebo Washout Period 1||20
1020073|NCT00620659|2475842|P4|STARTED|Placebo Washout Period 1||19
1020074|NCT00620659|2475843|P3|STARTED|Placebo Washout Period 1||20
1020075|NCT00620659|2475844|P2|STARTED|Placebo Washout Period 1||21
1020076|NCT00620659|2475845|P1|STARTED|Placebo Washout Period 1||18
1020077|NCT00620659|2475840|P6|NOT COMPLETED|Treatment Period 1||0
1020078|NCT00620659|2475841|P5|NOT COMPLETED|Treatment Period 1||1
1020079|NCT00620659|2475842|P4|NOT COMPLETED|Treatment Period 1||3
1020080|NCT00620659|2475843|P3|NOT COMPLETED|Treatment Period 1||1
1020081|NCT00620659|2475844|P2|NOT COMPLETED|Treatment Period 1||0
1020082|NCT00620659|2475845|P1|NOT COMPLETED|Treatment Period 1||3
1020083|NCT00620659|2475840|P6|COMPLETED|Treatment Period 1||20
1020084|NCT00620659|2475841|P5|COMPLETED|Treatment Period 1||20
1020085|NCT00620659|2475842|P4|COMPLETED|Treatment Period 1|1 patient discontinued from MK0249, but continued in following periods, & completed the study|18
1020086|NCT00620659|2475843|P3|COMPLETED|Treatment Period 1||20
1020087|NCT00620659|2475844|P2|COMPLETED|Treatment Period 1||21
1020088|NCT00620659|2475845|P1|COMPLETED|Treatment Period 1||18
1020089|NCT00620659|2475840|P6|STARTED|Treatment Period 1||20
1020090|NCT00620659|2475841|P5|STARTED|Treatment Period 1||21
1020091|NCT00620659|2475842|P4|STARTED|Treatment Period 1||21
1020092|NCT00620659|2475843|P3|STARTED|Treatment Period 1||21
1020093|NCT00620659|2475844|P2|STARTED|Treatment Period 1||21
1020094|NCT00620659|2475845|P1|STARTED|Treatment Period 1||21
1020095|NCT00620698|2475863|P1|NOT COMPLETED|Overall Study||29
1020096|NCT00620698|2475863|P1|COMPLETED|Overall Study||60
1020097|NCT00620698|2475863|P1|STARTED|Overall Study||89
1020098|NCT00620711|2475869|P1|NOT COMPLETED|Overall Study||0
1020099|NCT00620711|2475869|P1|COMPLETED|Overall Study||4
1020100|NCT00620711|2475869|P1|STARTED|Overall Study||4
1020101|NCT00620750|2475874|P1|NOT COMPLETED|Overall Study||25
1020102|NCT00620750|2475874|P1|COMPLETED|Overall Study||40
1020103|NCT00620750|2475874|P1|STARTED|Overall Study||65
1020104|NCT00620763|2475878|P2|NOT COMPLETED|Period: Second Intervention||0
1020105|NCT00620763|2475879|P1|NOT COMPLETED|Period: Second Intervention||1
1020106|NCT00620763|2475878|P2|COMPLETED|Period: Second Intervention||7
1020107|NCT00620763|2475879|P1|COMPLETED|Period: Second Intervention||9
1020108|NCT00620763|2475878|P2|STARTED|Period: Second Intervention||7
1020109|NCT00620763|2475879|P1|STARTED|Period: Second Intervention||10
1020110|NCT00620763|2475878|P2|NOT COMPLETED|Period: Washout Period of 1 Week||0
1020111|NCT00620763|2475879|P1|NOT COMPLETED|Period: Washout Period of 1 Week||0
1020112|NCT00620763|2475878|P2|COMPLETED|Period: Washout Period of 1 Week||7
1020113|NCT00620763|2475879|P1|COMPLETED|Period: Washout Period of 1 Week||10
1020114|NCT00620763|2475878|P2|STARTED|Period: Washout Period of 1 Week||7
1020115|NCT00620763|2475879|P1|STARTED|Period: Washout Period of 1 Week||10
1020116|NCT00620763|2475878|P2|NOT COMPLETED|Period: First Intervention||5
1020117|NCT00620763|2475879|P1|NOT COMPLETED|Period: First Intervention||0
1020118|NCT00620763|2475878|P2|COMPLETED|Period: First Intervention||7
1020119|NCT00620763|2475879|P1|COMPLETED|Period: First Intervention||10
1020120|NCT00620763|2475878|P2|STARTED|Period: First Intervention||12
1020121|NCT00620763|2475879|P1|STARTED|Period: First Intervention||10
1020122|NCT00620776|2475887|P2|NOT COMPLETED|Overall Study||16
1020123|NCT00620776|2475888|P1|NOT COMPLETED|Overall Study||12
1020124|NCT00620776|2475887|P2|COMPLETED|Overall Study|24 out of 35 attended the week 24 (last) assessment.|24
1020125|NCT00620776|2475888|P1|COMPLETED|Overall Study|17 out of 26 attended the week 24 (last) assessment.|17
1020126|NCT00620776|2475887|P2|Received at Least One Session/Dose|Overall Study|35 out of 40 that consented to receive medication alone received at least one dose of medication.|35
1020127|NCT00620776|2475888|P1|Received at Least One Session/Dose|Overall Study|26 out of 29 that consented to the combined treatment option received at least one session of CBT.|26
1020128|NCT00620776|2475887|P2|STARTED|Overall Study|All 40 patients that were randomly assigned to not be offered CBT consented to this option.|40
1020129|NCT00620776|2475888|P1|STARTED|Overall Study|29 patients (of the 77 that were randomly assigned to add on CBT) consented to this option.|29
1020130|NCT00620815|2475919|P3|NOT COMPLETED|Overall Study||7
1020131|NCT00620815|2475920|P2|NOT COMPLETED|Overall Study||11
1020132|NCT00620815|2475921|P1|NOT COMPLETED|Overall Study||4
1020133|NCT00620815|2475919|P3|COMPLETED|Overall Study||192
1020134|NCT00620815|2475920|P2|COMPLETED|Overall Study||192
1020135|NCT00620815|2475921|P1|COMPLETED|Overall Study||195
1020136|NCT00620815|2475919|P3|STARTED|Overall Study||199
1020137|NCT00620815|2475920|P2|STARTED|Overall Study||203
1020138|NCT00620815|2475921|P1|STARTED|Overall Study||199
1020139|NCT00620828|2475961|P2|NOT COMPLETED|Overall Study||0
1020140|NCT00620828|2475962|P1|NOT COMPLETED|Overall Study||0
1020141|NCT00620828|2475961|P2|COMPLETED|Overall Study||35
1020142|NCT00620828|2475962|P1|COMPLETED|Overall Study||32
1020143|NCT00620828|2475961|P2|Number of Subjects Enrolled = 67|Overall Study||35
1020144|NCT00620828|2475962|P1|Number of Subjects Enrolled = 67|Overall Study||32
1020145|NCT00620828|2475961|P2|STARTED|Overall Study||35
1020146|NCT00620828|2475962|P1|STARTED|Overall Study||32
1020147|NCT00620854|2475982|P6|NOT COMPLETED|Period 3||0
1020148|NCT00620854|2475983|P5|NOT COMPLETED|Period 3||0
1020149|NCT00620854|2475984|P4|NOT COMPLETED|Period 3||0
1020150|NCT00620854|2475985|P3|NOT COMPLETED|Period 3||0
1020151|NCT00620854|2475986|P2|NOT COMPLETED|Period 3||0
1020152|NCT00620854|2475987|P1|NOT COMPLETED|Period 3||0
1020153|NCT00620854|2475982|P6|COMPLETED|Period 3||4
1020154|NCT00620854|2475983|P5|COMPLETED|Period 3||4
1020155|NCT00620854|2475984|P4|COMPLETED|Period 3||3
1020156|NCT00620854|2475985|P3|COMPLETED|Period 3||3
1020157|NCT00620854|2475986|P2|COMPLETED|Period 3||4
1020158|NCT00620854|2475987|P1|COMPLETED|Period 3||4
1020159|NCT00620854|2475982|P6|STARTED|Period 3||4
1020160|NCT00620854|2475983|P5|STARTED|Period 3||4
1020161|NCT00620854|2475984|P4|STARTED|Period 3||3
1020162|NCT00620854|2475985|P3|STARTED|Period 3||3
1020163|NCT00620854|2475986|P2|STARTED|Period 3||4
1020164|NCT00620854|2475987|P1|STARTED|Period 3||4
1020165|NCT00620854|2475982|P6|NOT COMPLETED|Washout 2||0
1020166|NCT00620854|2475983|P5|NOT COMPLETED|Washout 2||0
1020167|NCT00620854|2475984|P4|NOT COMPLETED|Washout 2||0
1020168|NCT00620854|2475985|P3|NOT COMPLETED|Washout 2||0
1020169|NCT00620854|2475986|P2|NOT COMPLETED|Washout 2||0
1020170|NCT00620854|2475987|P1|NOT COMPLETED|Washout 2||0
1020171|NCT00620854|2475982|P6|COMPLETED|Washout 2||4
1020172|NCT00620854|2475983|P5|COMPLETED|Washout 2||4
1020173|NCT00620854|2475984|P4|COMPLETED|Washout 2||3
1020174|NCT00620854|2475985|P3|COMPLETED|Washout 2||3
1020175|NCT00620854|2475986|P2|COMPLETED|Washout 2||4
1020176|NCT00620854|2475987|P1|COMPLETED|Washout 2||4
1020177|NCT00620854|2475982|P6|STARTED|Washout 2||4
1020178|NCT00620854|2475983|P5|STARTED|Washout 2||4
1020179|NCT00620854|2475984|P4|STARTED|Washout 2||3
1020180|NCT00620854|2475985|P3|STARTED|Washout 2||3
1020181|NCT00620854|2475986|P2|STARTED|Washout 2||4
1020182|NCT00620854|2475987|P1|STARTED|Washout 2||4
1020183|NCT00620854|2475982|P6|NOT COMPLETED|Period 2||0
1020184|NCT00620854|2475983|P5|NOT COMPLETED|Period 2||0
1020185|NCT00620854|2475984|P4|NOT COMPLETED|Period 2||0
1020186|NCT00620854|2475985|P3|NOT COMPLETED|Period 2||0
1020187|NCT00620854|2475986|P2|NOT COMPLETED|Period 2||0
1020188|NCT00620854|2475987|P1|NOT COMPLETED|Period 2||0
1020189|NCT00620854|2475982|P6|COMPLETED|Period 2||4
1020190|NCT00620854|2475983|P5|COMPLETED|Period 2||4
1020191|NCT00620854|2475984|P4|COMPLETED|Period 2||3
1020192|NCT00620854|2475985|P3|COMPLETED|Period 2||3
1020193|NCT00620854|2475986|P2|COMPLETED|Period 2||4
1020194|NCT00620854|2475987|P1|COMPLETED|Period 2||4
1020195|NCT00620854|2475982|P6|STARTED|Period 2||4
1020196|NCT00620854|2475983|P5|STARTED|Period 2||4
1020197|NCT00620854|2475984|P4|STARTED|Period 2||3
1020198|NCT00620854|2475985|P3|STARTED|Period 2||3
1020199|NCT00620854|2475986|P2|STARTED|Period 2||4
1020200|NCT00620854|2475987|P1|STARTED|Period 2||4
1020201|NCT00620854|2475982|P6|NOT COMPLETED|Washout 1||0
1020202|NCT00620854|2475983|P5|NOT COMPLETED|Washout 1||0
1020203|NCT00620854|2475984|P4|NOT COMPLETED|Washout 1||1
1020204|NCT00620854|2475985|P3|NOT COMPLETED|Washout 1||1
1020205|NCT00620854|2475986|P2|NOT COMPLETED|Washout 1||0
1020206|NCT00620854|2475987|P1|NOT COMPLETED|Washout 1||0
1020207|NCT00620854|2475982|P6|COMPLETED|Washout 1||4
1020208|NCT00620854|2475983|P5|COMPLETED|Washout 1||4
1020209|NCT00620854|2475984|P4|COMPLETED|Washout 1||3
1020210|NCT00620854|2475985|P3|COMPLETED|Washout 1||3
1020211|NCT00620854|2475986|P2|COMPLETED|Washout 1||4
1020212|NCT00620854|2475987|P1|COMPLETED|Washout 1||4
1020213|NCT00620854|2475982|P6|STARTED|Washout 1||4
1020214|NCT00620854|2475983|P5|STARTED|Washout 1||4
1020215|NCT00620854|2475984|P4|STARTED|Washout 1||4
1020216|NCT00620854|2475985|P3|STARTED|Washout 1||4
1020217|NCT00620854|2475986|P2|STARTED|Washout 1||4
1020218|NCT00620854|2475987|P1|STARTED|Washout 1||4
1020219|NCT00620854|2475982|P6|NOT COMPLETED|Period 1||0
1020220|NCT00620854|2475983|P5|NOT COMPLETED|Period 1||0
1020221|NCT00620854|2475984|P4|NOT COMPLETED|Period 1||0
1020222|NCT00620854|2475985|P3|NOT COMPLETED|Period 1||0
1020223|NCT00620854|2475986|P2|NOT COMPLETED|Period 1||0
1020224|NCT00620854|2475987|P1|NOT COMPLETED|Period 1||0
1020225|NCT00620854|2475982|P6|COMPLETED|Period 1||4
1020226|NCT00620854|2475983|P5|COMPLETED|Period 1||4
1020227|NCT00620854|2475984|P4|COMPLETED|Period 1||4
1020228|NCT00620854|2475985|P3|COMPLETED|Period 1||4
1020229|NCT00620854|2475986|P2|COMPLETED|Period 1||4
1020230|NCT00620854|2475987|P1|COMPLETED|Period 1||4
1020231|NCT00620854|2475982|P6|STARTED|Period 1||4
1020232|NCT00620854|2475983|P5|STARTED|Period 1||4
1020233|NCT00620854|2475984|P4|STARTED|Period 1||4
1020234|NCT00620854|2475985|P3|STARTED|Period 1||4
1020235|NCT00620854|2475986|P2|STARTED|Period 1||4
1020236|NCT00620854|2475987|P1|STARTED|Period 1||4
1020237|NCT00614055|2476001|P3|NOT COMPLETED|Overall Study||5
1020238|NCT00614055|2476002|P2|NOT COMPLETED|Overall Study||6
1020239|NCT00614055|2476003|P1|NOT COMPLETED|Overall Study||4
1020240|NCT00614055|2476001|P3|COMPLETED|Overall Study||55
1020241|NCT00614055|2476002|P2|COMPLETED|Overall Study||53
1020242|NCT00614055|2476003|P1|COMPLETED|Overall Study||55
1020243|NCT00614055|2476001|P3|Exposed|Overall Study||60
1020244|NCT00614055|2476002|P2|Exposed|Overall Study||59
1020245|NCT00614055|2476003|P1|Exposed|Overall Study||59
1020246|NCT00614055|2476001|P3|STARTED|Overall Study||60
1020247|NCT00614055|2476002|P2|STARTED|Overall Study||59
1020248|NCT00614055|2476003|P1|STARTED|Overall Study||59
1020249|NCT00614120|2476051|P4|NOT COMPLETED|Overall Study||16
1020250|NCT00614120|2476052|P3|NOT COMPLETED|Overall Study||59
1020251|NCT00614120|2476053|P2|NOT COMPLETED|Overall Study||46
1020252|NCT00614120|2476054|P1|NOT COMPLETED|Overall Study||29
1020253|NCT00614120|2476051|P4|COMPLETED|Overall Study||215
1020254|NCT00614120|2476052|P3|COMPLETED|Overall Study||175
1020255|NCT00614120|2476053|P2|COMPLETED|Overall Study||187
1020256|NCT00614120|2476054|P1|COMPLETED|Overall Study||202
1020257|NCT00614120|2476051|P4|Exposed to Study Drug|Overall Study||231
1020258|NCT00614120|2476052|P3|Exposed to Study Drug|Overall Study|Subject withdrew before exposure to study products, and thus not included in full analysis set.|233
1020259|NCT00614120|2476053|P2|Exposed to Study Drug|Overall Study||233
1020260|NCT00614120|2476054|P1|Exposed to Study Drug|Overall Study||231
1020261|NCT00614120|2476051|P4|STARTED|Overall Study|Randomised|231
1020262|NCT00614120|2476052|P3|STARTED|Overall Study|Randomised|234
1020263|NCT00614120|2476053|P2|STARTED|Overall Study|Randomised|233
1020264|NCT00614120|2476054|P1|STARTED|Overall Study|Randomised|231
1020265|NCT00614198|2476094|P2|NOT COMPLETED|Stage 2||12
1020266|NCT00614198|2476095|P1|NOT COMPLETED|Stage 2||8
1020267|NCT00614198|2476094|P2|COMPLETED|Stage 2||17
1020268|NCT00614198|2476095|P1|COMPLETED|Stage 2||18
1020269|NCT00614198|2476094|P2|STARTED|Stage 2|Reallocated to gluten- and casein-free dietary intervention|29
1020270|NCT00614198|2476095|P1|STARTED|Stage 2||26
1020271|NCT00614198|2476094|P2|NOT COMPLETED|Stage 1||5
1020272|NCT00614198|2476095|P1|NOT COMPLETED|Stage 1||12
1020273|NCT00614198|2476094|P2|COMPLETED|Stage 1||29
1020274|NCT00614198|2476095|P1|COMPLETED|Stage 1||26
1020275|NCT00614198|2476094|P2|STARTED|Stage 1||34
1020276|NCT00614198|2476095|P1|STARTED|Stage 1||38
1020277|NCT00614315|2476101|P1|NOT COMPLETED|Overall Study||0
1020278|NCT00614315|2476101|P1|COMPLETED|Overall Study||30
1020279|NCT00614315|2476101|P1|STARTED|Overall Study||30
1020280|NCT00614380|2476110|P4|NOT COMPLETED|Overall Study||2
1020281|NCT00614380|2476111|P3|NOT COMPLETED|Overall Study||1
1020282|NCT00614380|2476112|P2|NOT COMPLETED|Overall Study||8
1020283|NCT00614380|2476113|P1|NOT COMPLETED|Overall Study||35
1020284|NCT00614380|2476110|P4|COMPLETED|Overall Study||179
1020285|NCT00614380|2476111|P3|COMPLETED|Overall Study||24
1020286|NCT00614380|2476112|P2|COMPLETED|Overall Study||198
1020287|NCT00614380|2476113|P1|COMPLETED|Overall Study||529
1020288|NCT00614380|2476110|P4|STARTED|Overall Study||181
1020289|NCT00614380|2476111|P3|STARTED|Overall Study||25
1020290|NCT00614380|2476112|P2|STARTED|Overall Study||206
1020291|NCT00614380|2476113|P1|STARTED|Overall Study||564
1020292|NCT00614393|2476167|P5|NOT COMPLETED|Overall Study||180
1020293|NCT00614393|2476168|P4|NOT COMPLETED|Overall Study||180
1020294|NCT00614393|2476169|P3|NOT COMPLETED|Overall Study||10
1020295|NCT00614393|2476170|P2|NOT COMPLETED|Overall Study||8
1020296|NCT00614393|2476171|P1|NOT COMPLETED|Overall Study||180
1020297|NCT00614393|2476167|P5|COMPLETED|Overall Study||0
1020298|NCT00614393|2476168|P4|COMPLETED|Overall Study||0
1020299|NCT00614393|2476169|P3|COMPLETED|Overall Study||0
1020300|NCT00614393|2476170|P2|COMPLETED|Overall Study||0
1020301|NCT00614393|2476171|P1|COMPLETED|Overall Study||0
1020302|NCT00614393|2476167|P5|Treated|Overall Study||178
1020303|NCT00614393|2476168|P4|Treated|Overall Study||180
1020304|NCT00614393|2476169|P3|Treated|Overall Study||10
1020305|NCT00614393|2476170|P2|Treated|Overall Study||8
1020306|NCT00614393|2476171|P1|Treated|Overall Study||180
1020307|NCT00614393|2476167|P5|STARTED|Overall Study||180
1020308|NCT00614393|2476168|P4|STARTED|Overall Study||180
1020309|NCT00614393|2476169|P3|STARTED|Overall Study||10
1020310|NCT00614393|2476170|P2|STARTED|Overall Study||8
1020311|NCT00614393|2476171|P1|STARTED|Overall Study||180
1020312|NCT00614406|2476215|P2|NOT COMPLETED|Overall Study||0
1020313|NCT00614406|2476216|P1|NOT COMPLETED|Overall Study||0
1020314|NCT00614406|2476215|P2|COMPLETED|Overall Study||4
1020315|NCT00614406|2476216|P1|COMPLETED|Overall Study||7
1020316|NCT00614406|2476215|P2|STARTED|Overall Study||4
1020317|NCT00614406|2476216|P1|STARTED|Overall Study||7
1020318|NCT00614445|2476224|P2|NOT COMPLETED|Overall Study||49
1020319|NCT00614445|2476225|P1|NOT COMPLETED|Overall Study||28
1020320|NCT00614445|2476224|P2|COMPLETED|Overall Study||91
1020321|NCT00614445|2476225|P1|COMPLETED|Overall Study||112
1020322|NCT00614445|2476224|P2|STARTED|Overall Study||140
1020323|NCT00614445|2476225|P1|STARTED|Overall Study||140
1020324|NCT00614458|2476231|P1|NOT COMPLETED|Overall Study||0
1020325|NCT00614458|2476231|P1|COMPLETED|Overall Study||6
1020326|NCT00614458|2476231|P1|STARTED|Overall Study||6
1020327|NCT00614484|2476235|P1|NOT COMPLETED|Overall Study||0
1020328|NCT00614484|2476235|P1|COMPLETED|Overall Study||28
1020329|NCT00614484|2476235|P1|STARTED|Overall Study||28
1020330|NCT00614523|2476242|P2|NOT COMPLETED|Overall Study||131
1020331|NCT00614523|2476243|P1|NOT COMPLETED|Overall Study||63
1020332|NCT00614523|2476242|P2|COMPLETED|Overall Study||36
1020333|NCT00614523|2476243|P1|COMPLETED|Overall Study||20
1020334|NCT00614523|2476242|P2|STARTED|Overall Study||167
1020335|NCT00614523|2476243|P1|STARTED|Overall Study||83
1020336|NCT00614575|2476267|P1|NOT COMPLETED|Overall Study||228
1020337|NCT00614575|2476267|P1|COMPLETED|Overall Study||861
1020338|NCT00614575|2476267|P1|STARTED|Overall Study|The number of patients enrolled.|1089
1020339|NCT00614614|2476278|P5|NOT COMPLETED|Booster Vaccination Phase||13
1020340|NCT00614614|2476279|P4|NOT COMPLETED|Booster Vaccination Phase||19
1020341|NCT00614614|2476280|P3|NOT COMPLETED|Booster Vaccination Phase||27
1020342|NCT00614614|2476281|P2|NOT COMPLETED|Booster Vaccination Phase||6
1020343|NCT00614614|2476282|P1|NOT COMPLETED|Booster Vaccination Phase||0
1020344|NCT00614614|2476278|P5|COMPLETED|Booster Vaccination Phase||396
1020345|NCT00614614|2476279|P4|COMPLETED|Booster Vaccination Phase||210
1020346|NCT00614614|2476280|P3|COMPLETED|Booster Vaccination Phase||405
1020347|NCT00614614|2476281|P2|COMPLETED|Booster Vaccination Phase||227
1020348|NCT00614614|2476282|P1|COMPLETED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
1020349|NCT00614614|2476278|P5|STARTED|Booster Vaccination Phase||409
1020350|NCT00614614|2476279|P4|STARTED|Booster Vaccination Phase||229
1020351|NCT00614614|2476280|P3|STARTED|Booster Vaccination Phase||432
1020352|NCT00614614|2476281|P2|STARTED|Booster Vaccination Phase||233
1020353|NCT00614614|2476282|P1|STARTED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
1020354|NCT00614614|2476278|P5|NOT COMPLETED|Primary Vaccination Phase||0
1020355|NCT00614614|2476279|P4|NOT COMPLETED|Primary Vaccination Phase||0
1020356|NCT00614614|2476280|P3|NOT COMPLETED|Primary Vaccination Phase||0
1020357|NCT00614614|2476281|P2|NOT COMPLETED|Primary Vaccination Phase||17
1020358|NCT00614614|2476282|P1|NOT COMPLETED|Primary Vaccination Phase||90
1020359|NCT00614614|2476278|P5|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
1020360|NCT00614614|2476279|P4|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
1020361|NCT00614614|2476280|P3|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
1020362|NCT00614614|2476281|P2|COMPLETED|Primary Vaccination Phase||265
1020363|NCT00614614|2476282|P1|COMPLETED|Primary Vaccination Phase||1182
1020364|NCT00614614|2476278|P5|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
1020365|NCT00614614|2476279|P4|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
1020366|NCT00614614|2476280|P3|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
1020367|NCT00614614|2476281|P2|STARTED|Primary Vaccination Phase||282
1020368|NCT00614614|2476282|P1|STARTED|Primary Vaccination Phase||1272
1020369|NCT00614744|2476407|P2|NOT COMPLETED|Overall Study||6
1020370|NCT00614744|2476408|P1|NOT COMPLETED|Overall Study||5
1020371|NCT00614744|2476407|P2|COMPLETED|Overall Study||79
1020372|NCT00614744|2476408|P1|COMPLETED|Overall Study||78
1020373|NCT00614744|2476407|P2|STARTED|Overall Study||85
1020374|NCT00614744|2476408|P1|STARTED|Overall Study||83
1020375|NCT00614874|2476432|P1|NOT COMPLETED|Overall Study||2
1020376|NCT00614874|2476432|P1|COMPLETED|Overall Study||14
1020377|NCT00614874|2476432|P1|STARTED|Overall Study||16
1020378|NCT00614913|2476439|P1|NOT COMPLETED|Overall Study||0
1020379|NCT00614913|2476439|P1|COMPLETED|Overall Study||76
1020380|NCT00614913|2476439|P1|STARTED|Overall Study||76
1020381|NCT00614926|2476446|P2|NOT COMPLETED|Overall Study||0
1020382|NCT00614926|2476447|P1|NOT COMPLETED|Overall Study||4
1020383|NCT00614926|2476446|P2|COMPLETED|Overall Study||7
1020384|NCT00614926|2476447|P1|COMPLETED|Overall Study||21
1020385|NCT00614926|2476446|P2|STARTED|Overall Study||7
1020386|NCT00614926|2476447|P1|STARTED|Overall Study||25
1020387|NCT00614939|2476457|P2|NOT COMPLETED|Overall Study||43
1020388|NCT00614939|2476458|P1|NOT COMPLETED|Overall Study||35
1020389|NCT00614939|2476457|P2|COMPLETED|Overall Study|Completed 52 weeks of treatment|42
1020390|NCT00614939|2476458|P1|COMPLETED|Overall Study|Completed 52 weeks of treatment|50
1020391|NCT00614939|2476457|P2|STARTED|Overall Study|Randomized and treated|85
1020392|NCT00614939|2476458|P1|STARTED|Overall Study|Randomized and treated|85
1020393|NCT00614991|2476496|P6|NOT COMPLETED|Overall Study||0
1020394|NCT00614991|2476497|P5|NOT COMPLETED|Overall Study||1
1020395|NCT00614991|2476498|P4|NOT COMPLETED|Overall Study||0
1020396|NCT00614991|2476499|P3|NOT COMPLETED|Overall Study||0
1020397|NCT00614991|2476500|P2|NOT COMPLETED|Overall Study||3
1020398|NCT00614991|2476501|P1|NOT COMPLETED|Overall Study||3
1020399|NCT00614991|2476496|P6|COMPLETED|Overall Study||6
1020400|NCT00614991|2476497|P5|COMPLETED|Overall Study||6
1020401|NCT00614991|2476498|P4|COMPLETED|Overall Study||7
1020402|NCT00614991|2476499|P3|COMPLETED|Overall Study||7
1020403|NCT00614991|2476500|P2|COMPLETED|Overall Study||6
1020404|NCT00614991|2476501|P1|COMPLETED|Overall Study||5
1020405|NCT00614991|2476496|P6|STARTED|Overall Study||6
1020406|NCT00614991|2476497|P5|STARTED|Overall Study||7
1020407|NCT00614991|2476498|P4|STARTED|Overall Study||7
1020408|NCT00614991|2476499|P3|STARTED|Overall Study||7
1020409|NCT00614991|2476500|P2|STARTED|Overall Study||9
1020410|NCT00614991|2476501|P1|STARTED|Overall Study||8
1020411|NCT00615017|2476539|P6|NOT COMPLETED|Overall Study||3
1020412|NCT00615017|2476540|P5|NOT COMPLETED|Overall Study||1
1020413|NCT00615017|2476541|P4|NOT COMPLETED|Overall Study||1
1020414|NCT00615017|2476542|P3|NOT COMPLETED|Overall Study||5
1020415|NCT00615017|2476543|P2|NOT COMPLETED|Overall Study||1
1020416|NCT00615017|2476544|P1|NOT COMPLETED|Overall Study||0
1020417|NCT00615017|2476539|P6|COMPLETED|Overall Study|Patient completed the study drug|20
1020418|NCT00615017|2476540|P5|COMPLETED|Overall Study|Patient completed the study drug|7
1020419|NCT00615017|2476541|P4|COMPLETED|Overall Study|Patient completed the study drug|9
1020420|NCT00615017|2476542|P3|COMPLETED|Overall Study|Patient completed the study drug|7
1020421|NCT00615017|2476543|P2|COMPLETED|Overall Study|Patient completed the study drug|8
1020422|NCT00615017|2476544|P1|COMPLETED|Overall Study|Patient completed the study drug|8
1020423|NCT00615017|2476539|P6|STARTED|Overall Study|Patients received treatment|23
1020424|NCT00615017|2476540|P5|STARTED|Overall Study|Patients received treatment|8
1020425|NCT00615017|2476541|P4|STARTED|Overall Study|Patients received treatment|10
1020426|NCT00615017|2476542|P3|STARTED|Overall Study|Patients received treatment|12
1020427|NCT00615017|2476543|P2|STARTED|Overall Study|Patients received treatment|9
1020428|NCT00615017|2476544|P1|STARTED|Overall Study|Patients received treatment|8
1020429|NCT00615030|2476696|P12|NOT COMPLETED|Period III||0
1020430|NCT00615030|2476697|P11|NOT COMPLETED|Period III||0
1020431|NCT00615030|2476698|P10|NOT COMPLETED|Period III||0
1020432|NCT00615030|2476699|P9|NOT COMPLETED|Period III||0
1020433|NCT00615030|2476700|P8|NOT COMPLETED|Period III||0
1020434|NCT00615030|2476701|P7|NOT COMPLETED|Period III||0
1020435|NCT00615030|2476702|P6|NOT COMPLETED|Period III||0
1020436|NCT00615030|2476703|P5|NOT COMPLETED|Period III||0
1020437|NCT00615030|2476704|P4|NOT COMPLETED|Period III||1
1020438|NCT00615030|2476705|P3|NOT COMPLETED|Period III||0
1020439|NCT00615030|2476706|P2|NOT COMPLETED|Period III||0
1020440|NCT00615030|2476707|P1|NOT COMPLETED|Period III||1
1020441|NCT00615030|2476696|P12|COMPLETED|Period III||6
1020442|NCT00615030|2476697|P11|COMPLETED|Period III||7
1020443|NCT00615030|2476698|P10|COMPLETED|Period III||8
1020444|NCT00615030|2476699|P9|COMPLETED|Period III||7
1020445|NCT00615030|2476700|P8|COMPLETED|Period III||7
1020446|NCT00615030|2476701|P7|COMPLETED|Period III||6
1020447|NCT00615030|2476702|P6|COMPLETED|Period III||5
1020448|NCT00615030|2476703|P5|COMPLETED|Period III||8
1020449|NCT00615030|2476704|P4|COMPLETED|Period III||6
1020450|NCT00615030|2476705|P3|COMPLETED|Period III||8
1020451|NCT00615030|2476706|P2|COMPLETED|Period III||8
1020452|NCT00615030|2476707|P1|COMPLETED|Period III||7
1020453|NCT00615030|2476696|P12|STARTED|Period III||6
1020454|NCT00615030|2476697|P11|STARTED|Period III||7
1020455|NCT00615030|2476698|P10|STARTED|Period III||8
1020456|NCT00615030|2476699|P9|STARTED|Period III||7
1020457|NCT00615030|2476700|P8|STARTED|Period III||7
1020458|NCT00615030|2476701|P7|STARTED|Period III||6
1020459|NCT00615030|2476702|P6|STARTED|Period III||5
1020460|NCT00615030|2476703|P5|STARTED|Period III||8
1020461|NCT00615030|2476704|P4|STARTED|Period III||7
1020462|NCT00615030|2476705|P3|STARTED|Period III||8
1020463|NCT00615030|2476706|P2|STARTED|Period III||8
1020464|NCT00615030|2476707|P1|STARTED|Period III||8
1020465|NCT00615030|2476696|P12|NOT COMPLETED|Period II||0
1020466|NCT00615030|2476697|P11|NOT COMPLETED|Period II||0
1020467|NCT00615030|2476698|P10|NOT COMPLETED|Period II||0
1020468|NCT00615030|2476699|P9|NOT COMPLETED|Period II||1
1020469|NCT00615030|2476700|P8|NOT COMPLETED|Period II||0
1020470|NCT00615030|2476701|P7|NOT COMPLETED|Period II||1
1020471|NCT00615030|2476702|P6|NOT COMPLETED|Period II||0
1020472|NCT00615030|2476703|P5|NOT COMPLETED|Period II||0
1020473|NCT00615030|2476704|P4|NOT COMPLETED|Period II||1
1020474|NCT00615030|2476705|P3|NOT COMPLETED|Period II||1
1020475|NCT00615030|2476706|P2|NOT COMPLETED|Period II||0
1020476|NCT00615030|2476707|P1|NOT COMPLETED|Period II||0
1020477|NCT00615030|2476696|P12|COMPLETED|Period II||6
1020478|NCT00615030|2476697|P11|COMPLETED|Period II||7
1020479|NCT00615030|2476698|P10|COMPLETED|Period II||8
1020480|NCT00615030|2476699|P9|COMPLETED|Period II||7
1020481|NCT00615030|2476700|P8|COMPLETED|Period II||7
1020482|NCT00615030|2476701|P7|COMPLETED|Period II||6
1020483|NCT00615030|2476702|P6|COMPLETED|Period II||5
1020484|NCT00615030|2476703|P5|COMPLETED|Period II||8
1020485|NCT00615030|2476704|P4|COMPLETED|Period II||7
1020486|NCT00615030|2476705|P3|COMPLETED|Period II||8
1020487|NCT00615030|2476706|P2|COMPLETED|Period II||8
1020488|NCT00615030|2476707|P1|COMPLETED|Period II||8
1020489|NCT00615030|2476696|P12|STARTED|Period II||6
1020490|NCT00615030|2476697|P11|STARTED|Period II||7
1020491|NCT00615030|2476698|P10|STARTED|Period II||8
1020492|NCT00615030|2476699|P9|STARTED|Period II||8
1020493|NCT00615030|2476700|P8|STARTED|Period II||7
1020494|NCT00615030|2476701|P7|STARTED|Period II||7
1020495|NCT00615030|2476702|P6|STARTED|Period II||5
1020496|NCT00615030|2476703|P5|STARTED|Period II||8
1020497|NCT00615030|2476704|P4|STARTED|Period II||8
1020498|NCT00615030|2476705|P3|STARTED|Period II||9
1020499|NCT00615030|2476706|P2|STARTED|Period II||8
1020500|NCT00615030|2476707|P1|STARTED|Period II||8
1020501|NCT00615030|2476696|P12|NOT COMPLETED|Period I||1
1020502|NCT00615030|2476697|P11|NOT COMPLETED|Period I||1
1020503|NCT00615030|2476698|P10|NOT COMPLETED|Period I||0
1020504|NCT00615030|2476699|P9|NOT COMPLETED|Period I||1
1020505|NCT00615030|2476700|P8|NOT COMPLETED|Period I||0
1020506|NCT00615030|2476701|P7|NOT COMPLETED|Period I||0
1020507|NCT00615030|2476702|P6|NOT COMPLETED|Period I||1
1020508|NCT00615030|2476703|P5|NOT COMPLETED|Period I||1
1020509|NCT00615030|2476704|P4|NOT COMPLETED|Period I||0
1020510|NCT00615030|2476705|P3|NOT COMPLETED|Period I||0
1020511|NCT00615030|2476706|P2|NOT COMPLETED|Period I||0
1020512|NCT00615030|2476707|P1|NOT COMPLETED|Period I||1
1020513|NCT00615030|2476696|P12|COMPLETED|Period I||6
1020514|NCT00615030|2476697|P11|COMPLETED|Period I||7
1020515|NCT00615030|2476698|P10|COMPLETED|Period I||8
1020516|NCT00615030|2476699|P9|COMPLETED|Period I||8
1020517|NCT00615030|2476700|P8|COMPLETED|Period I||7
1020518|NCT00615030|2476701|P7|COMPLETED|Period I||7
1020519|NCT00615030|2476702|P6|COMPLETED|Period I||5
1020520|NCT00615030|2476703|P5|COMPLETED|Period I||8
1020521|NCT00615030|2476704|P4|COMPLETED|Period I||8
1020522|NCT00615030|2476705|P3|COMPLETED|Period I||9
1020523|NCT00615030|2476706|P2|COMPLETED|Period I||8
1020524|NCT00615030|2476707|P1|COMPLETED|Period I||8
1020525|NCT00615030|2476696|P12|STARTED|Period I||7
1020526|NCT00615030|2476697|P11|STARTED|Period I||8
1020527|NCT00615030|2476698|P10|STARTED|Period I||8
1020528|NCT00615030|2476699|P9|STARTED|Period I||9
1020529|NCT00615030|2476700|P8|STARTED|Period I||7
1020530|NCT00615030|2476701|P7|STARTED|Period I||7
1020531|NCT00615030|2476702|P6|STARTED|Period I|1 randomized patient in this sequence dropped out before exposure to study drug in Period I.|6
1020532|NCT00615030|2476703|P5|STARTED|Period I||9
1020533|NCT00615030|2476704|P4|STARTED|Period I||8
1020534|NCT00615030|2476705|P3|STARTED|Period I||9
1020535|NCT00615030|2476706|P2|STARTED|Period I||8
1020536|NCT00615030|2476707|P1|STARTED|Period I||9
1020537|NCT00615056|2476725|P4|NOT COMPLETED|Overall Study||35
1020538|NCT00615056|2476726|P3|NOT COMPLETED|Overall Study||36
1020539|NCT00615056|2476727|P2|NOT COMPLETED|Overall Study||51
1020540|NCT00615056|2476728|P1|NOT COMPLETED|Overall Study||49
1020541|NCT00615056|2476725|P4|COMPLETED|Overall Study||0
1020542|NCT00615056|2476726|P3|COMPLETED|Overall Study||0
1020543|NCT00615056|2476727|P2|COMPLETED|Overall Study||0
1020544|NCT00615056|2476728|P1|COMPLETED|Overall Study||0
1020545|NCT00615056|2476725|P4|Treated|Overall Study||35
1020546|NCT00615056|2476726|P3|Treated|Overall Study||36
1020547|NCT00615056|2476727|P2|Treated|Overall Study||51
1020548|NCT00615056|2476728|P1|Treated|Overall Study||46
1020549|NCT00615056|2476725|P4|STARTED|Overall Study||35
1020550|NCT00615056|2476726|P3|STARTED|Overall Study||36
1020551|NCT00615056|2476727|P2|STARTED|Overall Study||51
1020552|NCT00615056|2476728|P1|STARTED|Overall Study||49
1020553|NCT00615069|2476758|P1|NOT COMPLETED|Overall Study||16
1020554|NCT00615069|2476758|P1|COMPLETED|Overall Study||19
1020555|NCT00615069|2476758|P1|STARTED|Overall Study||35
1020556|NCT00615108|2476763|P1|NOT COMPLETED|Overall Study||507
1020557|NCT00615108|2476763|P1|COMPLETED|Overall Study||2641
1020558|NCT00615108|2476763|P1|STARTED|Overall Study||3148
1020559|NCT00615199|2476782|P4|NOT COMPLETED|Overall Study||2
1020560|NCT00615199|2476783|P3|NOT COMPLETED|Overall Study||1
1020561|NCT00615199|2476784|P2|NOT COMPLETED|Overall Study||2
1020562|NCT00615199|2476785|P1|NOT COMPLETED|Overall Study||8
1020563|NCT00615199|2476782|P4|COMPLETED|Overall Study||33
1020564|NCT00615199|2476783|P3|COMPLETED|Overall Study||33
1020565|NCT00615199|2476784|P2|COMPLETED|Overall Study||34
1020566|NCT00615199|2476785|P1|COMPLETED|Overall Study||26
1020567|NCT00615199|2476782|P4|STARTED|Overall Study||35
1020568|NCT00615199|2476783|P3|STARTED|Overall Study||34
1020569|NCT00615199|2476784|P2|STARTED|Overall Study||36
1020570|NCT00615199|2476785|P1|STARTED|Overall Study||34
1020571|NCT00615264|2476821|P2|NOT COMPLETED|Overall Study||52
1020572|NCT00615264|2476822|P1|NOT COMPLETED|Overall Study||50
1020573|NCT00615264|2476821|P2|COMPLETED|Overall Study||180
1020574|NCT00615264|2476822|P1|COMPLETED|Overall Study||175
1020575|NCT00615264|2476821|P2|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||213
1020576|NCT00615264|2476822|P1|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||209
1020577|NCT00615264|2476821|P2|Received at Least One Dose (ITT)|Overall Study||231
1020578|NCT00615264|2476822|P1|Received at Least One Dose (ITT)|Overall Study||225
1020579|NCT00615264|2476821|P2|STARTED|Overall Study||232
1020580|NCT00615264|2476822|P1|STARTED|Overall Study||225
1020581|NCT00615290|2476830|P1|NOT COMPLETED|Overall Study||8
1020582|NCT00615290|2476830|P1|COMPLETED|Overall Study||34
1020583|NCT00615290|2476830|P1|STARTED|Overall Study||42
1020584|NCT00615433|2476846|P4|NOT COMPLETED|Overall Study||45
1020585|NCT00615433|2476847|P3|NOT COMPLETED|Overall Study||39
1020586|NCT00615433|2476848|P2|NOT COMPLETED|Overall Study||53
1020587|NCT00615433|2476849|P1|NOT COMPLETED|Overall Study||43
1020588|NCT00615433|2476846|P4|COMPLETED|Overall Study||71
1020589|NCT00615433|2476847|P3|COMPLETED|Overall Study||84
1020590|NCT00615433|2476848|P2|COMPLETED|Overall Study||66
1020591|NCT00615433|2476849|P1|COMPLETED|Overall Study||77
1020592|NCT00615433|2476846|P4|STARTED|Overall Study||116
1020593|NCT00615433|2476847|P3|STARTED|Overall Study||123
1020594|NCT00615433|2476848|P2|STARTED|Overall Study||119
1020595|NCT00615433|2476849|P1|STARTED|Overall Study||120
1020596|NCT00615459|2476863|P4|NOT COMPLETED|Period III||0
1020597|NCT00615459|2476864|P3|NOT COMPLETED|Period III||1
1020598|NCT00615459|2476865|P2|NOT COMPLETED|Period III||3
1020599|NCT00615459|2476866|P1|NOT COMPLETED|Period III||0
1020600|NCT00615459|2476863|P4|COMPLETED|Period III||41
1020601|NCT00615459|2476864|P3|COMPLETED|Period III||39
1020602|NCT00615459|2476865|P2|COMPLETED|Period III||37
1020603|NCT00615459|2476866|P1|COMPLETED|Period III||36
1020604|NCT00615459|2476863|P4|STARTED|Period III||41
1020605|NCT00615459|2476864|P3|STARTED|Period III||40
1020606|NCT00615459|2476865|P2|STARTED|Period III||40
1020607|NCT00615459|2476866|P1|STARTED|Period III||36
1020608|NCT00615459|2476863|P4|NOT COMPLETED|Period II||1
1020609|NCT00615459|2476864|P3|NOT COMPLETED|Period II||0
1020610|NCT00615459|2476865|P2|NOT COMPLETED|Period II||0
1020611|NCT00615459|2476866|P1|NOT COMPLETED|Period II||1
1020612|NCT00615459|2476863|P4|COMPLETED|Period II||41
1020613|NCT00615459|2476864|P3|COMPLETED|Period II||40
1020614|NCT00615459|2476865|P2|COMPLETED|Period II||40
1020615|NCT00615459|2476866|P1|COMPLETED|Period II||36
1020616|NCT00615459|2476863|P4|STARTED|Period II||42
1020617|NCT00615459|2476864|P3|STARTED|Period II||40
1020618|NCT00615459|2476865|P2|STARTED|Period II||40
1020619|NCT00615459|2476866|P1|STARTED|Period II||37
1020620|NCT00615459|2476863|P4|NOT COMPLETED|Period I||1
1020621|NCT00615459|2476864|P3|NOT COMPLETED|Period I||2
1020622|NCT00615459|2476865|P2|NOT COMPLETED|Period I||1
1020623|NCT00615459|2476866|P1|NOT COMPLETED|Period I||4
1020624|NCT00615459|2476863|P4|COMPLETED|Period I||42
1020625|NCT00615459|2476864|P3|COMPLETED|Period I||40
1020626|NCT00615459|2476865|P2|COMPLETED|Period I||40
1020627|NCT00615459|2476866|P1|COMPLETED|Period I||37
1020628|NCT00615459|2476863|P4|STARTED|Period I||43
1020629|NCT00615459|2476864|P3|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|42
1020630|NCT00615459|2476865|P2|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|41
1020631|NCT00615459|2476866|P1|STARTED|Period I||41
1020632|NCT00615472|2476882|P2|NOT COMPLETED|Overall Study||0
1020633|NCT00615472|2476883|P1|NOT COMPLETED|Overall Study||0
1020634|NCT00615472|2476882|P2|COMPLETED|Overall Study||28
1020635|NCT00615472|2476883|P1|COMPLETED|Overall Study||30
1020636|NCT00615472|2476882|P2|STARTED|Overall Study||28
1020637|NCT00615472|2476883|P1|STARTED|Overall Study||30
1020638|NCT00615550|2476891|P2|NOT COMPLETED|Overall Study||1
1020639|NCT00615550|2476892|P1|NOT COMPLETED|Overall Study||6
1020640|NCT00615550|2476891|P2|COMPLETED|Overall Study||235
1020641|NCT00615550|2476892|P1|COMPLETED|Overall Study||223
1020642|NCT00615550|2476891|P2|STARTED|Overall Study||236
1020643|NCT00615550|2476892|P1|STARTED|Overall Study||229
1020644|NCT00615589|2476906|P1|NOT COMPLETED|Overall Study||0
1020645|NCT00615589|2476906|P1|COMPLETED|Overall Study||22
1020646|NCT00615589|2476906|P1|STARTED|Overall Study||22
1020647|NCT00621023|2476914|P1|NOT COMPLETED|Overall Study||6
1020648|NCT00621023|2476914|P1|COMPLETED|Overall Study|Completed is defined as 5 years of follow up.|0
1020649|NCT00621023|2476914|P1|STARTED|Overall Study||6
1020650|NCT00621049|2476922|P2|NOT COMPLETED|Maintenance Treatment||0
1020651|NCT00621049|2476923|P1|NOT COMPLETED|Maintenance Treatment||15
1020652|NCT00621049|2476922|P2|COMPLETED|Maintenance Treatment||0
1020653|NCT00621049|2476923|P1|COMPLETED|Maintenance Treatment||34
1020654|NCT00621049|2476922|P2|STARTED|Maintenance Treatment|Per protocol, only the Docetaxel/Carboplatin/Bevacizumab/Erlotinib arm enters maintenance therapy|0
1020655|NCT00621049|2476923|P1|STARTED|Maintenance Treatment|3 patients came off study between the end of adjuvant therapy and the start of maintenance|49
1020656|NCT00621049|2476922|P2|NOT COMPLETED|Adjuvant Treatment||10
1020657|NCT00621049|2476923|P1|NOT COMPLETED|Adjuvant Treatment||3
1020658|NCT00621049|2476922|P2|COMPLETED|Adjuvant Treatment||47
1020659|NCT00621049|2476923|P1|COMPLETED|Adjuvant Treatment||52
1020660|NCT00621049|2476922|P2|STARTED|Adjuvant Treatment||57
1020661|NCT00621049|2476923|P1|STARTED|Adjuvant Treatment||55
1020662|NCT00621140|2476937|P2|NOT COMPLETED|Overall Study||18
1020663|NCT00621140|2476938|P1|NOT COMPLETED|Overall Study||15
1020664|NCT00621140|2476937|P2|COMPLETED|Overall Study|number who completed treatment|318
1020665|NCT00621140|2476938|P1|COMPLETED|Overall Study|number who completed treatment|152
1020666|NCT00621140|2476937|P2|STARTED|Overall Study|number who started treatment|336
1020667|NCT00621140|2476938|P1|STARTED|Overall Study|number who started treatment|167
1020668|NCT00621153|2476972|P2|NOT COMPLETED|Overall Study||15
1020669|NCT00621153|2476973|P1|NOT COMPLETED|Overall Study||20
1020670|NCT00621153|2476972|P2|COMPLETED|Overall Study|completed|101
1020671|NCT00621153|2476973|P1|COMPLETED|Overall Study|completed|97
1020672|NCT00621153|2476972|P2|Discontinued|Overall Study||15
1020673|NCT00621153|2476973|P1|Discontinued|Overall Study||20
1020674|NCT00621153|2476972|P2|STARTED|Overall Study|randomised|116
1020675|NCT00621153|2476973|P1|STARTED|Overall Study|randomised|117
1020676|NCT00621192|2476983|P4|NOT COMPLETED|Overall Study||3
1020677|NCT00621192|2476984|P3|NOT COMPLETED|Overall Study||5
1020678|NCT00621192|2476985|P2|NOT COMPLETED|Overall Study||9
1020679|NCT00621192|2476986|P1|NOT COMPLETED|Overall Study||4
1020680|NCT00621192|2476983|P4|COMPLETED|Overall Study||24
1020681|NCT00621192|2476984|P3|COMPLETED|Overall Study||26
1020682|NCT00621192|2476985|P2|COMPLETED|Overall Study||94
1020683|NCT00621192|2476986|P1|COMPLETED|Overall Study||35
1020684|NCT00621192|2476983|P4|Efficacy Population|Overall Study||27
1020685|NCT00621192|2476984|P3|Efficacy Population|Overall Study||28
1020686|NCT00621192|2476985|P2|Efficacy Population|Overall Study||101
1020687|NCT00621192|2476986|P1|Efficacy Population|Overall Study||39
1020688|NCT00621192|2476983|P4|Safety Population|Overall Study||27
1020689|NCT00621192|2476984|P3|Safety Population|Overall Study||31
1020690|NCT00621192|2476985|P2|Safety Population|Overall Study||103
1020691|NCT00621192|2476986|P1|Safety Population|Overall Study||39
1020692|NCT00621192|2476983|P4|STARTED|Overall Study||27
1020693|NCT00621192|2476984|P3|STARTED|Overall Study||31
1020694|NCT00621192|2476985|P2|STARTED|Overall Study||103
1020695|NCT00621192|2476986|P1|STARTED|Overall Study||39
1020696|NCT00621244|2477012|P4|NOT COMPLETED|Overall Study||23
1020697|NCT00621244|2477013|P3|NOT COMPLETED|Overall Study||33
1020698|NCT00621244|2477014|P2|NOT COMPLETED|Overall Study||34
1020699|NCT00621244|2477015|P1|NOT COMPLETED|Overall Study||86
1020700|NCT00621244|2477012|P4|COMPLETED|Overall Study||0
1020701|NCT00621244|2477013|P3|COMPLETED|Overall Study||0
1020702|NCT00621244|2477014|P2|COMPLETED|Overall Study||0
1020703|NCT00621244|2477015|P1|COMPLETED|Overall Study||0
1020704|NCT00621244|2477012|P4|STARTED|Overall Study||23
1020705|NCT00621244|2477013|P3|STARTED|Overall Study||33
1020706|NCT00621244|2477014|P2|STARTED|Overall Study||34
1020707|NCT00621244|2477015|P1|STARTED|Overall Study||86
1020708|NCT00621257|2477120|P5|NOT COMPLETED|Overall Study||9
1020709|NCT00621257|2477121|P4|NOT COMPLETED|Overall Study||6
1020710|NCT00621257|2477122|P3|NOT COMPLETED|Overall Study||3
1020711|NCT00621257|2477123|P2|NOT COMPLETED|Overall Study||3
1020712|NCT00621257|2477124|P1|NOT COMPLETED|Overall Study||4
1020713|NCT00621257|2477120|P5|COMPLETED|Overall Study||22
1020714|NCT00621257|2477121|P4|COMPLETED|Overall Study||26
1020715|NCT00621257|2477122|P3|COMPLETED|Overall Study||20
1020716|NCT00621257|2477123|P2|COMPLETED|Overall Study||21
1020717|NCT00621257|2477124|P1|COMPLETED|Overall Study||20
1020718|NCT00621257|2477120|P5|STARTED|Overall Study||31
1020719|NCT00621257|2477121|P4|STARTED|Overall Study||32
1020720|NCT00621257|2477122|P3|STARTED|Overall Study||23
1020721|NCT00621257|2477123|P2|STARTED|Overall Study||24
1020722|NCT00621257|2477124|P1|STARTED|Overall Study||24
1020723|NCT00621296|2477136|P1|NOT COMPLETED|Overall Study||14
1020724|NCT00621296|2477136|P1|COMPLETED|Overall Study||1
1020725|NCT00621296|2477136|P1|STARTED|Overall Study||15
1020726|NCT00621322|2477146|P6|NOT COMPLETED|Overall Study||4
1020727|NCT00621322|2477147|P5|NOT COMPLETED|Overall Study||1
1020728|NCT00621322|2477148|P4|NOT COMPLETED|Overall Study||3
1020729|NCT00621322|2477149|P3|NOT COMPLETED|Overall Study||2
1020730|NCT00621322|2477150|P2|NOT COMPLETED|Overall Study||0
1020731|NCT00621322|2477151|P1|NOT COMPLETED|Overall Study||1
1020732|NCT00621322|2477146|P6|COMPLETED|Overall Study||36
1020733|NCT00621322|2477147|P5|COMPLETED|Overall Study||39
1020734|NCT00621322|2477148|P4|COMPLETED|Overall Study||37
1020735|NCT00621322|2477149|P3|COMPLETED|Overall Study||38
1020736|NCT00621322|2477150|P2|COMPLETED|Overall Study||10
1020737|NCT00621322|2477151|P1|COMPLETED|Overall Study||9
1020738|NCT00621322|2477146|P6|STARTED|Overall Study||40
1020739|NCT00621322|2477147|P5|STARTED|Overall Study||40
1020740|NCT00621322|2477148|P4|STARTED|Overall Study||40
1020741|NCT00621322|2477149|P3|STARTED|Overall Study||40
1020742|NCT00621322|2477150|P2|STARTED|Overall Study||10
1020743|NCT00621322|2477151|P1|STARTED|Overall Study||10
1020744|NCT00621348|2477234|P3|NOT COMPLETED|Overall Study||0
1020745|NCT00621348|2477235|P2|NOT COMPLETED|Overall Study||0
1020746|NCT00621348|2477236|P1|NOT COMPLETED|Overall Study||0
1020747|NCT00621348|2477234|P3|COMPLETED|Overall Study||56
1020748|NCT00621348|2477235|P2|COMPLETED|Overall Study||53
1020749|NCT00621348|2477236|P1|COMPLETED|Overall Study||58
1020750|NCT00621348|2477234|P3|STARTED|Overall Study||56
1020751|NCT00621348|2477235|P2|STARTED|Overall Study||53
1020752|NCT00621348|2477236|P1|STARTED|Overall Study||58
1020753|NCT00622284|2477255|P2|NOT COMPLETED|Overall Study||171
1020754|NCT00622284|2477256|P1|NOT COMPLETED|Overall Study||189
1020755|NCT00622284|2477255|P2|COMPLETED|Overall Study|Number who completed treatment.|604
1020756|NCT00622284|2477256|P1|COMPLETED|Overall Study|Number who completed treatment.|587
1020757|NCT00622284|2477255|P2|STARTED|Overall Study|Number who started treatment.|775
1020758|NCT00622284|2477256|P1|STARTED|Overall Study|Number who started treatment. One patient in the Linagliptin group was randomized but not treated.|776
1020759|NCT00622336|2477318|P1|NOT COMPLETED|Extension Phase||21
1020760|NCT00622336|2477318|P1|COMPLETED|Extension Phase||0
1020761|NCT00622336|2477318|P1|STARTED|Extension Phase||21
1020762|NCT00622336|2477318|P1|NOT COMPLETED|Treatment Phase||309
1020763|NCT00622336|2477318|P1|COMPLETED|Treatment Phase|Completed = those who completed the treatment phase and were ongoing in the extension study|21
1020764|NCT00622336|2477318|P1|Safety Population|Treatment Phase||330
1020765|NCT00622336|2477318|P1|STARTED|Treatment Phase||330
1020766|NCT00622388|2477327|P1|NOT COMPLETED|Overall Study||72
1020767|NCT00622388|2477327|P1|COMPLETED|Overall Study||9
1020768|NCT00622388|2477327|P1|STARTED|Overall Study||81
1020769|NCT00622401|2477348|P3|NOT COMPLETED|Overall Study||0
1020770|NCT00622401|2477349|P2|NOT COMPLETED|Overall Study||2
1020771|NCT00622401|2477350|P1|NOT COMPLETED|Overall Study||3
1020772|NCT00622401|2477348|P3|COMPLETED|Overall Study||0
1020773|NCT00622401|2477349|P2|COMPLETED|Overall Study||0
1020774|NCT00622401|2477350|P1|COMPLETED|Overall Study||3
1020775|NCT00622401|2477348|P3|STARTED|Overall Study|Never Opened|0
1020776|NCT00622401|2477349|P2|STARTED|Overall Study||2
1020777|NCT00622401|2477350|P1|STARTED|Overall Study||6
1020778|NCT00622427|2477356|P2|NOT COMPLETED|Overall Study||0
1020779|NCT00622427|2477357|P1|NOT COMPLETED|Overall Study||0
1020780|NCT00622427|2477356|P2|COMPLETED|Overall Study|each subject received 2 weeks of placebo, then 2 weeks of Ramelteon after a two week wash out period|16
1020781|NCT00622427|2477357|P1|COMPLETED|Overall Study|each subject received 2 weeks of Ramelteon, then 2 weeks of placebo after a two week wash out period|16
1020782|NCT00622427|2477356|P2|STARTED|Overall Study||16
1020783|NCT00622427|2477357|P1|STARTED|Overall Study||16
1020784|NCT00622440|2477367|P2|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||1
1020785|NCT00622440|2477368|P1|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||0
1020786|NCT00622440|2477367|P2|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||27
1020787|NCT00622440|2477368|P1|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||28
1020788|NCT00622440|2477367|P2|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
1020789|NCT00622440|2477368|P1|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
1020790|NCT00622440|2477367|P2|NOT COMPLETED|Week 12 - Week 48 (Treatment)||6
1020791|NCT00622440|2477368|P1|NOT COMPLETED|Week 12 - Week 48 (Treatment)||3
1020792|NCT00622440|2477367|P2|COMPLETED|Week 12 - Week 48 (Treatment)||28
1020793|NCT00622440|2477368|P1|COMPLETED|Week 12 - Week 48 (Treatment)||28
1020794|NCT00622440|2477367|P2|STARTED|Week 12 - Week 48 (Treatment)||34
1020795|NCT00622440|2477368|P1|STARTED|Week 12 - Week 48 (Treatment)||31
1020796|NCT00622440|2477367|P2|NOT COMPLETED|Baseline - Week 12 (Treatment)||1
1020797|NCT00622440|2477368|P1|NOT COMPLETED|Baseline - Week 12 (Treatment)||4
1020798|NCT00622440|2477367|P2|COMPLETED|Baseline - Week 12 (Treatment)||34
1020799|NCT00622440|2477368|P1|COMPLETED|Baseline - Week 12 (Treatment)||31
1020800|NCT00622440|2477367|P2|STARTED|Baseline - Week 12 (Treatment)||35
1020801|NCT00622440|2477368|P1|STARTED|Baseline - Week 12 (Treatment)||35
1020802|NCT00622518|2477382|P2|NOT COMPLETED|Overall Study||0
1020803|NCT00622518|2477383|P1|NOT COMPLETED|Overall Study||0
1020804|NCT00622518|2477382|P2|COMPLETED|Overall Study||60
1020805|NCT00622518|2477383|P1|COMPLETED|Overall Study||59
1020806|NCT00622518|2477382|P2|STARTED|Overall Study||60
1020807|NCT00622518|2477383|P1|STARTED|Overall Study||59
1020808|NCT00622635|2477391|P6|NOT COMPLETED|Treatment Period 3||0
1020809|NCT00622635|2477392|P5|NOT COMPLETED|Treatment Period 3||0
1020810|NCT00622635|2477393|P4|NOT COMPLETED|Treatment Period 3||3
1020811|NCT00622635|2477394|P3|NOT COMPLETED|Treatment Period 3||0
1020812|NCT00622635|2477395|P2|NOT COMPLETED|Treatment Period 3||0
1020813|NCT00622635|2477396|P1|NOT COMPLETED|Treatment Period 3||0
1020814|NCT00622635|2477391|P6|COMPLETED|Treatment Period 3||10
1020815|NCT00622635|2477392|P5|COMPLETED|Treatment Period 3||9
1020816|NCT00622635|2477393|P4|COMPLETED|Treatment Period 3||10
1020817|NCT00622635|2477394|P3|COMPLETED|Treatment Period 3||10
1020818|NCT00622635|2477395|P2|COMPLETED|Treatment Period 3||10
1020819|NCT00622635|2477396|P1|COMPLETED|Treatment Period 3||12
1020820|NCT00622635|2477391|P6|STARTED|Treatment Period 3||10
1020821|NCT00622635|2477392|P5|STARTED|Treatment Period 3||9
1020822|NCT00622635|2477393|P4|STARTED|Treatment Period 3||13
1020823|NCT00622635|2477394|P3|STARTED|Treatment Period 3||10
1020824|NCT00622635|2477395|P2|STARTED|Treatment Period 3||10
1020825|NCT00622635|2477396|P1|STARTED|Treatment Period 3||12
1020826|NCT00622635|2477391|P6|NOT COMPLETED|Treatment Period 2||0
1020827|NCT00622635|2477392|P5|NOT COMPLETED|Treatment Period 2||0
1020828|NCT00622635|2477393|P4|NOT COMPLETED|Treatment Period 2||0
1020829|NCT00622635|2477394|P3|NOT COMPLETED|Treatment Period 2||0
1020830|NCT00622635|2477395|P2|NOT COMPLETED|Treatment Period 2||0
1020831|NCT00622635|2477396|P1|NOT COMPLETED|Treatment Period 2||1
1020832|NCT00622635|2477391|P6|COMPLETED|Treatment Period 2||10
1020833|NCT00622635|2477392|P5|COMPLETED|Treatment Period 2||9
1020834|NCT00622635|2477393|P4|COMPLETED|Treatment Period 2||13
1020835|NCT00622635|2477394|P3|COMPLETED|Treatment Period 2||10
1020836|NCT00622635|2477395|P2|COMPLETED|Treatment Period 2||10
1020837|NCT00622635|2477396|P1|COMPLETED|Treatment Period 2||12
1020838|NCT00622635|2477391|P6|STARTED|Treatment Period 2||10
1020839|NCT00622635|2477392|P5|STARTED|Treatment Period 2||9
1020840|NCT00622635|2477393|P4|STARTED|Treatment Period 2||13
1020841|NCT00622635|2477394|P3|STARTED|Treatment Period 2||10
1020842|NCT00622635|2477395|P2|STARTED|Treatment Period 2||10
1020843|NCT00622635|2477396|P1|STARTED|Treatment Period 2||13
1020844|NCT00622635|2477391|P6|NOT COMPLETED|Treatment Period 1||0
1020845|NCT00622635|2477392|P5|NOT COMPLETED|Treatment Period 1||1
1020846|NCT00622635|2477393|P4|NOT COMPLETED|Treatment Period 1||0
1020847|NCT00622635|2477394|P3|NOT COMPLETED|Treatment Period 1||1
1020848|NCT00622635|2477395|P2|NOT COMPLETED|Treatment Period 1||1
1020849|NCT00622635|2477396|P1|NOT COMPLETED|Treatment Period 1||0
1020850|NCT00622635|2477391|P6|COMPLETED|Treatment Period 1||10
1020851|NCT00622635|2477392|P5|COMPLETED|Treatment Period 1||9
1020852|NCT00622635|2477393|P4|COMPLETED|Treatment Period 1||13
1020853|NCT00622635|2477394|P3|COMPLETED|Treatment Period 1||10
1020854|NCT00622635|2477395|P2|COMPLETED|Treatment Period 1||10
1020855|NCT00622635|2477396|P1|COMPLETED|Treatment Period 1||13
1020856|NCT00622635|2477391|P6|STARTED|Treatment Period 1||10
1020857|NCT00622635|2477392|P5|STARTED|Treatment Period 1||10
1020858|NCT00622635|2477393|P4|STARTED|Treatment Period 1||13
1020859|NCT00622635|2477394|P3|STARTED|Treatment Period 1||11
1020860|NCT00622635|2477395|P2|STARTED|Treatment Period 1||11
1020861|NCT00622635|2477396|P1|STARTED|Treatment Period 1||13
1020862|NCT00622700|2477464|P7|NOT COMPLETED|Extension Treatment Period||30
1020863|NCT00622700|2477465|P6|NOT COMPLETED|Extension Treatment Period||17
1020864|NCT00622700|2477466|P5|NOT COMPLETED|Extension Treatment Period||39
1020865|NCT00622700|2477467|P4|NOT COMPLETED|Extension Treatment Period||21
1020866|NCT00622700|2477468|P3|NOT COMPLETED|Extension Treatment Period||0
1020867|NCT00622700|2477469|P2|NOT COMPLETED|Extension Treatment Period||0
1020868|NCT00622700|2477470|P1|NOT COMPLETED|Extension Treatment Period||0
1020869|NCT00622700|2477464|P7|COMPLETED|Extension Treatment Period||120
1020870|NCT00622700|2477465|P6|COMPLETED|Extension Treatment Period||50
1020871|NCT00622700|2477466|P5|COMPLETED|Extension Treatment Period||103
1020872|NCT00622700|2477467|P4|COMPLETED|Extension Treatment Period||43
1020873|NCT00622700|2477468|P3|COMPLETED|Extension Treatment Period||0
1020874|NCT00622700|2477469|P2|COMPLETED|Extension Treatment Period||0
1020875|NCT00622700|2477470|P1|COMPLETED|Extension Treatment Period||0
1020876|NCT00622700|2477464|P7|STARTED|Extension Treatment Period|13 participants completed core treatment period but did not enter in extension treatment period.|150
1020877|NCT00622700|2477465|P6|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|67
1020878|NCT00622700|2477466|P5|STARTED|Extension Treatment Period|8 participants completed core treatment period but did not enter in extension treatment period.|142
1020879|NCT00622700|2477467|P4|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|64
1020880|NCT00622700|2477468|P3|STARTED|Extension Treatment Period||0
1020881|NCT00622700|2477469|P2|STARTED|Extension Treatment Period||0
1020882|NCT00622700|2477470|P1|STARTED|Extension Treatment Period|Participants were re-randomized in a 1:1 ratio to either teriflunomide 7 mg or 14 mg treatment arm.|0
1020883|NCT00622700|2477464|P7|NOT COMPLETED|Core Treatment Period||0
1020884|NCT00622700|2477465|P6|NOT COMPLETED|Core Treatment Period||0
1020885|NCT00622700|2477466|P5|NOT COMPLETED|Core Treatment Period||0
1020886|NCT00622700|2477467|P4|NOT COMPLETED|Core Treatment Period||0
1020887|NCT00622700|2477468|P3|NOT COMPLETED|Core Treatment Period||53
1020888|NCT00622700|2477469|P2|NOT COMPLETED|Core Treatment Period||55
1020889|NCT00622700|2477470|P1|NOT COMPLETED|Core Treatment Period||56
1020890|NCT00622700|2477464|P7|COMPLETED|Core Treatment Period||0
1020891|NCT00622700|2477465|P6|COMPLETED|Core Treatment Period||0
1020892|NCT00622700|2477466|P5|COMPLETED|Core Treatment Period||0
1020893|NCT00622700|2477467|P4|COMPLETED|Core Treatment Period||0
1020894|NCT00622700|2477468|P3|COMPLETED|Core Treatment Period||163
1020895|NCT00622700|2477469|P2|COMPLETED|Core Treatment Period||150
1020896|NCT00622700|2477470|P1|COMPLETED|Core Treatment Period||141
1020897|NCT00622700|2477464|P7|Treated|Core Treatment Period||0
1020898|NCT00622700|2477465|P6|Treated|Core Treatment Period||0
1020899|NCT00622700|2477466|P5|Treated|Core Treatment Period||0
1020900|NCT00622700|2477467|P4|Treated|Core Treatment Period||0
1020901|NCT00622700|2477468|P3|Treated|Core Treatment Period||214
1020902|NCT00622700|2477469|P2|Treated|Core Treatment Period||203
1020903|NCT00622700|2477470|P1|Treated|Core Treatment Period||197
1020904|NCT00622700|2477464|P7|STARTED|Core Treatment Period||0
1020905|NCT00622700|2477465|P6|STARTED|Core Treatment Period||0
1020906|NCT00622700|2477466|P5|STARTED|Core Treatment Period||0
1020907|NCT00622700|2477467|P4|STARTED|Core Treatment Period||0
1020908|NCT00622700|2477468|P3|STARTED|Core Treatment Period||216
1020909|NCT00622700|2477469|P2|STARTED|Core Treatment Period||205
1020910|NCT00622700|2477470|P1|STARTED|Core Treatment Period||197
1020911|NCT00622713|2477529|P1|NOT COMPLETED|Overall Study||59
1020912|NCT00622713|2477529|P1|COMPLETED|Overall Study||169
1020913|NCT00622713|2477529|P1|Intent to Treat (ITT) Population|Overall Study||218
1020914|NCT00622713|2477529|P1|Exposed to Study Drug|Overall Study||226
1020915|NCT00622713|2477529|P1|STARTED|Overall Study||228
1020916|NCT00622726|2477539|P2|NOT COMPLETED|August, 2010 to April, 2013||5
1020917|NCT00622726|2477540|P1|NOT COMPLETED|August, 2010 to April, 2013||1
1020918|NCT00622726|2477539|P2|COMPLETED|August, 2010 to April, 2013||68
1020919|NCT00622726|2477540|P1|COMPLETED|August, 2010 to April, 2013||69
1020920|NCT00622726|2477539|P2|STARTED|August, 2010 to April, 2013||73
1020921|NCT00622726|2477540|P1|STARTED|August, 2010 to April, 2013||70
1020922|NCT00622726|2477539|P2|NOT COMPLETED|March, 2008 to August, 2010||2
1020923|NCT00622726|2477540|P1|NOT COMPLETED|March, 2008 to August, 2010||5
1020924|NCT00622726|2477539|P2|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|73
1020925|NCT00622726|2477540|P1|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|70
1020926|NCT00622726|2477539|P2|STARTED|March, 2008 to August, 2010||75
1020927|NCT00622726|2477540|P1|STARTED|March, 2008 to August, 2010||75
1020928|NCT00622739|2477552|P2|NOT COMPLETED|Overall Study||6
1020929|NCT00622739|2477553|P1|NOT COMPLETED|Overall Study||2
1020930|NCT00622739|2477552|P2|COMPLETED|Overall Study||9
1020931|NCT00622739|2477553|P1|COMPLETED|Overall Study||11
1020932|NCT00622739|2477552|P2|STARTED|Overall Study||15
1020933|NCT00622739|2477553|P1|STARTED|Overall Study||13
1020934|NCT00622869|2477562|P3|NOT COMPLETED|Overall Study||39
1020935|NCT00622869|2477563|P2|NOT COMPLETED|Overall Study||57
1020936|NCT00622869|2477564|P1|NOT COMPLETED|Overall Study||43
1020937|NCT00622869|2477562|P3|COMPLETED|Overall Study||204
1020938|NCT00622869|2477563|P2|COMPLETED|Overall Study||174
1020939|NCT00622869|2477564|P1|COMPLETED|Overall Study||202
1020940|NCT00622869|2477562|P3|STARTED|Overall Study||243
1020941|NCT00622869|2477563|P2|STARTED|Overall Study||231
1020942|NCT00622869|2477564|P1|STARTED|Overall Study||245
1020943|NCT00622908|2477583|P2|NOT COMPLETED|Overall Study||10
1020944|NCT00622908|2477584|P1|NOT COMPLETED|Overall Study||3
1020945|NCT00622908|2477583|P2|COMPLETED|Overall Study||122
1020946|NCT00622908|2477584|P1|COMPLETED|Overall Study||134
1020947|NCT00622908|2477583|P2|STARTED|Overall Study|Intent to treat population|132
1020948|NCT00622908|2477584|P1|STARTED|Overall Study|Intent to treat population|137
1020949|NCT00623012|2477596|P1|NOT COMPLETED|Overall Study||0
1020950|NCT00623012|2477596|P1|COMPLETED|Overall Study||2
1020951|NCT00623012|2477596|P1|STARTED|Overall Study||2
1020952|NCT00623103|2477604|P2|NOT COMPLETED|Overall Study||113
1020953|NCT00623103|2477605|P1|NOT COMPLETED|Overall Study||111
1020954|NCT00623103|2477604|P2|COMPLETED|Overall Study||175
1020955|NCT00623103|2477605|P1|COMPLETED|Overall Study||184
1020956|NCT00623103|2477604|P2|Safety Set: Received Study Drug|Overall Study||288
1020957|NCT00623103|2477605|P1|Safety Set: Received Study Drug|Overall Study|One randomized participant did not receive study drug and was not included in the Safety set.|294
1020958|NCT00623103|2477604|P2|STARTED|Overall Study||288
1020959|NCT00623103|2477605|P1|STARTED|Overall Study||295
1020960|NCT00623181|2477627|P2|NOT COMPLETED|Overall Study||0
1020961|NCT00623181|2477628|P1|NOT COMPLETED|Overall Study||0
1020962|NCT00623181|2477627|P2|COMPLETED|Overall Study||54
1020963|NCT00623181|2477628|P1|COMPLETED|Overall Study||56
1020964|NCT00623181|2477627|P2|STARTED|Overall Study||54
1020965|NCT00623181|2477628|P1|STARTED|Overall Study||56
1020966|NCT00623194|2477640|P1|NOT COMPLETED|Overall Study||5
1020967|NCT00623194|2477640|P1|COMPLETED|Overall Study||141
1020968|NCT00623194|2477640|P1|STARTED|Overall Study||146
1020969|NCT00623233|2477660|P1|NOT COMPLETED|Overall Study||24
1020970|NCT00623233|2477660|P1|COMPLETED|Overall Study|Included those who discontinued due to PD or death and those who achieved complete response (CR).|28
1020971|NCT00623233|2477660|P1|STARTED|Overall Study||52
1020972|NCT00623428|2477669|P2|NOT COMPLETED|Follow-up Period||15
1020973|NCT00623428|2477670|P1|NOT COMPLETED|Follow-up Period||29
1020974|NCT00623428|2477669|P2|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 24 weeks of follow-up|78
1020975|NCT00623428|2477670|P1|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 48 weeks of follow-up|66
1020976|NCT00623428|2477669|P2|STARTED|Follow-up Period||93
1020977|NCT00623428|2477670|P1|STARTED|Follow-up Period||95
1020978|NCT00623428|2477669|P2|NOT COMPLETED|Treatment Period||27
1020979|NCT00623428|2477670|P1|NOT COMPLETED|Treatment Period||0
1020980|NCT00623428|2477669|P2|COMPLETED|Treatment Period|Patients who completed 48 weeks of treatment|66
1020981|NCT00623428|2477670|P1|COMPLETED|Treatment Period|Patients who completed 24 weeks of treatment|95
1020982|NCT00623428|2477669|P2|STARTED|Treatment Period||93
1020983|NCT00623428|2477670|P1|STARTED|Treatment Period||95
1020984|NCT00623441|2477688|P1|NOT COMPLETED|Overall Study||0
1020985|NCT00623441|2477688|P1|COMPLETED|Overall Study|12 months follow-up compliance was 94.2%|8314
1020986|NCT00623441|2477688|P1|STARTED|Overall Study||8314
1020987|NCT00623467|2477692|P1|NOT COMPLETED|Overall Study||7
1020988|NCT00623467|2477692|P1|COMPLETED|Overall Study||336
1020989|NCT00623467|2477692|P1|STARTED|Overall Study||343
1020990|NCT00623480|2477758|P2|NOT COMPLETED|Overall Study||7
1020991|NCT00623480|2477759|P1|NOT COMPLETED|Overall Study||7
1020992|NCT00623480|2477758|P2|COMPLETED|Overall Study||35
1020993|NCT00623480|2477759|P1|COMPLETED|Overall Study||35
1020994|NCT00623480|2477758|P2|STARTED|Overall Study||42
1020995|NCT00623480|2477759|P1|STARTED|Overall Study||42
1020996|NCT00623506|2477773|P2|NOT COMPLETED|Overall Study||4
1020997|NCT00623506|2477774|P1|NOT COMPLETED|Overall Study||4
1020998|NCT00623506|2477773|P2|COMPLETED|Overall Study||11
1020999|NCT00623506|2477774|P1|COMPLETED|Overall Study||11
1021000|NCT00623506|2477773|P2|Week 4|Overall Study||11
1021001|NCT00623506|2477774|P1|Week 4|Overall Study||11
1021002|NCT00623506|2477773|P2|STARTED|Overall Study||15
1021003|NCT00623506|2477774|P1|STARTED|Overall Study||15
1021004|NCT00623545|2477784|P1|NOT COMPLETED|Overall Study||10
1021005|NCT00623545|2477784|P1|COMPLETED|Overall Study||18
1021006|NCT00623545|2477784|P1|STARTED|Overall Study||28
1021007|NCT00623597|2477791|P2|NOT COMPLETED|Overall Study||0
1021008|NCT00623597|2477792|P1|NOT COMPLETED|Overall Study||1
1021009|NCT00623597|2477791|P2|COMPLETED|Overall Study||13
1021010|NCT00623597|2477792|P1|COMPLETED|Overall Study||4
1021011|NCT00623597|2477791|P2|STARTED|Overall Study||13
1021012|NCT00623597|2477792|P1|STARTED|Overall Study||5
1021013|NCT00623636|2477857|P2|NOT COMPLETED|Open Label||412
1021014|NCT00623636|2477858|P1|NOT COMPLETED|Open Label||0
1021015|NCT00623636|2477857|P2|COMPLETED|Open Label||263
1021016|NCT00623636|2477858|P1|COMPLETED|Open Label||0
1021017|NCT00623636|2477857|P2|STARTED|Open Label|Includes eligible Placebo and MAP0004 patients from the double-blind period.|675
1021018|NCT00623636|2477858|P1|STARTED|Open Label|Eligible double-blind placebo patients received MAP0004 in the open-label period.|0
1021019|NCT00623636|2477857|P2|NOT COMPLETED|Double Blind||28
1021020|NCT00623636|2477858|P1|NOT COMPLETED|Double Blind||33
1021021|NCT00623636|2477857|P2|COMPLETED|Double Blind||422
1021022|NCT00623636|2477858|P1|COMPLETED|Double Blind||419
1021023|NCT00623636|2477857|P2|STARTED|Double Blind||450
1021024|NCT00623636|2477858|P1|STARTED|Double Blind||452
1021025|NCT00623714|2477879|P2|NOT COMPLETED|Period 2||0
1021026|NCT00623714|2477880|P1|NOT COMPLETED|Period 2||0
1021027|NCT00623714|2477879|P2|COMPLETED|Period 2||7
1021028|NCT00623714|2477880|P1|COMPLETED|Period 2||6
1021029|NCT00623714|2477879|P2|STARTED|Period 2||7
1021030|NCT00623714|2477880|P1|STARTED|Period 2||6
1021031|NCT00623714|2477879|P2|NOT COMPLETED|Period 1||0
1021032|NCT00623714|2477880|P1|NOT COMPLETED|Period 1||0
1021033|NCT00623714|2477879|P2|COMPLETED|Period 1||7
1021034|NCT00623714|2477880|P1|COMPLETED|Period 1||6
1021035|NCT00623714|2477879|P2|STARTED|Period 1||7
1021036|NCT00623714|2477880|P1|STARTED|Period 1||6
1021037|NCT00623727|2477890|P2|NOT COMPLETED|Open Label Extension Period||0
1021038|NCT00623727|2477891|P1|NOT COMPLETED|Open Label Extension Period||0
1021039|NCT00623727|2477890|P2|COMPLETED|Open Label Extension Period||0
1021040|NCT00623727|2477891|P1|COMPLETED|Open Label Extension Period||20
1021041|NCT00623727|2477890|P2|STARTED|Open Label Extension Period||0
1021042|NCT00623727|2477891|P1|STARTED|Open Label Extension Period|10 participants of each group entered open-label extension period after completion of DB study|20
1021043|NCT00623727|2477890|P2|NOT COMPLETED|Open Label Follow-up||8
1021044|NCT00623727|2477891|P1|NOT COMPLETED|Open Label Follow-up||0
1021045|NCT00623727|2477890|P2|COMPLETED|Open Label Follow-up||18
1021046|NCT00623727|2477891|P1|COMPLETED|Open Label Follow-up||0
1021047|NCT00623727|2477890|P2|STARTED|Open Label Follow-up|13 Participants from each group after DB period terminated entered open label follow up.|26
1021048|NCT00623727|2477891|P1|STARTED|Open Label Follow-up||0
1021049|NCT00623727|2477890|P2|NOT COMPLETED|Double Blind (DB)||32
1021050|NCT00623727|2477891|P1|NOT COMPLETED|Double Blind (DB)||36
1021051|NCT00623727|2477890|P2|COMPLETED|Double Blind (DB)||41
1021052|NCT00623727|2477891|P1|COMPLETED|Double Blind (DB)||34
1021053|NCT00623727|2477890|P2|Participants Received Treatment|Double Blind (DB)||72
1021054|NCT00623727|2477891|P1|Participants Received Treatment|Double Blind (DB)||67
1021055|NCT00623727|2477890|P2|STARTED|Double Blind (DB)|only 72 participants are applicable for baseline characteristic evaluation|73
1021056|NCT00623727|2477891|P1|STARTED|Double Blind (DB)|only 67 participants are applicable for baseline characteristic evaluation|70
1021069|NCT00623779|2477939|P3|NOT COMPLETED|Overall Study||1
1021070|NCT00623779|2477940|P2|NOT COMPLETED|Overall Study||3
1021071|NCT00623779|2477941|P1|NOT COMPLETED|Overall Study||3
1021072|NCT00623779|2477939|P3|COMPLETED|Overall Study||44
1021073|NCT00623779|2477940|P2|COMPLETED|Overall Study||39
1021074|NCT00623779|2477941|P1|COMPLETED|Overall Study||38
1021075|NCT00623779|2477939|P3|STARTED|Overall Study||45
1021076|NCT00623779|2477940|P2|STARTED|Overall Study||42
1021077|NCT00623779|2477941|P1|STARTED|Overall Study||41
1021078|NCT00623805|2477990|P2|NOT COMPLETED|Overall Study||22
1021079|NCT00623805|2477991|P1|NOT COMPLETED|Overall Study||20
1021080|NCT00623805|2477990|P2|COMPLETED|Overall Study||39
1021081|NCT00623805|2477991|P1|COMPLETED|Overall Study||42
1021082|NCT00623805|2477990|P2|STARTED|Overall Study||61
1021083|NCT00623805|2477991|P1|STARTED|Overall Study||62
1021084|NCT00623831|2478007|P2|NOT COMPLETED|Overall Study||1
1021085|NCT00623831|2478008|P1|NOT COMPLETED|Overall Study||1
1021086|NCT00623831|2478007|P2|COMPLETED|Overall Study||3
1021087|NCT00623831|2478008|P1|COMPLETED|Overall Study||12
1021088|NCT00623831|2478007|P2|STARTED|Overall Study||4
1021089|NCT00623831|2478008|P1|STARTED|Overall Study||13
1021090|NCT00623935|2478018|P1|NOT COMPLETED|Overall Study||2
1021091|NCT00623935|2478018|P1|COMPLETED|Overall Study||54
1021092|NCT00623935|2478018|P1|STARTED|Overall Study||56
1021093|NCT00623974|2478027|P4|NOT COMPLETED|Overall Study||0
1021094|NCT00623974|2478028|P3|NOT COMPLETED|Overall Study||0
1021095|NCT00623974|2478029|P2|NOT COMPLETED|Overall Study||0
1021096|NCT00623974|2478030|P1|NOT COMPLETED|Overall Study||0
1021097|NCT00623974|2478027|P4|COMPLETED|Overall Study||0
1021098|NCT00623974|2478028|P3|COMPLETED|Overall Study||0
1021099|NCT00623974|2478029|P2|COMPLETED|Overall Study||0
1021100|NCT00623974|2478030|P1|COMPLETED|Overall Study||0
1021101|NCT00623974|2478027|P4|STARTED|Overall Study||0
1021102|NCT00623974|2478028|P3|STARTED|Overall Study||0
1021103|NCT00623974|2478029|P2|STARTED|Overall Study||0
1021104|NCT00623974|2478030|P1|STARTED|Overall Study||0
1021105|NCT00624052|2478044|P4|NOT COMPLETED|Overall Study||4
1021106|NCT00624052|2478045|P3|NOT COMPLETED|Overall Study||3
1021107|NCT00624052|2478046|P2|NOT COMPLETED|Overall Study||14
1021108|NCT00624052|2478047|P1|NOT COMPLETED|Overall Study||15
1021109|NCT00624052|2478044|P4|COMPLETED|Overall Study||88
1021110|NCT00624052|2478045|P3|COMPLETED|Overall Study||88
1021111|NCT00624052|2478046|P2|COMPLETED|Overall Study||422
1021112|NCT00624052|2478047|P1|COMPLETED|Overall Study||204
1021113|NCT00624052|2478044|P4|STARTED|Overall Study||92
1021114|NCT00624052|2478045|P3|STARTED|Overall Study||91
1021115|NCT00624052|2478046|P2|STARTED|Overall Study||436
1021116|NCT00624052|2478047|P1|STARTED|Overall Study||219
1021117|NCT00624065|2478098|P2|NOT COMPLETED|Overall Study||24
1021118|NCT00624065|2478099|P1|NOT COMPLETED|Overall Study||19
1021119|NCT00624065|2478098|P2|COMPLETED|Overall Study||192
1021120|NCT00624065|2478099|P1|COMPLETED|Overall Study||197
1021121|NCT00624065|2478098|P2|STARTED|Overall Study||216
1021122|NCT00624065|2478099|P1|STARTED|Overall Study||216
1021123|NCT00624195|2478109|P2|NOT COMPLETED|Overall Study||7
1021124|NCT00624195|2478110|P1|NOT COMPLETED|Overall Study||3
1021125|NCT00624195|2478109|P2|COMPLETED|Overall Study||23
1021126|NCT00624195|2478110|P1|COMPLETED|Overall Study||26
1021127|NCT00624195|2478109|P2|STARTED|Overall Study||30
1021128|NCT00624195|2478110|P1|STARTED|Overall Study||29
1021129|NCT00624221|2478118|P2|NOT COMPLETED|Overall Study||0
1021130|NCT00624221|2478119|P1|NOT COMPLETED|Overall Study||0
1021131|NCT00624221|2478118|P2|COMPLETED|Overall Study||20
1021132|NCT00624221|2478119|P1|COMPLETED|Overall Study||20
1021133|NCT00624221|2478118|P2|STARTED|Overall Study||20
1021134|NCT00624221|2478119|P1|STARTED|Overall Study||20
1021135|NCT00624234|2478131|P6|NOT COMPLETED|Overall Study||0
1021136|NCT00624234|2478132|P5|NOT COMPLETED|Overall Study||0
1021137|NCT00624234|2478133|P4|NOT COMPLETED|Overall Study||0
1021138|NCT00624234|2478134|P3|NOT COMPLETED|Overall Study||0
1021139|NCT00624234|2478135|P2|NOT COMPLETED|Overall Study||0
1021140|NCT00624234|2478136|P1|NOT COMPLETED|Overall Study||0
1021141|NCT00624234|2478131|P6|COMPLETED|Overall Study||14
1021142|NCT00624234|2478132|P5|COMPLETED|Overall Study||18
1021143|NCT00624234|2478133|P4|COMPLETED|Overall Study||14
1021144|NCT00624234|2478134|P3|COMPLETED|Overall Study||26
1021145|NCT00624234|2478135|P2|COMPLETED|Overall Study||9
1021146|NCT00624234|2478136|P1|COMPLETED|Overall Study||8
1021147|NCT00624234|2478131|P6|STARTED|Overall Study||14
1021148|NCT00624234|2478132|P5|STARTED|Overall Study||18
1021149|NCT00624234|2478133|P4|STARTED|Overall Study||14
1021150|NCT00624234|2478134|P3|STARTED|Overall Study||26
1021151|NCT00624234|2478135|P2|STARTED|Overall Study||9
1021152|NCT00624234|2478136|P1|STARTED|Overall Study||8
1021153|NCT00624286|2478152|P2|NOT COMPLETED|Overall Study||27
1021154|NCT00624286|2478153|P1|NOT COMPLETED|Overall Study||25
1021155|NCT00624286|2478152|P2|COMPLETED|Overall Study||178
1021156|NCT00624286|2478153|P1|COMPLETED|Overall Study||186
1021157|NCT00624286|2478152|P2|STARTED|Overall Study||205
1021158|NCT00624286|2478153|P1|STARTED|Overall Study||211
1021159|NCT00624338|2478164|P3|NOT COMPLETED|Overall Study||46
1021160|NCT00624338|2478165|P2|NOT COMPLETED|Overall Study||83
1021161|NCT00624338|2478166|P1|NOT COMPLETED|Overall Study||47
1021162|NCT00624338|2478164|P3|COMPLETED|Overall Study||111
1021163|NCT00624338|2478165|P2|COMPLETED|Overall Study||62
1021164|NCT00624338|2478166|P1|COMPLETED|Overall Study||112
1021165|NCT00624338|2478164|P3|Treated|Overall Study||154
1021166|NCT00624338|2478165|P2|Treated|Overall Study||144
1021167|NCT00624338|2478166|P1|Treated|Overall Study||157
1021168|NCT00624338|2478164|P3|STARTED|Overall Study||157
1021169|NCT00624338|2478165|P2|STARTED|Overall Study||145
1021170|NCT00624338|2478166|P1|STARTED|Overall Study||159
1021171|NCT00624377|2478186|P1|NOT COMPLETED|Overall Study||644
1021172|NCT00624377|2478186|P1|COMPLETED|Overall Study||1387
1021173|NCT00624377|2478186|P1|STARTED|Overall Study||2031
1021174|NCT00624416|2478197|P1|NOT COMPLETED|Overall Study||0
1021175|NCT00624416|2478197|P1|COMPLETED|Overall Study||10
1021176|NCT00624416|2478197|P1|STARTED|Overall Study||10
1021177|NCT00624442|2478208|P5|NOT COMPLETED|Overall Study||2
1021178|NCT00624442|2478209|P4|NOT COMPLETED|Overall Study||0
1021179|NCT00624442|2478210|P3|NOT COMPLETED|Overall Study||2
1021180|NCT00624442|2478211|P2|NOT COMPLETED|Overall Study||1
1021181|NCT00624442|2478212|P1|NOT COMPLETED|Overall Study||0
1021182|NCT00624442|2478208|P5|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
1021183|NCT00624442|2478209|P4|COMPLETED|Overall Study||8
1021184|NCT00624442|2478210|P3|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
1021185|NCT00624442|2478211|P2|COMPLETED|Overall Study|One patient was discontinued after inadvertant overdose.|8
1021186|NCT00624442|2478212|P1|COMPLETED|Overall Study||8
1021187|NCT00624442|2478208|P5|STARTED|Overall Study||10
1021188|NCT00624442|2478209|P4|STARTED|Overall Study||8
1021189|NCT00624442|2478210|P3|STARTED|Overall Study||10
1021190|NCT00624442|2478211|P2|STARTED|Overall Study||9
1021191|NCT00624442|2478212|P1|STARTED|Overall Study||8
1021192|NCT00624468|2478240|P4|NOT COMPLETED|Safety Follow-up (SFU) Period||3
1021193|NCT00624468|2478241|P3|NOT COMPLETED|Safety Follow-up (SFU) Period||2
1021194|NCT00624468|2478242|P2|NOT COMPLETED|Safety Follow-up (SFU) Period||0
1021195|NCT00624468|2478243|P1|NOT COMPLETED|Safety Follow-up (SFU) Period||0
1021196|NCT00624468|2478240|P4|COMPLETED|Safety Follow-up (SFU) Period||11
1021197|NCT00624468|2478241|P3|COMPLETED|Safety Follow-up (SFU) Period||11
1021198|NCT00624468|2478242|P2|COMPLETED|Safety Follow-up (SFU) Period||0
1021199|NCT00624468|2478243|P1|COMPLETED|Safety Follow-up (SFU) Period||0
1021200|NCT00624468|2478240|P4|STARTED|Safety Follow-up (SFU) Period||14
1021201|NCT00624468|2478241|P3|STARTED|Safety Follow-up (SFU) Period||13
1021202|NCT00624468|2478242|P2|STARTED|Safety Follow-up (SFU) Period||0
1021203|NCT00624468|2478243|P1|STARTED|Safety Follow-up (SFU) Period||0
1021204|NCT00624468|2478240|P4|NOT COMPLETED|Double-blind Period||0
1021205|NCT00624468|2478241|P3|NOT COMPLETED|Double-blind Period||0
1021206|NCT00624468|2478242|P2|NOT COMPLETED|Double-blind Period||13
1021207|NCT00624468|2478243|P1|NOT COMPLETED|Double-blind Period||14
1021208|NCT00624468|2478240|P4|COMPLETED|Double-blind Period||0
1021209|NCT00624468|2478241|P3|COMPLETED|Double-blind Period||0
1021210|NCT00624468|2478242|P2|COMPLETED|Double-blind Period||4
1021211|NCT00624468|2478243|P1|COMPLETED|Double-blind Period||3
1021212|NCT00624468|2478240|P4|STARTED|Double-blind Period||0
1021213|NCT00624468|2478241|P3|STARTED|Double-blind Period||0
1021214|NCT00624468|2478242|P2|STARTED|Double-blind Period||17
1021215|NCT00624468|2478243|P1|STARTED|Double-blind Period||17
1021216|NCT00624520|2478271|P2|NOT COMPLETED|Overall Study||8
1021217|NCT00624520|2478272|P1|NOT COMPLETED|Overall Study||12
1021218|NCT00624520|2478271|P2|COMPLETED|Overall Study||39
1021219|NCT00624520|2478272|P1|COMPLETED|Overall Study||44
1021220|NCT00624520|2478271|P2|STARTED|Overall Study||47
1021221|NCT00624520|2478272|P1|STARTED|Overall Study||56
1021222|NCT00624559|2478301|P4|NOT COMPLETED|Overall Study||0
1021223|NCT00624559|2478302|P3|NOT COMPLETED|Overall Study||0
1021224|NCT00624559|2478303|P2|NOT COMPLETED|Overall Study||0
1021225|NCT00624559|2478304|P1|NOT COMPLETED|Overall Study||0
1021226|NCT00624559|2478301|P4|COMPLETED|Overall Study||3
1021227|NCT00624559|2478302|P3|COMPLETED|Overall Study||3
1021228|NCT00624559|2478303|P2|COMPLETED|Overall Study||3
1021229|NCT00624559|2478304|P1|COMPLETED|Overall Study||3
1021230|NCT00624559|2478301|P4|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
1021231|NCT00624559|2478302|P3|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
1021232|NCT00624559|2478303|P2|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
1021233|NCT00624559|2478304|P1|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
1021234|NCT00624585|2478318|P1|NOT COMPLETED|Overall Study||12
1021235|NCT00624585|2478318|P1|COMPLETED|Overall Study||6
1021236|NCT00624585|2478318|P1|STARTED|Overall Study||18
1021237|NCT00624780|2478331|P6|NOT COMPLETED|Follow-up (Week 26)||0
1021238|NCT00624780|2478332|P5|NOT COMPLETED|Follow-up (Week 26)||2
1021239|NCT00624780|2478333|P4|NOT COMPLETED|Follow-up (Week 26)||0
1021240|NCT00624780|2478334|P3|NOT COMPLETED|Follow-up (Week 26)||2
1021241|NCT00624780|2478335|P2|NOT COMPLETED|Follow-up (Week 26)||1
1021242|NCT00624780|2478336|P1|NOT COMPLETED|Follow-up (Week 26)||2
1021243|NCT00624780|2478331|P6|COMPLETED|Follow-up (Week 26)||29
1021244|NCT00624780|2478332|P5|COMPLETED|Follow-up (Week 26)||93
1021245|NCT00624780|2478333|P4|COMPLETED|Follow-up (Week 26)||26
1021246|NCT00624780|2478334|P3|COMPLETED|Follow-up (Week 26)||89
1021247|NCT00624780|2478335|P2|COMPLETED|Follow-up (Week 26)||27
1021248|NCT00624780|2478336|P1|COMPLETED|Follow-up (Week 26)||102
1021249|NCT00624780|2478331|P6|STARTED|Follow-up (Week 26)||29
1021250|NCT00624780|2478332|P5|STARTED|Follow-up (Week 26)||95
1021251|NCT00624780|2478333|P4|STARTED|Follow-up (Week 26)||26
1021252|NCT00624780|2478334|P3|STARTED|Follow-up (Week 26)||91
1021253|NCT00624780|2478335|P2|STARTED|Follow-up (Week 26)||28
1021254|NCT00624780|2478336|P1|STARTED|Follow-up (Week 26)||104
1021255|NCT00624780|2478331|P6|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
1021256|NCT00624780|2478332|P5|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
1021257|NCT00624780|2478333|P4|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
1021258|NCT00624780|2478334|P3|NOT COMPLETED|Treatment Discontinuation (Week 25)||3
1021259|NCT00624780|2478335|P2|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
1021260|NCT00624780|2478336|P1|NOT COMPLETED|Treatment Discontinuation (Week 25)||2
1021261|NCT00624780|2478331|P6|COMPLETED|Treatment Discontinuation (Week 25)||29
1021262|NCT00624780|2478332|P5|COMPLETED|Treatment Discontinuation (Week 25)||95
1021263|NCT00624780|2478333|P4|COMPLETED|Treatment Discontinuation (Week 25)||26
1021264|NCT00624780|2478334|P3|COMPLETED|Treatment Discontinuation (Week 25)||91
1021265|NCT00624780|2478335|P2|COMPLETED|Treatment Discontinuation (Week 25)||28
1021266|NCT00624780|2478336|P1|COMPLETED|Treatment Discontinuation (Week 25)||104
1021267|NCT00624780|2478331|P6|STARTED|Treatment Discontinuation (Week 25)||30
1021268|NCT00624780|2478332|P5|STARTED|Treatment Discontinuation (Week 25)||95
1021269|NCT00624780|2478333|P4|STARTED|Treatment Discontinuation (Week 25)||27
1021270|NCT00624780|2478334|P3|STARTED|Treatment Discontinuation (Week 25)||94
1021271|NCT00624780|2478335|P2|STARTED|Treatment Discontinuation (Week 25)||28
1021272|NCT00624780|2478336|P1|STARTED|Treatment Discontinuation (Week 25)||106
1021273|NCT00624780|2478331|P6|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||9
1021274|NCT00624780|2478332|P5|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||19
1021275|NCT00624780|2478333|P4|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
1021276|NCT00624780|2478334|P3|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||18
1021277|NCT00624780|2478335|P2|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
1021278|NCT00624780|2478336|P1|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||15
1021279|NCT00624780|2478331|P6|COMPLETED|Fixed Dosing (Week 13 to Week 24)||30
1021280|NCT00624780|2478332|P5|COMPLETED|Fixed Dosing (Week 13 to Week 24)||95
1021281|NCT00624780|2478333|P4|COMPLETED|Fixed Dosing (Week 13 to Week 24)||27
1021282|NCT00624780|2478334|P3|COMPLETED|Fixed Dosing (Week 13 to Week 24)||94
1021283|NCT00624780|2478335|P2|COMPLETED|Fixed Dosing (Week 13 to Week 24)||28
1021284|NCT00624780|2478336|P1|COMPLETED|Fixed Dosing (Week 13 to Week 24)||106
1021285|NCT00624780|2478331|P6|STARTED|Fixed Dosing (Week 13 to Week 24)||39
1021286|NCT00624780|2478332|P5|STARTED|Fixed Dosing (Week 13 to Week 24)||114
1021287|NCT00624780|2478333|P4|STARTED|Fixed Dosing (Week 13 to Week 24)||38
1021288|NCT00624780|2478334|P3|STARTED|Fixed Dosing (Week 13 to Week 24)||112
1021289|NCT00624780|2478335|P2|STARTED|Fixed Dosing (Week 13 to Week 24)||39
1021290|NCT00624780|2478336|P1|STARTED|Fixed Dosing (Week 13 to Week 24)||121
1021291|NCT00624780|2478331|P6|NOT COMPLETED|Treatment Optimization (Up to Week 12)||11
1021292|NCT00624780|2478332|P5|NOT COMPLETED|Treatment Optimization (Up to Week 12)||39
1021293|NCT00624780|2478333|P4|NOT COMPLETED|Treatment Optimization (Up to Week 12)||14
1021294|NCT00624780|2478334|P3|NOT COMPLETED|Treatment Optimization (Up to Week 12)||42
1021295|NCT00624780|2478335|P2|NOT COMPLETED|Treatment Optimization (Up to Week 12)||13
1021296|NCT00624780|2478336|P1|NOT COMPLETED|Treatment Optimization (Up to Week 12)||33
1021297|NCT00624780|2478331|P6|COMPLETED|Treatment Optimization (Up to Week 12)||39
1021298|NCT00624780|2478332|P5|COMPLETED|Treatment Optimization (Up to Week 12)||114
1021299|NCT00624780|2478333|P4|COMPLETED|Treatment Optimization (Up to Week 12)||38
1021300|NCT00624780|2478334|P3|COMPLETED|Treatment Optimization (Up to Week 12)||112
1021301|NCT00624780|2478335|P2|COMPLETED|Treatment Optimization (Up to Week 12)||39
1021302|NCT00624780|2478336|P1|COMPLETED|Treatment Optimization (Up to Week 12)||121
1021303|NCT00624780|2478331|P6|STARTED|Treatment Optimization (Up to Week 12)||50
1021304|NCT00624780|2478332|P5|STARTED|Treatment Optimization (Up to Week 12)||153
1021305|NCT00624780|2478333|P4|STARTED|Treatment Optimization (Up to Week 12)||52
1021306|NCT00624780|2478334|P3|STARTED|Treatment Optimization (Up to Week 12)||154
1021307|NCT00624780|2478335|P2|STARTED|Treatment Optimization (Up to Week 12)||52
1021308|NCT00624780|2478336|P1|STARTED|Treatment Optimization (Up to Week 12)||154
1021309|NCT00624806|2478520|P2|NOT COMPLETED|Overall Study||0
1021310|NCT00624806|2478521|P1|NOT COMPLETED|Overall Study||0
1021311|NCT00624806|2478520|P2|COMPLETED|Overall Study||8
1021312|NCT00624806|2478521|P1|COMPLETED|Overall Study||10
1021313|NCT00624806|2478520|P2|STARTED|Overall Study||8
1021314|NCT00624806|2478521|P1|STARTED|Overall Study||10
1021315|NCT00624832|2478535|P4|NOT COMPLETED|Overall Study||1
1021316|NCT00624832|2478536|P3|NOT COMPLETED|Overall Study||0
1021317|NCT00624832|2478537|P2|NOT COMPLETED|Overall Study||1
1021318|NCT00624832|2478538|P1|NOT COMPLETED|Overall Study||2
1021319|NCT00624832|2478535|P4|COMPLETED|Overall Study||15
1021320|NCT00624832|2478536|P3|COMPLETED|Overall Study||10
1021321|NCT00624832|2478537|P2|COMPLETED|Overall Study||15
1021322|NCT00624832|2478538|P1|COMPLETED|Overall Study||16
1021323|NCT00624832|2478535|P4|STARTED|Overall Study||16
1021324|NCT00624832|2478536|P3|STARTED|Overall Study||10
1021325|NCT00624832|2478537|P2|STARTED|Overall Study||16
1021326|NCT00624832|2478538|P1|STARTED|Overall Study||18
1021327|NCT00627393|2478552|P2|NOT COMPLETED|Per-Protocol Analysis||13
1021328|NCT00627393|2478553|P1|NOT COMPLETED|Per-Protocol Analysis||10
1021329|NCT00627393|2478552|P2|COMPLETED|Per-Protocol Analysis||35
1021330|NCT00627393|2478553|P1|COMPLETED|Per-Protocol Analysis||39
1021331|NCT00627393|2478552|P2|STARTED|Per-Protocol Analysis||48
1021332|NCT00627393|2478553|P1|STARTED|Per-Protocol Analysis||49
1021333|NCT00627393|2478552|P2|NOT COMPLETED|Intention-To-Treat Analysis||8
1021334|NCT00627393|2478553|P1|NOT COMPLETED|Intention-To-Treat Analysis||9
1021335|NCT00627393|2478552|P2|COMPLETED|Intention-To-Treat Analysis||48
1021336|NCT00627393|2478553|P1|COMPLETED|Intention-To-Treat Analysis||49
1021337|NCT00627393|2478552|P2|STARTED|Intention-To-Treat Analysis||56
1021338|NCT00627393|2478553|P1|STARTED|Intention-To-Treat Analysis||58
1021339|NCT00627406|2478576|P4|NOT COMPLETED|Overall Study||0
1021340|NCT00627406|2478577|P3|NOT COMPLETED|Overall Study||0
1021341|NCT00627406|2478578|P2|NOT COMPLETED|Overall Study||0
1021342|NCT00627406|2478579|P1|NOT COMPLETED|Overall Study||0
1021343|NCT00627406|2478576|P4|COMPLETED|Overall Study||141
1021344|NCT00627406|2478577|P3|COMPLETED|Overall Study||125
1021345|NCT00627406|2478578|P2|COMPLETED|Overall Study||58
1021346|NCT00627406|2478579|P1|COMPLETED|Overall Study||60
1021347|NCT00627406|2478576|P4|STARTED|Overall Study||141
1021348|NCT00627406|2478577|P3|STARTED|Overall Study||125
1021349|NCT00627406|2478578|P2|STARTED|Overall Study||58
1021350|NCT00627406|2478579|P1|STARTED|Overall Study||60
1021351|NCT00627445|2478595|P2|NOT COMPLETED|Overall Study||12
1021352|NCT00627445|2478596|P1|NOT COMPLETED|Overall Study||9
1021353|NCT00627445|2478595|P2|COMPLETED|Overall Study||210
1021354|NCT00627445|2478596|P1|COMPLETED|Overall Study||210
1021355|NCT00627445|2478595|P2|Exposed to Study Drug|Overall Study||222
1021356|NCT00627445|2478596|P1|Exposed to Study Drug|Overall Study||219
1021357|NCT00627445|2478595|P2|STARTED|Overall Study||222
1021358|NCT00627445|2478596|P1|STARTED|Overall Study||219
1021359|NCT00627458|2478619|P3|NOT COMPLETED|Overall Study||6
1021360|NCT00627458|2478620|P2|NOT COMPLETED|Overall Study||7
1021361|NCT00627458|2478621|P1|NOT COMPLETED|Overall Study||4
1021362|NCT00627458|2478619|P3|COMPLETED|Overall Study||133
1021363|NCT00627458|2478620|P2|COMPLETED|Overall Study||130
1021364|NCT00627458|2478621|P1|COMPLETED|Overall Study||123
1021365|NCT00627458|2478619|P3|STARTED|Overall Study||139
1021366|NCT00627458|2478620|P2|STARTED|Overall Study||137
1021367|NCT00627458|2478621|P1|STARTED|Overall Study||127
1021368|NCT00627497|2478698|P4|NOT COMPLETED|Overall Study||0
1021369|NCT00627497|2478699|P3|NOT COMPLETED|Overall Study||0
1021370|NCT00627497|2478700|P2|NOT COMPLETED|Overall Study||1
1021371|NCT00627497|2478701|P1|NOT COMPLETED|Overall Study||1
1021372|NCT00627497|2478698|P4|COMPLETED|Overall Study||2
1021373|NCT00627497|2478699|P3|COMPLETED|Overall Study||4
1021374|NCT00627497|2478700|P2|COMPLETED|Overall Study||11
1021375|NCT00627497|2478701|P1|COMPLETED|Overall Study||13
1021376|NCT00627497|2478698|P4|STARTED|Overall Study||2
1021377|NCT00627497|2478699|P3|STARTED|Overall Study||4
1021378|NCT00627497|2478700|P2|STARTED|Overall Study||12
1021379|NCT00627497|2478701|P1|STARTED|Overall Study||14
1021380|NCT00627523|2478761|P2|NOT COMPLETED|Overall Study||2
1021381|NCT00627523|2478762|P1|NOT COMPLETED|Overall Study||2
1021382|NCT00627523|2478761|P2|COMPLETED|Overall Study||20
1021383|NCT00627523|2478762|P1|COMPLETED|Overall Study||19
1021384|NCT00627523|2478761|P2|STARTED|Overall Study||22
1021385|NCT00627523|2478762|P1|STARTED|Overall Study|22 assigned to Genotropin and 21 in Control; 1 did not take Genotropin, so considered as Control.|21
1021386|NCT00627679|2478786|P4|NOT COMPLETED|Overall Study||0
1021387|NCT00627679|2478787|P3|NOT COMPLETED|Overall Study||0
1021388|NCT00627679|2478788|P2|NOT COMPLETED|Overall Study||0
1021389|NCT00627679|2478789|P1|NOT COMPLETED|Overall Study||0
1021390|NCT00627679|2478786|P4|COMPLETED|Overall Study||4
1021391|NCT00627679|2478787|P3|COMPLETED|Overall Study||4
1021392|NCT00627679|2478788|P2|COMPLETED|Overall Study||4
1021393|NCT00627679|2478789|P1|COMPLETED|Overall Study||4
1021394|NCT00627679|2478786|P4|STARTED|Overall Study||4
1021395|NCT00627679|2478787|P3|STARTED|Overall Study||4
1021396|NCT00627679|2478788|P2|STARTED|Overall Study||4
1021397|NCT00627679|2478789|P1|STARTED|Overall Study||4
1021398|NCT00627705|2478817|P2|NOT COMPLETED|Overall Study||6
1021399|NCT00627705|2478818|P1|NOT COMPLETED|Overall Study||2
1021400|NCT00627705|2478817|P2|COMPLETED|Overall Study||12
1021401|NCT00627705|2478818|P1|COMPLETED|Overall Study||13
1021402|NCT00627705|2478817|P2|STARTED|Overall Study||18
1021403|NCT00627705|2478818|P1|STARTED|Overall Study||15
1021404|NCT00627861|2478838|P1|NOT COMPLETED|Overall Study||0
1021405|NCT00627861|2478838|P1|COMPLETED|Overall Study||1
1021406|NCT00627861|2478838|P1|STARTED|Overall Study||1
1021407|NCT00627926|2478847|P3|NOT COMPLETED|Overall Study||95
1021408|NCT00627926|2478848|P2|NOT COMPLETED|Overall Study||104
1021409|NCT00627926|2478849|P1|NOT COMPLETED|Overall Study||159
1021410|NCT00627926|2478847|P3|COMPLETED|Overall Study||268
1021411|NCT00627926|2478848|P2|COMPLETED|Overall Study||260
1021412|NCT00627926|2478849|P1|COMPLETED|Overall Study||202
1021413|NCT00627926|2478847|P3|STARTED|Overall Study||363
1021414|NCT00627926|2478848|P2|STARTED|Overall Study||364
1021415|NCT00627926|2478849|P1|STARTED|Overall Study||361
1021416|NCT00627978|2478895|P2|NOT COMPLETED|Overall Study||0
1021417|NCT00627978|2478896|P1|NOT COMPLETED|Overall Study||0
1021418|NCT00627978|2478895|P2|COMPLETED|Overall Study||5
1021419|NCT00627978|2478896|P1|COMPLETED|Overall Study||10
1021420|NCT00627978|2478895|P2|STARTED|Overall Study||5
1021421|NCT00627978|2478896|P1|STARTED|Overall Study||10
1021422|NCT00628030|2478904|P2|NOT COMPLETED|Post to 6 Month Follow-up||30
1021423|NCT00628030|2478905|P1|NOT COMPLETED|Post to 6 Month Follow-up||32
1021424|NCT00628030|2478904|P2|COMPLETED|Post to 6 Month Follow-up||33
1021425|NCT00628030|2478905|P1|COMPLETED|Post to 6 Month Follow-up||27
1021426|NCT00628030|2478904|P2|STARTED|Post to 6 Month Follow-up||63
1021427|NCT00628030|2478905|P1|STARTED|Post to 6 Month Follow-up||59
1021428|NCT00628030|2478904|P2|NOT COMPLETED|Baseline to Post-Assessment||29
1021429|NCT00628030|2478905|P1|NOT COMPLETED|Baseline to Post-Assessment||33
1021430|NCT00628030|2478904|P2|COMPLETED|Baseline to Post-Assessment||63
1021431|NCT00628030|2478905|P1|COMPLETED|Baseline to Post-Assessment||59
1021432|NCT00628030|2478904|P2|STARTED|Baseline to Post-Assessment||92
1021433|NCT00628030|2478905|P1|STARTED|Baseline to Post-Assessment||92
1021434|NCT00628108|2478921|P2|NOT COMPLETED|Overall Study||3
1021435|NCT00628108|2478922|P1|NOT COMPLETED|Overall Study||1
1021436|NCT00628108|2478921|P2|COMPLETED|Overall Study||43
1021437|NCT00628108|2478922|P1|COMPLETED|Overall Study||22
1021438|NCT00628108|2478921|P2|Safety Population|Overall Study|Subjects in the Safety Population were analyzed as treated.|45
1021439|NCT00628108|2478922|P1|Safety Population|Overall Study||24
1021440|NCT00628108|2478921|P2|STARTED|Overall Study|One subject was randomized to levocetirizine but received placebo.|46
1021441|NCT00628108|2478922|P1|STARTED|Overall Study||23
1021442|NCT00628134|2478952|P2|NOT COMPLETED|Overall Study||0
1021443|NCT00628134|2478953|P1|NOT COMPLETED|Overall Study||0
1021444|NCT00628134|2478952|P2|COMPLETED|Overall Study||4
1021445|NCT00628134|2478953|P1|COMPLETED|Overall Study||4
1021446|NCT00628134|2478952|P2|STARTED|Overall Study||4
1021447|NCT00628134|2478953|P1|STARTED|Overall Study||4
1021448|NCT00628147|2478963|P2|NOT COMPLETED|Overall Study||1
1021449|NCT00628147|2478964|P1|NOT COMPLETED|Overall Study||7
1021450|NCT00628147|2478963|P2|COMPLETED|Overall Study||141
1021451|NCT00628147|2478964|P1|COMPLETED|Overall Study||135
1021452|NCT00628147|2478963|P2|STARTED|Overall Study||142
1021453|NCT00628147|2478964|P1|STARTED|Overall Study||142
1021454|NCT00628212|2478980|P4|NOT COMPLETED|Overall Study||5
1021455|NCT00628212|2478981|P3|NOT COMPLETED|Overall Study||3
1021456|NCT00628212|2478982|P2|NOT COMPLETED|Overall Study||1
1021457|NCT00628212|2478983|P1|NOT COMPLETED|Overall Study||3
1021458|NCT00628212|2478980|P4|COMPLETED|Overall Study||76
1021459|NCT00628212|2478981|P3|COMPLETED|Overall Study||76
1021460|NCT00628212|2478982|P2|COMPLETED|Overall Study||83
1021461|NCT00628212|2478983|P1|COMPLETED|Overall Study||77
1021462|NCT00628212|2478980|P4|STARTED|Overall Study||81
1021463|NCT00628212|2478981|P3|STARTED|Overall Study||79
1021464|NCT00628212|2478982|P2|STARTED|Overall Study||84
1021465|NCT00628212|2478983|P1|STARTED|Overall Study||80
1021466|NCT00628251|2479008|P3|NOT COMPLETED|Cross-over/ Continuation of Olaparib||17
1021467|NCT00628251|2479009|P2|NOT COMPLETED|Cross-over/ Continuation of Olaparib||26
1021468|NCT00628251|2479010|P1|NOT COMPLETED|Cross-over/ Continuation of Olaparib||27
1021469|NCT00628251|2479008|P3|COMPLETED|Cross-over/ Continuation of Olaparib|Patients ongoing crossover treatment|8
1021470|NCT00628251|2479009|P2|COMPLETED|Cross-over/ Continuation of Olaparib|Ongoing initial study treatment at primary data cut-off|6
1021471|NCT00628251|2479010|P1|COMPLETED|Cross-over/ Continuation of Olaparib|Ongoing initial study treatment at primary data cut-off|5
1021472|NCT00628251|2479008|P3|STARTED|Cross-over/ Continuation of Olaparib|Patients who crossed over from Liposomal doxorubicin to Olaparib 400 mg bd|25
1021473|NCT00628251|2479009|P2|STARTED|Cross-over/ Continuation of Olaparib|Patients who received treatment|32
1021474|NCT00628251|2479010|P1|STARTED|Cross-over/ Continuation of Olaparib|Patients who received treatment|32
1021475|NCT00628251|2479008|P3|NOT COMPLETED|Randomised Part||8
1021476|NCT00628251|2479009|P2|NOT COMPLETED|Randomised Part||0
1021477|NCT00628251|2479010|P1|NOT COMPLETED|Randomised Part||0
1021478|NCT00628251|2479008|P3|COMPLETED|Randomised Part|Patients who received olaparib (crossed over). 1 of 33 did not receive Liposomal Doxorubicin.|25
1021479|NCT00628251|2479009|P2|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
1021480|NCT00628251|2479010|P1|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
1021481|NCT00628251|2479008|P3|STARTED|Randomised Part|Patients randomised|33
1021482|NCT00628251|2479009|P2|STARTED|Randomised Part|Patients randomised|32
1021483|NCT00628251|2479010|P1|STARTED|Randomised Part|Patients randomised|32
1021484|NCT00628355|2479051|P2|NOT COMPLETED|Overall Study||1
1021485|NCT00628355|2479052|P1|NOT COMPLETED|Overall Study||1
1021486|NCT00628355|2479051|P2|COMPLETED|Overall Study||14
1021487|NCT00628355|2479052|P1|COMPLETED|Overall Study||14
1021488|NCT00628355|2479051|P2|STARTED|Overall Study||15
1021489|NCT00628355|2479052|P1|STARTED|Overall Study||15
1021490|NCT00628407|2479060|P1|NOT COMPLETED|Overall Study||0
1021491|NCT00628407|2479060|P1|COMPLETED|Overall Study||13
1021492|NCT00628407|2479060|P1|STARTED|Overall Study||13
1021493|NCT00628446|2479064|P1|NOT COMPLETED|Overall Study||7
1021494|NCT00628446|2479064|P1|COMPLETED|Overall Study||38
1021495|NCT00628446|2479064|P1|STARTED|Overall Study||45
1021496|NCT00628589|2479072|P3|NOT COMPLETED|Overall Study||3
1021497|NCT00628589|2479073|P2|NOT COMPLETED|Overall Study||2
1021498|NCT00628589|2479074|P1|NOT COMPLETED|Overall Study||1
1021499|NCT00628589|2479072|P3|COMPLETED|Overall Study||110
1021500|NCT00628589|2479073|P2|COMPLETED|Overall Study||114
1021501|NCT00628589|2479074|P1|COMPLETED|Overall Study||114
1021502|NCT00628589|2479072|P3|STARTED|Overall Study||113
1021503|NCT00628589|2479073|P2|STARTED|Overall Study||116
1021504|NCT00628589|2479074|P1|STARTED|Overall Study||115
1021505|NCT00628628|2479090|P2|NOT COMPLETED|Overall Study||0
1021506|NCT00628628|2479091|P1|NOT COMPLETED|Overall Study||0
1021507|NCT00628628|2479090|P2|COMPLETED|Overall Study||40
1021508|NCT00628628|2479091|P1|COMPLETED|Overall Study||40
1021509|NCT00628628|2479090|P2|STARTED|Overall Study||40
1021510|NCT00628628|2479091|P1|STARTED|Overall Study||40
1021511|NCT00628758|2479099|P2|NOT COMPLETED|Overall Study||42
1021512|NCT00628758|2479100|P1|NOT COMPLETED|Overall Study||44
1021513|NCT00628758|2479099|P2|COMPLETED|Overall Study||179
1021514|NCT00628758|2479100|P1|COMPLETED|Overall Study||165
1021515|NCT00628758|2479099|P2|STARTED|Overall Study||221
1021516|NCT00628758|2479100|P1|STARTED|Overall Study||209
1021517|NCT00628862|2479115|P3|NOT COMPLETED|Overall Study||22
1021518|NCT00628862|2479116|P2|NOT COMPLETED|Overall Study||17
1021519|NCT00628862|2479117|P1|NOT COMPLETED|Overall Study||11
1021520|NCT00628862|2479115|P3|COMPLETED|Overall Study|randomised patients|186
1021521|NCT00628862|2479116|P2|COMPLETED|Overall Study|randomised patients|182
1021522|NCT00628862|2479117|P1|COMPLETED|Overall Study|randomised patients|195
1021523|NCT00628862|2479115|P3|STARTED|Overall Study|randomised patients|208
1021524|NCT00628862|2479116|P2|STARTED|Overall Study|randomised patients|199
1021525|NCT00628862|2479117|P1|STARTED|Overall Study|randomised patients|206
1021526|NCT00628901|2479163|P2|NOT COMPLETED|Overall Study||1
1021527|NCT00628901|2479164|P1|NOT COMPLETED|Overall Study||3
1021528|NCT00628901|2479163|P2|COMPLETED|Overall Study||29
1021529|NCT00628901|2479164|P1|COMPLETED|Overall Study||27
1021530|NCT00628901|2479163|P2|STARTED|Overall Study||30
1021531|NCT00628901|2479164|P1|STARTED|Overall Study||30
1021532|NCT00628927|2479194|P2|NOT COMPLETED|Overall Study||0
1021533|NCT00628927|2479195|P1|NOT COMPLETED|Overall Study||8
1021534|NCT00628927|2479194|P2|COMPLETED|Overall Study||30
1021535|NCT00628927|2479195|P1|COMPLETED|Overall Study||175
1021536|NCT00628927|2479194|P2|STARTED|Overall Study||30
1021537|NCT00628927|2479195|P1|STARTED|Overall Study||183
1021538|NCT00629018|2479208|P2|NOT COMPLETED|Overall Study||0
1021539|NCT00629018|2479209|P1|NOT COMPLETED|Overall Study||0
1021540|NCT00629018|2479208|P2|COMPLETED|Overall Study||55
1021541|NCT00629018|2479209|P1|COMPLETED|Overall Study||55
1021542|NCT00629018|2479208|P2|STARTED|Overall Study||55
1021543|NCT00629018|2479209|P1|STARTED|Overall Study||55
1021544|NCT00629239|2479219|P2|NOT COMPLETED|Overall Study||4
1021545|NCT00629239|2479220|P1|NOT COMPLETED|Overall Study||8
1021546|NCT00629239|2479219|P2|COMPLETED|Overall Study||28
1021547|NCT00629239|2479220|P1|COMPLETED|Overall Study||26
1021548|NCT00629239|2479219|P2|STARTED|Overall Study||32
1021549|NCT00629239|2479220|P1|STARTED|Overall Study||34
1021550|NCT00629265|2479254|P2|NOT COMPLETED|Overall Study||20
1021551|NCT00629265|2479255|P1|NOT COMPLETED|Overall Study||32
1021552|NCT00629265|2479254|P2|COMPLETED|Overall Study||34
1021553|NCT00629265|2479255|P1|COMPLETED|Overall Study||84
1021554|NCT00629265|2479254|P2|STARTED|Overall Study||54
1021555|NCT00629265|2479255|P1|STARTED|Overall Study||116
1021556|NCT00629499|2479263|P1|NOT COMPLETED|Overall Study||0
1021557|NCT00629499|2479263|P1|COMPLETED|Overall Study||63
1021558|NCT00629499|2479263|P1|STARTED|Overall Study||63
1021559|NCT00629525|2479267|P1|NOT COMPLETED|Overall Study||3
1021560|NCT00629525|2479267|P1|COMPLETED|Overall Study||32
1021561|NCT00629525|2479267|P1|STARTED|Overall Study||35
1021562|NCT00629707|2479277|P2|NOT COMPLETED|Overall Study||2
1021563|NCT00629707|2479278|P1|NOT COMPLETED|Overall Study||0
1021564|NCT00629707|2479277|P2|COMPLETED|Overall Study||8
1021565|NCT00629707|2479278|P1|COMPLETED|Overall Study||10
1021566|NCT00629707|2479277|P2|STARTED|Overall Study||10
1021567|NCT00629707|2479278|P1|STARTED|Overall Study||10
1021568|NCT00629772|2479286|P2|NOT COMPLETED|Second Intervention Week 14 - Week 26||2
1021569|NCT00629772|2479287|P1|NOT COMPLETED|Second Intervention Week 14 - Week 26||1
1021570|NCT00629772|2479286|P2|COMPLETED|Second Intervention Week 14 - Week 26||10
1021571|NCT00629772|2479287|P1|COMPLETED|Second Intervention Week 14 - Week 26||11
1021572|NCT00629772|2479286|P2|STARTED|Second Intervention Week 14 - Week 26||12
1021573|NCT00629772|2479287|P1|STARTED|Second Intervention Week 14 - Week 26|Patient withdrew at Week 14 and therefore never received infliximab.|12
1021574|NCT00629772|2479286|P2|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
1021575|NCT00629772|2479287|P1|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
1021576|NCT00629772|2479286|P2|COMPLETED|First Intervention - Day 0 - Week 14||12
1021577|NCT00629772|2479287|P1|COMPLETED|First Intervention - Day 0 - Week 14||12
1021578|NCT00629772|2479286|P2|STARTED|First Intervention - Day 0 - Week 14||12
1021579|NCT00629772|2479287|P1|STARTED|First Intervention - Day 0 - Week 14||12
1021580|NCT00621504|2479307|P2|NOT COMPLETED|Overall Study||25
1021581|NCT00621504|2479308|P1|NOT COMPLETED|Overall Study||26
1021582|NCT00621504|2479307|P2|COMPLETED|Overall Study||282
1021583|NCT00621504|2479308|P1|COMPLETED|Overall Study||273
1021584|NCT00621504|2479307|P2|STARTED|Overall Study||307
1021585|NCT00621504|2479308|P1|STARTED|Overall Study||299
1021586|NCT00621517|2479316|P2|NOT COMPLETED|Overall Study||7
1021587|NCT00621517|2479317|P1|NOT COMPLETED|Overall Study||7
1021588|NCT00621517|2479316|P2|COMPLETED|Overall Study||24
1021589|NCT00621517|2479317|P1|COMPLETED|Overall Study||22
1021590|NCT00621517|2479316|P2|STARTED|Overall Study||31
1021591|NCT00621517|2479317|P1|STARTED|Overall Study||29
1021592|NCT00621530|2479325|P2|NOT COMPLETED|Overall Study||3
1021593|NCT00621530|2479326|P1|NOT COMPLETED|Overall Study||2
1021594|NCT00621530|2479325|P2|COMPLETED|Overall Study||29
1021595|NCT00621530|2479326|P1|COMPLETED|Overall Study||28
1021596|NCT00621530|2479325|P2|STARTED|Overall Study||32
1021597|NCT00621530|2479326|P1|STARTED|Overall Study||30
1021598|NCT00621543|2479340|P1|NOT COMPLETED|Overall Study||23
1021599|NCT00621543|2479340|P1|COMPLETED|Overall Study||97
1021600|NCT00621543|2479340|P1|STARTED|Overall Study||120
1021601|NCT00621582|2479345|P1|NOT COMPLETED|Overall Study||106
1021602|NCT00621582|2479345|P1|COMPLETED|Overall Study||4812
1021603|NCT00621582|2479345|P1|STARTED|Overall Study||4918
1021604|NCT00621621|2479355|P2|NOT COMPLETED|Overall Study||0
1021605|NCT00621621|2479356|P1|NOT COMPLETED|Overall Study||30
1021606|NCT00621621|2479355|P2|COMPLETED|Overall Study||705
1021607|NCT00621621|2479356|P1|COMPLETED|Overall Study|Treated with the experimental catheter|75
1021608|NCT00621621|2479355|P2|STARTED|Overall Study||705
1021609|NCT00621621|2479356|P1|STARTED|Overall Study|Date of Post- Approval Study protocol approval|105
1021610|NCT00621686|2479366|P2|NOT COMPLETED|Overall Study||0
1021611|NCT00621686|2479367|P1|NOT COMPLETED|Overall Study||0
1021612|NCT00621686|2479366|P2|COMPLETED|Overall Study||35
1021613|NCT00621686|2479367|P1|COMPLETED|Overall Study||19
1021614|NCT00621686|2479366|P2|STARTED|Overall Study||35
1021615|NCT00621686|2479367|P1|STARTED|Overall Study||19
1021616|NCT00621764|2479381|P4|NOT COMPLETED|Overall Study||1
1021617|NCT00621764|2479382|P3|NOT COMPLETED|Overall Study||0
1021618|NCT00621764|2479383|P2|NOT COMPLETED|Overall Study||0
1021619|NCT00621764|2479384|P1|NOT COMPLETED|Overall Study||0
1021620|NCT00621764|2479381|P4|COMPLETED|Overall Study||98
1021621|NCT00621764|2479382|P3|COMPLETED|Overall Study||101
1021622|NCT00621764|2479383|P2|COMPLETED|Overall Study||50
1021623|NCT00621764|2479384|P1|COMPLETED|Overall Study||50
1021624|NCT00621764|2479381|P4|STARTED|Overall Study||99
1021625|NCT00621764|2479382|P3|STARTED|Overall Study||101
1021626|NCT00621764|2479383|P2|STARTED|Overall Study||50
1021627|NCT00621764|2479384|P1|STARTED|Overall Study||50
1021628|NCT00621777|2479416|P2|NOT COMPLETED|Randomized Phase||19
1021629|NCT00621777|2479417|P1|NOT COMPLETED|Randomized Phase||7
1021630|NCT00621777|2479416|P2|COMPLETED|Randomized Phase||28
1021631|NCT00621777|2479417|P1|COMPLETED|Randomized Phase||33
1021632|NCT00621777|2479416|P2|STARTED|Randomized Phase||47
1021633|NCT00621777|2479417|P1|STARTED|Randomized Phase|87 open phase participants were continuously abstinent for at least 14 days and were randomized|40
1021634|NCT00621777|2479416|P2|NOT COMPLETED|Open Phase||0
1021635|NCT00621777|2479417|P1|NOT COMPLETED|Open Phase||116
1021636|NCT00621777|2479416|P2|COMPLETED|Open Phase||0
1021637|NCT00621777|2479417|P1|COMPLETED|Open Phase||87
1021638|NCT00621777|2479416|P2|STARTED|Open Phase|During this open label phase, all study participants received varenicline|0
1021639|NCT00621777|2479417|P1|STARTED|Open Phase||203
1021640|NCT00621842|2479424|P1|NOT COMPLETED|Overall Study||19
1021641|NCT00621842|2479424|P1|COMPLETED|Overall Study||38
1021642|NCT00621842|2479424|P1|STARTED|Overall Study||57
1021643|NCT00621855|2479444|P5|NOT COMPLETED|Overall Study||55
1021644|NCT00621855|2479445|P4|NOT COMPLETED|Overall Study||67
1021645|NCT00621855|2479446|P3|NOT COMPLETED|Overall Study||81
1021646|NCT00621855|2479447|P2|NOT COMPLETED|Overall Study||61
1021647|NCT00621855|2479448|P1|NOT COMPLETED|Overall Study||76
1021648|NCT00621855|2479444|P5|COMPLETED|Overall Study|Completed means completed treatment|318
1021649|NCT00621855|2479445|P4|COMPLETED|Overall Study|Completed means completed treatment|284
1021650|NCT00621855|2479446|P3|COMPLETED|Overall Study|Completed means completed treatment|330
1021651|NCT00621855|2479447|P2|COMPLETED|Overall Study|Completed means completed treatment|310
1021652|NCT00621855|2479448|P1|COMPLETED|Overall Study|Completed means completed treatment|296
1021653|NCT00621855|2479444|P5|STARTED|Overall Study|Started means randomised to treatment|373
1021654|NCT00621855|2479445|P4|STARTED|Overall Study|Started means randomised to treatment|351
1021655|NCT00621855|2479446|P3|STARTED|Overall Study|Started means randomised to treatment|411
1021656|NCT00621855|2479447|P2|STARTED|Overall Study|Started means randomised to treatment|371
1021657|NCT00621855|2479448|P1|STARTED|Overall Study|Started means randomised to treatment|372
1021658|NCT00621933|2479490|P1|NOT COMPLETED|Overall Study||0
1021659|NCT00621933|2479490|P1|COMPLETED|Overall Study||399
1021660|NCT00621933|2479490|P1|STARTED|Overall Study||399
1021661|NCT00621946|2479499|P2|NOT COMPLETED|Overall Study||1
1021662|NCT00621946|2479500|P1|NOT COMPLETED|Overall Study||0
1021663|NCT00621946|2479499|P2|COMPLETED|Overall Study||12
1021664|NCT00621946|2479500|P1|COMPLETED|Overall Study||13
1021665|NCT00621946|2479499|P2|STARTED|Overall Study||13
1021666|NCT00621946|2479500|P1|STARTED|Overall Study||13
1021667|NCT00621959|2479518|P2|NOT COMPLETED|Overall Study||9
1021668|NCT00621959|2479519|P1|NOT COMPLETED|Overall Study||7
1021669|NCT00621959|2479518|P2|COMPLETED|Overall Study||292
1021670|NCT00621959|2479519|P1|COMPLETED|Overall Study||288
1021671|NCT00621959|2479518|P2|STARTED|Overall Study||301
1021672|NCT00621959|2479519|P1|STARTED|Overall Study|In all 791 subjects have been screened and 596 have been randomized|295
1021673|NCT00621985|2479527|P1|NOT COMPLETED|Dexamethasone Admission||1
1021674|NCT00621985|2479527|P1|COMPLETED|Dexamethasone Admission||4
1021675|NCT00621985|2479527|P1|STARTED|Dexamethasone Admission||5
1021676|NCT00621985|2479527|P1|NOT COMPLETED|Hydrocortisone Admission||0
1021677|NCT00621985|2479527|P1|COMPLETED|Hydrocortisone Admission||5
1021678|NCT00621985|2479527|P1|STARTED|Hydrocortisone Admission||5
1021679|NCT00622167|2479533|P1|NOT COMPLETED|Overall Study||20
1021680|NCT00622167|2479533|P1|COMPLETED|Overall Study||4
1021681|NCT00622167|2479533|P1|STARTED|Overall Study||24
1021682|NCT00629850|2479539|P2|NOT COMPLETED|Overall Study||0
1021683|NCT00629850|2479540|P1|NOT COMPLETED|Overall Study||0
1021684|NCT00629850|2479539|P2|COMPLETED|Overall Study||0
1021685|NCT00629850|2479540|P1|COMPLETED|Overall Study||1
1021686|NCT00629850|2479539|P2|STARTED|Overall Study||0
1021687|NCT00629850|2479540|P1|STARTED|Overall Study||1
1021688|NCT00630058|2479552|P2|NOT COMPLETED|Overall Study||4
1021689|NCT00630058|2479553|P1|NOT COMPLETED|Overall Study||4
1021690|NCT00630058|2479552|P2|COMPLETED|Overall Study||6
1021691|NCT00630058|2479553|P1|COMPLETED|Overall Study||6
1021692|NCT00630058|2479552|P2|STARTED|Overall Study||10
1021693|NCT00630058|2479553|P1|STARTED|Overall Study||10
1021694|NCT00632411|2479571|P2|NOT COMPLETED|Overall Study||176
1021695|NCT00632411|2479572|P1|NOT COMPLETED|Overall Study||160
1021696|NCT00632411|2479571|P2|COMPLETED|Overall Study||473
1021697|NCT00632411|2479572|P1|COMPLETED|Overall Study||489
1021698|NCT00632411|2479571|P2|STARTED|Overall Study||649
1021699|NCT00632411|2479572|P1|STARTED|Overall Study||649
1021700|NCT00632424|2479581|P1|NOT COMPLETED|Overall Study||18
1021701|NCT00632424|2479581|P1|COMPLETED|Overall Study||0
1021702|NCT00632424|2479581|P1|STARTED|Overall Study||18
1021703|NCT00632463|2479606|P3|NOT COMPLETED|Overall Study||0
1021704|NCT00632463|2479607|P2|NOT COMPLETED|Overall Study||1
1021705|NCT00632463|2479608|P1|NOT COMPLETED|Overall Study||0
1021706|NCT00632463|2479606|P3|COMPLETED|Overall Study||7
1021707|NCT00632463|2479607|P2|COMPLETED|Overall Study||6
1021708|NCT00632463|2479608|P1|COMPLETED|Overall Study||7
1021709|NCT00632463|2479606|P3|STARTED|Overall Study||7
1021710|NCT00632463|2479607|P2|STARTED|Overall Study||7
1021711|NCT00632463|2479608|P1|STARTED|Overall Study||7
1021712|NCT00632489|2479625|P3|NOT COMPLETED|Overall Study||0
1021713|NCT00632489|2479626|P2|NOT COMPLETED|Overall Study||5
1021714|NCT00632489|2479627|P1|NOT COMPLETED|Overall Study||15
1021715|NCT00632489|2479625|P3|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
1021716|NCT00632489|2479626|P2|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
1021717|NCT00632489|2479627|P1|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
1021718|NCT00632489|2479625|P3|STARTED|Overall Study||0
1021719|NCT00632489|2479626|P2|STARTED|Overall Study||5
1021720|NCT00632489|2479627|P1|STARTED|Overall Study||15
1021721|NCT00632502|2479640|P2|NOT COMPLETED|Overall Study||1
1021722|NCT00632502|2479641|P1|NOT COMPLETED|Overall Study||3
1021723|NCT00632502|2479640|P2|COMPLETED|Overall Study||11
1021724|NCT00632502|2479641|P1|COMPLETED|Overall Study||22
1021725|NCT00632502|2479640|P2|Completed Treatment|Overall Study||9
1021726|NCT00632502|2479641|P1|Completed Treatment|Overall Study||19
1021727|NCT00632502|2479640|P2|Treated|Overall Study||12
1021728|NCT00632502|2479641|P1|Treated|Overall Study||22
1021729|NCT00632502|2479640|P2|STARTED|Overall Study||12
1021730|NCT00632502|2479641|P1|STARTED|Overall Study||25
1021731|NCT00632541|2479666|P1|NOT COMPLETED|Overall Study||7
1021732|NCT00632541|2479666|P1|COMPLETED|Overall Study||11
1021733|NCT00632541|2479666|P1|STARTED|Overall Study|18 subjects were accrued to the study|18
1021734|NCT00632619|2479672|P2|NOT COMPLETED|Overall Study||4
1021735|NCT00632619|2479673|P1|NOT COMPLETED|Overall Study||8
1021736|NCT00632619|2479672|P2|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10
nd cohort completed follow up 7/18/11"|31
1021737|NCT00632619|2479673|P1|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10
nd cohort completed follow up 7/18/11"|25
1021738|NCT00632619|2479672|P2|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|35
1021739|NCT00632619|2479673|P1|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|33
1021740|NCT00632632|2479689|P2|NOT COMPLETED|Overall Study||3
1021741|NCT00632632|2479690|P1|NOT COMPLETED|Overall Study||0
1021742|NCT00632632|2479689|P2|COMPLETED|Overall Study||9
1021743|NCT00632632|2479690|P1|COMPLETED|Overall Study||13
1021744|NCT00632632|2479689|P2|STARTED|Overall Study||12
1021745|NCT00632632|2479690|P1|STARTED|Overall Study||13
1021746|NCT00632736|2479700|P1|NOT COMPLETED|Overall Study||268
1021747|NCT00632736|2479700|P1|COMPLETED|Overall Study||151
1021748|NCT00632736|2479700|P1|STARTED|Overall Study||419
1021749|NCT00632749|2479719|P14|NOT COMPLETED|Overall Study||6
1021750|NCT00632749|2479720|P13|NOT COMPLETED|Overall Study||3
1021751|NCT00632749|2479721|P12|NOT COMPLETED|Overall Study||4
1021752|NCT00632749|2479722|P11|NOT COMPLETED|Overall Study||7
1021753|NCT00632749|2479723|P10|NOT COMPLETED|Overall Study||3
1021754|NCT00632749|2479724|P9|NOT COMPLETED|Overall Study||5
1021755|NCT00632749|2479725|P8|NOT COMPLETED|Overall Study||4
1021756|NCT00632749|2479726|P7|NOT COMPLETED|Overall Study||5
1021757|NCT00632749|2479727|P6|NOT COMPLETED|Overall Study||8
1021758|NCT00632749|2479728|P5|NOT COMPLETED|Overall Study||7
1021759|NCT00632749|2479729|P4|NOT COMPLETED|Overall Study||4
1021760|NCT00632749|2479730|P3|NOT COMPLETED|Overall Study||3
1021761|NCT00632749|2479731|P2|NOT COMPLETED|Overall Study||5
1021762|NCT00632749|2479732|P1|NOT COMPLETED|Overall Study||4
1021763|NCT00632749|2479719|P14|COMPLETED|Overall Study||0
1021764|NCT00632749|2479720|P13|COMPLETED|Overall Study||0
1021765|NCT00632749|2479721|P12|COMPLETED|Overall Study||0
1021766|NCT00632749|2479722|P11|COMPLETED|Overall Study||0
1021767|NCT00632749|2479723|P10|COMPLETED|Overall Study||0
1021768|NCT00632749|2479724|P9|COMPLETED|Overall Study||0
1021769|NCT00632749|2479725|P8|COMPLETED|Overall Study||0
1021770|NCT00632749|2479726|P7|COMPLETED|Overall Study||0
1021771|NCT00632749|2479727|P6|COMPLETED|Overall Study||0
1021772|NCT00632749|2479728|P5|COMPLETED|Overall Study||0
1021773|NCT00632749|2479729|P4|COMPLETED|Overall Study||0
1021774|NCT00632749|2479730|P3|COMPLETED|Overall Study||0
1021775|NCT00632749|2479731|P2|COMPLETED|Overall Study||0
1021776|NCT00632749|2479732|P1|COMPLETED|Overall Study||0
1021777|NCT00632749|2479719|P14|Not Treated|Overall Study||0
1021778|NCT00632749|2479720|P13|Not Treated|Overall Study||0
1021779|NCT00632749|2479721|P12|Not Treated|Overall Study||0
1021780|NCT00632749|2479722|P11|Not Treated|Overall Study||0
1021781|NCT00632749|2479723|P10|Not Treated|Overall Study||0
1021782|NCT00632749|2479724|P9|Not Treated|Overall Study||0
1021783|NCT00632749|2479725|P8|Not Treated|Overall Study||0
1021784|NCT00632749|2479726|P7|Not Treated|Overall Study||1
1021785|NCT00632749|2479727|P6|Not Treated|Overall Study||1
1021786|NCT00632749|2479728|P5|Not Treated|Overall Study||0
1021787|NCT00632749|2479729|P4|Not Treated|Overall Study||0
1021788|NCT00632749|2479730|P3|Not Treated|Overall Study||0
1021789|NCT00632749|2479731|P2|Not Treated|Overall Study||2
1021790|NCT00632749|2479732|P1|Not Treated|Overall Study||0
1021791|NCT00632749|2479719|P14|Treated|Overall Study||6
1021792|NCT00632749|2479720|P13|Treated|Overall Study||3
1021793|NCT00632749|2479721|P12|Treated|Overall Study||4
1021794|NCT00632749|2479722|P11|Treated|Overall Study||7
1021795|NCT00632749|2479723|P10|Treated|Overall Study||3
1021796|NCT00632749|2479724|P9|Treated|Overall Study||5
1021797|NCT00632749|2479725|P8|Treated|Overall Study||4
1021798|NCT00632749|2479726|P7|Treated|Overall Study||4
1021799|NCT00632749|2479727|P6|Treated|Overall Study||7
1021800|NCT00632749|2479728|P5|Treated|Overall Study||7
1021801|NCT00632749|2479729|P4|Treated|Overall Study||4
1021802|NCT00632749|2479730|P3|Treated|Overall Study||3
1021803|NCT00632749|2479731|P2|Treated|Overall Study||3
1021804|NCT00632749|2479732|P1|Treated|Overall Study||4
1021805|NCT00632749|2479719|P14|STARTED|Overall Study||6
1021806|NCT00632749|2479720|P13|STARTED|Overall Study||3
1021807|NCT00632749|2479721|P12|STARTED|Overall Study||4
1021808|NCT00632749|2479722|P11|STARTED|Overall Study||7
1021809|NCT00632749|2479723|P10|STARTED|Overall Study||3
1021810|NCT00632749|2479724|P9|STARTED|Overall Study||5
1021811|NCT00632749|2479725|P8|STARTED|Overall Study||4
1021812|NCT00632749|2479726|P7|STARTED|Overall Study||5
1021813|NCT00632749|2479727|P6|STARTED|Overall Study||8
1021814|NCT00632749|2479728|P5|STARTED|Overall Study||7
1021815|NCT00632749|2479729|P4|STARTED|Overall Study||4
1021816|NCT00632749|2479730|P3|STARTED|Overall Study||3
1021817|NCT00632749|2479731|P2|STARTED|Overall Study||5
1021818|NCT00632749|2479732|P1|STARTED|Overall Study||4
1021819|NCT00632814|2480029|P3|NOT COMPLETED|Overall Study||0
1021820|NCT00632814|2480030|P2|NOT COMPLETED|Overall Study||0
1021821|NCT00632814|2480031|P1|NOT COMPLETED|Overall Study||0
1021822|NCT00632814|2480029|P3|COMPLETED|Overall Study||8
1021823|NCT00632814|2480030|P2|COMPLETED|Overall Study||13
1021824|NCT00632814|2480031|P1|COMPLETED|Overall Study||11
1021825|NCT00632814|2480029|P3|STARTED|Overall Study||8
1021826|NCT00632814|2480030|P2|STARTED|Overall Study||13
1021827|NCT00632814|2480031|P1|STARTED|Overall Study||11
1021828|NCT00632931|2480063|P3|NOT COMPLETED|Part 2||24
1021829|NCT00632931|2480064|P2|NOT COMPLETED|Part 2||0
1021830|NCT00632931|2480065|P1|NOT COMPLETED|Part 2||0
1021831|NCT00632931|2480063|P3|COMPLETED|Part 2||0
1021832|NCT00632931|2480064|P2|COMPLETED|Part 2||0
1021833|NCT00632931|2480065|P1|COMPLETED|Part 2||0
1021834|NCT00632931|2480063|P3|STARTED|Part 2||24
1021835|NCT00632931|2480064|P2|STARTED|Part 2||0
1021836|NCT00632931|2480065|P1|STARTED|Part 2||0
1021837|NCT00632931|2480063|P3|NOT COMPLETED|Post-Part 1 Washout||0
1021838|NCT00632931|2480064|P2|NOT COMPLETED|Post-Part 1 Washout||0
1021839|NCT00632931|2480065|P1|NOT COMPLETED|Post-Part 1 Washout||0
1021840|NCT00632931|2480063|P3|COMPLETED|Post-Part 1 Washout||0
1021841|NCT00632931|2480064|P2|COMPLETED|Post-Part 1 Washout||12
1021842|NCT00632931|2480065|P1|COMPLETED|Post-Part 1 Washout||12
1021843|NCT00632931|2480063|P3|STARTED|Post-Part 1 Washout||0
1021844|NCT00632931|2480064|P2|STARTED|Post-Part 1 Washout||12
1021845|NCT00632931|2480065|P1|STARTED|Post-Part 1 Washout|1 patient who did not complete Period 1 was subsequently enrolled into Post Part 1|12
1021846|NCT00632931|2480063|P3|NOT COMPLETED|Part 1, Period 2||0
1021847|NCT00632931|2480064|P2|NOT COMPLETED|Part 1, Period 2||0
1021848|NCT00632931|2480065|P1|NOT COMPLETED|Part 1, Period 2||0
1021849|NCT00632931|2480063|P3|COMPLETED|Part 1, Period 2||0
1021850|NCT00632931|2480064|P2|COMPLETED|Part 1, Period 2||12
1021851|NCT00632931|2480065|P1|COMPLETED|Part 1, Period 2||11
1021852|NCT00632931|2480063|P3|STARTED|Part 1, Period 2||0
1021853|NCT00632931|2480064|P2|STARTED|Part 1, Period 2||12
1021854|NCT00632931|2480065|P1|STARTED|Part 1, Period 2||11
1021855|NCT00632931|2480063|P3|NOT COMPLETED|Part 1, Washout||0
1021856|NCT00632931|2480064|P2|NOT COMPLETED|Part 1, Washout||0
1021857|NCT00632931|2480065|P1|NOT COMPLETED|Part 1, Washout||0
1021858|NCT00632931|2480063|P3|COMPLETED|Part 1, Washout||0
1021859|NCT00632931|2480064|P2|COMPLETED|Part 1, Washout||12
1021860|NCT00632931|2480065|P1|COMPLETED|Part 1, Washout||11
1021861|NCT00632931|2480063|P3|STARTED|Part 1, Washout||0
1021862|NCT00632931|2480064|P2|STARTED|Part 1, Washout||12
1021863|NCT00632931|2480065|P1|STARTED|Part 1, Washout||11
1021864|NCT00632931|2480063|P3|NOT COMPLETED|Part 1, Period 1||0
1021865|NCT00632931|2480064|P2|NOT COMPLETED|Part 1, Period 1||0
1021866|NCT00632931|2480065|P1|NOT COMPLETED|Part 1, Period 1||2
1021867|NCT00632931|2480063|P3|COMPLETED|Part 1, Period 1||0
1021868|NCT00632931|2480064|P2|COMPLETED|Part 1, Period 1||12
1021869|NCT00632931|2480065|P1|COMPLETED|Part 1, Period 1||11
1021870|NCT00632931|2480063|P3|STARTED|Part 1, Period 1||0
1021871|NCT00632931|2480064|P2|STARTED|Part 1, Period 1||12
1021872|NCT00632931|2480065|P1|STARTED|Part 1, Period 1||13
1021873|NCT00632970|2480086|P2|NOT COMPLETED|Overall Study||0
1021874|NCT00632970|2480087|P1|NOT COMPLETED|Overall Study||0
1021875|NCT00632970|2480086|P2|COMPLETED|Overall Study||3
1021876|NCT00632970|2480087|P1|COMPLETED|Overall Study||3
1021877|NCT00632970|2480086|P2|STARTED|Overall Study||3
1021878|NCT00632970|2480087|P1|STARTED|Overall Study||3
1021879|NCT00633009|2480096|P3|NOT COMPLETED|Overall Study||1
1021880|NCT00633009|2480097|P2|NOT COMPLETED|Overall Study||4
1021881|NCT00633009|2480098|P1|NOT COMPLETED|Overall Study||4
1021882|NCT00633009|2480096|P3|COMPLETED|Overall Study||10
1021883|NCT00633009|2480097|P2|COMPLETED|Overall Study||23
1021884|NCT00633009|2480098|P1|COMPLETED|Overall Study||8
1021885|NCT00633009|2480096|P3|STARTED|Overall Study||11
1021886|NCT00633009|2480097|P2|STARTED|Overall Study||27
1021887|NCT00633009|2480098|P1|STARTED|Overall Study||12
1021888|NCT00633074|2480111|P2|NOT COMPLETED|Overall Study||0
1021889|NCT00633074|2480112|P1|NOT COMPLETED|Overall Study||1
1021890|NCT00633074|2480111|P2|COMPLETED|Overall Study||360
1021891|NCT00633074|2480112|P1|COMPLETED|Overall Study||359
1021892|NCT00633074|2480111|P2|STARTED|Overall Study||360
1021893|NCT00633074|2480112|P1|STARTED|Overall Study||360
1021894|NCT00633087|2480140|P1|NOT COMPLETED|Overall Study||0
1021895|NCT00633087|2480140|P1|COMPLETED|Overall Study||12
1021896|NCT00633087|2480140|P1|STARTED|Overall Study||12
1021897|NCT00633126|2480147|P1|NOT COMPLETED|Overall Study||1
1021898|NCT00633126|2480147|P1|COMPLETED|Overall Study||8
1021899|NCT00633126|2480147|P1|STARTED|Overall Study||9
1021900|NCT00633139|2480155|P3|NOT COMPLETED|Overall Study||1
1021901|NCT00633139|2480156|P2|NOT COMPLETED|Overall Study||1
1021902|NCT00633139|2480157|P1|NOT COMPLETED|Overall Study||0
1021903|NCT00633139|2480155|P3|COMPLETED|Overall Study||3
1021904|NCT00633139|2480156|P2|COMPLETED|Overall Study||4
1021905|NCT00633139|2480157|P1|COMPLETED|Overall Study||4
1021906|NCT00633139|2480155|P3|STARTED|Overall Study||4
1021907|NCT00633139|2480156|P2|STARTED|Overall Study||5
1021908|NCT00633139|2480157|P1|STARTED|Overall Study||4
1021909|NCT00633152|2480173|P2|NOT COMPLETED|Overall Study||6
1021910|NCT00633152|2480174|P1|NOT COMPLETED|Overall Study||14
1021911|NCT00633152|2480173|P2|COMPLETED|Overall Study||41
1021912|NCT00633152|2480174|P1|COMPLETED|Overall Study||89
1021913|NCT00633152|2480173|P2|Clinically Evaluable Population|Overall Study||39
1021914|NCT00633152|2480174|P1|Clinically Evaluable Population|Overall Study||86
1021915|NCT00633152|2480173|P2|MITT and Safety Population|Overall Study||45
1021916|NCT00633152|2480174|P1|MITT and Safety Population|Overall Study||98
1021917|NCT00633152|2480173|P2|STARTED|Overall Study||47
1021918|NCT00633152|2480174|P1|STARTED|Overall Study||103
1021919|NCT00633217|2480184|P2|NOT COMPLETED|Overall Study||23
1021920|NCT00633217|2480185|P1|NOT COMPLETED|Overall Study||15
1021921|NCT00633217|2480184|P2|COMPLETED|Overall Study||103
1021922|NCT00633217|2480185|P1|COMPLETED|Overall Study||106
1021923|NCT00633217|2480184|P2|STARTED|Overall Study||126
1021924|NCT00633217|2480185|P1|STARTED|Overall Study||121
1021925|NCT00633243|2480197|P2|NOT COMPLETED|Overall Study||7
1021926|NCT00633243|2480198|P1|NOT COMPLETED|Overall Study||1
1021927|NCT00633243|2480197|P2|COMPLETED|Overall Study||2
1021928|NCT00633243|2480198|P1|COMPLETED|Overall Study||11
1021929|NCT00633243|2480197|P2|STARTED|Overall Study||9
1021930|NCT00633243|2480198|P1|STARTED|Overall Study||12
1021931|NCT00633256|2480206|P2|NOT COMPLETED|Overall Study||3
1021932|NCT00633256|2480207|P1|NOT COMPLETED|Overall Study||4
1021933|NCT00633256|2480206|P2|COMPLETED|Overall Study||10
1021934|NCT00633256|2480207|P1|COMPLETED|Overall Study||8
1021935|NCT00633256|2480206|P2|STARTED|Overall Study||13
1021936|NCT00633256|2480207|P1|STARTED|Overall Study||12
1021937|NCT00633360|2480219|P2|NOT COMPLETED|Overall Study||3
1021938|NCT00633360|2480220|P1|NOT COMPLETED|Overall Study||4
1021939|NCT00633360|2480219|P2|COMPLETED|Overall Study||13
1021940|NCT00633360|2480220|P1|COMPLETED|Overall Study||12
1021941|NCT00633360|2480219|P2|STARTED|Overall Study||16
1021942|NCT00633360|2480220|P1|STARTED|Overall Study||16
1021943|NCT00633399|2480230|P2|NOT COMPLETED|Overall Study||15
1021944|NCT00633399|2480231|P1|NOT COMPLETED|Overall Study||22
1021945|NCT00633399|2480230|P2|COMPLETED|Overall Study||53
1021946|NCT00633399|2480231|P1|COMPLETED|Overall Study||49
1021947|NCT00633399|2480230|P2|STARTED|Overall Study||68
1021948|NCT00633399|2480231|P1|STARTED|Overall Study||71
1021949|NCT00633464|2480243|P2|NOT COMPLETED|Overall Study||2
1021950|NCT00633464|2480244|P1|NOT COMPLETED|Overall Study||0
1021951|NCT00633464|2480243|P2|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-25,study drug toxicity-4,subject request-3|37
1021952|NCT00633464|2480244|P1|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-27,study drug toxicity-7,max clinical benefit-3|40
1021953|NCT00633464|2480243|P2|Treated|Overall Study||37
1021954|NCT00633464|2480244|P1|Treated|Overall Study||40
1021955|NCT00633464|2480243|P2|STARTED|Overall Study||39
1021956|NCT00633464|2480244|P1|STARTED|Overall Study||40
1021957|NCT00633477|2480266|P2|NOT COMPLETED|Overall Study||0
1021958|NCT00633477|2480267|P1|NOT COMPLETED|Overall Study||2
1021959|NCT00633477|2480266|P2|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|11
1021960|NCT00633477|2480267|P1|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|5
1021961|NCT00633477|2480266|P2|Completed Study Through Day 28|Overall Study||8
1021962|NCT00633477|2480267|P1|Completed Study Through Day 28|Overall Study||4
1021963|NCT00633477|2480266|P2|Prematurely Discontinued Study Drug|Overall Study||0
1021964|NCT00633477|2480267|P1|Prematurely Discontinued Study Drug|Overall Study||1
1021965|NCT00633477|2480266|P2|Randomized But Not Treated|Overall Study||0
1021966|NCT00633477|2480267|P1|Randomized But Not Treated|Overall Study||1
1021967|NCT00633477|2480266|P2|STARTED|Overall Study||11
1021968|NCT00633477|2480267|P1|STARTED|Overall Study|Seven subjects were randomized, however, one was not treated.|7
1021969|NCT00633594|2480284|P3|NOT COMPLETED|Overall Study||10
1021970|NCT00633594|2480285|P2|NOT COMPLETED|Overall Study||5
1021971|NCT00633594|2480286|P1|NOT COMPLETED|Overall Study||0
1021972|NCT00633594|2480284|P3|COMPLETED|Overall Study||16
1021973|NCT00633594|2480285|P2|COMPLETED|Overall Study||3
1021974|NCT00633594|2480286|P1|COMPLETED|Overall Study||5
1021975|NCT00633594|2480284|P3|STARTED|Overall Study||26
1021976|NCT00633594|2480285|P2|STARTED|Overall Study||8
1021977|NCT00633594|2480286|P1|STARTED|Overall Study||5
1021978|NCT00633750|2480313|P1|NOT COMPLETED|Overall Study||5
1021979|NCT00633750|2480313|P1|COMPLETED|Overall Study||42
1021980|NCT00633750|2480313|P1|STARTED|Overall Study||47
1021981|NCT00633867|2480321|P2|NOT COMPLETED|Overall Study||0
1021982|NCT00633867|2480322|P1|NOT COMPLETED|Overall Study||0
1021983|NCT00633867|2480321|P2|COMPLETED|Overall Study||60
1021984|NCT00633867|2480322|P1|COMPLETED|Overall Study||60
1021985|NCT00633867|2480321|P2|STARTED|Overall Study||60
1021986|NCT00633867|2480322|P1|STARTED|Overall Study||60
1021987|NCT00633880|2480331|P3|NOT COMPLETED|Randomized Double Blind||0
1021988|NCT00633880|2480332|P2|NOT COMPLETED|Randomized Double Blind||0
1021989|NCT00633880|2480333|P1|NOT COMPLETED|Randomized Double Blind||0
1021990|NCT00633880|2480331|P3|COMPLETED|Randomized Double Blind||51
1021991|NCT00633880|2480332|P2|COMPLETED|Randomized Double Blind||50
1021992|NCT00633880|2480333|P1|COMPLETED|Randomized Double Blind||0
1021993|NCT00633880|2480331|P3|STARTED|Randomized Double Blind||51
1021994|NCT00633880|2480332|P2|STARTED|Randomized Double Blind||50
1021995|NCT00633880|2480333|P1|STARTED|Randomized Double Blind||0
1021996|NCT00633880|2480331|P3|NOT COMPLETED|Open Label Titration||0
1021997|NCT00633880|2480332|P2|NOT COMPLETED|Open Label Titration||0
1021998|NCT00633880|2480333|P1|NOT COMPLETED|Open Label Titration||80
1021999|NCT00633880|2480331|P3|COMPLETED|Open Label Titration||0
1022000|NCT00633880|2480332|P2|COMPLETED|Open Label Titration||0
1022001|NCT00633880|2480333|P1|COMPLETED|Open Label Titration||101
1022002|NCT00633880|2480331|P3|STARTED|Open Label Titration||0
1022003|NCT00633880|2480332|P2|STARTED|Open Label Titration||0
1022004|NCT00633880|2480333|P1|STARTED|Open Label Titration||181
1022005|NCT00633893|2480363|P3|NOT COMPLETED|Overall Study||188
1022006|NCT00633893|2480364|P2|NOT COMPLETED|Overall Study||129
1022007|NCT00633893|2480365|P1|NOT COMPLETED|Overall Study||114
1022008|NCT00633893|2480363|P3|COMPLETED|Overall Study||641
1022009|NCT00633893|2480364|P2|COMPLETED|Overall Study||684
1022010|NCT00633893|2480365|P1|COMPLETED|Overall Study||726
1022011|NCT00633893|2480363|P3|STARTED|Overall Study|3 participants were randomized to placebo but not treated.|829
1022012|NCT00633893|2480364|P2|STARTED|Overall Study|2 participants were randomized to 5 mg study drug but not treated.|813
1022013|NCT00633893|2480365|P1|STARTED|Overall Study||840
1022014|NCT00633919|2480438|P2|NOT COMPLETED|Overall Study||22
1022015|NCT00633919|2480439|P1|NOT COMPLETED|Overall Study||27
1022016|NCT00633919|2480438|P2|COMPLETED|Overall Study||39
1022017|NCT00633919|2480439|P1|COMPLETED|Overall Study||36
1022018|NCT00633919|2480438|P2|STARTED|Overall Study||61
1022019|NCT00633919|2480439|P1|STARTED|Overall Study||63
1022020|NCT00633932|2480456|P3|NOT COMPLETED|Overall Study||11
1022021|NCT00633932|2480457|P2|NOT COMPLETED|Overall Study||14
1022022|NCT00633932|2480458|P1|NOT COMPLETED|Overall Study||12
1022023|NCT00633932|2480456|P3|COMPLETED|Overall Study||180
1022024|NCT00633932|2480457|P2|COMPLETED|Overall Study||176
1022025|NCT00633932|2480458|P1|COMPLETED|Overall Study||179
1022026|NCT00633932|2480456|P3|STARTED|Overall Study|Randomised|191
1022027|NCT00633932|2480457|P2|STARTED|Overall Study|Randomised|190
1022028|NCT00633932|2480458|P1|STARTED|Overall Study|Randomised|191
1022029|NCT00633984|2480471|P2|NOT COMPLETED|Overall Study||13
1022030|NCT00633984|2480472|P1|NOT COMPLETED|Overall Study||9
1022031|NCT00633984|2480471|P2|COMPLETED|Overall Study||69
1022032|NCT00633984|2480472|P1|COMPLETED|Overall Study||78
1022033|NCT00633984|2480471|P2|STARTED|Overall Study||82
1022034|NCT00633984|2480472|P1|STARTED|Overall Study||87
1022035|NCT00634010|2480482|P2|NOT COMPLETED|Overall Study||14
1022036|NCT00634010|2480483|P1|NOT COMPLETED|Overall Study||10
1022037|NCT00634010|2480482|P2|COMPLETED|Overall Study||4
1022038|NCT00634010|2480483|P1|COMPLETED|Overall Study||8
1022039|NCT00634010|2480482|P2|STARTED|Overall Study||18
1022040|NCT00634010|2480483|P1|STARTED|Overall Study||18
1022041|NCT00634036|2480491|P2|NOT COMPLETED|Overall Study||2
1022042|NCT00634036|2480492|P1|NOT COMPLETED|Overall Study||2
1022043|NCT00634036|2480491|P2|COMPLETED|Overall Study||9
1022044|NCT00634036|2480492|P1|COMPLETED|Overall Study||10
1022045|NCT00634036|2480491|P2|STARTED|Overall Study||11
1022046|NCT00634036|2480492|P1|STARTED|Overall Study||12
1022047|NCT00634049|2480504|P1|NOT COMPLETED|Overall Study||3
1022048|NCT00634049|2480504|P1|COMPLETED|Overall Study||146
1022049|NCT00634049|2480504|P1|STARTED|Overall Study||149
1022050|NCT00634088|2480585|P4|NOT COMPLETED|Time Period 4: Triplet Combination||0
1022051|NCT00634088|2480586|P3|NOT COMPLETED|Time Period 4: Triplet Combination||0
1022052|NCT00634088|2480587|P2|NOT COMPLETED|Time Period 4: Triplet Combination||0
1022053|NCT00634088|2480588|P1|NOT COMPLETED|Time Period 4: Triplet Combination||0
1022054|NCT00634088|2480585|P4|COMPLETED|Time Period 4: Triplet Combination||0
1022055|NCT00634088|2480586|P3|COMPLETED|Time Period 4: Triplet Combination||0
1022056|NCT00634088|2480587|P2|COMPLETED|Time Period 4: Triplet Combination||0
1022057|NCT00634088|2480588|P1|COMPLETED|Time Period 4: Triplet Combination||0
1022058|NCT00634088|2480585|P4|STARTED|Time Period 4: Triplet Combination||0
1022059|NCT00634088|2480586|P3|STARTED|Time Period 4: Triplet Combination||0
1022060|NCT00634088|2480587|P2|STARTED|Time Period 4: Triplet Combination||0
1022061|NCT00634088|2480588|P1|STARTED|Time Period 4: Triplet Combination||0
1022062|NCT00634088|2480585|P4|NOT COMPLETED|Time Period 3: Dose Level 3||0
1022063|NCT00634088|2480586|P3|NOT COMPLETED|Time Period 3: Dose Level 3||1
1022064|NCT00634088|2480587|P2|NOT COMPLETED|Time Period 3: Dose Level 3||0
1022065|NCT00634088|2480588|P1|NOT COMPLETED|Time Period 3: Dose Level 3||0
1022066|NCT00634088|2480585|P4|COMPLETED|Time Period 3: Dose Level 3||0
1022067|NCT00634088|2480586|P3|COMPLETED|Time Period 3: Dose Level 3||0
1022068|NCT00634088|2480587|P2|COMPLETED|Time Period 3: Dose Level 3||0
1022069|NCT00634088|2480588|P1|COMPLETED|Time Period 3: Dose Level 3||0
1022070|NCT00634088|2480585|P4|STARTED|Time Period 3: Dose Level 3||0
1022071|NCT00634088|2480586|P3|STARTED|Time Period 3: Dose Level 3||1
1022072|NCT00634088|2480587|P2|STARTED|Time Period 3: Dose Level 3||0
1022073|NCT00634088|2480588|P1|STARTED|Time Period 3: Dose Level 3||0
1022074|NCT00634088|2480585|P4|NOT COMPLETED|Time Period 2: Dose Level 2||0
1022075|NCT00634088|2480586|P3|NOT COMPLETED|Time Period 2: Dose Level 2||0
1022076|NCT00634088|2480587|P2|NOT COMPLETED|Time Period 2: Dose Level 2||3
1022077|NCT00634088|2480588|P1|NOT COMPLETED|Time Period 2: Dose Level 2||0
1022078|NCT00634088|2480585|P4|COMPLETED|Time Period 2: Dose Level 2||0
1022079|NCT00634088|2480586|P3|COMPLETED|Time Period 2: Dose Level 2||0
1022080|NCT00634088|2480587|P2|COMPLETED|Time Period 2: Dose Level 2||0
1022081|NCT00634088|2480588|P1|COMPLETED|Time Period 2: Dose Level 2||0
1022082|NCT00634088|2480585|P4|STARTED|Time Period 2: Dose Level 2||0
1022083|NCT00634088|2480586|P3|STARTED|Time Period 2: Dose Level 2||0
1022084|NCT00634088|2480587|P2|STARTED|Time Period 2: Dose Level 2||3
1022085|NCT00634088|2480588|P1|STARTED|Time Period 2: Dose Level 2||0
1022086|NCT00634088|2480585|P4|NOT COMPLETED|Time Period 1: Dose Level 1||0
1022087|NCT00634088|2480586|P3|NOT COMPLETED|Time Period 1: Dose Level 1||0
1022088|NCT00634088|2480587|P2|NOT COMPLETED|Time Period 1: Dose Level 1||0
1022089|NCT00634088|2480588|P1|NOT COMPLETED|Time Period 1: Dose Level 1||6
1022090|NCT00634088|2480585|P4|COMPLETED|Time Period 1: Dose Level 1||0
1022091|NCT00634088|2480586|P3|COMPLETED|Time Period 1: Dose Level 1||0
1022092|NCT00634088|2480587|P2|COMPLETED|Time Period 1: Dose Level 1||0
1022093|NCT00634088|2480588|P1|COMPLETED|Time Period 1: Dose Level 1||0
1022094|NCT00634088|2480585|P4|STARTED|Time Period 1: Dose Level 1||0
1022095|NCT00634088|2480586|P3|STARTED|Time Period 1: Dose Level 1||0
1022096|NCT00634088|2480587|P2|STARTED|Time Period 1: Dose Level 1||0
1022097|NCT00634088|2480588|P1|STARTED|Time Period 1: Dose Level 1||6
1022098|NCT00634114|2480642|P3|NOT COMPLETED|Overall Study||39
1022099|NCT00634114|2480643|P2|NOT COMPLETED|Overall Study||35
1022100|NCT00634114|2480644|P1|NOT COMPLETED|Overall Study||28
1022101|NCT00634114|2480642|P3|COMPLETED|Overall Study|Completed|148
1022102|NCT00634114|2480643|P2|COMPLETED|Overall Study|Completed|154
1022103|NCT00634114|2480644|P1|COMPLETED|Overall Study|Completed|160
1022104|NCT00634114|2480642|P3|STARTED|Overall Study|Randomised|187
1022105|NCT00634114|2480643|P2|STARTED|Overall Study|Randomised|189
1022106|NCT00634114|2480644|P1|STARTED|Overall Study|Randomised|188
1022107|NCT00634166|2480660|P2|NOT COMPLETED|Overall Study||60
1022108|NCT00634166|2480661|P1|NOT COMPLETED|Overall Study||60
1022109|NCT00634166|2480660|P2|COMPLETED|Overall Study||78
1022110|NCT00634166|2480661|P1|COMPLETED|Overall Study||22
1022111|NCT00634166|2480660|P2|STARTED|Overall Study||138
1022112|NCT00634166|2480661|P1|STARTED|Overall Study||82
1022113|NCT00634179|2480667|P1|NOT COMPLETED|Phase II: Maintenance||1
1022114|NCT00634179|2480667|P1|COMPLETED|Phase II: Maintenance||29
1022115|NCT00634179|2480667|P1|STARTED|Phase II: Maintenance||30
1022116|NCT00634179|2480667|P1|NOT COMPLETED|Phase I: Induction||0
1022117|NCT00634179|2480667|P1|COMPLETED|Phase I: Induction||19
1022118|NCT00634179|2480667|P1|STARTED|Phase I: Induction||19
1022119|NCT00634244|2480677|P3|NOT COMPLETED|Overall Study||0
1022120|NCT00634244|2480678|P2|NOT COMPLETED|Overall Study||13
1022121|NCT00634244|2480679|P1|NOT COMPLETED|Overall Study||1
1022122|NCT00634244|2480677|P3|COMPLETED|Overall Study||20
1022123|NCT00634244|2480678|P2|COMPLETED|Overall Study||24
1022124|NCT00634244|2480679|P1|COMPLETED|Overall Study||34
1022125|NCT00634244|2480677|P3|Eligible and Treated|Overall Study||20
1022126|NCT00634244|2480678|P2|Eligible and Treated|Overall Study||36
1022127|NCT00634244|2480679|P1|Eligible and Treated|Overall Study||35
1022128|NCT00634244|2480677|P3|STARTED|Overall Study||20
1022129|NCT00634244|2480678|P2|STARTED|Overall Study||37
1022130|NCT00634244|2480679|P1|STARTED|Overall Study||35
1022131|NCT00634270|2480692|P2|NOT COMPLETED|Overall Study||1
1022132|NCT00634270|2480693|P1|NOT COMPLETED|Overall Study||3
1022133|NCT00634270|2480692|P2|COMPLETED|Overall Study||12
1022134|NCT00634270|2480693|P1|COMPLETED|Overall Study||46
1022135|NCT00634270|2480692|P2|STARTED|Overall Study||13
1022136|NCT00634270|2480693|P1|STARTED|Overall Study|February 12, 2008|49
1022137|NCT00634322|2480720|P3|NOT COMPLETED|Overall Study||0
1022138|NCT00634322|2480721|P2|NOT COMPLETED|Overall Study||0
1022139|NCT00634322|2480722|P1|NOT COMPLETED|Overall Study||0
1022140|NCT00634322|2480720|P3|COMPLETED|Overall Study||5
1022141|NCT00634322|2480721|P2|COMPLETED|Overall Study||1
1022142|NCT00634322|2480722|P1|COMPLETED|Overall Study||1
1022143|NCT00634322|2480720|P3|STARTED|Overall Study||5
1022144|NCT00634322|2480721|P2|STARTED|Overall Study||1
1022145|NCT00634322|2480722|P1|STARTED|Overall Study||1
1022146|NCT00634504|2480732|P2|NOT COMPLETED|Overall Study||0
1022147|NCT00634504|2480733|P1|NOT COMPLETED|Overall Study||1
1022148|NCT00634504|2480732|P2|COMPLETED|Overall Study||9
1022149|NCT00634504|2480733|P1|COMPLETED|Overall Study||10
1022150|NCT00634504|2480732|P2|STARTED|Overall Study||9
1022151|NCT00634504|2480733|P1|STARTED|Overall Study||11
1022152|NCT00634543|2480741|P2|NOT COMPLETED|Overall Study||21
1022153|NCT00634543|2480742|P1|NOT COMPLETED|Overall Study||19
1022154|NCT00634543|2480741|P2|COMPLETED|Overall Study||63
1022155|NCT00634543|2480742|P1|COMPLETED|Overall Study||59
1022156|NCT00634543|2480741|P2|Treated|Overall Study||80
1022157|NCT00634543|2480742|P1|Treated|Overall Study||76
1022158|NCT00634543|2480741|P2|STARTED|Overall Study||84
1022159|NCT00634543|2480742|P1|STARTED|Overall Study||78
1022160|NCT00634569|2480760|P2|NOT COMPLETED|Overall Study||5
1022161|NCT00634569|2480761|P1|NOT COMPLETED|Overall Study||0
1022162|NCT00634569|2480760|P2|COMPLETED|Overall Study||5
1022163|NCT00634569|2480761|P1|COMPLETED|Overall Study||14
1022164|NCT00634569|2480760|P2|STARTED|Overall Study||10
1022165|NCT00634569|2480761|P1|STARTED|Overall Study||14
1022166|NCT00634582|2480773|P1|NOT COMPLETED|Overall Study||0
1022167|NCT00634582|2480773|P1|COMPLETED|Overall Study||2
1022168|NCT00634582|2480773|P1|STARTED|Overall Study||2
1022169|NCT00634621|2480777|P1|NOT COMPLETED|Overall Study||0
1022170|NCT00634621|2480777|P1|COMPLETED|Overall Study||283
1022171|NCT00634621|2480777|P1|STARTED|Overall Study||283
1022172|NCT00634647|2480785|P1|NOT COMPLETED|Overall Study||9
1022173|NCT00634647|2480785|P1|COMPLETED|Overall Study||15
1022174|NCT00634647|2480785|P1|STARTED|Overall Study||24
1022175|NCT00634751|2480794|P4|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
1022176|NCT00634751|2480795|P3|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
1022177|NCT00634751|2480796|P2|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
1022178|NCT00634751|2480797|P1|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
1022179|NCT00634751|2480794|P4|COMPLETED|Pancreatic and Bilial Tract Cancer||7
1022180|NCT00634751|2480795|P3|COMPLETED|Pancreatic and Bilial Tract Cancer||23
1022181|NCT00634751|2480796|P2|COMPLETED|Pancreatic and Bilial Tract Cancer||0
1022182|NCT00634751|2480797|P1|COMPLETED|Pancreatic and Bilial Tract Cancer||0
1022183|NCT00634751|2480794|P4|STARTED|Pancreatic and Bilial Tract Cancer||8
1022184|NCT00634751|2480795|P3|STARTED|Pancreatic and Bilial Tract Cancer||24
1022185|NCT00634751|2480796|P2|STARTED|Pancreatic and Bilial Tract Cancer||0
1022186|NCT00634751|2480797|P1|STARTED|Pancreatic and Bilial Tract Cancer||0
1022187|NCT00634751|2480794|P4|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
1022188|NCT00634751|2480795|P3|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
1022189|NCT00634751|2480796|P2|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||1
1022190|NCT00634751|2480797|P1|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
1022191|NCT00634751|2480794|P4|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
1022192|NCT00634751|2480795|P3|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
1022193|NCT00634751|2480796|P2|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||6
1022194|NCT00634751|2480797|P1|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
1022195|NCT00634751|2480794|P4|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
1022196|NCT00634751|2480795|P3|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
1022197|NCT00634751|2480796|P2|STARTED|Phase I: 400mg Sorafenib BID+2DOC||7
1022198|NCT00634751|2480797|P1|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
1022199|NCT00634751|2480794|P4|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
1022200|NCT00634751|2480795|P3|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
1022201|NCT00634751|2480796|P2|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
1022202|NCT00634751|2480797|P1|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||1
1022203|NCT00634751|2480794|P4|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
1022204|NCT00634751|2480795|P3|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
1022205|NCT00634751|2480796|P2|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
1022206|NCT00634751|2480797|P1|COMPLETED|Phase I: 200mg Sorafenib+2DOC||8
1022207|NCT00634751|2480794|P4|STARTED|Phase I: 200mg Sorafenib+2DOC||0
1022208|NCT00634751|2480795|P3|STARTED|Phase I: 200mg Sorafenib+2DOC||0
1022209|NCT00634751|2480796|P2|STARTED|Phase I: 200mg Sorafenib+2DOC||0
1022210|NCT00634751|2480797|P1|STARTED|Phase I: 200mg Sorafenib+2DOC||9
1022211|NCT00625131|2480817|P3|NOT COMPLETED|Overall Study||5
1022212|NCT00625131|2480818|P2|NOT COMPLETED|Overall Study||2
1022213|NCT00625131|2480819|P1|NOT COMPLETED|Overall Study||4
1022214|NCT00625131|2480817|P3|COMPLETED|Overall Study||0
1022215|NCT00625131|2480818|P2|COMPLETED|Overall Study||42
1022216|NCT00625131|2480819|P1|COMPLETED|Overall Study||34
1022217|NCT00625131|2480817|P3|STARTED|Overall Study|These participants were not included in any analyses.|5
1022218|NCT00625131|2480818|P2|STARTED|Overall Study||44
1022219|NCT00625131|2480819|P1|STARTED|Overall Study||38
1022220|NCT00625183|2480829|P1|NOT COMPLETED|Overall Study||1
1022221|NCT00625183|2480829|P1|COMPLETED|Overall Study||4
1022222|NCT00625183|2480829|P1|STARTED|Overall Study||5
1022223|NCT00625365|2480836|P1|NOT COMPLETED|Overall Study||7
1022224|NCT00625365|2480836|P1|COMPLETED|Overall Study|Participants who were analyzed for safety|1053
1022225|NCT00625365|2480836|P1|STARTED|Overall Study||1060
1022226|NCT00625391|2480846|P4|NOT COMPLETED|Overall Study||1
1022227|NCT00625391|2480847|P3|NOT COMPLETED|Overall Study||5
1022228|NCT00625391|2480848|P2|NOT COMPLETED|Overall Study||8
1022229|NCT00625391|2480849|P1|NOT COMPLETED|Overall Study||7
1022230|NCT00625391|2480846|P4|COMPLETED|Overall Study||37
1022231|NCT00625391|2480847|P3|COMPLETED|Overall Study||37
1022232|NCT00625391|2480848|P2|COMPLETED|Overall Study||39
1022233|NCT00625391|2480849|P1|COMPLETED|Overall Study||37
1022234|NCT00625391|2480846|P4|STARTED|Overall Study||38
1022235|NCT00625391|2480847|P3|STARTED|Overall Study||42
1022236|NCT00625391|2480848|P2|STARTED|Overall Study||47
1022237|NCT00625391|2480849|P1|STARTED|Overall Study||44
1022244|NCT00625586|2480892|P1|NOT COMPLETED|Overall Study||1
1022245|NCT00625586|2480892|P1|COMPLETED|Overall Study||1
1022246|NCT00625586|2480892|P1|STARTED|Overall Study||2
1022247|NCT00625729|2480902|P1|NOT COMPLETED|Overall Study||0
1022248|NCT00625729|2480902|P1|COMPLETED|Overall Study||6
1022249|NCT00625729|2480902|P1|STARTED|Overall Study||6
1022250|NCT00625742|2480911|P1|NOT COMPLETED|Overall Study||12
1022251|NCT00625742|2480911|P1|COMPLETED|Overall Study||3
1022252|NCT00625742|2480911|P1|STARTED|Overall Study||15
1022253|NCT00625820|2480916|P1|NOT COMPLETED|Overall Study||1
1022254|NCT00625820|2480916|P1|COMPLETED|Overall Study||16
1022255|NCT00625820|2480916|P1|STARTED|Overall Study||17
1022256|NCT00625872|2480924|P2|NOT COMPLETED|Overall Study||6
1022257|NCT00625872|2480925|P1|NOT COMPLETED|Overall Study||4
1022258|NCT00625872|2480924|P2|COMPLETED|Overall Study||5
1022259|NCT00625872|2480925|P1|COMPLETED|Overall Study||8
1022260|NCT00625872|2480924|P2|Treated|Overall Study||10
1022261|NCT00625872|2480925|P1|Treated|Overall Study||12
1022262|NCT00625872|2480924|P2|STARTED|Overall Study||11
1022263|NCT00625872|2480925|P1|STARTED|Overall Study||12
1022264|NCT00625989|2481035|P2|NOT COMPLETED|Overall Study||0
1022265|NCT00625989|2481036|P1|NOT COMPLETED|Overall Study||0
1022266|NCT00625989|2481035|P2|COMPLETED|Overall Study||6
1022267|NCT00625989|2481036|P1|COMPLETED|Overall Study||6
1022268|NCT00625989|2481035|P2|STARTED|Overall Study||6
1022269|NCT00625989|2481036|P1|STARTED|Overall Study||6
1022270|NCT00626028|2481045|P2|NOT COMPLETED|Treatment 3 10 Minute Dose NO or O2||0
1022271|NCT00626028|2481046|P1|NOT COMPLETED|Treatment 3 10 Minute Dose NO or O2||0
1022272|NCT00626028|2481045|P2|COMPLETED|Treatment 3 10 Minute Dose NO or O2||59
1022273|NCT00626028|2481046|P1|COMPLETED|Treatment 3 10 Minute Dose NO or O2||62
1022274|NCT00626028|2481045|P2|STARTED|Treatment 3 10 Minute Dose NO or O2||59
1022275|NCT00626028|2481046|P1|STARTED|Treatment 3 10 Minute Dose NO or O2||62
1022276|NCT00626028|2481045|P2|NOT COMPLETED|Washout Period of 10 Minutes||0
1022277|NCT00626028|2481046|P1|NOT COMPLETED|Washout Period of 10 Minutes||0
1022278|NCT00626028|2481045|P2|COMPLETED|Washout Period of 10 Minutes||59
1022279|NCT00626028|2481046|P1|COMPLETED|Washout Period of 10 Minutes||62
1022280|NCT00626028|2481045|P2|STARTED|Washout Period of 10 Minutes||59
1022281|NCT00626028|2481046|P1|STARTED|Washout Period of 10 Minutes||62
1022282|NCT00626028|2481045|P2|NOT COMPLETED|Treatment 2 10 Minute Dose NO Plus O2||0
1022283|NCT00626028|2481046|P1|NOT COMPLETED|Treatment 2 10 Minute Dose NO Plus O2||0
1022284|NCT00626028|2481045|P2|COMPLETED|Treatment 2 10 Minute Dose NO Plus O2||59
1022285|NCT00626028|2481046|P1|COMPLETED|Treatment 2 10 Minute Dose NO Plus O2||62
1022286|NCT00626028|2481045|P2|STARTED|Treatment 2 10 Minute Dose NO Plus O2||59
1022287|NCT00626028|2481046|P1|STARTED|Treatment 2 10 Minute Dose NO Plus O2||62
1022288|NCT00626028|2481045|P2|NOT COMPLETED|Treatment 1 NO First, O2 Last||9
1022289|NCT00626028|2481046|P1|NOT COMPLETED|Treatment 1 NO First, O2 Last||6
1022290|NCT00626028|2481045|P2|COMPLETED|Treatment 1 NO First, O2 Last||59
1022291|NCT00626028|2481046|P1|COMPLETED|Treatment 1 NO First, O2 Last||62
1022292|NCT00626028|2481045|P2|STARTED|Treatment 1 NO First, O2 Last||68
1022293|NCT00626028|2481046|P1|STARTED|Treatment 1 NO First, O2 Last||68
1022294|NCT00626093|2481056|P1|NOT COMPLETED|Overall Study||23
1022295|NCT00626093|2481056|P1|COMPLETED|Overall Study||54
1022296|NCT00626093|2481056|P1|STARTED|Overall Study||77
1022297|NCT00626210|2481061|P1|NOT COMPLETED|Overall Study||0
1022298|NCT00626210|2481061|P1|COMPLETED|Overall Study||2
1022299|NCT00626210|2481061|P1|STARTED|Overall Study||2
1022300|NCT00626275|2481065|P8|NOT COMPLETED|Part B||1
1022301|NCT00626275|2481066|P7|NOT COMPLETED|Part B||1
1022302|NCT00626275|2481067|P6|NOT COMPLETED|Part B||0
1022303|NCT00626275|2481068|P5|NOT COMPLETED|Part B||0
1022304|NCT00626275|2481069|P4|NOT COMPLETED|Part B||0
1022305|NCT00626275|2481070|P3|NOT COMPLETED|Part B||0
1022306|NCT00626275|2481071|P2|NOT COMPLETED|Part B||0
1022307|NCT00626275|2481072|P1|NOT COMPLETED|Part B||0
1022308|NCT00626275|2481065|P8|COMPLETED|Part B||23
1022309|NCT00626275|2481066|P7|COMPLETED|Part B||19
1022310|NCT00626275|2481067|P6|COMPLETED|Part B||0
1022311|NCT00626275|2481068|P5|COMPLETED|Part B||0
1022312|NCT00626275|2481069|P4|COMPLETED|Part B||0
1022313|NCT00626275|2481070|P3|COMPLETED|Part B||0
1022314|NCT00626275|2481071|P2|COMPLETED|Part B||0
1022315|NCT00626275|2481072|P1|COMPLETED|Part B||0
1022316|NCT00626275|2481065|P8|STARTED|Part B||24
1022317|NCT00626275|2481066|P7|STARTED|Part B||20
1022318|NCT00626275|2481067|P6|STARTED|Part B||0
1022319|NCT00626275|2481068|P5|STARTED|Part B||0
1022320|NCT00626275|2481069|P4|STARTED|Part B||0
1022321|NCT00626275|2481070|P3|STARTED|Part B||0
1022322|NCT00626275|2481071|P2|STARTED|Part B||0
1022323|NCT00626275|2481072|P1|STARTED|Part B||0
1022324|NCT00626275|2481065|P8|NOT COMPLETED|Re-randomization Period for Part B||0
1022325|NCT00626275|2481066|P7|NOT COMPLETED|Re-randomization Period for Part B||0
1022326|NCT00626275|2481067|P6|NOT COMPLETED|Re-randomization Period for Part B||0
1022327|NCT00626275|2481068|P5|NOT COMPLETED|Re-randomization Period for Part B||0
1022328|NCT00626275|2481069|P4|NOT COMPLETED|Re-randomization Period for Part B||0
1022329|NCT00626275|2481070|P3|NOT COMPLETED|Re-randomization Period for Part B||0
1022330|NCT00626275|2481071|P2|NOT COMPLETED|Re-randomization Period for Part B||0
1022331|NCT00626275|2481072|P1|NOT COMPLETED|Re-randomization Period for Part B||0
1022332|NCT00626275|2481065|P8|COMPLETED|Re-randomization Period for Part B||24
1022333|NCT00626275|2481066|P7|COMPLETED|Re-randomization Period for Part B||20
1022334|NCT00626275|2481067|P6|COMPLETED|Re-randomization Period for Part B||0
1022335|NCT00626275|2481068|P5|COMPLETED|Re-randomization Period for Part B||0
1022336|NCT00626275|2481069|P4|COMPLETED|Re-randomization Period for Part B||0
1022337|NCT00626275|2481070|P3|COMPLETED|Re-randomization Period for Part B||0
1022338|NCT00626275|2481071|P2|COMPLETED|Re-randomization Period for Part B||0
1022339|NCT00626275|2481072|P1|COMPLETED|Re-randomization Period for Part B||0
1022340|NCT00626275|2481065|P8|STARTED|Re-randomization Period for Part B||24
1022341|NCT00626275|2481066|P7|STARTED|Re-randomization Period for Part B||20
1022342|NCT00626275|2481067|P6|STARTED|Re-randomization Period for Part B||0
1022343|NCT00626275|2481068|P5|STARTED|Re-randomization Period for Part B||0
1022344|NCT00626275|2481069|P4|STARTED|Re-randomization Period for Part B||0
1022345|NCT00626275|2481070|P3|STARTED|Re-randomization Period for Part B||0
1022346|NCT00626275|2481071|P2|STARTED|Re-randomization Period for Part B||0
1022347|NCT00626275|2481072|P1|STARTED|Re-randomization Period for Part B||0
1022348|NCT00626275|2481065|P8|NOT COMPLETED|Part A - Treatment Period 3||0
1022349|NCT00626275|2481066|P7|NOT COMPLETED|Part A - Treatment Period 3||0
1022350|NCT00626275|2481067|P6|NOT COMPLETED|Part A - Treatment Period 3||0
1022351|NCT00626275|2481068|P5|NOT COMPLETED|Part A - Treatment Period 3||0
1022352|NCT00626275|2481069|P4|NOT COMPLETED|Part A - Treatment Period 3||0
1022353|NCT00626275|2481070|P3|NOT COMPLETED|Part A - Treatment Period 3||0
1022354|NCT00626275|2481071|P2|NOT COMPLETED|Part A - Treatment Period 3||0
1022355|NCT00626275|2481072|P1|NOT COMPLETED|Part A - Treatment Period 3||0
1022356|NCT00626275|2481065|P8|COMPLETED|Part A - Treatment Period 3||0
1022357|NCT00626275|2481066|P7|COMPLETED|Part A - Treatment Period 3||0
1022358|NCT00626275|2481067|P6|COMPLETED|Part A - Treatment Period 3||8
1022359|NCT00626275|2481068|P5|COMPLETED|Part A - Treatment Period 3||9
1022360|NCT00626275|2481069|P4|COMPLETED|Part A - Treatment Period 3||8
1022361|NCT00626275|2481070|P3|COMPLETED|Part A - Treatment Period 3||6
1022362|NCT00626275|2481071|P2|COMPLETED|Part A - Treatment Period 3||7
1022363|NCT00626275|2481072|P1|COMPLETED|Part A - Treatment Period 3||6
1022364|NCT00626275|2481065|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
1022365|NCT00626275|2481066|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
1022366|NCT00626275|2481067|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
1022367|NCT00626275|2481068|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||9
1022368|NCT00626275|2481069|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
1022369|NCT00626275|2481070|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
1022370|NCT00626275|2481071|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||7
1022371|NCT00626275|2481072|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
1022372|NCT00626275|2481065|P8|STARTED|Part A - Treatment Period 3||0
1022373|NCT00626275|2481066|P7|STARTED|Part A - Treatment Period 3||0
1022374|NCT00626275|2481067|P6|STARTED|Part A - Treatment Period 3||8
1022375|NCT00626275|2481068|P5|STARTED|Part A - Treatment Period 3||9
1022376|NCT00626275|2481069|P4|STARTED|Part A - Treatment Period 3||8
1022377|NCT00626275|2481070|P3|STARTED|Part A - Treatment Period 3||6
1022378|NCT00626275|2481071|P2|STARTED|Part A - Treatment Period 3||7
1022379|NCT00626275|2481072|P1|STARTED|Part A - Treatment Period 3||6
1022380|NCT00626275|2481065|P8|NOT COMPLETED|Part A - Washout Period 2||0
1022381|NCT00626275|2481066|P7|NOT COMPLETED|Part A - Washout Period 2||0
1022382|NCT00626275|2481067|P6|NOT COMPLETED|Part A - Washout Period 2||0
1022383|NCT00626275|2481068|P5|NOT COMPLETED|Part A - Washout Period 2||0
1022384|NCT00626275|2481069|P4|NOT COMPLETED|Part A - Washout Period 2||0
1022385|NCT00626275|2481070|P3|NOT COMPLETED|Part A - Washout Period 2||0
1022386|NCT00626275|2481071|P2|NOT COMPLETED|Part A - Washout Period 2||0
1022387|NCT00626275|2481072|P1|NOT COMPLETED|Part A - Washout Period 2||0
1022388|NCT00626275|2481065|P8|COMPLETED|Part A - Washout Period 2||0
1022389|NCT00626275|2481066|P7|COMPLETED|Part A - Washout Period 2||0
1022390|NCT00626275|2481067|P6|COMPLETED|Part A - Washout Period 2||8
1022391|NCT00626275|2481068|P5|COMPLETED|Part A - Washout Period 2||9
1022392|NCT00626275|2481069|P4|COMPLETED|Part A - Washout Period 2||8
1022393|NCT00626275|2481070|P3|COMPLETED|Part A - Washout Period 2||6
1022394|NCT00626275|2481071|P2|COMPLETED|Part A - Washout Period 2||7
1022395|NCT00626275|2481072|P1|COMPLETED|Part A - Washout Period 2||6
1022396|NCT00626275|2481065|P8|STARTED|Part A - Washout Period 2||0
1022397|NCT00626275|2481066|P7|STARTED|Part A - Washout Period 2||0
1022398|NCT00626275|2481067|P6|STARTED|Part A - Washout Period 2||8
1022399|NCT00626275|2481068|P5|STARTED|Part A - Washout Period 2||9
1022400|NCT00626275|2481069|P4|STARTED|Part A - Washout Period 2||8
1022401|NCT00626275|2481070|P3|STARTED|Part A - Washout Period 2||6
1022402|NCT00626275|2481071|P2|STARTED|Part A - Washout Period 2||7
1022403|NCT00626275|2481072|P1|STARTED|Part A - Washout Period 2||6
1022404|NCT00626275|2481065|P8|NOT COMPLETED|Part A - Treatment Period 2||0
1022405|NCT00626275|2481066|P7|NOT COMPLETED|Part A - Treatment Period 2||0
1022406|NCT00626275|2481067|P6|NOT COMPLETED|Part A - Treatment Period 2||0
1022407|NCT00626275|2481068|P5|NOT COMPLETED|Part A - Treatment Period 2||0
1022408|NCT00626275|2481069|P4|NOT COMPLETED|Part A - Treatment Period 2||0
1022409|NCT00626275|2481070|P3|NOT COMPLETED|Part A - Treatment Period 2||0
1022410|NCT00626275|2481071|P2|NOT COMPLETED|Part A - Treatment Period 2||0
1022411|NCT00626275|2481072|P1|NOT COMPLETED|Part A - Treatment Period 2||0
1022412|NCT00626275|2481065|P8|COMPLETED|Part A - Treatment Period 2||0
1022413|NCT00626275|2481066|P7|COMPLETED|Part A - Treatment Period 2||0
1022414|NCT00626275|2481067|P6|COMPLETED|Part A - Treatment Period 2||8
1022415|NCT00626275|2481068|P5|COMPLETED|Part A - Treatment Period 2||9
1022416|NCT00626275|2481069|P4|COMPLETED|Part A - Treatment Period 2||8
1022417|NCT00626275|2481070|P3|COMPLETED|Part A - Treatment Period 2||6
1022418|NCT00626275|2481071|P2|COMPLETED|Part A - Treatment Period 2||7
1022419|NCT00626275|2481072|P1|COMPLETED|Part A - Treatment Period 2||6
1022420|NCT00626275|2481065|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
1022421|NCT00626275|2481066|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
1022422|NCT00626275|2481067|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
1022423|NCT00626275|2481068|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||9
1022424|NCT00626275|2481069|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
1022425|NCT00626275|2481070|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
1022426|NCT00626275|2481071|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||7
1022427|NCT00626275|2481072|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
1022428|NCT00626275|2481065|P8|STARTED|Part A - Treatment Period 2||0
1022429|NCT00626275|2481066|P7|STARTED|Part A - Treatment Period 2||0
1022430|NCT00626275|2481067|P6|STARTED|Part A - Treatment Period 2||8
1022431|NCT00626275|2481068|P5|STARTED|Part A - Treatment Period 2||9
1022432|NCT00626275|2481069|P4|STARTED|Part A - Treatment Period 2||8
1022433|NCT00626275|2481070|P3|STARTED|Part A - Treatment Period 2||6
1022434|NCT00626275|2481071|P2|STARTED|Part A - Treatment Period 2||7
1022435|NCT00626275|2481072|P1|STARTED|Part A - Treatment Period 2||6
1022436|NCT00626275|2481065|P8|NOT COMPLETED|Part A - Washout Period 1||0
1022437|NCT00626275|2481066|P7|NOT COMPLETED|Part A - Washout Period 1||0
1022438|NCT00626275|2481067|P6|NOT COMPLETED|Part A - Washout Period 1||0
1022439|NCT00626275|2481068|P5|NOT COMPLETED|Part A - Washout Period 1||0
1022440|NCT00626275|2481069|P4|NOT COMPLETED|Part A - Washout Period 1||0
1022441|NCT00626275|2481070|P3|NOT COMPLETED|Part A - Washout Period 1||0
1022442|NCT00626275|2481071|P2|NOT COMPLETED|Part A - Washout Period 1||0
1022443|NCT00626275|2481072|P1|NOT COMPLETED|Part A - Washout Period 1||0
1022444|NCT00626275|2481065|P8|COMPLETED|Part A - Washout Period 1||0
1022445|NCT00626275|2481066|P7|COMPLETED|Part A - Washout Period 1||0
1022446|NCT00626275|2481067|P6|COMPLETED|Part A - Washout Period 1||8
1022447|NCT00626275|2481068|P5|COMPLETED|Part A - Washout Period 1||9
1022448|NCT00626275|2481069|P4|COMPLETED|Part A - Washout Period 1||8
1022449|NCT00626275|2481070|P3|COMPLETED|Part A - Washout Period 1||6
1022450|NCT00626275|2481071|P2|COMPLETED|Part A - Washout Period 1||7
1022451|NCT00626275|2481072|P1|COMPLETED|Part A - Washout Period 1||6
1022452|NCT00626275|2481065|P8|STARTED|Part A - Washout Period 1||0
1022453|NCT00626275|2481066|P7|STARTED|Part A - Washout Period 1||0
1022454|NCT00626275|2481067|P6|STARTED|Part A - Washout Period 1||8
1022455|NCT00626275|2481068|P5|STARTED|Part A - Washout Period 1||9
1022456|NCT00626275|2481069|P4|STARTED|Part A - Washout Period 1||8
1022457|NCT00626275|2481070|P3|STARTED|Part A - Washout Period 1||6
1022458|NCT00626275|2481071|P2|STARTED|Part A - Washout Period 1||7
1022459|NCT00626275|2481072|P1|STARTED|Part A - Washout Period 1||6
1022460|NCT00626275|2481065|P8|NOT COMPLETED|Part A - Treatment Period 1||0
1022461|NCT00626275|2481066|P7|NOT COMPLETED|Part A - Treatment Period 1||0
1022462|NCT00626275|2481067|P6|NOT COMPLETED|Part A - Treatment Period 1||0
1022463|NCT00626275|2481068|P5|NOT COMPLETED|Part A - Treatment Period 1||0
1022464|NCT00626275|2481069|P4|NOT COMPLETED|Part A - Treatment Period 1||0
1022465|NCT00626275|2481070|P3|NOT COMPLETED|Part A - Treatment Period 1||1
1022466|NCT00626275|2481071|P2|NOT COMPLETED|Part A - Treatment Period 1||0
1022467|NCT00626275|2481072|P1|NOT COMPLETED|Part A - Treatment Period 1||1
1022468|NCT00626275|2481065|P8|COMPLETED|Part A - Treatment Period 1||0
1022469|NCT00626275|2481066|P7|COMPLETED|Part A - Treatment Period 1||0
1022470|NCT00626275|2481067|P6|COMPLETED|Part A - Treatment Period 1||8
1022471|NCT00626275|2481068|P5|COMPLETED|Part A - Treatment Period 1||9
1022472|NCT00626275|2481069|P4|COMPLETED|Part A - Treatment Period 1||8
1022473|NCT00626275|2481070|P3|COMPLETED|Part A - Treatment Period 1||6
1022474|NCT00626275|2481071|P2|COMPLETED|Part A - Treatment Period 1||7
1022475|NCT00626275|2481072|P1|COMPLETED|Part A - Treatment Period 1||6
1022476|NCT00626275|2481065|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
1022477|NCT00626275|2481066|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
1022478|NCT00626275|2481067|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
1022479|NCT00626275|2481068|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||9
1022480|NCT00626275|2481069|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
1022481|NCT00626275|2481070|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
1022482|NCT00626275|2481071|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
1022483|NCT00626275|2481072|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
1022484|NCT00626275|2481065|P8|STARTED|Part A - Treatment Period 1||0
1022485|NCT00626275|2481066|P7|STARTED|Part A - Treatment Period 1||0
1022486|NCT00626275|2481067|P6|STARTED|Part A - Treatment Period 1||8
1022487|NCT00626275|2481068|P5|STARTED|Part A - Treatment Period 1||9
1022488|NCT00626275|2481069|P4|STARTED|Part A - Treatment Period 1||8
1022489|NCT00626275|2481070|P3|STARTED|Part A - Treatment Period 1||7
1022490|NCT00626275|2481071|P2|STARTED|Part A - Treatment Period 1||7
1022491|NCT00626275|2481072|P1|STARTED|Part A - Treatment Period 1||7
1022492|NCT00626327|2481115|P3|NOT COMPLETED|Overall Study||88
1022493|NCT00626327|2481116|P2|NOT COMPLETED|Overall Study||59
1022494|NCT00626327|2481117|P1|NOT COMPLETED|Overall Study||78
1022495|NCT00626327|2481115|P3|COMPLETED|Overall Study||422
1022496|NCT00626327|2481116|P2|COMPLETED|Overall Study||557
1022497|NCT00626327|2481117|P1|COMPLETED|Overall Study||426
1022498|NCT00626327|2481115|P3|STARTED|Overall Study||510
1022499|NCT00626327|2481116|P2|STARTED|Overall Study||616
1022500|NCT00626327|2481117|P1|STARTED|Overall Study||504
1022501|NCT00626340|2481143|P1|NOT COMPLETED|Overall Study||0
1022502|NCT00626340|2481143|P1|COMPLETED|Overall Study||18
1022503|NCT00626340|2481143|P1|STARTED|Overall Study||18
1022504|NCT00626392|2481153|P6|NOT COMPLETED|Coadministration Period||6
1022505|NCT00626392|2481154|P5|NOT COMPLETED|Coadministration Period||5
1022506|NCT00626392|2481155|P4|NOT COMPLETED|Coadministration Period||7
1022507|NCT00626392|2481156|P3|NOT COMPLETED|Coadministration Period||10
1022508|NCT00626392|2481157|P2|NOT COMPLETED|Coadministration Period||5
1022509|NCT00626392|2481158|P1|NOT COMPLETED|Coadministration Period||4
1022510|NCT00626392|2481153|P6|COMPLETED|Coadministration Period||38
1022511|NCT00626392|2481154|P5|COMPLETED|Coadministration Period||36
1022512|NCT00626392|2481155|P4|COMPLETED|Coadministration Period||36
1022513|NCT00626392|2481156|P3|COMPLETED|Coadministration Period||31
1022514|NCT00626392|2481157|P2|COMPLETED|Coadministration Period||38
1022515|NCT00626392|2481158|P1|COMPLETED|Coadministration Period||40
1022516|NCT00626392|2481153|P6|STARTED|Coadministration Period||44
1022517|NCT00626392|2481154|P5|STARTED|Coadministration Period||41
1022518|NCT00626392|2481155|P4|STARTED|Coadministration Period||43
1022519|NCT00626392|2481156|P3|STARTED|Coadministration Period||41
1022520|NCT00626392|2481157|P2|STARTED|Coadministration Period||43
1022521|NCT00626392|2481158|P1|STARTED|Coadministration Period||44
1022522|NCT00626392|2481153|P6|NOT COMPLETED|Run-in Period||1
1022523|NCT00626392|2481154|P5|NOT COMPLETED|Run-in Period||4
1022524|NCT00626392|2481155|P4|NOT COMPLETED|Run-in Period||1
1022525|NCT00626392|2481156|P3|NOT COMPLETED|Run-in Period||3
1022526|NCT00626392|2481157|P2|NOT COMPLETED|Run-in Period||1
1022527|NCT00626392|2481158|P1|NOT COMPLETED|Run-in Period||1
1022528|NCT00626392|2481153|P6|COMPLETED|Run-in Period||44
1022529|NCT00626392|2481154|P5|COMPLETED|Run-in Period||41
1022530|NCT00626392|2481155|P4|COMPLETED|Run-in Period||43
1022531|NCT00626392|2481156|P3|COMPLETED|Run-in Period||41
1022532|NCT00626392|2481157|P2|COMPLETED|Run-in Period||43
1022533|NCT00626392|2481158|P1|COMPLETED|Run-in Period||44
1022534|NCT00626392|2481153|P6|STARTED|Run-in Period||45
1022535|NCT00626392|2481154|P5|STARTED|Run-in Period||45
1022536|NCT00626392|2481155|P4|STARTED|Run-in Period||44
1022537|NCT00626392|2481156|P3|STARTED|Run-in Period||44
1022538|NCT00626392|2481157|P2|STARTED|Run-in Period||44
1022539|NCT00626392|2481158|P1|STARTED|Run-in Period||45
1022540|NCT00626431|2481172|P2|NOT COMPLETED|Overall Study||45
1022541|NCT00626431|2481173|P1|NOT COMPLETED|Overall Study||17
1022542|NCT00626431|2481172|P2|COMPLETED|Overall Study||114
1022543|NCT00626431|2481173|P1|COMPLETED|Overall Study||134
1022544|NCT00626431|2481172|P2|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|159
1022545|NCT00626431|2481173|P1|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|151
1022546|NCT00626444|2481188|P1|NOT COMPLETED|Overall Study||0
1022547|NCT00626444|2481188|P1|COMPLETED|Overall Study||2
1022548|NCT00626444|2481188|P1|STARTED|Overall Study||2
1022549|NCT00626522|2481199|P6|NOT COMPLETED|Overall Study||2
1022550|NCT00626522|2481200|P5|NOT COMPLETED|Overall Study||7
1022551|NCT00626522|2481201|P4|NOT COMPLETED|Overall Study||2
1022552|NCT00626522|2481202|P3|NOT COMPLETED|Overall Study||8
1022553|NCT00626522|2481203|P2|NOT COMPLETED|Overall Study||7
1022554|NCT00626522|2481204|P1|NOT COMPLETED|Overall Study||6
1022555|NCT00626522|2481199|P6|COMPLETED|Overall Study||57
1022556|NCT00626522|2481200|P5|COMPLETED|Overall Study||58
1022557|NCT00626522|2481201|P4|COMPLETED|Overall Study||74
1022558|NCT00626522|2481202|P3|COMPLETED|Overall Study||117
1022559|NCT00626522|2481203|P2|COMPLETED|Overall Study||113
1022560|NCT00626522|2481204|P1|COMPLETED|Overall Study||115
1022561|NCT00626522|2481199|P6|STARTED|Overall Study||59
1022562|NCT00626522|2481200|P5|STARTED|Overall Study||65
1022563|NCT00626522|2481201|P4|STARTED|Overall Study||76
1022564|NCT00626522|2481202|P3|STARTED|Overall Study||125
1022565|NCT00626522|2481203|P2|STARTED|Overall Study||120
1022566|NCT00626522|2481204|P1|STARTED|Overall Study||121
1022567|NCT00626548|2481244|P2|NOT COMPLETED|Overall Study||716
1022568|NCT00626548|2481245|P1|NOT COMPLETED|Overall Study||705
1022569|NCT00626548|2481244|P2|COMPLETED|Overall Study||0
1022570|NCT00626548|2481245|P1|COMPLETED|Overall Study||0
1022571|NCT00626548|2481244|P2|Patients Received Treatment|Overall Study||712
1022572|NCT00626548|2481245|P1|Patients Received Treatment|Overall Study||703
1022573|NCT00626548|2481244|P2|STARTED|Overall Study||716
1022574|NCT00626548|2481245|P1|STARTED|Overall Study||705
1022575|NCT00626561|2481253|P1|NOT COMPLETED|Overall Study||4
1022576|NCT00626561|2481253|P1|COMPLETED|Overall Study||0
1022577|NCT00626561|2481253|P1|STARTED|Overall Study||4
1022578|NCT00626574|2481259|P2|NOT COMPLETED|Overall Study||0
1022579|NCT00626574|2481260|P1|NOT COMPLETED|Overall Study||0
1022580|NCT00626574|2481259|P2|COMPLETED|Overall Study||1
1022581|NCT00626574|2481260|P1|COMPLETED|Overall Study||2
1022582|NCT00626574|2481259|P2|STARTED|Overall Study||1
1022583|NCT00626574|2481260|P1|STARTED|Overall Study||2
1022584|NCT00626639|2481268|P2|NOT COMPLETED|Overall Study||2
1022585|NCT00626639|2481269|P1|NOT COMPLETED|Overall Study||2
1022586|NCT00626639|2481268|P2|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|1
1022587|NCT00626639|2481269|P1|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|0
1022588|NCT00626639|2481268|P2|STARTED|Overall Study||3
1022589|NCT00626639|2481269|P1|STARTED|Overall Study||2
1022590|NCT00626743|2481289|P2|NOT COMPLETED|Treatment Period 2||0
1022591|NCT00626743|2481290|P1|NOT COMPLETED|Treatment Period 2||0
1022592|NCT00626743|2481289|P2|COMPLETED|Treatment Period 2||6
1022593|NCT00626743|2481290|P1|COMPLETED|Treatment Period 2||6
1022594|NCT00626743|2481289|P2|STARTED|Treatment Period 2||6
1022595|NCT00626743|2481290|P1|STARTED|Treatment Period 2||6
1022596|NCT00626743|2481289|P2|NOT COMPLETED|Wash-out Period of 6 Days||0
1022597|NCT00626743|2481290|P1|NOT COMPLETED|Wash-out Period of 6 Days||0
1022598|NCT00626743|2481289|P2|COMPLETED|Wash-out Period of 6 Days||6
1022599|NCT00626743|2481290|P1|COMPLETED|Wash-out Period of 6 Days||6
1022600|NCT00626743|2481289|P2|STARTED|Wash-out Period of 6 Days||6
1022601|NCT00626743|2481290|P1|STARTED|Wash-out Period of 6 Days||6
1022602|NCT00626743|2481289|P2|NOT COMPLETED|Treatment Period 1||1
1022603|NCT00626743|2481290|P1|NOT COMPLETED|Treatment Period 1||0
1022604|NCT00626743|2481289|P2|COMPLETED|Treatment Period 1||6
1022605|NCT00626743|2481290|P1|COMPLETED|Treatment Period 1||6
1022606|NCT00626743|2481289|P2|STARTED|Treatment Period 1||7
1022607|NCT00626743|2481290|P1|STARTED|Treatment Period 1||6
1022608|NCT00626782|2481300|P2|NOT COMPLETED|Overall Study||0
1022609|NCT00626782|2481301|P1|NOT COMPLETED|Overall Study||0
1022610|NCT00626782|2481300|P2|COMPLETED|Overall Study||12
1022611|NCT00626782|2481301|P1|COMPLETED|Overall Study||12
1022612|NCT00626782|2481300|P2|STARTED|Overall Study||12
1022613|NCT00626782|2481301|P1|STARTED|Overall Study||12
1022614|NCT00626808|2481311|P4|NOT COMPLETED|Overall Study||0
1022615|NCT00626808|2481312|P3|NOT COMPLETED|Overall Study||0
1022616|NCT00626808|2481313|P2|NOT COMPLETED|Overall Study||0
1022617|NCT00626808|2481314|P1|NOT COMPLETED|Overall Study||0
1022618|NCT00626808|2481311|P4|COMPLETED|Overall Study||2906
1022619|NCT00626808|2481312|P3|COMPLETED|Overall Study||30011
1022620|NCT00626808|2481313|P2|COMPLETED|Overall Study||34316
1022621|NCT00626808|2481314|P1|COMPLETED|Overall Study||254464
1022622|NCT00626808|2481311|P4|STARTED|Overall Study||2906
1022623|NCT00626808|2481312|P3|STARTED|Overall Study||30011
1022624|NCT00626808|2481313|P2|STARTED|Overall Study||34316
1022625|NCT00626808|2481314|P1|STARTED|Overall Study||254464
1022626|NCT00626821|2481380|P1|NOT COMPLETED|Overall Study||221
1022627|NCT00626821|2481380|P1|COMPLETED|Overall Study||2796
1022628|NCT00626821|2481380|P1|Quality of Life|Overall Study|Attended both visit 1 and visit 2|2672
1022629|NCT00626821|2481380|P1|STARTED|Overall Study||3017
1022630|NCT00626925|2481386|P2|NOT COMPLETED|Overall Study||9
1022631|NCT00626925|2481387|P1|NOT COMPLETED|Overall Study||12
1022632|NCT00626925|2481386|P2|COMPLETED|Overall Study||62
1022633|NCT00626925|2481387|P1|COMPLETED|Overall Study||55
1022634|NCT00626925|2481386|P2|STARTED|Overall Study||71
1022635|NCT00626925|2481387|P1|STARTED|Overall Study||67
1022636|NCT00627016|2481415|P2|NOT COMPLETED|Overall Study||6
1022637|NCT00627016|2481416|P1|NOT COMPLETED|Overall Study||6
1022638|NCT00627016|2481415|P2|COMPLETED|Overall Study||146
1022639|NCT00627016|2481416|P1|COMPLETED|Overall Study||147
1022640|NCT00627016|2481415|P2|STARTED|Overall Study||152
1022641|NCT00627016|2481416|P1|STARTED|Overall Study||153
1022642|NCT00627042|2481426|P1|NOT COMPLETED|Overall Study||2
1022643|NCT00627042|2481426|P1|COMPLETED|Overall Study||40
1022644|NCT00627042|2481426|P1|Received at Least 1 Dose of Study Drug|Overall Study||42
1022645|NCT00627042|2481426|P1|STARTED|Overall Study||42
1022646|NCT00627094|2481438|P2|NOT COMPLETED|Overall Study||15
1022647|NCT00627094|2481439|P1|NOT COMPLETED|Overall Study||12
1022648|NCT00627094|2481438|P2|COMPLETED|Overall Study||45
1022649|NCT00627094|2481439|P1|COMPLETED|Overall Study||48
1022650|NCT00627094|2481438|P2|STARTED|Overall Study||60
1022651|NCT00627094|2481439|P1|STARTED|Overall Study||60
1022652|NCT00634842|2481453|P2|NOT COMPLETED|Overall Study||18
1022653|NCT00634842|2481454|P1|NOT COMPLETED|Overall Study||15
1022654|NCT00634842|2481453|P2|COMPLETED|Overall Study||104
1022655|NCT00634842|2481454|P1|COMPLETED|Overall Study||107
1022656|NCT00634842|2481453|P2|STARTED|Overall Study||122
1022657|NCT00634842|2481454|P1|STARTED|Overall Study||122
1022658|NCT00634907|2481468|P2|NOT COMPLETED|Overall Study||17
1022659|NCT00634907|2481469|P1|NOT COMPLETED|Overall Study||17
1022660|NCT00634907|2481468|P2|COMPLETED|Overall Study||115
1022661|NCT00634907|2481469|P1|COMPLETED|Overall Study||114
1022662|NCT00634907|2481468|P2|STARTED|Overall Study||132
1022663|NCT00634907|2481469|P1|STARTED|Overall Study||131
1022664|NCT00634920|2481494|P3|NOT COMPLETED|Period 2 - Post-Randomization||0
1022665|NCT00634920|2481495|P2|NOT COMPLETED|Period 2 - Post-Randomization||32
1022666|NCT00634920|2481496|P1|NOT COMPLETED|Period 2 - Post-Randomization||61
1022667|NCT00634920|2481494|P3|COMPLETED|Period 2 - Post-Randomization||0
1022668|NCT00634920|2481495|P2|COMPLETED|Period 2 - Post-Randomization||68
1022669|NCT00634920|2481496|P1|COMPLETED|Period 2 - Post-Randomization||43
1022670|NCT00634920|2481494|P3|Full Analysis Set (FAS)|Period 2 - Post-Randomization||0
1022671|NCT00634920|2481495|P2|Full Analysis Set (FAS)|Period 2 - Post-Randomization||90
1022672|NCT00634920|2481496|P1|Full Analysis Set (FAS)|Period 2 - Post-Randomization||92
1022673|NCT00634920|2481494|P3|STARTED|Period 2 - Post-Randomization|This group included patients who had renal TX but did not qualify for randomization at Visit 2.|0
1022674|NCT00634920|2481495|P2|STARTED|Period 2 - Post-Randomization||100
1022675|NCT00634920|2481496|P1|STARTED|Period 2 - Post-Randomization|2 patients randomized in this group did not receive at least one dose of study drug.|104
1022676|NCT00634920|2481494|P3|NOT COMPLETED|Period 1 - Pre-Randomization||137
1022677|NCT00634920|2481495|P2|NOT COMPLETED|Period 1 - Pre-Randomization||0
1022678|NCT00634920|2481496|P1|NOT COMPLETED|Period 1 - Pre-Randomization||0
1022679|NCT00634920|2481494|P3|COMPLETED|Period 1 - Pre-Randomization|Total number of patients who became randomized|204
1022680|NCT00634920|2481495|P2|COMPLETED|Period 1 - Pre-Randomization||0
1022681|NCT00634920|2481496|P1|COMPLETED|Period 1 - Pre-Randomization||0
1022682|NCT00634920|2481494|P3|STARTED|Period 1 - Pre-Randomization|Total number of Enrolled patients|341
1022683|NCT00634920|2481495|P2|STARTED|Period 1 - Pre-Randomization||0
1022684|NCT00634920|2481496|P1|STARTED|Period 1 - Pre-Randomization||0
1022685|NCT00634933|2481541|P5|NOT COMPLETED|Part B: Week 24 to Week 52||10
1022686|NCT00634933|2481542|P4|NOT COMPLETED|Part B: Week 24 to Week 52||6
1022687|NCT00634933|2481543|P3|NOT COMPLETED|Part B: Week 24 to Week 52||22
1022688|NCT00634933|2481544|P2|NOT COMPLETED|Part B: Week 24 to Week 52||14
1022689|NCT00634933|2481545|P1|NOT COMPLETED|Part B: Week 24 to Week 52||0
1022690|NCT00634933|2481541|P5|COMPLETED|Part B: Week 24 to Week 52||22
1022691|NCT00634933|2481542|P4|COMPLETED|Part B: Week 24 to Week 52||25
1022692|NCT00634933|2481543|P3|COMPLETED|Part B: Week 24 to Week 52||33
1022693|NCT00634933|2481544|P2|COMPLETED|Part B: Week 24 to Week 52||42
1022694|NCT00634933|2481545|P1|COMPLETED|Part B: Week 24 to Week 52||0
1022695|NCT00634933|2481541|P5|STARTED|Part B: Week 24 to Week 52||32
1022696|NCT00634933|2481542|P4|STARTED|Part B: Week 24 to Week 52||31
1022697|NCT00634933|2481543|P3|STARTED|Part B: Week 24 to Week 52||55
1022698|NCT00634933|2481544|P2|STARTED|Part B: Week 24 to Week 52||56
1022699|NCT00634933|2481545|P1|STARTED|Part B: Week 24 to Week 52||0
1022700|NCT00634933|2481541|P5|NOT COMPLETED|Between Part A and Part B||0
1022701|NCT00634933|2481542|P4|NOT COMPLETED|Between Part A and Part B||0
1022702|NCT00634933|2481543|P3|NOT COMPLETED|Between Part A and Part B||0
1022703|NCT00634933|2481544|P2|NOT COMPLETED|Between Part A and Part B||1
1022704|NCT00634933|2481545|P1|NOT COMPLETED|Between Part A and Part B||0
1022705|NCT00634933|2481541|P5|COMPLETED|Between Part A and Part B||32
1022706|NCT00634933|2481542|P4|COMPLETED|Between Part A and Part B||31
1022707|NCT00634933|2481543|P3|COMPLETED|Between Part A and Part B||55
1022708|NCT00634933|2481544|P2|COMPLETED|Between Part A and Part B||56
1022709|NCT00634933|2481545|P1|COMPLETED|Between Part A and Part B||0
1022710|NCT00634933|2481541|P5|STARTED|Between Part A and Part B||32
1022711|NCT00634933|2481542|P4|STARTED|Between Part A and Part B||31
1022712|NCT00634933|2481543|P3|STARTED|Between Part A and Part B||55
1022713|NCT00634933|2481544|P2|STARTED|Between Part A and Part B||57
1022714|NCT00634933|2481545|P1|STARTED|Between Part A and Part B||0
1022715|NCT00634933|2481541|P5|NOT COMPLETED|Part A: Baseline to Week 24||0
1022716|NCT00634933|2481542|P4|NOT COMPLETED|Part A: Baseline to Week 24||0
1022717|NCT00634933|2481543|P3|NOT COMPLETED|Part A: Baseline to Week 24||18
1022718|NCT00634933|2481544|P2|NOT COMPLETED|Part A: Baseline to Week 24||18
1022719|NCT00634933|2481545|P1|NOT COMPLETED|Part A: Baseline to Week 24||11
1022720|NCT00634933|2481541|P5|COMPLETED|Part A: Baseline to Week 24||0
1022721|NCT00634933|2481542|P4|COMPLETED|Part A: Baseline to Week 24||0
1022722|NCT00634933|2481543|P3|COMPLETED|Part A: Baseline to Week 24||55
1022723|NCT00634933|2481544|P2|COMPLETED|Part A: Baseline to Week 24||57
1022724|NCT00634933|2481545|P1|COMPLETED|Part A: Baseline to Week 24||63
1022725|NCT00634933|2481541|P5|STARTED|Part A: Baseline to Week 24||0
1022726|NCT00634933|2481542|P4|STARTED|Part A: Baseline to Week 24||0
1022727|NCT00634933|2481543|P3|STARTED|Part A: Baseline to Week 24||73
1022728|NCT00634933|2481544|P2|STARTED|Part A: Baseline to Week 24||75
1022729|NCT00634933|2481545|P1|STARTED|Part A: Baseline to Week 24||74
1022730|NCT00635024|2481611|P1|NOT COMPLETED|Overall Study||1
1022731|NCT00635024|2481611|P1|COMPLETED|Overall Study||0
1022732|NCT00635024|2481611|P1|STARTED|Overall Study||1
1022733|NCT00635050|2481619|P1|NOT COMPLETED|Overall Study||1
1022734|NCT00635050|2481619|P1|COMPLETED|Overall Study|Followup through 10 years planned.|31
1022735|NCT00635050|2481619|P1|STARTED|Overall Study|No patient received regimen B due to grade 3 toxicity in the third patient treated on regimen A.|32
1022736|NCT00635089|2481626|P1|NOT COMPLETED|Overall Study||78
1022737|NCT00635089|2481626|P1|COMPLETED|Overall Study|Participants who had not withdrawn at the time of study termination.|112
1022738|NCT00635089|2481626|P1|Completed >/= 16 Weeks of Study|Overall Study||181
1022739|NCT00635089|2481626|P1|STARTED|Overall Study||190
1022740|NCT00635102|2481655|P2|NOT COMPLETED|Overall Study||8
1022741|NCT00635102|2481656|P1|NOT COMPLETED|Overall Study||7
1022742|NCT00635102|2481655|P2|COMPLETED|Overall Study||22
1022743|NCT00635102|2481656|P1|COMPLETED|Overall Study||20
1022744|NCT00635102|2481655|P2|STARTED|Overall Study||30
1022745|NCT00635102|2481656|P1|STARTED|Overall Study||27
1022746|NCT00635128|2481752|P2|NOT COMPLETED|Overall Study||0
1022747|NCT00635128|2481753|P1|NOT COMPLETED|Overall Study||0
1022748|NCT00635128|2481752|P2|COMPLETED|Overall Study||64
1022749|NCT00635128|2481753|P1|COMPLETED|Overall Study||351
1022750|NCT00635128|2481752|P2|STARTED|Overall Study||64
1022751|NCT00635128|2481753|P1|STARTED|Overall Study||351
1022752|NCT00635154|2481781|P1|NOT COMPLETED|Overall Study||33
1022753|NCT00635154|2481781|P1|COMPLETED|Overall Study||21
1022754|NCT00635154|2481781|P1|STARTED|Overall Study||54
1022755|NCT00635661|2481791|P1|NOT COMPLETED|Overall Study||4
1022756|NCT00635661|2481791|P1|COMPLETED|Overall Study||30
1022757|NCT00635661|2481791|P1|STARTED|Overall Study||34
1022758|NCT00635700|2481797|P2|NOT COMPLETED|Overall Study||14
1022759|NCT00635700|2481798|P1|NOT COMPLETED|Overall Study||15
1022760|NCT00635700|2481797|P2|COMPLETED|Overall Study||13
1022761|NCT00635700|2481798|P1|COMPLETED|Overall Study||9
1022762|NCT00635700|2481797|P2|STARTED|Overall Study||27
1022763|NCT00635700|2481798|P1|STARTED|Overall Study||24
1022764|NCT00635804|2481812|P8|NOT COMPLETED|Overall Study||0
1022765|NCT00635804|2481813|P7|NOT COMPLETED|Overall Study||0
1022766|NCT00635804|2481814|P6|NOT COMPLETED|Overall Study||1
1022767|NCT00635804|2481815|P5|NOT COMPLETED|Overall Study||0
1022768|NCT00635804|2481816|P4|NOT COMPLETED|Overall Study||0
1022769|NCT00635804|2481817|P3|NOT COMPLETED|Overall Study||0
1022770|NCT00635804|2481818|P2|NOT COMPLETED|Overall Study||0
1022771|NCT00635804|2481819|P1|NOT COMPLETED|Overall Study||1
1022772|NCT00635804|2481812|P8|COMPLETED|Overall Study||14
1022773|NCT00635804|2481813|P7|COMPLETED|Overall Study||3
1022774|NCT00635804|2481814|P6|COMPLETED|Overall Study||11
1022775|NCT00635804|2481815|P5|COMPLETED|Overall Study||6
1022776|NCT00635804|2481816|P4|COMPLETED|Overall Study||6
1022777|NCT00635804|2481817|P3|COMPLETED|Overall Study||6
1022778|NCT00635804|2481818|P2|COMPLETED|Overall Study||6
1022779|NCT00635804|2481819|P1|COMPLETED|Overall Study||6
1022780|NCT00635804|2481812|P8|STARTED|Overall Study||14
1022781|NCT00635804|2481813|P7|STARTED|Overall Study||3
1022782|NCT00635804|2481814|P6|STARTED|Overall Study||12
1022783|NCT00635804|2481815|P5|STARTED|Overall Study||6
1022784|NCT00635804|2481816|P4|STARTED|Overall Study||6
1022785|NCT00635804|2481817|P3|STARTED|Overall Study||6
1022786|NCT00635804|2481818|P2|STARTED|Overall Study||6
1022787|NCT00635804|2481819|P1|STARTED|Overall Study||7
1022788|NCT00635817|2481920|P4|NOT COMPLETED|Overall Study||0
1022789|NCT00635817|2481921|P3|NOT COMPLETED|Overall Study||2
1022790|NCT00635817|2481922|P2|NOT COMPLETED|Overall Study||2
1022791|NCT00635817|2481923|P1|NOT COMPLETED|Overall Study||6
1022792|NCT00635817|2481920|P4|COMPLETED|Overall Study||21
1022793|NCT00635817|2481921|P3|COMPLETED|Overall Study||19
1022794|NCT00635817|2481922|P2|COMPLETED|Overall Study||19
1022795|NCT00635817|2481923|P1|COMPLETED|Overall Study||15
1022796|NCT00635817|2481920|P4|STARTED|Overall Study||21
1022797|NCT00635817|2481921|P3|STARTED|Overall Study||21
1022798|NCT00635817|2481922|P2|STARTED|Overall Study||21
1022799|NCT00635817|2481923|P1|STARTED|Overall Study||21
1022800|NCT00635830|2481969|P2|NOT COMPLETED|Overall Study||0
1022801|NCT00635830|2481970|P1|NOT COMPLETED|Overall Study||0
1022802|NCT00635830|2481969|P2|COMPLETED|Overall Study||20
1022803|NCT00635830|2481970|P1|COMPLETED|Overall Study||20
1022804|NCT00635830|2481969|P2|STARTED|Overall Study||20
1022805|NCT00635830|2481970|P1|STARTED|Overall Study||20
1022806|NCT00635882|2481982|P6|NOT COMPLETED|Overall Study||0
1022807|NCT00635882|2481983|P5|NOT COMPLETED|Overall Study||0
1022808|NCT00635882|2481984|P4|NOT COMPLETED|Overall Study||0
1022809|NCT00635882|2481985|P3|NOT COMPLETED|Overall Study||0
1022810|NCT00635882|2481986|P2|NOT COMPLETED|Overall Study||0
1022811|NCT00635882|2481987|P1|NOT COMPLETED|Overall Study||1
1022812|NCT00635882|2481982|P6|COMPLETED|Overall Study||13
1022813|NCT00635882|2481983|P5|COMPLETED|Overall Study||16
1022814|NCT00635882|2481984|P4|COMPLETED|Overall Study||15
1022815|NCT00635882|2481985|P3|COMPLETED|Overall Study||12
1022816|NCT00635882|2481986|P2|COMPLETED|Overall Study||17
1022817|NCT00635882|2481987|P1|COMPLETED|Overall Study||19
1022818|NCT00635882|2481982|P6|STARTED|Overall Study||13
1022819|NCT00635882|2481983|P5|STARTED|Overall Study||16
1022820|NCT00635882|2481984|P4|STARTED|Overall Study||15
1022821|NCT00635882|2481985|P3|STARTED|Overall Study||12
1022822|NCT00635882|2481986|P2|STARTED|Overall Study||17
1022823|NCT00635882|2481987|P1|STARTED|Overall Study||20
1022824|NCT00636077|2482049|P4|NOT COMPLETED|Week 4||0
1022825|NCT00636077|2482050|P3|NOT COMPLETED|Week 4||0
1022826|NCT00636077|2482051|P2|NOT COMPLETED|Week 4||0
1022827|NCT00636077|2482052|P1|NOT COMPLETED|Week 4||0
1022828|NCT00636077|2482049|P4|COMPLETED|Week 4||3
1022829|NCT00636077|2482050|P3|COMPLETED|Week 4||3
1022830|NCT00636077|2482051|P2|COMPLETED|Week 4||3
1022831|NCT00636077|2482052|P1|COMPLETED|Week 4||3
1022832|NCT00636077|2482049|P4|STARTED|Week 4||3
1022833|NCT00636077|2482050|P3|STARTED|Week 4||3
1022834|NCT00636077|2482051|P2|STARTED|Week 4||3
1022835|NCT00636077|2482052|P1|STARTED|Week 4||3
1022836|NCT00636077|2482049|P4|NOT COMPLETED|Week 3||0
1022837|NCT00636077|2482050|P3|NOT COMPLETED|Week 3||0
1022838|NCT00636077|2482051|P2|NOT COMPLETED|Week 3||0
1022839|NCT00636077|2482052|P1|NOT COMPLETED|Week 3||0
1022840|NCT00636077|2482049|P4|COMPLETED|Week 3||3
1022841|NCT00636077|2482050|P3|COMPLETED|Week 3||3
1022842|NCT00636077|2482051|P2|COMPLETED|Week 3||3
1022843|NCT00636077|2482052|P1|COMPLETED|Week 3||3
1022844|NCT00636077|2482049|P4|STARTED|Week 3||3
1022845|NCT00636077|2482050|P3|STARTED|Week 3||3
1022846|NCT00636077|2482051|P2|STARTED|Week 3||3
1022847|NCT00636077|2482052|P1|STARTED|Week 3||3
1022848|NCT00636077|2482049|P4|NOT COMPLETED|Week 2||0
1022849|NCT00636077|2482050|P3|NOT COMPLETED|Week 2||0
1022850|NCT00636077|2482051|P2|NOT COMPLETED|Week 2||0
1022851|NCT00636077|2482052|P1|NOT COMPLETED|Week 2||0
1022852|NCT00636077|2482049|P4|COMPLETED|Week 2||3
1022853|NCT00636077|2482050|P3|COMPLETED|Week 2||3
1022854|NCT00636077|2482051|P2|COMPLETED|Week 2||3
1022855|NCT00636077|2482052|P1|COMPLETED|Week 2||3
1022856|NCT00636077|2482049|P4|STARTED|Week 2||3
1022857|NCT00636077|2482050|P3|STARTED|Week 2||3
1022858|NCT00636077|2482051|P2|STARTED|Week 2||3
1022859|NCT00636077|2482052|P1|STARTED|Week 2||3
1022860|NCT00636077|2482049|P4|NOT COMPLETED|Week 1||0
1022861|NCT00636077|2482050|P3|NOT COMPLETED|Week 1||0
1022862|NCT00636077|2482051|P2|NOT COMPLETED|Week 1||0
1022863|NCT00636077|2482052|P1|NOT COMPLETED|Week 1||0
1022864|NCT00636077|2482049|P4|COMPLETED|Week 1||3
1022865|NCT00636077|2482050|P3|COMPLETED|Week 1||3
1022866|NCT00636077|2482051|P2|COMPLETED|Week 1||3
1022867|NCT00636077|2482052|P1|COMPLETED|Week 1||3
1022868|NCT00636077|2482049|P4|STARTED|Week 1||3
1022869|NCT00636077|2482050|P3|STARTED|Week 1||3
1022870|NCT00636077|2482051|P2|STARTED|Week 1||3
1022871|NCT00636077|2482052|P1|STARTED|Week 1||3
1022872|NCT00636155|2482082|P1|NOT COMPLETED|Overall Study||18
1022873|NCT00636155|2482082|P1|COMPLETED|Overall Study|Completed maximum 6 cycles of treatment|2
1022874|NCT00636155|2482082|P1|STARTED|Overall Study||20
1022875|NCT00636168|2482090|P2|NOT COMPLETED|Treated With Study Drug||411
1022876|NCT00636168|2482091|P1|NOT COMPLETED|Treated With Study Drug||447
1022877|NCT00636168|2482090|P2|COMPLETED|Treated With Study Drug||63
1022878|NCT00636168|2482091|P1|COMPLETED|Treated With Study Drug||24
1022879|NCT00636168|2482090|P2|STARTED|Treated With Study Drug||474
1022880|NCT00636168|2482091|P1|STARTED|Treated With Study Drug||471
1022881|NCT00636168|2482090|P2|NOT COMPLETED|Randomized to Study Drug||2
1022882|NCT00636168|2482091|P1|NOT COMPLETED|Randomized to Study Drug||4
1022883|NCT00636168|2482090|P2|COMPLETED|Randomized to Study Drug||474
1022884|NCT00636168|2482091|P1|COMPLETED|Randomized to Study Drug||471
1022885|NCT00636168|2482090|P2|STARTED|Randomized to Study Drug||476
1022886|NCT00636168|2482091|P1|STARTED|Randomized to Study Drug||475
1022887|NCT00636194|2482113|P2|NOT COMPLETED|Overall Study||0
1022888|NCT00636194|2482114|P1|NOT COMPLETED|Overall Study||3
1022889|NCT00636194|2482113|P2|COMPLETED|Overall Study||175
1022890|NCT00636194|2482114|P1|COMPLETED|Overall Study||172
1022891|NCT00636194|2482113|P2|STARTED|Overall Study||175
1022892|NCT00636194|2482114|P1|STARTED|Overall Study||175
1022893|NCT00636207|2482127|P7|NOT COMPLETED|Overall Study||0
1022894|NCT00636207|2482128|P6|NOT COMPLETED|Overall Study||0
1022895|NCT00636207|2482129|P5|NOT COMPLETED|Overall Study||1
1022896|NCT00636207|2482130|P4|NOT COMPLETED|Overall Study||0
1022897|NCT00636207|2482131|P3|NOT COMPLETED|Overall Study||0
1022898|NCT00636207|2482132|P2|NOT COMPLETED|Overall Study||1
1022899|NCT00636207|2482133|P1|NOT COMPLETED|Overall Study||1
1022900|NCT00636207|2482127|P7|COMPLETED|Overall Study||3
1022901|NCT00636207|2482128|P6|COMPLETED|Overall Study||1
1022902|NCT00636207|2482129|P5|COMPLETED|Overall Study||8
1022903|NCT00636207|2482130|P4|COMPLETED|Overall Study||6
1022904|NCT00636207|2482131|P3|COMPLETED|Overall Study||18
1022905|NCT00636207|2482132|P2|COMPLETED|Overall Study||7
1022906|NCT00636207|2482133|P1|COMPLETED|Overall Study||0
1022907|NCT00636207|2482127|P7|STARTED|Overall Study||3
1022908|NCT00636207|2482128|P6|STARTED|Overall Study||1
1022909|NCT00636207|2482129|P5|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|9
1022910|NCT00636207|2482130|P4|STARTED|Overall Study||6
1022911|NCT00636207|2482131|P3|STARTED|Overall Study||18
1022912|NCT00636207|2482132|P2|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|8
1022913|NCT00636207|2482133|P1|STARTED|Overall Study|One participant discontinued after completing Period 2. Doses in Periods 1 and 2 were Montelukast.|1
1022914|NCT00636220|2482195|P1|NOT COMPLETED|Overall Study||0
1022915|NCT00636220|2482195|P1|COMPLETED|Overall Study||101
1022916|NCT00636220|2482195|P1|STARTED|Overall Study||101
1022917|NCT00636363|2482202|P3|NOT COMPLETED|Overall Study||18
1022918|NCT00636363|2482203|P2|NOT COMPLETED|Overall Study||20
1022919|NCT00636363|2482204|P1|NOT COMPLETED|Overall Study||13
1022920|NCT00636363|2482202|P3|COMPLETED|Overall Study||163
1022921|NCT00636363|2482203|P2|COMPLETED|Overall Study||156
1022922|NCT00636363|2482204|P1|COMPLETED|Overall Study||165
1022923|NCT00636363|2482202|P3|STARTED|Overall Study||181
1022924|NCT00636363|2482203|P2|STARTED|Overall Study||176
1022925|NCT00636363|2482204|P1|STARTED|Overall Study||178
1022926|NCT00636389|2482218|P2|NOT COMPLETED|Period 2 - 1 Week||0
1022927|NCT00636389|2482219|P1|NOT COMPLETED|Period 2 - 1 Week||0
1022928|NCT00636389|2482218|P2|COMPLETED|Period 2 - 1 Week||5
1022929|NCT00636389|2482219|P1|COMPLETED|Period 2 - 1 Week||7
1022930|NCT00636389|2482218|P2|STARTED|Period 2 - 1 Week||5
1022931|NCT00636389|2482219|P1|STARTED|Period 2 - 1 Week||7
1022932|NCT00636389|2482218|P2|NOT COMPLETED|Period 1 - 1 Week||0
1022933|NCT00636389|2482219|P1|NOT COMPLETED|Period 1 - 1 Week||0
1022934|NCT00636389|2482218|P2|COMPLETED|Period 1 - 1 Week||5
1022935|NCT00636389|2482219|P1|COMPLETED|Period 1 - 1 Week||7
1022936|NCT00636389|2482218|P2|STARTED|Period 1 - 1 Week||5
1022937|NCT00636389|2482219|P1|STARTED|Period 1 - 1 Week||7
1022938|NCT00636441|2482236|P7|NOT COMPLETED|Overall Study||18
1022939|NCT00636441|2482237|P6|NOT COMPLETED|Overall Study||1
1022940|NCT00636441|2482238|P5|NOT COMPLETED|Overall Study||0
1022941|NCT00636441|2482239|P4|NOT COMPLETED|Overall Study||0
1022942|NCT00636441|2482240|P3|NOT COMPLETED|Overall Study||1
1022943|NCT00636441|2482241|P2|NOT COMPLETED|Overall Study||1
1022944|NCT00636441|2482242|P1|NOT COMPLETED|Overall Study||0
1022945|NCT00636441|2482236|P7|COMPLETED|Overall Study||0
1022946|NCT00636441|2482237|P6|COMPLETED|Overall Study||6
1022947|NCT00636441|2482238|P5|COMPLETED|Overall Study||6
1022948|NCT00636441|2482239|P4|COMPLETED|Overall Study||6
1022949|NCT00636441|2482240|P3|COMPLETED|Overall Study||5
1022950|NCT00636441|2482241|P2|COMPLETED|Overall Study||6
1022951|NCT00636441|2482242|P1|COMPLETED|Overall Study||6
1022952|NCT00636441|2482236|P7|Assigned Treatment|Overall Study|This is a late determined ineligibility.|1
1022953|NCT00636441|2482237|P6|Assigned Treatment|Overall Study||7
1022954|NCT00636441|2482238|P5|Assigned Treatment|Overall Study||6
1022955|NCT00636441|2482239|P4|Assigned Treatment|Overall Study||6
1022956|NCT00636441|2482240|P3|Assigned Treatment|Overall Study||6
1022957|NCT00636441|2482241|P2|Assigned Treatment|Overall Study||7
1022958|NCT00636441|2482242|P1|Assigned Treatment|Overall Study||6
1022959|NCT00636441|2482236|P7|STARTED|Overall Study||18
1022960|NCT00636441|2482237|P6|STARTED|Overall Study||7
1022961|NCT00636441|2482238|P5|STARTED|Overall Study||6
1022962|NCT00636441|2482239|P4|STARTED|Overall Study||6
1022963|NCT00636441|2482240|P3|STARTED|Overall Study||6
1022964|NCT00636441|2482241|P2|STARTED|Overall Study||7
1022965|NCT00636441|2482242|P1|STARTED|Overall Study||6
1022966|NCT00636610|2482273|P2|NOT COMPLETED|Overall Study||83
1022967|NCT00636610|2482274|P1|NOT COMPLETED|Overall Study||92
1022968|NCT00636610|2482273|P2|COMPLETED|Overall Study||18
1022969|NCT00636610|2482274|P1|COMPLETED|Overall Study||6
1022970|NCT00636610|2482273|P2|STARTED|Overall Study||101
1022971|NCT00636610|2482274|P1|STARTED|Overall Study||98
1022972|NCT00636636|2482286|P2|NOT COMPLETED|Overall Study||39
1022973|NCT00636636|2482287|P1|NOT COMPLETED|Overall Study||36
1022974|NCT00636636|2482286|P2|COMPLETED|Overall Study||192
1022975|NCT00636636|2482287|P1|COMPLETED|Overall Study||185
1022976|NCT00636636|2482286|P2|379|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
1022977|NCT00636636|2482287|P1|379|Overall Study||186
1022978|NCT00636636|2482286|P2|Safety & Efficacy of Gabapentin ER|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
1022979|NCT00636636|2482287|P1|Safety & Efficacy of Gabapentin ER|Overall Study||186
1022980|NCT00636636|2482286|P2|STARTED|Overall Study||231
1022981|NCT00636636|2482287|P1|STARTED|Overall Study||221
1022982|NCT00636649|2482303|P2|NOT COMPLETED|Overall Study||0
1022983|NCT00636649|2482304|P1|NOT COMPLETED|Overall Study||0
1022984|NCT00636649|2482303|P2|COMPLETED|Overall Study||20
1022985|NCT00636649|2482304|P1|COMPLETED|Overall Study||20
1022986|NCT00636649|2482303|P2|STARTED|Overall Study||20
1022987|NCT00636649|2482304|P1|STARTED|Overall Study||20
1022988|NCT00636701|2482334|P2|NOT COMPLETED|Overall Study||0
1022989|NCT00636701|2482335|P1|NOT COMPLETED|Overall Study||0
1022990|NCT00636701|2482334|P2|COMPLETED|Overall Study||2
1022991|NCT00636701|2482335|P1|COMPLETED|Overall Study||2
1022992|NCT00636701|2482334|P2|STARTED|Overall Study||2
1022993|NCT00636701|2482335|P1|STARTED|Overall Study||2
1022994|NCT00636792|2482341|P1|NOT COMPLETED|Overall Study||33
1022995|NCT00636792|2482341|P1|COMPLETED|Overall Study||40
1022996|NCT00636792|2482341|P1|STARTED|Overall Study||73
1022997|NCT00636805|2482346|P1|NOT COMPLETED|Overall Study||0
1022998|NCT00636805|2482346|P1|COMPLETED|Overall Study||63
1022999|NCT00636805|2482346|P1|STARTED|Overall Study||63
1023000|NCT00636818|2482356|P1|NOT COMPLETED|Overall Study||11
1023001|NCT00636818|2482356|P1|COMPLETED|Overall Study||34
1023002|NCT00636818|2482356|P1|Received at Least One Dose of Study Drug|Overall Study|One patient was lost to follow up and did not receive any study drug.|44
1023003|NCT00636818|2482356|P1|STARTED|Overall Study||45
1023004|NCT00636961|2482373|P2|NOT COMPLETED|Period 2||0
1023005|NCT00636961|2482374|P1|NOT COMPLETED|Period 2||1
1023006|NCT00636961|2482373|P2|COMPLETED|Period 2||12
1023007|NCT00636961|2482374|P1|COMPLETED|Period 2||12
1023008|NCT00636961|2482373|P2|STARTED|Period 2||12
1023009|NCT00636961|2482374|P1|STARTED|Period 2||13
1023010|NCT00636961|2482373|P2|NOT COMPLETED|Period 1||1
1023011|NCT00636961|2482374|P1|NOT COMPLETED|Period 1||1
1023012|NCT00636961|2482373|P2|COMPLETED|Period 1||12
1023013|NCT00636961|2482374|P1|COMPLETED|Period 1||13
1023014|NCT00636961|2482373|P2|STARTED|Period 1||13
1023015|NCT00636961|2482374|P1|STARTED|Period 1||14
1023016|NCT00636987|2482388|P1|NOT COMPLETED|Overall Study||189
1023017|NCT00636987|2482388|P1|COMPLETED|Overall Study||108
1023018|NCT00636987|2482388|P1|STARTED|Overall Study||297
1023019|NCT00637000|2482398|P2|NOT COMPLETED|Overall Study||3
1023020|NCT00637000|2482399|P1|NOT COMPLETED|Overall Study||4
1023021|NCT00637000|2482398|P2|COMPLETED|Overall Study||15
1023022|NCT00637000|2482399|P1|COMPLETED|Overall Study||16
1023023|NCT00637000|2482398|P2|Evaluable|Overall Study||16
1023024|NCT00637000|2482399|P1|Evaluable|Overall Study||18
1023025|NCT00637000|2482398|P2|STARTED|Overall Study|Randomized and treated|18
1023026|NCT00637000|2482399|P1|STARTED|Overall Study|Randomized and treated|20
1023027|NCT00637156|2482441|P2|NOT COMPLETED|Overall Study||24
1023028|NCT00637156|2482442|P1|NOT COMPLETED|Overall Study||10
1023029|NCT00637156|2482441|P2|COMPLETED|Overall Study||164
1023030|NCT00637156|2482442|P1|COMPLETED|Overall Study||199
1023031|NCT00637156|2482441|P2|STARTED|Overall Study||188
1023032|NCT00637156|2482442|P1|STARTED|Overall Study||209
1023033|NCT00637195|2482484|P2|NOT COMPLETED|Overall Study||1
1023034|NCT00637195|2482485|P1|NOT COMPLETED|Overall Study||3
1023035|NCT00637195|2482484|P2|COMPLETED|Overall Study||75
1023036|NCT00637195|2482485|P1|COMPLETED|Overall Study||73
1023037|NCT00637195|2482484|P2|STARTED|Overall Study||76
1023038|NCT00637195|2482485|P1|STARTED|Overall Study||76
1023039|NCT00637247|2482521|P2|NOT COMPLETED|Overall Study||0
1023040|NCT00637247|2482522|P1|NOT COMPLETED|Overall Study||0
1023041|NCT00637247|2482521|P2|COMPLETED|Overall Study||70
1023042|NCT00637247|2482522|P1|COMPLETED|Overall Study||72
1023043|NCT00637247|2482521|P2|STARTED|Overall Study||70
1023044|NCT00637247|2482522|P1|STARTED|Overall Study||72
1023045|NCT00637273|2482535|P3|NOT COMPLETED|Overall Study||41
1023046|NCT00637273|2482536|P2|NOT COMPLETED|Overall Study||28
1023047|NCT00637273|2482537|P1|NOT COMPLETED|Overall Study||43
1023048|NCT00637273|2482535|P3|COMPLETED|Overall Study||131
1023049|NCT00637273|2482536|P2|COMPLETED|Overall Study||144
1023050|NCT00637273|2482537|P1|COMPLETED|Overall Study||127
1023051|NCT00637273|2482535|P3|Intent to Treat (ITT)|Overall Study||165
1023052|NCT00637273|2482536|P2|Intent to Treat (ITT)|Overall Study||166
1023053|NCT00637273|2482537|P1|Intent to Treat (ITT)|Overall Study||160
1023054|NCT00637273|2482535|P3|STARTED|Overall Study||172
1023055|NCT00637273|2482536|P2|STARTED|Overall Study||172
1023056|NCT00637273|2482537|P1|STARTED|Overall Study||170
1023057|NCT00637299|2482580|P2|NOT COMPLETED|Overall Study||0
1023058|NCT00637299|2482581|P1|NOT COMPLETED|Overall Study||0
1023059|NCT00637299|2482580|P2|COMPLETED|Overall Study||10
1023060|NCT00637299|2482581|P1|COMPLETED|Overall Study||10
1023061|NCT00637299|2482580|P2|STARTED|Overall Study||10
1023062|NCT00637299|2482581|P1|STARTED|Overall Study||10
1023063|NCT00637312|2482591|P2|NOT COMPLETED|Overall Study||17
1023064|NCT00637312|2482592|P1|NOT COMPLETED|Overall Study||42
1023065|NCT00637312|2482591|P2|COMPLETED|Overall Study||19
1023066|NCT00637312|2482592|P1|COMPLETED|Overall Study||30
1023067|NCT00637312|2482591|P2|STARTED|Overall Study||36
1023068|NCT00637312|2482592|P1|STARTED|Overall Study||72
1023069|NCT00637377|2482602|P4|NOT COMPLETED|Overall Study||29
1023070|NCT00637377|2482603|P3|NOT COMPLETED|Overall Study||37
1023071|NCT00637377|2482604|P2|NOT COMPLETED|Overall Study||32
1023072|NCT00637377|2482605|P1|NOT COMPLETED|Overall Study||27
1023073|NCT00637377|2482602|P4|COMPLETED|Overall Study||284
1023074|NCT00637377|2482603|P3|COMPLETED|Overall Study||274
1023075|NCT00637377|2482604|P2|COMPLETED|Overall Study||281
1023076|NCT00637377|2482605|P1|COMPLETED|Overall Study||276
1023077|NCT00637377|2482602|P4|Participants Treated (FAS)|Overall Study||306
1023078|NCT00637377|2482603|P3|Participants Treated (FAS)|Overall Study||296
1023079|NCT00637377|2482604|P2|Participants Treated (FAS)|Overall Study||309
1023080|NCT00637377|2482605|P1|Participants Treated (FAS)|Overall Study||291
1023081|NCT00637377|2482602|P4|Participants Received Treatment|Overall Study|safety population|307
1023082|NCT00637377|2482603|P3|Participants Received Treatment|Overall Study|safety population|297
1023083|NCT00637377|2482604|P2|Participants Received Treatment|Overall Study|safety population|309
1023084|NCT00637377|2482605|P1|Participants Received Treatment|Overall Study|safety population|291
1023085|NCT00637377|2482602|P4|STARTED|Overall Study||313
1023086|NCT00637377|2482603|P3|STARTED|Overall Study||311
1023087|NCT00637377|2482604|P2|STARTED|Overall Study||313
1023088|NCT00637377|2482605|P1|STARTED|Overall Study||303
1023089|NCT00637416|2482633|P2|NOT COMPLETED|Overall Study||2
1023090|NCT00637416|2482634|P1|NOT COMPLETED|Overall Study||1
1023091|NCT00637416|2482633|P2|COMPLETED|Overall Study||3
1023092|NCT00637416|2482634|P1|COMPLETED|Overall Study||3
1023093|NCT00637416|2482633|P2|STARTED|Overall Study||5
1023094|NCT00637416|2482634|P1|STARTED|Overall Study||4
1023095|NCT00637494|2482642|P2|NOT COMPLETED|Overall Study||43
1023096|NCT00637494|2482643|P1|NOT COMPLETED|Overall Study||32
1023097|NCT00637494|2482642|P2|COMPLETED|Overall Study||108
1023098|NCT00637494|2482643|P1|COMPLETED|Overall Study||109
1023099|NCT00637494|2482642|P2|STARTED|Overall Study||151
1023100|NCT00637494|2482643|P1|STARTED|Overall Study||141
1023101|NCT00637572|2482653|P2|NOT COMPLETED|Overall Study||7
1023102|NCT00637572|2482654|P1|NOT COMPLETED|Overall Study||3
1023103|NCT00637572|2482653|P2|COMPLETED|Overall Study||24
1023104|NCT00637572|2482654|P1|COMPLETED|Overall Study||29
1023105|NCT00637572|2482653|P2|STARTED|Overall Study||31
1023106|NCT00637572|2482654|P1|STARTED|Overall Study||32
1023107|NCT00637728|2482682|P3|NOT COMPLETED|Extension Phase||0
1023108|NCT00637728|2482683|P2|NOT COMPLETED|Extension Phase||0
1023109|NCT00637728|2482684|P1|NOT COMPLETED|Extension Phase||0
1023110|NCT00637728|2482682|P3|COMPLETED|Extension Phase||0
1023111|NCT00637728|2482683|P2|COMPLETED|Extension Phase||0
1023112|NCT00637728|2482684|P1|COMPLETED|Extension Phase||0
1023113|NCT00637728|2482682|P3|STARTED|Extension Phase||0
1023114|NCT00637728|2482683|P2|STARTED|Extension Phase||0
1023115|NCT00637728|2482684|P1|STARTED|Extension Phase||0
1023116|NCT00637728|2482682|P3|NOT COMPLETED|Double-blind Phase||0
1023117|NCT00637728|2482683|P2|NOT COMPLETED|Double-blind Phase||1
1023118|NCT00637728|2482684|P1|NOT COMPLETED|Double-blind Phase||4
1023119|NCT00637728|2482682|P3|COMPLETED|Double-blind Phase||0
1023120|NCT00637728|2482683|P2|COMPLETED|Double-blind Phase||0
1023121|NCT00637728|2482684|P1|COMPLETED|Double-blind Phase||0
1023122|NCT00637728|2482682|P3|STARTED|Double-blind Phase||0
1023123|NCT00637728|2482683|P2|STARTED|Double-blind Phase||1
1023124|NCT00637728|2482684|P1|STARTED|Double-blind Phase||4
1023125|NCT00637780|2482697|P1|NOT COMPLETED|Overall Study||0
1023126|NCT00637780|2482697|P1|COMPLETED|Overall Study||2
1023127|NCT00637780|2482697|P1|STARTED|Overall Study||2
1023128|NCT00637806|2482715|P4|NOT COMPLETED|Extension Phase||1
1023129|NCT00637806|2482716|P3|NOT COMPLETED|Extension Phase||0
1023130|NCT00637806|2482717|P2|NOT COMPLETED|Extension Phase||0
1023131|NCT00637806|2482718|P1|NOT COMPLETED|Extension Phase||0
1023132|NCT00637806|2482715|P4|COMPLETED|Extension Phase||0
1023133|NCT00637806|2482716|P3|COMPLETED|Extension Phase||0
1023134|NCT00637806|2482717|P2|COMPLETED|Extension Phase||0
1023135|NCT00637806|2482718|P1|COMPLETED|Extension Phase||0
1023136|NCT00637806|2482715|P4|STARTED|Extension Phase||1
1023137|NCT00637806|2482716|P3|STARTED|Extension Phase||0
1023138|NCT00637806|2482717|P2|STARTED|Extension Phase||0
1023139|NCT00637806|2482718|P1|STARTED|Extension Phase||0
1023140|NCT00637806|2482715|P4|NOT COMPLETED|Double-blind Phase||0
1023141|NCT00637806|2482716|P3|NOT COMPLETED|Double-blind Phase||1
1023142|NCT00637806|2482717|P2|NOT COMPLETED|Double-blind Phase||0
1023143|NCT00637806|2482718|P1|NOT COMPLETED|Double-blind Phase||2
1023144|NCT00637806|2482715|P4|COMPLETED|Double-blind Phase||0
1023145|NCT00637806|2482716|P3|COMPLETED|Double-blind Phase||1
1023146|NCT00637806|2482717|P2|COMPLETED|Double-blind Phase||0
1023147|NCT00637806|2482718|P1|COMPLETED|Double-blind Phase||0
1023148|NCT00637806|2482715|P4|STARTED|Double-blind Phase||0
1023149|NCT00637806|2482716|P3|STARTED|Double-blind Phase||2
1023150|NCT00637806|2482717|P2|STARTED|Double-blind Phase||0
1023151|NCT00637806|2482718|P1|STARTED|Double-blind Phase||2
1023152|NCT00637923|2482738|P2|NOT COMPLETED|Overall Study||19
1023153|NCT00637923|2482739|P1|NOT COMPLETED|Overall Study||30
1023154|NCT00637923|2482738|P2|COMPLETED|Overall Study||18
1023155|NCT00637923|2482739|P1|COMPLETED|Overall Study||45
1023156|NCT00637923|2482738|P2|STARTED|Overall Study||37
1023157|NCT00637923|2482739|P1|STARTED|Overall Study||75
1023158|NCT00638014|2482761|P2|NOT COMPLETED|Overall Study||0
1023159|NCT00638014|2482762|P1|NOT COMPLETED|Overall Study||0
1023160|NCT00638014|2482761|P2|COMPLETED|Overall Study||28
1023161|NCT00638014|2482762|P1|COMPLETED|Overall Study||23
1023162|NCT00638014|2482761|P2|STARTED|Overall Study||28
1023163|NCT00638014|2482762|P1|STARTED|Overall Study||23
1023164|NCT00638027|2482772|P2|NOT COMPLETED|Overall Study||2
1023165|NCT00638027|2482773|P1|NOT COMPLETED|Overall Study||0
1023166|NCT00638027|2482772|P2|COMPLETED|Overall Study|all 10 included in analyses|8
1023167|NCT00638027|2482773|P1|COMPLETED|Overall Study||11
1023168|NCT00638027|2482772|P2|STARTED|Overall Study||10
1023169|NCT00638027|2482773|P1|STARTED|Overall Study||11
1023170|NCT00638157|2482785|P2|NOT COMPLETED|Overall Study||4
1023171|NCT00638157|2482786|P1|NOT COMPLETED|Overall Study||7
1023172|NCT00638157|2482785|P2|COMPLETED|Overall Study|4 subjects completed study drug in this arm|8
1023173|NCT00638157|2482786|P1|COMPLETED|Overall Study|4 subjects completed study drug in this arm|5
1023174|NCT00638157|2482785|P2|Treated|Overall Study||12
1023175|NCT00638157|2482786|P1|Treated|Overall Study||10
1023176|NCT00638157|2482785|P2|STARTED|Overall Study||12
1023177|NCT00638157|2482786|P1|STARTED|Overall Study||12
1023178|NCT00630292|2482794|P1|NOT COMPLETED|Overall Study||1
1023179|NCT00630292|2482794|P1|COMPLETED|Overall Study||5
1023180|NCT00630292|2482794|P1|STARTED|Overall Study||6
1023181|NCT00630305|2482798|P1|NOT COMPLETED|Overall Study||2
1023182|NCT00630305|2482798|P1|COMPLETED|Overall Study||35
1023183|NCT00630305|2482798|P1|STARTED|Overall Study||37
1023184|NCT00630331|2482823|P3|NOT COMPLETED|Overall Study||188
1023185|NCT00630331|2482824|P2|NOT COMPLETED|Overall Study||166
1023186|NCT00630331|2482825|P1|NOT COMPLETED|Overall Study||206
1023187|NCT00630331|2482823|P3|COMPLETED|Overall Study||3712
1023188|NCT00630331|2482824|P2|COMPLETED|Overall Study||3510
1023189|NCT00630331|2482825|P1|COMPLETED|Overall Study||3622
1023190|NCT00630331|2482823|P3|STARTED|Overall Study||3900
1023191|NCT00630331|2482824|P2|STARTED|Overall Study||3676
1023192|NCT00630331|2482825|P1|STARTED|Overall Study||3828
1023193|NCT00630344|2482866|P1|NOT COMPLETED|Overall Study||0
1023194|NCT00630344|2482866|P1|COMPLETED|Overall Study||36
1023195|NCT00630344|2482866|P1|STARTED|Overall Study||36
1023196|NCT00630396|2482870|P1|NOT COMPLETED|Overall Study||7
1023197|NCT00630396|2482870|P1|COMPLETED|Overall Study||53
1023198|NCT00630396|2482870|P1|STARTED|Overall Study||60
1023199|NCT00630409|2482876|P1|NOT COMPLETED|Overall Study||1
1023200|NCT00630409|2482876|P1|COMPLETED|Overall Study||4
1023201|NCT00630409|2482876|P1|STARTED|Overall Study||5
1023202|NCT00630487|2482883|P2|NOT COMPLETED|Overall Study||0
1023203|NCT00630487|2482884|P1|NOT COMPLETED|Overall Study||0
1023204|NCT00630487|2482883|P2|COMPLETED|Overall Study||0
1023205|NCT00630487|2482884|P1|COMPLETED|Overall Study||0
1023206|NCT00630487|2482883|P2|STARTED|Overall Study||0
1023207|NCT00630487|2482884|P1|STARTED|Overall Study||0
1023208|NCT00630539|2482922|P4|NOT COMPLETED|Overall Study||3
1023209|NCT00630539|2482923|P3|NOT COMPLETED|Overall Study||1
1023210|NCT00630539|2482924|P2|NOT COMPLETED|Overall Study||4
1023211|NCT00630539|2482925|P1|NOT COMPLETED|Overall Study||1
1023212|NCT00630539|2482922|P4|COMPLETED|Overall Study||27
1023213|NCT00630539|2482923|P3|COMPLETED|Overall Study||28
1023214|NCT00630539|2482924|P2|COMPLETED|Overall Study||29
1023215|NCT00630539|2482925|P1|COMPLETED|Overall Study||33
1023216|NCT00630539|2482922|P4|STARTED|Overall Study||30
1023217|NCT00630539|2482923|P3|STARTED|Overall Study||29
1023218|NCT00630539|2482924|P2|STARTED|Overall Study||33
1023219|NCT00630539|2482925|P1|STARTED|Overall Study||34
1023220|NCT00630734|2482982|P3|NOT COMPLETED|Overall Study||1
1023221|NCT00630734|2482983|P2|NOT COMPLETED|Overall Study||1
1023222|NCT00630734|2482984|P1|NOT COMPLETED|Overall Study||2
1023223|NCT00630734|2482982|P3|COMPLETED|Overall Study||7
1023224|NCT00630734|2482983|P2|COMPLETED|Overall Study||12
1023225|NCT00630734|2482984|P1|COMPLETED|Overall Study||9
1023226|NCT00630734|2482982|P3|STARTED|Overall Study||8
1023227|NCT00630734|2482983|P2|STARTED|Overall Study||13
1023228|NCT00630734|2482984|P1|STARTED|Overall Study||11
1023229|NCT00630747|2483019|P1|NOT COMPLETED|Overall Study||9
1023230|NCT00630747|2483019|P1|COMPLETED|Overall Study||85
1023231|NCT00630747|2483019|P1|Participants Treated in Phase I of Study|Overall Study||94
1023232|NCT00630747|2483019|P1|STARTED|Overall Study||94
1023233|NCT00630786|2483031|P3|NOT COMPLETED|Overall Study||2
1023234|NCT00630786|2483032|P2|NOT COMPLETED|Overall Study||2
1023235|NCT00630786|2483033|P1|NOT COMPLETED|Overall Study||1
1023236|NCT00630786|2483031|P3|COMPLETED|Overall Study|Completed study defined as participant death|7
1023237|NCT00630786|2483032|P2|COMPLETED|Overall Study|Completed study defined as participant death|23
1023238|NCT00630786|2483033|P1|COMPLETED|Overall Study|Completed study defined as participant death|18
1023239|NCT00630786|2483031|P3|Received Study Medication|Overall Study||8
1023240|NCT00630786|2483032|P2|Received Study Medication|Overall Study||25
1023241|NCT00630786|2483033|P1|Received Study Medication|Overall Study||19
1023242|NCT00630786|2483031|P3|STARTED|Overall Study|All patients were enrolled in Part 2.|9
1023243|NCT00630786|2483032|P2|STARTED|Overall Study|Includes 3 patients enrolled in Part 1 and 22 patients enrolled in Part 2.|25
1023244|NCT00630786|2483033|P1|STARTED|Overall Study|Includes 2 patients enrolled in Part 1 and 17 patients enrolled in Part 2.|19
1023245|NCT00630825|2483056|P4|NOT COMPLETED|Overall Study||6
1023246|NCT00630825|2483057|P3|NOT COMPLETED|Overall Study||8
1023247|NCT00630825|2483058|P2|NOT COMPLETED|Overall Study||7
1023248|NCT00630825|2483059|P1|NOT COMPLETED|Overall Study||9
1023249|NCT00630825|2483056|P4|COMPLETED|Overall Study||60
1023250|NCT00630825|2483057|P3|COMPLETED|Overall Study||58
1023251|NCT00630825|2483058|P2|COMPLETED|Overall Study||58
1023252|NCT00630825|2483059|P1|COMPLETED|Overall Study||56
1023253|NCT00630825|2483056|P4|Received at Least One Dose of Study Drug|Overall Study||66
1023254|NCT00630825|2483057|P3|Received at Least One Dose of Study Drug|Overall Study||66
1023255|NCT00630825|2483058|P2|Received at Least One Dose of Study Drug|Overall Study||65
1023256|NCT00630825|2483059|P1|Received at Least One Dose of Study Drug|Overall Study||65
1023257|NCT00630825|2483056|P4|STARTED|Overall Study||66
1023258|NCT00630825|2483057|P3|STARTED|Overall Study||66
1023259|NCT00630825|2483058|P2|STARTED|Overall Study||65
1023260|NCT00630825|2483059|P1|STARTED|Overall Study||65
1023261|NCT00630838|2483130|P2|NOT COMPLETED|Overall Study||2
1023262|NCT00630838|2483131|P1|NOT COMPLETED|Overall Study||0
1023263|NCT00630838|2483130|P2|COMPLETED|Overall Study||28
1023264|NCT00630838|2483131|P1|COMPLETED|Overall Study||32
1023265|NCT00630838|2483130|P2|STARTED|Overall Study||30
1023266|NCT00630838|2483131|P1|STARTED|Overall Study||32
1023267|NCT00630864|2483139|P1|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||2
1023268|NCT00630864|2483139|P1|COMPLETED|Part 2 (After Week 6 up to Month 12)||18
1023269|NCT00630864|2483139|P1|STARTED|Part 2 (After Week 6 up to Month 12)||20
1023270|NCT00630864|2483139|P1|NOT COMPLETED|Part 1 (up to Week 6)||1
1023271|NCT00630864|2483139|P1|COMPLETED|Part 1 (up to Week 6)||20
1023272|NCT00630864|2483139|P1|STARTED|Part 1 (up to Week 6)||21
1023273|NCT00630877|2483179|P3|NOT COMPLETED|Overall Study||10
1023274|NCT00630877|2483180|P2|NOT COMPLETED|Overall Study||15
1023275|NCT00630877|2483181|P1|NOT COMPLETED|Overall Study||19
1023276|NCT00630877|2483179|P3|COMPLETED|Overall Study||80
1023277|NCT00630877|2483180|P2|COMPLETED|Overall Study||75
1023278|NCT00630877|2483181|P1|COMPLETED|Overall Study||72
1023279|NCT00630877|2483179|P3|STARTED|Overall Study||90
1023280|NCT00630877|2483180|P2|STARTED|Overall Study||90
1023281|NCT00630877|2483181|P1|STARTED|Overall Study|For all arms, started means treated.|91
1023282|NCT00630916|2483199|P1|NOT COMPLETED|Overall Study||210
1023283|NCT00630916|2483199|P1|COMPLETED|Overall Study|The number of patients that were active (i.e. not drop out) at the end of the study.|546
1023284|NCT00630916|2483199|P1|Study Cohort|Overall Study|Enrolled but did not receive device via physician decision, protocol violation, or lack of efficacy.|699
1023285|NCT00630916|2483199|P1|STARTED|Overall Study|Total patients enrolled (i.e. consented) to participate in the study.|756
1023286|NCT00630955|2483209|P3|NOT COMPLETED|Overall Study||12
1023287|NCT00630955|2483210|P2|NOT COMPLETED|Overall Study||6
1023288|NCT00630955|2483211|P1|NOT COMPLETED|Overall Study||3
1023289|NCT00630955|2483209|P3|COMPLETED|Overall Study||28
1023290|NCT00630955|2483210|P2|COMPLETED|Overall Study||31
1023291|NCT00630955|2483211|P1|COMPLETED|Overall Study||31
1023292|NCT00630955|2483209|P3|STARTED|Overall Study||40
1023293|NCT00630955|2483210|P2|STARTED|Overall Study||37
1023294|NCT00630955|2483211|P1|STARTED|Overall Study||34
1023295|NCT00630994|2483222|P1|NOT COMPLETED|Overall Study||4
1023296|NCT00630994|2483222|P1|COMPLETED|Overall Study||0
1023297|NCT00630994|2483222|P1|STARTED|Overall Study||4
1023298|NCT00631007|2483236|P6|NOT COMPLETED|Overall Study||15
1023299|NCT00631007|2483237|P5|NOT COMPLETED|Overall Study||12
1023300|NCT00631007|2483238|P4|NOT COMPLETED|Overall Study||9
1023301|NCT00631007|2483239|P3|NOT COMPLETED|Overall Study||10
1023302|NCT00631007|2483240|P2|NOT COMPLETED|Overall Study||11
1023303|NCT00631007|2483241|P1|NOT COMPLETED|Overall Study||11
1023304|NCT00631007|2483236|P6|COMPLETED|Overall Study||46
1023305|NCT00631007|2483237|P5|COMPLETED|Overall Study||48
1023306|NCT00631007|2483238|P4|COMPLETED|Overall Study||53
1023307|NCT00631007|2483239|P3|COMPLETED|Overall Study||53
1023308|NCT00631007|2483240|P2|COMPLETED|Overall Study||50
1023309|NCT00631007|2483241|P1|COMPLETED|Overall Study||49
1023310|NCT00631007|2483236|P6|STARTED|Overall Study||61
1023311|NCT00631007|2483237|P5|STARTED|Overall Study||60
1023312|NCT00631007|2483238|P4|STARTED|Overall Study||62
1023313|NCT00631007|2483239|P3|STARTED|Overall Study||63
1023314|NCT00631007|2483240|P2|STARTED|Overall Study||61
1023315|NCT00631007|2483241|P1|STARTED|Overall Study||60
1023316|NCT00631020|2483261|P1|NOT COMPLETED|Overall Study||8
1023317|NCT00631020|2483261|P1|COMPLETED|Overall Study||26
1023318|NCT00631020|2483261|P1|STARTED|Overall Study||34
1023319|NCT00631189|2483274|P4|NOT COMPLETED|Treatment Phase||7
1023320|NCT00631189|2483275|P3|NOT COMPLETED|Treatment Phase||11
1023321|NCT00631189|2483276|P2|NOT COMPLETED|Treatment Phase||7
1023322|NCT00631189|2483277|P1|NOT COMPLETED|Treatment Phase||0
1023323|NCT00631189|2483274|P4|COMPLETED|Treatment Phase||103
1023324|NCT00631189|2483275|P3|COMPLETED|Treatment Phase||92
1023325|NCT00631189|2483276|P2|COMPLETED|Treatment Phase||97
1023326|NCT00631189|2483277|P1|COMPLETED|Treatment Phase||0
1023327|NCT00631189|2483274|P4|STARTED|Treatment Phase||110
1023328|NCT00631189|2483275|P3|STARTED|Treatment Phase||103
1023329|NCT00631189|2483276|P2|STARTED|Treatment Phase||104
1023330|NCT00631189|2483277|P1|STARTED|Treatment Phase||0
1023331|NCT00631189|2483274|P4|NOT COMPLETED|Initial Phase||0
1023332|NCT00631189|2483275|P3|NOT COMPLETED|Initial Phase||0
1023333|NCT00631189|2483276|P2|NOT COMPLETED|Initial Phase||0
1023334|NCT00631189|2483277|P1|NOT COMPLETED|Initial Phase||351
1023335|NCT00631189|2483274|P4|COMPLETED|Initial Phase||0
1023336|NCT00631189|2483275|P3|COMPLETED|Initial Phase||0
1023337|NCT00631189|2483276|P2|COMPLETED|Initial Phase||0
1023338|NCT00631189|2483277|P1|COMPLETED|Initial Phase||317
1023339|NCT00631189|2483274|P4|STARTED|Initial Phase||0
1023340|NCT00631189|2483275|P3|STARTED|Initial Phase||0
1023341|NCT00631189|2483276|P2|STARTED|Initial Phase||0
1023342|NCT00631189|2483277|P1|STARTED|Initial Phase||668
1023343|NCT00631358|2483321|P2|NOT COMPLETED|Overall Study||2
1023344|NCT00631358|2483322|P1|NOT COMPLETED|Overall Study||6
1023345|NCT00631358|2483321|P2|COMPLETED|Overall Study||45
1023346|NCT00631358|2483322|P1|COMPLETED|Overall Study||44
1023347|NCT00631358|2483321|P2|STARTED|Overall Study||47
1023348|NCT00631358|2483322|P1|STARTED|Overall Study||50
1023349|NCT00631371|2483338|P2|NOT COMPLETED|Overall Study||391
1023350|NCT00631371|2483339|P1|NOT COMPLETED|Overall Study||400
1023351|NCT00631371|2483338|P2|COMPLETED|Overall Study||0
1023352|NCT00631371|2483339|P1|COMPLETED|Overall Study||0
1023353|NCT00631371|2483338|P2|Treated|Overall Study||391
1023354|NCT00631371|2483339|P1|Treated|Overall Study||393
1023355|NCT00631371|2483338|P2|STARTED|Overall Study||391
1023356|NCT00631371|2483339|P1|STARTED|Overall Study||400
1023357|NCT00631410|2483353|P2|NOT COMPLETED|Overall Study||6
1023358|NCT00631410|2483354|P1|NOT COMPLETED|Overall Study||6
1023359|NCT00631410|2483353|P2|COMPLETED|Overall Study||0
1023360|NCT00631410|2483354|P1|COMPLETED|Overall Study||0
1023361|NCT00631410|2483353|P2|STARTED|Overall Study||6
1023362|NCT00631410|2483354|P1|STARTED|Overall Study||6
1023363|NCT00631449|2483373|P2|NOT COMPLETED|Overall Study||0
1023364|NCT00631449|2483374|P1|NOT COMPLETED|Overall Study||0
1023365|NCT00631449|2483373|P2|COMPLETED|Overall Study||15
1023366|NCT00631449|2483374|P1|COMPLETED|Overall Study||15
1023367|NCT00631449|2483373|P2|STARTED|Overall Study||15
1023368|NCT00631449|2483374|P1|STARTED|Overall Study||15
1023369|NCT00631475|2483380|P1|NOT COMPLETED|Overall Study||45
1023370|NCT00631475|2483380|P1|COMPLETED|Overall Study||83
1023371|NCT00631475|2483380|P1|STARTED|Overall Study||128
1023372|NCT00631488|2483391|P3|NOT COMPLETED|Overall Study||2
1023373|NCT00631488|2483392|P2|NOT COMPLETED|Overall Study||2
1023374|NCT00631488|2483393|P1|NOT COMPLETED|Overall Study||4
1023375|NCT00631488|2483391|P3|COMPLETED|Overall Study||47
1023376|NCT00631488|2483392|P2|COMPLETED|Overall Study||47
1023377|NCT00631488|2483393|P1|COMPLETED|Overall Study||44
1023378|NCT00631488|2483391|P3|Completed Post-Treatment Period|Overall Study||47
1023379|NCT00631488|2483392|P2|Completed Post-Treatment Period|Overall Study||47
1023380|NCT00631488|2483393|P1|Completed Post-Treatment Period|Overall Study||44
1023381|NCT00631488|2483391|P3|STARTED|Overall Study||49
1023382|NCT00631488|2483392|P2|STARTED|Overall Study||49
1023383|NCT00631488|2483393|P1|STARTED|Overall Study||48
1023384|NCT00631540|2483413|P1|NOT COMPLETED|Overall Study||14
1023385|NCT00631540|2483413|P1|COMPLETED|Overall Study||86
1023386|NCT00631540|2483413|P1|STARTED|Overall Study||100
1023387|NCT00631657|2483424|P3|NOT COMPLETED|7-Day Discontinuation Period||1
1023388|NCT00631657|2483425|P2|NOT COMPLETED|7-Day Discontinuation Period||1
1023389|NCT00631657|2483426|P1|NOT COMPLETED|7-Day Discontinuation Period||2
1023390|NCT00631657|2483424|P3|COMPLETED|7-Day Discontinuation Period||65
1023391|NCT00631657|2483425|P2|COMPLETED|7-Day Discontinuation Period||136
1023392|NCT00631657|2483426|P1|COMPLETED|7-Day Discontinuation Period||65
1023393|NCT00631657|2483424|P3|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|65
1023394|NCT00631657|2483425|P2|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|136
1023395|NCT00631657|2483426|P1|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|66
1023396|NCT00631657|2483424|P3|STARTED|7-Day Discontinuation Period||66
1023397|NCT00631657|2483425|P2|STARTED|7-Day Discontinuation Period||137
1023398|NCT00631657|2483426|P1|STARTED|7-Day Discontinuation Period|One participant was radomized in the Discont. Period, without completing the Treatment Period.|67
1023399|NCT00631657|2483424|P3|NOT COMPLETED|6-Month Treatment Period||50
1023400|NCT00631657|2483425|P2|NOT COMPLETED|6-Month Treatment Period||0
1023401|NCT00631657|2483426|P1|NOT COMPLETED|6-Month Treatment Period||141
1023402|NCT00631657|2483424|P3|COMPLETED|6-Month Treatment Period||66
1023403|NCT00631657|2483425|P2|COMPLETED|6-Month Treatment Period||0
1023404|NCT00631657|2483426|P1|COMPLETED|6-Month Treatment Period||203
1023405|NCT00631657|2483424|P3|Treated|6-Month Treatment Period|One randomized participant was not treated during the 6-month Treatment Period.|115
1023406|NCT00631657|2483425|P2|Treated|6-Month Treatment Period||0
1023407|NCT00631657|2483426|P1|Treated|6-Month Treatment Period|Two randomized participants were not treated during the 6-month Treatment Period.|342
1023408|NCT00631657|2483424|P3|STARTED|6-Month Treatment Period||116
1023409|NCT00631657|2483425|P2|STARTED|6-Month Treatment Period||0
1023410|NCT00631657|2483426|P1|STARTED|6-Month Treatment Period||344
1023411|NCT00631670|2483455|P2|NOT COMPLETED|Overall Study||0
1023412|NCT00631670|2483456|P1|NOT COMPLETED|Overall Study||0
1023413|NCT00631670|2483455|P2|COMPLETED|Overall Study||0
1023414|NCT00631670|2483456|P1|COMPLETED|Overall Study||21
1023415|NCT00631670|2483455|P2|STARTED|Overall Study||0
1023416|NCT00631670|2483456|P1|STARTED|Overall Study||21
1023417|NCT00631696|2483472|P2|NOT COMPLETED|Overall Study||40
1023418|NCT00631696|2483473|P1|NOT COMPLETED|Overall Study||37
1023419|NCT00631696|2483472|P2|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|70
1023420|NCT00631696|2483473|P1|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|75
1023421|NCT00631696|2483472|P2|Ongoing at Database Release 18Oct2011|Overall Study||0
1023422|NCT00631696|2483473|P1|Ongoing at Database Release 18Oct2011|Overall Study|Completed Tx at time of database release 18Oct2011; included in all analyses.|2
1023423|NCT00631696|2483472|P2|Received Study Treatment (Tx)|Overall Study||109
1023424|NCT00631696|2483473|P1|Received Study Treatment (Tx)|Overall Study||111
1023425|NCT00631696|2483472|P2|STARTED|Overall Study||110
1023426|NCT00631696|2483473|P1|STARTED|Overall Study||112
1023427|NCT00631748|2483499|P2|NOT COMPLETED|Overall Study||22
1023428|NCT00631748|2483500|P1|NOT COMPLETED|Overall Study||18
1023429|NCT00631748|2483499|P2|COMPLETED|Overall Study|9 participants completed the double-blind portion of the study; 5 participants completed follow-up.|9
1023430|NCT00631748|2483500|P1|COMPLETED|Overall Study|11 participants completed the double-blind portion of the study; 8 participants completed follow-up.|11
1023431|NCT00631748|2483499|P2|STARTED|Overall Study||31
1023432|NCT00631748|2483500|P1|STARTED|Overall Study||29
1023433|NCT00631917|2483510|P2|NOT COMPLETED|Overall Study||108
1023434|NCT00631917|2483511|P1|NOT COMPLETED|Overall Study||88
1023435|NCT00631917|2483510|P2|COMPLETED|Overall Study||291
1023436|NCT00631917|2483511|P1|COMPLETED|Overall Study||287
1023437|NCT00631917|2483510|P2|STARTED|Overall Study||399
1023438|NCT00631917|2483511|P1|STARTED|Overall Study||375
1023439|NCT00631969|2483527|P2|NOT COMPLETED|Overall Study||21
1023440|NCT00631969|2483528|P1|NOT COMPLETED|Overall Study||15
1023441|NCT00631969|2483527|P2|COMPLETED|Overall Study||155
1023442|NCT00631969|2483528|P1|COMPLETED|Overall Study||171
1023443|NCT00631969|2483527|P2|Received Treatment|Overall Study|safety population|174
1023444|NCT00631969|2483528|P1|Received Treatment|Overall Study|safety population|184
1023445|NCT00631969|2483527|P2|STARTED|Overall Study||176
1023446|NCT00631969|2483528|P1|STARTED|Overall Study||186
1023447|NCT00632021|2483574|P2|NOT COMPLETED|Overall Study||7
1023448|NCT00632021|2483575|P1|NOT COMPLETED|Overall Study||4
1023449|NCT00632021|2483574|P2|COMPLETED|Overall Study||423
1023450|NCT00632021|2483575|P1|COMPLETED|Overall Study||428
1023451|NCT00632021|2483574|P2|STARTED|Overall Study||430
1023452|NCT00632021|2483575|P1|STARTED|Overall Study||432
1023453|NCT00632099|2483585|P2|NOT COMPLETED|Overall Study||3
1023454|NCT00632099|2483586|P1|NOT COMPLETED|Overall Study||3
1023455|NCT00632099|2483585|P2|COMPLETED|Overall Study||8
1023456|NCT00632099|2483586|P1|COMPLETED|Overall Study||7
1023457|NCT00632099|2483585|P2|STARTED|Overall Study||11
1023458|NCT00632099|2483586|P1|STARTED|Overall Study||10
1023459|NCT00632125|2483592|P1|NOT COMPLETED|Overall Study||302
1023460|NCT00632125|2483592|P1|COMPLETED|Overall Study||1393
1023461|NCT00632125|2483592|P1|STARTED|Overall Study|1,698 patients were enrolled but 3 patients did not receive any study medication.|1695
1023462|NCT00632203|2483598|P2|NOT COMPLETED|Overall Study||0
1023463|NCT00632203|2483599|P1|NOT COMPLETED|Overall Study||1
1023464|NCT00632203|2483598|P2|COMPLETED|Overall Study||27
1023465|NCT00632203|2483599|P1|COMPLETED|Overall Study||25
1023466|NCT00632203|2483598|P2|STARTED|Overall Study||27
1023467|NCT00632203|2483599|P1|STARTED|Overall Study||26
1023468|NCT00632229|2483619|P2|NOT COMPLETED|Overall Study||6
1023469|NCT00632229|2483620|P1|NOT COMPLETED|Overall Study||6
1023470|NCT00632229|2483619|P2|COMPLETED|Overall Study||11
1023471|NCT00632229|2483620|P1|COMPLETED|Overall Study||11
1023472|NCT00632229|2483619|P2|STARTED|Overall Study||17
1023473|NCT00632229|2483620|P1|STARTED|Overall Study||17
1023474|NCT00632281|2483628|P1|NOT COMPLETED|Overall Study||0
1023475|NCT00632281|2483628|P1|COMPLETED|Overall Study||38
1023476|NCT00632281|2483628|P1|STARTED|Overall Study||38
1023477|NCT00638183|2483633|P1|NOT COMPLETED|Overall Study||119
1023478|NCT00638183|2483633|P1|COMPLETED|Overall Study||266
1023479|NCT00638183|2483633|P1|STARTED|Overall Study||385
1023480|NCT00638222|2483643|P3|NOT COMPLETED|Overall Study||0
1023481|NCT00638222|2483644|P2|NOT COMPLETED|Overall Study||0
1023482|NCT00638222|2483645|P1|NOT COMPLETED|Overall Study||0
1023483|NCT00638222|2483643|P3|COMPLETED|Overall Study||6
1023484|NCT00638222|2483644|P2|COMPLETED|Overall Study||0
1023485|NCT00638222|2483645|P1|COMPLETED|Overall Study||0
1023486|NCT00638222|2483643|P3|STARTED|Overall Study||6
1023487|NCT00638222|2483644|P2|STARTED|Overall Study||0
1023488|NCT00638222|2483645|P1|STARTED|Overall Study||0
1023489|NCT00638235|2483661|P9|NOT COMPLETED|Overall Study||18
1023490|NCT00638235|2483662|P8|NOT COMPLETED|Overall Study||1
1023491|NCT00638235|2483663|P7|NOT COMPLETED|Overall Study||0
1023492|NCT00638235|2483664|P6|NOT COMPLETED|Overall Study||26
1023493|NCT00638235|2483665|P5|NOT COMPLETED|Overall Study||13
1023494|NCT00638235|2483666|P4|NOT COMPLETED|Overall Study||10
1023495|NCT00638235|2483667|P3|NOT COMPLETED|Overall Study||18
1023496|NCT00638235|2483668|P2|NOT COMPLETED|Overall Study||3
1023497|NCT00638235|2483669|P1|NOT COMPLETED|Overall Study||31
1023498|NCT00638235|2483661|P9|COMPLETED|Overall Study||124
1023499|NCT00638235|2483662|P8|COMPLETED|Overall Study|Ph-VI ended after 12M b/c next generation of Elevate Anterior was already under trial in Phase VII|34
1023500|NCT00638235|2483663|P7|COMPLETED|Overall Study||23
1023501|NCT00638235|2483664|P6|COMPLETED|Overall Study||113
1023502|NCT00638235|2483665|P5|COMPLETED|Overall Study||42
1023503|NCT00638235|2483666|P4|COMPLETED|Overall Study||46
1023504|NCT00638235|2483667|P3|COMPLETED|Overall Study|Ph-II ended before all subjects had 24M b/c Perigee next generation was already under trial P-III/IV|63
1023505|NCT00638235|2483668|P2|COMPLETED|Overall Study||23
1023506|NCT00638235|2483669|P1|COMPLETED|Overall Study||110
1023507|NCT00638235|2483661|P9|STARTED|Overall Study||142
1023508|NCT00638235|2483662|P8|STARTED|Overall Study||35
1023509|NCT00638235|2483663|P7|STARTED|Overall Study||23
1023510|NCT00638235|2483664|P6|STARTED|Overall Study||139
1023511|NCT00638235|2483665|P5|STARTED|Overall Study||55
1023512|NCT00638235|2483666|P4|STARTED|Overall Study||56
1023513|NCT00638235|2483667|P3|STARTED|Overall Study||81
1023514|NCT00638235|2483668|P2|STARTED|Overall Study||26
1023515|NCT00638235|2483669|P1|STARTED|Overall Study||141
1023516|NCT00638365|2484070|P3|NOT COMPLETED|Overall Study||0
1023517|NCT00638365|2484071|P2|NOT COMPLETED|Overall Study||0
1023518|NCT00638365|2484072|P1|NOT COMPLETED|Overall Study||0
1023519|NCT00638365|2484070|P3|COMPLETED|Overall Study||8
1023520|NCT00638365|2484071|P2|COMPLETED|Overall Study||10
1023521|NCT00638365|2484072|P1|COMPLETED|Overall Study||9
1023522|NCT00638365|2484070|P3|STARTED|Overall Study||8
1023523|NCT00638365|2484071|P2|STARTED|Overall Study||10
1023524|NCT00638365|2484072|P1|STARTED|Overall Study||9
1023525|NCT00638378|2484080|P1|NOT COMPLETED|Overall Study||22
1023526|NCT00638378|2484080|P1|COMPLETED|Overall Study||0
1023527|NCT00638378|2484080|P1|STARTED|Overall Study||22
1023528|NCT00638443|2484087|P2|NOT COMPLETED|Second Intervention||0
1023529|NCT00638443|2484088|P1|NOT COMPLETED|Second Intervention||0
1023530|NCT00638443|2484087|P2|COMPLETED|Second Intervention||14
1023531|NCT00638443|2484088|P1|COMPLETED|Second Intervention||12
1023532|NCT00638443|2484087|P2|STARTED|Second Intervention||14
1023533|NCT00638443|2484088|P1|STARTED|Second Intervention||12
1023534|NCT00638443|2484087|P2|NOT COMPLETED|Washout||0
1023535|NCT00638443|2484088|P1|NOT COMPLETED|Washout||0
1023536|NCT00638443|2484087|P2|COMPLETED|Washout||14
1023537|NCT00638443|2484088|P1|COMPLETED|Washout||12
1023538|NCT00638443|2484087|P2|STARTED|Washout||14
1023539|NCT00638443|2484088|P1|STARTED|Washout||12
1023540|NCT00638443|2484087|P2|NOT COMPLETED|First Intervention||1
1023541|NCT00638443|2484088|P1|NOT COMPLETED|First Intervention||2
1023542|NCT00638443|2484087|P2|COMPLETED|First Intervention||14
1023543|NCT00638443|2484088|P1|COMPLETED|First Intervention||12
1023544|NCT00638443|2484087|P2|STARTED|First Intervention||15
1023545|NCT00638443|2484088|P1|STARTED|First Intervention||14
1023546|NCT00638924|2484116|P1|NOT COMPLETED|Overall Study||0
1023547|NCT00638924|2484116|P1|COMPLETED|Overall Study||40
1023548|NCT00638924|2484116|P1|2 Months|Overall Study||40
1023549|NCT00638924|2484116|P1|STARTED|Overall Study||40
1023550|NCT00638937|2484121|P1|NOT COMPLETED|Overall Study||0
1023551|NCT00638937|2484121|P1|COMPLETED|Overall Study||37
1023552|NCT00638937|2484121|P1|STARTED|Overall Study||37
1023553|NCT00638963|2484133|P2|NOT COMPLETED|Overall Study||0
1023554|NCT00638963|2484134|P1|NOT COMPLETED|Overall Study||1
1023555|NCT00638963|2484133|P2|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|3
1023556|NCT00638963|2484134|P1|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|2
1023557|NCT00638963|2484133|P2|STARTED|Overall Study|Received randomized treatment assignment|3
1023558|NCT00638963|2484134|P1|STARTED|Overall Study|Received randomized treatment assignment|3
1023559|NCT00638989|2484156|P3|NOT COMPLETED|Overall Study||1
1023560|NCT00638989|2484157|P2|NOT COMPLETED|Overall Study||0
1023561|NCT00638989|2484158|P1|NOT COMPLETED|Overall Study||0
1023562|NCT00638989|2484156|P3|COMPLETED|Overall Study||9
1023563|NCT00638989|2484157|P2|COMPLETED|Overall Study||10
1023564|NCT00638989|2484158|P1|COMPLETED|Overall Study||10
1023565|NCT00638989|2484156|P3|STARTED|Overall Study||10
1023566|NCT00638989|2484157|P2|STARTED|Overall Study||10
1023567|NCT00638989|2484158|P1|STARTED|Overall Study||10
1023568|NCT00639002|2484196|P1|NOT COMPLETED|Overall Study||13
1023569|NCT00639002|2484196|P1|COMPLETED|Overall Study||0
1023570|NCT00639002|2484196|P1|Received Ruxolitinib + Dexamethasone|Overall Study||7
1023571|NCT00639002|2484196|P1|Received Ruxolitinib|Overall Study||13
1023572|NCT00639002|2484196|P1|STARTED|Overall Study||13
1023573|NCT00639093|2484204|P2|NOT COMPLETED|Overall Study||0
1023574|NCT00639093|2484205|P1|NOT COMPLETED|Overall Study||0
1023575|NCT00639093|2484204|P2|COMPLETED|Overall Study|46|46
1023576|NCT00639093|2484205|P1|COMPLETED|Overall Study|45|45
1023577|NCT00639093|2484204|P2|STARTED|Overall Study|46|46
1023578|NCT00639093|2484205|P1|STARTED|Overall Study|45|45
1023579|NCT00639158|2484213|P2|NOT COMPLETED|Overall Study||30
1023580|NCT00639158|2484214|P1|NOT COMPLETED|Overall Study||26
1023581|NCT00639158|2484213|P2|COMPLETED|Overall Study|30 subjects prematurely discontinued treatment|240
1023582|NCT00639158|2484214|P1|COMPLETED|Overall Study|26 subjects prematurely discontinued treatment.|246
1023583|NCT00639158|2484213|P2|STARTED|Overall Study|1 subject was randomized but not treated because of an abnormal ECG that precluded treatment.|270
1023584|NCT00639158|2484214|P1|STARTED|Overall Study|All randomized subjects were treated.|272
1023585|NCT00639223|2484236|P2|NOT COMPLETED|Overall Study||2
1023586|NCT00639223|2484237|P1|NOT COMPLETED|Overall Study||0
1023587|NCT00639223|2484236|P2|COMPLETED|Overall Study||19
1023588|NCT00639223|2484237|P1|COMPLETED|Overall Study||22
1023589|NCT00639223|2484236|P2|STARTED|Overall Study||21
1023590|NCT00639223|2484237|P1|STARTED|Overall Study||22
1023591|NCT00639379|2484245|P2|NOT COMPLETED|Period 2 - 2 Weeks||0
1023592|NCT00639379|2484246|P1|NOT COMPLETED|Period 2 - 2 Weeks||0
1023593|NCT00639379|2484245|P2|COMPLETED|Period 2 - 2 Weeks||45
1023594|NCT00639379|2484246|P1|COMPLETED|Period 2 - 2 Weeks||39
1023595|NCT00639379|2484245|P2|STARTED|Period 2 - 2 Weeks||45
1023596|NCT00639379|2484246|P1|STARTED|Period 2 - 2 Weeks||39
1023597|NCT00639379|2484245|P2|NOT COMPLETED|Period 1 - 2 Weeks||0
1023598|NCT00639379|2484246|P1|NOT COMPLETED|Period 1 - 2 Weeks||5
1023599|NCT00639379|2484245|P2|COMPLETED|Period 1 - 2 Weeks||45
1023600|NCT00639379|2484246|P1|COMPLETED|Period 1 - 2 Weeks||39
1023601|NCT00639379|2484245|P2|STARTED|Period 1 - 2 Weeks||45
1023602|NCT00639379|2484246|P1|STARTED|Period 1 - 2 Weeks||44
1023603|NCT00639418|2484264|P4|NOT COMPLETED|Overall Study||0
1023604|NCT00639418|2484265|P3|NOT COMPLETED|Overall Study||0
1023605|NCT00639418|2484266|P2|NOT COMPLETED|Overall Study||0
1023606|NCT00639418|2484267|P1|NOT COMPLETED|Overall Study||0
1023607|NCT00639418|2484264|P4|COMPLETED|Overall Study||46930
1023608|NCT00639418|2484265|P3|COMPLETED|Overall Study||36496
1023609|NCT00639418|2484266|P2|COMPLETED|Overall Study||35967
1023610|NCT00639418|2484267|P1|COMPLETED|Overall Study||28101
1023611|NCT00639418|2484264|P4|STARTED|Overall Study||46930
1023612|NCT00639418|2484265|P3|STARTED|Overall Study||36496
1023613|NCT00639418|2484266|P2|STARTED|Overall Study||35967
1023614|NCT00639418|2484267|P1|STARTED|Overall Study||28101
1023615|NCT00639457|2484287|P2|NOT COMPLETED|Overall Study||3
1023616|NCT00639457|2484288|P1|NOT COMPLETED|Overall Study||2
1023617|NCT00639457|2484287|P2|COMPLETED|Overall Study||19
1023618|NCT00639457|2484288|P1|COMPLETED|Overall Study||20
1023619|NCT00639457|2484287|P2|STARTED|Overall Study||22
1023620|NCT00639457|2484288|P1|STARTED|Overall Study||22
1023621|NCT00639509|2484322|P1|NOT COMPLETED|Overall Study||1
1023622|NCT00639509|2484322|P1|COMPLETED|Overall Study||23
1023623|NCT00639509|2484322|P1|STARTED|Overall Study||24
1023624|NCT00639678|2484332|P4|NOT COMPLETED|Overall Study||0
1023625|NCT00639678|2484333|P3|NOT COMPLETED|Overall Study||11
1023626|NCT00639678|2484334|P2|NOT COMPLETED|Overall Study||1
1023627|NCT00639678|2484335|P1|NOT COMPLETED|Overall Study||4
1023628|NCT00639678|2484332|P4|COMPLETED|Overall Study||23
1023629|NCT00639678|2484333|P3|COMPLETED|Overall Study||206
1023630|NCT00639678|2484334|P2|COMPLETED|Overall Study||5
1023631|NCT00639678|2484335|P1|COMPLETED|Overall Study||70
1023632|NCT00639678|2484332|P4|STARTED|Overall Study||23
1023633|NCT00639678|2484333|P3|STARTED|Overall Study||217
1023634|NCT00639678|2484334|P2|STARTED|Overall Study||6
1023635|NCT00639678|2484335|P1|STARTED|Overall Study||74
1023636|NCT00639717|2484395|P1|NOT COMPLETED|Overall Study||0
1023637|NCT00639717|2484395|P1|COMPLETED|Overall Study||48
1023638|NCT00639717|2484395|P1|STARTED|Overall Study||48
1023639|NCT00639769|2484403|P1|NOT COMPLETED|Overall Study||40
1023640|NCT00639769|2484403|P1|COMPLETED|Overall Study||0
1023641|NCT00639769|2484403|P1|STARTED|Overall Study||40
1023642|NCT00639860|2484408|P1|NOT COMPLETED|Overall Study||0
1023643|NCT00639860|2484408|P1|COMPLETED|Overall Study||10
1023644|NCT00639860|2484408|P1|STARTED|Overall Study||10
1023645|NCT00640016|2484420|P4|NOT COMPLETED|Overall Study||3
1023646|NCT00640016|2484421|P3|NOT COMPLETED|Overall Study||3
1023647|NCT00640016|2484422|P2|NOT COMPLETED|Overall Study||2
1023648|NCT00640016|2484423|P1|NOT COMPLETED|Overall Study||2
1023649|NCT00640016|2484420|P4|COMPLETED|Overall Study||1
1023650|NCT00640016|2484421|P3|COMPLETED|Overall Study||1
1023651|NCT00640016|2484422|P2|COMPLETED|Overall Study||1
1023652|NCT00640016|2484423|P1|COMPLETED|Overall Study||1
1023653|NCT00640016|2484420|P4|Treated|Overall Study||4
1023654|NCT00640016|2484421|P3|Treated|Overall Study||4
1023655|NCT00640016|2484422|P2|Treated|Overall Study||2
1023656|NCT00640016|2484423|P1|Treated|Overall Study||3
1023657|NCT00640016|2484420|P4|STARTED|Overall Study||4
1023658|NCT00640016|2484421|P3|STARTED|Overall Study||4
1023659|NCT00640016|2484422|P2|STARTED|Overall Study||3
1023660|NCT00640016|2484423|P1|STARTED|Overall Study||3
1023661|NCT00640042|2484467|P1|NOT COMPLETED|Treatment||926
1023662|NCT00640042|2484467|P1|COMPLETED|Treatment||561
1023663|NCT00640042|2484467|P1|STARTED|Treatment||1487
1023664|NCT00640042|2484467|P1|NOT COMPLETED|Enrollment||83
1023665|NCT00640042|2484467|P1|COMPLETED|Enrollment|Number of patients with evidence of study drug receipt|1487
1023666|NCT00640042|2484467|P1|STARTED|Enrollment|Number of patients with evidence of prescription card receipt|1570
1023667|NCT00640315|2484481|P2|NOT COMPLETED|Overall Study||1
1023668|NCT00640315|2484482|P1|NOT COMPLETED|Overall Study||0
1023669|NCT00640315|2484481|P2|COMPLETED|Overall Study||12
1023670|NCT00640315|2484482|P1|COMPLETED|Overall Study||10
1023671|NCT00640315|2484481|P2|Participants Received Treatment|Overall Study||13
1023672|NCT00640315|2484482|P1|Participants Received Treatment|Overall Study||10
1023673|NCT00640315|2484481|P2|STARTED|Overall Study||13
1023674|NCT00640315|2484482|P1|STARTED|Overall Study||10
1023675|NCT00640328|2484614|P6|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
1023676|NCT00640328|2484615|P5|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
1023677|NCT00640328|2484616|P4|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
1023678|NCT00640328|2484617|P3|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
1023679|NCT00640328|2484618|P2|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
1023680|NCT00640328|2484619|P1|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
1023681|NCT00640328|2484614|P6|COMPLETED|IFUP (Week 48 to Individual Termination)||4
1023682|NCT00640328|2484615|P5|COMPLETED|IFUP (Week 48 to Individual Termination)||4
1023683|NCT00640328|2484616|P4|COMPLETED|IFUP (Week 48 to Individual Termination)||3
1023684|NCT00640328|2484617|P3|COMPLETED|IFUP (Week 48 to Individual Termination)||6
1023685|NCT00640328|2484618|P2|COMPLETED|IFUP (Week 48 to Individual Termination)||10
1023686|NCT00640328|2484619|P1|COMPLETED|IFUP (Week 48 to Individual Termination)||8
1023687|NCT00640328|2484614|P6|STARTED|IFUP (Week 48 to Individual Termination)||4
1023688|NCT00640328|2484615|P5|STARTED|IFUP (Week 48 to Individual Termination)||4
1023689|NCT00640328|2484616|P4|STARTED|IFUP (Week 48 to Individual Termination)||4
1023690|NCT00640328|2484617|P3|STARTED|IFUP (Week 48 to Individual Termination)||7
1023691|NCT00640328|2484618|P2|STARTED|IFUP (Week 48 to Individual Termination)||11
1023692|NCT00640328|2484619|P1|STARTED|IFUP (Week 48 to Individual Termination)||8
1023693|NCT00640328|2484614|P6|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
1023694|NCT00640328|2484615|P5|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||1
1023695|NCT00640328|2484616|P4|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
1023696|NCT00640328|2484617|P3|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
1023697|NCT00640328|2484618|P2|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
1023698|NCT00640328|2484619|P1|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
1023699|NCT00640328|2484614|P6|COMPLETED|Second Treatment Period (Weeks 24-48)||4
1023700|NCT00640328|2484615|P5|COMPLETED|Second Treatment Period (Weeks 24-48)||3
1023701|NCT00640328|2484616|P4|COMPLETED|Second Treatment Period (Weeks 24-48)||4
1023702|NCT00640328|2484617|P3|COMPLETED|Second Treatment Period (Weeks 24-48)||7
1023703|NCT00640328|2484618|P2|COMPLETED|Second Treatment Period (Weeks 24-48)||10
1023704|NCT00640328|2484619|P1|COMPLETED|Second Treatment Period (Weeks 24-48)||8
1023705|NCT00640328|2484614|P6|STARTED|Second Treatment Period (Weeks 24-48)||4
1023706|NCT00640328|2484615|P5|STARTED|Second Treatment Period (Weeks 24-48)||4
1023707|NCT00640328|2484616|P4|STARTED|Second Treatment Period (Weeks 24-48)||4
1023708|NCT00640328|2484617|P3|STARTED|Second Treatment Period (Weeks 24-48)||7
1023709|NCT00640328|2484618|P2|STARTED|Second Treatment Period (Weeks 24-48)||10
1023710|NCT00640328|2484619|P1|STARTED|Second Treatment Period (Weeks 24-48)||8
1023711|NCT00640328|2484614|P6|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
1023712|NCT00640328|2484615|P5|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
1023713|NCT00640328|2484616|P4|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
1023714|NCT00640328|2484617|P3|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
1023715|NCT00640328|2484618|P2|NOT COMPLETED|First Treatment Period (Weeks 0-24)||1
1023716|NCT00640328|2484619|P1|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
1023717|NCT00640328|2484614|P6|COMPLETED|First Treatment Period (Weeks 0-24)||4
1023718|NCT00640328|2484615|P5|COMPLETED|First Treatment Period (Weeks 0-24)||4
1023719|NCT00640328|2484616|P4|COMPLETED|First Treatment Period (Weeks 0-24)||4
1023720|NCT00640328|2484617|P3|COMPLETED|First Treatment Period (Weeks 0-24)||7
1023721|NCT00640328|2484618|P2|COMPLETED|First Treatment Period (Weeks 0-24)||10
1023722|NCT00640328|2484619|P1|COMPLETED|First Treatment Period (Weeks 0-24)||8
1023723|NCT00640328|2484614|P6|STARTED|First Treatment Period (Weeks 0-24)||4
1023724|NCT00640328|2484615|P5|STARTED|First Treatment Period (Weeks 0-24)||4
1023725|NCT00640328|2484616|P4|STARTED|First Treatment Period (Weeks 0-24)||4
1023726|NCT00640328|2484617|P3|STARTED|First Treatment Period (Weeks 0-24)||7
1023727|NCT00640328|2484618|P2|STARTED|First Treatment Period (Weeks 0-24)||11
1023728|NCT00640328|2484619|P1|STARTED|First Treatment Period (Weeks 0-24)||8
1023729|NCT00640341|2484786|P3|NOT COMPLETED|Overall Study||7
1023730|NCT00640341|2484787|P2|NOT COMPLETED|Overall Study||5
1023731|NCT00640341|2484788|P1|NOT COMPLETED|Overall Study||21
1023732|NCT00640341|2484786|P3|COMPLETED|Overall Study||163
1023733|NCT00640341|2484787|P2|COMPLETED|Overall Study||165
1023734|NCT00640341|2484788|P1|COMPLETED|Overall Study||149
1023735|NCT00640341|2484786|P3|Eligible Participants at Baseline|Overall Study||168
1023736|NCT00640341|2484787|P2|Eligible Participants at Baseline|Overall Study||167
1023737|NCT00640341|2484788|P1|Eligible Participants at Baseline|Overall Study||165
1023738|NCT00640341|2484786|P3|STARTED|Overall Study||170
1023739|NCT00640341|2484787|P2|STARTED|Overall Study||170
1023740|NCT00640341|2484788|P1|STARTED|Overall Study|All Starting participants were dispensed lenses|170
1023741|NCT00640393|2484802|P3|NOT COMPLETED|Part 2||3
1023742|NCT00640393|2484803|P2|NOT COMPLETED|Part 2||10
1023743|NCT00640393|2484804|P1|NOT COMPLETED|Part 2||0
1023744|NCT00640393|2484802|P3|COMPLETED|Part 2|Per protocol analysis of 27 to 29 participants that were compliant depending on evaluation or visit|35
1023745|NCT00640393|2484803|P2|COMPLETED|Part 2|Per Protocol analysis is of 7 participants that were compliant to protocol|27
1023746|NCT00640393|2484804|P1|COMPLETED|Part 2||0
1023747|NCT00640393|2484802|P3|STARTED|Part 2||38
1023748|NCT00640393|2484803|P2|STARTED|Part 2||37
1023749|NCT00640393|2484804|P1|STARTED|Part 2||0
1023750|NCT00640393|2484802|P3|NOT COMPLETED|Randomization||0
1023751|NCT00640393|2484803|P2|NOT COMPLETED|Randomization||0
1023752|NCT00640393|2484804|P1|NOT COMPLETED|Randomization||19
1023753|NCT00640393|2484802|P3|COMPLETED|Randomization||0
1023754|NCT00640393|2484803|P2|COMPLETED|Randomization||0
1023755|NCT00640393|2484804|P1|COMPLETED|Randomization||75
1023756|NCT00640393|2484802|P3|STARTED|Randomization||0
1023757|NCT00640393|2484803|P2|STARTED|Randomization||0
1023758|NCT00640393|2484804|P1|STARTED|Randomization||94
1023759|NCT00640393|2484802|P3|NOT COMPLETED|Part 1||0
1023760|NCT00640393|2484803|P2|NOT COMPLETED|Part 1||0
1023761|NCT00640393|2484804|P1|NOT COMPLETED|Part 1||5
1023762|NCT00640393|2484802|P3|COMPLETED|Part 1||0
1023763|NCT00640393|2484803|P2|COMPLETED|Part 1||0
1023764|NCT00640393|2484804|P1|COMPLETED|Part 1||94
1023765|NCT00640393|2484802|P3|STARTED|Part 1||0
1023766|NCT00640393|2484803|P2|STARTED|Part 1||0
1023767|NCT00640393|2484804|P1|STARTED|Part 1||99
1023768|NCT00640510|2484868|P2|NOT COMPLETED|Overall Study||2
1023769|NCT00640510|2484869|P1|NOT COMPLETED|Overall Study||1
1023770|NCT00640510|2484868|P2|COMPLETED|Overall Study||15
1023771|NCT00640510|2484869|P1|COMPLETED|Overall Study||16
1023772|NCT00640510|2484868|P2|STARTED|Overall Study|One patient randomized to placebo discontinued prior to receiving study drug.|17
1023773|NCT00640510|2484869|P1|STARTED|Overall Study||17
1023774|NCT00640562|2484883|P2|NOT COMPLETED|Overall Study||26
1023775|NCT00640562|2484884|P1|NOT COMPLETED|Overall Study||18
1023776|NCT00640562|2484883|P2|COMPLETED|Overall Study||81
1023777|NCT00640562|2484884|P1|COMPLETED|Overall Study||91
1023778|NCT00640562|2484883|P2|STARTED|Overall Study||107
1023779|NCT00640562|2484884|P1|STARTED|Overall Study||109
1023780|NCT00640601|2484910|P1|NOT COMPLETED|Overall Study||112
1023781|NCT00640601|2484910|P1|COMPLETED|Overall Study||183
1023782|NCT00640601|2484910|P1|STARTED|Overall Study|331 patients enrolled and 295 patients started investigational product (IP)|295
1023783|NCT00640614|2484926|P2|NOT COMPLETED|Overall Study||0
1023784|NCT00640614|2484927|P1|NOT COMPLETED|Overall Study||1
1023785|NCT00640614|2484926|P2|COMPLETED|Overall Study||110
1023786|NCT00640614|2484927|P1|COMPLETED|Overall Study||124
1023787|NCT00640614|2484926|P2|STARTED|Overall Study||110
1023788|NCT00640614|2484927|P1|STARTED|Overall Study||125
1023789|NCT00640822|2484972|P3|NOT COMPLETED|Overall Study||25
1023790|NCT00640822|2484973|P2|NOT COMPLETED|Overall Study||59
1023791|NCT00640822|2484974|P1|NOT COMPLETED|Overall Study||43
1023792|NCT00640822|2484972|P3|COMPLETED|Overall Study||77
1023793|NCT00640822|2484973|P2|COMPLETED|Overall Study||258
1023794|NCT00640822|2484974|P1|COMPLETED|Overall Study||279
1023795|NCT00640822|2484972|P3|STARTED|Overall Study||102
1023796|NCT00640822|2484973|P2|STARTED|Overall Study||317
1023797|NCT00640822|2484974|P1|STARTED|Overall Study||322
1023798|NCT00640835|2484984|P2|NOT COMPLETED|Overall Study||57
1023799|NCT00640835|2484985|P1|NOT COMPLETED|Overall Study||76
1023800|NCT00640835|2484984|P2|COMPLETED|Overall Study||131
1023801|NCT00640835|2484985|P1|COMPLETED|Overall Study||118
1023802|NCT00640835|2484984|P2|STARTED|Overall Study||188
1023803|NCT00640835|2484985|P1|STARTED|Overall Study||194
1023804|NCT00640926|2484996|P3|NOT COMPLETED|Overall Study||8
1023805|NCT00640926|2484997|P2|NOT COMPLETED|Overall Study||6
1023806|NCT00640926|2484998|P1|NOT COMPLETED|Overall Study||8
1023807|NCT00640926|2484996|P3|COMPLETED|Overall Study||45
1023808|NCT00640926|2484997|P2|COMPLETED|Overall Study||46
1023809|NCT00640926|2484998|P1|COMPLETED|Overall Study||45
1023810|NCT00640926|2484996|P3|STARTED|Overall Study||53
1023811|NCT00640926|2484997|P2|STARTED|Overall Study||52
1023812|NCT00640926|2484998|P1|STARTED|Overall Study||53
1023813|NCT00640978|2485009|P1|NOT COMPLETED|Overall Study||0
1023814|NCT00640978|2485009|P1|COMPLETED|Overall Study||15
1023815|NCT00640978|2485009|P1|STARTED|Overall Study||15
1023816|NCT00641043|2485015|P2|NOT COMPLETED|Overall Study||15
1023817|NCT00641043|2485016|P1|NOT COMPLETED|Overall Study||19
1023818|NCT00641043|2485015|P2|COMPLETED|Overall Study|number who completed treatment|244
1023819|NCT00641043|2485016|P1|COMPLETED|Overall Study|number who completed treatment|111
1023820|NCT00641043|2485015|P2|STARTED|Overall Study|number who started treatment|259
1023821|NCT00641043|2485016|P1|STARTED|Overall Study|number who started treatment|130
1023822|NCT00641056|2485048|P2|NOT COMPLETED|Overall Study||25
1023823|NCT00641056|2485049|P1|NOT COMPLETED|Overall Study||29
1023824|NCT00641056|2485048|P2|COMPLETED|Overall Study||209
1023825|NCT00641056|2485049|P1|COMPLETED|Overall Study||204
1023826|NCT00641056|2485048|P2|Intent to Treat (ITT)|Overall Study||223
1023827|NCT00641056|2485049|P1|Intent to Treat (ITT)|Overall Study||233
1023828|NCT00641056|2485048|P2|STARTED|Overall Study||234
1023829|NCT00641056|2485049|P1|STARTED|Overall Study||233
1023830|NCT00641147|2485077|P2|NOT COMPLETED|Completed 16 Months.||0
1023831|NCT00641147|2485078|P1|NOT COMPLETED|Completed 16 Months.||2
1023832|NCT00641147|2485077|P2|COMPLETED|Completed 16 Months.||19
1023833|NCT00641147|2485078|P1|COMPLETED|Completed 16 Months.||13
1023834|NCT00641147|2485077|P2|STARTED|Completed 16 Months.||19
1023835|NCT00641147|2485078|P1|STARTED|Completed 16 Months.||15
1023836|NCT00641147|2485077|P2|NOT COMPLETED|Completed 12 Months.||2
1023837|NCT00641147|2485078|P1|NOT COMPLETED|Completed 12 Months.||1
1023838|NCT00641147|2485077|P2|COMPLETED|Completed 12 Months.||19
1023839|NCT00641147|2485078|P1|COMPLETED|Completed 12 Months.||15
1023840|NCT00641147|2485077|P2|STARTED|Completed 12 Months.||21
1023841|NCT00641147|2485078|P1|STARTED|Completed 12 Months.||16
1023842|NCT00641147|2485077|P2|NOT COMPLETED|Completed 8 Months.||2
1023843|NCT00641147|2485078|P1|NOT COMPLETED|Completed 8 Months.||3
1023844|NCT00641147|2485077|P2|COMPLETED|Completed 8 Months.||21
1023845|NCT00641147|2485078|P1|COMPLETED|Completed 8 Months.||16
1023846|NCT00641147|2485077|P2|STARTED|Completed 8 Months.||23
1023847|NCT00641147|2485078|P1|STARTED|Completed 8 Months.||19
1023848|NCT00641147|2485077|P2|NOT COMPLETED|Completed 4 Months.||0
1023849|NCT00641147|2485078|P1|NOT COMPLETED|Completed 4 Months.||2
1023850|NCT00641147|2485077|P2|COMPLETED|Completed 4 Months.||23
1023851|NCT00641147|2485078|P1|COMPLETED|Completed 4 Months.||19
1023852|NCT00641147|2485077|P2|STARTED|Completed 4 Months.||23
1023853|NCT00641147|2485078|P1|STARTED|Completed 4 Months.||21
1023854|NCT00635219|2485125|P5|NOT COMPLETED|Overall Study||42
1023855|NCT00635219|2485126|P4|NOT COMPLETED|Overall Study||34
1023856|NCT00635219|2485127|P3|NOT COMPLETED|Overall Study||35
1023857|NCT00635219|2485128|P2|NOT COMPLETED|Overall Study||25
1023858|NCT00635219|2485129|P1|NOT COMPLETED|Overall Study||25
1023859|NCT00635219|2485125|P5|COMPLETED|Overall Study||113
1023860|NCT00635219|2485126|P4|COMPLETED|Overall Study||117
1023861|NCT00635219|2485127|P3|COMPLETED|Overall Study||122
1023862|NCT00635219|2485128|P2|COMPLETED|Overall Study||130
1023863|NCT00635219|2485129|P1|COMPLETED|Overall Study||123
1023864|NCT00635219|2485125|P5|STARTED|Overall Study||155
1023865|NCT00635219|2485126|P4|STARTED|Overall Study||151
1023866|NCT00635219|2485127|P3|STARTED|Overall Study||157
1023867|NCT00635219|2485128|P2|STARTED|Overall Study||155
1023868|NCT00635219|2485129|P1|STARTED|Overall Study||148
1023869|NCT00635232|2485191|P5|NOT COMPLETED|Overall Study||8
1023870|NCT00635232|2485192|P4|NOT COMPLETED|Overall Study||10
1023871|NCT00635232|2485193|P3|NOT COMPLETED|Overall Study||3
1023872|NCT00635232|2485194|P2|NOT COMPLETED|Overall Study||20
1023873|NCT00635232|2485195|P1|NOT COMPLETED|Overall Study||14
1023874|NCT00635232|2485191|P5|COMPLETED|Overall Study||20
1023875|NCT00635232|2485192|P4|COMPLETED|Overall Study||48
1023876|NCT00635232|2485193|P3|COMPLETED|Overall Study||55
1023877|NCT00635232|2485194|P2|COMPLETED|Overall Study||39
1023878|NCT00635232|2485195|P1|COMPLETED|Overall Study||44
1023879|NCT00635232|2485191|P5|STARTED|Overall Study||28
1023880|NCT00635232|2485192|P4|STARTED|Overall Study||58
1023881|NCT00635232|2485193|P3|STARTED|Overall Study||58
1023882|NCT00635232|2485194|P2|STARTED|Overall Study||59
1023883|NCT00635232|2485195|P1|STARTED|Overall Study||58
1023884|NCT00635349|2485219|P2|NOT COMPLETED|Overall Study||48
1023885|NCT00635349|2485220|P1|NOT COMPLETED|Overall Study||44
1023886|NCT00635349|2485219|P2|COMPLETED|Overall Study||19
1023887|NCT00635349|2485220|P1|COMPLETED|Overall Study||29
1023888|NCT00635349|2485219|P2|STARTED|Overall Study||67
1023889|NCT00635349|2485220|P1|STARTED|Overall Study||73
1023890|NCT00635362|2485240|P2|NOT COMPLETED|Overall Study||8
1023891|NCT00635362|2485241|P1|NOT COMPLETED|Overall Study||13
1023892|NCT00635362|2485240|P2|COMPLETED|Overall Study||12
1023893|NCT00635362|2485241|P1|COMPLETED|Overall Study||9
1023894|NCT00635362|2485240|P2|STARTED|Overall Study||20
1023895|NCT00635362|2485241|P1|STARTED|Overall Study||22
1023896|NCT00635427|2485260|P5|NOT COMPLETED|Overall Study||8
1023897|NCT00635427|2485261|P4|NOT COMPLETED|Overall Study||9
1023898|NCT00635427|2485262|P3|NOT COMPLETED|Overall Study||11
1023899|NCT00635427|2485263|P2|NOT COMPLETED|Overall Study||6
1023900|NCT00635427|2485264|P1|NOT COMPLETED|Overall Study||12
1023901|NCT00635427|2485260|P5|COMPLETED|Overall Study||30
1023902|NCT00635427|2485261|P4|COMPLETED|Overall Study||7
1023903|NCT00635427|2485262|P3|COMPLETED|Overall Study||5
1023904|NCT00635427|2485263|P2|COMPLETED|Overall Study||6
1023905|NCT00635427|2485264|P1|COMPLETED|Overall Study||1
1023906|NCT00635427|2485260|P5|STARTED|Overall Study||38
1023907|NCT00635427|2485261|P4|STARTED|Overall Study||16
1023908|NCT00635427|2485262|P3|STARTED|Overall Study||16
1023909|NCT00635427|2485263|P2|STARTED|Overall Study|11 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|12
1023910|NCT00635427|2485264|P1|STARTED|Overall Study|12 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|13
1023911|NCT00635479|2485286|P2|NOT COMPLETED|Overall Study||18
1023912|NCT00635479|2485287|P1|NOT COMPLETED|Overall Study||6
1023913|NCT00635479|2485286|P2|COMPLETED|Overall Study||42
1023914|NCT00635479|2485287|P1|COMPLETED|Overall Study||49
1023915|NCT00635479|2485286|P2|STARTED|Overall Study||60
1023916|NCT00635479|2485287|P1|STARTED|Overall Study||55
1023917|NCT00635492|2485295|P2|NOT COMPLETED|Overall Study||282
1023918|NCT00635492|2485296|P1|NOT COMPLETED|Overall Study||279
1023919|NCT00635492|2485295|P2|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|992
1023920|NCT00635492|2485296|P1|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|835
1023921|NCT00635492|2485295|P2|STARTED|Overall Study|This population consists of the analysis population.|1274
1023922|NCT00635492|2485296|P1|STARTED|Overall Study|This population consists of the analysis population.|1114
1023923|NCT00635570|2485342|P2|NOT COMPLETED|Overall Study||11
1023924|NCT00635570|2485343|P1|NOT COMPLETED|Overall Study||15
1023925|NCT00635570|2485342|P2|COMPLETED|Overall Study||126
1023926|NCT00635570|2485343|P1|COMPLETED|Overall Study||121
1023927|NCT00635570|2485342|P2|STARTED|Overall Study||137
1023928|NCT00635570|2485343|P1|STARTED|Overall Study||136
1023929|NCT00635609|2485357|P2|NOT COMPLETED|Overall Study||3
1023930|NCT00635609|2485358|P1|NOT COMPLETED|Overall Study||7
1023931|NCT00635609|2485357|P2|COMPLETED|Overall Study||42
1023932|NCT00635609|2485358|P1|COMPLETED|Overall Study||41
1023933|NCT00635609|2485357|P2|STARTED|Overall Study||45
1023934|NCT00635609|2485358|P1|STARTED|Overall Study||48
1023935|NCT00635648|2485368|P1|NOT COMPLETED|Overall Study||37
1023936|NCT00635648|2485368|P1|COMPLETED|Overall Study||26
1023937|NCT00635648|2485368|P1|STARTED|Overall Study||63
1023938|NCT00641537|2485380|P8|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
1023939|NCT00641537|2485381|P7|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
1023940|NCT00641537|2485382|P6|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
1023941|NCT00641537|2485383|P5|NOT COMPLETED|24-Week Supplemental Follow-up Period||5
1023942|NCT00641537|2485384|P4|NOT COMPLETED|24-Week Supplemental Follow-up Period||4
1023943|NCT00641537|2485385|P3|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
1023944|NCT00641537|2485386|P2|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
1023945|NCT00641537|2485387|P1|NOT COMPLETED|24-Week Supplemental Follow-up Period||0
1023946|NCT00641537|2485380|P8|COMPLETED|24-Week Supplemental Follow-up Period||10
1023947|NCT00641537|2485381|P7|COMPLETED|24-Week Supplemental Follow-up Period||8
1023948|NCT00641537|2485382|P6|COMPLETED|24-Week Supplemental Follow-up Period||14
1023949|NCT00641537|2485383|P5|COMPLETED|24-Week Supplemental Follow-up Period||193
1023950|NCT00641537|2485384|P4|COMPLETED|24-Week Supplemental Follow-up Period||147
1023951|NCT00641537|2485385|P3|COMPLETED|24-Week Supplemental Follow-up Period||140
1023952|NCT00641537|2485386|P2|COMPLETED|24-Week Supplemental Follow-up Period||66
1023953|NCT00641537|2485387|P1|COMPLETED|24-Week Supplemental Follow-up Period||75
1023954|NCT00641537|2485380|P8|STARTED|24-Week Supplemental Follow-up Period||11
1023955|NCT00641537|2485381|P7|STARTED|24-Week Supplemental Follow-up Period||9
1023956|NCT00641537|2485382|P6|STARTED|24-Week Supplemental Follow-up Period||15
1023957|NCT00641537|2485383|P5|STARTED|24-Week Supplemental Follow-up Period||198
1023958|NCT00641537|2485384|P4|STARTED|24-Week Supplemental Follow-up Period||151
1023959|NCT00641537|2485385|P3|STARTED|24-Week Supplemental Follow-up Period||143
1023960|NCT00641537|2485386|P2|STARTED|24-Week Supplemental Follow-up Period||69
1023961|NCT00641537|2485387|P1|STARTED|24-Week Supplemental Follow-up Period||75
1023962|NCT00641537|2485380|P8|NOT COMPLETED|96-week Period||6
1023963|NCT00641537|2485381|P7|NOT COMPLETED|96-week Period||5
1023964|NCT00641537|2485382|P6|NOT COMPLETED|96-week Period||7
1023965|NCT00641537|2485383|P5|NOT COMPLETED|96-week Period||18
1023966|NCT00641537|2485384|P4|NOT COMPLETED|96-week Period||12
1023967|NCT00641537|2485385|P3|NOT COMPLETED|96-week Period||20
1023968|NCT00641537|2485386|P2|NOT COMPLETED|96-week Period||10
1023969|NCT00641537|2485387|P1|NOT COMPLETED|96-week Period||9
1023970|NCT00641537|2485380|P8|COMPLETED|96-week Period||16
1023971|NCT00641537|2485381|P7|COMPLETED|96-week Period||12
1023972|NCT00641537|2485382|P6|COMPLETED|96-week Period||15
1023973|NCT00641537|2485383|P5|COMPLETED|96-week Period||226
1023974|NCT00641537|2485384|P4|COMPLETED|96-week Period||174
1023975|NCT00641537|2485385|P3|COMPLETED|96-week Period||166
1023976|NCT00641537|2485386|P2|COMPLETED|96-week Period||82
1023977|NCT00641537|2485387|P1|COMPLETED|96-week Period||89
1023978|NCT00641537|2485380|P8|STARTED|96-week Period||22
1023979|NCT00641537|2485381|P7|STARTED|96-week Period||17
1023980|NCT00641537|2485382|P6|STARTED|96-week Period||22
1023981|NCT00641537|2485383|P5|STARTED|96-week Period||244
1023982|NCT00641537|2485384|P4|STARTED|96-week Period||186
1023983|NCT00641537|2485385|P3|STARTED|96-week Period||186
1023984|NCT00641537|2485386|P2|STARTED|96-week Period||92
1023985|NCT00641537|2485387|P1|STARTED|96-week Period||98
1023986|NCT00641563|2485440|P2|NOT COMPLETED|Infusion 2||0
1023987|NCT00641563|2485441|P1|NOT COMPLETED|Infusion 2||0
1023988|NCT00641563|2485440|P2|COMPLETED|Infusion 2||5
1023989|NCT00641563|2485441|P1|COMPLETED|Infusion 2||5
1023990|NCT00641563|2485440|P2|STARTED|Infusion 2||5
1023991|NCT00641563|2485441|P1|STARTED|Infusion 2||5
1023992|NCT00641563|2485440|P2|NOT COMPLETED|Infusion 1||0
1023993|NCT00641563|2485441|P1|NOT COMPLETED|Infusion 1||0
1023994|NCT00641563|2485440|P2|COMPLETED|Infusion 1||5
1023995|NCT00641563|2485441|P1|COMPLETED|Infusion 1||5
1023996|NCT00641563|2485440|P2|STARTED|Infusion 1||5
1023997|NCT00641563|2485441|P1|STARTED|Infusion 1||5
1023998|NCT00641641|2485449|P1|NOT COMPLETED|Overall Study||0
1023999|NCT00641641|2485449|P1|COMPLETED|Overall Study||16
1024000|NCT00641641|2485449|P1|STARTED|Overall Study||16
1024001|NCT00641667|2485453|P1|NOT COMPLETED|Overall Study||6
1024002|NCT00641667|2485453|P1|COMPLETED|Overall Study||60
1024003|NCT00641667|2485453|P1|STARTED|Overall Study||66
1024004|NCT00641706|2485465|P2|NOT COMPLETED|Overall Study||3
1024005|NCT00641706|2485466|P1|NOT COMPLETED|Overall Study||9
1024006|NCT00641706|2485465|P2|COMPLETED|Overall Study||4
1024007|NCT00641706|2485466|P1|COMPLETED|Overall Study||28
1024008|NCT00641706|2485465|P2|STARTED|Overall Study||7
1024009|NCT00641706|2485466|P1|STARTED|Overall Study||37
1024010|NCT00641719|2485480|P2|NOT COMPLETED|Overall Study||37
1024011|NCT00641719|2485481|P1|NOT COMPLETED|Overall Study||30
1024012|NCT00641719|2485480|P2|COMPLETED|Overall Study|1 participant discontinued during taper phase, not during treatment phase.|92
1024013|NCT00641719|2485481|P1|COMPLETED|Overall Study||99
1024014|NCT00641719|2485480|P2|STARTED|Overall Study||129
1024015|NCT00641719|2485481|P1|STARTED|Overall Study||129
1024016|NCT00641745|2485505|P2|NOT COMPLETED|Overall Study||113
1024017|NCT00641745|2485506|P1|NOT COMPLETED|Overall Study||280
1024018|NCT00641745|2485505|P2|COMPLETED|Overall Study||89
1024019|NCT00641745|2485506|P1|COMPLETED|Overall Study||147
1024020|NCT00641745|2485505|P2|STARTED|Overall Study||202
1024021|NCT00641745|2485506|P1|STARTED|Overall Study||427
1024022|NCT00642473|2485514|P2|NOT COMPLETED|Overall Study||11
1024023|NCT00642473|2485515|P1|NOT COMPLETED|Overall Study||4
1024024|NCT00642473|2485514|P2|COMPLETED|Overall Study||5
1024025|NCT00642473|2485515|P1|COMPLETED|Overall Study||14
1024026|NCT00642473|2485514|P2|STARTED|Overall Study||16
1024027|NCT00642473|2485515|P1|STARTED|Overall Study||18
1024028|NCT00642603|2485529|P2|NOT COMPLETED|Overall Study||18
1024029|NCT00642603|2485530|P1|NOT COMPLETED|Overall Study||21
1024030|NCT00642603|2485529|P2|COMPLETED|Overall Study||2
1024031|NCT00642603|2485530|P1|COMPLETED|Overall Study||0
1024032|NCT00642603|2485529|P2|Safety Population|Overall Study||20
1024033|NCT00642603|2485530|P1|Safety Population|Overall Study||19
1024034|NCT00642603|2485529|P2|STARTED|Overall Study||20
1024035|NCT00642603|2485530|P1|STARTED|Overall Study||21
1024036|NCT00642616|2485540|P4|NOT COMPLETED|Overall Study||7
1024037|NCT00642616|2485541|P3|NOT COMPLETED|Overall Study||9
1024038|NCT00642616|2485542|P2|NOT COMPLETED|Overall Study||7
1024039|NCT00642616|2485543|P1|NOT COMPLETED|Overall Study||9
1024040|NCT00642616|2485540|P4|COMPLETED|Overall Study||1
1024041|NCT00642616|2485541|P3|COMPLETED|Overall Study||0
1024042|NCT00642616|2485542|P2|COMPLETED|Overall Study||1
1024043|NCT00642616|2485543|P1|COMPLETED|Overall Study||0
1024044|NCT00642616|2485540|P4|STARTED|Overall Study||8
1024045|NCT00642616|2485541|P3|STARTED|Overall Study||9
1024046|NCT00642616|2485542|P2|STARTED|Overall Study||8
1024047|NCT00642616|2485543|P1|STARTED|Overall Study||9
1024048|NCT00642642|2485565|P1|NOT COMPLETED|Treatment & Follow Up||17
1024049|NCT00642642|2485565|P1|COMPLETED|Treatment & Follow Up||92
1024050|NCT00642642|2485565|P1|STARTED|Treatment & Follow Up||109
1024051|NCT00642642|2485565|P1|NOT COMPLETED|Biopsy & Product Manufacture||13
1024052|NCT00642642|2485565|P1|COMPLETED|Biopsy & Product Manufacture|Patients biopsied and for whom study product could be produced are considered completed|109
1024053|NCT00642642|2485565|P1|STARTED|Biopsy & Product Manufacture||122
1024054|NCT00642668|2485578|P1|NOT COMPLETED|Overall Study||14
1024055|NCT00642668|2485578|P1|COMPLETED|Overall Study||21
1024056|NCT00642668|2485578|P1|STARTED|Overall Study||35
1024057|NCT00642694|2485588|P2|NOT COMPLETED|Overall Study||4
1024058|NCT00642694|2485589|P1|NOT COMPLETED|Overall Study||6
1024059|NCT00642694|2485588|P2|COMPLETED|Overall Study||11
1024060|NCT00642694|2485589|P1|COMPLETED|Overall Study||8
1024061|NCT00642694|2485588|P2|STARTED|Overall Study||15
1024062|NCT00642694|2485589|P1|STARTED|Overall Study||14
1024063|NCT00642707|2485601|P4|NOT COMPLETED|Overall Study||2
1024064|NCT00642707|2485602|P3|NOT COMPLETED|Overall Study||0
1024065|NCT00642707|2485603|P2|NOT COMPLETED|Overall Study||0
1024066|NCT00642707|2485604|P1|NOT COMPLETED|Overall Study||1
1024067|NCT00642707|2485601|P4|COMPLETED|Overall Study||8
1024068|NCT00642707|2485602|P3|COMPLETED|Overall Study||12
1024069|NCT00642707|2485603|P2|COMPLETED|Overall Study||11
1024070|NCT00642707|2485604|P1|COMPLETED|Overall Study||10
1024071|NCT00642707|2485601|P4|STARTED|Overall Study||10
1024072|NCT00642707|2485602|P3|STARTED|Overall Study||12
1024073|NCT00642707|2485603|P2|STARTED|Overall Study||11
1024074|NCT00642707|2485604|P1|STARTED|Overall Study||11
1024075|NCT00642746|2485616|P2|NOT COMPLETED|Overall Study||0
1024076|NCT00642746|2485617|P1|NOT COMPLETED|Overall Study||1
1024077|NCT00642746|2485616|P2|COMPLETED|Overall Study||1
1024078|NCT00642746|2485617|P1|COMPLETED|Overall Study||9
1024079|NCT00642746|2485616|P2|STARTED|Overall Study||1
1024080|NCT00642746|2485617|P1|STARTED|Overall Study||10
1024081|NCT00642759|2485627|P1|NOT COMPLETED|Overall Study||1
1024082|NCT00642759|2485627|P1|COMPLETED|Overall Study||35
1024083|NCT00642759|2485627|P1|STARTED|Overall Study||36
1024084|NCT00642772|2485634|P1|NOT COMPLETED|Overall Study||10
1024085|NCT00642772|2485634|P1|COMPLETED|Overall Study||14
1024086|NCT00642772|2485634|P1|STARTED|Overall Study||24
1024087|NCT00642811|2485644|P6|NOT COMPLETED|Overall Study||1
1024088|NCT00642811|2485645|P5|NOT COMPLETED|Overall Study||1
1024089|NCT00642811|2485646|P4|NOT COMPLETED|Overall Study||1
1024090|NCT00642811|2485647|P3|NOT COMPLETED|Overall Study||0
1024091|NCT00642811|2485648|P2|NOT COMPLETED|Overall Study||4
1024092|NCT00642811|2485649|P1|NOT COMPLETED|Overall Study||3
1024093|NCT00642811|2485644|P6|COMPLETED|Overall Study||13
1024094|NCT00642811|2485645|P5|COMPLETED|Overall Study||13
1024095|NCT00642811|2485646|P4|COMPLETED|Overall Study||15
1024096|NCT00642811|2485647|P3|COMPLETED|Overall Study||13
1024097|NCT00642811|2485648|P2|COMPLETED|Overall Study||17
1024098|NCT00642811|2485649|P1|COMPLETED|Overall Study||17
1024099|NCT00642811|2485644|P6|STARTED|Overall Study||14
1024100|NCT00642811|2485645|P5|STARTED|Overall Study||14
1024101|NCT00642811|2485646|P4|STARTED|Overall Study||16
1024102|NCT00642811|2485647|P3|STARTED|Overall Study||13
1024103|NCT00642811|2485648|P2|STARTED|Overall Study||21
1024104|NCT00642811|2485649|P1|STARTED|Overall Study||20
1024105|NCT00642850|2485671|P1|NOT COMPLETED|Overall Study||33
1024106|NCT00642850|2485671|P1|COMPLETED|Overall Study||155
1024107|NCT00642850|2485671|P1|STARTED|Overall Study||188
1024108|NCT00642902|2485685|P4|NOT COMPLETED|Overall Study||40
1024109|NCT00642902|2485686|P3|NOT COMPLETED|Overall Study||43
1024110|NCT00642902|2485687|P2|NOT COMPLETED|Overall Study||42
1024111|NCT00642902|2485688|P1|NOT COMPLETED|Overall Study||40
1024112|NCT00642902|2485685|P4|COMPLETED|Overall Study||25
1024113|NCT00642902|2485686|P3|COMPLETED|Overall Study||21
1024114|NCT00642902|2485687|P2|COMPLETED|Overall Study||21
1024115|NCT00642902|2485688|P1|COMPLETED|Overall Study||23
1024116|NCT00642902|2485685|P4|Treated|Overall Study||65
1024117|NCT00642902|2485686|P3|Treated|Overall Study||63
1024118|NCT00642902|2485687|P2|Treated|Overall Study||63
1024119|NCT00642902|2485688|P1|Treated|Overall Study||63
1024120|NCT00642902|2485685|P4|STARTED|Overall Study||65
1024121|NCT00642902|2485686|P3|STARTED|Overall Study||64
1024122|NCT00642902|2485687|P2|STARTED|Overall Study||63
1024123|NCT00642902|2485688|P1|STARTED|Overall Study||63
1024124|NCT00642993|2485712|P2|NOT COMPLETED|Overall Study||16
1024125|NCT00642993|2485713|P1|NOT COMPLETED|Overall Study||106
1024126|NCT00642993|2485712|P2|COMPLETED|Overall Study||118
1024127|NCT00642993|2485713|P1|COMPLETED|Overall Study||161
1024128|NCT00642993|2485712|P2|STARTED|Overall Study||134
1024129|NCT00642993|2485713|P1|STARTED|Overall Study||267
1024130|NCT00643006|2485729|P2|NOT COMPLETED|Overall Study||4
1024131|NCT00643006|2485730|P1|NOT COMPLETED|Overall Study||5
1024132|NCT00643006|2485729|P2|COMPLETED|Overall Study||29
1024133|NCT00643006|2485730|P1|COMPLETED|Overall Study||29
1024134|NCT00643006|2485729|P2|STARTED|Overall Study||33
1024135|NCT00643006|2485730|P1|STARTED|Overall Study||34
1024136|NCT00643097|2485741|P3|NOT COMPLETED|Overall Study||0
1024137|NCT00643097|2485742|P2|NOT COMPLETED|Overall Study||0
1024138|NCT00643097|2485743|P1|NOT COMPLETED|Overall Study||0
1024139|NCT00643097|2485741|P3|COMPLETED|Overall Study||10
1024140|NCT00643097|2485742|P2|COMPLETED|Overall Study||12
1024141|NCT00643097|2485743|P1|COMPLETED|Overall Study||18
1024142|NCT00643097|2485741|P3|STARTED|Overall Study||10
1024143|NCT00643097|2485742|P2|STARTED|Overall Study||12
1024144|NCT00643097|2485743|P1|STARTED|Overall Study||18
1024145|NCT00643201|2485762|P2|NOT COMPLETED|Completed Study Follow Up||79
1024146|NCT00643201|2485763|P1|NOT COMPLETED|Completed Study Follow Up||70
1024147|NCT00643201|2485762|P2|COMPLETED|Completed Study Follow Up|Of 79 who did not complete follow up: 3 completed treatment, 76 discontinued treatment|2560
1024148|NCT00643201|2485763|P1|COMPLETED|Completed Study Follow Up|Of 70 who did not complete follow up: 7 completed treatment; 63 discontinued treatment|2547
1024149|NCT00643201|2485762|P2|STARTED|Completed Study Follow Up||2639
1024150|NCT00643201|2485763|P1|STARTED|Completed Study Follow Up||2617
1024151|NCT00643201|2485762|P2|NOT COMPLETED|Randomized, Completed 6 Months of Study||413
1024152|NCT00643201|2485763|P1|NOT COMPLETED|Randomized, Completed 6 Months of Study||377
1024153|NCT00643201|2485762|P2|COMPLETED|Randomized, Completed 6 Months of Study||2291
1024154|NCT00643201|2485763|P1|COMPLETED|Randomized, Completed 6 Months of Study||2314
1024155|NCT00643201|2485762|P2|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2704
1024156|NCT00643201|2485763|P1|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2691
1024157|NCT00643448|2485812|P3|NOT COMPLETED|Overall Study||6
1024158|NCT00643448|2485813|P2|NOT COMPLETED|Overall Study||5
1024159|NCT00643448|2485814|P1|NOT COMPLETED|Overall Study||4
1024160|NCT00643448|2485812|P3|COMPLETED|Overall Study||16
1024161|NCT00643448|2485813|P2|COMPLETED|Overall Study||17
1024162|NCT00643448|2485814|P1|COMPLETED|Overall Study||17
1024163|NCT00643448|2485812|P3|STARTED|Overall Study||22
1024164|NCT00643448|2485813|P2|STARTED|Overall Study||22
1024165|NCT00643448|2485814|P1|STARTED|Overall Study||21
1024166|NCT00643487|2485829|P1|NOT COMPLETED|Overall Study||3
1024167|NCT00643487|2485829|P1|COMPLETED|Overall Study||5
1024168|NCT00643487|2485829|P1|STARTED|Overall Study||8
1024175|NCT00643578|2485858|P2|NOT COMPLETED|Overall Study||0
1024176|NCT00643578|2485859|P1|NOT COMPLETED|Overall Study||2
1024177|NCT00643578|2485858|P2|COMPLETED|Overall Study||6
1024178|NCT00643578|2485859|P1|COMPLETED|Overall Study||4
1024179|NCT00643578|2485858|P2|STARTED|Overall Study||6
1024180|NCT00643578|2485859|P1|STARTED|Overall Study||6
1024181|NCT00643604|2485867|P1|NOT COMPLETED|Overall Study||1
1024182|NCT00643604|2485867|P1|COMPLETED|Overall Study||6
1024183|NCT00643604|2485867|P1|STARTED|Overall Study||7
1024184|NCT00643682|2485886|P2|NOT COMPLETED|Overall Study||509
1024185|NCT00643682|2485887|P1|NOT COMPLETED|Overall Study||522
1024186|NCT00643682|2485886|P2|COMPLETED|Overall Study||492
1024187|NCT00643682|2485887|P1|COMPLETED|Overall Study||477
1024188|NCT00643682|2485886|P2|STARTED|Overall Study||1001
1024189|NCT00643682|2485887|P1|STARTED|Overall Study||999
1024190|NCT00643760|2485904|P5|NOT COMPLETED|Overall Study||19
1024191|NCT00643760|2485905|P4|NOT COMPLETED|Overall Study||38
1024192|NCT00643760|2485906|P3|NOT COMPLETED|Overall Study||19
1024193|NCT00643760|2485907|P2|NOT COMPLETED|Overall Study||15
1024194|NCT00643760|2485908|P1|NOT COMPLETED|Overall Study||30
1024195|NCT00643760|2485904|P5|COMPLETED|Overall Study||47
1024196|NCT00643760|2485905|P4|COMPLETED|Overall Study||79
1024197|NCT00643760|2485906|P3|COMPLETED|Overall Study||37
1024198|NCT00643760|2485907|P2|COMPLETED|Overall Study||47
1024199|NCT00643760|2485908|P1|COMPLETED|Overall Study||90
1024200|NCT00643760|2485904|P5|ITT Population|Overall Study||66
1024201|NCT00643760|2485905|P4|ITT Population|Overall Study||116
1024202|NCT00643760|2485906|P3|ITT Population|Overall Study||56
1024203|NCT00643760|2485907|P2|ITT Population|Overall Study||62
1024204|NCT00643760|2485908|P1|ITT Population|Overall Study||120
1024205|NCT00643760|2485904|P5|Safety Population/Treated With Drug|Overall Study||66
1024206|NCT00643760|2485905|P4|Safety Population/Treated With Drug|Overall Study||116
1024207|NCT00643760|2485906|P3|Safety Population/Treated With Drug|Overall Study||56
1024208|NCT00643760|2485907|P2|Safety Population/Treated With Drug|Overall Study||62
1024209|NCT00643760|2485908|P1|Safety Population/Treated With Drug|Overall Study||120
1024210|NCT00643760|2485904|P5|STARTED|Overall Study||66
1024211|NCT00643760|2485905|P4|STARTED|Overall Study||117
1024212|NCT00643760|2485906|P3|STARTED|Overall Study||56
1024213|NCT00643760|2485907|P2|STARTED|Overall Study||62
1024214|NCT00643760|2485908|P1|STARTED|Overall Study||120
1024215|NCT00643851|2486013|P3|NOT COMPLETED|Overall Study||30
1024216|NCT00643851|2486014|P2|NOT COMPLETED|Overall Study||33
1024217|NCT00643851|2486015|P1|NOT COMPLETED|Overall Study||17
1024218|NCT00643851|2486013|P3|COMPLETED|Overall Study||171
1024219|NCT00643851|2486014|P2|COMPLETED|Overall Study||170
1024220|NCT00643851|2486015|P1|COMPLETED|Overall Study||177
1024221|NCT00643851|2486013|P3|STARTED|Overall Study||201
1024222|NCT00643851|2486014|P2|STARTED|Overall Study||203
1024223|NCT00643851|2486015|P1|STARTED|Overall Study||194
1024224|NCT00643916|2486044|P6|NOT COMPLETED|Overall Study||1
1024225|NCT00643916|2486045|P5|NOT COMPLETED|Overall Study||2
1024226|NCT00643916|2486046|P4|NOT COMPLETED|Overall Study||2
1024227|NCT00643916|2486047|P3|NOT COMPLETED|Overall Study||6
1024228|NCT00643916|2486048|P2|NOT COMPLETED|Overall Study||6
1024229|NCT00643916|2486049|P1|NOT COMPLETED|Overall Study||4
1024230|NCT00643916|2486044|P6|COMPLETED|Overall Study||66
1024231|NCT00643916|2486045|P5|COMPLETED|Overall Study||57
1024232|NCT00643916|2486046|P4|COMPLETED|Overall Study||60
1024233|NCT00643916|2486047|P3|COMPLETED|Overall Study||62
1024234|NCT00643916|2486048|P2|COMPLETED|Overall Study||61
1024235|NCT00643916|2486049|P1|COMPLETED|Overall Study||51
1024236|NCT00643916|2486044|P6|STARTED|Overall Study||67
1024237|NCT00643916|2486045|P5|STARTED|Overall Study||59
1024238|NCT00643916|2486046|P4|STARTED|Overall Study||62
1024239|NCT00643916|2486047|P3|STARTED|Overall Study||68
1024240|NCT00643916|2486048|P2|STARTED|Overall Study||67
1024241|NCT00643916|2486049|P1|STARTED|Overall Study||55
1024242|NCT00644059|2486072|P3|NOT COMPLETED|Overall Study||65
1024243|NCT00644059|2486073|P2|NOT COMPLETED|Overall Study||123
1024244|NCT00644059|2486074|P1|NOT COMPLETED|Overall Study||124
1024245|NCT00644059|2486072|P3|COMPLETED|Overall Study||969
1024246|NCT00644059|2486073|P2|COMPLETED|Overall Study||1726
1024247|NCT00644059|2486074|P1|COMPLETED|Overall Study||1895
1024248|NCT00644059|2486072|P3|STARTED|Overall Study||1034
1024249|NCT00644059|2486073|P2|STARTED|Overall Study||1849
1024250|NCT00644059|2486074|P1|STARTED|Overall Study||2019
1024251|NCT00644189|2486158|P4|NOT COMPLETED|Phase II||0
1024252|NCT00644189|2486159|P3|NOT COMPLETED|Phase II||0
1024253|NCT00644189|2486160|P2|NOT COMPLETED|Phase II||0
1024254|NCT00644189|2486161|P1|NOT COMPLETED|Phase II||0
1024255|NCT00644189|2486158|P4|COMPLETED|Phase II||50
1024256|NCT00644189|2486159|P3|COMPLETED|Phase II||0
1024257|NCT00644189|2486160|P2|COMPLETED|Phase II||0
1024258|NCT00644189|2486161|P1|COMPLETED|Phase II||0
1024259|NCT00644189|2486158|P4|Completed All 6 Cycles of Treatment|Phase II||19
1024260|NCT00644189|2486159|P3|Completed All 6 Cycles of Treatment|Phase II||0
1024261|NCT00644189|2486160|P2|Completed All 6 Cycles of Treatment|Phase II||0
1024262|NCT00644189|2486161|P1|Completed All 6 Cycles of Treatment|Phase II||0
1024263|NCT00644189|2486158|P4|STARTED|Phase II|Additional participants were added to the phase I sample at the phase II 3mg dose level|50
1024264|NCT00644189|2486159|P3|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
1024265|NCT00644189|2486160|P2|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
1024266|NCT00644189|2486161|P1|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
1024267|NCT00644189|2486158|P4|NOT COMPLETED|Phase I||0
1024268|NCT00644189|2486159|P3|NOT COMPLETED|Phase I||0
1024269|NCT00644189|2486160|P2|NOT COMPLETED|Phase I||0
1024270|NCT00644189|2486161|P1|NOT COMPLETED|Phase I||0
1024271|NCT00644189|2486158|P4|COMPLETED|Phase I||18
1024272|NCT00644189|2486159|P3|COMPLETED|Phase I||6
1024273|NCT00644189|2486160|P2|COMPLETED|Phase I||3
1024274|NCT00644189|2486161|P1|COMPLETED|Phase I||3
1024275|NCT00644189|2486158|P4|STARTED|Phase I||18
1024276|NCT00644189|2486159|P3|STARTED|Phase I||6
1024277|NCT00644189|2486160|P2|STARTED|Phase I||3
1024278|NCT00644189|2486161|P1|STARTED|Phase I||3
1024279|NCT00644228|2486176|P2|NOT COMPLETED|Maintenance||135
1024280|NCT00644228|2486177|P1|NOT COMPLETED|Maintenance||143
1024281|NCT00644228|2486176|P2|COMPLETED|Maintenance||0
1024282|NCT00644228|2486177|P1|COMPLETED|Maintenance||0
1024283|NCT00644228|2486176|P2|STARTED|Maintenance|2 patients who completed induction did not continue on to maintenance due to other (2).|135
1024284|NCT00644228|2486177|P1|STARTED|Maintenance|3 patients who completed induction did not continue on to maintenance due to refusal (1), other (2).|143
1024285|NCT00644228|2486176|P2|NOT COMPLETED|Induction Therapy||105
1024286|NCT00644228|2486177|P1|NOT COMPLETED|Induction Therapy||83
1024287|NCT00644228|2486176|P2|COMPLETED|Induction Therapy||137
1024288|NCT00644228|2486177|P1|COMPLETED|Induction Therapy||146
1024289|NCT00644228|2486176|P2|STARTED|Induction Therapy||242
1024290|NCT00644228|2486177|P1|STARTED|Induction Therapy||229
1024291|NCT00644228|2486176|P2|NOT COMPLETED|Randomization & Eligibility||22
1024292|NCT00644228|2486177|P1|NOT COMPLETED|Randomization & Eligibility||32
1024293|NCT00644228|2486176|P2|COMPLETED|Randomization & Eligibility||242
1024294|NCT00644228|2486177|P1|COMPLETED|Randomization & Eligibility||229
1024295|NCT00644228|2486176|P2|Eligible and Analyzable|Randomization & Eligibility||242
1024296|NCT00644228|2486177|P1|Eligible and Analyzable|Randomization & Eligibility||229
1024297|NCT00644228|2486176|P2|STARTED|Randomization & Eligibility||264
1024298|NCT00644228|2486177|P1|STARTED|Randomization & Eligibility||261
1024299|NCT00644280|2486189|P2|NOT COMPLETED|Overall Study||0
1024300|NCT00644280|2486190|P1|NOT COMPLETED|Overall Study||0
1024301|NCT00644280|2486189|P2|COMPLETED|Overall Study||5
1024302|NCT00644280|2486190|P1|COMPLETED|Overall Study||6
1024303|NCT00644280|2486189|P2|STARTED|Overall Study||5
1024304|NCT00644280|2486190|P1|STARTED|Overall Study||6
1024305|NCT00644332|2486198|P1|NOT COMPLETED|Overall Study||21
1024306|NCT00644332|2486198|P1|COMPLETED|Overall Study||150
1024307|NCT00644332|2486198|P1|STARTED|Overall Study|172 patients were enrolled; one withdrew consent prior to starting treatment|171
1024308|NCT00644358|2486211|P1|NOT COMPLETED|Overall Study||362
1024309|NCT00644358|2486211|P1|COMPLETED|Overall Study||254
1024310|NCT00644358|2486211|P1|STARTED|Overall Study||616
1024311|NCT00644592|2486220|P2|NOT COMPLETED|Overall Study||0
1024312|NCT00644592|2486221|P1|NOT COMPLETED|Overall Study||0
1024313|NCT00644592|2486220|P2|COMPLETED|Overall Study||6
1024314|NCT00644592|2486221|P1|COMPLETED|Overall Study||5
1024315|NCT00644592|2486220|P2|STARTED|Overall Study||6
1024316|NCT00644592|2486221|P1|STARTED|Overall Study||5
1024317|NCT00644657|2486227|P1|NOT COMPLETED|Overall Study||0
1024318|NCT00644657|2486227|P1|COMPLETED|Overall Study||27
1024319|NCT00644657|2486227|P1|STARTED|Overall Study||27
1024320|NCT00644787|2486232|P3|NOT COMPLETED|Period 2: Double Blind Phase||7
1024321|NCT00644787|2486233|P2|NOT COMPLETED|Period 2: Double Blind Phase||9
1024322|NCT00644787|2486234|P1|NOT COMPLETED|Period 2: Double Blind Phase||0
1024323|NCT00644787|2486232|P3|COMPLETED|Period 2: Double Blind Phase||55
1024324|NCT00644787|2486233|P2|COMPLETED|Period 2: Double Blind Phase||49
1024325|NCT00644787|2486234|P1|COMPLETED|Period 2: Double Blind Phase||0
1024326|NCT00644787|2486232|P3|STARTED|Period 2: Double Blind Phase||62
1024327|NCT00644787|2486233|P2|STARTED|Period 2: Double Blind Phase||58
1024328|NCT00644787|2486234|P1|STARTED|Period 2: Double Blind Phase||0
1024329|NCT00644787|2486232|P3|NOT COMPLETED|Period 1: Titration Phase||0
1024330|NCT00644787|2486233|P2|NOT COMPLETED|Period 1: Titration Phase||0
1024331|NCT00644787|2486234|P1|NOT COMPLETED|Period 1: Titration Phase||27
1024332|NCT00644787|2486232|P3|COMPLETED|Period 1: Titration Phase||0
1024333|NCT00644787|2486233|P2|COMPLETED|Period 1: Titration Phase||0
1024334|NCT00644787|2486234|P1|COMPLETED|Period 1: Titration Phase||129
1024335|NCT00644787|2486232|P3|STARTED|Period 1: Titration Phase||0
1024336|NCT00644787|2486233|P2|STARTED|Period 1: Titration Phase||0
1024337|NCT00644787|2486234|P1|STARTED|Period 1: Titration Phase||156
1024338|NCT00644917|2486262|P1|NOT COMPLETED|Overall Study||2
1024339|NCT00644917|2486262|P1|COMPLETED|Overall Study||36
1024340|NCT00644917|2486262|P1|STARTED|Overall Study||38
1024341|NCT00638651|2486270|P1|NOT COMPLETED|Overall Study||0
1024342|NCT00638651|2486270|P1|COMPLETED|Overall Study||3
1024343|NCT00638651|2486270|P1|STARTED|Overall Study||3
1024344|NCT00638690|2486277|P2|NOT COMPLETED|Overall Study||342
1024345|NCT00638690|2486278|P1|NOT COMPLETED|Overall Study||681
1024346|NCT00638690|2486277|P2|COMPLETED|Overall Study||56
1024347|NCT00638690|2486278|P1|COMPLETED|Overall Study||116
1024348|NCT00638690|2486277|P2|STARTED|Overall Study||398
1024349|NCT00638690|2486278|P1|STARTED|Overall Study||797
1024350|NCT00638716|2486294|P3|NOT COMPLETED|Overall Study||12
1024351|NCT00638716|2486295|P2|NOT COMPLETED|Overall Study||15
1024352|NCT00638716|2486296|P1|NOT COMPLETED|Overall Study||7
1024353|NCT00638716|2486294|P3|COMPLETED|Overall Study||46
1024354|NCT00638716|2486295|P2|COMPLETED|Overall Study||37
1024355|NCT00638716|2486296|P1|COMPLETED|Overall Study||43
1024356|NCT00638716|2486294|P3|STARTED|Overall Study||58
1024357|NCT00638716|2486295|P2|STARTED|Overall Study||52
1024358|NCT00638716|2486296|P1|STARTED|Overall Study||50
1024359|NCT00638820|2486310|P1|NOT COMPLETED|Overall Study||0
1024360|NCT00638820|2486310|P1|COMPLETED|Overall Study||3
1024361|NCT00638820|2486310|P1|STARTED|Overall Study||3
1024362|NCT00638846|2486319|P2|NOT COMPLETED|Overall Study||6
1024363|NCT00638846|2486320|P1|NOT COMPLETED|Overall Study||4
1024364|NCT00638846|2486319|P2|COMPLETED|Overall Study||133
1024365|NCT00638846|2486320|P1|COMPLETED|Overall Study||133
1024366|NCT00638846|2486319|P2|STARTED|Overall Study||139
1024367|NCT00638846|2486320|P1|STARTED|Overall Study||137
1024368|NCT00638885|2486336|P1|NOT COMPLETED|Overall Study||0
1024369|NCT00638885|2486336|P1|COMPLETED|Overall Study||142
1024370|NCT00638885|2486336|P1|STARTED|Overall Study||142
1024371|NCT00644969|2486342|P2|NOT COMPLETED|Post Treatment Phase||3
1024372|NCT00644969|2486343|P1|NOT COMPLETED|Post Treatment Phase||10
1024373|NCT00644969|2486342|P2|COMPLETED|Post Treatment Phase||37
1024374|NCT00644969|2486343|P1|COMPLETED|Post Treatment Phase||61
1024375|NCT00644969|2486342|P2|STARTED|Post Treatment Phase||40
1024376|NCT00644969|2486343|P1|STARTED|Post Treatment Phase||71
1024377|NCT00644969|2486342|P2|NOT COMPLETED|Treatment Phase||3
1024378|NCT00644969|2486343|P1|NOT COMPLETED|Treatment Phase||14
1024379|NCT00644969|2486342|P2|COMPLETED|Treatment Phase||40
1024380|NCT00644969|2486343|P1|COMPLETED|Treatment Phase||71
1024381|NCT00644969|2486342|P2|STARTED|Treatment Phase||43
1024382|NCT00644969|2486343|P1|STARTED|Treatment Phase||85
1024391|NCT00645047|2486412|P2|NOT COMPLETED|Overall Study||39
1024392|NCT00645047|2486413|P1|NOT COMPLETED|Overall Study||43
1024393|NCT00645047|2486412|P2|COMPLETED|Overall Study||65
1024394|NCT00645047|2486413|P1|COMPLETED|Overall Study|6 month follow up|60
1024395|NCT00645047|2486412|P2|Post|Overall Study||80
1024396|NCT00645047|2486413|P1|Post|Overall Study||74
1024397|NCT00645047|2486412|P2|STARTED|Overall Study||104
1024398|NCT00645047|2486413|P1|STARTED|Overall Study||103
1024399|NCT00645099|2486437|P2|NOT COMPLETED|Overall Study||42
1024400|NCT00645099|2486438|P1|NOT COMPLETED|Overall Study||71
1024401|NCT00645099|2486437|P2|COMPLETED|Overall Study||178
1024402|NCT00645099|2486438|P1|COMPLETED|Overall Study||168
1024403|NCT00645099|2486437|P2|STARTED|Overall Study||220
1024404|NCT00645099|2486438|P1|STARTED|Overall Study||239
1024405|NCT00645164|2486480|P1|NOT COMPLETED|Overall Study||7
1024406|NCT00645164|2486480|P1|COMPLETED|Overall Study||52
1024407|NCT00645164|2486480|P1|STARTED|Overall Study||59
1024408|NCT00645671|2486486|P2|NOT COMPLETED|Overall Study||6
1024409|NCT00645671|2486487|P1|NOT COMPLETED|Overall Study||1
1024410|NCT00645671|2486486|P2|COMPLETED|Overall Study||193
1024411|NCT00645671|2486487|P1|COMPLETED|Overall Study||200
1024412|NCT00645671|2486486|P2|STARTED|Overall Study||199
1024413|NCT00645671|2486487|P1|STARTED|Overall Study||201
1024414|NCT00645762|2486499|P1|NOT COMPLETED|Overall Study||4
1024415|NCT00645762|2486499|P1|COMPLETED|Overall Study||67
1024416|NCT00645762|2486499|P1|STARTED|Overall Study||71
1024417|NCT00645788|2486509|P4|NOT COMPLETED|Overall Study||14
1024418|NCT00645788|2486510|P3|NOT COMPLETED|Overall Study||18
1024419|NCT00645788|2486511|P2|NOT COMPLETED|Overall Study||27
1024420|NCT00645788|2486512|P1|NOT COMPLETED|Overall Study||20
1024421|NCT00645788|2486509|P4|COMPLETED|Overall Study||21
1024422|NCT00645788|2486510|P3|COMPLETED|Overall Study||47
1024423|NCT00645788|2486511|P2|COMPLETED|Overall Study||67
1024424|NCT00645788|2486512|P1|COMPLETED|Overall Study||74
1024425|NCT00645788|2486509|P4|Participants Receive Treatment|Overall Study||35
1024426|NCT00645788|2486510|P3|Participants Receive Treatment|Overall Study||65
1024427|NCT00645788|2486511|P2|Participants Receive Treatment|Overall Study||93
1024428|NCT00645788|2486512|P1|Participants Receive Treatment|Overall Study||93
1024429|NCT00645788|2486509|P4|STARTED|Overall Study||35
1024430|NCT00645788|2486510|P3|STARTED|Overall Study||65
1024431|NCT00645788|2486511|P2|STARTED|Overall Study||94
1024432|NCT00645788|2486512|P1|STARTED|Overall Study||94
1024433|NCT00645827|2486564|P2|NOT COMPLETED|Overall Study||0
1024434|NCT00645827|2486565|P1|NOT COMPLETED|Overall Study||0
1024435|NCT00645827|2486564|P2|COMPLETED|Overall Study||17
1024436|NCT00645827|2486565|P1|COMPLETED|Overall Study||14
1024437|NCT00645827|2486564|P2|STARTED|Overall Study||17
1024438|NCT00645827|2486565|P1|STARTED|Overall Study||14
1024439|NCT00645853|2486573|P2|NOT COMPLETED|Overall Study||57
1024440|NCT00645853|2486574|P1|NOT COMPLETED|Overall Study||92
1024441|NCT00645853|2486573|P2|COMPLETED|Overall Study||178
1024442|NCT00645853|2486574|P1|COMPLETED|Overall Study||196
1024443|NCT00645853|2486573|P2|AZ Study Closure in Hungary|Overall Study||40
1024444|NCT00645853|2486574|P1|AZ Study Closure in Hungary|Overall Study||60
1024445|NCT00645853|2486573|P2|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|178
1024446|NCT00645853|2486574|P1|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|196
1024447|NCT00645853|2486573|P2|No of Patients After Dose Switch|Overall Study|No changes for VKA patients|188
1024448|NCT00645853|2486574|P1|No of Patients After Dose Switch|Overall Study|All patients in the AZD0837 arm switched from their initial doses, to a general dose of 300 mg od|209
1024449|NCT00645853|2486573|P2|STARTED|Overall Study||235
1024450|NCT00645853|2486574|P1|STARTED|Overall Study||288
1024463|NCT00645970|2486603|P2|NOT COMPLETED|Overall Study||186
1024464|NCT00645970|2486604|P1|NOT COMPLETED|Overall Study||109
1024465|NCT00645970|2486603|P2|COMPLETED|Overall Study||32
1024466|NCT00645970|2486604|P1|COMPLETED|Overall Study||32
1024467|NCT00645970|2486603|P2|1 Year|Overall Study||42
1024468|NCT00645970|2486604|P1|1 Year|Overall Study||37
1024469|NCT00645970|2486603|P2|6 Months|Overall Study||97
1024470|NCT00645970|2486604|P1|6 Months|Overall Study||58
1024471|NCT00645970|2486603|P2|STARTED|Overall Study||218
1024472|NCT00645970|2486604|P1|STARTED|Overall Study||141
1024473|NCT00646048|2486610|P1|NOT COMPLETED|Overall Study||16
1024474|NCT00646048|2486610|P1|COMPLETED|Overall Study||27
1024475|NCT00646048|2486610|P1|STARTED|Overall Study||43
1024476|NCT00646282|2486618|P2|NOT COMPLETED|Overall Study||4
1024477|NCT00646282|2486619|P1|NOT COMPLETED|Overall Study||4
1024478|NCT00646282|2486618|P2|COMPLETED|Overall Study||0
1024479|NCT00646282|2486619|P1|COMPLETED|Overall Study||0
1024480|NCT00646282|2486618|P2|STARTED|Overall Study||4
1024481|NCT00646282|2486619|P1|STARTED|Overall Study||4
1024482|NCT00646399|2486627|P2|NOT COMPLETED|Overall Study||74
1024483|NCT00646399|2486628|P1|NOT COMPLETED|Overall Study||83
1024484|NCT00646399|2486627|P2|COMPLETED|Overall Study||713
1024485|NCT00646399|2486628|P1|COMPLETED|Overall Study||709
1024486|NCT00646399|2486627|P2|STARTED|Overall Study||787
1024487|NCT00646399|2486628|P1|STARTED|Overall Study||792
1024488|NCT00646581|2486636|P2|NOT COMPLETED|Overall Study||0
1024489|NCT00646581|2486637|P1|NOT COMPLETED|Overall Study||0
1024490|NCT00646581|2486636|P2|COMPLETED|Overall Study||15
1024491|NCT00646581|2486637|P1|COMPLETED|Overall Study||15
1024492|NCT00646581|2486636|P2|STARTED|Overall Study||15
1024493|NCT00646581|2486637|P1|STARTED|Overall Study||15
1024506|NCT00646763|2486672|P2|NOT COMPLETED|Overall Study||0
1024507|NCT00646763|2486673|P1|NOT COMPLETED|Overall Study||0
1024508|NCT00646763|2486672|P2|COMPLETED|Overall Study||17
1024509|NCT00646763|2486673|P1|COMPLETED|Overall Study||18
1024510|NCT00646763|2486672|P2|STARTED|Overall Study||17
1024511|NCT00646763|2486673|P1|STARTED|Overall Study||18
1024512|NCT00646776|2486685|P2|NOT COMPLETED|Overall Study||13
1024513|NCT00646776|2486686|P1|NOT COMPLETED|Overall Study||1
1024514|NCT00646776|2486685|P2|COMPLETED|Overall Study||5
1024515|NCT00646776|2486686|P1|COMPLETED|Overall Study||14
1024516|NCT00646776|2486685|P2|STARTED|Overall Study|Treated on Day 1|18
1024517|NCT00646776|2486686|P1|STARTED|Overall Study|Treated on Day 1|15
1024518|NCT00646958|2486736|P3|NOT COMPLETED|Overall Study||9
1024519|NCT00646958|2486737|P2|NOT COMPLETED|Overall Study||9
1024520|NCT00646958|2486738|P1|NOT COMPLETED|Overall Study||11
1024521|NCT00646958|2486736|P3|COMPLETED|Overall Study||40
1024522|NCT00646958|2486737|P2|COMPLETED|Overall Study||41
1024523|NCT00646958|2486738|P1|COMPLETED|Overall Study||40
1024524|NCT00646958|2486736|P3|STARTED|Overall Study|No. Participants Randomized|49
1024525|NCT00646958|2486737|P2|STARTED|Overall Study|No. Participants Randomized|50
1024526|NCT00646958|2486738|P1|STARTED|Overall Study|Number (No.) Participants Randomized|51
1024527|NCT00647270|2486752|P3|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||7
1024528|NCT00647270|2486753|P2|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||9
1024529|NCT00647270|2486754|P1|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||3
1024530|NCT00647270|2486752|P3|COMPLETED|Period 2, Placebo Switched to Adalimumab||175
1024531|NCT00647270|2486753|P2|COMPLETED|Period 2, Placebo Switched to Adalimumab||137
1024532|NCT00647270|2486754|P1|COMPLETED|Period 2, Placebo Switched to Adalimumab||45
1024533|NCT00647270|2486752|P3|STARTED|Period 2, Placebo Switched to Adalimumab||182
1024534|NCT00647270|2486753|P2|STARTED|Period 2, Placebo Switched to Adalimumab||146
1024535|NCT00647270|2486754|P1|STARTED|Period 2, Placebo Switched to Adalimumab|Placebo subjects in Period 1 received adalimumab 40 mg eow in Period 2|48
1024536|NCT00647270|2486752|P3|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||23
1024537|NCT00647270|2486753|P2|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||13
1024538|NCT00647270|2486754|P1|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||8
1024539|NCT00647270|2486752|P3|COMPLETED|Period 1, Placebo-control (12 Weeks)||182
1024540|NCT00647270|2486753|P2|COMPLETED|Period 1, Placebo-control (12 Weeks)||146
1024541|NCT00647270|2486754|P1|COMPLETED|Period 1, Placebo-control (12 Weeks)||48
1024542|NCT00647270|2486752|P3|STARTED|Period 1, Placebo-control (12 Weeks)||205
1024543|NCT00647270|2486753|P2|STARTED|Period 1, Placebo-control (12 Weeks)||159
1024544|NCT00647270|2486754|P1|STARTED|Period 1, Placebo-control (12 Weeks)|Placebo subjects in Period 1 received adalimumab 40 mg every other week in Period 2.|56
1024545|NCT00647400|2486779|P2|NOT COMPLETED|Overall Study||13
1024546|NCT00647400|2486780|P1|NOT COMPLETED|Overall Study||22
1024547|NCT00647400|2486779|P2|COMPLETED|Overall Study||45
1024548|NCT00647400|2486780|P1|COMPLETED|Overall Study||67
1024549|NCT00647400|2486779|P2|STARTED|Overall Study||58
1024550|NCT00647400|2486780|P1|STARTED|Overall Study||89
1024551|NCT00647556|2486792|P2|NOT COMPLETED|Overall Study||2
1024552|NCT00647556|2486793|P1|NOT COMPLETED|Overall Study||3
1024553|NCT00647556|2486792|P2|COMPLETED|Overall Study||13
1024554|NCT00647556|2486793|P1|COMPLETED|Overall Study||12
1024555|NCT00647556|2486792|P2|STARTED|Overall Study||15
1024556|NCT00647556|2486793|P1|STARTED|Overall Study||15
1024557|NCT00647699|2486809|P2|NOT COMPLETED|Overall Study||12
1024558|NCT00647699|2486810|P1|NOT COMPLETED|Overall Study||8
1024559|NCT00647699|2486809|P2|COMPLETED|Overall Study||62
1024560|NCT00647699|2486810|P1|COMPLETED|Overall Study||65
1024561|NCT00647699|2486809|P2|STARTED|Overall Study||74
1024562|NCT00647699|2486810|P1|STARTED|Overall Study||73
1024563|NCT00647998|2486818|P2|NOT COMPLETED|Overall Study||0
1024564|NCT00647998|2486819|P1|NOT COMPLETED|Overall Study||0
1024565|NCT00647998|2486818|P2|COMPLETED|Overall Study||9
1024566|NCT00647998|2486819|P1|COMPLETED|Overall Study||9
1024567|NCT00647998|2486818|P2|STARTED|Overall Study||9
1024568|NCT00647998|2486819|P1|STARTED|Overall Study||9
1024569|NCT00648037|2486829|P1|NOT COMPLETED|Overall Study||16
1024570|NCT00648037|2486829|P1|COMPLETED|Overall Study||10
1024571|NCT00648037|2486829|P1|STARTED|Overall Study||26
1024572|NCT00648115|2486836|P3|NOT COMPLETED|Overall Study||0
1024573|NCT00648115|2486837|P2|NOT COMPLETED|Overall Study||0
1024574|NCT00648115|2486838|P1|NOT COMPLETED|Overall Study||0
1024575|NCT00648115|2486836|P3|COMPLETED|Overall Study||27
1024576|NCT00648115|2486837|P2|COMPLETED|Overall Study||42
1024577|NCT00648115|2486838|P1|COMPLETED|Overall Study||42
1024578|NCT00648115|2486836|P3|STARTED|Overall Study||27
1024579|NCT00648115|2486837|P2|STARTED|Overall Study||42
1024580|NCT00648115|2486838|P1|STARTED|Overall Study||42
1024581|NCT00648167|2486849|P1|NOT COMPLETED|Overall Study||7
1024582|NCT00648167|2486849|P1|COMPLETED|Overall Study||48
1024583|NCT00648167|2486849|P1|Start Dose 6 g/Day|Overall Study||21
1024584|NCT00648167|2486849|P1|Start Dose 4.5 g/Day|Overall Study||34
1024585|NCT00648167|2486849|P1|STARTED|Overall Study||55
1024586|NCT00641862|2486855|P2|NOT COMPLETED|Overall Study||38
1024587|NCT00641862|2486856|P1|NOT COMPLETED|Overall Study||44
1024588|NCT00641862|2486855|P2|COMPLETED|Overall Study||145
1024589|NCT00641862|2486856|P1|COMPLETED|Overall Study||139
1024590|NCT00641862|2486855|P2|STARTED|Overall Study||183
1024591|NCT00641862|2486856|P1|STARTED|Overall Study||183
1024592|NCT00642174|2486864|P2|NOT COMPLETED|Period 2 - Crossover Drug||0
1024593|NCT00642174|2486865|P1|NOT COMPLETED|Period 2 - Crossover Drug||0
1024594|NCT00642174|2486864|P2|COMPLETED|Period 2 - Crossover Drug||16
1024595|NCT00642174|2486865|P1|COMPLETED|Period 2 - Crossover Drug||18
1024596|NCT00642174|2486864|P2|STARTED|Period 2 - Crossover Drug||16
1024597|NCT00642174|2486865|P1|STARTED|Period 2 - Crossover Drug||18
1024598|NCT00642174|2486864|P2|NOT COMPLETED|Period 1 - Initial Drug||1
1024599|NCT00642174|2486865|P1|NOT COMPLETED|Period 1 - Initial Drug||0
1024600|NCT00642174|2486864|P2|COMPLETED|Period 1 - Initial Drug||16
1024601|NCT00642174|2486865|P1|COMPLETED|Period 1 - Initial Drug||18
1024602|NCT00642174|2486864|P2|STARTED|Period 1 - Initial Drug||17
1024603|NCT00642174|2486865|P1|STARTED|Period 1 - Initial Drug||18
1024604|NCT00642278|2486886|P7|NOT COMPLETED|Overall Study||5
1024605|NCT00642278|2486887|P6|NOT COMPLETED|Overall Study||7
1024606|NCT00642278|2486888|P5|NOT COMPLETED|Overall Study||8
1024607|NCT00642278|2486889|P4|NOT COMPLETED|Overall Study||9
1024608|NCT00642278|2486890|P3|NOT COMPLETED|Overall Study||5
1024609|NCT00642278|2486891|P2|NOT COMPLETED|Overall Study||5
1024610|NCT00642278|2486892|P1|NOT COMPLETED|Overall Study||10
1024611|NCT00642278|2486886|P7|COMPLETED|Overall Study||60
1024612|NCT00642278|2486887|P6|COMPLETED|Overall Study||57
1024613|NCT00642278|2486888|P5|COMPLETED|Overall Study||56
1024614|NCT00642278|2486889|P4|COMPLETED|Overall Study||56
1024615|NCT00642278|2486890|P3|COMPLETED|Overall Study||59
1024616|NCT00642278|2486891|P2|COMPLETED|Overall Study||59
1024617|NCT00642278|2486892|P1|COMPLETED|Overall Study||55
1024618|NCT00642278|2486886|P7|STARTED|Overall Study||65
1024619|NCT00642278|2486887|P6|STARTED|Overall Study||64
1024620|NCT00642278|2486888|P5|STARTED|Overall Study||64
1024621|NCT00642278|2486889|P4|STARTED|Overall Study||65
1024622|NCT00642278|2486890|P3|STARTED|Overall Study||64
1024623|NCT00642278|2486891|P2|STARTED|Overall Study||64
1024624|NCT00642278|2486892|P1|STARTED|Overall Study||65
1024625|NCT00642304|2486943|P1|NOT COMPLETED|Overall Study||6
1024626|NCT00642304|2486943|P1|COMPLETED|Overall Study||14
1024627|NCT00642304|2486943|P1|STARTED|Overall Study||20
1024628|NCT00642356|2486954|P2|NOT COMPLETED|Overall Study||3
1024629|NCT00642356|2486955|P1|NOT COMPLETED|Overall Study||2
1024630|NCT00642356|2486954|P2|COMPLETED|Overall Study||4
1024631|NCT00642356|2486955|P1|COMPLETED|Overall Study||5
1024632|NCT00642356|2486954|P2|STARTED|Overall Study||7
1024633|NCT00642356|2486955|P1|STARTED|Overall Study||7
1024634|NCT00642369|2486965|P2|NOT COMPLETED|Overall Study||6
1024635|NCT00642369|2486966|P1|NOT COMPLETED|Overall Study||5
1024636|NCT00642369|2486965|P2|COMPLETED|Overall Study||24
1024637|NCT00642369|2486966|P1|COMPLETED|Overall Study||25
1024638|NCT00642369|2486965|P2|STARTED|Overall Study||30
1024639|NCT00642369|2486966|P1|STARTED|Overall Study||30
1024640|NCT00642382|2486976|P2|NOT COMPLETED|Overall Study||0
1024641|NCT00642382|2486977|P1|NOT COMPLETED|Overall Study||0
1024642|NCT00642382|2486976|P2|COMPLETED|Overall Study||0
1024643|NCT00642382|2486977|P1|COMPLETED|Overall Study||0
1024644|NCT00642382|2486976|P2|STARTED|Overall Study||0
1024645|NCT00642382|2486977|P1|STARTED|Overall Study||0
1024646|NCT00642460|2486985|P6|NOT COMPLETED|Part III: Open-Label Up to Week 260||21
1024647|NCT00642460|2486986|P5|NOT COMPLETED|Part III: Open-Label Up to Week 260||25
1024648|NCT00642460|2486987|P4|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
1024649|NCT00642460|2486988|P3|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
1024650|NCT00642460|2486989|P2|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
1024651|NCT00642460|2486990|P1|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
1024652|NCT00642460|2486985|P6|COMPLETED|Part III: Open-Label Up to Week 260||38
1024653|NCT00642460|2486986|P5|COMPLETED|Part III: Open-Label Up to Week 260||28
1024654|NCT00642460|2486987|P4|COMPLETED|Part III: Open-Label Up to Week 260||0
1024655|NCT00642460|2486988|P3|COMPLETED|Part III: Open-Label Up to Week 260||0
1024656|NCT00642460|2486989|P2|COMPLETED|Part III: Open-Label Up to Week 260||0
1024657|NCT00642460|2486990|P1|COMPLETED|Part III: Open-Label Up to Week 260||0
1024658|NCT00642460|2486985|P6|STARTED|Part III: Open-Label Up to Week 260||59
1024659|NCT00642460|2486986|P5|STARTED|Part III: Open-Label Up to Week 260||53
1024660|NCT00642460|2486987|P4|STARTED|Part III: Open-Label Up to Week 260||0
1024661|NCT00642460|2486988|P3|STARTED|Part III: Open-Label Up to Week 260||0
1024662|NCT00642460|2486989|P2|STARTED|Part III: Open-Label Up to Week 260||0
1024663|NCT00642460|2486990|P1|STARTED|Part III: Open-Label Up to Week 260||0
1024664|NCT00642460|2486985|P6|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
1024665|NCT00642460|2486986|P5|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
1024666|NCT00642460|2486987|P4|NOT COMPLETED|Part II: Open-Label Up to Week 92||3
1024667|NCT00642460|2486988|P3|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
1024668|NCT00642460|2486989|P2|NOT COMPLETED|Part II: Open-Label Up to Week 92||8
1024669|NCT00642460|2486990|P1|NOT COMPLETED|Part II: Open-Label Up to Week 92||9
1024670|NCT00642460|2486985|P6|COMPLETED|Part II: Open-Label Up to Week 92||0
1024671|NCT00642460|2486986|P5|COMPLETED|Part II: Open-Label Up to Week 92||0
1024672|NCT00642460|2486987|P4|COMPLETED|Part II: Open-Label Up to Week 92||17
1024673|NCT00642460|2486988|P3|COMPLETED|Part II: Open-Label Up to Week 92||0
1024674|NCT00642460|2486989|P2|COMPLETED|Part II: Open-Label Up to Week 92||32
1024675|NCT00642460|2486990|P1|COMPLETED|Part II: Open-Label Up to Week 92||43
1024676|NCT00642460|2486985|P6|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
1024677|NCT00642460|2486986|P5|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
1024678|NCT00642460|2486987|P4|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||20
1024679|NCT00642460|2486988|P3|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
1024680|NCT00642460|2486989|P2|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||40
1024681|NCT00642460|2486990|P1|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||52
1024682|NCT00642460|2486985|P6|STARTED|Part II: Open-Label Up to Week 92||0
1024683|NCT00642460|2486986|P5|STARTED|Part II: Open-Label Up to Week 92||0
1024684|NCT00642460|2486987|P4|STARTED|Part II: Open-Label Up to Week 92|19 Participants switched from 12 mg/kg to 8 mg/kg and 1 Participant switched from 8mg/kg to 12 mg/kg|20
1024685|NCT00642460|2486988|P3|STARTED|Part II: Open-Label Up to Week 92|Placebo group received open-label Tocilizumab 8 mg/kg or 12 mg/kg based on body weight in Part II.|0
1024686|NCT00642460|2486989|P2|STARTED|Part II: Open-Label Up to Week 92||40
1024687|NCT00642460|2486990|P1|STARTED|Part II: Open-Label Up to Week 92|Includes Participants who received Open-Label in Part II or Open-Label escape therapy in Part I.|52
1024688|NCT00642460|2486985|P6|NOT COMPLETED|Part I: 12 Week Double-Blind||0
1024689|NCT00642460|2486986|P5|NOT COMPLETED|Part I: 12 Week Double-Blind||0
1024690|NCT00642460|2486987|P4|NOT COMPLETED|Part I: 12 Week Double-Blind||0
1024691|NCT00642460|2486988|P3|NOT COMPLETED|Part I: 12 Week Double-Blind||1
1024692|NCT00642460|2486989|P2|NOT COMPLETED|Part I: 12 Week Double-Blind||1
1024693|NCT00642460|2486990|P1|NOT COMPLETED|Part I: 12 Week Double-Blind||1
1024694|NCT00642460|2486985|P6|COMPLETED|Part I: 12 Week Double-Blind||0
1024695|NCT00642460|2486986|P5|COMPLETED|Part I: 12 Week Double-Blind||0
1024696|NCT00642460|2486987|P4|COMPLETED|Part I: 12 Week Double-Blind||0
1024697|NCT00642460|2486988|P3|COMPLETED|Part I: 12 Week Double-Blind||36
1024698|NCT00642460|2486989|P2|COMPLETED|Part I: 12 Week Double-Blind||37
1024699|NCT00642460|2486990|P1|COMPLETED|Part I: 12 Week Double-Blind||36
1024700|NCT00642460|2486985|P6|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
1024701|NCT00642460|2486986|P5|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
1024702|NCT00642460|2486987|P4|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
1024703|NCT00642460|2486988|P3|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
1024704|NCT00642460|2486989|P2|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||38
1024705|NCT00642460|2486990|P1|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
1024706|NCT00642460|2486985|P6|STARTED|Part I: 12 Week Double-Blind||0
1024707|NCT00642460|2486986|P5|STARTED|Part I: 12 Week Double-Blind||0
1024708|NCT00642460|2486987|P4|STARTED|Part I: 12 Week Double-Blind||0
1024709|NCT00642460|2486988|P3|STARTED|Part I: 12 Week Double-Blind||37
1024710|NCT00642460|2486989|P2|STARTED|Part I: 12 Week Double-Blind||38
1024711|NCT00642460|2486990|P1|STARTED|Part I: 12 Week Double-Blind||37
1024712|NCT00649389|2487058|P4|NOT COMPLETED|Overall Study||111
1024713|NCT00649389|2487059|P3|NOT COMPLETED|Overall Study||88
1024714|NCT00649389|2487060|P2|NOT COMPLETED|Overall Study||106
1024715|NCT00649389|2487061|P1|NOT COMPLETED|Overall Study||71
1024716|NCT00649389|2487058|P4|COMPLETED|Overall Study||516
1024717|NCT00649389|2487059|P3|COMPLETED|Overall Study||512
1024718|NCT00649389|2487060|P2|COMPLETED|Overall Study||531
1024719|NCT00649389|2487061|P1|COMPLETED|Overall Study||557
1024720|NCT00649389|2487058|P4|STARTED|Overall Study||627
1024721|NCT00649389|2487059|P3|STARTED|Overall Study||600
1024722|NCT00649389|2487060|P2|STARTED|Overall Study||637
1024723|NCT00649389|2487061|P1|STARTED|Overall Study||628
1024724|NCT00649428|2487085|P2|NOT COMPLETED|Overall Study||15
1024725|NCT00649428|2487086|P1|NOT COMPLETED|Overall Study||20
1024726|NCT00649428|2487085|P2|COMPLETED|Overall Study||88
1024727|NCT00649428|2487086|P1|COMPLETED|Overall Study||80
1024728|NCT00649428|2487085|P2|STARTED|Overall Study||103
1024729|NCT00649428|2487086|P1|STARTED|Overall Study||100
1024730|NCT00649792|2487098|P1|NOT COMPLETED|Overall Study||68
1024731|NCT00649792|2487098|P1|COMPLETED|Overall Study||146
1024732|NCT00649792|2487098|P1|STARTED|Overall Study||214
1024733|NCT00649961|2487106|P1|NOT COMPLETED|Overall Study||0
1024734|NCT00649961|2487106|P1|COMPLETED|Overall Study||18
1024735|NCT00649961|2487106|P1|STARTED|Overall Study||18
1024736|NCT00650078|2487112|P2|NOT COMPLETED|Overall Study||13
1024737|NCT00650078|2487113|P1|NOT COMPLETED|Overall Study||14
1024738|NCT00650078|2487112|P2|COMPLETED|Overall Study||106
1024739|NCT00650078|2487113|P1|COMPLETED|Overall Study||217
1024740|NCT00650078|2487112|P2|STARTED|Overall Study||119
1024741|NCT00650078|2487113|P1|STARTED|Overall Study||231
1024742|NCT00650091|2487123|P3|NOT COMPLETED|Amended Study Design||0
1024743|NCT00650091|2487124|P2|NOT COMPLETED|Amended Study Design||20
1024744|NCT00650091|2487125|P1|NOT COMPLETED|Amended Study Design||23
1024745|NCT00650091|2487123|P3|COMPLETED|Amended Study Design||0
1024746|NCT00650091|2487124|P2|COMPLETED|Amended Study Design||111
1024747|NCT00650091|2487125|P1|COMPLETED|Amended Study Design||110
1024748|NCT00650091|2487123|P3|STARTED|Amended Study Design|Study Drug was discontinued for all subjects due to safety concerns.|0
1024749|NCT00650091|2487124|P2|STARTED|Amended Study Design||131
1024750|NCT00650091|2487125|P1|STARTED|Amended Study Design||133
1024751|NCT00650091|2487123|P3|NOT COMPLETED|Initial Study Design - Interim Analysis||0
1024752|NCT00650091|2487124|P2|NOT COMPLETED|Initial Study Design - Interim Analysis||0
1024753|NCT00650091|2487125|P1|NOT COMPLETED|Initial Study Design - Interim Analysis||0
1024754|NCT00650091|2487123|P3|COMPLETED|Initial Study Design - Interim Analysis||77
1024755|NCT00650091|2487124|P2|COMPLETED|Initial Study Design - Interim Analysis||78
1024756|NCT00650091|2487125|P1|COMPLETED|Initial Study Design - Interim Analysis||81
1024757|NCT00650091|2487123|P3|STARTED|Initial Study Design - Interim Analysis||77
1024758|NCT00650091|2487124|P2|STARTED|Initial Study Design - Interim Analysis||78
1024759|NCT00650091|2487125|P1|STARTED|Initial Study Design - Interim Analysis||81
1024760|NCT00650104|2487143|P1|NOT COMPLETED|Overall Study||41
1024761|NCT00650104|2487143|P1|COMPLETED|Overall Study||42
1024762|NCT00650104|2487143|P1|STARTED|Overall Study||83
1024763|NCT00650260|2487158|P2|NOT COMPLETED|Overall Study||0
1024764|NCT00650260|2487159|P1|NOT COMPLETED|Overall Study||0
1024765|NCT00650260|2487158|P2|COMPLETED|Overall Study||21
1024766|NCT00650260|2487159|P1|COMPLETED|Overall Study||21
1024767|NCT00650260|2487158|P2|STARTED|Overall Study||21
1024768|NCT00650260|2487159|P1|STARTED|Overall Study||21
1024769|NCT00650546|2487175|P1|NOT COMPLETED|Overall Study||0
1024770|NCT00650546|2487175|P1|COMPLETED|Overall Study||8
1024771|NCT00650546|2487175|P1|STARTED|Overall Study||8
1024772|NCT00650585|2487182|P2|NOT COMPLETED|Overall Study||1477
1024773|NCT00650585|2487183|P1|NOT COMPLETED|Overall Study||1797
1024774|NCT00650585|2487182|P2|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2513
1024775|NCT00650585|2487183|P1|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2551
1024776|NCT00650585|2487182|P2|STARTED|Overall Study||3990
1024777|NCT00650585|2487183|P1|STARTED|Overall Study||4348
1024778|NCT00650767|2487207|P4|NOT COMPLETED|Overall Study||11
1024779|NCT00650767|2487208|P3|NOT COMPLETED|Overall Study||14
1024780|NCT00650767|2487209|P2|NOT COMPLETED|Overall Study||9
1024781|NCT00650767|2487210|P1|NOT COMPLETED|Overall Study||5
1024782|NCT00650767|2487207|P4|COMPLETED|Overall Study||39
1024783|NCT00650767|2487208|P3|COMPLETED|Overall Study||36
1024784|NCT00650767|2487209|P2|COMPLETED|Overall Study||41
1024785|NCT00650767|2487210|P1|COMPLETED|Overall Study||46
1024786|NCT00650767|2487207|P4|STARTED|Overall Study||50
1024787|NCT00650767|2487208|P3|STARTED|Overall Study||50
1024788|NCT00650767|2487209|P2|STARTED|Overall Study||50
1024789|NCT00650767|2487210|P1|STARTED|Overall Study||51
1024790|NCT00650806|2487716|P4|NOT COMPLETED|Overall Study||26
1024791|NCT00650806|2487717|P3|NOT COMPLETED|Overall Study||29
1024792|NCT00650806|2487718|P2|NOT COMPLETED|Overall Study||21
1024793|NCT00650806|2487719|P1|NOT COMPLETED|Overall Study||18
1024794|NCT00650806|2487716|P4|COMPLETED|Overall Study||70
1024795|NCT00650806|2487717|P3|COMPLETED|Overall Study||64
1024796|NCT00650806|2487718|P2|COMPLETED|Overall Study||77
1024797|NCT00650806|2487719|P1|COMPLETED|Overall Study||71
1024798|NCT00650806|2487716|P4|STARTED|Overall Study||96
1024799|NCT00650806|2487717|P3|STARTED|Overall Study||93
1024800|NCT00650806|2487718|P2|STARTED|Overall Study||98
1024801|NCT00650806|2487719|P1|STARTED|Overall Study||89
1024802|NCT00650845|2487759|P2|NOT COMPLETED|Overall Study||13
1024803|NCT00650845|2487760|P1|NOT COMPLETED|Overall Study||5
1024804|NCT00650845|2487759|P2|COMPLETED|Overall Study||44
1024805|NCT00650845|2487760|P1|COMPLETED|Overall Study||70
1024806|NCT00650845|2487759|P2|STARTED|Overall Study||57
1024807|NCT00650845|2487760|P1|STARTED|Overall Study||75
1024808|NCT00650858|2487779|P3|NOT COMPLETED|Overall Study||0
1024809|NCT00650858|2487780|P2|NOT COMPLETED|Overall Study||0
1024810|NCT00650858|2487781|P1|NOT COMPLETED|Overall Study||0
1024811|NCT00650858|2487779|P3|COMPLETED|Overall Study||36
1024812|NCT00650858|2487780|P2|COMPLETED|Overall Study||8
1024813|NCT00650858|2487781|P1|COMPLETED|Overall Study||8
1024814|NCT00650858|2487779|P3|STARTED|Overall Study||36
1024815|NCT00650858|2487780|P2|STARTED|Overall Study||8
1024816|NCT00650858|2487781|P1|STARTED|Overall Study||8
1024817|NCT00651040|2487797|P2|NOT COMPLETED|Overall Study||1
1024818|NCT00651040|2487798|P1|NOT COMPLETED|Overall Study||3
1024819|NCT00651040|2487797|P2|COMPLETED|Overall Study||14
1024820|NCT00651040|2487798|P1|COMPLETED|Overall Study||13
1024821|NCT00651040|2487797|P2|STARTED|Overall Study||15
1024822|NCT00651040|2487798|P1|STARTED|Overall Study||16
1024823|NCT00651118|2487808|P4|NOT COMPLETED|Overall Study||7
1024824|NCT00651118|2487809|P3|NOT COMPLETED|Overall Study||11
1024825|NCT00651118|2487810|P2|NOT COMPLETED|Overall Study||7
1024826|NCT00651118|2487811|P1|NOT COMPLETED|Overall Study||9
1024827|NCT00651118|2487808|P4|COMPLETED|Overall Study||203
1024828|NCT00651118|2487809|P3|COMPLETED|Overall Study||197
1024829|NCT00651118|2487810|P2|COMPLETED|Overall Study||200
1024830|NCT00651118|2487811|P1|COMPLETED|Overall Study||198
1024831|NCT00651118|2487808|P4|STARTED|Overall Study||210
1024832|NCT00651118|2487809|P3|STARTED|Overall Study||208
1024833|NCT00651118|2487810|P2|STARTED|Overall Study||207
1024834|NCT00651118|2487811|P1|STARTED|Overall Study||207
1024835|NCT00651157|2487829|P1|NOT COMPLETED|Overall Study||2
1024836|NCT00651157|2487829|P1|COMPLETED|Overall Study||21
1024837|NCT00651157|2487829|P1|STARTED|Overall Study||23
1024838|NCT00651183|2487837|P2|NOT COMPLETED|Overall Study||10
1024839|NCT00651183|2487838|P1|NOT COMPLETED|Overall Study||20
1024840|NCT00651183|2487837|P2|COMPLETED|Overall Study|"other reasons. No explanation was required to be given by the physicians"|87
1024841|NCT00651183|2487838|P1|COMPLETED|Overall Study|Case Report Form (CRF) listed reasons for early termination, of which one was|169
1024842|NCT00651183|2487837|P2|STARTED|Overall Study||97
1024843|NCT00651183|2487838|P1|STARTED|Overall Study|"For one patient the information was not given, therefore, the patient was listed missing"|189
1024844|NCT00651261|2487852|P2|NOT COMPLETED|Overall Study||306
1024845|NCT00651261|2487853|P1|NOT COMPLETED|Overall Study||291
1024846|NCT00651261|2487852|P2|COMPLETED|Overall Study||51
1024847|NCT00651261|2487853|P1|COMPLETED|Overall Study||69
1024848|NCT00651261|2487852|P2|STARTED|Overall Study||357
1024849|NCT00651261|2487853|P1|STARTED|Overall Study||360
1024850|NCT00651313|2487869|P2|NOT COMPLETED|Overall Study||6
1024851|NCT00651313|2487870|P1|NOT COMPLETED|Overall Study||6
1024852|NCT00651313|2487869|P2|COMPLETED|Overall Study||37
1024853|NCT00651313|2487870|P1|COMPLETED|Overall Study||35
1024854|NCT00651313|2487869|P2|STARTED|Overall Study||43
1024855|NCT00651313|2487870|P1|STARTED|Overall Study||41
1024856|NCT00651482|2487876|P1|NOT COMPLETED|Overall Study||0
1024857|NCT00651482|2487876|P1|COMPLETED|Overall Study||10
1024858|NCT00651482|2487876|P1|STARTED|Overall Study||10
1024859|NCT00651625|2487890|P2|NOT COMPLETED|Overall Study||0
1024860|NCT00651625|2487891|P1|NOT COMPLETED|Overall Study||0
1024861|NCT00651625|2487890|P2|COMPLETED|Overall Study||218
1024862|NCT00651625|2487891|P1|COMPLETED|Overall Study||219
1024863|NCT00651625|2487890|P2|STARTED|Overall Study||218
1024864|NCT00651625|2487891|P1|STARTED|Overall Study||219
1024865|NCT00651755|2487903|P2|NOT COMPLETED|Cycle 2 (Second 21 Days)||1
1024866|NCT00651755|2487904|P1|NOT COMPLETED|Cycle 2 (Second 21 Days)||0
1024867|NCT00651755|2487903|P2|COMPLETED|Cycle 2 (Second 21 Days)||8
1024868|NCT00651755|2487904|P1|COMPLETED|Cycle 2 (Second 21 Days)||10
1024869|NCT00651755|2487903|P2|STARTED|Cycle 2 (Second 21 Days)||9
1024870|NCT00651755|2487904|P1|STARTED|Cycle 2 (Second 21 Days)||10
1024871|NCT00651755|2487903|P2|NOT COMPLETED|Cycle 1 (First 21 Days)||0
1024872|NCT00651755|2487904|P1|NOT COMPLETED|Cycle 1 (First 21 Days)||1
1024873|NCT00651755|2487903|P2|COMPLETED|Cycle 1 (First 21 Days)||9
1024874|NCT00651755|2487904|P1|COMPLETED|Cycle 1 (First 21 Days)||10
1024875|NCT00651755|2487903|P2|STARTED|Cycle 1 (First 21 Days)||9
1024876|NCT00651755|2487904|P1|STARTED|Cycle 1 (First 21 Days)||11
1024877|NCT00645333|2487920|P1|NOT COMPLETED|Overall Study||0
1024878|NCT00645333|2487920|P1|COMPLETED|Overall Study||30
1024879|NCT00645333|2487920|P1|STARTED|Overall Study||30
1024880|NCT00645359|2487925|P1|NOT COMPLETED|Overall Study||0
1024881|NCT00645359|2487925|P1|COMPLETED|Overall Study||9
1024882|NCT00645359|2487925|P1|STARTED|Overall Study||9
1024883|NCT00645411|2487934|P4|NOT COMPLETED|Overall Study||103
1024884|NCT00645411|2487935|P3|NOT COMPLETED|Overall Study||151
1024885|NCT00645411|2487936|P2|NOT COMPLETED|Overall Study||6
1024886|NCT00645411|2487937|P1|NOT COMPLETED|Overall Study||13
1024887|NCT00645411|2487934|P4|COMPLETED|Overall Study||919
1024888|NCT00645411|2487935|P3|COMPLETED|Overall Study||1457
1024889|NCT00645411|2487936|P2|COMPLETED|Overall Study||312
1024890|NCT00645411|2487937|P1|COMPLETED|Overall Study||643
1024891|NCT00645411|2487934|P4|STARTED|Overall Study||1022
1024892|NCT00645411|2487935|P3|STARTED|Overall Study||1608
1024893|NCT00645411|2487936|P2|STARTED|Overall Study||318
1024894|NCT00645411|2487937|P1|STARTED|Overall Study||656
1024895|NCT00645528|2487969|P1|NOT COMPLETED|Overall Study||7
1024896|NCT00645528|2487969|P1|COMPLETED|Overall Study||32
1024897|NCT00645528|2487969|P1|STARTED|Overall Study||39
1024898|NCT00645567|2487978|P1|NOT COMPLETED|Overall Study||1
1024899|NCT00645567|2487978|P1|COMPLETED|Overall Study|One individual provided consent & was dropped due to an unrelated injury to his hand at his home.|4
1024900|NCT00645567|2487978|P1|STARTED|Overall Study||5
1024901|NCT00645593|2487988|P2|NOT COMPLETED|Overall Study||0
1024902|NCT00645593|2487989|P1|NOT COMPLETED|Overall Study||1
1024903|NCT00645593|2487988|P2|COMPLETED|Overall Study||60
1024904|NCT00645593|2487989|P1|COMPLETED|Overall Study||28
1024905|NCT00645593|2487988|P2|STARTED|Overall Study||60
1024906|NCT00645593|2487989|P1|STARTED|Overall Study||29
1024907|NCT00651820|2488001|P1|NOT COMPLETED|Overall Study||2
1024908|NCT00651820|2488001|P1|COMPLETED|Overall Study||26
1024909|NCT00651820|2488001|P1|STARTED|Overall Study||28
1024910|NCT00651924|2488010|P2|NOT COMPLETED|Overall Study||7
1024911|NCT00651924|2488011|P1|NOT COMPLETED|Overall Study||0
1024912|NCT00651924|2488010|P2|COMPLETED|Overall Study||2
1024913|NCT00651924|2488011|P1|COMPLETED|Overall Study||18
1024914|NCT00651924|2488010|P2|STARTED|Overall Study||9
1024915|NCT00651924|2488011|P1|STARTED|Overall Study||18
1024916|NCT00652028|2488021|P4|NOT COMPLETED|Overall Study||0
1024917|NCT00652028|2488022|P3|NOT COMPLETED|Overall Study||1
1024918|NCT00652028|2488023|P2|NOT COMPLETED|Overall Study||1
1024919|NCT00652028|2488024|P1|NOT COMPLETED|Overall Study||1
1024920|NCT00652028|2488021|P4|COMPLETED|Overall Study||14
1024921|NCT00652028|2488022|P3|COMPLETED|Overall Study||14
1024922|NCT00652028|2488023|P2|COMPLETED|Overall Study||13
1024923|NCT00652028|2488024|P1|COMPLETED|Overall Study||15
1024924|NCT00652028|2488021|P4|STARTED|Overall Study||14
1024925|NCT00652028|2488022|P3|STARTED|Overall Study||15
1024926|NCT00652028|2488023|P2|STARTED|Overall Study||14
1024927|NCT00652028|2488024|P1|STARTED|Overall Study||16
1024928|NCT00652093|2488072|P6|NOT COMPLETED|Overall Study||0
1024929|NCT00652093|2488073|P5|NOT COMPLETED|Overall Study||2
1024930|NCT00652093|2488074|P4|NOT COMPLETED|Overall Study||0
1024931|NCT00652093|2488075|P3|NOT COMPLETED|Overall Study||1
1024932|NCT00652093|2488076|P2|NOT COMPLETED|Overall Study||0
1024933|NCT00652093|2488077|P1|NOT COMPLETED|Overall Study||0
1024934|NCT00652093|2488072|P6|COMPLETED|Overall Study||4
1024935|NCT00652093|2488073|P5|COMPLETED|Overall Study||2
1024936|NCT00652093|2488074|P4|COMPLETED|Overall Study||4
1024937|NCT00652093|2488075|P3|COMPLETED|Overall Study||3
1024938|NCT00652093|2488076|P2|COMPLETED|Overall Study||4
1024939|NCT00652093|2488077|P1|COMPLETED|Overall Study||4
1024940|NCT00652093|2488072|P6|STARTED|Overall Study||4
1024941|NCT00652093|2488073|P5|STARTED|Overall Study||4
1024942|NCT00652093|2488074|P4|STARTED|Overall Study||4
1024943|NCT00652093|2488075|P3|STARTED|Overall Study||4
1024944|NCT00652093|2488076|P2|STARTED|Overall Study||4
1024945|NCT00652093|2488077|P1|STARTED|Overall Study||4
1024946|NCT00652314|2488159|P2|NOT COMPLETED|Overall Study||9
1024947|NCT00652314|2488160|P1|NOT COMPLETED|Overall Study||9
1024948|NCT00652314|2488159|P2|COMPLETED|Overall Study||26
1024949|NCT00652314|2488160|P1|COMPLETED|Overall Study||53
1024950|NCT00652314|2488159|P2|STARTED|Overall Study||35
1024951|NCT00652314|2488160|P1|STARTED|Overall Study||62
1024952|NCT00652327|2488176|P2|NOT COMPLETED|Overall Study||5
1024953|NCT00652327|2488177|P1|NOT COMPLETED|Overall Study||0
1024954|NCT00652327|2488176|P2|COMPLETED|Overall Study||36
1024955|NCT00652327|2488177|P1|COMPLETED|Overall Study||42
1024956|NCT00652327|2488176|P2|STARTED|Overall Study|Participants who recieved randomized treatment assignment to double the dose of ongoing statin|41
1024957|NCT00652327|2488177|P1|STARTED|Overall Study|Participants who recieved randomized treatment assignment to ezetimibe and ongoing statin|42
1024958|NCT00652340|2488185|P2|NOT COMPLETED|Overall Study||3
1024959|NCT00652340|2488186|P1|NOT COMPLETED|Overall Study||4
1024960|NCT00652340|2488185|P2|COMPLETED|Overall Study|3 patients remained on study at database lock.|39
1024961|NCT00652340|2488186|P1|COMPLETED|Overall Study|4 patients remained on study at database lock.|74
1024962|NCT00652340|2488185|P2|STARTED|Overall Study||42
1024963|NCT00652340|2488186|P1|STARTED|Overall Study||78
1024964|NCT00652366|2488199|P5|NOT COMPLETED|Overall Study||36
1024965|NCT00652366|2488200|P4|NOT COMPLETED|Overall Study||179
1024966|NCT00652366|2488201|P3|NOT COMPLETED|Overall Study||71
1024967|NCT00652366|2488202|P2|NOT COMPLETED|Overall Study||75
1024968|NCT00652366|2488203|P1|NOT COMPLETED|Overall Study||106
1024969|NCT00652366|2488199|P5|COMPLETED|Overall Study||0
1024970|NCT00652366|2488200|P4|COMPLETED|Overall Study||0
1024971|NCT00652366|2488201|P3|COMPLETED|Overall Study||0
1024972|NCT00652366|2488202|P2|COMPLETED|Overall Study||0
1024973|NCT00652366|2488203|P1|COMPLETED|Overall Study||0
1024974|NCT00652366|2488199|P5|STARTED|Overall Study||36
1024975|NCT00652366|2488200|P4|STARTED|Overall Study||179
1024976|NCT00652366|2488201|P3|STARTED|Overall Study||71
1024977|NCT00652366|2488202|P2|STARTED|Overall Study||75
1024978|NCT00652366|2488203|P1|STARTED|Overall Study||106
1024979|NCT00652626|2488243|P7|NOT COMPLETED|Extension Phase||3
1024980|NCT00652626|2488244|P6|NOT COMPLETED|Extension Phase||12
1024981|NCT00652626|2488245|P5|NOT COMPLETED|Extension Phase||0
1024982|NCT00652626|2488246|P4|NOT COMPLETED|Extension Phase||0
1024983|NCT00652626|2488247|P3|NOT COMPLETED|Extension Phase||0
1024984|NCT00652626|2488248|P2|NOT COMPLETED|Extension Phase||0
1024985|NCT00652626|2488249|P1|NOT COMPLETED|Extension Phase||0
1024986|NCT00652626|2488243|P7|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|1
1024987|NCT00652626|2488244|P6|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|2
1024988|NCT00652626|2488245|P5|COMPLETED|Extension Phase||0
1024989|NCT00652626|2488246|P4|COMPLETED|Extension Phase||0
1024990|NCT00652626|2488247|P3|COMPLETED|Extension Phase||0
1024991|NCT00652626|2488248|P2|COMPLETED|Extension Phase||0
1024992|NCT00652626|2488249|P1|COMPLETED|Extension Phase||0
1024993|NCT00652626|2488243|P7|STARTED|Extension Phase||4
1024994|NCT00652626|2488244|P6|STARTED|Extension Phase||14
1024995|NCT00652626|2488245|P5|STARTED|Extension Phase||0
1024996|NCT00652626|2488246|P4|STARTED|Extension Phase||0
1024997|NCT00652626|2488247|P3|STARTED|Extension Phase||0
1024998|NCT00652626|2488248|P2|STARTED|Extension Phase||0
1024999|NCT00652626|2488249|P1|STARTED|Extension Phase||0
1025000|NCT00652626|2488243|P7|NOT COMPLETED|Initial Treatment Phase||0
1025001|NCT00652626|2488244|P6|NOT COMPLETED|Initial Treatment Phase||0
1025002|NCT00652626|2488245|P5|NOT COMPLETED|Initial Treatment Phase||3
1025003|NCT00652626|2488246|P4|NOT COMPLETED|Initial Treatment Phase||1
1025004|NCT00652626|2488247|P3|NOT COMPLETED|Initial Treatment Phase||1
1025005|NCT00652626|2488248|P2|NOT COMPLETED|Initial Treatment Phase||0
1025006|NCT00652626|2488249|P1|NOT COMPLETED|Initial Treatment Phase||0
1025007|NCT00652626|2488243|P7|COMPLETED|Initial Treatment Phase||0
1025008|NCT00652626|2488244|P6|COMPLETED|Initial Treatment Phase||0
1025009|NCT00652626|2488245|P5|COMPLETED|Initial Treatment Phase||5
1025010|NCT00652626|2488246|P4|COMPLETED|Initial Treatment Phase||5
1025011|NCT00652626|2488247|P3|COMPLETED|Initial Treatment Phase||6
1025012|NCT00652626|2488248|P2|COMPLETED|Initial Treatment Phase||5
1025013|NCT00652626|2488249|P1|COMPLETED|Initial Treatment Phase||5
1025014|NCT00652626|2488243|P7|Received Study Drug|Initial Treatment Phase||0
1025015|NCT00652626|2488244|P6|Received Study Drug|Initial Treatment Phase||0
1025016|NCT00652626|2488245|P5|Received Study Drug|Initial Treatment Phase||6
1025017|NCT00652626|2488246|P4|Received Study Drug|Initial Treatment Phase||5
1025018|NCT00652626|2488247|P3|Received Study Drug|Initial Treatment Phase||6
1025019|NCT00652626|2488248|P2|Received Study Drug|Initial Treatment Phase||5
1025020|NCT00652626|2488249|P1|Received Study Drug|Initial Treatment Phase||5
1025021|NCT00652626|2488243|P7|STARTED|Initial Treatment Phase||0
1025022|NCT00652626|2488244|P6|STARTED|Initial Treatment Phase||0
1025023|NCT00652626|2488245|P5|STARTED|Initial Treatment Phase||8
1025024|NCT00652626|2488246|P4|STARTED|Initial Treatment Phase||6
1025025|NCT00652626|2488247|P3|STARTED|Initial Treatment Phase||7
1025026|NCT00652626|2488248|P2|STARTED|Initial Treatment Phase||5
1025027|NCT00652626|2488249|P1|STARTED|Initial Treatment Phase||5
1025028|NCT00652834|2488313|P1|NOT COMPLETED|Overall Study||5
1025029|NCT00652834|2488313|P1|COMPLETED|Overall Study|3 subjects withdrew after completing baseline questionnaire. 2 did not complete 30-day visit.|18
1025030|NCT00652834|2488313|P1|STARTED|Overall Study||23
1025031|NCT00652899|2488317|P1|NOT COMPLETED|Overall Study||2
1025032|NCT00652899|2488317|P1|COMPLETED|Overall Study||12
1025033|NCT00652899|2488317|P1|STARTED|Overall Study||14
1025034|NCT00652938|2488330|P3|NOT COMPLETED|Overall Study||5
1025035|NCT00652938|2488331|P2|NOT COMPLETED|Overall Study||7
1025036|NCT00652938|2488332|P1|NOT COMPLETED|Overall Study||1
1025037|NCT00652938|2488330|P3|COMPLETED|Overall Study||242
1025038|NCT00652938|2488331|P2|COMPLETED|Overall Study||240
1025039|NCT00652938|2488332|P1|COMPLETED|Overall Study||246
1025040|NCT00652938|2488330|P3|STARTED|Overall Study||247
1025041|NCT00652938|2488331|P2|STARTED|Overall Study||247
1025042|NCT00652938|2488332|P1|STARTED|Overall Study||247
1025043|NCT00653068|2488401|P1|NOT COMPLETED|Overall Study||50
1025044|NCT00653068|2488401|P1|COMPLETED|Overall Study||20
1025045|NCT00653068|2488401|P1|STARTED|Overall Study||70
1025046|NCT00653133|2488414|P2|NOT COMPLETED|Overall Study||0
1025047|NCT00653133|2488415|P1|NOT COMPLETED|Overall Study||0
1025048|NCT00653133|2488414|P2|COMPLETED|Overall Study||497
1025049|NCT00653133|2488415|P1|COMPLETED|Overall Study||1324
1025050|NCT00653133|2488414|P2|STARTED|Overall Study||497
1025051|NCT00653133|2488415|P1|STARTED|Overall Study||1324
1025052|NCT00653159|2488423|P2|NOT COMPLETED|Overall Study||3
1025053|NCT00653159|2488424|P1|NOT COMPLETED|Overall Study||5
1025054|NCT00653159|2488423|P2|COMPLETED|Overall Study||9
1025055|NCT00653159|2488424|P1|COMPLETED|Overall Study||6
1025056|NCT00653159|2488423|P2|STARTED|Overall Study||12
1025057|NCT00653159|2488424|P1|STARTED|Overall Study||11
1025058|NCT00653224|2488440|P2|NOT COMPLETED|Overall Study||7
1025059|NCT00653224|2488441|P1|NOT COMPLETED|Overall Study||7
1025060|NCT00653224|2488440|P2|COMPLETED|Overall Study||280
1025061|NCT00653224|2488441|P1|COMPLETED|Overall Study||286
1025062|NCT00653224|2488440|P2|STARTED|Overall Study||287
1025063|NCT00653224|2488441|P1|STARTED|Overall Study||293
1025064|NCT00653263|2488625|P1|NOT COMPLETED|Overall Study||2
1025065|NCT00653263|2488625|P1|COMPLETED|Overall Study||6
1025066|NCT00653263|2488625|P1|STARTED|Overall Study|1 dropped out of treatment and the other had untreated hypertension|8
1025067|NCT00653328|2488631|P1|NOT COMPLETED|Overall Study||15
1025068|NCT00653328|2488631|P1|COMPLETED|Overall Study||0
1025069|NCT00653328|2488631|P1|STARTED|Overall Study||15
1025070|NCT00653523|2488638|P1|NOT COMPLETED|Overall Study||19
1025071|NCT00653523|2488638|P1|COMPLETED|Overall Study||132
1025072|NCT00653523|2488638|P1|STARTED|Overall Study||151
1025073|NCT00653861|2488642|P1|NOT COMPLETED|Overall Study||0
1025074|NCT00653861|2488642|P1|COMPLETED|Overall Study||72
1025075|NCT00653861|2488642|P1|STARTED|Overall Study||72
1025076|NCT00653939|2488653|P2|NOT COMPLETED|Overall Study||15
1025077|NCT00653939|2488654|P1|NOT COMPLETED|Overall Study||12
1025078|NCT00653939|2488653|P2|COMPLETED|Overall Study||17
1025079|NCT00653939|2488654|P1|COMPLETED|Overall Study||19
1025080|NCT00653939|2488653|P2|STARTED|Overall Study|1 patient randomized did not receive treatment due to acute renal failure.|32
1025081|NCT00653939|2488654|P1|STARTED|Overall Study|2 patients randomized did not receive treatment due to brain metastasis or consent withdrawal.|31
1025082|NCT00654004|2488672|P2|NOT COMPLETED|Overall Study||0
1025083|NCT00654004|2488673|P1|NOT COMPLETED|Overall Study||1
1025084|NCT00654004|2488672|P2|COMPLETED|Overall Study||12
1025085|NCT00654004|2488673|P1|COMPLETED|Overall Study||13
1025086|NCT00654004|2488672|P2|STARTED|Overall Study||12
1025087|NCT00654004|2488673|P1|STARTED|Overall Study||14
1025088|NCT00654030|2488687|P1|NOT COMPLETED|Overall Study||2
1025089|NCT00654030|2488687|P1|COMPLETED|Overall Study||10
1025090|NCT00654030|2488687|P1|STARTED|Overall Study||12
1025091|NCT00654095|2488691|P1|NOT COMPLETED|Overall Study||32
1025092|NCT00654095|2488691|P1|COMPLETED|Overall Study||114
1025093|NCT00654095|2488691|P1|STARTED|Overall Study||146
1025094|NCT00654147|2488697|P2|NOT COMPLETED|Overall Study||4
1025095|NCT00654147|2488698|P1|NOT COMPLETED|Overall Study||2
1025096|NCT00654147|2488697|P2|COMPLETED|Overall Study||19
1025097|NCT00654147|2488698|P1|COMPLETED|Overall Study||19
1025098|NCT00654147|2488697|P2|STARTED|Overall Study||23
1025099|NCT00654147|2488698|P1|STARTED|Overall Study||21
1025100|NCT00654186|2488714|P1|NOT COMPLETED|Overall Study||5
1025101|NCT00654186|2488714|P1|COMPLETED|Overall Study||27
1025102|NCT00654186|2488714|P1|STARTED|Overall Study||32
1025103|NCT00654329|2488724|P4|NOT COMPLETED|Overall Study||0
1025104|NCT00654329|2488725|P3|NOT COMPLETED|Overall Study||0
1025105|NCT00654329|2488726|P2|NOT COMPLETED|Overall Study||0
1025106|NCT00654329|2488727|P1|NOT COMPLETED|Overall Study||0
1025107|NCT00654329|2488724|P4|COMPLETED|Overall Study||27
1025108|NCT00654329|2488725|P3|COMPLETED|Overall Study||23
1025109|NCT00654329|2488726|P2|COMPLETED|Overall Study||28
1025110|NCT00654329|2488727|P1|COMPLETED|Overall Study||23
1025111|NCT00654329|2488724|P4|STARTED|Overall Study||27
1025112|NCT00654329|2488725|P3|STARTED|Overall Study||23
1025113|NCT00654329|2488726|P2|STARTED|Overall Study||28
1025114|NCT00654329|2488727|P1|STARTED|Overall Study||23
1025115|NCT00654355|2488743|P2|NOT COMPLETED|Overall Study||2
1025116|NCT00654355|2488744|P1|NOT COMPLETED|Overall Study||2
1025117|NCT00654355|2488743|P2|COMPLETED|Overall Study||13
1025118|NCT00654355|2488744|P1|COMPLETED|Overall Study||13
1025119|NCT00654355|2488743|P2|STARTED|Overall Study||15
1025120|NCT00654355|2488744|P1|STARTED|Overall Study||15
1025121|NCT00654368|2488757|P3|NOT COMPLETED|Overall Study||32
1025122|NCT00654368|2488758|P2|NOT COMPLETED|Overall Study||48
1025123|NCT00654368|2488759|P1|NOT COMPLETED|Overall Study||53
1025124|NCT00654368|2488757|P3|COMPLETED|Overall Study||75
1025125|NCT00654368|2488758|P2|COMPLETED|Overall Study||50
1025126|NCT00654368|2488759|P1|COMPLETED|Overall Study||0
1025127|NCT00654368|2488757|P3|STARTED|Overall Study||107
1025128|NCT00654368|2488758|P2|STARTED|Overall Study||98
1025129|NCT00654368|2488759|P1|STARTED|Overall Study||53
1025130|NCT00654381|2488794|P6|NOT COMPLETED|Extension Stage||3
1025131|NCT00654381|2488795|P5|NOT COMPLETED|Extension Stage||3
1025132|NCT00654381|2488796|P4|NOT COMPLETED|Extension Stage||9
1025133|NCT00654381|2488797|P3|NOT COMPLETED|Extension Stage||11
1025134|NCT00654381|2488798|P2|NOT COMPLETED|Extension Stage||2
1025135|NCT00654381|2488799|P1|NOT COMPLETED|Extension Stage||1
1025136|NCT00654381|2488794|P6|COMPLETED|Extension Stage||73
1025137|NCT00654381|2488795|P5|COMPLETED|Extension Stage||68
1025138|NCT00654381|2488796|P4|COMPLETED|Extension Stage||142
1025139|NCT00654381|2488797|P3|COMPLETED|Extension Stage||142
1025140|NCT00654381|2488798|P2|COMPLETED|Extension Stage||36
1025141|NCT00654381|2488799|P1|COMPLETED|Extension Stage||33
1025142|NCT00654381|2488794|P6|STARTED|Extension Stage||76
1025143|NCT00654381|2488795|P5|STARTED|Extension Stage||71
1025144|NCT00654381|2488796|P4|STARTED|Extension Stage||151
1025145|NCT00654381|2488797|P3|STARTED|Extension Stage||153
1025146|NCT00654381|2488798|P2|STARTED|Extension Stage||38
1025147|NCT00654381|2488799|P1|STARTED|Extension Stage||34
1025148|NCT00654381|2488794|P6|NOT COMPLETED|2nd Stage||3
1025149|NCT00654381|2488795|P5|NOT COMPLETED|2nd Stage||8
1025150|NCT00654381|2488796|P4|NOT COMPLETED|2nd Stage||4
1025151|NCT00654381|2488797|P3|NOT COMPLETED|2nd Stage||3
1025152|NCT00654381|2488798|P2|NOT COMPLETED|2nd Stage||0
1025153|NCT00654381|2488799|P1|NOT COMPLETED|2nd Stage||2
1025154|NCT00654381|2488794|P6|COMPLETED|2nd Stage||76
1025155|NCT00654381|2488795|P5|COMPLETED|2nd Stage||71
1025156|NCT00654381|2488796|P4|COMPLETED|2nd Stage||151
1025157|NCT00654381|2488797|P3|COMPLETED|2nd Stage||153
1025158|NCT00654381|2488798|P2|COMPLETED|2nd Stage||38
1025159|NCT00654381|2488799|P1|COMPLETED|2nd Stage||34
1025160|NCT00654381|2488794|P6|STARTED|2nd Stage||79
1025161|NCT00654381|2488795|P5|STARTED|2nd Stage||79
1025162|NCT00654381|2488796|P4|STARTED|2nd Stage||155
1025163|NCT00654381|2488797|P3|STARTED|2nd Stage||156
1025164|NCT00654381|2488798|P2|STARTED|2nd Stage||38
1025165|NCT00654381|2488799|P1|STARTED|2nd Stage||36
1025166|NCT00654381|2488794|P6|NOT COMPLETED|1st Stage||2
1025167|NCT00654381|2488795|P5|NOT COMPLETED|1st Stage||2
1025168|NCT00654381|2488796|P4|NOT COMPLETED|1st Stage||5
1025169|NCT00654381|2488797|P3|NOT COMPLETED|1st Stage||3
1025170|NCT00654381|2488798|P2|NOT COMPLETED|1st Stage||3
1025171|NCT00654381|2488799|P1|NOT COMPLETED|1st Stage||3
1025172|NCT00654381|2488794|P6|COMPLETED|1st Stage||79
1025173|NCT00654381|2488795|P5|COMPLETED|1st Stage||79
1025174|NCT00654381|2488796|P4|COMPLETED|1st Stage||155
1025175|NCT00654381|2488797|P3|COMPLETED|1st Stage||156
1025176|NCT00654381|2488798|P2|COMPLETED|1st Stage||38
1025177|NCT00654381|2488799|P1|COMPLETED|1st Stage||36
1025178|NCT00654381|2488794|P6|STARTED|1st Stage||81
1025179|NCT00654381|2488795|P5|STARTED|1st Stage||81
1025180|NCT00654381|2488796|P4|STARTED|1st Stage||160
1025181|NCT00654381|2488797|P3|STARTED|1st Stage||159
1025182|NCT00654381|2488798|P2|STARTED|1st Stage||41
1025183|NCT00654381|2488799|P1|STARTED|1st Stage||39
1025184|NCT00654420|2488837|P4|NOT COMPLETED|Phase II||38
1025185|NCT00654420|2488838|P3|NOT COMPLETED|Phase II||37
1025186|NCT00654420|2488839|P2|NOT COMPLETED|Phase II||0
1025187|NCT00654420|2488840|P1|NOT COMPLETED|Phase II||0
1025188|NCT00654420|2488837|P4|COMPLETED|Phase II||0
1025189|NCT00654420|2488838|P3|COMPLETED|Phase II||0
1025190|NCT00654420|2488839|P2|COMPLETED|Phase II||0
1025191|NCT00654420|2488840|P1|COMPLETED|Phase II||0
1025192|NCT00654420|2488837|P4|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|38
1025193|NCT00654420|2488838|P3|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|37
1025194|NCT00654420|2488839|P2|STARTED|Phase II||0
1025195|NCT00654420|2488840|P1|STARTED|Phase II||0
1025196|NCT00654420|2488837|P4|NOT COMPLETED|Phase I (Dose Escalation)||0
1025197|NCT00654420|2488838|P3|NOT COMPLETED|Phase I (Dose Escalation)||0
1025198|NCT00654420|2488839|P2|NOT COMPLETED|Phase I (Dose Escalation)||16
1025199|NCT00654420|2488840|P1|NOT COMPLETED|Phase I (Dose Escalation)||4
1025200|NCT00654420|2488837|P4|COMPLETED|Phase I (Dose Escalation)||0
1025201|NCT00654420|2488838|P3|COMPLETED|Phase I (Dose Escalation)||0
1025202|NCT00654420|2488839|P2|COMPLETED|Phase I (Dose Escalation)||0
1025203|NCT00654420|2488840|P1|COMPLETED|Phase I (Dose Escalation)||0
1025204|NCT00654420|2488837|P4|STARTED|Phase I (Dose Escalation)||0
1025205|NCT00654420|2488838|P3|STARTED|Phase I (Dose Escalation)||0
1025206|NCT00654420|2488839|P2|STARTED|Phase I (Dose Escalation)||16
1025207|NCT00654420|2488840|P1|STARTED|Phase I (Dose Escalation)||4
1025208|NCT00654498|2488864|P2|NOT COMPLETED|Overall Study||12
1025209|NCT00654498|2488865|P1|NOT COMPLETED|Overall Study||14
1025210|NCT00654498|2488864|P2|COMPLETED|Overall Study||91
1025211|NCT00654498|2488865|P1|COMPLETED|Overall Study||189
1025212|NCT00654498|2488864|P2|STARTED|Overall Study||103
1025213|NCT00654498|2488865|P1|STARTED|Overall Study||203
1025214|NCT00654511|2488897|P4|NOT COMPLETED|Overall Study||0
1025215|NCT00654511|2488898|P3|NOT COMPLETED|Overall Study||0
1025216|NCT00654511|2488899|P2|NOT COMPLETED|Overall Study||0
1025217|NCT00654511|2488900|P1|NOT COMPLETED|Overall Study||0
1025218|NCT00654511|2488897|P4|COMPLETED|Overall Study||25
1025219|NCT00654511|2488898|P3|COMPLETED|Overall Study||25
1025220|NCT00654511|2488899|P2|COMPLETED|Overall Study||25
1025221|NCT00654511|2488900|P1|COMPLETED|Overall Study||26
1025222|NCT00654511|2488897|P4|STARTED|Overall Study||25
1025223|NCT00654511|2488898|P3|STARTED|Overall Study||25
1025224|NCT00654511|2488899|P2|STARTED|Overall Study||25
1025225|NCT00654511|2488900|P1|STARTED|Overall Study||26
1025226|NCT00654628|2488914|P1|NOT COMPLETED|6 –Week Extension Period (Single Site)||5
1025227|NCT00654628|2488914|P1|COMPLETED|6 –Week Extension Period (Single Site)||55
1025228|NCT00654628|2488914|P1|STARTED|6 –Week Extension Period (Single Site)|Subjects who completed the first 6-week period and participated in the second 6-week study period.|60
1025229|NCT00654628|2488914|P1|NOT COMPLETED|6-week Active Treatment Period||21
1025230|NCT00654628|2488914|P1|COMPLETED|6-week Active Treatment Period||152
1025231|NCT00654628|2488914|P1|STARTED|6-week Active Treatment Period||173
1025232|NCT00654641|2488931|P2|NOT COMPLETED|Overall Study||3
1025233|NCT00654641|2488932|P1|NOT COMPLETED|Overall Study||2
1025234|NCT00654641|2488931|P2|COMPLETED|Overall Study||23
1025235|NCT00654641|2488932|P1|COMPLETED|Overall Study||26
1025236|NCT00654641|2488931|P2|STARTED|Overall Study||26
1025237|NCT00654641|2488932|P1|STARTED|Overall Study||28
1025238|NCT00654654|2488938|P1|NOT COMPLETED|Overall Study||7
1025239|NCT00654654|2488938|P1|COMPLETED|Overall Study||43
1025240|NCT00654654|2488938|P1|STARTED|Overall Study||50
1025241|NCT00654745|2488943|P1|NOT COMPLETED|Overall Study||43
1025242|NCT00654745|2488943|P1|COMPLETED|Overall Study||164
1025243|NCT00654745|2488943|P1|STARTED|Overall Study|This is single group study in which subjects were titrated to the next of 7 arms if BP goal not met.|207
1025244|NCT00654784|2488983|P2|NOT COMPLETED|Overall Study||0
1025245|NCT00654784|2488984|P1|NOT COMPLETED|Overall Study||0
1025246|NCT00654784|2488983|P2|COMPLETED|Overall Study||8
1025247|NCT00654784|2488984|P1|COMPLETED|Overall Study||13
1025248|NCT00654784|2488983|P2|STARTED|Overall Study||8
1025249|NCT00654784|2488984|P1|STARTED|Overall Study||13
1025250|NCT00648895|2488992|P2|NOT COMPLETED|Overall Study||1
1025251|NCT00648895|2488993|P1|NOT COMPLETED|Overall Study||0
1025252|NCT00648895|2488992|P2|COMPLETED|Overall Study||5
1025253|NCT00648895|2488993|P1|COMPLETED|Overall Study||6
1025254|NCT00648895|2488992|P2|STARTED|Overall Study||6
1025255|NCT00648895|2488993|P1|STARTED|Overall Study||6
1025256|NCT00648908|2488999|P1|NOT COMPLETED|Overall Study||115
1025257|NCT00648908|2488999|P1|COMPLETED|Overall Study||154
1025258|NCT00648908|2488999|P1|STARTED|Overall Study||269
1025259|NCT00649220|2489007|P1|NOT COMPLETED|Overall Study||3
1025260|NCT00649220|2489007|P1|COMPLETED|Overall Study||16
1025261|NCT00649220|2489007|P1|STARTED|Overall Study||19
1025262|NCT00654836|2489018|P1|NOT COMPLETED|Overall Study||0
1025263|NCT00654836|2489018|P1|COMPLETED|Overall Study||32
1025264|NCT00654836|2489018|P1|STARTED|Overall Study||32
1025265|NCT00654875|2489026|P2|NOT COMPLETED|Overall Study||17
1025266|NCT00654875|2489027|P1|NOT COMPLETED|Overall Study||17
1025267|NCT00654875|2489026|P2|COMPLETED|Overall Study||147
1025268|NCT00654875|2489027|P1|COMPLETED|Overall Study||147
1025269|NCT00654875|2489026|P2|STARTED|Overall Study||164
1025270|NCT00654875|2489027|P1|STARTED|Overall Study||164
1025271|NCT00654901|2489049|P4|NOT COMPLETED|Overall Study||0
1025272|NCT00654901|2489050|P3|NOT COMPLETED|Overall Study||2
1025273|NCT00654901|2489051|P2|NOT COMPLETED|Overall Study||0
1025274|NCT00654901|2489052|P1|NOT COMPLETED|Overall Study||4
1025275|NCT00654901|2489049|P4|COMPLETED|Overall Study||113
1025276|NCT00654901|2489050|P3|COMPLETED|Overall Study||250
1025277|NCT00654901|2489051|P2|COMPLETED|Overall Study||262
1025278|NCT00654901|2489052|P1|COMPLETED|Overall Study||250
1025279|NCT00654901|2489049|P4|STARTED|Overall Study||113
1025280|NCT00654901|2489050|P3|STARTED|Overall Study||252
1025281|NCT00654901|2489051|P2|STARTED|Overall Study||262
1025282|NCT00654901|2489052|P1|STARTED|Overall Study||254
1025283|NCT00654927|2489070|P1|NOT COMPLETED|Overall Study||107
1025284|NCT00654927|2489070|P1|COMPLETED|Overall Study||70
1025285|NCT00654927|2489070|P1|STARTED|Overall Study||177
1025286|NCT00654940|2489080|P2|NOT COMPLETED|Period 2||0
1025287|NCT00654940|2489081|P1|NOT COMPLETED|Period 2||0
1025288|NCT00654940|2489080|P2|COMPLETED|Period 2||11
1025289|NCT00654940|2489081|P1|COMPLETED|Period 2||12
1025290|NCT00654940|2489080|P2|STARTED|Period 2||11
1025291|NCT00654940|2489081|P1|STARTED|Period 2||12
1025292|NCT00654940|2489080|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
1025293|NCT00654940|2489081|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
1025294|NCT00654940|2489080|P2|COMPLETED|Washout Period of 2 Weeks||11
1025295|NCT00654940|2489081|P1|COMPLETED|Washout Period of 2 Weeks||12
1025296|NCT00654940|2489080|P2|STARTED|Washout Period of 2 Weeks||11
1025297|NCT00654940|2489081|P1|STARTED|Washout Period of 2 Weeks||12
1025298|NCT00654940|2489080|P2|NOT COMPLETED|Period 1||1
1025299|NCT00654940|2489081|P1|NOT COMPLETED|Period 1||1
1025300|NCT00654940|2489080|P2|COMPLETED|Period 1||11
1025301|NCT00654940|2489081|P1|COMPLETED|Period 1||12
1025302|NCT00654940|2489080|P2|Received Study Treatment|Period 1||12
1025303|NCT00654940|2489081|P1|Received Study Treatment|Period 1||12
1025304|NCT00654940|2489080|P2|STARTED|Period 1|Assigned to study treatment.|12
1025305|NCT00654940|2489081|P1|STARTED|Period 1|Assigned to study treatment.|13
1025306|NCT00654953|2489096|P3|NOT COMPLETED|Overall Study||22
1025307|NCT00654953|2489097|P2|NOT COMPLETED|Overall Study||28
1025308|NCT00654953|2489098|P1|NOT COMPLETED|Overall Study||30
1025309|NCT00654953|2489096|P3|COMPLETED|Overall Study||8
1025310|NCT00654953|2489097|P2|COMPLETED|Overall Study||8
1025311|NCT00654953|2489098|P1|COMPLETED|Overall Study||6
1025312|NCT00654953|2489096|P3|STARTED|Overall Study||30
1025313|NCT00654953|2489097|P2|STARTED|Overall Study||36
1025314|NCT00654953|2489098|P1|STARTED|Overall Study||36
1025315|NCT00654992|2489108|P2|NOT COMPLETED|Overall Study||0
1025316|NCT00654992|2489109|P1|NOT COMPLETED|Overall Study||0
1025317|NCT00654992|2489108|P2|COMPLETED|Overall Study||35
1025318|NCT00654992|2489109|P1|COMPLETED|Overall Study||36
1025319|NCT00654992|2489108|P2|STARTED|Overall Study||35
1025320|NCT00654992|2489109|P1|STARTED|Overall Study||36
1025321|NCT00655083|2489117|P2|NOT COMPLETED|Overall Study||0
1025322|NCT00655083|2489118|P1|NOT COMPLETED|Overall Study||0
1025323|NCT00655083|2489117|P2|COMPLETED|Overall Study||8
1025324|NCT00655083|2489118|P1|COMPLETED|Overall Study||12
1025325|NCT00655083|2489117|P2|STARTED|Overall Study||8
1025326|NCT00655083|2489118|P1|STARTED|Overall Study||12
1025327|NCT00657267|2489130|P1|NOT COMPLETED|Overall Study||54
1025328|NCT00657267|2489130|P1|COMPLETED|Overall Study||4
1025329|NCT00657267|2489130|P1|STARTED|Overall Study||58
1025330|NCT00657280|2489138|P1|NOT COMPLETED|Overall Study||0
1025331|NCT00657280|2489138|P1|COMPLETED|Overall Study||16
1025332|NCT00657280|2489138|P1|STARTED|Overall Study||16
1025333|NCT00657358|2489142|P1|NOT COMPLETED|Overall Study||6
1025334|NCT00657358|2489142|P1|COMPLETED|Overall Study||16
1025335|NCT00657358|2489142|P1|STARTED|Overall Study||22
1025336|NCT00657371|2489150|P1|NOT COMPLETED|Overall Study||39
1025337|NCT00657371|2489150|P1|COMPLETED|Overall Study||249
1025338|NCT00657371|2489150|P1|STARTED|Overall Study||288
1025339|NCT00657540|2489157|P2|NOT COMPLETED|Overall Study||4
1025340|NCT00657540|2489158|P1|NOT COMPLETED|Overall Study||1
1025341|NCT00657540|2489157|P2|COMPLETED|Overall Study|All subjects had know treatment failure disposition at time of loss to follow-up.|27
1025342|NCT00657540|2489158|P1|COMPLETED|Overall Study|All subjects had know treatment failure disposition at time of loss to follow-up.|28
1025343|NCT00657540|2489157|P2|STARTED|Overall Study||31
1025344|NCT00657540|2489158|P1|STARTED|Overall Study||29
1025351|NCT00657657|2489181|P1|NOT COMPLETED|Overall Study||0
1025352|NCT00657657|2489181|P1|COMPLETED|Overall Study||29
1025353|NCT00657657|2489181|P1|STARTED|Overall Study||29
1025369|NCT00658112|2489239|P1|NOT COMPLETED|Overall Study||9
1025370|NCT00658112|2489239|P1|COMPLETED|Overall Study||11
1025371|NCT00658112|2489239|P1|STARTED|Overall Study||20
1025372|NCT00658138|2489243|P1|NOT COMPLETED|Overall Study||21
1025373|NCT00658138|2489243|P1|COMPLETED|Overall Study||40
1025374|NCT00658138|2489243|P1|STARTED|Overall Study||61
1025375|NCT00658320|2489250|P2|NOT COMPLETED|Extension Study: After Month 24||0
1025376|NCT00658320|2489251|P1|NOT COMPLETED|Extension Study: After Month 24||2
1025377|NCT00658320|2489250|P2|COMPLETED|Extension Study: After Month 24||0
1025378|NCT00658320|2489251|P1|COMPLETED|Extension Study: After Month 24||42
1025379|NCT00658320|2489250|P2|STARTED|Extension Study: After Month 24||0
1025380|NCT00658320|2489251|P1|STARTED|Extension Study: After Month 24||44
1025381|NCT00658320|2489250|P2|NOT COMPLETED|Extension Study: Month 12 to Month 24||7
1025382|NCT00658320|2489251|P1|NOT COMPLETED|Extension Study: Month 12 to Month 24||6
1025383|NCT00658320|2489250|P2|COMPLETED|Extension Study: Month 12 to Month 24||50
1025384|NCT00658320|2489251|P1|COMPLETED|Extension Study: Month 12 to Month 24||47
1025385|NCT00658320|2489250|P2|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
1025386|NCT00658320|2489251|P1|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
1025387|NCT00658320|2489250|P2|STARTED|Extension Study: Month 12 to Month 24||57
1025388|NCT00658320|2489251|P1|STARTED|Extension Study: Month 12 to Month 24||53
1025389|NCT00658320|2489250|P2|NOT COMPLETED|Core Study: 12 Months||3
1025390|NCT00658320|2489251|P1|NOT COMPLETED|Core Study: 12 Months||5
1025391|NCT00658320|2489250|P2|COMPLETED|Core Study: 12 Months||58
1025392|NCT00658320|2489251|P1|COMPLETED|Core Study: 12 Months||56
1025393|NCT00658320|2489250|P2|STARTED|Core Study: 12 Months||61
1025394|NCT00658320|2489251|P1|STARTED|Core Study: 12 Months||61
1025395|NCT00658333|2489276|P2|NOT COMPLETED|Overall Study||1
1025396|NCT00658333|2489277|P1|NOT COMPLETED|Overall Study||2
1025397|NCT00658333|2489276|P2|COMPLETED|Overall Study||14
1025398|NCT00658333|2489277|P1|COMPLETED|Overall Study||13
1025399|NCT00658333|2489276|P2|STARTED|Overall Study||15
1025400|NCT00658333|2489277|P1|STARTED|Overall Study||15
1025401|NCT00658385|2489285|P1|NOT COMPLETED|Overall Study||0
1025402|NCT00658385|2489285|P1|COMPLETED|Overall Study||5
1025403|NCT00658385|2489285|P1|STARTED|Overall Study||5
1025404|NCT00658411|2489289|P1|NOT COMPLETED|Overall Study||0
1025405|NCT00658411|2489289|P1|COMPLETED|Overall Study||5
1025406|NCT00658411|2489289|P1|STARTED|Overall Study||5
1025407|NCT00658528|2489299|P2|NOT COMPLETED|Overall Study||45
1025408|NCT00658528|2489300|P1|NOT COMPLETED|Overall Study||40
1025409|NCT00658528|2489299|P2|COMPLETED|Overall Study||479
1025410|NCT00658528|2489300|P1|COMPLETED|Overall Study||491
1025411|NCT00658528|2489299|P2|STARTED|Overall Study|Treated|524
1025412|NCT00658528|2489300|P1|STARTED|Overall Study|Treated|531
1025413|NCT00658541|2489310|P2|NOT COMPLETED|Second Intervention||0
1025414|NCT00658541|2489311|P1|NOT COMPLETED|Second Intervention||0
1025415|NCT00658541|2489310|P2|COMPLETED|Second Intervention||17
1025416|NCT00658541|2489311|P1|COMPLETED|Second Intervention||18
1025417|NCT00658541|2489310|P2|STARTED|Second Intervention||17
1025418|NCT00658541|2489311|P1|STARTED|Second Intervention||18
1025419|NCT00658541|2489310|P2|NOT COMPLETED|Washout Period of 7 Days||2
1025420|NCT00658541|2489311|P1|NOT COMPLETED|Washout Period of 7 Days||1
1025421|NCT00658541|2489310|P2|COMPLETED|Washout Period of 7 Days||17
1025422|NCT00658541|2489311|P1|COMPLETED|Washout Period of 7 Days||18
1025423|NCT00658541|2489310|P2|STARTED|Washout Period of 7 Days||19
1025424|NCT00658541|2489311|P1|STARTED|Washout Period of 7 Days||19
1025425|NCT00658541|2489310|P2|NOT COMPLETED|First Intervention||0
1025426|NCT00658541|2489311|P1|NOT COMPLETED|First Intervention||0
1025427|NCT00658541|2489310|P2|COMPLETED|First Intervention||19
1025428|NCT00658541|2489311|P1|COMPLETED|First Intervention||19
1025429|NCT00658541|2489310|P2|STARTED|First Intervention||19
1025430|NCT00658541|2489311|P1|STARTED|First Intervention||19
1025431|NCT00658567|2489324|P3|NOT COMPLETED|Overall Study||6
1025432|NCT00658567|2489325|P2|NOT COMPLETED|Overall Study||4
1025433|NCT00658567|2489326|P1|NOT COMPLETED|Overall Study||8
1025434|NCT00658567|2489324|P3|COMPLETED|Overall Study||35
1025435|NCT00658567|2489325|P2|COMPLETED|Overall Study||38
1025436|NCT00658567|2489326|P1|COMPLETED|Overall Study||32
1025437|NCT00658567|2489324|P3|STARTED|Overall Study||41
1025438|NCT00658567|2489325|P2|STARTED|Overall Study||42
1025439|NCT00658567|2489326|P1|STARTED|Overall Study||40
1025440|NCT00658606|2489339|P2|NOT COMPLETED|Overall Study||23
1025441|NCT00658606|2489340|P1|NOT COMPLETED|Overall Study||16
1025442|NCT00658606|2489339|P2|COMPLETED|Overall Study|Represents patients who completed follow-up|26
1025443|NCT00658606|2489340|P1|COMPLETED|Overall Study|Represents patients who completed follow-up|33
1025444|NCT00658606|2489339|P2|Completed Treatment|Overall Study||44
1025445|NCT00658606|2489340|P1|Completed Treatment|Overall Study||42
1025446|NCT00658606|2489339|P2|STARTED|Overall Study||49
1025447|NCT00658606|2489340|P1|STARTED|Overall Study||49
1025448|NCT00658619|2489371|P5|NOT COMPLETED|Overall Study||2
1025449|NCT00658619|2489372|P4|NOT COMPLETED|Overall Study||12
1025450|NCT00658619|2489373|P3|NOT COMPLETED|Overall Study||10
1025451|NCT00658619|2489374|P2|NOT COMPLETED|Overall Study||1
1025452|NCT00658619|2489375|P1|NOT COMPLETED|Overall Study||0
1025453|NCT00658619|2489371|P5|COMPLETED|Overall Study||21
1025454|NCT00658619|2489372|P4|COMPLETED|Overall Study||37
1025455|NCT00658619|2489373|P3|COMPLETED|Overall Study||31
1025456|NCT00658619|2489374|P2|COMPLETED|Overall Study||2
1025457|NCT00658619|2489375|P1|COMPLETED|Overall Study||3
1025458|NCT00658619|2489371|P5|STARTED|Overall Study||23
1025459|NCT00658619|2489372|P4|STARTED|Overall Study||49
1025460|NCT00658619|2489373|P3|STARTED|Overall Study||41
1025461|NCT00658619|2489374|P2|STARTED|Overall Study||3
1025462|NCT00658619|2489375|P1|STARTED|Overall Study||3
1025463|NCT00658632|2489397|P2|NOT COMPLETED|Overall Study||65
1025464|NCT00658632|2489398|P1|NOT COMPLETED|Overall Study||64
1025465|NCT00658632|2489397|P2|COMPLETED|Overall Study||633
1025466|NCT00658632|2489398|P1|COMPLETED|Overall Study||618
1025467|NCT00658632|2489397|P2|STARTED|Overall Study|Treated|698
1025468|NCT00658632|2489398|P1|STARTED|Overall Study|Treated|682
1025469|NCT00658658|2489413|P5|NOT COMPLETED|Overall Study||5
1025470|NCT00658658|2489414|P4|NOT COMPLETED|Overall Study||2
1025471|NCT00658658|2489415|P3|NOT COMPLETED|Overall Study||0
1025472|NCT00658658|2489416|P2|NOT COMPLETED|Overall Study||2
1025473|NCT00658658|2489417|P1|NOT COMPLETED|Overall Study||5
1025474|NCT00658658|2489413|P5|COMPLETED|Overall Study||3
1025475|NCT00658658|2489414|P4|COMPLETED|Overall Study||4
1025476|NCT00658658|2489415|P3|COMPLETED|Overall Study||4
1025477|NCT00658658|2489416|P2|COMPLETED|Overall Study||5
1025478|NCT00658658|2489417|P1|COMPLETED|Overall Study||1
1025479|NCT00658658|2489413|P5|STARTED|Overall Study||8
1025480|NCT00658658|2489414|P4|STARTED|Overall Study||6
1025481|NCT00658658|2489415|P3|STARTED|Overall Study||4
1025482|NCT00658658|2489416|P2|STARTED|Overall Study||7
1025483|NCT00658658|2489417|P1|STARTED|Overall Study||6
1025484|NCT00658684|2489477|P4|NOT COMPLETED|Overall Study||1
1025485|NCT00658684|2489478|P3|NOT COMPLETED|Overall Study||3
1025486|NCT00658684|2489479|P2|NOT COMPLETED|Overall Study||15
1025487|NCT00658684|2489480|P1|NOT COMPLETED|Overall Study||19
1025488|NCT00658684|2489477|P4|COMPLETED|Overall Study||27
1025489|NCT00658684|2489478|P3|COMPLETED|Overall Study||22
1025490|NCT00658684|2489479|P2|COMPLETED|Overall Study||84
1025491|NCT00658684|2489480|P1|COMPLETED|Overall Study||133
1025492|NCT00658684|2489477|P4|STARTED|Overall Study||28
1025493|NCT00658684|2489478|P3|STARTED|Overall Study||25
1025494|NCT00658684|2489479|P2|STARTED|Overall Study||99
1025495|NCT00658684|2489480|P1|STARTED|Overall Study||152
1025496|NCT00658697|2489530|P1|NOT COMPLETED|Overall Study||0
1025497|NCT00658697|2489530|P1|COMPLETED|Overall Study||41
1025498|NCT00658697|2489530|P1|STARTED|Overall Study||41
1025499|NCT00658723|2489540|P3|NOT COMPLETED|Overall Study||7
1025500|NCT00658723|2489541|P2|NOT COMPLETED|Overall Study||4
1025501|NCT00658723|2489542|P1|NOT COMPLETED|Overall Study||4
1025502|NCT00658723|2489540|P3|COMPLETED|Overall Study||44
1025503|NCT00658723|2489541|P2|COMPLETED|Overall Study||26
1025504|NCT00658723|2489542|P1|COMPLETED|Overall Study||56
1025505|NCT00658723|2489540|P3|STARTED|Overall Study||51
1025506|NCT00658723|2489541|P2|STARTED|Overall Study||30
1025507|NCT00658723|2489542|P1|STARTED|Overall Study||60
1025508|NCT00658736|2489571|P2|NOT COMPLETED|Overall Study||2
1025509|NCT00658736|2489572|P1|NOT COMPLETED|Overall Study||6
1025510|NCT00658736|2489571|P2|COMPLETED|Overall Study||19
1025511|NCT00658736|2489572|P1|COMPLETED|Overall Study||13
1025512|NCT00658736|2489571|P2|STARTED|Overall Study||21
1025513|NCT00658736|2489572|P1|STARTED|Overall Study||19
1025514|NCT00658775|2489582|P2|NOT COMPLETED|Overall Study||43
1025515|NCT00658775|2489583|P1|NOT COMPLETED|Overall Study||42
1025516|NCT00658775|2489582|P2|COMPLETED|Overall Study||485
1025517|NCT00658775|2489583|P1|COMPLETED|Overall Study||495
1025518|NCT00658775|2489582|P2|STARTED|Overall Study|Treated|528
1025519|NCT00658775|2489583|P1|STARTED|Overall Study|Treated|537
1025520|NCT00658788|2489593|P1|NOT COMPLETED|Overall Study||74
1025521|NCT00658788|2489593|P1|COMPLETED|Overall Study||231
1025522|NCT00658788|2489593|P1|STARTED|Overall Study||305
1025549|NCT00658996|2489663|P2|NOT COMPLETED|Second Intervention||1
1025550|NCT00658996|2489664|P1|NOT COMPLETED|Second Intervention||1
1025551|NCT00658996|2489663|P2|COMPLETED|Second Intervention||104
1025552|NCT00658996|2489664|P1|COMPLETED|Second Intervention||105
1025553|NCT00658996|2489663|P2|STARTED|Second Intervention||105
1025554|NCT00658996|2489664|P1|STARTED|Second Intervention||106
1025555|NCT00658996|2489663|P2|NOT COMPLETED|Crossover Period||1
1025556|NCT00658996|2489664|P1|NOT COMPLETED|Crossover Period||2
1025557|NCT00658996|2489663|P2|COMPLETED|Crossover Period||105
1025558|NCT00658996|2489664|P1|COMPLETED|Crossover Period||106
1025559|NCT00658996|2489663|P2|STARTED|Crossover Period||106
1025560|NCT00658996|2489664|P1|STARTED|Crossover Period||108
1025561|NCT00658996|2489663|P2|NOT COMPLETED|First Intervention||1
1025562|NCT00658996|2489664|P1|NOT COMPLETED|First Intervention||1
1025563|NCT00658996|2489663|P2|COMPLETED|First Intervention||106
1025564|NCT00658996|2489664|P1|COMPLETED|First Intervention||108
1025565|NCT00658996|2489663|P2|STARTED|First Intervention||107
1025566|NCT00658996|2489664|P1|STARTED|First Intervention||109
1025567|NCT00659061|2489676|P2|NOT COMPLETED|Overall Study||15
1025568|NCT00659061|2489677|P1|NOT COMPLETED|Overall Study||21
1025569|NCT00659061|2489676|P2|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
1025570|NCT00659061|2489677|P1|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
1025571|NCT00659061|2489676|P2|STARTED|Overall Study||302
1025572|NCT00659061|2489677|P1|STARTED|Overall Study||308
1025573|NCT00659165|2489697|P2|NOT COMPLETED|Overall Study||0
1025574|NCT00659165|2489698|P1|NOT COMPLETED|Overall Study||0
1025575|NCT00659165|2489697|P2|COMPLETED|Overall Study||5
1025576|NCT00659165|2489698|P1|COMPLETED|Overall Study||5
1025577|NCT00659165|2489697|P2|STARTED|Overall Study||5
1025578|NCT00659165|2489698|P1|STARTED|Overall Study||5
1025585|NCT00659269|2489721|P2|NOT COMPLETED|Overall Study||1
1025586|NCT00659269|2489722|P1|NOT COMPLETED|Overall Study||1
1025587|NCT00659269|2489721|P2|COMPLETED|Overall Study||161
1025588|NCT00659269|2489722|P1|COMPLETED|Overall Study||156
1025589|NCT00659269|2489721|P2|Group 3 (Taxanes)|Overall Study||97
1025590|NCT00659269|2489722|P1|Group 3 (Taxanes)|Overall Study||92
1025591|NCT00659269|2489721|P2|Group 2 (Vinca Alkaloids)|Overall Study||12
1025592|NCT00659269|2489722|P1|Group 2 (Vinca Alkaloids)|Overall Study||12
1025593|NCT00659269|2489721|P2|Group 1 (Heavy Metals)|Overall Study||52
1025594|NCT00659269|2489722|P1|Group 1 (Heavy Metals)|Overall Study||52
1025595|NCT00659269|2489721|P2|STARTED|Overall Study||162
1025596|NCT00659269|2489722|P1|STARTED|Overall Study||157
1025597|NCT00659295|2489752|P2|NOT COMPLETED|Overall Study||5603
1025598|NCT00659295|2489753|P1|NOT COMPLETED|Overall Study||2708
1025599|NCT00659295|2489752|P2|COMPLETED|Overall Study||32038
1025600|NCT00659295|2489753|P1|COMPLETED|Overall Study||10821
1025601|NCT00659295|2489752|P2|STARTED|Overall Study||37641
1025602|NCT00659295|2489753|P1|STARTED|Overall Study||13529
1025603|NCT00659334|2489766|P7|NOT COMPLETED|Overall Study||1
1025604|NCT00659334|2489767|P6|NOT COMPLETED|Overall Study||0
1025605|NCT00659334|2489768|P5|NOT COMPLETED|Overall Study||0
1025606|NCT00659334|2489769|P4|NOT COMPLETED|Overall Study||0
1025607|NCT00659334|2489770|P3|NOT COMPLETED|Overall Study||0
1025608|NCT00659334|2489771|P2|NOT COMPLETED|Overall Study||5
1025609|NCT00659334|2489772|P1|NOT COMPLETED|Overall Study||8
1025610|NCT00659334|2489766|P7|COMPLETED|Overall Study|1 screen failure|20
1025611|NCT00659334|2489767|P6|COMPLETED|Overall Study||0
1025612|NCT00659334|2489768|P5|COMPLETED|Overall Study||1
1025613|NCT00659334|2489769|P4|COMPLETED|Overall Study||2
1025614|NCT00659334|2489770|P3|COMPLETED|Overall Study||5
1025615|NCT00659334|2489771|P2|COMPLETED|Overall Study|5 Screen failures|36
1025616|NCT00659334|2489772|P1|COMPLETED|Overall Study|8 Screen failures|38
1025617|NCT00659334|2489766|P7|STARTED|Overall Study||21
1025618|NCT00659334|2489767|P6|STARTED|Overall Study||0
1025619|NCT00659334|2489768|P5|STARTED|Overall Study||1
1025620|NCT00659334|2489769|P4|STARTED|Overall Study||2
1025621|NCT00659334|2489770|P3|STARTED|Overall Study||5
1025622|NCT00659334|2489771|P2|STARTED|Overall Study||41
1025623|NCT00659334|2489772|P1|STARTED|Overall Study||46
1025624|NCT00659360|2489788|P1|NOT COMPLETED|Overall Study||0
1025625|NCT00659360|2489788|P1|COMPLETED|Overall Study||17
1025626|NCT00659360|2489788|P1|STARTED|Overall Study||17
1025627|NCT00659373|2489798|P2|NOT COMPLETED|Overall Study||7
1025628|NCT00659373|2489799|P1|NOT COMPLETED|Overall Study||5
1025629|NCT00659373|2489798|P2|COMPLETED|Overall Study||54
1025630|NCT00659373|2489799|P1|COMPLETED|Overall Study||20
1025631|NCT00659373|2489798|P2|STARTED|Overall Study||61
1025632|NCT00659373|2489799|P1|STARTED|Overall Study||25
1025633|NCT00659425|2489815|P10|NOT COMPLETED|Overall Study||13
1025634|NCT00659425|2489816|P9|NOT COMPLETED|Overall Study||6
1025635|NCT00659425|2489817|P8|NOT COMPLETED|Overall Study||11
1025636|NCT00659425|2489818|P7|NOT COMPLETED|Overall Study||8
1025637|NCT00659425|2489819|P6|NOT COMPLETED|Overall Study||4
1025638|NCT00659425|2489820|P5|NOT COMPLETED|Overall Study||4
1025639|NCT00659425|2489821|P4|NOT COMPLETED|Overall Study||4
1025640|NCT00659425|2489822|P3|NOT COMPLETED|Overall Study||1
1025641|NCT00659425|2489823|P2|NOT COMPLETED|Overall Study||1
1025642|NCT00659425|2489824|P1|NOT COMPLETED|Overall Study||1
1025643|NCT00659425|2489815|P10|COMPLETED|Overall Study||1
1025644|NCT00659425|2489816|P9|COMPLETED|Overall Study||0
1025645|NCT00659425|2489817|P8|COMPLETED|Overall Study||0
1025646|NCT00659425|2489818|P7|COMPLETED|Overall Study||0
1025647|NCT00659425|2489819|P6|COMPLETED|Overall Study||1
1025648|NCT00659425|2489820|P5|COMPLETED|Overall Study||0
1025649|NCT00659425|2489821|P4|COMPLETED|Overall Study||0
1025650|NCT00659425|2489822|P3|COMPLETED|Overall Study||0
1025651|NCT00659425|2489823|P2|COMPLETED|Overall Study||0
1025652|NCT00659425|2489824|P1|COMPLETED|Overall Study||0
1025653|NCT00659425|2489815|P10|STARTED|Overall Study||14
1025654|NCT00659425|2489816|P9|STARTED|Overall Study||6
1025655|NCT00659425|2489817|P8|STARTED|Overall Study||11
1025656|NCT00659425|2489818|P7|STARTED|Overall Study||8
1025657|NCT00659425|2489819|P6|STARTED|Overall Study||5
1025658|NCT00659425|2489820|P5|STARTED|Overall Study||4
1025659|NCT00659425|2489821|P4|STARTED|Overall Study||4
1025660|NCT00659425|2489822|P3|STARTED|Overall Study||1
1025661|NCT00659425|2489823|P2|STARTED|Overall Study||1
1025662|NCT00659425|2489824|P1|STARTED|Overall Study||1
1025663|NCT00659438|2490055|P2|NOT COMPLETED|Overall Study||8
1025664|NCT00659438|2490056|P1|NOT COMPLETED|Overall Study||14
1025665|NCT00659438|2490055|P2|COMPLETED|Overall Study||40
1025666|NCT00659438|2490056|P1|COMPLETED|Overall Study||33
1025667|NCT00659438|2490055|P2|Safety Analysis Set|Overall Study||47
1025668|NCT00659438|2490056|P1|Safety Analysis Set|Overall Study|One patient randomized to placebo was accounted in vandetanib group as he mistakenly received drug|48
1025669|NCT00659438|2490055|P2|Secondary Analysis Set|Overall Study||48
1025670|NCT00659438|2490056|P1|Secondary Analysis Set|Overall Study||47
1025671|NCT00659438|2490055|P2|Assessable Set : Primary Analysis|Overall Study||45
1025672|NCT00659438|2490056|P1|Assessable Set : Primary Analysis|Overall Study||44
1025673|NCT00659438|2490055|P2|STARTED|Overall Study||48
1025674|NCT00659438|2490056|P1|STARTED|Overall Study||47
1025675|NCT00659490|2490081|P3|NOT COMPLETED|Overall Study||1
1025676|NCT00659490|2490082|P2|NOT COMPLETED|Overall Study||0
1025677|NCT00659490|2490083|P1|NOT COMPLETED|Overall Study||2
1025678|NCT00659490|2490081|P3|COMPLETED|Overall Study||30
1025679|NCT00659490|2490082|P2|COMPLETED|Overall Study||59
1025680|NCT00659490|2490083|P1|COMPLETED|Overall Study||59
1025681|NCT00659490|2490081|P3|STARTED|Overall Study||31
1025682|NCT00659490|2490082|P2|STARTED|Overall Study||59
1025683|NCT00659490|2490083|P1|STARTED|Overall Study||61
1025684|NCT00659529|2490154|P1|NOT COMPLETED|Overall Study||16
1025685|NCT00659529|2490154|P1|COMPLETED|Overall Study|4 patients withdrew as a result of side effects. 3 subjects were withdrawn by the investigator.|20
1025686|NCT00659529|2490154|P1|Received at Least One Dose of Study Drug|Overall Study|Received at least one dose of study drug|27
1025687|NCT00659529|2490154|P1|STARTED|Overall Study|There were 9 screen failures (subjects who did not meet inclusion/exclusion criteria)|36
1025688|NCT00659581|2490158|P1|NOT COMPLETED|Overall Study||8582
1025689|NCT00659581|2490158|P1|COMPLETED|Overall Study||12412
1025690|NCT00659581|2490158|P1|STARTED|Overall Study||20994
1025691|NCT00659607|2490170|P1|NOT COMPLETED|Overall Study||316
1025692|NCT00659607|2490170|P1|COMPLETED|Overall Study||3616
1025693|NCT00659607|2490170|P1|STARTED|Overall Study||3932
1025694|NCT00659633|2490188|P1|NOT COMPLETED|Overall Study||0
1025695|NCT00659633|2490188|P1|COMPLETED|Overall Study||10
1025696|NCT00659633|2490188|P1|STARTED|Overall Study||10
1025697|NCT00652145|2490194|P2|NOT COMPLETED|Overall Study||0
1025698|NCT00652145|2490195|P1|NOT COMPLETED|Overall Study||0
1025699|NCT00652145|2490194|P2|COMPLETED|Overall Study||26
1025700|NCT00652145|2490195|P1|COMPLETED|Overall Study||26
1025701|NCT00652145|2490194|P2|STARTED|Overall Study||26
1025702|NCT00652145|2490195|P1|STARTED|Overall Study||26
1025703|NCT00659724|2490205|P1|NOT COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||0
1025704|NCT00659724|2490205|P1|COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||33
1025705|NCT00659724|2490205|P1|STARTED|Weeks 3-4: Assessment of HD-C4 Big||33
1025706|NCT00659724|2490205|P1|NOT COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||0
1025707|NCT00659724|2490205|P1|COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||33
1025708|NCT00659724|2490205|P1|STARTED|Weeks 1-2: Assessment of 180NR or 200NR||33
1025709|NCT00659737|2490225|P2|NOT COMPLETED|Overall Study||0
1025710|NCT00659737|2490226|P1|NOT COMPLETED|Overall Study||0
1025711|NCT00659737|2490225|P2|COMPLETED|Overall Study||58
1025712|NCT00659737|2490226|P1|COMPLETED|Overall Study||57
1025713|NCT00659737|2490225|P2|STARTED|Overall Study||58
1025714|NCT00659737|2490226|P1|STARTED|Overall Study||57
1025715|NCT00659789|2490234|P2|NOT COMPLETED|Overall Study||7
1025716|NCT00659789|2490235|P1|NOT COMPLETED|Overall Study||7
1025717|NCT00659789|2490234|P2|COMPLETED|Overall Study||36
1025718|NCT00659789|2490235|P1|COMPLETED|Overall Study||86
1025719|NCT00659789|2490234|P2|STARTED|Overall Study||43
1025720|NCT00659789|2490235|P1|STARTED|Overall Study||93
1025721|NCT00659815|2490253|P2|NOT COMPLETED|Overall Study||4
1025722|NCT00659815|2490254|P1|NOT COMPLETED|Overall Study||4
1025723|NCT00659815|2490253|P2|COMPLETED|Overall Study||147
1025724|NCT00659815|2490254|P1|COMPLETED|Overall Study||153
1025725|NCT00659815|2490253|P2|STARTED|Overall Study||151
1025726|NCT00659815|2490254|P1|STARTED|Overall Study||157
1025727|NCT00659880|2490264|P1|NOT COMPLETED|Overall Study||5
1025728|NCT00659880|2490264|P1|COMPLETED|Overall Study|60 months|4
1025729|NCT00659880|2490264|P1|24 Months|Overall Study||6
1025730|NCT00659880|2490264|P1|12 Months|Overall Study||7
1025731|NCT00659880|2490264|P1|6 Months|Overall Study||9
1025732|NCT00659880|2490264|P1|6 Weeks|Overall Study||9
1025733|NCT00659880|2490264|P1|STARTED|Overall Study||9
1025734|NCT00659945|2490271|P2|NOT COMPLETED|Overall Study||0
1025735|NCT00659945|2490272|P1|NOT COMPLETED|Overall Study||0
1025736|NCT00659945|2490271|P2|COMPLETED|Overall Study||75
1025737|NCT00659945|2490272|P1|COMPLETED|Overall Study||75
1025738|NCT00659945|2490271|P2|STARTED|Overall Study||75
1025739|NCT00659945|2490272|P1|STARTED|Overall Study||75
1025740|NCT00659984|2490278|P1|NOT COMPLETED|Overall Study||1
1025741|NCT00659984|2490278|P1|COMPLETED|Overall Study||14
1025742|NCT00659984|2490278|P1|STARTED|Overall Study||15
1025743|NCT00660010|2490289|P1|NOT COMPLETED|Overall Study||9
1025744|NCT00660010|2490289|P1|COMPLETED|Overall Study||46
1025745|NCT00660010|2490289|P1|STARTED|Overall Study||55
1025746|NCT00660023|2490303|P1|NOT COMPLETED|Overall Study||29
1025747|NCT00660023|2490303|P1|COMPLETED|Overall Study||95
1025748|NCT00660023|2490303|P1|Treated|Overall Study||114
1025749|NCT00660023|2490303|P1|STARTED|Overall Study||124
1025750|NCT00660049|2490314|P1|NOT COMPLETED|Overall Study||6
1025751|NCT00660049|2490314|P1|COMPLETED|Overall Study||6
1025752|NCT00660049|2490314|P1|STARTED|Overall Study||12
1025753|NCT00666835|2490320|P2|NOT COMPLETED|Overall Study||22
1025754|NCT00666835|2490321|P1|NOT COMPLETED|Overall Study||53
1025755|NCT00666835|2490320|P2|COMPLETED|Overall Study||142
1025756|NCT00666835|2490321|P1|COMPLETED|Overall Study||261
1025757|NCT00666835|2490320|P2|STARTED|Overall Study||164
1025758|NCT00666835|2490321|P1|STARTED|Overall Study||314
1025759|NCT00666848|2490332|P3|NOT COMPLETED|Overall Study||0
1025760|NCT00666848|2490333|P2|NOT COMPLETED|Overall Study||0
1025761|NCT00666848|2490334|P1|NOT COMPLETED|Overall Study||0
1025762|NCT00666848|2490332|P3|COMPLETED|Overall Study|finished Aim 3|7
1025763|NCT00666848|2490333|P2|COMPLETED|Overall Study|finished Aim 1|9
1025764|NCT00666848|2490334|P1|COMPLETED|Overall Study|finished Aim 2|8
1025765|NCT00666848|2490332|P3|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|7
1025766|NCT00666848|2490333|P2|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|9
1025767|NCT00666848|2490334|P1|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|8
1025768|NCT00666926|2490345|P16|NOT COMPLETED|Overall Study||8
1025769|NCT00666926|2490346|P15|NOT COMPLETED|Overall Study||7
1025770|NCT00666926|2490347|P14|NOT COMPLETED|Overall Study||4
1025771|NCT00666926|2490348|P13|NOT COMPLETED|Overall Study||3
1025772|NCT00666926|2490349|P12|NOT COMPLETED|Overall Study||33
1025773|NCT00666926|2490350|P11|NOT COMPLETED|Overall Study||6
1025774|NCT00666926|2490351|P10|NOT COMPLETED|Overall Study||10
1025775|NCT00666926|2490352|P9|NOT COMPLETED|Overall Study||3
1025776|NCT00666926|2490353|P8|NOT COMPLETED|Overall Study||1
1025777|NCT00666926|2490354|P7|NOT COMPLETED|Overall Study||4
1025778|NCT00666926|2490355|P6|NOT COMPLETED|Overall Study||4
1025779|NCT00666926|2490356|P5|NOT COMPLETED|Overall Study||3
1025780|NCT00666926|2490357|P4|NOT COMPLETED|Overall Study||4
1025781|NCT00666926|2490358|P3|NOT COMPLETED|Overall Study||3
1025782|NCT00666926|2490359|P2|NOT COMPLETED|Overall Study||4
1025783|NCT00666926|2490360|P1|NOT COMPLETED|Overall Study||2
1025784|NCT00666926|2490345|P16|COMPLETED|Overall Study||0
1025785|NCT00666926|2490346|P15|COMPLETED|Overall Study||0
1025786|NCT00666926|2490347|P14|COMPLETED|Overall Study||0
1025787|NCT00666926|2490348|P13|COMPLETED|Overall Study||0
1025788|NCT00666926|2490349|P12|COMPLETED|Overall Study||0
1025789|NCT00666926|2490350|P11|COMPLETED|Overall Study||0
1025790|NCT00666926|2490351|P10|COMPLETED|Overall Study||0
1025791|NCT00666926|2490352|P9|COMPLETED|Overall Study||0
1025792|NCT00666926|2490353|P8|COMPLETED|Overall Study||0
1025793|NCT00666926|2490354|P7|COMPLETED|Overall Study||0
1025794|NCT00666926|2490355|P6|COMPLETED|Overall Study||0
1025795|NCT00666926|2490356|P5|COMPLETED|Overall Study||0
1025796|NCT00666926|2490357|P4|COMPLETED|Overall Study||0
1025797|NCT00666926|2490358|P3|COMPLETED|Overall Study||0
1025798|NCT00666926|2490359|P2|COMPLETED|Overall Study||0
1025799|NCT00666926|2490360|P1|COMPLETED|Overall Study||0
1025800|NCT00666926|2490345|P16|STARTED|Overall Study||8
1025801|NCT00666926|2490346|P15|STARTED|Overall Study||7
1025802|NCT00666926|2490347|P14|STARTED|Overall Study||4
1025803|NCT00666926|2490348|P13|STARTED|Overall Study||3
1025804|NCT00666926|2490349|P12|STARTED|Overall Study||33
1025805|NCT00666926|2490350|P11|STARTED|Overall Study||6
1025806|NCT00666926|2490351|P10|STARTED|Overall Study||10
1025807|NCT00666926|2490352|P9|STARTED|Overall Study||3
1025808|NCT00666926|2490353|P8|STARTED|Overall Study||1
1025809|NCT00666926|2490354|P7|STARTED|Overall Study||4
1025810|NCT00666926|2490355|P6|STARTED|Overall Study||4
1025811|NCT00666926|2490356|P5|STARTED|Overall Study||3
1025812|NCT00666926|2490357|P4|STARTED|Overall Study||4
1025813|NCT00666926|2490358|P3|STARTED|Overall Study||3
1025814|NCT00666926|2490359|P2|STARTED|Overall Study||4
1025815|NCT00666926|2490360|P1|STARTED|Overall Study||2
1025816|NCT00666965|2490655|P4|NOT COMPLETED|Overall Study||15
1025817|NCT00666965|2490656|P3|NOT COMPLETED|Overall Study||2
1025818|NCT00666965|2490657|P2|NOT COMPLETED|Overall Study||4
1025819|NCT00666965|2490658|P1|NOT COMPLETED|Overall Study||3
1025820|NCT00666965|2490655|P4|COMPLETED|Overall Study||42
1025821|NCT00666965|2490656|P3|COMPLETED|Overall Study||56
1025822|NCT00666965|2490657|P2|COMPLETED|Overall Study||53
1025823|NCT00666965|2490658|P1|COMPLETED|Overall Study||55
1025824|NCT00666965|2490655|P4|STARTED|Overall Study||57
1025825|NCT00666965|2490656|P3|STARTED|Overall Study||58
1025826|NCT00666965|2490657|P2|STARTED|Overall Study||57
1025827|NCT00666965|2490658|P1|STARTED|Overall Study||58
1025828|NCT00666978|2490690|P2|NOT COMPLETED|Overall Study||83
1025829|NCT00666978|2490691|P1|NOT COMPLETED|Overall Study||78
1025830|NCT00666978|2490690|P2|COMPLETED|Overall Study||187
1025831|NCT00666978|2490691|P1|COMPLETED|Overall Study||192
1025832|NCT00666978|2490690|P2|STARTED|Overall Study||270
1025833|NCT00666978|2490691|P1|STARTED|Overall Study||270
1025834|NCT00667095|2490702|P2|NOT COMPLETED|Overall Study||1
1025835|NCT00667095|2490703|P1|NOT COMPLETED|Overall Study||0
1025836|NCT00667095|2490702|P2|COMPLETED|Overall Study||9
1025837|NCT00667095|2490703|P1|COMPLETED|Overall Study||11
1025838|NCT00667095|2490702|P2|STARTED|Overall Study||10
1025839|NCT00667095|2490703|P1|STARTED|Overall Study||11
1025840|NCT00667186|2490721|P2|NOT COMPLETED|Overall Study||0
1025841|NCT00667186|2490722|P1|NOT COMPLETED|Overall Study||0
1025842|NCT00667186|2490721|P2|COMPLETED|Overall Study||4880
1025843|NCT00667186|2490722|P1|COMPLETED|Overall Study||4692
1025844|NCT00667186|2490721|P2|STARTED|Overall Study||4880
1025845|NCT00667186|2490722|P1|STARTED|Overall Study||4692
1025846|NCT00667225|2490732|P2|NOT COMPLETED|Overall Study||1
1025847|NCT00667225|2490733|P1|NOT COMPLETED|Overall Study||1
1025848|NCT00667225|2490732|P2|COMPLETED|Overall Study||12
1025849|NCT00667225|2490733|P1|COMPLETED|Overall Study||15
1025850|NCT00667225|2490732|P2|STARTED|Overall Study||13
1025851|NCT00667225|2490733|P1|STARTED|Overall Study||16
1025852|NCT00667251|2490743|P2|NOT COMPLETED|Overall Study||95
1025853|NCT00667251|2490744|P1|NOT COMPLETED|Overall Study||70
1025854|NCT00667251|2490743|P2|COMPLETED|Overall Study||231
1025855|NCT00667251|2490744|P1|COMPLETED|Overall Study||256
1025856|NCT00667251|2490743|P2|Not Started|Overall Study||1
1025857|NCT00667251|2490744|P1|Not Started|Overall Study||4
1025858|NCT00667251|2490743|P2|Monotherapy|Overall Study||232
1025859|NCT00667251|2490744|P1|Monotherapy|Overall Study||225
1025860|NCT00667251|2490743|P2|Combination Rx|Overall Study||325
1025861|NCT00667251|2490744|P1|Combination Rx|Overall Study||322
1025862|NCT00667251|2490743|P2|STARTED|Overall Study||326
1025863|NCT00667251|2490744|P1|STARTED|Overall Study||326
1025864|NCT00667277|2490768|P1|NOT COMPLETED|Overall Study||2
1025865|NCT00667277|2490768|P1|COMPLETED|Overall Study||11
1025866|NCT00667277|2490768|P1|STARTED|Overall Study||13
1025867|NCT00667342|2490776|P3|NOT COMPLETED|Overall Study||9
1025868|NCT00667342|2490777|P2|NOT COMPLETED|Overall Study||0
1025869|NCT00667342|2490778|P1|NOT COMPLETED|Overall Study||14
1025870|NCT00667342|2490776|P3|COMPLETED|Overall Study||3
1025871|NCT00667342|2490777|P2|COMPLETED|Overall Study||0
1025872|NCT00667342|2490778|P1|COMPLETED|Overall Study||17
1025873|NCT00667342|2490776|P3|STARTED|Overall Study||12
1025874|NCT00667342|2490777|P2|STARTED|Overall Study||0
1025875|NCT00667342|2490778|P1|STARTED|Overall Study||31
1025876|NCT00667355|2490816|P1|NOT COMPLETED|Overall Study||11
1025877|NCT00667355|2490816|P1|COMPLETED|Overall Study||30
1025878|NCT00667355|2490816|P1|STARTED|Overall Study||41
1025879|NCT00667368|2490840|P2|NOT COMPLETED|Overall Study||172
1025880|NCT00667368|2490841|P1|NOT COMPLETED|Overall Study||200
1025881|NCT00667368|2490840|P2|COMPLETED|Overall Study||511
1025882|NCT00667368|2490841|P1|COMPLETED|Overall Study||482
1025883|NCT00667368|2490840|P2|STARTED|Overall Study||683
1025884|NCT00667368|2490841|P1|STARTED|Overall Study||682
1025885|NCT00667381|2490851|P2|NOT COMPLETED|Overall Study||0
1025886|NCT00667381|2490852|P1|NOT COMPLETED|Overall Study||0
1025887|NCT00667381|2490851|P2|COMPLETED|Overall Study||503
1025888|NCT00667381|2490852|P1|COMPLETED|Overall Study||501
1025889|NCT00667381|2490851|P2|STARTED|Overall Study||503
1025890|NCT00667381|2490852|P1|STARTED|Overall Study||501
1025891|NCT00667394|2490868|P2|NOT COMPLETED|Overall Study||0
1025892|NCT00667394|2490869|P1|NOT COMPLETED|Overall Study||4
1025893|NCT00667394|2490868|P2|COMPLETED|Overall Study||1
1025894|NCT00667394|2490869|P1|COMPLETED|Overall Study||37
1025895|NCT00667394|2490868|P2|STARTED|Overall Study||1
1025896|NCT00667394|2490869|P1|STARTED|Overall Study||41
1025897|NCT00667420|2490877|P1|NOT COMPLETED|Overall Study||10
1025898|NCT00667420|2490877|P1|COMPLETED|Overall Study||7
1025899|NCT00667420|2490877|P1|Completion of Surgery/Re-staging|Overall Study||11
1025900|NCT00667420|2490877|P1|Completion of Pre-operative EOX-P|Overall Study||15
1025901|NCT00667420|2490877|P1|STARTED|Overall Study||17
1025902|NCT00667446|2490887|P2|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||1
1025903|NCT00667446|2490888|P1|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||0
1025904|NCT00667446|2490887|P2|COMPLETED|Safety Follow-up Period (12 Weeks)||25
1025905|NCT00667446|2490888|P1|COMPLETED|Safety Follow-up Period (12 Weeks)||28
1025906|NCT00667446|2490887|P2|STARTED|Safety Follow-up Period (12 Weeks)||26
1025907|NCT00667446|2490888|P1|STARTED|Safety Follow-up Period (12 Weeks)||28
1025908|NCT00667446|2490887|P2|NOT COMPLETED|Treatment Period (36 Months)||25
1025909|NCT00667446|2490888|P1|NOT COMPLETED|Treatment Period (36 Months)||23
1025910|NCT00667446|2490887|P2|COMPLETED|Treatment Period (36 Months)||13
1025911|NCT00667446|2490888|P1|COMPLETED|Treatment Period (36 Months)||11
1025912|NCT00667446|2490887|P2|STARTED|Treatment Period (36 Months)||38
1025913|NCT00667446|2490888|P1|STARTED|Treatment Period (36 Months)||34
1025914|NCT00667459|2490912|P2|NOT COMPLETED|Overall Study||45
1025915|NCT00667459|2490913|P1|NOT COMPLETED|Overall Study||8
1025916|NCT00667459|2490912|P2|COMPLETED|Overall Study||220
1025917|NCT00667459|2490913|P1|COMPLETED|Overall Study||272
1025918|NCT00667459|2490912|P2|STARTED|Overall Study||265
1025919|NCT00667459|2490913|P1|STARTED|Overall Study||280
1025920|NCT00667511|2490953|P1|NOT COMPLETED|Intervention 2: Home NHD||4
1025921|NCT00667511|2490953|P1|COMPLETED|Intervention 2: Home NHD||39
1025922|NCT00667511|2490953|P1|STARTED|Intervention 2: Home NHD||43
1025923|NCT00667511|2490953|P1|NOT COMPLETED|Training/Transition Period||8
1025924|NCT00667511|2490953|P1|COMPLETED|Training/Transition Period||43
1025925|NCT00667511|2490953|P1|STARTED|Training/Transition Period||51
1025926|NCT00667511|2490953|P1|NOT COMPLETED|Intervention 1: Home DHD||7
1025927|NCT00667511|2490953|P1|COMPLETED|Intervention 1: Home DHD||51
1025928|NCT00667511|2490953|P1|STARTED|Intervention 1: Home DHD||58
1025929|NCT00667563|2490961|P1|NOT COMPLETED|Overall Study||24
1025930|NCT00667563|2490961|P1|COMPLETED|Overall Study||126
1025931|NCT00667563|2490961|P1|STARTED|Overall Study||150
1025932|NCT00667576|2490976|P5|NOT COMPLETED|Overall Study||1
1025933|NCT00667576|2490977|P4|NOT COMPLETED|Overall Study||4
1025934|NCT00667576|2490978|P3|NOT COMPLETED|Overall Study||2
1025935|NCT00667576|2490979|P2|NOT COMPLETED|Overall Study||1
1025936|NCT00667576|2490980|P1|NOT COMPLETED|Overall Study||2
1025937|NCT00667576|2490976|P5|COMPLETED|Overall Study||29
1025938|NCT00667576|2490977|P4|COMPLETED|Overall Study||27
1025939|NCT00667576|2490978|P3|COMPLETED|Overall Study||29
1025940|NCT00667576|2490979|P2|COMPLETED|Overall Study||30
1025941|NCT00667576|2490980|P1|COMPLETED|Overall Study||28
1025942|NCT00667576|2490976|P5|STARTED|Overall Study||30
1025943|NCT00667576|2490977|P4|STARTED|Overall Study||31
1025944|NCT00667576|2490978|P3|STARTED|Overall Study||31
1025945|NCT00667576|2490979|P2|STARTED|Overall Study||31
1025946|NCT00667576|2490980|P1|STARTED|Overall Study||30
1025947|NCT00667589|2491031|P4|NOT COMPLETED|Overall Study||1
1025948|NCT00667589|2491032|P3|NOT COMPLETED|Overall Study||3
1025949|NCT00667589|2491033|P2|NOT COMPLETED|Overall Study||0
1025950|NCT00667589|2491034|P1|NOT COMPLETED|Overall Study||1
1025951|NCT00667589|2491031|P4|COMPLETED|Overall Study||1
1025952|NCT00667589|2491032|P3|COMPLETED|Overall Study||0
1025953|NCT00667589|2491033|P2|COMPLETED|Overall Study||0
1025954|NCT00667589|2491034|P1|COMPLETED|Overall Study||0
1025955|NCT00667589|2491031|P4|STARTED|Overall Study||2
1025956|NCT00667589|2491032|P3|STARTED|Overall Study||3
1025957|NCT00667589|2491033|P2|STARTED|Overall Study||0
1025958|NCT00667589|2491034|P1|STARTED|Overall Study||1
1025959|NCT00667602|2491047|P3|NOT COMPLETED|Overall Study||18
1025960|NCT00667602|2491048|P2|NOT COMPLETED|Overall Study||15
1025961|NCT00667602|2491049|P1|NOT COMPLETED|Overall Study||8
1025962|NCT00667602|2491047|P3|COMPLETED|Overall Study||197
1025963|NCT00667602|2491048|P2|COMPLETED|Overall Study||213
1025964|NCT00667602|2491049|P1|COMPLETED|Overall Study||211
1025965|NCT00667602|2491047|P3|STARTED|Overall Study||215
1025966|NCT00667602|2491048|P2|STARTED|Overall Study||228
1025967|NCT00667602|2491049|P1|STARTED|Overall Study||219
1025968|NCT00667693|2491097|P2|NOT COMPLETED|Overall Study||2
1025969|NCT00667693|2491098|P1|NOT COMPLETED|Overall Study||0
1025970|NCT00667693|2491097|P2|COMPLETED|Overall Study||50
1025971|NCT00667693|2491098|P1|COMPLETED|Overall Study||49
1025972|NCT00667693|2491097|P2|STARTED|Overall Study||52
1025973|NCT00667693|2491098|P1|STARTED|Overall Study||49
1025974|NCT00667732|2491106|P3|NOT COMPLETED|Extension (26 Weeks)||0
1025975|NCT00667732|2491107|P2|NOT COMPLETED|Extension (26 Weeks)||0
1025976|NCT00667732|2491108|P1|NOT COMPLETED|Extension (26 Weeks)||0
1025977|NCT00667732|2491106|P3|COMPLETED|Extension (26 Weeks)||17
1025978|NCT00667732|2491107|P2|COMPLETED|Extension (26 Weeks)||14
1025979|NCT00667732|2491108|P1|COMPLETED|Extension (26 Weeks)||0
1025980|NCT00667732|2491106|P3|STARTED|Extension (26 Weeks)||17
1025981|NCT00667732|2491107|P2|STARTED|Extension (26 Weeks)||14
1025982|NCT00667732|2491108|P1|STARTED|Extension (26 Weeks)||0
1025983|NCT00667732|2491106|P3|NOT COMPLETED|Randomization (24 Weeks)||0
1025984|NCT00667732|2491107|P2|NOT COMPLETED|Randomization (24 Weeks)||1
1025985|NCT00667732|2491108|P1|NOT COMPLETED|Randomization (24 Weeks)||0
1025986|NCT00667732|2491106|P3|COMPLETED|Randomization (24 Weeks)||17
1025987|NCT00667732|2491107|P2|COMPLETED|Randomization (24 Weeks)||16
1025988|NCT00667732|2491108|P1|COMPLETED|Randomization (24 Weeks)||0
1025989|NCT00667732|2491106|P3|Participants Enrolled in Substudy|Randomization (24 Weeks)||9
1025990|NCT00667732|2491107|P2|Participants Enrolled in Substudy|Randomization (24 Weeks)||11
1025991|NCT00667732|2491108|P1|Participants Enrolled in Substudy|Randomization (24 Weeks)||0
1025992|NCT00667732|2491106|P3|STARTED|Randomization (24 Weeks)||17
1025993|NCT00667732|2491107|P2|STARTED|Randomization (24 Weeks)||17
1025994|NCT00667732|2491108|P1|STARTED|Randomization (24 Weeks)||0
1025995|NCT00667732|2491106|P3|NOT COMPLETED|Run -In (8 Weeks)||0
1025996|NCT00667732|2491107|P2|NOT COMPLETED|Run -In (8 Weeks)||0
1025997|NCT00667732|2491108|P1|NOT COMPLETED|Run -In (8 Weeks)||7
1025998|NCT00667732|2491106|P3|COMPLETED|Run -In (8 Weeks)||0
1025999|NCT00667732|2491107|P2|COMPLETED|Run -In (8 Weeks)||0
1026000|NCT00667732|2491108|P1|COMPLETED|Run -In (8 Weeks)||34
1026001|NCT00667732|2491106|P3|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
1026002|NCT00667732|2491107|P2|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
1026003|NCT00667732|2491108|P1|Participants Enrolled in Substudy|Run -In (8 Weeks)||20
1026004|NCT00667732|2491106|P3|STARTED|Run -In (8 Weeks)||0
1026005|NCT00667732|2491107|P2|STARTED|Run -In (8 Weeks)||0
1026006|NCT00667732|2491108|P1|STARTED|Run -In (8 Weeks)||41
1026007|NCT00667745|2491121|P2|NOT COMPLETED|Overall Study||21
1026008|NCT00667745|2491122|P1|NOT COMPLETED|Overall Study||25
1026009|NCT00667745|2491121|P2|COMPLETED|Overall Study||121
1026010|NCT00667745|2491122|P1|COMPLETED|Overall Study||116
1026011|NCT00667745|2491121|P2|STARTED|Overall Study||142
1026012|NCT00667745|2491122|P1|STARTED|Overall Study||141
1026013|NCT00667810|2491134|P4|NOT COMPLETED|Overall Study||2
1026014|NCT00667810|2491135|P3|NOT COMPLETED|Overall Study||222
1026015|NCT00667810|2491136|P2|NOT COMPLETED|Overall Study||170
1026016|NCT00667810|2491137|P1|NOT COMPLETED|Overall Study||167
1026017|NCT00667810|2491134|P4|COMPLETED|Overall Study||9
1026018|NCT00667810|2491135|P3|COMPLETED|Overall Study||124
1026019|NCT00667810|2491136|P2|COMPLETED|Overall Study||94
1026020|NCT00667810|2491137|P1|COMPLETED|Overall Study||102
1026021|NCT00667810|2491134|P4|Treated|Overall Study||11
1026022|NCT00667810|2491135|P3|Treated|Overall Study||344
1026023|NCT00667810|2491136|P2|Treated|Overall Study||263
1026024|NCT00667810|2491137|P1|Treated|Overall Study||267
1026025|NCT00667810|2491134|P4|STARTED|Overall Study||11
1026026|NCT00667810|2491135|P3|STARTED|Overall Study||346
1026027|NCT00667810|2491136|P2|STARTED|Overall Study||264
1026028|NCT00667810|2491137|P1|STARTED|Overall Study||269
1026029|NCT00667849|2491196|P2|NOT COMPLETED|Overall Study||121
1026030|NCT00667849|2491197|P1|NOT COMPLETED|Overall Study||108
1026031|NCT00667849|2491196|P2|COMPLETED|Overall Study||130
1026032|NCT00667849|2491197|P1|COMPLETED|Overall Study||142
1026033|NCT00667849|2491196|P2|STARTED|Overall Study||251
1026034|NCT00667849|2491197|P1|STARTED|Overall Study||250
1026035|NCT00667875|2491210|P3|NOT COMPLETED|Overall Study||13
1026036|NCT00667875|2491211|P2|NOT COMPLETED|Overall Study||11
1026037|NCT00667875|2491212|P1|NOT COMPLETED|Overall Study||10
1026038|NCT00667875|2491210|P3|COMPLETED|Overall Study||8
1026039|NCT00667875|2491211|P2|COMPLETED|Overall Study||10
1026040|NCT00667875|2491212|P1|COMPLETED|Overall Study|Subjects who dropped out during treatment are considered completed if they provide end of study data|13
1026041|NCT00667875|2491210|P3|Subjects Included in Analysisd|Overall Study||19
1026042|NCT00667875|2491211|P2|Subjects Included in Analysisd|Overall Study||21
1026043|NCT00667875|2491212|P1|Subjects Included in Analysisd|Overall Study||20
1026044|NCT00667875|2491210|P3|STARTED|Overall Study|2 subjects had no data following randomization and were excluded from the analysis.|21
1026045|NCT00667875|2491211|P2|STARTED|Overall Study||21
1026046|NCT00667875|2491212|P1|STARTED|Overall Study|3 subjects had no data after randomization and were excluded from analysis|23
1026047|NCT00667992|2491231|P2|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
1026048|NCT00667992|2491232|P1|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
1026049|NCT00667992|2491231|P2|COMPLETED|Forth Intervention 400 Mcg Twice Daily||35
1026050|NCT00667992|2491232|P1|COMPLETED|Forth Intervention 400 Mcg Twice Daily||33
1026051|NCT00667992|2491231|P2|STARTED|Forth Intervention 400 Mcg Twice Daily||35
1026052|NCT00667992|2491232|P1|STARTED|Forth Intervention 400 Mcg Twice Daily||33
1026053|NCT00667992|2491231|P2|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
1026054|NCT00667992|2491232|P1|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
1026055|NCT00667992|2491231|P2|COMPLETED|Third Intervention 100 Mcg Twice Daily||35
1026056|NCT00667992|2491232|P1|COMPLETED|Third Intervention 100 Mcg Twice Daily||33
1026057|NCT00667992|2491231|P2|STARTED|Third Intervention 100 Mcg Twice Daily||36
1026058|NCT00667992|2491232|P1|STARTED|Third Intervention 100 Mcg Twice Daily||34
1026059|NCT00667992|2491231|P2|NOT COMPLETED|Wash-out||5
1026060|NCT00667992|2491232|P1|NOT COMPLETED|Wash-out||7
1026061|NCT00667992|2491231|P2|COMPLETED|Wash-out||36
1026062|NCT00667992|2491232|P1|COMPLETED|Wash-out||34
1026063|NCT00667992|2491231|P2|STARTED|Wash-out||41
1026064|NCT00667992|2491232|P1|STARTED|Wash-out||41
1026065|NCT00667992|2491231|P2|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||4
1026066|NCT00667992|2491232|P1|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||3
1026067|NCT00667992|2491231|P2|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
1026068|NCT00667992|2491232|P1|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
1026069|NCT00667992|2491231|P2|STARTED|Second Intervention 400 Mcg Twice Daily||45
1026070|NCT00667992|2491232|P1|STARTED|Second Intervention 400 Mcg Twice Daily||44
1026071|NCT00667992|2491231|P2|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
1026072|NCT00667992|2491232|P1|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
1026073|NCT00667992|2491231|P2|COMPLETED|First Intervention 100 Mcg Twice Daily||45
1026074|NCT00667992|2491232|P1|COMPLETED|First Intervention 100 Mcg Twice Daily||44
1026075|NCT00667992|2491231|P2|STARTED|First Intervention 100 Mcg Twice Daily||50
1026076|NCT00667992|2491232|P1|STARTED|First Intervention 100 Mcg Twice Daily||49
1026077|NCT00668200|2491286|P1|NOT COMPLETED|Overall Study||3
1026078|NCT00668200|2491286|P1|COMPLETED|Overall Study||77
1026079|NCT00668200|2491286|P1|Intent to Treat (ITT)|Overall Study||80
1026080|NCT00668200|2491286|P1|Safety Population|Overall Study|1 patient was not included in the ITT patient was enrolled in error|81
1026081|NCT00668200|2491286|P1|STARTED|Overall Study||80
1026082|NCT00668265|2491294|P2|NOT COMPLETED|Overall Study||5
1026083|NCT00668265|2491295|P1|NOT COMPLETED|Overall Study||9
1026084|NCT00668265|2491294|P2|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
1026085|NCT00668265|2491295|P1|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
1026086|NCT00668265|2491294|P2|STARTED|Overall Study||5
1026087|NCT00668265|2491295|P1|STARTED|Overall Study||9
1026088|NCT00668317|2491303|P1|NOT COMPLETED|Overall Study||2
1026089|NCT00668317|2491303|P1|COMPLETED|Overall Study||3
1026090|NCT00668317|2491303|P1|STARTED|Overall Study||5
1026091|NCT00668382|2491307|P1|NOT COMPLETED|Overall Study||0
1026092|NCT00668382|2491307|P1|COMPLETED|Overall Study||11
1026093|NCT00668382|2491307|P1|STARTED|Overall Study|beginning of trial|11
1026094|NCT00668395|2491314|P3|NOT COMPLETED|Overall Study||1
1026095|NCT00668395|2491315|P2|NOT COMPLETED|Overall Study||6
1026096|NCT00668395|2491316|P1|NOT COMPLETED|Overall Study||6
1026097|NCT00668395|2491314|P3|COMPLETED|Overall Study||5
1026098|NCT00668395|2491315|P2|COMPLETED|Overall Study||16
1026099|NCT00668395|2491316|P1|COMPLETED|Overall Study||39
1026100|NCT00668395|2491314|P3|STARTED|Overall Study||6
1026101|NCT00668395|2491315|P2|STARTED|Overall Study||22
1026102|NCT00668395|2491316|P1|STARTED|Overall Study||45
1026103|NCT00668434|2491326|P2|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||11
1026104|NCT00668434|2491327|P1|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||22
1026105|NCT00668434|2491326|P2|COMPLETED|Secondary Outcome Time Point (52 Weeks)||77
1026106|NCT00668434|2491327|P1|COMPLETED|Secondary Outcome Time Point (52 Weeks)||157
1026107|NCT00668434|2491326|P2|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|88
1026108|NCT00668434|2491327|P1|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|179
1026109|NCT00668434|2491326|P2|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||0
1026110|NCT00668434|2491327|P1|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||2
1026111|NCT00668434|2491326|P2|COMPLETED|Primary Outcome Time Point (3 Weeks)||88
1026112|NCT00668434|2491327|P1|COMPLETED|Primary Outcome Time Point (3 Weeks)||179
1026113|NCT00668434|2491326|P2|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|88
1026114|NCT00668434|2491327|P1|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|181
1026115|NCT00668525|2491342|P3|NOT COMPLETED|Overall Study||53
1026116|NCT00668525|2491343|P2|NOT COMPLETED|Overall Study||93
1026117|NCT00668525|2491344|P1|NOT COMPLETED|Overall Study||77
1026118|NCT00668525|2491342|P3|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|167
1026119|NCT00668525|2491343|P2|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|239
1026120|NCT00668525|2491344|P1|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|248
1026121|NCT00668525|2491342|P3|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|220
1026122|NCT00668525|2491343|P2|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|332
1026123|NCT00668525|2491344|P1|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|325
1026124|NCT00668564|2491355|P1|NOT COMPLETED|Overall Study||0
1026125|NCT00668564|2491355|P1|COMPLETED|Overall Study||18
1026126|NCT00668564|2491355|P1|STARTED|Overall Study||18
1026127|NCT00668733|2491362|P2|NOT COMPLETED|Overall Study||7
1026128|NCT00668733|2491363|P1|NOT COMPLETED|Overall Study||2
1026129|NCT00668733|2491362|P2|COMPLETED|Overall Study||83
1026130|NCT00668733|2491363|P1|COMPLETED|Overall Study||87
1026131|NCT00668733|2491362|P2|STARTED|Overall Study||90
1026132|NCT00668733|2491363|P1|STARTED|Overall Study||89
1026133|NCT00668746|2491371|P2|NOT COMPLETED|Overall Study||1
1026134|NCT00668746|2491372|P1|NOT COMPLETED|Overall Study||2
1026135|NCT00668746|2491371|P2|COMPLETED|Overall Study||11
1026136|NCT00668746|2491372|P1|COMPLETED|Overall Study||21
1026137|NCT00668746|2491371|P2|STARTED|Overall Study||12
1026138|NCT00668746|2491372|P1|STARTED|Overall Study||23
1026139|NCT00668785|2491390|P1|NOT COMPLETED|Overall Study||0
1026140|NCT00668785|2491390|P1|COMPLETED|Overall Study||6
1026141|NCT00668785|2491390|P1|STARTED|Overall Study||6
1026142|NCT00668863|2491394|P1|NOT COMPLETED|Overall Study||71
1026143|NCT00668863|2491394|P1|COMPLETED|Overall Study||0
1026144|NCT00668863|2491394|P1|STARTED|Overall Study||71
1026145|NCT00668902|2491416|P3|NOT COMPLETED|Overall Study||0
1026146|NCT00668902|2491417|P2|NOT COMPLETED|Overall Study||0
1026147|NCT00668902|2491418|P1|NOT COMPLETED|Overall Study||0
1026148|NCT00668902|2491416|P3|COMPLETED|Overall Study||5
1026149|NCT00668902|2491417|P2|COMPLETED|Overall Study||10
1026150|NCT00668902|2491418|P1|COMPLETED|Overall Study||10
1026151|NCT00668902|2491416|P3|STARTED|Overall Study||5
1026152|NCT00668902|2491417|P2|STARTED|Overall Study||10
1026153|NCT00668902|2491418|P1|STARTED|Overall Study||10
1026154|NCT00669019|2491426|P1|NOT COMPLETED|Overall Study||0
1026155|NCT00669019|2491426|P1|COMPLETED|Overall Study||23
1026156|NCT00669019|2491426|P1|STARTED|Overall Study||23
1026157|NCT00669032|2491433|P2|NOT COMPLETED|Overall Study||59
1026158|NCT00669032|2491434|P1|NOT COMPLETED|Overall Study||44
1026159|NCT00669032|2491433|P2|COMPLETED|Overall Study||94
1026160|NCT00669032|2491434|P1|COMPLETED|Overall Study||109
1026161|NCT00669032|2491433|P2|STARTED|Overall Study||153
1026162|NCT00669032|2491434|P1|STARTED|Overall Study||153
1026163|NCT00669071|2491462|P1|NOT COMPLETED|Overall Study||4
1026164|NCT00669071|2491462|P1|COMPLETED|Overall Study||52
1026165|NCT00669071|2491462|P1|STARTED|Overall Study||56
1026166|NCT00669110|2491483|P2|NOT COMPLETED|Overall Study||13
1026167|NCT00669110|2491484|P1|NOT COMPLETED|Overall Study||8
1026168|NCT00669110|2491483|P2|COMPLETED|Overall Study||7
1026169|NCT00669110|2491484|P1|COMPLETED|Overall Study||12
1026170|NCT00669110|2491483|P2|STARTED|Overall Study||20
1026171|NCT00669110|2491484|P1|STARTED|Overall Study||20
1026172|NCT00669214|2491522|P2|NOT COMPLETED|Open-Label Treatment Period (Week 24)||9
1026173|NCT00669214|2491523|P1|NOT COMPLETED|Open-Label Treatment Period (Week 24)||4
1026174|NCT00669214|2491522|P2|COMPLETED|Open-Label Treatment Period (Week 24)||46
1026175|NCT00669214|2491523|P1|COMPLETED|Open-Label Treatment Period (Week 24)||18
1026176|NCT00669214|2491522|P2|STARTED|Open-Label Treatment Period (Week 24)||55
1026177|NCT00669214|2491523|P1|STARTED|Open-Label Treatment Period (Week 24)||22
1026178|NCT00669214|2491522|P2|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||7
1026179|NCT00669214|2491523|P1|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||5
1026180|NCT00669214|2491522|P2|COMPLETED|Double-Blind Treatment Period (Week 12)||55
1026181|NCT00669214|2491523|P1|COMPLETED|Double-Blind Treatment Period (Week 12)||22
1026182|NCT00669214|2491522|P2|STARTED|Double-Blind Treatment Period (Week 12)||62
1026183|NCT00669214|2491523|P1|STARTED|Double-Blind Treatment Period (Week 12)||27
1026184|NCT00669240|2491555|P1|NOT COMPLETED|Overall Study||165
1026185|NCT00669240|2491555|P1|COMPLETED|Overall Study||402
1026186|NCT00669240|2491555|P1|Received Treatment|Overall Study||551
1026187|NCT00669240|2491555|P1|Assigned to Treatment|Overall Study||566
1026188|NCT00669240|2491555|P1|STARTED|Overall Study||567
1026189|NCT00655356|2491571|P2|NOT COMPLETED|Overall Study||10
1026190|NCT00655356|2491572|P1|NOT COMPLETED|Overall Study||17
1026191|NCT00655356|2491571|P2|COMPLETED|Overall Study||98
1026192|NCT00655356|2491572|P1|COMPLETED|Overall Study||93
1026193|NCT00655356|2491571|P2|STARTED|Overall Study||108
1026194|NCT00655356|2491572|P1|STARTED|Overall Study||110
1026195|NCT00655486|2491584|P1|NOT COMPLETED|Overall Study||28
1026196|NCT00655486|2491584|P1|COMPLETED|Overall Study||69
1026197|NCT00655486|2491584|P1|STARTED|Overall Study||97
1026198|NCT00655551|2491592|P3|NOT COMPLETED|Period 4 (up to 7 Days)||0
1026199|NCT00655551|2491593|P2|NOT COMPLETED|Period 4 (up to 7 Days)||2
1026200|NCT00655551|2491594|P1|NOT COMPLETED|Period 4 (up to 7 Days)||0
1026201|NCT00655551|2491592|P3|COMPLETED|Period 4 (up to 7 Days)||0
1026202|NCT00655551|2491593|P2|COMPLETED|Period 4 (up to 7 Days)||23
1026203|NCT00655551|2491594|P1|COMPLETED|Period 4 (up to 7 Days)||0
1026204|NCT00655551|2491592|P3|STARTED|Period 4 (up to 7 Days)||0
1026205|NCT00655551|2491593|P2|STARTED|Period 4 (up to 7 Days)||25
1026206|NCT00655551|2491594|P1|STARTED|Period 4 (up to 7 Days)||0
1026207|NCT00655551|2491592|P3|NOT COMPLETED|Period 3 (up to 7 Days)||4
1026208|NCT00655551|2491593|P2|NOT COMPLETED|Period 3 (up to 7 Days)||0
1026209|NCT00655551|2491594|P1|NOT COMPLETED|Period 3 (up to 7 Days)||0
1026210|NCT00655551|2491592|P3|COMPLETED|Period 3 (up to 7 Days)||21
1026211|NCT00655551|2491593|P2|COMPLETED|Period 3 (up to 7 Days)||0
1026212|NCT00655551|2491594|P1|COMPLETED|Period 3 (up to 7 Days)||0
1026213|NCT00655551|2491592|P3|STARTED|Period 3 (up to 7 Days)||25
1026214|NCT00655551|2491593|P2|STARTED|Period 3 (up to 7 Days)||0
1026215|NCT00655551|2491594|P1|STARTED|Period 3 (up to 7 Days)||0
1026216|NCT00655551|2491592|P3|NOT COMPLETED|Period 2 (up to 7 Days)||0
1026217|NCT00655551|2491593|P2|NOT COMPLETED|Period 2 (up to 7 Days)||1
1026218|NCT00655551|2491594|P1|NOT COMPLETED|Period 2 (up to 7 Days)||0
1026219|NCT00655551|2491592|P3|COMPLETED|Period 2 (up to 7 Days)||0
1026220|NCT00655551|2491593|P2|COMPLETED|Period 2 (up to 7 Days)||24
1026221|NCT00655551|2491594|P1|COMPLETED|Period 2 (up to 7 Days)||0
1026222|NCT00655551|2491592|P3|STARTED|Period 2 (up to 7 Days)||0
1026223|NCT00655551|2491593|P2|STARTED|Period 2 (up to 7 Days)||25
1026224|NCT00655551|2491594|P1|STARTED|Period 2 (up to 7 Days)||0
1026225|NCT00655551|2491592|P3|NOT COMPLETED|Period 1 (up to 7 Days)||0
1026226|NCT00655551|2491593|P2|NOT COMPLETED|Period 1 (up to 7 Days)||0
1026227|NCT00655551|2491594|P1|NOT COMPLETED|Period 1 (up to 7 Days)||0
1026228|NCT00655551|2491592|P3|COMPLETED|Period 1 (up to 7 Days)||0
1026229|NCT00655551|2491593|P2|COMPLETED|Period 1 (up to 7 Days)||0
1026230|NCT00655551|2491594|P1|COMPLETED|Period 1 (up to 7 Days)||25
1026231|NCT00655551|2491592|P3|STARTED|Period 1 (up to 7 Days)||0
1026232|NCT00655551|2491593|P2|STARTED|Period 1 (up to 7 Days)||0
1026233|NCT00655551|2491594|P1|STARTED|Period 1 (up to 7 Days)||25
1026234|NCT00655551|2491592|P3|NOT COMPLETED|All Periods Combined||4
1026235|NCT00655551|2491593|P2|NOT COMPLETED|All Periods Combined||3
1026236|NCT00655551|2491594|P1|NOT COMPLETED|All Periods Combined||0
1026237|NCT00655551|2491592|P3|COMPLETED|All Periods Combined||21
1026238|NCT00655551|2491593|P2|COMPLETED|All Periods Combined||47
1026239|NCT00655551|2491594|P1|COMPLETED|All Periods Combined||25
1026240|NCT00655551|2491592|P3|STARTED|All Periods Combined||25
1026241|NCT00655551|2491593|P2|STARTED|All Periods Combined||50
1026242|NCT00655551|2491594|P1|STARTED|All Periods Combined||25
1026243|NCT00655564|2491608|P1|NOT COMPLETED|Overall Study||3
1026244|NCT00655564|2491608|P1|COMPLETED|Overall Study||12
1026245|NCT00655564|2491608|P1|STARTED|Overall Study||15
1026246|NCT00655629|2491615|P2|NOT COMPLETED|Overall Study||23
1026247|NCT00655629|2491616|P1|NOT COMPLETED|Overall Study||21
1026248|NCT00655629|2491615|P2|COMPLETED|Overall Study||144
1026249|NCT00655629|2491616|P1|COMPLETED|Overall Study||151
1026250|NCT00655629|2491615|P2|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion.(safety population)|166
1026251|NCT00655629|2491616|P1|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion. (safety population)|171
1026252|NCT00655629|2491615|P2|STARTED|Overall Study||167
1026253|NCT00655629|2491616|P1|STARTED|Overall Study||172
1026254|NCT00655642|2491656|P4|NOT COMPLETED|Overall Study||2
1026255|NCT00655642|2491657|P3|NOT COMPLETED|Overall Study||2
1026256|NCT00655642|2491658|P2|NOT COMPLETED|Overall Study||3
1026257|NCT00655642|2491659|P1|NOT COMPLETED|Overall Study||1
1026258|NCT00655642|2491656|P4|COMPLETED|Overall Study|1 patient's initial Visual analog scale (VAS)<40; 1 patient was withdrawn by treating physician|39
1026259|NCT00655642|2491657|P3|COMPLETED|Overall Study|1 patient left the ED prior to receiving drug; 1 patient's nausea resolved prior to receiving drug|43
1026260|NCT00655642|2491658|P2|COMPLETED|Overall Study|1 patient given drug orally rather than intravenous(iv);1 patient refused iv; 1 pt lost to follow-up|40
1026261|NCT00655642|2491659|P1|COMPLETED|Overall Study|1 patient withdrawn by treating physician after consent|41
1026262|NCT00655642|2491656|P4|STARTED|Overall Study||41
1026263|NCT00655642|2491657|P3|STARTED|Overall Study||45
1026264|NCT00655642|2491658|P2|STARTED|Overall Study||43
1026265|NCT00655642|2491659|P1|STARTED|Overall Study||42
1026266|NCT00655668|2491669|P1|NOT COMPLETED|Overall Study||54
1026267|NCT00655668|2491669|P1|COMPLETED|Overall Study|Participants dosed up to 24 months, disease progression or unacceptable adverse events developed.|0
1026268|NCT00655668|2491669|P1|STARTED|Overall Study|Planned enrollment: 80 participants|54
1026269|NCT00655733|2491679|P2|NOT COMPLETED|Overall Study||8
1026270|NCT00655733|2491680|P1|NOT COMPLETED|Overall Study||7
1026271|NCT00655733|2491679|P2|COMPLETED|Overall Study||42
1026272|NCT00655733|2491680|P1|COMPLETED|Overall Study||44
1026273|NCT00655733|2491679|P2|STARTED|Overall Study||50
1026274|NCT00655733|2491680|P1|STARTED|Overall Study||51
1026275|NCT00655746|2491686|P1|NOT COMPLETED|Overall Study||1
1026276|NCT00655746|2491686|P1|COMPLETED|Overall Study||13
1026277|NCT00655746|2491686|P1|STARTED|Overall Study||14
1026278|NCT00655811|2491703|P1|NOT COMPLETED|Overall Study||0
1026279|NCT00655811|2491703|P1|COMPLETED|Overall Study||40
1026280|NCT00655811|2491703|P1|STARTED|Overall Study||40
1026281|NCT00655824|2491717|P1|NOT COMPLETED|Follow-up (FU) Period||66
1026282|NCT00655824|2491717|P1|COMPLETED|Follow-up (FU) Period||13
1026283|NCT00655824|2491717|P1|STARTED|Follow-up (FU) Period|A participant who withdrew from the Treatment Phase could still enter the Follow-up Phase.|79
1026284|NCT00655824|2491717|P1|NOT COMPLETED|Treatment Period||84
1026285|NCT00655824|2491717|P1|COMPLETED|Treatment Period||8
1026286|NCT00655824|2491717|P1|STARTED|Treatment Period||92
1026287|NCT00655850|2491761|P1|NOT COMPLETED|Overall Study||3
1026288|NCT00655850|2491761|P1|COMPLETED|Overall Study||36
1026289|NCT00655850|2491761|P1|STARTED|Overall Study||39
1026290|NCT00655863|2491771|P3|NOT COMPLETED|Overall Study||1
1026291|NCT00655863|2491772|P2|NOT COMPLETED|Overall Study||0
1026292|NCT00655863|2491773|P1|NOT COMPLETED|Overall Study||0
1026293|NCT00655863|2491771|P3|COMPLETED|Overall Study||21
1026294|NCT00655863|2491772|P2|COMPLETED|Overall Study||25
1026295|NCT00655863|2491773|P1|COMPLETED|Overall Study||24
1026296|NCT00655863|2491771|P3|STARTED|Overall Study||22
1026297|NCT00655863|2491772|P2|STARTED|Overall Study||25
1026298|NCT00655863|2491773|P1|STARTED|Overall Study||24
1026299|NCT00655889|2491832|P1|NOT COMPLETED|Overall Study||2
1026300|NCT00655889|2491832|P1|COMPLETED|Overall Study||11
1026301|NCT00655889|2491832|P1|STARTED|Overall Study||13
1026302|NCT00656058|2491837|P1|NOT COMPLETED|Overall Study||6
1026303|NCT00656058|2491837|P1|COMPLETED|Overall Study||19
1026304|NCT00656058|2491837|P1|STARTED|Overall Study||25
1026305|NCT00656084|2491846|P1|NOT COMPLETED|Overall Study||7
1026306|NCT00656084|2491846|P1|COMPLETED|Overall Study||9
1026307|NCT00656084|2491846|P1|STARTED|Overall Study||16
1026308|NCT00656136|2491855|P2|NOT COMPLETED|Overall Study||390
1026309|NCT00656136|2491856|P1|NOT COMPLETED|Overall Study||195
1026310|NCT00656136|2491855|P2|COMPLETED|Overall Study||0
1026311|NCT00656136|2491856|P1|COMPLETED|Overall Study||0
1026312|NCT00656136|2491855|P2|STARTED|Overall Study|Randomised patients.|390
1026313|NCT00656136|2491856|P1|STARTED|Overall Study|Randomised patients.|195
1026314|NCT00656175|2491868|P2|NOT COMPLETED|Overall Study||1
1026315|NCT00656175|2491869|P1|NOT COMPLETED|Overall Study||1
1026316|NCT00656175|2491868|P2|COMPLETED|Overall Study||20
1026317|NCT00656175|2491869|P1|COMPLETED|Overall Study||17
1026318|NCT00656175|2491868|P2|STARTED|Overall Study||21
1026319|NCT00656175|2491869|P1|STARTED|Overall Study||18
1026320|NCT00656201|2491877|P2|NOT COMPLETED|Overall Study||32
1026321|NCT00656201|2491878|P1|NOT COMPLETED|Overall Study||29
1026322|NCT00656201|2491877|P2|COMPLETED|Overall Study||201
1026323|NCT00656201|2491878|P1|COMPLETED|Overall Study||206
1026324|NCT00656201|2491877|P2|STARTED|Overall Study||233
1026325|NCT00656201|2491878|P1|STARTED|Overall Study||235
1026326|NCT00656292|2491886|P2|NOT COMPLETED|Overall Study||5
1026327|NCT00656292|2491887|P1|NOT COMPLETED|Overall Study||3
1026328|NCT00656292|2491886|P2|COMPLETED|Overall Study||24
1026329|NCT00656292|2491887|P1|COMPLETED|Overall Study||29
1026330|NCT00656292|2491886|P2|STARTED|Overall Study||29
1026331|NCT00656292|2491887|P1|STARTED|Overall Study||32
1026332|NCT00656370|2491903|P1|NOT COMPLETED|Overall Study||10
1026333|NCT00656370|2491903|P1|COMPLETED|Overall Study|15 subjects were randomized and completed stage 1.|15
1026334|NCT00656370|2491903|P1|STARTED|Overall Study|25 subjects were assessed for eligibility and signed an Informed Consent Form.|25
1026335|NCT00656448|2491911|P2|NOT COMPLETED|Overall Study||0
1026336|NCT00656448|2491912|P1|NOT COMPLETED|Overall Study||0
1026337|NCT00656448|2491911|P2|COMPLETED|Overall Study||25
1026338|NCT00656448|2491912|P1|COMPLETED|Overall Study||25
1026339|NCT00656448|2491911|P2|STARTED|Overall Study||25
1026340|NCT00656448|2491912|P1|STARTED|Overall Study||25
1026341|NCT00656474|2491920|P1|NOT COMPLETED|Overall Study||1
1026342|NCT00656474|2491920|P1|COMPLETED|Overall Study||11
1026343|NCT00656474|2491920|P1|STARTED|Overall Study||12
1026344|NCT00656487|2491930|P3|NOT COMPLETED|Overall Study||0
1026345|NCT00656487|2491931|P2|NOT COMPLETED|Overall Study||4
1026346|NCT00656487|2491932|P1|NOT COMPLETED|Overall Study||2
1026347|NCT00656487|2491930|P3|COMPLETED|Overall Study||20
1026348|NCT00656487|2491931|P2|COMPLETED|Overall Study||19
1026349|NCT00656487|2491932|P1|COMPLETED|Overall Study||21
1026350|NCT00656487|2491930|P3|STARTED|Overall Study||20
1026351|NCT00656487|2491931|P2|STARTED|Overall Study||23
1026352|NCT00656487|2491932|P1|STARTED|Overall Study||23
1026353|NCT00656513|2491958|P3|NOT COMPLETED|Overall Study||22
1026354|NCT00656513|2491959|P2|NOT COMPLETED|Overall Study||30
1026355|NCT00656513|2491960|P1|NOT COMPLETED|Overall Study||4
1026356|NCT00656513|2491958|P3|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|53
1026357|NCT00656513|2491959|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|43
1026358|NCT00656513|2491960|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
1026359|NCT00656513|2491958|P3|STARTED|Overall Study||75
1026360|NCT00656513|2491959|P2|STARTED|Overall Study||73
1026361|NCT00656513|2491960|P1|STARTED|Overall Study||48
1026362|NCT00656617|2491979|P1|NOT COMPLETED|Overall Study||7
1026363|NCT00656617|2491979|P1|COMPLETED|Overall Study||99
1026364|NCT00656617|2491979|P1|Induction Phase|Overall Study|Induction phase following determination of safe combination Vorinostat with Idarubicin.|103
1026365|NCT00656617|2491979|P1|Run-in Induction Phase|Overall Study|Initial run-in: Vorinostat induction dose 500 mg orally three times daily for 3 days.|3
1026366|NCT00656617|2491979|P1|STARTED|Overall Study||106
1026367|NCT00656630|2491988|P3|NOT COMPLETED|Overall Study||2
1026368|NCT00656630|2491989|P2|NOT COMPLETED|Overall Study||2
1026369|NCT00656630|2491990|P1|NOT COMPLETED|Overall Study||2
1026370|NCT00656630|2491988|P3|COMPLETED|Overall Study||17
1026371|NCT00656630|2491989|P2|COMPLETED|Overall Study||25
1026372|NCT00656630|2491990|P1|COMPLETED|Overall Study||20
1026373|NCT00656630|2491988|P3|STARTED|Overall Study||19
1026374|NCT00656630|2491989|P2|STARTED|Overall Study||27
1026375|NCT00656630|2491990|P1|STARTED|Overall Study||22
1026376|NCT00656656|2492010|P1|NOT COMPLETED|Overall Study||0
1026377|NCT00656656|2492010|P1|COMPLETED|Overall Study||23
1026378|NCT00656656|2492010|P1|STARTED|Overall Study||23
1026379|NCT00656669|2492015|P1|NOT COMPLETED|AC (Cycles 6-9)||2
1026380|NCT00656669|2492015|P1|COMPLETED|AC (Cycles 6-9)||15
1026381|NCT00656669|2492015|P1|STARTED|AC (Cycles 6-9)||17
1026382|NCT00656669|2492015|P1|NOT COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||6
1026383|NCT00656669|2492015|P1|COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||17
1026384|NCT00656669|2492015|P1|STARTED|Paclitaxel/Sunitinib (Cycles 2-5)||23
1026385|NCT00656669|2492015|P1|NOT COMPLETED|Single Agent Sunitinib (Cycle 1)||0
1026386|NCT00656669|2492015|P1|COMPLETED|Single Agent Sunitinib (Cycle 1)||23
1026387|NCT00656669|2492015|P1|STARTED|Single Agent Sunitinib (Cycle 1)||23
1026388|NCT00656799|2492024|P1|NOT COMPLETED|Overall Study||2
1026389|NCT00656799|2492024|P1|COMPLETED|Overall Study||4
1026390|NCT00656799|2492024|P1|STARTED|Overall Study||6
1026391|NCT00656851|2492048|P2|NOT COMPLETED|Overall Study||4
1026392|NCT00656851|2492049|P1|NOT COMPLETED|Overall Study||0
1026393|NCT00656851|2492048|P2|COMPLETED|Overall Study||8
1026394|NCT00656851|2492049|P1|COMPLETED|Overall Study||12
1026395|NCT00656851|2492048|P2|STARTED|Overall Study||12
1026396|NCT00656851|2492049|P1|STARTED|Overall Study||12
1026397|NCT00656916|2492073|P2|NOT COMPLETED|Overall Study||0
1026398|NCT00656916|2492074|P1|NOT COMPLETED|Overall Study||0
1026399|NCT00656916|2492073|P2|COMPLETED|Overall Study||0
1026400|NCT00656916|2492074|P1|COMPLETED|Overall Study||1
1026401|NCT00656916|2492073|P2|STARTED|Overall Study||0
1026402|NCT00656916|2492074|P1|STARTED|Overall Study||1
1026403|NCT00656968|2492082|P2|NOT COMPLETED|Overall Study||0
1026404|NCT00656968|2492083|P1|NOT COMPLETED|Overall Study||0
1026405|NCT00656968|2492082|P2|COMPLETED|Overall Study||117
1026406|NCT00656968|2492083|P1|COMPLETED|Overall Study||115
1026407|NCT00656968|2492082|P2|STARTED|Overall Study||117
1026408|NCT00656968|2492083|P1|STARTED|Overall Study||115
1026409|NCT00657020|2492091|P2|NOT COMPLETED|PERIOD 2||0
1026410|NCT00657020|2492092|P1|NOT COMPLETED|PERIOD 2||0
1026411|NCT00657020|2492091|P2|COMPLETED|PERIOD 2||11
1026412|NCT00657020|2492092|P1|COMPLETED|PERIOD 2||11
1026413|NCT00657020|2492091|P2|STARTED|PERIOD 2||11
1026414|NCT00657020|2492092|P1|STARTED|PERIOD 2||11
1026415|NCT00657020|2492091|P2|NOT COMPLETED|PERIOD 1||1
1026416|NCT00657020|2492092|P1|NOT COMPLETED|PERIOD 1||0
1026417|NCT00657020|2492091|P2|COMPLETED|PERIOD 1||11
1026418|NCT00657020|2492092|P1|COMPLETED|PERIOD 1||11
1026419|NCT00657020|2492091|P2|STARTED|PERIOD 1||12
1026420|NCT00657020|2492092|P1|STARTED|PERIOD 1||11
1026421|NCT00657046|2492123|P3|NOT COMPLETED|Overall Study||2
1026422|NCT00657046|2492124|P2|NOT COMPLETED|Overall Study||3
1026423|NCT00657046|2492125|P1|NOT COMPLETED|Overall Study||4
1026424|NCT00657046|2492123|P3|COMPLETED|Overall Study||21
1026425|NCT00657046|2492124|P2|COMPLETED|Overall Study||29
1026426|NCT00657046|2492125|P1|COMPLETED|Overall Study||26
1026427|NCT00657046|2492123|P3|Had Visits up to Visit 18|Overall Study||23
1026428|NCT00657046|2492124|P2|Had Visits up to Visit 18|Overall Study||30
1026429|NCT00657046|2492125|P1|Had Visits up to Visit 18|Overall Study||28
1026430|NCT00657046|2492123|P3|Had at Least 1 Post Baseline Visit|Overall Study||23
1026431|NCT00657046|2492124|P2|Had at Least 1 Post Baseline Visit|Overall Study||31
1026432|NCT00657046|2492125|P1|Had at Least 1 Post Baseline Visit|Overall Study||30
1026433|NCT00657046|2492123|P3|STARTED|Overall Study||23
1026434|NCT00657046|2492124|P2|STARTED|Overall Study||32
1026435|NCT00657046|2492125|P1|STARTED|Overall Study||30
1026436|NCT00657150|2492159|P2|NOT COMPLETED|Treatment||97
1026437|NCT00657150|2492160|P1|NOT COMPLETED|Treatment||107
1026438|NCT00657150|2492159|P2|COMPLETED|Treatment||906
1026439|NCT00657150|2492160|P1|COMPLETED|Treatment||903
1026440|NCT00657150|2492159|P2|STARTED|Treatment||1003
1026441|NCT00657150|2492160|P1|STARTED|Treatment||1010
1026442|NCT00657150|2492159|P2|NOT COMPLETED|Overall Study||93
1026443|NCT00657150|2492160|P1|NOT COMPLETED|Overall Study||115
1026444|NCT00657150|2492159|P2|COMPLETED|Overall Study||910
1026445|NCT00657150|2492160|P1|COMPLETED|Overall Study||895
1026446|NCT00657150|2492159|P2|STARTED|Overall Study||1003
1026447|NCT00657150|2492160|P1|STARTED|Overall Study||1010
1026448|NCT00669279|2492190|P2|NOT COMPLETED|Overall Study||0
1026449|NCT00669279|2492191|P1|NOT COMPLETED|Overall Study||0
1026450|NCT00669279|2492190|P2|COMPLETED|Overall Study||19
1026451|NCT00669279|2492191|P1|COMPLETED|Overall Study||22
1026452|NCT00669279|2492190|P2|STARTED|Overall Study||19
1026453|NCT00669279|2492191|P1|STARTED|Overall Study||22
1026454|NCT00669318|2492197|P1|NOT COMPLETED|Overall Study||2
1026455|NCT00669318|2492197|P1|COMPLETED|Overall Study||39
1026456|NCT00669318|2492197|P1|STARTED|Overall Study||41
1026457|NCT00669331|2492207|P2|NOT COMPLETED|Blinded Treatment Period||39
1026458|NCT00669331|2492208|P1|NOT COMPLETED|Blinded Treatment Period||42
1026459|NCT00669331|2492207|P2|COMPLETED|Blinded Treatment Period||189
1026460|NCT00669331|2492208|P1|COMPLETED|Blinded Treatment Period||191
1026461|NCT00669331|2492207|P2|STARTED|Blinded Treatment Period||228
1026462|NCT00669331|2492208|P1|STARTED|Blinded Treatment Period||233
1026463|NCT00669331|2492207|P2|NOT COMPLETED|Randomisation to First Dose||13
1026464|NCT00669331|2492208|P1|NOT COMPLETED|Randomisation to First Dose||11
1026465|NCT00669331|2492207|P2|COMPLETED|Randomisation to First Dose||228
1026466|NCT00669331|2492208|P1|COMPLETED|Randomisation to First Dose||233
1026467|NCT00669331|2492207|P2|STARTED|Randomisation to First Dose||241
1026468|NCT00669331|2492208|P1|STARTED|Randomisation to First Dose||244
1026469|NCT00669396|2492252|P2|NOT COMPLETED|Overall Study||12
1026470|NCT00669396|2492253|P1|NOT COMPLETED|Overall Study||10
1026471|NCT00669396|2492252|P2|COMPLETED|Overall Study||22
1026472|NCT00669396|2492253|P1|COMPLETED|Overall Study||13
1026473|NCT00669396|2492252|P2|STARTED|Overall Study||34
1026474|NCT00669396|2492253|P1|STARTED|Overall Study||23
1026475|NCT00669461|2492265|P1|NOT COMPLETED|Overall Study||0
1026476|NCT00669461|2492265|P1|COMPLETED|Overall Study||1
1026477|NCT00669461|2492265|P1|STARTED|Overall Study||1
1026478|NCT00669539|2492272|P2|NOT COMPLETED|Overall Study||9
1026479|NCT00669539|2492273|P1|NOT COMPLETED|Overall Study||8
1026480|NCT00669539|2492272|P2|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|43
1026481|NCT00669539|2492273|P1|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|86
1026482|NCT00669539|2492272|P2|STARTED|Overall Study||52
1026483|NCT00669539|2492273|P1|STARTED|Overall Study||94
1026484|NCT00669552|2492279|P1|NOT COMPLETED|Overall Study||0
1026485|NCT00669552|2492279|P1|COMPLETED|Overall Study||11
1026486|NCT00669552|2492279|P1|STARTED|Overall Study||11
1026487|NCT00669578|2492285|P2|NOT COMPLETED|Overall Study||0
1026488|NCT00669578|2492286|P1|NOT COMPLETED|Overall Study||0
1026489|NCT00669578|2492285|P2|COMPLETED|Overall Study||65
1026490|NCT00669578|2492286|P1|COMPLETED|Overall Study||12
1026491|NCT00669578|2492285|P2|STARTED|Overall Study||65
1026492|NCT00669578|2492286|P1|STARTED|Overall Study||12
1026493|NCT00670449|2492303|P4|NOT COMPLETED|Overall Study||8
1026494|NCT00670449|2492304|P3|NOT COMPLETED|Overall Study||9
1026495|NCT00670449|2492305|P2|NOT COMPLETED|Overall Study||10
1026496|NCT00670449|2492306|P1|NOT COMPLETED|Overall Study||9
1026497|NCT00670449|2492303|P4|COMPLETED|Overall Study||15
1026498|NCT00670449|2492304|P3|COMPLETED|Overall Study||18
1026499|NCT00670449|2492305|P2|COMPLETED|Overall Study||36
1026500|NCT00670449|2492306|P1|COMPLETED|Overall Study||38
1026501|NCT00670449|2492303|P4|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|17
1026502|NCT00670449|2492304|P3|Switched to 0.5mg (Open Label)|Overall Study||23
1026503|NCT00670449|2492305|P2|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|41
1026504|NCT00670449|2492306|P1|Switched to 0.5mg (Open Label)|Overall Study||45
1026505|NCT00670449|2492303|P4|STARTED|Overall Study||23
1026506|NCT00670449|2492304|P3|STARTED|Overall Study||27
1026507|NCT00670449|2492305|P2|STARTED|Overall Study||46
1026508|NCT00670449|2492306|P1|STARTED|Overall Study||47
1026509|NCT00670462|2492332|P2|NOT COMPLETED|Overall Study||31
1026510|NCT00670462|2492333|P1|NOT COMPLETED|Overall Study||30
1026511|NCT00670462|2492332|P2|COMPLETED|Overall Study||76
1026512|NCT00670462|2492333|P1|COMPLETED|Overall Study||76
1026513|NCT00670462|2492332|P2|STARTED|Overall Study||107
1026514|NCT00670462|2492333|P1|STARTED|Overall Study||106
1026515|NCT00670540|2492361|P1|NOT COMPLETED|Overall Study||3325
1026516|NCT00670540|2492361|P1|COMPLETED|Overall Study|total recruited for the follow up|4931
1026517|NCT00670540|2492361|P1|STARTED|Overall Study||8256
1026518|NCT00670631|2492371|P1|NOT COMPLETED|Overall Study||0
1026519|NCT00670631|2492371|P1|COMPLETED|Overall Study||0
1026520|NCT00670631|2492371|P1|STARTED|Overall Study||0
1026521|NCT00670709|2492379|P2|NOT COMPLETED|Overall Study||0
1026522|NCT00670709|2492380|P1|NOT COMPLETED|Overall Study||0
1026523|NCT00670709|2492379|P2|COMPLETED|Overall Study||15
1026524|NCT00670709|2492380|P1|COMPLETED|Overall Study||27
1026525|NCT00670709|2492379|P2|STARTED|Overall Study||15
1026526|NCT00670709|2492380|P1|STARTED|Overall Study||27
1026527|NCT00670748|2492392|P4|NOT COMPLETED|Overall Study||1
1026528|NCT00670748|2492393|P3|NOT COMPLETED|Overall Study||2
1026529|NCT00670748|2492394|P2|NOT COMPLETED|Overall Study||2
1026530|NCT00670748|2492395|P1|NOT COMPLETED|Overall Study||3
1026531|NCT00670748|2492392|P4|COMPLETED|Overall Study||4
1026532|NCT00670748|2492393|P3|COMPLETED|Overall Study||5
1026533|NCT00670748|2492394|P2|COMPLETED|Overall Study||14
1026534|NCT00670748|2492395|P1|COMPLETED|Overall Study||14
1026535|NCT00670748|2492392|P4|STARTED|Overall Study||5
1026536|NCT00670748|2492393|P3|STARTED|Overall Study||7
1026537|NCT00670748|2492394|P2|STARTED|Overall Study||16
1026538|NCT00670748|2492395|P1|STARTED|Overall Study||17
1026539|NCT00670800|2492415|P2|NOT COMPLETED|Overall Study||2
1026540|NCT00670800|2492416|P1|NOT COMPLETED|Overall Study||0
1026541|NCT00670800|2492415|P2|COMPLETED|Overall Study|Two controls were found to have insulin resistance and were excluded from analysis.|5
1026542|NCT00670800|2492416|P1|COMPLETED|Overall Study||7
1026543|NCT00670800|2492415|P2|STARTED|Overall Study||7
1026544|NCT00670800|2492416|P1|STARTED|Overall Study||7
1026545|NCT00670930|2492434|P2|NOT COMPLETED|Overall Study||1
1026546|NCT00670930|2492435|P1|NOT COMPLETED|Overall Study||1
1026547|NCT00670930|2492434|P2|COMPLETED|Overall Study||12
1026548|NCT00670930|2492435|P1|COMPLETED|Overall Study||22
1026549|NCT00670930|2492434|P2|Intent to Treat (ITT) Population|Overall Study||12
1026550|NCT00670930|2492435|P1|Intent to Treat (ITT) Population|Overall Study||23
1026551|NCT00670930|2492434|P2|STARTED|Overall Study||13
1026552|NCT00670930|2492435|P1|STARTED|Overall Study|"Started indicates Randomized and Safety populaiton"|23
1026553|NCT00670956|2492449|P1|NOT COMPLETED|Overall Study||0
1026554|NCT00670956|2492449|P1|COMPLETED|Overall Study||1
1026555|NCT00670956|2492449|P1|STARTED|Overall Study||1
1026556|NCT00670982|2492457|P2|NOT COMPLETED|Overall Study||0
1026557|NCT00670982|2492458|P1|NOT COMPLETED|Overall Study||0
1026558|NCT00670982|2492457|P2|COMPLETED|Overall Study||7
1026559|NCT00670982|2492458|P1|COMPLETED|Overall Study||22
1026560|NCT00670982|2492457|P2|STARTED|Overall Study||7
1026561|NCT00670982|2492458|P1|STARTED|Overall Study||22
1026562|NCT00671060|2492469|P2|NOT COMPLETED|Overall Study||1
1026563|NCT00671060|2492470|P1|NOT COMPLETED|Overall Study||1
1026564|NCT00671060|2492469|P2|COMPLETED|Overall Study|1 woman was withdrawn from the study due to preeclampsia.|75
1026565|NCT00671060|2492470|P1|COMPLETED|Overall Study|1 woman completed study but was excluded from analysis because gestational age <14 weeks.|76
1026566|NCT00671060|2492469|P2|STARTED|Overall Study||76
1026567|NCT00671060|2492470|P1|STARTED|Overall Study||77
1026568|NCT00671177|2492478|P2|NOT COMPLETED|Overall Study||1
1026569|NCT00671177|2492479|P1|NOT COMPLETED|Overall Study||2
1026570|NCT00671177|2492478|P2|COMPLETED|Overall Study||114
1026571|NCT00671177|2492479|P1|COMPLETED|Overall Study||112
1026572|NCT00671177|2492478|P2|STARTED|Overall Study||115
1026573|NCT00671177|2492479|P1|STARTED|Overall Study||114
1026574|NCT00671437|2492489|P1|NOT COMPLETED|Overall Study||15
1026575|NCT00671437|2492489|P1|COMPLETED|Overall Study||27
1026576|NCT00671437|2492489|P1|STARTED|Overall Study||42
1026577|NCT00671502|2492511|P3|NOT COMPLETED|Overall Study||27
1026578|NCT00671502|2492512|P2|NOT COMPLETED|Overall Study||39
1026579|NCT00671502|2492513|P1|NOT COMPLETED|Overall Study||39
1026580|NCT00671502|2492511|P3|COMPLETED|Overall Study||252
1026581|NCT00671502|2492512|P2|COMPLETED|Overall Study||241
1026582|NCT00671502|2492513|P1|COMPLETED|Overall Study||242
1026583|NCT00671502|2492511|P3|STARTED|Overall Study||279
1026584|NCT00671502|2492512|P2|STARTED|Overall Study||280
1026585|NCT00671502|2492513|P1|STARTED|Overall Study||281
1026586|NCT00671515|2492521|P1|NOT COMPLETED|Phase 2||4
1026587|NCT00671515|2492521|P1|COMPLETED|Phase 2||9
1026588|NCT00671515|2492521|P1|STARTED|Phase 2||13
1026589|NCT00671515|2492521|P1|NOT COMPLETED|Phase 1||3
1026590|NCT00671515|2492521|P1|COMPLETED|Phase 1||20
1026591|NCT00671515|2492521|P1|STARTED|Phase 1||23
1026592|NCT00671528|2492529|P3|NOT COMPLETED|Overall Study||0
1026593|NCT00671528|2492530|P2|NOT COMPLETED|Overall Study||0
1026594|NCT00671528|2492531|P1|NOT COMPLETED|Overall Study||0
1026595|NCT00671528|2492529|P3|COMPLETED|Overall Study||1
1026596|NCT00671528|2492530|P2|COMPLETED|Overall Study||1
1026597|NCT00671528|2492531|P1|COMPLETED|Overall Study||1
1026598|NCT00671528|2492529|P3|STARTED|Overall Study||1
1026599|NCT00671528|2492530|P2|STARTED|Overall Study||1
1026600|NCT00671528|2492531|P1|STARTED|Overall Study||1
1026601|NCT00671554|2492542|P1|NOT COMPLETED|Overall Study||3
1026602|NCT00671554|2492542|P1|COMPLETED|Overall Study||0
1026603|NCT00671554|2492542|P1|STARTED|Overall Study||3
1026604|NCT00671606|2492547|P1|NOT COMPLETED|Overall Study||0
1026605|NCT00671606|2492547|P1|COMPLETED|Overall Study||5
1026606|NCT00671606|2492547|P1|STARTED|Overall Study||5
1026607|NCT00671671|2492553|P2|NOT COMPLETED|Overall Study||0
1026608|NCT00671671|2492554|P1|NOT COMPLETED|Overall Study||0
1026609|NCT00671671|2492553|P2|COMPLETED|Overall Study||10
1026610|NCT00671671|2492554|P1|COMPLETED|Overall Study||10
1026611|NCT00671671|2492553|P2|STARTED|Overall Study||10
1026612|NCT00671671|2492554|P1|STARTED|Overall Study||10
1026613|NCT00671723|2492583|P3|NOT COMPLETED|Overall Study||0
1026614|NCT00671723|2492584|P2|NOT COMPLETED|Overall Study||0
1026615|NCT00671723|2492585|P1|NOT COMPLETED|Overall Study||0
1026616|NCT00671723|2492583|P3|COMPLETED|Overall Study||11
1026617|NCT00671723|2492584|P2|COMPLETED|Overall Study||11
1026618|NCT00671723|2492585|P1|COMPLETED|Overall Study||11
1026619|NCT00671723|2492583|P3|STARTED|Overall Study||11
1026620|NCT00671723|2492584|P2|STARTED|Overall Study||11
1026621|NCT00671723|2492585|P1|STARTED|Overall Study||11
1026622|NCT00671749|2492596|P1|NOT COMPLETED|Overall Study||8
1026623|NCT00671749|2492596|P1|COMPLETED|Overall Study||92
1026624|NCT00671749|2492596|P1|STARTED|Overall Study||100
1026625|NCT00671788|2492606|P1|NOT COMPLETED|Overall Study||14
1026626|NCT00671788|2492606|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|21
1026627|NCT00671788|2492606|P1|STARTED|Overall Study||35
1026628|NCT00671853|2492615|P2|NOT COMPLETED|Overall Study||27
1026629|NCT00671853|2492616|P1|NOT COMPLETED|Overall Study||20
1026630|NCT00671853|2492615|P2|COMPLETED|Overall Study||18
1026631|NCT00671853|2492616|P1|COMPLETED|Overall Study||26
1026632|NCT00671853|2492615|P2|STARTED|Overall Study||45
1026633|NCT00671853|2492616|P1|STARTED|Overall Study||46
1026634|NCT00671879|2492635|P3|NOT COMPLETED|Overall Study||6
1026635|NCT00671879|2492636|P2|NOT COMPLETED|Overall Study||4
1026636|NCT00671879|2492637|P1|NOT COMPLETED|Overall Study||0
1026637|NCT00671879|2492635|P3|COMPLETED|Overall Study||274
1026638|NCT00671879|2492636|P2|COMPLETED|Overall Study||275
1026639|NCT00671879|2492637|P1|COMPLETED|Overall Study||281
1026640|NCT00671879|2492635|P3|STARTED|Overall Study||280
1026641|NCT00671879|2492636|P2|STARTED|Overall Study||279
1026642|NCT00671879|2492637|P1|STARTED|Overall Study||281
1026643|NCT00671918|2492648|P1|NOT COMPLETED|Overall Study||17
1026644|NCT00671918|2492648|P1|COMPLETED|Overall Study||169
1026645|NCT00671918|2492648|P1|STARTED|Overall Study||186
1026646|NCT00671931|2492658|P5|NOT COMPLETED|Overall Study||1
1026647|NCT00671931|2492659|P4|NOT COMPLETED|Overall Study||2
1026648|NCT00671931|2492660|P3|NOT COMPLETED|Overall Study||0
1026649|NCT00671931|2492661|P2|NOT COMPLETED|Overall Study||0
1026650|NCT00671931|2492662|P1|NOT COMPLETED|Overall Study||1
1026651|NCT00671931|2492658|P5|COMPLETED|Overall Study|Low heart rate requiring treatment|7
1026652|NCT00671931|2492659|P4|COMPLETED|Overall Study|Prepositioning - Neuromonitoring required|8
1026653|NCT00671931|2492660|P3|COMPLETED|Overall Study|all completed|9
1026654|NCT00671931|2492661|P2|COMPLETED|Overall Study|All completed|8
1026655|NCT00671931|2492662|P1|COMPLETED|Overall Study|Nueromonitoring equipment falure|8
1026656|NCT00671931|2492658|P5|STARTED|Overall Study||8
1026657|NCT00671931|2492659|P4|STARTED|Overall Study||10
1026658|NCT00671931|2492660|P3|STARTED|Overall Study||9
1026659|NCT00671931|2492661|P2|STARTED|Overall Study||8
1026660|NCT00671931|2492662|P1|STARTED|Overall Study||9
1026661|NCT00671970|2492676|P2|NOT COMPLETED|Overall Study||0
1026662|NCT00671970|2492677|P1|NOT COMPLETED|Overall Study||0
1026663|NCT00671970|2492676|P2|COMPLETED|Overall Study||25
1026664|NCT00671970|2492677|P1|COMPLETED|Overall Study||32
1026665|NCT00671970|2492676|P2|STARTED|Overall Study||25
1026666|NCT00671970|2492677|P1|STARTED|Overall Study||32
1026667|NCT00672100|2492703|P3|NOT COMPLETED|Overall Study||0
1026668|NCT00672100|2492704|P2|NOT COMPLETED|Overall Study||0
1026669|NCT00672100|2492705|P1|NOT COMPLETED|Overall Study||0
1026670|NCT00672100|2492703|P3|COMPLETED|Overall Study||12
1026671|NCT00672100|2492704|P2|COMPLETED|Overall Study||12
1026672|NCT00672100|2492705|P1|COMPLETED|Overall Study||12
1026673|NCT00672100|2492703|P3|PACU (Within 8 Hours)|Overall Study||12
1026674|NCT00672100|2492704|P2|PACU (Within 8 Hours)|Overall Study||12
1026675|NCT00672100|2492705|P1|PACU (Within 8 Hours)|Overall Study||12
1026676|NCT00672100|2492703|P3|STARTED|Overall Study||12
1026677|NCT00672100|2492704|P2|STARTED|Overall Study||12
1026678|NCT00672100|2492705|P1|STARTED|Overall Study||12
1026679|NCT00672178|2492720|P1|NOT COMPLETED|Overall Study||0
1026680|NCT00672178|2492720|P1|COMPLETED|Overall Study||1
1026681|NCT00672178|2492720|P1|STARTED|Overall Study||1
1026685|NCT00672243|2492728|P1|NOT COMPLETED|Overall Study||0
1026686|NCT00672243|2492728|P1|COMPLETED|Overall Study||32
1026687|NCT00672243|2492728|P1|STARTED|Overall Study||32
1026688|NCT00672256|2492736|P1|NOT COMPLETED|Overall Study||44
1026689|NCT00672256|2492736|P1|COMPLETED|Overall Study||18
1026690|NCT00672256|2492736|P1|STARTED|Overall Study|January 2007|62
1026691|NCT00672438|2492745|P2|NOT COMPLETED|Infusion 2||0
1026692|NCT00672438|2492746|P1|NOT COMPLETED|Infusion 2||0
1026693|NCT00672438|2492745|P2|COMPLETED|Infusion 2||118
1026694|NCT00672438|2492746|P1|COMPLETED|Infusion 2||119
1026695|NCT00672438|2492745|P2|STARTED|Infusion 2||118
1026696|NCT00672438|2492746|P1|STARTED|Infusion 2||119
1026697|NCT00672438|2492745|P2|NOT COMPLETED|Washout||0
1026698|NCT00672438|2492746|P1|NOT COMPLETED|Washout||0
1026699|NCT00672438|2492745|P2|COMPLETED|Washout||118
1026700|NCT00672438|2492746|P1|COMPLETED|Washout||119
1026701|NCT00672438|2492745|P2|STARTED|Washout||118
1026702|NCT00672438|2492746|P1|STARTED|Washout||119
1026703|NCT00672438|2492745|P2|NOT COMPLETED|Infusion 1||0
1026704|NCT00672438|2492746|P1|NOT COMPLETED|Infusion 1||0
1026705|NCT00672438|2492745|P2|COMPLETED|Infusion 1||118
1026706|NCT00672438|2492746|P1|COMPLETED|Infusion 1||119
1026707|NCT00672438|2492745|P2|STARTED|Infusion 1||118
1026708|NCT00672438|2492746|P1|STARTED|Infusion 1||119
1026709|NCT00672490|2492779|P2|NOT COMPLETED|Overall Study||32
1026710|NCT00672490|2492780|P1|NOT COMPLETED|Overall Study||24
1026711|NCT00672490|2492779|P2|COMPLETED|Overall Study||157
1026712|NCT00672490|2492780|P1|COMPLETED|Overall Study||163
1026713|NCT00672490|2492779|P2|STARTED|Overall Study||189
1026714|NCT00672490|2492780|P1|STARTED|Overall Study||187
1026715|NCT00672555|2492802|P1|NOT COMPLETED|Overall Study||6
1026716|NCT00672555|2492802|P1|COMPLETED|Overall Study|All patients were seen at 3 weeks in the outpatient clinic.|64
1026717|NCT00672555|2492802|P1|STARTED|Overall Study||70
1026718|NCT00672594|2492811|P1|NOT COMPLETED|Overall Study||3
1026719|NCT00672594|2492811|P1|COMPLETED|Overall Study||27
1026720|NCT00672594|2492811|P1|STARTED|Overall Study||30
1026721|NCT00672620|2492826|P4|NOT COMPLETED|Overall Study||42
1026722|NCT00672620|2492827|P3|NOT COMPLETED|Overall Study||31
1026723|NCT00672620|2492828|P2|NOT COMPLETED|Overall Study||54
1026724|NCT00672620|2492829|P1|NOT COMPLETED|Overall Study||33
1026725|NCT00672620|2492826|P4|COMPLETED|Overall Study||110
1026726|NCT00672620|2492827|P3|COMPLETED|Overall Study||122
1026727|NCT00672620|2492828|P2|COMPLETED|Overall Study||99
1026728|NCT00672620|2492829|P1|COMPLETED|Overall Study||120
1026729|NCT00672620|2492826|P4|Treated|Overall Study||150
1026730|NCT00672620|2492827|P3|Treated|Overall Study||153
1026731|NCT00672620|2492828|P2|Treated|Overall Study||149
1026732|NCT00672620|2492829|P1|Treated|Overall Study||151
1026733|NCT00672620|2492826|P4|STARTED|Overall Study||152
1026734|NCT00672620|2492827|P3|STARTED|Overall Study||153
1026735|NCT00672620|2492828|P2|STARTED|Overall Study||153
1026736|NCT00672620|2492829|P1|STARTED|Overall Study||153
1026737|NCT00672633|2492885|P2|NOT COMPLETED|Overall Study||1
1026738|NCT00672633|2492886|P1|NOT COMPLETED|Overall Study||0
1026739|NCT00672633|2492885|P2|COMPLETED|Overall Study||12
1026740|NCT00672633|2492886|P1|COMPLETED|Overall Study||12
1026741|NCT00672633|2492885|P2|STARTED|Overall Study||13
1026742|NCT00672633|2492886|P1|STARTED|Overall Study||12
1026743|NCT00672646|2492899|P3|NOT COMPLETED|Overall Study||3
1026744|NCT00672646|2492900|P2|NOT COMPLETED|Overall Study||1
1026745|NCT00672646|2492901|P1|NOT COMPLETED|Overall Study||0
1026746|NCT00672646|2492899|P3|COMPLETED|Overall Study||37
1026747|NCT00672646|2492900|P2|COMPLETED|Overall Study||22
1026748|NCT00672646|2492901|P1|COMPLETED|Overall Study||40
1026749|NCT00672646|2492899|P3|STARTED|Overall Study||40
1026750|NCT00672646|2492900|P2|STARTED|Overall Study||23
1026751|NCT00672646|2492901|P1|STARTED|Overall Study||40
1026752|NCT00672737|2492924|P1|NOT COMPLETED|Overall Study||8
1026753|NCT00672737|2492924|P1|COMPLETED|Overall Study||48
1026754|NCT00672737|2492924|P1|STARTED|Overall Study||56
1026755|NCT00672841|2492933|P2|NOT COMPLETED|Overall Study||15
1026756|NCT00672841|2492934|P1|NOT COMPLETED|Overall Study||1
1026757|NCT00672841|2492933|P2|COMPLETED|Overall Study||32
1026758|NCT00672841|2492934|P1|COMPLETED|Overall Study||16
1026759|NCT00672841|2492933|P2|STARTED|Overall Study||47
1026760|NCT00672841|2492934|P1|STARTED|Overall Study||17
1026761|NCT00672854|2492948|P2|NOT COMPLETED|Overall Study||0
1026762|NCT00672854|2492949|P1|NOT COMPLETED|Overall Study||0
1026763|NCT00672854|2492948|P2|COMPLETED|Overall Study||51
1026764|NCT00672854|2492949|P1|COMPLETED|Overall Study||49
1026765|NCT00672854|2492948|P2|STARTED|Overall Study||51
1026766|NCT00672854|2492949|P1|STARTED|Overall Study||49
1026767|NCT00672932|2492957|P2|NOT COMPLETED|Overall Study||0
1026768|NCT00672932|2492958|P1|NOT COMPLETED|Overall Study||0
1026769|NCT00672932|2492957|P2|COMPLETED|Overall Study||9
1026770|NCT00672932|2492958|P1|COMPLETED|Overall Study||9
1026771|NCT00672932|2492957|P2|Rolled Over to Raltegravir|Overall Study|6 subjects randomized to no drug later rolled over to receive raltegravir|6
1026772|NCT00672932|2492958|P1|Rolled Over to Raltegravir|Overall Study||0
1026773|NCT00672932|2492957|P2|Provided Analyzable Blood and CSF Sample|Overall Study||9
1026774|NCT00672932|2492958|P1|Provided Analyzable Blood and CSF Sample|Overall Study|one subject was censored when pharmacological study showed no drug in plasma or CSF|8
1026775|NCT00672932|2492957|P2|Completed Initial 12-week Assignment|Overall Study||9
1026776|NCT00672932|2492958|P1|Completed Initial 12-week Assignment|Overall Study||9
1026777|NCT00672932|2492957|P2|STARTED|Overall Study||9
1026778|NCT00672932|2492958|P1|STARTED|Overall Study||9
1026779|NCT00672958|2492968|P2|NOT COMPLETED|Overall Study||56
1026780|NCT00672958|2492969|P1|NOT COMPLETED|Overall Study||64
1026781|NCT00672958|2492968|P2|COMPLETED|Overall Study||244
1026782|NCT00672958|2492969|P1|COMPLETED|Overall Study||236
1026783|NCT00672958|2492968|P2|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|292
1026784|NCT00672958|2492969|P1|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|286
1026785|NCT00672958|2492968|P2|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|299
1026786|NCT00672958|2492969|P1|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|298
1026787|NCT00672958|2492968|P2|STARTED|Overall Study||300
1026788|NCT00672958|2492969|P1|STARTED|Overall Study||300
1026789|NCT00660075|2493001|P2|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
1026790|NCT00660075|2493002|P1|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
1026791|NCT00660075|2493001|P2|COMPLETED|Second Intervention (Week 11 to Week 16||18
1026792|NCT00660075|2493002|P1|COMPLETED|Second Intervention (Week 11 to Week 16||18
1026793|NCT00660075|2493001|P2|STARTED|Second Intervention (Week 11 to Week 16||18
1026794|NCT00660075|2493002|P1|STARTED|Second Intervention (Week 11 to Week 16||18
1026795|NCT00660075|2493001|P2|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
1026796|NCT00660075|2493002|P1|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
1026797|NCT00660075|2493001|P2|COMPLETED|Washout Period (Week 7 to Week 10)||18
1026798|NCT00660075|2493002|P1|COMPLETED|Washout Period (Week 7 to Week 10)||18
1026799|NCT00660075|2493001|P2|STARTED|Washout Period (Week 7 to Week 10)||18
1026800|NCT00660075|2493002|P1|STARTED|Washout Period (Week 7 to Week 10)||18
1026801|NCT00660075|2493001|P2|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
1026802|NCT00660075|2493002|P1|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
1026803|NCT00660075|2493001|P2|COMPLETED|First Intervention (Week 1 to Week 6)||18
1026804|NCT00660075|2493002|P1|COMPLETED|First Intervention (Week 1 to Week 6)||18
1026805|NCT00660075|2493001|P2|STARTED|First Intervention (Week 1 to Week 6)||18
1026806|NCT00660075|2493002|P1|STARTED|First Intervention (Week 1 to Week 6)||18
1026807|NCT00660179|2493011|P3|NOT COMPLETED|Overall Study||41
1026808|NCT00660179|2493012|P2|NOT COMPLETED|Overall Study||58
1026809|NCT00660179|2493013|P1|NOT COMPLETED|Overall Study||56
1026810|NCT00660179|2493011|P3|COMPLETED|Overall Study||201
1026811|NCT00660179|2493012|P2|COMPLETED|Overall Study||192
1026812|NCT00660179|2493013|P1|COMPLETED|Overall Study||194
1026813|NCT00660179|2493011|P3|STARTED|Overall Study||242
1026814|NCT00660179|2493012|P2|STARTED|Overall Study||250
1026815|NCT00660179|2493013|P1|STARTED|Overall Study||250
1026816|NCT00660192|2493047|P2|NOT COMPLETED|Overall Study||3
1026817|NCT00660192|2493048|P1|NOT COMPLETED|Overall Study||2
1026818|NCT00660192|2493047|P2|COMPLETED|Overall Study||10
1026819|NCT00660192|2493048|P1|COMPLETED|Overall Study||10
1026820|NCT00660192|2493047|P2|STARTED|Overall Study||13
1026821|NCT00660192|2493048|P1|STARTED|Overall Study||12
1026822|NCT00660309|2493058|P2|NOT COMPLETED|Overall Study||3
1026823|NCT00660309|2493059|P1|NOT COMPLETED|Overall Study||2
1026824|NCT00660309|2493058|P2|COMPLETED|Overall Study||19
1026825|NCT00660309|2493059|P1|COMPLETED|Overall Study||21
1026826|NCT00660309|2493058|P2|Pharmacodynamic Analysis Set|Overall Study||20
1026827|NCT00660309|2493059|P1|Pharmacodynamic Analysis Set|Overall Study||22
1026828|NCT00660309|2493058|P2|Treated With Aliskiren or Irbesartan|Overall Study||21
1026829|NCT00660309|2493059|P1|Treated With Aliskiren or Irbesartan|Overall Study||22
1026830|NCT00660309|2493058|P2|STARTED|Overall Study|Represents participants who received one dose of Captopril.|22
1026831|NCT00660309|2493059|P1|STARTED|Overall Study|Represents participants who received one dose of Captopril.|23
1026832|NCT00660348|2493100|P2|NOT COMPLETED|Overall Study||0
1026833|NCT00660348|2493101|P1|NOT COMPLETED|Overall Study||1
1026834|NCT00660348|2493100|P2|COMPLETED|Overall Study||0
1026835|NCT00660348|2493101|P1|COMPLETED|Overall Study||0
1026836|NCT00660348|2493100|P2|STARTED|Overall Study||0
1026837|NCT00660348|2493101|P1|STARTED|Overall Study||1
1026838|NCT00660387|2493109|P2|NOT COMPLETED|Overall Study||3
1026839|NCT00660387|2493110|P1|NOT COMPLETED|Overall Study||2
1026840|NCT00660387|2493109|P2|COMPLETED|Overall Study||31
1026841|NCT00660387|2493110|P1|COMPLETED|Overall Study||35
1026842|NCT00660387|2493109|P2|STARTED|Overall Study||34
1026843|NCT00660387|2493110|P1|STARTED|Overall Study||37
1026844|NCT00660400|2493162|P1|NOT COMPLETED|Overall Study||4
1026845|NCT00660400|2493162|P1|COMPLETED|Overall Study||21
1026846|NCT00660400|2493162|P1|STARTED|Overall Study||25
1026847|NCT00660504|2493171|P2|NOT COMPLETED|Overall Study||1
1026848|NCT00660504|2493172|P1|NOT COMPLETED|Overall Study||0
1026849|NCT00660504|2493171|P2|COMPLETED|Overall Study||150
1026850|NCT00660504|2493172|P1|COMPLETED|Overall Study||149
1026851|NCT00660504|2493171|P2|STARTED|Overall Study||151
1026852|NCT00660504|2493172|P1|STARTED|Overall Study||149
1026853|NCT00660517|2493188|P4|NOT COMPLETED|Overall Study||7
1026854|NCT00660517|2493189|P3|NOT COMPLETED|Overall Study||7
1026855|NCT00660517|2493190|P2|NOT COMPLETED|Overall Study||8
1026856|NCT00660517|2493191|P1|NOT COMPLETED|Overall Study||8
1026857|NCT00660517|2493188|P4|COMPLETED|Overall Study||144
1026858|NCT00660517|2493189|P3|COMPLETED|Overall Study||144
1026859|NCT00660517|2493190|P2|COMPLETED|Overall Study||144
1026860|NCT00660517|2493191|P1|COMPLETED|Overall Study||145
1026861|NCT00660517|2493188|P4|STARTED|Overall Study||151
1026862|NCT00660517|2493189|P3|STARTED|Overall Study||151
1026863|NCT00660517|2493190|P2|STARTED|Overall Study||152
1026864|NCT00660517|2493191|P1|STARTED|Overall Study||153
1026865|NCT00660543|2493209|P1|NOT COMPLETED|Overall Study||0
1026866|NCT00660543|2493209|P1|COMPLETED|Overall Study||14
1026867|NCT00660543|2493209|P1|STARTED|Overall Study||14
1026868|NCT00660595|2493220|P2|NOT COMPLETED|Overall Study||9
1026869|NCT00660595|2493221|P1|NOT COMPLETED|Overall Study||18
1026870|NCT00660595|2493220|P2|COMPLETED|Overall Study|One of the two was lost to follow-up|1
1026871|NCT00660595|2493221|P1|COMPLETED|Overall Study||1
1026872|NCT00660595|2493220|P2|STARTED|Overall Study||10
1026873|NCT00660595|2493221|P1|STARTED|Overall Study||19
1026874|NCT00660660|2493235|P2|NOT COMPLETED|Overall Study||9
1026875|NCT00660660|2493236|P1|NOT COMPLETED|Overall Study||5
1026876|NCT00660660|2493235|P2|COMPLETED|Overall Study|Number of completed patients is based on randomized population (133) minus withdrawals (9).|124
1026877|NCT00660660|2493236|P1|COMPLETED|Overall Study|Number of completed patients is based on randomized population (143) minus withdrawals (5).|138
1026878|NCT00660660|2493235|P2|Met Criteria for MITT Population|Overall Study||125
1026879|NCT00660660|2493236|P1|Met Criteria for MITT Population|Overall Study||137
1026880|NCT00660660|2493235|P2|STARTED|Overall Study|Randomized|133
1026881|NCT00660660|2493236|P1|STARTED|Overall Study|Randomized|143
1026882|NCT00660699|2493334|P1|NOT COMPLETED|Overall Study||2
1026883|NCT00660699|2493334|P1|COMPLETED|Overall Study||48
1026884|NCT00660699|2493334|P1|STARTED|Overall Study||50
1026885|NCT00661193|2493350|P2|NOT COMPLETED|Overall Study||26
1026886|NCT00661193|2493351|P1|NOT COMPLETED|Overall Study||33
1026887|NCT00661193|2493350|P2|COMPLETED|Overall Study||0
1026888|NCT00661193|2493351|P1|COMPLETED|Overall Study||0
1026889|NCT00661193|2493350|P2|STARTED|Overall Study||26
1026890|NCT00661193|2493351|P1|STARTED|Overall Study||33
1026891|NCT00661258|2493361|P2|NOT COMPLETED|Overall Study||1
1026892|NCT00661258|2493362|P1|NOT COMPLETED|Overall Study||3
1026893|NCT00661258|2493361|P2|COMPLETED|Overall Study||33
1026894|NCT00661258|2493362|P1|COMPLETED|Overall Study||31
1026895|NCT00661258|2493361|P2|STARTED|Overall Study||34
1026896|NCT00661258|2493362|P1|STARTED|Overall Study||34
1026897|NCT00661362|2493372|P2|NOT COMPLETED|Overall Study||40
1026898|NCT00661362|2493373|P1|NOT COMPLETED|Overall Study||29
1026899|NCT00661362|2493372|P2|COMPLETED|Overall Study|Completed 24 Weeks of treatment|247
1026900|NCT00661362|2493373|P1|COMPLETED|Overall Study|Completed 24 Weeks of treatment|254
1026901|NCT00661362|2493372|P2|STARTED|Overall Study|Randomized and treated|287
1026902|NCT00661362|2493373|P1|STARTED|Overall Study|Randomized and treated|283
1026903|NCT00661388|2493389|P1|NOT COMPLETED|Overall Study||24
1026904|NCT00661388|2493389|P1|COMPLETED|Overall Study||51
1026905|NCT00661388|2493389|P1|STARTED|Overall Study||75
1026912|NCT00661453|2493419|P1|NOT COMPLETED|Overall Study||13
1026913|NCT00661453|2493419|P1|COMPLETED|Overall Study||25
1026914|NCT00661453|2493419|P1|STARTED|Overall Study||38
1026915|NCT00661479|2493427|P4|NOT COMPLETED|Overall Study||0
1026916|NCT00661479|2493428|P3|NOT COMPLETED|Overall Study||0
1026917|NCT00661479|2493429|P2|NOT COMPLETED|Overall Study||0
1026918|NCT00661479|2493430|P1|NOT COMPLETED|Overall Study||0
1026919|NCT00661479|2493427|P4|COMPLETED|Overall Study||3
1026920|NCT00661479|2493428|P3|COMPLETED|Overall Study||3
1026921|NCT00661479|2493429|P2|COMPLETED|Overall Study||3
1026922|NCT00661479|2493430|P1|COMPLETED|Overall Study||12
1026923|NCT00661479|2493427|P4|STARTED|Overall Study||3
1026924|NCT00661479|2493428|P3|STARTED|Overall Study||3
1026925|NCT00661479|2493429|P2|STARTED|Overall Study||3
1026926|NCT00661479|2493430|P1|STARTED|Overall Study||12
1026927|NCT00661492|2493445|P2|NOT COMPLETED|Overall Study||29
1026928|NCT00661492|2493446|P1|NOT COMPLETED|Overall Study||68
1026929|NCT00661492|2493445|P2|COMPLETED|Overall Study||11
1026930|NCT00661492|2493446|P1|COMPLETED|Overall Study||7
1026931|NCT00661492|2493445|P2|STARTED|Overall Study||40
1026932|NCT00661492|2493446|P1|STARTED|Overall Study||75
1026933|NCT00661505|2493466|P1|NOT COMPLETED|Overall Study||30
1026934|NCT00661505|2493466|P1|COMPLETED|Overall Study||102
1026935|NCT00661505|2493466|P1|STARTED|Overall Study||132
1026936|NCT00661531|2493492|P1|NOT COMPLETED|Overall Study||3
1026937|NCT00661531|2493492|P1|COMPLETED|Overall Study||8
1026938|NCT00661531|2493492|P1|STARTED|Overall Study||11
1026939|NCT00661544|2493497|P1|NOT COMPLETED|Overall Study||0
1026940|NCT00661544|2493497|P1|COMPLETED|Overall Study||48
1026941|NCT00661544|2493497|P1|STARTED|Overall Study||48
1026942|NCT00661570|2493501|P1|NOT COMPLETED|Overall Study||0
1026943|NCT00661570|2493501|P1|COMPLETED|Overall Study||26
1026944|NCT00661570|2493501|P1|STARTED|Overall Study||26
1026945|NCT00661583|2493511|P3|NOT COMPLETED|Overall Study||0
1026946|NCT00661583|2493512|P2|NOT COMPLETED|Overall Study||0
1026947|NCT00661583|2493513|P1|NOT COMPLETED|Overall Study||0
1026948|NCT00661583|2493511|P3|COMPLETED|Overall Study||10
1026949|NCT00661583|2493512|P2|COMPLETED|Overall Study||10
1026950|NCT00661583|2493513|P1|COMPLETED|Overall Study||10
1026951|NCT00661583|2493511|P3|STARTED|Overall Study||10
1026952|NCT00661583|2493512|P2|STARTED|Overall Study||10
1026953|NCT00661583|2493513|P1|STARTED|Overall Study||10
1026954|NCT00661609|2493530|P1|NOT COMPLETED|Overall Study||41
1026955|NCT00661609|2493530|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
1026956|NCT00661609|2493530|P1|STARTED|Overall Study|All dosed patients|41
1026957|NCT00661622|2493539|P2|NOT COMPLETED|Overall Study||0
1026958|NCT00661622|2493540|P1|NOT COMPLETED|Overall Study||1
1026959|NCT00661622|2493539|P2|COMPLETED|Overall Study||27
1026960|NCT00661622|2493540|P1|COMPLETED|Overall Study||25
1026961|NCT00661622|2493539|P2|STARTED|Overall Study||27
1026962|NCT00661622|2493540|P1|STARTED|Overall Study||26
1026963|NCT00661661|2493556|P2|NOT COMPLETED|Overall Study||39
1026964|NCT00661661|2493557|P1|NOT COMPLETED|Overall Study||140
1026965|NCT00661661|2493556|P2|COMPLETED|Overall Study||66
1026966|NCT00661661|2493557|P1|COMPLETED|Overall Study||242
1026967|NCT00661661|2493556|P2|STARTED|Overall Study||105
1026968|NCT00661661|2493557|P1|STARTED|Overall Study||382
1026969|NCT00661674|2493631|P6|NOT COMPLETED|Overall Study||0
1026970|NCT00661674|2493632|P5|NOT COMPLETED|Overall Study||0
1026971|NCT00661674|2493633|P4|NOT COMPLETED|Overall Study||0
1026972|NCT00661674|2493634|P3|NOT COMPLETED|Overall Study||0
1026973|NCT00661674|2493635|P2|NOT COMPLETED|Overall Study||0
1026974|NCT00661674|2493636|P1|NOT COMPLETED|Overall Study||0
1026975|NCT00661674|2493631|P6|COMPLETED|Overall Study|Participant 9 completed sequence 6|1
1026976|NCT00661674|2493632|P5|COMPLETED|Overall Study|Participants 6 & 8 completed sequence 5|2
1026977|NCT00661674|2493633|P4|COMPLETED|Overall Study|Participant 5 completed sequence 4|1
1026978|NCT00661674|2493634|P3|COMPLETED|Overall Study|Participants 4 & 7 completed sequence 3|2
1026979|NCT00661674|2493635|P2|COMPLETED|Overall Study|Participants 2 & 3 completed sequence 2|2
1026980|NCT00661674|2493636|P1|COMPLETED|Overall Study|Participants 1 & 10 completed sequence 1|2
1026981|NCT00661674|2493631|P6|STARTED|Overall Study|Participant 9 was assigned to sequence 6|1
1026982|NCT00661674|2493632|P5|STARTED|Overall Study|Participants 6 & 8 were assigned to sequence 5|2
1026983|NCT00661674|2493633|P4|STARTED|Overall Study|Participant 5 was assigned to sequence 4|1
1026984|NCT00661674|2493634|P3|STARTED|Overall Study|Participants 4 & 7 were assigned to sequence 3|2
1026985|NCT00661674|2493635|P2|STARTED|Overall Study|Participants 2 & 3 were assigned to sequence 2|2
1026986|NCT00661674|2493636|P1|STARTED|Overall Study|Participants 1 & 10 were assigned to sequence 1|2
1026987|NCT00661687|2493647|P1|NOT COMPLETED|Overall Study||15
1026988|NCT00661687|2493647|P1|COMPLETED|Overall Study|Number indicates number of subjects successfully completing study.|189
1026989|NCT00661687|2493647|P1|STARTED|Overall Study|Contralateral study design, numbers indicate number of subjects.|204
1026990|NCT00661713|2493665|P8|NOT COMPLETED|Overall Study||11
1026991|NCT00661713|2493666|P7|NOT COMPLETED|Overall Study||64
1026992|NCT00661713|2493667|P6|NOT COMPLETED|Overall Study||37
1026993|NCT00661713|2493668|P5|NOT COMPLETED|Overall Study||20
1026994|NCT00661713|2493669|P4|NOT COMPLETED|Overall Study||28
1026995|NCT00661713|2493670|P3|NOT COMPLETED|Overall Study||17
1026996|NCT00661713|2493671|P2|NOT COMPLETED|Overall Study||39
1026997|NCT00661713|2493672|P1|NOT COMPLETED|Overall Study||16
1026998|NCT00661713|2493665|P8|COMPLETED|Overall Study||117
1026999|NCT00661713|2493666|P7|COMPLETED|Overall Study||309
1027000|NCT00661713|2493667|P6|COMPLETED|Overall Study||216
1027001|NCT00661713|2493668|P5|COMPLETED|Overall Study||107
1027002|NCT00661713|2493669|P4|COMPLETED|Overall Study||219
1027003|NCT00661713|2493670|P3|COMPLETED|Overall Study||111
1027004|NCT00661713|2493671|P2|COMPLETED|Overall Study||208
1027005|NCT00661713|2493672|P1|COMPLETED|Overall Study||112
1027006|NCT00661713|2493665|P8|STARTED|Overall Study||128
1027007|NCT00661713|2493666|P7|STARTED|Overall Study||373
1027008|NCT00661713|2493667|P6|STARTED|Overall Study||253
1027009|NCT00661713|2493668|P5|STARTED|Overall Study||127
1027010|NCT00661713|2493669|P4|STARTED|Overall Study||247
1027011|NCT00661713|2493670|P3|STARTED|Overall Study||128
1027012|NCT00661713|2493671|P2|STARTED|Overall Study||247
1027013|NCT00661713|2493672|P1|STARTED|Overall Study||128
1027014|NCT00661726|2493762|P1|NOT COMPLETED|Overall Study||1
1027015|NCT00661726|2493762|P1|COMPLETED|Overall Study||5
1027016|NCT00661726|2493762|P1|STARTED|Overall Study||6
1027017|NCT00661778|2493777|P1|NOT COMPLETED|Overall Study||50
1027018|NCT00661778|2493777|P1|COMPLETED|Overall Study||0
1027019|NCT00661778|2493777|P1|STARTED|Overall Study||50
1027020|NCT00661830|2493786|P2|NOT COMPLETED|Overall Study||42
1027021|NCT00661830|2493787|P1|NOT COMPLETED|Overall Study||40
1027022|NCT00661830|2493786|P2|COMPLETED|Overall Study||6
1027023|NCT00661830|2493787|P1|COMPLETED|Overall Study||9
1027024|NCT00661830|2493786|P2|STARTED|Overall Study||48
1027025|NCT00661830|2493787|P1|STARTED|Overall Study||49
1027026|NCT00661895|2493801|P2|NOT COMPLETED|Overall Study||0
1027027|NCT00661895|2493802|P1|NOT COMPLETED|Overall Study||0
1027028|NCT00661895|2493801|P2|COMPLETED|Overall Study||50
1027029|NCT00661895|2493802|P1|COMPLETED|Overall Study||49
1027030|NCT00661895|2493801|P2|STARTED|Overall Study||50
1027031|NCT00661895|2493802|P1|STARTED|Overall Study||49
1027032|NCT00661960|2493811|P3|NOT COMPLETED|Overall Study||1
1027033|NCT00661960|2493812|P2|NOT COMPLETED|Overall Study||3
1027034|NCT00661960|2493813|P1|NOT COMPLETED|Overall Study||0
1027035|NCT00661960|2493811|P3|COMPLETED|Overall Study||9
1027036|NCT00661960|2493812|P2|COMPLETED|Overall Study||7
1027037|NCT00661960|2493813|P1|COMPLETED|Overall Study||5
1027038|NCT00661960|2493811|P3|STARTED|Overall Study||10
1027039|NCT00661960|2493812|P2|STARTED|Overall Study||10
1027040|NCT00661960|2493813|P1|STARTED|Overall Study||5
1027041|NCT00661999|2493824|P3|NOT COMPLETED|Overall Study||57
1027042|NCT00661999|2493825|P2|NOT COMPLETED|Overall Study||50
1027043|NCT00661999|2493826|P1|NOT COMPLETED|Overall Study||59
1027044|NCT00661999|2493824|P3|COMPLETED|Overall Study||106
1027045|NCT00661999|2493825|P2|COMPLETED|Overall Study||113
1027046|NCT00661999|2493826|P1|COMPLETED|Overall Study||105
1027047|NCT00661999|2493824|P3|STARTED|Overall Study||163
1027048|NCT00661999|2493825|P2|STARTED|Overall Study||163
1027049|NCT00661999|2493826|P1|STARTED|Overall Study||164
1027050|NCT00662012|2493879|P1|NOT COMPLETED|Overall Study||87
1027051|NCT00662012|2493879|P1|COMPLETED|Overall Study||327
1027052|NCT00662012|2493879|P1|STARTED|Overall Study||414
1027053|NCT00662025|2493884|P1|NOT COMPLETED|Overall Study||63
1027054|NCT00662025|2493884|P1|COMPLETED|Overall Study||0
1027055|NCT00662025|2493884|P1|STARTED|Overall Study|All 63 participants were included in Full Analysis Set population.|63
1027056|NCT00662038|2493904|P1|NOT COMPLETED|Overall Study||631
1027057|NCT00662038|2493904|P1|COMPLETED|Overall Study||427
1027058|NCT00662038|2493904|P1|STARTED|Overall Study||1058
1027059|NCT00662129|2493908|P1|NOT COMPLETED|Overall Study||3
1027060|NCT00662129|2493908|P1|COMPLETED|Overall Study||47
1027061|NCT00662129|2493908|P1|STARTED|Overall Study||50
1027062|NCT00662155|2493922|P4|NOT COMPLETED|Overall Study||4
1027063|NCT00662155|2493923|P3|NOT COMPLETED|Overall Study||7
1027064|NCT00662155|2493924|P2|NOT COMPLETED|Overall Study||5
1027065|NCT00662155|2493925|P1|NOT COMPLETED|Overall Study||3
1027066|NCT00662155|2493922|P4|COMPLETED|Overall Study||14
1027067|NCT00662155|2493923|P3|COMPLETED|Overall Study||13
1027068|NCT00662155|2493924|P2|COMPLETED|Overall Study||15
1027069|NCT00662155|2493925|P1|COMPLETED|Overall Study||13
1027070|NCT00662155|2493922|P4|STARTED|Overall Study||18
1027071|NCT00662155|2493923|P3|STARTED|Overall Study||20
1027072|NCT00662155|2493924|P2|STARTED|Overall Study||20
1027073|NCT00662155|2493925|P1|STARTED|Overall Study||16
1027074|NCT00662207|2493939|P1|NOT COMPLETED|Overall Study||0
1027075|NCT00662207|2493939|P1|COMPLETED|Overall Study||3
1027076|NCT00662207|2493939|P1|STARTED|Overall Study||3
1027077|NCT00662311|2493949|P3|NOT COMPLETED|Overall Study||0
1027078|NCT00662311|2493950|P2|NOT COMPLETED|Overall Study||0
1027079|NCT00662311|2493951|P1|NOT COMPLETED|Overall Study||1
1027080|NCT00662311|2493949|P3|COMPLETED|Overall Study||0
1027081|NCT00662311|2493950|P2|COMPLETED|Overall Study||0
1027082|NCT00662311|2493951|P1|COMPLETED|Overall Study||4
1027083|NCT00662311|2493949|P3|STARTED|Overall Study||0
1027084|NCT00662311|2493950|P2|STARTED|Overall Study||0
1027085|NCT00662311|2493951|P1|STARTED|Overall Study||5
1027086|NCT00662363|2493976|P2|NOT COMPLETED|Overall Study||10
1027087|NCT00662363|2493977|P1|NOT COMPLETED|Overall Study||11
1027088|NCT00662363|2493976|P2|COMPLETED|Overall Study|one subject died before receiving any study med 2 subjects withdrew before taking any study med|22
1027089|NCT00662363|2493977|P1|COMPLETED|Overall Study|1 subject withdrew before taking any study medication|21
1027090|NCT00662363|2493976|P2|STARTED|Overall Study||32
1027091|NCT00662363|2493977|P1|STARTED|Overall Study||32
1027092|NCT00662389|2493985|P1|NOT COMPLETED|Overall Study||0
1027093|NCT00662389|2493985|P1|COMPLETED|Overall Study||4
1027094|NCT00662389|2493985|P1|STARTED|Overall Study||4
1027095|NCT00662532|2493990|P2|NOT COMPLETED|Overall Study||2
1027096|NCT00662532|2493991|P1|NOT COMPLETED|Overall Study||0
1027097|NCT00662532|2493990|P2|COMPLETED|Overall Study||20
1027098|NCT00662532|2493991|P1|COMPLETED|Overall Study||22
1027099|NCT00662532|2493990|P2|STARTED|Overall Study||22
1027100|NCT00662532|2493991|P1|STARTED|Overall Study||22
1027101|NCT00662545|2494003|P2|NOT COMPLETED|Overall Study||0
1027102|NCT00662545|2494004|P1|NOT COMPLETED|Overall Study||0
1027103|NCT00662545|2494003|P2|COMPLETED|Overall Study||5
1027104|NCT00662545|2494004|P1|COMPLETED|Overall Study||5
1027105|NCT00662545|2494003|P2|STARTED|Overall Study||5
1027106|NCT00662545|2494004|P1|STARTED|Overall Study||5
1027107|NCT00662558|2494020|P2|NOT COMPLETED|Overall Study||110
1027108|NCT00662558|2494021|P1|NOT COMPLETED|Overall Study||56
1027109|NCT00662558|2494020|P2|COMPLETED|Overall Study||294
1027110|NCT00662558|2494021|P1|COMPLETED|Overall Study||342
1027111|NCT00662558|2494020|P2|Received Treatment|Overall Study||396
1027112|NCT00662558|2494021|P1|Received Treatment|Overall Study||396
1027113|NCT00662558|2494020|P2|STARTED|Overall Study||404
1027114|NCT00662558|2494021|P1|STARTED|Overall Study||398
1027115|NCT00662649|2494057|P5|NOT COMPLETED|Extension Study (Month 24 to 60)||29
1027116|NCT00662649|2494058|P4|NOT COMPLETED|Extension Study (Month 24 to 60)||33
1027117|NCT00662649|2494059|P3|NOT COMPLETED|Extension Study (Month 24 to 60)||0
1027118|NCT00662649|2494060|P2|NOT COMPLETED|Extension Study (Month 24 to 60)||41
1027119|NCT00662649|2494061|P1|NOT COMPLETED|Extension Study (Month 24 to 60)||44
1027120|NCT00662649|2494057|P5|COMPLETED|Extension Study (Month 24 to 60)||126
1027121|NCT00662649|2494058|P4|COMPLETED|Extension Study (Month 24 to 60)||112
1027122|NCT00662649|2494059|P3|COMPLETED|Extension Study (Month 24 to 60)||0
1027123|NCT00662649|2494060|P2|COMPLETED|Extension Study (Month 24 to 60)||290
1027124|NCT00662649|2494061|P1|COMPLETED|Extension Study (Month 24 to 60)|"completed refers to patients that completed extension study in different time points."|245
1027125|NCT00662649|2494057|P5|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||13
1027126|NCT00662649|2494058|P4|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||11
1027127|NCT00662649|2494059|P3|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||0
1027128|NCT00662649|2494060|P2|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||32
1027129|NCT00662649|2494061|P1|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||31
1027130|NCT00662649|2494057|P5|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||67
1027131|NCT00662649|2494058|P4|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||58
1027132|NCT00662649|2494059|P3|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||0
1027133|NCT00662649|2494060|P2|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||152
1027134|NCT00662649|2494061|P1|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||125
1027135|NCT00662649|2494057|P5|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||136
1027136|NCT00662649|2494058|P4|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||120
1027137|NCT00662649|2494059|P3|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||0
1027138|NCT00662649|2494060|P2|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||301
1027139|NCT00662649|2494061|P1|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||254
1027140|NCT00662649|2494057|P5|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||145
1027141|NCT00662649|2494058|P4|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||130
1027142|NCT00662649|2494059|P3|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||0
1027143|NCT00662649|2494060|P2|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||311
1027144|NCT00662649|2494061|P1|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||270
1027145|NCT00662649|2494057|P5|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||152
1027146|NCT00662649|2494058|P4|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||136
1027147|NCT00662649|2494059|P3|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||0
1027148|NCT00662649|2494060|P2|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||324
1027149|NCT00662649|2494061|P1|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||276
1027150|NCT00662649|2494057|P5|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||155
1027151|NCT00662649|2494058|P4|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||145
1027152|NCT00662649|2494059|P3|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||0
1027153|NCT00662649|2494060|P2|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||331
1027154|NCT00662649|2494061|P1|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||289
1027155|NCT00662649|2494057|P5|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||154
1027156|NCT00662649|2494058|P4|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||145
1027157|NCT00662649|2494059|P3|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||0
1027158|NCT00662649|2494060|P2|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||330
1027159|NCT00662649|2494061|P1|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||287
1027160|NCT00662649|2494057|P5|STARTED|Extension Study (Month 24 to 60)||155
1027161|NCT00662649|2494058|P4|STARTED|Extension Study (Month 24 to 60)||145
1027162|NCT00662649|2494059|P3|STARTED|Extension Study (Month 24 to 60)|This reporting group is used only for core study|0
1027163|NCT00662649|2494060|P2|STARTED|Extension Study (Month 24 to 60)||331
1027164|NCT00662649|2494061|P1|STARTED|Extension Study (Month 24 to 60)||289
1027165|NCT00662649|2494057|P5|NOT COMPLETED|Core Study (24 Months)||0
1027166|NCT00662649|2494058|P4|NOT COMPLETED|Core Study (24 Months)||0
1027167|NCT00662649|2494059|P3|NOT COMPLETED|Core Study (24 Months)||86
1027168|NCT00662649|2494060|P2|NOT COMPLETED|Core Study (24 Months)||56
1027169|NCT00662649|2494061|P1|NOT COMPLETED|Core Study (24 Months)||97
1027170|NCT00662649|2494057|P5|COMPLETED|Core Study (24 Months)||0
1027171|NCT00662649|2494058|P4|COMPLETED|Core Study (24 Months)||0
1027172|NCT00662649|2494059|P3|COMPLETED|Core Study (24 Months)||332
1027173|NCT00662649|2494060|P2|COMPLETED|Core Study (24 Months)||369
1027174|NCT00662649|2494061|P1|COMPLETED|Core Study (24 Months)||332
1027175|NCT00662649|2494057|P5|Intent to Treat (ITT)|Core Study (24 Months)||0
1027176|NCT00662649|2494058|P4|Intent to Treat (ITT)|Core Study (24 Months)||0
1027177|NCT00662649|2494059|P3|Intent to Treat (ITT)|Core Study (24 Months)||418
1027178|NCT00662649|2494060|P2|Intent to Treat (ITT)|Core Study (24 Months)||425
1027179|NCT00662649|2494061|P1|Intent to Treat (ITT)|Core Study (24 Months)||429
1027180|NCT00662649|2494057|P5|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
1027181|NCT00662649|2494058|P4|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
1027182|NCT00662649|2494059|P3|STARTED|Core Study (24 Months)||418
1027183|NCT00662649|2494060|P2|STARTED|Core Study (24 Months)||425
1027184|NCT00662649|2494061|P1|STARTED|Core Study (24 Months)||429
1027185|NCT00662675|2494101|P2|NOT COMPLETED|Overall Study||0
1027186|NCT00662675|2494102|P1|NOT COMPLETED|Overall Study||0
1027187|NCT00662675|2494101|P2|COMPLETED|Overall Study||20
1027188|NCT00662675|2494102|P1|COMPLETED|Overall Study||20
1027189|NCT00662675|2494101|P2|STARTED|Overall Study||20
1027190|NCT00662675|2494102|P1|STARTED|Overall Study||20
1027191|NCT00662818|2494114|P2|NOT COMPLETED|Period 2 (6 Weeks)||12
1027192|NCT00662818|2494115|P1|NOT COMPLETED|Period 2 (6 Weeks)||13
1027193|NCT00662818|2494114|P2|COMPLETED|Period 2 (6 Weeks)||41
1027194|NCT00662818|2494115|P1|COMPLETED|Period 2 (6 Weeks)||38
1027195|NCT00662818|2494114|P2|STARTED|Period 2 (6 Weeks)||53
1027196|NCT00662818|2494115|P1|STARTED|Period 2 (6 Weeks)||51
1027197|NCT00662818|2494114|P2|NOT COMPLETED|Wash-Out (14 Days)||5
1027198|NCT00662818|2494115|P1|NOT COMPLETED|Wash-Out (14 Days)||5
1027199|NCT00662818|2494114|P2|COMPLETED|Wash-Out (14 Days)||53
1027200|NCT00662818|2494115|P1|COMPLETED|Wash-Out (14 Days)||51
1027201|NCT00662818|2494114|P2|STARTED|Wash-Out (14 Days)||58
1027202|NCT00662818|2494115|P1|STARTED|Wash-Out (14 Days)||56
1027203|NCT00662818|2494114|P2|NOT COMPLETED|Period 1 (6 Weeks)||23
1027204|NCT00662818|2494115|P1|NOT COMPLETED|Period 1 (6 Weeks)||28
1027205|NCT00662818|2494114|P2|COMPLETED|Period 1 (6 Weeks)||58
1027206|NCT00662818|2494115|P1|COMPLETED|Period 1 (6 Weeks)||56
1027207|NCT00662818|2494114|P2|Treated|Period 1 (6 Weeks)||58
1027208|NCT00662818|2494115|P1|Treated|Period 1 (6 Weeks)||56
1027209|NCT00662818|2494114|P2|STARTED|Period 1 (6 Weeks)||81
1027210|NCT00662818|2494115|P1|STARTED|Period 1 (6 Weeks)||84
1027211|NCT00662831|2494139|P2|NOT COMPLETED|Overall Study||59
1027212|NCT00662831|2494140|P1|NOT COMPLETED|Overall Study||106
1027213|NCT00662831|2494139|P2|COMPLETED|Overall Study||33
1027214|NCT00662831|2494140|P1|COMPLETED|Overall Study||78
1027215|NCT00662831|2494139|P2|STARTED|Overall Study||92
1027216|NCT00662831|2494140|P1|STARTED|Overall Study||184
1027217|NCT00662857|2494178|P2|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
1027218|NCT00662857|2494179|P1|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
1027219|NCT00662857|2494178|P2|COMPLETED|Lispro Dosing Period (1 Day)||14
1027220|NCT00662857|2494179|P1|COMPLETED|Lispro Dosing Period (1 Day)||12
1027221|NCT00662857|2494178|P2|STARTED|Lispro Dosing Period (1 Day)||14
1027222|NCT00662857|2494179|P1|STARTED|Lispro Dosing Period (1 Day)||12
1027223|NCT00662857|2494178|P2|NOT COMPLETED|Washout 2 (3 - 14 Days)||0
1027224|NCT00662857|2494179|P1|NOT COMPLETED|Washout 2 (3 - 14 Days)||1
1027225|NCT00662857|2494178|P2|COMPLETED|Washout 2 (3 - 14 Days)||14
1027226|NCT00662857|2494179|P1|COMPLETED|Washout 2 (3 - 14 Days)||12
1027227|NCT00662857|2494178|P2|STARTED|Washout 2 (3 - 14 Days)||14
1027228|NCT00662857|2494179|P1|STARTED|Washout 2 (3 - 14 Days)||13
1027229|NCT00662857|2494178|P2|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
1027230|NCT00662857|2494179|P1|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
1027231|NCT00662857|2494178|P2|COMPLETED|TI Dosing Period 2 (1 Day)||14
1027232|NCT00662857|2494179|P1|COMPLETED|TI Dosing Period 2 (1 Day)||13
1027233|NCT00662857|2494178|P2|STARTED|TI Dosing Period 2 (1 Day)||14
1027234|NCT00662857|2494179|P1|STARTED|TI Dosing Period 2 (1 Day)||13
1027235|NCT00662857|2494178|P2|NOT COMPLETED|Washout 1 (3 - 14 Days)||2
1027236|NCT00662857|2494179|P1|NOT COMPLETED|Washout 1 (3 - 14 Days)||0
1027237|NCT00662857|2494178|P2|COMPLETED|Washout 1 (3 - 14 Days)||14
1027238|NCT00662857|2494179|P1|COMPLETED|Washout 1 (3 - 14 Days)||13
1027239|NCT00662857|2494178|P2|STARTED|Washout 1 (3 - 14 Days)||16
1027240|NCT00662857|2494179|P1|STARTED|Washout 1 (3 - 14 Days)||13
1027241|NCT00662857|2494178|P2|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
1027242|NCT00662857|2494179|P1|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
1027243|NCT00662857|2494178|P2|COMPLETED|TI Dosing Period 1 (1 Day)||16
1027244|NCT00662857|2494179|P1|COMPLETED|TI Dosing Period 1 (1 Day)||13
1027245|NCT00662857|2494178|P2|STARTED|TI Dosing Period 1 (1 Day)||16
1027246|NCT00662857|2494179|P1|STARTED|TI Dosing Period 1 (1 Day)||13
1027247|NCT00662909|2494195|P3|NOT COMPLETED|Overall Study||53
1027248|NCT00662909|2494196|P2|NOT COMPLETED|Overall Study||59
1027249|NCT00662909|2494197|P1|NOT COMPLETED|Overall Study||69
1027250|NCT00662909|2494195|P3|COMPLETED|Overall Study||380
1027251|NCT00662909|2494196|P2|COMPLETED|Overall Study||383
1027252|NCT00662909|2494197|P1|COMPLETED|Overall Study||385
1027253|NCT00662909|2494195|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|296
1027254|NCT00662909|2494196|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|312
1027255|NCT00662909|2494197|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|325
1027256|NCT00662909|2494195|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|412
1027257|NCT00662909|2494196|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|425
1027258|NCT00662909|2494197|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|433
1027259|NCT00662909|2494195|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
1027260|NCT00662909|2494196|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|442
1027261|NCT00662909|2494197|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|453
1027262|NCT00662909|2494195|P3|STARTED|Overall Study||433
1027263|NCT00662909|2494196|P2|STARTED|Overall Study||442
1027264|NCT00662909|2494197|P1|STARTED|Overall Study||454
1027265|NCT00663026|2494298|P3|NOT COMPLETED|Overall Study||4
1027266|NCT00663026|2494299|P2|NOT COMPLETED|Overall Study||6
1027267|NCT00663026|2494300|P1|NOT COMPLETED|Overall Study||2
1027268|NCT00663026|2494298|P3|COMPLETED|Overall Study||27
1027269|NCT00663026|2494299|P2|COMPLETED|Overall Study||23
1027270|NCT00663026|2494300|P1|COMPLETED|Overall Study||17
1027271|NCT00663026|2494298|P3|STARTED|Overall Study||31
1027272|NCT00663026|2494299|P2|STARTED|Overall Study||29
1027273|NCT00663026|2494300|P1|STARTED|Overall Study||19
1027274|NCT00663052|2494322|P2|NOT COMPLETED|Overall Study||10
1027275|NCT00663052|2494323|P1|NOT COMPLETED|Overall Study||12
1027276|NCT00663052|2494322|P2|COMPLETED|Overall Study||127
1027277|NCT00663052|2494323|P1|COMPLETED|Overall Study||124
1027278|NCT00663052|2494322|P2|STARTED|Overall Study||137
1027279|NCT00663052|2494323|P1|STARTED|Overall Study||136
1027280|NCT00663117|2494405|P2|NOT COMPLETED|Overall Study||0
1027281|NCT00663117|2494406|P1|NOT COMPLETED|Overall Study||1
1027282|NCT00663117|2494405|P2|COMPLETED|Overall Study||20
1027283|NCT00663117|2494406|P1|COMPLETED|Overall Study|One patient in placebo flared and was unblinded and crossed over to active drug|19
1027284|NCT00663117|2494405|P2|STARTED|Overall Study||20
1027285|NCT00663117|2494406|P1|STARTED|Overall Study||20
1027286|NCT00663169|2494420|P2|NOT COMPLETED|Overall Study||0
1027287|NCT00663169|2494421|P1|NOT COMPLETED|Overall Study||0
1027288|NCT00663169|2494420|P2|COMPLETED|Overall Study||3
1027289|NCT00663169|2494421|P1|COMPLETED|Overall Study||3
1027290|NCT00663169|2494420|P2|STARTED|Overall Study||3
1027291|NCT00663169|2494421|P1|STARTED|Overall Study||3
1027292|NCT00663208|2494451|P7|NOT COMPLETED|Follow-up Period||1
1027293|NCT00663208|2494452|P6|NOT COMPLETED|Follow-up Period||0
1027294|NCT00663208|2494453|P5|NOT COMPLETED|Follow-up Period||0
1027295|NCT00663208|2494454|P4|NOT COMPLETED|Follow-up Period||2
1027296|NCT00663208|2494455|P3|NOT COMPLETED|Follow-up Period||3
1027297|NCT00663208|2494456|P2|NOT COMPLETED|Follow-up Period||0
1027298|NCT00663208|2494457|P1|NOT COMPLETED|Follow-up Period||3
1027299|NCT00663208|2494451|P7|COMPLETED|Follow-up Period||5
1027300|NCT00663208|2494452|P6|COMPLETED|Follow-up Period||4
1027301|NCT00663208|2494453|P5|COMPLETED|Follow-up Period||4
1027302|NCT00663208|2494454|P4|COMPLETED|Follow-up Period||2
1027303|NCT00663208|2494455|P3|COMPLETED|Follow-up Period||1
1027304|NCT00663208|2494456|P2|COMPLETED|Follow-up Period||3
1027305|NCT00663208|2494457|P1|COMPLETED|Follow-up Period||1
1027306|NCT00663208|2494451|P7|STARTED|Follow-up Period||6
1027307|NCT00663208|2494452|P6|STARTED|Follow-up Period||4
1027308|NCT00663208|2494453|P5|STARTED|Follow-up Period||4
1027309|NCT00663208|2494454|P4|STARTED|Follow-up Period||4
1027310|NCT00663208|2494455|P3|STARTED|Follow-up Period||4
1027311|NCT00663208|2494456|P2|STARTED|Follow-up Period||3
1027312|NCT00663208|2494457|P1|STARTED|Follow-up Period||4
1027313|NCT00663208|2494451|P7|NOT COMPLETED|Treatment Period||0
1027314|NCT00663208|2494452|P6|NOT COMPLETED|Treatment Period||0
1027315|NCT00663208|2494453|P5|NOT COMPLETED|Treatment Period||0
1027316|NCT00663208|2494454|P4|NOT COMPLETED|Treatment Period||0
1027317|NCT00663208|2494455|P3|NOT COMPLETED|Treatment Period||0
1027318|NCT00663208|2494456|P2|NOT COMPLETED|Treatment Period||1
1027319|NCT00663208|2494457|P1|NOT COMPLETED|Treatment Period||0
1027320|NCT00663208|2494451|P7|COMPLETED|Treatment Period||6
1027321|NCT00663208|2494452|P6|COMPLETED|Treatment Period||4
1027322|NCT00663208|2494453|P5|COMPLETED|Treatment Period||4
1027323|NCT00663208|2494454|P4|COMPLETED|Treatment Period||4
1027324|NCT00663208|2494455|P3|COMPLETED|Treatment Period||4
1027325|NCT00663208|2494456|P2|COMPLETED|Treatment Period||3
1027326|NCT00663208|2494457|P1|COMPLETED|Treatment Period||4
1027327|NCT00663208|2494451|P7|STARTED|Treatment Period||6
1027328|NCT00663208|2494452|P6|STARTED|Treatment Period||4
1027329|NCT00663208|2494453|P5|STARTED|Treatment Period||4
1027330|NCT00663208|2494454|P4|STARTED|Treatment Period||4
1027331|NCT00663208|2494455|P3|STARTED|Treatment Period||4
1027332|NCT00663208|2494456|P2|STARTED|Treatment Period||4
1027333|NCT00663208|2494457|P1|STARTED|Treatment Period||4
1027334|NCT00663234|2494607|P1|NOT COMPLETED|Overall Study||1
1027335|NCT00663234|2494607|P1|COMPLETED|Overall Study||27
1027336|NCT00663234|2494607|P1|Dose Increased to 20 mg at Week 8|Overall Study||10
1027337|NCT00663234|2494607|P1|STARTED|Overall Study||28
1027338|NCT00663260|2494636|P3|NOT COMPLETED|Overall Study||16
1027339|NCT00663260|2494637|P2|NOT COMPLETED|Overall Study||11
1027340|NCT00663260|2494638|P1|NOT COMPLETED|Overall Study||21
1027341|NCT00663260|2494636|P3|COMPLETED|Overall Study||69
1027342|NCT00663260|2494637|P2|COMPLETED|Overall Study||72
1027343|NCT00663260|2494638|P1|COMPLETED|Overall Study||63
1027344|NCT00663260|2494636|P3|STARTED|Overall Study||85
1027345|NCT00663260|2494637|P2|STARTED|Overall Study||83
1027346|NCT00663260|2494638|P1|STARTED|Overall Study||84
1027347|NCT00663403|2494652|P1|NOT COMPLETED|Overall Study||0
1027348|NCT00663403|2494652|P1|COMPLETED|Overall Study||8
1027349|NCT00663403|2494652|P1|STARTED|Overall Study||8
1027350|NCT00663702|2494664|P2|NOT COMPLETED|Overall Study||10
1027351|NCT00663702|2494665|P1|NOT COMPLETED|Overall Study||18
1027352|NCT00663702|2494664|P2|COMPLETED|Overall Study||61
1027353|NCT00663702|2494665|P1|COMPLETED|Overall Study||34
1027354|NCT00663702|2494664|P2|STARTED|Overall Study||71
1027355|NCT00663702|2494665|P1|STARTED|Overall Study||52
1027356|NCT00663793|2494690|P2|NOT COMPLETED|Overall Study||0
1027357|NCT00663793|2494691|P1|NOT COMPLETED|Overall Study||0
1027358|NCT00663793|2494690|P2|COMPLETED|Overall Study||8
1027359|NCT00663793|2494691|P1|COMPLETED|Overall Study||8
1027360|NCT00663793|2494690|P2|STARTED|Overall Study||8
1027361|NCT00663793|2494691|P1|STARTED|Overall Study||8
1027362|NCT00663819|2494703|P2|NOT COMPLETED|Overall Study||0
1027363|NCT00663819|2494704|P1|NOT COMPLETED|Overall Study||0
1027364|NCT00663819|2494703|P2|COMPLETED|Overall Study||135
1027365|NCT00663819|2494704|P1|COMPLETED|Overall Study||123
1027366|NCT00663819|2494703|P2|STARTED|Overall Study||135
1027367|NCT00663819|2494704|P1|STARTED|Overall Study||123
1027368|NCT00663858|2494713|P3|NOT COMPLETED|Overall Study||20
1027369|NCT00663858|2494714|P2|NOT COMPLETED|Overall Study||10
1027370|NCT00663858|2494715|P1|NOT COMPLETED|Overall Study||34
1027371|NCT00663858|2494713|P3|COMPLETED|Overall Study||82
1027372|NCT00663858|2494714|P2|COMPLETED|Overall Study||96
1027373|NCT00663858|2494715|P1|COMPLETED|Overall Study||178
1027374|NCT00663858|2494713|P3|STARTED|Overall Study||102
1027375|NCT00663858|2494714|P2|STARTED|Overall Study||106
1027376|NCT00663858|2494715|P1|STARTED|Overall Study||212
1027377|NCT00663923|2494723|P1|NOT COMPLETED|Overall Study||2
1027378|NCT00663923|2494723|P1|COMPLETED|Overall Study||48
1027379|NCT00663923|2494723|P1|STARTED|Overall Study||50
1027380|NCT00663962|2494739|P2|NOT COMPLETED|Overall Study||0
1027381|NCT00663962|2494740|P1|NOT COMPLETED|Overall Study||1
1027382|NCT00663962|2494739|P2|COMPLETED|Overall Study||8
1027383|NCT00663962|2494740|P1|COMPLETED|Overall Study|1 patient excluded for somnolence and unblinded--in 300mg group|6
1027384|NCT00663962|2494739|P2|STARTED|Overall Study||8
1027385|NCT00663962|2494740|P1|STARTED|Overall Study||7
1027386|NCT00664326|2494746|P1|NOT COMPLETED|Overall Study||24
1027387|NCT00664326|2494746|P1|COMPLETED|Overall Study||25
1027388|NCT00664326|2494746|P1|STARTED|Overall Study||49
1027389|NCT00664430|2494765|P1|NOT COMPLETED|Overall Study||13
1027390|NCT00664430|2494765|P1|COMPLETED|Overall Study|Study terminated early due to low enrollment rate.|0
1027391|NCT00664430|2494765|P1|STARTED|Overall Study||13
1027392|NCT00664521|2494773|P2|NOT COMPLETED|Overall Study||1
1027393|NCT00664521|2494774|P1|NOT COMPLETED|Overall Study||6
1027394|NCT00664521|2494773|P2|COMPLETED|Overall Study||8
1027395|NCT00664521|2494774|P1|COMPLETED|Overall Study||12
1027396|NCT00664521|2494773|P2|STARTED|Overall Study||9
1027397|NCT00664521|2494774|P1|STARTED|Overall Study||18
1027398|NCT00664534|2494796|P2|NOT COMPLETED|Overall Study||33
1027399|NCT00664534|2494797|P1|NOT COMPLETED|Overall Study||41
1027400|NCT00664534|2494796|P2|COMPLETED|Overall Study||138
1027401|NCT00664534|2494797|P1|COMPLETED|Overall Study||132
1027402|NCT00664534|2494796|P2|STARTED|Overall Study||171
1027403|NCT00664534|2494797|P1|STARTED|Overall Study||173
1027404|NCT00664560|2494826|P3|NOT COMPLETED|Overall Study||19
1027405|NCT00664560|2494827|P2|NOT COMPLETED|Overall Study||35
1027406|NCT00664560|2494828|P1|NOT COMPLETED|Overall Study||39
1027407|NCT00664560|2494826|P3|COMPLETED|Overall Study||105
1027408|NCT00664560|2494827|P2|COMPLETED|Overall Study||208
1027409|NCT00664560|2494828|P1|COMPLETED|Overall Study||208
1027410|NCT00664560|2494826|P3|STARTED|Overall Study|Safety Population|124
1027411|NCT00664560|2494827|P2|STARTED|Overall Study|Safety Population|243
1027412|NCT00664560|2494828|P1|STARTED|Overall Study|Safety Population|247
1027413|NCT00664742|2494869|P1|NOT COMPLETED|Overall Study||126
1027414|NCT00664742|2494869|P1|COMPLETED|Overall Study||481
1027415|NCT00664742|2494869|P1|STARTED|Overall Study||607
1027416|NCT00665002|2494874|P1|NOT COMPLETED|Overall Study||12
1027417|NCT00665002|2494874|P1|COMPLETED|Overall Study||4
1027418|NCT00665002|2494874|P1|STARTED|Overall Study||16
1027419|NCT00665132|2494879|P1|NOT COMPLETED|Overall Study||0
1027420|NCT00665132|2494879|P1|COMPLETED|Overall Study||10
1027421|NCT00665132|2494879|P1|STARTED|Overall Study||10
1027422|NCT00665353|2494886|P1|NOT COMPLETED|Study Step 2||14
1027423|NCT00665353|2494886|P1|COMPLETED|Study Step 2||2
1027424|NCT00665353|2494886|P1|STARTED|Study Step 2||16
1027425|NCT00665353|2494886|P1|NOT COMPLETED|Study Step 1||3
1027426|NCT00665353|2494886|P1|COMPLETED|Study Step 1||16
1027427|NCT00665353|2494886|P1|STARTED|Study Step 1||19
1027428|NCT00665366|2494898|P2|NOT COMPLETED|Overall Study||59
1027429|NCT00665366|2494899|P1|NOT COMPLETED|Overall Study||58
1027430|NCT00665366|2494898|P2|COMPLETED|Overall Study||122
1027431|NCT00665366|2494899|P1|COMPLETED|Overall Study||131
1027432|NCT00665366|2494898|P2|STARTED|Overall Study|Participants randomized|181
1027433|NCT00665366|2494899|P1|STARTED|Overall Study|Participants randomized|189
1027434|NCT00665431|2494930|P3|NOT COMPLETED|Overall Study||24
1027435|NCT00665431|2494931|P2|NOT COMPLETED|Overall Study||57
1027436|NCT00665431|2494932|P1|NOT COMPLETED|Overall Study||40
1027437|NCT00665431|2494930|P3|COMPLETED|Overall Study||98
1027438|NCT00665431|2494931|P2|COMPLETED|Overall Study||188
1027439|NCT00665431|2494932|P1|COMPLETED|Overall Study||203
1027440|NCT00665431|2494930|P3|STARTED|Overall Study|Safety population|122
1027441|NCT00665431|2494931|P2|STARTED|Overall Study|Safety population|245
1027442|NCT00665431|2494932|P1|STARTED|Overall Study|Safety population|243
1027443|NCT00665444|2494973|P1|NOT COMPLETED|Overall Study||2
1027444|NCT00665444|2494973|P1|COMPLETED|Overall Study||1
1027445|NCT00665444|2494973|P1|STARTED|Overall Study||3
1027446|NCT00665470|2494980|P2|NOT COMPLETED|Overall Study||0
1027447|NCT00665470|2494981|P1|NOT COMPLETED|Overall Study||0
1027448|NCT00665470|2494980|P2|COMPLETED|Overall Study||0
1027449|NCT00665470|2494981|P1|COMPLETED|Overall Study||10
1027450|NCT00665470|2494980|P2|STARTED|Overall Study||0
1027451|NCT00665470|2494981|P1|STARTED|Overall Study||10
1027452|NCT00665626|2494991|P2|NOT COMPLETED|Overall Study||22
1027453|NCT00665626|2494992|P1|NOT COMPLETED|Overall Study||10
1027454|NCT00665626|2494991|P2|COMPLETED|Overall Study|Participants completed the study|124
1027455|NCT00665626|2494992|P1|COMPLETED|Overall Study|Participants completed the study|63
1027456|NCT00665626|2494991|P2|STARTED|Overall Study|Participants randomized|146
1027457|NCT00665626|2494992|P1|STARTED|Overall Study|Participants randomized|73
1027458|NCT00665704|2495058|P1|NOT COMPLETED|Overall Study||0
1027459|NCT00665704|2495058|P1|COMPLETED|Overall Study||9
1027460|NCT00665704|2495058|P1|STARTED|Overall Study||9
1027461|NCT00665847|2495063|P1|NOT COMPLETED|Overall Study||25
1027462|NCT00665847|2495063|P1|COMPLETED|Overall Study||76
1027463|NCT00665847|2495063|P1|STARTED|Overall Study||101
1027464|NCT00665925|2495079|P4|NOT COMPLETED|Overall Study||21
1027465|NCT00665925|2495080|P3|NOT COMPLETED|Overall Study||26
1027466|NCT00665925|2495081|P2|NOT COMPLETED|Overall Study||17
1027467|NCT00665925|2495082|P1|NOT COMPLETED|Overall Study||15
1027468|NCT00665925|2495079|P4|COMPLETED|Overall Study|Participants completed the study|131
1027469|NCT00665925|2495080|P3|COMPLETED|Overall Study|Participants completed the study|126
1027470|NCT00665925|2495081|P2|COMPLETED|Overall Study|Participants completed the study|59
1027471|NCT00665925|2495082|P1|COMPLETED|Overall Study|Participants completed the study|62
1027472|NCT00665925|2495079|P4|STARTED|Overall Study|Participants randomized|152
1027473|NCT00665925|2495080|P3|STARTED|Overall Study|Participants randomized|152
1027474|NCT00665925|2495081|P2|STARTED|Overall Study|Participants randomized|76
1027475|NCT00665925|2495082|P1|STARTED|Overall Study|Participants randomized|77
1027476|NCT00666029|2495495|P2|NOT COMPLETED|Overall Study||0
1027477|NCT00666029|2495496|P1|NOT COMPLETED|Overall Study||1
1027478|NCT00666029|2495495|P2|COMPLETED|Overall Study||20
1027479|NCT00666029|2495496|P1|COMPLETED|Overall Study||19
1027480|NCT00666029|2495495|P2|STARTED|Overall Study||20
1027481|NCT00666029|2495496|P1|STARTED|Overall Study||20
1027482|NCT00666198|2495504|P1|NOT COMPLETED|Overall Study||33
1027483|NCT00666198|2495504|P1|COMPLETED|Overall Study||3304
1027484|NCT00666198|2495504|P1|STARTED|Overall Study||3337
1027485|NCT00666211|2495519|P2|NOT COMPLETED|Overall Study||38
1027486|NCT00666211|2495520|P1|NOT COMPLETED|Overall Study||20
1027487|NCT00666211|2495519|P2|COMPLETED|Overall Study||18
1027488|NCT00666211|2495520|P1|COMPLETED|Overall Study||22
1027489|NCT00666211|2495519|P2|STARTED|Overall Study||56
1027490|NCT00666211|2495520|P1|STARTED|Overall Study||42
1027491|NCT00666224|2495540|P2|NOT COMPLETED|Open-Label||85
1027492|NCT00666224|2495541|P1|NOT COMPLETED|Open-Label||35
1027493|NCT00666224|2495540|P2|COMPLETED|Open-Label||126
1027494|NCT00666224|2495541|P1|COMPLETED|Open-Label||163
1027495|NCT00666224|2495540|P2|STARTED|Open-Label||211
1027496|NCT00666224|2495541|P1|STARTED|Open-Label|454 participants took at least one dose of GA including 45 who didn't continue into the OL.|198
1027497|NCT00666224|2495540|P2|NOT COMPLETED|Double-Blind||27
1027498|NCT00666224|2495541|P1|NOT COMPLETED|Double-Blind||45
1027499|NCT00666224|2495540|P2|COMPLETED|Double-Blind|55 completed 3 years treatment, 109 converted to CDMS, 47 switched to OL as per DMC|211
1027500|NCT00666224|2495541|P1|COMPLETED|Double-Blind|78 completed 3 years treatment, 66 converted to CDMS, 54 switched to OL as per DMC|198
1027501|NCT00666224|2495540|P2|STARTED|Double-Blind||238
1027502|NCT00666224|2495541|P1|STARTED|Double-Blind||243
1027503|NCT00666263|2495558|P2|NOT COMPLETED|End of Study Visit||0
1027504|NCT00666263|2495559|P1|NOT COMPLETED|End of Study Visit||0
1027505|NCT00666263|2495558|P2|COMPLETED|End of Study Visit||22
1027506|NCT00666263|2495559|P1|COMPLETED|End of Study Visit||22
1027507|NCT00666263|2495558|P2|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
1027508|NCT00666263|2495559|P1|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
1027509|NCT00666263|2495558|P2|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||1
1027510|NCT00666263|2495559|P1|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||0
1027511|NCT00666263|2495558|P2|COMPLETED|Study Part 5 (Stabilization Phase 3)||20
1027512|NCT00666263|2495559|P1|COMPLETED|Study Part 5 (Stabilization Phase 3)||21
1027513|NCT00666263|2495558|P2|STARTED|Study Part 5 (Stabilization Phase 3)||21
1027514|NCT00666263|2495559|P1|STARTED|Study Part 5 (Stabilization Phase 3)||21
1027515|NCT00666263|2495558|P2|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||0
1027516|NCT00666263|2495559|P1|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||1
1027517|NCT00666263|2495558|P2|COMPLETED|Study Part 4 (Cross-over Period 2)||21
1027518|NCT00666263|2495559|P1|COMPLETED|Study Part 4 (Cross-over Period 2)||21
1027519|NCT00666263|2495558|P2|STARTED|Study Part 4 (Cross-over Period 2)||21
1027520|NCT00666263|2495559|P1|STARTED|Study Part 4 (Cross-over Period 2)||22
1027521|NCT00666263|2495558|P2|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
1027522|NCT00666263|2495559|P1|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
1027523|NCT00666263|2495558|P2|COMPLETED|Study Part 3 (Stabilization Phase 2)||21
1027524|NCT00666263|2495559|P1|COMPLETED|Study Part 3 (Stabilization Phase 2)||22
1027525|NCT00666263|2495558|P2|STARTED|Study Part 3 (Stabilization Phase 2)||21
1027526|NCT00666263|2495559|P1|STARTED|Study Part 3 (Stabilization Phase 2)||22
1027527|NCT00666263|2495558|P2|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
1027528|NCT00666263|2495559|P1|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
1027529|NCT00666263|2495558|P2|COMPLETED|Study Part 2 (Cross-over Period 1)||21
1027530|NCT00666263|2495559|P1|COMPLETED|Study Part 2 (Cross-over Period 1)||22
1027531|NCT00666263|2495558|P2|STARTED|Study Part 2 (Cross-over Period 1)||21
1027532|NCT00666263|2495559|P1|STARTED|Study Part 2 (Cross-over Period 1)||22
1027533|NCT00666263|2495558|P2|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||1
1027534|NCT00666263|2495559|P1|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||0
1027535|NCT00666263|2495558|P2|COMPLETED|Study Part 1 (Stabilization Phase 1)||21
1027536|NCT00666263|2495559|P1|COMPLETED|Study Part 1 (Stabilization Phase 1)||22
1027537|NCT00666263|2495558|P2|STARTED|Study Part 1 (Stabilization Phase 1)||22
1027538|NCT00666263|2495559|P1|STARTED|Study Part 1 (Stabilization Phase 1)||22
1027539|NCT00666276|2495701|P1|NOT COMPLETED|Overall Study||34
1027540|NCT00666276|2495701|P1|COMPLETED|Overall Study||970
1027541|NCT00666276|2495701|P1|STARTED|Overall Study||1004
1027542|NCT00666328|2495725|P1|NOT COMPLETED|Overall Study||5
1027543|NCT00666328|2495725|P1|COMPLETED|Overall Study|30/35 completed the study within the Safety population; 28/33 completed within the mITT population.|30
1027544|NCT00666328|2495725|P1|Modified Intent To Treat (mITT)|Overall Study|mITT population: participants dosed and in whom all inclusion and no exclusion criteria were met|33
1027545|NCT00666328|2495725|P1|STARTED|Overall Study|Safety population: participants dosed with study drug (primary population for Safety analyses)|35
1027546|NCT00666406|2495738|P2|NOT COMPLETED|Second PK Infusion||0
1027547|NCT00666406|2495739|P1|NOT COMPLETED|Second PK Infusion||0
1027548|NCT00666406|2495738|P2|COMPLETED|Second PK Infusion||3
1027549|NCT00666406|2495739|P1|COMPLETED|Second PK Infusion||6
1027550|NCT00666406|2495738|P2|STARTED|Second PK Infusion||3
1027551|NCT00666406|2495739|P1|STARTED|Second PK Infusion||6
1027552|NCT00666406|2495738|P2|NOT COMPLETED|First PK Infusion||0
1027553|NCT00666406|2495739|P1|NOT COMPLETED|First PK Infusion||0
1027554|NCT00666406|2495738|P2|COMPLETED|First PK Infusion||3
1027555|NCT00666406|2495739|P1|COMPLETED|First PK Infusion||6
1027556|NCT00666406|2495738|P2|STARTED|First PK Infusion||3
1027557|NCT00666406|2495739|P1|STARTED|First PK Infusion||6
1027558|NCT00666458|2495816|P2|NOT COMPLETED|Overall Study||24
1027559|NCT00666458|2495817|P1|NOT COMPLETED|Overall Study||38
1027560|NCT00666458|2495816|P2|COMPLETED|Overall Study|Completed 18 weeks of treatment|374
1027561|NCT00666458|2495817|P1|COMPLETED|Overall Study|Completed 18 weeks of treatment|365
1027562|NCT00666458|2495816|P2|STARTED|Overall Study|Randomized and treated|398
1027563|NCT00666458|2495817|P1|STARTED|Overall Study|Randomized and treated|403
1027564|NCT00666536|2495831|P2|NOT COMPLETED|Overall Study||37
1027565|NCT00666536|2495832|P1|NOT COMPLETED|Overall Study||33
1027566|NCT00666536|2495831|P2|COMPLETED|Overall Study||322
1027567|NCT00666536|2495832|P1|COMPLETED|Overall Study||336
1027568|NCT00666536|2495831|P2|STARTED|Overall Study||359
1027569|NCT00666536|2495832|P1|STARTED|Overall Study||369
1027570|NCT00666562|2495851|P3|NOT COMPLETED|Overall Study||0
1027571|NCT00666562|2495852|P2|NOT COMPLETED|Overall Study||2
1027572|NCT00666562|2495853|P1|NOT COMPLETED|Overall Study||0
1027573|NCT00666562|2495851|P3|COMPLETED|Overall Study||10
1027574|NCT00666562|2495852|P2|COMPLETED|Overall Study||8
1027575|NCT00666562|2495853|P1|COMPLETED|Overall Study||11
1027576|NCT00666562|2495851|P3|STARTED|Overall Study||10
1027577|NCT00666562|2495852|P2|STARTED|Overall Study||10
1027578|NCT00666562|2495853|P1|STARTED|Overall Study||11
1027579|NCT00666588|2495902|P4|NOT COMPLETED|Overall Study||2
1027580|NCT00666588|2495903|P3|NOT COMPLETED|Overall Study||0
1027581|NCT00666588|2495904|P2|NOT COMPLETED|Overall Study||0
1027582|NCT00666588|2495905|P1|NOT COMPLETED|Overall Study||4
1027583|NCT00666588|2495902|P4|COMPLETED|Overall Study||20
1027584|NCT00666588|2495903|P3|COMPLETED|Overall Study||6
1027585|NCT00666588|2495904|P2|COMPLETED|Overall Study||6
1027586|NCT00666588|2495905|P1|COMPLETED|Overall Study||14
1027587|NCT00666588|2495902|P4|STARTED|Overall Study||22
1027588|NCT00666588|2495903|P3|STARTED|Overall Study||6
1027589|NCT00666588|2495904|P2|STARTED|Overall Study||6
1027590|NCT00666588|2495905|P1|STARTED|Overall Study||18
1027591|NCT00666666|2495919|P1|NOT COMPLETED|Overall Study||0
1027592|NCT00666666|2495919|P1|COMPLETED|Overall Study||55
1027593|NCT00666666|2495919|P1|STARTED|Overall Study||55
1027594|NCT00666679|2495927|P2|NOT COMPLETED|Second Intervention||1
1027595|NCT00666679|2495928|P1|NOT COMPLETED|Second Intervention||1
1027596|NCT00666679|2495927|P2|COMPLETED|Second Intervention||64
1027597|NCT00666679|2495928|P1|COMPLETED|Second Intervention||61
1027598|NCT00666679|2495927|P2|STARTED|Second Intervention||65
1027599|NCT00666679|2495928|P1|STARTED|Second Intervention||62
1027600|NCT00666679|2495927|P2|NOT COMPLETED|Washout Period of 1 Week||2
1027601|NCT00666679|2495928|P1|NOT COMPLETED|Washout Period of 1 Week||0
1027602|NCT00666679|2495927|P2|COMPLETED|Washout Period of 1 Week||65
1027603|NCT00666679|2495928|P1|COMPLETED|Washout Period of 1 Week||62
1027604|NCT00666679|2495927|P2|STARTED|Washout Period of 1 Week||67
1027605|NCT00666679|2495928|P1|STARTED|Washout Period of 1 Week||62
1027606|NCT00666679|2495927|P2|NOT COMPLETED|First Intervention||1
1027607|NCT00666679|2495928|P1|NOT COMPLETED|First Intervention||4
1027608|NCT00666679|2495927|P2|COMPLETED|First Intervention||67
1027609|NCT00666679|2495928|P1|COMPLETED|First Intervention||62
1027610|NCT00666679|2495927|P2|STARTED|First Intervention||68
1027611|NCT00666679|2495928|P1|STARTED|First Intervention||66
1027612|NCT00666705|2495948|P1|NOT COMPLETED|Overall Study||1
1027613|NCT00666705|2495948|P1|COMPLETED|Overall Study||17
1027614|NCT00666705|2495948|P1|Raltegravir + Maraviroc (Days 12 - 14)|Overall Study|400 mg Raltegravir every 12 hours plus 300 mg Maraviroc every 12 hours (AM doses only on Day 14)|17
1027615|NCT00666705|2495948|P1|Maraviroc Alone (Days 6 - 11)|Overall Study|300 mg Maraviroc every 12 hours|18
1027616|NCT00666705|2495948|P1|Washout (Days 4 - 5)|Overall Study||18
1027617|NCT00666705|2495948|P1|Raltegravir Alone (Days 1 - 3)|Overall Study|400 mg Raltegravir every 12 hours (AM dose on Day 3)|18
1027618|NCT00666705|2495948|P1|STARTED|Overall Study||18
1027619|NCT00666718|2495967|P2|NOT COMPLETED|Overall Study||18
1027620|NCT00666718|2495968|P1|NOT COMPLETED|Overall Study||12
1027621|NCT00666718|2495967|P2|COMPLETED|Overall Study||169
1027622|NCT00666718|2495968|P1|COMPLETED|Overall Study||175
1027623|NCT00666718|2495967|P2|STARTED|Overall Study||187
1027624|NCT00666718|2495968|P1|STARTED|Overall Study||187
1027625|NCT00666757|2495996|P2|NOT COMPLETED|Overall Study||97
1027626|NCT00666757|2495997|P1|NOT COMPLETED|Overall Study||100
1027627|NCT00666757|2495996|P2|COMPLETED|Overall Study||281
1027628|NCT00666757|2495997|P1|COMPLETED|Overall Study||272
1027629|NCT00666757|2495996|P2|STARTED|Overall Study||378
1027630|NCT00666757|2495997|P1|STARTED|Overall Study||372
1027631|NCT00660816|2496056|P2|NOT COMPLETED|Overall Study||19
1027632|NCT00660816|2496057|P1|NOT COMPLETED|Overall Study||20
1027633|NCT00660816|2496056|P2|COMPLETED|Overall Study||3
1027634|NCT00660816|2496057|P1|COMPLETED|Overall Study||4
1027635|NCT00660816|2496056|P2|STARTED|Overall Study||22
1027636|NCT00660816|2496057|P1|STARTED|Overall Study||24
1027637|NCT00660829|2496071|P2|NOT COMPLETED|Overall Study||19
1027638|NCT00660829|2496072|P1|NOT COMPLETED|Overall Study||18
1027639|NCT00660829|2496071|P2|COMPLETED|Overall Study||249
1027640|NCT00660829|2496072|P1|COMPLETED|Overall Study||250
1027641|NCT00660829|2496071|P2|STARTED|Overall Study|2 subjects were randomized in error|268
1027642|NCT00660829|2496072|P1|STARTED|Overall Study|2 subjects were randomized in error|268
1027643|NCT00660907|2496090|P2|NOT COMPLETED|Overall Study||94
1027644|NCT00660907|2496091|P1|NOT COMPLETED|Overall Study||84
1027645|NCT00660907|2496090|P2|COMPLETED|Overall Study||314
1027646|NCT00660907|2496091|P1|COMPLETED|Overall Study||322
1027647|NCT00660907|2496090|P2|STARTED|Overall Study|Of the 408 randomized participants only 401 were included in the full analysis set.|408
1027648|NCT00660907|2496091|P1|STARTED|Overall Study|Of the 406 randomized participants only 400 were included in the full analysis set.|406
1027649|NCT00660985|2496105|P2|NOT COMPLETED|Overall Study||0
1027650|NCT00660985|2496106|P1|NOT COMPLETED|Overall Study||1
1027651|NCT00660985|2496105|P2|COMPLETED|Overall Study||25
1027652|NCT00660985|2496106|P1|COMPLETED|Overall Study||25
1027653|NCT00660985|2496105|P2|STARTED|Overall Study||25
1027654|NCT00660985|2496106|P1|STARTED|Overall Study||26
1027655|NCT00661037|2496130|P2|NOT COMPLETED|Overall Study||257
1027656|NCT00661037|2496131|P1|NOT COMPLETED|Overall Study||154
1027657|NCT00661037|2496130|P2|COMPLETED|Overall Study||1027
1027658|NCT00661037|2496131|P1|COMPLETED|Overall Study||682
1027659|NCT00661037|2496130|P2|Deaths|Overall Study||188
1027660|NCT00661037|2496131|P1|Deaths|Overall Study||108
1027661|NCT00661037|2496130|P2|Witdrawn|Overall Study||68
1027662|NCT00661037|2496131|P1|Witdrawn|Overall Study||47
1027663|NCT00661037|2496130|P2|STARTED|Overall Study||1284
1027664|NCT00661037|2496131|P1|STARTED|Overall Study||836
1027665|NCT00661089|2496143|P2|NOT COMPLETED|Overall Study||2
1027666|NCT00661089|2496144|P1|NOT COMPLETED|Overall Study||0
1027667|NCT00661089|2496143|P2|COMPLETED|Overall Study||9
1027668|NCT00661089|2496144|P1|COMPLETED|Overall Study||10
1027669|NCT00661089|2496143|P2|STARTED|Overall Study||11
1027670|NCT00661089|2496144|P1|STARTED|Overall Study||10
1027671|NCT00661141|2496155|P6|NOT COMPLETED|Overall Study||0
1027672|NCT00661141|2496156|P5|NOT COMPLETED|Overall Study||0
1027673|NCT00661141|2496157|P4|NOT COMPLETED|Overall Study||0
1027674|NCT00661141|2496158|P3|NOT COMPLETED|Overall Study||0
1027675|NCT00661141|2496159|P2|NOT COMPLETED|Overall Study||0
1027676|NCT00661141|2496160|P1|NOT COMPLETED|Overall Study||0
1027677|NCT00661141|2496155|P6|COMPLETED|Overall Study||4
1027678|NCT00661141|2496156|P5|COMPLETED|Overall Study||4
1027679|NCT00661141|2496157|P4|COMPLETED|Overall Study||4
1027680|NCT00661141|2496158|P3|COMPLETED|Overall Study||4
1027681|NCT00661141|2496159|P2|COMPLETED|Overall Study||8
1027682|NCT00661141|2496160|P1|COMPLETED|Overall Study||8
1027683|NCT00661141|2496155|P6|Administered 30 Minutes After Ethanol|Overall Study||0
1027684|NCT00661141|2496156|P5|Administered 30 Minutes After Ethanol|Overall Study||0
1027685|NCT00661141|2496157|P4|Administered 30 Minutes After Ethanol|Overall Study||2
1027686|NCT00661141|2496158|P3|Administered 30 Minutes After Ethanol|Overall Study||2
1027687|NCT00661141|2496159|P2|Administered 30 Minutes After Ethanol|Overall Study||2
1027688|NCT00661141|2496160|P1|Administered 30 Minutes After Ethanol|Overall Study||2
1027689|NCT00661141|2496155|P6|Administered 30 Minutes Prior to Ethanol|Overall Study||4
1027690|NCT00661141|2496156|P5|Administered 30 Minutes Prior to Ethanol|Overall Study||4
1027691|NCT00661141|2496157|P4|Administered 30 Minutes Prior to Ethanol|Overall Study||2
1027692|NCT00661141|2496158|P3|Administered 30 Minutes Prior to Ethanol|Overall Study||2
1027693|NCT00661141|2496159|P2|Administered 30 Minutes Prior to Ethanol|Overall Study||6
1027694|NCT00661141|2496160|P1|Administered 30 Minutes Prior to Ethanol|Overall Study||6
1027695|NCT00661141|2496155|P6|STARTED|Overall Study||4
1027696|NCT00661141|2496156|P5|STARTED|Overall Study||4
1027697|NCT00661141|2496157|P4|STARTED|Overall Study||4
1027698|NCT00661141|2496158|P3|STARTED|Overall Study||4
1027699|NCT00661141|2496159|P2|STARTED|Overall Study||8
1027700|NCT00661141|2496160|P1|STARTED|Overall Study||8
1027701|NCT00672984|2496370|P3|NOT COMPLETED|Third Intervention||1
1027702|NCT00672984|2496371|P2|NOT COMPLETED|Third Intervention||0
1027703|NCT00672984|2496372|P1|NOT COMPLETED|Third Intervention||1
1027704|NCT00672984|2496370|P3|COMPLETED|Third Intervention||23
1027705|NCT00672984|2496371|P2|COMPLETED|Third Intervention||17
1027706|NCT00672984|2496372|P1|COMPLETED|Third Intervention||21
1027707|NCT00672984|2496370|P3|STARTED|Third Intervention||24
1027708|NCT00672984|2496371|P2|STARTED|Third Intervention||17
1027709|NCT00672984|2496372|P1|STARTED|Third Intervention||22
1027710|NCT00672984|2496370|P3|NOT COMPLETED|Second Intervention||1
1027711|NCT00672984|2496371|P2|NOT COMPLETED|Second Intervention||6
1027712|NCT00672984|2496372|P1|NOT COMPLETED|Second Intervention||0
1027713|NCT00672984|2496370|P3|COMPLETED|Second Intervention||24
1027714|NCT00672984|2496371|P2|COMPLETED|Second Intervention||17
1027715|NCT00672984|2496372|P1|COMPLETED|Second Intervention||22
1027716|NCT00672984|2496370|P3|STARTED|Second Intervention||25
1027717|NCT00672984|2496371|P2|STARTED|Second Intervention||23
1027718|NCT00672984|2496372|P1|STARTED|Second Intervention||22
1027719|NCT00672984|2496370|P3|NOT COMPLETED|First Intervention||2
1027720|NCT00672984|2496371|P2|NOT COMPLETED|First Intervention||2
1027721|NCT00672984|2496372|P1|NOT COMPLETED|First Intervention||9
1027722|NCT00672984|2496370|P3|COMPLETED|First Intervention||25
1027723|NCT00672984|2496371|P2|COMPLETED|First Intervention||23
1027724|NCT00672984|2496372|P1|COMPLETED|First Intervention||22
1027725|NCT00672984|2496370|P3|STARTED|First Intervention||27
1027726|NCT00672984|2496371|P2|STARTED|First Intervention||25
1027727|NCT00672984|2496372|P1|STARTED|First Intervention||31
1027728|NCT00673049|2496423|P4|NOT COMPLETED|After Progression on Erlotinib||83
1027729|NCT00673049|2496424|P3|NOT COMPLETED|After Progression on Erlotinib||0
1027730|NCT00673049|2496425|P2|NOT COMPLETED|After Progression on Erlotinib||0
1027731|NCT00673049|2496426|P1|NOT COMPLETED|After Progression on Erlotinib||0
1027732|NCT00673049|2496423|P4|COMPLETED|After Progression on Erlotinib||0
1027733|NCT00673049|2496424|P3|COMPLETED|After Progression on Erlotinib||0
1027734|NCT00673049|2496425|P2|COMPLETED|After Progression on Erlotinib||0
1027735|NCT00673049|2496426|P1|COMPLETED|After Progression on Erlotinib||0
1027736|NCT00673049|2496423|P4|STARTED|After Progression on Erlotinib||83
1027737|NCT00673049|2496424|P3|STARTED|After Progression on Erlotinib||0
1027738|NCT00673049|2496425|P2|STARTED|After Progression on Erlotinib||0
1027739|NCT00673049|2496426|P1|STARTED|After Progression on Erlotinib||0
1027740|NCT00673049|2496423|P4|NOT COMPLETED|Before Progression on Erlotinib||0
1027741|NCT00673049|2496424|P3|NOT COMPLETED|Before Progression on Erlotinib||1
1027742|NCT00673049|2496425|P2|NOT COMPLETED|Before Progression on Erlotinib||290
1027743|NCT00673049|2496426|P1|NOT COMPLETED|Before Progression on Erlotinib||292
1027744|NCT00673049|2496423|P4|COMPLETED|Before Progression on Erlotinib||0
1027745|NCT00673049|2496424|P3|COMPLETED|Before Progression on Erlotinib||0
1027746|NCT00673049|2496425|P2|COMPLETED|Before Progression on Erlotinib||0
1027747|NCT00673049|2496426|P1|COMPLETED|Before Progression on Erlotinib||0
1027748|NCT00673049|2496423|P4|Treated|Before Progression on Erlotinib||0
1027749|NCT00673049|2496424|P3|Treated|Before Progression on Erlotinib||1
1027750|NCT00673049|2496425|P2|Treated|Before Progression on Erlotinib||289
1027751|NCT00673049|2496426|P1|Treated|Before Progression on Erlotinib||289
1027752|NCT00673049|2496423|P4|STARTED|Before Progression on Erlotinib|Participants treated with erlo alone who subsequently received figi upon disease progression.|0
1027753|NCT00673049|2496424|P3|STARTED|Before Progression on Erlotinib||1
1027754|NCT00673049|2496425|P2|STARTED|Before Progression on Erlotinib||290
1027755|NCT00673049|2496426|P1|STARTED|Before Progression on Erlotinib||292
1027756|NCT00673075|2496449|P2|NOT COMPLETED|Overall Study||7
1027757|NCT00673075|2496450|P1|NOT COMPLETED|Overall Study||9
1027758|NCT00673075|2496449|P2|COMPLETED|Overall Study||11
1027759|NCT00673075|2496450|P1|COMPLETED|Overall Study||12
1027760|NCT00673075|2496449|P2|STARTED|Overall Study||18
1027761|NCT00673075|2496450|P1|STARTED|Overall Study||21
1027762|NCT00673114|2496464|P1|NOT COMPLETED|Overall Study||0
1027763|NCT00673114|2496464|P1|COMPLETED|Overall Study||3
1027764|NCT00673114|2496464|P1|STARTED|Overall Study||3
1027765|NCT00673127|2496475|P1|NOT COMPLETED|Overall Study||0
1027766|NCT00673127|2496475|P1|COMPLETED|Overall Study||57
1027767|NCT00673127|2496475|P1|STARTED|Overall Study||57
1027768|NCT00673153|2496480|P1|NOT COMPLETED|Overall Study||1
1027769|NCT00673153|2496480|P1|COMPLETED|Overall Study||30
1027770|NCT00673153|2496480|P1|STARTED|Overall Study||31
1027771|NCT00673179|2496490|P2|NOT COMPLETED|Overall Study||0
1027772|NCT00673179|2496491|P1|NOT COMPLETED|Overall Study||3
1027773|NCT00673179|2496490|P2|COMPLETED|Overall Study||0
1027774|NCT00673179|2496491|P1|COMPLETED|Overall Study||4
1027775|NCT00673179|2496490|P2|STARTED|Overall Study||0
1027776|NCT00673179|2496491|P1|STARTED|Overall Study||7
1027777|NCT00673231|2496501|P4|NOT COMPLETED|Overall Study||18
1027778|NCT00673231|2496502|P3|NOT COMPLETED|Overall Study||26
1027779|NCT00673231|2496503|P2|NOT COMPLETED|Overall Study||22
1027780|NCT00673231|2496504|P1|NOT COMPLETED|Overall Study||29
1027781|NCT00673231|2496501|P4|COMPLETED|Overall Study||178
1027782|NCT00673231|2496502|P3|COMPLETED|Overall Study||186
1027783|NCT00673231|2496503|P2|COMPLETED|Overall Study||180
1027784|NCT00673231|2496504|P1|COMPLETED|Overall Study||168
1027785|NCT00673231|2496501|P4|STARTED|Overall Study|Of the 196 randomized participants only 194 were included in the full analysis set|196
1027786|NCT00673231|2496502|P3|STARTED|Overall Study|Of the 212 randomized participants only 211 were included in the full analysis set|212
1027787|NCT00673231|2496503|P2|STARTED|Overall Study|All 202 were included in the full analysis set|202
1027788|NCT00673231|2496504|P1|STARTED|Overall Study|Of the 197 randomized participants only 193 were included in the full analysis set|197
1027789|NCT00673257|2496534|P1|NOT COMPLETED|Overall Study||5
1027790|NCT00673257|2496534|P1|COMPLETED|Overall Study||102
1027791|NCT00673257|2496534|P1|STARTED|Overall Study||107
1027792|NCT00673712|2496541|P2|NOT COMPLETED|Overall Study||0
1027793|NCT00673712|2496542|P1|NOT COMPLETED|Overall Study||0
1027794|NCT00673712|2496541|P2|COMPLETED|Overall Study||326
1027795|NCT00673712|2496542|P1|COMPLETED|Overall Study||321
1027796|NCT00673712|2496541|P2|STARTED|Overall Study||326
1027797|NCT00673712|2496542|P1|STARTED|Overall Study||321
1027798|NCT00673738|2496552|P1|NOT COMPLETED|Overall Study||0
1027799|NCT00673738|2496552|P1|COMPLETED|Overall Study||27
1027800|NCT00673738|2496552|P1|STARTED|Overall Study||27
1027801|NCT00673764|2496558|P2|NOT COMPLETED|Overall Study||0
1027802|NCT00673764|2496559|P1|NOT COMPLETED|Overall Study||0
1027803|NCT00673764|2496558|P2|COMPLETED|Overall Study||24
1027804|NCT00673764|2496559|P1|COMPLETED|Overall Study||24
1027805|NCT00673764|2496558|P2|STARTED|Overall Study||24
1027806|NCT00673764|2496559|P1|STARTED|Overall Study||24
1027807|NCT00673816|2496567|P1|NOT COMPLETED|Overall Study||2
1027808|NCT00673816|2496567|P1|COMPLETED|Overall Study||0
1027809|NCT00673816|2496567|P1|STARTED|Overall Study||2
1027810|NCT00673855|2496574|P2|NOT COMPLETED|Second Intervention||0
1027811|NCT00673855|2496575|P1|NOT COMPLETED|Second Intervention||0
1027812|NCT00673855|2496574|P2|COMPLETED|Second Intervention||10
1027813|NCT00673855|2496575|P1|COMPLETED|Second Intervention||10
1027814|NCT00673855|2496574|P2|STARTED|Second Intervention||10
1027815|NCT00673855|2496575|P1|STARTED|Second Intervention||10
1027816|NCT00673855|2496574|P2|NOT COMPLETED|First Intervention||0
1027817|NCT00673855|2496575|P1|NOT COMPLETED|First Intervention||0
1027818|NCT00673855|2496574|P2|COMPLETED|First Intervention||10
1027819|NCT00673855|2496575|P1|COMPLETED|First Intervention||10
1027820|NCT00673855|2496574|P2|STARTED|First Intervention||10
1027821|NCT00673855|2496575|P1|STARTED|First Intervention||10
1027822|NCT00673881|2496581|P1|NOT COMPLETED|Overall Study||1
1027823|NCT00673881|2496581|P1|COMPLETED|Overall Study||24
1027824|NCT00673881|2496581|P1|STARTED|Overall Study||25
1027825|NCT00673933|2496588|P1|NOT COMPLETED|Overall Study||3
1027826|NCT00673933|2496588|P1|COMPLETED|Overall Study||17
1027827|NCT00673933|2496588|P1|STARTED|Overall Study||20
1027828|NCT00673959|2496604|P2|NOT COMPLETED|Overall Study||0
1027829|NCT00673959|2496605|P1|NOT COMPLETED|Overall Study||0
1027830|NCT00673959|2496604|P2|COMPLETED|Overall Study||10
1027831|NCT00673959|2496605|P1|COMPLETED|Overall Study||10
1027832|NCT00673959|2496604|P2|STARTED|Overall Study||10
1027833|NCT00673959|2496605|P1|STARTED|Overall Study||10
1027834|NCT00674115|2496611|P4|NOT COMPLETED|Third Intervention||0
1027835|NCT00674115|2496612|P3|NOT COMPLETED|Third Intervention||0
1027836|NCT00674115|2496613|P2|NOT COMPLETED|Third Intervention||0
1027837|NCT00674115|2496614|P1|NOT COMPLETED|Third Intervention||0
1027838|NCT00674115|2496611|P4|COMPLETED|Third Intervention||0
1027839|NCT00674115|2496612|P3|COMPLETED|Third Intervention||0
1027840|NCT00674115|2496613|P2|COMPLETED|Third Intervention||16
1027841|NCT00674115|2496614|P1|COMPLETED|Third Intervention||14
1027842|NCT00674115|2496611|P4|STARTED|Third Intervention||0
1027843|NCT00674115|2496612|P3|STARTED|Third Intervention||0
1027844|NCT00674115|2496613|P2|STARTED|Third Intervention||16
1027845|NCT00674115|2496614|P1|STARTED|Third Intervention||14
1027846|NCT00674115|2496611|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
1027847|NCT00674115|2496612|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
1027848|NCT00674115|2496613|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
1027849|NCT00674115|2496614|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
1027850|NCT00674115|2496611|P4|COMPLETED|Washout Period of 2 Weeks||0
1027851|NCT00674115|2496612|P3|COMPLETED|Washout Period of 2 Weeks||0
1027852|NCT00674115|2496613|P2|COMPLETED|Washout Period of 2 Weeks||16
1027853|NCT00674115|2496614|P1|COMPLETED|Washout Period of 2 Weeks||14
1027854|NCT00674115|2496611|P4|STARTED|Washout Period of 2 Weeks||0
1027855|NCT00674115|2496612|P3|STARTED|Washout Period of 2 Weeks||0
1027856|NCT00674115|2496613|P2|STARTED|Washout Period of 2 Weeks||16
1027857|NCT00674115|2496614|P1|STARTED|Washout Period of 2 Weeks||14
1027858|NCT00674115|2496611|P4|NOT COMPLETED|Second Intervention||0
1027859|NCT00674115|2496612|P3|NOT COMPLETED|Second Intervention||0
1027860|NCT00674115|2496613|P2|NOT COMPLETED|Second Intervention||0
1027861|NCT00674115|2496614|P1|NOT COMPLETED|Second Intervention||0
1027862|NCT00674115|2496611|P4|COMPLETED|Second Intervention||16
1027863|NCT00674115|2496612|P3|COMPLETED|Second Intervention||14
1027864|NCT00674115|2496613|P2|COMPLETED|Second Intervention||16
1027865|NCT00674115|2496614|P1|COMPLETED|Second Intervention||14
1027866|NCT00674115|2496611|P4|STARTED|Second Intervention||16
1027867|NCT00674115|2496612|P3|STARTED|Second Intervention||14
1027868|NCT00674115|2496613|P2|STARTED|Second Intervention||16
1027869|NCT00674115|2496614|P1|STARTED|Second Intervention||14
1027870|NCT00674115|2496611|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
1027871|NCT00674115|2496612|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
1027872|NCT00674115|2496613|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
1027873|NCT00674115|2496614|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
1027874|NCT00674115|2496611|P4|COMPLETED|Washout Period of 2 Weeks||16
1027875|NCT00674115|2496612|P3|COMPLETED|Washout Period of 2 Weeks||14
1027876|NCT00674115|2496613|P2|COMPLETED|Washout Period of 2 Weeks||16
1027877|NCT00674115|2496614|P1|COMPLETED|Washout Period of 2 Weeks||14
1027878|NCT00674115|2496611|P4|STARTED|Washout Period of 2 Weeks||16
1027879|NCT00674115|2496612|P3|STARTED|Washout Period of 2 Weeks||14
1027880|NCT00674115|2496613|P2|STARTED|Washout Period of 2 Weeks||16
1027881|NCT00674115|2496614|P1|STARTED|Washout Period of 2 Weeks||14
1027882|NCT00674115|2496611|P4|NOT COMPLETED|First Intervention||0
1027883|NCT00674115|2496612|P3|NOT COMPLETED|First Intervention||0
1027884|NCT00674115|2496613|P2|NOT COMPLETED|First Intervention||0
1027885|NCT00674115|2496614|P1|NOT COMPLETED|First Intervention||0
1027886|NCT00674115|2496611|P4|COMPLETED|First Intervention||16
1027887|NCT00674115|2496612|P3|COMPLETED|First Intervention||14
1027888|NCT00674115|2496613|P2|COMPLETED|First Intervention||16
1027889|NCT00674115|2496614|P1|COMPLETED|First Intervention||14
1027890|NCT00674115|2496611|P4|STARTED|First Intervention||16
1027891|NCT00674115|2496612|P3|STARTED|First Intervention||14
1027892|NCT00674115|2496613|P2|STARTED|First Intervention||16
1027893|NCT00674115|2496614|P1|STARTED|First Intervention||14
1027894|NCT00674128|2496625|P2|NOT COMPLETED|Overall Study||23
1027895|NCT00674128|2496626|P1|NOT COMPLETED|Overall Study||25
1027896|NCT00674128|2496625|P2|COMPLETED|Overall Study||21
1027897|NCT00674128|2496626|P1|COMPLETED|Overall Study||25
1027898|NCT00674128|2496625|P2|STARTED|Overall Study||44
1027899|NCT00674128|2496626|P1|STARTED|Overall Study||50
1027900|NCT00674154|2496634|P2|NOT COMPLETED|Overall Study||3
1027901|NCT00674154|2496635|P1|NOT COMPLETED|Overall Study||3
1027902|NCT00674154|2496634|P2|COMPLETED|Overall Study||20
1027903|NCT00674154|2496635|P1|COMPLETED|Overall Study||20
1027904|NCT00674154|2496634|P2|STARTED|Overall Study||23
1027905|NCT00674154|2496635|P1|STARTED|Overall Study||23
1027906|NCT00674206|2496641|P1|NOT COMPLETED|Overall Study||0
1027907|NCT00674206|2496641|P1|COMPLETED|Overall Study||6
1027908|NCT00674206|2496641|P1|STARTED|Overall Study||6
1027909|NCT00674323|2496649|P3|NOT COMPLETED|Overall Study||0
1027910|NCT00674323|2496650|P2|NOT COMPLETED|Overall Study||1
1027911|NCT00674323|2496651|P1|NOT COMPLETED|Overall Study||1
1027912|NCT00674323|2496649|P3|COMPLETED|Overall Study||21
1027913|NCT00674323|2496650|P2|COMPLETED|Overall Study||20
1027914|NCT00674323|2496651|P1|COMPLETED|Overall Study||18
1027915|NCT00674323|2496649|P3|STARTED|Overall Study||21
1027916|NCT00674323|2496650|P2|STARTED|Overall Study||21
1027917|NCT00674323|2496651|P1|STARTED|Overall Study||19
1027930|NCT00674466|2496739|P3|NOT COMPLETED|Overall Study||9
1027931|NCT00674466|2496740|P2|NOT COMPLETED|Overall Study||8
1027932|NCT00674466|2496741|P1|NOT COMPLETED|Overall Study||7
1027933|NCT00674466|2496739|P3|COMPLETED|Overall Study||21
1027934|NCT00674466|2496740|P2|COMPLETED|Overall Study||22
1027935|NCT00674466|2496741|P1|COMPLETED|Overall Study||23
1027936|NCT00674466|2496739|P3|STARTED|Overall Study||30
1027937|NCT00674466|2496740|P2|STARTED|Overall Study||30
1027938|NCT00674466|2496741|P1|STARTED|Overall Study||30
1027939|NCT00674492|2496755|P1|NOT COMPLETED|Overall Study||0
1027940|NCT00674492|2496755|P1|COMPLETED|Overall Study||21
1027941|NCT00674492|2496755|P1|STARTED|Overall Study||21
1027942|NCT00674609|2496762|P3|NOT COMPLETED|Overall Study||8
1027943|NCT00674609|2496763|P2|NOT COMPLETED|Overall Study||13
1027944|NCT00674609|2496764|P1|NOT COMPLETED|Overall Study||12
1027945|NCT00674609|2496762|P3|COMPLETED|Overall Study||51
1027946|NCT00674609|2496763|P2|COMPLETED|Overall Study||45
1027947|NCT00674609|2496764|P1|COMPLETED|Overall Study||48
1027948|NCT00674609|2496762|P3|STARTED|Overall Study||59
1027949|NCT00674609|2496763|P2|STARTED|Overall Study||58
1027950|NCT00674609|2496764|P1|STARTED|Overall Study||60
1027951|NCT00674622|2496799|P3|NOT COMPLETED|Overall Study||0
1027952|NCT00674622|2496800|P2|NOT COMPLETED|Overall Study||4
1027953|NCT00674622|2496801|P1|NOT COMPLETED|Overall Study||1
1027954|NCT00674622|2496799|P3|COMPLETED|Overall Study||22
1027955|NCT00674622|2496800|P2|COMPLETED|Overall Study||18
1027956|NCT00674622|2496801|P1|COMPLETED|Overall Study||21
1027957|NCT00674622|2496799|P3|STARTED|Overall Study||22
1027958|NCT00674622|2496800|P2|STARTED|Overall Study||22
1027959|NCT00674622|2496801|P1|STARTED|Overall Study||22
1027960|NCT00674661|2496823|P2|NOT COMPLETED|Overall Study||15
1027961|NCT00674661|2496824|P1|NOT COMPLETED|Overall Study||11
1027962|NCT00674661|2496823|P2|COMPLETED|Overall Study||48
1027963|NCT00674661|2496824|P1|COMPLETED|Overall Study||56
1027964|NCT00674661|2496823|P2|STARTED|Overall Study||63
1027965|NCT00674661|2496824|P1|STARTED|Overall Study||67
1027966|NCT00674700|2496833|P3|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
1027967|NCT00674700|2496834|P2|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
1027968|NCT00674700|2496835|P1|NOT COMPLETED|Year 2 Follow-up Without Treatment||6
1027969|NCT00674700|2496833|P3|COMPLETED|Year 2 Follow-up Without Treatment||141
1027970|NCT00674700|2496834|P2|COMPLETED|Year 2 Follow-up Without Treatment||123
1027971|NCT00674700|2496835|P1|COMPLETED|Year 2 Follow-up Without Treatment||133
1027972|NCT00674700|2496833|P3|STARTED|Year 2 Follow-up Without Treatment||153
1027973|NCT00674700|2496834|P2|STARTED|Year 2 Follow-up Without Treatment||135
1027974|NCT00674700|2496835|P1|STARTED|Year 2 Follow-up Without Treatment||139
1027975|NCT00674700|2496833|P3|NOT COMPLETED|Year 1||17
1027976|NCT00674700|2496834|P2|NOT COMPLETED|Year 1||34
1027977|NCT00674700|2496835|P1|NOT COMPLETED|Year 1||31
1027978|NCT00674700|2496833|P3|COMPLETED|Year 1||153
1027979|NCT00674700|2496834|P2|COMPLETED|Year 1||135
1027980|NCT00674700|2496835|P1|COMPLETED|Year 1||139
1027981|NCT00674700|2496833|P3|STARTED|Year 1||170
1027982|NCT00674700|2496834|P2|STARTED|Year 1||169
1027983|NCT00674700|2496835|P1|STARTED|Year 1||170
1027984|NCT00674739|2496849|P3|NOT COMPLETED|Overall Study||32
1027985|NCT00674739|2496850|P2|NOT COMPLETED|Overall Study||59
1027986|NCT00674739|2496851|P1|NOT COMPLETED|Overall Study||57
1027987|NCT00674739|2496849|P3|COMPLETED|Overall Study||65
1027988|NCT00674739|2496850|P2|COMPLETED|Overall Study||136
1027989|NCT00674739|2496851|P1|COMPLETED|Overall Study||121
1027990|NCT00674739|2496849|P3|STARTED|Overall Study||97
1027991|NCT00674739|2496850|P2|STARTED|Overall Study||195
1027992|NCT00674739|2496851|P1|STARTED|Overall Study||178
1027993|NCT00674765|2496867|P2|NOT COMPLETED|Overall Study||29
1027994|NCT00674765|2496868|P1|NOT COMPLETED|Overall Study||36
1027995|NCT00674765|2496867|P2|COMPLETED|Overall Study||46
1027996|NCT00674765|2496868|P1|COMPLETED|Overall Study||45
1027997|NCT00674765|2496867|P2|STARTED|Overall Study||75
1027998|NCT00674765|2496868|P1|STARTED|Overall Study||81
1027999|NCT00674817|2496874|P1|NOT COMPLETED|Period 6||0
1028000|NCT00674817|2496874|P1|COMPLETED|Period 6||38
1028001|NCT00674817|2496874|P1|STARTED|Period 6||38
1028002|NCT00674817|2496874|P1|NOT COMPLETED|Period 5||0
1028003|NCT00674817|2496874|P1|COMPLETED|Period 5||38
1028004|NCT00674817|2496874|P1|STARTED|Period 5||38
1028005|NCT00674817|2496874|P1|NOT COMPLETED|Period 4||1
1028006|NCT00674817|2496874|P1|COMPLETED|Period 4||38
1028007|NCT00674817|2496874|P1|STARTED|Period 4||39
1028008|NCT00674817|2496874|P1|NOT COMPLETED|Period 3||2
1028009|NCT00674817|2496874|P1|COMPLETED|Period 3||39
1028010|NCT00674817|2496874|P1|STARTED|Period 3||41
1028011|NCT00674817|2496874|P1|NOT COMPLETED|Period 2||0
1028012|NCT00674817|2496874|P1|COMPLETED|Period 2||41
1028013|NCT00674817|2496874|P1|STARTED|Period 2||41
1028014|NCT00674817|2496874|P1|NOT COMPLETED|Period 1||3
1028015|NCT00674817|2496874|P1|COMPLETED|Period 1||41
1028016|NCT00674817|2496874|P1|STARTED|Period 1||44
1028017|NCT00674973|2497022|P2|NOT COMPLETED|Overall Study||102
1028018|NCT00674973|2497023|P1|NOT COMPLETED|Overall Study||100
1028019|NCT00674973|2497022|P2|COMPLETED|Overall Study|Completed double-blind treatment.|2
1028020|NCT00674973|2497023|P1|COMPLETED|Overall Study|Completed double-blind treatment.|3
1028021|NCT00674973|2497022|P2|Switch to Open-Label Erlotinib|Overall Study||0
1028022|NCT00674973|2497023|P1|Switch to Open-Label Erlotinib|Overall Study|Participants with PD were given opportunity to switch.|57
1028023|NCT00674973|2497022|P2|STARTED|Overall Study||104
1028024|NCT00674973|2497023|P1|STARTED|Overall Study||103
1028025|NCT00674986|2497039|P2|NOT COMPLETED|Overall Study||81
1028026|NCT00674986|2497040|P1|NOT COMPLETED|Overall Study||43
1028027|NCT00674986|2497039|P2|COMPLETED|Overall Study||188
1028028|NCT00674986|2497040|P1|COMPLETED|Overall Study||187
1028029|NCT00674986|2497039|P2|Intent to Treat Population|Overall Study||256
1028030|NCT00674986|2497040|P1|Intent to Treat Population|Overall Study||227
1028031|NCT00674986|2497039|P2|STARTED|Overall Study||269
1028032|NCT00674986|2497040|P1|STARTED|Overall Study||230
1028033|NCT00675103|2497059|P1|NOT COMPLETED|Overall Study||3
1028034|NCT00675103|2497059|P1|COMPLETED|Overall Study||4
1028035|NCT00675103|2497059|P1|STARTED|Overall Study||7
1028036|NCT00675259|2497064|P1|NOT COMPLETED|Overall Study||14
1028037|NCT00675259|2497064|P1|COMPLETED|Overall Study||19
1028038|NCT00675259|2497064|P1|STARTED|Overall Study||33
1028039|NCT00675415|2497075|P2|NOT COMPLETED|Overall Study||8
1028040|NCT00675415|2497076|P1|NOT COMPLETED|Overall Study||8
1028041|NCT00675415|2497075|P2|COMPLETED|Overall Study||123
1028042|NCT00675415|2497076|P1|COMPLETED|Overall Study||124
1028043|NCT00675415|2497075|P2|STARTED|Overall Study||131
1028044|NCT00675415|2497076|P1|STARTED|Overall Study||132
1028045|NCT00675428|2497084|P2|NOT COMPLETED|Overall Study||3
1028046|NCT00675428|2497085|P1|NOT COMPLETED|Overall Study||3
1028047|NCT00675428|2497084|P2|COMPLETED|Overall Study||0
1028048|NCT00675428|2497085|P1|COMPLETED|Overall Study||0
1028049|NCT00675428|2497084|P2|STARTED|Overall Study||3
1028050|NCT00675428|2497085|P1|STARTED|Overall Study||3
1028051|NCT00675441|2497103|P1|NOT COMPLETED|Overall Study||3
1028052|NCT00675441|2497103|P1|COMPLETED|Overall Study||2
1028053|NCT00675441|2497103|P1|STARTED|Overall Study||5
1028054|NCT00675506|2497109|P2|NOT COMPLETED|Overall Study||12
1028055|NCT00675506|2497110|P1|NOT COMPLETED|Overall Study||12
1028056|NCT00675506|2497109|P2|COMPLETED|Overall Study||17
1028057|NCT00675506|2497110|P1|COMPLETED|Overall Study||19
1028058|NCT00675506|2497109|P2|Received Intervention|Overall Study||29
1028059|NCT00675506|2497110|P1|Received Intervention|Overall Study|Two subjects did not start treatment: 1) disclosed cancer history, 2) declined participation.|29
1028060|NCT00675506|2497109|P2|STARTED|Overall Study||29
1028061|NCT00675506|2497110|P1|STARTED|Overall Study||31
1028062|NCT00675558|2497125|P3|NOT COMPLETED|Second Operation||0
1028063|NCT00675558|2497126|P2|NOT COMPLETED|Second Operation||0
1028064|NCT00675558|2497127|P1|NOT COMPLETED|Second Operation||0
1028065|NCT00675558|2497125|P3|COMPLETED|Second Operation||10
1028066|NCT00675558|2497126|P2|COMPLETED|Second Operation||0
1028067|NCT00675558|2497127|P1|COMPLETED|Second Operation||0
1028068|NCT00675558|2497125|P3|STARTED|Second Operation|As predicted, only 10 SMO patients medically required a second operation, and thus met study goals.|10
1028069|NCT00675558|2497126|P2|STARTED|Second Operation|No medical reason, and none for the goals of the study, for MO pts to have a second procedure .|0
1028070|NCT00675558|2497127|P1|STARTED|Second Operation|No medical reason, and no study-related reason for non-obese pts to have a second procedure.|0
1028071|NCT00675558|2497125|P3|NOT COMPLETED|Surgery||0
1028072|NCT00675558|2497126|P2|NOT COMPLETED|Surgery||0
1028073|NCT00675558|2497127|P1|NOT COMPLETED|Surgery||0
1028074|NCT00675558|2497125|P3|COMPLETED|Surgery||30
1028075|NCT00675558|2497126|P2|COMPLETED|Surgery||10
1028076|NCT00675558|2497127|P1|COMPLETED|Surgery||10
1028077|NCT00675558|2497125|P3|STARTED|Surgery||30
1028078|NCT00675558|2497126|P2|STARTED|Surgery||10
1028079|NCT00675558|2497127|P1|STARTED|Surgery||10
1028080|NCT00675584|2497143|P2|NOT COMPLETED|Overall Study||26
1028081|NCT00675584|2497144|P1|NOT COMPLETED|Overall Study||39
1028082|NCT00675584|2497143|P2|COMPLETED|Overall Study||113
1028083|NCT00675584|2497144|P1|COMPLETED|Overall Study||100
1028084|NCT00675584|2497143|P2|STARTED|Overall Study||139
1028085|NCT00675584|2497144|P1|STARTED|Overall Study||139
1028086|NCT00675597|2497150|P1|NOT COMPLETED|Overall Study||3
1028087|NCT00675597|2497150|P1|COMPLETED|Overall Study||23
1028088|NCT00675597|2497150|P1|STARTED|Overall Study||26
1028089|NCT00675766|2497158|P4|NOT COMPLETED|Overall Study||26
1028090|NCT00675766|2497159|P3|NOT COMPLETED|Overall Study||21
1028091|NCT00675766|2497160|P2|NOT COMPLETED|Overall Study||5
1028092|NCT00675766|2497161|P1|NOT COMPLETED|Overall Study||6
1028093|NCT00675766|2497158|P4|COMPLETED|Overall Study||11
1028094|NCT00675766|2497159|P3|COMPLETED|Overall Study||29
1028095|NCT00675766|2497160|P2|COMPLETED|Overall Study||25
1028096|NCT00675766|2497161|P1|COMPLETED|Overall Study||100
1028097|NCT00675766|2497158|P4|Year 3|Overall Study||11
1028098|NCT00675766|2497159|P3|Year 3|Overall Study||29
1028099|NCT00675766|2497160|P2|Year 3|Overall Study||25
1028100|NCT00675766|2497161|P1|Year 3|Overall Study||100
1028101|NCT00675766|2497158|P4|Year 2|Overall Study||20
1028102|NCT00675766|2497159|P3|Year 2|Overall Study||34
1028103|NCT00675766|2497160|P2|Year 2|Overall Study||28
1028104|NCT00675766|2497161|P1|Year 2|Overall Study||105
1028105|NCT00675766|2497158|P4|STARTED|Overall Study||37
1028106|NCT00675766|2497159|P3|STARTED|Overall Study||50
1028107|NCT00675766|2497160|P2|STARTED|Overall Study||30
1028108|NCT00675766|2497161|P1|STARTED|Overall Study||106
1028109|NCT00675792|2497173|P2|NOT COMPLETED|Overall Study||0
1028110|NCT00675792|2497174|P1|NOT COMPLETED|Overall Study||0
1028111|NCT00675792|2497173|P2|COMPLETED|Overall Study||49
1028112|NCT00675792|2497174|P1|COMPLETED|Overall Study||51
1028113|NCT00675792|2497173|P2|STARTED|Overall Study||49
1028114|NCT00675792|2497174|P1|STARTED|Overall Study||51
1028115|NCT00675909|2497193|P3|NOT COMPLETED|Overall Study||0
1028116|NCT00675909|2497194|P2|NOT COMPLETED|Overall Study||0
1028117|NCT00675909|2497195|P1|NOT COMPLETED|Overall Study||0
1028118|NCT00675909|2497193|P3|COMPLETED|Overall Study||60
1028119|NCT00675909|2497194|P2|COMPLETED|Overall Study||60
1028120|NCT00675909|2497195|P1|COMPLETED|Overall Study||60
1028121|NCT00675909|2497193|P3|STARTED|Overall Study||60
1028122|NCT00675909|2497194|P2|STARTED|Overall Study||60
1028123|NCT00675909|2497195|P1|STARTED|Overall Study||60
1028124|NCT00675922|2497203|P1|NOT COMPLETED|Overall Study||0
1028125|NCT00675922|2497203|P1|COMPLETED|Overall Study||98
1028126|NCT00675922|2497203|P1|STARTED|Overall Study||98
1028127|NCT00675948|2497210|P2|NOT COMPLETED|Overall Study||3
1028128|NCT00675948|2497211|P1|NOT COMPLETED|Overall Study||39
1028129|NCT00675948|2497210|P2|COMPLETED|Overall Study||1
1028130|NCT00675948|2497211|P1|COMPLETED|Overall Study||0
1028131|NCT00675948|2497210|P2|STARTED|Overall Study||4
1028132|NCT00675948|2497211|P1|STARTED|Overall Study||39
1028133|NCT00675987|2497223|P2|NOT COMPLETED|Overall Study||0
1028134|NCT00675987|2497224|P1|NOT COMPLETED|Overall Study||0
1028135|NCT00675987|2497223|P2|COMPLETED|Overall Study||27
1028136|NCT00675987|2497224|P1|COMPLETED|Overall Study||26
1028137|NCT00675987|2497223|P2|STARTED|Overall Study||27
1028138|NCT00675987|2497224|P1|STARTED|Overall Study||26
1028139|NCT00676026|2497232|P1|NOT COMPLETED|Overall Study||0
1028140|NCT00676026|2497232|P1|COMPLETED|Overall Study||8
1028141|NCT00676026|2497232|P1|STARTED|Overall Study||8
1028160|NCT00676065|2497282|P3|NOT COMPLETED|Overall Study||0
1028161|NCT00676065|2497283|P2|NOT COMPLETED|Overall Study||0
1028162|NCT00676065|2497284|P1|NOT COMPLETED|Overall Study||0
1028163|NCT00676065|2497282|P3|COMPLETED|Overall Study||26341
1028164|NCT00676065|2497283|P2|COMPLETED|Overall Study||15428
1028165|NCT00676065|2497284|P1|COMPLETED|Overall Study||16534
1028166|NCT00676065|2497282|P3|STARTED|Overall Study||26341
1028167|NCT00676065|2497283|P2|STARTED|Overall Study||15428
1028168|NCT00676065|2497284|P1|STARTED|Overall Study||16534
1028169|NCT00676091|2497300|P2|NOT COMPLETED|Toddler Dose||0
1028170|NCT00676091|2497301|P1|NOT COMPLETED|Toddler Dose||3
1028171|NCT00676091|2497300|P2|COMPLETED|Toddler Dose||156
1028172|NCT00676091|2497301|P1|COMPLETED|Toddler Dose||153
1028173|NCT00676091|2497300|P2|STARTED|Toddler Dose||156
1028174|NCT00676091|2497301|P1|STARTED|Toddler Dose||156
1028175|NCT00676091|2497300|P2|NOT COMPLETED|After Infant Series||3
1028176|NCT00676091|2497301|P1|NOT COMPLETED|After Infant Series||1
1028177|NCT00676091|2497300|P2|COMPLETED|After Infant Series||156
1028178|NCT00676091|2497301|P1|COMPLETED|After Infant Series||156
1028179|NCT00676091|2497300|P2|STARTED|After Infant Series||159
1028180|NCT00676091|2497301|P1|STARTED|After Infant Series||157
1028181|NCT00676091|2497300|P2|NOT COMPLETED|Infant Series||18
1028182|NCT00676091|2497301|P1|NOT COMPLETED|Infant Series||20
1028183|NCT00676091|2497300|P2|COMPLETED|Infant Series||159
1028184|NCT00676091|2497301|P1|COMPLETED|Infant Series||157
1028185|NCT00676091|2497300|P2|Vaccinated Dose 3|Infant Series||161
1028186|NCT00676091|2497301|P1|Vaccinated Dose 3|Infant Series||158
1028187|NCT00676091|2497300|P2|Vaccinated Dose 2|Infant Series||162
1028188|NCT00676091|2497301|P1|Vaccinated Dose 2|Infant Series||159
1028189|NCT00676091|2497300|P2|Vaccinated Dose 1|Infant Series||162
1028190|NCT00676091|2497301|P1|Vaccinated Dose 1|Infant Series||163
1028191|NCT00676091|2497300|P2|STARTED|Infant Series||177
1028192|NCT00676091|2497301|P1|STARTED|Infant Series||177
1028193|NCT00676130|2497335|P2|NOT COMPLETED|Overall Study||4
1028194|NCT00676130|2497336|P1|NOT COMPLETED|Overall Study||3
1028195|NCT00676130|2497335|P2|COMPLETED|Overall Study||73
1028196|NCT00676130|2497336|P1|COMPLETED|Overall Study||73
1028197|NCT00676130|2497335|P2|STARTED|Overall Study||77
1028198|NCT00676130|2497336|P1|STARTED|Overall Study||76
1028199|NCT00676143|2497346|P2|NOT COMPLETED|Overall Study||260
1028200|NCT00676143|2497347|P1|NOT COMPLETED|Overall Study||156
1028201|NCT00676143|2497346|P2|COMPLETED|Overall Study||398
1028202|NCT00676143|2497347|P1|COMPLETED|Overall Study||285
1028203|NCT00676143|2497346|P2|Treated|Overall Study||654
1028204|NCT00676143|2497347|P1|Treated|Overall Study||439
1028205|NCT00676143|2497346|P2|STARTED|Overall Study||658
1028206|NCT00676143|2497347|P1|STARTED|Overall Study||441
1028207|NCT00664066|2497385|P1|NOT COMPLETED|Overall Study||3
1028208|NCT00664066|2497385|P1|COMPLETED|Overall Study||0
1028209|NCT00664066|2497385|P1|STARTED|Overall Study||3
1028210|NCT00664105|2497389|P1|NOT COMPLETED|Overall Study||24
1028211|NCT00664105|2497389|P1|COMPLETED|Overall Study||39
1028212|NCT00664105|2497389|P1|STARTED|Overall Study||63
1028213|NCT00669617|2497396|P5|NOT COMPLETED|Period 5||0
1028214|NCT00669617|2497397|P4|NOT COMPLETED|Period 5||0
1028215|NCT00669617|2497398|P3|NOT COMPLETED|Period 5||0
1028216|NCT00669617|2497399|P2|NOT COMPLETED|Period 5||0
1028217|NCT00669617|2497400|P1|NOT COMPLETED|Period 5||0
1028218|NCT00669617|2497396|P5|COMPLETED|Period 5||17
1028219|NCT00669617|2497397|P4|COMPLETED|Period 5||18
1028220|NCT00669617|2497398|P3|COMPLETED|Period 5||17
1028221|NCT00669617|2497399|P2|COMPLETED|Period 5||17
1028222|NCT00669617|2497400|P1|COMPLETED|Period 5||17
1028223|NCT00669617|2497396|P5|STARTED|Period 5||17
1028224|NCT00669617|2497397|P4|STARTED|Period 5||18
1028225|NCT00669617|2497398|P3|STARTED|Period 5||17
1028226|NCT00669617|2497399|P2|STARTED|Period 5||17
1028227|NCT00669617|2497400|P1|STARTED|Period 5||17
1028228|NCT00669617|2497396|P5|NOT COMPLETED|Period 4||0
1028229|NCT00669617|2497397|P4|NOT COMPLETED|Period 4||0
1028230|NCT00669617|2497398|P3|NOT COMPLETED|Period 4||0
1028231|NCT00669617|2497399|P2|NOT COMPLETED|Period 4||0
1028232|NCT00669617|2497400|P1|NOT COMPLETED|Period 4||0
1028233|NCT00669617|2497396|P5|COMPLETED|Period 4||17
1028234|NCT00669617|2497397|P4|COMPLETED|Period 4||18
1028235|NCT00669617|2497398|P3|COMPLETED|Period 4||17
1028236|NCT00669617|2497399|P2|COMPLETED|Period 4||17
1028237|NCT00669617|2497400|P1|COMPLETED|Period 4||17
1028238|NCT00669617|2497396|P5|STARTED|Period 4||17
1028239|NCT00669617|2497397|P4|STARTED|Period 4||18
1028240|NCT00669617|2497398|P3|STARTED|Period 4||17
1028241|NCT00669617|2497399|P2|STARTED|Period 4||17
1028242|NCT00669617|2497400|P1|STARTED|Period 4||17
1028243|NCT00669617|2497396|P5|NOT COMPLETED|Period 3||0
1028244|NCT00669617|2497397|P4|NOT COMPLETED|Period 3||0
1028245|NCT00669617|2497398|P3|NOT COMPLETED|Period 3||0
1028246|NCT00669617|2497399|P2|NOT COMPLETED|Period 3||0
1028247|NCT00669617|2497400|P1|NOT COMPLETED|Period 3||1
1028248|NCT00669617|2497396|P5|COMPLETED|Period 3||17
1028249|NCT00669617|2497397|P4|COMPLETED|Period 3||18
1028250|NCT00669617|2497398|P3|COMPLETED|Period 3||17
1028251|NCT00669617|2497399|P2|COMPLETED|Period 3||17
1028252|NCT00669617|2497400|P1|COMPLETED|Period 3||17
1028253|NCT00669617|2497396|P5|STARTED|Period 3||17
1028254|NCT00669617|2497397|P4|STARTED|Period 3||18
1028255|NCT00669617|2497398|P3|STARTED|Period 3||17
1028256|NCT00669617|2497399|P2|STARTED|Period 3||17
1028257|NCT00669617|2497400|P1|STARTED|Period 3||18
1028258|NCT00669617|2497396|P5|NOT COMPLETED|Period 2||0
1028259|NCT00669617|2497397|P4|NOT COMPLETED|Period 2||0
1028260|NCT00669617|2497398|P3|NOT COMPLETED|Period 2||0
1028261|NCT00669617|2497399|P2|NOT COMPLETED|Period 2||0
1028262|NCT00669617|2497400|P1|NOT COMPLETED|Period 2||0
1028263|NCT00669617|2497396|P5|COMPLETED|Period 2||17
1028264|NCT00669617|2497397|P4|COMPLETED|Period 2||18
1028265|NCT00669617|2497398|P3|COMPLETED|Period 2||17
1028266|NCT00669617|2497399|P2|COMPLETED|Period 2||17
1028267|NCT00669617|2497400|P1|COMPLETED|Period 2||18
1028268|NCT00669617|2497396|P5|STARTED|Period 2||17
1028269|NCT00669617|2497397|P4|STARTED|Period 2||18
1028270|NCT00669617|2497398|P3|STARTED|Period 2||17
1028271|NCT00669617|2497399|P2|STARTED|Period 2||17
1028272|NCT00669617|2497400|P1|STARTED|Period 2||18
1028273|NCT00669617|2497396|P5|NOT COMPLETED|Period 1||1
1028274|NCT00669617|2497397|P4|NOT COMPLETED|Period 1||0
1028275|NCT00669617|2497398|P3|NOT COMPLETED|Period 1||1
1028276|NCT00669617|2497399|P2|NOT COMPLETED|Period 1||0
1028277|NCT00669617|2497400|P1|NOT COMPLETED|Period 1||0
1028278|NCT00669617|2497396|P5|COMPLETED|Period 1||17
1028279|NCT00669617|2497397|P4|COMPLETED|Period 1||18
1028280|NCT00669617|2497398|P3|COMPLETED|Period 1||17
1028281|NCT00669617|2497399|P2|COMPLETED|Period 1||17
1028282|NCT00669617|2497400|P1|COMPLETED|Period 1||18
1028283|NCT00669617|2497396|P5|STARTED|Period 1||18
1028284|NCT00669617|2497397|P4|STARTED|Period 1||18
1028285|NCT00669617|2497398|P3|STARTED|Period 1||18
1028286|NCT00669617|2497399|P2|STARTED|Period 1||17
1028287|NCT00669617|2497400|P1|STARTED|Period 1||18
1028288|NCT00669682|2497412|P1|NOT COMPLETED|Overall Study||0
1028289|NCT00669682|2497412|P1|COMPLETED|Overall Study||9
1028290|NCT00669682|2497412|P1|STARTED|Overall Study||9
1028291|NCT00669864|2497417|P1|NOT COMPLETED|Overall Study||9
1028292|NCT00669864|2497417|P1|COMPLETED|Overall Study||284
1028293|NCT00669864|2497417|P1|STARTED|Overall Study||293
1028294|NCT00669903|2497430|P4|NOT COMPLETED|Overall Study||4
1028295|NCT00669903|2497431|P3|NOT COMPLETED|Overall Study||5
1028296|NCT00669903|2497432|P2|NOT COMPLETED|Overall Study||5
1028297|NCT00669903|2497433|P1|NOT COMPLETED|Overall Study||1
1028298|NCT00669903|2497430|P4|COMPLETED|Overall Study||18
1028299|NCT00669903|2497431|P3|COMPLETED|Overall Study||13
1028300|NCT00669903|2497432|P2|COMPLETED|Overall Study||32
1028301|NCT00669903|2497433|P1|COMPLETED|Overall Study||22
1028302|NCT00669903|2497430|P4|Completed Treatment Period|Overall Study||19
1028303|NCT00669903|2497431|P3|Completed Treatment Period|Overall Study||13
1028304|NCT00669903|2497432|P2|Completed Treatment Period|Overall Study||33
1028305|NCT00669903|2497433|P1|Completed Treatment Period|Overall Study||23
1028306|NCT00669903|2497430|P4|STARTED|Overall Study||22
1028307|NCT00669903|2497431|P3|STARTED|Overall Study||18
1028308|NCT00669903|2497432|P2|STARTED|Overall Study||37
1028309|NCT00669903|2497433|P1|STARTED|Overall Study||23
1028310|NCT00669916|2497465|P2|NOT COMPLETED|Overall Study||0
1028311|NCT00669916|2497466|P1|NOT COMPLETED|Overall Study||0
1028312|NCT00669916|2497465|P2|COMPLETED|Overall Study||18
1028313|NCT00669916|2497466|P1|COMPLETED|Overall Study||18
1028314|NCT00669916|2497465|P2|STARTED|Overall Study||18
1028315|NCT00669916|2497466|P1|STARTED|Overall Study||18
1028316|NCT00669942|2497492|P12|NOT COMPLETED|Healthy Volunteers||0
1028317|NCT00669942|2497493|P11|NOT COMPLETED|Healthy Volunteers||1
1028318|NCT00669942|2497494|P10|NOT COMPLETED|Healthy Volunteers||0
1028319|NCT00669942|2497495|P9|NOT COMPLETED|Healthy Volunteers||0
1028320|NCT00669942|2497496|P8|NOT COMPLETED|Healthy Volunteers||0
1028321|NCT00669942|2497497|P7|NOT COMPLETED|Healthy Volunteers||0
1028322|NCT00669942|2497498|P6|NOT COMPLETED|Healthy Volunteers||0
1028323|NCT00669942|2497499|P5|NOT COMPLETED|Healthy Volunteers||0
1028324|NCT00669942|2497500|P4|NOT COMPLETED|Healthy Volunteers||0
1028325|NCT00669942|2497501|P3|NOT COMPLETED|Healthy Volunteers||0
1028326|NCT00669942|2497502|P2|NOT COMPLETED|Healthy Volunteers||0
1028327|NCT00669942|2497503|P1|NOT COMPLETED|Healthy Volunteers||0
1028328|NCT00669942|2497492|P12|COMPLETED|Healthy Volunteers||2
1028329|NCT00669942|2497493|P11|COMPLETED|Healthy Volunteers||2
1028330|NCT00669942|2497494|P10|COMPLETED|Healthy Volunteers||3
1028331|NCT00669942|2497495|P9|COMPLETED|Healthy Volunteers||0
1028332|NCT00669942|2497496|P8|COMPLETED|Healthy Volunteers||0
1028333|NCT00669942|2497497|P7|COMPLETED|Healthy Volunteers||0
1028334|NCT00669942|2497498|P6|COMPLETED|Healthy Volunteers||0
1028335|NCT00669942|2497499|P5|COMPLETED|Healthy Volunteers||0
1028336|NCT00669942|2497500|P4|COMPLETED|Healthy Volunteers||0
1028337|NCT00669942|2497501|P3|COMPLETED|Healthy Volunteers||0
1028338|NCT00669942|2497502|P2|COMPLETED|Healthy Volunteers||0
1028339|NCT00669942|2497503|P1|COMPLETED|Healthy Volunteers||0
1028340|NCT00669942|2497492|P12|STARTED|Healthy Volunteers||2
1028341|NCT00669942|2497493|P11|STARTED|Healthy Volunteers||3
1028342|NCT00669942|2497494|P10|STARTED|Healthy Volunteers||3
1028343|NCT00669942|2497495|P9|STARTED|Healthy Volunteers||0
1028344|NCT00669942|2497496|P8|STARTED|Healthy Volunteers||0
1028345|NCT00669942|2497497|P7|STARTED|Healthy Volunteers||0
1028346|NCT00669942|2497498|P6|STARTED|Healthy Volunteers||0
1028347|NCT00669942|2497499|P5|STARTED|Healthy Volunteers||0
1028348|NCT00669942|2497500|P4|STARTED|Healthy Volunteers||0
1028349|NCT00669942|2497501|P3|STARTED|Healthy Volunteers||0
1028350|NCT00669942|2497502|P2|STARTED|Healthy Volunteers||0
1028351|NCT00669942|2497503|P1|STARTED|Healthy Volunteers||0
1028352|NCT00669942|2497492|P12|NOT COMPLETED|Parts 2 and 3||0
1028353|NCT00669942|2497493|P11|NOT COMPLETED|Parts 2 and 3||0
1028354|NCT00669942|2497494|P10|NOT COMPLETED|Parts 2 and 3||0
1028355|NCT00669942|2497495|P9|NOT COMPLETED|Parts 2 and 3||3
1028356|NCT00669942|2497496|P8|NOT COMPLETED|Parts 2 and 3||2
1028357|NCT00669942|2497497|P7|NOT COMPLETED|Parts 2 and 3||0
1028358|NCT00669942|2497498|P6|NOT COMPLETED|Parts 2 and 3||2
1028359|NCT00669942|2497499|P5|NOT COMPLETED|Parts 2 and 3||0
1028360|NCT00669942|2497500|P4|NOT COMPLETED|Parts 2 and 3||0
1028361|NCT00669942|2497501|P3|NOT COMPLETED|Parts 2 and 3||0
1028362|NCT00669942|2497502|P2|NOT COMPLETED|Parts 2 and 3||0
1028363|NCT00669942|2497503|P1|NOT COMPLETED|Parts 2 and 3||0
1028364|NCT00669942|2497492|P12|COMPLETED|Parts 2 and 3||0
1028365|NCT00669942|2497493|P11|COMPLETED|Parts 2 and 3||0
1028366|NCT00669942|2497494|P10|COMPLETED|Parts 2 and 3||0
1028367|NCT00669942|2497495|P9|COMPLETED|Parts 2 and 3||23
1028368|NCT00669942|2497496|P8|COMPLETED|Parts 2 and 3||24
1028369|NCT00669942|2497497|P7|COMPLETED|Parts 2 and 3||6
1028370|NCT00669942|2497498|P6|COMPLETED|Parts 2 and 3||4
1028371|NCT00669942|2497499|P5|COMPLETED|Parts 2 and 3||0
1028372|NCT00669942|2497500|P4|COMPLETED|Parts 2 and 3||0
1028373|NCT00669942|2497501|P3|COMPLETED|Parts 2 and 3||0
1028374|NCT00669942|2497502|P2|COMPLETED|Parts 2 and 3||0
1028375|NCT00669942|2497503|P1|COMPLETED|Parts 2 and 3||0
1028376|NCT00669942|2497492|P12|STARTED|Parts 2 and 3||0
1028377|NCT00669942|2497493|P11|STARTED|Parts 2 and 3||0
1028378|NCT00669942|2497494|P10|STARTED|Parts 2 and 3||0
1028379|NCT00669942|2497495|P9|STARTED|Parts 2 and 3||26
1028380|NCT00669942|2497496|P8|STARTED|Parts 2 and 3||26
1028381|NCT00669942|2497497|P7|STARTED|Parts 2 and 3||6
1028382|NCT00669942|2497498|P6|STARTED|Parts 2 and 3||6
1028383|NCT00669942|2497499|P5|STARTED|Parts 2 and 3||0
1028384|NCT00669942|2497500|P4|STARTED|Parts 2 and 3||0
1028385|NCT00669942|2497501|P3|STARTED|Parts 2 and 3||0
1028386|NCT00669942|2497502|P2|STARTED|Parts 2 and 3||0
1028387|NCT00669942|2497503|P1|STARTED|Parts 2 and 3||0
1028388|NCT00669942|2497492|P12|NOT COMPLETED|Part 1||0
1028389|NCT00669942|2497493|P11|NOT COMPLETED|Part 1||0
1028390|NCT00669942|2497494|P10|NOT COMPLETED|Part 1||0
1028391|NCT00669942|2497495|P9|NOT COMPLETED|Part 1||0
1028392|NCT00669942|2497496|P8|NOT COMPLETED|Part 1||0
1028393|NCT00669942|2497497|P7|NOT COMPLETED|Part 1||0
1028394|NCT00669942|2497498|P6|NOT COMPLETED|Part 1||0
1028395|NCT00669942|2497499|P5|NOT COMPLETED|Part 1||0
1028396|NCT00669942|2497500|P4|NOT COMPLETED|Part 1||0
1028397|NCT00669942|2497501|P3|NOT COMPLETED|Part 1||0
1028398|NCT00669942|2497502|P2|NOT COMPLETED|Part 1||0
1028399|NCT00669942|2497503|P1|NOT COMPLETED|Part 1||0
1028400|NCT00669942|2497492|P12|COMPLETED|Part 1||0
1028401|NCT00669942|2497493|P11|COMPLETED|Part 1||0
1028402|NCT00669942|2497494|P10|COMPLETED|Part 1||0
1028403|NCT00669942|2497495|P9|COMPLETED|Part 1||0
1028404|NCT00669942|2497496|P8|COMPLETED|Part 1||0
1028405|NCT00669942|2497497|P7|COMPLETED|Part 1||0
1028406|NCT00669942|2497498|P6|COMPLETED|Part 1||0
1028407|NCT00669942|2497499|P5|COMPLETED|Part 1||8
1028408|NCT00669942|2497500|P4|COMPLETED|Part 1||6
1028409|NCT00669942|2497501|P3|COMPLETED|Part 1||6
1028410|NCT00669942|2497502|P2|COMPLETED|Part 1||6
1028411|NCT00669942|2497503|P1|COMPLETED|Part 1||6
1028412|NCT00669942|2497492|P12|STARTED|Part 1||0
1028413|NCT00669942|2497493|P11|STARTED|Part 1||0
1028414|NCT00669942|2497494|P10|STARTED|Part 1||0
1028415|NCT00669942|2497495|P9|STARTED|Part 1||0
1028416|NCT00669942|2497496|P8|STARTED|Part 1||0
1028417|NCT00669942|2497497|P7|STARTED|Part 1||0
1028418|NCT00669942|2497498|P6|STARTED|Part 1||0
1028419|NCT00669942|2497499|P5|STARTED|Part 1||8
1028420|NCT00669942|2497500|P4|STARTED|Part 1||6
1028421|NCT00669942|2497501|P3|STARTED|Part 1||6
1028422|NCT00669942|2497502|P2|STARTED|Part 1||6
1028423|NCT00669942|2497503|P1|STARTED|Part 1||6
1028424|NCT00669955|2497567|P2|NOT COMPLETED|Overall Study||27
1028425|NCT00669955|2497568|P1|NOT COMPLETED|Overall Study||14
1028426|NCT00669955|2497567|P2|COMPLETED|Overall Study||195
1028427|NCT00669955|2497568|P1|COMPLETED|Overall Study||204
1028428|NCT00669955|2497567|P2|STARTED|Overall Study||222
1028429|NCT00669955|2497568|P1|STARTED|Overall Study|216 patients received study drug. 2 patients were dispensed study drug but did not take it|218
1028430|NCT00670007|2497586|P1|NOT COMPLETED|Overall Study||9
1028431|NCT00670007|2497586|P1|COMPLETED|Overall Study||131
1028432|NCT00670007|2497586|P1|STARTED|Overall Study||140
1028433|NCT00670111|2497614|P3|NOT COMPLETED|Six Months to Twelve Months||0
1028434|NCT00670111|2497615|P2|NOT COMPLETED|Six Months to Twelve Months||0
1028435|NCT00670111|2497616|P1|NOT COMPLETED|Six Months to Twelve Months||0
1028436|NCT00670111|2497614|P3|COMPLETED|Six Months to Twelve Months||0
1028437|NCT00670111|2497615|P2|COMPLETED|Six Months to Twelve Months||8
1028438|NCT00670111|2497616|P1|COMPLETED|Six Months to Twelve Months||4
1028439|NCT00670111|2497614|P3|STARTED|Six Months to Twelve Months||0
1028440|NCT00670111|2497615|P2|STARTED|Six Months to Twelve Months||8
1028441|NCT00670111|2497616|P1|STARTED|Six Months to Twelve Months||4
1028442|NCT00670111|2497614|P3|NOT COMPLETED|One Month to Six Months||0
1028443|NCT00670111|2497615|P2|NOT COMPLETED|One Month to Six Months||0
1028444|NCT00670111|2497616|P1|NOT COMPLETED|One Month to Six Months||0
1028445|NCT00670111|2497614|P3|COMPLETED|One Month to Six Months||0
1028446|NCT00670111|2497615|P2|COMPLETED|One Month to Six Months|8 patients in this group completed the 1 month visit; 4 had data eligible for endpoint analysis.|8
1028447|NCT00670111|2497616|P1|COMPLETED|One Month to Six Months|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
1028448|NCT00670111|2497614|P3|STARTED|One Month to Six Months||0
1028449|NCT00670111|2497615|P2|STARTED|One Month to Six Months||8
1028450|NCT00670111|2497616|P1|STARTED|One Month to Six Months||4
1028451|NCT00670111|2497614|P3|NOT COMPLETED|One Month Period B||0
1028452|NCT00670111|2497615|P2|NOT COMPLETED|One Month Period B||0
1028453|NCT00670111|2497616|P1|NOT COMPLETED|One Month Period B||0
1028454|NCT00670111|2497614|P3|COMPLETED|One Month Period B||0
1028455|NCT00670111|2497615|P2|COMPLETED|One Month Period B|8 patients in this group completed the 1 month visit; 6 had data eligible for endpoint analysis.|8
1028456|NCT00670111|2497616|P1|COMPLETED|One Month Period B|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
1028457|NCT00670111|2497614|P3|STARTED|One Month Period B||0
1028458|NCT00670111|2497615|P2|STARTED|One Month Period B||8
1028459|NCT00670111|2497616|P1|STARTED|One Month Period B||4
1028460|NCT00670111|2497614|P3|NOT COMPLETED|One Month Period A||0
1028461|NCT00670111|2497615|P2|NOT COMPLETED|One Month Period A||0
1028462|NCT00670111|2497616|P1|NOT COMPLETED|One Month Period A||0
1028463|NCT00670111|2497614|P3|COMPLETED|One Month Period A||0
1028464|NCT00670111|2497615|P2|COMPLETED|One Month Period A||8
1028465|NCT00670111|2497616|P1|COMPLETED|One Month Period A||4
1028466|NCT00670111|2497614|P3|STARTED|One Month Period A||0
1028467|NCT00670111|2497615|P2|STARTED|One Month Period A||8
1028468|NCT00670111|2497616|P1|STARTED|One Month Period A||4
1028469|NCT00670111|2497614|P3|NOT COMPLETED|Enrollment to One Month||19
1028470|NCT00670111|2497615|P2|NOT COMPLETED|Enrollment to One Month||0
1028471|NCT00670111|2497616|P1|NOT COMPLETED|Enrollment to One Month||1
1028472|NCT00670111|2497614|P3|COMPLETED|Enrollment to One Month||0
1028473|NCT00670111|2497615|P2|COMPLETED|Enrollment to One Month||8
1028474|NCT00670111|2497616|P1|COMPLETED|Enrollment to One Month||4
1028475|NCT00670111|2497614|P3|STARTED|Enrollment to One Month||19
1028476|NCT00670111|2497615|P2|STARTED|Enrollment to One Month||8
1028477|NCT00670111|2497616|P1|STARTED|Enrollment to One Month||5
1028478|NCT00670202|2497626|P2|NOT COMPLETED|Overall Study||0
1028479|NCT00670202|2497627|P1|NOT COMPLETED|Overall Study||0
1028480|NCT00670202|2497626|P2|COMPLETED|Overall Study||0
1028481|NCT00670202|2497627|P1|COMPLETED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
1028482|NCT00670202|2497626|P2|STARTED|Overall Study||0
1028483|NCT00670202|2497627|P1|STARTED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
1028484|NCT00670228|2497635|P2|NOT COMPLETED|Overall Study||3
1028485|NCT00670228|2497636|P1|NOT COMPLETED|Overall Study||5
1028486|NCT00670228|2497635|P2|COMPLETED|Overall Study||12
1028487|NCT00670228|2497636|P1|COMPLETED|Overall Study||13
1028488|NCT00670228|2497635|P2|STARTED|Overall Study||15
1028489|NCT00670228|2497636|P1|STARTED|Overall Study||18
1028490|NCT00670241|2497651|P3|NOT COMPLETED|Overall Study||27
1028491|NCT00670241|2497652|P2|NOT COMPLETED|Overall Study||21
1028492|NCT00670241|2497653|P1|NOT COMPLETED|Overall Study||12
1028493|NCT00670241|2497651|P3|COMPLETED|Overall Study||64
1028494|NCT00670241|2497652|P2|COMPLETED|Overall Study||163
1028495|NCT00670241|2497653|P1|COMPLETED|Overall Study||171
1028496|NCT00670241|2497651|P3|STARTED|Overall Study||91
1028497|NCT00670241|2497652|P2|STARTED|Overall Study||184
1028498|NCT00670241|2497653|P1|STARTED|Overall Study||183
1028499|NCT00670267|2497673|P1|NOT COMPLETED|Overall Study||1
1028500|NCT00670267|2497673|P1|COMPLETED|Overall Study||9
1028501|NCT00670267|2497673|P1|STARTED|Overall Study||10
1028502|NCT00670306|2497681|P1|NOT COMPLETED|Overall Study||55
1028503|NCT00670306|2497681|P1|COMPLETED|Overall Study||473
1028504|NCT00670306|2497681|P1|STARTED|Overall Study||528
1028505|NCT00676182|2497687|P1|NOT COMPLETED|Overall Study||0
1028506|NCT00676182|2497687|P1|COMPLETED|Overall Study||75
1028507|NCT00676182|2497687|P1|STARTED|Overall Study||75
1028508|NCT00676195|2497700|P1|NOT COMPLETED|Overall Study||3
1028509|NCT00676195|2497700|P1|COMPLETED|Overall Study||21
1028510|NCT00676195|2497700|P1|STARTED|Overall Study||24
1028511|NCT00676208|2497710|P2|NOT COMPLETED|Overall Study||6
1028512|NCT00676208|2497711|P1|NOT COMPLETED|Overall Study||2
1028513|NCT00676208|2497710|P2|COMPLETED|Overall Study||13
1028514|NCT00676208|2497711|P1|COMPLETED|Overall Study||12
1028515|NCT00676208|2497710|P2|STARTED|Overall Study||19
1028516|NCT00676208|2497711|P1|STARTED|Overall Study||14
1028517|NCT00676338|2497723|P4|NOT COMPLETED|Overall Study||23
1028518|NCT00676338|2497724|P3|NOT COMPLETED|Overall Study||30
1028519|NCT00676338|2497725|P2|NOT COMPLETED|Overall Study||33
1028520|NCT00676338|2497726|P1|NOT COMPLETED|Overall Study||38
1028521|NCT00676338|2497723|P4|COMPLETED|Overall Study||140
1028522|NCT00676338|2497724|P3|COMPLETED|Overall Study||133
1028523|NCT00676338|2497725|P2|COMPLETED|Overall Study||213
1028524|NCT00676338|2497726|P1|COMPLETED|Overall Study||210
1028525|NCT00676338|2497723|P4|STARTED|Overall Study||163
1028526|NCT00676338|2497724|P3|STARTED|Overall Study||163
1028527|NCT00676338|2497725|P2|STARTED|Overall Study||246
1028528|NCT00676338|2497726|P1|STARTED|Overall Study||248
1028529|NCT00676364|2497778|P2|NOT COMPLETED|Overall Study||0
1028530|NCT00676364|2497779|P1|NOT COMPLETED|Overall Study||0
1028531|NCT00676364|2497778|P2|COMPLETED|Overall Study||57
1028532|NCT00676364|2497779|P1|COMPLETED|Overall Study||57
1028533|NCT00676364|2497778|P2|STARTED|Overall Study||57
1028534|NCT00676364|2497779|P1|STARTED|Overall Study||57
1028535|NCT00676403|2497793|P6|NOT COMPLETED|Overall Study||5
1028536|NCT00676403|2497794|P5|NOT COMPLETED|Overall Study||1
1028537|NCT00676403|2497795|P4|NOT COMPLETED|Overall Study||5
1028538|NCT00676403|2497796|P3|NOT COMPLETED|Overall Study||1
1028539|NCT00676403|2497797|P2|NOT COMPLETED|Overall Study||2
1028540|NCT00676403|2497798|P1|NOT COMPLETED|Overall Study||2
1028541|NCT00676403|2497793|P6|COMPLETED|Overall Study||18
1028542|NCT00676403|2497794|P5|COMPLETED|Overall Study||23
1028543|NCT00676403|2497795|P4|COMPLETED|Overall Study||17
1028544|NCT00676403|2497796|P3|COMPLETED|Overall Study||22
1028545|NCT00676403|2497797|P2|COMPLETED|Overall Study||20
1028546|NCT00676403|2497798|P1|COMPLETED|Overall Study||21
1028547|NCT00676403|2497793|P6|STARTED|Overall Study||23
1028548|NCT00676403|2497794|P5|STARTED|Overall Study||24
1028549|NCT00676403|2497795|P4|STARTED|Overall Study||22
1028550|NCT00676403|2497796|P3|STARTED|Overall Study||23
1028551|NCT00676403|2497797|P2|STARTED|Overall Study||22
1028552|NCT00676403|2497798|P1|STARTED|Overall Study||23
1028553|NCT00676455|2497926|P1|NOT COMPLETED|Overall Study||0
1028554|NCT00676455|2497926|P1|COMPLETED|Overall Study||14
1028555|NCT00676455|2497926|P1|STARTED|Overall Study||14
1028556|NCT00676494|2497931|P1|NOT COMPLETED|Overall Study||14
1028557|NCT00676494|2497931|P1|COMPLETED|Overall Study||158
1028558|NCT00676494|2497931|P1|STARTED|Overall Study||172
1028559|NCT00676793|2497937|P1|NOT COMPLETED|Overall Study||13
1028560|NCT00676793|2497937|P1|COMPLETED|Overall Study||19
1028561|NCT00676793|2497937|P1|STARTED|Overall Study||32
1028562|NCT00676806|2497944|P2|NOT COMPLETED|Overall Study||0
1028563|NCT00676806|2497945|P1|NOT COMPLETED|Overall Study||0
1028564|NCT00676806|2497944|P2|COMPLETED|Overall Study||3
1028565|NCT00676806|2497945|P1|COMPLETED|Overall Study||3
1028566|NCT00676806|2497944|P2|STARTED|Overall Study||3
1028567|NCT00676806|2497945|P1|STARTED|Overall Study||3
1028568|NCT00676897|2497963|P2|NOT COMPLETED|Overall Study||0
1028569|NCT00676897|2497964|P1|NOT COMPLETED|Overall Study||0
1028570|NCT00676897|2497963|P2|COMPLETED|Overall Study||10
1028571|NCT00676897|2497964|P1|COMPLETED|Overall Study||8
1028572|NCT00676897|2497963|P2|STARTED|Overall Study||10
1028573|NCT00676897|2497964|P1|STARTED|Overall Study||8
1028574|NCT00677014|2497975|P3|NOT COMPLETED|Overall Study||49
1028575|NCT00677014|2497976|P2|NOT COMPLETED|Overall Study||41
1028576|NCT00677014|2497977|P1|NOT COMPLETED|Overall Study||44
1028577|NCT00677014|2497975|P3|COMPLETED|Overall Study||283
1028578|NCT00677014|2497976|P2|COMPLETED|Overall Study||282
1028579|NCT00677014|2497977|P1|COMPLETED|Overall Study||281
1028580|NCT00677014|2497975|P3|STARTED|Overall Study||332
1028581|NCT00677014|2497976|P2|STARTED|Overall Study||323
1028582|NCT00677014|2497977|P1|STARTED|Overall Study||325
1028583|NCT00677092|2497985|P1|NOT COMPLETED|Overall Study||6
1028584|NCT00677092|2497985|P1|COMPLETED|Overall Study||6
1028585|NCT00677092|2497985|P1|Received Study Treatment|Overall Study||11
1028586|NCT00677092|2497985|P1|STARTED|Overall Study||12
1028587|NCT00677235|2497996|P2|NOT COMPLETED|Overall Study||38
1028588|NCT00677235|2497997|P1|NOT COMPLETED|Overall Study||41
1028589|NCT00677235|2497996|P2|COMPLETED|Overall Study||94
1028590|NCT00677235|2497997|P1|COMPLETED|Overall Study||97
1028591|NCT00677235|2497996|P2|STARTED|Overall Study||132
1028592|NCT00677235|2497997|P1|STARTED|Overall Study||138
1028593|NCT00677352|2498039|P2|NOT COMPLETED|Tapering Phase||10
1028594|NCT00677352|2498040|P1|NOT COMPLETED|Tapering Phase||6
1028595|NCT00677352|2498039|P2|COMPLETED|Tapering Phase||112
1028596|NCT00677352|2498040|P1|COMPLETED|Tapering Phase||126
1028597|NCT00677352|2498039|P2|STARTED|Tapering Phase||122
1028598|NCT00677352|2498040|P1|STARTED|Tapering Phase||132
1028599|NCT00677352|2498039|P2|NOT COMPLETED|Treatment Phase||42
1028600|NCT00677352|2498040|P1|NOT COMPLETED|Treatment Phase||25
1028601|NCT00677352|2498039|P2|COMPLETED|Treatment Phase||122
1028602|NCT00677352|2498040|P1|COMPLETED|Treatment Phase||132
1028603|NCT00677352|2498039|P2|STARTED|Treatment Phase|2 subjects were not teated, therefore 162 subjects were treated with paroxetine.|164
1028604|NCT00677352|2498040|P1|STARTED|Treatment Phase|All 157 subjects were treated with Sertraline.|157
1028605|NCT00677365|2498062|P4|NOT COMPLETED|Overall Study||3
1028606|NCT00677365|2498063|P3|NOT COMPLETED|Overall Study||2
1028607|NCT00677365|2498064|P2|NOT COMPLETED|Overall Study||1
1028608|NCT00677365|2498065|P1|NOT COMPLETED|Overall Study||2
1028609|NCT00677365|2498062|P4|COMPLETED|Overall Study||36
1028610|NCT00677365|2498063|P3|COMPLETED|Overall Study||35
1028611|NCT00677365|2498064|P2|COMPLETED|Overall Study||37
1028612|NCT00677365|2498065|P1|COMPLETED|Overall Study||35
1028613|NCT00677365|2498062|P4|STARTED|Overall Study||39
1028614|NCT00677365|2498063|P3|STARTED|Overall Study||37
1028615|NCT00677365|2498064|P2|STARTED|Overall Study||38
1028616|NCT00677365|2498065|P1|STARTED|Overall Study||37
1028617|NCT00677534|2498095|P1|NOT COMPLETED|After Paricalcitol Restart (Weeks 13-14)||0
1028618|NCT00677534|2498095|P1|COMPLETED|After Paricalcitol Restart (Weeks 13-14)||7
1028619|NCT00677534|2498095|P1|STARTED|After Paricalcitol Restart (Weeks 13-14)||7
1028620|NCT00677534|2498095|P1|NOT COMPLETED|Cholecalciferol (Weeks 5-12)||0
1028621|NCT00677534|2498095|P1|COMPLETED|Cholecalciferol (Weeks 5-12)||7
1028622|NCT00677534|2498095|P1|STARTED|Cholecalciferol (Weeks 5-12)||7
1028623|NCT00677534|2498095|P1|NOT COMPLETED|Washout (Weeks 1-4)||3
1028624|NCT00677534|2498095|P1|COMPLETED|Washout (Weeks 1-4)||7
1028625|NCT00677534|2498095|P1|STARTED|Washout (Weeks 1-4)||10
1028626|NCT00677690|2498101|P2|NOT COMPLETED|Overall Study||0
1028627|NCT00677690|2498102|P1|NOT COMPLETED|Overall Study||0
1028628|NCT00677690|2498101|P2|COMPLETED|Overall Study||41
1028629|NCT00677690|2498102|P1|COMPLETED|Overall Study||42
1028630|NCT00677690|2498101|P2|STARTED|Overall Study||41
1028631|NCT00677690|2498102|P1|STARTED|Overall Study||42
1028632|NCT00677807|2498119|P3|NOT COMPLETED|Overall Study||20
1028633|NCT00677807|2498120|P2|NOT COMPLETED|Overall Study||11
1028634|NCT00677807|2498121|P1|NOT COMPLETED|Overall Study||18
1028635|NCT00677807|2498119|P3|COMPLETED|Overall Study||105
1028636|NCT00677807|2498120|P2|COMPLETED|Overall Study||135
1028637|NCT00677807|2498121|P1|COMPLETED|Overall Study||126
1028638|NCT00677807|2498119|P3|Safety/ITT: Received Study Drug|Overall Study|One patient did not take study medication.|124
1028639|NCT00677807|2498120|P2|Safety/ITT: Received Study Drug|Overall Study||146
1028640|NCT00677807|2498121|P1|Safety/ITT: Received Study Drug|Overall Study||144
1028641|NCT00677807|2498119|P3|STARTED|Overall Study||125
1028642|NCT00677807|2498120|P2|STARTED|Overall Study||146
1028643|NCT00677807|2498121|P1|STARTED|Overall Study||144
1028644|NCT00677820|2498152|P2|NOT COMPLETED|Overall Study||0
1028645|NCT00677820|2498153|P1|NOT COMPLETED|Overall Study||1
1028646|NCT00677820|2498152|P2|COMPLETED|Overall Study||60
1028647|NCT00677820|2498153|P1|COMPLETED|Overall Study||239
1028648|NCT00677820|2498152|P2|STARTED|Overall Study||60
1028649|NCT00677820|2498153|P1|STARTED|Overall Study||240
1028650|NCT00677833|2498175|P4|NOT COMPLETED|Overall Study||3
1028651|NCT00677833|2498176|P3|NOT COMPLETED|Overall Study||2
1028652|NCT00677833|2498177|P2|NOT COMPLETED|Overall Study||0
1028653|NCT00677833|2498178|P1|NOT COMPLETED|Overall Study||4
1028654|NCT00677833|2498175|P4|COMPLETED|Overall Study||128
1028655|NCT00677833|2498176|P3|COMPLETED|Overall Study||122
1028656|NCT00677833|2498177|P2|COMPLETED|Overall Study||51
1028657|NCT00677833|2498178|P1|COMPLETED|Overall Study||51
1028658|NCT00677833|2498175|P4|STARTED|Overall Study||131
1028659|NCT00677833|2498176|P3|STARTED|Overall Study||124
1028660|NCT00677833|2498177|P2|STARTED|Overall Study||51
1028661|NCT00677833|2498178|P1|STARTED|Overall Study||55
1028662|NCT00677898|2498228|P2|NOT COMPLETED|Overall Study||18
1028663|NCT00677898|2498229|P1|NOT COMPLETED|Overall Study||20
1028664|NCT00677898|2498228|P2|COMPLETED|Overall Study||102
1028665|NCT00677898|2498229|P1|COMPLETED|Overall Study||99
1028666|NCT00677898|2498228|P2|STARTED|Overall Study||120
1028667|NCT00677898|2498229|P1|STARTED|Overall Study||119
1028668|NCT00677924|2498247|P2|NOT COMPLETED|Overall Study||0
1028669|NCT00677924|2498248|P1|NOT COMPLETED|Overall Study||0
1028670|NCT00677924|2498247|P2|COMPLETED|Overall Study||6
1028671|NCT00677924|2498248|P1|COMPLETED|Overall Study||3
1028672|NCT00677924|2498247|P2|STARTED|Overall Study||6
1028673|NCT00677924|2498248|P1|STARTED|Overall Study||3
1028674|NCT00678015|2498256|P1|NOT COMPLETED|Overall Study||0
1028675|NCT00678015|2498256|P1|COMPLETED|Overall Study||12
1028676|NCT00678015|2498256|P1|STARTED|Overall Study||12
1028677|NCT00678041|2498265|P2|NOT COMPLETED|Overall Study||5
1028678|NCT00678041|2498266|P1|NOT COMPLETED|Overall Study||5
1028679|NCT00678041|2498265|P2|COMPLETED|Overall Study||0
1028680|NCT00678041|2498266|P1|COMPLETED|Overall Study||0
1028681|NCT00678041|2498265|P2|STARTED|Overall Study||5
1028682|NCT00678041|2498266|P1|STARTED|Overall Study||5
1028683|NCT00678210|2498282|P4|NOT COMPLETED|Overall Study||20
1028684|NCT00678210|2498283|P3|NOT COMPLETED|Overall Study||6
1028685|NCT00678210|2498284|P2|NOT COMPLETED|Overall Study||11
1028686|NCT00678210|2498285|P1|NOT COMPLETED|Overall Study||11
1028687|NCT00678210|2498282|P4|COMPLETED|Overall Study||30
1028688|NCT00678210|2498283|P3|COMPLETED|Overall Study||43
1028689|NCT00678210|2498284|P2|COMPLETED|Overall Study||38
1028690|NCT00678210|2498285|P1|COMPLETED|Overall Study||38
1028691|NCT00678210|2498282|P4|STARTED|Overall Study||50
1028692|NCT00678210|2498283|P3|STARTED|Overall Study||49
1028693|NCT00678210|2498284|P2|STARTED|Overall Study||49
1028694|NCT00678210|2498285|P1|STARTED|Overall Study||49
1028695|NCT00678249|2498322|P3|NOT COMPLETED|Overall Study||0
1028696|NCT00678249|2498323|P2|NOT COMPLETED|Overall Study||0
1028697|NCT00678249|2498324|P1|NOT COMPLETED|Overall Study||0
1028698|NCT00678249|2498322|P3|COMPLETED|Overall Study||37
1028699|NCT00678249|2498323|P2|COMPLETED|Overall Study||93
1028700|NCT00678249|2498324|P1|COMPLETED|Overall Study||97
1028701|NCT00678249|2498322|P3|STARTED|Overall Study||37
1028702|NCT00678249|2498323|P2|STARTED|Overall Study||93
1028703|NCT00678249|2498324|P1|STARTED|Overall Study||97
1028704|NCT00678288|2498358|P2|NOT COMPLETED|Overall Study||6
1028705|NCT00678288|2498359|P1|NOT COMPLETED|Overall Study||10
1028706|NCT00678288|2498358|P2|COMPLETED|Overall Study||0
1028707|NCT00678288|2498359|P1|COMPLETED|Overall Study||0
1028708|NCT00678288|2498358|P2|STARTED|Overall Study||6
1028709|NCT00678288|2498359|P1|STARTED|Overall Study||10
1028710|NCT00678379|2498376|P3|NOT COMPLETED|Overall Study||4
1028711|NCT00678379|2498377|P2|NOT COMPLETED|Overall Study||3
1028712|NCT00678379|2498378|P1|NOT COMPLETED|Overall Study||6
1028713|NCT00678379|2498376|P3|COMPLETED|Overall Study||36
1028714|NCT00678379|2498377|P2|COMPLETED|Overall Study||37
1028715|NCT00678379|2498378|P1|COMPLETED|Overall Study||34
1028716|NCT00678379|2498376|P3|STARTED|Overall Study||40
1028717|NCT00678379|2498377|P2|STARTED|Overall Study||40
1028718|NCT00678379|2498378|P1|STARTED|Overall Study||40
1028719|NCT00678392|2498406|P2|NOT COMPLETED|Overall Study||362
1028720|NCT00678392|2498407|P1|NOT COMPLETED|Overall Study||361
1028721|NCT00678392|2498406|P2|COMPLETED|Overall Study||0
1028722|NCT00678392|2498407|P1|COMPLETED|Overall Study||0
1028723|NCT00678392|2498406|P2|Treated|Overall Study||355
1028724|NCT00678392|2498407|P1|Treated|Overall Study||359
1028725|NCT00678392|2498406|P2|STARTED|Overall Study||362
1028726|NCT00678392|2498407|P1|STARTED|Overall Study||361
1028727|NCT00678418|2498441|P2|NOT COMPLETED|Part B (Open Label)||0
1028728|NCT00678418|2498442|P1|NOT COMPLETED|Part B (Open Label)||43
1028729|NCT00678418|2498441|P2|COMPLETED|Part B (Open Label)||0
1028730|NCT00678418|2498442|P1|COMPLETED|Part B (Open Label)||71
1028731|NCT00678418|2498441|P2|STARTED|Part B (Open Label)||0
1028732|NCT00678418|2498442|P1|STARTED|Part B (Open Label)|All participants who received placebo in Part A were switched to open-label VIVITROL in Part B.|114
1028733|NCT00678418|2498441|P2|NOT COMPLETED|Part A (Double Blind)||77
1028734|NCT00678418|2498442|P1|NOT COMPLETED|Part A (Double Blind)||59
1028735|NCT00678418|2498441|P2|COMPLETED|Part A (Double Blind)||47
1028736|NCT00678418|2498442|P1|COMPLETED|Part A (Double Blind)||67
1028737|NCT00678418|2498441|P2|STARTED|Part A (Double Blind)||124
1028738|NCT00678418|2498442|P1|STARTED|Part A (Double Blind)||126
1028739|NCT00678470|2498456|P1|NOT COMPLETED|Overall Study||3
1028740|NCT00678470|2498456|P1|COMPLETED|Overall Study||15
1028741|NCT00678470|2498456|P1|STARTED|Overall Study||18
1028742|NCT00678535|2498462|P2|NOT COMPLETED|Overall Study||98
1028743|NCT00678535|2498463|P1|NOT COMPLETED|Overall Study||93
1028744|NCT00678535|2498462|P2|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|351
1028745|NCT00678535|2498463|P1|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|362
1028746|NCT00678535|2498462|P2|STARTED|Overall Study|ITT population|449
1028747|NCT00678535|2498463|P1|STARTED|Overall Study|ITT population|455
1028748|NCT00678574|2498481|P2|NOT COMPLETED|Overall Study||0
1028749|NCT00678574|2498482|P1|NOT COMPLETED|Overall Study||0
1028750|NCT00678574|2498481|P2|COMPLETED|Overall Study||27
1028751|NCT00678574|2498482|P1|COMPLETED|Overall Study||18
1028752|NCT00678574|2498481|P2|STARTED|Overall Study||27
1028753|NCT00678574|2498482|P1|STARTED|Overall Study||18
1028754|NCT00678587|2498490|P2|NOT COMPLETED|Overall Study||18
1028755|NCT00678587|2498491|P1|NOT COMPLETED|Overall Study||20
1028756|NCT00678587|2498490|P2|COMPLETED|Overall Study||127
1028757|NCT00678587|2498491|P1|COMPLETED|Overall Study||127
1028758|NCT00678587|2498490|P2|STARTED|Overall Study||145
1028759|NCT00678587|2498491|P1|STARTED|Overall Study||147
1028760|NCT00678639|2498525|P2|NOT COMPLETED|Overall Study||0
1028761|NCT00678639|2498526|P1|NOT COMPLETED|Overall Study||2
1028762|NCT00678639|2498525|P2|COMPLETED|Overall Study||57
1028763|NCT00678639|2498526|P1|COMPLETED|Overall Study||51
1028764|NCT00678639|2498525|P2|Hospital Discharge|Overall Study||57
1028765|NCT00678639|2498526|P1|Hospital Discharge|Overall Study||53
1028766|NCT00678639|2498525|P2|STARTED|Overall Study||57
1028767|NCT00678639|2498526|P1|STARTED|Overall Study||53
1028768|NCT00678691|2498541|P2|NOT COMPLETED|Overall Study||4
1028769|NCT00678691|2498542|P1|NOT COMPLETED|Overall Study||6
1028770|NCT00678691|2498541|P2|COMPLETED|Overall Study||24
1028771|NCT00678691|2498542|P1|COMPLETED|Overall Study||21
1028772|NCT00678691|2498541|P2|STARTED|Overall Study||28
1028773|NCT00678691|2498542|P1|STARTED|Overall Study||27
1028774|NCT00678795|2498550|P2|NOT COMPLETED|Overall Study||6
1028775|NCT00678795|2498551|P1|NOT COMPLETED|Overall Study||11
1028776|NCT00678795|2498550|P2|COMPLETED|Overall Study||62
1028777|NCT00678795|2498551|P1|COMPLETED|Overall Study||56
1028778|NCT00678795|2498550|P2|STARTED|Overall Study||68
1028779|NCT00678795|2498551|P1|STARTED|Overall Study||67
1028780|NCT00678834|2498574|P3|NOT COMPLETED|Overall Study||9
1028781|NCT00678834|2498575|P2|NOT COMPLETED|Overall Study||0
1028782|NCT00678834|2498576|P1|NOT COMPLETED|Overall Study||16
1028783|NCT00678834|2498574|P3|COMPLETED|Overall Study||16
1028784|NCT00678834|2498575|P2|COMPLETED|Overall Study||15
1028785|NCT00678834|2498576|P1|COMPLETED|Overall Study||24
1028786|NCT00678834|2498574|P3|STARTED|Overall Study||25
1028787|NCT00678834|2498575|P2|STARTED|Overall Study||15
1028788|NCT00678834|2498576|P1|STARTED|Overall Study||40
1028789|NCT00678886|2498596|P4|NOT COMPLETED|Overall Study||9
1028790|NCT00678886|2498597|P3|NOT COMPLETED|Overall Study||9
1028791|NCT00678886|2498598|P2|NOT COMPLETED|Overall Study||0
1028792|NCT00678886|2498599|P1|NOT COMPLETED|Overall Study||0
1028793|NCT00678886|2498596|P4|COMPLETED|Overall Study||153
1028794|NCT00678886|2498597|P3|COMPLETED|Overall Study||72
1028795|NCT00678886|2498598|P2|COMPLETED|Overall Study||19
1028796|NCT00678886|2498599|P1|COMPLETED|Overall Study||10
1028797|NCT00678886|2498596|P4|STARTED|Overall Study||162
1028798|NCT00678886|2498597|P3|STARTED|Overall Study||81
1028799|NCT00678886|2498598|P2|STARTED|Overall Study||19
1028800|NCT00678886|2498599|P1|STARTED|Overall Study||10
1028801|NCT00678899|2498643|P1|NOT COMPLETED|Overall Study||1
1028802|NCT00678899|2498643|P1|COMPLETED|Overall Study||49
1028803|NCT00678899|2498643|P1|STARTED|Overall Study||50
1028804|NCT00679055|2498652|P2|NOT COMPLETED|Overall Study||5
1028805|NCT00679055|2498653|P1|NOT COMPLETED|Overall Study||2
1028806|NCT00679055|2498652|P2|COMPLETED|Overall Study||1
1028807|NCT00679055|2498653|P1|COMPLETED|Overall Study||6
1028808|NCT00679055|2498652|P2|STARTED|Overall Study||6
1028809|NCT00679055|2498653|P1|STARTED|Overall Study||8
1028810|NCT00679081|2498663|P1|NOT COMPLETED|Overall Study||1
1028811|NCT00679081|2498663|P1|COMPLETED|Overall Study||14
1028812|NCT00679081|2498663|P1|STARTED|Overall Study|Study design was within-subject control.|15
1028813|NCT00679172|2498676|P5|NOT COMPLETED|Overall Study||0
1028814|NCT00679172|2498677|P4|NOT COMPLETED|Overall Study||1
1028815|NCT00679172|2498678|P3|NOT COMPLETED|Overall Study||1
1028816|NCT00679172|2498679|P2|NOT COMPLETED|Overall Study||1
1028817|NCT00679172|2498680|P1|NOT COMPLETED|Overall Study||1
1028818|NCT00679172|2498676|P5|COMPLETED|Overall Study||37
1028819|NCT00679172|2498677|P4|COMPLETED|Overall Study||38
1028820|NCT00679172|2498678|P3|COMPLETED|Overall Study||35
1028821|NCT00679172|2498679|P2|COMPLETED|Overall Study||37
1028822|NCT00679172|2498680|P1|COMPLETED|Overall Study||36
1028823|NCT00679172|2498676|P5|STARTED|Overall Study||37
1028824|NCT00679172|2498677|P4|STARTED|Overall Study||39
1028825|NCT00679172|2498678|P3|STARTED|Overall Study||36
1028826|NCT00679172|2498679|P2|STARTED|Overall Study||38
1028827|NCT00679172|2498680|P1|STARTED|Overall Study||37
1028828|NCT00679211|2498743|P1|NOT COMPLETED|Overall Study||110
1028829|NCT00679211|2498743|P1|COMPLETED|Overall Study||0
1028830|NCT00679211|2498743|P1|STARTED|Overall Study||110
1028831|NCT00679263|2498758|P3|NOT COMPLETED|Visit 2/Dose 1||0
1028832|NCT00679263|2498759|P2|NOT COMPLETED|Visit 2/Dose 1||1
1028833|NCT00679263|2498760|P1|NOT COMPLETED|Visit 2/Dose 1||2
1028834|NCT00679263|2498758|P3|COMPLETED|Visit 2/Dose 1||11
1028835|NCT00679263|2498759|P2|COMPLETED|Visit 2/Dose 1||5
1028836|NCT00679263|2498760|P1|COMPLETED|Visit 2/Dose 1||9
1028837|NCT00679263|2498758|P3|STARTED|Visit 2/Dose 1||11
1028838|NCT00679263|2498759|P2|STARTED|Visit 2/Dose 1||6
1028839|NCT00679263|2498760|P1|STARTED|Visit 2/Dose 1||11
1028840|NCT00679263|2498758|P3|NOT COMPLETED|Visit 3/Dose 2||0
1028841|NCT00679263|2498759|P2|NOT COMPLETED|Visit 3/Dose 2||5
1028842|NCT00679263|2498760|P1|NOT COMPLETED|Visit 3/Dose 2||1
1028843|NCT00679263|2498758|P3|COMPLETED|Visit 3/Dose 2||11
1028844|NCT00679263|2498759|P2|COMPLETED|Visit 3/Dose 2||6
1028845|NCT00679263|2498760|P1|COMPLETED|Visit 3/Dose 2||9
1028846|NCT00679263|2498758|P3|STARTED|Visit 3/Dose 2||11
1028847|NCT00679263|2498759|P2|STARTED|Visit 3/Dose 2||11
1028848|NCT00679263|2498760|P1|STARTED|Visit 3/Dose 2||10
1028849|NCT00673361|2498771|P1|NOT COMPLETED|Overall Study||2
1028850|NCT00673361|2498771|P1|COMPLETED|Overall Study||7
1028851|NCT00673361|2498771|P1|STARTED|Overall Study||9
1028852|NCT00673387|2498783|P8|NOT COMPLETED|Overall Study||35
1028853|NCT00673387|2498784|P7|NOT COMPLETED|Overall Study||30
1028854|NCT00673387|2498785|P6|NOT COMPLETED|Overall Study||34
1028855|NCT00673387|2498786|P5|NOT COMPLETED|Overall Study||30
1028856|NCT00673387|2498787|P4|NOT COMPLETED|Overall Study||26
1028857|NCT00673387|2498788|P3|NOT COMPLETED|Overall Study||31
1028858|NCT00673387|2498789|P2|NOT COMPLETED|Overall Study||23
1028859|NCT00673387|2498790|P1|NOT COMPLETED|Overall Study||29
1028860|NCT00673387|2498783|P8|COMPLETED|Overall Study||40
1028861|NCT00673387|2498784|P7|COMPLETED|Overall Study||48
1028862|NCT00673387|2498785|P6|COMPLETED|Overall Study||44
1028863|NCT00673387|2498786|P5|COMPLETED|Overall Study||48
1028864|NCT00673387|2498787|P4|COMPLETED|Overall Study||49
1028865|NCT00673387|2498788|P3|COMPLETED|Overall Study||41
1028866|NCT00673387|2498789|P2|COMPLETED|Overall Study||54
1028867|NCT00673387|2498790|P1|COMPLETED|Overall Study||46
1028868|NCT00673387|2498783|P8|STARTED|Overall Study||75
1028869|NCT00673387|2498784|P7|STARTED|Overall Study||78
1028870|NCT00673387|2498785|P6|STARTED|Overall Study||78
1028871|NCT00673387|2498786|P5|STARTED|Overall Study||78
1028872|NCT00673387|2498787|P4|STARTED|Overall Study||75
1028873|NCT00673387|2498788|P3|STARTED|Overall Study||72
1028874|NCT00673387|2498789|P2|STARTED|Overall Study||77
1028875|NCT00673387|2498790|P1|STARTED|Overall Study||75
1028876|NCT00673400|2499006|P1|NOT COMPLETED|Overall Study||0
1028877|NCT00673400|2499006|P1|COMPLETED|Overall Study||52
1028878|NCT00673400|2499006|P1|STARTED|Overall Study||52
1028879|NCT00673439|2499023|P1|NOT COMPLETED|Overall Study||0
1028880|NCT00673439|2499023|P1|COMPLETED|Overall Study||3
1028881|NCT00673439|2499023|P1|STARTED|Overall Study||3
1028882|NCT00673452|2499029|P2|NOT COMPLETED|Continuation Double-Blind Phase||34
1028883|NCT00673452|2499030|P1|NOT COMPLETED|Continuation Double-Blind Phase||25
1028884|NCT00673452|2499029|P2|COMPLETED|Continuation Double-Blind Phase||153
1028885|NCT00673452|2499030|P1|COMPLETED|Continuation Double-Blind Phase||151
1028886|NCT00673452|2499029|P2|STARTED|Continuation Double-Blind Phase|Patients on placebo in acute phase received 60 mg duloxetine during the continuation phase.|187
1028887|NCT00673452|2499030|P1|STARTED|Continuation Double-Blind Phase||176
1028888|NCT00673452|2499029|P2|NOT COMPLETED|Acute Double-Blind Phase||80
1028889|NCT00673452|2499030|P1|NOT COMPLETED|Acute Double-Blind Phase||87
1028890|NCT00673452|2499029|P2|COMPLETED|Acute Double-Blind Phase||187
1028891|NCT00673452|2499030|P1|COMPLETED|Acute Double-Blind Phase||176
1028892|NCT00673452|2499029|P2|STARTED|Acute Double-Blind Phase||267
1028893|NCT00673452|2499030|P1|STARTED|Acute Double-Blind Phase||263
1028894|NCT00673465|2499064|P12|NOT COMPLETED|Part 2 (India)||0
1028895|NCT00673465|2499065|P11|NOT COMPLETED|Part 2 (India)||0
1028896|NCT00673465|2499066|P10|NOT COMPLETED|Part 2 (India)||0
1028897|NCT00673465|2499067|P9|NOT COMPLETED|Part 2 (India)||0
1028898|NCT00673465|2499068|P8|NOT COMPLETED|Part 2 (India)||0
1028899|NCT00673465|2499069|P7|NOT COMPLETED|Part 2 (India)||0
1028900|NCT00673465|2499070|P6|NOT COMPLETED|Part 2 (India)||0
1028901|NCT00673465|2499071|P5|NOT COMPLETED|Part 2 (India)||0
1028902|NCT00673465|2499072|P4|NOT COMPLETED|Part 2 (India)||0
1028903|NCT00673465|2499073|P3|NOT COMPLETED|Part 2 (India)||0
1028904|NCT00673465|2499074|P2|NOT COMPLETED|Part 2 (India)||0
1028905|NCT00673465|2499075|P1|NOT COMPLETED|Part 2 (India)||0
1028906|NCT00673465|2499064|P12|COMPLETED|Part 2 (India)||0
1028907|NCT00673465|2499065|P11|COMPLETED|Part 2 (India)||0
1028908|NCT00673465|2499066|P10|COMPLETED|Part 2 (India)||0
1028909|NCT00673465|2499067|P9|COMPLETED|Part 2 (India)||0
1028910|NCT00673465|2499068|P8|COMPLETED|Part 2 (India)||0
1028911|NCT00673465|2499069|P7|COMPLETED|Part 2 (India)||0
1028912|NCT00673465|2499070|P6|COMPLETED|Part 2 (India)||0
1028913|NCT00673465|2499071|P5|COMPLETED|Part 2 (India)||0
1028914|NCT00673465|2499072|P4|COMPLETED|Part 2 (India)||0
1028915|NCT00673465|2499073|P3|COMPLETED|Part 2 (India)||0
1028916|NCT00673465|2499074|P2|COMPLETED|Part 2 (India)||0
1028917|NCT00673465|2499075|P1|COMPLETED|Part 2 (India)||0
1028918|NCT00673465|2499064|P12|STARTED|Part 2 (India)||0
1028919|NCT00673465|2499065|P11|STARTED|Part 2 (India)||0
1028920|NCT00673465|2499066|P10|STARTED|Part 2 (India)||0
1028921|NCT00673465|2499067|P9|STARTED|Part 2 (India)||0
1028922|NCT00673465|2499068|P8|STARTED|Part 2 (India)||0
1028923|NCT00673465|2499069|P7|STARTED|Part 2 (India)||0
1028924|NCT00673465|2499070|P6|STARTED|Part 2 (India)||0
1028925|NCT00673465|2499071|P5|STARTED|Part 2 (India)||0
1028926|NCT00673465|2499072|P4|STARTED|Part 2 (India)||0
1028927|NCT00673465|2499073|P3|STARTED|Part 2 (India)||0
1028928|NCT00673465|2499074|P2|STARTED|Part 2 (India)||0
1028929|NCT00673465|2499075|P1|STARTED|Part 2 (India)||0
1028930|NCT00673465|2499064|P12|NOT COMPLETED|Part 1/Period 3 (United States)||0
1028931|NCT00673465|2499065|P11|NOT COMPLETED|Part 1/Period 3 (United States)||0
1028932|NCT00673465|2499066|P10|NOT COMPLETED|Part 1/Period 3 (United States)||0
1028933|NCT00673465|2499067|P9|NOT COMPLETED|Part 1/Period 3 (United States)||0
1028934|NCT00673465|2499068|P8|NOT COMPLETED|Part 1/Period 3 (United States)||0
1028935|NCT00673465|2499069|P7|NOT COMPLETED|Part 1/Period 3 (United States)||0
1028936|NCT00673465|2499070|P6|NOT COMPLETED|Part 1/Period 3 (United States)||0
1028937|NCT00673465|2499071|P5|NOT COMPLETED|Part 1/Period 3 (United States)||0
1028938|NCT00673465|2499072|P4|NOT COMPLETED|Part 1/Period 3 (United States)||0
1028939|NCT00673465|2499073|P3|NOT COMPLETED|Part 1/Period 3 (United States)||0
1028940|NCT00673465|2499074|P2|NOT COMPLETED|Part 1/Period 3 (United States)||0
1028941|NCT00673465|2499075|P1|NOT COMPLETED|Part 1/Period 3 (United States)||0
1028942|NCT00673465|2499064|P12|COMPLETED|Part 1/Period 3 (United States)||0
1028943|NCT00673465|2499065|P11|COMPLETED|Part 1/Period 3 (United States)||0
1028944|NCT00673465|2499066|P10|COMPLETED|Part 1/Period 3 (United States)||0
1028945|NCT00673465|2499067|P9|COMPLETED|Part 1/Period 3 (United States)||0
1028946|NCT00673465|2499068|P8|COMPLETED|Part 1/Period 3 (United States)||0
1028947|NCT00673465|2499069|P7|COMPLETED|Part 1/Period 3 (United States)||0
1028948|NCT00673465|2499070|P6|COMPLETED|Part 1/Period 3 (United States)||1
1028949|NCT00673465|2499071|P5|COMPLETED|Part 1/Period 3 (United States)||1
1028950|NCT00673465|2499072|P4|COMPLETED|Part 1/Period 3 (United States)||3
1028951|NCT00673465|2499073|P3|COMPLETED|Part 1/Period 3 (United States)||3
1028952|NCT00673465|2499074|P2|COMPLETED|Part 1/Period 3 (United States)||3
1028953|NCT00673465|2499075|P1|COMPLETED|Part 1/Period 3 (United States)||3
1028954|NCT00673465|2499064|P12|STARTED|Part 1/Period 3 (United States)||0
1028955|NCT00673465|2499065|P11|STARTED|Part 1/Period 3 (United States)||0
1028956|NCT00673465|2499066|P10|STARTED|Part 1/Period 3 (United States)||0
1028957|NCT00673465|2499067|P9|STARTED|Part 1/Period 3 (United States)||0
1028958|NCT00673465|2499068|P8|STARTED|Part 1/Period 3 (United States)||0
1028959|NCT00673465|2499069|P7|STARTED|Part 1/Period 3 (United States)||0
1028960|NCT00673465|2499070|P6|STARTED|Part 1/Period 3 (United States)||1
1028961|NCT00673465|2499071|P5|STARTED|Part 1/Period 3 (United States)||1
1028962|NCT00673465|2499072|P4|STARTED|Part 1/Period 3 (United States)||3
1028963|NCT00673465|2499073|P3|STARTED|Part 1/Period 3 (United States)||3
1028964|NCT00673465|2499074|P2|STARTED|Part 1/Period 3 (United States)||3
1028965|NCT00673465|2499075|P1|STARTED|Part 1/Period 3 (United States)||3
1028966|NCT00673465|2499064|P12|NOT COMPLETED|Part 1/Period 2 (United States)||0
1028967|NCT00673465|2499065|P11|NOT COMPLETED|Part 1/Period 2 (United States)||0
1028968|NCT00673465|2499066|P10|NOT COMPLETED|Part 1/Period 2 (United States)||0
1028969|NCT00673465|2499067|P9|NOT COMPLETED|Part 1/Period 2 (United States)||0
1028970|NCT00673465|2499068|P8|NOT COMPLETED|Part 1/Period 2 (United States)||0
1028971|NCT00673465|2499069|P7|NOT COMPLETED|Part 1/Period 2 (United States)||0
1028972|NCT00673465|2499070|P6|NOT COMPLETED|Part 1/Period 2 (United States)||0
1028973|NCT00673465|2499071|P5|NOT COMPLETED|Part 1/Period 2 (United States)||1
1028974|NCT00673465|2499072|P4|NOT COMPLETED|Part 1/Period 2 (United States)||0
1028975|NCT00673465|2499073|P3|NOT COMPLETED|Part 1/Period 2 (United States)||0
1028976|NCT00673465|2499074|P2|NOT COMPLETED|Part 1/Period 2 (United States)||0
1028977|NCT00673465|2499075|P1|NOT COMPLETED|Part 1/Period 2 (United States)||0
1028978|NCT00673465|2499064|P12|COMPLETED|Part 1/Period 2 (United States)||0
1028979|NCT00673465|2499065|P11|COMPLETED|Part 1/Period 2 (United States)||0
1028980|NCT00673465|2499066|P10|COMPLETED|Part 1/Period 2 (United States)||0
1028981|NCT00673465|2499067|P9|COMPLETED|Part 1/Period 2 (United States)||0
1028982|NCT00673465|2499068|P8|COMPLETED|Part 1/Period 2 (United States)||0
1028983|NCT00673465|2499069|P7|COMPLETED|Part 1/Period 2 (United States)||0
1028984|NCT00673465|2499070|P6|COMPLETED|Part 1/Period 2 (United States)||1
1028985|NCT00673465|2499071|P5|COMPLETED|Part 1/Period 2 (United States)||1
1028986|NCT00673465|2499072|P4|COMPLETED|Part 1/Period 2 (United States)||3
1028987|NCT00673465|2499073|P3|COMPLETED|Part 1/Period 2 (United States)||3
1028988|NCT00673465|2499074|P2|COMPLETED|Part 1/Period 2 (United States)||3
1028989|NCT00673465|2499075|P1|COMPLETED|Part 1/Period 2 (United States)||3
1028990|NCT00673465|2499064|P12|STARTED|Part 1/Period 2 (United States)||0
1028991|NCT00673465|2499065|P11|STARTED|Part 1/Period 2 (United States)||0
1028992|NCT00673465|2499066|P10|STARTED|Part 1/Period 2 (United States)||0
1028993|NCT00673465|2499067|P9|STARTED|Part 1/Period 2 (United States)||0
1028994|NCT00673465|2499068|P8|STARTED|Part 1/Period 2 (United States)||0
1028995|NCT00673465|2499069|P7|STARTED|Part 1/Period 2 (United States)||0
1028996|NCT00673465|2499070|P6|STARTED|Part 1/Period 2 (United States)||1
1028997|NCT00673465|2499071|P5|STARTED|Part 1/Period 2 (United States)||2
1028998|NCT00673465|2499072|P4|STARTED|Part 1/Period 2 (United States)||3
1028999|NCT00673465|2499073|P3|STARTED|Part 1/Period 2 (United States)||3
1029000|NCT00673465|2499074|P2|STARTED|Part 1/Period 2 (United States)||3
1029001|NCT00673465|2499075|P1|STARTED|Part 1/Period 2 (United States)||3
1029002|NCT00673465|2499064|P12|NOT COMPLETED|Part 1/Period 1 (United States)||0
1029003|NCT00673465|2499065|P11|NOT COMPLETED|Part 1/Period 1 (United States)||0
1029004|NCT00673465|2499066|P10|NOT COMPLETED|Part 1/Period 1 (United States)||0
1029005|NCT00673465|2499067|P9|NOT COMPLETED|Part 1/Period 1 (United States)||0
1029006|NCT00673465|2499068|P8|NOT COMPLETED|Part 1/Period 1 (United States)||0
1029007|NCT00673465|2499069|P7|NOT COMPLETED|Part 1/Period 1 (United States)||0
1029008|NCT00673465|2499070|P6|NOT COMPLETED|Part 1/Period 1 (United States)||1
1029009|NCT00673465|2499071|P5|NOT COMPLETED|Part 1/Period 1 (United States)||1
1029010|NCT00673465|2499072|P4|NOT COMPLETED|Part 1/Period 1 (United States)||0
1029011|NCT00673465|2499073|P3|NOT COMPLETED|Part 1/Period 1 (United States)||0
1029012|NCT00673465|2499074|P2|NOT COMPLETED|Part 1/Period 1 (United States)||0
1029013|NCT00673465|2499075|P1|NOT COMPLETED|Part 1/Period 1 (United States)||0
1029014|NCT00673465|2499064|P12|COMPLETED|Part 1/Period 1 (United States)||0
1029015|NCT00673465|2499065|P11|COMPLETED|Part 1/Period 1 (United States)||0
1029016|NCT00673465|2499066|P10|COMPLETED|Part 1/Period 1 (United States)||0
1029017|NCT00673465|2499067|P9|COMPLETED|Part 1/Period 1 (United States)||0
1029018|NCT00673465|2499068|P8|COMPLETED|Part 1/Period 1 (United States)||0
1029019|NCT00673465|2499069|P7|COMPLETED|Part 1/Period 1 (United States)||0
1029020|NCT00673465|2499070|P6|COMPLETED|Part 1/Period 1 (United States)||1
1029021|NCT00673465|2499071|P5|COMPLETED|Part 1/Period 1 (United States)||2
1029022|NCT00673465|2499072|P4|COMPLETED|Part 1/Period 1 (United States)||3
1029023|NCT00673465|2499073|P3|COMPLETED|Part 1/Period 1 (United States)||3
1029024|NCT00673465|2499074|P2|COMPLETED|Part 1/Period 1 (United States)||3
1029025|NCT00673465|2499075|P1|COMPLETED|Part 1/Period 1 (United States)||3
1029026|NCT00673465|2499064|P12|STARTED|Part 1/Period 1 (United States)||0
1029027|NCT00673465|2499065|P11|STARTED|Part 1/Period 1 (United States)||0
1029028|NCT00673465|2499066|P10|STARTED|Part 1/Period 1 (United States)||0
1029029|NCT00673465|2499067|P9|STARTED|Part 1/Period 1 (United States)||0
1029030|NCT00673465|2499068|P8|STARTED|Part 1/Period 1 (United States)||0
1029031|NCT00673465|2499069|P7|STARTED|Part 1/Period 1 (United States)||0
1029032|NCT00673465|2499070|P6|STARTED|Part 1/Period 1 (United States)||2
1029033|NCT00673465|2499071|P5|STARTED|Part 1/Period 1 (United States)||3
1029034|NCT00673465|2499072|P4|STARTED|Part 1/Period 1 (United States)||3
1029035|NCT00673465|2499073|P3|STARTED|Part 1/Period 1 (United States)||3
1029036|NCT00673465|2499074|P2|STARTED|Part 1/Period 1 (United States)||3
1029037|NCT00673465|2499075|P1|STARTED|Part 1/Period 1 (United States)||3
1029038|NCT00673595|2499124|P2|NOT COMPLETED|Overall Study||0
1029039|NCT00673595|2499125|P1|NOT COMPLETED|Overall Study||0
1029040|NCT00673595|2499124|P2|COMPLETED|Overall Study||11
1029041|NCT00673595|2499125|P1|COMPLETED|Overall Study||8
1029042|NCT00673595|2499124|P2|STARTED|Overall Study||11
1029043|NCT00673595|2499125|P1|STARTED|Overall Study||8
1029044|NCT00673660|2499133|P1|NOT COMPLETED|Overall Study||107
1029045|NCT00673660|2499133|P1|COMPLETED|Overall Study||268
1029046|NCT00673660|2499133|P1|STARTED|Overall Study||375
1029047|NCT00673673|2499144|P1|NOT COMPLETED|Overall Study||36
1029048|NCT00673673|2499144|P1|COMPLETED|Overall Study||3
1029049|NCT00673673|2499144|P1|STARTED|Overall Study||39
1029050|NCT00679302|2499152|P2|NOT COMPLETED|Overall Study||4
1029051|NCT00679302|2499153|P1|NOT COMPLETED|Overall Study||8
1029052|NCT00679302|2499152|P2|COMPLETED|Overall Study||73
1029053|NCT00679302|2499153|P1|COMPLETED|Overall Study||76
1029054|NCT00679302|2499152|P2|STARTED|Overall Study||77
1029055|NCT00679302|2499153|P1|STARTED|Overall Study||84
1029056|NCT00679341|2499163|P2|NOT COMPLETED|Overall Study||51
1029057|NCT00679341|2499164|P1|NOT COMPLETED|Overall Study||53
1029058|NCT00679341|2499163|P2|COMPLETED|Overall Study||19
1029059|NCT00679341|2499164|P1|COMPLETED|Overall Study||14
1029060|NCT00679341|2499163|P2|STARTED|Overall Study||70
1029061|NCT00679341|2499164|P1|STARTED|Overall Study||67
1029062|NCT00679354|2499182|P1|NOT COMPLETED|Overall Study||30
1029063|NCT00679354|2499182|P1|COMPLETED|Overall Study||0
1029064|NCT00679354|2499182|P1|STARTED|Overall Study||30
1029065|NCT00679367|2499186|P1|NOT COMPLETED|Overall Study||12
1029066|NCT00679367|2499186|P1|COMPLETED|Overall Study||4
1029067|NCT00679367|2499186|P1|STARTED|Overall Study||16
1029068|NCT00679380|2499196|P4|NOT COMPLETED|Overall Study||28
1029069|NCT00679380|2499197|P3|NOT COMPLETED|Overall Study||35
1029070|NCT00679380|2499198|P2|NOT COMPLETED|Overall Study||33
1029071|NCT00679380|2499199|P1|NOT COMPLETED|Overall Study||42
1029072|NCT00679380|2499196|P4|COMPLETED|Overall Study||61
1029073|NCT00679380|2499197|P3|COMPLETED|Overall Study||68
1029074|NCT00679380|2499198|P2|COMPLETED|Overall Study||76
1029075|NCT00679380|2499199|P1|COMPLETED|Overall Study||67
1029076|NCT00679380|2499196|P4|STARTED|Overall Study||89
1029077|NCT00679380|2499197|P3|STARTED|Overall Study||103
1029078|NCT00679380|2499198|P2|STARTED|Overall Study||109
1029079|NCT00679380|2499199|P1|STARTED|Overall Study||109
1029080|NCT00679432|2499221|P4|NOT COMPLETED|Overall Study||32
1029081|NCT00679432|2499222|P3|NOT COMPLETED|Overall Study||53
1029082|NCT00679432|2499223|P2|NOT COMPLETED|Overall Study||38
1029083|NCT00679432|2499224|P1|NOT COMPLETED|Overall Study||37
1029084|NCT00679432|2499221|P4|COMPLETED|Overall Study||95
1029085|NCT00679432|2499222|P3|COMPLETED|Overall Study||76
1029086|NCT00679432|2499223|P2|COMPLETED|Overall Study||89
1029087|NCT00679432|2499224|P1|COMPLETED|Overall Study||89
1029088|NCT00679432|2499221|P4|STARTED|Overall Study||127
1029089|NCT00679432|2499222|P3|STARTED|Overall Study||129
1029090|NCT00679432|2499223|P2|STARTED|Overall Study||127
1029091|NCT00679432|2499224|P1|STARTED|Overall Study||126
1029092|NCT00679627|2499244|P2|NOT COMPLETED|Overall Study||685
1029093|NCT00679627|2499245|P1|NOT COMPLETED|Overall Study||699
1029094|NCT00679627|2499244|P2|COMPLETED|Overall Study||339
1029095|NCT00679627|2499245|P1|COMPLETED|Overall Study||322
1029096|NCT00679627|2499244|P2|STARTED|Overall Study||1024
1029097|NCT00679627|2499245|P1|STARTED|Overall Study||1021
1029098|NCT00681265|2499267|P1|NOT COMPLETED|Overall Study||0
1029099|NCT00681265|2499267|P1|COMPLETED|Overall Study||16
1029100|NCT00681265|2499267|P1|STARTED|Overall Study||16
1029101|NCT00681291|2499277|P2|NOT COMPLETED|Overall Study||27
1029102|NCT00681291|2499278|P1|NOT COMPLETED|Overall Study||13
1029103|NCT00681291|2499277|P2|COMPLETED|Overall Study||57
1029104|NCT00681291|2499278|P1|COMPLETED|Overall Study||75
1029105|NCT00681291|2499277|P2|STARTED|Overall Study||84
1029106|NCT00681291|2499278|P1|STARTED|Overall Study||88
1029107|NCT00681473|2499290|P1|NOT COMPLETED|Overall Study||0
1029108|NCT00681473|2499290|P1|COMPLETED|Overall Study|All 20 patients completed RT and tolerated treatment well.|20
1029109|NCT00681473|2499290|P1|STARTED|Overall Study|20 patients with WHO Grade 2 Glioma were enrolled.|20
1029110|NCT00681538|2499298|P2|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||2
1029111|NCT00681538|2499299|P1|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||15
1029112|NCT00681538|2499298|P2|COMPLETED|Phase B- Responders;12 Week Double-blind||115
1029113|NCT00681538|2499299|P1|COMPLETED|Phase B- Responders;12 Week Double-blind||109
1029114|NCT00681538|2499298|P2|STARTED|Phase B- Responders;12 Week Double-blind||117
1029115|NCT00681538|2499299|P1|STARTED|Phase B- Responders;12 Week Double-blind||124
1029116|NCT00681538|2499298|P2|NOT COMPLETED|Phase A- 4 Weeks Single Blind||0
1029117|NCT00681538|2499299|P1|NOT COMPLETED|Phase A- 4 Weeks Single Blind||34
1029118|NCT00681538|2499298|P2|COMPLETED|Phase A- 4 Weeks Single Blind||0
1029119|NCT00681538|2499299|P1|COMPLETED|Phase A- 4 Weeks Single Blind||538
1029120|NCT00681538|2499298|P2|STARTED|Phase A- 4 Weeks Single Blind||0
1029121|NCT00681538|2499299|P1|STARTED|Phase A- 4 Weeks Single Blind||572
1029122|NCT00681564|2499331|P2|NOT COMPLETED|Overall Study||8
1029123|NCT00681564|2499332|P1|NOT COMPLETED|Overall Study||6
1029124|NCT00681564|2499331|P2|COMPLETED|Overall Study||47
1029125|NCT00681564|2499332|P1|COMPLETED|Overall Study||41
1029126|NCT00681564|2499331|P2|STARTED|Overall Study||55
1029127|NCT00681564|2499332|P1|STARTED|Overall Study||47
1029128|NCT00681590|2499362|P2|NOT COMPLETED|Overall Study||12
1029129|NCT00681590|2499363|P1|NOT COMPLETED|Overall Study||2
1029130|NCT00681590|2499362|P2|COMPLETED|Overall Study||59
1029131|NCT00681590|2499363|P1|COMPLETED|Overall Study||32
1029132|NCT00681590|2499362|P2|STARTED|Overall Study||71
1029133|NCT00681590|2499363|P1|STARTED|Overall Study||34
1029134|NCT00681629|2499373|P2|NOT COMPLETED|Overall Study||2
1029135|NCT00681629|2499374|P1|NOT COMPLETED|Overall Study||5
1029136|NCT00681629|2499373|P2|COMPLETED|Overall Study||0
1029137|NCT00681629|2499374|P1|COMPLETED|Overall Study||0
1029138|NCT00681629|2499373|P2|STARTED|Overall Study|It was planned to recruit 100 patient|2
1029139|NCT00681629|2499374|P1|STARTED|Overall Study|It was planned to recruit 100 patient|5
1029140|NCT00681668|2499418|P1|NOT COMPLETED|Overall Study||2
1029141|NCT00681668|2499418|P1|COMPLETED|Overall Study||3
1029142|NCT00681668|2499418|P1|STARTED|Overall Study||5
1029143|NCT00681811|2499427|P2|NOT COMPLETED|Overall Study||4
1029144|NCT00681811|2499428|P1|NOT COMPLETED|Overall Study||3
1029145|NCT00681811|2499427|P2|COMPLETED|Overall Study||1
1029146|NCT00681811|2499428|P1|COMPLETED|Overall Study||3
1029147|NCT00681811|2499427|P2|STARTED|Overall Study||5
1029148|NCT00681811|2499428|P1|STARTED|Overall Study||6
1029149|NCT00681824|2499459|P3|NOT COMPLETED|Overall Study||1
1029150|NCT00681824|2499460|P2|NOT COMPLETED|Overall Study||1
1029151|NCT00681824|2499461|P1|NOT COMPLETED|Overall Study||1
1029152|NCT00681824|2499459|P3|COMPLETED|Overall Study||33
1029153|NCT00681824|2499460|P2|COMPLETED|Overall Study||12
1029154|NCT00681824|2499461|P1|COMPLETED|Overall Study||27
1029155|NCT00681824|2499459|P3|STARTED|Overall Study||34
1029156|NCT00681824|2499460|P2|STARTED|Overall Study||13
1029157|NCT00681824|2499461|P1|STARTED|Overall Study||28
1029158|NCT00681863|2499477|P1|NOT COMPLETED|Overall Study||23
1029159|NCT00681863|2499477|P1|COMPLETED|Overall Study||22
1029160|NCT00681863|2499477|P1|STARTED|Overall Study||45
1029161|NCT00681889|2499522|P1|NOT COMPLETED|Overall Study||0
1029162|NCT00681889|2499522|P1|COMPLETED|Overall Study||9
1029163|NCT00681889|2499522|P1|STARTED|Overall Study||9
1029164|NCT00682357|2499529|P3|NOT COMPLETED|Overall Study||0
1029165|NCT00682357|2499530|P2|NOT COMPLETED|Overall Study||0
1029166|NCT00682357|2499531|P1|NOT COMPLETED|Overall Study||0
1029167|NCT00682357|2499529|P3|COMPLETED|Overall Study||5
1029168|NCT00682357|2499530|P2|COMPLETED|Overall Study||10
1029169|NCT00682357|2499531|P1|COMPLETED|Overall Study||10
1029170|NCT00682357|2499529|P3|STARTED|Overall Study||5
1029171|NCT00682357|2499530|P2|STARTED|Overall Study||10
1029172|NCT00682357|2499531|P1|STARTED|Overall Study||10
1029173|NCT00682461|2499550|P2|NOT COMPLETED|Overall Study||31
1029174|NCT00682461|2499551|P1|NOT COMPLETED|Overall Study||25
1029175|NCT00682461|2499550|P2|COMPLETED|Overall Study||69
1029176|NCT00682461|2499551|P1|COMPLETED|Overall Study||75
1029177|NCT00682461|2499550|P2|STARTED|Overall Study||100
1029178|NCT00682461|2499551|P1|STARTED|Overall Study||100
1029179|NCT00682539|2499568|P3|NOT COMPLETED|Ranibizumab vs Triamcinolone||8
1029180|NCT00682539|2499569|P2|NOT COMPLETED|Ranibizumab vs Triamcinolone||3
1029181|NCT00682539|2499570|P1|NOT COMPLETED|Ranibizumab vs Triamcinolone||0
1029182|NCT00682539|2499568|P3|COMPLETED|Ranibizumab vs Triamcinolone||10
1029183|NCT00682539|2499569|P2|COMPLETED|Ranibizumab vs Triamcinolone||15
1029184|NCT00682539|2499570|P1|COMPLETED|Ranibizumab vs Triamcinolone||0
1029185|NCT00682539|2499568|P3|STARTED|Ranibizumab vs Triamcinolone|Both periods recruited independently following the same criteria.|18
1029186|NCT00682539|2499569|P2|STARTED|Ranibizumab vs Triamcinolone|None of the patients of the 1st period was included in the second period.|18
1029187|NCT00682539|2499570|P1|STARTED|Ranibizumab vs Triamcinolone|Two independent periods.|0
1029188|NCT00682539|2499568|P3|NOT COMPLETED|Bevacizumab vs Triamcinolone||0
1029189|NCT00682539|2499569|P2|NOT COMPLETED|Bevacizumab vs Triamcinolone||1
1029190|NCT00682539|2499570|P1|NOT COMPLETED|Bevacizumab vs Triamcinolone||3
1029191|NCT00682539|2499568|P3|COMPLETED|Bevacizumab vs Triamcinolone||0
1029192|NCT00682539|2499569|P2|COMPLETED|Bevacizumab vs Triamcinolone||15
1029193|NCT00682539|2499570|P1|COMPLETED|Bevacizumab vs Triamcinolone||15
1029194|NCT00682539|2499568|P3|STARTED|Bevacizumab vs Triamcinolone||0
1029195|NCT00682539|2499569|P2|STARTED|Bevacizumab vs Triamcinolone||16
1029196|NCT00682539|2499570|P1|STARTED|Bevacizumab vs Triamcinolone||18
1029197|NCT00682565|2499584|P3|NOT COMPLETED|Overall Study||0
1029198|NCT00682565|2499585|P2|NOT COMPLETED|Overall Study||2
1029199|NCT00682565|2499586|P1|NOT COMPLETED|Overall Study||1
1029200|NCT00682565|2499584|P3|COMPLETED|Overall Study||29
1029201|NCT00682565|2499585|P2|COMPLETED|Overall Study||32
1029202|NCT00682565|2499586|P1|COMPLETED|Overall Study||30
1029203|NCT00682565|2499584|P3|STARTED|Overall Study||29
1029204|NCT00682565|2499585|P2|STARTED|Overall Study||34
1029205|NCT00682565|2499586|P1|STARTED|Overall Study||31
1029206|NCT00682643|2499609|P2|NOT COMPLETED|Overall Study||169
1029207|NCT00682643|2499610|P1|NOT COMPLETED|Overall Study||78
1029208|NCT00682643|2499609|P2|COMPLETED|Overall Study||199
1029209|NCT00682643|2499610|P1|COMPLETED|Overall Study||104
1029210|NCT00682643|2499609|P2|STARTED|Overall Study||368
1029211|NCT00682643|2499610|P1|STARTED|Overall Study||182
1029212|NCT00682734|2499645|P3|NOT COMPLETED|48 Hour Follow-up||11
1029213|NCT00682734|2499646|P2|NOT COMPLETED|48 Hour Follow-up||6
1029214|NCT00682734|2499647|P1|NOT COMPLETED|48 Hour Follow-up||6
1029215|NCT00682734|2499645|P3|COMPLETED|48 Hour Follow-up||106
1029216|NCT00682734|2499646|P2|COMPLETED|48 Hour Follow-up||111
1029217|NCT00682734|2499647|P1|COMPLETED|48 Hour Follow-up||107
1029218|NCT00682734|2499645|P3|STARTED|48 Hour Follow-up||117
1029219|NCT00682734|2499646|P2|STARTED|48 Hour Follow-up||117
1029220|NCT00682734|2499647|P1|STARTED|48 Hour Follow-up||113
1029221|NCT00682734|2499645|P3|NOT COMPLETED|Emergency Department Portion||1
1029222|NCT00682734|2499646|P2|NOT COMPLETED|Emergency Department Portion||1
1029223|NCT00682734|2499647|P1|NOT COMPLETED|Emergency Department Portion||0
1029224|NCT00682734|2499645|P3|COMPLETED|Emergency Department Portion||117
1029225|NCT00682734|2499646|P2|COMPLETED|Emergency Department Portion||117
1029226|NCT00682734|2499647|P1|COMPLETED|Emergency Department Portion||113
1029227|NCT00682734|2499645|P3|STARTED|Emergency Department Portion||118
1029228|NCT00682734|2499646|P2|STARTED|Emergency Department Portion||118
1029229|NCT00682734|2499647|P1|STARTED|Emergency Department Portion||113
1029230|NCT00682786|2499657|P2|NOT COMPLETED|Overall Study||3
1029231|NCT00682786|2499658|P1|NOT COMPLETED|Overall Study||2
1029232|NCT00682786|2499657|P2|COMPLETED|Overall Study||34
1029233|NCT00682786|2499658|P1|COMPLETED|Overall Study||96
1029234|NCT00682786|2499657|P2|STARTED|Overall Study||37
1029235|NCT00682786|2499658|P1|STARTED|Overall Study||98
1029236|NCT00682838|2499696|P4|NOT COMPLETED|Overall Study||0
1029237|NCT00682838|2499697|P3|NOT COMPLETED|Overall Study||0
1029238|NCT00682838|2499698|P2|NOT COMPLETED|Overall Study||0
1029239|NCT00682838|2499699|P1|NOT COMPLETED|Overall Study||0
1029240|NCT00682838|2499696|P4|COMPLETED|Overall Study||73
1029241|NCT00682838|2499697|P3|COMPLETED|Overall Study||75
1029242|NCT00682838|2499698|P2|COMPLETED|Overall Study||67
1029243|NCT00682838|2499699|P1|COMPLETED|Overall Study||65
1029244|NCT00682838|2499696|P4|STARTED|Overall Study||73
1029245|NCT00682838|2499697|P3|STARTED|Overall Study||75
1029246|NCT00682838|2499698|P2|STARTED|Overall Study||67
1029247|NCT00682838|2499699|P1|STARTED|Overall Study||65
1029248|NCT00682851|2499711|P2|NOT COMPLETED|Overall Study||0
1029249|NCT00682851|2499712|P1|NOT COMPLETED|Overall Study||0
1029250|NCT00682851|2499711|P2|COMPLETED|Overall Study||268
1029251|NCT00682851|2499712|P1|COMPLETED|Overall Study||251
1029252|NCT00682851|2499711|P2|STARTED|Overall Study||268
1029253|NCT00682851|2499712|P1|STARTED|Overall Study||251
1029254|NCT00682890|2499726|P2|NOT COMPLETED|Overall Study||2
1029255|NCT00682890|2499727|P1|NOT COMPLETED|Overall Study||2
1029256|NCT00682890|2499726|P2|COMPLETED|Overall Study||9
1029257|NCT00682890|2499727|P1|COMPLETED|Overall Study||10
1029258|NCT00682890|2499726|P2|STARTED|Overall Study||11
1029259|NCT00682890|2499727|P1|STARTED|Overall Study||12
1029260|NCT00683020|2499737|P2|NOT COMPLETED|Overall Study||55
1029261|NCT00683020|2499738|P1|NOT COMPLETED|Overall Study||55
1029262|NCT00683020|2499737|P2|COMPLETED|Overall Study||125
1029263|NCT00683020|2499738|P1|COMPLETED|Overall Study||127
1029264|NCT00683020|2499737|P2|STARTED|Overall Study||180
1029265|NCT00683020|2499738|P1|STARTED|Overall Study||182
1029266|NCT00683046|2499766|P1|NOT COMPLETED|Overall Study||0
1029267|NCT00683046|2499766|P1|COMPLETED|Overall Study||204
1029268|NCT00683046|2499766|P1|STARTED|Overall Study||204
1029269|NCT00683085|2499771|P1|NOT COMPLETED|Overall Study||0
1029270|NCT00683085|2499771|P1|COMPLETED|Overall Study||2
1029271|NCT00683085|2499771|P1|STARTED|Overall Study||2
1029272|NCT00683163|2499778|P2|NOT COMPLETED|Overall Study||0
1029273|NCT00683163|2499779|P1|NOT COMPLETED|Overall Study||0
1029274|NCT00683163|2499778|P2|COMPLETED|Overall Study||22
1029275|NCT00683163|2499779|P1|COMPLETED|Overall Study||22
1029276|NCT00683163|2499778|P2|STARTED|Overall Study||22
1029277|NCT00683163|2499779|P1|STARTED|Overall Study||22
1029278|NCT00683293|2499789|P2|NOT COMPLETED|Overall Study||3
1029279|NCT00683293|2499790|P1|NOT COMPLETED|Overall Study||2
1029280|NCT00683293|2499789|P2|COMPLETED|Overall Study||47
1029281|NCT00683293|2499790|P1|COMPLETED|Overall Study||48
1029282|NCT00683293|2499789|P2|STARTED|Overall Study||50
1029283|NCT00683293|2499790|P1|STARTED|Overall Study||50
1029284|NCT00683332|2499798|P1|NOT COMPLETED|Overall Study||0
1029285|NCT00683332|2499798|P1|COMPLETED|Overall Study||621
1029286|NCT00683332|2499798|P1|STARTED|Overall Study||621
1029287|NCT00683384|2499802|P1|NOT COMPLETED|Overall Study||2
1029288|NCT00683384|2499802|P1|COMPLETED|Overall Study||91
1029289|NCT00683384|2499802|P1|STARTED|Overall Study||93
1029290|NCT00683410|2499806|P1|NOT COMPLETED|Overall Study||0
1029291|NCT00683410|2499806|P1|COMPLETED|Overall Study||3366
1029292|NCT00683410|2499806|P1|Vaccinated Dose 4|Overall Study||175
1029293|NCT00683410|2499806|P1|Vaccinated Dose 3|Overall Study||817
1029294|NCT00683410|2499806|P1|Vaccinated Dose 2|Overall Study||1623
1029295|NCT00683410|2499806|P1|Vaccinated Dose 1|Overall Study||3240
1029296|NCT00683410|2499806|P1|STARTED|Overall Study||3366
1029297|NCT00683449|2499815|P5|NOT COMPLETED|Overall Study||0
1029298|NCT00683449|2499816|P4|NOT COMPLETED|Overall Study||0
1029299|NCT00683449|2499817|P3|NOT COMPLETED|Overall Study||0
1029300|NCT00683449|2499818|P2|NOT COMPLETED|Overall Study||1
1029301|NCT00683449|2499819|P1|NOT COMPLETED|Overall Study||0
1029302|NCT00683449|2499815|P5|COMPLETED|Overall Study||2
1029303|NCT00683449|2499816|P4|COMPLETED|Overall Study||6
1029304|NCT00683449|2499817|P3|COMPLETED|Overall Study||3
1029305|NCT00683449|2499818|P2|COMPLETED|Overall Study||12
1029306|NCT00683449|2499819|P1|COMPLETED|Overall Study||5
1029307|NCT00683449|2499815|P5|STARTED|Overall Study||2
1029308|NCT00683449|2499816|P4|STARTED|Overall Study||6
1029309|NCT00683449|2499817|P3|STARTED|Overall Study||3
1029310|NCT00683449|2499818|P2|STARTED|Overall Study||13
1029311|NCT00683449|2499819|P1|STARTED|Overall Study||5
1029312|NCT00683475|2499843|P2|NOT COMPLETED|Overall Study||3
1029313|NCT00683475|2499844|P1|NOT COMPLETED|Overall Study||4
1029314|NCT00683475|2499843|P2|COMPLETED|Overall Study||66
1029315|NCT00683475|2499844|P1|COMPLETED|Overall Study||65
1029316|NCT00683475|2499843|P2|Received Any Quantity of Study Drug|Overall Study||66
1029317|NCT00683475|2499844|P1|Received Any Quantity of Study Drug|Overall Study||66
1029318|NCT00683475|2499843|P2|STARTED|Overall Study||69
1029319|NCT00683475|2499844|P1|STARTED|Overall Study||69
1029320|NCT00683592|2499876|P2|NOT COMPLETED|Overall Study||46
1029321|NCT00683592|2499877|P1|NOT COMPLETED|Overall Study||47
1029322|NCT00683592|2499876|P2|COMPLETED|Overall Study||195
1029323|NCT00683592|2499877|P1|COMPLETED|Overall Study||193
1029324|NCT00683592|2499876|P2|Safety Population|Overall Study||233
1029325|NCT00683592|2499877|P1|Safety Population|Overall Study||235
1029326|NCT00683592|2499876|P2|Intent to Treat Population|Overall Study||232
1029327|NCT00683592|2499877|P1|Intent to Treat Population|Overall Study||231
1029328|NCT00683592|2499876|P2|STARTED|Overall Study||241
1029329|NCT00683592|2499877|P1|STARTED|Overall Study||240
1029330|NCT00683618|2499896|P3|NOT COMPLETED|Extension Treatment Period||0
1029331|NCT00683618|2499897|P2|NOT COMPLETED|Extension Treatment Period||0
1029332|NCT00683618|2499898|P1|NOT COMPLETED|Extension Treatment Period||3
1029333|NCT00683618|2499896|P3|COMPLETED|Extension Treatment Period||0
1029334|NCT00683618|2499897|P2|COMPLETED|Extension Treatment Period||23
1029335|NCT00683618|2499898|P1|COMPLETED|Extension Treatment Period||33
1029336|NCT00683618|2499896|P3|STARTED|Extension Treatment Period||0
1029337|NCT00683618|2499897|P2|STARTED|Extension Treatment Period||23
1029338|NCT00683618|2499898|P1|STARTED|Extension Treatment Period||36
1029339|NCT00683618|2499896|P3|NOT COMPLETED|Randomised Treatment Period||6
1029340|NCT00683618|2499897|P2|NOT COMPLETED|Randomised Treatment Period||2
1029341|NCT00683618|2499898|P1|NOT COMPLETED|Randomised Treatment Period||6
1029342|NCT00683618|2499896|P3|COMPLETED|Randomised Treatment Period||140
1029343|NCT00683618|2499897|P2|COMPLETED|Randomised Treatment Period||143
1029344|NCT00683618|2499898|P1|COMPLETED|Randomised Treatment Period||139
1029345|NCT00683618|2499896|P3|STARTED|Randomised Treatment Period||146
1029346|NCT00683618|2499897|P2|STARTED|Randomised Treatment Period||145
1029347|NCT00683618|2499898|P1|STARTED|Randomised Treatment Period||145
1029348|NCT00683657|2499948|P2|NOT COMPLETED|Overall Study||1
1029349|NCT00683657|2499949|P1|NOT COMPLETED|Overall Study||1
1029350|NCT00683657|2499948|P2|COMPLETED|Overall Study||46
1029351|NCT00683657|2499949|P1|COMPLETED|Overall Study||45
1029352|NCT00683657|2499948|P2|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|47
1029353|NCT00683657|2499949|P1|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|46
1029354|NCT00683657|2499948|P2|STARTED|Overall Study||47
1029355|NCT00683657|2499949|P1|STARTED|Overall Study||46
1029356|NCT00683696|2499965|P2|NOT COMPLETED|Overall Study||405
1029357|NCT00683696|2499966|P1|NOT COMPLETED|Overall Study||404
1029358|NCT00683696|2499965|P2|COMPLETED|Overall Study||0
1029359|NCT00683696|2499966|P1|COMPLETED|Overall Study||0
1029360|NCT00683696|2499965|P2|STARTED|Overall Study||405
1029361|NCT00683696|2499966|P1|STARTED|Overall Study||404
1029362|NCT00683774|2499975|P2|NOT COMPLETED|Overall Study||1
1029363|NCT00683774|2499976|P1|NOT COMPLETED|Overall Study||3
1029364|NCT00683774|2499975|P2|COMPLETED|Overall Study||9
1029365|NCT00683774|2499976|P1|COMPLETED|Overall Study||8
1029366|NCT00683774|2499975|P2|STARTED|Overall Study||10
1029367|NCT00683774|2499976|P1|STARTED|Overall Study||11
1029368|NCT00683787|2499987|P3|NOT COMPLETED|Overall Study||2
1029369|NCT00683787|2499988|P2|NOT COMPLETED|Overall Study||3
1029370|NCT00683787|2499989|P1|NOT COMPLETED|Overall Study||3
1029371|NCT00683787|2499987|P3|COMPLETED|Overall Study||0
1029372|NCT00683787|2499988|P2|COMPLETED|Overall Study||0
1029373|NCT00683787|2499989|P1|COMPLETED|Overall Study||0
1029374|NCT00683787|2499987|P3|STARTED|Overall Study||2
1029375|NCT00683787|2499988|P2|STARTED|Overall Study||3
1029376|NCT00683787|2499989|P1|STARTED|Overall Study||3
1029377|NCT00676520|2500006|P1|NOT COMPLETED|Overall Study||731
1029378|NCT00676520|2500006|P1|COMPLETED|Overall Study||7309
1029379|NCT00676520|2500006|P1|STARTED|Overall Study||8040
1029380|NCT00676585|2500065|P2|NOT COMPLETED|Overall Study||0
1029381|NCT00676585|2500066|P1|NOT COMPLETED|Overall Study||0
1029382|NCT00676585|2500065|P2|COMPLETED|Overall Study||25
1029383|NCT00676585|2500066|P1|COMPLETED|Overall Study||25
1029384|NCT00676585|2500065|P2|STARTED|Overall Study||25
1029385|NCT00676585|2500066|P1|STARTED|Overall Study||25
1029386|NCT00676650|2500078|P2|NOT COMPLETED|Overall Study||289
1029387|NCT00676650|2500079|P1|NOT COMPLETED|Overall Study||584
1029388|NCT00676650|2500078|P2|COMPLETED|Overall Study||0
1029389|NCT00676650|2500079|P1|COMPLETED|Overall Study||0
1029390|NCT00676650|2500078|P2|Treated|Overall Study||285
1029391|NCT00676650|2500079|P1|Treated|Overall Study||581
1029392|NCT00676650|2500078|P2|STARTED|Overall Study||289
1029393|NCT00676650|2500079|P1|STARTED|Overall Study||584
1029394|NCT00676676|2500097|P1|NOT COMPLETED|Overall Study||0
1029395|NCT00676676|2500097|P1|COMPLETED|Overall Study||9
1029396|NCT00676676|2500097|P1|STARTED|Overall Study||9
1029397|NCT00676689|2500101|P1|NOT COMPLETED|Overall Study||61
1029398|NCT00676689|2500101|P1|COMPLETED|Overall Study||20
1029399|NCT00676689|2500101|P1|1 Year Follow-up|Overall Study||64
1029400|NCT00676689|2500101|P1|30 Day Follow-up|Overall Study||78
1029401|NCT00676689|2500101|P1|Procedure|Overall Study|Two enrolled patients did not meet eligibility criteria and did not undergo the study procedure.|79
1029402|NCT00676689|2500101|P1|STARTED|Overall Study||81
1029415|NCT00676780|2500144|P1|NOT COMPLETED|Overall Study||7
1029416|NCT00676780|2500144|P1|COMPLETED|Overall Study||26
1029417|NCT00676780|2500144|P1|STARTED|Overall Study||33
1029418|NCT00683800|2500152|P2|NOT COMPLETED|Overall Study||366
1029419|NCT00683800|2500153|P1|NOT COMPLETED|Overall Study||432
1029420|NCT00683800|2500152|P2|COMPLETED|Overall Study||719
1029421|NCT00683800|2500153|P1|COMPLETED|Overall Study||669
1029422|NCT00683800|2500152|P2|Treated|Overall Study||1052
1029423|NCT00683800|2500153|P1|Treated|Overall Study||1066
1029424|NCT00683800|2500152|P2|STARTED|Overall Study||1085
1029425|NCT00683800|2500153|P1|STARTED|Overall Study||1101
1029426|NCT00683826|2500220|P1|NOT COMPLETED|Overall Study||1
1029427|NCT00683826|2500220|P1|COMPLETED|Overall Study||7
1029428|NCT00683826|2500220|P1|4g Leucine|Overall Study||7
1029429|NCT00683826|2500220|P1|8g Leucine|Overall Study||8
1029430|NCT00683826|2500220|P1|0g Leucine|Overall Study||8
1029431|NCT00683826|2500220|P1|STARTED|Overall Study||8
1029432|NCT00683852|2500230|P3|NOT COMPLETED|30-Day Phase 2 Period||9
1029433|NCT00683852|2500231|P2|NOT COMPLETED|30-Day Phase 2 Period||5
1029434|NCT00683852|2500232|P1|NOT COMPLETED|30-Day Phase 2 Period||6
1029435|NCT00683852|2500230|P3|COMPLETED|30-Day Phase 2 Period||75
1029436|NCT00683852|2500231|P2|COMPLETED|30-Day Phase 2 Period||78
1029437|NCT00683852|2500232|P1|COMPLETED|30-Day Phase 2 Period||48
1029438|NCT00683852|2500230|P3|STARTED|30-Day Phase 2 Period||84
1029439|NCT00683852|2500231|P2|STARTED|30-Day Phase 2 Period||83
1029440|NCT00683852|2500232|P1|STARTED|30-Day Phase 2 Period||54
1029441|NCT00683852|2500230|P3|NOT COMPLETED|30-Day Phase 1 Period||1
1029442|NCT00683852|2500231|P2|NOT COMPLETED|30-Day Phase 1 Period||1
1029443|NCT00683852|2500232|P1|NOT COMPLETED|30-Day Phase 1 Period||2
1029444|NCT00683852|2500230|P3|COMPLETED|30-Day Phase 1 Period||84
1029445|NCT00683852|2500231|P2|COMPLETED|30-Day Phase 1 Period||83
1029446|NCT00683852|2500232|P1|COMPLETED|30-Day Phase 1 Period||54
1029447|NCT00683852|2500230|P3|STARTED|30-Day Phase 1 Period||85
1029448|NCT00683852|2500231|P2|STARTED|30-Day Phase 1 Period||84
1029449|NCT00683852|2500232|P1|STARTED|30-Day Phase 1 Period||56
1029450|NCT00683878|2500266|P3|NOT COMPLETED|Overall Study||14
1029451|NCT00683878|2500267|P2|NOT COMPLETED|Overall Study||16
1029452|NCT00683878|2500268|P1|NOT COMPLETED|Overall Study||23
1029453|NCT00683878|2500266|P3|COMPLETED|Overall Study||126
1029454|NCT00683878|2500267|P2|COMPLETED|Overall Study||125
1029455|NCT00683878|2500268|P1|COMPLETED|Overall Study||116
1029456|NCT00683878|2500266|P3|STARTED|Overall Study||140
1029457|NCT00683878|2500267|P2|STARTED|Overall Study||141
1029458|NCT00683878|2500268|P1|STARTED|Overall Study||139
1029459|NCT00683904|2500296|P2|NOT COMPLETED|Dose Level 2||2
1029460|NCT00683904|2500297|P1|NOT COMPLETED|Dose Level 2||0
1029461|NCT00683904|2500296|P2|COMPLETED|Dose Level 2||4
1029462|NCT00683904|2500297|P1|COMPLETED|Dose Level 2||0
1029463|NCT00683904|2500296|P2|STARTED|Dose Level 2||6
1029464|NCT00683904|2500297|P1|STARTED|Dose Level 2||0
1029465|NCT00683904|2500296|P2|NOT COMPLETED|Dose Level 1||0
1029466|NCT00683904|2500297|P1|NOT COMPLETED|Dose Level 1||3
1029467|NCT00683904|2500296|P2|COMPLETED|Dose Level 1||0
1029468|NCT00683904|2500297|P1|COMPLETED|Dose Level 1||3
1029469|NCT00683904|2500296|P2|STARTED|Dose Level 1||0
1029470|NCT00683904|2500297|P1|STARTED|Dose Level 1||6
1029471|NCT00683917|2500333|P1|NOT COMPLETED|Overall Study||10
1029472|NCT00683917|2500333|P1|COMPLETED|Overall Study||0
1029473|NCT00683917|2500333|P1|STARTED|Overall Study||10
1029474|NCT00683930|2500344|P3|NOT COMPLETED|Overall Study||9
1029475|NCT00683930|2500345|P2|NOT COMPLETED|Overall Study||3
1029476|NCT00683930|2500346|P1|NOT COMPLETED|Overall Study||7
1029477|NCT00683930|2500344|P3|COMPLETED|Overall Study||28
1029478|NCT00683930|2500345|P2|COMPLETED|Overall Study||18
1029479|NCT00683930|2500346|P1|COMPLETED|Overall Study||29
1029480|NCT00683930|2500344|P3|STARTED|Overall Study||37
1029481|NCT00683930|2500345|P2|STARTED|Overall Study|One subject not included: no study drug dispensed.|21
1029482|NCT00683930|2500346|P1|STARTED|Overall Study|One subject not included: no study drug dispensed.|36
1029483|NCT00684021|2500365|P4|NOT COMPLETED|Overall Study||2
1029484|NCT00684021|2500366|P3|NOT COMPLETED|Overall Study||2
1029485|NCT00684021|2500367|P2|NOT COMPLETED|Overall Study||2
1029486|NCT00684021|2500368|P1|NOT COMPLETED|Overall Study||2
1029487|NCT00684021|2500365|P4|COMPLETED|Overall Study||15
1029488|NCT00684021|2500366|P3|COMPLETED|Overall Study||34
1029489|NCT00684021|2500367|P2|COMPLETED|Overall Study||22
1029490|NCT00684021|2500368|P1|COMPLETED|Overall Study||41
1029491|NCT00684021|2500365|P4|STARTED|Overall Study||17
1029492|NCT00684021|2500366|P3|STARTED|Overall Study||36
1029493|NCT00684021|2500367|P2|STARTED|Overall Study||24
1029494|NCT00684021|2500368|P1|STARTED|Overall Study||43
1029495|NCT00684047|2500409|P3|NOT COMPLETED|Overall Study||5
1029496|NCT00684047|2500410|P2|NOT COMPLETED|Overall Study||16
1029497|NCT00684047|2500411|P1|NOT COMPLETED|Overall Study||13
1029498|NCT00684047|2500409|P3|COMPLETED|Overall Study||52
1029499|NCT00684047|2500410|P2|COMPLETED|Overall Study||94
1029500|NCT00684047|2500411|P1|COMPLETED|Overall Study||59
1029501|NCT00684047|2500409|P3|STARTED|Overall Study||57
1029502|NCT00684047|2500410|P2|STARTED|Overall Study||110
1029503|NCT00684047|2500411|P1|STARTED|Overall Study||72
1029504|NCT00684060|2500423|P2|NOT COMPLETED|Overall Study||3
1029505|NCT00684060|2500424|P1|NOT COMPLETED|Overall Study||3
1029506|NCT00684060|2500423|P2|COMPLETED|Overall Study||26
1029507|NCT00684060|2500424|P1|COMPLETED|Overall Study||55
1029508|NCT00684060|2500423|P2|STARTED|Overall Study||29
1029509|NCT00684060|2500424|P1|STARTED|Overall Study||58
1029510|NCT00684073|2500444|P1|NOT COMPLETED|Treatment (Days 1 Through 5)||1
1029511|NCT00684073|2500444|P1|COMPLETED|Treatment (Days 1 Through 5)|number of subjects who had a Day 5 visit (and therefore completed study)|52
1029512|NCT00684073|2500444|P1|STARTED|Treatment (Days 1 Through 5)|number of subjects who had a Day 1 visit|53
1029513|NCT00684073|2500444|P1|NOT COMPLETED|Selection||7
1029514|NCT00684073|2500444|P1|COMPLETED|Selection|number of subjects who had a Day 1 visit|53
1029515|NCT00684073|2500444|P1|STARTED|Selection||60
1029516|NCT00684983|2500454|P2|NOT COMPLETED|Overall Study||0
1029517|NCT00684983|2500455|P1|NOT COMPLETED|Overall Study||0
1029518|NCT00684983|2500454|P2|COMPLETED|Overall Study|One major violation patient in Arm B is included in the primary analysis per protocol.|45
1029519|NCT00684983|2500455|P1|COMPLETED|Overall Study||19
1029520|NCT00684983|2500454|P2|STARTED|Overall Study||45
1029521|NCT00684983|2500455|P1|STARTED|Overall Study||19
1029522|NCT00684996|2500471|P1|NOT COMPLETED|Overall Study||5
1029523|NCT00684996|2500471|P1|COMPLETED|Overall Study||0
1029524|NCT00684996|2500471|P1|Eligible|Overall Study||5
1029525|NCT00684996|2500471|P1|STARTED|Overall Study||5
1029526|NCT00685035|2500484|P2|NOT COMPLETED|Period 3: 2nd Intervention||0
1029527|NCT00685035|2500485|P1|NOT COMPLETED|Period 3: 2nd Intervention||0
1029528|NCT00685035|2500484|P2|COMPLETED|Period 3: 2nd Intervention||8
1029529|NCT00685035|2500485|P1|COMPLETED|Period 3: 2nd Intervention||8
1029530|NCT00685035|2500484|P2|STARTED|Period 3: 2nd Intervention||8
1029531|NCT00685035|2500485|P1|STARTED|Period 3: 2nd Intervention||8
1029532|NCT00685035|2500484|P2|NOT COMPLETED|Period 2: 2-day Washout||0
1029533|NCT00685035|2500485|P1|NOT COMPLETED|Period 2: 2-day Washout||0
1029534|NCT00685035|2500484|P2|COMPLETED|Period 2: 2-day Washout||8
1029535|NCT00685035|2500485|P1|COMPLETED|Period 2: 2-day Washout||8
1029536|NCT00685035|2500484|P2|STARTED|Period 2: 2-day Washout||8
1029537|NCT00685035|2500485|P1|STARTED|Period 2: 2-day Washout||8
1029538|NCT00685035|2500484|P2|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||0
1029539|NCT00685035|2500485|P1|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||1
1029540|NCT00685035|2500484|P2|COMPLETED|Period 1: First Intervention: 30 Minutes||8
1029541|NCT00685035|2500485|P1|COMPLETED|Period 1: First Intervention: 30 Minutes||8
1029542|NCT00685035|2500484|P2|STARTED|Period 1: First Intervention: 30 Minutes||8
1029543|NCT00685035|2500485|P1|STARTED|Period 1: First Intervention: 30 Minutes||9
1029544|NCT00685139|2500509|P2|NOT COMPLETED|Second Intervention||0
1029545|NCT00685139|2500510|P1|NOT COMPLETED|Second Intervention||0
1029546|NCT00685139|2500509|P2|COMPLETED|Second Intervention||17
1029547|NCT00685139|2500510|P1|COMPLETED|Second Intervention||17
1029548|NCT00685139|2500509|P2|STARTED|Second Intervention||17
1029549|NCT00685139|2500510|P1|STARTED|Second Intervention||17
1029550|NCT00685139|2500509|P2|NOT COMPLETED|Washout Period of 28 Days||0
1029551|NCT00685139|2500510|P1|NOT COMPLETED|Washout Period of 28 Days||0
1029552|NCT00685139|2500509|P2|COMPLETED|Washout Period of 28 Days||17
1029553|NCT00685139|2500510|P1|COMPLETED|Washout Period of 28 Days||17
1029554|NCT00685139|2500509|P2|STARTED|Washout Period of 28 Days||17
1029555|NCT00685139|2500510|P1|STARTED|Washout Period of 28 Days||17
1029556|NCT00685139|2500509|P2|NOT COMPLETED|First Intervention||0
1029557|NCT00685139|2500510|P1|NOT COMPLETED|First Intervention||0
1029558|NCT00685139|2500509|P2|COMPLETED|First Intervention||17
1029559|NCT00685139|2500510|P1|COMPLETED|First Intervention||17
1029560|NCT00685139|2500509|P2|STARTED|First Intervention||17
1029561|NCT00685139|2500510|P1|STARTED|First Intervention||17
1029562|NCT00685165|2500518|P2|NOT COMPLETED|Second Intervention||0
1029563|NCT00685165|2500519|P1|NOT COMPLETED|Second Intervention||0
1029564|NCT00685165|2500518|P2|COMPLETED|Second Intervention||11
1029565|NCT00685165|2500519|P1|COMPLETED|Second Intervention||10
1029566|NCT00685165|2500518|P2|STARTED|Second Intervention||11
1029567|NCT00685165|2500519|P1|STARTED|Second Intervention||10
1029568|NCT00685165|2500518|P2|NOT COMPLETED|Washout Period of 14 Days||0
1029569|NCT00685165|2500519|P1|NOT COMPLETED|Washout Period of 14 Days||1
1029570|NCT00685165|2500518|P2|COMPLETED|Washout Period of 14 Days||11
1029571|NCT00685165|2500519|P1|COMPLETED|Washout Period of 14 Days|adverse event- possible upper respiratory infection|10
1029572|NCT00685165|2500518|P2|STARTED|Washout Period of 14 Days||11
1029573|NCT00685165|2500519|P1|STARTED|Washout Period of 14 Days||11
1029574|NCT00685165|2500518|P2|NOT COMPLETED|First Intervention||0
1029575|NCT00685165|2500519|P1|NOT COMPLETED|First Intervention||0
1029576|NCT00685165|2500518|P2|COMPLETED|First Intervention||11
1029577|NCT00685165|2500519|P1|COMPLETED|First Intervention||11
1029578|NCT00685165|2500518|P2|STARTED|First Intervention||11
1029579|NCT00685165|2500519|P1|STARTED|First Intervention||11
1029580|NCT00685178|2500533|P4|NOT COMPLETED|Overall Study||14
1029581|NCT00685178|2500534|P3|NOT COMPLETED|Overall Study||12
1029582|NCT00685178|2500535|P2|NOT COMPLETED|Overall Study||19
1029583|NCT00685178|2500536|P1|NOT COMPLETED|Overall Study||13
1029584|NCT00685178|2500533|P4|COMPLETED|Overall Study||33
1029585|NCT00685178|2500534|P3|COMPLETED|Overall Study||27
1029586|NCT00685178|2500535|P2|COMPLETED|Overall Study||26
1029587|NCT00685178|2500536|P1|COMPLETED|Overall Study||27
1029588|NCT00685178|2500533|P4|STARTED|Overall Study||47
1029589|NCT00685178|2500534|P3|STARTED|Overall Study||39
1029590|NCT00685178|2500535|P2|STARTED|Overall Study||45
1029591|NCT00685178|2500536|P1|STARTED|Overall Study||40
1029592|NCT00685295|2500552|P2|NOT COMPLETED|Overall Study||0
1029593|NCT00685295|2500553|P1|NOT COMPLETED|Overall Study||0
1029594|NCT00685295|2500552|P2|COMPLETED|Overall Study||30
1029595|NCT00685295|2500553|P1|COMPLETED|Overall Study||30
1029596|NCT00685295|2500552|P2|STARTED|Overall Study||30
1029597|NCT00685295|2500553|P1|STARTED|Overall Study||30
1029598|NCT00685334|2500565|P2|NOT COMPLETED|Overall Study||7
1029599|NCT00685334|2500566|P1|NOT COMPLETED|Overall Study||10
1029600|NCT00685334|2500565|P2|COMPLETED|Overall Study||3
1029601|NCT00685334|2500566|P1|COMPLETED|Overall Study||2
1029602|NCT00685334|2500565|P2|STARTED|Overall Study||10
1029603|NCT00685334|2500566|P1|STARTED|Overall Study||12
1029604|NCT00685373|2500574|P1|NOT COMPLETED|Overall Study||15
1029605|NCT00685373|2500574|P1|COMPLETED|Overall Study||151
1029606|NCT00685373|2500574|P1|STARTED|Overall Study||166
1029607|NCT00685399|2500588|P8|NOT COMPLETED|Extension||0
1029608|NCT00685399|2500589|P7|NOT COMPLETED|Extension||0
1029609|NCT00685399|2500590|P6|NOT COMPLETED|Extension||0
1029610|NCT00685399|2500591|P5|NOT COMPLETED|Extension||0
1029611|NCT00685399|2500592|P4|NOT COMPLETED|Extension||7
1029612|NCT00685399|2500593|P3|NOT COMPLETED|Extension||0
1029613|NCT00685399|2500594|P2|NOT COMPLETED|Extension||0
1029614|NCT00685399|2500595|P1|NOT COMPLETED|Extension||0
1029615|NCT00685399|2500588|P8|COMPLETED|Extension||0
1029616|NCT00685399|2500589|P7|COMPLETED|Extension||0
1029617|NCT00685399|2500590|P6|COMPLETED|Extension||0
1029618|NCT00685399|2500591|P5|COMPLETED|Extension||0
1029619|NCT00685399|2500592|P4|COMPLETED|Extension||21
1029620|NCT00685399|2500593|P3|COMPLETED|Extension||0
1029621|NCT00685399|2500594|P2|COMPLETED|Extension||0
1029622|NCT00685399|2500595|P1|COMPLETED|Extension||0
1029623|NCT00685399|2500588|P8|STARTED|Extension||0
1029624|NCT00685399|2500589|P7|STARTED|Extension||0
1029625|NCT00685399|2500590|P6|STARTED|Extension||0
1029626|NCT00685399|2500591|P5|STARTED|Extension||0
1029627|NCT00685399|2500592|P4|STARTED|Extension||28
1029628|NCT00685399|2500593|P3|STARTED|Extension||0
1029629|NCT00685399|2500594|P2|STARTED|Extension||0
1029630|NCT00685399|2500595|P1|STARTED|Extension||0
1029631|NCT00685399|2500588|P8|NOT COMPLETED|Treatment Period 2||2
1029632|NCT00685399|2500589|P7|NOT COMPLETED|Treatment Period 2||0
1029633|NCT00685399|2500590|P6|NOT COMPLETED|Treatment Period 2||2
1029634|NCT00685399|2500591|P5|NOT COMPLETED|Treatment Period 2||0
1029635|NCT00685399|2500592|P4|NOT COMPLETED|Treatment Period 2||0
1029636|NCT00685399|2500593|P3|NOT COMPLETED|Treatment Period 2||3
1029637|NCT00685399|2500594|P2|NOT COMPLETED|Treatment Period 2||12
1029638|NCT00685399|2500595|P1|NOT COMPLETED|Treatment Period 2||0
1029639|NCT00685399|2500588|P8|COMPLETED|Treatment Period 2||10
1029640|NCT00685399|2500589|P7|COMPLETED|Treatment Period 2||13
1029641|NCT00685399|2500590|P6|COMPLETED|Treatment Period 2||10
1029642|NCT00685399|2500591|P5|COMPLETED|Treatment Period 2||4
1029736|NCT00685763|2500810|P1|NOT COMPLETED|Overall Study||2
1029643|NCT00685399|2500592|P4|COMPLETED|Treatment Period 2|in extension period only|0
1029644|NCT00685399|2500593|P3|COMPLETED|Treatment Period 2||2
1029645|NCT00685399|2500594|P2|COMPLETED|Treatment Period 2||2
1029646|NCT00685399|2500595|P1|COMPLETED|Treatment Period 2||0
1029647|NCT00685399|2500588|P8|STARTED|Treatment Period 2||12
1029648|NCT00685399|2500589|P7|STARTED|Treatment Period 2||13
1029649|NCT00685399|2500590|P6|STARTED|Treatment Period 2||12
1029650|NCT00685399|2500591|P5|STARTED|Treatment Period 2||4
1029651|NCT00685399|2500592|P4|STARTED|Treatment Period 2|in extension period only|0
1029652|NCT00685399|2500593|P3|STARTED|Treatment Period 2||5
1029653|NCT00685399|2500594|P2|STARTED|Treatment Period 2||14
1029654|NCT00685399|2500595|P1|STARTED|Treatment Period 2||0
1029655|NCT00685399|2500588|P8|NOT COMPLETED|Treatment Period 1||0
1029656|NCT00685399|2500589|P7|NOT COMPLETED|Treatment Period 1||0
1029657|NCT00685399|2500590|P6|NOT COMPLETED|Treatment Period 1||0
1029658|NCT00685399|2500591|P5|NOT COMPLETED|Treatment Period 1||0
1029659|NCT00685399|2500592|P4|NOT COMPLETED|Treatment Period 1||0
1029660|NCT00685399|2500593|P3|NOT COMPLETED|Treatment Period 1||0
1029661|NCT00685399|2500594|P2|NOT COMPLETED|Treatment Period 1||0
1029662|NCT00685399|2500595|P1|NOT COMPLETED|Treatment Period 1||6
1029663|NCT00685399|2500588|P8|COMPLETED|Treatment Period 1||0
1029664|NCT00685399|2500589|P7|COMPLETED|Treatment Period 1||0
1029665|NCT00685399|2500590|P6|COMPLETED|Treatment Period 1||0
1029666|NCT00685399|2500591|P5|COMPLETED|Treatment Period 1||0
1029667|NCT00685399|2500592|P4|COMPLETED|Treatment Period 1||0
1029668|NCT00685399|2500593|P3|COMPLETED|Treatment Period 1||0
1029669|NCT00685399|2500594|P2|COMPLETED|Treatment Period 1||0
1029670|NCT00685399|2500595|P1|COMPLETED|Treatment Period 1||10
1029671|NCT00685399|2500588|P8|STARTED|Treatment Period 1||0
1029672|NCT00685399|2500589|P7|STARTED|Treatment Period 1||0
1029673|NCT00685399|2500590|P6|STARTED|Treatment Period 1||0
1029674|NCT00685399|2500591|P5|STARTED|Treatment Period 1||0
1029675|NCT00685399|2500592|P4|STARTED|Treatment Period 1||0
1029676|NCT00685399|2500593|P3|STARTED|Treatment Period 1||0
1029677|NCT00685399|2500594|P2|STARTED|Treatment Period 1||0
1029678|NCT00685399|2500595|P1|STARTED|Treatment Period 1||16
1029679|NCT00685477|2500628|P6|NOT COMPLETED|Overall Study||0
1029680|NCT00685477|2500629|P5|NOT COMPLETED|Overall Study||0
1029681|NCT00685477|2500630|P4|NOT COMPLETED|Overall Study||0
1029682|NCT00685477|2500631|P3|NOT COMPLETED|Overall Study||0
1029683|NCT00685477|2500632|P2|NOT COMPLETED|Overall Study||0
1029684|NCT00685477|2500633|P1|NOT COMPLETED|Overall Study||0
1029685|NCT00685477|2500628|P6|COMPLETED|Overall Study||10
1029686|NCT00685477|2500629|P5|COMPLETED|Overall Study||10
1029687|NCT00685477|2500630|P4|COMPLETED|Overall Study||10
1029688|NCT00685477|2500631|P3|COMPLETED|Overall Study||10
1029689|NCT00685477|2500632|P2|COMPLETED|Overall Study||10
1029690|NCT00685477|2500633|P1|COMPLETED|Overall Study||10
1029691|NCT00685477|2500628|P6|STARTED|Overall Study||10
1029692|NCT00685477|2500629|P5|STARTED|Overall Study||10
1029693|NCT00685477|2500630|P4|STARTED|Overall Study||10
1029694|NCT00685477|2500631|P3|STARTED|Overall Study||10
1029695|NCT00685477|2500632|P2|STARTED|Overall Study||10
1029696|NCT00685477|2500633|P1|STARTED|Overall Study||10
1029706|NCT00685659|2500667|P3|NOT COMPLETED|Overall Study||15
1029707|NCT00685659|2500668|P2|NOT COMPLETED|Overall Study||25
1029708|NCT00685659|2500669|P1|NOT COMPLETED|Overall Study||31
1029709|NCT00685659|2500667|P3|COMPLETED|Overall Study||92
1029710|NCT00685659|2500668|P2|COMPLETED|Overall Study||81
1029711|NCT00685659|2500669|P1|COMPLETED|Overall Study||77
1029712|NCT00685659|2500667|P3|STARTED|Overall Study||107
1029713|NCT00685659|2500668|P2|STARTED|Overall Study||106
1029714|NCT00685659|2500669|P1|STARTED|Overall Study||108
1029715|NCT00685685|2500764|P2|NOT COMPLETED|Second Intervention||0
1029716|NCT00685685|2500765|P1|NOT COMPLETED|Second Intervention||0
1029717|NCT00685685|2500764|P2|COMPLETED|Second Intervention||26
1029718|NCT00685685|2500765|P1|COMPLETED|Second Intervention||25
1029719|NCT00685685|2500764|P2|STARTED|Second Intervention||26
1029720|NCT00685685|2500765|P1|STARTED|Second Intervention||25
1029721|NCT00685685|2500764|P2|NOT COMPLETED|Washout Period of 7 Days||1
1029722|NCT00685685|2500765|P1|NOT COMPLETED|Washout Period of 7 Days||2
1029723|NCT00685685|2500764|P2|COMPLETED|Washout Period of 7 Days||26
1029724|NCT00685685|2500765|P1|COMPLETED|Washout Period of 7 Days||25
1029725|NCT00685685|2500764|P2|STARTED|Washout Period of 7 Days||27
1029726|NCT00685685|2500765|P1|STARTED|Washout Period of 7 Days||27
1029727|NCT00685685|2500764|P2|NOT COMPLETED|First Intervention||0
1029728|NCT00685685|2500765|P1|NOT COMPLETED|First Intervention||0
1029729|NCT00685685|2500764|P2|COMPLETED|First Intervention||27
1029730|NCT00685685|2500765|P1|COMPLETED|First Intervention||27
1029731|NCT00685685|2500764|P2|STARTED|First Intervention||27
1029732|NCT00685685|2500765|P1|STARTED|First Intervention||27
1029733|NCT00685698|2500775|P1|NOT COMPLETED|Overall Study||13
1029734|NCT00685698|2500775|P1|COMPLETED|Overall Study||25
1029735|NCT00685698|2500775|P1|STARTED|Overall Study||38
1029737|NCT00685763|2500810|P1|COMPLETED|Overall Study||11
1029738|NCT00685763|2500810|P1|STARTED|Overall Study||13
1029739|NCT00685802|2500814|P2|NOT COMPLETED|Second Intervention||0
1029740|NCT00685802|2500815|P1|NOT COMPLETED|Second Intervention||0
1029741|NCT00685802|2500814|P2|COMPLETED|Second Intervention||15
1029742|NCT00685802|2500815|P1|COMPLETED|Second Intervention||14
1029743|NCT00685802|2500814|P2|STARTED|Second Intervention||15
1029744|NCT00685802|2500815|P1|STARTED|Second Intervention||14
1029745|NCT00685802|2500814|P2|NOT COMPLETED|Washout Period of 7 Days||1
1029746|NCT00685802|2500815|P1|NOT COMPLETED|Washout Period of 7 Days||2
1029747|NCT00685802|2500814|P2|COMPLETED|Washout Period of 7 Days||15
1029748|NCT00685802|2500815|P1|COMPLETED|Washout Period of 7 Days||14
1029749|NCT00685802|2500814|P2|STARTED|Washout Period of 7 Days||16
1029750|NCT00685802|2500815|P1|STARTED|Washout Period of 7 Days||16
1029751|NCT00685802|2500814|P2|NOT COMPLETED|First Intervention||0
1029752|NCT00685802|2500815|P1|NOT COMPLETED|First Intervention||0
1029753|NCT00685802|2500814|P2|COMPLETED|First Intervention||16
1029754|NCT00685802|2500815|P1|COMPLETED|First Intervention||16
1029755|NCT00685802|2500814|P2|STARTED|First Intervention||16
1029756|NCT00685802|2500815|P1|STARTED|First Intervention||16
1029757|NCT00685880|2500827|P2|NOT COMPLETED|Overall Study||0
1029758|NCT00685880|2500828|P1|NOT COMPLETED|Overall Study||0
1029759|NCT00685880|2500827|P2|COMPLETED|Overall Study||2
1029760|NCT00685880|2500828|P1|COMPLETED|Overall Study||0
1029761|NCT00685880|2500827|P2|STARTED|Overall Study||2
1029762|NCT00685880|2500828|P1|STARTED|Overall Study||0
1029763|NCT00685945|2500834|P1|NOT COMPLETED|Sildenafil + L-NMMA + Bradykinin||0
1029764|NCT00685945|2500834|P1|COMPLETED|Sildenafil + L-NMMA + Bradykinin||12
1029765|NCT00685945|2500834|P1|STARTED|Sildenafil + L-NMMA + Bradykinin||12
1029766|NCT00685945|2500834|P1|NOT COMPLETED|Isosorbide + L-NMMA + Bradykinin||0
1029767|NCT00685945|2500834|P1|COMPLETED|Isosorbide + L-NMMA + Bradykinin||11
1029768|NCT00685945|2500834|P1|STARTED|Isosorbide + L-NMMA + Bradykinin||11
1029769|NCT00685945|2500834|P1|NOT COMPLETED|L-NMMA + Bradykinin||1
1029770|NCT00685945|2500834|P1|COMPLETED|L-NMMA + Bradykinin||23
1029771|NCT00685945|2500834|P1|STARTED|L-NMMA + Bradykinin||24
1029772|NCT00685945|2500834|P1|NOT COMPLETED|Control (Bradykinin Infusion)||0
1029773|NCT00685945|2500834|P1|COMPLETED|Control (Bradykinin Infusion)||24
1029774|NCT00685945|2500834|P1|STARTED|Control (Bradykinin Infusion)|A total of 24 subjects received an infusion of bradykinin|24
1029775|NCT00686036|2500851|P2|NOT COMPLETED|Overall Study||6
1029776|NCT00686036|2500852|P1|NOT COMPLETED|Overall Study||9
1029777|NCT00686036|2500851|P2|COMPLETED|Overall Study||2
1029778|NCT00686036|2500852|P1|COMPLETED|Overall Study||0
1029779|NCT00686036|2500851|P2|STARTED|Overall Study||8
1029780|NCT00686036|2500852|P1|STARTED|Overall Study||9
1029781|NCT00686075|2500874|P10|NOT COMPLETED|Overall Study||10
1029782|NCT00686075|2500875|P9|NOT COMPLETED|Overall Study||6
1029783|NCT00686075|2500876|P8|NOT COMPLETED|Overall Study||2
1029784|NCT00686075|2500877|P7|NOT COMPLETED|Overall Study||0
1029785|NCT00686075|2500878|P6|NOT COMPLETED|Overall Study||3
1029786|NCT00686075|2500879|P5|NOT COMPLETED|Overall Study||4
1029787|NCT00686075|2500880|P4|NOT COMPLETED|Overall Study||9
1029788|NCT00686075|2500881|P3|NOT COMPLETED|Overall Study||6
1029789|NCT00686075|2500882|P2|NOT COMPLETED|Overall Study||10
1029790|NCT00686075|2500883|P1|NOT COMPLETED|Overall Study||8
1029791|NCT00686075|2500874|P10|COMPLETED|Overall Study||69
1029792|NCT00686075|2500875|P9|COMPLETED|Overall Study||75
1029793|NCT00686075|2500876|P8|COMPLETED|Overall Study||76
1029794|NCT00686075|2500877|P7|COMPLETED|Overall Study||82
1029795|NCT00686075|2500878|P6|COMPLETED|Overall Study||37
1029796|NCT00686075|2500879|P5|COMPLETED|Overall Study||36
1029797|NCT00686075|2500880|P4|COMPLETED|Overall Study||71
1029798|NCT00686075|2500881|P3|COMPLETED|Overall Study||74
1029799|NCT00686075|2500882|P2|COMPLETED|Overall Study||71
1029800|NCT00686075|2500883|P1|COMPLETED|Overall Study||71
1029801|NCT00686075|2500874|P10|Treated|Overall Study||78
1029802|NCT00686075|2500875|P9|Treated|Overall Study||80
1029803|NCT00686075|2500876|P8|Treated|Overall Study||77
1029804|NCT00686075|2500877|P7|Treated|Overall Study||82
1029805|NCT00686075|2500878|P6|Treated|Overall Study||40
1029806|NCT00686075|2500879|P5|Treated|Overall Study||40
1029807|NCT00686075|2500880|P4|Treated|Overall Study||80
1029808|NCT00686075|2500881|P3|Treated|Overall Study||80
1029809|NCT00686075|2500882|P2|Treated|Overall Study||79
1029810|NCT00686075|2500883|P1|Treated|Overall Study||78
1029811|NCT00686075|2500874|P10|STARTED|Overall Study||79
1029812|NCT00686075|2500875|P9|STARTED|Overall Study||81
1029813|NCT00686075|2500876|P8|STARTED|Overall Study||78
1029814|NCT00686075|2500877|P7|STARTED|Overall Study||82
1029815|NCT00686075|2500878|P6|STARTED|Overall Study||40
1029816|NCT00686075|2500879|P5|STARTED|Overall Study||40
1029817|NCT00686075|2500880|P4|STARTED|Overall Study||80
1029818|NCT00686075|2500881|P3|STARTED|Overall Study||80
1029819|NCT00686075|2500882|P2|STARTED|Overall Study||81
1029820|NCT00686075|2500883|P1|STARTED|Overall Study||79
1029821|NCT00686127|2501077|P2|NOT COMPLETED|Overall Study||6
1029822|NCT00686127|2501078|P1|NOT COMPLETED|Overall Study||14
1029823|NCT00686127|2501077|P2|COMPLETED|Overall Study||1
1029824|NCT00686127|2501078|P1|COMPLETED|Overall Study|Patients withdrew from the study because they did not like wearing the patch.|0
1029825|NCT00686127|2501077|P2|STARTED|Overall Study||7
1029826|NCT00686127|2501078|P1|STARTED|Overall Study||14
1029827|NCT00686166|2501084|P1|NOT COMPLETED|Overall Study||20
1029828|NCT00686166|2501084|P1|COMPLETED|Overall Study||63
1029829|NCT00686166|2501084|P1|Eligible and Began Protocol Therapy|Overall Study||74
1029830|NCT00686166|2501084|P1|Eligible|Overall Study||78
1029831|NCT00686166|2501084|P1|STARTED|Overall Study||83
1029832|NCT00686205|2501096|P2|NOT COMPLETED|Overall Study||981
1029833|NCT00686205|2501097|P1|NOT COMPLETED|Overall Study||6007
1029834|NCT00686205|2501096|P2|COMPLETED|Overall Study||1524
1029835|NCT00686205|2501097|P1|COMPLETED|Overall Study||15599
1029836|NCT00686205|2501096|P2|STARTED|Overall Study||2505
1029837|NCT00686205|2501097|P1|STARTED|Overall Study||21606
1029838|NCT00686231|2501106|P3|NOT COMPLETED|Overall Study||0
1029839|NCT00686231|2501107|P2|NOT COMPLETED|Overall Study||0
1029840|NCT00686231|2501108|P1|NOT COMPLETED|Overall Study||0
1029841|NCT00686231|2501106|P3|COMPLETED|Overall Study||20
1029842|NCT00686231|2501107|P2|COMPLETED|Overall Study||20
1029843|NCT00686231|2501108|P1|COMPLETED|Overall Study||20
1029844|NCT00686231|2501106|P3|STARTED|Overall Study||20
1029845|NCT00686231|2501107|P2|STARTED|Overall Study||20
1029846|NCT00686231|2501108|P1|STARTED|Overall Study||20
1029847|NCT00686257|2501118|P2|NOT COMPLETED|Overall Study||0
1029848|NCT00686257|2501119|P1|NOT COMPLETED|Overall Study||0
1029849|NCT00686257|2501118|P2|COMPLETED|Overall Study||31
1029850|NCT00686257|2501119|P1|COMPLETED|Overall Study||29
1029851|NCT00686257|2501118|P2|STARTED|Overall Study||31
1029852|NCT00686257|2501119|P1|STARTED|Overall Study||29
1029853|NCT00686335|2501125|P1|NOT COMPLETED|Treatment Period||0
1029854|NCT00686335|2501125|P1|COMPLETED|Treatment Period||7
1029855|NCT00686335|2501125|P1|STARTED|Treatment Period||7
1029856|NCT00686335|2501125|P1|NOT COMPLETED|Run-in Period||5
1029857|NCT00686335|2501125|P1|COMPLETED|Run-in Period||7
1029858|NCT00686335|2501125|P1|STARTED|Run-in Period||12
1029859|NCT00686517|2501134|P3|NOT COMPLETED|Follow-up||10
1029860|NCT00686517|2501135|P2|NOT COMPLETED|Follow-up||10
1029861|NCT00686517|2501136|P1|NOT COMPLETED|Follow-up||8
1029862|NCT00686517|2501134|P3|COMPLETED|Follow-up||29
1029863|NCT00686517|2501135|P2|COMPLETED|Follow-up||28
1029864|NCT00686517|2501136|P1|COMPLETED|Follow-up||29
1029865|NCT00686517|2501134|P3|STARTED|Follow-up||39
1029866|NCT00686517|2501135|P2|STARTED|Follow-up||38
1029867|NCT00686517|2501136|P1|STARTED|Follow-up||37
1029868|NCT00686517|2501134|P3|NOT COMPLETED|Treatment||1
1029869|NCT00686517|2501135|P2|NOT COMPLETED|Treatment||3
1029870|NCT00686517|2501136|P1|NOT COMPLETED|Treatment||6
1029871|NCT00686517|2501134|P3|COMPLETED|Treatment||42
1029872|NCT00686517|2501135|P2|COMPLETED|Treatment||40
1029873|NCT00686517|2501136|P1|COMPLETED|Treatment||38
1029874|NCT00686517|2501134|P3|Completed Final Treatment Visit|Treatment|Included 1 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
1029875|NCT00686517|2501135|P2|Completed Final Treatment Visit|Treatment|Included 3 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
1029876|NCT00686517|2501136|P1|Completed Final Treatment Visit|Treatment|Included 6 that discontinued the treatment before completion,but performed the Final Treatment Visit|44
1029877|NCT00686517|2501134|P3|STARTED|Treatment||43
1029878|NCT00686517|2501135|P2|STARTED|Treatment||43
1029879|NCT00686517|2501136|P1|STARTED|Treatment||44
1029880|NCT00686543|2501163|P4|NOT COMPLETED|Overall Study||3
1029881|NCT00686543|2501164|P3|NOT COMPLETED|Overall Study||5
1029882|NCT00686543|2501165|P2|NOT COMPLETED|Overall Study||1
1029883|NCT00686543|2501166|P1|NOT COMPLETED|Overall Study||14
1029884|NCT00686543|2501163|P4|COMPLETED|Overall Study||17
1029885|NCT00686543|2501164|P3|COMPLETED|Overall Study||15
1029886|NCT00686543|2501165|P2|COMPLETED|Overall Study||20
1029887|NCT00686543|2501166|P1|COMPLETED|Overall Study||0
1029888|NCT00686543|2501163|P4|STARTED|Overall Study||20
1029889|NCT00686543|2501164|P3|STARTED|Overall Study||20
1029890|NCT00686543|2501165|P2|STARTED|Overall Study||21
1029891|NCT00686543|2501166|P1|STARTED|Overall Study||14
1029892|NCT00686595|2501184|P1|NOT COMPLETED|Overall Study||7
1029893|NCT00686595|2501184|P1|COMPLETED|Overall Study||31
1029894|NCT00686595|2501184|P1|STARTED|Overall Study||38
1029895|NCT00686634|2501209|P1|NOT COMPLETED|Overall Study||6
1029896|NCT00686634|2501209|P1|COMPLETED|Overall Study||102
1029897|NCT00686634|2501209|P1|STARTED|Overall Study||108
1029898|NCT00686647|2501216|P1|NOT COMPLETED|Overall Study||2
1029899|NCT00686647|2501216|P1|COMPLETED|Overall Study||91
1029900|NCT00686647|2501216|P1|STARTED|Overall Study||93
1029901|NCT00686686|2501222|P1|NOT COMPLETED|Overall Study||6
1029902|NCT00686686|2501222|P1|COMPLETED|Overall Study||17
1029903|NCT00686686|2501222|P1|STARTED|Overall Study||23
1029904|NCT00686699|2501232|P2|NOT COMPLETED|Treatment Period 2||0
1029905|NCT00686699|2501233|P1|NOT COMPLETED|Treatment Period 2||0
1029906|NCT00686699|2501232|P2|COMPLETED|Treatment Period 2||5
1029907|NCT00686699|2501233|P1|COMPLETED|Treatment Period 2||4
1029908|NCT00686699|2501232|P2|STARTED|Treatment Period 2||5
1029909|NCT00686699|2501233|P1|STARTED|Treatment Period 2||4
1029910|NCT00686699|2501232|P2|NOT COMPLETED|Treatment Period 1||2
1029911|NCT00686699|2501233|P1|NOT COMPLETED|Treatment Period 1||0
1029912|NCT00686699|2501232|P2|COMPLETED|Treatment Period 1||5
1029913|NCT00686699|2501233|P1|COMPLETED|Treatment Period 1||4
1029914|NCT00686699|2501232|P2|STARTED|Treatment Period 1||7
1029915|NCT00686699|2501233|P1|STARTED|Treatment Period 1||4
1029916|NCT00686712|2501260|P3|NOT COMPLETED|Overall Study||13
1029917|NCT00686712|2501261|P2|NOT COMPLETED|Overall Study||11
1029918|NCT00686712|2501262|P1|NOT COMPLETED|Overall Study||10
1029919|NCT00686712|2501260|P3|COMPLETED|Overall Study||17
1029920|NCT00686712|2501261|P2|COMPLETED|Overall Study||14
1029921|NCT00686712|2501262|P1|COMPLETED|Overall Study||20
1029922|NCT00686712|2501260|P3|STARTED|Overall Study||30
1029923|NCT00686712|2501261|P2|STARTED|Overall Study||25
1029924|NCT00686712|2501262|P1|STARTED|Overall Study||30
1029931|NCT00686777|2501313|P1|NOT COMPLETED|Overall Study||10
1029932|NCT00686777|2501313|P1|COMPLETED|Overall Study|Of 10 noncompleters, 6 had AEs including 4 meeting protocol prespecified AE discontinuance criteria.|65
1029933|NCT00686777|2501313|P1|Completed 24 Weeks of Follow-up|Overall Study||70
1029934|NCT00686777|2501313|P1|Included in Follow-up (All Treated)|Overall Study||75
1029935|NCT00686777|2501313|P1|Completed 48 Weeks of Treatment|Overall Study||65
1029936|NCT00686777|2501313|P1|Completed 24 Weeks of Treatment|Overall Study||69
1029937|NCT00686777|2501313|P1|STARTED|Overall Study||75
1029938|NCT00686790|2501319|P1|NOT COMPLETED|Overall Study||16
1029939|NCT00686790|2501319|P1|COMPLETED|Overall Study||32
1029940|NCT00686790|2501319|P1|STARTED|Overall Study||48
1029941|NCT00686803|2501330|P3|NOT COMPLETED|Overall Study||0
1029942|NCT00686803|2501331|P2|NOT COMPLETED|Overall Study||0
1029943|NCT00686803|2501332|P1|NOT COMPLETED|Overall Study||0
1029944|NCT00686803|2501330|P3|COMPLETED|Overall Study||3
1029945|NCT00686803|2501331|P2|COMPLETED|Overall Study||12
1029946|NCT00686803|2501332|P1|COMPLETED|Overall Study||6
1029947|NCT00686803|2501330|P3|STARTED|Overall Study||3
1029948|NCT00686803|2501331|P2|STARTED|Overall Study||12
1029949|NCT00686803|2501332|P1|STARTED|Overall Study||6
1029950|NCT00686842|2501343|P1|NOT COMPLETED|Overall Study||0
1029951|NCT00686842|2501343|P1|COMPLETED|Overall Study||17
1029952|NCT00686842|2501343|P1|STARTED|Overall Study||17
1029953|NCT00686855|2501349|P2|NOT COMPLETED|Overall Study||1
1029954|NCT00686855|2501350|P1|NOT COMPLETED|Overall Study||1
1029955|NCT00686855|2501349|P2|COMPLETED|Overall Study||17
1029956|NCT00686855|2501350|P1|COMPLETED|Overall Study||27
1029957|NCT00686855|2501349|P2|STARTED|Overall Study||18
1029958|NCT00686855|2501350|P1|STARTED|Overall Study||28
1029959|NCT00686881|2501358|P2|NOT COMPLETED|Overall Study||81
1029960|NCT00686881|2501359|P1|NOT COMPLETED|Overall Study||82
1029961|NCT00686881|2501358|P2|COMPLETED|Overall Study||53
1029962|NCT00686881|2501359|P1|COMPLETED|Overall Study||45
1029963|NCT00686881|2501358|P2|STARTED|Overall Study|After randomization, 6 participants withdrew consent and did not receive study drug.|134
1029964|NCT00686881|2501359|P1|STARTED|Overall Study|After randomization, 2 participants withdrew consent and did not receive study drug.|127
1029965|NCT00686894|2501369|P1|NOT COMPLETED|Overall Study||6
1029966|NCT00686894|2501369|P1|COMPLETED|Overall Study||1
1029967|NCT00686894|2501369|P1|STARTED|Overall Study||7
1029968|NCT00686959|2501375|P2|NOT COMPLETED|Overall Study||117
1029969|NCT00686959|2501376|P1|NOT COMPLETED|Overall Study||124
1029970|NCT00686959|2501375|P2|COMPLETED|Overall Study|Study completion includes death due to any cause.|180
1029971|NCT00686959|2501376|P1|COMPLETED|Overall Study|Study completion includes death due to any cause|177
1029972|NCT00686959|2501375|P2|Entered Consolidation Phase|Overall Study||202
1029973|NCT00686959|2501376|P1|Entered Consolidation Phase|Overall Study||229
1029974|NCT00686959|2501375|P2|Received at Least One Dose of Study Drug|Overall Study||272
1029975|NCT00686959|2501376|P1|Received at Least One Dose of Study Drug|Overall Study||283
1029976|NCT00686959|2501375|P2|STARTED|Overall Study||297
1029977|NCT00686959|2501376|P1|STARTED|Overall Study||301
1029978|NCT00686972|2501394|P1|NOT COMPLETED|Overall Study||51
1029979|NCT00686972|2501394|P1|COMPLETED|Overall Study||0
1029980|NCT00686972|2501394|P1|STARTED|Overall Study||51
1029981|NCT00686998|2501401|P3|NOT COMPLETED|Overall Study||4
1029982|NCT00686998|2501402|P2|NOT COMPLETED|Overall Study||8
1029983|NCT00686998|2501403|P1|NOT COMPLETED|Overall Study||13
1029984|NCT00686998|2501401|P3|COMPLETED|Overall Study||18
1029985|NCT00686998|2501402|P2|COMPLETED|Overall Study||33
1029986|NCT00686998|2501403|P1|COMPLETED|Overall Study||30
1029987|NCT00686998|2501401|P3|Completed Scheduled Treatment|Overall Study||18
1029988|NCT00686998|2501402|P2|Completed Scheduled Treatment|Overall Study||33
1029989|NCT00686998|2501403|P1|Completed Scheduled Treatment|Overall Study||30
1029990|NCT00686998|2501401|P3|Eligible for Efficacy Analysis|Overall Study||21
1029991|NCT00686998|2501402|P2|Eligible for Efficacy Analysis|Overall Study||39
1029992|NCT00686998|2501403|P1|Eligible for Efficacy Analysis|Overall Study||42
1029993|NCT00686998|2501401|P3|Received Treatment|Overall Study||22
1029994|NCT00686998|2501402|P2|Received Treatment|Overall Study||41
1029995|NCT00686998|2501403|P1|Received Treatment|Overall Study||43
1029996|NCT00686998|2501401|P3|Randomized|Overall Study||22
1029997|NCT00686998|2501402|P2|Randomized|Overall Study||41
1029998|NCT00686998|2501403|P1|Randomized|Overall Study||43
1029999|NCT00686998|2501401|P3|STARTED|Overall Study|Randomized & received study medication|22
1030000|NCT00686998|2501402|P2|STARTED|Overall Study|Randomized & received study medication|41
1030001|NCT00686998|2501403|P1|STARTED|Overall Study|Randomized & received study medication|43
1030002|NCT00687076|2501413|P2|NOT COMPLETED|Overall Study||30
1030003|NCT00687076|2501414|P1|NOT COMPLETED|Overall Study||32
1030004|NCT00687076|2501413|P2|COMPLETED|Overall Study||21
1030005|NCT00687076|2501414|P1|COMPLETED|Overall Study||19
1030006|NCT00687076|2501413|P2|STARTED|Overall Study||51
1030007|NCT00687076|2501414|P1|STARTED|Overall Study||51
1030008|NCT00687167|2501422|P2|NOT COMPLETED|Second Intervention||0
1030009|NCT00687167|2501423|P1|NOT COMPLETED|Second Intervention||0
1030010|NCT00687167|2501422|P2|COMPLETED|Second Intervention||17
1030011|NCT00687167|2501423|P1|COMPLETED|Second Intervention||17
1030012|NCT00687167|2501422|P2|STARTED|Second Intervention||17
1030013|NCT00687167|2501423|P1|STARTED|Second Intervention||17
1030014|NCT00687167|2501422|P2|NOT COMPLETED|Washout Period of 28 Days||0
1030015|NCT00687167|2501423|P1|NOT COMPLETED|Washout Period of 28 Days||0
1030016|NCT00687167|2501422|P2|COMPLETED|Washout Period of 28 Days||17
1030017|NCT00687167|2501423|P1|COMPLETED|Washout Period of 28 Days||17
1030018|NCT00687167|2501422|P2|STARTED|Washout Period of 28 Days||17
1030019|NCT00687167|2501423|P1|STARTED|Washout Period of 28 Days||17
1030020|NCT00687167|2501422|P2|NOT COMPLETED|First Intervention||0
1030021|NCT00687167|2501423|P1|NOT COMPLETED|First Intervention||0
1030022|NCT00687167|2501422|P2|COMPLETED|First Intervention||17
1030023|NCT00687167|2501423|P1|COMPLETED|First Intervention||17
1030024|NCT00687167|2501422|P2|STARTED|First Intervention||17
1030025|NCT00687167|2501423|P1|STARTED|First Intervention||17
1030026|NCT00687193|2501437|P6|NOT COMPLETED|Overall Study||4
1030027|NCT00687193|2501438|P5|NOT COMPLETED|Overall Study||2
1030028|NCT00687193|2501439|P4|NOT COMPLETED|Overall Study||4
1030029|NCT00687193|2501440|P3|NOT COMPLETED|Overall Study||2
1030030|NCT00687193|2501441|P2|NOT COMPLETED|Overall Study||4
1030031|NCT00687193|2501442|P1|NOT COMPLETED|Overall Study||2
1030032|NCT00687193|2501437|P6|COMPLETED|Overall Study||48
1030033|NCT00687193|2501438|P5|COMPLETED|Overall Study||52
1030034|NCT00687193|2501439|P4|COMPLETED|Overall Study||49
1030035|NCT00687193|2501440|P3|COMPLETED|Overall Study||50
1030036|NCT00687193|2501441|P2|COMPLETED|Overall Study||49
1030037|NCT00687193|2501442|P1|COMPLETED|Overall Study||51
1030038|NCT00687193|2501437|P6|STARTED|Overall Study|One participant withdrew after randomization but prior to treatment.|52
1030039|NCT00687193|2501438|P5|STARTED|Overall Study||54
1030040|NCT00687193|2501439|P4|STARTED|Overall Study||53
1030041|NCT00687193|2501440|P3|STARTED|Overall Study||52
1030042|NCT00687193|2501441|P2|STARTED|Overall Study||53
1030043|NCT00687193|2501442|P1|STARTED|Overall Study||53
1030044|NCT00687219|2501606|P1|NOT COMPLETED|Overall Study||51
1030045|NCT00687219|2501606|P1|COMPLETED|Overall Study||51
1030046|NCT00687219|2501606|P1|STARTED|Overall Study||102
1030047|NCT00687297|2501614|P2|NOT COMPLETED|Maintenance||1
1030048|NCT00687297|2501615|P1|NOT COMPLETED|Maintenance||3
1030049|NCT00687297|2501614|P2|COMPLETED|Maintenance||25
1030050|NCT00687297|2501615|P1|COMPLETED|Maintenance||29
1030051|NCT00687297|2501614|P2|STARTED|Maintenance||26
1030052|NCT00687297|2501615|P1|STARTED|Maintenance||32
1030053|NCT00687297|2501614|P2|NOT COMPLETED|Induction||55
1030054|NCT00687297|2501615|P1|NOT COMPLETED|Induction||45
1030055|NCT00687297|2501614|P2|COMPLETED|Induction||26
1030056|NCT00687297|2501615|P1|COMPLETED|Induction||32
1030057|NCT00687297|2501614|P2|STARTED|Induction||81
1030058|NCT00687297|2501615|P1|STARTED|Induction||77
1030059|NCT00687297|2501614|P2|NOT COMPLETED|Randomization||1
1030060|NCT00687297|2501615|P1|NOT COMPLETED|Randomization||3
1030061|NCT00687297|2501614|P2|COMPLETED|Randomization||81
1030062|NCT00687297|2501615|P1|COMPLETED|Randomization||77
1030063|NCT00687297|2501614|P2|STARTED|Randomization||82
1030064|NCT00687297|2501615|P1|STARTED|Randomization||80
1030065|NCT00687323|2501625|P1|NOT COMPLETED|Overall Study||180
1030066|NCT00687323|2501625|P1|COMPLETED|Overall Study|Number of participants alive at one year|15
1030067|NCT00687323|2501625|P1|Received Treatment|Overall Study||47
1030068|NCT00687323|2501625|P1|STARTED|Overall Study|Number of screened participants|195
1030069|NCT00687362|2501639|P1|NOT COMPLETED|Overall Study||3
1030070|NCT00687362|2501639|P1|COMPLETED|Overall Study|Completed protocol at Week 24|19
1030071|NCT00687362|2501639|P1|STARTED|Overall Study||22
1030072|NCT00687401|2501643|P1|NOT COMPLETED|Overall Study||30
1030073|NCT00687401|2501643|P1|COMPLETED|Overall Study||129
1030074|NCT00687401|2501643|P1|STARTED|Overall Study|215 participants enrolled in the study, of which 56 failed screening and did not receive study drug.|159
1030075|NCT00687440|2501648|P1|NOT COMPLETED|Overall Study||12
1030076|NCT00687440|2501648|P1|COMPLETED|Overall Study||15
1030077|NCT00687440|2501648|P1|STARTED|Overall Study|Number of screened participants|27
1030078|NCT00679783|2501659|P7|NOT COMPLETED|Overall Study||1
1030079|NCT00679783|2501660|P6|NOT COMPLETED|Overall Study||0
1030080|NCT00679783|2501661|P5|NOT COMPLETED|Overall Study||1
1030081|NCT00679783|2501662|P4|NOT COMPLETED|Overall Study||20
1030082|NCT00679783|2501663|P3|NOT COMPLETED|Overall Study||1
1030083|NCT00679783|2501664|P2|NOT COMPLETED|Overall Study||3
1030084|NCT00679783|2501665|P1|NOT COMPLETED|Overall Study||2
1030085|NCT00679783|2501659|P7|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|15
1030086|NCT00679783|2501660|P6|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|5
1030087|NCT00679783|2501661|P5|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|4
1030088|NCT00679783|2501662|P4|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|25
1030089|NCT00679783|2501663|P3|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
1030090|NCT00679783|2501664|P2|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|10
1030091|NCT00679783|2501665|P1|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
1030272|NCT00680953|2502217|P2|STARTED|Overall Study||511
1030092|NCT00679783|2501659|P7|STARTED|Overall Study|Gave Informed consent and passed screening|16
1030093|NCT00679783|2501660|P6|STARTED|Overall Study|Gave Informed consent and passed screening|5
1030094|NCT00679783|2501661|P5|STARTED|Overall Study|Gave Informed consent and passed screening|5
1030095|NCT00679783|2501662|P4|STARTED|Overall Study|Gave Informed consent and passed screening|45
1030096|NCT00679783|2501663|P3|STARTED|Overall Study|Gave Informed consent and passed screening|3
1030097|NCT00679783|2501664|P2|STARTED|Overall Study|Gave Informed consent and passed screening|13
1030098|NCT00679783|2501665|P1|STARTED|Overall Study|Gave Informed consent and passed screening|4
1030099|NCT00679913|2501718|P2|NOT COMPLETED|Overall Study||13
1030100|NCT00679913|2501719|P1|NOT COMPLETED|Overall Study||18
1030101|NCT00679913|2501718|P2|COMPLETED|Overall Study||86
1030102|NCT00679913|2501719|P1|COMPLETED|Overall Study||83
1030103|NCT00679913|2501718|P2|STARTED|Overall Study||99
1030104|NCT00679913|2501719|P1|STARTED|Overall Study||101
1030105|NCT00679939|2501729|P2|NOT COMPLETED|24-Week Open-Label (OL) Period||4
1030106|NCT00679939|2501730|P1|NOT COMPLETED|24-Week Open-Label (OL) Period||7
1030107|NCT00679939|2501729|P2|COMPLETED|24-Week Open-Label (OL) Period||80
1030108|NCT00679939|2501730|P1|COMPLETED|24-Week Open-Label (OL) Period||69
1030109|NCT00679939|2501729|P2|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|84
1030110|NCT00679939|2501730|P1|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|76
1030111|NCT00679939|2501729|P2|NOT COMPLETED|52-Week Double-Blind (DB) Period||27
1030112|NCT00679939|2501730|P1|NOT COMPLETED|52-Week Double-Blind (DB) Period||37
1030113|NCT00679939|2501729|P2|COMPLETED|52-Week Double-Blind (DB) Period||85
1030114|NCT00679939|2501730|P1|COMPLETED|52-Week Double-Blind (DB) Period||77
1030115|NCT00679939|2501729|P2|STARTED|52-Week Double-Blind (DB) Period||112
1030116|NCT00679939|2501730|P1|STARTED|52-Week Double-Blind (DB) Period||114
1030117|NCT00679952|2501881|P2|NOT COMPLETED|Overall Study||0
1030118|NCT00679952|2501882|P1|NOT COMPLETED|Overall Study||0
1030119|NCT00679952|2501881|P2|COMPLETED|Overall Study||82
1030120|NCT00679952|2501882|P1|COMPLETED|Overall Study||86
1030121|NCT00679952|2501881|P2|STARTED|Overall Study||82
1030122|NCT00679952|2501882|P1|STARTED|Overall Study||86
1030123|NCT00680017|2501890|P2|NOT COMPLETED|Overall Study||12
1030124|NCT00680017|2501891|P1|NOT COMPLETED|Overall Study||17
1030125|NCT00680017|2501890|P2|COMPLETED|Overall Study||128
1030126|NCT00680017|2501891|P1|COMPLETED|Overall Study||123
1030127|NCT00680017|2501890|P2|STARTED|Overall Study||140
1030128|NCT00680017|2501891|P1|STARTED|Overall Study||140
1030129|NCT00680043|2501902|P3|NOT COMPLETED|Overall Study||4
1030130|NCT00680043|2501903|P2|NOT COMPLETED|Overall Study||1
1030131|NCT00680043|2501904|P1|NOT COMPLETED|Overall Study||2
1030132|NCT00680043|2501902|P3|COMPLETED|Overall Study||34
1030133|NCT00680043|2501903|P2|COMPLETED|Overall Study||36
1030134|NCT00680043|2501904|P1|COMPLETED|Overall Study||37
1030135|NCT00680043|2501902|P3|STARTED|Overall Study||38
1030136|NCT00680043|2501903|P2|STARTED|Overall Study||37
1030137|NCT00680043|2501904|P1|STARTED|Overall Study||39
1030138|NCT00680056|2501920|P2|NOT COMPLETED|Second Intervention||1
1030139|NCT00680056|2501921|P1|NOT COMPLETED|Second Intervention||3
1030140|NCT00680056|2501920|P2|COMPLETED|Second Intervention||14
1030141|NCT00680056|2501921|P1|COMPLETED|Second Intervention||12
1030142|NCT00680056|2501920|P2|STARTED|Second Intervention||15
1030143|NCT00680056|2501921|P1|STARTED|Second Intervention||15
1030144|NCT00680056|2501920|P2|NOT COMPLETED|Washout Period of One Week||0
1030145|NCT00680056|2501921|P1|NOT COMPLETED|Washout Period of One Week||0
1030146|NCT00680056|2501920|P2|COMPLETED|Washout Period of One Week||15
1030147|NCT00680056|2501921|P1|COMPLETED|Washout Period of One Week||15
1030148|NCT00680056|2501920|P2|STARTED|Washout Period of One Week||15
1030149|NCT00680056|2501921|P1|STARTED|Washout Period of One Week||15
1030150|NCT00680056|2501920|P2|NOT COMPLETED|First Intervention||2
1030151|NCT00680056|2501921|P1|NOT COMPLETED|First Intervention||1
1030152|NCT00680056|2501920|P2|COMPLETED|First Intervention||15
1030153|NCT00680056|2501921|P1|COMPLETED|First Intervention||15
1030154|NCT00680056|2501920|P2|STARTED|First Intervention||17
1030155|NCT00680056|2501921|P1|STARTED|First Intervention||16
1030156|NCT00680121|2501931|P2|NOT COMPLETED|Overall Study||23
1030157|NCT00680121|2501932|P1|NOT COMPLETED|Overall Study||27
1030158|NCT00680121|2501931|P2|COMPLETED|Overall Study||37
1030159|NCT00680121|2501932|P1|COMPLETED|Overall Study||33
1030160|NCT00680121|2501931|P2|STARTED|Overall Study||60
1030161|NCT00680121|2501932|P1|STARTED|Overall Study||60
1030162|NCT00680186|2501946|P2|NOT COMPLETED|Overall Study||116
1030163|NCT00680186|2501947|P1|NOT COMPLETED|Overall Study||125
1030164|NCT00680186|2501946|P2|COMPLETED|Overall Study|Completed planned observation time.|1172
1030165|NCT00680186|2501947|P1|COMPLETED|Overall Study|Completed planned observation time.|1155
1030166|NCT00680186|2501946|P2|STARTED|Overall Study|Started treatment.|1288
1030167|NCT00680186|2501947|P1|STARTED|Overall Study|Started treatment.|1280
1030168|NCT00680225|2501971|P1|NOT COMPLETED|Overall Study||2
1030169|NCT00680225|2501971|P1|COMPLETED|Overall Study||8
1030170|NCT00680225|2501971|P1|STARTED|Overall Study||10
1030171|NCT00680316|2501978|P2|NOT COMPLETED|Overall Study||0
1030172|NCT00680316|2501979|P1|NOT COMPLETED|Overall Study||0
1030173|NCT00680316|2501978|P2|COMPLETED|Overall Study||2
1030174|NCT00680316|2501979|P1|COMPLETED|Overall Study||1
1030175|NCT00680316|2501978|P2|STARTED|Overall Study||2
1030176|NCT00680316|2501979|P1|STARTED|Overall Study||1
1030177|NCT00680368|2501991|P1|NOT COMPLETED|Overall Study||15
1030178|NCT00680368|2501991|P1|COMPLETED|Overall Study|15 residents excluded because their attending physician was not participating in the study|97
1030179|NCT00680368|2501991|P1|STARTED|Overall Study||112
1030180|NCT00680407|2502000|P3|NOT COMPLETED|Overall Study||3
1030181|NCT00680407|2502001|P2|NOT COMPLETED|Overall Study||5
1030182|NCT00680407|2502002|P1|NOT COMPLETED|Overall Study||8
1030183|NCT00680407|2502000|P3|COMPLETED|Overall Study||22
1030184|NCT00680407|2502001|P2|COMPLETED|Overall Study||22
1030185|NCT00680407|2502002|P1|COMPLETED|Overall Study||18
1030186|NCT00680407|2502000|P3|STARTED|Overall Study||25
1030187|NCT00680407|2502001|P2|STARTED|Overall Study||27
1030188|NCT00680407|2502002|P1|STARTED|Overall Study||26
1030189|NCT00680459|2502018|P2|NOT COMPLETED|Overall Study||0
1030190|NCT00680459|2502019|P1|NOT COMPLETED|Overall Study||0
1030191|NCT00680459|2502018|P2|COMPLETED|Overall Study||6
1030192|NCT00680459|2502019|P1|COMPLETED|Overall Study||7
1030193|NCT00680459|2502018|P2|STARTED|Overall Study||6
1030194|NCT00680459|2502019|P1|STARTED|Overall Study||7
1030195|NCT00680524|2502029|P1|NOT COMPLETED|Overall Study||3
1030196|NCT00680524|2502029|P1|COMPLETED|Overall Study||17
1030197|NCT00680524|2502029|P1|STARTED|Overall Study||20
1030198|NCT00680628|2502035|P2|NOT COMPLETED|Overall Study||0
1030199|NCT00680628|2502036|P1|NOT COMPLETED|Overall Study||0
1030200|NCT00680628|2502035|P2|COMPLETED|Overall Study||40
1030201|NCT00680628|2502036|P1|COMPLETED|Overall Study||43
1030202|NCT00680628|2502035|P2|STARTED|Overall Study||40
1030203|NCT00680628|2502036|P1|STARTED|Overall Study||43
1030204|NCT00680706|2502048|P2|NOT COMPLETED|Overall Study||5
1030205|NCT00680706|2502049|P1|NOT COMPLETED|Overall Study||7
1030206|NCT00680706|2502048|P2|COMPLETED|Overall Study||55
1030207|NCT00680706|2502049|P1|COMPLETED|Overall Study||63
1030208|NCT00680706|2502048|P2|STARTED|Overall Study||60
1030209|NCT00680706|2502049|P1|STARTED|Overall Study||70
1030210|NCT00680745|2502061|P4|NOT COMPLETED|Overall Study||13
1030211|NCT00680745|2502062|P3|NOT COMPLETED|Overall Study||10
1030212|NCT00680745|2502063|P2|NOT COMPLETED|Overall Study||13
1030213|NCT00680745|2502064|P1|NOT COMPLETED|Overall Study||14
1030214|NCT00680745|2502061|P4|COMPLETED|Overall Study||133
1030215|NCT00680745|2502062|P3|COMPLETED|Overall Study||141
1030216|NCT00680745|2502063|P2|COMPLETED|Overall Study||132
1030217|NCT00680745|2502064|P1|COMPLETED|Overall Study||140
1030218|NCT00680745|2502061|P4|STARTED|Overall Study|Safety Analysis Set|146
1030219|NCT00680745|2502062|P3|STARTED|Overall Study|Safety Analysis Set|151
1030220|NCT00680745|2502063|P2|STARTED|Overall Study|Safety Analysis Set|145
1030221|NCT00680745|2502064|P1|STARTED|Overall Study|Safety Analysis Set|154
1030222|NCT00680771|2502096|P2|NOT COMPLETED|Overall Study||2
1030223|NCT00680771|2502097|P1|NOT COMPLETED|Overall Study||6
1030224|NCT00680771|2502096|P2|COMPLETED|Overall Study||11
1030225|NCT00680771|2502097|P1|COMPLETED|Overall Study||9
1030226|NCT00680771|2502096|P2|STARTED|Overall Study||13
1030227|NCT00680771|2502097|P1|STARTED|Overall Study||15
1030228|NCT00680797|2502107|P4|NOT COMPLETED|Overall Study||0
1030229|NCT00680797|2502108|P3|NOT COMPLETED|Overall Study||0
1030230|NCT00680797|2502109|P2|NOT COMPLETED|Overall Study||0
1030231|NCT00680797|2502110|P1|NOT COMPLETED|Overall Study||0
1030232|NCT00680797|2502107|P4|COMPLETED|Overall Study||8
1030233|NCT00680797|2502108|P3|COMPLETED|Overall Study||8
1030234|NCT00680797|2502109|P2|COMPLETED|Overall Study||8
1030235|NCT00680797|2502110|P1|COMPLETED|Overall Study||9
1030236|NCT00680797|2502107|P4|STARTED|Overall Study||8
1030237|NCT00680797|2502108|P3|STARTED|Overall Study||8
1030238|NCT00680797|2502109|P2|STARTED|Overall Study||8
1030239|NCT00680797|2502110|P1|STARTED|Overall Study||9
1030240|NCT00680836|2502122|P2|NOT COMPLETED|Overall Study||2
1030241|NCT00680836|2502123|P1|NOT COMPLETED|Overall Study||8
1030242|NCT00680836|2502122|P2|COMPLETED|Overall Study||25
1030243|NCT00680836|2502123|P1|COMPLETED|Overall Study||19
1030244|NCT00680836|2502122|P2|STARTED|Overall Study||27
1030245|NCT00680836|2502123|P1|STARTED|Overall Study||27
1030246|NCT00680862|2502139|P1|NOT COMPLETED|Overall Study||0
1030247|NCT00680862|2502139|P1|COMPLETED|Overall Study||25
1030248|NCT00680862|2502139|P1|STARTED|Overall Study||25
1030249|NCT00680901|2502145|P2|NOT COMPLETED|Overall Study||76
1030250|NCT00680901|2502146|P1|NOT COMPLETED|Overall Study||73
1030251|NCT00680901|2502145|P2|COMPLETED|Overall Study||197
1030252|NCT00680901|2502146|P1|COMPLETED|Overall Study||199
1030253|NCT00680901|2502145|P2|Ongoing: In Follow Up|Overall Study||41
1030254|NCT00680901|2502146|P1|Ongoing: In Follow Up|Overall Study||45
1030255|NCT00680901|2502145|P2|Ongoing: On Study Treatment|Overall Study||13
1030256|NCT00680901|2502146|P1|Ongoing: On Study Treatment|Overall Study||16
1030257|NCT00680901|2502145|P2|STARTED|Overall Study||273
1030258|NCT00680901|2502146|P1|STARTED|Overall Study||272
1030259|NCT00680914|2502180|P2|NOT COMPLETED|Overall Study||4
1030260|NCT00680914|2502181|P1|NOT COMPLETED|Overall Study||10
1030261|NCT00680914|2502180|P2|COMPLETED|Overall Study||125
1030262|NCT00680914|2502181|P1|COMPLETED|Overall Study||364
1030263|NCT00680914|2502180|P2|STARTED|Overall Study||129
1030264|NCT00680914|2502181|P1|STARTED|Overall Study||374
1030265|NCT00680953|2502216|P3|NOT COMPLETED|Overall Study||47
1030266|NCT00680953|2502217|P2|NOT COMPLETED|Overall Study||95
1030267|NCT00680953|2502218|P1|NOT COMPLETED|Overall Study||86
1030268|NCT00680953|2502216|P3|COMPLETED|Overall Study||204
1030269|NCT00680953|2502217|P2|COMPLETED|Overall Study||416
1030270|NCT00680953|2502218|P1|COMPLETED|Overall Study||414
1030271|NCT00680953|2502216|P3|STARTED|Overall Study||251
1030273|NCT00680953|2502218|P1|STARTED|Overall Study||500
1030274|NCT00681031|2502232|P1|NOT COMPLETED|Overall Study||0
1030275|NCT00681031|2502232|P1|COMPLETED|Overall Study||96
1030276|NCT00681031|2502232|P1|STARTED|Overall Study||96
1030277|NCT00681044|2502236|P1|NOT COMPLETED|Overall Study||0
1030278|NCT00681044|2502236|P1|COMPLETED|Overall Study||4
1030279|NCT00681044|2502236|P1|STARTED|Overall Study||4
1030289|NCT00681187|2502259|P2|NOT COMPLETED|Overall Study||2
1030290|NCT00681187|2502260|P1|NOT COMPLETED|Overall Study||1
1030291|NCT00681187|2502259|P2|COMPLETED|Overall Study||13
1030292|NCT00681187|2502260|P1|COMPLETED|Overall Study||10
1030293|NCT00681187|2502259|P2|STARTED|Overall Study||15
1030294|NCT00681187|2502260|P1|STARTED|Overall Study||11
1030295|NCT00687453|2502294|P2|NOT COMPLETED|Overall Study||6
1030296|NCT00687453|2502295|P1|NOT COMPLETED|Overall Study||3
1030297|NCT00687453|2502294|P2|COMPLETED|Overall Study||7
1030298|NCT00687453|2502295|P1|COMPLETED|Overall Study||8
1030299|NCT00687453|2502294|P2|STARTED|Overall Study||13
1030300|NCT00687453|2502295|P1|STARTED|Overall Study||11
1030301|NCT00687531|2502301|P1|NOT COMPLETED|Overall Study||135
1030302|NCT00687531|2502301|P1|COMPLETED|Overall Study||250
1030303|NCT00687531|2502301|P1|RECEIVED TREATMENT|Overall Study||281
1030304|NCT00687531|2502301|P1|STARTED|Overall Study|Completed screening procedures|385
1030305|NCT00687544|2502315|P1|NOT COMPLETED|Overall Study||11
1030306|NCT00687544|2502315|P1|COMPLETED|Overall Study||0
1030307|NCT00687544|2502315|P1|STARTED|Overall Study||11
1030308|NCT00687609|2502324|P1|NOT COMPLETED|Overall Study||3
1030309|NCT00687609|2502324|P1|COMPLETED|Overall Study||4
1030310|NCT00687609|2502324|P1|STARTED|Overall Study||7
1030311|NCT00687674|2502338|P1|NOT COMPLETED|Overall Study||2
1030312|NCT00687674|2502338|P1|COMPLETED|Overall Study||11
1030313|NCT00687674|2502338|P1|STARTED|Overall Study||13
1030314|NCT00687713|2502347|P2|NOT COMPLETED|Overall Study||40
1030315|NCT00687713|2502348|P1|NOT COMPLETED|Overall Study||32
1030316|NCT00687713|2502347|P2|COMPLETED|Overall Study||64
1030317|NCT00687713|2502348|P1|COMPLETED|Overall Study||68
1030318|NCT00687713|2502347|P2|STARTED|Overall Study||104
1030319|NCT00687713|2502348|P1|STARTED|Overall Study||100
1030320|NCT00687804|2502359|P3|NOT COMPLETED|Open-Label Extension Study||11
1030321|NCT00687804|2502360|P2|NOT COMPLETED|Open-Label Extension Study||11
1030322|NCT00687804|2502361|P1|NOT COMPLETED|Open-Label Extension Study||10
1030323|NCT00687804|2502359|P3|COMPLETED|Open-Label Extension Study||63
1030324|NCT00687804|2502360|P2|COMPLETED|Open-Label Extension Study||72
1030325|NCT00687804|2502361|P1|COMPLETED|Open-Label Extension Study||73
1030326|NCT00687804|2502359|P3|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||15
1030327|NCT00687804|2502360|P2|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||21
1030328|NCT00687804|2502361|P1|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||16
1030329|NCT00687804|2502359|P3|STARTED|Open-Label Extension Study||74
1030330|NCT00687804|2502360|P2|STARTED|Open-Label Extension Study||83
1030331|NCT00687804|2502361|P1|STARTED|Open-Label Extension Study||83
1030332|NCT00687804|2502359|P3|NOT COMPLETED|Core Study||13
1030333|NCT00687804|2502360|P2|NOT COMPLETED|Core Study||15
1030334|NCT00687804|2502361|P1|NOT COMPLETED|Core Study||14
1030335|NCT00687804|2502359|P3|COMPLETED|Core Study||98
1030336|NCT00687804|2502360|P2|COMPLETED|Core Study||103
1030337|NCT00687804|2502361|P1|COMPLETED|Core Study||102
1030338|NCT00687804|2502359|P3|STARTED|Core Study||111
1030339|NCT00687804|2502360|P2|STARTED|Core Study||118
1030340|NCT00687804|2502361|P1|STARTED|Core Study||116
1030341|NCT00688467|2502406|P2|NOT COMPLETED|Treatment Period 2||2
1030342|NCT00688467|2502407|P1|NOT COMPLETED|Treatment Period 2||0
1030343|NCT00688467|2502406|P2|COMPLETED|Treatment Period 2||6
1030344|NCT00688467|2502407|P1|COMPLETED|Treatment Period 2||7
1030345|NCT00688467|2502406|P2|STARTED|Treatment Period 2||8
1030346|NCT00688467|2502407|P1|STARTED|Treatment Period 2||7
1030347|NCT00688467|2502406|P2|NOT COMPLETED|Treatment Period 1||2
1030348|NCT00688467|2502407|P1|NOT COMPLETED|Treatment Period 1||2
1030349|NCT00688467|2502406|P2|COMPLETED|Treatment Period 1||8
1030350|NCT00688467|2502407|P1|COMPLETED|Treatment Period 1||7
1030351|NCT00688467|2502406|P2|STARTED|Treatment Period 1||10
1030352|NCT00688467|2502407|P1|STARTED|Treatment Period 1||9
1030353|NCT00688519|2502439|P2|NOT COMPLETED|Overall Study||15
1030354|NCT00688519|2502440|P1|NOT COMPLETED|Overall Study||19
1030355|NCT00688519|2502439|P2|COMPLETED|Overall Study||98
1030356|NCT00688519|2502440|P1|COMPLETED|Overall Study||204
1030357|NCT00688519|2502439|P2|STARTED|Overall Study||113
1030358|NCT00688519|2502440|P1|STARTED|Overall Study||223
1030359|NCT00688545|2502458|P2|NOT COMPLETED|Overall Study||15
1030360|NCT00688545|2502459|P1|NOT COMPLETED|Overall Study||5
1030361|NCT00688545|2502458|P2|COMPLETED|Overall Study||204
1030362|NCT00688545|2502459|P1|COMPLETED|Overall Study||50
1030363|NCT00688545|2502458|P2|Switched Treatment at Least Once|Overall Study||13
1030364|NCT00688545|2502459|P1|Switched Treatment at Least Once|Overall Study||6
1030365|NCT00688545|2502458|P2|STARTED|Overall Study||219
1030366|NCT00688545|2502459|P1|STARTED|Overall Study||55
1030367|NCT00688636|2502469|P2|NOT COMPLETED|Overall Study||1
1030368|NCT00688636|2502470|P1|NOT COMPLETED|Overall Study||2
1030369|NCT00688636|2502469|P2|COMPLETED|Overall Study||12
1030370|NCT00688636|2502470|P1|COMPLETED|Overall Study||9
1030371|NCT00688636|2502469|P2|STARTED|Overall Study||13
1030372|NCT00688636|2502470|P1|STARTED|Overall Study||11
1030373|NCT00688662|2502486|P2|NOT COMPLETED|Overall Study||18
1030374|NCT00688662|2502487|P1|NOT COMPLETED|Overall Study||23
1030375|NCT00688662|2502486|P2|COMPLETED|Overall Study||55
1030376|NCT00688662|2502487|P1|COMPLETED|Overall Study||118
1030377|NCT00688662|2502486|P2|STARTED|Overall Study||73
1030378|NCT00688662|2502487|P1|STARTED|Overall Study||141
1030379|NCT00688688|2502498|P3|NOT COMPLETED|Overall Study||192
1030380|NCT00688688|2502499|P2|NOT COMPLETED|Overall Study||179
1030381|NCT00688688|2502500|P1|NOT COMPLETED|Overall Study||186
1030382|NCT00688688|2502498|P3|COMPLETED|Overall Study||621
1030383|NCT00688688|2502499|P2|COMPLETED|Overall Study||645
1030384|NCT00688688|2502500|P1|COMPLETED|Overall Study||629
1030385|NCT00688688|2502498|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|488
1030386|NCT00688688|2502499|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|483
1030387|NCT00688688|2502500|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|479
1030388|NCT00688688|2502498|P3|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|791
1030389|NCT00688688|2502499|P2|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|802
1030390|NCT00688688|2502500|P1|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|789
1030391|NCT00688688|2502498|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
1030392|NCT00688688|2502499|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|820
1030393|NCT00688688|2502500|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
1030394|NCT00688688|2502498|P3|STARTED|Overall Study||813
1030395|NCT00688688|2502499|P2|STARTED|Overall Study||824
1030396|NCT00688688|2502500|P1|STARTED|Overall Study||815
1030397|NCT00688701|2502592|P4|NOT COMPLETED|Overall Study||11
1030398|NCT00688701|2502593|P3|NOT COMPLETED|Overall Study||10
1030399|NCT00688701|2502594|P2|NOT COMPLETED|Overall Study||5
1030400|NCT00688701|2502595|P1|NOT COMPLETED|Overall Study||4
1030401|NCT00688701|2502592|P4|COMPLETED|Overall Study||108
1030402|NCT00688701|2502593|P3|COMPLETED|Overall Study||110
1030403|NCT00688701|2502594|P2|COMPLETED|Overall Study||56
1030404|NCT00688701|2502595|P1|COMPLETED|Overall Study||57
1030405|NCT00688701|2502592|P4|Subgroup for Standardized Meal Test|Overall Study||65
1030406|NCT00688701|2502593|P3|Subgroup for Standardized Meal Test|Overall Study||60
1030407|NCT00688701|2502594|P2|Subgroup for Standardized Meal Test|Overall Study||35
1030408|NCT00688701|2502595|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|27
1030409|NCT00688701|2502592|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||118
1030410|NCT00688701|2502593|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||120
1030411|NCT00688701|2502594|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||60
1030412|NCT00688701|2502595|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|61
1030413|NCT00688701|2502592|P4|Treated/Safety Population|Overall Study||119
1030414|NCT00688701|2502593|P3|Treated/Safety Population|Overall Study||120
1030415|NCT00688701|2502594|P2|Treated/Safety Population|Overall Study||61
1030416|NCT00688701|2502595|P1|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|61
1030417|NCT00688701|2502592|P4|STARTED|Overall Study||119
1030418|NCT00688701|2502593|P3|STARTED|Overall Study||120
1030419|NCT00688701|2502594|P2|STARTED|Overall Study||61
1030420|NCT00688701|2502595|P1|STARTED|Overall Study|Randomized|61
1030421|NCT00688740|2502635|P2|NOT COMPLETED|Overall Study||35
1030422|NCT00688740|2502636|P1|NOT COMPLETED|Overall Study||66
1030423|NCT00688740|2502635|P2|COMPLETED|Overall Study||711
1030424|NCT00688740|2502636|P1|COMPLETED|Overall Study||679
1030425|NCT00688740|2502635|P2|STARTED|Overall Study||746
1030426|NCT00688740|2502636|P1|STARTED|Overall Study||745
1030427|NCT00688753|2502646|P1|NOT COMPLETED|Overall Study||92
1030428|NCT00688753|2502646|P1|COMPLETED|Overall Study||0
1030429|NCT00688753|2502646|P1|STARTED|Overall Study||92
1030430|NCT00688844|2502655|P1|NOT COMPLETED|Overall Study||10
1030431|NCT00688844|2502655|P1|COMPLETED|Overall Study||48
1030432|NCT00688844|2502655|P1|STARTED|Overall Study||58
1030433|NCT00688870|2502667|P2|NOT COMPLETED|Toddler Dose||0
1030434|NCT00688870|2502668|P1|NOT COMPLETED|Toddler Dose||0
1030435|NCT00688870|2502667|P2|COMPLETED|Toddler Dose||84
1030436|NCT00688870|2502668|P1|COMPLETED|Toddler Dose||80
1030437|NCT00688870|2502667|P2|STARTED|Toddler Dose||84
1030438|NCT00688870|2502668|P1|STARTED|Toddler Dose||80
1030439|NCT00688870|2502667|P2|NOT COMPLETED|After Infant Series||0
1030440|NCT00688870|2502668|P1|NOT COMPLETED|After Infant Series||0
1030441|NCT00688870|2502667|P2|COMPLETED|After Infant Series||84
1030442|NCT00688870|2502668|P1|COMPLETED|After Infant Series||80
1030443|NCT00688870|2502667|P2|STARTED|After Infant Series||84
1030444|NCT00688870|2502668|P1|STARTED|After Infant Series||80
1030445|NCT00688870|2502667|P2|NOT COMPLETED|Infant Series||0
1030446|NCT00688870|2502668|P1|NOT COMPLETED|Infant Series||4
1030447|NCT00688870|2502667|P2|COMPLETED|Infant Series||84
1030448|NCT00688870|2502668|P1|COMPLETED|Infant Series||80
1030449|NCT00688870|2502667|P2|Vaccinated Dose 3|Infant Series||84
1030450|NCT00688870|2502668|P1|Vaccinated Dose 3|Infant Series||80
1030451|NCT00688870|2502667|P2|Vaccinated Dose 2|Infant Series||84
1030452|NCT00688870|2502668|P1|Vaccinated Dose 2|Infant Series||80
1030453|NCT00688870|2502667|P2|Vaccinated Dose 1|Infant Series||84
1030454|NCT00688870|2502668|P1|Vaccinated Dose 1|Infant Series||83
1030455|NCT00688870|2502667|P2|STARTED|Infant Series||84
1030456|NCT00688870|2502668|P1|STARTED|Infant Series||84
1030457|NCT00689026|2502702|P2|NOT COMPLETED|Overall Study||6
1030458|NCT00689026|2502703|P1|NOT COMPLETED|Overall Study||13
1030459|NCT00689026|2502702|P2|COMPLETED|Overall Study||24
1030460|NCT00689026|2502703|P1|COMPLETED|Overall Study||17
1030461|NCT00689026|2502702|P2|STARTED|Overall Study||30
1030462|NCT00689026|2502703|P1|STARTED|Overall Study||30
1030463|NCT00689052|2502711|P2|NOT COMPLETED|Overall Study||30
1030464|NCT00689052|2502712|P1|NOT COMPLETED|Overall Study||31
1030465|NCT00689052|2502711|P2|COMPLETED|Overall Study||0
1030466|NCT00689052|2502712|P1|COMPLETED|Overall Study||0
1030467|NCT00689052|2502711|P2|STARTED|Overall Study||30
1030468|NCT00689052|2502712|P1|STARTED|Overall Study||31
1030469|NCT00689091|2502744|P2|NOT COMPLETED|Overall Study||1394
1030470|NCT00689091|2502745|P1|NOT COMPLETED|Overall Study||1371
1030471|NCT00689091|2502744|P2|COMPLETED|Overall Study||9376
1030472|NCT00689091|2502745|P1|COMPLETED|Overall Study||9460
1030473|NCT00689091|2502744|P2|STARTED|Overall Study||10770
1030474|NCT00689091|2502745|P1|STARTED|Overall Study||10831
1030475|NCT00689104|2502755|P4|NOT COMPLETED|Overall Study||50
1030476|NCT00689104|2502756|P3|NOT COMPLETED|Overall Study||45
1030477|NCT00689104|2502757|P2|NOT COMPLETED|Overall Study||57
1030478|NCT00689104|2502758|P1|NOT COMPLETED|Overall Study||44
1030479|NCT00689104|2502755|P4|COMPLETED|Overall Study||445
1030480|NCT00689104|2502756|P3|COMPLETED|Overall Study||453
1030481|NCT00689104|2502757|P2|COMPLETED|Overall Study||440
1030482|NCT00689104|2502758|P1|COMPLETED|Overall Study||453
1030483|NCT00689104|2502755|P4|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|300
1030484|NCT00689104|2502756|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|281
1030485|NCT00689104|2502757|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|293
1030486|NCT00689104|2502758|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|291
1030487|NCT00689104|2502755|P4|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|475
1030488|NCT00689104|2502756|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|478
1030489|NCT00689104|2502757|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|473
1030490|NCT00689104|2502758|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|480
1030491|NCT00689104|2502755|P4|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|495
1030492|NCT00689104|2502756|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|496
1030493|NCT00689104|2502757|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|493
1030494|NCT00689104|2502758|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|494
1030495|NCT00689104|2502755|P4|STARTED|Overall Study||495
1030496|NCT00689104|2502756|P3|STARTED|Overall Study||498
1030497|NCT00689104|2502757|P2|STARTED|Overall Study||497
1030498|NCT00689104|2502758|P1|STARTED|Overall Study||497
1030499|NCT00689117|2502892|P4|NOT COMPLETED|Overall Study||31
1030500|NCT00689117|2502893|P3|NOT COMPLETED|Overall Study||59
1030501|NCT00689117|2502894|P2|NOT COMPLETED|Overall Study||51
1030502|NCT00689117|2502895|P1|NOT COMPLETED|Overall Study||62
1030503|NCT00689117|2502892|P4|COMPLETED|Overall Study||211
1030504|NCT00689117|2502893|P3|COMPLETED|Overall Study||405
1030505|NCT00689117|2502894|P2|COMPLETED|Overall Study||416
1030506|NCT00689117|2502895|P1|COMPLETED|Overall Study||414
1030507|NCT00689117|2502892|P4|STARTED|Overall Study||242
1030508|NCT00689117|2502893|P3|STARTED|Overall Study||464
1030509|NCT00689117|2502894|P2|STARTED|Overall Study||467
1030510|NCT00689117|2502895|P1|STARTED|Overall Study||476
1030511|NCT00689221|2502923|P2|NOT COMPLETED|Overall Study||36
1030512|NCT00689221|2502924|P1|NOT COMPLETED|Overall Study||39
1030513|NCT00689221|2502923|P2|COMPLETED|Overall Study||237
1030514|NCT00689221|2502924|P1|COMPLETED|Overall Study||233
1030515|NCT00689221|2502923|P2|STARTED|Overall Study||273
1030516|NCT00689221|2502924|P1|STARTED|Overall Study||272
1030517|NCT00689260|2502951|P2|NOT COMPLETED|Overall Study||0
1030518|NCT00689260|2502952|P1|NOT COMPLETED|Overall Study||2
1030519|NCT00689260|2502951|P2|COMPLETED|Overall Study||21
1030520|NCT00689260|2502952|P1|COMPLETED|Overall Study||19
1030521|NCT00689260|2502951|P2|STARTED|Overall Study||21
1030522|NCT00689260|2502952|P1|STARTED|Overall Study||21
1030523|NCT00689299|2502971|P3|NOT COMPLETED|Overall Study||5
1030524|NCT00689299|2502972|P2|NOT COMPLETED|Overall Study||3
1030525|NCT00689299|2502973|P1|NOT COMPLETED|Overall Study||7
1030526|NCT00689299|2502971|P3|COMPLETED|Overall Study||49
1030527|NCT00689299|2502972|P2|COMPLETED|Overall Study||54
1030528|NCT00689299|2502973|P1|COMPLETED|Overall Study||51
1030529|NCT00689299|2502971|P3|STARTED|Overall Study||54
1030530|NCT00689299|2502972|P2|STARTED|Overall Study||57
1030531|NCT00689299|2502973|P1|STARTED|Overall Study||58
1030532|NCT00689338|2502981|P1|NOT COMPLETED|Overall Study||143
1030533|NCT00689338|2502981|P1|COMPLETED|Overall Study||73
1030534|NCT00689338|2502981|P1|STARTED|Overall Study||216
1030535|NCT00689351|2502993|P2|NOT COMPLETED|Toddler Dose||0
1030536|NCT00689351|2502994|P1|NOT COMPLETED|Toddler Dose||0
1030537|NCT00689351|2502993|P2|COMPLETED|Toddler Dose||88
1030538|NCT00689351|2502994|P1|COMPLETED|Toddler Dose||84
1030539|NCT00689351|2502993|P2|STARTED|Toddler Dose||88
1030540|NCT00689351|2502994|P1|STARTED|Toddler Dose||84
1030541|NCT00689351|2502993|P2|NOT COMPLETED|After Infant Series||0
1030542|NCT00689351|2502994|P1|NOT COMPLETED|After Infant Series||1
1030543|NCT00689351|2502993|P2|COMPLETED|After Infant Series||88
1030544|NCT00689351|2502994|P1|COMPLETED|After Infant Series||84
1030545|NCT00689351|2502993|P2|STARTED|After Infant Series||88
1030546|NCT00689351|2502994|P1|STARTED|After Infant Series||85
1030547|NCT00689351|2502993|P2|NOT COMPLETED|Infant Series of Dosing||1
1030548|NCT00689351|2502994|P1|NOT COMPLETED|Infant Series of Dosing||6
1030549|NCT00689351|2502993|P2|COMPLETED|Infant Series of Dosing||88
1030550|NCT00689351|2502994|P1|COMPLETED|Infant Series of Dosing||85
1030551|NCT00689351|2502993|P2|Vaccinated Dose 3|Infant Series of Dosing||88
1030552|NCT00689351|2502994|P1|Vaccinated Dose 3|Infant Series of Dosing||85
1030553|NCT00689351|2502993|P2|Vaccinated Dose 2|Infant Series of Dosing||88
1030554|NCT00689351|2502994|P1|Vaccinated Dose 2|Infant Series of Dosing||86
1030555|NCT00689351|2502993|P2|Vaccinated Dose 1|Infant Series of Dosing||89
1030556|NCT00689351|2502994|P1|Vaccinated Dose 1|Infant Series of Dosing||88
1030557|NCT00689351|2502993|P2|STARTED|Infant Series of Dosing||89
1030558|NCT00689351|2502994|P1|STARTED|Infant Series of Dosing||91
1030559|NCT00689390|2503028|P2|NOT COMPLETED|Overall Study||10
1030560|NCT00689390|2503029|P1|NOT COMPLETED|Overall Study||426
1030561|NCT00689390|2503028|P2|COMPLETED|Overall Study||37
1030562|NCT00689390|2503029|P1|COMPLETED|Overall Study||1481
1030563|NCT00689390|2503028|P2|STARTED|Overall Study||47
1030564|NCT00689390|2503029|P1|STARTED|Overall Study||1907
1030565|NCT00689481|2503047|P2|NOT COMPLETED|Overall Study||14
1030566|NCT00689481|2503048|P1|NOT COMPLETED|Overall Study||24
1030567|NCT00689481|2503047|P2|COMPLETED|Overall Study||95
1030568|NCT00689481|2503048|P1|COMPLETED|Overall Study||190
1030569|NCT00689481|2503047|P2|STARTED|Overall Study||109
1030570|NCT00689481|2503048|P1|STARTED|Overall Study||214
1030571|NCT00689611|2503066|P2|NOT COMPLETED|Overall Study||46
1030572|NCT00689611|2503067|P1|NOT COMPLETED|Overall Study||41
1030573|NCT00689611|2503066|P2|COMPLETED|Overall Study||146
1030574|NCT00689611|2503067|P1|COMPLETED|Overall Study||159
1030575|NCT00689611|2503066|P2|STARTED|Overall Study||192
1030576|NCT00689611|2503067|P1|STARTED|Overall Study||200
1030577|NCT00689793|2503077|P2|NOT COMPLETED|Overall Study||5
1030578|NCT00689793|2503078|P1|NOT COMPLETED|Overall Study||4
1030579|NCT00689793|2503077|P2|COMPLETED|Overall Study||71
1030580|NCT00689793|2503078|P1|COMPLETED|Overall Study||74
1030581|NCT00689793|2503077|P2|STARTED|Overall Study||76
1030582|NCT00689793|2503078|P1|STARTED|Overall Study||78
1030583|NCT00689819|2503096|P2|NOT COMPLETED|Overall Study||15
1030584|NCT00689819|2503097|P1|NOT COMPLETED|Overall Study||20
1030585|NCT00689819|2503096|P2|COMPLETED|Overall Study||43
1030586|NCT00689819|2503097|P1|COMPLETED|Overall Study||45
1030587|NCT00689819|2503096|P2|STARTED|Overall Study||58
1030588|NCT00689819|2503097|P1|STARTED|Overall Study||65
1030589|NCT00689871|2503109|P4|NOT COMPLETED|Overall Study||7
1030590|NCT00689871|2503110|P3|NOT COMPLETED|Overall Study||73
1030591|NCT00689871|2503111|P2|NOT COMPLETED|Overall Study||52
1030592|NCT00689871|2503112|P1|NOT COMPLETED|Overall Study||175
1030593|NCT00689871|2503109|P4|COMPLETED|Overall Study|4 Patients discontinued|8
1030594|NCT00689871|2503110|P3|COMPLETED|Overall Study|28 Patients discontinued|74
1030595|NCT00689871|2503111|P2|COMPLETED|Overall Study|35 Patients discontinued|46
1030596|NCT00689871|2503112|P1|COMPLETED|Overall Study|35 Patients discontinued|280
1030597|NCT00689871|2503109|P4|STARTED|Overall Study|25 Implants|15
1030598|NCT00689871|2503110|P3|STARTED|Overall Study|288 Implants|147
1030599|NCT00689871|2503111|P2|STARTED|Overall Study|127 Implants|98
1030600|NCT00689871|2503112|P1|STARTED|Overall Study|908 Implants|455
1030601|NCT00689884|2503126|P1|NOT COMPLETED|Overall Study||0
1030602|NCT00689884|2503126|P1|COMPLETED|Overall Study||7
1030603|NCT00689884|2503126|P1|STARTED|Overall Study||7
1030637|NCT00690040|2503278|P2|NOT COMPLETED|Overall Study||0
1030638|NCT00690040|2503279|P1|NOT COMPLETED|Overall Study||0
1030639|NCT00690040|2503278|P2|COMPLETED|Overall Study||148
1030640|NCT00690040|2503279|P1|COMPLETED|Overall Study||145
1030641|NCT00690040|2503278|P2|STARTED|Overall Study||148
1030642|NCT00690040|2503279|P1|STARTED|Overall Study||145
1030643|NCT00690339|2503289|P4|NOT COMPLETED|Overall Study||25
1030644|NCT00690339|2503290|P3|NOT COMPLETED|Overall Study||57
1030645|NCT00690339|2503291|P2|NOT COMPLETED|Overall Study||81
1030646|NCT00690339|2503292|P1|NOT COMPLETED|Overall Study||117
1030647|NCT00690339|2503289|P4|COMPLETED|Overall Study||43
1030648|NCT00690339|2503290|P3|COMPLETED|Overall Study||99
1030649|NCT00690339|2503291|P2|COMPLETED|Overall Study||144
1030650|NCT00690339|2503292|P1|COMPLETED|Overall Study||375
1030651|NCT00690339|2503289|P4|STARTED|Overall Study||68
1030652|NCT00690339|2503290|P3|STARTED|Overall Study||156
1030653|NCT00690339|2503291|P2|STARTED|Overall Study||225
1030654|NCT00690339|2503292|P1|STARTED|Overall Study||492
1030655|NCT00690430|2503308|P3|NOT COMPLETED|Extension Phase||13
1030656|NCT00690430|2503309|P2|NOT COMPLETED|Extension Phase||5
1030657|NCT00690430|2503310|P1|NOT COMPLETED|Extension Phase||18
1030658|NCT00690430|2503308|P3|COMPLETED|Extension Phase||2
1030659|NCT00690430|2503309|P2|COMPLETED|Extension Phase||1
1030660|NCT00690430|2503310|P1|COMPLETED|Extension Phase||2
1030661|NCT00690430|2503308|P3|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|15
1030662|NCT00690430|2503309|P2|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|6
1030663|NCT00690430|2503310|P1|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|20
1030664|NCT00690430|2503308|P3|NOT COMPLETED|Core Phase||0
1030665|NCT00690430|2503309|P2|NOT COMPLETED|Core Phase||23
1030666|NCT00690430|2503310|P1|NOT COMPLETED|Core Phase||18
1030667|NCT00690430|2503308|P3|COMPLETED|Core Phase||0
1030668|NCT00690430|2503309|P2|COMPLETED|Core Phase||34
1030669|NCT00690430|2503310|P1|COMPLETED|Core Phase||35
1030670|NCT00690430|2503308|P3|STARTED|Core Phase|This arm belongs to Extension Phase.|0
1030671|NCT00690430|2503309|P2|STARTED|Core Phase||57
1030672|NCT00690430|2503310|P1|STARTED|Core Phase|"Started indicates Full Analysis Set (FAS) and Safety Set."|53
1030673|NCT00690443|2503339|P2|NOT COMPLETED|Overall Study||2
1030674|NCT00690443|2503340|P1|NOT COMPLETED|Overall Study||1
1030675|NCT00690443|2503339|P2|COMPLETED|Overall Study||19
1030676|NCT00690443|2503340|P1|COMPLETED|Overall Study||22
1030677|NCT00690443|2503339|P2|STARTED|Overall Study||21
1030678|NCT00690443|2503340|P1|STARTED|Overall Study||23
1030679|NCT00690482|2503350|P2|NOT COMPLETED|Overall Study||3
1030680|NCT00690482|2503351|P1|NOT COMPLETED|Overall Study||4
1030681|NCT00690482|2503350|P2|COMPLETED|Overall Study||54
1030682|NCT00690482|2503351|P1|COMPLETED|Overall Study||57
1030683|NCT00690482|2503350|P2|STARTED|Overall Study||57
1030684|NCT00690482|2503351|P1|STARTED|Overall Study||61
1030685|NCT00690495|2503385|P2|NOT COMPLETED|Overall Study||0
1030686|NCT00690495|2503386|P1|NOT COMPLETED|Overall Study||0
1030687|NCT00690495|2503385|P2|COMPLETED|Overall Study||50
1030688|NCT00690495|2503386|P1|COMPLETED|Overall Study||50
1030689|NCT00690495|2503385|P2|Primary Endpoint|Overall Study||50
1030690|NCT00690495|2503386|P1|Primary Endpoint|Overall Study||50
1030691|NCT00690495|2503385|P2|STARTED|Overall Study||50
1030692|NCT00690495|2503386|P1|STARTED|Overall Study||50
1030693|NCT00690573|2503392|P1|NOT COMPLETED|Overall Study||9
1030694|NCT00690573|2503392|P1|COMPLETED|Overall Study||16
1030695|NCT00690573|2503392|P1|STARTED|Overall Study||25
1030696|NCT00690612|2503400|P1|NOT COMPLETED|Overall Study||3
1030697|NCT00690612|2503400|P1|COMPLETED|Overall Study||32
1030698|NCT00690612|2503400|P1|STARTED|Overall Study||35
1030699|NCT00684138|2503407|P2|NOT COMPLETED|Overall Study||8
1030700|NCT00684138|2503408|P1|NOT COMPLETED|Overall Study||3
1030701|NCT00684138|2503407|P2|COMPLETED|Overall Study||131
1030702|NCT00684138|2503408|P1|COMPLETED|Overall Study||138
1030703|NCT00684138|2503407|P2|STARTED|Overall Study||139
1030704|NCT00684138|2503408|P1|STARTED|Overall Study||141
1030705|NCT00684177|2503426|P2|NOT COMPLETED|Overall Study||23
1030706|NCT00684177|2503427|P1|NOT COMPLETED|Overall Study||21
1030707|NCT00684177|2503426|P2|COMPLETED|Overall Study||141
1030708|NCT00684177|2503427|P1|COMPLETED|Overall Study||322
1030709|NCT00684177|2503426|P2|STARTED|Overall Study||164
1030710|NCT00684177|2503427|P1|STARTED|Overall Study||343
1030711|NCT00684203|2503449|P6|NOT COMPLETED|Overall Study||0
1030712|NCT00684203|2503450|P5|NOT COMPLETED|Overall Study||0
1030713|NCT00684203|2503451|P4|NOT COMPLETED|Overall Study||0
1030714|NCT00684203|2503452|P3|NOT COMPLETED|Overall Study||9
1030715|NCT00684203|2503453|P2|NOT COMPLETED|Overall Study||8
1030716|NCT00684203|2503454|P1|NOT COMPLETED|Overall Study||9
1030717|NCT00684203|2503449|P6|COMPLETED|Overall Study||2
1030718|NCT00684203|2503450|P5|COMPLETED|Overall Study||17
1030719|NCT00684203|2503451|P4|COMPLETED|Overall Study||6
1030720|NCT00684203|2503452|P3|COMPLETED|Overall Study||12
1030721|NCT00684203|2503453|P2|COMPLETED|Overall Study||23
1030722|NCT00684203|2503454|P1|COMPLETED|Overall Study||31
1030723|NCT00684203|2503449|P6|STARTED|Overall Study||2
1030724|NCT00684203|2503450|P5|STARTED|Overall Study||17
1030725|NCT00684203|2503451|P4|STARTED|Overall Study||6
1030726|NCT00684203|2503452|P3|STARTED|Overall Study||21
1030727|NCT00684203|2503453|P2|STARTED|Overall Study||31
1030728|NCT00684203|2503454|P1|STARTED|Overall Study||40
1030729|NCT00684242|2503513|P1|NOT COMPLETED|Overall Study||0
1030730|NCT00684242|2503513|P1|COMPLETED|Overall Study||3
1030731|NCT00684242|2503513|P1|STARTED|Overall Study||3
1030732|NCT00684255|2503517|P1|NOT COMPLETED|Overall Study||0
1030733|NCT00684255|2503517|P1|COMPLETED|Overall Study||1
1030734|NCT00684255|2503517|P1|STARTED|Overall Study||1
1030735|NCT00684307|2503527|P5|NOT COMPLETED|Overall Study||25
1030736|NCT00684307|2503528|P4|NOT COMPLETED|Overall Study||32
1030737|NCT00684307|2503529|P3|NOT COMPLETED|Overall Study||28
1030738|NCT00684307|2503530|P2|NOT COMPLETED|Overall Study||22
1030739|NCT00684307|2503531|P1|NOT COMPLETED|Overall Study||24
1030740|NCT00684307|2503527|P5|COMPLETED|Overall Study||293
1030741|NCT00684307|2503528|P4|COMPLETED|Overall Study||128
1030742|NCT00684307|2503529|P3|COMPLETED|Overall Study||128
1030743|NCT00684307|2503530|P2|COMPLETED|Overall Study||129
1030744|NCT00684307|2503531|P1|COMPLETED|Overall Study||140
1030745|NCT00684307|2503527|P5|On Treatment Period Completed|Overall Study||293
1030746|NCT00684307|2503528|P4|On Treatment Period Completed|Overall Study||128
1030747|NCT00684307|2503529|P3|On Treatment Period Completed|Overall Study||128
1030748|NCT00684307|2503530|P2|On Treatment Period Completed|Overall Study||129
1030749|NCT00684307|2503531|P1|On Treatment Period Completed|Overall Study|Patients who completed treatment|140
1030750|NCT00684307|2503527|P5|On Treatment Period Started|Overall Study||318
1030751|NCT00684307|2503528|P4|On Treatment Period Started|Overall Study||160
1030752|NCT00684307|2503529|P3|On Treatment Period Started|Overall Study||156
1030753|NCT00684307|2503530|P2|On Treatment Period Started|Overall Study||151
1030754|NCT00684307|2503531|P1|On Treatment Period Started|Overall Study||164
1030755|NCT00684307|2503527|P5|STARTED|Overall Study||318
1030756|NCT00684307|2503528|P4|STARTED|Overall Study||160
1030757|NCT00684307|2503529|P3|STARTED|Overall Study||156
1030758|NCT00684307|2503530|P2|STARTED|Overall Study||151
1030759|NCT00684307|2503531|P1|STARTED|Overall Study|Patients who received treatment|164
1030760|NCT00684320|2503600|P2|NOT COMPLETED|Overall Study||0
1030761|NCT00684320|2503601|P1|NOT COMPLETED|Overall Study||4
1030762|NCT00684320|2503600|P2|COMPLETED|Overall Study||22
1030763|NCT00684320|2503601|P1|COMPLETED|Overall Study||22
1030764|NCT00684320|2503600|P2|STARTED|Overall Study||22
1030765|NCT00684320|2503601|P1|STARTED|Overall Study||26
1030766|NCT00684411|2503609|P1|NOT COMPLETED|Overall Study||12
1030767|NCT00684411|2503609|P1|COMPLETED|Overall Study||0
1030768|NCT00684411|2503609|P1|Disease Evaluable|Overall Study||11
1030769|NCT00684411|2503609|P1|STARTED|Overall Study||12
1030770|NCT00684424|2503615|P1|NOT COMPLETED|Overall Study||5
1030771|NCT00684424|2503615|P1|COMPLETED|Overall Study||194
1030772|NCT00684424|2503615|P1|STARTED|Overall Study||199
1030773|NCT00684515|2503633|P3|NOT COMPLETED|Overall Study||1
1030774|NCT00684515|2503634|P2|NOT COMPLETED|Overall Study||3
1030775|NCT00684515|2503635|P1|NOT COMPLETED|Overall Study||4
1030776|NCT00684515|2503633|P3|COMPLETED|Overall Study||27
1030777|NCT00684515|2503634|P2|COMPLETED|Overall Study||26
1030778|NCT00684515|2503635|P1|COMPLETED|Overall Study||29
1030779|NCT00684515|2503633|P3|STARTED|Overall Study||28
1030780|NCT00684515|2503634|P2|STARTED|Overall Study||29
1030781|NCT00684515|2503635|P1|STARTED|Overall Study||33
1030782|NCT00684541|2503660|P2|NOT COMPLETED|Overall Study||3
1030783|NCT00684541|2503661|P1|NOT COMPLETED|Overall Study||3
1030784|NCT00684541|2503660|P2|COMPLETED|Overall Study||23
1030785|NCT00684541|2503661|P1|COMPLETED|Overall Study||20
1030786|NCT00684541|2503660|P2|STARTED|Overall Study||26
1030787|NCT00684541|2503661|P1|STARTED|Overall Study||23
1030788|NCT00684554|2503671|P2|NOT COMPLETED|Overall Study||0
1030789|NCT00684554|2503672|P1|NOT COMPLETED|Overall Study||0
1030790|NCT00684554|2503671|P2|COMPLETED|Overall Study||10
1030791|NCT00684554|2503672|P1|COMPLETED|Overall Study||10
1030792|NCT00684554|2503671|P2|STARTED|Overall Study||10
1030793|NCT00684554|2503672|P1|STARTED|Overall Study||10
1030794|NCT00684567|2503680|P1|NOT COMPLETED|Monotherapy Period||14
1030795|NCT00684567|2503680|P1|COMPLETED|Monotherapy Period||9
1030796|NCT00684567|2503680|P1|STARTED|Monotherapy Period|5 subjects completed radiotherapy combined therapy phase but did not proceed to monotherapy phase.|23
1030797|NCT00684567|2503680|P1|NOT COMPLETED|Concomitant Radiotherapy Period||2
1030798|NCT00684567|2503680|P1|COMPLETED|Concomitant Radiotherapy Period||28
1030799|NCT00684567|2503680|P1|STARTED|Concomitant Radiotherapy Period||30
1030800|NCT00684593|2503690|P2|NOT COMPLETED|Overall Study||2
1030801|NCT00684593|2503691|P1|NOT COMPLETED|Overall Study||0
1030802|NCT00684593|2503690|P2|COMPLETED|Overall Study||8
1030803|NCT00684593|2503691|P1|COMPLETED|Overall Study||21
1030804|NCT00684593|2503690|P2|STARTED|Overall Study||10
1030805|NCT00684593|2503691|P1|STARTED|Overall Study||21
1030806|NCT00684645|2503703|P1|NOT COMPLETED|Overall Study||114
1030807|NCT00684645|2503703|P1|COMPLETED|Overall Study||72
1030808|NCT00684645|2503703|P1|STARTED|Overall Study||186
1030809|NCT00684671|2503724|P3|NOT COMPLETED|Overall Study||0
1030810|NCT00684671|2503725|P2|NOT COMPLETED|Overall Study||0
1030811|NCT00684671|2503726|P1|NOT COMPLETED|Overall Study||3
1030812|NCT00684671|2503724|P3|COMPLETED|Overall Study||164
1030813|NCT00684671|2503725|P2|COMPLETED|Overall Study||170
1030814|NCT00684671|2503726|P1|COMPLETED|Overall Study||169
1030815|NCT00684671|2503724|P3|STARTED|Overall Study||164
1030816|NCT00684671|2503725|P2|STARTED|Overall Study||170
1030817|NCT00684671|2503726|P1|STARTED|Overall Study||172
1030818|NCT00684723|2503755|P2|NOT COMPLETED|Second Intervention||0
1030819|NCT00684723|2503756|P1|NOT COMPLETED|Second Intervention||0
1030820|NCT00684723|2503755|P2|COMPLETED|Second Intervention||27
1030821|NCT00684723|2503756|P1|COMPLETED|Second Intervention||27
1030822|NCT00684723|2503755|P2|STARTED|Second Intervention||27
1030823|NCT00684723|2503756|P1|STARTED|Second Intervention||27
1030824|NCT00684723|2503755|P2|NOT COMPLETED|Washout Period of 7 Days||0
1030825|NCT00684723|2503756|P1|NOT COMPLETED|Washout Period of 7 Days||0
1030826|NCT00684723|2503755|P2|COMPLETED|Washout Period of 7 Days||27
1030827|NCT00684723|2503756|P1|COMPLETED|Washout Period of 7 Days||27
1030828|NCT00684723|2503755|P2|STARTED|Washout Period of 7 Days||27
1030829|NCT00684723|2503756|P1|STARTED|Washout Period of 7 Days||27
1030830|NCT00684723|2503755|P2|NOT COMPLETED|First Intervention||0
1030831|NCT00684723|2503756|P1|NOT COMPLETED|First Intervention||0
1030832|NCT00684723|2503755|P2|COMPLETED|First Intervention||27
1030833|NCT00684723|2503756|P1|COMPLETED|First Intervention||27
1030834|NCT00684723|2503755|P2|STARTED|First Intervention||27
1030835|NCT00684723|2503756|P1|STARTED|First Intervention||27
1030836|NCT00684749|2503766|P1|NOT COMPLETED|Overall Study||0
1030837|NCT00684749|2503766|P1|COMPLETED|Overall Study||142
1030838|NCT00684749|2503766|P1|STARTED|Overall Study||142
1030839|NCT00684762|2503770|P2|NOT COMPLETED|Second Intervention||0
1030840|NCT00684762|2503771|P1|NOT COMPLETED|Second Intervention||0
1030841|NCT00684762|2503770|P2|COMPLETED|Second Intervention||14
1030842|NCT00684762|2503771|P1|COMPLETED|Second Intervention||14
1030843|NCT00684762|2503770|P2|STARTED|Second Intervention||14
1030844|NCT00684762|2503771|P1|STARTED|Second Intervention||14
1030845|NCT00684762|2503770|P2|NOT COMPLETED|Washout Period of 7 Days||2
1030846|NCT00684762|2503771|P1|NOT COMPLETED|Washout Period of 7 Days||2
1030847|NCT00684762|2503770|P2|COMPLETED|Washout Period of 7 Days||14
1030848|NCT00684762|2503771|P1|COMPLETED|Washout Period of 7 Days||14
1030849|NCT00684762|2503770|P2|STARTED|Washout Period of 7 Days||16
1030850|NCT00684762|2503771|P1|STARTED|Washout Period of 7 Days||16
1030851|NCT00684762|2503770|P2|NOT COMPLETED|First Intervention||0
1030852|NCT00684762|2503771|P1|NOT COMPLETED|First Intervention||0
1030853|NCT00684762|2503770|P2|COMPLETED|First Intervention||16
1030854|NCT00684762|2503771|P1|COMPLETED|First Intervention||16
1030855|NCT00684762|2503770|P2|STARTED|First Intervention||16
1030856|NCT00684762|2503771|P1|STARTED|First Intervention||16
1030857|NCT00684814|2503781|P2|NOT COMPLETED|Second Intervention||0
1030858|NCT00684814|2503782|P1|NOT COMPLETED|Second Intervention||1
1030859|NCT00684814|2503781|P2|COMPLETED|Second Intervention||15
1030860|NCT00684814|2503782|P1|COMPLETED|Second Intervention||16
1030861|NCT00684814|2503781|P2|STARTED|Second Intervention||15
1030862|NCT00684814|2503782|P1|STARTED|Second Intervention||17
1030863|NCT00684814|2503781|P2|NOT COMPLETED|Washout Period of 7 Days||4
1030864|NCT00684814|2503782|P1|NOT COMPLETED|Washout Period of 7 Days||2
1030865|NCT00684814|2503781|P2|COMPLETED|Washout Period of 7 Days||15
1030866|NCT00684814|2503782|P1|COMPLETED|Washout Period of 7 Days||17
1030867|NCT00684814|2503781|P2|STARTED|Washout Period of 7 Days||19
1030868|NCT00684814|2503782|P1|STARTED|Washout Period of 7 Days||19
1030869|NCT00684814|2503781|P2|NOT COMPLETED|First Intervention||0
1030870|NCT00684814|2503782|P1|NOT COMPLETED|First Intervention||0
1030871|NCT00684814|2503781|P2|COMPLETED|First Intervention||19
1030872|NCT00684814|2503782|P1|COMPLETED|First Intervention||19
1030873|NCT00684814|2503781|P2|STARTED|First Intervention||19
1030874|NCT00684814|2503782|P1|STARTED|First Intervention||19
1030875|NCT00690755|2503799|P7|NOT COMPLETED|Overall Study||0
1030876|NCT00690755|2503800|P6|NOT COMPLETED|Overall Study||4
1030877|NCT00690755|2503801|P5|NOT COMPLETED|Overall Study||0
1030878|NCT00690755|2503802|P4|NOT COMPLETED|Overall Study||5
1030879|NCT00690755|2503803|P3|NOT COMPLETED|Overall Study||46
1030880|NCT00690755|2503804|P2|NOT COMPLETED|Overall Study||0
1030881|NCT00690755|2503805|P1|NOT COMPLETED|Overall Study||2
1030882|NCT00690755|2503799|P7|COMPLETED|Overall Study||0
1030883|NCT00690755|2503800|P6|COMPLETED|Overall Study||6
1030884|NCT00690755|2503801|P5|COMPLETED|Overall Study||0
1030885|NCT00690755|2503802|P4|COMPLETED|Overall Study||15
1030886|NCT00690755|2503803|P3|COMPLETED|Overall Study||51
1030887|NCT00690755|2503804|P2|COMPLETED|Overall Study||0
1030888|NCT00690755|2503805|P1|COMPLETED|Overall Study|Patient recruitment ended on 12/31/2010|28
1030889|NCT00690755|2503799|P7|STARTED|Overall Study||0
1030890|NCT00690755|2503800|P6|STARTED|Overall Study||10
1030891|NCT00690755|2503801|P5|STARTED|Overall Study||0
1030892|NCT00690755|2503802|P4|STARTED|Overall Study||20
1030893|NCT00690755|2503803|P3|STARTED|Overall Study||97
1030894|NCT00690755|2503804|P2|STARTED|Overall Study||0
1030895|NCT00690755|2503805|P1|STARTED|Overall Study||30
1030896|NCT00690794|2503823|P2|NOT COMPLETED|Overall Study||35
1030897|NCT00690794|2503824|P1|NOT COMPLETED|Overall Study||21
1030898|NCT00690794|2503823|P2|COMPLETED|Overall Study||328
1030899|NCT00690794|2503824|P1|COMPLETED|Overall Study||342
1030900|NCT00690794|2503823|P2|STARTED|Overall Study||363
1030901|NCT00690794|2503824|P1|STARTED|Overall Study||363
1030902|NCT00690820|2503834|P2|NOT COMPLETED|Period 2||0
1030903|NCT00690820|2503835|P1|NOT COMPLETED|Period 2||0
1030904|NCT00690820|2503834|P2|COMPLETED|Period 2||8
1030905|NCT00690820|2503835|P1|COMPLETED|Period 2||8
1030906|NCT00690820|2503834|P2|STARTED|Period 2||8
1030907|NCT00690820|2503835|P1|STARTED|Period 2||8
1030908|NCT00690820|2503834|P2|NOT COMPLETED|Period 1||1
1030909|NCT00690820|2503835|P1|NOT COMPLETED|Period 1||0
1030910|NCT00690820|2503834|P2|COMPLETED|Period 1||8
1030911|NCT00690820|2503835|P1|COMPLETED|Period 1||8
1030912|NCT00690820|2503834|P2|STARTED|Period 1||9
1030913|NCT00690820|2503835|P1|STARTED|Period 1||8
1030914|NCT00690833|2503855|P1|NOT COMPLETED|Overall Study||2
1030915|NCT00690833|2503855|P1|COMPLETED|Overall Study||39
1030916|NCT00690833|2503855|P1|STARTED|Overall Study||41
1030917|NCT00690898|2503859|P1|NOT COMPLETED|TREATMENT||26
1030918|NCT00690898|2503859|P1|COMPLETED|TREATMENT||64
1030919|NCT00690898|2503859|P1|STARTED|TREATMENT|Total number of patients treated.|90
1030920|NCT00690898|2503859|P1|NOT COMPLETED|SCREENING||18
1030921|NCT00690898|2503859|P1|COMPLETED|SCREENING|Number of patients included in the study.|90
1030922|NCT00690898|2503859|P1|STARTED|SCREENING|Total of patients screened for the study.|108
1030923|NCT00691015|2503873|P1|NOT COMPLETED|Overall Study||1
1030924|NCT00691015|2503873|P1|COMPLETED|Overall Study||47
1030925|NCT00691015|2503873|P1|STARTED|Overall Study||48
1030926|NCT00691028|2503887|P4|NOT COMPLETED|Double-blind Period||0
1030927|NCT00691028|2503888|P3|NOT COMPLETED|Double-blind Period||9
1030928|NCT00691028|2503889|P2|NOT COMPLETED|Double-blind Period||13
1030929|NCT00691028|2503890|P1|NOT COMPLETED|Double-blind Period||13
1030930|NCT00691028|2503887|P4|COMPLETED|Double-blind Period||0
1030931|NCT00691028|2503888|P3|COMPLETED|Double-blind Period||95
1030932|NCT00691028|2503889|P2|COMPLETED|Double-blind Period||91
1030933|NCT00691028|2503890|P1|COMPLETED|Double-blind Period||86
1030934|NCT00691028|2503887|P4|STARTED|Double-blind Period||0
1030935|NCT00691028|2503888|P3|STARTED|Double-blind Period||104
1030936|NCT00691028|2503889|P2|STARTED|Double-blind Period||104
1030937|NCT00691028|2503890|P1|STARTED|Double-blind Period||99
1030938|NCT00691028|2503887|P4|NOT COMPLETED|Open-label Period||20
1030939|NCT00691028|2503888|P3|NOT COMPLETED|Open-label Period||0
1030940|NCT00691028|2503889|P2|NOT COMPLETED|Open-label Period||0
1030941|NCT00691028|2503890|P1|NOT COMPLETED|Open-label Period||0
1030942|NCT00691028|2503887|P4|COMPLETED|Open-label Period||307
1030943|NCT00691028|2503888|P3|COMPLETED|Open-label Period||0
1030944|NCT00691028|2503889|P2|COMPLETED|Open-label Period||0
1030945|NCT00691028|2503890|P1|COMPLETED|Open-label Period||0
1030946|NCT00691028|2503887|P4|STARTED|Open-label Period||327
1030947|NCT00691028|2503888|P3|STARTED|Open-label Period||0
1030948|NCT00691028|2503889|P2|STARTED|Open-label Period||0
1030949|NCT00691028|2503890|P1|STARTED|Open-label Period||0
1030950|NCT00691652|2503923|P1|NOT COMPLETED|Overall Study||1
1030951|NCT00691652|2503923|P1|COMPLETED|Overall Study||1
1030952|NCT00691652|2503923|P1|STARTED|Overall Study||2
1030953|NCT00691665|2503929|P2|NOT COMPLETED|Overall Study||0
1030954|NCT00691665|2503930|P1|NOT COMPLETED|Overall Study||0
1030955|NCT00691665|2503929|P2|COMPLETED|Overall Study||65
1030956|NCT00691665|2503930|P1|COMPLETED|Overall Study||65
1030957|NCT00691665|2503929|P2|STARTED|Overall Study||65
1030958|NCT00691665|2503930|P1|STARTED|Overall Study||65
1030959|NCT00691704|2503942|P1|NOT COMPLETED|Two Years of Maintenance Therapy||13
1030960|NCT00691704|2503942|P1|COMPLETED|Two Years of Maintenance Therapy||3
1030961|NCT00691704|2503942|P1|STARTED|Two Years of Maintenance Therapy||16
1030962|NCT00691704|2503942|P1|NOT COMPLETED|Induction Therapy||2
1030963|NCT00691704|2503942|P1|COMPLETED|Induction Therapy||16
1030964|NCT00691704|2503942|P1|STARTED|Induction Therapy||18
1030965|NCT00691808|2503953|P3|NOT COMPLETED|Overall Study||0
1030966|NCT00691808|2503954|P2|NOT COMPLETED|Overall Study||1
1030967|NCT00691808|2503955|P1|NOT COMPLETED|Overall Study||0
1030968|NCT00691808|2503953|P3|COMPLETED|Overall Study||32
1030969|NCT00691808|2503954|P2|COMPLETED|Overall Study||35
1030970|NCT00691808|2503955|P1|COMPLETED|Overall Study||35
1030971|NCT00691808|2503953|P3|STARTED|Overall Study||32
1030972|NCT00691808|2503954|P2|STARTED|Overall Study||36
1030973|NCT00691808|2503955|P1|STARTED|Overall Study||35
1030974|NCT00691938|2504003|P7|NOT COMPLETED|Overall Study||0
1030975|NCT00691938|2504004|P6|NOT COMPLETED|Overall Study||0
1030976|NCT00691938|2504005|P5|NOT COMPLETED|Overall Study||0
1030977|NCT00691938|2504006|P4|NOT COMPLETED|Overall Study||0
1030978|NCT00691938|2504007|P3|NOT COMPLETED|Overall Study||0
1030979|NCT00691938|2504008|P2|NOT COMPLETED|Overall Study||0
1030980|NCT00691938|2504009|P1|NOT COMPLETED|Overall Study||1
1030981|NCT00691938|2504003|P7|COMPLETED|Overall Study||14
1030982|NCT00691938|2504004|P6|COMPLETED|Overall Study||6
1030983|NCT00691938|2504005|P5|COMPLETED|Overall Study||10
1030984|NCT00691938|2504006|P4|COMPLETED|Overall Study||8
1030985|NCT00691938|2504007|P3|COMPLETED|Overall Study||6
1030986|NCT00691938|2504008|P2|COMPLETED|Overall Study||3
1030987|NCT00691938|2504009|P1|COMPLETED|Overall Study||4
1030988|NCT00691938|2504003|P7|STARTED|Overall Study||14
1030989|NCT00691938|2504004|P6|STARTED|Overall Study||6
1030990|NCT00691938|2504005|P5|STARTED|Overall Study||10
1030991|NCT00691938|2504006|P4|STARTED|Overall Study||8
1030992|NCT00691938|2504007|P3|STARTED|Overall Study||6
1030993|NCT00691938|2504008|P2|STARTED|Overall Study||3
1030994|NCT00691938|2504009|P1|STARTED|Overall Study||5
1030995|NCT00692003|2504032|P2|NOT COMPLETED|Overall Study||1
1030996|NCT00692003|2504033|P1|NOT COMPLETED|Overall Study||5
1030997|NCT00692003|2504032|P2|COMPLETED|Overall Study||0
1030998|NCT00692003|2504033|P1|COMPLETED|Overall Study||0
1030999|NCT00692003|2504032|P2|STARTED|Overall Study||1
1031000|NCT00692003|2504033|P1|STARTED|Overall Study||5
1031001|NCT00692185|2504043|P2|NOT COMPLETED|Overall Study||3
1031002|NCT00692185|2504044|P1|NOT COMPLETED|Overall Study||3
1031003|NCT00692185|2504043|P2|COMPLETED|Overall Study||9
1031004|NCT00692185|2504044|P1|COMPLETED|Overall Study||8
1031005|NCT00692185|2504043|P2|STARTED|Overall Study||12
1031006|NCT00692185|2504044|P1|STARTED|Overall Study||11
1031007|NCT00692198|2504052|P2|NOT COMPLETED|Overall Study||0
1031008|NCT00692198|2504053|P1|NOT COMPLETED|Overall Study||0
1031009|NCT00692198|2504052|P2|COMPLETED|Overall Study||370
1031010|NCT00692198|2504053|P1|COMPLETED|Overall Study||368
1031011|NCT00692198|2504052|P2|STARTED|Overall Study||370
1031012|NCT00692198|2504053|P1|STARTED|Overall Study||368
1031013|NCT00692211|2504088|P2|NOT COMPLETED|Overall Study||0
1031014|NCT00692211|2504089|P1|NOT COMPLETED|Overall Study||0
1031015|NCT00692211|2504088|P2|COMPLETED|Overall Study||202
1031016|NCT00692211|2504089|P1|COMPLETED|Overall Study||202
1031017|NCT00692211|2504088|P2|STARTED|Overall Study||202
1031018|NCT00692211|2504089|P1|STARTED|Overall Study||202
1031019|NCT00692237|2504097|P2|NOT COMPLETED|Overall Study||4
1031020|NCT00692237|2504098|P1|NOT COMPLETED|Overall Study||1
1031021|NCT00692237|2504097|P2|COMPLETED|Overall Study||25
1031022|NCT00692237|2504098|P1|COMPLETED|Overall Study||29
1031023|NCT00692237|2504097|P2|STARTED|Overall Study||29
1031024|NCT00692237|2504098|P1|STARTED|Overall Study||30
1031025|NCT00692341|2504109|P3|NOT COMPLETED|Overall Study||0
1031026|NCT00692341|2504110|P2|NOT COMPLETED|Overall Study||0
1031027|NCT00692341|2504111|P1|NOT COMPLETED|Overall Study||0
1031028|NCT00692341|2504109|P3|COMPLETED|Overall Study||8
1031029|NCT00692341|2504110|P2|COMPLETED|Overall Study||8
1031030|NCT00692341|2504111|P1|COMPLETED|Overall Study||8
1031031|NCT00692341|2504109|P3|STARTED|Overall Study||8
1031032|NCT00692341|2504110|P2|STARTED|Overall Study||8
1031033|NCT00692341|2504111|P1|STARTED|Overall Study||8
1031034|NCT00692406|2504155|P1|NOT COMPLETED|Overall Study||57
1031035|NCT00692406|2504155|P1|COMPLETED|Overall Study|This group quit smoking before their second scan.|23
1031036|NCT00692406|2504155|P1|STARTED|Overall Study|Initially this group was assigned to quit smoking before the second scan.|80
1031037|NCT00692419|2504168|P2|NOT COMPLETED|Overall Study||18
1031038|NCT00692419|2504169|P1|NOT COMPLETED|Overall Study||16
1031039|NCT00692419|2504168|P2|COMPLETED|Overall Study||102
1031040|NCT00692419|2504169|P1|COMPLETED|Overall Study||84
1031041|NCT00692419|2504168|P2|STARTED|Overall Study||120
1031042|NCT00692419|2504169|P1|STARTED|Overall Study||100
1031043|NCT00692692|2504179|P2|NOT COMPLETED|Overall Study||0
1031044|NCT00692692|2504180|P1|NOT COMPLETED|Overall Study||0
1031045|NCT00692692|2504179|P2|COMPLETED|Overall Study||16
1031046|NCT00692692|2504180|P1|COMPLETED|Overall Study||20
1031047|NCT00692692|2504179|P2|STARTED|Overall Study||16
1031048|NCT00692692|2504180|P1|STARTED|Overall Study||20
1031057|NCT00692913|2504209|P2|NOT COMPLETED|Overall Study||30
1031058|NCT00692913|2504210|P1|NOT COMPLETED|Overall Study||29
1031059|NCT00692913|2504209|P2|COMPLETED|Overall Study||228
1031060|NCT00692913|2504210|P1|COMPLETED|Overall Study||228
1031061|NCT00692913|2504209|P2|STARTED|Overall Study||258
1031062|NCT00692913|2504210|P1|STARTED|Overall Study||257
1031063|NCT00693017|2504232|P2|NOT COMPLETED|Overall Study||2
1031064|NCT00693017|2504233|P1|NOT COMPLETED|Overall Study||2
1031065|NCT00693017|2504232|P2|COMPLETED|Overall Study||0
1031066|NCT00693017|2504233|P1|COMPLETED|Overall Study||0
1031067|NCT00693017|2504232|P2|STARTED|Overall Study||2
1031068|NCT00693017|2504233|P1|STARTED|Overall Study||2
1031069|NCT00693160|2504243|P2|NOT COMPLETED|Overall Study||0
1031070|NCT00693160|2504244|P1|NOT COMPLETED|Overall Study||0
1031071|NCT00693160|2504243|P2|COMPLETED|Overall Study||16
1031072|NCT00693160|2504244|P1|COMPLETED|Overall Study||14
1031073|NCT00693160|2504243|P2|STARTED|Overall Study||16
1031074|NCT00693160|2504244|P1|STARTED|Overall Study||14
1031075|NCT00693225|2504254|P2|NOT COMPLETED|Overall Study||5
1031076|NCT00693225|2504255|P1|NOT COMPLETED|Overall Study||2
1031077|NCT00693225|2504254|P2|COMPLETED|Overall Study||43
1031078|NCT00693225|2504255|P1|COMPLETED|Overall Study||41
1031079|NCT00693225|2504254|P2|STARTED|Overall Study||48
1031080|NCT00693225|2504255|P1|STARTED|Overall Study||43
1031081|NCT00693238|2504267|P2|NOT COMPLETED|Overall Study||0
1031082|NCT00693238|2504268|P1|NOT COMPLETED|Overall Study||0
1031083|NCT00693238|2504267|P2|COMPLETED|Overall Study||106
1031084|NCT00693238|2504268|P1|COMPLETED|Overall Study||122
1031085|NCT00693238|2504267|P2|STARTED|Overall Study||106
1031086|NCT00693238|2504268|P1|STARTED|Overall Study||122
1031087|NCT00693303|2504274|P1|NOT COMPLETED|Overall Study||0
1031088|NCT00693303|2504274|P1|COMPLETED|Overall Study||21
1031089|NCT00693303|2504274|P1|STARTED|Overall Study||21
1031090|NCT00693420|2504280|P2|NOT COMPLETED|Overall Study||15
1031091|NCT00693420|2504281|P1|NOT COMPLETED|Overall Study||6
1031092|NCT00693420|2504280|P2|COMPLETED|Overall Study||126
1031093|NCT00693420|2504281|P1|COMPLETED|Overall Study||131
1031094|NCT00693420|2504280|P2|STARTED|Overall Study||141
1031095|NCT00693420|2504281|P1|STARTED|Overall Study||137
1031096|NCT00693472|2504309|P4|NOT COMPLETED|Part 2||2
1031097|NCT00693472|2504310|P3|NOT COMPLETED|Part 2||2
1031098|NCT00693472|2504311|P2|NOT COMPLETED|Part 2||0
1031099|NCT00693472|2504312|P1|NOT COMPLETED|Part 2||0
1031100|NCT00693472|2504309|P4|COMPLETED|Part 2||4
1031101|NCT00693472|2504310|P3|COMPLETED|Part 2||6
1031102|NCT00693472|2504311|P2|COMPLETED|Part 2||0
1031103|NCT00693472|2504312|P1|COMPLETED|Part 2||0
1031104|NCT00693472|2504309|P4|STARTED|Part 2||6
1031105|NCT00693472|2504310|P3|STARTED|Part 2||8
1031106|NCT00693472|2504311|P2|STARTED|Part 2||0
1031107|NCT00693472|2504312|P1|STARTED|Part 2||0
1031108|NCT00693472|2504309|P4|NOT COMPLETED|Part 1||0
1031109|NCT00693472|2504310|P3|NOT COMPLETED|Part 1||0
1031110|NCT00693472|2504311|P2|NOT COMPLETED|Part 1||4
1031111|NCT00693472|2504312|P1|NOT COMPLETED|Part 1||6
1031112|NCT00693472|2504309|P4|COMPLETED|Part 1||0
1031113|NCT00693472|2504310|P3|COMPLETED|Part 1||0
1031114|NCT00693472|2504311|P2|COMPLETED|Part 1||9
1031115|NCT00693472|2504312|P1|COMPLETED|Part 1||13
1031116|NCT00693472|2504309|P4|STARTED|Part 1||0
1031117|NCT00693472|2504310|P3|STARTED|Part 1||0
1031118|NCT00693472|2504311|P2|STARTED|Part 1||13
1031119|NCT00693472|2504312|P1|STARTED|Part 1||19
1031120|NCT00693485|2504333|P3|NOT COMPLETED|Overall Study||0
1031121|NCT00693485|2504334|P2|NOT COMPLETED|Overall Study||2
1031122|NCT00693485|2504335|P1|NOT COMPLETED|Overall Study||0
1031123|NCT00693485|2504333|P3|COMPLETED|Overall Study||24
1031124|NCT00693485|2504334|P2|COMPLETED|Overall Study||19
1031125|NCT00693485|2504335|P1|COMPLETED|Overall Study||25
1031126|NCT00693485|2504333|P3|STARTED|Overall Study||24
1031127|NCT00693485|2504334|P2|STARTED|Overall Study||21
1031128|NCT00693485|2504335|P1|STARTED|Overall Study||25
1031129|NCT00693498|2504348|P2|NOT COMPLETED|Overall Study||0
1031130|NCT00693498|2504349|P1|NOT COMPLETED|Overall Study||0
1031131|NCT00693498|2504348|P2|COMPLETED|Overall Study||81
1031132|NCT00693498|2504349|P1|COMPLETED|Overall Study||81
1031133|NCT00693498|2504348|P2|STARTED|Overall Study||81
1031134|NCT00693498|2504349|P1|STARTED|Overall Study||81
1031135|NCT00693628|2504357|P2|NOT COMPLETED|Overall Study||0
1031136|NCT00693628|2504358|P1|NOT COMPLETED|Overall Study||0
1031137|NCT00693628|2504357|P2|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment.|0
1031138|NCT00693628|2504358|P1|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment|0
1031139|NCT00693628|2504357|P2|STARTED|Overall Study|No data is available indicating to which group patients were assigned .|0
1031140|NCT00693628|2504358|P1|STARTED|Overall Study|No data is available indicating to which group patients were assigned.|0
1031141|NCT00693654|2504366|P2|NOT COMPLETED|Overall Study||0
1031142|NCT00693654|2504367|P1|NOT COMPLETED|Overall Study||0
1031143|NCT00693654|2504366|P2|COMPLETED|Overall Study||14
1031144|NCT00693654|2504367|P1|COMPLETED|Overall Study||14
1031145|NCT00693654|2504366|P2|STARTED|Overall Study||14
1031146|NCT00693654|2504367|P1|STARTED|Overall Study||14
1031147|NCT00693693|2504378|P3|NOT COMPLETED|Overall Study||2
1031148|NCT00693693|2504379|P2|NOT COMPLETED|Overall Study||1
1031149|NCT00693693|2504380|P1|NOT COMPLETED|Overall Study||1
1031150|NCT00693693|2504378|P3|COMPLETED|Overall Study||7
1031151|NCT00693693|2504379|P2|COMPLETED|Overall Study||8
1031152|NCT00693693|2504380|P1|COMPLETED|Overall Study||6
1031153|NCT00693693|2504378|P3|STARTED|Overall Study||9
1031154|NCT00693693|2504379|P2|STARTED|Overall Study||9
1031155|NCT00693693|2504380|P1|STARTED|Overall Study||7
1031156|NCT00693706|2504390|P2|NOT COMPLETED|Overall Study||1
1031157|NCT00693706|2504391|P1|NOT COMPLETED|Overall Study||0
1031158|NCT00693706|2504390|P2|COMPLETED|Overall Study||98
1031159|NCT00693706|2504391|P1|COMPLETED|Overall Study||101
1031160|NCT00693706|2504390|P2|STARTED|Overall Study||99
1031161|NCT00693706|2504391|P1|STARTED|Overall Study||101
1031162|NCT00693719|2504415|P1|NOT COMPLETED|Overall Study||0
1031163|NCT00693719|2504415|P1|COMPLETED|Overall Study||31
1031164|NCT00693719|2504415|P1|STARTED|Overall Study||31
1031165|NCT00693784|2504420|P1|NOT COMPLETED|Overall Study||4
1031166|NCT00693784|2504420|P1|COMPLETED|Overall Study||11
1031167|NCT00693784|2504420|P1|104-week Extended Follow-up|Overall Study||11
1031168|NCT00693784|2504420|P1|52-week Extended Follow-up|Overall Study||13
1031169|NCT00693784|2504420|P1|26-Week Primary Endpoint|Overall Study||15
1031170|NCT00693784|2504420|P1|STARTED|Overall Study||15
1031171|NCT00693992|2504428|P2|NOT COMPLETED|Overall Study||0
1031172|NCT00693992|2504429|P1|NOT COMPLETED|Overall Study||0
1031173|NCT00693992|2504428|P2|COMPLETED|Overall Study||104
1031174|NCT00693992|2504429|P1|COMPLETED|Overall Study||106
1031175|NCT00693992|2504428|P2|STARTED|Overall Study||104
1031176|NCT00693992|2504429|P1|STARTED|Overall Study||106
1031177|NCT00694018|2504447|P2|NOT COMPLETED|Overall Study||9
1031178|NCT00694018|2504448|P1|NOT COMPLETED|Overall Study||13
1031179|NCT00694018|2504447|P2|COMPLETED|Overall Study||102
1031180|NCT00694018|2504448|P1|COMPLETED|Overall Study||105
1031181|NCT00694018|2504447|P2|6 Months|Overall Study||101
1031182|NCT00694018|2504448|P1|6 Months|Overall Study||106
1031183|NCT00694018|2504447|P2|STARTED|Overall Study||111
1031184|NCT00694018|2504448|P1|STARTED|Overall Study||118
1031185|NCT00687830|2504456|P2|NOT COMPLETED|Overall Study||0
1031186|NCT00687830|2504457|P1|NOT COMPLETED|Overall Study||0
1031187|NCT00687830|2504456|P2|COMPLETED|Overall Study||68
1031188|NCT00687830|2504457|P1|COMPLETED|Overall Study||68
1031189|NCT00687830|2504456|P2|STARTED|Overall Study||68
1031190|NCT00687830|2504457|P1|STARTED|Overall Study||68
1031191|NCT00687856|2504465|P1|NOT COMPLETED|Overall Study||0
1031192|NCT00687856|2504465|P1|COMPLETED|Overall Study||211
1031193|NCT00687856|2504465|P1|STARTED|Overall Study||211
1031194|NCT00687908|2504471|P2|NOT COMPLETED|Overall Study||42
1031195|NCT00687908|2504472|P1|NOT COMPLETED|Overall Study||18
1031196|NCT00687908|2504471|P2|COMPLETED|Overall Study||78
1031197|NCT00687908|2504472|P1|COMPLETED|Overall Study||105
1031198|NCT00687908|2504471|P2|STARTED|Overall Study||120
1031199|NCT00687908|2504472|P1|STARTED|Overall Study||123
1031200|NCT00687973|2504488|P2|NOT COMPLETED|Overall Study||38
1031201|NCT00687973|2504489|P1|NOT COMPLETED|Overall Study||24
1031202|NCT00687973|2504488|P2|COMPLETED|Overall Study||162
1031203|NCT00687973|2504489|P1|COMPLETED|Overall Study||169
1031204|NCT00687973|2504488|P2|STARTED|Overall Study||200
1031205|NCT00687973|2504489|P1|STARTED|Overall Study||193
1031206|NCT00688064|2504518|P2|NOT COMPLETED|Overall Study||26
1031207|NCT00688064|2504519|P1|NOT COMPLETED|Overall Study||21
1031208|NCT00688064|2504518|P2|COMPLETED|Overall Study||201
1031209|NCT00688064|2504519|P1|COMPLETED|Overall Study||211
1031210|NCT00688064|2504518|P2|STARTED|Overall Study||227
1031211|NCT00688064|2504519|P1|STARTED|Overall Study||232
1031212|NCT00688103|2504535|P2|NOT COMPLETED|Overall Study||13
1031213|NCT00688103|2504536|P1|NOT COMPLETED|Overall Study||30
1031214|NCT00688103|2504535|P2|COMPLETED|Overall Study||64
1031215|NCT00688103|2504536|P1|COMPLETED|Overall Study||44
1031216|NCT00688103|2504535|P2|Actually Treated|Overall Study||76
1031217|NCT00688103|2504536|P1|Actually Treated|Overall Study||71
1031218|NCT00688103|2504535|P2|STARTED|Overall Study||77
1031219|NCT00688103|2504536|P1|STARTED|Overall Study||74
1031220|NCT00694070|2504546|P1|NOT COMPLETED|Overall Study||0
1031221|NCT00694070|2504546|P1|COMPLETED|Overall Study||51
1031222|NCT00694070|2504546|P1|STARTED|Overall Study||51
1031223|NCT00694096|2504552|P1|NOT COMPLETED|Overall Study||5
1031224|NCT00694096|2504552|P1|COMPLETED|Overall Study||20
1031225|NCT00694096|2504552|P1|STARTED|Overall Study||25
1031226|NCT00694109|2504558|P1|NOT COMPLETED|Overall Study||117
1031227|NCT00694109|2504558|P1|COMPLETED|Overall Study||25
1031228|NCT00694109|2504558|P1|Completed Consented Length of Treatment|Overall Study||60
1031229|NCT00694109|2504558|P1|Consented 2 Years Additional Treatment|Overall Study||42
1031230|NCT00694109|2504558|P1|Treated|Overall Study||141
1031231|NCT00694109|2504558|P1|STARTED|Overall Study|This does not include 2 patients from phase 2 trial with very different treatment experience.|142
1031232|NCT00694122|2504582|P2|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
1031233|NCT00694122|2504583|P1|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
1031234|NCT00694122|2504582|P2|COMPLETED|Second Intervention (3-4 Weeks)||5
1031235|NCT00694122|2504583|P1|COMPLETED|Second Intervention (3-4 Weeks)||10
1031236|NCT00694122|2504582|P2|STARTED|Second Intervention (3-4 Weeks)||5
1031237|NCT00694122|2504583|P1|STARTED|Second Intervention (3-4 Weeks)||10
1031238|NCT00694122|2504582|P2|NOT COMPLETED|Washout (1 Day)||0
1031239|NCT00694122|2504583|P1|NOT COMPLETED|Washout (1 Day)||0
1031240|NCT00694122|2504582|P2|COMPLETED|Washout (1 Day)||5
1031241|NCT00694122|2504583|P1|COMPLETED|Washout (1 Day)||10
1031242|NCT00694122|2504582|P2|STARTED|Washout (1 Day)||5
1031243|NCT00694122|2504583|P1|STARTED|Washout (1 Day)||10
1031244|NCT00694122|2504582|P2|NOT COMPLETED|First Intervention (3-4 Weeks)||2
1031245|NCT00694122|2504583|P1|NOT COMPLETED|First Intervention (3-4 Weeks)||10
1031246|NCT00694122|2504582|P2|COMPLETED|First Intervention (3-4 Weeks)||5
1031247|NCT00694122|2504583|P1|COMPLETED|First Intervention (3-4 Weeks)||10
1031248|NCT00694122|2504582|P2|STARTED|First Intervention (3-4 Weeks)|Started on NPH then on Lantus.|7
1031249|NCT00694122|2504583|P1|STARTED|First Intervention (3-4 Weeks)|Started Lantus then on NPH.|20
1031250|NCT00694161|2504599|P1|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||3
1031251|NCT00694161|2504599|P1|COMPLETED|Part 2 (After Week 6 up to Month 12)||32
1031252|NCT00694161|2504599|P1|STARTED|Part 2 (After Week 6 up to Month 12)||35
1031253|NCT00694161|2504599|P1|NOT COMPLETED|Part 1 (up to Week 6)||0
1031254|NCT00694161|2504599|P1|COMPLETED|Part 1 (up to Week 6)||35
1031255|NCT00694161|2504599|P1|STARTED|Part 1 (up to Week 6)||35
1031256|NCT00694304|2504638|P1|NOT COMPLETED|Overall Study||207
1031257|NCT00694304|2504638|P1|COMPLETED|Overall Study||328
1031258|NCT00694304|2504638|P1|STARTED|Overall Study||535
1031259|NCT00694356|2504654|P3|NOT COMPLETED|Overall Study||6
1031260|NCT00694356|2504655|P2|NOT COMPLETED|Overall Study||6
1031261|NCT00694356|2504656|P1|NOT COMPLETED|Overall Study||3
1031262|NCT00694356|2504654|P3|COMPLETED|Overall Study||0
1031263|NCT00694356|2504655|P2|COMPLETED|Overall Study||0
1031264|NCT00694356|2504656|P1|COMPLETED|Overall Study||0
1031265|NCT00694356|2504654|P3|STARTED|Overall Study||6
1031266|NCT00694356|2504655|P2|STARTED|Overall Study||6
1031267|NCT00694356|2504656|P1|STARTED|Overall Study||3
1031268|NCT00694369|2504696|P5|NOT COMPLETED|Overall Study||6
1031269|NCT00694369|2504697|P4|NOT COMPLETED|Overall Study||3
1031270|NCT00694369|2504698|P3|NOT COMPLETED|Overall Study||2
1031271|NCT00694369|2504699|P2|NOT COMPLETED|Overall Study||3
1031272|NCT00694369|2504700|P1|NOT COMPLETED|Overall Study||1
1031273|NCT00694369|2504696|P5|COMPLETED|Overall Study||56
1031274|NCT00694369|2504697|P4|COMPLETED|Overall Study||189
1031275|NCT00694369|2504698|P3|COMPLETED|Overall Study||95
1031276|NCT00694369|2504699|P2|COMPLETED|Overall Study||188
1031277|NCT00694369|2504700|P1|COMPLETED|Overall Study||45
1031278|NCT00694369|2504696|P5|STARTED|Overall Study||62
1031279|NCT00694369|2504697|P4|STARTED|Overall Study||192
1031280|NCT00694369|2504698|P3|STARTED|Overall Study||97
1031281|NCT00694369|2504699|P2|STARTED|Overall Study||191
1031282|NCT00694369|2504700|P1|STARTED|Overall Study||46
1031283|NCT00695864|2504717|P1|NOT COMPLETED|Ondansetron||5
1031284|NCT00695864|2504717|P1|COMPLETED|Ondansetron||9
1031285|NCT00695864|2504717|P1|STARTED|Ondansetron||14
1031286|NCT00695864|2504717|P1|NOT COMPLETED|Placebo||5
1031287|NCT00695864|2504717|P1|COMPLETED|Placebo||9
1031288|NCT00695864|2504717|P1|STARTED|Placebo||14
1031289|NCT00695903|2504725|P2|NOT COMPLETED|Had Test of Cure (TOC) Assessment||1
1031290|NCT00695903|2504726|P1|NOT COMPLETED|Had Test of Cure (TOC) Assessment||2
1031291|NCT00695903|2504725|P2|COMPLETED|Had Test of Cure (TOC) Assessment||3
1031292|NCT00695903|2504726|P1|COMPLETED|Had Test of Cure (TOC) Assessment||5
1031293|NCT00695903|2504725|P2|STARTED|Had Test of Cure (TOC) Assessment||4
1031294|NCT00695903|2504726|P1|STARTED|Had Test of Cure (TOC) Assessment||7
1031295|NCT00695903|2504725|P2|NOT COMPLETED|Had End of Therapy (EOT) Assessment||15
1031296|NCT00695903|2504726|P1|NOT COMPLETED|Had End of Therapy (EOT) Assessment||12
1031297|NCT00695903|2504725|P2|COMPLETED|Had End of Therapy (EOT) Assessment||4
1031298|NCT00695903|2504726|P1|COMPLETED|Had End of Therapy (EOT) Assessment||7
1031299|NCT00695903|2504725|P2|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||6
1031300|NCT00695903|2504726|P1|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||9
1031301|NCT00695903|2504725|P2|STARTED|Had End of Therapy (EOT) Assessment||19
1031302|NCT00695903|2504726|P1|STARTED|Had End of Therapy (EOT) Assessment||19
1031303|NCT00695955|2504738|P1|NOT COMPLETED|Cohort 2||104
1031304|NCT00695955|2504738|P1|COMPLETED|Cohort 2||203
1031305|NCT00695955|2504738|P1|STARTED|Cohort 2||307
1031306|NCT00695955|2504738|P1|NOT COMPLETED|Cohort 1||102
1031307|NCT00695955|2504738|P1|COMPLETED|Cohort 1||260
1031308|NCT00695955|2504738|P1|STARTED|Cohort 1||362
1031309|NCT00696020|2504752|P4|NOT COMPLETED|Overall Study||4
1031310|NCT00696020|2504753|P3|NOT COMPLETED|Overall Study||3
1031311|NCT00696020|2504754|P2|NOT COMPLETED|Overall Study||2
1031312|NCT00696020|2504755|P1|NOT COMPLETED|Overall Study||4
1031313|NCT00696020|2504752|P4|COMPLETED|Overall Study||84
1031314|NCT00696020|2504753|P3|COMPLETED|Overall Study||90
1031315|NCT00696020|2504754|P2|COMPLETED|Overall Study||87
1031316|NCT00696020|2504755|P1|COMPLETED|Overall Study||86
1031317|NCT00696020|2504752|P4|STARTED|Overall Study||88
1031318|NCT00696020|2504753|P3|STARTED|Overall Study||93
1031319|NCT00696020|2504754|P2|STARTED|Overall Study||89
1031320|NCT00696020|2504755|P1|STARTED|Overall Study||90
1031321|NCT00696072|2504865|P2|NOT COMPLETED|Overall Study||63
1031322|NCT00696072|2504866|P1|NOT COMPLETED|Overall Study||57
1031323|NCT00696072|2504865|P2|COMPLETED|Overall Study||0
1031324|NCT00696072|2504866|P1|COMPLETED|Overall Study||0
1031325|NCT00696072|2504865|P2|STARTED|Overall Study||63
1031326|NCT00696072|2504866|P1|STARTED|Overall Study||57
1031327|NCT00696241|2504888|P5|NOT COMPLETED|Overall Study||12
1031328|NCT00696241|2504889|P4|NOT COMPLETED|Overall Study||14
1031329|NCT00696241|2504890|P3|NOT COMPLETED|Overall Study||24
1031330|NCT00696241|2504891|P2|NOT COMPLETED|Overall Study||22
1031331|NCT00696241|2504892|P1|NOT COMPLETED|Overall Study||24
1031332|NCT00696241|2504888|P5|COMPLETED|Overall Study||130
1031333|NCT00696241|2504889|P4|COMPLETED|Overall Study||268
1031334|NCT00696241|2504890|P3|COMPLETED|Overall Study||261
1031335|NCT00696241|2504891|P2|COMPLETED|Overall Study||261
1031336|NCT00696241|2504892|P1|COMPLETED|Overall Study||259
1031337|NCT00696241|2504888|P5|STARTED|Overall Study||142
1031338|NCT00696241|2504889|P4|STARTED|Overall Study||282
1031339|NCT00696241|2504890|P3|STARTED|Overall Study||285
1031340|NCT00696241|2504891|P2|STARTED|Overall Study||283
1031341|NCT00696241|2504892|P1|STARTED|Overall Study||283
1031342|NCT00696293|2504974|P1|NOT COMPLETED|Overall Study||2
1031343|NCT00696293|2504974|P1|COMPLETED|Overall Study||28
1031344|NCT00696293|2504974|P1|STARTED|Overall Study||30
1031345|NCT00696384|2504979|P3|NOT COMPLETED|Double Blind Phase||6
1031346|NCT00696384|2504980|P2|NOT COMPLETED|Double Blind Phase||11
1031347|NCT00696384|2504981|P1|NOT COMPLETED|Double Blind Phase||0
1031348|NCT00696384|2504979|P3|COMPLETED|Double Blind Phase||145
1031349|NCT00696384|2504980|P2|COMPLETED|Double Blind Phase||137
1031350|NCT00696384|2504981|P1|COMPLETED|Double Blind Phase||0
1031351|NCT00696384|2504979|P3|STARTED|Double Blind Phase||151
1031352|NCT00696384|2504980|P2|STARTED|Double Blind Phase||148
1031353|NCT00696384|2504981|P1|STARTED|Double Blind Phase||0
1031354|NCT00696384|2504979|P3|NOT COMPLETED|Open Label Phase||0
1031355|NCT00696384|2504980|P2|NOT COMPLETED|Open Label Phase||0
1031356|NCT00696384|2504981|P1|NOT COMPLETED|Open Label Phase||119
1031357|NCT00696384|2504979|P3|COMPLETED|Open Label Phase||0
1031358|NCT00696384|2504980|P2|COMPLETED|Open Label Phase||0
1031359|NCT00696384|2504981|P1|COMPLETED|Open Label Phase||299
1031360|NCT00696384|2504979|P3|STARTED|Open Label Phase||0
1031361|NCT00696384|2504980|P2|STARTED|Open Label Phase||0
1031362|NCT00696384|2504981|P1|STARTED|Open Label Phase||418
1031363|NCT00696410|2504997|P2|NOT COMPLETED|Overall Study||0
1031364|NCT00696410|2504998|P1|NOT COMPLETED|Overall Study||13
1031365|NCT00696410|2504997|P2|COMPLETED|Overall Study||10
1031366|NCT00696410|2504998|P1|COMPLETED|Overall Study||25
1031367|NCT00696410|2504997|P2|STARTED|Overall Study||10
1031368|NCT00696410|2504998|P1|STARTED|Overall Study||38
1031369|NCT00696423|2505014|P2|NOT COMPLETED|Overall Study||5
1031370|NCT00696423|2505015|P1|NOT COMPLETED|Overall Study||0
1031371|NCT00696423|2505014|P2|COMPLETED|Overall Study||218
1031372|NCT00696423|2505015|P1|COMPLETED|Overall Study||244
1031373|NCT00696423|2505014|P2|STARTED|Overall Study||223
1031374|NCT00696423|2505015|P1|STARTED|Overall Study||244
1031375|NCT00696436|2505050|P5|NOT COMPLETED|Overall Study||13
1031376|NCT00696436|2505051|P4|NOT COMPLETED|Overall Study||22
1031377|NCT00696436|2505052|P3|NOT COMPLETED|Overall Study||28
1031378|NCT00696436|2505053|P2|NOT COMPLETED|Overall Study||30
1031379|NCT00696436|2505054|P1|NOT COMPLETED|Overall Study||23
1031380|NCT00696436|2505050|P5|COMPLETED|Overall Study||141
1031381|NCT00696436|2505051|P4|COMPLETED|Overall Study||268
1031382|NCT00696436|2505052|P3|COMPLETED|Overall Study||254
1031383|NCT00696436|2505053|P2|COMPLETED|Overall Study||255
1031384|NCT00696436|2505054|P1|COMPLETED|Overall Study||257
1031385|NCT00696436|2505050|P5|STARTED|Overall Study|Randomized participants only.|154
1031386|NCT00696436|2505051|P4|STARTED|Overall Study|Randomized participants only.|290
1031387|NCT00696436|2505052|P3|STARTED|Overall Study|Randomized participants only.|282
1031388|NCT00696436|2505053|P2|STARTED|Overall Study|Randomized participants only. One participant treated but not randomized and is not included.|285
1031389|NCT00696436|2505054|P1|STARTED|Overall Study|Randomized participants only.|280
1031390|NCT00696449|2505140|P4|NOT COMPLETED|Overall Study||3
1031391|NCT00696449|2505141|P3|NOT COMPLETED|Overall Study||1
1031392|NCT00696449|2505142|P2|NOT COMPLETED|Overall Study||6
1031393|NCT00696449|2505143|P1|NOT COMPLETED|Overall Study||3
1031394|NCT00696449|2505140|P4|COMPLETED|Overall Study||13
1031395|NCT00696449|2505141|P3|COMPLETED|Overall Study||14
1031396|NCT00696449|2505142|P2|COMPLETED|Overall Study||9
1031397|NCT00696449|2505143|P1|COMPLETED|Overall Study||12
1031398|NCT00696449|2505140|P4|STARTED|Overall Study||16
1031399|NCT00696449|2505141|P3|STARTED|Overall Study||15
1031400|NCT00696449|2505142|P2|STARTED|Overall Study||15
1031401|NCT00696449|2505143|P1|STARTED|Overall Study||15
1031402|NCT00696488|2505153|P1|NOT COMPLETED|Overall Study||0
1031403|NCT00696488|2505153|P1|COMPLETED|Overall Study||20
1031404|NCT00696488|2505153|P1|STARTED|Overall Study||20
1031405|NCT00696618|2505160|P3|NOT COMPLETED|Overall Study||0
1031406|NCT00696618|2505161|P2|NOT COMPLETED|Overall Study||0
1031407|NCT00696618|2505162|P1|NOT COMPLETED|Overall Study||0
1031408|NCT00696618|2505160|P3|COMPLETED|Overall Study||3
1031409|NCT00696618|2505161|P2|COMPLETED|Overall Study||3
1031410|NCT00696618|2505162|P1|COMPLETED|Overall Study||3
1031411|NCT00696618|2505160|P3|STARTED|Overall Study||3
1031412|NCT00696618|2505161|P2|STARTED|Overall Study||3
1031413|NCT00696618|2505162|P1|STARTED|Overall Study||3
1031414|NCT00696696|2505176|P1|NOT COMPLETED|Overall Study||18
1031415|NCT00696696|2505176|P1|COMPLETED|Overall Study|number of patients off treatment due to progression of disease only|26
1031416|NCT00696696|2505176|P1|STARTED|Overall Study||44
1031417|NCT00696761|2505186|P4|NOT COMPLETED|Overall Study||10
1031418|NCT00696761|2505187|P3|NOT COMPLETED|Overall Study||11
1031419|NCT00696761|2505188|P2|NOT COMPLETED|Overall Study||26
1031420|NCT00696761|2505189|P1|NOT COMPLETED|Overall Study||20
1031421|NCT00696761|2505186|P4|COMPLETED|Overall Study||44
1031422|NCT00696761|2505187|P3|COMPLETED|Overall Study||30
1031423|NCT00696761|2505188|P2|COMPLETED|Overall Study||50
1031424|NCT00696761|2505189|P1|COMPLETED|Overall Study||41
1031425|NCT00696761|2505186|P4|STARTED|Overall Study||54
1031426|NCT00696761|2505187|P3|STARTED|Overall Study||41
1031427|NCT00696761|2505188|P2|STARTED|Overall Study||76
1031428|NCT00696761|2505189|P1|STARTED|Overall Study||61
1031429|NCT00696774|2505206|P3|NOT COMPLETED|Period III||0
1031430|NCT00696774|2505207|P2|NOT COMPLETED|Period III||7
1031431|NCT00696774|2505208|P1|NOT COMPLETED|Period III||7
1031432|NCT00696774|2505206|P3|COMPLETED|Period III||0
1031433|NCT00696774|2505207|P2|COMPLETED|Period III|82 participants were reported at Week 8; 81 completed Week 8 as 1 participant decided to withdraw.|81
1031434|NCT00696774|2505208|P1|COMPLETED|Period III||106
1031435|NCT00696774|2505206|P3|STARTED|Period III||0
1031436|NCT00696774|2505207|P2|STARTED|Period III|91 reported at Week 4; 88 start Period 3 (1 adverse event, 1 protocol violation, 1 lack of efficacy)|88
1031437|NCT00696774|2505208|P1|STARTED|Period III|115 reported at Week 4; 113 started Period 3 (1 lost to follow-up and 1 protocol violation).|113
1031438|NCT00696774|2505206|P3|NOT COMPLETED|Period II||36
1031439|NCT00696774|2505207|P2|NOT COMPLETED|Period II||0
1031440|NCT00696774|2505208|P1|NOT COMPLETED|Period II||0
1031441|NCT00696774|2505206|P3|COMPLETED|Period II||0
1031442|NCT00696774|2505207|P2|COMPLETED|Period II||91
1031443|NCT00696774|2505208|P1|COMPLETED|Period II||115
1031444|NCT00696774|2505206|P3|STARTED|Period II|1 participant did not receive study drug and was not included in the safety analyses.|36
1031445|NCT00696774|2505207|P2|STARTED|Period II||91
1031446|NCT00696774|2505208|P1|STARTED|Period II||115
1031447|NCT00696787|2505245|P3|NOT COMPLETED|Overall Study||26
1031448|NCT00696787|2505246|P2|NOT COMPLETED|Overall Study||20
1031449|NCT00696787|2505247|P1|NOT COMPLETED|Overall Study||15
1031450|NCT00696787|2505245|P3|COMPLETED|Overall Study||17
1031451|NCT00696787|2505246|P2|COMPLETED|Overall Study||22
1031452|NCT00696787|2505247|P1|COMPLETED|Overall Study||25
1031453|NCT00696787|2505245|P3|STARTED|Overall Study||43
1031454|NCT00696787|2505246|P2|STARTED|Overall Study||42
1031455|NCT00696787|2505247|P1|STARTED|Overall Study||40
1031456|NCT00696800|2505260|P2|NOT COMPLETED|Overall Study||48
1031457|NCT00696800|2505261|P1|NOT COMPLETED|Overall Study||85
1031458|NCT00696800|2505260|P2|COMPLETED|Overall Study|Participants who had embryos transferred|704
1031459|NCT00696800|2505261|P1|COMPLETED|Overall Study|Participants who had embryos transferred|672
1031460|NCT00696800|2505260|P2|Treated (ITT)|Overall Study|The ITT group|750
1031461|NCT00696800|2505261|P1|Treated (ITT)|Overall Study|The ITT group|756
1031462|NCT00696800|2505260|P2|STARTED|Overall Study||752
1031463|NCT00696800|2505261|P1|STARTED|Overall Study||757
1031464|NCT00696878|2505311|P1|NOT COMPLETED|Overall Study||504
1031465|NCT00696878|2505311|P1|COMPLETED|Overall Study||178
1031466|NCT00696878|2505311|P1|STARTED|Overall Study||682
1031467|NCT00697073|2505383|P1|NOT COMPLETED|Overall Study||9
1031468|NCT00697073|2505383|P1|COMPLETED|Overall Study||59
1031469|NCT00697073|2505383|P1|STARTED|Overall Study||68
1031470|NCT00697112|2505387|P1|NOT COMPLETED|Overall Study||10
1031471|NCT00697112|2505387|P1|COMPLETED|Overall Study||43
1031472|NCT00697112|2505387|P1|Met the Inclusion Criteria|Overall Study||52
1031473|NCT00697112|2505387|P1|STARTED|Overall Study||53
1031474|NCT00697190|2505411|P2|NOT COMPLETED|Second Intervention||0
1031475|NCT00697190|2505412|P1|NOT COMPLETED|Second Intervention||0
1031476|NCT00697190|2505411|P2|COMPLETED|Second Intervention||20
1031477|NCT00697190|2505412|P1|COMPLETED|Second Intervention||18
1031478|NCT00697190|2505411|P2|STARTED|Second Intervention||20
1031479|NCT00697190|2505412|P1|STARTED|Second Intervention|one subject moved away between the first period and second period.|18
1031480|NCT00697190|2505411|P2|NOT COMPLETED|First Intervention||0
1031481|NCT00697190|2505412|P1|NOT COMPLETED|First Intervention||0
1031482|NCT00697190|2505411|P2|COMPLETED|First Intervention||20
1031483|NCT00697190|2505412|P1|COMPLETED|First Intervention||19
1031484|NCT00697190|2505411|P2|STARTED|First Intervention||20
1031485|NCT00697190|2505412|P1|STARTED|First Intervention||19
1031486|NCT00697255|2505448|P2|NOT COMPLETED|Stage 1b||2
1031487|NCT00697255|2505449|P1|NOT COMPLETED|Stage 1b||0
1031488|NCT00697255|2505448|P2|COMPLETED|Stage 1b|Participants who completed 1b received hCG bolus injection and did not proceed further in the trial|1
1031489|NCT00697255|2505449|P1|COMPLETED|Stage 1b||0
1031490|NCT00697255|2505448|P2|STARTED|Stage 1b|After enrollment in Stage 1a completed, a new cohort of participants enrolled in Stage 1b.|3
1031491|NCT00697255|2505449|P1|STARTED|Stage 1b||0
1031492|NCT00697255|2505448|P2|NOT COMPLETED|Stage 1a||0
1031493|NCT00697255|2505449|P1|NOT COMPLETED|Stage 1a||3
1031494|NCT00697255|2505448|P2|COMPLETED|Stage 1a||0
1031495|NCT00697255|2505449|P1|COMPLETED|Stage 1a|Participants who completed 1a received hCG bolus injection and did not proceed further in the trial|2
1031496|NCT00697255|2505448|P2|STARTED|Stage 1a||0
1031497|NCT00697255|2505449|P1|STARTED|Stage 1a||5
1031498|NCT00697515|2505465|P2|NOT COMPLETED|Second Intervention (Crossover Period)||1
1031499|NCT00697515|2505466|P1|NOT COMPLETED|Second Intervention (Crossover Period)||1
1031500|NCT00697515|2505465|P2|COMPLETED|Second Intervention (Crossover Period)||51
1031501|NCT00697515|2505466|P1|COMPLETED|Second Intervention (Crossover Period)||52
1031502|NCT00697515|2505465|P2|STARTED|Second Intervention (Crossover Period)||52
1031503|NCT00697515|2505466|P1|STARTED|Second Intervention (Crossover Period)||53
1031504|NCT00697515|2505465|P2|NOT COMPLETED|First Intervention (Crossover Period)||12
1031505|NCT00697515|2505466|P1|NOT COMPLETED|First Intervention (Crossover Period)||10
1031506|NCT00697515|2505465|P2|COMPLETED|First Intervention (Crossover Period)||52
1031507|NCT00697515|2505466|P1|COMPLETED|First Intervention (Crossover Period)||53
1031508|NCT00697515|2505465|P2|STARTED|First Intervention (Crossover Period)||64
1031509|NCT00697515|2505466|P1|STARTED|First Intervention (Crossover Period)||63
1031510|NCT00697515|2505465|P2|NOT COMPLETED|Dose Optimization Period||0
1031511|NCT00697515|2505466|P1|NOT COMPLETED|Dose Optimization Period||15
1031512|NCT00697515|2505465|P2|COMPLETED|Dose Optimization Period||0
1031513|NCT00697515|2505466|P1|COMPLETED|Dose Optimization Period||127
1031514|NCT00697515|2505465|P2|STARTED|Dose Optimization Period||0
1031515|NCT00697515|2505466|P1|STARTED|Dose Optimization Period||142
1031516|NCT00697541|2505496|P2|NOT COMPLETED|Overall Study||1
1031517|NCT00697541|2505497|P1|NOT COMPLETED|Overall Study||2
1031518|NCT00697541|2505496|P2|COMPLETED|Overall Study||9
1031519|NCT00697541|2505497|P1|COMPLETED|Overall Study||8
1031520|NCT00697541|2505496|P2|STARTED|Overall Study||10
1031521|NCT00697541|2505497|P1|STARTED|Overall Study||10
1031522|NCT00697593|2505507|P1|NOT COMPLETED|Overall Study||19
1031523|NCT00697593|2505507|P1|COMPLETED|Overall Study||51
1031524|NCT00697593|2505507|P1|STARTED|Overall Study||70
1031525|NCT00697619|2505540|P2|NOT COMPLETED|Overall Study||8
1031526|NCT00697619|2505541|P1|NOT COMPLETED|Overall Study||6
1031527|NCT00697619|2505540|P2|COMPLETED|Overall Study||22
1031528|NCT00697619|2505541|P1|COMPLETED|Overall Study||24
1031529|NCT00697619|2505540|P2|STARTED|Overall Study||30
1031530|NCT00697619|2505541|P1|STARTED|Overall Study||30
1031531|NCT00697697|2505549|P2|NOT COMPLETED|Overall Study||54
1031532|NCT00697697|2505550|P1|NOT COMPLETED|Overall Study||49
1031533|NCT00697697|2505549|P2|COMPLETED|Overall Study||44
1031534|NCT00697697|2505550|P1|COMPLETED|Overall Study||45
1031535|NCT00697697|2505549|P2|STARTED|Overall Study||98
1031536|NCT00697697|2505550|P1|STARTED|Overall Study||94
1031537|NCT00697788|2505558|P8|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1031538|NCT00697788|2505559|P7|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1031539|NCT00697788|2505560|P6|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1031540|NCT00697788|2505561|P5|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1031541|NCT00697788|2505562|P4|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1031542|NCT00697788|2505563|P3|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1031543|NCT00697788|2505564|P2|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1031544|NCT00697788|2505565|P1|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1031545|NCT00697788|2505558|P8|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
1031546|NCT00697788|2505559|P7|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1031547|NCT00697788|2505560|P6|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1031548|NCT00697788|2505561|P5|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1031549|NCT00697788|2505562|P4|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1031550|NCT00697788|2505563|P3|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1031551|NCT00697788|2505564|P2|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1031552|NCT00697788|2505565|P1|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1031553|NCT00697788|2505558|P8|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
1031554|NCT00697788|2505559|P7|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1031555|NCT00697788|2505560|P6|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1031556|NCT00697788|2505561|P5|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1031557|NCT00697788|2505562|P4|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1031558|NCT00697788|2505563|P3|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1031559|NCT00697788|2505564|P2|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1031560|NCT00697788|2505565|P1|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
1031561|NCT00697788|2505558|P8|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1031562|NCT00697788|2505559|P7|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1031563|NCT00697788|2505560|P6|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1031564|NCT00697788|2505561|P5|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1031565|NCT00697788|2505562|P4|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1031566|NCT00697788|2505563|P3|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1031567|NCT00697788|2505564|P2|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1031568|NCT00697788|2505565|P1|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1031569|NCT00697788|2505558|P8|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1031570|NCT00697788|2505559|P7|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
1031571|NCT00697788|2505560|P6|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1031572|NCT00697788|2505561|P5|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1031573|NCT00697788|2505562|P4|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1031574|NCT00697788|2505563|P3|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1031575|NCT00697788|2505564|P2|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1031576|NCT00697788|2505565|P1|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1031577|NCT00697788|2505558|P8|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1031578|NCT00697788|2505559|P7|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
1031579|NCT00697788|2505560|P6|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1031580|NCT00697788|2505561|P5|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1031581|NCT00697788|2505562|P4|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1031582|NCT00697788|2505563|P3|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1031583|NCT00697788|2505564|P2|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1031584|NCT00697788|2505565|P1|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
1031585|NCT00697788|2505558|P8|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1031586|NCT00697788|2505559|P7|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1031587|NCT00697788|2505560|P6|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1031588|NCT00697788|2505561|P5|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1031589|NCT00697788|2505562|P4|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1031590|NCT00697788|2505563|P3|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1031591|NCT00697788|2505564|P2|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1031592|NCT00697788|2505565|P1|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1031593|NCT00697788|2505558|P8|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1031594|NCT00697788|2505559|P7|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1031595|NCT00697788|2505560|P6|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
1031596|NCT00697788|2505561|P5|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1031597|NCT00697788|2505562|P4|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1031598|NCT00697788|2505563|P3|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1031599|NCT00697788|2505564|P2|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1031600|NCT00697788|2505565|P1|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1031601|NCT00697788|2505558|P8|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1031602|NCT00697788|2505559|P7|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1031603|NCT00697788|2505560|P6|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
1031604|NCT00697788|2505561|P5|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1031605|NCT00697788|2505562|P4|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1031606|NCT00697788|2505563|P3|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1031607|NCT00697788|2505564|P2|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1031608|NCT00697788|2505565|P1|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
1031609|NCT00697788|2505558|P8|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1031610|NCT00697788|2505559|P7|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1031611|NCT00697788|2505560|P6|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1031612|NCT00697788|2505561|P5|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||1
1031613|NCT00697788|2505562|P4|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1031614|NCT00697788|2505563|P3|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1031615|NCT00697788|2505564|P2|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1031616|NCT00697788|2505565|P1|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1031617|NCT00697788|2505558|P8|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1031618|NCT00697788|2505559|P7|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1031619|NCT00697788|2505560|P6|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1031620|NCT00697788|2505561|P5|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||2
1031621|NCT00697788|2505562|P4|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1031622|NCT00697788|2505563|P3|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1031623|NCT00697788|2505564|P2|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1031624|NCT00697788|2505565|P1|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1031625|NCT00697788|2505558|P8|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1031626|NCT00697788|2505559|P7|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1031627|NCT00697788|2505560|P6|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1031628|NCT00697788|2505561|P5|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||3
1031629|NCT00697788|2505562|P4|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1031630|NCT00697788|2505563|P3|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1031631|NCT00697788|2505564|P2|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1031632|NCT00697788|2505565|P1|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
1031633|NCT00697788|2505558|P8|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1031634|NCT00697788|2505559|P7|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1031635|NCT00697788|2505560|P6|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1031636|NCT00697788|2505561|P5|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1031637|NCT00697788|2505562|P4|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1031638|NCT00697788|2505563|P3|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1031639|NCT00697788|2505564|P2|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1031640|NCT00697788|2505565|P1|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1031641|NCT00697788|2505558|P8|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1031642|NCT00697788|2505559|P7|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1031643|NCT00697788|2505560|P6|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1031644|NCT00697788|2505561|P5|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1031645|NCT00697788|2505562|P4|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
1031646|NCT00697788|2505563|P3|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1031647|NCT00697788|2505564|P2|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1031648|NCT00697788|2505565|P1|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1031649|NCT00697788|2505558|P8|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1031650|NCT00697788|2505559|P7|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1031651|NCT00697788|2505560|P6|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1031652|NCT00697788|2505561|P5|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1031653|NCT00697788|2505562|P4|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
1031654|NCT00697788|2505563|P3|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1031655|NCT00697788|2505564|P2|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1031656|NCT00697788|2505565|P1|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
1031657|NCT00697788|2505558|P8|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1031658|NCT00697788|2505559|P7|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1031659|NCT00697788|2505560|P6|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1031660|NCT00697788|2505561|P5|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1031661|NCT00697788|2505562|P4|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1031662|NCT00697788|2505563|P3|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1031663|NCT00697788|2505564|P2|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1031664|NCT00697788|2505565|P1|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1031665|NCT00697788|2505558|P8|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1031666|NCT00697788|2505559|P7|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1031667|NCT00697788|2505560|P6|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1031668|NCT00697788|2505561|P5|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1031669|NCT00697788|2505562|P4|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1031670|NCT00697788|2505563|P3|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||3
1031671|NCT00697788|2505564|P2|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1031672|NCT00697788|2505565|P1|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1031673|NCT00697788|2505558|P8|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1031674|NCT00697788|2505559|P7|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1031675|NCT00697788|2505560|P6|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1031676|NCT00697788|2505561|P5|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1031677|NCT00697788|2505562|P4|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1031678|NCT00697788|2505563|P3|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion|2 participants did not begin this infusion due to hypotension (MAP<50)|3
1031679|NCT00697788|2505564|P2|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1031680|NCT00697788|2505565|P1|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
1031681|NCT00697788|2505558|P8|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1031682|NCT00697788|2505559|P7|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1031683|NCT00697788|2505560|P6|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1031684|NCT00697788|2505561|P5|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1031685|NCT00697788|2505562|P4|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1031686|NCT00697788|2505563|P3|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1031687|NCT00697788|2505564|P2|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||2
1031688|NCT00697788|2505565|P1|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1031689|NCT00697788|2505558|P8|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1031690|NCT00697788|2505559|P7|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1031691|NCT00697788|2505560|P6|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1031692|NCT00697788|2505561|P5|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1031693|NCT00697788|2505562|P4|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1031694|NCT00697788|2505563|P3|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1031695|NCT00697788|2505564|P2|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||5
1031696|NCT00697788|2505565|P1|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1031697|NCT00697788|2505558|P8|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1031698|NCT00697788|2505559|P7|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1031699|NCT00697788|2505560|P6|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1031700|NCT00697788|2505561|P5|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1031701|NCT00697788|2505562|P4|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1031702|NCT00697788|2505563|P3|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1031703|NCT00697788|2505564|P2|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion|1 participant did not begin infusion due to hypotension (MAP<50)|7
1031704|NCT00697788|2505565|P1|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
1031705|NCT00697788|2505558|P8|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1031706|NCT00697788|2505559|P7|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1031707|NCT00697788|2505560|P6|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1031708|NCT00697788|2505561|P5|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1031709|NCT00697788|2505562|P4|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1031710|NCT00697788|2505563|P3|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1031711|NCT00697788|2505564|P2|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1031712|NCT00697788|2505565|P1|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1031713|NCT00697788|2505558|P8|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1031714|NCT00697788|2505559|P7|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1031715|NCT00697788|2505560|P6|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1031716|NCT00697788|2505561|P5|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1031717|NCT00697788|2505562|P4|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1031718|NCT00697788|2505563|P3|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1031719|NCT00697788|2505564|P2|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
1031720|NCT00697788|2505565|P1|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||8
1031721|NCT00697788|2505558|P8|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
1031722|NCT00697788|2505559|P7|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
1031723|NCT00697788|2505560|P6|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
1031724|NCT00697788|2505561|P5|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
1031725|NCT00697788|2505562|P4|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
1031726|NCT00697788|2505563|P3|STARTED|Dexmedetomidine Bolus 1 mcg/kg|2 participants did not begin the ascending (1.0 mcg/kg/hr) due to MAP<50|0
1031727|NCT00697788|2505564|P2|STARTED|Dexmedetomidine Bolus 1 mcg/kg|One participant did not begin infusion due to hypotension (mean pressure <50)|0
1031728|NCT00697788|2505565|P1|STARTED|Dexmedetomidine Bolus 1 mcg/kg||8
1031729|NCT00697801|2505610|P3|NOT COMPLETED|Overall Study||24
1031730|NCT00697801|2505611|P2|NOT COMPLETED|Overall Study||12
1031731|NCT00697801|2505612|P1|NOT COMPLETED|Overall Study||12
1031732|NCT00697801|2505610|P3|COMPLETED|Overall Study||45
1031733|NCT00697801|2505611|P2|COMPLETED|Overall Study||58
1031734|NCT00697801|2505612|P1|COMPLETED|Overall Study||57
1031735|NCT00697801|2505610|P3|STARTED|Overall Study||69
1031736|NCT00697801|2505611|P2|STARTED|Overall Study||70
1031737|NCT00697801|2505612|P1|STARTED|Overall Study||69
1031738|NCT00697827|2505628|P2|NOT COMPLETED|Overall Study||1
1031739|NCT00697827|2505629|P1|NOT COMPLETED|Overall Study||2
1031740|NCT00697827|2505628|P2|COMPLETED|Overall Study||15
1031741|NCT00697827|2505629|P1|COMPLETED|Overall Study||26
1031742|NCT00697827|2505628|P2|STARTED|Overall Study||16
1031743|NCT00697827|2505629|P1|STARTED|Overall Study||28
1031744|NCT00698009|2505637|P1|NOT COMPLETED|Overall Study||1
1031745|NCT00698009|2505637|P1|COMPLETED|Overall Study||0
1031746|NCT00698009|2505637|P1|STARTED|Overall Study||1
1031747|NCT00698022|2505644|P3|NOT COMPLETED|Overall Study||2
1031748|NCT00698022|2505645|P2|NOT COMPLETED|Overall Study||10
1031749|NCT00698022|2505646|P1|NOT COMPLETED|Overall Study||16
1031750|NCT00698022|2505644|P3|COMPLETED|Overall Study||14
1031751|NCT00698022|2505645|P2|COMPLETED|Overall Study||20
1031752|NCT00698022|2505646|P1|COMPLETED|Overall Study||14
1031753|NCT00698022|2505644|P3|STARTED|Overall Study||16
1031754|NCT00698022|2505645|P2|STARTED|Overall Study||30
1031755|NCT00698022|2505646|P1|STARTED|Overall Study||30
1031756|NCT00698035|2505656|P2|NOT COMPLETED|Overall Study||2
1031757|NCT00698035|2505657|P1|NOT COMPLETED|Overall Study||4
1031758|NCT00698035|2505656|P2|COMPLETED|Overall Study||34
1031759|NCT00698035|2505657|P1|COMPLETED|Overall Study||35
1031760|NCT00698035|2505656|P2|STARTED|Overall Study||36
1031761|NCT00698035|2505657|P1|STARTED|Overall Study||39
1031762|NCT00698139|2505677|P3|NOT COMPLETED|Overall Study||0
1031763|NCT00698139|2505678|P2|NOT COMPLETED|Overall Study||0
1031764|NCT00698139|2505679|P1|NOT COMPLETED|Overall Study||0
1031765|NCT00698139|2505677|P3|COMPLETED|Overall Study||1
1031766|NCT00698139|2505678|P2|COMPLETED|Overall Study||1
1031767|NCT00698139|2505679|P1|COMPLETED|Overall Study||1
1031768|NCT00698139|2505677|P3|2nd Visit|Overall Study|1 subject in the Intervention Group did not have a 2nd visit (per design).|0
1031769|NCT00698139|2505678|P2|2nd Visit|Overall Study||1
1031770|NCT00698139|2505679|P1|2nd Visit|Overall Study||1
1031771|NCT00698139|2505677|P3|STARTED|Overall Study||1
1031772|NCT00698139|2505678|P2|STARTED|Overall Study||1
1031773|NCT00698139|2505679|P1|STARTED|Overall Study||1
1031774|NCT00698204|2505695|P2|NOT COMPLETED|Overall Study||0
1031775|NCT00698204|2505696|P1|NOT COMPLETED|Overall Study||1
1031776|NCT00698204|2505695|P2|COMPLETED|Overall Study||20
1031777|NCT00698204|2505696|P1|COMPLETED|Overall Study||19
1031778|NCT00698204|2505695|P2|STARTED|Overall Study||20
1031779|NCT00698204|2505696|P1|STARTED|Overall Study||20
1031780|NCT00691054|2505704|P1|NOT COMPLETED|Overall Study||1
1031781|NCT00691054|2505704|P1|COMPLETED|Overall Study||19
1031782|NCT00691054|2505704|P1|STARTED|Overall Study||20
1031783|NCT00691093|2505713|P1|NOT COMPLETED|Overall Study||7
1031784|NCT00691093|2505713|P1|COMPLETED|Overall Study||816
1031785|NCT00691093|2505713|P1|STARTED|Overall Study||823
1031786|NCT00691132|2505749|P2|NOT COMPLETED|Overall Study||13
1031787|NCT00691132|2505750|P1|NOT COMPLETED|Overall Study||12
1031788|NCT00691132|2505749|P2|COMPLETED|Overall Study|45 completed, but 4 excluded b/c urinary measures indicated they did not smoke study cigarettes.|41
1031789|NCT00691132|2505750|P1|COMPLETED|Overall Study||41
1031790|NCT00691132|2505749|P2|STARTED|Overall Study|107 total randomized. Approximately 1/2 per arm.|54
1031791|NCT00691132|2505750|P1|STARTED|Overall Study||53
1031792|NCT00691197|2505771|P2|NOT COMPLETED|Overall Study||5
1031793|NCT00691197|2505772|P1|NOT COMPLETED|Overall Study||11
1031794|NCT00691197|2505771|P2|COMPLETED|Overall Study||75
1031795|NCT00691197|2505772|P1|COMPLETED|Overall Study||155
1031796|NCT00691197|2505771|P2|STARTED|Overall Study||80
1031797|NCT00691197|2505772|P1|STARTED|Overall Study||166
1031798|NCT00691210|2505792|P8|NOT COMPLETED|Overall Study||0
1031799|NCT00691210|2505793|P7|NOT COMPLETED|Overall Study||0
1031800|NCT00691210|2505794|P6|NOT COMPLETED|Overall Study||1
1031801|NCT00691210|2505795|P5|NOT COMPLETED|Overall Study||0
1031802|NCT00691210|2505796|P4|NOT COMPLETED|Overall Study||3
1031803|NCT00691210|2505797|P3|NOT COMPLETED|Overall Study||0
1031804|NCT00691210|2505798|P2|NOT COMPLETED|Overall Study||0
1031805|NCT00691210|2505799|P1|NOT COMPLETED|Overall Study||0
1031806|NCT00691210|2505792|P8|COMPLETED|Overall Study||0
1031807|NCT00691210|2505793|P7|COMPLETED|Overall Study||6
1031808|NCT00691210|2505794|P6|COMPLETED|Overall Study||6
1031809|NCT00691210|2505795|P5|COMPLETED|Overall Study||5
1031810|NCT00691210|2505796|P4|COMPLETED|Overall Study||6
1031811|NCT00691210|2505797|P3|COMPLETED|Overall Study||3
1031812|NCT00691210|2505798|P2|COMPLETED|Overall Study||5
1031813|NCT00691210|2505799|P1|COMPLETED|Overall Study||3
1031814|NCT00691210|2505792|P8|STARTED|Overall Study||0
1031815|NCT00691210|2505793|P7|STARTED|Overall Study||6
1031816|NCT00691210|2505794|P6|STARTED|Overall Study||7
1031817|NCT00691210|2505795|P5|STARTED|Overall Study||5
1031818|NCT00691210|2505796|P4|STARTED|Overall Study||9
1031819|NCT00691210|2505797|P3|STARTED|Overall Study||3
1031820|NCT00691210|2505798|P2|STARTED|Overall Study||5
1031821|NCT00691210|2505799|P1|STARTED|Overall Study||3
1031822|NCT00691327|2505819|P2|NOT COMPLETED|Overall Study||2508
1031823|NCT00691327|2505820|P1|NOT COMPLETED|Overall Study||2841
1031824|NCT00691327|2505819|P2|COMPLETED|Overall Study||36766
1031825|NCT00691327|2505820|P1|COMPLETED|Overall Study||42214
1031826|NCT00691327|2505819|P2|STARTED|Overall Study||39274
1031827|NCT00691327|2505820|P1|STARTED|Overall Study||45055
1031828|NCT00691483|2505830|P2|NOT COMPLETED|Overall Study||25
1031829|NCT00691483|2505831|P1|NOT COMPLETED|Overall Study||68
1031830|NCT00691483|2505830|P2|COMPLETED|Overall Study||141
1031831|NCT00691483|2505831|P1|COMPLETED|Overall Study|Completed refers to completion of the study.|425
1031832|NCT00691483|2505830|P2|Received Treatment|Overall Study||165
1031833|NCT00691483|2505831|P1|Received Treatment|Overall Study||486
1031834|NCT00691483|2505830|P2|STARTED|Overall Study||166
1031835|NCT00691483|2505831|P1|STARTED|Overall Study||493
1031836|NCT00698451|2505847|P1|NOT COMPLETED|Overall Study||39
1031837|NCT00698451|2505847|P1|COMPLETED|Overall Study||15
1031838|NCT00698451|2505847|P1|STARTED|Overall Study||54
1031839|NCT00698516|2505852|P1|NOT COMPLETED|Overall Study||5
1031840|NCT00698516|2505852|P1|COMPLETED|Overall Study||45
1031841|NCT00698516|2505852|P1|STARTED|Overall Study||50
1031842|NCT00698581|2505872|P2|NOT COMPLETED|Overall Study||12
1031843|NCT00698581|2505873|P1|NOT COMPLETED|Overall Study||45
1031844|NCT00698581|2505872|P2|COMPLETED|Overall Study||8
1031845|NCT00698581|2505873|P1|COMPLETED|Overall Study||23
1031846|NCT00698581|2505872|P2|STARTED|Overall Study||20
1031847|NCT00698581|2505873|P1|STARTED|Overall Study||68
1031854|NCT00699842|2505906|P3|NOT COMPLETED|Overall Study||0
1031855|NCT00699842|2505907|P2|NOT COMPLETED|Overall Study||1
1031856|NCT00699842|2505908|P1|NOT COMPLETED|Overall Study||0
1031857|NCT00699842|2505906|P3|COMPLETED|Overall Study||0
1031858|NCT00699842|2505907|P2|COMPLETED|Overall Study||4
1031859|NCT00699842|2505908|P1|COMPLETED|Overall Study||3
1031860|NCT00699842|2505906|P3|STARTED|Overall Study||0
1031861|NCT00699842|2505907|P2|STARTED|Overall Study||5
1031862|NCT00699842|2505908|P1|STARTED|Overall Study||3
1031863|NCT00699972|2505922|P3|NOT COMPLETED|Overall Study||35
1031864|NCT00699972|2505923|P2|NOT COMPLETED|Overall Study||19
1031865|NCT00699972|2505924|P1|NOT COMPLETED|Overall Study||16
1031866|NCT00699972|2505922|P3|COMPLETED|Overall Study||100
1031867|NCT00699972|2505923|P2|COMPLETED|Overall Study||114
1031868|NCT00699972|2505924|P1|COMPLETED|Overall Study||106
1031869|NCT00699972|2505922|P3|STARTED|Overall Study||135
1031870|NCT00699972|2505923|P2|STARTED|Overall Study||133
1031871|NCT00699972|2505924|P1|STARTED|Overall Study||122
1031872|NCT00699998|2505942|P4|NOT COMPLETED|Overall Study||82
1031873|NCT00699998|2505943|P3|NOT COMPLETED|Overall Study||206
1031874|NCT00699998|2505944|P2|NOT COMPLETED|Overall Study||86
1031875|NCT00699998|2505945|P1|NOT COMPLETED|Overall Study||199
1031876|NCT00699998|2505942|P4|COMPLETED|Overall Study||958
1031877|NCT00699998|2505943|P3|COMPLETED|Overall Study||3417
1031878|NCT00699998|2505944|P2|COMPLETED|Overall Study||957
1031879|NCT00699998|2505945|P1|COMPLETED|Overall Study||3421
1031880|NCT00699998|2505942|P4|Received at Least 1 Dose of Study Drug|Overall Study||1027
1031881|NCT00699998|2505943|P3|Received at Least 1 Dose of Study Drug|Overall Study||3590
1031882|NCT00699998|2505944|P2|Received at Least 1 Dose of Study Drug|Overall Study||1033
1031883|NCT00699998|2505945|P1|Received at Least 1 Dose of Study Drug|Overall Study||3590
1031884|NCT00699998|2505942|P4|STARTED|Overall Study||1040
1031885|NCT00699998|2505943|P3|STARTED|Overall Study||3623
1031886|NCT00699998|2505944|P2|STARTED|Overall Study||1043
1031887|NCT00699998|2505945|P1|STARTED|Overall Study||3620
1031888|NCT00700011|2505989|P2|NOT COMPLETED|Overall Study||1
1031889|NCT00700011|2505990|P1|NOT COMPLETED|Overall Study||0
1031890|NCT00700011|2505989|P2|COMPLETED|Overall Study||1
1031891|NCT00700011|2505990|P1|COMPLETED|Overall Study||8
1031892|NCT00700011|2505989|P2|STARTED|Overall Study||2
1031893|NCT00700011|2505990|P1|STARTED|Overall Study||8
1031894|NCT00700063|2506010|P8|NOT COMPLETED|Overall Study||0
1031895|NCT00700063|2506011|P7|NOT COMPLETED|Overall Study||0
1031896|NCT00700063|2506012|P6|NOT COMPLETED|Overall Study||0
1031897|NCT00700063|2506013|P5|NOT COMPLETED|Overall Study||2
1031898|NCT00700063|2506014|P4|NOT COMPLETED|Overall Study||2
1031899|NCT00700063|2506015|P3|NOT COMPLETED|Overall Study||0
1031900|NCT00700063|2506016|P2|NOT COMPLETED|Overall Study||0
1031901|NCT00700063|2506017|P1|NOT COMPLETED|Overall Study||1
1031902|NCT00700063|2506010|P8|COMPLETED|Overall Study||33
1031903|NCT00700063|2506011|P7|COMPLETED|Overall Study||32
1031904|NCT00700063|2506012|P6|COMPLETED|Overall Study||34
1031905|NCT00700063|2506013|P5|COMPLETED|Overall Study||31
1031906|NCT00700063|2506014|P4|COMPLETED|Overall Study||31
1031907|NCT00700063|2506015|P3|COMPLETED|Overall Study||33
1031908|NCT00700063|2506016|P2|COMPLETED|Overall Study||34
1031909|NCT00700063|2506017|P1|COMPLETED|Overall Study||32
1031910|NCT00700063|2506010|P8|STARTED|Overall Study||33
1031911|NCT00700063|2506011|P7|STARTED|Overall Study||32
1031912|NCT00700063|2506012|P6|STARTED|Overall Study||34
1031913|NCT00700063|2506013|P5|STARTED|Overall Study||33
1031914|NCT00700063|2506014|P4|STARTED|Overall Study||33
1031915|NCT00700063|2506015|P3|STARTED|Overall Study||33
1031916|NCT00700063|2506016|P2|STARTED|Overall Study||34
1031917|NCT00700063|2506017|P1|STARTED|Overall Study||33
1031918|NCT00700102|2506125|P2|NOT COMPLETED|Overall Study||395
1031919|NCT00700102|2506126|P1|NOT COMPLETED|Overall Study||402
1031920|NCT00700102|2506125|P2|COMPLETED|Overall Study||14
1031921|NCT00700102|2506126|P1|COMPLETED|Overall Study||9
1031922|NCT00700102|2506125|P2|Received at Least One Dose|Overall Study||403
1031923|NCT00700102|2506126|P1|Received at Least One Dose|Overall Study||407
1031924|NCT00700102|2506125|P2|Intention to Treat|Overall Study||409
1031925|NCT00700102|2506126|P1|Intention to Treat|Overall Study||410
1031926|NCT00700102|2506125|P2|STARTED|Overall Study||409
1031927|NCT00700102|2506126|P1|STARTED|Overall Study||411
1031928|NCT00700115|2506144|P2|NOT COMPLETED|Overall Study||1
1031929|NCT00700115|2506145|P1|NOT COMPLETED|Overall Study||1
1031930|NCT00700115|2506144|P2|COMPLETED|Overall Study||19
1031931|NCT00700115|2506145|P1|COMPLETED|Overall Study||39
1031932|NCT00700115|2506144|P2|STARTED|Overall Study||20
1031933|NCT00700115|2506145|P1|STARTED|Overall Study||40
1031934|NCT00700141|2506153|P1|NOT COMPLETED|Overall Study||0
1031935|NCT00700141|2506153|P1|COMPLETED|Overall Study||482
1031936|NCT00700141|2506153|P1|STARTED|Overall Study||482
1031937|NCT00700180|2506160|P2|NOT COMPLETED|Overall Study||149
1031938|NCT00700180|2506161|P1|NOT COMPLETED|Overall Study||154
1031939|NCT00700180|2506160|P2|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
1031940|NCT00700180|2506161|P1|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
1031941|NCT00700180|2506160|P2|STARTED|Overall Study||149
1031942|NCT00700180|2506161|P1|STARTED|Overall Study||154
1031943|NCT00700271|2506185|P2|NOT COMPLETED|Overall Study||12
1031944|NCT00700271|2506186|P1|NOT COMPLETED|Overall Study||14
1031945|NCT00700271|2506185|P2|COMPLETED|Overall Study||256
1031946|NCT00700271|2506186|P1|COMPLETED|Overall Study||264
1031947|NCT00700271|2506185|P2|STARTED|Overall Study||268
1031948|NCT00700271|2506186|P1|STARTED|Overall Study||278
1031949|NCT00700310|2506216|P4|NOT COMPLETED|Overall Study||26
1031950|NCT00700310|2506217|P3|NOT COMPLETED|Overall Study||16
1031951|NCT00700310|2506218|P2|NOT COMPLETED|Overall Study||26
1031952|NCT00700310|2506219|P1|NOT COMPLETED|Overall Study||21
1031953|NCT00700310|2506216|P4|COMPLETED|Overall Study||145
1031954|NCT00700310|2506217|P3|COMPLETED|Overall Study||158
1031955|NCT00700310|2506218|P2|COMPLETED|Overall Study||154
1031956|NCT00700310|2506219|P1|COMPLETED|Overall Study||166
1031957|NCT00700310|2506216|P4|STARTED|Overall Study||171
1031958|NCT00700310|2506217|P3|STARTED|Overall Study||174
1031959|NCT00700310|2506218|P2|STARTED|Overall Study||180
1031960|NCT00700310|2506219|P1|STARTED|Overall Study||187
1031961|NCT00700375|2506239|P2|NOT COMPLETED|Overall Study||0
1031962|NCT00700375|2506240|P1|NOT COMPLETED|Overall Study||0
1031963|NCT00700375|2506239|P2|COMPLETED|Overall Study||29
1031964|NCT00700375|2506240|P1|COMPLETED|Overall Study||30
1031965|NCT00700375|2506239|P2|2 Days After Creatinine Mesurement|Overall Study||29
1031966|NCT00700375|2506240|P1|2 Days After Creatinine Mesurement|Overall Study||30
1031967|NCT00700375|2506239|P2|STARTED|Overall Study||29
1031968|NCT00700375|2506240|P1|STARTED|Overall Study||30
1031969|NCT00700401|2506246|P1|NOT COMPLETED|Overall Study||94
1031970|NCT00700401|2506246|P1|COMPLETED|Overall Study||168
1031971|NCT00700401|2506246|P1|STARTED|Overall Study||262
1031972|NCT00700427|2506257|P5|NOT COMPLETED|Study Period 4 (Open-Label Extension)||84
1031973|NCT00700427|2506258|P4|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
1031974|NCT00700427|2506259|P3|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
1031975|NCT00700427|2506260|P2|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
1031976|NCT00700427|2506261|P1|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
1031977|NCT00700427|2506257|P5|COMPLETED|Study Period 4 (Open-Label Extension)||96
1031978|NCT00700427|2506258|P4|COMPLETED|Study Period 4 (Open-Label Extension)||0
1031979|NCT00700427|2506259|P3|COMPLETED|Study Period 4 (Open-Label Extension)||0
1031980|NCT00700427|2506260|P2|COMPLETED|Study Period 4 (Open-Label Extension)||0
1031981|NCT00700427|2506261|P1|COMPLETED|Study Period 4 (Open-Label Extension)||0
1031982|NCT00700427|2506257|P5|STARTED|Study Period 4 (Open-Label Extension)||180
1031983|NCT00700427|2506258|P4|STARTED|Study Period 4 (Open-Label Extension)||0
1031984|NCT00700427|2506259|P3|STARTED|Study Period 4 (Open-Label Extension)||0
1031985|NCT00700427|2506260|P2|STARTED|Study Period 4 (Open-Label Extension)||0
1031986|NCT00700427|2506261|P1|STARTED|Study Period 4 (Open-Label Extension)||0
1031987|NCT00700427|2506257|P5|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
1031988|NCT00700427|2506258|P4|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||93
1031989|NCT00700427|2506259|P3|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||82
1031990|NCT00700427|2506260|P2|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
1031991|NCT00700427|2506261|P1|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
1031992|NCT00700427|2506257|P5|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
1031993|NCT00700427|2506258|P4|COMPLETED|Study Period 3B (Randomized Withdrawal)||165
1031994|NCT00700427|2506259|P3|COMPLETED|Study Period 3B (Randomized Withdrawal)||184
1031995|NCT00700427|2506260|P2|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
1031996|NCT00700427|2506261|P1|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
1031997|NCT00700427|2506257|P5|STARTED|Study Period 3B (Randomized Withdrawal)||0
1031998|NCT00700427|2506258|P4|STARTED|Study Period 3B (Randomized Withdrawal)||258
1031999|NCT00700427|2506259|P3|STARTED|Study Period 3B (Randomized Withdrawal)||266
1032000|NCT00700427|2506260|P2|STARTED|Study Period 3B (Randomized Withdrawal)||0
1032001|NCT00700427|2506261|P1|STARTED|Study Period 3B (Randomized Withdrawal)||0
1032002|NCT00700427|2506257|P5|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
1032003|NCT00700427|2506258|P4|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
1032004|NCT00700427|2506259|P3|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
1032005|NCT00700427|2506260|P2|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||481
1032006|NCT00700427|2506261|P1|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
1032007|NCT00700427|2506257|P5|COMPLETED|Study Period 3A (Blinded Maintenance)||0
1032008|NCT00700427|2506258|P4|COMPLETED|Study Period 3A (Blinded Maintenance)||0
1032009|NCT00700427|2506259|P3|COMPLETED|Study Period 3A (Blinded Maintenance)||0
1032010|NCT00700427|2506260|P2|COMPLETED|Study Period 3A (Blinded Maintenance)||524
1032011|NCT00700427|2506261|P1|COMPLETED|Study Period 3A (Blinded Maintenance)||0
1032012|NCT00700427|2506257|P5|STARTED|Study Period 3A (Blinded Maintenance)||0
1032013|NCT00700427|2506258|P4|STARTED|Study Period 3A (Blinded Maintenance)||0
1032014|NCT00700427|2506259|P3|STARTED|Study Period 3A (Blinded Maintenance)||0
1032015|NCT00700427|2506260|P2|STARTED|Study Period 3A (Blinded Maintenance)||1005
1032016|NCT00700427|2506261|P1|STARTED|Study Period 3A (Blinded Maintenance)||0
1032017|NCT00700427|2506257|P5|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
1032018|NCT00700427|2506258|P4|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
1032019|NCT00700427|2506259|P3|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
1032020|NCT00700427|2506260|P2|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
1032021|NCT00700427|2506261|P1|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||1011
1032022|NCT00700427|2506257|P5|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
1032023|NCT00700427|2506258|P4|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
1032024|NCT00700427|2506259|P3|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
1032025|NCT00700427|2506260|P2|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
1032026|NCT00700427|2506261|P1|COMPLETED|Study Period 2 (Open-Label Acute Trx)|One participant was mistakenly recorded as completed. The reason for discontinuation is unknown.|1006
1032027|NCT00700427|2506257|P5|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
1032028|NCT00700427|2506258|P4|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
1032029|NCT00700427|2506259|P3|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
1032030|NCT00700427|2506260|P2|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
1032031|NCT00700427|2506261|P1|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||2011
1032032|NCT00700427|2506257|P5|STARTED|Study Period 2 (Open-Label Acute Trx)||0
1032033|NCT00700427|2506258|P4|STARTED|Study Period 2 (Open-Label Acute Trx)||0
1032034|NCT00700427|2506259|P3|STARTED|Study Period 2 (Open-Label Acute Trx)||0
1032035|NCT00700427|2506260|P2|STARTED|Study Period 2 (Open-Label Acute Trx)||0
1032036|NCT00700427|2506261|P1|STARTED|Study Period 2 (Open-Label Acute Trx)||2017
1032037|NCT00700440|2506283|P1|NOT COMPLETED|Overall Study||0
1032038|NCT00700440|2506283|P1|COMPLETED|Overall Study||100
1032039|NCT00700440|2506283|P1|STARTED|Overall Study||100
1032040|NCT00700570|2506289|P2|NOT COMPLETED|Overall Study||26
1032041|NCT00700570|2506290|P1|NOT COMPLETED|Overall Study||11
1032042|NCT00700570|2506289|P2|COMPLETED|Overall Study||0
1032043|NCT00700570|2506290|P1|COMPLETED|Overall Study||8
1032044|NCT00700570|2506289|P2|STARTED|Overall Study||26
1032045|NCT00700570|2506290|P1|STARTED|Overall Study||19
1032046|NCT00700622|2506304|P2|NOT COMPLETED|Overall Study||5
1032047|NCT00700622|2506305|P1|NOT COMPLETED|Overall Study||13
1032048|NCT00700622|2506304|P2|COMPLETED|Overall Study||60
1032049|NCT00700622|2506305|P1|COMPLETED|Overall Study||52
1032050|NCT00700622|2506304|P2|STARTED|Overall Study||65
1032051|NCT00700622|2506305|P1|STARTED|Overall Study||65
1032061|NCT00700713|2506339|P3|NOT COMPLETED|Overall Study||2
1032062|NCT00700713|2506340|P2|NOT COMPLETED|Overall Study||0
1032063|NCT00700713|2506341|P1|NOT COMPLETED|Overall Study||1
1032064|NCT00700713|2506339|P3|COMPLETED|Overall Study||65
1032065|NCT00700713|2506340|P2|COMPLETED|Overall Study||66
1032066|NCT00700713|2506341|P1|COMPLETED|Overall Study||47
1032067|NCT00700713|2506339|P3|STARTED|Overall Study||67
1032068|NCT00700713|2506340|P2|STARTED|Overall Study||66
1032069|NCT00700713|2506341|P1|STARTED|Overall Study||48
1032070|NCT00700739|2506357|P2|NOT COMPLETED|Overall Study||4
1032071|NCT00700739|2506358|P1|NOT COMPLETED|Overall Study||4
1032072|NCT00700739|2506357|P2|COMPLETED|Overall Study||12
1032073|NCT00700739|2506358|P1|COMPLETED|Overall Study||18
1032074|NCT00700739|2506357|P2|STARTED|Overall Study||16
1032075|NCT00700739|2506358|P1|STARTED|Overall Study||22
1032076|NCT00700752|2506394|P2|NOT COMPLETED|Second Intervention||0
1032077|NCT00700752|2506395|P1|NOT COMPLETED|Second Intervention||0
1032078|NCT00700752|2506394|P2|COMPLETED|Second Intervention||18
1032079|NCT00700752|2506395|P1|COMPLETED|Second Intervention||20
1032080|NCT00700752|2506394|P2|STARTED|Second Intervention||18
1032081|NCT00700752|2506395|P1|STARTED|Second Intervention||20
1032082|NCT00700752|2506394|P2|NOT COMPLETED|First Intervention||2
1032083|NCT00700752|2506395|P1|NOT COMPLETED|First Intervention||0
1032084|NCT00700752|2506394|P2|COMPLETED|First Intervention||18
1032085|NCT00700752|2506395|P1|COMPLETED|First Intervention||20
1032086|NCT00700752|2506394|P2|STARTED|First Intervention||20
1032087|NCT00700752|2506395|P1|STARTED|First Intervention||20
1032088|NCT00700804|2506403|P2|NOT COMPLETED|Overall Study||4
1032089|NCT00700804|2506404|P1|NOT COMPLETED|Overall Study||3
1032090|NCT00700804|2506403|P2|COMPLETED|Overall Study||13
1032091|NCT00700804|2506404|P1|COMPLETED|Overall Study||14
1032092|NCT00700804|2506403|P2|STARTED|Overall Study||17
1032093|NCT00700804|2506404|P1|STARTED|Overall Study||17
1032094|NCT00700817|2506417|P5|NOT COMPLETED|Week 52-78 (Extension Period 2)||5
1032095|NCT00700817|2506418|P4|NOT COMPLETED|Week 52-78 (Extension Period 2)||8
1032096|NCT00700817|2506419|P3|NOT COMPLETED|Week 52-78 (Extension Period 2)||0
1032097|NCT00700817|2506420|P2|NOT COMPLETED|Week 52-78 (Extension Period 2)||15
1032098|NCT00700817|2506421|P1|NOT COMPLETED|Week 52-78 (Extension Period 2)||10
1032099|NCT00700817|2506417|P5|COMPLETED|Week 52-78 (Extension Period 2)||63
1032100|NCT00700817|2506418|P4|COMPLETED|Week 52-78 (Extension Period 2)||59
1032101|NCT00700817|2506419|P3|COMPLETED|Week 52-78 (Extension Period 2)||0
1032102|NCT00700817|2506420|P2|COMPLETED|Week 52-78 (Extension Period 2)||135
1032103|NCT00700817|2506421|P1|COMPLETED|Week 52-78 (Extension Period 2)||124
1032104|NCT00700817|2506417|P5|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|68
1032105|NCT00700817|2506418|P4|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|67
1032106|NCT00700817|2506419|P3|STARTED|Week 52-78 (Extension Period 2)|Re-randomised to lira 1.2 or 1.8 mg|0
1032107|NCT00700817|2506420|P2|STARTED|Week 52-78 (Extension Period 2)||150
1032108|NCT00700817|2506421|P1|STARTED|Week 52-78 (Extension Period 2)|Subject withdrew before entry to extension period 2|134
1032109|NCT00700817|2506417|P5|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
1032110|NCT00700817|2506418|P4|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
1032111|NCT00700817|2506419|P3|NOT COMPLETED|Week 26-52 (Extension Period 1)||15
1032112|NCT00700817|2506420|P2|NOT COMPLETED|Week 26-52 (Extension Period 1)||26
1032113|NCT00700817|2506421|P1|NOT COMPLETED|Week 26-52 (Extension Period 1)||20
1032114|NCT00700817|2506417|P5|COMPLETED|Week 26-52 (Extension Period 1)||0
1032115|NCT00700817|2506418|P4|COMPLETED|Week 26-52 (Extension Period 1)||0
1032116|NCT00700817|2506419|P3|COMPLETED|Week 26-52 (Extension Period 1)||151
1032117|NCT00700817|2506420|P2|COMPLETED|Week 26-52 (Extension Period 1)||150
1032118|NCT00700817|2506421|P1|COMPLETED|Week 26-52 (Extension Period 1)||135
1032119|NCT00700817|2506417|P5|STARTED|Week 26-52 (Extension Period 1)||0
1032120|NCT00700817|2506418|P4|STARTED|Week 26-52 (Extension Period 1)||0
1032121|NCT00700817|2506419|P3|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|166
1032122|NCT00700817|2506420|P2|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|176
1032123|NCT00700817|2506421|P1|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|155
1032124|NCT00700817|2506417|P5|NOT COMPLETED|Week 0-26 (Main Period)||0
1032125|NCT00700817|2506418|P4|NOT COMPLETED|Week 0-26 (Main Period)||0
1032126|NCT00700817|2506419|P3|NOT COMPLETED|Week 0-26 (Main Period)||25
1032127|NCT00700817|2506420|P2|NOT COMPLETED|Week 0-26 (Main Period)||30
1032128|NCT00700817|2506421|P1|NOT COMPLETED|Week 0-26 (Main Period)||56
1032129|NCT00700817|2506417|P5|COMPLETED|Week 0-26 (Main Period)||0
1032130|NCT00700817|2506418|P4|COMPLETED|Week 0-26 (Main Period)||0
1032131|NCT00700817|2506419|P3|COMPLETED|Week 0-26 (Main Period)||194
1032132|NCT00700817|2506420|P2|COMPLETED|Week 0-26 (Main Period)||191
1032133|NCT00700817|2506421|P1|COMPLETED|Week 0-26 (Main Period)||169
1032134|NCT00700817|2506417|P5|Exposed|Week 0-26 (Main Period)||0
1032135|NCT00700817|2506418|P4|Exposed|Week 0-26 (Main Period)||0
1032136|NCT00700817|2506419|P3|Exposed|Week 0-26 (Main Period)||219
1032137|NCT00700817|2506420|P2|Exposed|Week 0-26 (Main Period)|3 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|218
1032138|NCT00700817|2506421|P1|Exposed|Week 0-26 (Main Period)|4 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|221
1032139|NCT00700817|2506417|P5|STARTED|Week 0-26 (Main Period)||0
1032140|NCT00700817|2506418|P4|STARTED|Week 0-26 (Main Period)||0
1032141|NCT00700817|2506419|P3|STARTED|Week 0-26 (Main Period)|Randomised|219
1032142|NCT00700817|2506420|P2|STARTED|Week 0-26 (Main Period)|Randomised|221
1032143|NCT00700817|2506421|P1|STARTED|Week 0-26 (Main Period)|Randomised|225
1032144|NCT00700973|2506803|P2|NOT COMPLETED|Overall Study||7
1032145|NCT00700973|2506804|P1|NOT COMPLETED|Overall Study||8
1032146|NCT00700973|2506803|P2|COMPLETED|Overall Study||63
1032147|NCT00700973|2506804|P1|COMPLETED|Overall Study||63
1032148|NCT00700973|2506803|P2|STARTED|Overall Study||70
1032149|NCT00700973|2506804|P1|STARTED|Overall Study||71
1032150|NCT00700999|2506812|P2|NOT COMPLETED|Overall Study||9
1032151|NCT00700999|2506813|P1|NOT COMPLETED|Overall Study||15
1032152|NCT00700999|2506812|P2|COMPLETED|Overall Study||20
1032153|NCT00700999|2506813|P1|COMPLETED|Overall Study||21
1032154|NCT00700999|2506812|P2|Second MRI Scan|Overall Study||18
1032155|NCT00700999|2506813|P1|Second MRI Scan|Overall Study||19
1032156|NCT00700999|2506812|P2|First MRI Scan|Overall Study||22
1032157|NCT00700999|2506813|P1|First MRI Scan|Overall Study||29
1032158|NCT00700999|2506812|P2|STARTED|Overall Study||29
1032159|NCT00700999|2506813|P1|STARTED|Overall Study||36
1032160|NCT00701038|2506821|P2|NOT COMPLETED|Overall Study||4
1032161|NCT00701038|2506822|P1|NOT COMPLETED|Overall Study||4
1032162|NCT00701038|2506821|P2|COMPLETED|Overall Study||23
1032163|NCT00701038|2506822|P1|COMPLETED|Overall Study||23
1032164|NCT00701038|2506821|P2|STARTED|Overall Study||27
1032165|NCT00701038|2506822|P1|STARTED|Overall Study||27
1032166|NCT00701051|2506830|P3|NOT COMPLETED|Detraining Intervention (Optional)||0
1032167|NCT00701051|2506831|P2|NOT COMPLETED|Detraining Intervention (Optional)||0
1032168|NCT00701051|2506832|P1|NOT COMPLETED|Detraining Intervention (Optional)||0
1032169|NCT00701051|2506830|P3|COMPLETED|Detraining Intervention (Optional)||6
1032170|NCT00701051|2506831|P2|COMPLETED|Detraining Intervention (Optional)||6
1032171|NCT00701051|2506832|P1|COMPLETED|Detraining Intervention (Optional)||0
1032172|NCT00701051|2506830|P3|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
1032173|NCT00701051|2506831|P2|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
1032174|NCT00701051|2506832|P1|STARTED|Detraining Intervention (Optional)||0
1032175|NCT00701051|2506830|P3|NOT COMPLETED|Exercise Intervention||3
1032176|NCT00701051|2506831|P2|NOT COMPLETED|Exercise Intervention||5
1032177|NCT00701051|2506832|P1|NOT COMPLETED|Exercise Intervention||0
1032178|NCT00701051|2506830|P3|COMPLETED|Exercise Intervention||9
1032179|NCT00701051|2506831|P2|COMPLETED|Exercise Intervention||14
1032180|NCT00701051|2506832|P1|COMPLETED|Exercise Intervention||0
1032181|NCT00701051|2506830|P3|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|12
1032182|NCT00701051|2506831|P2|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|19
1032183|NCT00701051|2506832|P1|STARTED|Exercise Intervention|Participants assigned to Normal or Impaired glucose tolerance arm after screening.|0
1032184|NCT00701051|2506830|P3|NOT COMPLETED|Screening||0
1032185|NCT00701051|2506831|P2|NOT COMPLETED|Screening||0
1032186|NCT00701051|2506832|P1|NOT COMPLETED|Screening||59
1032187|NCT00701051|2506830|P3|COMPLETED|Screening||0
1032188|NCT00701051|2506831|P2|COMPLETED|Screening||0
1032189|NCT00701051|2506832|P1|COMPLETED|Screening|Arm assignment not known until baseline testing; both arms included in this number|31
1032190|NCT00701051|2506830|P3|STARTED|Screening||0
1032191|NCT00701051|2506831|P2|STARTED|Screening||0
1032192|NCT00701051|2506832|P1|STARTED|Screening|Arm assignment not known until baseline testing; both arms included in this number|90
1032193|NCT00701064|2506850|P2|NOT COMPLETED|Overall Study||4
1032194|NCT00701064|2506851|P1|NOT COMPLETED|Overall Study||4
1032195|NCT00701064|2506850|P2|COMPLETED|Overall Study||32
1032196|NCT00701064|2506851|P1|COMPLETED|Overall Study||31
1032197|NCT00701064|2506850|P2|STARTED|Overall Study||36
1032198|NCT00701064|2506851|P1|STARTED|Overall Study||35
1032199|NCT00701090|2506859|P2|NOT COMPLETED|Overall Study||51
1032200|NCT00701090|2506860|P1|NOT COMPLETED|Overall Study||48
1032201|NCT00701090|2506859|P2|COMPLETED|Overall Study||468
1032202|NCT00701090|2506860|P1|COMPLETED|Overall Study||468
1032203|NCT00701090|2506859|P2|STARTED|Overall Study||519
1032204|NCT00701090|2506860|P1|STARTED|Overall Study||516
1032205|NCT00701103|2506887|P11|NOT COMPLETED|Overall Study||11
1032206|NCT00701103|2506888|P10|NOT COMPLETED|Overall Study||11
1032207|NCT00701103|2506889|P9|NOT COMPLETED|Overall Study||9
1032208|NCT00701103|2506890|P8|NOT COMPLETED|Overall Study||7
1032209|NCT00701103|2506891|P7|NOT COMPLETED|Overall Study||8
1032210|NCT00701103|2506892|P6|NOT COMPLETED|Overall Study||6
1032211|NCT00701103|2506893|P5|NOT COMPLETED|Overall Study||6
1032212|NCT00701103|2506894|P4|NOT COMPLETED|Overall Study||6
1032213|NCT00701103|2506895|P3|NOT COMPLETED|Overall Study||8
1032214|NCT00701103|2506896|P2|NOT COMPLETED|Overall Study||3
1032215|NCT00701103|2506897|P1|NOT COMPLETED|Overall Study||5
1032216|NCT00701103|2506887|P11|COMPLETED|Overall Study||0
1032217|NCT00701103|2506888|P10|COMPLETED|Overall Study||0
1032218|NCT00701103|2506889|P9|COMPLETED|Overall Study||0
1032219|NCT00701103|2506890|P8|COMPLETED|Overall Study||0
1032220|NCT00701103|2506891|P7|COMPLETED|Overall Study||0
1032221|NCT00701103|2506892|P6|COMPLETED|Overall Study||0
1032222|NCT00701103|2506893|P5|COMPLETED|Overall Study||0
1032223|NCT00701103|2506894|P4|COMPLETED|Overall Study||0
1032224|NCT00701103|2506895|P3|COMPLETED|Overall Study||0
1032225|NCT00701103|2506896|P2|COMPLETED|Overall Study||0
1032226|NCT00701103|2506897|P1|COMPLETED|Overall Study||0
1032227|NCT00701103|2506887|P11|STARTED|Overall Study||11
1032228|NCT00701103|2506888|P10|STARTED|Overall Study||11
1032229|NCT00701103|2506889|P9|STARTED|Overall Study||9
1032230|NCT00701103|2506890|P8|STARTED|Overall Study||7
1032231|NCT00701103|2506891|P7|STARTED|Overall Study||8
1032232|NCT00701103|2506892|P6|STARTED|Overall Study||6
1032233|NCT00701103|2506893|P5|STARTED|Overall Study||6
1032234|NCT00701103|2506894|P4|STARTED|Overall Study||6
1032235|NCT00701103|2506895|P3|STARTED|Overall Study||8
1032236|NCT00701103|2506896|P2|STARTED|Overall Study||3
1032237|NCT00701103|2506897|P1|STARTED|Overall Study||5
1032238|NCT00701129|2507001|P1|NOT COMPLETED|Overall Study||2
1032239|NCT00701129|2507001|P1|COMPLETED|Overall Study||2
1032240|NCT00701129|2507001|P1|Full Analysis Set (FAS)|Overall Study|All enrolled patients who signed informed consent, received at least 1 dose of alglucosidase alfa.|4
1032241|NCT00701129|2507001|P1|STARTED|Overall Study||4
1032242|NCT00701311|2507012|P1|NOT COMPLETED|Overall Study||8
1032243|NCT00701311|2507012|P1|COMPLETED|Overall Study|Eight subjects did not complete full period of treatment but their data was included in analysis.|9
1032244|NCT00701311|2507012|P1|STARTED|Overall Study||17
1032245|NCT00701363|2507020|P4|NOT COMPLETED|Treatment Phase 2||0
1032246|NCT00701363|2507021|P3|NOT COMPLETED|Treatment Phase 2||2
1032247|NCT00701363|2507022|P2|NOT COMPLETED|Treatment Phase 2||0
1032248|NCT00701363|2507023|P1|NOT COMPLETED|Treatment Phase 2||0
1032249|NCT00701363|2507020|P4|COMPLETED|Treatment Phase 2||26
1032250|NCT00701363|2507021|P3|COMPLETED|Treatment Phase 2||68
1032251|NCT00701363|2507022|P2|COMPLETED|Treatment Phase 2||13
1032252|NCT00701363|2507023|P1|COMPLETED|Treatment Phase 2||0
1032253|NCT00701363|2507020|P4|STARTED|Treatment Phase 2||26
1032254|NCT00701363|2507021|P3|STARTED|Treatment Phase 2||70
1032255|NCT00701363|2507022|P2|STARTED|Treatment Phase 2||13
1032256|NCT00701363|2507023|P1|STARTED|Treatment Phase 2||0
1032257|NCT00701363|2507020|P4|NOT COMPLETED|Treatment Phase 1||0
1032258|NCT00701363|2507021|P3|NOT COMPLETED|Treatment Phase 1||0
1032259|NCT00701363|2507022|P2|NOT COMPLETED|Treatment Phase 1||0
1032260|NCT00701363|2507023|P1|NOT COMPLETED|Treatment Phase 1||15
1032261|NCT00701363|2507020|P4|COMPLETED|Treatment Phase 1||0
1032262|NCT00701363|2507021|P3|COMPLETED|Treatment Phase 1||0
1032263|NCT00701363|2507022|P2|COMPLETED|Treatment Phase 1||0
1032264|NCT00701363|2507023|P1|COMPLETED|Treatment Phase 1||109
1032265|NCT00701363|2507020|P4|STARTED|Treatment Phase 1||0
1032266|NCT00701363|2507021|P3|STARTED|Treatment Phase 1||0
1032267|NCT00701363|2507022|P2|STARTED|Treatment Phase 1||0
1032268|NCT00701363|2507023|P1|STARTED|Treatment Phase 1||124
1032269|NCT00701363|2507020|P4|NOT COMPLETED|Screening (Pre-assignment) Phase||0
1032270|NCT00701363|2507021|P3|NOT COMPLETED|Screening (Pre-assignment) Phase||0
1032271|NCT00701363|2507022|P2|NOT COMPLETED|Screening (Pre-assignment) Phase||0
1032272|NCT00701363|2507023|P1|NOT COMPLETED|Screening (Pre-assignment) Phase||4
1032273|NCT00701363|2507020|P4|COMPLETED|Screening (Pre-assignment) Phase||0
1032274|NCT00701363|2507021|P3|COMPLETED|Screening (Pre-assignment) Phase||0
1032275|NCT00701363|2507022|P2|COMPLETED|Screening (Pre-assignment) Phase||0
1032276|NCT00701363|2507023|P1|COMPLETED|Screening (Pre-assignment) Phase||124
1032277|NCT00701363|2507020|P4|STARTED|Screening (Pre-assignment) Phase||0
1032278|NCT00701363|2507021|P3|STARTED|Screening (Pre-assignment) Phase||0
1032279|NCT00701363|2507022|P2|STARTED|Screening (Pre-assignment) Phase||0
1032280|NCT00701363|2507023|P1|STARTED|Screening (Pre-assignment) Phase||128
1032281|NCT00701389|2507063|P4|NOT COMPLETED|Period 4||0
1032282|NCT00701389|2507064|P3|NOT COMPLETED|Period 4||0
1032283|NCT00701389|2507065|P2|NOT COMPLETED|Period 4||0
1032284|NCT00701389|2507066|P1|NOT COMPLETED|Period 4||0
1032285|NCT00701389|2507063|P4|COMPLETED|Period 4||6
1032286|NCT00701389|2507064|P3|COMPLETED|Period 4||6
1032287|NCT00701389|2507065|P2|COMPLETED|Period 4||6
1032288|NCT00701389|2507066|P1|COMPLETED|Period 4||6
1032289|NCT00701389|2507063|P4|STARTED|Period 4||6
1032290|NCT00701389|2507064|P3|STARTED|Period 4||6
1032291|NCT00701389|2507065|P2|STARTED|Period 4||6
1032292|NCT00701389|2507066|P1|STARTED|Period 4||6
1032293|NCT00701389|2507063|P4|NOT COMPLETED|Period 3||0
1032294|NCT00701389|2507064|P3|NOT COMPLETED|Period 3||0
1032295|NCT00701389|2507065|P2|NOT COMPLETED|Period 3||0
1032296|NCT00701389|2507066|P1|NOT COMPLETED|Period 3||0
1032297|NCT00701389|2507063|P4|COMPLETED|Period 3||6
1032298|NCT00701389|2507064|P3|COMPLETED|Period 3||6
1032299|NCT00701389|2507065|P2|COMPLETED|Period 3||6
1032300|NCT00701389|2507066|P1|COMPLETED|Period 3||6
1032301|NCT00701389|2507063|P4|STARTED|Period 3||6
1032302|NCT00701389|2507064|P3|STARTED|Period 3||6
1032303|NCT00701389|2507065|P2|STARTED|Period 3||6
1032304|NCT00701389|2507066|P1|STARTED|Period 3||6
1032305|NCT00701389|2507063|P4|NOT COMPLETED|Period 2||0
1032306|NCT00701389|2507064|P3|NOT COMPLETED|Period 2||0
1032307|NCT00701389|2507065|P2|NOT COMPLETED|Period 2||0
1032308|NCT00701389|2507066|P1|NOT COMPLETED|Period 2||0
1032309|NCT00701389|2507063|P4|COMPLETED|Period 2||6
1032310|NCT00701389|2507064|P3|COMPLETED|Period 2||6
1032311|NCT00701389|2507065|P2|COMPLETED|Period 2||6
1032312|NCT00701389|2507066|P1|COMPLETED|Period 2||6
1032313|NCT00701389|2507063|P4|STARTED|Period 2||6
1032314|NCT00701389|2507064|P3|STARTED|Period 2||6
1032315|NCT00701389|2507065|P2|STARTED|Period 2||6
1032316|NCT00701389|2507066|P1|STARTED|Period 2||6
1032317|NCT00701389|2507063|P4|NOT COMPLETED|Period 1||0
1032318|NCT00701389|2507064|P3|NOT COMPLETED|Period 1||0
1032319|NCT00701389|2507065|P2|NOT COMPLETED|Period 1||0
1032320|NCT00701389|2507066|P1|NOT COMPLETED|Period 1||0
1032321|NCT00701389|2507063|P4|COMPLETED|Period 1||6
1032322|NCT00701389|2507064|P3|COMPLETED|Period 1||6
1032323|NCT00701389|2507065|P2|COMPLETED|Period 1||6
1032324|NCT00701389|2507066|P1|COMPLETED|Period 1||6
1032325|NCT00701389|2507063|P4|STARTED|Period 1||6
1032326|NCT00701389|2507064|P3|STARTED|Period 1||6
1032327|NCT00701389|2507065|P2|STARTED|Period 1||6
1032328|NCT00701389|2507066|P1|STARTED|Period 1||6
1032329|NCT00701415|2507086|P2|NOT COMPLETED|Overall Study||1
1032330|NCT00701415|2507087|P1|NOT COMPLETED|Overall Study||1
1032331|NCT00701415|2507086|P2|COMPLETED|Overall Study||14
1032332|NCT00701415|2507087|P1|COMPLETED|Overall Study||15
1032333|NCT00701415|2507086|P2|STARTED|Overall Study||15
1032334|NCT00701415|2507087|P1|STARTED|Overall Study||16
1032335|NCT00701441|2507099|P2|NOT COMPLETED|Overall Study||4
1032336|NCT00701441|2507100|P1|NOT COMPLETED|Overall Study||0
1032337|NCT00701441|2507099|P2|COMPLETED|Overall Study||12
1032338|NCT00701441|2507100|P1|COMPLETED|Overall Study||9
1032339|NCT00701441|2507099|P2|STARTED|Overall Study||16
1032340|NCT00701441|2507100|P1|STARTED|Overall Study||9
1032341|NCT00701558|2507110|P1|NOT COMPLETED|Overall Study||15
1032342|NCT00701558|2507110|P1|COMPLETED|Overall Study||4
1032343|NCT00701558|2507110|P1|STARTED|Overall Study||19
1032344|NCT00701636|2507118|P2|NOT COMPLETED|Overall Study||0
1032345|NCT00701636|2507119|P1|NOT COMPLETED|Overall Study||0
1032346|NCT00701636|2507118|P2|COMPLETED|Overall Study||15
1032347|NCT00701636|2507119|P1|COMPLETED|Overall Study||15
1032348|NCT00701636|2507118|P2|STARTED|Overall Study||15
1032349|NCT00701636|2507119|P1|STARTED|Overall Study||15
1032350|NCT00701662|2507124|P1|NOT COMPLETED|Overall Study||1
1032351|NCT00701662|2507124|P1|COMPLETED|Overall Study||7
1032352|NCT00701662|2507124|P1|STARTED|Overall Study||8
1032353|NCT00701675|2507144|P3|NOT COMPLETED|Overall Study||7
1032354|NCT00701675|2507145|P2|NOT COMPLETED|Overall Study||8
1032355|NCT00701675|2507146|P1|NOT COMPLETED|Overall Study||4
1032356|NCT00701675|2507144|P3|COMPLETED|Overall Study||7
1032357|NCT00701675|2507145|P2|COMPLETED|Overall Study||6
1032358|NCT00701675|2507146|P1|COMPLETED|Overall Study||10
1032359|NCT00701675|2507144|P3|STARTED|Overall Study||14
1032360|NCT00701675|2507145|P2|STARTED|Overall Study||14
1032361|NCT00701675|2507146|P1|STARTED|Overall Study||14
1032362|NCT00701727|2507154|P2|NOT COMPLETED|Second Treatment Period||0
1032363|NCT00701727|2507155|P1|NOT COMPLETED|Second Treatment Period||2
1032364|NCT00701727|2507154|P2|COMPLETED|Second Treatment Period||13
1032365|NCT00701727|2507155|P1|COMPLETED|Second Treatment Period||13
1032366|NCT00701727|2507154|P2|STARTED|Second Treatment Period||13
1032367|NCT00701727|2507155|P1|STARTED|Second Treatment Period||15
1032368|NCT00701727|2507154|P2|NOT COMPLETED|First Treatment Period||2
1032369|NCT00701727|2507155|P1|NOT COMPLETED|First Treatment Period||1
1032370|NCT00701727|2507154|P2|COMPLETED|First Treatment Period||13
1032371|NCT00701727|2507155|P1|COMPLETED|First Treatment Period||15
1032372|NCT00701727|2507154|P2|STARTED|First Treatment Period||15
1032373|NCT00701727|2507155|P1|STARTED|First Treatment Period||16
1032374|NCT00701779|2507173|P1|NOT COMPLETED|Overall Study||9
1032375|NCT00701779|2507173|P1|COMPLETED|Overall Study||54
1032376|NCT00701779|2507173|P1|12 Month|Overall Study||54
1032377|NCT00701779|2507173|P1|9 Month|Overall Study||56
1032378|NCT00701779|2507173|P1|6 Month|Overall Study||58
1032379|NCT00701779|2507173|P1|3 Month|Overall Study||60
1032380|NCT00701779|2507173|P1|STARTED|Overall Study||63
1032381|NCT00701805|2507186|P4|NOT COMPLETED|Overall Study||4
1032382|NCT00701805|2507187|P3|NOT COMPLETED|Overall Study||7
1032383|NCT00701805|2507188|P2|NOT COMPLETED|Overall Study||4
1032384|NCT00701805|2507189|P1|NOT COMPLETED|Overall Study||3
1032385|NCT00701805|2507186|P4|COMPLETED|Overall Study||22
1032386|NCT00701805|2507187|P3|COMPLETED|Overall Study||16
1032387|NCT00701805|2507188|P2|COMPLETED|Overall Study||25
1032388|NCT00701805|2507189|P1|COMPLETED|Overall Study||23
1032389|NCT00701805|2507186|P4|STARTED|Overall Study||26
1032390|NCT00701805|2507187|P3|STARTED|Overall Study||23
1032391|NCT00701805|2507188|P2|STARTED|Overall Study||29
1032392|NCT00701805|2507189|P1|STARTED|Overall Study||26
1032393|NCT00701935|2507241|P2|NOT COMPLETED|Overall Study||11
1032394|NCT00701935|2507242|P1|NOT COMPLETED|Overall Study||16
1032395|NCT00701935|2507241|P2|COMPLETED|Overall Study||26
1032396|NCT00701935|2507242|P1|COMPLETED|Overall Study||27
1032397|NCT00701935|2507241|P2|STARTED|Overall Study||37
1032398|NCT00701935|2507242|P1|STARTED|Overall Study||43
1032399|NCT00702143|2507275|P3|NOT COMPLETED|Overall Study||1
1032400|NCT00702143|2507276|P2|NOT COMPLETED|Overall Study||0
1032401|NCT00702143|2507277|P1|NOT COMPLETED|Overall Study||0
1032402|NCT00702143|2507275|P3|COMPLETED|Overall Study||78
1032403|NCT00702143|2507276|P2|COMPLETED|Overall Study||60
1032404|NCT00702143|2507277|P1|COMPLETED|Overall Study||45
1032405|NCT00702143|2507275|P3|STARTED|Overall Study||79
1032406|NCT00702143|2507276|P2|STARTED|Overall Study||60
1032407|NCT00702143|2507277|P1|STARTED|Overall Study||45
1032408|NCT00702208|2507289|P1|NOT COMPLETED|Overall Study||31
1032409|NCT00702208|2507289|P1|COMPLETED|Overall Study||167
1032410|NCT00702208|2507289|P1|STARTED|Overall Study||198
1032411|NCT00702221|2507297|P2|NOT COMPLETED|Overall Study||3
1032412|NCT00702221|2507298|P1|NOT COMPLETED|Overall Study||4
1032413|NCT00702221|2507297|P2|COMPLETED|Overall Study||7
1032414|NCT00702221|2507298|P1|COMPLETED|Overall Study||6
1032415|NCT00702221|2507297|P2|STARTED|Overall Study||10
1032416|NCT00702221|2507298|P1|STARTED|Overall Study||10
1032417|NCT00702234|2507304|P2|NOT COMPLETED|Follow-up Study: Fetuses/Infants||27
1032418|NCT00702234|2507305|P1|NOT COMPLETED|Follow-up Study: Fetuses/Infants||0
1032419|NCT00702234|2507304|P2|COMPLETED|Follow-up Study: Fetuses/Infants|All 288 who completed were live born infants|288
1032420|NCT00702234|2507305|P1|COMPLETED|Follow-up Study: Fetuses/Infants||0
1032421|NCT00702234|2507304|P2|Live Born Infants|Follow-up Study: Fetuses/Infants|Of the 11 that were not live born infants, outcome is known for 8 (fetus was lost) and unknown for 3|304
1032422|NCT00702234|2507305|P1|Live Born Infants|Follow-up Study: Fetuses/Infants||0
1032423|NCT00702234|2507304|P2|STARTED|Follow-up Study: Fetuses/Infants|Fetuses present 10 weeks after fresh ET and/or at enrollment of expectant mother in follow-up study|315
1032424|NCT00702234|2507305|P1|STARTED|Follow-up Study: Fetuses/Infants||0
1032425|NCT00702234|2507304|P2|NOT COMPLETED|Follow-up Study: Expectant Mothers||0
1032426|NCT00702234|2507305|P1|NOT COMPLETED|Follow-up Study: Expectant Mothers||22
1032427|NCT00702234|2507304|P2|COMPLETED|Follow-up Study: Expectant Mothers||0
1032428|NCT00702234|2507305|P1|COMPLETED|Follow-up Study: Expectant Mothers||246
1032429|NCT00702234|2507304|P2|STARTED|Follow-up Study: Expectant Mothers||0
1032430|NCT00702234|2507305|P1|STARTED|Follow-up Study: Expectant Mothers|"A participant could enter follow-up study without meeting definition for Completion of base study"|268
1032431|NCT00702234|2507304|P2|NOT COMPLETED|Base Study (NCT00696878)||0
1032432|NCT00702234|2507305|P1|NOT COMPLETED|Base Study (NCT00696878)||504
1032433|NCT00702234|2507304|P2|COMPLETED|Base Study (NCT00696878)||0
1032434|NCT00702234|2507305|P1|COMPLETED|Base Study (NCT00696878)||178
1032435|NCT00702234|2507304|P2|STARTED|Base Study (NCT00696878)||0
1032436|NCT00702234|2507305|P1|STARTED|Base Study (NCT00696878)||682
1032437|NCT00702273|2507316|P2|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||29
1032438|NCT00702273|2507317|P1|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||20
1032439|NCT00702273|2507316|P2|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|147
1032440|NCT00702273|2507317|P1|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|148
1032441|NCT00702273|2507316|P2|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study, who had at least one embryo thawed for a FTET cycle|176
1032442|NCT00702273|2507317|P1|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study,who had at least one embryo thawed for a FTET cycle.|168
1032443|NCT00702273|2507316|P2|NOT COMPLETED|Base Study P05787 (NCT00696800)||48
1032444|NCT00702273|2507317|P1|NOT COMPLETED|Base Study P05787 (NCT00696800)||85
1032445|NCT00702273|2507316|P2|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|704
1032446|NCT00702273|2507317|P1|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|672
1032447|NCT00702273|2507316|P2|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|750
1032448|NCT00702273|2507317|P1|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|756
1032449|NCT00702273|2507316|P2|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|752
1032450|NCT00702273|2507317|P1|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|757
1032451|NCT00694473|2507335|P1|NOT COMPLETED|Overall Study||7
1032452|NCT00694473|2507335|P1|COMPLETED|Overall Study|Dec 2010|69
1032453|NCT00694473|2507335|P1|STARTED|Overall Study|Aug 2008|76
1032463|NCT00694564|2507364|P1|NOT COMPLETED|Overall Study||2
1032464|NCT00694564|2507364|P1|COMPLETED|Overall Study||6
1032465|NCT00694564|2507364|P1|STARTED|Overall Study||8
1032466|NCT00694603|2507368|P1|NOT COMPLETED|Overall Study||0
1032467|NCT00694603|2507368|P1|COMPLETED|Overall Study||18
1032468|NCT00694603|2507368|P1|STARTED|Overall Study||18
1032469|NCT00695019|2507376|P3|NOT COMPLETED|Overall Study||10
1032470|NCT00695019|2507377|P2|NOT COMPLETED|Overall Study||14
1032471|NCT00695019|2507378|P1|NOT COMPLETED|Overall Study||13
1032472|NCT00695019|2507376|P3|COMPLETED|Overall Study||47
1032473|NCT00695019|2507377|P2|COMPLETED|Overall Study||39
1032474|NCT00695019|2507378|P1|COMPLETED|Overall Study||46
1032475|NCT00695019|2507376|P3|STARTED|Overall Study||57
1032476|NCT00695019|2507377|P2|STARTED|Overall Study||53
1032477|NCT00695019|2507378|P1|STARTED|Overall Study||59
1032478|NCT00695097|2507409|P2|NOT COMPLETED|Overall Study||0
1032479|NCT00695097|2507410|P1|NOT COMPLETED|Overall Study||1
1032480|NCT00695097|2507409|P2|COMPLETED|Overall Study||5
1032481|NCT00695097|2507410|P1|COMPLETED|Overall Study||9
1032482|NCT00695097|2507409|P2|STARTED|Overall Study||5
1032483|NCT00695097|2507410|P1|STARTED|Overall Study||10
1032484|NCT00695136|2507416|P1|NOT COMPLETED|Overall Study||2
1032485|NCT00695136|2507416|P1|COMPLETED|Overall Study||5
1032486|NCT00695136|2507416|P1|STARTED|Overall Study|7|7
1032487|NCT00695188|2507422|P2|NOT COMPLETED|Overall Study||0
1032488|NCT00695188|2507423|P1|NOT COMPLETED|Overall Study||0
1032489|NCT00695188|2507422|P2|COMPLETED|Overall Study||9
1032490|NCT00695188|2507423|P1|COMPLETED|Overall Study||10
1032491|NCT00695188|2507422|P2|STARTED|Overall Study||9
1032492|NCT00695188|2507423|P1|STARTED|Overall Study||10
1032493|NCT00695292|2507429|P1|NOT COMPLETED|Overall Study||0
1032494|NCT00695292|2507429|P1|COMPLETED|Overall Study||37
1032495|NCT00695292|2507429|P1|STARTED|Overall Study||37
1032496|NCT00695318|2507436|P2|NOT COMPLETED|Overall Study||1
1032497|NCT00695318|2507437|P1|NOT COMPLETED|Overall Study||5
1032498|NCT00695318|2507436|P2|COMPLETED|Overall Study||6
1032499|NCT00695318|2507437|P1|COMPLETED|Overall Study||5
1032500|NCT00695318|2507436|P2|STARTED|Overall Study||7
1032501|NCT00695318|2507437|P1|STARTED|Overall Study||10
1032502|NCT00695396|2507451|P3|NOT COMPLETED|Overall Study||8
1032503|NCT00695396|2507452|P2|NOT COMPLETED|Overall Study||8
1032504|NCT00695396|2507453|P1|NOT COMPLETED|Overall Study||7
1032505|NCT00695396|2507451|P3|COMPLETED|Overall Study||1
1032506|NCT00695396|2507452|P2|COMPLETED|Overall Study||0
1032507|NCT00695396|2507453|P1|COMPLETED|Overall Study||1
1032508|NCT00695396|2507451|P3|STARTED|Overall Study||9
1032509|NCT00695396|2507452|P2|STARTED|Overall Study||8
1032510|NCT00695396|2507453|P1|STARTED|Overall Study||8
1032511|NCT00695435|2507467|P3|NOT COMPLETED|Overall Study||0
1032512|NCT00695435|2507468|P2|NOT COMPLETED|Overall Study||0
1032513|NCT00695435|2507469|P1|NOT COMPLETED|Overall Study||0
1032514|NCT00695435|2507467|P3|COMPLETED|Overall Study||7
1032515|NCT00695435|2507468|P2|COMPLETED|Overall Study||7
1032516|NCT00695435|2507469|P1|COMPLETED|Overall Study||7
1032517|NCT00695435|2507467|P3|STARTED|Overall Study||7
1032518|NCT00695435|2507468|P2|STARTED|Overall Study||7
1032519|NCT00695435|2507469|P1|STARTED|Overall Study||7
1032520|NCT00695500|2507482|P2|NOT COMPLETED|Overall Study||5
1032521|NCT00695500|2507483|P1|NOT COMPLETED|Overall Study||3
1032522|NCT00695500|2507482|P2|COMPLETED|Overall Study||17
1032523|NCT00695500|2507483|P1|COMPLETED|Overall Study||21
1032524|NCT00695500|2507482|P2|STARTED|Overall Study||22
1032525|NCT00695500|2507483|P1|STARTED|Overall Study||24
1032526|NCT00695565|2507495|P2|NOT COMPLETED|Overall Study||9
1032527|NCT00695565|2507496|P1|NOT COMPLETED|Overall Study||13
1032528|NCT00695565|2507495|P2|COMPLETED|Overall Study||81
1032529|NCT00695565|2507496|P1|COMPLETED|Overall Study||77
1032530|NCT00695565|2507495|P2|STARTED|Overall Study||90
1032531|NCT00695565|2507496|P1|STARTED|Overall Study||90
1032532|NCT00695669|2507532|P4|NOT COMPLETED|Overall Study||4
1032533|NCT00695669|2507533|P3|NOT COMPLETED|Overall Study||3
1032534|NCT00695669|2507534|P2|NOT COMPLETED|Overall Study||4
1032535|NCT00695669|2507535|P1|NOT COMPLETED|Overall Study||4
1032536|NCT00695669|2507532|P4|COMPLETED|Overall Study||74
1032537|NCT00695669|2507533|P3|COMPLETED|Overall Study||75
1032538|NCT00695669|2507534|P2|COMPLETED|Overall Study||74
1032539|NCT00695669|2507535|P1|COMPLETED|Overall Study||74
1032540|NCT00695669|2507532|P4|STARTED|Overall Study||78
1032541|NCT00695669|2507533|P3|STARTED|Overall Study||78
1032542|NCT00695669|2507534|P2|STARTED|Overall Study||78
1032543|NCT00695669|2507535|P1|STARTED|Overall Study||78
1032544|NCT00702299|2507609|P1|NOT COMPLETED|Overall Study||0
1032545|NCT00702299|2507609|P1|COMPLETED|Overall Study||15
1032546|NCT00702299|2507609|P1|STARTED|Overall Study||15
1032547|NCT00702325|2507622|P2|NOT COMPLETED|Overall Study||53
1032548|NCT00702325|2507623|P1|NOT COMPLETED|Overall Study||38
1032549|NCT00702325|2507622|P2|COMPLETED|Overall Study|Completed participants based on randomized population (155) minus discontinued participants (53).|102
1032550|NCT00702325|2507623|P1|COMPLETED|Overall Study|Completed participants based on randomized population (156) minus discontinued participants (38).|118
1032551|NCT00702325|2507622|P2|STARTED|Overall Study|Randomized|155
1032552|NCT00702325|2507623|P1|STARTED|Overall Study|Randomized|156
1032553|NCT00702338|2507675|P3|NOT COMPLETED|Follow-up Study: Infant FU||2
1032554|NCT00702338|2507676|P2|NOT COMPLETED|Follow-up Study: Infant FU||0
1032555|NCT00702338|2507677|P1|NOT COMPLETED|Follow-up Study: Infant FU||0
1032556|NCT00702338|2507675|P3|COMPLETED|Follow-up Study: Infant FU||0
1032557|NCT00702338|2507676|P2|COMPLETED|Follow-up Study: Infant FU||0
1032558|NCT00702338|2507677|P1|COMPLETED|Follow-up Study: Infant FU||0
1032559|NCT00702338|2507675|P3|STARTED|Follow-up Study: Infant FU|Participants died on day of delivery, did not complete follow-up visit at 4-12 weeks postpartum.|2
1032560|NCT00702338|2507676|P2|STARTED|Follow-up Study: Infant FU||0
1032561|NCT00702338|2507677|P1|STARTED|Follow-up Study: Infant FU||0
1032562|NCT00702338|2507675|P3|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
1032563|NCT00702338|2507676|P2|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||1
1032564|NCT00702338|2507677|P1|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
1032565|NCT00702338|2507675|P3|COMPLETED|Follow-up Study: Expectant Mothers FU||0
1032566|NCT00702338|2507676|P2|COMPLETED|Follow-up Study: Expectant Mothers FU|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|0
1032567|NCT00702338|2507677|P1|COMPLETED|Follow-up Study: Expectant Mothers FU||0
1032568|NCT00702338|2507675|P3|STARTED|Follow-up Study: Expectant Mothers FU||0
1032569|NCT00702338|2507676|P2|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|1
1032570|NCT00702338|2507677|P1|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|0
1032571|NCT00702338|2507675|P3|NOT COMPLETED|Base Study (NCT00697255)||0
1032572|NCT00702338|2507676|P2|NOT COMPLETED|Base Study (NCT00697255)||2
1032573|NCT00702338|2507677|P1|NOT COMPLETED|Base Study (NCT00697255)||3
1032574|NCT00702338|2507675|P3|COMPLETED|Base Study (NCT00697255)||0
1032575|NCT00702338|2507676|P2|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|1
1032576|NCT00702338|2507677|P1|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|2
1032577|NCT00702338|2507675|P3|STARTED|Base Study (NCT00697255)||0
1032578|NCT00702338|2507676|P2|STARTED|Base Study (NCT00697255)||3
1032579|NCT00702338|2507677|P1|STARTED|Base Study (NCT00697255)||5
1032580|NCT00702364|2507693|P2|NOT COMPLETED|Overall Study||4
1032581|NCT00702364|2507694|P1|NOT COMPLETED|Overall Study||2
1032582|NCT00702364|2507693|P2|COMPLETED|Overall Study||25
1032583|NCT00702364|2507694|P1|COMPLETED|Overall Study||24
1032584|NCT00702364|2507693|P2|STARTED|Overall Study||29
1032585|NCT00702364|2507694|P1|STARTED|Overall Study||26
1032586|NCT00702377|2507708|P2|NOT COMPLETED|Overall Study||3
1032587|NCT00702377|2507709|P1|NOT COMPLETED|Overall Study||1
1032588|NCT00702377|2507708|P2|COMPLETED|Overall Study||53
1032589|NCT00702377|2507709|P1|COMPLETED|Overall Study||52
1032590|NCT00702377|2507708|P2|STARTED|Overall Study||56
1032591|NCT00702377|2507709|P1|STARTED|Overall Study||53
1032592|NCT00702403|2507719|P1|NOT COMPLETED|From Engraftment to Study Completion||27
1032593|NCT00702403|2507719|P1|COMPLETED|From Engraftment to Study Completion||13
1032594|NCT00702403|2507719|P1|Patient Drop-outs|From Engraftment to Study Completion||27
1032595|NCT00702403|2507719|P1|STARTED|From Engraftment to Study Completion||40
1032596|NCT00702403|2507719|P1|NOT COMPLETED|From Consent to Engraftment||17
1032597|NCT00702403|2507719|P1|COMPLETED|From Consent to Engraftment|40 of 57 originally consented subjects remained eligible at engraftment (= the 2nd ITT population)|40
1032598|NCT00702403|2507719|P1|Ineligible for Study Drug|From Consent to Engraftment||17
1032599|NCT00702403|2507719|P1|STARTED|From Consent to Engraftment|"57 agreed to participate and completed informed consent (= the 1st intention to treat population)"|57
1032600|NCT00702468|2507729|P2|NOT COMPLETED|Overall Study||16
1032601|NCT00702468|2507730|P1|NOT COMPLETED|Overall Study||3
1032602|NCT00702468|2507729|P2|COMPLETED|Overall Study||2
1032603|NCT00702468|2507730|P1|COMPLETED|Overall Study||15
1032604|NCT00702468|2507729|P2|STARTED|Overall Study||18
1032605|NCT00702468|2507730|P1|STARTED|Overall Study||18
1032606|NCT00702507|2507752|P1|NOT COMPLETED|Follow-up Phase||27
1032607|NCT00702507|2507752|P1|COMPLETED|Follow-up Phase||132
1032608|NCT00702507|2507752|P1|STARTED|Follow-up Phase||159
1032609|NCT00702507|2507752|P1|NOT COMPLETED|Initial Treatment Phase||41
1032610|NCT00702507|2507752|P1|COMPLETED|Initial Treatment Phase||159
1032611|NCT00702507|2507752|P1|STARTED|Initial Treatment Phase||200
1032612|NCT00702520|2507766|P4|NOT COMPLETED|Follow-up Study P05783||0
1032613|NCT00702520|2507767|P3|NOT COMPLETED|Follow-up Study P05783||0
1032614|NCT00702520|2507768|P2|NOT COMPLETED|Follow-up Study P05783||0
1032615|NCT00702520|2507769|P1|NOT COMPLETED|Follow-up Study P05783||0
1032616|NCT00702520|2507766|P4|COMPLETED|Follow-up Study P05783||11
1032617|NCT00702520|2507767|P3|COMPLETED|Follow-up Study P05783||8
1032618|NCT00702520|2507768|P2|COMPLETED|Follow-up Study P05783||8
1032619|NCT00702520|2507769|P1|COMPLETED|Follow-up Study P05783||7
1032620|NCT00702520|2507766|P4|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 150 ug.|11
1032621|NCT00702520|2507767|P3|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 100 ug.|8
1032622|NCT00702520|2507768|P2|STARTED|Follow-up Study P05783||8
1032623|NCT00702520|2507769|P1|STARTED|Follow-up Study P05783||7
1032624|NCT00702520|2507766|P4|NOT COMPLETED|Base Study P05788 - Follow-Up||0
1032625|NCT00702520|2507767|P3|NOT COMPLETED|Base Study P05788 - Follow-Up||0
1032626|NCT00702520|2507768|P2|NOT COMPLETED|Base Study P05788 - Follow-Up||10
1032627|NCT00702520|2507769|P1|NOT COMPLETED|Base Study P05788 - Follow-Up||15
1032628|NCT00702520|2507766|P4|COMPLETED|Base Study P05788 - Follow-Up||0
1032629|NCT00702520|2507767|P3|COMPLETED|Base Study P05788 - Follow-Up||0
1032630|NCT00702520|2507768|P2|COMPLETED|Base Study P05788 - Follow-Up||8
1032631|NCT00702520|2507769|P1|COMPLETED|Base Study P05788 - Follow-Up||7
1032632|NCT00702520|2507766|P4|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
1032633|NCT00702520|2507767|P3|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
1032634|NCT00702520|2507768|P2|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||8
1032635|NCT00702520|2507769|P1|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||7
1032636|NCT00702520|2507766|P4|STARTED|Base Study P05788 - Follow-Up||0
1032637|NCT00702520|2507767|P3|STARTED|Base Study P05788 - Follow-Up||0
1032638|NCT00702520|2507768|P2|STARTED|Base Study P05788 - Follow-Up||18
1032639|NCT00702520|2507769|P1|STARTED|Base Study P05788 - Follow-Up||22
1032640|NCT00702520|2507766|P4|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
1032641|NCT00702520|2507767|P3|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
1032642|NCT00702520|2507768|P2|NOT COMPLETED|Base Study P05788 - Embryo Transfer||6
1032643|NCT00702520|2507769|P1|NOT COMPLETED|Base Study P05788 - Embryo Transfer||3
1032644|NCT00702520|2507766|P4|COMPLETED|Base Study P05788 - Embryo Transfer||0
1032645|NCT00702520|2507767|P3|COMPLETED|Base Study P05788 - Embryo Transfer||0
1032646|NCT00702520|2507768|P2|COMPLETED|Base Study P05788 - Embryo Transfer||18
1032647|NCT00702520|2507769|P1|COMPLETED|Base Study P05788 - Embryo Transfer||22
1032648|NCT00702520|2507766|P4|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
1032649|NCT00702520|2507767|P3|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
1032650|NCT00702520|2507768|P2|Embryo Transfer|Base Study P05788 - Embryo Transfer||18
1032651|NCT00702520|2507769|P1|Embryo Transfer|Base Study P05788 - Embryo Transfer||22
1032652|NCT00702520|2507766|P4|STARTED|Base Study P05788 - Embryo Transfer||0
1032653|NCT00702520|2507767|P3|STARTED|Base Study P05788 - Embryo Transfer||0
1032654|NCT00702520|2507768|P2|STARTED|Base Study P05788 - Embryo Transfer||24
1032655|NCT00702520|2507769|P1|STARTED|Base Study P05788 - Embryo Transfer||25
1032656|NCT00702520|2507766|P4|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
1032657|NCT00702520|2507767|P3|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
1032658|NCT00702520|2507768|P2|NOT COMPLETED|Base Study P05788 - Assigned Treatment||1
1032659|NCT00702520|2507769|P1|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
1032660|NCT00702520|2507766|P4|COMPLETED|Base Study P05788 - Assigned Treatment||0
1032661|NCT00702520|2507767|P3|COMPLETED|Base Study P05788 - Assigned Treatment||0
1032662|NCT00702520|2507768|P2|COMPLETED|Base Study P05788 - Assigned Treatment||24
1032663|NCT00702520|2507769|P1|COMPLETED|Base Study P05788 - Assigned Treatment||25
1032664|NCT00702520|2507766|P4|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
1032665|NCT00702520|2507767|P3|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
1032666|NCT00702520|2507768|P2|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||24
1032667|NCT00702520|2507769|P1|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||25
1032668|NCT00702520|2507766|P4|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
1032669|NCT00702520|2507767|P3|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
1032670|NCT00702520|2507768|P2|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||24
1032671|NCT00702520|2507769|P1|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||25
1032672|NCT00702520|2507766|P4|STARTED|Base Study P05788 - Assigned Treatment||0
1032673|NCT00702520|2507767|P3|STARTED|Base Study P05788 - Assigned Treatment||0
1032674|NCT00702520|2507768|P2|STARTED|Base Study P05788 - Assigned Treatment||25
1032675|NCT00702520|2507769|P1|STARTED|Base Study P05788 - Assigned Treatment||25
1032676|NCT00702546|2507787|P2|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||1
1032677|NCT00702546|2507788|P1|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||5
1032678|NCT00702546|2507787|P2|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|24
1032679|NCT00702546|2507788|P1|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|72
1032680|NCT00702546|2507787|P2|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|25
1032681|NCT00702546|2507788|P1|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|77
1032682|NCT00702546|2507787|P2|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
1032683|NCT00702546|2507788|P1|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
1032684|NCT00702546|2507787|P2|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
1032833|NCT00703157|2508134|P1|COMPLETED|Overall Study||22
1032685|NCT00702546|2507788|P1|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
1032686|NCT00702546|2507787|P2|STARTED|Base Study P05690 (NCT00702845)||128
1032687|NCT00702546|2507788|P1|STARTED|Base Study P05690 (NCT00702845)||268
1032688|NCT00702624|2507808|P4|NOT COMPLETED|Fetuses/Infant Follow-up||0
1032689|NCT00702624|2507809|P3|NOT COMPLETED|Fetuses/Infant Follow-up||10
1032690|NCT00702624|2507810|P2|NOT COMPLETED|Fetuses/Infant Follow-up||0
1032691|NCT00702624|2507811|P1|NOT COMPLETED|Fetuses/Infant Follow-up||0
1032692|NCT00702624|2507808|P4|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|55
1032693|NCT00702624|2507809|P3|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|78
1032694|NCT00702624|2507810|P2|COMPLETED|Fetuses/Infant Follow-up||0
1032695|NCT00702624|2507811|P1|COMPLETED|Fetuses/Infant Follow-up||0
1032696|NCT00702624|2507808|P4|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy.|55
1032697|NCT00702624|2507809|P3|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy|80
1032698|NCT00702624|2507810|P2|Live Born Infants|Fetuses/Infant Follow-up||0
1032699|NCT00702624|2507811|P1|Live Born Infants|Fetuses/Infant Follow-up||0
1032700|NCT00702624|2507808|P4|STARTED|Fetuses/Infant Follow-up||55
1032701|NCT00702624|2507809|P3|STARTED|Fetuses/Infant Follow-up||88
1032702|NCT00702624|2507810|P2|STARTED|Fetuses/Infant Follow-up||0
1032703|NCT00702624|2507811|P1|STARTED|Fetuses/Infant Follow-up||0
1032704|NCT00702624|2507808|P4|NOT COMPLETED|Expectant Mother Follow-up||0
1032705|NCT00702624|2507809|P3|NOT COMPLETED|Expectant Mother Follow-up||0
1032706|NCT00702624|2507810|P2|NOT COMPLETED|Expectant Mother Follow-up||0
1032707|NCT00702624|2507811|P1|NOT COMPLETED|Expectant Mother Follow-up||7
1032708|NCT00702624|2507808|P4|COMPLETED|Expectant Mother Follow-up||0
1032709|NCT00702624|2507809|P3|COMPLETED|Expectant Mother Follow-up||0
1032710|NCT00702624|2507810|P2|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|45
1032711|NCT00702624|2507811|P1|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|61
1032712|NCT00702624|2507808|P4|STARTED|Expectant Mother Follow-up||0
1032713|NCT00702624|2507809|P3|STARTED|Expectant Mother Follow-up||0
1032714|NCT00702624|2507810|P2|STARTED|Expectant Mother Follow-up||45
1032715|NCT00702624|2507811|P1|STARTED|Expectant Mother Follow-up||68
1032716|NCT00702624|2507808|P4|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
1032717|NCT00702624|2507809|P3|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
1032718|NCT00702624|2507810|P2|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
1032719|NCT00702624|2507811|P1|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
1032720|NCT00702624|2507808|P4|COMPLETED|Base Study P05690 (NCT00702845)||0
1032721|NCT00702624|2507809|P3|COMPLETED|Base Study P05690 (NCT00702845)||0
1032722|NCT00702624|2507810|P2|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
1032723|NCT00702624|2507811|P1|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
1032724|NCT00702624|2507808|P4|STARTED|Base Study P05690 (NCT00702845)||0
1032725|NCT00702624|2507809|P3|STARTED|Base Study P05690 (NCT00702845)||0
1032726|NCT00702624|2507810|P2|STARTED|Base Study P05690 (NCT00702845)||128
1032727|NCT00702624|2507811|P1|STARTED|Base Study P05690 (NCT00702845)||268
1032728|NCT00702923|2507827|P1|NOT COMPLETED|Overall Study||1
1032729|NCT00702923|2507827|P1|COMPLETED|Overall Study||11
1032730|NCT00702923|2507827|P1|STARTED|Overall Study||12
1032731|NCT00702949|2507839|P3|NOT COMPLETED|Overall Study||8
1032732|NCT00702949|2507840|P2|NOT COMPLETED|Overall Study||9
1032733|NCT00702949|2507841|P1|NOT COMPLETED|Overall Study||5
1032734|NCT00702949|2507839|P3|COMPLETED|Overall Study||54
1032735|NCT00702949|2507840|P2|COMPLETED|Overall Study||57
1032736|NCT00702949|2507841|P1|COMPLETED|Overall Study||58
1032737|NCT00702949|2507839|P3|Evaluable for Primary Endpoint|Overall Study||51
1032738|NCT00702949|2507840|P2|Evaluable for Primary Endpoint|Overall Study||56
1032739|NCT00702949|2507841|P1|Evaluable for Primary Endpoint|Overall Study||56
1032740|NCT00702949|2507839|P3|STARTED|Overall Study||62
1032741|NCT00702949|2507840|P2|STARTED|Overall Study||66
1032742|NCT00702949|2507841|P1|STARTED|Overall Study||63
1032743|NCT00703014|2507868|P4|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||42
1032744|NCT00703014|2507869|P3|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||47
1032745|NCT00703014|2507870|P2|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
1032746|NCT00703014|2507871|P1|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
1032747|NCT00703014|2507868|P4|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|284
1032748|NCT00703014|2507869|P3|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|305
1032749|NCT00703014|2507870|P2|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
1032750|NCT00703014|2507871|P1|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
1032751|NCT00703014|2507868|P4|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|315
1032752|NCT00703014|2507869|P3|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|344
1032753|NCT00703014|2507870|P2|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
1032754|NCT00703014|2507871|P1|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
1032755|NCT00703014|2507868|P4|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|326
1032834|NCT00703157|2508133|P2|24 Months FU|Overall Study||24
1032756|NCT00703014|2507869|P3|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|352
1032757|NCT00703014|2507870|P2|STARTED|Fetuses/Infants Follow Up Trial P05712||0
1032758|NCT00703014|2507871|P1|STARTED|Fetuses/Infants Follow Up Trial P05712||0
1032759|NCT00703014|2507868|P4|NOT COMPLETED|Mothers Follow Up Trial P05712||0
1032760|NCT00703014|2507869|P3|NOT COMPLETED|Mothers Follow Up Trial P05712||0
1032761|NCT00703014|2507870|P2|NOT COMPLETED|Mothers Follow Up Trial P05712||32
1032762|NCT00703014|2507871|P1|NOT COMPLETED|Mothers Follow Up Trial P05712||33
1032763|NCT00703014|2507868|P4|COMPLETED|Mothers Follow Up Trial P05712||0
1032764|NCT00703014|2507869|P3|COMPLETED|Mothers Follow Up Trial P05712||0
1032765|NCT00703014|2507870|P2|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|235
1032766|NCT00703014|2507871|P1|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|241
1032767|NCT00703014|2507868|P4|STARTED|Mothers Follow Up Trial P05712||0
1032768|NCT00703014|2507869|P3|STARTED|Mothers Follow Up Trial P05712||0
1032769|NCT00703014|2507870|P2|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|267
1032770|NCT00703014|2507871|P1|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|274
1032771|NCT00703014|2507868|P4|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
1032772|NCT00703014|2507869|P3|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
1032773|NCT00703014|2507870|P2|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||466
1032774|NCT00703014|2507871|P1|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||462
1032775|NCT00703014|2507868|P4|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
1032776|NCT00703014|2507869|P3|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
1032777|NCT00703014|2507870|P2|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|286
1032778|NCT00703014|2507871|P1|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|295
1032779|NCT00703014|2507868|P4|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
1032780|NCT00703014|2507869|P3|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
1032781|NCT00703014|2507870|P2|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|704
1032782|NCT00703014|2507871|P1|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|672
1032783|NCT00703014|2507868|P4|Treated|Mothers Base Trial P05787 (NCT00696800)||0
1032784|NCT00703014|2507869|P3|Treated|Mothers Base Trial P05787 (NCT00696800)||0
1032785|NCT00703014|2507870|P2|Treated|Mothers Base Trial P05787 (NCT00696800)|ITT group in Base Trial P05787 (NCT006968000)|750
1032786|NCT00703014|2507871|P1|Treated|Mothers Base Trial P05787 (NCT00696800)|Intent-To-Treat (ITT) group in Base Trial P05787 (NCT00696800)|756
1032787|NCT00703014|2507868|P4|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
1032788|NCT00703014|2507869|P3|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
1032789|NCT00703014|2507870|P2|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|752
1032790|NCT00703014|2507871|P1|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|757
1032791|NCT00703053|2507898|P9|NOT COMPLETED|Overall Study||1
1032792|NCT00703053|2507899|P8|NOT COMPLETED|Overall Study||6
1032793|NCT00703053|2507900|P7|NOT COMPLETED|Overall Study||7
1032794|NCT00703053|2507901|P6|NOT COMPLETED|Overall Study||6
1032795|NCT00703053|2507902|P5|NOT COMPLETED|Overall Study||1
1032796|NCT00703053|2507903|P4|NOT COMPLETED|Overall Study||3
1032797|NCT00703053|2507904|P3|NOT COMPLETED|Overall Study||3
1032798|NCT00703053|2507905|P2|NOT COMPLETED|Overall Study||2
1032799|NCT00703053|2507906|P1|NOT COMPLETED|Overall Study||1
1032800|NCT00703053|2507898|P9|COMPLETED|Overall Study||102
1032801|NCT00703053|2507899|P8|COMPLETED|Overall Study||91
1032802|NCT00703053|2507900|P7|COMPLETED|Overall Study||45
1032803|NCT00703053|2507901|P6|COMPLETED|Overall Study||43
1032804|NCT00703053|2507902|P5|COMPLETED|Overall Study||50
1032805|NCT00703053|2507903|P4|COMPLETED|Overall Study||46
1032806|NCT00703053|2507904|P3|COMPLETED|Overall Study||48
1032807|NCT00703053|2507905|P2|COMPLETED|Overall Study||24
1032808|NCT00703053|2507906|P1|COMPLETED|Overall Study||26
1032809|NCT00703053|2507898|P9|STARTED|Overall Study||103
1032810|NCT00703053|2507899|P8|STARTED|Overall Study||97
1032811|NCT00703053|2507900|P7|STARTED|Overall Study||52
1032812|NCT00703053|2507901|P6|STARTED|Overall Study||49
1032813|NCT00703053|2507902|P5|STARTED|Overall Study||51
1032814|NCT00703053|2507903|P4|STARTED|Overall Study||49
1032815|NCT00703053|2507904|P3|STARTED|Overall Study||51
1032816|NCT00703053|2507905|P2|STARTED|Overall Study||26
1032817|NCT00703053|2507906|P1|STARTED|Overall Study||27
1032821|NCT00703118|2508098|P3|NOT COMPLETED|Overall Study||22
1032822|NCT00703118|2508099|P2|NOT COMPLETED|Overall Study||16
1032823|NCT00703118|2508100|P1|NOT COMPLETED|Overall Study||21
1032824|NCT00703118|2508098|P3|COMPLETED|Overall Study||110
1032825|NCT00703118|2508099|P2|COMPLETED|Overall Study||248
1032826|NCT00703118|2508100|P1|COMPLETED|Overall Study||245
1032827|NCT00703118|2508098|P3|STARTED|Overall Study||132
1032828|NCT00703118|2508099|P2|STARTED|Overall Study||264
1032829|NCT00703118|2508100|P1|STARTED|Overall Study||266
1032830|NCT00703157|2508133|P2|NOT COMPLETED|Overall Study||2
1032831|NCT00703157|2508134|P1|NOT COMPLETED|Overall Study||4
1032832|NCT00703157|2508133|P2|COMPLETED|Overall Study||24
1032835|NCT00703157|2508134|P1|24 Months FU|Overall Study||22
1032836|NCT00703157|2508133|P2|6 Months FU|Overall Study||25
1032837|NCT00703157|2508134|P1|6 Months FU|Overall Study||25
1032838|NCT00703157|2508133|P2|STARTED|Overall Study||26
1032839|NCT00703157|2508134|P1|STARTED|Overall Study||26
1032840|NCT00703261|2508167|P2|NOT COMPLETED|Overall Study||6
1032841|NCT00703261|2508168|P1|NOT COMPLETED|Overall Study||6
1032842|NCT00703261|2508167|P2|COMPLETED|Overall Study||35
1032843|NCT00703261|2508168|P1|COMPLETED|Overall Study||36
1032844|NCT00703261|2508167|P2|STARTED|Overall Study||41
1032845|NCT00703261|2508168|P1|STARTED|Overall Study||42
1032846|NCT00703326|2508177|P2|NOT COMPLETED|Overall Study||225
1032847|NCT00703326|2508178|P1|NOT COMPLETED|Overall Study||447
1032848|NCT00703326|2508177|P2|COMPLETED|Overall Study||160
1032849|NCT00703326|2508178|P1|COMPLETED|Overall Study||312
1032850|NCT00703326|2508177|P2|Received at Least 1 Dose of Study Drug|Overall Study||382
1032851|NCT00703326|2508178|P1|Received at Least 1 Dose of Study Drug|Overall Study||752
1032852|NCT00703326|2508177|P2|STARTED|Overall Study||385
1032853|NCT00703326|2508178|P1|STARTED|Overall Study||759
1032854|NCT00703339|2508198|P1|NOT COMPLETED|Overall Study||0
1032855|NCT00703339|2508198|P1|COMPLETED|Overall Study||1
1032856|NCT00703339|2508198|P1|STARTED|Overall Study||1
1032857|NCT00703391|2508204|P2|NOT COMPLETED|Overall Study||0
1032858|NCT00703391|2508205|P1|NOT COMPLETED|Overall Study||0
1032859|NCT00703391|2508204|P2|COMPLETED|Overall Study||6
1032860|NCT00703391|2508205|P1|COMPLETED|Overall Study||12
1032861|NCT00703391|2508204|P2|STARTED|Overall Study||6
1032862|NCT00703391|2508205|P1|STARTED|Overall Study||12
1032863|NCT00703508|2508249|P1|NOT COMPLETED|Overall Study||0
1032864|NCT00703508|2508249|P1|COMPLETED|Overall Study||26
1032865|NCT00703508|2508249|P1|STARTED|Overall Study||26
1032866|NCT00703534|2508263|P2|NOT COMPLETED|Overall Study||25
1032867|NCT00703534|2508264|P1|NOT COMPLETED|Overall Study||30
1032868|NCT00703534|2508263|P2|COMPLETED|Overall Study||218
1032869|NCT00703534|2508264|P1|COMPLETED|Overall Study||205
1032870|NCT00703534|2508263|P2|STARTED|Overall Study||243
1032871|NCT00703534|2508264|P1|STARTED|Overall Study||235
1032872|NCT00703677|2508270|P1|NOT COMPLETED|Overall Study||3
1032873|NCT00703677|2508270|P1|COMPLETED|Overall Study||14
1032874|NCT00703677|2508270|P1|STARTED|Overall Study||17
1032875|NCT00703729|2508285|P2|NOT COMPLETED|Overall Study||3
1032876|NCT00703729|2508286|P1|NOT COMPLETED|Overall Study||0
1032877|NCT00703729|2508285|P2|COMPLETED|Overall Study||21
1032878|NCT00703729|2508286|P1|COMPLETED|Overall Study||25
1032879|NCT00703729|2508285|P2|STARTED|Overall Study||24
1032880|NCT00703729|2508286|P1|STARTED|Overall Study||25
1032881|NCT00703781|2508322|P2|NOT COMPLETED|Overall Study||2
1032882|NCT00703781|2508323|P1|NOT COMPLETED|Overall Study||2
1032883|NCT00703781|2508322|P2|COMPLETED|Overall Study||61
1032884|NCT00703781|2508323|P1|COMPLETED|Overall Study||61
1032885|NCT00703781|2508322|P2|STARTED|Overall Study||63
1032886|NCT00703781|2508323|P1|STARTED|Overall Study||63
1032887|NCT00703846|2508331|P1|NOT COMPLETED|Overall Study||137
1032888|NCT00703846|2508331|P1|COMPLETED|Overall Study||363
1032889|NCT00703846|2508331|P1|STARTED|Overall Study||500
1032890|NCT00703885|2508345|P1|NOT COMPLETED|Overall Study||0
1032891|NCT00703885|2508345|P1|COMPLETED|Overall Study||16
1032892|NCT00703885|2508345|P1|STARTED|Overall Study||16
1032893|NCT00703911|2508350|P1|NOT COMPLETED|Overall Study||10
1032894|NCT00703911|2508350|P1|COMPLETED|Overall Study||92
1032895|NCT00703911|2508350|P1|STARTED|Overall Study||102
1032896|NCT00703924|2508380|P2|NOT COMPLETED|Overall Study||1
1032897|NCT00703924|2508381|P1|NOT COMPLETED|Overall Study||1
1032898|NCT00703924|2508380|P2|COMPLETED|Overall Study||41
1032899|NCT00703924|2508381|P1|COMPLETED|Overall Study||49
1032900|NCT00703924|2508380|P2|STARTED|Overall Study||42
1032901|NCT00703924|2508381|P1|STARTED|Overall Study||50
1032902|NCT00703937|2508399|P2|NOT COMPLETED|Overall Study||93
1032903|NCT00703937|2508400|P1|NOT COMPLETED|Overall Study||65
1032904|NCT00703937|2508399|P2|COMPLETED|Overall Study||267
1032905|NCT00703937|2508400|P1|COMPLETED|Overall Study||278
1032906|NCT00703937|2508399|P2|STARTED|Overall Study||360
1032907|NCT00703937|2508400|P1|STARTED|Overall Study||343
1032908|NCT00703963|2508408|P2|NOT COMPLETED|Overall Study||14
1032909|NCT00703963|2508409|P1|NOT COMPLETED|Overall Study||7
1032910|NCT00703963|2508408|P2|COMPLETED|Overall Study||86
1032911|NCT00703963|2508409|P1|COMPLETED|Overall Study||93
1032912|NCT00703963|2508408|P2|STARTED|Overall Study||100
1032913|NCT00703963|2508409|P1|STARTED|Overall Study||100
1032914|NCT00703976|2508421|P2|NOT COMPLETED|Overall Study||0
1032915|NCT00703976|2508422|P1|NOT COMPLETED|Overall Study||0
1032916|NCT00703976|2508421|P2|COMPLETED|Overall Study||41
1032917|NCT00703976|2508422|P1|COMPLETED|Overall Study||37
1032918|NCT00703976|2508421|P2|STARTED|Overall Study||41
1032919|NCT00703976|2508422|P1|STARTED|Overall Study||37
1032920|NCT00704028|2508432|P2|NOT COMPLETED|Overall Study||21
1032921|NCT00704028|2508433|P1|NOT COMPLETED|Overall Study||12
1032922|NCT00704028|2508432|P2|COMPLETED|Overall Study||57
1032923|NCT00704028|2508433|P1|COMPLETED|Overall Study||70
1032924|NCT00704028|2508432|P2|STARTED|Overall Study|A subject randomized to iron dextran never received study drug and was d/c due to subject request.|78
1032925|NCT00704028|2508433|P1|STARTED|Overall Study||82
1032926|NCT00704132|2508441|P2|NOT COMPLETED|Overall Study||2
1032927|NCT00704132|2508442|P1|NOT COMPLETED|Overall Study||1
1032928|NCT00704132|2508441|P2|COMPLETED|Overall Study||22
1032929|NCT00704132|2508442|P1|COMPLETED|Overall Study||25
1032930|NCT00704132|2508441|P2|STARTED|Overall Study||24
1032931|NCT00704132|2508442|P1|STARTED|Overall Study||26
1032932|NCT00704171|2508450|P2|NOT COMPLETED|Overall Study||0
1032933|NCT00704171|2508451|P1|NOT COMPLETED|Overall Study||1
1032934|NCT00704171|2508450|P2|COMPLETED|Overall Study|All control subjects completed the study.|59
1032935|NCT00704171|2508451|P1|COMPLETED|Overall Study|One subject withdrew consent prior to study completion. No reason given.|61
1032936|NCT00704171|2508450|P2|STARTED|Overall Study||59
1032937|NCT00704171|2508451|P1|STARTED|Overall Study||62
1032938|NCT00704184|2508472|P5|NOT COMPLETED|Open-Label Treatment||3
1032939|NCT00704184|2508473|P4|NOT COMPLETED|Open-Label Treatment||5
1032940|NCT00704184|2508474|P3|NOT COMPLETED|Open-Label Treatment||4
1032941|NCT00704184|2508475|P2|NOT COMPLETED|Open-Label Treatment||2
1032942|NCT00704184|2508476|P1|NOT COMPLETED|Open-Label Treatment||1
1032943|NCT00704184|2508472|P5|COMPLETED|Open-Label Treatment||16
1032944|NCT00704184|2508473|P4|COMPLETED|Open-Label Treatment||13
1032945|NCT00704184|2508474|P3|COMPLETED|Open-Label Treatment||16
1032946|NCT00704184|2508475|P2|COMPLETED|Open-Label Treatment||16
1032947|NCT00704184|2508476|P1|COMPLETED|Open-Label Treatment||18
1032948|NCT00704184|2508472|P5|STARTED|Open-Label Treatment||19
1032949|NCT00704184|2508473|P4|STARTED|Open-Label Treatment||18
1032950|NCT00704184|2508474|P3|STARTED|Open-Label Treatment||20
1032951|NCT00704184|2508475|P2|STARTED|Open-Label Treatment||18
1032952|NCT00704184|2508476|P1|STARTED|Open-Label Treatment||19
1032953|NCT00704184|2508472|P5|NOT COMPLETED|Double-Blind Treatment||0
1032954|NCT00704184|2508473|P4|NOT COMPLETED|Double-Blind Treatment||0
1032955|NCT00704184|2508474|P3|NOT COMPLETED|Double-Blind Treatment||0
1032956|NCT00704184|2508475|P2|NOT COMPLETED|Double-Blind Treatment||0
1032957|NCT00704184|2508476|P1|NOT COMPLETED|Double-Blind Treatment||1
1032958|NCT00704184|2508472|P5|COMPLETED|Double-Blind Treatment||19
1032959|NCT00704184|2508473|P4|COMPLETED|Double-Blind Treatment||18
1032960|NCT00704184|2508474|P3|COMPLETED|Double-Blind Treatment||20
1032961|NCT00704184|2508475|P2|COMPLETED|Double-Blind Treatment||18
1032962|NCT00704184|2508476|P1|COMPLETED|Double-Blind Treatment||19
1032963|NCT00704184|2508472|P5|Treated|Double-Blind Treatment||19
1032964|NCT00704184|2508473|P4|Treated|Double-Blind Treatment||18
1032965|NCT00704184|2508474|P3|Treated|Double-Blind Treatment||20
1032966|NCT00704184|2508475|P2|Treated|Double-Blind Treatment||18
1032967|NCT00704184|2508476|P1|Treated|Double-Blind Treatment|One participant was randomized to placebo but withdrew prior to receiving study medication.|19
1032968|NCT00704184|2508472|P5|STARTED|Double-Blind Treatment||19
1032969|NCT00704184|2508473|P4|STARTED|Double-Blind Treatment||18
1032970|NCT00704184|2508474|P3|STARTED|Double-Blind Treatment||20
1032971|NCT00704184|2508475|P2|STARTED|Double-Blind Treatment||18
1032972|NCT00704184|2508476|P1|STARTED|Double-Blind Treatment||20
1032973|NCT00704340|2508515|P2|NOT COMPLETED|Overall Study||2
1032974|NCT00704340|2508516|P1|NOT COMPLETED|Overall Study||2
1032975|NCT00704340|2508515|P2|COMPLETED|Overall Study||115
1032976|NCT00704340|2508516|P1|COMPLETED|Overall Study||118
1032977|NCT00704340|2508515|P2|STARTED|Overall Study||117
1032978|NCT00704340|2508516|P1|STARTED|Overall Study||120
1032979|NCT00704353|2508528|P2|NOT COMPLETED|Overall Study||114
1032980|NCT00704353|2508529|P1|NOT COMPLETED|Overall Study||98
1032981|NCT00704353|2508528|P2|COMPLETED|Overall Study||255
1032982|NCT00704353|2508529|P1|COMPLETED|Overall Study||268
1032983|NCT00704353|2508528|P2|STARTED|Overall Study||369
1032984|NCT00704353|2508529|P1|STARTED|Overall Study||366
1032985|NCT00704379|2508537|P2|NOT COMPLETED|Overall Study||7
1032986|NCT00704379|2508538|P1|NOT COMPLETED|Overall Study||7
1032987|NCT00704379|2508537|P2|COMPLETED|Overall Study||41
1032988|NCT00704379|2508538|P1|COMPLETED|Overall Study||39
1032989|NCT00704379|2508537|P2|STARTED|Overall Study||48
1032990|NCT00704379|2508538|P1|STARTED|Overall Study||46
1032991|NCT00704405|2508559|P5|NOT COMPLETED|Overall Study (C Population)||0
1032992|NCT00704405|2508560|P4|NOT COMPLETED|Overall Study (C Population)||1
1032993|NCT00704405|2508561|P3|NOT COMPLETED|Overall Study (C Population)||1
1032994|NCT00704405|2508562|P2|NOT COMPLETED|Overall Study (C Population)||3
1032995|NCT00704405|2508563|P1|NOT COMPLETED|Overall Study (C Population)||1
1032996|NCT00704405|2508559|P5|COMPLETED|Overall Study (C Population)||14
1032997|NCT00704405|2508560|P4|COMPLETED|Overall Study (C Population)||14
1032998|NCT00704405|2508561|P3|COMPLETED|Overall Study (C Population)||14
1032999|NCT00704405|2508562|P2|COMPLETED|Overall Study (C Population)||11
1033000|NCT00704405|2508563|P1|COMPLETED|Overall Study (C Population)||15
1033001|NCT00704405|2508559|P5|STARTED|Overall Study (C Population)||14
1033002|NCT00704405|2508560|P4|STARTED|Overall Study (C Population)||15
1033003|NCT00704405|2508561|P3|STARTED|Overall Study (C Population)||15
1033004|NCT00704405|2508562|P2|STARTED|Overall Study (C Population)||14
1033005|NCT00704405|2508563|P1|STARTED|Overall Study (C Population)||16
1033006|NCT00704405|2508559|P5|NOT COMPLETED|Overall Study (NC Population)||5
1033007|NCT00704405|2508560|P4|NOT COMPLETED|Overall Study (NC Population)||4
1033008|NCT00704405|2508561|P3|NOT COMPLETED|Overall Study (NC Population)||3
1033009|NCT00704405|2508562|P2|NOT COMPLETED|Overall Study (NC Population)||4
1033010|NCT00704405|2508563|P1|NOT COMPLETED|Overall Study (NC Population)||5
1033011|NCT00704405|2508559|P5|COMPLETED|Overall Study (NC Population)||37
1033012|NCT00704405|2508560|P4|COMPLETED|Overall Study (NC Population)||38
1033013|NCT00704405|2508561|P3|COMPLETED|Overall Study (NC Population)||38
1033014|NCT00704405|2508562|P2|COMPLETED|Overall Study (NC Population)||40
1033015|NCT00704405|2508563|P1|COMPLETED|Overall Study (NC Population)||37
1033016|NCT00704405|2508559|P5|STARTED|Overall Study (NC Population)||42
1033017|NCT00704405|2508560|P4|STARTED|Overall Study (NC Population)||42
1033018|NCT00704405|2508561|P3|STARTED|Overall Study (NC Population)||41
1033019|NCT00704405|2508562|P2|STARTED|Overall Study (NC Population)||44
1033020|NCT00704405|2508563|P1|STARTED|Overall Study (NC Population)||42
1033021|NCT00704418|2508593|P2|NOT COMPLETED|Overall Study||6
1033022|NCT00704418|2508594|P1|NOT COMPLETED|Overall Study||5
1033023|NCT00704418|2508593|P2|COMPLETED|Overall Study||72
1033024|NCT00704418|2508594|P1|COMPLETED|Overall Study||73
1033025|NCT00704418|2508593|P2|STARTED|Overall Study||78
1033026|NCT00704418|2508594|P1|STARTED|Overall Study||78
1033027|NCT00704522|2508604|P2|NOT COMPLETED|Overall Study||45
1033028|NCT00704522|2508605|P1|NOT COMPLETED|Overall Study||183
1033029|NCT00704522|2508604|P2|COMPLETED|Overall Study||75
1033030|NCT00704522|2508605|P1|COMPLETED|Overall Study||298
1033031|NCT00704522|2508604|P2|STARTED|Overall Study||120
1033032|NCT00704522|2508605|P1|STARTED|Overall Study||481
1033033|NCT00704535|2508612|P1|NOT COMPLETED|Overall Study||146
1033034|NCT00704535|2508612|P1|COMPLETED|Overall Study||3959
1033035|NCT00704535|2508612|P1|STARTED|Overall Study||4105
1033036|NCT00704717|2508623|P1|NOT COMPLETED|Overall Study||0
1033037|NCT00704717|2508623|P1|COMPLETED|Overall Study||185
1033038|NCT00704717|2508623|P1|STARTED|Overall Study||185
1033039|NCT00704730|2508629|P2|NOT COMPLETED|Overall Study||96
1033040|NCT00704730|2508630|P1|NOT COMPLETED|Overall Study||121
1033041|NCT00704730|2508629|P2|COMPLETED|Overall Study|Continuing study treatment at the time of data cut-off.|15
1033042|NCT00704730|2508630|P1|COMPLETED|Overall Study|Continuing study treatment at the time of data cut-off.|98
1033043|NCT00704730|2508629|P2|STARTED|Overall Study|Randomized|111
1033044|NCT00704730|2508630|P1|STARTED|Overall Study|Randomized|219
1033045|NCT00704769|2508646|P1|NOT COMPLETED|Overall Study||0
1033046|NCT00704769|2508646|P1|COMPLETED|Overall Study||591
1033047|NCT00704769|2508646|P1|STARTED|Overall Study||591
1033048|NCT00704808|2508651|P1|NOT COMPLETED|Overall Study||131
1033049|NCT00704808|2508651|P1|COMPLETED|Overall Study||49
1033050|NCT00704808|2508651|P1|STARTED|Overall Study||180
1033051|NCT00704847|2508657|P2|NOT COMPLETED|Overall Study||170
1033052|NCT00704847|2508658|P1|NOT COMPLETED|Overall Study||221
1033053|NCT00704847|2508657|P2|COMPLETED|Overall Study||339
1033054|NCT00704847|2508658|P1|COMPLETED|Overall Study||300
1033055|NCT00704847|2508657|P2|STARTED|Overall Study||509
1033056|NCT00704847|2508658|P1|STARTED|Overall Study||521
1033057|NCT00704912|2508669|P3|NOT COMPLETED|Overall Study||7
1033058|NCT00704912|2508670|P2|NOT COMPLETED|Overall Study||4
1033059|NCT00704912|2508671|P1|NOT COMPLETED|Overall Study||6
1033060|NCT00704912|2508669|P3|COMPLETED|Overall Study||43
1033061|NCT00704912|2508670|P2|COMPLETED|Overall Study||45
1033062|NCT00704912|2508671|P1|COMPLETED|Overall Study||44
1033063|NCT00704912|2508669|P3|STARTED|Overall Study||50
1033064|NCT00704912|2508670|P2|STARTED|Overall Study||49
1033065|NCT00704912|2508671|P1|STARTED|Overall Study||50
1033066|NCT00704938|2508690|P2|NOT COMPLETED|Overall Study||0
1033067|NCT00704938|2508691|P1|NOT COMPLETED|Overall Study||0
1033068|NCT00704938|2508690|P2|COMPLETED|Overall Study||1
1033069|NCT00704938|2508691|P1|COMPLETED|Overall Study||2
1033070|NCT00704938|2508690|P2|STARTED|Overall Study||1
1033071|NCT00704938|2508691|P1|STARTED|Overall Study||2
1033072|NCT00704964|2508699|P1|NOT COMPLETED|Overall Study||328
1033073|NCT00704964|2508699|P1|COMPLETED|Overall Study|Number of participants who completed therapy as scheduled.|418
1033074|NCT00704964|2508699|P1|STARTED|Overall Study|Number of participants who took at least one dose of study medication.|746
1033075|NCT00705003|2508707|P3|NOT COMPLETED|Treated||3
1033076|NCT00705003|2508708|P2|NOT COMPLETED|Treated||6
1033077|NCT00705003|2508709|P1|NOT COMPLETED|Treated||13
1033078|NCT00705003|2508707|P3|COMPLETED|Treated||30
1033079|NCT00705003|2508708|P2|COMPLETED|Treated||28
1033080|NCT00705003|2508709|P1|COMPLETED|Treated||54
1033081|NCT00705003|2508707|P3|STARTED|Treated||33
1033082|NCT00705003|2508708|P2|STARTED|Treated||34
1033083|NCT00705003|2508709|P1|STARTED|Treated||67
1033084|NCT00705003|2508707|P3|NOT COMPLETED|Enrolled||1
1033085|NCT00705003|2508708|P2|NOT COMPLETED|Enrolled||3
1033086|NCT00705003|2508709|P1|NOT COMPLETED|Enrolled||4
1033087|NCT00705003|2508707|P3|COMPLETED|Enrolled||33
1033088|NCT00705003|2508708|P2|COMPLETED|Enrolled||34
1033089|NCT00705003|2508709|P1|COMPLETED|Enrolled||67
1033090|NCT00705003|2508707|P3|STARTED|Enrolled||34
1033091|NCT00705003|2508708|P2|STARTED|Enrolled||37
1033092|NCT00705003|2508709|P1|STARTED|Enrolled||71
1033093|NCT00705016|2508732|P3|NOT COMPLETED|Overall Study||58
1033094|NCT00705016|2508733|P2|NOT COMPLETED|Overall Study||58
1033095|NCT00705016|2508734|P1|NOT COMPLETED|Overall Study||60
1033096|NCT00705016|2508732|P3|COMPLETED|Overall Study||4
1033097|NCT00705016|2508733|P2|COMPLETED|Overall Study||2
1033098|NCT00705016|2508734|P1|COMPLETED|Overall Study||2
1033099|NCT00705016|2508732|P3|STARTED|Overall Study||62
1033100|NCT00705016|2508733|P2|STARTED|Overall Study||60
1033101|NCT00705016|2508734|P1|STARTED|Overall Study||62
1033102|NCT00705081|2508762|P2|NOT COMPLETED|Overall Study||0
1033103|NCT00705081|2508763|P1|NOT COMPLETED|Overall Study||0
1033104|NCT00705081|2508762|P2|COMPLETED|Overall Study||198
1033105|NCT00705081|2508763|P1|COMPLETED|Overall Study||255
1033106|NCT00705081|2508762|P2|STARTED|Overall Study||198
1033107|NCT00705081|2508763|P1|STARTED|Overall Study||255
1033108|NCT00705107|2508773|P1|NOT COMPLETED|Overall Study||49
1033109|NCT00705107|2508773|P1|COMPLETED|Overall Study||218
1033110|NCT00705107|2508773|P1|STARTED|Overall Study||267
1033111|NCT00705146|2508780|P2|NOT COMPLETED|Overall Study||1
1033112|NCT00705146|2508781|P1|NOT COMPLETED|Overall Study||1
1033113|NCT00705146|2508780|P2|COMPLETED|Overall Study||23
1033114|NCT00705146|2508781|P1|COMPLETED|Overall Study||31
1033115|NCT00705146|2508780|P2|STARTED|Overall Study||24
1033116|NCT00705146|2508781|P1|STARTED|Overall Study||32
1033117|NCT00705159|2508793|P4|NOT COMPLETED|Overall Study||4
1033118|NCT00705159|2508794|P3|NOT COMPLETED|Overall Study||5
1033119|NCT00705159|2508795|P2|NOT COMPLETED|Overall Study||2
1033120|NCT00705159|2508796|P1|NOT COMPLETED|Overall Study||0
1033121|NCT00705159|2508793|P4|COMPLETED|Overall Study||30
1033122|NCT00705159|2508794|P3|COMPLETED|Overall Study||29
1033123|NCT00705159|2508795|P2|COMPLETED|Overall Study||33
1033124|NCT00705159|2508796|P1|COMPLETED|Overall Study||34
1033125|NCT00705159|2508793|P4|STARTED|Overall Study||34
1033126|NCT00705159|2508794|P3|STARTED|Overall Study||34
1033127|NCT00705159|2508795|P2|STARTED|Overall Study||35
1033128|NCT00705159|2508796|P1|STARTED|Overall Study||34
1033129|NCT00705224|2508814|P1|NOT COMPLETED|Overall Study||11
1033130|NCT00705224|2508814|P1|COMPLETED|Overall Study||239
1033131|NCT00705224|2508814|P1|STARTED|Overall Study||250
1033132|NCT00705250|2508826|P1|NOT COMPLETED|Overall Study||2
1033133|NCT00705250|2508826|P1|COMPLETED|Overall Study||34
1033134|NCT00705250|2508826|P1|STARTED|Overall Study||36
1033135|NCT00705263|2508830|P1|NOT COMPLETED|Overall Study||2
1033136|NCT00705263|2508830|P1|COMPLETED|Overall Study||108
1033137|NCT00705263|2508830|P1|STARTED|Overall Study|113 patients started the treatment; however, data were available for only 110 patients.|110
1033138|NCT00705289|2508834|P1|NOT COMPLETED|Overall Study||131
1033139|NCT00705289|2508834|P1|COMPLETED|Overall Study||597
1033140|NCT00705289|2508834|P1|STARTED|Overall Study||728
1033141|NCT00705341|2508860|P4|NOT COMPLETED|Phase 2: Trial||4
1033142|NCT00705341|2508861|P3|NOT COMPLETED|Phase 2: Trial||7
1033143|NCT00705341|2508862|P2|NOT COMPLETED|Phase 2: Trial||0
1033144|NCT00705341|2508863|P1|NOT COMPLETED|Phase 2: Trial||0
1033145|NCT00705341|2508860|P4|COMPLETED|Phase 2: Trial||28
1033146|NCT00705341|2508861|P3|COMPLETED|Phase 2: Trial||23
1033147|NCT00705341|2508862|P2|COMPLETED|Phase 2: Trial||0
1033148|NCT00705341|2508863|P1|COMPLETED|Phase 2: Trial||0
1033149|NCT00705341|2508860|P4|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|32
1033150|NCT00705341|2508861|P3|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|30
1033151|NCT00705341|2508862|P2|STARTED|Phase 2: Trial||0
1033152|NCT00705341|2508863|P1|STARTED|Phase 2: Trial||0
1033153|NCT00705341|2508860|P4|NOT COMPLETED|Phase 1:Control Challenge||0
1033154|NCT00705341|2508861|P3|NOT COMPLETED|Phase 1:Control Challenge||0
1033155|NCT00705341|2508862|P2|NOT COMPLETED|Phase 1:Control Challenge||0
1033156|NCT00705341|2508863|P1|NOT COMPLETED|Phase 1:Control Challenge||0
1033157|NCT00705341|2508860|P4|COMPLETED|Phase 1:Control Challenge||0
1033158|NCT00705341|2508861|P3|COMPLETED|Phase 1:Control Challenge||0
1033159|NCT00705341|2508862|P2|COMPLETED|Phase 1:Control Challenge|Nonasthmatic controls did not advance to phase 2 due to design of study|93
1033160|NCT00705341|2508863|P1|COMPLETED|Phase 1:Control Challenge|If participants in this group met criteria, they were randomized into phase 2|126
1033161|NCT00705341|2508860|P4|STARTED|Phase 1:Control Challenge||0
1033162|NCT00705341|2508861|P3|STARTED|Phase 1:Control Challenge||0
1033163|NCT00705341|2508862|P2|STARTED|Phase 1:Control Challenge||93
1033164|NCT00705341|2508863|P1|STARTED|Phase 1:Control Challenge||126
1033165|NCT00705367|2508873|P2|NOT COMPLETED|Long-term Extension Period||0
1033166|NCT00705367|2508874|P1|NOT COMPLETED|Long-term Extension Period||9
1033167|NCT00705367|2508873|P2|COMPLETED|Long-term Extension Period||0
1033168|NCT00705367|2508874|P1|COMPLETED|Long-term Extension Period||0
1033169|NCT00705367|2508873|P2|STARTED|Long-term Extension Period||0
1033170|NCT00705367|2508874|P1|STARTED|Long-term Extension Period||9
1033171|NCT00705367|2508873|P2|NOT COMPLETED|Short-term Period||0
1033172|NCT00705367|2508874|P1|NOT COMPLETED|Short-term Period||0
1033173|NCT00705367|2508873|P2|COMPLETED|Short-term Period||3
1033174|NCT00705367|2508874|P1|COMPLETED|Short-term Period||6
1033175|NCT00705367|2508873|P2|STARTED|Short-term Period||3
1033176|NCT00705367|2508874|P1|STARTED|Short-term Period||6
1033177|NCT00705406|2508901|P2|NOT COMPLETED|Overall Study||5
1033178|NCT00705406|2508902|P1|NOT COMPLETED|Overall Study||4
1033179|NCT00705406|2508901|P2|COMPLETED|Overall Study||197
1033180|NCT00705406|2508902|P1|COMPLETED|Overall Study||199
1033181|NCT00705406|2508901|P2|STARTED|Overall Study||202
1033182|NCT00705406|2508902|P1|STARTED|Overall Study||203
1033183|NCT00698646|2508927|P3|NOT COMPLETED|Overall Study||29
1033184|NCT00698646|2508928|P2|NOT COMPLETED|Overall Study||31
1033185|NCT00698646|2508929|P1|NOT COMPLETED|Overall Study||36
1033186|NCT00698646|2508927|P3|COMPLETED|Overall Study||99
1033187|NCT00698646|2508928|P2|COMPLETED|Overall Study||97
1033188|NCT00698646|2508929|P1|COMPLETED|Overall Study||92
1033189|NCT00698646|2508927|P3|STARTED|Overall Study||128
1033190|NCT00698646|2508928|P2|STARTED|Overall Study||128
1033191|NCT00698646|2508929|P1|STARTED|Overall Study||128
1033192|NCT00698685|2508952|P1|NOT COMPLETED|Overall Study||2
1033193|NCT00698685|2508952|P1|COMPLETED|Overall Study||12
1033194|NCT00698685|2508952|P1|STARTED|Overall Study||14
1033195|NCT00698815|2508960|P3|NOT COMPLETED|Overall Study||10
1033196|NCT00698815|2508961|P2|NOT COMPLETED|Overall Study||14
1033197|NCT00698815|2508962|P1|NOT COMPLETED|Overall Study||10
1033198|NCT00698815|2508960|P3|COMPLETED|Overall Study||31
1033199|NCT00698815|2508961|P2|COMPLETED|Overall Study||33
1033200|NCT00698815|2508962|P1|COMPLETED|Overall Study||32
1033201|NCT00698815|2508960|P3|STARTED|Overall Study||41
1033202|NCT00698815|2508961|P2|STARTED|Overall Study||47
1033203|NCT00698815|2508962|P1|STARTED|Overall Study||42
1033204|NCT00698841|2508979|P1|NOT COMPLETED|Overall Study||18
1033205|NCT00698841|2508979|P1|COMPLETED|Overall Study||33
1033206|NCT00698841|2508979|P1|STARTED|Overall Study||51
1033207|NCT00698867|2508990|P1|NOT COMPLETED|Overall Study||91
1033208|NCT00698867|2508990|P1|COMPLETED|Overall Study||27
1033209|NCT00698867|2508990|P1|Subjects With 4 Year Data|Overall Study||34
1033210|NCT00698867|2508990|P1|Subjects With 3 Year Data|Overall Study||35
1033211|NCT00698867|2508990|P1|Subjects With 2 Year Data|Overall Study||55
1033212|NCT00698867|2508990|P1|Subjects With 1 Year Data|Overall Study||68
1033213|NCT00698867|2508990|P1|STARTED|Overall Study||118
1033214|NCT00698932|2509002|P2|NOT COMPLETED|Overall Study||36
1033215|NCT00698932|2509003|P1|NOT COMPLETED|Overall Study||22
1033216|NCT00698932|2509002|P2|COMPLETED|Overall Study|Completed 24 Weeks of treatment|248
1033217|NCT00698932|2509003|P1|COMPLETED|Overall Study|Completed 24 Weeks of treatment|262
1033218|NCT00698932|2509002|P2|STARTED|Overall Study|Randomized and treated|284
1033219|NCT00698932|2509003|P1|STARTED|Overall Study|Randomized and treated|284
1033220|NCT00699140|2509019|P1|NOT COMPLETED|Overall Study||0
1033221|NCT00699140|2509019|P1|COMPLETED|Overall Study||18
1033222|NCT00699140|2509019|P1|STARTED|Overall Study||18
1033223|NCT00699153|2509033|P2|NOT COMPLETED|Overall Study||2
1033224|NCT00699153|2509034|P1|NOT COMPLETED|Overall Study||3
1033225|NCT00699153|2509033|P2|COMPLETED|Overall Study||200
1033226|NCT00699153|2509034|P1|COMPLETED|Overall Study||200
1033227|NCT00699153|2509033|P2|STARTED|Overall Study|Intent to treat population|202
1033228|NCT00699153|2509034|P1|STARTED|Overall Study|Intent to treat population|203
1033229|NCT00699192|2509049|P3|NOT COMPLETED|Overall Study||11
1033230|NCT00699192|2509050|P2|NOT COMPLETED|Overall Study||12
1033231|NCT00699192|2509051|P1|NOT COMPLETED|Overall Study||16
1033232|NCT00699192|2509049|P3|COMPLETED|Overall Study||261
1033233|NCT00699192|2509050|P2|COMPLETED|Overall Study||260
1033234|NCT00699192|2509051|P1|COMPLETED|Overall Study||259
1033235|NCT00699192|2509049|P3|STARTED|Overall Study||272
1033236|NCT00699192|2509050|P2|STARTED|Overall Study||272
1033237|NCT00699192|2509051|P1|STARTED|Overall Study||275
1033238|NCT00699283|2509073|P2|NOT COMPLETED|Overall Study||8
1033239|NCT00699283|2509074|P1|NOT COMPLETED|Overall Study||33
1033240|NCT00699283|2509073|P2|COMPLETED|Overall Study||7
1033241|NCT00699283|2509074|P1|COMPLETED|Overall Study||14
1033242|NCT00699283|2509073|P2|STARTED|Overall Study||15
1033243|NCT00699283|2509074|P1|STARTED|Overall Study||47
1033244|NCT00699335|2509079|P1|NOT COMPLETED|Overall Study||228
1033245|NCT00699335|2509079|P1|COMPLETED|Overall Study||5080
1033246|NCT00699335|2509079|P1|STARTED|Overall Study||5308
1033247|NCT00699348|2509110|P1|NOT COMPLETED|Overall Study||90
1033248|NCT00699348|2509110|P1|COMPLETED|Overall Study||261
1033249|NCT00699348|2509110|P1|STARTED|Overall Study||351
1033250|NCT00699374|2509121|P2|NOT COMPLETED|Overall Study||544
1033251|NCT00699374|2509122|P1|NOT COMPLETED|Overall Study||530
1033252|NCT00699374|2509121|P2|COMPLETED|Overall Study||0
1033253|NCT00699374|2509122|P1|COMPLETED|Overall Study||0
1033254|NCT00699374|2509121|P2|Treated|Overall Study||542
1033255|NCT00699374|2509122|P1|Treated|Overall Study||526
1033256|NCT00699374|2509121|P2|STARTED|Overall Study||544
1033257|NCT00699374|2509122|P1|STARTED|Overall Study||530
1033258|NCT00699400|2509137|P6|NOT COMPLETED|Overall Study||11
1033259|NCT00699400|2509138|P5|NOT COMPLETED|Overall Study||0
1033260|NCT00699400|2509139|P4|NOT COMPLETED|Overall Study||0
1033261|NCT00699400|2509140|P3|NOT COMPLETED|Overall Study||0
1033262|NCT00699400|2509141|P2|NOT COMPLETED|Overall Study||0
1033263|NCT00699400|2509142|P1|NOT COMPLETED|Overall Study||0
1033264|NCT00699400|2509137|P6|COMPLETED|Overall Study||0
1033265|NCT00699400|2509138|P5|COMPLETED|Overall Study||4
1033266|NCT00699400|2509139|P4|COMPLETED|Overall Study||6
1033267|NCT00699400|2509140|P3|COMPLETED|Overall Study||138
1033268|NCT00699400|2509141|P2|COMPLETED|Overall Study||3
1033269|NCT00699400|2509142|P1|COMPLETED|Overall Study||42
1033270|NCT00699400|2509137|P6|STARTED|Overall Study||11
1033271|NCT00699400|2509138|P5|STARTED|Overall Study||4
1033272|NCT00699400|2509139|P4|STARTED|Overall Study||6
1033273|NCT00699400|2509140|P3|STARTED|Overall Study||138
1033274|NCT00699400|2509141|P2|STARTED|Overall Study||3
1033275|NCT00699400|2509142|P1|STARTED|Overall Study||42
1033276|NCT00699413|2509176|P2|NOT COMPLETED|Overall Study||2
1033277|NCT00699413|2509177|P1|NOT COMPLETED|Overall Study||0
1033278|NCT00699413|2509176|P2|COMPLETED|Overall Study||2
1033279|NCT00699413|2509177|P1|COMPLETED|Overall Study||4
1033280|NCT00699413|2509176|P2|STARTED|Overall Study||4
1033281|NCT00699413|2509177|P1|STARTED|Overall Study||4
1033282|NCT00699491|2509189|P6|NOT COMPLETED|Overall Study||0
1033283|NCT00699491|2509190|P5|NOT COMPLETED|Overall Study||0
1033284|NCT00699491|2509191|P4|NOT COMPLETED|Overall Study||0
1033285|NCT00699491|2509192|P3|NOT COMPLETED|Overall Study||0
1033286|NCT00699491|2509193|P2|NOT COMPLETED|Overall Study||0
1033287|NCT00699491|2509194|P1|NOT COMPLETED|Overall Study||0
1033288|NCT00699491|2509189|P6|COMPLETED|Overall Study||22
1033289|NCT00699491|2509190|P5|COMPLETED|Overall Study||8
1033290|NCT00699491|2509191|P4|COMPLETED|Overall Study||6
1033291|NCT00699491|2509192|P3|COMPLETED|Overall Study||7
1033292|NCT00699491|2509193|P2|COMPLETED|Overall Study||2
1033293|NCT00699491|2509194|P1|COMPLETED|Overall Study||3
1033294|NCT00699491|2509189|P6|STARTED|Overall Study||22
1033295|NCT00699491|2509190|P5|STARTED|Overall Study||8
1033296|NCT00699491|2509191|P4|STARTED|Overall Study||6
1033297|NCT00699491|2509192|P3|STARTED|Overall Study||7
1033298|NCT00699491|2509193|P2|STARTED|Overall Study||2
1033299|NCT00699491|2509194|P1|STARTED|Overall Study||3
1033300|NCT00699582|2509216|P3|NOT COMPLETED|Overall Study||28
1033301|NCT00699582|2509217|P2|NOT COMPLETED|Overall Study||22
1033302|NCT00699582|2509218|P1|NOT COMPLETED|Overall Study||18
1033303|NCT00699582|2509216|P3|COMPLETED|Overall Study||93
1033304|NCT00699582|2509217|P2|COMPLETED|Overall Study||108
1033305|NCT00699582|2509218|P1|COMPLETED|Overall Study||120
1033306|NCT00699582|2509216|P3|STARTED|Overall Study||121
1033307|NCT00699582|2509217|P2|STARTED|Overall Study||130
1033308|NCT00699582|2509218|P1|STARTED|Overall Study||138
1033309|NCT00699608|2509232|P6|NOT COMPLETED|Third Intervention||0
1033310|NCT00699608|2509233|P5|NOT COMPLETED|Third Intervention||0
1033311|NCT00699608|2509234|P4|NOT COMPLETED|Third Intervention||0
1033312|NCT00699608|2509235|P3|NOT COMPLETED|Third Intervention||0
1033313|NCT00699608|2509236|P2|NOT COMPLETED|Third Intervention||0
1033314|NCT00699608|2509237|P1|NOT COMPLETED|Third Intervention||0
1033315|NCT00699608|2509232|P6|COMPLETED|Third Intervention||15
1033316|NCT00699608|2509233|P5|COMPLETED|Third Intervention||14
1033317|NCT00699608|2509234|P4|COMPLETED|Third Intervention||14
1033318|NCT00699608|2509235|P3|COMPLETED|Third Intervention||13
1033319|NCT00699608|2509236|P2|COMPLETED|Third Intervention||15
1033320|NCT00699608|2509237|P1|COMPLETED|Third Intervention||16
1033321|NCT00699608|2509232|P6|STARTED|Third Intervention||15
1033322|NCT00699608|2509233|P5|STARTED|Third Intervention||14
1033323|NCT00699608|2509234|P4|STARTED|Third Intervention||14
1033324|NCT00699608|2509235|P3|STARTED|Third Intervention||13
1033325|NCT00699608|2509236|P2|STARTED|Third Intervention||15
1033326|NCT00699608|2509237|P1|STARTED|Third Intervention||16
1033327|NCT00699608|2509232|P6|NOT COMPLETED|Second 4-14 Day Washout Period||0
1033328|NCT00699608|2509233|P5|NOT COMPLETED|Second 4-14 Day Washout Period||0
1033329|NCT00699608|2509234|P4|NOT COMPLETED|Second 4-14 Day Washout Period||0
1033330|NCT00699608|2509235|P3|NOT COMPLETED|Second 4-14 Day Washout Period||0
1033331|NCT00699608|2509236|P2|NOT COMPLETED|Second 4-14 Day Washout Period||0
1033332|NCT00699608|2509237|P1|NOT COMPLETED|Second 4-14 Day Washout Period||0
1033333|NCT00699608|2509232|P6|COMPLETED|Second 4-14 Day Washout Period||15
1033334|NCT00699608|2509233|P5|COMPLETED|Second 4-14 Day Washout Period||14
1033335|NCT00699608|2509234|P4|COMPLETED|Second 4-14 Day Washout Period||14
1033336|NCT00699608|2509235|P3|COMPLETED|Second 4-14 Day Washout Period||13
1033337|NCT00699608|2509236|P2|COMPLETED|Second 4-14 Day Washout Period||15
1033338|NCT00699608|2509237|P1|COMPLETED|Second 4-14 Day Washout Period||16
1033339|NCT00699608|2509232|P6|STARTED|Second 4-14 Day Washout Period||15
1033340|NCT00699608|2509233|P5|STARTED|Second 4-14 Day Washout Period||14
1033341|NCT00699608|2509234|P4|STARTED|Second 4-14 Day Washout Period||14
1033342|NCT00699608|2509235|P3|STARTED|Second 4-14 Day Washout Period||13
1033343|NCT00699608|2509236|P2|STARTED|Second 4-14 Day Washout Period||15
1033344|NCT00699608|2509237|P1|STARTED|Second 4-14 Day Washout Period||16
1033345|NCT00699608|2509232|P6|NOT COMPLETED|Second Intervention||0
1033346|NCT00699608|2509233|P5|NOT COMPLETED|Second Intervention||0
1033347|NCT00699608|2509234|P4|NOT COMPLETED|Second Intervention||1
1033348|NCT00699608|2509235|P3|NOT COMPLETED|Second Intervention||1
1033349|NCT00699608|2509236|P2|NOT COMPLETED|Second Intervention||0
1033350|NCT00699608|2509237|P1|NOT COMPLETED|Second Intervention||0
1033351|NCT00699608|2509232|P6|COMPLETED|Second Intervention||15
1033352|NCT00699608|2509233|P5|COMPLETED|Second Intervention||14
1033353|NCT00699608|2509234|P4|COMPLETED|Second Intervention||14
1033354|NCT00699608|2509235|P3|COMPLETED|Second Intervention||13
1033355|NCT00699608|2509236|P2|COMPLETED|Second Intervention||15
1033356|NCT00699608|2509237|P1|COMPLETED|Second Intervention||16
1033357|NCT00699608|2509232|P6|STARTED|Second Intervention||15
1033358|NCT00699608|2509233|P5|STARTED|Second Intervention||14
1033359|NCT00699608|2509234|P4|STARTED|Second Intervention||15
1033360|NCT00699608|2509235|P3|STARTED|Second Intervention||14
1033361|NCT00699608|2509236|P2|STARTED|Second Intervention||15
1033362|NCT00699608|2509237|P1|STARTED|Second Intervention||16
1033363|NCT00699608|2509232|P6|NOT COMPLETED|First 4-14 Day Washout Period||0
1033364|NCT00699608|2509233|P5|NOT COMPLETED|First 4-14 Day Washout Period||0
1033365|NCT00699608|2509234|P4|NOT COMPLETED|First 4-14 Day Washout Period||0
1033366|NCT00699608|2509235|P3|NOT COMPLETED|First 4-14 Day Washout Period||0
1033367|NCT00699608|2509236|P2|NOT COMPLETED|First 4-14 Day Washout Period||0
1033368|NCT00699608|2509237|P1|NOT COMPLETED|First 4-14 Day Washout Period||0
1033369|NCT00699608|2509232|P6|COMPLETED|First 4-14 Day Washout Period||15
1033370|NCT00699608|2509233|P5|COMPLETED|First 4-14 Day Washout Period||14
1033371|NCT00699608|2509234|P4|COMPLETED|First 4-14 Day Washout Period||15
1033372|NCT00699608|2509235|P3|COMPLETED|First 4-14 Day Washout Period||14
1033373|NCT00699608|2509236|P2|COMPLETED|First 4-14 Day Washout Period||15
1033374|NCT00699608|2509237|P1|COMPLETED|First 4-14 Day Washout Period||16
1033375|NCT00699608|2509232|P6|STARTED|First 4-14 Day Washout Period||15
1033376|NCT00699608|2509233|P5|STARTED|First 4-14 Day Washout Period||14
1033377|NCT00699608|2509234|P4|STARTED|First 4-14 Day Washout Period||15
1033378|NCT00699608|2509235|P3|STARTED|First 4-14 Day Washout Period||14
1033379|NCT00699608|2509236|P2|STARTED|First 4-14 Day Washout Period||15
1033380|NCT00699608|2509237|P1|STARTED|First 4-14 Day Washout Period||16
1033381|NCT00699608|2509232|P6|NOT COMPLETED|First Intervention||0
1033382|NCT00699608|2509233|P5|NOT COMPLETED|First Intervention||1
1033383|NCT00699608|2509234|P4|NOT COMPLETED|First Intervention||0
1033384|NCT00699608|2509235|P3|NOT COMPLETED|First Intervention||1
1033385|NCT00699608|2509236|P2|NOT COMPLETED|First Intervention||0
1033386|NCT00699608|2509237|P1|NOT COMPLETED|First Intervention||0
1033387|NCT00699608|2509232|P6|COMPLETED|First Intervention||15
1033388|NCT00699608|2509233|P5|COMPLETED|First Intervention||14
1033389|NCT00699608|2509234|P4|COMPLETED|First Intervention||15
1033390|NCT00699608|2509235|P3|COMPLETED|First Intervention||14
1033391|NCT00699608|2509236|P2|COMPLETED|First Intervention||15
1033392|NCT00699608|2509237|P1|COMPLETED|First Intervention||16
1033393|NCT00699608|2509232|P6|STARTED|First Intervention||15
1033394|NCT00699608|2509233|P5|STARTED|First Intervention||15
1033395|NCT00699608|2509234|P4|STARTED|First Intervention||15
1033396|NCT00699608|2509235|P3|STARTED|First Intervention||15
1033397|NCT00699608|2509236|P2|STARTED|First Intervention||15
1033398|NCT00699608|2509237|P1|STARTED|First Intervention||16
1033399|NCT00699660|2509289|P2|NOT COMPLETED|Overall Study||8
1033400|NCT00699660|2509290|P1|NOT COMPLETED|Overall Study||14
1033401|NCT00699660|2509289|P2|COMPLETED|Overall Study||208
1033402|NCT00699660|2509290|P1|COMPLETED|Overall Study||176
1033403|NCT00699660|2509289|P2|STARTED|Overall Study||216
1033404|NCT00699660|2509290|P1|STARTED|Overall Study||190
1033405|NCT00699699|2509302|P1|NOT COMPLETED|Overall Study||57
1033406|NCT00699699|2509302|P1|COMPLETED|Overall Study||1223
1033407|NCT00699699|2509302|P1|STARTED|Overall Study||1280
1033408|NCT00699751|2509311|P2|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||9
1033409|NCT00699751|2509312|P1|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||0
1033410|NCT00699751|2509311|P2|COMPLETED|Period 2:Switched From Placebo to Xofigo|Completed all 6 injections|17
1033411|NCT00699751|2509312|P1|COMPLETED|Period 2:Switched From Placebo to Xofigo||0
1033412|NCT00699751|2509311|P2|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
1033413|NCT00699751|2509312|P1|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
1033414|NCT00699751|2509311|P2|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||15
1033415|NCT00699751|2509312|P1|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
1033416|NCT00699751|2509311|P2|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||24
1033417|NCT00699751|2509312|P1|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||0
1033418|NCT00699751|2509311|P2|STARTED|Period 2:Switched From Placebo to Xofigo|Participants in the placebo group switched to Xofigo treatment|26
1033419|NCT00699751|2509312|P1|STARTED|Period 2:Switched From Placebo to Xofigo||0
1033420|NCT00699751|2509311|P2|NOT COMPLETED|Period 1: Without/Before Drug Switch||162
1033421|NCT00699751|2509312|P1|NOT COMPLETED|Period 1: Without/Before Drug Switch||225
1033422|NCT00699751|2509311|P2|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|145
1033423|NCT00699751|2509312|P1|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|389
1033424|NCT00699751|2509311|P2|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||12
1033425|NCT00699751|2509312|P1|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||49
1033426|NCT00699751|2509311|P2|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|168
1033427|NCT00699751|2509312|P1|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|407
1033428|NCT00699751|2509311|P2|Participants Received Treatment|Period 1: Without/Before Drug Switch||301
1033429|NCT00699751|2509312|P1|Participants Received Treatment|Period 1: Without/Before Drug Switch||600
1033430|NCT00699751|2509311|P2|STARTED|Period 1: Without/Before Drug Switch||307
1033431|NCT00699751|2509312|P1|STARTED|Period 1: Without/Before Drug Switch||614
1033432|NCT00705432|2509403|P6|NOT COMPLETED|Follow-up Period (Upto Week 72)||7
1033433|NCT00705432|2509404|P5|NOT COMPLETED|Follow-up Period (Upto Week 72)||6
1033434|NCT00705432|2509405|P4|NOT COMPLETED|Follow-up Period (Upto Week 72)||14
1033435|NCT00705432|2509406|P3|NOT COMPLETED|Follow-up Period (Upto Week 72)||25
1033436|NCT00705432|2509407|P2|NOT COMPLETED|Follow-up Period (Upto Week 72)||43
1033437|NCT00705432|2509408|P1|NOT COMPLETED|Follow-up Period (Upto Week 72)||71
1033438|NCT00705432|2509403|P6|COMPLETED|Follow-up Period (Upto Week 72)||46
1033439|NCT00705432|2509404|P5|COMPLETED|Follow-up Period (Upto Week 72)||38
1033440|NCT00705432|2509405|P4|COMPLETED|Follow-up Period (Upto Week 72)||28
1033441|NCT00705432|2509406|P3|COMPLETED|Follow-up Period (Upto Week 72)||266
1033442|NCT00705432|2509407|P2|COMPLETED|Follow-up Period (Upto Week 72)||252
1033443|NCT00705432|2509408|P1|COMPLETED|Follow-up Period (Upto Week 72)||207
1033444|NCT00705432|2509403|P6|STARTED|Follow-up Period (Upto Week 72)||53
1033445|NCT00705432|2509404|P5|STARTED|Follow-up Period (Upto Week 72)||44
1033446|NCT00705432|2509405|P4|STARTED|Follow-up Period (Upto Week 72)||42
1033447|NCT00705432|2509406|P3|STARTED|Follow-up Period (Upto Week 72)||291
1033448|NCT00705432|2509407|P2|STARTED|Follow-up Period (Upto Week 72)||295
1033449|NCT00705432|2509408|P1|STARTED|Follow-up Period (Upto Week 72)||278
1033450|NCT00705432|2509403|P6|NOT COMPLETED|Treatment Period||30
1033451|NCT00705432|2509404|P5|NOT COMPLETED|Treatment Period||28
1033452|NCT00705432|2509405|P4|NOT COMPLETED|Treatment Period||41
1033453|NCT00705432|2509406|P3|NOT COMPLETED|Treatment Period||121
1033454|NCT00705432|2509407|P2|NOT COMPLETED|Treatment Period||111
1033455|NCT00705432|2509408|P1|NOT COMPLETED|Treatment Period||163
1033456|NCT00705432|2509403|P6|COMPLETED|Treatment Period||25
1033457|NCT00705432|2509404|P5|COMPLETED|Treatment Period||24
1033458|NCT00705432|2509405|P4|COMPLETED|Treatment Period||11
1033459|NCT00705432|2509406|P3|COMPLETED|Treatment Period||190
1033460|NCT00705432|2509407|P2|COMPLETED|Treatment Period||205
1033461|NCT00705432|2509408|P1|COMPLETED|Treatment Period||148
1033462|NCT00705432|2509403|P6|STARTED BOCEPREVIR/PLACEBO|Treatment Period||55
1033463|NCT00705432|2509404|P5|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
1033464|NCT00705432|2509405|P4|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
1033465|NCT00705432|2509406|P3|STARTED BOCEPREVIR/PLACEBO|Treatment Period||299
1033466|NCT00705432|2509407|P2|STARTED BOCEPREVIR/PLACEBO|Treatment Period||303
1033467|NCT00705432|2509408|P1|STARTED BOCEPREVIR/PLACEBO|Treatment Period||297
1033468|NCT00705432|2509403|P6|STARTED|Treatment Period||55
1033469|NCT00705432|2509404|P5|STARTED|Treatment Period||52
1033470|NCT00705432|2509405|P4|STARTED|Treatment Period||52
1033471|NCT00705432|2509406|P3|STARTED|Treatment Period||311
1033472|NCT00705432|2509407|P2|STARTED|Treatment Period||316
1033473|NCT00705432|2509408|P1|STARTED|Treatment Period||311
1033474|NCT00705523|2509445|P2|NOT COMPLETED|Overall Study||3
1033475|NCT00705523|2509446|P1|NOT COMPLETED|Overall Study||2
1033476|NCT00705523|2509445|P2|COMPLETED|Overall Study||18
1033477|NCT00705523|2509446|P1|COMPLETED|Overall Study||17
1033478|NCT00705523|2509445|P2|STARTED|Overall Study||21
1033479|NCT00705523|2509446|P1|STARTED|Overall Study||19
1033480|NCT00705536|2509456|P4|NOT COMPLETED|Completed Study||0
1033481|NCT00705536|2509457|P3|NOT COMPLETED|Completed Study||0
1033482|NCT00705536|2509458|P2|NOT COMPLETED|Completed Study||0
1033483|NCT00705536|2509459|P1|NOT COMPLETED|Completed Study||0
1033484|NCT00705536|2509456|P4|COMPLETED|Completed Study||6
1033485|NCT00705536|2509457|P3|COMPLETED|Completed Study||7
1033486|NCT00705536|2509458|P2|COMPLETED|Completed Study||6
1033487|NCT00705536|2509459|P1|COMPLETED|Completed Study||6
1033488|NCT00705536|2509456|P4|STARTED|Completed Study||6
1033489|NCT00705536|2509457|P3|STARTED|Completed Study||7
1033490|NCT00705536|2509458|P2|STARTED|Completed Study||6
1033491|NCT00705536|2509459|P1|STARTED|Completed Study||6
1033492|NCT00705536|2509456|P4|NOT COMPLETED|Start Period 2||0
1033493|NCT00705536|2509457|P3|NOT COMPLETED|Start Period 2||0
1033494|NCT00705536|2509458|P2|NOT COMPLETED|Start Period 2||0
1033495|NCT00705536|2509459|P1|NOT COMPLETED|Start Period 2||0
1033496|NCT00705536|2509456|P4|COMPLETED|Start Period 2||6
1033497|NCT00705536|2509457|P3|COMPLETED|Start Period 2||7
1033498|NCT00705536|2509458|P2|COMPLETED|Start Period 2||6
1033499|NCT00705536|2509459|P1|COMPLETED|Start Period 2||6
1033500|NCT00705536|2509456|P4|STARTED|Start Period 2||6
1033501|NCT00705536|2509457|P3|STARTED|Start Period 2||7
1033502|NCT00705536|2509458|P2|STARTED|Start Period 2||6
1033503|NCT00705536|2509459|P1|STARTED|Start Period 2||6
1033504|NCT00705536|2509456|P4|NOT COMPLETED|Washout Period of at Least 6 Days||0
1033505|NCT00705536|2509457|P3|NOT COMPLETED|Washout Period of at Least 6 Days||0
1033506|NCT00705536|2509458|P2|NOT COMPLETED|Washout Period of at Least 6 Days||0
1033507|NCT00705536|2509459|P1|NOT COMPLETED|Washout Period of at Least 6 Days||0
1033508|NCT00705536|2509456|P4|COMPLETED|Washout Period of at Least 6 Days||6
1033509|NCT00705536|2509457|P3|COMPLETED|Washout Period of at Least 6 Days||7
1033510|NCT00705536|2509458|P2|COMPLETED|Washout Period of at Least 6 Days||6
1033511|NCT00705536|2509459|P1|COMPLETED|Washout Period of at Least 6 Days||6
1033512|NCT00705536|2509456|P4|STARTED|Washout Period of at Least 6 Days||6
1033513|NCT00705536|2509457|P3|STARTED|Washout Period of at Least 6 Days||7
1033514|NCT00705536|2509458|P2|STARTED|Washout Period of at Least 6 Days||6
1033515|NCT00705536|2509459|P1|STARTED|Washout Period of at Least 6 Days||6
1033516|NCT00705536|2509456|P4|NOT COMPLETED|Start Period 1||1
1033517|NCT00705536|2509457|P3|NOT COMPLETED|Start Period 1||0
1033518|NCT00705536|2509458|P2|NOT COMPLETED|Start Period 1||0
1033519|NCT00705536|2509459|P1|NOT COMPLETED|Start Period 1||0
1033520|NCT00705536|2509456|P4|COMPLETED|Start Period 1||6
1033521|NCT00705536|2509457|P3|COMPLETED|Start Period 1||7
1033522|NCT00705536|2509458|P2|COMPLETED|Start Period 1||6
1033523|NCT00705536|2509459|P1|COMPLETED|Start Period 1||6
1033524|NCT00705536|2509456|P4|Received at Least 1 Dose of Study Drug|Start Period 1||7
1033525|NCT00705536|2509457|P3|Received at Least 1 Dose of Study Drug|Start Period 1||7
1033526|NCT00705536|2509458|P2|Received at Least 1 Dose of Study Drug|Start Period 1||6
1033527|NCT00705536|2509459|P1|Received at Least 1 Dose of Study Drug|Start Period 1||6
1033528|NCT00705536|2509456|P4|STARTED|Start Period 1||7
1033529|NCT00705536|2509457|P3|STARTED|Start Period 1||7
1033530|NCT00705536|2509458|P2|STARTED|Start Period 1||6
1033531|NCT00705536|2509459|P1|STARTED|Start Period 1||6
1033532|NCT00705575|2509520|P2|NOT COMPLETED|Overall Study||46
1033533|NCT00705575|2509521|P1|NOT COMPLETED|Overall Study||23
1033534|NCT00705575|2509520|P2|COMPLETED|Overall Study||293
1033535|NCT00705575|2509521|P1|COMPLETED|Overall Study||326
1033536|NCT00705575|2509520|P2|STARTED|Overall Study||339
1033537|NCT00705575|2509521|P1|STARTED|Overall Study||349
1033538|NCT00705614|2509535|P2|NOT COMPLETED|Switch to Remicade||49
1033539|NCT00705614|2509536|P1|NOT COMPLETED|Switch to Remicade||0
1033540|NCT00705614|2509535|P2|COMPLETED|Switch to Remicade||249
1033541|NCT00705614|2509536|P1|COMPLETED|Switch to Remicade||0
1033542|NCT00705614|2509535|P2|STARTED|Switch to Remicade||298
1033543|NCT00705614|2509536|P1|STARTED|Switch to Remicade||0
1033544|NCT00705614|2509535|P2|NOT COMPLETED|Initial Intervention||321
1033545|NCT00705614|2509536|P1|NOT COMPLETED|Initial Intervention||518
1033546|NCT00705614|2509535|P2|COMPLETED|Initial Intervention||800
1033547|NCT00705614|2509536|P1|COMPLETED|Initial Intervention||1023
1033548|NCT00705614|2509535|P2|STARTED|Initial Intervention||1121
1033549|NCT00705614|2509536|P1|STARTED|Initial Intervention||1541
1033550|NCT00705653|2509583|P1|NOT COMPLETED|Overall Study||0
1033551|NCT00705653|2509583|P1|COMPLETED|Overall Study||46
1033552|NCT00705653|2509583|P1|STARTED|Overall Study||46
1033553|NCT00705666|2509588|P1|NOT COMPLETED|Overall Study||339
1033554|NCT00705666|2509588|P1|COMPLETED|Overall Study||450
1033555|NCT00705666|2509588|P1|STARTED|Overall Study||789
1033556|NCT00705679|2509597|P5|NOT COMPLETED|Overall Study||69
1033557|NCT00705679|2509598|P4|NOT COMPLETED|Overall Study||80
1033558|NCT00705679|2509599|P3|NOT COMPLETED|Overall Study||115
1033559|NCT00705679|2509600|P2|NOT COMPLETED|Overall Study||139
1033560|NCT00705679|2509601|P1|NOT COMPLETED|Overall Study||65
1033561|NCT00705679|2509597|P5|COMPLETED|Overall Study||934
1033562|NCT00705679|2509598|P4|COMPLETED|Overall Study||927
1033563|NCT00705679|2509599|P3|COMPLETED|Overall Study||894
1033564|NCT00705679|2509600|P2|COMPLETED|Overall Study||864
1033565|NCT00705679|2509601|P1|COMPLETED|Overall Study||942
1033566|NCT00705679|2509597|P5|STARTED|Overall Study||1003
1033567|NCT00705679|2509598|P4|STARTED|Overall Study||1007
1033568|NCT00705679|2509599|P3|STARTED|Overall Study||1009
1033569|NCT00705679|2509600|P2|STARTED|Overall Study||1003
1033570|NCT00705679|2509601|P1|STARTED|Overall Study||1007
1033571|NCT00705718|2509638|P2|NOT COMPLETED|Overall Study||22
1033572|NCT00705718|2509639|P1|NOT COMPLETED|Overall Study||7
1033573|NCT00705718|2509638|P2|COMPLETED|Overall Study||128
1033574|NCT00705718|2509639|P1|COMPLETED|Overall Study||37
1033575|NCT00705718|2509638|P2|12 Month Follow up|Overall Study|4 Deaths, 12 Subjects Not due for next visit, 4 Subjects Missed Visit|128
1033576|NCT00705718|2509639|P1|12 Month Follow up|Overall Study|2 Deaths|37
1033577|NCT00705718|2509638|P2|6 Month Follow up|Overall Study|2 Deaths, 5 Subjects Missed Visit|143
1033578|NCT00705718|2509639|P1|6 Month Follow up|Overall Study|3 Deaths|40
1033579|NCT00705718|2509638|P2|1 Month Follow up|Overall Study|1 Subject Missed Visit|149
1033580|NCT00705718|2509639|P1|1 Month Follow up|Overall Study|1 Death|43
1033581|NCT00705718|2509638|P2|STARTED|Overall Study||150
1033582|NCT00705718|2509639|P1|STARTED|Overall Study||44
1033583|NCT00705757|2509658|P3|NOT COMPLETED|Overall Study||11
1033584|NCT00705757|2509659|P2|NOT COMPLETED|Overall Study||8
1033585|NCT00705757|2509660|P1|NOT COMPLETED|Overall Study||13
1033586|NCT00705757|2509658|P3|COMPLETED|Overall Study||17
1033587|NCT00705757|2509659|P2|COMPLETED|Overall Study||21
1033588|NCT00705757|2509660|P1|COMPLETED|Overall Study||19
1033589|NCT00705757|2509658|P3|STARTED|Overall Study||28
1033590|NCT00705757|2509659|P2|STARTED|Overall Study||29
1033591|NCT00705757|2509660|P1|STARTED|Overall Study||32
1033592|NCT00708019|2509670|P2|NOT COMPLETED|Overall Study||15
1033593|NCT00708019|2509671|P1|NOT COMPLETED|Overall Study||15
1033594|NCT00708019|2509670|P2|COMPLETED|Overall Study||78
1033595|NCT00708019|2509671|P1|COMPLETED|Overall Study||77
1033596|NCT00708019|2509670|P2|STARTED|Overall Study||93
1033597|NCT00708019|2509671|P1|STARTED|Overall Study||92
1033598|NCT00708032|2509681|P2|NOT COMPLETED|Overall Study||16
1033599|NCT00708032|2509682|P1|NOT COMPLETED|Overall Study||10
1033600|NCT00708032|2509681|P2|COMPLETED|Overall Study||22
1033601|NCT00708032|2509682|P1|COMPLETED|Overall Study||26
1033602|NCT00708032|2509681|P2|STARTED|Overall Study||38
1033603|NCT00708032|2509682|P1|STARTED|Overall Study||36
1033604|NCT00708071|2509696|P1|NOT COMPLETED|Overall Study||0
1033605|NCT00708071|2509696|P1|COMPLETED|Overall Study||45
1033606|NCT00708071|2509696|P1|STARTED|Overall Study|Randomized and treated|45
1033682|NCT00708110|2509812|P4|NOT COMPLETED|Overall Study||0
1033683|NCT00708110|2509813|P3|NOT COMPLETED|Overall Study||0
1033684|NCT00708110|2509814|P2|NOT COMPLETED|Overall Study||0
1033685|NCT00708110|2509815|P1|NOT COMPLETED|Overall Study||0
1033686|NCT00708110|2509812|P4|COMPLETED|Overall Study||10
1033687|NCT00708110|2509813|P3|COMPLETED|Overall Study||9
1033688|NCT00708110|2509814|P2|COMPLETED|Overall Study||9
1033689|NCT00708110|2509815|P1|COMPLETED|Overall Study||7
1033690|NCT00708110|2509812|P4|STARTED|Overall Study||10
1033691|NCT00708110|2509813|P3|STARTED|Overall Study||9
1033692|NCT00708110|2509814|P2|STARTED|Overall Study||9
1033693|NCT00708110|2509815|P1|STARTED|Overall Study||7
1033769|NCT00708162|2509947|P2|NOT COMPLETED|Open-Label Phase||30
1033770|NCT00708162|2509948|P1|NOT COMPLETED|Open-Label Phase||44
1033771|NCT00708162|2509947|P2|COMPLETED|Open-Label Phase||121
1033772|NCT00708162|2509948|P1|COMPLETED|Open-Label Phase||152
1033773|NCT00708162|2509947|P2|STARTED|Open-Label Phase|58 participants completing the Randomized Phase did not continue to the Open-Label Phase.|151
1033774|NCT00708162|2509948|P1|STARTED|Open-Label Phase|9 participants completing the Randomized Phase did not continue to the Open-Label Phase.|196
1033775|NCT00708162|2509947|P2|NOT COMPLETED|Randomized Phase||154
1033776|NCT00708162|2509948|P1|NOT COMPLETED|Randomized Phase||156
1033777|NCT00708162|2509947|P2|COMPLETED|Randomized Phase||209
1033778|NCT00708162|2509948|P1|COMPLETED|Randomized Phase||205
1033779|NCT00708162|2509947|P2|Randomized and Treated|Randomized Phase||358
1033780|NCT00708162|2509948|P1|Randomized and Treated|Randomized Phase||354
1033781|NCT00708162|2509947|P2|STARTED|Randomized Phase||363
1033782|NCT00708162|2509948|P1|STARTED|Randomized Phase||361
1033783|NCT00708175|2509991|P2|NOT COMPLETED|Overall Study||21
1033784|NCT00708175|2509992|P1|NOT COMPLETED|Overall Study||18
1033785|NCT00708175|2509991|P2|COMPLETED|Overall Study||57
1033786|NCT00708175|2509992|P1|COMPLETED|Overall Study||60
1033787|NCT00708175|2509991|P2|STARTED|Overall Study||78
1033788|NCT00708175|2509992|P1|STARTED|Overall Study||78
1033789|NCT00708201|2510008|P2|NOT COMPLETED|Overall Study||6
1033790|NCT00708201|2510009|P1|NOT COMPLETED|Overall Study||7
1033791|NCT00708201|2510008|P2|COMPLETED|Overall Study||137
1033792|NCT00708201|2510009|P1|COMPLETED|Overall Study||130
1033793|NCT00708201|2510008|P2|Received at Least 1 Dose of Study Drug|Overall Study||137
1033794|NCT00708201|2510009|P1|Received at Least 1 Dose of Study Drug|Overall Study||130
1033795|NCT00708201|2510008|P2|STARTED|Overall Study||143
1033796|NCT00708201|2510009|P1|STARTED|Overall Study||137
1033797|NCT00708214|2510034|P3|NOT COMPLETED|Overall Study||8
1033798|NCT00708214|2510035|P2|NOT COMPLETED|Overall Study||13
1033799|NCT00708214|2510036|P1|NOT COMPLETED|Overall Study||7
1033800|NCT00708214|2510034|P3|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
1033801|NCT00708214|2510035|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
1033802|NCT00708214|2510036|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
1033803|NCT00708214|2510034|P3|STARTED|Overall Study||8
1033804|NCT00708214|2510035|P2|STARTED|Overall Study||13
1033805|NCT00708214|2510036|P1|STARTED|Overall Study||7
1033854|NCT00708422|2510114|P2|NOT COMPLETED|Overall Study||1
1033855|NCT00708422|2510115|P1|NOT COMPLETED|Overall Study||4
1033856|NCT00708422|2510114|P2|COMPLETED|Overall Study||114
1033857|NCT00708422|2510115|P1|COMPLETED|Overall Study||112
1033858|NCT00708422|2510114|P2|STARTED|Overall Study||115
1033859|NCT00708422|2510115|P1|STARTED|Overall Study||116
1033860|NCT00708435|2510125|P2|NOT COMPLETED|Overall Study||17
1033861|NCT00708435|2510126|P1|NOT COMPLETED|Overall Study||25
1033862|NCT00708435|2510125|P2|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|92
1033863|NCT00708435|2510126|P1|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|82
1033864|NCT00708435|2510125|P2|STARTED|Overall Study||109
1033865|NCT00708435|2510126|P1|STARTED|Overall Study||107
1033866|NCT00708461|2510153|P2|NOT COMPLETED|Overall Study||200
1033867|NCT00708461|2510154|P1|NOT COMPLETED|Overall Study||141
1033868|NCT00708461|2510153|P2|COMPLETED|Overall Study||795
1033869|NCT00708461|2510154|P1|COMPLETED|Overall Study||611
1033870|NCT00708461|2510153|P2|STARTED|Overall Study||995
1033871|NCT00708461|2510154|P1|STARTED|Overall Study||752
1033872|NCT00708500|2510163|P3|NOT COMPLETED|FOLLOWUP||15
1033873|NCT00708500|2510164|P2|NOT COMPLETED|FOLLOWUP||15
1033874|NCT00708500|2510165|P1|NOT COMPLETED|FOLLOWUP||40
1033875|NCT00708500|2510163|P3|COMPLETED|FOLLOWUP||143
1033876|NCT00708500|2510164|P2|COMPLETED|FOLLOWUP||136
1033877|NCT00708500|2510165|P1|COMPLETED|FOLLOWUP||37
1033878|NCT00708500|2510163|P3|STARTED|FOLLOWUP||158
1033879|NCT00708500|2510164|P2|STARTED|FOLLOWUP||151
1033880|NCT00708500|2510165|P1|STARTED|FOLLOWUP||77
1033881|NCT00708500|2510163|P3|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
1033882|NCT00708500|2510164|P2|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||52
1033883|NCT00708500|2510165|P1|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
1033884|NCT00708500|2510163|P3|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||105
1033885|NCT00708500|2510164|P2|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||104
1033886|NCT00708500|2510165|P1|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||23
1033887|NCT00708500|2510163|P3|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||160
1033888|NCT00708500|2510164|P2|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||156
1033889|NCT00708500|2510165|P1|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||78
1033890|NCT00708500|2510163|P3|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
1033891|NCT00708500|2510164|P2|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||6
1033892|NCT00708500|2510165|P1|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
1033893|NCT00708500|2510163|P3|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||160
1033894|NCT00708500|2510164|P2|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||156
1033895|NCT00708500|2510165|P1|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||78
1033896|NCT00708500|2510163|P3|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||161
1033897|NCT00708500|2510164|P2|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
1033898|NCT00708500|2510165|P1|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
1033899|NCT00708500|2510163|P3|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
1033900|NCT00708500|2510164|P2|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
1033901|NCT00708500|2510165|P1|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
1033902|NCT00708526|2510184|P2|NOT COMPLETED|Return of Cognitive Function||0
1033903|NCT00708526|2510185|P1|NOT COMPLETED|Return of Cognitive Function||0
1033904|NCT00708526|2510184|P2|COMPLETED|Return of Cognitive Function||11
1033905|NCT00708526|2510185|P1|COMPLETED|Return of Cognitive Function||11
1033906|NCT00708526|2510184|P2|STARTED|Return of Cognitive Function||11
1033907|NCT00708526|2510185|P1|STARTED|Return of Cognitive Function||11
1033908|NCT00708526|2510184|P2|NOT COMPLETED|Wake up After Anesthesia||0
1033909|NCT00708526|2510185|P1|NOT COMPLETED|Wake up After Anesthesia||0
1033910|NCT00708526|2510184|P2|COMPLETED|Wake up After Anesthesia||11
1033911|NCT00708526|2510185|P1|COMPLETED|Wake up After Anesthesia||11
1033912|NCT00708526|2510184|P2|STARTED|Wake up After Anesthesia||11
1033913|NCT00708526|2510185|P1|STARTED|Wake up After Anesthesia||11
1033914|NCT00708643|2510195|P2|NOT COMPLETED|Overall Study||1
1033915|NCT00708643|2510196|P1|NOT COMPLETED|Overall Study||0
1033916|NCT00708643|2510195|P2|COMPLETED|Overall Study||39
1033917|NCT00708643|2510196|P1|COMPLETED|Overall Study||40
1033918|NCT00708643|2510195|P2|STARTED|Overall Study||40
1033919|NCT00708643|2510196|P1|STARTED|Overall Study||40
1033920|NCT00708682|2510212|P1|NOT COMPLETED|Toddler Dose||8
1033921|NCT00708682|2510212|P1|COMPLETED|Toddler Dose||183
1033922|NCT00708682|2510212|P1|STARTED|Toddler Dose||191
1033923|NCT00708682|2510212|P1|NOT COMPLETED|After Infant Series||1
1033924|NCT00708682|2510212|P1|COMPLETED|After Infant Series||191
1033925|NCT00708682|2510212|P1|STARTED|After Infant Series||192
1033926|NCT00708682|2510212|P1|NOT COMPLETED|Infant Series||33
1033927|NCT00708682|2510212|P1|COMPLETED|Infant Series||192
1033928|NCT00708682|2510212|P1|Vaccinated Dose 3|Infant Series||194
1033929|NCT00708682|2510212|P1|Vaccinated Dose 2|Infant Series||214
1033930|NCT00708682|2510212|P1|Vaccinated Dose 1|Infant Series||223
1033931|NCT00708682|2510212|P1|STARTED|Infant Series||225
1033932|NCT00708708|2510231|P1|NOT COMPLETED|Overall Study||742
1033933|NCT00708708|2510231|P1|COMPLETED|Overall Study|Included participants completed total observation period and participants with planned study end.|213
1033934|NCT00708708|2510231|P1|STARTED|Overall Study||955
1033935|NCT00708721|2510279|P4|NOT COMPLETED|Overall Study||0
1033936|NCT00708721|2510280|P3|NOT COMPLETED|Overall Study||0
1033937|NCT00708721|2510281|P2|NOT COMPLETED|Overall Study||0
1033938|NCT00708721|2510282|P1|NOT COMPLETED|Overall Study||0
1033939|NCT00708721|2510279|P4|COMPLETED|Overall Study||2
1033940|NCT00708721|2510280|P3|COMPLETED|Overall Study||3
1033941|NCT00708721|2510281|P2|COMPLETED|Overall Study||4
1033942|NCT00708721|2510282|P1|COMPLETED|Overall Study||2
1033943|NCT00708721|2510279|P4|STARTED|Overall Study||2
1033944|NCT00708721|2510280|P3|STARTED|Overall Study||3
1033945|NCT00708721|2510281|P2|STARTED|Overall Study||4
1033946|NCT00708721|2510282|P1|STARTED|Overall Study||2
1033947|NCT00708734|2510295|P1|NOT COMPLETED|Overall Study||7
1033948|NCT00708734|2510295|P1|COMPLETED|Overall Study|Ten subjects enrolled, three completed the intervention and all follow up sessions.|3
1033949|NCT00708734|2510295|P1|STARTED|Overall Study|94 subjects were screened, 45 did not meet criteria, and 39 declined participation after screening.|10
1033950|NCT00708851|2510299|P1|NOT COMPLETED|Overall Study||0
1033951|NCT00708851|2510299|P1|COMPLETED|Overall Study||12
1033952|NCT00708851|2510299|P1|STARTED|Overall Study||12
1033953|NCT00708877|2510307|P1|NOT COMPLETED|Overall Study||0
1033954|NCT00708877|2510307|P1|COMPLETED|Overall Study||5
1033955|NCT00708877|2510307|P1|STARTED|Overall Study||5
1033956|NCT00708942|2510316|P5|NOT COMPLETED|Overall Study||1
1033957|NCT00708942|2510317|P4|NOT COMPLETED|Overall Study||0
1033958|NCT00708942|2510318|P3|NOT COMPLETED|Overall Study||2
1033959|NCT00708942|2510319|P2|NOT COMPLETED|Overall Study||1
1033960|NCT00708942|2510320|P1|NOT COMPLETED|Overall Study||7
1033961|NCT00708942|2510316|P5|COMPLETED|Overall Study||2
1033962|NCT00708942|2510317|P4|COMPLETED|Overall Study||10
1033963|NCT00708942|2510318|P3|COMPLETED|Overall Study||9
1033964|NCT00708942|2510319|P2|COMPLETED|Overall Study||11
1033965|NCT00708942|2510320|P1|COMPLETED|Overall Study||40
1033966|NCT00708942|2510316|P5|STARTED|Overall Study||3
1033967|NCT00708942|2510317|P4|STARTED|Overall Study||10
1033968|NCT00708942|2510318|P3|STARTED|Overall Study||11
1033969|NCT00708942|2510319|P2|STARTED|Overall Study||12
1033970|NCT00708942|2510320|P1|STARTED|Overall Study||47
1033971|NCT00709059|2510342|P1|NOT COMPLETED|Overall Study||94
1033972|NCT00709059|2510342|P1|COMPLETED|Overall Study||444
1033973|NCT00709059|2510342|P1|STARTED|Overall Study||538
1033974|NCT00709098|2510349|P3|NOT COMPLETED|Open-label Period||14
1033975|NCT00709098|2510350|P2|NOT COMPLETED|Open-label Period||0
1033976|NCT00709098|2510351|P1|NOT COMPLETED|Open-label Period||0
1033977|NCT00709098|2510349|P3|COMPLETED|Open-label Period||18
1033978|NCT00709098|2510350|P2|COMPLETED|Open-label Period||0
1033979|NCT00709098|2510351|P1|COMPLETED|Open-label Period||0
1033980|NCT00709098|2510349|P3|STARTED|Open-label Period|The open-label period was only made available to patients in US centers|32
1033981|NCT00709098|2510350|P2|STARTED|Open-label Period||0
1033982|NCT00709098|2510351|P1|STARTED|Open-label Period||0
1033983|NCT00709098|2510349|P3|NOT COMPLETED|Double-blind Period||0
1033984|NCT00709098|2510350|P2|NOT COMPLETED|Double-blind Period||8
1033985|NCT00709098|2510351|P1|NOT COMPLETED|Double-blind Period||6
1033986|NCT00709098|2510349|P3|COMPLETED|Double-blind Period||0
1033987|NCT00709098|2510350|P2|COMPLETED|Double-blind Period||16
1033988|NCT00709098|2510351|P1|COMPLETED|Double-blind Period||19
1033989|NCT00709098|2510349|P3|STARTED|Double-blind Period||0
1033990|NCT00709098|2510350|P2|STARTED|Double-blind Period||24
1033991|NCT00709098|2510351|P1|STARTED|Double-blind Period||25
1033992|NCT00709111|2510370|P1|NOT COMPLETED|Overall Study||2
1033993|NCT00709111|2510370|P1|COMPLETED|Overall Study||32
1033994|NCT00709111|2510370|P1|Week 22/24|Overall Study||33
1033995|NCT00709111|2510370|P1|STARTED|Overall Study||34
1033996|NCT00709124|2510410|P2|NOT COMPLETED|Overall Study||1
1033997|NCT00709124|2510411|P1|NOT COMPLETED|Overall Study||4
1033998|NCT00709124|2510410|P2|COMPLETED|Overall Study||17
1033999|NCT00709124|2510411|P1|COMPLETED|Overall Study||12
1034000|NCT00709124|2510410|P2|STARTED|Overall Study||18
1034001|NCT00709124|2510411|P1|STARTED|Overall Study||16
1034002|NCT00709228|2510417|P1|NOT COMPLETED|Overall Study||332
1034003|NCT00709228|2510417|P1|COMPLETED|Overall Study|Number completed is defined as participants who completed the follow-up period.|164
1034004|NCT00709228|2510417|P1|STARTED|Overall Study||496
1034005|NCT00709319|2510421|P1|NOT COMPLETED|Overall Study||6
1034006|NCT00709319|2510421|P1|COMPLETED|Overall Study||81
1034007|NCT00709319|2510421|P1|STARTED|Overall Study||87
1034008|NCT00709592|2510431|P2|NOT COMPLETED|Overall Study||1
1034009|NCT00709592|2510432|P1|NOT COMPLETED|Overall Study||0
1034010|NCT00709592|2510431|P2|COMPLETED|Overall Study||22
1034011|NCT00709592|2510432|P1|COMPLETED|Overall Study||19
1034012|NCT00709592|2510431|P2|STARTED|Overall Study||23
1034013|NCT00709592|2510432|P1|STARTED|Overall Study||19
1034014|NCT00709618|2510452|P1|NOT COMPLETED|Overall Study||30
1034015|NCT00709618|2510452|P1|COMPLETED|Overall Study||14
1034016|NCT00709618|2510452|P1|STARTED|Overall Study||44
1034017|NCT00709722|2510462|P1|NOT COMPLETED|Overall Study||1
1034018|NCT00709722|2510462|P1|COMPLETED|Overall Study||20
1034019|NCT00709722|2510462|P1|STARTED|Overall Study||21
1034020|NCT00709735|2510470|P2|NOT COMPLETED|Overall Study||2
1034021|NCT00709735|2510471|P1|NOT COMPLETED|Overall Study||3
1034022|NCT00709735|2510470|P2|COMPLETED|Overall Study||10
1034023|NCT00709735|2510471|P1|COMPLETED|Overall Study||8
1034024|NCT00709735|2510470|P2|STARTED|Overall Study||12
1034025|NCT00709735|2510471|P1|STARTED|Overall Study||11
1034026|NCT00709761|2510479|P1|NOT COMPLETED|Overall Study||47
1034027|NCT00709761|2510479|P1|COMPLETED|Overall Study||13
1034028|NCT00709761|2510479|P1|Ongoing|Overall Study|At time of clinical data cut off, 11 participants were on study treatment; 29 were in follow up.|40
1034029|NCT00709761|2510479|P1|STARTED|Overall Study||60
1034030|NCT00709826|2510490|P2|NOT COMPLETED|Overall Study||1
1034031|NCT00709826|2510491|P1|NOT COMPLETED|Overall Study||2
1034032|NCT00709826|2510490|P2|COMPLETED|Overall Study||38
1034033|NCT00709826|2510491|P1|COMPLETED|Overall Study||68
1034034|NCT00709826|2510490|P2|STARTED|Overall Study||39
1034035|NCT00709826|2510491|P1|STARTED|Overall Study||70
1034036|NCT00709852|2510499|P2|NOT COMPLETED|Period 2||2
1034037|NCT00709852|2510500|P1|NOT COMPLETED|Period 2||9
1034038|NCT00709852|2510499|P2|COMPLETED|Period 2||169
1034039|NCT00709852|2510500|P1|COMPLETED|Period 2||211
1034040|NCT00709852|2510499|P2|STARTED|Period 2||171
1034041|NCT00709852|2510500|P1|STARTED|Period 2||220
1034042|NCT00709852|2510499|P2|NOT COMPLETED|Period 1||3
1034043|NCT00709852|2510500|P1|NOT COMPLETED|Period 1||8
1034044|NCT00709852|2510499|P2|COMPLETED|Period 1||171
1034045|NCT00709852|2510500|P1|COMPLETED|Period 1||220
1034046|NCT00709852|2510499|P2|STARTED|Period 1||174
1034047|NCT00709852|2510500|P1|STARTED|Period 1||228
1034048|NCT00709878|2510657|P4|NOT COMPLETED|Overall Study||0
1034049|NCT00709878|2510658|P3|NOT COMPLETED|Overall Study||0
1034050|NCT00709878|2510659|P2|NOT COMPLETED|Overall Study||0
1034051|NCT00709878|2510660|P1|NOT COMPLETED|Overall Study||0
1034052|NCT00709878|2510657|P4|COMPLETED|Overall Study||8
1034053|NCT00709878|2510658|P3|COMPLETED|Overall Study||8
1034054|NCT00709878|2510659|P2|COMPLETED|Overall Study||8
1034055|NCT00709878|2510660|P1|COMPLETED|Overall Study||8
1034056|NCT00709878|2510657|P4|STARTED|Overall Study||8
1034057|NCT00709878|2510658|P3|STARTED|Overall Study||8
1034058|NCT00709878|2510659|P2|STARTED|Overall Study||8
1034059|NCT00709878|2510660|P1|STARTED|Overall Study||8
1034060|NCT00709891|2510670|P1|NOT COMPLETED|Longitudinal Follow-up Phase||4982
1034061|NCT00709891|2510670|P1|COMPLETED|Longitudinal Follow-up Phase||5020
1034062|NCT00709891|2510670|P1|STARTED|Longitudinal Follow-up Phase|Only participants who met study criteria in the Baseline phase started the Follow-up phase.|10002
1034063|NCT00709891|2510670|P1|NOT COMPLETED|Baseline, Cross-sectional Phase||1450
1034064|NCT00709891|2510670|P1|COMPLETED|Baseline, Cross-sectional Phase||45758
1034065|NCT00709891|2510670|P1|STARTED|Baseline, Cross-sectional Phase||47208
1034066|NCT00709956|2510677|P2|NOT COMPLETED|Overall Study||4
1034067|NCT00709956|2510678|P1|NOT COMPLETED|Overall Study||3
1034068|NCT00709956|2510677|P2|COMPLETED|Overall Study||33
1034069|NCT00709956|2510678|P1|COMPLETED|Overall Study||30
1034070|NCT00709956|2510677|P2|Double-blind Crossover-period|Overall Study|Days 2 and 3|33
1034071|NCT00709956|2510678|P1|Double-blind Crossover-period|Overall Study|Days 2 and 3|31
1034072|NCT00709956|2510677|P2|STARTED|Overall Study|Day 1 Single-blind placebo run-in|37
1034073|NCT00709956|2510678|P1|STARTED|Overall Study|Day 1 Single-blind placebo run-in|33
1034074|NCT00710021|2510689|P3|NOT COMPLETED|Overall Study||1
1034075|NCT00710021|2510690|P2|NOT COMPLETED|Overall Study||3
1034076|NCT00710021|2510691|P1|NOT COMPLETED|Overall Study||1
1034077|NCT00710021|2510689|P3|COMPLETED|Overall Study||18
1034078|NCT00710021|2510690|P2|COMPLETED|Overall Study||16
1034079|NCT00710021|2510691|P1|COMPLETED|Overall Study||18
1034080|NCT00710021|2510689|P3|Modified Intent-to-Treat (mITT)|Overall Study|1 subject who did not take study drug was excluded from mITT|18
1034081|NCT00710021|2510690|P2|Modified Intent-to-Treat (mITT)|Overall Study|2 subjects who did not take study drug were excluded from mITT|17
1034082|NCT00710021|2510691|P1|Modified Intent-to-Treat (mITT)|Overall Study||19
1034083|NCT00710021|2510689|P3|STARTED|Overall Study||19
1034084|NCT00710021|2510690|P2|STARTED|Overall Study||19
1034085|NCT00710021|2510691|P1|STARTED|Overall Study||19
1034086|NCT00710203|2510804|P1|NOT COMPLETED|Overall Study||0
1034087|NCT00710203|2510804|P1|COMPLETED|Overall Study||10
1034088|NCT00710203|2510804|P1|STARTED|Overall Study||10
1034089|NCT00710385|2510830|P1|NOT COMPLETED|Overall Study||5
1034090|NCT00710385|2510830|P1|COMPLETED|Overall Study||12
1034091|NCT00710385|2510830|P1|STARTED|Overall Study|19 participants signed consent for the study 2 withdrew before any study procedures were initiated.|17
1034092|NCT00710424|2510849|P2|NOT COMPLETED|Overall Study||23
1034093|NCT00710424|2510850|P1|NOT COMPLETED|Overall Study||44
1034094|NCT00710424|2510849|P2|COMPLETED|Overall Study||125
1034095|NCT00710424|2510850|P1|COMPLETED|Overall Study||105
1034096|NCT00710424|2510849|P2|STARTED|Overall Study||148
1034097|NCT00710424|2510850|P1|STARTED|Overall Study||149
1034098|NCT00702650|2510874|P1|NOT COMPLETED|Overall Study||20
1034099|NCT00702650|2510874|P1|COMPLETED|Overall Study||135
1034100|NCT00702650|2510874|P1|STARTED|Overall Study||155
1034101|NCT00702689|2510892|P1|NOT COMPLETED|Overall Study||6
1034102|NCT00702689|2510892|P1|COMPLETED|Overall Study||14
1034103|NCT00702689|2510892|P1|STARTED|Overall Study||20
1034104|NCT00702702|2510906|P1|NOT COMPLETED|Overall Study||56
1034105|NCT00702702|2510906|P1|COMPLETED|Overall Study||0
1034106|NCT00702702|2510906|P1|STARTED|Overall Study||56
1034107|NCT00702715|2510916|P2|NOT COMPLETED|Overall Study||0
1034108|NCT00702715|2510917|P1|NOT COMPLETED|Overall Study||1
1034109|NCT00702715|2510916|P2|COMPLETED|Overall Study||33
1034110|NCT00702715|2510917|P1|COMPLETED|Overall Study||34
1034111|NCT00702715|2510916|P2|STARTED|Overall Study|One subject was enrolled but did not start study|33
1034112|NCT00702715|2510917|P1|STARTED|Overall Study||35
1034113|NCT00702754|2510927|P1|NOT COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||24
1034114|NCT00702754|2510927|P1|COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||329
1034115|NCT00702754|2510927|P1|STARTED|MYOBLOC Treatment Session 8 (App 84 Wks)||353
1034116|NCT00702754|2510927|P1|NOT COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||24
1034117|NCT00702754|2510927|P1|COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||353
1034118|NCT00702754|2510927|P1|STARTED|MYOBLOC Treatment Session 7 (App 72 Wks)||377
1034119|NCT00702754|2510927|P1|NOT COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||19
1034120|NCT00702754|2510927|P1|COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||377
1034121|NCT00702754|2510927|P1|STARTED|MYOBLOC Treatment Session 6 (App 60 Wks)||396
1034122|NCT00702754|2510927|P1|NOT COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||32
1034123|NCT00702754|2510927|P1|COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||396
1034124|NCT00702754|2510927|P1|STARTED|MYOBLOC Treatment Session 5 (App 48 Wks)||428
1034125|NCT00702754|2510927|P1|NOT COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||22
1034126|NCT00702754|2510927|P1|COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||428
1034127|NCT00702754|2510927|P1|STARTED|MYOBLOC Treatment Session 4 (App 36 Wks)||450
1034128|NCT00702754|2510927|P1|NOT COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||25
1034129|NCT00702754|2510927|P1|COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||450
1034130|NCT00702754|2510927|P1|STARTED|MYOBLOC Treatment Session 3 (App 24 Wks)||475
1034131|NCT00702754|2510927|P1|NOT COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||20
1034132|NCT00702754|2510927|P1|COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||475
1034133|NCT00702754|2510927|P1|STARTED|MYOBLOC Treatment Session 2 (App 12 Wks)||495
1034134|NCT00702754|2510927|P1|NOT COMPLETED|MYOBLOC Treatment Session 1 (Time 0)||7
1034135|NCT00702754|2510927|P1|COMPLETED|MYOBLOC Treatment Session 1 (Time 0)|Approximately 70% of subjects completed at least 2 years of treatment.|495
1034136|NCT00702754|2510927|P1|STARTED|MYOBLOC Treatment Session 1 (Time 0)||502
1034137|NCT00702780|2510940|P2|NOT COMPLETED|Overall Study||8
1034138|NCT00702780|2510941|P1|NOT COMPLETED|Overall Study||9
1034139|NCT00702780|2510940|P2|COMPLETED|Overall Study||29
1034140|NCT00702780|2510941|P1|COMPLETED|Overall Study||28
1034141|NCT00702780|2510940|P2|STARTED|Overall Study||37
1034142|NCT00702780|2510941|P1|STARTED|Overall Study||37
1034143|NCT00702845|2510951|P2|NOT COMPLETED|Overall Study||8
1034144|NCT00702845|2510952|P1|NOT COMPLETED|Overall Study||22
1034145|NCT00702845|2510951|P2|COMPLETED|Overall Study||121
1034146|NCT00702845|2510952|P1|COMPLETED|Overall Study||246
1034147|NCT00702845|2510951|P2|Randomized|Overall Study||128
1034148|NCT00702845|2510952|P1|Randomized|Overall Study||268
1034149|NCT00702845|2510951|P2|STARTED|Overall Study|Includes one treated participant who was not randomized|129
1034150|NCT00702845|2510952|P1|STARTED|Overall Study||268
1034151|NCT00702884|2510990|P1|NOT COMPLETED|Overall Study||0
1034152|NCT00702884|2510990|P1|COMPLETED|Overall Study||25
1034153|NCT00702884|2510990|P1|STARTED|Overall Study||25
1034154|NCT00710554|2511004|P2|NOT COMPLETED|Overall Study||24
1034155|NCT00710554|2511005|P1|NOT COMPLETED|Overall Study||49
1034156|NCT00710554|2511004|P2|COMPLETED|Overall Study||94
1034157|NCT00710554|2511005|P1|COMPLETED|Overall Study||79
1034158|NCT00710554|2511004|P2|STARTED|Overall Study||118
1034159|NCT00710554|2511005|P1|STARTED|Overall Study||128
1034160|NCT00710593|2511033|P2|NOT COMPLETED|Overall Study||5
1034161|NCT00710593|2511034|P1|NOT COMPLETED|Overall Study||15
1034162|NCT00710593|2511033|P2|COMPLETED|Overall Study|25 completed study and vaccine. 2 did not receive all vaccine, but completed all study visits.|25
1034163|NCT00710593|2511034|P1|COMPLETED|Overall Study|54 completed study and vaccine. 6 did not receive all vaccine, but completed all study visits.|54
1034164|NCT00710593|2511033|P2|STARTED|Overall Study||30
1034165|NCT00710593|2511034|P1|STARTED|Overall Study||69
1034166|NCT00710606|2511077|P2|NOT COMPLETED|Overall Study||2
1034167|NCT00710606|2511078|P1|NOT COMPLETED|Overall Study||0
1034168|NCT00710606|2511077|P2|COMPLETED|Overall Study||18
1034169|NCT00710606|2511078|P1|COMPLETED|Overall Study||20
1034170|NCT00710606|2511077|P2|STARTED|Overall Study||20
1034171|NCT00710606|2511078|P1|STARTED|Overall Study||20
1034172|NCT00710749|2511088|P2|NOT COMPLETED|Second Intervention||0
1034173|NCT00710749|2511089|P1|NOT COMPLETED|Second Intervention||0
1034174|NCT00710749|2511088|P2|COMPLETED|Second Intervention||30
1034175|NCT00710749|2511089|P1|COMPLETED|Second Intervention||29
1034176|NCT00710749|2511088|P2|STARTED|Second Intervention||30
1034177|NCT00710749|2511089|P1|STARTED|Second Intervention||29
1034178|NCT00710749|2511088|P2|NOT COMPLETED|First Intervention||0
1034179|NCT00710749|2511089|P1|NOT COMPLETED|First Intervention||1
1034180|NCT00710749|2511088|P2|COMPLETED|First Intervention||30
1034181|NCT00710749|2511089|P1|COMPLETED|First Intervention||29
1034182|NCT00710749|2511088|P2|STARTED|First Intervention||30
1034183|NCT00710749|2511089|P1|STARTED|First Intervention||30
1034184|NCT00710749|2511088|P2|NOT COMPLETED|Clinic Baseline Recording||0
1034185|NCT00710749|2511089|P1|NOT COMPLETED|Clinic Baseline Recording||0
1034186|NCT00710749|2511088|P2|COMPLETED|Clinic Baseline Recording||30
1034187|NCT00710749|2511089|P1|COMPLETED|Clinic Baseline Recording||30
1034188|NCT00710749|2511088|P2|STARTED|Clinic Baseline Recording||30
1034189|NCT00710749|2511089|P1|STARTED|Clinic Baseline Recording||30
1034190|NCT00710762|2511099|P2|NOT COMPLETED|Overall Study||40
1034191|NCT00710762|2511100|P1|NOT COMPLETED|Overall Study||39
1034192|NCT00710762|2511099|P2|COMPLETED|Overall Study||0
1034193|NCT00710762|2511100|P1|COMPLETED|Overall Study||5
1034194|NCT00710762|2511099|P2|STARTED|Overall Study||40
1034195|NCT00710762|2511100|P1|STARTED|Overall Study||44
1034196|NCT00710814|2511118|P2|NOT COMPLETED|Overall Study||3
1034197|NCT00710814|2511119|P1|NOT COMPLETED|Overall Study||1
1034198|NCT00710814|2511118|P2|COMPLETED|Overall Study||13
1034199|NCT00710814|2511119|P1|COMPLETED|Overall Study||14
1034200|NCT00710814|2511118|P2|STARTED|Overall Study||16
1034201|NCT00710814|2511119|P1|STARTED|Overall Study||15
1034202|NCT00710840|2511127|P2|NOT COMPLETED|Overall Study||3
1034203|NCT00710840|2511128|P1|NOT COMPLETED|Overall Study||0
1034204|NCT00710840|2511127|P2|COMPLETED|Overall Study||19
1034205|NCT00710840|2511128|P1|COMPLETED|Overall Study||22
1034206|NCT00710840|2511127|P2|STARTED|Overall Study||22
1034207|NCT00710840|2511128|P1|STARTED|Overall Study||22
1034208|NCT00712725|2511148|P8|NOT COMPLETED|Overall Study||11
1034209|NCT00712725|2511149|P7|NOT COMPLETED|Overall Study||22
1034210|NCT00712725|2511150|P6|NOT COMPLETED|Overall Study||16
1034211|NCT00712725|2511151|P5|NOT COMPLETED|Overall Study||19
1034212|NCT00712725|2511152|P4|NOT COMPLETED|Overall Study||17
1034213|NCT00712725|2511153|P3|NOT COMPLETED|Overall Study||10
1034214|NCT00712725|2511154|P2|NOT COMPLETED|Overall Study||6
1034215|NCT00712725|2511155|P1|NOT COMPLETED|Overall Study||29
1034216|NCT00712725|2511148|P8|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|63
1034217|NCT00712725|2511149|P7|COMPLETED|Overall Study|One patient received study drug. The remaining patients discontinued prior to receiving study drug.|61
1034218|NCT00712725|2511150|P6|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|68
1034219|NCT00712725|2511151|P5|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
1034220|NCT00712725|2511152|P4|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
1034221|NCT00712725|2511153|P3|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|47
1034222|NCT00712725|2511154|P2|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|33
1034223|NCT00712725|2511155|P1|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|140
1034224|NCT00712725|2511148|P8|STARTED|Overall Study||74
1034225|NCT00712725|2511149|P7|STARTED|Overall Study||83
1034226|NCT00712725|2511150|P6|STARTED|Overall Study||84
1034227|NCT00712725|2511151|P5|STARTED|Overall Study||86
1034228|NCT00712725|2511152|P4|STARTED|Overall Study||84
1034229|NCT00712725|2511153|P3|STARTED|Overall Study||57
1034230|NCT00712725|2511154|P2|STARTED|Overall Study||39
1034231|NCT00712725|2511155|P1|STARTED|Overall Study||169
1034232|NCT00712920|2511216|P3|NOT COMPLETED|Overall Study||12
1034233|NCT00712920|2511217|P2|NOT COMPLETED|Overall Study||17
1034234|NCT00712920|2511218|P1|NOT COMPLETED|Overall Study||17
1034235|NCT00712920|2511216|P3|COMPLETED|Overall Study||180
1034236|NCT00712920|2511217|P2|COMPLETED|Overall Study||180
1034237|NCT00712920|2511218|P1|COMPLETED|Overall Study||175
1034238|NCT00712920|2511216|P3|STARTED|Overall Study||192
1034239|NCT00712920|2511217|P2|STARTED|Overall Study|3 subjects were randomized in error|197
1034240|NCT00712920|2511218|P1|STARTED|Overall Study||192
1034241|NCT00712959|2511240|P2|NOT COMPLETED|Overall Study||3
1034242|NCT00712959|2511241|P1|NOT COMPLETED|Overall Study||19
1034243|NCT00712959|2511240|P2|COMPLETED|Overall Study||404
1034244|NCT00712959|2511241|P1|COMPLETED|Overall Study||342
1034245|NCT00712959|2511240|P2|STARTED|Overall Study||407
1034246|NCT00712959|2511241|P1|STARTED|Overall Study||361
1034247|NCT00712985|2511259|P1|NOT COMPLETED|Overall Study||5
1034248|NCT00712985|2511259|P1|COMPLETED|Overall Study||13
1034249|NCT00712985|2511259|P1|STARTED|Overall Study||18
1034250|NCT00713206|2511265|P2|NOT COMPLETED|Overall Study||3
1034251|NCT00713206|2511266|P1|NOT COMPLETED|Overall Study||7
1034252|NCT00713206|2511265|P2|COMPLETED|Overall Study||27
1034253|NCT00713206|2511266|P1|COMPLETED|Overall Study||55
1034254|NCT00713206|2511265|P2|STARTED|Overall Study||30
1034255|NCT00713206|2511266|P1|STARTED|Overall Study||62
1034256|NCT00713219|2511272|P1|NOT COMPLETED|Overall Study||2
1034257|NCT00713219|2511272|P1|COMPLETED|Overall Study||12
1034258|NCT00713219|2511272|P1|STARTED|Overall Study||14
1034259|NCT00713258|2511278|P2|NOT COMPLETED|Overall Study||6
1034260|NCT00713258|2511279|P1|NOT COMPLETED|Overall Study||5
1034261|NCT00713258|2511278|P2|COMPLETED|Overall Study||28
1034262|NCT00713258|2511279|P1|COMPLETED|Overall Study||36
1034263|NCT00713258|2511278|P2|STARTED|Overall Study||34
1034264|NCT00713258|2511279|P1|STARTED|Overall Study||41
1034265|NCT00713310|2511289|P2|NOT COMPLETED|Overall Study||6
1034266|NCT00713310|2511290|P1|NOT COMPLETED|Overall Study||5
1034267|NCT00713310|2511289|P2|COMPLETED|Overall Study||36
1034268|NCT00713310|2511290|P1|COMPLETED|Overall Study||36
1034269|NCT00713310|2511289|P2|mITT Population|Overall Study|1 subject randomized to high dose not dosed so not included in the mITT population.|41
1034270|NCT00713310|2511290|P1|mITT Population|Overall Study||41
1034271|NCT00713310|2511289|P2|STARTED|Overall Study||42
1034272|NCT00713310|2511290|P1|STARTED|Overall Study||41
1034273|NCT00713323|2511298|P1|NOT COMPLETED|Overall Study||146
1034274|NCT00713323|2511298|P1|COMPLETED|Overall Study||234
1034275|NCT00713323|2511298|P1|STARTED|Overall Study||380
1034276|NCT00713349|2511309|P1|NOT COMPLETED|Overall Study||1
1034277|NCT00713349|2511309|P1|COMPLETED|Overall Study||24
1034278|NCT00713349|2511309|P1|STARTED|Overall Study||25
1034279|NCT00713479|2511315|P2|NOT COMPLETED|Next Medication Condition||0
1034280|NCT00713479|2511316|P1|NOT COMPLETED|Next Medication Condition||0
1034281|NCT00713479|2511315|P2|COMPLETED|Next Medication Condition||6
1034282|NCT00713479|2511316|P1|COMPLETED|Next Medication Condition||2
1034283|NCT00713479|2511315|P2|STARTED|Next Medication Condition||6
1034284|NCT00713479|2511316|P1|STARTED|Next Medication Condition||2
1034285|NCT00713479|2511315|P2|NOT COMPLETED|Washout||0
1034286|NCT00713479|2511316|P1|NOT COMPLETED|Washout||0
1034287|NCT00713479|2511315|P2|COMPLETED|Washout||6
1034288|NCT00713479|2511316|P1|COMPLETED|Washout||2
1034289|NCT00713479|2511315|P2|STARTED|Washout||6
1034290|NCT00713479|2511316|P1|STARTED|Washout||2
1034291|NCT00713479|2511315|P2|NOT COMPLETED|First Medication Condition||0
1034292|NCT00713479|2511316|P1|NOT COMPLETED|First Medication Condition||4
1034293|NCT00713479|2511315|P2|COMPLETED|First Medication Condition||6
1034294|NCT00713479|2511316|P1|COMPLETED|First Medication Condition||2
1034295|NCT00713479|2511315|P2|STARTED|First Medication Condition||6
1034296|NCT00713479|2511316|P1|STARTED|First Medication Condition||6
1034297|NCT00713544|2511334|P6|NOT COMPLETED|Overall Study||9
1034298|NCT00713544|2511335|P5|NOT COMPLETED|Overall Study||8
1034299|NCT00713544|2511336|P4|NOT COMPLETED|Overall Study||10
1034300|NCT00713544|2511337|P3|NOT COMPLETED|Overall Study||11
1034301|NCT00713544|2511338|P2|NOT COMPLETED|Overall Study||6
1034302|NCT00713544|2511339|P1|NOT COMPLETED|Overall Study||7
1034303|NCT00713544|2511334|P6|COMPLETED|Overall Study||67
1034304|NCT00713544|2511335|P5|COMPLETED|Overall Study||57
1034305|NCT00713544|2511336|P4|COMPLETED|Overall Study||66
1034306|NCT00713544|2511337|P3|COMPLETED|Overall Study||41
1034307|NCT00713544|2511338|P2|COMPLETED|Overall Study||46
1034308|NCT00713544|2511339|P1|COMPLETED|Overall Study||45
1034309|NCT00713544|2511334|P6|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|76
1034310|NCT00713544|2511335|P5|STARTED|Overall Study||65
1034311|NCT00713544|2511336|P4|STARTED|Overall Study||76
1034402|NCT00714259|2511589|P1|NOT COMPLETED|Overall Study||2
1034312|NCT00713544|2511337|P3|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|52
1034313|NCT00713544|2511338|P2|STARTED|Overall Study||52
1034314|NCT00713544|2511339|P1|STARTED|Overall Study||52
1034315|NCT00713596|2511380|P3|NOT COMPLETED|Overall Study||2
1034316|NCT00713596|2511381|P2|NOT COMPLETED|Overall Study||3
1034317|NCT00713596|2511382|P1|NOT COMPLETED|Overall Study||2
1034318|NCT00713596|2511380|P3|COMPLETED|Overall Study||6
1034319|NCT00713596|2511381|P2|COMPLETED|Overall Study||5
1034320|NCT00713596|2511382|P1|COMPLETED|Overall Study||7
1034321|NCT00713596|2511380|P3|STARTED|Overall Study||8
1034322|NCT00713596|2511381|P2|STARTED|Overall Study||8
1034323|NCT00713596|2511382|P1|STARTED|Overall Study||9
1034324|NCT00713609|2511399|P6|NOT COMPLETED|Overall Study||8
1034325|NCT00713609|2511400|P5|NOT COMPLETED|Overall Study||19
1034326|NCT00713609|2511401|P4|NOT COMPLETED|Overall Study||9
1034327|NCT00713609|2511402|P3|NOT COMPLETED|Overall Study||15
1034328|NCT00713609|2511403|P2|NOT COMPLETED|Overall Study||15
1034329|NCT00713609|2511404|P1|NOT COMPLETED|Overall Study||21
1034330|NCT00713609|2511399|P6|COMPLETED|Overall Study||47
1034331|NCT00713609|2511400|P5|COMPLETED|Overall Study||87
1034332|NCT00713609|2511401|P4|COMPLETED|Overall Study||99
1034333|NCT00713609|2511402|P3|COMPLETED|Overall Study||92
1034334|NCT00713609|2511403|P2|COMPLETED|Overall Study||90
1034335|NCT00713609|2511404|P1|COMPLETED|Overall Study||85
1034336|NCT00713609|2511399|P6|STARTED|Overall Study||55
1034337|NCT00713609|2511400|P5|STARTED|Overall Study||106
1034338|NCT00713609|2511401|P4|STARTED|Overall Study||108
1034339|NCT00713609|2511402|P3|STARTED|Overall Study||107
1034340|NCT00713609|2511403|P2|STARTED|Overall Study||105
1034341|NCT00713609|2511404|P1|STARTED|Overall Study||106
1034342|NCT00713648|2511436|P1|NOT COMPLETED|Overall Study||8
1034343|NCT00713648|2511436|P1|COMPLETED|Overall Study||33
1034344|NCT00713648|2511436|P1|STARTED|Overall Study||41
1034345|NCT00713661|2511447|P4|NOT COMPLETED|Overall Study||0
1034346|NCT00713661|2511448|P3|NOT COMPLETED|Overall Study||0
1034347|NCT00713661|2511449|P2|NOT COMPLETED|Overall Study||0
1034348|NCT00713661|2511450|P1|NOT COMPLETED|Overall Study||0
1034349|NCT00713661|2511447|P4|COMPLETED|Overall Study||5
1034350|NCT00713661|2511448|P3|COMPLETED|Overall Study||4
1034351|NCT00713661|2511449|P2|COMPLETED|Overall Study||9
1034352|NCT00713661|2511450|P1|COMPLETED|Overall Study||7
1034353|NCT00713661|2511447|P4|STARTED|Overall Study||5
1034354|NCT00713661|2511448|P3|STARTED|Overall Study||4
1034355|NCT00713661|2511449|P2|STARTED|Overall Study||9
1034356|NCT00713661|2511450|P1|STARTED|Overall Study||7
1034357|NCT00713700|2511464|P1|NOT COMPLETED|Overall Study||4
1034358|NCT00713700|2511464|P1|COMPLETED|Overall Study||188
1034359|NCT00713700|2511464|P1|STARTED|Overall Study||192
1034360|NCT00713817|2511471|P2|NOT COMPLETED|Overall Study||0
1034361|NCT00713817|2511472|P1|NOT COMPLETED|Overall Study||0
1034362|NCT00713817|2511471|P2|COMPLETED|Overall Study||9
1034363|NCT00713817|2511472|P1|COMPLETED|Overall Study||10
1034364|NCT00713817|2511471|P2|STARTED|Overall Study||9
1034365|NCT00713817|2511472|P1|STARTED|Overall Study||10
1034366|NCT00713830|2511492|P2|NOT COMPLETED|Overall Study||177
1034367|NCT00713830|2511493|P1|NOT COMPLETED|Overall Study||82
1034368|NCT00713830|2511492|P2|COMPLETED|Overall Study||396
1034369|NCT00713830|2511493|P1|COMPLETED|Overall Study||204
1034370|NCT00713830|2511492|P2|Subgroup for Standardized Meal Test|Overall Study||313
1034371|NCT00713830|2511493|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal challenge test was performed.|155
1034372|NCT00713830|2511492|P2|Safety Population|Overall Study|1 patient randomized to placebo received Lixisenatide (at least one dose)|574
1034373|NCT00713830|2511493|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|285
1034374|NCT00713830|2511492|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||570
1034375|NCT00713830|2511493|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|286
1034376|NCT00713830|2511492|P2|STARTED|Overall Study||573
1034377|NCT00713830|2511493|P1|STARTED|Overall Study|Randomized.|286
1034378|NCT00714051|2511531|P2|NOT COMPLETED|Overall Study||1
1034379|NCT00714051|2511532|P1|NOT COMPLETED|Overall Study||1
1034380|NCT00714051|2511531|P2|COMPLETED|Overall Study||27
1034381|NCT00714051|2511532|P1|COMPLETED|Overall Study||26
1034382|NCT00714051|2511531|P2|STARTED|Overall Study||28
1034383|NCT00714051|2511532|P1|STARTED|Overall Study||27
1034384|NCT00714168|2511540|P2|NOT COMPLETED|Overall Study||59
1034385|NCT00714168|2511541|P1|NOT COMPLETED|Overall Study||44
1034386|NCT00714168|2511540|P2|COMPLETED|Overall Study||139
1034387|NCT00714168|2511541|P1|COMPLETED|Overall Study||121
1034388|NCT00714168|2511540|P2|STARTED|Overall Study||198
1034389|NCT00714168|2511541|P1|STARTED|Overall Study||165
1034390|NCT00714233|2511559|P4|NOT COMPLETED|Overall Study||4
1034391|NCT00714233|2511560|P3|NOT COMPLETED|Overall Study||1
1034392|NCT00714233|2511561|P2|NOT COMPLETED|Overall Study||1
1034393|NCT00714233|2511562|P1|NOT COMPLETED|Overall Study||4
1034394|NCT00714233|2511559|P4|COMPLETED|Overall Study||6
1034395|NCT00714233|2511560|P3|COMPLETED|Overall Study||10
1034396|NCT00714233|2511561|P2|COMPLETED|Overall Study||10
1034397|NCT00714233|2511562|P1|COMPLETED|Overall Study||6
1034398|NCT00714233|2511559|P4|STARTED|Overall Study||10
1034399|NCT00714233|2511560|P3|STARTED|Overall Study||11
1034400|NCT00714233|2511561|P2|STARTED|Overall Study||11
1034401|NCT00714233|2511562|P1|STARTED|Overall Study||10
1034403|NCT00714259|2511589|P1|COMPLETED|Overall Study||3
1034404|NCT00714259|2511589|P1|STARTED|Overall Study||5
1034405|NCT00714285|2511603|P4|NOT COMPLETED|Overall Study||1
1034406|NCT00714285|2511604|P3|NOT COMPLETED|Overall Study||0
1034407|NCT00714285|2511605|P2|NOT COMPLETED|Overall Study||3
1034408|NCT00714285|2511606|P1|NOT COMPLETED|Overall Study||0
1034409|NCT00714285|2511603|P4|COMPLETED|Overall Study|Completed upto Day 180|104
1034410|NCT00714285|2511604|P3|COMPLETED|Overall Study|Completed upto Day 180|105
1034411|NCT00714285|2511605|P2|COMPLETED|Overall Study|Completed upto Day 180|102
1034412|NCT00714285|2511606|P1|COMPLETED|Overall Study|Completed upto Day 180|105
1034413|NCT00714285|2511603|P4|STARTED|Overall Study||105
1034414|NCT00714285|2511604|P3|STARTED|Overall Study||105
1034415|NCT00714285|2511605|P2|STARTED|Overall Study||105
1034416|NCT00714285|2511606|P1|STARTED|Overall Study||105
1034417|NCT00714311|2511658|P2|NOT COMPLETED|Overall Study||22
1034418|NCT00714311|2511659|P1|NOT COMPLETED|Overall Study||13
1034419|NCT00714311|2511658|P2|COMPLETED|Overall Study||30
1034420|NCT00714311|2511659|P1|COMPLETED|Overall Study||39
1034421|NCT00714311|2511658|P2|STARTED|Overall Study||52
1034422|NCT00714311|2511659|P1|STARTED|Overall Study||52
1034423|NCT00714389|2511665|P1|NOT COMPLETED|Overall Study||0
1034424|NCT00714389|2511665|P1|COMPLETED|Overall Study||12
1034425|NCT00714389|2511665|P1|STARTED|Overall Study||12
1034426|NCT00714493|2511670|P1|NOT COMPLETED|Overall Study||49
1034427|NCT00714493|2511670|P1|COMPLETED|Overall Study||154
1034428|NCT00714493|2511670|P1|STARTED|Overall Study||203
1034429|NCT00714571|2511686|P6|NOT COMPLETED|Stage 2||0
1034430|NCT00714571|2511687|P5|NOT COMPLETED|Stage 2||0
1034431|NCT00714571|2511688|P4|NOT COMPLETED|Stage 2||0
1034432|NCT00714571|2511689|P3|NOT COMPLETED|Stage 2||0
1034433|NCT00714571|2511690|P2|NOT COMPLETED|Stage 2||0
1034434|NCT00714571|2511691|P1|NOT COMPLETED|Stage 2||0
1034435|NCT00714571|2511686|P6|COMPLETED|Stage 2||15
1034436|NCT00714571|2511687|P5|COMPLETED|Stage 2||15
1034437|NCT00714571|2511688|P4|COMPLETED|Stage 2||0
1034438|NCT00714571|2511689|P3|COMPLETED|Stage 2||0
1034439|NCT00714571|2511690|P2|COMPLETED|Stage 2||0
1034440|NCT00714571|2511691|P1|COMPLETED|Stage 2||0
1034441|NCT00714571|2511686|P6|STARTED|Stage 2||15
1034442|NCT00714571|2511687|P5|STARTED|Stage 2||15
1034443|NCT00714571|2511688|P4|STARTED|Stage 2||0
1034444|NCT00714571|2511689|P3|STARTED|Stage 2||0
1034445|NCT00714571|2511690|P2|STARTED|Stage 2||0
1034446|NCT00714571|2511691|P1|STARTED|Stage 2||0
1034447|NCT00714571|2511686|P6|NOT COMPLETED|Stage 1||0
1034448|NCT00714571|2511687|P5|NOT COMPLETED|Stage 1||0
1034449|NCT00714571|2511688|P4|NOT COMPLETED|Stage 1||0
1034450|NCT00714571|2511689|P3|NOT COMPLETED|Stage 1||1
1034451|NCT00714571|2511690|P2|NOT COMPLETED|Stage 1||0
1034452|NCT00714571|2511691|P1|NOT COMPLETED|Stage 1||0
1034453|NCT00714571|2511686|P6|COMPLETED|Stage 1||0
1034454|NCT00714571|2511687|P5|COMPLETED|Stage 1||0
1034455|NCT00714571|2511688|P4|COMPLETED|Stage 1||14
1034456|NCT00714571|2511689|P3|COMPLETED|Stage 1||10
1034457|NCT00714571|2511690|P2|COMPLETED|Stage 1||15
1034458|NCT00714571|2511691|P1|COMPLETED|Stage 1|1 patient excluded who completed training but did not disclose ongoing chemotherapy for cancer|12
1034459|NCT00714571|2511686|P6|STARTED|Stage 1||0
1034460|NCT00714571|2511687|P5|STARTED|Stage 1||0
1034461|NCT00714571|2511688|P4|STARTED|Stage 1||14
1034462|NCT00714571|2511689|P3|STARTED|Stage 1||11
1034463|NCT00714571|2511690|P2|STARTED|Stage 1|11 allocated to intervention, but 1 withdrew before the first intervention session|15
1034464|NCT00714571|2511691|P1|STARTED|Stage 1||12
1034465|NCT00714688|2511708|P3|NOT COMPLETED|Overall Study||37
1034466|NCT00714688|2511709|P2|NOT COMPLETED|Overall Study||35
1034467|NCT00714688|2511710|P1|NOT COMPLETED|Overall Study||29
1034468|NCT00714688|2511708|P3|COMPLETED|Overall Study||55
1034469|NCT00714688|2511709|P2|COMPLETED|Overall Study||55
1034470|NCT00714688|2511710|P1|COMPLETED|Overall Study||68
1034471|NCT00714688|2511708|P3|STARTED|Overall Study||92
1034472|NCT00714688|2511709|P2|STARTED|Overall Study||90
1034473|NCT00714688|2511710|P1|STARTED|Overall Study||97
1034474|NCT00714714|2511727|P1|NOT COMPLETED|Overall Study||1
1034475|NCT00714714|2511727|P1|COMPLETED|Overall Study||24
1034476|NCT00714714|2511727|P1|STARTED|Overall Study||25
1034477|NCT00714792|2511735|P2|NOT COMPLETED|Overall Study||0
1034478|NCT00714792|2511736|P1|NOT COMPLETED|Overall Study||0
1034479|NCT00714792|2511735|P2|COMPLETED|Overall Study||8
1034480|NCT00714792|2511736|P1|COMPLETED|Overall Study||10
1034481|NCT00714792|2511735|P2|STARTED|Overall Study||8
1034482|NCT00714792|2511736|P1|STARTED|Overall Study||10
1034483|NCT00714870|2511744|P2|NOT COMPLETED|Overall Study||5
1034484|NCT00714870|2511745|P1|NOT COMPLETED|Overall Study||27
1034485|NCT00714870|2511744|P2|COMPLETED|Overall Study||22
1034486|NCT00714870|2511745|P1|COMPLETED|Overall Study||22
1034487|NCT00714870|2511744|P2|STARTED|Overall Study||27
1034488|NCT00714870|2511745|P1|STARTED|Overall Study||49
1034489|NCT00714948|2511751|P1|NOT COMPLETED|Overall Study||2
1034490|NCT00714948|2511751|P1|COMPLETED|Overall Study||0
1034491|NCT00714948|2511751|P1|STARTED|Overall Study||2
1034492|NCT00715026|2511755|P1|NOT COMPLETED|Overall Study||10
1034493|NCT00715026|2511755|P1|COMPLETED|Overall Study|20 unilateral subjects and 1 bilateral|21
1034494|NCT00715026|2511755|P1|Subjects That Received Surgery|Overall Study|24 unilateral subjects and 1 bilateral|25
1034495|NCT00715026|2511755|P1|STARTED|Overall Study|30 unilateral subjects and 1 bilateral|31
1034496|NCT00715078|2511763|P3|NOT COMPLETED|Overall Study||38
1034497|NCT00715078|2511764|P2|NOT COMPLETED|Overall Study||36
1034498|NCT00715078|2511765|P1|NOT COMPLETED|Overall Study||30
1034499|NCT00715078|2511763|P3|COMPLETED|Overall Study||3
1034500|NCT00715078|2511764|P2|COMPLETED|Overall Study||4
1034501|NCT00715078|2511765|P1|COMPLETED|Overall Study||11
1034502|NCT00715078|2511763|P3|Received ≥ 1 Leukapheresis|Overall Study||40
1034503|NCT00715078|2511764|P2|Received ≥ 1 Leukapheresis|Overall Study||40
1034504|NCT00715078|2511765|P1|Received ≥ 1 Leukapheresis|Overall Study||40
1034505|NCT00715078|2511763|P3|Received ≥ 1 Study Infusion|Overall Study||39
1034506|NCT00715078|2511764|P2|Received ≥ 1 Study Infusion|Overall Study||40
1034507|NCT00715078|2511765|P1|Received ≥ 1 Study Infusion|Overall Study||40
1034508|NCT00715078|2511763|P3|STARTED|Overall Study||41
1034509|NCT00715078|2511764|P2|STARTED|Overall Study||40
1034510|NCT00715078|2511765|P1|STARTED|Overall Study||41
1034511|NCT00715104|2511776|P3|NOT COMPLETED|Overall Study||0
1034512|NCT00715104|2511777|P2|NOT COMPLETED|Overall Study||0
1034513|NCT00715104|2511778|P1|NOT COMPLETED|Overall Study||0
1034514|NCT00715104|2511776|P3|COMPLETED|Overall Study||8
1034515|NCT00715104|2511777|P2|COMPLETED|Overall Study||16
1034516|NCT00715104|2511778|P1|COMPLETED|Overall Study||18
1034517|NCT00715104|2511776|P3|STARTED|Overall Study||8
1034518|NCT00715104|2511777|P2|STARTED|Overall Study||16
1034519|NCT00715104|2511778|P1|STARTED|Overall Study||18
1034520|NCT00715117|2511829|P2|NOT COMPLETED|Overall Study||1
1034521|NCT00715117|2511830|P1|NOT COMPLETED|Overall Study||0
1034522|NCT00715117|2511829|P2|COMPLETED|Overall Study|One subject flared and was rescued with steroids|5
1034523|NCT00715117|2511830|P1|COMPLETED|Overall Study||6
1034524|NCT00715117|2511829|P2|Completion fo 8 Week Study|Overall Study||6
1034525|NCT00715117|2511830|P1|Completion fo 8 Week Study|Overall Study||6
1034526|NCT00715117|2511829|P2|STARTED|Overall Study||6
1034527|NCT00715117|2511830|P1|STARTED|Overall Study||6
1034570|NCT00705874|2511879|P7|NOT COMPLETED|Overall Study||0
1034571|NCT00705874|2511880|P6|NOT COMPLETED|Overall Study||4
1034572|NCT00705874|2511881|P5|NOT COMPLETED|Overall Study||12
1034573|NCT00705874|2511882|P4|NOT COMPLETED|Overall Study||1
1034574|NCT00705874|2511883|P3|NOT COMPLETED|Overall Study||2
1034575|NCT00705874|2511884|P2|NOT COMPLETED|Overall Study||1
1034576|NCT00705874|2511885|P1|NOT COMPLETED|Overall Study||2
1034577|NCT00705874|2511879|P7|COMPLETED|Overall Study||3
1034578|NCT00705874|2511880|P6|COMPLETED|Overall Study||28
1034579|NCT00705874|2511881|P5|COMPLETED|Overall Study||36
1034580|NCT00705874|2511882|P4|COMPLETED|Overall Study||33
1034581|NCT00705874|2511883|P3|COMPLETED|Overall Study||32
1034582|NCT00705874|2511884|P2|COMPLETED|Overall Study||8
1034583|NCT00705874|2511885|P1|COMPLETED|Overall Study||10
1034584|NCT00705874|2511879|P7|STARTED|Overall Study||3
1034585|NCT00705874|2511880|P6|STARTED|Overall Study||32
1034586|NCT00705874|2511881|P5|STARTED|Overall Study||48
1034587|NCT00705874|2511882|P4|STARTED|Overall Study||34
1034588|NCT00705874|2511883|P3|STARTED|Overall Study||34
1034589|NCT00705874|2511884|P2|STARTED|Overall Study||9
1034590|NCT00705874|2511885|P1|STARTED|Overall Study||12
1034591|NCT00705939|2511904|P3|NOT COMPLETED|Overall Study||4
1034592|NCT00705939|2511905|P2|NOT COMPLETED|Overall Study||2
1034593|NCT00705939|2511906|P1|NOT COMPLETED|Overall Study||0
1034594|NCT00705939|2511904|P3|COMPLETED|Overall Study||14
1034595|NCT00705939|2511905|P2|COMPLETED|Overall Study||12
1034596|NCT00705939|2511906|P1|COMPLETED|Overall Study||12
1034597|NCT00705939|2511904|P3|STARTED|Overall Study|1 subject enrolled but not treated in this protocol.|18
1034598|NCT00705939|2511905|P2|STARTED|Overall Study||14
1034599|NCT00705939|2511906|P1|STARTED|Overall Study||12
1034600|NCT00706004|2511929|P1|NOT COMPLETED|Overall Study||2
1034601|NCT00706004|2511929|P1|COMPLETED|Overall Study||7
1034602|NCT00706004|2511929|P1|STARTED|Overall Study||9
1034603|NCT00706095|2511957|P3|NOT COMPLETED|Overall Study||5
1034604|NCT00706095|2511958|P2|NOT COMPLETED|Overall Study||7
1034605|NCT00706095|2511959|P1|NOT COMPLETED|Overall Study||6
1034606|NCT00706095|2511957|P3|COMPLETED|Overall Study||0
1034607|NCT00706095|2511958|P2|COMPLETED|Overall Study||0
1034608|NCT00706095|2511959|P1|COMPLETED|Overall Study||0
1034609|NCT00706095|2511957|P3|STARTED|Overall Study||5
1034610|NCT00706095|2511958|P2|STARTED|Overall Study||7
1034611|NCT00706095|2511959|P1|STARTED|Overall Study||6
1034612|NCT00706121|2511977|P4|NOT COMPLETED|Overall Study||352
1034613|NCT00706121|2511978|P3|NOT COMPLETED|Overall Study||404
1034614|NCT00706121|2511979|P2|NOT COMPLETED|Overall Study||396
1034615|NCT00706121|2511980|P1|NOT COMPLETED|Overall Study||396
1034616|NCT00706121|2511977|P4|COMPLETED|Overall Study||1577
1034617|NCT00706121|2511978|P3|COMPLETED|Overall Study||1626
1034618|NCT00706121|2511979|P2|COMPLETED|Overall Study||1700
1034619|NCT00706121|2511980|P1|COMPLETED|Overall Study||1643
1034620|NCT00706121|2511977|P4|STARTED|Overall Study||1929
1034621|NCT00706121|2511978|P3|STARTED|Overall Study||2030
1034622|NCT00706121|2511979|P2|STARTED|Overall Study||2096
1034623|NCT00706121|2511980|P1|STARTED|Overall Study||2039
1034624|NCT00706134|2512010|P4|NOT COMPLETED|Overall Study||11
1034625|NCT00706134|2512011|P3|NOT COMPLETED|Overall Study||6
1034626|NCT00706134|2512012|P2|NOT COMPLETED|Overall Study||19
1034627|NCT00706134|2512013|P1|NOT COMPLETED|Overall Study||20
1034628|NCT00706134|2512010|P4|COMPLETED|Overall Study||175
1034629|NCT00706134|2512011|P3|COMPLETED|Overall Study||183
1034630|NCT00706134|2512012|P2|COMPLETED|Overall Study||173
1034631|NCT00706134|2512013|P1|COMPLETED|Overall Study||169
1034632|NCT00706134|2512010|P4|Entered Double-blind Period|Overall Study||186
1034633|NCT00706134|2512011|P3|Entered Double-blind Period|Overall Study||189
1034634|NCT00706134|2512012|P2|Entered Double-blind Period|Overall Study||192
1034635|NCT00706134|2512013|P1|Entered Double-blind Period|Overall Study||187
1034636|NCT00706134|2512010|P4|STARTED|Overall Study||186
1034637|NCT00706134|2512011|P3|STARTED|Overall Study||189
1034638|NCT00706134|2512012|P2|STARTED|Overall Study||192
1034639|NCT00706134|2512013|P1|STARTED|Overall Study||189
1034640|NCT00706329|2512043|P1|NOT COMPLETED|Overall Study||0
1034641|NCT00706329|2512043|P1|COMPLETED|Overall Study||25
1034642|NCT00706329|2512043|P1|STARTED|Overall Study||25
1034643|NCT00706342|2512047|P1|NOT COMPLETED|Overall Study||18
1034644|NCT00706342|2512047|P1|COMPLETED|Overall Study||0
1034645|NCT00706342|2512047|P1|STARTED|Overall Study||18
1034646|NCT00706355|2512060|P4|NOT COMPLETED|Period 4: PF-04217903 150 mg||4
1034647|NCT00706355|2512061|P3|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
1034648|NCT00706355|2512062|P2|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
1034649|NCT00706355|2512063|P1|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
1034650|NCT00706355|2512060|P4|COMPLETED|Period 4: PF-04217903 150 mg||0
1034651|NCT00706355|2512061|P3|COMPLETED|Period 4: PF-04217903 150 mg||0
1034652|NCT00706355|2512062|P2|COMPLETED|Period 4: PF-04217903 150 mg||0
1034653|NCT00706355|2512063|P1|COMPLETED|Period 4: PF-04217903 150 mg||0
1034654|NCT00706355|2512060|P4|STARTED|Period 4: PF-04217903 150 mg||4
1034655|NCT00706355|2512061|P3|STARTED|Period 4: PF-04217903 150 mg||0
1034656|NCT00706355|2512062|P2|STARTED|Period 4: PF-04217903 150 mg||0
1034657|NCT00706355|2512063|P1|STARTED|Period 4: PF-04217903 150 mg||0
1034658|NCT00706355|2512060|P4|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
1034659|NCT00706355|2512061|P3|NOT COMPLETED|Period 3: PF-04217903 200 mg||2
1034660|NCT00706355|2512062|P2|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
1034661|NCT00706355|2512063|P1|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
1034662|NCT00706355|2512060|P4|COMPLETED|Period 3: PF-04217903 200 mg||0
1034663|NCT00706355|2512061|P3|COMPLETED|Period 3: PF-04217903 200 mg||0
1034664|NCT00706355|2512062|P2|COMPLETED|Period 3: PF-04217903 200 mg||0
1034665|NCT00706355|2512063|P1|COMPLETED|Period 3: PF-04217903 200 mg||0
1034666|NCT00706355|2512060|P4|STARTED|Period 3: PF-04217903 200 mg||0
1034667|NCT00706355|2512061|P3|STARTED|Period 3: PF-04217903 200 mg||2
1034668|NCT00706355|2512062|P2|STARTED|Period 3: PF-04217903 200 mg||0
1034669|NCT00706355|2512063|P1|STARTED|Period 3: PF-04217903 200 mg||0
1034670|NCT00706355|2512060|P4|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
1034671|NCT00706355|2512061|P3|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
1034672|NCT00706355|2512062|P2|NOT COMPLETED|Period 2: PF-04217903 100 mg||7
1034673|NCT00706355|2512063|P1|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
1034674|NCT00706355|2512060|P4|COMPLETED|Period 2: PF-04217903 100 mg||0
1034675|NCT00706355|2512061|P3|COMPLETED|Period 2: PF-04217903 100 mg||0
1034676|NCT00706355|2512062|P2|COMPLETED|Period 2: PF-04217903 100 mg||0
1034677|NCT00706355|2512063|P1|COMPLETED|Period 2: PF-04217903 100 mg||0
1034678|NCT00706355|2512060|P4|STARTED|Period 2: PF-04217903 100 mg||0
1034679|NCT00706355|2512061|P3|STARTED|Period 2: PF-04217903 100 mg||0
1034680|NCT00706355|2512062|P2|STARTED|Period 2: PF-04217903 100 mg||7
1034681|NCT00706355|2512063|P1|STARTED|Period 2: PF-04217903 100 mg||0
1034682|NCT00706355|2512060|P4|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
1034683|NCT00706355|2512061|P3|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
1034684|NCT00706355|2512062|P2|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
1034685|NCT00706355|2512063|P1|NOT COMPLETED|Period 1: PF-04217903 50 mg||3
1034686|NCT00706355|2512060|P4|COMPLETED|Period 1: PF-04217903 50 mg||0
1034687|NCT00706355|2512061|P3|COMPLETED|Period 1: PF-04217903 50 mg||0
1034688|NCT00706355|2512062|P2|COMPLETED|Period 1: PF-04217903 50 mg||0
1034689|NCT00706355|2512063|P1|COMPLETED|Period 1: PF-04217903 50 mg||0
1034690|NCT00706355|2512060|P4|STARTED|Period 1: PF-04217903 50 mg||0
1034691|NCT00706355|2512061|P3|STARTED|Period 1: PF-04217903 50 mg||0
1034692|NCT00706355|2512062|P2|STARTED|Period 1: PF-04217903 50 mg||0
1034693|NCT00706355|2512063|P1|STARTED|Period 1: PF-04217903 50 mg||3
1034694|NCT00706433|2512119|P4|NOT COMPLETED|Overall Study||2
1034695|NCT00706433|2512120|P3|NOT COMPLETED|Overall Study||10
1034696|NCT00706433|2512121|P2|NOT COMPLETED|Overall Study||3
1034697|NCT00706433|2512122|P1|NOT COMPLETED|Overall Study||5
1034698|NCT00706433|2512119|P4|COMPLETED|Overall Study||64
1034699|NCT00706433|2512120|P3|COMPLETED|Overall Study||57
1034700|NCT00706433|2512121|P2|COMPLETED|Overall Study||62
1034701|NCT00706433|2512122|P1|COMPLETED|Overall Study||63
1034702|NCT00706433|2512119|P4|STARTED|Overall Study||66
1034703|NCT00706433|2512120|P3|STARTED|Overall Study||67
1034704|NCT00706433|2512121|P2|STARTED|Overall Study||65
1034705|NCT00706433|2512122|P1|STARTED|Overall Study||68
1034724|NCT00706485|2512485|P1|NOT COMPLETED|Overall Study||0
1034725|NCT00706485|2512485|P1|COMPLETED|Overall Study||5
1034726|NCT00706485|2512485|P1|STARTED|Overall Study||5
1034727|NCT00706550|2512493|P2|NOT COMPLETED|Overall Study||28
1034728|NCT00706550|2512494|P1|NOT COMPLETED|Overall Study||7
1034729|NCT00706550|2512493|P2|COMPLETED|Overall Study||36
1034730|NCT00706550|2512494|P1|COMPLETED|Overall Study||36
1034731|NCT00706550|2512493|P2|STARTED|Overall Study||64
1034732|NCT00706550|2512494|P1|STARTED|Overall Study||43
1034733|NCT00706563|2512512|P2|NOT COMPLETED|Overall Study||0
1034734|NCT00706563|2512513|P1|NOT COMPLETED|Overall Study||0
1034735|NCT00706563|2512512|P2|COMPLETED|Overall Study||59
1034736|NCT00706563|2512513|P1|COMPLETED|Overall Study||61
1034737|NCT00706563|2512512|P2|STARTED|Overall Study||59
1034738|NCT00706563|2512513|P1|STARTED|Overall Study||61
1034739|NCT00706589|2512537|P2|NOT COMPLETED|Overall Study||4
1034740|NCT00706589|2512538|P1|NOT COMPLETED|Overall Study||3
1034741|NCT00706589|2512537|P2|COMPLETED|Overall Study||25
1034742|NCT00706589|2512538|P1|COMPLETED|Overall Study||29
1034743|NCT00706589|2512537|P2|STARTED|Overall Study||29
1034744|NCT00706589|2512538|P1|STARTED|Overall Study||32
1034745|NCT00706628|2512548|P4|NOT COMPLETED|Overall Study||3
1034746|NCT00706628|2512549|P3|NOT COMPLETED|Overall Study||16
1034747|NCT00706628|2512550|P2|NOT COMPLETED|Overall Study||21
1034748|NCT00706628|2512551|P1|NOT COMPLETED|Overall Study||47
1034749|NCT00706628|2512548|P4|COMPLETED|Overall Study||0
1034750|NCT00706628|2512549|P3|COMPLETED|Overall Study||0
1034751|NCT00706628|2512550|P2|COMPLETED|Overall Study||0
1034752|NCT00706628|2512551|P1|COMPLETED|Overall Study||0
1034753|NCT00706628|2512548|P4|STARTED|Overall Study||3
1034754|NCT00706628|2512549|P3|STARTED|Overall Study||16
1034755|NCT00706628|2512550|P2|STARTED|Overall Study||21
1034756|NCT00706628|2512551|P1|STARTED|Overall Study||47
1034757|NCT00706641|2512599|P1|NOT COMPLETED|Radical Cystectomy||1
1034758|NCT00706641|2512599|P1|COMPLETED|Radical Cystectomy||22
1034759|NCT00706641|2512599|P1|STARTED|Radical Cystectomy||23
1034760|NCT00706641|2512599|P1|NOT COMPLETED|Dasatinib Administration||2
1034761|NCT00706641|2512599|P1|COMPLETED|Dasatinib Administration||23
1034762|NCT00706641|2512599|P1|Toxicity Evaluation|Dasatinib Administration||24
1034763|NCT00706641|2512599|P1|STARTED|Dasatinib Administration||25
1034764|NCT00706654|2512612|P4|NOT COMPLETED|Depot Maintenance Phase||70
1034765|NCT00706654|2512613|P3|NOT COMPLETED|Depot Maintenance Phase||88
1034766|NCT00706654|2512614|P2|NOT COMPLETED|Depot Maintenance Phase||69
1034767|NCT00706654|2512615|P1|NOT COMPLETED|Depot Maintenance Phase||0
1034768|NCT00706654|2512612|P4|COMPLETED|Depot Maintenance Phase||61
1034769|NCT00706654|2512613|P3|COMPLETED|Depot Maintenance Phase||178
1034770|NCT00706654|2512614|P2|COMPLETED|Depot Maintenance Phase||196
1034771|NCT00706654|2512615|P1|COMPLETED|Depot Maintenance Phase||0
1034772|NCT00706654|2512612|P4|STARTED|Depot Maintenance Phase||131
1034773|NCT00706654|2512613|P3|STARTED|Depot Maintenance Phase||266
1034774|NCT00706654|2512614|P2|STARTED|Depot Maintenance Phase||265
1034775|NCT00706654|2512615|P1|STARTED|Depot Maintenance Phase|Patients were randomized into the 3 aripiprazole treatment groups in this phase of the study.|0
1034776|NCT00706654|2512612|P4|NOT COMPLETED|Oral Stabilization Phase||0
1034777|NCT00706654|2512613|P3|NOT COMPLETED|Oral Stabilization Phase||0
1034778|NCT00706654|2512614|P2|NOT COMPLETED|Oral Stabilization Phase||0
1034779|NCT00706654|2512615|P1|NOT COMPLETED|Oral Stabilization Phase||180
1034780|NCT00706654|2512612|P4|COMPLETED|Oral Stabilization Phase||0
1034781|NCT00706654|2512613|P3|COMPLETED|Oral Stabilization Phase||0
1034782|NCT00706654|2512614|P2|COMPLETED|Oral Stabilization Phase||0
1034783|NCT00706654|2512615|P1|COMPLETED|Oral Stabilization Phase||662
1034784|NCT00706654|2512612|P4|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
1034785|NCT00706654|2512613|P3|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
1034786|NCT00706654|2512614|P2|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
1034787|NCT00706654|2512615|P1|STARTED|Oral Stabilization Phase|228 of the 842 patients who started this phase enrolled directly into this phase of the study.|842
1034788|NCT00706654|2512612|P4|NOT COMPLETED|Conversion Phase||0
1034789|NCT00706654|2512613|P3|NOT COMPLETED|Conversion Phase||0
1034790|NCT00706654|2512614|P2|NOT COMPLETED|Conversion Phase||0
1034791|NCT00706654|2512615|P1|NOT COMPLETED|Conversion Phase||95
1034792|NCT00706654|2512612|P4|COMPLETED|Conversion Phase||0
1034793|NCT00706654|2512613|P3|COMPLETED|Conversion Phase||0
1034794|NCT00706654|2512614|P2|COMPLETED|Conversion Phase||0
1034795|NCT00706654|2512615|P1|COMPLETED|Conversion Phase||614
1034796|NCT00706654|2512612|P4|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
1034797|NCT00706654|2512613|P3|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
1034798|NCT00706654|2512614|P2|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
1034799|NCT00706654|2512615|P1|STARTED|Conversion Phase||709
1034800|NCT00706706|2512634|P1|NOT COMPLETED|Overall Study||105
1034801|NCT00706706|2512634|P1|COMPLETED|Overall Study||0
1034802|NCT00706706|2512634|P1|STARTED|Overall Study||105
1034803|NCT00706719|2512644|P3|NOT COMPLETED|Overall Study||4
1034804|NCT00706719|2512645|P2|NOT COMPLETED|Overall Study||1
1034805|NCT00706719|2512646|P1|NOT COMPLETED|Overall Study||0
1034806|NCT00706719|2512644|P3|COMPLETED|Overall Study||1
1034807|NCT00706719|2512645|P2|COMPLETED|Overall Study||6
1034808|NCT00706719|2512646|P1|COMPLETED|Overall Study||5
1034809|NCT00706719|2512644|P3|STARTED|Overall Study||5
1034810|NCT00706719|2512645|P2|STARTED|Overall Study||7
1034811|NCT00706719|2512646|P1|STARTED|Overall Study||5
1034812|NCT00706784|2512663|P2|NOT COMPLETED|Overall Study||0
1034813|NCT00706784|2512664|P1|NOT COMPLETED|Overall Study||0
1034814|NCT00706784|2512663|P2|COMPLETED|Overall Study||3
1034815|NCT00706784|2512664|P1|COMPLETED|Overall Study||3
1034816|NCT00706784|2512663|P2|STARTED|Overall Study||3
1034817|NCT00706784|2512664|P1|STARTED|Overall Study||3
1034818|NCT00706797|2512672|P2|NOT COMPLETED|Overall Study||71
1034819|NCT00706797|2512673|P1|NOT COMPLETED|Overall Study||69
1034820|NCT00706797|2512672|P2|COMPLETED|Overall Study||0
1034821|NCT00706797|2512673|P1|COMPLETED|Overall Study||1
1034822|NCT00706797|2512672|P2|Safety Population|Overall Study||71
1034823|NCT00706797|2512673|P1|Safety Population|Overall Study|Safety population=all randomly assigned subjects who had at least 1 dose of study treatment.|63
1034824|NCT00706797|2512672|P2|STARTED|Overall Study||71
1034825|NCT00706797|2512673|P1|STARTED|Overall Study||70
1034826|NCT00706810|2512713|P1|NOT COMPLETED|Overall Study||1
1034827|NCT00706810|2512713|P1|COMPLETED|Overall Study||7
1034828|NCT00706810|2512713|P1|STARTED|Overall Study||8
1034829|NCT00706823|2512720|P2|NOT COMPLETED|Overall Study||0
1034830|NCT00706823|2512721|P1|NOT COMPLETED|Overall Study||0
1034831|NCT00706823|2512720|P2|COMPLETED|Overall Study||25
1034832|NCT00706823|2512721|P1|COMPLETED|Overall Study||25
1034833|NCT00706823|2512720|P2|STARTED|Overall Study||25
1034834|NCT00706823|2512721|P1|STARTED|Overall Study||25
1034835|NCT00706836|2512737|P1|NOT COMPLETED|Overall Study||0
1034836|NCT00706836|2512737|P1|COMPLETED|Overall Study||16
1034837|NCT00706836|2512737|P1|STARTED|Overall Study||16
1034838|NCT00706849|2512747|P2|NOT COMPLETED|Follow-up Period||3
1034839|NCT00706849|2512748|P1|NOT COMPLETED|Follow-up Period||0
1034840|NCT00706849|2512747|P2|COMPLETED|Follow-up Period||25
1034841|NCT00706849|2512748|P1|COMPLETED|Follow-up Period||3
1034842|NCT00706849|2512747|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|28
1034843|NCT00706849|2512748|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|3
1034844|NCT00706849|2512747|P2|NOT COMPLETED|Treatment Period||10
1034845|NCT00706849|2512748|P1|NOT COMPLETED|Treatment Period||0
1034846|NCT00706849|2512747|P2|COMPLETED|Treatment Period|55 patients entered the open-label extension study (301012-CS6; NCT00694109).|73
1034847|NCT00706849|2512748|P1|COMPLETED|Treatment Period|38 patients entered the open-label extension study (301012-CS6; NCT00694109).|41
1034848|NCT00706849|2512747|P2|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement.|82
1034849|NCT00706849|2512748|P1|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|41
1034850|NCT00706849|2512747|P2|STARTED|Treatment Period||83
1034851|NCT00706849|2512748|P1|STARTED|Treatment Period||41
1034852|NCT00706901|2512795|P3|NOT COMPLETED|Overall Study||8
1034853|NCT00706901|2512796|P2|NOT COMPLETED|Overall Study||5
1034854|NCT00706901|2512797|P1|NOT COMPLETED|Overall Study||8
1034855|NCT00706901|2512795|P3|COMPLETED|Overall Study||51
1034856|NCT00706901|2512796|P2|COMPLETED|Overall Study||57
1034857|NCT00706901|2512797|P1|COMPLETED|Overall Study||51
1034858|NCT00706901|2512795|P3|STARTED|Overall Study||59
1034859|NCT00706901|2512796|P2|STARTED|Overall Study||62
1034860|NCT00706901|2512797|P1|STARTED|Overall Study||59
1034861|NCT00706914|2512823|P3|NOT COMPLETED|Overall Study||1
1034862|NCT00706914|2512824|P2|NOT COMPLETED|Overall Study||4
1034863|NCT00706914|2512825|P1|NOT COMPLETED|Overall Study||6
1034864|NCT00706914|2512823|P3|COMPLETED|Overall Study||30
1034865|NCT00706914|2512824|P2|COMPLETED|Overall Study||58
1034866|NCT00706914|2512825|P1|COMPLETED|Overall Study||57
1034867|NCT00706914|2512823|P3|STARTED|Overall Study||31
1034868|NCT00706914|2512824|P2|STARTED|Overall Study||62
1034869|NCT00706914|2512825|P1|STARTED|Overall Study||63
1034870|NCT00706966|2512845|P1|NOT COMPLETED|Overall Study||1
1034871|NCT00706966|2512845|P1|COMPLETED|Overall Study||9
1034872|NCT00706966|2512845|P1|STARTED|Overall Study||10
1034873|NCT00706979|2512880|P2|NOT COMPLETED|Overall Study||0
1034874|NCT00706979|2512881|P1|NOT COMPLETED|Overall Study||0
1034875|NCT00706979|2512880|P2|COMPLETED|Overall Study||423
1034876|NCT00706979|2512881|P1|COMPLETED|Overall Study||426
1034877|NCT00706979|2512880|P2|STARTED|Overall Study||423
1034878|NCT00706979|2512881|P1|STARTED|Overall Study||426
1034879|NCT00706992|2512900|P7|NOT COMPLETED|Overall Study||3
1034880|NCT00706992|2512901|P6|NOT COMPLETED|Overall Study||2
1034881|NCT00706992|2512902|P5|NOT COMPLETED|Overall Study||4
1034882|NCT00706992|2512903|P4|NOT COMPLETED|Overall Study||2
1034883|NCT00706992|2512904|P3|NOT COMPLETED|Overall Study||6
1034884|NCT00706992|2512905|P2|NOT COMPLETED|Overall Study||5
1034885|NCT00706992|2512906|P1|NOT COMPLETED|Overall Study||5
1034886|NCT00706992|2512900|P7|COMPLETED|Overall Study||3
1034887|NCT00706992|2512901|P6|COMPLETED|Overall Study||3
1034888|NCT00706992|2512902|P5|COMPLETED|Overall Study||2
1034889|NCT00706992|2512903|P4|COMPLETED|Overall Study||6
1034890|NCT00706992|2512904|P3|COMPLETED|Overall Study||3
1034891|NCT00706992|2512905|P2|COMPLETED|Overall Study||3
1034892|NCT00706992|2512906|P1|COMPLETED|Overall Study||3
1034893|NCT00706992|2512900|P7|STARTED|Overall Study||6
1034894|NCT00706992|2512901|P6|STARTED|Overall Study||5
1034895|NCT00706992|2512902|P5|STARTED|Overall Study||6
1034896|NCT00706992|2512903|P4|STARTED|Overall Study||8
1034897|NCT00706992|2512904|P3|STARTED|Overall Study||9
1034898|NCT00706992|2512905|P2|STARTED|Overall Study||8
1034899|NCT00706992|2512906|P1|STARTED|Overall Study||8
1034900|NCT00707031|2512925|P2|NOT COMPLETED|Overall Study||99
1034901|NCT00707031|2512926|P1|NOT COMPLETED|Overall Study||104
1034902|NCT00707031|2512925|P2|COMPLETED|Overall Study||220
1034903|NCT00707031|2512926|P1|COMPLETED|Overall Study||216
1034904|NCT00707031|2512925|P2|Modified Intent-to-Treat Population|Overall Study||315
1034905|NCT00707031|2512926|P1|Modified Intent-to-Treat Population|Overall Study|All patients who received at least 1 dose;had baseline;at least 1 post-baseline efficacy assessment.|315
1034906|NCT00707031|2512925|P2|Treated/Safety Population|Overall Study||316
1034907|NCT00707031|2512926|P1|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|318
1034908|NCT00707031|2512925|P2|STARTED|Overall Study||319
1034909|NCT00707031|2512926|P1|STARTED|Overall Study|Randomized|320
1034910|NCT00707057|2512950|P2|NOT COMPLETED|Overall Study||4
1034911|NCT00707057|2512951|P1|NOT COMPLETED|Overall Study||8
1034912|NCT00707057|2512950|P2|COMPLETED|Overall Study||83
1034913|NCT00707057|2512951|P1|COMPLETED|Overall Study||161
1034914|NCT00707057|2512950|P2|STARTED|Overall Study||87
1034915|NCT00707057|2512951|P1|STARTED|Overall Study||169
1034916|NCT00707161|2512983|P1|NOT COMPLETED|Overall Study||6
1034917|NCT00707161|2512983|P1|COMPLETED|Overall Study||0
1034918|NCT00707161|2512983|P1|STARTED|Overall Study|3 deceased (1-Huntsman Cancer Institute, 2- LDS Hospital).|6
1034919|NCT00707174|2512989|P2|NOT COMPLETED|Overall Study||7
1034920|NCT00707174|2512990|P1|NOT COMPLETED|Overall Study||5
1034921|NCT00707174|2512989|P2|COMPLETED|Overall Study||37
1034922|NCT00707174|2512990|P1|COMPLETED|Overall Study||41
1034923|NCT00707174|2512989|P2|STARTED|Overall Study||44
1034924|NCT00707174|2512990|P1|STARTED|Overall Study||46
1034925|NCT00707239|2512999|P3|NOT COMPLETED|Overall Study||14
1034926|NCT00707239|2513000|P2|NOT COMPLETED|Overall Study||11
1034927|NCT00707239|2513001|P1|NOT COMPLETED|Overall Study||19
1034928|NCT00707239|2512999|P3|COMPLETED|Overall Study||21
1034929|NCT00707239|2513000|P2|COMPLETED|Overall Study||25
1034930|NCT00707239|2513001|P1|COMPLETED|Overall Study||18
1034931|NCT00707239|2512999|P3|Treated|Overall Study||34
1034932|NCT00707239|2513000|P2|Treated|Overall Study||35
1034933|NCT00707239|2513001|P1|Treated|Overall Study||36
1034934|NCT00707239|2512999|P3|STARTED|Overall Study||35
1034935|NCT00707239|2513000|P2|STARTED|Overall Study||36
1034936|NCT00707239|2513001|P1|STARTED|Overall Study||37
1034937|NCT00707343|2513047|P1|NOT COMPLETED|Overall Study||0
1034938|NCT00707343|2513047|P1|COMPLETED|Overall Study||15
1034939|NCT00707343|2513047|P1|STARTED|Overall Study||15
1034940|NCT00707447|2513053|P2|NOT COMPLETED|Overall Study||8
1034941|NCT00707447|2513054|P1|NOT COMPLETED|Overall Study||8
1034942|NCT00707447|2513053|P2|COMPLETED|Overall Study||85
1034943|NCT00707447|2513054|P1|COMPLETED|Overall Study||81
1034944|NCT00707447|2513053|P2|STARTED|Overall Study||93
1034945|NCT00707447|2513054|P1|STARTED|Overall Study||89
1034946|NCT00707486|2513078|P1|NOT COMPLETED|Overall Study||1
1034947|NCT00707486|2513078|P1|COMPLETED|Overall Study||71
1034948|NCT00707486|2513078|P1|STARTED|Overall Study||72
1034949|NCT00707577|2513089|P2|NOT COMPLETED|Overall Study||38
1034950|NCT00707577|2513090|P1|NOT COMPLETED|Overall Study||54
1034951|NCT00707577|2513089|P2|COMPLETED|Overall Study||118
1034952|NCT00707577|2513090|P1|COMPLETED|Overall Study||120
1034953|NCT00707577|2513089|P2|STARTED|Overall Study||156
1034954|NCT00707577|2513090|P1|STARTED|Overall Study||174
1034955|NCT00707655|2513098|P2|NOT COMPLETED|Overall Study||2
1034956|NCT00707655|2513099|P1|NOT COMPLETED|Overall Study||0
1034957|NCT00707655|2513098|P2|COMPLETED|Overall Study||3
1034958|NCT00707655|2513099|P1|COMPLETED|Overall Study||3
1034959|NCT00707655|2513098|P2|STARTED|Overall Study||5
1034960|NCT00707655|2513099|P1|STARTED|Overall Study||3
1034961|NCT00707746|2513111|P2|NOT COMPLETED|Follow-up Period||0
1034962|NCT00707746|2513112|P1|NOT COMPLETED|Follow-up Period||0
1034963|NCT00707746|2513111|P2|COMPLETED|Follow-up Period||21
1034964|NCT00707746|2513112|P1|COMPLETED|Follow-up Period||12
1034965|NCT00707746|2513111|P2|STARTED|Follow-up Period||21
1034966|NCT00707746|2513112|P1|STARTED|Follow-up Period||12
1034967|NCT00707746|2513111|P2|NOT COMPLETED|Treatment Period||5
1034968|NCT00707746|2513112|P1|NOT COMPLETED|Treatment Period||2
1034969|NCT00707746|2513111|P2|COMPLETED|Treatment Period||17
1034970|NCT00707746|2513112|P1|COMPLETED|Treatment Period||10
1034971|NCT00707746|2513111|P2|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|21
1034972|NCT00707746|2513112|P1|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|12
1034973|NCT00707746|2513111|P2|STARTED|Treatment Period||22
1034974|NCT00707746|2513112|P1|STARTED|Treatment Period||12
1034975|NCT00707759|2513160|P2|NOT COMPLETED|Overall Study||2
1034976|NCT00707759|2513161|P1|NOT COMPLETED|Overall Study||2
1034977|NCT00707759|2513160|P2|COMPLETED|Overall Study||12
1034978|NCT00707759|2513161|P1|COMPLETED|Overall Study||12
1034979|NCT00707759|2513160|P2|STARTED|Overall Study||14
1034980|NCT00707759|2513161|P1|STARTED|Overall Study||14
1034981|NCT00707863|2513169|P2|NOT COMPLETED|Overall Study||3
1034982|NCT00707863|2513170|P1|NOT COMPLETED|Overall Study||0
1034983|NCT00707863|2513169|P2|COMPLETED|Overall Study||8
1034984|NCT00707863|2513170|P1|COMPLETED|Overall Study||6
1034985|NCT00707863|2513169|P2|STARTED|Overall Study||11
1034986|NCT00707863|2513170|P1|STARTED|Overall Study||6
1034987|NCT00707915|2513176|P1|NOT COMPLETED|Overall Study||0
1034988|NCT00707915|2513176|P1|COMPLETED|Overall Study||30
1034989|NCT00707915|2513176|P1|Effects of Discontinuing Benzodiazepine|Overall Study||30
1034990|NCT00707915|2513176|P1|STARTED|Overall Study||30
1034991|NCT00707954|2513190|P5|NOT COMPLETED|Overall Study||1
1034992|NCT00707954|2513191|P4|NOT COMPLETED|Overall Study||0
1034993|NCT00707954|2513192|P3|NOT COMPLETED|Overall Study||0
1034994|NCT00707954|2513193|P2|NOT COMPLETED|Overall Study||0
1034995|NCT00707954|2513194|P1|NOT COMPLETED|Overall Study||0
1034996|NCT00707954|2513190|P5|COMPLETED|Overall Study||9
1034997|NCT00707954|2513191|P4|COMPLETED|Overall Study||13
1034998|NCT00707954|2513192|P3|COMPLETED|Overall Study||14
1034999|NCT00707954|2513193|P2|COMPLETED|Overall Study||12
1035000|NCT00707954|2513194|P1|COMPLETED|Overall Study||12
1035001|NCT00707954|2513190|P5|STARTED|Overall Study||10
1035002|NCT00707954|2513191|P4|STARTED|Overall Study||13
1035003|NCT00707954|2513192|P3|STARTED|Overall Study||14
1035004|NCT00707954|2513193|P2|STARTED|Overall Study||12
1035005|NCT00707954|2513194|P1|STARTED|Overall Study||12
1035006|NCT00707967|2513209|P3|NOT COMPLETED|Overall Study||0
1035007|NCT00707967|2513210|P2|NOT COMPLETED|Overall Study||0
1035008|NCT00707967|2513211|P1|NOT COMPLETED|Overall Study||0
1035009|NCT00707967|2513209|P3|COMPLETED|Overall Study||7
1035010|NCT00707967|2513210|P2|COMPLETED|Overall Study||8
1035011|NCT00707967|2513211|P1|COMPLETED|Overall Study||22
1035012|NCT00707967|2513209|P3|STARTED|Overall Study||7
1035013|NCT00707967|2513210|P2|STARTED|Overall Study||8
1035014|NCT00707967|2513211|P1|STARTED|Overall Study||22
1035015|NCT00707980|2513270|P1|NOT COMPLETED|Overall Study||310
1035016|NCT00707980|2513270|P1|COMPLETED|Overall Study||526
1035017|NCT00707980|2513270|P1|Received Treatment|Overall Study||834
1035018|NCT00707980|2513270|P1|STARTED|Overall Study||836
1035019|NCT00707993|2513287|P2|NOT COMPLETED|Overall Study||94
1035020|NCT00707993|2513288|P1|NOT COMPLETED|Overall Study||89
1035021|NCT00707993|2513287|P2|COMPLETED|Overall Study||125
1035022|NCT00707993|2513288|P1|COMPLETED|Overall Study||133
1035023|NCT00707993|2513287|P2|STARTED|Overall Study||219
1035024|NCT00707993|2513288|P1|STARTED|Overall Study||222
1035025|NCT00715208|2513332|P2|NOT COMPLETED|Overall Study||9
1035026|NCT00715208|2513333|P1|NOT COMPLETED|Overall Study||1
1035027|NCT00715208|2513332|P2|COMPLETED|Overall Study||39
1035028|NCT00715208|2513333|P1|COMPLETED|Overall Study||6
1035029|NCT00715208|2513332|P2|STARTED|Overall Study||48
1035030|NCT00715208|2513333|P1|STARTED|Overall Study||7
1035031|NCT00715299|2513347|P1|NOT COMPLETED|Overall Study||6
1035032|NCT00715299|2513347|P1|COMPLETED|Overall Study||30
1035033|NCT00715299|2513347|P1|STARTED|Overall Study|A total of 38 participants were consented to the study, but only 36 made it to day one of testing.|36
1035034|NCT00715390|2513351|P1|NOT COMPLETED|Overall Study||0
1035035|NCT00715390|2513351|P1|COMPLETED|Overall Study|These were broken down to different types of dysrhythymia.|234
1035036|NCT00715390|2513351|P1|Eligible|Overall Study||234
1035037|NCT00715390|2513351|P1|STARTED|Overall Study|114,209 Anesthetic records were screened to identify 234 records.|234
1035038|NCT00715403|2513362|P7|NOT COMPLETED|Overall Study||1
1035039|NCT00715403|2513363|P6|NOT COMPLETED|Overall Study||19
1035040|NCT00715403|2513364|P5|NOT COMPLETED|Overall Study||6
1035041|NCT00715403|2513365|P4|NOT COMPLETED|Overall Study||9
1035042|NCT00715403|2513366|P3|NOT COMPLETED|Overall Study||4
1035043|NCT00715403|2513367|P2|NOT COMPLETED|Overall Study||1
1035044|NCT00715403|2513368|P1|NOT COMPLETED|Overall Study||1
1035045|NCT00715403|2513362|P7|COMPLETED|Overall Study||0
1035046|NCT00715403|2513363|P6|COMPLETED|Overall Study||0
1035047|NCT00715403|2513364|P5|COMPLETED|Overall Study||0
1035048|NCT00715403|2513365|P4|COMPLETED|Overall Study||0
1035049|NCT00715403|2513366|P3|COMPLETED|Overall Study||0
1035050|NCT00715403|2513367|P2|COMPLETED|Overall Study||0
1035051|NCT00715403|2513368|P1|COMPLETED|Overall Study||0
1035052|NCT00715403|2513362|P7|STARTED|Overall Study||1
1035053|NCT00715403|2513363|P6|STARTED|Overall Study||19
1035054|NCT00715403|2513364|P5|STARTED|Overall Study||6
1035055|NCT00715403|2513365|P4|STARTED|Overall Study||9
1035056|NCT00715403|2513366|P3|STARTED|Overall Study||4
1035057|NCT00715403|2513367|P2|STARTED|Overall Study||1
1035058|NCT00715403|2513368|P1|STARTED|Overall Study||1
1035059|NCT00715741|2513507|P4|NOT COMPLETED|Overall Study||0
1035060|NCT00715741|2513508|P3|NOT COMPLETED|Overall Study||0
1035061|NCT00715741|2513509|P2|NOT COMPLETED|Overall Study||0
1035062|NCT00715741|2513510|P1|NOT COMPLETED|Overall Study||0
1035063|NCT00715741|2513507|P4|COMPLETED|Overall Study||25
1035064|NCT00715741|2513508|P3|COMPLETED|Overall Study||25
1035065|NCT00715741|2513509|P2|COMPLETED|Overall Study||25
1035066|NCT00715741|2513510|P1|COMPLETED|Overall Study||25
1035067|NCT00715741|2513507|P4|STARTED|Overall Study||25
1035068|NCT00715741|2513508|P3|STARTED|Overall Study||25
1035069|NCT00715741|2513509|P2|STARTED|Overall Study||25
1035070|NCT00715741|2513510|P1|STARTED|Overall Study||25
1035071|NCT00715754|2513532|P1|NOT COMPLETED|Overall Study||0
1035072|NCT00715754|2513532|P1|COMPLETED|Overall Study||47
1035073|NCT00715754|2513532|P1|STARTED|Overall Study||47
1035074|NCT00715793|2513538|P2|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||2
1035075|NCT00715793|2513539|P1|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
1035076|NCT00715793|2513538|P2|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||27
1035077|NCT00715793|2513539|P1|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
1035078|NCT00715793|2513538|P2|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||29
1035079|NCT00715793|2513539|P1|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
1035080|NCT00715793|2513538|P2|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||0
1035081|NCT00715793|2513539|P1|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||1
1035082|NCT00715793|2513538|P2|COMPLETED|Phase 1 RP2D DAC + TMZ||6
1035083|NCT00715793|2513539|P1|COMPLETED|Phase 1 RP2D DAC + TMZ||3
1035084|NCT00715793|2513538|P2|STARTED|Phase 1 RP2D DAC + TMZ||6
1035085|NCT00715793|2513539|P1|STARTED|Phase 1 RP2D DAC + TMZ||4
1035086|NCT00715884|2513553|P2|NOT COMPLETED|Overall Study||1
1035087|NCT00715884|2513554|P1|NOT COMPLETED|Overall Study||8
1035088|NCT00715884|2513553|P2|COMPLETED|Overall Study||225
1035089|NCT00715884|2513554|P1|COMPLETED|Overall Study||444
1035090|NCT00715884|2513553|P2|STARTED|Overall Study||226
1035091|NCT00715884|2513554|P1|STARTED|Overall Study||452
1035092|NCT00715910|2513600|P6|NOT COMPLETED|Booster and ESFU Phase||13
1035093|NCT00715910|2513601|P5|NOT COMPLETED|Booster and ESFU Phase||2
1035094|NCT00715910|2513602|P4|NOT COMPLETED|Booster and ESFU Phase||11
1035095|NCT00715910|2513603|P3|NOT COMPLETED|Booster and ESFU Phase||0
1035096|NCT00715910|2513604|P2|NOT COMPLETED|Booster and ESFU Phase||0
1035097|NCT00715910|2513605|P1|NOT COMPLETED|Booster and ESFU Phase||0
1035098|NCT00715910|2513600|P6|COMPLETED|Booster and ESFU Phase||88
1035099|NCT00715910|2513601|P5|COMPLETED|Booster and ESFU Phase||36
1035100|NCT00715910|2513602|P4|COMPLETED|Booster and ESFU Phase||172
1035101|NCT00715910|2513603|P3|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
1035102|NCT00715910|2513604|P2|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
1035103|NCT00715910|2513605|P1|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
1035104|NCT00715910|2513600|P6|STARTED|Booster and ESFU Phase||101
1035105|NCT00715910|2513601|P5|STARTED|Booster and ESFU Phase||38
1035106|NCT00715910|2513602|P4|STARTED|Booster and ESFU Phase||183
1035107|NCT00715910|2513603|P3|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
1035108|NCT00715910|2513604|P2|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
1035109|NCT00715910|2513605|P1|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
1035110|NCT00715910|2513600|P6|NOT COMPLETED|Year 5||0
1035111|NCT00715910|2513601|P5|NOT COMPLETED|Year 5||0
1035112|NCT00715910|2513602|P4|NOT COMPLETED|Year 5||0
1035113|NCT00715910|2513603|P3|NOT COMPLETED|Year 5||0
1035114|NCT00715910|2513604|P2|NOT COMPLETED|Year 5||0
1035115|NCT00715910|2513605|P1|NOT COMPLETED|Year 5||0
1035116|NCT00715910|2513600|P6|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
1035117|NCT00715910|2513601|P5|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
1035118|NCT00715910|2513602|P4|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
1035119|NCT00715910|2513603|P3|COMPLETED|Year 5||38
1035120|NCT00715910|2513604|P2|COMPLETED|Year 5||56
1035121|NCT00715910|2513605|P1|COMPLETED|Year 5||218
1035122|NCT00715910|2513600|P6|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
1035123|NCT00715910|2513601|P5|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
1035124|NCT00715910|2513602|P4|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
1035125|NCT00715910|2513603|P3|STARTED|Year 5||38
1035126|NCT00715910|2513604|P2|STARTED|Year 5||56
1035127|NCT00715910|2513605|P1|STARTED|Year 5||218
1035128|NCT00715910|2513600|P6|NOT COMPLETED|Year 3||0
1035129|NCT00715910|2513601|P5|NOT COMPLETED|Year 3||0
1035130|NCT00715910|2513602|P4|NOT COMPLETED|Year 3||0
1035131|NCT00715910|2513603|P3|NOT COMPLETED|Year 3||0
1035132|NCT00715910|2513604|P2|NOT COMPLETED|Year 3||0
1035133|NCT00715910|2513605|P1|NOT COMPLETED|Year 3||0
1035134|NCT00715910|2513600|P6|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
1035135|NCT00715910|2513601|P5|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
1035136|NCT00715910|2513602|P4|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
1035137|NCT00715910|2513603|P3|COMPLETED|Year 3||56
1035138|NCT00715910|2513604|P2|COMPLETED|Year 3||86
1035139|NCT00715910|2513605|P1|COMPLETED|Year 3||345
1035140|NCT00715910|2513600|P6|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
1035141|NCT00715910|2513601|P5|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
1035142|NCT00715910|2513602|P4|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
1035143|NCT00715910|2513603|P3|STARTED|Year 3||56
1035144|NCT00715910|2513604|P2|STARTED|Year 3||86
1035145|NCT00715910|2513605|P1|STARTED|Year 3||345
1035146|NCT00715910|2513600|P6|NOT COMPLETED|Year 1||0
1035147|NCT00715910|2513601|P5|NOT COMPLETED|Year 1||0
1035148|NCT00715910|2513602|P4|NOT COMPLETED|Year 1||0
1035149|NCT00715910|2513603|P3|NOT COMPLETED|Year 1||0
1035150|NCT00715910|2513604|P2|NOT COMPLETED|Year 1||0
1035151|NCT00715910|2513605|P1|NOT COMPLETED|Year 1||0
1035152|NCT00715910|2513600|P6|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
1035153|NCT00715910|2513601|P5|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
1035154|NCT00715910|2513602|P4|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
1035155|NCT00715910|2513603|P3|COMPLETED|Year 1||68
1035156|NCT00715910|2513604|P2|COMPLETED|Year 1||147
1035157|NCT00715910|2513605|P1|COMPLETED|Year 1||433
1035158|NCT00715910|2513600|P6|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
1035159|NCT00715910|2513601|P5|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
1035160|NCT00715910|2513602|P4|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
1035161|NCT00715910|2513603|P3|STARTED|Year 1||68
1035162|NCT00715910|2513604|P2|STARTED|Year 1||147
1035163|NCT00715910|2513605|P1|STARTED|Year 1||433
1035164|NCT00715949|2513679|P1|NOT COMPLETED|Overall Study||4
1035165|NCT00715949|2513679|P1|COMPLETED|Overall Study|116 patients completed first test|116
1035166|NCT00715949|2513679|P1|STARTED|Overall Study|4 dropped because could not finish first test|120
1035167|NCT00715962|2513685|P2|NOT COMPLETED|Overall Study||2
1035168|NCT00715962|2513686|P1|NOT COMPLETED|Overall Study||6
1035169|NCT00715962|2513685|P2|COMPLETED|Overall Study||48
1035170|NCT00715962|2513686|P1|COMPLETED|Overall Study||44
1035171|NCT00715962|2513685|P2|STARTED|Overall Study||50
1035172|NCT00715962|2513686|P1|STARTED|Overall Study||50
1035173|NCT00716079|2513698|P2|NOT COMPLETED|Overall Study||15
1035174|NCT00716079|2513699|P1|NOT COMPLETED|Overall Study||9
1035175|NCT00716079|2513698|P2|COMPLETED|Overall Study||1421
1035176|NCT00716079|2513699|P1|COMPLETED|Overall Study||1394
1035177|NCT00716079|2513698|P2|STARTED|Overall Study||1436
1035178|NCT00716079|2513699|P1|STARTED|Overall Study||1403
1035179|NCT00716092|2513710|P3|NOT COMPLETED|Overall Study||0
1035180|NCT00716092|2513711|P2|NOT COMPLETED|Overall Study||1
1035181|NCT00716092|2513712|P1|NOT COMPLETED|Overall Study||2
1035182|NCT00716092|2513710|P3|COMPLETED|Overall Study||41
1035183|NCT00716092|2513711|P2|COMPLETED|Overall Study||39
1035184|NCT00716092|2513712|P1|COMPLETED|Overall Study||38
1035185|NCT00716092|2513710|P3|STARTED|Overall Study||41
1035186|NCT00716092|2513711|P2|STARTED|Overall Study||40
1035187|NCT00716092|2513712|P1|STARTED|Overall Study||40
1035188|NCT00716417|2513751|P10|NOT COMPLETED|Overall Study||3
1035189|NCT00716417|2513752|P9|NOT COMPLETED|Overall Study||5
1035190|NCT00716417|2513753|P8|NOT COMPLETED|Overall Study||3
1035191|NCT00716417|2513754|P7|NOT COMPLETED|Overall Study||7
1035192|NCT00716417|2513755|P6|NOT COMPLETED|Overall Study||3
1035193|NCT00716417|2513756|P5|NOT COMPLETED|Overall Study||1
1035194|NCT00716417|2513757|P4|NOT COMPLETED|Overall Study||11
1035195|NCT00716417|2513758|P3|NOT COMPLETED|Overall Study||5
1035196|NCT00716417|2513759|P2|NOT COMPLETED|Overall Study||6
1035197|NCT00716417|2513760|P1|NOT COMPLETED|Overall Study||3
1035198|NCT00716417|2513751|P10|COMPLETED|Overall Study||0
1035199|NCT00716417|2513752|P9|COMPLETED|Overall Study||0
1035200|NCT00716417|2513753|P8|COMPLETED|Overall Study||0
1035201|NCT00716417|2513754|P7|COMPLETED|Overall Study||0
1035202|NCT00716417|2513755|P6|COMPLETED|Overall Study||0
1035203|NCT00716417|2513756|P5|COMPLETED|Overall Study||0
1035204|NCT00716417|2513757|P4|COMPLETED|Overall Study||0
1035205|NCT00716417|2513758|P3|COMPLETED|Overall Study||0
1035206|NCT00716417|2513759|P2|COMPLETED|Overall Study||0
1035207|NCT00716417|2513760|P1|COMPLETED|Overall Study||0
1035208|NCT00716417|2513751|P10|STARTED|Overall Study||3
1035209|NCT00716417|2513752|P9|STARTED|Overall Study||5
1035210|NCT00716417|2513753|P8|STARTED|Overall Study||3
1035211|NCT00716417|2513754|P7|STARTED|Overall Study||7
1035212|NCT00716417|2513755|P6|STARTED|Overall Study||3
1035213|NCT00716417|2513756|P5|STARTED|Overall Study||1
1035214|NCT00716417|2513757|P4|STARTED|Overall Study||11
1035215|NCT00716417|2513758|P3|STARTED|Overall Study||5
1035216|NCT00716417|2513759|P2|STARTED|Overall Study||6
1035217|NCT00716417|2513760|P1|STARTED|Overall Study||3
1035218|NCT00716443|2513804|P1|NOT COMPLETED|Overall Study||0
1035219|NCT00716443|2513804|P1|COMPLETED|Overall Study||51
1035220|NCT00716443|2513804|P1|STARTED|Overall Study||51
1035221|NCT00716456|2513840|P3|NOT COMPLETED|Overall Study||0
1035222|NCT00716456|2513841|P2|NOT COMPLETED|Overall Study||2
1035223|NCT00716456|2513842|P1|NOT COMPLETED|Overall Study||0
1035224|NCT00716456|2513840|P3|COMPLETED|Overall Study||13
1035225|NCT00716456|2513841|P2|COMPLETED|Overall Study||3
1035226|NCT00716456|2513842|P1|COMPLETED|Overall Study||3
1035227|NCT00716456|2513840|P3|STARTED|Overall Study||13
1035228|NCT00716456|2513841|P2|STARTED|Overall Study||5
1035229|NCT00716456|2513842|P1|STARTED|Overall Study||3
1035230|NCT00716482|2513850|P1|NOT COMPLETED|Overall Study||119
1035231|NCT00716482|2513850|P1|COMPLETED|Overall Study||1562
1035232|NCT00716482|2513850|P1|STARTED|Overall Study||1681
1035233|NCT00716625|2513860|P1|NOT COMPLETED|Overall Study||1
1035234|NCT00716625|2513860|P1|COMPLETED|Overall Study||1673
1035235|NCT00716625|2513860|P1|STARTED|Overall Study||1674
1035236|NCT00716742|2513888|P3|NOT COMPLETED|3 Year Follow-up||21
1035237|NCT00716742|2513889|P2|NOT COMPLETED|3 Year Follow-up||32
1035238|NCT00716742|2513890|P1|NOT COMPLETED|3 Year Follow-up||30
1035239|NCT00716742|2513888|P3|COMPLETED|3 Year Follow-up||29
1035240|NCT00716742|2513889|P2|COMPLETED|3 Year Follow-up||35
1035241|NCT00716742|2513890|P1|COMPLETED|3 Year Follow-up||26
1035242|NCT00716742|2513888|P3|STARTED|3 Year Follow-up||50
1035243|NCT00716742|2513889|P2|STARTED|3 Year Follow-up||67
1035244|NCT00716742|2513890|P1|STARTED|3 Year Follow-up||56
1035245|NCT00716742|2513888|P3|NOT COMPLETED|2 Year Follow-up||102
1035246|NCT00716742|2513889|P2|NOT COMPLETED|2 Year Follow-up||96
1035247|NCT00716742|2513890|P1|NOT COMPLETED|2 Year Follow-up||104
1035248|NCT00716742|2513888|P3|COMPLETED|2 Year Follow-up||50
1035249|NCT00716742|2513889|P2|COMPLETED|2 Year Follow-up||67
1035250|NCT00716742|2513890|P1|COMPLETED|2 Year Follow-up||56
1035251|NCT00716742|2513888|P3|STARTED|2 Year Follow-up||152
1035252|NCT00716742|2513889|P2|STARTED|2 Year Follow-up||163
1035253|NCT00716742|2513890|P1|STARTED|2 Year Follow-up||160
1035254|NCT00716742|2513888|P3|NOT COMPLETED|1 Year Follow-up||200
1035255|NCT00716742|2513889|P2|NOT COMPLETED|1 Year Follow-up||193
1035256|NCT00716742|2513890|P1|NOT COMPLETED|1 Year Follow-up||187
1035257|NCT00716742|2513888|P3|COMPLETED|1 Year Follow-up||152
1035258|NCT00716742|2513889|P2|COMPLETED|1 Year Follow-up||163
1035259|NCT00716742|2513890|P1|COMPLETED|1 Year Follow-up||160
1035260|NCT00716742|2513888|P3|STARTED|1 Year Follow-up||352
1035261|NCT00716742|2513889|P2|STARTED|1 Year Follow-up||356
1035262|NCT00716742|2513890|P1|STARTED|1 Year Follow-up||347
1035263|NCT00716742|2513888|P3|NOT COMPLETED|Baseline||13
1035264|NCT00716742|2513889|P2|NOT COMPLETED|Baseline||14
1035265|NCT00716742|2513890|P1|NOT COMPLETED|Baseline||17
1035266|NCT00716742|2513888|P3|COMPLETED|Baseline||352
1035267|NCT00716742|2513889|P2|COMPLETED|Baseline||356
1035268|NCT00716742|2513890|P1|COMPLETED|Baseline||347
1035269|NCT00716742|2513888|P3|STARTED|Baseline||365
1035270|NCT00716742|2513889|P2|STARTED|Baseline||370
1035271|NCT00716742|2513890|P1|STARTED|Baseline||364
1035272|NCT00716807|2513902|P4|NOT COMPLETED|Overall Study||0
1035273|NCT00716807|2513903|P3|NOT COMPLETED|Overall Study||0
1035274|NCT00716807|2513904|P2|NOT COMPLETED|Overall Study||0
1035275|NCT00716807|2513905|P1|NOT COMPLETED|Overall Study||0
1035276|NCT00716807|2513902|P4|COMPLETED|Overall Study||15
1035277|NCT00716807|2513903|P3|COMPLETED|Overall Study||18
1035278|NCT00716807|2513904|P2|COMPLETED|Overall Study||5
1035279|NCT00716807|2513905|P1|COMPLETED|Overall Study||8
1035280|NCT00716807|2513902|P4|STARTED|Overall Study||15
1035281|NCT00716807|2513903|P3|STARTED|Overall Study||18
1035282|NCT00716807|2513904|P2|STARTED|Overall Study||5
1035283|NCT00716807|2513905|P1|STARTED|Overall Study||8
1035284|NCT00716820|2513915|P1|NOT COMPLETED|Overall Study||0
1035285|NCT00716820|2513915|P1|COMPLETED|Overall Study||472
1035286|NCT00716820|2513915|P1|STARTED|Overall Study||472
1035287|NCT00716859|2513948|P2|NOT COMPLETED|Overall Study||5
1035288|NCT00716859|2513949|P1|NOT COMPLETED|Overall Study||9
1035289|NCT00716859|2513948|P2|COMPLETED|Overall Study||64
1035290|NCT00716859|2513949|P1|COMPLETED|Overall Study||61
1035291|NCT00716859|2513948|P2|Received Treatment|Overall Study||68
1035292|NCT00716859|2513949|P1|Received Treatment|Overall Study||69
1035293|NCT00716859|2513948|P2|STARTED|Overall Study||69
1035294|NCT00716859|2513949|P1|STARTED|Overall Study||70
1035295|NCT00716963|2513973|P6|NOT COMPLETED|Overall Study||0
1035296|NCT00716963|2513974|P5|NOT COMPLETED|Overall Study||0
1035297|NCT00716963|2513975|P4|NOT COMPLETED|Overall Study||0
1035298|NCT00716963|2513976|P3|NOT COMPLETED|Overall Study||0
1035299|NCT00716963|2513977|P2|NOT COMPLETED|Overall Study||0
1035300|NCT00716963|2513978|P1|NOT COMPLETED|Overall Study||1
1035301|NCT00716963|2513973|P6|COMPLETED|Overall Study||1
1035302|NCT00716963|2513974|P5|COMPLETED|Overall Study||1
1035303|NCT00716963|2513975|P4|COMPLETED|Overall Study||1
1035304|NCT00716963|2513976|P3|COMPLETED|Overall Study||1
1035305|NCT00716963|2513977|P2|COMPLETED|Overall Study||1
1035306|NCT00716963|2513978|P1|COMPLETED|Overall Study||1
1035307|NCT00716963|2513973|P6|STARTED|Overall Study||1
1035308|NCT00716963|2513974|P5|STARTED|Overall Study||1
1035309|NCT00716963|2513975|P4|STARTED|Overall Study||1
1035310|NCT00716963|2513976|P3|STARTED|Overall Study||1
1035311|NCT00716963|2513977|P2|STARTED|Overall Study||1
1035312|NCT00716963|2513978|P1|STARTED|Overall Study||2
1035319|NCT00717041|2514012|P1|NOT COMPLETED|Overall Study||0
1035320|NCT00717041|2514012|P1|COMPLETED|Overall Study||1206
1035321|NCT00717041|2514012|P1|STARTED|Overall Study||1206
1035322|NCT00717054|2514022|P2|NOT COMPLETED|Overall Study||0
1035323|NCT00717054|2514023|P1|NOT COMPLETED|Overall Study||0
1035324|NCT00717054|2514022|P2|COMPLETED|Overall Study||57
1035325|NCT00717054|2514023|P1|COMPLETED|Overall Study||58
1035326|NCT00717054|2514022|P2|STARTED|Overall Study||57
1035327|NCT00717054|2514023|P1|STARTED|Overall Study||58
1035328|NCT00717067|2514040|P5|NOT COMPLETED|Part 2: End Stage Renal Disease||0
1035329|NCT00717067|2514041|P4|NOT COMPLETED|Part 2: End Stage Renal Disease||0
1035330|NCT00717067|2514042|P3|NOT COMPLETED|Part 2: End Stage Renal Disease||0
1035331|NCT00717067|2514043|P2|NOT COMPLETED|Part 2: End Stage Renal Disease||0
1035332|NCT00717067|2514044|P1|NOT COMPLETED|Part 2: End Stage Renal Disease||0
1035333|NCT00717067|2514040|P5|COMPLETED|Part 2: End Stage Renal Disease||6
1035334|NCT00717067|2514041|P4|COMPLETED|Part 2: End Stage Renal Disease||0
1035335|NCT00717067|2514042|P3|COMPLETED|Part 2: End Stage Renal Disease||0
1035336|NCT00717067|2514043|P2|COMPLETED|Part 2: End Stage Renal Disease||0
1035337|NCT00717067|2514044|P1|COMPLETED|Part 2: End Stage Renal Disease||0
1035338|NCT00717067|2514040|P5|STARTED|Part 2: End Stage Renal Disease||6
1035339|NCT00717067|2514041|P4|STARTED|Part 2: End Stage Renal Disease||0
1035340|NCT00717067|2514042|P3|STARTED|Part 2: End Stage Renal Disease||0
1035341|NCT00717067|2514043|P2|STARTED|Part 2: End Stage Renal Disease||0
1035342|NCT00717067|2514044|P1|STARTED|Part 2: End Stage Renal Disease||0
1035343|NCT00717067|2514040|P5|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
1035344|NCT00717067|2514041|P4|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
1035345|NCT00717067|2514042|P3|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
1035346|NCT00717067|2514043|P2|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
1035347|NCT00717067|2514044|P1|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
1035348|NCT00717067|2514040|P5|COMPLETED|Part 1b: Severe Renal Impairment||0
1035349|NCT00717067|2514041|P4|COMPLETED|Part 1b: Severe Renal Impairment||6
1035350|NCT00717067|2514042|P3|COMPLETED|Part 1b: Severe Renal Impairment||0
1035351|NCT00717067|2514043|P2|COMPLETED|Part 1b: Severe Renal Impairment||0
1035352|NCT00717067|2514044|P1|COMPLETED|Part 1b: Severe Renal Impairment||0
1035353|NCT00717067|2514040|P5|STARTED|Part 1b: Severe Renal Impairment||0
1035354|NCT00717067|2514041|P4|STARTED|Part 1b: Severe Renal Impairment||6
1035355|NCT00717067|2514042|P3|STARTED|Part 1b: Severe Renal Impairment||0
1035356|NCT00717067|2514043|P2|STARTED|Part 1b: Severe Renal Impairment||0
1035357|NCT00717067|2514044|P1|STARTED|Part 1b: Severe Renal Impairment||0
1035358|NCT00717067|2514040|P5|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
1035359|NCT00717067|2514041|P4|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
1035360|NCT00717067|2514042|P3|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||1
1035361|NCT00717067|2514043|P2|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
1035362|NCT00717067|2514044|P1|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
1035363|NCT00717067|2514040|P5|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
1035364|NCT00717067|2514041|P4|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
1035365|NCT00717067|2514042|P3|COMPLETED|Part 1a: Normal/Mild/Moderate Group||5
1035366|NCT00717067|2514043|P2|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
1035367|NCT00717067|2514044|P1|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
1035368|NCT00717067|2514040|P5|STARTED|Part 1a: Normal/Mild/Moderate Group||0
1035369|NCT00717067|2514041|P4|STARTED|Part 1a: Normal/Mild/Moderate Group||0
1035370|NCT00717067|2514042|P3|STARTED|Part 1a: Normal/Mild/Moderate Group||6
1035371|NCT00717067|2514043|P2|STARTED|Part 1a: Normal/Mild/Moderate Group||6
1035372|NCT00717067|2514044|P1|STARTED|Part 1a: Normal/Mild/Moderate Group||6
1035373|NCT00717093|2514128|P2|NOT COMPLETED|Overall Study||48
1035374|NCT00717093|2514129|P1|NOT COMPLETED|Overall Study||44
1035375|NCT00717093|2514128|P2|COMPLETED|Overall Study||170
1035376|NCT00717093|2514129|P1|COMPLETED|Overall Study||170
1035377|NCT00717093|2514128|P2|Received Treatment|Overall Study||218
1035378|NCT00717093|2514129|P1|Received Treatment|Overall Study||213
1035379|NCT00717093|2514128|P2|STARTED|Overall Study||218
1035380|NCT00717093|2514129|P1|STARTED|Overall Study||214
1035381|NCT00717197|2514141|P1|NOT COMPLETED|Overall Study||7
1035382|NCT00717197|2514141|P1|COMPLETED|Overall Study||23
1035383|NCT00717197|2514141|P1|STARTED|Overall Study||30
1035384|NCT00717236|2514147|P2|NOT COMPLETED|Open-Label Period||21
1035385|NCT00717236|2514148|P1|NOT COMPLETED|Open-Label Period||125
1035386|NCT00717236|2514147|P2|COMPLETED|Open-Label Period||163
1035387|NCT00717236|2514148|P1|COMPLETED|Open-Label Period||646
1035388|NCT00717236|2514147|P2|STARTED|Open-Label Period||184
1035389|NCT00717236|2514148|P1|STARTED|Open-Label Period||771
1035390|NCT00717236|2514147|P2|NOT COMPLETED|Double-Blind Period||28
1035391|NCT00717236|2514148|P1|NOT COMPLETED|Double-Blind Period||80
1035392|NCT00717236|2514147|P2|COMPLETED|Double-Blind Period||184
1035393|NCT00717236|2514148|P1|COMPLETED|Double-Blind Period||771
1035394|NCT00717236|2514147|P2|STARTED|Double-Blind Period||212
1035395|NCT00717236|2514148|P1|STARTED|Double-Blind Period||851
1035396|NCT00717249|2514219|P2|NOT COMPLETED|Overall Study||15
1035397|NCT00717249|2514220|P1|NOT COMPLETED|Overall Study||22
1035398|NCT00717249|2514219|P2|COMPLETED|Overall Study||150
1035399|NCT00717249|2514220|P1|COMPLETED|Overall Study||304
1035400|NCT00717249|2514219|P2|STARTED|Overall Study||165
1035401|NCT00717249|2514220|P1|STARTED|Overall Study||326
1035402|NCT00717275|2514232|P1|NOT COMPLETED|Overall Study||3
1035403|NCT00717275|2514232|P1|COMPLETED|Overall Study||0
1035404|NCT00717275|2514232|P1|STARTED|Overall Study||3
1035405|NCT00717288|2514239|P3|NOT COMPLETED|Overall Study||0
1035406|NCT00717288|2514240|P2|NOT COMPLETED|Overall Study||0
1035407|NCT00717288|2514241|P1|NOT COMPLETED|Overall Study||0
1035408|NCT00717288|2514239|P3|COMPLETED|Overall Study||25
1035409|NCT00717288|2514240|P2|COMPLETED|Overall Study||29
1035410|NCT00717288|2514241|P1|COMPLETED|Overall Study||28
1035411|NCT00717288|2514239|P3|STARTED|Overall Study||25
1035412|NCT00717288|2514240|P2|STARTED|Overall Study||29
1035413|NCT00717288|2514241|P1|STARTED|Overall Study||28
1035414|NCT00717314|2514257|P2|NOT COMPLETED|Overall Study||10
1035415|NCT00717314|2514258|P1|NOT COMPLETED|Overall Study||6
1035416|NCT00717314|2514257|P2|COMPLETED|Overall Study||34
1035417|NCT00717314|2514258|P1|COMPLETED|Overall Study||37
1035418|NCT00717314|2514257|P2|STARTED|Overall Study||44
1035419|NCT00717314|2514258|P1|STARTED|Overall Study||43
1035420|NCT00717366|2514278|P2|NOT COMPLETED|Extension Period (52 Weeks)||16
1035421|NCT00717366|2514279|P1|NOT COMPLETED|Extension Period (52 Weeks)||4
1035422|NCT00717366|2514278|P2|COMPLETED|Extension Period (52 Weeks)||12
1035423|NCT00717366|2514279|P1|COMPLETED|Extension Period (52 Weeks)||5
1035424|NCT00717366|2514278|P2|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||28
1035425|NCT00717366|2514279|P1|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||8
1035426|NCT00717366|2514278|P2|STARTED|Extension Period (52 Weeks)||28
1035427|NCT00717366|2514279|P1|STARTED|Extension Period (52 Weeks)||9
1035428|NCT00717366|2514278|P2|NOT COMPLETED|Core Study Period (20 Weeks)||13
1035429|NCT00717366|2514279|P1|NOT COMPLETED|Core Study Period (20 Weeks)||4
1035430|NCT00717366|2514278|P2|COMPLETED|Core Study Period (20 Weeks)||35
1035431|NCT00717366|2514279|P1|COMPLETED|Core Study Period (20 Weeks)||12
1035432|NCT00717366|2514278|P2|STARTED|Core Study Period (20 Weeks)||48
1035433|NCT00717366|2514279|P1|STARTED|Core Study Period (20 Weeks)||16
1035434|NCT00717405|2514301|P1|NOT COMPLETED|Overall Study||0
1035435|NCT00717405|2514301|P1|COMPLETED|Overall Study||52
1035436|NCT00717405|2514301|P1|STARTED|Overall Study||52
1035437|NCT00717418|2514322|P4|NOT COMPLETED|1-Year Follow-Up||4
1035438|NCT00717418|2514323|P3|NOT COMPLETED|1-Year Follow-Up||434
1035439|NCT00717418|2514324|P2|NOT COMPLETED|1-Year Follow-Up||51
1035440|NCT00717418|2514325|P1|NOT COMPLETED|1-Year Follow-Up||147
1035441|NCT00717418|2514322|P4|COMPLETED|1-Year Follow-Up||0
1035442|NCT00717418|2514323|P3|COMPLETED|1-Year Follow-Up||74
1035443|NCT00717418|2514324|P2|COMPLETED|1-Year Follow-Up||23
1035444|NCT00717418|2514325|P1|COMPLETED|1-Year Follow-Up||33
1035445|NCT00717418|2514322|P4|STARTED|1-Year Follow-Up||4
1035446|NCT00717418|2514323|P3|STARTED|1-Year Follow-Up||508
1035447|NCT00717418|2514324|P2|STARTED|1-Year Follow-Up||74
1035448|NCT00717418|2514325|P1|STARTED|1-Year Follow-Up||180
1035449|NCT00717418|2514322|P4|NOT COMPLETED|Baseline||15
1035450|NCT00717418|2514323|P3|NOT COMPLETED|Baseline||0
1035451|NCT00717418|2514324|P2|NOT COMPLETED|Baseline||0
1035452|NCT00717418|2514325|P1|NOT COMPLETED|Baseline||0
1035453|NCT00717418|2514322|P4|COMPLETED|Baseline||4
1035454|NCT00717418|2514323|P3|COMPLETED|Baseline||508
1035455|NCT00717418|2514324|P2|COMPLETED|Baseline||74
1035456|NCT00717418|2514325|P1|COMPLETED|Baseline||180
1035457|NCT00717418|2514322|P4|STARTED|Baseline||19
1035458|NCT00717418|2514323|P3|STARTED|Baseline||508
1035459|NCT00717418|2514324|P2|STARTED|Baseline||74
1035460|NCT00717418|2514325|P1|STARTED|Baseline||180
1035461|NCT00717522|2514330|P1|NOT COMPLETED|Overall Study||7
1035462|NCT00717522|2514330|P1|COMPLETED|Overall Study||0
1035463|NCT00717522|2514330|P1|STARTED|Overall Study||7
1035464|NCT00717574|2514337|P2|NOT COMPLETED|Overall Study||2
1035465|NCT00717574|2514338|P1|NOT COMPLETED|Overall Study||2
1035466|NCT00717574|2514337|P2|COMPLETED|Overall Study||14
1035467|NCT00717574|2514338|P1|COMPLETED|Overall Study||14
1035468|NCT00717574|2514337|P2|STARTED|Overall Study||16
1035469|NCT00717574|2514338|P1|STARTED|Overall Study||16
1035470|NCT00717756|2514344|P1|NOT COMPLETED|Overall Study||1
1035471|NCT00717756|2514344|P1|COMPLETED|Overall Study||40
1035472|NCT00717756|2514344|P1|STARTED|Overall Study||41
1035473|NCT00717860|2514350|P2|NOT COMPLETED|Overall Study||28
1035474|NCT00717860|2514351|P1|NOT COMPLETED|Overall Study||27
1035475|NCT00717860|2514350|P2|COMPLETED|Overall Study||32
1035476|NCT00717860|2514351|P1|COMPLETED|Overall Study||34
1035477|NCT00717860|2514350|P2|STARTED|Overall Study||60
1035478|NCT00717860|2514351|P1|STARTED|Overall Study||61
1035479|NCT00717873|2514363|P2|NOT COMPLETED|Overall Study||0
1035480|NCT00717873|2514364|P1|NOT COMPLETED|Overall Study||0
1035481|NCT00717873|2514363|P2|COMPLETED|Overall Study||59
1035482|NCT00717873|2514364|P1|COMPLETED|Overall Study||46
1035483|NCT00717873|2514363|P2|STARTED|Overall Study||59
1035484|NCT00717873|2514364|P1|STARTED|Overall Study||46
1035485|NCT00717886|2514370|P1|NOT COMPLETED|Overall Study||4
1035486|NCT00717886|2514370|P1|COMPLETED|Overall Study||9
1035487|NCT00717886|2514370|P1|STARTED|Overall Study||13
1035488|NCT00717912|2514374|P6|NOT COMPLETED|Overall Study||0
1035489|NCT00717912|2514375|P5|NOT COMPLETED|Overall Study||0
1035490|NCT00717912|2514376|P4|NOT COMPLETED|Overall Study||0
1035491|NCT00717912|2514377|P3|NOT COMPLETED|Overall Study||0
1035492|NCT00717912|2514378|P2|NOT COMPLETED|Overall Study||0
1035493|NCT00717912|2514379|P1|NOT COMPLETED|Overall Study||0
1035494|NCT00717912|2514374|P6|COMPLETED|Overall Study||1
1035495|NCT00717912|2514375|P5|COMPLETED|Overall Study||1
1035496|NCT00717912|2514376|P4|COMPLETED|Overall Study||1
1035497|NCT00717912|2514377|P3|COMPLETED|Overall Study||1
1035498|NCT00717912|2514378|P2|COMPLETED|Overall Study||1
1035499|NCT00717912|2514379|P1|COMPLETED|Overall Study||1
1035500|NCT00717912|2514374|P6|STARTED|Overall Study||1
1035501|NCT00717912|2514375|P5|STARTED|Overall Study||1
1035502|NCT00717912|2514376|P4|STARTED|Overall Study||1
1035503|NCT00717912|2514377|P3|STARTED|Overall Study||1
1035504|NCT00717912|2514378|P2|STARTED|Overall Study||1
1035505|NCT00717912|2514379|P1|STARTED|Overall Study||1
1035506|NCT00717977|2514390|P1|NOT COMPLETED|Overall Study||0
1035507|NCT00717977|2514390|P1|COMPLETED|Overall Study||74
1035508|NCT00717977|2514390|P1|STARTED|Overall Study||74
1035509|NCT00718042|2514424|P6|NOT COMPLETED|Donor Follow-up||0
1035510|NCT00718042|2514425|P5|NOT COMPLETED|Donor Follow-up||19
1035511|NCT00718042|2514426|P4|NOT COMPLETED|Donor Follow-up||0
1035512|NCT00718042|2514427|P3|NOT COMPLETED|Donor Follow-up||0
1035513|NCT00718042|2514428|P2|NOT COMPLETED|Donor Follow-up||0
1035514|NCT00718042|2514429|P1|NOT COMPLETED|Donor Follow-up||13
1035515|NCT00718042|2514424|P6|COMPLETED|Donor Follow-up||0
1035516|NCT00718042|2514425|P5|COMPLETED|Donor Follow-up||24
1035517|NCT00718042|2514426|P4|COMPLETED|Donor Follow-up||0
1035518|NCT00718042|2514427|P3|COMPLETED|Donor Follow-up||0
1035519|NCT00718042|2514428|P2|COMPLETED|Donor Follow-up||0
1035520|NCT00718042|2514429|P1|COMPLETED|Donor Follow-up||23
1035521|NCT00718042|2514424|P6|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
1035522|NCT00718042|2514425|P5|STARTED|Donor Follow-up||43
1035523|NCT00718042|2514426|P4|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
1035524|NCT00718042|2514427|P3|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
1035525|NCT00718042|2514428|P2|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
1035526|NCT00718042|2514429|P1|STARTED|Donor Follow-up||36
1035527|NCT00718042|2514424|P6|NOT COMPLETED|ESA Chagas Testing||0
1035528|NCT00718042|2514425|P5|NOT COMPLETED|ESA Chagas Testing||0
1035529|NCT00718042|2514426|P4|NOT COMPLETED|ESA Chagas Testing||0
1035530|NCT00718042|2514427|P3|NOT COMPLETED|ESA Chagas Testing||0
1035531|NCT00718042|2514428|P2|NOT COMPLETED|ESA Chagas Testing||0
1035532|NCT00718042|2514429|P1|NOT COMPLETED|ESA Chagas Testing||0
1035533|NCT00718042|2514424|P6|COMPLETED|ESA Chagas Testing||330
1035534|NCT00718042|2514425|P5|COMPLETED|ESA Chagas Testing||43
1035535|NCT00718042|2514426|P4|COMPLETED|ESA Chagas Testing||110
1035536|NCT00718042|2514427|P3|COMPLETED|ESA Chagas Testing||524
1035537|NCT00718042|2514428|P2|COMPLETED|ESA Chagas Testing||287
1035538|NCT00718042|2514429|P1|COMPLETED|ESA Chagas Testing||36
1035539|NCT00718042|2514424|P6|STARTED|ESA Chagas Testing|Specimens only tested with ESA Chagas|330
1035540|NCT00718042|2514425|P5|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|43
1035541|NCT00718042|2514426|P4|STARTED|ESA Chagas Testing||110
1035542|NCT00718042|2514427|P3|STARTED|ESA Chagas Testing||524
1035543|NCT00718042|2514428|P2|STARTED|ESA Chagas Testing||287
1035544|NCT00718042|2514429|P1|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|36
1035545|NCT00718042|2514424|P6|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
1035546|NCT00718042|2514425|P5|NOT COMPLETED|ABBOTT PRISM Chagas Testing||38
1035547|NCT00718042|2514426|P4|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
1035548|NCT00718042|2514427|P3|NOT COMPLETED|ABBOTT PRISM Chagas Testing||1
1035549|NCT00718042|2514428|P2|NOT COMPLETED|ABBOTT PRISM Chagas Testing||2
1035550|NCT00718042|2514429|P1|NOT COMPLETED|ABBOTT PRISM Chagas Testing||64
1035551|NCT00718042|2514424|P6|COMPLETED|ABBOTT PRISM Chagas Testing||0
1035552|NCT00718042|2514425|P5|COMPLETED|ABBOTT PRISM Chagas Testing||25511
1035553|NCT00718042|2514426|P4|COMPLETED|ABBOTT PRISM Chagas Testing||110
1035554|NCT00718042|2514427|P3|COMPLETED|ABBOTT PRISM Chagas Testing||524
1035555|NCT00718042|2514428|P2|COMPLETED|ABBOTT PRISM Chagas Testing||287
1035556|NCT00718042|2514429|P1|COMPLETED|ABBOTT PRISM Chagas Testing||16249
1035557|NCT00718042|2514424|P6|STARTED|ABBOTT PRISM Chagas Testing|Specimens not screened with PRISM Chagas assay per protocol.|0
1035558|NCT00718042|2514425|P5|STARTED|ABBOTT PRISM Chagas Testing||25549
1035559|NCT00718042|2514426|P4|STARTED|ABBOTT PRISM Chagas Testing||110
1035560|NCT00718042|2514427|P3|STARTED|ABBOTT PRISM Chagas Testing||525
1035561|NCT00718042|2514428|P2|STARTED|ABBOTT PRISM Chagas Testing||289
1035562|NCT00718042|2514429|P1|STARTED|ABBOTT PRISM Chagas Testing||16313
1035563|NCT00718081|2514444|P3|NOT COMPLETED|Overall Study||21
1035564|NCT00718081|2514445|P2|NOT COMPLETED|Overall Study||4
1035565|NCT00718081|2514446|P1|NOT COMPLETED|Overall Study||7
1035566|NCT00718081|2514444|P3|COMPLETED|Overall Study||9
1035567|NCT00718081|2514445|P2|COMPLETED|Overall Study||25
1035568|NCT00718081|2514446|P1|COMPLETED|Overall Study||22
1035569|NCT00718081|2514444|P3|STARTED|Overall Study||30
1035570|NCT00718081|2514445|P2|STARTED|Overall Study||29
1035571|NCT00718081|2514446|P1|STARTED|Overall Study||29
1035572|NCT00718120|2514459|P2|NOT COMPLETED|Overall Study||0
1035573|NCT00718120|2514460|P1|NOT COMPLETED|Overall Study||0
1035574|NCT00718120|2514459|P2|COMPLETED|Overall Study||55
1035575|NCT00718120|2514460|P1|COMPLETED|Overall Study||55
1035576|NCT00718120|2514459|P2|STARTED|Overall Study||55
1035577|NCT00718120|2514460|P1|STARTED|Overall Study||55
1035578|NCT00710866|2514480|P2|NOT COMPLETED|Overall Study||6
1035579|NCT00710866|2514481|P1|NOT COMPLETED|Overall Study||9
1035580|NCT00710866|2514480|P2|COMPLETED|Overall Study||128
1035581|NCT00710866|2514481|P1|COMPLETED|Overall Study||124
1035582|NCT00710866|2514480|P2|STARTED|Overall Study||134
1035583|NCT00710866|2514481|P1|STARTED|Overall Study||133
1035584|NCT00710879|2514503|P2|NOT COMPLETED|Overall Study||4
1035585|NCT00710879|2514504|P1|NOT COMPLETED|Overall Study||2
1035586|NCT00710879|2514503|P2|COMPLETED|Overall Study||113
1035587|NCT00710879|2514504|P1|COMPLETED|Overall Study||58
1035588|NCT00710879|2514503|P2|STARTED|Overall Study||117
1035589|NCT00710879|2514504|P1|STARTED|Overall Study||60
1035590|NCT00710905|2514514|P1|NOT COMPLETED|Overall Study||16
1035591|NCT00710905|2514514|P1|COMPLETED|Overall Study||34
1035592|NCT00710905|2514514|P1|STARTED|Overall Study||50
1035593|NCT00710931|2514518|P1|NOT COMPLETED|Overall Study||5
1035594|NCT00710931|2514518|P1|COMPLETED|Overall Study||29
1035595|NCT00710931|2514518|P1|STARTED|Overall Study||34
1035596|NCT00710944|2514525|P3|NOT COMPLETED|Overall Study||2
1035597|NCT00710944|2514526|P2|NOT COMPLETED|Overall Study||9
1035598|NCT00710944|2514527|P1|NOT COMPLETED|Overall Study||10
1035599|NCT00710944|2514525|P3|COMPLETED|Overall Study||17
1035600|NCT00710944|2514526|P2|COMPLETED|Overall Study||49
1035601|NCT00710944|2514527|P1|COMPLETED|Overall Study||45
1035602|NCT00710944|2514525|P3|STARTED|Overall Study||19
1035603|NCT00710944|2514526|P2|STARTED|Overall Study||58
1035604|NCT00710944|2514527|P1|STARTED|Overall Study||55
1035605|NCT00710970|2514535|P1|NOT COMPLETED|Overall Study||10
1035606|NCT00710970|2514535|P1|COMPLETED|Overall Study||18
1035607|NCT00710970|2514535|P1|STARTED|Overall Study||28
1035608|NCT00710996|2514542|P3|NOT COMPLETED|Overall Study||0
1035609|NCT00710996|2514543|P2|NOT COMPLETED|Overall Study||4
1035610|NCT00710996|2514544|P1|NOT COMPLETED|Overall Study||1
1035611|NCT00710996|2514542|P3|COMPLETED|Overall Study||21
1035612|NCT00710996|2514543|P2|COMPLETED|Overall Study||16
1035613|NCT00710996|2514544|P1|COMPLETED|Overall Study||16
1035614|NCT00710996|2514542|P3|STARTED|Overall Study||21
1035615|NCT00710996|2514543|P2|STARTED|Overall Study||20
1035616|NCT00710996|2514544|P1|STARTED|Overall Study||17
1035617|NCT00711009|2514554|P2|NOT COMPLETED|Overall Study||19
1035618|NCT00711009|2514555|P1|NOT COMPLETED|Overall Study||15
1035619|NCT00711009|2514554|P2|COMPLETED|Overall Study||82
1035620|NCT00711009|2514555|P1|COMPLETED|Overall Study||90
1035621|NCT00711009|2514554|P2|STARTED|Overall Study||101
1035622|NCT00711009|2514555|P1|STARTED|Overall Study||105
1035623|NCT00711022|2514723|P1|NOT COMPLETED|Overall Study||11
1035624|NCT00711022|2514723|P1|COMPLETED|Overall Study||40
1035625|NCT00711022|2514723|P1|STARTED|Overall Study||51
1035626|NCT00711087|2514729|P2|NOT COMPLETED|Overall Study||0
1035627|NCT00711087|2514730|P1|NOT COMPLETED|Overall Study||1
1035628|NCT00711087|2514729|P2|COMPLETED|Overall Study||0
1035629|NCT00711087|2514730|P1|COMPLETED|Overall Study||0
1035630|NCT00711087|2514729|P2|STARTED|Overall Study||0
1035631|NCT00711087|2514730|P1|STARTED|Overall Study||1
1035632|NCT00711100|2514736|P1|NOT COMPLETED|Overall Study||13
1035633|NCT00711100|2514736|P1|COMPLETED|Overall Study||91
1035634|NCT00711100|2514736|P1|STARTED|Overall Study||104
1035635|NCT00711113|2514752|P1|NOT COMPLETED|Overall Study||11
1035636|NCT00711113|2514752|P1|COMPLETED|Overall Study||36
1035637|NCT00711113|2514752|P1|STARTED|Overall Study||47
1035638|NCT00711191|2514761|P3|NOT COMPLETED|Overall Study||12
1035639|NCT00711191|2514762|P2|NOT COMPLETED|Overall Study||5
1035640|NCT00711191|2514763|P1|NOT COMPLETED|Overall Study||3
1035641|NCT00711191|2514761|P3|COMPLETED|Overall Study||1
1035642|NCT00711191|2514762|P2|COMPLETED|Overall Study||1
1035643|NCT00711191|2514763|P1|COMPLETED|Overall Study||0
1035644|NCT00711191|2514761|P3|STARTED|Overall Study||13
1035645|NCT00711191|2514762|P2|STARTED|Overall Study||6
1035646|NCT00711191|2514763|P1|STARTED|Overall Study||3
1035647|NCT00711347|2514802|P2|NOT COMPLETED|Overall Study||0
1035648|NCT00711347|2514803|P1|NOT COMPLETED|Overall Study||0
1035649|NCT00711347|2514802|P2|COMPLETED|Overall Study||14
1035650|NCT00711347|2514803|P1|COMPLETED|Overall Study||14
1035651|NCT00711347|2514802|P2|STARTED|Overall Study||14
1035652|NCT00711347|2514803|P1|STARTED|Overall Study||14
1035653|NCT00711425|2514819|P1|NOT COMPLETED|Overall Study||4
1035654|NCT00711425|2514819|P1|COMPLETED|Overall Study||41
1035655|NCT00711425|2514819|P1|STARTED|Overall Study|Implant placement in 45 patients. Implant loading (baseline) in 44 patients.|45
1035656|NCT00711464|2514825|P1|NOT COMPLETED|Overall Study||0
1035657|NCT00711464|2514825|P1|COMPLETED|Overall Study||29
1035658|NCT00711464|2514825|P1|STARTED|Overall Study||29
1035659|NCT00711477|2514845|P2|NOT COMPLETED|Overall Study||3
1035660|NCT00711477|2514846|P1|NOT COMPLETED|Overall Study||3
1035661|NCT00711477|2514845|P2|COMPLETED|Overall Study||20
1035662|NCT00711477|2514846|P1|COMPLETED|Overall Study||20
1035663|NCT00711477|2514845|P2|STARTED|Overall Study||23
1035664|NCT00711477|2514846|P1|STARTED|Overall Study||23
1035665|NCT00711490|2514874|P1|NOT COMPLETED|Overall Study||0
1035666|NCT00711490|2514874|P1|COMPLETED|Overall Study||5
1035667|NCT00711490|2514874|P1|STARTED|Overall Study||5
1035668|NCT00711516|2514887|P2|NOT COMPLETED|Overall Study||3
1035669|NCT00711516|2514888|P1|NOT COMPLETED|Overall Study||1
1035670|NCT00711516|2514887|P2|COMPLETED|Overall Study||16
1035671|NCT00711516|2514888|P1|COMPLETED|Overall Study||20
1035672|NCT00711516|2514887|P2|STARTED|Overall Study||19
1035673|NCT00711516|2514888|P1|STARTED|Overall Study||21
1035674|NCT00711529|2514984|P2|NOT COMPLETED|Overall Study||6
1035675|NCT00711529|2514985|P1|NOT COMPLETED|Overall Study||4
1035676|NCT00711529|2514984|P2|COMPLETED|Overall Study||8
1035677|NCT00711529|2514985|P1|COMPLETED|Overall Study|2 women lost their hot flash diary, so only 7 patients were evaluable for primary endpoint.|9
1035678|NCT00711529|2514984|P2|STARTED|Overall Study||14
1035679|NCT00711529|2514985|P1|STARTED|Overall Study||13
1035680|NCT00711555|2515007|P1|NOT COMPLETED|Overall Study||3
1035681|NCT00711555|2515007|P1|COMPLETED|Overall Study||19
1035682|NCT00711555|2515007|P1|STARTED|Overall Study||22
1035683|NCT00711594|2515018|P4|NOT COMPLETED|Overall Study||62
1035684|NCT00711594|2515019|P3|NOT COMPLETED|Overall Study||6
1035685|NCT00711594|2515020|P2|NOT COMPLETED|Overall Study||3
1035686|NCT00711594|2515021|P1|NOT COMPLETED|Overall Study||3
1035687|NCT00711594|2515018|P4|COMPLETED|Overall Study||0
1035688|NCT00711594|2515019|P3|COMPLETED|Overall Study||0
1035689|NCT00711594|2515020|P2|COMPLETED|Overall Study||0
1035690|NCT00711594|2515021|P1|COMPLETED|Overall Study||0
1035691|NCT00711594|2515018|P4|STARTED|Overall Study||62
1035692|NCT00711594|2515019|P3|STARTED|Overall Study||6
1035693|NCT00711594|2515020|P2|STARTED|Overall Study||3
1035694|NCT00711594|2515021|P1|STARTED|Overall Study||3
1035695|NCT00711646|2515060|P2|NOT COMPLETED|Overall Study||3
1035696|NCT00711646|2515061|P1|NOT COMPLETED|Overall Study||12
1035697|NCT00711646|2515060|P2|COMPLETED|Overall Study||62
1035698|NCT00711646|2515061|P1|COMPLETED|Overall Study||112
1035699|NCT00711646|2515060|P2|STARTED|Overall Study||65
1035700|NCT00711646|2515061|P1|STARTED|Overall Study||124
1035701|NCT00711802|2515087|P8|NOT COMPLETED|Overall Study||2
1035702|NCT00711802|2515088|P7|NOT COMPLETED|Overall Study||5
1035703|NCT00711802|2515089|P6|NOT COMPLETED|Overall Study||8
1035704|NCT00711802|2515090|P5|NOT COMPLETED|Overall Study||14
1035705|NCT00711802|2515091|P4|NOT COMPLETED|Overall Study||3
1035706|NCT00711802|2515092|P3|NOT COMPLETED|Overall Study||6
1035707|NCT00711802|2515093|P2|NOT COMPLETED|Overall Study||6
1035708|NCT00711802|2515094|P1|NOT COMPLETED|Overall Study||2
1035709|NCT00711802|2515087|P8|COMPLETED|Overall Study||13
1035710|NCT00711802|2515088|P7|COMPLETED|Overall Study||25
1035711|NCT00711802|2515089|P6|COMPLETED|Overall Study||34
1035712|NCT00711802|2515090|P5|COMPLETED|Overall Study||69
1035713|NCT00711802|2515091|P4|COMPLETED|Overall Study||35
1035714|NCT00711802|2515092|P3|COMPLETED|Overall Study||69
1035715|NCT00711802|2515093|P2|COMPLETED|Overall Study||32
1035716|NCT00711802|2515094|P1|COMPLETED|Overall Study||73
1035717|NCT00711802|2515087|P8|Received at Least 1 Dose of Study Drug|Overall Study||15
1035718|NCT00711802|2515088|P7|Received at Least 1 Dose of Study Drug|Overall Study||30
1035719|NCT00711802|2515089|P6|Received at Least 1 Dose of Study Drug|Overall Study||42
1035720|NCT00711802|2515090|P5|Received at Least 1 Dose of Study Drug|Overall Study||81
1035721|NCT00711802|2515091|P4|Received at Least 1 Dose of Study Drug|Overall Study||38
1035722|NCT00711802|2515092|P3|Received at Least 1 Dose of Study Drug|Overall Study||73
1035723|NCT00711802|2515093|P2|Received at Least 1 Dose of Study Drug|Overall Study||37
1035724|NCT00711802|2515094|P1|Received at Least 1 Dose of Study Drug|Overall Study||73
1035725|NCT00711802|2515087|P8|STARTED|Overall Study||15
1035726|NCT00711802|2515088|P7|STARTED|Overall Study||30
1035727|NCT00711802|2515089|P6|STARTED|Overall Study||42
1035728|NCT00711802|2515090|P5|STARTED|Overall Study||83
1035729|NCT00711802|2515091|P4|STARTED|Overall Study||38
1035730|NCT00711802|2515092|P3|STARTED|Overall Study||75
1035731|NCT00711802|2515093|P2|STARTED|Overall Study||38
1035732|NCT00711802|2515094|P1|STARTED|Overall Study||75
1035733|NCT00711828|2515124|P1|NOT COMPLETED|Overall Study||0
1035734|NCT00711828|2515124|P1|COMPLETED|Overall Study||21
1035735|NCT00711828|2515124|P1|STARTED|Overall Study||21
1035736|NCT00711867|2515135|P2|NOT COMPLETED|Overall Study||4
1035737|NCT00711867|2515136|P1|NOT COMPLETED|Overall Study||5
1035738|NCT00711867|2515135|P2|COMPLETED|Overall Study|3 received additional warming. 1 missing primary measure.|21
1035739|NCT00711867|2515136|P1|COMPLETED|Overall Study|2 received additional warming. 3 missing primary measure.|25
1035740|NCT00711867|2515135|P2|STARTED|Overall Study||25
1035741|NCT00711867|2515136|P1|STARTED|Overall Study||30
1035742|NCT00711880|2515144|P2|NOT COMPLETED|Overall Study||7
1035743|NCT00711880|2515145|P1|NOT COMPLETED|Overall Study||13
1035744|NCT00711880|2515144|P2|COMPLETED|Overall Study||55
1035745|NCT00711880|2515145|P1|COMPLETED|Overall Study||50
1035746|NCT00711880|2515144|P2|STARTED|Overall Study||62
1035747|NCT00711880|2515145|P1|STARTED|Overall Study||63
1035748|NCT00711958|2515183|P2|NOT COMPLETED|Overall Study||23
1035749|NCT00711958|2515184|P1|NOT COMPLETED|Overall Study||33
1035750|NCT00711958|2515183|P2|COMPLETED|Overall Study||17
1035751|NCT00711958|2515184|P1|COMPLETED|Overall Study||41
1035752|NCT00711958|2515183|P2|STARTED|Overall Study||40
1035753|NCT00711958|2515184|P1|STARTED|Overall Study||74
1035754|NCT00711971|2515193|P3|NOT COMPLETED|Overall Study||1
1035755|NCT00711971|2515194|P2|NOT COMPLETED|Overall Study||4
1035756|NCT00711971|2515195|P1|NOT COMPLETED|Overall Study||3
1035757|NCT00711971|2515193|P3|COMPLETED|Overall Study||41
1035758|NCT00711971|2515194|P2|COMPLETED|Overall Study||38
1035759|NCT00711971|2515195|P1|COMPLETED|Overall Study||39
1035760|NCT00711971|2515193|P3|STARTED|Overall Study||42
1035761|NCT00711971|2515194|P2|STARTED|Overall Study||42
1035762|NCT00711971|2515195|P1|STARTED|Overall Study||42
1035763|NCT00711997|2515229|P2|NOT COMPLETED|Overall Study||0
1035764|NCT00711997|2515230|P1|NOT COMPLETED|Overall Study||0
1035765|NCT00711997|2515229|P2|COMPLETED|Overall Study||6
1035766|NCT00711997|2515230|P1|COMPLETED|Overall Study||3
1035767|NCT00711997|2515229|P2|STARTED|Overall Study||6
1035768|NCT00711997|2515230|P1|STARTED|Overall Study||3
1035769|NCT00712010|2515240|P1|NOT COMPLETED|7th and Last Protein Testing (1 Day)||0
1035770|NCT00712010|2515240|P1|COMPLETED|7th and Last Protein Testing (1 Day)||23
1035771|NCT00712010|2515240|P1|STARTED|7th and Last Protein Testing (1 Day)||23
1035772|NCT00712010|2515240|P1|NOT COMPLETED|Washout (7 Days)||0
1035773|NCT00712010|2515240|P1|COMPLETED|Washout (7 Days)||23
1035774|NCT00712010|2515240|P1|STARTED|Washout (7 Days)||23
1035775|NCT00712010|2515240|P1|NOT COMPLETED|6th Protein Testing (1 Day)||0
1035776|NCT00712010|2515240|P1|COMPLETED|6th Protein Testing (1 Day)||23
1035777|NCT00712010|2515240|P1|STARTED|6th Protein Testing (1 Day)||23
1035778|NCT00712010|2515240|P1|NOT COMPLETED|Washout (7 Days)||0
1035779|NCT00712010|2515240|P1|COMPLETED|Washout (7 Days)||23
1035780|NCT00712010|2515240|P1|STARTED|Washout (7 Days)||23
1035781|NCT00712010|2515240|P1|NOT COMPLETED|5th Protein Testing (1 Day)||0
1035782|NCT00712010|2515240|P1|COMPLETED|5th Protein Testing (1 Day)||23
1035783|NCT00712010|2515240|P1|STARTED|5th Protein Testing (1 Day)||23
1035784|NCT00712010|2515240|P1|NOT COMPLETED|Washout (7 Days)||1
1035785|NCT00712010|2515240|P1|COMPLETED|Washout (7 Days)||23
1035786|NCT00712010|2515240|P1|STARTED|Washout (7 Days)||24
1035787|NCT00712010|2515240|P1|NOT COMPLETED|4th Protein Testing (1 Day)||0
1035788|NCT00712010|2515240|P1|COMPLETED|4th Protein Testing (1 Day)||24
1035789|NCT00712010|2515240|P1|STARTED|4th Protein Testing (1 Day)||24
1035790|NCT00712010|2515240|P1|NOT COMPLETED|Washout (7 Days)||0
1035791|NCT00712010|2515240|P1|COMPLETED|Washout (7 Days)||24
1035792|NCT00712010|2515240|P1|STARTED|Washout (7 Days)||24
1035793|NCT00712010|2515240|P1|NOT COMPLETED|3rd Protein Testing (1 Day)||0
1035794|NCT00712010|2515240|P1|COMPLETED|3rd Protein Testing (1 Day)||24
1035795|NCT00712010|2515240|P1|STARTED|3rd Protein Testing (1 Day)||24
1035796|NCT00712010|2515240|P1|NOT COMPLETED|Washout (7 Days)||0
1035797|NCT00712010|2515240|P1|COMPLETED|Washout (7 Days)||24
1035798|NCT00712010|2515240|P1|STARTED|Washout (7 Days)||24
1035799|NCT00712010|2515240|P1|NOT COMPLETED|2nd Protein Testing (1 Day)||0
1035800|NCT00712010|2515240|P1|COMPLETED|2nd Protein Testing (1 Day)||24
1035801|NCT00712010|2515240|P1|STARTED|2nd Protein Testing (1 Day)||24
1035802|NCT00712010|2515240|P1|NOT COMPLETED|Washout (7 Days)||0
1035803|NCT00712010|2515240|P1|COMPLETED|Washout (7 Days)||24
1035804|NCT00712010|2515240|P1|STARTED|Washout (7 Days)||24
1035805|NCT00712010|2515240|P1|NOT COMPLETED|1st Protein Testing (1 Day)||0
1035806|NCT00712010|2515240|P1|COMPLETED|1st Protein Testing (1 Day)||24
1035807|NCT00712010|2515240|P1|STARTED|1st Protein Testing (1 Day)|1 subject withdrew his consent form before to starting the 1st intervention|24
1035808|NCT00712075|2515266|P3|NOT COMPLETED|Overall Study||11
1035809|NCT00712075|2515267|P2|NOT COMPLETED|Overall Study||4
1035810|NCT00712075|2515268|P1|NOT COMPLETED|Overall Study||5
1035811|NCT00712075|2515266|P3|COMPLETED|Overall Study||14
1035812|NCT00712075|2515267|P2|COMPLETED|Overall Study||26
1035813|NCT00712075|2515268|P1|COMPLETED|Overall Study||17
1035814|NCT00712075|2515266|P3|STARTED|Overall Study||25
1035815|NCT00712075|2515267|P2|STARTED|Overall Study||30
1035816|NCT00712075|2515268|P1|STARTED|Overall Study||22
1035817|NCT00712166|2515284|P2|NOT COMPLETED|Overall Study||1
1035818|NCT00712166|2515285|P1|NOT COMPLETED|Overall Study||0
1035819|NCT00712166|2515284|P2|COMPLETED|Overall Study||75
1035820|NCT00712166|2515285|P1|COMPLETED|Overall Study||81
1035821|NCT00712166|2515284|P2|STARTED|Overall Study||76
1035822|NCT00712166|2515285|P1|STARTED|Overall Study||81
1035823|NCT00712179|2515309|P1|NOT COMPLETED|Overall Study||12
1035824|NCT00712179|2515309|P1|COMPLETED|Overall Study|Data from 4 subjects was excluded due to noise in recorded EMG signal, so 33 subjects were analysed.|37
1035825|NCT00712179|2515309|P1|STARTED|Overall Study||49
1035826|NCT00712244|2515317|P4|NOT COMPLETED|Overall Study||1
1035827|NCT00712244|2515318|P3|NOT COMPLETED|Overall Study||2
1035828|NCT00712244|2515319|P2|NOT COMPLETED|Overall Study||1
1035829|NCT00712244|2515320|P1|NOT COMPLETED|Overall Study||4
1035830|NCT00712244|2515317|P4|COMPLETED|Overall Study||26
1035831|NCT00712244|2515318|P3|COMPLETED|Overall Study||25
1035832|NCT00712244|2515319|P2|COMPLETED|Overall Study||28
1035833|NCT00712244|2515320|P1|COMPLETED|Overall Study||25
1035834|NCT00712244|2515317|P4|STARTED|Overall Study||27
1035835|NCT00712244|2515318|P3|STARTED|Overall Study||27
1035836|NCT00712244|2515319|P2|STARTED|Overall Study||29
1035837|NCT00712244|2515320|P1|STARTED|Overall Study||29
1035838|NCT00712335|2515367|P5|NOT COMPLETED|Overall Study||0
1035839|NCT00712335|2515368|P4|NOT COMPLETED|Overall Study||5
1035840|NCT00712335|2515369|P3|NOT COMPLETED|Overall Study||5
1035841|NCT00712335|2515370|P2|NOT COMPLETED|Overall Study||17
1035842|NCT00712335|2515371|P1|NOT COMPLETED|Overall Study||3
1035843|NCT00712335|2515367|P5|COMPLETED|Overall Study||30
1035844|NCT00712335|2515368|P4|COMPLETED|Overall Study||19
1035845|NCT00712335|2515369|P3|COMPLETED|Overall Study||6
1035846|NCT00712335|2515370|P2|COMPLETED|Overall Study||15
1035847|NCT00712335|2515371|P1|COMPLETED|Overall Study||5
1035848|NCT00712335|2515367|P5|STARTED|Overall Study||30
1035849|NCT00712335|2515368|P4|STARTED|Overall Study||24
1035850|NCT00712335|2515369|P3|STARTED|Overall Study||11
1035851|NCT00712335|2515370|P2|STARTED|Overall Study||32
1035852|NCT00712335|2515371|P1|STARTED|Overall Study||8
1035853|NCT00712348|2515413|P1|NOT COMPLETED|Overall Study||1
1035854|NCT00712348|2515413|P1|COMPLETED|Overall Study||30
1035855|NCT00712348|2515413|P1|STARTED|Overall Study||31
1035856|NCT00712530|2515423|P3|NOT COMPLETED|Overall Study||0
1035857|NCT00712530|2515424|P2|NOT COMPLETED|Overall Study||0
1035858|NCT00712530|2515425|P1|NOT COMPLETED|Overall Study||0
1035859|NCT00712530|2515423|P3|COMPLETED|Overall Study||3
1035860|NCT00712530|2515424|P2|COMPLETED|Overall Study||3
1035861|NCT00712530|2515425|P1|COMPLETED|Overall Study||3
1035862|NCT00712530|2515423|P3|STARTED|Overall Study|Screened 4 patients, but one failed to meet entry criteria due to a history of bleeding and diabetes|3
1035863|NCT00712530|2515424|P2|STARTED|Overall Study||3
1035864|NCT00712530|2515425|P1|STARTED|Overall Study||3
1035865|NCT00712543|2515450|P2|NOT COMPLETED|Day 8-14||2
1035866|NCT00712543|2515451|P1|NOT COMPLETED|Day 8-14||0
1035867|NCT00712543|2515450|P2|COMPLETED|Day 8-14||25
1035868|NCT00712543|2515451|P1|COMPLETED|Day 8-14||23
1035869|NCT00712543|2515450|P2|STARTED|Day 8-14||27
1035870|NCT00712543|2515451|P1|STARTED|Day 8-14||23
1035871|NCT00712543|2515450|P2|NOT COMPLETED|Day 1-7||0
1035872|NCT00712543|2515451|P1|NOT COMPLETED|Day 1-7||0
1035873|NCT00712543|2515450|P2|COMPLETED|Day 1-7||27
1035874|NCT00712543|2515451|P1|COMPLETED|Day 1-7||23
1035875|NCT00712543|2515450|P2|STARTED|Day 1-7||27
1035876|NCT00712543|2515451|P1|STARTED|Day 1-7||23
1035877|NCT00712673|2515460|P4|NOT COMPLETED|Overall Study||70
1035878|NCT00712673|2515461|P3|NOT COMPLETED|Overall Study||57
1035879|NCT00712673|2515462|P2|NOT COMPLETED|Overall Study||21
1035880|NCT00712673|2515463|P1|NOT COMPLETED|Overall Study||21
1035881|NCT00712673|2515460|P4|COMPLETED|Overall Study||185
1035882|NCT00712673|2515461|P3|COMPLETED|Overall Study||198
1035883|NCT00712673|2515462|P2|COMPLETED|Overall Study||64
1035884|NCT00712673|2515463|P1|COMPLETED|Overall Study||64
1035885|NCT00712673|2515460|P4|Subgroup for Standardized Meal Test|Overall Study||0
1035886|NCT00712673|2515461|P3|Subgroup for Standardized Meal Test|Overall Study||255
1035887|NCT00712673|2515462|P2|Subgroup for Standardized Meal Test|Overall Study||0
1035888|NCT00712673|2515463|P1|Subgroup for Standardized Meal Test|Overall Study|Patients from morning injection arms where standardized meal test was performed.|85
1035889|NCT00712673|2515460|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||255
1035890|NCT00712673|2515461|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||255
1035891|NCT00712673|2515462|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||85
1035892|NCT00712673|2515463|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|85
1035893|NCT00712673|2515460|P4|Safety Population|Overall Study||255
1035894|NCT00712673|2515461|P3|Safety Population|Overall Study||255
1035895|NCT00712673|2515462|P2|Safety Population|Overall Study||85
1035896|NCT00712673|2515463|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|85
1035897|NCT00712673|2515460|P4|STARTED|Overall Study||255
1035898|NCT00712673|2515461|P3|STARTED|Overall Study||255
1035899|NCT00712673|2515462|P2|STARTED|Overall Study||85
1035900|NCT00712673|2515463|P1|STARTED|Overall Study|Randomized.|85
1035901|NCT00718237|2515527|P2|NOT COMPLETED|Overall Study||15
1035902|NCT00718237|2515528|P1|NOT COMPLETED|Overall Study||13
1035903|NCT00718237|2515527|P2|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|366
1035904|NCT00718237|2515528|P1|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|368
1035905|NCT00718237|2515527|P2|Vaccinated at Visit 3|Overall Study||369
1035906|NCT00718237|2515528|P1|Vaccinated at Visit 3|Overall Study||371
1035907|NCT00718237|2515527|P2|Vaccinated at Visit 2|Overall Study||374
1035908|NCT00718237|2515528|P1|Vaccinated at Visit 2|Overall Study||373
1035909|NCT00718237|2515527|P2|Vaccinated at Visit 1|Overall Study||381
1035910|NCT00718237|2515528|P1|Vaccinated at Visit 1|Overall Study||380
1035911|NCT00718237|2515527|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
1035912|NCT00718237|2515528|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
1035913|NCT00718302|2515540|P2|NOT COMPLETED|Overall Study||0
1035914|NCT00718302|2515541|P1|NOT COMPLETED|Overall Study||0
1035915|NCT00718302|2515540|P2|COMPLETED|Overall Study||114
1035916|NCT00718302|2515541|P1|COMPLETED|Overall Study||119
1035917|NCT00718302|2515540|P2|STARTED|Overall Study||114
1035918|NCT00718302|2515541|P1|STARTED|Overall Study||119
1035919|NCT00718315|2515558|P3|NOT COMPLETED|Overall Study||21
1035920|NCT00718315|2515559|P2|NOT COMPLETED|Overall Study||22
1035921|NCT00718315|2515560|P1|NOT COMPLETED|Overall Study||19
1035922|NCT00718315|2515558|P3|COMPLETED|Overall Study||46
1035923|NCT00718315|2515559|P2|COMPLETED|Overall Study||45
1035924|NCT00718315|2515560|P1|COMPLETED|Overall Study||48
1035925|NCT00718315|2515558|P3|STARTED|Overall Study||67
1035926|NCT00718315|2515559|P2|STARTED|Overall Study||67
1035927|NCT00718315|2515560|P1|STARTED|Overall Study||67
1035934|NCT00718770|2515601|P1|NOT COMPLETED|Overall Study||8
1035935|NCT00718770|2515601|P1|COMPLETED|Overall Study||2
1035936|NCT00718770|2515601|P1|STARTED|Overall Study||10
1035937|NCT00718809|2515607|P2|NOT COMPLETED|Overall Study||9
1035938|NCT00718809|2515608|P1|NOT COMPLETED|Overall Study||12
1035939|NCT00718809|2515607|P2|COMPLETED|Overall Study||0
1035940|NCT00718809|2515608|P1|COMPLETED|Overall Study||0
1035941|NCT00718809|2515607|P2|STARTED|Overall Study||9
1035942|NCT00718809|2515608|P1|STARTED|Overall Study||12
1035943|NCT00718861|2515624|P2|NOT COMPLETED|Overall Study||18
1035944|NCT00718861|2515625|P1|NOT COMPLETED|Overall Study||21
1035945|NCT00718861|2515624|P2|COMPLETED|Overall Study||77
1035946|NCT00718861|2515625|P1|COMPLETED|Overall Study||74
1035947|NCT00718861|2515624|P2|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|69
1035948|NCT00718861|2515625|P1|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|67
1035949|NCT00718861|2515624|P2|Safety Set|Overall Study||95
1035950|NCT00718861|2515625|P1|Safety Set|Overall Study|3 patients randomized but never received study drug|92
1035951|NCT00718861|2515624|P2|STARTED|Overall Study||95
1035952|NCT00718861|2515625|P1|STARTED|Overall Study|"Started indicates Randomized and Intent-to Treat (ITT) population"|95
1035953|NCT00718887|2515653|P2|NOT COMPLETED|Overall Study||9
1035954|NCT00718887|2515654|P1|NOT COMPLETED|Overall Study||5
1035955|NCT00718887|2515653|P2|COMPLETED|Overall Study||68
1035956|NCT00718887|2515654|P1|COMPLETED|Overall Study|Continued in study after 48 weeks|84
1035957|NCT00718887|2515653|P2|STARTED|Overall Study|Participants who received treatment.|77
1035958|NCT00718887|2515654|P1|STARTED|Overall Study|Participants who received treatment.|89
1035959|NCT00719043|2515683|P7|NOT COMPLETED|Overall Study||28
1035960|NCT00719043|2515684|P6|NOT COMPLETED|Overall Study||34
1035961|NCT00719043|2515685|P5|NOT COMPLETED|Overall Study||27
1035962|NCT00719043|2515686|P4|NOT COMPLETED|Overall Study||23
1035963|NCT00719043|2515687|P3|NOT COMPLETED|Overall Study||20
1035964|NCT00719043|2515688|P2|NOT COMPLETED|Overall Study||25
1035965|NCT00719043|2515689|P1|NOT COMPLETED|Overall Study||32
1035966|NCT00719043|2515683|P7|COMPLETED|Overall Study|Up to Day 909|92
1035967|NCT00719043|2515684|P6|COMPLETED|Overall Study|Up to Day 909|86
1035968|NCT00719043|2515685|P5|COMPLETED|Overall Study|Up to Day 909|95
1035969|NCT00719043|2515686|P4|COMPLETED|Overall Study|Up to Day 909|96
1035970|NCT00719043|2515687|P3|COMPLETED|Overall Study|Up to Day 909|99
1035971|NCT00719043|2515688|P2|COMPLETED|Overall Study|Up to Day 909|96
1035972|NCT00719043|2515689|P1|COMPLETED|Overall Study|Up to Day 909|88
1035973|NCT00719043|2515683|P7|STARTED|Overall Study||120
1035974|NCT00719043|2515684|P6|STARTED|Overall Study||120
1035975|NCT00719043|2515685|P5|STARTED|Overall Study||122
1035976|NCT00719043|2515686|P4|STARTED|Overall Study||119
1035977|NCT00719043|2515687|P3|STARTED|Overall Study||119
1035978|NCT00719043|2515688|P2|STARTED|Overall Study||121
1035979|NCT00719043|2515689|P1|STARTED|Overall Study||120
1035980|NCT00719134|2515811|P1|NOT COMPLETED|Overall Study||10
1035981|NCT00719134|2515811|P1|COMPLETED|Overall Study||66
1035982|NCT00719134|2515811|P1|STARTED|Overall Study||76
1035983|NCT00719160|2515817|P2|NOT COMPLETED|Overall Study||0
1035984|NCT00719160|2515818|P1|NOT COMPLETED|Overall Study||0
1035985|NCT00719160|2515817|P2|COMPLETED|Overall Study||6
1035986|NCT00719160|2515818|P1|COMPLETED|Overall Study||6
1035987|NCT00719160|2515817|P2|STARTED|Overall Study||6
1035988|NCT00719160|2515818|P1|STARTED|Overall Study||6
1035995|NCT00719212|2515840|P1|NOT COMPLETED|Overall Study||44
1035996|NCT00719212|2515840|P1|COMPLETED|Overall Study||17
1035997|NCT00719212|2515840|P1|STARTED|Overall Study||61
1035998|NCT00719264|2515852|P2|NOT COMPLETED|Overall Study||183
1035999|NCT00719264|2515853|P1|NOT COMPLETED|Overall Study||182
1036000|NCT00719264|2515852|P2|COMPLETED|Overall Study||0
1036001|NCT00719264|2515853|P1|COMPLETED|Overall Study||0
1036002|NCT00719264|2515852|P2|Safety Set|Overall Study||181
1036003|NCT00719264|2515853|P1|Safety Set|Overall Study||180
1036004|NCT00719264|2515852|P2|Full Analysis Set|Overall Study||183
1036005|NCT00719264|2515853|P1|Full Analysis Set|Overall Study||182
1036006|NCT00719264|2515852|P2|STARTED|Overall Study||183
1036007|NCT00719264|2515853|P1|STARTED|Overall Study||182
1036008|NCT00719329|2515875|P3|NOT COMPLETED|Overall Study||1
1036009|NCT00719329|2515876|P2|NOT COMPLETED|Overall Study||2
1036010|NCT00719329|2515877|P1|NOT COMPLETED|Overall Study||0
1036011|NCT00719329|2515875|P3|COMPLETED|Overall Study||646
1036012|NCT00719329|2515876|P2|COMPLETED|Overall Study||569
1036013|NCT00719329|2515877|P1|COMPLETED|Overall Study||705
1036014|NCT00719329|2515875|P3|Day 7 Swab|Overall Study||561
1036015|NCT00719329|2515876|P2|Day 7 Swab|Overall Study||467
1036016|NCT00719329|2515877|P1|Day 7 Swab|Overall Study||593
1036017|NCT00719329|2515875|P3|Day 3 Swab|Overall Study||578
1036018|NCT00719329|2515876|P2|Day 3 Swab|Overall Study||501
1036019|NCT00719329|2515877|P1|Day 3 Swab|Overall Study||614
1036020|NCT00719329|2515875|P3|Day 1 Swab|Overall Study||646
1036021|NCT00719329|2515876|P2|Day 1 Swab|Overall Study||569
1036022|NCT00719329|2515877|P1|Day 1 Swab|Overall Study||705
1036023|NCT00719329|2515875|P3|STARTED|Overall Study||647
1036024|NCT00719329|2515876|P2|STARTED|Overall Study||571
1036025|NCT00719329|2515877|P1|STARTED|Overall Study||705
1036026|NCT00719355|2515893|P2|NOT COMPLETED|Overall Study||13
1036027|NCT00719355|2515894|P1|NOT COMPLETED|Overall Study||18
1036028|NCT00719355|2515893|P2|COMPLETED|Overall Study||39
1036029|NCT00719355|2515894|P1|COMPLETED|Overall Study||33
1036030|NCT00719355|2515893|P2|Completed 32 Weeks|Overall Study||39
1036031|NCT00719355|2515894|P1|Completed 32 Weeks|Overall Study||33
1036032|NCT00719355|2515893|P2|Completed 24 Weeks|Overall Study||43
1036033|NCT00719355|2515894|P1|Completed 24 Weeks|Overall Study||34
1036034|NCT00719355|2515893|P2|Completed 12 Weeks|Overall Study||46
1036035|NCT00719355|2515894|P1|Completed 12 Weeks|Overall Study||43
1036036|NCT00719355|2515893|P2|Completed 6 Weeks|Overall Study||48
1036037|NCT00719355|2515894|P1|Completed 6 Weeks|Overall Study||49
1036038|NCT00719355|2515893|P2|STARTED|Overall Study||52
1036039|NCT00719355|2515894|P1|STARTED|Overall Study||51
1036040|NCT00719472|2515902|P1|NOT COMPLETED|Received Cycle 2 Treatment||68
1036041|NCT00719472|2515902|P1|COMPLETED|Received Cycle 2 Treatment||304
1036042|NCT00719472|2515902|P1|STARTED|Received Cycle 2 Treatment||372
1036043|NCT00719472|2515902|P1|NOT COMPLETED|Received Cycle 1 Treatment||53
1036044|NCT00719472|2515902|P1|COMPLETED|Received Cycle 1 Treatment||372
1036045|NCT00719472|2515902|P1|STARTED|Received Cycle 1 Treatment||425
1036046|NCT00719472|2515902|P1|NOT COMPLETED|Enrolled in Study||26
1036047|NCT00719472|2515902|P1|COMPLETED|Enrolled in Study||425
1036048|NCT00719472|2515902|P1|STARTED|Enrolled in Study||451
1036049|NCT00719537|2515913|P2|NOT COMPLETED|Overall Study||1
1036050|NCT00719537|2515914|P1|NOT COMPLETED|Overall Study||1
1036051|NCT00719537|2515913|P2|COMPLETED|Overall Study||0
1036052|NCT00719537|2515914|P1|COMPLETED|Overall Study||1
1036053|NCT00719537|2515913|P2|STARTED|Overall Study||1
1036054|NCT00719537|2515914|P1|STARTED|Overall Study||2
1036055|NCT00719563|2515922|P2|NOT COMPLETED|Overall Study||42
1036056|NCT00719563|2515923|P1|NOT COMPLETED|Overall Study||38
1036057|NCT00719563|2515922|P2|COMPLETED|Overall Study||128
1036058|NCT00719563|2515923|P1|COMPLETED|Overall Study||133
1036059|NCT00719563|2515922|P2|STARTED|Overall Study||170
1036060|NCT00719563|2515923|P1|STARTED|Overall Study||171
1036061|NCT00719615|2515956|P3|NOT COMPLETED|Overall Study||0
1036062|NCT00719615|2515957|P2|NOT COMPLETED|Overall Study||0
1036063|NCT00719615|2515958|P1|NOT COMPLETED|Overall Study||0
1036064|NCT00719615|2515956|P3|COMPLETED|Overall Study||24
1036065|NCT00719615|2515957|P2|COMPLETED|Overall Study||45
1036066|NCT00719615|2515958|P1|COMPLETED|Overall Study||42
1036067|NCT00719615|2515956|P3|STARTED|Overall Study||24
1036068|NCT00719615|2515957|P2|STARTED|Overall Study||45
1036069|NCT00719615|2515958|P1|STARTED|Overall Study||42
1036070|NCT00719680|2515966|P1|NOT COMPLETED|Overall Study||5
1036071|NCT00719680|2515966|P1|COMPLETED|Overall Study||16
1036072|NCT00719680|2515966|P1|STARTED|Overall Study||21
1036073|NCT00719706|2515988|P2|NOT COMPLETED|Overall Study||6
1036074|NCT00719706|2515989|P1|NOT COMPLETED|Overall Study||9
1036075|NCT00719706|2515988|P2|COMPLETED|Overall Study||14
1036076|NCT00719706|2515989|P1|COMPLETED|Overall Study||11
1036077|NCT00719706|2515988|P2|STARTED|Overall Study||20
1036078|NCT00719706|2515989|P1|STARTED|Overall Study||20
1036079|NCT00719732|2516003|P1|NOT COMPLETED|Overall Study||22
1036080|NCT00719732|2516003|P1|COMPLETED|Overall Study||196
1036081|NCT00719732|2516003|P1|STARTED|Overall Study||218
1036082|NCT00719810|2516010|P3|NOT COMPLETED|Overall Study||8
1036083|NCT00719810|2516011|P2|NOT COMPLETED|Overall Study||4
1036084|NCT00719810|2516012|P1|NOT COMPLETED|Overall Study||3
1036085|NCT00719810|2516010|P3|COMPLETED|Overall Study||42
1036086|NCT00719810|2516011|P2|COMPLETED|Overall Study||47
1036087|NCT00719810|2516012|P1|COMPLETED|Overall Study||46
1036088|NCT00719810|2516010|P3|STARTED|Overall Study||50
1036089|NCT00719810|2516011|P2|STARTED|Overall Study||51
1036090|NCT00719810|2516012|P1|STARTED|Overall Study||49
1036091|NCT00719849|2516025|P2|NOT COMPLETED|Overall Study||1
1036092|NCT00719849|2516026|P1|NOT COMPLETED|Overall Study||0
1036093|NCT00719849|2516025|P2|COMPLETED|Overall Study||8
1036094|NCT00719849|2516026|P1|COMPLETED|Overall Study||4
1036095|NCT00719849|2516025|P2|STARTED|Overall Study||9
1036096|NCT00719849|2516026|P1|STARTED|Overall Study||4
1036097|NCT00719862|2516064|P2|NOT COMPLETED|Overall Study||6
1036098|NCT00719862|2516065|P1|NOT COMPLETED|Overall Study||8
1036099|NCT00719862|2516064|P2|COMPLETED|Overall Study||233
1036100|NCT00719862|2516065|P1|COMPLETED|Overall Study||234
1036101|NCT00719862|2516064|P2|STARTED|Overall Study|1 subject was randomized in error|239
1036102|NCT00719862|2516065|P1|STARTED|Overall Study||242
1036103|NCT00719901|2516081|P1|NOT COMPLETED|Overall Study||11
1036104|NCT00719901|2516081|P1|COMPLETED|Overall Study||0
1036105|NCT00719901|2516081|P1|STARTED|Overall Study||11
1036106|NCT00719914|2516093|P2|NOT COMPLETED|Overall Study||0
1036107|NCT00719914|2516094|P1|NOT COMPLETED|Overall Study||0
1036108|NCT00719914|2516093|P2|COMPLETED|Overall Study||7
1036109|NCT00719914|2516094|P1|COMPLETED|Overall Study||10
1036110|NCT00719914|2516093|P2|STARTED|Overall Study||7
1036111|NCT00719914|2516094|P1|STARTED|Overall Study||10
1036112|NCT00719953|2516100|P1|NOT COMPLETED|Overall Study||4
1036113|NCT00719953|2516100|P1|COMPLETED|Overall Study||26
1036114|NCT00719953|2516100|P1|STARTED|Overall Study||30
1036115|NCT00720057|2516106|P2|NOT COMPLETED|Overall Study||3
1036116|NCT00720057|2516107|P1|NOT COMPLETED|Overall Study||1
1036117|NCT00720057|2516106|P2|COMPLETED|Overall Study||156
1036118|NCT00720057|2516107|P1|COMPLETED|Overall Study||152
1036119|NCT00720057|2516106|P2|STARTED|Overall Study||159
1036120|NCT00720057|2516107|P1|STARTED|Overall Study||153
1036121|NCT00720083|2516125|P2|NOT COMPLETED|Overall Study||2
1036122|NCT00720083|2516126|P1|NOT COMPLETED|Overall Study||1
1036123|NCT00720083|2516125|P2|COMPLETED|Overall Study||13
1036124|NCT00720083|2516126|P1|COMPLETED|Overall Study|Subjects with data for the primary analysis are considered to have completed the study.|16
1036125|NCT00720083|2516125|P2|STARTED|Overall Study||15
1036126|NCT00720083|2516126|P1|STARTED|Overall Study||17
1036133|NCT00720109|2516145|P3|NOT COMPLETED|Risk Stratification Period||8
1036134|NCT00720109|2516146|P2|NOT COMPLETED|Risk Stratification Period||15
1036135|NCT00720109|2516147|P1|NOT COMPLETED|Risk Stratification Period||0
1036136|NCT00720109|2516145|P3|COMPLETED|Risk Stratification Period||1
1036137|NCT00720109|2516146|P2|COMPLETED|Risk Stratification Period||33
1036138|NCT00720109|2516147|P1|COMPLETED|Risk Stratification Period||0
1036139|NCT00720109|2516145|P3|STARTED|Risk Stratification Period||9
1036140|NCT00720109|2516146|P2|STARTED|Risk Stratification Period||48
1036141|NCT00720109|2516147|P1|STARTED|Risk Stratification Period||0
1036142|NCT00720109|2516145|P3|NOT COMPLETED|Induction Period||0
1036143|NCT00720109|2516146|P2|NOT COMPLETED|Induction Period||0
1036144|NCT00720109|2516147|P1|NOT COMPLETED|Induction Period||6
1036145|NCT00720109|2516145|P3|COMPLETED|Induction Period||0
1036146|NCT00720109|2516146|P2|COMPLETED|Induction Period||0
1036147|NCT00720109|2516147|P1|COMPLETED|Induction Period||57
1036148|NCT00720109|2516145|P3|STARTED|Induction Period||0
1036149|NCT00720109|2516146|P2|STARTED|Induction Period||0
1036150|NCT00720109|2516147|P1|STARTED|Induction Period||63
1036151|NCT00720122|2516165|P1|NOT COMPLETED|Overall Study||9
1036152|NCT00720122|2516165|P1|COMPLETED|Overall Study||19
1036153|NCT00720122|2516165|P1|STARTED|Overall Study||28
1036154|NCT00720226|2516171|P2|NOT COMPLETED|Overall Study||4
1036155|NCT00720226|2516172|P1|NOT COMPLETED|Overall Study||7
1036156|NCT00720226|2516171|P2|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|48
1036157|NCT00720226|2516172|P1|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|47
1036158|NCT00720226|2516171|P2|STARTED|Overall Study||52
1036159|NCT00720226|2516172|P1|STARTED|Overall Study||54
1036160|NCT00720278|2516183|P3|NOT COMPLETED|Overall Study||6
1036161|NCT00720278|2516184|P2|NOT COMPLETED|Overall Study||4
1036162|NCT00720278|2516185|P1|NOT COMPLETED|Overall Study||7
1036163|NCT00720278|2516183|P3|COMPLETED|Overall Study||172
1036164|NCT00720278|2516184|P2|COMPLETED|Overall Study||166
1036165|NCT00720278|2516185|P1|COMPLETED|Overall Study||171
1036166|NCT00720278|2516183|P3|STARTED|Overall Study|1 subject was randomized in error|178
1036167|NCT00720278|2516184|P2|STARTED|Overall Study|1 subject was randomized in error|170
1036168|NCT00720278|2516185|P1|STARTED|Overall Study|1 subject was randomized in error|178
1036169|NCT00720330|2516208|P3|NOT COMPLETED|Overall Study||0
1036170|NCT00720330|2516209|P2|NOT COMPLETED|Overall Study||0
1036171|NCT00720330|2516210|P1|NOT COMPLETED|Overall Study||0
1036172|NCT00720330|2516208|P3|COMPLETED|Overall Study||3
1036173|NCT00720330|2516209|P2|COMPLETED|Overall Study||4
1036174|NCT00720330|2516210|P1|COMPLETED|Overall Study||5
1036175|NCT00720330|2516208|P3|STARTED|Overall Study||3
1036176|NCT00720330|2516209|P2|STARTED|Overall Study||4
1036177|NCT00720330|2516210|P1|STARTED|Overall Study||5
1036178|NCT00720343|2516230|P1|NOT COMPLETED|Overall Study||6
1036179|NCT00720343|2516230|P1|COMPLETED|Overall Study|3 removed by physician. 3 unable to be determined; Columbia will never have access to this data.|48
1036180|NCT00720343|2516230|P1|STARTED|Overall Study||54
1036181|NCT00720369|2516238|P2|NOT COMPLETED|Overall Study||0
1036182|NCT00720369|2516239|P1|NOT COMPLETED|Overall Study||1
1036183|NCT00720369|2516238|P2|COMPLETED|Overall Study||8
1036184|NCT00720369|2516239|P1|COMPLETED|Overall Study|one subject discontinued due to an adverse event.|10
1036185|NCT00720369|2516238|P2|STARTED|Overall Study||8
1036186|NCT00720369|2516239|P1|STARTED|Overall Study||11
1036187|NCT00720382|2516249|P2|NOT COMPLETED|Overall Study||59
1036188|NCT00720382|2516250|P1|NOT COMPLETED|Overall Study||176
1036189|NCT00720382|2516249|P2|COMPLETED|Overall Study||178
1036190|NCT00720382|2516250|P1|COMPLETED|Overall Study||290
1036191|NCT00720382|2516249|P2|STARTED|Overall Study||237
1036192|NCT00720382|2516250|P1|STARTED|Overall Study||466
1036193|NCT00720434|2516262|P4|NOT COMPLETED|Open-Label Period (Week 5-72)||4
1036194|NCT00720434|2516263|P3|NOT COMPLETED|Open-Label Period (Week 5-72)||4
1036195|NCT00720434|2516264|P2|NOT COMPLETED|Open-Label Period (Week 5-72)||3
1036196|NCT00720434|2516265|P1|NOT COMPLETED|Open-Label Period (Week 5-72)||6
1036197|NCT00720434|2516262|P4|COMPLETED|Open-Label Period (Week 5-72)||4
1036198|NCT00720434|2516263|P3|COMPLETED|Open-Label Period (Week 5-72)||4
1036199|NCT00720434|2516264|P2|COMPLETED|Open-Label Period (Week 5-72)||5
1036200|NCT00720434|2516265|P1|COMPLETED|Open-Label Period (Week 5-72)||4
1036201|NCT00720434|2516262|P4|STARTED|Open-Label Period (Week 5-72)||8
1036202|NCT00720434|2516263|P3|STARTED|Open-Label Period (Week 5-72)||8
1036203|NCT00720434|2516264|P2|STARTED|Open-Label Period (Week 5-72)||8
1036204|NCT00720434|2516265|P1|STARTED|Open-Label Period (Week 5-72)||10
1036205|NCT00720434|2516262|P4|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
1036206|NCT00720434|2516263|P3|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
1036207|NCT00720434|2516264|P2|NOT COMPLETED|Double-Blind Period (Week 1-4)||1
1036208|NCT00720434|2516265|P1|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
1036209|NCT00720434|2516262|P4|COMPLETED|Double-Blind Period (Week 1-4)||8
1036210|NCT00720434|2516263|P3|COMPLETED|Double-Blind Period (Week 1-4)||8
1036211|NCT00720434|2516264|P2|COMPLETED|Double-Blind Period (Week 1-4)||8
1036212|NCT00720434|2516265|P1|COMPLETED|Double-Blind Period (Week 1-4)||10
1036213|NCT00720434|2516262|P4|STARTED|Double-Blind Period (Week 1-4)||8
1036214|NCT00720434|2516263|P3|STARTED|Double-Blind Period (Week 1-4)||8
1036215|NCT00720434|2516264|P2|STARTED|Double-Blind Period (Week 1-4)||9
1036216|NCT00720434|2516265|P1|STARTED|Double-Blind Period (Week 1-4)||10
1036217|NCT00720473|2516289|P2|NOT COMPLETED|Overall Study||8
1036218|NCT00720473|2516290|P1|NOT COMPLETED|Overall Study||30
1036219|NCT00720473|2516289|P2|COMPLETED|Overall Study||16
1036220|NCT00720473|2516290|P1|COMPLETED|Overall Study||15
1036221|NCT00720473|2516289|P2|STARTED|Overall Study||24
1036222|NCT00720473|2516290|P1|STARTED|Overall Study||45
1036223|NCT00720499|2516314|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||3
1036224|NCT00720499|2516315|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||2
1036225|NCT00720499|2516314|P2|COMPLETED|Treatment Period 2 (4 Weeks)||67
1036226|NCT00720499|2516315|P1|COMPLETED|Treatment Period 2 (4 Weeks)||64
1036227|NCT00720499|2516314|P2|STARTED|Treatment Period 2 (4 Weeks)||70
1036228|NCT00720499|2516315|P1|STARTED|Treatment Period 2 (4 Weeks)||66
1036229|NCT00720499|2516314|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
1036230|NCT00720499|2516315|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
1036231|NCT00720499|2516314|P2|COMPLETED|Washout Period (2 Weeks)||70
1036232|NCT00720499|2516315|P1|COMPLETED|Washout Period (2 Weeks)||66
1036233|NCT00720499|2516314|P2|STARTED|Washout Period (2 Weeks)||70
1036234|NCT00720499|2516315|P1|STARTED|Washout Period (2 Weeks)||66
1036235|NCT00720499|2516314|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||2
1036236|NCT00720499|2516315|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||3
1036237|NCT00720499|2516314|P2|COMPLETED|Treatment Period 1 (4 Weeks)||70
1036238|NCT00720499|2516315|P1|COMPLETED|Treatment Period 1 (4 Weeks)||66
1036239|NCT00720499|2516314|P2|STARTED|Treatment Period 1 (4 Weeks)||72
1036240|NCT00720499|2516315|P1|STARTED|Treatment Period 1 (4 Weeks)||69
1036241|NCT00720629|2516377|P1|NOT COMPLETED|Overall Study||0
1036242|NCT00720629|2516377|P1|COMPLETED|Overall Study||8
1036243|NCT00720629|2516377|P1|STARTED|Overall Study||8
1036244|NCT00720759|2516391|P4|NOT COMPLETED|Overall Study||0
1036245|NCT00720759|2516392|P3|NOT COMPLETED|Overall Study||1
1036246|NCT00720759|2516393|P2|NOT COMPLETED|Overall Study||1
1036247|NCT00720759|2516394|P1|NOT COMPLETED|Overall Study||0
1036248|NCT00720759|2516391|P4|COMPLETED|Overall Study||6
1036249|NCT00720759|2516392|P3|COMPLETED|Overall Study||5
1036250|NCT00720759|2516393|P2|COMPLETED|Overall Study||5
1036251|NCT00720759|2516394|P1|COMPLETED|Overall Study||6
1036252|NCT00720759|2516391|P4|STARTED|Overall Study||6
1036253|NCT00720759|2516392|P3|STARTED|Overall Study||6
1036254|NCT00720759|2516393|P2|STARTED|Overall Study||6
1036255|NCT00720759|2516394|P1|STARTED|Overall Study||6
1036256|NCT00720798|2516404|P1|NOT COMPLETED|Overall Study||756
1036257|NCT00720798|2516404|P1|COMPLETED|Overall Study||1311
1036258|NCT00720798|2516404|P1|STARTED|Overall Study||2067
1036259|NCT00720941|2516425|P2|NOT COMPLETED|Overall Study||415
1036260|NCT00720941|2516426|P1|NOT COMPLETED|Overall Study||413
1036261|NCT00720941|2516425|P2|COMPLETED|Overall Study||138
1036262|NCT00720941|2516426|P1|COMPLETED|Overall Study||144
1036263|NCT00720941|2516425|P2|Ongoing|Overall Study||23
1036264|NCT00720941|2516426|P1|Ongoing|Overall Study||34
1036265|NCT00720941|2516425|P2|STARTED|Overall Study||553
1036266|NCT00720941|2516426|P1|STARTED|Overall Study||557
1036267|NCT00721110|2516470|P4|NOT COMPLETED|Overall Study||0
1036268|NCT00721110|2516471|P3|NOT COMPLETED|Overall Study||1
1036269|NCT00721110|2516472|P2|NOT COMPLETED|Overall Study||0
1036270|NCT00721110|2516473|P1|NOT COMPLETED|Overall Study||1
1036271|NCT00721110|2516470|P4|COMPLETED|Overall Study||16
1036272|NCT00721110|2516471|P3|COMPLETED|Overall Study||15
1036273|NCT00721110|2516472|P2|COMPLETED|Overall Study||16
1036274|NCT00721110|2516473|P1|COMPLETED|Overall Study||15
1036275|NCT00721110|2516470|P4|STARTED|Overall Study||16
1036276|NCT00721110|2516471|P3|STARTED|Overall Study||16
1036277|NCT00721110|2516472|P2|STARTED|Overall Study||16
1036278|NCT00721110|2516473|P1|STARTED|Overall Study||16
1036279|NCT00721123|2516499|P1|NOT COMPLETED|Overall Study||183
1036280|NCT00721123|2516499|P1|COMPLETED|Overall Study||355
1036281|NCT00721123|2516499|P1|STARTED|Overall Study||538
1036282|NCT00721136|2516577|P4|NOT COMPLETED|Overall Study||0
1036283|NCT00721136|2516578|P3|NOT COMPLETED|Overall Study||0
1036284|NCT00721136|2516579|P2|NOT COMPLETED|Overall Study||0
1036285|NCT00721136|2516580|P1|NOT COMPLETED|Overall Study||0
1036286|NCT00721136|2516577|P4|COMPLETED|Overall Study||8
1036287|NCT00721136|2516578|P3|COMPLETED|Overall Study||8
1036288|NCT00721136|2516579|P2|COMPLETED|Overall Study||42
1036289|NCT00721136|2516580|P1|COMPLETED|Overall Study||42
1036290|NCT00721136|2516577|P4|STARTED|Overall Study||8
1036291|NCT00721136|2516578|P3|STARTED|Overall Study||8
1036292|NCT00721136|2516579|P2|STARTED|Overall Study||42
1036293|NCT00721136|2516580|P1|STARTED|Overall Study||42
1036294|NCT00721149|2516598|P1|NOT COMPLETED|Overall Study||1
1036295|NCT00721149|2516598|P1|COMPLETED|Overall Study||9
1036296|NCT00721149|2516598|P1|STARTED|Overall Study|Enrollment was stopped after 10 subjects entered the trial.|10
1036297|NCT00721162|2516607|P1|NOT COMPLETED|Overall Study||0
1036298|NCT00721162|2516607|P1|COMPLETED|Overall Study||60
1036299|NCT00721162|2516607|P1|Received Any Amount of Study Drug|Overall Study||60
1036300|NCT00721162|2516607|P1|STARTED|Overall Study||60
1036301|NCT00721175|2516618|P2|NOT COMPLETED|Overall Study||0
1036302|NCT00721175|2516619|P1|NOT COMPLETED|Overall Study||0
1036303|NCT00721175|2516618|P2|COMPLETED|Overall Study||54
1036304|NCT00721175|2516619|P1|COMPLETED|Overall Study||54
1036305|NCT00721175|2516618|P2|STARTED|Overall Study||54
1036306|NCT00721175|2516619|P1|STARTED|Overall Study||54
1036307|NCT00721188|2516631|P1|NOT COMPLETED|Overall Study||0
1036308|NCT00721188|2516631|P1|COMPLETED|Overall Study||11
1036309|NCT00721188|2516631|P1|STARTED|Overall Study||11
1036310|NCT00715559|2516646|P1|NOT COMPLETED|Overall Study||1
1036311|NCT00715559|2516646|P1|COMPLETED|Overall Study||2
1036312|NCT00715559|2516646|P1|STARTED|Overall Study||3
1036313|NCT00715624|2516655|P2|NOT COMPLETED|Overall Study||116
1036314|NCT00715624|2516656|P1|NOT COMPLETED|Overall Study||52
1036315|NCT00715624|2516655|P2|COMPLETED|Overall Study||213
1036316|NCT00715624|2516656|P1|COMPLETED|Overall Study||115
1036317|NCT00715624|2516655|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||327
1036318|NCT00715624|2516656|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|166
1036319|NCT00715624|2516655|P2|Treated/Safety Population|Overall Study||328
1036320|NCT00715624|2516656|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|167
1036321|NCT00715624|2516655|P2|STARTED|Overall Study||329
1036322|NCT00715624|2516656|P1|STARTED|Overall Study|Randomized|167
1036323|NCT00715650|2516686|P2|NOT COMPLETED|Follow-up||5
1036324|NCT00715650|2516687|P1|NOT COMPLETED|Follow-up||13
1036325|NCT00715650|2516686|P2|COMPLETED|Follow-up||37
1036326|NCT00715650|2516687|P1|COMPLETED|Follow-up||29
1036327|NCT00715650|2516686|P2|Completed Month 6 Follow-up|Follow-up||37
1036328|NCT00715650|2516687|P1|Completed Month 6 Follow-up|Follow-up||29
1036329|NCT00715650|2516686|P2|Completed Month 3 Follow-up|Follow-up||40
1036330|NCT00715650|2516687|P1|Completed Month 3 Follow-up|Follow-up||35
1036331|NCT00715650|2516686|P2|Completed Month 1 Follow-up|Follow-up||38
1036332|NCT00715650|2516687|P1|Completed Month 1 Follow-up|Follow-up||40
1036333|NCT00715650|2516686|P2|STARTED|Follow-up||42
1036334|NCT00715650|2516687|P1|STARTED|Follow-up||42
1036335|NCT00715650|2516686|P2|NOT COMPLETED|Intervention||3
1036336|NCT00715650|2516687|P1|NOT COMPLETED|Intervention||5
1036337|NCT00715650|2516686|P2|COMPLETED|Intervention||42
1036338|NCT00715650|2516687|P1|COMPLETED|Intervention||42
1036339|NCT00715650|2516686|P2|Attended ≥ 3 Sessions|Intervention||17
1036340|NCT00715650|2516687|P1|Attended ≥ 3 Sessions|Intervention||23
1036341|NCT00715650|2516686|P2|Attended ≥ 2 Sessions|Intervention||33
1036342|NCT00715650|2516687|P1|Attended ≥ 2 Sessions|Intervention||36
1036343|NCT00715650|2516686|P2|Received Any Session|Intervention||38
1036344|NCT00715650|2516687|P1|Received Any Session|Intervention||39
1036345|NCT00715650|2516686|P2|STARTED|Intervention||45
1036346|NCT00715650|2516687|P1|STARTED|Intervention||47
1036347|NCT00715676|2516702|P3|NOT COMPLETED|Overall Study||32
1036348|NCT00715676|2516703|P2|NOT COMPLETED|Overall Study||11
1036349|NCT00715676|2516704|P1|NOT COMPLETED|Overall Study||6
1036350|NCT00715676|2516702|P3|COMPLETED|Overall Study||21
1036351|NCT00715676|2516703|P2|COMPLETED|Overall Study||43
1036352|NCT00715676|2516704|P1|COMPLETED|Overall Study||43
1036353|NCT00715676|2516702|P3|STARTED|Overall Study||53
1036354|NCT00715676|2516703|P2|STARTED|Overall Study||54
1036355|NCT00715676|2516704|P1|STARTED|Overall Study|1 additional subject was enrolled in the placebo group but discontinued before taking any study drug|49
1036356|NCT00721214|2516730|P1|NOT COMPLETED|Overall Study||4
1036357|NCT00721214|2516730|P1|COMPLETED|Overall Study||12
1036358|NCT00721214|2516730|P1|STARTED|Overall Study||16
1036359|NCT00721227|2516743|P2|NOT COMPLETED|Overall Study||0
1036360|NCT00721227|2516744|P1|NOT COMPLETED|Overall Study||4
1036361|NCT00721227|2516743|P2|COMPLETED|Overall Study||6
1036362|NCT00721227|2516744|P1|COMPLETED|Overall Study|3 subjects lost to follow up; 1 subject did not complete due to noncompliance of scheduled visits.|5
1036363|NCT00721227|2516743|P2|STARTED|Overall Study||6
1036364|NCT00721227|2516744|P1|STARTED|Overall Study||9
1036365|NCT00721253|2516756|P3|NOT COMPLETED|Overall Study||0
1036366|NCT00721253|2516757|P2|NOT COMPLETED|Overall Study||0
1036367|NCT00721253|2516758|P1|NOT COMPLETED|Overall Study||0
1036368|NCT00721253|2516756|P3|COMPLETED|Overall Study||0
1036369|NCT00721253|2516757|P2|COMPLETED|Overall Study||22
1036370|NCT00721253|2516758|P1|COMPLETED|Overall Study||20
1036371|NCT00721253|2516756|P3|STARTED|Overall Study|There were no subjects that were implanted with the Tecnis lens.|0
1036372|NCT00721253|2516757|P2|STARTED|Overall Study||22
1036373|NCT00721253|2516758|P1|STARTED|Overall Study||20
1036374|NCT00721279|2516770|P2|NOT COMPLETED|Overall Study||24
1036375|NCT00721279|2516771|P1|NOT COMPLETED|Overall Study||36
1036376|NCT00721279|2516770|P2|COMPLETED|Overall Study||73
1036377|NCT00721279|2516771|P1|COMPLETED|Overall Study||416
1036378|NCT00721279|2516770|P2|STARTED|Overall Study||97
1036379|NCT00721279|2516771|P1|STARTED|Overall Study||452
1036380|NCT00721357|2516785|P2|NOT COMPLETED|Overall Study||0
1036381|NCT00721357|2516786|P1|NOT COMPLETED|Overall Study||0
1036382|NCT00721357|2516785|P2|COMPLETED|Overall Study||15
1036383|NCT00721357|2516786|P1|COMPLETED|Overall Study||15
1036384|NCT00721357|2516785|P2|STARTED|Overall Study||15
1036385|NCT00721357|2516786|P1|STARTED|Overall Study||15
1036386|NCT00721396|2516796|P4|NOT COMPLETED|Overall Study||10
1036387|NCT00721396|2516797|P3|NOT COMPLETED|Overall Study||10
1036388|NCT00721396|2516798|P2|NOT COMPLETED|Overall Study||36
1036389|NCT00721396|2516799|P1|NOT COMPLETED|Overall Study||30
1036390|NCT00721396|2516796|P4|COMPLETED|Overall Study||302
1036391|NCT00721396|2516797|P3|COMPLETED|Overall Study||308
1036392|NCT00721396|2516798|P2|COMPLETED|Overall Study||592
1036393|NCT00721396|2516799|P1|COMPLETED|Overall Study||597
1036394|NCT00721396|2516796|P4|STARTED|Overall Study||312
1036395|NCT00721396|2516797|P3|STARTED|Overall Study||318
1036396|NCT00721396|2516798|P2|STARTED|Overall Study||628
1036397|NCT00721396|2516799|P1|STARTED|Overall Study||627
1036410|NCT00721500|2516963|P4|NOT COMPLETED|Period Three||0
1036411|NCT00721500|2516964|P3|NOT COMPLETED|Period Three||0
1036412|NCT00721500|2516965|P2|NOT COMPLETED|Period Three||0
1036413|NCT00721500|2516966|P1|NOT COMPLETED|Period Three||0
1036414|NCT00721500|2516963|P4|COMPLETED|Period Three||6
1036415|NCT00721500|2516964|P3|COMPLETED|Period Three||6
1036416|NCT00721500|2516965|P2|COMPLETED|Period Three||7
1036417|NCT00721500|2516966|P1|COMPLETED|Period Three||6
1036418|NCT00721500|2516963|P4|STARTED|Period Three||6
1036419|NCT00721500|2516964|P3|STARTED|Period Three||6
1036420|NCT00721500|2516965|P2|STARTED|Period Three||7
1036421|NCT00721500|2516966|P1|STARTED|Period Three||6
1036422|NCT00721500|2516963|P4|NOT COMPLETED|Period Two||0
1036423|NCT00721500|2516964|P3|NOT COMPLETED|Period Two||0
1036424|NCT00721500|2516965|P2|NOT COMPLETED|Period Two||0
1036425|NCT00721500|2516966|P1|NOT COMPLETED|Period Two||0
1036426|NCT00721500|2516963|P4|COMPLETED|Period Two||6
1036427|NCT00721500|2516964|P3|COMPLETED|Period Two||6
1036428|NCT00721500|2516965|P2|COMPLETED|Period Two||7
1036429|NCT00721500|2516966|P1|COMPLETED|Period Two||6
1036430|NCT00721500|2516963|P4|STARTED|Period Two||6
1036431|NCT00721500|2516964|P3|STARTED|Period Two||6
1036432|NCT00721500|2516965|P2|STARTED|Period Two||7
1036433|NCT00721500|2516966|P1|STARTED|Period Two||6
1036434|NCT00721500|2516963|P4|NOT COMPLETED|Period One||0
1036435|NCT00721500|2516964|P3|NOT COMPLETED|Period One||0
1036436|NCT00721500|2516965|P2|NOT COMPLETED|Period One||0
1036437|NCT00721500|2516966|P1|NOT COMPLETED|Period One||0
1036438|NCT00721500|2516963|P4|COMPLETED|Period One||6
1036439|NCT00721500|2516964|P3|COMPLETED|Period One||6
1036440|NCT00721500|2516965|P2|COMPLETED|Period One||7
1036441|NCT00721500|2516966|P1|COMPLETED|Period One||6
1036442|NCT00721500|2516963|P4|STARTED|Period One||6
1036443|NCT00721500|2516964|P3|STARTED|Period One||6
1036444|NCT00721500|2516965|P2|STARTED|Period One||7
1036445|NCT00721500|2516966|P1|STARTED|Period One||6
1036446|NCT00721539|2516984|P1|NOT COMPLETED|Overall Study||0
1036447|NCT00721539|2516984|P1|COMPLETED|Overall Study||9
1036448|NCT00721539|2516984|P1|STARTED|Overall Study||9
1036449|NCT00721630|2516991|P1|NOT COMPLETED|Overall Study||1
1036450|NCT00721630|2516991|P1|COMPLETED|Overall Study||23
1036451|NCT00721630|2516991|P1|STARTED|Overall Study||24
1036452|NCT00721734|2517001|P5|NOT COMPLETED|Overall Study||6
1036453|NCT00721734|2517002|P4|NOT COMPLETED|Overall Study||6
1036454|NCT00721734|2517003|P3|NOT COMPLETED|Overall Study||8
1036455|NCT00721734|2517004|P2|NOT COMPLETED|Overall Study||12
1036456|NCT00721734|2517005|P1|NOT COMPLETED|Overall Study||8
1036457|NCT00721734|2517001|P5|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
1036458|NCT00721734|2517002|P4|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
1036459|NCT00721734|2517003|P3|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
1036460|NCT00721734|2517004|P2|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|0
1036461|NCT00721734|2517005|P1|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|4
1036462|NCT00721734|2517001|P5|STARTED|Overall Study||8
1036463|NCT00721734|2517002|P4|STARTED|Overall Study||8
1036464|NCT00721734|2517003|P3|STARTED|Overall Study||10
1036465|NCT00721734|2517004|P2|STARTED|Overall Study||12
1036466|NCT00721734|2517005|P1|STARTED|Overall Study||12
1036467|NCT00721799|2517117|P1|NOT COMPLETED|Overall Study||8
1036468|NCT00721799|2517117|P1|COMPLETED|Overall Study||25
1036469|NCT00721799|2517117|P1|Received FLT PET Scan #2|Overall Study||25
1036470|NCT00721799|2517117|P1|Recieved FLT PET Scan 1|Overall Study||26
1036471|NCT00721799|2517117|P1|STARTED|Overall Study||33
1036472|NCT00721955|2517155|P3|NOT COMPLETED|Overall Study||2
1036473|NCT00721955|2517156|P2|NOT COMPLETED|Overall Study||0
1036474|NCT00721955|2517157|P1|NOT COMPLETED|Overall Study||0
1036475|NCT00721955|2517155|P3|COMPLETED|Overall Study||103
1036476|NCT00721955|2517156|P2|COMPLETED|Overall Study||104
1036477|NCT00721955|2517157|P1|COMPLETED|Overall Study||105
1036478|NCT00721955|2517155|P3|STARTED|Overall Study||105
1036479|NCT00721955|2517156|P2|STARTED|Overall Study||104
1036480|NCT00721955|2517157|P1|STARTED|Overall Study||105
1036481|NCT00721968|2517173|P2|NOT COMPLETED|Overall Study||0
1036482|NCT00721968|2517174|P1|NOT COMPLETED|Overall Study||2
1036483|NCT00721968|2517173|P2|COMPLETED|Overall Study||17
1036484|NCT00721968|2517174|P1|COMPLETED|Overall Study||25
1036485|NCT00721968|2517173|P2|STARTED|Overall Study||17
1036486|NCT00721968|2517174|P1|STARTED|Overall Study||27
1036487|NCT00722020|2517184|P2|NOT COMPLETED|Overall Study||0
1036488|NCT00722020|2517185|P1|NOT COMPLETED|Overall Study||0
1036489|NCT00722020|2517184|P2|COMPLETED|Overall Study||24
1036490|NCT00722020|2517185|P1|COMPLETED|Overall Study||19
1036491|NCT00722020|2517184|P2|STARTED|Overall Study||24
1036492|NCT00722020|2517185|P1|STARTED|Overall Study||19
1036493|NCT00722072|2517193|P1|NOT COMPLETED|Overall Study||3
1036494|NCT00722072|2517193|P1|COMPLETED|Overall Study||9
1036495|NCT00722072|2517193|P1|STARTED|Overall Study||12
1036496|NCT00722124|2517200|P3|NOT COMPLETED|Overall Study||20
1036497|NCT00722124|2517201|P2|NOT COMPLETED|Overall Study||14
1036498|NCT00722124|2517202|P1|NOT COMPLETED|Overall Study||17
1036499|NCT00722124|2517200|P3|COMPLETED|Overall Study||20
1036500|NCT00722124|2517201|P2|COMPLETED|Overall Study||26
1036501|NCT00722124|2517202|P1|COMPLETED|Overall Study||23
1036502|NCT00722124|2517200|P3|STARTED|Overall Study||40
1036503|NCT00722124|2517201|P2|STARTED|Overall Study||40
1036504|NCT00722124|2517202|P1|STARTED|Overall Study||40
1036505|NCT00722137|2517212|P2|NOT COMPLETED|Overall Study||45
1036506|NCT00722137|2517213|P1|NOT COMPLETED|Overall Study||48
1036507|NCT00722137|2517212|P2|COMPLETED|Overall Study||199
1036508|NCT00722137|2517213|P1|COMPLETED|Overall Study||195
1036509|NCT00722137|2517212|P2|STARTED|Overall Study||244
1036510|NCT00722137|2517213|P1|STARTED|Overall Study||243
1036511|NCT00722371|2517244|P7|NOT COMPLETED|Overall Study||51
1036512|NCT00722371|2517245|P6|NOT COMPLETED|Overall Study||53
1036513|NCT00722371|2517246|P5|NOT COMPLETED|Overall Study||48
1036514|NCT00722371|2517247|P4|NOT COMPLETED|Overall Study||63
1036515|NCT00722371|2517248|P3|NOT COMPLETED|Overall Study||65
1036516|NCT00722371|2517249|P2|NOT COMPLETED|Overall Study||72
1036517|NCT00722371|2517250|P1|NOT COMPLETED|Overall Study||56
1036518|NCT00722371|2517244|P7|COMPLETED|Overall Study||179
1036519|NCT00722371|2517245|P6|COMPLETED|Overall Study||178
1036520|NCT00722371|2517246|P5|COMPLETED|Overall Study||182
1036521|NCT00722371|2517247|P4|COMPLETED|Overall Study||167
1036522|NCT00722371|2517248|P3|COMPLETED|Overall Study||168
1036523|NCT00722371|2517249|P2|COMPLETED|Overall Study||158
1036524|NCT00722371|2517250|P1|COMPLETED|Overall Study||175
1036525|NCT00722371|2517244|P7|STARTED|Overall Study||230
1036526|NCT00722371|2517245|P6|STARTED|Overall Study||231
1036527|NCT00722371|2517246|P5|STARTED|Overall Study||230
1036528|NCT00722371|2517247|P4|STARTED|Overall Study||230
1036529|NCT00722371|2517248|P3|STARTED|Overall Study||233
1036530|NCT00722371|2517249|P2|STARTED|Overall Study||230
1036531|NCT00722371|2517250|P1|STARTED|Overall Study||231
1036532|NCT00722423|2517303|P2|NOT COMPLETED|Overall Study||1
1036533|NCT00722423|2517304|P1|NOT COMPLETED|Overall Study||0
1036534|NCT00722423|2517303|P2|COMPLETED|Overall Study||181
1036535|NCT00722423|2517304|P1|COMPLETED|Overall Study||182
1036536|NCT00722423|2517303|P2|STARTED|Overall Study||182
1036537|NCT00722423|2517304|P1|STARTED|Overall Study||182
1036538|NCT00722436|2517314|P2|NOT COMPLETED|Overall Study||0
1036539|NCT00722436|2517315|P1|NOT COMPLETED|Overall Study||0
1036540|NCT00722436|2517314|P2|COMPLETED|Overall Study||11
1036541|NCT00722436|2517315|P1|COMPLETED|Overall Study||9
1036542|NCT00722436|2517314|P2|STARTED|Overall Study||11
1036543|NCT00722436|2517315|P1|STARTED|Overall Study||9
1036544|NCT00722553|2517327|P1|NOT COMPLETED|Overall Study||0
1036545|NCT00722553|2517327|P1|COMPLETED|Overall Study||30
1036546|NCT00722553|2517327|P1|STARTED|Overall Study||30
1036547|NCT00722566|2517337|P2|NOT COMPLETED|Overall Study||35
1036548|NCT00722566|2517338|P1|NOT COMPLETED|Overall Study||67
1036549|NCT00722566|2517337|P2|COMPLETED|Overall Study|Completed 8 cycles|39
1036550|NCT00722566|2517338|P1|COMPLETED|Overall Study|Completed 8 cycles|81
1036551|NCT00722566|2517337|P2|STARTED|Overall Study||74
1036552|NCT00722566|2517338|P1|STARTED|Overall Study|One patient randomized and not dosed|148
1036553|NCT00722722|2517349|P3|NOT COMPLETED|Overall Study||0
1036554|NCT00722722|2517350|P2|NOT COMPLETED|Overall Study||0
1036555|NCT00722722|2517351|P1|NOT COMPLETED|Overall Study||0
1036556|NCT00722722|2517349|P3|COMPLETED|Overall Study||10
1036557|NCT00722722|2517350|P2|COMPLETED|Overall Study||5
1036558|NCT00722722|2517351|P1|COMPLETED|Overall Study||3
1036559|NCT00722722|2517349|P3|STARTED|Overall Study||10
1036560|NCT00722722|2517350|P2|STARTED|Overall Study||5
1036561|NCT00722722|2517351|P1|STARTED|Overall Study||3
1036562|NCT00722761|2517361|P2|NOT COMPLETED|Overall Study||6
1036563|NCT00722761|2517362|P1|NOT COMPLETED|Overall Study||6
1036564|NCT00722761|2517361|P2|COMPLETED|Overall Study||8
1036565|NCT00722761|2517362|P1|COMPLETED|Overall Study||10
1036566|NCT00722761|2517361|P2|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||10
1036656|NCT00723021|2517420|P1|STARTED|Intervention Period 2||3
1036567|NCT00722761|2517362|P1|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||15
1036568|NCT00722761|2517361|P2|STARTED|Overall Study||14
1036569|NCT00722761|2517362|P1|STARTED|Overall Study||16
1036570|NCT00722800|2517372|P2|NOT COMPLETED|Overall Study||0
1036571|NCT00722800|2517373|P1|NOT COMPLETED|Overall Study||2
1036572|NCT00722800|2517372|P2|COMPLETED|Overall Study||2
1036573|NCT00722800|2517373|P1|COMPLETED|Overall Study||0
1036574|NCT00722800|2517372|P2|STARTED|Overall Study||2
1036575|NCT00722800|2517373|P1|STARTED|Overall Study||2
1036579|NCT00723008|2517393|P2|NOT COMPLETED|4-Week Unblinded Treatment||1
1036580|NCT00723008|2517394|P1|NOT COMPLETED|4-Week Unblinded Treatment||1
1036581|NCT00723008|2517393|P2|COMPLETED|4-Week Unblinded Treatment||3
1036582|NCT00723008|2517394|P1|COMPLETED|4-Week Unblinded Treatment||4
1036583|NCT00723008|2517393|P2|STARTED|4-Week Unblinded Treatment||4
1036584|NCT00723008|2517394|P1|STARTED|4-Week Unblinded Treatment||5
1036585|NCT00723008|2517393|P2|NOT COMPLETED|4-Week Double Blinded||5
1036586|NCT00723008|2517394|P1|NOT COMPLETED|4-Week Double Blinded||5
1036587|NCT00723008|2517393|P2|COMPLETED|4-Week Double Blinded||4
1036588|NCT00723008|2517394|P1|COMPLETED|4-Week Double Blinded||5
1036589|NCT00723008|2517393|P2|STARTED|4-Week Double Blinded||9
1036590|NCT00723008|2517394|P1|STARTED|4-Week Double Blinded||10
1036591|NCT00723008|2517393|P2|NOT COMPLETED|Enrollment||0
1036592|NCT00723008|2517394|P1|NOT COMPLETED|Enrollment||1
1036593|NCT00723008|2517393|P2|COMPLETED|Enrollment||9
1036594|NCT00723008|2517394|P1|COMPLETED|Enrollment||10
1036595|NCT00723008|2517393|P2|STARTED|Enrollment||9
1036596|NCT00723008|2517394|P1|STARTED|Enrollment||11
1036597|NCT00723021|2517416|P5|NOT COMPLETED|Intervention Period 5||0
1036598|NCT00723021|2517417|P4|NOT COMPLETED|Intervention Period 5||0
1036599|NCT00723021|2517418|P3|NOT COMPLETED|Intervention Period 5||0
1036600|NCT00723021|2517419|P2|NOT COMPLETED|Intervention Period 5||0
1036601|NCT00723021|2517420|P1|NOT COMPLETED|Intervention Period 5||0
1036602|NCT00723021|2517416|P5|COMPLETED|Intervention Period 5||2
1036603|NCT00723021|2517417|P4|COMPLETED|Intervention Period 5||3
1036604|NCT00723021|2517418|P3|COMPLETED|Intervention Period 5||3
1036605|NCT00723021|2517419|P2|COMPLETED|Intervention Period 5||3
1036606|NCT00723021|2517420|P1|COMPLETED|Intervention Period 5||3
1036607|NCT00723021|2517416|P5|STARTED|Intervention Period 5||2
1036608|NCT00723021|2517417|P4|STARTED|Intervention Period 5||3
1036609|NCT00723021|2517418|P3|STARTED|Intervention Period 5||3
1036610|NCT00723021|2517419|P2|STARTED|Intervention Period 5||3
1036611|NCT00723021|2517420|P1|STARTED|Intervention Period 5||3
1036612|NCT00723021|2517416|P5|NOT COMPLETED|Intervention Period 4||1
1036613|NCT00723021|2517417|P4|NOT COMPLETED|Intervention Period 4||0
1036614|NCT00723021|2517418|P3|NOT COMPLETED|Intervention Period 4||0
1036615|NCT00723021|2517419|P2|NOT COMPLETED|Intervention Period 4||0
1036616|NCT00723021|2517420|P1|NOT COMPLETED|Intervention Period 4||0
1036617|NCT00723021|2517416|P5|COMPLETED|Intervention Period 4||2
1036618|NCT00723021|2517417|P4|COMPLETED|Intervention Period 4||3
1036619|NCT00723021|2517418|P3|COMPLETED|Intervention Period 4||3
1036620|NCT00723021|2517419|P2|COMPLETED|Intervention Period 4||3
1036621|NCT00723021|2517420|P1|COMPLETED|Intervention Period 4||3
1036622|NCT00723021|2517416|P5|STARTED|Intervention Period 4||3
1036623|NCT00723021|2517417|P4|STARTED|Intervention Period 4||3
1036624|NCT00723021|2517418|P3|STARTED|Intervention Period 4||3
1036625|NCT00723021|2517419|P2|STARTED|Intervention Period 4||3
1036626|NCT00723021|2517420|P1|STARTED|Intervention Period 4||3
1036627|NCT00723021|2517416|P5|NOT COMPLETED|Intervention Period 3||0
1036628|NCT00723021|2517417|P4|NOT COMPLETED|Intervention Period 3||0
1036629|NCT00723021|2517418|P3|NOT COMPLETED|Intervention Period 3||0
1036630|NCT00723021|2517419|P2|NOT COMPLETED|Intervention Period 3||0
1036631|NCT00723021|2517420|P1|NOT COMPLETED|Intervention Period 3||0
1036632|NCT00723021|2517416|P5|COMPLETED|Intervention Period 3||3
1036633|NCT00723021|2517417|P4|COMPLETED|Intervention Period 3||3
1036634|NCT00723021|2517418|P3|COMPLETED|Intervention Period 3||3
1036635|NCT00723021|2517419|P2|COMPLETED|Intervention Period 3||3
1036636|NCT00723021|2517420|P1|COMPLETED|Intervention Period 3||3
1036637|NCT00723021|2517416|P5|STARTED|Intervention Period 3||3
1036638|NCT00723021|2517417|P4|STARTED|Intervention Period 3||3
1036639|NCT00723021|2517418|P3|STARTED|Intervention Period 3||3
1036640|NCT00723021|2517419|P2|STARTED|Intervention Period 3||3
1036641|NCT00723021|2517420|P1|STARTED|Intervention Period 3||3
1036642|NCT00723021|2517416|P5|NOT COMPLETED|Intervention Period 2||0
1036643|NCT00723021|2517417|P4|NOT COMPLETED|Intervention Period 2||0
1036644|NCT00723021|2517418|P3|NOT COMPLETED|Intervention Period 2||0
1036645|NCT00723021|2517419|P2|NOT COMPLETED|Intervention Period 2||0
1036646|NCT00723021|2517420|P1|NOT COMPLETED|Intervention Period 2||0
1036647|NCT00723021|2517416|P5|COMPLETED|Intervention Period 2||3
1036648|NCT00723021|2517417|P4|COMPLETED|Intervention Period 2||3
1036649|NCT00723021|2517418|P3|COMPLETED|Intervention Period 2||3
1036650|NCT00723021|2517419|P2|COMPLETED|Intervention Period 2||3
1036651|NCT00723021|2517420|P1|COMPLETED|Intervention Period 2||3
1036652|NCT00723021|2517416|P5|STARTED|Intervention Period 2||3
1036653|NCT00723021|2517417|P4|STARTED|Intervention Period 2||3
1036654|NCT00723021|2517418|P3|STARTED|Intervention Period 2||3
1036655|NCT00723021|2517419|P2|STARTED|Intervention Period 2||3
1036657|NCT00723021|2517416|P5|NOT COMPLETED|Intervention Period 1||0
1036658|NCT00723021|2517417|P4|NOT COMPLETED|Intervention Period 1||0
1036659|NCT00723021|2517418|P3|NOT COMPLETED|Intervention Period 1||0
1036660|NCT00723021|2517419|P2|NOT COMPLETED|Intervention Period 1||0
1036661|NCT00723021|2517420|P1|NOT COMPLETED|Intervention Period 1||0
1036662|NCT00723021|2517416|P5|COMPLETED|Intervention Period 1||3
1036663|NCT00723021|2517417|P4|COMPLETED|Intervention Period 1||3
1036664|NCT00723021|2517418|P3|COMPLETED|Intervention Period 1||3
1036665|NCT00723021|2517419|P2|COMPLETED|Intervention Period 1||3
1036666|NCT00723021|2517420|P1|COMPLETED|Intervention Period 1||3
1036667|NCT00723021|2517416|P5|STARTED|Intervention Period 1||3
1036668|NCT00723021|2517417|P4|STARTED|Intervention Period 1||3
1036669|NCT00723021|2517418|P3|STARTED|Intervention Period 1||3
1036670|NCT00723021|2517419|P2|STARTED|Intervention Period 1||3
1036671|NCT00723021|2517420|P1|STARTED|Intervention Period 1||3
1036672|NCT00723073|2517474|P2|NOT COMPLETED|Overall Study||0
1036673|NCT00723073|2517475|P1|NOT COMPLETED|Overall Study||0
1036674|NCT00723073|2517474|P2|COMPLETED|Overall Study||174
1036675|NCT00723073|2517475|P1|COMPLETED|Overall Study||149
1036676|NCT00723073|2517474|P2|STARTED|Overall Study||174
1036677|NCT00723073|2517475|P1|STARTED|Overall Study||149
1036678|NCT00723125|2517501|P2|NOT COMPLETED|Overall Study||6
1036679|NCT00723125|2517502|P1|NOT COMPLETED|Overall Study||18
1036680|NCT00723125|2517501|P2|COMPLETED|Overall Study||21
1036681|NCT00723125|2517502|P1|COMPLETED|Overall Study||15
1036682|NCT00723125|2517501|P2|STARTED|Overall Study|27 evaluable Neo-adjuvant Of 27 patients neo-adjuvant, 24 DDAC Of 24 DDAC, 21 Avastin post-op|27
1036683|NCT00723125|2517502|P1|STARTED|Overall Study|33 pts Neo-adjuvant, 28 evaluable,DDAC: Of 28 pts,27 treated DDAC Avastin:Of 27,15 Avastin post-op|33
1036684|NCT00723177|2517515|P3|NOT COMPLETED|Overall Study||5
1036685|NCT00723177|2517516|P2|NOT COMPLETED|Overall Study||4
1036686|NCT00723177|2517517|P1|NOT COMPLETED|Overall Study||5
1036687|NCT00723177|2517515|P3|COMPLETED|Overall Study||10
1036688|NCT00723177|2517516|P2|COMPLETED|Overall Study||10
1036689|NCT00723177|2517517|P1|COMPLETED|Overall Study||10
1036690|NCT00723177|2517515|P3|STARTED|Overall Study||15
1036691|NCT00723177|2517516|P2|STARTED|Overall Study||14
1036692|NCT00723177|2517517|P1|STARTED|Overall Study||15
1036693|NCT00723190|2517528|P1|NOT COMPLETED|Overall Study||142
1036694|NCT00723190|2517528|P1|COMPLETED|Overall Study|53 participants completed 6-month protocol and 108 participants completed 12-month protocol|161
1036695|NCT00723190|2517528|P1|SAFETY POPULATION|Overall Study||301
1036696|NCT00723190|2517528|P1|STARTED|Overall Study|Study CLON-301 (168 participants) and Study CLON-302 (135 participants)|303
1036697|NCT00723203|2517543|P1|NOT COMPLETED|Overall Study||3
1036698|NCT00723203|2517543|P1|COMPLETED|Overall Study||13
1036699|NCT00723203|2517543|P1|STARTED|Overall Study||16
1036700|NCT00723229|2517549|P2|NOT COMPLETED|Second Intervention||0
1036701|NCT00723229|2517550|P1|NOT COMPLETED|Second Intervention||0
1036702|NCT00723229|2517549|P2|COMPLETED|Second Intervention||20
1036703|NCT00723229|2517550|P1|COMPLETED|Second Intervention||18
1036704|NCT00723229|2517549|P2|STARTED|Second Intervention||20
1036705|NCT00723229|2517550|P1|STARTED|Second Intervention||18
1036706|NCT00723229|2517549|P2|NOT COMPLETED|First Intervention||3
1036707|NCT00723229|2517550|P1|NOT COMPLETED|First Intervention||7
1036708|NCT00723229|2517549|P2|COMPLETED|First Intervention||20
1036709|NCT00723229|2517550|P1|COMPLETED|First Intervention||18
1036710|NCT00723229|2517549|P2|STARTED|First Intervention||23
1036711|NCT00723229|2517550|P1|STARTED|First Intervention||25
1036712|NCT00723255|2517562|P1|NOT COMPLETED|Overall Study||4
1036713|NCT00723255|2517562|P1|COMPLETED|Overall Study|Eligible and treated patients|49
1036714|NCT00723255|2517562|P1|STARTED|Overall Study||53
1036715|NCT00723294|2517581|P1|NOT COMPLETED|Overall Study||13
1036716|NCT00723294|2517581|P1|COMPLETED|Overall Study||86
1036717|NCT00723294|2517581|P1|STARTED|Overall Study||99
1036718|NCT00723450|2517588|P3|NOT COMPLETED|Randomized Phase||67
1036719|NCT00723450|2517589|P2|NOT COMPLETED|Randomized Phase||65
1036720|NCT00723450|2517590|P1|NOT COMPLETED|Randomized Phase||0
1036721|NCT00723450|2517588|P3|COMPLETED|Randomized Phase||20
1036722|NCT00723450|2517589|P2|COMPLETED|Randomized Phase||21
1036723|NCT00723450|2517590|P1|COMPLETED|Randomized Phase||0
1036724|NCT00723450|2517588|P3|STARTED|Randomized Phase||87
1036725|NCT00723450|2517589|P2|STARTED|Randomized Phase||86
1036726|NCT00723450|2517590|P1|STARTED|Randomized Phase||0
1036727|NCT00723450|2517588|P3|NOT COMPLETED|Open-Label Phase||0
1036728|NCT00723450|2517589|P2|NOT COMPLETED|Open-Label Phase||0
1036729|NCT00723450|2517590|P1|NOT COMPLETED|Open-Label Phase||125
1036730|NCT00723450|2517588|P3|COMPLETED|Open-Label Phase||0
1036731|NCT00723450|2517589|P2|COMPLETED|Open-Label Phase||0
1036732|NCT00723450|2517590|P1|COMPLETED|Open-Label Phase||173
1036733|NCT00723450|2517588|P3|STARTED|Open-Label Phase||0
1036734|NCT00723450|2517589|P2|STARTED|Open-Label Phase||0
1036735|NCT00723450|2517590|P1|STARTED|Open-Label Phase||298
1036736|NCT00723489|2517635|P4|NOT COMPLETED|Overall Study||3
1036737|NCT00723489|2517636|P3|NOT COMPLETED|Overall Study||0
1036738|NCT00723489|2517637|P2|NOT COMPLETED|Overall Study||4
1036739|NCT00723489|2517638|P1|NOT COMPLETED|Overall Study||1
1036740|NCT00723489|2517635|P4|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
1036741|NCT00723489|2517636|P3|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|19
1036742|NCT00723489|2517637|P2|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|15
1036743|NCT00723489|2517638|P1|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
1036744|NCT00723489|2517635|P4|STARTED|Overall Study||23
1036745|NCT00723489|2517636|P3|STARTED|Overall Study||19
1036746|NCT00723489|2517637|P2|STARTED|Overall Study||19
1036747|NCT00723489|2517638|P1|STARTED|Overall Study||21
1036748|NCT00723528|2517667|P7|NOT COMPLETED|Period 2: After Controlled Period||4
1036749|NCT00723528|2517668|P6|NOT COMPLETED|Period 2: After Controlled Period||6
1036750|NCT00723528|2517669|P5|NOT COMPLETED|Period 2: After Controlled Period||2
1036751|NCT00723528|2517670|P4|NOT COMPLETED|Period 2: After Controlled Period||1
1036752|NCT00723528|2517671|P3|NOT COMPLETED|Period 2: After Controlled Period||0
1036753|NCT00723528|2517672|P2|NOT COMPLETED|Period 2: After Controlled Period||0
1036754|NCT00723528|2517673|P1|NOT COMPLETED|Period 2: After Controlled Period||0
1036755|NCT00723528|2517667|P7|COMPLETED|Period 2: After Controlled Period||54
1036756|NCT00723528|2517668|P6|COMPLETED|Period 2: After Controlled Period||58
1036757|NCT00723528|2517669|P5|COMPLETED|Period 2: After Controlled Period||11
1036758|NCT00723528|2517670|P4|COMPLETED|Period 2: After Controlled Period||14
1036759|NCT00723528|2517671|P3|COMPLETED|Period 2: After Controlled Period||0
1036760|NCT00723528|2517672|P2|COMPLETED|Period 2: After Controlled Period||0
1036761|NCT00723528|2517673|P1|COMPLETED|Period 2: After Controlled Period||0
1036762|NCT00723528|2517667|P7|STARTED|Period 2: After Controlled Period||58
1036763|NCT00723528|2517668|P6|STARTED|Period 2: After Controlled Period||64
1036764|NCT00723528|2517669|P5|STARTED|Period 2: After Controlled Period||13
1036765|NCT00723528|2517670|P4|STARTED|Period 2: After Controlled Period||15
1036766|NCT00723528|2517671|P3|STARTED|Period 2: After Controlled Period||0
1036767|NCT00723528|2517672|P2|STARTED|Period 2: After Controlled Period||0
1036768|NCT00723528|2517673|P1|STARTED|Period 2: After Controlled Period||0
1036769|NCT00723528|2517667|P7|NOT COMPLETED|Period 1: Controlled Period (CP)||0
1036770|NCT00723528|2517668|P6|NOT COMPLETED|Period 1: Controlled Period (CP)||0
1036771|NCT00723528|2517669|P5|NOT COMPLETED|Period 1: Controlled Period (CP)||0
1036772|NCT00723528|2517670|P4|NOT COMPLETED|Period 1: Controlled Period (CP)||0
1036773|NCT00723528|2517671|P3|NOT COMPLETED|Period 1: Controlled Period (CP)||4
1036774|NCT00723528|2517672|P2|NOT COMPLETED|Period 1: Controlled Period (CP)||0
1036775|NCT00723528|2517673|P1|NOT COMPLETED|Period 1: Controlled Period (CP)||4
1036776|NCT00723528|2517667|P7|COMPLETED|Period 1: Controlled Period (CP)||0
1036777|NCT00723528|2517668|P6|COMPLETED|Period 1: Controlled Period (CP)||0
1036778|NCT00723528|2517669|P5|COMPLETED|Period 1: Controlled Period (CP)||0
1036779|NCT00723528|2517670|P4|COMPLETED|Period 1: Controlled Period (CP)||0
1036780|NCT00723528|2517671|P3|COMPLETED|Period 1: Controlled Period (CP)||58
1036781|NCT00723528|2517672|P2|COMPLETED|Period 1: Controlled Period (CP)||64
1036782|NCT00723528|2517673|P1|COMPLETED|Period 1: Controlled Period (CP)||28
1036783|NCT00723528|2517667|P7|STARTED|Period 1: Controlled Period (CP)||0
1036784|NCT00723528|2517668|P6|STARTED|Period 1: Controlled Period (CP)||0
1036785|NCT00723528|2517669|P5|STARTED|Period 1: Controlled Period (CP)||0
1036786|NCT00723528|2517670|P4|STARTED|Period 1: Controlled Period (CP)||0
1036787|NCT00723528|2517671|P3|STARTED|Period 1: Controlled Period (CP)||62
1036788|NCT00723528|2517672|P2|STARTED|Period 1: Controlled Period (CP)||64
1036789|NCT00723528|2517673|P1|STARTED|Period 1: Controlled Period (CP)||32
1036790|NCT00723554|2517731|P1|NOT COMPLETED|Overall Study||29
1036791|NCT00723554|2517731|P1|COMPLETED|Overall Study||34
1036792|NCT00723554|2517731|P1|STARTED|Overall Study||63
1036793|NCT00723580|2517778|P1|NOT COMPLETED|Overall Study||0
1036794|NCT00723580|2517778|P1|COMPLETED|Overall Study|Completion of repeated Measurements|1
1036795|NCT00723580|2517778|P1|Baseline Measurements|Overall Study|Actigraphic, Psychometric and Observational Baseline Data Collected.|1
1036796|NCT00723580|2517778|P1|STARTED|Overall Study|Study was extended with continued repeated measurements.|1
1036797|NCT00723606|2517784|P2|NOT COMPLETED|Overall Study||7
1036798|NCT00723606|2517785|P1|NOT COMPLETED|Overall Study||4
1036799|NCT00723606|2517784|P2|COMPLETED|Overall Study||180
1036800|NCT00723606|2517785|P1|COMPLETED|Overall Study||185
1036801|NCT00723606|2517784|P2|STARTED|Overall Study||187
1036802|NCT00723606|2517785|P1|STARTED|Overall Study||189
1036803|NCT00723632|2517801|P1|NOT COMPLETED|Overall Study||203
1036804|NCT00723632|2517801|P1|COMPLETED|Overall Study|Completed initial exam form and >= 1 follow up visit form; end of treatment and SVR status recorded|698
1036805|NCT00723632|2517801|P1|STARTED|Overall Study||901
1036806|NCT00723645|2517807|P1|NOT COMPLETED|Visit 3 (Week 72 Post-treatment)||0
1036807|NCT00723645|2517807|P1|COMPLETED|Visit 3 (Week 72 Post-treatment)||187
1036808|NCT00723645|2517807|P1|STARTED|Visit 3 (Week 72 Post-treatment)|61 discontinued before V3; 26 lost to followup, 34 HCV RNA+ at Wk 24,1 death,1 HCV RNA not available|187
1036809|NCT00723645|2517807|P1|NOT COMPLETED|Visit 2 (Week 24 Post-treatment)||0
1036810|NCT00723645|2517807|P1|COMPLETED|Visit 2 (Week 24 Post-treatment)||248
1036811|NCT00723645|2517807|P1|STARTED|Visit 2 (Week 24 Post-treatment)|10 discontinued before Visit 2; 7 lost to follow-up and 3 were HCV RNA+ before Wk 24|248
1036812|NCT00723645|2517807|P1|NOT COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||0
1036813|NCT00723645|2517807|P1|COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||258
1036814|NCT00723645|2517807|P1|STARTED|Visit 1 (≤4 Weeks Post-treatment)||258
1036815|NCT00723697|2517812|P1|NOT COMPLETED|Overall Study||18
1036816|NCT00723697|2517812|P1|COMPLETED|Overall Study||1289
1036817|NCT00723697|2517812|P1|STARTED|Overall Study||1307
1036818|NCT00723710|2517820|P1|NOT COMPLETED|Overall Study||174
1036819|NCT00723710|2517820|P1|COMPLETED|Overall Study||120
1036820|NCT00723710|2517820|P1|STARTED|Overall Study||294
1036821|NCT00723736|2517824|P1|NOT COMPLETED|Overall Study||1
1036822|NCT00723736|2517824|P1|COMPLETED|Overall Study|Subject's caregiver did not wish to continue, reasons unrelated.|99
1036823|NCT00723736|2517824|P1|STARTED|Overall Study||100
1036824|NCT00723749|2517828|P1|NOT COMPLETED|Overall Study||163
1036825|NCT00723749|2517828|P1|COMPLETED|Overall Study||182
1036826|NCT00723749|2517828|P1|STARTED|Overall Study|384 patients were enrolled, 36 non-eligible datasets were excluded from analysis|345
1036827|NCT00723788|2517835|P1|NOT COMPLETED|Overall Study||0
1036828|NCT00723788|2517835|P1|COMPLETED|Overall Study||21
1036829|NCT00723788|2517835|P1|STARTED|Overall Study||21
1036830|NCT00723801|2517843|P2|NOT COMPLETED|Overall Study||3
1036831|NCT00723801|2517844|P1|NOT COMPLETED|Overall Study||3
1036832|NCT00723801|2517843|P2|COMPLETED|Overall Study||17
1036833|NCT00723801|2517844|P1|COMPLETED|Overall Study||17
1036834|NCT00723801|2517843|P2|STARTED|Overall Study||20
1036835|NCT00723801|2517844|P1|STARTED|Overall Study||20
1036836|NCT00723827|2517852|P1|NOT COMPLETED|Overall Study||0
1036837|NCT00723827|2517852|P1|COMPLETED|Overall Study||682
1036838|NCT00723827|2517852|P1|STARTED|Overall Study||682
1036839|NCT00723840|2517860|P1|NOT COMPLETED|Overall Study||82
1036840|NCT00723840|2517860|P1|COMPLETED|Overall Study||163
1036841|NCT00723840|2517860|P1|STARTED|Overall Study||245
1036842|NCT00723892|2517873|P2|NOT COMPLETED|Overall Study||87
1036843|NCT00723892|2517874|P1|NOT COMPLETED|Overall Study||107
1036844|NCT00723892|2517873|P2|COMPLETED|Overall Study||168
1036845|NCT00723892|2517874|P1|COMPLETED|Overall Study||206
1036846|NCT00723892|2517873|P2|STARTED|Overall Study||255
1036847|NCT00723892|2517874|P1|STARTED|Overall Study||313
1036848|NCT00723931|2517881|P1|NOT COMPLETED|Overall Study||0
1036849|NCT00723931|2517881|P1|COMPLETED|Overall Study||1267
1036850|NCT00723931|2517881|P1|STARTED|Overall Study||1267
1036851|NCT00723944|2517888|P2|NOT COMPLETED|Two Year Post Placement Follow-up||0
1036852|NCT00723944|2517889|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
1036853|NCT00723944|2517888|P2|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 108|37
1036854|NCT00723944|2517889|P1|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 130|48
1036855|NCT00723944|2517888|P2|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 108|37
1036856|NCT00723944|2517889|P1|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 130|48
1036857|NCT00723944|2517888|P2|NOT COMPLETED|One Year Post Placement Follow-up||4
1036858|NCT00723944|2517889|P1|NOT COMPLETED|One Year Post Placement Follow-up||1
1036859|NCT00723944|2517888|P2|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 108|37
1036860|NCT00723944|2517889|P1|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 130|48
1036861|NCT00723944|2517888|P2|STARTED|One Year Post Placement Follow-up|number of individual implant units is 112|41
1036862|NCT00723944|2517889|P1|STARTED|One Year Post Placement Follow-up|number of individual implant units is 134|49
1036863|NCT00723944|2517888|P2|NOT COMPLETED|Permanent Prosthesis Placement||9
1036864|NCT00723944|2517889|P1|NOT COMPLETED|Permanent Prosthesis Placement||3
1036865|NCT00723944|2517888|P2|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 112|41
1036866|NCT00723944|2517889|P1|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 134|49
1036867|NCT00723944|2517888|P2|STARTED|Permanent Prosthesis Placement|number of individual implant units is 138|50
1036868|NCT00723944|2517889|P1|STARTED|Permanent Prosthesis Placement|number of individual implant units is 148|52
1036869|NCT00723944|2517888|P2|NOT COMPLETED|Implant Placement Surgery||0
1036870|NCT00723944|2517889|P1|NOT COMPLETED|Implant Placement Surgery||0
1036871|NCT00723944|2517888|P2|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 138|50
1036872|NCT00723944|2517889|P1|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 148|52
1036873|NCT00723944|2517888|P2|STARTED|Implant Placement Surgery|number of individual implant units is 138|50
1036874|NCT00723944|2517889|P1|STARTED|Implant Placement Surgery|number of individual implant units is 148|52
1036875|NCT00723957|2517897|P2|NOT COMPLETED|Overall Study||53
1036876|NCT00723957|2517898|P1|NOT COMPLETED|Overall Study||51
1036877|NCT00723957|2517897|P2|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|46
1036878|NCT00723957|2517898|P1|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|47
1036879|NCT00723957|2517897|P2|STARTED|Overall Study|Randomized|99
1036880|NCT00723957|2517898|P1|STARTED|Overall Study|Randomized|98
1036881|NCT00724009|2517920|P1|NOT COMPLETED|Overall Study||0
1036882|NCT00724009|2517920|P1|COMPLETED|Overall Study|One patient underwent conditioning but died 1 day before stem cell infusion due to sepsis.|29
1036883|NCT00724009|2517920|P1|STARTED|Overall Study||29
1036884|NCT00724061|2517931|P1|NOT COMPLETED|Maintenance Therapy||0
1036885|NCT00724061|2517931|P1|COMPLETED|Maintenance Therapy||2
1036886|NCT00724061|2517931|P1|STARTED|Maintenance Therapy||2
1036887|NCT00724061|2517931|P1|NOT COMPLETED|Dose Escalation Phase||5
1036888|NCT00724061|2517931|P1|COMPLETED|Dose Escalation Phase||2
1036889|NCT00724061|2517931|P1|STARTED|Dose Escalation Phase||7
1036890|NCT00724126|2517937|P2|NOT COMPLETED|Overall Study||15
1036891|NCT00724126|2517938|P1|NOT COMPLETED|Overall Study||19
1036892|NCT00724126|2517937|P2|COMPLETED|Overall Study||301
1036893|NCT00724126|2517938|P1|COMPLETED|Overall Study||302
1036894|NCT00724126|2517937|P2|STARTED|Overall Study||316
1036895|NCT00724126|2517938|P1|STARTED|Overall Study||321
1036896|NCT00724152|2517951|P3|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
1036897|NCT00724152|2517952|P2|NOT COMPLETED|Three-arm Study Period (+Standard Care)||2
1036898|NCT00724152|2517953|P1|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
1036899|NCT00724152|2517951|P3|COMPLETED|Three-arm Study Period (+Standard Care)||1
1036900|NCT00724152|2517952|P2|COMPLETED|Three-arm Study Period (+Standard Care)||0
1036901|NCT00724152|2517953|P1|COMPLETED|Three-arm Study Period (+Standard Care)||3
1036902|NCT00724152|2517951|P3|STARTED|Three-arm Study Period (+Standard Care)|3-group randomization began|2
1036903|NCT00724152|2517952|P2|STARTED|Three-arm Study Period (+Standard Care)||2
1036904|NCT00724152|2517953|P1|STARTED|Three-arm Study Period (+Standard Care)||4
1036905|NCT00724152|2517951|P3|NOT COMPLETED|Two-arm Study Period||0
1036906|NCT00724152|2517952|P2|NOT COMPLETED|Two-arm Study Period||2
1036907|NCT00724152|2517953|P1|NOT COMPLETED|Two-arm Study Period||3
1036908|NCT00724152|2517951|P3|COMPLETED|Two-arm Study Period||0
1036909|NCT00724152|2517952|P2|COMPLETED|Two-arm Study Period||9
1036910|NCT00724152|2517953|P1|COMPLETED|Two-arm Study Period||11
1036911|NCT00724152|2517951|P3|STARTED|Two-arm Study Period|Standard Care arm was added later (Period 2)|0
1036912|NCT00724152|2517952|P2|STARTED|Two-arm Study Period||11
1036913|NCT00724152|2517953|P1|STARTED|Two-arm Study Period||14
1036914|NCT00718510|2517970|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
1036915|NCT00718510|2517971|P1|NOT COMPLETED|Second Intervention (3 Weeks)||1
1036916|NCT00718510|2517970|P2|COMPLETED|Second Intervention (3 Weeks)||7
1036917|NCT00718510|2517971|P1|COMPLETED|Second Intervention (3 Weeks)||6
1036918|NCT00718510|2517970|P2|STARTED|Second Intervention (3 Weeks)||7
1036919|NCT00718510|2517971|P1|STARTED|Second Intervention (3 Weeks)||7
1036920|NCT00718510|2517970|P2|NOT COMPLETED|Washout (5 Days)||0
1036921|NCT00718510|2517971|P1|NOT COMPLETED|Washout (5 Days)||0
1036922|NCT00718510|2517970|P2|COMPLETED|Washout (5 Days)||7
1036923|NCT00718510|2517971|P1|COMPLETED|Washout (5 Days)||7
1036924|NCT00718510|2517970|P2|STARTED|Washout (5 Days)||7
1036925|NCT00718510|2517971|P1|STARTED|Washout (5 Days)||7
1036926|NCT00718510|2517970|P2|NOT COMPLETED|First Intervention (3 Weeks)||1
1036927|NCT00718510|2517971|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
1036928|NCT00718510|2517970|P2|COMPLETED|First Intervention (3 Weeks)||7
1036929|NCT00718510|2517971|P1|COMPLETED|First Intervention (3 Weeks)||7
1036930|NCT00718510|2517970|P2|Received Intervention|First Intervention (3 Weeks)||7
1036931|NCT00718510|2517971|P1|Received Intervention|First Intervention (3 Weeks)||7
1036932|NCT00718510|2517970|P2|STARTED|First Intervention (3 Weeks)||8
1036933|NCT00718510|2517971|P1|STARTED|First Intervention (3 Weeks)||7
1036934|NCT00718523|2517983|P2|NOT COMPLETED|Overall Study||24
1036935|NCT00718523|2517984|P1|NOT COMPLETED|Overall Study||18
1036936|NCT00718523|2517983|P2|COMPLETED|Overall Study||62
1036937|NCT00718523|2517984|P1|COMPLETED|Overall Study||66
1036938|NCT00718523|2517983|P2|STARTED|Overall Study||86
1036939|NCT00718523|2517984|P1|STARTED|Overall Study||84
1036940|NCT00718640|2517994|P1|NOT COMPLETED|Overall Study||7
1036941|NCT00718640|2517994|P1|COMPLETED|Overall Study||3
1036942|NCT00718640|2517994|P1|STARTED|Overall Study||10
1036943|NCT00724243|2518006|P1|NOT COMPLETED|Overall Study||15
1036944|NCT00724243|2518006|P1|COMPLETED|Overall Study||18
1036945|NCT00724243|2518006|P1|STARTED|Overall Study||33
1036946|NCT00724282|2518011|P1|NOT COMPLETED|Overall Study||4
1036947|NCT00724282|2518011|P1|COMPLETED|Overall Study||16
1036948|NCT00724282|2518011|P1|STARTED|Overall Study||20
1036949|NCT00724308|2518017|P2|NOT COMPLETED|Overall Study||97
1036950|NCT00724308|2518018|P1|NOT COMPLETED|Overall Study||80
1036951|NCT00724308|2518017|P2|COMPLETED|Overall Study||210
1036952|NCT00724308|2518018|P1|COMPLETED|Overall Study||190
1036953|NCT00724308|2518017|P2|STARTED|Overall Study||307
1036954|NCT00724308|2518018|P1|STARTED|Overall Study||270
1036955|NCT00724347|2518024|P1|NOT COMPLETED|Overall Study||2
1036956|NCT00724347|2518024|P1|COMPLETED|Overall Study||16
1036957|NCT00724347|2518024|P1|Baseline Testing|Overall Study||18
1036958|NCT00724347|2518024|P1|STARTED|Overall Study|Training was the final step in the program, once the outcome tests had been developed.|18
1036959|NCT00724373|2518028|P1|NOT COMPLETED|Overall Study||171
1036960|NCT00724373|2518028|P1|COMPLETED|Overall Study||271
1036961|NCT00724373|2518028|P1|STARTED|Overall Study||442
1036962|NCT00724451|2518032|P1|NOT COMPLETED|Overall Study||802
1036963|NCT00724451|2518032|P1|COMPLETED|Overall Study|Completed defined as participants who completed anti-viral treatment.|326
1036964|NCT00724451|2518032|P1|Received Antiviral Treatment|Overall Study||500
1036965|NCT00724451|2518032|P1|STARTED|Overall Study||1128
1036966|NCT00724464|2518038|P1|NOT COMPLETED|Overall Study||23
1036967|NCT00724464|2518038|P1|COMPLETED|Overall Study||309
1036968|NCT00724464|2518038|P1|STARTED|Overall Study||332
1036969|NCT00724477|2518050|P1|NOT COMPLETED|Overall Study||0
1036970|NCT00724477|2518050|P1|COMPLETED|Overall Study||1663
1036971|NCT00724477|2518050|P1|STARTED|Overall Study|This safety population (SAF)analysed consisted of all patients who took at least one tablet of INEGY|1663
1036972|NCT00727272|2518054|P3|NOT COMPLETED|Period III||0
1036973|NCT00727272|2518055|P2|NOT COMPLETED|Period III||0
1036974|NCT00727272|2518056|P1|NOT COMPLETED|Period III||0
1036975|NCT00727272|2518054|P3|COMPLETED|Period III||7
1036976|NCT00727272|2518055|P2|COMPLETED|Period III||9
1036977|NCT00727272|2518056|P1|COMPLETED|Period III||9
1036978|NCT00727272|2518054|P3|STARTED|Period III||7
1036979|NCT00727272|2518055|P2|STARTED|Period III||9
1036980|NCT00727272|2518056|P1|STARTED|Period III||9
1036981|NCT00727272|2518054|P3|NOT COMPLETED|Washout Period B||1
1036982|NCT00727272|2518055|P2|NOT COMPLETED|Washout Period B||0
1036983|NCT00727272|2518056|P1|NOT COMPLETED|Washout Period B||0
1036984|NCT00727272|2518054|P3|COMPLETED|Washout Period B|personal reasons|7
1036985|NCT00727272|2518055|P2|COMPLETED|Washout Period B||9
1036986|NCT00727272|2518056|P1|COMPLETED|Washout Period B||9
1036987|NCT00727272|2518054|P3|STARTED|Washout Period B||8
1036988|NCT00727272|2518055|P2|STARTED|Washout Period B||9
1036989|NCT00727272|2518056|P1|STARTED|Washout Period B||9
1036990|NCT00727272|2518054|P3|NOT COMPLETED|Period II||0
1036991|NCT00727272|2518055|P2|NOT COMPLETED|Period II||0
1036992|NCT00727272|2518056|P1|NOT COMPLETED|Period II||0
1036993|NCT00727272|2518054|P3|COMPLETED|Period II||8
1036994|NCT00727272|2518055|P2|COMPLETED|Period II||9
1036995|NCT00727272|2518056|P1|COMPLETED|Period II||9
1036996|NCT00727272|2518054|P3|STARTED|Period II||8
1036997|NCT00727272|2518055|P2|STARTED|Period II||9
1036998|NCT00727272|2518056|P1|STARTED|Period II||9
1036999|NCT00727272|2518054|P3|NOT COMPLETED|Washout Period A||1
1037000|NCT00727272|2518055|P2|NOT COMPLETED|Washout Period A||0
1037001|NCT00727272|2518056|P1|NOT COMPLETED|Washout Period A||0
1037002|NCT00727272|2518054|P3|COMPLETED|Washout Period A|positive pregnancy test - recorded as an adverse event|8
1037003|NCT00727272|2518055|P2|COMPLETED|Washout Period A||9
1037004|NCT00727272|2518056|P1|COMPLETED|Washout Period A||9
1037005|NCT00727272|2518054|P3|STARTED|Washout Period A||9
1037006|NCT00727272|2518055|P2|STARTED|Washout Period A||9
1037007|NCT00727272|2518056|P1|STARTED|Washout Period A||9
1037008|NCT00727272|2518054|P3|NOT COMPLETED|Period I||0
1037009|NCT00727272|2518055|P2|NOT COMPLETED|Period I||0
1037010|NCT00727272|2518056|P1|NOT COMPLETED|Period I||0
1037011|NCT00727272|2518054|P3|COMPLETED|Period I||9
1037012|NCT00727272|2518055|P2|COMPLETED|Period I||9
1037013|NCT00727272|2518056|P1|COMPLETED|Period I||9
1037014|NCT00727272|2518054|P3|STARTED|Period I||9
1037015|NCT00727272|2518055|P2|STARTED|Period I||9
1037016|NCT00727272|2518056|P1|STARTED|Period I||9
1037017|NCT00727298|2518073|P1|NOT COMPLETED|Overall Study||1257
1037018|NCT00727298|2518073|P1|COMPLETED|Overall Study||3228
1037019|NCT00727298|2518073|P1|STARTED|Overall Study||4485
1037020|NCT00727311|2518079|P1|NOT COMPLETED|Overall Study||1107
1037021|NCT00727311|2518079|P1|COMPLETED|Overall Study||1195
1037022|NCT00727311|2518079|P1|STARTED|Overall Study||2302
1037023|NCT00727337|2518090|P4|NOT COMPLETED|Overall Study||7
1037024|NCT00727337|2518091|P3|NOT COMPLETED|Overall Study||9
1037025|NCT00727337|2518092|P2|NOT COMPLETED|Overall Study||10
1037026|NCT00727337|2518093|P1|NOT COMPLETED|Overall Study||10
1037027|NCT00727337|2518090|P4|COMPLETED|Overall Study||61
1037028|NCT00727337|2518091|P3|COMPLETED|Overall Study||64
1037029|NCT00727337|2518092|P2|COMPLETED|Overall Study||63
1037030|NCT00727337|2518093|P1|COMPLETED|Overall Study||55
1037031|NCT00727337|2518090|P4|STARTED|Overall Study||68
1037032|NCT00727337|2518091|P3|STARTED|Overall Study||73
1037033|NCT00727337|2518092|P2|STARTED|Overall Study||73
1037034|NCT00727337|2518093|P1|STARTED|Overall Study||65
1037035|NCT00727402|2518103|P1|NOT COMPLETED|Overall Study||116
1037036|NCT00727402|2518103|P1|COMPLETED|Overall Study||89
1037037|NCT00727402|2518103|P1|STARTED|Overall Study||205
1037038|NCT00727506|2518113|P6|NOT COMPLETED|Overall Study||39
1037039|NCT00727506|2518114|P5|NOT COMPLETED|Overall Study||41
1037040|NCT00727506|2518115|P4|NOT COMPLETED|Overall Study||39
1037041|NCT00727506|2518116|P3|NOT COMPLETED|Overall Study||18
1037042|NCT00727506|2518117|P2|NOT COMPLETED|Overall Study||8
1037043|NCT00727506|2518118|P1|NOT COMPLETED|Overall Study||6
1037044|NCT00727506|2518113|P6|COMPLETED|Overall Study||0
1037045|NCT00727506|2518114|P5|COMPLETED|Overall Study||0
1037046|NCT00727506|2518115|P4|COMPLETED|Overall Study||0
1037047|NCT00727506|2518116|P3|COMPLETED|Overall Study||0
1037048|NCT00727506|2518117|P2|COMPLETED|Overall Study||0
1037049|NCT00727506|2518118|P1|COMPLETED|Overall Study||0
1037050|NCT00727506|2518113|P6|STARTED|Overall Study|Randomized|39
1037051|NCT00727506|2518114|P5|STARTED|Overall Study|Randomized|41
1037052|NCT00727506|2518115|P4|STARTED|Overall Study|Randomized|39
1037053|NCT00727506|2518116|P3|STARTED|Overall Study|Entered|18
1037054|NCT00727506|2518117|P2|STARTED|Overall Study|Entered|8
1037055|NCT00727506|2518118|P1|STARTED|Overall Study|Entered|6
1037056|NCT00727558|2518213|P2|NOT COMPLETED|Overall Study||3
1037057|NCT00727558|2518214|P1|NOT COMPLETED|Overall Study||2
1037058|NCT00727558|2518213|P2|COMPLETED|Overall Study||118
1037059|NCT00727558|2518214|P1|COMPLETED|Overall Study||125
1037060|NCT00727558|2518213|P2|STARTED|Overall Study||121
1037061|NCT00727558|2518214|P1|STARTED|Overall Study||127
1037062|NCT00727571|2518236|P4|NOT COMPLETED|Overall Study||6
1037063|NCT00727571|2518237|P3|NOT COMPLETED|Overall Study||30
1037064|NCT00727571|2518238|P2|NOT COMPLETED|Overall Study||55
1037065|NCT00727571|2518239|P1|NOT COMPLETED|Overall Study||1
1037066|NCT00727571|2518236|P4|COMPLETED|Overall Study||163
1037067|NCT00727571|2518237|P3|COMPLETED|Overall Study||135
1037068|NCT00727571|2518238|P2|COMPLETED|Overall Study||173
1037069|NCT00727571|2518239|P1|COMPLETED|Overall Study||231
1037070|NCT00727571|2518236|P4|STARTED|Overall Study||169
1037071|NCT00727571|2518237|P3|STARTED|Overall Study||165
1037072|NCT00727571|2518238|P2|STARTED|Overall Study||228
1037073|NCT00727571|2518239|P1|STARTED|Overall Study||232
1037074|NCT00727597|2518266|P2|NOT COMPLETED|Overall Study||0
1037075|NCT00727597|2518267|P1|NOT COMPLETED|Overall Study||0
1037076|NCT00727597|2518266|P2|COMPLETED|Overall Study||50
1037077|NCT00727597|2518267|P1|COMPLETED|Overall Study||51
1037078|NCT00727597|2518266|P2|STARTED|Overall Study||50
1037079|NCT00727597|2518267|P1|STARTED|Overall Study||51
1037080|NCT00727636|2518277|P2|NOT COMPLETED|Overall Study||0
1037081|NCT00727636|2518278|P1|NOT COMPLETED|Overall Study||4
1037082|NCT00727636|2518277|P2|COMPLETED|Overall Study||15
1037083|NCT00727636|2518278|P1|COMPLETED|Overall Study||33
1037084|NCT00727636|2518277|P2|STARTED|Overall Study||15
1037085|NCT00727636|2518278|P1|STARTED|Overall Study||37
1037086|NCT00727649|2518292|P2|NOT COMPLETED|Second Intervention (4-weeks)||3
1037087|NCT00727649|2518293|P1|NOT COMPLETED|Second Intervention (4-weeks)||1
1037088|NCT00727649|2518292|P2|COMPLETED|Second Intervention (4-weeks)||34
1037089|NCT00727649|2518293|P1|COMPLETED|Second Intervention (4-weeks)||29
1037090|NCT00727649|2518292|P2|STARTED|Second Intervention (4-weeks)||37
1037091|NCT00727649|2518293|P1|STARTED|Second Intervention (4-weeks)||30
1037092|NCT00727649|2518292|P2|NOT COMPLETED|Wash-out (2-weeks)||3
1037093|NCT00727649|2518293|P1|NOT COMPLETED|Wash-out (2-weeks)||4
1037094|NCT00727649|2518292|P2|COMPLETED|Wash-out (2-weeks)||37
1037095|NCT00727649|2518293|P1|COMPLETED|Wash-out (2-weeks)||30
1037096|NCT00727649|2518292|P2|STARTED|Wash-out (2-weeks)||40
1037097|NCT00727649|2518293|P1|STARTED|Wash-out (2-weeks)||34
1037098|NCT00727649|2518292|P2|NOT COMPLETED|First Intervention (4-weeks)||3
1037099|NCT00727649|2518293|P1|NOT COMPLETED|First Intervention (4-weeks)||3
1037100|NCT00727649|2518292|P2|COMPLETED|First Intervention (4-weeks)||40
1037101|NCT00727649|2518293|P1|COMPLETED|First Intervention (4-weeks)||34
1037102|NCT00727649|2518292|P2|STARTED|First Intervention (4-weeks)||43
1037103|NCT00727649|2518293|P1|STARTED|First Intervention (4-weeks)||37
1037104|NCT00727714|2518305|P1|NOT COMPLETED|Overall Study||2
1037105|NCT00727714|2518305|P1|COMPLETED|Overall Study||93
1037106|NCT00727714|2518305|P1|STARTED|Overall Study||95
1037107|NCT00727740|2518315|P2|NOT COMPLETED|Overall Study||0
1037108|NCT00727740|2518316|P1|NOT COMPLETED|Overall Study||0
1037109|NCT00727740|2518315|P2|COMPLETED|Overall Study||61
1037110|NCT00727740|2518316|P1|COMPLETED|Overall Study||56
1037111|NCT00727740|2518315|P2|STARTED|Overall Study||61
1037112|NCT00727740|2518316|P1|STARTED|Overall Study||56
1037113|NCT00727844|2518324|P4|NOT COMPLETED|Second Randomization||0
1037114|NCT00727844|2518325|P3|NOT COMPLETED|Second Randomization||0
1037115|NCT00727844|2518326|P2|NOT COMPLETED|Second Randomization||0
1037116|NCT00727844|2518327|P1|NOT COMPLETED|Second Randomization||0
1037117|NCT00727844|2518324|P4|COMPLETED|Second Randomization||16
1037118|NCT00727844|2518325|P3|COMPLETED|Second Randomization||17
1037119|NCT00727844|2518326|P2|COMPLETED|Second Randomization||0
1037120|NCT00727844|2518327|P1|COMPLETED|Second Randomization||0
1037121|NCT00727844|2518324|P4|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|16
1037122|NCT00727844|2518325|P3|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|17
1037123|NCT00727844|2518326|P2|STARTED|Second Randomization||0
1037124|NCT00727844|2518327|P1|STARTED|Second Randomization||0
1037125|NCT00727844|2518324|P4|NOT COMPLETED|Initial Randomization||0
1037126|NCT00727844|2518325|P3|NOT COMPLETED|Initial Randomization||0
1037127|NCT00727844|2518326|P2|NOT COMPLETED|Initial Randomization||0
1037128|NCT00727844|2518327|P1|NOT COMPLETED|Initial Randomization||2
1037129|NCT00727844|2518324|P4|COMPLETED|Initial Randomization||0
1037130|NCT00727844|2518325|P3|COMPLETED|Initial Randomization||0
1037131|NCT00727844|2518326|P2|COMPLETED|Initial Randomization||20
1037132|NCT00727844|2518327|P1|COMPLETED|Initial Randomization||19
1037133|NCT00727844|2518324|P4|Included in MITT Analysis|Initial Randomization||0
1037134|NCT00727844|2518325|P3|Included in MITT Analysis|Initial Randomization||0
1037135|NCT00727844|2518326|P2|Included in MITT Analysis|Initial Randomization||20
1037136|NCT00727844|2518327|P1|Included in MITT Analysis|Initial Randomization||19
1037137|NCT00727844|2518324|P4|STARTED|Initial Randomization||0
1037138|NCT00727844|2518325|P3|STARTED|Initial Randomization||0
1037139|NCT00727844|2518326|P2|STARTED|Initial Randomization||20
1037140|NCT00727844|2518327|P1|STARTED|Initial Randomization|2 patients withdrawn before receiving any linezolid owing to baseline neuropathy|21
1037141|NCT00727857|2518335|P3|NOT COMPLETED|Overall Study||68
1037142|NCT00727857|2518336|P2|NOT COMPLETED|Overall Study||64
1037143|NCT00727857|2518337|P1|NOT COMPLETED|Overall Study||44
1037144|NCT00727857|2518335|P3|COMPLETED|Overall Study||142
1037145|NCT00727857|2518336|P2|COMPLETED|Overall Study||125
1037146|NCT00727857|2518337|P1|COMPLETED|Overall Study||157
1037147|NCT00727857|2518335|P3|STARTED|Overall Study||210
1037148|NCT00727857|2518336|P2|STARTED|Overall Study||189
1037149|NCT00727857|2518337|P1|STARTED|Overall Study||201
1037150|NCT00727909|2518423|P4|NOT COMPLETED|Overall Study||5
1037151|NCT00727909|2518424|P3|NOT COMPLETED|Overall Study||9
1037152|NCT00727909|2518425|P2|NOT COMPLETED|Overall Study||11
1037153|NCT00727909|2518426|P1|NOT COMPLETED|Overall Study||5
1037154|NCT00727909|2518423|P4|COMPLETED|Overall Study||70
1037155|NCT00727909|2518424|P3|COMPLETED|Overall Study||58
1037156|NCT00727909|2518425|P2|COMPLETED|Overall Study||61
1037157|NCT00727909|2518426|P1|COMPLETED|Overall Study||60
1037158|NCT00727909|2518423|P4|STARTED|Overall Study||75
1037159|NCT00727909|2518424|P3|STARTED|Overall Study||67
1037160|NCT00727909|2518425|P2|STARTED|Overall Study||72
1037161|NCT00727909|2518426|P1|STARTED|Overall Study||65
1037162|NCT00727961|2518430|P1|NOT COMPLETED|Overall Study||37
1037163|NCT00727961|2518430|P1|COMPLETED|Overall Study||21
1037164|NCT00727961|2518430|P1|STARTED|Overall Study||58
1037165|NCT00728130|2518440|P1|NOT COMPLETED|Overall Study||3
1037166|NCT00728130|2518440|P1|COMPLETED|Overall Study||19
1037167|NCT00728130|2518440|P1|STARTED|Overall Study||22
1037168|NCT00728182|2518447|P2|NOT COMPLETED|Overall Study||3
1037169|NCT00728182|2518448|P1|NOT COMPLETED|Overall Study||3
1037170|NCT00728182|2518447|P2|COMPLETED|Overall Study||90
1037171|NCT00728182|2518448|P1|COMPLETED|Overall Study||89
1037172|NCT00728182|2518447|P2|STARTED|Overall Study||93
1037173|NCT00728182|2518448|P1|STARTED|Overall Study||92
1037174|NCT00728260|2518476|P1|NOT COMPLETED|Overall Study||0
1037175|NCT00728260|2518476|P1|COMPLETED|Overall Study||1421
1037176|NCT00728260|2518476|P1|STARTED|Overall Study||1421
1037177|NCT00728416|2518484|P2|NOT COMPLETED|Overall Study||2
1037178|NCT00728416|2518485|P1|NOT COMPLETED|Overall Study||2
1037179|NCT00728416|2518484|P2|COMPLETED|Overall Study||163
1037180|NCT00728416|2518485|P1|COMPLETED|Overall Study||166
1037181|NCT00728416|2518484|P2|STARTED|Overall Study||165
1037182|NCT00728416|2518485|P1|STARTED|Overall Study||168
1037183|NCT00728468|2518493|P1|NOT COMPLETED|Overall Study||16
1037184|NCT00728468|2518493|P1|COMPLETED|Overall Study||0
1037185|NCT00728468|2518493|P1|Treated|Overall Study||15
1037186|NCT00728468|2518493|P1|STARTED|Overall Study||16
1037187|NCT00728481|2518517|P2|NOT COMPLETED|Overall Study||4
1037188|NCT00728481|2518518|P1|NOT COMPLETED|Overall Study||1
1037189|NCT00728481|2518517|P2|COMPLETED|Overall Study||28
1037190|NCT00728481|2518518|P1|COMPLETED|Overall Study||18
1037191|NCT00728481|2518517|P2|STARTED|Overall Study||32
1037192|NCT00728481|2518518|P1|STARTED|Overall Study||19
1037193|NCT00728494|2518536|P2|NOT COMPLETED|Overall Study||7
1037194|NCT00728494|2518537|P1|NOT COMPLETED|Overall Study||9
1037195|NCT00728494|2518536|P2|COMPLETED|Overall Study||32
1037196|NCT00728494|2518537|P1|COMPLETED|Overall Study||51
1037197|NCT00728494|2518536|P2|STARTED|Overall Study||39
1037198|NCT00728494|2518537|P1|STARTED|Overall Study||60
1037199|NCT00728507|2518555|P2|NOT COMPLETED|Overall Study||8
1037200|NCT00728507|2518556|P1|NOT COMPLETED|Overall Study||2
1037201|NCT00728507|2518555|P2|COMPLETED|Overall Study||51
1037202|NCT00728507|2518556|P1|COMPLETED|Overall Study||60
1037203|NCT00728507|2518555|P2|STARTED|Overall Study||59
1037204|NCT00728507|2518556|P1|STARTED|Overall Study||62
1037205|NCT00728689|2518566|P2|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
1037206|NCT00728689|2518567|P1|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
1037207|NCT00728689|2518566|P2|COMPLETED|Second Intervention (Days 11 - 13)||6
1037208|NCT00728689|2518567|P1|COMPLETED|Second Intervention (Days 11 - 13)||5
1037209|NCT00728689|2518566|P2|STARTED|Second Intervention (Days 11 - 13)||6
1037210|NCT00728689|2518567|P1|STARTED|Second Intervention (Days 11 - 13)||5
1037211|NCT00728689|2518566|P2|NOT COMPLETED|Washout Period (Days 4 - 10)||0
1037212|NCT00728689|2518567|P1|NOT COMPLETED|Washout Period (Days 4 - 10)||1
1037213|NCT00728689|2518566|P2|COMPLETED|Washout Period (Days 4 - 10)||6
1037214|NCT00728689|2518567|P1|COMPLETED|Washout Period (Days 4 - 10)|Death in family during the Washout period. Completed First Intervention period with ST-246 Form I.|5
1037215|NCT00728689|2518566|P2|STARTED|Washout Period (Days 4 - 10)||6
1037216|NCT00728689|2518567|P1|STARTED|Washout Period (Days 4 - 10)||6
1037217|NCT00728689|2518566|P2|NOT COMPLETED|First Intervention (Days 1 - 3)||0
1037218|NCT00728689|2518567|P1|NOT COMPLETED|First Intervention (Days 1 - 3)||0
1037219|NCT00728689|2518566|P2|COMPLETED|First Intervention (Days 1 - 3)||6
1037220|NCT00728689|2518567|P1|COMPLETED|First Intervention (Days 1 - 3)||6
1037221|NCT00728689|2518566|P2|STARTED|First Intervention (Days 1 - 3)||6
1037222|NCT00728689|2518567|P1|STARTED|First Intervention (Days 1 - 3)||6
1037223|NCT00728728|2518585|P2|NOT COMPLETED|Overall Study||12
1037224|NCT00728728|2518586|P1|NOT COMPLETED|Overall Study||4
1037225|NCT00728728|2518585|P2|COMPLETED|Overall Study||34
1037226|NCT00728728|2518586|P1|COMPLETED|Overall Study||38
1037227|NCT00728728|2518585|P2|STARTED|Overall Study||46
1037228|NCT00728728|2518586|P1|STARTED|Overall Study||42
1037229|NCT00728754|2518606|P2|NOT COMPLETED|Two Year Post Placement Follow-up||0
1037230|NCT00728754|2518607|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
1037231|NCT00728754|2518606|P2|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 68|28
1037232|NCT00728754|2518607|P1|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 65|24
1037233|NCT00728754|2518606|P2|STARTED|Two Year Post Placement Follow-up|individual control implant units is 68|28
1037234|NCT00728754|2518607|P1|STARTED|Two Year Post Placement Follow-up|individual test implant units is 65|24
1037235|NCT00728754|2518606|P2|NOT COMPLETED|One Year Post Placement Follow-up||0
1037236|NCT00728754|2518607|P1|NOT COMPLETED|One Year Post Placement Follow-up||1
1037237|NCT00728754|2518606|P2|COMPLETED|One Year Post Placement Follow-up|individual control implant units completed= 68|28
1037238|NCT00728754|2518607|P1|COMPLETED|One Year Post Placement Follow-up|individual test implant units completing is 65|24
1037239|NCT00728754|2518606|P2|STARTED|One Year Post Placement Follow-up|individual control implant units is 68|28
1037240|NCT00728754|2518607|P1|STARTED|One Year Post Placement Follow-up|individual test implant units is 66|25
1037241|NCT00728754|2518606|P2|NOT COMPLETED|Permanent Prosthesis Placement||4
1037242|NCT00728754|2518607|P1|NOT COMPLETED|Permanent Prosthesis Placement||4
1037243|NCT00728754|2518606|P2|COMPLETED|Permanent Prosthesis Placement|Individual control implant units completed = 68|28
1037244|NCT00728754|2518607|P1|COMPLETED|Permanent Prosthesis Placement|Individual test implant units completed = 66|25
1037245|NCT00728754|2518606|P2|STARTED|Permanent Prosthesis Placement|Individual control implant units is 78|32
1037246|NCT00728754|2518607|P1|STARTED|Permanent Prosthesis Placement|Individual test implant units is 75|29
1037247|NCT00728754|2518606|P2|NOT COMPLETED|Implant Placement Surgery||0
1037248|NCT00728754|2518607|P1|NOT COMPLETED|Implant Placement Surgery||0
1037249|NCT00728754|2518606|P2|COMPLETED|Implant Placement Surgery|Individual control implant units completed = 78|32
1037250|NCT00728754|2518607|P1|COMPLETED|Implant Placement Surgery|Individual test implant units completed = 75|29
1037251|NCT00728754|2518606|P2|STARTED|Implant Placement Surgery|Individual control implant units is 78|32
1037252|NCT00728754|2518607|P1|STARTED|Implant Placement Surgery|Individual test implant units is 75|29
1037253|NCT00728845|2518615|P2|NOT COMPLETED|Overall Study||0
1037254|NCT00728845|2518616|P1|NOT COMPLETED|Overall Study||0
1037255|NCT00728845|2518615|P2|COMPLETED|Overall Study||0
1037256|NCT00728845|2518616|P1|COMPLETED|Overall Study||8
1037257|NCT00728845|2518615|P2|STARTED|Overall Study||0
1037258|NCT00728845|2518616|P1|STARTED|Overall Study||8
1037259|NCT00728884|2518630|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
1037260|NCT00728884|2518630|P1|COMPLETED|Two Year Post Placement Follow-up||145
1037261|NCT00728884|2518630|P1|STARTED|Two Year Post Placement Follow-up||145
1037262|NCT00728884|2518630|P1|NOT COMPLETED|One Year Post Placement Follow-up||4
1037263|NCT00728884|2518630|P1|COMPLETED|One Year Post Placement Follow-up||145
1037264|NCT00728884|2518630|P1|STARTED|One Year Post Placement Follow-up||149
1037265|NCT00728884|2518630|P1|NOT COMPLETED|Permanent Prosthesis Placement||13
1037266|NCT00728884|2518630|P1|COMPLETED|Permanent Prosthesis Placement||149
1037267|NCT00728884|2518630|P1|STARTED|Permanent Prosthesis Placement||162
1037268|NCT00728884|2518630|P1|NOT COMPLETED|Implant Placement Surgery||0
1037269|NCT00728884|2518630|P1|COMPLETED|Implant Placement Surgery||162
1037270|NCT00728884|2518630|P1|STARTED|Implant Placement Surgery||162
1037271|NCT00728910|2518634|P1|NOT COMPLETED|Atorvastatin+ABT335+ER Niacin||0
1037272|NCT00728910|2518634|P1|COMPLETED|Atorvastatin+ABT335+ER Niacin||22
1037273|NCT00728910|2518634|P1|STARTED|Atorvastatin+ABT335+ER Niacin||22
1037274|NCT00728910|2518634|P1|NOT COMPLETED|Atorvastatin+ABT335||0
1037275|NCT00728910|2518634|P1|COMPLETED|Atorvastatin+ABT335||22
1037276|NCT00728910|2518634|P1|STARTED|Atorvastatin+ABT335||22
1037277|NCT00728910|2518634|P1|NOT COMPLETED|Atorvastatin||3
1037278|NCT00728910|2518634|P1|COMPLETED|Atorvastatin||22
1037279|NCT00728910|2518634|P1|STARTED|Atorvastatin||25
1037280|NCT00728923|2518646|P1|NOT COMPLETED|Overall Study||0
1037281|NCT00728923|2518646|P1|COMPLETED|Overall Study||9
1037282|NCT00728923|2518646|P1|STARTED|Overall Study||9
1037283|NCT00728962|2518651|P1|NOT COMPLETED|Two Year Post Placement Follow-up||3
1037284|NCT00728962|2518651|P1|COMPLETED|Two Year Post Placement Follow-up||59
1037285|NCT00728962|2518651|P1|STARTED|Two Year Post Placement Follow-up||62
1037286|NCT00728962|2518651|P1|NOT COMPLETED|One Year Post Placement Follow-up||0
1037287|NCT00728962|2518651|P1|COMPLETED|One Year Post Placement Follow-up||62
1037288|NCT00728962|2518651|P1|STARTED|One Year Post Placement Follow-up||62
1037289|NCT00728962|2518651|P1|NOT COMPLETED|Permanent Prosthesis Placement||3
1037290|NCT00728962|2518651|P1|COMPLETED|Permanent Prosthesis Placement||62
1037291|NCT00728962|2518651|P1|STARTED|Permanent Prosthesis Placement||65
1037292|NCT00728962|2518651|P1|NOT COMPLETED|Implant Placement Surgery||10
1037293|NCT00728962|2518651|P1|COMPLETED|Implant Placement Surgery||65
1037294|NCT00728962|2518651|P1|STARTED|Implant Placement Surgery||75
1037295|NCT00728988|2518657|P2|NOT COMPLETED|Overall Study||88
1037296|NCT00728988|2518658|P1|NOT COMPLETED|Overall Study||93
1037297|NCT00728988|2518657|P2|COMPLETED|Overall Study||164
1037298|NCT00728988|2518658|P1|COMPLETED|Overall Study||154
1037299|NCT00728988|2518657|P2|Full Analysis Set|Overall Study||172
1037300|NCT00728988|2518658|P1|Full Analysis Set|Overall Study||163
1037301|NCT00728988|2518657|P2|Treated|Overall Study||250
1037302|NCT00728988|2518658|P1|Treated|Overall Study||245
1037303|NCT00728988|2518657|P2|STARTED|Overall Study||252
1037304|NCT00728988|2518658|P1|STARTED|Overall Study||247
1037305|NCT00729157|2518676|P1|NOT COMPLETED|Overall Study||1
1037306|NCT00729157|2518676|P1|COMPLETED|Overall Study||40
1037307|NCT00729157|2518676|P1|STARTED|Overall Study||41
1037308|NCT00729183|2518686|P2|NOT COMPLETED|Overall Study||15
1037309|NCT00729183|2518687|P1|NOT COMPLETED|Overall Study||25
1037310|NCT00729183|2518686|P2|COMPLETED|Overall Study|Completed 24 month visit|90
1037311|NCT00729183|2518687|P1|COMPLETED|Overall Study|Completed 24 month visit|84
1037312|NCT00729183|2518686|P2|STARTED|Overall Study||105
1037313|NCT00729183|2518687|P1|STARTED|Overall Study||109
1037314|NCT00729248|2518719|P1|NOT COMPLETED|Overall Study||2
1037315|NCT00729248|2518719|P1|COMPLETED|Overall Study||10
1037316|NCT00729248|2518719|P1|STARTED|Overall Study||12
1037317|NCT00729326|2518726|P2|NOT COMPLETED|Overall Study||9
1037318|NCT00729326|2518727|P1|NOT COMPLETED|Overall Study||10
1037319|NCT00729326|2518726|P2|COMPLETED|Overall Study||33
1037320|NCT00729326|2518727|P1|COMPLETED|Overall Study||31
1037321|NCT00729326|2518726|P2|STARTED|Overall Study||42
1037322|NCT00729326|2518727|P1|STARTED|Overall Study||41
1037323|NCT00729365|2518772|P3|NOT COMPLETED|Overall Study||7
1037324|NCT00729365|2518773|P2|NOT COMPLETED|Overall Study||6
1037325|NCT00729365|2518774|P1|NOT COMPLETED|Overall Study||33
1037326|NCT00729365|2518772|P3|COMPLETED|Overall Study|Study terminated|0
1037327|NCT00729365|2518773|P2|COMPLETED|Overall Study|Study Terminated|0
1037328|NCT00729365|2518774|P1|COMPLETED|Overall Study|Study terminated|0
1037329|NCT00729365|2518772|P3|STARTED|Overall Study||7
1037330|NCT00729365|2518773|P2|STARTED|Overall Study||6
1037331|NCT00729365|2518774|P1|STARTED|Overall Study||33
1037332|NCT00729430|2518787|P2|NOT COMPLETED|Overall Study||50
1037333|NCT00729430|2518788|P1|NOT COMPLETED|Overall Study||47
1037334|NCT00729430|2518787|P2|COMPLETED|Overall Study||128
1037335|NCT00729430|2518788|P1|COMPLETED|Overall Study||133
1037336|NCT00729430|2518787|P2|STARTED|Overall Study||178
1037337|NCT00729430|2518788|P1|STARTED|Overall Study||180
1037338|NCT00729469|2518802|P2|NOT COMPLETED|Overall Study||47
1037339|NCT00729469|2518803|P1|NOT COMPLETED|Overall Study||53
1037340|NCT00729469|2518802|P2|COMPLETED|Overall Study||416
1037341|NCT00729469|2518803|P1|COMPLETED|Overall Study||403
1037342|NCT00729469|2518802|P2|STARTED|Overall Study||463
1037343|NCT00729469|2518803|P1|STARTED|Overall Study||456
1037344|NCT00729482|2518839|P1|NOT COMPLETED|Overall Study||0
1037345|NCT00729482|2518839|P1|COMPLETED|Overall Study||54
1037346|NCT00729482|2518839|P1|STARTED|Overall Study||54
1037347|NCT00729521|2518849|P3|NOT COMPLETED|Overall Study||0
1037348|NCT00729521|2518850|P2|NOT COMPLETED|Overall Study||0
1037349|NCT00729521|2518851|P1|NOT COMPLETED|Overall Study||0
1037350|NCT00729521|2518849|P3|COMPLETED|Overall Study|Average annual population over 65 years old.|7701
1037351|NCT00729521|2518850|P2|COMPLETED|Overall Study|Average annual population over 65 years old.|14842
1037352|NCT00729521|2518851|P1|COMPLETED|Overall Study|Average annual population over 65 years old.|12494
1037353|NCT00729521|2518849|P3|STARTED|Overall Study|5 communities in Facilitative System with average annual pop. of 7,701 residents over 65 years.|7701
1037354|NCT00729521|2518850|P2|STARTED|Overall Study|Five communities with average annual population of 14,842 residents over 65 years old.|14842
1037355|NCT00729521|2518851|P1|STARTED|Overall Study|10 communities in Control with average annual population of 12,494 residents over 65 years old.|12494
1037356|NCT00729560|2518859|P1|NOT COMPLETED|Overall Study||3
1037357|NCT00729560|2518859|P1|COMPLETED|Overall Study||5
1037358|NCT00729560|2518859|P1|STARTED|Overall Study|Arm assignment can not be determined as study was ended prior to unblinding and no key found.|8
1037359|NCT00729612|2518863|P1|NOT COMPLETED|Overall Study||10
1037360|NCT00729612|2518863|P1|COMPLETED|Overall Study||53
1037361|NCT00729612|2518863|P1|Died After Cycle 2 Before Response Eval|Overall Study||1
1037362|NCT00729612|2518863|P1|Received Cycle 2|Overall Study||54
1037363|NCT00729612|2518863|P1|Did Not Receive Cycle 2|Overall Study||7
1037364|NCT00729612|2518863|P1|Received Cycle 1|Overall Study||62
1037365|NCT00729612|2518863|P1|Died Before Cycle 1|Overall Study||1
1037366|NCT00729612|2518863|P1|STARTED|Overall Study||63
1037367|NCT00729651|2518872|P2|NOT COMPLETED|Overall Study||18
1037368|NCT00729651|2518873|P1|NOT COMPLETED|Overall Study||19
1037369|NCT00729651|2518872|P2|COMPLETED|Overall Study||152
1037370|NCT00729651|2518873|P1|COMPLETED|Overall Study||154
1037371|NCT00729651|2518872|P2|STARTED|Overall Study||170
1037372|NCT00729651|2518873|P1|STARTED|Overall Study||173
1037373|NCT00729677|2518885|P1|NOT COMPLETED|Overall Study||0
1037374|NCT00729677|2518885|P1|COMPLETED|Overall Study||64
1037375|NCT00729677|2518885|P1|STARTED|Overall Study||64
1037376|NCT00729690|2518899|P3|NOT COMPLETED|Overall Study||2
1037377|NCT00729690|2518900|P2|NOT COMPLETED|Overall Study||2
1037378|NCT00729690|2518901|P1|NOT COMPLETED|Overall Study||0
1037379|NCT00729690|2518899|P3|COMPLETED|Overall Study||14
1037380|NCT00729690|2518900|P2|COMPLETED|Overall Study||14
1037381|NCT00729690|2518901|P1|COMPLETED|Overall Study||16
1037382|NCT00729690|2518899|P3|STARTED|Overall Study||16
1037383|NCT00729690|2518900|P2|STARTED|Overall Study||16
1037384|NCT00729690|2518901|P1|STARTED|Overall Study||16
1037385|NCT00721578|2518918|P2|NOT COMPLETED|Overall Study||2
1037386|NCT00721578|2518919|P1|NOT COMPLETED|Overall Study||2
1037387|NCT00721578|2518918|P2|COMPLETED|Overall Study||9
1037388|NCT00721578|2518919|P1|COMPLETED|Overall Study||10
1037389|NCT00721578|2518918|P2|STARTED|Overall Study||11
1037390|NCT00721578|2518919|P1|STARTED|Overall Study||12
1037391|NCT00721617|2518931|P1|NOT COMPLETED|8 Hours Into Intralipid/Dextrose||0
1037392|NCT00721617|2518931|P1|COMPLETED|8 Hours Into Intralipid/Dextrose||12
1037393|NCT00721617|2518931|P1|STARTED|8 Hours Into Intralipid/Dextrose||12
1037394|NCT00721617|2518931|P1|NOT COMPLETED|4 Hours Into Intralipid/Dextrose||0
1037395|NCT00721617|2518931|P1|COMPLETED|4 Hours Into Intralipid/Dextrose||12
1037396|NCT00721617|2518931|P1|STARTED|4 Hours Into Intralipid/Dextrose||12
1037397|NCT00721617|2518931|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||0
1037398|NCT00721617|2518931|P1|COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||12
1037399|NCT00721617|2518931|P1|STARTED|0 Hour (Baseline) of Intralipid/Dextrose||12
1037400|NCT00721617|2518931|P1|NOT COMPLETED|8 Hours Into Dextrose Infusion||0
1037401|NCT00721617|2518931|P1|COMPLETED|8 Hours Into Dextrose Infusion||12
1037402|NCT00721617|2518931|P1|STARTED|8 Hours Into Dextrose Infusion||12
1037403|NCT00721617|2518931|P1|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
1037404|NCT00721617|2518931|P1|COMPLETED|4 Hours Into Dextrose Infusion||12
1037405|NCT00721617|2518931|P1|STARTED|4 Hours Into Dextrose Infusion||12
1037406|NCT00721617|2518931|P1|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
1037407|NCT00721617|2518931|P1|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
1037408|NCT00721617|2518931|P1|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
1037409|NCT00721617|2518931|P1|NOT COMPLETED|8 Hours Into Intralipid Infusion||0
1037410|NCT00721617|2518931|P1|COMPLETED|8 Hours Into Intralipid Infusion||12
1037411|NCT00721617|2518931|P1|STARTED|8 Hours Into Intralipid Infusion||12
1037412|NCT00721617|2518931|P1|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
1037413|NCT00721617|2518931|P1|COMPLETED|4 Hours Into Intralipid Infusion||12
1037414|NCT00721617|2518931|P1|STARTED|4 Hours Into Intralipid Infusion||12
1037415|NCT00721617|2518931|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
1037416|NCT00721617|2518931|P1|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
1037417|NCT00721617|2518931|P1|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
1037418|NCT00721617|2518931|P1|NOT COMPLETED|8 Hours Into Saline Infusion||0
1037419|NCT00721617|2518931|P1|COMPLETED|8 Hours Into Saline Infusion||12
1037420|NCT00721617|2518931|P1|STARTED|8 Hours Into Saline Infusion||12
1037421|NCT00721617|2518931|P1|NOT COMPLETED|4 Hours Into Saline Infusion||0
1037422|NCT00721617|2518931|P1|COMPLETED|4 Hours Into Saline Infusion||12
1037423|NCT00721617|2518931|P1|STARTED|4 Hours Into Saline Infusion||12
1037424|NCT00721617|2518931|P1|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
1037425|NCT00721617|2518931|P1|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
1037426|NCT00721617|2518931|P1|STARTED|0 Hour (Baseline) of Saline Infusion||12
1037427|NCT00729781|2518955|P1|NOT COMPLETED|Long-term Follow-up Study||0
1037428|NCT00729781|2518955|P1|COMPLETED|Long-term Follow-up Study|All subjects completed the original study, but 3 did not consent to enroll in the follow-up study.|42
1037429|NCT00729781|2518955|P1|STARTED|Long-term Follow-up Study|Enrollment in the long-term follow-up required contact and a new Informed Consent.|42
1037430|NCT00729781|2518955|P1|NOT COMPLETED|Original Study||0
1037431|NCT00729781|2518955|P1|COMPLETED|Original Study||45
1037432|NCT00729781|2518955|P1|STARTED|Original Study||45
1037433|NCT00729807|2518961|P1|NOT COMPLETED|Overall Study||0
1037434|NCT00729807|2518961|P1|COMPLETED|Overall Study||6
1037435|NCT00729807|2518961|P1|STARTED|Overall Study||6
1037436|NCT00729833|2518965|P4|NOT COMPLETED|Overall Study||6
1037437|NCT00729833|2518966|P3|NOT COMPLETED|Overall Study||12
1037438|NCT00729833|2518967|P2|NOT COMPLETED|Overall Study||7
1037439|NCT00729833|2518968|P1|NOT COMPLETED|Overall Study||20
1037440|NCT00729833|2518965|P4|COMPLETED|Overall Study||0
1037441|NCT00729833|2518966|P3|COMPLETED|Overall Study||0
1037442|NCT00729833|2518967|P2|COMPLETED|Overall Study||0
1037443|NCT00729833|2518968|P1|COMPLETED|Overall Study||0
1037444|NCT00729833|2518965|P4|STARTED|Overall Study||6
1037445|NCT00729833|2518966|P3|STARTED|Overall Study||12
1037446|NCT00729833|2518967|P2|STARTED|Overall Study||7
1037447|NCT00729833|2518968|P1|STARTED|Overall Study||20
1037448|NCT00729846|2519009|P2|NOT COMPLETED|Overall Study||0
1037449|NCT00729846|2519010|P1|NOT COMPLETED|Overall Study||0
1037450|NCT00729846|2519009|P2|COMPLETED|Overall Study||11
1037451|NCT00729846|2519010|P1|COMPLETED|Overall Study||11
1037452|NCT00729846|2519009|P2|STARTED|Overall Study||11
1037453|NCT00729846|2519010|P1|STARTED|Overall Study||11
1037454|NCT00729859|2519019|P3|NOT COMPLETED|Overall Study||0
1037455|NCT00729859|2519020|P2|NOT COMPLETED|Overall Study||2
1037456|NCT00729859|2519021|P1|NOT COMPLETED|Overall Study||0
1037457|NCT00729859|2519019|P3|COMPLETED|Overall Study||8
1037458|NCT00729859|2519020|P2|COMPLETED|Overall Study||6
1037459|NCT00729859|2519021|P1|COMPLETED|Overall Study||8
1037460|NCT00729859|2519019|P3|STARTED|Overall Study||8
1037461|NCT00729859|2519020|P2|STARTED|Overall Study||8
1037462|NCT00729859|2519021|P1|STARTED|Overall Study||8
1037463|NCT00729924|2519056|P1|NOT COMPLETED|Overall Study||0
1037464|NCT00729924|2519056|P1|COMPLETED|Overall Study||40
1037465|NCT00729924|2519056|P1|STARTED|Overall Study||40
1037466|NCT00729937|2519069|P6|NOT COMPLETED|Overall Study||37
1037467|NCT00729937|2519070|P5|NOT COMPLETED|Overall Study||28
1037468|NCT00729937|2519071|P4|NOT COMPLETED|Overall Study||34
1037469|NCT00729937|2519072|P3|NOT COMPLETED|Overall Study||29
1037470|NCT00729937|2519073|P2|NOT COMPLETED|Overall Study||88
1037471|NCT00729937|2519074|P1|NOT COMPLETED|Overall Study||74
1037472|NCT00729937|2519069|P6|COMPLETED|Overall Study||214
1037473|NCT00729937|2519070|P5|COMPLETED|Overall Study||221
1037474|NCT00729937|2519071|P4|COMPLETED|Overall Study||215
1037475|NCT00729937|2519072|P3|COMPLETED|Overall Study||222
1037476|NCT00729937|2519073|P2|COMPLETED|Overall Study||548
1037477|NCT00729937|2519074|P1|COMPLETED|Overall Study||555
1037478|NCT00729937|2519069|P6|STARTED|Overall Study||251
1037479|NCT00729937|2519070|P5|STARTED|Overall Study||249
1037480|NCT00729937|2519071|P4|STARTED|Overall Study||249
1037481|NCT00729937|2519072|P3|STARTED|Overall Study||251
1037482|NCT00729937|2519073|P2|STARTED|Overall Study||636
1037483|NCT00729937|2519074|P1|STARTED|Overall Study||629
1037484|NCT00730015|2519271|P3|NOT COMPLETED|Overall Study||32
1037485|NCT00730015|2519272|P2|NOT COMPLETED|Overall Study||40
1037486|NCT00730015|2519273|P1|NOT COMPLETED|Overall Study||31
1037487|NCT00730015|2519271|P3|COMPLETED|Overall Study||177
1037488|NCT00730015|2519272|P2|COMPLETED|Overall Study||177
1037489|NCT00730015|2519273|P1|COMPLETED|Overall Study||186
1037490|NCT00730015|2519271|P3|STARTED|Overall Study||209
1037491|NCT00730015|2519272|P2|STARTED|Overall Study||217
1037492|NCT00730015|2519273|P1|STARTED|Overall Study||217
1037493|NCT00730028|2519312|P5|NOT COMPLETED|Overall Study||82
1037494|NCT00730028|2519313|P4|NOT COMPLETED|Overall Study||56
1037495|NCT00730028|2519314|P3|NOT COMPLETED|Overall Study||45
1037496|NCT00730028|2519315|P2|NOT COMPLETED|Overall Study||66
1037497|NCT00730028|2519316|P1|NOT COMPLETED|Overall Study||60
1037498|NCT00730028|2519312|P5|COMPLETED|Overall Study||175
1037499|NCT00730028|2519313|P4|COMPLETED|Overall Study||207
1037500|NCT00730028|2519314|P3|COMPLETED|Overall Study||221
1037501|NCT00730028|2519315|P2|COMPLETED|Overall Study||194
1037502|NCT00730028|2519316|P1|COMPLETED|Overall Study||204
1037503|NCT00730028|2519312|P5|STARTED|Overall Study||257
1037504|NCT00730028|2519313|P4|STARTED|Overall Study||263
1037505|NCT00730028|2519314|P3|STARTED|Overall Study||266
1037506|NCT00730028|2519315|P2|STARTED|Overall Study||260
1037507|NCT00730028|2519316|P1|STARTED|Overall Study||264
1037508|NCT00730041|2519365|P2|NOT COMPLETED|Overall Study||2
1037509|NCT00730041|2519366|P1|NOT COMPLETED|Overall Study||0
1037510|NCT00730041|2519365|P2|COMPLETED|Overall Study|One subject did not return for the final PSG or final visit, and one missed only the final visit.|23
1037511|NCT00730041|2519366|P1|COMPLETED|Overall Study||26
1037512|NCT00730041|2519365|P2|STARTED|Overall Study|4/25 (16.0%) female, 21/25 (84.0%) male|25
1037513|NCT00730041|2519366|P1|STARTED|Overall Study|4/26 (15.4%) female, 22/26 (84.6%) male|26
1037514|NCT00730730|2519384|P1|NOT COMPLETED|Overall Study||0
1037515|NCT00730730|2519384|P1|COMPLETED|Overall Study||50
1037516|NCT00730730|2519384|P1|STARTED|Overall Study||50
1037517|NCT00730756|2519393|P2|NOT COMPLETED|Overall Study||5
1037518|NCT00730756|2519394|P1|NOT COMPLETED|Overall Study||4
1037519|NCT00730756|2519393|P2|COMPLETED|Overall Study||48
1037520|NCT00730756|2519394|P1|COMPLETED|Overall Study||45
1037521|NCT00730756|2519393|P2|STARTED|Overall Study||53
1037522|NCT00730756|2519394|P1|STARTED|Overall Study||49
1037523|NCT00730847|2519416|P1|NOT COMPLETED|Overall Study||131
1037524|NCT00730847|2519416|P1|COMPLETED|Overall Study||465
1037525|NCT00730847|2519416|P1|STARTED|Overall Study||596
1037526|NCT00730912|2519426|P3|NOT COMPLETED|Overall Study||1
1037527|NCT00730912|2519427|P2|NOT COMPLETED|Overall Study||0
1037528|NCT00730912|2519428|P1|NOT COMPLETED|Overall Study||0
1037529|NCT00730912|2519426|P3|COMPLETED|Overall Study||103
1037530|NCT00730912|2519427|P2|COMPLETED|Overall Study||104
1037531|NCT00730912|2519428|P1|COMPLETED|Overall Study||53
1037532|NCT00730912|2519426|P3|STARTED|Overall Study||104
1037533|NCT00730912|2519427|P2|STARTED|Overall Study||104
1037534|NCT00730912|2519428|P1|STARTED|Overall Study||53
1037535|NCT00730925|2519439|P1|NOT COMPLETED|Overall Study||41
1037536|NCT00730925|2519439|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date|0
1037537|NCT00730925|2519439|P1|STARTED|Overall Study||41
1037538|NCT00730964|2519446|P1|NOT COMPLETED|Overall Study||0
1037539|NCT00730964|2519446|P1|COMPLETED|Overall Study||1039
1037540|NCT00730964|2519446|P1|STARTED|Overall Study||1039
1037541|NCT00731042|2519453|P2|NOT COMPLETED|Second Intervention||2
1037542|NCT00731042|2519454|P1|NOT COMPLETED|Second Intervention||0
1037543|NCT00731042|2519453|P2|COMPLETED|Second Intervention|2 subjects did not met inclusion criteria for Period 2 Visual scoring skin condition|15
1037544|NCT00731042|2519454|P1|COMPLETED|Second Intervention||16
1037545|NCT00731042|2519453|P2|STARTED|Second Intervention||17
1037546|NCT00731042|2519454|P1|STARTED|Second Intervention||16
1037547|NCT00731042|2519453|P2|NOT COMPLETED|Wash-out||0
1037548|NCT00731042|2519454|P1|NOT COMPLETED|Wash-out||0
1037549|NCT00731042|2519453|P2|COMPLETED|Wash-out||17
1037550|NCT00731042|2519454|P1|COMPLETED|Wash-out||16
1037551|NCT00731042|2519453|P2|STARTED|Wash-out||17
1037552|NCT00731042|2519454|P1|STARTED|Wash-out||16
1037553|NCT00731042|2519453|P2|NOT COMPLETED|First Intervention||0
1037554|NCT00731042|2519454|P1|NOT COMPLETED|First Intervention||0
1037555|NCT00731042|2519453|P2|COMPLETED|First Intervention||17
1037556|NCT00731042|2519454|P1|COMPLETED|First Intervention||16
1037557|NCT00731042|2519453|P2|STARTED|First Intervention||17
1037558|NCT00731042|2519454|P1|STARTED|First Intervention||16
1037559|NCT00731055|2519460|P1|NOT COMPLETED|Overall Study||0
1037560|NCT00731055|2519460|P1|COMPLETED|Overall Study||16
1037561|NCT00731055|2519460|P1|Received Varenicline 2.0 mg|Overall Study||16
1037562|NCT00731055|2519460|P1|Received Varenicline 1.0 mg|Overall Study||16
1037563|NCT00731055|2519460|P1|Received Varenicline 0.5 mg|Overall Study||16
1037564|NCT00731055|2519460|P1|Received Placebo|Overall Study||16
1037565|NCT00731055|2519460|P1|STARTED|Overall Study|This is a within-subjects study design.|16
1037566|NCT00731094|2519469|P2|NOT COMPLETED|Overall Study||11
1037567|NCT00731094|2519470|P1|NOT COMPLETED|Overall Study||18
1037568|NCT00731094|2519469|P2|COMPLETED|Overall Study||105
1037569|NCT00731094|2519470|P1|COMPLETED|Overall Study||98
1037570|NCT00731094|2519469|P2|Month 6|Overall Study||107
1037571|NCT00731094|2519470|P1|Month 6|Overall Study||101
1037572|NCT00731094|2519469|P2|STARTED|Overall Study||116
1037573|NCT00731094|2519470|P1|STARTED|Overall Study||116
1037574|NCT00731120|2519543|P3|NOT COMPLETED|Overall Study||36
1037575|NCT00731120|2519544|P2|NOT COMPLETED|Overall Study||43
1037576|NCT00731120|2519545|P1|NOT COMPLETED|Overall Study||42
1037577|NCT00731120|2519543|P3|COMPLETED|Overall Study||116
1037578|NCT00731120|2519544|P2|COMPLETED|Overall Study||109
1037579|NCT00731120|2519545|P1|COMPLETED|Overall Study||111
1037580|NCT00731120|2519543|P3|Treated|Overall Study||152
1037581|NCT00731120|2519544|P2|Treated|Overall Study||151
1037582|NCT00731120|2519545|P1|Treated|Overall Study||153
1037583|NCT00731120|2519543|P3|STARTED|Overall Study||152
1037584|NCT00731120|2519544|P2|STARTED|Overall Study||152
1037585|NCT00731120|2519545|P1|STARTED|Overall Study||153
1037586|NCT00731133|2519580|P1|NOT COMPLETED|Overall Study||10
1037587|NCT00731133|2519580|P1|COMPLETED|Overall Study||5
1037588|NCT00731133|2519580|P1|STARTED|Overall Study||15
1037589|NCT00731198|2519587|P2|NOT COMPLETED|Overall Study||6
1037590|NCT00731198|2519588|P1|NOT COMPLETED|Overall Study||6
1037591|NCT00731198|2519587|P2|COMPLETED|Overall Study||319
1037592|NCT00731198|2519588|P1|COMPLETED|Overall Study||319
1037593|NCT00731198|2519587|P2|STARTED|Overall Study||325
1037594|NCT00731198|2519588|P1|STARTED|Overall Study||325
1037595|NCT00731211|2519594|P1|NOT COMPLETED|Overall Study||0
1037596|NCT00731211|2519594|P1|COMPLETED|Overall Study||55
1037597|NCT00731211|2519594|P1|STARTED|Overall Study|2 patients ineligible (papillary histologic type-1 pt. Previous treatment with everolimus alone-1 pt|55
1037598|NCT00731341|2519599|P1|NOT COMPLETED|Overall Study||0
1037599|NCT00731341|2519599|P1|COMPLETED|Overall Study||3
1037600|NCT00731341|2519599|P1|STARTED|Overall Study||3
1037601|NCT00731484|2519608|P1|NOT COMPLETED|Overall Study||0
1037602|NCT00731484|2519608|P1|COMPLETED|Overall Study||233
1037603|NCT00731484|2519608|P1|STARTED|Overall Study||233
1037604|NCT00731549|2519612|P1|NOT COMPLETED|Overall Study||223
1037605|NCT00731549|2519612|P1|COMPLETED|Overall Study||858
1037606|NCT00731549|2519612|P1|STARTED|Overall Study||1081
1037607|NCT00731614|2519627|P2|NOT COMPLETED|Overall Study||13
1037608|NCT00731614|2519628|P1|NOT COMPLETED|Overall Study||7
1037609|NCT00731614|2519627|P2|COMPLETED|Overall Study||18
1037610|NCT00731614|2519628|P1|COMPLETED|Overall Study||16
1037611|NCT00731614|2519627|P2|12 Weeks Posttreatment|Overall Study||23
1037612|NCT00731614|2519628|P1|12 Weeks Posttreatment|Overall Study||18
1037613|NCT00731614|2519627|P2|End of Treatment|Overall Study||24
1037614|NCT00731614|2519628|P1|End of Treatment|Overall Study||16
1037615|NCT00731614|2519627|P2|STARTED|Overall Study||31
1037616|NCT00731614|2519628|P1|STARTED|Overall Study||23
1037617|NCT00731640|2519636|P2|NOT COMPLETED|Overall Study||0
1037618|NCT00731640|2519637|P1|NOT COMPLETED|Overall Study||0
1037619|NCT00731640|2519636|P2|COMPLETED|Overall Study||32
1037620|NCT00731640|2519637|P1|COMPLETED|Overall Study||20
1037621|NCT00731640|2519636|P2|STARTED|Overall Study||32
1037622|NCT00731640|2519637|P1|STARTED|Overall Study||20
1037623|NCT00731653|2519649|P1|NOT COMPLETED|Overall Study||9
1037624|NCT00731653|2519649|P1|COMPLETED|Overall Study||72
1037625|NCT00731653|2519649|P1|STARTED|Overall Study||81
1037626|NCT00731666|2519653|P1|NOT COMPLETED|Overall Study||12
1037627|NCT00731666|2519653|P1|COMPLETED|Overall Study||28
1037628|NCT00731666|2519653|P1|STARTED|Overall Study||40
1037629|NCT00731679|2519661|P2|NOT COMPLETED|Overall Study||26
1037630|NCT00731679|2519662|P1|NOT COMPLETED|Overall Study||22
1037631|NCT00731679|2519661|P2|COMPLETED|Overall Study||283
1037632|NCT00731679|2519662|P1|COMPLETED|Overall Study||292
1037633|NCT00731679|2519661|P2|STARTED|Overall Study||309
1037634|NCT00731679|2519662|P1|STARTED|Overall Study||314
1037635|NCT00731692|2519673|P3|NOT COMPLETED|Extension Phase||301
1037636|NCT00731692|2519674|P2|NOT COMPLETED|Extension Phase||196
1037637|NCT00731692|2519675|P1|NOT COMPLETED|Extension Phase||74
1037638|NCT00731692|2519673|P3|COMPLETED|Extension Phase||0
1037639|NCT00731692|2519674|P2|COMPLETED|Extension Phase||0
1037640|NCT00731692|2519675|P1|COMPLETED|Extension Phase||0
1037641|NCT00731692|2519673|P3|STARTED|Extension Phase||301
1037642|NCT00731692|2519674|P2|STARTED|Extension Phase||196
1037643|NCT00731692|2519675|P1|STARTED|Extension Phase||74
1037644|NCT00731692|2519673|P3|NOT COMPLETED|Core Study (36 Months)||170
1037645|NCT00731692|2519674|P2|NOT COMPLETED|Core Study (36 Months)||116
1037646|NCT00731692|2519675|P1|NOT COMPLETED|Core Study (36 Months)||68
1037647|NCT00731692|2519673|P3|COMPLETED|Core Study (36 Months)||317
1037648|NCT00731692|2519674|P2|COMPLETED|Core Study (36 Months)||220
1037649|NCT00731692|2519675|P1|COMPLETED|Core Study (36 Months)||79
1037650|NCT00731692|2519673|P3|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
1037651|NCT00731692|2519674|P2|Post Protocol Amendment 5 Switch|Core Study (36 Months)|post protocol amendment 121 patients switch to 0.5 mg dose from 125mg dose|121
1037652|NCT00731692|2519675|P1|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
1037653|NCT00731692|2519673|P3|Pharmacokinetic Analysis Set|Core Study (36 Months)||0
1037654|NCT00731692|2519674|P2|Pharmacokinetic Analysis Set|Core Study (36 Months)||249
1037655|NCT00731692|2519675|P1|Pharmacokinetic Analysis Set|Core Study (36 Months)||102
1037656|NCT00731692|2519673|P3|Full Analysis Set (FAS)|Core Study (36 Months)||487
1037657|NCT00731692|2519674|P2|Full Analysis Set (FAS)|Core Study (36 Months)||336
1037658|NCT00731692|2519675|P1|Full Analysis Set (FAS)|Core Study (36 Months)||0
1037659|NCT00731692|2519673|P3|Safety Set (SAF)|Core Study (36 Months)||487
1037660|NCT00731692|2519674|P2|Safety Set (SAF)|Core Study (36 Months)||336
1037661|NCT00731692|2519675|P1|Safety Set (SAF)|Core Study (36 Months)||0
1037662|NCT00731692|2519673|P3|STARTED|Core Study (36 Months)||487
1037663|NCT00731692|2519674|P2|STARTED|Core Study (36 Months)||336
1037664|NCT00731692|2519675|P1|STARTED|Core Study (36 Months)||147
1037674|NCT00731783|2519741|P2|NOT COMPLETED|12 Month Follow-Up Visit||7
1037675|NCT00731783|2519742|P1|NOT COMPLETED|12 Month Follow-Up Visit||6
1037676|NCT00731783|2519741|P2|COMPLETED|12 Month Follow-Up Visit||58
1037677|NCT00731783|2519742|P1|COMPLETED|12 Month Follow-Up Visit||68
1037678|NCT00731783|2519741|P2|STARTED|12 Month Follow-Up Visit||65
1037679|NCT00731783|2519742|P1|STARTED|12 Month Follow-Up Visit||74
1037680|NCT00731783|2519741|P2|NOT COMPLETED|Six Month Follow-Up Visit||3
1037681|NCT00731783|2519742|P1|NOT COMPLETED|Six Month Follow-Up Visit||6
1037682|NCT00731783|2519741|P2|COMPLETED|Six Month Follow-Up Visit||64
1037683|NCT00731783|2519742|P1|COMPLETED|Six Month Follow-Up Visit||71
1037684|NCT00731783|2519741|P2|STARTED|Six Month Follow-Up Visit||67
1037685|NCT00731783|2519742|P1|STARTED|Six Month Follow-Up Visit||77
1037686|NCT00731783|2519741|P2|NOT COMPLETED|Three Month Follow-Up Visit||16
1037687|NCT00731783|2519742|P1|NOT COMPLETED|Three Month Follow-Up Visit||7
1037688|NCT00731783|2519741|P2|COMPLETED|Three Month Follow-Up Visit||57
1037689|NCT00731783|2519742|P1|COMPLETED|Three Month Follow-Up Visit||72
1037690|NCT00731783|2519741|P2|STARTED|Three Month Follow-Up Visit||73
1037691|NCT00731783|2519742|P1|STARTED|Three Month Follow-Up Visit||79
1037692|NCT00731783|2519741|P2|NOT COMPLETED|One Month Follow-Up Visit||22
1037693|NCT00731783|2519742|P1|NOT COMPLETED|One Month Follow-Up Visit||14
1037694|NCT00731783|2519741|P2|COMPLETED|One Month Follow-Up Visit||69
1037695|NCT00731783|2519742|P1|COMPLETED|One Month Follow-Up Visit||78
1037696|NCT00731783|2519741|P2|STARTED|One Month Follow-Up Visit||91
1037697|NCT00731783|2519742|P1|STARTED|One Month Follow-Up Visit||92
1037698|NCT00731822|2519764|P2|NOT COMPLETED|Overall Study||1
1037699|NCT00731822|2519765|P1|NOT COMPLETED|Overall Study||4
1037700|NCT00731822|2519764|P2|COMPLETED|Overall Study||39
1037701|NCT00731822|2519765|P1|COMPLETED|Overall Study||16
1037702|NCT00731822|2519764|P2|STARTED|Overall Study||40
1037703|NCT00731822|2519765|P1|STARTED|Overall Study||20
1037704|NCT00731874|2519779|P2|NOT COMPLETED|Overall Study||0
1037705|NCT00731874|2519780|P1|NOT COMPLETED|Overall Study||0
1037706|NCT00731874|2519779|P2|COMPLETED|Overall Study||13
1037707|NCT00731874|2519780|P1|COMPLETED|Overall Study||10
1037708|NCT00731874|2519779|P2|STARTED|Overall Study||13
1037709|NCT00731874|2519780|P1|STARTED|Overall Study||10
1037710|NCT00731939|2519788|P1|NOT COMPLETED|Overall Study||34
1037711|NCT00731939|2519788|P1|COMPLETED|Overall Study||90
1037712|NCT00731939|2519788|P1|STARTED|Overall Study||124
1037713|NCT00732030|2519836|P1|NOT COMPLETED|Overall Study||2
1037714|NCT00732030|2519836|P1|COMPLETED|Overall Study||24
1037715|NCT00732030|2519836|P1|STARTED|Overall Study||26
1037716|NCT00732069|2519843|P6|NOT COMPLETED|Third Study Drug||0
1037717|NCT00732069|2519844|P5|NOT COMPLETED|Third Study Drug||0
1037718|NCT00732069|2519845|P4|NOT COMPLETED|Third Study Drug||0
1037719|NCT00732069|2519846|P3|NOT COMPLETED|Third Study Drug||0
1037720|NCT00732069|2519847|P2|NOT COMPLETED|Third Study Drug||0
1037721|NCT00732069|2519848|P1|NOT COMPLETED|Third Study Drug||0
1037722|NCT00732069|2519843|P6|COMPLETED|Third Study Drug||2
1037723|NCT00732069|2519844|P5|COMPLETED|Third Study Drug||3
1037724|NCT00732069|2519845|P4|COMPLETED|Third Study Drug||2
1037725|NCT00732069|2519846|P3|COMPLETED|Third Study Drug||3
1037726|NCT00732069|2519847|P2|COMPLETED|Third Study Drug||3
1037727|NCT00732069|2519848|P1|COMPLETED|Third Study Drug||2
1037728|NCT00732069|2519843|P6|STARTED|Third Study Drug||2
1037729|NCT00732069|2519844|P5|STARTED|Third Study Drug||3
1037730|NCT00732069|2519845|P4|STARTED|Third Study Drug||2
1037731|NCT00732069|2519846|P3|STARTED|Third Study Drug||3
1037732|NCT00732069|2519847|P2|STARTED|Third Study Drug||3
1037733|NCT00732069|2519848|P1|STARTED|Third Study Drug||2
1037734|NCT00732069|2519843|P6|NOT COMPLETED|Washout After Second Study Drug||0
1037735|NCT00732069|2519844|P5|NOT COMPLETED|Washout After Second Study Drug||0
1037736|NCT00732069|2519845|P4|NOT COMPLETED|Washout After Second Study Drug||0
1037737|NCT00732069|2519846|P3|NOT COMPLETED|Washout After Second Study Drug||0
1037738|NCT00732069|2519847|P2|NOT COMPLETED|Washout After Second Study Drug||0
1037739|NCT00732069|2519848|P1|NOT COMPLETED|Washout After Second Study Drug||0
1037740|NCT00732069|2519843|P6|COMPLETED|Washout After Second Study Drug||2
1037741|NCT00732069|2519844|P5|COMPLETED|Washout After Second Study Drug||3
1037742|NCT00732069|2519845|P4|COMPLETED|Washout After Second Study Drug||2
1037743|NCT00732069|2519846|P3|COMPLETED|Washout After Second Study Drug||3
1037744|NCT00732069|2519847|P2|COMPLETED|Washout After Second Study Drug||3
1037745|NCT00732069|2519848|P1|COMPLETED|Washout After Second Study Drug||2
1037746|NCT00732069|2519843|P6|STARTED|Washout After Second Study Drug||2
1037747|NCT00732069|2519844|P5|STARTED|Washout After Second Study Drug||3
1037748|NCT00732069|2519845|P4|STARTED|Washout After Second Study Drug||2
1037749|NCT00732069|2519846|P3|STARTED|Washout After Second Study Drug||3
1037750|NCT00732069|2519847|P2|STARTED|Washout After Second Study Drug||3
1037751|NCT00732069|2519848|P1|STARTED|Washout After Second Study Drug||2
1037752|NCT00732069|2519843|P6|NOT COMPLETED|Second Study Drug||0
1037753|NCT00732069|2519844|P5|NOT COMPLETED|Second Study Drug||0
1037754|NCT00732069|2519845|P4|NOT COMPLETED|Second Study Drug||0
1037755|NCT00732069|2519846|P3|NOT COMPLETED|Second Study Drug||0
1037756|NCT00732069|2519847|P2|NOT COMPLETED|Second Study Drug||0
1037757|NCT00732069|2519848|P1|NOT COMPLETED|Second Study Drug||0
1037758|NCT00732069|2519843|P6|COMPLETED|Second Study Drug||2
1037759|NCT00732069|2519844|P5|COMPLETED|Second Study Drug||3
1037760|NCT00732069|2519845|P4|COMPLETED|Second Study Drug||2
1037761|NCT00732069|2519846|P3|COMPLETED|Second Study Drug||3
1037762|NCT00732069|2519847|P2|COMPLETED|Second Study Drug||3
1037763|NCT00732069|2519848|P1|COMPLETED|Second Study Drug||2
1037764|NCT00732069|2519843|P6|STARTED|Second Study Drug||2
1037765|NCT00732069|2519844|P5|STARTED|Second Study Drug||3
1037766|NCT00732069|2519845|P4|STARTED|Second Study Drug||2
1037767|NCT00732069|2519846|P3|STARTED|Second Study Drug||3
1037768|NCT00732069|2519847|P2|STARTED|Second Study Drug||3
1037769|NCT00732069|2519848|P1|STARTED|Second Study Drug||2
1037770|NCT00732069|2519843|P6|NOT COMPLETED|Washout After First Study Drug||0
1037771|NCT00732069|2519844|P5|NOT COMPLETED|Washout After First Study Drug||0
1037772|NCT00732069|2519845|P4|NOT COMPLETED|Washout After First Study Drug||0
1037773|NCT00732069|2519846|P3|NOT COMPLETED|Washout After First Study Drug||0
1037774|NCT00732069|2519847|P2|NOT COMPLETED|Washout After First Study Drug||0
1037775|NCT00732069|2519848|P1|NOT COMPLETED|Washout After First Study Drug||1
1037776|NCT00732069|2519843|P6|COMPLETED|Washout After First Study Drug||2
1037777|NCT00732069|2519844|P5|COMPLETED|Washout After First Study Drug||3
1037778|NCT00732069|2519845|P4|COMPLETED|Washout After First Study Drug||2
1037779|NCT00732069|2519846|P3|COMPLETED|Washout After First Study Drug||3
1037780|NCT00732069|2519847|P2|COMPLETED|Washout After First Study Drug||3
1037781|NCT00732069|2519848|P1|COMPLETED|Washout After First Study Drug||2
1037782|NCT00732069|2519843|P6|STARTED|Washout After First Study Drug||2
1037783|NCT00732069|2519844|P5|STARTED|Washout After First Study Drug||3
1037784|NCT00732069|2519845|P4|STARTED|Washout After First Study Drug||2
1037785|NCT00732069|2519846|P3|STARTED|Washout After First Study Drug||3
1037786|NCT00732069|2519847|P2|STARTED|Washout After First Study Drug||3
1037787|NCT00732069|2519848|P1|STARTED|Washout After First Study Drug||3
1037788|NCT00732069|2519843|P6|NOT COMPLETED|First Study Drug||0
1037789|NCT00732069|2519844|P5|NOT COMPLETED|First Study Drug||0
1037790|NCT00732069|2519845|P4|NOT COMPLETED|First Study Drug||0
1037791|NCT00732069|2519846|P3|NOT COMPLETED|First Study Drug||0
1037792|NCT00732069|2519847|P2|NOT COMPLETED|First Study Drug||0
1037793|NCT00732069|2519848|P1|NOT COMPLETED|First Study Drug||0
1037794|NCT00732069|2519843|P6|COMPLETED|First Study Drug||2
1037795|NCT00732069|2519844|P5|COMPLETED|First Study Drug||3
1037796|NCT00732069|2519845|P4|COMPLETED|First Study Drug||2
1037797|NCT00732069|2519846|P3|COMPLETED|First Study Drug||3
1037798|NCT00732069|2519847|P2|COMPLETED|First Study Drug||3
1037799|NCT00732069|2519848|P1|COMPLETED|First Study Drug||3
1037800|NCT00732069|2519843|P6|STARTED|First Study Drug||2
1037801|NCT00732069|2519844|P5|STARTED|First Study Drug||3
1037802|NCT00732069|2519845|P4|STARTED|First Study Drug||2
1037803|NCT00732069|2519846|P3|STARTED|First Study Drug||3
1037804|NCT00732069|2519847|P2|STARTED|First Study Drug||3
1037805|NCT00732069|2519848|P1|STARTED|First Study Drug||3
1037806|NCT00732160|2519863|P4|NOT COMPLETED|Overall Study||2
1037807|NCT00732160|2519864|P3|NOT COMPLETED|Overall Study||3
1037808|NCT00732160|2519865|P2|NOT COMPLETED|Overall Study||4
1037809|NCT00732160|2519866|P1|NOT COMPLETED|Overall Study||5
1037810|NCT00732160|2519863|P4|COMPLETED|Overall Study||3
1037811|NCT00732160|2519864|P3|COMPLETED|Overall Study||3
1037812|NCT00732160|2519865|P2|COMPLETED|Overall Study||1
1037813|NCT00732160|2519866|P1|COMPLETED|Overall Study||2
1037814|NCT00732160|2519863|P4|LS Aldosterone|Overall Study||5
1037815|NCT00732160|2519864|P3|LS Aldosterone|Overall Study||6
1037816|NCT00732160|2519865|P2|LS Aldosterone|Overall Study||1
1037817|NCT00732160|2519866|P1|LS Aldosterone|Overall Study||2
1037818|NCT00732160|2519863|P4|LS Vehicle|Overall Study||5
1037819|NCT00732160|2519864|P3|LS Vehicle|Overall Study||6
1037820|NCT00732160|2519865|P2|LS Vehicle|Overall Study||1
1037821|NCT00732160|2519866|P1|LS Vehicle|Overall Study||2
1037822|NCT00732160|2519863|P4|HS Aldosterone|Overall Study||3
1037823|NCT00732160|2519864|P3|HS Aldosterone|Overall Study||3
1037824|NCT00732160|2519865|P2|HS Aldosterone|Overall Study||5
1037825|NCT00732160|2519866|P1|HS Aldosterone|Overall Study||7
1037826|NCT00732160|2519863|P4|HS Vehicle|Overall Study||3
1037827|NCT00732160|2519864|P3|HS Vehicle|Overall Study||3
1037828|NCT00732160|2519865|P2|HS Vehicle|Overall Study||5
1037829|NCT00732160|2519866|P1|HS Vehicle|Overall Study||7
1037830|NCT00732160|2519863|P4|STARTED|Overall Study||5
1037831|NCT00732160|2519864|P3|STARTED|Overall Study||6
1037832|NCT00732160|2519865|P2|STARTED|Overall Study||5
1037833|NCT00732160|2519866|P1|STARTED|Overall Study||7
1037834|NCT00732199|2519882|P2|NOT COMPLETED|Overall Study||26
1037835|NCT00732199|2519883|P1|NOT COMPLETED|Overall Study||34
1037836|NCT00732199|2519882|P2|COMPLETED|Overall Study||16
1037837|NCT00732199|2519883|P1|COMPLETED|Overall Study||16
1037838|NCT00732199|2519882|P2|STARTED|Overall Study||42
1037839|NCT00732199|2519883|P1|STARTED|Overall Study||50
1037840|NCT00732212|2519898|P2|NOT COMPLETED|Overall Study||0
1037841|NCT00732212|2519899|P1|NOT COMPLETED|Overall Study||0
1037842|NCT00732212|2519898|P2|COMPLETED|Overall Study||123
1037843|NCT00732212|2519899|P1|COMPLETED|Overall Study||112
1037844|NCT00732212|2519898|P2|Temporarily Suspended|Overall Study||50
1037845|NCT00732212|2519899|P1|Temporarily Suspended|Overall Study|Study was suspended for a 9 month period by the VA DMC because of slow enrollment, then restarted.|50
1037846|NCT00732212|2519898|P2|STARTED|Overall Study||123
1037847|NCT00732212|2519899|P1|STARTED|Overall Study||112
1037848|NCT00732225|2519934|P5|NOT COMPLETED|Overall Study||6
1037849|NCT00732225|2519935|P4|NOT COMPLETED|Overall Study||4
1037850|NCT00732225|2519936|P3|NOT COMPLETED|Overall Study||3
1037851|NCT00732225|2519937|P2|NOT COMPLETED|Overall Study||8
1037852|NCT00732225|2519938|P1|NOT COMPLETED|Overall Study||11
1037853|NCT00732225|2519934|P5|COMPLETED|Overall Study|48 eyes of 48 patients|48
1037854|NCT00732225|2519935|P4|COMPLETED|Overall Study|29 eyes of 29 patients|29
1037855|NCT00732225|2519936|P3|COMPLETED|Overall Study|23 eyes of 23 patients|23
1037856|NCT00732225|2519937|P2|COMPLETED|Overall Study|33 eyes of 32 patients|32
1037857|NCT00732225|2519938|P1|COMPLETED|Overall Study|64 eyes of 60 patients|60
1037858|NCT00732225|2519934|P5|STARTED|Overall Study|55 eyes of 54 patients|54
1037859|NCT00732225|2519935|P4|STARTED|Overall Study|33 eyes of 33 patients|33
1037860|NCT00732225|2519936|P3|STARTED|Overall Study|26 eyes of 26 patients|26
1037861|NCT00732225|2519937|P2|STARTED|Overall Study|41 eyes of 40 patients|40
1037862|NCT00732225|2519938|P1|STARTED|Overall Study|76 eyes of 71 patients|71
1037863|NCT00732238|2519987|P2|NOT COMPLETED|Overall Study||1
1037864|NCT00732238|2519988|P1|NOT COMPLETED|Overall Study||5
1037865|NCT00732238|2519987|P2|COMPLETED|Overall Study||27
1037866|NCT00732238|2519988|P1|COMPLETED|Overall Study||28
1037867|NCT00732238|2519987|P2|STARTED|Overall Study||28
1037868|NCT00732238|2519988|P1|STARTED|Overall Study||33
1037869|NCT00732303|2519996|P1|NOT COMPLETED|Overall Study||2
1037870|NCT00732303|2519996|P1|COMPLETED|Overall Study||6
1037871|NCT00732303|2519996|P1|STARTED|Overall Study||8
1037872|NCT00732381|2520004|P2|NOT COMPLETED|Overall Study||1
1037873|NCT00732381|2520005|P1|NOT COMPLETED|Overall Study||2
1037874|NCT00732381|2520004|P2|COMPLETED|Overall Study||174
1037875|NCT00732381|2520005|P1|COMPLETED|Overall Study||174
1037876|NCT00732381|2520004|P2|STARTED|Overall Study||175
1037877|NCT00732381|2520005|P1|STARTED|Overall Study||176
1037878|NCT00732472|2520017|P4|NOT COMPLETED|Overall Study||3
1037879|NCT00732472|2520018|P3|NOT COMPLETED|Overall Study||1
1037880|NCT00732472|2520019|P2|NOT COMPLETED|Overall Study||3
1037881|NCT00732472|2520020|P1|NOT COMPLETED|Overall Study||0
1037882|NCT00732472|2520017|P4|COMPLETED|Overall Study||6
1037883|NCT00732472|2520018|P3|COMPLETED|Overall Study||9
1037884|NCT00732472|2520019|P2|COMPLETED|Overall Study||7
1037885|NCT00732472|2520020|P1|COMPLETED|Overall Study||9
1037886|NCT00732472|2520017|P4|STARTED|Overall Study||9
1037887|NCT00732472|2520018|P3|STARTED|Overall Study||10
1037888|NCT00732472|2520019|P2|STARTED|Overall Study|One par. (counted as 2 on outputs) was randomized/dosed with UMEC 250 µg on 2 separate occasions.|10
1037889|NCT00732472|2520020|P1|STARTED|Overall Study||9
1037890|NCT00732615|2520120|P2|NOT COMPLETED|Overall Study||5
1037891|NCT00732615|2520121|P1|NOT COMPLETED|Overall Study||7
1037892|NCT00732615|2520120|P2|COMPLETED|Overall Study||79
1037893|NCT00732615|2520121|P1|COMPLETED|Overall Study||33
1037894|NCT00732615|2520120|P2|STARTED|Overall Study||84
1037895|NCT00732615|2520121|P1|STARTED|Overall Study||40
1037896|NCT00732641|2520135|P2|NOT COMPLETED|Overall Study||112
1037897|NCT00732641|2520136|P1|NOT COMPLETED|Overall Study||106
1037898|NCT00732641|2520135|P2|COMPLETED|Overall Study||9
1037899|NCT00732641|2520136|P1|COMPLETED|Overall Study||17
1037900|NCT00732641|2520135|P2|STARTED|Overall Study||121
1037901|NCT00732641|2520136|P1|STARTED|Overall Study||123
1037902|NCT00732654|2520157|P3|NOT COMPLETED|Overall Study||0
1037903|NCT00732654|2520158|P2|NOT COMPLETED|Overall Study||1
1037904|NCT00732654|2520159|P1|NOT COMPLETED|Overall Study||0
1037905|NCT00732654|2520157|P3|COMPLETED|Overall Study||10
1037906|NCT00732654|2520158|P2|COMPLETED|Overall Study||9
1037907|NCT00732654|2520159|P1|COMPLETED|Overall Study||10
1037908|NCT00732654|2520157|P3|STARTED|Overall Study||10
1037909|NCT00732654|2520158|P2|STARTED|Overall Study||10
1037910|NCT00732654|2520159|P1|STARTED|Overall Study||10
1037911|NCT00732680|2520176|P1|NOT COMPLETED|Overall Study||0
1037912|NCT00732680|2520176|P1|COMPLETED|Overall Study||9
1037913|NCT00732680|2520176|P1|STARTED|Overall Study||9
1037914|NCT00732758|2520182|P2|NOT COMPLETED|Overall Study||16
1037915|NCT00732758|2520183|P1|NOT COMPLETED|Overall Study||8
1037916|NCT00732758|2520182|P2|COMPLETED|Overall Study||63
1037917|NCT00732758|2520183|P1|COMPLETED|Overall Study||70
1037918|NCT00732758|2520182|P2|STARTED|Overall Study||79
1037919|NCT00732758|2520183|P1|STARTED|Overall Study||78
1037920|NCT00732875|2520195|P1|NOT COMPLETED|Overall Study||35
1037921|NCT00732875|2520195|P1|COMPLETED|Overall Study|These participants continued treatment until trial was completed by Sponsor.|57
1037922|NCT00732875|2520195|P1|STARTED|Overall Study||92
1037923|NCT00732901|2520203|P2|NOT COMPLETED|Overall Study||0
1037924|NCT00732901|2520204|P1|NOT COMPLETED|Overall Study||0
1037925|NCT00732901|2520203|P2|COMPLETED|Overall Study||12
1037926|NCT00732901|2520204|P1|COMPLETED|Overall Study||11
1037927|NCT00732901|2520203|P2|STARTED|Overall Study||12
1037928|NCT00732901|2520204|P1|STARTED|Overall Study||11
1037929|NCT00732940|2520216|P2|NOT COMPLETED|Overall Study||3
1037930|NCT00732940|2520217|P1|NOT COMPLETED|Overall Study||2
1037931|NCT00732940|2520216|P2|COMPLETED|Overall Study||25
1037932|NCT00732940|2520217|P1|COMPLETED|Overall Study||26
1037933|NCT00732940|2520216|P2|STARTED|Overall Study||28
1037934|NCT00732940|2520217|P1|STARTED|Overall Study||28
1037935|NCT00732992|2520287|P2|NOT COMPLETED|Overall Study||6
1037936|NCT00732992|2520288|P1|NOT COMPLETED|Overall Study||6
1037937|NCT00732992|2520287|P2|COMPLETED|Overall Study||0
1037938|NCT00732992|2520288|P1|COMPLETED|Overall Study||0
1037939|NCT00732992|2520287|P2|STARTED|Overall Study||6
1037940|NCT00732992|2520288|P1|STARTED|Overall Study||6
1037941|NCT00733005|2520307|P2|NOT COMPLETED|Overall Study||3
1037942|NCT00733005|2520308|P1|NOT COMPLETED|Overall Study||2
1037943|NCT00733005|2520307|P2|COMPLETED|Overall Study||159
1037944|NCT00733005|2520308|P1|COMPLETED|Overall Study||160
1037945|NCT00733005|2520307|P2|STARTED|Overall Study||162
1037946|NCT00733005|2520308|P1|STARTED|Overall Study||162
1037947|NCT00733096|2520319|P3|NOT COMPLETED|Overall Study||0
1037948|NCT00733096|2520320|P2|NOT COMPLETED|Overall Study||0
1037949|NCT00733096|2520321|P1|NOT COMPLETED|Overall Study||0
1037950|NCT00733096|2520319|P3|COMPLETED|Overall Study||30
1037951|NCT00733096|2520320|P2|COMPLETED|Overall Study||26
1037952|NCT00733096|2520321|P1|COMPLETED|Overall Study||28
1037953|NCT00733096|2520319|P3|STARTED|Overall Study||30
1037954|NCT00733096|2520320|P2|STARTED|Overall Study||26
1037955|NCT00733096|2520321|P1|STARTED|Overall Study||28
1037956|NCT00733135|2520338|P1|NOT COMPLETED|Overall Study||2
1037957|NCT00733135|2520338|P1|COMPLETED|Overall Study||131
1037958|NCT00733135|2520338|P1|STARTED|Overall Study||133
1037959|NCT00724815|2520349|P2|NOT COMPLETED|Overall Study||39
1037960|NCT00724815|2520350|P1|NOT COMPLETED|Overall Study||43
1037961|NCT00724815|2520349|P2|COMPLETED|Overall Study||226
1037962|NCT00724815|2520350|P1|COMPLETED|Overall Study||222
1037963|NCT00724815|2520349|P2|STARTED|Overall Study|subjects randomized|265
1037964|NCT00724815|2520350|P1|STARTED|Overall Study|subjects randomized|265
1037965|NCT00724854|2520364|P2|NOT COMPLETED|Overall Study||31
1037966|NCT00724854|2520365|P1|NOT COMPLETED|Overall Study||403
1037967|NCT00724854|2520364|P2|COMPLETED|Overall Study||41
1037968|NCT00724854|2520365|P1|COMPLETED|Overall Study||607
1037969|NCT00724854|2520364|P2|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|72
1037970|NCT00724854|2520365|P1|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|1010
1037971|NCT00724867|2520380|P1|NOT COMPLETED|Overall Study||128
1037972|NCT00724867|2520380|P1|COMPLETED|Overall Study||140
1037973|NCT00724867|2520380|P1|STARTED|Overall Study||268
1037974|NCT00724893|2520420|P2|NOT COMPLETED|Overall Study||458
1037975|NCT00724893|2520421|P1|NOT COMPLETED|Overall Study||364
1037976|NCT00724893|2520420|P2|COMPLETED|Overall Study||670
1037977|NCT00724893|2520421|P1|COMPLETED|Overall Study||938
1037978|NCT00724893|2520420|P2|STARTED|Overall Study||1128
1037979|NCT00724893|2520421|P1|STARTED|Overall Study||1302
1037980|NCT00724932|2520491|P2|NOT COMPLETED|Overall Study||3
1037981|NCT00724932|2520492|P1|NOT COMPLETED|Overall Study||5
1037982|NCT00724932|2520491|P2|COMPLETED|Overall Study||67
1037983|NCT00724932|2520492|P1|COMPLETED|Overall Study||65
1037984|NCT00724932|2520491|P2|STARTED|Overall Study||70
1037985|NCT00724932|2520492|P1|STARTED|Overall Study||70
1037986|NCT00724945|2520561|P2|NOT COMPLETED|Period 2||0
1037987|NCT00724945|2520562|P1|NOT COMPLETED|Period 2||4
1037988|NCT00724945|2520561|P2|COMPLETED|Period 2||54
1037989|NCT00724945|2520562|P1|COMPLETED|Period 2||51
1037990|NCT00724945|2520561|P2|STARTED|Period 2||54
1037991|NCT00724945|2520562|P1|STARTED|Period 2||55
1037992|NCT00724945|2520561|P2|NOT COMPLETED|Period 1||1
1037993|NCT00724945|2520562|P1|NOT COMPLETED|Period 1||3
1037994|NCT00724945|2520561|P2|COMPLETED|Period 1||54
1037995|NCT00724945|2520562|P1|COMPLETED|Period 1||55
1037996|NCT00724945|2520561|P2|STARTED|Period 1||55
1037997|NCT00724945|2520562|P1|STARTED|Period 1||58
1037998|NCT00724958|2520572|P1|NOT COMPLETED|Overall Study||182
1037999|NCT00724958|2520572|P1|COMPLETED|Overall Study||166
1038000|NCT00724958|2520572|P1|STARTED|Overall Study||348
1038001|NCT00724984|2520587|P6|NOT COMPLETED|Overall Study||5
1038002|NCT00724984|2520588|P5|NOT COMPLETED|Overall Study||4
1038003|NCT00724984|2520589|P4|NOT COMPLETED|Overall Study||2
1038004|NCT00724984|2520590|P3|NOT COMPLETED|Overall Study||0
1038005|NCT00724984|2520591|P2|NOT COMPLETED|Overall Study||1
1038006|NCT00724984|2520592|P1|NOT COMPLETED|Overall Study||1
1038007|NCT00724984|2520587|P6|COMPLETED|Overall Study||9
1038008|NCT00724984|2520588|P5|COMPLETED|Overall Study||12
1038009|NCT00724984|2520589|P4|COMPLETED|Overall Study||7
1038010|NCT00724984|2520590|P3|COMPLETED|Overall Study||3
1038011|NCT00724984|2520591|P2|COMPLETED|Overall Study||7
1038012|NCT00724984|2520592|P1|COMPLETED|Overall Study||4
1038013|NCT00724984|2520587|P6|STARTED|Overall Study||14
1038014|NCT00724984|2520588|P5|STARTED|Overall Study||16
1038015|NCT00724984|2520589|P4|STARTED|Overall Study||9
1038016|NCT00724984|2520590|P3|STARTED|Overall Study||3
1038017|NCT00724984|2520591|P2|STARTED|Overall Study||8
1038018|NCT00724984|2520592|P1|STARTED|Overall Study||5
1038019|NCT00725010|2520606|P1|NOT COMPLETED|Overall Study||25
1038020|NCT00725010|2520606|P1|COMPLETED|Overall Study||25
1038021|NCT00725010|2520606|P1|STARTED|Overall Study|Only in 50 of 64 participants the documentation of therapy and follow-up was received and evaluated.|50
1038022|NCT00725049|2520616|P2|NOT COMPLETED|Overall Study||0
1038023|NCT00725049|2520617|P1|NOT COMPLETED|Overall Study||0
1038024|NCT00725049|2520616|P2|COMPLETED|Overall Study||20
1038025|NCT00725049|2520617|P1|COMPLETED|Overall Study||17
1038026|NCT00725049|2520616|P2|STARTED|Overall Study||20
1038027|NCT00725049|2520617|P1|STARTED|Overall Study||17
1038028|NCT00725075|2520626|P3|NOT COMPLETED|Overall Study||9
1038029|NCT00725075|2520627|P2|NOT COMPLETED|Overall Study||8
1038030|NCT00725075|2520628|P1|NOT COMPLETED|Overall Study||11
1038031|NCT00725075|2520626|P3|COMPLETED|Overall Study||61
1038032|NCT00725075|2520627|P2|COMPLETED|Overall Study||65
1038033|NCT00725075|2520628|P1|COMPLETED|Overall Study||61
1038034|NCT00725075|2520626|P3|Treated|Overall Study||70
1038035|NCT00725075|2520627|P2|Treated|Overall Study||73
1038036|NCT00725075|2520628|P1|Treated|Overall Study||71
1038037|NCT00725075|2520626|P3|STARTED|Overall Study||70
1038038|NCT00725075|2520627|P2|STARTED|Overall Study||73
1038039|NCT00725075|2520628|P1|STARTED|Overall Study||72
1038040|NCT00725101|2520672|P1|NOT COMPLETED|Overall Study||495
1038041|NCT00725101|2520672|P1|COMPLETED|Overall Study||1205
1038042|NCT00725101|2520672|P1|STARTED|Overall Study||1700
1038043|NCT00725153|2520692|P2|NOT COMPLETED|Period Two, 10 Hours of Wear||0
1038044|NCT00725153|2520693|P1|NOT COMPLETED|Period Two, 10 Hours of Wear||0
1038045|NCT00725153|2520692|P2|COMPLETED|Period Two, 10 Hours of Wear||28
1038046|NCT00725153|2520693|P1|COMPLETED|Period Two, 10 Hours of Wear||27
1038047|NCT00725153|2520692|P2|STARTED|Period Two, 10 Hours of Wear||28
1038048|NCT00725153|2520693|P1|STARTED|Period Two, 10 Hours of Wear||27
1038049|NCT00725153|2520692|P2|NOT COMPLETED|Period One, 10 Hours of Wear||0
1038050|NCT00725153|2520693|P1|NOT COMPLETED|Period One, 10 Hours of Wear||0
1038051|NCT00725153|2520692|P2|COMPLETED|Period One, 10 Hours of Wear||28
1038052|NCT00725153|2520693|P1|COMPLETED|Period One, 10 Hours of Wear||27
1038053|NCT00725153|2520692|P2|STARTED|Period One, 10 Hours of Wear||28
1038054|NCT00725153|2520693|P1|STARTED|Period One, 10 Hours of Wear||27
1038055|NCT00725205|2520699|P1|NOT COMPLETED|Overall Study||87
1038056|NCT00725205|2520699|P1|COMPLETED|Overall Study||207
1038057|NCT00725205|2520699|P1|STARTED|Overall Study||294
1038058|NCT00725270|2520707|P2|NOT COMPLETED|Overall Study||0
1038059|NCT00725270|2520708|P1|NOT COMPLETED|Overall Study||0
1038060|NCT00725270|2520707|P2|COMPLETED|Overall Study||7
1038061|NCT00725270|2520708|P1|COMPLETED|Overall Study||5
1038062|NCT00725270|2520707|P2|STARTED|Overall Study||7
1038063|NCT00725270|2520708|P1|STARTED|Overall Study||5
1038064|NCT00725296|2520716|P1|NOT COMPLETED|Overall Study||62
1038065|NCT00725296|2520716|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive infusions.|101
1038066|NCT00725296|2520716|P1|STARTED|Overall Study|163 of the 178 enrolled participants received at least one dose of Infliximab.|163
1038067|NCT00725361|2520725|P1|NOT COMPLETED|Overall Study||4
1038068|NCT00725361|2520725|P1|COMPLETED|Overall Study||16
1038069|NCT00725361|2520725|P1|STARTED|Overall Study||20
1038070|NCT00725452|2520733|P1|NOT COMPLETED|Overall Study||11
1038071|NCT00725452|2520733|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Infliximab infusions.|15
1038072|NCT00725452|2520733|P1|STARTED|Overall Study||26
1038073|NCT00725491|2520744|P2|NOT COMPLETED|Overall Study||18
1038074|NCT00725491|2520745|P1|NOT COMPLETED|Overall Study||9
1038075|NCT00725491|2520744|P2|COMPLETED|Overall Study||102
1038076|NCT00725491|2520745|P1|COMPLETED|Overall Study||104
1038077|NCT00725491|2520744|P2|STARTED|Overall Study|Intent-to-Treat Group|120
1038078|NCT00725491|2520745|P1|STARTED|Overall Study|Intent-to-Treat Group|113
1038079|NCT00725504|2520751|P1|NOT COMPLETED|Overall Study||0
1038080|NCT00725504|2520751|P1|COMPLETED|Overall Study||71
1038081|NCT00725504|2520751|P1|STARTED|Overall Study||71
1038082|NCT00725530|2520758|P2|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
1038083|NCT00725530|2520759|P1|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
1038084|NCT00725530|2520758|P2|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
1038085|NCT00725530|2520759|P1|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
1038086|NCT00725530|2520758|P2|STARTED|Second Intervention, 7 Days (+0/-1)||27
1038087|NCT00725530|2520759|P1|STARTED|Second Intervention, 7 Days (+0/-1)||27
1038088|NCT00725530|2520758|P2|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
1038089|NCT00725530|2520759|P1|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
1038090|NCT00725530|2520758|P2|COMPLETED|First Intervention, 7 Days (+0/-1)||27
1038091|NCT00725530|2520759|P1|COMPLETED|First Intervention, 7 Days (+0/-1)||27
1038092|NCT00725530|2520758|P2|STARTED|First Intervention, 7 Days (+0/-1)||27
1038093|NCT00725530|2520759|P1|STARTED|First Intervention, 7 Days (+0/-1)||27
1038094|NCT00725543|2520765|P1|NOT COMPLETED|Overall Study||153
1038095|NCT00725543|2520765|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|205
1038096|NCT00725543|2520765|P1|STARTED|Overall Study||358
1038097|NCT00725608|2520774|P1|NOT COMPLETED|Overall Study||167
1038098|NCT00725608|2520774|P1|COMPLETED|Overall Study|1 patient terminated treatment at day 368 and was counted as dropout|140
1038099|NCT00725608|2520774|P1|STARTED|Overall Study|339 patients enrolled, 32 non-eligible datasets excluded from final general and safety analysis|307
1038100|NCT00725621|2520780|P1|NOT COMPLETED|Overall Study||271
1038101|NCT00725621|2520780|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|245
1038102|NCT00725621|2520780|P1|STARTED|Overall Study|Started was defined as the number of participants who received at least one infusion of Remicade.|516
1038103|NCT00725712|2520805|P2|NOT COMPLETED|Overall Study||26
1038104|NCT00725712|2520806|P1|NOT COMPLETED|Overall Study||48
1038105|NCT00725712|2520805|P2|COMPLETED|Overall Study||0
1038106|NCT00725712|2520806|P1|COMPLETED|Overall Study||0
1038107|NCT00725712|2520805|P2|STARTED|Overall Study||26
1038108|NCT00725712|2520806|P1|STARTED|Overall Study||48
1038109|NCT00725725|2520845|P3|NOT COMPLETED|Overall Study||5
1038110|NCT00725725|2520846|P2|NOT COMPLETED|Overall Study||4
1038111|NCT00725725|2520847|P1|NOT COMPLETED|Overall Study||4
1038112|NCT00725725|2520845|P3|COMPLETED|Overall Study||12
1038113|NCT00725725|2520846|P2|COMPLETED|Overall Study||11
1038114|NCT00725725|2520847|P1|COMPLETED|Overall Study||10
1038115|NCT00725725|2520845|P3|Treated|Overall Study||14
1038116|NCT00725725|2520846|P2|Treated|Overall Study||15
1038117|NCT00725725|2520847|P1|Treated|Overall Study||11
1038118|NCT00725725|2520845|P3|STARTED|Overall Study||17
1038119|NCT00725725|2520846|P2|STARTED|Overall Study||15
1038120|NCT00725725|2520847|P1|STARTED|Overall Study||14
1038121|NCT00725751|2520890|P2|NOT COMPLETED|Overall Study||108
1038122|NCT00725751|2520891|P1|NOT COMPLETED|Overall Study||34
1038123|NCT00725751|2520890|P2|COMPLETED|Overall Study||150
1038124|NCT00725751|2520891|P1|COMPLETED|Overall Study||56
1038125|NCT00725751|2520890|P2|STARTED|Overall Study||258
1038126|NCT00725751|2520891|P1|STARTED|Overall Study||90
1038127|NCT00725842|2520900|P1|NOT COMPLETED|Overall Study||40
1038128|NCT00725842|2520900|P1|COMPLETED|Overall Study||57
1038129|NCT00725842|2520900|P1|Participants Eligible for Analysis|Overall Study||90
1038130|NCT00725842|2520900|P1|STARTED|Overall Study||97
1038131|NCT00725920|2520909|P2|NOT COMPLETED|Overall Study||6
1038132|NCT00725920|2520910|P1|NOT COMPLETED|Overall Study||3
1038133|NCT00725920|2520909|P2|COMPLETED|Overall Study||12
1038134|NCT00725920|2520910|P1|COMPLETED|Overall Study||14
1038135|NCT00725920|2520909|P2|STARTED|Overall Study||18
1038136|NCT00725920|2520910|P1|STARTED|Overall Study||17
1038137|NCT00725985|2520919|P12|NOT COMPLETED|LTFU (No Cladribine Treatment)||14
1038138|NCT00725985|2520920|P11|NOT COMPLETED|LTFU (No Cladribine Treatment)||36
1038139|NCT00725985|2520921|P10|NOT COMPLETED|LTFU (No Cladribine Treatment)||34
1038140|NCT00725985|2520922|P9|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
1038141|NCT00725985|2520923|P8|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
1038142|NCT00725985|2520924|P7|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
1038143|NCT00725985|2520925|P6|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
1038144|NCT00725985|2520926|P5|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
1038145|NCT00725985|2520927|P4|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
1038146|NCT00725985|2520928|P3|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
1038147|NCT00725985|2520929|P2|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
1038148|NCT00725985|2520930|P1|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
1038149|NCT00725985|2520919|P12|COMPLETED|LTFU (No Cladribine Treatment)||0
1038150|NCT00725985|2520920|P11|COMPLETED|LTFU (No Cladribine Treatment)||0
1038151|NCT00725985|2520921|P10|COMPLETED|LTFU (No Cladribine Treatment)||0
1038152|NCT00725985|2520922|P9|COMPLETED|LTFU (No Cladribine Treatment)||0
1038153|NCT00725985|2520923|P8|COMPLETED|LTFU (No Cladribine Treatment)||0
1038154|NCT00725985|2520924|P7|COMPLETED|LTFU (No Cladribine Treatment)||0
1038155|NCT00725985|2520925|P6|COMPLETED|LTFU (No Cladribine Treatment)||0
1038156|NCT00725985|2520926|P5|COMPLETED|LTFU (No Cladribine Treatment)||0
1038157|NCT00725985|2520927|P4|COMPLETED|LTFU (No Cladribine Treatment)||0
1038158|NCT00725985|2520928|P3|COMPLETED|LTFU (No Cladribine Treatment)||0
1038159|NCT00725985|2520929|P2|COMPLETED|LTFU (No Cladribine Treatment)||0
1038160|NCT00725985|2520930|P1|COMPLETED|LTFU (No Cladribine Treatment)||0
1038161|NCT00725985|2520919|P12|STARTED|LTFU (No Cladribine Treatment)||14
1038162|NCT00725985|2520920|P11|STARTED|LTFU (No Cladribine Treatment)||36
1038163|NCT00725985|2520921|P10|STARTED|LTFU (No Cladribine Treatment)||34
1038164|NCT00725985|2520922|P9|STARTED|LTFU (No Cladribine Treatment)||0
1038165|NCT00725985|2520923|P8|STARTED|LTFU (No Cladribine Treatment)||0
1038166|NCT00725985|2520924|P7|STARTED|LTFU (No Cladribine Treatment)||0
1038167|NCT00725985|2520925|P6|STARTED|LTFU (No Cladribine Treatment)||0
1038168|NCT00725985|2520926|P5|STARTED|LTFU (No Cladribine Treatment)||0
1038169|NCT00725985|2520927|P4|STARTED|LTFU (No Cladribine Treatment)||0
1038170|NCT00725985|2520928|P3|STARTED|LTFU (No Cladribine Treatment)||0
1038171|NCT00725985|2520929|P2|STARTED|LTFU (No Cladribine Treatment)||0
1038172|NCT00725985|2520930|P1|STARTED|LTFU (No Cladribine Treatment)||0
1038173|NCT00725985|2520919|P12|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
1038174|NCT00725985|2520920|P11|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
1038175|NCT00725985|2520921|P10|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
1038176|NCT00725985|2520922|P9|NOT COMPLETED|LTFU (With Cladribine Treatment)||17
1038177|NCT00725985|2520923|P8|NOT COMPLETED|LTFU (With Cladribine Treatment)||9
1038178|NCT00725985|2520924|P7|NOT COMPLETED|LTFU (With Cladribine Treatment)||9
1038179|NCT00725985|2520925|P6|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
1038180|NCT00725985|2520926|P5|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
1038181|NCT00725985|2520927|P4|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
1038182|NCT00725985|2520928|P3|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
1038183|NCT00725985|2520929|P2|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
1038184|NCT00725985|2520930|P1|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
1038185|NCT00725985|2520919|P12|COMPLETED|LTFU (With Cladribine Treatment)||0
1038186|NCT00725985|2520920|P11|COMPLETED|LTFU (With Cladribine Treatment)||0
1038187|NCT00725985|2520921|P10|COMPLETED|LTFU (With Cladribine Treatment)||0
1038188|NCT00725985|2520922|P9|COMPLETED|LTFU (With Cladribine Treatment)||0
1038189|NCT00725985|2520923|P8|COMPLETED|LTFU (With Cladribine Treatment)||0
1038190|NCT00725985|2520924|P7|COMPLETED|LTFU (With Cladribine Treatment)||0
1038191|NCT00725985|2520925|P6|COMPLETED|LTFU (With Cladribine Treatment)||0
1038192|NCT00725985|2520926|P5|COMPLETED|LTFU (With Cladribine Treatment)||0
1038193|NCT00725985|2520927|P4|COMPLETED|LTFU (With Cladribine Treatment)||0
1038194|NCT00725985|2520928|P3|COMPLETED|LTFU (With Cladribine Treatment)||0
1038195|NCT00725985|2520929|P2|COMPLETED|LTFU (With Cladribine Treatment)||0
1038196|NCT00725985|2520930|P1|COMPLETED|LTFU (With Cladribine Treatment)||0
1038197|NCT00725985|2520919|P12|STARTED|LTFU (With Cladribine Treatment)||0
1038198|NCT00725985|2520920|P11|STARTED|LTFU (With Cladribine Treatment)||0
1038199|NCT00725985|2520921|P10|STARTED|LTFU (With Cladribine Treatment)||0
1038200|NCT00725985|2520922|P9|STARTED|LTFU (With Cladribine Treatment)||17
1038201|NCT00725985|2520923|P8|STARTED|LTFU (With Cladribine Treatment)||9
1038202|NCT00725985|2520924|P7|STARTED|LTFU (With Cladribine Treatment)||9
1038203|NCT00725985|2520925|P6|STARTED|LTFU (With Cladribine Treatment)||0
1038204|NCT00725985|2520926|P5|STARTED|LTFU (With Cladribine Treatment)||0
1038205|NCT00725985|2520927|P4|STARTED|LTFU (With Cladribine Treatment)||0
1038206|NCT00725985|2520928|P3|STARTED|LTFU (With Cladribine Treatment)||0
1038207|NCT00725985|2520929|P2|STARTED|LTFU (With Cladribine Treatment)||0
1038208|NCT00725985|2520930|P1|STARTED|LTFU (With Cladribine Treatment)||0
1038209|NCT00725985|2520919|P12|NOT COMPLETED|OLMP||0
1038210|NCT00725985|2520920|P11|NOT COMPLETED|OLMP||0
1038211|NCT00725985|2520921|P10|NOT COMPLETED|OLMP||0
1038212|NCT00725985|2520922|P9|NOT COMPLETED|OLMP||0
1038213|NCT00725985|2520923|P8|NOT COMPLETED|OLMP||0
1038214|NCT00725985|2520924|P7|NOT COMPLETED|OLMP||0
1038215|NCT00725985|2520925|P6|NOT COMPLETED|OLMP||53
1038216|NCT00725985|2520926|P5|NOT COMPLETED|OLMP||23
1038217|NCT00725985|2520927|P4|NOT COMPLETED|OLMP||18
1038218|NCT00725985|2520928|P3|NOT COMPLETED|OLMP||0
1038219|NCT00725985|2520929|P2|NOT COMPLETED|OLMP||0
1038220|NCT00725985|2520930|P1|NOT COMPLETED|OLMP||0
1038221|NCT00725985|2520919|P12|COMPLETED|OLMP||0
1038222|NCT00725985|2520920|P11|COMPLETED|OLMP||0
1038223|NCT00725985|2520921|P10|COMPLETED|OLMP||0
1038224|NCT00725985|2520922|P9|COMPLETED|OLMP||0
1038225|NCT00725985|2520923|P8|COMPLETED|OLMP||0
1038226|NCT00725985|2520924|P7|COMPLETED|OLMP||0
1038227|NCT00725985|2520925|P6|COMPLETED|OLMP||7
1038228|NCT00725985|2520926|P5|COMPLETED|OLMP||2
1038229|NCT00725985|2520927|P4|COMPLETED|OLMP||6
1038230|NCT00725985|2520928|P3|COMPLETED|OLMP||0
1038231|NCT00725985|2520929|P2|COMPLETED|OLMP||0
1038232|NCT00725985|2520930|P1|COMPLETED|OLMP||0
1038233|NCT00725985|2520919|P12|STARTED|OLMP||0
1038234|NCT00725985|2520920|P11|STARTED|OLMP||0
1038235|NCT00725985|2520921|P10|STARTED|OLMP||0
1038236|NCT00725985|2520922|P9|STARTED|OLMP||0
1038237|NCT00725985|2520923|P8|STARTED|OLMP||0
1038238|NCT00725985|2520924|P7|STARTED|OLMP||0
1038239|NCT00725985|2520925|P6|STARTED|OLMP||60
1038240|NCT00725985|2520926|P5|STARTED|OLMP||25
1038241|NCT00725985|2520927|P4|STARTED|OLMP||24
1038242|NCT00725985|2520928|P3|STARTED|OLMP||0
1038243|NCT00725985|2520929|P2|STARTED|OLMP||0
1038244|NCT00725985|2520930|P1|STARTED|OLMP||0
1038245|NCT00725985|2520919|P12|NOT COMPLETED|ITP (Up to 96 Weeks)||0
1038246|NCT00725985|2520920|P11|NOT COMPLETED|ITP (Up to 96 Weeks)||0
1038247|NCT00725985|2520921|P10|NOT COMPLETED|ITP (Up to 96 Weeks)||0
1038248|NCT00725985|2520922|P9|NOT COMPLETED|ITP (Up to 96 Weeks)||0
1038249|NCT00725985|2520923|P8|NOT COMPLETED|ITP (Up to 96 Weeks)||0
1038250|NCT00725985|2520924|P7|NOT COMPLETED|ITP (Up to 96 Weeks)||0
1038251|NCT00725985|2520925|P6|NOT COMPLETED|ITP (Up to 96 Weeks)||0
1038252|NCT00725985|2520926|P5|NOT COMPLETED|ITP (Up to 96 Weeks)||0
1038253|NCT00725985|2520927|P4|NOT COMPLETED|ITP (Up to 96 Weeks)||0
1038254|NCT00725985|2520928|P3|NOT COMPLETED|ITP (Up to 96 Weeks)||102
1038255|NCT00725985|2520929|P2|NOT COMPLETED|ITP (Up to 96 Weeks)||75
1038256|NCT00725985|2520930|P1|NOT COMPLETED|ITP (Up to 96 Weeks)||101
1038257|NCT00725985|2520919|P12|COMPLETED|ITP (Up to 96 Weeks)||0
1038258|NCT00725985|2520920|P11|COMPLETED|ITP (Up to 96 Weeks)||0
1038259|NCT00725985|2520921|P10|COMPLETED|ITP (Up to 96 Weeks)||0
1038260|NCT00725985|2520922|P9|COMPLETED|ITP (Up to 96 Weeks)||0
1038261|NCT00725985|2520923|P8|COMPLETED|ITP (Up to 96 Weeks)||0
1038262|NCT00725985|2520924|P7|COMPLETED|ITP (Up to 96 Weeks)||0
1038263|NCT00725985|2520925|P6|COMPLETED|ITP (Up to 96 Weeks)||0
1038264|NCT00725985|2520926|P5|COMPLETED|ITP (Up to 96 Weeks)||0
1038265|NCT00725985|2520927|P4|COMPLETED|ITP (Up to 96 Weeks)||0
1038266|NCT00725985|2520928|P3|COMPLETED|ITP (Up to 96 Weeks)||104
1038267|NCT00725985|2520929|P2|COMPLETED|ITP (Up to 96 Weeks)||131
1038268|NCT00725985|2520930|P1|COMPLETED|ITP (Up to 96 Weeks)||104
1038269|NCT00725985|2520919|P12|Treated|ITP (Up to 96 Weeks)||0
1038270|NCT00725985|2520920|P11|Treated|ITP (Up to 96 Weeks)||0
1038271|NCT00725985|2520921|P10|Treated|ITP (Up to 96 Weeks)||0
1038272|NCT00725985|2520922|P9|Treated|ITP (Up to 96 Weeks)||0
1038273|NCT00725985|2520923|P8|Treated|ITP (Up to 96 Weeks)||0
1038274|NCT00725985|2520924|P7|Treated|ITP (Up to 96 Weeks)||0
1038275|NCT00725985|2520925|P6|Treated|ITP (Up to 96 Weeks)||0
1038276|NCT00725985|2520926|P5|Treated|ITP (Up to 96 Weeks)||0
1038277|NCT00725985|2520927|P4|Treated|ITP (Up to 96 Weeks)||0
1038278|NCT00725985|2520928|P3|Treated|ITP (Up to 96 Weeks)||206
1038279|NCT00725985|2520929|P2|Treated|ITP (Up to 96 Weeks)||206
1038280|NCT00725985|2520930|P1|Treated|ITP (Up to 96 Weeks)||204
1038281|NCT00725985|2520919|P12|STARTED|ITP (Up to 96 Weeks)||0
1038282|NCT00725985|2520920|P11|STARTED|ITP (Up to 96 Weeks)||0
1038283|NCT00725985|2520921|P10|STARTED|ITP (Up to 96 Weeks)||0
1038284|NCT00725985|2520922|P9|STARTED|ITP (Up to 96 Weeks)||0
1038285|NCT00725985|2520923|P8|STARTED|ITP (Up to 96 Weeks)||0
1038286|NCT00725985|2520924|P7|STARTED|ITP (Up to 96 Weeks)||0
1038287|NCT00725985|2520925|P6|STARTED|ITP (Up to 96 Weeks)||0
1038288|NCT00725985|2520926|P5|STARTED|ITP (Up to 96 Weeks)||0
1038289|NCT00725985|2520927|P4|STARTED|ITP (Up to 96 Weeks)||0
1038290|NCT00725985|2520928|P3|STARTED|ITP (Up to 96 Weeks)||206
1038291|NCT00725985|2520929|P2|STARTED|ITP (Up to 96 Weeks)||206
1038292|NCT00725985|2520930|P1|STARTED|ITP (Up to 96 Weeks)||205
1038293|NCT00726037|2520956|P1|NOT COMPLETED|Overall Study||0
1038294|NCT00726037|2520956|P1|COMPLETED|Overall Study||7
1038295|NCT00726037|2520956|P1|STARTED|Overall Study||7
1038296|NCT00726063|2520963|P2|NOT COMPLETED|Overall Study||7
1038297|NCT00726063|2520964|P1|NOT COMPLETED|Overall Study||9
1038298|NCT00726063|2520963|P2|COMPLETED|Overall Study|Number of implants = 239|112
1038299|NCT00726063|2520964|P1|COMPLETED|Overall Study|Number of implants =230|113
1038300|NCT00726063|2520963|P2|STARTED|Overall Study|Number of implants= 246|119
1038301|NCT00726063|2520964|P1|STARTED|Overall Study|Number of implants= 239|122
1038302|NCT00726180|2520970|P1|NOT COMPLETED|Overall Study||0
1038303|NCT00726180|2520970|P1|COMPLETED|Overall Study||1
1038304|NCT00726180|2520970|P1|STARTED|Overall Study||1
1038305|NCT00726232|2520980|P6|NOT COMPLETED|Overall Study||4
1038306|NCT00726232|2520981|P5|NOT COMPLETED|Overall Study||5
1038307|NCT00726232|2520982|P4|NOT COMPLETED|Overall Study||1
1038308|NCT00726232|2520983|P3|NOT COMPLETED|Overall Study||0
1038309|NCT00726232|2520984|P2|NOT COMPLETED|Overall Study||1
1038310|NCT00726232|2520985|P1|NOT COMPLETED|Overall Study||5
1038311|NCT00726232|2520980|P6|COMPLETED|Overall Study||5
1038312|NCT00726232|2520981|P5|COMPLETED|Overall Study||17
1038313|NCT00726232|2520982|P4|COMPLETED|Overall Study||7
1038314|NCT00726232|2520983|P3|COMPLETED|Overall Study||7
1038315|NCT00726232|2520984|P2|COMPLETED|Overall Study||7
1038316|NCT00726232|2520985|P1|COMPLETED|Overall Study|Represents patients ongoing in the study as of the data cut-off date of 18 June 2010.|14
1038317|NCT00726232|2520980|P6|STARTED|Overall Study||9
1038318|NCT00726232|2520981|P5|STARTED|Overall Study|The starting dose selected for the ET expansion cohort was 25 mg bid hence the sample size is larger|22
1038319|NCT00726232|2520982|P4|STARTED|Overall Study||8
1038320|NCT00726232|2520983|P3|STARTED|Overall Study||7
1038321|NCT00726232|2520984|P2|STARTED|Overall Study||8
1038322|NCT00726232|2520985|P1|STARTED|Overall Study|The starting dose selected for the PV expansion cohort was 10 mg bid hence the sample size is larger|19
1038323|NCT00726375|2521029|P1|NOT COMPLETED|Overall Study||0
1038324|NCT00726375|2521029|P1|COMPLETED|Overall Study||34
1038325|NCT00726375|2521029|P1|STARTED|Overall Study||34
1038326|NCT00726414|2521034|P2|NOT COMPLETED|Second Intervention||0
1038327|NCT00726414|2521035|P1|NOT COMPLETED|Second Intervention||0
1038328|NCT00726414|2521034|P2|COMPLETED|Second Intervention||11
1038329|NCT00726414|2521035|P1|COMPLETED|Second Intervention||11
1038330|NCT00726414|2521034|P2|STARTED|Second Intervention||11
1038331|NCT00726414|2521035|P1|STARTED|Second Intervention||11
1038332|NCT00726414|2521034|P2|NOT COMPLETED|Washout Period of 7 Days||0
1038333|NCT00726414|2521035|P1|NOT COMPLETED|Washout Period of 7 Days||0
1038334|NCT00726414|2521034|P2|COMPLETED|Washout Period of 7 Days||11
1038335|NCT00726414|2521035|P1|COMPLETED|Washout Period of 7 Days||11
1038336|NCT00726414|2521034|P2|STARTED|Washout Period of 7 Days||11
1038337|NCT00726414|2521035|P1|STARTED|Washout Period of 7 Days||11
1038338|NCT00726414|2521034|P2|NOT COMPLETED|First Intervention||0
1038339|NCT00726414|2521035|P1|NOT COMPLETED|First Intervention||0
1038340|NCT00726414|2521034|P2|COMPLETED|First Intervention||11
1038341|NCT00726414|2521035|P1|COMPLETED|First Intervention||11
1038342|NCT00726414|2521034|P2|STARTED|First Intervention||11
1038343|NCT00726414|2521035|P1|STARTED|First Intervention||11
1038344|NCT00726453|2521047|P2|NOT COMPLETED|38 mm Length Group||3
1038345|NCT00726453|2521048|P1|NOT COMPLETED|38 mm Length Group||0
1038346|NCT00726453|2521047|P2|COMPLETED|38 mm Length Group|This sub-study completed the primary endpoint in March 2012 results not yet available.|111
1038347|NCT00726453|2521048|P1|COMPLETED|38 mm Length Group||0
1038348|NCT00726453|2521047|P2|STARTED|38 mm Length Group||114
1038349|NCT00726453|2521048|P1|STARTED|38 mm Length Group||0
1038350|NCT00726453|2521047|P2|NOT COMPLETED|Primary Enrollment Group||0
1038351|NCT00726453|2521048|P1|NOT COMPLETED|Primary Enrollment Group||31
1038352|NCT00726453|2521047|P2|COMPLETED|Primary Enrollment Group||0
1038353|NCT00726453|2521048|P1|COMPLETED|Primary Enrollment Group||1371
1038354|NCT00726453|2521047|P2|STARTED|Primary Enrollment Group||0
1038355|NCT00726453|2521048|P1|STARTED|Primary Enrollment Group||1402
1038356|NCT00726557|2521058|P1|NOT COMPLETED|Overall Study||128
1038357|NCT00726557|2521058|P1|COMPLETED|Overall Study|Completed is defined as those who finished the follow-up period.|118
1038358|NCT00726557|2521058|P1|STARTED|Overall Study||246
1038359|NCT00726609|2521063|P1|NOT COMPLETED|Overall Study||98
1038360|NCT00726609|2521063|P1|COMPLETED|Overall Study|For 26 participants in the Missing category, it is unknown if they completed the study.|116
1038361|NCT00726609|2521063|P1|STARTED|Overall Study||214
1038362|NCT00726622|2521069|P2|NOT COMPLETED|Overall Study||3
1038363|NCT00726622|2521070|P1|NOT COMPLETED|Overall Study||18
1038364|NCT00726622|2521069|P2|COMPLETED|Overall Study||240
1038365|NCT00726622|2521070|P1|COMPLETED|Overall Study||225
1038366|NCT00726622|2521069|P2|STARTED|Overall Study||243
1038367|NCT00726622|2521070|P1|STARTED|Overall Study||243
1038368|NCT00726661|2521090|P2|NOT COMPLETED|Overall Study||418
1038369|NCT00726661|2521091|P1|NOT COMPLETED|Overall Study||814
1038370|NCT00726661|2521090|P2|COMPLETED|Overall Study||17
1038371|NCT00726661|2521091|P1|COMPLETED|Overall Study||18
1038372|NCT00726661|2521090|P2|STARTED|Overall Study||435
1038373|NCT00726661|2521091|P1|STARTED|Overall Study||832
1038374|NCT00726713|2521108|P2|NOT COMPLETED|Overall Study||7
1038375|NCT00726713|2521109|P1|NOT COMPLETED|Overall Study||7
1038376|NCT00726713|2521108|P2|COMPLETED|Overall Study||101
1038377|NCT00726713|2521109|P1|COMPLETED|Overall Study||99
1038378|NCT00726713|2521108|P2|STARTED|Overall Study||108
1038379|NCT00726713|2521109|P1|STARTED|Overall Study||106
1038380|NCT00726739|2521137|P2|NOT COMPLETED|Overall Study||0
1038381|NCT00726739|2521138|P1|NOT COMPLETED|Overall Study||1
1038382|NCT00726739|2521137|P2|COMPLETED|Overall Study||10
1038383|NCT00726739|2521138|P1|COMPLETED|Overall Study|1 patient failed during screening due to brain metastasis.|10
1038384|NCT00726739|2521137|P2|STARTED|Overall Study||10
1038385|NCT00726739|2521138|P1|STARTED|Overall Study||11
1038386|NCT00726752|2521152|P1|NOT COMPLETED|Overall Study||6
1038387|NCT00726752|2521152|P1|COMPLETED|Overall Study||0
1038388|NCT00726752|2521152|P1|STARTED|Overall Study||6
1038389|NCT00726830|2521168|P2|NOT COMPLETED|Overall Study||0
1038390|NCT00726830|2521169|P1|NOT COMPLETED|Overall Study||0
1038391|NCT00726830|2521168|P2|COMPLETED|Overall Study||0
1038392|NCT00726830|2521169|P1|COMPLETED|Overall Study||1
1038393|NCT00726830|2521168|P2|STARTED|Overall Study||0
1038394|NCT00726830|2521169|P1|STARTED|Overall Study||1
1038395|NCT00726882|2521175|P1|NOT COMPLETED|Overall Study||22
1038396|NCT00726882|2521175|P1|COMPLETED|Overall Study||13
1038397|NCT00726882|2521175|P1|Received ABT-333 in Study M10-351|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00696904/M10-351).|6
1038398|NCT00726882|2521175|P1|Received ABT-333 in Study M10-380|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00851890/M10-380).|22
1038399|NCT00726882|2521175|P1|STARTED|Overall Study||35
1038400|NCT00726895|2521181|P2|NOT COMPLETED|Second Intervention||0
1038401|NCT00726895|2521182|P1|NOT COMPLETED|Second Intervention||0
1038402|NCT00726895|2521181|P2|COMPLETED|Second Intervention||11
1038403|NCT00726895|2521182|P1|COMPLETED|Second Intervention||12
1038404|NCT00726895|2521181|P2|STARTED|Second Intervention||11
1038405|NCT00726895|2521182|P1|STARTED|Second Intervention||12
1038406|NCT00726895|2521181|P2|NOT COMPLETED|Washout Period of 7 Days||1
1038407|NCT00726895|2521182|P1|NOT COMPLETED|Washout Period of 7 Days||0
1038408|NCT00726895|2521181|P2|COMPLETED|Washout Period of 7 Days||11
1038409|NCT00726895|2521182|P1|COMPLETED|Washout Period of 7 Days||12
1038410|NCT00726895|2521181|P2|STARTED|Washout Period of 7 Days||12
1038411|NCT00726895|2521182|P1|STARTED|Washout Period of 7 Days||12
1038412|NCT00726895|2521181|P2|NOT COMPLETED|First Intervention||0
1038413|NCT00726895|2521182|P1|NOT COMPLETED|First Intervention||0
1038414|NCT00726895|2521181|P2|COMPLETED|First Intervention||12
1038415|NCT00726895|2521182|P1|COMPLETED|First Intervention||12
1038416|NCT00726895|2521181|P2|STARTED|First Intervention||12
1038417|NCT00726895|2521182|P1|STARTED|First Intervention||12
1038418|NCT00726986|2521195|P1|NOT COMPLETED|Maintenance Phase||3
1038419|NCT00726986|2521195|P1|COMPLETED|Maintenance Phase||0
1038420|NCT00726986|2521195|P1|STARTED|Maintenance Phase||3
1038421|NCT00726986|2521195|P1|NOT COMPLETED|Induction Phase||15
1038422|NCT00726986|2521195|P1|COMPLETED|Induction Phase||3
1038423|NCT00726986|2521195|P1|Maintance|Induction Phase||3
1038424|NCT00726986|2521195|P1|STARTED|Induction Phase||18
1038425|NCT00726999|2521204|P2|NOT COMPLETED|Overall Study||1
1038426|NCT00726999|2521205|P1|NOT COMPLETED|Overall Study||3
1038427|NCT00726999|2521204|P2|COMPLETED|Overall Study||30
1038428|NCT00726999|2521205|P1|COMPLETED|Overall Study||29
1038429|NCT00726999|2521204|P2|STARTED|Overall Study||31
1038430|NCT00726999|2521205|P1|STARTED|Overall Study||32
1038431|NCT00727025|2521215|P1|NOT COMPLETED|Overall Study||23
1038432|NCT00727025|2521215|P1|COMPLETED|Overall Study||51
1038433|NCT00727025|2521215|P1|STARTED|Overall Study||74
1038434|NCT00727064|2521227|P2|NOT COMPLETED|Overall Study||0
1038435|NCT00727064|2521228|P1|NOT COMPLETED|Overall Study||0
1038436|NCT00727064|2521227|P2|COMPLETED|Overall Study||7
1038437|NCT00727064|2521228|P1|COMPLETED|Overall Study||7
1038438|NCT00727064|2521227|P2|STARTED|Overall Study||7
1038439|NCT00727064|2521228|P1|STARTED|Overall Study||7
1038440|NCT00727090|2521246|P2|NOT COMPLETED|Overall Study||0
1038441|NCT00727090|2521247|P1|NOT COMPLETED|Overall Study||0
1038442|NCT00727090|2521246|P2|COMPLETED|Overall Study||3
1038443|NCT00727090|2521247|P1|COMPLETED|Overall Study||3
1038444|NCT00727090|2521246|P2|STARTED|Overall Study||3
1038445|NCT00727090|2521247|P1|STARTED|Overall Study||3
1038446|NCT00727194|2521263|P3|NOT COMPLETED|Treatment Period 2||0
1038447|NCT00727194|2521264|P2|NOT COMPLETED|Treatment Period 2||1
1038448|NCT00727194|2521265|P1|NOT COMPLETED|Treatment Period 2||0
1038449|NCT00727194|2521263|P3|COMPLETED|Treatment Period 2||0
1038450|NCT00727194|2521264|P2|COMPLETED|Treatment Period 2||5
1038451|NCT00727194|2521265|P1|COMPLETED|Treatment Period 2||6
1038452|NCT00727194|2521263|P3|STARTED|Treatment Period 2||0
1038453|NCT00727194|2521264|P2|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
1038454|NCT00727194|2521265|P1|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
1038455|NCT00727194|2521263|P3|NOT COMPLETED|Washout Period||0
1038456|NCT00727194|2521264|P2|NOT COMPLETED|Washout Period||0
1038457|NCT00727194|2521265|P1|NOT COMPLETED|Washout Period||0
1038458|NCT00727194|2521263|P3|COMPLETED|Washout Period||0
1038459|NCT00727194|2521264|P2|COMPLETED|Washout Period||7
1038460|NCT00727194|2521265|P1|COMPLETED|Washout Period||7
1038461|NCT00727194|2521263|P3|STARTED|Washout Period||0
1038462|NCT00727194|2521264|P2|STARTED|Washout Period||7
1038463|NCT00727194|2521265|P1|STARTED|Washout Period||7
1038464|NCT00727194|2521263|P3|NOT COMPLETED|Treatment Period 1||0
1038465|NCT00727194|2521264|P2|NOT COMPLETED|Treatment Period 1||0
1038466|NCT00727194|2521265|P1|NOT COMPLETED|Treatment Period 1||0
1038467|NCT00727194|2521263|P3|COMPLETED|Treatment Period 1||0
1038468|NCT00727194|2521264|P2|COMPLETED|Treatment Period 1||7
1038469|NCT00727194|2521265|P1|COMPLETED|Treatment Period 1||7
1038470|NCT00727194|2521263|P3|STARTED|Treatment Period 1||0
1038471|NCT00727194|2521264|P2|STARTED|Treatment Period 1||7
1038472|NCT00727194|2521265|P1|STARTED|Treatment Period 1||7
1038473|NCT00727194|2521263|P3|NOT COMPLETED|Screening Period||16
1038474|NCT00727194|2521264|P2|NOT COMPLETED|Screening Period||0
1038475|NCT00727194|2521265|P1|NOT COMPLETED|Screening Period||0
1038476|NCT00727194|2521263|P3|COMPLETED|Screening Period||0
1038477|NCT00727194|2521264|P2|COMPLETED|Screening Period||7
1038478|NCT00727194|2521265|P1|COMPLETED|Screening Period||7
1038479|NCT00727194|2521263|P3|STARTED|Screening Period||16
1038480|NCT00727194|2521264|P2|STARTED|Screening Period||7
1038481|NCT00727194|2521265|P1|STARTED|Screening Period||7
1038482|NCT00727220|2521301|P2|NOT COMPLETED|Overall Study||4
1038483|NCT00727220|2521302|P1|NOT COMPLETED|Overall Study||1
1038484|NCT00727220|2521301|P2|COMPLETED|Overall Study||17
1038485|NCT00727220|2521302|P1|COMPLETED|Overall Study||20
1038486|NCT00727220|2521301|P2|STARTED|Overall Study||21
1038487|NCT00727220|2521302|P1|STARTED|Overall Study||21
1038488|NCT00727246|2521312|P4|NOT COMPLETED|Overall Study||2
1038489|NCT00727246|2521313|P3|NOT COMPLETED|Overall Study||1
1038490|NCT00727246|2521314|P2|NOT COMPLETED|Overall Study||1
1038491|NCT00727246|2521315|P1|NOT COMPLETED|Overall Study||0
1038492|NCT00727246|2521312|P4|COMPLETED|Overall Study||3
1038493|NCT00727246|2521313|P3|COMPLETED|Overall Study||7
1038494|NCT00727246|2521314|P2|COMPLETED|Overall Study||2
1038495|NCT00727246|2521315|P1|COMPLETED|Overall Study||3
1038496|NCT00727246|2521312|P4|STARTED|Overall Study||5
1038497|NCT00727246|2521313|P3|STARTED|Overall Study||8
1038498|NCT00727246|2521314|P2|STARTED|Overall Study||3
1038499|NCT00727246|2521315|P1|STARTED|Overall Study||3
1038500|NCT00727259|2521329|P1|NOT COMPLETED|Overall Study||1055
1038501|NCT00727259|2521329|P1|COMPLETED|Overall Study||940
1038502|NCT00727259|2521329|P1|STARTED|Overall Study||1995
1038503|NCT00733226|2521336|P2|NOT COMPLETED|Overall Study||0
1038504|NCT00733226|2521337|P1|NOT COMPLETED|Overall Study||5
1038505|NCT00733226|2521336|P2|COMPLETED|Overall Study||40
1038506|NCT00733226|2521337|P1|COMPLETED|Overall Study||35
1038507|NCT00733226|2521336|P2|STARTED|Overall Study||40
1038508|NCT00733226|2521337|P1|STARTED|Overall Study||40
1038509|NCT00733278|2521353|P1|NOT COMPLETED|Overall Study||0
1038510|NCT00733278|2521353|P1|COMPLETED|Overall Study||7
1038511|NCT00733278|2521353|P1|STARTED|Overall Study||7
1038512|NCT00733291|2521360|P4|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
1038513|NCT00733291|2521361|P3|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
1038514|NCT00733291|2521362|P2|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
1038515|NCT00733291|2521363|P1|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
1038516|NCT00733291|2521360|P4|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
1038517|NCT00733291|2521361|P3|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
1038518|NCT00733291|2521362|P2|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
1038519|NCT00733291|2521363|P1|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||12
1038520|NCT00733291|2521360|P4|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
1038521|NCT00733291|2521361|P3|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
1038522|NCT00733291|2521362|P2|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
1038523|NCT00733291|2521363|P1|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||12
1038524|NCT00733291|2521360|P4|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
1038525|NCT00733291|2521361|P3|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
1038526|NCT00733291|2521362|P2|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
1038527|NCT00733291|2521363|P1|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||1
1038528|NCT00733291|2521360|P4|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
1038529|NCT00733291|2521361|P3|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
1038530|NCT00733291|2521362|P2|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
1038531|NCT00733291|2521363|P1|COMPLETED|Washout Period, 3 Days (+/-1 Day)||12
1038532|NCT00733291|2521360|P4|STARTED|Washout Period, 3 Days (+/-1 Day)||17
1038533|NCT00733291|2521361|P3|STARTED|Washout Period, 3 Days (+/-1 Day)||17
1038534|NCT00733291|2521362|P2|STARTED|Washout Period, 3 Days (+/-1 Day)||17
1038535|NCT00733291|2521363|P1|STARTED|Washout Period, 3 Days (+/-1 Day)||13
1038536|NCT00733291|2521360|P4|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
1038537|NCT00733291|2521361|P3|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
1038538|NCT00733291|2521362|P2|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
1038539|NCT00733291|2521363|P1|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
1038540|NCT00733291|2521360|P4|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
1038541|NCT00733291|2521361|P3|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
1038542|NCT00733291|2521362|P2|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
1038543|NCT00733291|2521363|P1|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||13
1038544|NCT00733291|2521360|P4|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
1038545|NCT00733291|2521361|P3|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
1038546|NCT00733291|2521362|P2|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
1038547|NCT00733291|2521363|P1|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||13
1038548|NCT00733330|2521387|P2|NOT COMPLETED|Overall Study||4
1038549|NCT00733330|2521388|P1|NOT COMPLETED|Overall Study||2
1038550|NCT00733330|2521387|P2|COMPLETED|Overall Study||48
1038551|NCT00733330|2521388|P1|COMPLETED|Overall Study||30
1038552|NCT00733330|2521387|P2|STARTED|Overall Study||52
1038553|NCT00733330|2521388|P1|STARTED|Overall Study||32
1038554|NCT00733369|2521472|P2|NOT COMPLETED|Overall Study||9
1038555|NCT00733369|2521473|P1|NOT COMPLETED|Overall Study||10
1038556|NCT00733369|2521472|P2|COMPLETED|Overall Study||47
1038557|NCT00733369|2521473|P1|COMPLETED|Overall Study||40
1038558|NCT00733369|2521472|P2|STARTED|Overall Study||56
1038559|NCT00733369|2521473|P1|STARTED|Overall Study||50
1038560|NCT00733421|2521591|P2|NOT COMPLETED|Overall Study||1
1038561|NCT00733421|2521592|P1|NOT COMPLETED|Overall Study||1
1038562|NCT00733421|2521591|P2|COMPLETED|Overall Study|All but one randomised patient|49
1038563|NCT00733421|2521592|P1|COMPLETED|Overall Study|All but one randomsied patient|49
1038564|NCT00733421|2521591|P2|STARTED|Overall Study|November 2008|50
1038565|NCT00733421|2521592|P1|STARTED|Overall Study|November 2008|50
1038566|NCT00733499|2521616|P2|NOT COMPLETED|24 Months Follow-up||1
1038567|NCT00733499|2521617|P1|NOT COMPLETED|24 Months Follow-up||0
1038568|NCT00733499|2521616|P2|COMPLETED|24 Months Follow-up||95
1038569|NCT00733499|2521617|P1|COMPLETED|24 Months Follow-up||99
1038570|NCT00733499|2521616|P2|STARTED|24 Months Follow-up||96
1038571|NCT00733499|2521617|P1|STARTED|24 Months Follow-up||99
1038572|NCT00733499|2521616|P2|NOT COMPLETED|12 Months Follow-up||1
1038573|NCT00733499|2521617|P1|NOT COMPLETED|12 Months Follow-up||2
1038574|NCT00733499|2521616|P2|COMPLETED|12 Months Follow-up||96
1038575|NCT00733499|2521617|P1|COMPLETED|12 Months Follow-up||99
1038576|NCT00733499|2521616|P2|STARTED|12 Months Follow-up||97
1038577|NCT00733499|2521617|P1|STARTED|12 Months Follow-up||101
1038578|NCT00733499|2521616|P2|NOT COMPLETED|6 Months Follow-up||3
1038579|NCT00733499|2521617|P1|NOT COMPLETED|6 Months Follow-up||0
1038580|NCT00733499|2521616|P2|COMPLETED|6 Months Follow-up||97
1038581|NCT00733499|2521617|P1|COMPLETED|6 Months Follow-up||101
1038582|NCT00733499|2521616|P2|STARTED|6 Months Follow-up||100
1038583|NCT00733499|2521617|P1|STARTED|6 Months Follow-up||101
1038584|NCT00733499|2521616|P2|NOT COMPLETED|3 Months Follow-up||2
1038585|NCT00733499|2521617|P1|NOT COMPLETED|3 Months Follow-up||1
1038586|NCT00733499|2521616|P2|COMPLETED|3 Months Follow-up||100
1038587|NCT00733499|2521617|P1|COMPLETED|3 Months Follow-up||101
1038588|NCT00733499|2521616|P2|STARTED|3 Months Follow-up||102
1038589|NCT00733499|2521617|P1|STARTED|3 Months Follow-up||102
1038590|NCT00733499|2521616|P2|NOT COMPLETED|Pre-operative||1
1038591|NCT00733499|2521617|P1|NOT COMPLETED|Pre-operative||0
1038592|NCT00733499|2521616|P2|COMPLETED|Pre-operative||102
1038593|NCT00733499|2521617|P1|COMPLETED|Pre-operative||102
1038594|NCT00733499|2521616|P2|STARTED|Pre-operative||103
1038595|NCT00733499|2521617|P1|STARTED|Pre-operative||102
1038596|NCT00733512|2521623|P1|NOT COMPLETED|Overall Study||0
1038597|NCT00733512|2521623|P1|COMPLETED|Overall Study||146
1038598|NCT00733512|2521623|P1|STARTED|Overall Study||146
1038599|NCT00733746|2521628|P1|NOT COMPLETED|Overall Study||5
1038600|NCT00733746|2521628|P1|COMPLETED|Overall Study||114
1038601|NCT00733746|2521628|P1|STARTED|Overall Study||119
1038602|NCT00733824|2521641|P5|NOT COMPLETED|Phase II||0
1038603|NCT00733824|2521642|P4|NOT COMPLETED|Phase II||0
1038604|NCT00733824|2521643|P3|NOT COMPLETED|Phase II||0
1038605|NCT00733824|2521644|P2|NOT COMPLETED|Phase II||0
1038606|NCT00733824|2521645|P1|NOT COMPLETED|Phase II||0
1038607|NCT00733824|2521641|P5|COMPLETED|Phase II||36
1038608|NCT00733824|2521642|P4|COMPLETED|Phase II||0
1038609|NCT00733824|2521643|P3|COMPLETED|Phase II||0
1038610|NCT00733824|2521644|P2|COMPLETED|Phase II||0
1038611|NCT00733824|2521645|P1|COMPLETED|Phase II||0
1038612|NCT00733824|2521641|P5|STARTED|Phase II||36
1038613|NCT00733824|2521642|P4|STARTED|Phase II||0
1038614|NCT00733824|2521643|P3|STARTED|Phase II||0
1038615|NCT00733824|2521644|P2|STARTED|Phase II||0
1038616|NCT00733824|2521645|P1|STARTED|Phase II||0
1038617|NCT00733824|2521641|P5|NOT COMPLETED|Phase I||0
1038618|NCT00733824|2521642|P4|NOT COMPLETED|Phase I||0
1038619|NCT00733824|2521643|P3|NOT COMPLETED|Phase I||0
1038620|NCT00733824|2521644|P2|NOT COMPLETED|Phase I||0
1038621|NCT00733824|2521645|P1|NOT COMPLETED|Phase I||1
1038622|NCT00733824|2521641|P5|COMPLETED|Phase I||0
1038623|NCT00733824|2521642|P4|COMPLETED|Phase I||6
1038624|NCT00733824|2521643|P3|COMPLETED|Phase I||6
1038625|NCT00733824|2521644|P2|COMPLETED|Phase I||3
1038626|NCT00733824|2521645|P1|COMPLETED|Phase I||9
1038627|NCT00733824|2521641|P5|STARTED|Phase I||0
1038628|NCT00733824|2521642|P4|STARTED|Phase I||6
1038629|NCT00733824|2521643|P3|STARTED|Phase I||6
1038630|NCT00733824|2521644|P2|STARTED|Phase I||3
1038631|NCT00733824|2521645|P1|STARTED|Phase I||10
1038632|NCT00733954|2521666|P2|NOT COMPLETED|Overall Study||2
1038633|NCT00733954|2521667|P1|NOT COMPLETED|Overall Study||8
1038634|NCT00733954|2521666|P2|COMPLETED|Overall Study||123
1038635|NCT00733954|2521667|P1|COMPLETED|Overall Study||116
1038636|NCT00733954|2521666|P2|STARTED|Overall Study||125
1038637|NCT00733954|2521667|P1|STARTED|Overall Study||124
1038638|NCT00733993|2521711|P2|NOT COMPLETED|Overall Study||0
1038639|NCT00733993|2521712|P1|NOT COMPLETED|Overall Study||0
1038640|NCT00733993|2521711|P2|COMPLETED|Overall Study||10
1038641|NCT00733993|2521712|P1|COMPLETED|Overall Study||13
1038642|NCT00733993|2521711|P2|STARTED|Overall Study||10
1038643|NCT00733993|2521712|P1|STARTED|Overall Study||13
1038644|NCT00734071|2521747|P2|NOT COMPLETED|Overall Study||27
1038645|NCT00734071|2521748|P1|NOT COMPLETED|Overall Study||38
1038646|NCT00734071|2521747|P2|COMPLETED|Overall Study||125
1038647|NCT00734071|2521748|P1|COMPLETED|Overall Study||114
1038648|NCT00734071|2521747|P2|Treated|Overall Study||148
1038649|NCT00734071|2521748|P1|Treated|Overall Study||151
1038650|NCT00734071|2521747|P2|STARTED|Overall Study||152
1038651|NCT00734071|2521748|P1|STARTED|Overall Study||152
1038652|NCT00734097|2521802|P1|NOT COMPLETED|Open Label||16
1038653|NCT00734097|2521802|P1|COMPLETED|Open Label|16 patients discontinued after randomization|301
1038654|NCT00734097|2521802|P1|Per Protocol|Open Label||301
1038655|NCT00734097|2521802|P1|Full Analysis|Open Label||311
1038656|NCT00734097|2521802|P1|Safety Analysis|Open Label||317
1038657|NCT00734097|2521802|P1|STARTED|Open Label|Full analysis performed in 311|317
1038658|NCT00734097|2521802|P1|NOT COMPLETED|Screening||20
1038659|NCT00734097|2521802|P1|COMPLETED|Screening|20 participants were screening failure.|317
1038660|NCT00734097|2521802|P1|STARTED|Screening||337
1038661|NCT00734149|2521817|P1|NOT COMPLETED|Overall Study||1
1038662|NCT00734149|2521817|P1|COMPLETED|Overall Study||44
1038663|NCT00734149|2521817|P1|STARTED|Overall Study||45
1038664|NCT00734162|2521828|P4|NOT COMPLETED|Open-Label Phase||3
1038665|NCT00734162|2521829|P3|NOT COMPLETED|Open-Label Phase||1
1038666|NCT00734162|2521830|P2|NOT COMPLETED|Open-Label Phase||2
1038667|NCT00734162|2521831|P1|NOT COMPLETED|Open-Label Phase||3
1038668|NCT00734162|2521828|P4|COMPLETED|Open-Label Phase||36
1038669|NCT00734162|2521829|P3|COMPLETED|Open-Label Phase||12
1038670|NCT00734162|2521830|P2|COMPLETED|Open-Label Phase||39
1038671|NCT00734162|2521831|P1|COMPLETED|Open-Label Phase||7
1038760|NCT00734474|2522200|P3|Completed 26-Week Visit|Overall Study||258
1038672|NCT00734162|2521828|P4|STARTED|Open-Label Phase|2 participants switched to open-label treatment before completing double-blind period (elevated ALT)|39
1038673|NCT00734162|2521829|P3|STARTED|Open-Label Phase||13
1038674|NCT00734162|2521830|P2|STARTED|Open-Label Phase||41
1038675|NCT00734162|2521831|P1|STARTED|Open-Label Phase||10
1038676|NCT00734162|2521828|P4|NOT COMPLETED|Randomized Phase (Through Week 72)||4
1038677|NCT00734162|2521829|P3|NOT COMPLETED|Randomized Phase (Through Week 72)||0
1038678|NCT00734162|2521830|P2|NOT COMPLETED|Randomized Phase (Through Week 72)||1
1038679|NCT00734162|2521831|P1|NOT COMPLETED|Randomized Phase (Through Week 72)||0
1038680|NCT00734162|2521828|P4|COMPLETED|Randomized Phase (Through Week 72)||37
1038681|NCT00734162|2521829|P3|COMPLETED|Randomized Phase (Through Week 72)||13
1038682|NCT00734162|2521830|P2|COMPLETED|Randomized Phase (Through Week 72)||41
1038683|NCT00734162|2521831|P1|COMPLETED|Randomized Phase (Through Week 72)||10
1038684|NCT00734162|2521828|P4|STARTED|Randomized Phase (Through Week 72)||41
1038685|NCT00734162|2521829|P3|STARTED|Randomized Phase (Through Week 72)||13
1038686|NCT00734162|2521830|P2|STARTED|Randomized Phase (Through Week 72)||42
1038687|NCT00734162|2521831|P1|STARTED|Randomized Phase (Through Week 72)||10
1038688|NCT00734214|2522057|P2|NOT COMPLETED|Overall Study||4
1038689|NCT00734214|2522058|P1|NOT COMPLETED|Overall Study||4
1038690|NCT00734214|2522057|P2|COMPLETED|Overall Study||126
1038691|NCT00734214|2522058|P1|COMPLETED|Overall Study||124
1038692|NCT00734214|2522057|P2|STARTED|Overall Study||130
1038693|NCT00734214|2522058|P1|STARTED|Overall Study||128
1038694|NCT00734305|2522066|P7|NOT COMPLETED|Overall Study||0
1038695|NCT00734305|2522067|P6|NOT COMPLETED|Overall Study||0
1038696|NCT00734305|2522068|P5|NOT COMPLETED|Overall Study||0
1038697|NCT00734305|2522069|P4|NOT COMPLETED|Overall Study||0
1038698|NCT00734305|2522070|P3|NOT COMPLETED|Overall Study||0
1038699|NCT00734305|2522071|P2|NOT COMPLETED|Overall Study||0
1038700|NCT00734305|2522072|P1|NOT COMPLETED|Overall Study||1
1038701|NCT00734305|2522066|P7|COMPLETED|Overall Study||18
1038702|NCT00734305|2522067|P6|COMPLETED|Overall Study||4
1038703|NCT00734305|2522068|P5|COMPLETED|Overall Study||5
1038704|NCT00734305|2522069|P4|COMPLETED|Overall Study||3
1038705|NCT00734305|2522070|P3|COMPLETED|Overall Study||4
1038706|NCT00734305|2522071|P2|COMPLETED|Overall Study||3
1038707|NCT00734305|2522072|P1|COMPLETED|Overall Study|1 patient was enrolled but did not meet eligibility criteria at C1W1, and thus was never dosed|6
1038708|NCT00734305|2522066|P7|STARTED|Overall Study||18
1038709|NCT00734305|2522067|P6|STARTED|Overall Study||4
1038710|NCT00734305|2522068|P5|STARTED|Overall Study||5
1038711|NCT00734305|2522069|P4|STARTED|Overall Study||3
1038712|NCT00734305|2522070|P3|STARTED|Overall Study||4
1038713|NCT00734305|2522071|P2|STARTED|Overall Study||3
1038714|NCT00734305|2522072|P1|STARTED|Overall Study||7
1038715|NCT00734344|2522103|P2|NOT COMPLETED|Overall Study||0
1038716|NCT00734344|2522104|P1|NOT COMPLETED|Overall Study||0
1038717|NCT00734344|2522103|P2|COMPLETED|Overall Study||9
1038718|NCT00734344|2522104|P1|COMPLETED|Overall Study||9
1038719|NCT00734344|2522103|P2|STARTED|Overall Study||9
1038720|NCT00734344|2522104|P1|STARTED|Overall Study||9
1038721|NCT00734409|2522174|P2|NOT COMPLETED|Overall Study||0
1038722|NCT00734409|2522175|P1|NOT COMPLETED|Overall Study||0
1038723|NCT00734409|2522174|P2|COMPLETED|Overall Study||145
1038724|NCT00734409|2522175|P1|COMPLETED|Overall Study||155
1038725|NCT00734409|2522174|P2|STARTED|Overall Study||145
1038726|NCT00734409|2522175|P1|STARTED|Overall Study||155
1038727|NCT00734474|2522194|P9|NOT COMPLETED|Overall Study||82
1038728|NCT00734474|2522195|P8|NOT COMPLETED|Overall Study||129
1038729|NCT00734474|2522196|P7|NOT COMPLETED|Overall Study||24
1038730|NCT00734474|2522197|P6|NOT COMPLETED|Overall Study||25
1038731|NCT00734474|2522198|P5|NOT COMPLETED|Overall Study||118
1038732|NCT00734474|2522199|P4|NOT COMPLETED|Overall Study||10
1038733|NCT00734474|2522200|P3|NOT COMPLETED|Overall Study||112
1038734|NCT00734474|2522201|P2|NOT COMPLETED|Overall Study||30
1038735|NCT00734474|2522202|P1|NOT COMPLETED|Overall Study||15
1038736|NCT00734474|2522194|P9|COMPLETED|Overall Study||95
1038737|NCT00734474|2522195|P8|COMPLETED|Overall Study||186
1038738|NCT00734474|2522196|P7|COMPLETED|Overall Study||0
1038739|NCT00734474|2522197|P6|COMPLETED|Overall Study||0
1038740|NCT00734474|2522198|P5|COMPLETED|Overall Study||184
1038741|NCT00734474|2522199|P4|COMPLETED|Overall Study||0
1038742|NCT00734474|2522200|P3|COMPLETED|Overall Study||192
1038743|NCT00734474|2522201|P2|COMPLETED|Overall Study||0
1038744|NCT00734474|2522202|P1|COMPLETED|Overall Study||0
1038745|NCT00734474|2522194|P9|Completed 52-Week Visit|Overall Study||112
1038746|NCT00734474|2522195|P8|Completed 52-Week Visit|Overall Study||238
1038747|NCT00734474|2522196|P7|Completed 52-Week Visit|Overall Study||0
1038748|NCT00734474|2522197|P6|Completed 52-Week Visit|Overall Study||0
1038749|NCT00734474|2522198|P5|Completed 52-Week Visit|Overall Study||243
1038750|NCT00734474|2522199|P4|Completed 52-Week Visit|Overall Study||0
1038751|NCT00734474|2522200|P3|Completed 52-Week Visit|Overall Study||238
1038752|NCT00734474|2522201|P2|Completed 52-Week Visit|Overall Study||0
1038753|NCT00734474|2522202|P1|Completed 52-Week Visit|Overall Study||0
1038754|NCT00734474|2522194|P9|Completed 26-Week Visit|Overall Study||124
1038755|NCT00734474|2522195|P8|Completed 26-Week Visit|Overall Study||270
1038756|NCT00734474|2522196|P7|Completed 26-Week Visit|Overall Study||2
1038757|NCT00734474|2522197|P6|Completed 26-Week Visit|Overall Study||2
1038758|NCT00734474|2522198|P5|Completed 26-Week Visit|Overall Study||268
1038759|NCT00734474|2522199|P4|Completed 26-Week Visit|Overall Study||2
1038761|NCT00734474|2522201|P2|Completed 26-Week Visit|Overall Study||0
1038762|NCT00734474|2522202|P1|Completed 26-Week Visit|Overall Study||0
1038763|NCT00734474|2522194|P9|Entered Study After Dose Decision Point|Overall Study||139
1038764|NCT00734474|2522195|P8|Entered Study After Dose Decision Point|Overall Study||273
1038765|NCT00734474|2522196|P7|Entered Study After Dose Decision Point|Overall Study||0
1038766|NCT00734474|2522197|P6|Entered Study After Dose Decision Point|Overall Study||0
1038767|NCT00734474|2522198|P5|Entered Study After Dose Decision Point|Overall Study||281
1038768|NCT00734474|2522199|P4|Entered Study After Dose Decision Point|Overall Study||0
1038769|NCT00734474|2522200|P3|Entered Study After Dose Decision Point|Overall Study||279
1038770|NCT00734474|2522201|P2|Entered Study After Dose Decision Point|Overall Study||0
1038771|NCT00734474|2522202|P1|Entered Study After Dose Decision Point|Overall Study||0
1038772|NCT00734474|2522194|P9|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|34
1038773|NCT00734474|2522195|P8|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|42
1038774|NCT00734474|2522196|P7|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|23
1038775|NCT00734474|2522197|P6|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|21
1038776|NCT00734474|2522198|P5|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|21
1038777|NCT00734474|2522199|P4|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
1038778|NCT00734474|2522200|P3|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|24
1038779|NCT00734474|2522201|P2|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|25
1038780|NCT00734474|2522202|P1|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
1038781|NCT00734474|2522194|P9|Entered Study Before Dose Decision Point|Overall Study||38
1038782|NCT00734474|2522195|P8|Entered Study Before Dose Decision Point|Overall Study||42
1038783|NCT00734474|2522196|P7|Entered Study Before Dose Decision Point|Overall Study||24
1038784|NCT00734474|2522197|P6|Entered Study Before Dose Decision Point|Overall Study||25
1038785|NCT00734474|2522198|P5|Entered Study Before Dose Decision Point|Overall Study||21
1038786|NCT00734474|2522199|P4|Entered Study Before Dose Decision Point|Overall Study||10
1038787|NCT00734474|2522200|P3|Entered Study Before Dose Decision Point|Overall Study||25
1038788|NCT00734474|2522201|P2|Entered Study Before Dose Decision Point|Overall Study||30
1038789|NCT00734474|2522202|P1|Entered Study Before Dose Decision Point|Overall Study||15
1038790|NCT00734474|2522194|P9|Received at Least 1 Dose of Study Drug|Overall Study||177
1038791|NCT00734474|2522195|P8|Received at Least 1 Dose of Study Drug|Overall Study||315
1038792|NCT00734474|2522196|P7|Received at Least 1 Dose of Study Drug|Overall Study||24
1038793|NCT00734474|2522197|P6|Received at Least 1 Dose of Study Drug|Overall Study||25
1038794|NCT00734474|2522198|P5|Received at Least 1 Dose of Study Drug|Overall Study||302
1038795|NCT00734474|2522199|P4|Received at Least 1 Dose of Study Drug|Overall Study||10
1038796|NCT00734474|2522200|P3|Received at Least 1 Dose of Study Drug|Overall Study||304
1038797|NCT00734474|2522201|P2|Received at Least 1 Dose of Study Drug|Overall Study||30
1038798|NCT00734474|2522202|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
1038799|NCT00734474|2522194|P9|STARTED|Overall Study||177
1038800|NCT00734474|2522195|P8|STARTED|Overall Study||315
1038801|NCT00734474|2522196|P7|STARTED|Overall Study||24
1038802|NCT00734474|2522197|P6|STARTED|Overall Study||25
1038803|NCT00734474|2522198|P5|STARTED|Overall Study||302
1038804|NCT00734474|2522199|P4|STARTED|Overall Study||10
1038805|NCT00734474|2522200|P3|STARTED|Overall Study||304
1038806|NCT00734474|2522201|P2|STARTED|Overall Study||30
1038807|NCT00734474|2522202|P1|STARTED|Overall Study||15
1038808|NCT00734500|2522369|P1|NOT COMPLETED|Overall Study||1
1038809|NCT00734500|2522369|P1|COMPLETED|Overall Study||14
1038810|NCT00734500|2522369|P1|STARTED|Overall Study||15
1038823|NCT00734578|2522408|P3|NOT COMPLETED|Overall Study||25
1038824|NCT00734578|2522409|P2|NOT COMPLETED|Overall Study||25
1038825|NCT00734578|2522410|P1|NOT COMPLETED|Overall Study||33
1038826|NCT00734578|2522408|P3|COMPLETED|Overall Study||129
1038827|NCT00734578|2522409|P2|COMPLETED|Overall Study||128
1038828|NCT00734578|2522410|P1|COMPLETED|Overall Study||121
1038829|NCT00734578|2522408|P3|STARTED|Overall Study||154
1038830|NCT00734578|2522409|P2|STARTED|Overall Study||153
1038831|NCT00734578|2522410|P1|STARTED|Overall Study||154
1038832|NCT00734591|2522444|P2|NOT COMPLETED|Prospective Period||44
1038833|NCT00734591|2522445|P1|NOT COMPLETED|Prospective Period||51
1038834|NCT00734591|2522444|P2|COMPLETED|Prospective Period||1229
1038835|NCT00734591|2522445|P1|COMPLETED|Prospective Period||1307
1038836|NCT00734591|2522444|P2|STARTED|Prospective Period||1273
1038837|NCT00734591|2522445|P1|STARTED|Prospective Period||1358
1038838|NCT00734591|2522444|P2|NOT COMPLETED|Screening for Prospective Period||2291
1038839|NCT00734591|2522445|P1|NOT COMPLETED|Screening for Prospective Period||2517
1038840|NCT00734591|2522444|P2|COMPLETED|Screening for Prospective Period||1273
1038841|NCT00734591|2522445|P1|COMPLETED|Screening for Prospective Period||1358
1038842|NCT00734591|2522444|P2|STARTED|Screening for Prospective Period||3564
1038843|NCT00734591|2522445|P1|STARTED|Screening for Prospective Period||3875
1038844|NCT00734591|2522444|P2|NOT COMPLETED|Retrospective Period||0
1038845|NCT00734591|2522445|P1|NOT COMPLETED|Retrospective Period||0
1038846|NCT00734591|2522444|P2|COMPLETED|Retrospective Period||3564
1038847|NCT00734591|2522445|P1|COMPLETED|Retrospective Period||3875
1038848|NCT00734591|2522444|P2|STARTED|Retrospective Period||3564
1038849|NCT00734591|2522445|P1|STARTED|Retrospective Period||3875
1038850|NCT00734604|2522463|P6|NOT COMPLETED|Overall Study||6
1038851|NCT00734604|2522464|P5|NOT COMPLETED|Overall Study||8
1038852|NCT00734604|2522465|P4|NOT COMPLETED|Overall Study||9
1038853|NCT00734604|2522466|P3|NOT COMPLETED|Overall Study||6
1038854|NCT00734604|2522467|P2|NOT COMPLETED|Overall Study||12
1038855|NCT00734604|2522468|P1|NOT COMPLETED|Overall Study||3
1038856|NCT00734604|2522463|P6|COMPLETED|Overall Study||58
1038857|NCT00734604|2522464|P5|COMPLETED|Overall Study||55
1038858|NCT00734604|2522465|P4|COMPLETED|Overall Study||54
1038859|NCT00734604|2522466|P3|COMPLETED|Overall Study||57
1038860|NCT00734604|2522467|P2|COMPLETED|Overall Study||51
1038861|NCT00734604|2522468|P1|COMPLETED|Overall Study||59
1038862|NCT00734604|2522463|P6|STARTED|Overall Study||64
1038863|NCT00734604|2522464|P5|STARTED|Overall Study||63
1038864|NCT00734604|2522465|P4|STARTED|Overall Study||63
1038865|NCT00734604|2522466|P3|STARTED|Overall Study||63
1038866|NCT00734604|2522467|P2|STARTED|Overall Study||63
1038867|NCT00734604|2522468|P1|STARTED|Overall Study||62
1038868|NCT00734617|2522518|P2|NOT COMPLETED|Overall Study||102
1038869|NCT00734617|2522519|P1|NOT COMPLETED|Overall Study||107
1038870|NCT00734617|2522518|P2|COMPLETED|Overall Study||128
1038871|NCT00734617|2522519|P1|COMPLETED|Overall Study||142
1038872|NCT00734617|2522518|P2|STARTED|Overall Study||230
1038873|NCT00734617|2522519|P1|STARTED|Overall Study||249
1038874|NCT00734630|2522527|P2|NOT COMPLETED|Overall Study||33
1038875|NCT00734630|2522528|P1|NOT COMPLETED|Overall Study||29
1038876|NCT00734630|2522527|P2|COMPLETED|Overall Study||200
1038877|NCT00734630|2522528|P1|COMPLETED|Overall Study||229
1038878|NCT00734630|2522527|P2|STARTED|Overall Study||233
1038879|NCT00734630|2522528|P1|STARTED|Overall Study||258
1038880|NCT00734656|2522536|P4|NOT COMPLETED|Lab Session 4||1
1038881|NCT00734656|2522537|P3|NOT COMPLETED|Lab Session 4||0
1038882|NCT00734656|2522538|P2|NOT COMPLETED|Lab Session 4||0
1038883|NCT00734656|2522539|P1|NOT COMPLETED|Lab Session 4||0
1038884|NCT00734656|2522536|P4|COMPLETED|Lab Session 4||19
1038885|NCT00734656|2522537|P3|COMPLETED|Lab Session 4||16
1038886|NCT00734656|2522538|P2|COMPLETED|Lab Session 4||18
1038887|NCT00734656|2522539|P1|COMPLETED|Lab Session 4||20
1038888|NCT00734656|2522536|P4|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
1038889|NCT00734656|2522537|P3|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|16
1038890|NCT00734656|2522538|P2|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|18
1038891|NCT00734656|2522539|P1|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
1038892|NCT00734656|2522536|P4|NOT COMPLETED|Washout 3||1
1038893|NCT00734656|2522537|P3|NOT COMPLETED|Washout 3||0
1038894|NCT00734656|2522538|P2|NOT COMPLETED|Washout 3||0
1038895|NCT00734656|2522539|P1|NOT COMPLETED|Washout 3||1
1038896|NCT00734656|2522536|P4|COMPLETED|Washout 3||18
1038897|NCT00734656|2522537|P3|COMPLETED|Washout 3||20
1038898|NCT00734656|2522538|P2|COMPLETED|Washout 3||19
1038899|NCT00734656|2522539|P1|COMPLETED|Washout 3||17
1038900|NCT00734656|2522536|P4|STARTED|Washout 3||19
1038901|NCT00734656|2522537|P3|STARTED|Washout 3||20
1038902|NCT00734656|2522538|P2|STARTED|Washout 3||19
1038903|NCT00734656|2522539|P1|STARTED|Washout 3||18
1038904|NCT00734656|2522536|P4|NOT COMPLETED|Lab Session 3||0
1038905|NCT00734656|2522537|P3|NOT COMPLETED|Lab Session 3||0
1038906|NCT00734656|2522538|P2|NOT COMPLETED|Lab Session 3||0
1038907|NCT00734656|2522539|P1|NOT COMPLETED|Lab Session 3||0
1038908|NCT00734656|2522536|P4|COMPLETED|Lab Session 3||19
1038909|NCT00734656|2522537|P3|COMPLETED|Lab Session 3||20
1038910|NCT00734656|2522538|P2|COMPLETED|Lab Session 3||19
1038911|NCT00734656|2522539|P1|COMPLETED|Lab Session 3||18
1038912|NCT00734656|2522536|P4|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
1038913|NCT00734656|2522537|P3|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|20
1038914|NCT00734656|2522538|P2|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
1038915|NCT00734656|2522539|P1|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|18
1038916|NCT00734656|2522536|P4|NOT COMPLETED|Washout 2||0
1038917|NCT00734656|2522537|P3|NOT COMPLETED|Washout 2||1
1038918|NCT00734656|2522538|P2|NOT COMPLETED|Washout 2||1
1038919|NCT00734656|2522539|P1|NOT COMPLETED|Washout 2||1
1038920|NCT00734656|2522536|P4|COMPLETED|Washout 2||19
1038921|NCT00734656|2522537|P3|COMPLETED|Washout 2||20
1038922|NCT00734656|2522538|P2|COMPLETED|Washout 2||20
1038923|NCT00734656|2522539|P1|COMPLETED|Washout 2||17
1038924|NCT00734656|2522536|P4|STARTED|Washout 2||19
1038925|NCT00734656|2522537|P3|STARTED|Washout 2||21
1038926|NCT00734656|2522538|P2|STARTED|Washout 2||21
1038927|NCT00734656|2522539|P1|STARTED|Washout 2||18
1038928|NCT00734656|2522536|P4|NOT COMPLETED|Lab Session 2||1
1038929|NCT00734656|2522537|P3|NOT COMPLETED|Lab Session 2||0
1038930|NCT00734656|2522538|P2|NOT COMPLETED|Lab Session 2||0
1038931|NCT00734656|2522539|P1|NOT COMPLETED|Lab Session 2||1
1038932|NCT00734656|2522536|P4|COMPLETED|Lab Session 2||19
1038933|NCT00734656|2522537|P3|COMPLETED|Lab Session 2||21
1038934|NCT00734656|2522538|P2|COMPLETED|Lab Session 2||21
1038935|NCT00734656|2522539|P1|COMPLETED|Lab Session 2||18
1038936|NCT00734656|2522536|P4|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|20
1038937|NCT00734656|2522537|P3|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
1038938|NCT00734656|2522538|P2|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
1038939|NCT00734656|2522539|P1|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|19
1038940|NCT00734656|2522536|P4|NOT COMPLETED|Washout 1||3
1038941|NCT00734656|2522537|P3|NOT COMPLETED|Washout 1||2
1038942|NCT00734656|2522538|P2|NOT COMPLETED|Washout 1||5
1038943|NCT00734656|2522539|P1|NOT COMPLETED|Washout 1||1
1038944|NCT00734656|2522536|P4|COMPLETED|Washout 1||18
1038945|NCT00734656|2522537|P3|COMPLETED|Washout 1||24
1038946|NCT00734656|2522538|P2|COMPLETED|Washout 1||18
1038947|NCT00734656|2522539|P1|COMPLETED|Washout 1||21
1038948|NCT00734656|2522536|P4|STARTED|Washout 1||21
1038949|NCT00734656|2522537|P3|STARTED|Washout 1||26
1038950|NCT00734656|2522538|P2|STARTED|Washout 1||23
1038951|NCT00734656|2522539|P1|STARTED|Washout 1||22
1038952|NCT00734656|2522536|P4|NOT COMPLETED|Lab Session 1||0
1038953|NCT00734656|2522537|P3|NOT COMPLETED|Lab Session 1||0
1038954|NCT00734656|2522538|P2|NOT COMPLETED|Lab Session 1||0
1038955|NCT00734656|2522539|P1|NOT COMPLETED|Lab Session 1||2
1038956|NCT00734656|2522536|P4|COMPLETED|Lab Session 1||21
1038957|NCT00734656|2522537|P3|COMPLETED|Lab Session 1||26
1038958|NCT00734656|2522538|P2|COMPLETED|Lab Session 1||23
1038959|NCT00734656|2522539|P1|COMPLETED|Lab Session 1||22
1038960|NCT00734656|2522536|P4|STARTED|Lab Session 1||21
1038961|NCT00734656|2522537|P3|STARTED|Lab Session 1||26
1038962|NCT00734656|2522538|P2|STARTED|Lab Session 1||23
1038963|NCT00734656|2522539|P1|STARTED|Lab Session 1||24
1038964|NCT00734734|2522561|P1|NOT COMPLETED|Overall Study||0
1038965|NCT00734734|2522561|P1|COMPLETED|Overall Study||64
1038966|NCT00734734|2522561|P1|STARTED|Overall Study||64
1038967|NCT00734747|2522568|P1|NOT COMPLETED|6 Month Follow-up||3
1038968|NCT00734747|2522568|P1|COMPLETED|6 Month Follow-up||66
1038969|NCT00734747|2522568|P1|STARTED|6 Month Follow-up||69
1038970|NCT00734747|2522568|P1|NOT COMPLETED|SRS Procedure||3
1038971|NCT00734747|2522568|P1|COMPLETED|SRS Procedure||69
1038972|NCT00734747|2522568|P1|STARTED|SRS Procedure||72
1038973|NCT00734799|2522577|P2|NOT COMPLETED|Overall Study||4
1038974|NCT00734799|2522578|P1|NOT COMPLETED|Overall Study||0
1038975|NCT00734799|2522577|P2|COMPLETED|Overall Study||9
1038976|NCT00734799|2522578|P1|COMPLETED|Overall Study||9
1038977|NCT00734799|2522577|P2|STARTED|Overall Study||13
1038978|NCT00734799|2522578|P1|STARTED|Overall Study||9
1038979|NCT00734851|2522586|P1|NOT COMPLETED|Overall Study||21
1038980|NCT00734851|2522586|P1|COMPLETED|Overall Study||13
1038981|NCT00734851|2522586|P1|STARTED|Overall Study||34
1038982|NCT00734929|2522598|P2|NOT COMPLETED|Overall Study||5
1038983|NCT00734929|2522599|P1|NOT COMPLETED|Overall Study||6
1038984|NCT00734929|2522598|P2|COMPLETED|Overall Study||53
1038985|NCT00734929|2522599|P1|COMPLETED|Overall Study||51
1038986|NCT00734929|2522598|P2|STARTED|Overall Study||58
1038987|NCT00734929|2522599|P1|STARTED|Overall Study||57
1038988|NCT00734968|2522629|P2|NOT COMPLETED|Overall Study||1
1038989|NCT00734968|2522630|P1|NOT COMPLETED|Overall Study||1
1038990|NCT00734968|2522629|P2|COMPLETED|Overall Study||75
1038991|NCT00734968|2522630|P1|COMPLETED|Overall Study||76
1038992|NCT00734968|2522629|P2|STARTED|Overall Study||76
1038993|NCT00734968|2522630|P1|STARTED|Overall Study||77
1038994|NCT00734994|2522640|P1|NOT COMPLETED|Overall Study||1
1038995|NCT00734994|2522640|P1|COMPLETED|Overall Study||14
1038996|NCT00734994|2522640|P1|STARTED|Overall Study||15
1038997|NCT00735007|2522645|P1|NOT COMPLETED|Overall Study||5
1038998|NCT00735007|2522645|P1|COMPLETED|Overall Study||101
1038999|NCT00735007|2522645|P1|STARTED|Overall Study||106
1039000|NCT00735072|2522672|P2|NOT COMPLETED|Overall Study||1
1039001|NCT00735072|2522673|P1|NOT COMPLETED|Overall Study||1
1039002|NCT00735072|2522672|P2|COMPLETED|Overall Study||21
1039003|NCT00735072|2522673|P1|COMPLETED|Overall Study||22
1039004|NCT00735072|2522672|P2|STARTED|Overall Study||22
1039005|NCT00735072|2522673|P1|STARTED|Overall Study||23
1039006|NCT00735306|2522679|P1|NOT COMPLETED|Overall Study||0
1039007|NCT00735306|2522679|P1|COMPLETED|Overall Study||12
1039008|NCT00735306|2522679|P1|STARTED|Overall Study||12
1039009|NCT00735371|2522689|P4|NOT COMPLETED|Overall Study||10
1039010|NCT00735371|2522690|P3|NOT COMPLETED|Overall Study||11
1039011|NCT00735371|2522691|P2|NOT COMPLETED|Overall Study||13
1039012|NCT00735371|2522692|P1|NOT COMPLETED|Overall Study||15
1039013|NCT00735371|2522689|P4|COMPLETED|Overall Study||69
1039014|NCT00735371|2522690|P3|COMPLETED|Overall Study||67
1039015|NCT00735371|2522691|P2|COMPLETED|Overall Study||66
1039016|NCT00735371|2522692|P1|COMPLETED|Overall Study||63
1039017|NCT00735371|2522689|P4|STARTED|Overall Study||79
1039018|NCT00735371|2522690|P3|STARTED|Overall Study||78
1039019|NCT00735371|2522691|P2|STARTED|Overall Study||79
1039020|NCT00735371|2522692|P1|STARTED|Overall Study||78
1039021|NCT00735397|2522710|P1|NOT COMPLETED|Overall Study||1183
1039022|NCT00735397|2522710|P1|COMPLETED|Overall Study||35
1039023|NCT00735397|2522710|P1|STARTED|Overall Study||1218
1039024|NCT00735436|2522720|P1|NOT COMPLETED|Overall Study||0
1039025|NCT00735436|2522720|P1|COMPLETED|Overall Study||18
1039026|NCT00735436|2522720|P1|STARTED|Overall Study||18
1039027|NCT00735449|2522731|P2|NOT COMPLETED|Overall Study||6
1039028|NCT00735449|2522732|P1|NOT COMPLETED|Overall Study||7
1039029|NCT00735449|2522731|P2|COMPLETED|Overall Study||96
1039030|NCT00735449|2522732|P1|COMPLETED|Overall Study||95
1039031|NCT00735449|2522731|P2|STARTED|Overall Study||102
1039032|NCT00735449|2522732|P1|STARTED|Overall Study||102
1039033|NCT00735462|2522749|P3|NOT COMPLETED|Overall Study||28
1039034|NCT00735462|2522750|P2|NOT COMPLETED|Overall Study||55
1039035|NCT00735462|2522751|P1|NOT COMPLETED|Overall Study||63
1039036|NCT00735462|2522749|P3|COMPLETED|Overall Study||77
1039037|NCT00735462|2522750|P2|COMPLETED|Overall Study||149
1039038|NCT00735462|2522751|P1|COMPLETED|Overall Study||139
1039039|NCT00735462|2522749|P3|STARTED|Overall Study||105
1039040|NCT00735462|2522750|P2|STARTED|Overall Study||204
1039041|NCT00735462|2522751|P1|STARTED|Overall Study||202
1039042|NCT00735475|2522764|P2|NOT COMPLETED|Overall Study||11
1039043|NCT00735475|2522765|P1|NOT COMPLETED|Overall Study||8
1039044|NCT00735475|2522764|P2|COMPLETED|Overall Study||626
1039045|NCT00735475|2522765|P1|COMPLETED|Overall Study||623
1039046|NCT00735475|2522764|P2|STARTED|Overall Study||637
1039047|NCT00735475|2522765|P1|STARTED|Overall Study||631
1039048|NCT00735553|2522786|P1|NOT COMPLETED|Overall Study||77
1039049|NCT00735553|2522786|P1|COMPLETED|Overall Study||0
1039050|NCT00735553|2522786|P1|STARTED|Overall Study||77
1039051|NCT00735618|2522794|P1|NOT COMPLETED|Overall Study||0
1039052|NCT00735618|2522794|P1|COMPLETED|Overall Study||19
1039053|NCT00735618|2522794|P1|STARTED|Overall Study||19
1039054|NCT00735644|2522803|P5|NOT COMPLETED|Overall Study||0
1039055|NCT00735644|2522804|P4|NOT COMPLETED|Overall Study||1
1039056|NCT00735644|2522805|P3|NOT COMPLETED|Overall Study||1
1039057|NCT00735644|2522806|P2|NOT COMPLETED|Overall Study||2
1039058|NCT00735644|2522807|P1|NOT COMPLETED|Overall Study||0
1039059|NCT00735644|2522803|P5|COMPLETED|Overall Study||102
1039060|NCT00735644|2522804|P4|COMPLETED|Overall Study||198
1039061|NCT00735644|2522805|P3|COMPLETED|Overall Study||295
1039062|NCT00735644|2522806|P2|COMPLETED|Overall Study||298
1039063|NCT00735644|2522807|P1|COMPLETED|Overall Study||303
1039064|NCT00735644|2522803|P5|STARTED|Overall Study||102
1039065|NCT00735644|2522804|P4|STARTED|Overall Study||199
1039066|NCT00735644|2522805|P3|STARTED|Overall Study||296
1039067|NCT00735644|2522806|P2|STARTED|Overall Study||300
1039068|NCT00735644|2522807|P1|STARTED|Overall Study||303
1039069|NCT00735670|2522846|P2|NOT COMPLETED|Overall Study||5
1039070|NCT00735670|2522847|P1|NOT COMPLETED|Overall Study||4
1039071|NCT00735670|2522846|P2|COMPLETED|Overall Study||6
1039072|NCT00735670|2522847|P1|COMPLETED|Overall Study||6
1039073|NCT00735670|2522846|P2|STARTED|Overall Study||11
1039074|NCT00735670|2522847|P1|STARTED|Overall Study||10
1039075|NCT00735696|2522855|P1|NOT COMPLETED|Overall Study||2
1039076|NCT00735696|2522855|P1|COMPLETED|Overall Study||39
1039077|NCT00735696|2522855|P1|Received Any Quantity of Study Drug|Overall Study||40
1039078|NCT00735696|2522855|P1|STARTED|Overall Study||41
1039079|NCT00735709|2522871|P4|NOT COMPLETED|Overall Study||18
1039080|NCT00735709|2522872|P3|NOT COMPLETED|Overall Study||11
1039081|NCT00735709|2522873|P2|NOT COMPLETED|Overall Study||13
1039082|NCT00735709|2522874|P1|NOT COMPLETED|Overall Study||13
1039083|NCT00735709|2522871|P4|COMPLETED|Overall Study||122
1039084|NCT00735709|2522872|P3|COMPLETED|Overall Study||129
1039085|NCT00735709|2522873|P2|COMPLETED|Overall Study||127
1039086|NCT00735709|2522874|P1|COMPLETED|Overall Study||127
1039087|NCT00735709|2522871|P4|Treated|Overall Study||139
1039088|NCT00735709|2522872|P3|Treated|Overall Study||140
1039089|NCT00735709|2522873|P2|Treated|Overall Study||140
1039090|NCT00735709|2522874|P1|Treated|Overall Study||140
1039091|NCT00735709|2522871|P4|STARTED|Overall Study||140
1039092|NCT00735709|2522872|P3|STARTED|Overall Study||140
1039093|NCT00735709|2522873|P2|STARTED|Overall Study||140
1039094|NCT00735709|2522874|P1|STARTED|Overall Study||140
1039095|NCT00735787|2522986|P2|NOT COMPLETED|Period 2||1
1039096|NCT00735787|2522987|P1|NOT COMPLETED|Period 2||5
1039097|NCT00735787|2522986|P2|COMPLETED|Period 2||40
1039098|NCT00735787|2522987|P1|COMPLETED|Period 2||13
1039099|NCT00735787|2522986|P2|STARTED|Period 2||41
1039100|NCT00735787|2522987|P1|STARTED|Period 2||18
1039101|NCT00735787|2522986|P2|NOT COMPLETED|Period 1||8
1039102|NCT00735787|2522987|P1|NOT COMPLETED|Period 1||6
1039103|NCT00735787|2522986|P2|COMPLETED|Period 1||41
1039104|NCT00735787|2522987|P1|COMPLETED|Period 1|Per visit window, 18 completed; 17 completed per subject case report form.|17
1039105|NCT00735787|2522986|P2|STARTED|Period 1||49
1039106|NCT00735787|2522987|P1|STARTED|Period 1||23
1039107|NCT00735839|2523033|P2|NOT COMPLETED|Overall Study||0
1039108|NCT00735839|2523034|P1|NOT COMPLETED|Overall Study||0
1039109|NCT00735839|2523033|P2|COMPLETED|Overall Study||10
1039110|NCT00735839|2523034|P1|COMPLETED|Overall Study||30
1039111|NCT00735839|2523033|P2|STARTED|Overall Study||10
1039112|NCT00735839|2523034|P1|STARTED|Overall Study||30
1039113|NCT00735904|2523042|P1|NOT COMPLETED|Overall Study||38
1039114|NCT00735904|2523042|P1|COMPLETED|Overall Study||0
1039115|NCT00735904|2523042|P1|STARTED|Overall Study||38
1039116|NCT00735917|2523049|P1|NOT COMPLETED|Overall Study||0
1039117|NCT00735917|2523049|P1|COMPLETED|Overall Study||19
1039118|NCT00735917|2523049|P1|STARTED|Overall Study||19
1039119|NCT00735943|2523057|P1|NOT COMPLETED|Overall Study||2
1039120|NCT00735943|2523057|P1|COMPLETED|Overall Study||20
1039121|NCT00735943|2523057|P1|STARTED|Overall Study||22
1039122|NCT00735969|2523074|P1|NOT COMPLETED|Overall Study||0
1039123|NCT00735969|2523074|P1|COMPLETED|Overall Study||21
1039124|NCT00735969|2523074|P1|STARTED|Overall Study||21
1039125|NCT00736034|2523078|P1|NOT COMPLETED|Overall Study||2
1039126|NCT00736034|2523078|P1|COMPLETED|Overall Study||16
1039127|NCT00736034|2523078|P1|STARTED|Overall Study||18
1039128|NCT00736073|2523084|P2|NOT COMPLETED|Overall Study||0
1039129|NCT00736073|2523085|P1|NOT COMPLETED|Overall Study||0
1039130|NCT00736073|2523084|P2|COMPLETED|Overall Study||39
1039131|NCT00736073|2523085|P1|COMPLETED|Overall Study||34
1039132|NCT00736073|2523084|P2|STARTED|Overall Study||39
1039133|NCT00736073|2523085|P1|STARTED|Overall Study||34
1039134|NCT00736099|2523097|P2|NOT COMPLETED|Overall Study||58
1039135|NCT00736099|2523098|P1|NOT COMPLETED|Overall Study||183
1039136|NCT00736099|2523097|P2|COMPLETED|Overall Study|Number who completed treatment.|531
1039137|NCT00736099|2523098|P1|COMPLETED|Overall Study|Number who completed treatment.|1349
1039138|NCT00736099|2523097|P2|STARTED|Overall Study|Number who started treatment.|589
1039139|NCT00736099|2523098|P1|STARTED|Overall Study|Number who started treatment.|1532
1039140|NCT00736125|2523196|P2|NOT COMPLETED|Overall Study||2
1039141|NCT00736125|2523197|P1|NOT COMPLETED|Overall Study||1
1039142|NCT00736125|2523196|P2|COMPLETED|Overall Study||8
1039143|NCT00736125|2523197|P1|COMPLETED|Overall Study||9
1039144|NCT00736125|2523196|P2|STARTED|Overall Study||10
1039145|NCT00736125|2523197|P1|STARTED|Overall Study||10
1039146|NCT00724568|2523205|P2|NOT COMPLETED|Overall Study||0
1039147|NCT00724568|2523206|P1|NOT COMPLETED|Overall Study||0
1039148|NCT00724568|2523205|P2|COMPLETED|Overall Study||32
1039149|NCT00724568|2523206|P1|COMPLETED|Overall Study||42
1039150|NCT00724568|2523205|P2|STARTED|Overall Study||32
1039151|NCT00724568|2523206|P1|STARTED|Overall Study||42
1039152|NCT00724594|2523215|P4|NOT COMPLETED|Overall Study||1
1039153|NCT00724594|2523216|P3|NOT COMPLETED|Overall Study||0
1039154|NCT00724594|2523217|P2|NOT COMPLETED|Overall Study||0
1039155|NCT00724594|2523218|P1|NOT COMPLETED|Overall Study||0
1039156|NCT00724594|2523215|P4|COMPLETED|Overall Study||10
1039157|NCT00724594|2523216|P3|COMPLETED|Overall Study||11
1039158|NCT00724594|2523217|P2|COMPLETED|Overall Study||12
1039159|NCT00724594|2523218|P1|COMPLETED|Overall Study||12
1039160|NCT00724594|2523215|P4|STARTED|Overall Study||11
1039161|NCT00724594|2523216|P3|STARTED|Overall Study||11
1039162|NCT00724594|2523217|P2|STARTED|Overall Study||12
1039163|NCT00724594|2523218|P1|STARTED|Overall Study||12
1039164|NCT00724698|2523241|P1|NOT COMPLETED|Overall Study||90
1039165|NCT00724698|2523241|P1|COMPLETED|Overall Study||2921
1039166|NCT00724698|2523241|P1|STARTED|Overall Study||3011
1039167|NCT00724711|2523246|P2|NOT COMPLETED|Overall Study||17
1039168|NCT00724711|2523247|P1|NOT COMPLETED|Overall Study||17
1039169|NCT00724711|2523246|P2|COMPLETED|Overall Study||139
1039170|NCT00724711|2523247|P1|COMPLETED|Overall Study||138
1039171|NCT00724711|2523246|P2|STARTED|Overall Study||156
1039172|NCT00724711|2523247|P1|STARTED|Overall Study||155
1039173|NCT00724750|2523281|P2|NOT COMPLETED|Overall Study||0
1039174|NCT00724750|2523282|P1|NOT COMPLETED|Overall Study||0
1039175|NCT00724750|2523281|P2|COMPLETED|Overall Study||42
1039176|NCT00724750|2523282|P1|COMPLETED|Overall Study||45
1039177|NCT00724750|2523281|P2|STARTED|Overall Study||42
1039178|NCT00724750|2523282|P1|STARTED|Overall Study||45
1039179|NCT00730132|2523298|P1|NOT COMPLETED|Overall Study||155
1039180|NCT00730132|2523298|P1|COMPLETED|Overall Study||557
1039181|NCT00730132|2523298|P1|STARTED|Overall Study||712
1039182|NCT00730236|2523314|P1|NOT COMPLETED|Overall Study||6
1039183|NCT00730236|2523314|P1|COMPLETED|Overall Study||23
1039184|NCT00730236|2523314|P1|STARTED|Overall Study||29
1039185|NCT00730275|2523333|P4|NOT COMPLETED|Overall Study||1
1039186|NCT00730275|2523334|P3|NOT COMPLETED|Overall Study||0
1039187|NCT00730275|2523335|P2|NOT COMPLETED|Overall Study||0
1039188|NCT00730275|2523336|P1|NOT COMPLETED|Overall Study||0
1039189|NCT00730275|2523333|P4|COMPLETED|Overall Study||8
1039190|NCT00730275|2523334|P3|COMPLETED|Overall Study||8
1039191|NCT00730275|2523335|P2|COMPLETED|Overall Study||9
1039192|NCT00730275|2523336|P1|COMPLETED|Overall Study||9
1039193|NCT00730275|2523333|P4|STARTED|Overall Study||9
1039194|NCT00730275|2523334|P3|STARTED|Overall Study||8
1039195|NCT00730275|2523335|P2|STARTED|Overall Study||9
1039196|NCT00730275|2523336|P1|STARTED|Overall Study||9
1039197|NCT00730327|2523364|P2|NOT COMPLETED|Overall Study||37
1039198|NCT00730327|2523365|P1|NOT COMPLETED|Overall Study||27
1039199|NCT00730327|2523364|P2|COMPLETED|Overall Study||93
1039200|NCT00730327|2523365|P1|COMPLETED|Overall Study|Completed defined as subjects who completed the Week 52 follow-up visit.|98
1039201|NCT00730327|2523364|P2|Completed Week 26|Overall Study||99
1039295|NCT00736489|2523676|P3|STARTED|Period 6||6
1039296|NCT00736489|2523677|P2|STARTED|Period 6||5
1039202|NCT00730327|2523365|P1|Completed Week 26|Overall Study|Week 26 was halfway through the study, at which point the BIB group had their balloon removed.|125
1039203|NCT00730327|2523364|P2|STARTED|Overall Study||130
1039204|NCT00730327|2523365|P1|STARTED|Overall Study|Started is defined as subjects that began treatment.|125
1039205|NCT00730353|2523386|P1|NOT COMPLETED|Overall Study||0
1039206|NCT00730353|2523386|P1|COMPLETED|Overall Study||28
1039207|NCT00730353|2523386|P1|STARTED|Overall Study||28
1039208|NCT00730483|2523394|P1|NOT COMPLETED|Overall Study||7
1039209|NCT00730483|2523394|P1|COMPLETED|Overall Study||6
1039210|NCT00730483|2523394|P1|6 Months After First DEB-TACE|Overall Study||10
1039211|NCT00730483|2523394|P1|1 Month After First DEB-TACE|Overall Study||13
1039212|NCT00730483|2523394|P1|STARTED|Overall Study||13
1039213|NCT00730639|2523407|P5|NOT COMPLETED|Overall Study||131
1039214|NCT00730639|2523408|P4|NOT COMPLETED|Overall Study||54
1039215|NCT00730639|2523409|P3|NOT COMPLETED|Overall Study||86
1039216|NCT00730639|2523410|P2|NOT COMPLETED|Overall Study||18
1039217|NCT00730639|2523411|P1|NOT COMPLETED|Overall Study||17
1039218|NCT00730639|2523407|P5|COMPLETED|Overall Study||0
1039219|NCT00730639|2523408|P4|COMPLETED|Overall Study||0
1039220|NCT00730639|2523409|P3|COMPLETED|Overall Study||0
1039221|NCT00730639|2523410|P2|COMPLETED|Overall Study||0
1039222|NCT00730639|2523411|P1|COMPLETED|Overall Study||0
1039223|NCT00730639|2523407|P5|STARTED|Overall Study||131
1039224|NCT00730639|2523408|P4|STARTED|Overall Study||54
1039225|NCT00730639|2523409|P3|STARTED|Overall Study||86
1039226|NCT00730639|2523410|P2|STARTED|Overall Study||18
1039227|NCT00730639|2523411|P1|STARTED|Overall Study||17
1039228|NCT00730691|2523480|P5|NOT COMPLETED|Overall Study||50
1039229|NCT00730691|2523481|P4|NOT COMPLETED|Overall Study||45
1039230|NCT00730691|2523482|P3|NOT COMPLETED|Overall Study||39
1039231|NCT00730691|2523483|P2|NOT COMPLETED|Overall Study||36
1039232|NCT00730691|2523484|P1|NOT COMPLETED|Overall Study||36
1039233|NCT00730691|2523480|P5|COMPLETED|Overall Study||106
1039234|NCT00730691|2523481|P4|COMPLETED|Overall Study||111
1039235|NCT00730691|2523482|P3|COMPLETED|Overall Study||117
1039236|NCT00730691|2523483|P2|COMPLETED|Overall Study||120
1039237|NCT00730691|2523484|P1|COMPLETED|Overall Study||121
1039238|NCT00730691|2523480|P5|STARTED|Overall Study||156
1039239|NCT00730691|2523481|P4|STARTED|Overall Study||156
1039240|NCT00730691|2523482|P3|STARTED|Overall Study|One participant was randomized by error. Reason not completed is reported as Other.|156
1039241|NCT00730691|2523483|P2|STARTED|Overall Study||156
1039242|NCT00730691|2523484|P1|STARTED|Overall Study||157
1039243|NCT00736190|2523571|P1|NOT COMPLETED|Overall Study||3
1039244|NCT00736190|2523571|P1|COMPLETED|Overall Study||87
1039245|NCT00736190|2523571|P1|STARTED|Overall Study||90
1039246|NCT00736229|2523587|P3|NOT COMPLETED|Overall Study||0
1039247|NCT00736229|2523588|P2|NOT COMPLETED|Overall Study||0
1039248|NCT00736229|2523589|P1|NOT COMPLETED|Overall Study||0
1039249|NCT00736229|2523587|P3|COMPLETED|Overall Study||84
1039250|NCT00736229|2523588|P2|COMPLETED|Overall Study||71
1039251|NCT00736229|2523589|P1|COMPLETED|Overall Study|All patients received bolus and fixed infusion of study drug, thus completed the study|40
1039252|NCT00736229|2523587|P3|STARTED|Overall Study|Historic Control|84
1039253|NCT00736229|2523588|P2|STARTED|Overall Study|Historic control|71
1039254|NCT00736229|2523589|P1|STARTED|Overall Study|Actively Enrolled|40
1039255|NCT00736242|2523602|P1|NOT COMPLETED|Overall Study||125
1039256|NCT00736242|2523602|P1|COMPLETED|Overall Study||107
1039257|NCT00736242|2523602|P1|Participants in Safety Analysis Set|Overall Study||229
1039258|NCT00736242|2523602|P1|STARTED|Overall Study||232
1039259|NCT00736255|2523615|P2|NOT COMPLETED|Overall Study||1
1039260|NCT00736255|2523616|P1|NOT COMPLETED|Overall Study||3
1039261|NCT00736255|2523615|P2|COMPLETED|Overall Study||14
1039262|NCT00736255|2523616|P1|COMPLETED|Overall Study||14
1039263|NCT00736255|2523615|P2|STARTED|Overall Study||15
1039264|NCT00736255|2523616|P1|STARTED|Overall Study||17
1039265|NCT00736333|2523626|P1|NOT COMPLETED|Overall Study||111
1039266|NCT00736333|2523626|P1|COMPLETED|Overall Study||56
1039267|NCT00736333|2523626|P1|STARTED|Overall Study||167
1039268|NCT00736385|2523637|P2|NOT COMPLETED|Overall Study||3
1039269|NCT00736385|2523638|P1|NOT COMPLETED|Overall Study||2
1039270|NCT00736385|2523637|P2|COMPLETED|Overall Study||2
1039271|NCT00736385|2523638|P1|COMPLETED|Overall Study||2
1039272|NCT00736385|2523637|P2|STARTED|Overall Study||5
1039273|NCT00736385|2523638|P1|STARTED|Overall Study||4
1039274|NCT00736476|2523652|P2|NOT COMPLETED|Overall Study||0
1039275|NCT00736476|2523653|P1|NOT COMPLETED|Overall Study||1
1039276|NCT00736476|2523652|P2|COMPLETED|Overall Study||27
1039277|NCT00736476|2523653|P1|COMPLETED|Overall Study||35
1039278|NCT00736476|2523652|P2|STARTED|Overall Study||27
1039279|NCT00736476|2523653|P1|STARTED|Overall Study||36
1039280|NCT00736489|2523673|P6|NOT COMPLETED|Period 6||0
1039281|NCT00736489|2523674|P5|NOT COMPLETED|Period 6||0
1039282|NCT00736489|2523675|P4|NOT COMPLETED|Period 6||0
1039283|NCT00736489|2523676|P3|NOT COMPLETED|Period 6||0
1039284|NCT00736489|2523677|P2|NOT COMPLETED|Period 6||0
1039285|NCT00736489|2523678|P1|NOT COMPLETED|Period 6||0
1039286|NCT00736489|2523673|P6|COMPLETED|Period 6||5
1039287|NCT00736489|2523674|P5|COMPLETED|Period 6||7
1039288|NCT00736489|2523675|P4|COMPLETED|Period 6||7
1039289|NCT00736489|2523676|P3|COMPLETED|Period 6||6
1039290|NCT00736489|2523677|P2|COMPLETED|Period 6||5
1039291|NCT00736489|2523678|P1|COMPLETED|Period 6||5
1039292|NCT00736489|2523673|P6|STARTED|Period 6||5
1039293|NCT00736489|2523674|P5|STARTED|Period 6||7
1039294|NCT00736489|2523675|P4|STARTED|Period 6||7
1039297|NCT00736489|2523678|P1|STARTED|Period 6||5
1039298|NCT00736489|2523673|P6|NOT COMPLETED|Period 5||0
1039299|NCT00736489|2523674|P5|NOT COMPLETED|Period 5||0
1039300|NCT00736489|2523675|P4|NOT COMPLETED|Period 5||0
1039301|NCT00736489|2523676|P3|NOT COMPLETED|Period 5||0
1039302|NCT00736489|2523677|P2|NOT COMPLETED|Period 5||0
1039303|NCT00736489|2523678|P1|NOT COMPLETED|Period 5||0
1039304|NCT00736489|2523673|P6|COMPLETED|Period 5||5
1039305|NCT00736489|2523674|P5|COMPLETED|Period 5||7
1039306|NCT00736489|2523675|P4|COMPLETED|Period 5||7
1039307|NCT00736489|2523676|P3|COMPLETED|Period 5||6
1039308|NCT00736489|2523677|P2|COMPLETED|Period 5||5
1039309|NCT00736489|2523678|P1|COMPLETED|Period 5||5
1039310|NCT00736489|2523673|P6|STARTED|Period 5||5
1039311|NCT00736489|2523674|P5|STARTED|Period 5||7
1039312|NCT00736489|2523675|P4|STARTED|Period 5||7
1039313|NCT00736489|2523676|P3|STARTED|Period 5||6
1039314|NCT00736489|2523677|P2|STARTED|Period 5||5
1039315|NCT00736489|2523678|P1|STARTED|Period 5||5
1039316|NCT00736489|2523673|P6|NOT COMPLETED|Period 4||0
1039317|NCT00736489|2523674|P5|NOT COMPLETED|Period 4||0
1039318|NCT00736489|2523675|P4|NOT COMPLETED|Period 4||0
1039319|NCT00736489|2523676|P3|NOT COMPLETED|Period 4||0
1039320|NCT00736489|2523677|P2|NOT COMPLETED|Period 4||0
1039321|NCT00736489|2523678|P1|NOT COMPLETED|Period 4||0
1039322|NCT00736489|2523673|P6|COMPLETED|Period 4||5
1039323|NCT00736489|2523674|P5|COMPLETED|Period 4||7
1039324|NCT00736489|2523675|P4|COMPLETED|Period 4||7
1039325|NCT00736489|2523676|P3|COMPLETED|Period 4||6
1039326|NCT00736489|2523677|P2|COMPLETED|Period 4||5
1039327|NCT00736489|2523678|P1|COMPLETED|Period 4||5
1039328|NCT00736489|2523673|P6|STARTED|Period 4||5
1039329|NCT00736489|2523674|P5|STARTED|Period 4||7
1039330|NCT00736489|2523675|P4|STARTED|Period 4||7
1039331|NCT00736489|2523676|P3|STARTED|Period 4||6
1039332|NCT00736489|2523677|P2|STARTED|Period 4||5
1039333|NCT00736489|2523678|P1|STARTED|Period 4||5
1039334|NCT00736489|2523673|P6|NOT COMPLETED|Period 3||0
1039335|NCT00736489|2523674|P5|NOT COMPLETED|Period 3||0
1039336|NCT00736489|2523675|P4|NOT COMPLETED|Period 3||0
1039337|NCT00736489|2523676|P3|NOT COMPLETED|Period 3||0
1039338|NCT00736489|2523677|P2|NOT COMPLETED|Period 3||0
1039339|NCT00736489|2523678|P1|NOT COMPLETED|Period 3||0
1039340|NCT00736489|2523673|P6|COMPLETED|Period 3||5
1039341|NCT00736489|2523674|P5|COMPLETED|Period 3||7
1039342|NCT00736489|2523675|P4|COMPLETED|Period 3||7
1039343|NCT00736489|2523676|P3|COMPLETED|Period 3||6
1039344|NCT00736489|2523677|P2|COMPLETED|Period 3||5
1039345|NCT00736489|2523678|P1|COMPLETED|Period 3||5
1039346|NCT00736489|2523673|P6|STARTED|Period 3||5
1039347|NCT00736489|2523674|P5|STARTED|Period 3||7
1039348|NCT00736489|2523675|P4|STARTED|Period 3||7
1039349|NCT00736489|2523676|P3|STARTED|Period 3||6
1039350|NCT00736489|2523677|P2|STARTED|Period 3||5
1039351|NCT00736489|2523678|P1|STARTED|Period 3||5
1039352|NCT00736489|2523673|P6|NOT COMPLETED|Period 2||0
1039353|NCT00736489|2523674|P5|NOT COMPLETED|Period 2||0
1039354|NCT00736489|2523675|P4|NOT COMPLETED|Period 2||0
1039355|NCT00736489|2523676|P3|NOT COMPLETED|Period 2||0
1039356|NCT00736489|2523677|P2|NOT COMPLETED|Period 2||0
1039357|NCT00736489|2523678|P1|NOT COMPLETED|Period 2||0
1039358|NCT00736489|2523673|P6|COMPLETED|Period 2||5
1039359|NCT00736489|2523674|P5|COMPLETED|Period 2||7
1039360|NCT00736489|2523675|P4|COMPLETED|Period 2||7
1039361|NCT00736489|2523676|P3|COMPLETED|Period 2||6
1039362|NCT00736489|2523677|P2|COMPLETED|Period 2||5
1039363|NCT00736489|2523678|P1|COMPLETED|Period 2||5
1039364|NCT00736489|2523673|P6|STARTED|Period 2||5
1039365|NCT00736489|2523674|P5|STARTED|Period 2||7
1039366|NCT00736489|2523675|P4|STARTED|Period 2||7
1039367|NCT00736489|2523676|P3|STARTED|Period 2||6
1039368|NCT00736489|2523677|P2|STARTED|Period 2||5
1039369|NCT00736489|2523678|P1|STARTED|Period 2||5
1039370|NCT00736489|2523673|P6|NOT COMPLETED|Period 1||1
1039371|NCT00736489|2523674|P5|NOT COMPLETED|Period 1||0
1039372|NCT00736489|2523675|P4|NOT COMPLETED|Period 1||0
1039373|NCT00736489|2523676|P3|NOT COMPLETED|Period 1||0
1039374|NCT00736489|2523677|P2|NOT COMPLETED|Period 1||0
1039375|NCT00736489|2523678|P1|NOT COMPLETED|Period 1||1
1039376|NCT00736489|2523673|P6|COMPLETED|Period 1||5
1039377|NCT00736489|2523674|P5|COMPLETED|Period 1||7
1039378|NCT00736489|2523675|P4|COMPLETED|Period 1||7
1039379|NCT00736489|2523676|P3|COMPLETED|Period 1||6
1039380|NCT00736489|2523677|P2|COMPLETED|Period 1||5
1039381|NCT00736489|2523678|P1|COMPLETED|Period 1||5
1039382|NCT00736489|2523673|P6|STARTED|Period 1||6
1039383|NCT00736489|2523674|P5|STARTED|Period 1||7
1039384|NCT00736489|2523675|P4|STARTED|Period 1||7
1039385|NCT00736489|2523676|P3|STARTED|Period 1||6
1039386|NCT00736489|2523677|P2|STARTED|Period 1||5
1039387|NCT00736489|2523678|P1|STARTED|Period 1|Cross-over study|6
1039388|NCT00736502|2523830|P1|NOT COMPLETED|Overall Study||65
1039389|NCT00736502|2523830|P1|COMPLETED|Overall Study||213
1039390|NCT00736502|2523830|P1|STARTED|Overall Study|Entered and treated.|278
1039391|NCT00738023|2523838|P2|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
1039392|NCT00738023|2523839|P1|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
1039393|NCT00738023|2523838|P2|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
1039394|NCT00738023|2523839|P1|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||19
1039395|NCT00738023|2523838|P2|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||0
1039396|NCT00738023|2523839|P1|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||19
1039397|NCT00738023|2523838|P2|NOT COMPLETED|Saline Infusion||0
1039398|NCT00738023|2523839|P1|NOT COMPLETED|Saline Infusion||0
1039399|NCT00738023|2523838|P2|COMPLETED|Saline Infusion||0
1039400|NCT00738023|2523839|P1|COMPLETED|Saline Infusion||19
1039401|NCT00738023|2523838|P2|STARTED|Saline Infusion||0
1039402|NCT00738023|2523839|P1|STARTED|Saline Infusion||19
1039403|NCT00738023|2523838|P2|NOT COMPLETED|Intralipid Infusion||0
1039404|NCT00738023|2523839|P1|NOT COMPLETED|Intralipid Infusion||0
1039405|NCT00738023|2523838|P2|COMPLETED|Intralipid Infusion||13
1039406|NCT00738023|2523839|P1|COMPLETED|Intralipid Infusion||19
1039407|NCT00738023|2523838|P2|STARTED|Intralipid Infusion||13
1039408|NCT00738023|2523839|P1|STARTED|Intralipid Infusion||19
1039409|NCT00738049|2523849|P2|NOT COMPLETED|Washout||0
1039410|NCT00738049|2523850|P1|NOT COMPLETED|Washout||0
1039411|NCT00738049|2523849|P2|COMPLETED|Washout||7
1039412|NCT00738049|2523850|P1|COMPLETED|Washout||13
1039413|NCT00738049|2523849|P2|STARTED|Washout||7
1039414|NCT00738049|2523850|P1|STARTED|Washout||13
1039415|NCT00738049|2523849|P2|NOT COMPLETED|2nd Intervention(14 Days)||0
1039416|NCT00738049|2523850|P1|NOT COMPLETED|2nd Intervention(14 Days)||0
1039417|NCT00738049|2523849|P2|COMPLETED|2nd Intervention(14 Days)||7
1039418|NCT00738049|2523850|P1|COMPLETED|2nd Intervention(14 Days)||13
1039419|NCT00738049|2523849|P2|STARTED|2nd Intervention(14 Days)||7
1039420|NCT00738049|2523850|P1|STARTED|2nd Intervention(14 Days)||13
1039421|NCT00738049|2523849|P2|NOT COMPLETED|1st Intervention(14 Days)||0
1039422|NCT00738049|2523850|P1|NOT COMPLETED|1st Intervention(14 Days)||0
1039423|NCT00738049|2523849|P2|COMPLETED|1st Intervention(14 Days)||7
1039424|NCT00738049|2523850|P1|COMPLETED|1st Intervention(14 Days)||13
1039425|NCT00738049|2523849|P2|STARTED|1st Intervention(14 Days)||7
1039426|NCT00738049|2523850|P1|STARTED|1st Intervention(14 Days)||13
1039427|NCT00738062|2523865|P3|NOT COMPLETED|Open-Label Extension||0
1039428|NCT00738062|2523866|P2|NOT COMPLETED|Open-Label Extension||0
1039429|NCT00738062|2523867|P1|NOT COMPLETED|Open-Label Extension||17
1039430|NCT00738062|2523865|P3|COMPLETED|Open-Label Extension||0
1039431|NCT00738062|2523866|P2|COMPLETED|Open-Label Extension||0
1039432|NCT00738062|2523867|P1|COMPLETED|Open-Label Extension||57
1039433|NCT00738062|2523865|P3|STARTED|Open-Label Extension||0
1039434|NCT00738062|2523866|P2|STARTED|Open-Label Extension||0
1039435|NCT00738062|2523867|P1|STARTED|Open-Label Extension|One patient completed double blind randomization but did not enter the open label extension|74
1039436|NCT00738062|2523865|P3|NOT COMPLETED|2 Week Randomized Withdrawal||0
1039437|NCT00738062|2523866|P2|NOT COMPLETED|2 Week Randomized Withdrawal||0
1039438|NCT00738062|2523867|P1|NOT COMPLETED|2 Week Randomized Withdrawal||0
1039439|NCT00738062|2523865|P3|COMPLETED|2 Week Randomized Withdrawal||37
1039440|NCT00738062|2523866|P2|COMPLETED|2 Week Randomized Withdrawal||38
1039441|NCT00738062|2523867|P1|COMPLETED|2 Week Randomized Withdrawal||0
1039442|NCT00738062|2523865|P3|STARTED|2 Week Randomized Withdrawal||37
1039443|NCT00738062|2523866|P2|STARTED|2 Week Randomized Withdrawal||38
1039444|NCT00738062|2523867|P1|STARTED|2 Week Randomized Withdrawal|Patients completing the open label titration phase were randomized to either Droxidopa or Placebo|0
1039445|NCT00738062|2523865|P3|NOT COMPLETED|Open Label Treatment||0
1039446|NCT00738062|2523866|P2|NOT COMPLETED|Open Label Treatment||0
1039447|NCT00738062|2523867|P1|NOT COMPLETED|Open Label Treatment||28
1039448|NCT00738062|2523865|P3|COMPLETED|Open Label Treatment||0
1039449|NCT00738062|2523866|P2|COMPLETED|Open Label Treatment||0
1039450|NCT00738062|2523867|P1|COMPLETED|Open Label Treatment||75
1039451|NCT00738062|2523865|P3|STARTED|Open Label Treatment||0
1039452|NCT00738062|2523866|P2|STARTED|Open Label Treatment||0
1039453|NCT00738062|2523867|P1|STARTED|Open Label Treatment||103
1039454|NCT00738283|2523892|P1|NOT COMPLETED|Overall Study||4
1039455|NCT00738283|2523892|P1|COMPLETED|Overall Study||13
1039456|NCT00738283|2523892|P1|STARTED|Overall Study||17
1039457|NCT00738361|2523896|P1|NOT COMPLETED|Overall Study||0
1039458|NCT00738361|2523896|P1|COMPLETED|Overall Study||4
1039459|NCT00738361|2523896|P1|STARTED|Overall Study||4
1039460|NCT00738374|2523905|P4|NOT COMPLETED|Maintenance Treatment/Observation Phase||12
1039461|NCT00738374|2523906|P3|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
1039462|NCT00738374|2523907|P2|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
1039463|NCT00738374|2523908|P1|NOT COMPLETED|Maintenance Treatment/Observation Phase||0
1039464|NCT00738374|2523905|P4|COMPLETED|Maintenance Treatment/Observation Phase||20
1039465|NCT00738374|2523906|P3|COMPLETED|Maintenance Treatment/Observation Phase||27
1039466|NCT00738374|2523907|P2|COMPLETED|Maintenance Treatment/Observation Phase||0
1039467|NCT00738374|2523908|P1|COMPLETED|Maintenance Treatment/Observation Phase||0
1039468|NCT00738374|2523905|P4|STARTED|Maintenance Treatment/Observation Phase||32
1039469|NCT00738374|2523906|P3|STARTED|Maintenance Treatment/Observation Phase||34
1039470|NCT00738374|2523907|P2|STARTED|Maintenance Treatment/Observation Phase||7
1039471|NCT00738374|2523908|P1|STARTED|Maintenance Treatment/Observation Phase|Participants were randomized to either maintenance therapy or observation at the end of induction.|0
1039472|NCT00738374|2523905|P4|NOT COMPLETED|Induction Treatment Phase||0
1039473|NCT00738374|2523906|P3|NOT COMPLETED|Induction Treatment Phase||0
1039474|NCT00738374|2523907|P2|NOT COMPLETED|Induction Treatment Phase||0
1039475|NCT00738374|2523908|P1|NOT COMPLETED|Induction Treatment Phase||24
1039476|NCT00738374|2523905|P4|COMPLETED|Induction Treatment Phase||0
1039477|NCT00738374|2523906|P3|COMPLETED|Induction Treatment Phase||0
1039478|NCT00738374|2523907|P2|COMPLETED|Induction Treatment Phase||0
1039479|NCT00738374|2523908|P1|COMPLETED|Induction Treatment Phase||73
1039480|NCT00738374|2523905|P4|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
1039481|NCT00738374|2523906|P3|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
1039482|NCT00738374|2523907|P2|STARTED|Induction Treatment Phase||0
1039483|NCT00738374|2523908|P1|STARTED|Induction Treatment Phase||97
1039484|NCT00738400|2523942|P2|NOT COMPLETED|Overall Study||7
1039485|NCT00738400|2523943|P1|NOT COMPLETED|Overall Study||4
1039486|NCT00738400|2523942|P2|COMPLETED|Overall Study||67
1039487|NCT00738400|2523943|P1|COMPLETED|Overall Study||72
1039488|NCT00738400|2523942|P2|ITT (Intent To Treatment) Population|Overall Study|No post-baseline efficacy measurement in 2 participants|70
1039489|NCT00738400|2523943|P1|ITT (Intent To Treatment) Population|Overall Study||75
1039490|NCT00738400|2523942|P2|Received Treatment, Safety Population|Overall Study|Two invalid participants (no evidence that these randomized participants took study medication).|72
1039491|NCT00738400|2523943|P1|Received Treatment, Safety Population|Overall Study|One invalid participant (no evidence that this randomized participant took study medication).|75
1039492|NCT00738400|2523942|P2|STARTED|Overall Study||74
1039493|NCT00738400|2523943|P1|STARTED|Overall Study||76
1039494|NCT00738426|2523963|P2|NOT COMPLETED|Overall Study||3
1039495|NCT00738426|2523964|P1|NOT COMPLETED|Overall Study||2
1039496|NCT00738426|2523963|P2|COMPLETED|Overall Study||32
1039497|NCT00738426|2523964|P1|COMPLETED|Overall Study||35
1039498|NCT00738426|2523963|P2|STARTED|Overall Study||35
1039499|NCT00738426|2523964|P1|STARTED|Overall Study||37
1039500|NCT00738530|2523972|P2|NOT COMPLETED|Overall Study||238
1039501|NCT00738530|2523973|P1|NOT COMPLETED|Overall Study||234
1039502|NCT00738530|2523972|P2|COMPLETED|Overall Study||84
1039503|NCT00738530|2523973|P1|COMPLETED|Overall Study||93
1039504|NCT00738530|2523972|P2|Treated|Overall Study||316
1039505|NCT00738530|2523973|P1|Treated|Overall Study||325
1039506|NCT00738530|2523972|P2|STARTED|Overall Study||322
1039507|NCT00738530|2523973|P1|STARTED|Overall Study||327
1039508|NCT00738543|2523997|P1|NOT COMPLETED|Control||0
1039509|NCT00738543|2523997|P1|COMPLETED|Control||48
1039510|NCT00738543|2523997|P1|STARTED|Control||48
1039511|NCT00738543|2523997|P1|NOT COMPLETED|Sodium Hypochlorite||0
1039512|NCT00738543|2523997|P1|COMPLETED|Sodium Hypochlorite||48
1039513|NCT00738543|2523997|P1|STARTED|Sodium Hypochlorite||48
1039514|NCT00738543|2523997|P1|NOT COMPLETED|Povidone Iodine||0
1039515|NCT00738543|2523997|P1|COMPLETED|Povidone Iodine||48
1039516|NCT00738543|2523997|P1|STARTED|Povidone Iodine||48
1039517|NCT00738673|2524007|P2|NOT COMPLETED|Overall Study||11
1039518|NCT00738673|2524008|P1|NOT COMPLETED|Overall Study||24
1039519|NCT00738673|2524007|P2|COMPLETED|Overall Study||1
1039520|NCT00738673|2524008|P1|COMPLETED|Overall Study||1
1039521|NCT00738673|2524007|P2|Intent to Treat Population|Overall Study||12
1039522|NCT00738673|2524008|P1|Intent to Treat Population|Overall Study||24
1039523|NCT00738673|2524007|P2|STARTED|Overall Study||12
1039524|NCT00738673|2524008|P1|STARTED|Overall Study||25
1039525|NCT00738699|2524038|P2|NOT COMPLETED|Overall Study||140
1039526|NCT00738699|2524039|P1|NOT COMPLETED|Overall Study||275
1039527|NCT00738699|2524038|P2|COMPLETED|Overall Study||0
1039528|NCT00738699|2524039|P1|COMPLETED|Overall Study||0
1039529|NCT00738699|2524038|P2|Participants Treated|Overall Study||139
1039530|NCT00738699|2524039|P1|Participants Treated|Overall Study||273
1039531|NCT00738699|2524038|P2|Participants Not Treated|Overall Study||1
1039532|NCT00738699|2524039|P1|Participants Not Treated|Overall Study||2
1039533|NCT00738699|2524038|P2|STARTED|Overall Study||140
1039534|NCT00738699|2524039|P1|STARTED|Overall Study||275
1039535|NCT00738881|2524057|P2|NOT COMPLETED|Overall Study||2
1039536|NCT00738881|2524058|P1|NOT COMPLETED|Overall Study||0
1039537|NCT00738881|2524057|P2|COMPLETED|Overall Study||10
1039538|NCT00738881|2524058|P1|COMPLETED|Overall Study||11
1039539|NCT00738881|2524057|P2|STARTED|Overall Study||12
1039540|NCT00738881|2524058|P1|STARTED|Overall Study||11
1039553|NCT00739024|2524089|P2|NOT COMPLETED|Overall Study||0
1039554|NCT00739024|2524090|P1|NOT COMPLETED|Overall Study||0
1039555|NCT00739024|2524089|P2|COMPLETED|Overall Study||6
1039556|NCT00739024|2524090|P1|COMPLETED|Overall Study||7
1039557|NCT00739024|2524089|P2|STARTED|Overall Study||6
1039558|NCT00739024|2524090|P1|STARTED|Overall Study||7
1039559|NCT00739050|2524096|P2|NOT COMPLETED|Overall Study||0
1039560|NCT00739050|2524097|P1|NOT COMPLETED|Overall Study||1
1039561|NCT00739050|2524096|P2|COMPLETED|Overall Study||0
1039562|NCT00739050|2524097|P1|COMPLETED|Overall Study|These 3 patients completing treatment did not complete the required procedures during the trial.|3
1039563|NCT00739050|2524096|P2|STARTED|Overall Study||0
1039564|NCT00739050|2524097|P1|STARTED|Overall Study||4
1039565|NCT00739063|2524109|P1|NOT COMPLETED|Overall Study||8
1039566|NCT00739063|2524109|P1|COMPLETED|Overall Study||3
1039567|NCT00739063|2524109|P1|STARTED|Overall Study||11
1039568|NCT00739102|2524113|P1|NOT COMPLETED|Overall Study||15
1039569|NCT00739102|2524113|P1|COMPLETED|Overall Study|Completed 12-Month Follow-up|235
1039570|NCT00739102|2524113|P1|STARTED|Overall Study||250
1039571|NCT00739297|2524129|P7|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
1039572|NCT00739297|2524130|P6|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
1039573|NCT00739297|2524131|P5|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
1039574|NCT00739297|2524132|P4|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
1039575|NCT00739297|2524133|P3|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
1039576|NCT00739297|2524134|P2|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
1039577|NCT00739297|2524135|P1|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
1039578|NCT00739297|2524129|P7|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||65
1039579|NCT00739297|2524130|P6|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
1039580|NCT00739297|2524131|P5|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||7
1039581|NCT00739297|2524132|P4|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||15
1039582|NCT00739297|2524133|P3|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
1039583|NCT00739297|2524134|P2|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||11
1039584|NCT00739297|2524135|P1|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||16
1039585|NCT00739297|2524129|P7|STARTED|Fourth Intervention(Visit 9 to Visit 10)||66
1039586|NCT00739297|2524130|P6|STARTED|Fourth Intervention(Visit 9 to Visit 10)||9
1039587|NCT00739297|2524131|P5|STARTED|Fourth Intervention(Visit 9 to Visit 10)||7
1039588|NCT00739297|2524132|P4|STARTED|Fourth Intervention(Visit 9 to Visit 10)||15
1039589|NCT00739297|2524133|P3|STARTED|Fourth Intervention(Visit 9 to Visit 10)||8
1039590|NCT00739297|2524134|P2|STARTED|Fourth Intervention(Visit 9 to Visit 10)||11
1039591|NCT00739297|2524135|P1|STARTED|Fourth Intervention(Visit 9 to Visit 10)||16
1039592|NCT00739297|2524129|P7|NOT COMPLETED|Third Washout Period of 4-7 Days||0
1039593|NCT00739297|2524130|P6|NOT COMPLETED|Third Washout Period of 4-7 Days||0
1039594|NCT00739297|2524131|P5|NOT COMPLETED|Third Washout Period of 4-7 Days||0
1039595|NCT00739297|2524132|P4|NOT COMPLETED|Third Washout Period of 4-7 Days||0
1039596|NCT00739297|2524133|P3|NOT COMPLETED|Third Washout Period of 4-7 Days||0
1039597|NCT00739297|2524134|P2|NOT COMPLETED|Third Washout Period of 4-7 Days||0
1039598|NCT00739297|2524135|P1|NOT COMPLETED|Third Washout Period of 4-7 Days||0
1039599|NCT00739297|2524129|P7|COMPLETED|Third Washout Period of 4-7 Days||66
1039600|NCT00739297|2524130|P6|COMPLETED|Third Washout Period of 4-7 Days||8
1039601|NCT00739297|2524131|P5|COMPLETED|Third Washout Period of 4-7 Days||6
1039602|NCT00739297|2524132|P4|COMPLETED|Third Washout Period of 4-7 Days||18
1039603|NCT00739297|2524133|P3|COMPLETED|Third Washout Period of 4-7 Days||6
1039604|NCT00739297|2524134|P2|COMPLETED|Third Washout Period of 4-7 Days||12
1039605|NCT00739297|2524135|P1|COMPLETED|Third Washout Period of 4-7 Days||16
1039606|NCT00739297|2524129|P7|STARTED|Third Washout Period of 4-7 Days||66
1039607|NCT00739297|2524130|P6|STARTED|Third Washout Period of 4-7 Days||8
1039608|NCT00739297|2524131|P5|STARTED|Third Washout Period of 4-7 Days||6
1039609|NCT00739297|2524132|P4|STARTED|Third Washout Period of 4-7 Days||18
1039610|NCT00739297|2524133|P3|STARTED|Third Washout Period of 4-7 Days||6
1039611|NCT00739297|2524134|P2|STARTED|Third Washout Period of 4-7 Days||12
1039612|NCT00739297|2524135|P1|STARTED|Third Washout Period of 4-7 Days||16
1039613|NCT00739297|2524129|P7|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
1039614|NCT00739297|2524130|P6|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
1039615|NCT00739297|2524131|P5|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
1039616|NCT00739297|2524132|P4|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
1039617|NCT00739297|2524133|P3|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
1039618|NCT00739297|2524134|P2|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
1039619|NCT00739297|2524135|P1|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
1039620|NCT00739297|2524129|P7|COMPLETED|Third Intervention (Visit 7 to Visit 8)||66
1039621|NCT00739297|2524130|P6|COMPLETED|Third Intervention (Visit 7 to Visit 8)||8
1039622|NCT00739297|2524131|P5|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
1039623|NCT00739297|2524132|P4|COMPLETED|Third Intervention (Visit 7 to Visit 8)||18
1039624|NCT00739297|2524133|P3|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
1039625|NCT00739297|2524134|P2|COMPLETED|Third Intervention (Visit 7 to Visit 8)||12
1039626|NCT00739297|2524135|P1|COMPLETED|Third Intervention (Visit 7 to Visit 8)||16
1039627|NCT00739297|2524129|P7|STARTED|Third Intervention (Visit 7 to Visit 8)||66
1039628|NCT00739297|2524130|P6|STARTED|Third Intervention (Visit 7 to Visit 8)||8
1039629|NCT00739297|2524131|P5|STARTED|Third Intervention (Visit 7 to Visit 8)||6
1039630|NCT00739297|2524132|P4|STARTED|Third Intervention (Visit 7 to Visit 8)||18
1039631|NCT00739297|2524133|P3|STARTED|Third Intervention (Visit 7 to Visit 8)||6
1039632|NCT00739297|2524134|P2|STARTED|Third Intervention (Visit 7 to Visit 8)||12
1039633|NCT00739297|2524135|P1|STARTED|Third Intervention (Visit 7 to Visit 8)||16
1039634|NCT00739297|2524129|P7|NOT COMPLETED|Second Washout Period of 4-7 Days||0
1039635|NCT00739297|2524130|P6|NOT COMPLETED|Second Washout Period of 4-7 Days||0
1039636|NCT00739297|2524131|P5|NOT COMPLETED|Second Washout Period of 4-7 Days||0
1039637|NCT00739297|2524132|P4|NOT COMPLETED|Second Washout Period of 4-7 Days||0
1039638|NCT00739297|2524133|P3|NOT COMPLETED|Second Washout Period of 4-7 Days||0
1039639|NCT00739297|2524134|P2|NOT COMPLETED|Second Washout Period of 4-7 Days||0
1039640|NCT00739297|2524135|P1|NOT COMPLETED|Second Washout Period of 4-7 Days||0
1039641|NCT00739297|2524129|P7|COMPLETED|Second Washout Period of 4-7 Days||66
1039642|NCT00739297|2524130|P6|COMPLETED|Second Washout Period of 4-7 Days||10
1039643|NCT00739297|2524131|P5|COMPLETED|Second Washout Period of 4-7 Days||6
1039644|NCT00739297|2524132|P4|COMPLETED|Second Washout Period of 4-7 Days||14
1039645|NCT00739297|2524133|P3|COMPLETED|Second Washout Period of 4-7 Days||10
1039646|NCT00739297|2524134|P2|COMPLETED|Second Washout Period of 4-7 Days||8
1039647|NCT00739297|2524135|P1|COMPLETED|Second Washout Period of 4-7 Days||18
1039648|NCT00739297|2524129|P7|STARTED|Second Washout Period of 4-7 Days||66
1039649|NCT00739297|2524130|P6|STARTED|Second Washout Period of 4-7 Days||10
1039650|NCT00739297|2524131|P5|STARTED|Second Washout Period of 4-7 Days||6
1039651|NCT00739297|2524132|P4|STARTED|Second Washout Period of 4-7 Days||14
1039652|NCT00739297|2524133|P3|STARTED|Second Washout Period of 4-7 Days||10
1039653|NCT00739297|2524134|P2|STARTED|Second Washout Period of 4-7 Days||8
1039654|NCT00739297|2524135|P1|STARTED|Second Washout Period of 4-7 Days||18
1039655|NCT00739297|2524129|P7|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
1039656|NCT00739297|2524130|P6|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
1039657|NCT00739297|2524131|P5|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
1039658|NCT00739297|2524132|P4|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
1039659|NCT00739297|2524133|P3|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
1039660|NCT00739297|2524134|P2|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
1039661|NCT00739297|2524135|P1|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
1039662|NCT00739297|2524129|P7|COMPLETED|Second Intervention (Visit 5 to Visit 6)||66
1039663|NCT00739297|2524130|P6|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
1039664|NCT00739297|2524131|P5|COMPLETED|Second Intervention (Visit 5 to Visit 6)||6
1039665|NCT00739297|2524132|P4|COMPLETED|Second Intervention (Visit 5 to Visit 6)||14
1039666|NCT00739297|2524133|P3|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
1039667|NCT00739297|2524134|P2|COMPLETED|Second Intervention (Visit 5 to Visit 6)||8
1039668|NCT00739297|2524135|P1|COMPLETED|Second Intervention (Visit 5 to Visit 6)||18
1039669|NCT00739297|2524129|P7|STARTED|Second Intervention (Visit 5 to Visit 6)||66
1039670|NCT00739297|2524130|P6|STARTED|Second Intervention (Visit 5 to Visit 6)||10
1039671|NCT00739297|2524131|P5|STARTED|Second Intervention (Visit 5 to Visit 6)||6
1039672|NCT00739297|2524132|P4|STARTED|Second Intervention (Visit 5 to Visit 6)||14
1039673|NCT00739297|2524133|P3|STARTED|Second Intervention (Visit 5 to Visit 6)||10
1039674|NCT00739297|2524134|P2|STARTED|Second Intervention (Visit 5 to Visit 6)||8
1039675|NCT00739297|2524135|P1|STARTED|Second Intervention (Visit 5 to Visit 6)||18
1039676|NCT00739297|2524129|P7|NOT COMPLETED|First Washout Period of 4-7 Days||2
1039677|NCT00739297|2524130|P6|NOT COMPLETED|First Washout Period of 4-7 Days||0
1039678|NCT00739297|2524131|P5|NOT COMPLETED|First Washout Period of 4-7 Days||0
1039679|NCT00739297|2524132|P4|NOT COMPLETED|First Washout Period of 4-7 Days||2
1039680|NCT00739297|2524133|P3|NOT COMPLETED|First Washout Period of 4-7 Days||0
1039681|NCT00739297|2524134|P2|NOT COMPLETED|First Washout Period of 4-7 Days||0
1039682|NCT00739297|2524135|P1|NOT COMPLETED|First Washout Period of 4-7 Days||0
1039683|NCT00739297|2524129|P7|COMPLETED|First Washout Period of 4-7 Days||66
1039684|NCT00739297|2524130|P6|COMPLETED|First Washout Period of 4-7 Days||9
1039685|NCT00739297|2524131|P5|COMPLETED|First Washout Period of 4-7 Days||6
1039686|NCT00739297|2524132|P4|COMPLETED|First Washout Period of 4-7 Days||17
1039687|NCT00739297|2524133|P3|COMPLETED|First Washout Period of 4-7 Days||6
1039688|NCT00739297|2524134|P2|COMPLETED|First Washout Period of 4-7 Days||11
1039689|NCT00739297|2524135|P1|COMPLETED|First Washout Period of 4-7 Days||17
1039690|NCT00739297|2524129|P7|STARTED|First Washout Period of 4-7 Days||68
1039691|NCT00739297|2524130|P6|STARTED|First Washout Period of 4-7 Days||9
1039692|NCT00739297|2524131|P5|STARTED|First Washout Period of 4-7 Days||6
1039693|NCT00739297|2524132|P4|STARTED|First Washout Period of 4-7 Days||19
1039694|NCT00739297|2524133|P3|STARTED|First Washout Period of 4-7 Days||6
1039695|NCT00739297|2524134|P2|STARTED|First Washout Period of 4-7 Days||11
1039696|NCT00739297|2524135|P1|STARTED|First Washout Period of 4-7 Days||17
1039697|NCT00739297|2524129|P7|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
1039698|NCT00739297|2524130|P6|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
1039699|NCT00739297|2524131|P5|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
1039700|NCT00739297|2524132|P4|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
1039701|NCT00739297|2524133|P3|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
1039702|NCT00739297|2524134|P2|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
1039703|NCT00739297|2524135|P1|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
1039704|NCT00739297|2524129|P7|COMPLETED|First Intervention (Visit 3 to Visit 4)||68
1039705|NCT00739297|2524130|P6|COMPLETED|First Intervention (Visit 3 to Visit 4)||9
1039706|NCT00739297|2524131|P5|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
1039707|NCT00739297|2524132|P4|COMPLETED|First Intervention (Visit 3 to Visit 4)||19
1039708|NCT00739297|2524133|P3|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
1039709|NCT00739297|2524134|P2|COMPLETED|First Intervention (Visit 3 to Visit 4)||11
1039710|NCT00739297|2524135|P1|COMPLETED|First Intervention (Visit 3 to Visit 4)||17
1039711|NCT00739297|2524129|P7|STARTED|First Intervention (Visit 3 to Visit 4)||68
1039712|NCT00739297|2524130|P6|STARTED|First Intervention (Visit 3 to Visit 4)||9
1039713|NCT00739297|2524131|P5|STARTED|First Intervention (Visit 3 to Visit 4)||6
1039714|NCT00739297|2524132|P4|STARTED|First Intervention (Visit 3 to Visit 4)||19
1039715|NCT00739297|2524133|P3|STARTED|First Intervention (Visit 3 to Visit 4)||6
1039716|NCT00739297|2524134|P2|STARTED|First Intervention (Visit 3 to Visit 4)||11
1039717|NCT00739297|2524135|P1|STARTED|First Intervention (Visit 3 to Visit 4)||17
1039718|NCT00739310|2524163|P1|NOT COMPLETED|Overall Study||7
1039719|NCT00739310|2524163|P1|COMPLETED|Overall Study||22
1039720|NCT00739310|2524163|P1|STARTED|Overall Study||29
1039721|NCT00739336|2524170|P2|NOT COMPLETED|Overall Study||0
1039722|NCT00739336|2524171|P1|NOT COMPLETED|Overall Study||4
1039723|NCT00739336|2524170|P2|COMPLETED|Overall Study||24
1039724|NCT00739336|2524171|P1|COMPLETED|Overall Study||17
1039725|NCT00739336|2524170|P2|STARTED|Overall Study||24
1039726|NCT00739336|2524171|P1|STARTED|Overall Study||21
1039727|NCT00739583|2524185|P2|NOT COMPLETED|Overall Study||0
1039728|NCT00739583|2524186|P1|NOT COMPLETED|Overall Study||0
1039729|NCT00739583|2524185|P2|COMPLETED|Overall Study||10
1039730|NCT00739583|2524186|P1|COMPLETED|Overall Study||10
1039731|NCT00739583|2524185|P2|STARTED|Overall Study||10
1039732|NCT00739583|2524186|P1|STARTED|Overall Study||10
1039733|NCT00739596|2524198|P2|NOT COMPLETED|Overall Study||17
1039734|NCT00739596|2524199|P1|NOT COMPLETED|Overall Study||25
1039735|NCT00739596|2524198|P2|COMPLETED|Overall Study||149
1039736|NCT00739596|2524199|P1|COMPLETED|Overall Study||141
1039737|NCT00739596|2524198|P2|STARTED|Overall Study||166
1039738|NCT00739596|2524199|P1|STARTED|Overall Study||166
1039739|NCT00739648|2524215|P2|NOT COMPLETED|Overall Study||53
1039740|NCT00739648|2524216|P1|NOT COMPLETED|Overall Study||26
1039741|NCT00739648|2524215|P2|COMPLETED|Overall Study||161
1039742|NCT00739648|2524216|P1|COMPLETED|Overall Study||82
1039743|NCT00739648|2524215|P2|STARTED|Overall Study||214
1039744|NCT00739648|2524216|P1|STARTED|Overall Study||108
1039745|NCT00739661|2524230|P2|NOT COMPLETED|Overall Study||42
1039746|NCT00739661|2524231|P1|NOT COMPLETED|Overall Study||46
1039747|NCT00739661|2524230|P2|COMPLETED|Overall Study||10
1039748|NCT00739661|2524231|P1|COMPLETED|Overall Study||6
1039749|NCT00739661|2524230|P2|STARTED|Overall Study||52
1039750|NCT00739661|2524231|P1|STARTED|Overall Study||52
1039751|NCT00739674|2524243|P2|NOT COMPLETED|Overall Study||122
1039752|NCT00739674|2524244|P1|NOT COMPLETED|Overall Study||181
1039753|NCT00739674|2524243|P2|COMPLETED|Overall Study||335
1039754|NCT00739674|2524244|P1|COMPLETED|Overall Study||354
1039755|NCT00739674|2524243|P2|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|400
1039756|NCT00739674|2524244|P1|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|463
1039757|NCT00739674|2524243|P2|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|9
1039758|NCT00739674|2524244|P1|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|1
1039759|NCT00739674|2524243|P2|No Follow-up Data|Overall Study||18
1039760|NCT00739674|2524244|P1|No Follow-up Data|Overall Study||33
1039761|NCT00739674|2524243|P2|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|13
1039762|NCT00739674|2524244|P1|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|19
1039763|NCT00739674|2524243|P2|Screening Failures|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|17
1039764|NCT00739674|2524244|P1|Screening Failures|Overall Study||19
1039765|NCT00739674|2524243|P2|STARTED|Overall Study||457
1039766|NCT00739674|2524244|P1|STARTED|Overall Study||535
1039767|NCT00739765|2524273|P3|NOT COMPLETED|Overall Study||11
1039768|NCT00739765|2524274|P2|NOT COMPLETED|Overall Study||11
1039769|NCT00739765|2524275|P1|NOT COMPLETED|Overall Study||6
1039770|NCT00739765|2524273|P3|COMPLETED|Overall Study||21
1039771|NCT00739765|2524274|P2|COMPLETED|Overall Study||27
1039772|NCT00739765|2524275|P1|COMPLETED|Overall Study||34
1039773|NCT00739765|2524273|P3|STARTED|Overall Study||32
1039774|NCT00739765|2524274|P2|STARTED|Overall Study||38
1039775|NCT00739765|2524275|P1|STARTED|Overall Study||40
1039776|NCT00739882|2524288|P2|NOT COMPLETED|Open-label Period||5
1039777|NCT00739882|2524289|P1|NOT COMPLETED|Open-label Period||10
1039778|NCT00739882|2524288|P2|COMPLETED|Open-label Period||9
1039779|NCT00739882|2524289|P1|COMPLETED|Open-label Period||7
1039780|NCT00739882|2524288|P2|STARTED|Open-label Period||14
1039781|NCT00739882|2524289|P1|STARTED|Open-label Period||17
1039782|NCT00739882|2524288|P2|NOT COMPLETED|Double-blind Period||11
1039783|NCT00739882|2524289|P1|NOT COMPLETED|Double-blind Period||19
1039784|NCT00739882|2524288|P2|COMPLETED|Double-blind Period||14
1039785|NCT00739882|2524289|P1|COMPLETED|Double-blind Period||32
1039786|NCT00739882|2524288|P2|STARTED|Double-blind Period||25
1039787|NCT00739882|2524289|P1|STARTED|Double-blind Period||51
1039788|NCT00739908|2524309|P2|NOT COMPLETED|Overall Study||25
1039789|NCT00739908|2524310|P1|NOT COMPLETED|Overall Study||25
1039790|NCT00739908|2524309|P2|COMPLETED|Overall Study||118
1039791|NCT00739908|2524310|P1|COMPLETED|Overall Study||117
1039792|NCT00739908|2524309|P2|STARTED|Overall Study||143
1039793|NCT00739908|2524310|P1|STARTED|Overall Study||142
1039794|NCT00739934|2524328|P1|NOT COMPLETED|Voriconazole Oral||3
1039795|NCT00739934|2524328|P1|COMPLETED|Voriconazole Oral||31
1039796|NCT00739934|2524328|P1|STARTED|Voriconazole Oral||34
1039797|NCT00739934|2524328|P1|NOT COMPLETED|Voriconazole IV||6
1039798|NCT00739934|2524328|P1|COMPLETED|Voriconazole IV||34
1039799|NCT00739934|2524328|P1|STARTED|Voriconazole IV||40
1039800|NCT00739973|2524357|P9|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||14
1039801|NCT00739973|2524358|P8|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||10
1039802|NCT00739973|2524359|P7|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||13
1039803|NCT00739973|2524360|P6|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
1039804|NCT00739973|2524361|P5|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
1039805|NCT00739973|2524362|P4|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
1039806|NCT00739973|2524363|P3|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
1039807|NCT00739973|2524364|P2|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||20
1039808|NCT00739973|2524365|P1|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||30
1039809|NCT00739973|2524357|P9|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
1039810|NCT00739973|2524358|P8|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
1039811|NCT00739973|2524359|P7|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
1039812|NCT00739973|2524360|P6|COMPLETED|Double-blind:Randomized Period (8 Weeks)||169
1039813|NCT00739973|2524361|P5|COMPLETED|Double-blind:Randomized Period (8 Weeks)||162
1039814|NCT00739973|2524362|P4|COMPLETED|Double-blind:Randomized Period (8 Weeks)||173
1039815|NCT00739973|2524363|P3|COMPLETED|Double-blind:Randomized Period (8 Weeks)||184
1039816|NCT00739973|2524364|P2|COMPLETED|Double-blind:Randomized Period (8 Weeks)||175
1039817|NCT00739973|2524365|P1|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
1039818|NCT00739973|2524357|P9|STARTED|Double-blind:Randomized Period (8 Weeks)||184
1039819|NCT00739973|2524358|P8|STARTED|Double-blind:Randomized Period (8 Weeks)||178
1039820|NCT00739973|2524359|P7|STARTED|Double-blind:Randomized Period (8 Weeks)|2 pts. were mis-randomized, so discontinued from single-blind and were untreated in double-blind.|183
1039821|NCT00739973|2524360|P6|STARTED|Double-blind:Randomized Period (8 Weeks)||181
1039822|NCT00739973|2524361|P5|STARTED|Double-blind:Randomized Period (8 Weeks)||181
1039823|NCT00739973|2524362|P4|STARTED|Double-blind:Randomized Period (8 Weeks)||185
1039824|NCT00739973|2524363|P3|STARTED|Double-blind:Randomized Period (8 Weeks)||203
1039825|NCT00739973|2524364|P2|STARTED|Double-blind:Randomized Period (8 Weeks)|One pt. was mis-randomized, so discontinued from single-blind and was untreated in the double-blind.|195
1039826|NCT00739973|2524365|P1|STARTED|Double-blind:Randomized Period (8 Weeks)||198
1039827|NCT00739973|2524357|P9|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1039828|NCT00739973|2524358|P8|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1039829|NCT00739973|2524359|P7|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1039830|NCT00739973|2524360|P6|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1039831|NCT00739973|2524361|P5|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1039832|NCT00739973|2524362|P4|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1039833|NCT00739973|2524363|P3|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1039834|NCT00739973|2524364|P2|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1039835|NCT00739973|2524365|P1|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||1009
1039836|NCT00739973|2524357|P9|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1039837|NCT00739973|2524358|P8|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1039838|NCT00739973|2524359|P7|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1039839|NCT00739973|2524360|P6|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1039840|NCT00739973|2524361|P5|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1039841|NCT00739973|2524362|P4|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1039842|NCT00739973|2524363|P3|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1039843|NCT00739973|2524364|P2|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
1039844|NCT00739973|2524365|P1|COMPLETED|Single-blind Period (2 to 4 Weeks)||1685
1039845|NCT00739973|2524357|P9|STARTED|Single-blind Period (2 to 4 Weeks)||0
1039846|NCT00739973|2524358|P8|STARTED|Single-blind Period (2 to 4 Weeks)||0
1039847|NCT00739973|2524359|P7|STARTED|Single-blind Period (2 to 4 Weeks)||0
1039848|NCT00739973|2524360|P6|STARTED|Single-blind Period (2 to 4 Weeks)||0
1039849|NCT00739973|2524361|P5|STARTED|Single-blind Period (2 to 4 Weeks)||0
1039850|NCT00739973|2524362|P4|STARTED|Single-blind Period (2 to 4 Weeks)||0
1039851|NCT00739973|2524363|P3|STARTED|Single-blind Period (2 to 4 Weeks)||0
1039852|NCT00739973|2524364|P2|STARTED|Single-blind Period (2 to 4 Weeks)||0
1039853|NCT00739973|2524365|P1|STARTED|Single-blind Period (2 to 4 Weeks)|In this period, participants were enrolled to only Placebo arm.|2694
1039854|NCT00739999|2524453|P2|NOT COMPLETED|Overall Study||0
1039855|NCT00739999|2524454|P1|NOT COMPLETED|Overall Study||0
1039856|NCT00739999|2524453|P2|COMPLETED|Overall Study||24
1039857|NCT00739999|2524454|P1|COMPLETED|Overall Study||15
1039858|NCT00739999|2524453|P2|STARTED|Overall Study||24
1039859|NCT00739999|2524454|P1|STARTED|Overall Study||15
1039860|NCT00740051|2524527|P2|NOT COMPLETED|Overall Study||32
1039861|NCT00740051|2524528|P1|NOT COMPLETED|Overall Study||18
1039862|NCT00740051|2524527|P2|COMPLETED|Overall Study||119
1039863|NCT00740051|2524528|P1|COMPLETED|Overall Study||58
1039864|NCT00740051|2524527|P2|STARTED|Overall Study||151
1039865|NCT00740051|2524528|P1|STARTED|Overall Study||76
1039866|NCT00740181|2524548|P1|NOT COMPLETED|Overall Study||0
1039867|NCT00740181|2524548|P1|COMPLETED|Overall Study||9
1039868|NCT00740181|2524548|P1|STARTED|Overall Study||9
1039869|NCT00740207|2524554|P2|NOT COMPLETED|Overall Study||0
1039870|NCT00740207|2524555|P1|NOT COMPLETED|Overall Study||0
1039871|NCT00740207|2524554|P2|COMPLETED|Overall Study||16
1039872|NCT00740207|2524555|P1|COMPLETED|Overall Study||17
1039873|NCT00740207|2524554|P2|STARTED|Overall Study||16
1039874|NCT00740207|2524555|P1|STARTED|Overall Study||17
1039875|NCT00740220|2524567|P1|NOT COMPLETED|Overall Study||9
1039876|NCT00740220|2524567|P1|COMPLETED|Overall Study||88
1039877|NCT00740220|2524567|P1|STARTED|Overall Study||97
1039878|NCT00740480|2524571|P1|NOT COMPLETED|Overall Study||2
1039879|NCT00740480|2524571|P1|COMPLETED|Overall Study||23
1039880|NCT00740480|2524571|P1|STARTED|Overall Study||25
1039881|NCT00740584|2524575|P1|NOT COMPLETED|Overall Study||1
1039882|NCT00740584|2524575|P1|COMPLETED|Overall Study||11
1039883|NCT00740584|2524575|P1|STARTED|Overall Study||12
1039884|NCT00740597|2524579|P1|NOT COMPLETED|Overall Study||1
1039885|NCT00740597|2524579|P1|COMPLETED|Overall Study||0
1039886|NCT00740597|2524579|P1|STARTED|Overall Study||1
1039887|NCT00740636|2524585|P2|NOT COMPLETED|Overall Study||4
1039888|NCT00740636|2524586|P1|NOT COMPLETED|Overall Study||2
1039889|NCT00740636|2524585|P2|COMPLETED|Overall Study||63
1039890|NCT00740636|2524586|P1|COMPLETED|Overall Study||23
1039891|NCT00740636|2524585|P2|STARTED|Overall Study||67
1039892|NCT00740636|2524586|P1|STARTED|Overall Study||25
1039893|NCT00740714|2524595|P3|NOT COMPLETED|Overall Study||29
1039894|NCT00740714|2524596|P2|NOT COMPLETED|Overall Study||19
1039895|NCT00740714|2524597|P1|NOT COMPLETED|Overall Study||17
1039896|NCT00740714|2524595|P3|COMPLETED|Overall Study||174
1039897|NCT00740714|2524596|P2|COMPLETED|Overall Study||182
1039898|NCT00740714|2524597|P1|COMPLETED|Overall Study||179
1039899|NCT00740714|2524595|P3|Active Patients at Study Termination|Overall Study||33
1039900|NCT00740714|2524596|P2|Active Patients at Study Termination|Overall Study||12
1039901|NCT00740714|2524597|P1|Active Patients at Study Termination|Overall Study||24
1039902|NCT00740714|2524595|P3|Reaching Endpoint Before May 6, 2011|Overall Study||94
1039903|NCT00740714|2524596|P2|Reaching Endpoint Before May 6, 2011|Overall Study||87
1039904|NCT00740714|2524597|P1|Reaching Endpoint Before May 6, 2011|Overall Study||86
1039905|NCT00740714|2524595|P3|STARTED|Overall Study|Randomized throughout the recruitment period|203
1039906|NCT00740714|2524596|P2|STARTED|Overall Study|Randomized throughout the recruitment period|201
1039907|NCT00740714|2524597|P1|STARTED|Overall Study|Randomized throughout the recruitment period|196
1039908|NCT00740727|2524671|P1|NOT COMPLETED|Overall Study||0
1039909|NCT00740727|2524671|P1|COMPLETED|Overall Study||18
1039910|NCT00740727|2524671|P1|STARTED|Overall Study||18
1039911|NCT00740779|2524680|P3|NOT COMPLETED|Overall Study||13
1039912|NCT00740779|2524681|P2|NOT COMPLETED|Overall Study||14
1039913|NCT00740779|2524682|P1|NOT COMPLETED|Overall Study||9
1039914|NCT00740779|2524680|P3|COMPLETED|Overall Study||41
1039915|NCT00740779|2524681|P2|COMPLETED|Overall Study||31
1039916|NCT00740779|2524682|P1|COMPLETED|Overall Study||43
1039917|NCT00740779|2524680|P3|STARTED|Overall Study||54
1039918|NCT00740779|2524681|P2|STARTED|Overall Study||45
1039919|NCT00740779|2524682|P1|STARTED|Overall Study||52
1039920|NCT00740792|2524694|P4|NOT COMPLETED|Overall Study||10
1039921|NCT00740792|2524695|P3|NOT COMPLETED|Overall Study||9
1039922|NCT00740792|2524696|P2|NOT COMPLETED|Overall Study||8
1039923|NCT00740792|2524697|P1|NOT COMPLETED|Overall Study||10
1039924|NCT00740792|2524694|P4|COMPLETED|Overall Study||190
1039925|NCT00740792|2524695|P3|COMPLETED|Overall Study||180
1039926|NCT00740792|2524696|P2|COMPLETED|Overall Study||186
1039927|NCT00740792|2524697|P1|COMPLETED|Overall Study||183
1039928|NCT00740792|2524694|P4|STARTED|Overall Study||200
1039929|NCT00740792|2524695|P3|STARTED|Overall Study||189
1039930|NCT00740792|2524696|P2|STARTED|Overall Study||194
1039931|NCT00740792|2524697|P1|STARTED|Overall Study||193
1039932|NCT00740831|2524718|P3|NOT COMPLETED|Overall Study||6
1039933|NCT00740831|2524719|P2|NOT COMPLETED|Overall Study||3
1039934|NCT00740831|2524720|P1|NOT COMPLETED|Overall Study||4
1039935|NCT00740831|2524718|P3|COMPLETED|Overall Study|Patients who completed part A (visit 6)|95
1039936|NCT00740831|2524719|P2|COMPLETED|Overall Study|Patients who completed part A (visit 6)|100
1039937|NCT00740831|2524720|P1|COMPLETED|Overall Study|Patients who completed part A (visit 6)|93
1039938|NCT00740831|2524718|P3|STARTED|Overall Study|Safety population|101
1039939|NCT00740831|2524719|P2|STARTED|Overall Study|Safety population|103
1039940|NCT00740831|2524720|P1|STARTED|Overall Study|Safety population|97
1039941|NCT00740857|2524740|P3|NOT COMPLETED|Overall Study||0
1039942|NCT00740857|2524741|P2|NOT COMPLETED|Overall Study||0
1039943|NCT00740857|2524742|P1|NOT COMPLETED|Overall Study||1
1039944|NCT00740857|2524740|P3|COMPLETED|Overall Study||90
1039945|NCT00740857|2524741|P2|COMPLETED|Overall Study||88
1039946|NCT00740857|2524742|P1|COMPLETED|Overall Study||32
1039947|NCT00740857|2524740|P3|STARTED|Overall Study||90
1039948|NCT00740857|2524741|P2|STARTED|Overall Study||88
1039949|NCT00740857|2524742|P1|STARTED|Overall Study||33
1039953|NCT00741013|2524786|P3|NOT COMPLETED|Overall Study||1
1039954|NCT00741013|2524787|P2|NOT COMPLETED|Overall Study||2
1039955|NCT00741013|2524788|P1|NOT COMPLETED|Overall Study||1
1039956|NCT00741013|2524786|P3|COMPLETED|Overall Study||6
1039957|NCT00741013|2524787|P2|COMPLETED|Overall Study||6
1039958|NCT00741013|2524788|P1|COMPLETED|Overall Study||6
1039959|NCT00741013|2524786|P3|STARTED|Overall Study||7
1039960|NCT00741013|2524787|P2|STARTED|Overall Study||8
1039961|NCT00741013|2524788|P1|STARTED|Overall Study||7
1039962|NCT00741026|2524799|P1|NOT COMPLETED|Overall Study||0
1039963|NCT00741026|2524799|P1|COMPLETED|Overall Study||15
1039964|NCT00741026|2524799|P1|STARTED|Overall Study||15
1039965|NCT00741039|2524829|P2|NOT COMPLETED|Overall Study||0
1039966|NCT00741039|2524830|P1|NOT COMPLETED|Overall Study||2
1039967|NCT00741039|2524829|P2|COMPLETED|Overall Study||25
1039968|NCT00741039|2524830|P1|COMPLETED|Overall Study||100
1039969|NCT00741039|2524829|P2|STARTED|Overall Study||25
1039970|NCT00741039|2524830|P1|STARTED|Overall Study||102
1039971|NCT00741091|2524836|P1|NOT COMPLETED|Overall Study||57
1039972|NCT00741091|2524836|P1|COMPLETED|Overall Study||1040
1039973|NCT00741091|2524836|P1|STARTED|Overall Study||1097
1039974|NCT00741104|2524844|P1|NOT COMPLETED|Overall Study||0
1039975|NCT00741104|2524844|P1|COMPLETED|Overall Study||363
1039976|NCT00741104|2524844|P1|STARTED|Overall Study||363
1039977|NCT00741156|2524851|P1|NOT COMPLETED|Overall Study||0
1039978|NCT00741156|2524851|P1|COMPLETED|Overall Study||12
1039979|NCT00741156|2524851|P1|STARTED|Overall Study||12
1039980|NCT00741273|2524868|P2|NOT COMPLETED|Overall Study||0
1039981|NCT00741273|2524869|P1|NOT COMPLETED|Overall Study||0
1039982|NCT00741273|2524868|P2|COMPLETED|Overall Study||8
1039983|NCT00741273|2524869|P1|COMPLETED|Overall Study||8
1039984|NCT00741273|2524868|P2|STARTED|Overall Study||8
1039985|NCT00741273|2524869|P1|STARTED|Overall Study||8
1039986|NCT00741286|2524887|P2|NOT COMPLETED|Overall Study||19
1039987|NCT00741286|2524888|P1|NOT COMPLETED|Overall Study||20
1039988|NCT00741286|2524887|P2|COMPLETED|Overall Study||81
1039989|NCT00741286|2524888|P1|COMPLETED|Overall Study||83
1039990|NCT00741286|2524887|P2|STARTED|Overall Study||100
1039991|NCT00741286|2524888|P1|STARTED|Overall Study||103
1039992|NCT00741338|2524898|P2|NOT COMPLETED|Overall Study||1
1039993|NCT00741338|2524899|P1|NOT COMPLETED|Overall Study||0
1039994|NCT00741338|2524898|P2|COMPLETED|Overall Study||2
1039995|NCT00741338|2524899|P1|COMPLETED|Overall Study||3
1039996|NCT00741338|2524898|P2|STARTED|Overall Study||3
1039997|NCT00741338|2524899|P1|STARTED|Overall Study||3
1039998|NCT00741390|2524907|P4|NOT COMPLETED|Visit 2||1
1039999|NCT00741390|2524908|P3|NOT COMPLETED|Visit 2||1
1040000|NCT00741390|2524909|P2|NOT COMPLETED|Visit 2||0
1040001|NCT00741390|2524910|P1|NOT COMPLETED|Visit 2||0
1040002|NCT00741390|2524907|P4|COMPLETED|Visit 2||60
1040003|NCT00741390|2524908|P3|COMPLETED|Visit 2||54
1040004|NCT00741390|2524909|P2|COMPLETED|Visit 2||61
1040005|NCT00741390|2524910|P1|COMPLETED|Visit 2||59
1040006|NCT00741390|2524907|P4|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|61
1040007|NCT00741390|2524908|P3|STARTED|Visit 2||55
1040008|NCT00741390|2524909|P2|STARTED|Visit 2|2 subjects lost to follow-up between Visit 1 and Visit 2.|61
1040009|NCT00741390|2524910|P1|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|59
1040010|NCT00741390|2524907|P4|NOT COMPLETED|Visit 1||1
1040011|NCT00741390|2524908|P3|NOT COMPLETED|Visit 1||7
1040012|NCT00741390|2524909|P2|NOT COMPLETED|Visit 1||0
1040013|NCT00741390|2524910|P1|NOT COMPLETED|Visit 1||2
1040014|NCT00741390|2524907|P4|COMPLETED|Visit 1||62
1040015|NCT00741390|2524908|P3|COMPLETED|Visit 1||55
1040016|NCT00741390|2524909|P2|COMPLETED|Visit 1||63
1040017|NCT00741390|2524910|P1|COMPLETED|Visit 1||60
1040018|NCT00741390|2524907|P4|STARTED|Visit 1||63
1040019|NCT00741390|2524908|P3|STARTED|Visit 1||62
1040020|NCT00741390|2524909|P2|STARTED|Visit 1||63
1040021|NCT00741390|2524910|P1|STARTED|Visit 1||62
1040022|NCT00741468|2524929|P1|NOT COMPLETED|Overall Study||0
1040023|NCT00741468|2524929|P1|COMPLETED|Overall Study||18
1040024|NCT00741468|2524929|P1|STARTED|Overall Study||18
1040025|NCT00741598|2524939|P2|NOT COMPLETED|Overall Study||9
1040026|NCT00741598|2524940|P1|NOT COMPLETED|Overall Study||9
1040027|NCT00741598|2524939|P2|COMPLETED|Overall Study||30
1040028|NCT00741598|2524940|P1|COMPLETED|Overall Study||24
1040029|NCT00741598|2524939|P2|STARTED|Overall Study||39
1040030|NCT00741598|2524940|P1|STARTED|Overall Study||33
1040031|NCT00741611|2524957|P3|NOT COMPLETED|Overall Study||3
1040032|NCT00741611|2524958|P2|NOT COMPLETED|Overall Study||2
1040033|NCT00741611|2524959|P1|NOT COMPLETED|Overall Study||0
1040034|NCT00741611|2524957|P3|COMPLETED|Overall Study||26
1040035|NCT00741611|2524958|P2|COMPLETED|Overall Study||1
1040036|NCT00741611|2524959|P1|COMPLETED|Overall Study||4
1040037|NCT00741611|2524957|P3|STARTED|Overall Study||29
1040038|NCT00741611|2524958|P2|STARTED|Overall Study||3
1040039|NCT00741611|2524959|P1|STARTED|Overall Study||4
1040040|NCT00741819|2524976|P1|NOT COMPLETED|Overall Study||8
1040041|NCT00741819|2524976|P1|COMPLETED|Overall Study||65
1040042|NCT00741819|2524976|P1|STARTED|Overall Study||73
1040043|NCT00741858|2524989|P2|NOT COMPLETED|Overall Study||0
1040044|NCT00741858|2524990|P1|NOT COMPLETED|Overall Study||0
1040045|NCT00741858|2524989|P2|COMPLETED|Overall Study||18
1040046|NCT00741858|2524990|P1|COMPLETED|Overall Study||16
1040047|NCT00741858|2524989|P2|STARTED|Overall Study||18
1040048|NCT00741858|2524990|P1|STARTED|Overall Study||16
1040049|NCT00741936|2524998|P2|NOT COMPLETED|Overall Study||8
1040050|NCT00741936|2524999|P1|NOT COMPLETED|Overall Study||9
1040051|NCT00741936|2524998|P2|COMPLETED|Overall Study||52
1040052|NCT00741936|2524999|P1|COMPLETED|Overall Study||51
1040053|NCT00741936|2524998|P2|STARTED|Overall Study||60
1040054|NCT00741936|2524999|P1|STARTED|Overall Study||60
1040055|NCT00741988|2525027|P2|NOT COMPLETED|Overall Study||4
1040056|NCT00741988|2525028|P1|NOT COMPLETED|Overall Study||4
1040057|NCT00741988|2525027|P2|COMPLETED|Overall Study||36
1040058|NCT00741988|2525028|P1|COMPLETED|Overall Study||38
1040059|NCT00741988|2525027|P2|STARTED|Overall Study||40
1040060|NCT00741988|2525028|P1|STARTED|Overall Study||42
1040061|NCT00742053|2525038|P1|NOT COMPLETED|Overall Study||0
1040062|NCT00742053|2525038|P1|COMPLETED|Overall Study||7
1040063|NCT00742053|2525038|P1|STARTED|Overall Study||7
1040064|NCT00742079|2525044|P2|NOT COMPLETED|Overall Study||1
1040065|NCT00742079|2525045|P1|NOT COMPLETED|Overall Study||0
1040066|NCT00742079|2525044|P2|COMPLETED|Overall Study||9
1040067|NCT00742079|2525045|P1|COMPLETED|Overall Study||11
1040068|NCT00742079|2525044|P2|Week 2 (Received Dose 2)|Overall Study||9
1040069|NCT00742079|2525045|P1|Week 2 (Received Dose 2)|Overall Study||11
1040070|NCT00742079|2525044|P2|Baseline/Week 1 (Received Dose 1)|Overall Study||9
1040071|NCT00742079|2525045|P1|Baseline/Week 1 (Received Dose 1)|Overall Study||11
1040072|NCT00742079|2525044|P2|STARTED|Overall Study||10
1040073|NCT00742079|2525045|P1|STARTED|Overall Study||11
1040074|NCT00742170|2525053|P2|NOT COMPLETED|Overall Study||5
1040075|NCT00742170|2525054|P1|NOT COMPLETED|Overall Study||2
1040076|NCT00742170|2525053|P2|COMPLETED|Overall Study||24
1040077|NCT00742170|2525054|P1|COMPLETED|Overall Study||24
1040078|NCT00742170|2525053|P2|STARTED|Overall Study||29
1040079|NCT00742170|2525054|P1|STARTED|Overall Study||26
1040080|NCT00742183|2525064|P2|NOT COMPLETED|Overall Study||12
1040081|NCT00742183|2525065|P1|NOT COMPLETED|Overall Study||9
1040082|NCT00742183|2525064|P2|COMPLETED|Overall Study||39
1040083|NCT00742183|2525065|P1|COMPLETED|Overall Study||40
1040084|NCT00742183|2525064|P2|STARTED|Overall Study||51
1040085|NCT00742183|2525065|P1|STARTED|Overall Study|50 subjects randomised, one of them did not receive any treatment.|49
1040086|NCT00742209|2525076|P5|NOT COMPLETED|Overall Study||25
1040087|NCT00742209|2525077|P4|NOT COMPLETED|Overall Study||37
1040088|NCT00742209|2525078|P3|NOT COMPLETED|Overall Study||46
1040089|NCT00742209|2525079|P2|NOT COMPLETED|Overall Study||18
1040090|NCT00742209|2525080|P1|NOT COMPLETED|Overall Study||34
1040091|NCT00742209|2525076|P5|COMPLETED|Overall Study||37
1040092|NCT00742209|2525077|P4|COMPLETED|Overall Study||97
1040093|NCT00742209|2525078|P3|COMPLETED|Overall Study||88
1040094|NCT00742209|2525079|P2|COMPLETED|Overall Study||49
1040095|NCT00742209|2525080|P1|COMPLETED|Overall Study||95
1040096|NCT00742209|2525076|P5|STARTED|Overall Study||62
1040097|NCT00742209|2525077|P4|STARTED|Overall Study||134
1040098|NCT00742209|2525078|P3|STARTED|Overall Study||134
1040099|NCT00742209|2525079|P2|STARTED|Overall Study||67
1040100|NCT00742209|2525080|P1|STARTED|Overall Study||129
1040101|NCT00742235|2525183|P2|NOT COMPLETED|Overall Study||31
1040102|NCT00742235|2525184|P1|NOT COMPLETED|Overall Study||0
1040103|NCT00742235|2525183|P2|COMPLETED|Overall Study||36
1040104|NCT00742235|2525184|P1|COMPLETED|Overall Study||32
1040105|NCT00742235|2525183|P2|STARTED|Overall Study||67
1040106|NCT00742235|2525184|P1|STARTED|Overall Study||32
1040107|NCT00742274|2525194|P2|NOT COMPLETED|Overall Study||3
1040108|NCT00742274|2525195|P1|NOT COMPLETED|Overall Study||3
1040109|NCT00742274|2525194|P2|COMPLETED|Overall Study||28
1040110|NCT00742274|2525195|P1|COMPLETED|Overall Study||27
1040111|NCT00742274|2525194|P2|STARTED|Overall Study||31
1040112|NCT00742274|2525195|P1|STARTED|Overall Study||30
1040113|NCT00742313|2525203|P2|NOT COMPLETED|Overall Study||0
1040114|NCT00742313|2525204|P1|NOT COMPLETED|Overall Study||1
1040115|NCT00742313|2525203|P2|COMPLETED|Overall Study||19
1040116|NCT00742313|2525204|P1|COMPLETED|Overall Study||24
1040117|NCT00742313|2525203|P2|STARTED|Overall Study||19
1040118|NCT00742313|2525204|P1|STARTED|Overall Study||25
1040119|NCT00742326|2525212|P2|NOT COMPLETED|Overall Study||1
1040120|NCT00742326|2525213|P1|NOT COMPLETED|Overall Study||0
1040121|NCT00742326|2525212|P2|COMPLETED|Overall Study||6
1040122|NCT00742326|2525213|P1|COMPLETED|Overall Study||6
1040123|NCT00742326|2525212|P2|STARTED|Overall Study||7
1040124|NCT00742326|2525213|P1|STARTED|Overall Study||6
1040125|NCT00742391|2525223|P2|NOT COMPLETED|Overall Study||1
1040126|NCT00742391|2525224|P1|NOT COMPLETED|Overall Study||4
1040127|NCT00742391|2525223|P2|COMPLETED|Overall Study||128
1040128|NCT00742391|2525224|P1|COMPLETED|Overall Study||122
1040129|NCT00742391|2525223|P2|STARTED|Overall Study||129
1040130|NCT00742391|2525224|P1|STARTED|Overall Study||126
1040131|NCT00742417|2525234|P2|NOT COMPLETED|Maintenance II||0
1040132|NCT00742417|2525235|P1|NOT COMPLETED|Maintenance II||0
1040133|NCT00742417|2525234|P2|COMPLETED|Maintenance II||19
1040134|NCT00742417|2525235|P1|COMPLETED|Maintenance II||16
1040135|NCT00742417|2525234|P2|STARTED|Maintenance II||19
1040136|NCT00742417|2525235|P1|STARTED|Maintenance II||16
1040137|NCT00742417|2525234|P2|NOT COMPLETED|Maintenance I||0
1040138|NCT00742417|2525235|P1|NOT COMPLETED|Maintenance I||0
1040139|NCT00742417|2525234|P2|COMPLETED|Maintenance I||19
1040140|NCT00742417|2525235|P1|COMPLETED|Maintenance I||16
1040141|NCT00742417|2525234|P2|STARTED|Maintenance I||19
1040142|NCT00742417|2525235|P1|STARTED|Maintenance I||16
1040143|NCT00742417|2525234|P2|NOT COMPLETED|Intensive Period||1
1040144|NCT00742417|2525235|P1|NOT COMPLETED|Intensive Period||3
1040145|NCT00742417|2525234|P2|COMPLETED|Intensive Period|19 control patients completed all the 6 plasma exchange during the Intensive Period|19
1040146|NCT00742417|2525235|P1|COMPLETED|Intensive Period|16 patients completed all the 6 plasma exchange with Albutein 5% during the Intensive Period|16
1040147|NCT00742417|2525234|P2|STARTED|Intensive Period||20
1040148|NCT00742417|2525235|P1|STARTED|Intensive Period||19
1040149|NCT00742417|2525234|P2|NOT COMPLETED|Randomized||1
1040150|NCT00742417|2525235|P1|NOT COMPLETED|Randomized||2
1040151|NCT00742417|2525234|P2|COMPLETED|Randomized||20
1040152|NCT00742417|2525235|P1|COMPLETED|Randomized||19
1040153|NCT00742417|2525234|P2|STARTED|Randomized||21
1040154|NCT00742417|2525235|P1|STARTED|Randomized||21
1040155|NCT00742508|2525259|P2|NOT COMPLETED|4-Week Exploratory Evaluation Period||1
1040156|NCT00742508|2525260|P1|NOT COMPLETED|4-Week Exploratory Evaluation Period||0
1040157|NCT00742508|2525259|P2|COMPLETED|4-Week Exploratory Evaluation Period||7
1040158|NCT00742508|2525260|P1|COMPLETED|4-Week Exploratory Evaluation Period||0
1040159|NCT00742508|2525259|P2|STARTED|4-Week Exploratory Evaluation Period||8
1040160|NCT00742508|2525260|P1|STARTED|4-Week Exploratory Evaluation Period||0
1040161|NCT00742508|2525259|P2|NOT COMPLETED|8-Week Primary Evaluation Period||11
1040162|NCT00742508|2525260|P1|NOT COMPLETED|8-Week Primary Evaluation Period||11
1040163|NCT00742508|2525259|P2|COMPLETED|8-Week Primary Evaluation Period||8
1040164|NCT00742508|2525260|P1|COMPLETED|8-Week Primary Evaluation Period||11
1040165|NCT00742508|2525259|P2|STARTED|8-Week Primary Evaluation Period||19
1040166|NCT00742508|2525260|P1|STARTED|8-Week Primary Evaluation Period||22
1040167|NCT00742625|2525322|P1|NOT COMPLETED|Consolidation||21
1040168|NCT00742625|2525322|P1|COMPLETED|Consolidation||20
1040169|NCT00742625|2525322|P1|STARTED|Consolidation||41
1040170|NCT00742625|2525322|P1|NOT COMPLETED|Remission Induction||54
1040171|NCT00742625|2525322|P1|COMPLETED|Remission Induction||41
1040172|NCT00742625|2525322|P1|STARTED|Remission Induction||95
1040173|NCT00742781|2525331|P1|NOT COMPLETED|Overall Study||3
1040174|NCT00742781|2525331|P1|COMPLETED|Overall Study||18
1040175|NCT00742781|2525331|P1|STARTED|Overall Study||21
1040188|NCT00742872|2525363|P2|NOT COMPLETED|Overall Study||8
1040189|NCT00742872|2525364|P1|NOT COMPLETED|Overall Study||12
1040190|NCT00742872|2525363|P2|COMPLETED|Overall Study||12
1040191|NCT00742872|2525364|P1|COMPLETED|Overall Study||9
1040192|NCT00742872|2525363|P2|STARTED|Overall Study||20
1040193|NCT00742872|2525364|P1|STARTED|Overall Study||21
1040194|NCT00742885|2525372|P2|NOT COMPLETED|Overall Study||0
1040195|NCT00742885|2525373|P1|NOT COMPLETED|Overall Study||1
1040196|NCT00742885|2525372|P2|COMPLETED|Overall Study|to Day 182|50
1040197|NCT00742885|2525373|P1|COMPLETED|Overall Study|to Day 182|49
1040198|NCT00742885|2525372|P2|STARTED|Overall Study||50
1040199|NCT00742885|2525373|P1|STARTED|Overall Study||50
1040200|NCT00742924|2525423|P4|NOT COMPLETED|Overall Study||6
1040201|NCT00742924|2525424|P3|NOT COMPLETED|Overall Study||4
1040202|NCT00742924|2525425|P2|NOT COMPLETED|Overall Study||2
1040203|NCT00742924|2525426|P1|NOT COMPLETED|Overall Study||5
1040204|NCT00742924|2525423|P4|COMPLETED|Overall Study||0
1040205|NCT00742924|2525424|P3|COMPLETED|Overall Study||2
1040206|NCT00742924|2525425|P2|COMPLETED|Overall Study||4
1040207|NCT00742924|2525426|P1|COMPLETED|Overall Study||1
1040208|NCT00742924|2525423|P4|STARTED|Overall Study||6
1040209|NCT00742924|2525424|P3|STARTED|Overall Study||6
1040210|NCT00742924|2525425|P2|STARTED|Overall Study||6
1040211|NCT00742924|2525426|P1|STARTED|Overall Study||6
1040215|NCT00743093|2525442|P2|NOT COMPLETED|Extended Dosing Period||0
1040216|NCT00743093|2525443|P1|NOT COMPLETED|Extended Dosing Period||3
1040217|NCT00743093|2525442|P2|COMPLETED|Extended Dosing Period||1
1040218|NCT00743093|2525443|P1|COMPLETED|Extended Dosing Period||48
1040219|NCT00743093|2525442|P2|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|1
1040220|NCT00743093|2525443|P1|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|51
1040221|NCT00743093|2525442|P2|NOT COMPLETED|Base Study Period||5
1040222|NCT00743093|2525443|P1|NOT COMPLETED|Base Study Period||19
1040223|NCT00743093|2525442|P2|COMPLETED|Base Study Period||47
1040224|NCT00743093|2525443|P1|COMPLETED|Base Study Period||205
1040225|NCT00743093|2525442|P2|STARTED|Base Study Period||52
1040226|NCT00743093|2525443|P1|STARTED|Base Study Period||224
1040227|NCT00743106|2525453|P2|NOT COMPLETED|Overall Study||5
1040228|NCT00743106|2525454|P1|NOT COMPLETED|Overall Study||8
1040229|NCT00743106|2525453|P2|COMPLETED|Overall Study||43
1040230|NCT00743106|2525454|P1|COMPLETED|Overall Study||34
1040231|NCT00743106|2525453|P2|STARTED|Overall Study||48
1040232|NCT00743106|2525454|P1|STARTED|Overall Study||42
1040233|NCT00743197|2525462|P2|NOT COMPLETED|Overall Study||2
1040234|NCT00743197|2525463|P1|NOT COMPLETED|Overall Study||1
1040235|NCT00743197|2525462|P2|COMPLETED|Overall Study||0
1040236|NCT00743197|2525463|P1|COMPLETED|Overall Study||0
1040237|NCT00743197|2525462|P2|STARTED|Overall Study||2
1040238|NCT00743197|2525463|P1|STARTED|Overall Study||1
1040239|NCT00736580|2525471|P2|NOT COMPLETED|Overall Study||0
1040240|NCT00736580|2525472|P1|NOT COMPLETED|Overall Study||0
1040241|NCT00736580|2525471|P2|COMPLETED|Overall Study||123
1040242|NCT00736580|2525472|P1|COMPLETED|Overall Study||117
1040243|NCT00736580|2525471|P2|STARTED|Overall Study||123
1040244|NCT00736580|2525472|P1|STARTED|Overall Study||117
1040245|NCT00736723|2525480|P2|NOT COMPLETED|Overall Study||3
1040246|NCT00736723|2525481|P1|NOT COMPLETED|Overall Study||4
1040247|NCT00736723|2525480|P2|COMPLETED|Overall Study||18
1040248|NCT00736723|2525481|P1|COMPLETED|Overall Study||26
1040249|NCT00736723|2525480|P2|STARTED|Overall Study||21
1040250|NCT00736723|2525481|P1|STARTED|Overall Study||30
1040251|NCT00736840|2525487|P1|NOT COMPLETED|Overall Study||13
1040252|NCT00736840|2525487|P1|COMPLETED|Overall Study|9 subjects-no biopsy results, 2-no breath test, 2 no biopsy results and no complete breath test|401
1040253|NCT00736840|2525487|P1|STARTED|Overall Study||414
1040254|NCT00736853|2525492|P3|NOT COMPLETED|Double-Blind Period||48
1040255|NCT00736853|2525493|P2|NOT COMPLETED|Double-Blind Period||24
1040256|NCT00736853|2525494|P1|NOT COMPLETED|Double-Blind Period||0
1040257|NCT00736853|2525492|P3|COMPLETED|Double-Blind Period||45
1040258|NCT00736853|2525493|P2|COMPLETED|Double-Blind Period||70
1040259|NCT00736853|2525494|P1|COMPLETED|Double-Blind Period||0
1040260|NCT00736853|2525492|P3|STARTED|Double-Blind Period||93
1040261|NCT00736853|2525493|P2|STARTED|Double-Blind Period||94
1040262|NCT00736853|2525494|P1|STARTED|Double-Blind Period||0
1040263|NCT00736853|2525492|P3|NOT COMPLETED|Open-Label Period||0
1040264|NCT00736853|2525493|P2|NOT COMPLETED|Open-Label Period||0
1040265|NCT00736853|2525494|P1|NOT COMPLETED|Open-Label Period||132
1040266|NCT00736853|2525492|P3|COMPLETED|Open-Label Period||0
1040267|NCT00736853|2525493|P2|COMPLETED|Open-Label Period||0
1040268|NCT00736853|2525494|P1|COMPLETED|Open-Label Period||187
1040269|NCT00736853|2525492|P3|Treated|Open-Label Period||0
1040270|NCT00736853|2525493|P2|Treated|Open-Label Period||0
1040271|NCT00736853|2525494|P1|Treated|Open-Label Period||277
1040272|NCT00736853|2525492|P3|STARTED|Open-Label Period||0
1040273|NCT00736853|2525493|P2|STARTED|Open-Label Period||0
1040274|NCT00736853|2525494|P1|STARTED|Open-Label Period||319
1040275|NCT00736879|2525538|P4|NOT COMPLETED|Follow up Period - No Drug Treatment||0
1040276|NCT00736879|2525539|P3|NOT COMPLETED|Follow up Period - No Drug Treatment||0
1040277|NCT00736879|2525540|P2|NOT COMPLETED|Follow up Period - No Drug Treatment||3
1040278|NCT00736879|2525541|P1|NOT COMPLETED|Follow up Period - No Drug Treatment||1
1040279|NCT00736879|2525538|P4|COMPLETED|Follow up Period - No Drug Treatment||62
1040280|NCT00736879|2525539|P3|COMPLETED|Follow up Period - No Drug Treatment||66
1040281|NCT00736879|2525540|P2|COMPLETED|Follow up Period - No Drug Treatment||67
1040282|NCT00736879|2525541|P1|COMPLETED|Follow up Period - No Drug Treatment||65
1040283|NCT00736879|2525538|P4|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|62
1040284|NCT00736879|2525539|P3|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
1040285|NCT00736879|2525540|P2|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|70
1040286|NCT00736879|2525541|P1|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
1040287|NCT00736879|2525538|P4|NOT COMPLETED|Double Blind Treatment Period||5
1040288|NCT00736879|2525539|P3|NOT COMPLETED|Double Blind Treatment Period||7
1040289|NCT00736879|2525540|P2|NOT COMPLETED|Double Blind Treatment Period||4
1040290|NCT00736879|2525541|P1|NOT COMPLETED|Double Blind Treatment Period||3
1040291|NCT00736879|2525538|P4|COMPLETED|Double Blind Treatment Period||63
1040292|NCT00736879|2525539|P3|COMPLETED|Double Blind Treatment Period||67
1040293|NCT00736879|2525540|P2|COMPLETED|Double Blind Treatment Period||68
1040294|NCT00736879|2525541|P1|COMPLETED|Double Blind Treatment Period||65
1040295|NCT00736879|2525538|P4|STARTED|Double Blind Treatment Period||68
1040296|NCT00736879|2525539|P3|STARTED|Double Blind Treatment Period||74
1040297|NCT00736879|2525540|P2|STARTED|Double Blind Treatment Period||72
1040298|NCT00736879|2525541|P1|STARTED|Double Blind Treatment Period||68
1040299|NCT00736944|2525595|P1|NOT COMPLETED|Definitive Treatment||1
1040300|NCT00736944|2525595|P1|COMPLETED|Definitive Treatment||28
1040301|NCT00736944|2525595|P1|STARTED|Definitive Treatment||29
1040302|NCT00736944|2525595|P1|NOT COMPLETED|Induction||1
1040303|NCT00736944|2525595|P1|COMPLETED|Induction||29
1040304|NCT00736944|2525595|P1|STARTED|Induction||30
1040305|NCT00736957|2525622|P1|NOT COMPLETED|Overall Study||122
1040306|NCT00736957|2525622|P1|COMPLETED|Overall Study||97
1040307|NCT00736957|2525622|P1|Treated|Overall Study||190
1040308|NCT00736957|2525622|P1|STARTED|Overall Study||219
1040309|NCT00736996|2525635|P3|NOT COMPLETED|Overall Study||2
1040310|NCT00736996|2525636|P2|NOT COMPLETED|Overall Study||9
1040311|NCT00736996|2525637|P1|NOT COMPLETED|Overall Study||1
1040312|NCT00736996|2525635|P3|COMPLETED|Overall Study||25
1040313|NCT00736996|2525636|P2|COMPLETED|Overall Study||17
1040314|NCT00736996|2525637|P1|COMPLETED|Overall Study||24
1040315|NCT00736996|2525635|P3|STARTED|Overall Study||27
1040316|NCT00736996|2525636|P2|STARTED|Overall Study||26
1040317|NCT00736996|2525637|P1|STARTED|Overall Study||25
1040318|NCT00737048|2525654|P3|NOT COMPLETED|Overall Study||4
1040319|NCT00737048|2525655|P2|NOT COMPLETED|Overall Study||6
1040320|NCT00737048|2525656|P1|NOT COMPLETED|Overall Study||3
1040321|NCT00737048|2525654|P3|COMPLETED|Overall Study||126
1040322|NCT00737048|2525655|P2|COMPLETED|Overall Study||60
1040323|NCT00737048|2525656|P1|COMPLETED|Overall Study||129
1040324|NCT00737048|2525654|P3|STARTED|Overall Study||130
1040325|NCT00737048|2525655|P2|STARTED|Overall Study||66
1040326|NCT00737048|2525656|P1|STARTED|Overall Study||132
1040327|NCT00737061|2525697|P1|NOT COMPLETED|1 Year Wearing Period||17
1040328|NCT00737061|2525697|P1|COMPLETED|1 Year Wearing Period||553
1040329|NCT00737061|2525697|P1|STARTED|1 Year Wearing Period||570
1040330|NCT00737061|2525697|P1|NOT COMPLETED|Waiting Period||75
1040331|NCT00737061|2525697|P1|COMPLETED|Waiting Period||570
1040332|NCT00737061|2525697|P1|STARTED|Waiting Period||645
1040333|NCT00737100|2525714|P3|NOT COMPLETED|Overall Study||7
1040334|NCT00737100|2525715|P2|NOT COMPLETED|Overall Study||7
1040335|NCT00737100|2525716|P1|NOT COMPLETED|Overall Study||7
1040336|NCT00737100|2525714|P3|COMPLETED|Overall Study||169
1040337|NCT00737100|2525715|P2|COMPLETED|Overall Study||159
1040338|NCT00737100|2525716|P1|COMPLETED|Overall Study||161
1040339|NCT00737100|2525714|P3|STARTED|Overall Study||176
1040340|NCT00737100|2525715|P2|STARTED|Overall Study||166
1040341|NCT00737100|2525716|P1|STARTED|Overall Study||168
1040342|NCT00737178|2525762|P2|NOT COMPLETED|Overall Study||9
1040343|NCT00737178|2525763|P1|NOT COMPLETED|Overall Study||5
1040344|NCT00737178|2525762|P2|COMPLETED|Overall Study||76
1040345|NCT00737178|2525763|P1|COMPLETED|Overall Study||66
1040346|NCT00737178|2525762|P2|STARTED|Overall Study||85
1040347|NCT00737178|2525763|P1|STARTED|Overall Study||71
1040348|NCT00737204|2525775|P2|NOT COMPLETED|Overall Study||6
1040349|NCT00737204|2525776|P1|NOT COMPLETED|Overall Study||0
1040350|NCT00737204|2525775|P2|COMPLETED|Overall Study||28
1040351|NCT00737204|2525776|P1|COMPLETED|Overall Study||36
1040352|NCT00737204|2525775|P2|STARTED|Overall Study||34
1040353|NCT00737204|2525776|P1|STARTED|Overall Study||36
1040354|NCT00737243|2525788|P1|NOT COMPLETED|Overall Study||95
1040355|NCT00737243|2525788|P1|COMPLETED|Overall Study||194
1040356|NCT00737243|2525788|P1|Empiric CUP Therapy|Overall Study||29
1040357|NCT00737243|2525788|P1|Site Specific Therapy Less Responsive|Overall Study||79
1040358|NCT00737243|2525788|P1|Site Specific Therapy More Responsive|Overall Study||115
1040359|NCT00737243|2525788|P1|Not Treated|Overall Study|16 pts no longer met eligibility criteria; 13 came off study due to physician or pt preference.|29
1040360|NCT00737243|2525788|P1|Treated|Overall Study||223
1040361|NCT00737243|2525788|P1|Insufficient Tissue for Assay, Withdrawn|Overall Study||37
1040362|NCT00737243|2525788|P1|Successful Assay Performed|Overall Study||252
1040363|NCT00737243|2525788|P1|STARTED|Overall Study||289
1040364|NCT00737282|2525796|P1|NOT COMPLETED|Overall Study||175
1040365|NCT00737282|2525796|P1|COMPLETED|Overall Study||0
1040366|NCT00737282|2525796|P1|STARTED|Overall Study||175
1040367|NCT00737360|2525802|P1|NOT COMPLETED|Overall Study||0
1040368|NCT00737360|2525802|P1|COMPLETED|Overall Study||27
1040369|NCT00737360|2525802|P1|STARTED|Overall Study||27
1040370|NCT00737438|2525809|P1|NOT COMPLETED|Overall Study||3
1040371|NCT00737438|2525809|P1|COMPLETED|Overall Study||20
1040372|NCT00737438|2525809|P1|STARTED|Overall Study||23
1040373|NCT00737464|2525813|P1|NOT COMPLETED|Overall Study||18
1040374|NCT00737464|2525813|P1|COMPLETED|Overall Study||114
1040375|NCT00737464|2525813|P1|STARTED|Overall Study||132
1040376|NCT00737477|2525834|P1|NOT COMPLETED|Overall Study||34
1040377|NCT00737477|2525834|P1|COMPLETED|Overall Study||62
1040378|NCT00737477|2525834|P1|STARTED|Overall Study||96
1040379|NCT00737529|2525850|P1|NOT COMPLETED|Overall Study||112
1040380|NCT00737529|2525850|P1|COMPLETED|Overall Study|Completed equals participants ongoing on treatment at the time of the data cut-off of 02 July 2012|22
1040381|NCT00737529|2525850|P1|STARTED|Overall Study||134
1040382|NCT00737568|2525866|P2|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||18
1040383|NCT00737568|2525867|P1|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||26
1040384|NCT00737568|2525866|P2|COMPLETED|Treatment-Free Follow-up (TFFU) Period||19
1040385|NCT00737568|2525867|P1|COMPLETED|Treatment-Free Follow-up (TFFU) Period||12
1040386|NCT00737568|2525866|P2|STARTED|Treatment-Free Follow-up (TFFU) Period|4 participants not completing the 240 week treatment period enrolled in the TFFU period.|37
1040387|NCT00737568|2525867|P1|STARTED|Treatment-Free Follow-up (TFFU) Period|1 participant not completing the 240 week treatment period enrolled in the TFFU period.|38
1040388|NCT00737568|2525866|P2|NOT COMPLETED|Treatment Period Through Week 240||21
1040389|NCT00737568|2525867|P1|NOT COMPLETED|Treatment Period Through Week 240||20
1040390|NCT00737568|2525866|P2|COMPLETED|Treatment Period Through Week 240||118
1040391|NCT00737568|2525867|P1|COMPLETED|Treatment Period Through Week 240||121
1040392|NCT00737568|2525866|P2|STARTED|Treatment Period Through Week 240||139
1040393|NCT00737568|2525867|P1|STARTED|Treatment Period Through Week 240||141
1040394|NCT00737594|2525900|P3|NOT COMPLETED|Overall Study||0
1040395|NCT00737594|2525901|P2|NOT COMPLETED|Overall Study||0
1040396|NCT00737594|2525902|P1|NOT COMPLETED|Overall Study||0
1040397|NCT00737594|2525900|P3|COMPLETED|Overall Study||0
1040398|NCT00737594|2525901|P2|COMPLETED|Overall Study||0
1040399|NCT00737594|2525902|P1|COMPLETED|Overall Study||0
1040400|NCT00737594|2525900|P3|STARTED|Overall Study||0
1040401|NCT00737594|2525901|P2|STARTED|Overall Study||0
1040402|NCT00737594|2525902|P1|STARTED|Overall Study||0
1040403|NCT00737633|2525912|P2|NOT COMPLETED|Overall Study||57
1040404|NCT00737633|2525913|P1|NOT COMPLETED|Overall Study||44
1040405|NCT00737633|2525912|P2|COMPLETED|Overall Study||0
1040406|NCT00737633|2525913|P1|COMPLETED|Overall Study||0
1040407|NCT00737633|2525912|P2|STARTED|Overall Study||57
1040408|NCT00737633|2525913|P1|STARTED|Overall Study||44
1040419|NCT00737711|2525960|P1|NOT COMPLETED|Overall Study||31
1040420|NCT00737711|2525960|P1|COMPLETED|Overall Study||158
1040421|NCT00737711|2525960|P1|STARTED|Overall Study||189
1040422|NCT00737737|2525993|P2|NOT COMPLETED|Overall Study||0
1040423|NCT00737737|2525994|P1|NOT COMPLETED|Overall Study||0
1040424|NCT00737737|2525993|P2|COMPLETED|Overall Study||2
1040425|NCT00737737|2525994|P1|COMPLETED|Overall Study||2
1040426|NCT00737737|2525993|P2|STARTED|Overall Study||2
1040427|NCT00737737|2525994|P1|STARTED|Overall Study||2
1040428|NCT00743249|2526004|P2|NOT COMPLETED|Overall Study||6
1040429|NCT00743249|2526005|P1|NOT COMPLETED|Overall Study||2
1040430|NCT00743249|2526004|P2|COMPLETED|Overall Study||24
1040431|NCT00743249|2526005|P1|COMPLETED|Overall Study||28
1040432|NCT00743249|2526004|P2|STARTED|Overall Study||30
1040433|NCT00743249|2526005|P1|STARTED|Overall Study||30
1040434|NCT00743262|2526013|P1|NOT COMPLETED|Overall Study||0
1040435|NCT00743262|2526013|P1|COMPLETED|Overall Study||15
1040436|NCT00743262|2526013|P1|STARTED|Overall Study||15
1040437|NCT00743275|2526021|P2|NOT COMPLETED|Overall Study||1
1040438|NCT00743275|2526022|P1|NOT COMPLETED|Overall Study||0
1040439|NCT00743275|2526021|P2|COMPLETED|Overall Study||60
1040440|NCT00743275|2526022|P1|COMPLETED|Overall Study||59
1040441|NCT00743275|2526021|P2|STARTED|Overall Study||61
1040442|NCT00743275|2526022|P1|STARTED|Overall Study||59
1040443|NCT00743288|2526034|P7|NOT COMPLETED|Overall Study||9
1040444|NCT00743288|2526035|P6|NOT COMPLETED|Overall Study||5
1040445|NCT00743288|2526036|P5|NOT COMPLETED|Overall Study||6
1040446|NCT00743288|2526037|P4|NOT COMPLETED|Overall Study||7
1040447|NCT00743288|2526038|P3|NOT COMPLETED|Overall Study||5
1040448|NCT00743288|2526039|P2|NOT COMPLETED|Overall Study||3
1040449|NCT00743288|2526040|P1|NOT COMPLETED|Overall Study||3
1040450|NCT00743288|2526034|P7|COMPLETED|Overall Study||0
1040451|NCT00743288|2526035|P6|COMPLETED|Overall Study||1
1040452|NCT00743288|2526036|P5|COMPLETED|Overall Study||0
1040453|NCT00743288|2526037|P4|COMPLETED|Overall Study||0
1040454|NCT00743288|2526038|P3|COMPLETED|Overall Study||1
1040455|NCT00743288|2526039|P2|COMPLETED|Overall Study||0
1040456|NCT00743288|2526040|P1|COMPLETED|Overall Study||0
1040457|NCT00743288|2526034|P7|STARTED|Overall Study|6 subjects were enrolled in phase 1 and 3 subjects were enrolled as part of the phase 2 expansion.|9
1040458|NCT00743288|2526035|P6|STARTED|Overall Study||6
1040459|NCT00743288|2526036|P5|STARTED|Overall Study||6
1040460|NCT00743288|2526037|P4|STARTED|Overall Study||7
1040461|NCT00743288|2526038|P3|STARTED|Overall Study||6
1040462|NCT00743288|2526039|P2|STARTED|Overall Study||3
1040463|NCT00743288|2526040|P1|STARTED|Overall Study||3
1040464|NCT00743366|2526052|P2|NOT COMPLETED|Intervention 2 (8 Days)||0
1040465|NCT00743366|2526053|P1|NOT COMPLETED|Intervention 2 (8 Days)||0
1040466|NCT00743366|2526052|P2|COMPLETED|Intervention 2 (8 Days)||7
1040467|NCT00743366|2526053|P1|COMPLETED|Intervention 2 (8 Days)||7
1040468|NCT00743366|2526052|P2|STARTED|Intervention 2 (8 Days)||7
1040469|NCT00743366|2526053|P1|STARTED|Intervention 2 (8 Days)||7
1040470|NCT00743366|2526052|P2|NOT COMPLETED|Intervention 1 (8 Days)||3
1040471|NCT00743366|2526053|P1|NOT COMPLETED|Intervention 1 (8 Days)||3
1040472|NCT00743366|2526052|P2|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
1040473|NCT00743366|2526053|P1|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
1040474|NCT00743366|2526052|P2|STARTED|Intervention 1 (8 Days)||10
1040475|NCT00743366|2526053|P1|STARTED|Intervention 1 (8 Days)||10
1040476|NCT00743431|2526059|P1|NOT COMPLETED|Overall Study||126
1040477|NCT00743431|2526059|P1|COMPLETED|Overall Study||98
1040478|NCT00743431|2526059|P1|STARTED|Overall Study||224
1040479|NCT00743444|2526063|P2|NOT COMPLETED|Second Intervention||0
1040480|NCT00743444|2526064|P1|NOT COMPLETED|Second Intervention||0
1040481|NCT00743444|2526063|P2|COMPLETED|Second Intervention||11
1040482|NCT00743444|2526064|P1|COMPLETED|Second Intervention||14
1040483|NCT00743444|2526063|P2|STARTED|Second Intervention||11
1040484|NCT00743444|2526064|P1|STARTED|Second Intervention||14
1040485|NCT00743444|2526063|P2|NOT COMPLETED|Washout Period||1
1040486|NCT00743444|2526064|P1|NOT COMPLETED|Washout Period||0
1040487|NCT00743444|2526063|P2|COMPLETED|Washout Period||11
1040488|NCT00743444|2526064|P1|COMPLETED|Washout Period||14
1040489|NCT00743444|2526063|P2|STARTED|Washout Period||12
1040490|NCT00743444|2526064|P1|STARTED|Washout Period||14
1040491|NCT00743444|2526063|P2|NOT COMPLETED|First Intervention||1
1040492|NCT00743444|2526064|P1|NOT COMPLETED|First Intervention||0
1040493|NCT00743444|2526063|P2|COMPLETED|First Intervention||12
1040494|NCT00743444|2526064|P1|COMPLETED|First Intervention||14
1040495|NCT00743444|2526063|P2|STARTED|First Intervention||13
1040496|NCT00743444|2526064|P1|STARTED|First Intervention||14
1040497|NCT00743483|2526073|P1|NOT COMPLETED|Treatment Period||1
1040498|NCT00743483|2526073|P1|COMPLETED|Treatment Period||13
1040499|NCT00743483|2526073|P1|STARTED|Treatment Period||14
1040500|NCT00743483|2526073|P1|NOT COMPLETED|Baseline Period||1
1040501|NCT00743483|2526073|P1|COMPLETED|Baseline Period||14
1040502|NCT00743483|2526073|P1|STARTED|Baseline Period||15
1040503|NCT00743509|2526077|P1|NOT COMPLETED|Overall Study||2
1040504|NCT00743509|2526077|P1|COMPLETED|Overall Study||47
1040505|NCT00743509|2526077|P1|STARTED|Overall Study||49
1040506|NCT00744653|2526082|P1|NOT COMPLETED|Overall Study||16
1040507|NCT00744653|2526082|P1|COMPLETED|Overall Study||1
1040508|NCT00744653|2526082|P1|STARTED|Overall Study||17
1040509|NCT00744692|2526088|P1|NOT COMPLETED|Overall Study||0
1040510|NCT00744692|2526088|P1|COMPLETED|Overall Study||22
1040511|NCT00744692|2526088|P1|STARTED|Overall Study||22
1040512|NCT00744757|2526100|P1|NOT COMPLETED|Overall Study||21
1040513|NCT00744757|2526100|P1|COMPLETED|Overall Study||16
1040514|NCT00744757|2526100|P1|STARTED|Overall Study||37
1040515|NCT00744848|2526115|P2|NOT COMPLETED|Overall Study||0
1040516|NCT00744848|2526116|P1|NOT COMPLETED|Overall Study||0
1040517|NCT00744848|2526115|P2|COMPLETED|Overall Study||101
1040518|NCT00744848|2526116|P1|COMPLETED|Overall Study||103
1040519|NCT00744848|2526115|P2|STARTED|Overall Study||101
1040520|NCT00744848|2526116|P1|STARTED|Overall Study||103
1040521|NCT00744874|2526122|P1|NOT COMPLETED|Overall Study||4
1040522|NCT00744874|2526122|P1|COMPLETED|Overall Study||51
1040523|NCT00744874|2526122|P1|STARTED|Overall Study||55
1040524|NCT00744939|2526142|P1|NOT COMPLETED|Overall Study||91
1040525|NCT00744939|2526142|P1|COMPLETED|Overall Study||77
1040526|NCT00744939|2526142|P1|Treatment Received|Overall Study||141
1040527|NCT00744939|2526142|P1|STARTED|Overall Study||168
1040528|NCT00744978|2526180|P2|NOT COMPLETED|Period 2||1
1040529|NCT00744978|2526181|P1|NOT COMPLETED|Period 2||0
1040530|NCT00744978|2526180|P2|COMPLETED|Period 2||28
1040531|NCT00744978|2526181|P1|COMPLETED|Period 2||26
1040532|NCT00744978|2526180|P2|STARTED|Period 2||29
1040533|NCT00744978|2526181|P1|STARTED|Period 2||26
1040534|NCT00744978|2526180|P2|NOT COMPLETED|Placebo Washout||0
1040535|NCT00744978|2526181|P1|NOT COMPLETED|Placebo Washout||0
1040536|NCT00744978|2526180|P2|COMPLETED|Placebo Washout||29
1040537|NCT00744978|2526181|P1|COMPLETED|Placebo Washout||26
1040538|NCT00744978|2526180|P2|STARTED|Placebo Washout||29
1040539|NCT00744978|2526181|P1|STARTED|Placebo Washout||26
1040540|NCT00744978|2526180|P2|NOT COMPLETED|Period 1||5
1040541|NCT00744978|2526181|P1|NOT COMPLETED|Period 1||6
1040542|NCT00744978|2526180|P2|COMPLETED|Period 1||29
1040543|NCT00744978|2526181|P1|COMPLETED|Period 1||26
1040544|NCT00744978|2526180|P2|Treated|Period 1||33
1040545|NCT00744978|2526181|P1|Treated|Period 1||31
1040546|NCT00744978|2526180|P2|STARTED|Period 1||34
1040547|NCT00744978|2526181|P1|STARTED|Period 1||32
1040548|NCT00745030|2526231|P2|NOT COMPLETED|Overall Study||0
1040549|NCT00745030|2526232|P1|NOT COMPLETED|Overall Study||0
1040550|NCT00745030|2526231|P2|COMPLETED|Overall Study||2
1040551|NCT00745030|2526232|P1|COMPLETED|Overall Study||1
1040552|NCT00745030|2526231|P2|STARTED|Overall Study||2
1040553|NCT00745030|2526232|P1|STARTED|Overall Study||1
1040554|NCT00745095|2526244|P6|NOT COMPLETED|Overall Study||123
1040555|NCT00745095|2526245|P5|NOT COMPLETED|Overall Study||122
1040556|NCT00745095|2526246|P4|NOT COMPLETED|Overall Study||3
1040557|NCT00745095|2526247|P3|NOT COMPLETED|Overall Study||3
1040558|NCT00745095|2526248|P2|NOT COMPLETED|Overall Study||2
1040559|NCT00745095|2526249|P1|NOT COMPLETED|Overall Study||1
1040560|NCT00745095|2526244|P6|COMPLETED|Overall Study||27
1040561|NCT00745095|2526245|P5|COMPLETED|Overall Study||28
1040562|NCT00745095|2526246|P4|COMPLETED|Overall Study||12
1040563|NCT00745095|2526247|P3|COMPLETED|Overall Study||12
1040564|NCT00745095|2526248|P2|COMPLETED|Overall Study||13
1040565|NCT00745095|2526249|P1|COMPLETED|Overall Study||14
1040566|NCT00745095|2526244|P6|STARTED|Overall Study||150
1040567|NCT00745095|2526245|P5|STARTED|Overall Study||150
1040568|NCT00745095|2526246|P4|STARTED|Overall Study||15
1040569|NCT00745095|2526247|P3|STARTED|Overall Study||15
1040570|NCT00745095|2526248|P2|STARTED|Overall Study||15
1040571|NCT00745095|2526249|P1|STARTED|Overall Study||15
1040572|NCT00745251|2526271|P2|NOT COMPLETED|Overall Study||3
1040573|NCT00745251|2526272|P1|NOT COMPLETED|Overall Study||2
1040574|NCT00745251|2526271|P2|COMPLETED|Overall Study||19
1040575|NCT00745251|2526272|P1|COMPLETED|Overall Study||21
1040576|NCT00745251|2526271|P2|STARTED|Overall Study||22
1040577|NCT00745251|2526272|P1|STARTED|Overall Study||23
1040578|NCT00745290|2526282|P2|NOT COMPLETED|Overall Study||0
1040579|NCT00745290|2526283|P1|NOT COMPLETED|Overall Study||0
1040580|NCT00745290|2526282|P2|COMPLETED|Overall Study||122
1040581|NCT00745290|2526283|P1|COMPLETED|Overall Study||123
1040582|NCT00745290|2526282|P2|STARTED|Overall Study||122
1040583|NCT00745290|2526283|P1|STARTED|Overall Study||123
1040584|NCT00745368|2526289|P1|NOT COMPLETED|Overall Study||3
1040585|NCT00745368|2526289|P1|COMPLETED|Overall Study|3 male subjects were unable to provide a sample and are not included in the results|16
1040586|NCT00745368|2526289|P1|STARTED|Overall Study|Of the 28 subjects who enrolled, 19 participated in a study visit|19
1040587|NCT00745498|2526303|P3|NOT COMPLETED|Overall Study||8
1040588|NCT00745498|2526304|P2|NOT COMPLETED|Overall Study||6
1040589|NCT00745498|2526305|P1|NOT COMPLETED|Overall Study||5
1040590|NCT00745498|2526303|P3|COMPLETED|Overall Study||34
1040591|NCT00745498|2526304|P2|COMPLETED|Overall Study||37
1040592|NCT00745498|2526305|P1|COMPLETED|Overall Study||36
1040593|NCT00745498|2526303|P3|STARTED|Overall Study||42
1040594|NCT00745498|2526304|P2|STARTED|Overall Study||43
1040595|NCT00745498|2526305|P1|STARTED|Overall Study||41
1040604|NCT00745875|2526348|P2|NOT COMPLETED|Overall Study||4
1040605|NCT00745875|2526349|P1|NOT COMPLETED|Overall Study||4
1040606|NCT00745875|2526348|P2|COMPLETED|Overall Study|Completed – Number of patients discontinued study treatment at data cut-off (17th January 2010)|26
1040607|NCT00745875|2526349|P1|COMPLETED|Overall Study|Completed – Number of patients discontinued study treatment at data cut-off (17th January 2010)|32
1040608|NCT00745875|2526348|P2|STARTED|Overall Study|Started – Number of patients randomised|30
1040609|NCT00745875|2526349|P1|STARTED|Overall Study|Started – Number of patients randomised|36
1040610|NCT00745901|2526359|P2|NOT COMPLETED|Overall Study||21
1040611|NCT00745901|2526360|P1|NOT COMPLETED|Overall Study||24
1040612|NCT00745901|2526359|P2|COMPLETED|Overall Study||156
1040613|NCT00745901|2526360|P1|COMPLETED|Overall Study||154
1040614|NCT00745901|2526359|P2|STARTED|Overall Study|Number of Patients Randomized|177
1040615|NCT00745901|2526360|P1|STARTED|Overall Study|Number of Patients Randomized|178
1040616|NCT00745940|2526406|P2|NOT COMPLETED|Overall Study||10
1040617|NCT00745940|2526407|P1|NOT COMPLETED|Overall Study||19
1040618|NCT00745940|2526406|P2|COMPLETED|Overall Study||38
1040619|NCT00745940|2526407|P1|COMPLETED|Overall Study||38
1040620|NCT00745940|2526406|P2|STARTED|Overall Study||48
1040621|NCT00745940|2526407|P1|STARTED|Overall Study||57
1040622|NCT00746096|2526423|P2|NOT COMPLETED|Overall Study||3
1040623|NCT00746096|2526424|P1|NOT COMPLETED|Overall Study||10
1040624|NCT00746096|2526423|P2|COMPLETED|Overall Study||54
1040625|NCT00746096|2526424|P1|COMPLETED|Overall Study||48
1040626|NCT00746096|2526423|P2|STARTED|Overall Study||57
1040627|NCT00746096|2526424|P1|STARTED|Overall Study||58
1040628|NCT00746187|2526434|P2|NOT COMPLETED|Overall Study||2
1040629|NCT00746187|2526435|P1|NOT COMPLETED|Overall Study||3
1040630|NCT00746187|2526434|P2|COMPLETED|Overall Study||16
1040631|NCT00746187|2526435|P1|COMPLETED|Overall Study||15
1040632|NCT00746187|2526434|P2|STARTED|Overall Study||18
1040633|NCT00746187|2526435|P1|STARTED|Overall Study||18
1040634|NCT00746239|2526441|P1|NOT COMPLETED|Overall Study||6
1040635|NCT00746239|2526441|P1|COMPLETED|Overall Study|11 subjects total were enrolled - 6 withdrew from study and 5 competed|5
1040636|NCT00746239|2526441|P1|STARTED|Overall Study||11
1040637|NCT00746330|2526449|P4|NOT COMPLETED|Period 4||0
1040638|NCT00746330|2526450|P3|NOT COMPLETED|Period 4||0
1040639|NCT00746330|2526451|P2|NOT COMPLETED|Period 4||0
1040640|NCT00746330|2526452|P1|NOT COMPLETED|Period 4||0
1040641|NCT00746330|2526449|P4|COMPLETED|Period 4||7
1040642|NCT00746330|2526450|P3|COMPLETED|Period 4||8
1040643|NCT00746330|2526451|P2|COMPLETED|Period 4||9
1040644|NCT00746330|2526452|P1|COMPLETED|Period 4||7
1040645|NCT00746330|2526449|P4|STARTED|Period 4||7
1040646|NCT00746330|2526450|P3|STARTED|Period 4||8
1040647|NCT00746330|2526451|P2|STARTED|Period 4||9
1040648|NCT00746330|2526452|P1|STARTED|Period 4||7
1040649|NCT00746330|2526449|P4|NOT COMPLETED|Period 3||0
1040650|NCT00746330|2526450|P3|NOT COMPLETED|Period 3||0
1040651|NCT00746330|2526451|P2|NOT COMPLETED|Period 3||0
1040652|NCT00746330|2526452|P1|NOT COMPLETED|Period 3||0
1040653|NCT00746330|2526449|P4|COMPLETED|Period 3||7
1040654|NCT00746330|2526450|P3|COMPLETED|Period 3||8
1040655|NCT00746330|2526451|P2|COMPLETED|Period 3||9
1040656|NCT00746330|2526452|P1|COMPLETED|Period 3||7
1040657|NCT00746330|2526449|P4|STARTED|Period 3||7
1040658|NCT00746330|2526450|P3|STARTED|Period 3||8
1040659|NCT00746330|2526451|P2|STARTED|Period 3||9
1040660|NCT00746330|2526452|P1|STARTED|Period 3||7
1040661|NCT00746330|2526449|P4|NOT COMPLETED|Period 2||0
1040662|NCT00746330|2526450|P3|NOT COMPLETED|Period 2||0
1040663|NCT00746330|2526451|P2|NOT COMPLETED|Period 2||0
1040664|NCT00746330|2526452|P1|NOT COMPLETED|Period 2||0
1040665|NCT00746330|2526449|P4|COMPLETED|Period 2||7
1040666|NCT00746330|2526450|P3|COMPLETED|Period 2||8
1040667|NCT00746330|2526451|P2|COMPLETED|Period 2||9
1040668|NCT00746330|2526452|P1|COMPLETED|Period 2||7
1040669|NCT00746330|2526449|P4|STARTED|Period 2||7
1040670|NCT00746330|2526450|P3|STARTED|Period 2||8
1040671|NCT00746330|2526451|P2|STARTED|Period 2||9
1040672|NCT00746330|2526452|P1|STARTED|Period 2||7
1040673|NCT00746330|2526449|P4|NOT COMPLETED|Period 1||0
1040674|NCT00746330|2526450|P3|NOT COMPLETED|Period 1||1
1040675|NCT00746330|2526451|P2|NOT COMPLETED|Period 1||0
1040676|NCT00746330|2526452|P1|NOT COMPLETED|Period 1||0
1040677|NCT00746330|2526449|P4|COMPLETED|Period 1||7
1040678|NCT00746330|2526450|P3|COMPLETED|Period 1||8
1040679|NCT00746330|2526451|P2|COMPLETED|Period 1||9
1040680|NCT00746330|2526452|P1|COMPLETED|Period 1||7
1040681|NCT00746330|2526449|P4|STARTED|Period 1||7
1040682|NCT00746330|2526450|P3|STARTED|Period 1||9
1040683|NCT00746330|2526451|P2|STARTED|Period 1||9
1040684|NCT00746330|2526452|P1|STARTED|Period 1||7
1040685|NCT00746356|2526480|P2|NOT COMPLETED|Overall Study||7
1040686|NCT00746356|2526481|P1|NOT COMPLETED|Overall Study||11
1040687|NCT00746356|2526480|P2|COMPLETED|Overall Study||40
1040688|NCT00746356|2526481|P1|COMPLETED|Overall Study||70
1040689|NCT00746356|2526480|P2|STARTED|Overall Study||47
1040690|NCT00746356|2526481|P1|STARTED|Overall Study||81
1040691|NCT00746395|2526491|P2|NOT COMPLETED|Overall Study||0
1040692|NCT00746395|2526492|P1|NOT COMPLETED|Overall Study||0
1040693|NCT00746395|2526491|P2|COMPLETED|Overall Study||20
1040694|NCT00746395|2526492|P1|COMPLETED|Overall Study||20
1040695|NCT00746395|2526491|P2|STARTED|Overall Study||20
1040696|NCT00746395|2526492|P1|STARTED|Overall Study||20
1040697|NCT00746421|2526502|P2|NOT COMPLETED|Overall Study||2
1040698|NCT00746421|2526503|P1|NOT COMPLETED|Overall Study||7
1040699|NCT00746421|2526502|P2|COMPLETED|Overall Study||9
1040700|NCT00746421|2526503|P1|COMPLETED|Overall Study||5
1040701|NCT00746421|2526502|P2|STARTED|Overall Study||11
1040702|NCT00746421|2526503|P1|STARTED|Overall Study||12
1040703|NCT00746512|2526515|P4|NOT COMPLETED|Overall Study||0
1040704|NCT00746512|2526516|P3|NOT COMPLETED|Overall Study||0
1040705|NCT00746512|2526517|P2|NOT COMPLETED|Overall Study||0
1040706|NCT00746512|2526518|P1|NOT COMPLETED|Overall Study||0
1040707|NCT00746512|2526515|P4|COMPLETED|Overall Study||9
1040708|NCT00746512|2526516|P3|COMPLETED|Overall Study||18
1040709|NCT00746512|2526517|P2|COMPLETED|Overall Study||10
1040710|NCT00746512|2526518|P1|COMPLETED|Overall Study||8
1040711|NCT00746512|2526515|P4|STARTED|Overall Study||9
1040712|NCT00746512|2526516|P3|STARTED|Overall Study||18
1040713|NCT00746512|2526517|P2|STARTED|Overall Study||10
1040714|NCT00746512|2526518|P1|STARTED|Overall Study||8
1040715|NCT00746551|2526534|P2|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
1040716|NCT00746551|2526535|P1|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
1040717|NCT00746551|2526534|P2|COMPLETED|At Delivery (GA of 39 Weeks)||25
1040718|NCT00746551|2526535|P1|COMPLETED|At Delivery (GA of 39 Weeks)||25
1040719|NCT00746551|2526534|P2|STARTED|At Delivery (GA of 39 Weeks)||40
1040720|NCT00746551|2526535|P1|STARTED|At Delivery (GA of 39 Weeks)||40
1040721|NCT00746551|2526534|P2|NOT COMPLETED|At Gestational Age of 36 Weeks||4
1040722|NCT00746551|2526535|P1|NOT COMPLETED|At Gestational Age of 36 Weeks||2
1040723|NCT00746551|2526534|P2|COMPLETED|At Gestational Age of 36 Weeks||36
1040724|NCT00746551|2526535|P1|COMPLETED|At Gestational Age of 36 Weeks||38
1040725|NCT00746551|2526534|P2|STARTED|At Gestational Age of 36 Weeks||40
1040726|NCT00746551|2526535|P1|STARTED|At Gestational Age of 36 Weeks||40
1040727|NCT00746564|2526543|P1|NOT COMPLETED|Overall Study||2
1040728|NCT00746564|2526543|P1|COMPLETED|Overall Study||73
1040729|NCT00746564|2526543|P1|STARTED|Overall Study||75
1040730|NCT00746590|2526556|P1|NOT COMPLETED|Overall Study||1
1040731|NCT00746590|2526556|P1|COMPLETED|Overall Study||0
1040732|NCT00746590|2526556|P1|STARTED|Overall Study||1
1040733|NCT00746668|2526560|P7|NOT COMPLETED|Overall Study||0
1040734|NCT00746668|2526561|P6|NOT COMPLETED|Overall Study||0
1040735|NCT00746668|2526562|P5|NOT COMPLETED|Overall Study||0
1040736|NCT00746668|2526563|P4|NOT COMPLETED|Overall Study||0
1040737|NCT00746668|2526564|P3|NOT COMPLETED|Overall Study||0
1040738|NCT00746668|2526565|P2|NOT COMPLETED|Overall Study||0
1040739|NCT00746668|2526566|P1|NOT COMPLETED|Overall Study||0
1040740|NCT00746668|2526560|P7|COMPLETED|Overall Study||5
1040741|NCT00746668|2526561|P6|COMPLETED|Overall Study||5
1040742|NCT00746668|2526562|P5|COMPLETED|Overall Study||5
1040743|NCT00746668|2526563|P4|COMPLETED|Overall Study||5
1040744|NCT00746668|2526564|P3|COMPLETED|Overall Study||5
1040745|NCT00746668|2526565|P2|COMPLETED|Overall Study||5
1040746|NCT00746668|2526566|P1|COMPLETED|Overall Study||6
1040747|NCT00746668|2526560|P7|STARTED|Overall Study||5
1040748|NCT00746668|2526561|P6|STARTED|Overall Study||5
1040749|NCT00746668|2526562|P5|STARTED|Overall Study||5
1040750|NCT00746668|2526563|P4|STARTED|Overall Study||5
1040751|NCT00746668|2526564|P3|STARTED|Overall Study||5
1040752|NCT00746668|2526565|P2|STARTED|Overall Study||5
1040753|NCT00746668|2526566|P1|STARTED|Overall Study||6
1040754|NCT00746694|2526579|P1|NOT COMPLETED|Overall Study||0
1040755|NCT00746694|2526579|P1|COMPLETED|Overall Study||154
1040756|NCT00746694|2526579|P1|STARTED|Overall Study||154
1040757|NCT00746733|2526584|P2|NOT COMPLETED|Fourth Intervention||0
1040758|NCT00746733|2526585|P1|NOT COMPLETED|Fourth Intervention||0
1040759|NCT00746733|2526584|P2|COMPLETED|Fourth Intervention||11
1040760|NCT00746733|2526585|P1|COMPLETED|Fourth Intervention||10
1040761|NCT00746733|2526584|P2|STARTED|Fourth Intervention||11
1040762|NCT00746733|2526585|P1|STARTED|Fourth Intervention||10
1040763|NCT00746733|2526584|P2|NOT COMPLETED|Third Intervention||1
1040764|NCT00746733|2526585|P1|NOT COMPLETED|Third Intervention||1
1040765|NCT00746733|2526584|P2|COMPLETED|Third Intervention||11
1040766|NCT00746733|2526585|P1|COMPLETED|Third Intervention||10
1040767|NCT00746733|2526584|P2|STARTED|Third Intervention||12
1040768|NCT00746733|2526585|P1|STARTED|Third Intervention||11
1040769|NCT00746733|2526584|P2|NOT COMPLETED|Second Intervention||0
1040770|NCT00746733|2526585|P1|NOT COMPLETED|Second Intervention||1
1040771|NCT00746733|2526584|P2|COMPLETED|Second Intervention||12
1040772|NCT00746733|2526585|P1|COMPLETED|Second Intervention||11
1040773|NCT00746733|2526584|P2|STARTED|Second Intervention||12
1040774|NCT00746733|2526585|P1|STARTED|Second Intervention||12
1040775|NCT00746733|2526584|P2|NOT COMPLETED|First Intervention||0
1040776|NCT00746733|2526585|P1|NOT COMPLETED|First Intervention||0
1040777|NCT00746733|2526584|P2|COMPLETED|First Intervention||12
1040778|NCT00746733|2526585|P1|COMPLETED|First Intervention||12
1040779|NCT00746733|2526584|P2|STARTED|First Intervention||12
1040780|NCT00746733|2526585|P1|STARTED|First Intervention||12
1040781|NCT00746785|2526648|P3|NOT COMPLETED|Overall Study||27
1040782|NCT00746785|2526649|P2|NOT COMPLETED|Overall Study||25
1040783|NCT00746785|2526650|P1|NOT COMPLETED|Overall Study||29
1040784|NCT00746785|2526648|P3|COMPLETED|Overall Study||13
1040785|NCT00746785|2526649|P2|COMPLETED|Overall Study||21
1040786|NCT00746785|2526650|P1|COMPLETED|Overall Study||14
1040787|NCT00746785|2526648|P3|STARTED|Overall Study||40
1040788|NCT00746785|2526649|P2|STARTED|Overall Study||46
1040789|NCT00746785|2526650|P1|STARTED|Overall Study||43
1040790|NCT00746798|2526662|P4|NOT COMPLETED|Overall Study||0
1040791|NCT00746798|2526663|P3|NOT COMPLETED|Overall Study||3
1040792|NCT00746798|2526664|P2|NOT COMPLETED|Overall Study||2
1040793|NCT00746798|2526665|P1|NOT COMPLETED|Overall Study||1
1040794|NCT00746798|2526662|P4|COMPLETED|Overall Study||120
1040795|NCT00746798|2526663|P3|COMPLETED|Overall Study||110
1040796|NCT00746798|2526664|P2|COMPLETED|Overall Study||122
1040797|NCT00746798|2526665|P1|COMPLETED|Overall Study||121
1040798|NCT00746798|2526662|P4|STARTED|Overall Study||120
1040799|NCT00746798|2526663|P3|STARTED|Overall Study||113
1040800|NCT00746798|2526664|P2|STARTED|Overall Study||124
1040801|NCT00746798|2526665|P1|STARTED|Overall Study||122
1040802|NCT00746863|2526689|P2|NOT COMPLETED|Overall Study||0
1040803|NCT00746863|2526690|P1|NOT COMPLETED|Overall Study||0
1040804|NCT00746863|2526689|P2|COMPLETED|Overall Study||21
1040805|NCT00746863|2526690|P1|COMPLETED|Overall Study||21
1040806|NCT00746863|2526689|P2|STARTED|Overall Study||21
1040807|NCT00746863|2526690|P1|STARTED|Overall Study||21
1040808|NCT00746889|2526706|P2|NOT COMPLETED|Overall Study||4
1040809|NCT00746889|2526707|P1|NOT COMPLETED|Overall Study||4
1040810|NCT00746889|2526706|P2|COMPLETED|Overall Study||35
1040811|NCT00746889|2526707|P1|COMPLETED|Overall Study||36
1040812|NCT00746889|2526706|P2|STARTED|Overall Study||39
1040813|NCT00746889|2526707|P1|STARTED|Overall Study||40
1040814|NCT00746941|2526719|P4|NOT COMPLETED|Overall Study||13
1040815|NCT00746941|2526720|P3|NOT COMPLETED|Overall Study||2
1040816|NCT00746941|2526721|P2|NOT COMPLETED|Overall Study||4
1040817|NCT00746941|2526722|P1|NOT COMPLETED|Overall Study||7
1040818|NCT00746941|2526719|P4|COMPLETED|Overall Study||7
1040819|NCT00746941|2526720|P3|COMPLETED|Overall Study||3
1040820|NCT00746941|2526721|P2|COMPLETED|Overall Study||1
1040821|NCT00746941|2526722|P1|COMPLETED|Overall Study||0
1040822|NCT00746941|2526719|P4|STARTED|Overall Study||20
1040823|NCT00746941|2526720|P3|STARTED|Overall Study||5
1040824|NCT00746941|2526721|P2|STARTED|Overall Study||5
1040825|NCT00746941|2526722|P1|STARTED|Overall Study||7
1040826|NCT00746954|2526748|P3|NOT COMPLETED|Overall Study||0
1040827|NCT00746954|2526749|P2|NOT COMPLETED|Overall Study||0
1040828|NCT00746954|2526750|P1|NOT COMPLETED|Overall Study||0
1040829|NCT00746954|2526748|P3|COMPLETED|Overall Study||2
1040830|NCT00746954|2526749|P2|COMPLETED|Overall Study||3
1040831|NCT00746954|2526750|P1|COMPLETED|Overall Study||3
1040832|NCT00746954|2526748|P3|STARTED|Overall Study||2
1040833|NCT00746954|2526749|P2|STARTED|Overall Study||3
1040834|NCT00746954|2526750|P1|STARTED|Overall Study||3
1040835|NCT00747006|2526759|P3|NOT COMPLETED|Overall Study||1
1040836|NCT00747006|2526760|P2|NOT COMPLETED|Overall Study||1
1040837|NCT00747006|2526761|P1|NOT COMPLETED|Overall Study||3
1040838|NCT00747006|2526759|P3|COMPLETED|Overall Study||2
1040839|NCT00747006|2526760|P2|COMPLETED|Overall Study||7
1040840|NCT00747006|2526761|P1|COMPLETED|Overall Study||4
1040841|NCT00747006|2526759|P3|STARTED|Overall Study||3
1040842|NCT00747006|2526760|P2|STARTED|Overall Study||8
1040843|NCT00747006|2526761|P1|STARTED|Overall Study||7
1040844|NCT00747149|2526829|P2|NOT COMPLETED|Overall Study||43
1040845|NCT00747149|2526830|P1|NOT COMPLETED|Overall Study||1
1040846|NCT00747149|2526829|P2|COMPLETED|Overall Study||401
1040847|NCT00747149|2526830|P1|COMPLETED|Overall Study||153
1040848|NCT00747149|2526829|P2|STARTED|Overall Study||444
1040849|NCT00747149|2526830|P1|STARTED|Overall Study||154
1040850|NCT00747214|2526844|P2|NOT COMPLETED|Overall Study||3
1040851|NCT00747214|2526845|P1|NOT COMPLETED|Overall Study||8
1040852|NCT00747214|2526844|P2|COMPLETED|Overall Study||29
1040853|NCT00747214|2526845|P1|COMPLETED|Overall Study||19
1040854|NCT00747214|2526844|P2|STARTED|Overall Study||32
1040855|NCT00747214|2526845|P1|STARTED|Overall Study||27
1040856|NCT00747227|2526859|P2|NOT COMPLETED|Overall Study||4
1040857|NCT00747227|2526860|P1|NOT COMPLETED|Overall Study||6
1040858|NCT00747227|2526859|P2|COMPLETED|Overall Study||120
1040859|NCT00747227|2526860|P1|COMPLETED|Overall Study||120
1040860|NCT00747227|2526859|P2|STARTED|Overall Study||124
1040861|NCT00747227|2526860|P1|STARTED|Overall Study||126
1040862|NCT00747344|2526874|P4|NOT COMPLETED|After Controlled Period||1
1040863|NCT00747344|2526875|P3|NOT COMPLETED|After Controlled Period||0
1040864|NCT00747344|2526876|P2|NOT COMPLETED|After Controlled Period||0
1040865|NCT00747344|2526877|P1|NOT COMPLETED|After Controlled Period||0
1040866|NCT00747344|2526874|P4|COMPLETED|After Controlled Period||56
1040867|NCT00747344|2526875|P3|COMPLETED|After Controlled Period||55
1040868|NCT00747344|2526876|P2|COMPLETED|After Controlled Period||0
1040869|NCT00747344|2526877|P1|COMPLETED|After Controlled Period||0
1040870|NCT00747344|2526874|P4|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|57
1040871|NCT00747344|2526875|P3|STARTED|After Controlled Period||55
1040872|NCT00747344|2526876|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
1040873|NCT00747344|2526877|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
1040874|NCT00747344|2526874|P4|NOT COMPLETED|Controlled Period||0
1040875|NCT00747344|2526875|P3|NOT COMPLETED|Controlled Period||0
1040876|NCT00747344|2526876|P2|NOT COMPLETED|Controlled Period||4
1040877|NCT00747344|2526877|P1|NOT COMPLETED|Controlled Period||5
1040878|NCT00747344|2526874|P4|COMPLETED|Controlled Period||0
1040879|NCT00747344|2526875|P3|COMPLETED|Controlled Period||0
1040880|NCT00747344|2526876|P2|COMPLETED|Controlled Period||57
1040881|NCT00747344|2526877|P1|COMPLETED|Controlled Period||55
1040882|NCT00747344|2526874|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
1040883|NCT00747344|2526875|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
1040884|NCT00747344|2526876|P2|STARTED|Controlled Period||61
1040885|NCT00747344|2526877|P1|STARTED|Controlled Period||60
1040886|NCT00747435|2526889|P1|NOT COMPLETED|Overall Study||6
1040887|NCT00747435|2526889|P1|COMPLETED|Overall Study||67
1040888|NCT00747435|2526889|P1|STARTED|Overall Study||73
1040889|NCT00747461|2526897|P1|NOT COMPLETED|Overall Study||5
1040890|NCT00747461|2526897|P1|COMPLETED|Overall Study||0
1040891|NCT00747461|2526897|P1|STARTED|Overall Study||5
1040892|NCT00747474|2526902|P12|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1040893|NCT00747474|2526903|P11|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1040894|NCT00747474|2526904|P10|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1040895|NCT00747474|2526905|P9|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1040896|NCT00747474|2526906|P8|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1040897|NCT00747474|2526907|P7|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1040898|NCT00747474|2526908|P6|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1040899|NCT00747474|2526909|P5|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1040900|NCT00747474|2526910|P4|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1040901|NCT00747474|2526911|P3|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1040902|NCT00747474|2526912|P2|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1040903|NCT00747474|2526913|P1|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1040904|NCT00747474|2526902|P12|COMPLETED|Cohort 12 (60 mg/m^2) Period||6
1040905|NCT00747474|2526903|P11|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1040906|NCT00747474|2526904|P10|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1040907|NCT00747474|2526905|P9|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1040908|NCT00747474|2526906|P8|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1040909|NCT00747474|2526907|P7|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1040910|NCT00747474|2526908|P6|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1040911|NCT00747474|2526909|P5|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1040912|NCT00747474|2526910|P4|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1040913|NCT00747474|2526911|P3|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1040914|NCT00747474|2526912|P2|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1040915|NCT00747474|2526913|P1|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
1040916|NCT00747474|2526902|P12|STARTED|Cohort 12 (60 mg/m^2) Period||6
1040917|NCT00747474|2526903|P11|STARTED|Cohort 12 (60 mg/m^2) Period||0
1040918|NCT00747474|2526904|P10|STARTED|Cohort 12 (60 mg/m^2) Period||0
1040919|NCT00747474|2526905|P9|STARTED|Cohort 12 (60 mg/m^2) Period||0
1040920|NCT00747474|2526906|P8|STARTED|Cohort 12 (60 mg/m^2) Period||0
1040921|NCT00747474|2526907|P7|STARTED|Cohort 12 (60 mg/m^2) Period||0
1040922|NCT00747474|2526908|P6|STARTED|Cohort 12 (60 mg/m^2) Period||0
1040923|NCT00747474|2526909|P5|STARTED|Cohort 12 (60 mg/m^2) Period||0
1040924|NCT00747474|2526910|P4|STARTED|Cohort 12 (60 mg/m^2) Period||0
1040925|NCT00747474|2526911|P3|STARTED|Cohort 12 (60 mg/m^2) Period||0
1040926|NCT00747474|2526912|P2|STARTED|Cohort 12 (60 mg/m^2) Period||0
1040927|NCT00747474|2526913|P1|STARTED|Cohort 12 (60 mg/m^2) Period||0
1040928|NCT00747474|2526902|P12|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1040929|NCT00747474|2526903|P11|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1040930|NCT00747474|2526904|P10|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1040931|NCT00747474|2526905|P9|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1040932|NCT00747474|2526906|P8|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1040933|NCT00747474|2526907|P7|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1040934|NCT00747474|2526908|P6|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1040935|NCT00747474|2526909|P5|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1040936|NCT00747474|2526910|P4|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1040937|NCT00747474|2526911|P3|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1040938|NCT00747474|2526912|P2|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1040939|NCT00747474|2526913|P1|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1040940|NCT00747474|2526902|P12|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1040941|NCT00747474|2526903|P11|COMPLETED|Cohort 11 (50 mg/m^2) Period||5
1040942|NCT00747474|2526904|P10|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1040943|NCT00747474|2526905|P9|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1040944|NCT00747474|2526906|P8|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1040945|NCT00747474|2526907|P7|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1040946|NCT00747474|2526908|P6|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1040947|NCT00747474|2526909|P5|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1040948|NCT00747474|2526910|P4|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1040949|NCT00747474|2526911|P3|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1040950|NCT00747474|2526912|P2|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1040951|NCT00747474|2526913|P1|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
1040952|NCT00747474|2526902|P12|STARTED|Cohort 11 (50 mg/m^2) Period||0
1040953|NCT00747474|2526903|P11|STARTED|Cohort 11 (50 mg/m^2) Period||5
1040954|NCT00747474|2526904|P10|STARTED|Cohort 11 (50 mg/m^2) Period||0
1040955|NCT00747474|2526905|P9|STARTED|Cohort 11 (50 mg/m^2) Period||0
1040956|NCT00747474|2526906|P8|STARTED|Cohort 11 (50 mg/m^2) Period||0
1040957|NCT00747474|2526907|P7|STARTED|Cohort 11 (50 mg/m^2) Period||0
1040958|NCT00747474|2526908|P6|STARTED|Cohort 11 (50 mg/m^2) Period||0
1040959|NCT00747474|2526909|P5|STARTED|Cohort 11 (50 mg/m^2) Period||0
1040960|NCT00747474|2526910|P4|STARTED|Cohort 11 (50 mg/m^2) Period||0
1040961|NCT00747474|2526911|P3|STARTED|Cohort 11 (50 mg/m^2) Period||0
1040962|NCT00747474|2526912|P2|STARTED|Cohort 11 (50 mg/m^2) Period||0
1040963|NCT00747474|2526913|P1|STARTED|Cohort 11 (50 mg/m^2) Period||0
1040964|NCT00747474|2526902|P12|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1040965|NCT00747474|2526903|P11|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1040966|NCT00747474|2526904|P10|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1040967|NCT00747474|2526905|P9|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1040968|NCT00747474|2526906|P8|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1040969|NCT00747474|2526907|P7|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1040970|NCT00747474|2526908|P6|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1040971|NCT00747474|2526909|P5|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1040972|NCT00747474|2526910|P4|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1040973|NCT00747474|2526911|P3|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1040974|NCT00747474|2526912|P2|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1040975|NCT00747474|2526913|P1|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1040976|NCT00747474|2526902|P12|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1040977|NCT00747474|2526903|P11|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1040978|NCT00747474|2526904|P10|COMPLETED|Cohort 10 (40 mg/m^2) Period||7
1040979|NCT00747474|2526905|P9|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1040980|NCT00747474|2526906|P8|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1040981|NCT00747474|2526907|P7|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1040982|NCT00747474|2526908|P6|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1040983|NCT00747474|2526909|P5|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1040984|NCT00747474|2526910|P4|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1040985|NCT00747474|2526911|P3|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1040986|NCT00747474|2526912|P2|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1040987|NCT00747474|2526913|P1|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
1040988|NCT00747474|2526902|P12|STARTED|Cohort 10 (40 mg/m^2) Period||0
1040989|NCT00747474|2526903|P11|STARTED|Cohort 10 (40 mg/m^2) Period||0
1040990|NCT00747474|2526904|P10|STARTED|Cohort 10 (40 mg/m^2) Period||7
1040991|NCT00747474|2526905|P9|STARTED|Cohort 10 (40 mg/m^2) Period||0
1040992|NCT00747474|2526906|P8|STARTED|Cohort 10 (40 mg/m^2) Period||0
1040993|NCT00747474|2526907|P7|STARTED|Cohort 10 (40 mg/m^2) Period||0
1040994|NCT00747474|2526908|P6|STARTED|Cohort 10 (40 mg/m^2) Period||0
1040995|NCT00747474|2526909|P5|STARTED|Cohort 10 (40 mg/m^2) Period||0
1040996|NCT00747474|2526910|P4|STARTED|Cohort 10 (40 mg/m^2) Period||0
1040997|NCT00747474|2526911|P3|STARTED|Cohort 10 (40 mg/m^2) Period||0
1040998|NCT00747474|2526912|P2|STARTED|Cohort 10 (40 mg/m^2) Period||0
1040999|NCT00747474|2526913|P1|STARTED|Cohort 10 (40 mg/m^2) Period||0
1041000|NCT00747474|2526902|P12|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1041001|NCT00747474|2526903|P11|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1041002|NCT00747474|2526904|P10|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1041003|NCT00747474|2526905|P9|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1041004|NCT00747474|2526906|P8|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1041005|NCT00747474|2526907|P7|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1041006|NCT00747474|2526908|P6|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1041007|NCT00747474|2526909|P5|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1041008|NCT00747474|2526910|P4|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1041009|NCT00747474|2526911|P3|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1041010|NCT00747474|2526912|P2|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1041011|NCT00747474|2526913|P1|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1041012|NCT00747474|2526902|P12|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1041013|NCT00747474|2526903|P11|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1041014|NCT00747474|2526904|P10|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1041015|NCT00747474|2526905|P9|COMPLETED|Cohort 9 (35 mg/m^2) Period||4
1041016|NCT00747474|2526906|P8|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1041017|NCT00747474|2526907|P7|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1041018|NCT00747474|2526908|P6|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1041019|NCT00747474|2526909|P5|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1041020|NCT00747474|2526910|P4|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1041021|NCT00747474|2526911|P3|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1041022|NCT00747474|2526912|P2|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1041023|NCT00747474|2526913|P1|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
1041024|NCT00747474|2526902|P12|STARTED|Cohort 9 (35 mg/m^2) Period||0
1041025|NCT00747474|2526903|P11|STARTED|Cohort 9 (35 mg/m^2) Period||0
1041026|NCT00747474|2526904|P10|STARTED|Cohort 9 (35 mg/m^2) Period||0
1041027|NCT00747474|2526905|P9|STARTED|Cohort 9 (35 mg/m^2) Period||4
1041028|NCT00747474|2526906|P8|STARTED|Cohort 9 (35 mg/m^2) Period||0
1041029|NCT00747474|2526907|P7|STARTED|Cohort 9 (35 mg/m^2) Period||0
1041030|NCT00747474|2526908|P6|STARTED|Cohort 9 (35 mg/m^2) Period||0
1041031|NCT00747474|2526909|P5|STARTED|Cohort 9 (35 mg/m^2) Period||0
1041032|NCT00747474|2526910|P4|STARTED|Cohort 9 (35 mg/m^2) Period||0
1041033|NCT00747474|2526911|P3|STARTED|Cohort 9 (35 mg/m^2) Period||0
1041034|NCT00747474|2526912|P2|STARTED|Cohort 9 (35 mg/m^2) Period||0
1041035|NCT00747474|2526913|P1|STARTED|Cohort 9 (35 mg/m^2) Period||0
1041036|NCT00747474|2526902|P12|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1041037|NCT00747474|2526903|P11|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1041038|NCT00747474|2526904|P10|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1041039|NCT00747474|2526905|P9|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1041040|NCT00747474|2526906|P8|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||1
1041041|NCT00747474|2526907|P7|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1041042|NCT00747474|2526908|P6|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1041043|NCT00747474|2526909|P5|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1041044|NCT00747474|2526910|P4|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1041045|NCT00747474|2526911|P3|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1041046|NCT00747474|2526912|P2|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1041047|NCT00747474|2526913|P1|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1041048|NCT00747474|2526902|P12|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1041049|NCT00747474|2526903|P11|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1041050|NCT00747474|2526904|P10|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1041051|NCT00747474|2526905|P9|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1041052|NCT00747474|2526906|P8|COMPLETED|Cohort 8 (40 mg/m^2) Period||5
1041053|NCT00747474|2526907|P7|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1041054|NCT00747474|2526908|P6|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1041055|NCT00747474|2526909|P5|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1041056|NCT00747474|2526910|P4|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1041057|NCT00747474|2526911|P3|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1041058|NCT00747474|2526912|P2|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1041059|NCT00747474|2526913|P1|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
1041060|NCT00747474|2526902|P12|STARTED|Cohort 8 (40 mg/m^2) Period||0
1041061|NCT00747474|2526903|P11|STARTED|Cohort 8 (40 mg/m^2) Period||0
1041062|NCT00747474|2526904|P10|STARTED|Cohort 8 (40 mg/m^2) Period||0
1041063|NCT00747474|2526905|P9|STARTED|Cohort 8 (40 mg/m^2) Period||0
1041064|NCT00747474|2526906|P8|STARTED|Cohort 8 (40 mg/m^2) Period||6
1041065|NCT00747474|2526907|P7|STARTED|Cohort 8 (40 mg/m^2) Period||0
1041066|NCT00747474|2526908|P6|STARTED|Cohort 8 (40 mg/m^2) Period||0
1041067|NCT00747474|2526909|P5|STARTED|Cohort 8 (40 mg/m^2) Period||0
1041068|NCT00747474|2526910|P4|STARTED|Cohort 8 (40 mg/m^2) Period||0
1041069|NCT00747474|2526911|P3|STARTED|Cohort 8 (40 mg/m^2) Period||0
1041070|NCT00747474|2526912|P2|STARTED|Cohort 8 (40 mg/m^2) Period||0
1041071|NCT00747474|2526913|P1|STARTED|Cohort 8 (40 mg/m^2) Period||0
1041072|NCT00747474|2526902|P12|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1041073|NCT00747474|2526903|P11|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1041074|NCT00747474|2526904|P10|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1041075|NCT00747474|2526905|P9|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1041076|NCT00747474|2526906|P8|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1041077|NCT00747474|2526907|P7|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1041078|NCT00747474|2526908|P6|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1041079|NCT00747474|2526909|P5|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1041080|NCT00747474|2526910|P4|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1041081|NCT00747474|2526911|P3|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1041082|NCT00747474|2526912|P2|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1041083|NCT00747474|2526913|P1|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1041084|NCT00747474|2526902|P12|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1041085|NCT00747474|2526903|P11|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1041086|NCT00747474|2526904|P10|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1041087|NCT00747474|2526905|P9|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1041088|NCT00747474|2526906|P8|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1041089|NCT00747474|2526907|P7|COMPLETED|Cohort 7 (30 mg/m^2) Period||4
1041090|NCT00747474|2526908|P6|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1041091|NCT00747474|2526909|P5|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1041092|NCT00747474|2526910|P4|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1041093|NCT00747474|2526911|P3|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1041094|NCT00747474|2526912|P2|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1041095|NCT00747474|2526913|P1|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
1041096|NCT00747474|2526902|P12|STARTED|Cohort 7 (30 mg/m^2) Period||0
1041097|NCT00747474|2526903|P11|STARTED|Cohort 7 (30 mg/m^2) Period||0
1041098|NCT00747474|2526904|P10|STARTED|Cohort 7 (30 mg/m^2) Period||0
1041099|NCT00747474|2526905|P9|STARTED|Cohort 7 (30 mg/m^2) Period||0
1041100|NCT00747474|2526906|P8|STARTED|Cohort 7 (30 mg/m^2) Period||0
1041101|NCT00747474|2526907|P7|STARTED|Cohort 7 (30 mg/m^2) Period||4
1041102|NCT00747474|2526908|P6|STARTED|Cohort 7 (30 mg/m^2) Period||0
1041103|NCT00747474|2526909|P5|STARTED|Cohort 7 (30 mg/m^2) Period||0
1041104|NCT00747474|2526910|P4|STARTED|Cohort 7 (30 mg/m^2) Period||0
1041105|NCT00747474|2526911|P3|STARTED|Cohort 7 (30 mg/m^2) Period||0
1041106|NCT00747474|2526912|P2|STARTED|Cohort 7 (30 mg/m^2) Period||0
1041107|NCT00747474|2526913|P1|STARTED|Cohort 7 (30 mg/m^2) Period||0
1041108|NCT00747474|2526902|P12|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1041109|NCT00747474|2526903|P11|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1041110|NCT00747474|2526904|P10|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1041111|NCT00747474|2526905|P9|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1041112|NCT00747474|2526906|P8|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1041113|NCT00747474|2526907|P7|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1041114|NCT00747474|2526908|P6|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1041115|NCT00747474|2526909|P5|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1041116|NCT00747474|2526910|P4|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1041117|NCT00747474|2526911|P3|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1041118|NCT00747474|2526912|P2|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1041119|NCT00747474|2526913|P1|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1041120|NCT00747474|2526902|P12|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1041121|NCT00747474|2526903|P11|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1041122|NCT00747474|2526904|P10|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1041123|NCT00747474|2526905|P9|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1041124|NCT00747474|2526906|P8|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1041125|NCT00747474|2526907|P7|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1041126|NCT00747474|2526908|P6|COMPLETED|Cohort 6 (20 mg/m^2) Period||4
1041127|NCT00747474|2526909|P5|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1041128|NCT00747474|2526910|P4|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1041129|NCT00747474|2526911|P3|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1041130|NCT00747474|2526912|P2|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1041131|NCT00747474|2526913|P1|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
1041132|NCT00747474|2526902|P12|STARTED|Cohort 6 (20 mg/m^2) Period||0
1041133|NCT00747474|2526903|P11|STARTED|Cohort 6 (20 mg/m^2) Period||0
1041134|NCT00747474|2526904|P10|STARTED|Cohort 6 (20 mg/m^2) Period||0
1041135|NCT00747474|2526905|P9|STARTED|Cohort 6 (20 mg/m^2) Period||0
1041136|NCT00747474|2526906|P8|STARTED|Cohort 6 (20 mg/m^2) Period||0
1041137|NCT00747474|2526907|P7|STARTED|Cohort 6 (20 mg/m^2) Period||0
1041138|NCT00747474|2526908|P6|STARTED|Cohort 6 (20 mg/m^2) Period||4
1041139|NCT00747474|2526909|P5|STARTED|Cohort 6 (20 mg/m^2) Period||0
1041140|NCT00747474|2526910|P4|STARTED|Cohort 6 (20 mg/m^2) Period||0
1041141|NCT00747474|2526911|P3|STARTED|Cohort 6 (20 mg/m^2) Period||0
1041142|NCT00747474|2526912|P2|STARTED|Cohort 6 (20 mg/m^2) Period||0
1041143|NCT00747474|2526913|P1|STARTED|Cohort 6 (20 mg/m^2) Period||0
1041144|NCT00747474|2526902|P12|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1041145|NCT00747474|2526903|P11|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1041146|NCT00747474|2526904|P10|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1041147|NCT00747474|2526905|P9|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1041148|NCT00747474|2526906|P8|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1041149|NCT00747474|2526907|P7|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1041150|NCT00747474|2526908|P6|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1041151|NCT00747474|2526909|P5|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1041152|NCT00747474|2526910|P4|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1041153|NCT00747474|2526911|P3|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1041154|NCT00747474|2526912|P2|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1041155|NCT00747474|2526913|P1|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1041156|NCT00747474|2526902|P12|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1041157|NCT00747474|2526903|P11|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1041158|NCT00747474|2526904|P10|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1041159|NCT00747474|2526905|P9|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1041160|NCT00747474|2526906|P8|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1041161|NCT00747474|2526907|P7|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1041162|NCT00747474|2526908|P6|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1041163|NCT00747474|2526909|P5|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||4
1041164|NCT00747474|2526910|P4|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1041165|NCT00747474|2526911|P3|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1041166|NCT00747474|2526912|P2|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1041167|NCT00747474|2526913|P1|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
1041168|NCT00747474|2526902|P12|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
1041169|NCT00747474|2526903|P11|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
1041170|NCT00747474|2526904|P10|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
1041171|NCT00747474|2526905|P9|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
1041172|NCT00747474|2526906|P8|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
1041173|NCT00747474|2526907|P7|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
1041174|NCT00747474|2526908|P6|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
1041175|NCT00747474|2526909|P5|STARTED|Cohort 5 (13.5 mg/m^2) Period||4
1041176|NCT00747474|2526910|P4|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
1041177|NCT00747474|2526911|P3|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
1041178|NCT00747474|2526912|P2|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
1041179|NCT00747474|2526913|P1|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
1041180|NCT00747474|2526902|P12|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1041181|NCT00747474|2526903|P11|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1041182|NCT00747474|2526904|P10|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1041183|NCT00747474|2526905|P9|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1041184|NCT00747474|2526906|P8|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1041185|NCT00747474|2526907|P7|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1041186|NCT00747474|2526908|P6|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1041187|NCT00747474|2526909|P5|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1041188|NCT00747474|2526910|P4|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1041189|NCT00747474|2526911|P3|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1041190|NCT00747474|2526912|P2|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1041191|NCT00747474|2526913|P1|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1041192|NCT00747474|2526902|P12|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1041193|NCT00747474|2526903|P11|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1041194|NCT00747474|2526904|P10|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1041195|NCT00747474|2526905|P9|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1041196|NCT00747474|2526906|P8|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1041197|NCT00747474|2526907|P7|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1041198|NCT00747474|2526908|P6|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1041199|NCT00747474|2526909|P5|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1041200|NCT00747474|2526910|P4|COMPLETED|Cohort 4 (9 mg/m^2) Period||4
1041201|NCT00747474|2526911|P3|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1041202|NCT00747474|2526912|P2|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1041203|NCT00747474|2526913|P1|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
1041204|NCT00747474|2526902|P12|STARTED|Cohort 4 (9 mg/m^2) Period||0
1041205|NCT00747474|2526903|P11|STARTED|Cohort 4 (9 mg/m^2) Period||0
1041206|NCT00747474|2526904|P10|STARTED|Cohort 4 (9 mg/m^2) Period||0
1041207|NCT00747474|2526905|P9|STARTED|Cohort 4 (9 mg/m^2) Period||0
1041208|NCT00747474|2526906|P8|STARTED|Cohort 4 (9 mg/m^2) Period||0
1041209|NCT00747474|2526907|P7|STARTED|Cohort 4 (9 mg/m^2) Period||0
1041210|NCT00747474|2526908|P6|STARTED|Cohort 4 (9 mg/m^2) Period||0
1041211|NCT00747474|2526909|P5|STARTED|Cohort 4 (9 mg/m^2) Period||0
1041212|NCT00747474|2526910|P4|STARTED|Cohort 4 (9 mg/m^2) Period||4
1041213|NCT00747474|2526911|P3|STARTED|Cohort 4 (9 mg/m^2) Period||0
1041214|NCT00747474|2526912|P2|STARTED|Cohort 4 (9 mg/m^2) Period||0
1041215|NCT00747474|2526913|P1|STARTED|Cohort 4 (9 mg/m^2) Period||0
1041216|NCT00747474|2526902|P12|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1041217|NCT00747474|2526903|P11|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1041218|NCT00747474|2526904|P10|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1041219|NCT00747474|2526905|P9|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1041220|NCT00747474|2526906|P8|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1041221|NCT00747474|2526907|P7|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1041222|NCT00747474|2526908|P6|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1041223|NCT00747474|2526909|P5|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1041224|NCT00747474|2526910|P4|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1041225|NCT00747474|2526911|P3|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1041226|NCT00747474|2526912|P2|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1041227|NCT00747474|2526913|P1|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1041228|NCT00747474|2526902|P12|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1041229|NCT00747474|2526903|P11|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1041230|NCT00747474|2526904|P10|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1041231|NCT00747474|2526905|P9|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1041232|NCT00747474|2526906|P8|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1041233|NCT00747474|2526907|P7|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1041234|NCT00747474|2526908|P6|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1041235|NCT00747474|2526909|P5|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1041236|NCT00747474|2526910|P4|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1041237|NCT00747474|2526911|P3|COMPLETED|Cohort 3 (6 mg/m^2) Period||3
1041238|NCT00747474|2526912|P2|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1041239|NCT00747474|2526913|P1|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
1041240|NCT00747474|2526902|P12|STARTED|Cohort 3 (6 mg/m^2) Period||0
1041241|NCT00747474|2526903|P11|STARTED|Cohort 3 (6 mg/m^2) Period||0
1041242|NCT00747474|2526904|P10|STARTED|Cohort 3 (6 mg/m^2) Period||0
1041243|NCT00747474|2526905|P9|STARTED|Cohort 3 (6 mg/m^2) Period||0
1041244|NCT00747474|2526906|P8|STARTED|Cohort 3 (6 mg/m^2) Period||0
1041245|NCT00747474|2526907|P7|STARTED|Cohort 3 (6 mg/m^2) Period||0
1041246|NCT00747474|2526908|P6|STARTED|Cohort 3 (6 mg/m^2) Period||0
1041247|NCT00747474|2526909|P5|STARTED|Cohort 3 (6 mg/m^2) Period||0
1041248|NCT00747474|2526910|P4|STARTED|Cohort 3 (6 mg/m^2) Period||0
1041249|NCT00747474|2526911|P3|STARTED|Cohort 3 (6 mg/m^2) Period||3
1041250|NCT00747474|2526912|P2|STARTED|Cohort 3 (6 mg/m^2) Period||0
1041251|NCT00747474|2526913|P1|STARTED|Cohort 3 (6 mg/m^2) Period||0
1041252|NCT00747474|2526902|P12|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1041253|NCT00747474|2526903|P11|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1041254|NCT00747474|2526904|P10|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1041255|NCT00747474|2526905|P9|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1041256|NCT00747474|2526906|P8|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1041257|NCT00747474|2526907|P7|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1041258|NCT00747474|2526908|P6|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1041259|NCT00747474|2526909|P5|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1041260|NCT00747474|2526910|P4|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1041261|NCT00747474|2526911|P3|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1041262|NCT00747474|2526912|P2|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1041263|NCT00747474|2526913|P1|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1041264|NCT00747474|2526902|P12|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1041265|NCT00747474|2526903|P11|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1041266|NCT00747474|2526904|P10|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1041267|NCT00747474|2526905|P9|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1041268|NCT00747474|2526906|P8|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1041269|NCT00747474|2526907|P7|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1041270|NCT00747474|2526908|P6|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1041271|NCT00747474|2526909|P5|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1041272|NCT00747474|2526910|P4|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1041273|NCT00747474|2526911|P3|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1041274|NCT00747474|2526912|P2|COMPLETED|Cohort 2 (3 mg/m^2) Period||4
1041275|NCT00747474|2526913|P1|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
1041276|NCT00747474|2526902|P12|STARTED|Cohort 2 (3 mg/m^2) Period||0
1041277|NCT00747474|2526903|P11|STARTED|Cohort 2 (3 mg/m^2) Period||0
1041278|NCT00747474|2526904|P10|STARTED|Cohort 2 (3 mg/m^2) Period||0
1041279|NCT00747474|2526905|P9|STARTED|Cohort 2 (3 mg/m^2) Period||0
1041280|NCT00747474|2526906|P8|STARTED|Cohort 2 (3 mg/m^2) Period||0
1041281|NCT00747474|2526907|P7|STARTED|Cohort 2 (3 mg/m^2) Period||0
1041282|NCT00747474|2526908|P6|STARTED|Cohort 2 (3 mg/m^2) Period||0
1041283|NCT00747474|2526909|P5|STARTED|Cohort 2 (3 mg/m^2) Period||0
1041284|NCT00747474|2526910|P4|STARTED|Cohort 2 (3 mg/m^2) Period||0
1041285|NCT00747474|2526911|P3|STARTED|Cohort 2 (3 mg/m^2) Period||0
1041286|NCT00747474|2526912|P2|STARTED|Cohort 2 (3 mg/m^2) Period||4
1041287|NCT00747474|2526913|P1|STARTED|Cohort 2 (3 mg/m^2) Period||0
1041288|NCT00747474|2526902|P12|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1041289|NCT00747474|2526903|P11|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1041290|NCT00747474|2526904|P10|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1041291|NCT00747474|2526905|P9|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1041292|NCT00747474|2526906|P8|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1041293|NCT00747474|2526907|P7|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1041294|NCT00747474|2526908|P6|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1041295|NCT00747474|2526909|P5|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1041296|NCT00747474|2526910|P4|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1041297|NCT00747474|2526911|P3|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1041298|NCT00747474|2526912|P2|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1041299|NCT00747474|2526913|P1|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1041300|NCT00747474|2526902|P12|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1041301|NCT00747474|2526903|P11|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1041302|NCT00747474|2526904|P10|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1041303|NCT00747474|2526905|P9|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1041304|NCT00747474|2526906|P8|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1041305|NCT00747474|2526907|P7|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1041306|NCT00747474|2526908|P6|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1041307|NCT00747474|2526909|P5|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1041308|NCT00747474|2526910|P4|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1041309|NCT00747474|2526911|P3|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1041310|NCT00747474|2526912|P2|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
1041311|NCT00747474|2526913|P1|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||3
1041312|NCT00747474|2526902|P12|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
1041313|NCT00747474|2526903|P11|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
1041314|NCT00747474|2526904|P10|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
1041315|NCT00747474|2526905|P9|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
1041316|NCT00747474|2526906|P8|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
1041317|NCT00747474|2526907|P7|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
1041318|NCT00747474|2526908|P6|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
1041319|NCT00747474|2526909|P5|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
1041320|NCT00747474|2526910|P4|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
1041321|NCT00747474|2526911|P3|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
1041322|NCT00747474|2526912|P2|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
1041323|NCT00747474|2526913|P1|STARTED|Cohort 1 (1.5 mg/m^2) Period||3
1041324|NCT00747552|2526939|P1|NOT COMPLETED|Overall Study||0
1041325|NCT00747552|2526939|P1|COMPLETED|Overall Study||30
1041326|NCT00747552|2526939|P1|STARTED|Overall Study|This number does not include the 2 who were enrolled but had no data collected on them.|30
1041327|NCT00747565|2526946|P2|NOT COMPLETED|Overall Study||7
1041328|NCT00747565|2526947|P1|NOT COMPLETED|Overall Study||14
1041329|NCT00747565|2526946|P2|COMPLETED|Overall Study||116
1041330|NCT00747565|2526947|P1|COMPLETED|Overall Study|118 multifocal subjects in the original study plus 215 multifocal subejcts in the expansion study.|333
1041331|NCT00747565|2526946|P2|STARTED|Overall Study||123
1041332|NCT00747565|2526947|P1|STARTED|Overall Study|125 multifocal subjects in original study plus 222 multifocal subjects in the expansion study.|347
1041333|NCT00747617|2526957|P2|NOT COMPLETED|Overall Study||1
1041334|NCT00747617|2526958|P1|NOT COMPLETED|Overall Study||3
1041335|NCT00747617|2526957|P2|COMPLETED|Overall Study||11
1041336|NCT00747617|2526958|P1|COMPLETED|Overall Study||10
1041337|NCT00747617|2526957|P2|STARTED|Overall Study||12
1041338|NCT00747617|2526958|P1|STARTED|Overall Study||13
1041339|NCT00747643|2526966|P2|NOT COMPLETED|Overall Study||27
1041340|NCT00747643|2526967|P1|NOT COMPLETED|Overall Study||36
1041341|NCT00747643|2526966|P2|COMPLETED|Overall Study||54
1041342|NCT00747643|2526967|P1|COMPLETED|Overall Study||46
1041343|NCT00747643|2526966|P2|STARTED|Overall Study||81
1041344|NCT00747643|2526967|P1|STARTED|Overall Study||82
1041345|NCT00747747|2526982|P3|NOT COMPLETED|Overall Study||0
1041346|NCT00747747|2526983|P2|NOT COMPLETED|Overall Study||0
1041347|NCT00747747|2526984|P1|NOT COMPLETED|Overall Study||0
1041348|NCT00747747|2526982|P3|COMPLETED|Overall Study|17 with acute episode + 4 with recurrent episode|21
1041349|NCT00747747|2526983|P2|COMPLETED|Overall Study|11 with acute episode + 3 with recurrent episode|14
1041350|NCT00747747|2526984|P1|COMPLETED|Overall Study|13 with acute episode + 1 with recurrent episode|14
1041351|NCT00747747|2526982|P3|STARTED|Overall Study||21
1041352|NCT00747747|2526983|P2|STARTED|Overall Study||14
1041353|NCT00747747|2526984|P1|STARTED|Overall Study||14
1041354|NCT00747812|2527009|P2|NOT COMPLETED|Overall Study||3
1041355|NCT00747812|2527010|P1|NOT COMPLETED|Overall Study||5
1041356|NCT00747812|2527009|P2|COMPLETED|Overall Study||0
1041357|NCT00747812|2527010|P1|COMPLETED|Overall Study||0
1041358|NCT00747812|2527009|P2|STARTED|Overall Study|4 subjects were randomized to the Control Group; 1 was not implanted due to early enrollment closure|3
1041359|NCT00747812|2527010|P1|STARTED|Overall Study||5
1041360|NCT00747916|2527018|P1|NOT COMPLETED|Overall Study||0
1041361|NCT00747916|2527018|P1|COMPLETED|Overall Study||3
1041362|NCT00747916|2527018|P1|STARTED|Overall Study||3
1041363|NCT00748072|2527025|P2|NOT COMPLETED|Overall Study||0
1041364|NCT00748072|2527026|P1|NOT COMPLETED|Overall Study||0
1041365|NCT00748072|2527025|P2|COMPLETED|Overall Study||80
1041366|NCT00748072|2527026|P1|COMPLETED|Overall Study||82
1041367|NCT00748072|2527025|P2|STARTED|Overall Study||80
1041368|NCT00748072|2527026|P1|STARTED|Overall Study||82
1041369|NCT00748085|2527032|P1|NOT COMPLETED|Overall Study||0
1041370|NCT00748085|2527032|P1|COMPLETED|Overall Study|No analysis -study terminated for business reasons.|5
1041371|NCT00748085|2527032|P1|STARTED|Overall Study||5
1041372|NCT00748098|2527037|P2|NOT COMPLETED|Second Taper Period||0
1041373|NCT00748098|2527038|P1|NOT COMPLETED|Second Taper Period||0
1041374|NCT00748098|2527037|P2|COMPLETED|Second Taper Period||61
1041375|NCT00748098|2527038|P1|COMPLETED|Second Taper Period||53
1041376|NCT00748098|2527037|P2|STARTED|Second Taper Period||61
1041377|NCT00748098|2527038|P1|STARTED|Second Taper Period||53
1041378|NCT00748098|2527037|P2|NOT COMPLETED|Second Treatment Intervention Period||3
1041379|NCT00748098|2527038|P1|NOT COMPLETED|Second Treatment Intervention Period||6
1041380|NCT00748098|2527037|P2|COMPLETED|Second Treatment Intervention Period||61
1041381|NCT00748098|2527038|P1|COMPLETED|Second Treatment Intervention Period||53
1041382|NCT00748098|2527037|P2|STARTED|Second Treatment Intervention Period||64
1041383|NCT00748098|2527038|P1|STARTED|Second Treatment Intervention Period||59
1041384|NCT00748098|2527037|P2|NOT COMPLETED|1-Week Washout Period||1
1041385|NCT00748098|2527038|P1|NOT COMPLETED|1-Week Washout Period||2
1041386|NCT00748098|2527037|P2|COMPLETED|1-Week Washout Period||64
1041387|NCT00748098|2527038|P1|COMPLETED|1-Week Washout Period||59
1041388|NCT00748098|2527037|P2|STARTED|1-Week Washout Period||65
1041389|NCT00748098|2527038|P1|STARTED|1-Week Washout Period||61
1041390|NCT00748098|2527037|P2|NOT COMPLETED|First Taper Period||1
1041391|NCT00748098|2527038|P1|NOT COMPLETED|First Taper Period||3
1041392|NCT00748098|2527037|P2|COMPLETED|First Taper Period||65
1041393|NCT00748098|2527038|P1|COMPLETED|First Taper Period||61
1041394|NCT00748098|2527037|P2|STARTED|First Taper Period||66
1041395|NCT00748098|2527038|P1|STARTED|First Taper Period||64
1041396|NCT00748098|2527037|P2|NOT COMPLETED|First Treatment Intervention Period||1
1041397|NCT00748098|2527038|P1|NOT COMPLETED|First Treatment Intervention Period||5
1041398|NCT00748098|2527037|P2|COMPLETED|First Treatment Intervention Period||66
1041399|NCT00748098|2527038|P1|COMPLETED|First Treatment Intervention Period||64
1041400|NCT00748098|2527037|P2|STARTED|First Treatment Intervention Period||67
1041401|NCT00748098|2527038|P1|STARTED|First Treatment Intervention Period||69
1041402|NCT00748189|2527100|P2|NOT COMPLETED|Overall Study||221
1041403|NCT00748189|2527101|P1|NOT COMPLETED|Overall Study||225
1041404|NCT00748189|2527100|P2|COMPLETED|Overall Study||0
1041405|NCT00748189|2527101|P1|COMPLETED|Overall Study|This participant was entered incorrectly by the site and has not completed the 5 year follow-up.|1
1041406|NCT00748189|2527100|P2|Ongoing|Overall Study|One par. was incorrectly recorded as withdrawn due to “Study Terminated by Sponsor” and is ongoing.|162
1041407|NCT00748189|2527101|P1|Ongoing|Overall Study||155
1041408|NCT00748189|2527100|P2|STARTED|Overall Study||221
1041409|NCT00748189|2527101|P1|STARTED|Overall Study||226
1041410|NCT00748241|2527155|P1|NOT COMPLETED|Overall Study||8
1041411|NCT00748241|2527155|P1|COMPLETED|Overall Study||11
1041412|NCT00748241|2527155|P1|STARTED|Overall Study||19
1041413|NCT00748553|2527165|P2|NOT COMPLETED|Overall Study||1
1041414|NCT00748553|2527166|P1|NOT COMPLETED|Overall Study||3
1041415|NCT00748553|2527165|P2|COMPLETED|Overall Study||13
1041416|NCT00748553|2527166|P1|COMPLETED|Overall Study||13
1041417|NCT00748553|2527165|P2|STARTED|Overall Study||14
1041418|NCT00748553|2527166|P1|STARTED|Overall Study||16
1041419|NCT00748566|2527173|P1|NOT COMPLETED|Overall Study||112
1041420|NCT00748566|2527173|P1|COMPLETED|Overall Study||60
1041421|NCT00748566|2527173|P1|STARTED|Overall Study||172
1041422|NCT00748579|2527203|P2|NOT COMPLETED|Overall Study||0
1041423|NCT00748579|2527204|P1|NOT COMPLETED|Overall Study||0
1041424|NCT00748579|2527203|P2|COMPLETED|Overall Study||0
1041425|NCT00748579|2527204|P1|COMPLETED|Overall Study||2
1041426|NCT00748579|2527203|P2|STARTED|Overall Study||0
1041427|NCT00748579|2527204|P1|STARTED|Overall Study||2
1041428|NCT00748657|2527210|P1|NOT COMPLETED|Overall Study||0
1041429|NCT00748657|2527210|P1|COMPLETED|Overall Study||36
1041430|NCT00748657|2527210|P1|STARTED|Overall Study||36
1041431|NCT00748709|2527216|P1|NOT COMPLETED|Overall Study||20
1041432|NCT00748709|2527216|P1|COMPLETED|Overall Study||0
1041433|NCT00748709|2527216|P1|STARTED|Overall Study|Treated|20
1041434|NCT00748826|2527228|P1|NOT COMPLETED|Overall Study||301
1041435|NCT00748826|2527228|P1|COMPLETED|Overall Study||207
1041436|NCT00748826|2527228|P1|STARTED|Overall Study|Of 576 total enrolled, 68 out of scope participants were not used for analyses|508
1041437|NCT00748865|2527235|P2|NOT COMPLETED|Overall Study||0
1041438|NCT00748865|2527236|P1|NOT COMPLETED|Overall Study||0
1041439|NCT00748865|2527235|P2|COMPLETED|Overall Study||10
1041440|NCT00748865|2527236|P1|COMPLETED|Overall Study||10
1041441|NCT00748865|2527235|P2|STARTED|Overall Study||10
1041442|NCT00748865|2527236|P1|STARTED|Overall Study||10
1041443|NCT00748956|2527245|P3|NOT COMPLETED|Overall Study||0
1041444|NCT00748956|2527246|P2|NOT COMPLETED|Overall Study||0
1041445|NCT00748956|2527247|P1|NOT COMPLETED|Overall Study||0
1041446|NCT00748956|2527245|P3|COMPLETED|Overall Study||5
1041447|NCT00748956|2527246|P2|COMPLETED|Overall Study||5
1041448|NCT00748956|2527247|P1|COMPLETED|Overall Study||0
1041449|NCT00748956|2527245|P3|STARTED|Overall Study||5
1041450|NCT00748956|2527246|P2|STARTED|Overall Study||5
1041451|NCT00748956|2527247|P1|STARTED|Overall Study||0
1041452|NCT00748969|2527272|P2|NOT COMPLETED|Overall Study||0
1041453|NCT00748969|2527273|P1|NOT COMPLETED|Overall Study||0
1041454|NCT00748969|2527272|P2|COMPLETED|Overall Study||1
1041455|NCT00748969|2527273|P1|COMPLETED|Overall Study||1
1041456|NCT00748969|2527272|P2|STARTED|Overall Study||1
1041457|NCT00748969|2527273|P1|STARTED|Overall Study||1
1041458|NCT00748982|2527281|P2|NOT COMPLETED|Overall Study||0
1041459|NCT00748982|2527282|P1|NOT COMPLETED|Overall Study||0
1041460|NCT00748982|2527281|P2|COMPLETED|Overall Study||4
1041461|NCT00748982|2527282|P1|COMPLETED|Overall Study||12
1041462|NCT00748982|2527281|P2|STARTED|Overall Study||4
1041463|NCT00748982|2527282|P1|STARTED|Overall Study||12
1041464|NCT00749073|2527294|P1|NOT COMPLETED|Overall Study||0
1041465|NCT00749073|2527294|P1|COMPLETED|Overall Study||10
1041466|NCT00749073|2527294|P1|STARTED|Overall Study||10
1041467|NCT00749190|2527307|P7|NOT COMPLETED|Overall Study||1
1041468|NCT00749190|2527308|P6|NOT COMPLETED|Overall Study||5
1041469|NCT00749190|2527309|P5|NOT COMPLETED|Overall Study||0
1041470|NCT00749190|2527310|P4|NOT COMPLETED|Overall Study||5
1041471|NCT00749190|2527311|P3|NOT COMPLETED|Overall Study||1
1041472|NCT00749190|2527312|P2|NOT COMPLETED|Overall Study||5
1041473|NCT00749190|2527313|P1|NOT COMPLETED|Overall Study||5
1041474|NCT00749190|2527307|P7|COMPLETED|Overall Study||70
1041475|NCT00749190|2527308|P6|COMPLETED|Overall Study||65
1041476|NCT00749190|2527309|P5|COMPLETED|Overall Study||70
1041477|NCT00749190|2527310|P4|COMPLETED|Overall Study||66
1041478|NCT00749190|2527311|P3|COMPLETED|Overall Study||70
1041479|NCT00749190|2527312|P2|COMPLETED|Overall Study||66
1041480|NCT00749190|2527313|P1|COMPLETED|Overall Study||66
1041481|NCT00749190|2527307|P7|STARTED|Overall Study||71
1041482|NCT00749190|2527308|P6|STARTED|Overall Study||70
1041483|NCT00749190|2527309|P5|STARTED|Overall Study||70
1041484|NCT00749190|2527310|P4|STARTED|Overall Study||71
1041485|NCT00749190|2527311|P3|STARTED|Overall Study||71
1041486|NCT00749190|2527312|P2|STARTED|Overall Study||71
1041487|NCT00749190|2527313|P1|STARTED|Overall Study||71
1041488|NCT00749268|2527394|P2|NOT COMPLETED|Overall Study||36
1041489|NCT00749268|2527395|P1|NOT COMPLETED|Overall Study||34
1041490|NCT00749268|2527394|P2|COMPLETED|Overall Study||74
1041491|NCT00749268|2527395|P1|COMPLETED|Overall Study||72
1041492|NCT00749268|2527394|P2|STARTED|Overall Study||110
1041493|NCT00749268|2527395|P1|STARTED|Overall Study||106
1041494|NCT00749398|2527417|P1|NOT COMPLETED|Overall Study||53
1041495|NCT00749398|2527417|P1|COMPLETED|Overall Study||71
1041496|NCT00749398|2527417|P1|STARTED|Overall Study|Nine participants were excluded because they did not fulfill the inclusion criteria.|124
1041497|NCT00749463|2527434|P3|NOT COMPLETED|Overall Study||1
1041498|NCT00749463|2527435|P2|NOT COMPLETED|Overall Study||4
1041499|NCT00749463|2527436|P1|NOT COMPLETED|Overall Study||1
1041500|NCT00749463|2527434|P3|COMPLETED|Overall Study||149
1041501|NCT00749463|2527435|P2|COMPLETED|Overall Study||60
1041502|NCT00749463|2527436|P1|COMPLETED|Overall Study||85
1041503|NCT00749463|2527434|P3|STARTED|Overall Study||150
1041504|NCT00749463|2527435|P2|STARTED|Overall Study||64
1041505|NCT00749463|2527436|P1|STARTED|Overall Study||86
1041506|NCT00749476|2527462|P1|NOT COMPLETED|Overall Study||0
1041507|NCT00749476|2527462|P1|COMPLETED|Overall Study||1
1041508|NCT00749476|2527462|P1|STARTED|Overall Study||1
1041509|NCT00749580|2527468|P2|NOT COMPLETED|Overall Study||9
1041510|NCT00749580|2527469|P1|NOT COMPLETED|Overall Study||4
1041511|NCT00749580|2527468|P2|COMPLETED|Overall Study||16
1041512|NCT00749580|2527469|P1|COMPLETED|Overall Study|December 2010|17
1041513|NCT00749580|2527468|P2|STARTED|Overall Study||25
1041514|NCT00749580|2527469|P1|STARTED|Overall Study|September 2008|21
1041515|NCT00749671|2527479|P2|NOT COMPLETED|Overall Study||0
1041516|NCT00749671|2527480|P1|NOT COMPLETED|Overall Study||0
1041517|NCT00749671|2527479|P2|COMPLETED|Overall Study||9
1041518|NCT00749671|2527480|P1|COMPLETED|Overall Study||11
1041519|NCT00749671|2527479|P2|STARTED|Overall Study||9
1041520|NCT00749671|2527480|P1|STARTED|Overall Study||11
1041521|NCT00749684|2527488|P1|NOT COMPLETED|Overall Study||82
1041522|NCT00749684|2527488|P1|COMPLETED|Overall Study||56
1041523|NCT00749684|2527488|P1|STARTED|Overall Study||138
1041524|NCT00749775|2527493|P1|NOT COMPLETED|Overall Study||107
1041525|NCT00749775|2527493|P1|COMPLETED|Overall Study||3210
1041526|NCT00749775|2527493|P1|STARTED|Overall Study||3317
1041527|NCT00749931|2527511|P3|NOT COMPLETED|Overall Study||0
1041528|NCT00749931|2527512|P2|NOT COMPLETED|Overall Study||0
1041529|NCT00749931|2527513|P1|NOT COMPLETED|Overall Study||0
1041530|NCT00749931|2527511|P3|COMPLETED|Overall Study||68
1041531|NCT00749931|2527512|P2|COMPLETED|Overall Study||298
1041532|NCT00749931|2527513|P1|COMPLETED|Overall Study||298
1041533|NCT00749931|2527511|P3|STARTED|Overall Study||68
1041534|NCT00749931|2527512|P2|STARTED|Overall Study||298
1041535|NCT00749931|2527513|P1|STARTED|Overall Study||298
1041536|NCT00749944|2527524|P2|NOT COMPLETED|Overall Study||1
1041537|NCT00749944|2527525|P1|NOT COMPLETED|Overall Study||5
1041538|NCT00749944|2527524|P2|COMPLETED|Overall Study||54
1041539|NCT00749944|2527525|P1|COMPLETED|Overall Study||50
1041540|NCT00749944|2527524|P2|STARTED|Overall Study||55
1041541|NCT00749944|2527525|P1|STARTED|Overall Study||55
1041542|NCT00749957|2527593|P2|NOT COMPLETED|Overall Study||0
1041543|NCT00749957|2527594|P1|NOT COMPLETED|Overall Study||0
1041544|NCT00749957|2527593|P2|COMPLETED|Overall Study||6
1041545|NCT00749957|2527594|P1|COMPLETED|Overall Study||6
1041546|NCT00749957|2527593|P2|STARTED|Overall Study||6
1041547|NCT00749957|2527594|P1|STARTED|Overall Study||6
1041548|NCT00743574|2527604|P1|NOT COMPLETED|Overall Study||24
1041549|NCT00743574|2527604|P1|COMPLETED|Overall Study||12
1041550|NCT00743574|2527604|P1|Dropped Out After Initiating Trial|Overall Study||3
1041551|NCT00743574|2527604|P1|Further Exclusions|Overall Study||8
1041552|NCT00743574|2527604|P1|Dropped Out Before Eligibility Testing|Overall Study||13
1041553|NCT00743574|2527604|P1|STARTED|Overall Study||36
1041554|NCT00743652|2527618|P5|NOT COMPLETED|Overall Study||0
1041555|NCT00743652|2527619|P4|NOT COMPLETED|Overall Study||4
1041556|NCT00743652|2527620|P3|NOT COMPLETED|Overall Study||2
1041557|NCT00743652|2527621|P2|NOT COMPLETED|Overall Study||3
1041558|NCT00743652|2527622|P1|NOT COMPLETED|Overall Study||10
1041559|NCT00743652|2527618|P5|COMPLETED|Overall Study||79
1041560|NCT00743652|2527619|P4|COMPLETED|Overall Study||63
1041561|NCT00743652|2527620|P3|COMPLETED|Overall Study||23
1041562|NCT00743652|2527621|P2|COMPLETED|Overall Study||48
1041563|NCT00743652|2527622|P1|COMPLETED|Overall Study||141
1041564|NCT00743652|2527618|P5|Toddler Dose|Overall Study||0
1041565|NCT00743652|2527619|P4|Toddler Dose|Overall Study||0
1041566|NCT00743652|2527620|P3|Toddler Dose|Overall Study||16
1041567|NCT00743652|2527621|P2|Toddler Dose|Overall Study||23
1041568|NCT00743652|2527622|P1|Toddler Dose|Overall Study||15
1041569|NCT00743652|2527618|P5|Vaccinated Dose 3|Overall Study||0
1041570|NCT00743652|2527619|P4|Vaccinated Dose 3|Overall Study||0
1041571|NCT00743652|2527620|P3|Vaccinated Dose 3|Overall Study||0
1041572|NCT00743652|2527621|P2|Vaccinated Dose 3|Overall Study||0
1041573|NCT00743652|2527622|P1|Vaccinated Dose 3|Overall Study||74
1041574|NCT00743652|2527618|P5|Vaccinated Dose 2|Overall Study||0
1041575|NCT00743652|2527619|P4|Vaccinated Dose 2|Overall Study||49
1041576|NCT00743652|2527620|P3|Vaccinated Dose 2|Overall Study||0
1041577|NCT00743652|2527621|P2|Vaccinated Dose 2|Overall Study||41
1041578|NCT00743652|2527622|P1|Vaccinated Dose 2|Overall Study||112
1041579|NCT00743652|2527618|P5|Vaccinated Dose 1|Overall Study||79
1041580|NCT00743652|2527619|P4|Vaccinated Dose 1|Overall Study||66
1041581|NCT00743652|2527620|P3|Vaccinated Dose 1|Overall Study||25
1041582|NCT00743652|2527621|P2|Vaccinated Dose 1|Overall Study||51
1041583|NCT00743652|2527622|P1|Vaccinated Dose 1|Overall Study||151
1041584|NCT00743652|2527618|P5|STARTED|Overall Study||79
1041585|NCT00743652|2527619|P4|STARTED|Overall Study||67
1041586|NCT00743652|2527620|P3|STARTED|Overall Study||25
1041587|NCT00743652|2527621|P2|STARTED|Overall Study||51
1041588|NCT00743652|2527622|P1|STARTED|Overall Study||151
1041589|NCT00743717|2527699|P2|NOT COMPLETED|Overall Study||0
1041590|NCT00743717|2527700|P1|NOT COMPLETED|Overall Study||0
1041591|NCT00743717|2527699|P2|COMPLETED|Overall Study||2
1041592|NCT00743717|2527700|P1|COMPLETED|Overall Study||2
1041593|NCT00743717|2527699|P2|STARTED|Overall Study||2
1041594|NCT00743717|2527700|P1|STARTED|Overall Study||2
1041595|NCT00743730|2527709|P3|NOT COMPLETED|Overall Study||5
1041596|NCT00743730|2527710|P2|NOT COMPLETED|Overall Study||4
1041597|NCT00743730|2527711|P1|NOT COMPLETED|Overall Study||5
1041598|NCT00743730|2527709|P3|COMPLETED|Overall Study||28
1041599|NCT00743730|2527710|P2|COMPLETED|Overall Study||30
1041600|NCT00743730|2527711|P1|COMPLETED|Overall Study||22
1041601|NCT00743730|2527709|P3|STARTED|Overall Study||33
1041602|NCT00743730|2527710|P2|STARTED|Overall Study||34
1041603|NCT00743730|2527711|P1|STARTED|Overall Study||27
1041604|NCT00744042|2527722|P1|NOT COMPLETED|Overall Study||1
1041605|NCT00744042|2527722|P1|COMPLETED|Overall Study||10
1041606|NCT00744042|2527722|P1|STARTED|Overall Study||11
1041607|NCT00744055|2527737|P2|NOT COMPLETED|Overall Study||14
1041608|NCT00744055|2527738|P1|NOT COMPLETED|Overall Study||7
1041609|NCT00744055|2527737|P2|COMPLETED|Overall Study||32
1041610|NCT00744055|2527738|P1|COMPLETED|Overall Study||43
1041611|NCT00744055|2527737|P2|STARTED|Overall Study||46
1041612|NCT00744055|2527738|P1|STARTED|Overall Study||50
1041613|NCT00744237|2527749|P3|NOT COMPLETED|Overall Study||15
1041614|NCT00744237|2527750|P2|NOT COMPLETED|Overall Study||27
1041615|NCT00744237|2527751|P1|NOT COMPLETED|Overall Study||27
1041616|NCT00744237|2527749|P3|COMPLETED|Overall Study||59
1041617|NCT00744237|2527750|P2|COMPLETED|Overall Study||46
1041618|NCT00744237|2527751|P1|COMPLETED|Overall Study||56
1041619|NCT00744237|2527749|P3|STARTED|Overall Study||74
1041620|NCT00744237|2527750|P2|STARTED|Overall Study||73
1041621|NCT00744237|2527751|P1|STARTED|Overall Study||83
1041622|NCT00744263|2527764|P2|NOT COMPLETED|Overall Study||5320
1041623|NCT00744263|2527765|P1|NOT COMPLETED|Overall Study||5236
1041624|NCT00744263|2527764|P2|COMPLETED|Overall Study||36936
1041625|NCT00744263|2527765|P1|COMPLETED|Overall Study||37004
1041626|NCT00744263|2527764|P2|STARTED|Overall Study||42256
1041627|NCT00744263|2527765|P1|STARTED|Overall Study||42240
1041628|NCT00744328|2527788|P3|NOT COMPLETED|Overall Study||8
1041629|NCT00744328|2527789|P2|NOT COMPLETED|Overall Study||8
1041630|NCT00744328|2527790|P1|NOT COMPLETED|Overall Study||7
1041631|NCT00744328|2527788|P3|COMPLETED|Overall Study||21
1041632|NCT00744328|2527789|P2|COMPLETED|Overall Study||22
1041633|NCT00744328|2527790|P1|COMPLETED|Overall Study||19
1041634|NCT00744328|2527788|P3|STARTED|Overall Study||29
1041635|NCT00744328|2527789|P2|STARTED|Overall Study||30
1041636|NCT00744328|2527790|P1|STARTED|Overall Study||26
1041637|NCT00744380|2527800|P2|NOT COMPLETED|Overall Study||0
1041638|NCT00744380|2527801|P1|NOT COMPLETED|Overall Study||0
1041639|NCT00744380|2527800|P2|COMPLETED|Overall Study||11
1041640|NCT00744380|2527801|P1|COMPLETED|Overall Study||12
1041641|NCT00744380|2527800|P2|STARTED|Overall Study||11
1041642|NCT00744380|2527801|P1|STARTED|Overall Study||12
1041643|NCT00744497|2527823|P2|NOT COMPLETED|Overall Study||762
1041644|NCT00744497|2527824|P1|NOT COMPLETED|Overall Study||760
1041645|NCT00744497|2527823|P2|COMPLETED|Overall Study||0
1041646|NCT00744497|2527824|P1|COMPLETED|Overall Study||0
1041647|NCT00744497|2527823|P2|Received Treatment|Overall Study||761
1041648|NCT00744497|2527824|P1|Received Treatment|Overall Study||757
1041649|NCT00744497|2527823|P2|STARTED|Overall Study|Randomized|762
1041650|NCT00744497|2527824|P1|STARTED|Overall Study|Randomized|760
1041651|NCT00744523|2527860|P2|NOT COMPLETED|30 Days After the Procedure||5
1041652|NCT00744523|2527861|P1|NOT COMPLETED|30 Days After the Procedure||0
1041653|NCT00744523|2527860|P2|COMPLETED|30 Days After the Procedure||220
1041654|NCT00744523|2527861|P1|COMPLETED|30 Days After the Procedure||37
1041655|NCT00744523|2527860|P2|STARTED|30 Days After the Procedure||225
1041656|NCT00744523|2527861|P1|STARTED|30 Days After the Procedure||37
1041657|NCT00744523|2527860|P2|NOT COMPLETED|Procedure||0
1041658|NCT00744523|2527861|P1|NOT COMPLETED|Procedure||0
1041659|NCT00744523|2527860|P2|COMPLETED|Procedure||225
1041660|NCT00744523|2527861|P1|COMPLETED|Procedure||37
1041661|NCT00744523|2527860|P2|STARTED|Procedure||225
1041662|NCT00744523|2527861|P1|STARTED|Procedure||37
1041663|NCT00744627|2527881|P2|NOT COMPLETED|Overall Study||22
1041664|NCT00744627|2527882|P1|NOT COMPLETED|Overall Study||25
1041665|NCT00744627|2527881|P2|COMPLETED|Overall Study||128
1041666|NCT00744627|2527882|P1|COMPLETED|Overall Study||126
1041667|NCT00744627|2527881|P2|Treated|Overall Study||150
1041668|NCT00744627|2527882|P1|Treated|Overall Study||150
1041669|NCT00744627|2527881|P2|STARTED|Overall Study||150
1041670|NCT00744627|2527882|P1|STARTED|Overall Study||151
1041671|NCT00749996|2527938|P2|NOT COMPLETED|Overall Study||13
1041672|NCT00749996|2527939|P1|NOT COMPLETED|Overall Study||18
1041673|NCT00749996|2527938|P2|COMPLETED|Overall Study||58
1041674|NCT00749996|2527939|P1|COMPLETED|Overall Study||57
1041675|NCT00749996|2527938|P2|24 Months Follow up|Overall Study|Withdrawn (n=3). Lost to follow-up (n=3)|58
1041676|NCT00749996|2527939|P1|24 Months Follow up|Overall Study|Withdrawn (n=5) Accidental death (n=1) Lost to follow up (n=7)|57
1041677|NCT00749996|2527938|P2|12 Months Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=4). Lost to follow-up (n=1)|60
1041678|NCT00749996|2527939|P1|12 Months Follow-up|Overall Study|Withdrawn(n=4). Visit not done (n=2)|68
1041679|NCT00749996|2527938|P2|6 Months Follow-up|Overall Study|Withdrawn (n=3). Visit not done (n=3)|63
1041680|NCT00749996|2527939|P1|6 Months Follow-up|Overall Study|Visit not done (n=3)|71
1041681|NCT00749996|2527938|P2|3 Months Follow-up|Overall Study|Visit not done (n=1)|68
1041682|NCT00749996|2527939|P1|3 Months Follow-up|Overall Study|Visit not done (n=2)|72
1041683|NCT00749996|2527938|P2|6 Weeks Follow-up|Overall Study|Withdrawn (n=2). Visit not done (n=2)|67
1041684|NCT00749996|2527939|P1|6 Weeks Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=2)|72
1041685|NCT00749996|2527938|P2|STARTED|Overall Study|5 pts were removed due to compliance issue. 1 pt was randomized but not treated (Non-eligible)|71
1041686|NCT00749996|2527939|P1|STARTED|Overall Study|4 pts were removed due to compliance issue. 2 pts were randomized but not treated (non-eligible)|75
1041687|NCT00750061|2527949|P2|NOT COMPLETED|Overall Study||2
1041688|NCT00750061|2527950|P1|NOT COMPLETED|Overall Study||2
1041689|NCT00750061|2527949|P2|COMPLETED|Overall Study||18
1041690|NCT00750061|2527950|P1|COMPLETED|Overall Study||18
1041691|NCT00750061|2527949|P2|STARTED|Overall Study||20
1041692|NCT00750061|2527950|P1|STARTED|Overall Study||20
1041693|NCT00750139|2527962|P4|NOT COMPLETED|Overall Study||46
1041694|NCT00750139|2527963|P3|NOT COMPLETED|Overall Study||101
1041695|NCT00750139|2527964|P2|NOT COMPLETED|Overall Study||59
1041696|NCT00750139|2527965|P1|NOT COMPLETED|Overall Study||89
1041697|NCT00750139|2527962|P4|COMPLETED|Overall Study||73
1041698|NCT00750139|2527963|P3|COMPLETED|Overall Study||135
1041699|NCT00750139|2527964|P2|COMPLETED|Overall Study||59
1041700|NCT00750139|2527965|P1|COMPLETED|Overall Study||145
1041701|NCT00750139|2527962|P4|STARTED|Overall Study||119
1041702|NCT00750139|2527963|P3|STARTED|Overall Study||236
1041703|NCT00750139|2527964|P2|STARTED|Overall Study||118
1041704|NCT00750139|2527965|P1|STARTED|Overall Study||234
1041705|NCT00750152|2527981|P2|NOT COMPLETED|Overall Study||27
1041706|NCT00750152|2527982|P1|NOT COMPLETED|Overall Study||22
1041707|NCT00750152|2527981|P2|COMPLETED|Overall Study||141
1041708|NCT00750152|2527982|P1|COMPLETED|Overall Study||144
1041709|NCT00750152|2527981|P2|STARTED|Overall Study||168
1041710|NCT00750152|2527982|P1|STARTED|Overall Study||166
1041711|NCT00750191|2527992|P2|NOT COMPLETED|Overall Study||10
1041712|NCT00750191|2527993|P1|NOT COMPLETED|Overall Study||5
1041713|NCT00750191|2527992|P2|COMPLETED|Overall Study||20
1041714|NCT00750191|2527993|P1|COMPLETED|Overall Study||22
1041715|NCT00750191|2527992|P2|STARTED|Overall Study||30
1041716|NCT00750191|2527993|P1|STARTED|Overall Study||27
1041717|NCT00750204|2528007|P2|NOT COMPLETED|Overall Study||1
1041718|NCT00750204|2528008|P1|NOT COMPLETED|Overall Study||1
1041719|NCT00750204|2528007|P2|COMPLETED|Overall Study||0
1041720|NCT00750204|2528008|P1|COMPLETED|Overall Study||0
1041721|NCT00750204|2528007|P2|STARTED|Overall Study||1
1041722|NCT00750204|2528008|P1|STARTED|Overall Study||1
1041723|NCT00750269|2528019|P5|NOT COMPLETED|Overall Study||10
1041724|NCT00750269|2528020|P4|NOT COMPLETED|Overall Study||5
1041725|NCT00750269|2528021|P3|NOT COMPLETED|Overall Study||4
1041726|NCT00750269|2528022|P2|NOT COMPLETED|Overall Study||1
1041727|NCT00750269|2528023|P1|NOT COMPLETED|Overall Study||0
1041728|NCT00750269|2528019|P5|COMPLETED|Overall Study||33
1041729|NCT00750269|2528020|P4|COMPLETED|Overall Study||38
1041730|NCT00750269|2528021|P3|COMPLETED|Overall Study||14
1041731|NCT00750269|2528022|P2|COMPLETED|Overall Study||7
1041732|NCT00750269|2528023|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|8
1041733|NCT00750269|2528019|P5|STARTED|Overall Study||43
1041734|NCT00750269|2528020|P4|STARTED|Overall Study||43
1041735|NCT00750269|2528021|P3|STARTED|Overall Study||18
1041736|NCT00750269|2528022|P2|STARTED|Overall Study||8
1041737|NCT00750269|2528023|P1|STARTED|Overall Study||8
1041738|NCT00750282|2528072|P4|NOT COMPLETED|Overall Study||1
1041739|NCT00750282|2528073|P3|NOT COMPLETED|Overall Study||1
1041740|NCT00750282|2528074|P2|NOT COMPLETED|Overall Study||1
1041741|NCT00750282|2528075|P1|NOT COMPLETED|Overall Study||0
1041742|NCT00750282|2528072|P4|COMPLETED|Overall Study||147
1041743|NCT00750282|2528073|P3|COMPLETED|Overall Study||125
1041744|NCT00750282|2528074|P2|COMPLETED|Overall Study||81
1041745|NCT00750282|2528075|P1|COMPLETED|Overall Study||69
1041746|NCT00750282|2528072|P4|STARTED|Overall Study||148
1041747|NCT00750282|2528073|P3|STARTED|Overall Study||126
1041748|NCT00750282|2528074|P2|STARTED|Overall Study||82
1041749|NCT00750282|2528075|P1|STARTED|Overall Study||69
1041750|NCT00750308|2528099|P12|NOT COMPLETED|Fourth Treatment||0
1041751|NCT00750308|2528100|P11|NOT COMPLETED|Fourth Treatment||0
1041752|NCT00750308|2528101|P10|NOT COMPLETED|Fourth Treatment||0
1041753|NCT00750308|2528102|P9|NOT COMPLETED|Fourth Treatment||0
1041754|NCT00750308|2528103|P8|NOT COMPLETED|Fourth Treatment||0
1041755|NCT00750308|2528104|P7|NOT COMPLETED|Fourth Treatment||0
1041756|NCT00750308|2528105|P6|NOT COMPLETED|Fourth Treatment||0
1041757|NCT00750308|2528106|P5|NOT COMPLETED|Fourth Treatment||0
1041758|NCT00750308|2528107|P4|NOT COMPLETED|Fourth Treatment||0
1041759|NCT00750308|2528108|P3|NOT COMPLETED|Fourth Treatment||0
1041760|NCT00750308|2528109|P2|NOT COMPLETED|Fourth Treatment||0
1041761|NCT00750308|2528110|P1|NOT COMPLETED|Fourth Treatment||0
1041762|NCT00750308|2528099|P12|COMPLETED|Fourth Treatment||1
1041763|NCT00750308|2528100|P11|COMPLETED|Fourth Treatment||1
1041764|NCT00750308|2528101|P10|COMPLETED|Fourth Treatment||2
1041765|NCT00750308|2528102|P9|COMPLETED|Fourth Treatment||1
1041766|NCT00750308|2528103|P8|COMPLETED|Fourth Treatment||2
1041767|NCT00750308|2528104|P7|COMPLETED|Fourth Treatment||2
1041768|NCT00750308|2528105|P6|COMPLETED|Fourth Treatment||2
1041769|NCT00750308|2528106|P5|COMPLETED|Fourth Treatment||1
1041770|NCT00750308|2528107|P4|COMPLETED|Fourth Treatment||1
1041771|NCT00750308|2528108|P3|COMPLETED|Fourth Treatment||2
1041772|NCT00750308|2528109|P2|COMPLETED|Fourth Treatment||1
1041773|NCT00750308|2528110|P1|COMPLETED|Fourth Treatment||2
1041774|NCT00750308|2528099|P12|STARTED|Fourth Treatment||1
1041775|NCT00750308|2528100|P11|STARTED|Fourth Treatment||1
1041776|NCT00750308|2528101|P10|STARTED|Fourth Treatment||2
1041777|NCT00750308|2528102|P9|STARTED|Fourth Treatment||1
1041778|NCT00750308|2528103|P8|STARTED|Fourth Treatment||2
1041779|NCT00750308|2528104|P7|STARTED|Fourth Treatment||2
1041780|NCT00750308|2528105|P6|STARTED|Fourth Treatment||2
1041781|NCT00750308|2528106|P5|STARTED|Fourth Treatment||1
1041782|NCT00750308|2528107|P4|STARTED|Fourth Treatment||1
1041783|NCT00750308|2528108|P3|STARTED|Fourth Treatment||2
1041784|NCT00750308|2528109|P2|STARTED|Fourth Treatment||1
1041785|NCT00750308|2528110|P1|STARTED|Fourth Treatment||2
1041786|NCT00750308|2528099|P12|NOT COMPLETED|Washout||0
1041787|NCT00750308|2528100|P11|NOT COMPLETED|Washout||0
1041788|NCT00750308|2528101|P10|NOT COMPLETED|Washout||0
1041789|NCT00750308|2528102|P9|NOT COMPLETED|Washout||0
1041790|NCT00750308|2528103|P8|NOT COMPLETED|Washout||0
1041791|NCT00750308|2528104|P7|NOT COMPLETED|Washout||0
1041792|NCT00750308|2528105|P6|NOT COMPLETED|Washout||0
1041793|NCT00750308|2528106|P5|NOT COMPLETED|Washout||0
1041794|NCT00750308|2528107|P4|NOT COMPLETED|Washout||0
1041795|NCT00750308|2528108|P3|NOT COMPLETED|Washout||0
1041796|NCT00750308|2528109|P2|NOT COMPLETED|Washout||0
1041797|NCT00750308|2528110|P1|NOT COMPLETED|Washout||0
1041798|NCT00750308|2528099|P12|COMPLETED|Washout||1
1041799|NCT00750308|2528100|P11|COMPLETED|Washout||1
1041800|NCT00750308|2528101|P10|COMPLETED|Washout||2
1041801|NCT00750308|2528102|P9|COMPLETED|Washout||1
1041802|NCT00750308|2528103|P8|COMPLETED|Washout||2
1041803|NCT00750308|2528104|P7|COMPLETED|Washout||2
1041804|NCT00750308|2528105|P6|COMPLETED|Washout||2
1041805|NCT00750308|2528106|P5|COMPLETED|Washout||1
1041806|NCT00750308|2528107|P4|COMPLETED|Washout||1
1041807|NCT00750308|2528108|P3|COMPLETED|Washout||2
1041808|NCT00750308|2528109|P2|COMPLETED|Washout||1
1041809|NCT00750308|2528110|P1|COMPLETED|Washout||2
1041810|NCT00750308|2528099|P12|STARTED|Washout||1
1041811|NCT00750308|2528100|P11|STARTED|Washout||1
1041812|NCT00750308|2528101|P10|STARTED|Washout||2
1041813|NCT00750308|2528102|P9|STARTED|Washout||1
1041814|NCT00750308|2528103|P8|STARTED|Washout||2
1041815|NCT00750308|2528104|P7|STARTED|Washout||2
1041816|NCT00750308|2528105|P6|STARTED|Washout||2
1041817|NCT00750308|2528106|P5|STARTED|Washout||1
1041818|NCT00750308|2528107|P4|STARTED|Washout||1
1041819|NCT00750308|2528108|P3|STARTED|Washout||2
1041820|NCT00750308|2528109|P2|STARTED|Washout||1
1041821|NCT00750308|2528110|P1|STARTED|Washout||2
1041822|NCT00750308|2528099|P12|NOT COMPLETED|Third Treatment||0
1041823|NCT00750308|2528100|P11|NOT COMPLETED|Third Treatment||0
1041824|NCT00750308|2528101|P10|NOT COMPLETED|Third Treatment||0
1041825|NCT00750308|2528102|P9|NOT COMPLETED|Third Treatment||0
1041826|NCT00750308|2528103|P8|NOT COMPLETED|Third Treatment||0
1041827|NCT00750308|2528104|P7|NOT COMPLETED|Third Treatment||0
1041828|NCT00750308|2528105|P6|NOT COMPLETED|Third Treatment||0
1041829|NCT00750308|2528106|P5|NOT COMPLETED|Third Treatment||0
1041830|NCT00750308|2528107|P4|NOT COMPLETED|Third Treatment||0
1041831|NCT00750308|2528108|P3|NOT COMPLETED|Third Treatment||0
1041832|NCT00750308|2528109|P2|NOT COMPLETED|Third Treatment||1
1041833|NCT00750308|2528110|P1|NOT COMPLETED|Third Treatment||0
1041834|NCT00750308|2528099|P12|COMPLETED|Third Treatment||1
1041835|NCT00750308|2528100|P11|COMPLETED|Third Treatment||1
1041836|NCT00750308|2528101|P10|COMPLETED|Third Treatment||2
1041837|NCT00750308|2528102|P9|COMPLETED|Third Treatment||1
1041838|NCT00750308|2528103|P8|COMPLETED|Third Treatment||2
1041839|NCT00750308|2528104|P7|COMPLETED|Third Treatment||2
1041840|NCT00750308|2528105|P6|COMPLETED|Third Treatment||2
1041841|NCT00750308|2528106|P5|COMPLETED|Third Treatment||1
1041842|NCT00750308|2528107|P4|COMPLETED|Third Treatment||1
1041843|NCT00750308|2528108|P3|COMPLETED|Third Treatment||2
1041844|NCT00750308|2528109|P2|COMPLETED|Third Treatment||1
1041845|NCT00750308|2528110|P1|COMPLETED|Third Treatment||2
1041846|NCT00750308|2528099|P12|STARTED|Third Treatment||1
1041847|NCT00750308|2528100|P11|STARTED|Third Treatment||1
1041848|NCT00750308|2528101|P10|STARTED|Third Treatment||2
1041849|NCT00750308|2528102|P9|STARTED|Third Treatment||1
1041850|NCT00750308|2528103|P8|STARTED|Third Treatment||2
1041851|NCT00750308|2528104|P7|STARTED|Third Treatment||2
1041852|NCT00750308|2528105|P6|STARTED|Third Treatment||2
1041853|NCT00750308|2528106|P5|STARTED|Third Treatment||1
1041854|NCT00750308|2528107|P4|STARTED|Third Treatment||1
1041855|NCT00750308|2528108|P3|STARTED|Third Treatment||2
1041856|NCT00750308|2528109|P2|STARTED|Third Treatment||2
1041857|NCT00750308|2528110|P1|STARTED|Third Treatment||2
1041858|NCT00750308|2528099|P12|NOT COMPLETED|Washout||0
1041859|NCT00750308|2528100|P11|NOT COMPLETED|Washout||0
1041860|NCT00750308|2528101|P10|NOT COMPLETED|Washout||0
1041861|NCT00750308|2528102|P9|NOT COMPLETED|Washout||0
1041862|NCT00750308|2528103|P8|NOT COMPLETED|Washout||0
1041863|NCT00750308|2528104|P7|NOT COMPLETED|Washout||0
1041864|NCT00750308|2528105|P6|NOT COMPLETED|Washout||0
1041865|NCT00750308|2528106|P5|NOT COMPLETED|Washout||0
1041866|NCT00750308|2528107|P4|NOT COMPLETED|Washout||0
1041867|NCT00750308|2528108|P3|NOT COMPLETED|Washout||0
1041868|NCT00750308|2528109|P2|NOT COMPLETED|Washout||0
1041869|NCT00750308|2528110|P1|NOT COMPLETED|Washout||0
1041870|NCT00750308|2528099|P12|COMPLETED|Washout||1
1041871|NCT00750308|2528100|P11|COMPLETED|Washout||1
1041872|NCT00750308|2528101|P10|COMPLETED|Washout||2
1041873|NCT00750308|2528102|P9|COMPLETED|Washout||1
1041874|NCT00750308|2528103|P8|COMPLETED|Washout||2
1041875|NCT00750308|2528104|P7|COMPLETED|Washout||2
1041876|NCT00750308|2528105|P6|COMPLETED|Washout||2
1041877|NCT00750308|2528106|P5|COMPLETED|Washout||1
1041878|NCT00750308|2528107|P4|COMPLETED|Washout||1
1041879|NCT00750308|2528108|P3|COMPLETED|Washout||2
1041880|NCT00750308|2528109|P2|COMPLETED|Washout||2
1041881|NCT00750308|2528110|P1|COMPLETED|Washout||2
1041882|NCT00750308|2528099|P12|STARTED|Washout||1
1041883|NCT00750308|2528100|P11|STARTED|Washout||1
1041884|NCT00750308|2528101|P10|STARTED|Washout||2
1041885|NCT00750308|2528102|P9|STARTED|Washout||1
1041886|NCT00750308|2528103|P8|STARTED|Washout||2
1041887|NCT00750308|2528104|P7|STARTED|Washout||2
1041888|NCT00750308|2528105|P6|STARTED|Washout||2
1041889|NCT00750308|2528106|P5|STARTED|Washout||1
1041890|NCT00750308|2528107|P4|STARTED|Washout||1
1041891|NCT00750308|2528108|P3|STARTED|Washout||2
1041892|NCT00750308|2528109|P2|STARTED|Washout||2
1041893|NCT00750308|2528110|P1|STARTED|Washout||2
1041894|NCT00750308|2528099|P12|NOT COMPLETED|Second Treatment||0
1041895|NCT00750308|2528100|P11|NOT COMPLETED|Second Treatment||0
1041896|NCT00750308|2528101|P10|NOT COMPLETED|Second Treatment||0
1041897|NCT00750308|2528102|P9|NOT COMPLETED|Second Treatment||1
1041898|NCT00750308|2528103|P8|NOT COMPLETED|Second Treatment||0
1041899|NCT00750308|2528104|P7|NOT COMPLETED|Second Treatment||0
1041900|NCT00750308|2528105|P6|NOT COMPLETED|Second Treatment||1
1041901|NCT00750308|2528106|P5|NOT COMPLETED|Second Treatment||1
1041902|NCT00750308|2528107|P4|NOT COMPLETED|Second Treatment||0
1041903|NCT00750308|2528108|P3|NOT COMPLETED|Second Treatment||0
1041904|NCT00750308|2528109|P2|NOT COMPLETED|Second Treatment||0
1041905|NCT00750308|2528110|P1|NOT COMPLETED|Second Treatment||0
1041906|NCT00750308|2528099|P12|COMPLETED|Second Treatment||1
1041907|NCT00750308|2528100|P11|COMPLETED|Second Treatment||1
1041908|NCT00750308|2528101|P10|COMPLETED|Second Treatment||2
1041909|NCT00750308|2528102|P9|COMPLETED|Second Treatment||1
1041910|NCT00750308|2528103|P8|COMPLETED|Second Treatment||2
1041911|NCT00750308|2528104|P7|COMPLETED|Second Treatment||2
1041912|NCT00750308|2528105|P6|COMPLETED|Second Treatment||2
1041913|NCT00750308|2528106|P5|COMPLETED|Second Treatment||1
1041914|NCT00750308|2528107|P4|COMPLETED|Second Treatment||1
1041915|NCT00750308|2528108|P3|COMPLETED|Second Treatment||2
1041916|NCT00750308|2528109|P2|COMPLETED|Second Treatment||2
1041917|NCT00750308|2528110|P1|COMPLETED|Second Treatment||2
1041918|NCT00750308|2528099|P12|STARTED|Second Treatment||1
1041919|NCT00750308|2528100|P11|STARTED|Second Treatment||1
1041920|NCT00750308|2528101|P10|STARTED|Second Treatment||2
1041921|NCT00750308|2528102|P9|STARTED|Second Treatment||2
1041922|NCT00750308|2528103|P8|STARTED|Second Treatment||2
1041923|NCT00750308|2528104|P7|STARTED|Second Treatment||2
1041924|NCT00750308|2528105|P6|STARTED|Second Treatment||3
1041925|NCT00750308|2528106|P5|STARTED|Second Treatment||2
1041926|NCT00750308|2528107|P4|STARTED|Second Treatment||1
1041927|NCT00750308|2528108|P3|STARTED|Second Treatment||2
1041928|NCT00750308|2528109|P2|STARTED|Second Treatment||2
1041929|NCT00750308|2528110|P1|STARTED|Second Treatment||2
1041930|NCT00750308|2528099|P12|NOT COMPLETED|Washout||0
1041931|NCT00750308|2528100|P11|NOT COMPLETED|Washout||0
1041932|NCT00750308|2528101|P10|NOT COMPLETED|Washout||0
1041933|NCT00750308|2528102|P9|NOT COMPLETED|Washout||0
1041934|NCT00750308|2528103|P8|NOT COMPLETED|Washout||0
1041935|NCT00750308|2528104|P7|NOT COMPLETED|Washout||0
1041936|NCT00750308|2528105|P6|NOT COMPLETED|Washout||0
1041937|NCT00750308|2528106|P5|NOT COMPLETED|Washout||0
1041938|NCT00750308|2528107|P4|NOT COMPLETED|Washout||0
1041939|NCT00750308|2528108|P3|NOT COMPLETED|Washout||0
1041940|NCT00750308|2528109|P2|NOT COMPLETED|Washout||0
1041941|NCT00750308|2528110|P1|NOT COMPLETED|Washout||0
1041942|NCT00750308|2528099|P12|COMPLETED|Washout||1
1041943|NCT00750308|2528100|P11|COMPLETED|Washout||1
1041944|NCT00750308|2528101|P10|COMPLETED|Washout||2
1041945|NCT00750308|2528102|P9|COMPLETED|Washout||2
1041946|NCT00750308|2528103|P8|COMPLETED|Washout||2
1041947|NCT00750308|2528104|P7|COMPLETED|Washout||2
1041948|NCT00750308|2528105|P6|COMPLETED|Washout||3
1041949|NCT00750308|2528106|P5|COMPLETED|Washout||2
1041950|NCT00750308|2528107|P4|COMPLETED|Washout||1
1041951|NCT00750308|2528108|P3|COMPLETED|Washout||2
1041952|NCT00750308|2528109|P2|COMPLETED|Washout||2
1041953|NCT00750308|2528110|P1|COMPLETED|Washout||2
1041954|NCT00750308|2528099|P12|STARTED|Washout||1
1041955|NCT00750308|2528100|P11|STARTED|Washout||1
1041956|NCT00750308|2528101|P10|STARTED|Washout||2
1041957|NCT00750308|2528102|P9|STARTED|Washout||2
1041958|NCT00750308|2528103|P8|STARTED|Washout||2
1041959|NCT00750308|2528104|P7|STARTED|Washout||2
1041960|NCT00750308|2528105|P6|STARTED|Washout||3
1041961|NCT00750308|2528106|P5|STARTED|Washout||2
1041962|NCT00750308|2528107|P4|STARTED|Washout||1
1041963|NCT00750308|2528108|P3|STARTED|Washout||2
1041964|NCT00750308|2528109|P2|STARTED|Washout||2
1041965|NCT00750308|2528110|P1|STARTED|Washout||2
1041966|NCT00750308|2528099|P12|NOT COMPLETED|First Treatment||1
1041967|NCT00750308|2528100|P11|NOT COMPLETED|First Treatment||1
1041968|NCT00750308|2528101|P10|NOT COMPLETED|First Treatment||0
1041969|NCT00750308|2528102|P9|NOT COMPLETED|First Treatment||0
1041970|NCT00750308|2528103|P8|NOT COMPLETED|First Treatment||1
1041971|NCT00750308|2528104|P7|NOT COMPLETED|First Treatment||0
1041972|NCT00750308|2528105|P6|NOT COMPLETED|First Treatment||0
1041973|NCT00750308|2528106|P5|NOT COMPLETED|First Treatment||0
1041974|NCT00750308|2528107|P4|NOT COMPLETED|First Treatment||1
1041975|NCT00750308|2528108|P3|NOT COMPLETED|First Treatment||0
1041976|NCT00750308|2528109|P2|NOT COMPLETED|First Treatment||1
1041977|NCT00750308|2528110|P1|NOT COMPLETED|First Treatment||0
1041978|NCT00750308|2528099|P12|COMPLETED|First Treatment||1
1041979|NCT00750308|2528100|P11|COMPLETED|First Treatment||1
1041980|NCT00750308|2528101|P10|COMPLETED|First Treatment||2
1041981|NCT00750308|2528102|P9|COMPLETED|First Treatment||2
1041982|NCT00750308|2528103|P8|COMPLETED|First Treatment||2
1041983|NCT00750308|2528104|P7|COMPLETED|First Treatment||2
1041984|NCT00750308|2528105|P6|COMPLETED|First Treatment||3
1041985|NCT00750308|2528106|P5|COMPLETED|First Treatment||2
1041986|NCT00750308|2528107|P4|COMPLETED|First Treatment||1
1041987|NCT00750308|2528108|P3|COMPLETED|First Treatment||2
1041988|NCT00750308|2528109|P2|COMPLETED|First Treatment||2
1041989|NCT00750308|2528110|P1|COMPLETED|First Treatment||2
1041990|NCT00750308|2528099|P12|STARTED|First Treatment||2
1041991|NCT00750308|2528100|P11|STARTED|First Treatment||2
1041992|NCT00750308|2528101|P10|STARTED|First Treatment||2
1041993|NCT00750308|2528102|P9|STARTED|First Treatment||2
1041994|NCT00750308|2528103|P8|STARTED|First Treatment||3
1041995|NCT00750308|2528104|P7|STARTED|First Treatment||2
1041996|NCT00750308|2528105|P6|STARTED|First Treatment||3
1041997|NCT00750308|2528106|P5|STARTED|First Treatment||2
1041998|NCT00750308|2528107|P4|STARTED|First Treatment||2
1041999|NCT00750308|2528108|P3|STARTED|First Treatment||2
1042000|NCT00750308|2528109|P2|STARTED|First Treatment||3
1042001|NCT00750308|2528110|P1|STARTED|First Treatment|One female withdrew due to muscle pain|2
1042002|NCT00751114|2528126|P2|NOT COMPLETED|Overall Study||32
1042003|NCT00751114|2528127|P1|NOT COMPLETED|Overall Study||38
1042004|NCT00751114|2528126|P2|COMPLETED|Overall Study||233
1042005|NCT00751114|2528127|P1|COMPLETED|Overall Study||212
1042006|NCT00751114|2528126|P2|mITT Population|Overall Study||253
1042007|NCT00751114|2528127|P1|mITT Population|Overall Study|modified Intent-To-Treat population: treated patients with at least 1 on-treatment efficacy measure|227
1042008|NCT00751114|2528126|P2|TREATED = Safety Population|Overall Study||264
1042009|NCT00751114|2528127|P1|TREATED = Safety Population|Overall Study|safety population: randomized patients who received at least one dose of investigational product|237
1042010|NCT00751114|2528126|P2|STARTED|Overall Study||265
1042011|NCT00751114|2528127|P1|STARTED|Overall Study|randomized|250
1042012|NCT00751140|2528150|P1|NOT COMPLETED|Overall Study||1
1042013|NCT00751140|2528150|P1|COMPLETED|Overall Study||19
1042014|NCT00751140|2528150|P1|STARTED|Overall Study||20
1042015|NCT00751179|2528160|P2|NOT COMPLETED|Overall Study||15
1042016|NCT00751179|2528161|P1|NOT COMPLETED|Overall Study||14
1042017|NCT00751179|2528160|P2|COMPLETED|Overall Study||70
1042018|NCT00751179|2528161|P1|COMPLETED|Overall Study||62
1042019|NCT00751179|2528160|P2|STARTED|Overall Study|5 of 85 randomized were not treated with succinylcholine|85
1042020|NCT00751179|2528161|P1|STARTED|Overall Study|10 of 76 randomized were not treated with sugammadex; 4 of these 10 received rocuronium only|76
1042021|NCT00751296|2528181|P1|NOT COMPLETED|Overall Study||2
1042022|NCT00751296|2528181|P1|COMPLETED|Overall Study||25
1042023|NCT00751296|2528181|P1|STARTED|Overall Study|The start date of the study was 25 August 2006.|27
1042024|NCT00751348|2528188|P2|NOT COMPLETED|Overall Study||2
1042025|NCT00751348|2528189|P1|NOT COMPLETED|Overall Study||6
1042026|NCT00751348|2528188|P2|COMPLETED|Overall Study||159
1042027|NCT00751348|2528189|P1|COMPLETED|Overall Study||307
1042028|NCT00751348|2528188|P2|STARTED|Overall Study||161
1042029|NCT00751348|2528189|P1|STARTED|Overall Study||313
1042030|NCT00751400|2528211|P1|NOT COMPLETED|Overall Study||10
1042031|NCT00751400|2528211|P1|COMPLETED|Overall Study||487
1042032|NCT00751400|2528211|P1|Subjects Provided Detailed Use Data|Overall Study||467
1042033|NCT00751400|2528211|P1|Subjects Consumed Drug|Overall Study||485
1042034|NCT00751400|2528211|P1|Subjects Provided Drug|Overall Study||497
1042035|NCT00751400|2528211|P1|STARTED|Overall Study||497
1042036|NCT00751530|2528226|P2|NOT COMPLETED|Overall Study||0
1042037|NCT00751530|2528227|P1|NOT COMPLETED|Overall Study||0
1042038|NCT00751530|2528226|P2|COMPLETED|Overall Study||110
1042039|NCT00751530|2528227|P1|COMPLETED|Overall Study||332
1042040|NCT00751530|2528226|P2|STARTED|Overall Study||110
1042041|NCT00751530|2528227|P1|STARTED|Overall Study||332
1042042|NCT00751621|2528241|P1|NOT COMPLETED|Overall Study||4
1042043|NCT00751621|2528241|P1|COMPLETED|Overall Study||36
1042044|NCT00751621|2528241|P1|STARTED|Overall Study||40
1042045|NCT00751634|2528258|P1|NOT COMPLETED|Overall Study||0
1042046|NCT00751634|2528258|P1|COMPLETED|Overall Study||20
1042047|NCT00751634|2528258|P1|STARTED|Overall Study||20
1042048|NCT00751777|2528268|P2|NOT COMPLETED|Overall Study||3
1042049|NCT00751777|2528269|P1|NOT COMPLETED|Overall Study||11
1042050|NCT00751777|2528268|P2|COMPLETED|Overall Study|Day 194: study completion for placebo group|36
1042051|NCT00751777|2528269|P1|COMPLETED|Overall Study|Day 380: study completion for LT group|70
1042052|NCT00751777|2528268|P2|STARTED|Overall Study||39
1042053|NCT00751777|2528269|P1|STARTED|Overall Study||81
1042054|NCT00751790|2528279|P1|NOT COMPLETED|Overall Study||5
1042055|NCT00751790|2528279|P1|COMPLETED|Overall Study||115
1042056|NCT00751790|2528279|P1|STARTED|Overall Study||120
1042057|NCT00751881|2528286|P3|NOT COMPLETED|Extension Study Period||66
1042058|NCT00751881|2528287|P2|NOT COMPLETED|Extension Study Period||71
1042059|NCT00751881|2528288|P1|NOT COMPLETED|Extension Study Period||65
1042060|NCT00751881|2528286|P3|COMPLETED|Extension Study Period||167
1042061|NCT00751881|2528287|P2|COMPLETED|Extension Study Period||194
1042062|NCT00751881|2528288|P1|COMPLETED|Extension Study Period||188
1042063|NCT00751881|2528286|P3|STARTED|Extension Study Period|11 participants completed core treatment period but did not enter in extension treatment period.|233
1042064|NCT00751881|2528287|P2|STARTED|Extension Study Period|8 participants completed core treatment period but did not enter in extension treatment period.|265
1042065|NCT00751881|2528288|P1|STARTED|Extension Study Period|10 participants completed core treatment period but did not enter in extension treatment period.|253
1042066|NCT00751881|2528286|P3|NOT COMPLETED|Core Treatment Period||128
1042067|NCT00751881|2528287|P2|NOT COMPLETED|Core Treatment Period||135
1042068|NCT00751881|2528288|P1|NOT COMPLETED|Core Treatment Period||126
1042069|NCT00751881|2528286|P3|COMPLETED|Core Treatment Period||244
1042070|NCT00751881|2528287|P2|COMPLETED|Core Treatment Period||273
1042071|NCT00751881|2528288|P1|COMPLETED|Core Treatment Period||263
1042072|NCT00751881|2528286|P3|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 1 participant placebo (at least 1 dose)|370
1042073|NCT00751881|2528287|P2|Treated|Core Treatment Period|1 participant received placebo (at least 1 dose)|407
1042074|NCT00751881|2528288|P1|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 2 participants teriflunomide 14 mg (at least 1 dose)|388
1042075|NCT00751881|2528286|P3|STARTED|Core Treatment Period|Randomized|372
1042076|NCT00751881|2528287|P2|STARTED|Core Treatment Period|Randomized|408
1042077|NCT00751881|2528288|P1|STARTED|Core Treatment Period|Randomized|389
1042078|NCT00751933|2528335|P4|NOT COMPLETED|Overall Study||1
1042079|NCT00751933|2528336|P3|NOT COMPLETED|Overall Study||1
1042080|NCT00751933|2528337|P2|NOT COMPLETED|Overall Study||1
1042081|NCT00751933|2528338|P1|NOT COMPLETED|Overall Study||0
1042082|NCT00751933|2528335|P4|COMPLETED|Overall Study||0
1042083|NCT00751933|2528336|P3|COMPLETED|Overall Study||0
1042084|NCT00751933|2528337|P2|COMPLETED|Overall Study||0
1042085|NCT00751933|2528338|P1|COMPLETED|Overall Study||0
1042086|NCT00751933|2528335|P4|STARTED|Overall Study||1
1042087|NCT00751933|2528336|P3|STARTED|Overall Study||1
1042088|NCT00751933|2528337|P2|STARTED|Overall Study||1
1042089|NCT00751933|2528338|P1|STARTED|Overall Study||0
1042090|NCT00751972|2528345|P2|NOT COMPLETED|Overall Study||0
1042091|NCT00751972|2528346|P1|NOT COMPLETED|Overall Study||0
1042092|NCT00751972|2528345|P2|COMPLETED|Overall Study||499
1042093|NCT00751972|2528346|P1|COMPLETED|Overall Study||140
1042094|NCT00751972|2528345|P2|STARTED|Overall Study||499
1042095|NCT00751972|2528346|P1|STARTED|Overall Study||140
1042096|NCT00751998|2528358|P1|NOT COMPLETED|Overall Study||20
1042097|NCT00751998|2528358|P1|COMPLETED|Overall Study||277
1042098|NCT00751998|2528358|P1|STARTED|Overall Study||297
1042106|NCT00752128|2528376|P1|NOT COMPLETED|Overall Study||4
1042107|NCT00752128|2528376|P1|COMPLETED|Overall Study||2345
1042108|NCT00752128|2528376|P1|STARTED|Overall Study||2349
1042109|NCT00752232|2528388|P7|NOT COMPLETED|Overall Study||0
1042110|NCT00752232|2528389|P6|NOT COMPLETED|Overall Study||1
1042111|NCT00752232|2528390|P5|NOT COMPLETED|Overall Study||3
1042112|NCT00752232|2528391|P4|NOT COMPLETED|Overall Study||1
1042113|NCT00752232|2528392|P3|NOT COMPLETED|Overall Study||1
1042114|NCT00752232|2528393|P2|NOT COMPLETED|Overall Study||0
1042115|NCT00752232|2528394|P1|NOT COMPLETED|Overall Study||2
1042116|NCT00752232|2528388|P7|COMPLETED|Overall Study||4
1042117|NCT00752232|2528389|P6|COMPLETED|Overall Study||5
1042118|NCT00752232|2528390|P5|COMPLETED|Overall Study||3
1042119|NCT00752232|2528391|P4|COMPLETED|Overall Study||5
1042120|NCT00752232|2528392|P3|COMPLETED|Overall Study||5
1042121|NCT00752232|2528393|P2|COMPLETED|Overall Study||6
1042122|NCT00752232|2528394|P1|COMPLETED|Overall Study||4
1042123|NCT00752232|2528388|P7|STARTED|Overall Study||4
1042124|NCT00752232|2528389|P6|STARTED|Overall Study||6
1042125|NCT00752232|2528390|P5|STARTED|Overall Study||6
1042126|NCT00752232|2528391|P4|STARTED|Overall Study||6
1042127|NCT00752232|2528392|P3|STARTED|Overall Study||6
1042128|NCT00752232|2528393|P2|STARTED|Overall Study||6
1042129|NCT00752232|2528394|P1|STARTED|Overall Study||6
1042130|NCT00752609|2528468|P2|NOT COMPLETED|Overall Study||2
1042131|NCT00752609|2528469|P1|NOT COMPLETED|Overall Study||9
1042132|NCT00752609|2528468|P2|COMPLETED|Overall Study||47
1042133|NCT00752609|2528469|P1|COMPLETED|Overall Study||44
1042134|NCT00752609|2528468|P2|Full Analysis Set|Overall Study||49
1042135|NCT00752609|2528469|P1|Full Analysis Set|Overall Study|One patient withdrew consent before receiving any study medication.|52
1042136|NCT00752609|2528468|P2|STARTED|Overall Study||49
1042137|NCT00752609|2528469|P1|STARTED|Overall Study||53
1042138|NCT00752622|2528488|P1|NOT COMPLETED|Interventional Phase||8
1042139|NCT00752622|2528488|P1|COMPLETED|Interventional Phase|8 participants received at least 1 infusion of interventional treatment, but none completed trial|0
1042140|NCT00752622|2528488|P1|STARTED|Interventional Phase|5 participants randomized into increased dose group and 3 randomized into shortened interval group|8
1042141|NCT00752622|2528488|P1|NOT COMPLETED|Observational Phase||43
1042142|NCT00752622|2528488|P1|COMPLETED|Observational Phase|14 completed without loss of response 8 had loss of response & randomized into interventional phase|22
1042143|NCT00752622|2528488|P1|STARTED|Observational Phase||65
1042144|NCT00752622|2528488|P1|NOT COMPLETED|Induction Phase||35
1042145|NCT00752622|2528488|P1|COMPLETED|Induction Phase||65
1042146|NCT00752622|2528488|P1|STARTED|Induction Phase|The ELIG population comprised of 98 participants|100
1042147|NCT00752726|2528501|P2|NOT COMPLETED|Overall Study||13
1042148|NCT00752726|2528502|P1|NOT COMPLETED|Overall Study||11
1042149|NCT00752726|2528501|P2|COMPLETED|Overall Study||53
1042150|NCT00752726|2528502|P1|COMPLETED|Overall Study||54
1042151|NCT00752726|2528501|P2|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|61
1042152|NCT00752726|2528502|P1|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|62
1042153|NCT00752726|2528501|P2|Safety Population|Overall Study|2 participants were never dosed with the study medication.|64
1042154|NCT00752726|2528502|P1|Safety Population|Overall Study|2 participants were never dosed with the study medication.|63
1042155|NCT00752726|2528501|P2|STARTED|Overall Study||66
1042156|NCT00752726|2528502|P1|STARTED|Overall Study||65
1042157|NCT00752791|2528527|P1|NOT COMPLETED|Overall Study||16
1042158|NCT00752791|2528527|P1|COMPLETED|Overall Study||43
1042159|NCT00752791|2528527|P1|STARTED|Overall Study||59
1042160|NCT00752895|2528539|P2|NOT COMPLETED|Overall Study||3
1042161|NCT00752895|2528540|P1|NOT COMPLETED|Overall Study||8
1042162|NCT00752895|2528539|P2|COMPLETED|Overall Study||143
1042163|NCT00752895|2528540|P1|COMPLETED|Overall Study||139
1042164|NCT00752895|2528539|P2|STARTED|Overall Study||146
1042165|NCT00752895|2528540|P1|STARTED|Overall Study||147
1042166|NCT00752973|2528548|P1|NOT COMPLETED|Overall Study||0
1042167|NCT00752973|2528548|P1|COMPLETED|Overall Study||12
1042168|NCT00752973|2528548|P1|STARTED|Overall Study||12
1042169|NCT00752986|2528561|P3|NOT COMPLETED|Overall Study||2
1042170|NCT00752986|2528562|P2|NOT COMPLETED|Overall Study||1
1042171|NCT00752986|2528563|P1|NOT COMPLETED|Overall Study||5
1042172|NCT00752986|2528561|P3|COMPLETED|Overall Study||9
1042173|NCT00752986|2528562|P2|COMPLETED|Overall Study||11
1042174|NCT00752986|2528563|P1|COMPLETED|Overall Study||11
1042175|NCT00752986|2528561|P3|STARTED|Overall Study||11
1042176|NCT00752986|2528562|P2|STARTED|Overall Study||12
1042177|NCT00752986|2528563|P1|STARTED|Overall Study||16
1042178|NCT00753012|2528582|P2|NOT COMPLETED|Overall Study||1
1042179|NCT00753012|2528583|P1|NOT COMPLETED|Overall Study||8
1042180|NCT00753012|2528582|P2|COMPLETED|Overall Study||8
1042181|NCT00753012|2528583|P1|COMPLETED|Overall Study||7
1042182|NCT00753012|2528582|P2|STARTED|Overall Study||9
1042183|NCT00753012|2528583|P1|STARTED|Overall Study||15
1042184|NCT00753142|2528596|P3|NOT COMPLETED|Overall Study||0
1042185|NCT00753142|2528597|P2|NOT COMPLETED|Overall Study||0
1042186|NCT00753142|2528598|P1|NOT COMPLETED|Overall Study||0
1042187|NCT00753142|2528596|P3|COMPLETED|Overall Study||13
1042188|NCT00753142|2528597|P2|COMPLETED|Overall Study||7
1042189|NCT00753142|2528598|P1|COMPLETED|Overall Study||8
1042190|NCT00753142|2528596|P3|STARTED|Overall Study||13
1042191|NCT00753142|2528597|P2|STARTED|Overall Study||7
1042192|NCT00753142|2528598|P1|STARTED|Overall Study||8
1042193|NCT00753220|2528606|P1|NOT COMPLETED|Overall Study||5
1042194|NCT00753220|2528606|P1|COMPLETED|Overall Study||2
1042195|NCT00753220|2528606|P1|STARTED|Overall Study||7
1042196|NCT00753272|2528612|P2|NOT COMPLETED|Overall Study||4907
1042197|NCT00753272|2528613|P1|NOT COMPLETED|Overall Study||4982
1042198|NCT00753272|2528612|P2|COMPLETED|Overall Study||16895
1042199|NCT00753272|2528613|P1|COMPLETED|Overall Study||16911
1042200|NCT00753272|2528612|P2|STARTED|Overall Study||21802
1042201|NCT00753272|2528613|P1|STARTED|Overall Study||21893
1042202|NCT00753298|2528681|P2|NOT COMPLETED|Overall Study||4
1042203|NCT00753298|2528682|P1|NOT COMPLETED|Overall Study||8
1042204|NCT00753298|2528681|P2|COMPLETED|Overall Study||94
1042205|NCT00753298|2528682|P1|COMPLETED|Overall Study||89
1042206|NCT00753298|2528681|P2|STARTED|Overall Study||98
1042207|NCT00753298|2528682|P1|STARTED|Overall Study||97
1042208|NCT00753337|2528698|P1|NOT COMPLETED|Overall Study||0
1042209|NCT00753337|2528698|P1|COMPLETED|Overall Study||123
1042210|NCT00753337|2528698|P1|STARTED|Overall Study||123
1042211|NCT00753363|2528714|P2|NOT COMPLETED|Overall Study||39
1042212|NCT00753363|2528715|P1|NOT COMPLETED|Overall Study||40
1042213|NCT00753363|2528714|P2|COMPLETED|Overall Study||21
1042214|NCT00753363|2528715|P1|COMPLETED|Overall Study||19
1042215|NCT00753363|2528714|P2|STARTED|Overall Study||60
1042216|NCT00753363|2528715|P1|STARTED|Overall Study||59
1042217|NCT00753415|2528730|P10|NOT COMPLETED|Part B||1
1042218|NCT00753415|2528731|P9|NOT COMPLETED|Part B||3
1042219|NCT00753415|2528732|P8|NOT COMPLETED|Part B||1
1042220|NCT00753415|2528733|P7|NOT COMPLETED|Part B||0
1042221|NCT00753415|2528734|P6|NOT COMPLETED|Part B||0
1042222|NCT00753415|2528735|P5|NOT COMPLETED|Part B||0
1042223|NCT00753415|2528736|P4|NOT COMPLETED|Part B||0
1042224|NCT00753415|2528737|P3|NOT COMPLETED|Part B||0
1042225|NCT00753415|2528738|P2|NOT COMPLETED|Part B||0
1042226|NCT00753415|2528739|P1|NOT COMPLETED|Part B||0
1042227|NCT00753415|2528730|P10|COMPLETED|Part B||8
1042228|NCT00753415|2528731|P9|COMPLETED|Part B||6
1042229|NCT00753415|2528732|P8|COMPLETED|Part B||6
1042230|NCT00753415|2528733|P7|COMPLETED|Part B||2
1042231|NCT00753415|2528734|P6|COMPLETED|Part B||1
1042232|NCT00753415|2528735|P5|COMPLETED|Part B||0
1042233|NCT00753415|2528736|P4|COMPLETED|Part B||0
1042234|NCT00753415|2528737|P3|COMPLETED|Part B||0
1042235|NCT00753415|2528738|P2|COMPLETED|Part B||0
1042236|NCT00753415|2528739|P1|COMPLETED|Part B||0
1042237|NCT00753415|2528730|P10|STARTED|Part B|Of 10 eligible participants who completed Part A, 9 chose to enter Part B|9
1042238|NCT00753415|2528731|P9|STARTED|Part B|9 participants who completed Part A were eligible and enrolled in Part B|9
1042239|NCT00753415|2528732|P8|STARTED|Part B|Of 8 eligible participants who completed Part A, 7 chose to enter Part B|7
1042240|NCT00753415|2528733|P7|STARTED|Part B|Of 3 eligible participants who completed Part A, 2 chose to enter Part B|2
1042241|NCT00753415|2528734|P6|STARTED|Part B|Of 2 eligible participants who completed Part A, 1 chose to enter Part B|1
1042242|NCT00753415|2528735|P5|STARTED|Part B||0
1042243|NCT00753415|2528736|P4|STARTED|Part B||0
1042244|NCT00753415|2528737|P3|STARTED|Part B||0
1042245|NCT00753415|2528738|P2|STARTED|Part B||0
1042246|NCT00753415|2528739|P1|STARTED|Part B||0
1042247|NCT00753415|2528730|P10|NOT COMPLETED|Part A||0
1042248|NCT00753415|2528731|P9|NOT COMPLETED|Part A||0
1042249|NCT00753415|2528732|P8|NOT COMPLETED|Part A||0
1042250|NCT00753415|2528733|P7|NOT COMPLETED|Part A||0
1042251|NCT00753415|2528734|P6|NOT COMPLETED|Part A||0
1042252|NCT00753415|2528735|P5|NOT COMPLETED|Part A||0
1042253|NCT00753415|2528736|P4|NOT COMPLETED|Part A||2
1042254|NCT00753415|2528737|P3|NOT COMPLETED|Part A||2
1042255|NCT00753415|2528738|P2|NOT COMPLETED|Part A||0
1042256|NCT00753415|2528739|P1|NOT COMPLETED|Part A||1
1042257|NCT00753415|2528730|P10|COMPLETED|Part A||0
1042258|NCT00753415|2528731|P9|COMPLETED|Part A||0
1042259|NCT00753415|2528732|P8|COMPLETED|Part A||0
1042260|NCT00753415|2528733|P7|COMPLETED|Part A||0
1042261|NCT00753415|2528734|P6|COMPLETED|Part A||0
1042262|NCT00753415|2528735|P5|COMPLETED|Part A||10
1042263|NCT00753415|2528736|P4|COMPLETED|Part A||9
1042264|NCT00753415|2528737|P3|COMPLETED|Part A||8
1042265|NCT00753415|2528738|P2|COMPLETED|Part A||3
1042266|NCT00753415|2528739|P1|COMPLETED|Part A||2
1042267|NCT00753415|2528730|P10|STARTED|Part A||0
1042268|NCT00753415|2528731|P9|STARTED|Part A||0
1042269|NCT00753415|2528732|P8|STARTED|Part A||0
1042270|NCT00753415|2528733|P7|STARTED|Part A||0
1042271|NCT00753415|2528734|P6|STARTED|Part A||0
1042272|NCT00753415|2528735|P5|STARTED|Part A||10
1042273|NCT00753415|2528736|P4|STARTED|Part A||11
1042274|NCT00753415|2528737|P3|STARTED|Part A||10
1042275|NCT00753415|2528738|P2|STARTED|Part A||3
1042276|NCT00753415|2528739|P1|STARTED|Part A||3
1042277|NCT00753454|2528781|P1|NOT COMPLETED|Overall Study||14
1042278|NCT00753454|2528781|P1|COMPLETED|Overall Study||154
1042279|NCT00753454|2528781|P1|STARTED|Overall Study||168
1042280|NCT00753506|2528812|P2|NOT COMPLETED|Overall Study||2
1042281|NCT00753506|2528813|P1|NOT COMPLETED|Overall Study||7
1042282|NCT00753506|2528812|P2|COMPLETED|Overall Study||31
1042283|NCT00753506|2528813|P1|COMPLETED|Overall Study||26
1042284|NCT00753506|2528812|P2|STARTED|Overall Study||33
1042285|NCT00753506|2528813|P1|STARTED|Overall Study||33
1042286|NCT00753519|2528821|P2|NOT COMPLETED|Overall Study||2
1042287|NCT00753519|2528822|P1|NOT COMPLETED|Overall Study||0
1042288|NCT00753519|2528821|P2|COMPLETED|Overall Study||13
1042289|NCT00753519|2528822|P1|COMPLETED|Overall Study||13
1042290|NCT00753519|2528821|P2|STARTED|Overall Study||15
1042291|NCT00753519|2528822|P1|STARTED|Overall Study||13
1042292|NCT00753545|2528844|P2|NOT COMPLETED|Overall Study||118
1042293|NCT00753545|2528845|P1|NOT COMPLETED|Overall Study||108
1042294|NCT00753545|2528844|P2|COMPLETED|Overall Study|Patients completing the Study|11
1042295|NCT00753545|2528845|P1|COMPLETED|Overall Study|Patients completing the Study|28
1042296|NCT00753545|2528844|P2|STARTED|Overall Study|Patients randomized|129
1042297|NCT00753545|2528845|P1|STARTED|Overall Study|Patients randomized|136
1042298|NCT00753623|2528883|P2|NOT COMPLETED|Phase II (14 Days)||1
1042299|NCT00753623|2528884|P1|NOT COMPLETED|Phase II (14 Days)||0
1042300|NCT00753623|2528883|P2|COMPLETED|Phase II (14 Days)||7
1042301|NCT00753623|2528884|P1|COMPLETED|Phase II (14 Days)||8
1042302|NCT00753623|2528883|P2|STARTED|Phase II (14 Days)||8
1042303|NCT00753623|2528884|P1|STARTED|Phase II (14 Days)||8
1042304|NCT00753623|2528883|P2|NOT COMPLETED|Washout (7 Days)||0
1042305|NCT00753623|2528884|P1|NOT COMPLETED|Washout (7 Days)||1
1042306|NCT00753623|2528883|P2|COMPLETED|Washout (7 Days)||8
1042307|NCT00753623|2528884|P1|COMPLETED|Washout (7 Days)||8
1042308|NCT00753623|2528883|P2|STARTED|Washout (7 Days)||8
1042309|NCT00753623|2528884|P1|STARTED|Washout (7 Days)||9
1042310|NCT00753623|2528883|P2|NOT COMPLETED|Phase I (14 Days)||4
1042311|NCT00753623|2528884|P1|NOT COMPLETED|Phase I (14 Days)||2
1042312|NCT00753623|2528883|P2|COMPLETED|Phase I (14 Days)||8
1042313|NCT00753623|2528884|P1|COMPLETED|Phase I (14 Days)||9
1042314|NCT00753623|2528883|P2|STARTED|Phase I (14 Days)||12
1042315|NCT00753623|2528884|P1|STARTED|Phase I (14 Days)||11
1042316|NCT00753636|2528890|P1|NOT COMPLETED|Overall Study||6
1042317|NCT00753636|2528890|P1|COMPLETED|Overall Study||25
1042318|NCT00753636|2528890|P1|STARTED|Overall Study||31
1042319|NCT00753649|2528902|P2|NOT COMPLETED|Overall Study||0
1042320|NCT00753649|2528903|P1|NOT COMPLETED|Overall Study||7
1042321|NCT00753649|2528902|P2|COMPLETED|Overall Study||112
1042322|NCT00753649|2528903|P1|COMPLETED|Overall Study||105
1042323|NCT00753649|2528902|P2|STARTED|Overall Study||112
1042324|NCT00753649|2528903|P1|STARTED|Overall Study||112
1042325|NCT00753675|2528926|P3|NOT COMPLETED|Overall Study||56
1042326|NCT00753675|2528927|P2|NOT COMPLETED|Overall Study||59
1042327|NCT00753675|2528928|P1|NOT COMPLETED|Overall Study||59
1042328|NCT00753675|2528926|P3|COMPLETED|Overall Study||0
1042329|NCT00753675|2528927|P2|COMPLETED|Overall Study||0
1042330|NCT00753675|2528928|P1|COMPLETED|Overall Study||0
1042331|NCT00753675|2528926|P3|STARTED|Overall Study||56
1042332|NCT00753675|2528927|P2|STARTED|Overall Study||59
1042333|NCT00753675|2528928|P1|STARTED|Overall Study||59
1042334|NCT00753688|2528950|P2|NOT COMPLETED|Overall Study||246
1042335|NCT00753688|2528951|P1|NOT COMPLETED|Overall Study||123
1042336|NCT00753688|2528950|P2|COMPLETED|Overall Study||0
1042337|NCT00753688|2528951|P1|COMPLETED|Overall Study||0
1042338|NCT00753688|2528950|P2|Ongoing - in Follow-up|Overall Study||31
1042339|NCT00753688|2528951|P1|Ongoing - in Follow-up|Overall Study||15
1042340|NCT00753688|2528950|P2|STARTED|Overall Study||246
1042341|NCT00753688|2528951|P1|STARTED|Overall Study||123
1042342|NCT00753714|2528979|P2|NOT COMPLETED|Overall Study||62
1042343|NCT00753714|2528980|P1|NOT COMPLETED|Overall Study||60
1042344|NCT00753714|2528979|P2|COMPLETED|Overall Study||1
1042345|NCT00753714|2528980|P1|COMPLETED|Overall Study||1
1042346|NCT00753714|2528979|P2|STARTED|Overall Study||63
1042347|NCT00753714|2528980|P1|STARTED|Overall Study||61
1042348|NCT00753766|2528996|P2|NOT COMPLETED|Overall Study||0
1042349|NCT00753766|2528997|P1|NOT COMPLETED|Overall Study||1
1042350|NCT00753766|2528996|P2|COMPLETED|Overall Study||0
1042351|NCT00753766|2528997|P1|COMPLETED|Overall Study||0
1042352|NCT00753766|2528996|P2|STARTED|Overall Study||0
1042353|NCT00753766|2528997|P1|STARTED|Overall Study||1
1042354|NCT00753896|2529005|P1|NOT COMPLETED|Overall Study||16
1042355|NCT00753896|2529005|P1|COMPLETED|Overall Study||118
1042356|NCT00753896|2529005|P1|STARTED|Overall Study||134
1042357|NCT00753922|2529023|P4|NOT COMPLETED|Overall Study||23
1042358|NCT00753922|2529024|P3|NOT COMPLETED|Overall Study||63
1042359|NCT00753922|2529025|P2|NOT COMPLETED|Overall Study||94
1042360|NCT00753922|2529026|P1|NOT COMPLETED|Overall Study||246
1042361|NCT00753922|2529023|P4|COMPLETED|Overall Study||37
1042362|NCT00753922|2529024|P3|COMPLETED|Overall Study||82
1042363|NCT00753922|2529025|P2|COMPLETED|Overall Study||157
1042364|NCT00753922|2529026|P1|COMPLETED|Overall Study||306
1042365|NCT00753922|2529023|P4|STARTED|Overall Study||60
1042366|NCT00753922|2529024|P3|STARTED|Overall Study||145
1042367|NCT00753922|2529025|P2|STARTED|Overall Study||251
1042368|NCT00753922|2529026|P1|STARTED|Overall Study||552
1042369|NCT00754234|2529056|P1|NOT COMPLETED|Overall Study||3
1042370|NCT00754234|2529056|P1|COMPLETED|Overall Study|2 participants did not receive the Day 1,4,5,6 menu and 1 did not receive the Day 2 menu|13
1042371|NCT00754234|2529056|P1|STARTED|Overall Study|7 Menus were consumed in randomized order|16
1042372|NCT00754325|2529062|P2|NOT COMPLETED|Progression and Cross-over||21
1042373|NCT00754325|2529063|P1|NOT COMPLETED|Progression and Cross-over||0
1042374|NCT00754325|2529062|P2|COMPLETED|Progression and Cross-over||0
1042375|NCT00754325|2529063|P1|COMPLETED|Progression and Cross-over||0
1042376|NCT00754325|2529062|P2|STARTED|Progression and Cross-over|Progressive disease participants in Arm 2 could add dasatinib (Arm 2b) at investigator discretion.|21
1042377|NCT00754325|2529063|P1|STARTED|Progression and Cross-over|Arm 1 participants with dasatinib-related toxicity stop dasatinib, continue fulvestrant (Arm 1b).|0
1042378|NCT00754325|2529062|P2|NOT COMPLETED|Initial Treatment||49
1042379|NCT00754325|2529063|P1|NOT COMPLETED|Initial Treatment||50
1042380|NCT00754325|2529062|P2|COMPLETED|Initial Treatment||0
1042381|NCT00754325|2529063|P1|COMPLETED|Initial Treatment||0
1042382|NCT00754325|2529062|P2|STARTED|Initial Treatment||49
1042383|NCT00754325|2529063|P1|STARTED|Initial Treatment||50
1042384|NCT00754338|2529086|P4|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
1042385|NCT00754338|2529087|P3|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
1042386|NCT00754338|2529088|P2|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
1042387|NCT00754338|2529089|P1|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
1042388|NCT00754338|2529086|P4|COMPLETED|Second Intervention for Phase1&Phase2||18
1042389|NCT00754338|2529087|P3|COMPLETED|Second Intervention for Phase1&Phase2||16
1042390|NCT00754338|2529088|P2|COMPLETED|Second Intervention for Phase1&Phase2||17
1042391|NCT00754338|2529089|P1|COMPLETED|Second Intervention for Phase1&Phase2||17
1042392|NCT00754338|2529086|P4|STARTED|Second Intervention for Phase1&Phase2||19
1042393|NCT00754338|2529087|P3|STARTED|Second Intervention for Phase1&Phase2||16
1042394|NCT00754338|2529088|P2|STARTED|Second Intervention for Phase1&Phase2||18
1042395|NCT00754338|2529089|P1|STARTED|Second Intervention for Phase1&Phase2||17
1042486|NCT00754832|2529358|P1|COMPLETED|Second 6 Weeks Intervention||17
1042396|NCT00754338|2529086|P4|NOT COMPLETED|First Intervention for Phase1&Phase2||0
1042397|NCT00754338|2529087|P3|NOT COMPLETED|First Intervention for Phase1&Phase2||3
1042398|NCT00754338|2529088|P2|NOT COMPLETED|First Intervention for Phase1&Phase2||3
1042399|NCT00754338|2529089|P1|NOT COMPLETED|First Intervention for Phase1&Phase2||0
1042400|NCT00754338|2529086|P4|COMPLETED|First Intervention for Phase1&Phase2||19
1042401|NCT00754338|2529087|P3|COMPLETED|First Intervention for Phase1&Phase2||16
1042402|NCT00754338|2529088|P2|COMPLETED|First Intervention for Phase1&Phase2||18
1042403|NCT00754338|2529089|P1|COMPLETED|First Intervention for Phase1&Phase2||17
1042404|NCT00754338|2529086|P4|STARTED|First Intervention for Phase1&Phase2||19
1042405|NCT00754338|2529087|P3|STARTED|First Intervention for Phase1&Phase2||19
1042406|NCT00754338|2529088|P2|STARTED|First Intervention for Phase1&Phase2||21
1042407|NCT00754338|2529089|P1|STARTED|First Intervention for Phase1&Phase2||17
1042408|NCT00754377|2529121|P2|NOT COMPLETED|Overall Study||0
1042409|NCT00754377|2529122|P1|NOT COMPLETED|Overall Study||0
1042410|NCT00754377|2529121|P2|COMPLETED|Overall Study||42
1042411|NCT00754377|2529122|P1|COMPLETED|Overall Study||50
1042412|NCT00754377|2529121|P2|STARTED|Overall Study||42
1042413|NCT00754377|2529122|P1|STARTED|Overall Study||50
1042414|NCT00754390|2529130|P1|NOT COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||1
1042415|NCT00754390|2529130|P1|COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||10
1042416|NCT00754390|2529130|P1|STARTED|Ca/Phytate Test Meal 4 (Randomized)||11
1042417|NCT00754390|2529130|P1|NOT COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||1
1042418|NCT00754390|2529130|P1|COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||11
1042419|NCT00754390|2529130|P1|STARTED|Ca/Phytate Test Meal 3 (Randomized)||12
1042420|NCT00754390|2529130|P1|NOT COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||0
1042421|NCT00754390|2529130|P1|COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||12
1042422|NCT00754390|2529130|P1|STARTED|Ca/Phytate Test Meal 2 (Randomized)||12
1042423|NCT00754390|2529130|P1|NOT COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||5
1042424|NCT00754390|2529130|P1|COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||12
1042425|NCT00754390|2529130|P1|STARTED|Ca/Phytate Test Meal 1 (Randomized)||17
1042426|NCT00754442|2529139|P2|NOT COMPLETED|Overall Study||3
1042427|NCT00754442|2529140|P1|NOT COMPLETED|Overall Study||5
1042428|NCT00754442|2529139|P2|COMPLETED|Overall Study||6
1042429|NCT00754442|2529140|P1|COMPLETED|Overall Study||6
1042430|NCT00754442|2529139|P2|STARTED|Overall Study|patients 9|9
1042431|NCT00754442|2529140|P1|STARTED|Overall Study|controls 11|11
1042432|NCT00754468|2529149|P2|NOT COMPLETED|Overall Study||0
1042433|NCT00754468|2529150|P1|NOT COMPLETED|Overall Study||0
1042434|NCT00754468|2529149|P2|COMPLETED|Overall Study||3
1042435|NCT00754468|2529150|P1|COMPLETED|Overall Study||4
1042436|NCT00754468|2529149|P2|STARTED|Overall Study||3
1042437|NCT00754468|2529150|P1|STARTED|Overall Study||4
1042438|NCT00754494|2529161|P3|NOT COMPLETED|Overall Study||1
1042439|NCT00754494|2529162|P2|NOT COMPLETED|Overall Study||0
1042440|NCT00754494|2529163|P1|NOT COMPLETED|Overall Study||2
1042441|NCT00754494|2529161|P3|COMPLETED|Overall Study||14
1042442|NCT00754494|2529162|P2|COMPLETED|Overall Study||15
1042443|NCT00754494|2529163|P1|COMPLETED|Overall Study||13
1042444|NCT00754494|2529161|P3|STARTED|Overall Study||15
1042445|NCT00754494|2529162|P2|STARTED|Overall Study||15
1042446|NCT00754494|2529163|P1|STARTED|Overall Study||15
1042447|NCT00754546|2529207|P1|NOT COMPLETED|Overall Study||0
1042448|NCT00754546|2529207|P1|COMPLETED|Overall Study||20
1042449|NCT00754546|2529207|P1|STARTED|Overall Study||20
1042450|NCT00754559|2529221|P1|NOT COMPLETED|Overall Study||47
1042451|NCT00754559|2529221|P1|COMPLETED|Overall Study||239
1042452|NCT00754559|2529221|P1|STARTED|Overall Study||286
1042453|NCT00754572|2529245|P1|NOT COMPLETED|Overall Study||71
1042454|NCT00754572|2529245|P1|COMPLETED|Overall Study||347
1042455|NCT00754572|2529245|P1|STARTED|Overall Study||418
1042456|NCT00754624|2529272|P1|NOT COMPLETED|Overall Study||69
1042457|NCT00754624|2529272|P1|COMPLETED|Overall Study||160
1042458|NCT00754624|2529272|P1|STARTED|Overall Study||229
1042459|NCT00754650|2529282|P1|NOT COMPLETED|Overall Study||2
1042460|NCT00754650|2529282|P1|COMPLETED|Overall Study||0
1042461|NCT00754650|2529282|P1|STARTED|Overall Study||2
1042462|NCT00754741|2529290|P3|NOT COMPLETED|Overall Study||54
1042463|NCT00754741|2529291|P2|NOT COMPLETED|Overall Study||69
1042464|NCT00754741|2529292|P1|NOT COMPLETED|Overall Study||57
1042465|NCT00754741|2529290|P3|COMPLETED|Overall Study||502
1042466|NCT00754741|2529291|P2|COMPLETED|Overall Study||500
1042467|NCT00754741|2529292|P1|COMPLETED|Overall Study||510
1042468|NCT00754741|2529290|P3|STARTED|Overall Study||556
1042469|NCT00754741|2529291|P2|STARTED|Overall Study||569
1042470|NCT00754741|2529292|P1|STARTED|Overall Study||567
1042471|NCT00754767|2529341|P2|NOT COMPLETED|Overall Study||0
1042472|NCT00754767|2529342|P1|NOT COMPLETED|Overall Study||0
1042473|NCT00754767|2529341|P2|COMPLETED|Overall Study||0
1042474|NCT00754767|2529342|P1|COMPLETED|Overall Study||2
1042475|NCT00754767|2529341|P2|STARTED|Overall Study||0
1042476|NCT00754767|2529342|P1|STARTED|Overall Study||2
1042477|NCT00754793|2529350|P2|NOT COMPLETED|Overall Study||1
1042478|NCT00754793|2529351|P1|NOT COMPLETED|Overall Study||0
1042479|NCT00754793|2529350|P2|COMPLETED|Overall Study||1
1042480|NCT00754793|2529351|P1|COMPLETED|Overall Study||1
1042481|NCT00754793|2529350|P2|STARTED|Overall Study||2
1042482|NCT00754793|2529351|P1|STARTED|Overall Study||1
1042483|NCT00754832|2529357|P2|NOT COMPLETED|Second 6 Weeks Intervention||2
1042484|NCT00754832|2529358|P1|NOT COMPLETED|Second 6 Weeks Intervention||0
1042485|NCT00754832|2529357|P2|COMPLETED|Second 6 Weeks Intervention||24
1042487|NCT00754832|2529357|P2|STARTED|Second 6 Weeks Intervention||26
1042488|NCT00754832|2529358|P1|STARTED|Second 6 Weeks Intervention||17
1042489|NCT00754832|2529357|P2|NOT COMPLETED|2 Weeks Washout||2
1042490|NCT00754832|2529358|P1|NOT COMPLETED|2 Weeks Washout||1
1042491|NCT00754832|2529357|P2|COMPLETED|2 Weeks Washout||26
1042492|NCT00754832|2529358|P1|COMPLETED|2 Weeks Washout||17
1042493|NCT00754832|2529357|P2|STARTED|2 Weeks Washout||28
1042494|NCT00754832|2529358|P1|STARTED|2 Weeks Washout||18
1042495|NCT00754832|2529357|P2|NOT COMPLETED|First 6 Weeks Intervention||2
1042496|NCT00754832|2529358|P1|NOT COMPLETED|First 6 Weeks Intervention||8
1042497|NCT00754832|2529357|P2|COMPLETED|First 6 Weeks Intervention||28
1042498|NCT00754832|2529358|P1|COMPLETED|First 6 Weeks Intervention||18
1042499|NCT00754832|2529357|P2|STARTED|First 6 Weeks Intervention||30
1042500|NCT00754832|2529358|P1|STARTED|First 6 Weeks Intervention||26
1042501|NCT00754923|2529368|P1|NOT COMPLETED|Overall Study||0
1042502|NCT00754923|2529368|P1|COMPLETED|Overall Study||11
1042503|NCT00754923|2529368|P1|STARTED|Overall Study||11
1042504|NCT00755040|2529375|P2|NOT COMPLETED|Overall Study||34
1042505|NCT00755040|2529376|P1|NOT COMPLETED|Overall Study||43
1042506|NCT00755040|2529375|P2|COMPLETED|Overall Study||47
1042507|NCT00755040|2529376|P1|COMPLETED|Overall Study||40
1042508|NCT00755040|2529375|P2|STARTED|Overall Study||81
1042509|NCT00755040|2529376|P1|STARTED|Overall Study||83
1042510|NCT00755079|2529386|P2|NOT COMPLETED|Overall Study||6
1042511|NCT00755079|2529387|P1|NOT COMPLETED|Overall Study||1
1042512|NCT00755079|2529386|P2|COMPLETED|Overall Study||16
1042513|NCT00755079|2529387|P1|COMPLETED|Overall Study||17
1042514|NCT00755079|2529386|P2|STARTED|Overall Study||22
1042515|NCT00755079|2529387|P1|STARTED|Overall Study||18
1042516|NCT00755105|2529398|P3|NOT COMPLETED|Overall Study||4
1042517|NCT00755105|2529399|P2|NOT COMPLETED|Overall Study||11
1042518|NCT00755105|2529400|P1|NOT COMPLETED|Overall Study||9
1042519|NCT00755105|2529398|P3|COMPLETED|Overall Study||5
1042520|NCT00755105|2529399|P2|COMPLETED|Overall Study||19
1042521|NCT00755105|2529400|P1|COMPLETED|Overall Study||29
1042522|NCT00755105|2529398|P3|STARTED|Overall Study||9
1042523|NCT00755105|2529399|P2|STARTED|Overall Study||30
1042524|NCT00755105|2529400|P1|STARTED|Overall Study||38
1042525|NCT00755131|2529410|P2|NOT COMPLETED|Overall Study||0
1042526|NCT00755131|2529411|P1|NOT COMPLETED|Overall Study||0
1042527|NCT00755131|2529410|P2|COMPLETED|Overall Study||38
1042528|NCT00755131|2529411|P1|COMPLETED|Overall Study||37
1042529|NCT00755131|2529410|P2|STARTED|Overall Study||38
1042530|NCT00755131|2529411|P1|STARTED|Overall Study||37
1042531|NCT00755196|2529421|P1|NOT COMPLETED|Overall Study||2
1042532|NCT00755196|2529421|P1|COMPLETED|Overall Study||28
1042533|NCT00755196|2529421|P1|STARTED|Overall Study||30
1042534|NCT00755222|2529428|P2|NOT COMPLETED|Overall Study||2
1042535|NCT00755222|2529429|P1|NOT COMPLETED|Overall Study||8
1042536|NCT00755222|2529428|P2|COMPLETED|Overall Study||34
1042537|NCT00755222|2529429|P1|COMPLETED|Overall Study||103
1042538|NCT00755222|2529428|P2|STARTED|Overall Study||36
1042539|NCT00755222|2529429|P1|STARTED|Overall Study||111
1042540|NCT00755235|2529445|P2|NOT COMPLETED|Overall Study||9
1042541|NCT00755235|2529446|P1|NOT COMPLETED|Overall Study||2
1042542|NCT00755235|2529445|P2|COMPLETED|Overall Study||93
1042543|NCT00755235|2529446|P1|COMPLETED|Overall Study||104
1042544|NCT00755235|2529445|P2|STARTED|Overall Study||102
1042545|NCT00755235|2529446|P1|STARTED|Overall Study||106
1042546|NCT00755261|2529454|P1|NOT COMPLETED|Overall Study||2
1042547|NCT00755261|2529454|P1|COMPLETED|Overall Study||4
1042548|NCT00755261|2529454|P1|STARTED|Overall Study||6
1042549|NCT00755274|2529460|P2|NOT COMPLETED|Overall Study||0
1042550|NCT00755274|2529461|P1|NOT COMPLETED|Overall Study||0
1042551|NCT00755274|2529460|P2|COMPLETED|Overall Study||8
1042552|NCT00755274|2529461|P1|COMPLETED|Overall Study||24
1042553|NCT00755274|2529460|P2|STARTED|Overall Study||8
1042554|NCT00755274|2529461|P1|STARTED|Overall Study||24
1042555|NCT00755417|2529484|P3|NOT COMPLETED|Overall Study||42
1042556|NCT00755417|2529485|P2|NOT COMPLETED|Overall Study||55
1042557|NCT00755417|2529486|P1|NOT COMPLETED|Overall Study||62
1042558|NCT00755417|2529484|P3|COMPLETED|Overall Study||135
1042559|NCT00755417|2529485|P2|COMPLETED|Overall Study||126
1042560|NCT00755417|2529486|P1|COMPLETED|Overall Study||112
1042561|NCT00755417|2529484|P3|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|177
1042562|NCT00755417|2529485|P2|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|181
1042563|NCT00755417|2529486|P1|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|174
1042573|NCT00755755|2529522|P3|NOT COMPLETED|Overall Study||3
1042574|NCT00755755|2529523|P2|NOT COMPLETED|Overall Study||8
1042575|NCT00755755|2529524|P1|NOT COMPLETED|Overall Study||6
1042576|NCT00755755|2529522|P3|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|45
1042577|NCT00755755|2529523|P2|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|90
1042578|NCT00755755|2529524|P1|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|89
1042579|NCT00755755|2529522|P3|STARTED|Overall Study|Safety population|48
1042580|NCT00755755|2529523|P2|STARTED|Overall Study|Safety population|98
1042581|NCT00755755|2529524|P1|STARTED|Overall Study|Safety population|95
1042582|NCT00755807|2529537|P2|NOT COMPLETED|Open-label Extension Phase||16
1042583|NCT00755807|2529538|P1|NOT COMPLETED|Open-label Extension Phase||18
1042584|NCT00755807|2529537|P2|COMPLETED|Open-label Extension Phase||93
1042585|NCT00755807|2529538|P1|COMPLETED|Open-label Extension Phase||82
1042586|NCT00755807|2529537|P2|STARTED|Open-label Extension Phase||109
1042587|NCT00755807|2529538|P1|STARTED|Open-label Extension Phase||100
1042588|NCT00755807|2529537|P2|NOT COMPLETED|Acute Phase||12
1042589|NCT00755807|2529538|P1|NOT COMPLETED|Acute Phase||18
1042590|NCT00755807|2529537|P2|COMPLETED|Acute Phase||109
1042591|NCT00755807|2529538|P1|COMPLETED|Acute Phase||100
1042592|NCT00755807|2529537|P2|STARTED|Acute Phase||121
1042593|NCT00755807|2529538|P1|STARTED|Acute Phase||118
1042594|NCT00755846|2529605|P6|NOT COMPLETED|Overall Study||14
1042595|NCT00755846|2529606|P5|NOT COMPLETED|Overall Study||17
1042596|NCT00755846|2529607|P4|NOT COMPLETED|Overall Study||13
1042597|NCT00755846|2529608|P3|NOT COMPLETED|Overall Study||12
1042598|NCT00755846|2529609|P2|NOT COMPLETED|Overall Study||17
1042599|NCT00755846|2529610|P1|NOT COMPLETED|Overall Study||25
1042600|NCT00755846|2529605|P6|COMPLETED|Overall Study||31
1042601|NCT00755846|2529606|P5|COMPLETED|Overall Study||27
1042602|NCT00755846|2529607|P4|COMPLETED|Overall Study||32
1042603|NCT00755846|2529608|P3|COMPLETED|Overall Study||32
1042604|NCT00755846|2529609|P2|COMPLETED|Overall Study||27
1042605|NCT00755846|2529610|P1|COMPLETED|Overall Study||18
1042606|NCT00755846|2529605|P6|STARTED|Overall Study||45
1042607|NCT00755846|2529606|P5|STARTED|Overall Study||44
1042608|NCT00755846|2529607|P4|STARTED|Overall Study||45
1042609|NCT00755846|2529608|P3|STARTED|Overall Study||44
1042610|NCT00755846|2529609|P2|STARTED|Overall Study||44
1042611|NCT00755846|2529610|P1|STARTED|Overall Study||43
1042612|NCT00755911|2529710|P2|NOT COMPLETED|Overall Study||0
1042613|NCT00755911|2529711|P1|NOT COMPLETED|Overall Study||0
1042614|NCT00755911|2529710|P2|COMPLETED|Overall Study||12
1042615|NCT00755911|2529711|P1|COMPLETED|Overall Study||12
1042616|NCT00755911|2529710|P2|STARTED|Overall Study||12
1042617|NCT00755911|2529711|P1|STARTED|Overall Study||12
1042618|NCT00755937|2529719|P1|NOT COMPLETED|Observational Follow-up||148
1042619|NCT00755937|2529719|P1|COMPLETED|Observational Follow-up|Subjects followed until end of study/subjects for whom end of participation data were collected|244
1042620|NCT00755937|2529719|P1|STARTED|Observational Follow-up||392
1042621|NCT00755937|2529719|P1|NOT COMPLETED|Recruitment||164
1042622|NCT00755937|2529719|P1|COMPLETED|Recruitment|Subjects who had a baseline visit and at least 1 additional follow-up visit (analyzed population)|392
1042623|NCT00755937|2529719|P1|STARTED|Recruitment|Subjects registered in the program|556
1042624|NCT00756002|2529731|P2|NOT COMPLETED|Placebo Run-out||0
1042625|NCT00756002|2529732|P1|NOT COMPLETED|Placebo Run-out||0
1042626|NCT00756002|2529731|P2|COMPLETED|Placebo Run-out||0
1042627|NCT00756002|2529732|P1|COMPLETED|Placebo Run-out||114
1042628|NCT00756002|2529731|P2|STARTED|Placebo Run-out||0
1042629|NCT00756002|2529732|P1|STARTED|Placebo Run-out||114
1042630|NCT00756002|2529731|P2|NOT COMPLETED|Double-Blind Treatment Period||15
1042631|NCT00756002|2529732|P1|NOT COMPLETED|Double-Blind Treatment Period||15
1042632|NCT00756002|2529731|P2|COMPLETED|Double-Blind Treatment Period||115
1042633|NCT00756002|2529732|P1|COMPLETED|Double-Blind Treatment Period||114
1042634|NCT00756002|2529731|P2|STARTED|Double-Blind Treatment Period||130
1042635|NCT00756002|2529732|P1|STARTED|Double-Blind Treatment Period||129
1042636|NCT00756002|2529731|P2|NOT COMPLETED|Placebo Run-in||0
1042637|NCT00756002|2529732|P1|NOT COMPLETED|Placebo Run-in||229
1042638|NCT00756002|2529731|P2|COMPLETED|Placebo Run-in||0
1042639|NCT00756002|2529732|P1|COMPLETED|Placebo Run-in||259
1042640|NCT00756002|2529731|P2|STARTED|Placebo Run-in||0
1042641|NCT00756002|2529732|P1|STARTED|Placebo Run-in||488
1042642|NCT00756093|2529826|P4|NOT COMPLETED|Fourth Intervention||0
1042643|NCT00756093|2529827|P3|NOT COMPLETED|Fourth Intervention||0
1042644|NCT00756093|2529828|P2|NOT COMPLETED|Fourth Intervention||0
1042645|NCT00756093|2529829|P1|NOT COMPLETED|Fourth Intervention||0
1042646|NCT00756093|2529826|P4|COMPLETED|Fourth Intervention||5
1042647|NCT00756093|2529827|P3|COMPLETED|Fourth Intervention||5
1042648|NCT00756093|2529828|P2|COMPLETED|Fourth Intervention||5
1042649|NCT00756093|2529829|P1|COMPLETED|Fourth Intervention||5
1042650|NCT00756093|2529826|P4|STARTED|Fourth Intervention||5
1042651|NCT00756093|2529827|P3|STARTED|Fourth Intervention||5
1042652|NCT00756093|2529828|P2|STARTED|Fourth Intervention||5
1042653|NCT00756093|2529829|P1|STARTED|Fourth Intervention||5
1042654|NCT00756093|2529826|P4|NOT COMPLETED|Third Intervention||0
1042655|NCT00756093|2529827|P3|NOT COMPLETED|Third Intervention||0
1042656|NCT00756093|2529828|P2|NOT COMPLETED|Third Intervention||0
1042657|NCT00756093|2529829|P1|NOT COMPLETED|Third Intervention||0
1042658|NCT00756093|2529826|P4|COMPLETED|Third Intervention||5
1042659|NCT00756093|2529827|P3|COMPLETED|Third Intervention||5
1042660|NCT00756093|2529828|P2|COMPLETED|Third Intervention||5
1042661|NCT00756093|2529829|P1|COMPLETED|Third Intervention||5
1042662|NCT00756093|2529826|P4|STARTED|Third Intervention||5
1042663|NCT00756093|2529827|P3|STARTED|Third Intervention||5
1042664|NCT00756093|2529828|P2|STARTED|Third Intervention||5
1042665|NCT00756093|2529829|P1|STARTED|Third Intervention||5
1042666|NCT00756093|2529826|P4|NOT COMPLETED|Second Intervention||0
1042667|NCT00756093|2529827|P3|NOT COMPLETED|Second Intervention||0
1042668|NCT00756093|2529828|P2|NOT COMPLETED|Second Intervention||0
1042669|NCT00756093|2529829|P1|NOT COMPLETED|Second Intervention||0
1042670|NCT00756093|2529826|P4|COMPLETED|Second Intervention||5
1042671|NCT00756093|2529827|P3|COMPLETED|Second Intervention||5
1042672|NCT00756093|2529828|P2|COMPLETED|Second Intervention||5
1042673|NCT00756093|2529829|P1|COMPLETED|Second Intervention||5
1042674|NCT00756093|2529826|P4|STARTED|Second Intervention||5
1042675|NCT00756093|2529827|P3|STARTED|Second Intervention||5
1042676|NCT00756093|2529828|P2|STARTED|Second Intervention||5
1042677|NCT00756093|2529829|P1|STARTED|Second Intervention||5
1042678|NCT00756093|2529826|P4|NOT COMPLETED|First Intervention||0
1042679|NCT00756093|2529827|P3|NOT COMPLETED|First Intervention||0
1042680|NCT00756093|2529828|P2|NOT COMPLETED|First Intervention||0
1042681|NCT00756093|2529829|P1|NOT COMPLETED|First Intervention||0
1042682|NCT00756093|2529826|P4|COMPLETED|First Intervention||5
1042683|NCT00756093|2529827|P3|COMPLETED|First Intervention||5
1042684|NCT00756093|2529828|P2|COMPLETED|First Intervention||5
1042685|NCT00756093|2529829|P1|COMPLETED|First Intervention||5
1042686|NCT00756093|2529826|P4|STARTED|First Intervention||5
1042687|NCT00756093|2529827|P3|STARTED|First Intervention||5
1042688|NCT00756093|2529828|P2|STARTED|First Intervention||5
1042689|NCT00756093|2529829|P1|STARTED|First Intervention||5
1042690|NCT00756236|2529842|P3|NOT COMPLETED|Overall Study||0
1042691|NCT00756236|2529843|P2|NOT COMPLETED|Overall Study||0
1042692|NCT00756236|2529844|P1|NOT COMPLETED|Overall Study||0
1042693|NCT00756236|2529842|P3|COMPLETED|Overall Study||20
1042694|NCT00756236|2529843|P2|COMPLETED|Overall Study||20
1042695|NCT00756236|2529844|P1|COMPLETED|Overall Study||20
1042696|NCT00756236|2529842|P3|STARTED|Overall Study||20
1042697|NCT00756236|2529843|P2|STARTED|Overall Study||20
1042698|NCT00756236|2529844|P1|STARTED|Overall Study||20
1042699|NCT00756314|2529854|P2|NOT COMPLETED|Overall Study||59
1042700|NCT00756314|2529855|P1|NOT COMPLETED|Overall Study||2
1042701|NCT00756314|2529854|P2|COMPLETED|Overall Study|"4 participants did not do the follow up, 55 discontinued and were analyzed by intention to treat"|64
1042702|NCT00756314|2529855|P1|COMPLETED|Overall Study|"2 participants discontinued the intervention and were analyzed by intention to treat analysis."|121
1042703|NCT00756314|2529854|P2|STARTED|Overall Study||123
1042704|NCT00756314|2529855|P1|STARTED|Overall Study||123
1042705|NCT00756444|2529871|P2|NOT COMPLETED|Overall Study||21
1042706|NCT00756444|2529872|P1|NOT COMPLETED|Overall Study||15
1042707|NCT00756444|2529871|P2|COMPLETED|Overall Study||13
1042708|NCT00756444|2529872|P1|COMPLETED|Overall Study||18
1042709|NCT00756444|2529871|P2|STARTED|Overall Study||34
1042710|NCT00756444|2529872|P1|STARTED|Overall Study||33
1042711|NCT00756457|2529883|P2|NOT COMPLETED|Overall Study||2
1042712|NCT00756457|2529884|P1|NOT COMPLETED|Overall Study||1
1042713|NCT00756457|2529883|P2|COMPLETED|Overall Study|One participant moved overseas; the other participant resumed cancer treatment|17
1042714|NCT00756457|2529884|P1|COMPLETED|Overall Study|One participant in the Active treatment group decided to have surgery after the 2 week follow-up.|19
1042715|NCT00756457|2529883|P2|STARTED|Overall Study||19
1042716|NCT00756457|2529884|P1|STARTED|Overall Study||20
1042717|NCT00756470|2529912|P1|NOT COMPLETED|Overall Study||5
1042718|NCT00756470|2529912|P1|COMPLETED|Overall Study||10
1042719|NCT00756470|2529912|P1|STARTED|Overall Study||15
1042720|NCT00756548|2529919|P2|NOT COMPLETED|Overall Study||0
1042721|NCT00756548|2529920|P1|NOT COMPLETED|Overall Study||2
1042722|NCT00756548|2529919|P2|COMPLETED|Overall Study||185
1042723|NCT00756548|2529920|P1|COMPLETED|Overall Study||184
1042724|NCT00756548|2529919|P2|STARTED|Overall Study||185
1042725|NCT00756548|2529920|P1|STARTED|Overall Study||186
1042726|NCT00756561|2529946|P1|NOT COMPLETED|Overall Study||0
1042727|NCT00756561|2529946|P1|COMPLETED|Overall Study||10
1042728|NCT00756561|2529946|P1|STARTED|Overall Study||10
1042729|NCT00756574|2529953|P2|NOT COMPLETED|Overall Study||11
1042730|NCT00756574|2529954|P1|NOT COMPLETED|Overall Study||13
1042731|NCT00756574|2529953|P2|COMPLETED|Overall Study||210
1042732|NCT00756574|2529954|P1|COMPLETED|Overall Study||212
1042733|NCT00756574|2529953|P2|STARTED|Overall Study||221
1042734|NCT00756574|2529954|P1|STARTED|Overall Study||225
1042735|NCT00756678|2529964|P1|NOT COMPLETED|Overall Study||1
1042736|NCT00756678|2529964|P1|COMPLETED|Overall Study||50
1042737|NCT00756678|2529964|P1|STARTED|Overall Study||51
1042738|NCT00750360|2529981|P6|NOT COMPLETED|Overall Study||0
1042739|NCT00750360|2529982|P5|NOT COMPLETED|Overall Study||0
1042740|NCT00750360|2529983|P4|NOT COMPLETED|Overall Study||0
1042741|NCT00750360|2529984|P3|NOT COMPLETED|Overall Study||0
1042742|NCT00750360|2529985|P2|NOT COMPLETED|Overall Study||0
1042743|NCT00750360|2529986|P1|NOT COMPLETED|Overall Study||0
1042744|NCT00750360|2529981|P6|COMPLETED|Overall Study||71
1042745|NCT00750360|2529982|P5|COMPLETED|Overall Study||46
1042746|NCT00750360|2529983|P4|COMPLETED|Overall Study||79
1042747|NCT00750360|2529984|P3|COMPLETED|Overall Study||384
1042748|NCT00750360|2529985|P2|COMPLETED|Overall Study||1
1042749|NCT00750360|2529986|P1|COMPLETED|Overall Study||294
1042750|NCT00750360|2529981|P6|STARTED|Overall Study||71
1042751|NCT00750360|2529982|P5|STARTED|Overall Study||46
1042752|NCT00750360|2529983|P4|STARTED|Overall Study||79
1042753|NCT00750360|2529984|P3|STARTED|Overall Study||384
1042754|NCT00750360|2529985|P2|STARTED|Overall Study|"One subject enrolled in this group was not vaccinated and as such not included as STARTED."|1
1042940|NCT00757601|2530278|P2|NOT COMPLETED|Period 3||0
1042755|NCT00750360|2529986|P1|STARTED|Overall Study|"Seven subjects enrolled in this group were not vaccinated and as such not included as STARTED."|294
1042756|NCT00750373|2530020|P2|NOT COMPLETED|Overall Study||0
1042757|NCT00750373|2530021|P1|NOT COMPLETED|Overall Study||0
1042758|NCT00750373|2530020|P2|COMPLETED|Overall Study||37
1042759|NCT00750373|2530021|P1|COMPLETED|Overall Study||39
1042760|NCT00750373|2530020|P2|STARTED|Overall Study||37
1042761|NCT00750373|2530021|P1|STARTED|Overall Study||39
1042762|NCT00750737|2530029|P2|NOT COMPLETED|Overall Study||3
1042763|NCT00750737|2530030|P1|NOT COMPLETED|Overall Study||3
1042764|NCT00750737|2530029|P2|COMPLETED|Overall Study||19
1042765|NCT00750737|2530030|P1|COMPLETED|Overall Study||21
1042766|NCT00750737|2530029|P2|STARTED|Overall Study||22
1042767|NCT00750737|2530030|P1|STARTED|Overall Study||24
1042768|NCT00750815|2530040|P2|NOT COMPLETED|Overall Study||0
1042769|NCT00750815|2530041|P1|NOT COMPLETED|Overall Study||0
1042770|NCT00750815|2530040|P2|COMPLETED|Overall Study||46
1042771|NCT00750815|2530041|P1|COMPLETED|Overall Study||12
1042772|NCT00750815|2530040|P2|STARTED|Overall Study||46
1042773|NCT00750815|2530041|P1|STARTED|Overall Study||12
1042774|NCT00750867|2530052|P1|NOT COMPLETED|Overall Study||2
1042775|NCT00750867|2530052|P1|COMPLETED|Overall Study||7
1042776|NCT00750867|2530052|P1|STARTED|Overall Study||9
1042777|NCT00750880|2530057|P1|NOT COMPLETED|Overall Study||215
1042778|NCT00750880|2530057|P1|COMPLETED|Overall Study||1466
1042779|NCT00750880|2530057|P1|STARTED|Overall Study||1681
1042780|NCT00750893|2530080|P1|NOT COMPLETED|Overall Study||542
1042781|NCT00750893|2530080|P1|COMPLETED|Overall Study||2569
1042782|NCT00750893|2530080|P1|STARTED|Overall Study||3111
1042783|NCT00750919|2530095|P1|NOT COMPLETED|Overall Study||58
1042784|NCT00750919|2530095|P1|COMPLETED|Overall Study||126
1042785|NCT00750919|2530095|P1|STARTED|Overall Study||184
1042786|NCT00751036|2530105|P2|NOT COMPLETED|Overall Study||46
1042787|NCT00751036|2530106|P1|NOT COMPLETED|Overall Study||48
1042788|NCT00751036|2530105|P2|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
1042789|NCT00751036|2530106|P1|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
1042790|NCT00751036|2530105|P2|STARTED|Overall Study|Started = Treated|46
1042791|NCT00751036|2530106|P1|STARTED|Overall Study|Started = Treated|48
1042792|NCT00756730|2530120|P2|NOT COMPLETED|Overall Study||2
1042793|NCT00756730|2530121|P1|NOT COMPLETED|Overall Study||0
1042794|NCT00756730|2530120|P2|COMPLETED|Overall Study||22
1042795|NCT00756730|2530121|P1|COMPLETED|Overall Study||25
1042796|NCT00756730|2530120|P2|STARTED|Overall Study||24
1042797|NCT00756730|2530121|P1|STARTED|Overall Study||25
1042798|NCT00756886|2530143|P2|NOT COMPLETED|Overall Study||7
1042799|NCT00756886|2530144|P1|NOT COMPLETED|Overall Study||11
1042800|NCT00756886|2530143|P2|COMPLETED|Overall Study||25
1042801|NCT00756886|2530144|P1|COMPLETED|Overall Study||30
1042802|NCT00756886|2530143|P2|STARTED|Overall Study||32
1042803|NCT00756886|2530144|P1|STARTED|Overall Study||41
1042828|NCT00756964|2530184|P2|NOT COMPLETED|Overall Study||0
1042829|NCT00756964|2530185|P1|NOT COMPLETED|Overall Study||0
1042830|NCT00756964|2530184|P2|COMPLETED|Overall Study||13
1042831|NCT00756964|2530185|P1|COMPLETED|Overall Study||13
1042832|NCT00756964|2530184|P2|STARTED|Overall Study||13
1042833|NCT00756964|2530185|P1|STARTED|Overall Study||13
1042834|NCT00756977|2530193|P2|NOT COMPLETED|Overall Study||11
1042835|NCT00756977|2530194|P1|NOT COMPLETED|Overall Study||21
1042836|NCT00756977|2530193|P2|COMPLETED|Overall Study||187
1042837|NCT00756977|2530194|P1|COMPLETED|Overall Study||175
1042838|NCT00756977|2530193|P2|STARTED|Overall Study||198
1042839|NCT00756977|2530194|P1|STARTED|Overall Study||196
1042840|NCT00757003|2530220|P1|NOT COMPLETED|Overall Study||49
1042841|NCT00757003|2530220|P1|COMPLETED|Overall Study||51
1042842|NCT00757003|2530220|P1|STARTED|Overall Study||100
1042843|NCT00757484|2530226|P1|NOT COMPLETED|Overall Study||0
1042844|NCT00757484|2530226|P1|COMPLETED|Overall Study||491
1042845|NCT00757484|2530226|P1|STARTED|Overall Study||491
1042941|NCT00757601|2530279|P1|NOT COMPLETED|Period 3||0
1042846|NCT00757588|2530235|P2|NOT COMPLETED|Period 2: Long-term (52-week) Phase||9
1042847|NCT00757588|2530236|P1|NOT COMPLETED|Period 2: Long-term (52-week) Phase||22
1042848|NCT00757588|2530235|P2|COMPLETED|Period 2: Long-term (52-week) Phase||125
1042849|NCT00757588|2530236|P1|COMPLETED|Period 2: Long-term (52-week) Phase||246
1042850|NCT00757588|2530235|P2|STARTED|Period 2: Long-term (52-week) Phase||134
1042851|NCT00757588|2530236|P1|STARTED|Period 2: Long-term (52-week) Phase|270 participants completed short-term phase; 2 of these did not enter long-term phase.|268
1042852|NCT00757588|2530235|P2|NOT COMPLETED|Period 1: Short-term (24-week) Phase||17
1042853|NCT00757588|2530236|P1|NOT COMPLETED|Period 1: Short-term (24-week) Phase||36
1042854|NCT00757588|2530235|P2|COMPLETED|Period 1: Short-term (24-week) Phase||134
1042855|NCT00757588|2530236|P1|COMPLETED|Period 1: Short-term (24-week) Phase|Does not include 2 who completed Period 1 but were erroneously reported in the CSR as noncompleters.|268
1042856|NCT00757588|2530235|P2|STARTED|Period 1: Short-term (24-week) Phase||151
1042857|NCT00757588|2530236|P1|STARTED|Period 1: Short-term (24-week) Phase||304
1042858|NCT00757601|2530268|P12|NOT COMPLETED|Period 5||0
1042859|NCT00757601|2530269|P11|NOT COMPLETED|Period 5||0
1042860|NCT00757601|2530270|P10|NOT COMPLETED|Period 5||0
1042861|NCT00757601|2530271|P9|NOT COMPLETED|Period 5||0
1042862|NCT00757601|2530272|P8|NOT COMPLETED|Period 5||0
1042863|NCT00757601|2530273|P7|NOT COMPLETED|Period 5||0
1042864|NCT00757601|2530274|P6|NOT COMPLETED|Period 5||0
1042865|NCT00757601|2530275|P5|NOT COMPLETED|Period 5||0
1042866|NCT00757601|2530276|P4|NOT COMPLETED|Period 5||0
1042867|NCT00757601|2530277|P3|NOT COMPLETED|Period 5||0
1042868|NCT00757601|2530278|P2|NOT COMPLETED|Period 5||0
1042869|NCT00757601|2530279|P1|NOT COMPLETED|Period 5||0
1042870|NCT00757601|2530268|P12|COMPLETED|Period 5||1
1042871|NCT00757601|2530269|P11|COMPLETED|Period 5||2
1042872|NCT00757601|2530270|P10|COMPLETED|Period 5||1
1042873|NCT00757601|2530271|P9|COMPLETED|Period 5||2
1042874|NCT00757601|2530272|P8|COMPLETED|Period 5||2
1042875|NCT00757601|2530273|P7|COMPLETED|Period 5||2
1042876|NCT00757601|2530274|P6|COMPLETED|Period 5||2
1042877|NCT00757601|2530275|P5|COMPLETED|Period 5||2
1042878|NCT00757601|2530276|P4|COMPLETED|Period 5||2
1042879|NCT00757601|2530277|P3|COMPLETED|Period 5||2
1042880|NCT00757601|2530278|P2|COMPLETED|Period 5||2
1042881|NCT00757601|2530279|P1|COMPLETED|Period 5||2
1042882|NCT00757601|2530268|P12|STARTED|Period 5||1
1042883|NCT00757601|2530269|P11|STARTED|Period 5||2
1042884|NCT00757601|2530270|P10|STARTED|Period 5||1
1042885|NCT00757601|2530271|P9|STARTED|Period 5||2
1042886|NCT00757601|2530272|P8|STARTED|Period 5||2
1042887|NCT00757601|2530273|P7|STARTED|Period 5||2
1042888|NCT00757601|2530274|P6|STARTED|Period 5||2
1042889|NCT00757601|2530275|P5|STARTED|Period 5||2
1042890|NCT00757601|2530276|P4|STARTED|Period 5||2
1042891|NCT00757601|2530277|P3|STARTED|Period 5||2
1042892|NCT00757601|2530278|P2|STARTED|Period 5||2
1042893|NCT00757601|2530279|P1|STARTED|Period 5||2
1042894|NCT00757601|2530268|P12|NOT COMPLETED|Period 4||1
1042895|NCT00757601|2530269|P11|NOT COMPLETED|Period 4||0
1042896|NCT00757601|2530270|P10|NOT COMPLETED|Period 4||1
1042897|NCT00757601|2530271|P9|NOT COMPLETED|Period 4||0
1042898|NCT00757601|2530272|P8|NOT COMPLETED|Period 4||0
1042899|NCT00757601|2530273|P7|NOT COMPLETED|Period 4||0
1042900|NCT00757601|2530274|P6|NOT COMPLETED|Period 4||0
1042901|NCT00757601|2530275|P5|NOT COMPLETED|Period 4||0
1042902|NCT00757601|2530276|P4|NOT COMPLETED|Period 4||0
1042903|NCT00757601|2530277|P3|NOT COMPLETED|Period 4||0
1042904|NCT00757601|2530278|P2|NOT COMPLETED|Period 4||0
1042905|NCT00757601|2530279|P1|NOT COMPLETED|Period 4||0
1042906|NCT00757601|2530268|P12|COMPLETED|Period 4|Replacement participant discontinued after receiving placebo to 230mg MK1006 and was not replaced|1
1042907|NCT00757601|2530269|P11|COMPLETED|Period 4||2
1042908|NCT00757601|2530270|P10|COMPLETED|Period 4|One participant discontinued after receiving the 230 mg dose of MK1006 and was not replaced|1
1042909|NCT00757601|2530271|P9|COMPLETED|Period 4||2
1042910|NCT00757601|2530272|P8|COMPLETED|Period 4||2
1042911|NCT00757601|2530273|P7|COMPLETED|Period 4||2
1042912|NCT00757601|2530274|P6|COMPLETED|Period 4||2
1042913|NCT00757601|2530275|P5|COMPLETED|Period 4||2
1042914|NCT00757601|2530276|P4|COMPLETED|Period 4||2
1042915|NCT00757601|2530277|P3|COMPLETED|Period 4||2
1042916|NCT00757601|2530278|P2|COMPLETED|Period 4||2
1042917|NCT00757601|2530279|P1|COMPLETED|Period 4||2
1042918|NCT00757601|2530268|P12|STARTED|Period 4||2
1042919|NCT00757601|2530269|P11|STARTED|Period 4||2
1042920|NCT00757601|2530270|P10|STARTED|Period 4||2
1042921|NCT00757601|2530271|P9|STARTED|Period 4||2
1042922|NCT00757601|2530272|P8|STARTED|Period 4||2
1042923|NCT00757601|2530273|P7|STARTED|Period 4||2
1042924|NCT00757601|2530274|P6|STARTED|Period 4||2
1042925|NCT00757601|2530275|P5|STARTED|Period 4||2
1042926|NCT00757601|2530276|P4|STARTED|Period 4||2
1042927|NCT00757601|2530277|P3|STARTED|Period 4||2
1042928|NCT00757601|2530278|P2|STARTED|Period 4||2
1042929|NCT00757601|2530279|P1|STARTED|Period 4||2
1042930|NCT00757601|2530268|P12|NOT COMPLETED|Period 3||0
1042931|NCT00757601|2530269|P11|NOT COMPLETED|Period 3||0
1042932|NCT00757601|2530270|P10|NOT COMPLETED|Period 3||0
1042933|NCT00757601|2530271|P9|NOT COMPLETED|Period 3||0
1042934|NCT00757601|2530272|P8|NOT COMPLETED|Period 3||0
1042935|NCT00757601|2530273|P7|NOT COMPLETED|Period 3||0
1042936|NCT00757601|2530274|P6|NOT COMPLETED|Period 3||0
1042937|NCT00757601|2530275|P5|NOT COMPLETED|Period 3||0
1042938|NCT00757601|2530276|P4|NOT COMPLETED|Period 3||0
1042939|NCT00757601|2530277|P3|NOT COMPLETED|Period 3||0
1042942|NCT00757601|2530268|P12|COMPLETED|Period 3||2
1042943|NCT00757601|2530269|P11|COMPLETED|Period 3||2
1042944|NCT00757601|2530270|P10|COMPLETED|Period 3||2
1042945|NCT00757601|2530271|P9|COMPLETED|Period 3||2
1042946|NCT00757601|2530272|P8|COMPLETED|Period 3||2
1042947|NCT00757601|2530273|P7|COMPLETED|Period 3||2
1042948|NCT00757601|2530274|P6|COMPLETED|Period 3||2
1042949|NCT00757601|2530275|P5|COMPLETED|Period 3||2
1042950|NCT00757601|2530276|P4|COMPLETED|Period 3||2
1042951|NCT00757601|2530277|P3|COMPLETED|Period 3||2
1042952|NCT00757601|2530278|P2|COMPLETED|Period 3||2
1042953|NCT00757601|2530279|P1|COMPLETED|Period 3||2
1042954|NCT00757601|2530268|P12|STARTED|Period 3||2
1042955|NCT00757601|2530269|P11|STARTED|Period 3||2
1042956|NCT00757601|2530270|P10|STARTED|Period 3||2
1042957|NCT00757601|2530271|P9|STARTED|Period 3||2
1042958|NCT00757601|2530272|P8|STARTED|Period 3||2
1042959|NCT00757601|2530273|P7|STARTED|Period 3||2
1042960|NCT00757601|2530274|P6|STARTED|Period 3||2
1042961|NCT00757601|2530275|P5|STARTED|Period 3||2
1042962|NCT00757601|2530276|P4|STARTED|Period 3||2
1042963|NCT00757601|2530277|P3|STARTED|Period 3||2
1042964|NCT00757601|2530278|P2|STARTED|Period 3||2
1042965|NCT00757601|2530279|P1|STARTED|Period 3||2
1042966|NCT00757601|2530268|P12|NOT COMPLETED|Period 2||1
1042967|NCT00757601|2530269|P11|NOT COMPLETED|Period 2||0
1042968|NCT00757601|2530270|P10|NOT COMPLETED|Period 2||0
1042969|NCT00757601|2530271|P9|NOT COMPLETED|Period 2||0
1042970|NCT00757601|2530272|P8|NOT COMPLETED|Period 2||0
1042971|NCT00757601|2530273|P7|NOT COMPLETED|Period 2||0
1042972|NCT00757601|2530274|P6|NOT COMPLETED|Period 2||0
1042973|NCT00757601|2530275|P5|NOT COMPLETED|Period 2||0
1042974|NCT00757601|2530276|P4|NOT COMPLETED|Period 2||0
1042975|NCT00757601|2530277|P3|NOT COMPLETED|Period 2||0
1042976|NCT00757601|2530278|P2|NOT COMPLETED|Period 2||0
1042977|NCT00757601|2530279|P1|NOT COMPLETED|Period 2||0
1042978|NCT00757601|2530268|P12|COMPLETED|Period 2|One participant discontinued the study after Period 2 and was replaced by another participant.|2
1042979|NCT00757601|2530269|P11|COMPLETED|Period 2||2
1042980|NCT00757601|2530270|P10|COMPLETED|Period 2||2
1042981|NCT00757601|2530271|P9|COMPLETED|Period 2||2
1042982|NCT00757601|2530272|P8|COMPLETED|Period 2||2
1042983|NCT00757601|2530273|P7|COMPLETED|Period 2||2
1042984|NCT00757601|2530274|P6|COMPLETED|Period 2||2
1042985|NCT00757601|2530275|P5|COMPLETED|Period 2||2
1042986|NCT00757601|2530276|P4|COMPLETED|Period 2||2
1042987|NCT00757601|2530277|P3|COMPLETED|Period 2||2
1042988|NCT00757601|2530278|P2|COMPLETED|Period 2||2
1042989|NCT00757601|2530279|P1|COMPLETED|Period 2||2
1042990|NCT00757601|2530268|P12|STARTED|Period 2||3
1042991|NCT00757601|2530269|P11|STARTED|Period 2||2
1042992|NCT00757601|2530270|P10|STARTED|Period 2||2
1042993|NCT00757601|2530271|P9|STARTED|Period 2||2
1042994|NCT00757601|2530272|P8|STARTED|Period 2||2
1042995|NCT00757601|2530273|P7|STARTED|Period 2||2
1042996|NCT00757601|2530274|P6|STARTED|Period 2||2
1042997|NCT00757601|2530275|P5|STARTED|Period 2||2
1042998|NCT00757601|2530276|P4|STARTED|Period 2||2
1042999|NCT00757601|2530277|P3|STARTED|Period 2||2
1043000|NCT00757601|2530278|P2|STARTED|Period 2||2
1043001|NCT00757601|2530279|P1|STARTED|Period 2||2
1043002|NCT00757601|2530268|P12|NOT COMPLETED|Period 1||0
1043003|NCT00757601|2530269|P11|NOT COMPLETED|Period 1||0
1043004|NCT00757601|2530270|P10|NOT COMPLETED|Period 1||0
1043005|NCT00757601|2530271|P9|NOT COMPLETED|Period 1||0
1043006|NCT00757601|2530272|P8|NOT COMPLETED|Period 1||0
1043007|NCT00757601|2530273|P7|NOT COMPLETED|Period 1||0
1043008|NCT00757601|2530274|P6|NOT COMPLETED|Period 1||0
1043009|NCT00757601|2530275|P5|NOT COMPLETED|Period 1||0
1043010|NCT00757601|2530276|P4|NOT COMPLETED|Period 1||0
1043011|NCT00757601|2530277|P3|NOT COMPLETED|Period 1||0
1043012|NCT00757601|2530278|P2|NOT COMPLETED|Period 1||0
1043013|NCT00757601|2530279|P1|NOT COMPLETED|Period 1||0
1043014|NCT00757601|2530268|P12|COMPLETED|Period 1||3
1043015|NCT00757601|2530269|P11|COMPLETED|Period 1||2
1043016|NCT00757601|2530270|P10|COMPLETED|Period 1||2
1043017|NCT00757601|2530271|P9|COMPLETED|Period 1||2
1043018|NCT00757601|2530272|P8|COMPLETED|Period 1||2
1043019|NCT00757601|2530273|P7|COMPLETED|Period 1||2
1043020|NCT00757601|2530274|P6|COMPLETED|Period 1||2
1043021|NCT00757601|2530275|P5|COMPLETED|Period 1||2
1043022|NCT00757601|2530276|P4|COMPLETED|Period 1||2
1043023|NCT00757601|2530277|P3|COMPLETED|Period 1||2
1043024|NCT00757601|2530278|P2|COMPLETED|Period 1||2
1043025|NCT00757601|2530279|P1|COMPLETED|Period 1||2
1043026|NCT00757601|2530268|P12|STARTED|Period 1||3
1043027|NCT00757601|2530269|P11|STARTED|Period 1||2
1043028|NCT00757601|2530270|P10|STARTED|Period 1||2
1043029|NCT00757601|2530271|P9|STARTED|Period 1||2
1043030|NCT00757601|2530272|P8|STARTED|Period 1||2
1043031|NCT00757601|2530273|P7|STARTED|Period 1||2
1043032|NCT00757601|2530274|P6|STARTED|Period 1||2
1043033|NCT00757601|2530275|P5|STARTED|Period 1||2
1043034|NCT00757601|2530276|P4|STARTED|Period 1||2
1043035|NCT00757601|2530277|P3|STARTED|Period 1||2
1043036|NCT00757601|2530278|P2|STARTED|Period 1||2
1043037|NCT00757601|2530279|P1|STARTED|Period 1||2
1043038|NCT00757627|2530388|P1|NOT COMPLETED|Overall Study||81
1043039|NCT00757627|2530388|P1|COMPLETED|Overall Study||419
1043040|NCT00757627|2530388|P1|STARTED|Overall Study||500
1043041|NCT00757666|2530403|P2|NOT COMPLETED|Overall Study||23
1043042|NCT00757666|2530404|P1|NOT COMPLETED|Overall Study||22
1043043|NCT00757666|2530403|P2|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|11
1043044|NCT00757666|2530404|P1|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|12
1043045|NCT00757666|2530403|P2|STARTED|Overall Study||34
1043046|NCT00757666|2530404|P1|STARTED|Overall Study||34
1043047|NCT00757705|2530418|P1|NOT COMPLETED|Overall Study||121
1043048|NCT00757705|2530418|P1|COMPLETED|Overall Study||178
1043049|NCT00757705|2530418|P1|STARTED|Overall Study||299
1043050|NCT00757783|2530432|P2|NOT COMPLETED|Overall Study||6
1043051|NCT00757783|2530433|P1|NOT COMPLETED|Overall Study||5
1043052|NCT00757783|2530432|P2|COMPLETED|Overall Study||25
1043053|NCT00757783|2530433|P1|COMPLETED|Overall Study||29
1043054|NCT00757783|2530432|P2|STARTED|Overall Study||31
1043055|NCT00757783|2530433|P1|STARTED|Overall Study||34
1043056|NCT00757822|2530471|P2|NOT COMPLETED|Overall Study||31
1043057|NCT00757822|2530472|P1|NOT COMPLETED|Overall Study||28
1043058|NCT00757822|2530471|P2|COMPLETED|Overall Study||57
1043059|NCT00757822|2530472|P1|COMPLETED|Overall Study||64
1043060|NCT00757822|2530471|P2|Data Lock, Unblinding Analysis|Overall Study||57
1043061|NCT00757822|2530472|P1|Data Lock, Unblinding Analysis|Overall Study||64
1043062|NCT00757822|2530471|P2|Withdrawn-protocol Deviation|Overall Study||8
1043063|NCT00757822|2530472|P1|Withdrawn-protocol Deviation|Overall Study||9
1043064|NCT00757822|2530471|P2|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk < 2|9
1043065|NCT00757822|2530472|P1|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk<2|12
1043066|NCT00757822|2530471|P2|Data Entry, QC Assessment|Overall Study||74
1043067|NCT00757822|2530472|P1|Data Entry, QC Assessment|Overall Study||85
1043068|NCT00757822|2530471|P2|2-6 wk Post-op Assessment|Overall Study||74
1043069|NCT00757822|2530472|P1|2-6 wk Post-op Assessment|Overall Study||85
1043070|NCT00757822|2530471|P2|24-48 hr Telephone Assessment|Overall Study||74
1043071|NCT00757822|2530472|P1|24-48 hr Telephone Assessment|Overall Study||85
1043072|NCT00757822|2530471|P2|DOS: Post-operative Assessments|Overall Study||74
1043073|NCT00757822|2530472|P1|DOS: Post-operative Assessments|Overall Study||85
1043074|NCT00757822|2530471|P2|Received Study Intervention|Overall Study||74
1043075|NCT00757822|2530472|P1|Received Study Intervention|Overall Study||85
1043076|NCT00757822|2530471|P2|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|11
1043077|NCT00757822|2530472|P1|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|6
1043078|NCT00757822|2530471|P2|Withdrawal by Subject-no Intervention|Overall Study||3
1043079|NCT00757822|2530472|P1|Withdrawal by Subject-no Intervention|Overall Study||1
1043080|NCT00757822|2530471|P2|Day of Surgery (DOS) Assessment|Overall Study||88
1043081|NCT00757822|2530472|P1|Day of Surgery (DOS) Assessment|Overall Study||92
1043082|NCT00757822|2530471|P2|STARTED|Overall Study||88
1043083|NCT00757822|2530472|P1|STARTED|Overall Study||92
1043084|NCT00757848|2530494|P2|NOT COMPLETED|Overall Study||2
1043085|NCT00757848|2530495|P1|NOT COMPLETED|Overall Study||3
1043086|NCT00757848|2530494|P2|COMPLETED|Overall Study||27
1043087|NCT00757848|2530495|P1|COMPLETED|Overall Study||24
1043088|NCT00757848|2530494|P2|STARTED|Overall Study||29
1043089|NCT00757848|2530495|P1|STARTED|Overall Study||27
1043090|NCT00758043|2530543|P4|NOT COMPLETED|Overall Study||100
1043091|NCT00758043|2530544|P3|NOT COMPLETED|Overall Study||39
1043092|NCT00758043|2530545|P2|NOT COMPLETED|Overall Study||41
1043093|NCT00758043|2530546|P1|NOT COMPLETED|Overall Study||1
1043094|NCT00758043|2530543|P4|COMPLETED|Overall Study||0
1043095|NCT00758043|2530544|P3|COMPLETED|Overall Study||79
1043096|NCT00758043|2530545|P2|COMPLETED|Overall Study||119
1043097|NCT00758043|2530546|P1|COMPLETED|Overall Study||161
1043098|NCT00758043|2530543|P4|STARTED|Overall Study||100
1043099|NCT00758043|2530544|P3|STARTED|Overall Study||118
1043100|NCT00758043|2530545|P2|STARTED|Overall Study||160
1043101|NCT00758043|2530546|P1|STARTED|Overall Study||162
1043102|NCT00758069|2530575|P3|NOT COMPLETED|Overall Study||1
1043103|NCT00758069|2530576|P2|NOT COMPLETED|Overall Study||0
1043104|NCT00758069|2530577|P1|NOT COMPLETED|Overall Study||1
1043105|NCT00758069|2530575|P3|COMPLETED|Overall Study||27
1043106|NCT00758069|2530576|P2|COMPLETED|Overall Study||25
1043107|NCT00758069|2530577|P1|COMPLETED|Overall Study||26
1043108|NCT00758069|2530575|P3|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|28
1043109|NCT00758069|2530576|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|25
1043110|NCT00758069|2530577|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|27
1043111|NCT00758160|2530588|P1|NOT COMPLETED|Overall Study||66
1043112|NCT00758160|2530588|P1|COMPLETED|Overall Study||230
1043113|NCT00758160|2530588|P1|STARTED|Overall Study||296
1043114|NCT00758290|2530608|P2|NOT COMPLETED|Overall Study||0
1043115|NCT00758290|2530609|P1|NOT COMPLETED|Overall Study||0
1043116|NCT00758290|2530608|P2|COMPLETED|Overall Study||12
1043117|NCT00758290|2530609|P1|COMPLETED|Overall Study||11
1043118|NCT00758290|2530608|P2|STARTED|Overall Study||12
1043119|NCT00758290|2530609|P1|STARTED|Overall Study||11
1043120|NCT00758342|2530615|P2|NOT COMPLETED|Overall Study||1
1043121|NCT00758342|2530616|P1|NOT COMPLETED|Overall Study||4
1043122|NCT00758342|2530615|P2|COMPLETED|Overall Study||17
1043123|NCT00758342|2530616|P1|COMPLETED|Overall Study||15
1043124|NCT00758342|2530615|P2|STARTED|Overall Study||18
1043125|NCT00758342|2530616|P1|STARTED|Overall Study||19
1043126|NCT00758394|2530626|P4|NOT COMPLETED|4th Intervention||0
1043127|NCT00758394|2530627|P3|NOT COMPLETED|4th Intervention||0
1043128|NCT00758394|2530628|P2|NOT COMPLETED|4th Intervention||0
1043129|NCT00758394|2530629|P1|NOT COMPLETED|4th Intervention||0
1043130|NCT00758394|2530626|P4|COMPLETED|4th Intervention||7
1043131|NCT00758394|2530627|P3|COMPLETED|4th Intervention||6
1043132|NCT00758394|2530628|P2|COMPLETED|4th Intervention||6
1043133|NCT00758394|2530629|P1|COMPLETED|4th Intervention||7
1043134|NCT00758394|2530626|P4|STARTED|4th Intervention||7
1043135|NCT00758394|2530627|P3|STARTED|4th Intervention||6
1043136|NCT00758394|2530628|P2|STARTED|4th Intervention||6
1043137|NCT00758394|2530629|P1|STARTED|4th Intervention||7
1043138|NCT00758394|2530626|P4|NOT COMPLETED|Washout After 3rd Intervention||0
1043139|NCT00758394|2530627|P3|NOT COMPLETED|Washout After 3rd Intervention||0
1043140|NCT00758394|2530628|P2|NOT COMPLETED|Washout After 3rd Intervention||0
1043141|NCT00758394|2530629|P1|NOT COMPLETED|Washout After 3rd Intervention||0
1043142|NCT00758394|2530626|P4|COMPLETED|Washout After 3rd Intervention||7
1043143|NCT00758394|2530627|P3|COMPLETED|Washout After 3rd Intervention||6
1043144|NCT00758394|2530628|P2|COMPLETED|Washout After 3rd Intervention||6
1043145|NCT00758394|2530629|P1|COMPLETED|Washout After 3rd Intervention||7
1043146|NCT00758394|2530626|P4|STARTED|Washout After 3rd Intervention||7
1043147|NCT00758394|2530627|P3|STARTED|Washout After 3rd Intervention||6
1043148|NCT00758394|2530628|P2|STARTED|Washout After 3rd Intervention||6
1043149|NCT00758394|2530629|P1|STARTED|Washout After 3rd Intervention||7
1043150|NCT00758394|2530626|P4|NOT COMPLETED|3rd Intervention||1
1043151|NCT00758394|2530627|P3|NOT COMPLETED|3rd Intervention||0
1043152|NCT00758394|2530628|P2|NOT COMPLETED|3rd Intervention||0
1043153|NCT00758394|2530629|P1|NOT COMPLETED|3rd Intervention||1
1043154|NCT00758394|2530626|P4|COMPLETED|3rd Intervention||7
1043155|NCT00758394|2530627|P3|COMPLETED|3rd Intervention||6
1043156|NCT00758394|2530628|P2|COMPLETED|3rd Intervention||6
1043157|NCT00758394|2530629|P1|COMPLETED|3rd Intervention||7
1043158|NCT00758394|2530626|P4|STARTED|3rd Intervention||8
1043159|NCT00758394|2530627|P3|STARTED|3rd Intervention||6
1043160|NCT00758394|2530628|P2|STARTED|3rd Intervention||6
1043161|NCT00758394|2530629|P1|STARTED|3rd Intervention||8
1043162|NCT00758394|2530626|P4|NOT COMPLETED|Washout After 2nd Intervention||0
1043163|NCT00758394|2530627|P3|NOT COMPLETED|Washout After 2nd Intervention||0
1043164|NCT00758394|2530628|P2|NOT COMPLETED|Washout After 2nd Intervention||0
1043165|NCT00758394|2530629|P1|NOT COMPLETED|Washout After 2nd Intervention||0
1043166|NCT00758394|2530626|P4|COMPLETED|Washout After 2nd Intervention||8
1043167|NCT00758394|2530627|P3|COMPLETED|Washout After 2nd Intervention||6
1043168|NCT00758394|2530628|P2|COMPLETED|Washout After 2nd Intervention||6
1043169|NCT00758394|2530629|P1|COMPLETED|Washout After 2nd Intervention||8
1043170|NCT00758394|2530626|P4|STARTED|Washout After 2nd Intervention||8
1043171|NCT00758394|2530627|P3|STARTED|Washout After 2nd Intervention||6
1043172|NCT00758394|2530628|P2|STARTED|Washout After 2nd Intervention||6
1043173|NCT00758394|2530629|P1|STARTED|Washout After 2nd Intervention||8
1043174|NCT00758394|2530626|P4|NOT COMPLETED|2nd Intervention Order||0
1043175|NCT00758394|2530627|P3|NOT COMPLETED|2nd Intervention Order||0
1043176|NCT00758394|2530628|P2|NOT COMPLETED|2nd Intervention Order||1
1043177|NCT00758394|2530629|P1|NOT COMPLETED|2nd Intervention Order||0
1043178|NCT00758394|2530626|P4|COMPLETED|2nd Intervention Order||8
1043179|NCT00758394|2530627|P3|COMPLETED|2nd Intervention Order||6
1043180|NCT00758394|2530628|P2|COMPLETED|2nd Intervention Order||6
1043181|NCT00758394|2530629|P1|COMPLETED|2nd Intervention Order||8
1043182|NCT00758394|2530626|P4|STARTED|2nd Intervention Order||8
1043183|NCT00758394|2530627|P3|STARTED|2nd Intervention Order||6
1043184|NCT00758394|2530628|P2|STARTED|2nd Intervention Order||7
1043185|NCT00758394|2530629|P1|STARTED|2nd Intervention Order||8
1043186|NCT00758394|2530626|P4|NOT COMPLETED|Washout After 1st Intervention||0
1043187|NCT00758394|2530627|P3|NOT COMPLETED|Washout After 1st Intervention||0
1043188|NCT00758394|2530628|P2|NOT COMPLETED|Washout After 1st Intervention||0
1043189|NCT00758394|2530629|P1|NOT COMPLETED|Washout After 1st Intervention||0
1043190|NCT00758394|2530626|P4|COMPLETED|Washout After 1st Intervention||8
1043191|NCT00758394|2530627|P3|COMPLETED|Washout After 1st Intervention||6
1043192|NCT00758394|2530628|P2|COMPLETED|Washout After 1st Intervention||7
1043193|NCT00758394|2530629|P1|COMPLETED|Washout After 1st Intervention||8
1043194|NCT00758394|2530626|P4|STARTED|Washout After 1st Intervention||8
1043195|NCT00758394|2530627|P3|STARTED|Washout After 1st Intervention||6
1043196|NCT00758394|2530628|P2|STARTED|Washout After 1st Intervention||7
1043197|NCT00758394|2530629|P1|STARTED|Washout After 1st Intervention||8
1043198|NCT00758394|2530626|P4|NOT COMPLETED|1st Intervention||0
1043199|NCT00758394|2530627|P3|NOT COMPLETED|1st Intervention||0
1043200|NCT00758394|2530628|P2|NOT COMPLETED|1st Intervention||0
1043201|NCT00758394|2530629|P1|NOT COMPLETED|1st Intervention||0
1043202|NCT00758394|2530626|P4|COMPLETED|1st Intervention||8
1043203|NCT00758394|2530627|P3|COMPLETED|1st Intervention||6
1043204|NCT00758394|2530628|P2|COMPLETED|1st Intervention||7
1043205|NCT00758394|2530629|P1|COMPLETED|1st Intervention||8
1043206|NCT00758394|2530626|P4|STARTED|1st Intervention||8
1043207|NCT00758394|2530627|P3|STARTED|1st Intervention||6
1043208|NCT00758394|2530628|P2|STARTED|1st Intervention||7
1043209|NCT00758394|2530629|P1|STARTED|1st Intervention||8
1043210|NCT00758420|2530641|P2|NOT COMPLETED|Overall Study||0
1043211|NCT00758420|2530642|P1|NOT COMPLETED|Overall Study||0
1043212|NCT00758420|2530641|P2|COMPLETED|Overall Study||38
1043213|NCT00758420|2530642|P1|COMPLETED|Overall Study||39
1043214|NCT00758420|2530641|P2|STARTED|Overall Study||38
1043215|NCT00758420|2530642|P1|STARTED|Overall Study||39
1043216|NCT00758459|2530650|P2|NOT COMPLETED|Overall Study||4
1043217|NCT00758459|2530651|P1|NOT COMPLETED|Overall Study||3
1043218|NCT00758459|2530650|P2|COMPLETED|Overall Study||35
1043219|NCT00758459|2530651|P1|COMPLETED|Overall Study||32
1043220|NCT00758459|2530650|P2|STARTED|Overall Study||39
1043221|NCT00758459|2530651|P1|STARTED|Overall Study||35
1043222|NCT00758485|2530685|P2|NOT COMPLETED|Overall Study||3
1043223|NCT00758485|2530686|P1|NOT COMPLETED|Overall Study||1
1043224|NCT00758485|2530685|P2|COMPLETED|Overall Study||67
1043225|NCT00758485|2530686|P1|COMPLETED|Overall Study||69
1043226|NCT00758485|2530685|P2|TREATED|Overall Study||68
1043227|NCT00758485|2530686|P1|TREATED|Overall Study||69
1043228|NCT00758485|2530685|P2|STARTED|Overall Study||70
1043229|NCT00758485|2530686|P1|STARTED|Overall Study||70
1043230|NCT00758498|2530699|P3|NOT COMPLETED|Overall Study||5
1043231|NCT00758498|2530700|P2|NOT COMPLETED|Overall Study||2
1043232|NCT00758498|2530701|P1|NOT COMPLETED|Overall Study||3
1043233|NCT00758498|2530699|P3|COMPLETED|Overall Study||137
1043234|NCT00758498|2530700|P2|COMPLETED|Overall Study||141
1043235|NCT00758498|2530701|P1|COMPLETED|Overall Study||139
1043236|NCT00758498|2530699|P3|STARTED|Overall Study||142
1043237|NCT00758498|2530700|P2|STARTED|Overall Study||143
1043238|NCT00758498|2530701|P1|STARTED|Overall Study||142
1043239|NCT00758550|2530786|P2|NOT COMPLETED|Overall Study||0
1043240|NCT00758550|2530787|P1|NOT COMPLETED|Overall Study||0
1043241|NCT00758550|2530786|P2|COMPLETED|Overall Study||30
1043242|NCT00758550|2530787|P1|COMPLETED|Overall Study||30
1043243|NCT00758550|2530786|P2|STARTED|Overall Study||30
1043244|NCT00758550|2530787|P1|STARTED|Overall Study||30
1043245|NCT00758563|2530797|P2|NOT COMPLETED|Overall Study||0
1043246|NCT00758563|2530798|P1|NOT COMPLETED|Overall Study||0
1043247|NCT00758563|2530797|P2|COMPLETED|Overall Study||8
1043248|NCT00758563|2530798|P1|COMPLETED|Overall Study||7
1043249|NCT00758563|2530797|P2|STARTED|Overall Study||8
1043250|NCT00758563|2530798|P1|STARTED|Overall Study||7
1043251|NCT00758576|2530802|P1|NOT COMPLETED|Overall Study||1
1043252|NCT00758576|2530802|P1|COMPLETED|Overall Study||63
1043253|NCT00758576|2530802|P1|STARTED|Overall Study||64
1043254|NCT00758589|2530812|P4|NOT COMPLETED|Overall Study||6
1043255|NCT00758589|2530813|P3|NOT COMPLETED|Overall Study||6
1043256|NCT00758589|2530814|P2|NOT COMPLETED|Overall Study||3
1043257|NCT00758589|2530815|P1|NOT COMPLETED|Overall Study||3
1043258|NCT00758589|2530812|P4|COMPLETED|Overall Study||85
1043259|NCT00758589|2530813|P3|COMPLETED|Overall Study||86
1043260|NCT00758589|2530814|P2|COMPLETED|Overall Study||87
1043261|NCT00758589|2530815|P1|COMPLETED|Overall Study||92
1043262|NCT00758589|2530812|P4|STARTED|Overall Study||91
1043263|NCT00758589|2530813|P3|STARTED|Overall Study||92
1043264|NCT00758589|2530814|P2|STARTED|Overall Study||90
1043265|NCT00758589|2530815|P1|STARTED|Overall Study||95
1043266|NCT00758602|2530883|P2|NOT COMPLETED|Overall Study||22
1043267|NCT00758602|2530884|P1|NOT COMPLETED|Overall Study||19
1043268|NCT00758602|2530883|P2|COMPLETED|Overall Study||84
1043269|NCT00758602|2530884|P1|COMPLETED|Overall Study||85
1043270|NCT00758602|2530883|P2|STARTED|Overall Study||106
1043271|NCT00758602|2530884|P1|STARTED|Overall Study||104
1043272|NCT00758667|2530908|P2|NOT COMPLETED|Overall Study||0
1043273|NCT00758667|2530909|P1|NOT COMPLETED|Overall Study||0
1043274|NCT00758667|2530908|P2|COMPLETED|Overall Study||11
1043275|NCT00758667|2530909|P1|COMPLETED|Overall Study||9
1043276|NCT00758667|2530908|P2|STARTED|Overall Study||11
1043277|NCT00758667|2530909|P1|STARTED|Overall Study||9
1043278|NCT00758680|2530917|P10|NOT COMPLETED|Overall Study||1
1043279|NCT00758680|2530918|P9|NOT COMPLETED|Overall Study||2
1043280|NCT00758680|2530919|P8|NOT COMPLETED|Overall Study||1
1043281|NCT00758680|2530920|P7|NOT COMPLETED|Overall Study||1
1043282|NCT00758680|2530921|P6|NOT COMPLETED|Overall Study||0
1043283|NCT00758680|2530922|P5|NOT COMPLETED|Overall Study||0
1043284|NCT00758680|2530923|P4|NOT COMPLETED|Overall Study||0
1043285|NCT00758680|2530924|P3|NOT COMPLETED|Overall Study||0
1043286|NCT00758680|2530925|P2|NOT COMPLETED|Overall Study||0
1043287|NCT00758680|2530926|P1|NOT COMPLETED|Overall Study||0
1043288|NCT00758680|2530917|P10|COMPLETED|Overall Study||28
1043289|NCT00758680|2530918|P9|COMPLETED|Overall Study||18
1043290|NCT00758680|2530919|P8|COMPLETED|Overall Study||19
1043291|NCT00758680|2530920|P7|COMPLETED|Overall Study||6
1043292|NCT00758680|2530921|P6|COMPLETED|Overall Study||6
1043293|NCT00758680|2530922|P5|COMPLETED|Overall Study||6
1043294|NCT00758680|2530923|P4|COMPLETED|Overall Study||6
1043295|NCT00758680|2530924|P3|COMPLETED|Overall Study||6
1043296|NCT00758680|2530925|P2|COMPLETED|Overall Study||6
1043297|NCT00758680|2530926|P1|COMPLETED|Overall Study||6
1043298|NCT00758680|2530917|P10|STARTED|Overall Study||29
1043299|NCT00758680|2530918|P9|STARTED|Overall Study||20
1043300|NCT00758680|2530919|P8|STARTED|Overall Study||20
1043301|NCT00758680|2530920|P7|STARTED|Overall Study||7
1043302|NCT00758680|2530921|P6|STARTED|Overall Study||6
1043303|NCT00758680|2530922|P5|STARTED|Overall Study||6
1043304|NCT00758680|2530923|P4|STARTED|Overall Study||6
1043305|NCT00758680|2530924|P3|STARTED|Overall Study||6
1043306|NCT00758680|2530925|P2|STARTED|Overall Study||6
1043307|NCT00758680|2530926|P1|STARTED|Overall Study||6
1043308|NCT00758706|2530968|P2|NOT COMPLETED|Overall Study||4
1043309|NCT00758706|2530969|P1|NOT COMPLETED|Overall Study||4
1043310|NCT00758706|2530968|P2|COMPLETED|Overall Study||25
1043311|NCT00758706|2530969|P1|COMPLETED|Overall Study||22
1043312|NCT00758706|2530968|P2|STARTED|Overall Study||29
1043313|NCT00758706|2530969|P1|STARTED|Overall Study||26
1043314|NCT00758745|2531007|P2|NOT COMPLETED|Overall Study||21
1043315|NCT00758745|2531008|P1|NOT COMPLETED|Overall Study||21
1043316|NCT00758745|2531007|P2|COMPLETED|Overall Study||60
1043317|NCT00758745|2531008|P1|COMPLETED|Overall Study||60
1043318|NCT00758745|2531007|P2|STARTED|Overall Study||81
1043319|NCT00758745|2531008|P1|STARTED|Overall Study||81
1043320|NCT00758758|2531022|P8|NOT COMPLETED|Overall Study||0
1043321|NCT00758758|2531023|P7|NOT COMPLETED|Overall Study||14
1043322|NCT00758758|2531024|P6|NOT COMPLETED|Overall Study||14
1043323|NCT00758758|2531025|P5|NOT COMPLETED|Overall Study||2
1043324|NCT00758758|2531026|P4|NOT COMPLETED|Overall Study||2
1043325|NCT00758758|2531027|P3|NOT COMPLETED|Overall Study||18
1043326|NCT00758758|2531028|P2|NOT COMPLETED|Overall Study||25
1043327|NCT00758758|2531029|P1|NOT COMPLETED|Overall Study||3
1043328|NCT00758758|2531022|P8|COMPLETED|Overall Study||0
1043329|NCT00758758|2531023|P7|COMPLETED|Overall Study||17
1043330|NCT00758758|2531024|P6|COMPLETED|Overall Study||36
1043331|NCT00758758|2531025|P5|COMPLETED|Overall Study||1
1043332|NCT00758758|2531026|P4|COMPLETED|Overall Study||4
1043333|NCT00758758|2531027|P3|COMPLETED|Overall Study||35
1043334|NCT00758758|2531028|P2|COMPLETED|Overall Study||49
1043335|NCT00758758|2531029|P1|COMPLETED|Overall Study||11
1043336|NCT00758758|2531022|P8|STARTED|Overall Study||0
1043337|NCT00758758|2531023|P7|STARTED|Overall Study||31
1043338|NCT00758758|2531024|P6|STARTED|Overall Study||50
1043339|NCT00758758|2531025|P5|STARTED|Overall Study||3
1043340|NCT00758758|2531026|P4|STARTED|Overall Study||6
1043341|NCT00758758|2531027|P3|STARTED|Overall Study||53
1043342|NCT00758758|2531028|P2|STARTED|Overall Study||74
1043343|NCT00758758|2531029|P1|STARTED|Overall Study||14
1043344|NCT00758771|2531057|P2|NOT COMPLETED|Overall Study||5
1043345|NCT00758771|2531058|P1|NOT COMPLETED|Overall Study||3
1043346|NCT00758771|2531057|P2|COMPLETED|Overall Study||15
1043347|NCT00758771|2531058|P1|COMPLETED|Overall Study||15
1043348|NCT00758771|2531057|P2|STARTED|Overall Study||20
1043349|NCT00758771|2531058|P1|STARTED|Overall Study||18
1043350|NCT00758836|2531068|P4|NOT COMPLETED|Overall Study||32
1043351|NCT00758836|2531069|P3|NOT COMPLETED|Overall Study||38
1043352|NCT00758836|2531070|P2|NOT COMPLETED|Overall Study||26
1043353|NCT00758836|2531071|P1|NOT COMPLETED|Overall Study||24
1043354|NCT00758836|2531068|P4|COMPLETED|Overall Study||138
1043355|NCT00758836|2531069|P3|COMPLETED|Overall Study||133
1043356|NCT00758836|2531070|P2|COMPLETED|Overall Study||145
1043357|NCT00758836|2531071|P1|COMPLETED|Overall Study||147
1043358|NCT00758836|2531068|P4|Treated|Overall Study||138
1043359|NCT00758836|2531069|P3|Treated|Overall Study||133
1043360|NCT00758836|2531070|P2|Treated|Overall Study||145
1043361|NCT00758836|2531071|P1|Treated|Overall Study||147
1043362|NCT00758836|2531068|P4|STARTED|Overall Study||170
1043363|NCT00758836|2531069|P3|STARTED|Overall Study||171
1043364|NCT00758836|2531070|P2|STARTED|Overall Study||171
1043365|NCT00758836|2531071|P1|STARTED|Overall Study||171
1043366|NCT00759031|2531095|P2|NOT COMPLETED|Second Intervention (1 Day)||0
1043367|NCT00759031|2531096|P1|NOT COMPLETED|Second Intervention (1 Day)||0
1043368|NCT00759031|2531095|P2|COMPLETED|Second Intervention (1 Day)||8
1043369|NCT00759031|2531096|P1|COMPLETED|Second Intervention (1 Day)||8
1043370|NCT00759031|2531095|P2|STARTED|Second Intervention (1 Day)||8
1043371|NCT00759031|2531096|P1|STARTED|Second Intervention (1 Day)||8
1043372|NCT00759031|2531095|P2|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
1043373|NCT00759031|2531096|P1|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
1043374|NCT00759031|2531095|P2|COMPLETED|Washout After 1st Intervention (1 Week)||8
1043375|NCT00759031|2531096|P1|COMPLETED|Washout After 1st Intervention (1 Week)||8
1043376|NCT00759031|2531095|P2|STARTED|Washout After 1st Intervention (1 Week)||8
1043377|NCT00759031|2531096|P1|STARTED|Washout After 1st Intervention (1 Week)||8
1043378|NCT00759031|2531095|P2|NOT COMPLETED|First Intervention (1 Day)||1
1043379|NCT00759031|2531096|P1|NOT COMPLETED|First Intervention (1 Day)||2
1043380|NCT00759031|2531095|P2|COMPLETED|First Intervention (1 Day)||8
1043381|NCT00759031|2531096|P1|COMPLETED|First Intervention (1 Day)||8
1043382|NCT00759031|2531095|P2|STARTED|First Intervention (1 Day)||9
1043383|NCT00759031|2531096|P1|STARTED|First Intervention (1 Day)||10
1043384|NCT00759096|2531102|P1|NOT COMPLETED|Overall Study||0
1043385|NCT00759096|2531102|P1|COMPLETED|Overall Study||30
1043386|NCT00759096|2531102|P1|STARTED|Overall Study||30
1043393|NCT00759148|2531127|P2|NOT COMPLETED|Overall Study||32
1043394|NCT00759148|2531128|P1|NOT COMPLETED|Overall Study||14
1043395|NCT00759148|2531127|P2|COMPLETED|Overall Study||554
1043396|NCT00759148|2531128|P1|COMPLETED|Overall Study||579
1043397|NCT00759148|2531127|P2|STARTED|Overall Study||586
1043398|NCT00759148|2531128|P1|STARTED|Overall Study||593
1043399|NCT00759161|2531136|P1|NOT COMPLETED|Overall Study||0
1043400|NCT00759161|2531136|P1|COMPLETED|Overall Study||35
1043401|NCT00759161|2531136|P1|STARTED|Overall Study||35
1043402|NCT00759174|2531151|P2|NOT COMPLETED|Overall Study||2
1043403|NCT00759174|2531152|P1|NOT COMPLETED|Overall Study||0
1043404|NCT00759174|2531151|P2|COMPLETED|Overall Study||595
1043405|NCT00759174|2531152|P1|COMPLETED|Overall Study||76
1043406|NCT00759174|2531151|P2|STARTED|Overall Study||597
1043407|NCT00759174|2531152|P1|STARTED|Overall Study||76
1043408|NCT00759187|2531164|P3|NOT COMPLETED|Overall Study||0
1043409|NCT00759187|2531165|P2|NOT COMPLETED|Overall Study||0
1043410|NCT00759187|2531166|P1|NOT COMPLETED|Overall Study||0
1043411|NCT00759187|2531164|P3|COMPLETED|Overall Study||9
1043412|NCT00759187|2531165|P2|COMPLETED|Overall Study||8
1043413|NCT00759187|2531166|P1|COMPLETED|Overall Study||8
1043414|NCT00759187|2531164|P3|STARTED|Overall Study||9
1043415|NCT00759187|2531165|P2|STARTED|Overall Study||8
1043416|NCT00759187|2531166|P1|STARTED|Overall Study||8
1043417|NCT00759330|2531178|P4|NOT COMPLETED|Overall Study||2
1043418|NCT00759330|2531179|P3|NOT COMPLETED|Overall Study||0
1043419|NCT00759330|2531180|P2|NOT COMPLETED|Overall Study||1
1043420|NCT00759330|2531181|P1|NOT COMPLETED|Overall Study||1
1043421|NCT00759330|2531178|P4|COMPLETED|Overall Study||41
1043422|NCT00759330|2531179|P3|COMPLETED|Overall Study||22
1043423|NCT00759330|2531180|P2|COMPLETED|Overall Study||41
1043424|NCT00759330|2531181|P1|COMPLETED|Overall Study||19
1043425|NCT00759330|2531178|P4|STARTED|Overall Study||43
1043426|NCT00759330|2531179|P3|STARTED|Overall Study||22
1043427|NCT00759330|2531180|P2|STARTED|Overall Study||42
1043428|NCT00759330|2531181|P1|STARTED|Overall Study||20
1043429|NCT00759356|2531229|P2|NOT COMPLETED|Overall Study||3
1043430|NCT00759356|2531230|P1|NOT COMPLETED|Overall Study||1
1043431|NCT00759356|2531229|P2|COMPLETED|Overall Study||15
1043432|NCT00759356|2531230|P1|COMPLETED|Overall Study||17
1043433|NCT00759356|2531229|P2|STARTED|Overall Study||18
1043434|NCT00759356|2531230|P1|STARTED|Overall Study||18
1043435|NCT00759395|2531244|P2|NOT COMPLETED|Overall Study||2
1043436|NCT00759395|2531245|P1|NOT COMPLETED|Overall Study||2
1043437|NCT00759395|2531244|P2|COMPLETED|Overall Study||7
1043438|NCT00759395|2531245|P1|COMPLETED|Overall Study||11
1043439|NCT00759395|2531244|P2|STARTED|Overall Study||9
1043440|NCT00759395|2531245|P1|STARTED|Overall Study||13
1043441|NCT00759473|2531264|P5|NOT COMPLETED|Overall Study||0
1043442|NCT00759473|2531265|P4|NOT COMPLETED|Overall Study||0
1043443|NCT00759473|2531266|P3|NOT COMPLETED|Overall Study||0
1043444|NCT00759473|2531267|P2|NOT COMPLETED|Overall Study||0
1043445|NCT00759473|2531268|P1|NOT COMPLETED|Overall Study||0
1043446|NCT00759473|2531264|P5|COMPLETED|Overall Study||24
1043447|NCT00759473|2531265|P4|COMPLETED|Overall Study||23
1043448|NCT00759473|2531266|P3|COMPLETED|Overall Study||12
1043449|NCT00759473|2531267|P2|COMPLETED|Overall Study||10
1043450|NCT00759473|2531268|P1|COMPLETED|Overall Study||10
1043451|NCT00759473|2531264|P5|STARTED|Overall Study||24
1043452|NCT00759473|2531265|P4|STARTED|Overall Study||23
1043453|NCT00759473|2531266|P3|STARTED|Overall Study||12
1043454|NCT00759473|2531267|P2|STARTED|Overall Study||10
1043455|NCT00759473|2531268|P1|STARTED|Overall Study||10
1043456|NCT00759525|2531280|P2|NOT COMPLETED|Second Intervention (14 Days)||0
1043457|NCT00759525|2531281|P1|NOT COMPLETED|Second Intervention (14 Days)||0
1043458|NCT00759525|2531280|P2|COMPLETED|Second Intervention (14 Days)||8
1043459|NCT00759525|2531281|P1|COMPLETED|Second Intervention (14 Days)||7
1043460|NCT00759525|2531280|P2|STARTED|Second Intervention (14 Days)||8
1043461|NCT00759525|2531281|P1|STARTED|Second Intervention (14 Days)||7
1043462|NCT00759525|2531280|P2|NOT COMPLETED|Washout (14 Days)||0
1043463|NCT00759525|2531281|P1|NOT COMPLETED|Washout (14 Days)||0
1043464|NCT00759525|2531280|P2|COMPLETED|Washout (14 Days)||8
1043465|NCT00759525|2531281|P1|COMPLETED|Washout (14 Days)||7
1043466|NCT00759525|2531280|P2|STARTED|Washout (14 Days)||8
1043467|NCT00759525|2531281|P1|STARTED|Washout (14 Days)||7
1043468|NCT00759525|2531280|P2|NOT COMPLETED|First Intervention (14 Days)||0
1043469|NCT00759525|2531281|P1|NOT COMPLETED|First Intervention (14 Days)||0
1043470|NCT00759525|2531280|P2|COMPLETED|First Intervention (14 Days)||8
1043471|NCT00759525|2531281|P1|COMPLETED|First Intervention (14 Days)||7
1043472|NCT00759525|2531280|P2|STARTED|First Intervention (14 Days)||8
1043473|NCT00759525|2531281|P1|STARTED|First Intervention (14 Days)||7
1043474|NCT00759564|2531292|P5|NOT COMPLETED|Second Intervention Period (4 Days)||0
1043475|NCT00759564|2531293|P4|NOT COMPLETED|Second Intervention Period (4 Days)||0
1043476|NCT00759564|2531294|P3|NOT COMPLETED|Second Intervention Period (4 Days)||0
1043477|NCT00759564|2531295|P2|NOT COMPLETED|Second Intervention Period (4 Days)||0
1043478|NCT00759564|2531296|P1|NOT COMPLETED|Second Intervention Period (4 Days)||0
1043479|NCT00759564|2531292|P5|COMPLETED|Second Intervention Period (4 Days)||3
1043480|NCT00759564|2531293|P4|COMPLETED|Second Intervention Period (4 Days)||1
1043481|NCT00759564|2531294|P3|COMPLETED|Second Intervention Period (4 Days)||8
1043482|NCT00759564|2531295|P2|COMPLETED|Second Intervention Period (4 Days)||8
1043483|NCT00759564|2531296|P1|COMPLETED|Second Intervention Period (4 Days)||8
1043484|NCT00759564|2531292|P5|STARTED|Second Intervention Period (4 Days)||3
1043485|NCT00759564|2531293|P4|STARTED|Second Intervention Period (4 Days)||1
1043486|NCT00759564|2531294|P3|STARTED|Second Intervention Period (4 Days)||8
1043487|NCT00759564|2531295|P2|STARTED|Second Intervention Period (4 Days)||8
1043488|NCT00759564|2531296|P1|STARTED|Second Intervention Period (4 Days)||8
1043489|NCT00759564|2531292|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||1
1043490|NCT00759564|2531293|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1043491|NCT00759564|2531294|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1043492|NCT00759564|2531295|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1043493|NCT00759564|2531296|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1043494|NCT00759564|2531292|P5|COMPLETED|Washout Period (at Least 14 Days)||3
1043495|NCT00759564|2531293|P4|COMPLETED|Washout Period (at Least 14 Days)||1
1043496|NCT00759564|2531294|P3|COMPLETED|Washout Period (at Least 14 Days)||8
1043497|NCT00759564|2531295|P2|COMPLETED|Washout Period (at Least 14 Days)||8
1043498|NCT00759564|2531296|P1|COMPLETED|Washout Period (at Least 14 Days)||8
1043499|NCT00759564|2531292|P5|STARTED|Washout Period (at Least 14 Days)||4
1043500|NCT00759564|2531293|P4|STARTED|Washout Period (at Least 14 Days)||1
1043501|NCT00759564|2531294|P3|STARTED|Washout Period (at Least 14 Days)||8
1043502|NCT00759564|2531295|P2|STARTED|Washout Period (at Least 14 Days)||8
1043503|NCT00759564|2531296|P1|STARTED|Washout Period (at Least 14 Days)||8
1043504|NCT00759564|2531292|P5|NOT COMPLETED|First Intervention Period (4 Days)||0
1043505|NCT00759564|2531293|P4|NOT COMPLETED|First Intervention Period (4 Days)||0
1043506|NCT00759564|2531294|P3|NOT COMPLETED|First Intervention Period (4 Days)||0
1043507|NCT00759564|2531295|P2|NOT COMPLETED|First Intervention Period (4 Days)||0
1043508|NCT00759564|2531296|P1|NOT COMPLETED|First Intervention Period (4 Days)||0
1043509|NCT00759564|2531292|P5|COMPLETED|First Intervention Period (4 Days)||4
1043510|NCT00759564|2531293|P4|COMPLETED|First Intervention Period (4 Days)||1
1043511|NCT00759564|2531294|P3|COMPLETED|First Intervention Period (4 Days)||8
1043512|NCT00759564|2531295|P2|COMPLETED|First Intervention Period (4 Days)||8
1043513|NCT00759564|2531296|P1|COMPLETED|First Intervention Period (4 Days)||8
1043514|NCT00759564|2531292|P5|STARTED|First Intervention Period (4 Days)||4
1043515|NCT00759564|2531293|P4|STARTED|First Intervention Period (4 Days)||1
1043516|NCT00759564|2531294|P3|STARTED|First Intervention Period (4 Days)||8
1043517|NCT00759564|2531295|P2|STARTED|First Intervention Period (4 Days)||8
1043518|NCT00759564|2531296|P1|STARTED|First Intervention Period (4 Days)||8
1043519|NCT00759577|2531436|P1|NOT COMPLETED|Overall Study||0
1043520|NCT00759577|2531436|P1|COMPLETED|Overall Study||36
1043521|NCT00759577|2531436|P1|STARTED|Overall Study||36
1043522|NCT00759603|2531440|P1|NOT COMPLETED|Overall Study||0
1043523|NCT00759603|2531440|P1|COMPLETED|Overall Study||59
1043524|NCT00759603|2531440|P1|STARTED|Overall Study||59
1043525|NCT00759642|2531444|P1|NOT COMPLETED|Overall Study||0
1043526|NCT00759642|2531444|P1|COMPLETED|Overall Study||33
1043527|NCT00759642|2531444|P1|STARTED|Overall Study||33
1043528|NCT00759655|2531448|P1|NOT COMPLETED|Overall Study||1
1043529|NCT00759655|2531448|P1|COMPLETED|Overall Study||0
1043530|NCT00759655|2531448|P1|STARTED|Overall Study||1
1043531|NCT00759668|2531461|P2|NOT COMPLETED|Overall Study||3
1043532|NCT00759668|2531462|P1|NOT COMPLETED|Overall Study||1
1043533|NCT00759668|2531461|P2|COMPLETED|Overall Study||15
1043534|NCT00759668|2531462|P1|COMPLETED|Overall Study||16
1043535|NCT00759668|2531461|P2|STARTED|Overall Study||18
1043536|NCT00759668|2531462|P1|STARTED|Overall Study||17
1043537|NCT00759681|2531480|P2|NOT COMPLETED|Overall Study||10
1043538|NCT00759681|2531481|P1|NOT COMPLETED|Overall Study||10
1043539|NCT00759681|2531480|P2|COMPLETED|Overall Study||100
1043540|NCT00759681|2531481|P1|COMPLETED|Overall Study||97
1043541|NCT00759681|2531480|P2|STARTED|Overall Study||110
1043542|NCT00759681|2531481|P1|STARTED|Overall Study||107
1043543|NCT00759707|2531489|P1|NOT COMPLETED|Overall Study||0
1043544|NCT00759707|2531489|P1|COMPLETED|Overall Study||19
1043545|NCT00759707|2531489|P1|STARTED|Overall Study||19
1043546|NCT00759759|2531495|P2|NOT COMPLETED|Overall Study||1
1043547|NCT00759759|2531496|P1|NOT COMPLETED|Overall Study||4
1043548|NCT00759759|2531495|P2|COMPLETED|Overall Study||17
1043549|NCT00759759|2531496|P1|COMPLETED|Overall Study||14
1043550|NCT00759759|2531495|P2|STARTED|Overall Study||18
1043551|NCT00759759|2531496|P1|STARTED|Overall Study||18
1043552|NCT00753948|2531511|P3|NOT COMPLETED|Overall Study||0
1043553|NCT00753948|2531512|P2|NOT COMPLETED|Overall Study||0
1043554|NCT00753948|2531513|P1|NOT COMPLETED|Overall Study||0
1043555|NCT00753948|2531511|P3|COMPLETED|Overall Study||7
1043556|NCT00753948|2531512|P2|COMPLETED|Overall Study||7
1043557|NCT00753948|2531513|P1|COMPLETED|Overall Study||9
1043558|NCT00753948|2531511|P3|STARTED|Overall Study||7
1043559|NCT00753948|2531512|P2|STARTED|Overall Study||7
1043560|NCT00753948|2531513|P1|STARTED|Overall Study||9
1043561|NCT00754013|2531523|P2|NOT COMPLETED|Overall Study||5
1043562|NCT00754013|2531524|P1|NOT COMPLETED|Overall Study||4
1043563|NCT00754013|2531523|P2|COMPLETED|Overall Study||0
1043564|NCT00754013|2531524|P1|COMPLETED|Overall Study||0
1043565|NCT00754013|2531523|P2|STARTED|Overall Study||5
1043566|NCT00754013|2531524|P1|STARTED|Overall Study||4
1043567|NCT00754065|2531534|P2|NOT COMPLETED|Overall Study||80
1043568|NCT00754065|2531535|P1|NOT COMPLETED|Overall Study||81
1043569|NCT00754065|2531534|P2|COMPLETED|Overall Study||126
1043570|NCT00754065|2531535|P1|COMPLETED|Overall Study||122
1043571|NCT00754065|2531534|P2|Cycle 6|Overall Study||153
1043572|NCT00754065|2531535|P1|Cycle 6|Overall Study||141
1043573|NCT00754065|2531534|P2|Participants Received Treatment|Overall Study||204
1043574|NCT00754065|2531535|P1|Participants Received Treatment|Overall Study||191
1043575|NCT00754065|2531534|P2|STARTED|Overall Study||206
1043576|NCT00754065|2531535|P1|STARTED|Overall Study||203
1043577|NCT00754130|2531779|P6|NOT COMPLETED|Period 2 (5 Days)||0
1043578|NCT00754130|2531780|P5|NOT COMPLETED|Period 2 (5 Days)||0
1043579|NCT00754130|2531781|P4|NOT COMPLETED|Period 2 (5 Days)||0
1043580|NCT00754130|2531782|P3|NOT COMPLETED|Period 2 (5 Days)||0
1043581|NCT00754130|2531783|P2|NOT COMPLETED|Period 2 (5 Days)||0
1043582|NCT00754130|2531784|P1|NOT COMPLETED|Period 2 (5 Days)||0
1043583|NCT00754130|2531779|P6|COMPLETED|Period 2 (5 Days)||4
1043584|NCT00754130|2531780|P5|COMPLETED|Period 2 (5 Days)||2
1043585|NCT00754130|2531781|P4|COMPLETED|Period 2 (5 Days)||2
1043586|NCT00754130|2531782|P3|COMPLETED|Period 2 (5 Days)||4
1043587|NCT00754130|2531783|P2|COMPLETED|Period 2 (5 Days)||2
1043588|NCT00754130|2531784|P1|COMPLETED|Period 2 (5 Days)||2
1043589|NCT00754130|2531779|P6|STARTED|Period 2 (5 Days)|One participant received MK-0941 35 mg starting with Dose 3 on Day 3.|4
1043590|NCT00754130|2531780|P5|STARTED|Period 2 (5 Days)||2
1043591|NCT00754130|2531781|P4|STARTED|Period 2 (5 Days)||2
1043592|NCT00754130|2531782|P3|STARTED|Period 2 (5 Days)||4
1043593|NCT00754130|2531783|P2|STARTED|Period 2 (5 Days)||2
1043594|NCT00754130|2531784|P1|STARTED|Period 2 (5 Days)|One participant received MK-0941 15 mg starting with Dose 2 on Day 2.|2
1043595|NCT00754130|2531779|P6|NOT COMPLETED|Washout Period (>=8 Days)||0
1043596|NCT00754130|2531780|P5|NOT COMPLETED|Washout Period (>=8 Days)||0
1043597|NCT00754130|2531781|P4|NOT COMPLETED|Washout Period (>=8 Days)||0
1043598|NCT00754130|2531782|P3|NOT COMPLETED|Washout Period (>=8 Days)||0
1043599|NCT00754130|2531783|P2|NOT COMPLETED|Washout Period (>=8 Days)||0
1043600|NCT00754130|2531784|P1|NOT COMPLETED|Washout Period (>=8 Days)||0
1043601|NCT00754130|2531779|P6|COMPLETED|Washout Period (>=8 Days)||4
1043602|NCT00754130|2531780|P5|COMPLETED|Washout Period (>=8 Days)||2
1043603|NCT00754130|2531781|P4|COMPLETED|Washout Period (>=8 Days)||2
1043604|NCT00754130|2531782|P3|COMPLETED|Washout Period (>=8 Days)||4
1043605|NCT00754130|2531783|P2|COMPLETED|Washout Period (>=8 Days)||2
1043606|NCT00754130|2531784|P1|COMPLETED|Washout Period (>=8 Days)||2
1043607|NCT00754130|2531779|P6|STARTED|Washout Period (>=8 Days)||4
1043608|NCT00754130|2531780|P5|STARTED|Washout Period (>=8 Days)||2
1043609|NCT00754130|2531781|P4|STARTED|Washout Period (>=8 Days)||2
1043610|NCT00754130|2531782|P3|STARTED|Washout Period (>=8 Days)||4
1043611|NCT00754130|2531783|P2|STARTED|Washout Period (>=8 Days)||2
1043612|NCT00754130|2531784|P1|STARTED|Washout Period (>=8 Days)||2
1043613|NCT00754130|2531779|P6|NOT COMPLETED|Period 1 (5 Days)||0
1043614|NCT00754130|2531780|P5|NOT COMPLETED|Period 1 (5 Days)||0
1043615|NCT00754130|2531781|P4|NOT COMPLETED|Period 1 (5 Days)||0
1043616|NCT00754130|2531782|P3|NOT COMPLETED|Period 1 (5 Days)||0
1043617|NCT00754130|2531783|P2|NOT COMPLETED|Period 1 (5 Days)||0
1043618|NCT00754130|2531784|P1|NOT COMPLETED|Period 1 (5 Days)||0
1043619|NCT00754130|2531779|P6|COMPLETED|Period 1 (5 Days)||4
1043620|NCT00754130|2531780|P5|COMPLETED|Period 1 (5 Days)||2
1043621|NCT00754130|2531781|P4|COMPLETED|Period 1 (5 Days)||2
1043622|NCT00754130|2531782|P3|COMPLETED|Period 1 (5 Days)||4
1043623|NCT00754130|2531783|P2|COMPLETED|Period 1 (5 Days)||2
1043624|NCT00754130|2531784|P1|COMPLETED|Period 1 (5 Days)||2
1043625|NCT00754130|2531779|P6|STARTED|Period 1 (5 Days)|One participant received MK-0941 10 mg in both Periods 1 and 2.|4
1043626|NCT00754130|2531780|P5|STARTED|Period 1 (5 Days)||2
1043627|NCT00754130|2531781|P4|STARTED|Period 1 (5 Days)||2
1043628|NCT00754130|2531782|P3|STARTED|Period 1 (5 Days)||4
1043629|NCT00754130|2531783|P2|STARTED|Period 1 (5 Days)||2
1043630|NCT00754130|2531784|P1|STARTED|Period 1 (5 Days)||2
1043631|NCT00754156|2531827|P2|NOT COMPLETED|Overall Study||0
1043632|NCT00754156|2531828|P1|NOT COMPLETED|Overall Study||0
1043633|NCT00754156|2531827|P2|COMPLETED|Overall Study||6
1043634|NCT00754156|2531828|P1|COMPLETED|Overall Study||8
1043635|NCT00754156|2531827|P2|STARTED|Overall Study||6
1043636|NCT00754156|2531828|P1|STARTED|Overall Study||8
1043637|NCT00759772|2531848|P2|NOT COMPLETED|Overall Study||0
1043638|NCT00759772|2531849|P1|NOT COMPLETED|Overall Study||0
1043639|NCT00759772|2531848|P2|COMPLETED|Overall Study||11
1043640|NCT00759772|2531849|P1|COMPLETED|Overall Study||12
1043641|NCT00759772|2531848|P2|STARTED|Overall Study||11
1043642|NCT00759772|2531849|P1|STARTED|Overall Study||12
1043643|NCT00759785|2531857|P2|NOT COMPLETED|Overall Study||5
1043644|NCT00759785|2531858|P1|NOT COMPLETED|Overall Study||12
1043645|NCT00759785|2531857|P2|COMPLETED|Overall Study||17
1043646|NCT00759785|2531858|P1|COMPLETED|Overall Study||14
1043647|NCT00759785|2531857|P2|Treated|Overall Study||20
1043648|NCT00759785|2531858|P1|Treated|Overall Study||25
1043649|NCT00759785|2531857|P2|STARTED|Overall Study||22
1043650|NCT00759785|2531858|P1|STARTED|Overall Study||26
1043651|NCT00759811|2531872|P2|NOT COMPLETED|Overall Study||1
1043652|NCT00759811|2531873|P1|NOT COMPLETED|Overall Study||2
1043653|NCT00759811|2531872|P2|COMPLETED|Overall Study||24
1043654|NCT00759811|2531873|P1|COMPLETED|Overall Study||23
1043655|NCT00759811|2531872|P2|STARTED|Overall Study||25
1043656|NCT00759811|2531873|P1|STARTED|Overall Study||25
1043657|NCT00759863|2531881|P2|NOT COMPLETED|Overall Study||18
1043658|NCT00759863|2531882|P1|NOT COMPLETED|Overall Study||20
1043659|NCT00759863|2531881|P2|COMPLETED|Overall Study||80
1043660|NCT00759863|2531882|P1|COMPLETED|Overall Study||124
1043661|NCT00759863|2531881|P2|STARTED|Overall Study||98
1043662|NCT00759863|2531882|P1|STARTED|Overall Study||144
1043663|NCT00759902|2531894|P2|NOT COMPLETED|Overall Study||1
1043664|NCT00759902|2531895|P1|NOT COMPLETED|Overall Study||0
1043665|NCT00759902|2531894|P2|COMPLETED|Overall Study||17
1043666|NCT00759902|2531895|P1|COMPLETED|Overall Study||18
1043667|NCT00759902|2531894|P2|STARTED|Overall Study||18
1043668|NCT00759902|2531895|P1|STARTED|Overall Study||18
1043669|NCT00759915|2531909|P2|NOT COMPLETED|Overall Study||1
1043670|NCT00759915|2531910|P1|NOT COMPLETED|Overall Study||1
1043671|NCT00759915|2531909|P2|COMPLETED|Overall Study||17
1043672|NCT00759915|2531910|P1|COMPLETED|Overall Study||17
1043673|NCT00759915|2531909|P2|STARTED|Overall Study||18
1043674|NCT00759915|2531910|P1|STARTED|Overall Study||18
1043675|NCT00759941|2531924|P2|NOT COMPLETED|Overall Study||1
1043676|NCT00759941|2531925|P1|NOT COMPLETED|Overall Study||3
1043677|NCT00759941|2531924|P2|COMPLETED|Overall Study||43
1043678|NCT00759941|2531925|P1|COMPLETED|Overall Study||39
1043679|NCT00759941|2531924|P2|STARTED|Overall Study||44
1043680|NCT00759941|2531925|P1|STARTED|Overall Study||42
1043681|NCT00759954|2531939|P2|NOT COMPLETED|Overall Study||2
1043682|NCT00759954|2531940|P1|NOT COMPLETED|Overall Study||2
1043683|NCT00759954|2531939|P2|COMPLETED|Overall Study|Two participants (#202 and #228) did not enter Period 2.|16
1043684|NCT00759954|2531940|P1|COMPLETED|Overall Study|One participant(#225) did not enter Period 2 and one participant (#203)dropped out during Period 2|16
1043685|NCT00759954|2531939|P2|STARTED|Overall Study|All assigned participants entered trial|18
1043686|NCT00759954|2531940|P1|STARTED|Overall Study|All assigned participants entered trial|18
1043687|NCT00759967|2531952|P2|NOT COMPLETED|Second Intervention||0
1043688|NCT00759967|2531953|P1|NOT COMPLETED|Second Intervention||2
1043689|NCT00759967|2531952|P2|COMPLETED|Second Intervention||9
1043690|NCT00759967|2531953|P1|COMPLETED|Second Intervention||8
1043691|NCT00759967|2531952|P2|STARTED|Second Intervention||9
1043692|NCT00759967|2531953|P1|STARTED|Second Intervention||10
1043693|NCT00759967|2531952|P2|NOT COMPLETED|First Intervention||0
1043694|NCT00759967|2531953|P1|NOT COMPLETED|First Intervention||0
1043695|NCT00759967|2531952|P2|COMPLETED|First Intervention||9
1043696|NCT00759967|2531953|P1|COMPLETED|First Intervention||10
1043697|NCT00759967|2531952|P2|STARTED|First Intervention||9
1043698|NCT00759967|2531953|P1|STARTED|First Intervention||10
1043699|NCT00760019|2531971|P4|NOT COMPLETED|Overall Study||0
1043700|NCT00760019|2531972|P3|NOT COMPLETED|Overall Study||0
1043701|NCT00760019|2531973|P2|NOT COMPLETED|Overall Study||0
1043702|NCT00760019|2531974|P1|NOT COMPLETED|Overall Study||0
1043703|NCT00760019|2531971|P4|COMPLETED|Overall Study||14
1043704|NCT00760019|2531972|P3|COMPLETED|Overall Study||14
1043705|NCT00760019|2531973|P2|COMPLETED|Overall Study||15
1043706|NCT00760019|2531974|P1|COMPLETED|Overall Study||15
1043707|NCT00760019|2531971|P4|STARTED|Overall Study||14
1043708|NCT00760019|2531972|P3|STARTED|Overall Study||14
1043709|NCT00760019|2531973|P2|STARTED|Overall Study||15
1043710|NCT00760019|2531974|P1|STARTED|Overall Study||15
1043711|NCT00760084|2531980|P1|NOT COMPLETED|Overall Study||10
1043712|NCT00760084|2531980|P1|COMPLETED|Overall Study||0
1043713|NCT00760084|2531980|P1|STARTED|Overall Study||10
1043714|NCT00761007|2531988|P4|NOT COMPLETED|Overall Study||7
1043715|NCT00761007|2531989|P3|NOT COMPLETED|Overall Study||18
1043716|NCT00761007|2531990|P2|NOT COMPLETED|Overall Study||11
1043717|NCT00761007|2531991|P1|NOT COMPLETED|Overall Study||13
1043718|NCT00761007|2531988|P4|COMPLETED|Overall Study||131
1043719|NCT00761007|2531989|P3|COMPLETED|Overall Study||121
1043720|NCT00761007|2531990|P2|COMPLETED|Overall Study||124
1043721|NCT00761007|2531991|P1|COMPLETED|Overall Study||129
1043722|NCT00761007|2531988|P4|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||136
1043723|NCT00761007|2531989|P3|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||135
1043724|NCT00761007|2531990|P2|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||133
1043725|NCT00761007|2531991|P1|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||140
1043726|NCT00761007|2531988|P4|Safety (>=1 Dose of Study Medication)|Overall Study||137
1043727|NCT00761007|2531989|P3|Safety (>=1 Dose of Study Medication)|Overall Study||139
1043728|NCT00761007|2531990|P2|Safety (>=1 Dose of Study Medication)|Overall Study||135
1043729|NCT00761007|2531991|P1|Safety (>=1 Dose of Study Medication)|Overall Study||140
1043730|NCT00761007|2531988|P4|STARTED|Overall Study||138
1043731|NCT00761007|2531989|P3|STARTED|Overall Study||139
1043732|NCT00761007|2531990|P2|STARTED|Overall Study||135
1043733|NCT00761007|2531991|P1|STARTED|Overall Study||142
1043734|NCT00761137|2532013|P1|NOT COMPLETED|Overall Study||0
1043735|NCT00761137|2532013|P1|COMPLETED|Overall Study||19
1043736|NCT00761137|2532013|P1|3 mg Tropicamide|Overall Study||19
1043737|NCT00761137|2532013|P1|1 mg Tropicamide|Overall Study||19
1043738|NCT00761137|2532013|P1|0.3 mg Tropicamide|Overall Study||19
1043739|NCT00761137|2532013|P1|Placebo|Overall Study||19
1043740|NCT00761137|2532013|P1|STARTED|Overall Study||19
1043741|NCT00761150|2532027|P3|NOT COMPLETED|Double-blind Period||29
1043742|NCT00761150|2532028|P2|NOT COMPLETED|Double-blind Period||14
1043743|NCT00761150|2532029|P1|NOT COMPLETED|Double-blind Period||0
1043744|NCT00761150|2532027|P3|COMPLETED|Double-blind Period||89
1043745|NCT00761150|2532028|P2|COMPLETED|Double-blind Period||106
1043746|NCT00761150|2532029|P1|COMPLETED|Double-blind Period||0
1043747|NCT00761150|2532027|P3|STARTED|Double-blind Period||118
1043748|NCT00761150|2532028|P2|STARTED|Double-blind Period||120
1043749|NCT00761150|2532029|P1|STARTED|Double-blind Period||0
1043750|NCT00761150|2532027|P3|NOT COMPLETED|Open-label Period||0
1043751|NCT00761150|2532028|P2|NOT COMPLETED|Open-label Period||0
1043752|NCT00761150|2532029|P1|NOT COMPLETED|Open-label Period||70
1043753|NCT00761150|2532027|P3|COMPLETED|Open-label Period||0
1043754|NCT00761150|2532028|P2|COMPLETED|Open-label Period||0
1043755|NCT00761150|2532029|P1|COMPLETED|Open-label Period||238
1043756|NCT00761150|2532027|P3|STARTED|Open-label Period||0
1043757|NCT00761150|2532028|P2|STARTED|Open-label Period||0
1043758|NCT00761150|2532029|P1|STARTED|Open-label Period||308
1043759|NCT00761176|2532040|P2|NOT COMPLETED|Overall Study||1
1043760|NCT00761176|2532041|P1|NOT COMPLETED|Overall Study||2
1043761|NCT00761176|2532040|P2|COMPLETED|Overall Study||3
1043762|NCT00761176|2532041|P1|COMPLETED|Overall Study||2
1043763|NCT00761176|2532040|P2|STARTED|Overall Study||4
1043764|NCT00761176|2532041|P1|STARTED|Overall Study||4
1043765|NCT00761189|2532047|P1|NOT COMPLETED|Overall Study||185
1043766|NCT00761189|2532047|P1|COMPLETED|Overall Study||306
1043767|NCT00761189|2532047|P1|STARTED|Overall Study||491
1043768|NCT00761202|2532064|P2|NOT COMPLETED|Overall Study||2
1043769|NCT00761202|2532065|P1|NOT COMPLETED|Overall Study||1
1043770|NCT00761202|2532064|P2|COMPLETED|Overall Study||26
1043771|NCT00761202|2532065|P1|COMPLETED|Overall Study||21
1043772|NCT00761202|2532064|P2|STARTED|Overall Study||28
1043773|NCT00761202|2532065|P1|STARTED|Overall Study||22
1043774|NCT00761215|2532084|P3|NOT COMPLETED|Overall Study||8
1043775|NCT00761215|2532085|P2|NOT COMPLETED|Overall Study||4
1043776|NCT00761215|2532086|P1|NOT COMPLETED|Overall Study||9
1043777|NCT00761215|2532084|P3|COMPLETED|Overall Study||56
1043778|NCT00761215|2532085|P2|COMPLETED|Overall Study||60
1043779|NCT00761215|2532086|P1|COMPLETED|Overall Study||55
1043780|NCT00761215|2532084|P3|STARTED|Overall Study||64
1043781|NCT00761215|2532085|P2|STARTED|Overall Study||64
1043782|NCT00761215|2532086|P1|STARTED|Overall Study||64
1043799|NCT00761306|2532140|P1|NOT COMPLETED|Overall Study||20
1043800|NCT00761306|2532140|P1|COMPLETED|Overall Study||54
1043801|NCT00761306|2532140|P1|STARTED|Overall Study||74
1043802|NCT00761319|2532151|P2|NOT COMPLETED|Overall Study||34
1043803|NCT00761319|2532152|P1|NOT COMPLETED|Overall Study||48
1043804|NCT00761319|2532151|P2|COMPLETED|Overall Study||318
1043805|NCT00761319|2532152|P1|COMPLETED|Overall Study||305
1043806|NCT00761319|2532151|P2|STARTED|Overall Study||352
1043807|NCT00761319|2532152|P1|STARTED|Overall Study||353
1043808|NCT00761345|2532160|P1|NOT COMPLETED|Overall Study||3
1043809|NCT00761345|2532160|P1|COMPLETED|Overall Study||24
1043810|NCT00761345|2532160|P1|STARTED|Overall Study||27
1043811|NCT00761462|2532166|P2|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||51
1043812|NCT00761462|2532167|P1|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||154
1043813|NCT00761462|2532166|P2|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 2 year safety Follow-up.|456
1043814|NCT00761462|2532167|P1|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 5 year safety Follow-up.|333
1043815|NCT00761462|2532166|P2|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||507
1043816|NCT00761462|2532167|P1|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||485
1043817|NCT00761462|2532166|P2|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||507
1043818|NCT00761462|2532167|P1|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||487
1043819|NCT00761462|2532166|P2|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|507
1043820|NCT00761462|2532167|P1|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|487
1043821|NCT00761462|2532166|P2|NOT COMPLETED|Treatment||12
1043822|NCT00761462|2532167|P1|NOT COMPLETED|Treatment||23
1043823|NCT00761462|2532166|P2|COMPLETED|Treatment|Patients with confirmed intake of study drug|507
1043824|NCT00761462|2532167|P1|COMPLETED|Treatment|Patients with confirmed intake of study drug|487
1043825|NCT00761462|2532166|P2|STARTED|Treatment|Patients enrolled in study group|519
1043826|NCT00761462|2532167|P1|STARTED|Treatment|Patients enrolled in study group|510
1043827|NCT00761514|2532175|P1|NOT COMPLETED|Overall Study||7
1043828|NCT00761514|2532175|P1|COMPLETED|Overall Study||7
1043829|NCT00761514|2532175|P1|STARTED|Overall Study||14
1043830|NCT00761527|2532180|P1|NOT COMPLETED|Overall Study||22
1043831|NCT00761527|2532180|P1|COMPLETED|Overall Study||2958
1043832|NCT00761527|2532180|P1|Received One Dose of Study Medication|Overall Study||2978
1043833|NCT00761527|2532180|P1|STARTED|Overall Study||2980
1043834|NCT00761579|2532187|P1|NOT COMPLETED|Overall Study||92
1043835|NCT00761579|2532187|P1|COMPLETED|Overall Study||98
1043836|NCT00761579|2532187|P1|STARTED|Overall Study||190
1043837|NCT00761592|2532222|P2|NOT COMPLETED|Overall Study||1
1043838|NCT00761592|2532223|P1|NOT COMPLETED|Overall Study||1
1043839|NCT00761592|2532222|P2|COMPLETED|Overall Study||32
1043840|NCT00761592|2532223|P1|COMPLETED|Overall Study||31
1043841|NCT00761592|2532222|P2|STARTED|Overall Study||33
1043842|NCT00761592|2532223|P1|STARTED|Overall Study||32
1043843|NCT00761605|2532237|P1|NOT COMPLETED|Overall Study||141
1043844|NCT00761605|2532237|P1|COMPLETED|Overall Study||246
1043845|NCT00761605|2532237|P1|STARTED|Overall Study||387
1043846|NCT00761631|2532268|P6|NOT COMPLETED|Overall Study||5
1043847|NCT00761631|2532269|P5|NOT COMPLETED|Overall Study||22
1043848|NCT00761631|2532270|P4|NOT COMPLETED|Overall Study||3
1043849|NCT00761631|2532271|P3|NOT COMPLETED|Overall Study||16
1043850|NCT00761631|2532272|P2|NOT COMPLETED|Overall Study||7
1043851|NCT00761631|2532273|P1|NOT COMPLETED|Overall Study||15
1043852|NCT00761631|2532268|P6|COMPLETED|Overall Study||294
1043853|NCT00761631|2532269|P5|COMPLETED|Overall Study||277
1043854|NCT00761631|2532270|P4|COMPLETED|Overall Study||116
1043855|NCT00761631|2532271|P3|COMPLETED|Overall Study||160
1043856|NCT00761631|2532272|P2|COMPLETED|Overall Study||174
1043857|NCT00761631|2532273|P1|COMPLETED|Overall Study||111
1043858|NCT00761631|2532268|P6|Vaccinated Dose 2|Overall Study||0
1043859|NCT00761631|2532269|P5|Vaccinated Dose 2|Overall Study||0
1043860|NCT00761631|2532270|P4|Vaccinated Dose 2|Overall Study||0
1043861|NCT00761631|2532271|P3|Vaccinated Dose 2|Overall Study||165
1043862|NCT00761631|2532272|P2|Vaccinated Dose 2|Overall Study||0
1043863|NCT00761631|2532273|P1|Vaccinated Dose 2|Overall Study||112
1043864|NCT00761631|2532268|P6|Vaccinated Dose 1|Overall Study||298
1043865|NCT00761631|2532269|P5|Vaccinated Dose 1|Overall Study||294
1043866|NCT00761631|2532270|P4|Vaccinated Dose 1|Overall Study||118
1043867|NCT00761631|2532271|P3|Vaccinated Dose 1|Overall Study||175
1043868|NCT00761631|2532272|P2|Vaccinated Dose 1|Overall Study||179
1043869|NCT00761631|2532273|P1|Vaccinated Dose 1|Overall Study||124
1043870|NCT00761631|2532268|P6|STARTED|Overall Study||299
1043871|NCT00761631|2532269|P5|STARTED|Overall Study||299
1043872|NCT00761631|2532270|P4|STARTED|Overall Study||119
1043873|NCT00761631|2532271|P3|STARTED|Overall Study||176
1043874|NCT00761631|2532272|P2|STARTED|Overall Study||181
1043875|NCT00761631|2532273|P1|STARTED|Overall Study||126
1043876|NCT00761735|2532308|P1|NOT COMPLETED|Overall Study||14
1043877|NCT00761735|2532308|P1|COMPLETED|Overall Study||80
1043878|NCT00761735|2532308|P1|STARTED|Overall Study||94
1043879|NCT00761748|2532320|P2|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
1043880|NCT00761748|2532321|P1|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
1043881|NCT00761748|2532320|P2|COMPLETED|Second Intervention (21 +/- 3 Days)||7
1043882|NCT00761748|2532321|P1|COMPLETED|Second Intervention (21 +/- 3 Days)||17
1043883|NCT00761748|2532320|P2|STARTED|Second Intervention (21 +/- 3 Days)||7
1043884|NCT00761748|2532321|P1|STARTED|Second Intervention (21 +/- 3 Days)||17
1043885|NCT00761748|2532320|P2|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
1043886|NCT00761748|2532321|P1|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
1043887|NCT00761748|2532320|P2|COMPLETED|First Intervention (21 +/- 3 Days)||7
1043888|NCT00761748|2532321|P1|COMPLETED|First Intervention (21 +/- 3 Days)||17
1043889|NCT00761748|2532320|P2|STARTED|First Intervention (21 +/- 3 Days)||10
1043890|NCT00761748|2532321|P1|STARTED|First Intervention (21 +/- 3 Days)||20
1043891|NCT00761761|2532329|P2|NOT COMPLETED|Overall Study||1
1043892|NCT00761761|2532330|P1|NOT COMPLETED|Overall Study||6
1043893|NCT00761761|2532329|P2|COMPLETED|Overall Study||29
1043894|NCT00761761|2532330|P1|COMPLETED|Overall Study||24
1043895|NCT00761761|2532329|P2|STARTED|Overall Study||30
1043896|NCT00761761|2532330|P1|STARTED|Overall Study||30
1043897|NCT00761865|2532344|P2|NOT COMPLETED|Overall Study||7
1043898|NCT00761865|2532345|P1|NOT COMPLETED|Overall Study||8
1043899|NCT00761865|2532344|P2|COMPLETED|Overall Study||11
1043900|NCT00761865|2532345|P1|COMPLETED|Overall Study||8
1043901|NCT00761865|2532344|P2|STARTED|Overall Study||18
1043902|NCT00761865|2532345|P1|STARTED|Overall Study||16
1043903|NCT00761930|2532356|P3|NOT COMPLETED|Overall Study||0
1043904|NCT00761930|2532357|P2|NOT COMPLETED|Overall Study||0
1043905|NCT00761930|2532358|P1|NOT COMPLETED|Overall Study||0
1043906|NCT00761930|2532356|P3|COMPLETED|Overall Study||35
1043907|NCT00761930|2532357|P2|COMPLETED|Overall Study||34
1043908|NCT00761930|2532358|P1|COMPLETED|Overall Study||34
1043909|NCT00761930|2532356|P3|STARTED|Overall Study||35
1043910|NCT00761930|2532357|P2|STARTED|Overall Study||34
1043911|NCT00761930|2532358|P1|STARTED|Overall Study||34
1043912|NCT00761956|2532374|P2|NOT COMPLETED|Overall Study||54
1043913|NCT00761956|2532375|P1|NOT COMPLETED|Overall Study||35
1043914|NCT00761956|2532374|P2|COMPLETED|Overall Study||48
1043915|NCT00761956|2532375|P1|COMPLETED|Overall Study||52
1043916|NCT00761956|2532374|P2|STARTED|Overall Study||102
1043917|NCT00761956|2532375|P1|STARTED|Overall Study||87
1043918|NCT00761969|2532385|P2|NOT COMPLETED|Overall Study||140
1043919|NCT00761969|2532386|P1|NOT COMPLETED|Overall Study||200
1043920|NCT00761969|2532385|P2|COMPLETED|Overall Study||573
1043921|NCT00761969|2532386|P1|COMPLETED|Overall Study||542
1043922|NCT00761969|2532385|P2|STARTED|Overall Study||713
1043923|NCT00761969|2532386|P1|STARTED|Overall Study||742
1043924|NCT00762021|2532396|P2|NOT COMPLETED|Overall Study||8
1043925|NCT00762021|2532397|P1|NOT COMPLETED|Overall Study||8
1043926|NCT00762021|2532396|P2|COMPLETED|Overall Study||44
1043927|NCT00762021|2532397|P1|COMPLETED|Overall Study||44
1043928|NCT00762021|2532396|P2|STARTED|Overall Study||52
1043929|NCT00762021|2532397|P1|STARTED|Overall Study||52
1043930|NCT00762034|2532409|P2|NOT COMPLETED|Maintenance Period||298
1043931|NCT00762034|2532410|P1|NOT COMPLETED|Maintenance Period||294
1043932|NCT00762034|2532409|P2|COMPLETED|Maintenance Period||0
1043933|NCT00762034|2532410|P1|COMPLETED|Maintenance Period||0
1043934|NCT00762034|2532409|P2|Received at Least 1 Dose of Study Drug|Maintenance Period||298
1044024|NCT00762268|2532656|P2|NOT COMPLETED|Overall Study||2
1043935|NCT00762034|2532410|P1|Received at Least 1 Dose of Study Drug|Maintenance Period||294
1043936|NCT00762034|2532409|P2|STARTED|Maintenance Period||298
1043937|NCT00762034|2532410|P1|STARTED|Maintenance Period||294
1043938|NCT00762034|2532409|P2|NOT COMPLETED|Induction Period||169
1043939|NCT00762034|2532410|P1|NOT COMPLETED|Induction Period||178
1043940|NCT00762034|2532409|P2|COMPLETED|Induction Period||298
1043941|NCT00762034|2532410|P1|COMPLETED|Induction Period||294
1043942|NCT00762034|2532409|P2|Received at Least 1 Dose of Study Drug|Induction Period||443
1043943|NCT00762034|2532410|P1|Received at Least 1 Dose of Study Drug|Induction Period||442
1043944|NCT00762034|2532409|P2|STARTED|Induction Period||467
1043945|NCT00762034|2532410|P1|STARTED|Induction Period||472
1043946|NCT00762073|2532471|P4|NOT COMPLETED|Overall Study||3
1043947|NCT00762073|2532472|P3|NOT COMPLETED|Overall Study||2
1043948|NCT00762073|2532473|P2|NOT COMPLETED|Overall Study||4
1043949|NCT00762073|2532474|P1|NOT COMPLETED|Overall Study||4
1043950|NCT00762073|2532471|P4|COMPLETED|Overall Study||17
1043951|NCT00762073|2532472|P3|COMPLETED|Overall Study|One participant was enrolled and randomized then withdrew consent and did not receive study drug.|18
1043952|NCT00762073|2532473|P2|COMPLETED|Overall Study||17
1043953|NCT00762073|2532474|P1|COMPLETED|Overall Study||17
1043954|NCT00762073|2532471|P4|STARTED|Overall Study||20
1043955|NCT00762073|2532472|P3|STARTED|Overall Study||20
1043956|NCT00762073|2532473|P2|STARTED|Overall Study||21
1043957|NCT00762073|2532474|P1|STARTED|Overall Study||21
1043958|NCT00762086|2532538|P2|NOT COMPLETED|Overall Study||4
1043959|NCT00762086|2532539|P1|NOT COMPLETED|Overall Study||6
1043960|NCT00762086|2532538|P2|COMPLETED|Overall Study||24
1043961|NCT00762086|2532539|P1|COMPLETED|Overall Study||33
1043962|NCT00762086|2532538|P2|STARTED|Overall Study||28
1043963|NCT00762086|2532539|P1|STARTED|Overall Study||39
1043964|NCT00762164|2532547|P2|NOT COMPLETED|Overall Study||2
1043965|NCT00762164|2532548|P1|NOT COMPLETED|Overall Study||3
1043966|NCT00762164|2532547|P2|COMPLETED|Overall Study||15
1043967|NCT00762164|2532548|P1|COMPLETED|Overall Study||14
1043968|NCT00762164|2532547|P2|STARTED|Overall Study||17
1043969|NCT00762164|2532548|P1|STARTED|Overall Study||17
1043970|NCT00762177|2532559|P3|NOT COMPLETED|3rd Treatment Period||0
1043971|NCT00762177|2532560|P2|NOT COMPLETED|3rd Treatment Period||0
1043972|NCT00762177|2532561|P1|NOT COMPLETED|3rd Treatment Period||0
1043973|NCT00762177|2532559|P3|COMPLETED|3rd Treatment Period||8
1043974|NCT00762177|2532560|P2|COMPLETED|3rd Treatment Period||8
1043975|NCT00762177|2532561|P1|COMPLETED|3rd Treatment Period||8
1043976|NCT00762177|2532559|P3|STARTED|3rd Treatment Period||8
1043977|NCT00762177|2532560|P2|STARTED|3rd Treatment Period||8
1043978|NCT00762177|2532561|P1|STARTED|3rd Treatment Period||8
1043979|NCT00762177|2532559|P3|NOT COMPLETED|Washout After 2nd Treatment||0
1043980|NCT00762177|2532560|P2|NOT COMPLETED|Washout After 2nd Treatment||0
1043981|NCT00762177|2532561|P1|NOT COMPLETED|Washout After 2nd Treatment||0
1043982|NCT00762177|2532559|P3|COMPLETED|Washout After 2nd Treatment||8
1043983|NCT00762177|2532560|P2|COMPLETED|Washout After 2nd Treatment||8
1043984|NCT00762177|2532561|P1|COMPLETED|Washout After 2nd Treatment||8
1043985|NCT00762177|2532559|P3|STARTED|Washout After 2nd Treatment||8
1043986|NCT00762177|2532560|P2|STARTED|Washout After 2nd Treatment||8
1043987|NCT00762177|2532561|P1|STARTED|Washout After 2nd Treatment||8
1043988|NCT00762177|2532559|P3|NOT COMPLETED|2nd Treatment Period||0
1043989|NCT00762177|2532560|P2|NOT COMPLETED|2nd Treatment Period||0
1043990|NCT00762177|2532561|P1|NOT COMPLETED|2nd Treatment Period||0
1043991|NCT00762177|2532559|P3|COMPLETED|2nd Treatment Period||8
1043992|NCT00762177|2532560|P2|COMPLETED|2nd Treatment Period||8
1043993|NCT00762177|2532561|P1|COMPLETED|2nd Treatment Period||8
1043994|NCT00762177|2532559|P3|STARTED|2nd Treatment Period||8
1043995|NCT00762177|2532560|P2|STARTED|2nd Treatment Period||8
1043996|NCT00762177|2532561|P1|STARTED|2nd Treatment Period||8
1043997|NCT00762177|2532559|P3|NOT COMPLETED|Washout After 1st Treatment||0
1043998|NCT00762177|2532560|P2|NOT COMPLETED|Washout After 1st Treatment||0
1043999|NCT00762177|2532561|P1|NOT COMPLETED|Washout After 1st Treatment||0
1044000|NCT00762177|2532559|P3|COMPLETED|Washout After 1st Treatment||8
1044001|NCT00762177|2532560|P2|COMPLETED|Washout After 1st Treatment||8
1044002|NCT00762177|2532561|P1|COMPLETED|Washout After 1st Treatment||8
1044003|NCT00762177|2532559|P3|STARTED|Washout After 1st Treatment||8
1044004|NCT00762177|2532560|P2|STARTED|Washout After 1st Treatment||8
1044005|NCT00762177|2532561|P1|STARTED|Washout After 1st Treatment||8
1044006|NCT00762177|2532559|P3|NOT COMPLETED|1st Treatment Period||0
1044007|NCT00762177|2532560|P2|NOT COMPLETED|1st Treatment Period||0
1044008|NCT00762177|2532561|P1|NOT COMPLETED|1st Treatment Period||0
1044009|NCT00762177|2532559|P3|COMPLETED|1st Treatment Period||8
1044010|NCT00762177|2532560|P2|COMPLETED|1st Treatment Period||8
1044011|NCT00762177|2532561|P1|COMPLETED|1st Treatment Period||8
1044012|NCT00762177|2532559|P3|STARTED|1st Treatment Period||8
1044013|NCT00762177|2532560|P2|STARTED|1st Treatment Period||8
1044014|NCT00762177|2532561|P1|STARTED|1st Treatment Period||8
1044015|NCT00762216|2532638|P1|NOT COMPLETED|Overall Study||0
1044016|NCT00762216|2532638|P1|COMPLETED|Overall Study||71
1044017|NCT00762216|2532638|P1|STARTED|Overall Study||71
1044018|NCT00762229|2532645|P2|NOT COMPLETED|Overall Study||2
1044019|NCT00762229|2532646|P1|NOT COMPLETED|Overall Study||1
1044020|NCT00762229|2532645|P2|COMPLETED|Overall Study||22
1044021|NCT00762229|2532646|P1|COMPLETED|Overall Study||14
1044022|NCT00762229|2532645|P2|STARTED|Overall Study||24
1044023|NCT00762229|2532646|P1|STARTED|Overall Study||15
1044025|NCT00762268|2532657|P1|NOT COMPLETED|Overall Study||1
1044026|NCT00762268|2532656|P2|COMPLETED|Overall Study||8
1044027|NCT00762268|2532657|P1|COMPLETED|Overall Study||9
1044028|NCT00762268|2532656|P2|STARTED|Overall Study||10
1044029|NCT00762268|2532657|P1|STARTED|Overall Study||10
1044030|NCT00762320|2532663|P1|NOT COMPLETED|Overall Study||0
1044031|NCT00762320|2532663|P1|COMPLETED|Overall Study||8
1044032|NCT00762320|2532663|P1|STARTED|Overall Study||8
1044033|NCT00762359|2532680|P2|NOT COMPLETED|Overall Study||57
1044034|NCT00762359|2532681|P1|NOT COMPLETED|Overall Study||59
1044035|NCT00762359|2532680|P2|COMPLETED|Overall Study||178
1044036|NCT00762359|2532681|P1|COMPLETED|Overall Study||167
1044037|NCT00762359|2532680|P2|STARTED|Overall Study||235
1044038|NCT00762359|2532681|P1|STARTED|Overall Study||226
1044039|NCT00762385|2532781|P2|NOT COMPLETED|Second Intervention||3
1044040|NCT00762385|2532782|P1|NOT COMPLETED|Second Intervention||3
1044041|NCT00762385|2532781|P2|COMPLETED|Second Intervention||39
1044042|NCT00762385|2532782|P1|COMPLETED|Second Intervention||46
1044043|NCT00762385|2532781|P2|STARTED|Second Intervention||42
1044044|NCT00762385|2532782|P1|STARTED|Second Intervention||49
1044045|NCT00762385|2532781|P2|NOT COMPLETED|First Intervention||4
1044046|NCT00762385|2532782|P1|NOT COMPLETED|First Intervention||2
1044047|NCT00762385|2532781|P2|COMPLETED|First Intervention||42
1044048|NCT00762385|2532782|P1|COMPLETED|First Intervention||49
1044049|NCT00762385|2532781|P2|STARTED|First Intervention||46
1044050|NCT00762385|2532782|P1|STARTED|First Intervention||51
1044051|NCT00762411|2532794|P2|NOT COMPLETED|Safety Follow Up (SFU)-Optional||118
1044052|NCT00762411|2532795|P1|NOT COMPLETED|Safety Follow Up (SFU)-Optional||84
1044053|NCT00762411|2532794|P2|COMPLETED|Safety Follow Up (SFU)-Optional||312
1044054|NCT00762411|2532795|P1|COMPLETED|Safety Follow Up (SFU)-Optional||228
1044055|NCT00762411|2532794|P2|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|430
1044056|NCT00762411|2532795|P1|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|312
1044057|NCT00762411|2532794|P2|NOT COMPLETED|Delayed Start||26
1044058|NCT00762411|2532795|P1|NOT COMPLETED|Delayed Start||17
1044059|NCT00762411|2532794|P2|COMPLETED|Delayed Start||8
1044060|NCT00762411|2532795|P1|COMPLETED|Delayed Start||5
1044061|NCT00762411|2532794|P2|STARTED|Delayed Start||34
1044062|NCT00762411|2532795|P1|STARTED|Delayed Start||22
1044063|NCT00762411|2532794|P2|NOT COMPLETED|Initial Treatment||521
1044064|NCT00762411|2532795|P1|NOT COMPLETED|Initial Treatment||534
1044065|NCT00762411|2532794|P2|COMPLETED|Initial Treatment||34
1044066|NCT00762411|2532795|P1|COMPLETED|Initial Treatment||22
1044067|NCT00762411|2532794|P2|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who received at least 1 dose of study drug.|553
1044068|NCT00762411|2532795|P1|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants(pts) who received at least 1 dose of study drug.|555
1044069|NCT00762411|2532794|P2|STARTED|Initial Treatment||555
1044070|NCT00762411|2532795|P1|STARTED|Initial Treatment||556
1044071|NCT00762424|2532861|P2|NOT COMPLETED|Overall Study||0
1044072|NCT00762424|2532862|P1|NOT COMPLETED|Overall Study||0
1044073|NCT00762424|2532861|P2|COMPLETED|Overall Study||25
1044074|NCT00762424|2532862|P1|COMPLETED|Overall Study||28
1044075|NCT00762424|2532861|P2|STARTED|Overall Study||25
1044076|NCT00762424|2532862|P1|STARTED|Overall Study||28
1044077|NCT00762450|2532871|P3|NOT COMPLETED|3rd Treatment Period||0
1044078|NCT00762450|2532872|P2|NOT COMPLETED|3rd Treatment Period||0
1044079|NCT00762450|2532873|P1|NOT COMPLETED|3rd Treatment Period||0
1044080|NCT00762450|2532871|P3|COMPLETED|3rd Treatment Period||2
1044081|NCT00762450|2532872|P2|COMPLETED|3rd Treatment Period||2
1044082|NCT00762450|2532873|P1|COMPLETED|3rd Treatment Period||2
1044083|NCT00762450|2532871|P3|STARTED|3rd Treatment Period||2
1044084|NCT00762450|2532872|P2|STARTED|3rd Treatment Period||2
1044085|NCT00762450|2532873|P1|STARTED|3rd Treatment Period||2
1044086|NCT00762450|2532871|P3|NOT COMPLETED|Washout After 2nd Treatment Period||0
1044087|NCT00762450|2532872|P2|NOT COMPLETED|Washout After 2nd Treatment Period||0
1044088|NCT00762450|2532873|P1|NOT COMPLETED|Washout After 2nd Treatment Period||0
1044089|NCT00762450|2532871|P3|COMPLETED|Washout After 2nd Treatment Period||2
1044090|NCT00762450|2532872|P2|COMPLETED|Washout After 2nd Treatment Period||2
1044091|NCT00762450|2532873|P1|COMPLETED|Washout After 2nd Treatment Period||2
1044092|NCT00762450|2532871|P3|STARTED|Washout After 2nd Treatment Period||2
1044093|NCT00762450|2532872|P2|STARTED|Washout After 2nd Treatment Period||2
1044094|NCT00762450|2532873|P1|STARTED|Washout After 2nd Treatment Period||2
1044095|NCT00762450|2532871|P3|NOT COMPLETED|2nd Treatment Period||0
1044096|NCT00762450|2532872|P2|NOT COMPLETED|2nd Treatment Period||0
1044097|NCT00762450|2532873|P1|NOT COMPLETED|2nd Treatment Period||0
1044098|NCT00762450|2532871|P3|COMPLETED|2nd Treatment Period||2
1044099|NCT00762450|2532872|P2|COMPLETED|2nd Treatment Period||2
1044100|NCT00762450|2532873|P1|COMPLETED|2nd Treatment Period||2
1044101|NCT00762450|2532871|P3|STARTED|2nd Treatment Period||2
1044102|NCT00762450|2532872|P2|STARTED|2nd Treatment Period||2
1044103|NCT00762450|2532873|P1|STARTED|2nd Treatment Period||2
1044104|NCT00762450|2532871|P3|NOT COMPLETED|Washout After 1st Treatment Period||0
1044105|NCT00762450|2532872|P2|NOT COMPLETED|Washout After 1st Treatment Period||0
1044106|NCT00762450|2532873|P1|NOT COMPLETED|Washout After 1st Treatment Period||0
1044107|NCT00762450|2532871|P3|COMPLETED|Washout After 1st Treatment Period||2
1044108|NCT00762450|2532872|P2|COMPLETED|Washout After 1st Treatment Period||2
1044109|NCT00762450|2532873|P1|COMPLETED|Washout After 1st Treatment Period||2
1044110|NCT00762450|2532871|P3|STARTED|Washout After 1st Treatment Period||2
1044111|NCT00762450|2532872|P2|STARTED|Washout After 1st Treatment Period||2
1044112|NCT00762450|2532873|P1|STARTED|Washout After 1st Treatment Period||2
1044113|NCT00762450|2532871|P3|NOT COMPLETED|1st Treatment Period||0
1044114|NCT00762450|2532872|P2|NOT COMPLETED|1st Treatment Period||0
1044115|NCT00762450|2532873|P1|NOT COMPLETED|1st Treatment Period||0
1044116|NCT00762450|2532871|P3|COMPLETED|1st Treatment Period||2
1044117|NCT00762450|2532872|P2|COMPLETED|1st Treatment Period||2
1044118|NCT00762450|2532873|P1|COMPLETED|1st Treatment Period||2
1044119|NCT00762450|2532871|P3|STARTED|1st Treatment Period||2
1044120|NCT00762450|2532872|P2|STARTED|1st Treatment Period||2
1044121|NCT00762450|2532873|P1|STARTED|1st Treatment Period||2
1044122|NCT00762463|2532883|P4|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||2
1044123|NCT00762463|2532884|P3|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||4
1044124|NCT00762463|2532885|P2|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||1
1044125|NCT00762463|2532886|P1|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||3
1044126|NCT00762463|2532883|P4|COMPLETED|Extension Phase (Week 6 to Week 12)||52
1044127|NCT00762463|2532884|P3|COMPLETED|Extension Phase (Week 6 to Week 12)||50
1044128|NCT00762463|2532885|P2|COMPLETED|Extension Phase (Week 6 to Week 12)||54
1044129|NCT00762463|2532886|P1|COMPLETED|Extension Phase (Week 6 to Week 12)||52
1044130|NCT00762463|2532883|P4|STARTED|Extension Phase (Week 6 to Week 12)||54
1044131|NCT00762463|2532884|P3|STARTED|Extension Phase (Week 6 to Week 12)||54
1044132|NCT00762463|2532885|P2|STARTED|Extension Phase (Week 6 to Week 12)||55
1044133|NCT00762463|2532886|P1|STARTED|Extension Phase (Week 6 to Week 12)||55
1044134|NCT00762463|2532883|P4|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
1044135|NCT00762463|2532884|P3|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
1044136|NCT00762463|2532885|P2|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||1
1044137|NCT00762463|2532886|P1|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||4
1044138|NCT00762463|2532883|P4|COMPLETED|Enrollment in Extension Phase (Week 6)||0
1044139|NCT00762463|2532884|P3|COMPLETED|Enrollment in Extension Phase (Week 6)||0
1044140|NCT00762463|2532885|P2|COMPLETED|Enrollment in Extension Phase (Week 6)||109
1044141|NCT00762463|2532886|P1|COMPLETED|Enrollment in Extension Phase (Week 6)||109
1044142|NCT00762463|2532883|P4|STARTED|Enrollment in Extension Phase (Week 6)||0
1044143|NCT00762463|2532884|P3|STARTED|Enrollment in Extension Phase (Week 6)||0
1044144|NCT00762463|2532885|P2|STARTED|Enrollment in Extension Phase (Week 6)||110
1044145|NCT00762463|2532886|P1|STARTED|Enrollment in Extension Phase (Week 6)||113
1044146|NCT00762463|2532883|P4|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
1044147|NCT00762463|2532884|P3|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
1044148|NCT00762463|2532885|P2|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||10
1044149|NCT00762463|2532886|P1|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||7
1044150|NCT00762463|2532883|P4|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
1044151|NCT00762463|2532884|P3|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
1044152|NCT00762463|2532885|P2|COMPLETED|Double-blind Phase (Baseline to Week 6)||110
1044153|NCT00762463|2532886|P1|COMPLETED|Double-blind Phase (Baseline to Week 6)||113
1044154|NCT00762463|2532883|P4|STARTED|Double-blind Phase (Baseline to Week 6)||0
1044155|NCT00762463|2532884|P3|STARTED|Double-blind Phase (Baseline to Week 6)||0
1044156|NCT00762463|2532885|P2|STARTED|Double-blind Phase (Baseline to Week 6)||120
1044157|NCT00762463|2532886|P1|STARTED|Double-blind Phase (Baseline to Week 6)||120
1044158|NCT00762476|2532970|P2|NOT COMPLETED|Overall Study||36
1044159|NCT00762476|2532971|P1|NOT COMPLETED|Overall Study||23
1044160|NCT00762476|2532970|P2|COMPLETED|Overall Study||169
1044161|NCT00762476|2532971|P1|COMPLETED|Overall Study||183
1044162|NCT00762476|2532970|P2|STARTED|Overall Study||205
1044163|NCT00762476|2532971|P1|STARTED|Overall Study||206
1044164|NCT00762502|2532984|P3|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
1044165|NCT00762502|2532985|P2|NOT COMPLETED|Month 3 to Month 6 (Period 2)||1
1044166|NCT00762502|2532986|P1|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
1044167|NCT00762502|2532984|P3|COMPLETED|Month 3 to Month 6 (Period 2)||23
1044168|NCT00762502|2532985|P2|COMPLETED|Month 3 to Month 6 (Period 2)||4
1044169|NCT00762502|2532986|P1|COMPLETED|Month 3 to Month 6 (Period 2)||9
1044170|NCT00762502|2532984|P3|STARTED|Month 3 to Month 6 (Period 2)||23
1044171|NCT00762502|2532985|P2|STARTED|Month 3 to Month 6 (Period 2)||5
1044172|NCT00762502|2532986|P1|STARTED|Month 3 to Month 6 (Period 2)||9
1044173|NCT00762502|2532984|P3|NOT COMPLETED|Baseline to Month 3 (Period 1)||19
1044174|NCT00762502|2532985|P2|NOT COMPLETED|Baseline to Month 3 (Period 1)||6
1044175|NCT00762502|2532986|P1|NOT COMPLETED|Baseline to Month 3 (Period 1)||10
1044176|NCT00762502|2532984|P3|COMPLETED|Baseline to Month 3 (Period 1)||32
1044177|NCT00762502|2532985|P2|COMPLETED|Baseline to Month 3 (Period 1)||19
1044178|NCT00762502|2532986|P1|COMPLETED|Baseline to Month 3 (Period 1)||26
1044179|NCT00762502|2532984|P3|STARTED|Baseline to Month 3 (Period 1)||51
1044180|NCT00762502|2532985|P2|STARTED|Baseline to Month 3 (Period 1)||25
1044181|NCT00762502|2532986|P1|STARTED|Baseline to Month 3 (Period 1)||36
1044182|NCT00762515|2533000|P2|NOT COMPLETED|Overall Study||0
1044183|NCT00762515|2533001|P1|NOT COMPLETED|Overall Study||0
1044184|NCT00762515|2533000|P2|COMPLETED|Overall Study||22
1044185|NCT00762515|2533001|P1|COMPLETED|Overall Study||22
1044186|NCT00762515|2533000|P2|STARTED|Overall Study||22
1044187|NCT00762515|2533001|P1|STARTED|Overall Study||22
1044188|NCT00762528|2533011|P2|NOT COMPLETED|Overall Study||0
1044189|NCT00762528|2533012|P1|NOT COMPLETED|Overall Study||0
1044190|NCT00762528|2533011|P2|COMPLETED|Overall Study||25
1044191|NCT00762528|2533012|P1|COMPLETED|Overall Study||24
1044192|NCT00762528|2533011|P2|STARTED|Overall Study||25
1044193|NCT00762528|2533012|P1|STARTED|Overall Study||24
1044194|NCT00762606|2533034|P2|NOT COMPLETED|Overall Study||13
1044195|NCT00762606|2533035|P1|NOT COMPLETED|Overall Study||18
1044196|NCT00762606|2533034|P2|COMPLETED|Overall Study||38
1044197|NCT00762606|2533035|P1|COMPLETED|Overall Study||37
1044198|NCT00762606|2533034|P2|STARTED|Overall Study||51
1044199|NCT00762606|2533035|P1|STARTED|Overall Study||55
1044200|NCT00762619|2533045|P2|NOT COMPLETED|Overall Study||0
1044201|NCT00762619|2533046|P1|NOT COMPLETED|Overall Study||0
1044202|NCT00762619|2533045|P2|COMPLETED|Overall Study||50
1044203|NCT00762619|2533046|P1|COMPLETED|Overall Study||55
1044204|NCT00762619|2533045|P2|STARTED|Overall Study||50
1044205|NCT00762619|2533046|P1|STARTED|Overall Study||55
1044206|NCT00762645|2533188|P2|NOT COMPLETED|Overall Study||2
1044207|NCT00762645|2533189|P1|NOT COMPLETED|Overall Study||4
1044208|NCT00762645|2533188|P2|COMPLETED|Overall Study||12
1044209|NCT00762645|2533189|P1|COMPLETED|Overall Study||12
1044210|NCT00762645|2533188|P2|STARTED|Overall Study||14
1044211|NCT00762645|2533189|P1|STARTED|Overall Study||16
1044212|NCT00762723|2533200|P3|NOT COMPLETED|Overall Study||3
1044213|NCT00762723|2533201|P2|NOT COMPLETED|Overall Study||5
1044214|NCT00762723|2533202|P1|NOT COMPLETED|Overall Study||5
1044215|NCT00762723|2533200|P3|COMPLETED|Overall Study||0
1044216|NCT00762723|2533201|P2|COMPLETED|Overall Study||6
1044217|NCT00762723|2533202|P1|COMPLETED|Overall Study||0
1044218|NCT00762723|2533200|P3|STARTED|Overall Study||3
1044219|NCT00762723|2533201|P2|STARTED|Overall Study||11
1044220|NCT00762723|2533202|P1|STARTED|Overall Study||5
1044221|NCT00762762|2533212|P2|NOT COMPLETED|Overall Study||10
1044222|NCT00762762|2533213|P1|NOT COMPLETED|Overall Study||8
1044223|NCT00762762|2533212|P2|COMPLETED|Overall Study||20
1044224|NCT00762762|2533213|P1|COMPLETED|Overall Study||22
1044225|NCT00762762|2533212|P2|STARTED|Overall Study||30
1044226|NCT00762762|2533213|P1|STARTED|Overall Study||30
1044227|NCT00762788|2533233|P6|NOT COMPLETED|Overall Study||21
1044228|NCT00762788|2533234|P5|NOT COMPLETED|Overall Study||13
1044229|NCT00762788|2533235|P4|NOT COMPLETED|Overall Study||26
1044230|NCT00762788|2533236|P3|NOT COMPLETED|Overall Study||21
1044231|NCT00762788|2533237|P2|NOT COMPLETED|Overall Study||37
1044232|NCT00762788|2533238|P1|NOT COMPLETED|Overall Study||26
1044233|NCT00762788|2533233|P6|COMPLETED|Overall Study||31
1044234|NCT00762788|2533234|P5|COMPLETED|Overall Study||30
1044235|NCT00762788|2533235|P4|COMPLETED|Overall Study||38
1044236|NCT00762788|2533236|P3|COMPLETED|Overall Study||21
1044237|NCT00762788|2533237|P2|COMPLETED|Overall Study||21
1044238|NCT00762788|2533238|P1|COMPLETED|Overall Study||29
1044239|NCT00762788|2533233|P6|STARTED|Overall Study||52
1044240|NCT00762788|2533234|P5|STARTED|Overall Study||43
1044241|NCT00762788|2533235|P4|STARTED|Overall Study||64
1044242|NCT00762788|2533236|P3|STARTED|Overall Study||42
1044243|NCT00762788|2533237|P2|STARTED|Overall Study||58
1044244|NCT00762788|2533238|P1|STARTED|Overall Study||55
1044245|NCT00762853|2533260|P2|NOT COMPLETED|Second Treatment Period||0
1044246|NCT00762853|2533261|P1|NOT COMPLETED|Second Treatment Period||0
1044247|NCT00762853|2533260|P2|COMPLETED|Second Treatment Period||10
1044248|NCT00762853|2533261|P1|COMPLETED|Second Treatment Period||10
1044249|NCT00762853|2533260|P2|STARTED|Second Treatment Period||10
1044250|NCT00762853|2533261|P1|STARTED|Second Treatment Period||10
1044251|NCT00762853|2533260|P2|NOT COMPLETED|1 Week Washout After Treatment 1||0
1044252|NCT00762853|2533261|P1|NOT COMPLETED|1 Week Washout After Treatment 1||0
1044253|NCT00762853|2533260|P2|COMPLETED|1 Week Washout After Treatment 1||10
1044254|NCT00762853|2533261|P1|COMPLETED|1 Week Washout After Treatment 1||10
1044255|NCT00762853|2533260|P2|STARTED|1 Week Washout After Treatment 1||10
1044256|NCT00762853|2533261|P1|STARTED|1 Week Washout After Treatment 1||10
1044257|NCT00762853|2533260|P2|NOT COMPLETED|First Treatment Period||0
1044258|NCT00762853|2533261|P1|NOT COMPLETED|First Treatment Period||0
1044259|NCT00762853|2533260|P2|COMPLETED|First Treatment Period||10
1044260|NCT00762853|2533261|P1|COMPLETED|First Treatment Period||10
1044261|NCT00762853|2533260|P2|STARTED|First Treatment Period||10
1044262|NCT00762853|2533261|P1|STARTED|First Treatment Period||10
1044263|NCT00762892|2533269|P2|NOT COMPLETED|Overall Study||6
1044264|NCT00762892|2533270|P1|NOT COMPLETED|Overall Study||5
1044265|NCT00762892|2533269|P2|COMPLETED|Overall Study||8
1044266|NCT00762892|2533270|P1|COMPLETED|Overall Study||9
1044267|NCT00762892|2533269|P2|STARTED|Overall Study||14
1044268|NCT00762892|2533270|P1|STARTED|Overall Study||14
1044269|NCT00762970|2533287|P3|NOT COMPLETED|Overall Study||1
1044270|NCT00762970|2533288|P2|NOT COMPLETED|Overall Study||9
1044271|NCT00762970|2533289|P1|NOT COMPLETED|Overall Study||12
1044272|NCT00762970|2533287|P3|COMPLETED|Overall Study||46
1044273|NCT00762970|2533288|P2|COMPLETED|Overall Study||35
1044274|NCT00762970|2533289|P1|COMPLETED|Overall Study||34
1044275|NCT00762970|2533287|P3|STARTED|Overall Study||47
1044276|NCT00762970|2533288|P2|STARTED|Overall Study||44
1044277|NCT00762970|2533289|P1|STARTED|Overall Study||46
1044278|NCT00762996|2533300|P4|NOT COMPLETED|Period Two||0
1044279|NCT00762996|2533301|P3|NOT COMPLETED|Period Two||0
1044280|NCT00762996|2533302|P2|NOT COMPLETED|Period Two||0
1044281|NCT00762996|2533303|P1|NOT COMPLETED|Period Two||0
1044282|NCT00762996|2533300|P4|COMPLETED|Period Two||16
1044283|NCT00762996|2533301|P3|COMPLETED|Period Two||13
1044284|NCT00762996|2533302|P2|COMPLETED|Period Two||16
1044285|NCT00762996|2533303|P1|COMPLETED|Period Two||15
1044286|NCT00762996|2533300|P4|STARTED|Period Two||16
1044287|NCT00762996|2533301|P3|STARTED|Period Two||13
1044288|NCT00762996|2533302|P2|STARTED|Period Two||16
1044289|NCT00762996|2533303|P1|STARTED|Period Two||15
1044290|NCT00762996|2533300|P4|NOT COMPLETED|Period One||1
1044291|NCT00762996|2533301|P3|NOT COMPLETED|Period One||4
1044292|NCT00762996|2533302|P2|NOT COMPLETED|Period One||0
1044293|NCT00762996|2533303|P1|NOT COMPLETED|Period One||0
1044294|NCT00762996|2533300|P4|COMPLETED|Period One||16
1044295|NCT00762996|2533301|P3|COMPLETED|Period One||13
1044296|NCT00762996|2533302|P2|COMPLETED|Period One||16
1044297|NCT00762996|2533303|P1|COMPLETED|Period One||15
1044298|NCT00762996|2533300|P4|STARTED|Period One||17
1044299|NCT00762996|2533301|P3|STARTED|Period One||17
1044300|NCT00762996|2533302|P2|STARTED|Period One||16
1044301|NCT00762996|2533303|P1|STARTED|Period One||15
1044302|NCT00763009|2533313|P1|NOT COMPLETED|Overall Study||1
1044303|NCT00763009|2533313|P1|COMPLETED|Overall Study||7
1044304|NCT00763009|2533313|P1|STARTED|Overall Study||8
1044305|NCT00763048|2533319|P2|NOT COMPLETED|Overall Study||0
1044306|NCT00763048|2533320|P1|NOT COMPLETED|Overall Study||0
1044307|NCT00763048|2533319|P2|COMPLETED|Overall Study||18
1044308|NCT00763048|2533320|P1|COMPLETED|Overall Study||21
1044309|NCT00763048|2533319|P2|STARTED|Overall Study||18
1044310|NCT00763048|2533320|P1|STARTED|Overall Study||21
1044311|NCT00763061|2533346|P2|NOT COMPLETED|Overall Study||13
1044312|NCT00763061|2533347|P1|NOT COMPLETED|Overall Study||5
1044313|NCT00763061|2533346|P2|COMPLETED|Overall Study||44
1044314|NCT00763061|2533347|P1|COMPLETED|Overall Study||49
1044315|NCT00763061|2533346|P2|STARTED|Overall Study||57
1044316|NCT00763061|2533347|P1|STARTED|Overall Study||54
1044317|NCT00763139|2533359|P2|NOT COMPLETED|Overall Study||3
1044318|NCT00763139|2533360|P1|NOT COMPLETED|Overall Study||5
1044319|NCT00763139|2533359|P2|COMPLETED|Overall Study||14
1044320|NCT00763139|2533360|P1|COMPLETED|Overall Study||12
1044321|NCT00763139|2533359|P2|STARTED|Overall Study||17
1044322|NCT00763139|2533360|P1|STARTED|Overall Study||17
1044323|NCT00763243|2533380|P1|NOT COMPLETED|6-Month Follow-Up Period||0
1044324|NCT00763243|2533380|P1|COMPLETED|6-Month Follow-Up Period||9
1044325|NCT00763243|2533380|P1|STARTED|6-Month Follow-Up Period||9
1044326|NCT00763243|2533380|P1|NOT COMPLETED|1-Month Follow-Up Period||0
1044327|NCT00763243|2533380|P1|COMPLETED|1-Month Follow-Up Period||9
1044328|NCT00763243|2533380|P1|STARTED|1-Month Follow-Up Period||9
1044329|NCT00763243|2533380|P1|NOT COMPLETED|Training Period||0
1044330|NCT00763243|2533380|P1|COMPLETED|Training Period||9
1044331|NCT00763243|2533380|P1|STARTED|Training Period||9
1044332|NCT00763243|2533380|P1|NOT COMPLETED|Waiting Period||0
1044333|NCT00763243|2533380|P1|COMPLETED|Waiting Period||9
1044334|NCT00763243|2533380|P1|STARTED|Waiting Period||9
1044335|NCT00763256|2533404|P2|NOT COMPLETED|Overall Study||10
1044336|NCT00763256|2533405|P1|NOT COMPLETED|Overall Study||7
1044337|NCT00763256|2533404|P2|COMPLETED|Overall Study||8
1044338|NCT00763256|2533405|P1|COMPLETED|Overall Study||8
1044339|NCT00763256|2533404|P2|STARTED|Overall Study||18
1044340|NCT00763256|2533405|P1|STARTED|Overall Study||15
1044341|NCT00763269|2533421|P2|NOT COMPLETED|Overall Study||13
1044342|NCT00763269|2533422|P1|NOT COMPLETED|Overall Study||12
1044343|NCT00763269|2533421|P2|COMPLETED|Overall Study||299
1044344|NCT00763269|2533422|P1|COMPLETED|Overall Study||302
1044345|NCT00763269|2533421|P2|STARTED|Overall Study||312
1044346|NCT00763269|2533422|P1|STARTED|Overall Study||314
1044347|NCT00763282|2533436|P2|NOT COMPLETED|Overall Study||34
1044348|NCT00763282|2533437|P1|NOT COMPLETED|Overall Study||32
1044349|NCT00763282|2533436|P2|COMPLETED|Overall Study||38
1044350|NCT00763282|2533437|P1|COMPLETED|Overall Study||40
1044351|NCT00763282|2533436|P2|STARTED|Overall Study||72
1044352|NCT00763282|2533437|P1|STARTED|Overall Study||72
1044353|NCT00763321|2533454|P3|NOT COMPLETED|Double-blind Period||29
1044354|NCT00763321|2533455|P2|NOT COMPLETED|Double-blind Period||21
1044355|NCT00763321|2533456|P1|NOT COMPLETED|Double-blind Period||0
1044356|NCT00763321|2533454|P3|COMPLETED|Double-blind Period||84
1044357|NCT00763321|2533455|P2|COMPLETED|Double-blind Period||88
1044358|NCT00763321|2533456|P1|COMPLETED|Double-blind Period||0
1044359|NCT00763321|2533454|P3|STARTED|Double-blind Period||113
1044360|NCT00763321|2533455|P2|STARTED|Double-blind Period||109
1044361|NCT00763321|2533456|P1|STARTED|Double-blind Period||0
1044362|NCT00763321|2533454|P3|NOT COMPLETED|Open-label Period||0
1044363|NCT00763321|2533455|P2|NOT COMPLETED|Open-label Period||0
1044364|NCT00763321|2533456|P1|NOT COMPLETED|Open-label Period||63
1044365|NCT00763321|2533454|P3|COMPLETED|Open-label Period||0
1044366|NCT00763321|2533455|P2|COMPLETED|Open-label Period||0
1044367|NCT00763321|2533456|P1|COMPLETED|Open-label Period||222
1044368|NCT00763321|2533454|P3|STARTED|Open-label Period||0
1044369|NCT00763321|2533455|P2|STARTED|Open-label Period||0
1044370|NCT00763321|2533456|P1|STARTED|Open-label Period||285
1044371|NCT00763360|2533468|P3|NOT COMPLETED|Overall Study||0
1044372|NCT00763360|2533469|P2|NOT COMPLETED|Overall Study||2
1044373|NCT00763360|2533470|P1|NOT COMPLETED|Overall Study||0
1044374|NCT00763360|2533468|P3|COMPLETED|Overall Study||63
1044375|NCT00763360|2533469|P2|COMPLETED|Overall Study||58
1044376|NCT00763360|2533470|P1|COMPLETED|Overall Study||61
1044377|NCT00763360|2533468|P3|STARTED|Overall Study||63
1044378|NCT00763360|2533469|P2|STARTED|Overall Study||60
1044379|NCT00763360|2533470|P1|STARTED|Overall Study||61
1044380|NCT00763386|2533489|P2|NOT COMPLETED|Overall Study||40
1044381|NCT00763386|2533490|P1|NOT COMPLETED|Overall Study||48
1044382|NCT00763386|2533489|P2|COMPLETED|Overall Study||127
1044383|NCT00763386|2533490|P1|COMPLETED|Overall Study||116
1044384|NCT00763386|2533489|P2|STARTED|Overall Study||167
1044385|NCT00763386|2533490|P1|STARTED|Overall Study||164
1044386|NCT00763412|2533500|P2|NOT COMPLETED|Overall Study||4
1044387|NCT00763412|2533501|P1|NOT COMPLETED|Overall Study||4
1044388|NCT00763412|2533500|P2|COMPLETED|Overall Study||4
1044389|NCT00763412|2533501|P1|COMPLETED|Overall Study||4
1044390|NCT00763412|2533500|P2|STARTED|Overall Study||8
1044391|NCT00763412|2533501|P1|STARTED|Overall Study||8
1044392|NCT00757172|2533523|P1|NOT COMPLETED|Overall Study||11
1044393|NCT00757172|2533523|P1|COMPLETED|Overall Study|Participants underwent surgery.|54
1044394|NCT00757172|2533523|P1|STARTED|Overall Study||65
1044395|NCT00757237|2533533|P2|NOT COMPLETED|Overall Study||25
1044396|NCT00757237|2533534|P1|NOT COMPLETED|Overall Study||13
1044397|NCT00757237|2533533|P2|COMPLETED|Overall Study||111
1044398|NCT00757237|2533534|P1|COMPLETED|Overall Study||124
1044399|NCT00757237|2533533|P2|Treated|Overall Study||132
1044400|NCT00757237|2533534|P1|Treated|Overall Study||136
1044401|NCT00757237|2533533|P2|STARTED|Overall Study||136
1044402|NCT00757237|2533534|P1|STARTED|Overall Study||137
1044403|NCT00763451|2533566|P4|NOT COMPLETED|Overall Study||30
1044404|NCT00763451|2533567|P3|NOT COMPLETED|Overall Study||40
1044405|NCT00763451|2533568|P2|NOT COMPLETED|Overall Study||22
1044406|NCT00763451|2533569|P1|NOT COMPLETED|Overall Study||13
1044407|NCT00763451|2533566|P4|COMPLETED|Overall Study||131
1044408|NCT00763451|2533567|P3|COMPLETED|Overall Study||121
1044409|NCT00763451|2533568|P2|COMPLETED|Overall Study||60
1044410|NCT00763451|2533569|P1|COMPLETED|Overall Study||67
1044411|NCT00763451|2533566|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||160
1044412|NCT00763451|2533567|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||160
1044413|NCT00763451|2533568|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||80
1044414|NCT00763451|2533569|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|79
1044415|NCT00763451|2533566|P4|Treated/Safety Population|Overall Study||161
1044416|NCT00763451|2533567|P3|Treated/Safety Population|Overall Study||161
1044417|NCT00763451|2533568|P2|Treated/Safety Population|Overall Study||81
1044418|NCT00763451|2533569|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|79
1044419|NCT00763451|2533566|P4|STARTED|Overall Study||161
1044420|NCT00763451|2533567|P3|STARTED|Overall Study||161
1044421|NCT00763451|2533568|P2|STARTED|Overall Study||82
1044422|NCT00763451|2533569|P1|STARTED|Overall Study|Randomized.|80
1044423|NCT00763490|2533601|P1|NOT COMPLETED|Overall Study||0
1044424|NCT00763490|2533601|P1|COMPLETED|Overall Study||20
1044425|NCT00763490|2533601|P1|STARTED|Overall Study||20
1044426|NCT00763698|2533608|P1|NOT COMPLETED|Overall Study||10
1044427|NCT00763698|2533608|P1|COMPLETED|Overall Study||76
1044428|NCT00763698|2533608|P1|STARTED|Overall Study||86
1044429|NCT00763750|2533614|P1|NOT COMPLETED|Overall Study||0
1044430|NCT00763750|2533614|P1|COMPLETED|Overall Study||25
1044431|NCT00763750|2533614|P1|STARTED|Overall Study||25
1044432|NCT00766415|2533620|P2|NOT COMPLETED|Overall Study||1
1044433|NCT00766415|2533621|P1|NOT COMPLETED|Overall Study||0
1044434|NCT00766415|2533620|P2|COMPLETED|Overall Study||26
1044435|NCT00766415|2533621|P1|COMPLETED|Overall Study||25
1044436|NCT00766415|2533620|P2|STARTED|Overall Study||27
1044437|NCT00766415|2533621|P1|STARTED|Overall Study||25
1044438|NCT00766467|2533671|P2|NOT COMPLETED|Overall Study||8
1044439|NCT00766467|2533672|P1|NOT COMPLETED|Overall Study||11
1044440|NCT00766467|2533671|P2|COMPLETED|Overall Study||31
1044441|NCT00766467|2533672|P1|COMPLETED|Overall Study||31
1044442|NCT00766467|2533671|P2|Initiated Treatment|Overall Study||38
1044443|NCT00766467|2533672|P1|Initiated Treatment|Overall Study||39
1044444|NCT00766467|2533671|P2|STARTED|Overall Study||39
1044445|NCT00766467|2533672|P1|STARTED|Overall Study||42
1044446|NCT00766493|2533682|P1|NOT COMPLETED|30 Days Post-Procedure||12
1044447|NCT00766493|2533682|P1|COMPLETED|30 Days Post-Procedure||238
1044448|NCT00766493|2533682|P1|STARTED|30 Days Post-Procedure||250
1044449|NCT00766493|2533682|P1|NOT COMPLETED|Pre-Discharge||0
1044450|NCT00766493|2533682|P1|COMPLETED|Pre-Discharge||250
1044451|NCT00766493|2533682|P1|STARTED|Pre-Discharge||250
1044452|NCT00766506|2533692|P2|NOT COMPLETED|Overall Study||2
1044453|NCT00766506|2533693|P1|NOT COMPLETED|Overall Study||5
1044454|NCT00766506|2533692|P2|COMPLETED|Overall Study||48
1044455|NCT00766506|2533693|P1|COMPLETED|Overall Study||53
1044456|NCT00766506|2533692|P2|STARTED|Overall Study||50
1044457|NCT00766506|2533693|P1|STARTED|Overall Study||58
1044458|NCT00766532|2533717|P1|NOT COMPLETED|Overall Study||2
1044459|NCT00766532|2533717|P1|COMPLETED|Overall Study||10
1044460|NCT00766532|2533717|P1|STARTED|Overall Study||12
1044461|NCT00766597|2533721|P1|NOT COMPLETED|Overall Study||9
1044462|NCT00766597|2533721|P1|COMPLETED|Overall Study|Treatment duration is 48 weeks plus 5 years of follow-up|0
1044463|NCT00766597|2533721|P1|Completed Week 48|Overall Study|Week 48 is the second primary time point of analysis|0
1044464|NCT00766597|2533721|P1|Completed Week 24|Overall Study|Week 24 is the first primary time point of analysis|1
1044465|NCT00766597|2533721|P1|Without CCR5-tropic Virus|Overall Study|Not evaluable participants, did not receive the study drug|5
1044466|NCT00766597|2533721|P1|With CCR5-tropic Virus|Overall Study|Evaluable participants, received the study drug|4
1044467|NCT00766597|2533721|P1|STARTED|Overall Study|Screened participants who were evaluated for co-receptor tropism|9
1044468|NCT00766636|2533735|P2|NOT COMPLETED|Overall Study||2
1044469|NCT00766636|2533736|P1|NOT COMPLETED|Overall Study||3
1044470|NCT00766636|2533735|P2|COMPLETED|Overall Study||0
1044471|NCT00766636|2533736|P1|COMPLETED|Overall Study|Number that completed pre- and post-operative therapy as well as surgery.|0
1044472|NCT00766636|2533735|P2|STARTED|Overall Study||2
1044473|NCT00766636|2533736|P1|STARTED|Overall Study||3
1044474|NCT00766649|2533742|P1|NOT COMPLETED|Overall Study||10
1044475|NCT00766649|2533742|P1|COMPLETED|Overall Study||1
1044476|NCT00766649|2533742|P1|STARTED|Overall Study||11
1044477|NCT00766675|2533754|P1|NOT COMPLETED|Overall Study||40
1044478|NCT00766675|2533754|P1|COMPLETED|Overall Study||40
1044479|NCT00766675|2533754|P1|STARTED|Overall Study||80
1044480|NCT00766753|2533769|P2|NOT COMPLETED|Overall Study||0
1044481|NCT00766753|2533770|P1|NOT COMPLETED|Overall Study||0
1044482|NCT00766753|2533769|P2|COMPLETED|Overall Study||11
1044483|NCT00766753|2533770|P1|COMPLETED|Overall Study||11
1044484|NCT00766753|2533769|P2|Completed at Least Four Vaccines|Overall Study||9
1044485|NCT00766753|2533770|P1|Completed at Least Four Vaccines|Overall Study||10
1044486|NCT00766753|2533769|P2|Received at Least One Vaccine|Overall Study||11
1044487|NCT00766753|2533770|P1|Received at Least One Vaccine|Overall Study||11
1044488|NCT00766753|2533769|P2|STARTED|Overall Study||11
1044489|NCT00766753|2533770|P1|STARTED|Overall Study||11
1044490|NCT00766831|2533781|P1|NOT COMPLETED|Overall Study||115
1044491|NCT00766831|2533781|P1|COMPLETED|Overall Study||75
1044492|NCT00766831|2533781|P1|STARTED|Overall Study||190
1044493|NCT00767000|2533802|P5|NOT COMPLETED|Optional 104-week Extension||4
1044494|NCT00767000|2533803|P4|NOT COMPLETED|Optional 104-week Extension||2
1044495|NCT00767000|2533804|P3|NOT COMPLETED|Optional 104-week Extension||7
1044496|NCT00767000|2533805|P2|NOT COMPLETED|Optional 104-week Extension||3
1044497|NCT00767000|2533806|P1|NOT COMPLETED|Optional 104-week Extension||7
1044498|NCT00767000|2533802|P5|COMPLETED|Optional 104-week Extension||0
1044499|NCT00767000|2533803|P4|COMPLETED|Optional 104-week Extension||0
1044500|NCT00767000|2533804|P3|COMPLETED|Optional 104-week Extension||0
1044501|NCT00767000|2533805|P2|COMPLETED|Optional 104-week Extension||0
1044502|NCT00767000|2533806|P1|COMPLETED|Optional 104-week Extension||0
1044503|NCT00767000|2533802|P5|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|4
1044504|NCT00767000|2533803|P4|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|2
1044505|NCT00767000|2533804|P3|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
1044506|NCT00767000|2533805|P2|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|3
1044507|NCT00767000|2533806|P1|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
1044508|NCT00767000|2533802|P5|NOT COMPLETED|54-week Study||224
1044509|NCT00767000|2533803|P4|NOT COMPLETED|54-week Study||225
1044510|NCT00767000|2533804|P3|NOT COMPLETED|54-week Study||109
1044511|NCT00767000|2533805|P2|NOT COMPLETED|54-week Study||113
1044512|NCT00767000|2533806|P1|NOT COMPLETED|54-week Study||108
1044513|NCT00767000|2533802|P5|COMPLETED|54-week Study||7
1044514|NCT00767000|2533803|P4|COMPLETED|54-week Study||4
1044515|NCT00767000|2533804|P3|COMPLETED|54-week Study||8
1044516|NCT00767000|2533805|P2|COMPLETED|54-week Study||4
1044517|NCT00767000|2533806|P1|COMPLETED|54-week Study||11
1044518|NCT00767000|2533802|P5|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|231
1044519|NCT00767000|2533803|P4|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|229
1044520|NCT00767000|2533804|P3|STARTED|54-week Study||117
1044521|NCT00767000|2533805|P2|STARTED|54-week Study||117
1044522|NCT00767000|2533806|P1|STARTED|54-week Study||119
1044523|NCT00767039|2533850|P2|NOT COMPLETED|Overall Study||2
1044524|NCT00767039|2533851|P1|NOT COMPLETED|Overall Study||5
1044525|NCT00767039|2533850|P2|COMPLETED|Overall Study||23
1044526|NCT00767039|2533851|P1|COMPLETED|Overall Study||22
1044527|NCT00767039|2533850|P2|STARTED|Overall Study||25
1044528|NCT00767039|2533851|P1|STARTED|Overall Study|Two early deaths and 3 late deaths occurred in this group|27
1044529|NCT00767104|2533879|P2|NOT COMPLETED|Overall Study||2
1044530|NCT00767104|2533880|P1|NOT COMPLETED|Overall Study||1
1044531|NCT00767104|2533879|P2|COMPLETED|Overall Study||18
1044532|NCT00767104|2533880|P1|COMPLETED|Overall Study||19
1044533|NCT00767104|2533879|P2|STARTED|Overall Study||20
1044534|NCT00767104|2533880|P1|STARTED|Overall Study||20
1044535|NCT00767325|2533888|P1|NOT COMPLETED|Overall Study||15
1044536|NCT00767325|2533888|P1|COMPLETED|Overall Study||89
1044537|NCT00767325|2533888|P1|STARTED|Overall Study||104
1044538|NCT00767338|2533901|P4|NOT COMPLETED|Overall Study||0
1044539|NCT00767338|2533902|P3|NOT COMPLETED|Overall Study||0
1044540|NCT00767338|2533903|P2|NOT COMPLETED|Overall Study||2
1044541|NCT00767338|2533904|P1|NOT COMPLETED|Overall Study||1
1044542|NCT00767338|2533901|P4|COMPLETED|Overall Study||0
1044543|NCT00767338|2533902|P3|COMPLETED|Overall Study||0
1044544|NCT00767338|2533903|P2|COMPLETED|Overall Study||0
1044545|NCT00767338|2533904|P1|COMPLETED|Overall Study||0
1044546|NCT00767338|2533901|P4|STARTED|Overall Study||0
1044547|NCT00767338|2533902|P3|STARTED|Overall Study||0
1044548|NCT00767338|2533903|P2|STARTED|Overall Study||2
1044549|NCT00767338|2533904|P1|STARTED|Overall Study||1
1044550|NCT00767364|2533916|P2|NOT COMPLETED|Overall Study||0
1044551|NCT00767364|2533917|P1|NOT COMPLETED|Overall Study||0
1044552|NCT00767364|2533916|P2|COMPLETED|Overall Study||3
1044553|NCT00767364|2533917|P1|COMPLETED|Overall Study||5
1044554|NCT00767364|2533916|P2|STARTED|Overall Study||3
1044555|NCT00767364|2533917|P1|STARTED|Overall Study||5
1044556|NCT00767455|2533925|P1|NOT COMPLETED|Overall Study||19
1044557|NCT00767455|2533925|P1|COMPLETED|Overall Study||40
1044558|NCT00767455|2533925|P1|STARTED|Overall Study||59
1044559|NCT00767507|2533935|P4|NOT COMPLETED|Overall Study||3
1044560|NCT00767507|2533936|P3|NOT COMPLETED|Overall Study||0
1044561|NCT00767507|2533937|P2|NOT COMPLETED|Overall Study||0
1044562|NCT00767507|2533938|P1|NOT COMPLETED|Overall Study||0
1044563|NCT00767507|2533935|P4|COMPLETED|Overall Study||101
1044564|NCT00767507|2533936|P3|COMPLETED|Overall Study||106
1044565|NCT00767507|2533937|P2|COMPLETED|Overall Study||6
1044566|NCT00767507|2533938|P1|COMPLETED|Overall Study||5
1044567|NCT00767507|2533935|P4|STARTED|Overall Study||104
1044568|NCT00767507|2533936|P3|STARTED|Overall Study||106
1044569|NCT00767507|2533937|P2|STARTED|Overall Study||6
1044570|NCT00767507|2533938|P1|STARTED|Overall Study||5
1044571|NCT00767520|2533964|P2|NOT COMPLETED|Overall Study||17
1044572|NCT00767520|2533965|P1|NOT COMPLETED|Overall Study||11
1044573|NCT00767520|2533964|P2|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-56, study drug toxicity-2,AE-1,Death-1|61
1044574|NCT00767520|2533965|P1|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-50, study drug toxicity-10,AE-3,Death-2|68
1044575|NCT00767520|2533964|P2|STARTED|Overall Study||78
1044576|NCT00767520|2533965|P1|STARTED|Overall Study||79
1044577|NCT00767572|2533987|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
1044578|NCT00767572|2533987|P1|COMPLETED|Second Intervention (12 Weeks)||12
1044579|NCT00767572|2533987|P1|STARTED|Second Intervention (12 Weeks)||12
1044580|NCT00767572|2533987|P1|NOT COMPLETED|Washout (4 Weeks)||0
1044581|NCT00767572|2533987|P1|COMPLETED|Washout (4 Weeks)||12
1044582|NCT00767572|2533987|P1|STARTED|Washout (4 Weeks)||12
1044583|NCT00767572|2533987|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
1044584|NCT00767572|2533987|P1|COMPLETED|First Intervention (12 Weeks)||12
1044585|NCT00767572|2533987|P1|STARTED|First Intervention (12 Weeks)||12
1044586|NCT00767624|2533995|P2|NOT COMPLETED|Overall Study||17
1044587|NCT00767624|2533996|P1|NOT COMPLETED|Overall Study||24
1044588|NCT00767624|2533995|P2|COMPLETED|Overall Study||58
1044589|NCT00767624|2533996|P1|COMPLETED|Overall Study||51
1044590|NCT00767624|2533995|P2|STARTED|Overall Study||75
1044591|NCT00767624|2533996|P1|STARTED|Overall Study||75
1044592|NCT00767676|2534004|P1|NOT COMPLETED|Overall Study||54
1044593|NCT00767676|2534004|P1|COMPLETED|Overall Study||205
1044594|NCT00767676|2534004|P1|STARTED|Overall Study||259
1044595|NCT00767767|2534013|P5|NOT COMPLETED|Overall Study||0
1044596|NCT00767767|2534014|P4|NOT COMPLETED|Overall Study||0
1044597|NCT00767767|2534015|P3|NOT COMPLETED|Overall Study||0
1044598|NCT00767767|2534016|P2|NOT COMPLETED|Overall Study||0
1044599|NCT00767767|2534017|P1|NOT COMPLETED|Overall Study||0
1044600|NCT00767767|2534013|P5|COMPLETED|Overall Study||3
1044601|NCT00767767|2534014|P4|COMPLETED|Overall Study||3
1044602|NCT00767767|2534015|P3|COMPLETED|Overall Study||20
1044603|NCT00767767|2534016|P2|COMPLETED|Overall Study||20
1044604|NCT00767767|2534017|P1|COMPLETED|Overall Study||21
1044605|NCT00767767|2534013|P5|STARTED|Overall Study||3
1044606|NCT00767767|2534014|P4|STARTED|Overall Study||3
1044607|NCT00767767|2534015|P3|STARTED|Overall Study||20
1044608|NCT00767767|2534016|P2|STARTED|Overall Study||20
1044609|NCT00767767|2534017|P1|STARTED|Overall Study||21
1044610|NCT00767806|2534031|P2|NOT COMPLETED|Overall Study||47
1044611|NCT00767806|2534032|P1|NOT COMPLETED|Overall Study||51
1044612|NCT00767806|2534031|P2|COMPLETED|Overall Study||156
1044613|NCT00767806|2534032|P1|COMPLETED|Overall Study||147
1044614|NCT00767806|2534031|P2|STARTED|Overall Study||203
1044615|NCT00767806|2534032|P1|STARTED|Overall Study||198
1044616|NCT00768040|2534090|P2|NOT COMPLETED|Overall Study||3
1044617|NCT00768040|2534091|P1|NOT COMPLETED|Overall Study||4
1044618|NCT00768040|2534090|P2|COMPLETED|Overall Study||16
1044619|NCT00768040|2534091|P1|COMPLETED|Overall Study||16
1044620|NCT00768040|2534090|P2|STARTED|Overall Study||19
1044621|NCT00768040|2534091|P1|STARTED|Overall Study|"Started indicates randomized, safety and full analysis set."|20
1044622|NCT00768053|2534097|P1|NOT COMPLETED|Overall Study||11
1044623|NCT00768053|2534097|P1|COMPLETED|Overall Study||97
1044624|NCT00768053|2534097|P1|STARTED|Overall Study||108
1044625|NCT00768066|2534129|P3|NOT COMPLETED|Overall Study||0
1044626|NCT00768066|2534130|P2|NOT COMPLETED|Overall Study||3
1044627|NCT00768066|2534131|P1|NOT COMPLETED|Overall Study||3
1044628|NCT00768066|2534129|P3|COMPLETED|Overall Study||21
1044629|NCT00768066|2534130|P2|COMPLETED|Overall Study||19
1044630|NCT00768066|2534131|P1|COMPLETED|Overall Study||19
1044631|NCT00768066|2534129|P3|STARTED|Overall Study||21
1044632|NCT00768066|2534130|P2|STARTED|Overall Study||22
1044633|NCT00768066|2534131|P1|STARTED|Overall Study||22
1044634|NCT00768118|2534163|P1|NOT COMPLETED|Overall Study||0
1044635|NCT00768118|2534163|P1|COMPLETED|Overall Study||11
1044636|NCT00768118|2534163|P1|STARTED|Overall Study||11
1044637|NCT00768144|2534167|P1|NOT COMPLETED|Overall Study||36
1044638|NCT00768144|2534167|P1|COMPLETED|Overall Study||0
1044639|NCT00768144|2534167|P1|STARTED|Overall Study||36
1044640|NCT00768222|2534175|P2|NOT COMPLETED|Overall Study||4
1044641|NCT00768222|2534176|P1|NOT COMPLETED|Overall Study||4
1044642|NCT00768222|2534175|P2|COMPLETED|Overall Study||47
1044643|NCT00768222|2534176|P1|COMPLETED|Overall Study||46
1044644|NCT00768222|2534175|P2|STARTED|Overall Study||51
1044645|NCT00768222|2534176|P1|STARTED|Overall Study||50
1044646|NCT00768300|2534200|P2|NOT COMPLETED|Overall Study||163
1044647|NCT00768300|2534201|P1|NOT COMPLETED|Overall Study||329
1044648|NCT00768300|2534200|P2|COMPLETED|Overall Study||1
1044649|NCT00768300|2534201|P1|COMPLETED|Overall Study||1
1044650|NCT00768300|2534200|P2|Randomized and Treated|Overall Study||163
1044651|NCT00768300|2534201|P1|Randomized and Treated|Overall Study||329
1044652|NCT00768300|2534200|P2|STARTED|Overall Study||164
1044653|NCT00768300|2534201|P1|STARTED|Overall Study||330
1044654|NCT00768430|2534225|P2|NOT COMPLETED|7 Day Endpoint||3
1044655|NCT00768430|2534226|P1|NOT COMPLETED|7 Day Endpoint||2
1044656|NCT00768430|2534225|P2|COMPLETED|7 Day Endpoint||22
1044657|NCT00768430|2534226|P1|COMPLETED|7 Day Endpoint||45
1044658|NCT00768430|2534225|P2|STARTED|7 Day Endpoint||25
1044659|NCT00768430|2534226|P1|STARTED|7 Day Endpoint||47
1044660|NCT00768430|2534225|P2|NOT COMPLETED|24 Hour Endpoint||0
1044661|NCT00768430|2534226|P1|NOT COMPLETED|24 Hour Endpoint||1
1044662|NCT00768430|2534225|P2|COMPLETED|24 Hour Endpoint||25
1044663|NCT00768430|2534226|P1|COMPLETED|24 Hour Endpoint||47
1044664|NCT00768430|2534225|P2|STARTED|24 Hour Endpoint||25
1044665|NCT00768430|2534226|P1|STARTED|24 Hour Endpoint||48
1044666|NCT00768521|2534232|P2|NOT COMPLETED|Period 2||0
1044667|NCT00768521|2534233|P1|NOT COMPLETED|Period 2||0
1044668|NCT00768521|2534232|P2|COMPLETED|Period 2||11
1044669|NCT00768521|2534233|P1|COMPLETED|Period 2||9
1044670|NCT00768521|2534232|P2|STARTED|Period 2||11
1044671|NCT00768521|2534233|P1|STARTED|Period 2||9
1044672|NCT00768521|2534232|P2|NOT COMPLETED|Period 1||0
1044673|NCT00768521|2534233|P1|NOT COMPLETED|Period 1||0
1044674|NCT00768521|2534232|P2|COMPLETED|Period 1||11
1044675|NCT00768521|2534233|P1|COMPLETED|Period 1||9
1044676|NCT00768521|2534232|P2|STARTED|Period 1||11
1044677|NCT00768521|2534233|P1|STARTED|Period 1||9
1044678|NCT00768560|2534247|P6|NOT COMPLETED|Intervention Set 3||0
1044679|NCT00768560|2534248|P5|NOT COMPLETED|Intervention Set 3||0
1044680|NCT00768560|2534249|P4|NOT COMPLETED|Intervention Set 3||0
1044681|NCT00768560|2534250|P3|NOT COMPLETED|Intervention Set 3||0
1044682|NCT00768560|2534251|P2|NOT COMPLETED|Intervention Set 3||0
1044683|NCT00768560|2534252|P1|NOT COMPLETED|Intervention Set 3||0
1044684|NCT00768560|2534247|P6|COMPLETED|Intervention Set 3||6
1044685|NCT00768560|2534248|P5|COMPLETED|Intervention Set 3||6
1044686|NCT00768560|2534249|P4|COMPLETED|Intervention Set 3||6
1044687|NCT00768560|2534250|P3|COMPLETED|Intervention Set 3||6
1044688|NCT00768560|2534251|P2|COMPLETED|Intervention Set 3||5
1044689|NCT00768560|2534252|P1|COMPLETED|Intervention Set 3||5
1044690|NCT00768560|2534247|P6|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
1044691|NCT00768560|2534248|P5|STARTED|Intervention Set 3|40 mg BID for 2 weeks|6
1044692|NCT00768560|2534249|P4|STARTED|Intervention Set 3|80 mg OD for 2 weeks|6
1044693|NCT00768560|2534250|P3|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
1044694|NCT00768560|2534251|P2|STARTED|Intervention Set 3|40 mg BID for 2 weeks|5
1044695|NCT00768560|2534252|P1|STARTED|Intervention Set 3|80 mg OD for 2 weeks|5
1044696|NCT00768560|2534247|P6|NOT COMPLETED|Intervention Set 2||0
1044697|NCT00768560|2534248|P5|NOT COMPLETED|Intervention Set 2||0
1044698|NCT00768560|2534249|P4|NOT COMPLETED|Intervention Set 2||0
1044699|NCT00768560|2534250|P3|NOT COMPLETED|Intervention Set 2||0
1044700|NCT00768560|2534251|P2|NOT COMPLETED|Intervention Set 2||0
1044701|NCT00768560|2534252|P1|NOT COMPLETED|Intervention Set 2||0
1044702|NCT00768560|2534247|P6|COMPLETED|Intervention Set 2||6
1044703|NCT00768560|2534248|P5|COMPLETED|Intervention Set 2||6
1044704|NCT00768560|2534249|P4|COMPLETED|Intervention Set 2||6
1044705|NCT00768560|2534250|P3|COMPLETED|Intervention Set 2||6
1044706|NCT00768560|2534251|P2|COMPLETED|Intervention Set 2||5
1044707|NCT00768560|2534252|P1|COMPLETED|Intervention Set 2||5
1044708|NCT00768560|2534247|P6|STARTED|Intervention Set 2|40 mg BID for 2 weeks|6
1044709|NCT00768560|2534248|P5|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
1044710|NCT00768560|2534249|P4|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
1044711|NCT00768560|2534250|P3|STARTED|Intervention Set 2|80 mg OD for 2 weeks|6
1044712|NCT00768560|2534251|P2|STARTED|Intervention Set 2|80 mg OD for 2 weeks|5
1044713|NCT00768560|2534252|P1|STARTED|Intervention Set 2|40 mg BID for 2 weeks|5
1044714|NCT00768560|2534247|P6|NOT COMPLETED|Intervention Set 1||0
1044715|NCT00768560|2534248|P5|NOT COMPLETED|Intervention Set 1||0
1044716|NCT00768560|2534249|P4|NOT COMPLETED|Intervention Set 1||0
1044717|NCT00768560|2534250|P3|NOT COMPLETED|Intervention Set 1||0
1044718|NCT00768560|2534251|P2|NOT COMPLETED|Intervention Set 1||1
1044719|NCT00768560|2534252|P1|NOT COMPLETED|Intervention Set 1||0
1044720|NCT00768560|2534247|P6|COMPLETED|Intervention Set 1||6
1044721|NCT00768560|2534248|P5|COMPLETED|Intervention Set 1||6
1044722|NCT00768560|2534249|P4|COMPLETED|Intervention Set 1||6
1044723|NCT00768560|2534250|P3|COMPLETED|Intervention Set 1||6
1044724|NCT00768560|2534251|P2|COMPLETED|Intervention Set 1||5
1044725|NCT00768560|2534252|P1|COMPLETED|Intervention Set 1||5
1044726|NCT00768560|2534247|P6|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
1044727|NCT00768560|2534248|P5|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
1044728|NCT00768560|2534249|P4|Subjects Received Treatment|Intervention Set 1|40 mg BID for 2 weeks|6
1044729|NCT00768560|2534250|P3|Subjects Received Treatment|Intervention Set 1|40 mg twice daily (BID) for 2 weeks|6
1044730|NCT00768560|2534251|P2|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|6
1044731|NCT00768560|2534252|P1|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|5
1044732|NCT00768560|2534247|P6|STARTED|Intervention Set 1|3-period/treatment crossover|6
1044733|NCT00768560|2534248|P5|STARTED|Intervention Set 1|3-period/treatment crossover|6
1044734|NCT00768560|2534249|P4|STARTED|Intervention Set 1|3-period/treatment crossover|6
1044735|NCT00768560|2534250|P3|STARTED|Intervention Set 1|3-period/treatment crossover|6
1044736|NCT00768560|2534251|P2|STARTED|Intervention Set 1|3-period/treatment crossover|6
1044737|NCT00768560|2534252|P1|STARTED|Intervention Set 1|3-period/treatment crossover|5
1044738|NCT00768599|2534281|P3|NOT COMPLETED|Overall Study||12
1044739|NCT00768599|2534282|P2|NOT COMPLETED|Overall Study||16
1044740|NCT00768599|2534283|P1|NOT COMPLETED|Overall Study||11
1044741|NCT00768599|2534281|P3|COMPLETED|Overall Study||35
1044742|NCT00768599|2534282|P2|COMPLETED|Overall Study||27
1044743|NCT00768599|2534283|P1|COMPLETED|Overall Study||34
1044744|NCT00768599|2534281|P3|STARTED|Overall Study||47
1044745|NCT00768599|2534282|P2|STARTED|Overall Study||43
1044746|NCT00768599|2534283|P1|STARTED|Overall Study||45
1044747|NCT00768651|2534306|P1|NOT COMPLETED|Overall Study||1
1044748|NCT00768651|2534306|P1|COMPLETED|Overall Study||7
1044749|NCT00768651|2534306|P1|STARTED|Overall Study||8
1044750|NCT00768755|2534315|P4|NOT COMPLETED|Phase 2||57
1044751|NCT00768755|2534316|P3|NOT COMPLETED|Phase 2||58
1044752|NCT00768755|2534317|P2|NOT COMPLETED|Phase 2||55
1044753|NCT00768755|2534318|P1|NOT COMPLETED|Phase 2||0
1044754|NCT00768755|2534315|P4|COMPLETED|Phase 2||0
1044755|NCT00768755|2534316|P3|COMPLETED|Phase 2||0
1044756|NCT00768755|2534317|P2|COMPLETED|Phase 2||0
1044757|NCT00768755|2534318|P1|COMPLETED|Phase 2||0
1044758|NCT00768755|2534315|P4|Treated|Phase 2||55
1044759|NCT00768755|2534316|P3|Treated|Phase 2||58
1044760|NCT00768755|2534317|P2|Treated|Phase 2||55
1044761|NCT00768755|2534318|P1|Treated|Phase 2||0
1044762|NCT00768755|2534315|P4|STARTED|Phase 2||57
1044763|NCT00768755|2534316|P3|STARTED|Phase 2||58
1044764|NCT00768755|2534317|P2|STARTED|Phase 2||55
1044765|NCT00768755|2534318|P1|STARTED|Phase 2||0
1044766|NCT00768755|2534315|P4|NOT COMPLETED|Phase 1||0
1044767|NCT00768755|2534316|P3|NOT COMPLETED|Phase 1||0
1044768|NCT00768755|2534317|P2|NOT COMPLETED|Phase 1||0
1044769|NCT00768755|2534318|P1|NOT COMPLETED|Phase 1||10
1044770|NCT00768755|2534315|P4|COMPLETED|Phase 1||0
1044771|NCT00768755|2534316|P3|COMPLETED|Phase 1||0
1044772|NCT00768755|2534317|P2|COMPLETED|Phase 1||0
1044773|NCT00768755|2534318|P1|COMPLETED|Phase 1||0
1044774|NCT00768755|2534315|P4|STARTED|Phase 1||0
1044775|NCT00768755|2534316|P3|STARTED|Phase 1||0
1044776|NCT00768755|2534317|P2|STARTED|Phase 1||0
1044777|NCT00768755|2534318|P1|STARTED|Phase 1||10
1044778|NCT00768898|2534342|P1|NOT COMPLETED|Overall Study||2
1044779|NCT00768898|2534342|P1|COMPLETED|Overall Study||28
1044780|NCT00768898|2534342|P1|STARTED|Overall Study||30
1044781|NCT00760214|2534365|P3|NOT COMPLETED|Overall Study||41
1044782|NCT00760214|2534366|P2|NOT COMPLETED|Overall Study||30
1044783|NCT00760214|2534367|P1|NOT COMPLETED|Overall Study||30
1044784|NCT00760214|2534365|P3|COMPLETED|Overall Study||255
1044785|NCT00760214|2534366|P2|COMPLETED|Overall Study||264
1044786|NCT00760214|2534367|P1|COMPLETED|Overall Study||265
1044787|NCT00760214|2534365|P3|STARTED|Overall Study||296
1044788|NCT00760214|2534366|P2|STARTED|Overall Study||294
1044789|NCT00760214|2534367|P1|STARTED|Overall Study||295
1044790|NCT00760266|2534410|P2|NOT COMPLETED|Overall Study||18
1044791|NCT00760266|2534411|P1|NOT COMPLETED|Overall Study||24
1044792|NCT00760266|2534410|P2|COMPLETED|Overall Study||205
1044793|NCT00760266|2534411|P1|COMPLETED|Overall Study||204
1044794|NCT00760266|2534410|P2|STARTED|Overall Study||223
1044795|NCT00760266|2534411|P1|STARTED|Overall Study||228
1044796|NCT00760383|2534427|P2|NOT COMPLETED|Overall Study||7
1044797|NCT00760383|2534428|P1|NOT COMPLETED|Overall Study||5
1044798|NCT00760383|2534427|P2|COMPLETED|Overall Study||12
1044799|NCT00760383|2534428|P1|COMPLETED|Overall Study||16
1044800|NCT00760383|2534427|P2|STARTED|Overall Study||19
1044801|NCT00760383|2534428|P1|STARTED|Overall Study||21
1044802|NCT00760435|2534440|P2|NOT COMPLETED|Overall Study||5
1044803|NCT00760435|2534441|P1|NOT COMPLETED|Overall Study||4
1044804|NCT00760435|2534440|P2|COMPLETED|Overall Study||93
1044805|NCT00760435|2534441|P1|COMPLETED|Overall Study||94
1044806|NCT00760435|2534440|P2|STARTED|Overall Study||98
1044807|NCT00760435|2534441|P1|STARTED|Overall Study||98
1044808|NCT00760461|2534453|P1|NOT COMPLETED|Overall Study||44
1044809|NCT00760461|2534453|P1|COMPLETED|Overall Study||0
1044810|NCT00760461|2534453|P1|STARTED|Overall Study||44
1044811|NCT00760474|2534457|P2|NOT COMPLETED|Period 2 (P2)||1
1044812|NCT00760474|2534458|P1|NOT COMPLETED|Period 2 (P2)||1
1044813|NCT00760474|2534457|P2|COMPLETED|Period 2 (P2)||11
1044814|NCT00760474|2534458|P1|COMPLETED|Period 2 (P2)||11
1044815|NCT00760474|2534457|P2|STARTED|Period 2 (P2)||12
1044816|NCT00760474|2534458|P1|STARTED|Period 2 (P2)||12
1044817|NCT00760474|2534457|P2|NOT COMPLETED|Placebo Washout Period||1
1044818|NCT00760474|2534458|P1|NOT COMPLETED|Placebo Washout Period||0
1044819|NCT00760474|2534457|P2|COMPLETED|Placebo Washout Period||12
1044820|NCT00760474|2534458|P1|COMPLETED|Placebo Washout Period||12
1044821|NCT00760474|2534457|P2|STARTED|Placebo Washout Period||13
1044822|NCT00760474|2534458|P1|STARTED|Placebo Washout Period||12
1044823|NCT00760474|2534457|P2|NOT COMPLETED|Period 1 (P1)||1
1044824|NCT00760474|2534458|P1|NOT COMPLETED|Period 1 (P1)||1
1044825|NCT00760474|2534457|P2|COMPLETED|Period 1 (P1)||13
1044826|NCT00760474|2534458|P1|COMPLETED|Period 1 (P1)||12
1044827|NCT00760474|2534457|P2|Overall Number of Unique Participants|Period 1 (P1)||13
1044828|NCT00760474|2534458|P1|Overall Number of Unique Participants|Period 1 (P1)||12
1044829|NCT00760474|2534457|P2|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|14
1044830|NCT00760474|2534458|P1|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|13
1044831|NCT00760474|2534457|P2|STARTED|Period 1 (P1)||14
1044832|NCT00760474|2534458|P1|STARTED|Period 1 (P1)||13
1044833|NCT00760487|2534494|P1|NOT COMPLETED|Overall Study||3
1044834|NCT00760487|2534494|P1|COMPLETED|Overall Study||117
1044835|NCT00760487|2534494|P1|STARTED|Overall Study||120
1044836|NCT00760526|2534502|P2|NOT COMPLETED|Overall Study||4
1044837|NCT00760526|2534503|P1|NOT COMPLETED|Overall Study||5
1044838|NCT00760526|2534502|P2|COMPLETED|Overall Study||68
1044839|NCT00760526|2534503|P1|COMPLETED|Overall Study||69
1044840|NCT00760526|2534502|P2|STARTED|Overall Study||72
1044841|NCT00760526|2534503|P1|STARTED|Overall Study||74
1044842|NCT00760552|2534530|P2|NOT COMPLETED|Overall Study||10
1044843|NCT00760552|2534531|P1|NOT COMPLETED|Overall Study||13
1044844|NCT00760552|2534530|P2|COMPLETED|Overall Study||52
1044845|NCT00760552|2534531|P1|COMPLETED|Overall Study||48
1044846|NCT00760552|2534530|P2|STARTED|Overall Study||62
1044847|NCT00760552|2534531|P1|STARTED|Overall Study||61
1044848|NCT00760578|2534541|P4|NOT COMPLETED|Overall Study||4
1044849|NCT00760578|2534542|P3|NOT COMPLETED|Overall Study||5
1044850|NCT00760578|2534543|P2|NOT COMPLETED|Overall Study||2
1044851|NCT00760578|2534544|P1|NOT COMPLETED|Overall Study||3
1044852|NCT00760578|2534541|P4|COMPLETED|Overall Study||18
1044853|NCT00760578|2534542|P3|COMPLETED|Overall Study||16
1044854|NCT00760578|2534543|P2|COMPLETED|Overall Study||19
1044855|NCT00760578|2534544|P1|COMPLETED|Overall Study||19
1044856|NCT00760578|2534541|P4|Entered Drug Treatment Period|Overall Study||22
1044857|NCT00760578|2534542|P3|Entered Drug Treatment Period|Overall Study||19
1044858|NCT00760578|2534543|P2|Entered Drug Treatment Period|Overall Study||20
1044859|NCT00760578|2534544|P1|Entered Drug Treatment Period|Overall Study||21
1044860|NCT00760578|2534541|P4|STARTED|Overall Study||22
1044861|NCT00760578|2534542|P3|STARTED|Overall Study||21
1044862|NCT00760578|2534543|P2|STARTED|Overall Study||21
1044863|NCT00760578|2534544|P1|STARTED|Overall Study||22
1044864|NCT00760617|2534581|P3|NOT COMPLETED|Overall Study||5
1044865|NCT00760617|2534582|P2|NOT COMPLETED|Overall Study||2
1044866|NCT00760617|2534583|P1|NOT COMPLETED|Overall Study||5
1044867|NCT00760617|2534581|P3|COMPLETED|Overall Study||111
1044868|NCT00760617|2534582|P2|COMPLETED|Overall Study||142
1044869|NCT00760617|2534583|P1|COMPLETED|Overall Study||261
1044870|NCT00760617|2534581|P3|STARTED|Overall Study||116
1044871|NCT00760617|2534582|P2|STARTED|Overall Study||144
1044872|NCT00760617|2534583|P1|STARTED|Overall Study||266
1044873|NCT00760669|2534654|P1|NOT COMPLETED|Overall Study||30
1044874|NCT00760669|2534654|P1|COMPLETED|Overall Study||1031
1044875|NCT00760669|2534654|P1|STARTED|Overall Study||1061
1044876|NCT00760747|2534670|P2|NOT COMPLETED|Study Period III||3
1044877|NCT00760747|2534671|P1|NOT COMPLETED|Study Period III||3
1044878|NCT00760747|2534670|P2|COMPLETED|Study Period III||38
1044879|NCT00760747|2534671|P1|COMPLETED|Study Period III||41
1044880|NCT00760747|2534670|P2|STARTED|Study Period III||41
1044881|NCT00760747|2534671|P1|STARTED|Study Period III||44
1044882|NCT00760747|2534670|P2|NOT COMPLETED|Study Period II||14
1044883|NCT00760747|2534671|P1|NOT COMPLETED|Study Period II||13
1044884|NCT00760747|2534670|P2|COMPLETED|Study Period II||41
1044885|NCT00760747|2534671|P1|COMPLETED|Study Period II||44
1044886|NCT00760747|2534670|P2|Received at Least One Dose of Study Drug|Study Period II||54
1044887|NCT00760747|2534671|P1|Received at Least One Dose of Study Drug|Study Period II||57
1044888|NCT00760747|2534670|P2|STARTED|Study Period II||55
1044889|NCT00760747|2534671|P1|STARTED|Study Period II||57
1044890|NCT00760838|2534701|P2|NOT COMPLETED|Overall Study||2
1044891|NCT00760838|2534702|P1|NOT COMPLETED|Overall Study||5
1044892|NCT00760838|2534701|P2|COMPLETED|Overall Study||53
1044893|NCT00760838|2534702|P1|COMPLETED|Overall Study||49
1044894|NCT00760838|2534701|P2|STARTED|Overall Study||55
1044895|NCT00760838|2534702|P1|STARTED|Overall Study||54
1044896|NCT00760877|2534720|P2|NOT COMPLETED|Overall Study||26
1044897|NCT00760877|2534721|P1|NOT COMPLETED|Overall Study||45
1044898|NCT00760877|2534720|P2|COMPLETED|Overall Study||77
1044899|NCT00760877|2534721|P1|COMPLETED|Overall Study||59
1044900|NCT00760877|2534720|P2|Safety Set|Overall Study||103
1044901|NCT00760877|2534721|P1|Safety Set|Overall Study||101
1044902|NCT00760877|2534720|P2|Cross-over to Nilotinib|Overall Study||46
1044903|NCT00760877|2534721|P1|Cross-over to Nilotinib|Overall Study|Not applicable: cross-over occurred from imatinib to nilotinib only.|0
1044904|NCT00760877|2534720|P2|STARTED|Overall Study||103
1044905|NCT00760877|2534721|P1|STARTED|Overall Study||104
1044906|NCT00768989|2534739|P2|NOT COMPLETED|On or After Week 36||27
1044907|NCT00768989|2534740|P1|NOT COMPLETED|On or After Week 36||51
1044908|NCT00768989|2534739|P2|COMPLETED|On or After Week 36||0
1044909|NCT00768989|2534740|P1|COMPLETED|On or After Week 36||0
1044910|NCT00768989|2534739|P2|STARTED|On or After Week 36||27
1044911|NCT00768989|2534740|P1|STARTED|On or After Week 36||51
1044912|NCT00768989|2534739|P2|NOT COMPLETED|Week 24 to Prior to Week 36||0
1044913|NCT00768989|2534740|P1|NOT COMPLETED|Week 24 to Prior to Week 36||8
1044914|NCT00768989|2534739|P2|COMPLETED|Week 24 to Prior to Week 36||27
1044915|NCT00768989|2534740|P1|COMPLETED|Week 24 to Prior to Week 36||51
1044916|NCT00768989|2534739|P2|STARTED|Week 24 to Prior to Week 36||27
1044917|NCT00768989|2534740|P1|STARTED|Week 24 to Prior to Week 36||59
1044918|NCT00768989|2534739|P2|NOT COMPLETED|Prior to Week 24||3
1044919|NCT00768989|2534740|P1|NOT COMPLETED|Prior to Week 24||4
1044920|NCT00768989|2534739|P2|COMPLETED|Prior to Week 24||27
1044921|NCT00768989|2534740|P1|COMPLETED|Prior to Week 24||59
1044922|NCT00768989|2534739|P2|STARTED|Prior to Week 24||30
1044923|NCT00768989|2534740|P1|STARTED|Prior to Week 24||63
1044924|NCT00769015|2534790|P2|NOT COMPLETED|Overall Study||16
1044925|NCT00769015|2534791|P1|NOT COMPLETED|Overall Study||9
1044926|NCT00769015|2534790|P2|COMPLETED|Overall Study||76
1044927|NCT00769015|2534791|P1|COMPLETED|Overall Study||87
1044928|NCT00769015|2534790|P2|STARTED|Overall Study||92
1044929|NCT00769015|2534791|P1|STARTED|Overall Study||96
1044930|NCT00769067|2534811|P2|NOT COMPLETED|Overall Study||94
1044931|NCT00769067|2534812|P1|NOT COMPLETED|Overall Study||94
1044932|NCT00769067|2534811|P2|COMPLETED|Overall Study||0
1044933|NCT00769067|2534812|P1|COMPLETED|Overall Study||0
1044934|NCT00769067|2534811|P2|Treated|Overall Study|One participant was not treated: refused treatment for reason other than an adverse event (AE).|93
1044935|NCT00769067|2534812|P1|Treated|Overall Study||94
1044936|NCT00769067|2534811|P2|STARTED|Overall Study||94
1044937|NCT00769067|2534812|P1|STARTED|Overall Study||94
1044938|NCT00769119|2534839|P2|NOT COMPLETED|Overall Study||3
1044939|NCT00769119|2534840|P1|NOT COMPLETED|Overall Study||2
1044940|NCT00769119|2534839|P2|COMPLETED|Overall Study||13
1044941|NCT00769119|2534840|P1|COMPLETED|Overall Study||20
1044942|NCT00769119|2534839|P2|STARTED|Overall Study||16
1044943|NCT00769119|2534840|P1|STARTED|Overall Study||22
1044944|NCT00769132|2534884|P4|NOT COMPLETED|Period 4||0
1044945|NCT00769132|2534885|P3|NOT COMPLETED|Period 4||0
1044946|NCT00769132|2534886|P2|NOT COMPLETED|Period 4||1
1044947|NCT00769132|2534887|P1|NOT COMPLETED|Period 4||0
1044948|NCT00769132|2534884|P4|COMPLETED|Period 4||5
1044949|NCT00769132|2534885|P3|COMPLETED|Period 4||6
1044950|NCT00769132|2534886|P2|COMPLETED|Period 4||5
1044951|NCT00769132|2534887|P1|COMPLETED|Period 4||5
1044952|NCT00769132|2534884|P4|STARTED|Period 4||5
1044953|NCT00769132|2534885|P3|STARTED|Period 4||6
1044954|NCT00769132|2534886|P2|STARTED|Period 4||6
1044955|NCT00769132|2534887|P1|STARTED|Period 4||5
1044956|NCT00769132|2534884|P4|NOT COMPLETED|Period 3||0
1044957|NCT00769132|2534885|P3|NOT COMPLETED|Period 3||0
1044958|NCT00769132|2534886|P2|NOT COMPLETED|Period 3||0
1044959|NCT00769132|2534887|P1|NOT COMPLETED|Period 3||1
1044960|NCT00769132|2534884|P4|COMPLETED|Period 3||5
1044961|NCT00769132|2534885|P3|COMPLETED|Period 3||6
1044962|NCT00769132|2534886|P2|COMPLETED|Period 3||6
1044963|NCT00769132|2534887|P1|COMPLETED|Period 3||5
1044964|NCT00769132|2534884|P4|STARTED|Period 3||5
1044965|NCT00769132|2534885|P3|STARTED|Period 3||6
1044966|NCT00769132|2534886|P2|STARTED|Period 3||6
1044967|NCT00769132|2534887|P1|STARTED|Period 3||6
1044968|NCT00769132|2534884|P4|NOT COMPLETED|Period 2||1
1044969|NCT00769132|2534885|P3|NOT COMPLETED|Period 2||0
1044970|NCT00769132|2534886|P2|NOT COMPLETED|Period 2||0
1044971|NCT00769132|2534887|P1|NOT COMPLETED|Period 2||0
1044972|NCT00769132|2534884|P4|COMPLETED|Period 2||5
1044973|NCT00769132|2534885|P3|COMPLETED|Period 2||6
1044974|NCT00769132|2534886|P2|COMPLETED|Period 2||6
1044975|NCT00769132|2534887|P1|COMPLETED|Period 2||6
1044976|NCT00769132|2534884|P4|STARTED|Period 2||6
1044977|NCT00769132|2534885|P3|STARTED|Period 2||6
1044978|NCT00769132|2534886|P2|STARTED|Period 2||6
1044979|NCT00769132|2534887|P1|STARTED|Period 2||6
1044980|NCT00769132|2534884|P4|NOT COMPLETED|Period 1||1
1044981|NCT00769132|2534885|P3|NOT COMPLETED|Period 1||0
1044982|NCT00769132|2534886|P2|NOT COMPLETED|Period 1||0
1044983|NCT00769132|2534887|P1|NOT COMPLETED|Period 1||1
1044984|NCT00769132|2534884|P4|COMPLETED|Period 1||6
1044985|NCT00769132|2534885|P3|COMPLETED|Period 1||6
1044986|NCT00769132|2534886|P2|COMPLETED|Period 1||6
1044987|NCT00769132|2534887|P1|COMPLETED|Period 1||6
1044988|NCT00769132|2534884|P4|STARTED|Period 1||7
1044989|NCT00769132|2534885|P3|STARTED|Period 1||6
1044990|NCT00769132|2534886|P2|STARTED|Period 1||6
1044991|NCT00769132|2534887|P1|STARTED|Period 1||7
1044992|NCT00769184|2534901|P2|NOT COMPLETED|No Treatment (6 Weeks)||1
1044993|NCT00769184|2534902|P1|NOT COMPLETED|No Treatment (6 Weeks)||1
1044994|NCT00769184|2534901|P2|COMPLETED|No Treatment (6 Weeks)||6
1044995|NCT00769184|2534902|P1|COMPLETED|No Treatment (6 Weeks)||5
1044996|NCT00769184|2534901|P2|STARTED|No Treatment (6 Weeks)||7
1044997|NCT00769184|2534902|P1|STARTED|No Treatment (6 Weeks)||6
1044998|NCT00769184|2534901|P2|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
1044999|NCT00769184|2534902|P1|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
1045000|NCT00769184|2534901|P2|COMPLETED|+LCD / +Placebo Only (4 Weeks)||7
1045001|NCT00769184|2534902|P1|COMPLETED|+LCD / +Placebo Only (4 Weeks)||6
1045002|NCT00769184|2534901|P2|STARTED|+LCD / +Placebo Only (4 Weeks)||7
1045003|NCT00769184|2534902|P1|STARTED|+LCD / +Placebo Only (4 Weeks)||6
1045004|NCT00769184|2534901|P2|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
1045005|NCT00769184|2534902|P1|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
1045006|NCT00769184|2534901|P2|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
1045007|NCT00769184|2534902|P1|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||6
1045008|NCT00769184|2534901|P2|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||8
1045009|NCT00769184|2534902|P1|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
1045010|NCT00769561|2534912|P2|NOT COMPLETED|Overall Study||5
1045011|NCT00769561|2534913|P1|NOT COMPLETED|Overall Study||3
1045012|NCT00769561|2534912|P2|COMPLETED|Overall Study||24
1045013|NCT00769561|2534913|P1|COMPLETED|Overall Study||26
1045014|NCT00769561|2534912|P2|STARTED|Overall Study||29
1045015|NCT00769561|2534913|P1|STARTED|Overall Study||29
1045016|NCT00769652|2534935|P2|NOT COMPLETED|Overall Study||0
1045017|NCT00769652|2534936|P1|NOT COMPLETED|Overall Study||0
1045018|NCT00769652|2534935|P2|COMPLETED|Overall Study||1
1045019|NCT00769652|2534936|P1|COMPLETED|Overall Study||6
1045020|NCT00769652|2534935|P2|STARTED|Overall Study||1
1045021|NCT00769652|2534936|P1|STARTED|Overall Study||6
1045022|NCT00769704|2534948|P2|NOT COMPLETED|Overall Study||199
1045023|NCT00769704|2534949|P1|NOT COMPLETED|Overall Study||111
1045024|NCT00769704|2534948|P2|COMPLETED|Overall Study||97
1045025|NCT00769704|2534949|P1|COMPLETED|Overall Study||30
1045026|NCT00769704|2534948|P2|Received Treatment|Overall Study||292
1045027|NCT00769704|2534949|P1|Received Treatment|Overall Study||127
1045028|NCT00769704|2534948|P2|Intent-to-treat Population|Overall Study|Participants who were randomized once to study treatment; excludes 1 participant randomized 3 times|295
1045029|NCT00769704|2534949|P1|Intent-to-treat Population|Overall Study|All participants who were randomized once to study treatment|141
1045030|NCT00769704|2534948|P2|STARTED|Overall Study||296
1045031|NCT00769704|2534949|P1|STARTED|Overall Study||141
1045032|NCT00769860|2534969|P2|NOT COMPLETED|Overall Study||0
1045033|NCT00769860|2534970|P1|NOT COMPLETED|Overall Study||2
1045034|NCT00769860|2534969|P2|COMPLETED|Overall Study||8
1045035|NCT00769860|2534970|P1|COMPLETED|Overall Study||14
1045036|NCT00769860|2534969|P2|Month 8|Overall Study||8
1045037|NCT00769860|2534970|P1|Month 8|Overall Study||14
1045038|NCT00769860|2534969|P2|Month 4|Overall Study||8
1045039|NCT00769860|2534970|P1|Month 4|Overall Study||16
1045040|NCT00769860|2534969|P2|STARTED|Overall Study||8
1045041|NCT00769860|2534970|P1|STARTED|Overall Study||16
1045042|NCT00770029|2534998|P2|NOT COMPLETED|Overall Study||3
1045043|NCT00770029|2534999|P1|NOT COMPLETED|Overall Study||6
1045044|NCT00770029|2534998|P2|COMPLETED|Overall Study||89
1045045|NCT00770029|2534999|P1|COMPLETED|Overall Study||178
1045046|NCT00770029|2534998|P2|STARTED|Overall Study||92
1045047|NCT00770029|2534999|P1|STARTED|Overall Study||184
1045048|NCT00770120|2535013|P1|NOT COMPLETED|Overall Study||61
1045049|NCT00770120|2535013|P1|COMPLETED|Overall Study||0
1045050|NCT00770120|2535013|P1|Not Analyzable|Overall Study||1
1045051|NCT00770120|2535013|P1|Eligible|Overall Study||60
1045052|NCT00770120|2535013|P1|STARTED|Overall Study||61
1045053|NCT00770146|2535022|P2|NOT COMPLETED|Follow-up Period||20
1045054|NCT00770146|2535023|P1|NOT COMPLETED|Follow-up Period||11
1045055|NCT00770146|2535022|P2|COMPLETED|Follow-up Period||85
1045056|NCT00770146|2535023|P1|COMPLETED|Follow-up Period||42
1045057|NCT00770146|2535022|P2|STARTED|Follow-up Period||105
1045058|NCT00770146|2535023|P1|STARTED|Follow-up Period||53
1045059|NCT00770146|2535022|P2|NOT COMPLETED|Treatment Period||45
1045060|NCT00770146|2535023|P1|NOT COMPLETED|Treatment Period||9
1045061|NCT00770146|2535022|P2|COMPLETED|Treatment Period||60
1045062|NCT00770146|2535023|P1|COMPLETED|Treatment Period||44
1045063|NCT00770146|2535022|P2|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|101
1045064|NCT00770146|2535023|P1|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|50
1045065|NCT00770146|2535022|P2|Treated|Treatment Period||105
1045066|NCT00770146|2535023|P1|Treated|Treatment Period||52
1045067|NCT00770146|2535022|P2|STARTED|Treatment Period||105
1045068|NCT00770146|2535023|P1|STARTED|Treatment Period||53
1045069|NCT00770211|2535069|P2|NOT COMPLETED|Overall Study||2
1045070|NCT00770211|2535070|P1|NOT COMPLETED|Overall Study||1
1045071|NCT00770211|2535069|P2|COMPLETED|Overall Study||87
1045072|NCT00770211|2535070|P1|COMPLETED|Overall Study||181
1045073|NCT00770211|2535069|P2|STARTED|Overall Study||89
1045074|NCT00770211|2535070|P1|STARTED|Overall Study||182
1045075|NCT00770289|2535084|P1|NOT COMPLETED|Overall Study||6
1045076|NCT00770289|2535084|P1|COMPLETED|Overall Study||845
1045077|NCT00770289|2535084|P1|STARTED|Overall Study||851
1045078|NCT00770315|2535097|P4|NOT COMPLETED|Overall Study||38
1045079|NCT00770315|2535098|P3|NOT COMPLETED|Overall Study||57
1045080|NCT00770315|2535099|P2|NOT COMPLETED|Overall Study||43
1045081|NCT00770315|2535100|P1|NOT COMPLETED|Overall Study||40
1045082|NCT00770315|2535097|P4|COMPLETED|Overall Study||160
1045083|NCT00770315|2535098|P3|COMPLETED|Overall Study||137
1045084|NCT00770315|2535099|P2|COMPLETED|Overall Study||152
1045085|NCT00770315|2535100|P1|COMPLETED|Overall Study||157
1045086|NCT00770315|2535097|P4|STARTED|Overall Study||198
1045087|NCT00770315|2535098|P3|STARTED|Overall Study||194
1045088|NCT00770315|2535099|P2|STARTED|Overall Study||195
1045089|NCT00770315|2535100|P1|STARTED|Overall Study||197
1045099|NCT00770367|2535157|P2|NOT COMPLETED|Second Intervention||0
1045100|NCT00770367|2535158|P1|NOT COMPLETED|Second Intervention||2
1045101|NCT00770367|2535157|P2|COMPLETED|Second Intervention||15
1045102|NCT00770367|2535158|P1|COMPLETED|Second Intervention||16
1045103|NCT00770367|2535157|P2|STARTED|Second Intervention||15
1045104|NCT00770367|2535158|P1|STARTED|Second Intervention||18
1045105|NCT00770367|2535157|P2|NOT COMPLETED|Washout Period of 4 Weeks||1
1045106|NCT00770367|2535158|P1|NOT COMPLETED|Washout Period of 4 Weeks||0
1045107|NCT00770367|2535157|P2|COMPLETED|Washout Period of 4 Weeks||15
1045108|NCT00770367|2535158|P1|COMPLETED|Washout Period of 4 Weeks||18
1045109|NCT00770367|2535157|P2|STARTED|Washout Period of 4 Weeks||16
1045110|NCT00770367|2535158|P1|STARTED|Washout Period of 4 Weeks||18
1045111|NCT00770367|2535157|P2|NOT COMPLETED|First Intervention||2
1045112|NCT00770367|2535158|P1|NOT COMPLETED|First Intervention||0
1045113|NCT00770367|2535157|P2|COMPLETED|First Intervention||16
1045114|NCT00770367|2535158|P1|COMPLETED|First Intervention||18
1045115|NCT00770367|2535157|P2|STARTED|First Intervention||18
1045116|NCT00770367|2535158|P1|STARTED|First Intervention||18
1045117|NCT00770432|2535166|P2|NOT COMPLETED|Overall Study||7
1045118|NCT00770432|2535167|P1|NOT COMPLETED|Overall Study||4
1045119|NCT00770432|2535166|P2|COMPLETED|Overall Study||94
1045120|NCT00770432|2535167|P1|COMPLETED|Overall Study||98
1045121|NCT00770432|2535166|P2|STARTED|Overall Study||101
1045122|NCT00770432|2535167|P1|STARTED|Overall Study||102
1045123|NCT00770484|2535175|P2|NOT COMPLETED|Overall Study||0
1045124|NCT00770484|2535176|P1|NOT COMPLETED|Overall Study||1
1045125|NCT00770484|2535175|P2|COMPLETED|Overall Study||4
1045126|NCT00770484|2535176|P1|COMPLETED|Overall Study||7
1045127|NCT00770484|2535175|P2|STARTED|Overall Study||4
1045128|NCT00770484|2535176|P1|STARTED|Overall Study||8
1045129|NCT00770510|2535182|P1|NOT COMPLETED|Overall Study||5
1045130|NCT00770510|2535182|P1|COMPLETED|Overall Study||67
1045131|NCT00770510|2535182|P1|STARTED|Overall Study||72
1045132|NCT00770562|2535221|P2|NOT COMPLETED|Overall Study||1
1045133|NCT00770562|2535222|P1|NOT COMPLETED|Overall Study||1
1045134|NCT00770562|2535221|P2|COMPLETED|Overall Study||49
1045135|NCT00770562|2535222|P1|COMPLETED|Overall Study||52
1045136|NCT00770562|2535221|P2|STARTED|Overall Study||50
1045137|NCT00770562|2535222|P1|STARTED|Overall Study||53
1045138|NCT00770588|2535235|P2|NOT COMPLETED|Overall Study||95
1045139|NCT00770588|2535236|P1|NOT COMPLETED|Overall Study||81
1045140|NCT00770588|2535235|P2|COMPLETED|Overall Study||53
1045141|NCT00770588|2535236|P1|COMPLETED|Overall Study||67
1045142|NCT00770588|2535235|P2|STARTED|Overall Study||148
1045143|NCT00770588|2535236|P1|STARTED|Overall Study||148
1045144|NCT00770653|2535252|P2|NOT COMPLETED|Overall Study||29
1045145|NCT00770653|2535253|P1|NOT COMPLETED|Overall Study||32
1045146|NCT00770653|2535252|P2|COMPLETED|Overall Study||121
1045147|NCT00770653|2535253|P1|COMPLETED|Overall Study||123
1045148|NCT00770653|2535252|P2|STARTED|Overall Study||150
1045149|NCT00770653|2535253|P1|STARTED|Overall Study||155
1045150|NCT00770679|2535321|P1|NOT COMPLETED|Overall Study||6
1045151|NCT00770679|2535321|P1|COMPLETED|Overall Study||10
1045152|NCT00770679|2535321|P1|STARTED|Overall Study||16
1045153|NCT00770692|2535331|P4|NOT COMPLETED|Overall Study||11
1045154|NCT00770692|2535332|P3|NOT COMPLETED|Overall Study||14
1045155|NCT00770692|2535333|P2|NOT COMPLETED|Overall Study||9
1045156|NCT00770692|2535334|P1|NOT COMPLETED|Overall Study||12
1045157|NCT00770692|2535331|P4|COMPLETED|Overall Study||66
1045158|NCT00770692|2535332|P3|COMPLETED|Overall Study||70
1045159|NCT00770692|2535333|P2|COMPLETED|Overall Study||74
1045160|NCT00770692|2535334|P1|COMPLETED|Overall Study||69
1045161|NCT00770692|2535331|P4|STARTED|Overall Study||77
1045162|NCT00770692|2535332|P3|STARTED|Overall Study||84
1045163|NCT00770692|2535333|P2|STARTED|Overall Study||83
1045164|NCT00770692|2535334|P1|STARTED|Overall Study|"1 participant whose compliance was unknown, was regarded as a treatment compliance unknown"|81
1045165|NCT00770757|2535360|P1|NOT COMPLETED|Overall Study||0
1045166|NCT00770757|2535360|P1|COMPLETED|Overall Study||13
1045167|NCT00770757|2535360|P1|STARTED|Overall Study||13
1045168|NCT00770770|2535370|P2|NOT COMPLETED|Overall Study||1
1045169|NCT00770770|2535371|P1|NOT COMPLETED|Overall Study||10
1045170|NCT00770770|2535370|P2|COMPLETED|Overall Study||5
1045171|NCT00770770|2535371|P1|COMPLETED|Overall Study||4
1045172|NCT00770770|2535370|P2|STARTED|Overall Study||6
1045173|NCT00770770|2535371|P1|STARTED|Overall Study||14
1045174|NCT00770809|2535380|P3|NOT COMPLETED|Overall Study||23
1045175|NCT00770809|2535381|P2|NOT COMPLETED|Overall Study||10
1045176|NCT00770809|2535382|P1|NOT COMPLETED|Overall Study||17
1045177|NCT00770809|2535380|P3|COMPLETED|Overall Study||44
1045178|NCT00770809|2535381|P2|COMPLETED|Overall Study||110
1045179|NCT00770809|2535382|P1|COMPLETED|Overall Study||101
1045180|NCT00770809|2535380|P3|STARTED|Overall Study||67
1045181|NCT00770809|2535381|P2|STARTED|Overall Study||120
1045182|NCT00770809|2535382|P1|STARTED|Overall Study||118
1045183|NCT00770861|2535392|P2|NOT COMPLETED|Overall Study||16
1045184|NCT00770861|2535393|P1|NOT COMPLETED|Overall Study||10
1045185|NCT00770861|2535392|P2|COMPLETED|Overall Study||120
1045186|NCT00770861|2535393|P1|COMPLETED|Overall Study||131
1045187|NCT00770861|2535392|P2|STARTED|Overall Study||136
1045188|NCT00770861|2535393|P1|STARTED|Overall Study||141
1045189|NCT00770913|2535404|P3|NOT COMPLETED|Overall Study||13
1045190|NCT00770913|2535405|P2|NOT COMPLETED|Overall Study||8
1045191|NCT00770913|2535406|P1|NOT COMPLETED|Overall Study||11
1045192|NCT00770913|2535404|P3|COMPLETED|Overall Study||100
1045193|NCT00770913|2535405|P2|COMPLETED|Overall Study||103
1045194|NCT00770913|2535406|P1|COMPLETED|Overall Study||102
1045195|NCT00770913|2535404|P3|STARTED|Overall Study||113
1045196|NCT00770913|2535405|P2|STARTED|Overall Study||111
1045197|NCT00770913|2535406|P1|STARTED|Overall Study||113
1045198|NCT00770965|2535418|P4|NOT COMPLETED|Excluded Set||13
1045199|NCT00770965|2535419|P3|NOT COMPLETED|Excluded Set||14
1045200|NCT00770965|2535420|P2|NOT COMPLETED|Excluded Set||13
1045201|NCT00770965|2535421|P1|NOT COMPLETED|Excluded Set||15
1045202|NCT00770965|2535418|P4|COMPLETED|Excluded Set||2
1045203|NCT00770965|2535419|P3|COMPLETED|Excluded Set||2
1045204|NCT00770965|2535420|P2|COMPLETED|Excluded Set||3
1045205|NCT00770965|2535421|P1|COMPLETED|Excluded Set||3
1045206|NCT00770965|2535418|P4|STARTED|Excluded Set||15
1045207|NCT00770965|2535419|P3|STARTED|Excluded Set||16
1045208|NCT00770965|2535420|P2|STARTED|Excluded Set||16
1045209|NCT00770965|2535421|P1|STARTED|Excluded Set||18
1045210|NCT00770965|2535418|P4|NOT COMPLETED|Safety Set||1
1045211|NCT00770965|2535419|P3|NOT COMPLETED|Safety Set||1
1045212|NCT00770965|2535420|P2|NOT COMPLETED|Safety Set||0
1045213|NCT00770965|2535421|P1|NOT COMPLETED|Safety Set||0
1045214|NCT00770965|2535418|P4|COMPLETED|Safety Set||4
1045215|NCT00770965|2535419|P3|COMPLETED|Safety Set||3
1045216|NCT00770965|2535420|P2|COMPLETED|Safety Set||4
1045217|NCT00770965|2535421|P1|COMPLETED|Safety Set||2
1045218|NCT00770965|2535418|P4|STARTED|Safety Set||5
1045219|NCT00770965|2535419|P3|STARTED|Safety Set||4
1045220|NCT00770965|2535420|P2|STARTED|Safety Set||4
1045221|NCT00770965|2535421|P1|STARTED|Safety Set||2
1045222|NCT00770991|2535441|P2|NOT COMPLETED|Overall Study||5
1045223|NCT00770991|2535442|P1|NOT COMPLETED|Overall Study||5
1045224|NCT00770991|2535441|P2|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
1045225|NCT00770991|2535442|P1|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
1045226|NCT00770991|2535441|P2|STARTED|Overall Study|We anticipated 26-30 subjects with FAP 18 year or olders would need to be enrolled to randomize 18|12
1045227|NCT00770991|2535442|P1|STARTED|Overall Study|34 participants enrolled (signed informed consent). 24 subjects were eligible to be randomized.|12
1045228|NCT00771056|2535454|P1|NOT COMPLETED|Overall Study||5
1045229|NCT00771056|2535454|P1|COMPLETED|Overall Study||18
1045230|NCT00771056|2535454|P1|STARTED|Overall Study||23
1045231|NCT00771173|2535461|P2|NOT COMPLETED|Overall Study||17
1045232|NCT00771173|2535462|P1|NOT COMPLETED|Overall Study||22
1045233|NCT00771173|2535461|P2|COMPLETED|Overall Study||112
1045234|NCT00771173|2535462|P1|COMPLETED|Overall Study||107
1045235|NCT00771173|2535461|P2|STARTED|Overall Study||129
1045236|NCT00771173|2535462|P1|STARTED|Overall Study||129
1045237|NCT00771238|2535470|P2|NOT COMPLETED|Overall Study||0
1045238|NCT00771238|2535471|P1|NOT COMPLETED|Overall Study||0
1045239|NCT00771238|2535470|P2|COMPLETED|Overall Study||21
1045240|NCT00771238|2535471|P1|COMPLETED|Overall Study||31
1045241|NCT00771238|2535470|P2|STARTED|Overall Study||21
1045242|NCT00771238|2535471|P1|STARTED|Overall Study||31
1045243|NCT00771264|2535481|P2|NOT COMPLETED|Overall Study||5
1045244|NCT00771264|2535482|P1|NOT COMPLETED|Overall Study||7
1045245|NCT00771264|2535481|P2|COMPLETED|Overall Study||105
1045246|NCT00771264|2535482|P1|COMPLETED|Overall Study||103
1045247|NCT00771264|2535481|P2|STARTED|Overall Study||110
1045248|NCT00771264|2535482|P1|STARTED|Overall Study||110
1045249|NCT00771277|2535488|P1|NOT COMPLETED|Overall Study||0
1045250|NCT00771277|2535488|P1|COMPLETED|Overall Study||6
1045251|NCT00771277|2535488|P1|STARTED|Overall Study||6
1045252|NCT00771316|2535496|P2|NOT COMPLETED|Overall Study||1
1045253|NCT00771316|2535497|P1|NOT COMPLETED|Overall Study||2
1045254|NCT00771316|2535496|P2|COMPLETED|Overall Study||1
1045255|NCT00771316|2535497|P1|COMPLETED|Overall Study||2
1045256|NCT00771316|2535496|P2|STARTED|Overall Study||2
1045257|NCT00771316|2535497|P1|STARTED|Overall Study||4
1045258|NCT00771407|2535509|P2|NOT COMPLETED|Overall Study||25
1045259|NCT00771407|2535510|P1|NOT COMPLETED|Overall Study||20
1045260|NCT00771407|2535509|P2|COMPLETED|Overall Study||35
1045261|NCT00771407|2535510|P1|COMPLETED|Overall Study||40
1045262|NCT00771407|2535509|P2|STARTED|Overall Study||60
1045263|NCT00771407|2535510|P1|STARTED|Overall Study||60
1045264|NCT00771472|2535516|P2|NOT COMPLETED|Overall Study||4
1045265|NCT00771472|2535517|P1|NOT COMPLETED|Overall Study||6
1045266|NCT00771472|2535516|P2|COMPLETED|Overall Study||0
1045267|NCT00771472|2535517|P1|COMPLETED|Overall Study||0
1045268|NCT00771472|2535516|P2|STARTED|Overall Study||4
1045269|NCT00771472|2535517|P1|STARTED|Overall Study||6
1045270|NCT00771537|2535542|P16|NOT COMPLETED|Overall Study||0
1045271|NCT00771537|2535543|P15|NOT COMPLETED|Overall Study||0
1045272|NCT00771537|2535544|P14|NOT COMPLETED|Overall Study||0
1045273|NCT00771537|2535545|P13|NOT COMPLETED|Overall Study||0
1045274|NCT00771537|2535546|P12|NOT COMPLETED|Overall Study||0
1045275|NCT00771537|2535547|P11|NOT COMPLETED|Overall Study||0
1045276|NCT00771537|2535548|P10|NOT COMPLETED|Overall Study||0
1045277|NCT00771537|2535549|P9|NOT COMPLETED|Overall Study||0
1045278|NCT00771537|2535550|P8|NOT COMPLETED|Overall Study||0
1045279|NCT00771537|2535551|P7|NOT COMPLETED|Overall Study||0
1045280|NCT00771537|2535552|P6|NOT COMPLETED|Overall Study||0
1045281|NCT00771537|2535553|P5|NOT COMPLETED|Overall Study||0
1045282|NCT00771537|2535554|P4|NOT COMPLETED|Overall Study||0
1045283|NCT00771537|2535555|P3|NOT COMPLETED|Overall Study||0
1045284|NCT00771537|2535556|P2|NOT COMPLETED|Overall Study||0
1045285|NCT00771537|2535557|P1|NOT COMPLETED|Overall Study||0
1045286|NCT00771537|2535542|P16|COMPLETED|Overall Study||122
1045287|NCT00771537|2535543|P15|COMPLETED|Overall Study||124
1045288|NCT00771537|2535544|P14|COMPLETED|Overall Study||124
1045289|NCT00771537|2535545|P13|COMPLETED|Overall Study||128
1045290|NCT00771537|2535546|P12|COMPLETED|Overall Study||137
1045291|NCT00771537|2535547|P11|COMPLETED|Overall Study||133
1045292|NCT00771537|2535548|P10|COMPLETED|Overall Study||119
1045293|NCT00771537|2535549|P9|COMPLETED|Overall Study||115
1045294|NCT00771537|2535550|P8|COMPLETED|Overall Study||132
1045295|NCT00771537|2535551|P7|COMPLETED|Overall Study||128
1045296|NCT00771537|2535552|P6|COMPLETED|Overall Study||118
1045297|NCT00771537|2535553|P5|COMPLETED|Overall Study||127
1045298|NCT00771537|2535554|P4|COMPLETED|Overall Study||114
1045299|NCT00771537|2535555|P3|COMPLETED|Overall Study||151
1045300|NCT00771537|2535556|P2|COMPLETED|Overall Study||124
1045301|NCT00771537|2535557|P1|COMPLETED|Overall Study||135
1045302|NCT00771537|2535542|P16|STARTED|Overall Study||122
1045303|NCT00771537|2535543|P15|STARTED|Overall Study||124
1045304|NCT00771537|2535544|P14|STARTED|Overall Study||124
1045305|NCT00771537|2535545|P13|STARTED|Overall Study||128
1045306|NCT00771537|2535546|P12|STARTED|Overall Study||137
1045307|NCT00771537|2535547|P11|STARTED|Overall Study||133
1045308|NCT00771537|2535548|P10|STARTED|Overall Study||119
1045309|NCT00771537|2535549|P9|STARTED|Overall Study||115
1045310|NCT00771537|2535550|P8|STARTED|Overall Study||132
1045311|NCT00771537|2535551|P7|STARTED|Overall Study||128
1045312|NCT00771537|2535552|P6|STARTED|Overall Study||118
1045313|NCT00771537|2535553|P5|STARTED|Overall Study||127
1045314|NCT00771537|2535554|P4|STARTED|Overall Study||114
1045315|NCT00771537|2535555|P3|STARTED|Overall Study||151
1045316|NCT00771537|2535556|P2|STARTED|Overall Study||124
1045317|NCT00771537|2535557|P1|STARTED|Overall Study||135
1045318|NCT00771602|2535586|P3|NOT COMPLETED|Overall Study||0
1045319|NCT00771602|2535587|P2|NOT COMPLETED|Overall Study||0
1045320|NCT00771602|2535588|P1|NOT COMPLETED|Overall Study||0
1045321|NCT00771602|2535586|P3|COMPLETED|Overall Study||0
1045322|NCT00771602|2535587|P2|COMPLETED|Overall Study||0
1045323|NCT00771602|2535588|P1|COMPLETED|Overall Study||1
1045324|NCT00771602|2535586|P3|STARTED|Overall Study||0
1045325|NCT00771602|2535587|P2|STARTED|Overall Study||0
1045326|NCT00771602|2535588|P1|STARTED|Overall Study||1
1045327|NCT00771615|2535605|P9|NOT COMPLETED|Overall Study||0
1045328|NCT00771615|2535606|P8|NOT COMPLETED|Overall Study||1
1045329|NCT00771615|2535607|P7|NOT COMPLETED|Overall Study||1
1045330|NCT00771615|2535608|P6|NOT COMPLETED|Overall Study||1
1045331|NCT00771615|2535609|P5|NOT COMPLETED|Overall Study||0
1045332|NCT00771615|2535610|P4|NOT COMPLETED|Overall Study||1
1045333|NCT00771615|2535611|P3|NOT COMPLETED|Overall Study||1
1045334|NCT00771615|2535612|P2|NOT COMPLETED|Overall Study||2
1045335|NCT00771615|2535613|P1|NOT COMPLETED|Overall Study||1
1045336|NCT00771615|2535605|P9|COMPLETED|Overall Study|Up to Day 364|41
1045337|NCT00771615|2535606|P8|COMPLETED|Overall Study|Up to Day 364|58
1045338|NCT00771615|2535607|P7|COMPLETED|Overall Study|Up to Day 364|45
1045339|NCT00771615|2535608|P6|COMPLETED|Overall Study|Up to Day 364|60
1045340|NCT00771615|2535609|P5|COMPLETED|Overall Study|Up to Day 364|40
1045341|NCT00771615|2535610|P4|COMPLETED|Overall Study|Up to Day 364|59
1045342|NCT00771615|2535611|P3|COMPLETED|Overall Study|Up to Day 364|40
1045343|NCT00771615|2535612|P2|COMPLETED|Overall Study|Up to Day 364|70
1045344|NCT00771615|2535613|P1|COMPLETED|Overall Study|Up to Day 364|48
1045345|NCT00771615|2535605|P9|STARTED|Overall Study||41
1045346|NCT00771615|2535606|P8|STARTED|Overall Study||59
1045347|NCT00771615|2535607|P7|STARTED|Overall Study||46
1045348|NCT00771615|2535608|P6|STARTED|Overall Study||61
1045349|NCT00771615|2535609|P5|STARTED|Overall Study||40
1045350|NCT00771615|2535610|P4|STARTED|Overall Study||60
1045351|NCT00771615|2535611|P3|STARTED|Overall Study||41
1045352|NCT00771615|2535612|P2|STARTED|Overall Study||72
1045353|NCT00771615|2535613|P1|STARTED|Overall Study||49
1045466|NCT00771927|2536117|P1|NOT COMPLETED|Overall Study||255
1045414|NCT00771745|2535855|P2|NOT COMPLETED|Overall Study||0
1045415|NCT00771745|2535856|P1|NOT COMPLETED|Overall Study||0
1045416|NCT00771745|2535855|P2|COMPLETED|Overall Study||5
1045417|NCT00771745|2535856|P1|COMPLETED|Overall Study||6
1045418|NCT00771745|2535855|P2|STARTED|Overall Study||5
1045419|NCT00771745|2535856|P1|STARTED|Overall Study||6
1045420|NCT00771758|2535865|P3|NOT COMPLETED|Overall Study||2
1045421|NCT00771758|2535866|P2|NOT COMPLETED|Overall Study||12
1045422|NCT00771758|2535867|P1|NOT COMPLETED|Overall Study||8
1045423|NCT00771758|2535865|P3|COMPLETED|Overall Study||19
1045424|NCT00771758|2535866|P2|COMPLETED|Overall Study||31
1045425|NCT00771758|2535867|P1|COMPLETED|Overall Study||36
1045426|NCT00771758|2535865|P3|STARTED|Overall Study||21
1045427|NCT00771758|2535866|P2|STARTED|Overall Study||43
1045428|NCT00771758|2535867|P1|STARTED|Overall Study||44
1045429|NCT00771810|2536018|P3|NOT COMPLETED|Overall Study||7
1045430|NCT00771810|2536019|P2|NOT COMPLETED|Overall Study||5
1045431|NCT00771810|2536020|P1|NOT COMPLETED|Overall Study||5
1045432|NCT00771810|2536018|P3|COMPLETED|Overall Study||6
1045433|NCT00771810|2536019|P2|COMPLETED|Overall Study||6
1045434|NCT00771810|2536020|P1|COMPLETED|Overall Study||5
1045435|NCT00771810|2536018|P3|STARTED|Overall Study||13
1045436|NCT00771810|2536019|P2|STARTED|Overall Study||11
1045437|NCT00771810|2536020|P1|STARTED|Overall Study||10
1045438|NCT00771849|2536057|P2|NOT COMPLETED|Overall Study||4
1045439|NCT00771849|2536058|P1|NOT COMPLETED|Overall Study||2
1045440|NCT00771849|2536057|P2|COMPLETED|Overall Study||47
1045441|NCT00771849|2536058|P1|COMPLETED|Overall Study||50
1045442|NCT00771849|2536057|P2|STARTED|Overall Study|One subject was not vaccinated|51
1045443|NCT00771849|2536058|P1|STARTED|Overall Study||52
1045444|NCT00771875|2536069|P3|NOT COMPLETED|Overall Study||0
1045445|NCT00771875|2536070|P2|NOT COMPLETED|Overall Study||1
1045446|NCT00771875|2536071|P1|NOT COMPLETED|Overall Study||0
1045447|NCT00771875|2536069|P3|COMPLETED|Overall Study||10
1045448|NCT00771875|2536070|P2|COMPLETED|Overall Study||9
1045449|NCT00771875|2536071|P1|COMPLETED|Overall Study||10
1045450|NCT00771875|2536069|P3|STARTED|Overall Study||10
1045451|NCT00771875|2536070|P2|STARTED|Overall Study||10
1045452|NCT00771875|2536071|P1|STARTED|Overall Study||10
1045453|NCT00771914|2536101|P4|NOT COMPLETED|Overall Study||2
1045454|NCT00771914|2536102|P3|NOT COMPLETED|Overall Study||0
1045455|NCT00771914|2536103|P2|NOT COMPLETED|Overall Study||0
1045456|NCT00771914|2536104|P1|NOT COMPLETED|Overall Study||0
1045457|NCT00771914|2536101|P4|COMPLETED|Overall Study||6
1045458|NCT00771914|2536102|P3|COMPLETED|Overall Study||6
1045459|NCT00771914|2536103|P2|COMPLETED|Overall Study||6
1045460|NCT00771914|2536104|P1|COMPLETED|Overall Study||7
1045461|NCT00771914|2536101|P4|STARTED|Overall Study||8
1045462|NCT00771914|2536102|P3|STARTED|Overall Study||6
1045463|NCT00771914|2536103|P2|STARTED|Overall Study||6
1045464|NCT00771914|2536104|P1|STARTED|Overall Study||7
1045465|NCT00771927|2536116|P2|NOT COMPLETED|Overall Study||237
1045467|NCT00771927|2536116|P2|COMPLETED|Overall Study||256
1045468|NCT00771927|2536117|P1|COMPLETED|Overall Study||256
1045469|NCT00771927|2536116|P2|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|493
1045470|NCT00771927|2536117|P1|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|511
1045471|NCT00771953|2536127|P2|NOT COMPLETED|Overall Study||10
1045472|NCT00771953|2536128|P1|NOT COMPLETED|Overall Study||10
1045473|NCT00771953|2536127|P2|COMPLETED|Overall Study||26
1045474|NCT00771953|2536128|P1|COMPLETED|Overall Study||26
1045475|NCT00771953|2536127|P2|STARTED|Overall Study||36
1045476|NCT00771953|2536128|P1|STARTED|Overall Study||36
1045477|NCT00763815|2536138|P2|NOT COMPLETED|Overall Study||84
1045478|NCT00763815|2536139|P1|NOT COMPLETED|Overall Study||52
1045479|NCT00763815|2536138|P2|COMPLETED|Overall Study||239
1045480|NCT00763815|2536139|P1|COMPLETED|Overall Study||109
1045481|NCT00763815|2536138|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||320
1045482|NCT00763815|2536139|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|159
1045483|NCT00763815|2536138|P2|Treated/Safety Population|Overall Study||323
1045484|NCT00763815|2536139|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|161
1045485|NCT00763815|2536138|P2|STARTED|Overall Study||323
1045486|NCT00763815|2536139|P1|STARTED|Overall Study|Randomized.|161
1045487|NCT00763867|2536165|P2|NOT COMPLETED|Overall Study||12
1045488|NCT00763867|2536166|P1|NOT COMPLETED|Overall Study||5
1045489|NCT00763867|2536165|P2|COMPLETED|Overall Study||101
1045490|NCT00763867|2536166|P1|COMPLETED|Overall Study||98
1045491|NCT00763867|2536165|P2|STARTED|Overall Study||113
1045492|NCT00763867|2536166|P1|STARTED|Overall Study||103
1045493|NCT00763919|2536260|P1|NOT COMPLETED|Overall Study||13
1045494|NCT00763919|2536260|P1|COMPLETED|Overall Study||30
1045495|NCT00763919|2536260|P1|STARTED|Overall Study||43
1045496|NCT00763958|2536288|P2|NOT COMPLETED|Overall Study||11
1045497|NCT00763958|2536289|P1|NOT COMPLETED|Overall Study||14
1045498|NCT00763958|2536288|P2|COMPLETED|Overall Study||5
1045499|NCT00763958|2536289|P1|COMPLETED|Overall Study||14
1045500|NCT00763958|2536288|P2|STARTED|Overall Study||16
1045501|NCT00763958|2536289|P1|STARTED|Overall Study||28
1045502|NCT00763971|2536302|P3|NOT COMPLETED|Overall Study||69
1045503|NCT00763971|2536303|P2|NOT COMPLETED|Overall Study||38
1045504|NCT00763971|2536304|P1|NOT COMPLETED|Overall Study||33
1045505|NCT00763971|2536302|P3|COMPLETED|Overall Study||42
1045506|NCT00763971|2536303|P2|COMPLETED|Overall Study||74
1045507|NCT00763971|2536304|P1|COMPLETED|Overall Study||80
1045508|NCT00763971|2536302|P3|STARTED|Overall Study||111
1045509|NCT00763971|2536303|P2|STARTED|Overall Study||112
1045510|NCT00763971|2536304|P1|STARTED|Overall Study||113
1045511|NCT00764309|2536333|P1|NOT COMPLETED|Overall Study||0
1045512|NCT00764309|2536333|P1|COMPLETED|Overall Study|Completed=off study. Major Reasons for off study: AE-13; withdrawn by sponsor-10; Lack of efficacy-3|31
1045513|NCT00764309|2536333|P1|STARTED|Overall Study|Number of participants treated.|31
1045514|NCT00764322|2536342|P1|NOT COMPLETED|Overall Study||20
1045515|NCT00764322|2536342|P1|COMPLETED|Overall Study||480
1045516|NCT00764322|2536342|P1|STARTED|Overall Study||500
1045517|NCT00764361|2536361|P2|NOT COMPLETED|Overall Study||4
1045518|NCT00764361|2536362|P1|NOT COMPLETED|Overall Study||2
1045519|NCT00764361|2536361|P2|COMPLETED|Overall Study||3
1045520|NCT00764361|2536362|P1|COMPLETED|Overall Study||6
1045521|NCT00764361|2536361|P2|STARTED|Overall Study||7
1045522|NCT00764361|2536362|P1|STARTED|Overall Study||8
1045523|NCT00764465|2536374|P6|NOT COMPLETED|Overall Study||1
1045524|NCT00764465|2536375|P5|NOT COMPLETED|Overall Study||1
1045525|NCT00764465|2536376|P4|NOT COMPLETED|Overall Study||1
1045526|NCT00764465|2536377|P3|NOT COMPLETED|Overall Study||1
1045527|NCT00764465|2536378|P2|NOT COMPLETED|Overall Study||1
1045528|NCT00764465|2536379|P1|NOT COMPLETED|Overall Study||2
1045529|NCT00764465|2536374|P6|COMPLETED|Overall Study||7
1045530|NCT00764465|2536375|P5|COMPLETED|Overall Study||6
1045531|NCT00764465|2536376|P4|COMPLETED|Overall Study||6
1045532|NCT00764465|2536377|P3|COMPLETED|Overall Study||6
1045533|NCT00764465|2536378|P2|COMPLETED|Overall Study||6
1045534|NCT00764465|2536379|P1|COMPLETED|Overall Study||7
1045535|NCT00764465|2536374|P6|STARTED|Overall Study||8
1045536|NCT00764465|2536375|P5|STARTED|Overall Study||7
1045537|NCT00764465|2536376|P4|STARTED|Overall Study||7
1045538|NCT00764465|2536377|P3|STARTED|Overall Study||7
1045539|NCT00764465|2536378|P2|STARTED|Overall Study||7
1045540|NCT00764465|2536379|P1|STARTED|Overall Study||9
1045541|NCT00764478|2536408|P3|NOT COMPLETED|Overall Study||8
1045542|NCT00764478|2536409|P2|NOT COMPLETED|Overall Study||22
1045543|NCT00764478|2536410|P1|NOT COMPLETED|Overall Study||15
1045544|NCT00764478|2536408|P3|COMPLETED|Overall Study||118
1045545|NCT00764478|2536409|P2|COMPLETED|Overall Study||97
1045546|NCT00764478|2536410|P1|COMPLETED|Overall Study||107
1045547|NCT00764478|2536408|P3|STARTED|Overall Study||126
1045548|NCT00764478|2536409|P2|STARTED|Overall Study||119
1045549|NCT00764478|2536410|P1|STARTED|Overall Study||122
1045550|NCT00764504|2536487|P3|NOT COMPLETED|Overall Study||103
1045551|NCT00764504|2536488|P2|NOT COMPLETED|Overall Study||70
1045552|NCT00764504|2536489|P1|NOT COMPLETED|Overall Study||66
1045553|NCT00764504|2536487|P3|COMPLETED|Overall Study||131
1045554|NCT00764504|2536488|P2|COMPLETED|Overall Study||71
1045555|NCT00764504|2536489|P1|COMPLETED|Overall Study||75
1045556|NCT00764504|2536487|P3|STARTED|Overall Study||234
1045557|NCT00764504|2536488|P2|STARTED|Overall Study||141
1045558|NCT00764504|2536489|P1|STARTED|Overall Study||141
1045559|NCT00764660|2536517|P2|NOT COMPLETED|Overall Study||11
1045560|NCT00764660|2536518|P1|NOT COMPLETED|Overall Study||22
1045561|NCT00764660|2536517|P2|COMPLETED|Overall Study||55
1045562|NCT00764660|2536518|P1|COMPLETED|Overall Study||53
1045563|NCT00764660|2536517|P2|STARTED|Overall Study||66
1045564|NCT00764660|2536518|P1|STARTED|Overall Study||75
1045565|NCT00764673|2536550|P1|NOT COMPLETED|Overall Study||12
1045566|NCT00764673|2536550|P1|COMPLETED|Overall Study||59
1045567|NCT00764673|2536550|P1|STARTED|Overall Study||71
1045568|NCT00764790|2536561|P3|NOT COMPLETED|Overall Study||30
1045569|NCT00764790|2536562|P2|NOT COMPLETED|Overall Study||41
1045570|NCT00764790|2536563|P1|NOT COMPLETED|Overall Study||38
1045571|NCT00764790|2536561|P3|COMPLETED|Overall Study||1074
1045572|NCT00764790|2536562|P2|COMPLETED|Overall Study||1065
1045573|NCT00764790|2536563|P1|COMPLETED|Overall Study||1069
1045574|NCT00764790|2536561|P3|STARTED|Overall Study||1104
1045575|NCT00764790|2536562|P2|STARTED|Overall Study||1106
1045576|NCT00764790|2536563|P1|STARTED|Overall Study||1107
1045577|NCT00764868|2536595|P1|NOT COMPLETED|Overall Study||113
1045578|NCT00764868|2536595|P1|COMPLETED|Overall Study||156
1045579|NCT00764868|2536595|P1|STARTED|Overall Study||269
1045580|NCT00764881|2536603|P2|NOT COMPLETED|Overall Study||10
1045581|NCT00764881|2536604|P1|NOT COMPLETED|Overall Study||16
1045582|NCT00764881|2536603|P2|COMPLETED|Overall Study||99
1045583|NCT00764881|2536604|P1|COMPLETED|Overall Study||92
1045584|NCT00764881|2536603|P2|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|107
1045585|NCT00764881|2536604|P1|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|106
1045586|NCT00764881|2536603|P2|STARTED|Overall Study||109
1045587|NCT00764881|2536604|P1|STARTED|Overall Study||108
1045588|NCT00764946|2536831|P3|NOT COMPLETED|Overall Study||4
1045589|NCT00764946|2536832|P2|NOT COMPLETED|Overall Study||17
1045590|NCT00764946|2536833|P1|NOT COMPLETED|Overall Study||13
1045591|NCT00764946|2536831|P3|COMPLETED|Overall Study||18
1045592|NCT00764946|2536832|P2|COMPLETED|Overall Study||72
1045593|NCT00764946|2536833|P1|COMPLETED|Overall Study||85
1045594|NCT00764946|2536831|P3|TREATED|Overall Study||21
1045595|NCT00764946|2536832|P2|TREATED|Overall Study||88
1045596|NCT00764946|2536833|P1|TREATED|Overall Study||97
1045597|NCT00764946|2536831|P3|STARTED|Overall Study||22
1045598|NCT00764946|2536832|P2|STARTED|Overall Study||89
1045599|NCT00764946|2536833|P1|STARTED|Overall Study||98
1045600|NCT00765037|2536859|P1|NOT COMPLETED|Overall Study||6
1045601|NCT00765037|2536859|P1|COMPLETED|Overall Study|Subjects who came in for 1 year visit.|13
1045602|NCT00765037|2536859|P1|STARTED|Overall Study|Original number of eligible subjects who signed a consent form.|19
1045603|NCT00765063|2536863|P1|NOT COMPLETED|Overall Study||32
1045604|NCT00765063|2536863|P1|COMPLETED|Overall Study||30
1045605|NCT00765063|2536863|P1|STARTED|Overall Study||62
1045606|NCT00765076|2536882|P3|NOT COMPLETED|Overall Study||1
1045607|NCT00765076|2536883|P2|NOT COMPLETED|Overall Study||0
1045608|NCT00765076|2536884|P1|NOT COMPLETED|Overall Study||1
1045609|NCT00765076|2536882|P3|COMPLETED|Overall Study||49
1045610|NCT00765076|2536883|P2|COMPLETED|Overall Study||73
1045611|NCT00765076|2536884|P1|COMPLETED|Overall Study||68
1045612|NCT00765076|2536882|P3|STARTED|Overall Study||50
1045613|NCT00765076|2536883|P2|STARTED|Overall Study||73
1045614|NCT00765076|2536884|P1|STARTED|Overall Study||69
1045615|NCT00765102|2536937|P1|NOT COMPLETED|Overall Study||31
1045616|NCT00765102|2536937|P1|COMPLETED|Overall Study|Completed 8 cycles of treatment|1
1045617|NCT00765102|2536937|P1|STARTED|Overall Study||32
1045618|NCT00765128|2536961|P2|NOT COMPLETED|Overall Study||0
1045619|NCT00765128|2536962|P1|NOT COMPLETED|Overall Study||0
1045620|NCT00765128|2536961|P2|COMPLETED|Overall Study||9
1045621|NCT00765128|2536962|P1|COMPLETED|Overall Study||8
1045622|NCT00765128|2536961|P2|STARTED|Overall Study||9
1045623|NCT00765128|2536962|P1|STARTED|Overall Study||8
1045624|NCT00765193|2536970|P1|NOT COMPLETED|Full Body Examination||0
1045625|NCT00765193|2536970|P1|COMPLETED|Full Body Examination||14381
1045626|NCT00765193|2536970|P1|STARTED|Full Body Examination||14381
1045627|NCT00765193|2536970|P1|NOT COMPLETED|Problem Area Examination||0
1045628|NCT00765193|2536970|P1|COMPLETED|Problem Area Examination||14381
1045629|NCT00765193|2536970|P1|STARTED|Problem Area Examination||14381
1045630|NCT00765206|2536975|P4|NOT COMPLETED|Second Intervention||0
1045631|NCT00765206|2536976|P3|NOT COMPLETED|Second Intervention||0
1045632|NCT00765206|2536977|P2|NOT COMPLETED|Second Intervention||0
1045633|NCT00765206|2536978|P1|NOT COMPLETED|Second Intervention||0
1045634|NCT00765206|2536975|P4|COMPLETED|Second Intervention||15
1045635|NCT00765206|2536976|P3|COMPLETED|Second Intervention||15
1045636|NCT00765206|2536977|P2|COMPLETED|Second Intervention||15
1045637|NCT00765206|2536978|P1|COMPLETED|Second Intervention||15
1045638|NCT00765206|2536975|P4|STARTED|Second Intervention||15
1045639|NCT00765206|2536976|P3|STARTED|Second Intervention||15
1045640|NCT00765206|2536977|P2|STARTED|Second Intervention||15
1045641|NCT00765206|2536978|P1|STARTED|Second Intervention||15
1045642|NCT00765206|2536975|P4|NOT COMPLETED|Washout Period of 14 Days||0
1045643|NCT00765206|2536976|P3|NOT COMPLETED|Washout Period of 14 Days||0
1045644|NCT00765206|2536977|P2|NOT COMPLETED|Washout Period of 14 Days||0
1045645|NCT00765206|2536978|P1|NOT COMPLETED|Washout Period of 14 Days||0
1045646|NCT00765206|2536975|P4|COMPLETED|Washout Period of 14 Days||15
1045647|NCT00765206|2536976|P3|COMPLETED|Washout Period of 14 Days||15
1045648|NCT00765206|2536977|P2|COMPLETED|Washout Period of 14 Days||15
1045649|NCT00765206|2536978|P1|COMPLETED|Washout Period of 14 Days||15
1045650|NCT00765206|2536975|P4|STARTED|Washout Period of 14 Days||15
1045651|NCT00765206|2536976|P3|STARTED|Washout Period of 14 Days||15
1045652|NCT00765206|2536977|P2|STARTED|Washout Period of 14 Days||15
1045653|NCT00765206|2536978|P1|STARTED|Washout Period of 14 Days||15
1045654|NCT00765206|2536975|P4|NOT COMPLETED|First Intervention||0
1045655|NCT00765206|2536976|P3|NOT COMPLETED|First Intervention||0
1045656|NCT00765206|2536977|P2|NOT COMPLETED|First Intervention||0
1045657|NCT00765206|2536978|P1|NOT COMPLETED|First Intervention||0
1045658|NCT00765206|2536975|P4|COMPLETED|First Intervention||15
1045659|NCT00765206|2536976|P3|COMPLETED|First Intervention||15
1045660|NCT00765206|2536977|P2|COMPLETED|First Intervention||15
1045661|NCT00765206|2536978|P1|COMPLETED|First Intervention||15
1045662|NCT00765206|2536975|P4|STARTED|First Intervention||15
1045663|NCT00765206|2536976|P3|STARTED|First Intervention||15
1045664|NCT00765206|2536977|P2|STARTED|First Intervention||15
1045665|NCT00765206|2536978|P1|STARTED|First Intervention||15
1045666|NCT00765232|2536986|P2|NOT COMPLETED|Overall Study||0
1045667|NCT00765232|2536987|P1|NOT COMPLETED|Overall Study||0
1045668|NCT00765232|2536986|P2|COMPLETED|Overall Study||54
1045669|NCT00765232|2536987|P1|COMPLETED|Overall Study||57
1045670|NCT00765232|2536986|P2|STARTED|Overall Study||54
1045671|NCT00765232|2536987|P1|STARTED|Overall Study||57
1045672|NCT00765245|2536997|P2|NOT COMPLETED|Overall Study||2
1045673|NCT00765245|2536998|P1|NOT COMPLETED|Overall Study||13
1045674|NCT00765245|2536997|P2|COMPLETED|Overall Study||20
1045675|NCT00765245|2536998|P1|COMPLETED|Overall Study||9
1045676|NCT00765245|2536997|P2|STARTED|Overall Study||22
1045677|NCT00765245|2536998|P1|STARTED|Overall Study||22
1045678|NCT00765336|2537010|P2|NOT COMPLETED|Overall Study||16
1045679|NCT00765336|2537011|P1|NOT COMPLETED|Overall Study||19
1045680|NCT00765336|2537010|P2|COMPLETED|Overall Study||73
1045681|NCT00765336|2537011|P1|COMPLETED|Overall Study||72
1045682|NCT00765336|2537010|P2|STARTED|Overall Study||89
1045683|NCT00765336|2537011|P1|STARTED|Overall Study||91
1045684|NCT00765362|2537017|P1|NOT COMPLETED|Overall Study||137
1045685|NCT00765362|2537017|P1|COMPLETED|Overall Study||282
1045686|NCT00765362|2537017|P1|STARTED|Overall Study||419
1045687|NCT00765375|2537023|P1|NOT COMPLETED|Overall Study||0
1045688|NCT00765375|2537023|P1|COMPLETED|Overall Study||5
1045689|NCT00765375|2537023|P1|STARTED|Overall Study||5
1045690|NCT00765388|2537029|P2|NOT COMPLETED|Period 2||0
1045691|NCT00765388|2537030|P1|NOT COMPLETED|Period 2||0
1045692|NCT00765388|2537029|P2|COMPLETED|Period 2||6
1045693|NCT00765388|2537030|P1|COMPLETED|Period 2||15
1045694|NCT00765388|2537029|P2|STARTED|Period 2||6
1045695|NCT00765388|2537030|P1|STARTED|Period 2||15
1045696|NCT00765388|2537029|P2|NOT COMPLETED|Period 1||5
1045697|NCT00765388|2537030|P1|NOT COMPLETED|Period 1||1
1045698|NCT00765388|2537029|P2|COMPLETED|Period 1||6
1045699|NCT00765388|2537030|P1|COMPLETED|Period 1||15
1045700|NCT00765388|2537029|P2|STARTED|Period 1||11
1045701|NCT00765388|2537030|P1|STARTED|Period 1|A cross-over study|16
1045702|NCT00765570|2537060|P2|NOT COMPLETED|Overall Study||0
1045703|NCT00765570|2537061|P1|NOT COMPLETED|Overall Study||2
1045704|NCT00765570|2537060|P2|COMPLETED|Overall Study||3
1045705|NCT00765570|2537061|P1|COMPLETED|Overall Study||7
1045706|NCT00765570|2537060|P2|STARTED|Overall Study||3
1045707|NCT00765570|2537061|P1|STARTED|Overall Study||9
1045708|NCT00765648|2537071|P2|NOT COMPLETED|Overall Study||2
1045709|NCT00765648|2537072|P1|NOT COMPLETED|Overall Study||1
1045710|NCT00765648|2537071|P2|COMPLETED|Overall Study||114
1045711|NCT00765648|2537072|P1|COMPLETED|Overall Study||109
1045712|NCT00765648|2537071|P2|STARTED|Overall Study||116
1045713|NCT00765648|2537072|P1|STARTED|Overall Study||110
1045714|NCT00765661|2537090|P2|NOT COMPLETED|Overall Study||0
1045715|NCT00765661|2537091|P1|NOT COMPLETED|Overall Study||0
1045716|NCT00765661|2537090|P2|COMPLETED|Overall Study||31
1045717|NCT00765661|2537091|P1|COMPLETED|Overall Study||32
1045718|NCT00765661|2537090|P2|STARTED|Overall Study||31
1045719|NCT00765661|2537091|P1|STARTED|Overall Study||32
1045720|NCT00765674|2537107|P4|NOT COMPLETED|Overall Study||25
1045721|NCT00765674|2537108|P3|NOT COMPLETED|Overall Study||17
1045722|NCT00765674|2537109|P2|NOT COMPLETED|Overall Study||22
1045723|NCT00765674|2537110|P1|NOT COMPLETED|Overall Study||21
1045724|NCT00765674|2537107|P4|COMPLETED|Overall Study||285
1045725|NCT00765674|2537108|P3|COMPLETED|Overall Study||279
1045726|NCT00765674|2537109|P2|COMPLETED|Overall Study||276
1045727|NCT00765674|2537110|P1|COMPLETED|Overall Study||266
1045728|NCT00765674|2537107|P4|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|310
1045729|NCT00765674|2537108|P3|STARTED|Overall Study||296
1045730|NCT00765674|2537109|P2|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|298
1045731|NCT00765674|2537110|P1|STARTED|Overall Study||287
1045732|NCT00765726|2537132|P1|NOT COMPLETED|Overall Study||9
1045733|NCT00765726|2537132|P1|COMPLETED|Overall Study||3
1045734|NCT00765726|2537132|P1|STARTED|Overall Study||12
1045735|NCT00765765|2537136|P1|NOT COMPLETED|Overall Study||0
1045736|NCT00765765|2537136|P1|COMPLETED|Overall Study||6
1045737|NCT00765765|2537136|P1|STARTED|Overall Study||6
1045738|NCT00765817|2537148|P2|NOT COMPLETED|Overall Study||22
1045739|NCT00765817|2537149|P1|NOT COMPLETED|Overall Study||26
1045740|NCT00765817|2537148|P2|COMPLETED|Overall Study||101
1045741|NCT00765817|2537149|P1|COMPLETED|Overall Study||112
1045827|NCT00766090|2537269|P10|COMPLETED|Washout Period 2 (14 Days)||8
1045742|NCT00765817|2537148|P2|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|123
1045743|NCT00765817|2537149|P1|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|138
1045744|NCT00765843|2537190|P3|NOT COMPLETED|Overall Study||3
1045745|NCT00765843|2537191|P2|NOT COMPLETED|Overall Study||4
1045746|NCT00765843|2537192|P1|NOT COMPLETED|Overall Study||1
1045747|NCT00765843|2537190|P3|COMPLETED|Overall Study||23
1045748|NCT00765843|2537191|P2|COMPLETED|Overall Study||21
1045749|NCT00765843|2537192|P1|COMPLETED|Overall Study||25
1045750|NCT00765843|2537190|P3|STARTED|Overall Study||26
1045751|NCT00765843|2537191|P2|STARTED|Overall Study||25
1045752|NCT00765843|2537192|P1|STARTED|Overall Study||26
1045753|NCT00765882|2537203|P3|NOT COMPLETED|Overall Study||36
1045754|NCT00765882|2537204|P2|NOT COMPLETED|Overall Study||40
1045755|NCT00765882|2537205|P1|NOT COMPLETED|Overall Study||24
1045756|NCT00765882|2537203|P3|COMPLETED|Overall Study||169
1045757|NCT00765882|2537204|P2|COMPLETED|Overall Study||173
1045758|NCT00765882|2537205|P1|COMPLETED|Overall Study||191
1045759|NCT00765882|2537203|P3|STARTED|Overall Study||205
1045760|NCT00765882|2537204|P2|STARTED|Overall Study||213
1045761|NCT00765882|2537205|P1|STARTED|Overall Study||215
1045762|NCT00765895|2537236|P2|NOT COMPLETED|Overall Study||0
1045763|NCT00765895|2537237|P1|NOT COMPLETED|Overall Study||0
1045764|NCT00765895|2537236|P2|COMPLETED|Overall Study||65
1045765|NCT00765895|2537237|P1|COMPLETED|Overall Study||65
1045766|NCT00765895|2537236|P2|STARTED|Overall Study||65
1045767|NCT00765895|2537237|P1|STARTED|Overall Study||65
1045768|NCT00765947|2537243|P1|NOT COMPLETED|Overall Study||24
1045769|NCT00765947|2537243|P1|COMPLETED|Overall Study||232
1045770|NCT00765947|2537243|P1|STARTED|Overall Study||256
1045771|NCT00766051|2537254|P2|NOT COMPLETED|Overall Study||0
1045772|NCT00766051|2537255|P1|NOT COMPLETED|Overall Study||2
1045773|NCT00766051|2537254|P2|COMPLETED|Overall Study||10
1045774|NCT00766051|2537255|P1|COMPLETED|Overall Study||10
1045775|NCT00766051|2537254|P2|STARTED|Overall Study||10
1045776|NCT00766051|2537255|P1|STARTED|Overall Study||12
1045777|NCT00766090|2537267|P12|NOT COMPLETED|Treatment Period 3 (28 Days)||1
1045778|NCT00766090|2537268|P11|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1045779|NCT00766090|2537269|P10|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1045780|NCT00766090|2537270|P9|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1045781|NCT00766090|2537271|P8|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1045782|NCT00766090|2537272|P7|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1045783|NCT00766090|2537273|P6|NOT COMPLETED|Treatment Period 3 (28 Days)||1
1045784|NCT00766090|2537274|P5|NOT COMPLETED|Treatment Period 3 (28 Days)||1
1045785|NCT00766090|2537275|P4|NOT COMPLETED|Treatment Period 3 (28 Days)||1
1045786|NCT00766090|2537276|P3|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1045787|NCT00766090|2537277|P2|NOT COMPLETED|Treatment Period 3 (28 Days)||1
1045788|NCT00766090|2537278|P1|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1045789|NCT00766090|2537267|P12|COMPLETED|Treatment Period 3 (28 Days)||6
1045790|NCT00766090|2537268|P11|COMPLETED|Treatment Period 3 (28 Days)||7
1045791|NCT00766090|2537269|P10|COMPLETED|Treatment Period 3 (28 Days)||8
1045792|NCT00766090|2537270|P9|COMPLETED|Treatment Period 3 (28 Days)||6
1045793|NCT00766090|2537271|P8|COMPLETED|Treatment Period 3 (28 Days)||8
1045794|NCT00766090|2537272|P7|COMPLETED|Treatment Period 3 (28 Days)||6
1045795|NCT00766090|2537273|P6|COMPLETED|Treatment Period 3 (28 Days)||22
1045796|NCT00766090|2537274|P5|COMPLETED|Treatment Period 3 (28 Days)||20
1045797|NCT00766090|2537275|P4|COMPLETED|Treatment Period 3 (28 Days)||24
1045798|NCT00766090|2537276|P3|COMPLETED|Treatment Period 3 (28 Days)||20
1045799|NCT00766090|2537277|P2|COMPLETED|Treatment Period 3 (28 Days)||26
1045800|NCT00766090|2537278|P1|COMPLETED|Treatment Period 3 (28 Days)||22
1045801|NCT00766090|2537267|P12|STARTED|Treatment Period 3 (28 Days)||7
1045802|NCT00766090|2537268|P11|STARTED|Treatment Period 3 (28 Days)||7
1045803|NCT00766090|2537269|P10|STARTED|Treatment Period 3 (28 Days)||8
1045804|NCT00766090|2537270|P9|STARTED|Treatment Period 3 (28 Days)||6
1045805|NCT00766090|2537271|P8|STARTED|Treatment Period 3 (28 Days)||8
1045806|NCT00766090|2537272|P7|STARTED|Treatment Period 3 (28 Days)||6
1045807|NCT00766090|2537273|P6|STARTED|Treatment Period 3 (28 Days)||23
1045808|NCT00766090|2537274|P5|STARTED|Treatment Period 3 (28 Days)||21
1045809|NCT00766090|2537275|P4|STARTED|Treatment Period 3 (28 Days)||25
1045810|NCT00766090|2537276|P3|STARTED|Treatment Period 3 (28 Days)||20
1045811|NCT00766090|2537277|P2|STARTED|Treatment Period 3 (28 Days)||27
1045812|NCT00766090|2537278|P1|STARTED|Treatment Period 3 (28 Days)||22
1045813|NCT00766090|2537267|P12|NOT COMPLETED|Washout Period 2 (14 Days)||0
1045814|NCT00766090|2537268|P11|NOT COMPLETED|Washout Period 2 (14 Days)||0
1045815|NCT00766090|2537269|P10|NOT COMPLETED|Washout Period 2 (14 Days)||0
1045816|NCT00766090|2537270|P9|NOT COMPLETED|Washout Period 2 (14 Days)||0
1045817|NCT00766090|2537271|P8|NOT COMPLETED|Washout Period 2 (14 Days)||0
1045818|NCT00766090|2537272|P7|NOT COMPLETED|Washout Period 2 (14 Days)||0
1045819|NCT00766090|2537273|P6|NOT COMPLETED|Washout Period 2 (14 Days)||0
1045820|NCT00766090|2537274|P5|NOT COMPLETED|Washout Period 2 (14 Days)||0
1045821|NCT00766090|2537275|P4|NOT COMPLETED|Washout Period 2 (14 Days)||0
1045822|NCT00766090|2537276|P3|NOT COMPLETED|Washout Period 2 (14 Days)||1
1045823|NCT00766090|2537277|P2|NOT COMPLETED|Washout Period 2 (14 Days)||0
1045824|NCT00766090|2537278|P1|NOT COMPLETED|Washout Period 2 (14 Days)||0
1045825|NCT00766090|2537267|P12|COMPLETED|Washout Period 2 (14 Days)||7
1045826|NCT00766090|2537268|P11|COMPLETED|Washout Period 2 (14 Days)||7
1045828|NCT00766090|2537270|P9|COMPLETED|Washout Period 2 (14 Days)||6
1045829|NCT00766090|2537271|P8|COMPLETED|Washout Period 2 (14 Days)||8
1045830|NCT00766090|2537272|P7|COMPLETED|Washout Period 2 (14 Days)||6
1045831|NCT00766090|2537273|P6|COMPLETED|Washout Period 2 (14 Days)||23
1045832|NCT00766090|2537274|P5|COMPLETED|Washout Period 2 (14 Days)||21
1045833|NCT00766090|2537275|P4|COMPLETED|Washout Period 2 (14 Days)||25
1045834|NCT00766090|2537276|P3|COMPLETED|Washout Period 2 (14 Days)||20
1045835|NCT00766090|2537277|P2|COMPLETED|Washout Period 2 (14 Days)||27
1045836|NCT00766090|2537278|P1|COMPLETED|Washout Period 2 (14 Days)||22
1045837|NCT00766090|2537267|P12|STARTED|Washout Period 2 (14 Days)||7
1045838|NCT00766090|2537268|P11|STARTED|Washout Period 2 (14 Days)||7
1045839|NCT00766090|2537269|P10|STARTED|Washout Period 2 (14 Days)||8
1045840|NCT00766090|2537270|P9|STARTED|Washout Period 2 (14 Days)||6
1045841|NCT00766090|2537271|P8|STARTED|Washout Period 2 (14 Days)||8
1045842|NCT00766090|2537272|P7|STARTED|Washout Period 2 (14 Days)||6
1045843|NCT00766090|2537273|P6|STARTED|Washout Period 2 (14 Days)||23
1045844|NCT00766090|2537274|P5|STARTED|Washout Period 2 (14 Days)||21
1045845|NCT00766090|2537275|P4|STARTED|Washout Period 2 (14 Days)||25
1045846|NCT00766090|2537276|P3|STARTED|Washout Period 2 (14 Days)||21
1045847|NCT00766090|2537277|P2|STARTED|Washout Period 2 (14 Days)||27
1045848|NCT00766090|2537278|P1|STARTED|Washout Period 2 (14 Days)||22
1045849|NCT00766090|2537267|P12|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1045850|NCT00766090|2537268|P11|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1045851|NCT00766090|2537269|P10|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1045852|NCT00766090|2537270|P9|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1045853|NCT00766090|2537271|P8|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1045854|NCT00766090|2537272|P7|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1045855|NCT00766090|2537273|P6|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1045856|NCT00766090|2537274|P5|NOT COMPLETED|Treatment Period 2 (28 Days)||2
1045857|NCT00766090|2537275|P4|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1045858|NCT00766090|2537276|P3|NOT COMPLETED|Treatment Period 2 (28 Days)||1
1045859|NCT00766090|2537277|P2|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1045860|NCT00766090|2537278|P1|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1045861|NCT00766090|2537267|P12|COMPLETED|Treatment Period 2 (28 Days)||7
1045862|NCT00766090|2537268|P11|COMPLETED|Treatment Period 2 (28 Days)||7
1045863|NCT00766090|2537269|P10|COMPLETED|Treatment Period 2 (28 Days)||8
1045864|NCT00766090|2537270|P9|COMPLETED|Treatment Period 2 (28 Days)||6
1045865|NCT00766090|2537271|P8|COMPLETED|Treatment Period 2 (28 Days)||8
1045866|NCT00766090|2537272|P7|COMPLETED|Treatment Period 2 (28 Days)||6
1045867|NCT00766090|2537273|P6|COMPLETED|Treatment Period 2 (28 Days)||23
1045868|NCT00766090|2537274|P5|COMPLETED|Treatment Period 2 (28 Days)||21
1045869|NCT00766090|2537275|P4|COMPLETED|Treatment Period 2 (28 Days)||25
1045870|NCT00766090|2537276|P3|COMPLETED|Treatment Period 2 (28 Days)||21
1045871|NCT00766090|2537277|P2|COMPLETED|Treatment Period 2 (28 Days)||27
1045872|NCT00766090|2537278|P1|COMPLETED|Treatment Period 2 (28 Days)||22
1045873|NCT00766090|2537267|P12|STARTED|Treatment Period 2 (28 Days)||7
1045874|NCT00766090|2537268|P11|STARTED|Treatment Period 2 (28 Days)||7
1045875|NCT00766090|2537269|P10|STARTED|Treatment Period 2 (28 Days)||8
1045876|NCT00766090|2537270|P9|STARTED|Treatment Period 2 (28 Days)||6
1045877|NCT00766090|2537271|P8|STARTED|Treatment Period 2 (28 Days)||8
1045878|NCT00766090|2537272|P7|STARTED|Treatment Period 2 (28 Days)||6
1045879|NCT00766090|2537273|P6|STARTED|Treatment Period 2 (28 Days)||23
1045880|NCT00766090|2537274|P5|STARTED|Treatment Period 2 (28 Days)||23
1045881|NCT00766090|2537275|P4|STARTED|Treatment Period 2 (28 Days)||25
1045882|NCT00766090|2537276|P3|STARTED|Treatment Period 2 (28 Days)||22
1045883|NCT00766090|2537277|P2|STARTED|Treatment Period 2 (28 Days)||27
1045884|NCT00766090|2537278|P1|STARTED|Treatment Period 2 (28 Days)||22
1045885|NCT00766090|2537267|P12|NOT COMPLETED|Washout Period 1 (14 Days)||0
1045886|NCT00766090|2537268|P11|NOT COMPLETED|Washout Period 1 (14 Days)||0
1045887|NCT00766090|2537269|P10|NOT COMPLETED|Washout Period 1 (14 Days)||0
1045888|NCT00766090|2537270|P9|NOT COMPLETED|Washout Period 1 (14 Days)||0
1045889|NCT00766090|2537271|P8|NOT COMPLETED|Washout Period 1 (14 Days)||0
1045890|NCT00766090|2537272|P7|NOT COMPLETED|Washout Period 1 (14 Days)||0
1045891|NCT00766090|2537273|P6|NOT COMPLETED|Washout Period 1 (14 Days)||0
1045892|NCT00766090|2537274|P5|NOT COMPLETED|Washout Period 1 (14 Days)||0
1045893|NCT00766090|2537275|P4|NOT COMPLETED|Washout Period 1 (14 Days)||0
1045894|NCT00766090|2537276|P3|NOT COMPLETED|Washout Period 1 (14 Days)||1
1045895|NCT00766090|2537277|P2|NOT COMPLETED|Washout Period 1 (14 Days)||0
1045896|NCT00766090|2537278|P1|NOT COMPLETED|Washout Period 1 (14 Days)||0
1045897|NCT00766090|2537267|P12|COMPLETED|Washout Period 1 (14 Days)||7
1045898|NCT00766090|2537268|P11|COMPLETED|Washout Period 1 (14 Days)||7
1045899|NCT00766090|2537269|P10|COMPLETED|Washout Period 1 (14 Days)||8
1045900|NCT00766090|2537270|P9|COMPLETED|Washout Period 1 (14 Days)||6
1045901|NCT00766090|2537271|P8|COMPLETED|Washout Period 1 (14 Days)||8
1045902|NCT00766090|2537272|P7|COMPLETED|Washout Period 1 (14 Days)||6
1045903|NCT00766090|2537273|P6|COMPLETED|Washout Period 1 (14 Days)||23
1045904|NCT00766090|2537274|P5|COMPLETED|Washout Period 1 (14 Days)||23
1045905|NCT00766090|2537275|P4|COMPLETED|Washout Period 1 (14 Days)||25
1045906|NCT00766090|2537276|P3|COMPLETED|Washout Period 1 (14 Days)||22
1045907|NCT00766090|2537277|P2|COMPLETED|Washout Period 1 (14 Days)||27
1045908|NCT00766090|2537278|P1|COMPLETED|Washout Period 1 (14 Days)||22
1045909|NCT00766090|2537267|P12|STARTED|Washout Period 1 (14 Days)||7
1045910|NCT00766090|2537268|P11|STARTED|Washout Period 1 (14 Days)||7
1045911|NCT00766090|2537269|P10|STARTED|Washout Period 1 (14 Days)||8
1045912|NCT00766090|2537270|P9|STARTED|Washout Period 1 (14 Days)||6
1045913|NCT00766090|2537271|P8|STARTED|Washout Period 1 (14 Days)||8
1045914|NCT00766090|2537272|P7|STARTED|Washout Period 1 (14 Days)||6
1045915|NCT00766090|2537273|P6|STARTED|Washout Period 1 (14 Days)||23
1045916|NCT00766090|2537274|P5|STARTED|Washout Period 1 (14 Days)||23
1045917|NCT00766090|2537275|P4|STARTED|Washout Period 1 (14 Days)||25
1045918|NCT00766090|2537276|P3|STARTED|Washout Period 1 (14 Days)||23
1045919|NCT00766090|2537277|P2|STARTED|Washout Period 1 (14 Days)||27
1045920|NCT00766090|2537278|P1|STARTED|Washout Period 1 (14 Days)||22
1045921|NCT00766090|2537267|P12|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1045922|NCT00766090|2537268|P11|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1045923|NCT00766090|2537269|P10|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1045924|NCT00766090|2537270|P9|NOT COMPLETED|Treatment Period 1 (28 Days)||1
1045925|NCT00766090|2537271|P8|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1045926|NCT00766090|2537272|P7|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1045927|NCT00766090|2537273|P6|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1045928|NCT00766090|2537274|P5|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1045929|NCT00766090|2537275|P4|NOT COMPLETED|Treatment Period 1 (28 Days)||1
1045930|NCT00766090|2537276|P3|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1045931|NCT00766090|2537277|P2|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1045932|NCT00766090|2537278|P1|NOT COMPLETED|Treatment Period 1 (28 Days)||3
1045933|NCT00766090|2537267|P12|COMPLETED|Treatment Period 1 (28 Days)||7
1045934|NCT00766090|2537268|P11|COMPLETED|Treatment Period 1 (28 Days)||7
1045935|NCT00766090|2537269|P10|COMPLETED|Treatment Period 1 (28 Days)||8
1045936|NCT00766090|2537270|P9|COMPLETED|Treatment Period 1 (28 Days)||6
1045937|NCT00766090|2537271|P8|COMPLETED|Treatment Period 1 (28 Days)||8
1045938|NCT00766090|2537272|P7|COMPLETED|Treatment Period 1 (28 Days)||6
1045939|NCT00766090|2537273|P6|COMPLETED|Treatment Period 1 (28 Days)||23
1045940|NCT00766090|2537274|P5|COMPLETED|Treatment Period 1 (28 Days)||23
1045941|NCT00766090|2537275|P4|COMPLETED|Treatment Period 1 (28 Days)||25
1045942|NCT00766090|2537276|P3|COMPLETED|Treatment Period 1 (28 Days)||23
1045943|NCT00766090|2537277|P2|COMPLETED|Treatment Period 1 (28 Days)||27
1045944|NCT00766090|2537278|P1|COMPLETED|Treatment Period 1 (28 Days)||22
1045945|NCT00766090|2537267|P12|STARTED|Treatment Period 1 (28 Days)||7
1045946|NCT00766090|2537268|P11|STARTED|Treatment Period 1 (28 Days)||7
1045947|NCT00766090|2537269|P10|STARTED|Treatment Period 1 (28 Days)||8
1045948|NCT00766090|2537270|P9|STARTED|Treatment Period 1 (28 Days)||7
1045949|NCT00766090|2537271|P8|STARTED|Treatment Period 1 (28 Days)||8
1045950|NCT00766090|2537272|P7|STARTED|Treatment Period 1 (28 Days)||6
1045951|NCT00766090|2537273|P6|STARTED|Treatment Period 1 (28 Days)||23
1045952|NCT00766090|2537274|P5|STARTED|Treatment Period 1 (28 Days)||23
1045953|NCT00766090|2537275|P4|STARTED|Treatment Period 1 (28 Days)||26
1045954|NCT00766090|2537276|P3|STARTED|Treatment Period 1 (28 Days)||23
1045955|NCT00766090|2537277|P2|STARTED|Treatment Period 1 (28 Days)||27
1045956|NCT00766090|2537278|P1|STARTED|Treatment Period 1 (28 Days)||25
1045957|NCT00766363|2537321|P4|NOT COMPLETED|Overall Study||0
1045958|NCT00766363|2537322|P3|NOT COMPLETED|Overall Study||0
1045959|NCT00766363|2537323|P2|NOT COMPLETED|Overall Study||1
1045960|NCT00766363|2537324|P1|NOT COMPLETED|Overall Study||1
1045961|NCT00766363|2537321|P4|COMPLETED|Overall Study||12
1045962|NCT00766363|2537322|P3|COMPLETED|Overall Study||12
1045963|NCT00766363|2537323|P2|COMPLETED|Overall Study||12
1045964|NCT00766363|2537324|P1|COMPLETED|Overall Study||11
1045965|NCT00766363|2537321|P4|PK POPULATION|Overall Study||13
1045966|NCT00766363|2537322|P3|PK POPULATION|Overall Study||10
1045967|NCT00766363|2537323|P2|PK POPULATION|Overall Study||13
1045968|NCT00766363|2537324|P1|PK POPULATION|Overall Study||12
1045969|NCT00766363|2537321|P4|SAFETY POPULATION|Overall Study|Increased by one subject who took placebo due to treatment assignment error.|13
1045970|NCT00766363|2537322|P3|SAFETY POPULATION|Overall Study|Decreased by one subject who took placebo instead due to treatment assignment error.|11
1045971|NCT00766363|2537323|P2|SAFETY POPULATION|Overall Study||13
1045972|NCT00766363|2537324|P1|SAFETY POPULATION|Overall Study||12
1045973|NCT00766363|2537321|P4|STARTED|Overall Study|Number randomized.|12
1045974|NCT00766363|2537322|P3|STARTED|Overall Study|Number randomized.|12
1045975|NCT00766363|2537323|P2|STARTED|Overall Study||13
1045976|NCT00766363|2537324|P1|STARTED|Overall Study||12
1045977|NCT00766376|2537361|P1|NOT COMPLETED|Overall Study||27
1045978|NCT00766376|2537361|P1|COMPLETED|Overall Study||124
1045979|NCT00766376|2537361|P1|STARTED|Overall Study||151
1045980|NCT00772005|2537370|P4|NOT COMPLETED|Overall Study||26
1045981|NCT00772005|2537371|P3|NOT COMPLETED|Overall Study||28
1045982|NCT00772005|2537372|P2|NOT COMPLETED|Overall Study||30
1045983|NCT00772005|2537373|P1|NOT COMPLETED|Overall Study||25
1045984|NCT00772005|2537370|P4|COMPLETED|Overall Study||46
1045985|NCT00772005|2537371|P3|COMPLETED|Overall Study||44
1045986|NCT00772005|2537372|P2|COMPLETED|Overall Study||40
1045987|NCT00772005|2537373|P1|COMPLETED|Overall Study||46
1045988|NCT00772005|2537370|P4|STARTED|Overall Study|Two patients withdrew before taking any study drug.|72
1045989|NCT00772005|2537371|P3|STARTED|Overall Study|One patient withdrew before taking any study drug.|72
1045990|NCT00772005|2537372|P2|STARTED|Overall Study|One patient withdrew before taking any study drug.|70
1045991|NCT00772005|2537373|P1|STARTED|Overall Study||71
1045992|NCT00772031|2538061|P2|NOT COMPLETED|Overall Study||43
1045993|NCT00772031|2538062|P1|NOT COMPLETED|Overall Study||32
1045994|NCT00772031|2538061|P2|COMPLETED|Overall Study||52
1045995|NCT00772031|2538062|P1|COMPLETED|Overall Study||64
1045996|NCT00772031|2538061|P2|STARTED|Overall Study||95
1045997|NCT00772031|2538062|P1|STARTED|Overall Study||96
1045998|NCT00772070|2538086|P2|NOT COMPLETED|Overall Study||10
1045999|NCT00772070|2538087|P1|NOT COMPLETED|Overall Study||2
1046000|NCT00772070|2538086|P2|COMPLETED|Overall Study||61
1046001|NCT00772070|2538087|P1|COMPLETED|Overall Study|Two participants had vaccination errors, they were removed from analysis.|100
1046002|NCT00772070|2538086|P2|STARTED|Overall Study||71
1046003|NCT00772070|2538087|P1|STARTED|Overall Study||102
1046004|NCT00772109|2538101|P4|NOT COMPLETED|Overall Study||31
1046005|NCT00772109|2538102|P3|NOT COMPLETED|Overall Study||19
1046006|NCT00772109|2538103|P2|NOT COMPLETED|Overall Study||19
1046007|NCT00772109|2538104|P1|NOT COMPLETED|Overall Study||21
1046008|NCT00772109|2538101|P4|COMPLETED|Overall Study||1397
1046009|NCT00772109|2538102|P3|COMPLETED|Overall Study||936
1046010|NCT00772109|2538103|P2|COMPLETED|Overall Study||934
1046011|NCT00772109|2538104|P1|COMPLETED|Overall Study||935
1046012|NCT00772109|2538101|P4|STARTED|Overall Study||1428
1046013|NCT00772109|2538102|P3|STARTED|Overall Study||955
1046014|NCT00772109|2538103|P2|STARTED|Overall Study||953
1046015|NCT00772109|2538104|P1|STARTED|Overall Study||956
1046016|NCT00772148|2538128|P2|NOT COMPLETED|Maintenance Phase (Week 52)||5
1046017|NCT00772148|2538129|P1|NOT COMPLETED|Maintenance Phase (Week 52)||4
1046018|NCT00772148|2538128|P2|COMPLETED|Maintenance Phase (Week 52)||18
1046019|NCT00772148|2538129|P1|COMPLETED|Maintenance Phase (Week 52)||17
1046020|NCT00772148|2538128|P2|STARTED|Maintenance Phase (Week 52)||23
1046021|NCT00772148|2538129|P1|STARTED|Maintenance Phase (Week 52)||21
1046022|NCT00772148|2538128|P2|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||6
1046023|NCT00772148|2538129|P1|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||8
1046024|NCT00772148|2538128|P2|COMPLETED|Pharmacokinetic Phase (14 Days)||23
1046025|NCT00772148|2538129|P1|COMPLETED|Pharmacokinetic Phase (14 Days)||21
1046026|NCT00772148|2538128|P2|STARTED|Pharmacokinetic Phase (14 Days)||29
1046027|NCT00772148|2538129|P1|STARTED|Pharmacokinetic Phase (14 Days)||29
1046028|NCT00772538|2538147|P2|NOT COMPLETED|Overall Study||26
1046029|NCT00772538|2538148|P1|NOT COMPLETED|Overall Study||20
1046030|NCT00772538|2538147|P2|COMPLETED|Overall Study||211
1046031|NCT00772538|2538148|P1|COMPLETED|Overall Study||202
1046032|NCT00772538|2538147|P2|STARTED|Overall Study||237
1046033|NCT00772538|2538148|P1|STARTED|Overall Study||222
1046034|NCT00772577|2538220|P2|NOT COMPLETED|Overall Study||23
1046035|NCT00772577|2538221|P1|NOT COMPLETED|Overall Study||23
1046036|NCT00772577|2538220|P2|COMPLETED|Overall Study||170
1046037|NCT00772577|2538221|P1|COMPLETED|Overall Study||170
1046038|NCT00772577|2538220|P2|STARTED|Overall Study||193
1046039|NCT00772577|2538221|P1|STARTED|Overall Study||193
1046040|NCT00772590|2538239|P4|NOT COMPLETED|Overall Study||0
1046041|NCT00772590|2538240|P3|NOT COMPLETED|Overall Study||0
1046042|NCT00772590|2538241|P2|NOT COMPLETED|Overall Study||0
1046043|NCT00772590|2538242|P1|NOT COMPLETED|Overall Study||0
1046044|NCT00772590|2538239|P4|COMPLETED|Overall Study||17
1046045|NCT00772590|2538240|P3|COMPLETED|Overall Study||18
1046046|NCT00772590|2538241|P2|COMPLETED|Overall Study||19
1046047|NCT00772590|2538242|P1|COMPLETED|Overall Study||19
1046048|NCT00772590|2538239|P4|STARTED|Overall Study||17
1046049|NCT00772590|2538240|P3|STARTED|Overall Study||18
1046050|NCT00772590|2538241|P2|STARTED|Overall Study||19
1046051|NCT00772590|2538242|P1|STARTED|Overall Study||19
1046052|NCT00772603|2538255|P3|NOT COMPLETED|Overall Study||26
1046053|NCT00772603|2538256|P2|NOT COMPLETED|Overall Study||40
1046054|NCT00772603|2538257|P1|NOT COMPLETED|Overall Study||52
1046055|NCT00772603|2538255|P3|COMPLETED|Overall Study||95
1046056|NCT00772603|2538256|P2|COMPLETED|Overall Study||82
1046057|NCT00772603|2538257|P1|COMPLETED|Overall Study||71
1046058|NCT00772603|2538255|P3|STARTED|Overall Study||121
1046059|NCT00772603|2538256|P2|STARTED|Overall Study||122
1046060|NCT00772603|2538257|P1|STARTED|Overall Study||123
1046061|NCT00772629|2538279|P2|NOT COMPLETED|Overall Study||0
1046062|NCT00772629|2538280|P1|NOT COMPLETED|Overall Study||1
1046063|NCT00772629|2538279|P2|COMPLETED|Overall Study||1
1046064|NCT00772629|2538280|P1|COMPLETED|Overall Study||16
1046065|NCT00772629|2538279|P2|STARTED|Overall Study||1
1046066|NCT00772629|2538280|P1|STARTED|Overall Study||17
1046067|NCT00772668|2538286|P1|NOT COMPLETED|Overall Study||3
1046068|NCT00772668|2538286|P1|COMPLETED|Overall Study||0
1046069|NCT00772668|2538286|P1|STARTED|Overall Study||3
1046070|NCT00772707|2538290|P1|NOT COMPLETED|Overall Study||3
1046071|NCT00772707|2538290|P1|COMPLETED|Overall Study||111
1046072|NCT00772707|2538290|P1|STARTED|Overall Study||114
1046073|NCT00772772|2538295|P1|NOT COMPLETED|Overall Study||0
1046074|NCT00772772|2538295|P1|COMPLETED|Overall Study||12
1046075|NCT00772772|2538295|P1|STARTED|Overall Study||12
1046076|NCT00772889|2538303|P3|NOT COMPLETED|Overall Study||16
1046077|NCT00772889|2538304|P2|NOT COMPLETED|Overall Study||18
1046078|NCT00772889|2538305|P1|NOT COMPLETED|Overall Study||22
1046079|NCT00772889|2538303|P3|COMPLETED|Overall Study||187
1046080|NCT00772889|2538304|P2|COMPLETED|Overall Study||375
1046081|NCT00772889|2538305|P1|COMPLETED|Overall Study||353
1046082|NCT00772889|2538303|P3|Completed at Day 21|Overall Study||203
1046083|NCT00772889|2538304|P2|Completed at Day 21|Overall Study||390
1046084|NCT00772889|2538305|P1|Completed at Day 21|Overall Study||374
1046085|NCT00772889|2538303|P3|STARTED|Overall Study||203
1046086|NCT00772889|2538304|P2|STARTED|Overall Study||393
1046087|NCT00772889|2538305|P1|STARTED|Overall Study||375
1046088|NCT00772915|2538358|P1|NOT COMPLETED|Overall Study||15
1046089|NCT00772915|2538358|P1|COMPLETED|Overall Study||23
1046090|NCT00772915|2538358|P1|STARTED|Overall Study||38
1046091|NCT00772928|2538364|P2|NOT COMPLETED|Overall Study||41
1046092|NCT00772928|2538365|P1|NOT COMPLETED|Overall Study||44
1046093|NCT00772928|2538364|P2|COMPLETED|Overall Study||538
1046094|NCT00772928|2538365|P1|COMPLETED|Overall Study||543
1046095|NCT00772928|2538364|P2|STARTED|Overall Study||579
1046096|NCT00772928|2538365|P1|STARTED|Overall Study||587
1046097|NCT00772941|2538375|P1|NOT COMPLETED|Overall Study||682
1046098|NCT00772941|2538375|P1|COMPLETED|Overall Study||3257
1046099|NCT00772941|2538375|P1|STARTED|Overall Study||3939
1046100|NCT00772954|2538407|P3|NOT COMPLETED|Overall Study||1
1046101|NCT00772954|2538408|P2|NOT COMPLETED|Overall Study||0
1046102|NCT00772954|2538409|P1|NOT COMPLETED|Overall Study||0
1046103|NCT00772954|2538407|P3|COMPLETED|Overall Study||11
1046104|NCT00772954|2538408|P2|COMPLETED|Overall Study||12
1046105|NCT00772954|2538409|P1|COMPLETED|Overall Study||12
1046106|NCT00772954|2538407|P3|STARTED|Overall Study||12
1046107|NCT00772954|2538408|P2|STARTED|Overall Study||12
1046108|NCT00772954|2538409|P1|STARTED|Overall Study||12
1046109|NCT00772967|2538417|P6|NOT COMPLETED|Crossover Treatment 3||0
1046110|NCT00772967|2538418|P5|NOT COMPLETED|Crossover Treatment 3||1
1046111|NCT00772967|2538419|P4|NOT COMPLETED|Crossover Treatment 3||0
1046112|NCT00772967|2538420|P3|NOT COMPLETED|Crossover Treatment 3||0
1046113|NCT00772967|2538421|P2|NOT COMPLETED|Crossover Treatment 3||0
1046114|NCT00772967|2538422|P1|NOT COMPLETED|Crossover Treatment 3||0
1046115|NCT00772967|2538417|P6|COMPLETED|Crossover Treatment 3||3
1046116|NCT00772967|2538418|P5|COMPLETED|Crossover Treatment 3||3
1046117|NCT00772967|2538419|P4|COMPLETED|Crossover Treatment 3||3
1046118|NCT00772967|2538420|P3|COMPLETED|Crossover Treatment 3||3
1046119|NCT00772967|2538421|P2|COMPLETED|Crossover Treatment 3||4
1046120|NCT00772967|2538422|P1|COMPLETED|Crossover Treatment 3||3
1046121|NCT00772967|2538417|P6|STARTED|Crossover Treatment 3||3
1046122|NCT00772967|2538418|P5|STARTED|Crossover Treatment 3||4
1046123|NCT00772967|2538419|P4|STARTED|Crossover Treatment 3||3
1046124|NCT00772967|2538420|P3|STARTED|Crossover Treatment 3||3
1046125|NCT00772967|2538421|P2|STARTED|Crossover Treatment 3||4
1046126|NCT00772967|2538422|P1|STARTED|Crossover Treatment 3||3
1046127|NCT00772967|2538417|P6|NOT COMPLETED|Break 2 (4-7 Days)||0
1046128|NCT00772967|2538418|P5|NOT COMPLETED|Break 2 (4-7 Days)||0
1046129|NCT00772967|2538419|P4|NOT COMPLETED|Break 2 (4-7 Days)||0
1046130|NCT00772967|2538420|P3|NOT COMPLETED|Break 2 (4-7 Days)||0
1046131|NCT00772967|2538421|P2|NOT COMPLETED|Break 2 (4-7 Days)||0
1046132|NCT00772967|2538422|P1|NOT COMPLETED|Break 2 (4-7 Days)||0
1046133|NCT00772967|2538417|P6|COMPLETED|Break 2 (4-7 Days)||3
1046134|NCT00772967|2538418|P5|COMPLETED|Break 2 (4-7 Days)||4
1046135|NCT00772967|2538419|P4|COMPLETED|Break 2 (4-7 Days)||3
1046136|NCT00772967|2538420|P3|COMPLETED|Break 2 (4-7 Days)||3
1046137|NCT00772967|2538421|P2|COMPLETED|Break 2 (4-7 Days)||4
1046138|NCT00772967|2538422|P1|COMPLETED|Break 2 (4-7 Days)||3
1046139|NCT00772967|2538417|P6|STARTED|Break 2 (4-7 Days)||3
1046140|NCT00772967|2538418|P5|STARTED|Break 2 (4-7 Days)||4
1046141|NCT00772967|2538419|P4|STARTED|Break 2 (4-7 Days)||3
1046142|NCT00772967|2538420|P3|STARTED|Break 2 (4-7 Days)||3
1046143|NCT00772967|2538421|P2|STARTED|Break 2 (4-7 Days)||4
1046144|NCT00772967|2538422|P1|STARTED|Break 2 (4-7 Days)||3
1046145|NCT00772967|2538417|P6|NOT COMPLETED|Crossover Treatment 2||0
1046146|NCT00772967|2538418|P5|NOT COMPLETED|Crossover Treatment 2||0
1046147|NCT00772967|2538419|P4|NOT COMPLETED|Crossover Treatment 2||0
1046148|NCT00772967|2538420|P3|NOT COMPLETED|Crossover Treatment 2||0
1046149|NCT00772967|2538421|P2|NOT COMPLETED|Crossover Treatment 2||0
1046150|NCT00772967|2538422|P1|NOT COMPLETED|Crossover Treatment 2||0
1046151|NCT00772967|2538417|P6|COMPLETED|Crossover Treatment 2||3
1046152|NCT00772967|2538418|P5|COMPLETED|Crossover Treatment 2||4
1046153|NCT00772967|2538419|P4|COMPLETED|Crossover Treatment 2||3
1046154|NCT00772967|2538420|P3|COMPLETED|Crossover Treatment 2||3
1046155|NCT00772967|2538421|P2|COMPLETED|Crossover Treatment 2||4
1046156|NCT00772967|2538422|P1|COMPLETED|Crossover Treatment 2||3
1046157|NCT00772967|2538417|P6|STARTED|Crossover Treatment 2||3
1046158|NCT00772967|2538418|P5|STARTED|Crossover Treatment 2||4
1046159|NCT00772967|2538419|P4|STARTED|Crossover Treatment 2||3
1046160|NCT00772967|2538420|P3|STARTED|Crossover Treatment 2||3
1046161|NCT00772967|2538421|P2|STARTED|Crossover Treatment 2||4
1046162|NCT00772967|2538422|P1|STARTED|Crossover Treatment 2||3
1046163|NCT00772967|2538417|P6|NOT COMPLETED|Break 1 (4-7 Days)||0
1046164|NCT00772967|2538418|P5|NOT COMPLETED|Break 1 (4-7 Days)||0
1046165|NCT00772967|2538419|P4|NOT COMPLETED|Break 1 (4-7 Days)||0
1046166|NCT00772967|2538420|P3|NOT COMPLETED|Break 1 (4-7 Days)||0
1046167|NCT00772967|2538421|P2|NOT COMPLETED|Break 1 (4-7 Days)||1
1046168|NCT00772967|2538422|P1|NOT COMPLETED|Break 1 (4-7 Days)||0
1046169|NCT00772967|2538417|P6|COMPLETED|Break 1 (4-7 Days)||3
1046170|NCT00772967|2538418|P5|COMPLETED|Break 1 (4-7 Days)||4
1046171|NCT00772967|2538419|P4|COMPLETED|Break 1 (4-7 Days)||3
1046172|NCT00772967|2538420|P3|COMPLETED|Break 1 (4-7 Days)||3
1046173|NCT00772967|2538421|P2|COMPLETED|Break 1 (4-7 Days)||4
1046174|NCT00772967|2538422|P1|COMPLETED|Break 1 (4-7 Days)||3
1046175|NCT00772967|2538417|P6|STARTED|Break 1 (4-7 Days)||3
1046176|NCT00772967|2538418|P5|STARTED|Break 1 (4-7 Days)||4
1046177|NCT00772967|2538419|P4|STARTED|Break 1 (4-7 Days)||3
1046178|NCT00772967|2538420|P3|STARTED|Break 1 (4-7 Days)||3
1046179|NCT00772967|2538421|P2|STARTED|Break 1 (4-7 Days)||5
1046180|NCT00772967|2538422|P1|STARTED|Break 1 (4-7 Days)||3
1046181|NCT00772967|2538417|P6|NOT COMPLETED|Crossover Treatment 1||0
1046182|NCT00772967|2538418|P5|NOT COMPLETED|Crossover Treatment 1||0
1046183|NCT00772967|2538419|P4|NOT COMPLETED|Crossover Treatment 1||1
1046184|NCT00772967|2538420|P3|NOT COMPLETED|Crossover Treatment 1||0
1046185|NCT00772967|2538421|P2|NOT COMPLETED|Crossover Treatment 1||0
1046186|NCT00772967|2538422|P1|NOT COMPLETED|Crossover Treatment 1||0
1046187|NCT00772967|2538417|P6|COMPLETED|Crossover Treatment 1||3
1046188|NCT00772967|2538418|P5|COMPLETED|Crossover Treatment 1||4
1046189|NCT00772967|2538419|P4|COMPLETED|Crossover Treatment 1|The withdrawal is not included in any outcomes; but is part of the Adverse Event group for placebo|3
1046190|NCT00772967|2538420|P3|COMPLETED|Crossover Treatment 1||3
1046191|NCT00772967|2538421|P2|COMPLETED|Crossover Treatment 1||5
1046192|NCT00772967|2538422|P1|COMPLETED|Crossover Treatment 1||3
1046193|NCT00772967|2538417|P6|STARTED|Crossover Treatment 1||3
1046194|NCT00772967|2538418|P5|STARTED|Crossover Treatment 1||4
1046195|NCT00772967|2538419|P4|STARTED|Crossover Treatment 1||4
1046196|NCT00772967|2538420|P3|STARTED|Crossover Treatment 1||3
1046197|NCT00772967|2538421|P2|STARTED|Crossover Treatment 1||5
1046198|NCT00772967|2538422|P1|STARTED|Crossover Treatment 1||3
1046199|NCT00773097|2538439|P1|NOT COMPLETED|Overall Study||7
1046200|NCT00773097|2538439|P1|COMPLETED|Overall Study||39
1046201|NCT00773097|2538439|P1|STARTED|Overall Study||46
1046202|NCT00773136|2538445|P1|NOT COMPLETED|Overall Study||2
1046203|NCT00773136|2538445|P1|COMPLETED|Overall Study||19
1046204|NCT00773136|2538445|P1|STARTED|Overall Study||21
1046205|NCT00773253|2538452|P2|NOT COMPLETED|Second Intervention (Week 24-48)||0
1046206|NCT00773253|2538453|P1|NOT COMPLETED|Second Intervention (Week 24-48)||0
1046207|NCT00773253|2538452|P2|COMPLETED|Second Intervention (Week 24-48)||4
1046208|NCT00773253|2538453|P1|COMPLETED|Second Intervention (Week 24-48)||5
1046209|NCT00773253|2538452|P2|STARTED|Second Intervention (Week 24-48)||4
1046210|NCT00773253|2538453|P1|STARTED|Second Intervention (Week 24-48)||5
1046211|NCT00773253|2538452|P2|NOT COMPLETED|First Intervention (Week 0-24)||1
1046212|NCT00773253|2538453|P1|NOT COMPLETED|First Intervention (Week 0-24)||0
1046213|NCT00773253|2538452|P2|COMPLETED|First Intervention (Week 0-24)||4
1046214|NCT00773253|2538453|P1|COMPLETED|First Intervention (Week 0-24)||5
1046215|NCT00773253|2538452|P2|STARTED|First Intervention (Week 0-24)||5
1046216|NCT00773253|2538453|P1|STARTED|First Intervention (Week 0-24)||5
1046217|NCT00773279|2538459|P2|NOT COMPLETED|Period 2||6
1046218|NCT00773279|2538460|P1|NOT COMPLETED|Period 2||3
1046219|NCT00773279|2538459|P2|COMPLETED|Period 2||111
1046220|NCT00773279|2538460|P1|COMPLETED|Period 2||111
1046221|NCT00773279|2538459|P2|STARTED|Period 2||117
1046222|NCT00773279|2538460|P1|STARTED|Period 2||114
1046223|NCT00773279|2538459|P2|NOT COMPLETED|Period 1||4
1046224|NCT00773279|2538460|P1|NOT COMPLETED|Period 1||7
1046225|NCT00773279|2538459|P2|COMPLETED|Period 1||117
1046226|NCT00773279|2538460|P1|COMPLETED|Period 1||114
1046227|NCT00773279|2538459|P2|STARTED|Period 1||121
1046228|NCT00773279|2538460|P1|STARTED|Period 1||121
1046229|NCT00773370|2538481|P2|NOT COMPLETED|Overall Study||10
1046230|NCT00773370|2538482|P1|NOT COMPLETED|Overall Study||18
1046231|NCT00773370|2538481|P2|COMPLETED|Overall Study||23
1046232|NCT00773370|2538482|P1|COMPLETED|Overall Study||25
1046233|NCT00773370|2538481|P2|STARTED|Overall Study||33
1046234|NCT00773370|2538482|P1|STARTED|Overall Study||43
1046235|NCT00773383|2538494|P1|NOT COMPLETED|Overall Study||31
1046236|NCT00773383|2538494|P1|COMPLETED|Overall Study|this includes at the time of clinical cut-off (2/23/2010) there were 4 patients ongoing|4
1046237|NCT00773383|2538494|P1|Received Study Drug|Overall Study||34
1046238|NCT00773383|2538494|P1|STARTED|Overall Study||35
1046239|NCT00773461|2538516|P2|NOT COMPLETED|Overall Study||4
1046240|NCT00773461|2538517|P1|NOT COMPLETED|Overall Study||5
1046241|NCT00773461|2538516|P2|COMPLETED|Overall Study||135
1046242|NCT00773461|2538517|P1|COMPLETED|Overall Study||65
1046243|NCT00773461|2538516|P2|STARTED|Overall Study||139
1046244|NCT00773461|2538517|P1|STARTED|Overall Study||70
1046245|NCT00773474|2538555|P1|NOT COMPLETED|Overall Study||0
1046246|NCT00773474|2538555|P1|COMPLETED|Overall Study||29
1046247|NCT00773474|2538555|P1|STARTED|Overall Study||29
1046248|NCT00773734|2538566|P6|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
1046249|NCT00773734|2538567|P5|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
1046250|NCT00773734|2538568|P4|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
1046251|NCT00773734|2538569|P3|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
1046252|NCT00773734|2538570|P2|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
1046253|NCT00773734|2538571|P1|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
1046254|NCT00773734|2538566|P6|COMPLETED|LTE Period: Week 52 to 6 Years||0
1046255|NCT00773734|2538567|P5|COMPLETED|LTE Period: Week 52 to 6 Years||0
1046256|NCT00773734|2538568|P4|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|5
1046257|NCT00773734|2538569|P3|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|4
1046258|NCT00773734|2538570|P2|COMPLETED|LTE Period: Week 52 to 6 Years||0
1046259|NCT00773734|2538571|P1|COMPLETED|LTE Period: Week 52 to 6 Years||0
1046260|NCT00773734|2538566|P6|STARTED|LTE Period: Week 52 to 6 Years||0
1046261|NCT00773734|2538567|P5|STARTED|LTE Period: Week 52 to 6 Years||0
1046262|NCT00773734|2538568|P4|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|17
1046330|NCT00773786|2539133|P2|STARTED|Second Intervention (1 Week)||10
1046263|NCT00773734|2538569|P3|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|16
1046264|NCT00773734|2538570|P2|STARTED|LTE Period: Week 52 to 6 Years||0
1046265|NCT00773734|2538571|P1|STARTED|LTE Period: Week 52 to 6 Years||0
1046266|NCT00773734|2538566|P6|NOT COMPLETED|Extension: Active Treatment Week 24-52||8
1046267|NCT00773734|2538567|P5|NOT COMPLETED|Extension: Active Treatment Week 24-52||5
1046268|NCT00773734|2538568|P4|NOT COMPLETED|Extension: Active Treatment Week 24-52||10
1046269|NCT00773734|2538569|P3|NOT COMPLETED|Extension: Active Treatment Week 24-52||17
1046270|NCT00773734|2538570|P2|NOT COMPLETED|Extension: Active Treatment Week 24-52||13
1046271|NCT00773734|2538571|P1|NOT COMPLETED|Extension: Active Treatment Week 24-52||0
1046272|NCT00773734|2538566|P6|COMPLETED|Extension: Active Treatment Week 24-52||19
1046273|NCT00773734|2538567|P5|COMPLETED|Extension: Active Treatment Week 24-52||22
1046274|NCT00773734|2538568|P4|COMPLETED|Extension: Active Treatment Week 24-52||48
1046275|NCT00773734|2538569|P3|COMPLETED|Extension: Active Treatment Week 24-52||33
1046276|NCT00773734|2538570|P2|COMPLETED|Extension: Active Treatment Week 24-52|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|34
1046277|NCT00773734|2538571|P1|COMPLETED|Extension: Active Treatment Week 24-52||0
1046278|NCT00773734|2538566|P6|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
1046279|NCT00773734|2538567|P5|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
1046280|NCT00773734|2538568|P4|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
1046281|NCT00773734|2538569|P3|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
1046282|NCT00773734|2538570|P2|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||5
1046283|NCT00773734|2538571|P1|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||0
1046284|NCT00773734|2538566|P6|STARTED|Extension: Active Treatment Week 24-52||27
1046285|NCT00773734|2538567|P5|STARTED|Extension: Active Treatment Week 24-52||27
1046286|NCT00773734|2538568|P4|STARTED|Extension: Active Treatment Week 24-52||58
1046287|NCT00773734|2538569|P3|STARTED|Extension: Active Treatment Week 24-52||50
1046288|NCT00773734|2538570|P2|STARTED|Extension: Active Treatment Week 24-52||47
1046289|NCT00773734|2538571|P1|STARTED|Extension: Active Treatment Week 24-52||0
1046290|NCT00773734|2538566|P6|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||5
1046291|NCT00773734|2538567|P5|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||1
1046292|NCT00773734|2538568|P4|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||2
1046293|NCT00773734|2538569|P3|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||7
1046294|NCT00773734|2538570|P2|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||12
1046295|NCT00773734|2538571|P1|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||0
1046296|NCT00773734|2538566|P6|COMPLETED|Core: Active Treatment Phase Week 16-24||31
1046297|NCT00773734|2538567|P5|COMPLETED|Core: Active Treatment Phase Week 16-24||33
1046298|NCT00773734|2538568|P4|COMPLETED|Core: Active Treatment Phase Week 16-24||65
1046299|NCT00773734|2538569|P3|COMPLETED|Core: Active Treatment Phase Week 16-24||59
1046300|NCT00773734|2538570|P2|COMPLETED|Core: Active Treatment Phase Week 16-24||65
1046301|NCT00773734|2538571|P1|COMPLETED|Core: Active Treatment Phase Week 16-24||0
1046302|NCT00773734|2538566|P6|STARTED|Core: Active Treatment Phase Week 16-24||36
1046303|NCT00773734|2538567|P5|STARTED|Core: Active Treatment Phase Week 16-24||34
1046304|NCT00773734|2538568|P4|STARTED|Core: Active Treatment Phase Week 16-24|3 participants elected not to continue from previous period|67
1046305|NCT00773734|2538569|P3|STARTED|Core: Active Treatment Phase Week 16-24||66
1046306|NCT00773734|2538570|P2|STARTED|Core: Active Treatment Phase Week 16-24|2 participants elected not to continue from previous period|77
1046307|NCT00773734|2538571|P1|STARTED|Core: Active Treatment Phase Week 16-24|Placebo participants were re-randomized at Week 16 to receive apremilast 20mg or 30mg PO BID.|0
1046308|NCT00773734|2538566|P6|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
1046309|NCT00773734|2538567|P5|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
1046310|NCT00773734|2538568|P4|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||18
1046311|NCT00773734|2538569|P3|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||21
1046312|NCT00773734|2538570|P2|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||10
1046313|NCT00773734|2538571|P1|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||16
1046314|NCT00773734|2538566|P6|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
1046315|NCT00773734|2538567|P5|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
1046316|NCT00773734|2538568|P4|COMPLETED|Core: Placebo Controlled Phase Week 0-16|3 participants completed placebo controlled phase but elected not to continue|70
1046317|NCT00773734|2538569|P3|COMPLETED|Core: Placebo Controlled Phase Week 0-16||66
1046318|NCT00773734|2538570|P2|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|79
1046319|NCT00773734|2538571|P1|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|72
1046320|NCT00773734|2538566|P6|STARTED|Core: Placebo Controlled Phase Week 0-16||0
1046321|NCT00773734|2538567|P5|STARTED|Core: Placebo Controlled Phase Week 0-16||0
1046322|NCT00773734|2538568|P4|STARTED|Core: Placebo Controlled Phase Week 0-16||88
1046323|NCT00773734|2538569|P3|STARTED|Core: Placebo Controlled Phase Week 0-16||87
1046324|NCT00773734|2538570|P2|STARTED|Core: Placebo Controlled Phase Week 0-16||89
1046325|NCT00773734|2538571|P1|STARTED|Core: Placebo Controlled Phase Week 0-16||88
1046326|NCT00773786|2539133|P2|NOT COMPLETED|Second Intervention (1 Week)||0
1046327|NCT00773786|2539134|P1|NOT COMPLETED|Second Intervention (1 Week)||0
1046328|NCT00773786|2539133|P2|COMPLETED|Second Intervention (1 Week)||10
1046329|NCT00773786|2539134|P1|COMPLETED|Second Intervention (1 Week)||10
1046331|NCT00773786|2539134|P1|STARTED|Second Intervention (1 Week)||10
1046332|NCT00773786|2539133|P2|NOT COMPLETED|Washout (1 Week)||0
1046333|NCT00773786|2539134|P1|NOT COMPLETED|Washout (1 Week)||0
1046334|NCT00773786|2539133|P2|COMPLETED|Washout (1 Week)||10
1046335|NCT00773786|2539134|P1|COMPLETED|Washout (1 Week)||10
1046336|NCT00773786|2539133|P2|STARTED|Washout (1 Week)||10
1046337|NCT00773786|2539134|P1|STARTED|Washout (1 Week)||10
1046338|NCT00773786|2539133|P2|NOT COMPLETED|First Intervention (1 Week)||0
1046339|NCT00773786|2539134|P1|NOT COMPLETED|First Intervention (1 Week)||0
1046340|NCT00773786|2539133|P2|COMPLETED|First Intervention (1 Week)||10
1046341|NCT00773786|2539134|P1|COMPLETED|First Intervention (1 Week)||10
1046342|NCT00773786|2539133|P2|STARTED|First Intervention (1 Week)||10
1046343|NCT00773786|2539134|P1|STARTED|First Intervention (1 Week)||10
1046344|NCT00773955|2539144|P1|NOT COMPLETED|Overall Study||0
1046345|NCT00773955|2539144|P1|COMPLETED|Overall Study||15
1046346|NCT00773955|2539144|P1|STARTED|Overall Study||15
1046347|NCT00773968|2539151|P1|NOT COMPLETED|Overall Study||45
1046348|NCT00773968|2539151|P1|COMPLETED|Overall Study||95
1046349|NCT00773968|2539151|P1|Treated|Overall Study||111
1046350|NCT00773968|2539151|P1|STARTED|Overall Study||140
1046351|NCT00774046|2539160|P1|NOT COMPLETED|Autologous Transplant||0
1046352|NCT00774046|2539160|P1|COMPLETED|Autologous Transplant||4
1046353|NCT00774046|2539160|P1|STARTED|Autologous Transplant|2 patients died in remission and 1 relapsed without having received transplant|4
1046354|NCT00774046|2539160|P1|NOT COMPLETED|Stem Cell Mobilization||3
1046355|NCT00774046|2539160|P1|COMPLETED|Stem Cell Mobilization||7
1046356|NCT00774046|2539160|P1|STARTED|Stem Cell Mobilization|For mobilization, the patient must have had a CR and not been a candidate for allogeneic transplant|10
1046357|NCT00774046|2539160|P1|NOT COMPLETED|Induction Therapy||0
1046358|NCT00774046|2539160|P1|COMPLETED|Induction Therapy||32
1046359|NCT00774046|2539160|P1|STARTED|Induction Therapy||32
1046360|NCT00774046|2539160|P1|NOT COMPLETED|Enrollment||28
1046361|NCT00774046|2539160|P1|COMPLETED|Enrollment||32
1046362|NCT00774046|2539160|P1|STARTED|Enrollment||60
1046363|NCT00774046|2539160|P1|NOT COMPLETED|Screening||56
1046364|NCT00774046|2539160|P1|COMPLETED|Screening||60
1046365|NCT00774046|2539160|P1|STARTED|Screening||116
1046366|NCT00774163|2539172|P2|NOT COMPLETED|Overall Study||0
1046367|NCT00774163|2539173|P1|NOT COMPLETED|Overall Study||0
1046368|NCT00774163|2539172|P2|COMPLETED|Overall Study||15
1046369|NCT00774163|2539173|P1|COMPLETED|Overall Study||30
1046370|NCT00774163|2539172|P2|STARTED|Overall Study||15
1046371|NCT00774163|2539173|P1|STARTED|Overall Study||30
1046372|NCT00774267|2539215|P4|NOT COMPLETED|Overall Study||0
1046373|NCT00774267|2539216|P3|NOT COMPLETED|Overall Study||0
1046374|NCT00774267|2539217|P2|NOT COMPLETED|Overall Study||0
1046375|NCT00774267|2539218|P1|NOT COMPLETED|Overall Study||0
1046376|NCT00774267|2539215|P4|COMPLETED|Overall Study||135
1046377|NCT00774267|2539216|P3|COMPLETED|Overall Study||129
1046378|NCT00774267|2539217|P2|COMPLETED|Overall Study||111
1046379|NCT00774267|2539218|P1|COMPLETED|Overall Study||132
1046380|NCT00774267|2539215|P4|STARTED|Overall Study||135
1046381|NCT00774267|2539216|P3|STARTED|Overall Study||129
1046382|NCT00774267|2539217|P2|STARTED|Overall Study||111
1046383|NCT00774267|2539218|P1|STARTED|Overall Study||132
1046384|NCT00774306|2539232|P4|NOT COMPLETED|Overall Study||5
1046385|NCT00774306|2539233|P3|NOT COMPLETED|Overall Study||8
1046386|NCT00774306|2539234|P2|NOT COMPLETED|Overall Study||2
1046387|NCT00774306|2539235|P1|NOT COMPLETED|Overall Study||18
1046388|NCT00774306|2539232|P4|COMPLETED|Overall Study||2
1046389|NCT00774306|2539233|P3|COMPLETED|Overall Study||8
1046390|NCT00774306|2539234|P2|COMPLETED|Overall Study||3
1046391|NCT00774306|2539235|P1|COMPLETED|Overall Study||6
1046392|NCT00774306|2539232|P4|STARTED|Overall Study||7
1046393|NCT00774306|2539233|P3|STARTED|Overall Study||16
1046394|NCT00774306|2539234|P2|STARTED|Overall Study||5
1046395|NCT00774306|2539235|P1|STARTED|Overall Study||24
1046396|NCT00774397|2539252|P7|NOT COMPLETED|Overall Study||30
1046397|NCT00774397|2539253|P6|NOT COMPLETED|Overall Study||22
1046398|NCT00774397|2539254|P5|NOT COMPLETED|Overall Study||46
1046399|NCT00774397|2539255|P4|NOT COMPLETED|Overall Study||17
1046400|NCT00774397|2539256|P3|NOT COMPLETED|Overall Study||30
1046401|NCT00774397|2539257|P2|NOT COMPLETED|Overall Study||13
1046402|NCT00774397|2539258|P1|NOT COMPLETED|Overall Study||14
1046403|NCT00774397|2539252|P7|COMPLETED|Overall Study||41
1046404|NCT00774397|2539253|P6|COMPLETED|Overall Study||54
1046405|NCT00774397|2539254|P5|COMPLETED|Overall Study||97
1046406|NCT00774397|2539255|P4|COMPLETED|Overall Study||129
1046407|NCT00774397|2539256|P3|COMPLETED|Overall Study||113
1046408|NCT00774397|2539257|P2|COMPLETED|Overall Study||56
1046409|NCT00774397|2539258|P1|COMPLETED|Overall Study||57
1046410|NCT00774397|2539252|P7|STARTED|Overall Study||71
1046411|NCT00774397|2539253|P6|STARTED|Overall Study||76
1046412|NCT00774397|2539254|P5|STARTED|Overall Study||143
1046413|NCT00774397|2539255|P4|STARTED|Overall Study||146
1046414|NCT00774397|2539256|P3|STARTED|Overall Study||143
1046415|NCT00774397|2539257|P2|STARTED|Overall Study||69
1046416|NCT00774397|2539258|P1|STARTED|Overall Study||71
1046417|NCT00774748|2539490|P1|NOT COMPLETED|Overall Study||3
1046418|NCT00774748|2539490|P1|COMPLETED|Overall Study||18
1046419|NCT00774748|2539490|P1|STARTED|Overall Study||21
1046420|NCT00774787|2539498|P1|NOT COMPLETED|Overall Study||1
1046421|NCT00774787|2539498|P1|COMPLETED|Overall Study||26
1046422|NCT00774787|2539498|P1|STARTED|Overall Study||27
1046423|NCT00774800|2539505|P1|NOT COMPLETED|Intervention 4||1
1046424|NCT00774800|2539505|P1|COMPLETED|Intervention 4||21
1046425|NCT00774800|2539505|P1|Received at Least One Dose of Study Drug|Intervention 4||21
1046426|NCT00774800|2539505|P1|STARTED|Intervention 4||22
1046427|NCT00774800|2539505|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
1046428|NCT00774800|2539505|P1|COMPLETED|Washout (3 to 10 Days)||22
1046429|NCT00774800|2539505|P1|STARTED|Washout (3 to 10 Days)||22
1046430|NCT00774800|2539505|P1|NOT COMPLETED|Intervention 3||0
1046431|NCT00774800|2539505|P1|COMPLETED|Intervention 3||22
1046432|NCT00774800|2539505|P1|Received at Least One Dose of Study Drug|Intervention 3||22
1046433|NCT00774800|2539505|P1|STARTED|Intervention 3||22
1046434|NCT00774800|2539505|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
1046435|NCT00774800|2539505|P1|COMPLETED|Washout (3 to 10 Days)||22
1046436|NCT00774800|2539505|P1|STARTED|Washout (3 to 10 Days)||22
1046437|NCT00774800|2539505|P1|NOT COMPLETED|Intervention 2||0
1046438|NCT00774800|2539505|P1|COMPLETED|Intervention 2||22
1046439|NCT00774800|2539505|P1|Received at Least One Dose of Study Drug|Intervention 2||22
1046440|NCT00774800|2539505|P1|STARTED|Intervention 2||22
1046441|NCT00774800|2539505|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
1046442|NCT00774800|2539505|P1|COMPLETED|Washout (3 to 10 Days)||22
1046443|NCT00774800|2539505|P1|STARTED|Washout (3 to 10 Days)||22
1046444|NCT00774800|2539505|P1|NOT COMPLETED|Intervention 1||0
1046445|NCT00774800|2539505|P1|COMPLETED|Intervention 1||22
1046446|NCT00774800|2539505|P1|Received at Least One Dose of Study Drug|Intervention 1||22
1046447|NCT00774800|2539505|P1|STARTED|Intervention 1||22
1046448|NCT00774852|2539529|P2|NOT COMPLETED|Overall Study||41
1046449|NCT00774852|2539530|P1|NOT COMPLETED|Overall Study||45
1046450|NCT00774852|2539529|P2|COMPLETED|Overall Study||27
1046451|NCT00774852|2539530|P1|COMPLETED|Overall Study||24
1046452|NCT00774852|2539529|P2|STARTED|Overall Study||68
1046453|NCT00774852|2539530|P1|STARTED|Overall Study||69
1046454|NCT00774930|2539580|P2|NOT COMPLETED|LTOLE Phase||17
1046455|NCT00774930|2539581|P1|NOT COMPLETED|LTOLE Phase||15
1046456|NCT00774930|2539580|P2|COMPLETED|LTOLE Phase||8
1046457|NCT00774930|2539581|P1|COMPLETED|LTOLE Phase||17
1046458|NCT00774930|2539580|P2|STARTED|LTOLE Phase|20 subjects from IOL did not enter LTOLE (12 completed IOL, 8 did not complete IOL).|25
1046459|NCT00774930|2539581|P1|STARTED|LTOLE Phase|24 subjects from IOL did not enter LTOLE (11 completed IOL, 13 did not complete IOL).|32
1046460|NCT00774930|2539580|P2|NOT COMPLETED|IOL Phase||9
1046461|NCT00774930|2539581|P1|NOT COMPLETED|IOL Phase||13
1046462|NCT00774930|2539580|P2|COMPLETED|IOL Phase||37
1046463|NCT00774930|2539581|P1|COMPLETED|IOL Phase||43
1046464|NCT00774930|2539580|P2|STARTED|IOL Phase|Includes 1 subject listed as completing and withdrawing from the DB phase due to brain radiation|46
1046465|NCT00774930|2539581|P1|STARTED|IOL Phase||56
1046466|NCT00774930|2539580|P2|NOT COMPLETED|DB Phase||22
1046467|NCT00774930|2539581|P1|NOT COMPLETED|DB Phase||14
1046468|NCT00774930|2539580|P2|COMPLETED|DB Phase|had diary data at least up to day 21 after 4th dose, regardless of missing diary data before day 21.|34
1046469|NCT00774930|2539581|P1|COMPLETED|DB Phase|Received 4 DB study injections AND continued to IOL phase OR|45
1046470|NCT00774930|2539580|P2|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|56
1046471|NCT00774930|2539581|P1|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|59
1046472|NCT00769314|2539609|P2|NOT COMPLETED|Overall Study||13
1046473|NCT00769314|2539610|P1|NOT COMPLETED|Overall Study||17
1046474|NCT00769314|2539609|P2|COMPLETED|Overall Study||384
1046475|NCT00769314|2539610|P1|COMPLETED|Overall Study||361
1046476|NCT00769314|2539609|P2|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|397
1046477|NCT00769314|2539610|P1|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|378
1046478|NCT00774995|2539640|P4|NOT COMPLETED|Overall Study||0
1046479|NCT00774995|2539641|P3|NOT COMPLETED|Overall Study||1
1046480|NCT00774995|2539642|P2|NOT COMPLETED|Overall Study||0
1046481|NCT00774995|2539643|P1|NOT COMPLETED|Overall Study||0
1046482|NCT00774995|2539640|P4|COMPLETED|Overall Study||16
1046483|NCT00774995|2539641|P3|COMPLETED|Overall Study||7
1046484|NCT00774995|2539642|P2|COMPLETED|Overall Study||16
1046485|NCT00774995|2539643|P1|COMPLETED|Overall Study||9
1046486|NCT00774995|2539640|P4|STARTED|Overall Study||16
1046487|NCT00774995|2539641|P3|STARTED|Overall Study||8
1046488|NCT00774995|2539642|P2|STARTED|Overall Study||16
1046489|NCT00774995|2539643|P1|STARTED|Overall Study||9
1046490|NCT00775021|2539681|P2|NOT COMPLETED|Second Intervention||1
1046491|NCT00775021|2539682|P1|NOT COMPLETED|Second Intervention||0
1046492|NCT00775021|2539681|P2|COMPLETED|Second Intervention||59
1046493|NCT00775021|2539682|P1|COMPLETED|Second Intervention||62
1046494|NCT00775021|2539681|P2|STARTED|Second Intervention||60
1046495|NCT00775021|2539682|P1|STARTED|Second Intervention||62
1046496|NCT00775021|2539681|P2|NOT COMPLETED|First Intervention||0
1046497|NCT00775021|2539682|P1|NOT COMPLETED|First Intervention||1
1046498|NCT00775021|2539681|P2|COMPLETED|First Intervention||60
1046499|NCT00775021|2539682|P1|COMPLETED|First Intervention||62
1046500|NCT00775021|2539681|P2|STARTED|First Intervention||60
1046501|NCT00775021|2539682|P1|STARTED|First Intervention||63
1046502|NCT00775190|2539698|P2|NOT COMPLETED|Overall Study||5
1046503|NCT00775190|2539699|P1|NOT COMPLETED|Overall Study||4
1046504|NCT00775190|2539698|P2|COMPLETED|Overall Study||0
1046505|NCT00775190|2539699|P1|COMPLETED|Overall Study||3
1046506|NCT00775190|2539698|P2|STARTED|Overall Study||5
1046507|NCT00775190|2539699|P1|STARTED|Overall Study||7
1046508|NCT00775203|2539723|P2|NOT COMPLETED|Overall Study||43
1046509|NCT00775203|2539724|P1|NOT COMPLETED|Overall Study||62
1046510|NCT00775203|2539723|P2|COMPLETED|Overall Study||163
1046511|NCT00775203|2539724|P1|COMPLETED|Overall Study||144
1046512|NCT00775203|2539723|P2|Received Study Medication|Overall Study||204
1046513|NCT00775203|2539724|P1|Received Study Medication|Overall Study||202
1046514|NCT00775203|2539723|P2|STARTED|Overall Study||206
1046515|NCT00775203|2539724|P1|STARTED|Overall Study||206
1046516|NCT00775229|2539758|P2|NOT COMPLETED|Overall Study||2
1046517|NCT00775229|2539759|P1|NOT COMPLETED|Overall Study||5
1046518|NCT00775229|2539758|P2|COMPLETED|Overall Study||24
1046519|NCT00775229|2539759|P1|COMPLETED|Overall Study||20
1046520|NCT00775229|2539758|P2|STARTED|Overall Study||26
1046521|NCT00775229|2539759|P1|STARTED|Overall Study||25
1046522|NCT00775944|2539773|P4|NOT COMPLETED|Overall Study||16
1046523|NCT00775944|2539774|P3|NOT COMPLETED|Overall Study||16
1046524|NCT00775944|2539775|P2|NOT COMPLETED|Overall Study||9
1046525|NCT00775944|2539776|P1|NOT COMPLETED|Overall Study||15
1046526|NCT00775944|2539773|P4|COMPLETED|Overall Study|16 participants withdrew consent|632
1046527|NCT00775944|2539774|P3|COMPLETED|Overall Study|16 participants withdrew consent|632
1046528|NCT00775944|2539775|P2|COMPLETED|Overall Study|9 participants withdrew consent|638
1046529|NCT00775944|2539776|P1|COMPLETED|Overall Study|15 participants withdrew consent|633
1046530|NCT00775944|2539773|P4|STARTED|Overall Study||648
1046531|NCT00775944|2539774|P3|STARTED|Overall Study||648
1046532|NCT00775944|2539775|P2|STARTED|Overall Study||647
1046533|NCT00775944|2539776|P1|STARTED|Overall Study||648
1046534|NCT00775983|2539804|P2|NOT COMPLETED|Overall Study||2
1046535|NCT00775983|2539805|P1|NOT COMPLETED|Overall Study||1
1046536|NCT00775983|2539804|P2|COMPLETED|Overall Study||34
1046537|NCT00775983|2539805|P1|COMPLETED|Overall Study||35
1046538|NCT00775983|2539804|P2|STARTED|Overall Study||36
1046539|NCT00775983|2539805|P1|STARTED|Overall Study||36
1046540|NCT00776009|2539819|P6|NOT COMPLETED|Period 3: Third Intervention||0
1046541|NCT00776009|2539820|P5|NOT COMPLETED|Period 3: Third Intervention||0
1046542|NCT00776009|2539821|P4|NOT COMPLETED|Period 3: Third Intervention||0
1046543|NCT00776009|2539822|P3|NOT COMPLETED|Period 3: Third Intervention||0
1046544|NCT00776009|2539823|P2|NOT COMPLETED|Period 3: Third Intervention||0
1046545|NCT00776009|2539824|P1|NOT COMPLETED|Period 3: Third Intervention||1
1046546|NCT00776009|2539819|P6|COMPLETED|Period 3: Third Intervention||26
1046547|NCT00776009|2539820|P5|COMPLETED|Period 3: Third Intervention||26
1046548|NCT00776009|2539821|P4|COMPLETED|Period 3: Third Intervention||27
1046549|NCT00776009|2539822|P3|COMPLETED|Period 3: Third Intervention||27
1046550|NCT00776009|2539823|P2|COMPLETED|Period 3: Third Intervention||27
1046551|NCT00776009|2539824|P1|COMPLETED|Period 3: Third Intervention||24
1046552|NCT00776009|2539819|P6|STARTED|Period 3: Third Intervention||26
1046553|NCT00776009|2539820|P5|STARTED|Period 3: Third Intervention||26
1046554|NCT00776009|2539821|P4|STARTED|Period 3: Third Intervention||27
1046555|NCT00776009|2539822|P3|STARTED|Period 3: Third Intervention||27
1046556|NCT00776009|2539823|P2|STARTED|Period 3: Third Intervention||27
1046557|NCT00776009|2539824|P1|STARTED|Period 3: Third Intervention||25
1046558|NCT00776009|2539819|P6|NOT COMPLETED|Period 2: Second Intervention||1
1046559|NCT00776009|2539820|P5|NOT COMPLETED|Period 2: Second Intervention||0
1046560|NCT00776009|2539821|P4|NOT COMPLETED|Period 2: Second Intervention||0
1046561|NCT00776009|2539822|P3|NOT COMPLETED|Period 2: Second Intervention||1
1046562|NCT00776009|2539823|P2|NOT COMPLETED|Period 2: Second Intervention||0
1046563|NCT00776009|2539824|P1|NOT COMPLETED|Period 2: Second Intervention||1
1046564|NCT00776009|2539819|P6|COMPLETED|Period 2: Second Intervention||26
1046565|NCT00776009|2539820|P5|COMPLETED|Period 2: Second Intervention||26
1046566|NCT00776009|2539821|P4|COMPLETED|Period 2: Second Intervention||27
1046567|NCT00776009|2539822|P3|COMPLETED|Period 2: Second Intervention||27
1046568|NCT00776009|2539823|P2|COMPLETED|Period 2: Second Intervention||27
1046569|NCT00776009|2539824|P1|COMPLETED|Period 2: Second Intervention||25
1046570|NCT00776009|2539819|P6|STARTED|Period 2: Second Intervention||27
1046571|NCT00776009|2539820|P5|STARTED|Period 2: Second Intervention||26
1046572|NCT00776009|2539821|P4|STARTED|Period 2: Second Intervention||27
1046573|NCT00776009|2539822|P3|STARTED|Period 2: Second Intervention||28
1046574|NCT00776009|2539823|P2|STARTED|Period 2: Second Intervention||27
1046575|NCT00776009|2539824|P1|STARTED|Period 2: Second Intervention||26
1046576|NCT00776009|2539819|P6|NOT COMPLETED|Period 1: First Intervention||0
1046577|NCT00776009|2539820|P5|NOT COMPLETED|Period 1: First Intervention||2
1046578|NCT00776009|2539821|P4|NOT COMPLETED|Period 1: First Intervention||0
1046579|NCT00776009|2539822|P3|NOT COMPLETED|Period 1: First Intervention||1
1046580|NCT00776009|2539823|P2|NOT COMPLETED|Period 1: First Intervention||1
1046581|NCT00776009|2539824|P1|NOT COMPLETED|Period 1: First Intervention||0
1046582|NCT00776009|2539819|P6|COMPLETED|Period 1: First Intervention||27
1046583|NCT00776009|2539820|P5|COMPLETED|Period 1: First Intervention||26
1046584|NCT00776009|2539821|P4|COMPLETED|Period 1: First Intervention||27
1046585|NCT00776009|2539822|P3|COMPLETED|Period 1: First Intervention||28
1046586|NCT00776009|2539823|P2|COMPLETED|Period 1: First Intervention||27
1046587|NCT00776009|2539824|P1|COMPLETED|Period 1: First Intervention||26
1046588|NCT00776009|2539819|P6|STARTED|Period 1: First Intervention||27
1046589|NCT00776009|2539820|P5|STARTED|Period 1: First Intervention||28
1046590|NCT00776009|2539821|P4|STARTED|Period 1: First Intervention||27
1046591|NCT00776009|2539822|P3|STARTED|Period 1: First Intervention||29
1046592|NCT00776009|2539823|P2|STARTED|Period 1: First Intervention||28
1046593|NCT00776009|2539824|P1|STARTED|Period 1: First Intervention||26
1046594|NCT00776100|2539846|P2|NOT COMPLETED|Overall Study||0
1046595|NCT00776100|2539847|P1|NOT COMPLETED|Overall Study||1
1046596|NCT00776100|2539846|P2|COMPLETED|Overall Study||1
1046597|NCT00776100|2539847|P1|COMPLETED|Overall Study||0
1046598|NCT00776100|2539846|P2|STARTED|Overall Study||1
1046599|NCT00776100|2539847|P1|STARTED|Overall Study||1
1046600|NCT00776230|2539866|P3|NOT COMPLETED|Overall Study||5
1046601|NCT00776230|2539867|P2|NOT COMPLETED|Overall Study||3
1046602|NCT00776230|2539868|P1|NOT COMPLETED|Overall Study||3
1046603|NCT00776230|2539866|P3|COMPLETED|Overall Study||97
1046604|NCT00776230|2539867|P2|COMPLETED|Overall Study||100
1046605|NCT00776230|2539868|P1|COMPLETED|Overall Study||96
1046606|NCT00776230|2539866|P3|Enrolled and Vaccinated at Day 0|Overall Study||102
1046607|NCT00776230|2539867|P2|Enrolled and Vaccinated at Day 0|Overall Study||103
1046608|NCT00776230|2539868|P1|Enrolled and Vaccinated at Day 0|Overall Study||98
1046609|NCT00776230|2539866|P3|STARTED|Overall Study||102
1046610|NCT00776230|2539867|P2|STARTED|Overall Study||103
1046611|NCT00776230|2539868|P1|STARTED|Overall Study||99
1046612|NCT00776295|2539876|P1|NOT COMPLETED|Overall Study||0
1046613|NCT00776295|2539876|P1|COMPLETED|Overall Study||2
1046614|NCT00776295|2539876|P1|STARTED|Overall Study||2
1046615|NCT00776555|2539883|P2|NOT COMPLETED|Overall Study||0
1046616|NCT00776555|2539884|P1|NOT COMPLETED|Overall Study||3
1046617|NCT00776555|2539883|P2|COMPLETED|Overall Study||0
1046618|NCT00776555|2539884|P1|COMPLETED|Overall Study||0
1046619|NCT00776555|2539883|P2|STARTED|Overall Study||0
1046620|NCT00776555|2539884|P1|STARTED|Overall Study||3
1046621|NCT00776594|2539896|P2|NOT COMPLETED|Overall Study||2
1046622|NCT00776594|2539897|P1|NOT COMPLETED|Overall Study||4
1046623|NCT00776594|2539896|P2|COMPLETED|Overall Study||34
1046624|NCT00776594|2539897|P1|COMPLETED|Overall Study||62
1046625|NCT00776594|2539896|P2|STARTED|Overall Study||36
1046626|NCT00776594|2539897|P1|STARTED|Overall Study||66
1046627|NCT00776659|2539909|P1|NOT COMPLETED|Overall Study||26
1046628|NCT00776659|2539909|P1|COMPLETED|Overall Study||13
1046629|NCT00776659|2539909|P1|STARTED|Overall Study||39
1046630|NCT00776789|2539921|P2|NOT COMPLETED|Overall Study||3
1046631|NCT00776789|2539922|P1|NOT COMPLETED|Overall Study||3
1046632|NCT00776789|2539921|P2|COMPLETED|Overall Study||18
1046633|NCT00776789|2539922|P1|COMPLETED|Overall Study||17
1046634|NCT00776789|2539921|P2|STARTED|Overall Study||21
1046635|NCT00776789|2539922|P1|STARTED|Overall Study||20
1046636|NCT00776919|2539938|P4|NOT COMPLETED|Overall Study||39
1046637|NCT00776919|2539939|P3|NOT COMPLETED|Overall Study||32
1046638|NCT00776919|2539940|P2|NOT COMPLETED|Overall Study||33
1046639|NCT00776919|2539941|P1|NOT COMPLETED|Overall Study||27
1046640|NCT00776919|2539938|P4|COMPLETED|Overall Study||293
1046641|NCT00776919|2539939|P3|COMPLETED|Overall Study||296
1046642|NCT00776919|2539940|P2|COMPLETED|Overall Study||295
1046643|NCT00776919|2539941|P1|COMPLETED|Overall Study||300
1046644|NCT00776919|2539938|P4|STARTED|Overall Study||332
1046645|NCT00776919|2539939|P3|STARTED|Overall Study||328
1046646|NCT00776919|2539940|P2|STARTED|Overall Study||328
1046647|NCT00776919|2539941|P1|STARTED|Overall Study||327
1046648|NCT00776984|2540005|P2|NOT COMPLETED|Overall Study||21
1046649|NCT00776984|2540006|P1|NOT COMPLETED|Overall Study||31
1046650|NCT00776984|2540005|P2|COMPLETED|Overall Study||198
1046651|NCT00776984|2540006|P1|COMPLETED|Overall Study||203
1046652|NCT00776984|2540005|P2|STARTED|Overall Study||219
1046653|NCT00776984|2540006|P1|STARTED|Overall Study||234
1046654|NCT00776997|2540076|P1|NOT COMPLETED|Overall Study||2
1046655|NCT00776997|2540076|P1|COMPLETED|Overall Study|98 subjects evaluated at 12-months. Endpoint analysis based on all subjects treated (n=100)|98
1046656|NCT00776997|2540076|P1|STARTED|Overall Study||100
1046657|NCT00777023|2540086|P3|NOT COMPLETED|Overall Study||37
1046658|NCT00777023|2540087|P2|NOT COMPLETED|Overall Study||41
1046659|NCT00777023|2540088|P1|NOT COMPLETED|Overall Study||35
1046660|NCT00777023|2540086|P3|COMPLETED|Overall Study||146
1046661|NCT00777023|2540087|P2|COMPLETED|Overall Study||149
1046662|NCT00777023|2540088|P1|COMPLETED|Overall Study||151
1046663|NCT00777023|2540086|P3|STARTED|Overall Study|183 patients were randomized, and 183 received study treatment.|183
1046664|NCT00777023|2540087|P2|STARTED|Overall Study|190 patients were randomized, and 190 received study treatment.|190
1046665|NCT00777023|2540088|P1|STARTED|Overall Study|192 patients were randomized, but only 186 received study treatment.|186
1046666|NCT00777049|2540107|P2|NOT COMPLETED|Overall Study||1
1046667|NCT00777049|2540108|P1|NOT COMPLETED|Overall Study||1
1046668|NCT00777049|2540107|P2|COMPLETED|Overall Study||20
1046669|NCT00777049|2540108|P1|COMPLETED|Overall Study||32
1046670|NCT00777049|2540107|P2|STARTED|Overall Study||21
1046671|NCT00777049|2540108|P1|STARTED|Overall Study||33
1046672|NCT00777062|2540116|P2|NOT COMPLETED|Overall Study||5
1046673|NCT00777062|2540117|P1|NOT COMPLETED|Overall Study||3
1046674|NCT00777062|2540116|P2|COMPLETED|Overall Study||36
1046675|NCT00777062|2540117|P1|COMPLETED|Overall Study||36
1046676|NCT00777062|2540116|P2|STARTED|Overall Study||41
1046677|NCT00777062|2540117|P1|STARTED|Overall Study||39
1046678|NCT00777153|2540128|P3|NOT COMPLETED|Overall Study||37
1046679|NCT00777153|2540129|P2|NOT COMPLETED|Overall Study||83
1046680|NCT00777153|2540130|P1|NOT COMPLETED|Overall Study||90
1046681|NCT00777153|2540128|P3|COMPLETED|Overall Study||28
1046682|NCT00777153|2540129|P2|COMPLETED|Overall Study||46
1046683|NCT00777153|2540130|P1|COMPLETED|Overall Study||41
1046684|NCT00777153|2540128|P3|STARTED|Overall Study||65
1046685|NCT00777153|2540129|P2|STARTED|Overall Study||129
1046686|NCT00777153|2540130|P1|STARTED|Overall Study||131
1046687|NCT00777179|2540155|P2|NOT COMPLETED|Overall Study||0
1046688|NCT00777179|2540156|P1|NOT COMPLETED|Overall Study||0
1046689|NCT00777179|2540155|P2|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|42
1046690|NCT00777179|2540156|P1|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|75
1046691|NCT00777179|2540155|P2|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|42
1046692|NCT00777179|2540156|P1|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|75
1046693|NCT00777205|2540172|P2|NOT COMPLETED|Overall Study||71
1046694|NCT00777205|2540173|P1|NOT COMPLETED|Overall Study||31
1046695|NCT00777205|2540172|P2|COMPLETED|Overall Study||129
1046696|NCT00777205|2540173|P1|COMPLETED|Overall Study||212
1046697|NCT00777205|2540172|P2|Intervention Interruption|Overall Study|56 participants excluded from main analyses due to 2 mos interruption in study intervention|56
1046698|NCT00777205|2540173|P1|Intervention Interruption|Overall Study||0
1046699|NCT00777205|2540172|P2|STARTED|Overall Study||200
1046700|NCT00777205|2540173|P1|STARTED|Overall Study||243
1046701|NCT00777257|2540190|P3|NOT COMPLETED|Overall Study||9
1046702|NCT00777257|2540191|P2|NOT COMPLETED|Overall Study||12
1046703|NCT00777257|2540192|P1|NOT COMPLETED|Overall Study||11
1046704|NCT00777257|2540190|P3|COMPLETED|Overall Study||442
1046705|NCT00777257|2540191|P2|COMPLETED|Overall Study||438
1046706|NCT00777257|2540192|P1|COMPLETED|Overall Study||433
1046707|NCT00777257|2540190|P3|STARTED|Overall Study||451
1046708|NCT00777257|2540191|P2|STARTED|Overall Study||450
1046709|NCT00777257|2540192|P1|STARTED|Overall Study||444
1046710|NCT00777335|2540211|P2|NOT COMPLETED|Overall Study||0
1046711|NCT00777335|2540212|P1|NOT COMPLETED|Overall Study||0
1046712|NCT00777335|2540211|P2|COMPLETED|Overall Study||2
1046713|NCT00777335|2540212|P1|COMPLETED|Overall Study||2
1046714|NCT00777335|2540211|P2|STARTED|Overall Study||2
1046715|NCT00777335|2540212|P1|STARTED|Overall Study||2
1046716|NCT00777556|2540220|P1|NOT COMPLETED|Overall Study||66
1046717|NCT00777556|2540220|P1|COMPLETED|Overall Study|Completed all 3 follow-up visits|277
1046718|NCT00777556|2540220|P1|Used Product|Overall Study||297
1046719|NCT00777556|2540220|P1|Safety Population|Overall Study|Participants who used the product; two were given product in error (inappropriately self-selected)|299
1046720|NCT00777556|2540220|P1|Dispensed Product|Overall Study||307
1046721|NCT00777556|2540220|P1|STARTED|Overall Study|Enrolled; signed informed consent|343
1046722|NCT00777608|2540229|P2|NOT COMPLETED|Overall Study||6
1046723|NCT00777608|2540230|P1|NOT COMPLETED|Overall Study||4
1046724|NCT00777608|2540229|P2|COMPLETED|Overall Study||47
1046725|NCT00777608|2540230|P1|COMPLETED|Overall Study||49
1046726|NCT00777608|2540229|P2|STARTED|Overall Study||53
1046727|NCT00777608|2540230|P1|STARTED|Overall Study||53
1046728|NCT00777634|2540242|P2|NOT COMPLETED|Overall Study||1
1046729|NCT00777634|2540243|P1|NOT COMPLETED|Overall Study||5
1046730|NCT00777634|2540242|P2|COMPLETED|Overall Study||133
1046731|NCT00777634|2540243|P1|COMPLETED|Overall Study||129
1046732|NCT00777634|2540242|P2|STARTED|Overall Study||134
1046733|NCT00777634|2540243|P1|STARTED|Overall Study||134
1046734|NCT00777764|2540261|P2|NOT COMPLETED|Overall Study||1
1046735|NCT00777764|2540262|P1|NOT COMPLETED|Overall Study||0
1046736|NCT00777764|2540261|P2|COMPLETED|Overall Study||29
1046737|NCT00777764|2540262|P1|COMPLETED|Overall Study||30
1046738|NCT00777764|2540261|P2|STARTED|Overall Study||30
1046739|NCT00777764|2540262|P1|STARTED|Overall Study||30
1046740|NCT00777790|2540275|P3|NOT COMPLETED|Overall Study||0
1046741|NCT00777790|2540276|P2|NOT COMPLETED|Overall Study||0
1046742|NCT00777790|2540277|P1|NOT COMPLETED|Overall Study||0
1046743|NCT00777790|2540275|P3|COMPLETED|Overall Study||88
1046744|NCT00777790|2540276|P2|COMPLETED|Overall Study||77
1046745|NCT00777790|2540277|P1|COMPLETED|Overall Study||76
1046746|NCT00777790|2540275|P3|STARTED|Overall Study||88
1046747|NCT00777790|2540276|P2|STARTED|Overall Study||77
1046748|NCT00777790|2540277|P1|STARTED|Overall Study||76
1046749|NCT00777803|2540287|P2|NOT COMPLETED|Overall Study||7
1046750|NCT00777803|2540288|P1|NOT COMPLETED|Overall Study||15
1046751|NCT00777803|2540287|P2|COMPLETED|Overall Study||90
1046752|NCT00777803|2540288|P1|COMPLETED|Overall Study||269
1046753|NCT00777803|2540287|P2|STARTED|Overall Study||97
1046754|NCT00777803|2540288|P1|STARTED|Overall Study||284
1046755|NCT00777855|2540320|P2|NOT COMPLETED|Second Intervention||0
1046756|NCT00777855|2540321|P1|NOT COMPLETED|Second Intervention||0
1046757|NCT00777855|2540320|P2|COMPLETED|Second Intervention||5
1046758|NCT00777855|2540321|P1|COMPLETED|Second Intervention||5
1046759|NCT00777855|2540320|P2|STARTED|Second Intervention||5
1046760|NCT00777855|2540321|P1|STARTED|Second Intervention||5
1046761|NCT00777855|2540320|P2|NOT COMPLETED|Washout Period (>= 14 Days)||0
1046762|NCT00777855|2540321|P1|NOT COMPLETED|Washout Period (>= 14 Days)||0
1046763|NCT00777855|2540320|P2|COMPLETED|Washout Period (>= 14 Days)||5
1046764|NCT00777855|2540321|P1|COMPLETED|Washout Period (>= 14 Days)||5
1046765|NCT00777855|2540320|P2|STARTED|Washout Period (>= 14 Days)||5
1046766|NCT00777855|2540321|P1|STARTED|Washout Period (>= 14 Days)||5
1046767|NCT00777855|2540320|P2|NOT COMPLETED|First Intervention||0
1046768|NCT00777855|2540321|P1|NOT COMPLETED|First Intervention||0
1046769|NCT00777855|2540320|P2|COMPLETED|First Intervention||5
1046770|NCT00777855|2540321|P1|COMPLETED|First Intervention||5
1046771|NCT00777855|2540320|P2|STARTED|First Intervention||5
1046772|NCT00777855|2540321|P1|STARTED|First Intervention||5
1046773|NCT00777946|2540333|P3|NOT COMPLETED|Overall Study||16
1046774|NCT00777946|2540334|P2|NOT COMPLETED|Overall Study||6
1046775|NCT00777946|2540335|P1|NOT COMPLETED|Overall Study||21
1046776|NCT00777946|2540333|P3|COMPLETED|Overall Study||244
1046777|NCT00777946|2540334|P2|COMPLETED|Overall Study||271
1046778|NCT00777946|2540335|P1|COMPLETED|Overall Study||262
1046779|NCT00777946|2540333|P3|Safety & Full Analysis Sets|Overall Study||260
1046780|NCT00777946|2540334|P2|Safety & Full Analysis Sets|Overall Study||276
1046781|NCT00777946|2540335|P1|Safety & Full Analysis Sets|Overall Study||282
1046782|NCT00777946|2540333|P3|STARTED|Overall Study||260
1046783|NCT00777946|2540334|P2|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 5 mg group was randomized in error.|277
1046784|NCT00777946|2540335|P1|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 10 mg group was randomized in error.|283
1046785|NCT00778102|2540360|P2|NOT COMPLETED|Overall Study||22
1046786|NCT00778102|2540361|P1|NOT COMPLETED|Overall Study||21
1046787|NCT00778102|2540360|P2|COMPLETED|Overall Study||19
1046788|NCT00778102|2540361|P1|COMPLETED|Overall Study||18
1046789|NCT00778102|2540360|P2|STARTED|Overall Study||41
1046790|NCT00778102|2540361|P1|STARTED|Overall Study||39
1046791|NCT00778167|2540396|P3|NOT COMPLETED|Overall Study||0
1046792|NCT00778167|2540397|P2|NOT COMPLETED|Overall Study||0
1046793|NCT00778167|2540398|P1|NOT COMPLETED|Overall Study||0
1046794|NCT00778167|2540396|P3|COMPLETED|Overall Study||4
1046795|NCT00778167|2540397|P2|COMPLETED|Overall Study||8
1046796|NCT00778167|2540398|P1|COMPLETED|Overall Study||6
1046797|NCT00778167|2540396|P3|STARTED|Overall Study||4
1046798|NCT00778167|2540397|P2|STARTED|Overall Study||8
1046799|NCT00778167|2540398|P1|STARTED|Overall Study||6
1046800|NCT00778258|2540415|P9|NOT COMPLETED|Overall Study||4
1046801|NCT00778258|2540416|P8|NOT COMPLETED|Overall Study||15
1046802|NCT00778258|2540417|P7|NOT COMPLETED|Overall Study||15
1046803|NCT00778258|2540418|P6|NOT COMPLETED|Overall Study||10
1046804|NCT00778258|2540419|P5|NOT COMPLETED|Overall Study||0
1046805|NCT00778258|2540420|P4|NOT COMPLETED|Overall Study||3
1046806|NCT00778258|2540421|P3|NOT COMPLETED|Overall Study||10
1046807|NCT00778258|2540422|P2|NOT COMPLETED|Overall Study||2
1046808|NCT00778258|2540423|P1|NOT COMPLETED|Overall Study||7
1046809|NCT00778258|2540415|P9|COMPLETED|Overall Study||6
1046810|NCT00778258|2540416|P8|COMPLETED|Overall Study||26
1046811|NCT00778258|2540417|P7|COMPLETED|Overall Study||19
1046812|NCT00778258|2540418|P6|COMPLETED|Overall Study||13
1046813|NCT00778258|2540419|P5|COMPLETED|Overall Study||6
1046814|NCT00778258|2540420|P4|COMPLETED|Overall Study||12
1046815|NCT00778258|2540421|P3|COMPLETED|Overall Study||10
1046816|NCT00778258|2540422|P2|COMPLETED|Overall Study||3
1046817|NCT00778258|2540423|P1|COMPLETED|Overall Study||9
1046818|NCT00778258|2540415|P9|STARTED|Overall Study||10
1046819|NCT00778258|2540416|P8|STARTED|Overall Study||41
1046820|NCT00778258|2540417|P7|STARTED|Overall Study||34
1046821|NCT00778258|2540418|P6|STARTED|Overall Study||23
1046822|NCT00778258|2540419|P5|STARTED|Overall Study||6
1046823|NCT00778258|2540420|P4|STARTED|Overall Study||15
1046824|NCT00778258|2540421|P3|STARTED|Overall Study||20
1046825|NCT00778258|2540422|P2|STARTED|Overall Study||5
1046826|NCT00778258|2540423|P1|STARTED|Overall Study||16
1046827|NCT00778310|2540477|P2|NOT COMPLETED|Overall Study||0
1046828|NCT00778310|2540478|P1|NOT COMPLETED|Overall Study||0
1046829|NCT00778310|2540477|P2|COMPLETED|Overall Study||26
1046830|NCT00778310|2540478|P1|COMPLETED|Overall Study||17
1046831|NCT00778310|2540477|P2|Usable Data|Overall Study||21
1046832|NCT00778310|2540478|P1|Usable Data|Overall Study||14
1046833|NCT00778310|2540477|P2|STARTED|Overall Study||26
1046834|NCT00778310|2540478|P1|STARTED|Overall Study||17
1046835|NCT00778336|2540490|P4|NOT COMPLETED|3 Month Follow Up||0
1046836|NCT00778336|2540491|P3|NOT COMPLETED|3 Month Follow Up||5
1046837|NCT00778336|2540492|P2|NOT COMPLETED|3 Month Follow Up||23
1046838|NCT00778336|2540493|P1|NOT COMPLETED|3 Month Follow Up||23
1046839|NCT00778336|2540490|P4|COMPLETED|3 Month Follow Up||12
1046840|NCT00778336|2540491|P3|COMPLETED|3 Month Follow Up||65
1046841|NCT00778336|2540492|P2|COMPLETED|3 Month Follow Up||144
1046842|NCT00778336|2540493|P1|COMPLETED|3 Month Follow Up||169
1046843|NCT00778336|2540490|P4|STARTED|3 Month Follow Up||12
1046844|NCT00778336|2540491|P3|STARTED|3 Month Follow Up||70
1046845|NCT00778336|2540492|P2|STARTED|3 Month Follow Up||167
1046846|NCT00778336|2540493|P1|STARTED|3 Month Follow Up||192
1046847|NCT00778336|2540490|P4|NOT COMPLETED|Index Procedure-Discharge||0
1046848|NCT00778336|2540491|P3|NOT COMPLETED|Index Procedure-Discharge||2
1046849|NCT00778336|2540492|P2|NOT COMPLETED|Index Procedure-Discharge||3
1046850|NCT00778336|2540493|P1|NOT COMPLETED|Index Procedure-Discharge||6
1046851|NCT00778336|2540490|P4|COMPLETED|Index Procedure-Discharge||12
1046852|NCT00778336|2540491|P3|COMPLETED|Index Procedure-Discharge||70
1046853|NCT00778336|2540492|P2|COMPLETED|Index Procedure-Discharge||167
1046854|NCT00778336|2540493|P1|COMPLETED|Index Procedure-Discharge||192
1046855|NCT00778336|2540490|P4|STARTED|Index Procedure-Discharge||12
1046856|NCT00778336|2540491|P3|STARTED|Index Procedure-Discharge||72
1046857|NCT00778336|2540492|P2|STARTED|Index Procedure-Discharge||170
1046858|NCT00778336|2540493|P1|STARTED|Index Procedure-Discharge||198
1046859|NCT00778375|2540511|P1|NOT COMPLETED|Overall Study||3
1046860|NCT00778375|2540511|P1|COMPLETED|Overall Study||119
1046861|NCT00778375|2540511|P1|STARTED|Overall Study||122
1046862|NCT00772304|2540521|P1|NOT COMPLETED|Overall Study||0
1046863|NCT00772304|2540521|P1|COMPLETED|Overall Study||102
1046864|NCT00772304|2540521|P1|STARTED|Overall Study||102
1046865|NCT00772369|2540525|P1|NOT COMPLETED|Overall Study||1
1046866|NCT00772369|2540525|P1|COMPLETED|Overall Study||3213
1046867|NCT00772369|2540525|P1|STARTED|Overall Study||3214
1046868|NCT00772382|2540530|P1|NOT COMPLETED|Overall Study||55
1046869|NCT00772382|2540530|P1|COMPLETED|Overall Study||61
1046870|NCT00772382|2540530|P1|STARTED|Overall Study||116
1046871|NCT00772447|2540537|P2|NOT COMPLETED|Overall Study||24
1046872|NCT00772447|2540538|P1|NOT COMPLETED|Overall Study||20
1046873|NCT00772447|2540537|P2|COMPLETED|Overall Study||110
1046874|NCT00772447|2540538|P1|COMPLETED|Overall Study||111
1046875|NCT00772447|2540537|P2|STARTED|Overall Study||134
1046876|NCT00772447|2540538|P1|STARTED|Overall Study||131
1046877|NCT00778622|2540569|P3|NOT COMPLETED|Overall Study||15
1046878|NCT00778622|2540570|P2|NOT COMPLETED|Overall Study||15
1046879|NCT00778622|2540571|P1|NOT COMPLETED|Overall Study||16
1046880|NCT00778622|2540569|P3|COMPLETED|Overall Study||109
1046881|NCT00778622|2540570|P2|COMPLETED|Overall Study||107
1046882|NCT00778622|2540571|P1|COMPLETED|Overall Study||109
1046883|NCT00778622|2540569|P3|STARTED|Overall Study||124
1046884|NCT00778622|2540570|P2|STARTED|Overall Study||122
1046885|NCT00778622|2540571|P1|STARTED|Overall Study||125
1046886|NCT00778648|2540626|P2|NOT COMPLETED|Overall Study||5
1046887|NCT00778648|2540627|P1|NOT COMPLETED|Overall Study||9
1046888|NCT00778648|2540626|P2|COMPLETED|Overall Study||266
1046889|NCT00778648|2540627|P1|COMPLETED|Overall Study||263
1046890|NCT00778648|2540626|P2|STARTED|Overall Study||271
1046891|NCT00778648|2540627|P1|STARTED|Overall Study||272
1046892|NCT00780572|2540635|P2|NOT COMPLETED|Overall Study||0
1046893|NCT00780572|2540636|P1|NOT COMPLETED|Overall Study||0
1046894|NCT00780572|2540635|P2|COMPLETED|Overall Study||298
1046895|NCT00780572|2540636|P1|COMPLETED|Overall Study||297
1046896|NCT00780572|2540635|P2|STARTED|Overall Study||298
1046897|NCT00780572|2540636|P1|STARTED|Overall Study||297
1046898|NCT00780676|2540647|P5|NOT COMPLETED|Overall Study||0
1046899|NCT00780676|2540648|P4|NOT COMPLETED|Overall Study||0
1046900|NCT00780676|2540649|P3|NOT COMPLETED|Overall Study||0
1046901|NCT00780676|2540650|P2|NOT COMPLETED|Overall Study||0
1046902|NCT00780676|2540651|P1|NOT COMPLETED|Overall Study||0
1046903|NCT00780676|2540647|P5|COMPLETED|Overall Study||0
1046904|NCT00780676|2540648|P4|COMPLETED|Overall Study||0
1046905|NCT00780676|2540649|P3|COMPLETED|Overall Study||13
1046906|NCT00780676|2540650|P2|COMPLETED|Overall Study||8
1046907|NCT00780676|2540651|P1|COMPLETED|Overall Study||9
1046908|NCT00780676|2540647|P5|STARTED|Overall Study||0
1046909|NCT00780676|2540648|P4|STARTED|Overall Study||0
1046910|NCT00780676|2540649|P3|STARTED|Overall Study||13
1046911|NCT00780676|2540650|P2|STARTED|Overall Study||8
1046912|NCT00780676|2540651|P1|STARTED|Overall Study||9
1046913|NCT00780741|2540659|P2|NOT COMPLETED|Overall Study||10
1046914|NCT00780741|2540660|P1|NOT COMPLETED|Overall Study||7
1046915|NCT00780741|2540659|P2|COMPLETED|Overall Study|18 months of age (±4 weeks)|71
1046916|NCT00780741|2540660|P1|COMPLETED|Overall Study|18 months of age (±4 weeks)|75
1046917|NCT00780741|2540659|P2|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|67
1046918|NCT00780741|2540660|P1|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|73
1046919|NCT00780741|2540659|P2|STARTED|Overall Study|randomized|81
1046920|NCT00780741|2540660|P1|STARTED|Overall Study|randomized|82
1046921|NCT00780910|2540672|P1|NOT COMPLETED|Overall Study||2
1046922|NCT00780910|2540672|P1|COMPLETED|Overall Study||107
1046923|NCT00780910|2540672|P1|STARTED|Overall Study||109
1046924|NCT00781079|2540678|P2|NOT COMPLETED|Overall Study||17
1046925|NCT00781079|2540679|P1|NOT COMPLETED|Overall Study||27
1046926|NCT00781079|2540678|P2|COMPLETED|Overall Study||116
1046927|NCT00781079|2540679|P1|COMPLETED|Overall Study||122
1046928|NCT00781079|2540678|P2|STARTED|Overall Study||133
1046929|NCT00781079|2540679|P1|STARTED|Overall Study||149
1046930|NCT00781274|2540687|P1|NOT COMPLETED|Overall Study||2
1046931|NCT00781274|2540687|P1|COMPLETED|Overall Study||30
1046932|NCT00781274|2540687|P1|STARTED|Overall Study||32
1046933|NCT00781326|2540691|P1|NOT COMPLETED|Phase 2||0
1046934|NCT00781326|2540691|P1|COMPLETED|Phase 2||0
1046935|NCT00781326|2540691|P1|STARTED|Phase 2|Study terminated prior to enrollment into Phase II|0
1046936|NCT00781326|2540691|P1|NOT COMPLETED|Phase I||4
1046937|NCT00781326|2540691|P1|COMPLETED|Phase I||2
1046938|NCT00781326|2540691|P1|STARTED|Phase I|Nine subjects consented; 3 did not meet eligibility criteria. 6 started antidepressant treatment.|6
1046939|NCT00781365|2540697|P2|NOT COMPLETED|Overall Study||36
1046940|NCT00781365|2540698|P1|NOT COMPLETED|Overall Study||34
1046941|NCT00781365|2540697|P2|COMPLETED|Overall Study|completed both 6 and 12 month follow up|186
1046942|NCT00781365|2540698|P1|COMPLETED|Overall Study|completed both 6 and 12 month follow up|194
1046943|NCT00781365|2540697|P2|STARTED|Overall Study||222
1046944|NCT00781365|2540698|P1|STARTED|Overall Study||228
1046945|NCT00781391|2540711|P3|NOT COMPLETED|Overall Study||784
1046946|NCT00781391|2540712|P2|NOT COMPLETED|Overall Study||807
1046947|NCT00781391|2540713|P1|NOT COMPLETED|Overall Study||879
1046948|NCT00781391|2540711|P3|COMPLETED|Overall Study||6250
1046949|NCT00781391|2540712|P2|COMPLETED|Overall Study||6228
1046950|NCT00781391|2540713|P1|COMPLETED|Overall Study||6157
1046951|NCT00781391|2540711|P3|Per Protocol Analysis Set|Overall Study||6982
1046952|NCT00781391|2540712|P2|Per Protocol Analysis Set|Overall Study||6995
1046953|NCT00781391|2540713|P1|Per Protocol Analysis Set|Overall Study||6993
1046954|NCT00781391|2540711|P3|mITT Analysis Set (Received Drug)|Overall Study||7002
1046955|NCT00781391|2540712|P2|mITT Analysis Set (Received Drug)|Overall Study||7012
1046956|NCT00781391|2540713|P1|mITT Analysis Set (Received Drug)|Overall Study||7012
1046957|NCT00781391|2540711|P3|Safety Analysis Set (Received Drug)|Overall Study||7002
1046958|NCT00781391|2540712|P2|Safety Analysis Set (Received Drug)|Overall Study||7012
1046959|NCT00781391|2540713|P1|Safety Analysis Set (Received Drug)|Overall Study||7012
1046960|NCT00781391|2540711|P3|STARTED|Overall Study||7034
1046961|NCT00781391|2540712|P2|STARTED|Overall Study||7035
1046962|NCT00781391|2540713|P1|STARTED|Overall Study||7036
1046963|NCT00781456|2540747|P2|NOT COMPLETED|Overall Study||16
1046964|NCT00781456|2540748|P1|NOT COMPLETED|Overall Study||21
1046965|NCT00781456|2540747|P2|COMPLETED|Overall Study||35
1046966|NCT00781456|2540748|P1|COMPLETED|Overall Study||37
1046967|NCT00781456|2540747|P2|Received Study Drug|Overall Study||49
1046968|NCT00781456|2540748|P1|Received Study Drug|Overall Study||57
1046969|NCT00781456|2540747|P2|STARTED|Overall Study||51
1046970|NCT00781456|2540748|P1|STARTED|Overall Study||58
1046971|NCT00781508|2540770|P2|NOT COMPLETED|Overall Study||0
1046972|NCT00781508|2540771|P1|NOT COMPLETED|Overall Study||0
1046973|NCT00781508|2540770|P2|COMPLETED|Overall Study||5
1046974|NCT00781508|2540771|P1|COMPLETED|Overall Study||5
1046975|NCT00781508|2540770|P2|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
1046976|NCT00781508|2540771|P1|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
1046977|NCT00781599|2540781|P2|NOT COMPLETED|Overall Study||4
1046978|NCT00781599|2540782|P1|NOT COMPLETED|Overall Study||7
1046979|NCT00781599|2540781|P2|COMPLETED|Overall Study||32
1046980|NCT00781599|2540782|P1|COMPLETED|Overall Study||29
1046981|NCT00781599|2540781|P2|STARTED|Overall Study||36
1046982|NCT00781599|2540782|P1|STARTED|Overall Study||36
1046983|NCT00781859|2540796|P2|NOT COMPLETED|Overall Study||9
1046984|NCT00781859|2540797|P1|NOT COMPLETED|Overall Study||19
1046985|NCT00781859|2540796|P2|COMPLETED|Overall Study||98
1046986|NCT00781859|2540797|P1|COMPLETED|Overall Study||200
1046987|NCT00781859|2540796|P2|STARTED|Overall Study||107
1046988|NCT00781859|2540797|P1|STARTED|Overall Study||219
1047001|NCT00781950|2540866|P2|NOT COMPLETED|Overall Study||13
1047002|NCT00781950|2540867|P1|NOT COMPLETED|Overall Study||11
1047003|NCT00781950|2540866|P2|COMPLETED|Overall Study||45
1047004|NCT00781950|2540867|P1|COMPLETED|Overall Study||41
1047005|NCT00781950|2540866|P2|STARTED|Overall Study||58
1047006|NCT00781950|2540867|P1|STARTED|Overall Study||52
1047007|NCT00781963|2540878|P3|NOT COMPLETED|Overall Study||2
1047008|NCT00781963|2540879|P2|NOT COMPLETED|Overall Study||9
1047009|NCT00781963|2540880|P1|NOT COMPLETED|Overall Study||8
1047010|NCT00781963|2540878|P3|COMPLETED|Overall Study||51
1047011|NCT00781963|2540879|P2|COMPLETED|Overall Study||43
1047012|NCT00781963|2540880|P1|COMPLETED|Overall Study||46
1047013|NCT00781963|2540878|P3|6-month Follow-up|Overall Study||52
1047014|NCT00781963|2540879|P2|6-month Follow-up|Overall Study||44
1047015|NCT00781963|2540880|P1|6-month Follow-up|Overall Study||48
1047016|NCT00781963|2540878|P3|Post-treatment|Overall Study||53
1047017|NCT00781963|2540879|P2|Post-treatment|Overall Study||45
1047018|NCT00781963|2540880|P1|Post-treatment|Overall Study||52
1047019|NCT00781963|2540878|P3|STARTED|Overall Study||53
1047020|NCT00781963|2540879|P2|STARTED|Overall Study||52
1047021|NCT00781963|2540880|P1|STARTED|Overall Study||54
1047022|NCT00782067|2540888|P1|NOT COMPLETED|Overall Study||95
1047023|NCT00782067|2540888|P1|COMPLETED|Overall Study||21
1047024|NCT00782067|2540888|P1|Primary Efficacy Population (PEP)|Overall Study||89
1047025|NCT00782067|2540888|P1|Treatment Ongoing|Overall Study||21
1047026|NCT00782067|2540888|P1|STARTED|Overall Study||116
1047027|NCT00782171|2540897|P2|NOT COMPLETED|Overall Study||19
1047028|NCT00782171|2540898|P1|NOT COMPLETED|Overall Study||22
1047029|NCT00782171|2540897|P2|COMPLETED|Overall Study||115
1047030|NCT00782171|2540898|P1|COMPLETED|Overall Study||124
1047031|NCT00782171|2540897|P2|Surgery (Baseline)|Overall Study||128
1047032|NCT00782171|2540898|P1|Surgery (Baseline)|Overall Study||138
1047033|NCT00782171|2540897|P2|1 Year|Overall Study||120
1047034|NCT00782171|2540898|P1|1 Year|Overall Study||131
1047035|NCT00782171|2540897|P2|20-23 Weeks|Overall Study||124
1047036|NCT00782171|2540898|P1|20-23 Weeks|Overall Study||135
1047037|NCT00782171|2540897|P2|STARTED|Overall Study||134
1047038|NCT00782171|2540898|P1|STARTED|Overall Study||146
1047039|NCT00782184|2540932|P2|NOT COMPLETED|Overall Study||5
1047040|NCT00782184|2540933|P1|NOT COMPLETED|Overall Study||4
1047041|NCT00782184|2540932|P2|COMPLETED|Overall Study||125
1047042|NCT00782184|2540933|P1|COMPLETED|Overall Study||116
1047043|NCT00782184|2540932|P2|STARTED|Overall Study||130
1047044|NCT00782184|2540933|P1|STARTED|Overall Study||120
1047045|NCT00782210|2540971|P3|NOT COMPLETED|Overall Study||35
1047046|NCT00782210|2540972|P2|NOT COMPLETED|Overall Study||35
1047047|NCT00782210|2540973|P1|NOT COMPLETED|Overall Study||50
1047048|NCT00782210|2540971|P3|COMPLETED|Overall Study||172
1047049|NCT00782210|2540972|P2|COMPLETED|Overall Study||173
1047050|NCT00782210|2540973|P1|COMPLETED|Overall Study||159
1047051|NCT00782210|2540971|P3|STARTED|Overall Study||207
1047052|NCT00782210|2540972|P2|STARTED|Overall Study||208
1047053|NCT00782210|2540973|P1|STARTED|Overall Study||209
1047054|NCT00782288|2541167|P3|NOT COMPLETED|Overall Study||0
1047055|NCT00782288|2541168|P2|NOT COMPLETED|Overall Study||0
1047056|NCT00782288|2541169|P1|NOT COMPLETED|Overall Study||0
1047057|NCT00782288|2541167|P3|COMPLETED|Overall Study||8
1047058|NCT00782288|2541168|P2|COMPLETED|Overall Study||8
1047059|NCT00782288|2541169|P1|COMPLETED|Overall Study||8
1047060|NCT00782288|2541167|P3|STARTED|Overall Study||8
1047061|NCT00782288|2541168|P2|STARTED|Overall Study||8
1047062|NCT00782288|2541169|P1|STARTED|Overall Study||8
1047063|NCT00782340|2541214|P3|NOT COMPLETED|Randomized Double Blind||0
1047064|NCT00782340|2541215|P2|NOT COMPLETED|Randomized Double Blind||0
1047065|NCT00782340|2541216|P1|NOT COMPLETED|Randomized Double Blind||0
1047066|NCT00782340|2541214|P3|COMPLETED|Randomized Double Blind||80
1047067|NCT00782340|2541215|P2|COMPLETED|Randomized Double Blind||82
1047068|NCT00782340|2541216|P1|COMPLETED|Randomized Double Blind||0
1047069|NCT00782340|2541214|P3|STARTED|Randomized Double Blind||80
1047070|NCT00782340|2541215|P2|STARTED|Randomized Double Blind||82
1047071|NCT00782340|2541216|P1|STARTED|Randomized Double Blind||0
1047072|NCT00782340|2541214|P3|NOT COMPLETED|Open Label Titration||0
1047073|NCT00782340|2541215|P2|NOT COMPLETED|Open Label Titration||0
1047074|NCT00782340|2541216|P1|NOT COMPLETED|Open Label Titration||101
1047075|NCT00782340|2541214|P3|COMPLETED|Open Label Titration||0
1047076|NCT00782340|2541215|P2|COMPLETED|Open Label Titration||0
1047077|NCT00782340|2541216|P1|COMPLETED|Open Label Titration||162
1047078|NCT00782340|2541214|P3|STARTED|Open Label Titration||0
1047079|NCT00782340|2541215|P2|STARTED|Open Label Titration||0
1047080|NCT00782340|2541216|P1|STARTED|Open Label Titration||263
1047081|NCT00782379|2541239|P1|NOT COMPLETED|Overall Study||0
1047082|NCT00782379|2541239|P1|COMPLETED|Overall Study||20
1047083|NCT00782379|2541239|P1|STARTED|Overall Study||20
1047084|NCT00782418|2541253|P7|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
1047085|NCT00782418|2541254|P6|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
1047086|NCT00782418|2541255|P5|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
1047087|NCT00782418|2541256|P4|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
1047088|NCT00782418|2541257|P3|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
1047089|NCT00782418|2541258|P2|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
1047090|NCT00782418|2541259|P1|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
1047091|NCT00782418|2541253|P7|COMPLETED|Period 2 Procedure/Treatment Groups||4
1047092|NCT00782418|2541254|P6|COMPLETED|Period 2 Procedure/Treatment Groups||4
1047093|NCT00782418|2541255|P5|COMPLETED|Period 2 Procedure/Treatment Groups||3
1047094|NCT00782418|2541256|P4|COMPLETED|Period 2 Procedure/Treatment Groups||1
1047095|NCT00782418|2541257|P3|COMPLETED|Period 2 Procedure/Treatment Groups||4
1047096|NCT00782418|2541258|P2|COMPLETED|Period 2 Procedure/Treatment Groups||4
1047097|NCT00782418|2541259|P1|COMPLETED|Period 2 Procedure/Treatment Groups||3
1047098|NCT00782418|2541253|P7|STARTED|Period 2 Procedure/Treatment Groups||4
1047099|NCT00782418|2541254|P6|STARTED|Period 2 Procedure/Treatment Groups||4
1047100|NCT00782418|2541255|P5|STARTED|Period 2 Procedure/Treatment Groups||3
1047101|NCT00782418|2541256|P4|STARTED|Period 2 Procedure/Treatment Groups||1
1047102|NCT00782418|2541257|P3|STARTED|Period 2 Procedure/Treatment Groups||4
1047103|NCT00782418|2541258|P2|STARTED|Period 2 Procedure/Treatment Groups||4
1047104|NCT00782418|2541259|P1|STARTED|Period 2 Procedure/Treatment Groups||3
1047105|NCT00782418|2541253|P7|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
1047106|NCT00782418|2541254|P6|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
1047107|NCT00782418|2541255|P5|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
1047108|NCT00782418|2541256|P4|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
1047109|NCT00782418|2541257|P3|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
1047110|NCT00782418|2541258|P2|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
1047111|NCT00782418|2541259|P1|NOT COMPLETED|Period 1 Procedure/Treatment Groups||2
1047112|NCT00782418|2541253|P7|COMPLETED|Period 1 Procedure/Treatment Groups||4
1047113|NCT00782418|2541254|P6|COMPLETED|Period 1 Procedure/Treatment Groups||4
1047114|NCT00782418|2541255|P5|COMPLETED|Period 1 Procedure/Treatment Groups||4
1047115|NCT00782418|2541256|P4|COMPLETED|Period 1 Procedure/Treatment Groups||2
1047116|NCT00782418|2541257|P3|COMPLETED|Period 1 Procedure/Treatment Groups||4
1047117|NCT00782418|2541258|P2|COMPLETED|Period 1 Procedure/Treatment Groups||4
1047118|NCT00782418|2541259|P1|COMPLETED|Period 1 Procedure/Treatment Groups||1
1047119|NCT00782418|2541253|P7|STARTED|Period 1 Procedure/Treatment Groups||4
1047120|NCT00782418|2541254|P6|STARTED|Period 1 Procedure/Treatment Groups||5
1047121|NCT00782418|2541255|P5|STARTED|Period 1 Procedure/Treatment Groups||5
1047122|NCT00782418|2541256|P4|STARTED|Period 1 Procedure/Treatment Groups||2
1047123|NCT00782418|2541257|P3|STARTED|Period 1 Procedure/Treatment Groups||4
1047124|NCT00782418|2541258|P2|STARTED|Period 1 Procedure/Treatment Groups||4
1047125|NCT00782418|2541259|P1|STARTED|Period 1 Procedure/Treatment Groups||3
1047126|NCT00782483|2541279|P1|NOT COMPLETED|Overall Study||6
1047127|NCT00782483|2541279|P1|COMPLETED|Overall Study||0
1047128|NCT00782483|2541279|P1|STARTED|Overall Study|6 subjects enrolled beginning on 04/27/2009 with last enrollment on 04/13/2010.|6
1047129|NCT00782496|2541285|P2|NOT COMPLETED|Overall Study||15
1047130|NCT00782496|2541286|P1|NOT COMPLETED|Overall Study||14
1047131|NCT00782496|2541285|P2|COMPLETED|Overall Study||90
1047132|NCT00782496|2541286|P1|COMPLETED|Overall Study||92
1047133|NCT00782496|2541285|P2|STARTED|Overall Study||105
1047134|NCT00782496|2541286|P1|STARTED|Overall Study||106
1047135|NCT00782509|2541296|P3|NOT COMPLETED|Overall Study||36
1047136|NCT00782509|2541297|P2|NOT COMPLETED|Overall Study||24
1047137|NCT00782509|2541298|P1|NOT COMPLETED|Overall Study||41
1047138|NCT00782509|2541296|P3|COMPLETED|Overall Study||181
1047139|NCT00782509|2541297|P2|COMPLETED|Overall Study||185
1047140|NCT00782509|2541298|P1|COMPLETED|Overall Study||175
1047141|NCT00782509|2541296|P3|STARTED|Overall Study||217
1047142|NCT00782509|2541297|P2|STARTED|Overall Study||209
1047143|NCT00782509|2541298|P1|STARTED|Overall Study||216
1047144|NCT00782626|2541489|P1|NOT COMPLETED|Overall Study||7
1047145|NCT00782626|2541489|P1|COMPLETED|Overall Study||16
1047146|NCT00782626|2541489|P1|STARTED|Overall Study||23
1047147|NCT00782639|2541495|P2|NOT COMPLETED|Overall Study||0
1047148|NCT00782639|2541496|P1|NOT COMPLETED|Overall Study||0
1047149|NCT00782639|2541495|P2|COMPLETED|Overall Study|This study was terminated due to low enrollment.|11
1047150|NCT00782639|2541496|P1|COMPLETED|Overall Study|This study was terminated due to low enrollment.|12
1047151|NCT00782639|2541495|P2|STARTED|Overall Study||11
1047152|NCT00782639|2541496|P1|STARTED|Overall Study||12
1047153|NCT00782717|2541514|P2|NOT COMPLETED|Overall Study||28
1047154|NCT00782717|2541515|P1|NOT COMPLETED|Overall Study||15
1047155|NCT00782717|2541514|P2|COMPLETED|Overall Study||102
1047156|NCT00782717|2541515|P1|COMPLETED|Overall Study||118
1047157|NCT00782717|2541514|P2|STARTED|Overall Study||130
1047158|NCT00782717|2541515|P1|STARTED|Overall Study||133
1047159|NCT00782821|2541527|P4|NOT COMPLETED|Overall Study||2
1047160|NCT00782821|2541528|P3|NOT COMPLETED|Overall Study||1
1047161|NCT00782821|2541529|P2|NOT COMPLETED|Overall Study||0
1047162|NCT00782821|2541530|P1|NOT COMPLETED|Overall Study||0
1047163|NCT00782821|2541527|P4|COMPLETED|Overall Study||8
1047164|NCT00782821|2541528|P3|COMPLETED|Overall Study||9
1047165|NCT00782821|2541529|P2|COMPLETED|Overall Study||10
1047166|NCT00782821|2541530|P1|COMPLETED|Overall Study||10
1047167|NCT00782821|2541527|P4|STARTED|Overall Study||10
1047168|NCT00782821|2541528|P3|STARTED|Overall Study||10
1047169|NCT00782821|2541529|P2|STARTED|Overall Study||10
1047170|NCT00782821|2541530|P1|STARTED|Overall Study||10
1047171|NCT00782834|2541556|P1|NOT COMPLETED|Treatment Phase||1
1047172|NCT00782834|2541556|P1|COMPLETED|Treatment Phase||13
1047173|NCT00782834|2541556|P1|STARTED|Treatment Phase||14
1047174|NCT00782834|2541556|P1|NOT COMPLETED|Screened Patients||1
1047175|NCT00782834|2541556|P1|COMPLETED|Screened Patients|1 pt ineligible d/t arrhythmia|14
1047176|NCT00782834|2541556|P1|STARTED|Screened Patients||15
1047177|NCT00775346|2541561|P1|NOT COMPLETED|Overall Study||0
1047178|NCT00775346|2541561|P1|COMPLETED|Overall Study||92
1047179|NCT00775346|2541561|P1|STARTED|Overall Study||92
1047180|NCT00775411|2541565|P1|NOT COMPLETED|Overall Study||1
1047181|NCT00775411|2541565|P1|COMPLETED|Overall Study||43
1047182|NCT00775411|2541565|P1|STARTED|Overall Study||44
1047183|NCT00775437|2541571|P1|NOT COMPLETED|Overall Study||6
1047184|NCT00775437|2541571|P1|COMPLETED|Overall Study||26
1047185|NCT00775437|2541571|P1|STARTED|Overall Study||32
1047186|NCT00775450|2541626|P5|NOT COMPLETED|Overall Study||2
1047187|NCT00775450|2541627|P4|NOT COMPLETED|Overall Study||0
1047188|NCT00775450|2541628|P3|NOT COMPLETED|Overall Study||0
1047189|NCT00775450|2541629|P2|NOT COMPLETED|Overall Study||0
1047190|NCT00775450|2541630|P1|NOT COMPLETED|Overall Study||3
1047191|NCT00775450|2541626|P5|COMPLETED|Overall Study||199
1047192|NCT00775450|2541627|P4|COMPLETED|Overall Study||108
1047193|NCT00775450|2541628|P3|COMPLETED|Overall Study||105
1047194|NCT00775450|2541629|P2|COMPLETED|Overall Study||98
1047195|NCT00775450|2541630|P1|COMPLETED|Overall Study||292
1047196|NCT00775450|2541626|P5|STARTED|Overall Study||201
1047197|NCT00775450|2541627|P4|STARTED|Overall Study||108
1047198|NCT00775450|2541628|P3|STARTED|Overall Study||105
1047199|NCT00775450|2541629|P2|STARTED|Overall Study||98
1047200|NCT00775450|2541630|P1|STARTED|Overall Study||295
1047201|NCT00775463|2541659|P2|NOT COMPLETED|Overall Study||13
1047202|NCT00775463|2541660|P1|NOT COMPLETED|Overall Study||11
1047203|NCT00775463|2541659|P2|COMPLETED|Overall Study||59
1047204|NCT00775463|2541660|P1|COMPLETED|Overall Study||65
1047205|NCT00775463|2541659|P2|STARTED|Overall Study||72
1047206|NCT00775463|2541660|P1|STARTED|Overall Study||76
1047207|NCT00775528|2541692|P1|NOT COMPLETED|Overall Study||1
1047208|NCT00775528|2541692|P1|COMPLETED|Overall Study||18
1047209|NCT00775528|2541692|P1|STARTED|Overall Study|Started means number of patients who consented|19
1047210|NCT00775593|2541699|P1|NOT COMPLETED|Overall Study||7
1047211|NCT00775593|2541699|P1|COMPLETED|Overall Study||53
1047212|NCT00775593|2541699|P1|STARTED|Overall Study||60
1047213|NCT00775606|2541708|P2|NOT COMPLETED|Overall Study||0
1047214|NCT00775606|2541709|P1|NOT COMPLETED|Overall Study||3
1047215|NCT00775606|2541708|P2|COMPLETED|Overall Study||5
1047216|NCT00775606|2541709|P1|COMPLETED|Overall Study||5
1047217|NCT00775606|2541708|P2|STARTED|Overall Study||5
1047218|NCT00775606|2541709|P1|STARTED|Overall Study||8
1047219|NCT00775645|2541721|P2|NOT COMPLETED|Overall Study||20
1047220|NCT00775645|2541722|P1|NOT COMPLETED|Overall Study||17
1047221|NCT00775645|2541721|P2|COMPLETED|Overall Study||181
1047222|NCT00775645|2541722|P1|COMPLETED|Overall Study||191
1047223|NCT00775645|2541721|P2|STARTED|Overall Study||201
1047224|NCT00775645|2541722|P1|STARTED|Overall Study||208
1047225|NCT00775658|2541742|P2|NOT COMPLETED|Second Intervention||0
1047226|NCT00775658|2541743|P1|NOT COMPLETED|Second Intervention||0
1047227|NCT00775658|2541742|P2|COMPLETED|Second Intervention||11
1047228|NCT00775658|2541743|P1|COMPLETED|Second Intervention||10
1047229|NCT00775658|2541742|P2|STARTED|Second Intervention||11
1047230|NCT00775658|2541743|P1|STARTED|Second Intervention||10
1047231|NCT00775658|2541742|P2|NOT COMPLETED|First Intervention||0
1047232|NCT00775658|2541743|P1|NOT COMPLETED|First Intervention||0
1047233|NCT00775658|2541742|P2|COMPLETED|First Intervention||11
1047234|NCT00775658|2541743|P1|COMPLETED|First Intervention||10
1047235|NCT00775658|2541742|P2|STARTED|First Intervention||11
1047236|NCT00775658|2541743|P1|STARTED|First Intervention||10
1047237|NCT00775671|2541753|P2|NOT COMPLETED|Overall Study||0
1047238|NCT00775671|2541754|P1|NOT COMPLETED|Overall Study||0
1047239|NCT00775671|2541753|P2|COMPLETED|Overall Study||23
1047240|NCT00775671|2541754|P1|COMPLETED|Overall Study||23
1047241|NCT00775671|2541753|P2|STARTED|Overall Study||23
1047242|NCT00775671|2541754|P1|STARTED|Overall Study||23
1047243|NCT00783094|2541765|P3|NOT COMPLETED|Open-Label Extension Period||30
1047244|NCT00783094|2541766|P2|NOT COMPLETED|Open-Label Extension Period||19
1047245|NCT00783094|2541767|P1|NOT COMPLETED|Open-Label Extension Period||22
1047246|NCT00783094|2541765|P3|COMPLETED|Open-Label Extension Period||101
1047247|NCT00783094|2541766|P2|COMPLETED|Open-Label Extension Period||109
1047248|NCT00783094|2541767|P1|COMPLETED|Open-Label Extension Period||113
1047249|NCT00783094|2541765|P3|STARTED|Open-Label Extension Period||131
1047250|NCT00783094|2541766|P2|STARTED|Open-Label Extension Period||128
1047251|NCT00783094|2541767|P1|STARTED|Open-Label Extension Period||135
1047252|NCT00783094|2541765|P3|NOT COMPLETED|Randomized Double-Blind Treatment Period||9
1047253|NCT00783094|2541766|P2|NOT COMPLETED|Randomized Double-Blind Treatment Period||12
1047254|NCT00783094|2541767|P1|NOT COMPLETED|Randomized Double-Blind Treatment Period||7
1047255|NCT00783094|2541765|P3|COMPLETED|Randomized Double-Blind Treatment Period||131
1047256|NCT00783094|2541766|P2|COMPLETED|Randomized Double-Blind Treatment Period||128
1047257|NCT00783094|2541767|P1|COMPLETED|Randomized Double-Blind Treatment Period||135
1047258|NCT00783094|2541765|P3|STARTED|Randomized Double-Blind Treatment Period||140
1047259|NCT00783094|2541766|P2|STARTED|Randomized Double-Blind Treatment Period||140
1047260|NCT00783094|2541767|P1|STARTED|Randomized Double-Blind Treatment Period||142
1047261|NCT00783198|2541846|P3|NOT COMPLETED|Overall Study||42
1047262|NCT00783198|2541847|P2|NOT COMPLETED|Overall Study||43
1047263|NCT00783198|2541848|P1|NOT COMPLETED|Overall Study||57
1047264|NCT00783198|2541846|P3|COMPLETED|Overall Study||146
1047265|NCT00783198|2541847|P2|COMPLETED|Overall Study||144
1047266|NCT00783198|2541848|P1|COMPLETED|Overall Study||133
1047267|NCT00783198|2541846|P3|STARTED|Overall Study||188
1047268|NCT00783198|2541847|P2|STARTED|Overall Study||187
1047269|NCT00783198|2541848|P1|STARTED|Overall Study||190
1047270|NCT00783224|2541872|P4|NOT COMPLETED|Overall Study||2
1047271|NCT00783224|2541873|P3|NOT COMPLETED|Overall Study||1
1047272|NCT00783224|2541874|P2|NOT COMPLETED|Overall Study||0
1047273|NCT00783224|2541875|P1|NOT COMPLETED|Overall Study||0
1047274|NCT00783224|2541872|P4|COMPLETED|Overall Study||140
1047275|NCT00783224|2541873|P3|COMPLETED|Overall Study||142
1047276|NCT00783224|2541874|P2|COMPLETED|Overall Study||34
1047277|NCT00783224|2541875|P1|COMPLETED|Overall Study||32
1047278|NCT00783224|2541872|P4|STARTED|Overall Study||142
1047279|NCT00783224|2541873|P3|STARTED|Overall Study||143
1047280|NCT00783224|2541874|P2|STARTED|Overall Study||34
1047281|NCT00783224|2541875|P1|STARTED|Overall Study||32
1047294|NCT00783302|2541917|P1|NOT COMPLETED|Overall Study||35
1047295|NCT00783302|2541917|P1|COMPLETED|Overall Study||850
1047296|NCT00783302|2541917|P1|STARTED|Overall Study||885
1047297|NCT00785291|2541938|P3|NOT COMPLETED|Overall Study||106
1047298|NCT00785291|2541939|P2|NOT COMPLETED|Overall Study||149
1047299|NCT00785291|2541940|P1|NOT COMPLETED|Overall Study||136
1047300|NCT00785291|2541938|P3|COMPLETED|Overall Study||139
1047301|NCT00785291|2541939|P2|COMPLETED|Overall Study||122
1047302|NCT00785291|2541940|P1|COMPLETED|Overall Study||147
1047303|NCT00785291|2541938|P3|STARTED|Overall Study||245
1047304|NCT00785291|2541939|P2|STARTED|Overall Study||271
1047305|NCT00785291|2541940|P1|STARTED|Overall Study||283
1047306|NCT00785356|2541963|P1|NOT COMPLETED|Overall Study||8
1047307|NCT00785356|2541963|P1|COMPLETED|Overall Study||0
1047308|NCT00785356|2541963|P1|STARTED|Overall Study||8
1047309|NCT00785486|2541971|P1|NOT COMPLETED|Midazolam With Qualaquin at Steady State||0
1047310|NCT00785486|2541971|P1|COMPLETED|Midazolam With Qualaquin at Steady State||23
1047311|NCT00785486|2541971|P1|STARTED|Midazolam With Qualaquin at Steady State||23
1047312|NCT00785486|2541971|P1|NOT COMPLETED|Qualaquin Alone at Steady State||0
1047313|NCT00785486|2541971|P1|COMPLETED|Qualaquin Alone at Steady State||23
1047314|NCT00785486|2541971|P1|STARTED|Qualaquin Alone at Steady State||23
1047315|NCT00785486|2541971|P1|NOT COMPLETED|3 Day Washout||0
1047316|NCT00785486|2541971|P1|COMPLETED|3 Day Washout||23
1047317|NCT00785486|2541971|P1|STARTED|3 Day Washout||23
1047318|NCT00785486|2541971|P1|NOT COMPLETED|Midazolam Alone||1
1047319|NCT00785486|2541971|P1|COMPLETED|Midazolam Alone|one participant withdrew for personal reasons after first midazolam dose|23
1047320|NCT00785486|2541971|P1|STARTED|Midazolam Alone||24
1047321|NCT00785512|2541994|P2|NOT COMPLETED|Overall Study||4
1047322|NCT00785512|2541995|P1|NOT COMPLETED|Overall Study||3
1047323|NCT00785512|2541994|P2|COMPLETED|Overall Study||101
1047324|NCT00785512|2541995|P1|COMPLETED|Overall Study||99
1047325|NCT00785512|2541994|P2|STARTED|Overall Study||105
1047326|NCT00785512|2541995|P1|STARTED|Overall Study||102
1047327|NCT00785577|2542009|P5|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
1047328|NCT00785577|2542010|P4|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
1047329|NCT00785577|2542011|P3|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
1047330|NCT00785577|2542012|P2|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
1047331|NCT00785577|2542013|P1|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
1047332|NCT00785577|2542009|P5|COMPLETED|Study Period 3: 1-Week Washout Phase||26
1047333|NCT00785577|2542010|P4|COMPLETED|Study Period 3: 1-Week Washout Phase||35
1047334|NCT00785577|2542011|P3|COMPLETED|Study Period 3: 1-Week Washout Phase||25
1047335|NCT00785577|2542012|P2|COMPLETED|Study Period 3: 1-Week Washout Phase||36
1047336|NCT00785577|2542013|P1|COMPLETED|Study Period 3: 1-Week Washout Phase||78
1047337|NCT00785577|2542009|P5|STARTED|Study Period 3: 1-Week Washout Phase||27
1047338|NCT00785577|2542010|P4|STARTED|Study Period 3: 1-Week Washout Phase||36
1047339|NCT00785577|2542011|P3|STARTED|Study Period 3: 1-Week Washout Phase||25
1047340|NCT00785577|2542012|P2|STARTED|Study Period 3: 1-Week Washout Phase||36
1047341|NCT00785577|2542013|P1|STARTED|Study Period 3: 1-Week Washout Phase||78
1047342|NCT00785577|2542009|P5|NOT COMPLETED|Study Period 2: Therapy Phase||20
1047343|NCT00785577|2542010|P4|NOT COMPLETED|Study Period 2: Therapy Phase||13
1047344|NCT00785577|2542011|P3|NOT COMPLETED|Study Period 2: Therapy Phase||18
1047345|NCT00785577|2542012|P2|NOT COMPLETED|Study Period 2: Therapy Phase||9
1047346|NCT00785577|2542013|P1|NOT COMPLETED|Study Period 2: Therapy Phase||11
1047347|NCT00785577|2542009|P5|COMPLETED|Study Period 2: Therapy Phase||27
1047348|NCT00785577|2542010|P4|COMPLETED|Study Period 2: Therapy Phase||36
1047349|NCT00785577|2542011|P3|COMPLETED|Study Period 2: Therapy Phase||25
1047350|NCT00785577|2542012|P2|COMPLETED|Study Period 2: Therapy Phase||36
1047351|NCT00785577|2542013|P1|COMPLETED|Study Period 2: Therapy Phase||78
1047352|NCT00785577|2542009|P5|STARTED|Study Period 2: Therapy Phase||47
1047353|NCT00785577|2542010|P4|STARTED|Study Period 2: Therapy Phase||49
1047354|NCT00785577|2542011|P3|STARTED|Study Period 2: Therapy Phase||43
1047355|NCT00785577|2542012|P2|STARTED|Study Period 2: Therapy Phase||45
1047356|NCT00785577|2542013|P1|STARTED|Study Period 2: Therapy Phase||89
1047357|NCT00785629|2542153|P4|NOT COMPLETED|Overall Study||16
1047358|NCT00785629|2542154|P3|NOT COMPLETED|Overall Study||10
1047359|NCT00785629|2542155|P2|NOT COMPLETED|Overall Study||5
1047360|NCT00785629|2542156|P1|NOT COMPLETED|Overall Study||8
1047361|NCT00785629|2542153|P4|COMPLETED|Overall Study|16 not completed|41
1047362|NCT00785629|2542154|P3|COMPLETED|Overall Study|10 not completed|18
1047363|NCT00785629|2542155|P2|COMPLETED|Overall Study|5 not completed|25
1047364|NCT00785629|2542156|P1|COMPLETED|Overall Study|8 not completed|22
1047365|NCT00785629|2542153|P4|STARTED|Overall Study||57
1047366|NCT00785629|2542154|P3|STARTED|Overall Study||28
1047367|NCT00785629|2542155|P2|STARTED|Overall Study||30
1047368|NCT00785629|2542156|P1|STARTED|Overall Study||30
1047369|NCT00785707|2542164|P1|NOT COMPLETED|Overall Study||7
1047370|NCT00785707|2542164|P1|COMPLETED|Overall Study||24
1047371|NCT00785707|2542164|P1|STARTED|Overall Study||31
1047372|NCT00785772|2542169|P1|NOT COMPLETED|Overall Study||0
1047373|NCT00785772|2542169|P1|COMPLETED|Overall Study||1
1047374|NCT00785772|2542169|P1|STARTED|Overall Study||1
1047375|NCT00785785|2542177|P2|NOT COMPLETED|Optional Extension Phase||125
1047376|NCT00785785|2542178|P1|NOT COMPLETED|Optional Extension Phase||39
1047377|NCT00785785|2542177|P2|COMPLETED|Optional Extension Phase||0
1047378|NCT00785785|2542178|P1|COMPLETED|Optional Extension Phase||0
1047379|NCT00785785|2542177|P2|STARTED|Optional Extension Phase|crossover extension phase was optional|125
1047380|NCT00785785|2542178|P1|STARTED|Optional Extension Phase|crossover extension phase was optional|39
1047381|NCT00785785|2542177|P2|NOT COMPLETED|Core Phase up to 36 Months||320
1047382|NCT00785785|2542178|P1|NOT COMPLETED|Core Phase up to 36 Months||324
1047383|NCT00785785|2542177|P2|COMPLETED|Core Phase up to 36 Months||0
1047384|NCT00785785|2542178|P1|COMPLETED|Core Phase up to 36 Months||0
1047385|NCT00785785|2542177|P2|STARTED|Core Phase up to 36 Months||320
1047386|NCT00785785|2542178|P1|STARTED|Core Phase up to 36 Months||324
1047387|NCT00785798|2542186|P1|NOT COMPLETED|Overall Study||1
1047388|NCT00785798|2542186|P1|COMPLETED|Overall Study||16
1047389|NCT00785798|2542186|P1|STARTED|Overall Study||17
1047390|NCT00785980|2542191|P1|NOT COMPLETED|Quinine Sulfate With Ciprofloxacin||0
1047391|NCT00785980|2542191|P1|COMPLETED|Quinine Sulfate With Ciprofloxacin||21
1047392|NCT00785980|2542191|P1|STARTED|Quinine Sulfate With Ciprofloxacin||21
1047393|NCT00785980|2542191|P1|NOT COMPLETED|Ciprofloxacin Alone||0
1047394|NCT00785980|2542191|P1|COMPLETED|Ciprofloxacin Alone||21
1047395|NCT00785980|2542191|P1|STARTED|Ciprofloxacin Alone||21
1047396|NCT00785980|2542191|P1|NOT COMPLETED|7 Day Washout Period||3
1047397|NCT00785980|2542191|P1|COMPLETED|7 Day Washout Period||21
1047398|NCT00785980|2542191|P1|STARTED|7 Day Washout Period||24
1047399|NCT00785980|2542191|P1|NOT COMPLETED|Quinine Sulfate Alone||0
1047400|NCT00785980|2542191|P1|COMPLETED|Quinine Sulfate Alone||24
1047401|NCT00785980|2542191|P1|STARTED|Quinine Sulfate Alone||24
1047402|NCT00786032|2542202|P1|NOT COMPLETED|Overall Study||24
1047403|NCT00786032|2542202|P1|COMPLETED|Overall Study||3
1047404|NCT00786032|2542202|P1|Independent Users|Overall Study|All data analyses were based on the 14 independent users.|14
1047405|NCT00786032|2542202|P1|STARTED|Overall Study||27
1047406|NCT00786188|2542214|P2|NOT COMPLETED|Overall Study||1
1047407|NCT00786188|2542215|P1|NOT COMPLETED|Overall Study||5
1047408|NCT00786188|2542214|P2|COMPLETED|Overall Study||51
1047409|NCT00786188|2542215|P1|COMPLETED|Overall Study||45
1047410|NCT00786188|2542214|P2|STARTED|Overall Study||52
1047411|NCT00786188|2542215|P1|STARTED|Overall Study||50
1047412|NCT00786422|2542241|P1|NOT COMPLETED|Follow-up Period||3
1047413|NCT00786422|2542241|P1|COMPLETED|Follow-up Period||17
1047414|NCT00786422|2542241|P1|STARTED|Follow-up Period|Participants entered follow-up period. No reason documents for those not entering this period|20
1047415|NCT00786422|2542241|P1|NOT COMPLETED|Rivaroxaban Treatment||11
1047416|NCT00786422|2542241|P1|COMPLETED|Rivaroxaban Treatment||14
1047417|NCT00786422|2542241|P1|STARTED|Rivaroxaban Treatment||25
1047418|NCT00786474|2542259|P2|NOT COMPLETED|Overall Study||43
1047419|NCT00786474|2542260|P1|NOT COMPLETED|Overall Study||37
1047420|NCT00786474|2542259|P2|COMPLETED|Overall Study||891
1047421|NCT00786474|2542260|P1|COMPLETED|Overall Study||913
1047422|NCT00786474|2542259|P2|STARTED|Overall Study||934
1047423|NCT00786474|2542260|P1|STARTED|Overall Study||950
1047424|NCT00786487|2542276|P4|NOT COMPLETED|Overall Study||0
1047425|NCT00786487|2542277|P3|NOT COMPLETED|Overall Study||0
1047426|NCT00786487|2542278|P2|NOT COMPLETED|Overall Study||0
1047427|NCT00786487|2542279|P1|NOT COMPLETED|Overall Study||0
1047428|NCT00786487|2542276|P4|COMPLETED|Overall Study||7
1047429|NCT00786487|2542277|P3|COMPLETED|Overall Study||9
1047430|NCT00786487|2542278|P2|COMPLETED|Overall Study||7
1047431|NCT00786487|2542279|P1|COMPLETED|Overall Study||10
1047432|NCT00786487|2542276|P4|STARTED|Overall Study||7
1047433|NCT00786487|2542277|P3|STARTED|Overall Study||9
1047434|NCT00786487|2542278|P2|STARTED|Overall Study||7
1047435|NCT00786487|2542279|P1|STARTED|Overall Study||10
1047436|NCT00786565|2542289|P1|NOT COMPLETED|Post Surgery||2
1047437|NCT00786565|2542289|P1|COMPLETED|Post Surgery|67 Participants (134 eyes) completed the study.|67
1047438|NCT00786565|2542289|P1|STARTED|Post Surgery||69
1047439|NCT00786565|2542289|P1|NOT COMPLETED|Enrollment Prior to Surgery||6
1047440|NCT00786565|2542289|P1|COMPLETED|Enrollment Prior to Surgery|69 participants - Akreos Advanced Optic Lens in one eye and Akreos Adapt Lens in the fellow eye.|69
1047441|NCT00786565|2542289|P1|STARTED|Enrollment Prior to Surgery||75
1047442|NCT00786643|2542329|P2|NOT COMPLETED|Overall Study||0
1047443|NCT00786643|2542330|P1|NOT COMPLETED|Overall Study||0
1047444|NCT00786643|2542329|P2|COMPLETED|Overall Study||28
1047445|NCT00786643|2542330|P1|COMPLETED|Overall Study||20
1047446|NCT00786643|2542329|P2|STARTED|Overall Study||28
1047447|NCT00786643|2542330|P1|STARTED|Overall Study||20
1047448|NCT00786682|2542340|P1|NOT COMPLETED|Overall Study||0
1047449|NCT00786682|2542340|P1|COMPLETED|Overall Study||11
1047450|NCT00786682|2542340|P1|STARTED|Overall Study||11
1047451|NCT00786799|2542348|P2|NOT COMPLETED|Overall Study||1
1047452|NCT00786799|2542349|P1|NOT COMPLETED|Overall Study||1
1047453|NCT00786799|2542348|P2|COMPLETED|Overall Study||12
1047454|NCT00786799|2542349|P1|COMPLETED|Overall Study||13
1047455|NCT00786799|2542348|P2|STARTED|Overall Study||13
1047456|NCT00786799|2542349|P1|STARTED|Overall Study||14
1047457|NCT00786838|2542360|P1|NOT COMPLETED|Overall Study||49
1047458|NCT00786838|2542360|P1|COMPLETED|Overall Study||26
1047459|NCT00786838|2542360|P1|STARTED|Overall Study||75
1047460|NCT00786864|2542387|P2|NOT COMPLETED|Overall Study||1
1047461|NCT00786864|2542388|P1|NOT COMPLETED|Overall Study||1
1047462|NCT00786864|2542387|P2|COMPLETED|Overall Study|1 child lost to study immediately post-intervention as she left the school|32
1047463|NCT00786864|2542388|P1|COMPLETED|Overall Study|1 child excluded at the 3 month follow-up, as he sustained a serious back injury|38
1047464|NCT00786864|2542387|P2|STARTED|Overall Study||33
1047465|NCT00786864|2542388|P1|STARTED|Overall Study||39
1047466|NCT00786916|2542403|P3|NOT COMPLETED|Overall Study||0
1047467|NCT00786916|2542404|P2|NOT COMPLETED|Overall Study||0
1047468|NCT00786916|2542405|P1|NOT COMPLETED|Overall Study||0
1047469|NCT00786916|2542403|P3|COMPLETED|Overall Study||34
1047470|NCT00786916|2542404|P2|COMPLETED|Overall Study||36
1047471|NCT00786916|2542405|P1|COMPLETED|Overall Study||39
1047472|NCT00786916|2542403|P3|STARTED|Overall Study||34
1047473|NCT00786916|2542404|P2|STARTED|Overall Study||36
1047474|NCT00786916|2542405|P1|STARTED|Overall Study||39
1047475|NCT00786994|2542417|P4|NOT COMPLETED|Overall Study||6
1047476|NCT00786994|2542418|P3|NOT COMPLETED|Overall Study||2
1047477|NCT00786994|2542419|P2|NOT COMPLETED|Overall Study||15
1047478|NCT00786994|2542420|P1|NOT COMPLETED|Overall Study||10
1047479|NCT00786994|2542417|P4|COMPLETED|Overall Study||22
1047480|NCT00786994|2542418|P3|COMPLETED|Overall Study||24
1047481|NCT00786994|2542419|P2|COMPLETED|Overall Study||39
1047482|NCT00786994|2542420|P1|COMPLETED|Overall Study||47
1047483|NCT00786994|2542417|P4|ITT|Overall Study||28
1047484|NCT00786994|2542418|P3|ITT|Overall Study||25
1047485|NCT00786994|2542419|P2|ITT|Overall Study||51
1047486|NCT00786994|2542420|P1|ITT|Overall Study||53
1047487|NCT00786994|2542417|P4|STARTED|Overall Study||28
1047488|NCT00786994|2542418|P3|STARTED|Overall Study||26
1047489|NCT00786994|2542419|P2|STARTED|Overall Study||54
1047490|NCT00786994|2542420|P1|STARTED|Overall Study||57
1047491|NCT00787020|2542431|P2|NOT COMPLETED|Overall Study||0
1047492|NCT00787020|2542432|P1|NOT COMPLETED|Overall Study||0
1047493|NCT00787020|2542431|P2|COMPLETED|Overall Study||13
1047494|NCT00787020|2542432|P1|COMPLETED|Overall Study||24
1047495|NCT00787020|2542431|P2|STARTED|Overall Study||13
1047496|NCT00787020|2542432|P1|STARTED|Overall Study||24
1047497|NCT00787124|2542444|P2|NOT COMPLETED|Overall Study||0
1047498|NCT00787124|2542445|P1|NOT COMPLETED|Overall Study||0
1047499|NCT00787124|2542444|P2|COMPLETED|Overall Study||4
1047500|NCT00787124|2542445|P1|COMPLETED|Overall Study||4
1047501|NCT00787124|2542444|P2|STARTED|Overall Study||4
1047502|NCT00787124|2542445|P1|STARTED|Overall Study||4
1047503|NCT00787137|2542456|P3|NOT COMPLETED|Overall Study||1
1047504|NCT00787137|2542457|P2|NOT COMPLETED|Overall Study||0
1047505|NCT00787137|2542458|P1|NOT COMPLETED|Overall Study||0
1047506|NCT00787137|2542456|P3|COMPLETED|Overall Study||4
1047507|NCT00787137|2542457|P2|COMPLETED|Overall Study||6
1047508|NCT00787137|2542458|P1|COMPLETED|Overall Study||6
1047509|NCT00787137|2542456|P3|STARTED|Overall Study||5
1047510|NCT00787137|2542457|P2|STARTED|Overall Study||6
1047511|NCT00787137|2542458|P1|STARTED|Overall Study||6
1047512|NCT00787150|2542481|P3|NOT COMPLETED|Overall Study||5
1047513|NCT00787150|2542482|P2|NOT COMPLETED|Overall Study||7
1047514|NCT00787150|2542483|P1|NOT COMPLETED|Overall Study||9
1047515|NCT00787150|2542481|P3|COMPLETED|Overall Study||66
1047516|NCT00787150|2542482|P2|COMPLETED|Overall Study||65
1047517|NCT00787150|2542483|P1|COMPLETED|Overall Study||66
1047518|NCT00787150|2542481|P3|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|71
1047519|NCT00787150|2542482|P2|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|72
1047520|NCT00787150|2542483|P1|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|75
1047521|NCT00787189|2542527|P2|NOT COMPLETED|Overall Study||2
1047522|NCT00787189|2542528|P1|NOT COMPLETED|Overall Study||2
1047523|NCT00787189|2542527|P2|COMPLETED|Overall Study|To study end point.|30
1047524|NCT00787189|2542528|P1|COMPLETED|Overall Study|To study end point.|30
1047525|NCT00787189|2542527|P2|STARTED|Overall Study||32
1047526|NCT00787189|2542528|P1|STARTED|Overall Study||32
1047527|NCT00787202|2542539|P5|NOT COMPLETED|Overall Study||4
1047528|NCT00787202|2542540|P4|NOT COMPLETED|Overall Study||2
1047529|NCT00787202|2542541|P3|NOT COMPLETED|Overall Study||7
1047530|NCT00787202|2542542|P2|NOT COMPLETED|Overall Study||11
1047531|NCT00787202|2542543|P1|NOT COMPLETED|Overall Study||14
1047532|NCT00787202|2542539|P5|COMPLETED|Overall Study||45
1047533|NCT00787202|2542540|P4|COMPLETED|Overall Study||31
1047534|NCT00787202|2542541|P3|COMPLETED|Overall Study||26
1047535|NCT00787202|2542542|P2|COMPLETED|Overall Study||20
1047536|NCT00787202|2542543|P1|COMPLETED|Overall Study||35
1047537|NCT00787202|2542539|P5|Treated|Overall Study||49
1047538|NCT00787202|2542540|P4|Treated|Overall Study||33
1047539|NCT00787202|2542541|P3|Treated|Overall Study||33
1047540|NCT00787202|2542542|P2|Treated|Overall Study||31
1047541|NCT00787202|2542543|P1|Treated|Overall Study||48
1047542|NCT00787202|2542539|P5|STARTED|Overall Study||49
1047543|NCT00787202|2542540|P4|STARTED|Overall Study||33
1047544|NCT00787202|2542541|P3|STARTED|Overall Study||33
1047545|NCT00787202|2542542|P2|STARTED|Overall Study||31
1047546|NCT00787202|2542543|P1|STARTED|Overall Study||49
1047547|NCT00787241|2542597|P3|NOT COMPLETED|Overall Study||0
1047548|NCT00787241|2542598|P2|NOT COMPLETED|Overall Study||0
1047549|NCT00787241|2542599|P1|NOT COMPLETED|Overall Study||0
1047550|NCT00787241|2542597|P3|COMPLETED|Overall Study||41
1047551|NCT00787241|2542598|P2|COMPLETED|Overall Study||143
1047552|NCT00787241|2542599|P1|COMPLETED|Overall Study||261
1047553|NCT00787241|2542597|P3|STARTED|Overall Study||41
1047554|NCT00787241|2542598|P2|STARTED|Overall Study||143
1047555|NCT00787241|2542599|P1|STARTED|Overall Study||261
1047556|NCT00787254|2542615|P2|NOT COMPLETED|Overall Study||82
1047557|NCT00787254|2542616|P1|NOT COMPLETED|Overall Study||76
1047558|NCT00787254|2542615|P2|COMPLETED|Overall Study||99
1047559|NCT00787254|2542616|P1|COMPLETED|Overall Study||109
1047560|NCT00787254|2542615|P2|STARTED|Overall Study||181
1047561|NCT00787254|2542616|P1|STARTED|Overall Study||185
1047562|NCT00787267|2542716|P1|NOT COMPLETED|Overall Study||12
1047563|NCT00787267|2542716|P1|COMPLETED|Overall Study|Received at least one dose of study drug|25
1047564|NCT00787267|2542716|P1|STARTED|Overall Study|Signed a consent form|37
1047565|NCT00787319|2542724|P1|NOT COMPLETED|Overall Study||63
1047566|NCT00787319|2542724|P1|COMPLETED|Overall Study||45
1047567|NCT00787319|2542724|P1|STARTED|Overall Study||108
1047568|NCT00787332|2542738|P2|NOT COMPLETED|Overall Study||0
1047569|NCT00787332|2542739|P1|NOT COMPLETED|Overall Study||0
1047570|NCT00787332|2542738|P2|COMPLETED|Overall Study||8
1047571|NCT00787332|2542739|P1|COMPLETED|Overall Study||8
1047572|NCT00787332|2542738|P2|STARTED|Overall Study||8
1047573|NCT00787332|2542739|P1|STARTED|Overall Study||8
1047574|NCT00787527|2542745|P1|NOT COMPLETED|Overall Study||3
1047575|NCT00787527|2542745|P1|COMPLETED|Overall Study||11
1047576|NCT00787527|2542745|P1|STARTED|Overall Study||14
1047577|NCT00787566|2542756|P3|NOT COMPLETED|Overall Study||0
1047578|NCT00787566|2542757|P2|NOT COMPLETED|Overall Study||1
1047579|NCT00787566|2542758|P1|NOT COMPLETED|Overall Study||0
1047580|NCT00787566|2542756|P3|COMPLETED|Overall Study||22
1047581|NCT00787566|2542757|P2|COMPLETED|Overall Study|1 patient withdrew from the study due to an AE related to chemotherapy agent administration.|24
1047582|NCT00787566|2542758|P1|COMPLETED|Overall Study||21
1047583|NCT00787566|2542756|P3|STARTED|Overall Study||22
1047584|NCT00787566|2542757|P2|STARTED|Overall Study||25
1047585|NCT00787566|2542758|P1|STARTED|Overall Study||21
1047586|NCT00787605|2542768|P2|NOT COMPLETED|Overall Study||56
1047587|NCT00787605|2542769|P1|NOT COMPLETED|Overall Study||46
1047588|NCT00787605|2542768|P2|COMPLETED|Overall Study||376
1047589|NCT00787605|2542769|P1|COMPLETED|Overall Study||382
1047590|NCT00787605|2542768|P2|STARTED|Overall Study||432
1047591|NCT00787605|2542769|P1|STARTED|Overall Study||428
1047592|NCT00787618|2542788|P3|NOT COMPLETED|Overall Study||0
1047593|NCT00787618|2542789|P2|NOT COMPLETED|Overall Study||0
1047594|NCT00787618|2542790|P1|NOT COMPLETED|Overall Study||0
1047595|NCT00787618|2542788|P3|COMPLETED|Overall Study||3
1047596|NCT00787618|2542789|P2|COMPLETED|Overall Study||0
1047597|NCT00787618|2542790|P1|COMPLETED|Overall Study||3
1047598|NCT00787618|2542788|P3|STARTED|Overall Study||3
1047599|NCT00787618|2542789|P2|STARTED|Overall Study||0
1047600|NCT00787618|2542790|P1|STARTED|Overall Study||3
1047601|NCT00787644|2542800|P2|NOT COMPLETED|Overall Study||2
1047602|NCT00787644|2542801|P1|NOT COMPLETED|Overall Study||2
1047603|NCT00787644|2542800|P2|COMPLETED|Overall Study||9
1047604|NCT00787644|2542801|P1|COMPLETED|Overall Study||10
1047605|NCT00787644|2542800|P2|STARTED|Overall Study||11
1047606|NCT00787644|2542801|P1|STARTED|Overall Study||12
1047607|NCT00778817|2542807|P1|NOT COMPLETED|Overall Study||4
1047608|NCT00778817|2542807|P1|COMPLETED|Overall Study||16
1047609|NCT00778817|2542807|P1|STARTED|Overall Study||20
1047610|NCT00778830|2542824|P2|NOT COMPLETED|Overall Study||1
1047611|NCT00778830|2542825|P1|NOT COMPLETED|Overall Study||0
1047612|NCT00778830|2542824|P2|COMPLETED|Overall Study||187
1047613|NCT00778830|2542825|P1|COMPLETED|Overall Study||101
1047614|NCT00778830|2542824|P2|STARTED|Overall Study||188
1047615|NCT00778830|2542825|P1|STARTED|Overall Study||101
1047616|NCT00778869|2542837|P1|NOT COMPLETED|Overall Study||0
1047617|NCT00778869|2542837|P1|COMPLETED|Overall Study||10
1047618|NCT00778869|2542837|P1|STARTED|Overall Study||10
1047619|NCT00778895|2542844|P3|NOT COMPLETED|ESFU Phase||2
1047620|NCT00778895|2542845|P2|NOT COMPLETED|ESFU Phase||12
1047621|NCT00778895|2542846|P1|NOT COMPLETED|ESFU Phase||11
1047622|NCT00778895|2542844|P3|COMPLETED|ESFU Phase||41
1047623|NCT00778895|2542845|P2|COMPLETED|ESFU Phase||155
1047624|NCT00778895|2542846|P1|COMPLETED|ESFU Phase||153
1047625|NCT00778895|2542844|P3|STARTED|ESFU Phase||43
1047626|NCT00778895|2542845|P2|STARTED|ESFU Phase||167
1047627|NCT00778895|2542846|P1|STARTED|ESFU Phase||164
1047628|NCT00778895|2542844|P3|NOT COMPLETED|Active Phase||0
1047629|NCT00778895|2542845|P2|NOT COMPLETED|Active Phase||6
1047630|NCT00778895|2542846|P1|NOT COMPLETED|Active Phase||7
1047631|NCT00778895|2542844|P3|COMPLETED|Active Phase||43
1047632|NCT00778895|2542845|P2|COMPLETED|Active Phase||161
1047633|NCT00778895|2542846|P1|COMPLETED|Active Phase||157
1047634|NCT00778895|2542844|P3|STARTED|Active Phase||43
1047635|NCT00778895|2542845|P2|STARTED|Active Phase||167
1047636|NCT00778895|2542846|P1|STARTED|Active Phase||164
1047637|NCT00778921|2542887|P3|NOT COMPLETED|Overall Study||28
1047638|NCT00778921|2542888|P2|NOT COMPLETED|Overall Study||19
1047639|NCT00778921|2542889|P1|NOT COMPLETED|Overall Study||18
1047640|NCT00778921|2542887|P3|COMPLETED|Overall Study||255
1047641|NCT00778921|2542888|P2|COMPLETED|Overall Study||266
1047642|NCT00778921|2542889|P1|COMPLETED|Overall Study||261
1047643|NCT00778921|2542887|P3|STARTED|Overall Study||283
1047644|NCT00778921|2542888|P2|STARTED|Overall Study||285
1047645|NCT00778921|2542889|P1|STARTED|Overall Study||279
1047646|NCT00778999|2542905|P2|NOT COMPLETED|Overall Study||34
1047647|NCT00778999|2542906|P1|NOT COMPLETED|Overall Study||28
1047648|NCT00778999|2542905|P2|COMPLETED|Overall Study||185
1047649|NCT00778999|2542906|P1|COMPLETED|Overall Study||195
1047650|NCT00778999|2542905|P2|STARTED|Overall Study||219
1047651|NCT00778999|2542906|P1|STARTED|Overall Study||223
1047652|NCT00779025|2542912|P1|NOT COMPLETED|Overall Study||1
1047653|NCT00779025|2542912|P1|COMPLETED|Overall Study||81
1047654|NCT00779025|2542912|P1|STARTED|Overall Study||82
1047655|NCT00779038|2542921|P1|NOT COMPLETED|Overall Study||13
1047656|NCT00779038|2542921|P1|COMPLETED|Overall Study||0
1047657|NCT00779038|2542921|P1|STARTED|Overall Study||13
1047658|NCT00779116|2542930|P2|NOT COMPLETED|Second Intervention||0
1047659|NCT00779116|2542931|P1|NOT COMPLETED|Second Intervention||0
1047660|NCT00779116|2542930|P2|COMPLETED|Second Intervention||108
1047661|NCT00779116|2542931|P1|COMPLETED|Second Intervention||109
1047662|NCT00779116|2542930|P2|STARTED|Second Intervention||108
1047663|NCT00779116|2542931|P1|STARTED|Second Intervention||109
1047664|NCT00779116|2542930|P2|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
1047665|NCT00779116|2542931|P1|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
1047666|NCT00779116|2542930|P2|COMPLETED|Interval Between Doses (8-10 Minutes)||108
1047667|NCT00779116|2542931|P1|COMPLETED|Interval Between Doses (8-10 Minutes)||109
1047668|NCT00779116|2542930|P2|STARTED|Interval Between Doses (8-10 Minutes)||108
1047669|NCT00779116|2542931|P1|STARTED|Interval Between Doses (8-10 Minutes)||109
1047670|NCT00779116|2542930|P2|NOT COMPLETED|First Intervention||0
1047671|NCT00779116|2542931|P1|NOT COMPLETED|First Intervention||0
1047672|NCT00779116|2542930|P2|COMPLETED|First Intervention||108
1047673|NCT00779116|2542931|P1|COMPLETED|First Intervention||109
1047674|NCT00779116|2542930|P2|STARTED|First Intervention||108
1047675|NCT00779116|2542931|P1|STARTED|First Intervention||109
1047676|NCT00779142|2542938|P1|NOT COMPLETED|Overall Study||3
1047677|NCT00779142|2542938|P1|COMPLETED|Overall Study|Only 2 patients were actually enrolled.|2
1047678|NCT00779142|2542938|P1|STARTED|Overall Study|5 patients signed consent and were screened.|5
1047679|NCT00779155|2542944|P2|NOT COMPLETED|Overall Study||0
1047680|NCT00779155|2542945|P1|NOT COMPLETED|Overall Study||0
1047681|NCT00779155|2542944|P2|COMPLETED|Overall Study||6
1047682|NCT00779155|2542945|P1|COMPLETED|Overall Study||6
1047683|NCT00779155|2542944|P2|STARTED|Overall Study||6
1047684|NCT00779155|2542945|P1|STARTED|Overall Study||6
1047685|NCT00779246|2542953|P2|NOT COMPLETED|Overall Study||53
1047686|NCT00779246|2542954|P1|NOT COMPLETED|Overall Study||33
1047687|NCT00779246|2542953|P2|COMPLETED|Overall Study||715
1047688|NCT00779246|2542954|P1|COMPLETED|Overall Study||717
1047689|NCT00779246|2542953|P2|STARTED|Overall Study||768
1047690|NCT00779246|2542954|P1|STARTED|Overall Study||750
1047691|NCT00779259|2542960|P1|NOT COMPLETED|Theophylline With Quinine||0
1047692|NCT00779259|2542960|P1|COMPLETED|Theophylline With Quinine||22
1047693|NCT00779259|2542960|P1|STARTED|Theophylline With Quinine||22
1047694|NCT00779259|2542960|P1|NOT COMPLETED|Quinine Alone||2
1047695|NCT00779259|2542960|P1|COMPLETED|Quinine Alone||22
1047696|NCT00779259|2542960|P1|STARTED|Quinine Alone||24
1047697|NCT00779259|2542960|P1|NOT COMPLETED|4 Day Washout Period||0
1047698|NCT00779259|2542960|P1|COMPLETED|4 Day Washout Period||24
1047699|NCT00779259|2542960|P1|STARTED|4 Day Washout Period||24
1047700|NCT00779259|2542960|P1|NOT COMPLETED|Theophylline Alone||0
1047701|NCT00779259|2542960|P1|COMPLETED|Theophylline Alone||24
1047702|NCT00779259|2542960|P1|STARTED|Theophylline Alone||24
1047703|NCT00779285|2542979|P1|NOT COMPLETED|Overall Study||0
1047704|NCT00779285|2542979|P1|COMPLETED|Overall Study||1
1047705|NCT00779285|2542979|P1|STARTED|Overall Study||1
1047706|NCT00779311|2542988|P5|NOT COMPLETED|Overall Study||0
1047707|NCT00779311|2542989|P4|NOT COMPLETED|Overall Study||0
1047708|NCT00779311|2542990|P3|NOT COMPLETED|Overall Study||0
1047709|NCT00779311|2542991|P2|NOT COMPLETED|Overall Study||0
1047710|NCT00779311|2542992|P1|NOT COMPLETED|Overall Study||0
1047711|NCT00779311|2542988|P5|COMPLETED|Overall Study||0
1047712|NCT00779311|2542989|P4|COMPLETED|Overall Study||0
1047713|NCT00779311|2542990|P3|COMPLETED|Overall Study||0
1047714|NCT00779311|2542991|P2|COMPLETED|Overall Study||0
1047715|NCT00779311|2542992|P1|COMPLETED|Overall Study||8
1047716|NCT00779311|2542988|P5|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
1047717|NCT00779311|2542989|P4|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
1047718|NCT00779311|2542990|P3|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
1047719|NCT00779311|2542991|P2|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
1047720|NCT00779311|2542992|P1|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||6
1047721|NCT00779311|2542988|P5|STARTED|Overall Study||0
1047722|NCT00779311|2542989|P4|STARTED|Overall Study||0
1047723|NCT00779311|2542990|P3|STARTED|Overall Study||0
1047724|NCT00779311|2542991|P2|STARTED|Overall Study||0
1047725|NCT00779311|2542992|P1|STARTED|Overall Study|2 of 6 patients were not evaluable for DLT assessment and were replaced for a total of 8 enrolled.|8
1047726|NCT00779467|2543018|P4|NOT COMPLETED|Overall Study||19
1047727|NCT00779467|2543019|P3|NOT COMPLETED|Overall Study||10
1047728|NCT00779467|2543020|P2|NOT COMPLETED|Overall Study||5
1047729|NCT00779467|2543021|P1|NOT COMPLETED|Overall Study||15
1047730|NCT00779467|2543018|P4|COMPLETED|Overall Study||35
1047731|NCT00779467|2543019|P3|COMPLETED|Overall Study||38
1047732|NCT00779467|2543020|P2|COMPLETED|Overall Study||40
1047733|NCT00779467|2543021|P1|COMPLETED|Overall Study||38
1047734|NCT00779467|2543018|P4|STARTED|Overall Study||54
1047735|NCT00779467|2543019|P3|STARTED|Overall Study||48
1047736|NCT00779467|2543020|P2|STARTED|Overall Study||45
1047737|NCT00779467|2543021|P1|STARTED|Overall Study||53
1047738|NCT00779506|2543059|P1|NOT COMPLETED|Overall Study||29
1047739|NCT00779506|2543059|P1|COMPLETED|Overall Study||67
1047740|NCT00779506|2543059|P1|Withdrawal Treatment|Overall Study||27
1047741|NCT00779506|2543059|P1|Treatment Complete|Overall Study||67
1047742|NCT00779506|2543059|P1|MITT|Overall Study||89
1047743|NCT00779506|2543059|P1|Assigned|Overall Study||94
1047744|NCT00779506|2543059|P1|Screen Failed|Overall Study||2
1047745|NCT00779506|2543059|P1|Enrolled|Overall Study||96
1047746|NCT00779506|2543059|P1|STARTED|Overall Study||96
1047747|NCT00779558|2543071|P2|NOT COMPLETED|Overall Study||7
1047748|NCT00779558|2543072|P1|NOT COMPLETED|Overall Study||4
1047749|NCT00779558|2543071|P2|COMPLETED|Overall Study||37
1047750|NCT00779558|2543072|P1|COMPLETED|Overall Study||53
1047751|NCT00779558|2543071|P2|STARTED|Overall Study||44
1047752|NCT00779558|2543072|P1|STARTED|Overall Study||57
1047753|NCT00779584|2543095|P9|NOT COMPLETED|Overall Study||2
1047754|NCT00779584|2543096|P8|NOT COMPLETED|Overall Study||3
1047755|NCT00779584|2543097|P7|NOT COMPLETED|Overall Study||8
1047756|NCT00779584|2543098|P6|NOT COMPLETED|Overall Study||6
1047757|NCT00779584|2543099|P5|NOT COMPLETED|Overall Study||7
1047758|NCT00779584|2543100|P4|NOT COMPLETED|Overall Study||6
1047759|NCT00779584|2543101|P3|NOT COMPLETED|Overall Study||7
1047760|NCT00779584|2543102|P2|NOT COMPLETED|Overall Study||3
1047761|NCT00779584|2543103|P1|NOT COMPLETED|Overall Study||3
1047762|NCT00779584|2543095|P9|COMPLETED|Overall Study||0
1047763|NCT00779584|2543096|P8|COMPLETED|Overall Study||0
1047764|NCT00779584|2543097|P7|COMPLETED|Overall Study||0
1047765|NCT00779584|2543098|P6|COMPLETED|Overall Study||0
1047766|NCT00779584|2543099|P5|COMPLETED|Overall Study||0
1047767|NCT00779584|2543100|P4|COMPLETED|Overall Study||0
1047768|NCT00779584|2543101|P3|COMPLETED|Overall Study||0
1047769|NCT00779584|2543102|P2|COMPLETED|Overall Study||0
1047770|NCT00779584|2543103|P1|COMPLETED|Overall Study||0
1047771|NCT00779584|2543095|P9|Treated|Overall Study||2
1047772|NCT00779584|2543096|P8|Treated|Overall Study||3
1047773|NCT00779584|2543097|P7|Treated|Overall Study||8
1047774|NCT00779584|2543098|P6|Treated|Overall Study||4
1047775|NCT00779584|2543099|P5|Treated|Overall Study||7
1047776|NCT00779584|2543100|P4|Treated|Overall Study||6
1047777|NCT00779584|2543101|P3|Treated|Overall Study||7
1047778|NCT00779584|2543102|P2|Treated|Overall Study||3
1047779|NCT00779584|2543103|P1|Treated|Overall Study||3
1047780|NCT00779584|2543095|P9|STARTED|Overall Study||2
1047781|NCT00779584|2543096|P8|STARTED|Overall Study||3
1047782|NCT00779584|2543097|P7|STARTED|Overall Study||8
1047783|NCT00779584|2543098|P6|STARTED|Overall Study||6
1047784|NCT00779584|2543099|P5|STARTED|Overall Study||7
1047785|NCT00779584|2543100|P4|STARTED|Overall Study||6
1047786|NCT00779584|2543101|P3|STARTED|Overall Study||7
1047787|NCT00779584|2543102|P2|STARTED|Overall Study||3
1047788|NCT00779584|2543103|P1|STARTED|Overall Study||3
1047789|NCT00779675|2543177|P1|NOT COMPLETED|Extended Treatment Period||46
1047790|NCT00779675|2543177|P1|COMPLETED|Extended Treatment Period||147
1047791|NCT00779675|2543177|P1|STARTED|Extended Treatment Period|Clinical responders during the treatment period could enter the extended treatment period.|193
1047792|NCT00779675|2543177|P1|NOT COMPLETED|Treatment Period||332
1047793|NCT00779675|2543177|P1|COMPLETED|Treatment Period||328
1047794|NCT00779675|2543177|P1|STARTED|Treatment Period|One of the 660 participants did not receive study treatment.|660
1047795|NCT00779701|2543196|P1|NOT COMPLETED|Overall Study||0
1047796|NCT00779701|2543196|P1|COMPLETED|Overall Study||27
1047797|NCT00779701|2543196|P1|STARTED|Overall Study||27
1047798|NCT00779766|2543202|P2|NOT COMPLETED|Overall Study||68
1047799|NCT00779766|2543203|P1|NOT COMPLETED|Overall Study||85
1047800|NCT00779766|2543202|P2|COMPLETED|Overall Study|Among those 2814 subjects, 1408 completed the study and 1406 had an unknown completion status.|2957
1047801|NCT00779766|2543203|P1|COMPLETED|Overall Study|Among those 2831 subjects, 1432 completed the study and 1399 had an unknown completion status.|2941
1047802|NCT00779766|2543202|P2|STARTED|Overall Study||3025
1047803|NCT00779766|2543203|P1|STARTED|Overall Study||3026
1047804|NCT00779779|2543281|P1|NOT COMPLETED|Overall Study||24
1047805|NCT00779779|2543281|P1|COMPLETED|Overall Study||498
1047806|NCT00779779|2543281|P1|STARTED|Overall Study||522
1047807|NCT00779857|2543288|P1|NOT COMPLETED|Overall Study||6
1047808|NCT00779857|2543288|P1|COMPLETED|Overall Study|12 Month Post procedure, 64 subjects available for evaluation|64
1047809|NCT00779857|2543288|P1|3 Month Post Procedure|Overall Study|3 month follow-up, 65 of the subjects were available for evaluation.|65
1047810|NCT00779857|2543288|P1|30 Day Post Procedure|Overall Study|2 missed Visit|68
1047811|NCT00779857|2543288|P1|STARTED|Overall Study|70 patients treated|70
1047812|NCT00779909|2543297|P4|NOT COMPLETED|Overall Study||1
1047813|NCT00779909|2543298|P3|NOT COMPLETED|Overall Study||0
1047814|NCT00779909|2543299|P2|NOT COMPLETED|Overall Study||1
1047815|NCT00779909|2543300|P1|NOT COMPLETED|Overall Study||1
1047816|NCT00779909|2543297|P4|COMPLETED|Overall Study||7
1047817|NCT00779909|2543298|P3|COMPLETED|Overall Study||8
1047818|NCT00779909|2543299|P2|COMPLETED|Overall Study||8
1047819|NCT00779909|2543300|P1|COMPLETED|Overall Study||9
1047820|NCT00779909|2543297|P4|STARTED|Overall Study||8
1047821|NCT00779909|2543298|P3|STARTED|Overall Study||8
1047822|NCT00779909|2543299|P2|STARTED|Overall Study||9
1047823|NCT00779909|2543300|P1|STARTED|Overall Study||10
1047824|NCT00780273|2543342|P1|NOT COMPLETED|Overall Study||2
1047825|NCT00780273|2543342|P1|COMPLETED|Overall Study||17
1047826|NCT00780273|2543342|P1|STARTED|Overall Study||19
1047827|NCT00780338|2543353|P2|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||5
1047828|NCT00780338|2543354|P1|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||13
1047829|NCT00780338|2543353|P2|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||159
1047830|NCT00780338|2543354|P1|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||156
1047831|NCT00780338|2543353|P2|STARTED|Mid to Post (1 Year; 2 Years in Total)||164
1047832|NCT00780338|2543354|P1|STARTED|Mid to Post (1 Year; 2 Years in Total)||169
1047833|NCT00780338|2543353|P2|NOT COMPLETED|Baseline to Mid (1 Year)||38
1047834|NCT00780338|2543354|P1|NOT COMPLETED|Baseline to Mid (1 Year)||5
1047835|NCT00780338|2543353|P2|COMPLETED|Baseline to Mid (1 Year)||164
1047836|NCT00780338|2543354|P1|COMPLETED|Baseline to Mid (1 Year)||169
1047837|NCT00780338|2543353|P2|STARTED|Baseline to Mid (1 Year)||202
1047838|NCT00780338|2543354|P1|STARTED|Baseline to Mid (1 Year)||174
1047839|NCT00780403|2543382|P2|NOT COMPLETED|Second Intervention||0
1047840|NCT00780403|2543383|P1|NOT COMPLETED|Second Intervention||0
1047841|NCT00780403|2543382|P2|COMPLETED|Second Intervention||111
1047842|NCT00780403|2543383|P1|COMPLETED|Second Intervention||109
1047843|NCT00780403|2543382|P2|STARTED|Second Intervention||111
1047844|NCT00780403|2543383|P1|STARTED|Second Intervention||109
1047845|NCT00780403|2543382|P2|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
1047846|NCT00780403|2543383|P1|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
1047847|NCT00780403|2543382|P2|COMPLETED|Interval Between Doses (8-10 Minutes)||111
1047848|NCT00780403|2543383|P1|COMPLETED|Interval Between Doses (8-10 Minutes)||109
1047849|NCT00780403|2543382|P2|STARTED|Interval Between Doses (8-10 Minutes)||111
1047850|NCT00780403|2543383|P1|STARTED|Interval Between Doses (8-10 Minutes)||109
1047851|NCT00780403|2543382|P2|NOT COMPLETED|First Intervention||0
1047852|NCT00780403|2543383|P1|NOT COMPLETED|First Intervention||0
1047853|NCT00780403|2543382|P2|COMPLETED|First Intervention||111
1047854|NCT00780403|2543383|P1|COMPLETED|First Intervention||109
1047855|NCT00780403|2543382|P2|STARTED|First Intervention||111
1047856|NCT00780403|2543383|P1|STARTED|First Intervention||109
1047857|NCT00780416|2543392|P2|NOT COMPLETED|Overall Study||9
1047858|NCT00780416|2543393|P1|NOT COMPLETED|Overall Study||12
1047859|NCT00780416|2543392|P2|COMPLETED|Overall Study||54
1047860|NCT00780416|2543393|P1|COMPLETED|Overall Study||114
1047861|NCT00780416|2543392|P2|STARTED|Overall Study||63
1047862|NCT00780416|2543393|P1|STARTED|Overall Study||126
1047863|NCT00780455|2543401|P2|NOT COMPLETED|Overall Study||0
1047864|NCT00780455|2543402|P1|NOT COMPLETED|Overall Study||0
1047865|NCT00780455|2543401|P2|COMPLETED|Overall Study||2
1047866|NCT00780455|2543402|P1|COMPLETED|Overall Study||2
1047867|NCT00780455|2543401|P2|STARTED|Overall Study||2
1047868|NCT00780455|2543402|P1|STARTED|Overall Study||2
1047869|NCT00780481|2543426|P1|NOT COMPLETED|Overall Study||0
1047870|NCT00780481|2543426|P1|COMPLETED|Overall Study||13
1047871|NCT00780481|2543426|P1|STARTED|Overall Study||13
1047872|NCT00787761|2543433|P1|NOT COMPLETED|Overall Study||0
1047873|NCT00787761|2543433|P1|COMPLETED|Overall Study||24
1047874|NCT00787761|2543433|P1|STARTED|Overall Study||24
1047875|NCT00787787|2543444|P1|NOT COMPLETED|Overall Study||7
1047876|NCT00787787|2543444|P1|COMPLETED|Overall Study||0
1047877|NCT00787787|2543444|P1|STARTED|Overall Study||7
1047878|NCT00787800|2543452|P2|NOT COMPLETED|Overall Study||7
1047879|NCT00787800|2543453|P1|NOT COMPLETED|Overall Study||3
1047880|NCT00787800|2543452|P2|COMPLETED|Overall Study||43
1047881|NCT00787800|2543453|P1|COMPLETED|Overall Study||47
1047882|NCT00787800|2543452|P2|STARTED|Overall Study||50
1047883|NCT00787800|2543453|P1|STARTED|Overall Study||50
1047884|NCT00787839|2543469|P1|NOT COMPLETED|Overall Study||404
1047885|NCT00787839|2543469|P1|COMPLETED|Overall Study||1535
1047886|NCT00787839|2543469|P1|Complete GCT, OGTT, A1c, Demographics|Overall Study||1535
1047887|NCT00787839|2543469|P1|Completed GCT Screening|Overall Study||1876
1047888|NCT00787839|2543469|P1|Consented|Overall Study|consented|1939
1047889|NCT00787839|2543469|P1|STARTED|Overall Study||1939
1047890|NCT00787852|2543492|P2|NOT COMPLETED|Overall Study||0
1047891|NCT00787852|2543493|P1|NOT COMPLETED|Overall Study||1
1047892|NCT00787852|2543492|P2|COMPLETED|Overall Study||5
1047893|NCT00787852|2543493|P1|COMPLETED|Overall Study|1 patient withdrew consent prior to starting|5
1047894|NCT00787852|2543492|P2|STARTED|Overall Study|The study was terminated prior to enrolled to group 2|5
1047895|NCT00787852|2543493|P1|STARTED|Overall Study||6
1047896|NCT00787891|2543501|P2|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
1047897|NCT00787891|2543502|P1|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
1047898|NCT00787891|2543501|P2|COMPLETED|Maintenance Double-blind Phase (Part 2)||24
1047899|NCT00787891|2543502|P1|COMPLETED|Maintenance Double-blind Phase (Part 2)||26
1047900|NCT00787891|2543501|P2|STARTED|Maintenance Double-blind Phase (Part 2)||31
1047901|NCT00787891|2543502|P1|STARTED|Maintenance Double-blind Phase (Part 2)||33
1047902|NCT00787891|2543501|P2|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||9
1047903|NCT00787891|2543502|P1|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||10
1047904|NCT00787891|2543501|P2|COMPLETED|Short-term Double-blind Phase (Part 1)||53
1047905|NCT00787891|2543502|P1|COMPLETED|Short-term Double-blind Phase (Part 1)||55
1047906|NCT00787891|2543501|P2|STARTED|Short-term Double-blind Phase (Part 1)||62
1047907|NCT00787891|2543502|P1|STARTED|Short-term Double-blind Phase (Part 1)||65
1047908|NCT00787904|2543522|P2|NOT COMPLETED|Overall Study||0
1047909|NCT00787904|2543523|P1|NOT COMPLETED|Overall Study||0
1047910|NCT00787904|2543522|P2|COMPLETED|Overall Study||13
1047911|NCT00787904|2543523|P1|COMPLETED|Overall Study||6
1047912|NCT00787904|2543522|P2|STARTED|Overall Study||13
1047913|NCT00787904|2543523|P1|STARTED|Overall Study||6
1047914|NCT00787917|2543533|P2|NOT COMPLETED|Open Label||0
1047915|NCT00787917|2543534|P1|NOT COMPLETED|Open Label||4
1047916|NCT00787917|2543533|P2|COMPLETED|Open Label||0
1047917|NCT00787917|2543534|P1|COMPLETED|Open Label||3
1047918|NCT00787917|2543533|P2|STARTED|Open Label|"Placebo was not an arm in open label treatment."|0
1047919|NCT00787917|2543534|P1|STARTED|Open Label||7
1047920|NCT00787917|2543533|P2|NOT COMPLETED|Blinded Treatment||2
1047921|NCT00787917|2543534|P1|NOT COMPLETED|Blinded Treatment||5
1047922|NCT00787917|2543533|P2|COMPLETED|Blinded Treatment||3
1047923|NCT00787917|2543534|P1|COMPLETED|Blinded Treatment||4
1047924|NCT00787917|2543533|P2|STARTED|Blinded Treatment||5
1047925|NCT00787917|2543534|P1|STARTED|Blinded Treatment||9
1047926|NCT00787930|2543551|P1|NOT COMPLETED|Continuation Treatment -- up to 12 Month||3
1047927|NCT00787930|2543551|P1|COMPLETED|Continuation Treatment -- up to 12 Month||16
1047928|NCT00787930|2543551|P1|STARTED|Continuation Treatment -- up to 12 Month||19
1047929|NCT00787930|2543551|P1|NOT COMPLETED|Acute Treatment -- 3 Weeks||0
1047930|NCT00787930|2543551|P1|COMPLETED|Acute Treatment -- 3 Weeks||19
1047931|NCT00787930|2543551|P1|STARTED|Acute Treatment -- 3 Weeks||19
1047932|NCT00787943|2543564|P1|NOT COMPLETED|Overall Study||0
1047933|NCT00787943|2543564|P1|COMPLETED|Overall Study||10
1047934|NCT00787943|2543564|P1|STARTED|Overall Study||10
1047935|NCT00788008|2543574|P2|NOT COMPLETED|Overall Study||0
1047936|NCT00788008|2543575|P1|NOT COMPLETED|Overall Study||0
1047937|NCT00788008|2543574|P2|COMPLETED|Overall Study||101
1047938|NCT00788008|2543575|P1|COMPLETED|Overall Study||98
1047939|NCT00788008|2543574|P2|STARTED|Overall Study||101
1047940|NCT00788008|2543575|P1|STARTED|Overall Study||98
1047941|NCT00788073|2543583|P2|NOT COMPLETED|Placebo Then STX209||1
1047942|NCT00788073|2543584|P1|NOT COMPLETED|Placebo Then STX209||2
1047943|NCT00788073|2543583|P2|COMPLETED|Placebo Then STX209||29
1047944|NCT00788073|2543584|P1|COMPLETED|Placebo Then STX209||27
1047945|NCT00788073|2543583|P2|STARTED|Placebo Then STX209||30
1047946|NCT00788073|2543584|P1|STARTED|Placebo Then STX209||29
1047947|NCT00788073|2543583|P2|NOT COMPLETED|STX209 Then Placebo||3
1047948|NCT00788073|2543584|P1|NOT COMPLETED|STX209 Then Placebo||1
1047949|NCT00788073|2543583|P2|COMPLETED|STX209 Then Placebo||30
1047950|NCT00788073|2543584|P1|COMPLETED|STX209 Then Placebo||29
1047951|NCT00788073|2543583|P2|STARTED|STX209 Then Placebo||33
1047952|NCT00788073|2543584|P1|STARTED|STX209 Then Placebo||30
1047953|NCT00791479|2543598|P6|NOT COMPLETED|Overall Study||3
1047954|NCT00791479|2543599|P5|NOT COMPLETED|Overall Study||3
1047955|NCT00791479|2543600|P4|NOT COMPLETED|Overall Study||4
1047956|NCT00791479|2543601|P3|NOT COMPLETED|Overall Study||0
1047957|NCT00791479|2543602|P2|NOT COMPLETED|Overall Study||3
1047958|NCT00791479|2543603|P1|NOT COMPLETED|Overall Study||2
1047959|NCT00791479|2543598|P6|COMPLETED|Overall Study||29
1047960|NCT00791479|2543599|P5|COMPLETED|Overall Study||0
1047961|NCT00791479|2543600|P4|COMPLETED|Overall Study||25
1047962|NCT00791479|2543601|P3|COMPLETED|Overall Study||34
1047963|NCT00791479|2543602|P2|COMPLETED|Overall Study||31
1047964|NCT00791479|2543603|P1|COMPLETED|Overall Study||33
1047965|NCT00791479|2543598|P6|Received at Least One Dose of Study Drug|Overall Study||32
1047966|NCT00791479|2543599|P5|Received at Least One Dose of Study Drug|Overall Study||3
1047967|NCT00791479|2543600|P4|Received at Least One Dose of Study Drug|Overall Study||29
1047968|NCT00791479|2543601|P3|Received at Least One Dose of Study Drug|Overall Study||34
1047969|NCT00791479|2543602|P2|Received at Least One Dose of Study Drug|Overall Study||34
1047970|NCT00791479|2543603|P1|Received at Least One Dose of Study Drug|Overall Study||35
1047971|NCT00791479|2543598|P6|STARTED|Overall Study||32
1047972|NCT00791479|2543599|P5|STARTED|Overall Study|3mg LY2189265 discont. Replaced with 1.5mg dose based on dose finding Study H9X-MC-GBCF; NCT00734474|3
1047973|NCT00791479|2543600|P4|STARTED|Overall Study||29
1047974|NCT00791479|2543601|P3|STARTED|Overall Study||34
1047975|NCT00791479|2543602|P2|STARTED|Overall Study||34
1047976|NCT00791479|2543603|P1|STARTED|Overall Study||35
1047977|NCT00791492|2543699|P2|NOT COMPLETED|Overall Study||3
1047978|NCT00791492|2543700|P1|NOT COMPLETED|Overall Study||6
1047979|NCT00791492|2543699|P2|COMPLETED|Overall Study||38
1047980|NCT00791492|2543700|P1|COMPLETED|Overall Study||39
1047981|NCT00791492|2543699|P2|TREATED|Overall Study||41
1047982|NCT00791492|2543700|P1|TREATED|Overall Study||44
1047983|NCT00791492|2543699|P2|STARTED|Overall Study||41
1047984|NCT00791492|2543700|P1|STARTED|Overall Study||45
1047985|NCT00791518|2543742|P1|NOT COMPLETED|Overall Study||93
1047986|NCT00791518|2543742|P1|COMPLETED|Overall Study||991
1047987|NCT00791518|2543742|P1|STARTED|Overall Study||1084
1047988|NCT00791557|2543768|P1|NOT COMPLETED|Overall Study||1
1047989|NCT00791557|2543768|P1|COMPLETED|Overall Study||1
1047990|NCT00791557|2543768|P1|STARTED|Overall Study||2
1047991|NCT00791648|2543774|P2|NOT COMPLETED|Overall Study||2
1047992|NCT00791648|2543775|P1|NOT COMPLETED|Overall Study||0
1047993|NCT00791648|2543774|P2|COMPLETED|Overall Study||307
1047994|NCT00791648|2543775|P1|COMPLETED|Overall Study||308
1047995|NCT00791648|2543774|P2|STARTED|Overall Study||309
1047996|NCT00791648|2543775|P1|STARTED|Overall Study||308
1047997|NCT00791661|2543794|P3|NOT COMPLETED|Period 3||0
1047998|NCT00791661|2543795|P2|NOT COMPLETED|Period 3||0
1047999|NCT00791661|2543796|P1|NOT COMPLETED|Period 3||0
1048000|NCT00791661|2543794|P3|COMPLETED|Period 3||6
1048001|NCT00791661|2543795|P2|COMPLETED|Period 3||8
1048002|NCT00791661|2543796|P1|COMPLETED|Period 3||8
1048003|NCT00791661|2543794|P3|Received Matching Placebo to MK-1006|Period 3||1
1048004|NCT00791661|2543795|P2|Received Matching Placebo to MK-1006|Period 3||2
1048005|NCT00791661|2543796|P1|Received Matching Placebo to MK-1006|Period 3||2
1048006|NCT00791661|2543794|P3|Received MK-1006|Period 3||5
1048007|NCT00791661|2543795|P2|Received MK-1006|Period 3||6
1048008|NCT00791661|2543796|P1|Received MK-1006|Period 3||6
1048009|NCT00791661|2543794|P3|STARTED|Period 3||6
1048010|NCT00791661|2543795|P2|STARTED|Period 3||8
1048011|NCT00791661|2543796|P1|STARTED|Period 3||8
1048012|NCT00791661|2543794|P3|NOT COMPLETED|7 Day Wash-out||0
1048013|NCT00791661|2543795|P2|NOT COMPLETED|7 Day Wash-out||0
1048014|NCT00791661|2543796|P1|NOT COMPLETED|7 Day Wash-out||0
1048015|NCT00791661|2543794|P3|COMPLETED|7 Day Wash-out||6
1048016|NCT00791661|2543795|P2|COMPLETED|7 Day Wash-out||8
1048017|NCT00791661|2543796|P1|COMPLETED|7 Day Wash-out||8
1048018|NCT00791661|2543794|P3|STARTED|7 Day Wash-out||6
1048019|NCT00791661|2543795|P2|STARTED|7 Day Wash-out||8
1048020|NCT00791661|2543796|P1|STARTED|7 Day Wash-out||8
1048021|NCT00791661|2543794|P3|NOT COMPLETED|Period 2||0
1048022|NCT00791661|2543795|P2|NOT COMPLETED|Period 2||0
1048023|NCT00791661|2543796|P1|NOT COMPLETED|Period 2||0
1048024|NCT00791661|2543794|P3|COMPLETED|Period 2||6
1048025|NCT00791661|2543795|P2|COMPLETED|Period 2||8
1048026|NCT00791661|2543796|P1|COMPLETED|Period 2||8
1048027|NCT00791661|2543794|P3|Received Matching Placebo to MK-1006|Period 2||2
1048028|NCT00791661|2543795|P2|Received Matching Placebo to MK-1006|Period 2||2
1048029|NCT00791661|2543796|P1|Received Matching Placebo to MK-1006|Period 2||2
1048030|NCT00791661|2543794|P3|Received MK-1006|Period 2||4
1048031|NCT00791661|2543795|P2|Received MK-1006|Period 2||6
1048032|NCT00791661|2543796|P1|Received MK-1006|Period 2||6
1048033|NCT00791661|2543794|P3|STARTED|Period 2||6
1048034|NCT00791661|2543795|P2|STARTED|Period 2||8
1048035|NCT00791661|2543796|P1|STARTED|Period 2||8
1048036|NCT00791661|2543794|P3|NOT COMPLETED|7 Day Wash-out||2
1048037|NCT00791661|2543795|P2|NOT COMPLETED|7 Day Wash-out||0
1048038|NCT00791661|2543796|P1|NOT COMPLETED|7 Day Wash-out||0
1048039|NCT00791661|2543794|P3|COMPLETED|7 Day Wash-out||6
1048040|NCT00791661|2543795|P2|COMPLETED|7 Day Wash-out||8
1048041|NCT00791661|2543796|P1|COMPLETED|7 Day Wash-out||8
1048042|NCT00791661|2543794|P3|STARTED|7 Day Wash-out||8
1048043|NCT00791661|2543795|P2|STARTED|7 Day Wash-out||8
1048044|NCT00791661|2543796|P1|STARTED|7 Day Wash-out||8
1048045|NCT00791661|2543794|P3|NOT COMPLETED|Period 1||0
1048046|NCT00791661|2543795|P2|NOT COMPLETED|Period 1||0
1048047|NCT00791661|2543796|P1|NOT COMPLETED|Period 1||0
1048048|NCT00791661|2543794|P3|COMPLETED|Period 1||8
1048049|NCT00791661|2543795|P2|COMPLETED|Period 1||8
1048050|NCT00791661|2543796|P1|COMPLETED|Period 1||8
1048051|NCT00791661|2543794|P3|Received Matching Placebo to MK-1006|Period 1||2
1048052|NCT00791661|2543795|P2|Received Matching Placebo to MK-1006|Period 1||2
1048053|NCT00791661|2543796|P1|Received Matching Placebo to MK-1006|Period 1||2
1048054|NCT00791661|2543794|P3|Received MK-1006|Period 1||6
1048055|NCT00791661|2543795|P2|Received MK-1006|Period 1||6
1048056|NCT00791661|2543796|P1|Received MK-1006|Period 1||6
1048057|NCT00791661|2543794|P3|STARTED|Period 1||8
1048058|NCT00791661|2543795|P2|STARTED|Period 1||8
1048059|NCT00791661|2543796|P1|STARTED|Period 1||8
1048060|NCT00791700|2543891|P4|NOT COMPLETED|Overall Study||18
1048061|NCT00791700|2543892|P3|NOT COMPLETED|Overall Study||4
1048062|NCT00791700|2543893|P2|NOT COMPLETED|Overall Study||5
1048063|NCT00791700|2543894|P1|NOT COMPLETED|Overall Study||4
1048064|NCT00791700|2543891|P4|COMPLETED|Overall Study|Two participants discontinued treatment after the lower bound (days 313 and 314) of Week 48 window.|25
1048065|NCT00791700|2543892|P3|COMPLETED|Overall Study||9
1048066|NCT00791700|2543893|P2|COMPLETED|Overall Study||26
1048067|NCT00791700|2543894|P1|COMPLETED|Overall Study||12
1048068|NCT00791700|2543891|P4|STARTED|Overall Study|Please note that the data presented here is Subject Discontinuations Through Week 48.|43
1048069|NCT00791700|2543892|P3|STARTED|Overall Study|Please note that the data presented here is Subject Discontinuations Through Week 48.|13
1048070|NCT00791700|2543893|P2|STARTED|Overall Study|Please note that the data presented here is Subject Discontinuations Through Week 48.|31
1048071|NCT00791700|2543894|P1|STARTED|Overall Study|Please note that the data presented here is Subject Discontinuations Through Week 48.|16
1048072|NCT00791765|2543981|P2|NOT COMPLETED|Weeks 13 to 24||8
1048073|NCT00791765|2543982|P1|NOT COMPLETED|Weeks 13 to 24||5
1048074|NCT00791765|2543981|P2|COMPLETED|Weeks 13 to 24||49
1048075|NCT00791765|2543982|P1|COMPLETED|Weeks 13 to 24||49
1048076|NCT00791765|2543981|P2|STARTED|Weeks 13 to 24|1 participant discontinued due to an adverse event after completing 12 weeks.|57
1048077|NCT00791765|2543982|P1|STARTED|Weeks 13 to 24||54
1048078|NCT00791765|2543981|P2|NOT COMPLETED|Weeks 1 to 12||4
1048079|NCT00791765|2543982|P1|NOT COMPLETED|Weeks 1 to 12||8
1048080|NCT00791765|2543981|P2|COMPLETED|Weeks 1 to 12||58
1048081|NCT00791765|2543982|P1|COMPLETED|Weeks 1 to 12||54
1048082|NCT00791765|2543981|P2|Treated|Weeks 1 to 12||59
1048083|NCT00791765|2543982|P1|Treated|Weeks 1 to 12||62
1048084|NCT00791765|2543981|P2|STARTED|Weeks 1 to 12||62
1048085|NCT00791765|2543982|P1|STARTED|Weeks 1 to 12||62
1048086|NCT00791778|2543995|P2|NOT COMPLETED|Follow-up||1
1048087|NCT00791778|2543996|P1|NOT COMPLETED|Follow-up||5
1048088|NCT00791778|2543995|P2|COMPLETED|Follow-up|Includes 78 participants with study follow-up terminated by sponsor and 12 deaths|90
1048089|NCT00791778|2543996|P1|COMPLETED|Follow-up|Includes 79 participants with study follow-up terminated by sponsor and 16 deaths|95
1048090|NCT00791778|2543995|P2|STARTED|Follow-up||91
1048091|NCT00791778|2543996|P1|STARTED|Follow-up||100
1048092|NCT00791778|2543995|P2|NOT COMPLETED|Double-blind Treatment||48
1048093|NCT00791778|2543996|P1|NOT COMPLETED|Double-blind Treatment||77
1048094|NCT00791778|2543995|P2|COMPLETED|Double-blind Treatment|includes: 75 subjects with progression|75
1048095|NCT00791778|2543996|P1|COMPLETED|Double-blind Treatment|includes: 42 subjects with progression, 4 subjects transferred to a continuation study|46
1048096|NCT00791778|2543995|P2|STARTED|Double-blind Treatment||123
1048097|NCT00791778|2543996|P1|STARTED|Double-blind Treatment||123
1048098|NCT00791817|2544050|P2|NOT COMPLETED|2: Single Dose||0
1048099|NCT00791817|2544051|P1|NOT COMPLETED|2: Single Dose||0
1048100|NCT00791817|2544050|P2|COMPLETED|2: Single Dose||5
1048101|NCT00791817|2544051|P1|COMPLETED|2: Single Dose||5
1048102|NCT00791817|2544050|P2|STARTED|2: Single Dose||5
1048103|NCT00791817|2544051|P1|STARTED|2: Single Dose||5
1048104|NCT00791817|2544050|P2|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
1048105|NCT00791817|2544051|P1|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
1048106|NCT00791817|2544050|P2|COMPLETED|1: Single Dose Followed by Week Washout||5
1048107|NCT00791817|2544051|P1|COMPLETED|1: Single Dose Followed by Week Washout||5
1048108|NCT00791817|2544050|P2|STARTED|1: Single Dose Followed by Week Washout||5
1048109|NCT00791817|2544051|P1|STARTED|1: Single Dose Followed by Week Washout||5
1048110|NCT00791908|2544057|P1|NOT COMPLETED|Overall Study||0
1048111|NCT00791908|2544057|P1|COMPLETED|Overall Study||15
1048112|NCT00791908|2544057|P1|STARTED|Overall Study||15
1048113|NCT00791921|2544067|P2|NOT COMPLETED|Overall Study||96
1048114|NCT00791921|2544068|P1|NOT COMPLETED|Overall Study||34
1048115|NCT00791921|2544067|P2|COMPLETED|Overall Study||18
1048116|NCT00791921|2544068|P1|COMPLETED|Overall Study||82
1048117|NCT00791921|2544067|P2|STARTED|Overall Study||114
1048118|NCT00791921|2544068|P1|STARTED|Overall Study||116
1048119|NCT00791934|2544076|P1|NOT COMPLETED|Overall Study||15
1048120|NCT00791934|2544076|P1|COMPLETED|Overall Study|Follow-up extended to 1 yr. 13 subjects chose not to participate in the extension.|48
1048121|NCT00791934|2544076|P1|STARTED|Overall Study||63
1048122|NCT00791973|2544086|P2|NOT COMPLETED|Second Intervention (1 Week)||0
1048123|NCT00791973|2544087|P1|NOT COMPLETED|Second Intervention (1 Week)||0
1048124|NCT00791973|2544086|P2|COMPLETED|Second Intervention (1 Week)||7
1048125|NCT00791973|2544087|P1|COMPLETED|Second Intervention (1 Week)||8
1048126|NCT00791973|2544086|P2|STARTED|Second Intervention (1 Week)||7
1048127|NCT00791973|2544087|P1|STARTED|Second Intervention (1 Week)||8
1048128|NCT00791973|2544086|P2|NOT COMPLETED|Washout (1 Week)||0
1048129|NCT00791973|2544087|P1|NOT COMPLETED|Washout (1 Week)||0
1048130|NCT00791973|2544086|P2|COMPLETED|Washout (1 Week)||7
1048131|NCT00791973|2544087|P1|COMPLETED|Washout (1 Week)||8
1048132|NCT00791973|2544086|P2|STARTED|Washout (1 Week)||7
1048133|NCT00791973|2544087|P1|STARTED|Washout (1 Week)||8
1048134|NCT00791973|2544086|P2|NOT COMPLETED|First Intervention (1 Week)||0
1048135|NCT00791973|2544087|P1|NOT COMPLETED|First Intervention (1 Week)||0
1048136|NCT00791973|2544086|P2|COMPLETED|First Intervention (1 Week)||7
1048137|NCT00791973|2544087|P1|COMPLETED|First Intervention (1 Week)||8
1048138|NCT00791973|2544086|P2|STARTED|First Intervention (1 Week)||7
1048139|NCT00791973|2544087|P1|STARTED|First Intervention (1 Week)||8
1048140|NCT00791999|2544099|P4|NOT COMPLETED|Overall Study||52
1048141|NCT00791999|2544100|P3|NOT COMPLETED|Overall Study||20
1048142|NCT00791999|2544101|P2|NOT COMPLETED|Overall Study||16
1048143|NCT00791999|2544102|P1|NOT COMPLETED|Overall Study||21
1048144|NCT00791999|2544099|P4|COMPLETED|Overall Study||25
1048145|NCT00791999|2544100|P3|COMPLETED|Overall Study||65
1048146|NCT00791999|2544101|P2|COMPLETED|Overall Study||66
1048147|NCT00791999|2544102|P1|COMPLETED|Overall Study||51
1048148|NCT00791999|2544099|P4|STARTED|Overall Study||77
1048149|NCT00791999|2544100|P3|STARTED|Overall Study||85
1048150|NCT00791999|2544101|P2|STARTED|Overall Study||82
1048151|NCT00791999|2544102|P1|STARTED|Overall Study||72
1048152|NCT00792103|2544116|P1|NOT COMPLETED|Overall Study||133
1048153|NCT00792103|2544116|P1|COMPLETED|Overall Study||65
1048154|NCT00792103|2544116|P1|STARTED|Overall Study|15 subjects were enrolled but did not treat for a total of 183 subjects in the safety population|198
1048155|NCT00792116|2544126|P2|NOT COMPLETED|Overall Study||1
1048156|NCT00792116|2544127|P1|NOT COMPLETED|Overall Study||1
1048157|NCT00792116|2544126|P2|COMPLETED|Overall Study||54
1048158|NCT00792116|2544127|P1|COMPLETED|Overall Study||52
1048159|NCT00792116|2544126|P2|STARTED|Overall Study||55
1048160|NCT00792116|2544127|P1|STARTED|Overall Study||53
1048161|NCT00792259|2544140|P3|NOT COMPLETED|Overall Study||0
1048162|NCT00792259|2544141|P2|NOT COMPLETED|Overall Study||0
1048163|NCT00792259|2544142|P1|NOT COMPLETED|Overall Study||1
1048164|NCT00792259|2544140|P3|COMPLETED|Overall Study||13
1048165|NCT00792259|2544141|P2|COMPLETED|Overall Study||20
1048166|NCT00792259|2544142|P1|COMPLETED|Overall Study||14
1048167|NCT00792259|2544140|P3|STARTED|Overall Study||13
1048168|NCT00792259|2544141|P2|STARTED|Overall Study||20
1048169|NCT00792259|2544142|P1|STARTED|Overall Study||15
1048170|NCT00792298|2544150|P8|NOT COMPLETED|Treatment Period 2||2
1048171|NCT00792298|2544151|P7|NOT COMPLETED|Treatment Period 2||1
1048172|NCT00792298|2544152|P6|NOT COMPLETED|Treatment Period 2||0
1048173|NCT00792298|2544153|P5|NOT COMPLETED|Treatment Period 2||2
1048174|NCT00792298|2544154|P4|NOT COMPLETED|Treatment Period 2||2
1048175|NCT00792298|2544155|P3|NOT COMPLETED|Treatment Period 2||1
1048176|NCT00792298|2544156|P2|NOT COMPLETED|Treatment Period 2||1
1048177|NCT00792298|2544157|P1|NOT COMPLETED|Treatment Period 2||1
1048178|NCT00792298|2544150|P8|COMPLETED|Treatment Period 2||28
1048179|NCT00792298|2544151|P7|COMPLETED|Treatment Period 2||28
1048180|NCT00792298|2544152|P6|COMPLETED|Treatment Period 2||27
1048181|NCT00792298|2544153|P5|COMPLETED|Treatment Period 2||30
1048182|NCT00792298|2544154|P4|COMPLETED|Treatment Period 2||26
1048183|NCT00792298|2544155|P3|COMPLETED|Treatment Period 2||30
1048184|NCT00792298|2544156|P2|COMPLETED|Treatment Period 2||30
1048185|NCT00792298|2544157|P1|COMPLETED|Treatment Period 2||29
1048186|NCT00792298|2544150|P8|STARTED|Treatment Period 2||30
1048187|NCT00792298|2544151|P7|STARTED|Treatment Period 2||29
1048188|NCT00792298|2544152|P6|STARTED|Treatment Period 2||27
1048189|NCT00792298|2544153|P5|STARTED|Treatment Period 2||32
1048190|NCT00792298|2544154|P4|STARTED|Treatment Period 2||28
1048191|NCT00792298|2544155|P3|STARTED|Treatment Period 2||31
1048192|NCT00792298|2544156|P2|STARTED|Treatment Period 2||31
1048193|NCT00792298|2544157|P1|STARTED|Treatment Period 2||30
1048194|NCT00792298|2544150|P8|NOT COMPLETED|Washout||0
1048195|NCT00792298|2544151|P7|NOT COMPLETED|Washout||0
1048196|NCT00792298|2544152|P6|NOT COMPLETED|Washout||2
1048197|NCT00792298|2544153|P5|NOT COMPLETED|Washout||0
1048198|NCT00792298|2544154|P4|NOT COMPLETED|Washout||0
1048199|NCT00792298|2544155|P3|NOT COMPLETED|Washout||1
1048200|NCT00792298|2544156|P2|NOT COMPLETED|Washout||0
1048201|NCT00792298|2544157|P1|NOT COMPLETED|Washout||0
1048202|NCT00792298|2544150|P8|COMPLETED|Washout||30
1048203|NCT00792298|2544151|P7|COMPLETED|Washout||29
1048204|NCT00792298|2544152|P6|COMPLETED|Washout||27
1048205|NCT00792298|2544153|P5|COMPLETED|Washout||32
1048206|NCT00792298|2544154|P4|COMPLETED|Washout||28
1048207|NCT00792298|2544155|P3|COMPLETED|Washout||31
1048208|NCT00792298|2544156|P2|COMPLETED|Washout||31
1048209|NCT00792298|2544157|P1|COMPLETED|Washout||30
1048210|NCT00792298|2544150|P8|STARTED|Washout||30
1048211|NCT00792298|2544151|P7|STARTED|Washout|2 participants discontinued therapy during Period 1 but entered the Washout as allowed per protocol|29
1048212|NCT00792298|2544152|P6|STARTED|Washout||29
1048213|NCT00792298|2544153|P5|STARTED|Washout||32
1048214|NCT00792298|2544154|P4|STARTED|Washout||28
1048215|NCT00792298|2544155|P3|STARTED|Washout|1 participant discontinued therapy during Period 1 but entered the Washout as allowed per protocol|32
1048216|NCT00792298|2544156|P2|STARTED|Washout||31
1048217|NCT00792298|2544157|P1|STARTED|Washout||30
1048218|NCT00792298|2544150|P8|NOT COMPLETED|Treatment Period 1||1
1048219|NCT00792298|2544151|P7|NOT COMPLETED|Treatment Period 1||4
1048220|NCT00792298|2544152|P6|NOT COMPLETED|Treatment Period 1||3
1048221|NCT00792298|2544153|P5|NOT COMPLETED|Treatment Period 1||0
1048222|NCT00792298|2544154|P4|NOT COMPLETED|Treatment Period 1||4
1048223|NCT00792298|2544155|P3|NOT COMPLETED|Treatment Period 1||2
1048224|NCT00792298|2544156|P2|NOT COMPLETED|Treatment Period 1||1
1048225|NCT00792298|2544157|P1|NOT COMPLETED|Treatment Period 1||1
1048226|NCT00792298|2544150|P8|COMPLETED|Treatment Period 1||30
1048227|NCT00792298|2544151|P7|COMPLETED|Treatment Period 1||27
1048228|NCT00792298|2544152|P6|COMPLETED|Treatment Period 1||29
1048229|NCT00792298|2544153|P5|COMPLETED|Treatment Period 1||32
1048230|NCT00792298|2544154|P4|COMPLETED|Treatment Period 1||28
1048231|NCT00792298|2544155|P3|COMPLETED|Treatment Period 1||31
1048232|NCT00792298|2544156|P2|COMPLETED|Treatment Period 1||31
1048233|NCT00792298|2544157|P1|COMPLETED|Treatment Period 1||30
1048234|NCT00792298|2544150|P8|STARTED|Treatment Period 1||31
1048235|NCT00792298|2544151|P7|STARTED|Treatment Period 1||31
1048236|NCT00792298|2544152|P6|STARTED|Treatment Period 1||32
1048237|NCT00792298|2544153|P5|STARTED|Treatment Period 1||32
1048238|NCT00792298|2544154|P4|STARTED|Treatment Period 1||32
1048239|NCT00792298|2544155|P3|STARTED|Treatment Period 1||33
1048240|NCT00792298|2544156|P2|STARTED|Treatment Period 1||32
1048241|NCT00792298|2544157|P1|STARTED|Treatment Period 1||31
1048242|NCT00792428|2544186|P2|NOT COMPLETED|Overall Study||0
1048243|NCT00792428|2544187|P1|NOT COMPLETED|Overall Study||0
1048244|NCT00792428|2544186|P2|COMPLETED|Overall Study||10
1048245|NCT00792428|2544187|P1|COMPLETED|Overall Study||10
1048246|NCT00792428|2544186|P2|STARTED|Overall Study||10
1048247|NCT00792428|2544187|P1|STARTED|Overall Study||10
1048248|NCT00792610|2544195|P1|NOT COMPLETED|Overall Study||0
1048249|NCT00792610|2544195|P1|COMPLETED|Overall Study||127
1048250|NCT00792610|2544195|P1|Youths|Overall Study||127
1048251|NCT00792610|2544195|P1|STARTED|Overall Study||127
1048252|NCT00792623|2544199|P1|NOT COMPLETED|Overall Study||7
1048253|NCT00792623|2544199|P1|COMPLETED|Overall Study||22
1048254|NCT00792623|2544199|P1|STARTED|Overall Study||29
1048255|NCT00792636|2544215|P3|NOT COMPLETED|Overall Study||81
1048256|NCT00792636|2544216|P2|NOT COMPLETED|Overall Study||81
1048257|NCT00792636|2544217|P1|NOT COMPLETED|Overall Study||68
1048258|NCT00792636|2544215|P3|COMPLETED|Overall Study||55
1048259|NCT00792636|2544216|P2|COMPLETED|Overall Study||55
1048260|NCT00792636|2544217|P1|COMPLETED|Overall Study||67
1048261|NCT00792636|2544215|P3|STARTED|Overall Study||136
1048262|NCT00792636|2544216|P2|STARTED|Overall Study||136
1048263|NCT00792636|2544217|P1|STARTED|Overall Study||135
1048264|NCT00792688|2544257|P3|NOT COMPLETED|Overall Study||0
1048265|NCT00792688|2544258|P2|NOT COMPLETED|Overall Study||0
1048266|NCT00792688|2544259|P1|NOT COMPLETED|Overall Study||0
1048267|NCT00792688|2544257|P3|COMPLETED|Overall Study||9
1048268|NCT00792688|2544258|P2|COMPLETED|Overall Study||8
1048269|NCT00792688|2544259|P1|COMPLETED|Overall Study||9
1048270|NCT00792688|2544257|P3|STARTED|Overall Study||9
1048271|NCT00792688|2544258|P2|STARTED|Overall Study||8
1048272|NCT00792688|2544259|P1|STARTED|Overall Study||9
1048273|NCT00792701|2544272|P2|NOT COMPLETED|Overall Study||44
1048274|NCT00792701|2544273|P1|NOT COMPLETED|Overall Study||19
1048275|NCT00792701|2544272|P2|COMPLETED|Overall Study||22
1048276|NCT00792701|2544273|P1|COMPLETED|Overall Study||0
1048277|NCT00792701|2544272|P2|Eligible and Analyzable|Overall Study||44
1048278|NCT00792701|2544273|P1|Eligible and Analyzable|Overall Study||17
1048279|NCT00792701|2544272|P2|Eligible|Overall Study||63
1048280|NCT00792701|2544273|P1|Eligible|Overall Study||18
1048281|NCT00792701|2544272|P2|STARTED|Overall Study||66
1048282|NCT00792701|2544273|P1|STARTED|Overall Study||19
1048283|NCT00792805|2544287|P3|NOT COMPLETED|Overall Study||33
1048284|NCT00792805|2544288|P2|NOT COMPLETED|Overall Study||26
1048285|NCT00792805|2544289|P1|NOT COMPLETED|Overall Study||22
1048286|NCT00792805|2544287|P3|COMPLETED|Overall Study||154
1048287|NCT00792805|2544288|P2|COMPLETED|Overall Study||162
1048288|NCT00792805|2544289|P1|COMPLETED|Overall Study||166
1048289|NCT00792805|2544287|P3|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|186
1048290|NCT00792805|2544288|P2|Exposed to Study Medication or Placebo|Overall Study||188
1048291|NCT00792805|2544289|P1|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|187
1048292|NCT00792805|2544287|P3|STARTED|Overall Study||187
1048293|NCT00792805|2544288|P2|STARTED|Overall Study||188
1048294|NCT00792805|2544289|P1|STARTED|Overall Study||188
1048295|NCT00792922|2544301|P4|NOT COMPLETED|At 3 Years||0
1048296|NCT00792922|2544302|P3|NOT COMPLETED|At 3 Years||0
1048297|NCT00792922|2544303|P2|NOT COMPLETED|At 3 Years||0
1048298|NCT00792922|2544304|P1|NOT COMPLETED|At 3 Years||0
1048299|NCT00792922|2544301|P4|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
1048300|NCT00792922|2544302|P3|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
1048301|NCT00792922|2544303|P2|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
1048302|NCT00792922|2544304|P1|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
1048303|NCT00792922|2544301|P4|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
1048304|NCT00792922|2544302|P3|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
1048305|NCT00792922|2544303|P2|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
1048306|NCT00792922|2544304|P1|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
1048307|NCT00792922|2544301|P4|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
1048308|NCT00792922|2544302|P3|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
1048309|NCT00792922|2544303|P2|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
1048310|NCT00792922|2544304|P1|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
1048311|NCT00792922|2544301|P4|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
1048312|NCT00792922|2544302|P3|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
1048313|NCT00792922|2544303|P2|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
1048314|NCT00792922|2544304|P1|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
1048315|NCT00792922|2544301|P4|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months
the trial was conducted at community level and data reported per community basis"|0
1048316|NCT00792922|2544302|P3|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months
the trial was conducted at community level and data reported per community basis"|0
1048317|NCT00792922|2544303|P2|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months
the trial was conducted at community level and data reported per community basis"|0
1048318|NCT00792922|2544304|P1|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months
the trial was conducted at community level and data reported per community basis"|0
1048319|NCT00792922|2544301|P4|NOT COMPLETED|At Baseline||0
1048320|NCT00792922|2544302|P3|NOT COMPLETED|At Baseline||0
1048321|NCT00792922|2544303|P2|NOT COMPLETED|At Baseline||0
1048322|NCT00792922|2544304|P1|NOT COMPLETED|At Baseline||0
1048323|NCT00792922|2544301|P4|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
1048324|NCT00792922|2544302|P3|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
1048325|NCT00792922|2544303|P2|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
1048326|NCT00792922|2544304|P1|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
1048327|NCT00792922|2544301|P4|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
1048328|NCT00792922|2544302|P3|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
1048329|NCT00792922|2544303|P2|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
1048330|NCT00792922|2544304|P1|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
1048331|NCT00792922|2544301|P4|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
1048332|NCT00792922|2544302|P3|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
1048333|NCT00792922|2544303|P2|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
1048334|NCT00792922|2544304|P1|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
1048335|NCT00792922|2544301|P4|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
1048336|NCT00792922|2544302|P3|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
1048337|NCT00792922|2544303|P2|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
1048338|NCT00792922|2544304|P1|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
1048339|NCT00792922|2544301|P4|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
1048340|NCT00792922|2544302|P3|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
1048341|NCT00792922|2544303|P2|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
1048342|NCT00792922|2544304|P1|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
1048343|NCT00792935|2544320|P2|NOT COMPLETED|Overall Study||3
1048344|NCT00792935|2544321|P1|NOT COMPLETED|Overall Study||4
1048345|NCT00792935|2544320|P2|COMPLETED|Overall Study||68
1048346|NCT00792935|2544321|P1|COMPLETED|Overall Study||68
1048347|NCT00792935|2544320|P2|STARTED|Overall Study||71
1048348|NCT00792935|2544321|P1|STARTED|Overall Study||72
1048349|NCT00792948|2544329|P1|NOT COMPLETED|Overall Study||28
1048350|NCT00792948|2544329|P1|COMPLETED|Overall Study|Patients who completed induction/consolidation step|69
1048351|NCT00792948|2544329|P1|STARTED|Overall Study|Patients registered to induction/consolidation step|97
1048352|NCT00793104|2544338|P1|NOT COMPLETED|Overall Study||1
1048353|NCT00793104|2544338|P1|COMPLETED|Overall Study||9
1048354|NCT00793104|2544338|P1|STARTED|Overall Study||10
1048355|NCT00793169|2544346|P1|NOT COMPLETED|Overall Study||0
1048356|NCT00793169|2544346|P1|COMPLETED|Overall Study||19
1048357|NCT00793169|2544346|P1|STARTED|Overall Study||19
1048358|NCT00793182|2544350|P1|NOT COMPLETED|Overall Study||1
1048359|NCT00793182|2544350|P1|COMPLETED|Overall Study||5
1048360|NCT00793182|2544350|P1|STARTED|Overall Study||6
1048361|NCT00793325|2544354|P1|NOT COMPLETED|Overall Study||19
1048362|NCT00793325|2544354|P1|COMPLETED|Overall Study||890
1048363|NCT00793325|2544354|P1|STARTED|Overall Study||909
1048364|NCT00793403|2544378|P1|NOT COMPLETED|Overall Study||73
1048365|NCT00793403|2544378|P1|COMPLETED|Overall Study||220
1048366|NCT00793403|2544378|P1|STARTED|Overall Study||293
1048367|NCT00793455|2544427|P2|NOT COMPLETED|Overall Study||0
1048368|NCT00793455|2544428|P1|NOT COMPLETED|Overall Study||0
1048369|NCT00793455|2544427|P2|COMPLETED|Overall Study||314
1048370|NCT00793455|2544428|P1|COMPLETED|Overall Study||314
1048371|NCT00793455|2544427|P2|STARTED|Overall Study||314
1048372|NCT00793455|2544428|P1|STARTED|Overall Study||314
1048373|NCT00793520|2544438|P2|NOT COMPLETED|Placebo Crossover to Milnacipran||1
1048374|NCT00793520|2544439|P1|NOT COMPLETED|Placebo Crossover to Milnacipran||0
1048375|NCT00793520|2544438|P2|COMPLETED|Placebo Crossover to Milnacipran||0
1048376|NCT00793520|2544439|P1|COMPLETED|Placebo Crossover to Milnacipran||0
1048377|NCT00793520|2544438|P2|STARTED|Placebo Crossover to Milnacipran||1
1048378|NCT00793520|2544439|P1|STARTED|Placebo Crossover to Milnacipran||0
1048379|NCT00793520|2544438|P2|NOT COMPLETED|Milnacipran Crossover to Placebo||0
1048380|NCT00793520|2544439|P1|NOT COMPLETED|Milnacipran Crossover to Placebo||1
1048381|NCT00793520|2544438|P2|COMPLETED|Milnacipran Crossover to Placebo||0
1048382|NCT00793520|2544439|P1|COMPLETED|Milnacipran Crossover to Placebo||0
1048383|NCT00793520|2544438|P2|STARTED|Milnacipran Crossover to Placebo||0
1048384|NCT00793520|2544439|P1|STARTED|Milnacipran Crossover to Placebo||1
1048385|NCT00793546|2544449|P2|NOT COMPLETED|Overall Study||28
1048386|NCT00793546|2544450|P1|NOT COMPLETED|Overall Study||14
1048387|NCT00793546|2544449|P2|COMPLETED|Overall Study||0
1048388|NCT00793546|2544450|P1|COMPLETED|Overall Study||0
1048389|NCT00793546|2544449|P2|STARTED|Overall Study||28
1048390|NCT00793546|2544450|P1|STARTED|Overall Study||14
1048391|NCT00793572|2544478|P1|NOT COMPLETED|Overall Study||0
1048392|NCT00793572|2544478|P1|COMPLETED|Overall Study||32
1048393|NCT00793572|2544478|P1|STARTED|Overall Study||32
1048394|NCT00793585|2544489|P2|NOT COMPLETED|Overall Study||3
1048395|NCT00793585|2544490|P1|NOT COMPLETED|Overall Study||2
1048396|NCT00793585|2544489|P2|COMPLETED|Overall Study||18
1048397|NCT00793585|2544490|P1|COMPLETED|Overall Study||17
1048398|NCT00793585|2544489|P2|STARTED|Overall Study||21
1048399|NCT00793585|2544490|P1|STARTED|Overall Study||19
1048406|NCT00793624|2544515|P4|NOT COMPLETED|Overall Study||43
1048407|NCT00793624|2544516|P3|NOT COMPLETED|Overall Study||39
1048408|NCT00793624|2544517|P2|NOT COMPLETED|Overall Study||36
1048409|NCT00793624|2544518|P1|NOT COMPLETED|Overall Study||57
1048410|NCT00793624|2544515|P4|COMPLETED|Overall Study||184
1048411|NCT00793624|2544516|P3|COMPLETED|Overall Study||186
1048412|NCT00793624|2544517|P2|COMPLETED|Overall Study||191
1048413|NCT00793624|2544518|P1|COMPLETED|Overall Study||168
1048414|NCT00793624|2544515|P4|STARTED|Overall Study||227
1048415|NCT00793624|2544516|P3|STARTED|Overall Study||225
1048416|NCT00793624|2544517|P2|STARTED|Overall Study||227
1048417|NCT00793624|2544518|P1|STARTED|Overall Study||225
1048418|NCT00793650|2544786|P2|NOT COMPLETED|Overall Study||0
1048419|NCT00793650|2544787|P1|NOT COMPLETED|Overall Study||0
1048420|NCT00793650|2544786|P2|COMPLETED|Overall Study||20
1048421|NCT00793650|2544787|P1|COMPLETED|Overall Study||19
1048422|NCT00793650|2544786|P2|STARTED|Overall Study||20
1048423|NCT00793650|2544787|P1|STARTED|Overall Study||19
1048434|NCT00793793|2544826|P12|NOT COMPLETED|Overall Study||6
1048435|NCT00793793|2544827|P11|NOT COMPLETED|Overall Study||3
1048436|NCT00793793|2544828|P10|NOT COMPLETED|Overall Study||9
1048437|NCT00793793|2544829|P9|NOT COMPLETED|Overall Study||9
1048438|NCT00793793|2544830|P8|NOT COMPLETED|Overall Study||0
1048439|NCT00793793|2544831|P7|NOT COMPLETED|Overall Study||4
1048440|NCT00793793|2544832|P6|NOT COMPLETED|Overall Study||2
1048441|NCT00793793|2544833|P5|NOT COMPLETED|Overall Study||2
1048442|NCT00793793|2544834|P4|NOT COMPLETED|Overall Study||3
1048443|NCT00793793|2544835|P3|NOT COMPLETED|Overall Study||2
1048444|NCT00793793|2544836|P2|NOT COMPLETED|Overall Study||1
1048445|NCT00793793|2544837|P1|NOT COMPLETED|Overall Study||0
1048446|NCT00793793|2544826|P12|COMPLETED|Overall Study||1
1048447|NCT00793793|2544827|P11|COMPLETED|Overall Study||3
1048448|NCT00793793|2544828|P10|COMPLETED|Overall Study||6
1048449|NCT00793793|2544829|P9|COMPLETED|Overall Study||6
1048450|NCT00793793|2544830|P8|COMPLETED|Overall Study||6
1048451|NCT00793793|2544831|P7|COMPLETED|Overall Study||3
1048452|NCT00793793|2544832|P6|COMPLETED|Overall Study||4
1048453|NCT00793793|2544833|P5|COMPLETED|Overall Study||4
1048454|NCT00793793|2544834|P4|COMPLETED|Overall Study||4
1048455|NCT00793793|2544835|P3|COMPLETED|Overall Study||5
1048456|NCT00793793|2544836|P2|COMPLETED|Overall Study||5
1048457|NCT00793793|2544837|P1|COMPLETED|Overall Study||8
1048458|NCT00793793|2544826|P12|STARTED|Overall Study||7
1048459|NCT00793793|2544827|P11|STARTED|Overall Study||6
1048460|NCT00793793|2544828|P10|STARTED|Overall Study||15
1048461|NCT00793793|2544829|P9|STARTED|Overall Study||15
1048462|NCT00793793|2544830|P8|STARTED|Overall Study||6
1048463|NCT00793793|2544831|P7|STARTED|Overall Study||7
1048464|NCT00793793|2544832|P6|STARTED|Overall Study||6
1048465|NCT00793793|2544833|P5|STARTED|Overall Study||6
1048466|NCT00793793|2544834|P4|STARTED|Overall Study||7
1048467|NCT00793793|2544835|P3|STARTED|Overall Study||7
1048468|NCT00793793|2544836|P2|STARTED|Overall Study||6
1048469|NCT00793793|2544837|P1|STARTED|Overall Study||8
1048470|NCT00793819|2545212|P2|NOT COMPLETED|Overall Study||9
1048471|NCT00793819|2545213|P1|NOT COMPLETED|Overall Study||14
1048472|NCT00793819|2545212|P2|COMPLETED|Overall Study||89
1048473|NCT00793819|2545213|P1|COMPLETED|Overall Study||97
1048474|NCT00793819|2545212|P2|STARTED|Overall Study||98
1048475|NCT00793819|2545213|P1|STARTED|Overall Study||111
1048476|NCT00793871|2545219|P1|NOT COMPLETED|Overall Study||60
1048477|NCT00793871|2545219|P1|COMPLETED|Overall Study||0
1048478|NCT00793871|2545219|P1|Received Treatment|Overall Study||59
1048479|NCT00793871|2545219|P1|STARTED|Overall Study||60
1048480|NCT00793910|2545233|P2|NOT COMPLETED|Overall Study||7
1048481|NCT00793910|2545234|P1|NOT COMPLETED|Overall Study||5
1048482|NCT00793910|2545233|P2|COMPLETED|Overall Study||46
1048483|NCT00793910|2545234|P1|COMPLETED|Overall Study||48
1048484|NCT00793910|2545233|P2|STARTED|Overall Study||53
1048485|NCT00793910|2545234|P1|STARTED|Overall Study||53
1048486|NCT00783432|2545250|P2|NOT COMPLETED|Overall Study||78
1048487|NCT00783432|2545251|P1|NOT COMPLETED|Overall Study||85
1048488|NCT00783432|2545250|P2|COMPLETED|Overall Study||354
1048489|NCT00783432|2545251|P1|COMPLETED|Overall Study||345
1048490|NCT00783432|2545250|P2|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|432
1048491|NCT00783432|2545251|P1|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|430
1048492|NCT00783614|2545265|P4|NOT COMPLETED|Overall Study||0
1048493|NCT00783614|2545266|P3|NOT COMPLETED|Overall Study||0
1048494|NCT00783614|2545267|P2|NOT COMPLETED|Overall Study||0
1048495|NCT00783614|2545268|P1|NOT COMPLETED|Overall Study||0
1048496|NCT00783614|2545265|P4|COMPLETED|Overall Study||5
1048497|NCT00783614|2545266|P3|COMPLETED|Overall Study||5
1048498|NCT00783614|2545267|P2|COMPLETED|Overall Study||6
1048499|NCT00783614|2545268|P1|COMPLETED|Overall Study||6
1048500|NCT00783614|2545265|P4|STARTED|Overall Study||5
1048501|NCT00783614|2545266|P3|STARTED|Overall Study||5
1048502|NCT00783614|2545267|P2|STARTED|Overall Study||6
1048503|NCT00783614|2545268|P1|STARTED|Overall Study||6
1048504|NCT00783692|2545281|P7|NOT COMPLETED|Maintenance Phase||249
1048505|NCT00783692|2545282|P6|NOT COMPLETED|Maintenance Phase||72
1048506|NCT00783692|2545283|P5|NOT COMPLETED|Maintenance Phase||81
1048507|NCT00783692|2545284|P4|NOT COMPLETED|Maintenance Phase||89
1048508|NCT00783692|2545285|P3|NOT COMPLETED|Maintenance Phase||0
1048509|NCT00783692|2545286|P2|NOT COMPLETED|Maintenance Phase||0
1048510|NCT00783692|2545287|P1|NOT COMPLETED|Maintenance Phase||95
1048511|NCT00783692|2545281|P7|COMPLETED|Maintenance Phase||163
1048512|NCT00783692|2545282|P6|COMPLETED|Maintenance Phase||82
1048513|NCT00783692|2545283|P5|COMPLETED|Maintenance Phase||73
1048514|NCT00783692|2545284|P4|COMPLETED|Maintenance Phase||64
1048515|NCT00783692|2545285|P3|COMPLETED|Maintenance Phase||0
1048516|NCT00783692|2545286|P2|COMPLETED|Maintenance Phase||0
1048517|NCT00783692|2545287|P1|COMPLETED|Maintenance Phase||42
1048518|NCT00783692|2545281|P7|STARTED|Maintenance Phase||412
1048519|NCT00783692|2545282|P6|STARTED|Maintenance Phase||154
1048520|NCT00783692|2545283|P5|STARTED|Maintenance Phase||154
1048521|NCT00783692|2545284|P4|STARTED|Maintenance Phase||153
1048522|NCT00783692|2545285|P3|STARTED|Maintenance Phase||0
1048523|NCT00783692|2545286|P2|STARTED|Maintenance Phase||0
1048524|NCT00783692|2545287|P1|STARTED|Maintenance Phase||137
1048525|NCT00783692|2545281|P7|NOT COMPLETED|Induction Phase||0
1048526|NCT00783692|2545282|P6|NOT COMPLETED|Induction Phase||0
1048527|NCT00783692|2545283|P5|NOT COMPLETED|Induction Phase||0
1048528|NCT00783692|2545284|P4|NOT COMPLETED|Induction Phase||0
1048529|NCT00783692|2545285|P3|NOT COMPLETED|Induction Phase||74
1048530|NCT00783692|2545286|P2|NOT COMPLETED|Induction Phase||21
1048531|NCT00783692|2545287|P1|NOT COMPLETED|Induction Phase||11
1048532|NCT00783692|2545281|P7|COMPLETED|Induction Phase||0
1048533|NCT00783692|2545282|P6|COMPLETED|Induction Phase||0
1048534|NCT00783692|2545283|P5|COMPLETED|Induction Phase||0
1048535|NCT00783692|2545284|P4|COMPLETED|Induction Phase||0
1048536|NCT00783692|2545285|P3|COMPLETED|Induction Phase||674
1048537|NCT00783692|2545286|P2|COMPLETED|Induction Phase||199
1048538|NCT00783692|2545287|P1|COMPLETED|Induction Phase||137
1048539|NCT00783692|2545281|P7|Treated|Induction Phase||0
1048540|NCT00783692|2545282|P6|Treated|Induction Phase||0
1048541|NCT00783692|2545283|P5|Treated|Induction Phase||0
1048542|NCT00783692|2545284|P4|Treated|Induction Phase||0
1048543|NCT00783692|2545285|P3|Treated|Induction Phase||747
1048544|NCT00783692|2545286|P2|Treated|Induction Phase||220
1048545|NCT00783692|2545287|P1|Treated|Induction Phase||148
1048546|NCT00783692|2545281|P7|STARTED|Induction Phase||0
1048547|NCT00783692|2545282|P6|STARTED|Induction Phase||0
1048548|NCT00783692|2545283|P5|STARTED|Induction Phase||0
1048549|NCT00783692|2545284|P4|STARTED|Induction Phase||0
1048550|NCT00783692|2545285|P3|STARTED|Induction Phase||748
1048551|NCT00783692|2545286|P2|STARTED|Induction Phase||220
1048552|NCT00783692|2545287|P1|STARTED|Induction Phase||148
1048553|NCT00783705|2545312|P2|NOT COMPLETED|Overall Study||5
1048554|NCT00783705|2545313|P1|NOT COMPLETED|Overall Study||6
1048555|NCT00783705|2545312|P2|COMPLETED|Overall Study||36
1048556|NCT00783705|2545313|P1|COMPLETED|Overall Study||38
1048557|NCT00783705|2545312|P2|STARTED|Overall Study||41
1048558|NCT00783705|2545313|P1|STARTED|Overall Study||44
1048559|NCT00783718|2545358|P7|NOT COMPLETED|Maintenance Phase||195
1048560|NCT00783718|2545359|P6|NOT COMPLETED|Maintenance Phase||41
1048561|NCT00783718|2545360|P5|NOT COMPLETED|Maintenance Phase||45
1048562|NCT00783718|2545361|P4|NOT COMPLETED|Maintenance Phase||78
1048563|NCT00783718|2545362|P3|NOT COMPLETED|Maintenance Phase||0
1048564|NCT00783718|2545363|P2|NOT COMPLETED|Maintenance Phase||0
1048565|NCT00783718|2545364|P1|NOT COMPLETED|Maintenance Phase||105
1048566|NCT00783718|2545358|P7|COMPLETED|Maintenance Phase||135
1048567|NCT00783718|2545359|P6|COMPLETED|Maintenance Phase||84
1048568|NCT00783718|2545360|P5|COMPLETED|Maintenance Phase||77
1048569|NCT00783718|2545361|P4|COMPLETED|Maintenance Phase||48
1048570|NCT00783718|2545362|P3|COMPLETED|Maintenance Phase||0
1048571|NCT00783718|2545363|P2|COMPLETED|Maintenance Phase||0
1048572|NCT00783718|2545364|P1|COMPLETED|Maintenance Phase||30
1048573|NCT00783718|2545358|P7|STARTED|Maintenance Phase||330
1048574|NCT00783718|2545359|P6|STARTED|Maintenance Phase||125
1048575|NCT00783718|2545360|P5|STARTED|Maintenance Phase||122
1048576|NCT00783718|2545361|P4|STARTED|Maintenance Phase||126
1048577|NCT00783718|2545362|P3|STARTED|Maintenance Phase||0
1048578|NCT00783718|2545363|P2|STARTED|Maintenance Phase||0
1048579|NCT00783718|2545364|P1|STARTED|Maintenance Phase||135
1048580|NCT00783718|2545358|P7|NOT COMPLETED|Induction Phase||0
1048581|NCT00783718|2545359|P6|NOT COMPLETED|Induction Phase||0
1048582|NCT00783718|2545360|P5|NOT COMPLETED|Induction Phase||0
1048583|NCT00783718|2545361|P4|NOT COMPLETED|Induction Phase||0
1048584|NCT00783718|2545362|P3|NOT COMPLETED|Induction Phase||36
1048585|NCT00783718|2545363|P2|NOT COMPLETED|Induction Phase||7
1048586|NCT00783718|2545364|P1|NOT COMPLETED|Induction Phase||14
1048587|NCT00783718|2545358|P7|COMPLETED|Induction Phase||0
1048588|NCT00783718|2545359|P6|COMPLETED|Induction Phase||0
1048589|NCT00783718|2545360|P5|COMPLETED|Induction Phase||0
1048590|NCT00783718|2545361|P4|COMPLETED|Induction Phase||0
1048591|NCT00783718|2545362|P3|COMPLETED|Induction Phase||485
1048592|NCT00783718|2545363|P2|COMPLETED|Induction Phase||218
1048593|NCT00783718|2545364|P1|COMPLETED|Induction Phase||135
1048594|NCT00783718|2545358|P7|STARTED|Induction Phase||0
1048595|NCT00783718|2545359|P6|STARTED|Induction Phase||0
1048596|NCT00783718|2545360|P5|STARTED|Induction Phase||0
1048597|NCT00783718|2545361|P4|STARTED|Induction Phase||0
1048598|NCT00783718|2545362|P3|STARTED|Induction Phase||521
1048599|NCT00783718|2545363|P2|STARTED|Induction Phase||225
1048600|NCT00783718|2545364|P1|STARTED|Induction Phase||149
1048601|NCT00783796|2545390|P1|NOT COMPLETED|Overall Study||6
1048602|NCT00783796|2545390|P1|COMPLETED|Overall Study||144
1048603|NCT00783796|2545390|P1|STARTED|Overall Study||150
1048604|NCT00783835|2545492|P1|NOT COMPLETED|Overall Study||10
1048605|NCT00783835|2545492|P1|COMPLETED|Overall Study||50
1048606|NCT00783835|2545492|P1|STARTED|Overall Study||60
1048607|NCT00783952|2545504|P1|NOT COMPLETED|Overall Study||0
1048608|NCT00783952|2545504|P1|COMPLETED|Overall Study||8
1048609|NCT00783952|2545504|P1|STARTED|Overall Study||8
1048610|NCT00783965|2545511|P2|NOT COMPLETED|Second Intervention (24 Months)||9
1048611|NCT00783965|2545512|P1|NOT COMPLETED|Second Intervention (24 Months)||0
1048612|NCT00783965|2545511|P2|COMPLETED|Second Intervention (24 Months)||16
1048613|NCT00783965|2545512|P1|COMPLETED|Second Intervention (24 Months)||2
1048614|NCT00783965|2545511|P2|STARTED|Second Intervention (24 Months)||25
1048615|NCT00783965|2545512|P1|STARTED|Second Intervention (24 Months)||2
1048616|NCT00783965|2545511|P2|NOT COMPLETED|First Intervention (12 Months)||4
1048617|NCT00783965|2545512|P1|NOT COMPLETED|First Intervention (12 Months)||3
1048618|NCT00783965|2545511|P2|COMPLETED|First Intervention (12 Months)||25
1048619|NCT00783965|2545512|P1|COMPLETED|First Intervention (12 Months)||2
1048620|NCT00783965|2545511|P2|STARTED|First Intervention (12 Months)||29
1048621|NCT00783965|2545512|P1|STARTED|First Intervention (12 Months)||5
1048622|NCT00784030|2545522|P2|NOT COMPLETED|Overall Study||0
1048623|NCT00784030|2545523|P1|NOT COMPLETED|Overall Study||0
1048624|NCT00784030|2545522|P2|COMPLETED|Overall Study||10
1048625|NCT00784030|2545523|P1|COMPLETED|Overall Study||13
1048626|NCT00784030|2545522|P2|STARTED|Overall Study||10
1048627|NCT00784030|2545523|P1|STARTED|Overall Study||13
1048628|NCT00784095|2545532|P3|NOT COMPLETED|Overall Study||1
1048629|NCT00784095|2545533|P2|NOT COMPLETED|Overall Study||1
1048630|NCT00784095|2545534|P1|NOT COMPLETED|Overall Study||0
1048631|NCT00784095|2545532|P3|COMPLETED|Overall Study||11
1048632|NCT00784095|2545533|P2|COMPLETED|Overall Study||11
1048633|NCT00784095|2545534|P1|COMPLETED|Overall Study||12
1048634|NCT00784095|2545532|P3|STARTED|Overall Study||12
1048635|NCT00784095|2545533|P2|STARTED|Overall Study||12
1048636|NCT00784095|2545534|P1|STARTED|Overall Study||12
1048637|NCT00784134|2545556|P2|NOT COMPLETED|Overall Study||6
1048638|NCT00784134|2545557|P1|NOT COMPLETED|Overall Study||3
1048639|NCT00784134|2545556|P2|COMPLETED|Overall Study||245
1048640|NCT00784134|2545557|P1|COMPLETED|Overall Study||246
1048641|NCT00784134|2545556|P2|STARTED|Overall Study||251
1048642|NCT00784134|2545557|P1|STARTED|Overall Study||249
1048643|NCT00784147|2545655|P2|NOT COMPLETED|Overall Study||9
1048644|NCT00784147|2545656|P1|NOT COMPLETED|Overall Study||8
1048645|NCT00784147|2545655|P2|COMPLETED|Overall Study||45
1048646|NCT00784147|2545656|P1|COMPLETED|Overall Study||51
1048647|NCT00784147|2545655|P2|STARTED|Overall Study||54
1048648|NCT00784147|2545656|P1|STARTED|Overall Study||59
1048649|NCT00784238|2545674|P1|NOT COMPLETED|Overall Study||119
1048650|NCT00784238|2545674|P1|COMPLETED|Overall Study||170
1048651|NCT00784238|2545674|P1|STARTED|Overall Study||289
1048652|NCT00784277|2545719|P7|NOT COMPLETED|ER Treatment||15
1048653|NCT00784277|2545720|P6|NOT COMPLETED|ER Treatment||24
1048654|NCT00784277|2545721|P5|NOT COMPLETED|ER Treatment||9
1048655|NCT00784277|2545722|P4|NOT COMPLETED|ER Treatment||0
1048656|NCT00784277|2545723|P3|NOT COMPLETED|ER Treatment||0
1048657|NCT00784277|2545724|P2|NOT COMPLETED|ER Treatment||0
1048658|NCT00784277|2545725|P1|NOT COMPLETED|ER Treatment||0
1048659|NCT00784277|2545719|P7|COMPLETED|ER Treatment||76
1048660|NCT00784277|2545720|P6|COMPLETED|ER Treatment||226
1048661|NCT00784277|2545721|P5|COMPLETED|ER Treatment||113
1048662|NCT00784277|2545722|P4|COMPLETED|ER Treatment||0
1048663|NCT00784277|2545723|P3|COMPLETED|ER Treatment||0
1048664|NCT00784277|2545724|P2|COMPLETED|ER Treatment||0
1048665|NCT00784277|2545725|P1|COMPLETED|ER Treatment||0
1048666|NCT00784277|2545719|P7|STARTED|ER Treatment|9 participants who had completed IR treatment have not taken any ER treatment.|91
1048667|NCT00784277|2545720|P6|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|250
1048668|NCT00784277|2545721|P5|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|122
1048669|NCT00784277|2545722|P4|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
1048670|NCT00784277|2545723|P3|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
1048671|NCT00784277|2545724|P2|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
1048672|NCT00784277|2545725|P1|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
1048673|NCT00784277|2545719|P7|NOT COMPLETED|IR Treatment||0
1048674|NCT00784277|2545720|P6|NOT COMPLETED|IR Treatment||0
1048675|NCT00784277|2545721|P5|NOT COMPLETED|IR Treatment||0
1048676|NCT00784277|2545722|P4|NOT COMPLETED|IR Treatment||43
1048677|NCT00784277|2545723|P3|NOT COMPLETED|IR Treatment||28
1048678|NCT00784277|2545724|P2|NOT COMPLETED|IR Treatment||17
1048679|NCT00784277|2545725|P1|NOT COMPLETED|IR Treatment||16
1048680|NCT00784277|2545719|P7|COMPLETED|IR Treatment||0
1048681|NCT00784277|2545720|P6|COMPLETED|IR Treatment||0
1048682|NCT00784277|2545721|P5|COMPLETED|IR Treatment||0
1048683|NCT00784277|2545722|P4|COMPLETED|IR Treatment||100
1048684|NCT00784277|2545723|P3|COMPLETED|IR Treatment||126
1048685|NCT00784277|2545724|P2|COMPLETED|IR Treatment||134
1048686|NCT00784277|2545725|P1|COMPLETED|IR Treatment||132
1048687|NCT00784277|2545719|P7|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
1048688|NCT00784277|2545720|P6|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
1048689|NCT00784277|2545721|P5|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
1048690|NCT00784277|2545722|P4|STARTED|IR Treatment||143
1048691|NCT00784277|2545723|P3|STARTED|IR Treatment||154
1048692|NCT00784277|2545724|P2|STARTED|IR Treatment||151
1048693|NCT00784277|2545725|P1|STARTED|IR Treatment||148
1048694|NCT00784368|2545745|P3|NOT COMPLETED|Overall Study||11
1048695|NCT00784368|2545746|P2|NOT COMPLETED|Overall Study||11
1048696|NCT00784368|2545747|P1|NOT COMPLETED|Overall Study||8
1048697|NCT00784368|2545745|P3|COMPLETED|Overall Study||12
1048698|NCT00784368|2545746|P2|COMPLETED|Overall Study||5
1048699|NCT00784368|2545747|P1|COMPLETED|Overall Study||8
1048700|NCT00784368|2545745|P3|STARTED|Overall Study||23
1048701|NCT00784368|2545746|P2|STARTED|Overall Study||16
1048702|NCT00784368|2545747|P1|STARTED|Overall Study||16
1048703|NCT00784459|2545783|P2|NOT COMPLETED|Overall Study||2
1048704|NCT00784459|2545784|P1|NOT COMPLETED|Overall Study||0
1048705|NCT00784459|2545783|P2|COMPLETED|Overall Study||11
1048706|NCT00784459|2545784|P1|COMPLETED|Overall Study||11
1048707|NCT00784459|2545783|P2|STARTED|Overall Study||13
1048708|NCT00784459|2545784|P1|STARTED|Overall Study||11
1048709|NCT00784550|2545794|P2|NOT COMPLETED|Overall Study||42
1048710|NCT00784550|2545795|P1|NOT COMPLETED|Overall Study||36
1048711|NCT00784550|2545794|P2|COMPLETED|Overall Study||127
1048712|NCT00784550|2545795|P1|COMPLETED|Overall Study||137
1048713|NCT00784550|2545794|P2|STARTED|Overall Study||169
1048714|NCT00784550|2545795|P1|STARTED|Overall Study||173
1048715|NCT00784563|2545814|P3|NOT COMPLETED|Year 3||3
1048716|NCT00784563|2545815|P2|NOT COMPLETED|Year 3||0
1048717|NCT00784563|2545816|P1|NOT COMPLETED|Year 3||0
1048718|NCT00784563|2545814|P3|COMPLETED|Year 3||14
1048719|NCT00784563|2545815|P2|COMPLETED|Year 3||0
1048720|NCT00784563|2545816|P1|COMPLETED|Year 3||0
1048721|NCT00784563|2545814|P3|STARTED|Year 3||17
1048722|NCT00784563|2545815|P2|STARTED|Year 3||0
1048723|NCT00784563|2545816|P1|STARTED|Year 3||0
1048724|NCT00784563|2545814|P3|NOT COMPLETED|Years 1 & 2||0
1048725|NCT00784563|2545815|P2|NOT COMPLETED|Years 1 & 2||5
1048726|NCT00784563|2545816|P1|NOT COMPLETED|Years 1 & 2||3
1048727|NCT00784563|2545814|P3|COMPLETED|Years 1 & 2||0
1048728|NCT00784563|2545815|P2|COMPLETED|Years 1 & 2||17
1048729|NCT00784563|2545816|P1|COMPLETED|Years 1 & 2||18
1048730|NCT00784563|2545814|P3|STARTED|Years 1 & 2||0
1048731|NCT00784563|2545815|P2|STARTED|Years 1 & 2||22
1048732|NCT00784563|2545816|P1|STARTED|Years 1 & 2||21
1048733|NCT00784654|2545832|P3|NOT COMPLETED|Randomized Withdrawal Period||63
1048734|NCT00784654|2545833|P2|NOT COMPLETED|Randomized Withdrawal Period||18
1048735|NCT00784654|2545834|P1|NOT COMPLETED|Randomized Withdrawal Period||0
1048736|NCT00784654|2545832|P3|COMPLETED|Randomized Withdrawal Period||16
1048737|NCT00784654|2545833|P2|COMPLETED|Randomized Withdrawal Period||60
1048738|NCT00784654|2545834|P1|COMPLETED|Randomized Withdrawal Period||0
1048739|NCT00784654|2545832|P3|STARTED|Randomized Withdrawal Period||79
1048740|NCT00784654|2545833|P2|STARTED|Randomized Withdrawal Period||78
1048741|NCT00784654|2545834|P1|STARTED|Randomized Withdrawal Period||0
1048742|NCT00784654|2545832|P3|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
1048743|NCT00784654|2545833|P2|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
1048744|NCT00784654|2545834|P1|NOT COMPLETED|Open-Label Period (Non-Randomized)||111
1048745|NCT00784654|2545832|P3|COMPLETED|Open-Label Period (Non-Randomized)||0
1048746|NCT00784654|2545833|P2|COMPLETED|Open-Label Period (Non-Randomized)||0
1048747|NCT00784654|2545834|P1|COMPLETED|Open-Label Period (Non-Randomized)||165
1048748|NCT00784654|2545832|P3|STARTED|Open-Label Period (Non-Randomized)||0
1048749|NCT00784654|2545833|P2|STARTED|Open-Label Period (Non-Randomized)||0
1048750|NCT00784654|2545834|P1|STARTED|Open-Label Period (Non-Randomized)||276
1048751|NCT00784719|2545873|P7|NOT COMPLETED|Overall Study||5
1048752|NCT00784719|2545874|P6|NOT COMPLETED|Overall Study||3
1048753|NCT00784719|2545875|P5|NOT COMPLETED|Overall Study||6
1048754|NCT00784719|2545876|P4|NOT COMPLETED|Overall Study||0
1048755|NCT00784719|2545877|P3|NOT COMPLETED|Overall Study||1
1048756|NCT00784719|2545878|P2|NOT COMPLETED|Overall Study||3
1048757|NCT00784719|2545879|P1|NOT COMPLETED|Overall Study||3
1048758|NCT00784719|2545873|P7|COMPLETED|Overall Study||42
1048759|NCT00784719|2545874|P6|COMPLETED|Overall Study||41
1048760|NCT00784719|2545875|P5|COMPLETED|Overall Study||42
1048761|NCT00784719|2545876|P4|COMPLETED|Overall Study||48
1048762|NCT00784719|2545877|P3|COMPLETED|Overall Study||46
1048763|NCT00784719|2545878|P2|COMPLETED|Overall Study||43
1048764|NCT00784719|2545879|P1|COMPLETED|Overall Study||44
1048765|NCT00784719|2545873|P7|STARTED|Overall Study||47
1048766|NCT00784719|2545874|P6|STARTED|Overall Study||44
1048767|NCT00784719|2545875|P5|STARTED|Overall Study||48
1048768|NCT00784719|2545876|P4|STARTED|Overall Study||48
1048769|NCT00784719|2545877|P3|STARTED|Overall Study||47
1048770|NCT00784719|2545878|P2|STARTED|Overall Study||46
1048771|NCT00784719|2545879|P1|STARTED|Overall Study||47
1048772|NCT00784784|2546051|P2|NOT COMPLETED|Overall Study||2
1048773|NCT00784784|2546052|P1|NOT COMPLETED|Overall Study||2
1048774|NCT00784784|2546051|P2|COMPLETED|Overall Study||40
1048775|NCT00784784|2546052|P1|COMPLETED|Overall Study||20
1048776|NCT00784784|2546051|P2|STARTED|Overall Study||42
1048777|NCT00784784|2546052|P1|STARTED|Overall Study||22
1048778|NCT00784810|2546062|P2|NOT COMPLETED|Overall Study||49
1048779|NCT00784810|2546063|P1|NOT COMPLETED|Overall Study||63
1048780|NCT00784810|2546062|P2|COMPLETED|Overall Study||74
1048781|NCT00784810|2546063|P1|COMPLETED|Overall Study||61
1048782|NCT00784810|2546062|P2|STARTED|Overall Study||123
1048783|NCT00784810|2546063|P1|STARTED|Overall Study||124
1048784|NCT00784836|2546071|P1|NOT COMPLETED|Overall Study||3
1048785|NCT00784836|2546071|P1|COMPLETED|Overall Study|The study was terminated early by the Sponsor for business reason not related to safety.|0
1048786|NCT00784836|2546071|P1|STARTED|Overall Study||3
1048787|NCT00784849|2546076|P1|NOT COMPLETED|Overall Study||0
1048788|NCT00784849|2546076|P1|COMPLETED|Overall Study||62
1048789|NCT00784849|2546076|P1|STARTED|Overall Study||62
1048790|NCT00784875|2546086|P4|NOT COMPLETED|Period D||1
1048791|NCT00784875|2546087|P3|NOT COMPLETED|Period D||6
1048792|NCT00784875|2546088|P2|NOT COMPLETED|Period D||4
1048793|NCT00784875|2546089|P1|NOT COMPLETED|Period D||5
1048794|NCT00784875|2546086|P4|COMPLETED|Period D||87
1048795|NCT00784875|2546087|P3|COMPLETED|Period D||88
1048796|NCT00784875|2546088|P2|COMPLETED|Period D||85
1048797|NCT00784875|2546089|P1|COMPLETED|Period D||86
1048798|NCT00784875|2546086|P4|STARTED|Period D||88
1048799|NCT00784875|2546087|P3|STARTED|Period D||94
1048800|NCT00784875|2546088|P2|STARTED|Period D||89
1048801|NCT00784875|2546089|P1|STARTED|Period D||91
1048802|NCT00784875|2546086|P4|NOT COMPLETED|Period C||7
1048803|NCT00784875|2546087|P3|NOT COMPLETED|Period C||13
1048804|NCT00784875|2546088|P2|NOT COMPLETED|Period C||6
1048805|NCT00784875|2546089|P1|NOT COMPLETED|Period C||7
1048806|NCT00784875|2546086|P4|COMPLETED|Period C||91
1048807|NCT00784875|2546087|P3|COMPLETED|Period C||84
1048808|NCT00784875|2546088|P2|COMPLETED|Period C||91
1048809|NCT00784875|2546089|P1|COMPLETED|Period C||96
1048810|NCT00784875|2546086|P4|STARTED|Period C||98
1048811|NCT00784875|2546087|P3|STARTED|Period C||97
1048812|NCT00784875|2546088|P2|STARTED|Period C||97
1048813|NCT00784875|2546089|P1|STARTED|Period C||103
1048814|NCT00784875|2546086|P4|NOT COMPLETED|Period B - Efficacy Endpoint||19
1048815|NCT00784875|2546087|P3|NOT COMPLETED|Period B - Efficacy Endpoint||21
1048816|NCT00784875|2546088|P2|NOT COMPLETED|Period B - Efficacy Endpoint||12
1048817|NCT00784875|2546089|P1|NOT COMPLETED|Period B - Efficacy Endpoint||14
1048818|NCT00784875|2546086|P4|COMPLETED|Period B - Efficacy Endpoint||98
1048819|NCT00784875|2546087|P3|COMPLETED|Period B - Efficacy Endpoint||96
1048820|NCT00784875|2546088|P2|COMPLETED|Period B - Efficacy Endpoint||101
1048821|NCT00784875|2546089|P1|COMPLETED|Period B - Efficacy Endpoint||100
1048822|NCT00784875|2546086|P4|Cohort 2|Period B - Efficacy Endpoint||101
1048823|NCT00784875|2546087|P3|Cohort 2|Period B - Efficacy Endpoint||102
1048824|NCT00784875|2546088|P2|Cohort 2|Period B - Efficacy Endpoint||102
1048825|NCT00784875|2546089|P1|Cohort 2|Period B - Efficacy Endpoint||102
1048826|NCT00784875|2546086|P4|STARTED|Period B - Efficacy Endpoint||117
1048827|NCT00784875|2546087|P3|STARTED|Period B - Efficacy Endpoint||117
1048828|NCT00784875|2546088|P2|STARTED|Period B - Efficacy Endpoint||113
1048829|NCT00784875|2546089|P1|STARTED|Period B - Efficacy Endpoint||114
1048830|NCT00784875|2546086|P4|NOT COMPLETED|Period A - Baseline||182
1048831|NCT00784875|2546087|P3|NOT COMPLETED|Period A - Baseline||0
1048832|NCT00784875|2546088|P2|NOT COMPLETED|Period A - Baseline||0
1048833|NCT00784875|2546089|P1|NOT COMPLETED|Period A - Baseline||0
1048834|NCT00784875|2546086|P4|COMPLETED|Period A - Baseline||461
1048835|NCT00784875|2546087|P3|COMPLETED|Period A - Baseline||0
1048836|NCT00784875|2546088|P2|COMPLETED|Period A - Baseline||0
1048837|NCT00784875|2546089|P1|COMPLETED|Period A - Baseline||0
1048838|NCT00784875|2546086|P4|STARTED|Period A - Baseline||643
1048839|NCT00784875|2546087|P3|STARTED|Period A - Baseline||0
1048840|NCT00784875|2546088|P2|STARTED|Period A - Baseline||0
1048841|NCT00784875|2546089|P1|STARTED|Period A - Baseline||0
1048842|NCT00784927|2546203|P1|NOT COMPLETED|Overall Study||3
1048843|NCT00784927|2546203|P1|COMPLETED|Overall Study||33
1048844|NCT00784927|2546203|P1|STARTED|Overall Study||36
1048845|NCT00784979|2546211|P1|NOT COMPLETED|Overall Study||6
1048846|NCT00784979|2546211|P1|COMPLETED|Overall Study||20
1048847|NCT00784979|2546211|P1|STARTED|Overall Study||26
1048848|NCT00785044|2546215|P1|NOT COMPLETED|Overall Study||496
1048849|NCT00785044|2546215|P1|COMPLETED|Overall Study|Data for 471 participants (MBG313) combined with data from MBG311 and MBG312 for efficacy analysis|468
1048850|NCT00785044|2546215|P1|Enrolled Participants|Overall Study|Out of 964 from MBG311 and MBG312 HF participants, 471 enrolled into the extension MBG313 study.|471
1048851|NCT00785044|2546215|P1|STARTED|Overall Study|Eligible to participate in MBG313|964
1048852|NCT00785213|2546220|P1|NOT COMPLETED|Rosiglitazone With Quinine Sulfate||1
1048853|NCT00785213|2546220|P1|COMPLETED|Rosiglitazone With Quinine Sulfate||18
1048854|NCT00785213|2546220|P1|STARTED|Rosiglitazone With Quinine Sulfate||19
1048855|NCT00785213|2546220|P1|NOT COMPLETED|Quinine Sulfate Alone||4
1048856|NCT00785213|2546220|P1|COMPLETED|Quinine Sulfate Alone||19
1048857|NCT00785213|2546220|P1|STARTED|Quinine Sulfate Alone||23
1048858|NCT00785213|2546220|P1|NOT COMPLETED|2 Day Washout Period||0
1048859|NCT00785213|2546220|P1|COMPLETED|2 Day Washout Period||23
1048860|NCT00785213|2546220|P1|STARTED|2 Day Washout Period||23
1048861|NCT00785213|2546220|P1|NOT COMPLETED|Rosiglitazone Alone||0
1048862|NCT00785213|2546220|P1|COMPLETED|Rosiglitazone Alone||23
1048863|NCT00785213|2546220|P1|STARTED|Rosiglitazone Alone||23
1048864|NCT00794118|2546231|P1|NOT COMPLETED|Overall Study||27
1048865|NCT00794118|2546231|P1|COMPLETED|Overall Study||272
1048866|NCT00794118|2546231|P1|STARTED|Overall Study||299
1048867|NCT00794144|2546289|P2|NOT COMPLETED|Overall Study||3
1048868|NCT00794144|2546290|P1|NOT COMPLETED|Overall Study||3
1048869|NCT00794144|2546289|P2|COMPLETED|Overall Study||63
1048870|NCT00794144|2546290|P1|COMPLETED|Overall Study||63
1048871|NCT00794144|2546289|P2|STARTED|Overall Study||66
1048872|NCT00794144|2546290|P1|STARTED|Overall Study||66
1048873|NCT00794157|2546299|P3|NOT COMPLETED|Overall Study||19
1048874|NCT00794157|2546300|P2|NOT COMPLETED|Overall Study||10
1048875|NCT00794157|2546301|P1|NOT COMPLETED|Overall Study||10
1048876|NCT00794157|2546299|P3|COMPLETED|Overall Study||98
1048877|NCT00794157|2546300|P2|COMPLETED|Overall Study||106
1048878|NCT00794157|2546301|P1|COMPLETED|Overall Study||104
1048879|NCT00794157|2546299|P3|STARTED|Overall Study||117
1048880|NCT00794157|2546300|P2|STARTED|Overall Study||116
1048881|NCT00794157|2546301|P1|STARTED|Overall Study||114
1048882|NCT00794170|2546323|P2|NOT COMPLETED|Overall Study||3
1048883|NCT00794170|2546324|P1|NOT COMPLETED|Overall Study||7
1048884|NCT00794170|2546323|P2|COMPLETED|Overall Study||152
1048885|NCT00794170|2546324|P1|COMPLETED|Overall Study||150
1048886|NCT00794170|2546323|P2|STARTED|Overall Study||155
1048887|NCT00794170|2546324|P1|STARTED|Overall Study||157
1048888|NCT00794196|2546332|P2|NOT COMPLETED|Overall Study||23
1048889|NCT00794196|2546333|P1|NOT COMPLETED|Overall Study||5
1048890|NCT00794196|2546332|P2|COMPLETED|Overall Study||64
1048891|NCT00794196|2546333|P1|COMPLETED|Overall Study||87
1048892|NCT00794196|2546332|P2|STARTED|Overall Study||87
1048893|NCT00794196|2546333|P1|STARTED|Overall Study||92
1048894|NCT00794313|2546341|P3|NOT COMPLETED|Overall Study||0
1048895|NCT00794313|2546342|P2|NOT COMPLETED|Overall Study||0
1048896|NCT00794313|2546343|P1|NOT COMPLETED|Overall Study||0
1048897|NCT00794313|2546341|P3|COMPLETED|Overall Study||1
1048898|NCT00794313|2546342|P2|COMPLETED|Overall Study||1
1048899|NCT00794313|2546343|P1|COMPLETED|Overall Study||1
1048900|NCT00794313|2546341|P3|STARTED|Overall Study||1
1048901|NCT00794313|2546342|P2|STARTED|Overall Study||1
1048902|NCT00794313|2546343|P1|STARTED|Overall Study||1
1048903|NCT00801632|2546354|P1|NOT COMPLETED|Overall Study||1
1048904|NCT00801632|2546354|P1|COMPLETED|Overall Study||4
1048905|NCT00801632|2546354|P1|STARTED|Overall Study||5
1048906|NCT00801684|2546365|P1|NOT COMPLETED|Overall Study||0
1048907|NCT00801684|2546365|P1|COMPLETED|Overall Study||24
1048908|NCT00801684|2546365|P1|STARTED|Overall Study||24
1048909|NCT00801801|2546387|P1|NOT COMPLETED|Overall Study||0
1048910|NCT00801801|2546387|P1|COMPLETED|Overall Study||5
1048911|NCT00801801|2546387|P1|STARTED|Overall Study||5
1048912|NCT00801827|2546392|P1|NOT COMPLETED|Overall Study||0
1048913|NCT00801827|2546392|P1|COMPLETED|Overall Study||5
1048914|NCT00801827|2546392|P1|STARTED|Overall Study|2 others consented but due to scheduling did not complete|5
1048915|NCT00801892|2546398|P2|NOT COMPLETED|Overall Study||0
1048916|NCT00801892|2546399|P1|NOT COMPLETED|Overall Study||0
1048917|NCT00801892|2546398|P2|COMPLETED|Overall Study||12
1048918|NCT00801892|2546399|P1|COMPLETED|Overall Study||11
1048919|NCT00801892|2546398|P2|STARTED|Overall Study||12
1048920|NCT00801892|2546399|P1|STARTED|Overall Study||11
1048921|NCT00801983|2546407|P2|NOT COMPLETED|Period 2||1
1048922|NCT00801983|2546408|P1|NOT COMPLETED|Period 2||2
1048923|NCT00801983|2546407|P2|COMPLETED|Period 2||32
1048924|NCT00801983|2546408|P1|COMPLETED|Period 2||38
1048925|NCT00801983|2546407|P2|STARTED|Period 2||33
1048926|NCT00801983|2546408|P1|STARTED|Period 2||40
1048927|NCT00801983|2546407|P2|NOT COMPLETED|Period 1||8
1048928|NCT00801983|2546408|P1|NOT COMPLETED|Period 1||4
1048929|NCT00801983|2546407|P2|COMPLETED|Period 1||33
1048930|NCT00801983|2546408|P1|COMPLETED|Period 1||40
1048931|NCT00801983|2546407|P2|STARTED|Period 1||41
1048932|NCT00801983|2546408|P1|STARTED|Period 1||44
1048933|NCT00802074|2546420|P6|NOT COMPLETED|Overall Study||0
1048934|NCT00802074|2546421|P5|NOT COMPLETED|Overall Study||0
1048935|NCT00802074|2546422|P4|NOT COMPLETED|Overall Study||0
1048936|NCT00802074|2546423|P3|NOT COMPLETED|Overall Study||1
1048937|NCT00802074|2546424|P2|NOT COMPLETED|Overall Study||1
1048938|NCT00802074|2546425|P1|NOT COMPLETED|Overall Study||2
1048939|NCT00802074|2546420|P6|COMPLETED|Overall Study||7
1048940|NCT00802074|2546421|P5|COMPLETED|Overall Study||7
1048941|NCT00802074|2546422|P4|COMPLETED|Overall Study||7
1048942|NCT00802074|2546423|P3|COMPLETED|Overall Study||6
1048943|NCT00802074|2546424|P2|COMPLETED|Overall Study||7
1048944|NCT00802074|2546425|P1|COMPLETED|Overall Study||7
1048945|NCT00802074|2546420|P6|STARTED|Overall Study||7
1048946|NCT00802074|2546421|P5|STARTED|Overall Study||7
1048947|NCT00802074|2546422|P4|STARTED|Overall Study||7
1048948|NCT00802074|2546423|P3|STARTED|Overall Study||7
1048949|NCT00802074|2546424|P2|STARTED|Overall Study||8
1048950|NCT00802074|2546425|P1|STARTED|Overall Study||9
1048951|NCT00802100|2546460|P3|NOT COMPLETED|Overall Study||4
1048952|NCT00802100|2546461|P2|NOT COMPLETED|Overall Study||7
1048953|NCT00802100|2546462|P1|NOT COMPLETED|Overall Study||6
1048954|NCT00802100|2546460|P3|COMPLETED|Overall Study||2
1048955|NCT00802100|2546461|P2|COMPLETED|Overall Study||2
1048956|NCT00802100|2546462|P1|COMPLETED|Overall Study||0
1048957|NCT00802100|2546460|P3|STARTED|Overall Study||6
1048958|NCT00802100|2546461|P2|STARTED|Overall Study||9
1048959|NCT00802100|2546462|P1|STARTED|Overall Study||6
1048960|NCT00802178|2546471|P1|NOT COMPLETED|Overall Study||113
1048961|NCT00802178|2546471|P1|COMPLETED|Overall Study||2335
1048962|NCT00802178|2546471|P1|STARTED|Overall Study||2448
1048963|NCT00802204|2546480|P2|NOT COMPLETED|Overall Study||1
1048964|NCT00802204|2546481|P1|NOT COMPLETED|Overall Study||1
1048965|NCT00802204|2546480|P2|COMPLETED|Overall Study||18
1048966|NCT00802204|2546481|P1|COMPLETED|Overall Study||8
1048967|NCT00802204|2546480|P2|STARTED|Overall Study||19
1048968|NCT00802204|2546481|P1|STARTED|Overall Study||9
1048969|NCT00802360|2546509|P4|NOT COMPLETED|Overall Study||22
1048970|NCT00802360|2546510|P3|NOT COMPLETED|Overall Study||25
1048971|NCT00802360|2546511|P2|NOT COMPLETED|Overall Study||26
1048972|NCT00802360|2546512|P1|NOT COMPLETED|Overall Study||24
1048973|NCT00802360|2546509|P4|COMPLETED|Overall Study||17
1048974|NCT00802360|2546510|P3|COMPLETED|Overall Study||17
1048975|NCT00802360|2546511|P2|COMPLETED|Overall Study||16
1048976|NCT00802360|2546512|P1|COMPLETED|Overall Study||18
1048977|NCT00802360|2546509|P4|STARTED|Overall Study||39
1048978|NCT00802360|2546510|P3|STARTED|Overall Study||42
1048979|NCT00802360|2546511|P2|STARTED|Overall Study||42
1048980|NCT00802360|2546512|P1|STARTED|Overall Study||42
1048981|NCT00802412|2546554|P2|NOT COMPLETED|Overall Study||1
1048982|NCT00802412|2546555|P1|NOT COMPLETED|Overall Study||2
1048983|NCT00802412|2546554|P2|COMPLETED|Overall Study||66
1048984|NCT00802412|2546555|P1|COMPLETED|Overall Study||63
1048985|NCT00802412|2546554|P2|STARTED|Overall Study||67
1048986|NCT00802412|2546555|P1|STARTED|Overall Study||65
1048987|NCT00802503|2546565|P2|NOT COMPLETED|Overall Study||20
1048988|NCT00802503|2546566|P1|NOT COMPLETED|Overall Study||10
1048989|NCT00802503|2546565|P2|COMPLETED|Overall Study||133
1048990|NCT00802503|2546566|P1|COMPLETED|Overall Study||142
1048991|NCT00802503|2546565|P2|STARTED|Overall Study||153
1048992|NCT00802503|2546566|P1|STARTED|Overall Study||152
1048993|NCT00802529|2546590|P2|NOT COMPLETED|Overall Study||1
1048994|NCT00802529|2546591|P1|NOT COMPLETED|Overall Study||0
1048995|NCT00802529|2546590|P2|COMPLETED|Overall Study||29
1048996|NCT00802529|2546591|P1|COMPLETED|Overall Study|2 patients crossed-over to gentamicin after steroids failed to control vertigo (as per protocol).|30
1048997|NCT00802529|2546590|P2|STARTED|Overall Study||30
1048998|NCT00802529|2546591|P1|STARTED|Overall Study||30
1048999|NCT00802633|2546603|P2|NOT COMPLETED|Overall Study||0
1049000|NCT00802633|2546604|P1|NOT COMPLETED|Overall Study||0
1049001|NCT00802633|2546603|P2|COMPLETED|Overall Study||40
1049002|NCT00802633|2546604|P1|COMPLETED|Overall Study||40
1049003|NCT00802633|2546603|P2|STARTED|Overall Study||40
1049004|NCT00802633|2546604|P1|STARTED|Overall Study||40
1049005|NCT00802659|2546616|P4|NOT COMPLETED|Overall Study||0
1049006|NCT00802659|2546617|P3|NOT COMPLETED|Overall Study||0
1049007|NCT00802659|2546618|P2|NOT COMPLETED|Overall Study||1
1049008|NCT00802659|2546619|P1|NOT COMPLETED|Overall Study||0
1049009|NCT00802659|2546616|P4|COMPLETED|Overall Study||0
1049010|NCT00802659|2546617|P3|COMPLETED|Overall Study||0
1049011|NCT00802659|2546618|P2|COMPLETED|Overall Study||1
1049012|NCT00802659|2546619|P1|COMPLETED|Overall Study||0
1049013|NCT00802659|2546616|P4|STARTED|Overall Study||0
1049014|NCT00802659|2546617|P3|STARTED|Overall Study||0
1049015|NCT00802659|2546618|P2|STARTED|Overall Study||2
1049016|NCT00802659|2546619|P1|STARTED|Overall Study||0
1049017|NCT00802672|2546648|P3|NOT COMPLETED|Overall Study||34
1049018|NCT00802672|2546649|P2|NOT COMPLETED|Overall Study||52
1049019|NCT00802672|2546650|P1|NOT COMPLETED|Overall Study||68
1049020|NCT00802672|2546648|P3|COMPLETED|Overall Study||77
1049021|NCT00802672|2546649|P2|COMPLETED|Overall Study||174
1049022|NCT00802672|2546650|P1|COMPLETED|Overall Study||156
1049023|NCT00802672|2546648|P3|STARTED|Overall Study||111
1049024|NCT00802672|2546649|P2|STARTED|Overall Study||226
1049025|NCT00802672|2546650|P1|STARTED|Overall Study||224
1049026|NCT00802685|2546666|P2|NOT COMPLETED|Overall Study||0
1049027|NCT00802685|2546667|P1|NOT COMPLETED|Overall Study||0
1049028|NCT00802685|2546666|P2|COMPLETED|Overall Study||51
1049029|NCT00802685|2546667|P1|COMPLETED|Overall Study||54
1049030|NCT00802685|2546666|P2|STARTED|Overall Study||51
1049031|NCT00802685|2546667|P1|STARTED|Overall Study||54
1049032|NCT00802737|2546678|P3|NOT COMPLETED|Overall Study||1
1049033|NCT00802737|2546679|P2|NOT COMPLETED|Overall Study||11
1049034|NCT00802737|2546680|P1|NOT COMPLETED|Overall Study||17
1049035|NCT00802737|2546678|P3|COMPLETED|Overall Study||0
1049036|NCT00802737|2546679|P2|COMPLETED|Overall Study||0
1049037|NCT00802737|2546680|P1|COMPLETED|Overall Study||0
1049038|NCT00802737|2546678|P3|STARTED|Overall Study||1
1049039|NCT00802737|2546679|P2|STARTED|Overall Study||11
1049040|NCT00802737|2546680|P1|STARTED|Overall Study||17
1049041|NCT00802841|2546728|P2|NOT COMPLETED|Overall Study||95
1049042|NCT00802841|2546729|P1|NOT COMPLETED|Overall Study||96
1049043|NCT00802841|2546728|P2|COMPLETED|Overall Study||0
1049044|NCT00802841|2546729|P1|COMPLETED|Overall Study||0
1049045|NCT00802841|2546728|P2|Cross-over Set|Overall Study||56
1049046|NCT00802841|2546729|P1|Cross-over Set|Overall Study||13
1049047|NCT00802841|2546728|P2|Safety Set|Overall Study||93
1049048|NCT00802841|2546729|P1|Safety Set|Overall Study||96
1049049|NCT00802841|2546728|P2|Full Analysis Set|Overall Study||95
1049050|NCT00802841|2546729|P1|Full Analysis Set|Overall Study||96
1049051|NCT00802841|2546728|P2|STARTED|Overall Study||95
1049052|NCT00802841|2546729|P1|STARTED|Overall Study||96
1049053|NCT00802867|2546751|P1|NOT COMPLETED|Overall Study||13
1049054|NCT00802867|2546751|P1|COMPLETED|Overall Study||976
1049055|NCT00802867|2546751|P1|STARTED|Overall Study||989
1049056|NCT00802880|2546759|P1|NOT COMPLETED|Overall Study||0
1049057|NCT00802880|2546759|P1|COMPLETED|Overall Study||80
1049058|NCT00802880|2546759|P1|STARTED|Overall Study||80
1049059|NCT00802893|2546778|P1|NOT COMPLETED|Overall Study||3
1049060|NCT00802893|2546778|P1|COMPLETED|Overall Study||0
1049061|NCT00802893|2546778|P1|STARTED|Overall Study||3
1049062|NCT00802997|2546785|P2|NOT COMPLETED|6 Month to 9 Months||0
1049063|NCT00802997|2546786|P1|NOT COMPLETED|6 Month to 9 Months||2
1049064|NCT00802997|2546785|P2|COMPLETED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
1049065|NCT00802997|2546786|P1|COMPLETED|6 Month to 9 Months||25
1049066|NCT00802997|2546785|P2|STARTED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
1049067|NCT00802997|2546786|P1|STARTED|6 Month to 9 Months||27
1049068|NCT00802997|2546785|P2|NOT COMPLETED|3 Months to 6 Months||0
1049069|NCT00802997|2546786|P1|NOT COMPLETED|3 Months to 6 Months||7
1049070|NCT00802997|2546785|P2|COMPLETED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
1049071|NCT00802997|2546786|P1|COMPLETED|3 Months to 6 Months||27
1049072|NCT00802997|2546785|P2|STARTED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
1049073|NCT00802997|2546786|P1|STARTED|3 Months to 6 Months||34
1049074|NCT00802997|2546785|P2|NOT COMPLETED|Baseline to 3 Months||0
1049075|NCT00802997|2546786|P1|NOT COMPLETED|Baseline to 3 Months||0
1049076|NCT00802997|2546785|P2|COMPLETED|Baseline to 3 Months||17
1049077|NCT00802997|2546786|P1|COMPLETED|Baseline to 3 Months||34
1049078|NCT00802997|2546785|P2|STARTED|Baseline to 3 Months||17
1049079|NCT00802997|2546786|P1|STARTED|Baseline to 3 Months||34
1049080|NCT00803010|2546798|P2|NOT COMPLETED|Overall Study||0
1049081|NCT00803010|2546799|P1|NOT COMPLETED|Overall Study||0
1049082|NCT00803010|2546798|P2|COMPLETED|Overall Study||37
1049083|NCT00803010|2546799|P1|COMPLETED|Overall Study||37
1049084|NCT00803010|2546798|P2|STARTED|Overall Study||37
1049085|NCT00803010|2546799|P1|STARTED|Overall Study||37
1049086|NCT00803023|2546813|P4|NOT COMPLETED|Overall Study||8
1049087|NCT00803023|2546814|P3|NOT COMPLETED|Overall Study||11
1049088|NCT00803023|2546815|P2|NOT COMPLETED|Overall Study||8
1049089|NCT00803023|2546816|P1|NOT COMPLETED|Overall Study||5
1049090|NCT00803023|2546813|P4|COMPLETED|Overall Study||25
1049091|NCT00803023|2546814|P3|COMPLETED|Overall Study||20
1049092|NCT00803023|2546815|P2|COMPLETED|Overall Study||25
1049093|NCT00803023|2546816|P1|COMPLETED|Overall Study||27
1049094|NCT00803023|2546813|P4|STARTED|Overall Study||33
1049095|NCT00803023|2546814|P3|STARTED|Overall Study||31
1049096|NCT00803023|2546815|P2|STARTED|Overall Study||33
1049097|NCT00803023|2546816|P1|STARTED|Overall Study||32
1049098|NCT00803049|2546830|P4|NOT COMPLETED|Overall Study||102
1049099|NCT00803049|2546831|P3|NOT COMPLETED|Overall Study||44
1049100|NCT00803049|2546832|P2|NOT COMPLETED|Overall Study||118
1049101|NCT00803049|2546833|P1|NOT COMPLETED|Overall Study||61
1049102|NCT00803049|2546830|P4|COMPLETED|Overall Study||151
1049103|NCT00803049|2546831|P3|COMPLETED|Overall Study||64
1049104|NCT00803049|2546832|P2|COMPLETED|Overall Study||134
1049105|NCT00803049|2546833|P1|COMPLETED|Overall Study||68
1049106|NCT00803049|2546830|P4|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|250
1049107|NCT00803049|2546831|P3|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|107
1049108|NCT00803049|2546832|P2|Safety Population|Overall Study|Included 1 participant from Placebo/Teriflunomide 14 mg and 1 from Teriflunomide14 mg/14 mg arm|254
1049109|NCT00803049|2546833|P1|Safety Population|Overall Study||129
1049110|NCT00803049|2546830|P4|Treated|Overall Study||251
1049111|NCT00803049|2546831|P3|Treated|Overall Study||108
1049112|NCT00803049|2546832|P2|Treated|Overall Study||252
1049113|NCT00803049|2546833|P1|Treated|Overall Study||129
1049114|NCT00803049|2546830|P4|STARTED|Overall Study|Randomized in extension study|253
1049115|NCT00803049|2546831|P3|STARTED|Overall Study|Randomized in extension study|108
1049116|NCT00803049|2546832|P2|STARTED|Overall Study|Randomized in extension study|252
1049117|NCT00803049|2546833|P1|STARTED|Overall Study|Randomized in extension study|129
1049118|NCT00803062|2546867|P4|NOT COMPLETED|Overall Study||0
1049119|NCT00803062|2546868|P3|NOT COMPLETED|Overall Study||0
1049120|NCT00803062|2546869|P2|NOT COMPLETED|Overall Study||0
1049121|NCT00803062|2546870|P1|NOT COMPLETED|Overall Study||0
1049122|NCT00803062|2546867|P4|COMPLETED|Overall Study||112
1049123|NCT00803062|2546868|P3|COMPLETED|Overall Study||111
1049124|NCT00803062|2546869|P2|COMPLETED|Overall Study||115
1049125|NCT00803062|2546870|P1|COMPLETED|Overall Study||114
1049126|NCT00803062|2546867|P4|STARTED|Overall Study||112
1049127|NCT00803062|2546868|P3|STARTED|Overall Study||111
1049128|NCT00803062|2546869|P2|STARTED|Overall Study||115
1049129|NCT00803062|2546870|P1|STARTED|Overall Study||114
1049130|NCT00803101|2546890|P2|NOT COMPLETED|Overall Study||22
1049131|NCT00803101|2546891|P1|NOT COMPLETED|Overall Study||18
1049132|NCT00803101|2546890|P2|COMPLETED|Overall Study||66
1049133|NCT00803101|2546891|P1|COMPLETED|Overall Study||70
1049134|NCT00803101|2546890|P2|STARTED|Overall Study||88
1049135|NCT00803101|2546891|P1|STARTED|Overall Study||88
1049136|NCT00803114|2546911|P2|NOT COMPLETED|Overall Study||0
1049137|NCT00803114|2546912|P1|NOT COMPLETED|Overall Study||0
1049138|NCT00803114|2546911|P2|COMPLETED|Overall Study||115
1049139|NCT00803114|2546912|P1|COMPLETED|Overall Study||113
1049140|NCT00803114|2546911|P2|STARTED|Overall Study||115
1049141|NCT00803114|2546912|P1|STARTED|Overall Study||113
1049142|NCT00803179|2546922|P1|NOT COMPLETED|Overall Study||3
1049143|NCT00803179|2546922|P1|COMPLETED|Overall Study||2
1049144|NCT00803179|2546922|P1|STARTED|Overall Study||5
1049145|NCT00803244|2546928|P2|NOT COMPLETED|Overall Study||15
1049146|NCT00803244|2546929|P1|NOT COMPLETED|Overall Study||7
1049147|NCT00803244|2546928|P2|COMPLETED|Overall Study||178
1049148|NCT00803244|2546929|P1|COMPLETED|Overall Study||181
1049149|NCT00803244|2546928|P2|STARTED|Overall Study||193
1049150|NCT00803244|2546929|P1|STARTED|Overall Study||188
1049151|NCT00803270|2546939|P2|NOT COMPLETED|Overall Study||2
1049152|NCT00803270|2546940|P1|NOT COMPLETED|Overall Study||1
1049153|NCT00803270|2546939|P2|COMPLETED|Overall Study||12
1049154|NCT00803270|2546940|P1|COMPLETED|Overall Study||12
1049155|NCT00803270|2546939|P2|STARTED|Overall Study||14
1049156|NCT00803270|2546940|P1|STARTED|Overall Study||13
1049157|NCT00803283|2546950|P2|NOT COMPLETED|Overall Study||0
1049158|NCT00803283|2546951|P1|NOT COMPLETED|Overall Study||0
1049159|NCT00803283|2546950|P2|COMPLETED|Overall Study||1
1049160|NCT00803283|2546951|P1|COMPLETED|Overall Study||1
1049161|NCT00803283|2546950|P2|STARTED|Overall Study||1
1049162|NCT00803283|2546951|P1|STARTED|Overall Study||1
1049163|NCT00803361|2546977|P2|NOT COMPLETED|Overall Study||28
1049164|NCT00803361|2546978|P1|NOT COMPLETED|Overall Study||26
1049165|NCT00803361|2546977|P2|COMPLETED|Overall Study||74
1049166|NCT00803361|2546978|P1|COMPLETED|Overall Study||82
1049167|NCT00803361|2546977|P2|STARTED|Overall Study||102
1049168|NCT00803361|2546978|P1|STARTED|Overall Study||108
1049169|NCT00803400|2546998|P2|NOT COMPLETED|Overall Study||24
1049170|NCT00803400|2546999|P1|NOT COMPLETED|Overall Study||20
1049171|NCT00803400|2546998|P2|COMPLETED|Overall Study||51
1049172|NCT00803400|2546999|P1|COMPLETED|Overall Study||55
1049173|NCT00803400|2546998|P2|STARTED|Overall Study||75
1049174|NCT00803400|2546999|P1|STARTED|Overall Study||75
1049175|NCT00803413|2547013|P4|NOT COMPLETED|Overall Period||0
1049176|NCT00803413|2547014|P3|NOT COMPLETED|Overall Period||0
1049177|NCT00803413|2547015|P2|NOT COMPLETED|Overall Period||0
1049178|NCT00803413|2547016|P1|NOT COMPLETED|Overall Period||0
1049179|NCT00803413|2547013|P4|COMPLETED|Overall Period||30
1049180|NCT00803413|2547014|P3|COMPLETED|Overall Period||29
1049181|NCT00803413|2547015|P2|COMPLETED|Overall Period||32
1049182|NCT00803413|2547016|P1|COMPLETED|Overall Period||28
1049183|NCT00803413|2547013|P4|STARTED|Overall Period||30
1049184|NCT00803413|2547014|P3|STARTED|Overall Period||29
1049185|NCT00803413|2547015|P2|STARTED|Overall Period||32
1049186|NCT00803413|2547016|P1|STARTED|Overall Period||28
1049187|NCT00803517|2547028|P2|NOT COMPLETED|Overall Study||0
1049188|NCT00803517|2547029|P1|NOT COMPLETED|Overall Study||0
1049189|NCT00803517|2547028|P2|COMPLETED|Overall Study||12
1049190|NCT00803517|2547029|P1|COMPLETED|Overall Study||12
1049191|NCT00803517|2547028|P2|STARTED|Overall Study||12
1049192|NCT00803517|2547029|P1|STARTED|Overall Study||12
1049193|NCT00803543|2547037|P2|NOT COMPLETED|Overall Study||12
1049194|NCT00803543|2547038|P1|NOT COMPLETED|Overall Study||24
1049195|NCT00803543|2547037|P2|COMPLETED|Overall Study||22
1049196|NCT00803543|2547038|P1|COMPLETED|Overall Study||45
1049197|NCT00803543|2547037|P2|STARTED|Overall Study||34
1049198|NCT00803543|2547038|P1|STARTED|Overall Study||69
1049199|NCT00803595|2547053|P3|NOT COMPLETED|Overall Study||16
1049200|NCT00803595|2547054|P2|NOT COMPLETED|Overall Study||8
1049201|NCT00803595|2547055|P1|NOT COMPLETED|Overall Study||15
1049202|NCT00803595|2547053|P3|COMPLETED|Overall Study||322
1049203|NCT00803595|2547054|P2|COMPLETED|Overall Study||319
1049204|NCT00803595|2547055|P1|COMPLETED|Overall Study||322
1049205|NCT00803595|2547053|P3|STARTED|Overall Study||338
1049206|NCT00803595|2547054|P2|STARTED|Overall Study||327
1049207|NCT00803595|2547055|P1|STARTED|Overall Study||337
1049208|NCT00803634|2547068|P2|NOT COMPLETED|Overall Study||5
1049209|NCT00803634|2547069|P1|NOT COMPLETED|Overall Study||6
1049210|NCT00803634|2547068|P2|COMPLETED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|48
1049211|NCT00803634|2547069|P1|COMPLETED|Overall Study|All patients dosed with clevidipine [Safety population]|45
1049212|NCT00803634|2547068|P2|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with SOC antihypertensive therapy and confirmed to have AHF [mITT population]|41
1049213|NCT00803634|2547069|P1|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with clevidipine and confirmed to have AHF [mITT population]|44
1049214|NCT00803634|2547068|P2|STARTED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|53
1049215|NCT00803634|2547069|P1|STARTED|Overall Study|All patients dosed with clevidipine [Safety population]|51
1049216|NCT00803647|2547095|P1|NOT COMPLETED|Overall Study||0
1049217|NCT00803647|2547095|P1|COMPLETED|Overall Study||20
1049218|NCT00803647|2547095|P1|STARTED|Overall Study||20
1049219|NCT00803686|2547106|P4|NOT COMPLETED|Part 2, Period 3||0
1049220|NCT00803686|2547107|P3|NOT COMPLETED|Part 2, Period 3||0
1049221|NCT00803686|2547108|P2|NOT COMPLETED|Part 2, Period 3||0
1049222|NCT00803686|2547109|P1|NOT COMPLETED|Part 2, Period 3||0
1049223|NCT00803686|2547106|P4|COMPLETED|Part 2, Period 3|All who started this period completed|4
1049224|NCT00803686|2547107|P3|COMPLETED|Part 2, Period 3|All who started this period completed|5
1049225|NCT00803686|2547108|P2|COMPLETED|Part 2, Period 3|No subjects were treated in this period.|0
1049226|NCT00803686|2547109|P1|COMPLETED|Part 2, Period 3|No subjects were treated in this period|0
1049227|NCT00803686|2547106|P4|STARTED|Part 2, Period 3|Of the 6 eligible, 2 elected not to continue into Period 3.|4
1049228|NCT00803686|2547107|P3|STARTED|Part 2, Period 3|Of the 6 eligible, 1 elected not to continue into Period 3.|5
1049229|NCT00803686|2547108|P2|STARTED|Part 2, Period 3|No subjects were treated in this period.|0
1049230|NCT00803686|2547109|P1|STARTED|Part 2, Period 3|No subjects were treated in this period|0
1049231|NCT00803686|2547106|P4|NOT COMPLETED|Part 1, Period 2||0
1049232|NCT00803686|2547107|P3|NOT COMPLETED|Part 1, Period 2||0
1049233|NCT00803686|2547108|P2|NOT COMPLETED|Part 1, Period 2||0
1049234|NCT00803686|2547109|P1|NOT COMPLETED|Part 1, Period 2||0
1049235|NCT00803686|2547106|P4|COMPLETED|Part 1, Period 2|No subjects treated.|0
1049236|NCT00803686|2547107|P3|COMPLETED|Part 1, Period 2|No subjects treated.|0
1049237|NCT00803686|2547108|P2|COMPLETED|Part 1, Period 2||6
1049238|NCT00803686|2547109|P1|COMPLETED|Part 1, Period 2||6
1049239|NCT00803686|2547106|P4|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
1049240|NCT00803686|2547107|P3|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
1049241|NCT00803686|2547108|P2|STARTED|Part 1, Period 2||6
1049242|NCT00803686|2547109|P1|STARTED|Part 1, Period 2||6
1049243|NCT00803686|2547106|P4|NOT COMPLETED|Part 1, Period 1||0
1049244|NCT00803686|2547107|P3|NOT COMPLETED|Part 1, Period 1||0
1049245|NCT00803686|2547108|P2|NOT COMPLETED|Part 1, Period 1||0
1049246|NCT00803686|2547109|P1|NOT COMPLETED|Part 1, Period 1||0
1049247|NCT00803686|2547106|P4|COMPLETED|Part 1, Period 1||0
1049248|NCT00803686|2547107|P3|COMPLETED|Part 1, Period 1||0
1049249|NCT00803686|2547108|P2|COMPLETED|Part 1, Period 1||6
1049250|NCT00803686|2547109|P1|COMPLETED|Part 1, Period 1||6
1049251|NCT00803686|2547106|P4|STARTED|Part 1, Period 1||0
1049252|NCT00803686|2547107|P3|STARTED|Part 1, Period 1||0
1049253|NCT00803686|2547108|P2|STARTED|Part 1, Period 1||6
1049254|NCT00803686|2547109|P1|STARTED|Part 1, Period 1||6
1049255|NCT00803712|2547129|P2|NOT COMPLETED|Overall Study||27
1049256|NCT00803712|2547130|P1|NOT COMPLETED|Overall Study||36
1049257|NCT00803712|2547129|P2|COMPLETED|Overall Study|128 participants randomized to the control group completed the study|128
1049258|NCT00803712|2547130|P1|COMPLETED|Overall Study|118 participants randomized to the cinacalcet group completed the study|118
1049259|NCT00803712|2547129|P2|Safety Analysis Set|Overall Study|Randomized to the control group|154
1049260|NCT00803712|2547130|P1|Safety Analysis Set|Overall Study|Rz'ed to cinacalcet and received at least 1 dose, or to control but received cinacalcet throughout|155
1049351|NCT00789321|2547414|P1|NOT COMPLETED|Overall Study||0
1049261|NCT00803712|2547129|P2|Full Analysis Set|Overall Study|151 participants randomized and had at least one PTH concentration available after study day 1.|151
1049262|NCT00803712|2547130|P1|Full Analysis Set|Overall Study|153 participants randomized and had at least one PTH concentration available after study day 1.|153
1049263|NCT00803712|2547129|P2|STARTED|Overall Study|155 participants were randomized to the control group|155
1049264|NCT00803712|2547130|P1|STARTED|Overall Study|154 participants were randomized to the cinacalcet group|154
1049265|NCT00803738|2547196|P2|NOT COMPLETED|Overall Study||110
1049266|NCT00803738|2547197|P1|NOT COMPLETED|Overall Study||94
1049267|NCT00803738|2547196|P2|COMPLETED|Overall Study||176
1049268|NCT00803738|2547197|P1|COMPLETED|Overall Study||192
1049269|NCT00803738|2547196|P2|STARTED|Overall Study||286
1049270|NCT00803738|2547197|P1|STARTED|Overall Study||286
1049271|NCT00803751|2547209|P2|NOT COMPLETED|Overall Study||0
1049272|NCT00803751|2547210|P1|NOT COMPLETED|Overall Study||0
1049273|NCT00803751|2547209|P2|COMPLETED|Overall Study||23
1049274|NCT00803751|2547210|P1|COMPLETED|Overall Study||26
1049275|NCT00803751|2547209|P2|STARTED|Overall Study||23
1049276|NCT00803751|2547210|P1|STARTED|Overall Study||26
1049277|NCT00803777|2547226|P1|NOT COMPLETED|Overall Study||0
1049278|NCT00803777|2547226|P1|COMPLETED|Overall Study||147
1049279|NCT00803777|2547226|P1|STARTED|Overall Study||147
1049280|NCT00803790|2547236|P4|NOT COMPLETED|Period 2||1
1049281|NCT00803790|2547237|P3|NOT COMPLETED|Period 2||1
1049282|NCT00803790|2547238|P2|NOT COMPLETED|Period 2||0
1049283|NCT00803790|2547239|P1|NOT COMPLETED|Period 2||2
1049284|NCT00803790|2547236|P4|COMPLETED|Period 2||30
1049285|NCT00803790|2547237|P3|COMPLETED|Period 2||30
1049286|NCT00803790|2547238|P2|COMPLETED|Period 2||114
1049287|NCT00803790|2547239|P1|COMPLETED|Period 2||114
1049288|NCT00803790|2547236|P4|STARTED|Period 2||31
1049289|NCT00803790|2547237|P3|STARTED|Period 2||31
1049290|NCT00803790|2547238|P2|STARTED|Period 2||114
1049291|NCT00803790|2547239|P1|STARTED|Period 2||116
1049292|NCT00803790|2547236|P4|NOT COMPLETED|Period 1||4
1049293|NCT00803790|2547237|P3|NOT COMPLETED|Period 1||1
1049294|NCT00803790|2547238|P2|NOT COMPLETED|Period 1||12
1049295|NCT00803790|2547239|P1|NOT COMPLETED|Period 1||9
1049296|NCT00803790|2547236|P4|COMPLETED|Period 1||31
1049297|NCT00803790|2547237|P3|COMPLETED|Period 1||31
1049298|NCT00803790|2547238|P2|COMPLETED|Period 1||114
1049299|NCT00803790|2547239|P1|COMPLETED|Period 1||116
1049300|NCT00803790|2547236|P4|STARTED|Period 1||35
1049301|NCT00803790|2547237|P3|STARTED|Period 1||32
1049302|NCT00803790|2547238|P2|STARTED|Period 1||126
1049303|NCT00803790|2547239|P1|STARTED|Period 1||125
1049304|NCT00803959|2547252|P2|NOT COMPLETED|Overall Study||51
1049305|NCT00803959|2547253|P1|NOT COMPLETED|Overall Study||56
1049306|NCT00803959|2547252|P2|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=264).|264
1049307|NCT00803959|2547253|P1|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=259).|259
1049308|NCT00803959|2547252|P2|ITT Analysis With Primary Outcome Data|Overall Study||272
1049309|NCT00803959|2547253|P1|ITT Analysis With Primary Outcome Data|Overall Study||266
1049310|NCT00803959|2547252|P2|STARTED|Overall Study||315
1049311|NCT00803959|2547253|P1|STARTED|Overall Study||315
1049312|NCT00789035|2547288|P5|NOT COMPLETED|Overall Study||6
1049313|NCT00789035|2547289|P4|NOT COMPLETED|Overall Study||1
1049314|NCT00789035|2547290|P3|NOT COMPLETED|Overall Study||1
1049315|NCT00789035|2547291|P2|NOT COMPLETED|Overall Study||7
1049316|NCT00789035|2547292|P1|NOT COMPLETED|Overall Study||6
1049317|NCT00789035|2547288|P5|COMPLETED|Overall Study||74
1049318|NCT00789035|2547289|P4|COMPLETED|Overall Study||81
1049319|NCT00789035|2547290|P3|COMPLETED|Overall Study||80
1049320|NCT00789035|2547291|P2|COMPLETED|Overall Study||74
1049321|NCT00789035|2547292|P1|COMPLETED|Overall Study||76
1049322|NCT00789035|2547288|P5|STARTED|Overall Study||80
1049323|NCT00789035|2547289|P4|STARTED|Overall Study||82
1049324|NCT00789035|2547290|P3|STARTED|Overall Study||81
1049325|NCT00789035|2547291|P2|STARTED|Overall Study||81
1049326|NCT00789035|2547292|P1|STARTED|Overall Study||82
1049327|NCT00789074|2547349|P2|NOT COMPLETED|Overall Study||13
1049328|NCT00789074|2547350|P1|NOT COMPLETED|Overall Study||11
1049329|NCT00789074|2547349|P2|COMPLETED|Overall Study||35
1049330|NCT00789074|2547350|P1|COMPLETED|Overall Study||42
1049331|NCT00789074|2547349|P2|STARTED|Overall Study||48
1049332|NCT00789074|2547350|P1|STARTED|Overall Study||53
1049333|NCT00789113|2547366|P1|NOT COMPLETED|Overall Study||0
1049334|NCT00789113|2547366|P1|COMPLETED|Overall Study||12
1049335|NCT00789113|2547366|P1|STARTED|Overall Study||12
1049336|NCT00789191|2547373|P2|NOT COMPLETED|Overall Study||19
1049337|NCT00789191|2547374|P1|NOT COMPLETED|Overall Study||14
1049338|NCT00789191|2547373|P2|COMPLETED|Overall Study||92
1049339|NCT00789191|2547374|P1|COMPLETED|Overall Study||97
1049340|NCT00789191|2547373|P2|Exposed|Overall Study|1 non-compliance|110
1049341|NCT00789191|2547374|P1|Exposed|Overall Study|2 withdrew informed consent. 1 randomised by mistake. 1 non-compliance|107
1049342|NCT00789191|2547373|P2|STARTED|Overall Study||111
1049343|NCT00789191|2547374|P1|STARTED|Overall Study||111
1049344|NCT00789256|2547404|P2|NOT COMPLETED|Overall Study||0
1049345|NCT00789256|2547405|P1|NOT COMPLETED|Overall Study||0
1049346|NCT00789256|2547404|P2|COMPLETED|Overall Study||12
1049347|NCT00789256|2547405|P1|COMPLETED|Overall Study|Strata 1 had 5 responders and continued accrual, but the study was closed due to low accrual.|14
1049348|NCT00789256|2547404|P2|STARTED|Overall Study||12
1049349|NCT00789256|2547405|P1|STARTED|Overall Study||14
1049350|NCT00789321|2547413|P2|NOT COMPLETED|Overall Study||1
1049352|NCT00789321|2547413|P2|COMPLETED|Overall Study||22
1049353|NCT00789321|2547414|P1|COMPLETED|Overall Study||24
1049354|NCT00789321|2547413|P2|STARTED|Overall Study||23
1049355|NCT00789321|2547414|P1|STARTED|Overall Study||24
1049356|NCT00789373|2547422|P3|NOT COMPLETED|Maintenance||180
1049357|NCT00789373|2547423|P2|NOT COMPLETED|Maintenance||359
1049358|NCT00789373|2547424|P1|NOT COMPLETED|Maintenance||0
1049359|NCT00789373|2547422|P3|COMPLETED|Maintenance||0
1049360|NCT00789373|2547423|P2|COMPLETED|Maintenance||0
1049361|NCT00789373|2547424|P1|COMPLETED|Maintenance||0
1049362|NCT00789373|2547422|P3|STARTED|Maintenance||180
1049363|NCT00789373|2547423|P2|STARTED|Maintenance||359
1049364|NCT00789373|2547424|P1|STARTED|Maintenance||0
1049365|NCT00789373|2547422|P3|NOT COMPLETED|Induction||0
1049366|NCT00789373|2547423|P2|NOT COMPLETED|Induction||0
1049367|NCT00789373|2547424|P1|NOT COMPLETED|Induction||399
1049368|NCT00789373|2547422|P3|COMPLETED|Induction||0
1049369|NCT00789373|2547423|P2|COMPLETED|Induction||0
1049370|NCT00789373|2547424|P1|COMPLETED|Induction|1 patient received maintenance therapy post-induction but was never randomized.|540
1049371|NCT00789373|2547422|P3|STARTED|Induction||0
1049372|NCT00789373|2547423|P2|STARTED|Induction||0
1049373|NCT00789373|2547424|P1|STARTED|Induction||939
1049374|NCT00789438|2547452|P3|NOT COMPLETED|Overall Study||0
1049375|NCT00789438|2547453|P2|NOT COMPLETED|Overall Study||0
1049376|NCT00789438|2547454|P1|NOT COMPLETED|Overall Study||0
1049377|NCT00789438|2547452|P3|COMPLETED|Overall Study||28
1049378|NCT00789438|2547453|P2|COMPLETED|Overall Study||20
1049379|NCT00789438|2547454|P1|COMPLETED|Overall Study||21
1049380|NCT00789438|2547452|P3|STARTED|Overall Study||28
1049381|NCT00789438|2547453|P2|STARTED|Overall Study||20
1049382|NCT00789438|2547454|P1|STARTED|Overall Study||21
1049383|NCT00789477|2547467|P5|NOT COMPLETED|Overall Study||7
1049384|NCT00789477|2547468|P4|NOT COMPLETED|Overall Study||10
1049385|NCT00789477|2547469|P3|NOT COMPLETED|Overall Study||11
1049386|NCT00789477|2547470|P2|NOT COMPLETED|Overall Study||6
1049387|NCT00789477|2547471|P1|NOT COMPLETED|Overall Study||11
1049388|NCT00789477|2547467|P5|COMPLETED|Overall Study||38
1049389|NCT00789477|2547468|P4|COMPLETED|Overall Study||34
1049390|NCT00789477|2547469|P3|COMPLETED|Overall Study||33
1049391|NCT00789477|2547470|P2|COMPLETED|Overall Study||38
1049392|NCT00789477|2547471|P1|COMPLETED|Overall Study||33
1049393|NCT00789477|2547467|P5|Participants Received Treatment|Overall Study|SAF|45
1049394|NCT00789477|2547468|P4|Participants Received Treatment|Overall Study|SAF|42
1049395|NCT00789477|2547469|P3|Participants Received Treatment|Overall Study|SAF|44
1049396|NCT00789477|2547470|P2|Participants Received Treatment|Overall Study|SAF|44
1049397|NCT00789477|2547471|P1|Participants Received Treatment|Overall Study|safety analysis set (SAF)|44
1049398|NCT00789477|2547467|P5|STARTED|Overall Study|randomized|45
1049399|NCT00789477|2547468|P4|STARTED|Overall Study|randomized|44
1049400|NCT00789477|2547469|P3|STARTED|Overall Study|randomized|44
1049401|NCT00789477|2547470|P2|STARTED|Overall Study|randomized|44
1049402|NCT00789477|2547471|P1|STARTED|Overall Study|randomized|44
1049403|NCT00789529|2547505|P2|NOT COMPLETED|Overall Study||1
1049404|NCT00789529|2547506|P1|NOT COMPLETED|Overall Study||1
1049405|NCT00789529|2547505|P2|COMPLETED|Overall Study||15
1049406|NCT00789529|2547506|P1|COMPLETED|Overall Study||15
1049407|NCT00789529|2547505|P2|STARTED|Overall Study||16
1049408|NCT00789529|2547506|P1|STARTED|Overall Study||16
1049409|NCT00789555|2547517|P3|NOT COMPLETED|Overall Study||159
1049410|NCT00789555|2547518|P2|NOT COMPLETED|Overall Study||139
1049411|NCT00789555|2547519|P1|NOT COMPLETED|Overall Study||159
1049412|NCT00789555|2547517|P3|COMPLETED|Overall Study||263
1049413|NCT00789555|2547518|P2|COMPLETED|Overall Study||278
1049414|NCT00789555|2547519|P1|COMPLETED|Overall Study||262
1049415|NCT00789555|2547517|P3|STARTED|Overall Study||422
1049416|NCT00789555|2547518|P2|STARTED|Overall Study||417
1049417|NCT00789555|2547519|P1|STARTED|Overall Study||421
1049418|NCT00789581|2547544|P2|NOT COMPLETED|Adjuvant Therapy||57
1049419|NCT00789581|2547545|P1|NOT COMPLETED|Adjuvant Therapy||40
1049420|NCT00789581|2547544|P2|COMPLETED|Adjuvant Therapy||234
1049421|NCT00789581|2547545|P1|COMPLETED|Adjuvant Therapy||255
1049422|NCT00789581|2547544|P2|STARTED|Adjuvant Therapy||291
1049423|NCT00789581|2547545|P1|STARTED|Adjuvant Therapy||295
1049424|NCT00789581|2547544|P2|NOT COMPLETED|AC Therapy||17
1049425|NCT00789581|2547545|P1|NOT COMPLETED|AC Therapy||11
1049426|NCT00789581|2547544|P2|COMPLETED|AC Therapy||291
1049427|NCT00789581|2547545|P1|COMPLETED|AC Therapy||295
1049428|NCT00789581|2547544|P2|STARTED|AC Therapy||308
1049429|NCT00789581|2547545|P1|STARTED|AC Therapy||306
1049430|NCT00789672|2547555|P2|NOT COMPLETED|Overall Study||0
1049431|NCT00789672|2547556|P1|NOT COMPLETED|Overall Study||0
1049432|NCT00789672|2547555|P2|COMPLETED|Overall Study||17
1049433|NCT00789672|2547556|P1|COMPLETED|Overall Study||16
1049434|NCT00789672|2547555|P2|STARTED|Overall Study||17
1049435|NCT00789672|2547556|P1|STARTED|Overall Study||16
1049436|NCT00789685|2547586|P1|NOT COMPLETED|Overall Study||12
1049437|NCT00789685|2547586|P1|COMPLETED|Overall Study|Completed the study to Day 28|25
1049438|NCT00789685|2547586|P1|STARTED|Overall Study||37
1049439|NCT00789698|2547596|P4|NOT COMPLETED|Overall Study||52
1049440|NCT00789698|2547597|P3|NOT COMPLETED|Overall Study||27
1049441|NCT00789698|2547598|P2|NOT COMPLETED|Overall Study||33
1049442|NCT00789698|2547599|P1|NOT COMPLETED|Overall Study||40
1049443|NCT00789698|2547596|P4|COMPLETED|Overall Study||33
1049444|NCT00789698|2547597|P3|COMPLETED|Overall Study||29
1049445|NCT00789698|2547598|P2|COMPLETED|Overall Study||46
1049446|NCT00789698|2547599|P1|COMPLETED|Overall Study||32
1049447|NCT00789698|2547596|P4|STARTED|Overall Study||85
1049448|NCT00789698|2547597|P3|STARTED|Overall Study||56
1049449|NCT00789698|2547598|P2|STARTED|Overall Study||79
1049450|NCT00789698|2547599|P1|STARTED|Overall Study||72
1049451|NCT00789724|2547615|P2|NOT COMPLETED|Overall Study||0
1049452|NCT00789724|2547616|P1|NOT COMPLETED|Overall Study||0
1049453|NCT00789724|2547615|P2|COMPLETED|Overall Study||5
1049454|NCT00789724|2547616|P1|COMPLETED|Overall Study||5
1049455|NCT00789724|2547615|P2|STARTED|Overall Study||5
1049456|NCT00789724|2547616|P1|STARTED|Overall Study||5
1049457|NCT00789737|2547624|P2|NOT COMPLETED|Overall Study||55
1049458|NCT00789737|2547625|P1|NOT COMPLETED|Overall Study||48
1049459|NCT00789737|2547624|P2|COMPLETED|Overall Study||126
1049460|NCT00789737|2547625|P1|COMPLETED|Overall Study||128
1049461|NCT00789737|2547624|P2|STARTED|Overall Study||181
1049462|NCT00789737|2547625|P1|STARTED|Overall Study||176
1049463|NCT00789750|2547657|P2|NOT COMPLETED|Overall Study||60
1049464|NCT00789750|2547658|P1|NOT COMPLETED|Overall Study||59
1049465|NCT00789750|2547657|P2|COMPLETED|Overall Study||222
1049466|NCT00789750|2547658|P1|COMPLETED|Overall Study||221
1049467|NCT00789750|2547657|P2|Intent to Treat Set|Overall Study||276
1049468|NCT00789750|2547658|P1|Intent to Treat Set|Overall Study||271
1049469|NCT00789750|2547657|P2|Safety Set|Overall Study||277
1049470|NCT00789750|2547658|P1|Safety Set|Overall Study||274
1049471|NCT00789750|2547657|P2|Dropped During run-in Period|Overall Study||5
1049472|NCT00789750|2547658|P1|Dropped During run-in Period|Overall Study||6
1049473|NCT00789750|2547657|P2|STARTED|Overall Study||282
1049474|NCT00789750|2547658|P1|STARTED|Overall Study||280
1049475|NCT00789802|2547703|P3|NOT COMPLETED|Overall Study||6
1049476|NCT00789802|2547704|P2|NOT COMPLETED|Overall Study||7
1049477|NCT00789802|2547705|P1|NOT COMPLETED|Overall Study||10
1049478|NCT00789802|2547703|P3|COMPLETED|Overall Study||37
1049479|NCT00789802|2547704|P2|COMPLETED|Overall Study||35
1049480|NCT00789802|2547705|P1|COMPLETED|Overall Study||34
1049481|NCT00789802|2547703|P3|STARTED|Overall Study||43
1049482|NCT00789802|2547704|P2|STARTED|Overall Study||42
1049483|NCT00789802|2547705|P1|STARTED|Overall Study||44
1049484|NCT00789815|2547715|P2|NOT COMPLETED|Overall Study||1
1049485|NCT00789815|2547716|P1|NOT COMPLETED|Overall Study||7
1049486|NCT00789815|2547715|P2|COMPLETED|Overall Study||249
1049487|NCT00789815|2547716|P1|COMPLETED|Overall Study||243
1049488|NCT00789815|2547715|P2|STARTED|Overall Study||250
1049489|NCT00789815|2547716|P1|STARTED|Overall Study||250
1049490|NCT00789828|2547738|P2|NOT COMPLETED|Open-label Extension Period (4 Years)||0
1049491|NCT00789828|2547739|P1|NOT COMPLETED|Open-label Extension Period (4 Years)||29
1049492|NCT00789828|2547738|P2|COMPLETED|Open-label Extension Period (4 Years)||0
1049493|NCT00789828|2547739|P1|COMPLETED|Open-label Extension Period (4 Years)||82
1049494|NCT00789828|2547738|P2|STARTED|Open-label Extension Period (4 Years)|No participant received placebo.|0
1049495|NCT00789828|2547739|P1|STARTED|Open-label Extension Period (4 Years)|Of 117 participants only 111 completed the core period and continued in the extension period|111
1049496|NCT00789828|2547738|P2|NOT COMPLETED|Core Period (48 Weeks)||6
1049497|NCT00789828|2547739|P1|NOT COMPLETED|Core Period (48 Weeks)||0
1049498|NCT00789828|2547738|P2|COMPLETED|Core Period (48 Weeks)||33
1049499|NCT00789828|2547739|P1|COMPLETED|Core Period (48 Weeks)||78
1049500|NCT00789828|2547738|P2|STARTED|Core Period (48 Weeks)||39
1049501|NCT00789828|2547739|P1|STARTED|Core Period (48 Weeks)||78
1049502|NCT00789854|2547774|P3|NOT COMPLETED|Overall Study||47
1049503|NCT00789854|2547775|P2|NOT COMPLETED|Overall Study||35
1049504|NCT00789854|2547776|P1|NOT COMPLETED|Overall Study||49
1049505|NCT00789854|2547774|P3|COMPLETED|Overall Study||182
1049506|NCT00789854|2547775|P2|COMPLETED|Overall Study||196
1049507|NCT00789854|2547776|P1|COMPLETED|Overall Study||179
1049508|NCT00789854|2547774|P3|STARTED|Overall Study||229
1049509|NCT00789854|2547775|P2|STARTED|Overall Study||231
1049510|NCT00789854|2547776|P1|STARTED|Overall Study||228
1049511|NCT00789880|2547877|P6|NOT COMPLETED|Overall Study||0
1049512|NCT00789880|2547878|P5|NOT COMPLETED|Overall Study||3
1049513|NCT00789880|2547879|P4|NOT COMPLETED|Overall Study||1
1049514|NCT00789880|2547880|P3|NOT COMPLETED|Overall Study||0
1049515|NCT00789880|2547881|P2|NOT COMPLETED|Overall Study||1
1049516|NCT00789880|2547882|P1|NOT COMPLETED|Overall Study||1
1049517|NCT00789880|2547877|P6|COMPLETED|Overall Study||8
1049518|NCT00789880|2547878|P5|COMPLETED|Overall Study||15
1049519|NCT00789880|2547879|P4|COMPLETED|Overall Study||15
1049520|NCT00789880|2547880|P3|COMPLETED|Overall Study||8
1049521|NCT00789880|2547881|P2|COMPLETED|Overall Study||15
1049522|NCT00789880|2547882|P1|COMPLETED|Overall Study||15
1049523|NCT00789880|2547877|P6|STARTED|Overall Study||8
1049524|NCT00789880|2547878|P5|STARTED|Overall Study||18
1049525|NCT00789880|2547879|P4|STARTED|Overall Study||16
1049526|NCT00789880|2547880|P3|STARTED|Overall Study||8
1049527|NCT00789880|2547881|P2|STARTED|Overall Study||16
1049528|NCT00789880|2547882|P1|STARTED|Overall Study||16
1049529|NCT00789958|2547908|P1|NOT COMPLETED|Overall Study||37
1049530|NCT00789958|2547908|P1|COMPLETED|Overall Study||68
1049531|NCT00789958|2547908|P1|Eligible and Analyzable|Overall Study||79
1049532|NCT00789958|2547908|P1|STARTED|Overall Study||105
1049533|NCT00789997|2547923|P2|NOT COMPLETED|Overall Study||2
1049534|NCT00789997|2547924|P1|NOT COMPLETED|Overall Study||1
1049535|NCT00789997|2547923|P2|COMPLETED|Overall Study||38
1049536|NCT00789997|2547924|P1|COMPLETED|Overall Study||40
1049537|NCT00789997|2547923|P2|STARTED|Overall Study||40
1049538|NCT00789997|2547924|P1|STARTED|Overall Study||41
1049539|NCT00790023|2547935|P3|NOT COMPLETED|Overall Study||21
1049540|NCT00790023|2547936|P2|NOT COMPLETED|Overall Study||10
1049541|NCT00790023|2547937|P1|NOT COMPLETED|Overall Study||11
1049542|NCT00790023|2547935|P3|COMPLETED|Overall Study||214
1049543|NCT00790023|2547936|P2|COMPLETED|Overall Study||225
1049544|NCT00790023|2547937|P1|COMPLETED|Overall Study||226
1049545|NCT00790023|2547935|P3|STARTED|Overall Study||235
1049546|NCT00790023|2547936|P2|STARTED|Overall Study||235
1049547|NCT00790023|2547937|P1|STARTED|Overall Study||237
1049548|NCT00790036|2548027|P2|NOT COMPLETED|Overall Study||121
1049549|NCT00790036|2548028|P1|NOT COMPLETED|Overall Study||195
1049550|NCT00790036|2548027|P2|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|249
1049551|NCT00790036|2548028|P1|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|177
1049552|NCT00790036|2548027|P2|Untreated Participants|Overall Study|not treated due to administrative problems and subject withdrawal of consent.|6
1049553|NCT00790036|2548028|P1|Untreated Participants|Overall Study|not treated due to administrative problems, protocol deviation, and subject withdrawal of consent.|4
1049554|NCT00790036|2548027|P2|STARTED|Overall Study||370
1049555|NCT00790036|2548028|P1|STARTED|Overall Study||372
1049556|NCT00790062|2548042|P3|NOT COMPLETED|Overall Study||0
1049557|NCT00790062|2548043|P2|NOT COMPLETED|Overall Study||0
1049558|NCT00790062|2548044|P1|NOT COMPLETED|Overall Study||0
1049559|NCT00790062|2548042|P3|COMPLETED|Overall Study||658
1049560|NCT00790062|2548043|P2|COMPLETED|Overall Study||481
1049561|NCT00790062|2548044|P1|COMPLETED|Overall Study||659
1049562|NCT00790062|2548042|P3|STARTED|Overall Study||658
1049563|NCT00790062|2548043|P2|STARTED|Overall Study||481
1049564|NCT00790062|2548044|P1|STARTED|Overall Study||659
1049565|NCT00790192|2548077|P4|NOT COMPLETED|Overall Study||48
1049566|NCT00790192|2548078|P3|NOT COMPLETED|Overall Study||23
1049567|NCT00790192|2548079|P2|NOT COMPLETED|Overall Study||28
1049568|NCT00790192|2548080|P1|NOT COMPLETED|Overall Study||36
1049569|NCT00790192|2548077|P4|COMPLETED|Overall Study||74
1049570|NCT00790192|2548078|P3|COMPLETED|Overall Study||97
1049571|NCT00790192|2548079|P2|COMPLETED|Overall Study||93
1049572|NCT00790192|2548080|P1|COMPLETED|Overall Study||89
1049573|NCT00790192|2548077|P4|STARTED|Overall Study||122
1049574|NCT00790192|2548078|P3|STARTED|Overall Study||120
1049575|NCT00790192|2548079|P2|STARTED|Overall Study||121
1049576|NCT00790192|2548080|P1|STARTED|Overall Study||125
1049577|NCT00790205|2548096|P2|NOT COMPLETED|Overall Study||434
1049578|NCT00790205|2548097|P1|NOT COMPLETED|Overall Study||360
1049579|NCT00790205|2548096|P2|COMPLETED|Overall Study||6905
1049580|NCT00790205|2548097|P1|COMPLETED|Overall Study||6972
1049581|NCT00790205|2548096|P2|Treated|Overall Study||7274
1049582|NCT00790205|2548097|P1|Treated|Overall Study||7266
1049583|NCT00790205|2548096|P2|STARTED|Overall Study||7339
1049584|NCT00790205|2548097|P1|STARTED|Overall Study||7332
1049585|NCT00790218|2548137|P3|NOT COMPLETED|Overall Study||0
1049586|NCT00790218|2548138|P2|NOT COMPLETED|Overall Study||0
1049587|NCT00790218|2548139|P1|NOT COMPLETED|Overall Study||1
1049588|NCT00790218|2548137|P3|COMPLETED|Overall Study||7
1049589|NCT00790218|2548138|P2|COMPLETED|Overall Study||6
1049590|NCT00790218|2548139|P1|COMPLETED|Overall Study||5
1049591|NCT00790218|2548137|P3|STARTED|Overall Study||7
1049592|NCT00790218|2548138|P2|STARTED|Overall Study||6
1049593|NCT00790218|2548139|P1|STARTED|Overall Study||6
1049594|NCT00790270|2548150|P3|NOT COMPLETED|Overall Study||0
1049595|NCT00790270|2548151|P2|NOT COMPLETED|Overall Study||0
1049596|NCT00790270|2548152|P1|NOT COMPLETED|Overall Study||0
1049597|NCT00790270|2548150|P3|COMPLETED|Overall Study||20
1049598|NCT00790270|2548151|P2|COMPLETED|Overall Study||20
1049599|NCT00790270|2548152|P1|COMPLETED|Overall Study||21
1049600|NCT00790270|2548150|P3|STARTED|Overall Study||20
1049601|NCT00790270|2548151|P2|STARTED|Overall Study||20
1049602|NCT00790270|2548152|P1|STARTED|Overall Study||21
1049603|NCT00790296|2548165|P2|NOT COMPLETED|Overall Study||2
1049604|NCT00790296|2548166|P1|NOT COMPLETED|Overall Study||1
1049605|NCT00790296|2548165|P2|COMPLETED|Overall Study||4
1049606|NCT00790296|2548166|P1|COMPLETED|Overall Study||4
1049607|NCT00790296|2548165|P2|STARTED|Overall Study||6
1049608|NCT00790296|2548166|P1|STARTED|Overall Study||5
1049609|NCT00790400|2548174|P2|NOT COMPLETED|Everolimus Period (Core or Extension)||0
1049610|NCT00790400|2548175|P1|NOT COMPLETED|Everolimus Period (Core or Extension)||29
1049611|NCT00790400|2548174|P2|COMPLETED|Everolimus Period (Core or Extension)||0
1049612|NCT00790400|2548175|P1|COMPLETED|Everolimus Period (Core or Extension)|Treatment duration completed as per protocol|83
1049613|NCT00790400|2548174|P2|STARTED|Everolimus Period (Core or Extension)|"Placebo randomized patients who switched to Everolimus are reported in Everolimus arm."|0
1049614|NCT00790400|2548175|P1|STARTED|Everolimus Period (Core or Extension)|112 pts had Everolimus during core and/or extension (6 from placebo did not switch to Eve. in ext.)|112
1049615|NCT00790400|2548174|P2|NOT COMPLETED|Double-blind Period (Core Phase)||13
1049616|NCT00790400|2548175|P1|NOT COMPLETED|Double-blind Period (Core Phase)||7
1049617|NCT00790400|2548174|P2|COMPLETED|Double-blind Period (Core Phase)|Completed = 1st received Placebo in the Core phase, switched to Everolimus in Extension phase|26
1049618|NCT00790400|2548175|P1|COMPLETED|Double-blind Period (Core Phase)|Completed = Completed the Core phase & moved to Extension phase|72
1049619|NCT00790400|2548174|P2|STARTED|Double-blind Period (Core Phase)||39
1049620|NCT00790400|2548175|P1|STARTED|Double-blind Period (Core Phase)||79
1049621|NCT00790452|2548204|P2|NOT COMPLETED|Overall Study||0
1049622|NCT00790452|2548205|P1|NOT COMPLETED|Overall Study||1
1049623|NCT00790452|2548204|P2|COMPLETED|Overall Study||0
1049624|NCT00790452|2548205|P1|COMPLETED|Overall Study||0
1049625|NCT00790452|2548204|P2|STARTED|Overall Study||0
1049626|NCT00790452|2548205|P1|STARTED|Overall Study||1
1049627|NCT00790556|2548211|P2|NOT COMPLETED|Treatment Period 2||0
1049628|NCT00790556|2548212|P1|NOT COMPLETED|Treatment Period 2||0
1049629|NCT00790556|2548211|P2|COMPLETED|Treatment Period 2||6
1049630|NCT00790556|2548212|P1|COMPLETED|Treatment Period 2||6
1049631|NCT00790556|2548211|P2|STARTED|Treatment Period 2||6
1049632|NCT00790556|2548212|P1|STARTED|Treatment Period 2||6
1049633|NCT00790556|2548211|P2|NOT COMPLETED|Washout After Period 1||0
1049634|NCT00790556|2548212|P1|NOT COMPLETED|Washout After Period 1||0
1049635|NCT00790556|2548211|P2|COMPLETED|Washout After Period 1||6
1049636|NCT00790556|2548212|P1|COMPLETED|Washout After Period 1||6
1049637|NCT00790556|2548211|P2|STARTED|Washout After Period 1||6
1049638|NCT00790556|2548212|P1|STARTED|Washout After Period 1||6
1049639|NCT00790556|2548211|P2|NOT COMPLETED|Treatment Period 1||0
1049640|NCT00790556|2548212|P1|NOT COMPLETED|Treatment Period 1||2
1049641|NCT00790556|2548211|P2|COMPLETED|Treatment Period 1||6
1049642|NCT00790556|2548212|P1|COMPLETED|Treatment Period 1||6
1049643|NCT00790556|2548211|P2|STARTED|Treatment Period 1||6
1049644|NCT00790556|2548212|P1|STARTED|Treatment Period 1||8
1049663|NCT00790647|2548250|P1|NOT COMPLETED|Overall Study||1
1049664|NCT00790647|2548250|P1|COMPLETED|Overall Study||9
1049665|NCT00790647|2548250|P1|STARTED|Overall Study||10
1049666|NCT00790673|2548261|P4|NOT COMPLETED|Overall Study||0
1049667|NCT00790673|2548262|P3|NOT COMPLETED|Overall Study||0
1049668|NCT00790673|2548263|P2|NOT COMPLETED|Overall Study||0
1049669|NCT00790673|2548264|P1|NOT COMPLETED|Overall Study||0
1049670|NCT00790673|2548261|P4|COMPLETED|Overall Study||8
1049671|NCT00790673|2548262|P3|COMPLETED|Overall Study||12
1049672|NCT00790673|2548263|P2|COMPLETED|Overall Study||6
1049673|NCT00790673|2548264|P1|COMPLETED|Overall Study||6
1049674|NCT00790673|2548261|P4|STARTED|Overall Study||8
1049675|NCT00790673|2548262|P3|STARTED|Overall Study||12
1049676|NCT00790673|2548263|P2|STARTED|Overall Study||6
1049677|NCT00790673|2548264|P1|STARTED|Overall Study||6
1049678|NCT00790738|2548276|P2|NOT COMPLETED|Overall Study||3
1049679|NCT00790738|2548277|P1|NOT COMPLETED|Overall Study||2
1049680|NCT00790738|2548276|P2|COMPLETED|Overall Study||3
1049681|NCT00790738|2548277|P1|COMPLETED|Overall Study||3
1049682|NCT00790738|2548276|P2|STARTED|Overall Study||6
1049683|NCT00790738|2548277|P1|STARTED|Overall Study||5
1049684|NCT00790751|2548291|P4|NOT COMPLETED|Overall Study||21
1049685|NCT00790751|2548292|P3|NOT COMPLETED|Overall Study||20
1049686|NCT00790751|2548293|P2|NOT COMPLETED|Overall Study||30
1049687|NCT00790751|2548294|P1|NOT COMPLETED|Overall Study||25
1049688|NCT00790751|2548291|P4|COMPLETED|Overall Study||141
1049689|NCT00790751|2548292|P3|COMPLETED|Overall Study||141
1049690|NCT00790751|2548293|P2|COMPLETED|Overall Study||131
1049691|NCT00790751|2548294|P1|COMPLETED|Overall Study||137
1049692|NCT00790751|2548291|P4|STARTED|Overall Study||162
1049693|NCT00790751|2548292|P3|STARTED|Overall Study||161
1049694|NCT00790751|2548293|P2|STARTED|Overall Study||161
1049695|NCT00790751|2548294|P1|STARTED|Overall Study||162
1049696|NCT00790790|2548315|P3|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
1049697|NCT00790790|2548316|P2|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
1049698|NCT00790790|2548317|P1|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
1049699|NCT00790790|2548315|P3|COMPLETED|Study Period 3: 1-Week Washout Phase||26
1049700|NCT00790790|2548316|P2|COMPLETED|Study Period 3: 1-Week Washout Phase||31
1049701|NCT00790790|2548317|P1|COMPLETED|Study Period 3: 1-Week Washout Phase||37
1049702|NCT00790790|2548315|P3|STARTED|Study Period 3: 1-Week Washout Phase||27
1049703|NCT00790790|2548316|P2|STARTED|Study Period 3: 1-Week Washout Phase||32
1049704|NCT00790790|2548317|P1|STARTED|Study Period 3: 1-Week Washout Phase||37
1049705|NCT00790790|2548315|P3|NOT COMPLETED|Study Period 2: Therapy Phase||21
1049706|NCT00790790|2548316|P2|NOT COMPLETED|Study Period 2: Therapy Phase||18
1049707|NCT00790790|2548317|P1|NOT COMPLETED|Study Period 2: Therapy Phase||12
1049708|NCT00790790|2548315|P3|COMPLETED|Study Period 2: Therapy Phase||27
1049709|NCT00790790|2548316|P2|COMPLETED|Study Period 2: Therapy Phase||32
1049710|NCT00790790|2548317|P1|COMPLETED|Study Period 2: Therapy Phase||37
1049711|NCT00790790|2548315|P3|STARTED|Study Period 2: Therapy Phase||48
1049712|NCT00790790|2548316|P2|STARTED|Study Period 2: Therapy Phase||50
1049713|NCT00790790|2548317|P1|STARTED|Study Period 2: Therapy Phase||49
1049714|NCT00790803|2548390|P1|NOT COMPLETED|Overall Study||0
1049715|NCT00790803|2548390|P1|COMPLETED|Overall Study||5
1049716|NCT00790803|2548390|P1|STARTED|Overall Study||5
1049717|NCT00790855|2548398|P1|NOT COMPLETED|Overall Study||0
1049718|NCT00790855|2548398|P1|COMPLETED|Overall Study||25
1049719|NCT00790855|2548398|P1|STARTED|Overall Study||25
1049720|NCT00790907|2548406|P3|NOT COMPLETED|Overall Study||339
1049721|NCT00790907|2548407|P2|NOT COMPLETED|Overall Study||340
1049722|NCT00790907|2548408|P1|NOT COMPLETED|Overall Study||455
1049723|NCT00790907|2548406|P3|COMPLETED|Overall Study||663
1049724|NCT00790907|2548407|P2|COMPLETED|Overall Study||684
1049725|NCT00790907|2548408|P1|COMPLETED|Overall Study||754
1049726|NCT00790907|2548406|P3|STARTED|Overall Study||1002
1049727|NCT00790907|2548407|P2|STARTED|Overall Study||1024
1049728|NCT00790907|2548408|P1|STARTED|Overall Study||1209
1049729|NCT00791037|2548429|P1|NOT COMPLETED|Overall Study||0
1049730|NCT00791037|2548429|P1|COMPLETED|Overall Study||23
1049731|NCT00791037|2548429|P1|Skeletal or Bone-only Disease by FDG-PET|Overall Study||1
1049732|NCT00791037|2548429|P1|Primary Outcome|Overall Study||19
1049733|NCT00791037|2548429|P1|STARTED|Overall Study||23
1049734|NCT00791076|2548436|P1|NOT COMPLETED|Overall Study||8
1049735|NCT00791076|2548436|P1|COMPLETED|Overall Study||0
1049736|NCT00791076|2548436|P1|STARTED|Overall Study||8
1049737|NCT00791089|2548446|P2|NOT COMPLETED|Overall Study||6
1049738|NCT00791089|2548447|P1|NOT COMPLETED|Overall Study||6
1049739|NCT00791089|2548446|P2|COMPLETED|Overall Study||0
1049740|NCT00791089|2548447|P1|COMPLETED|Overall Study||0
1049741|NCT00791089|2548446|P2|Six-month Data Collected|Overall Study||5
1049742|NCT00791089|2548447|P1|Six-month Data Collected|Overall Study||6
1049743|NCT00791089|2548446|P2|Began Actually Taking Fish Oil or Placeb|Overall Study||5
1049744|NCT00791089|2548447|P1|Began Actually Taking Fish Oil or Placeb|Overall Study||6
1049745|NCT00791089|2548446|P2|STARTED|Overall Study||6
1049746|NCT00791089|2548447|P1|STARTED|Overall Study||6
1049747|NCT00791102|2548453|P2|NOT COMPLETED|Period 2||0
1049748|NCT00791102|2548454|P1|NOT COMPLETED|Period 2||0
1049749|NCT00791102|2548453|P2|COMPLETED|Period 2||10
1049750|NCT00791102|2548454|P1|COMPLETED|Period 2||10
1049751|NCT00791102|2548453|P2|STARTED|Period 2||10
1049752|NCT00791102|2548454|P1|STARTED|Period 2||10
1049753|NCT00791102|2548453|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
1049754|NCT00791102|2548454|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
1049755|NCT00791102|2548453|P2|COMPLETED|Washout Period of 2 Weeks||10
1049756|NCT00791102|2548454|P1|COMPLETED|Washout Period of 2 Weeks||10
1049757|NCT00791102|2548453|P2|STARTED|Washout Period of 2 Weeks||10
1049758|NCT00791102|2548454|P1|STARTED|Washout Period of 2 Weeks||10
1049759|NCT00791102|2548453|P2|NOT COMPLETED|Period 1||0
1049760|NCT00791102|2548454|P1|NOT COMPLETED|Period 1||0
1049761|NCT00791102|2548453|P2|COMPLETED|Period 1||10
1049762|NCT00791102|2548454|P1|COMPLETED|Period 1||10
1049763|NCT00791102|2548453|P2|STARTED|Period 1||10
1049764|NCT00791102|2548454|P1|STARTED|Period 1||10
1049765|NCT00791128|2548470|P1|NOT COMPLETED|Overall Study||9
1049766|NCT00791128|2548470|P1|COMPLETED|Overall Study||13
1049767|NCT00791128|2548470|P1|STARTED|Overall Study||22
1049768|NCT00791258|2548475|P1|NOT COMPLETED|Overall Study||263
1049769|NCT00791258|2548475|P1|COMPLETED|Overall Study||736
1049770|NCT00791258|2548475|P1|STARTED|Overall Study||999
1049771|NCT00791323|2548539|P2|NOT COMPLETED|Overall Study||0
1049772|NCT00791323|2548540|P1|NOT COMPLETED|Overall Study||0
1049773|NCT00791323|2548539|P2|COMPLETED|Overall Study||3
1049774|NCT00791323|2548540|P1|COMPLETED|Overall Study||6
1049775|NCT00791323|2548539|P2|STARTED|Overall Study||3
1049776|NCT00791323|2548540|P1|STARTED|Overall Study||6
1049777|NCT00791336|2548546|P1|NOT COMPLETED|Overall Study||0
1049778|NCT00791336|2548546|P1|COMPLETED|Overall Study||1
1049779|NCT00791336|2548546|P1|STARTED|Overall Study||1
1049780|NCT00791388|2548557|P5|NOT COMPLETED|Period 4 - 400 mg Dose Group||4
1049781|NCT00791388|2548558|P4|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
1049782|NCT00791388|2548559|P3|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
1049783|NCT00791388|2548560|P2|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
1049784|NCT00791388|2548561|P1|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
1049785|NCT00791388|2548557|P5|COMPLETED|Period 4 - 400 mg Dose Group||4
1049786|NCT00791388|2548558|P4|COMPLETED|Period 4 - 400 mg Dose Group||0
1049787|NCT00791388|2548559|P3|COMPLETED|Period 4 - 400 mg Dose Group||0
1049788|NCT00791388|2548560|P2|COMPLETED|Period 4 - 400 mg Dose Group||0
1049789|NCT00791388|2548561|P1|COMPLETED|Period 4 - 400 mg Dose Group||4
1049790|NCT00791388|2548557|P5|STARTED|Period 4 - 400 mg Dose Group||8
1049791|NCT00791388|2548558|P4|STARTED|Period 4 - 400 mg Dose Group||0
1049792|NCT00791388|2548559|P3|STARTED|Period 4 - 400 mg Dose Group||0
1049793|NCT00791388|2548560|P2|STARTED|Period 4 - 400 mg Dose Group||0
1049794|NCT00791388|2548561|P1|STARTED|Period 4 - 400 mg Dose Group||4
1049795|NCT00791388|2548557|P5|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
1049796|NCT00791388|2548558|P4|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
1049797|NCT00791388|2548559|P3|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
1049798|NCT00791388|2548560|P2|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
1049799|NCT00791388|2548561|P1|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
1049800|NCT00791388|2548557|P5|COMPLETED|Period 3 - 200 mg Dose Group||0
1049801|NCT00791388|2548558|P4|COMPLETED|Period 3 - 200 mg Dose Group||8
1049802|NCT00791388|2548559|P3|COMPLETED|Period 3 - 200 mg Dose Group||0
1049803|NCT00791388|2548560|P2|COMPLETED|Period 3 - 200 mg Dose Group||0
1049804|NCT00791388|2548561|P1|COMPLETED|Period 3 - 200 mg Dose Group||3
1049805|NCT00791388|2548557|P5|STARTED|Period 3 - 200 mg Dose Group||0
1049806|NCT00791388|2548558|P4|STARTED|Period 3 - 200 mg Dose Group||8
1049807|NCT00791388|2548559|P3|STARTED|Period 3 - 200 mg Dose Group||0
1049808|NCT00791388|2548560|P2|STARTED|Period 3 - 200 mg Dose Group||0
1049809|NCT00791388|2548561|P1|STARTED|Period 3 - 200 mg Dose Group||3
1049810|NCT00791388|2548557|P5|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
1049811|NCT00791388|2548558|P4|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
1049812|NCT00791388|2548559|P3|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
1049813|NCT00791388|2548560|P2|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
1049814|NCT00791388|2548561|P1|NOT COMPLETED|Period 2 - 100 mg Dose Group||1
1049815|NCT00791388|2548557|P5|COMPLETED|Period 2 - 100 mg Dose Group||0
1049816|NCT00791388|2548558|P4|COMPLETED|Period 2 - 100 mg Dose Group||0
1049817|NCT00791388|2548559|P3|COMPLETED|Period 2 - 100 mg Dose Group||8
1049818|NCT00791388|2548560|P2|COMPLETED|Period 2 - 100 mg Dose Group||0
1049819|NCT00791388|2548561|P1|COMPLETED|Period 2 - 100 mg Dose Group||2
1049820|NCT00791388|2548557|P5|STARTED|Period 2 - 100 mg Dose Group||0
1049821|NCT00791388|2548558|P4|STARTED|Period 2 - 100 mg Dose Group||0
1049822|NCT00791388|2548559|P3|STARTED|Period 2 - 100 mg Dose Group||8
1049823|NCT00791388|2548560|P2|STARTED|Period 2 - 100 mg Dose Group||0
1049824|NCT00791388|2548561|P1|STARTED|Period 2 - 100 mg Dose Group||3
1049825|NCT00791388|2548557|P5|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
1049826|NCT00791388|2548558|P4|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
1049827|NCT00791388|2548559|P3|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
1049828|NCT00791388|2548560|P2|NOT COMPLETED|Period 1 - 50 mg Dose Group||1
1049829|NCT00791388|2548561|P1|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
1049830|NCT00791388|2548557|P5|COMPLETED|Period 1 - 50 mg Dose Group||0
1049831|NCT00791388|2548558|P4|COMPLETED|Period 1 - 50 mg Dose Group||0
1049832|NCT00791388|2548559|P3|COMPLETED|Period 1 - 50 mg Dose Group||0
1049833|NCT00791388|2548560|P2|COMPLETED|Period 1 - 50 mg Dose Group||7
1049834|NCT00791388|2548561|P1|COMPLETED|Period 1 - 50 mg Dose Group||3
1049835|NCT00791388|2548557|P5|STARTED|Period 1 - 50 mg Dose Group||0
1049836|NCT00791388|2548558|P4|STARTED|Period 1 - 50 mg Dose Group||0
1049837|NCT00791388|2548559|P3|STARTED|Period 1 - 50 mg Dose Group||0
1049838|NCT00791388|2548560|P2|STARTED|Period 1 - 50 mg Dose Group||8
1049839|NCT00791388|2548561|P1|STARTED|Period 1 - 50 mg Dose Group||3
1049840|NCT00804193|2548591|P3|NOT COMPLETED|Overall Study||32
1049841|NCT00804193|2548592|P2|NOT COMPLETED|Overall Study||44
1049842|NCT00804193|2548593|P1|NOT COMPLETED|Overall Study||39
1049843|NCT00804193|2548591|P3|COMPLETED|Overall Study||77
1049844|NCT00804193|2548592|P2|COMPLETED|Overall Study||180
1049845|NCT00804193|2548593|P1|COMPLETED|Overall Study||181
1049846|NCT00804193|2548591|P3|STARTED|Overall Study||109
1049847|NCT00804193|2548592|P2|STARTED|Overall Study||224
1049848|NCT00804193|2548593|P1|STARTED|Overall Study||220
1049849|NCT00808132|2548612|P5|NOT COMPLETED|Overall Study||100
1049850|NCT00808132|2548613|P4|NOT COMPLETED|Overall Study||69
1049851|NCT00808132|2548614|P3|NOT COMPLETED|Overall Study||54
1049852|NCT00808132|2548615|P2|NOT COMPLETED|Overall Study||88
1049853|NCT00808132|2548616|P1|NOT COMPLETED|Overall Study||98
1049854|NCT00808132|2548612|P5|COMPLETED|Overall Study||383
1049855|NCT00808132|2548613|P4|COMPLETED|Overall Study||159
1049856|NCT00808132|2548614|P3|COMPLETED|Overall Study||185
1049857|NCT00808132|2548615|P2|COMPLETED|Overall Study||393
1049858|NCT00808132|2548616|P1|COMPLETED|Overall Study||357
1049859|NCT00808132|2548612|P5|Treated|Overall Study||474
1049860|NCT00808132|2548613|P4|Treated|Overall Study||220
1049861|NCT00808132|2548614|P3|Treated|Overall Study||230
1049862|NCT00808132|2548615|P2|Treated|Overall Study||474
1049863|NCT00808132|2548616|P1|Treated|Overall Study||445
1049864|NCT00808132|2548612|P5|STARTED|Overall Study||483
1049865|NCT00808132|2548613|P4|STARTED|Overall Study||228
1049866|NCT00808132|2548614|P3|STARTED|Overall Study||239
1049867|NCT00808132|2548615|P2|STARTED|Overall Study||481
1049868|NCT00808132|2548616|P1|STARTED|Overall Study||455
1049869|NCT00808236|2548690|P2|NOT COMPLETED|Overall Study||91
1049870|NCT00808236|2548691|P1|NOT COMPLETED|Overall Study||82
1049871|NCT00808236|2548690|P2|COMPLETED|Overall Study||13
1049872|NCT00808236|2548691|P1|COMPLETED|Overall Study||14
1049873|NCT00808236|2548690|P2|Admitted to Hospital|Overall Study|Died during transport to hospital(1)|42
1049874|NCT00808236|2548691|P1|Admitted to Hospital|Overall Study|Died during transport to hospital(2); DNAR determination was made at hospital(1)|30
1049875|NCT00808236|2548690|P2|Achieved ROSC|Overall Study||43
1049876|NCT00808236|2548691|P1|Achieved ROSC|Overall Study||33
1049877|NCT00808236|2548690|P2|Included in Analysis|Overall Study|Crossed over & withdrawn (1); Lost to Follow-Up: taken to non-participating hospital (1)|99
1049878|NCT00808236|2548691|P1|Included in Analysis|Overall Study|Lost to Follow-Up: taken to non-participating hospital (1)|83
1049879|NCT00808236|2548690|P2|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: Terminal(1); Asphyxia(1), In-hospital(1)|101
1049880|NCT00808236|2548691|P1|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: DNAR(4); had pulse(2); CVA(2); Drug OD(2); On home oxygen(1); Unwitnessed(1)|84
1049881|NCT00808236|2548690|P2|STARTED|Overall Study||104
1049882|NCT00808236|2548691|P1|STARTED|Overall Study||96
1049883|NCT00808249|2548723|P4|NOT COMPLETED|Overall Study||16
1049884|NCT00808249|2548724|P3|NOT COMPLETED|Overall Study||22
1049885|NCT00808249|2548725|P2|NOT COMPLETED|Overall Study||15
1049886|NCT00808249|2548726|P1|NOT COMPLETED|Overall Study||17
1049887|NCT00808249|2548723|P4|COMPLETED|Overall Study||90
1049888|NCT00808249|2548724|P3|COMPLETED|Overall Study||83
1049889|NCT00808249|2548725|P2|COMPLETED|Overall Study||91
1049890|NCT00808249|2548726|P1|COMPLETED|Overall Study||90
1049891|NCT00808249|2548723|P4|STARTED|Overall Study||106
1049892|NCT00808249|2548724|P3|STARTED|Overall Study||105
1049893|NCT00808249|2548725|P2|STARTED|Overall Study||106
1049894|NCT00808249|2548726|P1|STARTED|Overall Study||107
1049895|NCT00808340|2548752|P6|NOT COMPLETED|Third Intervention||0
1049896|NCT00808340|2548753|P5|NOT COMPLETED|Third Intervention||0
1049897|NCT00808340|2548754|P4|NOT COMPLETED|Third Intervention||0
1049898|NCT00808340|2548755|P3|NOT COMPLETED|Third Intervention||0
1049899|NCT00808340|2548756|P2|NOT COMPLETED|Third Intervention||0
1049900|NCT00808340|2548757|P1|NOT COMPLETED|Third Intervention||0
1049901|NCT00808340|2548752|P6|COMPLETED|Third Intervention||6
1049902|NCT00808340|2548753|P5|COMPLETED|Third Intervention||5
1049903|NCT00808340|2548754|P4|COMPLETED|Third Intervention||3
1049904|NCT00808340|2548755|P3|COMPLETED|Third Intervention||7
1049905|NCT00808340|2548756|P2|COMPLETED|Third Intervention||9
1049906|NCT00808340|2548757|P1|COMPLETED|Third Intervention||4
1049907|NCT00808340|2548752|P6|STARTED|Third Intervention||6
1049908|NCT00808340|2548753|P5|STARTED|Third Intervention||5
1049909|NCT00808340|2548754|P4|STARTED|Third Intervention||3
1049910|NCT00808340|2548755|P3|STARTED|Third Intervention||7
1049911|NCT00808340|2548756|P2|STARTED|Third Intervention||9
1049912|NCT00808340|2548757|P1|STARTED|Third Intervention||4
1049913|NCT00808340|2548752|P6|NOT COMPLETED|Second Intervention||0
1049914|NCT00808340|2548753|P5|NOT COMPLETED|Second Intervention||0
1049915|NCT00808340|2548754|P4|NOT COMPLETED|Second Intervention||0
1049916|NCT00808340|2548755|P3|NOT COMPLETED|Second Intervention||0
1049917|NCT00808340|2548756|P2|NOT COMPLETED|Second Intervention||0
1049918|NCT00808340|2548757|P1|NOT COMPLETED|Second Intervention||0
1049919|NCT00808340|2548752|P6|COMPLETED|Second Intervention||6
1049920|NCT00808340|2548753|P5|COMPLETED|Second Intervention||5
1049921|NCT00808340|2548754|P4|COMPLETED|Second Intervention||3
1049922|NCT00808340|2548755|P3|COMPLETED|Second Intervention||7
1049923|NCT00808340|2548756|P2|COMPLETED|Second Intervention||9
1049924|NCT00808340|2548757|P1|COMPLETED|Second Intervention||4
1049925|NCT00808340|2548752|P6|STARTED|Second Intervention||6
1049926|NCT00808340|2548753|P5|STARTED|Second Intervention||5
1049927|NCT00808340|2548754|P4|STARTED|Second Intervention||3
1049928|NCT00808340|2548755|P3|STARTED|Second Intervention||7
1049929|NCT00808340|2548756|P2|STARTED|Second Intervention||9
1049930|NCT00808340|2548757|P1|STARTED|Second Intervention||4
1049931|NCT00808340|2548752|P6|NOT COMPLETED|First Intervention||0
1049932|NCT00808340|2548753|P5|NOT COMPLETED|First Intervention||0
1049933|NCT00808340|2548754|P4|NOT COMPLETED|First Intervention||0
1049934|NCT00808340|2548755|P3|NOT COMPLETED|First Intervention||0
1049935|NCT00808340|2548756|P2|NOT COMPLETED|First Intervention||0
1049936|NCT00808340|2548757|P1|NOT COMPLETED|First Intervention||0
1049937|NCT00808340|2548752|P6|COMPLETED|First Intervention||6
1049938|NCT00808340|2548753|P5|COMPLETED|First Intervention||5
1049939|NCT00808340|2548754|P4|COMPLETED|First Intervention||3
1049940|NCT00808340|2548755|P3|COMPLETED|First Intervention||7
1049941|NCT00808340|2548756|P2|COMPLETED|First Intervention||9
1049942|NCT00808340|2548757|P1|COMPLETED|First Intervention||4
1049943|NCT00808340|2548752|P6|STARTED|First Intervention||6
1049944|NCT00808340|2548753|P5|STARTED|First Intervention||5
1049945|NCT00808340|2548754|P4|STARTED|First Intervention||3
1049946|NCT00808340|2548755|P3|STARTED|First Intervention||7
1049947|NCT00808340|2548756|P2|STARTED|First Intervention||9
1049948|NCT00808340|2548757|P1|STARTED|First Intervention||4
1049955|NCT00808444|2548787|P2|NOT COMPLETED|Overall Study||1
1049956|NCT00808444|2548788|P1|NOT COMPLETED|Overall Study||1
1049957|NCT00808444|2548787|P2|COMPLETED|Overall Study||232
1049958|NCT00808444|2548788|P1|COMPLETED|Overall Study||232
1049959|NCT00808444|2548787|P2|STARTED|Overall Study||233
1049960|NCT00808444|2548788|P1|STARTED|Overall Study||233
1049961|NCT00808470|2548828|P2|NOT COMPLETED|Overall Study||0
1049962|NCT00808470|2548829|P1|NOT COMPLETED|Overall Study||2
1049963|NCT00808470|2548828|P2|COMPLETED|Overall Study||35
1049964|NCT00808470|2548829|P1|COMPLETED|Overall Study||35
1049965|NCT00808470|2548828|P2|STARTED|Overall Study||35
1049966|NCT00808470|2548829|P1|STARTED|Overall Study||37
1049967|NCT00808483|2548843|P2|NOT COMPLETED|From 5 Months to 12 Months||0
1049968|NCT00808483|2548844|P1|NOT COMPLETED|From 5 Months to 12 Months||1
1049969|NCT00808483|2548843|P2|COMPLETED|From 5 Months to 12 Months||32
1049970|NCT00808483|2548844|P1|COMPLETED|From 5 Months to 12 Months||32
1049971|NCT00808483|2548843|P2|STARTED|From 5 Months to 12 Months||32
1049972|NCT00808483|2548844|P1|STARTED|From 5 Months to 12 Months||33
1049973|NCT00808483|2548843|P2|NOT COMPLETED|From 3 to 5 Months After Surgery||1
1049974|NCT00808483|2548844|P1|NOT COMPLETED|From 3 to 5 Months After Surgery||2
1049975|NCT00808483|2548843|P2|COMPLETED|From 3 to 5 Months After Surgery||32
1049976|NCT00808483|2548844|P1|COMPLETED|From 3 to 5 Months After Surgery||33
1049977|NCT00808483|2548843|P2|STARTED|From 3 to 5 Months After Surgery||33
1049978|NCT00808483|2548844|P1|STARTED|From 3 to 5 Months After Surgery||35
1049979|NCT00808509|2548866|P2|NOT COMPLETED|Observation Phase||0
1049980|NCT00808509|2548867|P1|NOT COMPLETED|Observation Phase||0
1049981|NCT00808509|2548866|P2|COMPLETED|Observation Phase||15
1049982|NCT00808509|2548867|P1|COMPLETED|Observation Phase||16
1049983|NCT00808509|2548866|P2|STARTED|Observation Phase|The observation phase was open to all participants|15
1049984|NCT00808509|2548867|P1|STARTED|Observation Phase|The observation phase was open to all participants|16
1049985|NCT00808509|2548866|P2|NOT COMPLETED|Randomized Phase||5
1049986|NCT00808509|2548867|P1|NOT COMPLETED|Randomized Phase||2
1049987|NCT00808509|2548866|P2|COMPLETED|Randomized Phase|Includes participants who received rescue therapy & follow-up for 12 weeks|11
1049988|NCT00808509|2548867|P1|COMPLETED|Randomized Phase||15
1049989|NCT00808509|2548866|P2|Received Rescue Therapy|Randomized Phase||9
1049990|NCT00808509|2548867|P1|Received Rescue Therapy|Randomized Phase||0
1049991|NCT00808509|2548866|P2|STARTED|Randomized Phase||16
1049992|NCT00808509|2548867|P1|STARTED|Randomized Phase||17
1049993|NCT00808639|2548963|P1|NOT COMPLETED|Overall Study||1
1049994|NCT00808639|2548963|P1|COMPLETED|Overall Study|One patient went off treatment due to disease progression before surgery.|38
1049995|NCT00808639|2548963|P1|STARTED|Overall Study||39
1049996|NCT00808769|2548969|P2|NOT COMPLETED|Second Intervention||0
1049997|NCT00808769|2548970|P1|NOT COMPLETED|Second Intervention||0
1049998|NCT00808769|2548969|P2|COMPLETED|Second Intervention||15
1049999|NCT00808769|2548970|P1|COMPLETED|Second Intervention||15
1050000|NCT00808769|2548969|P2|STARTED|Second Intervention||15
1050001|NCT00808769|2548970|P1|STARTED|Second Intervention||15
1050002|NCT00808769|2548969|P2|NOT COMPLETED|First Intervention||0
1050003|NCT00808769|2548970|P1|NOT COMPLETED|First Intervention||0
1050004|NCT00808769|2548969|P2|COMPLETED|First Intervention||15
1050005|NCT00808769|2548970|P1|COMPLETED|First Intervention||15
1050006|NCT00808769|2548969|P2|STARTED|First Intervention||15
1050007|NCT00808769|2548970|P1|STARTED|First Intervention||15
1050008|NCT00808808|2548979|P3|NOT COMPLETED|Overall Study||2557
1050009|NCT00808808|2548980|P2|NOT COMPLETED|Overall Study||2437
1050010|NCT00808808|2548981|P1|NOT COMPLETED|Overall Study||2817
1050011|NCT00808808|2548979|P3|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1830
1050012|NCT00808808|2548980|P2|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1320
1050013|NCT00808808|2548981|P1|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1261
1050014|NCT00808808|2548979|P3|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|2132
1050015|NCT00808808|2548980|P2|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1489
1050016|NCT00808808|2548981|P1|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1392
1050017|NCT00808808|2548979|P3|STARTED|Overall Study|Started includes all employees at participating sites.|4387
1050018|NCT00808808|2548980|P2|STARTED|Overall Study|Started includes all employees at participating sites|3757
1050019|NCT00808808|2548981|P1|STARTED|Overall Study|Started includes all employees at participating sites.|4078
1050020|NCT00808834|2549007|P2|NOT COMPLETED|Period 2||0
1050021|NCT00808834|2549008|P1|NOT COMPLETED|Period 2||0
1050022|NCT00808834|2549007|P2|COMPLETED|Period 2||99
1050023|NCT00808834|2549008|P1|COMPLETED|Period 2||97
1050024|NCT00808834|2549007|P2|STARTED|Period 2||99
1050025|NCT00808834|2549008|P1|STARTED|Period 2||97
1050026|NCT00808834|2549007|P2|NOT COMPLETED|Period 1||0
1050027|NCT00808834|2549008|P1|NOT COMPLETED|Period 1||0
1050028|NCT00808834|2549007|P2|COMPLETED|Period 1||99
1050029|NCT00808834|2549008|P1|COMPLETED|Period 1||97
1050030|NCT00808834|2549007|P2|STARTED|Period 1||99
1050031|NCT00808834|2549008|P1|STARTED|Period 1||97
1050032|NCT00808899|2549014|P1|NOT COMPLETED|Overall Study||4
1050033|NCT00808899|2549014|P1|COMPLETED|Overall Study||0
1050034|NCT00808899|2549014|P1|STARTED|Overall Study||4
1050035|NCT00809055|2549020|P2|NOT COMPLETED|Overall Study||7
1050036|NCT00809055|2549021|P1|NOT COMPLETED|Overall Study||9
1050037|NCT00809055|2549020|P2|COMPLETED|Overall Study||30
1050038|NCT00809055|2549021|P1|COMPLETED|Overall Study||28
1050039|NCT00809055|2549020|P2|STARTED|Overall Study||37
1050040|NCT00809055|2549021|P1|STARTED|Overall Study||37
1050041|NCT00809094|2549047|P2|NOT COMPLETED|Overall Study||1
1050042|NCT00809094|2549048|P1|NOT COMPLETED|Overall Study||0
1050043|NCT00809094|2549047|P2|COMPLETED|Overall Study||33
1050044|NCT00809094|2549048|P1|COMPLETED|Overall Study||36
1050045|NCT00809094|2549047|P2|STARTED|Overall Study||34
1050046|NCT00809094|2549048|P1|STARTED|Overall Study||36
1050047|NCT00809133|2549080|P14|NOT COMPLETED|Overall Study||7
1050048|NCT00809133|2549081|P13|NOT COMPLETED|Overall Study||5
1050049|NCT00809133|2549082|P12|NOT COMPLETED|Overall Study||8
1050050|NCT00809133|2549083|P11|NOT COMPLETED|Overall Study||6
1050051|NCT00809133|2549084|P10|NOT COMPLETED|Overall Study||9
1050052|NCT00809133|2549085|P9|NOT COMPLETED|Overall Study||3
1050053|NCT00809133|2549086|P8|NOT COMPLETED|Overall Study||8
1050054|NCT00809133|2549087|P7|NOT COMPLETED|Overall Study||6
1050055|NCT00809133|2549088|P6|NOT COMPLETED|Overall Study||7
1050056|NCT00809133|2549089|P5|NOT COMPLETED|Overall Study||5
1050057|NCT00809133|2549090|P4|NOT COMPLETED|Overall Study||3
1050058|NCT00809133|2549091|P3|NOT COMPLETED|Overall Study||6
1050059|NCT00809133|2549092|P2|NOT COMPLETED|Overall Study||7
1050060|NCT00809133|2549093|P1|NOT COMPLETED|Overall Study||3
1050061|NCT00809133|2549080|P14|COMPLETED|Overall Study||0
1050062|NCT00809133|2549081|P13|COMPLETED|Overall Study||0
1050063|NCT00809133|2549082|P12|COMPLETED|Overall Study||0
1050064|NCT00809133|2549083|P11|COMPLETED|Overall Study||0
1050065|NCT00809133|2549084|P10|COMPLETED|Overall Study||0
1050066|NCT00809133|2549085|P9|COMPLETED|Overall Study||0
1050067|NCT00809133|2549086|P8|COMPLETED|Overall Study||0
1050068|NCT00809133|2549087|P7|COMPLETED|Overall Study||0
1050069|NCT00809133|2549088|P6|COMPLETED|Overall Study||0
1050070|NCT00809133|2549089|P5|COMPLETED|Overall Study||0
1050071|NCT00809133|2549090|P4|COMPLETED|Overall Study||0
1050072|NCT00809133|2549091|P3|COMPLETED|Overall Study||0
1050073|NCT00809133|2549092|P2|COMPLETED|Overall Study||0
1050074|NCT00809133|2549093|P1|COMPLETED|Overall Study||0
1050075|NCT00809133|2549080|P14|STARTED|Overall Study||7
1050076|NCT00809133|2549081|P13|STARTED|Overall Study||5
1050077|NCT00809133|2549082|P12|STARTED|Overall Study||8
1050078|NCT00809133|2549083|P11|STARTED|Overall Study||6
1050079|NCT00809133|2549084|P10|STARTED|Overall Study||9
1050080|NCT00809133|2549085|P9|STARTED|Overall Study||3
1050081|NCT00809133|2549086|P8|STARTED|Overall Study||8
1050082|NCT00809133|2549087|P7|STARTED|Overall Study||6
1050083|NCT00809133|2549088|P6|STARTED|Overall Study||7
1050084|NCT00809133|2549089|P5|STARTED|Overall Study||5
1050085|NCT00809133|2549090|P4|STARTED|Overall Study||3
1050086|NCT00809133|2549091|P3|STARTED|Overall Study||6
1050087|NCT00809133|2549092|P2|STARTED|Overall Study||7
1050088|NCT00809133|2549093|P1|STARTED|Overall Study||3
1050089|NCT00809146|2549247|P2|NOT COMPLETED|Overall Study||0
1050090|NCT00809146|2549248|P1|NOT COMPLETED|Overall Study||0
1050091|NCT00809146|2549247|P2|COMPLETED|Overall Study||445
1050092|NCT00809146|2549248|P1|COMPLETED|Overall Study||448
1050093|NCT00809146|2549247|P2|STARTED|Overall Study||445
1050094|NCT00809146|2549248|P1|STARTED|Overall Study||448
1050095|NCT00809159|2549276|P6|NOT COMPLETED|Part 1 and 2||3
1050096|NCT00809159|2549277|P5|NOT COMPLETED|Part 1 and 2||6
1050097|NCT00809159|2549278|P4|NOT COMPLETED|Part 1 and 2||5
1050098|NCT00809159|2549279|P3|NOT COMPLETED|Part 1 and 2||10
1050099|NCT00809159|2549280|P2|NOT COMPLETED|Part 1 and 2||0
1050100|NCT00809159|2549281|P1|NOT COMPLETED|Part 1 and 2||0
1050101|NCT00809159|2549276|P6|COMPLETED|Part 1 and 2||3
1050102|NCT00809159|2549277|P5|COMPLETED|Part 1 and 2||6
1050103|NCT00809159|2549278|P4|COMPLETED|Part 1 and 2||7
1050104|NCT00809159|2549279|P3|COMPLETED|Part 1 and 2||20
1050105|NCT00809159|2549280|P2|COMPLETED|Part 1 and 2||0
1050106|NCT00809159|2549281|P1|COMPLETED|Part 1 and 2||0
1050107|NCT00809159|2549276|P6|PD Analysis Set|Part 1 and 2||6
1050108|NCT00809159|2549277|P5|PD Analysis Set|Part 1 and 2||12
1050109|NCT00809159|2549278|P4|PD Analysis Set|Part 1 and 2||12
1050110|NCT00809159|2549279|P3|PD Analysis Set|Part 1 and 2||28
1050111|NCT00809159|2549280|P2|PD Analysis Set|Part 1 and 2||0
1050112|NCT00809159|2549281|P1|PD Analysis Set|Part 1 and 2||0
1050113|NCT00809159|2549276|P6|PK Analysis Set|Part 1 and 2||6
1050114|NCT00809159|2549277|P5|PK Analysis Set|Part 1 and 2||12
1050115|NCT00809159|2549278|P4|PK Analysis Set|Part 1 and 2||12
1050116|NCT00809159|2549279|P3|PK Analysis Set|Part 1 and 2||30
1050117|NCT00809159|2549280|P2|PK Analysis Set|Part 1 and 2||0
1050118|NCT00809159|2549281|P1|PK Analysis Set|Part 1 and 2||0
1050119|NCT00809159|2549276|P6|STARTED|Part 1 and 2||6
1050120|NCT00809159|2549277|P5|STARTED|Part 1 and 2||12
1050121|NCT00809159|2549278|P4|STARTED|Part 1 and 2||12
1050122|NCT00809159|2549279|P3|STARTED|Part 1 and 2||30
1050123|NCT00809159|2549280|P2|STARTED|Part 1 and 2||0
1050124|NCT00809159|2549281|P1|STARTED|Part 1 and 2||0
1050125|NCT00809159|2549276|P6|NOT COMPLETED|Part 1||0
1050126|NCT00809159|2549277|P5|NOT COMPLETED|Part 1||0
1050127|NCT00809159|2549278|P4|NOT COMPLETED|Part 1||0
1050128|NCT00809159|2549279|P3|NOT COMPLETED|Part 1||0
1050129|NCT00809159|2549280|P2|NOT COMPLETED|Part 1||3
1050130|NCT00809159|2549281|P1|NOT COMPLETED|Part 1||8
1050131|NCT00809159|2549276|P6|COMPLETED|Part 1||0
1050132|NCT00809159|2549277|P5|COMPLETED|Part 1||0
1050133|NCT00809159|2549278|P4|COMPLETED|Part 1||0
1050134|NCT00809159|2549279|P3|COMPLETED|Part 1||0
1050135|NCT00809159|2549280|P2|COMPLETED|Part 1||3
1050136|NCT00809159|2549281|P1|COMPLETED|Part 1||16
1050137|NCT00809159|2549276|P6|PD Analysis Set|Part 1||0
1050138|NCT00809159|2549277|P5|PD Analysis Set|Part 1||0
1050139|NCT00809159|2549278|P4|PD Analysis Set|Part 1||0
1050140|NCT00809159|2549279|P3|PD Analysis Set|Part 1||0
1050141|NCT00809159|2549280|P2|PD Analysis Set|Part 1||6
1050142|NCT00809159|2549281|P1|PD Analysis Set|Part 1||23
1050143|NCT00809159|2549276|P6|PK Analysis Set|Part 1||0
1050144|NCT00809159|2549277|P5|PK Analysis Set|Part 1||0
1050145|NCT00809159|2549278|P4|PK Analysis Set|Part 1||0
1050146|NCT00809159|2549279|P3|PK Analysis Set|Part 1||0
1050147|NCT00809159|2549280|P2|PK Analysis Set|Part 1||6
1050148|NCT00809159|2549281|P1|PK Analysis Set|Part 1||24
1050149|NCT00809159|2549276|P6|STARTED|Part 1||0
1050150|NCT00809159|2549277|P5|STARTED|Part 1||0
1050151|NCT00809159|2549278|P4|STARTED|Part 1||0
1050152|NCT00809159|2549279|P3|STARTED|Part 1||0
1050153|NCT00809159|2549280|P2|STARTED|Part 1||6
1050154|NCT00809159|2549281|P1|STARTED|Part 1||24
1050155|NCT00809185|2549345|P1|NOT COMPLETED|Overall Study||0
1050156|NCT00809185|2549345|P1|COMPLETED|Overall Study||7
1050157|NCT00809185|2549345|P1|STARTED|Overall Study||7
1050158|NCT00809276|2549349|P1|NOT COMPLETED|Overall Study||0
1050159|NCT00809276|2549349|P1|COMPLETED|Overall Study||92
1050160|NCT00809276|2549349|P1|STARTED|Overall Study||92
1050161|NCT00809328|2549353|P1|NOT COMPLETED|Overall Study||29
1050162|NCT00809328|2549353|P1|COMPLETED|Overall Study||73
1050163|NCT00809328|2549353|P1|STARTED|Overall Study||102
1050164|NCT00809445|2549364|P3|NOT COMPLETED|6 Month Follow-up||24
1050165|NCT00809445|2549365|P2|NOT COMPLETED|6 Month Follow-up||23
1050166|NCT00809445|2549366|P1|NOT COMPLETED|6 Month Follow-up||24
1050167|NCT00809445|2549364|P3|COMPLETED|6 Month Follow-up||395
1050168|NCT00809445|2549365|P2|COMPLETED|6 Month Follow-up||410
1050169|NCT00809445|2549366|P1|COMPLETED|6 Month Follow-up||405
1050170|NCT00809445|2549364|P3|STARTED|6 Month Follow-up||419
1050171|NCT00809445|2549365|P2|STARTED|6 Month Follow-up||433
1050172|NCT00809445|2549366|P1|STARTED|6 Month Follow-up||429
1050173|NCT00809445|2549364|P3|NOT COMPLETED|1 Month Follow-up||4
1050174|NCT00809445|2549365|P2|NOT COMPLETED|1 Month Follow-up||4
1050175|NCT00809445|2549366|P1|NOT COMPLETED|1 Month Follow-up||2
1050176|NCT00809445|2549364|P3|COMPLETED|1 Month Follow-up||415
1050177|NCT00809445|2549365|P2|COMPLETED|1 Month Follow-up||429
1050178|NCT00809445|2549366|P1|COMPLETED|1 Month Follow-up||427
1050179|NCT00809445|2549364|P3|STARTED|1 Month Follow-up||419
1050180|NCT00809445|2549365|P2|STARTED|1 Month Follow-up||433
1050181|NCT00809445|2549366|P1|STARTED|1 Month Follow-up||429
1050182|NCT00809458|2549385|P2|NOT COMPLETED|Overall Study||1
1050183|NCT00809458|2549386|P1|NOT COMPLETED|Overall Study||1
1050184|NCT00809458|2549385|P2|COMPLETED|Overall Study||5
1050185|NCT00809458|2549386|P1|COMPLETED|Overall Study||8
1050186|NCT00809458|2549385|P2|STARTED|Overall Study||6
1050187|NCT00809458|2549386|P1|STARTED|Overall Study||9
1050188|NCT00809471|2549399|P3|NOT COMPLETED|Overall Study||17
1050189|NCT00809471|2549400|P2|NOT COMPLETED|Overall Study||20
1050190|NCT00809471|2549401|P1|NOT COMPLETED|Overall Study||20
1050191|NCT00809471|2549399|P3|COMPLETED|Overall Study||114
1050192|NCT00809471|2549400|P2|COMPLETED|Overall Study||109
1050193|NCT00809471|2549401|P1|COMPLETED|Overall Study||110
1050194|NCT00809471|2549399|P3|STARTED|Overall Study||131
1050195|NCT00809471|2549400|P2|STARTED|Overall Study||129
1050196|NCT00809471|2549401|P1|STARTED|Overall Study||130
1050197|NCT00809523|2549417|P2|NOT COMPLETED|Overall Study||4
1050198|NCT00809523|2549418|P1|NOT COMPLETED|Overall Study||7
1050199|NCT00809523|2549417|P2|COMPLETED|Overall Study||48
1050200|NCT00809523|2549418|P1|COMPLETED|Overall Study||47
1050201|NCT00809523|2549417|P2|STARTED|Overall Study||52
1050202|NCT00809523|2549418|P1|STARTED|Overall Study||54
1050203|NCT00809614|2549430|P2|NOT COMPLETED|Overall Study||4
1050204|NCT00809614|2549431|P1|NOT COMPLETED|Overall Study||3
1050205|NCT00809614|2549430|P2|COMPLETED|Overall Study||10
1050206|NCT00809614|2549431|P1|COMPLETED|Overall Study||25
1050207|NCT00809614|2549430|P2|Pharmacodynamic (PD) Set|Overall Study||13
1050208|NCT00809614|2549431|P1|Pharmacodynamic (PD) Set|Overall Study||24
1050209|NCT00809614|2549430|P2|Pharmacokinetic Safety Set|Overall Study||14
1050210|NCT00809614|2549431|P1|Pharmacokinetic Safety Set|Overall Study||27
1050211|NCT00809614|2549430|P2|STARTED|Overall Study||14
1050212|NCT00809614|2549431|P1|STARTED|Overall Study||28
1050213|NCT00809757|2549462|P3|NOT COMPLETED|Overall Study||11
1050214|NCT00809757|2549463|P2|NOT COMPLETED|Overall Study||5
1050215|NCT00809757|2549464|P1|NOT COMPLETED|Overall Study||6
1050216|NCT00809757|2549462|P3|COMPLETED|Overall Study||53
1050217|NCT00809757|2549463|P2|COMPLETED|Overall Study||60
1050218|NCT00809757|2549464|P1|COMPLETED|Overall Study||62
1050219|NCT00809757|2549462|P3|STARTED|Overall Study||64
1050220|NCT00809757|2549463|P2|STARTED|Overall Study||65
1050221|NCT00809757|2549464|P1|STARTED|Overall Study||68
1050222|NCT00809809|2549549|P2|NOT COMPLETED|Overall Study||2
1050223|NCT00809809|2549550|P1|NOT COMPLETED|Overall Study||3
1050224|NCT00809809|2549549|P2|COMPLETED|Overall Study|2 dropped from the study when it was discovered they met the exclusion criteria|77
1050225|NCT00809809|2549550|P1|COMPLETED|Overall Study|3 dropped from the study when it was discovered they met the exclusion criteria|75
1050226|NCT00809809|2549549|P2|STARTED|Overall Study||79
1050227|NCT00809809|2549550|P1|STARTED|Overall Study||78
1050228|NCT00809835|2549560|P4|NOT COMPLETED|Overall Study||2
1050229|NCT00809835|2549561|P3|NOT COMPLETED|Overall Study||11
1050230|NCT00809835|2549562|P2|NOT COMPLETED|Overall Study||7
1050231|NCT00809835|2549563|P1|NOT COMPLETED|Overall Study||8
1050232|NCT00809835|2549560|P4|COMPLETED|Overall Study||25
1050233|NCT00809835|2549561|P3|COMPLETED|Overall Study||27
1050234|NCT00809835|2549562|P2|COMPLETED|Overall Study||20
1050235|NCT00809835|2549563|P1|COMPLETED|Overall Study||20
1050236|NCT00809835|2549560|P4|STARTED|Overall Study||27
1050237|NCT00809835|2549561|P3|STARTED|Overall Study||38
1050238|NCT00809835|2549562|P2|STARTED|Overall Study||27
1050239|NCT00809835|2549563|P1|STARTED|Overall Study||28
1050240|NCT00809848|2549586|P5|NOT COMPLETED|Overall Study||3
1050241|NCT00809848|2549587|P4|NOT COMPLETED|Overall Study||1
1050242|NCT00809848|2549588|P3|NOT COMPLETED|Overall Study||0
1050243|NCT00809848|2549589|P2|NOT COMPLETED|Overall Study||0
1050244|NCT00809848|2549590|P1|NOT COMPLETED|Overall Study||0
1050245|NCT00809848|2549586|P5|COMPLETED|Overall Study||34
1050246|NCT00809848|2549587|P4|COMPLETED|Overall Study||30
1050247|NCT00809848|2549588|P3|COMPLETED|Overall Study||34
1050248|NCT00809848|2549589|P2|COMPLETED|Overall Study||34
1050249|NCT00809848|2549590|P1|COMPLETED|Overall Study||36
1050250|NCT00809848|2549586|P5|STARTED|Overall Study||37
1050251|NCT00809848|2549587|P4|STARTED|Overall Study||31
1050252|NCT00809848|2549588|P3|STARTED|Overall Study||34
1050253|NCT00809848|2549589|P2|STARTED|Overall Study||34
1050254|NCT00809848|2549590|P1|STARTED|Overall Study||36
1050255|NCT00809926|2549609|P2|NOT COMPLETED|Overall Study||23
1050256|NCT00809926|2549610|P1|NOT COMPLETED|Overall Study||31
1050257|NCT00809926|2549609|P2|COMPLETED|Overall Study||196
1050258|NCT00809926|2549610|P1|COMPLETED|Overall Study||201
1050259|NCT00809926|2549609|P2|STARTED|Overall Study||219
1050260|NCT00809926|2549610|P1|STARTED|Overall Study||232
1050261|NCT00809965|2549637|P3|NOT COMPLETED|Overall Study||844
1050262|NCT00809965|2549638|P2|NOT COMPLETED|Overall Study||775
1050263|NCT00809965|2549639|P1|NOT COMPLETED|Overall Study||783
1050264|NCT00809965|2549637|P3|COMPLETED|Overall Study||4332
1050265|NCT00809965|2549638|P2|COMPLETED|Overall Study||4399
1050266|NCT00809965|2549639|P1|COMPLETED|Overall Study||4393
1050267|NCT00809965|2549637|P3|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5115
1050268|NCT00809965|2549638|P2|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5114
1050269|NCT00809965|2549639|P1|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5113
1050270|NCT00809965|2549637|P3|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5110
1050271|NCT00809965|2549638|P2|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5115
1050272|NCT00809965|2549639|P1|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5125
1050273|NCT00809965|2549637|P3|STARTED|Overall Study||5176
1050274|NCT00809965|2549638|P2|STARTED|Overall Study||5174
1050275|NCT00809965|2549639|P1|STARTED|Overall Study||5176
1050276|NCT00810043|2549661|P3|NOT COMPLETED|Overall Study||8
1050277|NCT00810043|2549662|P2|NOT COMPLETED|Overall Study||1
1050278|NCT00810043|2549663|P1|NOT COMPLETED|Overall Study||4
1050279|NCT00810043|2549661|P3|COMPLETED|Overall Study||0
1050280|NCT00810043|2549662|P2|COMPLETED|Overall Study||54
1050281|NCT00810043|2549663|P1|COMPLETED|Overall Study||53
1050282|NCT00810043|2549661|P3|STARTED|Overall Study||8
1050283|NCT00810043|2549662|P2|STARTED|Overall Study||55
1050284|NCT00810043|2549663|P1|STARTED|Overall Study||57
1050285|NCT00810069|2549684|P3|NOT COMPLETED|Double-Blind Period II||72
1050286|NCT00810069|2549685|P2|NOT COMPLETED|Double-Blind Period II||56
1050287|NCT00810069|2549686|P1|NOT COMPLETED|Double-Blind Period II||0
1050288|NCT00810069|2549684|P3|COMPLETED|Double-Blind Period II||212
1050289|NCT00810069|2549685|P2|COMPLETED|Double-Blind Period II||226
1050290|NCT00810069|2549686|P1|COMPLETED|Double-Blind Period II||0
1050291|NCT00810069|2549684|P3|STARTED|Double-Blind Period II|At Week 8 - delayed intervention divided by response to treatment (nonresponders or responders).|284
1050292|NCT00810069|2549685|P2|STARTED|Double-Blind Period II||282
1050293|NCT00810069|2549686|P1|STARTED|Double-Blind Period II||0
1050294|NCT00810069|2549684|P3|NOT COMPLETED|Lead-in Period I||0
1050295|NCT00810069|2549685|P2|NOT COMPLETED|Lead-in Period I||0
1050296|NCT00810069|2549686|P1|NOT COMPLETED|Lead-in Period I||274
1050297|NCT00810069|2549684|P3|COMPLETED|Lead-in Period I||0
1050298|NCT00810069|2549685|P2|COMPLETED|Lead-in Period I||0
1050299|NCT00810069|2549686|P1|COMPLETED|Lead-in Period I||566
1050300|NCT00810069|2549684|P3|STARTED|Lead-in Period I||0
1050301|NCT00810069|2549685|P2|STARTED|Lead-in Period I||0
1050302|NCT00810069|2549686|P1|STARTED|Lead-in Period I||840
1050303|NCT00810082|2549731|P2|NOT COMPLETED|Overall Study||4
1050304|NCT00810082|2549732|P1|NOT COMPLETED|Overall Study||0
1050305|NCT00810082|2549731|P2|COMPLETED|Overall Study||27
1050306|NCT00810082|2549732|P1|COMPLETED|Overall Study||34
1050307|NCT00810082|2549731|P2|STARTED|Overall Study||31
1050308|NCT00810082|2549732|P1|STARTED|Overall Study||34
1050309|NCT00810095|2549738|P1|NOT COMPLETED|Overall Study||0
1050310|NCT00810095|2549738|P1|COMPLETED|Overall Study||40
1050311|NCT00810095|2549738|P1|STARTED|Overall Study||40
1050312|NCT00810108|2549747|P2|NOT COMPLETED|Overall Study||0
1050313|NCT00810108|2549748|P1|NOT COMPLETED|Overall Study||1
1050314|NCT00810108|2549747|P2|COMPLETED|Overall Study||7
1050315|NCT00810108|2549748|P1|COMPLETED|Overall Study||5
1050316|NCT00810108|2549747|P2|STARTED|Overall Study||7
1050317|NCT00810108|2549748|P1|STARTED|Overall Study||6
1050318|NCT00810199|2549755|P2|NOT COMPLETED|Overall Study||82
1050319|NCT00810199|2549756|P1|NOT COMPLETED|Overall Study||59
1050320|NCT00810199|2549755|P2|COMPLETED|Overall Study|Completed=Completed Treatment|195
1050321|NCT00810199|2549756|P1|COMPLETED|Overall Study||220
1050322|NCT00810199|2549755|P2|Completed Week 104|Overall Study||201
1050323|NCT00810199|2549756|P1|Completed Week 104|Overall Study||222
1050324|NCT00810199|2549755|P2|Completed Week 52|Overall Study||229
1050325|NCT00810199|2549756|P1|Completed Week 52|Overall Study||243
1050326|NCT00810199|2549755|P2|Completed Week 24|Overall Study||250
1050327|NCT00810199|2549756|P1|Completed Week 24|Overall Study||259
1050328|NCT00810199|2549755|P2|Received Study Drug|Overall Study||276
1050329|NCT00810199|2549756|P1|Received Study Drug|Overall Study||277
1050330|NCT00810199|2549755|P2|STARTED|Overall Study||277
1050331|NCT00810199|2549756|P1|STARTED|Overall Study||279
1050332|NCT00810277|2549832|P1|NOT COMPLETED|Overall Study||1
1050333|NCT00810277|2549832|P1|COMPLETED|Overall Study||13
1050334|NCT00810277|2549832|P1|STARTED|Overall Study||14
1050335|NCT00810303|2549845|P1|NOT COMPLETED|Ezetimibe and Efavirenz - Day 21-30||0
1050336|NCT00810303|2549845|P1|COMPLETED|Ezetimibe and Efavirenz - Day 21-30||12
1050337|NCT00810303|2549845|P1|STARTED|Ezetimibe and Efavirenz - Day 21-30||12
1050338|NCT00810303|2549845|P1|NOT COMPLETED|Ezetimibe and Efavirenz - Day 16-20||0
1050339|NCT00810303|2549845|P1|COMPLETED|Ezetimibe and Efavirenz - Day 16-20||12
1050340|NCT00810303|2549845|P1|STARTED|Ezetimibe and Efavirenz - Day 16-20||12
1050341|NCT00810303|2549845|P1|NOT COMPLETED|Ezetimibe Alone - Day 6-15||0
1050342|NCT00810303|2549845|P1|COMPLETED|Ezetimibe Alone - Day 6-15||12
1050343|NCT00810303|2549845|P1|STARTED|Ezetimibe Alone - Day 6-15||12
1050344|NCT00810303|2549845|P1|NOT COMPLETED|Efavirenz Alone - Day 1-5||0
1050345|NCT00810303|2549845|P1|COMPLETED|Efavirenz Alone - Day 1-5||12
1050346|NCT00810303|2549845|P1|STARTED|Efavirenz Alone - Day 1-5||12
1050347|NCT00810342|2549872|P2|NOT COMPLETED|12-month Followup||11
1050348|NCT00810342|2549873|P1|NOT COMPLETED|12-month Followup||12
1050349|NCT00810342|2549872|P2|COMPLETED|12-month Followup||136
1050350|NCT00810342|2549873|P1|COMPLETED|12-month Followup||113
1050351|NCT00810342|2549872|P2|STARTED|12-month Followup||147
1050352|NCT00810342|2549873|P1|STARTED|12-month Followup||125
1050353|NCT00810342|2549872|P2|NOT COMPLETED|6-month Follow-up||8
1050354|NCT00810342|2549873|P1|NOT COMPLETED|6-month Follow-up||24
1050355|NCT00810342|2549872|P2|COMPLETED|6-month Follow-up||147
1050356|NCT00810342|2549873|P1|COMPLETED|6-month Follow-up||125
1050357|NCT00810342|2549872|P2|STARTED|6-month Follow-up||155
1050358|NCT00810342|2549873|P1|STARTED|6-month Follow-up||149
1050359|NCT00810342|2549872|P2|NOT COMPLETED|Month 1 Follow-up||2
1050360|NCT00810342|2549873|P1|NOT COMPLETED|Month 1 Follow-up||5
1050361|NCT00810342|2549872|P2|COMPLETED|Month 1 Follow-up||155
1050362|NCT00810342|2549873|P1|COMPLETED|Month 1 Follow-up||149
1050363|NCT00810342|2549872|P2|STARTED|Month 1 Follow-up||157
1050364|NCT00810342|2549873|P1|STARTED|Month 1 Follow-up||154
1050365|NCT00810355|2549884|P3|NOT COMPLETED|Overall Study||11
1050366|NCT00810355|2549885|P2|NOT COMPLETED|Overall Study||17
1050367|NCT00810355|2549886|P1|NOT COMPLETED|Overall Study||14
1050368|NCT00810355|2549884|P3|COMPLETED|Overall Study||14
1050369|NCT00810355|2549885|P2|COMPLETED|Overall Study||8
1050370|NCT00810355|2549886|P1|COMPLETED|Overall Study||11
1050371|NCT00810355|2549884|P3|STARTED|Overall Study||25
1050372|NCT00810355|2549885|P2|STARTED|Overall Study||25
1050373|NCT00810355|2549886|P1|STARTED|Overall Study||25
1050374|NCT00810368|2549902|P2|NOT COMPLETED|Overall Study||2
1050375|NCT00810368|2549903|P1|NOT COMPLETED|Overall Study||6
1050376|NCT00810368|2549902|P2|COMPLETED|Overall Study||13
1050377|NCT00810368|2549903|P1|COMPLETED|Overall Study||12
1050378|NCT00810368|2549902|P2|STARTED|Overall Study||15
1050379|NCT00810368|2549903|P1|STARTED|Overall Study||18
1050380|NCT00810394|2549921|P1|NOT COMPLETED|Overall Study||3
1050381|NCT00810394|2549921|P1|COMPLETED|Overall Study||47
1050382|NCT00810394|2549921|P1|Cycle 3 400mg Twice Daily|Overall Study||5
1050383|NCT00810394|2549921|P1|Cycle 3 800 mg Twice Daily|Overall Study||4
1050384|NCT00810394|2549921|P1|Cycle 2 400mg Once Daily|Overall Study||22
1050385|NCT00810394|2549921|P1|Cycle 2 600mg Twice Daily|Overall Study||13
1050386|NCT00810394|2549921|P1|STARTED|Overall Study||50
1050387|NCT00810511|2549929|P2|NOT COMPLETED|Overall Study||4
1050388|NCT00810511|2549930|P1|NOT COMPLETED|Overall Study||10
1050389|NCT00810511|2549929|P2|COMPLETED|Overall Study||102
1050390|NCT00810511|2549930|P1|COMPLETED|Overall Study||97
1050391|NCT00810511|2549929|P2|STARTED|Overall Study||106
1050392|NCT00810511|2549930|P1|STARTED|Overall Study||107
1050393|NCT00810576|2549936|P1|NOT COMPLETED|Overall Study||0
1050394|NCT00810576|2549936|P1|COMPLETED|Overall Study||1
1050395|NCT00810576|2549936|P1|STARTED|Overall Study||1
1050396|NCT00810602|2549940|P2|NOT COMPLETED|Overall Study||3
1050397|NCT00810602|2549941|P1|NOT COMPLETED|Overall Study||8
1050398|NCT00810602|2549940|P2|COMPLETED|Overall Study||31
1050399|NCT00810602|2549941|P1|COMPLETED|Overall Study||19
1050400|NCT00810602|2549940|P2|STARTED|Overall Study||34
1050401|NCT00810602|2549941|P1|STARTED|Overall Study||27
1050402|NCT00788255|2549948|P1|NOT COMPLETED|Overall Study||0
1050403|NCT00788255|2549948|P1|COMPLETED|Overall Study||25
1050404|NCT00788255|2549948|P1|Oxytocin: 0 μU/mL|Overall Study||25
1050405|NCT00788255|2549948|P1|Oxytocin Infusion 3: 32.9μU/mL|Overall Study||25
1050406|NCT00788255|2549948|P1|Oxytocin Infusion 2: 30.1μU/mL|Overall Study||25
1050407|NCT00788255|2549948|P1|Oxytocin Infusion 1: 22.5 μU/mL|Overall Study||25
1050408|NCT00788255|2549948|P1|STARTED|Overall Study||25
1050409|NCT00788372|2549961|P1|NOT COMPLETED|Period 2 (Week 4 to Week 52)||32
1050410|NCT00788372|2549961|P1|COMPLETED|Period 2 (Week 4 to Week 52)||79
1050411|NCT00788372|2549961|P1|STARTED|Period 2 (Week 4 to Week 52)||111
1050412|NCT00788372|2549961|P1|NOT COMPLETED|Period 1 (up to 4 Weeks)||31
1050413|NCT00788372|2549961|P1|COMPLETED|Period 1 (up to 4 Weeks)||111
1050414|NCT00788372|2549961|P1|STARTED|Period 1 (up to 4 Weeks)||142
1050415|NCT00788593|2549975|P3|NOT COMPLETED|Second Intervention Period||1
1050416|NCT00788593|2549976|P2|NOT COMPLETED|Second Intervention Period||1
1050417|NCT00788593|2549977|P1|NOT COMPLETED|Second Intervention Period||0
1050418|NCT00788593|2549975|P3|COMPLETED|Second Intervention Period||36
1050419|NCT00788593|2549976|P2|COMPLETED|Second Intervention Period||37
1050420|NCT00788593|2549977|P1|COMPLETED|Second Intervention Period||0
1050421|NCT00788593|2549975|P3|STARTED|Second Intervention Period||37
1050422|NCT00788593|2549976|P2|STARTED|Second Intervention Period||38
1050423|NCT00788593|2549977|P1|STARTED|Second Intervention Period||0
1050424|NCT00788593|2549975|P3|NOT COMPLETED|First Intervention Period||0
1050425|NCT00788593|2549976|P2|NOT COMPLETED|First Intervention Period||1
1050426|NCT00788593|2549977|P1|NOT COMPLETED|First Intervention Period||0
1050427|NCT00788593|2549975|P3|COMPLETED|First Intervention Period||37
1050428|NCT00788593|2549976|P2|COMPLETED|First Intervention Period||38
1050429|NCT00788593|2549977|P1|COMPLETED|First Intervention Period||0
1050430|NCT00788593|2549975|P3|STARTED|First Intervention Period||37
1050431|NCT00788593|2549976|P2|STARTED|First Intervention Period||39
1050432|NCT00788593|2549977|P1|STARTED|First Intervention Period||0
1050433|NCT00788593|2549975|P3|NOT COMPLETED|Placebo Run-in Phase||0
1050434|NCT00788593|2549976|P2|NOT COMPLETED|Placebo Run-in Phase||0
1050435|NCT00788593|2549977|P1|NOT COMPLETED|Placebo Run-in Phase||6
1050436|NCT00788593|2549975|P3|COMPLETED|Placebo Run-in Phase||0
1050437|NCT00788593|2549976|P2|COMPLETED|Placebo Run-in Phase||0
1050438|NCT00788593|2549977|P1|COMPLETED|Placebo Run-in Phase||76
1050439|NCT00788593|2549975|P3|STARTED|Placebo Run-in Phase||0
1050440|NCT00788593|2549976|P2|STARTED|Placebo Run-in Phase||0
1050441|NCT00788593|2549977|P1|STARTED|Placebo Run-in Phase||82
1050445|NCT00788710|2550044|P3|NOT COMPLETED|Overall Study||6
1050446|NCT00788710|2550045|P2|NOT COMPLETED|Overall Study||8
1050447|NCT00788710|2550046|P1|NOT COMPLETED|Overall Study||5
1050448|NCT00788710|2550044|P3|COMPLETED|Overall Study||138
1050449|NCT00788710|2550045|P2|COMPLETED|Overall Study||134
1050450|NCT00788710|2550046|P1|COMPLETED|Overall Study||139
1050451|NCT00788710|2550044|P3|STARTED|Overall Study||144
1050452|NCT00788710|2550045|P2|STARTED|Overall Study||142
1050453|NCT00788710|2550046|P1|STARTED|Overall Study||144
1050454|NCT00788775|2550062|P2|NOT COMPLETED|Overall Study||8
1050455|NCT00788775|2550063|P1|NOT COMPLETED|Overall Study||10
1050456|NCT00788775|2550062|P2|COMPLETED|Overall Study||1
1050457|NCT00788775|2550063|P1|COMPLETED|Overall Study||1
1050458|NCT00788775|2550062|P2|Treated|Overall Study||8
1050459|NCT00788775|2550063|P1|Treated|Overall Study||11
1050460|NCT00788775|2550062|P2|STARTED|Overall Study||9
1050461|NCT00788775|2550063|P1|STARTED|Overall Study||11
1050462|NCT00788957|2550079|P6|NOT COMPLETED|Part 3||11
1050463|NCT00788957|2550080|P5|NOT COMPLETED|Part 3||9
1050464|NCT00788957|2550081|P4|NOT COMPLETED|Part 3||0
1050465|NCT00788957|2550082|P3|NOT COMPLETED|Part 3||0
1050466|NCT00788957|2550083|P2|NOT COMPLETED|Part 3||0
1050467|NCT00788957|2550084|P1|NOT COMPLETED|Part 3||0
1050468|NCT00788957|2550079|P6|COMPLETED|Part 3|Completed the safety follow-up visit|1
1050469|NCT00788957|2550080|P5|COMPLETED|Part 3|Completed the safety follow-up visit|4
1050470|NCT00788957|2550081|P4|COMPLETED|Part 3||0
1050471|NCT00788957|2550082|P3|COMPLETED|Part 3||0
1050472|NCT00788957|2550083|P2|COMPLETED|Part 3||0
1050473|NCT00788957|2550084|P1|COMPLETED|Part 3||0
1050474|NCT00788957|2550079|P6|STARTED|Part 3||12
1050475|NCT00788957|2550080|P5|STARTED|Part 3||13
1050476|NCT00788957|2550081|P4|STARTED|Part 3||0
1050477|NCT00788957|2550082|P3|STARTED|Part 3||0
1050478|NCT00788957|2550083|P2|STARTED|Part 3||0
1050479|NCT00788957|2550084|P1|STARTED|Part 3||0
1050480|NCT00788957|2550079|P6|NOT COMPLETED|Part 2||0
1050481|NCT00788957|2550080|P5|NOT COMPLETED|Part 2||0
1050482|NCT00788957|2550081|P4|NOT COMPLETED|Part 2||41
1050483|NCT00788957|2550082|P3|NOT COMPLETED|Part 2||44
1050484|NCT00788957|2550083|P2|NOT COMPLETED|Part 2||42
1050485|NCT00788957|2550084|P1|NOT COMPLETED|Part 2||0
1050486|NCT00788957|2550079|P6|COMPLETED|Part 2||0
1050487|NCT00788957|2550080|P5|COMPLETED|Part 2||0
1050488|NCT00788957|2550081|P4|COMPLETED|Part 2|Completed the safety follow-up visit|5
1050489|NCT00788957|2550082|P3|COMPLETED|Part 2|Completed the safety follow-up visit|4
1050490|NCT00788957|2550083|P2|COMPLETED|Part 2|Completed the safety follow-up visit at the end of the study|6
1050491|NCT00788957|2550084|P1|COMPLETED|Part 2||0
1050492|NCT00788957|2550079|P6|STARTED|Part 2||0
1050493|NCT00788957|2550080|P5|STARTED|Part 2||0
1050494|NCT00788957|2550081|P4|STARTED|Part 2||46
1050495|NCT00788957|2550082|P3|STARTED|Part 2||48
1050496|NCT00788957|2550083|P2|STARTED|Part 2||48
1050497|NCT00788957|2550084|P1|STARTED|Part 2||0
1050498|NCT00788957|2550079|P6|NOT COMPLETED|Part 1||0
1050499|NCT00788957|2550080|P5|NOT COMPLETED|Part 1||0
1050500|NCT00788957|2550081|P4|NOT COMPLETED|Part 1||0
1050501|NCT00788957|2550082|P3|NOT COMPLETED|Part 1||0
1050502|NCT00788957|2550083|P2|NOT COMPLETED|Part 1||0
1050503|NCT00788957|2550084|P1|NOT COMPLETED|Part 1||9
1050504|NCT00788957|2550079|P6|COMPLETED|Part 1||0
1050505|NCT00788957|2550080|P5|COMPLETED|Part 1||0
1050506|NCT00788957|2550081|P4|COMPLETED|Part 1||0
1050507|NCT00788957|2550082|P3|COMPLETED|Part 1||0
1050508|NCT00788957|2550083|P2|COMPLETED|Part 1||0
1050509|NCT00788957|2550084|P1|COMPLETED|Part 1|Completed the safety follow-up visit|2
1050510|NCT00788957|2550079|P6|STARTED|Part 1||0
1050511|NCT00788957|2550080|P5|STARTED|Part 1||0
1050512|NCT00788957|2550081|P4|STARTED|Part 1||0
1050513|NCT00788957|2550082|P3|STARTED|Part 1||0
1050514|NCT00788957|2550083|P2|STARTED|Part 1||0
1050515|NCT00788957|2550084|P1|STARTED|Part 1||11
1050516|NCT00794365|2550138|P1|NOT COMPLETED|Overall Study||79
1050517|NCT00794365|2550138|P1|COMPLETED|Overall Study||251
1050518|NCT00794365|2550138|P1|STARTED|Overall Study||330
1050519|NCT00794469|2550144|P1|NOT COMPLETED|Overall Study||0
1050520|NCT00794469|2550144|P1|COMPLETED|Overall Study||21
1050521|NCT00794469|2550144|P1|STARTED|Overall Study||21
1050522|NCT00794508|2550149|P1|NOT COMPLETED|Overall Study||0
1050523|NCT00794508|2550149|P1|COMPLETED|Overall Study||10
1050524|NCT00794508|2550149|P1|STARTED|Overall Study||10
1050525|NCT00794547|2550155|P2|NOT COMPLETED|Overall Study||0
1050526|NCT00794547|2550156|P1|NOT COMPLETED|Overall Study||0
1050527|NCT00794547|2550155|P2|COMPLETED|Overall Study||16
1050528|NCT00794547|2550156|P1|COMPLETED|Overall Study||18
1050529|NCT00794547|2550155|P2|STARTED|Overall Study||16
1050530|NCT00794547|2550156|P1|STARTED|Overall Study||18
1050531|NCT00794560|2550167|P4|NOT COMPLETED|Overall Study||4
1050532|NCT00794560|2550168|P3|NOT COMPLETED|Overall Study||4
1050533|NCT00794560|2550169|P2|NOT COMPLETED|Overall Study||4
1050534|NCT00794560|2550170|P1|NOT COMPLETED|Overall Study||3
1050535|NCT00794560|2550167|P4|COMPLETED|Overall Study||34
1050536|NCT00794560|2550168|P3|COMPLETED|Overall Study||40
1050537|NCT00794560|2550169|P2|COMPLETED|Overall Study||32
1050538|NCT00794560|2550170|P1|COMPLETED|Overall Study||33
1050539|NCT00794560|2550167|P4|STARTED|Overall Study||38
1050540|NCT00794560|2550168|P3|STARTED|Overall Study||44
1050541|NCT00794560|2550169|P2|STARTED|Overall Study||36
1050542|NCT00794560|2550170|P1|STARTED|Overall Study||36
1050543|NCT00794664|2550186|P2|NOT COMPLETED|Follow-up Period||5
1050544|NCT00794664|2550187|P1|NOT COMPLETED|Follow-up Period||1
1050545|NCT00794664|2550186|P2|COMPLETED|Follow-up Period||28
1050546|NCT00794664|2550187|P1|COMPLETED|Follow-up Period||15
1050547|NCT00794664|2550186|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|33
1050548|NCT00794664|2550187|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|16
1050549|NCT00794664|2550186|P2|NOT COMPLETED|Treatment Period||12
1050550|NCT00794664|2550187|P1|NOT COMPLETED|Treatment Period||1
1050551|NCT00794664|2550186|P2|COMPLETED|Treatment Period|6 participants enrolled in open-label extension study NCT00694109|27
1050552|NCT00794664|2550187|P1|COMPLETED|Treatment Period|3 participants enrolled in open-label extension study NCT00694109|18
1050553|NCT00794664|2550186|P2|STARTED|Treatment Period||39
1050554|NCT00794664|2550187|P1|STARTED|Treatment Period||19
1050555|NCT00794677|2550233|P2|NOT COMPLETED|Second Intervention||0
1050556|NCT00794677|2550234|P1|NOT COMPLETED|Second Intervention||0
1050557|NCT00794677|2550233|P2|COMPLETED|Second Intervention||13
1050558|NCT00794677|2550234|P1|COMPLETED|Second Intervention||11
1050559|NCT00794677|2550233|P2|STARTED|Second Intervention||13
1050560|NCT00794677|2550234|P1|STARTED|Second Intervention||11
1050561|NCT00794677|2550233|P2|NOT COMPLETED|First Intervention||0
1050562|NCT00794677|2550234|P1|NOT COMPLETED|First Intervention||2
1050563|NCT00794677|2550233|P2|COMPLETED|First Intervention||13
1050564|NCT00794677|2550234|P1|COMPLETED|First Intervention||11
1050565|NCT00794677|2550233|P2|STARTED|First Intervention||13
1050566|NCT00794677|2550234|P1|STARTED|First Intervention||13
1050567|NCT00794820|2550254|P1|NOT COMPLETED|Overall Study||16
1050568|NCT00794820|2550254|P1|COMPLETED|Overall Study||50
1050569|NCT00794820|2550254|P1|STARTED|Overall Study||66
1050570|NCT00794924|2550262|P2|NOT COMPLETED|Overall Study||70
1050571|NCT00794924|2550263|P1|NOT COMPLETED|Overall Study||60
1050572|NCT00794924|2550262|P2|COMPLETED|Overall Study||101
1050573|NCT00794924|2550263|P1|COMPLETED|Overall Study||114
1050574|NCT00794924|2550262|P2|STARTED|Overall Study|14 patients refused to start the study|171
1050575|NCT00794924|2550263|P1|STARTED|Overall Study|14 patients refused to start the study|174
1050576|NCT00794963|2550269|P2|NOT COMPLETED|Overall Study||4
1050577|NCT00794963|2550270|P1|NOT COMPLETED|Overall Study||1
1050578|NCT00794963|2550269|P2|COMPLETED|Overall Study||0
1050579|NCT00794963|2550270|P1|COMPLETED|Overall Study||3
1050580|NCT00794963|2550269|P2|STARTED|Overall Study||4
1050581|NCT00794963|2550270|P1|STARTED|Overall Study||4
1050582|NCT00795002|2550278|P2|NOT COMPLETED|Overall Study||2
1050583|NCT00795002|2550279|P1|NOT COMPLETED|Overall Study||2
1050584|NCT00795002|2550278|P2|COMPLETED|Overall Study||37
1050585|NCT00795002|2550279|P1|COMPLETED|Overall Study||37
1050586|NCT00795002|2550278|P2|STARTED|Overall Study||39
1050587|NCT00795002|2550279|P1|STARTED|Overall Study||39
1050588|NCT00795132|2550285|P1|NOT COMPLETED|Overall Study||3
1050589|NCT00795132|2550285|P1|COMPLETED|Overall Study||44
1050590|NCT00795132|2550285|P1|STARTED|Overall Study||47
1050591|NCT00795145|2550299|P7|NOT COMPLETED|Cohort 2||0
1050592|NCT00795145|2550300|P6|NOT COMPLETED|Cohort 2||0
1050593|NCT00795145|2550301|P5|NOT COMPLETED|Cohort 2||0
1050594|NCT00795145|2550302|P4|NOT COMPLETED|Cohort 2||0
1050595|NCT00795145|2550303|P3|NOT COMPLETED|Cohort 2||0
1050596|NCT00795145|2550304|P2|NOT COMPLETED|Cohort 2||0
1050597|NCT00795145|2550305|P1|NOT COMPLETED|Cohort 2||0
1050598|NCT00795145|2550299|P7|COMPLETED|Cohort 2||10
1050599|NCT00795145|2550300|P6|COMPLETED|Cohort 2||10
1050600|NCT00795145|2550301|P5|COMPLETED|Cohort 2||10
1050601|NCT00795145|2550302|P4|COMPLETED|Cohort 2||10
1050602|NCT00795145|2550303|P3|COMPLETED|Cohort 2||0
1050603|NCT00795145|2550304|P2|COMPLETED|Cohort 2||0
1050604|NCT00795145|2550305|P1|COMPLETED|Cohort 2||0
1050605|NCT00795145|2550299|P7|STARTED|Cohort 2||10
1050606|NCT00795145|2550300|P6|STARTED|Cohort 2||10
1050607|NCT00795145|2550301|P5|STARTED|Cohort 2||10
1050608|NCT00795145|2550302|P4|STARTED|Cohort 2||10
1050609|NCT00795145|2550303|P3|STARTED|Cohort 2||0
1050610|NCT00795145|2550304|P2|STARTED|Cohort 2||0
1050611|NCT00795145|2550305|P1|STARTED|Cohort 2||0
1050612|NCT00795145|2550299|P7|NOT COMPLETED|Cohort 1||0
1050613|NCT00795145|2550300|P6|NOT COMPLETED|Cohort 1||0
1050614|NCT00795145|2550301|P5|NOT COMPLETED|Cohort 1||0
1050615|NCT00795145|2550302|P4|NOT COMPLETED|Cohort 1||0
1050616|NCT00795145|2550303|P3|NOT COMPLETED|Cohort 1||0
1050617|NCT00795145|2550304|P2|NOT COMPLETED|Cohort 1||0
1050618|NCT00795145|2550305|P1|NOT COMPLETED|Cohort 1||0
1050619|NCT00795145|2550299|P7|COMPLETED|Cohort 1||0
1050620|NCT00795145|2550300|P6|COMPLETED|Cohort 1||0
1050621|NCT00795145|2550301|P5|COMPLETED|Cohort 1||0
1050622|NCT00795145|2550302|P4|COMPLETED|Cohort 1||0
1050623|NCT00795145|2550303|P3|COMPLETED|Cohort 1||3
1050624|NCT00795145|2550304|P2|COMPLETED|Cohort 1||3
1050625|NCT00795145|2550305|P1|COMPLETED|Cohort 1||3
1050626|NCT00795145|2550299|P7|STARTED|Cohort 1||0
1050627|NCT00795145|2550300|P6|STARTED|Cohort 1||0
1050628|NCT00795145|2550301|P5|STARTED|Cohort 1||0
1050629|NCT00795145|2550302|P4|STARTED|Cohort 1||0
1050630|NCT00795145|2550303|P3|STARTED|Cohort 1||3
1050631|NCT00795145|2550304|P2|STARTED|Cohort 1||3
1050632|NCT00795145|2550305|P1|STARTED|Cohort 1||3
1050633|NCT00795184|2550349|P2|NOT COMPLETED|Overall Study||13
1050634|NCT00795184|2550350|P1|NOT COMPLETED|Overall Study||8
1050635|NCT00795184|2550349|P2|COMPLETED|Overall Study|44 patients analysable, completed all 3 imaging procedures|44
1050636|NCT00795184|2550350|P1|COMPLETED|Overall Study|57 patients analysable, completed all 3 imaging procedures|57
1050637|NCT00795184|2550349|P2|STARTED|Overall Study||57
1050638|NCT00795184|2550350|P1|STARTED|Overall Study||65
1050639|NCT00795210|2550362|P3|NOT COMPLETED|Overall Study||2
1050640|NCT00795210|2550363|P2|NOT COMPLETED|Overall Study||1
1050641|NCT00795210|2550364|P1|NOT COMPLETED|Overall Study||0
1050642|NCT00795210|2550362|P3|COMPLETED|Overall Study||3
1050643|NCT00795210|2550363|P2|COMPLETED|Overall Study||11
1050644|NCT00795210|2550364|P1|COMPLETED|Overall Study||8
1050645|NCT00795210|2550362|P3|STARTED|Overall Study||5
1050646|NCT00795210|2550363|P2|STARTED|Overall Study||12
1050647|NCT00795210|2550364|P1|STARTED|Overall Study||8
1050648|NCT00795288|2550377|P2|NOT COMPLETED|Overall Study||0
1050649|NCT00795288|2550378|P1|NOT COMPLETED|Overall Study||0
1050650|NCT00795288|2550377|P2|COMPLETED|Overall Study||21
1050651|NCT00795288|2550378|P1|COMPLETED|Overall Study||21
1050652|NCT00795288|2550377|P2|STARTED|Overall Study||21
1050653|NCT00795288|2550378|P1|STARTED|Overall Study||21
1050654|NCT00795340|2550390|P2|NOT COMPLETED|Overall Study||0
1050655|NCT00795340|2550391|P1|NOT COMPLETED|Overall Study||7
1050656|NCT00795340|2550390|P2|COMPLETED|Overall Study||153
1050657|NCT00795340|2550391|P1|COMPLETED|Overall Study||146
1050658|NCT00795340|2550390|P2|STARTED|Overall Study||153
1050659|NCT00795340|2550391|P1|STARTED|Overall Study||153
1050660|NCT00795366|2550403|P2|NOT COMPLETED|Overall Study||0
1050661|NCT00795366|2550404|P1|NOT COMPLETED|Overall Study||0
1050662|NCT00795366|2550403|P2|COMPLETED|Overall Study||54
1050663|NCT00795366|2550404|P1|COMPLETED|Overall Study||42
1050664|NCT00795366|2550403|P2|STARTED|Overall Study||54
1050665|NCT00795366|2550404|P1|STARTED|Overall Study||42
1050666|NCT00795509|2550410|P1|NOT COMPLETED|Overall Study||31
1050667|NCT00795509|2550410|P1|COMPLETED|Overall Study||343
1050668|NCT00795509|2550410|P1|STARTED|Overall Study||374
1050669|NCT00795535|2550415|P1|NOT COMPLETED|Overall Study||20
1050670|NCT00795535|2550415|P1|COMPLETED|Overall Study||75
1050671|NCT00795535|2550415|P1|STARTED|Overall Study||95
1050672|NCT00795600|2550424|P2|NOT COMPLETED|Overall Study||4
1050673|NCT00795600|2550425|P1|NOT COMPLETED|Overall Study||4
1050674|NCT00795600|2550424|P2|COMPLETED|Overall Study||31
1050675|NCT00795600|2550425|P1|COMPLETED|Overall Study||21
1050676|NCT00795600|2550424|P2|Exposed to Drug|Overall Study||35
1050677|NCT00795600|2550425|P1|Exposed to Drug|Overall Study|1 patient did not take study medication because the patient withdrew consent|24
1050678|NCT00795600|2550424|P2|STARTED|Overall Study||35
1050679|NCT00795600|2550425|P1|STARTED|Overall Study||25
1050680|NCT00795639|2550547|P2|NOT COMPLETED|Overall Study||26
1050681|NCT00795639|2550548|P1|NOT COMPLETED|Overall Study||21
1050682|NCT00795639|2550547|P2|COMPLETED|Overall Study||66
1050683|NCT00795639|2550548|P1|COMPLETED|Overall Study||70
1050684|NCT00795639|2550547|P2|Randomized and Not Treated|Overall Study||1
1050685|NCT00795639|2550548|P1|Randomized and Not Treated|Overall Study||0
1050686|NCT00795639|2550547|P2|STARTED|Overall Study||92
1050687|NCT00795639|2550548|P1|STARTED|Overall Study||91
1050688|NCT00795704|2550560|P2|NOT COMPLETED|Overall Study||3
1050689|NCT00795704|2550561|P1|NOT COMPLETED|Overall Study||4
1050690|NCT00795704|2550560|P2|COMPLETED|Overall Study||9
1050691|NCT00795704|2550561|P1|COMPLETED|Overall Study||8
1050692|NCT00795704|2550560|P2|STARTED|Overall Study||12
1050693|NCT00795704|2550561|P1|STARTED|Overall Study||12
1050694|NCT00795717|2550573|P2|NOT COMPLETED|Phase II||1
1050695|NCT00795717|2550574|P1|NOT COMPLETED|Phase II||0
1050696|NCT00795717|2550573|P2|COMPLETED|Phase II||18
1050697|NCT00795717|2550574|P1|COMPLETED|Phase II||18
1050698|NCT00795717|2550573|P2|STARTED|Phase II||19
1050699|NCT00795717|2550574|P1|STARTED|Phase II||18
1050700|NCT00795717|2550573|P2|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
1050701|NCT00795717|2550574|P1|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
1050702|NCT00795717|2550573|P2|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||19
1050703|NCT00795717|2550574|P1|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||18
1050704|NCT00795717|2550573|P2|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to placebo first|21
1050705|NCT00795717|2550574|P1|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to treatment first|20
1050706|NCT00795769|2550584|P1|NOT COMPLETED|Overall Study||0
1050707|NCT00795769|2550584|P1|COMPLETED|Overall Study||49
1050708|NCT00795769|2550584|P1|STARTED|Overall Study||49
1050709|NCT00795886|2550588|P1|NOT COMPLETED|Overall Study||10
1050710|NCT00795886|2550588|P1|COMPLETED|Overall Study||53
1050711|NCT00795886|2550588|P1|STARTED|Overall Study||63
1050712|NCT00795951|2550594|P1|NOT COMPLETED|Overall Study||2
1050713|NCT00795951|2550594|P1|COMPLETED|Overall Study||100
1050714|NCT00795951|2550594|P1|STARTED|Overall Study||102
1050715|NCT00796003|2550633|P2|NOT COMPLETED|Overall Study||29
1050716|NCT00796003|2550634|P1|NOT COMPLETED|Overall Study||3
1050717|NCT00796003|2550633|P2|COMPLETED|Overall Study|Includes 2 participants from Phase I (20 mg/m2) group|7
1050718|NCT00796003|2550634|P1|COMPLETED|Overall Study||0
1050719|NCT00796003|2550633|P2|Treated|Overall Study|Number of participants treated|34
1050720|NCT00796003|2550634|P1|Treated|Overall Study|Number of participants treated|3
1050721|NCT00796003|2550633|P2|STARTED|Overall Study|Number of participants enrolled. Includes 6 participants from Phase I (20 mg/m2) group|36
1050722|NCT00796003|2550634|P1|STARTED|Overall Study|Number of participants enrolled|3
1050723|NCT00796120|2550657|P2|NOT COMPLETED|Overall Study||60
1050724|NCT00796120|2550658|P1|NOT COMPLETED|Overall Study||61
1050725|NCT00796120|2550657|P2|COMPLETED|Overall Study||0
1050726|NCT00796120|2550658|P1|COMPLETED|Overall Study||0
1050727|NCT00796120|2550657|P2|Treated|Overall Study||57
1050728|NCT00796120|2550658|P1|Treated|Overall Study||61
1050729|NCT00796120|2550657|P2|STARTED|Overall Study||60
1050730|NCT00796120|2550658|P1|STARTED|Overall Study||61
1050731|NCT00796224|2550674|P2|NOT COMPLETED|Overall Study||1
1050732|NCT00796224|2550675|P1|NOT COMPLETED|Overall Study||1
1050733|NCT00796224|2550674|P2|COMPLETED|Overall Study||18
1050734|NCT00796224|2550675|P1|COMPLETED|Overall Study||18
1050735|NCT00796224|2550674|P2|STARTED|Overall Study||19
1050736|NCT00796224|2550675|P1|STARTED|Overall Study||19
1050737|NCT00796302|2550695|P2|NOT COMPLETED|Overall Study||18
1050738|NCT00796302|2550696|P1|NOT COMPLETED|Overall Study||13
1050739|NCT00796302|2550695|P2|COMPLETED|Overall Study||66
1050740|NCT00796302|2550696|P1|COMPLETED|Overall Study||71
1050741|NCT00796302|2550695|P2|STARTED|Overall Study||84
1050742|NCT00796302|2550696|P1|STARTED|Overall Study||84
1050743|NCT00796315|2550708|P3|NOT COMPLETED|Overall Study||0
1050744|NCT00796315|2550709|P2|NOT COMPLETED|Overall Study||1
1050745|NCT00796315|2550710|P1|NOT COMPLETED|Overall Study||0
1050746|NCT00796315|2550708|P3|COMPLETED|Overall Study||15
1050747|NCT00796315|2550709|P2|COMPLETED|Overall Study||16
1050748|NCT00796315|2550710|P1|COMPLETED|Overall Study||9
1050749|NCT00796315|2550708|P3|STARTED|Overall Study||15
1050750|NCT00796315|2550709|P2|STARTED|Overall Study||17
1050751|NCT00796315|2550710|P1|STARTED|Overall Study||9
1050752|NCT00796328|2550721|P1|NOT COMPLETED|Overall Study||6
1050753|NCT00796328|2550721|P1|COMPLETED|Overall Study||40
1050754|NCT00796328|2550721|P1|STARTED|Overall Study||46
1050755|NCT00796367|2550728|P3|NOT COMPLETED|Overall Study||47
1050756|NCT00796367|2550729|P2|NOT COMPLETED|Overall Study||25
1050757|NCT00796367|2550730|P1|NOT COMPLETED|Overall Study||30
1050758|NCT00796367|2550728|P3|COMPLETED|Overall Study||248
1050759|NCT00796367|2550729|P2|COMPLETED|Overall Study||129
1050760|NCT00796367|2550730|P1|COMPLETED|Overall Study||197
1050761|NCT00796367|2550728|P3|STARTED|Overall Study||295
1050762|NCT00796367|2550729|P2|STARTED|Overall Study|one participant signed ICF but withdrew from study prior to first dosing in OB-305|154
1050763|NCT00796367|2550730|P1|STARTED|Overall Study||227
1050764|NCT00796419|2550743|P2|NOT COMPLETED|Overall Study||1
1050765|NCT00796419|2550744|P1|NOT COMPLETED|Overall Study||0
1050766|NCT00796419|2550743|P2|COMPLETED|Overall Study||13
1050767|NCT00796419|2550744|P1|COMPLETED|Overall Study||13
1050768|NCT00796419|2550743|P2|STARTED|Overall Study||14
1050769|NCT00796419|2550744|P1|STARTED|Overall Study||13
1050770|NCT00796510|2550756|P2|NOT COMPLETED|Overall Study||0
1050771|NCT00796510|2550757|P1|NOT COMPLETED|Overall Study||3
1050772|NCT00796510|2550756|P2|COMPLETED|Overall Study||0
1050773|NCT00796510|2550757|P1|COMPLETED|Overall Study||0
1050774|NCT00796510|2550756|P2|STARTED|Overall Study||0
1050775|NCT00796510|2550757|P1|STARTED|Overall Study||3
1050776|NCT00796523|2550769|P2|NOT COMPLETED|Overall Study||7
1050777|NCT00796523|2550770|P1|NOT COMPLETED|Overall Study||9
1050778|NCT00796523|2550769|P2|COMPLETED|Overall Study||17
1050779|NCT00796523|2550770|P1|COMPLETED|Overall Study||18
1050780|NCT00796523|2550769|P2|STARTED|Overall Study||24
1050781|NCT00796523|2550770|P1|STARTED|Overall Study||27
1050782|NCT00796549|2550778|P1|NOT COMPLETED|Overall Study||218
1050783|NCT00796549|2550778|P1|COMPLETED|Overall Study||0
1050784|NCT00796549|2550778|P1|Entered|Overall Study|entered and treated|69
1050785|NCT00796549|2550778|P1|STARTED|Overall Study|Excluding duplicate records for 5 patients who were screened twice|218
1050786|NCT00796614|2550797|P4|NOT COMPLETED|Overall Study||1
1050787|NCT00796614|2550798|P3|NOT COMPLETED|Overall Study||3
1050788|NCT00796614|2550799|P2|NOT COMPLETED|Overall Study||4
1050789|NCT00796614|2550800|P1|NOT COMPLETED|Overall Study||5
1050790|NCT00796614|2550797|P4|COMPLETED|Overall Study||40
1050791|NCT00796614|2550798|P3|COMPLETED|Overall Study||36
1050792|NCT00796614|2550799|P2|COMPLETED|Overall Study||36
1050793|NCT00796614|2550800|P1|COMPLETED|Overall Study||36
1050794|NCT00796614|2550797|P4|Not Treated|Overall Study||0
1050795|NCT00796614|2550798|P3|Not Treated|Overall Study||1
1050796|NCT00796614|2550799|P2|Not Treated|Overall Study||0
1050797|NCT00796614|2550800|P1|Not Treated|Overall Study||0
1050798|NCT00796614|2550797|P4|STARTED|Overall Study||41
1050799|NCT00796614|2550798|P3|STARTED|Overall Study||39
1050800|NCT00796614|2550799|P2|STARTED|Overall Study||40
1050801|NCT00796614|2550800|P1|STARTED|Overall Study||41
1050802|NCT00796627|2550844|P2|NOT COMPLETED|Overall Study||0
1050803|NCT00796627|2550845|P1|NOT COMPLETED|Overall Study||0
1050804|NCT00796627|2550844|P2|COMPLETED|Overall Study||31
1050805|NCT00796627|2550845|P1|COMPLETED|Overall Study||10
1050806|NCT00796627|2550844|P2|STARTED|Overall Study||31
1050807|NCT00796627|2550845|P1|STARTED|Overall Study||10
1050808|NCT00796653|2550861|P4|NOT COMPLETED|Overall Study||40
1050809|NCT00796653|2550862|P3|NOT COMPLETED|Overall Study||36
1050810|NCT00796653|2550863|P2|NOT COMPLETED|Overall Study||37
1050811|NCT00796653|2550864|P1|NOT COMPLETED|Overall Study||51
1050812|NCT00796653|2550861|P4|COMPLETED|Overall Study||193
1050813|NCT00796653|2550862|P3|COMPLETED|Overall Study||198
1050814|NCT00796653|2550863|P2|COMPLETED|Overall Study||195
1050815|NCT00796653|2550864|P1|COMPLETED|Overall Study||184
1050816|NCT00796653|2550861|P4|STARTED|Overall Study||233
1050817|NCT00796653|2550862|P3|STARTED|Overall Study||234
1050818|NCT00796653|2550863|P2|STARTED|Overall Study||232
1050819|NCT00796653|2550864|P1|STARTED|Overall Study||235
1050820|NCT00796666|2551132|P2|NOT COMPLETED|Overall Study||64
1050821|NCT00796666|2551133|P1|NOT COMPLETED|Overall Study||67
1050822|NCT00796666|2551132|P2|COMPLETED|Overall Study||0
1050823|NCT00796666|2551133|P1|COMPLETED|Overall Study||0
1050824|NCT00796666|2551132|P2|Randomized and Not Treated|Overall Study||0
1050825|NCT00796666|2551133|P1|Randomized and Not Treated|Overall Study||1
1050826|NCT00796666|2551132|P2|Treated|Overall Study||64
1050827|NCT00796666|2551133|P1|Treated|Overall Study||66
1050828|NCT00796666|2551132|P2|STARTED|Overall Study||64
1050829|NCT00796666|2551133|P1|STARTED|Overall Study||67
1050830|NCT00796705|2551167|P4|NOT COMPLETED|Overall Study||0
1050831|NCT00796705|2551168|P3|NOT COMPLETED|Overall Study||0
1050832|NCT00796705|2551169|P2|NOT COMPLETED|Overall Study||0
1050833|NCT00796705|2551170|P1|NOT COMPLETED|Overall Study||0
1050834|NCT00796705|2551167|P4|COMPLETED|Overall Study||2
1050835|NCT00796705|2551168|P3|COMPLETED|Overall Study||4
1050836|NCT00796705|2551169|P2|COMPLETED|Overall Study||4
1050837|NCT00796705|2551170|P1|COMPLETED|Overall Study||3
1050838|NCT00796705|2551167|P4|STARTED|Overall Study||2
1050839|NCT00796705|2551168|P3|STARTED|Overall Study||4
1050840|NCT00796705|2551169|P2|STARTED|Overall Study||4
1050841|NCT00796705|2551170|P1|STARTED|Overall Study||3
1050842|NCT00796718|2551206|P1|NOT COMPLETED|Overall Study||9
1050843|NCT00796718|2551206|P1|COMPLETED|Overall Study||53
1050844|NCT00796718|2551206|P1|STARTED|Overall Study||62
1050845|NCT00796744|2551216|P3|NOT COMPLETED|Overall Study||1
1050846|NCT00796744|2551217|P2|NOT COMPLETED|Overall Study||0
1050847|NCT00796744|2551218|P1|NOT COMPLETED|Overall Study||0
1050848|NCT00796744|2551216|P3|COMPLETED|Overall Study||27
1050849|NCT00796744|2551217|P2|COMPLETED|Overall Study||26
1050850|NCT00796744|2551218|P1|COMPLETED|Overall Study||24
1050851|NCT00796744|2551216|P3|STARTED|Overall Study||28
1050852|NCT00796744|2551217|P2|STARTED|Overall Study||26
1050853|NCT00796744|2551218|P1|STARTED|Overall Study||24
1050854|NCT00796757|2551235|P1|NOT COMPLETED|Overall Study||86
1050855|NCT00796757|2551235|P1|COMPLETED|Overall Study||60
1050856|NCT00796757|2551235|P1|STARTED|Overall Study||146
1050857|NCT00796822|2551249|P2|NOT COMPLETED|Overall Study||0
1050858|NCT00796822|2551250|P1|NOT COMPLETED|Overall Study||3
1050859|NCT00796822|2551249|P2|COMPLETED|Overall Study||13
1050860|NCT00796822|2551250|P1|COMPLETED|Overall Study||10
1050861|NCT00796822|2551249|P2|STARTED|Overall Study||13
1050862|NCT00796822|2551250|P1|STARTED|Overall Study||13
1050863|NCT00796926|2551258|P2|NOT COMPLETED|Overall Study||0
1050864|NCT00796926|2551259|P1|NOT COMPLETED|Overall Study||1
1050865|NCT00796926|2551258|P2|COMPLETED|Overall Study||15
1050866|NCT00796926|2551259|P1|COMPLETED|Overall Study||14
1050867|NCT00796926|2551258|P2|STARTED|Overall Study||15
1050868|NCT00796926|2551259|P1|STARTED|Overall Study||15
1050869|NCT00796991|2551268|P3|NOT COMPLETED|Overall Study||14
1050870|NCT00796991|2551269|P2|NOT COMPLETED|Overall Study||12
1050871|NCT00796991|2551270|P1|NOT COMPLETED|Overall Study||15
1050872|NCT00796991|2551268|P3|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|6
1050873|NCT00796991|2551269|P2|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|7
1050874|NCT00796991|2551270|P1|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|5
1050875|NCT00796991|2551268|P3|STARTED|Overall Study||20
1050876|NCT00796991|2551269|P2|STARTED|Overall Study||19
1050877|NCT00796991|2551270|P1|STARTED|Overall Study||20
1050878|NCT00797108|2551371|P3|NOT COMPLETED|Overall Study||6
1050879|NCT00797108|2551372|P2|NOT COMPLETED|Overall Study||2
1050880|NCT00797108|2551373|P1|NOT COMPLETED|Overall Study||4
1050881|NCT00797108|2551371|P3|COMPLETED|Overall Study||6
1050882|NCT00797108|2551372|P2|COMPLETED|Overall Study||9
1050883|NCT00797108|2551373|P1|COMPLETED|Overall Study||8
1050884|NCT00797108|2551371|P3|Treated|Overall Study||12
1050885|NCT00797108|2551372|P2|Treated|Overall Study||11
1050886|NCT00797108|2551373|P1|Treated|Overall Study||10
1050887|NCT00797108|2551371|P3|STARTED|Overall Study||12
1050888|NCT00797108|2551372|P2|STARTED|Overall Study||11
1050889|NCT00797108|2551373|P1|STARTED|Overall Study||12
1050890|NCT00797212|2551405|P1|NOT COMPLETED|Overall Study||0
1050891|NCT00797212|2551405|P1|COMPLETED|Overall Study||50
1050892|NCT00797212|2551405|P1|STARTED|Overall Study||50
1050893|NCT00797277|2551413|P2|NOT COMPLETED|Overall Study||0
1050894|NCT00797277|2551414|P1|NOT COMPLETED|Overall Study||0
1050895|NCT00797277|2551413|P2|COMPLETED|Overall Study||30
1050896|NCT00797277|2551414|P1|COMPLETED|Overall Study||37
1050897|NCT00797277|2551413|P2|STARTED|Overall Study||30
1050898|NCT00797277|2551414|P1|STARTED|Overall Study||37
1050899|NCT00797316|2551424|P2|NOT COMPLETED|Overall Study||32
1050900|NCT00797316|2551425|P1|NOT COMPLETED|Overall Study||23
1050901|NCT00797316|2551424|P2|COMPLETED|Overall Study||233
1050902|NCT00797316|2551425|P1|COMPLETED|Overall Study||244
1050903|NCT00797316|2551424|P2|STARTED|Overall Study||265
1050904|NCT00797316|2551425|P1|STARTED|Overall Study||267
1050905|NCT00797459|2551439|P1|NOT COMPLETED|Overall Study||0
1050906|NCT00797459|2551439|P1|COMPLETED|Overall Study||60
1050907|NCT00797459|2551439|P1|STARTED|Overall Study||60
1050908|NCT00797511|2551447|P1|NOT COMPLETED|Overall Study||1
1050909|NCT00797511|2551447|P1|COMPLETED|Overall Study||131
1050910|NCT00797511|2551447|P1|STARTED|Overall Study||132
1050911|NCT00797563|2551455|P1|NOT COMPLETED|Overall Study||1
1050912|NCT00797563|2551455|P1|COMPLETED|Overall Study||101
1050913|NCT00797563|2551455|P1|STARTED|Overall Study|number of subjects|102
1050914|NCT00799227|2551461|P1|NOT COMPLETED|Overall Study||3
1050915|NCT00799227|2551461|P1|COMPLETED|Overall Study||53
1050916|NCT00799227|2551461|P1|STARTED|Overall Study||56
1050917|NCT00799292|2551470|P2|NOT COMPLETED|Overall Study||0
1050918|NCT00799292|2551471|P1|NOT COMPLETED|Overall Study||0
1050919|NCT00799292|2551470|P2|COMPLETED|Overall Study||29
1050920|NCT00799292|2551471|P1|COMPLETED|Overall Study||29
1050921|NCT00799292|2551470|P2|STARTED|Overall Study||29
1050922|NCT00799292|2551471|P1|STARTED|Overall Study||29
1050923|NCT00799396|2551475|P1|NOT COMPLETED|Clopidogrel Plus Aspirin||6
1050924|NCT00799396|2551475|P1|COMPLETED|Clopidogrel Plus Aspirin||663
1050925|NCT00799396|2551475|P1|STARTED|Clopidogrel Plus Aspirin||669
1050926|NCT00799396|2551475|P1|NOT COMPLETED|Clopidogrel Treatment||13
1050927|NCT00799396|2551475|P1|COMPLETED|Clopidogrel Treatment||669
1050928|NCT00799396|2551475|P1|STARTED|Clopidogrel Treatment||682
1050929|NCT00799409|2551483|P3|NOT COMPLETED|Overall Study||0
1050930|NCT00799409|2551484|P2|NOT COMPLETED|Overall Study||0
1050931|NCT00799409|2551485|P1|NOT COMPLETED|Overall Study||7
1050932|NCT00799409|2551483|P3|COMPLETED|Overall Study||35
1050933|NCT00799409|2551484|P2|COMPLETED|Overall Study||36
1050934|NCT00799409|2551485|P1|COMPLETED|Overall Study||0
1050935|NCT00799409|2551483|P3|STARTED|Overall Study||35
1050936|NCT00799409|2551484|P2|STARTED|Overall Study||36
1050937|NCT00799409|2551485|P1|STARTED|Overall Study||7
1050938|NCT00799422|2551565|P6|NOT COMPLETED|Third Week of Wear||0
1050939|NCT00799422|2551566|P5|NOT COMPLETED|Third Week of Wear||0
1050940|NCT00799422|2551567|P4|NOT COMPLETED|Third Week of Wear||0
1050941|NCT00799422|2551568|P3|NOT COMPLETED|Third Week of Wear||0
1050942|NCT00799422|2551569|P2|NOT COMPLETED|Third Week of Wear||0
1050943|NCT00799422|2551570|P1|NOT COMPLETED|Third Week of Wear||0
1050944|NCT00799422|2551565|P6|COMPLETED|Third Week of Wear||4
1050945|NCT00799422|2551566|P5|COMPLETED|Third Week of Wear||4
1050946|NCT00799422|2551567|P4|COMPLETED|Third Week of Wear||3
1050947|NCT00799422|2551568|P3|COMPLETED|Third Week of Wear||3
1050948|NCT00799422|2551569|P2|COMPLETED|Third Week of Wear||4
1050949|NCT00799422|2551570|P1|COMPLETED|Third Week of Wear||4
1050950|NCT00799422|2551565|P6|STARTED|Third Week of Wear||4
1050951|NCT00799422|2551566|P5|STARTED|Third Week of Wear||4
1050952|NCT00799422|2551567|P4|STARTED|Third Week of Wear||3
1050953|NCT00799422|2551568|P3|STARTED|Third Week of Wear||3
1050954|NCT00799422|2551569|P2|STARTED|Third Week of Wear||4
1050955|NCT00799422|2551570|P1|STARTED|Third Week of Wear||4
1050956|NCT00799422|2551565|P6|NOT COMPLETED|Second Week of Wear||0
1050957|NCT00799422|2551566|P5|NOT COMPLETED|Second Week of Wear||0
1050958|NCT00799422|2551567|P4|NOT COMPLETED|Second Week of Wear||0
1050959|NCT00799422|2551568|P3|NOT COMPLETED|Second Week of Wear||0
1050960|NCT00799422|2551569|P2|NOT COMPLETED|Second Week of Wear||0
1050961|NCT00799422|2551570|P1|NOT COMPLETED|Second Week of Wear||0
1050962|NCT00799422|2551565|P6|COMPLETED|Second Week of Wear||4
1050963|NCT00799422|2551566|P5|COMPLETED|Second Week of Wear||4
1050964|NCT00799422|2551567|P4|COMPLETED|Second Week of Wear||3
1050965|NCT00799422|2551568|P3|COMPLETED|Second Week of Wear||3
1050966|NCT00799422|2551569|P2|COMPLETED|Second Week of Wear||4
1050967|NCT00799422|2551570|P1|COMPLETED|Second Week of Wear||4
1050968|NCT00799422|2551565|P6|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|4
1050969|NCT00799422|2551566|P5|STARTED|Second Week of Wear||4
1050970|NCT00799422|2551567|P4|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|3
1050971|NCT00799422|2551568|P3|STARTED|Second Week of Wear||3
1050972|NCT00799422|2551569|P2|STARTED|Second Week of Wear||4
1050973|NCT00799422|2551570|P1|STARTED|Second Week of Wear||4
1050974|NCT00799422|2551565|P6|NOT COMPLETED|First Week of Wear||0
1050975|NCT00799422|2551566|P5|NOT COMPLETED|First Week of Wear||0
1050976|NCT00799422|2551567|P4|NOT COMPLETED|First Week of Wear||1
1050977|NCT00799422|2551568|P3|NOT COMPLETED|First Week of Wear||1
1050978|NCT00799422|2551569|P2|NOT COMPLETED|First Week of Wear||0
1050979|NCT00799422|2551570|P1|NOT COMPLETED|First Week of Wear||0
1050980|NCT00799422|2551565|P6|COMPLETED|First Week of Wear||5
1050981|NCT00799422|2551566|P5|COMPLETED|First Week of Wear||4
1050982|NCT00799422|2551567|P4|COMPLETED|First Week of Wear||4
1050983|NCT00799422|2551568|P3|COMPLETED|First Week of Wear||3
1050984|NCT00799422|2551569|P2|COMPLETED|First Week of Wear||4
1050985|NCT00799422|2551570|P1|COMPLETED|First Week of Wear||4
1050986|NCT00799422|2551565|P6|STARTED|First Week of Wear||5
1050987|NCT00799422|2551566|P5|STARTED|First Week of Wear||4
1050988|NCT00799422|2551567|P4|STARTED|First Week of Wear||5
1050989|NCT00799422|2551568|P3|STARTED|First Week of Wear||4
1050990|NCT00799422|2551569|P2|STARTED|First Week of Wear||4
1050991|NCT00799422|2551570|P1|STARTED|First Week of Wear||4
1050992|NCT00799435|2551586|P2|NOT COMPLETED|Overall Study||0
1050993|NCT00799435|2551587|P1|NOT COMPLETED|Overall Study||0
1050994|NCT00799435|2551586|P2|COMPLETED|Overall Study||1
1050995|NCT00799435|2551587|P1|COMPLETED|Overall Study||1
1050996|NCT00799435|2551586|P2|STARTED|Overall Study||1
1050997|NCT00799435|2551587|P1|STARTED|Overall Study||1
1050998|NCT00799474|2551593|P1|NOT COMPLETED|Overall Study||0
1050999|NCT00799474|2551593|P1|COMPLETED|Overall Study||609
1051000|NCT00799474|2551593|P1|STARTED|Overall Study||609
1051001|NCT00799487|2551602|P3|NOT COMPLETED|Double-Blind Assessment Period||2
1051002|NCT00799487|2551603|P2|NOT COMPLETED|Double-Blind Assessment Period||1
1051003|NCT00799487|2551604|P1|NOT COMPLETED|Double-Blind Assessment Period||0
1051004|NCT00799487|2551602|P3|COMPLETED|Double-Blind Assessment Period||32
1051005|NCT00799487|2551603|P2|COMPLETED|Double-Blind Assessment Period||33
1051006|NCT00799487|2551604|P1|COMPLETED|Double-Blind Assessment Period||0
1051007|NCT00799487|2551602|P3|STARTED|Double-Blind Assessment Period||34
1051008|NCT00799487|2551603|P2|STARTED|Double-Blind Assessment Period||34
1051009|NCT00799487|2551604|P1|STARTED|Double-Blind Assessment Period||0
1051010|NCT00799487|2551602|P3|NOT COMPLETED|Dose Adjustment Period||0
1051011|NCT00799487|2551603|P2|NOT COMPLETED|Dose Adjustment Period||0
1051012|NCT00799487|2551604|P1|NOT COMPLETED|Dose Adjustment Period||21
1051013|NCT00799487|2551602|P3|COMPLETED|Dose Adjustment Period||34
1051014|NCT00799487|2551603|P2|COMPLETED|Dose Adjustment Period||34
1051015|NCT00799487|2551604|P1|COMPLETED|Dose Adjustment Period||0
1051016|NCT00799487|2551602|P3|STARTED|Dose Adjustment Period||34
1051017|NCT00799487|2551603|P2|STARTED|Dose Adjustment Period||34
1051018|NCT00799487|2551604|P1|STARTED|Dose Adjustment Period||21
1051019|NCT00799578|2551684|P1|NOT COMPLETED|Overall Study||2
1051020|NCT00799578|2551684|P1|COMPLETED|Overall Study||11
1051021|NCT00799578|2551684|P1|STARTED|Overall Study||13
1051022|NCT00799591|2551688|P1|NOT COMPLETED|Overall Study||66
1051023|NCT00799591|2551688|P1|COMPLETED|Overall Study||90
1051024|NCT00799591|2551688|P1|STARTED|Overall Study||156
1051025|NCT00799604|2551702|P3|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
1051026|NCT00799604|2551703|P2|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
1051027|NCT00799604|2551704|P1|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
1051028|NCT00799604|2551702|P3|COMPLETED|Bolus 2 (With Anesthesia)||3
1051029|NCT00799604|2551703|P2|COMPLETED|Bolus 2 (With Anesthesia)||12
1051030|NCT00799604|2551704|P1|COMPLETED|Bolus 2 (With Anesthesia)||6
1051031|NCT00799604|2551702|P3|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|3
1051032|NCT00799604|2551703|P2|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|12
1051033|NCT00799604|2551704|P1|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|6
1051034|NCT00799604|2551702|P3|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
1051035|NCT00799604|2551703|P2|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
1051036|NCT00799604|2551704|P1|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
1051037|NCT00799604|2551702|P3|COMPLETED|Bolus 1 (Pre-anesthesia)||10
1051038|NCT00799604|2551703|P2|COMPLETED|Bolus 1 (Pre-anesthesia)||10
1051039|NCT00799604|2551704|P1|COMPLETED|Bolus 1 (Pre-anesthesia)||10
1051040|NCT00799604|2551702|P3|STARTED|Bolus 1 (Pre-anesthesia)||10
1051041|NCT00799604|2551703|P2|STARTED|Bolus 1 (Pre-anesthesia)||10
1051042|NCT00799604|2551704|P1|STARTED|Bolus 1 (Pre-anesthesia)||10
1051091|NCT00799643|2551811|P2|NOT COMPLETED|Overall Study||27
1051092|NCT00799643|2551812|P1|NOT COMPLETED|Overall Study||25
1051093|NCT00799643|2551811|P2|COMPLETED|Overall Study||119
1051094|NCT00799643|2551812|P1|COMPLETED|Overall Study||115
1051095|NCT00799643|2551811|P2|STARTED|Overall Study||146
1051096|NCT00799643|2551812|P1|STARTED|Overall Study||140
1051097|NCT00799708|2551823|P3|NOT COMPLETED|Overall Study||0
1051098|NCT00799708|2551824|P2|NOT COMPLETED|Overall Study||0
1051099|NCT00799708|2551825|P1|NOT COMPLETED|Overall Study||1
1051100|NCT00799708|2551823|P3|COMPLETED|Overall Study||11
1051101|NCT00799708|2551824|P2|COMPLETED|Overall Study||6
1051102|NCT00799708|2551825|P1|COMPLETED|Overall Study||9
1051103|NCT00799708|2551823|P3|STARTED|Overall Study||11
1051104|NCT00799708|2551824|P2|STARTED|Overall Study||6
1051105|NCT00799708|2551825|P1|STARTED|Overall Study||10
1051106|NCT00799773|2551837|P2|NOT COMPLETED|Overall Study||0
1051107|NCT00799773|2551838|P1|NOT COMPLETED|Overall Study||0
1051108|NCT00799773|2551837|P2|COMPLETED|Overall Study||1
1051109|NCT00799773|2551838|P1|COMPLETED|Overall Study||2
1051110|NCT00799773|2551837|P2|STARTED|Overall Study||1
1051111|NCT00799773|2551838|P1|STARTED|Overall Study||2
1051112|NCT00799825|2551866|P1|NOT COMPLETED|Overall Study||48
1051113|NCT00799825|2551866|P1|COMPLETED|Overall Study||296
1051114|NCT00799825|2551866|P1|STARTED|Overall Study||344
1051115|NCT00799903|2551874|P2|NOT COMPLETED|Overall Study||278
1051116|NCT00799903|2551875|P1|NOT COMPLETED|Overall Study||273
1051117|NCT00799903|2551874|P2|COMPLETED|Overall Study||7646
1051118|NCT00799903|2551875|P1|COMPLETED|Overall Study||7631
1051119|NCT00799903|2551874|P2|STARTED|Overall Study||7924
1051120|NCT00799903|2551875|P1|STARTED|Overall Study||7904
1051121|NCT00800202|2551897|P2|NOT COMPLETED|Overall Study||24
1051122|NCT00800202|2551898|P1|NOT COMPLETED|Overall Study||67
1051123|NCT00800202|2551897|P2|COMPLETED|Overall Study||0
1051124|NCT00800202|2551898|P1|COMPLETED|Overall Study||0
1051125|NCT00800202|2551897|P2|STARTED|Overall Study||24
1051126|NCT00800202|2551898|P1|STARTED|Overall Study||67
1051127|NCT00800254|2551918|P2|NOT COMPLETED|Overall Study||6
1051128|NCT00800254|2551919|P1|NOT COMPLETED|Overall Study||5
1051129|NCT00800254|2551918|P2|COMPLETED|Overall Study||25
1051130|NCT00800254|2551919|P1|COMPLETED|Overall Study||30
1051131|NCT00800254|2551918|P2|3.5 Weeks Post-operatively|Overall Study||31
1051132|NCT00800254|2551919|P1|3.5 Weeks Post-operatively|Overall Study||31
1051133|NCT00800254|2551918|P2|STARTED|Overall Study||31
1051134|NCT00800254|2551919|P1|STARTED|Overall Study||35
1051135|NCT00800345|2551939|P1|NOT COMPLETED|Overall Study||0
1051136|NCT00800345|2551939|P1|COMPLETED|Overall Study||33
1051137|NCT00800345|2551939|P1|STARTED|Overall Study||33
1051138|NCT00800384|2551946|P2|NOT COMPLETED|Overall Study||43
1051139|NCT00800384|2551947|P1|NOT COMPLETED|Overall Study||41
1051140|NCT00800384|2551946|P2|COMPLETED|Overall Study||1210
1051141|NCT00800384|2551947|P1|COMPLETED|Overall Study||1206
1051142|NCT00800384|2551946|P2|STARTED|Overall Study||1253
1051143|NCT00800384|2551947|P1|STARTED|Overall Study||1247
1051144|NCT00800436|2551962|P7|NOT COMPLETED|Overall Study||0
1051145|NCT00800436|2551963|P6|NOT COMPLETED|Overall Study||0
1051146|NCT00800436|2551964|P5|NOT COMPLETED|Overall Study||0
1051147|NCT00800436|2551965|P4|NOT COMPLETED|Overall Study||1
1051148|NCT00800436|2551966|P3|NOT COMPLETED|Overall Study||1
1051149|NCT00800436|2551967|P2|NOT COMPLETED|Overall Study||0
1051150|NCT00800436|2551968|P1|NOT COMPLETED|Overall Study||0
1051151|NCT00800436|2551962|P7|COMPLETED|Overall Study||20
1051152|NCT00800436|2551963|P6|COMPLETED|Overall Study||20
1051153|NCT00800436|2551964|P5|COMPLETED|Overall Study||6
1051154|NCT00800436|2551965|P4|COMPLETED|Overall Study||5
1051155|NCT00800436|2551966|P3|COMPLETED|Overall Study||5
1051156|NCT00800436|2551967|P2|COMPLETED|Overall Study||6
1051157|NCT00800436|2551968|P1|COMPLETED|Overall Study||6
1051158|NCT00800436|2551962|P7|STARTED|Overall Study||20
1051159|NCT00800436|2551963|P6|STARTED|Overall Study||20
1051160|NCT00800436|2551964|P5|STARTED|Overall Study||6
1051161|NCT00800436|2551965|P4|STARTED|Overall Study||6
1051162|NCT00800436|2551966|P3|STARTED|Overall Study||6
1051163|NCT00800436|2551967|P2|STARTED|Overall Study||6
1051164|NCT00800436|2551968|P1|STARTED|Overall Study||6
1051165|NCT00800540|2552012|P2|NOT COMPLETED|Period 2: 6 Weeks||1
1051166|NCT00800540|2552013|P1|NOT COMPLETED|Period 2: 6 Weeks||0
1051167|NCT00800540|2552012|P2|COMPLETED|Period 2: 6 Weeks||16
1051168|NCT00800540|2552013|P1|COMPLETED|Period 2: 6 Weeks||16
1051169|NCT00800540|2552012|P2|STARTED|Period 2: 6 Weeks||17
1051170|NCT00800540|2552013|P1|STARTED|Period 2: 6 Weeks||16
1051171|NCT00800540|2552012|P2|NOT COMPLETED|Washout: 4 Weeks||0
1051172|NCT00800540|2552013|P1|NOT COMPLETED|Washout: 4 Weeks||0
1051173|NCT00800540|2552012|P2|COMPLETED|Washout: 4 Weeks||17
1051174|NCT00800540|2552013|P1|COMPLETED|Washout: 4 Weeks||16
1051175|NCT00800540|2552012|P2|STARTED|Washout: 4 Weeks||17
1051176|NCT00800540|2552013|P1|STARTED|Washout: 4 Weeks||16
1051177|NCT00800540|2552012|P2|NOT COMPLETED|Period One: 6 Weeks||1
1051178|NCT00800540|2552013|P1|NOT COMPLETED|Period One: 6 Weeks||1
1051179|NCT00800540|2552012|P2|COMPLETED|Period One: 6 Weeks||17
1051180|NCT00800540|2552013|P1|COMPLETED|Period One: 6 Weeks||16
1051181|NCT00800540|2552012|P2|STARTED|Period One: 6 Weeks||18
1051182|NCT00800540|2552013|P1|STARTED|Period One: 6 Weeks||17
1051183|NCT00800683|2552043|P2|NOT COMPLETED|Overall Study||19
1051184|NCT00800683|2552044|P1|NOT COMPLETED|Overall Study||17
1051185|NCT00800683|2552043|P2|COMPLETED|Overall Study|Number who completed treatment|49
1051186|NCT00800683|2552044|P1|COMPLETED|Overall Study|Number who completed treatment|48
1051187|NCT00800683|2552043|P2|STARTED|Overall Study|Number who started treatment|68
1051188|NCT00800683|2552044|P1|STARTED|Overall Study|Number who started treatment|65
1051189|NCT00800735|2552090|P1|NOT COMPLETED|Overall Study||14
1051190|NCT00800735|2552090|P1|COMPLETED|Overall Study||16
1051191|NCT00800735|2552090|P1|STARTED|Overall Study||30
1051192|NCT00800839|2552094|P1|NOT COMPLETED|Overall Study||7
1051193|NCT00800839|2552094|P1|COMPLETED|Overall Study||49
1051194|NCT00800839|2552094|P1|STARTED|Overall Study||56
1051195|NCT00800865|2552105|P2|NOT COMPLETED|Overall Study||0
1051196|NCT00800865|2552106|P1|NOT COMPLETED|Overall Study||0
1051197|NCT00800865|2552105|P2|COMPLETED|Overall Study||16
1051198|NCT00800865|2552106|P1|COMPLETED|Overall Study||15
1051199|NCT00800865|2552105|P2|STARTED|Overall Study||16
1051200|NCT00800865|2552106|P1|STARTED|Overall Study||15
1051201|NCT00800982|2552116|P2|NOT COMPLETED|Overall Study||3
1051202|NCT00800982|2552117|P1|NOT COMPLETED|Overall Study||2
1051203|NCT00800982|2552116|P2|COMPLETED|Overall Study||12
1051204|NCT00800982|2552117|P1|COMPLETED|Overall Study||13
1051205|NCT00800982|2552116|P2|STARTED|Overall Study||15
1051206|NCT00800982|2552117|P1|STARTED|Overall Study||15
1051207|NCT00801099|2552123|P1|NOT COMPLETED|Overall Study||101
1051208|NCT00801099|2552123|P1|COMPLETED|Overall Study||175
1051209|NCT00801099|2552123|P1|STARTED|Overall Study||276
1051210|NCT00801138|2552131|P4|NOT COMPLETED|Overall Study||0
1051211|NCT00801138|2552132|P3|NOT COMPLETED|Overall Study||0
1051212|NCT00801138|2552133|P2|NOT COMPLETED|Overall Study||0
1051213|NCT00801138|2552134|P1|NOT COMPLETED|Overall Study||0
1051214|NCT00801138|2552131|P4|COMPLETED|Overall Study||54
1051215|NCT00801138|2552132|P3|COMPLETED|Overall Study||54
1051216|NCT00801138|2552133|P2|COMPLETED|Overall Study||56
1051217|NCT00801138|2552134|P1|COMPLETED|Overall Study||54
1051218|NCT00801138|2552131|P4|STARTED|Overall Study||54
1051219|NCT00801138|2552132|P3|STARTED|Overall Study||54
1051220|NCT00801138|2552133|P2|STARTED|Overall Study||56
1051221|NCT00801138|2552134|P1|STARTED|Overall Study||54
1051222|NCT00801229|2552158|P2|NOT COMPLETED|Received Study Drug/Placebo||4
1051223|NCT00801229|2552159|P1|NOT COMPLETED|Received Study Drug/Placebo||4
1051224|NCT00801229|2552158|P2|COMPLETED|Received Study Drug/Placebo||30
1051225|NCT00801229|2552159|P1|COMPLETED|Received Study Drug/Placebo||31
1051226|NCT00801229|2552158|P2|STARTED|Received Study Drug/Placebo||34
1051227|NCT00801229|2552159|P1|STARTED|Received Study Drug/Placebo||35
1051228|NCT00801229|2552158|P2|NOT COMPLETED|Signed Consent||3
1051229|NCT00801229|2552159|P1|NOT COMPLETED|Signed Consent||3
1051230|NCT00801229|2552158|P2|COMPLETED|Signed Consent||34
1051231|NCT00801229|2552159|P1|COMPLETED|Signed Consent||35
1051232|NCT00801229|2552158|P2|STARTED|Signed Consent||37
1051233|NCT00801229|2552159|P1|STARTED|Signed Consent||38
1051234|NCT00801242|2552165|P1|NOT COMPLETED|Overall Study||52
1051235|NCT00801242|2552165|P1|COMPLETED|Overall Study|42, 10, and 0 participants withdrew during Cycles 1, 2, and 3 (i.e. 168 completed the trial).|168
1051236|NCT00801242|2552165|P1|Started Cycle 3|Overall Study||2
1051237|NCT00801242|2552165|P1|Started Cycle 2|Overall Study||35
1051238|NCT00801242|2552165|P1|FAS, Off-treatment Cycle 1|Overall Study|Completed 7 months induction period and were enrolled in the off-treatment period of cycle 1.|191
1051239|NCT00801242|2552165|P1|Full Analysis Set (FAS), Cycle 1|Overall Study|Randomized participants who received ≥1 dose and had ≥1 efficacy assessment.|213
1051240|NCT00801242|2552165|P1|Safety Analysis Set|Overall Study|Randomized participants who received ≥1 dose of degarelix.|216
1051241|NCT00801242|2552165|P1|STARTED|Overall Study|Randomized participants.|220
1051242|NCT00810641|2552179|P3|NOT COMPLETED|Overall Study||2
1051243|NCT00810641|2552180|P2|NOT COMPLETED|Overall Study||1
1051244|NCT00810641|2552181|P1|NOT COMPLETED|Overall Study||0
1051245|NCT00810641|2552179|P3|COMPLETED|Overall Study||49
1051246|NCT00810641|2552180|P2|COMPLETED|Overall Study||53
1051247|NCT00810641|2552181|P1|COMPLETED|Overall Study||52
1051248|NCT00810641|2552179|P3|STARTED|Overall Study||51
1051249|NCT00810641|2552180|P2|STARTED|Overall Study||54
1051250|NCT00810641|2552181|P1|STARTED|Overall Study||52
1051251|NCT00810693|2552192|P3|NOT COMPLETED|Follow-up Period (FUP)||4
1051252|NCT00810693|2552193|P2|NOT COMPLETED|Follow-up Period (FUP)||3
1051253|NCT00810693|2552194|P1|NOT COMPLETED|Follow-up Period (FUP)||8
1051254|NCT00810693|2552192|P3|COMPLETED|Follow-up Period (FUP)||12
1051255|NCT00810693|2552193|P2|COMPLETED|Follow-up Period (FUP)||4
1051256|NCT00810693|2552194|P1|COMPLETED|Follow-up Period (FUP)||15
1051257|NCT00810693|2552192|P3|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|16
1051258|NCT00810693|2552193|P2|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|7
1051259|NCT00810693|2552194|P1|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|23
1051260|NCT00810693|2552192|P3|NOT COMPLETED|Treatment Period||16
1051261|NCT00810693|2552193|P2|NOT COMPLETED|Treatment Period||7
1051262|NCT00810693|2552194|P1|NOT COMPLETED|Treatment Period||17
1051263|NCT00810693|2552192|P3|COMPLETED|Treatment Period||111
1051264|NCT00810693|2552193|P2|COMPLETED|Treatment Period||57
1051265|NCT00810693|2552194|P1|COMPLETED|Treatment Period||237
1051266|NCT00810693|2552192|P3|Participants Received Treatment|Treatment Period||126
1051267|NCT00810693|2552193|P2|Participants Received Treatment|Treatment Period||63
1051268|NCT00810693|2552194|P1|Participants Received Treatment|Treatment Period||254
1051269|NCT00810693|2552192|P3|STARTED|Treatment Period|1 randomized but not treated|127
1051270|NCT00810693|2552193|P2|STARTED|Treatment Period|1 randomized but not treated|64
1051271|NCT00810693|2552194|P1|STARTED|Treatment Period||254
1051272|NCT00810719|2552223|P1|NOT COMPLETED|Overall Study||0
1051273|NCT00810719|2552223|P1|COMPLETED|Overall Study||30
1051274|NCT00810719|2552223|P1|STARTED|Overall Study||30
1051275|NCT00810771|2552232|P3|NOT COMPLETED|Overall Study||0
1051276|NCT00810771|2552233|P2|NOT COMPLETED|Overall Study||0
1051277|NCT00810771|2552234|P1|NOT COMPLETED|Overall Study||0
1051278|NCT00810771|2552232|P3|COMPLETED|Overall Study||84
1051279|NCT00810771|2552233|P2|COMPLETED|Overall Study||234
1051280|NCT00810771|2552234|P1|COMPLETED|Overall Study||232
1051281|NCT00810771|2552232|P3|STARTED|Overall Study||84
1051282|NCT00810771|2552233|P2|STARTED|Overall Study||234
1051283|NCT00810771|2552234|P1|STARTED|Overall Study||232
1051284|NCT00810901|2552256|P2|NOT COMPLETED|Overall Study||58
1051285|NCT00810901|2552257|P1|NOT COMPLETED|Overall Study||88
1051286|NCT00810901|2552256|P2|COMPLETED|Overall Study||118
1051287|NCT00810901|2552257|P1|COMPLETED|Overall Study||165
1051288|NCT00810901|2552256|P2|6-month Follow-up|Overall Study||122
1051289|NCT00810901|2552257|P1|6-month Follow-up|Overall Study||181
1051290|NCT00810901|2552256|P2|1-month Follow up|Overall Study||146
1051291|NCT00810901|2552257|P1|1-month Follow up|Overall Study||242
1051292|NCT00810901|2552256|P2|STARTED|Overall Study||176
1051293|NCT00810901|2552257|P1|STARTED|Overall Study||253
1051294|NCT00811382|2552267|P2|NOT COMPLETED|Overall Study||0
1051295|NCT00811382|2552268|P1|NOT COMPLETED|Overall Study||0
1051296|NCT00811382|2552267|P2|COMPLETED|Overall Study||75
1051297|NCT00811382|2552268|P1|COMPLETED|Overall Study||88
1051298|NCT00811382|2552267|P2|STARTED|Overall Study||75
1051299|NCT00811382|2552268|P1|STARTED|Overall Study||88
1051300|NCT00811395|2552286|P6|NOT COMPLETED|Extension Treatment||2
1051301|NCT00811395|2552287|P5|NOT COMPLETED|Extension Treatment||0
1051302|NCT00811395|2552288|P4|NOT COMPLETED|Extension Treatment||3
1051303|NCT00811395|2552289|P3|NOT COMPLETED|Extension Treatment||3
1051304|NCT00811395|2552290|P2|NOT COMPLETED|Extension Treatment||6
1051305|NCT00811395|2552291|P1|NOT COMPLETED|Extension Treatment||2
1051306|NCT00811395|2552286|P6|COMPLETED|Extension Treatment|completed 48-week treatment|27
1051307|NCT00811395|2552287|P5|COMPLETED|Extension Treatment|completed 48-week treatment|30
1051308|NCT00811395|2552288|P4|COMPLETED|Extension Treatment|completed 48-week treatment|34
1051309|NCT00811395|2552289|P3|COMPLETED|Extension Treatment|completed 48-week treatment|24
1051310|NCT00811395|2552290|P2|COMPLETED|Extension Treatment|completed 48-week treatment|22
1051311|NCT00811395|2552291|P1|COMPLETED|Extension Treatment|completed 48-week treatment|29
1051312|NCT00811395|2552286|P6|STARTED|Extension Treatment|continued initial treatment|29
1051313|NCT00811395|2552287|P5|STARTED|Extension Treatment|continued initial treatment|30
1051314|NCT00811395|2552288|P4|STARTED|Extension Treatment|continued initial treatment|37
1051315|NCT00811395|2552289|P3|STARTED|Extension Treatment|continued initial treatment|27
1051316|NCT00811395|2552290|P2|STARTED|Extension Treatment|continued initial treatment|28
1051317|NCT00811395|2552291|P1|STARTED|Extension Treatment|continued initial treatment|31
1051318|NCT00811395|2552286|P6|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||6
1051319|NCT00811395|2552287|P5|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||5
1051320|NCT00811395|2552288|P4|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
1051321|NCT00811395|2552289|P3|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
1051322|NCT00811395|2552290|P2|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||4
1051323|NCT00811395|2552291|P1|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||3
1051324|NCT00811395|2552286|P6|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|35
1051325|NCT00811395|2552287|P5|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|37
1051326|NCT00811395|2552288|P4|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|38
1051327|NCT00811395|2552289|P3|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|36
1051328|NCT00811395|2552290|P2|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|33
1051329|NCT00811395|2552291|P1|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|38
1051330|NCT00811395|2552286|P6|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
1051331|NCT00811395|2552287|P5|STARTED|Initial Treatment (PDY6045 or PDY6046)||42
1051332|NCT00811395|2552288|P4|STARTED|Initial Treatment (PDY6045 or PDY6046)||40
1051333|NCT00811395|2552289|P3|STARTED|Initial Treatment (PDY6045 or PDY6046)||38
1051334|NCT00811395|2552290|P2|STARTED|Initial Treatment (PDY6045 or PDY6046)|One participant received 7 mg instead of 14 mg as per randomization|37
1051335|NCT00811395|2552291|P1|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
1051336|NCT00811434|2552353|P2|NOT COMPLETED|Second Intervention||0
1051337|NCT00811434|2552354|P1|NOT COMPLETED|Second Intervention||0
1051338|NCT00811434|2552353|P2|COMPLETED|Second Intervention||5
1051339|NCT00811434|2552354|P1|COMPLETED|Second Intervention||4
1051340|NCT00811434|2552353|P2|STARTED|Second Intervention||5
1051341|NCT00811434|2552354|P1|STARTED|Second Intervention||4
1051342|NCT00811434|2552353|P2|NOT COMPLETED|Washout (1 Month)||0
1051343|NCT00811434|2552354|P1|NOT COMPLETED|Washout (1 Month)||0
1051344|NCT00811434|2552353|P2|COMPLETED|Washout (1 Month)||5
1051345|NCT00811434|2552354|P1|COMPLETED|Washout (1 Month)||4
1051346|NCT00811434|2552353|P2|STARTED|Washout (1 Month)||5
1051347|NCT00811434|2552354|P1|STARTED|Washout (1 Month)||4
1051348|NCT00811434|2552353|P2|NOT COMPLETED|First Intervention||0
1051349|NCT00811434|2552354|P1|NOT COMPLETED|First Intervention||3
1051350|NCT00811434|2552353|P2|COMPLETED|First Intervention||5
1051351|NCT00811434|2552354|P1|COMPLETED|First Intervention||4
1051352|NCT00811434|2552353|P2|STARTED|First Intervention||5
1051353|NCT00811434|2552354|P1|STARTED|First Intervention||7
1051354|NCT00811473|2552364|P2|NOT COMPLETED|Overall Study||26
1051355|NCT00811473|2552365|P1|NOT COMPLETED|Overall Study||23
1051356|NCT00811473|2552364|P2|COMPLETED|Overall Study||74
1051357|NCT00811473|2552365|P1|COMPLETED|Overall Study||70
1051358|NCT00811473|2552364|P2|STARTED|Overall Study||100
1051359|NCT00811473|2552365|P1|STARTED|Overall Study||93
1051360|NCT00811564|2552383|P2|NOT COMPLETED|Overall Study||2
1051361|NCT00811564|2552384|P1|NOT COMPLETED|Overall Study||9
1051362|NCT00811564|2552383|P2|COMPLETED|Overall Study||73
1051363|NCT00811564|2552384|P1|COMPLETED|Overall Study||64
1051364|NCT00811564|2552383|P2|STARTED|Overall Study||75
1051365|NCT00811564|2552384|P1|STARTED|Overall Study||73
1051366|NCT00811577|2552392|P2|NOT COMPLETED|Overall Study||1
1051367|NCT00811577|2552393|P1|NOT COMPLETED|Overall Study||10
1051368|NCT00811577|2552392|P2|COMPLETED|Overall Study||23
1051369|NCT00811577|2552393|P1|COMPLETED|Overall Study||116
1051370|NCT00811577|2552392|P2|STARTED|Overall Study||24
1051371|NCT00811577|2552393|P1|STARTED|Overall Study||126
1051372|NCT00811590|2552442|P1|NOT COMPLETED|Overall Study||0
1051373|NCT00811590|2552442|P1|COMPLETED|Overall Study||3
1051374|NCT00811590|2552442|P1|STARTED|Overall Study||3
1051375|NCT00811642|2552446|P1|NOT COMPLETED|Overall Study||15
1051376|NCT00811642|2552446|P1|COMPLETED|Overall Study|The Per Protocol Set (PPS) includes the 47 participants who completed the study per protocol.|47
1051377|NCT00811642|2552446|P1|STARTED|Overall Study|63 participants were screened and enrolled; 62 participants from Safety Set (SS) started study drug.|62
1051378|NCT00811655|2552456|P1|NOT COMPLETED|Overall Study||1
1051379|NCT00811655|2552456|P1|COMPLETED|Overall Study||5
1051380|NCT00811655|2552456|P1|STARTED|Overall Study||6
1051381|NCT00811720|2552470|P2|NOT COMPLETED|All Treated Patients||164
1051382|NCT00811720|2552471|P1|NOT COMPLETED|All Treated Patients||96
1051383|NCT00811720|2552470|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|138
1051384|NCT00811720|2552471|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|200
1051385|NCT00811720|2552470|P2|STARTED|All Treated Patients||302
1051386|NCT00811720|2552471|P1|STARTED|All Treated Patients||296
1051387|NCT00811720|2552470|P2|NOT COMPLETED|All Randomised Patients||4
1051388|NCT00811720|2552471|P1|NOT COMPLETED|All Randomised Patients||2
1051389|NCT00811720|2552470|P2|COMPLETED|All Randomised Patients||302
1051390|NCT00811720|2552471|P1|COMPLETED|All Randomised Patients||296
1051391|NCT00811720|2552470|P2|STARTED|All Randomised Patients||306
1051392|NCT00811720|2552471|P1|STARTED|All Randomised Patients||298
1051393|NCT00811733|2552491|P2|NOT COMPLETED|Overall Study||10
1051394|NCT00811733|2552492|P1|NOT COMPLETED|Overall Study||11
1051395|NCT00811733|2552491|P2|COMPLETED|Overall Study||12
1051396|NCT00811733|2552492|P1|COMPLETED|Overall Study||4
1051397|NCT00811733|2552491|P2|STARTED|Overall Study||22
1051398|NCT00811733|2552492|P1|STARTED|Overall Study||15
1051399|NCT00811798|2552538|P1|NOT COMPLETED|Overall Study||0
1051400|NCT00811798|2552538|P1|COMPLETED|Overall Study||92
1051401|NCT00811798|2552538|P1|STARTED|Overall Study||92
1051402|NCT00811850|2552542|P1|NOT COMPLETED|Treatment Period 3: Combigan® or Cosopt®||0
1051403|NCT00811850|2552542|P1|COMPLETED|Treatment Period 3: Combigan® or Cosopt®||15
1051404|NCT00811850|2552542|P1|STARTED|Treatment Period 3: Combigan® or Cosopt®||15
1051405|NCT00811850|2552542|P1|NOT COMPLETED|Treatment Period 2: Wash Out||0
1051406|NCT00811850|2552542|P1|COMPLETED|Treatment Period 2: Wash Out||15
1051407|NCT00811850|2552542|P1|STARTED|Treatment Period 2: Wash Out||15
1051408|NCT00811850|2552542|P1|NOT COMPLETED|Treatment Period 1: Combigan® or Cosopt®||0
1051409|NCT00811850|2552542|P1|COMPLETED|Treatment Period 1: Combigan® or Cosopt®||15
1051410|NCT00811850|2552542|P1|STARTED|Treatment Period 1: Combigan® or Cosopt®||15
1051417|NCT00811941|2552585|P2|NOT COMPLETED|All Treated Patients||191
1051418|NCT00811941|2552586|P1|NOT COMPLETED|All Treated Patients||52
1051419|NCT00811941|2552585|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|310
1051420|NCT00811941|2552586|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|112
1051421|NCT00811941|2552585|P2|STARTED|All Treated Patients||501
1051422|NCT00811941|2552586|P1|STARTED|All Treated Patients||164
1051423|NCT00811941|2552585|P2|NOT COMPLETED|All Randomised Patients||8
1051424|NCT00811941|2552586|P1|NOT COMPLETED|All Randomised Patients||2
1051425|NCT00811941|2552585|P2|COMPLETED|All Randomised Patients||501
1051426|NCT00811941|2552586|P1|COMPLETED|All Randomised Patients||164
1051427|NCT00811941|2552585|P2|STARTED|All Randomised Patients||509
1051428|NCT00811941|2552586|P1|STARTED|All Randomised Patients||166
1051429|NCT00811954|2552625|P3|NOT COMPLETED|Overall Study||101
1051430|NCT00811954|2552626|P2|NOT COMPLETED|Overall Study||72
1051431|NCT00811954|2552627|P1|NOT COMPLETED|Overall Study||89
1051432|NCT00811954|2552625|P3|COMPLETED|Overall Study||500
1051433|NCT00811954|2552626|P2|COMPLETED|Overall Study||531
1051434|NCT00811954|2552627|P1|COMPLETED|Overall Study||516
1051435|NCT00811954|2552625|P3|STARTED|Overall Study||601
1051436|NCT00811954|2552626|P2|STARTED|Overall Study||603
1051437|NCT00811954|2552627|P1|STARTED|Overall Study||605
1051438|NCT00812006|2552692|P3|NOT COMPLETED|Overall Study||6
1051439|NCT00812006|2552693|P2|NOT COMPLETED|Overall Study||3
1051440|NCT00812006|2552694|P1|NOT COMPLETED|Overall Study||6
1051441|NCT00812006|2552692|P3|COMPLETED|Overall Study||30
1051442|NCT00812006|2552693|P2|COMPLETED|Overall Study||33
1051443|NCT00812006|2552694|P1|COMPLETED|Overall Study||30
1051444|NCT00812006|2552692|P3|STARTED|Overall Study||36
1051445|NCT00812006|2552693|P2|STARTED|Overall Study||36
1051446|NCT00812006|2552694|P1|STARTED|Overall Study||36
1051447|NCT00812097|2552712|P4|NOT COMPLETED|Overall Study||35
1051448|NCT00812097|2552713|P3|NOT COMPLETED|Overall Study||57
1051449|NCT00812097|2552714|P2|NOT COMPLETED|Overall Study||89
1051450|NCT00812097|2552715|P1|NOT COMPLETED|Overall Study||245
1051451|NCT00812097|2552712|P4|COMPLETED|Overall Study||34
1051452|NCT00812097|2552713|P3|COMPLETED|Overall Study||67
1051453|NCT00812097|2552714|P2|COMPLETED|Overall Study||101
1051454|NCT00812097|2552715|P1|COMPLETED|Overall Study||327
1051455|NCT00812097|2552712|P4|STARTED|Overall Study||69
1051456|NCT00812097|2552713|P3|STARTED|Overall Study||124
1051457|NCT00812097|2552714|P2|STARTED|Overall Study||190
1051458|NCT00812097|2552715|P1|STARTED|Overall Study||572
1051459|NCT00812110|2552741|P1|NOT COMPLETED|Overall Study||0
1051460|NCT00812110|2552741|P1|COMPLETED|Overall Study||292
1051461|NCT00812110|2552741|P1|STARTED|Overall Study||292
1051462|NCT00812253|2552748|P2|NOT COMPLETED|Overall Study||3
1051463|NCT00812253|2552749|P1|NOT COMPLETED|Overall Study||6
1051464|NCT00812253|2552748|P2|COMPLETED|Overall Study||39
1051465|NCT00812253|2552749|P1|COMPLETED|Overall Study||26
1051466|NCT00812253|2552748|P2|STARTED|Overall Study||42
1051467|NCT00812253|2552749|P1|STARTED|Overall Study||32
1051468|NCT00812331|2552764|P5|NOT COMPLETED|Overall Study||0
1051469|NCT00812331|2552765|P4|NOT COMPLETED|Overall Study||0
1051470|NCT00812331|2552766|P3|NOT COMPLETED|Overall Study||0
1051471|NCT00812331|2552767|P2|NOT COMPLETED|Overall Study||0
1051472|NCT00812331|2552768|P1|NOT COMPLETED|Overall Study||1
1051473|NCT00812331|2552764|P5|COMPLETED|Overall Study||8
1051474|NCT00812331|2552765|P4|COMPLETED|Overall Study||7
1051475|NCT00812331|2552766|P3|COMPLETED|Overall Study||8
1051476|NCT00812331|2552767|P2|COMPLETED|Overall Study||8
1051477|NCT00812331|2552768|P1|COMPLETED|Overall Study||5
1051478|NCT00812331|2552764|P5|STARTED|Overall Study||8
1051479|NCT00812331|2552765|P4|STARTED|Overall Study||7
1051480|NCT00812331|2552766|P3|STARTED|Overall Study||8
1051481|NCT00812331|2552767|P2|STARTED|Overall Study||8
1051482|NCT00812331|2552768|P1|STARTED|Overall Study||6
1051483|NCT00812461|2552843|P2|NOT COMPLETED|All Treated Patients||147
1051484|NCT00812461|2552844|P1|NOT COMPLETED|All Treated Patients||132
1051485|NCT00812461|2552843|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|194
1051486|NCT00812461|2552844|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|205
1051487|NCT00812461|2552843|P2|STARTED|All Treated Patients||341
1051488|NCT00812461|2552844|P1|STARTED|All Treated Patients||337
1051489|NCT00812461|2552843|P2|NOT COMPLETED|All Randomised Patients||17
1051490|NCT00812461|2552844|P1|NOT COMPLETED|All Randomised Patients||23
1051491|NCT00812461|2552843|P2|COMPLETED|All Randomised Patients||341
1051492|NCT00812461|2552844|P1|COMPLETED|All Randomised Patients||337
1051493|NCT00812461|2552843|P2|STARTED|All Randomised Patients||358
1051494|NCT00812461|2552844|P1|STARTED|All Randomised Patients||360
1051495|NCT00812487|2552864|P2|NOT COMPLETED|Overall Study||3
1051496|NCT00812487|2552865|P1|NOT COMPLETED|Overall Study||6
1051497|NCT00812487|2552864|P2|COMPLETED|Overall Study||39
1051498|NCT00812487|2552865|P1|COMPLETED|Overall Study||26
1051499|NCT00812487|2552864|P2|STARTED|Overall Study||42
1051500|NCT00812487|2552865|P1|STARTED|Overall Study||32
1051501|NCT00812565|2552897|P8|NOT COMPLETED|Overall Study||1
1051502|NCT00812565|2552898|P7|NOT COMPLETED|Overall Study||0
1051503|NCT00812565|2552899|P6|NOT COMPLETED|Overall Study||1
1051504|NCT00812565|2552900|P5|NOT COMPLETED|Overall Study||1
1051505|NCT00812565|2552901|P4|NOT COMPLETED|Overall Study||2
1051506|NCT00812565|2552902|P3|NOT COMPLETED|Overall Study||0
1051507|NCT00812565|2552903|P2|NOT COMPLETED|Overall Study||1
1051508|NCT00812565|2552904|P1|NOT COMPLETED|Overall Study||3
1051509|NCT00812565|2552897|P8|COMPLETED|Overall Study||6
1051510|NCT00812565|2552898|P7|COMPLETED|Overall Study||8
1051511|NCT00812565|2552899|P6|COMPLETED|Overall Study||6
1051512|NCT00812565|2552900|P5|COMPLETED|Overall Study||6
1051513|NCT00812565|2552901|P4|COMPLETED|Overall Study||5
1051514|NCT00812565|2552902|P3|COMPLETED|Overall Study||7
1051515|NCT00812565|2552903|P2|COMPLETED|Overall Study||6
1051516|NCT00812565|2552904|P1|COMPLETED|Overall Study||5
1051517|NCT00812565|2552897|P8|STARTED|Overall Study||7
1051518|NCT00812565|2552898|P7|STARTED|Overall Study||8
1051519|NCT00812565|2552899|P6|STARTED|Overall Study||7
1051520|NCT00812565|2552900|P5|STARTED|Overall Study||7
1051521|NCT00812565|2552901|P4|STARTED|Overall Study||7
1051522|NCT00812565|2552902|P3|STARTED|Overall Study||7
1051523|NCT00812565|2552903|P2|STARTED|Overall Study||7
1051524|NCT00812565|2552904|P1|STARTED|Overall Study||8
1051525|NCT00812604|2553028|P2|NOT COMPLETED|Overall Study||5
1051526|NCT00812604|2553029|P1|NOT COMPLETED|Overall Study||5
1051527|NCT00812604|2553028|P2|COMPLETED|Overall Study||22
1051528|NCT00812604|2553029|P1|COMPLETED|Overall Study||23
1051529|NCT00812604|2553028|P2|STARTED|Overall Study||27
1051530|NCT00812604|2553029|P1|STARTED|Overall Study||28
1051531|NCT00812812|2553039|P2|NOT COMPLETED|Overall Study||4
1051532|NCT00812812|2553040|P1|NOT COMPLETED|Overall Study||3
1051533|NCT00812812|2553039|P2|COMPLETED|Overall Study||25
1051534|NCT00812812|2553040|P1|COMPLETED|Overall Study||24
1051535|NCT00812812|2553039|P2|STARTED|Overall Study||29
1051536|NCT00812812|2553040|P1|STARTED|Overall Study||27
1051537|NCT00812877|2553055|P2|NOT COMPLETED|Overall Study||51
1051538|NCT00812877|2553056|P1|NOT COMPLETED|Overall Study||37
1051539|NCT00812877|2553055|P2|COMPLETED|Overall Study||130
1051540|NCT00812877|2553056|P1|COMPLETED|Overall Study||158
1051541|NCT00812877|2553055|P2|STARTED|Overall Study||181
1051542|NCT00812877|2553056|P1|STARTED|Overall Study||195
1051543|NCT00812916|2553064|P1|NOT COMPLETED|Overall Study||3
1051544|NCT00812916|2553064|P1|COMPLETED|Overall Study||203
1051545|NCT00812916|2553064|P1|CFAE - Guided Ablation|Overall Study||203
1051546|NCT00812916|2553064|P1|Data Available|Overall Study||205
1051547|NCT00812916|2553064|P1|STARTED|Overall Study|206 enrolled (consented)|206
1051548|NCT00812929|2553073|P10|NOT COMPLETED|Treatment Period 5||0
1051549|NCT00812929|2553074|P9|NOT COMPLETED|Treatment Period 5||0
1051550|NCT00812929|2553075|P8|NOT COMPLETED|Treatment Period 5||0
1051551|NCT00812929|2553076|P7|NOT COMPLETED|Treatment Period 5||0
1051552|NCT00812929|2553077|P6|NOT COMPLETED|Treatment Period 5||0
1051553|NCT00812929|2553078|P5|NOT COMPLETED|Treatment Period 5||0
1051554|NCT00812929|2553079|P4|NOT COMPLETED|Treatment Period 5||0
1051555|NCT00812929|2553080|P3|NOT COMPLETED|Treatment Period 5||0
1051556|NCT00812929|2553081|P2|NOT COMPLETED|Treatment Period 5||0
1051557|NCT00812929|2553082|P1|NOT COMPLETED|Treatment Period 5||0
1051558|NCT00812929|2553073|P10|COMPLETED|Treatment Period 5||4
1051559|NCT00812929|2553074|P9|COMPLETED|Treatment Period 5||4
1051560|NCT00812929|2553075|P8|COMPLETED|Treatment Period 5||5
1051561|NCT00812929|2553076|P7|COMPLETED|Treatment Period 5||5
1051562|NCT00812929|2553077|P6|COMPLETED|Treatment Period 5||4
1051563|NCT00812929|2553078|P5|COMPLETED|Treatment Period 5||5
1051564|NCT00812929|2553079|P4|COMPLETED|Treatment Period 5||4
1051565|NCT00812929|2553080|P3|COMPLETED|Treatment Period 5||4
1051566|NCT00812929|2553081|P2|COMPLETED|Treatment Period 5||4
1051567|NCT00812929|2553082|P1|COMPLETED|Treatment Period 5||5
1051568|NCT00812929|2553073|P10|STARTED|Treatment Period 5||4
1051569|NCT00812929|2553074|P9|STARTED|Treatment Period 5||4
1051570|NCT00812929|2553075|P8|STARTED|Treatment Period 5||5
1051571|NCT00812929|2553076|P7|STARTED|Treatment Period 5||5
1051572|NCT00812929|2553077|P6|STARTED|Treatment Period 5||4
1051573|NCT00812929|2553078|P5|STARTED|Treatment Period 5||5
1051574|NCT00812929|2553079|P4|STARTED|Treatment Period 5||4
1051575|NCT00812929|2553080|P3|STARTED|Treatment Period 5||4
1051576|NCT00812929|2553081|P2|STARTED|Treatment Period 5||4
1051577|NCT00812929|2553082|P1|STARTED|Treatment Period 5||5
1051578|NCT00812929|2553073|P10|NOT COMPLETED|Washout Period 4 (7 Days)||0
1051579|NCT00812929|2553074|P9|NOT COMPLETED|Washout Period 4 (7 Days)||0
1051580|NCT00812929|2553075|P8|NOT COMPLETED|Washout Period 4 (7 Days)||0
1051581|NCT00812929|2553076|P7|NOT COMPLETED|Washout Period 4 (7 Days)||0
1051582|NCT00812929|2553077|P6|NOT COMPLETED|Washout Period 4 (7 Days)||0
1051583|NCT00812929|2553078|P5|NOT COMPLETED|Washout Period 4 (7 Days)||0
1051584|NCT00812929|2553079|P4|NOT COMPLETED|Washout Period 4 (7 Days)||0
1051585|NCT00812929|2553080|P3|NOT COMPLETED|Washout Period 4 (7 Days)||0
1051586|NCT00812929|2553081|P2|NOT COMPLETED|Washout Period 4 (7 Days)||0
1051587|NCT00812929|2553082|P1|NOT COMPLETED|Washout Period 4 (7 Days)||0
1051588|NCT00812929|2553073|P10|COMPLETED|Washout Period 4 (7 Days)||4
1051589|NCT00812929|2553074|P9|COMPLETED|Washout Period 4 (7 Days)||4
1051590|NCT00812929|2553075|P8|COMPLETED|Washout Period 4 (7 Days)||5
1051591|NCT00812929|2553076|P7|COMPLETED|Washout Period 4 (7 Days)||5
1051592|NCT00812929|2553077|P6|COMPLETED|Washout Period 4 (7 Days)||4
1051593|NCT00812929|2553078|P5|COMPLETED|Washout Period 4 (7 Days)||5
1051594|NCT00812929|2553079|P4|COMPLETED|Washout Period 4 (7 Days)||4
1051595|NCT00812929|2553080|P3|COMPLETED|Washout Period 4 (7 Days)||4
1051596|NCT00812929|2553081|P2|COMPLETED|Washout Period 4 (7 Days)||4
1051597|NCT00812929|2553082|P1|COMPLETED|Washout Period 4 (7 Days)||5
1051598|NCT00812929|2553073|P10|STARTED|Washout Period 4 (7 Days)||4
1051599|NCT00812929|2553074|P9|STARTED|Washout Period 4 (7 Days)||4
1051600|NCT00812929|2553075|P8|STARTED|Washout Period 4 (7 Days)||5
1051601|NCT00812929|2553076|P7|STARTED|Washout Period 4 (7 Days)||5
1051602|NCT00812929|2553077|P6|STARTED|Washout Period 4 (7 Days)||4
1051603|NCT00812929|2553078|P5|STARTED|Washout Period 4 (7 Days)||5
1051604|NCT00812929|2553079|P4|STARTED|Washout Period 4 (7 Days)||4
1051605|NCT00812929|2553080|P3|STARTED|Washout Period 4 (7 Days)||4
1051606|NCT00812929|2553081|P2|STARTED|Washout Period 4 (7 Days)||4
1051607|NCT00812929|2553082|P1|STARTED|Washout Period 4 (7 Days)||5
1051608|NCT00812929|2553073|P10|NOT COMPLETED|Treatment Period 4||0
1051609|NCT00812929|2553074|P9|NOT COMPLETED|Treatment Period 4||0
1051610|NCT00812929|2553075|P8|NOT COMPLETED|Treatment Period 4||0
1051611|NCT00812929|2553076|P7|NOT COMPLETED|Treatment Period 4||0
1051612|NCT00812929|2553077|P6|NOT COMPLETED|Treatment Period 4||0
1051613|NCT00812929|2553078|P5|NOT COMPLETED|Treatment Period 4||0
1051614|NCT00812929|2553079|P4|NOT COMPLETED|Treatment Period 4||0
1051615|NCT00812929|2553080|P3|NOT COMPLETED|Treatment Period 4||0
1051616|NCT00812929|2553081|P2|NOT COMPLETED|Treatment Period 4||0
1051617|NCT00812929|2553082|P1|NOT COMPLETED|Treatment Period 4||0
1051618|NCT00812929|2553073|P10|COMPLETED|Treatment Period 4||4
1051619|NCT00812929|2553074|P9|COMPLETED|Treatment Period 4||4
1051620|NCT00812929|2553075|P8|COMPLETED|Treatment Period 4||5
1051621|NCT00812929|2553076|P7|COMPLETED|Treatment Period 4||5
1051622|NCT00812929|2553077|P6|COMPLETED|Treatment Period 4||4
1051623|NCT00812929|2553078|P5|COMPLETED|Treatment Period 4||5
1051624|NCT00812929|2553079|P4|COMPLETED|Treatment Period 4||4
1051625|NCT00812929|2553080|P3|COMPLETED|Treatment Period 4||4
1051626|NCT00812929|2553081|P2|COMPLETED|Treatment Period 4||4
1051627|NCT00812929|2553082|P1|COMPLETED|Treatment Period 4||5
1051628|NCT00812929|2553073|P10|STARTED|Treatment Period 4||4
1051629|NCT00812929|2553074|P9|STARTED|Treatment Period 4||4
1051630|NCT00812929|2553075|P8|STARTED|Treatment Period 4||5
1051631|NCT00812929|2553076|P7|STARTED|Treatment Period 4||5
1051632|NCT00812929|2553077|P6|STARTED|Treatment Period 4||4
1051633|NCT00812929|2553078|P5|STARTED|Treatment Period 4||5
1051634|NCT00812929|2553079|P4|STARTED|Treatment Period 4||4
1051635|NCT00812929|2553080|P3|STARTED|Treatment Period 4||4
1051636|NCT00812929|2553081|P2|STARTED|Treatment Period 4||4
1051637|NCT00812929|2553082|P1|STARTED|Treatment Period 4||5
1051638|NCT00812929|2553073|P10|NOT COMPLETED|Washout Period 3 (7 Days)||0
1051639|NCT00812929|2553074|P9|NOT COMPLETED|Washout Period 3 (7 Days)||0
1051640|NCT00812929|2553075|P8|NOT COMPLETED|Washout Period 3 (7 Days)||0
1051641|NCT00812929|2553076|P7|NOT COMPLETED|Washout Period 3 (7 Days)||0
1051642|NCT00812929|2553077|P6|NOT COMPLETED|Washout Period 3 (7 Days)||1
1051643|NCT00812929|2553078|P5|NOT COMPLETED|Washout Period 3 (7 Days)||0
1051644|NCT00812929|2553079|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
1051645|NCT00812929|2553080|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
1051646|NCT00812929|2553081|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
1051647|NCT00812929|2553082|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
1051648|NCT00812929|2553073|P10|COMPLETED|Washout Period 3 (7 Days)||4
1051649|NCT00812929|2553074|P9|COMPLETED|Washout Period 3 (7 Days)||4
1051650|NCT00812929|2553075|P8|COMPLETED|Washout Period 3 (7 Days)||5
1051651|NCT00812929|2553076|P7|COMPLETED|Washout Period 3 (7 Days)||5
1051652|NCT00812929|2553077|P6|COMPLETED|Washout Period 3 (7 Days)||4
1051653|NCT00812929|2553078|P5|COMPLETED|Washout Period 3 (7 Days)||5
1051654|NCT00812929|2553079|P4|COMPLETED|Washout Period 3 (7 Days)||4
1051655|NCT00812929|2553080|P3|COMPLETED|Washout Period 3 (7 Days)||4
1051656|NCT00812929|2553081|P2|COMPLETED|Washout Period 3 (7 Days)||4
1051657|NCT00812929|2553082|P1|COMPLETED|Washout Period 3 (7 Days)||5
1051658|NCT00812929|2553073|P10|STARTED|Washout Period 3 (7 Days)||4
1051659|NCT00812929|2553074|P9|STARTED|Washout Period 3 (7 Days)||4
1051660|NCT00812929|2553075|P8|STARTED|Washout Period 3 (7 Days)||5
1051661|NCT00812929|2553076|P7|STARTED|Washout Period 3 (7 Days)||5
1051662|NCT00812929|2553077|P6|STARTED|Washout Period 3 (7 Days)||5
1051663|NCT00812929|2553078|P5|STARTED|Washout Period 3 (7 Days)||5
1051664|NCT00812929|2553079|P4|STARTED|Washout Period 3 (7 Days)||4
1051665|NCT00812929|2553080|P3|STARTED|Washout Period 3 (7 Days)||4
1051666|NCT00812929|2553081|P2|STARTED|Washout Period 3 (7 Days)||4
1051667|NCT00812929|2553082|P1|STARTED|Washout Period 3 (7 Days)||5
1051668|NCT00812929|2553073|P10|NOT COMPLETED|Treatment Period 3||0
1051669|NCT00812929|2553074|P9|NOT COMPLETED|Treatment Period 3||0
1051670|NCT00812929|2553075|P8|NOT COMPLETED|Treatment Period 3||0
1051671|NCT00812929|2553076|P7|NOT COMPLETED|Treatment Period 3||0
1051672|NCT00812929|2553077|P6|NOT COMPLETED|Treatment Period 3||0
1051673|NCT00812929|2553078|P5|NOT COMPLETED|Treatment Period 3||0
1051674|NCT00812929|2553079|P4|NOT COMPLETED|Treatment Period 3||0
1051675|NCT00812929|2553080|P3|NOT COMPLETED|Treatment Period 3||0
1051676|NCT00812929|2553081|P2|NOT COMPLETED|Treatment Period 3||0
1051677|NCT00812929|2553082|P1|NOT COMPLETED|Treatment Period 3||0
1051678|NCT00812929|2553073|P10|COMPLETED|Treatment Period 3||4
1051679|NCT00812929|2553074|P9|COMPLETED|Treatment Period 3||4
1051680|NCT00812929|2553075|P8|COMPLETED|Treatment Period 3||5
1051681|NCT00812929|2553076|P7|COMPLETED|Treatment Period 3||5
1051682|NCT00812929|2553077|P6|COMPLETED|Treatment Period 3||5
1051683|NCT00812929|2553078|P5|COMPLETED|Treatment Period 3||5
1051684|NCT00812929|2553079|P4|COMPLETED|Treatment Period 3||4
1051685|NCT00812929|2553080|P3|COMPLETED|Treatment Period 3||4
1051686|NCT00812929|2553081|P2|COMPLETED|Treatment Period 3||4
1051687|NCT00812929|2553082|P1|COMPLETED|Treatment Period 3||5
1051688|NCT00812929|2553073|P10|STARTED|Treatment Period 3||4
1051689|NCT00812929|2553074|P9|STARTED|Treatment Period 3||4
1051690|NCT00812929|2553075|P8|STARTED|Treatment Period 3||5
1051691|NCT00812929|2553076|P7|STARTED|Treatment Period 3||5
1051692|NCT00812929|2553077|P6|STARTED|Treatment Period 3||5
1051693|NCT00812929|2553078|P5|STARTED|Treatment Period 3||5
1051694|NCT00812929|2553079|P4|STARTED|Treatment Period 3||4
1051695|NCT00812929|2553080|P3|STARTED|Treatment Period 3||4
1051696|NCT00812929|2553081|P2|STARTED|Treatment Period 3||4
1051697|NCT00812929|2553082|P1|STARTED|Treatment Period 3||5
1051698|NCT00812929|2553073|P10|NOT COMPLETED|Washout Period 2 (7 Days)||1
1051699|NCT00812929|2553074|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
1051700|NCT00812929|2553075|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
1051701|NCT00812929|2553076|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
1051702|NCT00812929|2553077|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
1051703|NCT00812929|2553078|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
1051704|NCT00812929|2553079|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
1051705|NCT00812929|2553080|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
1051706|NCT00812929|2553081|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
1051707|NCT00812929|2553082|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
1051708|NCT00812929|2553073|P10|COMPLETED|Washout Period 2 (7 Days)||4
1051709|NCT00812929|2553074|P9|COMPLETED|Washout Period 2 (7 Days)||4
1051710|NCT00812929|2553075|P8|COMPLETED|Washout Period 2 (7 Days)||5
1051711|NCT00812929|2553076|P7|COMPLETED|Washout Period 2 (7 Days)||5
1051712|NCT00812929|2553077|P6|COMPLETED|Washout Period 2 (7 Days)||5
1051713|NCT00812929|2553078|P5|COMPLETED|Washout Period 2 (7 Days)||5
1051714|NCT00812929|2553079|P4|COMPLETED|Washout Period 2 (7 Days)||4
1051715|NCT00812929|2553080|P3|COMPLETED|Washout Period 2 (7 Days)||4
1051716|NCT00812929|2553081|P2|COMPLETED|Washout Period 2 (7 Days)||4
1051717|NCT00812929|2553082|P1|COMPLETED|Washout Period 2 (7 Days)||5
1051718|NCT00812929|2553073|P10|STARTED|Washout Period 2 (7 Days)||5
1051719|NCT00812929|2553074|P9|STARTED|Washout Period 2 (7 Days)||4
1051720|NCT00812929|2553075|P8|STARTED|Washout Period 2 (7 Days)||5
1051721|NCT00812929|2553076|P7|STARTED|Washout Period 2 (7 Days)||5
1051722|NCT00812929|2553077|P6|STARTED|Washout Period 2 (7 Days)||5
1051723|NCT00812929|2553078|P5|STARTED|Washout Period 2 (7 Days)||5
1051724|NCT00812929|2553079|P4|STARTED|Washout Period 2 (7 Days)||4
1051725|NCT00812929|2553080|P3|STARTED|Washout Period 2 (7 Days)||4
1051726|NCT00812929|2553081|P2|STARTED|Washout Period 2 (7 Days)||4
1051727|NCT00812929|2553082|P1|STARTED|Washout Period 2 (7 Days)||5
1051728|NCT00812929|2553073|P10|NOT COMPLETED|Treatment Period 2||0
1051729|NCT00812929|2553074|P9|NOT COMPLETED|Treatment Period 2||0
1051730|NCT00812929|2553075|P8|NOT COMPLETED|Treatment Period 2||0
1051731|NCT00812929|2553076|P7|NOT COMPLETED|Treatment Period 2||0
1051732|NCT00812929|2553077|P6|NOT COMPLETED|Treatment Period 2||0
1051733|NCT00812929|2553078|P5|NOT COMPLETED|Treatment Period 2||0
1051734|NCT00812929|2553079|P4|NOT COMPLETED|Treatment Period 2||0
1051735|NCT00812929|2553080|P3|NOT COMPLETED|Treatment Period 2||0
1051736|NCT00812929|2553081|P2|NOT COMPLETED|Treatment Period 2||0
1051737|NCT00812929|2553082|P1|NOT COMPLETED|Treatment Period 2||0
1051738|NCT00812929|2553073|P10|COMPLETED|Treatment Period 2||5
1051739|NCT00812929|2553074|P9|COMPLETED|Treatment Period 2||4
1051740|NCT00812929|2553075|P8|COMPLETED|Treatment Period 2||5
1051741|NCT00812929|2553076|P7|COMPLETED|Treatment Period 2||5
1051742|NCT00812929|2553077|P6|COMPLETED|Treatment Period 2||5
1051743|NCT00812929|2553078|P5|COMPLETED|Treatment Period 2||5
1051744|NCT00812929|2553079|P4|COMPLETED|Treatment Period 2||4
1051745|NCT00812929|2553080|P3|COMPLETED|Treatment Period 2||4
1051746|NCT00812929|2553081|P2|COMPLETED|Treatment Period 2||4
1051747|NCT00812929|2553082|P1|COMPLETED|Treatment Period 2||5
1051748|NCT00812929|2553073|P10|STARTED|Treatment Period 2||5
1051749|NCT00812929|2553074|P9|STARTED|Treatment Period 2||4
1051750|NCT00812929|2553075|P8|STARTED|Treatment Period 2||5
1051751|NCT00812929|2553076|P7|STARTED|Treatment Period 2||5
1051752|NCT00812929|2553077|P6|STARTED|Treatment Period 2||5
1051753|NCT00812929|2553078|P5|STARTED|Treatment Period 2||5
1051754|NCT00812929|2553079|P4|STARTED|Treatment Period 2||4
1051755|NCT00812929|2553080|P3|STARTED|Treatment Period 2||4
1051756|NCT00812929|2553081|P2|STARTED|Treatment Period 2||4
1051757|NCT00812929|2553082|P1|STARTED|Treatment Period 2||5
1051758|NCT00812929|2553073|P10|NOT COMPLETED|Washout Period 1 (7 Days)||0
1051759|NCT00812929|2553074|P9|NOT COMPLETED|Washout Period 1 (7 Days)||0
1051760|NCT00812929|2553075|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
1051761|NCT00812929|2553076|P7|NOT COMPLETED|Washout Period 1 (7 Days)||0
1051762|NCT00812929|2553077|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
1051763|NCT00812929|2553078|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
1051764|NCT00812929|2553079|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
1051765|NCT00812929|2553080|P3|NOT COMPLETED|Washout Period 1 (7 Days)||1
1051766|NCT00812929|2553081|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
1051767|NCT00812929|2553082|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
1051768|NCT00812929|2553073|P10|COMPLETED|Washout Period 1 (7 Days)||5
1051769|NCT00812929|2553074|P9|COMPLETED|Washout Period 1 (7 Days)||4
1051770|NCT00812929|2553075|P8|COMPLETED|Washout Period 1 (7 Days)||5
1051771|NCT00812929|2553076|P7|COMPLETED|Washout Period 1 (7 Days)||5
1051772|NCT00812929|2553077|P6|COMPLETED|Washout Period 1 (7 Days)||5
1051773|NCT00812929|2553078|P5|COMPLETED|Washout Period 1 (7 Days)||5
1051774|NCT00812929|2553079|P4|COMPLETED|Washout Period 1 (7 Days)||4
1051775|NCT00812929|2553080|P3|COMPLETED|Washout Period 1 (7 Days)||4
1051776|NCT00812929|2553081|P2|COMPLETED|Washout Period 1 (7 Days)||4
1051777|NCT00812929|2553082|P1|COMPLETED|Washout Period 1 (7 Days)||5
1051778|NCT00812929|2553073|P10|STARTED|Washout Period 1 (7 Days)||5
1051779|NCT00812929|2553074|P9|STARTED|Washout Period 1 (7 Days)||4
1051780|NCT00812929|2553075|P8|STARTED|Washout Period 1 (7 Days)||5
1051781|NCT00812929|2553076|P7|STARTED|Washout Period 1 (7 Days)||5
1051782|NCT00812929|2553077|P6|STARTED|Washout Period 1 (7 Days)||5
1051783|NCT00812929|2553078|P5|STARTED|Washout Period 1 (7 Days)||5
1051784|NCT00812929|2553079|P4|STARTED|Washout Period 1 (7 Days)||4
1051785|NCT00812929|2553080|P3|STARTED|Washout Period 1 (7 Days)||5
1051786|NCT00812929|2553081|P2|STARTED|Washout Period 1 (7 Days)||4
1051787|NCT00812929|2553082|P1|STARTED|Washout Period 1 (7 Days)||5
1051788|NCT00812929|2553073|P10|NOT COMPLETED|Treatment Period 1||0
1051789|NCT00812929|2553074|P9|NOT COMPLETED|Treatment Period 1||0
1051790|NCT00812929|2553075|P8|NOT COMPLETED|Treatment Period 1||0
1051791|NCT00812929|2553076|P7|NOT COMPLETED|Treatment Period 1||0
1051792|NCT00812929|2553077|P6|NOT COMPLETED|Treatment Period 1||0
1051793|NCT00812929|2553078|P5|NOT COMPLETED|Treatment Period 1||0
1051794|NCT00812929|2553079|P4|NOT COMPLETED|Treatment Period 1||0
1051795|NCT00812929|2553080|P3|NOT COMPLETED|Treatment Period 1||0
1051796|NCT00812929|2553081|P2|NOT COMPLETED|Treatment Period 1||0
1051797|NCT00812929|2553082|P1|NOT COMPLETED|Treatment Period 1||0
1051798|NCT00812929|2553073|P10|COMPLETED|Treatment Period 1||5
1051799|NCT00812929|2553074|P9|COMPLETED|Treatment Period 1||4
1051800|NCT00812929|2553075|P8|COMPLETED|Treatment Period 1||5
1051801|NCT00812929|2553076|P7|COMPLETED|Treatment Period 1||5
1051802|NCT00812929|2553077|P6|COMPLETED|Treatment Period 1||5
1051803|NCT00812929|2553078|P5|COMPLETED|Treatment Period 1||5
1051804|NCT00812929|2553079|P4|COMPLETED|Treatment Period 1||4
1051805|NCT00812929|2553080|P3|COMPLETED|Treatment Period 1||5
1051806|NCT00812929|2553081|P2|COMPLETED|Treatment Period 1||4
1051807|NCT00812929|2553082|P1|COMPLETED|Treatment Period 1||5
1051808|NCT00812929|2553073|P10|STARTED|Treatment Period 1||5
1051809|NCT00812929|2553074|P9|STARTED|Treatment Period 1||4
1051810|NCT00812929|2553075|P8|STARTED|Treatment Period 1||5
1051811|NCT00812929|2553076|P7|STARTED|Treatment Period 1||5
1051812|NCT00812929|2553077|P6|STARTED|Treatment Period 1||5
1051813|NCT00812929|2553078|P5|STARTED|Treatment Period 1||5
1051814|NCT00812929|2553079|P4|STARTED|Treatment Period 1||4
1051815|NCT00812929|2553080|P3|STARTED|Treatment Period 1||5
1051816|NCT00812929|2553081|P2|STARTED|Treatment Period 1||4
1051817|NCT00812929|2553082|P1|STARTED|Treatment Period 1||5
1051818|NCT00812955|2553202|P4|NOT COMPLETED|Overall Study||8
1051819|NCT00812955|2553203|P3|NOT COMPLETED|Overall Study||6
1051820|NCT00812955|2553204|P2|NOT COMPLETED|Overall Study||7
1051821|NCT00812955|2553205|P1|NOT COMPLETED|Overall Study||10
1051822|NCT00812955|2553202|P4|COMPLETED|Overall Study||110
1051823|NCT00812955|2553203|P3|COMPLETED|Overall Study||113
1051824|NCT00812955|2553204|P2|COMPLETED|Overall Study||111
1051825|NCT00812955|2553205|P1|COMPLETED|Overall Study||109
1051826|NCT00812955|2553202|P4|STARTED|Overall Study||118
1051827|NCT00812955|2553203|P3|STARTED|Overall Study||119
1051828|NCT00812955|2553204|P2|STARTED|Overall Study||118
1051829|NCT00812955|2553205|P1|STARTED|Overall Study||119
1051830|NCT00812968|2553225|P1|NOT COMPLETED|Overall Study||11
1051831|NCT00812968|2553225|P1|COMPLETED|Overall Study||0
1051832|NCT00812968|2553225|P1|STARTED|Overall Study||11
1051833|NCT00812981|2553258|P2|NOT COMPLETED|Overall Study||1
1051834|NCT00812981|2553259|P1|NOT COMPLETED|Overall Study||0
1051835|NCT00812981|2553258|P2|COMPLETED|Overall Study||159
1051836|NCT00812981|2553259|P1|COMPLETED|Overall Study||160
1051837|NCT00812981|2553258|P2|STARTED|Overall Study||160
1051838|NCT00812981|2553259|P1|STARTED|Overall Study||160
1051839|NCT00813098|2553300|P3|NOT COMPLETED|Overall Study||2
1051840|NCT00813098|2553301|P2|NOT COMPLETED|Overall Study||8
1051841|NCT00813098|2553302|P1|NOT COMPLETED|Overall Study||3
1051842|NCT00813098|2553300|P3|COMPLETED|Overall Study||50
1051843|NCT00813098|2553301|P2|COMPLETED|Overall Study||46
1051844|NCT00813098|2553302|P1|COMPLETED|Overall Study||46
1051845|NCT00813098|2553300|P3|STARTED|Overall Study||52
1051846|NCT00813098|2553301|P2|STARTED|Overall Study||54
1051847|NCT00813098|2553302|P1|STARTED|Overall Study||49
1051848|NCT00813111|2553327|P2|NOT COMPLETED|Overall Study||0
1051849|NCT00813111|2553328|P1|NOT COMPLETED|Overall Study||2
1051850|NCT00813111|2553327|P2|COMPLETED|Overall Study||70
1051851|NCT00813111|2553328|P1|COMPLETED|Overall Study||64
1051852|NCT00813111|2553327|P2|STARTED|Overall Study||70
1051853|NCT00813111|2553328|P1|STARTED|Overall Study||66
1051854|NCT00813150|2553336|P2|NOT COMPLETED|Long Term Follow-up||31
1051855|NCT00813150|2553337|P1|NOT COMPLETED|Long Term Follow-up||24
1051856|NCT00813150|2553336|P2|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|0
1051857|NCT00813150|2553337|P1|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|2
1051858|NCT00813150|2553336|P2|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|31
1051859|NCT00813150|2553337|P1|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|26
1051860|NCT00813150|2553336|P2|NOT COMPLETED|Treatment Period||32
1051861|NCT00813150|2553337|P1|NOT COMPLETED|Treatment Period||32
1051862|NCT00813150|2553336|P2|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|15
1051863|NCT00813150|2553337|P1|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|14
1051864|NCT00813150|2553336|P2|Intent-to-treat Participants|Treatment Period||47
1051865|NCT00813150|2553337|P1|Intent-to-treat Participants|Treatment Period||43
1051866|NCT00813150|2553336|P2|STARTED|Treatment Period|Number of randomized and treated participants|47
1051867|NCT00813150|2553337|P1|STARTED|Treatment Period|Number of randomized and treated participants|46
1051868|NCT00813319|2553351|P2|NOT COMPLETED|Overall Study||0
1051869|NCT00813319|2553352|P1|NOT COMPLETED|Overall Study||0
1051870|NCT00813319|2553351|P2|COMPLETED|Overall Study|104 out of 108 have complete follow-up data, there were 4 missing charts 7 months post-randomization|108
1051871|NCT00813319|2553352|P1|COMPLETED|Overall Study|100 out of 108 have complete follow-up data, there were 8 missing charts 7 months post-randomization|108
1051872|NCT00813319|2553351|P2|STARTED|Overall Study||108
1051873|NCT00813319|2553352|P1|STARTED|Overall Study||108
1051874|NCT00813488|2553362|P2|NOT COMPLETED|Open-label Extension||7
1051875|NCT00813488|2553363|P1|NOT COMPLETED|Open-label Extension||12
1051876|NCT00813488|2553362|P2|COMPLETED|Open-label Extension|This group received standard of care (including immediate-release oxycodone)|59
1051877|NCT00813488|2553363|P1|COMPLETED|Open-label Extension|This group received FBT open--label|53
1051878|NCT00813488|2553362|P2|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|66
1051879|NCT00813488|2553363|P1|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|65
1051880|NCT00813488|2553362|P2|NOT COMPLETED|Double-blind Treatment Period 2||1
1051881|NCT00813488|2553363|P1|NOT COMPLETED|Double-blind Treatment Period 2||5
1051882|NCT00813488|2553362|P2|COMPLETED|Double-blind Treatment Period 2||65
1051883|NCT00813488|2553363|P1|COMPLETED|Double-blind Treatment Period 2||66
1051884|NCT00813488|2553362|P2|STARTED|Double-blind Treatment Period 2||66
1051885|NCT00813488|2553363|P1|STARTED|Double-blind Treatment Period 2||71
1051886|NCT00813488|2553362|P2|NOT COMPLETED|Double-blind Treatment Period 1||5
1051887|NCT00813488|2553363|P1|NOT COMPLETED|Double-blind Treatment Period 1||1
1051888|NCT00813488|2553362|P2|COMPLETED|Double-blind Treatment Period 1||66
1051889|NCT00813488|2553363|P1|COMPLETED|Double-blind Treatment Period 1||71
1051890|NCT00813488|2553362|P2|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|71
1051891|NCT00813488|2553363|P1|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|72
1051892|NCT00813488|2553362|P2|NOT COMPLETED|Titration Period 2||10
1051893|NCT00813488|2553363|P1|NOT COMPLETED|Titration Period 2||16
1051894|NCT00813488|2553362|P2|COMPLETED|Titration Period 2||79
1051895|NCT00813488|2553363|P1|COMPLETED|Titration Period 2||64
1051896|NCT00813488|2553362|P2|STARTED|Titration Period 2||89
1051897|NCT00813488|2553363|P1|STARTED|Titration Period 2||80
1051898|NCT00813488|2553362|P2|NOT COMPLETED|Titration Period 1||17
1051899|NCT00813488|2553363|P1|NOT COMPLETED|Titration Period 1||27
1051900|NCT00813488|2553362|P2|COMPLETED|Titration Period 1||89
1051901|NCT00813488|2553363|P1|COMPLETED|Titration Period 1||80
1051902|NCT00813488|2553362|P2|STARTED|Titration Period 1||106
1051903|NCT00813488|2553363|P1|STARTED|Titration Period 1||107
1051904|NCT00813592|2553459|P1|NOT COMPLETED|Overall Study||2
1051905|NCT00813592|2553459|P1|COMPLETED|Overall Study||0
1051906|NCT00813592|2553459|P1|Response Assessment|Overall Study|One patient met the response assessment.|1
1051907|NCT00813592|2553459|P1|Treated|Overall Study|Two patients were treated.|2
1051908|NCT00813592|2553459|P1|STARTED|Overall Study||2
1051909|NCT00813709|2553471|P6|NOT COMPLETED|Open Label Period||11
1051910|NCT00813709|2553472|P5|NOT COMPLETED|Open Label Period||10
1051911|NCT00813709|2553473|P4|NOT COMPLETED|Open Label Period||20
1051912|NCT00813709|2553474|P3|NOT COMPLETED|Open Label Period||0
1051913|NCT00813709|2553475|P2|NOT COMPLETED|Open Label Period||0
1051914|NCT00813709|2553476|P1|NOT COMPLETED|Open Label Period||0
1051915|NCT00813709|2553471|P6|COMPLETED|Open Label Period||35
1051916|NCT00813709|2553472|P5|COMPLETED|Open Label Period||41
1051917|NCT00813709|2553473|P4|COMPLETED|Open Label Period||38
1051918|NCT00813709|2553474|P3|COMPLETED|Open Label Period||0
1051919|NCT00813709|2553475|P2|COMPLETED|Open Label Period||0
1051920|NCT00813709|2553476|P1|COMPLETED|Open Label Period||0
1051921|NCT00813709|2553471|P6|Treated|Open Label Period||45
1051922|NCT00813709|2553472|P5|Treated|Open Label Period||51
1051923|NCT00813709|2553473|P4|Treated|Open Label Period||57
1051924|NCT00813709|2553474|P3|Treated|Open Label Period||0
1051925|NCT00813709|2553475|P2|Treated|Open Label Period||0
1051926|NCT00813709|2553476|P1|Treated|Open Label Period||0
1051927|NCT00813709|2553471|P6|STARTED|Open Label Period|28 participants in OL period initially + 18 participants from DB converted to CDMS during the study|46
1051928|NCT00813709|2553472|P5|STARTED|Open Label Period|25 participants in OL period initially + 26 participants from DB converted to CDMS during the study|51
1051929|NCT00813709|2553473|P4|STARTED|Open Label Period|49 participants in OL period initially + 9 participants from DB converted to CDMS during the study|58
1051930|NCT00813709|2553474|P3|STARTED|Open Label Period||0
1051931|NCT00813709|2553475|P2|STARTED|Open Label Period||0
1051932|NCT00813709|2553476|P1|STARTED|Open Label Period||0
1051933|NCT00813709|2553471|P6|NOT COMPLETED|Double Blind Period||0
1051934|NCT00813709|2553472|P5|NOT COMPLETED|Double Blind Period||0
1051935|NCT00813709|2553473|P4|NOT COMPLETED|Double Blind Period||0
1051936|NCT00813709|2553474|P3|NOT COMPLETED|Double Blind Period||31
1051937|NCT00813709|2553475|P2|NOT COMPLETED|Double Blind Period||41
1051938|NCT00813709|2553476|P1|NOT COMPLETED|Double Blind Period||31
1051939|NCT00813709|2553471|P6|COMPLETED|Double Blind Period||0
1051940|NCT00813709|2553472|P5|COMPLETED|Double Blind Period||0
1051941|NCT00813709|2553473|P4|COMPLETED|Double Blind Period||0
1051942|NCT00813709|2553474|P3|COMPLETED|Double Blind Period||68
1051943|NCT00813709|2553475|P2|COMPLETED|Double Blind Period||76
1051944|NCT00813709|2553476|P1|COMPLETED|Double Blind Period||53
1051945|NCT00813709|2553471|P6|Treated|Double Blind Period||0
1051946|NCT00813709|2553472|P5|Treated|Double Blind Period||0
1051947|NCT00813709|2553473|P4|Treated|Double Blind Period||0
1051948|NCT00813709|2553474|P3|Treated|Double Blind Period||98
1051949|NCT00813709|2553475|P2|Treated|Double Blind Period||114
1051950|NCT00813709|2553476|P1|Treated|Double Blind Period||83
1051951|NCT00813709|2553471|P6|STARTED|Double Blind Period||0
1051952|NCT00813709|2553472|P5|STARTED|Double Blind Period||0
1051953|NCT00813709|2553473|P4|STARTED|Double Blind Period||0
1051954|NCT00813709|2553474|P3|STARTED|Double Blind Period||99
1051955|NCT00813709|2553475|P2|STARTED|Double Blind Period||117
1051956|NCT00813709|2553476|P1|STARTED|Double Blind Period||84
1051957|NCT00813748|2553558|P2|NOT COMPLETED|Skin Test Substudy||1
1051958|NCT00813748|2553559|P1|NOT COMPLETED|Skin Test Substudy||0
1051959|NCT00813748|2553558|P2|COMPLETED|Skin Test Substudy||7
1051960|NCT00813748|2553559|P1|COMPLETED|Skin Test Substudy||3
1051961|NCT00813748|2553558|P2|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|8
1051962|NCT00813748|2553559|P1|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|3
1051963|NCT00813748|2553558|P2|NOT COMPLETED|Main Observational Study||0
1051964|NCT00813748|2553559|P1|NOT COMPLETED|Main Observational Study||0
1051965|NCT00813748|2553558|P2|COMPLETED|Main Observational Study||88
1051966|NCT00813748|2553559|P1|COMPLETED|Main Observational Study||30
1051967|NCT00813748|2553558|P2|STARTED|Main Observational Study||88
1051968|NCT00813748|2553559|P1|STARTED|Main Observational Study||30
1051969|NCT00813761|2553587|P4|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||5
1051970|NCT00813761|2553588|P3|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
1051971|NCT00813761|2553589|P2|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
1051972|NCT00813761|2553590|P1|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||16
1051973|NCT00813761|2553587|P4|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||100
1051974|NCT00813761|2553588|P3|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||94
1051975|NCT00813761|2553589|P2|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||91
1051976|NCT00813761|2553590|P1|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||101
1051977|NCT00813761|2553587|P4|STARTED|Phase 2 (4 Weeks to 24 Weeks)||105
1051978|NCT00813761|2553588|P3|STARTED|Phase 2 (4 Weeks to 24 Weeks)||103
1051979|NCT00813761|2553589|P2|STARTED|Phase 2 (4 Weeks to 24 Weeks)||100
1051980|NCT00813761|2553590|P1|STARTED|Phase 2 (4 Weeks to 24 Weeks)||117
1051981|NCT00813761|2553587|P4|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||2
1051982|NCT00813761|2553588|P3|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||12
1051983|NCT00813761|2553589|P2|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||3
1051984|NCT00813761|2553590|P1|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||4
1051985|NCT00813761|2553587|P4|COMPLETED|Phase 1 (Baseline to 4 Weeks)||105
1051986|NCT00813761|2553588|P3|COMPLETED|Phase 1 (Baseline to 4 Weeks)||103
1051987|NCT00813761|2553589|P2|COMPLETED|Phase 1 (Baseline to 4 Weeks)||100
1051988|NCT00813761|2553590|P1|COMPLETED|Phase 1 (Baseline to 4 Weeks)||117
1051989|NCT00813761|2553587|P4|STARTED|Phase 1 (Baseline to 4 Weeks)||107
1051990|NCT00813761|2553588|P3|STARTED|Phase 1 (Baseline to 4 Weeks)||115
1051991|NCT00813761|2553589|P2|STARTED|Phase 1 (Baseline to 4 Weeks)||103
1051992|NCT00813761|2553590|P1|STARTED|Phase 1 (Baseline to 4 Weeks)||121
1051993|NCT00805545|2553640|P2|NOT COMPLETED|Overall Study||3
1051994|NCT00805545|2553641|P1|NOT COMPLETED|Overall Study||6
1051995|NCT00805545|2553640|P2|COMPLETED|Overall Study||197
1051996|NCT00805545|2553641|P1|COMPLETED|Overall Study||194
1051997|NCT00805545|2553640|P2|STARTED|Overall Study||200
1051998|NCT00805545|2553641|P1|STARTED|Overall Study||200
1051999|NCT00805675|2553650|P3|NOT COMPLETED|Overall Study||1
1052000|NCT00805675|2553651|P2|NOT COMPLETED|Overall Study||0
1052001|NCT00805675|2553652|P1|NOT COMPLETED|Overall Study||0
1052002|NCT00805675|2553650|P3|COMPLETED|Overall Study||15
1052003|NCT00805675|2553651|P2|COMPLETED|Overall Study||14
1052004|NCT00805675|2553652|P1|COMPLETED|Overall Study||16
1052005|NCT00805675|2553650|P3|STARTED|Overall Study||16
1052006|NCT00805675|2553651|P2|STARTED|Overall Study||14
1052007|NCT00805675|2553652|P1|STARTED|Overall Study||16
1052008|NCT00805740|2553686|P2|NOT COMPLETED|Overall Study||4
1052009|NCT00805740|2553687|P1|NOT COMPLETED|Overall Study||11
1052010|NCT00805740|2553686|P2|COMPLETED|Overall Study||9
1052011|NCT00805740|2553687|P1|COMPLETED|Overall Study||17
1052012|NCT00805740|2553686|P2|Treated|Overall Study||13
1052013|NCT00805740|2553687|P1|Treated|Overall Study||26
1052014|NCT00805740|2553686|P2|STARTED|Overall Study||13
1052015|NCT00805740|2553687|P1|STARTED|Overall Study||28
1052016|NCT00805766|2553709|P1|NOT COMPLETED|Increased Dose Period||13
1052017|NCT00805766|2553709|P1|COMPLETED|Increased Dose Period||26
1052018|NCT00805766|2553709|P1|STARTED|Increased Dose Period||39
1052019|NCT00805766|2553709|P1|NOT COMPLETED|Screening Period||6
1052020|NCT00805766|2553709|P1|COMPLETED|Screening Period||39
1052021|NCT00805766|2553709|P1|STARTED|Screening Period||45
1052022|NCT00805792|2553716|P1|NOT COMPLETED|Overall Study||5
1052023|NCT00805792|2553716|P1|COMPLETED|Overall Study||28
1052024|NCT00805792|2553716|P1|STARTED|Overall Study||33
1052025|NCT00805870|2553726|P2|NOT COMPLETED|Overall Study||0
1052026|NCT00805870|2553727|P1|NOT COMPLETED|Overall Study||0
1052027|NCT00805870|2553726|P2|COMPLETED|Overall Study||10
1052028|NCT00805870|2553727|P1|COMPLETED|Overall Study||10
1052029|NCT00805870|2553726|P2|STARTED|Overall Study||10
1052030|NCT00805870|2553727|P1|STARTED|Overall Study||10
1052031|NCT00805935|2553743|P4|NOT COMPLETED|Overall Study||11
1052032|NCT00805935|2553744|P3|NOT COMPLETED|Overall Study||15
1052033|NCT00805935|2553745|P2|NOT COMPLETED|Overall Study||19
1052034|NCT00805935|2553746|P1|NOT COMPLETED|Overall Study||13
1052035|NCT00805935|2553743|P4|COMPLETED|Overall Study||19
1052036|NCT00805935|2553744|P3|COMPLETED|Overall Study||13
1052037|NCT00805935|2553745|P2|COMPLETED|Overall Study||8
1052038|NCT00805935|2553746|P1|COMPLETED|Overall Study||12
1052039|NCT00805935|2553743|P4|STARTED|Overall Study||30
1052040|NCT00805935|2553744|P3|STARTED|Overall Study||28
1052041|NCT00805935|2553745|P2|STARTED|Overall Study||27
1052042|NCT00805935|2553746|P1|STARTED|Overall Study||25
1052043|NCT00805961|2553798|P1|NOT COMPLETED|Maintenance Treatment||34
1052044|NCT00805961|2553798|P1|COMPLETED|Maintenance Treatment||23
1052045|NCT00805961|2553798|P1|STARTED|Maintenance Treatment||57
1052046|NCT00805961|2553798|P1|NOT COMPLETED|Treatment-Free Interval||7
1052047|NCT00805961|2553798|P1|COMPLETED|Treatment-Free Interval||57
1052048|NCT00805961|2553798|P1|STARTED|Treatment-Free Interval||64
1052049|NCT00805961|2553798|P1|NOT COMPLETED|Modality Therapy||4
1052050|NCT00805961|2553798|P1|COMPLETED|Modality Therapy||64
1052051|NCT00805961|2553798|P1|STARTED|Modality Therapy||68
1052052|NCT00806026|2553810|P6|NOT COMPLETED|Overall Study||32
1052053|NCT00806026|2553811|P5|NOT COMPLETED|Overall Study||30
1052054|NCT00806026|2553812|P4|NOT COMPLETED|Overall Study||29
1052055|NCT00806026|2553813|P3|NOT COMPLETED|Overall Study||93
1052056|NCT00806026|2553814|P2|NOT COMPLETED|Overall Study||101
1052057|NCT00806026|2553815|P1|NOT COMPLETED|Overall Study||92
1052058|NCT00806026|2553810|P6|COMPLETED|Overall Study||29
1052059|NCT00806026|2553811|P5|COMPLETED|Overall Study||29
1052060|NCT00806026|2553812|P4|COMPLETED|Overall Study||32
1052061|NCT00806026|2553813|P3|COMPLETED|Overall Study||89
1052062|NCT00806026|2553814|P2|COMPLETED|Overall Study||82
1052063|NCT00806026|2553815|P1|COMPLETED|Overall Study||93
1052064|NCT00806026|2553810|P6|Treated|Overall Study||61
1052065|NCT00806026|2553811|P5|Treated|Overall Study||59
1052066|NCT00806026|2553812|P4|Treated|Overall Study||59
1052067|NCT00806026|2553813|P3|Treated|Overall Study||180
1052068|NCT00806026|2553814|P2|Treated|Overall Study||178
1052069|NCT00806026|2553815|P1|Treated|Overall Study||182
1052070|NCT00806026|2553810|P6|STARTED|Overall Study||61
1052071|NCT00806026|2553811|P5|STARTED|Overall Study||59
1052072|NCT00806026|2553812|P4|STARTED|Overall Study||61
1052073|NCT00806026|2553813|P3|STARTED|Overall Study||182
1052074|NCT00806026|2553814|P2|STARTED|Overall Study||183
1052075|NCT00806026|2553815|P1|STARTED|Overall Study||185
1052076|NCT00806078|2553912|P2|NOT COMPLETED|Second Intervention||0
1052077|NCT00806078|2553913|P1|NOT COMPLETED|Second Intervention||0
1052078|NCT00806078|2553912|P2|COMPLETED|Second Intervention||9
1052079|NCT00806078|2553913|P1|COMPLETED|Second Intervention||9
1052080|NCT00806078|2553912|P2|STARTED|Second Intervention||9
1052081|NCT00806078|2553913|P1|STARTED|Second Intervention||9
1052082|NCT00806078|2553912|P2|NOT COMPLETED|7 Day Washout Period||0
1052083|NCT00806078|2553913|P1|NOT COMPLETED|7 Day Washout Period||0
1052084|NCT00806078|2553912|P2|COMPLETED|7 Day Washout Period||9
1052085|NCT00806078|2553913|P1|COMPLETED|7 Day Washout Period||9
1052086|NCT00806078|2553912|P2|STARTED|7 Day Washout Period||9
1052087|NCT00806078|2553913|P1|STARTED|7 Day Washout Period||9
1052088|NCT00806078|2553912|P2|NOT COMPLETED|First Intervention||0
1052089|NCT00806078|2553913|P1|NOT COMPLETED|First Intervention||0
1052090|NCT00806078|2553912|P2|COMPLETED|First Intervention||9
1052091|NCT00806078|2553913|P1|COMPLETED|First Intervention||9
1052092|NCT00806078|2553912|P2|STARTED|First Intervention||9
1052093|NCT00806078|2553913|P1|STARTED|First Intervention||9
1052094|NCT00806195|2553927|P4|NOT COMPLETED|Overall Study||106
1052095|NCT00806195|2553928|P3|NOT COMPLETED|Overall Study||270
1052096|NCT00806195|2553929|P2|NOT COMPLETED|Overall Study||162
1052097|NCT00806195|2553930|P1|NOT COMPLETED|Overall Study||514
1052098|NCT00806195|2553927|P4|COMPLETED|Overall Study||383
1052099|NCT00806195|2553928|P3|COMPLETED|Overall Study||1139
1052100|NCT00806195|2553929|P2|COMPLETED|Overall Study||1321
1052101|NCT00806195|2553930|P1|COMPLETED|Overall Study||3849
1052102|NCT00806195|2553927|P4|STARTED|Overall Study||489
1052103|NCT00806195|2553928|P3|STARTED|Overall Study||1409
1052104|NCT00806195|2553929|P2|STARTED|Overall Study||1483
1052105|NCT00806195|2553930|P1|STARTED|Overall Study||4363
1052106|NCT00806221|2553942|P1|NOT COMPLETED|Overall Study||2
1052107|NCT00806221|2553942|P1|COMPLETED|Overall Study||20
1052108|NCT00806221|2553942|P1|STARTED|Overall Study||22
1052109|NCT00806234|2553952|P3|NOT COMPLETED|Overall Study||12
1052110|NCT00806234|2553953|P2|NOT COMPLETED|Overall Study||12
1052111|NCT00806234|2553954|P1|NOT COMPLETED|Overall Study||13
1052112|NCT00806234|2553952|P3|COMPLETED|Overall Study||37
1052113|NCT00806234|2553953|P2|COMPLETED|Overall Study||19
1052114|NCT00806234|2553954|P1|COMPLETED|Overall Study||34
1052115|NCT00806234|2553952|P3|STARTED|Overall Study||49
1052116|NCT00806234|2553953|P2|STARTED|Overall Study||31
1052117|NCT00806234|2553954|P1|STARTED|Overall Study||47
1052118|NCT00806260|2553977|P6|NOT COMPLETED|Period 3||0
1052119|NCT00806260|2553978|P5|NOT COMPLETED|Period 3||0
1052120|NCT00806260|2553979|P4|NOT COMPLETED|Period 3||0
1052121|NCT00806260|2553980|P3|NOT COMPLETED|Period 3||1
1052122|NCT00806260|2553981|P2|NOT COMPLETED|Period 3||1
1052123|NCT00806260|2553982|P1|NOT COMPLETED|Period 3||1
1052124|NCT00806260|2553977|P6|COMPLETED|Period 3||0
1052125|NCT00806260|2553978|P5|COMPLETED|Period 3||0
1052126|NCT00806260|2553979|P4|COMPLETED|Period 3||12
1052127|NCT00806260|2553980|P3|COMPLETED|Period 3||5
1052128|NCT00806260|2553981|P2|COMPLETED|Period 3||7
1052129|NCT00806260|2553982|P1|COMPLETED|Period 3||12
1052130|NCT00806260|2553977|P6|STARTED|Period 3||0
1052131|NCT00806260|2553978|P5|STARTED|Period 3||0
1052132|NCT00806260|2553979|P4|STARTED|Period 3||12
1052133|NCT00806260|2553980|P3|STARTED|Period 3||6
1052134|NCT00806260|2553981|P2|STARTED|Period 3||8
1052135|NCT00806260|2553982|P1|STARTED|Period 3||13
1052136|NCT00806260|2553977|P6|NOT COMPLETED|Period 2||0
1052137|NCT00806260|2553978|P5|NOT COMPLETED|Period 2||0
1052138|NCT00806260|2553979|P4|NOT COMPLETED|Period 2||2
1052139|NCT00806260|2553980|P3|NOT COMPLETED|Period 2||2
1052140|NCT00806260|2553981|P2|NOT COMPLETED|Period 2||0
1052141|NCT00806260|2553982|P1|NOT COMPLETED|Period 2||2
1052142|NCT00806260|2553977|P6|COMPLETED|Period 2||0
1052143|NCT00806260|2553978|P5|COMPLETED|Period 2||0
1052144|NCT00806260|2553979|P4|COMPLETED|Period 2||12
1052145|NCT00806260|2553980|P3|COMPLETED|Period 2||6
1052146|NCT00806260|2553981|P2|COMPLETED|Period 2||8
1052147|NCT00806260|2553982|P1|COMPLETED|Period 2||13
1052148|NCT00806260|2553977|P6|STARTED|Period 2||0
1052149|NCT00806260|2553978|P5|STARTED|Period 2||0
1052150|NCT00806260|2553979|P4|STARTED|Period 2||14
1052151|NCT00806260|2553980|P3|STARTED|Period 2||8
1052152|NCT00806260|2553981|P2|STARTED|Period 2||8
1052153|NCT00806260|2553982|P1|STARTED|Period 2||15
1052154|NCT00806260|2553977|P6|NOT COMPLETED|Period 1 (1 Day)||0
1052155|NCT00806260|2553978|P5|NOT COMPLETED|Period 1 (1 Day)||3
1052156|NCT00806260|2553979|P4|NOT COMPLETED|Period 1 (1 Day)||0
1052157|NCT00806260|2553980|P3|NOT COMPLETED|Period 1 (1 Day)||0
1052158|NCT00806260|2553981|P2|NOT COMPLETED|Period 1 (1 Day)||0
1052159|NCT00806260|2553982|P1|NOT COMPLETED|Period 1 (1 Day)||0
1052160|NCT00806260|2553977|P6|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|17
1052161|NCT00806260|2553978|P5|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|15
1052162|NCT00806260|2553979|P4|COMPLETED|Period 1 (1 Day)||14
1052163|NCT00806260|2553980|P3|COMPLETED|Period 1 (1 Day)||8
1052164|NCT00806260|2553981|P2|COMPLETED|Period 1 (1 Day)||8
1052165|NCT00806260|2553982|P1|COMPLETED|Period 1 (1 Day)||15
1052166|NCT00806260|2553977|P6|STARTED|Period 1 (1 Day)||17
1052167|NCT00806260|2553978|P5|STARTED|Period 1 (1 Day)||18
1052168|NCT00806260|2553979|P4|STARTED|Period 1 (1 Day)||14
1052169|NCT00806260|2553980|P3|STARTED|Period 1 (1 Day)||8
1052170|NCT00806260|2553981|P2|STARTED|Period 1 (1 Day)||8
1052171|NCT00806260|2553982|P1|STARTED|Period 1 (1 Day)||15
1052178|NCT00806390|2554030|P2|NOT COMPLETED|Overall Study||0
1052179|NCT00806390|2554031|P1|NOT COMPLETED|Overall Study||0
1052180|NCT00806390|2554030|P2|COMPLETED|Overall Study||8
1052181|NCT00806390|2554031|P1|COMPLETED|Overall Study||7
1052182|NCT00806390|2554030|P2|STARTED|Overall Study||8
1052183|NCT00806390|2554031|P1|STARTED|Overall Study||7
1052184|NCT00806403|2554039|P2|NOT COMPLETED|Overall Study||3
1052185|NCT00806403|2554040|P1|NOT COMPLETED|Overall Study||4
1052186|NCT00806403|2554039|P2|COMPLETED|Overall Study||98
1052187|NCT00806403|2554040|P1|COMPLETED|Overall Study||100
1052188|NCT00806403|2554039|P2|STARTED|Overall Study||101
1052189|NCT00806403|2554040|P1|STARTED|Overall Study||104
1052190|NCT00806416|2554054|P4|NOT COMPLETED|Period 2 - Part II||0
1052191|NCT00806416|2554055|P3|NOT COMPLETED|Period 2 - Part II||0
1052192|NCT00806416|2554056|P2|NOT COMPLETED|Period 2 - Part II||0
1052193|NCT00806416|2554057|P1|NOT COMPLETED|Period 2 - Part II||0
1052194|NCT00806416|2554054|P4|COMPLETED|Period 2 - Part II||14
1052195|NCT00806416|2554055|P3|COMPLETED|Period 2 - Part II||14
1052196|NCT00806416|2554056|P2|COMPLETED|Period 2 - Part II||0
1052197|NCT00806416|2554057|P1|COMPLETED|Period 2 - Part II||0
1052198|NCT00806416|2554054|P4|STARTED|Period 2 - Part II||14
1052199|NCT00806416|2554055|P3|STARTED|Period 2 - Part II||14
1052200|NCT00806416|2554056|P2|STARTED|Period 2 - Part II||0
1052201|NCT00806416|2554057|P1|STARTED|Period 2 - Part II||0
1052202|NCT00806416|2554054|P4|NOT COMPLETED|Period 1 - Part II||2
1052203|NCT00806416|2554055|P3|NOT COMPLETED|Period 1 - Part II||0
1052204|NCT00806416|2554056|P2|NOT COMPLETED|Period 1 - Part II||0
1052205|NCT00806416|2554057|P1|NOT COMPLETED|Period 1 - Part II||0
1052206|NCT00806416|2554054|P4|COMPLETED|Period 1 - Part II||14
1052207|NCT00806416|2554055|P3|COMPLETED|Period 1 - Part II||14
1052208|NCT00806416|2554056|P2|COMPLETED|Period 1 - Part II||0
1052209|NCT00806416|2554057|P1|COMPLETED|Period 1 - Part II||0
1052210|NCT00806416|2554054|P4|STARTED|Period 1 - Part II||16
1052211|NCT00806416|2554055|P3|STARTED|Period 1 - Part II||14
1052212|NCT00806416|2554056|P2|STARTED|Period 1 - Part II||0
1052213|NCT00806416|2554057|P1|STARTED|Period 1 - Part II||0
1052214|NCT00806416|2554054|P4|NOT COMPLETED|Period 2 - Part I||0
1052215|NCT00806416|2554055|P3|NOT COMPLETED|Period 2 - Part I||0
1052216|NCT00806416|2554056|P2|NOT COMPLETED|Period 2 - Part I||0
1052217|NCT00806416|2554057|P1|NOT COMPLETED|Period 2 - Part I||0
1052218|NCT00806416|2554054|P4|COMPLETED|Period 2 - Part I||0
1052219|NCT00806416|2554055|P3|COMPLETED|Period 2 - Part I||0
1052220|NCT00806416|2554056|P2|COMPLETED|Period 2 - Part I||103
1052221|NCT00806416|2554057|P1|COMPLETED|Period 2 - Part I||104
1052222|NCT00806416|2554054|P4|STARTED|Period 2 - Part I||0
1052223|NCT00806416|2554055|P3|STARTED|Period 2 - Part I||0
1052224|NCT00806416|2554056|P2|STARTED|Period 2 - Part I||103
1052225|NCT00806416|2554057|P1|STARTED|Period 2 - Part I||104
1052226|NCT00806416|2554054|P4|NOT COMPLETED|Period 1 - Part I||0
1052227|NCT00806416|2554055|P3|NOT COMPLETED|Period 1 - Part I||0
1052228|NCT00806416|2554056|P2|NOT COMPLETED|Period 1 - Part I||4
1052229|NCT00806416|2554057|P1|NOT COMPLETED|Period 1 - Part I||3
1052230|NCT00806416|2554054|P4|COMPLETED|Period 1 - Part I||0
1052231|NCT00806416|2554055|P3|COMPLETED|Period 1 - Part I||0
1052232|NCT00806416|2554056|P2|COMPLETED|Period 1 - Part I||103
1052233|NCT00806416|2554057|P1|COMPLETED|Period 1 - Part I||104
1052234|NCT00806416|2554054|P4|STARTED|Period 1 - Part I||0
1052235|NCT00806416|2554055|P3|STARTED|Period 1 - Part I||0
1052236|NCT00806416|2554056|P2|STARTED|Period 1 - Part I||107
1052237|NCT00806416|2554057|P1|STARTED|Period 1 - Part I||107
1052238|NCT00806442|2554068|P2|NOT COMPLETED|Overall Study||7
1052239|NCT00806442|2554069|P1|NOT COMPLETED|Overall Study||4
1052240|NCT00806442|2554068|P2|COMPLETED|Overall Study||14
1052241|NCT00806442|2554069|P1|COMPLETED|Overall Study||14
1052242|NCT00806442|2554068|P2|Second Intervention (3 Wks)|Overall Study||14
1052243|NCT00806442|2554069|P1|Second Intervention (3 Wks)|Overall Study||15
1052244|NCT00806442|2554068|P2|Washout (3 Wks)|Overall Study||14
1052245|NCT00806442|2554069|P1|Washout (3 Wks)|Overall Study||15
1052246|NCT00806442|2554068|P2|First Intervention (3 Wks)|Overall Study||21
1052247|NCT00806442|2554069|P1|First Intervention (3 Wks)|Overall Study||18
1052248|NCT00806442|2554068|P2|STARTED|Overall Study||21
1052249|NCT00806442|2554069|P1|STARTED|Overall Study||18
1052250|NCT00806494|2554089|P1|NOT COMPLETED|Overall Study||80
1052251|NCT00806494|2554089|P1|COMPLETED|Overall Study||251
1052252|NCT00806494|2554089|P1|STARTED|Overall Study||331
1052253|NCT00806546|2554113|P1|NOT COMPLETED|Overall Study||307
1052254|NCT00806546|2554113|P1|COMPLETED|Overall Study||207
1052255|NCT00806546|2554113|P1|STARTED|Overall Study|35 subjects were enrolled but did not treat for a total of 479 subjects in the safety population|514
1052256|NCT00806585|2554122|P5|NOT COMPLETED|Overall Study||31
1052257|NCT00806585|2554123|P4|NOT COMPLETED|Overall Study||15
1052258|NCT00806585|2554124|P3|NOT COMPLETED|Overall Study||32
1052259|NCT00806585|2554125|P2|NOT COMPLETED|Overall Study||31
1052260|NCT00806585|2554126|P1|NOT COMPLETED|Overall Study||32
1052261|NCT00806585|2554122|P5|COMPLETED|Overall Study||106
1052262|NCT00806585|2554123|P4|COMPLETED|Overall Study||56
1052263|NCT00806585|2554124|P3|COMPLETED|Overall Study||109
1052264|NCT00806585|2554125|P2|COMPLETED|Overall Study||103
1052265|NCT00806585|2554126|P1|COMPLETED|Overall Study||105
1052266|NCT00806585|2554122|P5|STARTED|Overall Study||137
1052267|NCT00806585|2554123|P4|STARTED|Overall Study||71
1052268|NCT00806585|2554124|P3|STARTED|Overall Study||141
1052269|NCT00806585|2554125|P2|STARTED|Overall Study||134
1052270|NCT00806585|2554126|P1|STARTED|Overall Study||137
1052271|NCT00806598|2554158|P1|NOT COMPLETED|Overall Study||0
1052272|NCT00806598|2554158|P1|COMPLETED|Overall Study||48
1052273|NCT00806598|2554158|P1|STARTED|Overall Study||48
1052274|NCT00806624|2554165|P3|NOT COMPLETED|Overall Study||6
1052275|NCT00806624|2554166|P2|NOT COMPLETED|Overall Study||12
1052276|NCT00806624|2554167|P1|NOT COMPLETED|Overall Study||9
1052277|NCT00806624|2554165|P3|COMPLETED|Overall Study||69
1052278|NCT00806624|2554166|P2|COMPLETED|Overall Study||68
1052279|NCT00806624|2554167|P1|COMPLETED|Overall Study||70
1052280|NCT00806624|2554165|P3|STARTED|Overall Study||75
1052281|NCT00806624|2554166|P2|STARTED|Overall Study||80
1052282|NCT00806624|2554167|P1|STARTED|Overall Study||79
1052283|NCT00806676|2554178|P3|NOT COMPLETED|Overall Study||6
1052284|NCT00806676|2554179|P2|NOT COMPLETED|Overall Study||0
1052285|NCT00806676|2554180|P1|NOT COMPLETED|Overall Study||4
1052286|NCT00806676|2554178|P3|COMPLETED|Overall Study||23
1052287|NCT00806676|2554179|P2|COMPLETED|Overall Study||9
1052288|NCT00806676|2554180|P1|COMPLETED|Overall Study||25
1052289|NCT00806676|2554178|P3|STARTED|Overall Study||29
1052290|NCT00806676|2554179|P2|STARTED|Overall Study||9
1052291|NCT00806676|2554180|P1|STARTED|Overall Study||29
1052292|NCT00806819|2554211|P2|NOT COMPLETED|Overall Study||358
1052293|NCT00806819|2554212|P1|NOT COMPLETED|Overall Study||346
1052294|NCT00806819|2554211|P2|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|2
1052295|NCT00806819|2554212|P1|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|7
1052296|NCT00806819|2554211|P2|STARTED|Overall Study|randomised patients|360
1052297|NCT00806819|2554212|P1|STARTED|Overall Study|randomised patients|353
1052298|NCT00806988|2554246|P2|NOT COMPLETED|Overall Study||43
1052299|NCT00806988|2554247|P1|NOT COMPLETED|Overall Study||27
1052300|NCT00806988|2554246|P2|COMPLETED|Overall Study||108
1052301|NCT00806988|2554247|P1|COMPLETED|Overall Study||123
1052302|NCT00806988|2554246|P2|STARTED|Overall Study||151
1052303|NCT00806988|2554247|P1|STARTED|Overall Study||150
1052304|NCT00807001|2554260|P5|NOT COMPLETED|Overall Study||0
1052305|NCT00807001|2554261|P4|NOT COMPLETED|Overall Study||0
1052306|NCT00807001|2554262|P3|NOT COMPLETED|Overall Study||0
1052307|NCT00807001|2554263|P2|NOT COMPLETED|Overall Study||1
1052308|NCT00807001|2554264|P1|NOT COMPLETED|Overall Study||0
1052309|NCT00807001|2554260|P5|COMPLETED|Overall Study||9
1052310|NCT00807001|2554261|P4|COMPLETED|Overall Study||8
1052311|NCT00807001|2554262|P3|COMPLETED|Overall Study||8
1052312|NCT00807001|2554263|P2|COMPLETED|Overall Study||7
1052313|NCT00807001|2554264|P1|COMPLETED|Overall Study||8
1052314|NCT00807001|2554260|P5|STARTED|Overall Study||9
1052315|NCT00807001|2554261|P4|STARTED|Overall Study||8
1052316|NCT00807001|2554262|P3|STARTED|Overall Study||8
1052317|NCT00807001|2554263|P2|STARTED|Overall Study||8
1052318|NCT00807001|2554264|P1|STARTED|Overall Study|For all groups, number of subjects who received at least one dose of study drug.|8
1052319|NCT00807014|2554283|P2|NOT COMPLETED|Overall Study||27
1052320|NCT00807014|2554284|P1|NOT COMPLETED|Overall Study||27
1052321|NCT00807014|2554283|P2|COMPLETED|Overall Study||58
1052322|NCT00807014|2554284|P1|COMPLETED|Overall Study||56
1052323|NCT00807014|2554283|P2|STARTED|Overall Study||85
1052324|NCT00807014|2554284|P1|STARTED|Overall Study||83
1052325|NCT00807040|2554312|P2|NOT COMPLETED|Overall Study||41
1052326|NCT00807040|2554313|P1|NOT COMPLETED|Overall Study||36
1052327|NCT00807040|2554312|P2|COMPLETED|Overall Study||84
1052328|NCT00807040|2554313|P1|COMPLETED|Overall Study||90
1052329|NCT00807040|2554312|P2|STARTED|Overall Study||125
1052330|NCT00807040|2554313|P1|STARTED|Overall Study||126
1052331|NCT00807092|2554323|P2|NOT COMPLETED|Overall Study||4
1052332|NCT00807092|2554324|P1|NOT COMPLETED|Overall Study||1
1052333|NCT00807092|2554323|P2|COMPLETED|Overall Study||69
1052334|NCT00807092|2554324|P1|COMPLETED|Overall Study||71
1052335|NCT00807092|2554323|P2|Exposed to Drug|Overall Study||73
1052336|NCT00807092|2554324|P1|Exposed to Drug|Overall Study|Subject was randomised, but not exposed to any trial drug|71
1052337|NCT00807092|2554323|P2|STARTED|Overall Study||73
1052338|NCT00807092|2554324|P1|STARTED|Overall Study||72
1052339|NCT00807209|2554355|P3|NOT COMPLETED|Overall Study||0
1052340|NCT00807209|2554356|P2|NOT COMPLETED|Overall Study||0
1052341|NCT00807209|2554357|P1|NOT COMPLETED|Overall Study||0
1052342|NCT00807209|2554355|P3|COMPLETED|Overall Study||1
1052343|NCT00807209|2554356|P2|COMPLETED|Overall Study||1
1052344|NCT00807209|2554357|P1|COMPLETED|Overall Study||1
1052345|NCT00807209|2554355|P3|STARTED|Overall Study||1
1052346|NCT00807209|2554356|P2|STARTED|Overall Study||1
1052347|NCT00807209|2554357|P1|STARTED|Overall Study||1
1052348|NCT00807235|2554367|P2|NOT COMPLETED|Overall Study||0
1052349|NCT00807235|2554368|P1|NOT COMPLETED|Overall Study||1
1052350|NCT00807235|2554367|P2|COMPLETED|Overall Study||6
1052351|NCT00807235|2554368|P1|COMPLETED|Overall Study||10
1052352|NCT00807235|2554367|P2|STARTED|Overall Study||6
1052353|NCT00807235|2554368|P1|STARTED|Overall Study||11
1052354|NCT00807248|2554402|P4|NOT COMPLETED|Overall Study||14
1052355|NCT00807248|2554403|P3|NOT COMPLETED|Overall Study||18
1052356|NCT00807248|2554404|P2|NOT COMPLETED|Overall Study||12
1052357|NCT00807248|2554405|P1|NOT COMPLETED|Overall Study||21
1052358|NCT00807248|2554402|P4|COMPLETED|Overall Study||126
1052359|NCT00807248|2554403|P3|COMPLETED|Overall Study||121
1052360|NCT00807248|2554404|P2|COMPLETED|Overall Study||128
1052361|NCT00807248|2554405|P1|COMPLETED|Overall Study||50
1052362|NCT00807248|2554402|P4|STARTED|Overall Study||140
1052363|NCT00807248|2554403|P3|STARTED|Overall Study||139
1052364|NCT00807248|2554404|P2|STARTED|Overall Study||140
1052365|NCT00807248|2554405|P1|STARTED|Overall Study||71
1052366|NCT00807365|2554447|P1|NOT COMPLETED|Overall Study||5
1052367|NCT00807365|2554447|P1|COMPLETED|Overall Study||0
1052368|NCT00807365|2554447|P1|STARTED|Overall Study||5
1052369|NCT00807456|2554451|P1|NOT COMPLETED|Overall Study||0
1052370|NCT00807456|2554451|P1|COMPLETED|Overall Study||65
1052371|NCT00807456|2554451|P1|STARTED|Overall Study||65
1052372|NCT00807560|2554457|P2|NOT COMPLETED|Overall Study||0
1052373|NCT00807560|2554458|P1|NOT COMPLETED|Overall Study||0
1052374|NCT00807560|2554457|P2|COMPLETED|Overall Study||39
1052375|NCT00807560|2554458|P1|COMPLETED|Overall Study||38
1052376|NCT00807560|2554457|P2|STARTED|Overall Study||39
1052377|NCT00807560|2554458|P1|STARTED|Overall Study||38
1052378|NCT00807573|2554492|P1|NOT COMPLETED|Overall Study||2
1052379|NCT00807573|2554492|P1|COMPLETED|Overall Study||42
1052380|NCT00807573|2554492|P1|STARTED|Overall Study||44
1052381|NCT00807846|2554498|P2|NOT COMPLETED|Overall Study||4
1052382|NCT00807846|2554499|P1|NOT COMPLETED|Overall Study||12
1052383|NCT00807846|2554498|P2|COMPLETED|Overall Study||94
1052384|NCT00807846|2554499|P1|COMPLETED|Overall Study||88
1052385|NCT00807846|2554498|P2|STARTED|Overall Study||98
1052386|NCT00807846|2554499|P1|STARTED|Overall Study||100
1052387|NCT00807885|2554540|P9|NOT COMPLETED|Overall Study||0
1052388|NCT00807885|2554541|P8|NOT COMPLETED|Overall Study||0
1052389|NCT00807885|2554542|P7|NOT COMPLETED|Overall Study||0
1052390|NCT00807885|2554543|P6|NOT COMPLETED|Overall Study||1
1052391|NCT00807885|2554544|P5|NOT COMPLETED|Overall Study||0
1052392|NCT00807885|2554545|P4|NOT COMPLETED|Overall Study||0
1052393|NCT00807885|2554546|P3|NOT COMPLETED|Overall Study||0
1052394|NCT00807885|2554547|P2|NOT COMPLETED|Overall Study||0
1052395|NCT00807885|2554548|P1|NOT COMPLETED|Overall Study||0
1052396|NCT00807885|2554540|P9|COMPLETED|Overall Study||11
1052397|NCT00807885|2554541|P8|COMPLETED|Overall Study||11
1052398|NCT00807885|2554542|P7|COMPLETED|Overall Study||12
1052399|NCT00807885|2554543|P6|COMPLETED|Overall Study|Subject completed treatment, but lost to follow-up|11
1052400|NCT00807885|2554544|P5|COMPLETED|Overall Study||12
1052401|NCT00807885|2554545|P4|COMPLETED|Overall Study||10
1052402|NCT00807885|2554546|P3|COMPLETED|Overall Study||11
1052403|NCT00807885|2554547|P2|COMPLETED|Overall Study||11
1052404|NCT00807885|2554548|P1|COMPLETED|Overall Study||10
1052405|NCT00807885|2554540|P9|STARTED|Overall Study||11
1052406|NCT00807885|2554541|P8|STARTED|Overall Study||11
1052407|NCT00807885|2554542|P7|STARTED|Overall Study||12
1052408|NCT00807885|2554543|P6|STARTED|Overall Study||12
1052409|NCT00807885|2554544|P5|STARTED|Overall Study||12
1052410|NCT00807885|2554545|P4|STARTED|Overall Study||10
1052411|NCT00807885|2554546|P3|STARTED|Overall Study||11
1052412|NCT00807885|2554547|P2|STARTED|Overall Study||11
1052413|NCT00807885|2554548|P1|STARTED|Overall Study||10
1052414|NCT00807937|2554599|P4|NOT COMPLETED|Overall Study||15
1052415|NCT00807937|2554600|P3|NOT COMPLETED|Overall Study||14
1052416|NCT00807937|2554601|P2|NOT COMPLETED|Overall Study||25
1052417|NCT00807937|2554602|P1|NOT COMPLETED|Overall Study||27
1052418|NCT00807937|2554599|P4|COMPLETED|Overall Study||77
1052419|NCT00807937|2554600|P3|COMPLETED|Overall Study||78
1052420|NCT00807937|2554601|P2|COMPLETED|Overall Study||67
1052421|NCT00807937|2554602|P1|COMPLETED|Overall Study||66
1052422|NCT00807937|2554599|P4|STARTED|Overall Study||92
1052423|NCT00807937|2554600|P3|STARTED|Overall Study||92
1052424|NCT00807937|2554601|P2|STARTED|Overall Study||92
1052425|NCT00807937|2554602|P1|STARTED|Overall Study||93
1052426|NCT00807989|2554630|P2|NOT COMPLETED|Overall Study||2
1052427|NCT00807989|2554631|P1|NOT COMPLETED|Overall Study||3
1052428|NCT00807989|2554630|P2|COMPLETED|Overall Study||98
1052429|NCT00807989|2554631|P1|COMPLETED|Overall Study||104
1052430|NCT00807989|2554630|P2|STARTED|Overall Study||100
1052431|NCT00807989|2554631|P1|STARTED|Overall Study||107
1052432|NCT00808015|2554641|P1|NOT COMPLETED|Overall Study||344
1052433|NCT00808015|2554641|P1|COMPLETED|Overall Study||1033
1052434|NCT00808015|2554641|P1|Treated|Overall Study||1373
1052435|NCT00808015|2554641|P1|STARTED|Overall Study||1377
1052436|NCT00808028|2554657|P4|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||23
1052437|NCT00808028|2554658|P3|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||29
1052438|NCT00808028|2554659|P2|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||0
1052439|NCT00808028|2554660|P1|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||11
1052440|NCT00808028|2554657|P4|COMPLETED|Stage 2 (Followed up to 48 Months )||128
1052441|NCT00808028|2554658|P3|COMPLETED|Stage 2 (Followed up to 48 Months )||141
1052442|NCT00808028|2554659|P2|COMPLETED|Stage 2 (Followed up to 48 Months )||0
1052443|NCT00808028|2554660|P1|COMPLETED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|69
1052444|NCT00808028|2554657|P4|STARTED|Stage 2 (Followed up to 48 Months )||151
1052445|NCT00808028|2554658|P3|STARTED|Stage 2 (Followed up to 48 Months )||170
1052446|NCT00808028|2554659|P2|STARTED|Stage 2 (Followed up to 48 Months )||0
1052447|NCT00808028|2554660|P1|STARTED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|80
1052448|NCT00808028|2554657|P4|NOT COMPLETED|Stage 1 (6 Months)||15
1052449|NCT00808028|2554658|P3|NOT COMPLETED|Stage 1 (6 Months)||7
1052450|NCT00808028|2554659|P2|NOT COMPLETED|Stage 1 (6 Months)||1
1052451|NCT00808028|2554660|P1|NOT COMPLETED|Stage 1 (6 Months)||5
1052452|NCT00808028|2554657|P4|COMPLETED|Stage 1 (6 Months)||183
1052453|NCT00808028|2554658|P3|COMPLETED|Stage 1 (6 Months)||191
1052454|NCT00808028|2554659|P2|COMPLETED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|21
1052455|NCT00808028|2554660|P1|COMPLETED|Stage 1 (6 Months)||116
1052456|NCT00808028|2554657|P4|STARTED|Stage 1 (6 Months)||198
1052457|NCT00808028|2554658|P3|STARTED|Stage 1 (6 Months)||198
1052458|NCT00808028|2554659|P2|STARTED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|22
1052459|NCT00808028|2554660|P1|STARTED|Stage 1 (6 Months)||121
1052460|NCT00808067|2554698|P2|NOT COMPLETED|Overall Study||518
1052461|NCT00808067|2554699|P1|NOT COMPLETED|Overall Study||481
1052462|NCT00808067|2554698|P2|COMPLETED|Overall Study||2438
1052463|NCT00808067|2554699|P1|COMPLETED|Overall Study||2446
1052464|NCT00808067|2554698|P2|STARTED|Overall Study|Number of patients which are treated.|2956
1052465|NCT00808067|2554699|P1|STARTED|Overall Study|Number of patients which are treated.|2927
1052466|NCT00808080|2554731|P1|NOT COMPLETED|Overall Study||6
1052467|NCT00808080|2554731|P1|COMPLETED|Overall Study||0
1052468|NCT00808080|2554731|P1|STARTED|Overall Study||6
1052469|NCT00813800|2554735|P1|NOT COMPLETED|Overall Study||6
1052470|NCT00813800|2554735|P1|COMPLETED|Overall Study||5
1052471|NCT00813800|2554735|P1|STARTED|Overall Study||11
1052472|NCT00813813|2554743|P2|NOT COMPLETED|Overall Study||9
1052473|NCT00813813|2554744|P1|NOT COMPLETED|Overall Study||3
1052474|NCT00813813|2554743|P2|COMPLETED|Overall Study||16
1052475|NCT00813813|2554744|P1|COMPLETED|Overall Study||4
1052476|NCT00813813|2554743|P2|STARTED|Overall Study||25
1052477|NCT00813813|2554744|P1|STARTED|Overall Study||7
1052478|NCT00813904|2554760|P1|NOT COMPLETED|Overall Study||1
1052479|NCT00813904|2554760|P1|COMPLETED|Overall Study||30
1052480|NCT00813904|2554760|P1|STARTED|Overall Study||31
1052481|NCT00813917|2554768|P2|NOT COMPLETED|Overall Study||6
1052482|NCT00813917|2554769|P1|NOT COMPLETED|Overall Study||6
1052483|NCT00813917|2554768|P2|COMPLETED|Overall Study||32
1052484|NCT00813917|2554769|P1|COMPLETED|Overall Study||32
1052485|NCT00813917|2554768|P2|STARTED|Overall Study||38
1052486|NCT00813917|2554769|P1|STARTED|Overall Study||38
1052487|NCT00813943|2554778|P3|NOT COMPLETED|Overall Study||3
1052488|NCT00813943|2554779|P2|NOT COMPLETED|Overall Study||5
1052489|NCT00813943|2554780|P1|NOT COMPLETED|Overall Study||5
1052490|NCT00813943|2554778|P3|COMPLETED|Overall Study||86
1052491|NCT00813943|2554779|P2|COMPLETED|Overall Study||83
1052492|NCT00813943|2554780|P1|COMPLETED|Overall Study||83
1052493|NCT00813943|2554778|P3|STARTED|Overall Study||89
1052494|NCT00813943|2554779|P2|STARTED|Overall Study||88
1052495|NCT00813943|2554780|P1|STARTED|Overall Study||88
1052496|NCT00813982|2554808|P1|NOT COMPLETED|Overall Study||0
1052497|NCT00813982|2554808|P1|COMPLETED|Overall Study||59
1052498|NCT00813982|2554808|P1|STARTED|Overall Study||59
1052499|NCT00813995|2554816|P2|NOT COMPLETED|Overall Study||16
1052500|NCT00813995|2554817|P1|NOT COMPLETED|Overall Study||23
1052501|NCT00813995|2554816|P2|COMPLETED|Overall Study||182
1052502|NCT00813995|2554817|P1|COMPLETED|Overall Study||174
1052503|NCT00813995|2554816|P2|STARTED|Overall Study||198
1052504|NCT00813995|2554817|P1|STARTED|Overall Study||197
1052505|NCT00814710|2554833|P2|NOT COMPLETED|Overall Study||3
1052506|NCT00814710|2554834|P1|NOT COMPLETED|Overall Study||8
1052507|NCT00814710|2554833|P2|COMPLETED|Overall Study||117
1052508|NCT00814710|2554834|P1|COMPLETED|Overall Study||232
1052509|NCT00814710|2554833|P2|STARTED|Overall Study||120
1052510|NCT00814710|2554834|P1|STARTED|Overall Study||240
1052511|NCT00814775|2554874|P2|NOT COMPLETED|Overall Study||0
1052512|NCT00814775|2554875|P1|NOT COMPLETED|Overall Study||0
1052513|NCT00814775|2554874|P2|COMPLETED|Overall Study||20
1052514|NCT00814775|2554875|P1|COMPLETED|Overall Study||23
1052515|NCT00814775|2554874|P2|STARTED|Overall Study||20
1052516|NCT00814775|2554875|P1|STARTED|Overall Study||23
1052517|NCT00814788|2554883|P1|NOT COMPLETED|Overall Study||0
1052518|NCT00814788|2554883|P1|COMPLETED|Overall Study||24
1052519|NCT00814788|2554883|P1|STARTED|Overall Study||24
1052520|NCT00814801|2554892|P3|NOT COMPLETED|Overall Study||43
1052521|NCT00814801|2554893|P2|NOT COMPLETED|Overall Study||38
1052522|NCT00814801|2554894|P1|NOT COMPLETED|Overall Study||34
1052523|NCT00814801|2554892|P3|COMPLETED|Overall Study||151
1052524|NCT00814801|2554893|P2|COMPLETED|Overall Study||154
1052525|NCT00814801|2554894|P1|COMPLETED|Overall Study||160
1052526|NCT00814801|2554892|P3|STARTED|Overall Study||194
1052527|NCT00814801|2554893|P2|STARTED|Overall Study||192
1052528|NCT00814801|2554894|P1|STARTED|Overall Study||194
1052529|NCT00814879|2554916|P2|NOT COMPLETED|By Week 48||3
1052530|NCT00814879|2554917|P1|NOT COMPLETED|By Week 48||2
1052531|NCT00814879|2554916|P2|COMPLETED|By Week 48||26
1052532|NCT00814879|2554917|P1|COMPLETED|By Week 48||25
1052533|NCT00814879|2554916|P2|STARTED|By Week 48||29
1052534|NCT00814879|2554917|P1|STARTED|By Week 48||27
1052535|NCT00814879|2554916|P2|NOT COMPLETED|By Week 24||1
1052536|NCT00814879|2554917|P1|NOT COMPLETED|By Week 24||1
1052537|NCT00814879|2554916|P2|COMPLETED|By Week 24||29
1052538|NCT00814879|2554917|P1|COMPLETED|By Week 24||27
1052539|NCT00814879|2554916|P2|STARTED|By Week 24||30
1052540|NCT00814879|2554917|P1|STARTED|By Week 24||28
1052541|NCT00814892|2554933|P1|NOT COMPLETED|Overall Study||2
1052542|NCT00814892|2554933|P1|COMPLETED|Overall Study||0
1052543|NCT00814892|2554933|P1|STARTED|Overall Study||2
1052544|NCT00814970|2554943|P1|NOT COMPLETED|Overall Study||50
1052545|NCT00814970|2554943|P1|COMPLETED|Overall Study||146
1052546|NCT00814970|2554943|P1|STARTED|Overall Study||196
1052547|NCT00814983|2554966|P2|NOT COMPLETED|Overall Study||0
1052548|NCT00814983|2554967|P1|NOT COMPLETED|Overall Study||3
1052549|NCT00814983|2554966|P2|COMPLETED|Overall Study||0
1052550|NCT00814983|2554967|P1|COMPLETED|Overall Study||12
1052551|NCT00814983|2554966|P2|STARTED|Overall Study||0
1052552|NCT00814983|2554967|P1|STARTED|Overall Study||15
1052553|NCT00815035|2554979|P3|NOT COMPLETED|Open Label Extension Phase||6
1052554|NCT00815035|2554980|P2|NOT COMPLETED|Open Label Extension Phase||0
1052555|NCT00815035|2554981|P1|NOT COMPLETED|Open Label Extension Phase||0
1052556|NCT00815035|2554979|P3|COMPLETED|Open Label Extension Phase||9
1052557|NCT00815035|2554980|P2|COMPLETED|Open Label Extension Phase||0
1052558|NCT00815035|2554981|P1|COMPLETED|Open Label Extension Phase||0
1052559|NCT00815035|2554979|P3|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|15
1052560|NCT00815035|2554980|P2|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
1052561|NCT00815035|2554981|P1|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
1052562|NCT00815035|2554979|P3|NOT COMPLETED|Blinded Phase||0
1052563|NCT00815035|2554980|P2|NOT COMPLETED|Blinded Phase||0
1052564|NCT00815035|2554981|P1|NOT COMPLETED|Blinded Phase||1
1052565|NCT00815035|2554979|P3|COMPLETED|Blinded Phase||0
1052566|NCT00815035|2554980|P2|COMPLETED|Blinded Phase||6
1052567|NCT00815035|2554981|P1|COMPLETED|Blinded Phase||9
1052568|NCT00815035|2554979|P3|STARTED|Blinded Phase||0
1052569|NCT00815035|2554980|P2|STARTED|Blinded Phase||6
1052570|NCT00815035|2554981|P1|STARTED|Blinded Phase||10
1052571|NCT00815087|2554999|P2|NOT COMPLETED|Overall Study||0
1052572|NCT00815087|2555000|P1|NOT COMPLETED|Overall Study||0
1052573|NCT00815087|2554999|P2|COMPLETED|Overall Study||10
1052574|NCT00815087|2555000|P1|COMPLETED|Overall Study||10
1052575|NCT00815087|2554999|P2|STARTED|Overall Study||10
1052576|NCT00815087|2555000|P1|STARTED|Overall Study||10
1052577|NCT00815191|2555008|P2|NOT COMPLETED|Overall Study||1
1052578|NCT00815191|2555009|P1|NOT COMPLETED|Overall Study||1
1052579|NCT00815191|2555008|P2|COMPLETED|Overall Study||34
1052580|NCT00815191|2555009|P1|COMPLETED|Overall Study||37
1052581|NCT00815191|2555008|P2|STARTED|Overall Study||35
1052582|NCT00815191|2555009|P1|STARTED|Overall Study||38
1052583|NCT00815295|2555018|P3|NOT COMPLETED|Overall Study||3
1052584|NCT00815295|2555019|P2|NOT COMPLETED|Overall Study||1
1052585|NCT00815295|2555020|P1|NOT COMPLETED|Overall Study||0
1052586|NCT00815295|2555018|P3|COMPLETED|Overall Study||9
1052587|NCT00815295|2555019|P2|COMPLETED|Overall Study||7
1052588|NCT00815295|2555020|P1|COMPLETED|Overall Study||8
1052589|NCT00815295|2555018|P3|STARTED|Overall Study||12
1052590|NCT00815295|2555019|P2|STARTED|Overall Study||8
1052591|NCT00815295|2555020|P1|STARTED|Overall Study||8
1052592|NCT00815308|2555030|P1|NOT COMPLETED|Overall Study||10
1052593|NCT00815308|2555030|P1|COMPLETED|Overall Study||45
1052594|NCT00815308|2555030|P1|STARTED|Overall Study||55
1052595|NCT00815347|2555036|P1|NOT COMPLETED|Overall Study||4
1052596|NCT00815347|2555036|P1|COMPLETED|Overall Study||7
1052597|NCT00815347|2555036|P1|STARTED|Overall Study||11
1052598|NCT00815360|2555054|P2|NOT COMPLETED|Overall Study||0
1052599|NCT00815360|2555055|P1|NOT COMPLETED|Overall Study||0
1052600|NCT00815360|2555054|P2|COMPLETED|Overall Study||11
1052601|NCT00815360|2555055|P1|COMPLETED|Overall Study||11
1052602|NCT00815360|2555054|P2|STARTED|Overall Study||11
1052603|NCT00815360|2555055|P1|STARTED|Overall Study||11
1052604|NCT00815490|2555065|P2|NOT COMPLETED|Overall Study||0
1052605|NCT00815490|2555066|P1|NOT COMPLETED|Overall Study||0
1052606|NCT00815490|2555065|P2|COMPLETED|Overall Study||9
1052607|NCT00815490|2555066|P1|COMPLETED|Overall Study||9
1052608|NCT00815490|2555065|P2|STARTED|Overall Study||9
1052609|NCT00815490|2555066|P1|STARTED|Overall Study||9
1052610|NCT00815516|2555074|P2|NOT COMPLETED|Overall Study||1
1052611|NCT00815516|2555075|P1|NOT COMPLETED|Overall Study||4
1052612|NCT00815516|2555074|P2|COMPLETED|Overall Study||9
1052613|NCT00815516|2555075|P1|COMPLETED|Overall Study||16
1052614|NCT00815516|2555074|P2|STARTED|Overall Study||10
1052615|NCT00815516|2555075|P1|STARTED|Overall Study||20
1052616|NCT00815659|2555104|P1|NOT COMPLETED|Overall Study||23
1052617|NCT00815659|2555104|P1|COMPLETED|Overall Study||74
1052618|NCT00815659|2555104|P1|STARTED|Overall Study||97
1052619|NCT00815685|2555147|P1|NOT COMPLETED|Overall Study||22
1052620|NCT00815685|2555147|P1|COMPLETED|Overall Study|Complete pre and post-treatment serum samples were available for 14 participants.|14
1052621|NCT00815685|2555147|P1|STARTED|Overall Study||36
1052622|NCT00815698|2555154|P2|NOT COMPLETED|Overall Study||0
1052623|NCT00815698|2555155|P1|NOT COMPLETED|Overall Study||0
1052624|NCT00815698|2555154|P2|COMPLETED|Overall Study||171
1052625|NCT00815698|2555155|P1|COMPLETED|Overall Study||163
1052626|NCT00815698|2555154|P2|STARTED|Overall Study||171
1052627|NCT00815698|2555155|P1|STARTED|Overall Study||163
1052628|NCT00815776|2555166|P3|NOT COMPLETED|Overall Study||6
1052629|NCT00815776|2555167|P2|NOT COMPLETED|Overall Study||8
1052630|NCT00815776|2555168|P1|NOT COMPLETED|Overall Study||8
1052631|NCT00815776|2555166|P3|COMPLETED|Overall Study||22
1052632|NCT00815776|2555167|P2|COMPLETED|Overall Study||56
1052633|NCT00815776|2555168|P1|COMPLETED|Overall Study||52
1052634|NCT00815776|2555166|P3|STARTED|Overall Study||28
1052635|NCT00815776|2555167|P2|STARTED|Overall Study||64
1052636|NCT00815776|2555168|P1|STARTED|Overall Study||60
1052637|NCT00815919|2555182|P1|NOT COMPLETED|Overall Study||4
1052638|NCT00815919|2555182|P1|COMPLETED|Overall Study||18
1052639|NCT00815919|2555182|P1|STARTED|Overall Study||22
1052640|NCT00816023|2555194|P4|NOT COMPLETED|Overall Study||12
1052641|NCT00816023|2555195|P3|NOT COMPLETED|Overall Study||9
1052642|NCT00816023|2555196|P2|NOT COMPLETED|Overall Study||6
1052643|NCT00816023|2555197|P1|NOT COMPLETED|Overall Study||9
1052644|NCT00816023|2555194|P4|COMPLETED|Overall Study||62
1052645|NCT00816023|2555195|P3|COMPLETED|Overall Study||60
1052646|NCT00816023|2555196|P2|COMPLETED|Overall Study||56
1052647|NCT00816023|2555197|P1|COMPLETED|Overall Study||62
1052648|NCT00816023|2555194|P4|Completed Therapy|Overall Study||63
1052649|NCT00816023|2555195|P3|Completed Therapy|Overall Study||61
1052650|NCT00816023|2555196|P2|Completed Therapy|Overall Study||59
1052651|NCT00816023|2555197|P1|Completed Therapy|Overall Study||65
1052652|NCT00816023|2555194|P4|STARTED|Overall Study||74
1052653|NCT00816023|2555195|P3|STARTED|Overall Study||69
1052654|NCT00816023|2555196|P2|STARTED|Overall Study||62
1052655|NCT00816023|2555197|P1|STARTED|Overall Study||71
1052656|NCT00816036|2555213|P2|NOT COMPLETED|Overall Study||108
1052657|NCT00816036|2555214|P1|NOT COMPLETED|Overall Study||176
1052658|NCT00816036|2555213|P2|COMPLETED|Overall Study||287
1052659|NCT00816036|2555214|P1|COMPLETED|Overall Study||327
1052660|NCT00816036|2555213|P2|STARTED|Overall Study||395
1052661|NCT00816036|2555214|P1|STARTED|Overall Study||503
1052662|NCT00816101|2555227|P3|NOT COMPLETED|Overall Study||0
1052663|NCT00816101|2555228|P2|NOT COMPLETED|Overall Study||0
1052664|NCT00816101|2555229|P1|NOT COMPLETED|Overall Study||0
1052665|NCT00816101|2555227|P3|COMPLETED|Overall Study||5
1052666|NCT00816101|2555228|P2|COMPLETED|Overall Study||8
1052667|NCT00816101|2555229|P1|COMPLETED|Overall Study||13
1052668|NCT00816101|2555227|P3|STARTED|Overall Study||5
1052669|NCT00816101|2555228|P2|STARTED|Overall Study||8
1052670|NCT00816101|2555229|P1|STARTED|Overall Study||13
1052671|NCT00816166|2555245|P2|NOT COMPLETED|Overall Study||12
1052672|NCT00816166|2555246|P1|NOT COMPLETED|Overall Study||10
1052673|NCT00816166|2555245|P2|COMPLETED|Overall Study||41
1052674|NCT00816166|2555246|P1|COMPLETED|Overall Study||49
1052675|NCT00816166|2555245|P2|ITT Population (Met Eligibility)|Overall Study||53
1052676|NCT00816166|2555246|P1|ITT Population (Met Eligibility)|Overall Study|Of 59 randomized to Stent Arm, 1 subject failed to meet eligibility and was excluded from the ITT|58
1052770|NCT00798304|2555685|P2|NOT COMPLETED|Overall Study||22
1052677|NCT00816166|2555245|P2|STARTED|Overall Study|Of 53 randomized to Medical Therapy Arm, 9 were treated with Stent+Medical Therapy|53
1052678|NCT00816166|2555246|P1|STARTED|Overall Study|Of 59 randomized to Stent Arm, 4 were treated with Medical Therapy Only|59
1052679|NCT00816348|2555252|P1|NOT COMPLETED|Overall Study||0
1052680|NCT00816348|2555252|P1|COMPLETED|Overall Study||15
1052681|NCT00816348|2555252|P1|STARTED|Overall Study||15
1052682|NCT00816400|2555265|P9|NOT COMPLETED|Overall Study||6
1052683|NCT00816400|2555266|P8|NOT COMPLETED|Overall Study||5
1052684|NCT00816400|2555267|P7|NOT COMPLETED|Overall Study||2
1052685|NCT00816400|2555268|P6|NOT COMPLETED|Overall Study||3
1052686|NCT00816400|2555269|P5|NOT COMPLETED|Overall Study||2
1052687|NCT00816400|2555270|P4|NOT COMPLETED|Overall Study||3
1052688|NCT00816400|2555271|P3|NOT COMPLETED|Overall Study||5
1052689|NCT00816400|2555272|P2|NOT COMPLETED|Overall Study||3
1052690|NCT00816400|2555273|P1|NOT COMPLETED|Overall Study||2
1052691|NCT00816400|2555265|P9|COMPLETED|Overall Study||0
1052692|NCT00816400|2555266|P8|COMPLETED|Overall Study||1
1052693|NCT00816400|2555267|P7|COMPLETED|Overall Study||1
1052694|NCT00816400|2555268|P6|COMPLETED|Overall Study||0
1052695|NCT00816400|2555269|P5|COMPLETED|Overall Study||1
1052696|NCT00816400|2555270|P4|COMPLETED|Overall Study||0
1052697|NCT00816400|2555271|P3|COMPLETED|Overall Study||0
1052698|NCT00816400|2555272|P2|COMPLETED|Overall Study||0
1052699|NCT00816400|2555273|P1|COMPLETED|Overall Study||1
1052700|NCT00816400|2555265|P9|STARTED|Overall Study||6
1052701|NCT00816400|2555266|P8|STARTED|Overall Study||6
1052702|NCT00816400|2555267|P7|STARTED|Overall Study||3
1052703|NCT00816400|2555268|P6|STARTED|Overall Study||3
1052704|NCT00816400|2555269|P5|STARTED|Overall Study||3
1052705|NCT00816400|2555270|P4|STARTED|Overall Study||3
1052706|NCT00816400|2555271|P3|STARTED|Overall Study||5
1052707|NCT00816400|2555272|P2|STARTED|Overall Study||3
1052708|NCT00816400|2555273|P1|STARTED|Overall Study||3
1052709|NCT00816556|2555460|P3|NOT COMPLETED|Overall Study||3
1052710|NCT00816556|2555461|P2|NOT COMPLETED|Overall Study||2
1052711|NCT00816556|2555462|P1|NOT COMPLETED|Overall Study||2
1052712|NCT00816556|2555460|P3|COMPLETED|Overall Study||19
1052713|NCT00816556|2555461|P2|COMPLETED|Overall Study||19
1052714|NCT00816556|2555462|P1|COMPLETED|Overall Study||18
1052715|NCT00816556|2555460|P3|STARTED|Overall Study||22
1052716|NCT00816556|2555461|P2|STARTED|Overall Study||21
1052717|NCT00816556|2555462|P1|STARTED|Overall Study||20
1052718|NCT00816595|2555478|P2|NOT COMPLETED|Overall Study||0
1052719|NCT00816595|2555479|P1|NOT COMPLETED|Overall Study||2
1052720|NCT00816595|2555478|P2|COMPLETED|Overall Study||33
1052721|NCT00816595|2555479|P1|COMPLETED|Overall Study||33
1052722|NCT00816595|2555478|P2|STARTED|Overall Study||33
1052723|NCT00816595|2555479|P1|STARTED|Overall Study||35
1052724|NCT00816777|2555491|P2|NOT COMPLETED|Overall Study||0
1052725|NCT00816777|2555492|P1|NOT COMPLETED|Overall Study||0
1052726|NCT00816777|2555491|P2|COMPLETED|Overall Study||2
1052727|NCT00816777|2555492|P1|COMPLETED|Overall Study||2
1052728|NCT00816777|2555491|P2|STARTED|Overall Study||2
1052729|NCT00816777|2555492|P1|STARTED|Overall Study||2
1052730|NCT00816829|2555500|P2|NOT COMPLETED|Overall Study||0
1052731|NCT00816829|2555501|P1|NOT COMPLETED|Overall Study||0
1052732|NCT00816829|2555500|P2|COMPLETED|Overall Study||18
1052733|NCT00816829|2555501|P1|COMPLETED|Overall Study||16
1052734|NCT00816829|2555500|P2|STARTED|Overall Study||18
1052735|NCT00816829|2555501|P1|STARTED|Overall Study||16
1052736|NCT00816907|2555527|P2|NOT COMPLETED|Overall Study||17
1052737|NCT00816907|2555528|P1|NOT COMPLETED|Overall Study||13
1052738|NCT00816907|2555527|P2|COMPLETED|Overall Study||58
1052739|NCT00816907|2555528|P1|COMPLETED|Overall Study||58
1052740|NCT00816907|2555527|P2|STARTED|Overall Study||75
1052741|NCT00816907|2555528|P1|STARTED|Overall Study||71
1052742|NCT00798096|2555548|P1|NOT COMPLETED|Overall Study||2
1052743|NCT00798096|2555548|P1|COMPLETED|Overall Study|Completion of Study is defined as a minimum of 8 weeks of treatment or early disease progression|16
1052744|NCT00798096|2555548|P1|STARTED|Overall Study|Treatment with 200 mg bid, oral Fostamatanib until disease progression, toxicity or withdrawal|18
1052745|NCT00798135|2555555|P1|NOT COMPLETED|Overall Study||13
1052746|NCT00798135|2555555|P1|COMPLETED|Overall Study||0
1052747|NCT00798135|2555555|P1|STARTED|Overall Study||13
1052748|NCT00798161|2555568|P7|NOT COMPLETED|Overall Study||10
1052749|NCT00798161|2555569|P6|NOT COMPLETED|Overall Study||11
1052750|NCT00798161|2555570|P5|NOT COMPLETED|Overall Study||16
1052751|NCT00798161|2555571|P4|NOT COMPLETED|Overall Study||21
1052752|NCT00798161|2555572|P3|NOT COMPLETED|Overall Study||21
1052753|NCT00798161|2555573|P2|NOT COMPLETED|Overall Study||17
1052754|NCT00798161|2555574|P1|NOT COMPLETED|Overall Study||18
1052755|NCT00798161|2555568|P7|COMPLETED|Overall Study||56
1052756|NCT00798161|2555569|P6|COMPLETED|Overall Study||132
1052757|NCT00798161|2555570|P5|COMPLETED|Overall Study||127
1052758|NCT00798161|2555571|P4|COMPLETED|Overall Study||121
1052759|NCT00798161|2555572|P3|COMPLETED|Overall Study||126
1052760|NCT00798161|2555573|P2|COMPLETED|Overall Study||127
1052761|NCT00798161|2555574|P1|COMPLETED|Overall Study||54
1052762|NCT00798161|2555568|P7|STARTED|Overall Study||66
1052763|NCT00798161|2555569|P6|STARTED|Overall Study||143
1052764|NCT00798161|2555570|P5|STARTED|Overall Study||143
1052765|NCT00798161|2555571|P4|STARTED|Overall Study||142
1052766|NCT00798161|2555572|P3|STARTED|Overall Study||147
1052767|NCT00798161|2555573|P2|STARTED|Overall Study||144
1052768|NCT00798161|2555574|P1|STARTED|Overall Study||72
1052769|NCT00798304|2555684|P3|NOT COMPLETED|Overall Study||10
1052771|NCT00798304|2555686|P1|NOT COMPLETED|Overall Study||14
1052772|NCT00798304|2555684|P3|COMPLETED|Overall Study||0
1052773|NCT00798304|2555685|P2|COMPLETED|Overall Study||0
1052774|NCT00798304|2555686|P1|COMPLETED|Overall Study||0
1052775|NCT00798304|2555684|P3|STARTED|Overall Study||10
1052776|NCT00798304|2555685|P2|STARTED|Overall Study||22
1052777|NCT00798304|2555686|P1|STARTED|Overall Study||14
1052778|NCT00798317|2555714|P2|NOT COMPLETED|Overall Study||7
1052779|NCT00798317|2555715|P1|NOT COMPLETED|Overall Study||10
1052780|NCT00798317|2555714|P2|COMPLETED|Overall Study||74
1052781|NCT00798317|2555715|P1|COMPLETED|Overall Study||235
1052782|NCT00798317|2555714|P2|STARTED|Overall Study||81
1052783|NCT00798317|2555715|P1|STARTED|Overall Study||245
1052784|NCT00798369|2555729|P6|NOT COMPLETED|Overall Study||3
1052785|NCT00798369|2555730|P5|NOT COMPLETED|Overall Study||1
1052786|NCT00798369|2555731|P4|NOT COMPLETED|Overall Study||1
1052787|NCT00798369|2555732|P3|NOT COMPLETED|Overall Study||2
1052788|NCT00798369|2555733|P2|NOT COMPLETED|Overall Study||1
1052789|NCT00798369|2555734|P1|NOT COMPLETED|Overall Study||1
1052790|NCT00798369|2555729|P6|COMPLETED|Overall Study||54
1052791|NCT00798369|2555730|P5|COMPLETED|Overall Study||27
1052792|NCT00798369|2555731|P4|COMPLETED|Overall Study||28
1052793|NCT00798369|2555732|P3|COMPLETED|Overall Study||27
1052794|NCT00798369|2555733|P2|COMPLETED|Overall Study||28
1052795|NCT00798369|2555734|P1|COMPLETED|Overall Study||27
1052796|NCT00798369|2555729|P6|STARTED|Overall Study||57
1052797|NCT00798369|2555730|P5|STARTED|Overall Study||28
1052798|NCT00798369|2555731|P4|STARTED|Overall Study||29
1052799|NCT00798369|2555732|P3|STARTED|Overall Study||29
1052800|NCT00798369|2555733|P2|STARTED|Overall Study||29
1052801|NCT00798369|2555734|P1|STARTED|Overall Study||28
1052802|NCT00798434|2555781|P2|NOT COMPLETED|Open-Label||32
1052803|NCT00798434|2555782|P1|NOT COMPLETED|Open-Label||42
1052804|NCT00798434|2555781|P2|COMPLETED|Open-Label||282
1052805|NCT00798434|2555782|P1|COMPLETED|Open-Label||299
1052806|NCT00798434|2555781|P2|Received Treatment|Open-Label||313
1052807|NCT00798434|2555782|P1|Received Treatment|Open-Label||341
1052808|NCT00798434|2555781|P2|STARTED|Open-Label||314
1052809|NCT00798434|2555782|P1|STARTED|Open-Label||341
1052810|NCT00798434|2555781|P2|NOT COMPLETED|Double-Blind||84
1052811|NCT00798434|2555782|P1|NOT COMPLETED|Double-Blind||55
1052812|NCT00798434|2555781|P2|COMPLETED|Double-Blind||314
1052813|NCT00798434|2555782|P1|COMPLETED|Double-Blind||341
1052814|NCT00798434|2555781|P2|Received Treatment|Double-Blind||392
1052815|NCT00798434|2555782|P1|Received Treatment|Double-Blind||393
1052816|NCT00798434|2555781|P2|STARTED|Double-Blind||398
1052817|NCT00798434|2555782|P1|STARTED|Double-Blind||396
1052818|NCT00798486|2555862|P1|NOT COMPLETED|Overall Study||0
1052819|NCT00798486|2555862|P1|COMPLETED|Overall Study||110
1052820|NCT00798486|2555862|P1|STARTED|Overall Study||110
1052821|NCT00798577|2555871|P2|NOT COMPLETED|Overall Study||0
1052822|NCT00798577|2555872|P1|NOT COMPLETED|Overall Study||0
1052823|NCT00798577|2555871|P2|COMPLETED|Overall Study||7
1052824|NCT00798577|2555872|P1|COMPLETED|Overall Study||17
1052825|NCT00798577|2555871|P2|STARTED|Overall Study||7
1052826|NCT00798577|2555872|P1|STARTED|Overall Study||17
1052827|NCT00798590|2555888|P2|NOT COMPLETED|Overall Study||8
1052828|NCT00798590|2555889|P1|NOT COMPLETED|Overall Study||11
1052829|NCT00798590|2555888|P2|COMPLETED|Overall Study||0
1052830|NCT00798590|2555889|P1|COMPLETED|Overall Study||0
1052831|NCT00798590|2555888|P2|STARTED|Overall Study||8
1052832|NCT00798590|2555889|P1|STARTED|Overall Study||11
1052833|NCT00798603|2555897|P1|NOT COMPLETED|Overall Study||35
1052834|NCT00798603|2555897|P1|COMPLETED|Overall Study||27
1052835|NCT00798603|2555897|P1|STARTED|Overall Study||62
1052836|NCT00798655|2555917|P1|NOT COMPLETED|Overall Study||2
1052837|NCT00798655|2555917|P1|COMPLETED|Overall Study||44
1052838|NCT00798655|2555917|P1|STARTED|Overall Study||46
1052839|NCT00798707|2555925|P3|NOT COMPLETED|Overall Study||22
1052840|NCT00798707|2555926|P2|NOT COMPLETED|Overall Study||33
1052841|NCT00798707|2555927|P1|NOT COMPLETED|Overall Study||26
1052842|NCT00798707|2555925|P3|COMPLETED|Overall Study||215
1052843|NCT00798707|2555926|P2|COMPLETED|Overall Study||204
1052844|NCT00798707|2555927|P1|COMPLETED|Overall Study||209
1052845|NCT00798707|2555925|P3|Treated|Overall Study||236
1052846|NCT00798707|2555926|P2|Treated|Overall Study||232
1052847|NCT00798707|2555927|P1|Treated|Overall Study||231
1052848|NCT00798707|2555925|P3|STARTED|Overall Study||237
1052849|NCT00798707|2555926|P2|STARTED|Overall Study||237
1052850|NCT00798707|2555927|P1|STARTED|Overall Study||235
1052851|NCT00798720|2555977|P1|NOT COMPLETED|Overall Study||0
1052852|NCT00798720|2555977|P1|COMPLETED|Overall Study||18
1052853|NCT00798720|2555977|P1|STARTED|Overall Study||18
1052854|NCT00798759|2555986|P2|NOT COMPLETED|Overall Study||13
1052855|NCT00798759|2555987|P1|NOT COMPLETED|Overall Study||8
1052856|NCT00798759|2555986|P2|COMPLETED|Overall Study||106
1052857|NCT00798759|2555987|P1|COMPLETED|Overall Study||109
1052858|NCT00798759|2555986|P2|STARTED|Overall Study||119
1052859|NCT00798759|2555987|P1|STARTED|Overall Study||117
1052860|NCT00798889|2555995|P1|NOT COMPLETED|Overall Study||314
1052861|NCT00798889|2555995|P1|COMPLETED|Overall Study||0
1052862|NCT00798889|2555995|P1|Treated|Overall Study||311
1052863|NCT00798889|2555995|P1|STARTED|Overall Study||314
1052864|NCT00798967|2556001|P2|NOT COMPLETED|Overall Study||4
1052865|NCT00798967|2556002|P1|NOT COMPLETED|Overall Study||4
1052866|NCT00798967|2556001|P2|COMPLETED|Overall Study||39
1052867|NCT00798967|2556002|P1|COMPLETED|Overall Study||39
1052868|NCT00798967|2556001|P2|Discontinued During Dosing Period|Overall Study||4
1052869|NCT00798967|2556002|P1|Discontinued During Dosing Period|Overall Study||4
1052870|NCT00798967|2556001|P2|STARTED|Overall Study||43
1052871|NCT00798967|2556002|P1|STARTED|Overall Study||43
1052872|NCT00804570|2556012|P2|NOT COMPLETED|Overall Study||94
1052873|NCT00804570|2556013|P1|NOT COMPLETED|Overall Study||72
1052874|NCT00804570|2556012|P2|COMPLETED|Overall Study||94
1052875|NCT00804570|2556013|P1|COMPLETED|Overall Study||115
1052876|NCT00804570|2556012|P2|STARTED|Overall Study||188
1052877|NCT00804570|2556013|P1|STARTED|Overall Study||187
1052878|NCT00804596|2556069|P1|NOT COMPLETED|Overall Study||0
1052879|NCT00804596|2556069|P1|COMPLETED|Overall Study||74
1052880|NCT00804596|2556069|P1|STARTED|Overall Study||74
1052887|NCT00804648|2556083|P6|NOT COMPLETED|Third Invervention||0
1052888|NCT00804648|2556084|P5|NOT COMPLETED|Third Invervention||0
1052889|NCT00804648|2556085|P4|NOT COMPLETED|Third Invervention||0
1052890|NCT00804648|2556086|P3|NOT COMPLETED|Third Invervention||0
1052891|NCT00804648|2556087|P2|NOT COMPLETED|Third Invervention||0
1052892|NCT00804648|2556088|P1|NOT COMPLETED|Third Invervention||0
1052893|NCT00804648|2556083|P6|COMPLETED|Third Invervention||8
1052894|NCT00804648|2556084|P5|COMPLETED|Third Invervention||4
1052895|NCT00804648|2556085|P4|COMPLETED|Third Invervention||4
1052896|NCT00804648|2556086|P3|COMPLETED|Third Invervention||6
1052897|NCT00804648|2556087|P2|COMPLETED|Third Invervention||5
1052898|NCT00804648|2556088|P1|COMPLETED|Third Invervention||3
1052899|NCT00804648|2556083|P6|STARTED|Third Invervention||8
1052900|NCT00804648|2556084|P5|STARTED|Third Invervention||4
1052901|NCT00804648|2556085|P4|STARTED|Third Invervention||4
1052902|NCT00804648|2556086|P3|STARTED|Third Invervention||6
1052903|NCT00804648|2556087|P2|STARTED|Third Invervention||5
1052904|NCT00804648|2556088|P1|STARTED|Third Invervention||3
1052905|NCT00804648|2556083|P6|NOT COMPLETED|Second Intervention||0
1052906|NCT00804648|2556084|P5|NOT COMPLETED|Second Intervention||0
1052907|NCT00804648|2556085|P4|NOT COMPLETED|Second Intervention||0
1052908|NCT00804648|2556086|P3|NOT COMPLETED|Second Intervention||0
1052909|NCT00804648|2556087|P2|NOT COMPLETED|Second Intervention||0
1052910|NCT00804648|2556088|P1|NOT COMPLETED|Second Intervention||0
1052911|NCT00804648|2556083|P6|COMPLETED|Second Intervention||8
1052912|NCT00804648|2556084|P5|COMPLETED|Second Intervention||4
1052913|NCT00804648|2556085|P4|COMPLETED|Second Intervention||4
1052914|NCT00804648|2556086|P3|COMPLETED|Second Intervention||6
1052915|NCT00804648|2556087|P2|COMPLETED|Second Intervention||5
1052916|NCT00804648|2556088|P1|COMPLETED|Second Intervention||3
1052917|NCT00804648|2556083|P6|STARTED|Second Intervention||8
1052918|NCT00804648|2556084|P5|STARTED|Second Intervention||4
1052919|NCT00804648|2556085|P4|STARTED|Second Intervention||4
1052920|NCT00804648|2556086|P3|STARTED|Second Intervention||6
1052921|NCT00804648|2556087|P2|STARTED|Second Intervention||5
1052922|NCT00804648|2556088|P1|STARTED|Second Intervention||3
1052923|NCT00804648|2556083|P6|NOT COMPLETED|First Intervention||0
1052924|NCT00804648|2556084|P5|NOT COMPLETED|First Intervention||0
1052925|NCT00804648|2556085|P4|NOT COMPLETED|First Intervention||0
1052926|NCT00804648|2556086|P3|NOT COMPLETED|First Intervention||0
1052927|NCT00804648|2556087|P2|NOT COMPLETED|First Intervention||0
1052928|NCT00804648|2556088|P1|NOT COMPLETED|First Intervention||0
1052929|NCT00804648|2556083|P6|COMPLETED|First Intervention||8
1052930|NCT00804648|2556084|P5|COMPLETED|First Intervention||4
1052931|NCT00804648|2556085|P4|COMPLETED|First Intervention||4
1052932|NCT00804648|2556086|P3|COMPLETED|First Intervention||6
1052933|NCT00804648|2556087|P2|COMPLETED|First Intervention||5
1052934|NCT00804648|2556088|P1|COMPLETED|First Intervention||3
1052935|NCT00804648|2556083|P6|STARTED|First Intervention||8
1052936|NCT00804648|2556084|P5|STARTED|First Intervention||4
1052937|NCT00804648|2556085|P4|STARTED|First Intervention||4
1052938|NCT00804648|2556086|P3|STARTED|First Intervention||6
1052939|NCT00804648|2556087|P2|STARTED|First Intervention||5
1052940|NCT00804648|2556088|P1|STARTED|First Intervention||3
1052941|NCT00804687|2556129|P6|NOT COMPLETED|Period 5: Treatment Period||0
1052942|NCT00804687|2556130|P5|NOT COMPLETED|Period 5: Treatment Period||1
1052943|NCT00804687|2556131|P4|NOT COMPLETED|Period 5: Treatment Period||0
1052944|NCT00804687|2556132|P3|NOT COMPLETED|Period 5: Treatment Period||1
1052945|NCT00804687|2556133|P2|NOT COMPLETED|Period 5: Treatment Period||0
1052946|NCT00804687|2556134|P1|NOT COMPLETED|Period 5: Treatment Period||1
1052947|NCT00804687|2556129|P6|COMPLETED|Period 5: Treatment Period||8
1052948|NCT00804687|2556130|P5|COMPLETED|Period 5: Treatment Period||8
1052949|NCT00804687|2556131|P4|COMPLETED|Period 5: Treatment Period||8
1052950|NCT00804687|2556132|P3|COMPLETED|Period 5: Treatment Period||8
1052951|NCT00804687|2556133|P2|COMPLETED|Period 5: Treatment Period||9
1052952|NCT00804687|2556134|P1|COMPLETED|Period 5: Treatment Period||8
1052953|NCT00804687|2556129|P6|STARTED|Period 5: Treatment Period||8
1052954|NCT00804687|2556130|P5|STARTED|Period 5: Treatment Period||9
1052955|NCT00804687|2556131|P4|STARTED|Period 5: Treatment Period||8
1052956|NCT00804687|2556132|P3|STARTED|Period 5: Treatment Period||9
1052957|NCT00804687|2556133|P2|STARTED|Period 5: Treatment Period||9
1052958|NCT00804687|2556134|P1|STARTED|Period 5: Treatment Period||9
1052959|NCT00804687|2556129|P6|NOT COMPLETED|Period 4: Washout Period||0
1052960|NCT00804687|2556130|P5|NOT COMPLETED|Period 4: Washout Period||0
1052961|NCT00804687|2556131|P4|NOT COMPLETED|Period 4: Washout Period||0
1052962|NCT00804687|2556132|P3|NOT COMPLETED|Period 4: Washout Period||0
1052963|NCT00804687|2556133|P2|NOT COMPLETED|Period 4: Washout Period||0
1052964|NCT00804687|2556134|P1|NOT COMPLETED|Period 4: Washout Period||0
1052965|NCT00804687|2556129|P6|COMPLETED|Period 4: Washout Period||8
1052966|NCT00804687|2556130|P5|COMPLETED|Period 4: Washout Period||9
1052967|NCT00804687|2556131|P4|COMPLETED|Period 4: Washout Period||8
1052968|NCT00804687|2556132|P3|COMPLETED|Period 4: Washout Period||9
1052969|NCT00804687|2556133|P2|COMPLETED|Period 4: Washout Period||9
1052970|NCT00804687|2556134|P1|COMPLETED|Period 4: Washout Period||9
1052971|NCT00804687|2556129|P6|STARTED|Period 4: Washout Period||8
1052972|NCT00804687|2556130|P5|STARTED|Period 4: Washout Period||9
1052973|NCT00804687|2556131|P4|STARTED|Period 4: Washout Period||8
1052974|NCT00804687|2556132|P3|STARTED|Period 4: Washout Period||9
1052975|NCT00804687|2556133|P2|STARTED|Period 4: Washout Period||9
1052976|NCT00804687|2556134|P1|STARTED|Period 4: Washout Period||9
1052977|NCT00804687|2556129|P6|NOT COMPLETED|Period 3: Treatment Period||0
1052978|NCT00804687|2556130|P5|NOT COMPLETED|Period 3: Treatment Period||0
1052979|NCT00804687|2556131|P4|NOT COMPLETED|Period 3: Treatment Period||1
1052980|NCT00804687|2556132|P3|NOT COMPLETED|Period 3: Treatment Period||0
1052981|NCT00804687|2556133|P2|NOT COMPLETED|Period 3: Treatment Period||0
1052982|NCT00804687|2556134|P1|NOT COMPLETED|Period 3: Treatment Period||0
1052983|NCT00804687|2556129|P6|COMPLETED|Period 3: Treatment Period||8
1052984|NCT00804687|2556130|P5|COMPLETED|Period 3: Treatment Period||9
1052985|NCT00804687|2556131|P4|COMPLETED|Period 3: Treatment Period||8
1052986|NCT00804687|2556132|P3|COMPLETED|Period 3: Treatment Period||9
1052987|NCT00804687|2556133|P2|COMPLETED|Period 3: Treatment Period||9
1052988|NCT00804687|2556134|P1|COMPLETED|Period 3: Treatment Period||9
1052989|NCT00804687|2556129|P6|STARTED|Period 3: Treatment Period||8
1052990|NCT00804687|2556130|P5|STARTED|Period 3: Treatment Period||9
1052991|NCT00804687|2556131|P4|STARTED|Period 3: Treatment Period||9
1052992|NCT00804687|2556132|P3|STARTED|Period 3: Treatment Period||9
1052993|NCT00804687|2556133|P2|STARTED|Period 3: Treatment Period||9
1052994|NCT00804687|2556134|P1|STARTED|Period 3: Treatment Period||9
1052995|NCT00804687|2556129|P6|NOT COMPLETED|Period 2: Washout Period||0
1052996|NCT00804687|2556130|P5|NOT COMPLETED|Period 2: Washout Period||0
1052997|NCT00804687|2556131|P4|NOT COMPLETED|Period 2: Washout Period||0
1052998|NCT00804687|2556132|P3|NOT COMPLETED|Period 2: Washout Period||0
1052999|NCT00804687|2556133|P2|NOT COMPLETED|Period 2: Washout Period||0
1053000|NCT00804687|2556134|P1|NOT COMPLETED|Period 2: Washout Period||0
1053001|NCT00804687|2556129|P6|COMPLETED|Period 2: Washout Period||8
1053002|NCT00804687|2556130|P5|COMPLETED|Period 2: Washout Period||9
1053003|NCT00804687|2556131|P4|COMPLETED|Period 2: Washout Period||9
1053004|NCT00804687|2556132|P3|COMPLETED|Period 2: Washout Period||9
1053005|NCT00804687|2556133|P2|COMPLETED|Period 2: Washout Period||9
1053006|NCT00804687|2556134|P1|COMPLETED|Period 2: Washout Period||9
1053007|NCT00804687|2556129|P6|STARTED|Period 2: Washout Period||8
1053008|NCT00804687|2556130|P5|STARTED|Period 2: Washout Period||9
1053009|NCT00804687|2556131|P4|STARTED|Period 2: Washout Period||9
1053010|NCT00804687|2556132|P3|STARTED|Period 2: Washout Period||9
1053011|NCT00804687|2556133|P2|STARTED|Period 2: Washout Period||9
1053012|NCT00804687|2556134|P1|STARTED|Period 2: Washout Period||9
1053013|NCT00804687|2556129|P6|NOT COMPLETED|Period 1: Treatment Period||0
1053014|NCT00804687|2556130|P5|NOT COMPLETED|Period 1: Treatment Period||0
1053015|NCT00804687|2556131|P4|NOT COMPLETED|Period 1: Treatment Period||0
1053016|NCT00804687|2556132|P3|NOT COMPLETED|Period 1: Treatment Period||0
1053017|NCT00804687|2556133|P2|NOT COMPLETED|Period 1: Treatment Period||0
1053018|NCT00804687|2556134|P1|NOT COMPLETED|Period 1: Treatment Period||0
1053019|NCT00804687|2556129|P6|COMPLETED|Period 1: Treatment Period||8
1053020|NCT00804687|2556130|P5|COMPLETED|Period 1: Treatment Period||9
1053021|NCT00804687|2556131|P4|COMPLETED|Period 1: Treatment Period||9
1053022|NCT00804687|2556132|P3|COMPLETED|Period 1: Treatment Period||9
1053023|NCT00804687|2556133|P2|COMPLETED|Period 1: Treatment Period||9
1053024|NCT00804687|2556134|P1|COMPLETED|Period 1: Treatment Period||9
1053025|NCT00804687|2556129|P6|STARTED|Period 1: Treatment Period||8
1053026|NCT00804687|2556130|P5|STARTED|Period 1: Treatment Period||9
1053027|NCT00804687|2556131|P4|STARTED|Period 1: Treatment Period||9
1053028|NCT00804687|2556132|P3|STARTED|Period 1: Treatment Period||9
1053029|NCT00804687|2556133|P2|STARTED|Period 1: Treatment Period||9
1053030|NCT00804687|2556134|P1|STARTED|Period 1: Treatment Period||9
1053031|NCT00804713|2556151|P1|NOT COMPLETED|Overall Study||0
1053032|NCT00804713|2556151|P1|COMPLETED|Overall Study||1978
1053033|NCT00804713|2556151|P1|STARTED|Overall Study||1978
1053040|NCT00804908|2556175|P3|NOT COMPLETED|Overall Study||114
1053041|NCT00804908|2556176|P2|NOT COMPLETED|Overall Study||116
1053042|NCT00804908|2556177|P1|NOT COMPLETED|Overall Study||115
1053043|NCT00804908|2556175|P3|COMPLETED|Overall Study||1
1053044|NCT00804908|2556176|P2|COMPLETED|Overall Study||0
1053045|NCT00804908|2556177|P1|COMPLETED|Overall Study||0
1053046|NCT00804908|2556175|P3|STARTED|Overall Study||115
1053047|NCT00804908|2556176|P2|STARTED|Overall Study||116
1053048|NCT00804908|2556177|P1|STARTED|Overall Study||115
1053049|NCT00804986|2556212|P6|NOT COMPLETED|Overall Study||10
1053050|NCT00804986|2556213|P5|NOT COMPLETED|Overall Study||9
1053051|NCT00804986|2556214|P4|NOT COMPLETED|Overall Study||8
1053052|NCT00804986|2556215|P3|NOT COMPLETED|Overall Study||2
1053053|NCT00804986|2556216|P2|NOT COMPLETED|Overall Study||8
1053054|NCT00804986|2556217|P1|NOT COMPLETED|Overall Study||1
1053055|NCT00804986|2556212|P6|COMPLETED|Overall Study||31
1053056|NCT00804986|2556213|P5|COMPLETED|Overall Study||34
1053057|NCT00804986|2556214|P4|COMPLETED|Overall Study||34
1053058|NCT00804986|2556215|P3|COMPLETED|Overall Study||40
1053059|NCT00804986|2556216|P2|COMPLETED|Overall Study||35
1053060|NCT00804986|2556217|P1|COMPLETED|Overall Study||35
1053061|NCT00804986|2556212|P6|STARTED|Overall Study||41
1053062|NCT00804986|2556213|P5|STARTED|Overall Study||43
1053063|NCT00804986|2556214|P4|STARTED|Overall Study||42
1053064|NCT00804986|2556215|P3|STARTED|Overall Study||42
1053065|NCT00804986|2556216|P2|STARTED|Overall Study||43
1053066|NCT00804986|2556217|P1|STARTED|Overall Study||36
1053067|NCT00805025|2556309|P1|NOT COMPLETED|Overall Study||49
1053068|NCT00805025|2556309|P1|COMPLETED|Overall Study||82
1053069|NCT00805025|2556309|P1|Enrolled and Treated|Overall Study||89
1053070|NCT00805025|2556309|P1|STARTED|Overall Study||131
1053071|NCT00805038|2556317|P2|NOT COMPLETED|Overall Study||0
1053072|NCT00805038|2556318|P1|NOT COMPLETED|Overall Study||0
1053073|NCT00805038|2556317|P2|COMPLETED|Overall Study||92
1053074|NCT00805038|2556318|P1|COMPLETED|Overall Study||75
1053075|NCT00805038|2556317|P2|STARTED|Overall Study||92
1053076|NCT00805038|2556318|P1|STARTED|Overall Study||75
1053077|NCT00805142|2556326|P2|NOT COMPLETED|Maintenance Period||2
1053078|NCT00805142|2556327|P1|NOT COMPLETED|Maintenance Period||0
1053079|NCT00805142|2556326|P2|COMPLETED|Maintenance Period||30
1053080|NCT00805142|2556327|P1|COMPLETED|Maintenance Period||30
1053081|NCT00805142|2556326|P2|STARTED|Maintenance Period||32
1053082|NCT00805142|2556327|P1|STARTED|Maintenance Period||30
1053083|NCT00805142|2556326|P2|NOT COMPLETED|Titration Period||10
1053084|NCT00805142|2556327|P1|NOT COMPLETED|Titration Period||6
1053085|NCT00805142|2556326|P2|COMPLETED|Titration Period||32
1053086|NCT00805142|2556327|P1|COMPLETED|Titration Period||30
1053087|NCT00805142|2556326|P2|STARTED|Titration Period||42
1053088|NCT00805142|2556327|P1|STARTED|Titration Period||36
1053095|NCT00805285|2556386|P1|NOT COMPLETED|Overall Study||1
1053096|NCT00805285|2556386|P1|COMPLETED|Overall Study||0
1053097|NCT00805285|2556386|P1|STARTED|Overall Study||1
1053098|NCT00805389|2556399|P5|NOT COMPLETED|Overall Study||13
1053099|NCT00805389|2556400|P4|NOT COMPLETED|Overall Study||17
1053100|NCT00805389|2556401|P3|NOT COMPLETED|Overall Study||12
1053101|NCT00805389|2556402|P2|NOT COMPLETED|Overall Study||5
1053102|NCT00805389|2556403|P1|NOT COMPLETED|Overall Study||7
1053103|NCT00805389|2556399|P5|COMPLETED|Overall Study||129
1053104|NCT00805389|2556400|P4|COMPLETED|Overall Study||128
1053105|NCT00805389|2556401|P3|COMPLETED|Overall Study||129
1053106|NCT00805389|2556402|P2|COMPLETED|Overall Study||137
1053107|NCT00805389|2556403|P1|COMPLETED|Overall Study||136
1053108|NCT00805389|2556399|P5|STARTED|Overall Study||142
1053109|NCT00805389|2556400|P4|STARTED|Overall Study||145
1053110|NCT00805389|2556401|P3|STARTED|Overall Study||141
1053111|NCT00805389|2556402|P2|STARTED|Overall Study||142
1053112|NCT00805389|2556403|P1|STARTED|Overall Study||143
1053113|NCT00805467|2556649|P4|NOT COMPLETED|Overall Study||237
1053114|NCT00805467|2556650|P3|NOT COMPLETED|Overall Study||103
1053115|NCT00805467|2556651|P2|NOT COMPLETED|Overall Study||34
1053116|NCT00805467|2556652|P1|NOT COMPLETED|Overall Study||0
1053117|NCT00805467|2556649|P4|COMPLETED|Overall Study|Ongoing when study terminated|144
1053118|NCT00805467|2556650|P3|COMPLETED|Overall Study|Ongoing when study terminated|80
1053119|NCT00805467|2556651|P2|COMPLETED|Overall Study|Ongoing when study terminated|25
1053120|NCT00805467|2556652|P1|COMPLETED|Overall Study|Ongoing when study terminated|1
1053121|NCT00805467|2556649|P4|Enrolled But Did Not Receive Treatment|Overall Study||0
1053122|NCT00805467|2556650|P3|Enrolled But Did Not Receive Treatment|Overall Study||0
1053123|NCT00805467|2556651|P2|Enrolled But Did Not Receive Treatment|Overall Study||0
1053124|NCT00805467|2556652|P1|Enrolled But Did Not Receive Treatment|Overall Study||0
1053125|NCT00805467|2556649|P4|STARTED|Overall Study|Patients who received treatment|381
1053126|NCT00805467|2556650|P3|STARTED|Overall Study|Patients who received treatment|183
1053127|NCT00805467|2556651|P2|STARTED|Overall Study|Patients who received treatment|59
1053128|NCT00805467|2556652|P1|STARTED|Overall Study|Patients who received treatment|1
1053129|NCT00805480|2556674|P4|NOT COMPLETED|Overall Study||5
1053130|NCT00805480|2556675|P3|NOT COMPLETED|Overall Study||12
1053131|NCT00805480|2556676|P2|NOT COMPLETED|Overall Study||7
1053132|NCT00805480|2556677|P1|NOT COMPLETED|Overall Study||14
1053133|NCT00805480|2556674|P4|COMPLETED|Overall Study||5
1053134|NCT00805480|2556675|P3|COMPLETED|Overall Study||19
1053135|NCT00805480|2556676|P2|COMPLETED|Overall Study||22
1053136|NCT00805480|2556677|P1|COMPLETED|Overall Study||16
1053137|NCT00805480|2556674|P4|Pharmacodynamic Analysis Set|Overall Study||10
1053138|NCT00805480|2556675|P3|Pharmacodynamic Analysis Set|Overall Study||29
1053139|NCT00805480|2556676|P2|Pharmacodynamic Analysis Set|Overall Study||25
1053140|NCT00805480|2556677|P1|Pharmacodynamic Analysis Set|Overall Study||30
1053141|NCT00805480|2556674|P4|STARTED|Overall Study||10
1053142|NCT00805480|2556675|P3|STARTED|Overall Study||31
1053143|NCT00805480|2556676|P2|STARTED|Overall Study||29
1053144|NCT00805480|2556677|P1|STARTED|Overall Study||30
1053145|NCT00805493|2556705|P3|NOT COMPLETED|Overall Study||1
1053146|NCT00805493|2556706|P2|NOT COMPLETED|Overall Study||0
1053147|NCT00805493|2556707|P1|NOT COMPLETED|Overall Study||2
1053148|NCT00805493|2556705|P3|COMPLETED|Overall Study||0
1053149|NCT00805493|2556706|P2|COMPLETED|Overall Study||2
1053150|NCT00805493|2556707|P1|COMPLETED|Overall Study||1
1053151|NCT00805493|2556705|P3|STARTED|Overall Study||1
1053152|NCT00805493|2556706|P2|STARTED|Overall Study||2
1053153|NCT00805493|2556707|P1|STARTED|Overall Study||3
1053154|NCT00811018|2556718|P1|NOT COMPLETED|Overall Study||968
1053155|NCT00811018|2556718|P1|COMPLETED|Overall Study||224
1053156|NCT00811018|2556718|P1|STARTED|Overall Study||1192
1053157|NCT00811057|2556737|P3|NOT COMPLETED|Overall Study||10
1053158|NCT00811057|2556738|P2|NOT COMPLETED|Overall Study||10
1053159|NCT00811057|2556739|P1|NOT COMPLETED|Overall Study||5
1053160|NCT00811057|2556737|P3|COMPLETED|Overall Study||87
1053161|NCT00811057|2556738|P2|COMPLETED|Overall Study||104
1053162|NCT00811057|2556739|P1|COMPLETED|Overall Study||85
1053163|NCT00811057|2556737|P3|STARTED|Overall Study||97
1053164|NCT00811057|2556738|P2|STARTED|Overall Study||114
1053165|NCT00811057|2556739|P1|STARTED|Overall Study||90
1053166|NCT00811070|2556756|P6|NOT COMPLETED|Overall Study||1
1053167|NCT00811070|2556757|P5|NOT COMPLETED|Overall Study||5
1053168|NCT00811070|2556758|P4|NOT COMPLETED|Overall Study||2
1053169|NCT00811070|2556759|P3|NOT COMPLETED|Overall Study||0
1053170|NCT00811070|2556760|P2|NOT COMPLETED|Overall Study||1
1053171|NCT00811070|2556761|P1|NOT COMPLETED|Overall Study||1
1053172|NCT00811070|2556756|P6|COMPLETED|Overall Study||10
1053173|NCT00811070|2556757|P5|COMPLETED|Overall Study||2
1053174|NCT00811070|2556758|P4|COMPLETED|Overall Study||26
1053175|NCT00811070|2556759|P3|COMPLETED|Overall Study||3
1053176|NCT00811070|2556760|P2|COMPLETED|Overall Study||6
1053177|NCT00811070|2556761|P1|COMPLETED|Overall Study||6
1053178|NCT00811070|2556756|P6|STARTED|Overall Study||11
1053179|NCT00811070|2556757|P5|STARTED|Overall Study||7
1053180|NCT00811070|2556758|P4|STARTED|Overall Study||28
1053181|NCT00811070|2556759|P3|STARTED|Overall Study||3
1053182|NCT00811070|2556760|P2|STARTED|Overall Study||7
1053183|NCT00811070|2556761|P1|STARTED|Overall Study||7
1053184|NCT00811135|2556818|P1|NOT COMPLETED|Overall Study||88
1053185|NCT00811135|2556818|P1|COMPLETED|Overall Study||0
1053186|NCT00811135|2556818|P1|STARTED|Overall Study||88
1053187|NCT00811174|2556830|P1|NOT COMPLETED|Overall Study||3
1053188|NCT00811174|2556830|P1|COMPLETED|Overall Study||2
1053189|NCT00811174|2556830|P1|STARTED|Overall Study||5
1053190|NCT00811252|2556844|P3|NOT COMPLETED|Overall Study||23
1053191|NCT00811252|2556845|P2|NOT COMPLETED|Overall Study||20
1053192|NCT00811252|2556846|P1|NOT COMPLETED|Overall Study||17
1053193|NCT00811252|2556844|P3|COMPLETED|Overall Study||128
1053194|NCT00811252|2556845|P2|COMPLETED|Overall Study||136
1053195|NCT00811252|2556846|P1|COMPLETED|Overall Study||128
1053196|NCT00811252|2556844|P3|STARTED|Overall Study||151
1053197|NCT00811252|2556845|P2|STARTED|Overall Study||156
1053198|NCT00811252|2556846|P1|STARTED|Overall Study||145
1053199|NCT00817206|2556892|P2|NOT COMPLETED|Overall Study||9
1053200|NCT00817206|2556893|P1|NOT COMPLETED|Overall Study||21
1053201|NCT00817206|2556892|P2|COMPLETED|Overall Study||154
1053202|NCT00817206|2556893|P1|COMPLETED|Overall Study||142
1053203|NCT00817206|2556892|P2|STARTED|Overall Study||163
1053204|NCT00817206|2556893|P1|STARTED|Overall Study||163
1053205|NCT00817219|2556899|P1|NOT COMPLETED|Overall Study||0
1053206|NCT00817219|2556899|P1|COMPLETED|Overall Study||33
1053207|NCT00817219|2556899|P1|STARTED|Overall Study||33
1053208|NCT00817336|2556914|P2|NOT COMPLETED|Overall Study||1
1053209|NCT00817336|2556915|P1|NOT COMPLETED|Overall Study||1
1053210|NCT00817336|2556914|P2|COMPLETED|Overall Study||7
1053211|NCT00817336|2556915|P1|COMPLETED|Overall Study||7
1053212|NCT00817336|2556914|P2|STARTED|Overall Study||8
1053213|NCT00817336|2556915|P1|STARTED|Overall Study||8
1053214|NCT00817479|2556928|P2|NOT COMPLETED|Overall Study||1
1053215|NCT00817479|2556929|P1|NOT COMPLETED|Overall Study||1
1053216|NCT00817479|2556928|P2|COMPLETED|Overall Study||13
1053217|NCT00817479|2556929|P1|COMPLETED|Overall Study||5
1053218|NCT00817479|2556928|P2|STARTED|Overall Study||14
1053219|NCT00817479|2556929|P1|STARTED|Overall Study||6
1053220|NCT00818441|2556939|P2|NOT COMPLETED|Overall Study||30
1053221|NCT00818441|2556940|P1|NOT COMPLETED|Overall Study||89
1053222|NCT00818441|2556939|P2|COMPLETED|Overall Study||0
1053223|NCT00818441|2556940|P1|COMPLETED|Overall Study||0
1053224|NCT00818441|2556939|P2|STARTED|Overall Study||30
1053225|NCT00818441|2556940|P1|STARTED|Overall Study||89
1053226|NCT00818454|2556960|P4|NOT COMPLETED|Treatment Period 3||1
1053227|NCT00818454|2556961|P3|NOT COMPLETED|Treatment Period 3||0
1053228|NCT00818454|2556962|P2|NOT COMPLETED|Treatment Period 3||0
1053229|NCT00818454|2556963|P1|NOT COMPLETED|Treatment Period 3||0
1053230|NCT00818454|2556960|P4|COMPLETED|Treatment Period 3||138
1053231|NCT00818454|2556961|P3|COMPLETED|Treatment Period 3||26
1053232|NCT00818454|2556962|P2|COMPLETED|Treatment Period 3||0
1053233|NCT00818454|2556963|P1|COMPLETED|Treatment Period 3||0
1053234|NCT00818454|2556960|P4|STARTED|Treatment Period 3||139
1053235|NCT00818454|2556961|P3|STARTED|Treatment Period 3||26
1053236|NCT00818454|2556962|P2|STARTED|Treatment Period 3||0
1053237|NCT00818454|2556963|P1|STARTED|Treatment Period 3||0
1053238|NCT00818454|2556960|P4|NOT COMPLETED|Treatment Period 2||0
1053239|NCT00818454|2556961|P3|NOT COMPLETED|Treatment Period 2||0
1053240|NCT00818454|2556962|P2|NOT COMPLETED|Treatment Period 2||1
1053241|NCT00818454|2556963|P1|NOT COMPLETED|Treatment Period 2||2
1053242|NCT00818454|2556960|P4|COMPLETED|Treatment Period 2||0
1053243|NCT00818454|2556961|P3|COMPLETED|Treatment Period 2||0
1053244|NCT00818454|2556962|P2|COMPLETED|Treatment Period 2||106
1053245|NCT00818454|2556963|P1|COMPLETED|Treatment Period 2||106
1053246|NCT00818454|2556960|P4|STARTED|Treatment Period 2||0
1053247|NCT00818454|2556961|P3|STARTED|Treatment Period 2||0
1053248|NCT00818454|2556962|P2|STARTED|Treatment Period 2||107
1053249|NCT00818454|2556963|P1|STARTED|Treatment Period 2||108
1053250|NCT00818454|2556960|P4|NOT COMPLETED|Washout Period of 1 Week||0
1053251|NCT00818454|2556961|P3|NOT COMPLETED|Washout Period of 1 Week||0
1053252|NCT00818454|2556962|P2|NOT COMPLETED|Washout Period of 1 Week||3
1053253|NCT00818454|2556963|P1|NOT COMPLETED|Washout Period of 1 Week||4
1053254|NCT00818454|2556960|P4|COMPLETED|Washout Period of 1 Week||0
1053255|NCT00818454|2556961|P3|COMPLETED|Washout Period of 1 Week||0
1053256|NCT00818454|2556962|P2|COMPLETED|Washout Period of 1 Week||107
1053257|NCT00818454|2556963|P1|COMPLETED|Washout Period of 1 Week||108
1053258|NCT00818454|2556960|P4|STARTED|Washout Period of 1 Week||0
1053259|NCT00818454|2556961|P3|STARTED|Washout Period of 1 Week||0
1053260|NCT00818454|2556962|P2|STARTED|Washout Period of 1 Week||110
1053261|NCT00818454|2556963|P1|STARTED|Washout Period of 1 Week||112
1053262|NCT00818454|2556960|P4|NOT COMPLETED|Treatment Period 1||0
1053263|NCT00818454|2556961|P3|NOT COMPLETED|Treatment Period 1||0
1053264|NCT00818454|2556962|P2|NOT COMPLETED|Treatment Period 1||1
1053265|NCT00818454|2556963|P1|NOT COMPLETED|Treatment Period 1||3
1053266|NCT00818454|2556960|P4|COMPLETED|Treatment Period 1||0
1053267|NCT00818454|2556961|P3|COMPLETED|Treatment Period 1||0
1053268|NCT00818454|2556962|P2|COMPLETED|Treatment Period 1||110
1053269|NCT00818454|2556963|P1|COMPLETED|Treatment Period 1||112
1053270|NCT00818454|2556960|P4|STARTED|Treatment Period 1||0
1053271|NCT00818454|2556961|P3|STARTED|Treatment Period 1||0
1053272|NCT00818454|2556962|P2|STARTED|Treatment Period 1||111
1053273|NCT00818454|2556963|P1|STARTED|Treatment Period 1||115
1053274|NCT00818519|2556991|P2|NOT COMPLETED|Overall Study||19
1053275|NCT00818519|2556992|P1|NOT COMPLETED|Overall Study||14
1053276|NCT00818519|2556991|P2|COMPLETED|Overall Study||71
1053277|NCT00818519|2556992|P1|COMPLETED|Overall Study||75
1053278|NCT00818519|2556991|P2|Participants Received Treatment|Overall Study|= Baseline|86
1053279|NCT00818519|2556992|P1|Participants Received Treatment|Overall Study|= Baseline|87
1053280|NCT00818519|2556991|P2|STARTED|Overall Study|4 excluded from FAS because study drug intake unknown or never administered|90
1053281|NCT00818519|2556992|P1|STARTED|Overall Study|2 excluded from FAS because study drug intake unknown or never administered|89
1053282|NCT00818623|2557030|P8|NOT COMPLETED|Overall Study||1
1053283|NCT00818623|2557031|P7|NOT COMPLETED|Overall Study||4
1053284|NCT00818623|2557032|P6|NOT COMPLETED|Overall Study||3
1053285|NCT00818623|2557033|P5|NOT COMPLETED|Overall Study||4
1053286|NCT00818623|2557034|P4|NOT COMPLETED|Overall Study||5
1053287|NCT00818623|2557035|P3|NOT COMPLETED|Overall Study||4
1053288|NCT00818623|2557036|P2|NOT COMPLETED|Overall Study||4
1053289|NCT00818623|2557037|P1|NOT COMPLETED|Overall Study||2
1053290|NCT00818623|2557030|P8|COMPLETED|Overall Study||26
1053291|NCT00818623|2557031|P7|COMPLETED|Overall Study||23
1053292|NCT00818623|2557032|P6|COMPLETED|Overall Study||21
1053293|NCT00818623|2557033|P5|COMPLETED|Overall Study||23
1053294|NCT00818623|2557034|P4|COMPLETED|Overall Study||19
1053295|NCT00818623|2557035|P3|COMPLETED|Overall Study||9
1053296|NCT00818623|2557036|P2|COMPLETED|Overall Study||8
1053297|NCT00818623|2557037|P1|COMPLETED|Overall Study||24
1053298|NCT00818623|2557030|P8|Intent-to-treat (ITT) Population|Overall Study||27
1053299|NCT00818623|2557031|P7|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
1053300|NCT00818623|2557032|P6|Intent-to-treat (ITT) Population|Overall Study||24
1053301|NCT00818623|2557033|P5|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
1053302|NCT00818623|2557034|P4|Intent-to-treat (ITT) Population|Overall Study||24
1053303|NCT00818623|2557035|P3|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|12
1053304|NCT00818623|2557036|P2|Intent-to-treat (ITT) Population|Overall Study||12
1053305|NCT00818623|2557037|P1|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|25
1053306|NCT00818623|2557030|P8|STARTED|Overall Study||27
1053307|NCT00818623|2557031|P7|STARTED|Overall Study||27
1053308|NCT00818623|2557032|P6|STARTED|Overall Study||24
1053309|NCT00818623|2557033|P5|STARTED|Overall Study||27
1053310|NCT00818623|2557034|P4|STARTED|Overall Study||24
1053311|NCT00818623|2557035|P3|STARTED|Overall Study||13
1053312|NCT00818623|2557036|P2|STARTED|Overall Study||12
1053313|NCT00818623|2557037|P1|STARTED|Overall Study||26
1053314|NCT00818649|2557111|P1|NOT COMPLETED|Overall Study||4
1053315|NCT00818649|2557111|P1|COMPLETED|Overall Study||12
1053316|NCT00818649|2557111|P1|STARTED|Overall Study||16
1053317|NCT00818662|2557121|P4|NOT COMPLETED|Overall Study||16
1053318|NCT00818662|2557122|P3|NOT COMPLETED|Overall Study||9
1053319|NCT00818662|2557123|P2|NOT COMPLETED|Overall Study||33
1053320|NCT00818662|2557124|P1|NOT COMPLETED|Overall Study||23
1053321|NCT00818662|2557121|P4|COMPLETED|Overall Study||47
1053322|NCT00818662|2557122|P3|COMPLETED|Overall Study||49
1053323|NCT00818662|2557123|P2|COMPLETED|Overall Study||102
1053324|NCT00818662|2557124|P1|COMPLETED|Overall Study||104
1053325|NCT00818662|2557121|P4|STARTED|Overall Study||63
1053326|NCT00818662|2557122|P3|STARTED|Overall Study||58
1053327|NCT00818662|2557123|P2|STARTED|Overall Study||135
1053328|NCT00818662|2557124|P1|STARTED|Overall Study||127
1053329|NCT00818753|2557213|P3|NOT COMPLETED|Overall Study||1
1053330|NCT00818753|2557214|P2|NOT COMPLETED|Overall Study||0
1053331|NCT00818753|2557215|P1|NOT COMPLETED|Overall Study||3
1053332|NCT00818753|2557213|P3|COMPLETED|Overall Study||9
1053333|NCT00818753|2557214|P2|COMPLETED|Overall Study||21
1053334|NCT00818753|2557215|P1|COMPLETED|Overall Study||19
1053335|NCT00818753|2557213|P3|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|10
1053336|NCT00818753|2557214|P2|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|21
1053337|NCT00818753|2557215|P1|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|22
1053338|NCT00818766|2557237|P2|NOT COMPLETED|Overall Study||10
1053339|NCT00818766|2557238|P1|NOT COMPLETED|Overall Study||15
1053340|NCT00818766|2557237|P2|COMPLETED|Overall Study||116
1053341|NCT00818766|2557238|P1|COMPLETED|Overall Study||110
1053342|NCT00818766|2557237|P2|Intent-to-Treat Population|Overall Study|2 participants were randomized twice but only counted once (per first randomization).|124
1053343|NCT00818766|2557238|P1|Intent-to-Treat Population|Overall Study|1 participant was randomized twice but only counted once (per first randomization).|121
1053344|NCT00818766|2557237|P2|Received Allocated Intervention|Overall Study||126
1053345|NCT00818766|2557238|P1|Received Allocated Intervention|Overall Study|1 withdrew consent, 1 had active infection and 1 was given open-label antibiotic after surgery.|122
1053346|NCT00818766|2557237|P2|STARTED|Overall Study||126
1053347|NCT00818766|2557238|P1|STARTED|Overall Study||125
1053354|NCT00818805|2557273|P2|NOT COMPLETED|Second Intervention||0
1053355|NCT00818805|2557274|P1|NOT COMPLETED|Second Intervention||0
1053356|NCT00818805|2557273|P2|COMPLETED|Second Intervention||25
1053357|NCT00818805|2557274|P1|COMPLETED|Second Intervention||25
1053358|NCT00818805|2557273|P2|STARTED|Second Intervention||25
1053359|NCT00818805|2557274|P1|STARTED|Second Intervention||25
1053360|NCT00818805|2557273|P2|NOT COMPLETED|First Intervention||0
1053361|NCT00818805|2557274|P1|NOT COMPLETED|First Intervention||0
1053362|NCT00818805|2557273|P2|COMPLETED|First Intervention||25
1053363|NCT00818805|2557274|P1|COMPLETED|First Intervention||25
1053364|NCT00818805|2557273|P2|STARTED|First Intervention||25
1053365|NCT00818805|2557274|P1|STARTED|First Intervention||25
1053366|NCT00818883|2557286|P2|NOT COMPLETED|Overall Study||46
1053367|NCT00818883|2557287|P1|NOT COMPLETED|Overall Study||51
1053368|NCT00818883|2557286|P2|COMPLETED|Overall Study||260
1053369|NCT00818883|2557287|P1|COMPLETED|Overall Study||252
1053370|NCT00818883|2557286|P2|STARTED|Overall Study||306
1053371|NCT00818883|2557287|P1|STARTED|Overall Study||303
1053372|NCT00818961|2557321|P1|NOT COMPLETED|Overall Study||0
1053373|NCT00818961|2557321|P1|COMPLETED|Overall Study||36
1053374|NCT00818961|2557321|P1|STARTED|Overall Study||36
1053375|NCT00819013|2557339|P4|NOT COMPLETED|Overall Study||4
1053376|NCT00819013|2557340|P3|NOT COMPLETED|Overall Study||5
1053377|NCT00819013|2557341|P2|NOT COMPLETED|Overall Study||1
1053378|NCT00819013|2557342|P1|NOT COMPLETED|Overall Study||3
1053379|NCT00819013|2557339|P4|COMPLETED|Overall Study||17
1053380|NCT00819013|2557340|P3|COMPLETED|Overall Study||16
1053381|NCT00819013|2557341|P2|COMPLETED|Overall Study||22
1053382|NCT00819013|2557342|P1|COMPLETED|Overall Study||19
1053383|NCT00819013|2557339|P4|STARTED|Overall Study||21
1053384|NCT00819013|2557340|P3|STARTED|Overall Study||21
1053385|NCT00819013|2557341|P2|STARTED|Overall Study||23
1053386|NCT00819013|2557342|P1|STARTED|Overall Study||22
1053387|NCT00819039|2557395|P3|NOT COMPLETED|Overall Study||1
1053388|NCT00819039|2557396|P2|NOT COMPLETED|Overall Study||0
1053389|NCT00819039|2557397|P1|NOT COMPLETED|Overall Study||2
1053390|NCT00819039|2557395|P3|COMPLETED|Overall Study||24
1053391|NCT00819039|2557396|P2|COMPLETED|Overall Study||27
1053392|NCT00819039|2557397|P1|COMPLETED|Overall Study||44
1053393|NCT00819039|2557395|P3|STARTED|Overall Study||25
1053394|NCT00819039|2557396|P2|STARTED|Overall Study||27
1053395|NCT00819039|2557397|P1|STARTED|Overall Study||46
1053396|NCT00819052|2557425|P2|NOT COMPLETED|Overall Study||14
1053397|NCT00819052|2557426|P1|NOT COMPLETED|Overall Study||6
1053398|NCT00819052|2557425|P2|COMPLETED|Overall Study||281
1053399|NCT00819052|2557426|P1|COMPLETED|Overall Study||142
1053400|NCT00819052|2557425|P2|STARTED|Overall Study||295
1053401|NCT00819052|2557426|P1|STARTED|Overall Study||148
1053402|NCT00819091|2557540|P2|NOT COMPLETED|Overall Study||10
1053403|NCT00819091|2557541|P1|NOT COMPLETED|Overall Study||7
1053404|NCT00819091|2557540|P2|COMPLETED|Overall Study||151
1053405|NCT00819091|2557541|P1|COMPLETED|Overall Study||77
1053406|NCT00819091|2557540|P2|STARTED|Overall Study||161
1053407|NCT00819091|2557541|P1|STARTED|Overall Study||84
1053408|NCT00819156|2557571|P6|NOT COMPLETED|Overall Study||8
1053409|NCT00819156|2557572|P5|NOT COMPLETED|Overall Study||6
1053410|NCT00819156|2557573|P4|NOT COMPLETED|Overall Study||2
1053411|NCT00819156|2557574|P3|NOT COMPLETED|Overall Study||6
1053412|NCT00819156|2557575|P2|NOT COMPLETED|Overall Study||10
1053413|NCT00819156|2557576|P1|NOT COMPLETED|Overall Study||10
1053414|NCT00819156|2557571|P6|COMPLETED|Overall Study||23
1053415|NCT00819156|2557572|P5|COMPLETED|Overall Study||27
1053416|NCT00819156|2557573|P4|COMPLETED|Overall Study||28
1053417|NCT00819156|2557574|P3|COMPLETED|Overall Study||26
1053418|NCT00819156|2557575|P2|COMPLETED|Overall Study||23
1053419|NCT00819156|2557576|P1|COMPLETED|Overall Study||20
1053420|NCT00819156|2557571|P6|Randomised and Treated (ITT Population)|Overall Study||30
1053421|NCT00819156|2557572|P5|Randomised and Treated (ITT Population)|Overall Study||33
1053422|NCT00819156|2557573|P4|Randomised and Treated (ITT Population)|Overall Study||30
1053423|NCT00819156|2557574|P3|Randomised and Treated (ITT Population)|Overall Study||32
1053424|NCT00819156|2557575|P2|Randomised and Treated (ITT Population)|Overall Study||32
1053425|NCT00819156|2557576|P1|Randomised and Treated (ITT Population)|Overall Study||30
1053426|NCT00819156|2557571|P6|STARTED|Overall Study||31
1053427|NCT00819156|2557572|P5|STARTED|Overall Study||33
1053428|NCT00819156|2557573|P4|STARTED|Overall Study||30
1053429|NCT00819156|2557574|P3|STARTED|Overall Study||32
1053430|NCT00819156|2557575|P2|STARTED|Overall Study||33
1053431|NCT00819156|2557576|P1|STARTED|Overall Study||30
1053432|NCT00819182|2557667|P3|NOT COMPLETED|Overall Study||1
1053433|NCT00819182|2557668|P2|NOT COMPLETED|Overall Study||8
1053434|NCT00819182|2557669|P1|NOT COMPLETED|Overall Study||13
1053435|NCT00819182|2557667|P3|COMPLETED|Overall Study||43
1053436|NCT00819182|2557668|P2|COMPLETED|Overall Study||78
1053437|NCT00819182|2557669|P1|COMPLETED|Overall Study||75
1053438|NCT00819182|2557667|P3|Week 16 Visit|Overall Study||43
1053439|NCT00819182|2557668|P2|Week 16 Visit|Overall Study||78
1053440|NCT00819182|2557669|P1|Week 16 Visit|Overall Study||75
1053441|NCT00819182|2557667|P3|STARTED|Overall Study|Consented participants allocated to this arm.|44
1053442|NCT00819182|2557668|P2|STARTED|Overall Study|Consented participants allocated to this arm.|86
1053443|NCT00819182|2557669|P1|STARTED|Overall Study|Consented participants allocated to this arm.|88
1053444|NCT00819234|2557699|P10|NOT COMPLETED|Overall Study||7
1053445|NCT00819234|2557700|P9|NOT COMPLETED|Overall Study||6
1053446|NCT00819234|2557701|P8|NOT COMPLETED|Overall Study||9
1053447|NCT00819234|2557702|P7|NOT COMPLETED|Overall Study||5
1053448|NCT00819234|2557703|P6|NOT COMPLETED|Overall Study||7
1053449|NCT00819234|2557704|P5|NOT COMPLETED|Overall Study||1
1053450|NCT00819234|2557705|P4|NOT COMPLETED|Overall Study||6
1053451|NCT00819234|2557706|P3|NOT COMPLETED|Overall Study||8
1053452|NCT00819234|2557707|P2|NOT COMPLETED|Overall Study||15
1053453|NCT00819234|2557708|P1|NOT COMPLETED|Overall Study||10
1053454|NCT00819234|2557699|P10|COMPLETED|Overall Study||30
1053455|NCT00819234|2557700|P9|COMPLETED|Overall Study||31
1053456|NCT00819234|2557701|P8|COMPLETED|Overall Study||20
1053457|NCT00819234|2557702|P7|COMPLETED|Overall Study||8
1053458|NCT00819234|2557703|P6|COMPLETED|Overall Study||7
1053459|NCT00819234|2557704|P5|COMPLETED|Overall Study||12
1053460|NCT00819234|2557705|P4|COMPLETED|Overall Study||22
1053461|NCT00819234|2557706|P3|COMPLETED|Overall Study||28
1053462|NCT00819234|2557707|P2|COMPLETED|Overall Study||20
1053463|NCT00819234|2557708|P1|COMPLETED|Overall Study||21
1053464|NCT00819234|2557699|P10|STARTED|Overall Study||37
1053465|NCT00819234|2557700|P9|STARTED|Overall Study||37
1053466|NCT00819234|2557701|P8|STARTED|Overall Study||29
1053467|NCT00819234|2557702|P7|STARTED|Overall Study||13
1053468|NCT00819234|2557703|P6|STARTED|Overall Study||14
1053469|NCT00819234|2557704|P5|STARTED|Overall Study||13
1053470|NCT00819234|2557705|P4|STARTED|Overall Study||28
1053471|NCT00819234|2557706|P3|STARTED|Overall Study||36
1053472|NCT00819234|2557707|P2|STARTED|Overall Study||35
1053473|NCT00819234|2557708|P1|STARTED|Overall Study||31
1053474|NCT00819247|2557869|P3|NOT COMPLETED|Overall Study||14
1053475|NCT00819247|2557870|P2|NOT COMPLETED|Overall Study||16
1053476|NCT00819247|2557871|P1|NOT COMPLETED|Overall Study||11
1053477|NCT00819247|2557869|P3|COMPLETED|Overall Study||26
1053478|NCT00819247|2557870|P2|COMPLETED|Overall Study||30
1053479|NCT00819247|2557871|P1|COMPLETED|Overall Study||32
1053480|NCT00819247|2557869|P3|Per Protocol Population|Overall Study|One participant - baseline testosterone outside normal range.|38
1053481|NCT00819247|2557870|P2|Per Protocol Population|Overall Study|Two participants - prohibited drugs|44
1053482|NCT00819247|2557871|P1|Per Protocol Population|Overall Study|One participant- baseline testosterone outside normal range. Three participants- prohibited drugs.|38
1053483|NCT00819247|2557869|P3|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|39
1053484|NCT00819247|2557870|P2|Intent-to-treat Population|Overall Study||46
1053485|NCT00819247|2557871|P1|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|42
1053486|NCT00819247|2557869|P3|Randomized|Overall Study||40
1053487|NCT00819247|2557870|P2|Randomized|Overall Study||46
1053488|NCT00819247|2557871|P1|Randomized|Overall Study||43
1053489|NCT00819247|2557869|P3|STARTED|Overall Study||40
1053490|NCT00819247|2557870|P2|STARTED|Overall Study||46
1053491|NCT00819247|2557871|P1|STARTED|Overall Study||43
1053492|NCT00819260|2557897|P1|NOT COMPLETED|Overall Study||0
1053493|NCT00819260|2557897|P1|COMPLETED|Overall Study||31
1053494|NCT00819260|2557897|P1|STARTED|Overall Study||31
1053495|NCT00819286|2557911|P2|NOT COMPLETED|Overall Study||25
1053496|NCT00819286|2557912|P1|NOT COMPLETED|Overall Study||14
1053497|NCT00819286|2557911|P2|COMPLETED|Overall Study||45
1053498|NCT00819286|2557912|P1|COMPLETED|Overall Study||56
1053499|NCT00819286|2557911|P2|STARTED|Overall Study||70
1053500|NCT00819286|2557912|P1|STARTED|Overall Study||70
1053513|NCT00819403|2558039|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
1053514|NCT00819403|2558040|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
1053515|NCT00819403|2558039|P2|COMPLETED|Second Intervention (6 Weeks)||8
1053516|NCT00819403|2558040|P1|COMPLETED|Second Intervention (6 Weeks)||7
1053517|NCT00819403|2558039|P2|STARTED|Second Intervention (6 Weeks)||8
1053518|NCT00819403|2558040|P1|STARTED|Second Intervention (6 Weeks)||7
1053519|NCT00819403|2558039|P2|NOT COMPLETED|Washout (14 Days)||0
1053520|NCT00819403|2558040|P1|NOT COMPLETED|Washout (14 Days)||0
1053521|NCT00819403|2558039|P2|COMPLETED|Washout (14 Days)||8
1053522|NCT00819403|2558040|P1|COMPLETED|Washout (14 Days)||7
1053523|NCT00819403|2558039|P2|STARTED|Washout (14 Days)||8
1053524|NCT00819403|2558040|P1|STARTED|Washout (14 Days)||7
1053525|NCT00819403|2558039|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
1053526|NCT00819403|2558040|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
1053527|NCT00819403|2558039|P2|COMPLETED|First Intervention (6 Weeks)||8
1053528|NCT00819403|2558040|P1|COMPLETED|First Intervention (6 Weeks)||7
1053529|NCT00819403|2558039|P2|STARTED|First Intervention (6 Weeks)||8
1053530|NCT00819403|2558040|P1|STARTED|First Intervention (6 Weeks)||7
1053531|NCT00819507|2558048|P1|NOT COMPLETED|Overall Study||0
1053532|NCT00819507|2558048|P1|COMPLETED|Overall Study||25
1053533|NCT00819507|2558048|P1|STARTED|Overall Study||25
1053534|NCT00819585|2558060|P7|NOT COMPLETED|Overall Study||13
1053535|NCT00819585|2558061|P6|NOT COMPLETED|Overall Study||2
1053536|NCT00819585|2558062|P5|NOT COMPLETED|Overall Study||3
1053537|NCT00819585|2558063|P4|NOT COMPLETED|Overall Study||5
1053538|NCT00819585|2558064|P3|NOT COMPLETED|Overall Study||6
1053539|NCT00819585|2558065|P2|NOT COMPLETED|Overall Study||6
1053540|NCT00819585|2558066|P1|NOT COMPLETED|Overall Study||6
1053541|NCT00819585|2558060|P7|COMPLETED|Overall Study||95
1053542|NCT00819585|2558061|P6|COMPLETED|Overall Study||52
1053543|NCT00819585|2558062|P5|COMPLETED|Overall Study||50
1053544|NCT00819585|2558063|P4|COMPLETED|Overall Study||49
1053545|NCT00819585|2558064|P3|COMPLETED|Overall Study||48
1053546|NCT00819585|2558065|P2|COMPLETED|Overall Study||48
1053547|NCT00819585|2558066|P1|COMPLETED|Overall Study||49
1053548|NCT00819585|2558060|P7|Safety Population|Overall Study||108
1053549|NCT00819585|2558061|P6|Safety Population|Overall Study|A pt. who was randomized to repeated dose regimen, found as HIV +ve, didn't take any study drug.|53
1053550|NCT00819585|2558062|P5|Safety Population|Overall Study||53
1053551|NCT00819585|2558063|P4|Safety Population|Overall Study||54
1053552|NCT00819585|2558064|P3|Safety Population|Overall Study||54
1053553|NCT00819585|2558065|P2|Safety Population|Overall Study||54
1053554|NCT00819585|2558066|P1|Safety Population|Overall Study||55
1053555|NCT00819585|2558060|P7|STARTED|Overall Study||108
1053556|NCT00819585|2558061|P6|STARTED|Overall Study||54
1053557|NCT00819585|2558062|P5|STARTED|Overall Study||53
1053558|NCT00819585|2558063|P4|STARTED|Overall Study||54
1053559|NCT00819585|2558064|P3|STARTED|Overall Study||54
1053560|NCT00819585|2558065|P2|STARTED|Overall Study||54
1053561|NCT00819585|2558066|P1|STARTED|Overall Study|"Started indicates randomized as well as full analysis set."|55
1053562|NCT00819637|2558126|P3|NOT COMPLETED|Overall Study||0
1053563|NCT00819637|2558127|P2|NOT COMPLETED|Overall Study||0
1053564|NCT00819637|2558128|P1|NOT COMPLETED|Overall Study||0
1053565|NCT00819637|2558126|P3|COMPLETED|Overall Study||0
1053566|NCT00819637|2558127|P2|COMPLETED|Overall Study||0
1053567|NCT00819637|2558128|P1|COMPLETED|Overall Study||2
1053568|NCT00819637|2558126|P3|STARTED|Overall Study||0
1053569|NCT00819637|2558127|P2|STARTED|Overall Study||0
1053570|NCT00819637|2558128|P1|STARTED|Overall Study||2
1053571|NCT00819741|2558138|P2|NOT COMPLETED|Overall Study||14
1053572|NCT00819741|2558139|P1|NOT COMPLETED|Overall Study||22
1053573|NCT00819741|2558138|P2|COMPLETED|Overall Study||201
1053574|NCT00819741|2558139|P1|COMPLETED|Overall Study||196
1053575|NCT00819741|2558138|P2|Exposed to Drug|Overall Study|One subject after randomisation was not exposed to the treatment due to non-compliance|214
1053576|NCT00819741|2558139|P1|Exposed to Drug|Overall Study||218
1053577|NCT00819741|2558138|P2|STARTED|Overall Study||215
1053578|NCT00819741|2558139|P1|STARTED|Overall Study||218
1053579|NCT00819767|2558175|P2|NOT COMPLETED|Overall Study||2
1053580|NCT00819767|2558176|P1|NOT COMPLETED|Overall Study||1
1053581|NCT00819767|2558175|P2|COMPLETED|Overall Study||33
1053582|NCT00819767|2558176|P1|COMPLETED|Overall Study||32
1053583|NCT00819767|2558175|P2|STARTED|Overall Study||35
1053584|NCT00819767|2558176|P1|STARTED|Overall Study||33
1053585|NCT00819780|2558188|P2|NOT COMPLETED|Overall Study||21
1053586|NCT00819780|2558189|P1|NOT COMPLETED|Overall Study||28
1053587|NCT00819780|2558188|P2|COMPLETED|Overall Study|Indicates participants who ended study treatment|122
1053588|NCT00819780|2558189|P1|COMPLETED|Overall Study|Indicates participants who ended study treatment|114
1053589|NCT00819780|2558188|P2|Received Study Treatment|Overall Study||139
1053590|NCT00819780|2558189|P1|Received Study Treatment|Overall Study||139
1053591|NCT00819780|2558188|P2|STARTED|Overall Study||143
1053592|NCT00819780|2558189|P1|STARTED|Overall Study||142
1053593|NCT00819832|2558227|P6|NOT COMPLETED|Overall Study||0
1053594|NCT00819832|2558228|P5|NOT COMPLETED|Overall Study||0
1053595|NCT00819832|2558229|P4|NOT COMPLETED|Overall Study||0
1053596|NCT00819832|2558230|P3|NOT COMPLETED|Overall Study||0
1053597|NCT00819832|2558231|P2|NOT COMPLETED|Overall Study||0
1053598|NCT00819832|2558232|P1|NOT COMPLETED|Overall Study||3
1053599|NCT00819832|2558227|P6|COMPLETED|Overall Study||0
1053600|NCT00819832|2558228|P5|COMPLETED|Overall Study||0
1053601|NCT00819832|2558229|P4|COMPLETED|Overall Study||0
1053602|NCT00819832|2558230|P3|COMPLETED|Overall Study||0
1053603|NCT00819832|2558231|P2|COMPLETED|Overall Study||0
1053604|NCT00819832|2558232|P1|COMPLETED|Overall Study||0
1053605|NCT00819832|2558227|P6|STARTED|Overall Study||0
1053606|NCT00819832|2558228|P5|STARTED|Overall Study||0
1053607|NCT00819832|2558229|P4|STARTED|Overall Study||0
1053608|NCT00819832|2558230|P3|STARTED|Overall Study||0
1053609|NCT00819832|2558231|P2|STARTED|Overall Study||0
1053610|NCT00819832|2558232|P1|STARTED|Overall Study|No patient data analysis.|3
1053611|NCT00819910|2558250|P4|NOT COMPLETED|Overall Study||1
1053612|NCT00819910|2558251|P3|NOT COMPLETED|Overall Study||3
1053613|NCT00819910|2558252|P2|NOT COMPLETED|Overall Study||1
1053614|NCT00819910|2558253|P1|NOT COMPLETED|Overall Study||2
1053615|NCT00819910|2558250|P4|COMPLETED|Overall Study||10
1053616|NCT00819910|2558251|P3|COMPLETED|Overall Study||7
1053617|NCT00819910|2558252|P2|COMPLETED|Overall Study||9
1053618|NCT00819910|2558253|P1|COMPLETED|Overall Study||8
1053619|NCT00819910|2558250|P4|STARTED|Overall Study||11
1053620|NCT00819910|2558251|P3|STARTED|Overall Study||10
1053621|NCT00819910|2558252|P2|STARTED|Overall Study||10
1053622|NCT00819910|2558253|P1|STARTED|Overall Study||10
1053623|NCT00820222|2558281|P2|NOT COMPLETED|Overall Study||211
1053624|NCT00820222|2558282|P1|NOT COMPLETED|Overall Study||201
1053625|NCT00820222|2558281|P2|COMPLETED|Overall Study||58
1053626|NCT00820222|2558282|P1|COMPLETED|Overall Study||70
1053627|NCT00820222|2558281|P2|Ongoing|Overall Study||191
1053628|NCT00820222|2558282|P1|Ongoing|Overall Study||185
1053629|NCT00820222|2558281|P2|STARTED|Overall Study||269
1053630|NCT00820222|2558282|P1|STARTED|Overall Study||271
1053631|NCT00820248|2558310|P2|NOT COMPLETED|Overall Study||1
1053632|NCT00820248|2558311|P1|NOT COMPLETED|Overall Study||4
1053633|NCT00820248|2558310|P2|COMPLETED|Overall Study||159
1053634|NCT00820248|2558311|P1|COMPLETED|Overall Study||156
1053635|NCT00820248|2558310|P2|Received Protocol Treatment|Overall Study||159
1053636|NCT00820248|2558311|P1|Received Protocol Treatment|Overall Study||156
1053637|NCT00820248|2558310|P2|STARTED|Overall Study||160
1053638|NCT00820248|2558311|P1|STARTED|Overall Study||160
1053639|NCT00820443|2558319|P1|NOT COMPLETED|24 Month||43
1053640|NCT00820443|2558319|P1|COMPLETED|24 Month||202
1053641|NCT00820443|2558319|P1|STARTED|24 Month||245
1053642|NCT00820443|2558319|P1|NOT COMPLETED|12 Month||24
1053643|NCT00820443|2558319|P1|COMPLETED|12 Month||226
1053644|NCT00820443|2558319|P1|STARTED|12 Month||250
1053645|NCT00820443|2558319|P1|NOT COMPLETED|6 Month||20
1053646|NCT00820443|2558319|P1|COMPLETED|6 Month||233
1053647|NCT00820443|2558319|P1|STARTED|6 Month||253
1053648|NCT00820443|2558319|P1|NOT COMPLETED|3 Month||9
1053649|NCT00820443|2558319|P1|COMPLETED|3 Month||244
1053650|NCT00820443|2558319|P1|STARTED|3 Month||253
1053651|NCT00820443|2558319|P1|NOT COMPLETED|Immediately||5
1053652|NCT00820443|2558319|P1|COMPLETED|Immediately||248
1053653|NCT00820443|2558319|P1|STARTED|Immediately||253
1053654|NCT00820443|2558319|P1|NOT COMPLETED|Op||0
1053655|NCT00820443|2558319|P1|COMPLETED|Op||253
1053656|NCT00820443|2558319|P1|STARTED|Op||253
1053657|NCT00820443|2558319|P1|NOT COMPLETED|Pre-Op||0
1053658|NCT00820443|2558319|P1|COMPLETED|Pre-Op||253
1053659|NCT00820443|2558319|P1|STARTED|Pre-Op||253
1053660|NCT00820534|2558329|P2|NOT COMPLETED|Overall Study||0
1053661|NCT00820534|2558330|P1|NOT COMPLETED|Overall Study||0
1053662|NCT00820534|2558329|P2|COMPLETED|Overall Study||62
1053663|NCT00820534|2558330|P1|COMPLETED|Overall Study||64
1053664|NCT00820534|2558329|P2|STARTED|Overall Study||62
1053665|NCT00820534|2558330|P1|STARTED|Overall Study||64
1053666|NCT00820573|2558342|P4|NOT COMPLETED|Overall Study||0
1053667|NCT00820573|2558343|P3|NOT COMPLETED|Overall Study||0
1053668|NCT00820573|2558344|P2|NOT COMPLETED|Overall Study||0
1053669|NCT00820573|2558345|P1|NOT COMPLETED|Overall Study||0
1053670|NCT00820573|2558342|P4|COMPLETED|Overall Study||4
1053671|NCT00820573|2558343|P3|COMPLETED|Overall Study||4
1053672|NCT00820573|2558344|P2|COMPLETED|Overall Study||4
1053673|NCT00820573|2558345|P1|COMPLETED|Overall Study||4
1053674|NCT00820573|2558342|P4|STARTED|Overall Study||4
1053675|NCT00820573|2558343|P3|STARTED|Overall Study||4
1053676|NCT00820573|2558344|P2|STARTED|Overall Study||4
1053677|NCT00820573|2558345|P1|STARTED|Overall Study||4
1053678|NCT00820612|2558369|P2|NOT COMPLETED|Overall Study||0
1053679|NCT00820612|2558370|P1|NOT COMPLETED|Overall Study||0
1053680|NCT00820612|2558369|P2|COMPLETED|Overall Study||295
1053681|NCT00820612|2558370|P1|COMPLETED|Overall Study||307
1053682|NCT00820612|2558369|P2|STARTED|Overall Study||295
1053683|NCT00820612|2558370|P1|STARTED|Overall Study||307
1053684|NCT00820664|2558379|P3|NOT COMPLETED|Overall Study||0
1053685|NCT00820664|2558380|P2|NOT COMPLETED|Overall Study||0
1053686|NCT00820664|2558381|P1|NOT COMPLETED|Overall Study||0
1053687|NCT00820664|2558379|P3|COMPLETED|Overall Study||9
1053688|NCT00820664|2558380|P2|COMPLETED|Overall Study||11
1053689|NCT00820664|2558381|P1|COMPLETED|Overall Study||9
1053690|NCT00820664|2558379|P3|STARTED|Overall Study||9
1053691|NCT00820664|2558380|P2|STARTED|Overall Study||11
1053692|NCT00820664|2558381|P1|STARTED|Overall Study||9
1053693|NCT00820755|2558389|P3|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
1053694|NCT00820755|2558390|P2|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
1053695|NCT00820755|2558391|P1|NOT COMPLETED|Period 2: Maintenance Therapy Phase||0
1053696|NCT00820755|2558389|P3|COMPLETED|Period 2: Maintenance Therapy Phase||109
1053697|NCT00820755|2558390|P2|COMPLETED|Period 2: Maintenance Therapy Phase||112
1053698|NCT00820755|2558391|P1|COMPLETED|Period 2: Maintenance Therapy Phase||0
1053699|NCT00820755|2558389|P3|STARTED|Period 2: Maintenance Therapy Phase||154
1053700|NCT00820755|2558390|P2|STARTED|Period 2: Maintenance Therapy Phase||157
1053701|NCT00820755|2558391|P1|STARTED|Period 2: Maintenance Therapy Phase||0
1053702|NCT00820755|2558389|P3|NOT COMPLETED|Period 1: Combination Therapy Phase||0
1053703|NCT00820755|2558390|P2|NOT COMPLETED|Period 1: Combination Therapy Phase||0
1053704|NCT00820755|2558391|P1|NOT COMPLETED|Period 1: Combination Therapy Phase||270
1053705|NCT00820755|2558389|P3|COMPLETED|Period 1: Combination Therapy Phase||0
1053706|NCT00820755|2558390|P2|COMPLETED|Period 1: Combination Therapy Phase||0
1053707|NCT00820755|2558391|P1|COMPLETED|Period 1: Combination Therapy Phase|2 of 313 participants excluded from maintenance phase analysis (reason: not eligible)|313
1053708|NCT00820755|2558389|P3|STARTED|Period 1: Combination Therapy Phase||0
1053709|NCT00820755|2558390|P2|STARTED|Period 1: Combination Therapy Phase||0
1053710|NCT00820755|2558391|P1|STARTED|Period 1: Combination Therapy Phase||583
1053711|NCT00820872|2558412|P1|NOT COMPLETED|Overall Study||0
1053712|NCT00820872|2558412|P1|COMPLETED|Overall Study||30
1053713|NCT00820872|2558412|P1|STARTED|Overall Study||30
1053714|NCT00797667|2558419|P3|NOT COMPLETED|Overall Study||127
1053715|NCT00797667|2558420|P2|NOT COMPLETED|Overall Study||259
1053716|NCT00797667|2558421|P1|NOT COMPLETED|Overall Study||260
1053717|NCT00797667|2558419|P3|COMPLETED|Overall Study||4
1053718|NCT00797667|2558420|P2|COMPLETED|Overall Study||5
1053719|NCT00797667|2558421|P1|COMPLETED|Overall Study||5
1053720|NCT00797667|2558419|P3|Treated|Overall Study||130
1053721|NCT00797667|2558420|P2|Treated|Overall Study||263
1053722|NCT00797667|2558421|P1|Treated|Overall Study||263
1053723|NCT00797667|2558419|P3|STARTED|Overall Study||131
1053724|NCT00797667|2558420|P2|STARTED|Overall Study||264
1053725|NCT00797667|2558421|P1|STARTED|Overall Study||265
1053726|NCT00797797|2558449|P2|NOT COMPLETED|Overall Study||43
1053727|NCT00797797|2558450|P1|NOT COMPLETED|Overall Study||55
1053728|NCT00797797|2558449|P2|COMPLETED|Overall Study||141
1053729|NCT00797797|2558450|P1|COMPLETED|Overall Study||123
1053730|NCT00797797|2558449|P2|STARTED|Overall Study||184
1053731|NCT00797797|2558450|P1|STARTED|Overall Study|Two patients took no background stable dose of pregabalin after randomization and are not included.|178
1053732|NCT00797823|2558461|P3|NOT COMPLETED|Second Period (Crossover)||0
1053733|NCT00797823|2558462|P2|NOT COMPLETED|Second Period (Crossover)||0
1053734|NCT00797823|2558463|P1|NOT COMPLETED|Second Period (Crossover)||0
1053735|NCT00797823|2558461|P3|COMPLETED|Second Period (Crossover)||0
1053736|NCT00797823|2558462|P2|COMPLETED|Second Period (Crossover)||4
1053737|NCT00797823|2558463|P1|COMPLETED|Second Period (Crossover)||3
1053738|NCT00797823|2558461|P3|STARTED|Second Period (Crossover)||0
1053739|NCT00797823|2558462|P2|STARTED|Second Period (Crossover)||4
1053740|NCT00797823|2558463|P1|STARTED|Second Period (Crossover)||3
1053741|NCT00797823|2558461|P3|NOT COMPLETED|First Period (Initial Randomization)||0
1053742|NCT00797823|2558462|P2|NOT COMPLETED|First Period (Initial Randomization)||0
1053743|NCT00797823|2558463|P1|NOT COMPLETED|First Period (Initial Randomization)||1
1053744|NCT00797823|2558461|P3|COMPLETED|First Period (Initial Randomization)||0
1053745|NCT00797823|2558462|P2|COMPLETED|First Period (Initial Randomization)||4
1053746|NCT00797823|2558463|P1|COMPLETED|First Period (Initial Randomization)||3
1053747|NCT00797823|2558461|P3|STARTED|First Period (Initial Randomization)|Pilot studies only performed during initial period.|0
1053748|NCT00797823|2558462|P2|STARTED|First Period (Initial Randomization)||4
1053749|NCT00797823|2558463|P1|STARTED|First Period (Initial Randomization)||4
1053750|NCT00797823|2558461|P3|NOT COMPLETED|Pilot Studies||0
1053751|NCT00797823|2558462|P2|NOT COMPLETED|Pilot Studies||0
1053752|NCT00797823|2558463|P1|NOT COMPLETED|Pilot Studies||0
1053753|NCT00797823|2558461|P3|COMPLETED|Pilot Studies||6
1053754|NCT00797823|2558462|P2|COMPLETED|Pilot Studies||0
1053755|NCT00797823|2558463|P1|COMPLETED|Pilot Studies||0
1053756|NCT00797823|2558461|P3|STARTED|Pilot Studies||6
1053757|NCT00797823|2558462|P2|STARTED|Pilot Studies|Not involved in pilot studies|0
1053758|NCT00797823|2558463|P1|STARTED|Pilot Studies|Not involved in pilot studies|0
1053759|NCT00797862|2558475|P3|NOT COMPLETED|Overall Study||86
1053760|NCT00797862|2558476|P2|NOT COMPLETED|Overall Study||68
1053761|NCT00797862|2558477|P1|NOT COMPLETED|Overall Study||124
1053762|NCT00797862|2558475|P3|COMPLETED|Overall Study||230
1053763|NCT00797862|2558476|P2|COMPLETED|Overall Study||250
1053764|NCT00797862|2558477|P1|COMPLETED|Overall Study||496
1053765|NCT00797862|2558475|P3|Entered Double-Blind Treatment (FAS)|Overall Study||315
1053766|NCT00797862|2558476|P2|Entered Double-Blind Treatment (FAS)|Overall Study||315
1053767|NCT00797862|2558477|P1|Entered Double-Blind Treatment (FAS)|Overall Study||617
1053768|NCT00797862|2558475|P3|STARTED|Overall Study|1 participant was mis-randomized and discontinued. Only 315 participants received study drug.|316
1053769|NCT00797862|2558476|P2|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 315 participants received study drug.|318
1053770|NCT00797862|2558477|P1|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 617 participants received study drug.|620
1053771|NCT00797966|2558507|P6|NOT COMPLETED|Phase A+||28
1053772|NCT00797966|2558508|P5|NOT COMPLETED|Phase A+||0
1053773|NCT00797966|2558509|P4|NOT COMPLETED|Phase A+||0
1053774|NCT00797966|2558510|P3|NOT COMPLETED|Phase A+||0
1053775|NCT00797966|2558511|P2|NOT COMPLETED|Phase A+||0
1053776|NCT00797966|2558512|P1|NOT COMPLETED|Phase A+||0
1053777|NCT00797966|2558507|P6|COMPLETED|Phase A+||207
1053778|NCT00797966|2558508|P5|COMPLETED|Phase A+||0
1053779|NCT00797966|2558509|P4|COMPLETED|Phase A+||0
1053780|NCT00797966|2558510|P3|COMPLETED|Phase A+||0
1053781|NCT00797966|2558511|P2|COMPLETED|Phase A+||0
1053782|NCT00797966|2558512|P1|COMPLETED|Phase A+||0
1053783|NCT00797966|2558507|P6|STARTED|Phase A+||235
1053784|NCT00797966|2558508|P5|STARTED|Phase A+||0
1053785|NCT00797966|2558509|P4|STARTED|Phase A+||0
1053786|NCT00797966|2558510|P3|STARTED|Phase A+||0
1053787|NCT00797966|2558511|P2|STARTED|Phase A+||0
1053788|NCT00797966|2558512|P1|STARTED|Phase A+||0
1053789|NCT00797966|2558507|P6|NOT COMPLETED|Phase B||0
1053790|NCT00797966|2558508|P5|NOT COMPLETED|Phase B||0
1053791|NCT00797966|2558509|P4|NOT COMPLETED|Phase B||16
1053792|NCT00797966|2558510|P3|NOT COMPLETED|Phase B||21
1053793|NCT00797966|2558511|P2|NOT COMPLETED|Phase B||18
1053794|NCT00797966|2558512|P1|NOT COMPLETED|Phase B||11
1053795|NCT00797966|2558507|P6|COMPLETED|Phase B||0
1053796|NCT00797966|2558508|P5|COMPLETED|Phase B||0
1053797|NCT00797966|2558509|P4|COMPLETED|Phase B||110
1053798|NCT00797966|2558510|P3|COMPLETED|Phase B||100
1053799|NCT00797966|2558511|P2|COMPLETED|Phase B||102
1053800|NCT00797966|2558512|P1|COMPLETED|Phase B||51
1053801|NCT00797966|2558507|P6|STARTED|Phase B||0
1053802|NCT00797966|2558508|P5|STARTED|Phase B||0
1053803|NCT00797966|2558509|P4|STARTED|Phase B|Randomized participants.|126
1053804|NCT00797966|2558510|P3|STARTED|Phase B|Randomized participants.|121
1053805|NCT00797966|2558511|P2|STARTED|Phase B|Randomized participants.|120
1053806|NCT00797966|2558512|P1|STARTED|Phase B|Randomized participants.|62
1053807|NCT00797966|2558507|P6|NOT COMPLETED|Phase A||0
1053808|NCT00797966|2558508|P5|NOT COMPLETED|Phase A||185
1053809|NCT00797966|2558509|P4|NOT COMPLETED|Phase A||0
1053810|NCT00797966|2558510|P3|NOT COMPLETED|Phase A||0
1053811|NCT00797966|2558511|P2|NOT COMPLETED|Phase A||0
1053812|NCT00797966|2558512|P1|NOT COMPLETED|Phase A||0
1053813|NCT00797966|2558507|P6|COMPLETED|Phase A||0
1053814|NCT00797966|2558508|P5|COMPLETED|Phase A||664
1053815|NCT00797966|2558509|P4|COMPLETED|Phase A||0
1053816|NCT00797966|2558510|P3|COMPLETED|Phase A||0
1053817|NCT00797966|2558511|P2|COMPLETED|Phase A||0
1053818|NCT00797966|2558512|P1|COMPLETED|Phase A||0
1053819|NCT00797966|2558507|P6|STARTED|Phase A||0
1053820|NCT00797966|2558508|P5|STARTED|Phase A|850 participants entered Phase A; 849 participants were treated.|849
1053821|NCT00797966|2558509|P4|STARTED|Phase A||0
1053822|NCT00797966|2558510|P3|STARTED|Phase A||0
1053823|NCT00797966|2558511|P2|STARTED|Phase A||0
1053824|NCT00797966|2558512|P1|STARTED|Phase A||0
1053825|NCT00798018|2558578|P4|NOT COMPLETED|Overall Study||0
1053826|NCT00798018|2558579|P3|NOT COMPLETED|Overall Study||0
1053827|NCT00798018|2558580|P2|NOT COMPLETED|Overall Study||0
1053828|NCT00798018|2558581|P1|NOT COMPLETED|Overall Study||0
1053829|NCT00798018|2558578|P4|COMPLETED|Overall Study||25
1053830|NCT00798018|2558579|P3|COMPLETED|Overall Study||25
1053831|NCT00798018|2558580|P2|COMPLETED|Overall Study||25
1053832|NCT00798018|2558581|P1|COMPLETED|Overall Study||25
1053833|NCT00798018|2558578|P4|STARTED|Overall Study||25
1053834|NCT00798018|2558579|P3|STARTED|Overall Study||25
1053835|NCT00798018|2558580|P2|STARTED|Overall Study||25
1053836|NCT00798018|2558581|P1|STARTED|Overall Study||25
1053837|NCT00814138|2558593|P2|NOT COMPLETED|Overall Study||7
1053838|NCT00814138|2558594|P1|NOT COMPLETED|Overall Study||1
1053839|NCT00814138|2558593|P2|COMPLETED|Overall Study||18
1053840|NCT00814138|2558594|P1|COMPLETED|Overall Study||24
1053841|NCT00814138|2558593|P2|STARTED|Overall Study||25
1053842|NCT00814138|2558594|P1|STARTED|Overall Study||25
1053843|NCT00814164|2558612|P1|NOT COMPLETED|Overall Study||19
1053844|NCT00814164|2558612|P1|COMPLETED|Overall Study||2
1053845|NCT00814164|2558612|P1|STARTED|Overall Study||21
1053846|NCT00814177|2558625|P2|NOT COMPLETED|Overall Study||0
1053847|NCT00814177|2558626|P1|NOT COMPLETED|Overall Study||0
1053848|NCT00814177|2558625|P2|COMPLETED|Overall Study||80
1053849|NCT00814177|2558626|P1|COMPLETED|Overall Study||80
1053850|NCT00814177|2558625|P2|STARTED|Overall Study||80
1053851|NCT00814177|2558626|P1|STARTED|Overall Study||80
1053852|NCT00814255|2558635|P3|NOT COMPLETED|Overall Study||1
1053853|NCT00814255|2558636|P2|NOT COMPLETED|Overall Study||0
1053854|NCT00814255|2558637|P1|NOT COMPLETED|Overall Study||1
1053855|NCT00814255|2558635|P3|COMPLETED|Overall Study||7
1053856|NCT00814255|2558636|P2|COMPLETED|Overall Study||7
1053857|NCT00814255|2558637|P1|COMPLETED|Overall Study||7
1053858|NCT00814255|2558635|P3|STARTED|Overall Study||8
1053859|NCT00814255|2558636|P2|STARTED|Overall Study||7
1053860|NCT00814255|2558637|P1|STARTED|Overall Study||8
1053861|NCT00814307|2558661|P4|NOT COMPLETED|Overall Study||10
1053862|NCT00814307|2558662|P3|NOT COMPLETED|Overall Study||7
1053863|NCT00814307|2558663|P2|NOT COMPLETED|Overall Study||27
1053864|NCT00814307|2558664|P1|NOT COMPLETED|Overall Study||12
1053865|NCT00814307|2558661|P4|COMPLETED|Overall Study||51
1053866|NCT00814307|2558662|P3|COMPLETED|Overall Study||54
1053867|NCT00814307|2558663|P2|COMPLETED|Overall Study||218
1053868|NCT00814307|2558664|P1|COMPLETED|Overall Study||232
1053869|NCT00814307|2558661|P4|Treated|Overall Study||61
1053870|NCT00814307|2558662|P3|Treated|Overall Study||61
1053871|NCT00814307|2558663|P2|Treated|Overall Study||245
1053872|NCT00814307|2558664|P1|Treated|Overall Study||243
1053873|NCT00814307|2558661|P4|STARTED|Overall Study||61
1053874|NCT00814307|2558662|P3|STARTED|Overall Study||61
1053875|NCT00814307|2558663|P2|STARTED|Overall Study||245
1053876|NCT00814307|2558664|P1|STARTED|Overall Study||244
1053877|NCT00814320|2558828|P2|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||10
1053878|NCT00814320|2558829|P1|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||3
1053879|NCT00814320|2558828|P2|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)|Three participants who switched to safety follow-up remained in the study.|60
1053880|NCT00814320|2558829|P1|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||8
1053881|NCT00814320|2558828|P2|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||70
1053882|NCT00814320|2558829|P1|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||11
1053883|NCT00814320|2558828|P2|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||0
1053884|NCT00814320|2558829|P1|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||2
1053885|NCT00814320|2558828|P2|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||70
1053886|NCT00814320|2558829|P1|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||11
1053887|NCT00814320|2558828|P2|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||70
1053888|NCT00814320|2558829|P1|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||13
1053889|NCT00814320|2558828|P2|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||1
1053890|NCT00814320|2558829|P1|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||0
1053891|NCT00814320|2558828|P2|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||70
1053892|NCT00814320|2558829|P1|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
1053893|NCT00814320|2558828|P2|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||71
1053894|NCT00814320|2558829|P1|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
1053895|NCT00814320|2558828|P2|NOT COMPLETED|Epoch 1 (IV Treatment)||2
1053896|NCT00814320|2558829|P1|NOT COMPLETED|Epoch 1 (IV Treatment)||1
1053897|NCT00814320|2558828|P2|COMPLETED|Epoch 1 (IV Treatment)||71
1053898|NCT00814320|2558829|P1|COMPLETED|Epoch 1 (IV Treatment)||13
1053899|NCT00814320|2558828|P2|STARTED|Epoch 1 (IV Treatment)||73
1053900|NCT00814320|2558829|P1|STARTED|Epoch 1 (IV Treatment)||14
1053901|NCT00814333|2558959|P2|NOT COMPLETED|Treatment Period||0
1053902|NCT00814333|2558960|P1|NOT COMPLETED|Treatment Period||0
1053903|NCT00814333|2558959|P2|COMPLETED|Treatment Period||0
1053904|NCT00814333|2558960|P1|COMPLETED|Treatment Period||0
1053905|NCT00814333|2558959|P2|STARTED|Treatment Period||0
1053906|NCT00814333|2558960|P1|STARTED|Treatment Period||0
1053907|NCT00814333|2558959|P2|NOT COMPLETED|Enrollment||0
1053908|NCT00814333|2558960|P1|NOT COMPLETED|Enrollment||1
1053909|NCT00814333|2558959|P2|COMPLETED|Enrollment||0
1053910|NCT00814333|2558960|P1|COMPLETED|Enrollment||0
1053911|NCT00814333|2558959|P2|STARTED|Enrollment||0
1053912|NCT00814333|2558960|P1|STARTED|Enrollment||1
1053913|NCT00814346|2558968|P2|NOT COMPLETED|Open Phase (17 Months)||0
1053914|NCT00814346|2558969|P1|NOT COMPLETED|Open Phase (17 Months)||10
1053915|NCT00814346|2558968|P2|COMPLETED|Open Phase (17 Months)||0
1053916|NCT00814346|2558969|P1|COMPLETED|Open Phase (17 Months)||31
1053917|NCT00814346|2558968|P2|AD|Open Phase (17 Months)||0
1053918|NCT00814346|2558969|P1|AD|Open Phase (17 Months)|Open period was not proposed to AD subjects.|0
1053919|NCT00814346|2558968|P2|MC|Open Phase (17 Months)||0
1053920|NCT00814346|2558969|P1|MC|Open Phase (17 Months)||20
1053921|NCT00814346|2558968|P2|CNE|Open Phase (17 Months)||0
1053922|NCT00814346|2558969|P1|CNE|Open Phase (17 Months)||21
1053923|NCT00814346|2558968|P2|STARTED|Open Phase (17 Months)|This was an open period, without placebo arm, the number of subject on placebo is 0.|0
1053924|NCT00814346|2558969|P1|STARTED|Open Phase (17 Months)|Open period was treated with EGB761®. 41 subjects accepted follow-up open period(21 in CNE,20 in MC)|41
1053925|NCT00814346|2558968|P2|NOT COMPLETED|Double-blind Phase (4 Weeks)||3
1053926|NCT00814346|2558969|P1|NOT COMPLETED|Double-blind Phase (4 Weeks)||0
1053927|NCT00814346|2558968|P2|COMPLETED|Double-blind Phase (4 Weeks)||23
1053928|NCT00814346|2558969|P1|COMPLETED|Double-blind Phase (4 Weeks)||23
1053929|NCT00814346|2558968|P2|AD|Double-blind Phase (4 Weeks)||2
1053930|NCT00814346|2558969|P1|AD|Double-blind Phase (4 Weeks)||3
1053931|NCT00814346|2558968|P2|MC|Double-blind Phase (4 Weeks)||11
1053932|NCT00814346|2558969|P1|MC|Double-blind Phase (4 Weeks)||10
1053933|NCT00814346|2558968|P2|CNE|Double-blind Phase (4 Weeks)||13
1053934|NCT00814346|2558969|P1|CNE|Double-blind Phase (4 Weeks)||10
1053935|NCT00814346|2558968|P2|STARTED|Double-blind Phase (4 Weeks)||26
1053936|NCT00814346|2558969|P1|STARTED|Double-blind Phase (4 Weeks)||23
1053937|NCT00814463|2559033|P1|NOT COMPLETED|Overall Study||1
1053938|NCT00814463|2559033|P1|COMPLETED|Overall Study||0
1053939|NCT00814463|2559033|P1|STARTED|Overall Study||1
1053940|NCT00814489|2559040|P3|NOT COMPLETED|Overall Study||1
1053941|NCT00814489|2559041|P2|NOT COMPLETED|Overall Study||0
1053942|NCT00814489|2559042|P1|NOT COMPLETED|Overall Study||2
1053943|NCT00814489|2559040|P3|COMPLETED|Overall Study||7
1053944|NCT00814489|2559041|P2|COMPLETED|Overall Study||17
1053945|NCT00814489|2559042|P1|COMPLETED|Overall Study||13
1053946|NCT00814489|2559040|P3|STARTED|Overall Study||8
1053947|NCT00814489|2559041|P2|STARTED|Overall Study||17
1053948|NCT00814489|2559042|P1|STARTED|Overall Study||15
1053949|NCT00814502|2559076|P2|NOT COMPLETED|Overall Study||2
1053950|NCT00814502|2559077|P1|NOT COMPLETED|Overall Study||1
1053951|NCT00814502|2559076|P2|COMPLETED|Overall Study||7
1053952|NCT00814502|2559077|P1|COMPLETED|Overall Study||7
1053953|NCT00814502|2559076|P2|STARTED|Overall Study||9
1053954|NCT00814502|2559077|P1|STARTED|Overall Study||8
1053955|NCT00814580|2559089|P2|NOT COMPLETED|Overall Study||47
1053956|NCT00814580|2559090|P1|NOT COMPLETED|Overall Study||31
1053957|NCT00814580|2559089|P2|COMPLETED|Overall Study||141
1053958|NCT00814580|2559090|P1|COMPLETED|Overall Study||163
1053959|NCT00814580|2559089|P2|STARTED|Overall Study||188
1053960|NCT00814580|2559090|P1|STARTED|Overall Study||194
1053961|NCT00814632|2559218|P1|NOT COMPLETED|Overall Study||2
1053962|NCT00814632|2559218|P1|COMPLETED|Overall Study|Two subjects withdrew early due to lack of efficacy.|7
1053963|NCT00814632|2559218|P1|STARTED|Overall Study|Ten were allocated to treatment intervention however one was not treated due to lactose allergy.|9
1053964|NCT00814658|2559224|P2|NOT COMPLETED|Overall Study||4
1053965|NCT00814658|2559225|P1|NOT COMPLETED|Overall Study||4
1053966|NCT00814658|2559224|P2|COMPLETED|Overall Study||8
1053967|NCT00814658|2559225|P1|COMPLETED|Overall Study||5
1053968|NCT00814658|2559224|P2|STARTED|Overall Study||12
1053969|NCT00814658|2559225|P1|STARTED|Overall Study||9
1053970|NCT00814671|2559294|P3|NOT COMPLETED|Overall Study||2
1053971|NCT00814671|2559295|P2|NOT COMPLETED|Overall Study||4
1053972|NCT00814671|2559296|P1|NOT COMPLETED|Overall Study||7
1053973|NCT00814671|2559294|P3|COMPLETED|Overall Study||49
1053974|NCT00814671|2559295|P2|COMPLETED|Overall Study||44
1053975|NCT00814671|2559296|P1|COMPLETED|Overall Study||47
1053976|NCT00814671|2559294|P3|STARTED|Overall Study||51
1053977|NCT00814671|2559295|P2|STARTED|Overall Study||48
1053978|NCT00814671|2559296|P1|STARTED|Overall Study||54
1053979|NCT00814697|2559307|P1|NOT COMPLETED|Overall Study||0
1053980|NCT00814697|2559307|P1|COMPLETED|Overall Study||12
1053981|NCT00814697|2559307|P1|STARTED|Overall Study||12
1053982|NCT00821041|2559313|P2|NOT COMPLETED|Overall Study||0
1053983|NCT00821041|2559314|P1|NOT COMPLETED|Overall Study||0
1053984|NCT00821041|2559313|P2|COMPLETED|Overall Study||59
1053985|NCT00821041|2559314|P1|COMPLETED|Overall Study||59
1053986|NCT00821041|2559313|P2|STARTED|Overall Study||59
1053987|NCT00821041|2559314|P1|STARTED|Overall Study||59
1053988|NCT00821093|2559324|P2|NOT COMPLETED|Overall Study||40
1053989|NCT00821093|2559325|P1|NOT COMPLETED|Overall Study||49
1053990|NCT00821093|2559324|P2|COMPLETED|Overall Study||523
1053991|NCT00821093|2559325|P1|COMPLETED|Overall Study||511
1053992|NCT00821093|2559324|P2|Exposed to Drug|Overall Study||562
1053993|NCT00821093|2559325|P1|Exposed to Drug|Overall Study||559
1053994|NCT00821093|2559324|P2|STARTED|Overall Study||563
1053995|NCT00821093|2559325|P1|STARTED|Overall Study||560
1053996|NCT00821119|2559335|P2|NOT COMPLETED|Overall Study||0
1053997|NCT00821119|2559336|P1|NOT COMPLETED|Overall Study||0
1053998|NCT00821119|2559335|P2|COMPLETED|Overall Study||100
1053999|NCT00821119|2559336|P1|COMPLETED|Overall Study||100
1054000|NCT00821119|2559335|P2|STARTED|Overall Study||100
1054001|NCT00821119|2559336|P1|STARTED|Overall Study||100
1054002|NCT00821184|2559348|P2|NOT COMPLETED|Overall Study||0
1054003|NCT00821184|2559349|P1|NOT COMPLETED|Overall Study||0
1054004|NCT00821184|2559348|P2|COMPLETED|Overall Study||6
1054005|NCT00821184|2559349|P1|COMPLETED|Overall Study||6
1054006|NCT00821184|2559348|P2|STARTED|Overall Study||6
1054007|NCT00821184|2559349|P1|STARTED|Overall Study||6
1054008|NCT00821236|2559358|P1|NOT COMPLETED|Overall Study||3
1054009|NCT00821236|2559358|P1|COMPLETED|Overall Study||37
1054010|NCT00821236|2559358|P1|STARTED|Overall Study||40
1054011|NCT00822094|2559374|P2|NOT COMPLETED|Overall Study||25
1054012|NCT00822094|2559375|P1|NOT COMPLETED|Overall Study||44
1054013|NCT00822094|2559374|P2|COMPLETED|Overall Study||20
1054014|NCT00822094|2559375|P1|COMPLETED|Overall Study||37
1054015|NCT00822094|2559374|P2|STARTED|Overall Study||45
1054016|NCT00822094|2559375|P1|STARTED|Overall Study||81
1054017|NCT00822172|2559393|P2|NOT COMPLETED|Overall Study||19
1054018|NCT00822172|2559394|P1|NOT COMPLETED|Overall Study||15
1054019|NCT00822172|2559393|P2|COMPLETED|Overall Study||64
1054020|NCT00822172|2559394|P1|COMPLETED|Overall Study||65
1054021|NCT00822172|2559393|P2|STARTED|Overall Study||83
1054022|NCT00822172|2559394|P1|STARTED|Overall Study||80
1054023|NCT00822185|2559405|P5|NOT COMPLETED|Overall Study||0
1054024|NCT00822185|2559406|P4|NOT COMPLETED|Overall Study||0
1054025|NCT00822185|2559407|P3|NOT COMPLETED|Overall Study||0
1054026|NCT00822185|2559408|P2|NOT COMPLETED|Overall Study||0
1054027|NCT00822185|2559409|P1|NOT COMPLETED|Overall Study||0
1054028|NCT00822185|2559405|P5|COMPLETED|Overall Study||8
1054029|NCT00822185|2559406|P4|COMPLETED|Overall Study||6
1054030|NCT00822185|2559407|P3|COMPLETED|Overall Study||6
1054031|NCT00822185|2559408|P2|COMPLETED|Overall Study||6
1054032|NCT00822185|2559409|P1|COMPLETED|Overall Study||6
1054033|NCT00822185|2559405|P5|STARTED|Overall Study||8
1054034|NCT00822185|2559406|P4|STARTED|Overall Study||6
1054035|NCT00822185|2559407|P3|STARTED|Overall Study||6
1054036|NCT00822185|2559408|P2|STARTED|Overall Study||6
1054037|NCT00822185|2559409|P1|STARTED|Overall Study||6
1054038|NCT00822237|2559476|P2|NOT COMPLETED|Dose 2 Vaccination||11
1054039|NCT00822237|2559477|P1|NOT COMPLETED|Dose 2 Vaccination||4
1054040|NCT00822237|2559476|P2|COMPLETED|Dose 2 Vaccination||262
1054041|NCT00822237|2559477|P1|COMPLETED|Dose 2 Vaccination||270
1054042|NCT00822237|2559476|P2|STARTED|Dose 2 Vaccination|Number who received second dose|273
1054043|NCT00822237|2559477|P1|STARTED|Dose 2 Vaccination|Number who received second dose|274
1054044|NCT00822237|2559476|P2|NOT COMPLETED|Dose 1 Vaccination||26
1054045|NCT00822237|2559477|P1|NOT COMPLETED|Dose 1 Vaccination||25
1054046|NCT00822237|2559476|P2|COMPLETED|Dose 1 Vaccination||273
1054047|NCT00822237|2559477|P1|COMPLETED|Dose 1 Vaccination||274
1054048|NCT00822237|2559476|P2|STARTED|Dose 1 Vaccination|Number randomized|299
1054049|NCT00822237|2559477|P1|STARTED|Dose 1 Vaccination|Number randomized|299
1054050|NCT00822328|2559484|P2|NOT COMPLETED|Overall Study||0
1054051|NCT00822328|2559485|P1|NOT COMPLETED|Overall Study||0
1054052|NCT00822328|2559484|P2|COMPLETED|Overall Study||12
1054053|NCT00822328|2559485|P1|COMPLETED|Overall Study||12
1054054|NCT00822328|2559484|P2|STARTED|Overall Study||12
1054055|NCT00822328|2559485|P1|STARTED|Overall Study||12
1054056|NCT00822354|2559495|P2|NOT COMPLETED|Second Intervention (28 Days)||0
1054057|NCT00822354|2559496|P1|NOT COMPLETED|Second Intervention (28 Days)||1
1054058|NCT00822354|2559495|P2|COMPLETED|Second Intervention (28 Days)||5
1054059|NCT00822354|2559496|P1|COMPLETED|Second Intervention (28 Days)||3
1054060|NCT00822354|2559495|P2|STARTED|Second Intervention (28 Days)||5
1054061|NCT00822354|2559496|P1|STARTED|Second Intervention (28 Days)||4
1054062|NCT00822354|2559495|P2|NOT COMPLETED|Washout (7 Days)||0
1054063|NCT00822354|2559496|P1|NOT COMPLETED|Washout (7 Days)||0
1054064|NCT00822354|2559495|P2|COMPLETED|Washout (7 Days)||5
1054065|NCT00822354|2559496|P1|COMPLETED|Washout (7 Days)||4
1054066|NCT00822354|2559495|P2|STARTED|Washout (7 Days)||5
1054067|NCT00822354|2559496|P1|STARTED|Washout (7 Days)||4
1054068|NCT00822354|2559495|P2|NOT COMPLETED|First Intervention (28 Days)||0
1054069|NCT00822354|2559496|P1|NOT COMPLETED|First Intervention (28 Days)||1
1054070|NCT00822354|2559495|P2|COMPLETED|First Intervention (28 Days)||5
1054071|NCT00822354|2559496|P1|COMPLETED|First Intervention (28 Days)||4
1054072|NCT00822354|2559495|P2|STARTED|First Intervention (28 Days)||5
1054073|NCT00822354|2559496|P1|STARTED|First Intervention (28 Days)||5
1054074|NCT00822510|2559526|P2|NOT COMPLETED|Overall Study||5
1054075|NCT00822510|2559527|P1|NOT COMPLETED|Overall Study||3
1054076|NCT00822510|2559526|P2|COMPLETED|Overall Study||36
1054077|NCT00822510|2559527|P1|COMPLETED|Overall Study||35
1054078|NCT00822510|2559526|P2|STARTED|Overall Study||41
1054079|NCT00822510|2559527|P1|STARTED|Overall Study||38
1054080|NCT00822523|2559548|P3|NOT COMPLETED|Overall Study||0
1054081|NCT00822523|2559549|P2|NOT COMPLETED|Overall Study||0
1054082|NCT00822523|2559550|P1|NOT COMPLETED|Overall Study||0
1054083|NCT00822523|2559548|P3|COMPLETED|Overall Study||4
1054084|NCT00822523|2559549|P2|COMPLETED|Overall Study||4
1054085|NCT00822523|2559550|P1|COMPLETED|Overall Study||5
1054086|NCT00822523|2559548|P3|STARTED|Overall Study||4
1054087|NCT00822523|2559549|P2|STARTED|Overall Study||4
1054088|NCT00822523|2559550|P1|STARTED|Overall Study||5
1054089|NCT00822588|2559596|P2|NOT COMPLETED|Overall Study||4
1054090|NCT00822588|2559597|P1|NOT COMPLETED|Overall Study||7
1054091|NCT00822588|2559596|P2|COMPLETED|Overall Study|APT/ITT analysis set|110
1054092|NCT00822588|2559597|P1|COMPLETED|Overall Study|APT/ITT analysis set|106
1054093|NCT00822588|2559596|P2|STARTED|Overall Study|4 participants excluded before surgery. No baseline data available|114
1054094|NCT00822588|2559597|P1|STARTED|Overall Study|7 participants excluded before surgery. No baseline data available|113
1054095|NCT00822679|2559605|P2|NOT COMPLETED|Overall Study||0
1054096|NCT00822679|2559606|P1|NOT COMPLETED|Overall Study||0
1054097|NCT00822679|2559605|P2|COMPLETED|Overall Study||0
1054098|NCT00822679|2559606|P1|COMPLETED|Overall Study||0
1054099|NCT00822679|2559605|P2|STARTED|Overall Study||0
1054100|NCT00822679|2559606|P1|STARTED|Overall Study||0
1054101|NCT00822692|2559614|P2|NOT COMPLETED|Overall Study||25
1054102|NCT00822692|2559615|P1|NOT COMPLETED|Overall Study||17
1054103|NCT00822692|2559614|P2|COMPLETED|Overall Study|June 1 , 2009|51
1054104|NCT00822692|2559615|P1|COMPLETED|Overall Study|June 1, 2009|46
1054105|NCT00822692|2559614|P2|STARTED|Overall Study|July 1, 2008|76
1054106|NCT00822692|2559615|P1|STARTED|Overall Study|July 1, 2008|63
1054107|NCT00822757|2559623|P2|NOT COMPLETED|Overall Study||0
1054108|NCT00822757|2559624|P1|NOT COMPLETED|Overall Study||0
1054109|NCT00822757|2559623|P2|COMPLETED|Overall Study||10
1054110|NCT00822757|2559624|P1|COMPLETED|Overall Study||41
1054111|NCT00822757|2559623|P2|STARTED|Overall Study||10
1054112|NCT00822757|2559624|P1|STARTED|Overall Study||41
1054113|NCT00822770|2559634|P1|NOT COMPLETED|Overall Study||0
1054114|NCT00822770|2559634|P1|COMPLETED|Overall Study||47
1054115|NCT00822770|2559634|P1|STARTED|Overall Study||47
1054116|NCT00822900|2559640|P2|NOT COMPLETED|Overall Study||93
1054117|NCT00822900|2559641|P1|NOT COMPLETED|Overall Study||108
1054118|NCT00822900|2559640|P2|COMPLETED|Overall Study||347
1054119|NCT00822900|2559641|P1|COMPLETED|Overall Study||334
1054120|NCT00822900|2559640|P2|STARTED|Overall Study||440
1054121|NCT00822900|2559641|P1|STARTED|Overall Study||442
1054122|NCT00822926|2559671|P2|NOT COMPLETED|Second Injection Visit||1
1054123|NCT00822926|2559672|P1|NOT COMPLETED|Second Injection Visit||1
1054124|NCT00822926|2559671|P2|COMPLETED|Second Injection Visit||2
1054125|NCT00822926|2559672|P1|COMPLETED|Second Injection Visit||1
1054126|NCT00822926|2559671|P2|STARTED|Second Injection Visit||3
1054127|NCT00822926|2559672|P1|STARTED|Second Injection Visit||2
1054128|NCT00822926|2559671|P2|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
1054129|NCT00822926|2559672|P1|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
1054130|NCT00822926|2559671|P2|COMPLETED|Washout (Varies Based on Scheduling)||3
1054131|NCT00822926|2559672|P1|COMPLETED|Washout (Varies Based on Scheduling)||2
1054132|NCT00822926|2559671|P2|STARTED|Washout (Varies Based on Scheduling)||3
1054133|NCT00822926|2559672|P1|STARTED|Washout (Varies Based on Scheduling)||2
1054134|NCT00822926|2559671|P2|NOT COMPLETED|First Injection Visit||0
1054135|NCT00822926|2559672|P1|NOT COMPLETED|First Injection Visit||0
1054136|NCT00822926|2559671|P2|COMPLETED|First Injection Visit||3
1054137|NCT00822926|2559672|P1|COMPLETED|First Injection Visit||2
1054138|NCT00822926|2559671|P2|STARTED|First Injection Visit||3
1054139|NCT00822926|2559672|P1|STARTED|First Injection Visit||2
1054140|NCT00823043|2559684|P2|NOT COMPLETED|Overall Study||0
1054141|NCT00823043|2559685|P1|NOT COMPLETED|Overall Study||0
1054142|NCT00823043|2559684|P2|COMPLETED|Overall Study||39
1054143|NCT00823043|2559685|P1|COMPLETED|Overall Study||64
1054144|NCT00823043|2559684|P2|STARTED|Overall Study||39
1054145|NCT00823043|2559685|P1|STARTED|Overall Study||64
1054146|NCT00823069|2559696|P1|NOT COMPLETED|Overall Study||0
1054147|NCT00823069|2559696|P1|COMPLETED|Overall Study||60
1054148|NCT00823069|2559696|P1|STARTED|Overall Study||60
1054149|NCT00823082|2559705|P2|NOT COMPLETED|Overall Study||1
1054150|NCT00823082|2559706|P1|NOT COMPLETED|Overall Study||0
1054151|NCT00823082|2559705|P2|COMPLETED|Overall Study||99
1054152|NCT00823082|2559706|P1|COMPLETED|Overall Study||100
1054153|NCT00823082|2559705|P2|Intent-to-Treat/Per Protocol Populations|Overall Study||94
1054154|NCT00823082|2559706|P1|Intent-to-Treat/Per Protocol Populations|Overall Study||100
1054155|NCT00823082|2559705|P2|Safety Population|Overall Study||99
1054156|NCT00823082|2559706|P1|Safety Population|Overall Study||100
1054157|NCT00823082|2559705|P2|STARTED|Overall Study||100
1054158|NCT00823082|2559706|P1|STARTED|Overall Study||100
1054159|NCT00823095|2559740|P1|NOT COMPLETED|Overall Study||0
1054160|NCT00823095|2559740|P1|COMPLETED|Overall Study||7
1054161|NCT00823095|2559740|P1|STARTED|Overall Study||7
1054162|NCT00823199|2559745|P1|NOT COMPLETED|Overall Study||2
1054163|NCT00823199|2559745|P1|COMPLETED|Overall Study||8
1054164|NCT00823199|2559745|P1|STARTED|Overall Study||10
1054165|NCT00823212|2559753|P2|NOT COMPLETED|Overall Study||33
1054166|NCT00823212|2559754|P1|NOT COMPLETED|Overall Study||35
1054167|NCT00823212|2559753|P2|COMPLETED|Overall Study|12-month follow-up|735
1054168|NCT00823212|2559754|P1|COMPLETED|Overall Study|12-month follow-up|727
1054169|NCT00823212|2559753|P2|STARTED|Overall Study||768
1054170|NCT00823212|2559754|P1|STARTED|Overall Study||762
1054171|NCT00823264|2559838|P2|NOT COMPLETED|Overall Study||0
1054172|NCT00823264|2559839|P1|NOT COMPLETED|Overall Study||2
1054173|NCT00823264|2559838|P2|COMPLETED|Overall Study||7
1054174|NCT00823264|2559839|P1|COMPLETED|Overall Study||8
1054175|NCT00823264|2559838|P2|STARTED|Overall Study||7
1054176|NCT00823264|2559839|P1|STARTED|Overall Study||10
1054177|NCT00823303|2559847|P2|NOT COMPLETED|Overall Study||11
1054178|NCT00823303|2559848|P1|NOT COMPLETED|Overall Study||9
1054179|NCT00823303|2559847|P2|COMPLETED|Overall Study||45
1054180|NCT00823303|2559848|P1|COMPLETED|Overall Study||45
1054181|NCT00823303|2559847|P2|STARTED|Overall Study||56
1054182|NCT00823303|2559848|P1|STARTED|Overall Study||54
1054183|NCT00823472|2559856|P2|NOT COMPLETED|Overall Study||28
1054184|NCT00823472|2559857|P1|NOT COMPLETED|Overall Study||24
1054185|NCT00823472|2559856|P2|COMPLETED|Overall Study||39
1054186|NCT00823472|2559857|P1|COMPLETED|Overall Study||56
1054187|NCT00823472|2559856|P2|STARTED|Overall Study||67
1054188|NCT00823472|2559857|P1|STARTED|Overall Study||80
1054189|NCT00823615|2559865|P2|NOT COMPLETED|Period 2||2
1054190|NCT00823615|2559866|P1|NOT COMPLETED|Period 2||3
1054191|NCT00823615|2559865|P2|COMPLETED|Period 2||17
1054192|NCT00823615|2559866|P1|COMPLETED|Period 2||16
1054193|NCT00823615|2559865|P2|STARTED|Period 2||19
1054194|NCT00823615|2559866|P1|STARTED|Period 2||19
1054195|NCT00823615|2559865|P2|NOT COMPLETED|Period 1||0
1054196|NCT00823615|2559866|P1|NOT COMPLETED|Period 1||0
1054197|NCT00823615|2559865|P2|COMPLETED|Period 1||19
1054198|NCT00823615|2559866|P1|COMPLETED|Period 1||19
1054199|NCT00823615|2559865|P2|STARTED|Period 1||19
1054200|NCT00823615|2559866|P1|STARTED|Period 1||19
1054201|NCT00823719|2559876|P2|NOT COMPLETED|Overall Study||11
1054202|NCT00823719|2559877|P1|NOT COMPLETED|Overall Study||6
1054203|NCT00823719|2559876|P2|COMPLETED|Overall Study||24
1054204|NCT00823719|2559877|P1|COMPLETED|Overall Study||20
1054205|NCT00823719|2559876|P2|STARTED|Overall Study||35
1054206|NCT00823719|2559877|P1|STARTED|Overall Study||26
1054207|NCT00823797|2559932|P2|NOT COMPLETED|Overall Study||0
1054208|NCT00823797|2559933|P1|NOT COMPLETED|Overall Study||0
1054209|NCT00823797|2559932|P2|COMPLETED|Overall Study||16
1054210|NCT00823797|2559933|P1|COMPLETED|Overall Study||29
1054211|NCT00823797|2559932|P2|STARTED|Overall Study||16
1054212|NCT00823797|2559933|P1|STARTED|Overall Study||29
1054213|NCT00823823|2559946|P2|NOT COMPLETED|Overall Study||6
1054214|NCT00823823|2559947|P1|NOT COMPLETED|Overall Study||8
1054215|NCT00823823|2559946|P2|COMPLETED|Overall Study||101
1054216|NCT00823823|2559947|P1|COMPLETED|Overall Study||101
1054217|NCT00823823|2559946|P2|STARTED|Overall Study||107
1054218|NCT00823823|2559947|P1|STARTED|Overall Study||109
1054219|NCT00823836|2559957|P2|NOT COMPLETED|Long-term Phase||5
1054220|NCT00823836|2559958|P1|NOT COMPLETED|Long-term Phase||5
1054221|NCT00823836|2559957|P2|COMPLETED|Long-term Phase||79
1054222|NCT00823836|2559958|P1|COMPLETED|Long-term Phase||68
1054223|NCT00823836|2559957|P2|STARTED|Long-term Phase||84
1054224|NCT00823836|2559958|P1|STARTED|Long-term Phase||73
1054225|NCT00823836|2559957|P2|NOT COMPLETED|NV and PR/XR Switching Phases||29
1054226|NCT00823836|2559958|P1|NOT COMPLETED|NV and PR/XR Switching Phases||32
1054227|NCT00823836|2559957|P2|COMPLETED|NV and PR/XR Switching Phases||117
1054228|NCT00823836|2559958|P1|COMPLETED|NV and PR/XR Switching Phases||124
1054229|NCT00823836|2559957|P2|STARTED|NV and PR/XR Switching Phases||146
1054230|NCT00823836|2559958|P1|STARTED|NV and PR/XR Switching Phases||156
1054231|NCT00823901|2560064|P2|NOT COMPLETED|Overall Study||2
1054232|NCT00823901|2560065|P1|NOT COMPLETED|Overall Study||4
1054233|NCT00823901|2560064|P2|COMPLETED|Overall Study|Discontinued intervention (n=1) Only baseline completed (n=1)|38
1054234|NCT00823901|2560065|P1|COMPLETED|Overall Study|Discontinued intervention (n=2) Only baseline completed (n=2)|39
1054235|NCT00823901|2560064|P2|STARTED|Overall Study|Randomized to placebo gel|40
1054236|NCT00823901|2560065|P1|STARTED|Overall Study|Randomized to clindamycin/tretinoin gel|43
1054237|NCT00823966|2560071|P1|NOT COMPLETED|Overall Study||0
1054238|NCT00823966|2560071|P1|COMPLETED|Overall Study||3
1054239|NCT00823966|2560071|P1|STARTED|Overall Study||3
1054240|NCT00823979|2560079|P3|NOT COMPLETED|Overall Study||24
1054241|NCT00823979|2560080|P2|NOT COMPLETED|Overall Study||32
1054242|NCT00823979|2560081|P1|NOT COMPLETED|Overall Study||29
1054243|NCT00823979|2560079|P3|COMPLETED|Overall Study||11
1054244|NCT00823979|2560080|P2|COMPLETED|Overall Study||3
1054245|NCT00823979|2560081|P1|COMPLETED|Overall Study||6
1054246|NCT00823979|2560079|P3|Treated|Overall Study||34
1054247|NCT00823979|2560080|P2|Treated|Overall Study||32
1054248|NCT00823979|2560081|P1|Treated|Overall Study||31
1054249|NCT00823979|2560079|P3|STARTED|Overall Study||35
1054250|NCT00823979|2560080|P2|STARTED|Overall Study||35
1054251|NCT00823979|2560081|P1|STARTED|Overall Study||35
1054252|NCT00824005|2560121|P2|NOT COMPLETED|Overall Study||2
1054253|NCT00824005|2560122|P1|NOT COMPLETED|Overall Study||0
1054254|NCT00824005|2560121|P2|COMPLETED|Overall Study||59
1054255|NCT00824005|2560122|P1|COMPLETED|Overall Study||31
1054256|NCT00824005|2560121|P2|STARTED|Overall Study||61
1054257|NCT00824005|2560122|P1|STARTED|Overall Study||31
1054258|NCT00824044|2560156|P2|NOT COMPLETED|Overall Study||6
1054259|NCT00824044|2560157|P1|NOT COMPLETED|Overall Study||9
1054260|NCT00824044|2560156|P2|COMPLETED|Overall Study||10
1054261|NCT00824044|2560157|P1|COMPLETED|Overall Study||14
1054262|NCT00824044|2560156|P2|STARTED|Overall Study||16
1054263|NCT00824044|2560157|P1|STARTED|Overall Study||23
1054264|NCT00824070|2560166|P3|NOT COMPLETED|Overall Study||0
1054265|NCT00824070|2560167|P2|NOT COMPLETED|Overall Study||0
1054266|NCT00824070|2560168|P1|NOT COMPLETED|Overall Study||0
1054267|NCT00824070|2560166|P3|COMPLETED|Overall Study||36
1054268|NCT00824070|2560167|P2|COMPLETED|Overall Study||35
1054269|NCT00824070|2560168|P1|COMPLETED|Overall Study||34
1054270|NCT00824070|2560166|P3|STARTED|Overall Study||36
1054271|NCT00824070|2560167|P2|STARTED|Overall Study||35
1054272|NCT00824070|2560168|P1|STARTED|Overall Study||34
1054273|NCT00824161|2560176|P1|NOT COMPLETED|Overall Study||2
1054274|NCT00824161|2560176|P1|COMPLETED|Overall Study||26
1054275|NCT00824161|2560176|P1|STARTED|Overall Study||28
1054276|NCT00824265|2560184|P2|NOT COMPLETED|Overall Study||80
1054277|NCT00824265|2560185|P1|NOT COMPLETED|Overall Study||64
1054278|NCT00824265|2560184|P2|COMPLETED|Overall Study||102
1054279|NCT00824265|2560185|P1|COMPLETED|Overall Study||119
1054280|NCT00824265|2560184|P2|STARTED|Overall Study||182
1054281|NCT00824265|2560185|P1|STARTED|Overall Study||183
1054282|NCT00824291|2560246|P2|NOT COMPLETED|Overall Study||35
1054283|NCT00824291|2560247|P1|NOT COMPLETED|Overall Study||54
1054284|NCT00824291|2560246|P2|COMPLETED|Overall Study||107
1054285|NCT00824291|2560247|P1|COMPLETED|Overall Study||231
1054286|NCT00824291|2560246|P2|STARTED|Overall Study||142
1054287|NCT00824291|2560247|P1|STARTED|Overall Study||285
1054288|NCT00824369|2560273|P6|NOT COMPLETED|Overall Study||1
1054289|NCT00824369|2560274|P5|NOT COMPLETED|Overall Study||1
1054290|NCT00824369|2560275|P4|NOT COMPLETED|Overall Study||2
1054291|NCT00824369|2560276|P3|NOT COMPLETED|Overall Study||1
1054292|NCT00824369|2560277|P2|NOT COMPLETED|Overall Study||0
1054293|NCT00824369|2560278|P1|NOT COMPLETED|Overall Study||1
1054294|NCT00824369|2560273|P6|COMPLETED|Overall Study||16
1054295|NCT00824369|2560274|P5|COMPLETED|Overall Study||11
1054296|NCT00824369|2560275|P4|COMPLETED|Overall Study||9
1054297|NCT00824369|2560276|P3|COMPLETED|Overall Study||2
1054298|NCT00824369|2560277|P2|COMPLETED|Overall Study||4
1054299|NCT00824369|2560278|P1|COMPLETED|Overall Study||4
1054300|NCT00824369|2560273|P6|STARTED|Overall Study||17
1054301|NCT00824369|2560274|P5|STARTED|Overall Study||12
1054302|NCT00824369|2560275|P4|STARTED|Overall Study||11
1054303|NCT00824369|2560276|P3|STARTED|Overall Study||3
1054304|NCT00824369|2560277|P2|STARTED|Overall Study||4
1054305|NCT00824369|2560278|P1|STARTED|Overall Study||5
1054306|NCT00824382|2560320|P4|NOT COMPLETED|Overall Study||5
1054307|NCT00824382|2560321|P3|NOT COMPLETED|Overall Study||3
1054308|NCT00824382|2560322|P2|NOT COMPLETED|Overall Study||2
1054309|NCT00824382|2560323|P1|NOT COMPLETED|Overall Study||5
1054310|NCT00824382|2560320|P4|COMPLETED|Overall Study||81
1054311|NCT00824382|2560321|P3|COMPLETED|Overall Study||76
1054312|NCT00824382|2560322|P2|COMPLETED|Overall Study||82
1054313|NCT00824382|2560323|P1|COMPLETED|Overall Study||74
1054314|NCT00824382|2560320|P4|STARTED|Overall Study||86
1054315|NCT00824382|2560321|P3|STARTED|Overall Study||79
1054316|NCT00824382|2560322|P2|STARTED|Overall Study||84
1054317|NCT00824382|2560323|P1|STARTED|Overall Study||79
1054318|NCT00824408|2560398|P5|NOT COMPLETED|Randomized Phase||46
1054319|NCT00824408|2560399|P4|NOT COMPLETED|Randomized Phase||46
1054320|NCT00824408|2560400|P3|NOT COMPLETED|Randomized Phase||36
1054321|NCT00824408|2560401|P2|NOT COMPLETED|Randomized Phase||0
1054322|NCT00824408|2560402|P1|NOT COMPLETED|Randomized Phase||0
1054323|NCT00824408|2560398|P5|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
1054324|NCT00824408|2560399|P4|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
1054325|NCT00824408|2560400|P3|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
1054326|NCT00824408|2560401|P2|COMPLETED|Randomized Phase||0
1054327|NCT00824408|2560402|P1|COMPLETED|Randomized Phase||0
1054328|NCT00824408|2560398|P5|STARTED|Randomized Phase||47
1054329|NCT00824408|2560399|P4|STARTED|Randomized Phase||47
1054330|NCT00824408|2560400|P3|STARTED|Randomized Phase||37
1054331|NCT00824408|2560401|P2|STARTED|Randomized Phase||0
1054332|NCT00824408|2560402|P1|STARTED|Randomized Phase||0
1054333|NCT00824408|2560398|P5|NOT COMPLETED|Run-in Phase||0
1054334|NCT00824408|2560399|P4|NOT COMPLETED|Run-in Phase||0
1054335|NCT00824408|2560400|P3|NOT COMPLETED|Run-in Phase||0
1054336|NCT00824408|2560401|P2|NOT COMPLETED|Run-in Phase||6
1054337|NCT00824408|2560402|P1|NOT COMPLETED|Run-in Phase||6
1054338|NCT00824408|2560398|P5|COMPLETED|Run-in Phase||0
1054339|NCT00824408|2560399|P4|COMPLETED|Run-in Phase||0
1054340|NCT00824408|2560400|P3|COMPLETED|Run-in Phase||0
1054341|NCT00824408|2560401|P2|COMPLETED|Run-in Phase||0
1054342|NCT00824408|2560402|P1|COMPLETED|Run-in Phase||0
1054343|NCT00824408|2560398|P5|STARTED|Run-in Phase||0
1054344|NCT00824408|2560399|P4|STARTED|Run-in Phase||0
1054345|NCT00824408|2560400|P3|STARTED|Run-in Phase||0
1054346|NCT00824408|2560401|P2|STARTED|Run-in Phase||6
1054347|NCT00824408|2560402|P1|STARTED|Run-in Phase||6
1054348|NCT00824421|2560453|P3|NOT COMPLETED|Overall Study||14
1054349|NCT00824421|2560454|P2|NOT COMPLETED|Overall Study||22
1054350|NCT00824421|2560455|P1|NOT COMPLETED|Overall Study||17
1054351|NCT00824421|2560453|P3|COMPLETED|Overall Study||49
1054352|NCT00824421|2560454|P2|COMPLETED|Overall Study||44
1054353|NCT00824421|2560455|P1|COMPLETED|Overall Study||49
1054354|NCT00824421|2560453|P3|Treated|Overall Study||63
1054355|NCT00824421|2560454|P2|Treated|Overall Study||65
1054356|NCT00824421|2560455|P1|Treated|Overall Study||65
1054357|NCT00824421|2560453|P3|STARTED|Overall Study||63
1054358|NCT00824421|2560454|P2|STARTED|Overall Study||66
1054359|NCT00824421|2560455|P1|STARTED|Overall Study||66
1054360|NCT00824434|2560501|P1|NOT COMPLETED|Overall Study||0
1054361|NCT00824434|2560501|P1|COMPLETED|Overall Study||100
1054362|NCT00824434|2560501|P1|STARTED|Overall Study||100
1054363|NCT00824460|2560526|P6|NOT COMPLETED|Overall Study||8
1054364|NCT00824460|2560527|P5|NOT COMPLETED|Overall Study||9
1054365|NCT00824460|2560528|P4|NOT COMPLETED|Overall Study||12
1054366|NCT00824460|2560529|P3|NOT COMPLETED|Overall Study||5
1054367|NCT00824460|2560530|P2|NOT COMPLETED|Overall Study||9
1054368|NCT00824460|2560531|P1|NOT COMPLETED|Overall Study||8
1054369|NCT00824460|2560526|P6|COMPLETED|Overall Study||18
1054370|NCT00824460|2560527|P5|COMPLETED|Overall Study||15
1054371|NCT00824460|2560528|P4|COMPLETED|Overall Study||15
1054372|NCT00824460|2560529|P3|COMPLETED|Overall Study||20
1054373|NCT00824460|2560530|P2|COMPLETED|Overall Study||17
1054374|NCT00824460|2560531|P1|COMPLETED|Overall Study||18
1054375|NCT00824460|2560526|P6|STARTED|Overall Study||26
1054376|NCT00824460|2560527|P5|STARTED|Overall Study||24
1054377|NCT00824460|2560528|P4|STARTED|Overall Study||27
1054378|NCT00824460|2560529|P3|STARTED|Overall Study||25
1054379|NCT00824460|2560530|P2|STARTED|Overall Study||26
1054380|NCT00824460|2560531|P1|STARTED|Overall Study||26
1054381|NCT00824473|2560565|P2|NOT COMPLETED|Overall Study||13
1054382|NCT00824473|2560566|P1|NOT COMPLETED|Overall Study||15
1054383|NCT00824473|2560565|P2|COMPLETED|Overall Study||238
1054384|NCT00824473|2560566|P1|COMPLETED|Overall Study||240
1054385|NCT00824473|2560565|P2|STARTED|Overall Study||251
1054386|NCT00824473|2560566|P1|STARTED|Overall Study|1 subject was randomized in error|255
1054387|NCT00817531|2560582|P1|NOT COMPLETED|Overall Study||2
1054388|NCT00817531|2560582|P1|COMPLETED|Overall Study|20 out of 22 patients finished study treatment. 2 patients stopped the treatment after the 1st week.|20
1054389|NCT00817531|2560582|P1|STARTED|Overall Study|22 patients were eligible for this study and started the treatment.|22
1054390|NCT00817596|2560586|P1|NOT COMPLETED|Overall Study||48
1054391|NCT00817596|2560586|P1|COMPLETED|Overall Study||62
1054392|NCT00817596|2560586|P1|STARTED|Overall Study||110
1054393|NCT00817778|2560592|P2|NOT COMPLETED|Overall Study||3
1054394|NCT00817778|2560593|P1|NOT COMPLETED|Overall Study||3
1054395|NCT00817778|2560592|P2|COMPLETED|Overall Study||5
1054396|NCT00817778|2560593|P1|COMPLETED|Overall Study||16
1054397|NCT00817778|2560592|P2|STARTED|Overall Study||8
1054398|NCT00817778|2560593|P1|STARTED|Overall Study||19
1054399|NCT00817804|2560620|P2|NOT COMPLETED|Overall Study||0
1054400|NCT00817804|2560621|P1|NOT COMPLETED|Overall Study||0
1054401|NCT00817804|2560620|P2|COMPLETED|Overall Study||2
1054402|NCT00817804|2560621|P1|COMPLETED|Overall Study||1
1054403|NCT00817804|2560620|P2|STARTED|Overall Study||2
1054404|NCT00817804|2560621|P1|STARTED|Overall Study||1
1054405|NCT00817843|2560627|P2|NOT COMPLETED|Second Period (6 Weeks)||1
1054406|NCT00817843|2560628|P1|NOT COMPLETED|Second Period (6 Weeks)||0
1054407|NCT00817843|2560627|P2|COMPLETED|Second Period (6 Weeks)||44
1054408|NCT00817843|2560628|P1|COMPLETED|Second Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|41
1054409|NCT00817843|2560627|P2|STARTED|Second Period (6 Weeks)||45
1054410|NCT00817843|2560628|P1|STARTED|Second Period (6 Weeks)||41
1054411|NCT00817843|2560627|P2|NOT COMPLETED|Washout Period (6 Weeks)||1
1054412|NCT00817843|2560628|P1|NOT COMPLETED|Washout Period (6 Weeks)||1
1054413|NCT00817843|2560627|P2|COMPLETED|Washout Period (6 Weeks)||45
1054414|NCT00817843|2560628|P1|COMPLETED|Washout Period (6 Weeks)||41
1054415|NCT00817843|2560627|P2|STARTED|Washout Period (6 Weeks)||46
1054416|NCT00817843|2560628|P1|STARTED|Washout Period (6 Weeks)||42
1054417|NCT00817843|2560627|P2|NOT COMPLETED|First Period (6 Weeks)||4
1054418|NCT00817843|2560628|P1|NOT COMPLETED|First Period (6 Weeks)||8
1054419|NCT00817843|2560627|P2|COMPLETED|First Period (6 Weeks)||46
1054420|NCT00817843|2560628|P1|COMPLETED|First Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|42
1054421|NCT00817843|2560627|P2|STARTED|First Period (6 Weeks)||50
1054422|NCT00817843|2560628|P1|STARTED|First Period (6 Weeks)||50
1054423|NCT00817999|2560635|P2|NOT COMPLETED|No Grapefruit Juice||0
1054424|NCT00817999|2560636|P1|NOT COMPLETED|No Grapefruit Juice||0
1054425|NCT00817999|2560635|P2|COMPLETED|No Grapefruit Juice||17
1054426|NCT00817999|2560636|P1|COMPLETED|No Grapefruit Juice||15
1054427|NCT00817999|2560635|P2|STARTED|No Grapefruit Juice||17
1054428|NCT00817999|2560636|P1|STARTED|No Grapefruit Juice||15
1054429|NCT00817999|2560635|P2|NOT COMPLETED|Grapefruit Juice||0
1054430|NCT00817999|2560636|P1|NOT COMPLETED|Grapefruit Juice||0
1054431|NCT00817999|2560635|P2|COMPLETED|Grapefruit Juice||17
1054432|NCT00817999|2560636|P1|COMPLETED|Grapefruit Juice||15
1054433|NCT00817999|2560635|P2|STARTED|Grapefruit Juice||17
1054434|NCT00817999|2560636|P1|STARTED|Grapefruit Juice||15
1054435|NCT00818116|2560644|P1|NOT COMPLETED|Overall Study||0
1054436|NCT00818116|2560644|P1|COMPLETED|Overall Study||34
1054437|NCT00818116|2560644|P1|STARTED|Overall Study||34
1054438|NCT00818168|2560648|P1|NOT COMPLETED|Overall Study||70
1054439|NCT00818168|2560648|P1|COMPLETED|Overall Study|Includes 78 participants whose completer/non-completer status was not reported (missing)|250
1054440|NCT00818168|2560648|P1|STARTED|Overall Study||320
1054441|NCT00818207|2560658|P2|NOT COMPLETED|Overall Study||267
1054442|NCT00818207|2560659|P1|NOT COMPLETED|Overall Study||222
1054443|NCT00818207|2560658|P2|COMPLETED|Overall Study||417
1054444|NCT00818207|2560659|P1|COMPLETED|Overall Study||474
1054445|NCT00818207|2560658|P2|STARTED|Overall Study||684
1054446|NCT00818207|2560659|P1|STARTED|Overall Study||696
1054447|NCT00818246|2560673|P1|NOT COMPLETED|Overall Study||5
1054448|NCT00818246|2560673|P1|COMPLETED|Overall Study|split-face study|35
1054449|NCT00818246|2560673|P1|STARTED|Overall Study||40
1054450|NCT00818259|2560687|P9|NOT COMPLETED|Part V||0
1054451|NCT00818259|2560688|P8|NOT COMPLETED|Part V||1
1054452|NCT00818259|2560689|P7|NOT COMPLETED|Part V||0
1054453|NCT00818259|2560690|P6|NOT COMPLETED|Part V||0
1054454|NCT00818259|2560691|P5|NOT COMPLETED|Part V||0
1054455|NCT00818259|2560692|P4|NOT COMPLETED|Part V||0
1054456|NCT00818259|2560693|P3|NOT COMPLETED|Part V||0
1054457|NCT00818259|2560694|P2|NOT COMPLETED|Part V||0
1054458|NCT00818259|2560695|P1|NOT COMPLETED|Part V||0
1054459|NCT00818259|2560687|P9|COMPLETED|Part V||6
1054460|NCT00818259|2560688|P8|COMPLETED|Part V||16
1054461|NCT00818259|2560689|P7|COMPLETED|Part V||0
1054462|NCT00818259|2560690|P6|COMPLETED|Part V||0
1054463|NCT00818259|2560691|P5|COMPLETED|Part V||0
1054464|NCT00818259|2560692|P4|COMPLETED|Part V||0
1054465|NCT00818259|2560693|P3|COMPLETED|Part V||0
1054466|NCT00818259|2560694|P2|COMPLETED|Part V||0
1054467|NCT00818259|2560695|P1|COMPLETED|Part V||0
1054468|NCT00818259|2560687|P9|STARTED|Part V|Newly enrolled participants|6
1054469|NCT00818259|2560688|P8|STARTED|Part V|Participants continuing from Part IV|17
1054470|NCT00818259|2560689|P7|STARTED|Part V||0
1054471|NCT00818259|2560690|P6|STARTED|Part V||0
1054472|NCT00818259|2560691|P5|STARTED|Part V||0
1054473|NCT00818259|2560692|P4|STARTED|Part V||0
1054474|NCT00818259|2560693|P3|STARTED|Part V||0
1054475|NCT00818259|2560694|P2|STARTED|Part V||0
1054476|NCT00818259|2560695|P1|STARTED|Part V||0
1054477|NCT00818259|2560687|P9|NOT COMPLETED|Part IV||0
1054478|NCT00818259|2560688|P8|NOT COMPLETED|Part IV||0
1054479|NCT00818259|2560689|P7|NOT COMPLETED|Part IV||0
1054480|NCT00818259|2560690|P6|NOT COMPLETED|Part IV||1
1054481|NCT00818259|2560691|P5|NOT COMPLETED|Part IV||0
1054482|NCT00818259|2560692|P4|NOT COMPLETED|Part IV||0
1054483|NCT00818259|2560693|P3|NOT COMPLETED|Part IV||0
1054484|NCT00818259|2560694|P2|NOT COMPLETED|Part IV||0
1054485|NCT00818259|2560695|P1|NOT COMPLETED|Part IV||0
1054486|NCT00818259|2560687|P9|COMPLETED|Part IV||0
1054487|NCT00818259|2560688|P8|COMPLETED|Part IV||0
1054488|NCT00818259|2560689|P7|COMPLETED|Part IV||5
1054489|NCT00818259|2560690|P6|COMPLETED|Part IV||14
1054490|NCT00818259|2560691|P5|COMPLETED|Part IV||0
1054491|NCT00818259|2560692|P4|COMPLETED|Part IV||0
1054492|NCT00818259|2560693|P3|COMPLETED|Part IV||0
1054493|NCT00818259|2560694|P2|COMPLETED|Part IV||0
1054494|NCT00818259|2560695|P1|COMPLETED|Part IV||0
1054495|NCT00818259|2560687|P9|STARTED|Part IV||0
1054496|NCT00818259|2560688|P8|STARTED|Part IV||0
1054497|NCT00818259|2560689|P7|STARTED|Part IV|Newly enrolled participants|5
1054498|NCT00818259|2560690|P6|STARTED|Part IV|Participants continuing from Part III|15
1054499|NCT00818259|2560691|P5|STARTED|Part IV||0
1054500|NCT00818259|2560692|P4|STARTED|Part IV||0
1054501|NCT00818259|2560693|P3|STARTED|Part IV||0
1054502|NCT00818259|2560694|P2|STARTED|Part IV||0
1054503|NCT00818259|2560695|P1|STARTED|Part IV||0
1054504|NCT00818259|2560687|P9|NOT COMPLETED|Part III||0
1054505|NCT00818259|2560688|P8|NOT COMPLETED|Part III||0
1054506|NCT00818259|2560689|P7|NOT COMPLETED|Part III||0
1054507|NCT00818259|2560690|P6|NOT COMPLETED|Part III||0
1054508|NCT00818259|2560691|P5|NOT COMPLETED|Part III||0
1054509|NCT00818259|2560692|P4|NOT COMPLETED|Part III||0
1054510|NCT00818259|2560693|P3|NOT COMPLETED|Part III||0
1054511|NCT00818259|2560694|P2|NOT COMPLETED|Part III||0
1054512|NCT00818259|2560695|P1|NOT COMPLETED|Part III||0
1054513|NCT00818259|2560687|P9|COMPLETED|Part III||0
1054514|NCT00818259|2560688|P8|COMPLETED|Part III||0
1054515|NCT00818259|2560689|P7|COMPLETED|Part III||0
1054516|NCT00818259|2560690|P6|COMPLETED|Part III||0
1054517|NCT00818259|2560691|P5|COMPLETED|Part III||19
1054518|NCT00818259|2560692|P4|COMPLETED|Part III||0
1054519|NCT00818259|2560693|P3|COMPLETED|Part III||0
1054520|NCT00818259|2560694|P2|COMPLETED|Part III||0
1054521|NCT00818259|2560695|P1|COMPLETED|Part III||0
1054522|NCT00818259|2560687|P9|STARTED|Part III||0
1054523|NCT00818259|2560688|P8|STARTED|Part III||0
1054524|NCT00818259|2560689|P7|STARTED|Part III||0
1054525|NCT00818259|2560690|P6|STARTED|Part III||0
1054526|NCT00818259|2560691|P5|STARTED|Part III|Newly enrolled participants|19
1054527|NCT00818259|2560692|P4|STARTED|Part III||0
1054528|NCT00818259|2560693|P3|STARTED|Part III||0
1054529|NCT00818259|2560694|P2|STARTED|Part III||0
1054530|NCT00818259|2560695|P1|STARTED|Part III||0
1054531|NCT00818259|2560687|P9|NOT COMPLETED|Part II||0
1054532|NCT00818259|2560688|P8|NOT COMPLETED|Part II||0
1054533|NCT00818259|2560689|P7|NOT COMPLETED|Part II||0
1054534|NCT00818259|2560690|P6|NOT COMPLETED|Part II||0
1054535|NCT00818259|2560691|P5|NOT COMPLETED|Part II||0
1054536|NCT00818259|2560692|P4|NOT COMPLETED|Part II||2
1054537|NCT00818259|2560693|P3|NOT COMPLETED|Part II||1
1054538|NCT00818259|2560694|P2|NOT COMPLETED|Part II||0
1054539|NCT00818259|2560695|P1|NOT COMPLETED|Part II||0
1054540|NCT00818259|2560687|P9|COMPLETED|Part II||0
1054541|NCT00818259|2560688|P8|COMPLETED|Part II||0
1054542|NCT00818259|2560689|P7|COMPLETED|Part II||0
1054543|NCT00818259|2560690|P6|COMPLETED|Part II||0
1054544|NCT00818259|2560691|P5|COMPLETED|Part II||0
1054545|NCT00818259|2560692|P4|COMPLETED|Part II||18
1054546|NCT00818259|2560693|P3|COMPLETED|Part II||18
1054547|NCT00818259|2560694|P2|COMPLETED|Part II||0
1054548|NCT00818259|2560695|P1|COMPLETED|Part II||0
1054549|NCT00818259|2560687|P9|Treated|Part II||0
1054550|NCT00818259|2560688|P8|Treated|Part II||0
1054551|NCT00818259|2560689|P7|Treated|Part II||0
1054552|NCT00818259|2560690|P6|Treated|Part II||0
1054553|NCT00818259|2560691|P5|Treated|Part II||0
1054554|NCT00818259|2560692|P4|Treated|Part II||19
1054555|NCT00818259|2560693|P3|Treated|Part II||19
1054556|NCT00818259|2560694|P2|Treated|Part II||0
1054557|NCT00818259|2560695|P1|Treated|Part II||0
1054558|NCT00818259|2560687|P9|STARTED|Part II||0
1054559|NCT00818259|2560688|P8|STARTED|Part II||0
1054560|NCT00818259|2560689|P7|STARTED|Part II||0
1054561|NCT00818259|2560690|P6|STARTED|Part II||0
1054562|NCT00818259|2560691|P5|STARTED|Part II||0
1054563|NCT00818259|2560692|P4|STARTED|Part II|Newly enrolled participants|20
1054564|NCT00818259|2560693|P3|STARTED|Part II|Newly enrolled participants|19
1054565|NCT00818259|2560694|P2|STARTED|Part II||0
1054566|NCT00818259|2560695|P1|STARTED|Part II||0
1054567|NCT00818259|2560687|P9|NOT COMPLETED|Part I||0
1054568|NCT00818259|2560688|P8|NOT COMPLETED|Part I||0
1054569|NCT00818259|2560689|P7|NOT COMPLETED|Part I||0
1054570|NCT00818259|2560690|P6|NOT COMPLETED|Part I||0
1054571|NCT00818259|2560691|P5|NOT COMPLETED|Part I||0
1054572|NCT00818259|2560692|P4|NOT COMPLETED|Part I||0
1054573|NCT00818259|2560693|P3|NOT COMPLETED|Part I||0
1054574|NCT00818259|2560694|P2|NOT COMPLETED|Part I||0
1054575|NCT00818259|2560695|P1|NOT COMPLETED|Part I||1
1054576|NCT00818259|2560687|P9|COMPLETED|Part I||0
1054577|NCT00818259|2560688|P8|COMPLETED|Part I||0
1054578|NCT00818259|2560689|P7|COMPLETED|Part I||0
1054579|NCT00818259|2560690|P6|COMPLETED|Part I||0
1054580|NCT00818259|2560691|P5|COMPLETED|Part I||0
1054581|NCT00818259|2560692|P4|COMPLETED|Part I||0
1054582|NCT00818259|2560693|P3|COMPLETED|Part I||0
1054583|NCT00818259|2560694|P2|COMPLETED|Part I||11
1054584|NCT00818259|2560695|P1|COMPLETED|Part I||11
1054585|NCT00818259|2560687|P9|STARTED|Part I||0
1054586|NCT00818259|2560688|P8|STARTED|Part I||0
1054587|NCT00818259|2560689|P7|STARTED|Part I||0
1054588|NCT00818259|2560690|P6|STARTED|Part I||0
1054589|NCT00818259|2560691|P5|STARTED|Part I||0
1054590|NCT00818259|2560692|P4|STARTED|Part I||0
1054591|NCT00818259|2560693|P3|STARTED|Part I||0
1054592|NCT00818259|2560694|P2|STARTED|Part I|Newly enrolled participants|11
1054593|NCT00818259|2560695|P1|STARTED|Part I|Newly enrolled participants|12
1054594|NCT00818259|2560687|P9|NOT COMPLETED|Randomization||0
1054595|NCT00818259|2560688|P8|NOT COMPLETED|Randomization||0
1054596|NCT00818259|2560689|P7|NOT COMPLETED|Randomization||0
1054597|NCT00818259|2560690|P6|NOT COMPLETED|Randomization||0
1054598|NCT00818259|2560691|P5|NOT COMPLETED|Randomization||0
1054599|NCT00818259|2560692|P4|NOT COMPLETED|Randomization||0
1054600|NCT00818259|2560693|P3|NOT COMPLETED|Randomization||0
1054601|NCT00818259|2560694|P2|NOT COMPLETED|Randomization||0
1054602|NCT00818259|2560695|P1|NOT COMPLETED|Randomization||0
1054603|NCT00818259|2560687|P9|COMPLETED|Randomization||6
1054604|NCT00818259|2560688|P8|COMPLETED|Randomization||0
1054605|NCT00818259|2560689|P7|COMPLETED|Randomization||5
1054606|NCT00818259|2560690|P6|COMPLETED|Randomization||0
1054607|NCT00818259|2560691|P5|COMPLETED|Randomization||19
1054608|NCT00818259|2560692|P4|COMPLETED|Randomization||20
1054609|NCT00818259|2560693|P3|COMPLETED|Randomization||19
1054610|NCT00818259|2560694|P2|COMPLETED|Randomization||11
1054611|NCT00818259|2560695|P1|COMPLETED|Randomization||12
1054612|NCT00818259|2560687|P9|STARTED|Randomization||6
1054613|NCT00818259|2560688|P8|STARTED|Randomization||0
1054614|NCT00818259|2560689|P7|STARTED|Randomization||5
1054615|NCT00818259|2560690|P6|STARTED|Randomization||0
1054616|NCT00818259|2560691|P5|STARTED|Randomization||19
1054617|NCT00818259|2560692|P4|STARTED|Randomization||20
1054618|NCT00818259|2560693|P3|STARTED|Randomization||19
1054619|NCT00818259|2560694|P2|STARTED|Randomization||11
1054620|NCT00818259|2560695|P1|STARTED|Randomization||12
1054621|NCT00818272|2560767|P1|NOT COMPLETED|Overall Study||74
1054622|NCT00818272|2560767|P1|COMPLETED|Overall Study||74
1054623|NCT00818272|2560767|P1|STARTED|Overall Study||148
1054624|NCT00818324|2560775|P1|NOT COMPLETED|Overall Study||27
1054625|NCT00818324|2560775|P1|COMPLETED|Overall Study||127
1054626|NCT00818324|2560775|P1|STARTED|Overall Study||154
1054627|NCT00818337|2560780|P1|NOT COMPLETED|Overall Study||0
1054628|NCT00818337|2560780|P1|COMPLETED|Overall Study||36
1054629|NCT00818337|2560780|P1|STARTED|Overall Study||36
1054630|NCT00818389|2560787|P2|NOT COMPLETED|Overall Study||6
1054631|NCT00818389|2560788|P1|NOT COMPLETED|Overall Study||4
1054632|NCT00818389|2560787|P2|COMPLETED|Overall Study|6 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|38
1054633|NCT00818389|2560788|P1|COMPLETED|Overall Study|4 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|36
1054634|NCT00818389|2560787|P2|STARTED|Overall Study||44
1054635|NCT00818389|2560788|P1|STARTED|Overall Study||40
1054636|NCT00824512|2560800|P2|NOT COMPLETED|Overall Study||0
1054637|NCT00824512|2560801|P1|NOT COMPLETED|Overall Study||0
1054638|NCT00824512|2560800|P2|COMPLETED|Overall Study||11
1054639|NCT00824512|2560801|P1|COMPLETED|Overall Study||11
1054640|NCT00824512|2560800|P2|STARTED|Overall Study||11
1054641|NCT00824512|2560801|P1|STARTED|Overall Study||11
1054642|NCT00824538|2560849|P1|NOT COMPLETED|Overall Study||2
1054643|NCT00824538|2560849|P1|COMPLETED|Overall Study||11
1054644|NCT00824538|2560849|P1|STARTED|Overall Study|13 patients entered the study|13
1054645|NCT00824564|2560857|P2|NOT COMPLETED|Overall Study||10
1054646|NCT00824564|2560858|P1|NOT COMPLETED|Overall Study||8
1054647|NCT00824564|2560857|P2|COMPLETED|Overall Study||30
1054648|NCT00824564|2560858|P1|COMPLETED|Overall Study||34
1054649|NCT00824564|2560857|P2|Treated|Overall Study||40
1054650|NCT00824564|2560858|P1|Treated|Overall Study||41
1054651|NCT00824564|2560857|P2|STARTED|Overall Study||40
1054652|NCT00824564|2560858|P1|STARTED|Overall Study||42
1054653|NCT00824616|2560878|P2|NOT COMPLETED|Overall Study||7
1054654|NCT00824616|2560879|P1|NOT COMPLETED|Overall Study||6
1054655|NCT00824616|2560878|P2|COMPLETED|Overall Study||27
1054656|NCT00824616|2560879|P1|COMPLETED|Overall Study||28
1054657|NCT00824616|2560878|P2|STARTED|Overall Study||34
1054658|NCT00824616|2560879|P1|STARTED|Overall Study||34
1054659|NCT00824655|2560889|P2|NOT COMPLETED|Toddler Dose (12 Months of Age)||0
1054660|NCT00824655|2560890|P1|NOT COMPLETED|Toddler Dose (12 Months of Age)||2
1054661|NCT00824655|2560889|P2|COMPLETED|Toddler Dose (12 Months of Age)||116
1054662|NCT00824655|2560890|P1|COMPLETED|Toddler Dose (12 Months of Age)||116
1054663|NCT00824655|2560889|P2|STARTED|Toddler Dose (12 Months of Age)||116
1054664|NCT00824655|2560890|P1|STARTED|Toddler Dose (12 Months of Age)||118
1054665|NCT00824655|2560889|P2|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
1054666|NCT00824655|2560890|P1|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
1054667|NCT00824655|2560889|P2|COMPLETED|After Infant Dose (6 Months of Age)||0
1054668|NCT00824655|2560890|P1|COMPLETED|After Infant Dose (6 Months of Age)||118
1054669|NCT00824655|2560889|P2|STARTED|After Infant Dose (6 Months of Age)||0
1054670|NCT00824655|2560890|P1|STARTED|After Infant Dose (6 Months of Age)||118
1054671|NCT00824655|2560889|P2|NOT COMPLETED|Infant Series (5 Months of Age)||0
1054672|NCT00824655|2560890|P1|NOT COMPLETED|Infant Series (5 Months of Age)||0
1054673|NCT00824655|2560889|P2|COMPLETED|Infant Series (5 Months of Age)||0
1054674|NCT00824655|2560890|P1|COMPLETED|Infant Series (5 Months of Age)||118
1054675|NCT00824655|2560889|P2|STARTED|Infant Series (5 Months of Age)||0
1054676|NCT00824655|2560890|P1|STARTED|Infant Series (5 Months of Age)||118
1054677|NCT00824720|2560911|P3|NOT COMPLETED|Overall Study||1
1054678|NCT00824720|2560912|P2|NOT COMPLETED|Overall Study||1
1054679|NCT00824720|2560913|P1|NOT COMPLETED|Overall Study||3
1054680|NCT00824720|2560911|P3|COMPLETED|Overall Study||19
1054681|NCT00824720|2560912|P2|COMPLETED|Overall Study||15
1054682|NCT00824720|2560913|P1|COMPLETED|Overall Study||16
1054683|NCT00824720|2560911|P3|STARTED|Overall Study||20
1054684|NCT00824720|2560912|P2|STARTED|Overall Study|1 subject in the low dose group did not receive device - unable to insert.|16
1054685|NCT00824720|2560913|P1|STARTED|Overall Study|3 subjects in the high dose group did not receive device - unable to insert.|19
1054686|NCT00824733|2560927|P1|NOT COMPLETED|Overall Study||0
1054687|NCT00824733|2560927|P1|COMPLETED|Overall Study||6
1054688|NCT00824733|2560927|P1|STARTED|Overall Study||6
1054689|NCT00824746|2560933|P1|NOT COMPLETED|Overall Study||0
1054690|NCT00824746|2560933|P1|COMPLETED|Overall Study||23
1054691|NCT00824746|2560933|P1|STARTED|Overall Study||23
1054692|NCT00824772|2560939|P1|NOT COMPLETED|Overall Study||8
1054693|NCT00824772|2560939|P1|COMPLETED|Overall Study||196
1054694|NCT00824772|2560939|P1|STARTED|Overall Study||204
1054695|NCT00824824|2560946|P2|NOT COMPLETED|Overall Study||0
1054696|NCT00824824|2560947|P1|NOT COMPLETED|Overall Study||0
1054697|NCT00824824|2560946|P2|COMPLETED|Overall Study||3
1054698|NCT00824824|2560947|P1|COMPLETED|Overall Study||4
1054699|NCT00824824|2560946|P2|STARTED|Overall Study||3
1054700|NCT00824824|2560947|P1|STARTED|Overall Study||4
1054701|NCT00826176|2560955|P2|NOT COMPLETED|Overall Study||0
1054702|NCT00826176|2560956|P1|NOT COMPLETED|Overall Study||13
1054703|NCT00826176|2560955|P2|COMPLETED|Overall Study|treated and completed|36
1054704|NCT00826176|2560956|P1|COMPLETED|Overall Study|treated and completed|115
1054705|NCT00826176|2560955|P2|STARTED|Overall Study|enrolled|36
1054706|NCT00826176|2560956|P1|STARTED|Overall Study|enrolled|128
1054707|NCT00826202|2560968|P2|NOT COMPLETED|Overall Study||13
1054708|NCT00826202|2560969|P1|NOT COMPLETED|Overall Study||10
1054709|NCT00826202|2560968|P2|COMPLETED|Overall Study||11
1054710|NCT00826202|2560969|P1|COMPLETED|Overall Study||10
1054711|NCT00826202|2560968|P2|Completed Visit 4 (1st Efficacy Visit)|Overall Study||20
1054712|NCT00826202|2560969|P1|Completed Visit 4 (1st Efficacy Visit)|Overall Study||15
1054713|NCT00826202|2560968|P2|STARTED|Overall Study||24
1054714|NCT00826202|2560969|P1|STARTED|Overall Study||20
1054715|NCT00826228|2560981|P1|NOT COMPLETED|Overall Study||1
1054716|NCT00826228|2560981|P1|COMPLETED|Overall Study||11
1054717|NCT00826228|2560981|P1|STARTED|Overall Study||12
1054718|NCT00826267|2560989|P3|NOT COMPLETED|Overall Study||0
1054719|NCT00826267|2560990|P2|NOT COMPLETED|Overall Study||0
1054720|NCT00826267|2560991|P1|NOT COMPLETED|Overall Study||1
1054721|NCT00826267|2560989|P3|COMPLETED|Overall Study||11
1054722|NCT00826267|2560990|P2|COMPLETED|Overall Study||8
1054723|NCT00826267|2560991|P1|COMPLETED|Overall Study||9
1054724|NCT00826267|2560989|P3|STARTED|Overall Study||11
1054725|NCT00826267|2560990|P2|STARTED|Overall Study||8
1054726|NCT00826267|2560991|P1|STARTED|Overall Study||10
1054727|NCT00826280|2561012|P3|NOT COMPLETED|Overall Study||46
1054728|NCT00826280|2561013|P2|NOT COMPLETED|Overall Study||46
1054729|NCT00826280|2561014|P1|NOT COMPLETED|Overall Study||48
1054730|NCT00826280|2561012|P3|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|71
1054731|NCT00826280|2561013|P2|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|70
1054732|NCT00826280|2561014|P1|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|66
1054733|NCT00826280|2561012|P3|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|72
1054734|NCT00826280|2561013|P2|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|71
1054735|NCT00826280|2561014|P1|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|66
1054736|NCT00826280|2561012|P3|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
1054737|NCT00826280|2561013|P2|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
1054738|NCT00826280|2561014|P1|Safety Analysis Set|Overall Study|Safety Analysis Set (SAF) was all randomized subjects who received at least one dose of regadenoson|113
1054739|NCT00826280|2561012|P3|STARTED|Overall Study||117
1054740|NCT00826280|2561013|P2|STARTED|Overall Study||116
1054741|NCT00826280|2561014|P1|STARTED|Overall Study||114
1054742|NCT00826449|2561042|P1|NOT COMPLETED|Overall Study||5
1054743|NCT00826449|2561042|P1|COMPLETED|Overall Study||42
1054744|NCT00826449|2561042|P1|Phase II|Overall Study||35
1054745|NCT00826449|2561042|P1|Phase I|Overall Study||12
1054746|NCT00826449|2561042|P1|STARTED|Overall Study||47
1054747|NCT00826540|2561048|P1|NOT COMPLETED|Overall Study||4
1054748|NCT00826540|2561048|P1|COMPLETED|Overall Study||79
1054749|NCT00826540|2561048|P1|STARTED|Overall Study||83
1054750|NCT00826618|2561052|P1|NOT COMPLETED|Overall Study||1
1054751|NCT00826618|2561052|P1|COMPLETED|Overall Study||5
1054752|NCT00826618|2561052|P1|STARTED|Overall Study||6
1054753|NCT00826800|2561056|P1|NOT COMPLETED|Overall Study||0
1054754|NCT00826800|2561056|P1|COMPLETED|Overall Study||2
1054755|NCT00826800|2561056|P1|STARTED|Overall Study||2
1054756|NCT00826943|2561060|P6|NOT COMPLETED|Overall Study||0
1054757|NCT00826943|2561061|P5|NOT COMPLETED|Overall Study||1
1054758|NCT00826943|2561062|P4|NOT COMPLETED|Overall Study||0
1054759|NCT00826943|2561063|P3|NOT COMPLETED|Overall Study||0
1054760|NCT00826943|2561064|P2|NOT COMPLETED|Overall Study||0
1054761|NCT00826943|2561065|P1|NOT COMPLETED|Overall Study||0
1054762|NCT00826943|2561060|P6|COMPLETED|Overall Study||2
1054763|NCT00826943|2561061|P5|COMPLETED|Overall Study||6
1054764|NCT00826943|2561062|P4|COMPLETED|Overall Study||5
1054765|NCT00826943|2561063|P3|COMPLETED|Overall Study||4
1054766|NCT00826943|2561064|P2|COMPLETED|Overall Study||6
1054767|NCT00826943|2561065|P1|COMPLETED|Overall Study||6
1054768|NCT00826943|2561060|P6|STARTED|Overall Study||2
1054769|NCT00826943|2561061|P5|STARTED|Overall Study||7
1054770|NCT00826943|2561062|P4|STARTED|Overall Study||5
1054771|NCT00826943|2561063|P3|STARTED|Overall Study||4
1054772|NCT00826943|2561064|P2|STARTED|Overall Study||6
1054773|NCT00826943|2561065|P1|STARTED|Overall Study||6
1054774|NCT00827073|2561081|P2|NOT COMPLETED|Overall Study||0
1054775|NCT00827073|2561082|P1|NOT COMPLETED|Overall Study||0
1054776|NCT00827073|2561081|P2|COMPLETED|Overall Study||20
1054777|NCT00827073|2561082|P1|COMPLETED|Overall Study||20
1054778|NCT00827073|2561081|P2|STARTED|Overall Study||20
1054779|NCT00827073|2561082|P1|STARTED|Overall Study||20
1054780|NCT00827099|2561090|P1|NOT COMPLETED|Overall Study||0
1054781|NCT00827099|2561090|P1|COMPLETED|Overall Study||5
1054782|NCT00827099|2561090|P1|STARTED|Overall Study||5
1054783|NCT00827112|2561101|P2|NOT COMPLETED|Overall Study||12
1054784|NCT00827112|2561102|P1|NOT COMPLETED|Overall Study||15
1054785|NCT00827112|2561101|P2|COMPLETED|Overall Study||52
1054786|NCT00827112|2561102|P1|COMPLETED|Overall Study||50
1054787|NCT00827112|2561101|P2|Treated|Overall Study||61
1054788|NCT00827112|2561102|P1|Treated|Overall Study||60
1054789|NCT00827112|2561101|P2|STARTED|Overall Study||64
1054790|NCT00827112|2561102|P1|STARTED|Overall Study||65
1054791|NCT00827242|2561137|P2|NOT COMPLETED|Overall Study||12
1054792|NCT00827242|2561138|P1|NOT COMPLETED|Overall Study||13
1054793|NCT00827242|2561137|P2|COMPLETED|Overall Study||152
1054794|NCT00827242|2561138|P1|COMPLETED|Overall Study||148
1054795|NCT00827242|2561137|P2|STARTED|Overall Study||164
1054796|NCT00827242|2561138|P1|STARTED|Overall Study||161
1054797|NCT00827255|2561174|P1|NOT COMPLETED|Overall Study||0
1054798|NCT00827255|2561174|P1|COMPLETED|Overall Study||35
1054799|NCT00827255|2561174|P1|STARTED|Overall Study||35
1054800|NCT00827372|2561179|P1|NOT COMPLETED|Overall Study||8
1054801|NCT00827372|2561179|P1|COMPLETED|Overall Study||2
1054802|NCT00827372|2561179|P1|STARTED|Overall Study||10
1054803|NCT00827502|2561187|P1|NOT COMPLETED|Overall Study||21
1054804|NCT00827502|2561187|P1|COMPLETED|Overall Study||400
1054805|NCT00827502|2561187|P1|Received Treatment (Number Treated)|Overall Study||410
1054806|NCT00827502|2561187|P1|STARTED|Overall Study||421
1054807|NCT00827541|2561195|P2|NOT COMPLETED|Overall Study||11
1054808|NCT00827541|2561196|P1|NOT COMPLETED|Overall Study||4
1054809|NCT00827541|2561195|P2|COMPLETED|Overall Study||85
1054810|NCT00827541|2561196|P1|COMPLETED|Overall Study||15
1054811|NCT00827541|2561195|P2|STARTED|Overall Study||96
1054812|NCT00827541|2561196|P1|STARTED|Overall Study||19
1054813|NCT00827567|2561208|P1|NOT COMPLETED|Overall Study||4
1054814|NCT00827567|2561208|P1|COMPLETED|Overall Study|2 screen failures, 4 withdrew from study to go on to other therapies|0
1054815|NCT00827567|2561208|P1|STARTED|Overall Study||4
1054816|NCT00827606|2561214|P2|NOT COMPLETED|Overall Study||38
1054817|NCT00827606|2561215|P1|NOT COMPLETED|Overall Study||27
1054818|NCT00827606|2561214|P2|COMPLETED|Overall Study||94
1054819|NCT00827606|2561215|P1|COMPLETED|Overall Study||112
1054820|NCT00827606|2561214|P2|STARTED|Overall Study||132
1054821|NCT00827606|2561215|P1|STARTED|Overall Study||139
1054822|NCT00827632|2561278|P2|NOT COMPLETED|Overall Study||23
1054823|NCT00827632|2561279|P1|NOT COMPLETED|Overall Study||22
1054824|NCT00827632|2561278|P2|COMPLETED|Overall Study||75
1054825|NCT00827632|2561279|P1|COMPLETED|Overall Study||106
1054826|NCT00827632|2561278|P2|STARTED|Overall Study||98
1054827|NCT00827632|2561279|P1|STARTED|Overall Study||128
1054828|NCT00827827|2561287|P2|NOT COMPLETED|Overall Study||0
1054829|NCT00827827|2561288|P1|NOT COMPLETED|Overall Study||8
1054830|NCT00827827|2561287|P2|COMPLETED|Overall Study||16
1054831|NCT00827827|2561288|P1|COMPLETED|Overall Study||14
1054832|NCT00827827|2561287|P2|STARTED|Overall Study||16
1054833|NCT00827827|2561288|P1|STARTED|Overall Study||22
1054834|NCT00827918|2561333|P3|NOT COMPLETED|Overall Study||21
1054835|NCT00827918|2561334|P2|NOT COMPLETED|Overall Study||9
1054836|NCT00827918|2561335|P1|NOT COMPLETED|Overall Study||28
1054837|NCT00827918|2561333|P3|COMPLETED|Overall Study||62
1054838|NCT00827918|2561334|P2|COMPLETED|Overall Study||38
1054839|NCT00827918|2561335|P1|COMPLETED|Overall Study||58
1054840|NCT00827918|2561333|P3|STARTED|Overall Study||83
1054841|NCT00827918|2561334|P2|STARTED|Overall Study||47
1054842|NCT00827918|2561335|P1|STARTED|Overall Study||86
1054843|NCT00827931|2561363|P2|NOT COMPLETED|Overall Study||6
1054844|NCT00827931|2561364|P1|NOT COMPLETED|Overall Study||6
1054845|NCT00827931|2561363|P2|COMPLETED|Overall Study||39
1054846|NCT00827931|2561364|P1|COMPLETED|Overall Study||43
1054847|NCT00827931|2561363|P2|STARTED|Overall Study||45
1054848|NCT00827931|2561364|P1|STARTED|Overall Study||49
1054849|NCT00827944|2561384|P2|NOT COMPLETED|Overall Study||59
1054850|NCT00827944|2561385|P1|NOT COMPLETED|Overall Study||63
1054851|NCT00827944|2561384|P2|COMPLETED|Overall Study||240
1054852|NCT00827944|2561385|P1|COMPLETED|Overall Study||241
1054853|NCT00827944|2561384|P2|STARTED|Overall Study||299
1054854|NCT00827944|2561385|P1|STARTED|Overall Study||304
1054855|NCT00827983|2561405|P2|NOT COMPLETED|Overall Study||16
1054856|NCT00827983|2561406|P1|NOT COMPLETED|Overall Study||18
1054857|NCT00827983|2561405|P2|COMPLETED|Overall Study|patients who performed the pregnancy test|328
1054858|NCT00827983|2561406|P1|COMPLETED|Overall Study|patients who performed the pregnancy test|321
1054859|NCT00827983|2561405|P2|STARTED|Overall Study|all randomised patients|344
1054860|NCT00827983|2561406|P1|STARTED|Overall Study|All randomised patients|339
1054861|NCT00828061|2561416|P6|NOT COMPLETED|Period 3||0
1054862|NCT00828061|2561417|P5|NOT COMPLETED|Period 3||0
1054863|NCT00828061|2561418|P4|NOT COMPLETED|Period 3||0
1054864|NCT00828061|2561419|P3|NOT COMPLETED|Period 3||0
1054865|NCT00828061|2561420|P2|NOT COMPLETED|Period 3||0
1054866|NCT00828061|2561421|P1|NOT COMPLETED|Period 3||0
1054867|NCT00828061|2561416|P6|COMPLETED|Period 3||3
1054868|NCT00828061|2561417|P5|COMPLETED|Period 3||3
1054869|NCT00828061|2561418|P4|COMPLETED|Period 3||3
1054870|NCT00828061|2561419|P3|COMPLETED|Period 3||3
1054871|NCT00828061|2561420|P2|COMPLETED|Period 3||3
1054872|NCT00828061|2561421|P1|COMPLETED|Period 3||4
1054873|NCT00828061|2561416|P6|STARTED|Period 3||3
1054874|NCT00828061|2561417|P5|STARTED|Period 3||3
1054875|NCT00828061|2561418|P4|STARTED|Period 3||3
1054876|NCT00828061|2561419|P3|STARTED|Period 3||3
1054877|NCT00828061|2561420|P2|STARTED|Period 3||3
1054878|NCT00828061|2561421|P1|STARTED|Period 3||4
1054879|NCT00828061|2561416|P6|NOT COMPLETED|Period 2||0
1054880|NCT00828061|2561417|P5|NOT COMPLETED|Period 2||0
1054881|NCT00828061|2561418|P4|NOT COMPLETED|Period 2||0
1054882|NCT00828061|2561419|P3|NOT COMPLETED|Period 2||0
1054883|NCT00828061|2561420|P2|NOT COMPLETED|Period 2||0
1054884|NCT00828061|2561421|P1|NOT COMPLETED|Period 2||0
1054885|NCT00828061|2561416|P6|COMPLETED|Period 2||3
1054886|NCT00828061|2561417|P5|COMPLETED|Period 2||3
1054887|NCT00828061|2561418|P4|COMPLETED|Period 2||3
1054888|NCT00828061|2561419|P3|COMPLETED|Period 2||3
1054889|NCT00828061|2561420|P2|COMPLETED|Period 2||3
1054890|NCT00828061|2561421|P1|COMPLETED|Period 2||4
1054891|NCT00828061|2561416|P6|STARTED|Period 2||3
1054892|NCT00828061|2561417|P5|STARTED|Period 2||3
1054893|NCT00828061|2561418|P4|STARTED|Period 2||3
1054894|NCT00828061|2561419|P3|STARTED|Period 2||3
1054895|NCT00828061|2561420|P2|STARTED|Period 2||3
1054896|NCT00828061|2561421|P1|STARTED|Period 2||4
1054897|NCT00828061|2561416|P6|NOT COMPLETED|Period 1||0
1054898|NCT00828061|2561417|P5|NOT COMPLETED|Period 1||0
1054899|NCT00828061|2561418|P4|NOT COMPLETED|Period 1||0
1054900|NCT00828061|2561419|P3|NOT COMPLETED|Period 1||0
1054901|NCT00828061|2561420|P2|NOT COMPLETED|Period 1||0
1054902|NCT00828061|2561421|P1|NOT COMPLETED|Period 1||0
1054903|NCT00828061|2561416|P6|COMPLETED|Period 1||3
1054904|NCT00828061|2561417|P5|COMPLETED|Period 1||3
1054905|NCT00828061|2561418|P4|COMPLETED|Period 1||3
1054906|NCT00828061|2561419|P3|COMPLETED|Period 1||3
1054907|NCT00828061|2561420|P2|COMPLETED|Period 1||3
1054908|NCT00828061|2561421|P1|COMPLETED|Period 1||4
1054909|NCT00828061|2561416|P6|STARTED|Period 1||3
1054910|NCT00828061|2561417|P5|STARTED|Period 1||3
1054911|NCT00828061|2561418|P4|STARTED|Period 1||3
1054912|NCT00828061|2561419|P3|STARTED|Period 1||3
1054913|NCT00828061|2561420|P2|STARTED|Period 1||3
1054914|NCT00828061|2561421|P1|STARTED|Period 1||4
1054915|NCT00828074|2561434|P3|NOT COMPLETED|Overall Study||0
1054916|NCT00828074|2561435|P2|NOT COMPLETED|Overall Study||0
1054917|NCT00828074|2561436|P1|NOT COMPLETED|Overall Study||0
1054918|NCT00828074|2561434|P3|COMPLETED|Overall Study||35
1054919|NCT00828074|2561435|P2|COMPLETED|Overall Study||5
1054920|NCT00828074|2561436|P1|COMPLETED|Overall Study||6
1054921|NCT00828074|2561434|P3|STARTED|Overall Study||35
1054922|NCT00828074|2561435|P2|STARTED|Overall Study||5
1054923|NCT00828074|2561436|P1|STARTED|Overall Study||6
1054924|NCT00828113|2561450|P2|NOT COMPLETED|Overall Study||31
1054925|NCT00828113|2561451|P1|NOT COMPLETED|Overall Study||30
1054926|NCT00828113|2561450|P2|COMPLETED|Overall Study||20
1054927|NCT00828113|2561451|P1|COMPLETED|Overall Study||20
1054928|NCT00828113|2561450|P2|STARTED|Overall Study||51
1054929|NCT00828113|2561451|P1|STARTED|Overall Study||50
1054930|NCT00828139|2561461|P4|NOT COMPLETED|Overall Study||51
1054931|NCT00828139|2561462|P3|NOT COMPLETED|Overall Study||55
1054932|NCT00828139|2561463|P2|NOT COMPLETED|Overall Study||41
1054933|NCT00828139|2561464|P1|NOT COMPLETED|Overall Study||41
1054934|NCT00828139|2561461|P4|COMPLETED|Overall Study||0
1054935|NCT00828139|2561462|P3|COMPLETED|Overall Study||0
1054936|NCT00828139|2561463|P2|COMPLETED|Overall Study||0
1054937|NCT00828139|2561464|P1|COMPLETED|Overall Study||1
1054938|NCT00828139|2561461|P4|STARTED|Overall Study||51
1054939|NCT00828139|2561462|P3|STARTED|Overall Study||55
1054940|NCT00828139|2561463|P2|STARTED|Overall Study||41
1054941|NCT00828139|2561464|P1|STARTED|Overall Study||42
1054942|NCT00828178|2561484|P2|NOT COMPLETED|Overall Study||2
1054943|NCT00828178|2561485|P1|NOT COMPLETED|Overall Study||0
1054944|NCT00828178|2561484|P2|COMPLETED|Overall Study|Two patients did not complete the study.|43
1054945|NCT00828178|2561485|P1|COMPLETED|Overall Study||42
1054946|NCT00828178|2561484|P2|STARTED|Overall Study|Eighty seven participants were randomized.|45
1054947|NCT00828178|2561485|P1|STARTED|Overall Study||42
1054948|NCT00828191|2561497|P2|NOT COMPLETED|Overall Study||10
1054949|NCT00828191|2561498|P1|NOT COMPLETED|Overall Study||8
1054950|NCT00828191|2561497|P2|COMPLETED|Overall Study|Patients with at least one embryo transferred.|390
1054951|NCT00828191|2561498|P1|COMPLETED|Overall Study|Patients with at least one embryo transferred.|392
1054952|NCT00828191|2561497|P2|STARTED|Overall Study|Randomized patients|400
1054953|NCT00828191|2561498|P1|STARTED|Overall Study|Randomized patients|400
1054954|NCT00828204|2561510|P2|NOT COMPLETED|Extension Study||3
1054955|NCT00828204|2561511|P1|NOT COMPLETED|Extension Study||0
1054956|NCT00828204|2561510|P2|COMPLETED|Extension Study||61
1054957|NCT00828204|2561511|P1|COMPLETED|Extension Study||0
1054958|NCT00828204|2561510|P2|STARTED|Extension Study|Participation in Extension Study was optional for Main Subset participants completing Main Study.|64
1054959|NCT00828204|2561511|P1|STARTED|Extension Study|Participation in the Extension Study was not offered to Initial Subset after completing Main Study.|0
1054960|NCT00828204|2561510|P2|NOT COMPLETED|Main Study: After Study Restart||3
1054961|NCT00828204|2561511|P1|NOT COMPLETED|Main Study: After Study Restart||0
1054962|NCT00828204|2561510|P2|COMPLETED|Main Study: After Study Restart||71
1054963|NCT00828204|2561511|P1|COMPLETED|Main Study: After Study Restart||0
1055047|NCT00828568|2561611|P2|COMPLETED|Randomized||179
1054964|NCT00828204|2561510|P2|Continued With Autoinjector Injections|Main Study: After Study Restart||72
1054965|NCT00828204|2561511|P1|Continued With Autoinjector Injections|Main Study: After Study Restart||0
1054966|NCT00828204|2561510|P2|Completed Manual Injection|Main Study: After Study Restart||74
1054967|NCT00828204|2561511|P1|Completed Manual Injection|Main Study: After Study Restart||0
1054968|NCT00828204|2561510|P2|STARTED|Main Study: After Study Restart|After a protocol amendment, the Main Subset participants were enrolled.|74
1054969|NCT00828204|2561511|P1|STARTED|Main Study: After Study Restart|Initial Subset participants did not continue after the study was suspended.|0
1054970|NCT00828204|2561510|P2|NOT COMPLETED|Main Study: Prior to Study Suspension||0
1054971|NCT00828204|2561511|P1|NOT COMPLETED|Main Study: Prior to Study Suspension||14
1054972|NCT00828204|2561510|P2|COMPLETED|Main Study: Prior to Study Suspension||0
1054973|NCT00828204|2561511|P1|COMPLETED|Main Study: Prior to Study Suspension||7
1054974|NCT00828204|2561510|P2|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||0
1054975|NCT00828204|2561511|P1|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||19
1054976|NCT00828204|2561510|P2|Completed Manual Injection|Main Study: Prior to Study Suspension||0
1054977|NCT00828204|2561511|P1|Completed Manual Injection|Main Study: Prior to Study Suspension||21
1054978|NCT00828204|2561510|P2|STARTED|Main Study: Prior to Study Suspension|Main Subset was not enrolled until after study suspension (period 2, below).|0
1054979|NCT00828204|2561511|P1|STARTED|Main Study: Prior to Study Suspension||21
1054980|NCT00828295|2561530|P2|NOT COMPLETED|Overall Study||0
1054981|NCT00828295|2561531|P1|NOT COMPLETED|Overall Study||0
1054982|NCT00828295|2561530|P2|COMPLETED|Overall Study||75
1054983|NCT00828295|2561531|P1|COMPLETED|Overall Study||75
1054984|NCT00828295|2561530|P2|STARTED|Overall Study||75
1054985|NCT00828295|2561531|P1|STARTED|Overall Study||75
1054986|NCT00828308|2561539|P1|NOT COMPLETED|Overall Study||0
1054987|NCT00828308|2561539|P1|COMPLETED|Overall Study||16
1054988|NCT00828308|2561539|P1|STARTED|Overall Study||16
1054989|NCT00828321|2561545|P2|NOT COMPLETED|Second Intervention||1
1054990|NCT00828321|2561546|P1|NOT COMPLETED|Second Intervention||0
1054991|NCT00828321|2561545|P2|COMPLETED|Second Intervention||19
1054992|NCT00828321|2561546|P1|COMPLETED|Second Intervention||18
1054993|NCT00828321|2561545|P2|STARTED|Second Intervention||20
1054994|NCT00828321|2561546|P1|STARTED|Second Intervention||18
1054995|NCT00828321|2561545|P2|NOT COMPLETED|Washout of 42 Days||0
1054996|NCT00828321|2561546|P1|NOT COMPLETED|Washout of 42 Days||2
1054997|NCT00828321|2561545|P2|COMPLETED|Washout of 42 Days||20
1054998|NCT00828321|2561546|P1|COMPLETED|Washout of 42 Days||18
1054999|NCT00828321|2561545|P2|STARTED|Washout of 42 Days||20
1055000|NCT00828321|2561546|P1|STARTED|Washout of 42 Days||20
1055001|NCT00828321|2561545|P2|NOT COMPLETED|First Intervention||0
1055002|NCT00828321|2561546|P1|NOT COMPLETED|First Intervention||0
1055003|NCT00828321|2561545|P2|COMPLETED|First Intervention||20
1055004|NCT00828321|2561546|P1|COMPLETED|First Intervention||20
1055005|NCT00828321|2561545|P2|STARTED|First Intervention||20
1055006|NCT00828321|2561546|P1|STARTED|First Intervention||20
1055007|NCT00828347|2561560|P2|NOT COMPLETED|Overall Study||0
1055008|NCT00828347|2561561|P1|NOT COMPLETED|Overall Study||0
1055009|NCT00828347|2561560|P2|COMPLETED|Overall Study||11
1055010|NCT00828347|2561561|P1|COMPLETED|Overall Study||12
1055011|NCT00828347|2561560|P2|STARTED|Overall Study||11
1055012|NCT00828347|2561561|P1|STARTED|Overall Study||12
1055013|NCT00828412|2561569|P2|NOT COMPLETED|Overall Study||2
1055014|NCT00828412|2561570|P1|NOT COMPLETED|Overall Study||9
1055015|NCT00828412|2561569|P2|COMPLETED|Overall Study||48
1055016|NCT00828412|2561570|P1|COMPLETED|Overall Study||41
1055017|NCT00828412|2561569|P2|STARTED|Overall Study||50
1055018|NCT00828412|2561570|P1|STARTED|Overall Study||50
1055019|NCT00828464|2561576|P1|NOT COMPLETED|Overall Study||1
1055020|NCT00828464|2561576|P1|COMPLETED|Overall Study||29
1055021|NCT00828464|2561576|P1|STARTED|Overall Study||30
1055022|NCT00828516|2561593|P1|NOT COMPLETED|Clinical Phase: Series 2||0
1055023|NCT00828516|2561593|P1|COMPLETED|Clinical Phase: Series 2||30
1055024|NCT00828516|2561593|P1|STARTED|Clinical Phase: Series 2||30
1055025|NCT00828516|2561593|P1|NOT COMPLETED|Clinical Phase: Series 1||2
1055026|NCT00828516|2561593|P1|COMPLETED|Clinical Phase: Series 1||33
1055027|NCT00828516|2561593|P1|STARTED|Clinical Phase: Series 1||35
1055028|NCT00828542|2561600|P2|NOT COMPLETED|Overall Study||3
1055029|NCT00828542|2561601|P1|NOT COMPLETED|Overall Study||3
1055030|NCT00828542|2561600|P2|COMPLETED|Overall Study||20
1055031|NCT00828542|2561601|P1|COMPLETED|Overall Study||20
1055032|NCT00828542|2561600|P2|STARTED|Overall Study||23
1055033|NCT00828542|2561601|P1|STARTED|Overall Study||23
1055034|NCT00828568|2561610|P3|NOT COMPLETED|Treated - Received at Least One Dose||5
1055035|NCT00828568|2561611|P2|NOT COMPLETED|Treated - Received at Least One Dose||29
1055036|NCT00828568|2561612|P1|NOT COMPLETED|Treated - Received at Least One Dose||30
1055037|NCT00828568|2561610|P3|COMPLETED|Treated - Received at Least One Dose||55
1055038|NCT00828568|2561611|P2|COMPLETED|Treated - Received at Least One Dose||150
1055039|NCT00828568|2561612|P1|COMPLETED|Treated - Received at Least One Dose||153
1055040|NCT00828568|2561610|P3|STARTED|Treated - Received at Least One Dose||60
1055041|NCT00828568|2561611|P2|STARTED|Treated - Received at Least One Dose||179
1055042|NCT00828568|2561612|P1|STARTED|Treated - Received at Least One Dose||183
1055043|NCT00828568|2561610|P3|NOT COMPLETED|Randomized||2
1055044|NCT00828568|2561611|P2|NOT COMPLETED|Randomized||0
1055045|NCT00828568|2561612|P1|NOT COMPLETED|Randomized||1
1055046|NCT00828568|2561610|P3|COMPLETED|Randomized||60
1055048|NCT00828568|2561612|P1|COMPLETED|Randomized||183
1055049|NCT00828568|2561610|P3|STARTED|Randomized||62
1055050|NCT00828568|2561611|P2|STARTED|Randomized||179
1055051|NCT00828568|2561612|P1|STARTED|Randomized||184
1055052|NCT00821327|2561625|P1|NOT COMPLETED|Overall Study||35
1055053|NCT00821327|2561625|P1|COMPLETED|Overall Study||1
1055054|NCT00821327|2561625|P1|STARTED|Overall Study||36
1055055|NCT00821431|2561633|P2|NOT COMPLETED|Overall Study||5
1055056|NCT00821431|2561634|P1|NOT COMPLETED|Overall Study||15
1055057|NCT00821431|2561633|P2|COMPLETED|Overall Study||47
1055058|NCT00821431|2561634|P1|COMPLETED|Overall Study||23
1055059|NCT00821431|2561633|P2|STARTED|Overall Study||52
1055060|NCT00821431|2561634|P1|STARTED|Overall Study||38
1055061|NCT00821509|2561645|P3|NOT COMPLETED|Overall Study||34
1055062|NCT00821509|2561646|P2|NOT COMPLETED|Overall Study||11
1055063|NCT00821509|2561647|P1|NOT COMPLETED|Overall Study||12
1055064|NCT00821509|2561645|P3|COMPLETED|Overall Study|This is a result of 50 lost-to-follow-up and 16 new recruits|190
1055065|NCT00821509|2561646|P2|COMPLETED|Overall Study|This is a result of 57 lost-to-follow-up and 46 new recruits|191
1055066|NCT00821509|2561647|P1|COMPLETED|Overall Study|This is a result of 56 lost-to-follow-up and 44 new recruits|245
1055067|NCT00821509|2561645|P3|STARTED|Overall Study||224
1055068|NCT00821509|2561646|P2|STARTED|Overall Study||202
1055069|NCT00821509|2561647|P1|STARTED|Overall Study||257
1055070|NCT00821587|2561660|P2|NOT COMPLETED|Overall Study||1
1055071|NCT00821587|2561661|P1|NOT COMPLETED|Overall Study||0
1055072|NCT00821587|2561660|P2|COMPLETED|Overall Study||18
1055073|NCT00821587|2561661|P1|COMPLETED|Overall Study||20
1055074|NCT00821587|2561660|P2|STARTED|Overall Study||19
1055075|NCT00821587|2561661|P1|STARTED|Overall Study||20
1055076|NCT00821678|2561669|P2|NOT COMPLETED|Overall Study||14
1055077|NCT00821678|2561670|P1|NOT COMPLETED|Overall Study||21
1055078|NCT00821678|2561669|P2|COMPLETED|Overall Study||118
1055079|NCT00821678|2561670|P1|COMPLETED|Overall Study||112
1055080|NCT00821678|2561669|P2|STARTED|Overall Study||132
1055081|NCT00821678|2561670|P1|STARTED|Overall Study||133
1055082|NCT00821821|2561689|P3|NOT COMPLETED|Overall Study||0
1055083|NCT00821821|2561690|P2|NOT COMPLETED|Overall Study||0
1055084|NCT00821821|2561691|P1|NOT COMPLETED|Overall Study||0
1055085|NCT00821821|2561689|P3|COMPLETED|Overall Study||11
1055086|NCT00821821|2561690|P2|COMPLETED|Overall Study||13
1055087|NCT00821821|2561691|P1|COMPLETED|Overall Study||12
1055088|NCT00821821|2561689|P3|STARTED|Overall Study||11
1055089|NCT00821821|2561690|P2|STARTED|Overall Study||13
1055090|NCT00821821|2561691|P1|STARTED|Overall Study||12
1055091|NCT00821873|2561701|P1|NOT COMPLETED|Overall Study||4
1055092|NCT00821873|2561701|P1|COMPLETED|Overall Study||5
1055093|NCT00821873|2561701|P1|STARTED|Overall Study||9
1055094|NCT00821886|2561705|P1|NOT COMPLETED|Overall Study||9
1055095|NCT00821886|2561705|P1|COMPLETED|Overall Study||49
1055096|NCT00821886|2561705|P1|STARTED|Overall Study|Two patients were enrolled, but subsequently found to be ineligible|58
1055097|NCT00821951|2561712|P1|NOT COMPLETED|Overall Study||5
1055098|NCT00821951|2561712|P1|COMPLETED|Overall Study||12
1055099|NCT00821951|2561712|P1|STARTED|Overall Study||17
1055100|NCT00821964|2561716|P1|NOT COMPLETED|Overall Study||6
1055101|NCT00821964|2561716|P1|COMPLETED|Overall Study||9
1055102|NCT00821964|2561716|P1|Evaluable for Pathologic Response|Overall Study||7
1055103|NCT00821964|2561716|P1|Evaluable for Clinical Response|Overall Study||14
1055104|NCT00821964|2561716|P1|STARTED|Overall Study||15
1055105|NCT00828711|2561725|P3|NOT COMPLETED|Overall Study||0
1055106|NCT00828711|2561726|P2|NOT COMPLETED|Overall Study||0
1055107|NCT00828711|2561727|P1|NOT COMPLETED|Overall Study||1
1055108|NCT00828711|2561725|P3|COMPLETED|Overall Study||131
1055109|NCT00828711|2561726|P2|COMPLETED|Overall Study||125
1055110|NCT00828711|2561727|P1|COMPLETED|Overall Study||117
1055111|NCT00828711|2561725|P3|STARTED|Overall Study||131
1055112|NCT00828711|2561726|P2|STARTED|Overall Study||125
1055113|NCT00828711|2561727|P1|STARTED|Overall Study||118
1055114|NCT00828750|2561756|P1|NOT COMPLETED|Overall Study||4
1055115|NCT00828750|2561756|P1|COMPLETED|Overall Study||15
1055116|NCT00828750|2561756|P1|STARTED|Overall Study||19
1055117|NCT00828841|2561770|P3|NOT COMPLETED|Overall Study||4
1055118|NCT00828841|2561771|P2|NOT COMPLETED|Overall Study||4
1055119|NCT00828841|2561772|P1|NOT COMPLETED|Overall Study||4
1055120|NCT00828841|2561770|P3|COMPLETED|Overall Study||126
1055121|NCT00828841|2561771|P2|COMPLETED|Overall Study||232
1055122|NCT00828841|2561772|P1|COMPLETED|Overall Study||231
1055123|NCT00828841|2561770|P3|STARTED|Overall Study||130
1055124|NCT00828841|2561771|P2|STARTED|Overall Study||236
1055125|NCT00828841|2561772|P1|STARTED|Overall Study||235
1055126|NCT00833755|2561789|P4|NOT COMPLETED|Overall Study||6
1055127|NCT00833755|2561790|P3|NOT COMPLETED|Overall Study||2
1055128|NCT00833755|2561791|P2|NOT COMPLETED|Overall Study||5
1055129|NCT00833755|2561792|P1|NOT COMPLETED|Overall Study||4
1055130|NCT00833755|2561789|P4|COMPLETED|Overall Study||17
1055131|NCT00833755|2561790|P3|COMPLETED|Overall Study||20
1055132|NCT00833755|2561791|P2|COMPLETED|Overall Study||13
1055133|NCT00833755|2561792|P1|COMPLETED|Overall Study||12
1055134|NCT00833755|2561789|P4|STARTED|Overall Study||23
1055135|NCT00833755|2561790|P3|STARTED|Overall Study||22
1055136|NCT00833755|2561791|P2|STARTED|Overall Study||18
1055137|NCT00833755|2561792|P1|STARTED|Overall Study||16
1055138|NCT00833781|2561812|P2|NOT COMPLETED|Overall Study||0
1055139|NCT00833781|2561813|P1|NOT COMPLETED|Overall Study||0
1055140|NCT00833781|2561812|P2|COMPLETED|Overall Study||5
1055141|NCT00833781|2561813|P1|COMPLETED|Overall Study||10
1055142|NCT00833781|2561812|P2|STARTED|Overall Study||5
1055143|NCT00833781|2561813|P1|STARTED|Overall Study||10
1055144|NCT00833794|2561826|P2|NOT COMPLETED|Double-blind Phase||49
1055145|NCT00833794|2561827|P1|NOT COMPLETED|Double-blind Phase||106
1055146|NCT00833794|2561826|P2|COMPLETED|Double-blind Phase||165
1055147|NCT00833794|2561827|P1|COMPLETED|Double-blind Phase||326
1055148|NCT00833794|2561826|P2|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 214 were randomized to Placebo|214
1055149|NCT00833794|2561827|P1|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 432 were randomized to Tramadol Once A Day|432
1055150|NCT00833794|2561826|P2|NOT COMPLETED|Open-label Phase||0
1055151|NCT00833794|2561827|P1|NOT COMPLETED|Open-label Phase||382
1055152|NCT00833794|2561826|P2|COMPLETED|Open-label Phase||0
1055153|NCT00833794|2561827|P1|COMPLETED|Open-label Phase|Randomized in double-blind phase|646
1055154|NCT00833794|2561826|P2|Received Open-Label Treatment|Open-label Phase||0
1055155|NCT00833794|2561827|P1|Received Open-Label Treatment|Open-label Phase||1023
1055156|NCT00833794|2561826|P2|Entered run-in Period|Open-label Phase||0
1055157|NCT00833794|2561827|P1|Entered run-in Period|Open-label Phase||1027
1055158|NCT00833794|2561826|P2|STARTED|Open-label Phase|No Placebo arm during open-label phase.|0
1055159|NCT00833794|2561827|P1|STARTED|Open-label Phase|Enrolled. Population described in the baseline characteristics is 1023 patients (Open-Label safety).|1028
1055160|NCT00833833|2561859|P6|NOT COMPLETED|Phase 2 (as of 01 April 2011)||61
1055161|NCT00833833|2561860|P5|NOT COMPLETED|Phase 2 (as of 01 April 2011)||55
1055162|NCT00833833|2561861|P4|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
1055163|NCT00833833|2561862|P3|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
1055164|NCT00833833|2561863|P2|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
1055165|NCT00833833|2561864|P1|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
1055166|NCT00833833|2561859|P6|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|47
1055167|NCT00833833|2561860|P5|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|58
1055168|NCT00833833|2561861|P4|COMPLETED|Phase 2 (as of 01 April 2011)||0
1055169|NCT00833833|2561862|P3|COMPLETED|Phase 2 (as of 01 April 2011)||0
1055170|NCT00833833|2561863|P2|COMPLETED|Phase 2 (as of 01 April 2011)||0
1055171|NCT00833833|2561864|P1|COMPLETED|Phase 2 (as of 01 April 2011)||0
1055172|NCT00833833|2561859|P6|Safety Population|Phase 2 (as of 01 April 2011)||107
1055173|NCT00833833|2561860|P5|Safety Population|Phase 2 (as of 01 April 2011)||112
1055174|NCT00833833|2561861|P4|Safety Population|Phase 2 (as of 01 April 2011)||0
1055175|NCT00833833|2561862|P3|Safety Population|Phase 2 (as of 01 April 2011)||0
1055176|NCT00833833|2561863|P2|Safety Population|Phase 2 (as of 01 April 2011)||0
1055177|NCT00833833|2561864|P1|Safety Population|Phase 2 (as of 01 April 2011)||0
1055178|NCT00833833|2561859|P6|STARTED|Phase 2 (as of 01 April 2011)||108
1055179|NCT00833833|2561860|P5|STARTED|Phase 2 (as of 01 April 2011)||113
1055180|NCT00833833|2561861|P4|STARTED|Phase 2 (as of 01 April 2011)||0
1055181|NCT00833833|2561862|P3|STARTED|Phase 2 (as of 01 April 2011)||0
1055182|NCT00833833|2561863|P2|STARTED|Phase 2 (as of 01 April 2011)||0
1055183|NCT00833833|2561864|P1|STARTED|Phase 2 (as of 01 April 2011)||0
1055184|NCT00833833|2561859|P6|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
1055185|NCT00833833|2561860|P5|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
1055186|NCT00833833|2561861|P4|NOT COMPLETED|Phase 1 (as of 01 April 2011)||6
1055187|NCT00833833|2561862|P3|NOT COMPLETED|Phase 1 (as of 01 April 2011)||9
1055188|NCT00833833|2561863|P2|NOT COMPLETED|Phase 1 (as of 01 April 2011)||5
1055189|NCT00833833|2561864|P1|NOT COMPLETED|Phase 1 (as of 01 April 2011)||4
1055190|NCT00833833|2561859|P6|COMPLETED|Phase 1 (as of 01 April 2011)||0
1055191|NCT00833833|2561860|P5|COMPLETED|Phase 1 (as of 01 April 2011)||0
1055192|NCT00833833|2561861|P4|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|4
1055193|NCT00833833|2561862|P3|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|5
1055194|NCT00833833|2561863|P2|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|3
1055195|NCT00833833|2561864|P1|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|2
1055196|NCT00833833|2561859|P6|STARTED|Phase 1 (as of 01 April 2011)||0
1055197|NCT00833833|2561860|P5|STARTED|Phase 1 (as of 01 April 2011)||0
1055198|NCT00833833|2561861|P4|STARTED|Phase 1 (as of 01 April 2011)||10
1055199|NCT00833833|2561862|P3|STARTED|Phase 1 (as of 01 April 2011)||14
1055200|NCT00833833|2561863|P2|STARTED|Phase 1 (as of 01 April 2011)||8
1055201|NCT00833833|2561864|P1|STARTED|Phase 1 (as of 01 April 2011)||6
1055205|NCT00833898|2561911|P2|NOT COMPLETED|Overall Study||36
1055206|NCT00833898|2561912|P1|NOT COMPLETED|Overall Study||40
1055207|NCT00833898|2561911|P2|COMPLETED|Overall Study||38
1055208|NCT00833898|2561912|P1|COMPLETED|Overall Study||34
1055209|NCT00833898|2561911|P2|Month 12 (Post Transplantation)|Overall Study||50
1055210|NCT00833898|2561912|P1|Month 12 (Post Transplantation)|Overall Study||50
1055211|NCT00833898|2561911|P2|Month 6 (Post Transplantation)|Overall Study||54
1055212|NCT00833898|2561912|P1|Month 6 (Post Transplantation)|Overall Study||59
1055213|NCT00833898|2561911|P2|Month 3 (Post Transplantation)|Overall Study||64
1055214|NCT00833898|2561912|P1|Month 3 (Post Transplantation)|Overall Study||66
1055215|NCT00833898|2561911|P2|Month 1 (Post Transplantation)|Overall Study||74
1055216|NCT00833898|2561912|P1|Month 1 (Post Transplantation)|Overall Study||72
1055217|NCT00833898|2561911|P2|STARTED|Overall Study||74
1055218|NCT00833898|2561912|P1|STARTED|Overall Study||74
1055219|NCT00833911|2561958|P1|NOT COMPLETED|Maintenance Phase II||10
1055220|NCT00833911|2561958|P1|COMPLETED|Maintenance Phase II||166
1055221|NCT00833911|2561958|P1|STARTED|Maintenance Phase II|97 patients chose not to continue into Maintenance Phase II|176
1055222|NCT00833911|2561958|P1|NOT COMPLETED|Maintenance Phase I||98
1055223|NCT00833911|2561958|P1|COMPLETED|Maintenance Phase I||273
1055224|NCT00833911|2561958|P1|STARTED|Maintenance Phase I||371
1055225|NCT00833911|2561958|P1|NOT COMPLETED|Titration||21
1055226|NCT00833911|2561958|P1|COMPLETED|Titration||371
1055227|NCT00833911|2561958|P1|STARTED|Titration||392
1055228|NCT00833924|2561966|P1|NOT COMPLETED|Overall Study||109
1055229|NCT00833924|2561966|P1|COMPLETED|Overall Study||11
1055230|NCT00833924|2561966|P1|12-month|Overall Study||113
1055231|NCT00833924|2561966|P1|30-day|Overall Study||120
1055232|NCT00833924|2561966|P1|STARTED|Overall Study||120
1055233|NCT00833937|2561973|P2|NOT COMPLETED|Second Intervention||0
1055234|NCT00833937|2561974|P1|NOT COMPLETED|Second Intervention||0
1055235|NCT00833937|2561973|P2|COMPLETED|Second Intervention||12
1055236|NCT00833937|2561974|P1|COMPLETED|Second Intervention||11
1055237|NCT00833937|2561973|P2|STARTED|Second Intervention||12
1055238|NCT00833937|2561974|P1|STARTED|Second Intervention||11
1055239|NCT00833937|2561973|P2|NOT COMPLETED|Washout||0
1055240|NCT00833937|2561974|P1|NOT COMPLETED|Washout||1
1055241|NCT00833937|2561973|P2|COMPLETED|Washout||12
1055242|NCT00833937|2561974|P1|COMPLETED|Washout||11
1055243|NCT00833937|2561973|P2|STARTED|Washout||12
1055244|NCT00833937|2561974|P1|STARTED|Washout||12
1055245|NCT00833937|2561973|P2|NOT COMPLETED|First Intervention||0
1055246|NCT00833937|2561974|P1|NOT COMPLETED|First Intervention||0
1055247|NCT00833937|2561973|P2|COMPLETED|First Intervention||12
1055248|NCT00833937|2561974|P1|COMPLETED|First Intervention||12
1055249|NCT00833937|2561973|P2|STARTED|First Intervention||12
1055250|NCT00833937|2561974|P1|STARTED|First Intervention||12
1055251|NCT00833976|2561982|P1|NOT COMPLETED|Overall Study||51
1055252|NCT00833976|2561982|P1|COMPLETED|Overall Study||14
1055253|NCT00833976|2561982|P1|STARTED|Overall Study||65
1055254|NCT00834041|2561990|P2|NOT COMPLETED|Overall Study||1
1055255|NCT00834041|2561991|P1|NOT COMPLETED|Overall Study||1
1055256|NCT00834041|2561990|P2|COMPLETED|Overall Study||19
1055257|NCT00834041|2561991|P1|COMPLETED|Overall Study||18
1055258|NCT00834041|2561990|P2|STARTED|Overall Study||20
1055259|NCT00834041|2561991|P1|STARTED|Overall Study||19
1055260|NCT00834067|2562007|P2|NOT COMPLETED|Second Intervention||0
1055261|NCT00834067|2562008|P1|NOT COMPLETED|Second Intervention||0
1055262|NCT00834067|2562007|P2|COMPLETED|Second Intervention||29
1055263|NCT00834067|2562008|P1|COMPLETED|Second Intervention||30
1055264|NCT00834067|2562007|P2|STARTED|Second Intervention||29
1055265|NCT00834067|2562008|P1|STARTED|Second Intervention||30
1055266|NCT00834067|2562007|P2|NOT COMPLETED|Washout of 21 Days||1
1055267|NCT00834067|2562008|P1|NOT COMPLETED|Washout of 21 Days||0
1055268|NCT00834067|2562007|P2|COMPLETED|Washout of 21 Days||29
1055269|NCT00834067|2562008|P1|COMPLETED|Washout of 21 Days||30
1055270|NCT00834067|2562007|P2|STARTED|Washout of 21 Days||30
1055271|NCT00834067|2562008|P1|STARTED|Washout of 21 Days||30
1055272|NCT00834067|2562007|P2|NOT COMPLETED|First Intervention||0
1055273|NCT00834067|2562008|P1|NOT COMPLETED|First Intervention||0
1055274|NCT00834067|2562007|P2|COMPLETED|First Intervention||30
1055275|NCT00834067|2562008|P1|COMPLETED|First Intervention||30
1055276|NCT00834067|2562007|P2|STARTED|First Intervention||30
1055277|NCT00834067|2562008|P1|STARTED|First Intervention||30
1055278|NCT00834080|2562028|P1|NOT COMPLETED|Overall Study||23
1055279|NCT00834080|2562028|P1|COMPLETED|Overall Study||15
1055280|NCT00834080|2562028|P1|STARTED|Overall Study||38
1055281|NCT00834132|2562034|P2|NOT COMPLETED|Second Intervention||0
1055282|NCT00834132|2562035|P1|NOT COMPLETED|Second Intervention||0
1055283|NCT00834132|2562034|P2|COMPLETED|Second Intervention||12
1055284|NCT00834132|2562035|P1|COMPLETED|Second Intervention||12
1055285|NCT00834132|2562034|P2|STARTED|Second Intervention||12
1055286|NCT00834132|2562035|P1|STARTED|Second Intervention||12
1055287|NCT00834132|2562034|P2|NOT COMPLETED|Washout: 21 Days||0
1055288|NCT00834132|2562035|P1|NOT COMPLETED|Washout: 21 Days||0
1055289|NCT00834132|2562034|P2|COMPLETED|Washout: 21 Days||12
1055290|NCT00834132|2562035|P1|COMPLETED|Washout: 21 Days||12
1055291|NCT00834132|2562034|P2|STARTED|Washout: 21 Days||12
1055292|NCT00834132|2562035|P1|STARTED|Washout: 21 Days||12
1055293|NCT00834132|2562034|P2|NOT COMPLETED|First Intervention||0
1055294|NCT00834132|2562035|P1|NOT COMPLETED|First Intervention||0
1055295|NCT00834132|2562034|P2|COMPLETED|First Intervention||12
1055296|NCT00834132|2562035|P1|COMPLETED|First Intervention||12
1055297|NCT00834132|2562034|P2|STARTED|First Intervention||12
1055298|NCT00834132|2562035|P1|STARTED|First Intervention||12
1055299|NCT00834171|2562045|P2|NOT COMPLETED|Overall Study||0
1055300|NCT00834171|2562046|P1|NOT COMPLETED|Overall Study||0
1055301|NCT00834171|2562045|P2|COMPLETED|Overall Study||7
1055302|NCT00834171|2562046|P1|COMPLETED|Overall Study||43
1055303|NCT00834171|2562045|P2|STARTED|Overall Study||7
1055304|NCT00834171|2562046|P1|STARTED|Overall Study||43
1055305|NCT00834197|2562054|P2|NOT COMPLETED|Second Intervention||0
1055306|NCT00834197|2562055|P1|NOT COMPLETED|Second Intervention||0
1055307|NCT00834197|2562054|P2|COMPLETED|Second Intervention||16
1055308|NCT00834197|2562055|P1|COMPLETED|Second Intervention||16
1055309|NCT00834197|2562054|P2|STARTED|Second Intervention||16
1055310|NCT00834197|2562055|P1|STARTED|Second Intervention||16
1055311|NCT00834197|2562054|P2|NOT COMPLETED|Washout of 14 Days||0
1055312|NCT00834197|2562055|P1|NOT COMPLETED|Washout of 14 Days||0
1055313|NCT00834197|2562054|P2|COMPLETED|Washout of 14 Days||16
1055314|NCT00834197|2562055|P1|COMPLETED|Washout of 14 Days||16
1055315|NCT00834197|2562054|P2|STARTED|Washout of 14 Days||16
1055316|NCT00834197|2562055|P1|STARTED|Washout of 14 Days||16
1055317|NCT00834197|2562054|P2|NOT COMPLETED|First Intervention||0
1055318|NCT00834197|2562055|P1|NOT COMPLETED|First Intervention||0
1055319|NCT00834197|2562054|P2|COMPLETED|First Intervention||16
1055320|NCT00834197|2562055|P1|COMPLETED|First Intervention||16
1055321|NCT00834197|2562054|P2|STARTED|First Intervention||16
1055322|NCT00834197|2562055|P1|STARTED|First Intervention||16
1055323|NCT00834210|2562065|P2|NOT COMPLETED|Overall Study||8
1055324|NCT00834210|2562066|P1|NOT COMPLETED|Overall Study||3
1055325|NCT00834210|2562065|P2|COMPLETED|Overall Study||77
1055326|NCT00834210|2562066|P1|COMPLETED|Overall Study||83
1055327|NCT00834210|2562065|P2|STARTED|Overall Study||85
1055328|NCT00834210|2562066|P1|STARTED|Overall Study||86
1055329|NCT00834236|2562080|P2|NOT COMPLETED|Overall Study||0
1055330|NCT00834236|2562081|P1|NOT COMPLETED|Overall Study||0
1055331|NCT00834236|2562080|P2|COMPLETED|Overall Study||47
1055332|NCT00834236|2562081|P1|COMPLETED|Overall Study||29
1055333|NCT00834236|2562080|P2|STARTED|Overall Study||47
1055334|NCT00834236|2562081|P1|STARTED|Overall Study||29
1055335|NCT00834249|2562089|P2|NOT COMPLETED|Second Intervention||0
1055336|NCT00834249|2562090|P1|NOT COMPLETED|Second Intervention||1
1055337|NCT00834249|2562089|P2|COMPLETED|Second Intervention||8
1055338|NCT00834249|2562090|P1|COMPLETED|Second Intervention||7
1055339|NCT00834249|2562089|P2|STARTED|Second Intervention||8
1055340|NCT00834249|2562090|P1|STARTED|Second Intervention||8
1055341|NCT00834249|2562089|P2|NOT COMPLETED|Washout: 7 Days||1
1055342|NCT00834249|2562090|P1|NOT COMPLETED|Washout: 7 Days||1
1055343|NCT00834249|2562089|P2|COMPLETED|Washout: 7 Days||8
1055344|NCT00834249|2562090|P1|COMPLETED|Washout: 7 Days||8
1055345|NCT00834249|2562089|P2|STARTED|Washout: 7 Days||9
1055346|NCT00834249|2562090|P1|STARTED|Washout: 7 Days||9
1055347|NCT00834249|2562089|P2|NOT COMPLETED|First Intervention||0
1055348|NCT00834249|2562090|P1|NOT COMPLETED|First Intervention||0
1055349|NCT00834249|2562089|P2|COMPLETED|First Intervention||9
1055350|NCT00834249|2562090|P1|COMPLETED|First Intervention||9
1055351|NCT00834249|2562089|P2|STARTED|First Intervention||9
1055352|NCT00834249|2562090|P1|STARTED|First Intervention||9
1055353|NCT00834275|2562106|P2|NOT COMPLETED|Second Intervention||0
1055354|NCT00834275|2562107|P1|NOT COMPLETED|Second Intervention||0
1055355|NCT00834275|2562106|P2|COMPLETED|Second Intervention||13
1055356|NCT00834275|2562107|P1|COMPLETED|Second Intervention||13
1055357|NCT00834275|2562106|P2|STARTED|Second Intervention||13
1055358|NCT00834275|2562107|P1|STARTED|Second Intervention||13
1055359|NCT00834275|2562106|P2|NOT COMPLETED|Washout of 7 Days||0
1055360|NCT00834275|2562107|P1|NOT COMPLETED|Washout of 7 Days||0
1055361|NCT00834275|2562106|P2|COMPLETED|Washout of 7 Days||13
1055362|NCT00834275|2562107|P1|COMPLETED|Washout of 7 Days||13
1055363|NCT00834275|2562106|P2|STARTED|Washout of 7 Days||13
1055364|NCT00834275|2562107|P1|STARTED|Washout of 7 Days||13
1055365|NCT00834275|2562106|P2|NOT COMPLETED|First Intervention||0
1055366|NCT00834275|2562107|P1|NOT COMPLETED|First Intervention||0
1055367|NCT00834275|2562106|P2|COMPLETED|First Intervention||13
1055368|NCT00834275|2562107|P1|COMPLETED|First Intervention||13
1055369|NCT00834275|2562106|P2|STARTED|First Intervention||13
1055370|NCT00834275|2562107|P1|STARTED|First Intervention||13
1055371|NCT00834288|2562117|P2|NOT COMPLETED|Treatment Phase II||0
1055372|NCT00834288|2562118|P1|NOT COMPLETED|Treatment Phase II||0
1055373|NCT00834288|2562117|P2|COMPLETED|Treatment Phase II||13
1055374|NCT00834288|2562118|P1|COMPLETED|Treatment Phase II||13
1055375|NCT00834288|2562117|P2|STARTED|Treatment Phase II||13
1055376|NCT00834288|2562118|P1|STARTED|Treatment Phase II||13
1055377|NCT00834288|2562117|P2|NOT COMPLETED|Treatment Phase I||0
1055378|NCT00834288|2562118|P1|NOT COMPLETED|Treatment Phase I||0
1055379|NCT00834288|2562117|P2|COMPLETED|Treatment Phase I||13
1055380|NCT00834288|2562118|P1|COMPLETED|Treatment Phase I||13
1055381|NCT00834288|2562117|P2|STARTED|Treatment Phase I||13
1055382|NCT00834288|2562118|P1|STARTED|Treatment Phase I||13
1055383|NCT00834340|2562140|P2|NOT COMPLETED|Second Intervention||0
1055384|NCT00834340|2562141|P1|NOT COMPLETED|Second Intervention||0
1055385|NCT00834340|2562140|P2|COMPLETED|Second Intervention||16
1055386|NCT00834340|2562141|P1|COMPLETED|Second Intervention||14
1055387|NCT00834340|2562140|P2|STARTED|Second Intervention||16
1055388|NCT00834340|2562141|P1|STARTED|Second Intervention||14
1055389|NCT00834340|2562140|P2|NOT COMPLETED|Washout||0
1055390|NCT00834340|2562141|P1|NOT COMPLETED|Washout||2
1055391|NCT00834340|2562140|P2|COMPLETED|Washout||16
1055392|NCT00834340|2562141|P1|COMPLETED|Washout||14
1055393|NCT00834340|2562140|P2|STARTED|Washout||16
1055394|NCT00834340|2562141|P1|STARTED|Washout||16
1055395|NCT00834340|2562140|P2|NOT COMPLETED|First Intervention||0
1055396|NCT00834340|2562141|P1|NOT COMPLETED|First Intervention||0
1055397|NCT00834340|2562140|P2|COMPLETED|First Intervention||16
1055398|NCT00834340|2562141|P1|COMPLETED|First Intervention||16
1055399|NCT00834340|2562140|P2|STARTED|First Intervention||16
1055400|NCT00834340|2562141|P1|STARTED|First Intervention||16
1055401|NCT00834366|2562151|P2|NOT COMPLETED|Treatment Period 2||0
1055402|NCT00834366|2562152|P1|NOT COMPLETED|Treatment Period 2||0
1055403|NCT00834366|2562151|P2|COMPLETED|Treatment Period 2||12
1055404|NCT00834366|2562152|P1|COMPLETED|Treatment Period 2||12
1055405|NCT00834366|2562151|P2|STARTED|Treatment Period 2||12
1055406|NCT00834366|2562152|P1|STARTED|Treatment Period 2||12
1055407|NCT00834366|2562151|P2|NOT COMPLETED|Treatment Period 1||1
1055408|NCT00834366|2562152|P1|NOT COMPLETED|Treatment Period 1||1
1055409|NCT00834366|2562151|P2|COMPLETED|Treatment Period 1||12
1055410|NCT00834366|2562152|P1|COMPLETED|Treatment Period 1||12
1055411|NCT00834366|2562151|P2|STARTED|Treatment Period 1||13
1055412|NCT00834366|2562152|P1|STARTED|Treatment Period 1||13
1055413|NCT00834405|2562168|P2|NOT COMPLETED|Overall Study||0
1055414|NCT00834405|2562169|P1|NOT COMPLETED|Overall Study||0
1055415|NCT00834405|2562168|P2|COMPLETED|Overall Study||17
1055416|NCT00834405|2562169|P1|COMPLETED|Overall Study||20
1055417|NCT00834405|2562168|P2|STARTED|Overall Study||17
1055418|NCT00834405|2562169|P1|STARTED|Overall Study||20
1055419|NCT00834418|2562177|P2|NOT COMPLETED|Overall Study||2
1055420|NCT00834418|2562178|P1|NOT COMPLETED|Overall Study||0
1055421|NCT00834418|2562177|P2|COMPLETED|Overall Study||40
1055422|NCT00834418|2562178|P1|COMPLETED|Overall Study||42
1055423|NCT00834418|2562177|P2|STARTED|Overall Study||42
1055424|NCT00834418|2562178|P1|STARTED|Overall Study||42
1055425|NCT00834431|2562186|P2|NOT COMPLETED|Second Intervention||0
1055426|NCT00834431|2562187|P1|NOT COMPLETED|Second Intervention||0
1055427|NCT00834431|2562186|P2|COMPLETED|Second Intervention||16
1055428|NCT00834431|2562187|P1|COMPLETED|Second Intervention||18
1055429|NCT00834431|2562186|P2|STARTED|Second Intervention||16
1055430|NCT00834431|2562187|P1|STARTED|Second Intervention||18
1055431|NCT00834431|2562186|P2|NOT COMPLETED|Washout of 7 Days||1
1055432|NCT00834431|2562187|P1|NOT COMPLETED|Washout of 7 Days||0
1055433|NCT00834431|2562186|P2|COMPLETED|Washout of 7 Days||16
1055434|NCT00834431|2562187|P1|COMPLETED|Washout of 7 Days||18
1055435|NCT00834431|2562186|P2|STARTED|Washout of 7 Days||17
1055436|NCT00834431|2562187|P1|STARTED|Washout of 7 Days||18
1055437|NCT00834431|2562186|P2|NOT COMPLETED|First Intervention||1
1055438|NCT00834431|2562187|P1|NOT COMPLETED|First Intervention||0
1055439|NCT00834431|2562186|P2|COMPLETED|First Intervention||17
1055440|NCT00834431|2562187|P1|COMPLETED|First Intervention||18
1055441|NCT00834431|2562186|P2|STARTED|First Intervention||18
1055442|NCT00834431|2562187|P1|STARTED|First Intervention||18
1055443|NCT00834444|2562197|P2|NOT COMPLETED|Second Intervention||0
1055444|NCT00834444|2562198|P1|NOT COMPLETED|Second Intervention||1
1055445|NCT00834444|2562197|P2|COMPLETED|Second Intervention||16
1055446|NCT00834444|2562198|P1|COMPLETED|Second Intervention||16
1055447|NCT00834444|2562197|P2|STARTED|Second Intervention||16
1055448|NCT00834444|2562198|P1|STARTED|Second Intervention||17
1055449|NCT00834444|2562197|P2|NOT COMPLETED|Washout of 7 Days||1
1055450|NCT00834444|2562198|P1|NOT COMPLETED|Washout of 7 Days||0
1055451|NCT00834444|2562197|P2|COMPLETED|Washout of 7 Days||16
1055452|NCT00834444|2562198|P1|COMPLETED|Washout of 7 Days||17
1055453|NCT00834444|2562197|P2|STARTED|Washout of 7 Days||17
1055454|NCT00834444|2562198|P1|STARTED|Washout of 7 Days||17
1055455|NCT00834444|2562197|P2|NOT COMPLETED|First Intervention||1
1055456|NCT00834444|2562198|P1|NOT COMPLETED|First Intervention||1
1055457|NCT00834444|2562197|P2|COMPLETED|First Intervention||17
1055458|NCT00834444|2562198|P1|COMPLETED|First Intervention||17
1055459|NCT00834444|2562197|P2|STARTED|First Intervention||18
1055460|NCT00834444|2562198|P1|STARTED|First Intervention||18
1055461|NCT00834483|2562208|P2|NOT COMPLETED|Overall Study||0
1055462|NCT00834483|2562209|P1|NOT COMPLETED|Overall Study||0
1055463|NCT00834483|2562208|P2|COMPLETED|Overall Study||29
1055464|NCT00834483|2562209|P1|COMPLETED|Overall Study||31
1055465|NCT00834483|2562208|P2|STARTED|Overall Study||29
1055466|NCT00834483|2562209|P1|STARTED|Overall Study||31
1055467|NCT00834522|2562221|P2|NOT COMPLETED|Second Intervention||0
1055468|NCT00834522|2562222|P1|NOT COMPLETED|Second Intervention||0
1055469|NCT00834522|2562221|P2|COMPLETED|Second Intervention||39
1055470|NCT00834522|2562222|P1|COMPLETED|Second Intervention||37
1055471|NCT00834522|2562221|P2|STARTED|Second Intervention||39
1055472|NCT00834522|2562222|P1|STARTED|Second Intervention||37
1055473|NCT00834522|2562221|P2|NOT COMPLETED|Washout||1
1055474|NCT00834522|2562222|P1|NOT COMPLETED|Washout||3
1055475|NCT00834522|2562221|P2|COMPLETED|Washout||39
1055476|NCT00834522|2562222|P1|COMPLETED|Washout||37
1055477|NCT00834522|2562221|P2|STARTED|Washout||40
1055478|NCT00834522|2562222|P1|STARTED|Washout||40
1055479|NCT00834522|2562221|P2|NOT COMPLETED|First Intervention||0
1055480|NCT00834522|2562222|P1|NOT COMPLETED|First Intervention||0
1055481|NCT00834522|2562221|P2|COMPLETED|First Intervention||40
1055482|NCT00834522|2562222|P1|COMPLETED|First Intervention||40
1055483|NCT00834522|2562221|P2|STARTED|First Intervention||40
1055484|NCT00834522|2562222|P1|STARTED|First Intervention||40
1055485|NCT00834535|2562232|P2|NOT COMPLETED|Second Intervention||0
1055486|NCT00834535|2562233|P1|NOT COMPLETED|Second Intervention||0
1055487|NCT00834535|2562232|P2|COMPLETED|Second Intervention||16
1055488|NCT00834535|2562233|P1|COMPLETED|Second Intervention||16
1055489|NCT00834535|2562232|P2|STARTED|Second Intervention||16
1055490|NCT00834535|2562233|P1|STARTED|Second Intervention||16
1055491|NCT00834535|2562232|P2|NOT COMPLETED|Washout of 7 Days||0
1055492|NCT00834535|2562233|P1|NOT COMPLETED|Washout of 7 Days||0
1055493|NCT00834535|2562232|P2|COMPLETED|Washout of 7 Days||16
1055494|NCT00834535|2562233|P1|COMPLETED|Washout of 7 Days||16
1055495|NCT00834535|2562232|P2|STARTED|Washout of 7 Days||16
1055496|NCT00834535|2562233|P1|STARTED|Washout of 7 Days||16
1055497|NCT00834535|2562232|P2|NOT COMPLETED|First Intervention||0
1055498|NCT00834535|2562233|P1|NOT COMPLETED|First Intervention||0
1055499|NCT00834535|2562232|P2|COMPLETED|First Intervention||16
1055500|NCT00834535|2562233|P1|COMPLETED|First Intervention||16
1055501|NCT00834535|2562232|P2|STARTED|First Intervention||16
1055502|NCT00834535|2562233|P1|STARTED|First Intervention||16
1055503|NCT00834561|2562243|P2|NOT COMPLETED|Second Intervention||0
1055504|NCT00834561|2562244|P1|NOT COMPLETED|Second Intervention||0
1055505|NCT00834561|2562243|P2|COMPLETED|Second Intervention||16
1055506|NCT00834561|2562244|P1|COMPLETED|Second Intervention||16
1055507|NCT00834561|2562243|P2|STARTED|Second Intervention||16
1055508|NCT00834561|2562244|P1|STARTED|Second Intervention||16
1055509|NCT00834561|2562243|P2|NOT COMPLETED|First Intervention||0
1055510|NCT00834561|2562244|P1|NOT COMPLETED|First Intervention||0
1055511|NCT00834561|2562243|P2|COMPLETED|First Intervention||16
1055512|NCT00834561|2562244|P1|COMPLETED|First Intervention||16
1055513|NCT00834561|2562243|P2|STARTED|First Intervention||16
1055514|NCT00834561|2562244|P1|STARTED|First Intervention||16
1055515|NCT00834574|2562254|P2|NOT COMPLETED|Second Intervention||0
1055516|NCT00834574|2562255|P1|NOT COMPLETED|Second Intervention||0
1055517|NCT00834574|2562254|P2|COMPLETED|Second Intervention||16
1055518|NCT00834574|2562255|P1|COMPLETED|Second Intervention||16
1055519|NCT00834574|2562254|P2|STARTED|Second Intervention||16
1055520|NCT00834574|2562255|P1|STARTED|Second Intervention||16
1055521|NCT00834574|2562254|P2|NOT COMPLETED|Washout of 7 Days||0
1055522|NCT00834574|2562255|P1|NOT COMPLETED|Washout of 7 Days||0
1055523|NCT00834574|2562254|P2|COMPLETED|Washout of 7 Days||16
1055524|NCT00834574|2562255|P1|COMPLETED|Washout of 7 Days||16
1055525|NCT00834574|2562254|P2|STARTED|Washout of 7 Days||16
1055526|NCT00834574|2562255|P1|STARTED|Washout of 7 Days||16
1055527|NCT00834574|2562254|P2|NOT COMPLETED|First Intervention||0
1055528|NCT00834574|2562255|P1|NOT COMPLETED|First Intervention||0
1055529|NCT00834574|2562254|P2|COMPLETED|First Intervention||16
1055530|NCT00834574|2562255|P1|COMPLETED|First Intervention||16
1055531|NCT00834574|2562254|P2|STARTED|First Intervention||16
1055532|NCT00834574|2562255|P1|STARTED|First Intervention||16
1055533|NCT00834587|2562265|P2|NOT COMPLETED|Second Intervention||0
1055534|NCT00834587|2562266|P1|NOT COMPLETED|Second Intervention||0
1055535|NCT00834587|2562265|P2|COMPLETED|Second Intervention||20
1055536|NCT00834587|2562266|P1|COMPLETED|Second Intervention||19
1055537|NCT00834587|2562265|P2|STARTED|Second Intervention||20
1055538|NCT00834587|2562266|P1|STARTED|Second Intervention||19
1055539|NCT00834587|2562265|P2|NOT COMPLETED|Washout: 7 Days||0
1055540|NCT00834587|2562266|P1|NOT COMPLETED|Washout: 7 Days||1
1055541|NCT00834587|2562265|P2|COMPLETED|Washout: 7 Days||20
1055542|NCT00834587|2562266|P1|COMPLETED|Washout: 7 Days||19
1055543|NCT00834587|2562265|P2|STARTED|Washout: 7 Days||20
1055544|NCT00834587|2562266|P1|STARTED|Washout: 7 Days||20
1055545|NCT00834587|2562265|P2|NOT COMPLETED|First Intervention||0
1055546|NCT00834587|2562266|P1|NOT COMPLETED|First Intervention||0
1055547|NCT00834587|2562265|P2|COMPLETED|First Intervention||20
1055548|NCT00834587|2562266|P1|COMPLETED|First Intervention||20
1055549|NCT00834587|2562265|P2|STARTED|First Intervention||20
1055550|NCT00834587|2562266|P1|STARTED|First Intervention||20
1055551|NCT00834613|2562282|P2|NOT COMPLETED|Second Intervention||0
1055552|NCT00834613|2562283|P1|NOT COMPLETED|Second Intervention||0
1055553|NCT00834613|2562282|P2|COMPLETED|Second Intervention||16
1055554|NCT00834613|2562283|P1|COMPLETED|Second Intervention||15
1055555|NCT00834613|2562282|P2|STARTED|Second Intervention||16
1055556|NCT00834613|2562283|P1|STARTED|Second Intervention||15
1055557|NCT00834613|2562282|P2|NOT COMPLETED|Washout of 7 Days||0
1055558|NCT00834613|2562283|P1|NOT COMPLETED|Washout of 7 Days||0
1055559|NCT00834613|2562282|P2|COMPLETED|Washout of 7 Days||16
1055560|NCT00834613|2562283|P1|COMPLETED|Washout of 7 Days||15
1055561|NCT00834613|2562282|P2|STARTED|Washout of 7 Days||16
1055562|NCT00834613|2562283|P1|STARTED|Washout of 7 Days||15
1055563|NCT00834613|2562282|P2|NOT COMPLETED|First Intervention||0
1055564|NCT00834613|2562283|P1|NOT COMPLETED|First Intervention||1
1055565|NCT00834613|2562282|P2|COMPLETED|First Intervention||16
1055566|NCT00834613|2562283|P1|COMPLETED|First Intervention||15
1055567|NCT00834613|2562282|P2|STARTED|First Intervention||16
1055568|NCT00834613|2562283|P1|STARTED|First Intervention||16
1055569|NCT00834626|2562291|P1|NOT COMPLETED|Overall Study||0
1055570|NCT00834626|2562291|P1|COMPLETED|Overall Study||30
1055571|NCT00834626|2562291|P1|1 Year Follow-up|Overall Study||30
1055572|NCT00834626|2562291|P1|STARTED|Overall Study||30
1055573|NCT00834639|2562300|P2|NOT COMPLETED|Second Intervention||2
1055574|NCT00834639|2562301|P1|NOT COMPLETED|Second Intervention||0
1055575|NCT00834639|2562300|P2|COMPLETED|Second Intervention||10
1055576|NCT00834639|2562301|P1|COMPLETED|Second Intervention||12
1055577|NCT00834639|2562300|P2|STARTED|Second Intervention||12
1055578|NCT00834639|2562301|P1|STARTED|Second Intervention||12
1055579|NCT00834639|2562300|P2|NOT COMPLETED|Washout of 7 Days||0
1055580|NCT00834639|2562301|P1|NOT COMPLETED|Washout of 7 Days||0
1055581|NCT00834639|2562300|P2|COMPLETED|Washout of 7 Days||12
1055582|NCT00834639|2562301|P1|COMPLETED|Washout of 7 Days||12
1055583|NCT00834639|2562300|P2|STARTED|Washout of 7 Days||12
1055584|NCT00834639|2562301|P1|STARTED|Washout of 7 Days||12
1055585|NCT00834639|2562300|P2|NOT COMPLETED|First Intervention||0
1055586|NCT00834639|2562301|P1|NOT COMPLETED|First Intervention||0
1055587|NCT00834639|2562300|P2|COMPLETED|First Intervention||12
1055588|NCT00834639|2562301|P1|COMPLETED|First Intervention||12
1055589|NCT00834639|2562300|P2|STARTED|First Intervention||12
1055590|NCT00834639|2562301|P1|STARTED|First Intervention||12
1055591|NCT00834678|2562309|P1|NOT COMPLETED|Overall Study||0
1055592|NCT00834678|2562309|P1|COMPLETED|Overall Study||11
1055593|NCT00834678|2562309|P1|STARTED|Overall Study||11
1055594|NCT00834717|2562322|P2|NOT COMPLETED|Second Intervention||0
1055595|NCT00834717|2562323|P1|NOT COMPLETED|Second Intervention||0
1055596|NCT00834717|2562322|P2|COMPLETED|Second Intervention||19
1055597|NCT00834717|2562323|P1|COMPLETED|Second Intervention||19
1055598|NCT00834717|2562322|P2|STARTED|Second Intervention||19
1055599|NCT00834717|2562323|P1|STARTED|Second Intervention||19
1055600|NCT00834717|2562322|P2|NOT COMPLETED|First Intervention||1
1055601|NCT00834717|2562323|P1|NOT COMPLETED|First Intervention||1
1055602|NCT00834717|2562322|P2|COMPLETED|First Intervention||19
1055603|NCT00834717|2562323|P1|COMPLETED|First Intervention||19
1055604|NCT00834717|2562322|P2|STARTED|First Intervention||20
1055605|NCT00834717|2562323|P1|STARTED|First Intervention||20
1055606|NCT00834743|2562333|P2|NOT COMPLETED|Second Intervention||0
1055607|NCT00834743|2562334|P1|NOT COMPLETED|Second Intervention||1
1055608|NCT00834743|2562333|P2|COMPLETED|Second Intervention||16
1055609|NCT00834743|2562334|P1|COMPLETED|Second Intervention||15
1055610|NCT00834743|2562333|P2|STARTED|Second Intervention||16
1055611|NCT00834743|2562334|P1|STARTED|Second Intervention||16
1055612|NCT00834743|2562333|P2|NOT COMPLETED|Washout of 7 Days||0
1055613|NCT00834743|2562334|P1|NOT COMPLETED|Washout of 7 Days||0
1055614|NCT00834743|2562333|P2|COMPLETED|Washout of 7 Days||16
1055615|NCT00834743|2562334|P1|COMPLETED|Washout of 7 Days||16
1055616|NCT00834743|2562333|P2|STARTED|Washout of 7 Days||16
1055617|NCT00834743|2562334|P1|STARTED|Washout of 7 Days||16
1055618|NCT00834743|2562333|P2|NOT COMPLETED|First Intervention||0
1055619|NCT00834743|2562334|P1|NOT COMPLETED|First Intervention||0
1055620|NCT00834743|2562333|P2|COMPLETED|First Intervention||16
1055621|NCT00834743|2562334|P1|COMPLETED|First Intervention||16
1055622|NCT00834743|2562333|P2|STARTED|First Intervention||16
1055623|NCT00834743|2562334|P1|STARTED|First Intervention||16
1055624|NCT00834756|2562344|P2|NOT COMPLETED|Second Intervention||0
1055625|NCT00834756|2562345|P1|NOT COMPLETED|Second Intervention||0
1055626|NCT00834756|2562344|P2|COMPLETED|Second Intervention||18
1055627|NCT00834756|2562345|P1|COMPLETED|Second Intervention||16
1055628|NCT00834756|2562344|P2|STARTED|Second Intervention||18
1055629|NCT00834756|2562345|P1|STARTED|Second Intervention||16
1055630|NCT00834756|2562344|P2|NOT COMPLETED|Washout: 21 Days||0
1055631|NCT00834756|2562345|P1|NOT COMPLETED|Washout: 21 Days||1
1055632|NCT00834756|2562344|P2|COMPLETED|Washout: 21 Days||18
1055633|NCT00834756|2562345|P1|COMPLETED|Washout: 21 Days||16
1055634|NCT00834756|2562344|P2|STARTED|Washout: 21 Days||18
1055635|NCT00834756|2562345|P1|STARTED|Washout: 21 Days||17
1055636|NCT00834756|2562344|P2|NOT COMPLETED|First Intervention||0
1055637|NCT00834756|2562345|P1|NOT COMPLETED|First Intervention||1
1055638|NCT00834756|2562344|P2|COMPLETED|First Intervention||18
1055639|NCT00834756|2562345|P1|COMPLETED|First Intervention||17
1055640|NCT00834756|2562344|P2|STARTED|First Intervention||18
1055641|NCT00834756|2562345|P1|STARTED|First Intervention||18
1055642|NCT00834795|2562355|P2|NOT COMPLETED|Second Intervention||0
1055643|NCT00834795|2562356|P1|NOT COMPLETED|Second Intervention||1
1055644|NCT00834795|2562355|P2|COMPLETED|Second Intervention||17
1055645|NCT00834795|2562356|P1|COMPLETED|Second Intervention||17
1055646|NCT00834795|2562355|P2|STARTED|Second Intervention||17
1055647|NCT00834795|2562356|P1|STARTED|Second Intervention||18
1055648|NCT00834795|2562355|P2|NOT COMPLETED|Washout: 7 Days||1
1055649|NCT00834795|2562356|P1|NOT COMPLETED|Washout: 7 Days||0
1055650|NCT00834795|2562355|P2|COMPLETED|Washout: 7 Days||17
1055651|NCT00834795|2562356|P1|COMPLETED|Washout: 7 Days||18
1055652|NCT00834795|2562355|P2|STARTED|Washout: 7 Days||18
1055653|NCT00834795|2562356|P1|STARTED|Washout: 7 Days||18
1055654|NCT00834795|2562355|P2|NOT COMPLETED|First Intervention||0
1055655|NCT00834795|2562356|P1|NOT COMPLETED|First Intervention||0
1055656|NCT00834795|2562355|P2|COMPLETED|First Intervention||18
1055657|NCT00834795|2562356|P1|COMPLETED|First Intervention||18
1055658|NCT00834795|2562355|P2|STARTED|First Intervention||18
1055659|NCT00834795|2562356|P1|STARTED|First Intervention||18
1055660|NCT00834808|2562367|P3|NOT COMPLETED|Treatment Period 3 (Day 15)||0
1055661|NCT00834808|2562368|P2|NOT COMPLETED|Treatment Period 3 (Day 15)||0
1055662|NCT00834808|2562369|P1|NOT COMPLETED|Treatment Period 3 (Day 15)||0
1055663|NCT00834808|2562367|P3|COMPLETED|Treatment Period 3 (Day 15)||9
1055664|NCT00834808|2562368|P2|COMPLETED|Treatment Period 3 (Day 15)||9
1055665|NCT00834808|2562369|P1|COMPLETED|Treatment Period 3 (Day 15)||9
1055666|NCT00834808|2562367|P3|STARTED|Treatment Period 3 (Day 15)||9
1055667|NCT00834808|2562368|P2|STARTED|Treatment Period 3 (Day 15)||9
1055668|NCT00834808|2562369|P1|STARTED|Treatment Period 3 (Day 15)||9
1055669|NCT00834808|2562367|P3|NOT COMPLETED|Treatment Period 2 (Day 8)||0
1055670|NCT00834808|2562368|P2|NOT COMPLETED|Treatment Period 2 (Day 8)||0
1055671|NCT00834808|2562369|P1|NOT COMPLETED|Treatment Period 2 (Day 8)||0
1055672|NCT00834808|2562367|P3|COMPLETED|Treatment Period 2 (Day 8)||9
1055673|NCT00834808|2562368|P2|COMPLETED|Treatment Period 2 (Day 8)||9
1055674|NCT00834808|2562369|P1|COMPLETED|Treatment Period 2 (Day 8)||9
1055675|NCT00834808|2562367|P3|STARTED|Treatment Period 2 (Day 8)||9
1055676|NCT00834808|2562368|P2|STARTED|Treatment Period 2 (Day 8)||9
1055677|NCT00834808|2562369|P1|STARTED|Treatment Period 2 (Day 8)||9
1055678|NCT00834808|2562367|P3|NOT COMPLETED|Treatment Period 1 (Day 1)||0
1055679|NCT00834808|2562368|P2|NOT COMPLETED|Treatment Period 1 (Day 1)||0
1055680|NCT00834808|2562369|P1|NOT COMPLETED|Treatment Period 1 (Day 1)||0
1055681|NCT00834808|2562367|P3|COMPLETED|Treatment Period 1 (Day 1)||9
1055682|NCT00834808|2562368|P2|COMPLETED|Treatment Period 1 (Day 1)||9
1055683|NCT00834808|2562369|P1|COMPLETED|Treatment Period 1 (Day 1)||9
1055684|NCT00834808|2562367|P3|STARTED|Treatment Period 1 (Day 1)||9
1055685|NCT00834808|2562368|P2|STARTED|Treatment Period 1 (Day 1)||9
1055686|NCT00834808|2562369|P1|STARTED|Treatment Period 1 (Day 1)||9
1055687|NCT00834834|2562391|P2|NOT COMPLETED|Overall Study||3
1055688|NCT00834834|2562392|P1|NOT COMPLETED|Overall Study||4
1055689|NCT00834834|2562391|P2|COMPLETED|Overall Study||39
1055690|NCT00834834|2562392|P1|COMPLETED|Overall Study||38
1055691|NCT00834834|2562391|P2|STARTED|Overall Study||42
1055692|NCT00834834|2562392|P1|STARTED|Overall Study||42
1055693|NCT00834873|2562402|P2|NOT COMPLETED|Second Intervention||0
1055694|NCT00834873|2562403|P1|NOT COMPLETED|Second Intervention||0
1055695|NCT00834873|2562402|P2|COMPLETED|Second Intervention||11
1055696|NCT00834873|2562403|P1|COMPLETED|Second Intervention||12
1055697|NCT00834873|2562402|P2|STARTED|Second Intervention||11
1055698|NCT00834873|2562403|P1|STARTED|Second Intervention||12
1055699|NCT00834873|2562402|P2|NOT COMPLETED|Washout: 7 Days||0
1055700|NCT00834873|2562403|P1|NOT COMPLETED|Washout: 7 Days||0
1055701|NCT00834873|2562402|P2|COMPLETED|Washout: 7 Days||11
1055702|NCT00834873|2562403|P1|COMPLETED|Washout: 7 Days||12
1055703|NCT00834873|2562402|P2|STARTED|Washout: 7 Days||11
1055704|NCT00834873|2562403|P1|STARTED|Washout: 7 Days||12
1055705|NCT00834873|2562402|P2|NOT COMPLETED|First Intervention||1
1055706|NCT00834873|2562403|P1|NOT COMPLETED|First Intervention||0
1055707|NCT00834873|2562402|P2|COMPLETED|First Intervention||11
1055708|NCT00834873|2562403|P1|COMPLETED|First Intervention||12
1055709|NCT00834873|2562402|P2|STARTED|First Intervention||12
1055710|NCT00834873|2562403|P1|STARTED|First Intervention||12
1055711|NCT00834886|2562415|P4|NOT COMPLETED|Overall Study||0
1055712|NCT00834886|2562416|P3|NOT COMPLETED|Overall Study||1
1055713|NCT00834886|2562417|P2|NOT COMPLETED|Overall Study||1
1055714|NCT00834886|2562418|P1|NOT COMPLETED|Overall Study||0
1055715|NCT00834886|2562415|P4|COMPLETED|Overall Study||10
1055716|NCT00834886|2562416|P3|COMPLETED|Overall Study||9
1055717|NCT00834886|2562417|P2|COMPLETED|Overall Study||9
1055718|NCT00834886|2562418|P1|COMPLETED|Overall Study||10
1055719|NCT00834886|2562415|P4|STARTED|Overall Study||10
1055720|NCT00834886|2562416|P3|STARTED|Overall Study||10
1055721|NCT00834886|2562417|P2|STARTED|Overall Study||10
1055722|NCT00834886|2562418|P1|STARTED|Overall Study||10
1055723|NCT00834899|2562438|P2|NOT COMPLETED|Overall Study||1
1055724|NCT00834899|2562439|P1|NOT COMPLETED|Overall Study||1
1055725|NCT00834899|2562438|P2|COMPLETED|Overall Study|One patient was withdrawn early because she did not meet eligibility criteria.|3
1055726|NCT00834899|2562439|P1|COMPLETED|Overall Study|One patient withdrew consent following completion of the study drug infusion.|8
1055727|NCT00834899|2562438|P2|STARTED|Overall Study||4
1055728|NCT00834899|2562439|P1|STARTED|Overall Study||9
1055729|NCT00834912|2562457|P6|NOT COMPLETED|Treatment Period 3||0
1055730|NCT00834912|2562458|P5|NOT COMPLETED|Treatment Period 3||0
1055731|NCT00834912|2562459|P4|NOT COMPLETED|Treatment Period 3||0
1055732|NCT00834912|2562460|P3|NOT COMPLETED|Treatment Period 3||0
1055733|NCT00834912|2562461|P2|NOT COMPLETED|Treatment Period 3||0
1055734|NCT00834912|2562462|P1|NOT COMPLETED|Treatment Period 3||0
1055735|NCT00834912|2562457|P6|COMPLETED|Treatment Period 3||6
1055736|NCT00834912|2562458|P5|COMPLETED|Treatment Period 3||5
1055737|NCT00834912|2562459|P4|COMPLETED|Treatment Period 3||5
1055738|NCT00834912|2562460|P3|COMPLETED|Treatment Period 3||5
1055739|NCT00834912|2562461|P2|COMPLETED|Treatment Period 3||5
1055740|NCT00834912|2562462|P1|COMPLETED|Treatment Period 3||6
1055741|NCT00834912|2562457|P6|STARTED|Treatment Period 3||6
1055742|NCT00834912|2562458|P5|STARTED|Treatment Period 3||5
1055743|NCT00834912|2562459|P4|STARTED|Treatment Period 3||5
1055744|NCT00834912|2562460|P3|STARTED|Treatment Period 3||5
1055745|NCT00834912|2562461|P2|STARTED|Treatment Period 3||5
1055746|NCT00834912|2562462|P1|STARTED|Treatment Period 3||6
1055747|NCT00834912|2562457|P6|NOT COMPLETED|Treatment Period 2||0
1055748|NCT00834912|2562458|P5|NOT COMPLETED|Treatment Period 2||1
1055749|NCT00834912|2562459|P4|NOT COMPLETED|Treatment Period 2||0
1055750|NCT00834912|2562460|P3|NOT COMPLETED|Treatment Period 2||1
1055751|NCT00834912|2562461|P2|NOT COMPLETED|Treatment Period 2||0
1055752|NCT00834912|2562462|P1|NOT COMPLETED|Treatment Period 2||0
1055753|NCT00834912|2562457|P6|COMPLETED|Treatment Period 2||6
1055754|NCT00834912|2562458|P5|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
1055755|NCT00834912|2562459|P4|COMPLETED|Treatment Period 2||5
1055756|NCT00834912|2562460|P3|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
1055757|NCT00834912|2562461|P2|COMPLETED|Treatment Period 2||5
1055758|NCT00834912|2562462|P1|COMPLETED|Treatment Period 2||6
1055759|NCT00834912|2562457|P6|STARTED|Treatment Period 2||6
1055760|NCT00834912|2562458|P5|STARTED|Treatment Period 2||6
1055761|NCT00834912|2562459|P4|STARTED|Treatment Period 2||5
1055762|NCT00834912|2562460|P3|STARTED|Treatment Period 2||6
1055763|NCT00834912|2562461|P2|STARTED|Treatment Period 2||5
1055764|NCT00834912|2562462|P1|STARTED|Treatment Period 2||6
1055765|NCT00834912|2562457|P6|NOT COMPLETED|Treatment Period 1||0
1055766|NCT00834912|2562458|P5|NOT COMPLETED|Treatment Period 1||0
1055767|NCT00834912|2562459|P4|NOT COMPLETED|Treatment Period 1||1
1055768|NCT00834912|2562460|P3|NOT COMPLETED|Treatment Period 1||0
1055769|NCT00834912|2562461|P2|NOT COMPLETED|Treatment Period 1||1
1055770|NCT00834912|2562462|P1|NOT COMPLETED|Treatment Period 1||0
1055771|NCT00834912|2562457|P6|COMPLETED|Treatment Period 1||6
1055772|NCT00834912|2562458|P5|COMPLETED|Treatment Period 1||6
1055773|NCT00834912|2562459|P4|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
1055774|NCT00834912|2562460|P3|COMPLETED|Treatment Period 1||6
1055775|NCT00834912|2562461|P2|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
1055776|NCT00834912|2562462|P1|COMPLETED|Treatment Period 1||6
1055777|NCT00834912|2562457|P6|STARTED|Treatment Period 1||6
1055778|NCT00834912|2562458|P5|STARTED|Treatment Period 1||6
1055779|NCT00834912|2562459|P4|STARTED|Treatment Period 1||6
1055780|NCT00834912|2562460|P3|STARTED|Treatment Period 1||6
1055781|NCT00834912|2562461|P2|STARTED|Treatment Period 1||6
1055782|NCT00834912|2562462|P1|STARTED|Treatment Period 1||6
1055783|NCT00834964|2562484|P2|NOT COMPLETED|Second Intervention||0
1055784|NCT00834964|2562485|P1|NOT COMPLETED|Second Intervention||0
1055785|NCT00834964|2562484|P2|COMPLETED|Second Intervention||15
1055786|NCT00834964|2562485|P1|COMPLETED|Second Intervention||15
1055787|NCT00834964|2562484|P2|STARTED|Second Intervention||15
1055788|NCT00834964|2562485|P1|STARTED|Second Intervention||15
1055789|NCT00834964|2562484|P2|NOT COMPLETED|Washout: 7 Days||0
1055790|NCT00834964|2562485|P1|NOT COMPLETED|Washout: 7 Days||0
1055791|NCT00834964|2562484|P2|COMPLETED|Washout: 7 Days||15
1055792|NCT00834964|2562485|P1|COMPLETED|Washout: 7 Days||15
1055793|NCT00834964|2562484|P2|STARTED|Washout: 7 Days||15
1055794|NCT00834964|2562485|P1|STARTED|Washout: 7 Days||15
1055795|NCT00834964|2562484|P2|NOT COMPLETED|First Intervention||0
1055796|NCT00834964|2562485|P1|NOT COMPLETED|First Intervention||0
1055797|NCT00834964|2562484|P2|COMPLETED|First Intervention||15
1055798|NCT00834964|2562485|P1|COMPLETED|First Intervention||15
1055799|NCT00834964|2562484|P2|STARTED|First Intervention||15
1055800|NCT00834964|2562485|P1|STARTED|First Intervention||15
1055801|NCT00834977|2562501|P2|NOT COMPLETED|Second Intervention||0
1055802|NCT00834977|2562502|P1|NOT COMPLETED|Second Intervention||0
1055803|NCT00834977|2562501|P2|COMPLETED|Second Intervention||24
1055804|NCT00834977|2562502|P1|COMPLETED|Second Intervention||24
1055805|NCT00834977|2562501|P2|STARTED|Second Intervention||24
1055806|NCT00834977|2562502|P1|STARTED|Second Intervention||24
1055807|NCT00834977|2562501|P2|NOT COMPLETED|First Intervention||0
1055808|NCT00834977|2562502|P1|NOT COMPLETED|First Intervention||0
1055809|NCT00834977|2562501|P2|COMPLETED|First Intervention||24
1055810|NCT00834977|2562502|P1|COMPLETED|First Intervention||24
1055811|NCT00834977|2562501|P2|STARTED|First Intervention||24
1055812|NCT00834977|2562502|P1|STARTED|First Intervention||24
1055813|NCT00834990|2562524|P2|NOT COMPLETED|Second Intervention||0
1055814|NCT00834990|2562525|P1|NOT COMPLETED|Second Intervention||0
1055815|NCT00834990|2562524|P2|COMPLETED|Second Intervention||11
1055816|NCT00834990|2562525|P1|COMPLETED|Second Intervention||12
1055817|NCT00834990|2562524|P2|STARTED|Second Intervention||11
1055818|NCT00834990|2562525|P1|STARTED|Second Intervention||12
1055819|NCT00834990|2562524|P2|NOT COMPLETED|Washout of 7 Days||0
1055820|NCT00834990|2562525|P1|NOT COMPLETED|Washout of 7 Days||0
1055821|NCT00834990|2562524|P2|COMPLETED|Washout of 7 Days||11
1055822|NCT00834990|2562525|P1|COMPLETED|Washout of 7 Days||12
1055823|NCT00834990|2562524|P2|STARTED|Washout of 7 Days||11
1055824|NCT00834990|2562525|P1|STARTED|Washout of 7 Days||12
1055825|NCT00834990|2562524|P2|NOT COMPLETED|First Intervention||0
1055826|NCT00834990|2562525|P1|NOT COMPLETED|First Intervention||0
1055827|NCT00834990|2562524|P2|COMPLETED|First Intervention||11
1055828|NCT00834990|2562525|P1|COMPLETED|First Intervention||12
1055829|NCT00834990|2562524|P2|STARTED|First Intervention||11
1055830|NCT00834990|2562525|P1|STARTED|First Intervention||12
1055831|NCT00835003|2562535|P2|NOT COMPLETED|Overall Study||0
1055832|NCT00835003|2562536|P1|NOT COMPLETED|Overall Study||0
1055833|NCT00835003|2562535|P2|COMPLETED|Overall Study||638
1055834|NCT00835003|2562536|P1|COMPLETED|Overall Study||636
1055835|NCT00835003|2562535|P2|STARTED|Overall Study||638
1055836|NCT00835003|2562536|P1|STARTED|Overall Study||636
1055837|NCT00835042|2562544|P2|NOT COMPLETED|Second Intervention||0
1055838|NCT00835042|2562545|P1|NOT COMPLETED|Second Intervention||0
1055839|NCT00835042|2562544|P2|COMPLETED|Second Intervention||24
1055840|NCT00835042|2562545|P1|COMPLETED|Second Intervention||26
1055841|NCT00835042|2562544|P2|STARTED|Second Intervention||24
1055842|NCT00835042|2562545|P1|STARTED|Second Intervention||26
1055843|NCT00835042|2562544|P2|NOT COMPLETED|Washout of 21 Days||2
1055844|NCT00835042|2562545|P1|NOT COMPLETED|Washout of 21 Days||0
1055845|NCT00835042|2562544|P2|COMPLETED|Washout of 21 Days||24
1055846|NCT00835042|2562545|P1|COMPLETED|Washout of 21 Days||26
1055847|NCT00835042|2562544|P2|STARTED|Washout of 21 Days||26
1055848|NCT00835042|2562545|P1|STARTED|Washout of 21 Days||26
1055849|NCT00835042|2562544|P2|NOT COMPLETED|First Intervention||2
1055850|NCT00835042|2562545|P1|NOT COMPLETED|First Intervention||4
1055851|NCT00835042|2562544|P2|COMPLETED|First Intervention||26
1055852|NCT00835042|2562545|P1|COMPLETED|First Intervention||26
1055853|NCT00835042|2562544|P2|STARTED|First Intervention||28
1055854|NCT00835042|2562545|P1|STARTED|First Intervention||30
1055855|NCT00835068|2562567|P2|NOT COMPLETED|Overall Study||1
1055856|NCT00835068|2562568|P1|NOT COMPLETED|Overall Study||10
1055857|NCT00835068|2562567|P2|COMPLETED|Overall Study||0
1055858|NCT00835068|2562568|P1|COMPLETED|Overall Study||47
1055859|NCT00835068|2562567|P2|STARTED|Overall Study||1
1055860|NCT00835068|2562568|P1|STARTED|Overall Study||57
1055861|NCT00835081|2562588|P2|NOT COMPLETED|Second Intervention||0
1055862|NCT00835081|2562589|P1|NOT COMPLETED|Second Intervention||0
1055863|NCT00835081|2562588|P2|COMPLETED|Second Intervention||13
1055864|NCT00835081|2562589|P1|COMPLETED|Second Intervention||12
1055865|NCT00835081|2562588|P2|STARTED|Second Intervention||13
1055866|NCT00835081|2562589|P1|STARTED|Second Intervention||12
1055867|NCT00835081|2562588|P2|NOT COMPLETED|Washout of 7 Days||0
1055868|NCT00835081|2562589|P1|NOT COMPLETED|Washout of 7 Days||1
1055869|NCT00835081|2562588|P2|COMPLETED|Washout of 7 Days||13
1055870|NCT00835081|2562589|P1|COMPLETED|Washout of 7 Days||12
1055871|NCT00835081|2562588|P2|STARTED|Washout of 7 Days||13
1055872|NCT00835081|2562589|P1|STARTED|Washout of 7 Days||13
1055873|NCT00835081|2562588|P2|NOT COMPLETED|First Intervention||0
1055874|NCT00835081|2562589|P1|NOT COMPLETED|First Intervention||0
1055875|NCT00835081|2562588|P2|COMPLETED|First Intervention||13
1055876|NCT00835081|2562589|P1|COMPLETED|First Intervention||13
1055877|NCT00835081|2562588|P2|STARTED|First Intervention||13
1055878|NCT00835081|2562589|P1|STARTED|First Intervention||13
1055879|NCT00835120|2562597|P1|NOT COMPLETED|Overall Study||8
1055880|NCT00835120|2562597|P1|COMPLETED|Overall Study||26
1055881|NCT00835120|2562597|P1|STARTED|Overall Study||34
1055882|NCT00835146|2562607|P2|NOT COMPLETED|Second Intervention||0
1055883|NCT00835146|2562608|P1|NOT COMPLETED|Second Intervention||0
1055884|NCT00835146|2562607|P2|COMPLETED|Second Intervention||14
1055885|NCT00835146|2562608|P1|COMPLETED|Second Intervention||14
1055886|NCT00835146|2562607|P2|STARTED|Second Intervention||14
1055887|NCT00835146|2562608|P1|STARTED|Second Intervention||14
1055888|NCT00835146|2562607|P2|NOT COMPLETED|Washout of 5 Weeks||0
1055889|NCT00835146|2562608|P1|NOT COMPLETED|Washout of 5 Weeks||0
1055890|NCT00835146|2562607|P2|COMPLETED|Washout of 5 Weeks||14
1055891|NCT00835146|2562608|P1|COMPLETED|Washout of 5 Weeks||14
1055892|NCT00835146|2562607|P2|STARTED|Washout of 5 Weeks||14
1055893|NCT00835146|2562608|P1|STARTED|Washout of 5 Weeks||14
1055894|NCT00835146|2562607|P2|NOT COMPLETED|First Intervention||0
1055895|NCT00835146|2562608|P1|NOT COMPLETED|First Intervention||0
1055896|NCT00835146|2562607|P2|COMPLETED|First Intervention||14
1055897|NCT00835146|2562608|P1|COMPLETED|First Intervention||14
1055898|NCT00835146|2562607|P2|STARTED|First Intervention||14
1055899|NCT00835146|2562608|P1|STARTED|First Intervention||14
1055900|NCT00835159|2562616|P2|NOT COMPLETED|Overall Study||0
1055901|NCT00835159|2562617|P1|NOT COMPLETED|Overall Study||0
1055902|NCT00835159|2562616|P2|COMPLETED|Overall Study||17
1055903|NCT00835159|2562617|P1|COMPLETED|Overall Study||11
1055904|NCT00835159|2562616|P2|STARTED|Overall Study||17
1055905|NCT00835159|2562617|P1|STARTED|Overall Study||11
1055906|NCT00835172|2562625|P2|NOT COMPLETED|Second Intervention||0
1055907|NCT00835172|2562626|P1|NOT COMPLETED|Second Intervention||0
1055908|NCT00835172|2562625|P2|COMPLETED|Second Intervention||15
1055909|NCT00835172|2562626|P1|COMPLETED|Second Intervention||16
1055910|NCT00835172|2562625|P2|STARTED|Second Intervention||15
1055911|NCT00835172|2562626|P1|STARTED|Second Intervention||16
1055912|NCT00835172|2562625|P2|NOT COMPLETED|Washout||1
1055913|NCT00835172|2562626|P1|NOT COMPLETED|Washout||0
1055914|NCT00835172|2562625|P2|COMPLETED|Washout||15
1055915|NCT00835172|2562626|P1|COMPLETED|Washout||16
1055916|NCT00835172|2562625|P2|STARTED|Washout||16
1055917|NCT00835172|2562626|P1|STARTED|Washout||16
1055918|NCT00835172|2562625|P2|NOT COMPLETED|First Intervention||0
1055919|NCT00835172|2562626|P1|NOT COMPLETED|First Intervention||0
1055920|NCT00835172|2562625|P2|COMPLETED|First Intervention||16
1055921|NCT00835172|2562626|P1|COMPLETED|First Intervention||16
1055922|NCT00835172|2562625|P2|STARTED|First Intervention||16
1055923|NCT00835172|2562626|P1|STARTED|First Intervention||16
1055924|NCT00835185|2562634|P1|NOT COMPLETED|Overall Study||0
1055925|NCT00835185|2562634|P1|COMPLETED|Overall Study||44
1055926|NCT00835185|2562634|P1|Received at Least 1 Dose of Study Drug|Overall Study||44
1055927|NCT00835185|2562634|P1|STARTED|Overall Study||44
1055928|NCT00835198|2562657|P2|NOT COMPLETED|Overall Study||7
1055929|NCT00835198|2562658|P1|NOT COMPLETED|Overall Study||8
1055930|NCT00835198|2562657|P2|COMPLETED|Overall Study||74
1055931|NCT00835198|2562658|P1|COMPLETED|Overall Study||74
1055932|NCT00835198|2562657|P2|STARTED|Overall Study||81
1055933|NCT00835198|2562658|P1|STARTED|Overall Study||82
1055934|NCT00835211|2562672|P2|NOT COMPLETED|Second Intervention||0
1055935|NCT00835211|2562673|P1|NOT COMPLETED|Second Intervention||0
1055936|NCT00835211|2562672|P2|COMPLETED|Second Intervention||22
1055937|NCT00835211|2562673|P1|COMPLETED|Second Intervention||21
1055938|NCT00835211|2562672|P2|STARTED|Second Intervention||22
1055939|NCT00835211|2562673|P1|STARTED|Second Intervention||21
1055940|NCT00835211|2562672|P2|NOT COMPLETED|Washout: 7 Days||1
1055941|NCT00835211|2562673|P1|NOT COMPLETED|Washout: 7 Days||3
1055942|NCT00835211|2562672|P2|COMPLETED|Washout: 7 Days||22
1055943|NCT00835211|2562673|P1|COMPLETED|Washout: 7 Days||21
1055944|NCT00835211|2562672|P2|STARTED|Washout: 7 Days||23
1055945|NCT00835211|2562673|P1|STARTED|Washout: 7 Days||24
1055946|NCT00835211|2562672|P2|NOT COMPLETED|First Intervention||1
1055947|NCT00835211|2562673|P1|NOT COMPLETED|First Intervention||0
1055948|NCT00835211|2562672|P2|COMPLETED|First Intervention||23
1055949|NCT00835211|2562673|P1|COMPLETED|First Intervention||24
1055950|NCT00835211|2562672|P2|STARTED|First Intervention||24
1055951|NCT00835211|2562673|P1|STARTED|First Intervention||24
1055952|NCT00835224|2562681|P1|NOT COMPLETED|Overall Study||10
1055953|NCT00835224|2562681|P1|COMPLETED|Overall Study||24
1055954|NCT00835224|2562681|P1|STARTED|Overall Study||34
1055955|NCT00835237|2562697|P2|NOT COMPLETED|Overall Study||0
1055956|NCT00835237|2562698|P1|NOT COMPLETED|Overall Study||6
1055957|NCT00835237|2562697|P2|COMPLETED|Overall Study||445
1055958|NCT00835237|2562698|P1|COMPLETED|Overall Study||881
1055959|NCT00835237|2562697|P2|STARTED|Overall Study||445
1055960|NCT00835237|2562698|P1|STARTED|Overall Study||887
1055961|NCT00835263|2562724|P2|NOT COMPLETED|Second Intervention||0
1055962|NCT00835263|2562725|P1|NOT COMPLETED|Second Intervention||1
1055963|NCT00835263|2562724|P2|COMPLETED|Second Intervention||16
1055964|NCT00835263|2562725|P1|COMPLETED|Second Intervention||15
1055965|NCT00835263|2562724|P2|STARTED|Second Intervention||16
1055966|NCT00835263|2562725|P1|STARTED|Second Intervention||16
1055967|NCT00835263|2562724|P2|NOT COMPLETED|First Intervention||0
1055968|NCT00835263|2562725|P1|NOT COMPLETED|First Intervention||0
1055969|NCT00835263|2562724|P2|COMPLETED|First Intervention||16
1055970|NCT00835263|2562725|P1|COMPLETED|First Intervention||16
1055971|NCT00835263|2562724|P2|STARTED|First Intervention||16
1055972|NCT00835263|2562725|P1|STARTED|First Intervention||16
1055973|NCT00835276|2562735|P2|NOT COMPLETED|Second Intervention||0
1055974|NCT00835276|2562736|P1|NOT COMPLETED|Second Intervention||0
1055975|NCT00835276|2562735|P2|COMPLETED|Second Intervention||24
1055976|NCT00835276|2562736|P1|COMPLETED|Second Intervention||24
1055977|NCT00835276|2562735|P2|STARTED|Second Intervention||24
1055978|NCT00835276|2562736|P1|STARTED|Second Intervention||24
1055979|NCT00835276|2562735|P2|NOT COMPLETED|Washout of 7 Days||0
1055980|NCT00835276|2562736|P1|NOT COMPLETED|Washout of 7 Days||0
1055981|NCT00835276|2562735|P2|COMPLETED|Washout of 7 Days||24
1055982|NCT00835276|2562736|P1|COMPLETED|Washout of 7 Days||24
1055983|NCT00835276|2562735|P2|STARTED|Washout of 7 Days||24
1055984|NCT00835276|2562736|P1|STARTED|Washout of 7 Days||24
1055985|NCT00835276|2562735|P2|NOT COMPLETED|First Intervention||0
1055986|NCT00835276|2562736|P1|NOT COMPLETED|First Intervention||0
1055987|NCT00835276|2562735|P2|COMPLETED|First Intervention||24
1055988|NCT00835276|2562736|P1|COMPLETED|First Intervention||24
1055989|NCT00835276|2562735|P2|STARTED|First Intervention||24
1055990|NCT00835276|2562736|P1|STARTED|First Intervention||24
1055991|NCT00835341|2562746|P2|NOT COMPLETED|Overall Study||12
1055992|NCT00835341|2562747|P1|NOT COMPLETED|Overall Study||3
1055993|NCT00835341|2562746|P2|COMPLETED|Overall Study||46
1055994|NCT00835341|2562747|P1|COMPLETED|Overall Study||32
1055995|NCT00835341|2562746|P2|STARTED|Overall Study||58
1055996|NCT00835341|2562747|P1|STARTED|Overall Study||35
1055997|NCT00835354|2562755|P2|NOT COMPLETED|Second Intervention||0
1055998|NCT00835354|2562756|P1|NOT COMPLETED|Second Intervention||0
1055999|NCT00835354|2562755|P2|COMPLETED|Second Intervention||12
1056000|NCT00835354|2562756|P1|COMPLETED|Second Intervention||13
1056001|NCT00835354|2562755|P2|STARTED|Second Intervention||12
1056002|NCT00835354|2562756|P1|STARTED|Second Intervention||13
1056003|NCT00835354|2562755|P2|NOT COMPLETED|Washout of 7 Days||0
1056004|NCT00835354|2562756|P1|NOT COMPLETED|Washout of 7 Days||0
1056005|NCT00835354|2562755|P2|COMPLETED|Washout of 7 Days||12
1056006|NCT00835354|2562756|P1|COMPLETED|Washout of 7 Days||13
1056007|NCT00835354|2562755|P2|STARTED|Washout of 7 Days||12
1056008|NCT00835354|2562756|P1|STARTED|Washout of 7 Days||13
1056009|NCT00835354|2562755|P2|NOT COMPLETED|First Intervention||1
1056010|NCT00835354|2562756|P1|NOT COMPLETED|First Intervention||0
1056011|NCT00835354|2562755|P2|COMPLETED|First Intervention||12
1056012|NCT00835354|2562756|P1|COMPLETED|First Intervention||13
1056013|NCT00835354|2562755|P2|STARTED|First Intervention||13
1056014|NCT00835354|2562756|P1|STARTED|First Intervention||13
1056015|NCT00835367|2562766|P2|NOT COMPLETED|Second Intervention||1
1056016|NCT00835367|2562767|P1|NOT COMPLETED|Second Intervention||1
1056017|NCT00835367|2562766|P2|COMPLETED|Second Intervention||33
1056018|NCT00835367|2562767|P1|COMPLETED|Second Intervention||30
1056019|NCT00835367|2562766|P2|STARTED|Second Intervention||34
1056020|NCT00835367|2562767|P1|STARTED|Second Intervention||31
1056021|NCT00835367|2562766|P2|NOT COMPLETED|Washout||0
1056022|NCT00835367|2562767|P1|NOT COMPLETED|Washout||3
1056023|NCT00835367|2562766|P2|COMPLETED|Washout||34
1056024|NCT00835367|2562767|P1|COMPLETED|Washout||31
1056025|NCT00835367|2562766|P2|STARTED|Washout||34
1056026|NCT00835367|2562767|P1|STARTED|Washout||34
1056027|NCT00835367|2562766|P2|NOT COMPLETED|First Intervention||0
1056028|NCT00835367|2562767|P1|NOT COMPLETED|First Intervention||0
1056029|NCT00835367|2562766|P2|COMPLETED|First Intervention||34
1056030|NCT00835367|2562767|P1|COMPLETED|First Intervention||34
1056031|NCT00835367|2562766|P2|STARTED|First Intervention||34
1056032|NCT00835367|2562767|P1|STARTED|First Intervention||34
1056033|NCT00835380|2562787|P1|NOT COMPLETED|Overall Study||2
1056034|NCT00835380|2562787|P1|COMPLETED|Overall Study||78
1056035|NCT00835380|2562787|P1|STARTED|Overall Study||80
1056036|NCT00835406|2562794|P2|NOT COMPLETED|Period: Second Intervention||0
1056037|NCT00835406|2562795|P1|NOT COMPLETED|Period: Second Intervention||0
1056038|NCT00835406|2562794|P2|COMPLETED|Period: Second Intervention||67
1056039|NCT00835406|2562795|P1|COMPLETED|Period: Second Intervention||68
1056040|NCT00835406|2562794|P2|STARTED|Period: Second Intervention||67
1056041|NCT00835406|2562795|P1|STARTED|Period: Second Intervention||68
1056042|NCT00835406|2562794|P2|NOT COMPLETED|Period: Washout of 7 Days||2
1056043|NCT00835406|2562795|P1|NOT COMPLETED|Period: Washout of 7 Days||0
1056044|NCT00835406|2562794|P2|COMPLETED|Period: Washout of 7 Days||67
1056045|NCT00835406|2562795|P1|COMPLETED|Period: Washout of 7 Days||68
1056046|NCT00835406|2562794|P2|STARTED|Period: Washout of 7 Days||69
1056047|NCT00835406|2562795|P1|STARTED|Period: Washout of 7 Days||68
1056048|NCT00835406|2562794|P2|NOT COMPLETED|Period: First Intervention||1
1056049|NCT00835406|2562795|P1|NOT COMPLETED|Period: First Intervention||2
1056050|NCT00835406|2562794|P2|COMPLETED|Period: First Intervention||69
1056051|NCT00835406|2562795|P1|COMPLETED|Period: First Intervention||68
1056052|NCT00835406|2562794|P2|STARTED|Period: First Intervention||70
1056053|NCT00835406|2562795|P1|STARTED|Period: First Intervention||70
1056054|NCT00835484|2562803|P2|NOT COMPLETED|Second Intervention||0
1056055|NCT00835484|2562804|P1|NOT COMPLETED|Second Intervention||0
1056056|NCT00835484|2562803|P2|COMPLETED|Second Intervention||16
1056057|NCT00835484|2562804|P1|COMPLETED|Second Intervention||16
1056058|NCT00835484|2562803|P2|STARTED|Second Intervention||16
1056059|NCT00835484|2562804|P1|STARTED|Second Intervention||16
1056060|NCT00835484|2562803|P2|NOT COMPLETED|Washout of 7 Days||0
1056061|NCT00835484|2562804|P1|NOT COMPLETED|Washout of 7 Days||0
1056062|NCT00835484|2562803|P2|COMPLETED|Washout of 7 Days||16
1056063|NCT00835484|2562804|P1|COMPLETED|Washout of 7 Days||16
1056064|NCT00835484|2562803|P2|STARTED|Washout of 7 Days||16
1056065|NCT00835484|2562804|P1|STARTED|Washout of 7 Days||16
1056066|NCT00835484|2562803|P2|NOT COMPLETED|First Intervention||0
1056067|NCT00835484|2562804|P1|NOT COMPLETED|First Intervention||0
1056068|NCT00835484|2562803|P2|COMPLETED|First Intervention||16
1056069|NCT00835484|2562804|P1|COMPLETED|First Intervention||16
1056070|NCT00835484|2562803|P2|STARTED|First Intervention||16
1056071|NCT00835484|2562804|P1|STARTED|First Intervention||16
1056072|NCT00835497|2562814|P2|NOT COMPLETED|Second Intervention||0
1056073|NCT00835497|2562815|P1|NOT COMPLETED|Second Intervention||0
1056074|NCT00835497|2562814|P2|COMPLETED|Second Intervention||20
1056075|NCT00835497|2562815|P1|COMPLETED|Second Intervention||20
1056076|NCT00835497|2562814|P2|STARTED|Second Intervention||20
1056077|NCT00835497|2562815|P1|STARTED|Second Intervention||20
1056078|NCT00835497|2562814|P2|NOT COMPLETED|Washout: 7 Days||0
1056079|NCT00835497|2562815|P1|NOT COMPLETED|Washout: 7 Days||0
1056080|NCT00835497|2562814|P2|COMPLETED|Washout: 7 Days||20
1056081|NCT00835497|2562815|P1|COMPLETED|Washout: 7 Days||20
1056082|NCT00835497|2562814|P2|STARTED|Washout: 7 Days||20
1056083|NCT00835497|2562815|P1|STARTED|Washout: 7 Days||20
1056084|NCT00835497|2562814|P2|NOT COMPLETED|First Intervention||0
1056085|NCT00835497|2562815|P1|NOT COMPLETED|First Intervention||0
1056086|NCT00835497|2562814|P2|COMPLETED|First Intervention||20
1056087|NCT00835497|2562815|P1|COMPLETED|First Intervention||20
1056088|NCT00835497|2562814|P2|STARTED|First Intervention||20
1056089|NCT00835497|2562815|P1|STARTED|First Intervention||20
1056090|NCT00835510|2562832|P3|NOT COMPLETED|Overall Study||38
1056091|NCT00835510|2562833|P2|NOT COMPLETED|Overall Study||69
1056092|NCT00835510|2562834|P1|NOT COMPLETED|Overall Study||76
1056093|NCT00835510|2562832|P3|COMPLETED|Overall Study||70
1056094|NCT00835510|2562833|P2|COMPLETED|Overall Study||152
1056095|NCT00835510|2562834|P1|COMPLETED|Overall Study||143
1056096|NCT00835510|2562832|P3|Positive Fungal Culture|Overall Study||71
1056097|NCT00835510|2562833|P2|Positive Fungal Culture|Overall Study||155
1056098|NCT00835510|2562834|P1|Positive Fungal Culture|Overall Study||149
1056099|NCT00835510|2562832|P3|STARTED|Overall Study||108
1056100|NCT00835510|2562833|P2|STARTED|Overall Study||221
1056101|NCT00835510|2562834|P1|STARTED|Overall Study||219
1056102|NCT00835536|2562856|P2|NOT COMPLETED|Second Intervention||0
1056103|NCT00835536|2562857|P1|NOT COMPLETED|Second Intervention||0
1056104|NCT00835536|2562856|P2|COMPLETED|Second Intervention||14
1056105|NCT00835536|2562857|P1|COMPLETED|Second Intervention||12
1056106|NCT00835536|2562856|P2|STARTED|Second Intervention||14
1056107|NCT00835536|2562857|P1|STARTED|Second Intervention||12
1056108|NCT00835536|2562856|P2|NOT COMPLETED|Washout of 5 Weeks||0
1056109|NCT00835536|2562857|P1|NOT COMPLETED|Washout of 5 Weeks||1
1056110|NCT00835536|2562856|P2|COMPLETED|Washout of 5 Weeks||14
1056111|NCT00835536|2562857|P1|COMPLETED|Washout of 5 Weeks||12
1056112|NCT00835536|2562856|P2|STARTED|Washout of 5 Weeks||14
1056113|NCT00835536|2562857|P1|STARTED|Washout of 5 Weeks||13
1056114|NCT00835536|2562856|P2|NOT COMPLETED|First Intervention||0
1056115|NCT00835536|2562857|P1|NOT COMPLETED|First Intervention||0
1056116|NCT00835536|2562856|P2|COMPLETED|First Intervention||14
1056117|NCT00835536|2562857|P1|COMPLETED|First Intervention||13
1056118|NCT00835536|2562856|P2|STARTED|First Intervention||14
1056119|NCT00835536|2562857|P1|STARTED|First Intervention||13
1056120|NCT00835549|2562865|P2|NOT COMPLETED|Second Intervention||0
1056121|NCT00835549|2562866|P1|NOT COMPLETED|Second Intervention||0
1056122|NCT00835549|2562865|P2|COMPLETED|Second Intervention||16
1056123|NCT00835549|2562866|P1|COMPLETED|Second Intervention||14
1056124|NCT00835549|2562865|P2|STARTED|Second Intervention||16
1056125|NCT00835549|2562866|P1|STARTED|Second Intervention||14
1056126|NCT00835549|2562865|P2|NOT COMPLETED|Washout of 7 Days||0
1056127|NCT00835549|2562866|P1|NOT COMPLETED|Washout of 7 Days||2
1056128|NCT00835549|2562865|P2|COMPLETED|Washout of 7 Days||16
1056129|NCT00835549|2562866|P1|COMPLETED|Washout of 7 Days||14
1056130|NCT00835549|2562865|P2|STARTED|Washout of 7 Days||16
1056131|NCT00835549|2562866|P1|STARTED|Washout of 7 Days||16
1056132|NCT00835549|2562865|P2|NOT COMPLETED|First Intervention||0
1056133|NCT00835549|2562866|P1|NOT COMPLETED|First Intervention||0
1056134|NCT00835549|2562865|P2|COMPLETED|First Intervention||16
1056135|NCT00835549|2562866|P1|COMPLETED|First Intervention||16
1056136|NCT00835549|2562865|P2|STARTED|First Intervention||16
1056137|NCT00835549|2562866|P1|STARTED|First Intervention||16
1056138|NCT00835575|2562876|P2|NOT COMPLETED|Second Intervention||0
1056139|NCT00835575|2562877|P1|NOT COMPLETED|Second Intervention||0
1056140|NCT00835575|2562876|P2|COMPLETED|Second Intervention||16
1056141|NCT00835575|2562877|P1|COMPLETED|Second Intervention||15
1056142|NCT00835575|2562876|P2|STARTED|Second Intervention||16
1056143|NCT00835575|2562877|P1|STARTED|Second Intervention||15
1056144|NCT00835575|2562876|P2|NOT COMPLETED|Washout of 14 Days||0
1056145|NCT00835575|2562877|P1|NOT COMPLETED|Washout of 14 Days||1
1056146|NCT00835575|2562876|P2|COMPLETED|Washout of 14 Days||16
1056147|NCT00835575|2562877|P1|COMPLETED|Washout of 14 Days||15
1056148|NCT00835575|2562876|P2|STARTED|Washout of 14 Days||16
1056149|NCT00835575|2562877|P1|STARTED|Washout of 14 Days||16
1056150|NCT00835575|2562876|P2|NOT COMPLETED|First Intervention||0
1056151|NCT00835575|2562877|P1|NOT COMPLETED|First Intervention||0
1056152|NCT00835575|2562876|P2|COMPLETED|First Intervention||16
1056153|NCT00835575|2562877|P1|COMPLETED|First Intervention||16
1056154|NCT00835575|2562876|P2|STARTED|First Intervention||16
1056155|NCT00835575|2562877|P1|STARTED|First Intervention||16
1056156|NCT00835588|2562887|P2|NOT COMPLETED|Second Intervention||0
1056157|NCT00835588|2562888|P1|NOT COMPLETED|Second Intervention||0
1056158|NCT00835588|2562887|P2|COMPLETED|Second Intervention||50
1056159|NCT00835588|2562888|P1|COMPLETED|Second Intervention||50
1056160|NCT00835588|2562887|P2|STARTED|Second Intervention||50
1056161|NCT00835588|2562888|P1|STARTED|Second Intervention||50
1056162|NCT00835588|2562887|P2|NOT COMPLETED|Washout: 5 Days||0
1056163|NCT00835588|2562888|P1|NOT COMPLETED|Washout: 5 Days||0
1056164|NCT00835588|2562887|P2|COMPLETED|Washout: 5 Days||50
1056165|NCT00835588|2562888|P1|COMPLETED|Washout: 5 Days||50
1056166|NCT00835588|2562887|P2|STARTED|Washout: 5 Days||50
1056167|NCT00835588|2562888|P1|STARTED|Washout: 5 Days||50
1056168|NCT00835588|2562887|P2|NOT COMPLETED|First Intervention||0
1056169|NCT00835588|2562888|P1|NOT COMPLETED|First Intervention||0
1056170|NCT00835588|2562887|P2|COMPLETED|First Intervention||50
1056171|NCT00835588|2562888|P1|COMPLETED|First Intervention||50
1056172|NCT00835588|2562887|P2|STARTED|First Intervention||50
1056173|NCT00835588|2562888|P1|STARTED|First Intervention||50
1056174|NCT00835614|2562898|P2|NOT COMPLETED|Second Intervention||0
1056175|NCT00835614|2562899|P1|NOT COMPLETED|Second Intervention||0
1056176|NCT00835614|2562898|P2|COMPLETED|Second Intervention||13
1056177|NCT00835614|2562899|P1|COMPLETED|Second Intervention||13
1056178|NCT00835614|2562898|P2|STARTED|Second Intervention||13
1056179|NCT00835614|2562899|P1|STARTED|Second Intervention||13
1056180|NCT00835614|2562898|P2|NOT COMPLETED|Washout of 7 Days||0
1056181|NCT00835614|2562899|P1|NOT COMPLETED|Washout of 7 Days||0
1056182|NCT00835614|2562898|P2|COMPLETED|Washout of 7 Days||13
1056183|NCT00835614|2562899|P1|COMPLETED|Washout of 7 Days||13
1056184|NCT00835614|2562898|P2|STARTED|Washout of 7 Days||13
1056185|NCT00835614|2562899|P1|STARTED|Washout of 7 Days||13
1056186|NCT00835614|2562898|P2|NOT COMPLETED|First Intervention||0
1056187|NCT00835614|2562899|P1|NOT COMPLETED|First Intervention||0
1056188|NCT00835614|2562898|P2|COMPLETED|First Intervention||13
1056189|NCT00835614|2562899|P1|COMPLETED|First Intervention||13
1056190|NCT00835614|2562898|P2|STARTED|First Intervention||13
1056191|NCT00835614|2562899|P1|STARTED|First Intervention||13
1056192|NCT00835640|2562909|P2|NOT COMPLETED|Second Intervention||0
1056193|NCT00835640|2562910|P1|NOT COMPLETED|Second Intervention||1
1056194|NCT00835640|2562909|P2|COMPLETED|Second Intervention||12
1056195|NCT00835640|2562910|P1|COMPLETED|Second Intervention||11
1056196|NCT00835640|2562909|P2|STARTED|Second Intervention||12
1056197|NCT00835640|2562910|P1|STARTED|Second Intervention||12
1056198|NCT00835640|2562909|P2|NOT COMPLETED|Washout of 7 Days||0
1056199|NCT00835640|2562910|P1|NOT COMPLETED|Washout of 7 Days||0
1056200|NCT00835640|2562909|P2|COMPLETED|Washout of 7 Days||12
1056201|NCT00835640|2562910|P1|COMPLETED|Washout of 7 Days||12
1056202|NCT00835640|2562909|P2|STARTED|Washout of 7 Days||12
1056203|NCT00835640|2562910|P1|STARTED|Washout of 7 Days||12
1056204|NCT00835640|2562909|P2|NOT COMPLETED|First Intervention||0
1056205|NCT00835640|2562910|P1|NOT COMPLETED|First Intervention||0
1056206|NCT00835640|2562909|P2|COMPLETED|First Intervention||12
1056207|NCT00835640|2562910|P1|COMPLETED|First Intervention||12
1056208|NCT00835640|2562909|P2|STARTED|First Intervention||12
1056209|NCT00835640|2562910|P1|STARTED|First Intervention||12
1056210|NCT00835666|2562920|P2|NOT COMPLETED|Second Intervention||0
1056211|NCT00835666|2562921|P1|NOT COMPLETED|Second Intervention||0
1056212|NCT00835666|2562920|P2|COMPLETED|Second Intervention||16
1056213|NCT00835666|2562921|P1|COMPLETED|Second Intervention||14
1056214|NCT00835666|2562920|P2|STARTED|Second Intervention||16
1056215|NCT00835666|2562921|P1|STARTED|Second Intervention||14
1056216|NCT00835666|2562920|P2|NOT COMPLETED|Washout||0
1056217|NCT00835666|2562921|P1|NOT COMPLETED|Washout||2
1056218|NCT00835666|2562920|P2|COMPLETED|Washout||16
1056219|NCT00835666|2562921|P1|COMPLETED|Washout||14
1056220|NCT00835666|2562920|P2|STARTED|Washout||16
1056221|NCT00835666|2562921|P1|STARTED|Washout||16
1056222|NCT00835666|2562920|P2|NOT COMPLETED|First Intervention||0
1056223|NCT00835666|2562921|P1|NOT COMPLETED|First Intervention||0
1056224|NCT00835666|2562920|P2|COMPLETED|First Intervention||16
1056225|NCT00835666|2562921|P1|COMPLETED|First Intervention||16
1056226|NCT00835666|2562920|P2|STARTED|First Intervention||16
1056227|NCT00835666|2562921|P1|STARTED|First Intervention||16
1056228|NCT00835679|2562933|P4|NOT COMPLETED|Overall Study||0
1056229|NCT00835679|2562934|P3|NOT COMPLETED|Overall Study||0
1056230|NCT00835679|2562935|P2|NOT COMPLETED|Overall Study||0
1056231|NCT00835679|2562936|P1|NOT COMPLETED|Overall Study||1
1056232|NCT00835679|2562933|P4|COMPLETED|Overall Study||0
1056233|NCT00835679|2562934|P3|COMPLETED|Overall Study||0
1056234|NCT00835679|2562935|P2|COMPLETED|Overall Study||0
1056235|NCT00835679|2562936|P1|COMPLETED|Overall Study||8
1056236|NCT00835679|2562933|P4|STARTED|Overall Study||0
1056237|NCT00835679|2562934|P3|STARTED|Overall Study||0
1056238|NCT00835679|2562935|P2|STARTED|Overall Study|This study closed prematurely, thus no patients went on Cohort B, C or D.|0
1056239|NCT00835679|2562936|P1|STARTED|Overall Study||9
1056240|NCT00835692|2562960|P2|NOT COMPLETED|Second Intervention||0
1056241|NCT00835692|2562961|P1|NOT COMPLETED|Second Intervention||0
1056242|NCT00835692|2562960|P2|COMPLETED|Second Intervention||28
1056243|NCT00835692|2562961|P1|COMPLETED|Second Intervention||27
1056244|NCT00835692|2562960|P2|STARTED|Second Intervention||28
1056245|NCT00835692|2562961|P1|STARTED|Second Intervention||27
1056246|NCT00835692|2562960|P2|NOT COMPLETED|Washout||0
1056247|NCT00835692|2562961|P1|NOT COMPLETED|Washout||0
1056248|NCT00835692|2562960|P2|COMPLETED|Washout||28
1056249|NCT00835692|2562961|P1|COMPLETED|Washout||27
1056250|NCT00835692|2562960|P2|STARTED|Washout||28
1056251|NCT00835692|2562961|P1|STARTED|Washout||27
1056252|NCT00835692|2562960|P2|NOT COMPLETED|First Intervention||0
1056253|NCT00835692|2562961|P1|NOT COMPLETED|First Intervention||1
1056254|NCT00835692|2562960|P2|COMPLETED|First Intervention||28
1056255|NCT00835692|2562961|P1|COMPLETED|First Intervention||27
1056256|NCT00835692|2562960|P2|STARTED|First Intervention||28
1056257|NCT00835692|2562961|P1|STARTED|First Intervention||28
1056258|NCT00835705|2562971|P2|NOT COMPLETED|Second Intervention||0
1056259|NCT00835705|2562972|P1|NOT COMPLETED|Second Intervention||1
1056260|NCT00835705|2562971|P2|COMPLETED|Second Intervention||28
1056261|NCT00835705|2562972|P1|COMPLETED|Second Intervention||22
1056262|NCT00835705|2562971|P2|STARTED|Second Intervention||28
1056263|NCT00835705|2562972|P1|STARTED|Second Intervention||23
1056264|NCT00835705|2562971|P2|NOT COMPLETED|First Intervention||0
1056265|NCT00835705|2562972|P1|NOT COMPLETED|First Intervention||1
1056266|NCT00835705|2562971|P2|COMPLETED|First Intervention||28
1056267|NCT00835705|2562972|P1|COMPLETED|First Intervention||23
1056268|NCT00835705|2562971|P2|STARTED|First Intervention||28
1056269|NCT00835705|2562972|P1|STARTED|First Intervention||24
1056276|NCT00835796|2563005|P2|NOT COMPLETED|Second Intervention||0
1056277|NCT00835796|2563006|P1|NOT COMPLETED|Second Intervention||0
1056278|NCT00835796|2563005|P2|COMPLETED|Second Intervention||9
1056279|NCT00835796|2563006|P1|COMPLETED|Second Intervention||10
1056280|NCT00835796|2563005|P2|STARTED|Second Intervention||9
1056281|NCT00835796|2563006|P1|STARTED|Second Intervention||10
1056282|NCT00835796|2563005|P2|NOT COMPLETED|Washout||0
1056283|NCT00835796|2563006|P1|NOT COMPLETED|Washout||0
1056284|NCT00835796|2563005|P2|COMPLETED|Washout||9
1056285|NCT00835796|2563006|P1|COMPLETED|Washout||10
1056286|NCT00835796|2563005|P2|STARTED|Washout||9
1056287|NCT00835796|2563006|P1|STARTED|Washout||10
1056288|NCT00835796|2563005|P2|NOT COMPLETED|First Intervention||1
1056289|NCT00835796|2563006|P1|NOT COMPLETED|First Intervention||0
1056290|NCT00835796|2563005|P2|COMPLETED|First Intervention||9
1056291|NCT00835796|2563006|P1|COMPLETED|First Intervention||10
1056292|NCT00835796|2563005|P2|STARTED|First Intervention||10
1056293|NCT00835796|2563006|P1|STARTED|First Intervention||10
1056294|NCT00835861|2563016|P2|NOT COMPLETED|Overall Study||2
1056295|NCT00835861|2563017|P1|NOT COMPLETED|Overall Study||1
1056296|NCT00835861|2563016|P2|COMPLETED|Overall Study||14
1056297|NCT00835861|2563017|P1|COMPLETED|Overall Study||14
1056298|NCT00835861|2563016|P2|STARTED|Overall Study||16
1056299|NCT00835861|2563017|P1|STARTED|Overall Study||15
1056300|NCT00835900|2563041|P2|NOT COMPLETED|Overall Study||6
1056301|NCT00835900|2563042|P1|NOT COMPLETED|Overall Study||5
1056302|NCT00835900|2563041|P2|COMPLETED|Overall Study||22
1056303|NCT00835900|2563042|P1|COMPLETED|Overall Study||27
1056304|NCT00835900|2563041|P2|STARTED|Overall Study||28
1056305|NCT00835900|2563042|P1|STARTED|Overall Study||32
1056306|NCT00835926|2563052|P2|NOT COMPLETED|Overall Study||0
1056307|NCT00835926|2563053|P1|NOT COMPLETED|Overall Study||0
1056308|NCT00835926|2563052|P2|COMPLETED|Overall Study||60
1056309|NCT00835926|2563053|P1|COMPLETED|Overall Study||61
1056310|NCT00835926|2563052|P2|STARTED|Overall Study||60
1056311|NCT00835926|2563053|P1|STARTED|Overall Study||61
1056312|NCT00835978|2563069|P4|NOT COMPLETED|Overall Study||10
1056313|NCT00835978|2563070|P3|NOT COMPLETED|Overall Study||91
1056314|NCT00835978|2563071|P2|NOT COMPLETED|Overall Study||56
1056315|NCT00835978|2563072|P1|NOT COMPLETED|Overall Study||56
1056316|NCT00835978|2563069|P4|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
1056317|NCT00835978|2563070|P3|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
1056318|NCT00835978|2563071|P2|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
1056319|NCT00835978|2563072|P1|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
1056320|NCT00835978|2563069|P4|Treated|Overall Study||10
1056321|NCT00835978|2563070|P3|Treated|Overall Study||91
1056322|NCT00835978|2563071|P2|Treated|Overall Study||56
1056323|NCT00835978|2563072|P1|Treated|Overall Study||56
1056324|NCT00835978|2563069|P4|STARTED|Overall Study||10
1056325|NCT00835978|2563070|P3|STARTED|Overall Study||91
1056326|NCT00835978|2563071|P2|STARTED|Overall Study||56
1056327|NCT00835978|2563072|P1|STARTED|Overall Study||56
1056328|NCT00835991|2563132|P2|NOT COMPLETED|Second Intervention||0
1056329|NCT00835991|2563133|P1|NOT COMPLETED|Second Intervention||0
1056330|NCT00835991|2563132|P2|COMPLETED|Second Intervention||26
1056331|NCT00835991|2563133|P1|COMPLETED|Second Intervention||27
1056332|NCT00835991|2563132|P2|STARTED|Second Intervention||26
1056333|NCT00835991|2563133|P1|STARTED|Second Intervention||27
1056334|NCT00835991|2563132|P2|NOT COMPLETED|Washout||3
1056335|NCT00835991|2563133|P1|NOT COMPLETED|Washout||3
1056336|NCT00835991|2563132|P2|COMPLETED|Washout||26
1056337|NCT00835991|2563133|P1|COMPLETED|Washout||27
1056338|NCT00835991|2563132|P2|STARTED|Washout||29
1056339|NCT00835991|2563133|P1|STARTED|Washout||30
1056340|NCT00835991|2563132|P2|NOT COMPLETED|First Intervention||1
1056341|NCT00835991|2563133|P1|NOT COMPLETED|First Intervention||0
1056342|NCT00835991|2563132|P2|COMPLETED|First Intervention||29
1056343|NCT00835991|2563133|P1|COMPLETED|First Intervention||30
1056344|NCT00835991|2563132|P2|STARTED|First Intervention||30
1056345|NCT00835991|2563133|P1|STARTED|First Intervention||30
1056346|NCT00836004|2563149|P2|NOT COMPLETED|Second Intervention||0
1056347|NCT00836004|2563150|P1|NOT COMPLETED|Second Intervention||0
1056348|NCT00836004|2563149|P2|COMPLETED|Second Intervention||12
1056349|NCT00836004|2563150|P1|COMPLETED|Second Intervention||12
1056350|NCT00836004|2563149|P2|STARTED|Second Intervention||12
1056351|NCT00836004|2563150|P1|STARTED|Second Intervention||12
1056352|NCT00836004|2563149|P2|NOT COMPLETED|Washout: 7 Days||0
1056353|NCT00836004|2563150|P1|NOT COMPLETED|Washout: 7 Days||0
1056354|NCT00836004|2563149|P2|COMPLETED|Washout: 7 Days||12
1056355|NCT00836004|2563150|P1|COMPLETED|Washout: 7 Days||12
1056356|NCT00836004|2563149|P2|STARTED|Washout: 7 Days||12
1056357|NCT00836004|2563150|P1|STARTED|Washout: 7 Days||12
1056358|NCT00836004|2563149|P2|NOT COMPLETED|First Intervention||0
1056359|NCT00836004|2563150|P1|NOT COMPLETED|First Intervention||0
1056360|NCT00836004|2563149|P2|COMPLETED|First Intervention||12
1056361|NCT00836004|2563150|P1|COMPLETED|First Intervention||12
1056362|NCT00836004|2563149|P2|STARTED|First Intervention||12
1056363|NCT00836004|2563150|P1|STARTED|First Intervention||12
1056364|NCT00836017|2563158|P1|NOT COMPLETED|Overall Study||544
1056365|NCT00836017|2563158|P1|COMPLETED|Overall Study||502
1056366|NCT00836017|2563158|P1|STARTED|Overall Study||1046
1056367|NCT00836056|2563168|P2|NOT COMPLETED|Second Intervention||0
1056368|NCT00836056|2563169|P1|NOT COMPLETED|Second Intervention||0
1056369|NCT00836056|2563168|P2|COMPLETED|Second Intervention||12
1056370|NCT00836056|2563169|P1|COMPLETED|Second Intervention||11
1056371|NCT00836056|2563168|P2|STARTED|Second Intervention||12
1056372|NCT00836056|2563169|P1|STARTED|Second Intervention||11
1056373|NCT00836056|2563168|P2|NOT COMPLETED|Washout: 7 Days||0
1056374|NCT00836056|2563169|P1|NOT COMPLETED|Washout: 7 Days||0
1056375|NCT00836056|2563168|P2|COMPLETED|Washout: 7 Days||12
1056376|NCT00836056|2563169|P1|COMPLETED|Washout: 7 Days||11
1056377|NCT00836056|2563168|P2|STARTED|Washout: 7 Days||12
1056378|NCT00836056|2563169|P1|STARTED|Washout: 7 Days||11
1056379|NCT00836056|2563168|P2|NOT COMPLETED|First Intervention||0
1056380|NCT00836056|2563169|P1|NOT COMPLETED|First Intervention||1
1056381|NCT00836056|2563168|P2|COMPLETED|First Intervention||12
1056382|NCT00836056|2563169|P1|COMPLETED|First Intervention||11
1056383|NCT00836056|2563168|P2|STARTED|First Intervention||12
1056384|NCT00836056|2563169|P1|STARTED|First Intervention||12
1056385|NCT00836095|2563179|P2|NOT COMPLETED|Overall Study||3
1056386|NCT00836095|2563180|P1|NOT COMPLETED|Overall Study||0
1056387|NCT00836095|2563179|P2|COMPLETED|Overall Study||27
1056388|NCT00836095|2563180|P1|COMPLETED|Overall Study||22
1056389|NCT00836095|2563179|P2|STARTED|Overall Study||30
1056390|NCT00836095|2563180|P1|STARTED|Overall Study||22
1056391|NCT00824850|2563190|P2|NOT COMPLETED|Overall Study||1
1056392|NCT00824850|2563191|P1|NOT COMPLETED|Overall Study||0
1056393|NCT00824850|2563190|P2|COMPLETED|Overall Study||36
1056394|NCT00824850|2563191|P1|COMPLETED|Overall Study||38
1056395|NCT00824850|2563190|P2|Received Vaccination 13vPnC|Overall Study||36
1056396|NCT00824850|2563191|P1|Received Vaccination 13vPnC|Overall Study||38
1056397|NCT00824850|2563190|P2|STARTED|Overall Study||37
1056398|NCT00824850|2563191|P1|STARTED|Overall Study||38
1056399|NCT00825162|2563238|P3|NOT COMPLETED|Overall Study||6
1056400|NCT00825162|2563239|P2|NOT COMPLETED|Overall Study||21
1056401|NCT00825162|2563240|P1|NOT COMPLETED|Overall Study||28
1056402|NCT00825162|2563238|P3|COMPLETED|Overall Study||396
1056403|NCT00825162|2563239|P2|COMPLETED|Overall Study||859
1056404|NCT00825162|2563240|P1|COMPLETED|Overall Study||682
1056405|NCT00825162|2563238|P3|STARTED|Overall Study||402
1056406|NCT00825162|2563239|P2|STARTED|Overall Study||880
1056407|NCT00825162|2563240|P1|STARTED|Overall Study||710
1056408|NCT00825175|2563266|P2|NOT COMPLETED|Overall Study||5
1056409|NCT00825175|2563267|P1|NOT COMPLETED|Overall Study||0
1056410|NCT00825175|2563266|P2|COMPLETED|Overall Study||7
1056411|NCT00825175|2563267|P1|COMPLETED|Overall Study||10
1056412|NCT00825175|2563266|P2|STARTED|Overall Study||12
1056413|NCT00825175|2563267|P1|STARTED|Overall Study||10
1056414|NCT00825227|2563275|P2|NOT COMPLETED|Overall Study||0
1056415|NCT00825227|2563276|P1|NOT COMPLETED|Overall Study||0
1056416|NCT00825227|2563275|P2|COMPLETED|Overall Study||4
1056417|NCT00825227|2563276|P1|COMPLETED|Overall Study||6
1056418|NCT00825227|2563275|P2|STARTED|Overall Study||4
1056419|NCT00825227|2563276|P1|STARTED|Overall Study||6
1056420|NCT00825266|2563284|P2|NOT COMPLETED|Overall Study||0
1056421|NCT00825266|2563285|P1|NOT COMPLETED|Overall Study||0
1056422|NCT00825266|2563284|P2|COMPLETED|Overall Study||1
1056423|NCT00825266|2563285|P1|COMPLETED|Overall Study||1
1056424|NCT00825266|2563284|P2|STARTED|Overall Study||1
1056425|NCT00825266|2563285|P1|STARTED|Overall Study||1
1056426|NCT00825305|2563297|P2|NOT COMPLETED|Overall Study||23
1056427|NCT00825305|2563298|P1|NOT COMPLETED|Overall Study||17
1056428|NCT00825305|2563297|P2|COMPLETED|Overall Study||252
1056429|NCT00825305|2563298|P1|COMPLETED|Overall Study||533
1056430|NCT00825305|2563297|P2|STARTED|Overall Study||275
1056431|NCT00825305|2563298|P1|STARTED|Overall Study||550
1056432|NCT00825318|2563310|P1|NOT COMPLETED|Overall Study||1
1056433|NCT00825318|2563310|P1|COMPLETED|Overall Study||12
1056434|NCT00825318|2563310|P1|STARTED|Overall Study||13
1056435|NCT00825344|2563320|P2|NOT COMPLETED|Overall Study||1
1056436|NCT00825344|2563321|P1|NOT COMPLETED|Overall Study||1
1056437|NCT00825344|2563320|P2|COMPLETED|Overall Study||42
1056438|NCT00825344|2563321|P1|COMPLETED|Overall Study||33
1056439|NCT00825344|2563320|P2|STARTED|Overall Study||43
1056440|NCT00825344|2563321|P1|STARTED|Overall Study||34
1056441|NCT00825500|2563334|P3|NOT COMPLETED|Overall Study||0
1056442|NCT00825500|2563335|P2|NOT COMPLETED|Overall Study||0
1056443|NCT00825500|2563336|P1|NOT COMPLETED|Overall Study||0
1056444|NCT00825500|2563334|P3|COMPLETED|Overall Study||120
1056445|NCT00825500|2563335|P2|COMPLETED|Overall Study||121
1056446|NCT00825500|2563336|P1|COMPLETED|Overall Study||125
1056447|NCT00825500|2563334|P3|STARTED|Overall Study||120
1056448|NCT00825500|2563335|P2|STARTED|Overall Study||121
1056449|NCT00825500|2563336|P1|STARTED|Overall Study||125
1056450|NCT00825565|2563347|P1|NOT COMPLETED|Overall Study||0
1056451|NCT00825565|2563347|P1|COMPLETED|Overall Study||8
1056452|NCT00825565|2563347|P1|STARTED|Overall Study||8
1056453|NCT00825630|2563356|P4|NOT COMPLETED|Overall Study||0
1056454|NCT00825630|2563357|P3|NOT COMPLETED|Overall Study||0
1056455|NCT00825630|2563358|P2|NOT COMPLETED|Overall Study||0
1056456|NCT00825630|2563359|P1|NOT COMPLETED|Overall Study||0
1056457|NCT00825630|2563356|P4|COMPLETED|Overall Study||13
1056458|NCT00825630|2563357|P3|COMPLETED|Overall Study||19
1056459|NCT00825630|2563358|P2|COMPLETED|Overall Study||62
1056460|NCT00825630|2563359|P1|COMPLETED|Overall Study||29
1056461|NCT00825630|2563356|P4|STARTED|Overall Study||13
1056462|NCT00825630|2563357|P3|STARTED|Overall Study||19
1056463|NCT00825630|2563358|P2|STARTED|Overall Study||62
1056464|NCT00825630|2563359|P1|STARTED|Overall Study||29
1056465|NCT00825682|2563371|P2|NOT COMPLETED|Overall Study||5
1056466|NCT00825682|2563372|P1|NOT COMPLETED|Overall Study||13
1056467|NCT00825682|2563371|P2|COMPLETED|Overall Study||20
1056468|NCT00825682|2563372|P1|COMPLETED|Overall Study||34
1056469|NCT00825682|2563371|P2|STARTED|Overall Study||25
1056470|NCT00825682|2563372|P1|STARTED|Overall Study||47
1056471|NCT00825734|2563382|P3|NOT COMPLETED|Phase II||76
1056472|NCT00825734|2563383|P2|NOT COMPLETED|Phase II||0
1056473|NCT00825734|2563384|P1|NOT COMPLETED|Phase II||0
1056474|NCT00825734|2563382|P3|COMPLETED|Phase II||0
1056475|NCT00825734|2563383|P2|COMPLETED|Phase II||0
1056476|NCT00825734|2563384|P1|COMPLETED|Phase II||0
1056477|NCT00825734|2563382|P3|STARTED|Phase II|Includes patients treated at MTD during Phase I and 73 additional patients enrolled for Phase II|76
1056478|NCT00825734|2563383|P2|STARTED|Phase II||0
1056479|NCT00825734|2563384|P1|STARTED|Phase II||0
1056480|NCT00825734|2563382|P3|NOT COMPLETED|Phase I||0
1056481|NCT00825734|2563383|P2|NOT COMPLETED|Phase I||3
1056482|NCT00825734|2563384|P1|NOT COMPLETED|Phase I||4
1056483|NCT00825734|2563382|P3|COMPLETED|Phase I||3
1056484|NCT00825734|2563383|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
1056485|NCT00825734|2563384|P1|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
1056486|NCT00825734|2563382|P3|STARTED|Phase I||3
1056487|NCT00825734|2563383|P2|STARTED|Phase I||3
1056488|NCT00825734|2563384|P1|STARTED|Phase I||4
1056489|NCT00825786|2563394|P2|NOT COMPLETED|Overall Study||0
1056490|NCT00825786|2563395|P1|NOT COMPLETED|Overall Study||0
1056491|NCT00825786|2563394|P2|COMPLETED|Overall Study||51
1056492|NCT00825786|2563395|P1|COMPLETED|Overall Study||52
1056493|NCT00825786|2563394|P2|STARTED|Overall Study||51
1056494|NCT00825786|2563395|P1|STARTED|Overall Study||52
1056495|NCT00825812|2563417|P4|NOT COMPLETED|Overall Study||10
1056496|NCT00825812|2563418|P3|NOT COMPLETED|Overall Study||6
1056497|NCT00825812|2563419|P2|NOT COMPLETED|Overall Study||1
1056498|NCT00825812|2563420|P1|NOT COMPLETED|Overall Study||0
1056499|NCT00825812|2563417|P4|COMPLETED|Overall Study||111
1056500|NCT00825812|2563418|P3|COMPLETED|Overall Study||120
1056501|NCT00825812|2563419|P2|COMPLETED|Overall Study||31
1056502|NCT00825812|2563420|P1|COMPLETED|Overall Study||29
1056503|NCT00825812|2563417|P4|TREATED|Overall Study||111
1056504|NCT00825812|2563418|P3|TREATED|Overall Study||120
1056505|NCT00825812|2563419|P2|TREATED|Overall Study||31
1056506|NCT00825812|2563420|P1|TREATED|Overall Study||29
1056507|NCT00825812|2563417|P4|STARTED|Overall Study||121
1056508|NCT00825812|2563418|P3|STARTED|Overall Study||126
1056509|NCT00825812|2563419|P2|STARTED|Overall Study||32
1056510|NCT00825812|2563420|P1|STARTED|Overall Study||29
1056511|NCT00825825|2563434|P6|NOT COMPLETED|Third Medication Period (14 Days)||2
1056512|NCT00825825|2563435|P5|NOT COMPLETED|Third Medication Period (14 Days)||0
1056513|NCT00825825|2563436|P4|NOT COMPLETED|Third Medication Period (14 Days)||0
1056514|NCT00825825|2563437|P3|NOT COMPLETED|Third Medication Period (14 Days)||0
1056515|NCT00825825|2563438|P2|NOT COMPLETED|Third Medication Period (14 Days)||2
1056516|NCT00825825|2563439|P1|NOT COMPLETED|Third Medication Period (14 Days)||0
1056517|NCT00825825|2563434|P6|COMPLETED|Third Medication Period (14 Days)||1
1056518|NCT00825825|2563435|P5|COMPLETED|Third Medication Period (14 Days)||3
1056519|NCT00825825|2563436|P4|COMPLETED|Third Medication Period (14 Days)||3
1056520|NCT00825825|2563437|P3|COMPLETED|Third Medication Period (14 Days)||2
1056521|NCT00825825|2563438|P2|COMPLETED|Third Medication Period (14 Days)||2
1056522|NCT00825825|2563439|P1|COMPLETED|Third Medication Period (14 Days)||1
1056523|NCT00825825|2563434|P6|STARTED|Third Medication Period (14 Days)||3
1056524|NCT00825825|2563435|P5|STARTED|Third Medication Period (14 Days)||3
1056525|NCT00825825|2563436|P4|STARTED|Third Medication Period (14 Days)||3
1056526|NCT00825825|2563437|P3|STARTED|Third Medication Period (14 Days)||2
1056527|NCT00825825|2563438|P2|STARTED|Third Medication Period (14 Days)||4
1056528|NCT00825825|2563439|P1|STARTED|Third Medication Period (14 Days)||1
1056529|NCT00825825|2563434|P6|NOT COMPLETED|Second Washout Period (14 Days)||0
1056530|NCT00825825|2563435|P5|NOT COMPLETED|Second Washout Period (14 Days)||0
1056531|NCT00825825|2563436|P4|NOT COMPLETED|Second Washout Period (14 Days)||0
1056532|NCT00825825|2563437|P3|NOT COMPLETED|Second Washout Period (14 Days)||0
1056533|NCT00825825|2563438|P2|NOT COMPLETED|Second Washout Period (14 Days)||0
1056534|NCT00825825|2563439|P1|NOT COMPLETED|Second Washout Period (14 Days)||0
1056535|NCT00825825|2563434|P6|COMPLETED|Second Washout Period (14 Days)||3
1056536|NCT00825825|2563435|P5|COMPLETED|Second Washout Period (14 Days)||3
1056537|NCT00825825|2563436|P4|COMPLETED|Second Washout Period (14 Days)||3
1056538|NCT00825825|2563437|P3|COMPLETED|Second Washout Period (14 Days)||2
1056539|NCT00825825|2563438|P2|COMPLETED|Second Washout Period (14 Days)||4
1056540|NCT00825825|2563439|P1|COMPLETED|Second Washout Period (14 Days)||1
1056541|NCT00825825|2563434|P6|STARTED|Second Washout Period (14 Days)||3
1056542|NCT00825825|2563435|P5|STARTED|Second Washout Period (14 Days)||3
1056543|NCT00825825|2563436|P4|STARTED|Second Washout Period (14 Days)||3
1056544|NCT00825825|2563437|P3|STARTED|Second Washout Period (14 Days)||2
1056545|NCT00825825|2563438|P2|STARTED|Second Washout Period (14 Days)||4
1056546|NCT00825825|2563439|P1|STARTED|Second Washout Period (14 Days)||1
1056547|NCT00825825|2563434|P6|NOT COMPLETED|Second Medication Period (14 Days)||0
1056548|NCT00825825|2563435|P5|NOT COMPLETED|Second Medication Period (14 Days)||1
1056549|NCT00825825|2563436|P4|NOT COMPLETED|Second Medication Period (14 Days)||2
1056550|NCT00825825|2563437|P3|NOT COMPLETED|Second Medication Period (14 Days)||0
1056551|NCT00825825|2563438|P2|NOT COMPLETED|Second Medication Period (14 Days)||0
1056552|NCT00825825|2563439|P1|NOT COMPLETED|Second Medication Period (14 Days)||2
1056553|NCT00825825|2563434|P6|COMPLETED|Second Medication Period (14 Days)||3
1056554|NCT00825825|2563435|P5|COMPLETED|Second Medication Period (14 Days)||3
1056555|NCT00825825|2563436|P4|COMPLETED|Second Medication Period (14 Days)||3
1056556|NCT00825825|2563437|P3|COMPLETED|Second Medication Period (14 Days)||2
1056557|NCT00825825|2563438|P2|COMPLETED|Second Medication Period (14 Days)||4
1056558|NCT00825825|2563439|P1|COMPLETED|Second Medication Period (14 Days)||1
1056559|NCT00825825|2563434|P6|STARTED|Second Medication Period (14 Days)||3
1056560|NCT00825825|2563435|P5|STARTED|Second Medication Period (14 Days)||4
1056561|NCT00825825|2563436|P4|STARTED|Second Medication Period (14 Days)||5
1056562|NCT00825825|2563437|P3|STARTED|Second Medication Period (14 Days)||2
1056563|NCT00825825|2563438|P2|STARTED|Second Medication Period (14 Days)||4
1056564|NCT00825825|2563439|P1|STARTED|Second Medication Period (14 Days)||3
1056565|NCT00825825|2563434|P6|NOT COMPLETED|First Washout Period (14 Days)||0
1056566|NCT00825825|2563435|P5|NOT COMPLETED|First Washout Period (14 Days)||0
1056567|NCT00825825|2563436|P4|NOT COMPLETED|First Washout Period (14 Days)||0
1056568|NCT00825825|2563437|P3|NOT COMPLETED|First Washout Period (14 Days)||0
1056569|NCT00825825|2563438|P2|NOT COMPLETED|First Washout Period (14 Days)||0
1056570|NCT00825825|2563439|P1|NOT COMPLETED|First Washout Period (14 Days)||0
1056571|NCT00825825|2563434|P6|COMPLETED|First Washout Period (14 Days)||3
1056572|NCT00825825|2563435|P5|COMPLETED|First Washout Period (14 Days)||4
1056573|NCT00825825|2563436|P4|COMPLETED|First Washout Period (14 Days)||5
1056574|NCT00825825|2563437|P3|COMPLETED|First Washout Period (14 Days)||2
1056575|NCT00825825|2563438|P2|COMPLETED|First Washout Period (14 Days)||4
1056576|NCT00825825|2563439|P1|COMPLETED|First Washout Period (14 Days)||3
1056577|NCT00825825|2563434|P6|STARTED|First Washout Period (14 Days)||3
1056578|NCT00825825|2563435|P5|STARTED|First Washout Period (14 Days)||4
1056579|NCT00825825|2563436|P4|STARTED|First Washout Period (14 Days)||5
1056580|NCT00825825|2563437|P3|STARTED|First Washout Period (14 Days)||2
1056581|NCT00825825|2563438|P2|STARTED|First Washout Period (14 Days)||4
1056582|NCT00825825|2563439|P1|STARTED|First Washout Period (14 Days)||3
1056583|NCT00825825|2563434|P6|NOT COMPLETED|First Medication Period (14 Days)||2
1056584|NCT00825825|2563435|P5|NOT COMPLETED|First Medication Period (14 Days)||0
1056585|NCT00825825|2563436|P4|NOT COMPLETED|First Medication Period (14 Days)||0
1056586|NCT00825825|2563437|P3|NOT COMPLETED|First Medication Period (14 Days)||1
1056587|NCT00825825|2563438|P2|NOT COMPLETED|First Medication Period (14 Days)||0
1056588|NCT00825825|2563439|P1|NOT COMPLETED|First Medication Period (14 Days)||3
1056589|NCT00825825|2563434|P6|COMPLETED|First Medication Period (14 Days)||3
1056590|NCT00825825|2563435|P5|COMPLETED|First Medication Period (14 Days)||4
1056591|NCT00825825|2563436|P4|COMPLETED|First Medication Period (14 Days)||5
1056592|NCT00825825|2563437|P3|COMPLETED|First Medication Period (14 Days)||2
1056593|NCT00825825|2563438|P2|COMPLETED|First Medication Period (14 Days)||4
1056594|NCT00825825|2563439|P1|COMPLETED|First Medication Period (14 Days)||3
1056595|NCT00825825|2563434|P6|STARTED|First Medication Period (14 Days)||5
1056596|NCT00825825|2563435|P5|STARTED|First Medication Period (14 Days)||4
1056597|NCT00825825|2563436|P4|STARTED|First Medication Period (14 Days)||5
1056598|NCT00825825|2563437|P3|STARTED|First Medication Period (14 Days)||3
1056599|NCT00825825|2563438|P2|STARTED|First Medication Period (14 Days)||4
1056600|NCT00825825|2563439|P1|STARTED|First Medication Period (14 Days)||6
1056601|NCT00825916|2563454|P3|NOT COMPLETED|Overall Study||1
1056602|NCT00825916|2563455|P2|NOT COMPLETED|Overall Study||2
1056603|NCT00825916|2563456|P1|NOT COMPLETED|Overall Study||4
1056604|NCT00825916|2563454|P3|COMPLETED|Overall Study||19
1056605|NCT00825916|2563455|P2|COMPLETED|Overall Study||18
1056606|NCT00825916|2563456|P1|COMPLETED|Overall Study||15
1056607|NCT00825916|2563454|P3|STARTED|Overall Study||20
1056608|NCT00825916|2563455|P2|STARTED|Overall Study||20
1056609|NCT00825916|2563456|P1|STARTED|Overall Study||19
1056610|NCT00825994|2563497|P1|NOT COMPLETED|Overall Study||5
1056611|NCT00825994|2563497|P1|COMPLETED|Overall Study||19
1056612|NCT00825994|2563497|P1|STARTED|Overall Study||24
1056613|NCT00826007|2563504|P2|NOT COMPLETED|Overall Study||0
1056614|NCT00826007|2563505|P1|NOT COMPLETED|Overall Study||0
1056615|NCT00826007|2563504|P2|COMPLETED|Overall Study||279
1056616|NCT00826007|2563505|P1|COMPLETED|Overall Study|Retrospective review|308
1056617|NCT00826007|2563504|P2|STARTED|Overall Study||279
1056618|NCT00826007|2563505|P1|STARTED|Overall Study|Retrospective review|308
1056619|NCT00826111|2563512|P2|NOT COMPLETED|Overall Study||2
1056620|NCT00826111|2563513|P1|NOT COMPLETED|Overall Study||7
1056621|NCT00826111|2563512|P2|COMPLETED|Overall Study||3
1056622|NCT00826111|2563513|P1|COMPLETED|Overall Study||7
1056623|NCT00826111|2563512|P2|STARTED|Overall Study||5
1056624|NCT00826111|2563513|P1|STARTED|Overall Study||14
1056625|NCT00836277|2563535|P1|NOT COMPLETED|Overall Study||6
1056626|NCT00836277|2563535|P1|COMPLETED|Overall Study||18
1056627|NCT00836277|2563535|P1|STARTED|Overall Study||24
1056628|NCT00836342|2563546|P3|NOT COMPLETED|Overall Study||0
1056629|NCT00836342|2563547|P2|NOT COMPLETED|Overall Study||0
1056630|NCT00836342|2563548|P1|NOT COMPLETED|Overall Study||0
1056631|NCT00836342|2563546|P3|COMPLETED|Overall Study||36
1056632|NCT00836342|2563547|P2|COMPLETED|Overall Study||23
1056633|NCT00836342|2563548|P1|COMPLETED|Overall Study||22
1056634|NCT00836342|2563546|P3|STARTED|Overall Study||36
1056635|NCT00836342|2563547|P2|STARTED|Overall Study||23
1056636|NCT00836342|2563548|P1|STARTED|Overall Study||22
1056637|NCT00836355|2563563|P4|NOT COMPLETED|Overall Study||0
1056638|NCT00836355|2563564|P3|NOT COMPLETED|Overall Study||0
1056639|NCT00836355|2563565|P2|NOT COMPLETED|Overall Study||0
1056640|NCT00836355|2563566|P1|NOT COMPLETED|Overall Study||0
1056641|NCT00836355|2563563|P4|COMPLETED|Overall Study||2
1056642|NCT00836355|2563564|P3|COMPLETED|Overall Study||0
1056643|NCT00836355|2563565|P2|COMPLETED|Overall Study||4
1056644|NCT00836355|2563566|P1|COMPLETED|Overall Study||0
1056645|NCT00836355|2563563|P4|STARTED|Overall Study||2
1056646|NCT00836355|2563564|P3|STARTED|Overall Study||0
1056647|NCT00836355|2563565|P2|STARTED|Overall Study||4
1056648|NCT00836355|2563566|P1|STARTED|Overall Study||0
1056649|NCT00836407|2563586|P2|NOT COMPLETED|Overall Study||8
1056650|NCT00836407|2563587|P1|NOT COMPLETED|Overall Study||11
1056651|NCT00836407|2563586|P2|COMPLETED|Overall Study||7
1056652|NCT00836407|2563587|P1|COMPLETED|Overall Study||4
1056653|NCT00836407|2563586|P2|STARTED|Overall Study||15
1056654|NCT00836407|2563587|P1|STARTED|Overall Study||15
1056655|NCT00836433|2563597|P2|NOT COMPLETED|Overall Study||7
1056656|NCT00836433|2563598|P1|NOT COMPLETED|Overall Study||12
1056657|NCT00836433|2563597|P2|COMPLETED|Overall Study||321
1056658|NCT00836433|2563598|P1|COMPLETED|Overall Study||349
1056659|NCT00836433|2563597|P2|STARTED|Overall Study||328
1056660|NCT00836433|2563598|P1|STARTED|Overall Study||361
1056661|NCT00836472|2563608|P2|NOT COMPLETED|Second Intervention||0
1056662|NCT00836472|2563609|P1|NOT COMPLETED|Second Intervention||0
1056663|NCT00836472|2563608|P2|COMPLETED|Second Intervention||27
1056664|NCT00836472|2563609|P1|COMPLETED|Second Intervention||28
1056665|NCT00836472|2563608|P2|STARTED|Second Intervention||27
1056666|NCT00836472|2563609|P1|STARTED|Second Intervention||28
1056667|NCT00836472|2563608|P2|NOT COMPLETED|Washout||3
1056668|NCT00836472|2563609|P1|NOT COMPLETED|Washout||2
1056669|NCT00836472|2563608|P2|COMPLETED|Washout||27
1056670|NCT00836472|2563609|P1|COMPLETED|Washout||28
1056671|NCT00836472|2563608|P2|STARTED|Washout||30
1056672|NCT00836472|2563609|P1|STARTED|Washout||30
1056673|NCT00836472|2563608|P2|NOT COMPLETED|First Intervention||0
1056674|NCT00836472|2563609|P1|NOT COMPLETED|First Intervention||0
1056675|NCT00836472|2563608|P2|COMPLETED|First Intervention||30
1056676|NCT00836472|2563609|P1|COMPLETED|First Intervention||30
1056677|NCT00836472|2563608|P2|STARTED|First Intervention||30
1056678|NCT00836472|2563609|P1|STARTED|First Intervention||30
1056679|NCT00836498|2563625|P2|NOT COMPLETED|Overall Study||1
1056680|NCT00836498|2563626|P1|NOT COMPLETED|Overall Study||4
1056681|NCT00836498|2563625|P2|COMPLETED|Overall Study||21
1056682|NCT00836498|2563626|P1|COMPLETED|Overall Study|Participant who discontinued the study vaccination due to AE completed the 180-day safety follow-up.|40
1056683|NCT00836498|2563625|P2|STARTED|Overall Study||22
1056684|NCT00836498|2563626|P1|STARTED|Overall Study||44
1056685|NCT00836641|2563658|P2|NOT COMPLETED|Overall Study||0
1056686|NCT00836641|2563659|P1|NOT COMPLETED|Overall Study||0
1056687|NCT00836641|2563658|P2|COMPLETED|Overall Study||34
1056688|NCT00836641|2563659|P1|COMPLETED|Overall Study||36
1056689|NCT00836641|2563658|P2|STARTED|Overall Study||34
1056690|NCT00836641|2563659|P1|STARTED|Overall Study||36
1056691|NCT00836693|2563668|P2|NOT COMPLETED|Overall Study||6
1056692|NCT00836693|2563669|P1|NOT COMPLETED|Overall Study||17
1056693|NCT00836693|2563668|P2|COMPLETED|Overall Study||64
1056694|NCT00836693|2563669|P1|COMPLETED|Overall Study||130
1056695|NCT00836693|2563668|P2|STARTED|Overall Study||70
1056696|NCT00836693|2563669|P1|STARTED|Overall Study||147
1056697|NCT00836706|2563711|P2|NOT COMPLETED|Second Intervention||0
1056698|NCT00836706|2563712|P1|NOT COMPLETED|Second Intervention||0
1056699|NCT00836706|2563711|P2|COMPLETED|Second Intervention||11
1056700|NCT00836706|2563712|P1|COMPLETED|Second Intervention||11
1056701|NCT00836706|2563711|P2|STARTED|Second Intervention||11
1056702|NCT00836706|2563712|P1|STARTED|Second Intervention||11
1056703|NCT00836706|2563711|P2|NOT COMPLETED|Washout: 7 Days||1
1056704|NCT00836706|2563712|P1|NOT COMPLETED|Washout: 7 Days||0
1056705|NCT00836706|2563711|P2|COMPLETED|Washout: 7 Days||11
1056706|NCT00836706|2563712|P1|COMPLETED|Washout: 7 Days||11
1056707|NCT00836706|2563711|P2|STARTED|Washout: 7 Days||12
1056708|NCT00836706|2563712|P1|STARTED|Washout: 7 Days||11
1056709|NCT00836706|2563711|P2|NOT COMPLETED|First Intervention||0
1056710|NCT00836706|2563712|P1|NOT COMPLETED|First Intervention||0
1056711|NCT00836706|2563711|P2|COMPLETED|First Intervention||12
1056712|NCT00836706|2563712|P1|COMPLETED|First Intervention||11
1056713|NCT00836706|2563711|P2|STARTED|First Intervention||12
1056714|NCT00836706|2563712|P1|STARTED|First Intervention||11
1056715|NCT00836719|2563720|P1|NOT COMPLETED|Overall Study||0
1056716|NCT00836719|2563720|P1|COMPLETED|Overall Study||10
1056717|NCT00836719|2563720|P1|STARTED|Overall Study||10
1056718|NCT00836745|2563725|P1|NOT COMPLETED|Overall Study||21
1056719|NCT00836745|2563725|P1|COMPLETED|Overall Study||15
1056720|NCT00836745|2563725|P1|STARTED|Overall Study||36
1056721|NCT00836875|2563734|P2|NOT COMPLETED|Overall Study||3
1056722|NCT00836875|2563735|P1|NOT COMPLETED|Overall Study||3
1056723|NCT00836875|2563734|P2|COMPLETED|Overall Study||17
1056724|NCT00836875|2563735|P1|COMPLETED|Overall Study||8
1056725|NCT00836875|2563734|P2|STARTED|Overall Study||20
1056726|NCT00836875|2563735|P1|STARTED|Overall Study||11
1056727|NCT00836901|2563751|P2|NOT COMPLETED|Second Intervention||0
1056728|NCT00836901|2563752|P1|NOT COMPLETED|Second Intervention||0
1056729|NCT00836901|2563751|P2|COMPLETED|Second Intervention||28
1056730|NCT00836901|2563752|P1|COMPLETED|Second Intervention||23
1056731|NCT00836901|2563751|P2|STARTED|Second Intervention||28
1056732|NCT00836901|2563752|P1|STARTED|Second Intervention||23
1056733|NCT00836901|2563751|P2|NOT COMPLETED|First Intervention||0
1056734|NCT00836901|2563752|P1|NOT COMPLETED|First Intervention||1
1056735|NCT00836901|2563751|P2|COMPLETED|First Intervention||28
1056736|NCT00836901|2563752|P1|COMPLETED|First Intervention||23
1056737|NCT00836901|2563751|P2|STARTED|First Intervention||28
1056738|NCT00836901|2563752|P1|STARTED|First Intervention||24
1056739|NCT00836953|2563766|P1|NOT COMPLETED|Overall Study||2
1056740|NCT00836953|2563766|P1|COMPLETED|Overall Study||31
1056741|NCT00836953|2563766|P1|STARTED|Overall Study||33
1056742|NCT00837031|2563772|P1|NOT COMPLETED|Overall Study||0
1056743|NCT00837031|2563772|P1|COMPLETED|Overall Study||72
1056744|NCT00837031|2563772|P1|STARTED|Overall Study||72
1056745|NCT00837148|2563778|P1|NOT COMPLETED|Overall Study||2
1056746|NCT00837148|2563778|P1|COMPLETED|Overall Study||35
1056747|NCT00837148|2563778|P1|STARTED|Overall Study||37
1056748|NCT00837161|2563782|P1|NOT COMPLETED|Overall Study||2
1056749|NCT00837161|2563782|P1|COMPLETED|Overall Study||9
1056750|NCT00837161|2563782|P1|STARTED|Overall Study||11
1056751|NCT00837200|2563790|P1|NOT COMPLETED|Overall Study||0
1056752|NCT00837200|2563790|P1|COMPLETED|Overall Study||13
1056753|NCT00837200|2563790|P1|STARTED|Overall Study||13
1056754|NCT00837213|2563798|P2|NOT COMPLETED|Overall Study||5
1056755|NCT00837213|2563799|P1|NOT COMPLETED|Overall Study||6
1056756|NCT00837213|2563798|P2|COMPLETED|Overall Study||12
1056757|NCT00837213|2563799|P1|COMPLETED|Overall Study||10
1056758|NCT00837213|2563798|P2|STARTED|Overall Study||17
1056759|NCT00837213|2563799|P1|STARTED|Overall Study||16
1056760|NCT00837252|2563819|P1|NOT COMPLETED|Overall Study||0
1056761|NCT00837252|2563819|P1|COMPLETED|Overall Study||5
1056762|NCT00837252|2563819|P1|STARTED|Overall Study||5
1056763|NCT00837330|2563836|P2|NOT COMPLETED|Overall Study||3
1056764|NCT00837330|2563837|P1|NOT COMPLETED|Overall Study||1
1056765|NCT00837330|2563836|P2|COMPLETED|Overall Study||7
1056766|NCT00837330|2563837|P1|COMPLETED|Overall Study||9
1056767|NCT00837330|2563836|P2|STARTED|Overall Study||10
1056768|NCT00837330|2563837|P1|STARTED|Overall Study||10
1056775|NCT00837447|2563864|P1|NOT COMPLETED|Overall Study||0
1056776|NCT00837447|2563864|P1|COMPLETED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
1056777|NCT00837447|2563864|P1|STARTED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
1056778|NCT00837486|2563871|P2|NOT COMPLETED|Long-term Follow-up Phase - Open Label||0
1056779|NCT00837486|2563872|P1|NOT COMPLETED|Long-term Follow-up Phase - Open Label||5
1056780|NCT00837486|2563871|P2|COMPLETED|Long-term Follow-up Phase - Open Label||0
1056781|NCT00837486|2563872|P1|COMPLETED|Long-term Follow-up Phase - Open Label||24
1056782|NCT00837486|2563871|P2|STARTED|Long-term Follow-up Phase - Open Label||0
1056783|NCT00837486|2563872|P1|STARTED|Long-term Follow-up Phase - Open Label|All subjects received open-label stimulation during this phase.|29
1056784|NCT00837486|2563871|P2|NOT COMPLETED|Blinded-treatment Phase||0
1056785|NCT00837486|2563872|P1|NOT COMPLETED|Blinded-treatment Phase||1
1056786|NCT00837486|2563871|P2|COMPLETED|Blinded-treatment Phase||14
1056787|NCT00837486|2563872|P1|COMPLETED|Blinded-treatment Phase|One subject did not receive the allocated intervention.|15
1056788|NCT00837486|2563871|P2|STARTED|Blinded-treatment Phase||14
1056789|NCT00837486|2563872|P1|STARTED|Blinded-treatment Phase||16
1056790|NCT00837512|2563884|P2|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
1056791|NCT00837512|2563885|P1|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
1056792|NCT00837512|2563884|P2|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
1056793|NCT00837512|2563885|P1|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
1056794|NCT00837512|2563884|P2|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
1056795|NCT00837512|2563885|P1|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
1056796|NCT00837512|2563884|P2|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
1056797|NCT00837512|2563885|P1|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
1056798|NCT00837512|2563884|P2|COMPLETED|Both Arms: Washout (7-28 Days)||8
1056799|NCT00837512|2563885|P1|COMPLETED|Both Arms: Washout (7-28 Days)||8
1056800|NCT00837512|2563884|P2|STARTED|Both Arms: Washout (7-28 Days)||8
1056801|NCT00837512|2563885|P1|STARTED|Both Arms: Washout (7-28 Days)||8
1056802|NCT00837512|2563884|P2|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
1056803|NCT00837512|2563885|P1|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
1056804|NCT00837512|2563884|P2|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
1056805|NCT00837512|2563885|P1|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
1056806|NCT00837512|2563884|P2|STARTED|First Intervention (6hrs) - RANDOMIZED||8
1056807|NCT00837512|2563885|P1|STARTED|First Intervention (6hrs) - RANDOMIZED||8
1056808|NCT00837577|2563893|P2|NOT COMPLETED|Open-label Period||9
1056809|NCT00837577|2563894|P1|NOT COMPLETED|Open-label Period||8
1056810|NCT00837577|2563893|P2|COMPLETED|Open-label Period||54
1056811|NCT00837577|2563894|P1|COMPLETED|Open-label Period||60
1056812|NCT00837577|2563893|P2|STARTED|Open-label Period||63
1056813|NCT00837577|2563894|P1|STARTED|Open-label Period||68
1056814|NCT00837577|2563893|P2|NOT COMPLETED|Double-blind Period||0
1056815|NCT00837577|2563894|P1|NOT COMPLETED|Double-blind Period||2
1056816|NCT00837577|2563893|P2|COMPLETED|Double-blind Period||63
1056817|NCT00837577|2563894|P1|COMPLETED|Double-blind Period||68
1056818|NCT00837577|2563893|P2|STARTED|Double-blind Period||63
1056819|NCT00837577|2563894|P1|STARTED|Double-blind Period||70
1056820|NCT00837616|2563907|P2|NOT COMPLETED|Overall Study||1
1056821|NCT00837616|2563908|P1|NOT COMPLETED|Overall Study||0
1056822|NCT00837616|2563907|P2|COMPLETED|Overall Study||20
1056823|NCT00837616|2563908|P1|COMPLETED|Overall Study||20
1056824|NCT00837616|2563907|P2|STARTED|Overall Study||21
1056825|NCT00837616|2563908|P1|STARTED|Overall Study||20
1056826|NCT00837759|2563932|P1|NOT COMPLETED|Overall Study||4
1056827|NCT00837759|2563932|P1|COMPLETED|Overall Study||3
1056828|NCT00837759|2563932|P1|STARTED|Overall Study||7
1056829|NCT00837824|2563943|P2|NOT COMPLETED|Overall Study||0
1056830|NCT00837824|2563944|P1|NOT COMPLETED|Overall Study||0
1056831|NCT00837824|2563943|P2|COMPLETED|Overall Study||9
1056832|NCT00837824|2563944|P1|COMPLETED|Overall Study||11
1056833|NCT00837824|2563943|P2|STARTED|Overall Study||9
1056834|NCT00837824|2563944|P1|STARTED|Overall Study||11
1056835|NCT00837876|2563953|P1|NOT COMPLETED|Overall Study||37
1056836|NCT00837876|2563953|P1|COMPLETED|Overall Study||0
1056837|NCT00837876|2563953|P1|STARTED|Overall Study||37
1056838|NCT00837967|2563960|P2|NOT COMPLETED|Second Intervention||0
1056839|NCT00837967|2563961|P1|NOT COMPLETED|Second Intervention||0
1056840|NCT00837967|2563960|P2|COMPLETED|Second Intervention||12
1056841|NCT00837967|2563961|P1|COMPLETED|Second Intervention||11
1056842|NCT00837967|2563960|P2|STARTED|Second Intervention||12
1056843|NCT00837967|2563961|P1|STARTED|Second Intervention||11
1056844|NCT00837967|2563960|P2|NOT COMPLETED|Washout Period of 7 - 14 Days||0
1056845|NCT00837967|2563961|P1|NOT COMPLETED|Washout Period of 7 - 14 Days||2
1056846|NCT00837967|2563960|P2|COMPLETED|Washout Period of 7 - 14 Days||12
1056847|NCT00837967|2563961|P1|COMPLETED|Washout Period of 7 - 14 Days||11
1056848|NCT00837967|2563960|P2|STARTED|Washout Period of 7 - 14 Days||12
1056849|NCT00837967|2563961|P1|STARTED|Washout Period of 7 - 14 Days||13
1056850|NCT00837967|2563960|P2|NOT COMPLETED|First Intervention||0
1056851|NCT00837967|2563961|P1|NOT COMPLETED|First Intervention||0
1056852|NCT00837967|2563960|P2|COMPLETED|First Intervention||12
1056853|NCT00837967|2563961|P1|COMPLETED|First Intervention||13
1056854|NCT00837967|2563960|P2|STARTED|First Intervention||12
1056855|NCT00837967|2563961|P1|STARTED|First Intervention||13
1056856|NCT00838097|2563977|P1|NOT COMPLETED|Overall Study||176
1056857|NCT00838097|2563977|P1|COMPLETED|Overall Study||145
1056858|NCT00838097|2563977|P1|Received Darbepoetin Alfa|Overall Study||319
1056859|NCT00838097|2563977|P1|STARTED|Overall Study||321
1056860|NCT00838110|2563987|P4|NOT COMPLETED|Overall Study||18
1056861|NCT00838110|2563988|P3|NOT COMPLETED|Overall Study||17
1056862|NCT00838110|2563989|P2|NOT COMPLETED|Overall Study||22
1056863|NCT00838110|2563990|P1|NOT COMPLETED|Overall Study||22
1056864|NCT00838110|2563987|P4|COMPLETED|Overall Study||226
1056865|NCT00838110|2563988|P3|COMPLETED|Overall Study||226
1056866|NCT00838110|2563989|P2|COMPLETED|Overall Study||106
1056867|NCT00838110|2563990|P1|COMPLETED|Overall Study||105
1056868|NCT00838110|2563987|P4|Treated|Overall Study||244
1056869|NCT00838110|2563988|P3|Treated|Overall Study||243
1056870|NCT00838110|2563989|P2|Treated|Overall Study||127
1056871|NCT00838110|2563990|P1|Treated|Overall Study||127
1056872|NCT00838110|2563987|P4|STARTED|Overall Study||244
1056873|NCT00838110|2563988|P3|STARTED|Overall Study||243
1056874|NCT00838110|2563989|P2|STARTED|Overall Study||128
1056875|NCT00838110|2563990|P1|STARTED|Overall Study||127
1056876|NCT00838136|2564012|P2|NOT COMPLETED|Second Intervention||1
1056877|NCT00838136|2564013|P1|NOT COMPLETED|Second Intervention||0
1056878|NCT00838136|2564012|P2|COMPLETED|Second Intervention||15
1056879|NCT00838136|2564013|P1|COMPLETED|Second Intervention||16
1056880|NCT00838136|2564012|P2|STARTED|Second Intervention||16
1056881|NCT00838136|2564013|P1|STARTED|Second Intervention||16
1056882|NCT00838136|2564012|P2|NOT COMPLETED|First Intervention||0
1056883|NCT00838136|2564013|P1|NOT COMPLETED|First Intervention||0
1056884|NCT00838136|2564012|P2|COMPLETED|First Intervention||16
1056885|NCT00838136|2564013|P1|COMPLETED|First Intervention||16
1056886|NCT00838136|2564012|P2|STARTED|First Intervention||16
1056887|NCT00838136|2564013|P1|STARTED|First Intervention||16
1056888|NCT00838162|2564025|P4|NOT COMPLETED|Overall Study||0
1056889|NCT00838162|2564026|P3|NOT COMPLETED|Overall Study||0
1056890|NCT00838162|2564027|P2|NOT COMPLETED|Overall Study||0
1056891|NCT00838162|2564028|P1|NOT COMPLETED|Overall Study||0
1056892|NCT00838162|2564025|P4|COMPLETED|Overall Study||8
1056893|NCT00838162|2564026|P3|COMPLETED|Overall Study||8
1056894|NCT00838162|2564027|P2|COMPLETED|Overall Study||8
1056895|NCT00838162|2564028|P1|COMPLETED|Overall Study||9
1056896|NCT00838162|2564025|P4|STARTED|Overall Study||8
1056897|NCT00838162|2564026|P3|STARTED|Overall Study||8
1056898|NCT00838162|2564027|P2|STARTED|Overall Study||8
1056899|NCT00838162|2564028|P1|STARTED|Overall Study||9
1056900|NCT00838201|2564072|P2|NOT COMPLETED|Overall Study||53
1056901|NCT00838201|2564073|P1|NOT COMPLETED|Overall Study||42
1056902|NCT00838201|2564072|P2|COMPLETED|Overall Study||145
1056903|NCT00838201|2564073|P1|COMPLETED|Overall Study||144
1056904|NCT00838201|2564072|P2|STARTED|Overall Study||198
1056905|NCT00838201|2564073|P1|STARTED|Overall Study||186
1056906|NCT00838279|2564081|P2|NOT COMPLETED|Second Intervention||0
1056907|NCT00838279|2564082|P1|NOT COMPLETED|Second Intervention||0
1056908|NCT00838279|2564081|P2|COMPLETED|Second Intervention||15
1056909|NCT00838279|2564082|P1|COMPLETED|Second Intervention||15
1056910|NCT00838279|2564081|P2|STARTED|Second Intervention||15
1056911|NCT00838279|2564082|P1|STARTED|Second Intervention||15
1056912|NCT00838279|2564081|P2|NOT COMPLETED|Washout||1
1056913|NCT00838279|2564082|P1|NOT COMPLETED|Washout||1
1056914|NCT00838279|2564081|P2|COMPLETED|Washout||15
1056915|NCT00838279|2564082|P1|COMPLETED|Washout||15
1056916|NCT00838279|2564081|P2|STARTED|Washout||16
1056917|NCT00838279|2564082|P1|STARTED|Washout||16
1056918|NCT00838279|2564081|P2|NOT COMPLETED|First Intervention||0
1056919|NCT00838279|2564082|P1|NOT COMPLETED|First Intervention||0
1056920|NCT00838279|2564081|P2|COMPLETED|First Intervention||16
1056921|NCT00838279|2564082|P1|COMPLETED|First Intervention||16
1056922|NCT00838279|2564081|P2|STARTED|First Intervention||16
1056923|NCT00838279|2564082|P1|STARTED|First Intervention||16
1056924|NCT00838331|2564090|P1|NOT COMPLETED|Aged Blood Transfusion||9
1056925|NCT00838331|2564090|P1|COMPLETED|Aged Blood Transfusion||8
1056926|NCT00838331|2564090|P1|STARTED|Aged Blood Transfusion||17
1056927|NCT00838331|2564090|P1|NOT COMPLETED|Fresh Blood Transfusion||0
1056928|NCT00838331|2564090|P1|COMPLETED|Fresh Blood Transfusion||17
1056929|NCT00838331|2564090|P1|STARTED|Fresh Blood Transfusion||17
1056930|NCT00838513|2564094|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
1056931|NCT00838513|2564094|P1|COMPLETED|Post Treatment Period (Patients Who Disc||4
1056932|NCT00838513|2564094|P1|STARTED|Post Treatment Period (Patients Who Disc||5
1056933|NCT00838513|2564094|P1|NOT COMPLETED|Extension Treatment Period||1
1056934|NCT00838513|2564094|P1|COMPLETED|Extension Treatment Period||18
1056935|NCT00838513|2564094|P1|STARTED|Extension Treatment Period||19
1056936|NCT00838513|2564094|P1|NOT COMPLETED|Treatment Period (26 Weeks)||0
1056937|NCT00838513|2564094|P1|COMPLETED|Treatment Period (26 Weeks)||20
1056938|NCT00838513|2564094|P1|STARTED|Treatment Period (26 Weeks)||20
1056939|NCT00838513|2564094|P1|NOT COMPLETED|Observation Period (8 Weeks)||0
1056940|NCT00838513|2564094|P1|COMPLETED|Observation Period (8 Weeks)||20
1056941|NCT00838513|2564094|P1|STARTED|Observation Period (8 Weeks)||20
1056942|NCT00838513|2564094|P1|NOT COMPLETED|Screening Period||3
1056943|NCT00838513|2564094|P1|COMPLETED|Screening Period||20
1056944|NCT00838513|2564094|P1|STARTED|Screening Period||23
1056945|NCT00838526|2564112|P2|NOT COMPLETED|Overall Study||39
1056946|NCT00838526|2564113|P1|NOT COMPLETED|Overall Study||24
1056947|NCT00838526|2564112|P2|COMPLETED|Overall Study||137
1056948|NCT00838526|2564113|P1|COMPLETED|Overall Study||35
1056949|NCT00838526|2564112|P2|STARTED|Overall Study|Treated|176
1056950|NCT00838526|2564113|P1|STARTED|Overall Study|Treated|59
1056951|NCT00838578|2564121|P1|NOT COMPLETED|Overall Study||2
1056952|NCT00838578|2564121|P1|COMPLETED|Overall Study||63
1056953|NCT00838578|2564121|P1|STARTED|Overall Study|In this Ph 1/2 study, 65 subjects were enrolled; 2 were protocol violators, so only 63 treated.|65
1056954|NCT00838630|2564131|P2|NOT COMPLETED|Second Intervention||0
1056955|NCT00838630|2564132|P1|NOT COMPLETED|Second Intervention||0
1056956|NCT00838630|2564131|P2|COMPLETED|Second Intervention||18
1056957|NCT00838630|2564132|P1|COMPLETED|Second Intervention||16
1056958|NCT00838630|2564131|P2|STARTED|Second Intervention||18
1056959|NCT00838630|2564132|P1|STARTED|Second Intervention||16
1056960|NCT00838630|2564131|P2|NOT COMPLETED|Washout: 7 Days||0
1056961|NCT00838630|2564132|P1|NOT COMPLETED|Washout: 7 Days||1
1056962|NCT00838630|2564131|P2|COMPLETED|Washout: 7 Days||18
1056963|NCT00838630|2564132|P1|COMPLETED|Washout: 7 Days||16
1056964|NCT00838630|2564131|P2|STARTED|Washout: 7 Days||18
1056965|NCT00838630|2564132|P1|STARTED|Washout: 7 Days||17
1056966|NCT00838630|2564131|P2|NOT COMPLETED|First Intervention||0
1056967|NCT00838630|2564132|P1|NOT COMPLETED|First Intervention||1
1056968|NCT00838630|2564131|P2|COMPLETED|First Intervention||18
1056969|NCT00838630|2564132|P1|COMPLETED|First Intervention||17
1056970|NCT00838630|2564131|P2|STARTED|First Intervention||18
1056971|NCT00838630|2564132|P1|STARTED|First Intervention||18
1056972|NCT00838682|2564142|P2|NOT COMPLETED|Overall Study||19
1056973|NCT00838682|2564143|P1|NOT COMPLETED|Overall Study||25
1056974|NCT00838682|2564142|P2|COMPLETED|Overall Study||33
1056975|NCT00838682|2564143|P1|COMPLETED|Overall Study||29
1056976|NCT00838682|2564142|P2|STARTED|Overall Study||52
1056977|NCT00838682|2564143|P1|STARTED|Overall Study||54
1056978|NCT00838903|2564163|P4|NOT COMPLETED|Follow-up Period (8 Weeks)||58
1056979|NCT00838903|2564164|P3|NOT COMPLETED|Follow-up Period (8 Weeks)||64
1056980|NCT00838903|2564165|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||65
1056981|NCT00838903|2564166|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||26
1056982|NCT00838903|2564163|P4|COMPLETED|Follow-up Period (8 Weeks)||244
1056983|NCT00838903|2564164|P3|COMPLETED|Follow-up Period (8 Weeks)||243
1056984|NCT00838903|2564165|P2|COMPLETED|Follow-up Period (8 Weeks)||237
1056985|NCT00838903|2564166|P1|COMPLETED|Follow-up Period (8 Weeks)||75
1056986|NCT00838903|2564163|P4|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
1056987|NCT00838903|2564164|P3|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|307
1056988|NCT00838903|2564165|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
1056989|NCT00838903|2564166|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
1056990|NCT00838903|2564163|P4|NOT COMPLETED|Treatment Period (156 Weeks)||110
1056991|NCT00838903|2564164|P3|NOT COMPLETED|Treatment Period (156 Weeks)||116
1056992|NCT00838903|2564165|P2|NOT COMPLETED|Treatment Period (156 Weeks)||112
1056993|NCT00838903|2564166|P1|NOT COMPLETED|Treatment Period (156 Weeks)||46
1056994|NCT00838903|2564163|P4|COMPLETED|Treatment Period (156 Weeks)||192
1056995|NCT00838903|2564164|P3|COMPLETED|Treatment Period (156 Weeks)||191
1056996|NCT00838903|2564165|P2|COMPLETED|Treatment Period (156 Weeks)||190
1056997|NCT00838903|2564166|P1|COMPLETED|Treatment Period (156 Weeks)||55
1056998|NCT00838903|2564163|P4|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
1056999|NCT00838903|2564164|P3|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
1057000|NCT00838903|2564165|P2|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
1057001|NCT00838903|2564166|P1|Missing Active Treatment Status|Treatment Period (156 Weeks)||1
1057002|NCT00838903|2564163|P4|STARTED|Treatment Period (156 Weeks)||302
1057003|NCT00838903|2564164|P3|STARTED|Treatment Period (156 Weeks)||307
1057004|NCT00838903|2564165|P2|STARTED|Treatment Period (156 Weeks)||302
1057005|NCT00838903|2564166|P1|STARTED|Treatment Period (156 Weeks)||101
1057006|NCT00838916|2564210|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||51
1057007|NCT00838916|2564211|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||96
1057008|NCT00838916|2564210|P2|COMPLETED|Follow-up Period (8 Weeks)||190
1057009|NCT00838916|2564211|P1|COMPLETED|Follow-up Period (8 Weeks)||408
1057010|NCT00838916|2564210|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|241
1057011|NCT00838916|2564211|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|504
1057012|NCT00838916|2564210|P2|NOT COMPLETED|Treatment Period (156 Weeks)||77
1057013|NCT00838916|2564211|P1|NOT COMPLETED|Treatment Period (156 Weeks)||196
1057014|NCT00838916|2564210|P2|COMPLETED|Treatment Period (156 Weeks)||164
1057015|NCT00838916|2564211|P1|COMPLETED|Treatment Period (156 Weeks)||308
1057016|NCT00838916|2564210|P2|STARTED|Treatment Period (156 Weeks)||241
1057017|NCT00838916|2564211|P1|STARTED|Treatment Period (156 Weeks)||504
1057018|NCT00838929|2564239|P3|NOT COMPLETED|Overall Study||1
1057019|NCT00838929|2564240|P2|NOT COMPLETED|Overall Study||3
1057020|NCT00838929|2564241|P1|NOT COMPLETED|Overall Study||0
1057021|NCT00838929|2564239|P3|COMPLETED|Overall Study||5
1057022|NCT00838929|2564240|P2|COMPLETED|Overall Study||5
1057023|NCT00838929|2564241|P1|COMPLETED|Overall Study||3
1057024|NCT00838929|2564239|P3|STARTED|Overall Study||6
1057025|NCT00838929|2564240|P2|STARTED|Overall Study||8
1057026|NCT00838929|2564241|P1|STARTED|Overall Study||3
1057027|NCT00838981|2564251|P4|NOT COMPLETED|Day 4 to Week 11||7
1057028|NCT00838981|2564252|P3|NOT COMPLETED|Day 4 to Week 11||11
1057029|NCT00838981|2564253|P2|NOT COMPLETED|Day 4 to Week 11||8
1057030|NCT00838981|2564254|P1|NOT COMPLETED|Day 4 to Week 11||7
1057031|NCT00838981|2564251|P4|COMPLETED|Day 4 to Week 11||12
1057032|NCT00838981|2564252|P3|COMPLETED|Day 4 to Week 11||16
1057033|NCT00838981|2564253|P2|COMPLETED|Day 4 to Week 11||11
1057034|NCT00838981|2564254|P1|COMPLETED|Day 4 to Week 11||19
1057035|NCT00838981|2564251|P4|Completed Main Treatment on 400mg|Day 4 to Week 11||14
1057036|NCT00838981|2564252|P3|Completed Main Treatment on 400mg|Day 4 to Week 11||17
1057037|NCT00838981|2564253|P2|Completed Main Treatment on 400mg|Day 4 to Week 11||13
1057038|NCT00838981|2564254|P1|Completed Main Treatment on 400mg|Day 4 to Week 11||22
1057039|NCT00838981|2564251|P4|STARTED|Day 4 to Week 11||19
1057040|NCT00838981|2564252|P3|STARTED|Day 4 to Week 11||27
1057041|NCT00838981|2564253|P2|STARTED|Day 4 to Week 11||19
1057042|NCT00838981|2564254|P1|STARTED|Day 4 to Week 11||26
1057043|NCT00838981|2564251|P4|NOT COMPLETED|Week 1 Days 1-3||0
1057044|NCT00838981|2564252|P3|NOT COMPLETED|Week 1 Days 1-3||0
1057045|NCT00838981|2564253|P2|NOT COMPLETED|Week 1 Days 1-3||0
1057046|NCT00838981|2564254|P1|NOT COMPLETED|Week 1 Days 1-3||0
1057047|NCT00838981|2564251|P4|COMPLETED|Week 1 Days 1-3||19
1057048|NCT00838981|2564252|P3|COMPLETED|Week 1 Days 1-3||27
1057049|NCT00838981|2564253|P2|COMPLETED|Week 1 Days 1-3||19
1057050|NCT00838981|2564254|P1|COMPLETED|Week 1 Days 1-3||26
1057051|NCT00838981|2564251|P4|STARTED|Week 1 Days 1-3||19
1057052|NCT00838981|2564252|P3|STARTED|Week 1 Days 1-3||27
1057053|NCT00838981|2564253|P2|STARTED|Week 1 Days 1-3||19
1057054|NCT00838981|2564254|P1|STARTED|Week 1 Days 1-3||26
1057055|NCT00839072|2564272|P2|NOT COMPLETED|Second Intervention Period||0
1057056|NCT00839072|2564273|P1|NOT COMPLETED|Second Intervention Period||1
1057057|NCT00839072|2564272|P2|COMPLETED|Second Intervention Period||11
1057058|NCT00839072|2564273|P1|COMPLETED|Second Intervention Period||9
1057059|NCT00839072|2564272|P2|STARTED|Second Intervention Period||11
1057060|NCT00839072|2564273|P1|STARTED|Second Intervention Period||10
1057061|NCT00839072|2564272|P2|NOT COMPLETED|Washout Period of 7 Days||0
1057062|NCT00839072|2564273|P1|NOT COMPLETED|Washout Period of 7 Days||0
1057063|NCT00839072|2564272|P2|COMPLETED|Washout Period of 7 Days||11
1057064|NCT00839072|2564273|P1|COMPLETED|Washout Period of 7 Days||10
1057065|NCT00839072|2564272|P2|STARTED|Washout Period of 7 Days||11
1057066|NCT00839072|2564273|P1|STARTED|Washout Period of 7 Days||10
1057067|NCT00839072|2564272|P2|NOT COMPLETED|First Intervention Period||1
1057068|NCT00839072|2564273|P1|NOT COMPLETED|First Intervention Period||2
1057069|NCT00839072|2564272|P2|COMPLETED|First Intervention Period||11
1057070|NCT00839072|2564273|P1|COMPLETED|First Intervention Period||10
1057071|NCT00839072|2564272|P2|STARTED|First Intervention Period||12
1057072|NCT00839072|2564273|P1|STARTED|First Intervention Period||12
1057073|NCT00839098|2564292|P3|NOT COMPLETED|Overall Study||7
1057074|NCT00839098|2564293|P2|NOT COMPLETED|Overall Study||1
1057075|NCT00839098|2564294|P1|NOT COMPLETED|Overall Study||2
1057076|NCT00839098|2564292|P3|COMPLETED|Overall Study||6
1057077|NCT00839098|2564293|P2|COMPLETED|Overall Study||11
1057078|NCT00839098|2564294|P1|COMPLETED|Overall Study||1
1057079|NCT00839098|2564292|P3|STARTED|Overall Study||13
1057080|NCT00839098|2564293|P2|STARTED|Overall Study||12
1057081|NCT00839098|2564294|P1|STARTED|Overall Study||3
1057082|NCT00828945|2564320|P1|NOT COMPLETED|Overall Study||41
1057083|NCT00828945|2564320|P1|COMPLETED|Overall Study||216
1057084|NCT00828945|2564320|P1|STARTED|Overall Study||257
1057085|NCT00828984|2564337|P3|NOT COMPLETED|Overall Study||9
1057086|NCT00828984|2564338|P2|NOT COMPLETED|Overall Study||16
1057087|NCT00828984|2564339|P1|NOT COMPLETED|Overall Study||14
1057088|NCT00828984|2564337|P3|COMPLETED|Overall Study||19
1057089|NCT00828984|2564338|P2|COMPLETED|Overall Study||15
1057090|NCT00828984|2564339|P1|COMPLETED|Overall Study||14
1057091|NCT00828984|2564337|P3|Post Intervention Follow-Up|Overall Study||19
1057092|NCT00828984|2564338|P2|Post Intervention Follow-Up|Overall Study||16
1057093|NCT00828984|2564339|P1|Post Intervention Follow-Up|Overall Study||15
1057094|NCT00828984|2564337|P3|Flexible Sigmoidoscopy|Overall Study||19
1057095|NCT00828984|2564338|P2|Flexible Sigmoidoscopy|Overall Study||19
1057096|NCT00828984|2564339|P1|Flexible Sigmoidoscopy|Overall Study||20
1057097|NCT00828984|2564337|P3|Treatment|Overall Study||24
1057098|NCT00828984|2564338|P2|Treatment|Overall Study||26
1057099|NCT00828984|2564339|P1|Treatment|Overall Study||24
1057100|NCT00828984|2564337|P3|Randomization|Overall Study||28
1057101|NCT00828984|2564338|P2|Randomization|Overall Study||31
1057102|NCT00828984|2564339|P1|Randomization|Overall Study||28
1057103|NCT00828984|2564337|P3|STARTED|Overall Study||28
1057104|NCT00828984|2564338|P2|STARTED|Overall Study||31
1057105|NCT00828984|2564339|P1|STARTED|Overall Study||28
1057106|NCT00829010|2564367|P5|NOT COMPLETED|Overall Study||2
1057107|NCT00829010|2564368|P4|NOT COMPLETED|Overall Study||8
1057108|NCT00829010|2564369|P3|NOT COMPLETED|Overall Study||3
1057109|NCT00829010|2564370|P2|NOT COMPLETED|Overall Study||9
1057110|NCT00829010|2564371|P1|NOT COMPLETED|Overall Study||10
1057111|NCT00829010|2564367|P5|COMPLETED|Overall Study||98
1057112|NCT00829010|2564368|P4|COMPLETED|Overall Study||92
1057113|NCT00829010|2564369|P3|COMPLETED|Overall Study||97
1057114|NCT00829010|2564370|P2|COMPLETED|Overall Study||92
1057115|NCT00829010|2564371|P1|COMPLETED|Overall Study||73
1057116|NCT00829010|2564367|P5|STARTED|Overall Study||100
1057117|NCT00829010|2564368|P4|STARTED|Overall Study||100
1057118|NCT00829010|2564369|P3|STARTED|Overall Study||100
1057119|NCT00829010|2564370|P2|STARTED|Overall Study||101
1057120|NCT00829010|2564371|P1|STARTED|Overall Study||83
1057121|NCT00829036|2564533|P1|NOT COMPLETED|Overall Study||0
1057122|NCT00829036|2564533|P1|COMPLETED|Overall Study||24
1057123|NCT00829036|2564533|P1|STARTED|Overall Study||24
1057124|NCT00829049|2564539|P2|NOT COMPLETED|Overall Study||20
1057125|NCT00829049|2564540|P1|NOT COMPLETED|Overall Study||17
1057126|NCT00829049|2564539|P2|COMPLETED|Overall Study||68
1057127|NCT00829049|2564540|P1|COMPLETED|Overall Study||60
1057128|NCT00829049|2564539|P2|STARTED|Overall Study||88
1057129|NCT00829049|2564540|P1|STARTED|Overall Study||77
1057130|NCT00829166|2564554|P2|NOT COMPLETED|Overall Study||496
1057131|NCT00829166|2564555|P1|NOT COMPLETED|Overall Study||495
1057132|NCT00829166|2564554|P2|COMPLETED|Overall Study||0
1057133|NCT00829166|2564555|P1|COMPLETED|Overall Study||0
1057134|NCT00829166|2564554|P2|Treated|Overall Study||488
1057135|NCT00829166|2564555|P1|Treated|Overall Study||490
1057136|NCT00829166|2564554|P2|STARTED|Overall Study||496
1057137|NCT00829166|2564555|P1|STARTED|Overall Study||495
1057138|NCT00829179|2564594|P1|NOT COMPLETED|Overall Study||1
1057139|NCT00829179|2564594|P1|COMPLETED|Overall Study||19
1057140|NCT00829179|2564594|P1|STARTED|Overall Study||20
1057141|NCT00829244|2564600|P2|NOT COMPLETED|Overall Study||21
1057142|NCT00829244|2564601|P1|NOT COMPLETED|Overall Study||14
1057143|NCT00829244|2564600|P2|COMPLETED|Overall Study||83
1057144|NCT00829244|2564601|P1|COMPLETED|Overall Study||82
1057145|NCT00829244|2564600|P2|STARTED|Overall Study||104
1057146|NCT00829244|2564601|P1|STARTED|Overall Study||96
1057147|NCT00829283|2564633|P2|NOT COMPLETED|Overall Study||25
1057148|NCT00829283|2564634|P1|NOT COMPLETED|Overall Study||7
1057149|NCT00829283|2564633|P2|COMPLETED|Overall Study||127
1057150|NCT00829283|2564634|P1|COMPLETED|Overall Study||32
1057151|NCT00829283|2564633|P2|STARTED|Overall Study||152
1057152|NCT00829283|2564634|P1|STARTED|Overall Study||39
1057153|NCT00829296|2564644|P2|NOT COMPLETED|Overall Study||4
1057154|NCT00829296|2564645|P1|NOT COMPLETED|Overall Study||5
1057155|NCT00829296|2564644|P2|COMPLETED|Overall Study||32
1057156|NCT00829296|2564645|P1|COMPLETED|Overall Study||29
1057157|NCT00829296|2564644|P2|STARTED|Overall Study||36
1057158|NCT00829296|2564645|P1|STARTED|Overall Study||34
1057159|NCT00829309|2564659|P2|NOT COMPLETED|Second Intervention||0
1057160|NCT00829309|2564660|P1|NOT COMPLETED|Second Intervention||0
1057161|NCT00829309|2564659|P2|COMPLETED|Second Intervention||8
1057162|NCT00829309|2564660|P1|COMPLETED|Second Intervention||7
1057163|NCT00829309|2564659|P2|STARTED|Second Intervention||8
1057164|NCT00829309|2564660|P1|STARTED|Second Intervention||7
1057165|NCT00829309|2564659|P2|NOT COMPLETED|Washout: 7 Days||0
1057166|NCT00829309|2564660|P1|NOT COMPLETED|Washout: 7 Days||1
1057167|NCT00829309|2564659|P2|COMPLETED|Washout: 7 Days||8
1057168|NCT00829309|2564660|P1|COMPLETED|Washout: 7 Days||7
1057169|NCT00829309|2564659|P2|STARTED|Washout: 7 Days||8
1057170|NCT00829309|2564660|P1|STARTED|Washout: 7 Days||8
1057171|NCT00829309|2564659|P2|NOT COMPLETED|First Intervention||0
1057172|NCT00829309|2564660|P1|NOT COMPLETED|First Intervention||0
1057173|NCT00829309|2564659|P2|COMPLETED|First Intervention||8
1057174|NCT00829309|2564660|P1|COMPLETED|First Intervention||8
1057175|NCT00829309|2564659|P2|STARTED|First Intervention||8
1057176|NCT00829309|2564660|P1|STARTED|First Intervention||8
1057177|NCT00829387|2564670|P2|NOT COMPLETED|Overall Study||3
1057178|NCT00829387|2564671|P1|NOT COMPLETED|Overall Study||3
1057179|NCT00829387|2564670|P2|COMPLETED|Overall Study||21
1057180|NCT00829387|2564671|P1|COMPLETED|Overall Study||20
1057181|NCT00829387|2564670|P2|STARTED|Overall Study||24
1057182|NCT00829387|2564671|P1|STARTED|Overall Study||23
1057183|NCT00829426|2564689|P2|NOT COMPLETED|Second Intervention||0
1057184|NCT00829426|2564690|P1|NOT COMPLETED|Second Intervention||0
1057185|NCT00829426|2564689|P2|COMPLETED|Second Intervention||16
1057186|NCT00829426|2564690|P1|COMPLETED|Second Intervention||15
1057187|NCT00829426|2564689|P2|STARTED|Second Intervention||16
1057188|NCT00829426|2564690|P1|STARTED|Second Intervention||15
1057189|NCT00829426|2564689|P2|NOT COMPLETED|Washout: 7 Days||0
1057190|NCT00829426|2564690|P1|NOT COMPLETED|Washout: 7 Days||1
1057191|NCT00829426|2564689|P2|COMPLETED|Washout: 7 Days||16
1057192|NCT00829426|2564690|P1|COMPLETED|Washout: 7 Days||15
1057193|NCT00829426|2564689|P2|STARTED|Washout: 7 Days||16
1057194|NCT00829426|2564690|P1|STARTED|Washout: 7 Days||16
1057195|NCT00829426|2564689|P2|NOT COMPLETED|First Intervention||0
1057196|NCT00829426|2564690|P1|NOT COMPLETED|First Intervention||0
1057197|NCT00829426|2564689|P2|COMPLETED|First Intervention||16
1057198|NCT00829426|2564690|P1|COMPLETED|First Intervention||16
1057199|NCT00829426|2564689|P2|STARTED|First Intervention||16
1057200|NCT00829426|2564690|P1|STARTED|First Intervention||16
1057201|NCT00829439|2564698|P4|NOT COMPLETED|Overall Study||0
1057202|NCT00829439|2564699|P3|NOT COMPLETED|Overall Study||1
1057203|NCT00829439|2564700|P2|NOT COMPLETED|Overall Study||0
1057204|NCT00829439|2564701|P1|NOT COMPLETED|Overall Study||0
1057205|NCT00829439|2564698|P4|COMPLETED|Overall Study||4
1057206|NCT00829439|2564699|P3|COMPLETED|Overall Study||5
1057207|NCT00829439|2564700|P2|COMPLETED|Overall Study||3
1057208|NCT00829439|2564701|P1|COMPLETED|Overall Study||3
1057209|NCT00829439|2564698|P4|STARTED|Overall Study||4
1057210|NCT00829439|2564699|P3|STARTED|Overall Study||6
1057211|NCT00829439|2564700|P2|STARTED|Overall Study||3
1057212|NCT00829439|2564701|P1|STARTED|Overall Study||3
1057213|NCT00829452|2564707|P2|NOT COMPLETED|Second Intervention||1
1057214|NCT00829452|2564708|P1|NOT COMPLETED|Second Intervention||0
1057215|NCT00829452|2564707|P2|COMPLETED|Second Intervention||17
1057216|NCT00829452|2564708|P1|COMPLETED|Second Intervention||20
1057217|NCT00829452|2564707|P2|STARTED|Second Intervention||18
1057218|NCT00829452|2564708|P1|STARTED|Second Intervention||20
1057219|NCT00829452|2564707|P2|NOT COMPLETED|Washout of 42 Days||1
1057220|NCT00829452|2564708|P1|NOT COMPLETED|Washout of 42 Days||0
1057221|NCT00829452|2564707|P2|COMPLETED|Washout of 42 Days||18
1057222|NCT00829452|2564708|P1|COMPLETED|Washout of 42 Days||20
1057223|NCT00829452|2564707|P2|STARTED|Washout of 42 Days||19
1057224|NCT00829452|2564708|P1|STARTED|Washout of 42 Days||20
1057225|NCT00829452|2564707|P2|NOT COMPLETED|First Intervention||1
1057226|NCT00829452|2564708|P1|NOT COMPLETED|First Intervention||0
1057227|NCT00829452|2564707|P2|COMPLETED|First Intervention||19
1057228|NCT00829452|2564708|P1|COMPLETED|First Intervention||20
1057229|NCT00829452|2564707|P2|STARTED|First Intervention||20
1057230|NCT00829452|2564708|P1|STARTED|First Intervention||20
1057231|NCT00829504|2564722|P2|NOT COMPLETED|Second Intervention||0
1057232|NCT00829504|2564723|P1|NOT COMPLETED|Second Intervention||1
1057233|NCT00829504|2564722|P2|COMPLETED|Second Intervention||22
1057234|NCT00829504|2564723|P1|COMPLETED|Second Intervention||19
1057235|NCT00829504|2564722|P2|STARTED|Second Intervention||22
1057236|NCT00829504|2564723|P1|STARTED|Second Intervention||20
1057237|NCT00829504|2564722|P2|NOT COMPLETED|Washout of 7 Days||0
1057238|NCT00829504|2564723|P1|NOT COMPLETED|Washout of 7 Days||1
1057239|NCT00829504|2564722|P2|COMPLETED|Washout of 7 Days||22
1057240|NCT00829504|2564723|P1|COMPLETED|Washout of 7 Days||20
1057241|NCT00829504|2564722|P2|STARTED|Washout of 7 Days||22
1057242|NCT00829504|2564723|P1|STARTED|Washout of 7 Days||21
1057243|NCT00829504|2564722|P2|NOT COMPLETED|First Intervention||0
1057244|NCT00829504|2564723|P1|NOT COMPLETED|First Intervention||1
1057245|NCT00829504|2564722|P2|COMPLETED|First Intervention||22
1057246|NCT00829504|2564723|P1|COMPLETED|First Intervention||21
1057247|NCT00829504|2564722|P2|STARTED|First Intervention||22
1057248|NCT00829504|2564723|P1|STARTED|First Intervention||22
1057249|NCT00829530|2564733|P2|NOT COMPLETED|Second Intervention||0
1057250|NCT00829530|2564734|P1|NOT COMPLETED|Second Intervention||1
1057251|NCT00829530|2564733|P2|COMPLETED|Second Intervention||18
1057252|NCT00829530|2564734|P1|COMPLETED|Second Intervention||19
1057253|NCT00829530|2564733|P2|STARTED|Second Intervention||18
1057254|NCT00829530|2564734|P1|STARTED|Second Intervention||20
1057255|NCT00829530|2564733|P2|NOT COMPLETED|Washout of 42 Days||0
1057256|NCT00829530|2564734|P1|NOT COMPLETED|Washout of 42 Days||0
1057257|NCT00829530|2564733|P2|COMPLETED|Washout of 42 Days||18
1057258|NCT00829530|2564734|P1|COMPLETED|Washout of 42 Days||20
1057259|NCT00829530|2564733|P2|STARTED|Washout of 42 Days||18
1057260|NCT00829530|2564734|P1|STARTED|Washout of 42 Days||20
1057261|NCT00829530|2564733|P2|NOT COMPLETED|First Intervention||2
1057262|NCT00829530|2564734|P1|NOT COMPLETED|First Intervention||0
1057263|NCT00829530|2564733|P2|COMPLETED|First Intervention||18
1057264|NCT00829530|2564734|P1|COMPLETED|First Intervention||20
1057265|NCT00829530|2564733|P2|STARTED|First Intervention||20
1057266|NCT00829530|2564734|P1|STARTED|First Intervention||20
1057267|NCT00829621|2564748|P2|NOT COMPLETED|Overall Study||4
1057268|NCT00829621|2564749|P1|NOT COMPLETED|Overall Study||4
1057269|NCT00829621|2564748|P2|COMPLETED|Overall Study||8
1057270|NCT00829621|2564749|P1|COMPLETED|Overall Study||4
1057271|NCT00829621|2564748|P2|STARTED|Overall Study||12
1057272|NCT00829621|2564749|P1|STARTED|Overall Study||8
1057273|NCT00829673|2564757|P2|NOT COMPLETED|Second Intervention||0
1057274|NCT00829673|2564758|P1|NOT COMPLETED|Second Intervention||0
1057275|NCT00829673|2564757|P2|COMPLETED|Second Intervention||12
1057276|NCT00829673|2564758|P1|COMPLETED|Second Intervention||11
1057277|NCT00829673|2564757|P2|STARTED|Second Intervention||12
1057278|NCT00829673|2564758|P1|STARTED|Second Intervention||11
1057279|NCT00829673|2564757|P2|NOT COMPLETED|Washout of 7 Days||0
1057280|NCT00829673|2564758|P1|NOT COMPLETED|Washout of 7 Days||1
1057281|NCT00829673|2564757|P2|COMPLETED|Washout of 7 Days||12
1057282|NCT00829673|2564758|P1|COMPLETED|Washout of 7 Days||11
1057283|NCT00829673|2564757|P2|STARTED|Washout of 7 Days||12
1057284|NCT00829673|2564758|P1|STARTED|Washout of 7 Days||12
1057285|NCT00829673|2564757|P2|NOT COMPLETED|First Intervention||0
1057286|NCT00829673|2564758|P1|NOT COMPLETED|First Intervention||0
1057287|NCT00829673|2564757|P2|COMPLETED|First Intervention||12
1057288|NCT00829673|2564758|P1|COMPLETED|First Intervention||12
1057289|NCT00829673|2564757|P2|STARTED|First Intervention||12
1057290|NCT00829673|2564758|P1|STARTED|First Intervention||12
1057291|NCT00829686|2564768|P2|NOT COMPLETED|Overall Study||0
1057292|NCT00829686|2564769|P1|NOT COMPLETED|Overall Study||0
1057293|NCT00829686|2564768|P2|COMPLETED|Overall Study||18
1057294|NCT00829686|2564769|P1|COMPLETED|Overall Study||13
1057295|NCT00829686|2564768|P2|STARTED|Overall Study||18
1057296|NCT00829686|2564769|P1|STARTED|Overall Study||13
1057297|NCT00829712|2564777|P2|NOT COMPLETED|Second Intervention||0
1057298|NCT00829712|2564778|P1|NOT COMPLETED|Second Intervention||0
1057299|NCT00829712|2564777|P2|COMPLETED|Second Intervention||11
1057300|NCT00829712|2564778|P1|COMPLETED|Second Intervention||12
1057301|NCT00829712|2564777|P2|STARTED|Second Intervention||11
1057302|NCT00829712|2564778|P1|STARTED|Second Intervention||12
1057303|NCT00829712|2564777|P2|NOT COMPLETED|Washout of 7 Days||1
1057304|NCT00829712|2564778|P1|NOT COMPLETED|Washout of 7 Days||0
1057305|NCT00829712|2564777|P2|COMPLETED|Washout of 7 Days||11
1057306|NCT00829712|2564778|P1|COMPLETED|Washout of 7 Days||12
1057307|NCT00829712|2564777|P2|STARTED|Washout of 7 Days||12
1057308|NCT00829712|2564778|P1|STARTED|Washout of 7 Days||12
1057309|NCT00829712|2564777|P2|NOT COMPLETED|First Intervention||0
1057310|NCT00829712|2564778|P1|NOT COMPLETED|First Intervention||0
1057311|NCT00829712|2564777|P2|COMPLETED|First Intervention||12
1057312|NCT00829712|2564778|P1|COMPLETED|First Intervention||12
1057313|NCT00829712|2564777|P2|STARTED|First Intervention||12
1057314|NCT00829712|2564778|P1|STARTED|First Intervention||12
1057315|NCT00829738|2564786|P1|NOT COMPLETED|Overall Study||8
1057316|NCT00829738|2564786|P1|COMPLETED|Overall Study||4180
1057317|NCT00829738|2564786|P1|STARTED|Overall Study||4188
1057318|NCT00829764|2564804|P2|NOT COMPLETED|Second Intervention||0
1057319|NCT00829764|2564805|P1|NOT COMPLETED|Second Intervention||0
1057320|NCT00829764|2564804|P2|COMPLETED|Second Intervention||14
1057321|NCT00829764|2564805|P1|COMPLETED|Second Intervention||13
1057322|NCT00829764|2564804|P2|STARTED|Second Intervention||14
1057323|NCT00829764|2564805|P1|STARTED|Second Intervention||13
1057324|NCT00829764|2564804|P2|NOT COMPLETED|Washout of 14 Days||0
1057325|NCT00829764|2564805|P1|NOT COMPLETED|Washout of 14 Days||0
1057326|NCT00829764|2564804|P2|COMPLETED|Washout of 14 Days||14
1057327|NCT00829764|2564805|P1|COMPLETED|Washout of 14 Days||13
1057328|NCT00829764|2564804|P2|STARTED|Washout of 14 Days||14
1057329|NCT00829764|2564805|P1|STARTED|Washout of 14 Days||13
1057330|NCT00829764|2564804|P2|NOT COMPLETED|First Intervention||1
1057331|NCT00829764|2564805|P1|NOT COMPLETED|First Intervention||2
1057332|NCT00829764|2564804|P2|COMPLETED|First Intervention||14
1057333|NCT00829764|2564805|P1|COMPLETED|First Intervention||13
1057334|NCT00829764|2564804|P2|STARTED|First Intervention||15
1057335|NCT00829764|2564805|P1|STARTED|First Intervention||15
1057336|NCT00829790|2564815|P2|NOT COMPLETED|Second Intervention||0
1057337|NCT00829790|2564816|P1|NOT COMPLETED|Second Intervention||0
1057338|NCT00829790|2564815|P2|COMPLETED|Second Intervention||14
1057339|NCT00829790|2564816|P1|COMPLETED|Second Intervention||15
1057340|NCT00829790|2564815|P2|STARTED|Second Intervention||14
1057341|NCT00829790|2564816|P1|STARTED|Second Intervention||15
1057342|NCT00829790|2564815|P2|NOT COMPLETED|Washout of 14 Days||1
1057343|NCT00829790|2564816|P1|NOT COMPLETED|Washout of 14 Days||0
1057344|NCT00829790|2564815|P2|COMPLETED|Washout of 14 Days||14
1057345|NCT00829790|2564816|P1|COMPLETED|Washout of 14 Days||15
1057346|NCT00829790|2564815|P2|STARTED|Washout of 14 Days||15
1057347|NCT00829790|2564816|P1|STARTED|Washout of 14 Days||15
1057348|NCT00829790|2564815|P2|NOT COMPLETED|First Intervention||0
1057349|NCT00829790|2564816|P1|NOT COMPLETED|First Intervention||0
1057350|NCT00829790|2564815|P2|COMPLETED|First Intervention||15
1057351|NCT00829790|2564816|P1|COMPLETED|First Intervention||15
1057352|NCT00829790|2564815|P2|STARTED|First Intervention||15
1057353|NCT00829790|2564816|P1|STARTED|First Intervention||15
1057354|NCT00829829|2564827|P3|NOT COMPLETED|Overall Study||11
1057355|NCT00829829|2564828|P2|NOT COMPLETED|Overall Study||16
1057356|NCT00829829|2564829|P1|NOT COMPLETED|Overall Study||22
1057357|NCT00829829|2564827|P3|COMPLETED|Overall Study||70
1057358|NCT00829829|2564828|P2|COMPLETED|Overall Study||64
1057359|NCT00829829|2564829|P1|COMPLETED|Overall Study||58
1057360|NCT00829829|2564827|P3|Treated|Overall Study||81
1057361|NCT00829829|2564828|P2|Treated|Overall Study||80
1057362|NCT00829829|2564829|P1|Treated|Overall Study||79
1057363|NCT00829829|2564827|P3|STARTED|Overall Study||81
1057364|NCT00829829|2564828|P2|STARTED|Overall Study||80
1057365|NCT00829829|2564829|P1|STARTED|Overall Study||80
1057366|NCT00829868|2564854|P2|NOT COMPLETED|Second Intervention||0
1057367|NCT00829868|2564855|P1|NOT COMPLETED|Second Intervention||0
1057368|NCT00829868|2564854|P2|COMPLETED|Second Intervention||21
1057369|NCT00829868|2564855|P1|COMPLETED|Second Intervention||20
1057370|NCT00829868|2564854|P2|STARTED|Second Intervention||21
1057371|NCT00829868|2564855|P1|STARTED|Second Intervention||20
1057372|NCT00829868|2564854|P2|NOT COMPLETED|Washout||0
1057373|NCT00829868|2564855|P1|NOT COMPLETED|Washout||1
1057374|NCT00829868|2564854|P2|COMPLETED|Washout||21
1057375|NCT00829868|2564855|P1|COMPLETED|Washout||20
1057376|NCT00829868|2564854|P2|STARTED|Washout||21
1057377|NCT00829868|2564855|P1|STARTED|Washout||21
1057378|NCT00829868|2564854|P2|NOT COMPLETED|First Intervention||0
1057379|NCT00829868|2564855|P1|NOT COMPLETED|First Intervention||0
1057380|NCT00829868|2564854|P2|COMPLETED|First Intervention||21
1057381|NCT00829868|2564855|P1|COMPLETED|First Intervention||21
1057382|NCT00829868|2564854|P2|STARTED|First Intervention||21
1057383|NCT00829868|2564855|P1|STARTED|First Intervention||21
1057384|NCT00829933|2564867|P4|NOT COMPLETED|Overall Study||14
1057385|NCT00829933|2564868|P3|NOT COMPLETED|Overall Study||13
1057386|NCT00829933|2564869|P2|NOT COMPLETED|Overall Study||13
1057387|NCT00829933|2564870|P1|NOT COMPLETED|Overall Study||14
1057388|NCT00829933|2564867|P4|COMPLETED|Overall Study||120
1057389|NCT00829933|2564868|P3|COMPLETED|Overall Study||119
1057390|NCT00829933|2564869|P2|COMPLETED|Overall Study||122
1057391|NCT00829933|2564870|P1|COMPLETED|Overall Study||121
1057392|NCT00829933|2564867|P4|Baseline Analysis Population|Overall Study||129
1057393|NCT00829933|2564868|P3|Baseline Analysis Population|Overall Study||131
1057394|NCT00829933|2564869|P2|Baseline Analysis Population|Overall Study||134
1057395|NCT00829933|2564870|P1|Baseline Analysis Population|Overall Study||131
1057396|NCT00829933|2564867|P4|STARTED|Overall Study||134
1057397|NCT00829933|2564868|P3|STARTED|Overall Study||132
1057398|NCT00829933|2564869|P2|STARTED|Overall Study||135
1057399|NCT00829933|2564870|P1|STARTED|Overall Study||135
1057400|NCT00829985|2564882|P2|NOT COMPLETED|Overall Study||4
1057401|NCT00829985|2564883|P1|NOT COMPLETED|Overall Study||9
1057402|NCT00829985|2564882|P2|COMPLETED|Overall Study||22
1057403|NCT00829985|2564883|P1|COMPLETED|Overall Study||19
1057404|NCT00829985|2564882|P2|STARTED|Overall Study||26
1057405|NCT00829985|2564883|P1|STARTED|Overall Study||28
1057406|NCT00829998|2564899|P2|NOT COMPLETED|Second Intervention||0
1057407|NCT00829998|2564900|P1|NOT COMPLETED|Second Intervention||0
1057408|NCT00829998|2564899|P2|COMPLETED|Second Intervention||19
1057409|NCT00829998|2564900|P1|COMPLETED|Second Intervention||21
1057410|NCT00829998|2564899|P2|STARTED|Second Intervention||19
1057411|NCT00829998|2564900|P1|STARTED|Second Intervention||21
1057412|NCT00829998|2564899|P2|NOT COMPLETED|Washout||1
1057413|NCT00829998|2564900|P1|NOT COMPLETED|Washout||0
1057414|NCT00829998|2564899|P2|COMPLETED|Washout||19
1057415|NCT00829998|2564900|P1|COMPLETED|Washout||21
1057416|NCT00829998|2564899|P2|STARTED|Washout||20
1057417|NCT00829998|2564900|P1|STARTED|Washout||21
1057418|NCT00829998|2564899|P2|NOT COMPLETED|First Intervention||0
1057419|NCT00829998|2564900|P1|NOT COMPLETED|First Intervention||0
1057420|NCT00829998|2564899|P2|COMPLETED|First Intervention||20
1057421|NCT00829998|2564900|P1|COMPLETED|First Intervention||21
1057422|NCT00829998|2564899|P2|STARTED|First Intervention||20
1057423|NCT00829998|2564900|P1|STARTED|First Intervention||21
1057424|NCT00830024|2564910|P2|NOT COMPLETED|Second Intervention||0
1057425|NCT00830024|2564911|P1|NOT COMPLETED|Second Intervention||0
1057426|NCT00830024|2564910|P2|COMPLETED|Second Intervention||18
1057427|NCT00830024|2564911|P1|COMPLETED|Second Intervention||17
1057428|NCT00830024|2564910|P2|STARTED|Second Intervention||18
1057429|NCT00830024|2564911|P1|STARTED|Second Intervention||17
1057430|NCT00830024|2564910|P2|NOT COMPLETED|Washout: 7 Days||0
1057431|NCT00830024|2564911|P1|NOT COMPLETED|Washout: 7 Days||1
1057432|NCT00830024|2564910|P2|COMPLETED|Washout: 7 Days||18
1057433|NCT00830024|2564911|P1|COMPLETED|Washout: 7 Days||17
1057434|NCT00830024|2564910|P2|STARTED|Washout: 7 Days||18
1057435|NCT00830024|2564911|P1|STARTED|Washout: 7 Days||18
1057436|NCT00830024|2564910|P2|NOT COMPLETED|First Intervention||0
1057437|NCT00830024|2564911|P1|NOT COMPLETED|First Intervention||0
1057438|NCT00830024|2564910|P2|COMPLETED|First Intervention||18
1057439|NCT00830024|2564911|P1|COMPLETED|First Intervention||18
1057440|NCT00830024|2564910|P2|STARTED|First Intervention||18
1057441|NCT00830024|2564911|P1|STARTED|First Intervention||18
1057442|NCT00830037|2564921|P2|NOT COMPLETED|Overall Study||19
1057443|NCT00830037|2564922|P1|NOT COMPLETED|Overall Study||18
1057444|NCT00830037|2564921|P2|COMPLETED|Overall Study||50
1057445|NCT00830037|2564922|P1|COMPLETED|Overall Study||49
1057446|NCT00830037|2564921|P2|STARTED|Overall Study||69
1057447|NCT00830037|2564922|P1|STARTED|Overall Study||67
1057448|NCT00830076|2564930|P1|NOT COMPLETED|Placebo Sitagliptin + Placebo Metformin||0
1057449|NCT00830076|2564930|P1|COMPLETED|Placebo Sitagliptin + Placebo Metformin||18
1057450|NCT00830076|2564930|P1|STARTED|Placebo Sitagliptin + Placebo Metformin||18
1057451|NCT00830076|2564930|P1|NOT COMPLETED|7-day Washout||0
1057452|NCT00830076|2564930|P1|COMPLETED|7-day Washout||18
1057453|NCT00830076|2564930|P1|STARTED|7-day Washout||18
1057454|NCT00830076|2564930|P1|NOT COMPLETED|Sitagliptin + Metformin||0
1057455|NCT00830076|2564930|P1|COMPLETED|Sitagliptin + Metformin||18
1057456|NCT00830076|2564930|P1|STARTED|Sitagliptin + Metformin||18
1057457|NCT00830076|2564930|P1|NOT COMPLETED|7-day Washout||0
1057458|NCT00830076|2564930|P1|COMPLETED|7-day Washout||18
1057459|NCT00830076|2564930|P1|STARTED|7-day Washout||18
1057460|NCT00830076|2564930|P1|NOT COMPLETED|Metformin + Placebo Sitagliptin||0
1057461|NCT00830076|2564930|P1|COMPLETED|Metformin + Placebo Sitagliptin||18
1057462|NCT00830076|2564930|P1|STARTED|Metformin + Placebo Sitagliptin||18
1057463|NCT00830076|2564930|P1|NOT COMPLETED|7-day Washout||0
1057464|NCT00830076|2564930|P1|COMPLETED|7-day Washout||18
1057465|NCT00830076|2564930|P1|STARTED|7-day Washout||18
1057466|NCT00830076|2564930|P1|NOT COMPLETED|Sitagliptin + Placebo Metformin||0
1057467|NCT00830076|2564930|P1|COMPLETED|Sitagliptin + Placebo Metformin||18
1057468|NCT00830076|2564930|P1|STARTED|Sitagliptin + Placebo Metformin||18
1057469|NCT00830115|2564939|P1|NOT COMPLETED|Overall Study||3
1057470|NCT00830115|2564939|P1|COMPLETED|Overall Study||1042
1057471|NCT00830115|2564939|P1|STARTED|Overall Study||1045
1057472|NCT00830128|2564955|P1|NOT COMPLETED|Overall Study||19
1057473|NCT00830128|2564955|P1|COMPLETED|Overall Study||87
1057474|NCT00830128|2564955|P1|STARTED|Overall Study||106
1057475|NCT00830167|2564972|P2|NOT COMPLETED|Overall Study||43
1057476|NCT00830167|2564973|P1|NOT COMPLETED|Overall Study||40
1057477|NCT00830167|2564972|P2|COMPLETED|Overall Study||207
1057478|NCT00830167|2564973|P1|COMPLETED|Overall Study||208
1057479|NCT00830167|2564972|P2|STARTED|Overall Study|Treated|250
1057480|NCT00830167|2564973|P1|STARTED|Overall Study|Treated|248
1057481|NCT00830206|2565045|P2|NOT COMPLETED|Second Intervention||0
1057482|NCT00830206|2565046|P1|NOT COMPLETED|Second Intervention||0
1057483|NCT00830206|2565045|P2|COMPLETED|Second Intervention||39
1057484|NCT00830206|2565046|P1|COMPLETED|Second Intervention||39
1057485|NCT00830206|2565045|P2|STARTED|Second Intervention||39
1057486|NCT00830206|2565046|P1|STARTED|Second Intervention||39
1057487|NCT00830206|2565045|P2|NOT COMPLETED|Washout: 21 Days||1
1057488|NCT00830206|2565046|P1|NOT COMPLETED|Washout: 21 Days||1
1057489|NCT00830206|2565045|P2|COMPLETED|Washout: 21 Days||39
1057490|NCT00830206|2565046|P1|COMPLETED|Washout: 21 Days||39
1057491|NCT00830206|2565045|P2|STARTED|Washout: 21 Days||40
1057492|NCT00830206|2565046|P1|STARTED|Washout: 21 Days||40
1057493|NCT00830206|2565045|P2|NOT COMPLETED|First Intervention||0
1057494|NCT00830206|2565046|P1|NOT COMPLETED|First Intervention||0
1057495|NCT00830206|2565045|P2|COMPLETED|First Intervention||40
1057496|NCT00830206|2565046|P1|COMPLETED|First Intervention||40
1057497|NCT00830206|2565045|P2|STARTED|First Intervention||40
1057498|NCT00830206|2565046|P1|STARTED|First Intervention||40
1057499|NCT00830219|2565056|P2|NOT COMPLETED|Second Intervention||0
1057500|NCT00830219|2565057|P1|NOT COMPLETED|Second Intervention||0
1057501|NCT00830219|2565056|P2|COMPLETED|Second Intervention||22
1057502|NCT00830219|2565057|P1|COMPLETED|Second Intervention||22
1057503|NCT00830219|2565056|P2|STARTED|Second Intervention||22
1057504|NCT00830219|2565057|P1|STARTED|Second Intervention||22
1057505|NCT00830219|2565056|P2|NOT COMPLETED|Washout of 7 Days||1
1057506|NCT00830219|2565057|P1|NOT COMPLETED|Washout of 7 Days||1
1057507|NCT00830219|2565056|P2|COMPLETED|Washout of 7 Days||22
1057508|NCT00830219|2565057|P1|COMPLETED|Washout of 7 Days||22
1057509|NCT00830219|2565056|P2|STARTED|Washout of 7 Days||23
1057510|NCT00830219|2565057|P1|STARTED|Washout of 7 Days||23
1057511|NCT00830219|2565056|P2|NOT COMPLETED|First Intervention||0
1057512|NCT00830219|2565057|P1|NOT COMPLETED|First Intervention||0
1057513|NCT00830219|2565056|P2|COMPLETED|First Intervention||23
1057514|NCT00830219|2565057|P1|COMPLETED|First Intervention||23
1057515|NCT00830219|2565056|P2|STARTED|First Intervention||23
1057516|NCT00830219|2565057|P1|STARTED|First Intervention||23
1057517|NCT00830232|2565067|P2|NOT COMPLETED|Overall Study||0
1057518|NCT00830232|2565068|P1|NOT COMPLETED|Overall Study||0
1057519|NCT00830232|2565067|P2|COMPLETED|Overall Study||20
1057520|NCT00830232|2565068|P1|COMPLETED|Overall Study||20
1057521|NCT00830232|2565067|P2|STARTED|Overall Study||20
1057522|NCT00830232|2565068|P1|STARTED|Overall Study||20
1057523|NCT00830258|2565076|P2|NOT COMPLETED|Second Intervention||0
1057524|NCT00830258|2565077|P1|NOT COMPLETED|Second Intervention||0
1057525|NCT00830258|2565076|P2|COMPLETED|Second Intervention||30
1057526|NCT00830258|2565077|P1|COMPLETED|Second Intervention||28
1057527|NCT00830258|2565076|P2|STARTED|Second Intervention||30
1057528|NCT00830258|2565077|P1|STARTED|Second Intervention||28
1057529|NCT00830258|2565076|P2|NOT COMPLETED|Washout: 7 Days||0
1057530|NCT00830258|2565077|P1|NOT COMPLETED|Washout: 7 Days||1
1057531|NCT00830258|2565076|P2|COMPLETED|Washout: 7 Days||30
1057532|NCT00830258|2565077|P1|COMPLETED|Washout: 7 Days||28
1057533|NCT00830258|2565076|P2|STARTED|Washout: 7 Days||30
1057534|NCT00830258|2565077|P1|STARTED|Washout: 7 Days||29
1057535|NCT00830258|2565076|P2|NOT COMPLETED|First Intervention||0
1057536|NCT00830258|2565077|P1|NOT COMPLETED|First Intervention||1
1057537|NCT00830258|2565076|P2|COMPLETED|First Intervention||30
1057538|NCT00830258|2565077|P1|COMPLETED|First Intervention||29
1057539|NCT00830258|2565076|P2|STARTED|First Intervention||30
1057540|NCT00830258|2565077|P1|STARTED|First Intervention||30
1057541|NCT00830284|2565085|P1|NOT COMPLETED|Overall Study||2
1057542|NCT00830284|2565085|P1|COMPLETED|Overall Study||10
1057543|NCT00830284|2565085|P1|STARTED|Overall Study|The study was started in our Medical Surgical ICU October of 2008.|12
1057544|NCT00830310|2565090|P1|NOT COMPLETED|Overall Study||13
1057545|NCT00830310|2565090|P1|COMPLETED|Overall Study||30
1057546|NCT00830310|2565090|P1|STARTED|Overall Study||43
1057547|NCT00830336|2565104|P2|NOT COMPLETED|Second Intervention||0
1057548|NCT00830336|2565105|P1|NOT COMPLETED|Second Intervention||0
1057549|NCT00830336|2565104|P2|COMPLETED|Second Intervention||40
1057550|NCT00830336|2565105|P1|COMPLETED|Second Intervention||39
1057551|NCT00830336|2565104|P2|STARTED|Second Intervention||40
1057552|NCT00830336|2565105|P1|STARTED|Second Intervention||39
1057553|NCT00830336|2565104|P2|NOT COMPLETED|Washout: 21 Days||0
1057554|NCT00830336|2565105|P1|NOT COMPLETED|Washout: 21 Days||1
1057555|NCT00830336|2565104|P2|COMPLETED|Washout: 21 Days||40
1057556|NCT00830336|2565105|P1|COMPLETED|Washout: 21 Days||39
1057557|NCT00830336|2565104|P2|STARTED|Washout: 21 Days||40
1057558|NCT00830336|2565105|P1|STARTED|Washout: 21 Days||40
1057559|NCT00830336|2565104|P2|NOT COMPLETED|First Intervention||0
1057560|NCT00830336|2565105|P1|NOT COMPLETED|First Intervention||0
1057561|NCT00830336|2565104|P2|COMPLETED|First Intervention||40
1057562|NCT00830336|2565105|P1|COMPLETED|First Intervention||40
1057563|NCT00830336|2565104|P2|STARTED|First Intervention||40
1057564|NCT00830336|2565105|P1|STARTED|First Intervention||40
1057565|NCT00830362|2565115|P2|NOT COMPLETED|Overall Study||4
1057566|NCT00830362|2565116|P1|NOT COMPLETED|Overall Study||4
1057567|NCT00830362|2565115|P2|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|20
1057568|NCT00830362|2565116|P1|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|23
1057569|NCT00830362|2565115|P2|Completed Sessions 1 and 2|Overall Study|Received palcebo and completed both Test and Retrieval sessions (Session 1 and 2).|24
1057570|NCT00830362|2565116|P1|Completed Sessions 1 and 2|Overall Study|Received propranolol and completed both Test and Retrieval sessions (Session 1 and 2).|26
1057571|NCT00830362|2565115|P2|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|24
1057572|NCT00830362|2565116|P1|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|27
1057573|NCT00830375|2565122|P1|NOT COMPLETED|Overall Study||1
1057574|NCT00830375|2565122|P1|COMPLETED|Overall Study||9
1057575|NCT00830375|2565122|P1|STARTED|Overall Study||10
1057576|NCT00830388|2565126|P1|NOT COMPLETED|Overall Study||0
1057577|NCT00830388|2565126|P1|COMPLETED|Overall Study||11
1057578|NCT00830388|2565126|P1|STARTED|Overall Study||11
1057579|NCT00830440|2565133|P2|NOT COMPLETED|Overall Study||0
1057580|NCT00830440|2565134|P1|NOT COMPLETED|Overall Study||8
1057581|NCT00830440|2565133|P2|COMPLETED|Overall Study||11
1057582|NCT00830440|2565134|P1|COMPLETED|Overall Study||24
1057583|NCT00830440|2565133|P2|Completed 24 Week Follow up|Overall Study||0
1057584|NCT00830440|2565134|P1|Completed 24 Week Follow up|Overall Study||3
1057585|NCT00830440|2565133|P2|Completed 16 Week Follow up|Overall Study||0
1057586|NCT00830440|2565134|P1|Completed 16 Week Follow up|Overall Study||4
1057587|NCT00830440|2565133|P2|Completed 12 Week Follow up|Overall Study||11
1057588|NCT00830440|2565134|P1|Completed 12 Week Follow up|Overall Study||24
1057589|NCT00830440|2565133|P2|Received Device|Overall Study||0
1057590|NCT00830440|2565134|P1|Received Device|Overall Study||26
1057591|NCT00830440|2565133|P2|STARTED|Overall Study||11
1057592|NCT00830440|2565134|P1|STARTED|Overall Study||32
1057593|NCT00830596|2565147|P3|NOT COMPLETED|Overall Study||6
1057594|NCT00830596|2565148|P2|NOT COMPLETED|Overall Study||2
1057595|NCT00830596|2565149|P1|NOT COMPLETED|Overall Study||2
1057596|NCT00830596|2565147|P3|COMPLETED|Overall Study||67
1057597|NCT00830596|2565148|P2|COMPLETED|Overall Study||72
1057598|NCT00830596|2565149|P1|COMPLETED|Overall Study||72
1057599|NCT00830596|2565147|P3|STARTED|Overall Study||73
1057600|NCT00830596|2565148|P2|STARTED|Overall Study||74
1057601|NCT00830596|2565149|P1|STARTED|Overall Study||74
1057602|NCT00830765|2565171|P2|NOT COMPLETED|Overall Study||2
1057603|NCT00830765|2565172|P1|NOT COMPLETED|Overall Study||3
1057604|NCT00830765|2565171|P2|COMPLETED|Overall Study||69
1057605|NCT00830765|2565172|P1|COMPLETED|Overall Study||70
1057606|NCT00830765|2565171|P2|STARTED|Overall Study||71
1057607|NCT00830765|2565172|P1|STARTED|Overall Study||73
1057608|NCT00831233|2565180|P2|NOT COMPLETED|Overall Study||1
1057609|NCT00831233|2565181|P1|NOT COMPLETED|Overall Study||3
1057610|NCT00831233|2565180|P2|COMPLETED|Overall Study||12
1057611|NCT00831233|2565181|P1|COMPLETED|Overall Study||26
1057612|NCT00831233|2565180|P2|Per Protocol (PP) Analysis Set|Overall Study||11
1057613|NCT00831233|2565181|P1|Per Protocol (PP) Analysis Set|Overall Study||26
1057614|NCT00831233|2565180|P2|Full Analysis Set (FAS)|Overall Study||13
1057615|NCT00831233|2565181|P1|Full Analysis Set (FAS)|Overall Study|2 participants were randomised but never treated.|27
1057616|NCT00831233|2565180|P2|STARTED|Overall Study|ITT population.|13
1057617|NCT00831233|2565181|P1|STARTED|Overall Study|Intention-to-treat (ITT) population.|29
1057618|NCT00831272|2565209|P4|NOT COMPLETED|Overall Study||10
1057619|NCT00831272|2565210|P3|NOT COMPLETED|Overall Study||10
1057620|NCT00831272|2565211|P2|NOT COMPLETED|Overall Study||7
1057621|NCT00831272|2565212|P1|NOT COMPLETED|Overall Study||8
1057622|NCT00831272|2565209|P4|COMPLETED|Overall Study||56
1057623|NCT00831272|2565210|P3|COMPLETED|Overall Study||63
1057624|NCT00831272|2565211|P2|COMPLETED|Overall Study||37
1057625|NCT00831272|2565212|P1|COMPLETED|Overall Study||30
1057626|NCT00831272|2565209|P4|STARTED|Overall Study||66
1057627|NCT00831272|2565210|P3|STARTED|Overall Study||73
1057628|NCT00831272|2565211|P2|STARTED|Overall Study||44
1057629|NCT00831272|2565212|P1|STARTED|Overall Study||38
1057630|NCT00831311|2565224|P2|NOT COMPLETED|Overall Study||8
1057631|NCT00831311|2565225|P1|NOT COMPLETED|Overall Study||12
1057632|NCT00831311|2565224|P2|COMPLETED|Overall Study||304
1057633|NCT00831311|2565225|P1|COMPLETED|Overall Study||300
1057634|NCT00831311|2565224|P2|STARTED|Overall Study||312
1057635|NCT00831311|2565225|P1|STARTED|Overall Study||312
1057636|NCT00831389|2565243|P1|NOT COMPLETED|Overall Study||1
1057637|NCT00831389|2565243|P1|COMPLETED|Overall Study||12
1057638|NCT00831389|2565243|P1|STARTED|Overall Study||13
1057639|NCT00831415|2565267|P1|NOT COMPLETED|Overall Study||75
1057640|NCT00831415|2565267|P1|COMPLETED|Overall Study|In addition to Completers for Study includes 2 participants who discontinued after on-therapy period|229
1057641|NCT00831415|2565267|P1|"Study Completers"|Overall Study|Defined as participants whose conclusion of study participation status was “study completed.”|227
1057642|NCT00831415|2565267|P1|"Completers for Exposure"|Overall Study|Participants with ≥ 301 days of exposure to study drug and completed study day 308 evaluations.|227
1057643|NCT00831415|2565267|P1|STARTED|Overall Study||304
1057644|NCT00831428|2565274|P1|NOT COMPLETED|Overall Study||0
1057645|NCT00831428|2565274|P1|COMPLETED|Overall Study||97
1057646|NCT00831428|2565274|P1|STARTED|Overall Study||97
1057647|NCT00831441|2565280|P2|NOT COMPLETED|Follow Up (30 Days)||174
1057648|NCT00831441|2565281|P1|NOT COMPLETED|Follow Up (30 Days)||133
1057649|NCT00831441|2565280|P2|COMPLETED|Follow Up (30 Days)||3355
1057650|NCT00831441|2565281|P1|COMPLETED|Follow Up (30 Days)||3375
1057651|NCT00831441|2565280|P2|STARTED|Follow Up (30 Days)|3529 participants entered the follow up period.|3529
1057652|NCT00831441|2565281|P1|STARTED|Follow Up (30 Days)|3508 participants entered the follow up period.|3508
1057653|NCT00831441|2565280|P2|NOT COMPLETED|Randomized||3705
1057654|NCT00831441|2565281|P1|NOT COMPLETED|Randomized||3687
1057655|NCT00831441|2565280|P2|COMPLETED|Randomized||0
1057656|NCT00831441|2565281|P1|COMPLETED|Randomized||0
1057657|NCT00831441|2565280|P2|Treated|Randomized||3672
1057658|NCT00831441|2565281|P1|Treated|Randomized||3643
1057659|NCT00831441|2565280|P2|STARTED|Randomized||3705
1057660|NCT00831441|2565281|P1|STARTED|Randomized||3687
1057661|NCT00831480|2565309|P1|NOT COMPLETED|Overall Study||2
1057662|NCT00831480|2565309|P1|COMPLETED|Overall Study||7
1057663|NCT00831480|2565309|P1|STARTED|Overall Study||9
1057664|NCT00831493|2565313|P1|NOT COMPLETED|Overall Study||1
1057665|NCT00831493|2565313|P1|COMPLETED|Overall Study||2
1057666|NCT00831493|2565313|P1|STARTED|Overall Study||3
1057667|NCT00831675|2565319|P2|NOT COMPLETED|Overall Study||0
1057668|NCT00831675|2565320|P1|NOT COMPLETED|Overall Study||0
1057669|NCT00831675|2565319|P2|COMPLETED|Overall Study||18
1057670|NCT00831675|2565320|P1|COMPLETED|Overall Study||12
1057671|NCT00831675|2565319|P2|STARTED|Overall Study||18
1057672|NCT00831675|2565320|P1|STARTED|Overall Study||12
1057673|NCT00831701|2565334|P2|NOT COMPLETED|Overall Study||5
1057674|NCT00831701|2565335|P1|NOT COMPLETED|Overall Study||5
1057675|NCT00831701|2565334|P2|COMPLETED|Overall Study||45
1057676|NCT00831701|2565335|P1|COMPLETED|Overall Study||45
1057677|NCT00831701|2565334|P2|STARTED|Overall Study||50
1057678|NCT00831701|2565335|P1|STARTED|Overall Study||50
1057679|NCT00831753|2565351|P2|NOT COMPLETED|Overall Study||0
1057680|NCT00831753|2565352|P1|NOT COMPLETED|Overall Study||0
1057681|NCT00831753|2565351|P2|COMPLETED|Overall Study||131
1057682|NCT00831753|2565352|P1|COMPLETED|Overall Study||132
1057683|NCT00831753|2565351|P2|STARTED|Overall Study||131
1057684|NCT00831753|2565352|P1|STARTED|Overall Study||132
1057685|NCT00831766|2565366|P2|NOT COMPLETED|Overall Study||0
1057686|NCT00831766|2565367|P1|NOT COMPLETED|Overall Study||0
1057687|NCT00831766|2565366|P2|COMPLETED|Overall Study||28
1057688|NCT00831766|2565367|P1|COMPLETED|Overall Study||23
1057689|NCT00831766|2565366|P2|STARTED|Overall Study||28
1057690|NCT00831766|2565367|P1|STARTED|Overall Study||23
1057691|NCT00831779|2565375|P2|NOT COMPLETED|Overall Study||1
1057692|NCT00831779|2565376|P1|NOT COMPLETED|Overall Study||1
1057693|NCT00831779|2565375|P2|COMPLETED|Overall Study||22
1057694|NCT00831779|2565376|P1|COMPLETED|Overall Study||20
1057695|NCT00831779|2565375|P2|STARTED|Overall Study||23
1057696|NCT00831779|2565376|P1|STARTED|Overall Study||21
1057697|NCT00831844|2565394|P10|NOT COMPLETED|Overall Study||0
1057698|NCT00831844|2565395|P9|NOT COMPLETED|Overall Study||9
1057699|NCT00831844|2565396|P8|NOT COMPLETED|Overall Study||10
1057700|NCT00831844|2565397|P7|NOT COMPLETED|Overall Study||10
1057701|NCT00831844|2565398|P6|NOT COMPLETED|Overall Study||19
1057702|NCT00831844|2565399|P5|NOT COMPLETED|Overall Study||14
1057703|NCT00831844|2565400|P4|NOT COMPLETED|Overall Study||10
1057704|NCT00831844|2565401|P3|NOT COMPLETED|Overall Study||20
1057705|NCT00831844|2565402|P2|NOT COMPLETED|Overall Study||12
1057706|NCT00831844|2565403|P1|NOT COMPLETED|Overall Study||10
1057707|NCT00831844|2565394|P10|COMPLETED|Overall Study||0
1057708|NCT00831844|2565395|P9|COMPLETED|Overall Study||0
1057709|NCT00831844|2565396|P8|COMPLETED|Overall Study||0
1057710|NCT00831844|2565397|P7|COMPLETED|Overall Study||0
1057711|NCT00831844|2565398|P6|COMPLETED|Overall Study||1
1057712|NCT00831844|2565399|P5|COMPLETED|Overall Study||0
1057713|NCT00831844|2565400|P4|COMPLETED|Overall Study||0
1057714|NCT00831844|2565401|P3|COMPLETED|Overall Study||1
1057715|NCT00831844|2565402|P2|COMPLETED|Overall Study||0
1057716|NCT00831844|2565403|P1|COMPLETED|Overall Study||0
1057717|NCT00831844|2565394|P10|STARTED|Overall Study||0
1057718|NCT00831844|2565395|P9|STARTED|Overall Study||9
1057719|NCT00831844|2565396|P8|STARTED|Overall Study||10
1057720|NCT00831844|2565397|P7|STARTED|Overall Study||10
1057721|NCT00831844|2565398|P6|STARTED|Overall Study||20
1057722|NCT00831844|2565399|P5|STARTED|Overall Study||14
1057723|NCT00831844|2565400|P4|STARTED|Overall Study||10
1057724|NCT00831844|2565401|P3|STARTED|Overall Study||21
1057725|NCT00831844|2565402|P2|STARTED|Overall Study||12
1057726|NCT00831844|2565403|P1|STARTED|Overall Study||10
1057727|NCT00831987|2565427|P2|NOT COMPLETED|Overall Study||0
1057728|NCT00831987|2565428|P1|NOT COMPLETED|Overall Study||0
1057729|NCT00831987|2565427|P2|COMPLETED|Overall Study||60
1057730|NCT00831987|2565428|P1|COMPLETED|Overall Study||60
1057731|NCT00831987|2565427|P2|STARTED|Overall Study||60
1057732|NCT00831987|2565428|P1|STARTED|Overall Study||60
1057733|NCT00832000|2565440|P2|NOT COMPLETED|Overall Study||1
1057734|NCT00832000|2565441|P1|NOT COMPLETED|Overall Study||6
1057735|NCT00832000|2565440|P2|COMPLETED|Overall Study||29
1057736|NCT00832000|2565441|P1|COMPLETED|Overall Study||23
1057737|NCT00832000|2565440|P2|Crossed Over to Opposite Intervention|Overall Study|Mexiletine 200 mg orally three times daily|29
1057738|NCT00832000|2565441|P1|Crossed Over to Opposite Intervention|Overall Study|Placebo|25
1057739|NCT00832000|2565440|P2|STARTED|Overall Study|Placebo|30
1057740|NCT00832000|2565441|P1|STARTED|Overall Study|Mexiletine 200 mg orally three times daily|29
1057741|NCT00832078|2565477|P2|NOT COMPLETED|Test Day 2 - 2 Period||0
1057742|NCT00832078|2565478|P1|NOT COMPLETED|Test Day 2 - 2 Period||1
1057743|NCT00832078|2565477|P2|COMPLETED|Test Day 2 - 2 Period||10
1057744|NCT00832078|2565478|P1|COMPLETED|Test Day 2 - 2 Period||12
1057745|NCT00832078|2565477|P2|STARTED|Test Day 2 - 2 Period||10
1057746|NCT00832078|2565478|P1|STARTED|Test Day 2 - 2 Period||13
1057747|NCT00832078|2565477|P2|NOT COMPLETED|Test Day 2 - 1 Period||0
1057748|NCT00832078|2565478|P1|NOT COMPLETED|Test Day 2 - 1 Period||0
1057749|NCT00832078|2565477|P2|COMPLETED|Test Day 2 - 1 Period||10
1057750|NCT00832078|2565478|P1|COMPLETED|Test Day 2 - 1 Period||13
1057751|NCT00832078|2565477|P2|STARTED|Test Day 2 - 1 Period||10
1057752|NCT00832078|2565478|P1|STARTED|Test Day 2 - 1 Period||13
1057753|NCT00832078|2565477|P2|NOT COMPLETED|Test Day 1-2 Period||2
1057754|NCT00832078|2565478|P1|NOT COMPLETED|Test Day 1-2 Period||0
1057755|NCT00832078|2565477|P2|COMPLETED|Test Day 1-2 Period||10
1057756|NCT00832078|2565478|P1|COMPLETED|Test Day 1-2 Period||13
1057757|NCT00832078|2565477|P2|STARTED|Test Day 1-2 Period||12
1057758|NCT00832078|2565478|P1|STARTED|Test Day 1-2 Period||13
1057759|NCT00832078|2565477|P2|NOT COMPLETED|Test Day 1- 1 Period||0
1057760|NCT00832078|2565478|P1|NOT COMPLETED|Test Day 1- 1 Period||0
1057761|NCT00832078|2565477|P2|COMPLETED|Test Day 1- 1 Period||12
1057762|NCT00832078|2565478|P1|COMPLETED|Test Day 1- 1 Period||13
1057763|NCT00832078|2565477|P2|STARTED|Test Day 1- 1 Period||12
1057764|NCT00832078|2565478|P1|STARTED|Test Day 1- 1 Period||13
1057765|NCT00832091|2565486|P2|NOT COMPLETED|Overall Study||2
1057766|NCT00832091|2565487|P1|NOT COMPLETED|Overall Study||5
1057767|NCT00832091|2565486|P2|COMPLETED|Overall Study||53
1057768|NCT00832091|2565487|P1|COMPLETED|Overall Study||12
1057769|NCT00832091|2565486|P2|STARTED|Overall Study||55
1057770|NCT00832091|2565487|P1|STARTED|Overall Study||17
1057771|NCT00832117|2565497|P1|NOT COMPLETED|Overall Study||12
1057772|NCT00832117|2565497|P1|COMPLETED|Overall Study||17
1057773|NCT00832117|2565497|P1|STARTED|Overall Study||29
1057774|NCT00832130|2565516|P2|NOT COMPLETED|Overall Study||0
1057775|NCT00832130|2565517|P1|NOT COMPLETED|Overall Study||0
1057776|NCT00832130|2565516|P2|COMPLETED|Overall Study||70
1057777|NCT00832130|2565517|P1|COMPLETED|Overall Study||69
1057778|NCT00832130|2565516|P2|STARTED|Overall Study||70
1057779|NCT00832130|2565517|P1|STARTED|Overall Study||69
1057780|NCT00832260|2565537|P1|NOT COMPLETED|Overall Study||0
1057781|NCT00832260|2565537|P1|COMPLETED|Overall Study||70
1057782|NCT00832260|2565537|P1|STARTED|Overall Study||70
1057783|NCT00832299|2565542|P1|NOT COMPLETED|Overall Study||0
1057784|NCT00832299|2565542|P1|COMPLETED|Overall Study||2
1057785|NCT00832299|2565542|P1|STARTED|Overall Study||2
1057786|NCT00832338|2565546|P1|NOT COMPLETED|Overall Study||0
1057787|NCT00832338|2565546|P1|COMPLETED|Overall Study||23
1057788|NCT00832338|2565546|P1|STARTED|Overall Study||23
1057789|NCT00832377|2565550|P1|NOT COMPLETED|Overall Study||1
1057790|NCT00832377|2565550|P1|COMPLETED|Overall Study||36
1057791|NCT00832377|2565550|P1|STARTED|Overall Study||37
1057792|NCT00832390|2565560|P3|NOT COMPLETED|Overall Study||0
1057793|NCT00832390|2565561|P2|NOT COMPLETED|Overall Study||0
1057794|NCT00832390|2565562|P1|NOT COMPLETED|Overall Study||0
1057795|NCT00832390|2565560|P3|COMPLETED|Overall Study||1
1057796|NCT00832390|2565561|P2|COMPLETED|Overall Study||16
1057797|NCT00832390|2565562|P1|COMPLETED|Overall Study||12
1057798|NCT00832390|2565560|P3|STARTED|Overall Study||1
1057799|NCT00832390|2565561|P2|STARTED|Overall Study||16
1057800|NCT00832390|2565562|P1|STARTED|Overall Study||12
1057801|NCT00832416|2565574|P4|NOT COMPLETED|Overall Study||83
1057802|NCT00832416|2565575|P3|NOT COMPLETED|Overall Study||61
1057803|NCT00832416|2565576|P2|NOT COMPLETED|Overall Study||53
1057804|NCT00832416|2565577|P1|NOT COMPLETED|Overall Study||46
1057805|NCT00832416|2565574|P4|COMPLETED|Overall Study||144
1057806|NCT00832416|2565575|P3|COMPLETED|Overall Study||54
1057807|NCT00832416|2565576|P2|COMPLETED|Overall Study||60
1057808|NCT00832416|2565577|P1|COMPLETED|Overall Study||64
1057809|NCT00832416|2565574|P4|STARTED|Overall Study||227
1057810|NCT00832416|2565575|P3|STARTED|Overall Study||115
1057811|NCT00832416|2565576|P2|STARTED|Overall Study||113
1057812|NCT00832416|2565577|P1|STARTED|Overall Study||110
1057813|NCT00832455|2565615|P1|NOT COMPLETED|Overall Study||72
1057814|NCT00832455|2565615|P1|COMPLETED|Overall Study||373
1057815|NCT00832455|2565615|P1|Week 12|Overall Study||373
1057816|NCT00832455|2565615|P1|Week 8 (Optional)|Overall Study||247
1057817|NCT00832455|2565615|P1|Week 4|Overall Study||411
1057818|NCT00832455|2565615|P1|Baseline|Overall Study|420 –patients that received at least one dose of study medication and had 1 follow-up visit (ITT)|420
1057819|NCT00832455|2565615|P1|STARTED|Overall Study|445 – number of patients that signed the informed consent form (Safety population)|445
1057823|NCT00832572|2565641|P2|NOT COMPLETED|Period 2||0
1057824|NCT00832572|2565642|P1|NOT COMPLETED|Period 2||0
1057825|NCT00832572|2565641|P2|COMPLETED|Period 2||2
1057826|NCT00832572|2565642|P1|COMPLETED|Period 2||3
1057827|NCT00832572|2565641|P2|STARTED|Period 2||2
1057828|NCT00832572|2565642|P1|STARTED|Period 2||3
1057829|NCT00832572|2565641|P2|NOT COMPLETED|Period 1||0
1057830|NCT00832572|2565642|P1|NOT COMPLETED|Period 1||0
1057831|NCT00832572|2565641|P2|COMPLETED|Period 1||2
1057832|NCT00832572|2565642|P1|COMPLETED|Period 1||3
1057833|NCT00832572|2565641|P2|STARTED|Period 1||2
1057834|NCT00832572|2565642|P1|STARTED|Period 1||3
1057835|NCT00832585|2565654|P1|NOT COMPLETED|Overall Study||2
1057836|NCT00832585|2565654|P1|COMPLETED|Overall Study|Only three subjects completed all of the visits for the study as per protocol.|3
1057837|NCT00832585|2565654|P1|STARTED|Overall Study|Eight subjects were screened but only 5 started the study and received study drug.|5
1057838|NCT00832624|2565659|P1|NOT COMPLETED|Overall Study||10
1057839|NCT00832624|2565659|P1|COMPLETED|Overall Study||0
1057840|NCT00832624|2565659|P1|STARTED|Overall Study||10
1057844|NCT00832650|2565674|P3|NOT COMPLETED|Overall Study||1
1057845|NCT00832650|2565675|P2|NOT COMPLETED|Overall Study||0
1057846|NCT00832650|2565676|P1|NOT COMPLETED|Overall Study||0
1057847|NCT00832650|2565674|P3|COMPLETED|Overall Study||22
1057848|NCT00832650|2565675|P2|COMPLETED|Overall Study||12
1057849|NCT00832650|2565676|P1|COMPLETED|Overall Study||25
1057850|NCT00832650|2565674|P3|Treated|Overall Study||22
1057851|NCT00832650|2565675|P2|Treated|Overall Study||12
1057852|NCT00832650|2565676|P1|Treated|Overall Study||25
1057853|NCT00832650|2565674|P3|STARTED|Overall Study||23
1057854|NCT00832650|2565675|P2|STARTED|Overall Study||12
1057855|NCT00832650|2565676|P1|STARTED|Overall Study||25
1057856|NCT00832819|2565711|P3|NOT COMPLETED|Overall Study||1
1057857|NCT00832819|2565712|P2|NOT COMPLETED|Overall Study||1
1057858|NCT00832819|2565713|P1|NOT COMPLETED|Overall Study||0
1057859|NCT00832819|2565711|P3|COMPLETED|Overall Study||15
1057860|NCT00832819|2565712|P2|COMPLETED|Overall Study||5
1057861|NCT00832819|2565713|P1|COMPLETED|Overall Study||6
1057862|NCT00832819|2565711|P3|STARTED|Overall Study||16
1057863|NCT00832819|2565712|P2|STARTED|Overall Study||6
1057864|NCT00832819|2565713|P1|STARTED|Overall Study||6
1057865|NCT00832871|2565719|P1|NOT COMPLETED|Overall Study||0
1057866|NCT00832871|2565719|P1|COMPLETED|Overall Study||4
1057867|NCT00832871|2565719|P1|STARTED|Overall Study||4
1057868|NCT00832975|2565725|P1|NOT COMPLETED|Overall Study||39
1057869|NCT00832975|2565725|P1|COMPLETED|Overall Study||118
1057870|NCT00832975|2565725|P1|STARTED|Overall Study||157
1057871|NCT00833027|2565730|P1|NOT COMPLETED|Overall Study||211
1057872|NCT00833027|2565730|P1|COMPLETED|Overall Study||397
1057873|NCT00833027|2565730|P1|STARTED|Overall Study||608
1057874|NCT00833040|2565735|P6|NOT COMPLETED|Overall Study||1
1057875|NCT00833040|2565736|P5|NOT COMPLETED|Overall Study||0
1057876|NCT00833040|2565737|P4|NOT COMPLETED|Overall Study||0
1057877|NCT00833040|2565738|P3|NOT COMPLETED|Overall Study||0
1057878|NCT00833040|2565739|P2|NOT COMPLETED|Overall Study||0
1057879|NCT00833040|2565740|P1|NOT COMPLETED|Overall Study||0
1057880|NCT00833040|2565735|P6|COMPLETED|Overall Study||4
1057881|NCT00833040|2565736|P5|COMPLETED|Overall Study||5
1057882|NCT00833040|2565737|P4|COMPLETED|Overall Study||6
1057883|NCT00833040|2565738|P3|COMPLETED|Overall Study||6
1057884|NCT00833040|2565739|P2|COMPLETED|Overall Study||6
1057885|NCT00833040|2565740|P1|COMPLETED|Overall Study||6
1057886|NCT00833040|2565735|P6|STARTED|Overall Study||5
1057887|NCT00833040|2565736|P5|STARTED|Overall Study||5
1057888|NCT00833040|2565737|P4|STARTED|Overall Study||6
1057889|NCT00833040|2565738|P3|STARTED|Overall Study||6
1057890|NCT00833040|2565739|P2|STARTED|Overall Study||6
1057891|NCT00833040|2565740|P1|STARTED|Overall Study||6
1057892|NCT00833053|2565747|P2|NOT COMPLETED|Overall Study||3
1057893|NCT00833053|2565748|P1|NOT COMPLETED|Overall Study||9
1057894|NCT00833053|2565747|P2|COMPLETED|Overall Study||17
1057895|NCT00833053|2565748|P1|COMPLETED|Overall Study||10
1057896|NCT00833053|2565747|P2|STARTED|Overall Study||20
1057897|NCT00833053|2565748|P1|STARTED|Overall Study||19
1057898|NCT00833092|2565768|P2|NOT COMPLETED|Overall Study||7
1057899|NCT00833092|2565769|P1|NOT COMPLETED|Overall Study||4
1057900|NCT00833092|2565768|P2|COMPLETED|Overall Study||50
1057901|NCT00833092|2565769|P1|COMPLETED|Overall Study||50
1057902|NCT00833092|2565768|P2|STARTED|Overall Study||57
1057903|NCT00833092|2565769|P1|STARTED|Overall Study||54
1057904|NCT00833248|2565777|P2|NOT COMPLETED|Overall Study||3
1057905|NCT00833248|2565778|P1|NOT COMPLETED|Overall Study||4
1057906|NCT00833248|2565777|P2|COMPLETED|Overall Study||62
1057907|NCT00833248|2565778|P1|COMPLETED|Overall Study||177
1057908|NCT00833248|2565777|P2|Safety Analysis Set|Overall Study||64
1057909|NCT00833248|2565778|P1|Safety Analysis Set|Overall Study||181
1057910|NCT00833248|2565777|P2|Per Protocol (PP) Analysis Set|Overall Study||57
1057911|NCT00833248|2565778|P1|Per Protocol (PP) Analysis Set|Overall Study||164
1057912|NCT00833248|2565777|P2|Full Analysis Set (FAS)|Overall Study||64
1057913|NCT00833248|2565778|P1|Full Analysis Set (FAS)|Overall Study||180
1057914|NCT00833248|2565777|P2|STARTED|Overall Study||65
1057915|NCT00833248|2565778|P1|STARTED|Overall Study||181
1057916|NCT00833365|2565802|P2|NOT COMPLETED|Overall Study||0
1057917|NCT00833365|2565803|P1|NOT COMPLETED|Overall Study||0
1057918|NCT00833365|2565802|P2|COMPLETED|Overall Study||6
1057919|NCT00833365|2565803|P1|COMPLETED|Overall Study||9
1057920|NCT00833365|2565802|P2|STARTED|Overall Study||6
1057921|NCT00833365|2565803|P1|STARTED|Overall Study||9
1057922|NCT00833417|2565813|P2|NOT COMPLETED|Overall Study||71
1057923|NCT00833417|2565814|P1|NOT COMPLETED|Overall Study||33
1057924|NCT00833417|2565813|P2|COMPLETED|Overall Study||0
1057925|NCT00833417|2565814|P1|COMPLETED|Overall Study||0
1057926|NCT00833417|2565813|P2|STARTED|Overall Study||71
1057927|NCT00833417|2565814|P1|STARTED|Overall Study||33
1057928|NCT00833443|2565829|P2|NOT COMPLETED|Overall Study||28
1057929|NCT00833443|2565830|P1|NOT COMPLETED|Overall Study||20
1057930|NCT00833443|2565829|P2|COMPLETED|Overall Study||15
1057931|NCT00833443|2565830|P1|COMPLETED|Overall Study||21
1057932|NCT00833443|2565829|P2|STARTED|Overall Study||43
1057933|NCT00833443|2565830|P1|STARTED|Overall Study||41
1057934|NCT00833469|2565842|P1|NOT COMPLETED|Overall Study||2
1057935|NCT00833469|2565842|P1|COMPLETED|Overall Study||3
1057936|NCT00833469|2565842|P1|STARTED|Overall Study||5
1057937|NCT00833482|2565850|P6|NOT COMPLETED|Days 21-30||0
1057938|NCT00833482|2565851|P5|NOT COMPLETED|Days 21-30||1
1057939|NCT00833482|2565852|P4|NOT COMPLETED|Days 21-30||0
1057940|NCT00833482|2565853|P3|NOT COMPLETED|Days 21-30||1
1057941|NCT00833482|2565854|P2|NOT COMPLETED|Days 21-30||0
1057942|NCT00833482|2565855|P1|NOT COMPLETED|Days 21-30||0
1057943|NCT00833482|2565850|P6|COMPLETED|Days 21-30||0
1057944|NCT00833482|2565851|P5|COMPLETED|Days 21-30||7
1057945|NCT00833482|2565852|P4|COMPLETED|Days 21-30||0
1057946|NCT00833482|2565853|P3|COMPLETED|Days 21-30||20
1057947|NCT00833482|2565854|P2|COMPLETED|Days 21-30||0
1057948|NCT00833482|2565855|P1|COMPLETED|Days 21-30||0
1057949|NCT00833482|2565850|P6|STARTED|Days 21-30||0
1057950|NCT00833482|2565851|P5|STARTED|Days 21-30||8
1057951|NCT00833482|2565852|P4|STARTED|Days 21-30||0
1057952|NCT00833482|2565853|P3|STARTED|Days 21-30||21
1057953|NCT00833482|2565854|P2|STARTED|Days 21-30||0
1057954|NCT00833482|2565855|P1|STARTED|Days 21-30||0
1057955|NCT00833482|2565850|P6|NOT COMPLETED|Days 11-20||0
1057956|NCT00833482|2565851|P5|NOT COMPLETED|Days 11-20||0
1057957|NCT00833482|2565852|P4|NOT COMPLETED|Days 11-20||0
1057958|NCT00833482|2565853|P3|NOT COMPLETED|Days 11-20||0
1057959|NCT00833482|2565854|P2|NOT COMPLETED|Days 11-20||3
1057960|NCT00833482|2565855|P1|NOT COMPLETED|Days 11-20||0
1057961|NCT00833482|2565850|P6|COMPLETED|Days 11-20||8
1057962|NCT00833482|2565851|P5|COMPLETED|Days 11-20||0
1057963|NCT00833482|2565852|P4|COMPLETED|Days 11-20||0
1057964|NCT00833482|2565853|P3|COMPLETED|Days 11-20||0
1057965|NCT00833482|2565854|P2|COMPLETED|Days 11-20||21
1057966|NCT00833482|2565855|P1|COMPLETED|Days 11-20||0
1057967|NCT00833482|2565850|P6|STARTED|Days 11-20|Participants who received treatment.|8
1057968|NCT00833482|2565851|P5|STARTED|Days 11-20||0
1057969|NCT00833482|2565852|P4|STARTED|Days 11-20||0
1057970|NCT00833482|2565853|P3|STARTED|Days 11-20||0
1057971|NCT00833482|2565854|P2|STARTED|Days 11-20|Participants who received treatment.|24
1057972|NCT00833482|2565855|P1|STARTED|Days 11-20||0
1057973|NCT00833482|2565850|P6|NOT COMPLETED|Days 1-3||0
1057974|NCT00833482|2565851|P5|NOT COMPLETED|Days 1-3||0
1057975|NCT00833482|2565852|P4|NOT COMPLETED|Days 1-3||0
1057976|NCT00833482|2565853|P3|NOT COMPLETED|Days 1-3||0
1057977|NCT00833482|2565854|P2|NOT COMPLETED|Days 1-3||0
1057978|NCT00833482|2565855|P1|NOT COMPLETED|Days 1-3||0
1057979|NCT00833482|2565850|P6|COMPLETED|Days 1-3||0
1057980|NCT00833482|2565851|P5|COMPLETED|Days 1-3||0
1057981|NCT00833482|2565852|P4|COMPLETED|Days 1-3||8
1057982|NCT00833482|2565853|P3|COMPLETED|Days 1-3||0
1057983|NCT00833482|2565854|P2|COMPLETED|Days 1-3||0
1057984|NCT00833482|2565855|P1|COMPLETED|Days 1-3||24
1057985|NCT00833482|2565850|P6|STARTED|Days 1-3||0
1057986|NCT00833482|2565851|P5|STARTED|Days 1-3||0
1057987|NCT00833482|2565852|P4|STARTED|Days 1-3||8
1057988|NCT00833482|2565853|P3|STARTED|Days 1-3||0
1057989|NCT00833482|2565854|P2|STARTED|Days 1-3|Participants who received treatment|0
1057990|NCT00833482|2565855|P1|STARTED|Days 1-3|Participants who received treatment|24
1057991|NCT00833521|2565913|P2|NOT COMPLETED|Second Intervention||0
1057992|NCT00833521|2565914|P1|NOT COMPLETED|Second Intervention||0
1057993|NCT00833521|2565913|P2|COMPLETED|Second Intervention||19
1057994|NCT00833521|2565914|P1|COMPLETED|Second Intervention||19
1057995|NCT00833521|2565913|P2|STARTED|Second Intervention||19
1057996|NCT00833521|2565914|P1|STARTED|Second Intervention||19
1057997|NCT00833521|2565913|P2|NOT COMPLETED|First Intervention||0
1057998|NCT00833521|2565914|P1|NOT COMPLETED|First Intervention||0
1057999|NCT00833521|2565913|P2|COMPLETED|First Intervention||19
1058000|NCT00833521|2565914|P1|COMPLETED|First Intervention||19
1058001|NCT00833521|2565913|P2|STARTED|First Intervention||19
1058002|NCT00833521|2565914|P1|STARTED|First Intervention||19
1058003|NCT00833547|2565924|P2|NOT COMPLETED|Overall Study||2
1058004|NCT00833547|2565925|P1|NOT COMPLETED|Overall Study||2
1058005|NCT00833547|2565924|P2|COMPLETED|Overall Study||10
1058006|NCT00833547|2565925|P1|COMPLETED|Overall Study||11
1058007|NCT00833547|2565924|P2|STARTED|Overall Study||12
1058008|NCT00833547|2565925|P1|STARTED|Overall Study||13
1058009|NCT00833560|2565933|P1|NOT COMPLETED|Overall Study||42
1058010|NCT00833560|2565933|P1|COMPLETED|Overall Study||353
1058011|NCT00833560|2565933|P1|STARTED|Overall Study||395
1058012|NCT00833586|2565942|P2|NOT COMPLETED|Second Intervention||0
1058013|NCT00833586|2565943|P1|NOT COMPLETED|Second Intervention||0
1058014|NCT00833586|2565942|P2|COMPLETED|Second Intervention||14
1058015|NCT00833586|2565943|P1|COMPLETED|Second Intervention||14
1058016|NCT00833586|2565942|P2|STARTED|Second Intervention||14
1058017|NCT00833586|2565943|P1|STARTED|Second Intervention||14
1058018|NCT00833586|2565942|P2|NOT COMPLETED|Washout: 14 Days||0
1058019|NCT00833586|2565943|P1|NOT COMPLETED|Washout: 14 Days||0
1058020|NCT00833586|2565942|P2|COMPLETED|Washout: 14 Days||14
1058021|NCT00833586|2565943|P1|COMPLETED|Washout: 14 Days||14
1058022|NCT00833586|2565942|P2|STARTED|Washout: 14 Days||14
1058023|NCT00833586|2565943|P1|STARTED|Washout: 14 Days||14
1058024|NCT00833586|2565942|P2|NOT COMPLETED|First Intervention||0
1058025|NCT00833586|2565943|P1|NOT COMPLETED|First Intervention||0
1058026|NCT00833586|2565942|P2|COMPLETED|First Intervention||14
1058027|NCT00833586|2565943|P1|COMPLETED|First Intervention||14
1058028|NCT00833586|2565942|P2|STARTED|First Intervention||14
1058029|NCT00833586|2565943|P1|STARTED|First Intervention||14
1058030|NCT00833638|2565954|P3|NOT COMPLETED|Phase 3: Open-label Extension Phase||2
1058031|NCT00833638|2565955|P2|NOT COMPLETED|Phase 3: Open-label Extension Phase||3
1058032|NCT00833638|2565956|P1|NOT COMPLETED|Phase 3: Open-label Extension Phase||1
1058033|NCT00833638|2565954|P3|COMPLETED|Phase 3: Open-label Extension Phase||122
1058034|NCT00833638|2565955|P2|COMPLETED|Phase 3: Open-label Extension Phase||105
1058035|NCT00833638|2565956|P1|COMPLETED|Phase 3: Open-label Extension Phase||110
1058036|NCT00833638|2565954|P3|STARTED|Phase 3: Open-label Extension Phase||124
1058037|NCT00833638|2565955|P2|STARTED|Phase 3: Open-label Extension Phase||108
1058038|NCT00833638|2565956|P1|STARTED|Phase 3: Open-label Extension Phase||111
1058039|NCT00833638|2565954|P3|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||9
1058040|NCT00833638|2565955|P2|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
1058041|NCT00833638|2565956|P1|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
1058042|NCT00833638|2565954|P3|COMPLETED|Phase 2: Double-blind Treatment Phase||124
1058043|NCT00833638|2565955|P2|COMPLETED|Phase 2: Double-blind Treatment Phase||108
1058044|NCT00833638|2565956|P1|COMPLETED|Phase 2: Double-blind Treatment Phase||111
1058045|NCT00833638|2565954|P3|STARTED|Phase 2: Double-blind Treatment Phase||133
1058046|NCT00833638|2565955|P2|STARTED|Phase 2: Double-blind Treatment Phase||118
1058047|NCT00833638|2565956|P1|STARTED|Phase 2: Double-blind Treatment Phase||121
1058048|NCT00833664|2565998|P2|NOT COMPLETED|Second Intervention||0
1058049|NCT00833664|2565999|P1|NOT COMPLETED|Second Intervention||0
1058050|NCT00833664|2565998|P2|COMPLETED|Second Intervention||11
1058051|NCT00833664|2565999|P1|COMPLETED|Second Intervention||10
1058052|NCT00833664|2565998|P2|STARTED|Second Intervention||11
1058053|NCT00833664|2565999|P1|STARTED|Second Intervention||10
1058054|NCT00833664|2565998|P2|NOT COMPLETED|Washout: 14 Days||0
1058055|NCT00833664|2565999|P1|NOT COMPLETED|Washout: 14 Days||1
1058056|NCT00833664|2565998|P2|COMPLETED|Washout: 14 Days||11
1058057|NCT00833664|2565999|P1|COMPLETED|Washout: 14 Days||10
1058058|NCT00833664|2565998|P2|STARTED|Washout: 14 Days||11
1058059|NCT00833664|2565999|P1|STARTED|Washout: 14 Days||11
1058060|NCT00833664|2565998|P2|NOT COMPLETED|First Intervention||0
1058061|NCT00833664|2565999|P1|NOT COMPLETED|First Intervention||0
1058062|NCT00833664|2565998|P2|COMPLETED|First Intervention||11
1058063|NCT00833664|2565999|P1|COMPLETED|First Intervention||11
1058064|NCT00833664|2565998|P2|STARTED|First Intervention||11
1058065|NCT00833664|2565999|P1|STARTED|First Intervention||11
1058066|NCT00833690|2566010|P3|NOT COMPLETED|Overall Study||0
1058067|NCT00833690|2566011|P2|NOT COMPLETED|Overall Study||2
1058068|NCT00833690|2566012|P1|NOT COMPLETED|Overall Study||4
1058069|NCT00833690|2566010|P3|COMPLETED|Overall Study||26
1058070|NCT00833690|2566011|P2|COMPLETED|Overall Study||22
1058071|NCT00833690|2566012|P1|COMPLETED|Overall Study||21
1058072|NCT00833690|2566010|P3|STARTED|Overall Study||26
1058073|NCT00833690|2566011|P2|STARTED|Overall Study||24
1058074|NCT00833690|2566012|P1|STARTED|Overall Study||25
1058075|NCT00833703|2566136|P2|NOT COMPLETED|Overall Study||1
1058076|NCT00833703|2566137|P1|NOT COMPLETED|Overall Study||0
1058077|NCT00833703|2566136|P2|COMPLETED|Overall Study|Completed follow-up|25
1058078|NCT00833703|2566137|P1|COMPLETED|Overall Study|Completed follow-up|23
1058079|NCT00833703|2566136|P2|Completed Treatment|Overall Study||24
1058080|NCT00833703|2566137|P1|Completed Treatment|Overall Study||22
1058081|NCT00833703|2566136|P2|Treated|Overall Study||26
1058082|NCT00833703|2566137|P1|Treated|Overall Study||23
1058083|NCT00833703|2566136|P2|STARTED|Overall Study|Included|26
1058084|NCT00833703|2566137|P1|STARTED|Overall Study|Included|23
1058085|NCT00839241|2566149|P2|NOT COMPLETED|Overall Study||17
1058086|NCT00839241|2566150|P1|NOT COMPLETED|Overall Study||5
1058087|NCT00839241|2566149|P2|COMPLETED|Overall Study||8
1058088|NCT00839241|2566150|P1|COMPLETED|Overall Study||15
1058089|NCT00839241|2566149|P2|STARTED|Overall Study||25
1058090|NCT00839241|2566150|P1|STARTED|Overall Study||20
1058091|NCT00839306|2566236|P2|NOT COMPLETED|Overall Study||43
1058092|NCT00839306|2566237|P1|NOT COMPLETED|Overall Study||25
1058093|NCT00839306|2566236|P2|COMPLETED|Overall Study||134
1058094|NCT00839306|2566237|P1|COMPLETED|Overall Study||35
1058095|NCT00839306|2566236|P2|STARTED|Overall Study|Treated|177
1058096|NCT00839306|2566237|P1|STARTED|Overall Study|Treated|60
1058097|NCT00839319|2566250|P5|NOT COMPLETED|Overall Study||0
1058098|NCT00839319|2566251|P4|NOT COMPLETED|Overall Study||3
1058099|NCT00839319|2566252|P3|NOT COMPLETED|Overall Study||3
1058100|NCT00839319|2566253|P2|NOT COMPLETED|Overall Study||1
1058101|NCT00839319|2566254|P1|NOT COMPLETED|Overall Study||2
1058102|NCT00839319|2566250|P5|COMPLETED|Overall Study||8
1058103|NCT00839319|2566251|P4|COMPLETED|Overall Study|1 withdrawn by investigator for syncopal reaction , 2 excluded from analysis (low serum LH)|5
1058104|NCT00839319|2566252|P3|COMPLETED|Overall Study|1 dropped out after Day 1 visit, 2 excluded from analysis (low serum LH)|5
1058105|NCT00839319|2566253|P2|COMPLETED|Overall Study|1 excluded from analysis (low serum LH)|7
1058106|NCT00839319|2566254|P1|COMPLETED|Overall Study|1 withdrew consent prior to procedures; 1 excluded from analysis (low serum LH)|6
1058107|NCT00839319|2566250|P5|STARTED|Overall Study||8
1058108|NCT00839319|2566251|P4|STARTED|Overall Study||8
1058109|NCT00839319|2566252|P3|STARTED|Overall Study||8
1058110|NCT00839319|2566253|P2|STARTED|Overall Study||8
1058111|NCT00839319|2566254|P1|STARTED|Overall Study||8
1058112|NCT00839423|2566285|P4|NOT COMPLETED|Overall Study||20
1058113|NCT00839423|2566286|P3|NOT COMPLETED|Overall Study||18
1058114|NCT00839423|2566287|P2|NOT COMPLETED|Overall Study||10
1058115|NCT00839423|2566288|P1|NOT COMPLETED|Overall Study||18
1058116|NCT00839423|2566285|P4|COMPLETED|Overall Study||93
1058117|NCT00839423|2566286|P3|COMPLETED|Overall Study||82
1058118|NCT00839423|2566287|P2|COMPLETED|Overall Study||98
1058119|NCT00839423|2566288|P1|COMPLETED|Overall Study||87
1058120|NCT00839423|2566285|P4|STARTED|Overall Study||113
1058121|NCT00839423|2566286|P3|STARTED|Overall Study||100
1058122|NCT00839423|2566287|P2|STARTED|Overall Study||108
1058123|NCT00839423|2566288|P1|STARTED|Overall Study||105
1058124|NCT00839436|2566329|P3|NOT COMPLETED|Overall Study||1
1058125|NCT00839436|2566330|P2|NOT COMPLETED|Overall Study||1
1058126|NCT00839436|2566331|P1|NOT COMPLETED|Overall Study||1
1058127|NCT00839436|2566329|P3|COMPLETED|Overall Study||0
1058128|NCT00839436|2566330|P2|COMPLETED|Overall Study||4
1058129|NCT00839436|2566331|P1|COMPLETED|Overall Study||2
1058130|NCT00839436|2566329|P3|STARTED|Overall Study||1
1058131|NCT00839436|2566330|P2|STARTED|Overall Study||5
1058132|NCT00839436|2566331|P1|STARTED|Overall Study||3
1058133|NCT00841269|2566339|P1|NOT COMPLETED|Overall Study||2
1058134|NCT00841269|2566339|P1|COMPLETED|Overall Study||5
1058135|NCT00841269|2566339|P1|STARTED|Overall Study||7
1058136|NCT00841321|2566345|P2|NOT COMPLETED|Overall Study||3
1058137|NCT00841321|2566346|P1|NOT COMPLETED|Overall Study||1
1058138|NCT00841321|2566345|P2|COMPLETED|Overall Study||58
1058139|NCT00841321|2566346|P1|COMPLETED|Overall Study||58
1058140|NCT00841321|2566345|P2|STARTED|Overall Study||61
1058141|NCT00841321|2566346|P1|STARTED|Overall Study||59
1058142|NCT00841412|2566358|P2|NOT COMPLETED|Overall Study||30
1058143|NCT00841412|2566359|P1|NOT COMPLETED|Overall Study||40
1058144|NCT00841412|2566358|P2|COMPLETED|Overall Study||50
1058145|NCT00841412|2566359|P1|COMPLETED|Overall Study|130 residents completed all study phases across both groups, including follow-up.|80
1058146|NCT00841412|2566358|P2|STARTED|Overall Study|80 residents were in the delayed intervention group, but all residents received intervention.|80
1058147|NCT00841412|2566359|P1|STARTED|Overall Study|200 of 222 consented residents completed baseline assessments across both groups.|120
1058148|NCT00841542|2566365|P2|NOT COMPLETED|Period 2||0
1058149|NCT00841542|2566366|P1|NOT COMPLETED|Period 2||0
1058150|NCT00841542|2566365|P2|COMPLETED|Period 2||14
1058151|NCT00841542|2566366|P1|COMPLETED|Period 2||13
1058152|NCT00841542|2566365|P2|STARTED|Period 2||14
1058153|NCT00841542|2566366|P1|STARTED|Period 2||13
1058154|NCT00841542|2566365|P2|NOT COMPLETED|Period 1||0
1058155|NCT00841542|2566366|P1|NOT COMPLETED|Period 1||1
1058156|NCT00841542|2566365|P2|COMPLETED|Period 1||14
1058157|NCT00841542|2566366|P1|COMPLETED|Period 1||13
1058158|NCT00841542|2566365|P2|STARTED|Period 1||14
1058159|NCT00841542|2566366|P1|STARTED|Period 1||14
1058160|NCT00841555|2566377|P3|NOT COMPLETED|Overall Study||0
1058161|NCT00841555|2566378|P2|NOT COMPLETED|Overall Study||0
1058162|NCT00841555|2566379|P1|NOT COMPLETED|Overall Study||0
1058163|NCT00841555|2566377|P3|COMPLETED|Overall Study||3
1058164|NCT00841555|2566378|P2|COMPLETED|Overall Study||3
1058165|NCT00841555|2566379|P1|COMPLETED|Overall Study||3
1058166|NCT00841555|2566377|P3|STARTED|Overall Study||3
1058167|NCT00841555|2566378|P2|STARTED|Overall Study||3
1058168|NCT00841555|2566379|P1|STARTED|Overall Study||3
1058169|NCT00841659|2566389|P2|NOT COMPLETED|Second Intervention||0
1058170|NCT00841659|2566390|P1|NOT COMPLETED|Second Intervention||0
1058171|NCT00841659|2566389|P2|COMPLETED|Second Intervention||12
1058172|NCT00841659|2566390|P1|COMPLETED|Second Intervention||11
1058173|NCT00841659|2566389|P2|STARTED|Second Intervention||12
1058174|NCT00841659|2566390|P1|STARTED|Second Intervention||11
1058175|NCT00841659|2566389|P2|NOT COMPLETED|Washout: 2 Weeks||0
1058176|NCT00841659|2566390|P1|NOT COMPLETED|Washout: 2 Weeks||1
1058177|NCT00841659|2566389|P2|COMPLETED|Washout: 2 Weeks||12
1058178|NCT00841659|2566390|P1|COMPLETED|Washout: 2 Weeks||11
1058179|NCT00841659|2566389|P2|STARTED|Washout: 2 Weeks||12
1058180|NCT00841659|2566390|P1|STARTED|Washout: 2 Weeks||12
1058181|NCT00841659|2566389|P2|NOT COMPLETED|First Intervention||0
1058182|NCT00841659|2566390|P1|NOT COMPLETED|First Intervention||0
1058183|NCT00841659|2566389|P2|COMPLETED|First Intervention||12
1058184|NCT00841659|2566390|P1|COMPLETED|First Intervention||12
1058185|NCT00841659|2566389|P2|STARTED|First Intervention||12
1058186|NCT00841659|2566390|P1|STARTED|First Intervention||12
1058187|NCT00841672|2566400|P2|NOT COMPLETED|Overall Study||32
1058188|NCT00841672|2566401|P1|NOT COMPLETED|Overall Study||20
1058189|NCT00841672|2566400|P2|COMPLETED|Overall Study||209
1058190|NCT00841672|2566401|P1|COMPLETED|Overall Study||224
1058191|NCT00841672|2566400|P2|STARTED|Overall Study||241
1058192|NCT00841672|2566401|P1|STARTED|Overall Study|One patient was mis-randomized and was not treated in the double-blind treatment period.|244
1058193|NCT00841698|2566417|P2|NOT COMPLETED|Second Intervention||0
1058194|NCT00841698|2566418|P1|NOT COMPLETED|Second Intervention||0
1058195|NCT00841698|2566417|P2|COMPLETED|Second Intervention||25
1058196|NCT00841698|2566418|P1|COMPLETED|Second Intervention||24
1058197|NCT00841698|2566417|P2|STARTED|Second Intervention||25
1058198|NCT00841698|2566418|P1|STARTED|Second Intervention||24
1058199|NCT00841698|2566417|P2|NOT COMPLETED|Washout: 2 Weeks||0
1058200|NCT00841698|2566418|P1|NOT COMPLETED|Washout: 2 Weeks||0
1058201|NCT00841698|2566417|P2|COMPLETED|Washout: 2 Weeks||25
1058202|NCT00841698|2566418|P1|COMPLETED|Washout: 2 Weeks||24
1058203|NCT00841698|2566417|P2|STARTED|Washout: 2 Weeks||25
1058204|NCT00841698|2566418|P1|STARTED|Washout: 2 Weeks||24
1058205|NCT00841698|2566417|P2|NOT COMPLETED|First Intervention||0
1058206|NCT00841698|2566418|P1|NOT COMPLETED|First Intervention||1
1058207|NCT00841698|2566417|P2|COMPLETED|First Intervention||25
1058208|NCT00841698|2566418|P1|COMPLETED|First Intervention||24
1058209|NCT00841698|2566417|P2|STARTED|First Intervention||25
1058210|NCT00841698|2566418|P1|STARTED|First Intervention||25
1058211|NCT00841763|2566428|P4|NOT COMPLETED|Overall Study||3
1058212|NCT00841763|2566429|P3|NOT COMPLETED|Overall Study||8
1058213|NCT00841763|2566430|P2|NOT COMPLETED|Overall Study||57
1058214|NCT00841763|2566431|P1|NOT COMPLETED|Overall Study||162
1058215|NCT00841763|2566428|P4|COMPLETED|Overall Study||53
1058216|NCT00841763|2566429|P3|COMPLETED|Overall Study||211
1058217|NCT00841763|2566430|P2|COMPLETED|Overall Study||624
1058218|NCT00841763|2566431|P1|COMPLETED|Overall Study||2529
1058219|NCT00841763|2566428|P4|STARTED|Overall Study||56
1058220|NCT00841763|2566429|P3|STARTED|Overall Study||219
1058221|NCT00841763|2566430|P2|STARTED|Overall Study||681
1058222|NCT00841763|2566431|P1|STARTED|Overall Study||2691
1058223|NCT00841776|2566493|P2|NOT COMPLETED|Overall Study||3
1058224|NCT00841776|2566494|P1|NOT COMPLETED|Overall Study||2
1058225|NCT00841776|2566493|P2|COMPLETED|Overall Study||24
1058226|NCT00841776|2566494|P1|COMPLETED|Overall Study||25
1058227|NCT00841776|2566493|P2|STARTED|Overall Study||27
1058228|NCT00841776|2566494|P1|STARTED|Overall Study||27
1058229|NCT00841815|2566512|P2|NOT COMPLETED|Period 2||0
1058230|NCT00841815|2566513|P1|NOT COMPLETED|Period 2||0
1058231|NCT00841815|2566512|P2|COMPLETED|Period 2||13
1058232|NCT00841815|2566513|P1|COMPLETED|Period 2||14
1058233|NCT00841815|2566512|P2|STARTED|Period 2||13
1058234|NCT00841815|2566513|P1|STARTED|Period 2||14
1058235|NCT00841815|2566512|P2|NOT COMPLETED|Washout||1
1058236|NCT00841815|2566513|P1|NOT COMPLETED|Washout||0
1058237|NCT00841815|2566512|P2|COMPLETED|Washout||13
1058238|NCT00841815|2566513|P1|COMPLETED|Washout||14
1058239|NCT00841815|2566512|P2|STARTED|Washout||14
1058240|NCT00841815|2566513|P1|STARTED|Washout||14
1058241|NCT00841815|2566512|P2|NOT COMPLETED|Period 1||0
1058242|NCT00841815|2566513|P1|NOT COMPLETED|Period 1||0
1058243|NCT00841815|2566512|P2|COMPLETED|Period 1||14
1058244|NCT00841815|2566513|P1|COMPLETED|Period 1||14
1058245|NCT00841815|2566512|P2|STARTED|Period 1||14
1058246|NCT00841815|2566513|P1|STARTED|Period 1||14
1058247|NCT00841906|2566523|P2|NOT COMPLETED|Overall Study||0
1058248|NCT00841906|2566524|P1|NOT COMPLETED|Overall Study||2
1058249|NCT00841906|2566523|P2|COMPLETED|Overall Study||15
1058250|NCT00841906|2566524|P1|COMPLETED|Overall Study||15
1058251|NCT00841906|2566523|P2|STARTED|Overall Study||15
1058252|NCT00841906|2566524|P1|STARTED|Overall Study||17
1058253|NCT00841971|2566538|P2|NOT COMPLETED|Overall Study||1
1058254|NCT00841971|2566539|P1|NOT COMPLETED|Overall Study||2
1058255|NCT00841971|2566538|P2|COMPLETED|Overall Study||99
1058256|NCT00841971|2566539|P1|COMPLETED|Overall Study||98
1058257|NCT00841971|2566538|P2|STARTED|Overall Study||100
1058258|NCT00841971|2566539|P1|STARTED|Overall Study||100
1058259|NCT00842023|2566549|P2|NOT COMPLETED|Overall Study||0
1058260|NCT00842023|2566550|P1|NOT COMPLETED|Overall Study||0
1058261|NCT00842023|2566549|P2|COMPLETED|Overall Study||44
1058262|NCT00842023|2566550|P1|COMPLETED|Overall Study||45
1058263|NCT00842023|2566549|P2|STARTED|Overall Study||44
1058264|NCT00842023|2566550|P1|STARTED|Overall Study||45
1058265|NCT00842075|2566562|P2|NOT COMPLETED|Overall Study||0
1058266|NCT00842075|2566563|P1|NOT COMPLETED|Overall Study||0
1058267|NCT00842075|2566562|P2|COMPLETED|Overall Study||5
1058268|NCT00842075|2566563|P1|COMPLETED|Overall Study||5
1058269|NCT00842075|2566562|P2|STARTED|Overall Study||5
1058270|NCT00842075|2566563|P1|STARTED|Overall Study||5
1058277|NCT00842231|2566612|P1|NOT COMPLETED|Overall Study||0
1058278|NCT00842231|2566612|P1|COMPLETED|Overall Study||40
1058279|NCT00842231|2566612|P1|STARTED|Overall Study||40
1058280|NCT00842244|2566618|P1|NOT COMPLETED|Overall Study||21
1058281|NCT00842244|2566618|P1|COMPLETED|Overall Study||1
1058282|NCT00842244|2566618|P1|STARTED|Overall Study||22
1058283|NCT00842257|2566637|P1|NOT COMPLETED|Overall Study||1
1058284|NCT00842257|2566637|P1|COMPLETED|Overall Study||19
1058285|NCT00842257|2566637|P1|STARTED|Overall Study||20
1058286|NCT00842335|2566644|P1|NOT COMPLETED|Overall Study||0
1058287|NCT00842335|2566644|P1|COMPLETED|Overall Study||18
1058288|NCT00842335|2566644|P1|STARTED|Overall Study||18
1058289|NCT00842348|2566653|P2|NOT COMPLETED|Study 729||38
1058290|NCT00842348|2566654|P1|NOT COMPLETED|Study 729||26
1058291|NCT00842348|2566653|P2|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|9
1058292|NCT00842348|2566654|P1|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|16
1058293|NCT00842348|2566653|P2|STARTED|Study 729||47
1058294|NCT00842348|2566654|P1|STARTED|Study 729||42
1058295|NCT00842348|2566653|P2|NOT COMPLETED|Patients Randomised in Study 726||56
1058296|NCT00842348|2566654|P1|NOT COMPLETED|Patients Randomised in Study 726||59
1058297|NCT00842348|2566653|P2|COMPLETED|Patients Randomised in Study 726|15 patients had stable disease and 32 patients had progressive disease.|47
1058298|NCT00842348|2566654|P1|COMPLETED|Patients Randomised in Study 726|41 patients had stable disease and 1 patient had progressive disease.|42
1058299|NCT00842348|2566653|P2|STARTED|Patients Randomised in Study 726||103
1058300|NCT00842348|2566654|P1|STARTED|Patients Randomised in Study 726||101
1058301|NCT00842361|2566666|P2|NOT COMPLETED|Overall Study||2
1058302|NCT00842361|2566667|P1|NOT COMPLETED|Overall Study||1
1058303|NCT00842361|2566666|P2|COMPLETED|Overall Study||31
1058304|NCT00842361|2566667|P1|COMPLETED|Overall Study||32
1058305|NCT00842361|2566666|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|32
1058306|NCT00842361|2566667|P1|Exposed|Overall Study||33
1058307|NCT00842361|2566666|P2|STARTED|Overall Study||33
1058308|NCT00842361|2566667|P1|STARTED|Overall Study||33
1058309|NCT00842543|2566689|P4|NOT COMPLETED|Overall Study||4
1058310|NCT00842543|2566690|P3|NOT COMPLETED|Overall Study||3
1058311|NCT00842543|2566691|P2|NOT COMPLETED|Overall Study||0
1058312|NCT00842543|2566692|P1|NOT COMPLETED|Overall Study||2
1058313|NCT00842543|2566689|P4|COMPLETED|Overall Study||4
1058314|NCT00842543|2566690|P3|COMPLETED|Overall Study||10
1058315|NCT00842543|2566691|P2|COMPLETED|Overall Study||5
1058316|NCT00842543|2566692|P1|COMPLETED|Overall Study||11
1058317|NCT00842543|2566689|P4|STARTED|Overall Study||8
1058318|NCT00842543|2566690|P3|STARTED|Overall Study||13
1058319|NCT00842543|2566691|P2|STARTED|Overall Study||5
1058320|NCT00842543|2566692|P1|STARTED|Overall Study||13
1058321|NCT00842608|2566708|P4|NOT COMPLETED|Overall Study||0
1058322|NCT00842608|2566709|P3|NOT COMPLETED|Overall Study||0
1058323|NCT00842608|2566710|P2|NOT COMPLETED|Overall Study||0
1058324|NCT00842608|2566711|P1|NOT COMPLETED|Overall Study||0
1058325|NCT00842608|2566708|P4|COMPLETED|Overall Study||100
1058326|NCT00842608|2566709|P3|COMPLETED|Overall Study||99
1058327|NCT00842608|2566710|P2|COMPLETED|Overall Study||176
1058328|NCT00842608|2566711|P1|COMPLETED|Overall Study||170
1058329|NCT00842608|2566708|P4|STARTED|Overall Study||100
1058330|NCT00842608|2566709|P3|STARTED|Overall Study||99
1058331|NCT00842608|2566710|P2|STARTED|Overall Study||176
1058332|NCT00842608|2566711|P1|STARTED|Overall Study||170
1058333|NCT00842712|2566736|P7|NOT COMPLETED|Randomized Part||6
1058334|NCT00842712|2566737|P6|NOT COMPLETED|Randomized Part||1
1058335|NCT00842712|2566738|P5|NOT COMPLETED|Randomized Part||0
1058336|NCT00842712|2566739|P4|NOT COMPLETED|Randomized Part||0
1058337|NCT00842712|2566740|P3|NOT COMPLETED|Randomized Part||0
1058338|NCT00842712|2566741|P2|NOT COMPLETED|Randomized Part||0
1058339|NCT00842712|2566742|P1|NOT COMPLETED|Randomized Part||0
1058340|NCT00842712|2566736|P7|COMPLETED|Randomized Part||78
1058341|NCT00842712|2566737|P6|COMPLETED|Randomized Part||50
1058342|NCT00842712|2566738|P5|COMPLETED|Randomized Part||85
1058343|NCT00842712|2566739|P4|COMPLETED|Randomized Part||0
1058344|NCT00842712|2566740|P3|COMPLETED|Randomized Part||0
1058345|NCT00842712|2566741|P2|COMPLETED|Randomized Part||0
1058346|NCT00842712|2566742|P1|COMPLETED|Randomized Part||0
1058347|NCT00842712|2566736|P7|Treated|Randomized Part||80
1058348|NCT00842712|2566737|P6|Treated|Randomized Part||50
1058349|NCT00842712|2566738|P5|Treated|Randomized Part||85
1058350|NCT00842712|2566739|P4|Treated|Randomized Part||0
1058351|NCT00842712|2566740|P3|Treated|Randomized Part||0
1058352|NCT00842712|2566741|P2|Treated|Randomized Part||0
1058353|NCT00842712|2566742|P1|Treated|Randomized Part||0
1058354|NCT00842712|2566736|P7|STARTED|Randomized Part||84
1058355|NCT00842712|2566737|P6|STARTED|Randomized Part||51
1058356|NCT00842712|2566738|P5|STARTED|Randomized Part||85
1058357|NCT00842712|2566739|P4|STARTED|Randomized Part||0
1058358|NCT00842712|2566740|P3|STARTED|Randomized Part||0
1058359|NCT00842712|2566741|P2|STARTED|Randomized Part||0
1058360|NCT00842712|2566742|P1|STARTED|Randomized Part||0
1058361|NCT00842712|2566736|P7|NOT COMPLETED|Safety Run-in Part||0
1058362|NCT00842712|2566737|P6|NOT COMPLETED|Safety Run-in Part||0
1058363|NCT00842712|2566738|P5|NOT COMPLETED|Safety Run-in Part||0
1058364|NCT00842712|2566739|P4|NOT COMPLETED|Safety Run-in Part||1
1058365|NCT00842712|2566740|P3|NOT COMPLETED|Safety Run-in Part||0
1058366|NCT00842712|2566741|P2|NOT COMPLETED|Safety Run-in Part||2
1058367|NCT00842712|2566742|P1|NOT COMPLETED|Safety Run-in Part||3
1058368|NCT00842712|2566736|P7|COMPLETED|Safety Run-in Part||0
1058369|NCT00842712|2566737|P6|COMPLETED|Safety Run-in Part||0
1058370|NCT00842712|2566738|P5|COMPLETED|Safety Run-in Part||0
1058371|NCT00842712|2566739|P4|COMPLETED|Safety Run-in Part||2
1058372|NCT00842712|2566740|P3|COMPLETED|Safety Run-in Part||3
1058373|NCT00842712|2566741|P2|COMPLETED|Safety Run-in Part||1
1058374|NCT00842712|2566742|P1|COMPLETED|Safety Run-in Part||0
1058375|NCT00842712|2566736|P7|STARTED|Safety Run-in Part||0
1058376|NCT00842712|2566737|P6|STARTED|Safety Run-in Part||0
1058377|NCT00842712|2566738|P5|STARTED|Safety Run-in Part||0
1058378|NCT00842712|2566739|P4|STARTED|Safety Run-in Part||3
1058379|NCT00842712|2566740|P3|STARTED|Safety Run-in Part||3
1058380|NCT00842712|2566741|P2|STARTED|Safety Run-in Part||3
1058381|NCT00842712|2566742|P1|STARTED|Safety Run-in Part||3
1058382|NCT00842751|2566770|P1|NOT COMPLETED|Overall Study||0
1058383|NCT00842751|2566770|P1|COMPLETED|Overall Study||11
1058384|NCT00842751|2566770|P1|STARTED|Overall Study||11
1058385|NCT00842829|2566786|P3|NOT COMPLETED|Continuation Period||61
1058386|NCT00842829|2566787|P2|NOT COMPLETED|Continuation Period||0
1058387|NCT00842829|2566788|P1|NOT COMPLETED|Continuation Period||0
1058388|NCT00842829|2566786|P3|COMPLETED|Continuation Period||27
1058389|NCT00842829|2566787|P2|COMPLETED|Continuation Period||0
1058390|NCT00842829|2566788|P1|COMPLETED|Continuation Period||0
1058391|NCT00842829|2566786|P3|Continuation Safety Analysis Set|Continuation Period|Received at least one dose of study drug|87
1058392|NCT00842829|2566787|P2|Continuation Safety Analysis Set|Continuation Period||0
1058393|NCT00842829|2566788|P1|Continuation Safety Analysis Set|Continuation Period||0
1058394|NCT00842829|2566786|P3|STARTED|Continuation Period|Eligible for Continuation Period|88
1058395|NCT00842829|2566787|P2|STARTED|Continuation Period||0
1058396|NCT00842829|2566788|P1|STARTED|Continuation Period||0
1058397|NCT00842829|2566786|P3|NOT COMPLETED|Treatment Period||63
1058398|NCT00842829|2566787|P2|NOT COMPLETED|Treatment Period||0
1058399|NCT00842829|2566788|P1|NOT COMPLETED|Treatment Period||0
1058400|NCT00842829|2566786|P3|COMPLETED|Treatment Period||218
1058401|NCT00842829|2566787|P2|COMPLETED|Treatment Period||0
1058402|NCT00842829|2566788|P1|COMPLETED|Treatment Period||0
1058403|NCT00842829|2566786|P3|Safety Analysis Set|Treatment Period|Received at least one dose of study drug|223
1058404|NCT00842829|2566787|P2|Safety Analysis Set|Treatment Period||0
1058405|NCT00842829|2566788|P1|Safety Analysis Set|Treatment Period||0
1058406|NCT00842829|2566786|P3|STARTED|Treatment Period||281
1058407|NCT00842829|2566787|P2|STARTED|Treatment Period||0
1058408|NCT00842829|2566788|P1|STARTED|Treatment Period||0
1058409|NCT00842829|2566786|P3|NOT COMPLETED|Dose Titration Period||0
1058410|NCT00842829|2566787|P2|NOT COMPLETED|Dose Titration Period||23
1058411|NCT00842829|2566788|P1|NOT COMPLETED|Dose Titration Period||26
1058412|NCT00842829|2566786|P3|COMPLETED|Dose Titration Period||0
1058413|NCT00842829|2566787|P2|COMPLETED|Dose Titration Period||151
1058414|NCT00842829|2566788|P1|COMPLETED|Dose Titration Period||130
1058415|NCT00842829|2566786|P3|Titration Safety Analysis Set|Dose Titration Period||0
1058416|NCT00842829|2566787|P2|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|167
1058417|NCT00842829|2566788|P1|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|145
1058418|NCT00842829|2566786|P3|STARTED|Dose Titration Period||0
1058419|NCT00842829|2566787|P2|STARTED|Dose Titration Period||174
1058420|NCT00842829|2566788|P1|STARTED|Dose Titration Period||156
1058421|NCT00842946|2566824|P2|NOT COMPLETED|Overall Study||5
1058422|NCT00842946|2566825|P1|NOT COMPLETED|Overall Study||5
1058423|NCT00842946|2566824|P2|COMPLETED|Overall Study||19
1058424|NCT00842946|2566825|P1|COMPLETED|Overall Study||16
1058425|NCT00842946|2566824|P2|STARTED|Overall Study||24
1058426|NCT00842946|2566825|P1|STARTED|Overall Study||21
1058427|NCT00842985|2566831|P1|NOT COMPLETED|Fourth Intervention||0
1058428|NCT00842985|2566831|P1|COMPLETED|Fourth Intervention||15
1058429|NCT00842985|2566831|P1|STARTED|Fourth Intervention||15
1058430|NCT00842985|2566831|P1|NOT COMPLETED|Washout Period of GE 4 Days||0
1058431|NCT00842985|2566831|P1|COMPLETED|Washout Period of GE 4 Days||15
1058432|NCT00842985|2566831|P1|STARTED|Washout Period of GE 4 Days||15
1058433|NCT00842985|2566831|P1|NOT COMPLETED|Third Intervention||0
1058434|NCT00842985|2566831|P1|COMPLETED|Third Intervention||15
1058435|NCT00842985|2566831|P1|STARTED|Third Intervention||15
1058436|NCT00842985|2566831|P1|NOT COMPLETED|Washout Period of GE 4 Days||2
1058437|NCT00842985|2566831|P1|COMPLETED|Washout Period of GE 4 Days||15
1058438|NCT00842985|2566831|P1|STARTED|Washout Period of GE 4 Days||17
1058439|NCT00842985|2566831|P1|NOT COMPLETED|Second Intervention||1
1058440|NCT00842985|2566831|P1|COMPLETED|Second Intervention||17
1058441|NCT00842985|2566831|P1|STARTED|Second Intervention||18
1058442|NCT00842985|2566831|P1|NOT COMPLETED|Washout Period of GE 4 Days||2
1058443|NCT00842985|2566831|P1|COMPLETED|Washout Period of GE 4 Days||18
1058444|NCT00842985|2566831|P1|STARTED|Washout Period of GE 4 Days||20
1058445|NCT00842985|2566831|P1|NOT COMPLETED|First Intervention||6
1058446|NCT00842985|2566831|P1|COMPLETED|First Intervention|Completed 1st Intervention|20
1058447|NCT00842985|2566831|P1|STARTED|First Intervention|Signed Consent|26
1058448|NCT00842985|2566831|P1|NOT COMPLETED|Screening||27
1058449|NCT00842985|2566831|P1|COMPLETED|Screening||26
1058450|NCT00842985|2566831|P1|STARTED|Screening||53
1058451|NCT00843024|2566842|P6|NOT COMPLETED|Double-blind Treatment Phase||25
1058452|NCT00843024|2566843|P5|NOT COMPLETED|Double-blind Treatment Phase||20
1058453|NCT00843024|2566844|P4|NOT COMPLETED|Double-blind Treatment Phase||23
1058454|NCT00843024|2566845|P3|NOT COMPLETED|Double-blind Treatment Phase||31
1058455|NCT00843024|2566846|P2|NOT COMPLETED|Double-blind Treatment Phase||0
1058456|NCT00843024|2566847|P1|NOT COMPLETED|Double-blind Treatment Phase||0
1058457|NCT00843024|2566842|P6|COMPLETED|Double-blind Treatment Phase||152
1058458|NCT00843024|2566843|P5|COMPLETED|Double-blind Treatment Phase||97
1058459|NCT00843024|2566844|P4|COMPLETED|Double-blind Treatment Phase||96
1058460|NCT00843024|2566845|P3|COMPLETED|Double-blind Treatment Phase||145
1058461|NCT00843024|2566846|P2|COMPLETED|Double-blind Treatment Phase||0
1058462|NCT00843024|2566847|P1|COMPLETED|Double-blind Treatment Phase||0
1058463|NCT00843024|2566842|P6|STARTED|Double-blind Treatment Phase||177
1058464|NCT00843024|2566843|P5|STARTED|Double-blind Treatment Phase||117
1058465|NCT00843024|2566844|P4|STARTED|Double-blind Treatment Phase||119
1058466|NCT00843024|2566845|P3|STARTED|Double-blind Treatment Phase||176
1058467|NCT00843024|2566846|P2|STARTED|Double-blind Treatment Phase||0
1058468|NCT00843024|2566847|P1|STARTED|Double-blind Treatment Phase||0
1058469|NCT00843024|2566842|P6|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
1058470|NCT00843024|2566843|P5|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
1058471|NCT00843024|2566844|P4|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
1058472|NCT00843024|2566845|P3|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
1058473|NCT00843024|2566846|P2|NOT COMPLETED|Single-blind Placebo Run-In Phase||136
1058474|NCT00843024|2566847|P1|NOT COMPLETED|Single-blind Placebo Run-In Phase||140
1058475|NCT00843024|2566842|P6|COMPLETED|Single-blind Placebo Run-In Phase||0
1058476|NCT00843024|2566843|P5|COMPLETED|Single-blind Placebo Run-In Phase||0
1058477|NCT00843024|2566844|P4|COMPLETED|Single-blind Placebo Run-In Phase||0
1058478|NCT00843024|2566845|P3|COMPLETED|Single-blind Placebo Run-In Phase||0
1058479|NCT00843024|2566846|P2|COMPLETED|Single-blind Placebo Run-In Phase||321
1058480|NCT00843024|2566847|P1|COMPLETED|Single-blind Placebo Run-In Phase||268
1058481|NCT00843024|2566842|P6|STARTED|Single-blind Placebo Run-In Phase||0
1058482|NCT00843024|2566843|P5|STARTED|Single-blind Placebo Run-In Phase||0
1058483|NCT00843024|2566844|P4|STARTED|Single-blind Placebo Run-In Phase||0
1058484|NCT00843024|2566845|P3|STARTED|Single-blind Placebo Run-In Phase||0
1058485|NCT00843024|2566846|P2|STARTED|Single-blind Placebo Run-In Phase||457
1058486|NCT00843024|2566847|P1|STARTED|Single-blind Placebo Run-In Phase||408
1058487|NCT00843050|2566912|P1|NOT COMPLETED|Overall Study||13
1058488|NCT00843050|2566912|P1|COMPLETED|Overall Study||0
1058489|NCT00843050|2566912|P1|STARTED|Overall Study||13
1058490|NCT00843115|2566918|P1|NOT COMPLETED|Overall Study||66
1058491|NCT00843115|2566918|P1|COMPLETED|Overall Study||304
1058492|NCT00843115|2566918|P1|STARTED|Overall Study||370
1058493|NCT00843167|2566966|P2|NOT COMPLETED|Follow-up||0
1058494|NCT00843167|2566967|P1|NOT COMPLETED|Follow-up||0
1058495|NCT00843167|2566966|P2|COMPLETED|Follow-up||24
1058496|NCT00843167|2566967|P1|COMPLETED|Follow-up||24
1058497|NCT00843167|2566966|P2|Completed Final Visit|Follow-up||24
1058498|NCT00843167|2566967|P1|Completed Final Visit|Follow-up||24
1058499|NCT00843167|2566966|P2|STARTED|Follow-up||24
1058500|NCT00843167|2566967|P1|STARTED|Follow-up||24
1058501|NCT00843167|2566966|P2|NOT COMPLETED|Treatment Period||8
1058502|NCT00843167|2566967|P1|NOT COMPLETED|Treatment Period||3
1058503|NCT00843167|2566966|P2|COMPLETED|Treatment Period||19
1058504|NCT00843167|2566967|P1|COMPLETED|Treatment Period||24
1058505|NCT00843167|2566966|P2|STARTED|Treatment Period||27
1058506|NCT00843167|2566967|P1|STARTED|Treatment Period||27
1058507|NCT00843180|2566982|P2|NOT COMPLETED|Overall Study||0
1058508|NCT00843180|2566983|P1|NOT COMPLETED|Overall Study||0
1058509|NCT00843180|2566982|P2|COMPLETED|Overall Study||7
1058510|NCT00843180|2566983|P1|COMPLETED|Overall Study||16
1058511|NCT00843180|2566982|P2|STARTED|Overall Study||7
1058512|NCT00843180|2566983|P1|STARTED|Overall Study||16
1058513|NCT00843284|2566995|P1|NOT COMPLETED|Overall Study||72
1058514|NCT00843284|2566995|P1|COMPLETED|Overall Study||619
1058515|NCT00843284|2566995|P1|STARTED|Overall Study||691
1058516|NCT00843310|2567003|P1|NOT COMPLETED|Overall Study||7
1058517|NCT00843310|2567003|P1|COMPLETED|Overall Study||1
1058518|NCT00843310|2567003|P1|STARTED|Overall Study||8
1058519|NCT00843349|2567011|P4|NOT COMPLETED|Overall Study||1
1058520|NCT00843349|2567012|P3|NOT COMPLETED|Overall Study||0
1058521|NCT00843349|2567013|P2|NOT COMPLETED|Overall Study||0
1058522|NCT00843349|2567014|P1|NOT COMPLETED|Overall Study||3
1058523|NCT00843349|2567011|P4|COMPLETED|Overall Study||10
1058524|NCT00843349|2567012|P3|COMPLETED|Overall Study||10
1058525|NCT00843349|2567013|P2|COMPLETED|Overall Study||11
1058526|NCT00843349|2567014|P1|COMPLETED|Overall Study||8
1058527|NCT00843349|2567011|P4|STARTED|Overall Study||11
1058528|NCT00843349|2567012|P3|STARTED|Overall Study||10
1058529|NCT00843349|2567013|P2|STARTED|Overall Study||11
1058530|NCT00843349|2567014|P1|STARTED|Overall Study||11
1058531|NCT00843466|2567030|P2|NOT COMPLETED|Overall Study||0
1058532|NCT00843466|2567031|P1|NOT COMPLETED|Overall Study||0
1058533|NCT00843466|2567030|P2|COMPLETED|Overall Study||18
1058534|NCT00843466|2567031|P1|COMPLETED|Overall Study||24
1058535|NCT00843466|2567030|P2|STARTED|Overall Study||18
1058536|NCT00843466|2567031|P1|STARTED|Overall Study||24
1058537|NCT00843479|2567039|P2|NOT COMPLETED|Overall Study||0
1058538|NCT00843479|2567040|P1|NOT COMPLETED|Overall Study||0
1058539|NCT00843479|2567039|P2|COMPLETED|Overall Study||12
1058540|NCT00843479|2567040|P1|COMPLETED|Overall Study||12
1058541|NCT00843479|2567039|P2|STARTED|Overall Study||12
1058542|NCT00843479|2567040|P1|STARTED|Overall Study||12
1058543|NCT00843492|2567058|P2|NOT COMPLETED|Overall Study||14
1058544|NCT00843492|2567059|P1|NOT COMPLETED|Overall Study||8
1058545|NCT00843492|2567058|P2|COMPLETED|Overall Study||607
1058546|NCT00843492|2567059|P1|COMPLETED|Overall Study||614
1058547|NCT00843492|2567058|P2|STARTED|Overall Study||621
1058548|NCT00843492|2567059|P1|STARTED|Overall Study||622
1058549|NCT00843622|2567079|P2|NOT COMPLETED|Overall Study||55
1058550|NCT00843622|2567080|P1|NOT COMPLETED|Overall Study||43
1058551|NCT00843622|2567079|P2|COMPLETED|Overall Study||70
1058552|NCT00843622|2567080|P1|COMPLETED|Overall Study||82
1058553|NCT00843622|2567079|P2|STARTED|Overall Study||125
1058554|NCT00843622|2567080|P1|STARTED|Overall Study||125
1058555|NCT00843635|2567089|P3|NOT COMPLETED|Overall Study||0
1058556|NCT00843635|2567090|P2|NOT COMPLETED|Overall Study||2
1058557|NCT00843635|2567091|P1|NOT COMPLETED|Overall Study||2
1058558|NCT00843635|2567089|P3|COMPLETED|Overall Study||5
1058559|NCT00843635|2567090|P2|COMPLETED|Overall Study||13
1058560|NCT00843635|2567091|P1|COMPLETED|Overall Study||13
1058561|NCT00843635|2567089|P3|STARTED|Overall Study||5
1058562|NCT00843635|2567090|P2|STARTED|Overall Study||15
1058563|NCT00843635|2567091|P1|STARTED|Overall Study||15
1058564|NCT00843713|2567111|P2|NOT COMPLETED|Overall Study||0
1058565|NCT00843713|2567112|P1|NOT COMPLETED|Overall Study||0
1058566|NCT00843713|2567111|P2|COMPLETED|Overall Study||26
1058567|NCT00843713|2567112|P1|COMPLETED|Overall Study||30
1058568|NCT00843713|2567111|P2|STARTED|Overall Study||26
1058569|NCT00843713|2567112|P1|STARTED|Overall Study||30
1058570|NCT00843778|2567118|P1|NOT COMPLETED|Overall Study||35
1058571|NCT00843778|2567118|P1|COMPLETED|Overall Study||96
1058572|NCT00843778|2567118|P1|STARTED|Overall Study||131
1058573|NCT00830791|2567157|P6|NOT COMPLETED|Overall Study||0
1058574|NCT00830791|2567158|P5|NOT COMPLETED|Overall Study||0
1058575|NCT00830791|2567159|P4|NOT COMPLETED|Overall Study||0
1058576|NCT00830791|2567160|P3|NOT COMPLETED|Overall Study||0
1058577|NCT00830791|2567161|P2|NOT COMPLETED|Overall Study||0
1058578|NCT00830791|2567162|P1|NOT COMPLETED|Overall Study||0
1058579|NCT00830791|2567157|P6|COMPLETED|Overall Study||0
1058580|NCT00830791|2567158|P5|COMPLETED|Overall Study||0
1058581|NCT00830791|2567159|P4|COMPLETED|Overall Study||8
1058582|NCT00830791|2567160|P3|COMPLETED|Overall Study||8
1058583|NCT00830791|2567161|P2|COMPLETED|Overall Study||8
1058584|NCT00830791|2567162|P1|COMPLETED|Overall Study||8
1058585|NCT00830791|2567157|P6|STARTED|Overall Study||0
1058586|NCT00830791|2567158|P5|STARTED|Overall Study||0
1058587|NCT00830791|2567159|P4|STARTED|Overall Study||8
1058588|NCT00830791|2567160|P3|STARTED|Overall Study||8
1058589|NCT00830791|2567161|P2|STARTED|Overall Study||8
1058590|NCT00830791|2567162|P1|STARTED|Overall Study||8
1058591|NCT00830804|2567209|P1|NOT COMPLETED|Overall Study||15
1058592|NCT00830804|2567209|P1|COMPLETED|Overall Study||97
1058593|NCT00830804|2567209|P1|STARTED|Overall Study|113 subjects enrolled. One subject never started study treatment and was excluded in all analysis.|112
1058594|NCT00830947|2567231|P2|NOT COMPLETED|Overall Study||4
1058595|NCT00830947|2567232|P1|NOT COMPLETED|Overall Study||4
1058596|NCT00830947|2567231|P2|COMPLETED|Overall Study||18
1058597|NCT00830947|2567232|P1|COMPLETED|Overall Study||19
1058598|NCT00830947|2567231|P2|STARTED|Overall Study||22
1058599|NCT00830947|2567232|P1|STARTED|Overall Study||23
1058600|NCT00830960|2567244|P6|NOT COMPLETED|Overall Study||37
1058601|NCT00830960|2567245|P5|NOT COMPLETED|Overall Study||32
1058602|NCT00830960|2567246|P4|NOT COMPLETED|Overall Study||32
1058603|NCT00830960|2567247|P3|NOT COMPLETED|Overall Study||29
1058604|NCT00830960|2567248|P2|NOT COMPLETED|Overall Study||28
1058605|NCT00830960|2567249|P1|NOT COMPLETED|Overall Study||33
1058606|NCT00830960|2567244|P6|COMPLETED|Overall Study||63
1058607|NCT00830960|2567245|P5|COMPLETED|Overall Study|6 participants not completed due to death; 1 additional death occurred after study discontinuation.|64
1058608|NCT00830960|2567246|P4|COMPLETED|Overall Study||106
1058609|NCT00830960|2567247|P3|COMPLETED|Overall Study||108
1058610|NCT00830960|2567248|P2|COMPLETED|Overall Study||96
1058611|NCT00830960|2567249|P1|COMPLETED|Overall Study||91
1058612|NCT00830960|2567244|P6|Received at Least 1 Dose of Study Drug|Overall Study||93
1058613|NCT00830960|2567245|P5|Received at Least 1 Dose of Study Drug|Overall Study||91
1058614|NCT00830960|2567246|P4|Received at Least 1 Dose of Study Drug|Overall Study||135
1058615|NCT00830960|2567247|P3|Received at Least 1 Dose of Study Drug|Overall Study||133
1058616|NCT00830960|2567248|P2|Received at Least 1 Dose of Study Drug|Overall Study||122
1058617|NCT00830960|2567249|P1|Received at Least 1 Dose of Study Drug|Overall Study|Baseline Characteristics (below) include those who received ≥1 dose study drug, not all who STARTED.|117
1058618|NCT00830960|2567244|P6|STARTED|Overall Study|Total 720 participants were randomized; 1 was not included in a cohort as baseline weight missing.|100
1058619|NCT00830960|2567245|P5|STARTED|Overall Study||96
1058620|NCT00830960|2567246|P4|STARTED|Overall Study||138
1058621|NCT00830960|2567247|P3|STARTED|Overall Study||137
1058622|NCT00830960|2567248|P2|STARTED|Overall Study||124
1058623|NCT00830960|2567249|P1|STARTED|Overall Study|"Number of participants STARTED equals the number of participants randomized."|124
1058624|NCT00831129|2567365|P2|NOT COMPLETED|Overall Study||10
1058625|NCT00831129|2567366|P1|NOT COMPLETED|Overall Study||0
1058626|NCT00831129|2567365|P2|COMPLETED|Overall Study||23
1058627|NCT00831129|2567366|P1|COMPLETED|Overall Study||20
1058628|NCT00831129|2567365|P2|STARTED|Overall Study||33
1058629|NCT00831129|2567366|P1|STARTED|Overall Study||20
1058630|NCT00843830|2567402|P1|NOT COMPLETED|Overall Study||0
1058631|NCT00843830|2567402|P1|COMPLETED|Overall Study||4
1058632|NCT00843830|2567402|P1|STARTED|Overall Study||4
1058633|NCT00843843|2567409|P2|NOT COMPLETED|Overall Study||2
1058634|NCT00843843|2567410|P1|NOT COMPLETED|Overall Study||2
1058635|NCT00843843|2567409|P2|COMPLETED|Overall Study||6
1058636|NCT00843843|2567410|P1|COMPLETED|Overall Study||6
1058637|NCT00843843|2567409|P2|STARTED|Overall Study||8
1058638|NCT00843843|2567410|P1|STARTED|Overall Study||8
1058639|NCT00843986|2567420|P2|NOT COMPLETED|Overall Study||1
1058640|NCT00843986|2567421|P1|NOT COMPLETED|Overall Study||1
1058641|NCT00843986|2567420|P2|COMPLETED|Overall Study||5
1058642|NCT00843986|2567421|P1|COMPLETED|Overall Study||2
1058643|NCT00843986|2567420|P2|Completed Treatment (Infusion)|Overall Study||6
1058644|NCT00843986|2567421|P1|Completed Treatment (Infusion)|Overall Study||2
1058645|NCT00843986|2567420|P2|STARTED|Overall Study||6
1058646|NCT00843986|2567421|P1|STARTED|Overall Study||3
1058647|NCT00844051|2567449|P2|NOT COMPLETED|Overall Study||0
1058648|NCT00844051|2567450|P1|NOT COMPLETED|Overall Study||0
1058649|NCT00844051|2567449|P2|COMPLETED|Overall Study||2368
1058650|NCT00844051|2567450|P1|COMPLETED|Overall Study||2087
1058651|NCT00844051|2567449|P2|STARTED|Overall Study||2368
1058652|NCT00844051|2567450|P1|STARTED|Overall Study||2087
1058653|NCT00844090|2567460|P2|NOT COMPLETED|Overall Study||8
1058654|NCT00844090|2567461|P1|NOT COMPLETED|Overall Study||6
1058655|NCT00844090|2567460|P2|COMPLETED|Overall Study||46
1058656|NCT00844090|2567461|P1|COMPLETED|Overall Study||46
1058657|NCT00844090|2567460|P2|STARTED|Overall Study||54
1058658|NCT00844090|2567461|P1|STARTED|Overall Study||52
1058659|NCT00845897|2567470|P3|NOT COMPLETED|Overall Study||3
1058660|NCT00845897|2567471|P2|NOT COMPLETED|Overall Study||5
1058661|NCT00845897|2567472|P1|NOT COMPLETED|Overall Study||2
1058662|NCT00845897|2567470|P3|COMPLETED|Overall Study||2
1058663|NCT00845897|2567471|P2|COMPLETED|Overall Study||2
1058664|NCT00845897|2567472|P1|COMPLETED|Overall Study||3
1058665|NCT00845897|2567470|P3|STARTED|Overall Study||5
1058666|NCT00845897|2567471|P2|STARTED|Overall Study||7
1058667|NCT00845897|2567472|P1|STARTED|Overall Study||5
1058668|NCT00845975|2567485|P2|NOT COMPLETED|Overall Study||0
1058669|NCT00845975|2567486|P1|NOT COMPLETED|Overall Study||0
1058670|NCT00845975|2567485|P2|COMPLETED|Overall Study||9
1058671|NCT00845975|2567486|P1|COMPLETED|Overall Study||9
1058672|NCT00845975|2567485|P2|STARTED|Overall Study||9
1058673|NCT00845975|2567486|P1|STARTED|Overall Study||9
1058674|NCT00846027|2567496|P1|NOT COMPLETED|Overall Study||90
1058675|NCT00846027|2567496|P1|COMPLETED|Overall Study||0
1058676|NCT00846027|2567496|P1|Received Treatment|Overall Study||83
1058677|NCT00846027|2567496|P1|STARTED|Overall Study||90
1058678|NCT00846066|2567505|P2|NOT COMPLETED|Overall Study||0
1058679|NCT00846066|2567506|P1|NOT COMPLETED|Overall Study||0
1058680|NCT00846066|2567505|P2|COMPLETED|Overall Study||29
1058681|NCT00846066|2567506|P1|COMPLETED|Overall Study||27
1058682|NCT00846066|2567505|P2|STARTED|Overall Study||29
1058683|NCT00846066|2567506|P1|STARTED|Overall Study||27
1058684|NCT00846287|2567520|P2|NOT COMPLETED|Overall Study||5
1058685|NCT00846287|2567521|P1|NOT COMPLETED|Overall Study||10
1058686|NCT00846287|2567520|P2|COMPLETED|Overall Study||10
1058687|NCT00846287|2567521|P1|COMPLETED|Overall Study||6
1058688|NCT00846287|2567520|P2|STARTED|Overall Study||15
1058689|NCT00846287|2567521|P1|STARTED|Overall Study||16
1058690|NCT00846365|2567532|P3|NOT COMPLETED|Overall Study||33
1058691|NCT00846365|2567533|P2|NOT COMPLETED|Overall Study||49
1058692|NCT00846365|2567534|P1|NOT COMPLETED|Overall Study||55
1058693|NCT00846365|2567532|P3|COMPLETED|Overall Study||323
1058694|NCT00846365|2567533|P2|COMPLETED|Overall Study||308
1058695|NCT00846365|2567534|P1|COMPLETED|Overall Study||317
1058696|NCT00846365|2567532|P3|STARTED|Overall Study||356
1058697|NCT00846365|2567533|P2|STARTED|Overall Study||357
1058698|NCT00846365|2567534|P1|STARTED|Overall Study||372
1058699|NCT00846391|2567590|P3|NOT COMPLETED|Overall Study||3
1058700|NCT00846391|2567591|P2|NOT COMPLETED|Overall Study||2
1058701|NCT00846391|2567592|P1|NOT COMPLETED|Overall Study||1
1058702|NCT00846391|2567590|P3|COMPLETED|Overall Study||3
1058703|NCT00846391|2567591|P2|COMPLETED|Overall Study||2
1058704|NCT00846391|2567592|P1|COMPLETED|Overall Study||3
1058705|NCT00846391|2567590|P3|STARTED|Overall Study||6
1058706|NCT00846391|2567591|P2|STARTED|Overall Study||4
1058707|NCT00846391|2567592|P1|STARTED|Overall Study||4
1058708|NCT00846495|2567602|P2|NOT COMPLETED|Overall Study||3
1058709|NCT00846495|2567603|P1|NOT COMPLETED|Overall Study||8
1058710|NCT00846495|2567602|P2|COMPLETED|Overall Study||24
1058711|NCT00846495|2567603|P1|COMPLETED|Overall Study||20
1058712|NCT00846495|2567602|P2|STARTED|Overall Study||27
1058713|NCT00846495|2567603|P1|STARTED|Overall Study||28
1058714|NCT00846521|2567623|P1|NOT COMPLETED|Overall Study||11
1058715|NCT00846521|2567623|P1|COMPLETED|Overall Study||12
1058716|NCT00846521|2567623|P1|STARTED|Overall Study||23
1058717|NCT00846547|2567628|P1|NOT COMPLETED|Overall Study||7
1058718|NCT00846547|2567628|P1|COMPLETED|Overall Study||25
1058719|NCT00846547|2567628|P1|STARTED|Overall Study||32
1058720|NCT00846573|2567635|P4|NOT COMPLETED|Overall Study||0
1058721|NCT00846573|2567636|P3|NOT COMPLETED|Overall Study||0
1058722|NCT00846573|2567637|P2|NOT COMPLETED|Overall Study||0
1058723|NCT00846573|2567638|P1|NOT COMPLETED|Overall Study||0
1058724|NCT00846573|2567635|P4|COMPLETED|Overall Study||0
1058725|NCT00846573|2567636|P3|COMPLETED|Overall Study||7
1058726|NCT00846573|2567637|P2|COMPLETED|Overall Study||2
1058727|NCT00846573|2567638|P1|COMPLETED|Overall Study||5
1058728|NCT00846573|2567635|P4|STARTED|Overall Study||0
1058729|NCT00846573|2567636|P3|STARTED|Overall Study||7
1058730|NCT00846573|2567637|P2|STARTED|Overall Study||2
1058731|NCT00846573|2567638|P1|STARTED|Overall Study||5
1058732|NCT00846586|2567648|P2|NOT COMPLETED|Overall Study||35
1058733|NCT00846586|2567649|P1|NOT COMPLETED|Overall Study||39
1058734|NCT00846586|2567648|P2|COMPLETED|Overall Study||529
1058735|NCT00846586|2567649|P1|COMPLETED|Overall Study||531
1058736|NCT00846586|2567648|P2|Received Study Drug|Overall Study|Three patients were not exposed to study treatment in this group.|561
1058737|NCT00846586|2567649|P1|Received Study Drug|Overall Study||570
1058738|NCT00846586|2567648|P2|STARTED|Overall Study||564
1058739|NCT00846586|2567649|P1|STARTED|Overall Study||570
1058746|NCT00846768|2567682|P4|NOT COMPLETED|Overall Study||0
1058747|NCT00846768|2567683|P3|NOT COMPLETED|Overall Study||0
1058748|NCT00846768|2567684|P2|NOT COMPLETED|Overall Study||1
1058749|NCT00846768|2567685|P1|NOT COMPLETED|Overall Study||0
1058750|NCT00846768|2567682|P4|COMPLETED|Overall Study||12
1058751|NCT00846768|2567683|P3|COMPLETED|Overall Study||12
1058752|NCT00846768|2567684|P2|COMPLETED|Overall Study||11
1058753|NCT00846768|2567685|P1|COMPLETED|Overall Study||11
1058754|NCT00846768|2567682|P4|STARTED|Overall Study||12
1058755|NCT00846768|2567683|P3|STARTED|Overall Study||12
1058756|NCT00846768|2567684|P2|STARTED|Overall Study||12
1058757|NCT00846768|2567685|P1|STARTED|Overall Study||11
1058758|NCT00846807|2567755|P1|NOT COMPLETED|Overall Study||632
1058759|NCT00846807|2567755|P1|COMPLETED|Overall Study|Completed treatment.|4660
1058760|NCT00846807|2567755|P1|STARTED|Overall Study|Entered and treated.|5292
1058761|NCT00846846|2567763|P1|NOT COMPLETED|Overall Study||75
1058762|NCT00846846|2567763|P1|COMPLETED|Overall Study|Study ongoing but not recruiting participants.|943
1058763|NCT00846846|2567763|P1|STARTED|Overall Study||1018
1058764|NCT00846885|2567770|P2|NOT COMPLETED|Second Intervention||0
1058765|NCT00846885|2567771|P1|NOT COMPLETED|Second Intervention||0
1058766|NCT00846885|2567770|P2|COMPLETED|Second Intervention||14
1058767|NCT00846885|2567771|P1|COMPLETED|Second Intervention||14
1058768|NCT00846885|2567770|P2|STARTED|Second Intervention||14
1058769|NCT00846885|2567771|P1|STARTED|Second Intervention||14
1058770|NCT00846885|2567770|P2|NOT COMPLETED|Washout of 7 Days||0
1058771|NCT00846885|2567771|P1|NOT COMPLETED|Washout of 7 Days||0
1058772|NCT00846885|2567770|P2|COMPLETED|Washout of 7 Days||14
1058773|NCT00846885|2567771|P1|COMPLETED|Washout of 7 Days||14
1058774|NCT00846885|2567770|P2|STARTED|Washout of 7 Days||14
1058775|NCT00846885|2567771|P1|STARTED|Washout of 7 Days||14
1058776|NCT00846885|2567770|P2|NOT COMPLETED|First Intervention||0
1058777|NCT00846885|2567771|P1|NOT COMPLETED|First Intervention||0
1058778|NCT00846885|2567770|P2|COMPLETED|First Intervention||14
1058779|NCT00846885|2567771|P1|COMPLETED|First Intervention||14
1058780|NCT00846885|2567770|P2|STARTED|First Intervention||14
1058781|NCT00846885|2567771|P1|STARTED|First Intervention||14
1058782|NCT00847002|2567781|P2|NOT COMPLETED|Overall Study||0
1058783|NCT00847002|2567782|P1|NOT COMPLETED|Overall Study||0
1058784|NCT00847002|2567781|P2|COMPLETED|Overall Study||4
1058785|NCT00847002|2567782|P1|COMPLETED|Overall Study||4
1058786|NCT00847002|2567781|P2|STARTED|Overall Study||4
1058787|NCT00847002|2567782|P1|STARTED|Overall Study||4
1058788|NCT00847015|2567790|P1|NOT COMPLETED|Overall Study||3
1058789|NCT00847015|2567790|P1|COMPLETED|Overall Study||15
1058790|NCT00847015|2567790|P1|STARTED|Overall Study||18
1058791|NCT00847132|2567798|P2|NOT COMPLETED|Overall Study||1
1058792|NCT00847132|2567799|P1|NOT COMPLETED|Overall Study||1
1058793|NCT00847132|2567798|P2|COMPLETED|Overall Study||84
1058794|NCT00847132|2567799|P1|COMPLETED|Overall Study||89
1058795|NCT00847132|2567798|P2|STARTED|Overall Study||85
1058796|NCT00847132|2567799|P1|STARTED|Overall Study||90
1058797|NCT00847145|2567815|P8|NOT COMPLETED|Overall Study||4
1058798|NCT00847145|2567816|P7|NOT COMPLETED|Overall Study||9
1058799|NCT00847145|2567817|P6|NOT COMPLETED|Overall Study||4
1058800|NCT00847145|2567818|P5|NOT COMPLETED|Overall Study||6
1058801|NCT00847145|2567819|P4|NOT COMPLETED|Overall Study||1
1058802|NCT00847145|2567820|P3|NOT COMPLETED|Overall Study||11
1058803|NCT00847145|2567821|P2|NOT COMPLETED|Overall Study||6
1058804|NCT00847145|2567822|P1|NOT COMPLETED|Overall Study||6
1058805|NCT00847145|2567815|P8|COMPLETED|Overall Study||136
1058806|NCT00847145|2567816|P7|COMPLETED|Overall Study||143
1058807|NCT00847145|2567817|P6|COMPLETED|Overall Study||152
1058808|NCT00847145|2567818|P5|COMPLETED|Overall Study||131
1058809|NCT00847145|2567819|P4|COMPLETED|Overall Study||116
1058810|NCT00847145|2567820|P3|COMPLETED|Overall Study||274
1058811|NCT00847145|2567821|P2|COMPLETED|Overall Study||627
1058812|NCT00847145|2567822|P1|COMPLETED|Overall Study||623
1058813|NCT00847145|2567815|P8|STARTED|Overall Study||140
1058814|NCT00847145|2567816|P7|STARTED|Overall Study||152
1058815|NCT00847145|2567817|P6|STARTED|Overall Study||156
1058816|NCT00847145|2567818|P5|STARTED|Overall Study||137
1058817|NCT00847145|2567819|P4|STARTED|Overall Study||117
1058818|NCT00847145|2567820|P3|STARTED|Overall Study||285
1058819|NCT00847145|2567821|P2|STARTED|Overall Study||633
1058820|NCT00847145|2567822|P1|STARTED|Overall Study||629
1058821|NCT00847197|2567872|P2|NOT COMPLETED|Overall Study||5
1058822|NCT00847197|2567873|P1|NOT COMPLETED|Overall Study||24
1058823|NCT00847197|2567872|P2|COMPLETED|Overall Study||70
1058824|NCT00847197|2567873|P1|COMPLETED|Overall Study||92
1058825|NCT00847197|2567872|P2|STARTED|Overall Study||75
1058826|NCT00847197|2567873|P1|STARTED|Overall Study||116
1058827|NCT00847210|2567885|P2|NOT COMPLETED|Overall Study||0
1058828|NCT00847210|2567886|P1|NOT COMPLETED|Overall Study||0
1058829|NCT00847210|2567885|P2|COMPLETED|Overall Study||18
1058830|NCT00847210|2567886|P1|COMPLETED|Overall Study||18
1058831|NCT00847210|2567885|P2|STARTED|Overall Study||18
1058832|NCT00847210|2567886|P1|STARTED|Overall Study||18
1058833|NCT00847288|2567908|P2|NOT COMPLETED|Overall Study||47
1058834|NCT00847288|2567909|P1|NOT COMPLETED|Overall Study||30
1058835|NCT00847288|2567908|P2|COMPLETED|Overall Study||780
1058836|NCT00847288|2567909|P1|COMPLETED|Overall Study||811
1058837|NCT00847288|2567908|P2|STARTED|Overall Study||827
1058838|NCT00847288|2567909|P1|STARTED|Overall Study||841
1058839|NCT00847301|2567921|P1|NOT COMPLETED|Overall Study||54
1058840|NCT00847301|2567921|P1|COMPLETED|Overall Study||374
1058841|NCT00847301|2567921|P1|STARTED|Overall Study||428
1058842|NCT00847405|2567931|P2|NOT COMPLETED|Second Intervention||0
1058843|NCT00847405|2567932|P1|NOT COMPLETED|Second Intervention||0
1058844|NCT00847405|2567931|P2|COMPLETED|Second Intervention||13
1058845|NCT00847405|2567932|P1|COMPLETED|Second Intervention||13
1058846|NCT00847405|2567931|P2|STARTED|Second Intervention||13
1058847|NCT00847405|2567932|P1|STARTED|Second Intervention||13
1058848|NCT00847405|2567931|P2|NOT COMPLETED|Washout of 7 Days||0
1058849|NCT00847405|2567932|P1|NOT COMPLETED|Washout of 7 Days||1
1058850|NCT00847405|2567931|P2|COMPLETED|Washout of 7 Days||13
1058851|NCT00847405|2567932|P1|COMPLETED|Washout of 7 Days||13
1058852|NCT00847405|2567931|P2|STARTED|Washout of 7 Days||13
1058853|NCT00847405|2567932|P1|STARTED|Washout of 7 Days||14
1058854|NCT00847405|2567931|P2|NOT COMPLETED|First Intervention||1
1058855|NCT00847405|2567932|P1|NOT COMPLETED|First Intervention||0
1058856|NCT00847405|2567931|P2|COMPLETED|First Intervention||13
1058857|NCT00847405|2567932|P1|COMPLETED|First Intervention||14
1058858|NCT00847405|2567931|P2|STARTED|First Intervention||14
1058859|NCT00847405|2567932|P1|STARTED|First Intervention||14
1058860|NCT00847509|2567940|P1|NOT COMPLETED|Overall Study||11
1058861|NCT00847509|2567940|P1|COMPLETED|Overall Study||38
1058862|NCT00847509|2567940|P1|STARTED|Overall Study||49
1058863|NCT00847535|2567944|P3|NOT COMPLETED|Overall Study||1
1058864|NCT00847535|2567945|P2|NOT COMPLETED|Overall Study||2
1058865|NCT00847535|2567946|P1|NOT COMPLETED|Overall Study||2
1058866|NCT00847535|2567944|P3|COMPLETED|Overall Study||15
1058867|NCT00847535|2567945|P2|COMPLETED|Overall Study||22
1058868|NCT00847535|2567946|P1|COMPLETED|Overall Study||22
1058869|NCT00847535|2567944|P3|200 Million AMDC|Overall Study||8
1058870|NCT00847535|2567945|P2|200 Million AMDC|Overall Study||0
1058871|NCT00847535|2567946|P1|200 Million AMDC|Overall Study||0
1058872|NCT00847535|2567944|P3|100 Million AMDC|Overall Study||8
1058873|NCT00847535|2567945|P2|100 Million AMDC|Overall Study||8
1058874|NCT00847535|2567946|P1|100 Million AMDC|Overall Study||8
1058875|NCT00847535|2567944|P3|50 Million AMDC|Overall Study||0
1058876|NCT00847535|2567945|P2|50 Million AMDC|Overall Study||8
1058877|NCT00847535|2567946|P1|50 Million AMDC|Overall Study||8
1058878|NCT00847535|2567944|P3|10 Million AMDC|Overall Study||0
1058879|NCT00847535|2567945|P2|10 Million AMDC|Overall Study||8
1058880|NCT00847535|2567946|P1|10 Million AMDC|Overall Study||8
1058881|NCT00847535|2567944|P3|STARTED|Overall Study||16
1058882|NCT00847535|2567945|P2|STARTED|Overall Study||24
1058883|NCT00847535|2567946|P1|STARTED|Overall Study||24
1058884|NCT00847561|2567956|P2|NOT COMPLETED|Overall Study||4
1058885|NCT00847561|2567957|P1|NOT COMPLETED|Overall Study||13
1058886|NCT00847561|2567956|P2|COMPLETED|Overall Study||62
1058887|NCT00847561|2567957|P1|COMPLETED|Overall Study||57
1058888|NCT00847561|2567956|P2|STARTED|Overall Study||66
1058889|NCT00847561|2567957|P1|STARTED|Overall Study||70
1058890|NCT00847587|2567965|P2|NOT COMPLETED|Overall Study||0
1058891|NCT00847587|2567966|P1|NOT COMPLETED|Overall Study||1
1058892|NCT00847587|2567965|P2|COMPLETED|Overall Study||34
1058893|NCT00847587|2567966|P1|COMPLETED|Overall Study|Patient declined study after randomization.|34
1058894|NCT00847587|2567965|P2|STARTED|Overall Study||34
1058895|NCT00847587|2567966|P1|STARTED|Overall Study||35
1058896|NCT00847613|2567978|P4|NOT COMPLETED|Overall Study||79
1058897|NCT00847613|2567979|P3|NOT COMPLETED|Overall Study||81
1058898|NCT00847613|2567980|P2|NOT COMPLETED|Overall Study||319
1058899|NCT00847613|2567981|P1|NOT COMPLETED|Overall Study||321
1058900|NCT00847613|2567978|P4|COMPLETED|Overall Study||0
1058901|NCT00847613|2567979|P3|COMPLETED|Overall Study||0
1058902|NCT00847613|2567980|P2|COMPLETED|Overall Study||0
1058903|NCT00847613|2567981|P1|COMPLETED|Overall Study||0
1058904|NCT00847613|2567978|P4|Treated|Overall Study||79
1058905|NCT00847613|2567979|P3|Treated|Overall Study||81
1058906|NCT00847613|2567980|P2|Treated|Overall Study||316
1058907|NCT00847613|2567981|P1|Treated|Overall Study||321
1058908|NCT00847613|2567978|P4|STARTED|Overall Study||79
1058909|NCT00847613|2567979|P3|STARTED|Overall Study||81
1058910|NCT00847613|2567980|P2|STARTED|Overall Study||319
1058911|NCT00847613|2567981|P1|STARTED|Overall Study||321
1058912|NCT00847626|2568230|P11|NOT COMPLETED|Overall Study||20
1058913|NCT00847626|2568231|P10|NOT COMPLETED|Overall Study||14
1058914|NCT00847626|2568232|P9|NOT COMPLETED|Overall Study||14
1058915|NCT00847626|2568233|P8|NOT COMPLETED|Overall Study||19
1058916|NCT00847626|2568234|P7|NOT COMPLETED|Overall Study||22
1058917|NCT00847626|2568235|P6|NOT COMPLETED|Overall Study||37
1058918|NCT00847626|2568236|P5|NOT COMPLETED|Overall Study||28
1058919|NCT00847626|2568237|P4|NOT COMPLETED|Overall Study||31
1058920|NCT00847626|2568238|P3|NOT COMPLETED|Overall Study||16
1058921|NCT00847626|2568239|P2|NOT COMPLETED|Overall Study||23
1058922|NCT00847626|2568240|P1|NOT COMPLETED|Overall Study||21
1058923|NCT00847626|2568230|P11|COMPLETED|Overall Study||142
1058924|NCT00847626|2568231|P10|COMPLETED|Overall Study||139
1058925|NCT00847626|2568232|P9|COMPLETED|Overall Study||141
1058926|NCT00847626|2568233|P8|COMPLETED|Overall Study||141
1058927|NCT00847626|2568234|P7|COMPLETED|Overall Study||135
1058928|NCT00847626|2568235|P6|COMPLETED|Overall Study||125
1058929|NCT00847626|2568236|P5|COMPLETED|Overall Study||125
1058930|NCT00847626|2568237|P4|COMPLETED|Overall Study||125
1058931|NCT00847626|2568238|P3|COMPLETED|Overall Study||131
1058932|NCT00847626|2568239|P2|COMPLETED|Overall Study||131
1058933|NCT00847626|2568240|P1|COMPLETED|Overall Study||135
1058934|NCT00847626|2568230|P11|STARTED|Overall Study||162
1058935|NCT00847626|2568231|P10|STARTED|Overall Study||153
1058936|NCT00847626|2568232|P9|STARTED|Overall Study||155
1058937|NCT00847626|2568233|P8|STARTED|Overall Study|Includes participant who was treated with double-blind study medication but not randomized.|160
1058938|NCT00847626|2568234|P7|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|157
1058939|NCT00847626|2568235|P6|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|162
1058940|NCT00847626|2568236|P5|STARTED|Overall Study||153
1058941|NCT00847626|2568237|P4|STARTED|Overall Study||156
1058942|NCT00847626|2568238|P3|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|147
1058943|NCT00847626|2568239|P2|STARTED|Overall Study||154
1058944|NCT00847626|2568240|P1|STARTED|Overall Study||156
1058945|NCT00847665|2568437|P2|NOT COMPLETED|Overall Study||0
1058946|NCT00847665|2568438|P1|NOT COMPLETED|Overall Study||1
1058947|NCT00847665|2568437|P2|COMPLETED|Overall Study||165
1058948|NCT00847665|2568438|P1|COMPLETED|Overall Study||164
1058949|NCT00847665|2568437|P2|STARTED|Overall Study||165
1058950|NCT00847665|2568438|P1|STARTED|Overall Study||165
1058951|NCT00847704|2568450|P1|NOT COMPLETED|Overall Study||1
1058952|NCT00847704|2568450|P1|COMPLETED|Overall Study||2
1058953|NCT00847704|2568450|P1|STARTED|Overall Study||3
1058954|NCT00847808|2568459|P1|NOT COMPLETED|Overall Study||15
1058955|NCT00847808|2568459|P1|COMPLETED|Overall Study||163
1058956|NCT00847808|2568459|P1|STARTED|Overall Study||178
1058957|NCT00847886|2568478|P2|NOT COMPLETED|Overall Study||1
1058958|NCT00847886|2568479|P1|NOT COMPLETED|Overall Study||0
1058959|NCT00847886|2568478|P2|COMPLETED|Overall Study||3
1058960|NCT00847886|2568479|P1|COMPLETED|Overall Study||12
1058961|NCT00847886|2568478|P2|STARTED|Overall Study||4
1058962|NCT00847886|2568479|P1|STARTED|Overall Study||12
1058969|NCT00848016|2568516|P1|NOT COMPLETED|Overall Study||0
1058970|NCT00848016|2568516|P1|COMPLETED|Overall Study||29
1058971|NCT00848016|2568516|P1|STARTED|Overall Study||29
1058972|NCT00848042|2568525|P3|NOT COMPLETED|Overall Study||0
1058973|NCT00848042|2568526|P2|NOT COMPLETED|Overall Study||2
1058974|NCT00848042|2568527|P1|NOT COMPLETED|Overall Study||4
1058975|NCT00848042|2568525|P3|COMPLETED|Overall Study||1
1058976|NCT00848042|2568526|P2|COMPLETED|Overall Study||3
1058977|NCT00848042|2568527|P1|COMPLETED|Overall Study||1
1058978|NCT00848042|2568525|P3|Month 6|Overall Study||1
1058979|NCT00848042|2568526|P2|Month 6|Overall Study||3
1058980|NCT00848042|2568527|P1|Month 6|Overall Study||1
1058981|NCT00848042|2568525|P3|Month 5|Overall Study||1
1058982|NCT00848042|2568526|P2|Month 5|Overall Study||3
1058983|NCT00848042|2568527|P1|Month 5|Overall Study||1
1058984|NCT00848042|2568525|P3|Month 4|Overall Study||1
1058985|NCT00848042|2568526|P2|Month 4|Overall Study||4
1058986|NCT00848042|2568527|P1|Month 4|Overall Study||1
1058987|NCT00848042|2568525|P3|Month 3|Overall Study||1
1058988|NCT00848042|2568526|P2|Month 3|Overall Study||4
1058989|NCT00848042|2568527|P1|Month 3|Overall Study||1
1058990|NCT00848042|2568525|P3|Month 2|Overall Study||1
1058991|NCT00848042|2568526|P2|Month 2|Overall Study||5
1058992|NCT00848042|2568527|P1|Month 2|Overall Study||1
1058993|NCT00848042|2568525|P3|Month 1|Overall Study||1
1058994|NCT00848042|2568526|P2|Month 1|Overall Study||5
1058995|NCT00848042|2568527|P1|Month 1|Overall Study||4
1058996|NCT00848042|2568525|P3|Day 15|Overall Study||1
1058997|NCT00848042|2568526|P2|Day 15|Overall Study||5
1058998|NCT00848042|2568527|P1|Day 15|Overall Study||4
1058999|NCT00848042|2568525|P3|Day 8|Overall Study||1
1059000|NCT00848042|2568526|P2|Day 8|Overall Study||5
1059001|NCT00848042|2568527|P1|Day 8|Overall Study||5
1059002|NCT00848042|2568525|P3|Day 3|Overall Study||1
1059003|NCT00848042|2568526|P2|Day 3|Overall Study||5
1059004|NCT00848042|2568527|P1|Day 3|Overall Study||5
1059005|NCT00848042|2568525|P3|Day 2|Overall Study||1
1059006|NCT00848042|2568526|P2|Day 2|Overall Study||5
1059007|NCT00848042|2568527|P1|Day 2|Overall Study||5
1059008|NCT00848042|2568525|P3|Day 1|Overall Study||1
1059009|NCT00848042|2568526|P2|Day 1|Overall Study||5
1059010|NCT00848042|2568527|P1|Day 1|Overall Study||5
1059011|NCT00848042|2568525|P3|STARTED|Overall Study||1
1059012|NCT00848042|2568526|P2|STARTED|Overall Study||5
1059013|NCT00848042|2568527|P1|STARTED|Overall Study||5
1059014|NCT00848081|2568540|P2|NOT COMPLETED|Overall Study||18
1059015|NCT00848081|2568541|P1|NOT COMPLETED|Overall Study||20
1059016|NCT00848081|2568540|P2|COMPLETED|Overall Study||140
1059017|NCT00848081|2568541|P1|COMPLETED|Overall Study||140
1059018|NCT00848081|2568540|P2|STARTED|Overall Study||158
1059019|NCT00848081|2568541|P1|STARTED|Overall Study||160
1059020|NCT00848107|2568555|P1|NOT COMPLETED|Overall Study||21
1059021|NCT00848107|2568555|P1|COMPLETED|Overall Study||94
1059022|NCT00848107|2568555|P1|STARTED|Overall Study||115
1059023|NCT00848120|2568563|P1|NOT COMPLETED|Overall Study||1
1059024|NCT00848120|2568563|P1|COMPLETED|Overall Study||28
1059025|NCT00848120|2568563|P1|STARTED|Overall Study||29
1059026|NCT00848172|2568577|P2|NOT COMPLETED|Visit 3 - Follow Up||0
1059027|NCT00848172|2568578|P1|NOT COMPLETED|Visit 3 - Follow Up||0
1059028|NCT00848172|2568577|P2|COMPLETED|Visit 3 - Follow Up||8
1059029|NCT00848172|2568578|P1|COMPLETED|Visit 3 - Follow Up||10
1059030|NCT00848172|2568577|P2|STARTED|Visit 3 - Follow Up||8
1059031|NCT00848172|2568578|P1|STARTED|Visit 3 - Follow Up||10
1059032|NCT00848172|2568577|P2|NOT COMPLETED|Visit 2 - Drug Administration||1
1059033|NCT00848172|2568578|P1|NOT COMPLETED|Visit 2 - Drug Administration||0
1059034|NCT00848172|2568577|P2|COMPLETED|Visit 2 - Drug Administration||8
1059035|NCT00848172|2568578|P1|COMPLETED|Visit 2 - Drug Administration||10
1059036|NCT00848172|2568577|P2|STARTED|Visit 2 - Drug Administration||9
1059037|NCT00848172|2568578|P1|STARTED|Visit 2 - Drug Administration||10
1059038|NCT00848185|2568592|P3|NOT COMPLETED|Overall Study||0
1059039|NCT00848185|2568593|P2|NOT COMPLETED|Overall Study||0
1059040|NCT00848185|2568594|P1|NOT COMPLETED|Overall Study||0
1059041|NCT00848185|2568592|P3|COMPLETED|Overall Study||32
1059042|NCT00848185|2568593|P2|COMPLETED|Overall Study||32
1059043|NCT00848185|2568594|P1|COMPLETED|Overall Study||32
1059044|NCT00848185|2568592|P3|STARTED|Overall Study||32
1059045|NCT00848185|2568593|P2|STARTED|Overall Study||32
1059046|NCT00848185|2568594|P1|STARTED|Overall Study||32
1059047|NCT00848198|2568602|P1|NOT COMPLETED|Overall Study||15
1059048|NCT00848198|2568602|P1|COMPLETED|Overall Study||299
1059049|NCT00848198|2568602|P1|STARTED|Overall Study||314
1059050|NCT00848211|2568644|P4|NOT COMPLETED|Overall Study||0
1059051|NCT00848211|2568645|P3|NOT COMPLETED|Overall Study||1
1059052|NCT00848211|2568646|P2|NOT COMPLETED|Overall Study||1
1059053|NCT00848211|2568647|P1|NOT COMPLETED|Overall Study||0
1059054|NCT00848211|2568644|P4|COMPLETED|Overall Study||5
1059055|NCT00848211|2568645|P3|COMPLETED|Overall Study||5
1059056|NCT00848211|2568646|P2|COMPLETED|Overall Study||6
1059057|NCT00848211|2568647|P1|COMPLETED|Overall Study||6
1059058|NCT00848211|2568644|P4|STARTED|Overall Study||5
1059059|NCT00848211|2568645|P3|STARTED|Overall Study||6
1059060|NCT00848211|2568646|P2|STARTED|Overall Study||7
1059061|NCT00848211|2568647|P1|STARTED|Overall Study||6
1059062|NCT00848237|2568665|P1|NOT COMPLETED|Overall Study||539
1059063|NCT00848237|2568665|P1|COMPLETED|Overall Study||4982
1059064|NCT00848237|2568665|P1|STARTED|Overall Study||5521
1059065|NCT00848250|2568676|P2|NOT COMPLETED|Overall Study||1
1059066|NCT00848250|2568677|P1|NOT COMPLETED|Overall Study||0
1059067|NCT00848250|2568676|P2|COMPLETED|Overall Study||9
1059068|NCT00848250|2568677|P1|COMPLETED|Overall Study||11
1059069|NCT00848250|2568676|P2|STARTED|Overall Study||10
1059070|NCT00848250|2568677|P1|STARTED|Overall Study||11
1059071|NCT00848354|2568697|P2|NOT COMPLETED|Phase 2 Year 2||7
1059072|NCT00848354|2568698|P1|NOT COMPLETED|Phase 2 Year 2||23
1059073|NCT00848354|2568697|P2|COMPLETED|Phase 2 Year 2||113
1059074|NCT00848354|2568698|P1|COMPLETED|Phase 2 Year 2||218
1059075|NCT00848354|2568697|P2|STARTED|Phase 2 Year 2|Randomized Phase 1 treatment assignment.|120
1059076|NCT00848354|2568698|P1|STARTED|Phase 2 Year 2|"Randomized Phase 1 treatment assignment.
1 participant discontinued between Year 1 and Year 2."|241
1059077|NCT00848354|2568697|P2|NOT COMPLETED|Phase 2 Year 1||6
1059078|NCT00848354|2568698|P1|NOT COMPLETED|Phase 2 Year 1||18
1059079|NCT00848354|2568697|P2|COMPLETED|Phase 2 Year 1||120
1059080|NCT00848354|2568698|P1|COMPLETED|Phase 2 Year 1||242
1059081|NCT00848354|2568697|P2|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 3 participants discontinued between Phase 1 and Phase 2.|126
1059082|NCT00848354|2568698|P1|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 9 participants discontinued between Phase 1 and Phase 2.|260
1059083|NCT00848354|2568697|P2|NOT COMPLETED|Phase 1||14
1059084|NCT00848354|2568698|P1|NOT COMPLETED|Phase 1||12
1059085|NCT00848354|2568697|P2|COMPLETED|Phase 1||129
1059086|NCT00848354|2568698|P1|COMPLETED|Phase 1||269
1059087|NCT00848354|2568697|P2|STARTED|Phase 1||143
1059088|NCT00848354|2568698|P1|STARTED|Phase 1|One participant was randomized to the Etanercept + Methotrexate group but received SSZ in error.|281
1059089|NCT00848367|2568850|P2|NOT COMPLETED|Overall Study||9
1059090|NCT00848367|2568851|P1|NOT COMPLETED|Overall Study||9
1059091|NCT00848367|2568850|P2|COMPLETED|Overall Study||41
1059092|NCT00848367|2568851|P1|COMPLETED|Overall Study||43
1059093|NCT00848367|2568850|P2|STARTED|Overall Study||50
1059094|NCT00848367|2568851|P1|STARTED|Overall Study||52
1059095|NCT00839527|2568862|P3|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||62
1059096|NCT00839527|2568863|P2|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||56
1059097|NCT00839527|2568864|P1|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||28
1059098|NCT00839527|2568862|P3|COMPLETED|Follow-up Period (FUP) (8 Weeks)||204
1059099|NCT00839527|2568863|P2|COMPLETED|Follow-up Period (FUP) (8 Weeks)||217
1059100|NCT00839527|2568864|P1|COMPLETED|Follow-up Period (FUP) (8 Weeks)||86
1059101|NCT00839527|2568862|P3|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Five par. did not participate in the FUP.|266
1059102|NCT00839527|2568863|P2|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Four par. did not participate in the FUP.|273
1059103|NCT00839527|2568864|P1|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|114
1059104|NCT00839527|2568862|P3|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||119
1059105|NCT00839527|2568863|P2|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||118
1059106|NCT00839527|2568864|P1|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||60
1059107|NCT00839527|2568862|P3|COMPLETED|Treatment Period (TP) (156 Weeks)||152
1059108|NCT00839527|2568863|P2|COMPLETED|Treatment Period (TP) (156 Weeks)||159
1059109|NCT00839527|2568864|P1|COMPLETED|Treatment Period (TP) (156 Weeks)||55
1059110|NCT00839527|2568862|P3|STARTED|Treatment Period (TP) (156 Weeks)||271
1059111|NCT00839527|2568863|P2|STARTED|Treatment Period (TP) (156 Weeks)||277
1059112|NCT00839527|2568864|P1|STARTED|Treatment Period (TP) (156 Weeks)||115
1059113|NCT00839540|2568899|P3|NOT COMPLETED|Overall Study||0
1059114|NCT00839540|2568900|P2|NOT COMPLETED|Overall Study||0
1059115|NCT00839540|2568901|P1|NOT COMPLETED|Overall Study||0
1059116|NCT00839540|2568899|P3|COMPLETED|Overall Study||5
1059117|NCT00839540|2568900|P2|COMPLETED|Overall Study||8
1059118|NCT00839540|2568901|P1|COMPLETED|Overall Study||8
1059119|NCT00839540|2568899|P3|STARTED|Overall Study||5
1059120|NCT00839540|2568900|P2|STARTED|Overall Study||8
1059121|NCT00839540|2568901|P1|STARTED|Overall Study||8
1059122|NCT00839800|2568911|P2|NOT COMPLETED|Overall Study||110
1059123|NCT00839800|2568912|P1|NOT COMPLETED|Overall Study||93
1059124|NCT00839800|2568911|P2|COMPLETED|Overall Study||932
1059125|NCT00839800|2568912|P1|COMPLETED|Overall Study||956
1059126|NCT00839800|2568911|P2|STARTED|Overall Study||1042
1059127|NCT00839800|2568912|P1|STARTED|Overall Study||1049
1059128|NCT00839917|2568944|P2|NOT COMPLETED|Overall Study||1
1059129|NCT00839917|2568945|P1|NOT COMPLETED|Overall Study||1
1059130|NCT00839917|2568944|P2|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|16
1059131|NCT00839917|2568945|P1|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|12
1059132|NCT00839917|2568944|P2|STARTED|Overall Study||17
1059133|NCT00839917|2568945|P1|STARTED|Overall Study||13
1059134|NCT00839930|2568983|P2|NOT COMPLETED|Second Intervention||0
1059135|NCT00839930|2568984|P1|NOT COMPLETED|Second Intervention||0
1059136|NCT00839930|2568983|P2|COMPLETED|Second Intervention||15
1059137|NCT00839930|2568984|P1|COMPLETED|Second Intervention||15
1059138|NCT00839930|2568983|P2|STARTED|Second Intervention||15
1059139|NCT00839930|2568984|P1|STARTED|Second Intervention||15
1059140|NCT00839930|2568983|P2|NOT COMPLETED|Washout: 7 Days||0
1059141|NCT00839930|2568984|P1|NOT COMPLETED|Washout: 7 Days||0
1059142|NCT00839930|2568983|P2|COMPLETED|Washout: 7 Days||15
1059143|NCT00839930|2568984|P1|COMPLETED|Washout: 7 Days||15
1059144|NCT00839930|2568983|P2|STARTED|Washout: 7 Days||15
1059145|NCT00839930|2568984|P1|STARTED|Washout: 7 Days||15
1059146|NCT00839930|2568983|P2|NOT COMPLETED|First Intervention||0
1059147|NCT00839930|2568984|P1|NOT COMPLETED|First Intervention||0
1059148|NCT00839930|2568983|P2|COMPLETED|First Intervention||15
1059149|NCT00839930|2568984|P1|COMPLETED|First Intervention||15
1059150|NCT00839930|2568983|P2|STARTED|First Intervention||15
1059151|NCT00839930|2568984|P1|STARTED|First Intervention||15
1059152|NCT00839956|2568992|P1|NOT COMPLETED|Overall Study||12
1059153|NCT00839956|2568992|P1|COMPLETED|Overall Study||19
1059154|NCT00839956|2568992|P1|STARTED|Overall Study||31
1059155|NCT00839982|2568999|P4|NOT COMPLETED|Overall Study||0
1059156|NCT00839982|2569000|P3|NOT COMPLETED|Overall Study||0
1059157|NCT00839982|2569001|P2|NOT COMPLETED|Overall Study||0
1059158|NCT00839982|2569002|P1|NOT COMPLETED|Overall Study||0
1059159|NCT00839982|2568999|P4|COMPLETED|Overall Study||3
1059160|NCT00839982|2569000|P3|COMPLETED|Overall Study||2
1059161|NCT00839982|2569001|P2|COMPLETED|Overall Study||26
1059162|NCT00839982|2569002|P1|COMPLETED|Overall Study||4
1059163|NCT00839982|2568999|P4|STARTED|Overall Study||3
1059164|NCT00839982|2569000|P3|STARTED|Overall Study||2
1059165|NCT00839982|2569001|P2|STARTED|Overall Study||26
1059166|NCT00839982|2569002|P1|STARTED|Overall Study||4
1059167|NCT00840060|2569018|P2|NOT COMPLETED|Overall Study||1
1059168|NCT00840060|2569019|P1|NOT COMPLETED|Overall Study||1
1059169|NCT00840060|2569018|P2|COMPLETED|Overall Study||19
1059170|NCT00840060|2569019|P1|COMPLETED|Overall Study||19
1059171|NCT00840060|2569018|P2|STARTED|Overall Study||20
1059172|NCT00840060|2569019|P1|STARTED|Overall Study||20
1059173|NCT00840073|2569029|P2|NOT COMPLETED|Second Intervention||1
1059174|NCT00840073|2569030|P1|NOT COMPLETED|Second Intervention||1
1059175|NCT00840073|2569029|P2|COMPLETED|Second Intervention||24
1059176|NCT00840073|2569030|P1|COMPLETED|Second Intervention||24
1059177|NCT00840073|2569029|P2|STARTED|Second Intervention||25
1059178|NCT00840073|2569030|P1|STARTED|Second Intervention||25
1059179|NCT00840073|2569029|P2|NOT COMPLETED|First Intervention||0
1059180|NCT00840073|2569030|P1|NOT COMPLETED|First Intervention||0
1059181|NCT00840073|2569029|P2|COMPLETED|First Intervention||25
1059182|NCT00840073|2569030|P1|COMPLETED|First Intervention||25
1059183|NCT00840073|2569029|P2|STARTED|First Intervention||25
1059184|NCT00840073|2569030|P1|STARTED|First Intervention||25
1059185|NCT00840086|2569042|P1|NOT COMPLETED|Overall Study||4
1059186|NCT00840086|2569042|P1|COMPLETED|Overall Study||146
1059187|NCT00840086|2569042|P1|STARTED|Overall Study||150
1059188|NCT00840099|2569051|P2|NOT COMPLETED|Period 2||0
1059189|NCT00840099|2569052|P1|NOT COMPLETED|Period 2||0
1059190|NCT00840099|2569051|P2|COMPLETED|Period 2||24
1059191|NCT00840099|2569052|P1|COMPLETED|Period 2||21
1059192|NCT00840099|2569051|P2|STARTED|Period 2||24
1059193|NCT00840099|2569052|P1|STARTED|Period 2|3 subjects were dismissed from study prior to period 2 dosing|21
1059194|NCT00840099|2569051|P2|NOT COMPLETED|Period 1||0
1059195|NCT00840099|2569052|P1|NOT COMPLETED|Period 1||0
1059196|NCT00840099|2569051|P2|COMPLETED|Period 1||24
1059197|NCT00840099|2569052|P1|COMPLETED|Period 1||24
1059198|NCT00840099|2569051|P2|STARTED|Period 1||24
1059199|NCT00840099|2569052|P1|STARTED|Period 1||24
1059200|NCT00840203|2569068|P2|NOT COMPLETED|Second Intervention||0
1059201|NCT00840203|2569069|P1|NOT COMPLETED|Second Intervention||0
1059202|NCT00840203|2569068|P2|COMPLETED|Second Intervention||34
1059203|NCT00840203|2569069|P1|COMPLETED|Second Intervention||35
1059204|NCT00840203|2569068|P2|STARTED|Second Intervention||34
1059205|NCT00840203|2569069|P1|STARTED|Second Intervention||35
1059206|NCT00840203|2569068|P2|NOT COMPLETED|Washout||0
1059207|NCT00840203|2569069|P1|NOT COMPLETED|Washout||1
1059208|NCT00840203|2569068|P2|COMPLETED|Washout||34
1059209|NCT00840203|2569069|P1|COMPLETED|Washout||35
1059210|NCT00840203|2569068|P2|STARTED|Washout||34
1059211|NCT00840203|2569069|P1|STARTED|Washout||36
1059212|NCT00840203|2569068|P2|NOT COMPLETED|First Intervention||1
1059213|NCT00840203|2569069|P1|NOT COMPLETED|First Intervention||1
1059214|NCT00840203|2569068|P2|COMPLETED|First Intervention||34
1059215|NCT00840203|2569069|P1|COMPLETED|First Intervention||36
1059216|NCT00840203|2569068|P2|STARTED|First Intervention||35
1059217|NCT00840203|2569069|P1|STARTED|First Intervention||37
1059218|NCT00840216|2569085|P2|NOT COMPLETED|Second Intervention||0
1059219|NCT00840216|2569086|P1|NOT COMPLETED|Second Intervention||0
1059220|NCT00840216|2569085|P2|COMPLETED|Second Intervention||11
1059221|NCT00840216|2569086|P1|COMPLETED|Second Intervention||10
1059222|NCT00840216|2569085|P2|STARTED|Second Intervention||11
1059223|NCT00840216|2569086|P1|STARTED|Second Intervention||10
1059224|NCT00840216|2569085|P2|NOT COMPLETED|Washout: 7 Days||0
1059225|NCT00840216|2569086|P1|NOT COMPLETED|Washout: 7 Days||1
1059226|NCT00840216|2569085|P2|COMPLETED|Washout: 7 Days||11
1059227|NCT00840216|2569086|P1|COMPLETED|Washout: 7 Days||10
1059228|NCT00840216|2569085|P2|STARTED|Washout: 7 Days||11
1059229|NCT00840216|2569086|P1|STARTED|Washout: 7 Days||11
1059230|NCT00840216|2569085|P2|NOT COMPLETED|First Intervention||0
1059231|NCT00840216|2569086|P1|NOT COMPLETED|First Intervention||0
1059232|NCT00840216|2569085|P2|COMPLETED|First Intervention||11
1059233|NCT00840216|2569086|P1|COMPLETED|First Intervention||11
1059234|NCT00840216|2569085|P2|STARTED|First Intervention||11
1059235|NCT00840216|2569086|P1|STARTED|First Intervention||11
1059236|NCT00840281|2569096|P2|NOT COMPLETED|Second Intervention||0
1059237|NCT00840281|2569097|P1|NOT COMPLETED|Second Intervention||0
1059238|NCT00840281|2569096|P2|COMPLETED|Second Intervention||19
1059239|NCT00840281|2569097|P1|COMPLETED|Second Intervention||19
1059240|NCT00840281|2569096|P2|STARTED|Second Intervention||19
1059241|NCT00840281|2569097|P1|STARTED|Second Intervention||19
1059242|NCT00840281|2569096|P2|NOT COMPLETED|Washout of 7 Days||0
1059243|NCT00840281|2569097|P1|NOT COMPLETED|Washout of 7 Days||0
1059244|NCT00840281|2569096|P2|COMPLETED|Washout of 7 Days||19
1059245|NCT00840281|2569097|P1|COMPLETED|Washout of 7 Days||19
1059246|NCT00840281|2569096|P2|STARTED|Washout of 7 Days||19
1059247|NCT00840281|2569097|P1|STARTED|Washout of 7 Days||19
1059248|NCT00840281|2569096|P2|NOT COMPLETED|First Intervention||0
1059249|NCT00840281|2569097|P1|NOT COMPLETED|First Intervention||0
1059250|NCT00840281|2569096|P2|COMPLETED|First Intervention||19
1059251|NCT00840281|2569097|P1|COMPLETED|First Intervention||19
1059252|NCT00840281|2569096|P2|STARTED|First Intervention||19
1059253|NCT00840281|2569097|P1|STARTED|First Intervention||19
1059254|NCT00840294|2569107|P2|NOT COMPLETED|Overall Study||5
1059255|NCT00840294|2569108|P1|NOT COMPLETED|Overall Study||3
1059256|NCT00840294|2569107|P2|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|38
1059257|NCT00840294|2569108|P1|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|39
1059258|NCT00840294|2569107|P2|STARTED|Overall Study||43
1059259|NCT00840294|2569108|P1|STARTED|Overall Study||42
1059260|NCT00840411|2569118|P2|NOT COMPLETED|Second Intervention||0
1059261|NCT00840411|2569119|P1|NOT COMPLETED|Second Intervention||0
1059262|NCT00840411|2569118|P2|COMPLETED|Second Intervention||33
1059263|NCT00840411|2569119|P1|COMPLETED|Second Intervention||31
1059264|NCT00840411|2569118|P2|STARTED|Second Intervention||33
1059265|NCT00840411|2569119|P1|STARTED|Second Intervention||31
1059266|NCT00840411|2569118|P2|NOT COMPLETED|Washout||0
1059267|NCT00840411|2569119|P1|NOT COMPLETED|Washout||1
1059268|NCT00840411|2569118|P2|COMPLETED|Washout||33
1059269|NCT00840411|2569119|P1|COMPLETED|Washout||31
1059270|NCT00840411|2569118|P2|STARTED|Washout||33
1059271|NCT00840411|2569119|P1|STARTED|Washout||32
1059272|NCT00840411|2569118|P2|NOT COMPLETED|First Intervention||0
1059273|NCT00840411|2569119|P1|NOT COMPLETED|First Intervention||1
1059274|NCT00840411|2569118|P2|COMPLETED|First Intervention||33
1059275|NCT00840411|2569119|P1|COMPLETED|First Intervention||32
1059276|NCT00840411|2569118|P2|STARTED|First Intervention||33
1059277|NCT00840411|2569119|P1|STARTED|First Intervention||33
1059278|NCT00840450|2569127|P1|NOT COMPLETED|Overall Study||3
1059279|NCT00840450|2569127|P1|COMPLETED|Overall Study||9
1059280|NCT00840450|2569127|P1|STARTED|Overall Study||12
1059281|NCT00840476|2569135|P2|NOT COMPLETED|Second Intervention||0
1059282|NCT00840476|2569136|P1|NOT COMPLETED|Second Intervention||0
1059283|NCT00840476|2569135|P2|COMPLETED|Second Intervention||14
1059284|NCT00840476|2569136|P1|COMPLETED|Second Intervention||14
1059285|NCT00840476|2569135|P2|STARTED|Second Intervention||14
1059286|NCT00840476|2569136|P1|STARTED|Second Intervention||14
1059287|NCT00840476|2569135|P2|NOT COMPLETED|Washout: 14 Days||0
1059288|NCT00840476|2569136|P1|NOT COMPLETED|Washout: 14 Days||0
1059289|NCT00840476|2569135|P2|COMPLETED|Washout: 14 Days||14
1059290|NCT00840476|2569136|P1|COMPLETED|Washout: 14 Days||14
1059291|NCT00840476|2569135|P2|STARTED|Washout: 14 Days||14
1059292|NCT00840476|2569136|P1|STARTED|Washout: 14 Days||14
1059293|NCT00840476|2569135|P2|NOT COMPLETED|First Intervention||0
1059294|NCT00840476|2569136|P1|NOT COMPLETED|First Intervention||0
1059295|NCT00840476|2569135|P2|COMPLETED|First Intervention||14
1059296|NCT00840476|2569136|P1|COMPLETED|First Intervention||14
1059297|NCT00840476|2569135|P2|STARTED|First Intervention||14
1059298|NCT00840476|2569136|P1|STARTED|First Intervention||14
1059299|NCT00840632|2569146|P2|NOT COMPLETED|Second Intervention||0
1059300|NCT00840632|2569147|P1|NOT COMPLETED|Second Intervention||0
1059301|NCT00840632|2569146|P2|COMPLETED|Second Intervention||18
1059302|NCT00840632|2569147|P1|COMPLETED|Second Intervention||19
1059303|NCT00840632|2569146|P2|STARTED|Second Intervention||18
1059304|NCT00840632|2569147|P1|STARTED|Second Intervention||19
1059305|NCT00840632|2569146|P2|NOT COMPLETED|Washout||1
1059306|NCT00840632|2569147|P1|NOT COMPLETED|Washout||1
1059307|NCT00840632|2569146|P2|COMPLETED|Washout||18
1059308|NCT00840632|2569147|P1|COMPLETED|Washout||19
1059309|NCT00840632|2569146|P2|STARTED|Washout||19
1059310|NCT00840632|2569147|P1|STARTED|Washout||20
1059311|NCT00840632|2569146|P2|NOT COMPLETED|First Intervention||1
1059312|NCT00840632|2569147|P1|NOT COMPLETED|First Intervention||0
1059313|NCT00840632|2569146|P2|COMPLETED|First Intervention||19
1059314|NCT00840632|2569147|P1|COMPLETED|First Intervention||20
1059315|NCT00840632|2569146|P2|STARTED|First Intervention||20
1059316|NCT00840632|2569147|P1|STARTED|First Intervention||20
1059317|NCT00840658|2569165|P4|NOT COMPLETED|Overall Study||4
1059318|NCT00840658|2569166|P3|NOT COMPLETED|Overall Study||5
1059319|NCT00840658|2569167|P2|NOT COMPLETED|Overall Study||3
1059320|NCT00840658|2569168|P1|NOT COMPLETED|Overall Study||5
1059321|NCT00840658|2569165|P4|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|142
1059322|NCT00840658|2569166|P3|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
1059323|NCT00840658|2569167|P2|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
1059324|NCT00840658|2569168|P1|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|139
1059325|NCT00840658|2569165|P4|STARTED|Overall Study||146
1059326|NCT00840658|2569166|P3|STARTED|Overall Study||148
1059327|NCT00840658|2569167|P2|STARTED|Overall Study||146
1059328|NCT00840658|2569168|P1|STARTED|Overall Study||144
1059329|NCT00840840|2569180|P2|NOT COMPLETED|Period 2||0
1059330|NCT00840840|2569181|P1|NOT COMPLETED|Period 2||0
1059331|NCT00840840|2569180|P2|COMPLETED|Period 2||24
1059332|NCT00840840|2569181|P1|COMPLETED|Period 2||23
1059333|NCT00840840|2569180|P2|STARTED|Period 2||24
1059334|NCT00840840|2569181|P1|STARTED|Period 2|One subject was withdrawn due to AE after Period 1|23
1059335|NCT00840840|2569180|P2|NOT COMPLETED|Period 1||0
1059336|NCT00840840|2569181|P1|NOT COMPLETED|Period 1||0
1059337|NCT00840840|2569180|P2|COMPLETED|Period 1||24
1059338|NCT00840840|2569181|P1|COMPLETED|Period 1||24
1059339|NCT00840840|2569180|P2|STARTED|Period 1||24
1059340|NCT00840840|2569181|P1|STARTED|Period 1||24
1059341|NCT00840866|2569197|P2|NOT COMPLETED|Second Intervention||0
1059342|NCT00840866|2569198|P1|NOT COMPLETED|Second Intervention||0
1059343|NCT00840866|2569197|P2|COMPLETED|Second Intervention||19
1059344|NCT00840866|2569198|P1|COMPLETED|Second Intervention||20
1059345|NCT00840866|2569197|P2|STARTED|Second Intervention||19
1059346|NCT00840866|2569198|P1|STARTED|Second Intervention||20
1059347|NCT00840866|2569197|P2|NOT COMPLETED|Washout of 7 Days||0
1059348|NCT00840866|2569198|P1|NOT COMPLETED|Washout of 7 Days||0
1059349|NCT00840866|2569197|P2|COMPLETED|Washout of 7 Days||19
1059350|NCT00840866|2569198|P1|COMPLETED|Washout of 7 Days||20
1059351|NCT00840866|2569197|P2|STARTED|Washout of 7 Days||19
1059352|NCT00840866|2569198|P1|STARTED|Washout of 7 Days||20
1059353|NCT00840866|2569197|P2|NOT COMPLETED|First Intervention||0
1059354|NCT00840866|2569198|P1|NOT COMPLETED|First Intervention||0
1059355|NCT00840866|2569197|P2|COMPLETED|First Intervention||19
1059356|NCT00840866|2569198|P1|COMPLETED|First Intervention||20
1059357|NCT00840866|2569197|P2|STARTED|First Intervention||19
1059358|NCT00840866|2569198|P1|STARTED|First Intervention||20
1059359|NCT00840879|2569208|P2|NOT COMPLETED|Second Intervention||0
1059360|NCT00840879|2569209|P1|NOT COMPLETED|Second Intervention||1
1059361|NCT00840879|2569208|P2|COMPLETED|Second Intervention||14
1059362|NCT00840879|2569209|P1|COMPLETED|Second Intervention||13
1059363|NCT00840879|2569208|P2|STARTED|Second Intervention||14
1059364|NCT00840879|2569209|P1|STARTED|Second Intervention||14
1059365|NCT00840879|2569208|P2|NOT COMPLETED|Washout: 14 Days||0
1059366|NCT00840879|2569209|P1|NOT COMPLETED|Washout: 14 Days||0
1059367|NCT00840879|2569208|P2|COMPLETED|Washout: 14 Days||14
1059368|NCT00840879|2569209|P1|COMPLETED|Washout: 14 Days||14
1059369|NCT00840879|2569208|P2|STARTED|Washout: 14 Days||14
1059370|NCT00840879|2569209|P1|STARTED|Washout: 14 Days||14
1059371|NCT00840879|2569208|P2|NOT COMPLETED|First Intervention||0
1059372|NCT00840879|2569209|P1|NOT COMPLETED|First Intervention||0
1059373|NCT00840879|2569208|P2|COMPLETED|First Intervention||14
1059374|NCT00840879|2569209|P1|COMPLETED|First Intervention||14
1059375|NCT00840879|2569208|P2|STARTED|First Intervention||14
1059376|NCT00840879|2569209|P1|STARTED|First Intervention||14
1059377|NCT00840996|2569219|P2|NOT COMPLETED|Overall Study||0
1059378|NCT00840996|2569220|P1|NOT COMPLETED|Overall Study||1
1059379|NCT00840996|2569219|P2|COMPLETED|Overall Study||58
1059380|NCT00840996|2569220|P1|COMPLETED|Overall Study||57
1059381|NCT00840996|2569219|P2|STARTED|Overall Study||58
1059382|NCT00840996|2569220|P1|STARTED|Overall Study||58
1059383|NCT00841035|2569238|P1|NOT COMPLETED|Phase 2 of Overall Study||0
1059384|NCT00841035|2569238|P1|COMPLETED|Phase 2 of Overall Study||6
1059385|NCT00841035|2569238|P1|STARTED|Phase 2 of Overall Study||6
1059386|NCT00841035|2569238|P1|NOT COMPLETED|Phase 1 Overall Study||13
1059387|NCT00841035|2569238|P1|COMPLETED|Phase 1 Overall Study||6
1059388|NCT00841035|2569238|P1|STARTED|Phase 1 Overall Study|2 phase enrollment,1st phase enrolled with cancer by fine needle aspiration in endoscopic ultrasound|19
1059389|NCT00841087|2569245|P2|NOT COMPLETED|Overall Study||0
1059390|NCT00841087|2569246|P1|NOT COMPLETED|Overall Study||0
1059391|NCT00841087|2569245|P2|COMPLETED|Overall Study||32
1059392|NCT00841087|2569246|P1|COMPLETED|Overall Study||33
1059393|NCT00841087|2569245|P2|STARTED|Overall Study||32
1059394|NCT00841087|2569246|P1|STARTED|Overall Study||33
1059395|NCT00841204|2569266|P2|NOT COMPLETED|Overall Study||0
1059396|NCT00841204|2569267|P1|NOT COMPLETED|Overall Study||0
1059397|NCT00841204|2569266|P2|COMPLETED|Overall Study||25
1059398|NCT00841204|2569267|P1|COMPLETED|Overall Study||25
1059399|NCT00841204|2569266|P2|STARTED|Overall Study||25
1059400|NCT00841204|2569267|P1|STARTED|Overall Study||25
1059401|NCT00848484|2569279|P2|NOT COMPLETED|Second Intervention (Treatment Period 2)||1
1059402|NCT00848484|2569280|P1|NOT COMPLETED|Second Intervention (Treatment Period 2)||0
1059403|NCT00848484|2569279|P2|COMPLETED|Second Intervention (Treatment Period 2)||20
1059404|NCT00848484|2569280|P1|COMPLETED|Second Intervention (Treatment Period 2)||25
1059405|NCT00848484|2569279|P2|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
1059406|NCT00848484|2569280|P1|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
1059407|NCT00848484|2569279|P2|STARTED|Second Intervention (Treatment Period 2)||21
1059408|NCT00848484|2569280|P1|STARTED|Second Intervention (Treatment Period 2)||25
1059409|NCT00848484|2569279|P2|NOT COMPLETED|Washout Period of Two Weeks||3
1059410|NCT00848484|2569280|P1|NOT COMPLETED|Washout Period of Two Weeks||0
1059411|NCT00848484|2569279|P2|COMPLETED|Washout Period of Two Weeks||21
1059412|NCT00848484|2569280|P1|COMPLETED|Washout Period of Two Weeks||25
1059413|NCT00848484|2569279|P2|STARTED|Washout Period of Two Weeks||24
1059414|NCT00848484|2569280|P1|STARTED|Washout Period of Two Weeks||25
1059415|NCT00848484|2569279|P2|NOT COMPLETED|First Intervention (Treatment Period 1)||3
1059416|NCT00848484|2569280|P1|NOT COMPLETED|First Intervention (Treatment Period 1)||2
1059417|NCT00848484|2569279|P2|COMPLETED|First Intervention (Treatment Period 1)||24
1059418|NCT00848484|2569280|P1|COMPLETED|First Intervention (Treatment Period 1)||25
1059419|NCT00848484|2569279|P2|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||1
1059420|NCT00848484|2569280|P1|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||2
1059421|NCT00848484|2569279|P2|STARTED|First Intervention (Treatment Period 1)||27
1059422|NCT00848484|2569280|P1|STARTED|First Intervention (Treatment Period 1)||27
1059423|NCT00848497|2569298|P2|NOT COMPLETED|Overall Study||1
1059424|NCT00848497|2569299|P1|NOT COMPLETED|Overall Study||2
1059425|NCT00848497|2569298|P2|COMPLETED|Overall Study||0
1059426|NCT00848497|2569299|P1|COMPLETED|Overall Study||0
1059427|NCT00848497|2569298|P2|STARTED|Overall Study|Completed Visit 4|1
1059428|NCT00848497|2569299|P1|STARTED|Overall Study||2
1059429|NCT00848510|2569315|P4|NOT COMPLETED|Overall Study||0
1059430|NCT00848510|2569316|P3|NOT COMPLETED|Overall Study||0
1059431|NCT00848510|2569317|P2|NOT COMPLETED|Overall Study||0
1059432|NCT00848510|2569318|P1|NOT COMPLETED|Overall Study||0
1059433|NCT00848510|2569315|P4|COMPLETED|Overall Study||10
1059434|NCT00848510|2569316|P3|COMPLETED|Overall Study||8
1059435|NCT00848510|2569317|P2|COMPLETED|Overall Study||13
1059436|NCT00848510|2569318|P1|COMPLETED|Overall Study||10
1059437|NCT00848510|2569315|P4|STARTED|Overall Study||10
1059438|NCT00848510|2569316|P3|STARTED|Overall Study||8
1059439|NCT00848510|2569317|P2|STARTED|Overall Study||13
1059440|NCT00848510|2569318|P1|STARTED|Overall Study||10
1059441|NCT00848536|2569366|P2|NOT COMPLETED|Overall Study||7
1059442|NCT00848536|2569367|P1|NOT COMPLETED|Overall Study||4
1059443|NCT00848536|2569366|P2|COMPLETED|Overall Study||179
1059444|NCT00848536|2569367|P1|COMPLETED|Overall Study||181
1059445|NCT00848536|2569366|P2|STARTED|Overall Study||186
1059446|NCT00848536|2569367|P1|STARTED|Overall Study||185
1059447|NCT00848549|2569379|P2|NOT COMPLETED|E2090-E044-314 (Extension Study)||24
1059448|NCT00848549|2569380|P1|NOT COMPLETED|E2090-E044-314 (Extension Study)||17
1059449|NCT00848549|2569379|P2|COMPLETED|E2090-E044-314 (Extension Study)||134
1059450|NCT00848549|2569380|P1|COMPLETED|E2090-E044-314 (Extension Study)||120
1059451|NCT00848549|2569379|P2|STARTED|E2090-E044-314 (Extension Study)||158
1059452|NCT00848549|2569380|P1|STARTED|E2090-E044-314 (Extension Study)||137
1059453|NCT00848549|2569379|P2|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||34
1059454|NCT00848549|2569380|P1|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||24
1059455|NCT00848549|2569379|P2|COMPLETED|E2090-E044-310 (Base Study) Transition||158
1059456|NCT00848549|2569380|P1|COMPLETED|E2090-E044-310 (Base Study) Transition||137
1059457|NCT00848549|2569379|P2|STARTED|E2090-E044-310 (Base Study) Transition||192
1059458|NCT00848549|2569380|P1|STARTED|E2090-E044-310 (Base Study) Transition||161
1059459|NCT00848549|2569379|P2|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||109
1059460|NCT00848549|2569380|P1|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||121
1059461|NCT00848549|2569379|P2|COMPLETED|E2090-E044-310 (Base Study) Disposition||192
1059462|NCT00848549|2569380|P1|COMPLETED|E2090-E044-310 (Base Study) Disposition||161
1059463|NCT00848549|2569379|P2|STARTED|E2090-E044-310 (Base Study) Disposition||301
1059464|NCT00848549|2569380|P1|STARTED|E2090-E044-310 (Base Study) Disposition||282
1059465|NCT00848926|2569396|P1|NOT COMPLETED|Follow-up Period||12
1059466|NCT00848926|2569396|P1|COMPLETED|Follow-up Period|Completed survival follow-up due to death [57] or study termination by sponsor [33]|90
1059467|NCT00848926|2569396|P1|STARTED|Follow-up Period|All participants were to be followed after treatment|102
1059468|NCT00848926|2569396|P1|NOT COMPLETED|Treatment Period||84
1059469|NCT00848926|2569396|P1|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|18
1059470|NCT00848926|2569396|P1|STARTED|Treatment Period||102
1059471|NCT00848965|2569412|P1|NOT COMPLETED|Overall Study||2
1059472|NCT00848965|2569412|P1|COMPLETED|Overall Study||57
1059473|NCT00848965|2569412|P1|STARTED|Overall Study||59
1059474|NCT00849017|2569457|P3|NOT COMPLETED|Follow-up Period (8 Weeks)||25
1059475|NCT00849017|2569458|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||18
1059476|NCT00849017|2569459|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||25
1059477|NCT00849017|2569457|P3|COMPLETED|Follow-up Period (8 Weeks)||74
1059478|NCT00849017|2569458|P2|COMPLETED|Follow-up Period (8 Weeks)||83
1059479|NCT00849017|2569459|P1|COMPLETED|Follow-up Period (8 Weeks)||76
1059480|NCT00849017|2569457|P3|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|99
1059481|NCT00849017|2569458|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
1059482|NCT00849017|2569459|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
1059483|NCT00849017|2569457|P3|NOT COMPLETED|Treatment Period (156 Weeks)||42
1059484|NCT00849017|2569458|P2|NOT COMPLETED|Treatment Period (156 Weeks)||33
1059485|NCT00849017|2569459|P1|NOT COMPLETED|Treatment Period (156 Weeks)||43
1059486|NCT00849017|2569457|P3|COMPLETED|Treatment Period (156 Weeks)||57
1059487|NCT00849017|2569458|P2|COMPLETED|Treatment Period (156 Weeks)||68
1059488|NCT00849017|2569459|P1|COMPLETED|Treatment Period (156 Weeks)||58
1059489|NCT00849017|2569457|P3|STARTED|Treatment Period (156 Weeks)||99
1059490|NCT00849017|2569458|P2|STARTED|Treatment Period (156 Weeks)||101
1059491|NCT00849017|2569459|P1|STARTED|Treatment Period (156 Weeks)||101
1059492|NCT00849056|2569504|P2|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||25
1059493|NCT00849056|2569505|P1|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||27
1059494|NCT00849056|2569504|P2|COMPLETED|Follow-up Period (FUP) (8 Weeks)||124
1059495|NCT00849056|2569505|P1|COMPLETED|Follow-up Period (FUP) (8 Weeks)||122
1059496|NCT00849056|2569504|P2|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|149
1059497|NCT00849056|2569505|P1|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Two par. did not participate in the FUP.|149
1059498|NCT00849056|2569504|P2|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||50
1059499|NCT00849056|2569505|P1|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||63
1059500|NCT00849056|2569504|P2|COMPLETED|Treatment Period (TP) (156 Weeks)||100
1059501|NCT00849056|2569505|P1|COMPLETED|Treatment Period (TP) (156 Weeks)||88
1059502|NCT00849056|2569504|P2|STARTED|Treatment Period (TP) (156 Weeks)||150
1059503|NCT00849056|2569505|P1|STARTED|Treatment Period (TP) (156 Weeks)||151
1059504|NCT00849108|2569530|P2|NOT COMPLETED|Cohort 2 Efficacy||10
1059505|NCT00849108|2569531|P1|NOT COMPLETED|Cohort 2 Efficacy||0
1059506|NCT00849108|2569530|P2|COMPLETED|Cohort 2 Efficacy||133
1059507|NCT00849108|2569531|P1|COMPLETED|Cohort 2 Efficacy||0
1059508|NCT00849108|2569530|P2|STARTED|Cohort 2 Efficacy||143
1059509|NCT00849108|2569531|P1|STARTED|Cohort 2 Efficacy|Cohort 1 subjects did not participate in period 2: efficacy|0
1059510|NCT00849108|2569530|P2|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
1059511|NCT00849108|2569531|P1|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||1
1059512|NCT00849108|2569530|P2|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
1059513|NCT00849108|2569531|P1|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||32
1059514|NCT00849108|2569530|P2|STARTED|Cohort 1 Dose Ranging and Dose Interval|Cohort 2(Pharm Stress) subjects did not participate in dose range, dose frequency|0
1059515|NCT00849108|2569531|P1|STARTED|Cohort 1 Dose Ranging and Dose Interval||33
1059516|NCT00849121|2569541|P2|NOT COMPLETED|Overall Study||0
1059517|NCT00849121|2569542|P1|NOT COMPLETED|Overall Study||0
1059518|NCT00849121|2569541|P2|COMPLETED|Overall Study||9
1059519|NCT00849121|2569542|P1|COMPLETED|Overall Study||8
1059520|NCT00849121|2569541|P2|STARTED|Overall Study||9
1059521|NCT00849121|2569542|P1|STARTED|Overall Study||8
1059522|NCT00849147|2569554|P1|NOT COMPLETED|Overall Study||5
1059523|NCT00849147|2569554|P1|COMPLETED|Overall Study||50
1059524|NCT00849147|2569554|P1|STARTED|Overall Study||55
1059525|NCT00849186|2569569|P1|NOT COMPLETED|Overall Study||10
1059526|NCT00849186|2569569|P1|COMPLETED|Overall Study||16
1059527|NCT00849186|2569569|P1|STARTED|Overall Study||26
1059528|NCT00849212|2569575|P1|NOT COMPLETED|Overall Study||7
1059529|NCT00849212|2569575|P1|COMPLETED|Overall Study||23
1059530|NCT00849212|2569575|P1|STARTED|Overall Study||30
1059531|NCT00849251|2569580|P2|NOT COMPLETED|Overall Study||1
1059532|NCT00849251|2569581|P1|NOT COMPLETED|Overall Study||1
1059533|NCT00849251|2569580|P2|COMPLETED|Overall Study||24
1059534|NCT00849251|2569581|P1|COMPLETED|Overall Study||5
1059535|NCT00849251|2569580|P2|STARTED|Overall Study||25
1059536|NCT00849251|2569581|P1|STARTED|Overall Study||6
1059537|NCT00849290|2569587|P1|NOT COMPLETED|Overall Study||55
1059538|NCT00849290|2569587|P1|COMPLETED|Overall Study||58
1059539|NCT00849290|2569587|P1|STARTED|Overall Study||113
1059540|NCT00849381|2569591|P1|NOT COMPLETED|Overall Study||145
1059541|NCT00849381|2569591|P1|COMPLETED|Overall Study|Out of the subjects who completed, 167 were enrolled at the center having compliance issues.|1092
1059542|NCT00849381|2569591|P1|STARTED|Overall Study|Out of the subjects who started, 243 were enrolled at the center having compliance issues.|1237
1059543|NCT00849472|2569597|P1|NOT COMPLETED|Pazopanib Postsurgery Treatment||26
1059544|NCT00849472|2569597|P1|COMPLETED|Pazopanib Postsurgery Treatment||16
1059545|NCT00849472|2569597|P1|STARTED|Pazopanib Postsurgery Treatment|36 participants completed PPT; 7 participants who discontinued PPT resumed treatment postsurgery.|42
1059546|NCT00849472|2569597|P1|NOT COMPLETED|Pazopanib Presurgery Treatment (PPT)||58
1059547|NCT00849472|2569597|P1|COMPLETED|Pazopanib Presurgery Treatment (PPT)||36
1059548|NCT00849472|2569597|P1|STARTED|Pazopanib Presurgery Treatment (PPT)||94
1059549|NCT00849472|2569597|P1|NOT COMPLETED|Weekly Paclitaxel||16
1059550|NCT00849472|2569597|P1|COMPLETED|Weekly Paclitaxel||78
1059551|NCT00849472|2569597|P1|STARTED|Weekly Paclitaxel|One par. was deemed ineligible after completing AC therapy and did not start paclitaxel+pazopanib.|94
1059552|NCT00849472|2569597|P1|NOT COMPLETED|Doxorubicin and Cyclophosphamide (AC)||6
1059553|NCT00849472|2569597|P1|COMPLETED|Doxorubicin and Cyclophosphamide (AC)||95
1059554|NCT00849472|2569597|P1|STARTED|Doxorubicin and Cyclophosphamide (AC)||101
1059555|NCT00849485|2569613|P2|NOT COMPLETED|Second Intervention||0
1059556|NCT00849485|2569614|P1|NOT COMPLETED|Second Intervention||0
1059557|NCT00849485|2569613|P2|COMPLETED|Second Intervention||11
1059558|NCT00849485|2569614|P1|COMPLETED|Second Intervention||11
1059559|NCT00849485|2569613|P2|STARTED|Second Intervention||11
1059560|NCT00849485|2569614|P1|STARTED|Second Intervention||11
1059561|NCT00849485|2569613|P2|NOT COMPLETED|Washout: 7 Days||0
1059562|NCT00849485|2569614|P1|NOT COMPLETED|Washout: 7 Days||0
1059563|NCT00849485|2569613|P2|COMPLETED|Washout: 7 Days||11
1059564|NCT00849485|2569614|P1|COMPLETED|Washout: 7 Days||11
1059565|NCT00849485|2569613|P2|STARTED|Washout: 7 Days||11
1059566|NCT00849485|2569614|P1|STARTED|Washout: 7 Days||11
1059567|NCT00849485|2569613|P2|NOT COMPLETED|First Intervention||0
1059568|NCT00849485|2569614|P1|NOT COMPLETED|First Intervention||0
1059569|NCT00849485|2569613|P2|COMPLETED|First Intervention||11
1059570|NCT00849485|2569614|P1|COMPLETED|First Intervention||11
1059571|NCT00849485|2569613|P2|STARTED|First Intervention||11
1059572|NCT00849485|2569614|P1|STARTED|First Intervention||11
1059573|NCT00849524|2569622|P1|NOT COMPLETED|Overall Study||3
1059574|NCT00849524|2569622|P1|COMPLETED|Overall Study||3
1059575|NCT00849524|2569622|P1|STARTED|Overall Study||6
1059576|NCT00849680|2569636|P8|NOT COMPLETED|Overall Study||8
1059577|NCT00849680|2569637|P7|NOT COMPLETED|Overall Study||17
1059578|NCT00849680|2569638|P6|NOT COMPLETED|Overall Study||15
1059579|NCT00849680|2569639|P5|NOT COMPLETED|Overall Study||10
1059580|NCT00849680|2569640|P4|NOT COMPLETED|Overall Study||14
1059581|NCT00849680|2569641|P3|NOT COMPLETED|Overall Study||15
1059582|NCT00849680|2569642|P2|NOT COMPLETED|Overall Study||3
1059583|NCT00849680|2569643|P1|NOT COMPLETED|Overall Study||11
1059584|NCT00849680|2569636|P8|COMPLETED|Overall Study||23
1059585|NCT00849680|2569637|P7|COMPLETED|Overall Study||61
1059586|NCT00849680|2569638|P6|COMPLETED|Overall Study||27
1059587|NCT00849680|2569639|P5|COMPLETED|Overall Study||32
1059588|NCT00849680|2569640|P4|COMPLETED|Overall Study||28
1059589|NCT00849680|2569641|P3|COMPLETED|Overall Study||27
1059590|NCT00849680|2569642|P2|COMPLETED|Overall Study||10
1059591|NCT00849680|2569643|P1|COMPLETED|Overall Study||16
1059592|NCT00849680|2569636|P8|STARTED|Overall Study||31
1059593|NCT00849680|2569637|P7|STARTED|Overall Study||78
1059594|NCT00849680|2569638|P6|STARTED|Overall Study||42
1059595|NCT00849680|2569639|P5|STARTED|Overall Study||42
1059596|NCT00849680|2569640|P4|STARTED|Overall Study||42
1059597|NCT00849680|2569641|P3|STARTED|Overall Study||42
1059598|NCT00849680|2569642|P2|STARTED|Overall Study||13
1059599|NCT00849680|2569643|P1|STARTED|Overall Study||27
1059600|NCT00849693|2569689|P4|NOT COMPLETED|Extension Phase||38
1059601|NCT00849693|2569690|P3|NOT COMPLETED|Extension Phase||35
1059602|NCT00849693|2569691|P2|NOT COMPLETED|Extension Phase||30
1059603|NCT00849693|2569692|P1|NOT COMPLETED|Extension Phase||30
1059604|NCT00849693|2569689|P4|COMPLETED|Extension Phase||44
1059605|NCT00849693|2569690|P3|COMPLETED|Extension Phase||49
1059606|NCT00849693|2569691|P2|COMPLETED|Extension Phase||50
1059607|NCT00849693|2569692|P1|COMPLETED|Extension Phase||43
1059608|NCT00849693|2569689|P4|STARTED|Extension Phase||82
1059609|NCT00849693|2569690|P3|STARTED|Extension Phase||84
1059610|NCT00849693|2569691|P2|STARTED|Extension Phase||80
1059611|NCT00849693|2569692|P1|STARTED|Extension Phase||73
1059612|NCT00849693|2569689|P4|NOT COMPLETED|Acute Treatment Phase||37
1059613|NCT00849693|2569690|P3|NOT COMPLETED|Acute Treatment Phase||33
1059614|NCT00849693|2569691|P2|NOT COMPLETED|Acute Treatment Phase||35
1059615|NCT00849693|2569692|P1|NOT COMPLETED|Acute Treatment Phase||33
1059616|NCT00849693|2569689|P4|COMPLETED|Acute Treatment Phase|3 didn't enter extension phase|85
1059617|NCT00849693|2569690|P3|COMPLETED|Acute Treatment Phase||84
1059618|NCT00849693|2569691|P2|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase|81
1059619|NCT00849693|2569692|P1|COMPLETED|Acute Treatment Phase|2 didn't enter extension phase.|75
1059620|NCT00849693|2569689|P4|STARTED|Acute Treatment Phase||122
1059621|NCT00849693|2569690|P3|STARTED|Acute Treatment Phase||117
1059622|NCT00849693|2569691|P2|STARTED|Acute Treatment Phase||116
1059623|NCT00849693|2569692|P1|STARTED|Acute Treatment Phase||108
1059624|NCT00849797|2569753|P2|NOT COMPLETED|Second Intervention||0
1059625|NCT00849797|2569754|P1|NOT COMPLETED|Second Intervention||0
1059626|NCT00849797|2569753|P2|COMPLETED|Second Intervention||57
1059627|NCT00849797|2569754|P1|COMPLETED|Second Intervention||59
1059628|NCT00849797|2569753|P2|STARTED|Second Intervention||57
1059629|NCT00849797|2569754|P1|STARTED|Second Intervention||59
1059630|NCT00849797|2569753|P2|NOT COMPLETED|Washout: One Week||2
1059631|NCT00849797|2569754|P1|NOT COMPLETED|Washout: One Week||0
1059632|NCT00849797|2569753|P2|COMPLETED|Washout: One Week||57
1059633|NCT00849797|2569754|P1|COMPLETED|Washout: One Week||59
1059634|NCT00849797|2569753|P2|STARTED|Washout: One Week||59
1059635|NCT00849797|2569754|P1|STARTED|Washout: One Week||59
1059636|NCT00849797|2569753|P2|NOT COMPLETED|First Intervention||1
1059637|NCT00849797|2569754|P1|NOT COMPLETED|First Intervention||1
1059638|NCT00849797|2569753|P2|COMPLETED|First Intervention||59
1059639|NCT00849797|2569754|P1|COMPLETED|First Intervention||59
1059640|NCT00849797|2569753|P2|STARTED|First Intervention||60
1059641|NCT00849797|2569754|P1|STARTED|First Intervention||60
1059642|NCT00849810|2569768|P1|NOT COMPLETED|Overall Study||0
1059643|NCT00849810|2569768|P1|COMPLETED|Overall Study||1
1059644|NCT00849810|2569768|P1|STARTED|Overall Study||1
1059645|NCT00849862|2569774|P2|NOT COMPLETED|Second Intervention||0
1059646|NCT00849862|2569775|P1|NOT COMPLETED|Second Intervention||0
1059647|NCT00849862|2569774|P2|COMPLETED|Second Intervention||11
1059648|NCT00849862|2569775|P1|COMPLETED|Second Intervention||11
1059649|NCT00849862|2569774|P2|STARTED|Second Intervention||11
1059650|NCT00849862|2569775|P1|STARTED|Second Intervention||11
1059651|NCT00849862|2569774|P2|NOT COMPLETED|Washout: 7 Days||0
1059652|NCT00849862|2569775|P1|NOT COMPLETED|Washout: 7 Days||0
1059653|NCT00849862|2569774|P2|COMPLETED|Washout: 7 Days||11
1059654|NCT00849862|2569775|P1|COMPLETED|Washout: 7 Days||11
1059655|NCT00849862|2569774|P2|STARTED|Washout: 7 Days||11
1059656|NCT00849862|2569775|P1|STARTED|Washout: 7 Days||11
1059657|NCT00849862|2569774|P2|NOT COMPLETED|First Intervention||0
1059658|NCT00849862|2569775|P1|NOT COMPLETED|First Intervention||0
1059659|NCT00849862|2569774|P2|COMPLETED|First Intervention||11
1059660|NCT00849862|2569775|P1|COMPLETED|First Intervention||11
1059661|NCT00849862|2569774|P2|STARTED|First Intervention||11
1059662|NCT00849862|2569775|P1|STARTED|First Intervention||11
1059663|NCT00849875|2569786|P1|NOT COMPLETED|Overall Study||47
1059664|NCT00849875|2569786|P1|COMPLETED|Overall Study||1
1059665|NCT00849875|2569786|P1|STARTED|Overall Study||48
1059666|NCT00849901|2569869|P3|NOT COMPLETED|Extension Phase||17
1059667|NCT00849901|2569870|P2|NOT COMPLETED|Extension Phase||26
1059668|NCT00849901|2569871|P1|NOT COMPLETED|Extension Phase||27
1059669|NCT00849901|2569869|P3|COMPLETED|Extension Phase||69
1059670|NCT00849901|2569870|P2|COMPLETED|Extension Phase||65
1059671|NCT00849901|2569871|P1|COMPLETED|Extension Phase||56
1059672|NCT00849901|2569869|P3|STARTED|Extension Phase||86
1059673|NCT00849901|2569870|P2|STARTED|Extension Phase||91
1059674|NCT00849901|2569871|P1|STARTED|Extension Phase||83
1059675|NCT00849901|2569869|P3|NOT COMPLETED|Acute Treatment Phase||16
1059676|NCT00849901|2569870|P2|NOT COMPLETED|Acute Treatment Phase||26
1059677|NCT00849901|2569871|P1|NOT COMPLETED|Acute Treatment Phase||30
1059678|NCT00849901|2569869|P3|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase.|87
1059679|NCT00849901|2569870|P2|COMPLETED|Acute Treatment Phase||91
1059680|NCT00849901|2569871|P1|COMPLETED|Acute Treatment Phase|4 didn't enter extension phase.|87
1059681|NCT00849901|2569869|P3|STARTED|Acute Treatment Phase||103
1059682|NCT00849901|2569870|P2|STARTED|Acute Treatment Phase||117
1059683|NCT00849901|2569871|P1|STARTED|Acute Treatment Phase||117
1059684|NCT00849940|2569915|P1|NOT COMPLETED|Overall Study||4
1059685|NCT00849940|2569915|P1|COMPLETED|Overall Study||68
1059686|NCT00849940|2569915|P1|STARTED|Overall Study||72
1059687|NCT00850031|2569923|P1|NOT COMPLETED|Overall Study||17
1059688|NCT00850031|2569923|P1|COMPLETED|Overall Study||101
1059689|NCT00850031|2569923|P1|STARTED|Overall Study||118
1059690|NCT00850070|2569930|P2|NOT COMPLETED|Overall Study||1
1059691|NCT00850070|2569931|P1|NOT COMPLETED|Overall Study||3
1059692|NCT00850070|2569930|P2|COMPLETED|Overall Study||22
1059693|NCT00850070|2569931|P1|COMPLETED|Overall Study||20
1059694|NCT00850070|2569930|P2|STARTED|Overall Study||23
1059695|NCT00850070|2569931|P1|STARTED|Overall Study||23
1059696|NCT00850096|2569949|P2|NOT COMPLETED|Overall Study||2
1059697|NCT00850096|2569950|P1|NOT COMPLETED|Overall Study||3
1059698|NCT00850096|2569949|P2|COMPLETED|Overall Study||45
1059699|NCT00850096|2569950|P1|COMPLETED|Overall Study||44
1059700|NCT00850096|2569949|P2|STARTED|Overall Study||47
1059701|NCT00850096|2569950|P1|STARTED|Overall Study||47
1059702|NCT00850135|2569958|P1|NOT COMPLETED|Overall Study||1
1059703|NCT00850135|2569958|P1|COMPLETED|Overall Study||56
1059704|NCT00850135|2569958|P1|STARTED|Overall Study||57
1059705|NCT00850174|2569966|P2|NOT COMPLETED|Second Intervention||0
1059706|NCT00850174|2569967|P1|NOT COMPLETED|Second Intervention||1
1059707|NCT00850174|2569966|P2|COMPLETED|Second Intervention||28
1059708|NCT00850174|2569967|P1|COMPLETED|Second Intervention||29
1059709|NCT00850174|2569966|P2|STARTED|Second Intervention||28
1059710|NCT00850174|2569967|P1|STARTED|Second Intervention||30
1059711|NCT00850174|2569966|P2|NOT COMPLETED|Washout: One Week||2
1059712|NCT00850174|2569967|P1|NOT COMPLETED|Washout: One Week||0
1059713|NCT00850174|2569966|P2|COMPLETED|Washout: One Week||28
1059714|NCT00850174|2569967|P1|COMPLETED|Washout: One Week||30
1059715|NCT00850174|2569966|P2|STARTED|Washout: One Week||30
1059716|NCT00850174|2569967|P1|STARTED|Washout: One Week||30
1059717|NCT00850174|2569966|P2|NOT COMPLETED|First Intervention||0
1059718|NCT00850174|2569967|P1|NOT COMPLETED|First Intervention||0
1059719|NCT00850174|2569966|P2|COMPLETED|First Intervention||30
1059720|NCT00850174|2569967|P1|COMPLETED|First Intervention||30
1059721|NCT00850174|2569966|P2|STARTED|First Intervention||30
1059722|NCT00850174|2569967|P1|STARTED|First Intervention||30
1059723|NCT00850200|2569981|P1|NOT COMPLETED|Overall Study||1
1059724|NCT00850200|2569981|P1|COMPLETED|Overall Study||19
1059725|NCT00850200|2569981|P1|STARTED|Overall Study||20
1059726|NCT00850343|2569991|P4|NOT COMPLETED|Overall Study||13
1059727|NCT00850343|2569992|P3|NOT COMPLETED|Overall Study||14
1059728|NCT00850343|2569993|P2|NOT COMPLETED|Overall Study||3
1059729|NCT00850343|2569994|P1|NOT COMPLETED|Overall Study||46
1059730|NCT00850343|2569991|P4|COMPLETED|Overall Study||30
1059731|NCT00850343|2569992|P3|COMPLETED|Overall Study||29
1059732|NCT00850343|2569993|P2|COMPLETED|Overall Study||9
1059733|NCT00850343|2569994|P1|COMPLETED|Overall Study||64
1059734|NCT00850343|2569991|P4|Completed Week 52|Overall Study||37
1059735|NCT00850343|2569992|P3|Completed Week 52|Overall Study||37
1059736|NCT00850343|2569993|P2|Completed Week 52|Overall Study||11
1059737|NCT00850343|2569994|P1|Completed Week 52|Overall Study||88
1059738|NCT00850343|2569991|P4|Completed Week 24|Overall Study||39
1059739|NCT00850343|2569992|P3|Completed Week 24|Overall Study||39
1059740|NCT00850343|2569993|P2|Completed Week 24|Overall Study||12
1059741|NCT00850343|2569994|P1|Completed Week 24|Overall Study||94
1059742|NCT00850343|2569991|P4|STARTED|Overall Study||43
1059743|NCT00850343|2569992|P3|STARTED|Overall Study||43
1059744|NCT00850343|2569993|P2|STARTED|Overall Study||12
1059745|NCT00850343|2569994|P1|STARTED|Overall Study||110
1059746|NCT00850395|2570024|P1|NOT COMPLETED|Overall Study||10
1059747|NCT00850395|2570024|P1|COMPLETED|Overall Study||69
1059748|NCT00850395|2570024|P1|STARTED|Overall Study||79
1059749|NCT00850421|2570040|P1|NOT COMPLETED|Overall Study||17
1059750|NCT00850421|2570040|P1|COMPLETED|Overall Study||18
1059751|NCT00850421|2570040|P1|STARTED|Overall Study||35
1059752|NCT00850460|2570046|P2|NOT COMPLETED|Overall Study||4
1059753|NCT00850460|2570047|P1|NOT COMPLETED|Overall Study||4
1059754|NCT00850460|2570046|P2|COMPLETED|Overall Study||3
1059755|NCT00850460|2570047|P1|COMPLETED|Overall Study||3
1059756|NCT00850460|2570046|P2|Completion - Week 8|Overall Study||3
1059757|NCT00850460|2570047|P1|Completion - Week 8|Overall Study||3
1059758|NCT00850460|2570046|P2|Started - Week 0|Overall Study||7
1059759|NCT00850460|2570047|P1|Started - Week 0|Overall Study||7
1059760|NCT00850460|2570046|P2|STARTED|Overall Study||7
1059761|NCT00850460|2570047|P1|STARTED|Overall Study||7
1059762|NCT00850499|2570057|P2|NOT COMPLETED|Overall Study||2
1059763|NCT00850499|2570058|P1|NOT COMPLETED|Overall Study||3
1059764|NCT00850499|2570057|P2|COMPLETED|Overall Study||6
1059765|NCT00850499|2570058|P1|COMPLETED|Overall Study||1
1059766|NCT00850499|2570057|P2|STARTED|Overall Study||8
1059767|NCT00850499|2570058|P1|STARTED|Overall Study||4
1059768|NCT00850538|2570066|P1|NOT COMPLETED|Overall Study||41
1059769|NCT00850538|2570066|P1|COMPLETED|Overall Study||60
1059770|NCT00850538|2570066|P1|STARTED|Overall Study||101
1059771|NCT00850564|2570070|P1|NOT COMPLETED|Overall Study||2
1059772|NCT00850564|2570070|P1|COMPLETED|Overall Study||13
1059773|NCT00850564|2570070|P1|STARTED|Overall Study||15
1059774|NCT00850603|2570080|P5|NOT COMPLETED|Overall Study||0
1059775|NCT00850603|2570081|P4|NOT COMPLETED|Overall Study||0
1059776|NCT00850603|2570082|P3|NOT COMPLETED|Overall Study||0
1059777|NCT00850603|2570083|P2|NOT COMPLETED|Overall Study||0
1059778|NCT00850603|2570084|P1|NOT COMPLETED|Overall Study||0
1059779|NCT00850603|2570080|P5|COMPLETED|Overall Study||34
1059780|NCT00850603|2570081|P4|COMPLETED|Overall Study||34
1059781|NCT00850603|2570082|P3|COMPLETED|Overall Study||34
1059782|NCT00850603|2570083|P2|COMPLETED|Overall Study||34
1059783|NCT00850603|2570084|P1|COMPLETED|Overall Study||34
1059784|NCT00850603|2570080|P5|STARTED|Overall Study||34
1059785|NCT00850603|2570081|P4|STARTED|Overall Study||34
1059786|NCT00850603|2570082|P3|STARTED|Overall Study||34
1059787|NCT00850603|2570083|P2|STARTED|Overall Study||34
1059788|NCT00850603|2570084|P1|STARTED|Overall Study||34
1059789|NCT00850720|2570106|P1|NOT COMPLETED|Overall Study||0
1059790|NCT00850720|2570106|P1|COMPLETED|Overall Study||0
1059791|NCT00850720|2570106|P1|STARTED|Overall Study||0
1059792|NCT00850759|2570114|P4|NOT COMPLETED|Overall Study||3
1059793|NCT00850759|2570115|P3|NOT COMPLETED|Overall Study||5
1059794|NCT00850759|2570116|P2|NOT COMPLETED|Overall Study||5
1059795|NCT00850759|2570117|P1|NOT COMPLETED|Overall Study||7
1059796|NCT00850759|2570114|P4|COMPLETED|Overall Study||55
1059797|NCT00850759|2570115|P3|COMPLETED|Overall Study||52
1059798|NCT00850759|2570116|P2|COMPLETED|Overall Study||52
1059799|NCT00850759|2570117|P1|COMPLETED|Overall Study||52
1059800|NCT00850759|2570114|P4|STARTED|Overall Study||58
1059801|NCT00850759|2570115|P3|STARTED|Overall Study||57
1059802|NCT00850759|2570116|P2|STARTED|Overall Study||57
1059803|NCT00850759|2570117|P1|STARTED|Overall Study||59
1059804|NCT00850889|2570127|P1|NOT COMPLETED|Overall Study||0
1059805|NCT00850889|2570127|P1|COMPLETED|Overall Study||32
1059806|NCT00850889|2570127|P1|STARTED|Overall Study||32
1059807|NCT00850993|2570142|P4|NOT COMPLETED|Overall Study||0
1059808|NCT00850993|2570143|P3|NOT COMPLETED|Overall Study||0
1059809|NCT00850993|2570144|P2|NOT COMPLETED|Overall Study||1
1059810|NCT00850993|2570145|P1|NOT COMPLETED|Overall Study||0
1059811|NCT00850993|2570142|P4|COMPLETED|Overall Study||8
1059812|NCT00850993|2570143|P3|COMPLETED|Overall Study||18
1059813|NCT00850993|2570144|P2|COMPLETED|Overall Study||16
1059814|NCT00850993|2570145|P1|COMPLETED|Overall Study||15
1059815|NCT00850993|2570142|P4|STARTED|Overall Study||8
1059816|NCT00850993|2570143|P3|STARTED|Overall Study||18
1059817|NCT00850993|2570144|P2|STARTED|Overall Study||17
1059818|NCT00850993|2570145|P1|STARTED|Overall Study||15
1059819|NCT00851006|2570159|P2|NOT COMPLETED|Overall Study||0
1059820|NCT00851006|2570160|P1|NOT COMPLETED|Overall Study||0
1059821|NCT00851006|2570159|P2|COMPLETED|Overall Study||6
1059822|NCT00851006|2570160|P1|COMPLETED|Overall Study||7
1059823|NCT00851006|2570159|P2|STARTED|Overall Study||6
1059824|NCT00851006|2570160|P1|STARTED|Overall Study||7
1059825|NCT00851084|2570169|P2|NOT COMPLETED|Overall Study||119
1059826|NCT00851084|2570170|P1|NOT COMPLETED|Overall Study||117
1059827|NCT00851084|2570169|P2|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
1059828|NCT00851084|2570170|P1|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
1059829|NCT00851084|2570169|P2|STARTED|Overall Study||119
1059830|NCT00851084|2570170|P1|STARTED|Overall Study||117
1059831|NCT00851279|2570186|P1|NOT COMPLETED|Overall Study||0
1059832|NCT00851279|2570186|P1|COMPLETED|Overall Study||53
1059833|NCT00851279|2570186|P1|STARTED|Overall Study||53
1059834|NCT00851318|2570194|P4|NOT COMPLETED|Overall Study||19
1059835|NCT00851318|2570195|P3|NOT COMPLETED|Overall Study||21
1059836|NCT00851318|2570196|P2|NOT COMPLETED|Overall Study||5
1059837|NCT00851318|2570197|P1|NOT COMPLETED|Overall Study||30
1059838|NCT00851318|2570194|P4|COMPLETED|Overall Study||73
1059839|NCT00851318|2570195|P3|COMPLETED|Overall Study||72
1059840|NCT00851318|2570196|P2|COMPLETED|Overall Study||14
1059841|NCT00851318|2570197|P1|COMPLETED|Overall Study||51
1059842|NCT00851318|2570194|P4|Completed Week 52|Overall Study||85
1059843|NCT00851318|2570195|P3|Completed Week 52|Overall Study||87
1059844|NCT00851318|2570196|P2|Completed Week 52|Overall Study||16
1059845|NCT00851318|2570197|P1|Completed Week 52|Overall Study||64
1059846|NCT00851318|2570194|P4|Completed Week 24|Overall Study||87
1059847|NCT00851318|2570195|P3|Completed Week 24|Overall Study||90
1059848|NCT00851318|2570196|P2|Completed Week 24|Overall Study||17
1059849|NCT00851318|2570197|P1|Completed Week 24|Overall Study||69
1059850|NCT00851318|2570194|P4|STARTED|Overall Study||92
1059851|NCT00851318|2570195|P3|STARTED|Overall Study||93
1059852|NCT00851318|2570196|P2|STARTED|Overall Study||19
1059853|NCT00851318|2570197|P1|STARTED|Overall Study||81
1059854|NCT00851409|2570227|P1|NOT COMPLETED|Overall Study||0
1059855|NCT00851409|2570227|P1|COMPLETED|Overall Study||25
1059856|NCT00851409|2570227|P1|STARTED|Overall Study||25
1059857|NCT00844194|2570234|P2|NOT COMPLETED|Overall Study||8
1059858|NCT00844194|2570235|P1|NOT COMPLETED|Overall Study||25
1059859|NCT00844194|2570234|P2|COMPLETED|Overall Study||22
1059860|NCT00844194|2570235|P1|COMPLETED|Overall Study||53
1059861|NCT00844194|2570234|P2|STARTED|Overall Study||30
1059862|NCT00844194|2570235|P1|STARTED|Overall Study||78
1059863|NCT00844298|2570439|P1|NOT COMPLETED|Overall Study||0
1059864|NCT00844298|2570439|P1|COMPLETED|Overall Study||91
1059865|NCT00844298|2570439|P1|STARTED|Overall Study||91
1059866|NCT00844376|2570443|P2|NOT COMPLETED|Period 2: Second Intervention||0
1059867|NCT00844376|2570444|P1|NOT COMPLETED|Period 2: Second Intervention||0
1059868|NCT00844376|2570443|P2|COMPLETED|Period 2: Second Intervention||6
1059869|NCT00844376|2570444|P1|COMPLETED|Period 2: Second Intervention|Total subjects administered Test drug = 12; total subjects administered Reference drug = 11.|5
1059870|NCT00844376|2570443|P2|STARTED|Period 2: Second Intervention||6
1059871|NCT00844376|2570444|P1|STARTED|Period 2: Second Intervention||5
1059872|NCT00844376|2570443|P2|NOT COMPLETED|Period 1: First Intervention||0
1059873|NCT00844376|2570444|P1|NOT COMPLETED|Period 1: First Intervention||1
1059874|NCT00844376|2570443|P2|COMPLETED|Period 1: First Intervention||6
1059875|NCT00844376|2570444|P1|COMPLETED|Period 1: First Intervention||5
1059876|NCT00844376|2570443|P2|STARTED|Period 1: First Intervention||6
1059877|NCT00844376|2570444|P1|STARTED|Period 1: First Intervention||6
1059878|NCT00844415|2570462|P1|NOT COMPLETED|Overall Study||1
1059879|NCT00844415|2570462|P1|COMPLETED|Overall Study|Completed.|8
1059880|NCT00844415|2570462|P1|Pat. Received Single Dose 75mg|Overall Study||1
1059881|NCT00844415|2570462|P1|Pat. Received 125mg Followed by 150mg|Overall Study||2
1059882|NCT00844415|2570462|P1|Pat. Received 100mg Followed by 125mg|Overall Study||3
1059883|NCT00844415|2570462|P1|Pat. Received 75mg Followed by 100mg|Overall Study||3
1059884|NCT00844415|2570462|P1|STARTED|Overall Study|Entered and treated.|9
1059885|NCT00844428|2570476|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
1059886|NCT00844428|2570476|P1|COMPLETED|Post Treatment Period (Patients Who Disc||4
1059887|NCT00844428|2570476|P1|STARTED|Post Treatment Period (Patients Who Disc||5
1059888|NCT00844428|2570476|P1|NOT COMPLETED|Extension Treatment Period||1
1059889|NCT00844428|2570476|P1|COMPLETED|Extension Treatment Period||18
1059890|NCT00844428|2570476|P1|STARTED|Extension Treatment Period||19
1059891|NCT00844428|2570476|P1|NOT COMPLETED|Treatment Period (26 Weeks)||0
1059892|NCT00844428|2570476|P1|COMPLETED|Treatment Period (26 Weeks)||20
1059893|NCT00844428|2570476|P1|STARTED|Treatment Period (26 Weeks)||20
1059894|NCT00844428|2570476|P1|NOT COMPLETED|Observation Period (8 Weeks)||0
1059895|NCT00844428|2570476|P1|COMPLETED|Observation Period (8 Weeks)||20
1059896|NCT00844428|2570476|P1|STARTED|Observation Period (8 Weeks)||20
1059897|NCT00844428|2570476|P1|NOT COMPLETED|Screening Period||3
1059898|NCT00844428|2570476|P1|COMPLETED|Screening Period||20
1059899|NCT00844428|2570476|P1|STARTED|Screening Period||23
1059900|NCT00844480|2570494|P2|NOT COMPLETED|Overall Study||3
1059901|NCT00844480|2570495|P1|NOT COMPLETED|Overall Study||2
1059902|NCT00844480|2570494|P2|COMPLETED|Overall Study||6
1059903|NCT00844480|2570495|P1|COMPLETED|Overall Study||6
1059904|NCT00844480|2570494|P2|STARTED|Overall Study||9
1059905|NCT00844480|2570495|P1|STARTED|Overall Study||8
1059906|NCT00844519|2570505|P2|NOT COMPLETED|Overall Study||1
1059907|NCT00844519|2570506|P1|NOT COMPLETED|Overall Study||2
1059908|NCT00844519|2570505|P2|COMPLETED|Overall Study||25
1059909|NCT00844519|2570506|P1|COMPLETED|Overall Study||24
1059910|NCT00844519|2570505|P2|STARTED|Overall Study||26
1059911|NCT00844519|2570506|P1|STARTED|Overall Study||26
1059912|NCT00844532|2570512|P1|NOT COMPLETED|Overall Study||39
1059913|NCT00844532|2570512|P1|COMPLETED|Overall Study||112
1059914|NCT00844532|2570512|P1|STARTED|Overall Study||151
1059915|NCT00844545|2570596|P1|NOT COMPLETED|Post Treatment Period||1
1059916|NCT00844545|2570596|P1|COMPLETED|Post Treatment Period||5
1059917|NCT00844545|2570596|P1|STARTED|Post Treatment Period||6
1059918|NCT00844545|2570596|P1|NOT COMPLETED|Extension Treatment Period||2
1059919|NCT00844545|2570596|P1|COMPLETED|Extension Treatment Period||11
1059920|NCT00844545|2570596|P1|STARTED|Extension Treatment Period||13
1059921|NCT00844545|2570596|P1|NOT COMPLETED|Treatment Period (26 Weeks)||2
1059922|NCT00844545|2570596|P1|COMPLETED|Treatment Period (26 Weeks)||15
1059923|NCT00844545|2570596|P1|STARTED|Treatment Period (26 Weeks)||17
1059924|NCT00844545|2570596|P1|NOT COMPLETED|Screening Period||0
1059925|NCT00844545|2570596|P1|COMPLETED|Screening Period||17
1059926|NCT00844545|2570596|P1|STARTED|Screening Period||17
1059927|NCT00844558|2570612|P2|NOT COMPLETED|Overall Study||4
1059928|NCT00844558|2570613|P1|NOT COMPLETED|Overall Study||12
1059929|NCT00844558|2570612|P2|COMPLETED|Overall Study||18
1059930|NCT00844558|2570613|P1|COMPLETED|Overall Study||24
1059931|NCT00844558|2570612|P2|12 Month Visit|Overall Study|-Discontinued intervention (n=0)|18
1059932|NCT00844558|2570613|P1|12 Month Visit|Overall Study|Discontinued intervention (n=4)|24
1059933|NCT00844558|2570612|P2|6 Month Visit|Overall Study|-Discontinued intervention (n=1)|18
1059934|NCT00844558|2570613|P1|6 Month Visit|Overall Study|Discontinued intervention (n=1)|28
1059935|NCT00844558|2570612|P2|3 Month Visit|Overall Study|"Lost to follow-up (n=1)
Discontinued Intervention (n=1)"|19
1059936|NCT00844558|2570613|P1|3 Month Visit|Overall Study|Discontinued intervention (n=4)|29
1059937|NCT00844558|2570612|P2|Received Allocated Intervention|Overall Study||21
1059938|NCT00844558|2570613|P1|Received Allocated Intervention|Overall Study||33
1059939|NCT00844558|2570612|P2|STARTED|Overall Study|"Received allocated intervention (n=21)
Did not receive allocated intervention (n=1)"|22
1059940|NCT00844558|2570613|P1|STARTED|Overall Study|"Received allocated intervention (n=33)
Did not receive allocated intervention (n=3)"|36
1059941|NCT00844597|2570635|P6|NOT COMPLETED|Overall Study||0
1059942|NCT00844597|2570636|P5|NOT COMPLETED|Overall Study||0
1059943|NCT00844597|2570637|P4|NOT COMPLETED|Overall Study||1
1059944|NCT00844597|2570638|P3|NOT COMPLETED|Overall Study||0
1059945|NCT00844597|2570639|P2|NOT COMPLETED|Overall Study||0
1059946|NCT00844597|2570640|P1|NOT COMPLETED|Overall Study||0
1059947|NCT00844597|2570635|P6|COMPLETED|Overall Study||4
1059948|NCT00844597|2570636|P5|COMPLETED|Overall Study||4
1059949|NCT00844597|2570637|P4|COMPLETED|Overall Study||2
1059950|NCT00844597|2570638|P3|COMPLETED|Overall Study||2
1059951|NCT00844597|2570639|P2|COMPLETED|Overall Study||2
1059952|NCT00844597|2570640|P1|COMPLETED|Overall Study||4
1059953|NCT00844597|2570635|P6|STARTED|Overall Study||4
1059954|NCT00844597|2570636|P5|STARTED|Overall Study||4
1059955|NCT00844597|2570637|P4|STARTED|Overall Study||3
1059956|NCT00844597|2570638|P3|STARTED|Overall Study||2
1059957|NCT00844597|2570639|P2|STARTED|Overall Study||2
1059958|NCT00844597|2570640|P1|STARTED|Overall Study||4
1059959|NCT00844649|2570660|P2|NOT COMPLETED|Overall Study||418
1059960|NCT00844649|2570661|P1|NOT COMPLETED|Overall Study||405
1059961|NCT00844649|2570660|P2|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|12
1059962|NCT00844649|2570661|P1|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|26
1059963|NCT00844649|2570660|P2|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|402
1059964|NCT00844649|2570661|P1|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|421
1059965|NCT00844649|2570660|P2|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|430
1059966|NCT00844649|2570661|P1|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|431
1059967|NCT00844714|2570679|P1|NOT COMPLETED|Overall Study||0
1059968|NCT00844714|2570679|P1|COMPLETED|Overall Study||20
1059969|NCT00844714|2570679|P1|STARTED|Overall Study||20
1059970|NCT00844753|2570687|P4|NOT COMPLETED|Overall Study||11
1059971|NCT00844753|2570688|P3|NOT COMPLETED|Overall Study||7
1059972|NCT00844753|2570689|P2|NOT COMPLETED|Overall Study||3
1059973|NCT00844753|2570690|P1|NOT COMPLETED|Overall Study||8
1059974|NCT00844753|2570687|P4|COMPLETED|Overall Study||21
1059975|NCT00844753|2570688|P3|COMPLETED|Overall Study||25
1059976|NCT00844753|2570689|P2|COMPLETED|Overall Study||29
1059977|NCT00844753|2570690|P1|COMPLETED|Overall Study||24
1059978|NCT00844753|2570687|P4|STARTED|Overall Study||32
1059979|NCT00844753|2570688|P3|STARTED|Overall Study||32
1059980|NCT00844753|2570689|P2|STARTED|Overall Study||32
1059981|NCT00844753|2570690|P1|STARTED|Overall Study||32
1059982|NCT00844805|2570704|P4|NOT COMPLETED|Follow-Up Phase||9
1059983|NCT00844805|2570705|P3|NOT COMPLETED|Follow-Up Phase||9
1059984|NCT00844805|2570706|P2|NOT COMPLETED|Follow-Up Phase||0
1059985|NCT00844805|2570707|P1|NOT COMPLETED|Follow-Up Phase||0
1059986|NCT00844805|2570704|P4|COMPLETED|Follow-Up Phase||32
1059987|NCT00844805|2570705|P3|COMPLETED|Follow-Up Phase||32
1059988|NCT00844805|2570706|P2|COMPLETED|Follow-Up Phase||0
1059989|NCT00844805|2570707|P1|COMPLETED|Follow-Up Phase||0
1059990|NCT00844805|2570704|P4|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
1059991|NCT00844805|2570705|P3|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
1059992|NCT00844805|2570706|P2|STARTED|Follow-Up Phase||0
1059993|NCT00844805|2570707|P1|STARTED|Follow-Up Phase||0
1059994|NCT00844805|2570704|P4|NOT COMPLETED|Treatment Phase||0
1059995|NCT00844805|2570705|P3|NOT COMPLETED|Treatment Phase||0
1059996|NCT00844805|2570706|P2|NOT COMPLETED|Treatment Phase||7
1059997|NCT00844805|2570707|P1|NOT COMPLETED|Treatment Phase||10
1059998|NCT00844805|2570704|P4|COMPLETED|Treatment Phase||0
1059999|NCT00844805|2570705|P3|COMPLETED|Treatment Phase||0
1060000|NCT00844805|2570706|P2|COMPLETED|Treatment Phase||45
1060001|NCT00844805|2570707|P1|COMPLETED|Treatment Phase||96
1060002|NCT00844805|2570704|P4|STARTED|Treatment Phase||0
1060003|NCT00844805|2570705|P3|STARTED|Treatment Phase||0
1060004|NCT00844805|2570706|P2|STARTED|Treatment Phase||52
1060005|NCT00844805|2570707|P1|STARTED|Treatment Phase||106
1060006|NCT00844831|2570747|P1|NOT COMPLETED|Overall Study||6
1060007|NCT00844831|2570747|P1|COMPLETED|Overall Study||19
1060008|NCT00844831|2570747|P1|STARTED|Overall Study||25
1060009|NCT00844844|2570755|P1|NOT COMPLETED|Post Treatment Period||1
1060010|NCT00844844|2570755|P1|COMPLETED|Post Treatment Period||5
1060011|NCT00844844|2570755|P1|STARTED|Post Treatment Period||6
1060012|NCT00844844|2570755|P1|NOT COMPLETED|Extension Treatment Period||2
1060013|NCT00844844|2570755|P1|COMPLETED|Extension Treatment Period||11
1060014|NCT00844844|2570755|P1|STARTED|Extension Treatment Period||13
1060015|NCT00844844|2570755|P1|NOT COMPLETED|Treatment Period (26 Weeks)||2
1060016|NCT00844844|2570755|P1|COMPLETED|Treatment Period (26 Weeks)||15
1060017|NCT00844844|2570755|P1|STARTED|Treatment Period (26 Weeks)||17
1060018|NCT00844844|2570755|P1|NOT COMPLETED|Screening Period||0
1060019|NCT00844844|2570755|P1|COMPLETED|Screening Period||17
1060020|NCT00844844|2570755|P1|STARTED|Screening Period||17
1060021|NCT00844857|2570771|P2|NOT COMPLETED|Overall Study||37
1060022|NCT00844857|2570772|P1|NOT COMPLETED|Overall Study||78
1060023|NCT00844857|2570771|P2|COMPLETED|Overall Study||60
1060024|NCT00844857|2570772|P1|COMPLETED|Overall Study||116
1060025|NCT00844857|2570771|P2|Population Analyzed|Overall Study|randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|85
1060026|NCT00844857|2570772|P1|Population Analyzed|Overall Study|Randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|170
1060027|NCT00844857|2570771|P2|STARTED|Overall Study||97
1060028|NCT00844857|2570772|P1|STARTED|Overall Study||194
1060029|NCT00844883|2570816|P1|NOT COMPLETED|Overall Study||4
1060030|NCT00844883|2570816|P1|COMPLETED|Overall Study||46
1060031|NCT00844883|2570816|P1|Patients Who Received TACE|Overall Study|2 patients withdrawn at Week 1 prior to TACE for intolerance to sorafenib|48
1060032|NCT00844883|2570816|P1|STARTED|Overall Study||50
1060033|NCT00844896|2570828|P2|NOT COMPLETED|Overall Study||17
1060034|NCT00844896|2570829|P1|NOT COMPLETED|Overall Study||12
1060035|NCT00844896|2570828|P2|COMPLETED|Overall Study||11
1060036|NCT00844896|2570829|P1|COMPLETED|Overall Study||17
1060037|NCT00844896|2570828|P2|STARTED|Overall Study||28
1060038|NCT00844896|2570829|P1|STARTED|Overall Study||29
1060039|NCT00845000|2570857|P6|NOT COMPLETED|Period 3||0
1060040|NCT00845000|2570858|P5|NOT COMPLETED|Period 3||0
1060041|NCT00845000|2570859|P4|NOT COMPLETED|Period 3||0
1060042|NCT00845000|2570860|P3|NOT COMPLETED|Period 3||0
1060043|NCT00845000|2570861|P2|NOT COMPLETED|Period 3||0
1060044|NCT00845000|2570862|P1|NOT COMPLETED|Period 3||0
1060045|NCT00845000|2570857|P6|COMPLETED|Period 3||2
1060046|NCT00845000|2570858|P5|COMPLETED|Period 3||2
1060047|NCT00845000|2570859|P4|COMPLETED|Period 3||2
1060048|NCT00845000|2570860|P3|COMPLETED|Period 3||2
1060049|NCT00845000|2570861|P2|COMPLETED|Period 3||2
1060050|NCT00845000|2570862|P1|COMPLETED|Period 3||2
1060051|NCT00845000|2570857|P6|STARTED|Period 3||2
1060052|NCT00845000|2570858|P5|STARTED|Period 3||2
1060053|NCT00845000|2570859|P4|STARTED|Period 3||2
1060054|NCT00845000|2570860|P3|STARTED|Period 3||2
1060055|NCT00845000|2570861|P2|STARTED|Period 3||2
1060056|NCT00845000|2570862|P1|STARTED|Period 3||2
1060057|NCT00845000|2570857|P6|NOT COMPLETED|Period 2||0
1060058|NCT00845000|2570858|P5|NOT COMPLETED|Period 2||0
1060059|NCT00845000|2570859|P4|NOT COMPLETED|Period 2||0
1060060|NCT00845000|2570860|P3|NOT COMPLETED|Period 2||0
1060061|NCT00845000|2570861|P2|NOT COMPLETED|Period 2||0
1060062|NCT00845000|2570862|P1|NOT COMPLETED|Period 2||0
1060063|NCT00845000|2570857|P6|COMPLETED|Period 2||2
1060064|NCT00845000|2570858|P5|COMPLETED|Period 2||2
1060065|NCT00845000|2570859|P4|COMPLETED|Period 2||2
1060066|NCT00845000|2570860|P3|COMPLETED|Period 2||2
1060067|NCT00845000|2570861|P2|COMPLETED|Period 2||2
1060068|NCT00845000|2570862|P1|COMPLETED|Period 2||2
1060069|NCT00845000|2570857|P6|STARTED|Period 2||2
1060070|NCT00845000|2570858|P5|STARTED|Period 2||2
1060071|NCT00845000|2570859|P4|STARTED|Period 2||2
1060072|NCT00845000|2570860|P3|STARTED|Period 2||2
1060073|NCT00845000|2570861|P2|STARTED|Period 2||2
1060074|NCT00845000|2570862|P1|STARTED|Period 2||2
1060075|NCT00845000|2570857|P6|NOT COMPLETED|Period 1||0
1060076|NCT00845000|2570858|P5|NOT COMPLETED|Period 1||0
1060077|NCT00845000|2570859|P4|NOT COMPLETED|Period 1||0
1060078|NCT00845000|2570860|P3|NOT COMPLETED|Period 1||0
1060079|NCT00845000|2570861|P2|NOT COMPLETED|Period 1||0
1060080|NCT00845000|2570862|P1|NOT COMPLETED|Period 1||0
1060081|NCT00845000|2570857|P6|COMPLETED|Period 1||2
1060082|NCT00845000|2570858|P5|COMPLETED|Period 1||2
1060083|NCT00845000|2570859|P4|COMPLETED|Period 1||2
1060084|NCT00845000|2570860|P3|COMPLETED|Period 1||2
1060085|NCT00845000|2570861|P2|COMPLETED|Period 1||2
1060086|NCT00845000|2570862|P1|COMPLETED|Period 1||2
1060087|NCT00845000|2570857|P6|STARTED|Period 1||2
1060088|NCT00845000|2570858|P5|STARTED|Period 1||2
1060089|NCT00845000|2570859|P4|STARTED|Period 1||2
1060090|NCT00845000|2570860|P3|STARTED|Period 1||2
1060091|NCT00845000|2570861|P2|STARTED|Period 1||2
1060092|NCT00845000|2570862|P1|STARTED|Period 1||2
1060093|NCT00845065|2570881|P2|NOT COMPLETED|Overall Study||55
1060094|NCT00845065|2570882|P1|NOT COMPLETED|Overall Study||47
1060095|NCT00845065|2570881|P2|COMPLETED|Overall Study||79
1060096|NCT00845065|2570882|P1|COMPLETED|Overall Study||20
1060097|NCT00845065|2570881|P2|STARTED|Overall Study||134
1060098|NCT00845065|2570882|P1|STARTED|Overall Study||67
1060099|NCT00845130|2570898|P2|NOT COMPLETED|Overall Study||3
1060100|NCT00845130|2570899|P1|NOT COMPLETED|Overall Study||4
1060101|NCT00845130|2570898|P2|COMPLETED|Overall Study||19
1060102|NCT00845130|2570899|P1|COMPLETED|Overall Study||16
1060103|NCT00845130|2570898|P2|STARTED|Overall Study||22
1060104|NCT00845130|2570899|P1|STARTED|Overall Study||20
1060114|NCT00845195|2570925|P2|NOT COMPLETED|Overall Study||0
1060115|NCT00845195|2570926|P1|NOT COMPLETED|Overall Study||0
1060116|NCT00845195|2570925|P2|COMPLETED|Overall Study||75
1060117|NCT00845195|2570926|P1|COMPLETED|Overall Study||75
1060118|NCT00845195|2570925|P2|STARTED|Overall Study||75
1060119|NCT00845195|2570926|P1|STARTED|Overall Study||75
1060120|NCT00845429|2570941|P3|NOT COMPLETED|Overall Study||20
1060121|NCT00845429|2570942|P2|NOT COMPLETED|Overall Study||15
1060122|NCT00845429|2570943|P1|NOT COMPLETED|Overall Study||14
1060123|NCT00845429|2570941|P3|COMPLETED|Overall Study||224
1060124|NCT00845429|2570942|P2|COMPLETED|Overall Study||226
1060125|NCT00845429|2570943|P1|COMPLETED|Overall Study||230
1060126|NCT00845429|2570941|P3|STARTED|Overall Study||244
1060127|NCT00845429|2570942|P2|STARTED|Overall Study||241
1060128|NCT00845429|2570943|P1|STARTED|Overall Study||244
1060129|NCT00845481|2570960|P1|NOT COMPLETED|Overall Study||0
1060130|NCT00845481|2570960|P1|COMPLETED|Overall Study||24
1060131|NCT00845481|2570960|P1|STARTED|Overall Study||24
1060132|NCT00845663|2570971|P2|NOT COMPLETED|Overall Study||0
1060133|NCT00845663|2570972|P1|NOT COMPLETED|Overall Study||0
1060134|NCT00845663|2570971|P2|COMPLETED|Overall Study||49
1060135|NCT00845663|2570972|P1|COMPLETED|Overall Study||49
1060136|NCT00845663|2570971|P2|STARTED|Overall Study||49
1060137|NCT00845663|2570972|P1|STARTED|Overall Study||49
1060138|NCT00845676|2571020|P1|NOT COMPLETED|Overall Study||2
1060139|NCT00845676|2571020|P1|COMPLETED|Overall Study||19
1060140|NCT00845676|2571020|P1|STARTED|Overall Study||21
1060141|NCT00845702|2571024|P1|NOT COMPLETED|Dotarem MRA||0
1060142|NCT00845702|2571024|P1|COMPLETED|Dotarem MRA||32
1060143|NCT00845702|2571024|P1|STARTED|Dotarem MRA||32
1060144|NCT00845702|2571024|P1|NOT COMPLETED|TOF MRA||1
1060145|NCT00845702|2571024|P1|COMPLETED|TOF MRA|One patient did not perform study MRA procedures.|32
1060146|NCT00845702|2571024|P1|STARTED|TOF MRA||33
1060147|NCT00845728|2571032|P2|NOT COMPLETED|Overall Study||342
1060148|NCT00845728|2571033|P1|NOT COMPLETED|Overall Study||386
1060149|NCT00845728|2571032|P2|COMPLETED|Overall Study||1379
1060150|NCT00845728|2571033|P1|COMPLETED|Overall Study||1337
1060151|NCT00845728|2571032|P2|Exposed|Overall Study||1718
1060152|NCT00845728|2571033|P1|Exposed|Overall Study||1721
1060153|NCT00845728|2571032|P2|STARTED|Overall Study||1721
1060154|NCT00845728|2571033|P1|STARTED|Overall Study||1723
1060155|NCT00845832|2571044|P3|NOT COMPLETED|Extended Safety Follow-Up||7
1060156|NCT00845832|2571045|P2|NOT COMPLETED|Extended Safety Follow-Up||0
1060157|NCT00845832|2571046|P1|NOT COMPLETED|Extended Safety Follow-Up||0
1060158|NCT00845832|2571044|P3|COMPLETED|Extended Safety Follow-Up||0
1060159|NCT00845832|2571045|P2|COMPLETED|Extended Safety Follow-Up||5
1060160|NCT00845832|2571046|P1|COMPLETED|Extended Safety Follow-Up||2
1060161|NCT00845832|2571044|P3|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|7
1060162|NCT00845832|2571045|P2|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|5
1060163|NCT00845832|2571046|P1|STARTED|Extended Safety Follow-Up||2
1060164|NCT00845832|2571044|P3|NOT COMPLETED|Safety Follow-Up||0
1060165|NCT00845832|2571045|P2|NOT COMPLETED|Safety Follow-Up||0
1060166|NCT00845832|2571046|P1|NOT COMPLETED|Safety Follow-Up||1
1060167|NCT00845832|2571044|P3|COMPLETED|Safety Follow-Up||12
1060168|NCT00845832|2571045|P2|COMPLETED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|9
1060169|NCT00845832|2571046|P1|COMPLETED|Safety Follow-Up||2
1060170|NCT00845832|2571044|P3|STARTED|Safety Follow-Up|One participant each from the placebo and TCZ (2 mg/kg) groups were re-assigned to this group.|12
1060171|NCT00845832|2571045|P2|STARTED|Safety Follow-Up|All participants who withdrew from study were asked to return for safety follow-up.|9
1060172|NCT00845832|2571046|P1|STARTED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|3
1060173|NCT00845832|2571044|P3|NOT COMPLETED|Treatment Period||0
1060174|NCT00845832|2571045|P2|NOT COMPLETED|Treatment Period||3
1060175|NCT00845832|2571046|P1|NOT COMPLETED|Treatment Period||1
1060176|NCT00845832|2571044|P3|COMPLETED|Treatment Period||10
1060177|NCT00845832|2571045|P2|COMPLETED|Treatment Period||7
1060178|NCT00845832|2571046|P1|COMPLETED|Treatment Period||3
1060179|NCT00845832|2571044|P3|STARTED|Treatment Period||10
1060180|NCT00845832|2571045|P2|STARTED|Treatment Period||10
1060181|NCT00845832|2571046|P1|STARTED|Treatment Period||4
1060182|NCT00845845|2571092|P2|NOT COMPLETED|Overall Study||4
1060183|NCT00845845|2571093|P1|NOT COMPLETED|Overall Study||0
1060184|NCT00845845|2571092|P2|COMPLETED|Overall Study||2
1060185|NCT00845845|2571093|P1|COMPLETED|Overall Study||3
1060186|NCT00845845|2571092|P2|STARTED|Overall Study||6
1060187|NCT00845845|2571093|P1|STARTED|Overall Study||3
1060188|NCT00845858|2571104|P3|NOT COMPLETED|Overall Study||8
1060189|NCT00845858|2571105|P2|NOT COMPLETED|Overall Study||12
1060190|NCT00845858|2571106|P1|NOT COMPLETED|Overall Study||8
1060191|NCT00845858|2571104|P3|COMPLETED|Overall Study||87
1060192|NCT00845858|2571105|P2|COMPLETED|Overall Study||84
1060193|NCT00845858|2571106|P1|COMPLETED|Overall Study||88
1060194|NCT00845858|2571104|P3|STARTED|Overall Study||95
1060195|NCT00845858|2571105|P2|STARTED|Overall Study|"95 subjects received allocated intervention.
1 subject was not eligible and was not dosed."|96
1060196|NCT00845858|2571106|P1|STARTED|Overall Study|"95 subjects received allocated intervention.
1 subject withdrew consent and was not dosed."|96
1060197|NCT00851552|2571117|P1|NOT COMPLETED|Overall Study||7
1060198|NCT00851552|2571117|P1|COMPLETED|Overall Study||2
1060199|NCT00851552|2571117|P1|STARTED|Overall Study||9
1060200|NCT00851591|2571124|P2|NOT COMPLETED|Overall Study||0
1060201|NCT00851591|2571125|P1|NOT COMPLETED|Overall Study||2
1060202|NCT00851591|2571124|P2|COMPLETED|Overall Study||1
1060203|NCT00851591|2571125|P1|COMPLETED|Overall Study||0
1060204|NCT00851591|2571124|P2|STARTED|Overall Study|One received treatment.|1
1060205|NCT00851591|2571125|P1|STARTED|Overall Study|These 2 participants did not receive treatment.|2
1060206|NCT00851630|2571133|P2|NOT COMPLETED|Overall Study||2
1060207|NCT00851630|2571134|P1|NOT COMPLETED|Overall Study||2
1060208|NCT00851630|2571133|P2|COMPLETED|Overall Study||33
1060209|NCT00851630|2571134|P1|COMPLETED|Overall Study||33
1060210|NCT00851630|2571133|P2|STARTED|Overall Study||35
1060211|NCT00851630|2571134|P1|STARTED|Overall Study||35
1060212|NCT00851643|2571152|P6|NOT COMPLETED|Extension Study (Up to 36 Months)||1
1060213|NCT00851643|2571153|P5|NOT COMPLETED|Extension Study (Up to 36 Months)||2
1060214|NCT00851643|2571154|P4|NOT COMPLETED|Extension Study (Up to 36 Months)||2
1060215|NCT00851643|2571155|P3|NOT COMPLETED|Extension Study (Up to 36 Months)||5
1060216|NCT00851643|2571156|P2|NOT COMPLETED|Extension Study (Up to 36 Months)||4
1060217|NCT00851643|2571157|P1|NOT COMPLETED|Extension Study (Up to 36 Months)||4
1060218|NCT00851643|2571152|P6|COMPLETED|Extension Study (Up to 36 Months)||14
1060219|NCT00851643|2571153|P5|COMPLETED|Extension Study (Up to 36 Months)||19
1060220|NCT00851643|2571154|P4|COMPLETED|Extension Study (Up to 36 Months)||5
1060221|NCT00851643|2571155|P3|COMPLETED|Extension Study (Up to 36 Months)||14
1060222|NCT00851643|2571156|P2|COMPLETED|Extension Study (Up to 36 Months)||15
1060223|NCT00851643|2571157|P1|COMPLETED|Extension Study (Up to 36 Months)||6
1060224|NCT00851643|2571152|P6|STARTED|Extension Study (Up to 36 Months)||15
1060225|NCT00851643|2571153|P5|STARTED|Extension Study (Up to 36 Months)||21
1060226|NCT00851643|2571154|P4|STARTED|Extension Study (Up to 36 Months)||7
1060227|NCT00851643|2571155|P3|STARTED|Extension Study (Up to 36 Months)||19
1060228|NCT00851643|2571156|P2|STARTED|Extension Study (Up to 36 Months)||19
1060229|NCT00851643|2571157|P1|STARTED|Extension Study (Up to 36 Months)||10
1060230|NCT00851643|2571152|P6|NOT COMPLETED|Base Study (Up to 12 Months)||1
1060231|NCT00851643|2571153|P5|NOT COMPLETED|Base Study (Up to 12 Months)||0
1060232|NCT00851643|2571154|P4|NOT COMPLETED|Base Study (Up to 12 Months)||0
1060233|NCT00851643|2571155|P3|NOT COMPLETED|Base Study (Up to 12 Months)||0
1060234|NCT00851643|2571156|P2|NOT COMPLETED|Base Study (Up to 12 Months)||0
1060235|NCT00851643|2571157|P1|NOT COMPLETED|Base Study (Up to 12 Months)||1
1060236|NCT00851643|2571152|P6|COMPLETED|Base Study (Up to 12 Months)||29
1060237|NCT00851643|2571153|P5|COMPLETED|Base Study (Up to 12 Months)||30
1060238|NCT00851643|2571154|P4|COMPLETED|Base Study (Up to 12 Months)||15
1060239|NCT00851643|2571155|P3|COMPLETED|Base Study (Up to 12 Months)||30
1060240|NCT00851643|2571156|P2|COMPLETED|Base Study (Up to 12 Months)||30
1060241|NCT00851643|2571157|P1|COMPLETED|Base Study (Up to 12 Months)||14
1060242|NCT00851643|2571152|P6|STARTED|Base Study (Up to 12 Months)||30
1060243|NCT00851643|2571153|P5|STARTED|Base Study (Up to 12 Months)||30
1060244|NCT00851643|2571154|P4|STARTED|Base Study (Up to 12 Months)||15
1060245|NCT00851643|2571155|P3|STARTED|Base Study (Up to 12 Months)||30
1060246|NCT00851643|2571156|P2|STARTED|Base Study (Up to 12 Months)||30
1060247|NCT00851643|2571157|P1|STARTED|Base Study (Up to 12 Months)||15
1060248|NCT00851682|2571178|P2|NOT COMPLETED|Overall Study||0
1060249|NCT00851682|2571179|P1|NOT COMPLETED|Overall Study||5
1060250|NCT00851682|2571178|P2|COMPLETED|Overall Study||5
1060251|NCT00851682|2571179|P1|COMPLETED|Overall Study||55
1060252|NCT00851682|2571178|P2|STARTED|Overall Study||5
1060253|NCT00851682|2571179|P1|STARTED|Overall Study||60
1060254|NCT00851721|2571189|P2|NOT COMPLETED|Overall Study||1
1060255|NCT00851721|2571190|P1|NOT COMPLETED|Overall Study||2
1060256|NCT00851721|2571189|P2|COMPLETED|Overall Study||16
1060257|NCT00851721|2571190|P1|COMPLETED|Overall Study||17
1060258|NCT00851721|2571189|P2|STARTED|Overall Study||17
1060259|NCT00851721|2571190|P1|STARTED|Overall Study||19
1060260|NCT00851786|2571280|P2|NOT COMPLETED|Overall Study||2
1060261|NCT00851786|2571281|P1|NOT COMPLETED|Overall Study||5
1060262|NCT00851786|2571280|P2|COMPLETED|Overall Study||97
1060263|NCT00851786|2571281|P1|COMPLETED|Overall Study||291
1060264|NCT00851786|2571280|P2|STARTED|Overall Study|Two subjects (one found ineligible and one withdrew consent) were off study with no vaccine.|99
1060265|NCT00851786|2571281|P1|STARTED|Overall Study|One subject cannot adhere to protocol requirement and was off study with no vaccine.|296
1060266|NCT00851799|2571292|P3|NOT COMPLETED|Overall Study||24
1060267|NCT00851799|2571293|P2|NOT COMPLETED|Overall Study||13
1060268|NCT00851799|2571294|P1|NOT COMPLETED|Overall Study||16
1060269|NCT00851799|2571292|P3|COMPLETED|Overall Study||89
1060270|NCT00851799|2571293|P2|COMPLETED|Overall Study||93
1060271|NCT00851799|2571294|P1|COMPLETED|Overall Study||93
1060272|NCT00851799|2571292|P3|STARTED|Overall Study||113
1060273|NCT00851799|2571293|P2|STARTED|Overall Study||106
1060274|NCT00851799|2571294|P1|STARTED|Overall Study||109
1060275|NCT00854308|2571382|P2|NOT COMPLETED|Overall Study||67
1060276|NCT00854308|2571383|P1|NOT COMPLETED|Overall Study||62
1060277|NCT00854308|2571382|P2|COMPLETED|Overall Study||1
1060278|NCT00854308|2571383|P1|COMPLETED|Overall Study|Completed participants in both arms were still receiving study drug when analyses were performed.|7
1060279|NCT00854308|2571382|P2|Received Study Drug|Overall Study||67
1060280|NCT00854308|2571383|P1|Received Study Drug|Overall Study||69
1060281|NCT00854308|2571382|P2|STARTED|Overall Study||68
1060282|NCT00854308|2571383|P1|STARTED|Overall Study||69
1060283|NCT00854360|2571401|P4|NOT COMPLETED|Overall Study||10
1060284|NCT00854360|2571402|P3|NOT COMPLETED|Overall Study||2
1060285|NCT00854360|2571403|P2|NOT COMPLETED|Overall Study||3
1060286|NCT00854360|2571404|P1|NOT COMPLETED|Overall Study||2
1060287|NCT00854360|2571401|P4|COMPLETED|Overall Study||114
1060288|NCT00854360|2571402|P3|COMPLETED|Overall Study||120
1060289|NCT00854360|2571403|P2|COMPLETED|Overall Study|One patient discontinued due to both an AE and study medication discontinuation.|120
1060290|NCT00854360|2571404|P1|COMPLETED|Overall Study||116
1060291|NCT00854360|2571401|P4|Intent to Treat / Safety Population|Overall Study|One patient did not receive any double-blind study medication.|123
1060292|NCT00854360|2571402|P3|Intent to Treat / Safety Population|Overall Study||122
1060293|NCT00854360|2571403|P2|Intent to Treat / Safety Population|Overall Study||123
1060294|NCT00854360|2571404|P1|Intent to Treat / Safety Population|Overall Study||118
1060295|NCT00854360|2571401|P4|STARTED|Overall Study||124
1060296|NCT00854360|2571402|P3|STARTED|Overall Study||122
1060297|NCT00854360|2571403|P2|STARTED|Overall Study||123
1060298|NCT00854360|2571404|P1|STARTED|Overall Study||118
1060299|NCT00854373|2571436|P2|NOT COMPLETED|Overall Study||4
1060300|NCT00854373|2571437|P1|NOT COMPLETED|Overall Study||2
1060301|NCT00854373|2571436|P2|COMPLETED|Overall Study||89
1060302|NCT00854373|2571437|P1|COMPLETED|Overall Study||93
1060303|NCT00854373|2571436|P2|STARTED|Overall Study||93
1060304|NCT00854373|2571437|P1|STARTED|Overall Study||95
1060305|NCT00854581|2571447|P1|NOT COMPLETED|Overall Study||2
1060306|NCT00854581|2571447|P1|COMPLETED|Overall Study||11
1060307|NCT00854581|2571447|P1|STARTED|Overall Study||13
1060308|NCT00854594|2571454|P2|NOT COMPLETED|Overall Study||0
1060309|NCT00854594|2571455|P1|NOT COMPLETED|Overall Study||0
1060310|NCT00854594|2571454|P2|COMPLETED|Overall Study||69
1060311|NCT00854594|2571455|P1|COMPLETED|Overall Study||48
1060312|NCT00854594|2571454|P2|STARTED|Overall Study|9 sites randomized to intervention, providers completed surveys before and/or after study period|69
1060313|NCT00854594|2571455|P1|STARTED|Overall Study|9 sites randomized to control arm, providers completed surveys before and/or after study period|48
1060314|NCT00854607|2571467|P1|NOT COMPLETED|2 Weeks After Start Anti-fungal Therapy||65
1060315|NCT00854607|2571467|P1|COMPLETED|2 Weeks After Start Anti-fungal Therapy||51
1060316|NCT00854607|2571467|P1|STARTED|2 Weeks After Start Anti-fungal Therapy||116
1060317|NCT00854607|2571467|P1|NOT COMPLETED|Enrollment||0
1060318|NCT00854607|2571467|P1|COMPLETED|Enrollment||116
1060319|NCT00854607|2571467|P1|STARTED|Enrollment||116
1060320|NCT00854620|2571500|P1|NOT COMPLETED|Overall Study||1
1060321|NCT00854620|2571500|P1|COMPLETED|Overall Study||8
1060322|NCT00854620|2571500|P1|STARTED|Overall Study||9
1060323|NCT00854724|2571506|P2|NOT COMPLETED|Second Intervention||1
1060324|NCT00854724|2571507|P1|NOT COMPLETED|Second Intervention||1
1060325|NCT00854724|2571506|P2|COMPLETED|Second Intervention||5
1060326|NCT00854724|2571507|P1|COMPLETED|Second Intervention||5
1060327|NCT00854724|2571506|P2|STARTED|Second Intervention||6
1060328|NCT00854724|2571507|P1|STARTED|Second Intervention||6
1060329|NCT00854724|2571506|P2|NOT COMPLETED|Washout||1
1060330|NCT00854724|2571507|P1|NOT COMPLETED|Washout||1
1060331|NCT00854724|2571506|P2|COMPLETED|Washout||6
1060332|NCT00854724|2571507|P1|COMPLETED|Washout||6
1060333|NCT00854724|2571506|P2|STARTED|Washout||7
1060334|NCT00854724|2571507|P1|STARTED|Washout||7
1060335|NCT00854724|2571506|P2|NOT COMPLETED|First Intervention||1
1060336|NCT00854724|2571507|P1|NOT COMPLETED|First Intervention||1
1060337|NCT00854724|2571506|P2|COMPLETED|First Intervention||7
1060338|NCT00854724|2571507|P1|COMPLETED|First Intervention||7
1060339|NCT00854724|2571506|P2|STARTED|First Intervention||8
1060340|NCT00854724|2571507|P1|STARTED|First Intervention||8
1060341|NCT00854906|2571513|P1|NOT COMPLETED|Overall Study||1
1060342|NCT00854906|2571513|P1|COMPLETED|Overall Study|There were 26 participants in this group. One person was excluded be causes of no ocular history.|25
1060343|NCT00854906|2571513|P1|STARTED|Overall Study|There were 26 participants whose eyes were measured in the KTBUT group.|26
1060344|NCT00855062|2571522|P2|NOT COMPLETED|Step2||6
1060345|NCT00855062|2571523|P1|NOT COMPLETED|Step2||6
1060346|NCT00855062|2571522|P2|COMPLETED|Step2||15
1060347|NCT00855062|2571523|P1|COMPLETED|Step2||13
1060348|NCT00855062|2571522|P2|STARTED|Step2|26 participants completed STEP1; however, only 21 out of the 26 decided to enroll in STEP2.|21
1060349|NCT00855062|2571523|P1|STARTED|Step2|26 participants completed STEP1; however, only 19 out of the 26 decided to enroll in STEP2.|19
1060350|NCT00855062|2571522|P2|NOT COMPLETED|Step1||11
1060351|NCT00855062|2571523|P1|NOT COMPLETED|Step1||10
1060352|NCT00855062|2571522|P2|COMPLETED|Step1||26
1060353|NCT00855062|2571523|P1|COMPLETED|Step1||26
1060354|NCT00855062|2571522|P2|STARTED|Step1||37
1060355|NCT00855062|2571523|P1|STARTED|Step1||36
1060356|NCT00855166|2571549|P2|NOT COMPLETED|Overall Study||8
1060357|NCT00855166|2571550|P1|NOT COMPLETED|Overall Study||5
1060358|NCT00855166|2571549|P2|COMPLETED|Overall Study||83
1060359|NCT00855166|2571550|P1|COMPLETED|Overall Study||86
1060360|NCT00855166|2571549|P2|STARTED|Overall Study|Of the 91 randomized participants only 89 were included in the full analysis set.|91
1060361|NCT00855166|2571550|P1|STARTED|Overall Study||91
1060362|NCT00855218|2571570|P2|NOT COMPLETED|Overall Study||153
1060363|NCT00855218|2571571|P1|NOT COMPLETED|Overall Study||154
1060364|NCT00855218|2571570|P2|COMPLETED|Overall Study||0
1060365|NCT00855218|2571571|P1|COMPLETED|Overall Study||0
1060366|NCT00855218|2571570|P2|Participants Received Treatment|Overall Study||151
1060367|NCT00855218|2571571|P1|Participants Received Treatment|Overall Study||153
1060368|NCT00855218|2571570|P2|STARTED|Overall Study||153
1060369|NCT00855218|2571571|P1|STARTED|Overall Study||154
1060370|NCT00855309|2571589|P2|NOT COMPLETED|Overall Study||0
1060371|NCT00855309|2571590|P1|NOT COMPLETED|Overall Study||1
1060372|NCT00855309|2571589|P2|COMPLETED|Overall Study||55
1060373|NCT00855309|2571590|P1|COMPLETED|Overall Study||56
1060374|NCT00855309|2571589|P2|STARTED|Overall Study||55
1060375|NCT00855309|2571590|P1|STARTED|Overall Study||57
1060376|NCT00855335|2571600|P4|NOT COMPLETED|Overall Study||7
1060377|NCT00855335|2571601|P3|NOT COMPLETED|Overall Study||5
1060378|NCT00855335|2571602|P2|NOT COMPLETED|Overall Study||2
1060379|NCT00855335|2571603|P1|NOT COMPLETED|Overall Study||5
1060380|NCT00855335|2571600|P4|COMPLETED|Overall Study||12
1060381|NCT00855335|2571601|P3|COMPLETED|Overall Study||10
1060382|NCT00855335|2571602|P2|COMPLETED|Overall Study||15
1060383|NCT00855335|2571603|P1|COMPLETED|Overall Study||12
1060384|NCT00855335|2571600|P4|STARTED|Overall Study||19
1060385|NCT00855335|2571601|P3|STARTED|Overall Study||15
1060386|NCT00855335|2571602|P2|STARTED|Overall Study||17
1060387|NCT00855335|2571603|P1|STARTED|Overall Study||17
1060388|NCT00855439|2571671|P2|NOT COMPLETED|Overall Study||0
1060389|NCT00855439|2571672|P1|NOT COMPLETED|Overall Study||3
1060390|NCT00855439|2571671|P2|COMPLETED|Overall Study||24
1060391|NCT00855439|2571672|P1|COMPLETED|Overall Study||19
1060392|NCT00855439|2571671|P2|STARTED|Overall Study||24
1060393|NCT00855439|2571672|P1|STARTED|Overall Study||22
1060394|NCT00855465|2571686|P2|NOT COMPLETED|Follow-up Period (FUP)||2
1060395|NCT00855465|2571687|P1|NOT COMPLETED|Follow-up Period (FUP)||8
1060396|NCT00855465|2571686|P2|COMPLETED|Follow-up Period (FUP)||2
1060397|NCT00855465|2571687|P1|COMPLETED|Follow-up Period (FUP)||9
1060398|NCT00855465|2571686|P2|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|4
1060399|NCT00855465|2571687|P1|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|17
1060400|NCT00855465|2571686|P2|NOT COMPLETED|Treatment Period||5
1060401|NCT00855465|2571687|P1|NOT COMPLETED|Treatment Period||14
1060402|NCT00855465|2571686|P2|COMPLETED|Treatment Period||83
1060403|NCT00855465|2571687|P1|COMPLETED|Treatment Period||160
1060404|NCT00855465|2571686|P2|Participants Received Treatment|Treatment Period||88
1060405|NCT00855465|2571687|P1|Participants Received Treatment|Treatment Period|1 subject randomized but not treated|173
1060406|NCT00855465|2571686|P2|STARTED|Treatment Period||88
1060407|NCT00855465|2571687|P1|STARTED|Treatment Period||174
1060408|NCT00855582|2571778|P3|NOT COMPLETED|Overall Study||30
1060409|NCT00855582|2571779|P2|NOT COMPLETED|Overall Study||24
1060410|NCT00855582|2571780|P1|NOT COMPLETED|Overall Study||26
1060411|NCT00855582|2571778|P3|COMPLETED|Overall Study||170
1060412|NCT00855582|2571779|P2|COMPLETED|Overall Study||184
1060413|NCT00855582|2571780|P1|COMPLETED|Overall Study||172
1060414|NCT00855582|2571778|P3|STARTED|Overall Study||200
1060415|NCT00855582|2571779|P2|STARTED|Overall Study||208
1060416|NCT00855582|2571780|P1|STARTED|Overall Study||198
1060417|NCT00855595|2571869|P2|NOT COMPLETED|Overall Study||7
1060418|NCT00855595|2571870|P1|NOT COMPLETED|Overall Study||6
1060419|NCT00855595|2571869|P2|COMPLETED|Overall Study||94
1060420|NCT00855595|2571870|P1|COMPLETED|Overall Study||100
1060421|NCT00855595|2571869|P2|STARTED|Overall Study||101
1060422|NCT00855595|2571870|P1|STARTED|Overall Study||106
1060423|NCT00855738|2571906|P1|NOT COMPLETED|Overall Study||5
1060424|NCT00855738|2571906|P1|COMPLETED|Overall Study||106
1060425|NCT00855738|2571906|P1|At Least 1 Dose and 1 Endpoint|Overall Study|Received at least 1 dose of study drug and had data for at least 1 efficacy endpoint.|108
1060426|NCT00855738|2571906|P1|STARTED|Overall Study||111
1060427|NCT00855816|2571934|P2|NOT COMPLETED|Overall Study||21
1060428|NCT00855816|2571935|P1|NOT COMPLETED|Overall Study||26
1060429|NCT00855816|2571934|P2|COMPLETED|Overall Study||12
1060430|NCT00855816|2571935|P1|COMPLETED|Overall Study||21
1060431|NCT00855816|2571934|P2|STARTED|Overall Study||33
1060432|NCT00855816|2571935|P1|STARTED|Overall Study||47
1060433|NCT00855842|2571941|P1|NOT COMPLETED|Overall Study||0
1060434|NCT00855842|2571941|P1|COMPLETED|Overall Study||4
1060435|NCT00855842|2571941|P1|STARTED|Overall Study||4
1060436|NCT00855868|2571947|P2|NOT COMPLETED|Overall Study||1
1060437|NCT00855868|2571948|P1|NOT COMPLETED|Overall Study||1
1060438|NCT00855868|2571947|P2|COMPLETED|Overall Study||14
1060439|NCT00855868|2571948|P1|COMPLETED|Overall Study||12
1060440|NCT00855868|2571947|P2|STARTED|Overall Study||15
1060441|NCT00855868|2571948|P1|STARTED|Overall Study||13
1060442|NCT00855894|2571954|P1|NOT COMPLETED|Overall Study||33
1060443|NCT00855894|2571954|P1|COMPLETED|Overall Study||8
1060444|NCT00855894|2571954|P1|STARTED|Overall Study||41
1060445|NCT00855920|2571965|P3|NOT COMPLETED|Overall Study||11
1060446|NCT00855920|2571966|P2|NOT COMPLETED|Overall Study||9
1060447|NCT00855920|2571967|P1|NOT COMPLETED|Overall Study||8
1060448|NCT00855920|2571965|P3|COMPLETED|Overall Study||64
1060449|NCT00855920|2571966|P2|COMPLETED|Overall Study||65
1060450|NCT00855920|2571967|P1|COMPLETED|Overall Study||68
1060451|NCT00855920|2571965|P3|Safety Population|Overall Study||75
1060452|NCT00855920|2571966|P2|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|73
1060453|NCT00855920|2571967|P1|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|77
1060454|NCT00855920|2571965|P3|STARTED|Overall Study||75
1060455|NCT00855920|2571966|P2|STARTED|Overall Study||74
1060456|NCT00855920|2571967|P1|STARTED|Overall Study||76
1060457|NCT00855933|2571986|P2|NOT COMPLETED|Overall Study||1
1060458|NCT00855933|2571987|P1|NOT COMPLETED|Overall Study||0
1060459|NCT00855933|2571986|P2|COMPLETED|Overall Study||29
1060460|NCT00855933|2571987|P1|COMPLETED|Overall Study||30
1060461|NCT00855933|2571986|P2|STARTED|Overall Study||30
1060462|NCT00855933|2571987|P1|STARTED|Overall Study||30
1060463|NCT00855959|2571993|P1|NOT COMPLETED|Overall Study||9
1060464|NCT00855959|2571993|P1|COMPLETED|Overall Study||99
1060465|NCT00855959|2571993|P1|Patients Who Received Pulmicort Respules|Overall Study||105
1060466|NCT00855959|2571993|P1|STARTED|Overall Study||108
1060467|NCT00856024|2572008|P1|NOT COMPLETED|Overall Study||0
1060468|NCT00856024|2572008|P1|COMPLETED|Overall Study||902
1060469|NCT00856024|2572008|P1|STARTED|Overall Study||902
1060470|NCT00856050|2572020|P1|NOT COMPLETED|Overall Study||0
1060471|NCT00856050|2572020|P1|COMPLETED|Overall Study||26
1060472|NCT00856050|2572020|P1|STARTED|Overall Study||26
1060473|NCT00856180|2572024|P1|NOT COMPLETED|Overall Study||20
1060474|NCT00856180|2572024|P1|COMPLETED|Overall Study||0
1060475|NCT00856180|2572024|P1|STARTED|Overall Study||20
1060476|NCT00856193|2572033|P2|NOT COMPLETED|Period 2||2
1060477|NCT00856193|2572034|P1|NOT COMPLETED|Period 2||0
1060478|NCT00856193|2572033|P2|COMPLETED|Period 2||15
1060479|NCT00856193|2572034|P1|COMPLETED|Period 2||16
1060480|NCT00856193|2572033|P2|STARTED|Period 2||17
1060481|NCT00856193|2572034|P1|STARTED|Period 2||16
1060482|NCT00856193|2572033|P2|NOT COMPLETED|Period 1||0
1060483|NCT00856193|2572034|P1|NOT COMPLETED|Period 1||0
1060484|NCT00856193|2572033|P2|COMPLETED|Period 1||17
1060485|NCT00856193|2572034|P1|COMPLETED|Period 1||16
1060486|NCT00856193|2572033|P2|STARTED|Period 1||17
1060487|NCT00856193|2572034|P1|STARTED|Period 1||16
1060488|NCT00856206|2572048|P2|NOT COMPLETED|Overall Study||161
1060489|NCT00856206|2572049|P1|NOT COMPLETED|Overall Study||54
1060490|NCT00856206|2572048|P2|COMPLETED|Overall Study||824
1060491|NCT00856206|2572049|P1|COMPLETED|Overall Study||276
1060492|NCT00856206|2572048|P2|STARTED|Overall Study||985
1060493|NCT00856206|2572049|P1|STARTED|Overall Study||330
1060494|NCT00856232|2572066|P3|NOT COMPLETED|Overall Study||0
1060495|NCT00856232|2572067|P2|NOT COMPLETED|Overall Study||0
1060496|NCT00856232|2572068|P1|NOT COMPLETED|Overall Study||0
1060497|NCT00856232|2572066|P3|COMPLETED|Overall Study||36
1060498|NCT00856232|2572067|P2|COMPLETED|Overall Study||29
1060499|NCT00856232|2572068|P1|COMPLETED|Overall Study||26
1060500|NCT00856232|2572066|P3|STARTED|Overall Study||36
1060501|NCT00856232|2572067|P2|STARTED|Overall Study||29
1060502|NCT00856232|2572068|P1|STARTED|Overall Study||26
1060503|NCT00856245|2572079|P1|NOT COMPLETED|Overall Study||5
1060504|NCT00856245|2572079|P1|COMPLETED|Overall Study||14
1060505|NCT00856245|2572079|P1|STARTED|Overall Study||19
1060518|NCT00856297|2572120|P5|NOT COMPLETED|Overall Study||0
1060519|NCT00856297|2572121|P4|NOT COMPLETED|Overall Study||0
1060520|NCT00856297|2572122|P3|NOT COMPLETED|Overall Study||0
1060521|NCT00856297|2572123|P2|NOT COMPLETED|Overall Study||0
1060522|NCT00856297|2572124|P1|NOT COMPLETED|Overall Study||2
1060523|NCT00856297|2572120|P5|COMPLETED|Overall Study||31
1060524|NCT00856297|2572121|P4|COMPLETED|Overall Study||44
1060525|NCT00856297|2572122|P3|COMPLETED|Overall Study||107
1060526|NCT00856297|2572123|P2|COMPLETED|Overall Study||76
1060527|NCT00856297|2572124|P1|COMPLETED|Overall Study||129
1060528|NCT00856297|2572120|P5|STARTED|Overall Study||31
1060529|NCT00856297|2572121|P4|STARTED|Overall Study||44
1060530|NCT00856297|2572122|P3|STARTED|Overall Study||107
1060531|NCT00856297|2572123|P2|STARTED|Overall Study||76
1060532|NCT00856297|2572124|P1|STARTED|Overall Study||131
1060533|NCT00856323|2572154|P1|NOT COMPLETED|Overall Study||2
1060534|NCT00856323|2572154|P1|COMPLETED|Overall Study||51
1060535|NCT00856323|2572154|P1|STARTED|Overall Study||53
1060536|NCT00856349|2572161|P1|NOT COMPLETED|Overall Study||1021
1060537|NCT00856349|2572161|P1|COMPLETED|Overall Study||3111
1060538|NCT00856349|2572161|P1|24 Month Follow-up|Overall Study||1698
1060539|NCT00856349|2572161|P1|18 Month Follow-up|Overall Study||2467
1060540|NCT00856349|2572161|P1|12 Month Follow-up|Overall Study||3228
1060541|NCT00856349|2572161|P1|STARTED|Overall Study||4132
1060542|NCT00856388|2572170|P1|NOT COMPLETED|Overall Study||1
1060543|NCT00856388|2572170|P1|COMPLETED|Overall Study||61
1060544|NCT00856388|2572170|P1|STARTED|Overall Study||62
1060545|NCT00856414|2572181|P1|NOT COMPLETED|Overall Study||0
1060546|NCT00856414|2572181|P1|COMPLETED|Overall Study||45
1060547|NCT00856414|2572181|P1|STARTED|Overall Study||45
1060548|NCT00856492|2572192|P3|NOT COMPLETED|Overall Study||2
1060549|NCT00856492|2572193|P2|NOT COMPLETED|Overall Study||1
1060550|NCT00856492|2572194|P1|NOT COMPLETED|Overall Study||1
1060551|NCT00856492|2572192|P3|COMPLETED|Overall Study||51
1060552|NCT00856492|2572193|P2|COMPLETED|Overall Study||62
1060553|NCT00856492|2572194|P1|COMPLETED|Overall Study||98
1060554|NCT00856492|2572192|P3|Toxicity Eval|Overall Study||51
1060555|NCT00856492|2572193|P2|Toxicity Eval|Overall Study||60
1060556|NCT00856492|2572194|P1|Toxicity Eval|Overall Study||96
1060557|NCT00856492|2572192|P3|STARTED|Overall Study||53
1060558|NCT00856492|2572193|P2|STARTED|Overall Study||63
1060559|NCT00856492|2572194|P1|STARTED|Overall Study||99
1060560|NCT00856518|2572210|P2|NOT COMPLETED|Overall Study||2
1060561|NCT00856518|2572211|P1|NOT COMPLETED|Overall Study||4
1060562|NCT00856518|2572210|P2|COMPLETED|Overall Study||16
1060563|NCT00856518|2572211|P1|COMPLETED|Overall Study||20
1060564|NCT00856518|2572210|P2|STARTED|Overall Study||18
1060565|NCT00856518|2572211|P1|STARTED|Overall Study||24
1060566|NCT00856544|2572225|P4|NOT COMPLETED|Overall Study||13
1060567|NCT00856544|2572226|P3|NOT COMPLETED|Overall Study||8
1060568|NCT00856544|2572227|P2|NOT COMPLETED|Overall Study||66
1060569|NCT00856544|2572228|P1|NOT COMPLETED|Overall Study||57
1060570|NCT00856544|2572225|P4|COMPLETED|Overall Study||67
1060571|NCT00856544|2572226|P3|COMPLETED|Overall Study||71
1060572|NCT00856544|2572227|P2|COMPLETED|Overall Study||252
1060573|NCT00856544|2572228|P1|COMPLETED|Overall Study||261
1060574|NCT00856544|2572225|P4|Treated|Overall Study||80
1060575|NCT00856544|2572226|P3|Treated|Overall Study||79
1060576|NCT00856544|2572227|P2|Treated|Overall Study||318
1060577|NCT00856544|2572228|P1|Treated|Overall Study||315
1060578|NCT00856544|2572225|P4|STARTED|Overall Study||80
1060579|NCT00856544|2572226|P3|STARTED|Overall Study||79
1060580|NCT00856544|2572227|P2|STARTED|Overall Study||318
1060581|NCT00856544|2572228|P1|STARTED|Overall Study||318
1060582|NCT00856557|2572407|P2|NOT COMPLETED|Overall Study||16
1060583|NCT00856557|2572408|P1|NOT COMPLETED|Overall Study||12
1060584|NCT00856557|2572407|P2|COMPLETED|Overall Study||60
1060585|NCT00856557|2572408|P1|COMPLETED|Overall Study||50
1060586|NCT00856557|2572407|P2|With Patients With Contextual Flags|Overall Study||60
1060587|NCT00856557|2572408|P1|With Patients With Contextual Flags|Overall Study||50
1060588|NCT00856557|2572407|P2|Tested With Standardized Patients|Overall Study||76
1060589|NCT00856557|2572408|P1|Tested With Standardized Patients|Overall Study||62
1060590|NCT00856557|2572407|P2|Received Intervention/Control|Overall Study||76
1060591|NCT00856557|2572408|P1|Received Intervention/Control|Overall Study||62
1060592|NCT00856557|2572407|P2|STARTED|Overall Study||76
1060593|NCT00856557|2572408|P1|STARTED|Overall Study||62
1060594|NCT00856583|2572420|P2|NOT COMPLETED|Overall Study||2597
1060595|NCT00856583|2572421|P1|NOT COMPLETED|Overall Study||3137
1060596|NCT00856583|2572420|P2|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|2307
1060597|NCT00856583|2572421|P1|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|1768
1060598|NCT00856583|2572420|P2|STARTED|Overall Study|Patients treated|4904
1060599|NCT00856583|2572421|P1|STARTED|Overall Study|Patients treated|4905
1060600|NCT00856635|2572451|P2|NOT COMPLETED|Overall Study||8
1060601|NCT00856635|2572452|P1|NOT COMPLETED|Overall Study||10
1060602|NCT00856635|2572451|P2|COMPLETED|Overall Study||14
1060603|NCT00856635|2572452|P1|COMPLETED|Overall Study||12
1060604|NCT00856635|2572451|P2|Received Study Drug|Overall Study||20
1060605|NCT00856635|2572452|P1|Received Study Drug|Overall Study||20
1060606|NCT00856635|2572451|P2|STARTED|Overall Study||22
1060607|NCT00856635|2572452|P1|STARTED|Overall Study||22
1060608|NCT00856661|2572460|P2|NOT COMPLETED|Overall Study||29
1060609|NCT00856661|2572461|P1|NOT COMPLETED|Overall Study||27
1060610|NCT00856661|2572460|P2|COMPLETED|Overall Study||106
1060611|NCT00856661|2572461|P1|COMPLETED|Overall Study||108
1060612|NCT00856661|2572460|P2|Randomized Not Treated|Overall Study||4
1060613|NCT00856661|2572461|P1|Randomized Not Treated|Overall Study||9
1060614|NCT00856661|2572460|P2|Treated|Overall Study||131
1060615|NCT00856661|2572461|P1|Treated|Overall Study||126
1060616|NCT00856661|2572460|P2|STARTED|Overall Study|Randomised|135
1060617|NCT00856661|2572461|P1|STARTED|Overall Study|Randomised|135
1060618|NCT00856726|2572473|P1|NOT COMPLETED|Overall Study||0
1060619|NCT00856726|2572473|P1|COMPLETED|Overall Study||26
1060620|NCT00856726|2572473|P1|STARTED|Overall Study||26
1060621|NCT00856739|2572485|P3|NOT COMPLETED|Overall Study||0
1060622|NCT00856739|2572486|P2|NOT COMPLETED|Overall Study||0
1060623|NCT00856739|2572487|P1|NOT COMPLETED|Overall Study||0
1060624|NCT00856739|2572485|P3|COMPLETED|Overall Study||55
1060625|NCT00856739|2572486|P2|COMPLETED|Overall Study||52
1060626|NCT00856739|2572487|P1|COMPLETED|Overall Study||70
1060627|NCT00856739|2572485|P3|STARTED|Overall Study||55
1060628|NCT00856739|2572486|P2|STARTED|Overall Study||52
1060629|NCT00856739|2572487|P1|STARTED|Overall Study||70
1060633|NCT00848783|2572506|P3|NOT COMPLETED|Overall Study||0
1060634|NCT00848783|2572507|P2|NOT COMPLETED|Overall Study||2
1060635|NCT00848783|2572508|P1|NOT COMPLETED|Overall Study||3
1060636|NCT00848783|2572506|P3|COMPLETED|Overall Study||1
1060637|NCT00848783|2572507|P2|COMPLETED|Overall Study||1
1060638|NCT00848783|2572508|P1|COMPLETED|Overall Study||1
1060639|NCT00848783|2572506|P3|STARTED|Overall Study||1
1060640|NCT00848783|2572507|P2|STARTED|Overall Study||3
1060641|NCT00848783|2572508|P1|STARTED|Overall Study||4
1060642|NCT00856778|2572514|P1|NOT COMPLETED|Overall Study||24
1060643|NCT00856778|2572514|P1|COMPLETED|Overall Study||74
1060644|NCT00856778|2572514|P1|STARTED|Overall Study||98
1060645|NCT00856791|2572530|P1|NOT COMPLETED|Overall Study||0
1060646|NCT00856791|2572530|P1|COMPLETED|Overall Study||1
1060647|NCT00856791|2572530|P1|STARTED|Overall Study||1
1060648|NCT00856830|2572539|P4|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
1060649|NCT00856830|2572540|P3|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
1060650|NCT00856830|2572541|P2|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
1060651|NCT00856830|2572542|P1|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
1060652|NCT00856830|2572539|P4|COMPLETED|Regimen - B (Carboplatin & Etoposide)||12
1060653|NCT00856830|2572540|P3|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
1060654|NCT00856830|2572541|P2|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
1060655|NCT00856830|2572542|P1|COMPLETED|Regimen - B (Carboplatin & Etoposide)||3
1060656|NCT00856830|2572539|P4|STARTED|Regimen - B (Carboplatin & Etoposide)||12
1060657|NCT00856830|2572540|P3|STARTED|Regimen - B (Carboplatin & Etoposide)||6
1060658|NCT00856830|2572541|P2|STARTED|Regimen - B (Carboplatin & Etoposide)||6
1060659|NCT00856830|2572542|P1|STARTED|Regimen - B (Carboplatin & Etoposide)||3
1060660|NCT00856830|2572539|P4|NOT COMPLETED|Irinotecan & Bendamustine||3
1060661|NCT00856830|2572540|P3|NOT COMPLETED|Irinotecan & Bendamustine||0
1060662|NCT00856830|2572541|P2|NOT COMPLETED|Irinotecan & Bendamustine||0
1060663|NCT00856830|2572542|P1|NOT COMPLETED|Irinotecan & Bendamustine||0
1060664|NCT00856830|2572539|P4|COMPLETED|Irinotecan & Bendamustine||12
1060665|NCT00856830|2572540|P3|COMPLETED|Irinotecan & Bendamustine||6
1060666|NCT00856830|2572541|P2|COMPLETED|Irinotecan & Bendamustine||6
1060667|NCT00856830|2572542|P1|COMPLETED|Irinotecan & Bendamustine||3
1060668|NCT00856830|2572539|P4|Maximum Tolerated Dose|Irinotecan & Bendamustine||12
1060669|NCT00856830|2572540|P3|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
1060670|NCT00856830|2572541|P2|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
1060671|NCT00856830|2572542|P1|Maximum Tolerated Dose|Irinotecan & Bendamustine||3
1060672|NCT00856830|2572539|P4|STARTED|Irinotecan & Bendamustine||15
1060673|NCT00856830|2572540|P3|STARTED|Irinotecan & Bendamustine||6
1060674|NCT00856830|2572541|P2|STARTED|Irinotecan & Bendamustine||6
1060675|NCT00856830|2572542|P1|STARTED|Irinotecan & Bendamustine||3
1060676|NCT00856843|2572550|P2|NOT COMPLETED|Overall Study||5
1060677|NCT00856843|2572551|P1|NOT COMPLETED|Overall Study||2
1060678|NCT00856843|2572550|P2|COMPLETED|Overall Study||63
1060679|NCT00856843|2572551|P1|COMPLETED|Overall Study||66
1060680|NCT00856843|2572550|P2|STARTED|Overall Study||68
1060681|NCT00856843|2572551|P1|STARTED|Overall Study||68
1060682|NCT00856908|2572585|P2|NOT COMPLETED|Overall Study||0
1060683|NCT00856908|2572586|P1|NOT COMPLETED|Overall Study||1
1060684|NCT00856908|2572585|P2|COMPLETED|Overall Study||5
1060685|NCT00856908|2572586|P1|COMPLETED|Overall Study||14
1060686|NCT00856908|2572585|P2|STARTED|Overall Study||5
1060687|NCT00856908|2572586|P1|STARTED|Overall Study||15
1060688|NCT00856934|2572614|P3|NOT COMPLETED|Overall Study||0
1060689|NCT00856934|2572615|P2|NOT COMPLETED|Overall Study||0
1060690|NCT00856934|2572616|P1|NOT COMPLETED|Overall Study||0
1060691|NCT00856934|2572614|P3|COMPLETED|Overall Study||15
1060692|NCT00856934|2572615|P2|COMPLETED|Overall Study||15
1060693|NCT00856934|2572616|P1|COMPLETED|Overall Study||15
1060694|NCT00856934|2572614|P3|STARTED|Overall Study||15
1060695|NCT00856934|2572615|P2|STARTED|Overall Study||15
1060696|NCT00856934|2572616|P1|STARTED|Overall Study||15
1060697|NCT00856973|2572627|P3|NOT COMPLETED|Overall Study||38
1060698|NCT00856973|2572628|P2|NOT COMPLETED|Overall Study||41
1060699|NCT00856973|2572629|P1|NOT COMPLETED|Overall Study||36
1060700|NCT00856973|2572627|P3|COMPLETED|Overall Study||123
1060701|NCT00856973|2572628|P2|COMPLETED|Overall Study||122
1060702|NCT00856973|2572629|P1|COMPLETED|Overall Study||126
1060703|NCT00856973|2572627|P3|STARTED|Overall Study||161
1060704|NCT00856973|2572628|P2|STARTED|Overall Study||163
1060705|NCT00856973|2572629|P1|STARTED|Overall Study||162
1060706|NCT00856986|2572699|P5|NOT COMPLETED|Extension Period, Weeks 26-52||0
1060707|NCT00856986|2572700|P4|NOT COMPLETED|Extension Period, Weeks 26-52||0
1060708|NCT00856986|2572701|P3|NOT COMPLETED|Extension Period, Weeks 26-52||38
1060709|NCT00856986|2572702|P2|NOT COMPLETED|Extension Period, Weeks 26-52||14
1060710|NCT00856986|2572703|P1|NOT COMPLETED|Extension Period, Weeks 26-52||19
1060711|NCT00856986|2572699|P5|COMPLETED|Extension Period, Weeks 26-52||0
1060712|NCT00856986|2572700|P4|COMPLETED|Extension Period, Weeks 26-52||0
1060713|NCT00856986|2572701|P3|COMPLETED|Extension Period, Weeks 26-52||432
1060714|NCT00856986|2572702|P2|COMPLETED|Extension Period, Weeks 26-52||130
1060715|NCT00856986|2572703|P1|COMPLETED|Extension Period, Weeks 26-52||108
1060716|NCT00856986|2572699|P5|Enrolled in Extension|Extension Period, Weeks 26-52||0
1060717|NCT00856986|2572700|P4|Enrolled in Extension|Extension Period, Weeks 26-52||0
1060718|NCT00856986|2572701|P3|Enrolled in Extension|Extension Period, Weeks 26-52||461
1060719|NCT00856986|2572702|P2|Enrolled in Extension|Extension Period, Weeks 26-52||140
1060720|NCT00856986|2572703|P1|Enrolled in Extension|Extension Period, Weeks 26-52||122
1060721|NCT00856986|2572699|P5|STARTED|Extension Period, Weeks 26-52||0
1060722|NCT00856986|2572700|P4|STARTED|Extension Period, Weeks 26-52||0
1060723|NCT00856986|2572701|P3|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 7 (Intensified Group)|470
1060724|NCT00856986|2572702|P2|STARTED|Extension Period, Weeks 26-52||144
1060725|NCT00856986|2572703|P1|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 17 (Intensified Group)|127
1060726|NCT00856986|2572699|P5|NOT COMPLETED|Main Period, Weeks 0-26||0
1060727|NCT00856986|2572700|P4|NOT COMPLETED|Main Period, Weeks 0-26||0
1060728|NCT00856986|2572701|P3|NOT COMPLETED|Main Period, Weeks 0-26||28
1060729|NCT00856986|2572702|P2|NOT COMPLETED|Main Period, Weeks 0-26||18
1060730|NCT00856986|2572703|P1|NOT COMPLETED|Main Period, Weeks 0-26||34
1060731|NCT00856986|2572699|P5|COMPLETED|Main Period, Weeks 0-26||0
1060732|NCT00856986|2572700|P4|COMPLETED|Main Period, Weeks 0-26||0
1060733|NCT00856986|2572701|P3|COMPLETED|Main Period, Weeks 0-26||470
1060734|NCT00856986|2572702|P2|COMPLETED|Main Period, Weeks 0-26||144
1060735|NCT00856986|2572703|P1|COMPLETED|Main Period, Weeks 0-26||127
1060736|NCT00856986|2572699|P5|STARTED|Main Period, Weeks 0-26||0
1060737|NCT00856986|2572700|P4|STARTED|Main Period, Weeks 0-26||0
1060738|NCT00856986|2572701|P3|STARTED|Main Period, Weeks 0-26||498
1060739|NCT00856986|2572702|P2|STARTED|Main Period, Weeks 0-26||162
1060740|NCT00856986|2572703|P1|STARTED|Main Period, Weeks 0-26||161
1060741|NCT00856986|2572699|P5|NOT COMPLETED|Run-in Period, Weeks -12-0||0
1060742|NCT00856986|2572700|P4|NOT COMPLETED|Run-in Period, Weeks -12-0||167
1060743|NCT00856986|2572701|P3|NOT COMPLETED|Run-in Period, Weeks -12-0||0
1060744|NCT00856986|2572702|P2|NOT COMPLETED|Run-in Period, Weeks -12-0||0
1060745|NCT00856986|2572703|P1|NOT COMPLETED|Run-in Period, Weeks -12-0||0
1060746|NCT00856986|2572699|P5|COMPLETED|Run-in Period, Weeks -12-0||0
1060747|NCT00856986|2572700|P4|COMPLETED|Run-in Period, Weeks -12-0|Subjects who withdrew during run-in and before randomisation were Early Withdrawals|0
1060748|NCT00856986|2572701|P3|COMPLETED|Run-in Period, Weeks -12-0||498
1060749|NCT00856986|2572702|P2|COMPLETED|Run-in Period, Weeks -12-0||162
1060750|NCT00856986|2572703|P1|COMPLETED|Run-in Period, Weeks -12-0||161
1060751|NCT00856986|2572699|P5|STARTED|Run-in Period, Weeks -12-0||0
1060752|NCT00856986|2572700|P4|STARTED|Run-in Period, Weeks -12-0||167
1060753|NCT00856986|2572701|P3|STARTED|Run-in Period, Weeks -12-0||498
1060754|NCT00856986|2572702|P2|STARTED|Run-in Period, Weeks -12-0||162
1060755|NCT00856986|2572703|P1|STARTED|Run-in Period, Weeks -12-0||161
1060759|NCT00857233|2572887|P1|NOT COMPLETED|Overall Study||55
1060760|NCT00857233|2572887|P1|COMPLETED|Overall Study||242
1060761|NCT00857233|2572887|P1|STARTED|Overall Study||297
1060762|NCT00857246|2572896|P1|NOT COMPLETED|ChemoRT||3
1060763|NCT00857246|2572896|P1|COMPLETED|ChemoRT||12
1060764|NCT00857246|2572896|P1|STARTED|ChemoRT|6 did not start adjuvant therapy due to disease-related complications or patient withdrawal.|15
1060765|NCT00857246|2572896|P1|NOT COMPLETED|Surgery (Curative)||6
1060766|NCT00857246|2572896|P1|COMPLETED|Surgery (Curative)||21
1060767|NCT00857246|2572896|P1|STARTED|Surgery (Curative)||27
1060768|NCT00857246|2572896|P1|NOT COMPLETED|Induction Regimen||3
1060769|NCT00857246|2572896|P1|COMPLETED|Induction Regimen||27
1060770|NCT00857246|2572896|P1|STARTED|Induction Regimen||30
1060771|NCT00857259|2572909|P3|NOT COMPLETED|Overall Study||1
1060772|NCT00857259|2572910|P2|NOT COMPLETED|Overall Study||0
1060773|NCT00857259|2572911|P1|NOT COMPLETED|Overall Study||1
1060774|NCT00857259|2572909|P3|COMPLETED|Overall Study||6
1060775|NCT00857259|2572910|P2|COMPLETED|Overall Study||1
1060776|NCT00857259|2572911|P1|COMPLETED|Overall Study||7
1060777|NCT00857259|2572909|P3|STARTED|Overall Study||7
1060778|NCT00857259|2572910|P2|STARTED|Overall Study||1
1060779|NCT00857259|2572911|P1|STARTED|Overall Study||8
1060780|NCT00857272|2572923|P2|NOT COMPLETED|Overall Study||9
1060781|NCT00857272|2572924|P1|NOT COMPLETED|Overall Study||9
1060782|NCT00857272|2572923|P2|COMPLETED|Overall Study||145
1060783|NCT00857272|2572924|P1|COMPLETED|Overall Study||145
1060784|NCT00857272|2572923|P2|STARTED|Overall Study|Includes 7 non-ITT patients that withdrew consent|154
1060785|NCT00857272|2572924|P1|STARTED|Overall Study|Includes 6 non-ITT patients that withdrew consent|154
1060786|NCT00857285|2572932|P2|NOT COMPLETED|Overall Study||6
1060787|NCT00857285|2572933|P1|NOT COMPLETED|Overall Study||12
1060788|NCT00857285|2572932|P2|COMPLETED|Overall Study||59
1060789|NCT00857285|2572933|P1|COMPLETED|Overall Study||53
1060790|NCT00857285|2572932|P2|STARTED|Overall Study||65
1060791|NCT00857285|2572933|P1|STARTED|Overall Study||65
1060792|NCT00857311|2572941|P4|NOT COMPLETED|Overall Study||0
1060793|NCT00857311|2572942|P3|NOT COMPLETED|Overall Study||0
1060794|NCT00857311|2572943|P2|NOT COMPLETED|Overall Study||0
1060795|NCT00857311|2572944|P1|NOT COMPLETED|Overall Study||1
1060796|NCT00857311|2572941|P4|COMPLETED|Overall Study||0
1060797|NCT00857311|2572942|P3|COMPLETED|Overall Study||8
1060798|NCT00857311|2572943|P2|COMPLETED|Overall Study||0
1060799|NCT00857311|2572944|P1|COMPLETED|Overall Study||8
1060800|NCT00857311|2572941|P4|STARTED|Overall Study||0
1060801|NCT00857311|2572942|P3|STARTED|Overall Study||8
1060802|NCT00857311|2572943|P2|STARTED|Overall Study||0
1060803|NCT00857311|2572944|P1|STARTED|Overall Study||9
1060804|NCT00857415|2572956|P2|NOT COMPLETED|Overall Study||0
1060805|NCT00857415|2572957|P1|NOT COMPLETED|Overall Study||117
1060806|NCT00857415|2572956|P2|COMPLETED|Overall Study||74
1060807|NCT00857415|2572957|P1|COMPLETED|Overall Study||35
1060808|NCT00857415|2572956|P2|Deceased Within One Year of AV-45 Scan|Overall Study|Subjects in the specificity cohort were not followed to autopsy|0
1060809|NCT00857415|2572957|P1|Deceased Within One Year of AV-45 Scan|Overall Study||37
1060810|NCT00857415|2572956|P2|STARTED|Overall Study||74
1060811|NCT00857415|2572957|P1|STARTED|Overall Study||152
1060812|NCT00857454|2572964|P1|NOT COMPLETED|Overall Study||20
1060813|NCT00857454|2572964|P1|COMPLETED|Overall Study||51
1060814|NCT00857454|2572964|P1|STARTED|Overall Study||71
1060815|NCT00857506|2572978|P3|NOT COMPLETED|Overall Study||18
1060816|NCT00857506|2572979|P2|NOT COMPLETED|Overall Study||15
1060817|NCT00857506|2572980|P1|NOT COMPLETED|Overall Study||15
1060818|NCT00857506|2572978|P3|COMPLETED|Overall Study||51
1060819|NCT00857506|2572979|P2|COMPLETED|Overall Study||37
1060820|NCT00857506|2572980|P1|COMPLETED|Overall Study||16
1060821|NCT00857506|2572978|P3|STARTED|Overall Study||69
1060822|NCT00857506|2572979|P2|STARTED|Overall Study||52
1060823|NCT00857506|2572980|P1|STARTED|Overall Study||31
1060824|NCT00857532|2573006|P1|NOT COMPLETED|Overall Study||0
1060825|NCT00857532|2573006|P1|COMPLETED|Overall Study||31
1060826|NCT00857532|2573006|P1|STARTED|Overall Study||31
1060827|NCT00857545|2573016|P2|NOT COMPLETED|Overall Study||0
1060828|NCT00857545|2573017|P1|NOT COMPLETED|Overall Study||0
1060829|NCT00857545|2573016|P2|COMPLETED|Overall Study||85
1060830|NCT00857545|2573017|P1|COMPLETED|Overall Study|Enrolled and randomized participants.|86
1060831|NCT00857545|2573016|P2|STARTED|Overall Study||85
1060832|NCT00857545|2573017|P1|STARTED|Overall Study||86
1060833|NCT00857584|2573029|P2|NOT COMPLETED|Overall Study||5
1060834|NCT00857584|2573030|P1|NOT COMPLETED|Overall Study||4
1060835|NCT00857584|2573029|P2|COMPLETED|Overall Study||8
1060836|NCT00857584|2573030|P1|COMPLETED|Overall Study||10
1060837|NCT00857584|2573029|P2|Week 8|Overall Study||8
1060838|NCT00857584|2573030|P1|Week 8|Overall Study||10
1060839|NCT00857584|2573029|P2|Week 4|Overall Study||9
1060840|NCT00857584|2573030|P1|Week 4|Overall Study||11
1060841|NCT00857584|2573029|P2|Week 2|Overall Study||11
1060842|NCT00857584|2573030|P1|Week 2|Overall Study||14
1060843|NCT00857584|2573029|P2|Week 1|Overall Study||13
1060844|NCT00857584|2573030|P1|Week 1|Overall Study||14
1060845|NCT00857584|2573029|P2|STARTED|Overall Study||13
1060846|NCT00857584|2573030|P1|STARTED|Overall Study||14
1060847|NCT00857623|2573072|P2|NOT COMPLETED|Overall Study||10
1060848|NCT00857623|2573073|P1|NOT COMPLETED|Overall Study||14
1060849|NCT00857623|2573072|P2|COMPLETED|Overall Study||55
1060850|NCT00857623|2573073|P1|COMPLETED|Overall Study||48
1060851|NCT00857623|2573072|P2|STARTED|Overall Study||65
1060852|NCT00857623|2573073|P1|STARTED|Overall Study||62
1060853|NCT00857649|2573097|P2|NOT COMPLETED|Overall Study||32
1060854|NCT00857649|2573098|P1|NOT COMPLETED|Overall Study||31
1060855|NCT00857649|2573097|P2|COMPLETED|Overall Study||155
1060856|NCT00857649|2573098|P1|COMPLETED|Overall Study||151
1060857|NCT00857649|2573097|P2|STARTED|Overall Study||187
1060858|NCT00857649|2573098|P1|STARTED|Overall Study||182
1060859|NCT00857714|2573112|P1|NOT COMPLETED|Overall Study||0
1060860|NCT00857714|2573112|P1|COMPLETED|Overall Study||1
1060861|NCT00857714|2573112|P1|STARTED|Overall Study||1
1060862|NCT00857766|2573119|P2|NOT COMPLETED|Overall Study||30
1060863|NCT00857766|2573120|P1|NOT COMPLETED|Overall Study||31
1060864|NCT00857766|2573119|P2|COMPLETED|Overall Study||96
1060865|NCT00857766|2573120|P1|COMPLETED|Overall Study||92
1060866|NCT00857766|2573119|P2|STARTED|Overall Study||126
1060867|NCT00857766|2573120|P1|STARTED|Overall Study||123
1060868|NCT00857792|2573130|P1|NOT COMPLETED|Overall Study||12
1060869|NCT00857792|2573130|P1|COMPLETED|Overall Study||108
1060870|NCT00857792|2573130|P1|STARTED|Overall Study||120
1060871|NCT00857818|2573136|P2|NOT COMPLETED|Overall Study||8
1060872|NCT00857818|2573137|P1|NOT COMPLETED|Overall Study||11
1060873|NCT00857818|2573136|P2|COMPLETED|Overall Study||6
1060874|NCT00857818|2573137|P1|COMPLETED|Overall Study||3
1060875|NCT00857818|2573136|P2|Received Treatment|Overall Study||12
1060876|NCT00857818|2573137|P1|Received Treatment|Overall Study||14
1060877|NCT00857818|2573136|P2|STARTED|Overall Study||14
1060878|NCT00857818|2573137|P1|STARTED|Overall Study||14
1060879|NCT00857896|2573165|P1|NOT COMPLETED|Week 5 to Week 8||0
1060880|NCT00857896|2573165|P1|COMPLETED|Week 5 to Week 8||20
1060881|NCT00857896|2573165|P1|STARTED|Week 5 to Week 8||20
1060882|NCT00857896|2573165|P1|NOT COMPLETED|Baseline to Week 4||1
1060883|NCT00857896|2573165|P1|COMPLETED|Baseline to Week 4||20
1060884|NCT00857896|2573165|P1|STARTED|Baseline to Week 4||21
1060885|NCT00857948|2573181|P4|NOT COMPLETED|Overall Study||0
1060886|NCT00857948|2573182|P3|NOT COMPLETED|Overall Study||1
1060887|NCT00857948|2573183|P2|NOT COMPLETED|Overall Study||0
1060888|NCT00857948|2573184|P1|NOT COMPLETED|Overall Study||3
1060889|NCT00857948|2573181|P4|COMPLETED|Overall Study||23
1060890|NCT00857948|2573182|P3|COMPLETED|Overall Study||18
1060891|NCT00857948|2573183|P2|COMPLETED|Overall Study||18
1060892|NCT00857948|2573184|P1|COMPLETED|Overall Study||15
1060893|NCT00857948|2573181|P4|STARTED|Overall Study||23
1060894|NCT00857948|2573182|P3|STARTED|Overall Study||19
1060895|NCT00857948|2573183|P2|STARTED|Overall Study||18
1060896|NCT00857948|2573184|P1|STARTED|Overall Study||18
1060897|NCT00857961|2573206|P1|NOT COMPLETED|Overall Study||0
1060898|NCT00857961|2573206|P1|COMPLETED|Overall Study||21
1060899|NCT00857961|2573206|P1|STARTED|Overall Study||21
1060900|NCT00858013|2573242|P2|NOT COMPLETED|Overall Study||19
1060901|NCT00858013|2573243|P1|NOT COMPLETED|Overall Study||22
1060902|NCT00858013|2573242|P2|COMPLETED|Overall Study||23
1060903|NCT00858013|2573243|P1|COMPLETED|Overall Study||24
1060904|NCT00858013|2573242|P2|STARTED|Overall Study||42
1060905|NCT00858013|2573243|P1|STARTED|Overall Study||46
1060906|NCT00858143|2573257|P1|NOT COMPLETED|Overall Study||50
1060907|NCT00858143|2573257|P1|COMPLETED|Overall Study||261
1060908|NCT00858143|2573257|P1|STARTED|Overall Study|Baseline|311
1060909|NCT00858208|2573306|P1|NOT COMPLETED|Overall Study||79
1060910|NCT00858208|2573306|P1|COMPLETED|Overall Study||6
1060911|NCT00858208|2573306|P1|STARTED|Overall Study||85
1060912|NCT00858247|2573325|P2|NOT COMPLETED|Week 12 Follow-up||1
1060913|NCT00858247|2573326|P1|NOT COMPLETED|Week 12 Follow-up||0
1060914|NCT00858247|2573325|P2|COMPLETED|Week 12 Follow-up||23
1060915|NCT00858247|2573326|P1|COMPLETED|Week 12 Follow-up||23
1060916|NCT00858247|2573325|P2|STARTED|Week 12 Follow-up||24
1060917|NCT00858247|2573326|P1|STARTED|Week 12 Follow-up||23
1060918|NCT00858247|2573325|P2|NOT COMPLETED|Baseline Assessment||2
1060919|NCT00858247|2573326|P1|NOT COMPLETED|Baseline Assessment||2
1060920|NCT00858247|2573325|P2|COMPLETED|Baseline Assessment||24
1060921|NCT00858247|2573326|P1|COMPLETED|Baseline Assessment||23
1060922|NCT00858247|2573325|P2|STARTED|Baseline Assessment||26
1060923|NCT00858247|2573326|P1|STARTED|Baseline Assessment||25
1060924|NCT00858390|2573344|P2|NOT COMPLETED|Overall Study||0
1060925|NCT00858390|2573345|P1|NOT COMPLETED|Overall Study||0
1060926|NCT00858390|2573344|P2|COMPLETED|Overall Study||18
1060927|NCT00858390|2573345|P1|COMPLETED|Overall Study||18
1060928|NCT00858390|2573344|P2|STARTED|Overall Study||18
1060929|NCT00858390|2573345|P1|STARTED|Overall Study||18
1060930|NCT00858403|2573351|P1|NOT COMPLETED|Overall Study||5
1060931|NCT00858403|2573351|P1|COMPLETED|Overall Study||2
1060932|NCT00858403|2573351|P1|STARTED|Overall Study||7
1060933|NCT00858442|2573363|P2|NOT COMPLETED|Compression:Start to Finish||3
1060934|NCT00858442|2573364|P1|NOT COMPLETED|Compression:Start to Finish||1
1060935|NCT00858442|2573363|P2|COMPLETED|Compression:Start to Finish||20
1060936|NCT00858442|2573364|P1|COMPLETED|Compression:Start to Finish||20
1060937|NCT00858442|2573363|P2|STARTED|Compression:Start to Finish||23
1060938|NCT00858442|2573364|P1|STARTED|Compression:Start to Finish||21
1060939|NCT00858442|2573363|P2|NOT COMPLETED|From Surgery to Start Compression;||0
1060940|NCT00858442|2573364|P1|NOT COMPLETED|From Surgery to Start Compression;||0
1060941|NCT00858442|2573363|P2|COMPLETED|From Surgery to Start Compression;||23
1060942|NCT00858442|2573364|P1|COMPLETED|From Surgery to Start Compression;||21
1060943|NCT00858442|2573363|P2|STARTED|From Surgery to Start Compression;||23
1060944|NCT00858442|2573364|P1|STARTED|From Surgery to Start Compression;||21
1060945|NCT00858468|2573376|P2|NOT COMPLETED|Overall Study||0
1060946|NCT00858468|2573377|P1|NOT COMPLETED|Overall Study||0
1060947|NCT00858468|2573376|P2|COMPLETED|Overall Study||192
1060948|NCT00858468|2573377|P1|COMPLETED|Overall Study||201
1060949|NCT00858468|2573376|P2|STARTED|Overall Study||192
1060950|NCT00858468|2573377|P1|STARTED|Overall Study|1 enrolled participant was not vaccinated and removed from analysis|201
1060954|NCT00858507|2573396|P2|NOT COMPLETED|Overall Study||15
1060955|NCT00858507|2573397|P1|NOT COMPLETED|Overall Study||22
1060956|NCT00858507|2573396|P2|COMPLETED|Overall Study||101
1060957|NCT00858507|2573397|P1|COMPLETED|Overall Study||83
1060958|NCT00858507|2573396|P2|STARTED|Overall Study||116
1060959|NCT00858507|2573397|P1|STARTED|Overall Study||105
1060960|NCT00858637|2573405|P6|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
1060961|NCT00858637|2573406|P5|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
1060962|NCT00858637|2573407|P4|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
1060963|NCT00858637|2573408|P3|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
1060964|NCT00858637|2573409|P2|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
1060965|NCT00858637|2573410|P1|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
1060966|NCT00858637|2573405|P6|COMPLETED|Placebo-controlled Withdrawal Phase||58
1060967|NCT00858637|2573406|P5|COMPLETED|Placebo-controlled Withdrawal Phase||55
1060968|NCT00858637|2573407|P4|COMPLETED|Placebo-controlled Withdrawal Phase||0
1060969|NCT00858637|2573408|P3|COMPLETED|Placebo-controlled Withdrawal Phase||53
1060970|NCT00858637|2573409|P2|COMPLETED|Placebo-controlled Withdrawal Phase||49
1060971|NCT00858637|2573410|P1|COMPLETED|Placebo-controlled Withdrawal Phase||0
1060972|NCT00858637|2573405|P6|STARTED|Placebo-controlled Withdrawal Phase||59
1060973|NCT00858637|2573406|P5|STARTED|Placebo-controlled Withdrawal Phase||56
1060974|NCT00858637|2573407|P4|STARTED|Placebo-controlled Withdrawal Phase||0
1060975|NCT00858637|2573408|P3|STARTED|Placebo-controlled Withdrawal Phase||54
1060976|NCT00858637|2573409|P2|STARTED|Placebo-controlled Withdrawal Phase||49
1060977|NCT00858637|2573410|P1|STARTED|Placebo-controlled Withdrawal Phase||0
1060978|NCT00858637|2573405|P6|NOT COMPLETED|Active Comparison Phase||0
1060979|NCT00858637|2573406|P5|NOT COMPLETED|Active Comparison Phase||0
1060980|NCT00858637|2573407|P4|NOT COMPLETED|Active Comparison Phase||18
1060981|NCT00858637|2573408|P3|NOT COMPLETED|Active Comparison Phase||0
1060982|NCT00858637|2573409|P2|NOT COMPLETED|Active Comparison Phase||0
1060983|NCT00858637|2573410|P1|NOT COMPLETED|Active Comparison Phase||24
1060984|NCT00858637|2573405|P6|COMPLETED|Active Comparison Phase||0
1060985|NCT00858637|2573406|P5|COMPLETED|Active Comparison Phase||0
1060986|NCT00858637|2573407|P4|COMPLETED|Active Comparison Phase||115
1060987|NCT00858637|2573408|P3|COMPLETED|Active Comparison Phase||0
1060988|NCT00858637|2573409|P2|COMPLETED|Active Comparison Phase||0
1060989|NCT00858637|2573410|P1|COMPLETED|Active Comparison Phase||103
1060990|NCT00858637|2573405|P6|STARTED|Active Comparison Phase||0
1060991|NCT00858637|2573406|P5|STARTED|Active Comparison Phase||0
1060992|NCT00858637|2573407|P4|STARTED|Active Comparison Phase||133
1060993|NCT00858637|2573408|P3|STARTED|Active Comparison Phase||0
1060994|NCT00858637|2573409|P2|STARTED|Active Comparison Phase||0
1060995|NCT00858637|2573410|P1|STARTED|Active Comparison Phase||127
1060996|NCT00858689|2573420|P1|NOT COMPLETED|Overall Study||1
1060997|NCT00858689|2573420|P1|COMPLETED|Overall Study||19
1060998|NCT00858689|2573420|P1|STARTED|Overall Study||20
1061005|NCT00858780|2573438|P5|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||2
1061006|NCT00858780|2573439|P4|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
1061007|NCT00858780|2573440|P3|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
1061008|NCT00858780|2573441|P2|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
1061009|NCT00858780|2573442|P1|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
1061010|NCT00858780|2573438|P5|COMPLETED|OL Re-Treatment (Failure to Week 48)||41
1061011|NCT00858780|2573439|P4|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
1061012|NCT00858780|2573440|P3|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
1061013|NCT00858780|2573441|P2|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
1061014|NCT00858780|2573442|P1|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
1061015|NCT00858780|2573438|P5|STARTED|OL Re-Treatment (Failure to Week 48)|43 participants showed treatment failure in Period 2 and entered in Period 3.|43
1061016|NCT00858780|2573439|P4|STARTED|OL Re-Treatment (Failure to Week 48)||0
1061017|NCT00858780|2573440|P3|STARTED|OL Re-Treatment (Failure to Week 48)||0
1061018|NCT00858780|2573441|P2|STARTED|OL Re-Treatment (Failure to Week 48)||0
1061019|NCT00858780|2573442|P1|STARTED|OL Re-Treatment (Failure to Week 48)||0
1061020|NCT00858780|2573438|P5|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
1061021|NCT00858780|2573439|P4|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||1
1061022|NCT00858780|2573440|P3|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
1061023|NCT00858780|2573441|P2|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
1061024|NCT00858780|2573442|P1|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
1061025|NCT00858780|2573438|P5|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
1061026|NCT00858780|2573439|P4|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||22
1061027|NCT00858780|2573440|P3|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||25
1061028|NCT00858780|2573441|P2|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||21
1061029|NCT00858780|2573442|P1|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
1061030|NCT00858780|2573438|P5|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
1061031|NCT00858780|2573439|P4|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
1061032|NCT00858780|2573440|P3|STARTED|Double-Blind (Week 0 to Failure/Week 48)||27
1061033|NCT00858780|2573441|P2|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
1061034|NCT00858780|2573442|P1|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
1061035|NCT00858780|2573438|P5|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
1061036|NCT00858780|2573439|P4|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
1061037|NCT00858780|2573440|P3|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
1061038|NCT00858780|2573441|P2|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
1061039|NCT00858780|2573442|P1|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||18
1061040|NCT00858780|2573438|P5|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
1061041|NCT00858780|2573439|P4|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
1061042|NCT00858780|2573440|P3|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
1061043|NCT00858780|2573441|P2|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
1061044|NCT00858780|2573442|P1|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||73
1061045|NCT00858780|2573438|P5|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
1061046|NCT00858780|2573439|P4|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
1061047|NCT00858780|2573440|P3|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
1061048|NCT00858780|2573441|P2|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
1061049|NCT00858780|2573442|P1|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||91
1061050|NCT00858832|2573517|P2|NOT COMPLETED|Overall Study||1
1061051|NCT00858832|2573518|P1|NOT COMPLETED|Overall Study||1
1061052|NCT00858832|2573517|P2|COMPLETED|Overall Study||22
1061053|NCT00858832|2573518|P1|COMPLETED|Overall Study||20
1061054|NCT00858832|2573517|P2|STARTED|Overall Study||23
1061055|NCT00858832|2573518|P1|STARTED|Overall Study|study terminated early due to enrollment deficiencies|21
1061056|NCT00858845|2573524|P1|NOT COMPLETED|Overall Study||1
1061057|NCT00858845|2573524|P1|COMPLETED|Overall Study||10
1061058|NCT00858845|2573524|P1|STARTED|Overall Study||11
1061059|NCT00858858|2573528|P1|NOT COMPLETED|Overall Study||18
1061060|NCT00858858|2573528|P1|COMPLETED|Overall Study||42
1061061|NCT00858858|2573528|P1|STARTED|Overall Study||60
1061062|NCT00858962|2573532|P1|NOT COMPLETED|Overall Study||0
1061063|NCT00858962|2573532|P1|COMPLETED|Overall Study||12
1061064|NCT00858962|2573532|P1|STARTED|Overall Study||12
1061065|NCT00859014|2573536|P1|NOT COMPLETED|Overall Study||5
1061066|NCT00859014|2573536|P1|COMPLETED|Overall Study||20
1061067|NCT00859014|2573536|P1|STARTED|Overall Study||25
1061068|NCT00859027|2573543|P2|NOT COMPLETED|Overall Study||5
1061069|NCT00859027|2573544|P1|NOT COMPLETED|Overall Study||5
1061070|NCT00859027|2573543|P2|COMPLETED|Overall Study||20
1061071|NCT00859027|2573544|P1|COMPLETED|Overall Study||20
1061072|NCT00859027|2573543|P2|STARTED|Overall Study||25
1061073|NCT00859027|2573544|P1|STARTED|Overall Study||25
1061080|NCT00859053|2573569|P4|NOT COMPLETED|Overall Study||0
1061081|NCT00859053|2573570|P3|NOT COMPLETED|Overall Study||0
1061082|NCT00859053|2573571|P2|NOT COMPLETED|Overall Study||0
1061083|NCT00859053|2573572|P1|NOT COMPLETED|Overall Study||0
1061084|NCT00859053|2573569|P4|COMPLETED|Overall Study||12
1061085|NCT00859053|2573570|P3|COMPLETED|Overall Study||6
1061086|NCT00859053|2573571|P2|COMPLETED|Overall Study||6
1061087|NCT00859053|2573572|P1|COMPLETED|Overall Study||6
1061088|NCT00859053|2573569|P4|STARTED|Overall Study||12
1061089|NCT00859053|2573570|P3|STARTED|Overall Study||6
1061090|NCT00859053|2573571|P2|STARTED|Overall Study||6
1061091|NCT00859053|2573572|P1|STARTED|Overall Study||6
1061092|NCT00859131|2573616|P2|NOT COMPLETED|Overall Study||0
1061093|NCT00859131|2573617|P1|NOT COMPLETED|Overall Study||0
1061094|NCT00859131|2573616|P2|COMPLETED|Overall Study||98
1061095|NCT00859131|2573617|P1|COMPLETED|Overall Study||102
1061096|NCT00859131|2573616|P2|STARTED|Overall Study||98
1061097|NCT00859131|2573617|P1|STARTED|Overall Study||102
1061098|NCT00859222|2573638|P5|NOT COMPLETED|Overall Study||15
1061099|NCT00859222|2573639|P4|NOT COMPLETED|Overall Study||24
1061100|NCT00859222|2573640|P3|NOT COMPLETED|Overall Study||6
1061101|NCT00859222|2573641|P2|NOT COMPLETED|Overall Study||3
1061102|NCT00859222|2573642|P1|NOT COMPLETED|Overall Study||3
1061103|NCT00859222|2573638|P5|COMPLETED|Overall Study||0
1061104|NCT00859222|2573639|P4|COMPLETED|Overall Study||0
1061105|NCT00859222|2573640|P3|COMPLETED|Overall Study||0
1061106|NCT00859222|2573641|P2|COMPLETED|Overall Study||0
1061107|NCT00859222|2573642|P1|COMPLETED|Overall Study||0
1061108|NCT00859222|2573638|P5|STARTED|Overall Study||15
1061109|NCT00859222|2573639|P4|STARTED|Overall Study||24
1061110|NCT00859222|2573640|P3|STARTED|Overall Study||6
1061111|NCT00859222|2573641|P2|STARTED|Overall Study||3
1061112|NCT00859222|2573642|P1|STARTED|Overall Study||3
1061113|NCT00859313|2573667|P1|NOT COMPLETED|Overall Study||4
1061114|NCT00859313|2573667|P1|COMPLETED|Overall Study||26
1061115|NCT00859313|2573667|P1|STARTED|Overall Study||30
1061116|NCT00859339|2573671|P1|NOT COMPLETED|Overall Study||0
1061117|NCT00859339|2573671|P1|COMPLETED|Overall Study||9
1061118|NCT00859339|2573671|P1|STARTED|Overall Study||9
1061119|NCT00859430|2573681|P2|NOT COMPLETED|Second Intervention||0
1061120|NCT00859430|2573682|P1|NOT COMPLETED|Second Intervention||0
1061121|NCT00859430|2573681|P2|COMPLETED|Second Intervention||10
1061122|NCT00859430|2573682|P1|COMPLETED|Second Intervention||11
1061123|NCT00859430|2573681|P2|STARTED|Second Intervention||10
1061124|NCT00859430|2573682|P1|STARTED|Second Intervention||11
1061125|NCT00859430|2573681|P2|NOT COMPLETED|First Intervention||1
1061126|NCT00859430|2573682|P1|NOT COMPLETED|First Intervention||0
1061127|NCT00859430|2573681|P2|COMPLETED|First Intervention||10
1061128|NCT00859430|2573682|P1|COMPLETED|First Intervention||11
1061129|NCT00859430|2573681|P2|STARTED|First Intervention||11
1061130|NCT00859430|2573682|P1|STARTED|First Intervention||11
1061131|NCT00859469|2573690|P1|NOT COMPLETED|Overall Study||28
1061132|NCT00859469|2573690|P1|COMPLETED|Overall Study||1
1061133|NCT00859469|2573690|P1|6 Cycles|Overall Study||16
1061134|NCT00859469|2573690|P1|STARTED|Overall Study||29
1061135|NCT00859508|2573698|P2|NOT COMPLETED|Overall Study||0
1061136|NCT00859508|2573699|P1|NOT COMPLETED|Overall Study||6
1061137|NCT00859508|2573698|P2|COMPLETED|Overall Study||37
1061138|NCT00859508|2573699|P1|COMPLETED|Overall Study||62
1061139|NCT00859508|2573698|P2|STARTED|Overall Study||37
1061140|NCT00859508|2573699|P1|STARTED|Overall Study||68
1061141|NCT00859521|2573707|P2|NOT COMPLETED|Second Intervention||0
1061142|NCT00859521|2573708|P1|NOT COMPLETED|Second Intervention||0
1061143|NCT00859521|2573707|P2|COMPLETED|Second Intervention||14
1061144|NCT00859521|2573708|P1|COMPLETED|Second Intervention||15
1061145|NCT00859521|2573707|P2|STARTED|Second Intervention||14
1061146|NCT00859521|2573708|P1|STARTED|Second Intervention||15
1061147|NCT00859521|2573707|P2|NOT COMPLETED|Washout||1
1061148|NCT00859521|2573708|P1|NOT COMPLETED|Washout||0
1061149|NCT00859521|2573707|P2|COMPLETED|Washout||14
1061150|NCT00859521|2573708|P1|COMPLETED|Washout||15
1061151|NCT00859521|2573707|P2|STARTED|Washout||15
1061152|NCT00859521|2573708|P1|STARTED|Washout||15
1061153|NCT00859521|2573707|P2|NOT COMPLETED|First Intervention||0
1061154|NCT00859521|2573708|P1|NOT COMPLETED|First Intervention||0
1061155|NCT00859521|2573707|P2|COMPLETED|First Intervention||15
1061156|NCT00859521|2573708|P1|COMPLETED|First Intervention||15
1061157|NCT00859521|2573707|P2|STARTED|First Intervention||15
1061158|NCT00859521|2573708|P1|STARTED|First Intervention||15
1061159|NCT00859547|2573716|P1|NOT COMPLETED|Overall Study||2
1061160|NCT00859547|2573716|P1|COMPLETED|Overall Study||28
1061161|NCT00859547|2573716|P1|STARTED|Overall Study||30
1061168|NCT00859586|2573736|P1|NOT COMPLETED|Overall Study||4
1061169|NCT00859586|2573736|P1|COMPLETED|Overall Study||4
1061170|NCT00859586|2573736|P1|STARTED|Overall Study||8
1061171|NCT00859638|2573742|P2|NOT COMPLETED|Overall Study||4
1061172|NCT00859638|2573743|P1|NOT COMPLETED|Overall Study||10
1061173|NCT00859638|2573742|P2|COMPLETED|Overall Study||55
1061174|NCT00859638|2573743|P1|COMPLETED|Overall Study||55
1061175|NCT00859638|2573742|P2|STARTED|Overall Study||59
1061176|NCT00859638|2573743|P1|STARTED|Overall Study||65
1061177|NCT00859651|2573751|P2|NOT COMPLETED|Overall Study||0
1061178|NCT00859651|2573752|P1|NOT COMPLETED|Overall Study||0
1061179|NCT00859651|2573751|P2|COMPLETED|Overall Study||22
1061180|NCT00859651|2573752|P1|COMPLETED|Overall Study||18
1061181|NCT00859651|2573751|P2|STARTED|Overall Study||22
1061182|NCT00859651|2573752|P1|STARTED|Overall Study||18
1061183|NCT00851890|2573764|P4|NOT COMPLETED|Overall Study||1
1061184|NCT00851890|2573765|P3|NOT COMPLETED|Overall Study||0
1061185|NCT00851890|2573766|P2|NOT COMPLETED|Overall Study||1
1061186|NCT00851890|2573767|P1|NOT COMPLETED|Overall Study||0
1061187|NCT00851890|2573764|P4|COMPLETED|Overall Study||5
1061188|NCT00851890|2573765|P3|COMPLETED|Overall Study||8
1061189|NCT00851890|2573766|P2|COMPLETED|Overall Study||7
1061190|NCT00851890|2573767|P1|COMPLETED|Overall Study||8
1061191|NCT00851890|2573764|P4|STARTED|Overall Study||6
1061192|NCT00851890|2573765|P3|STARTED|Overall Study||8
1061193|NCT00851890|2573766|P2|STARTED|Overall Study||8
1061194|NCT00851890|2573767|P1|STARTED|Overall Study||8
1061195|NCT00851903|2573824|P1|NOT COMPLETED|Overall Study||2
1061196|NCT00851903|2573824|P1|COMPLETED|Overall Study||110
1061197|NCT00851903|2573824|P1|Modified Intent-To-Treat Population|Overall Study|mITT population: patients treated by combination with at least 1 on-treatment efficacy measure|111
1061198|NCT00851903|2573824|P1|Treated by Combination|Overall Study|patients treated with at least one dose of insulin glargine AND one dose of sitagliptin|111
1061199|NCT00851903|2573824|P1|Safety Population|Overall Study|patients treated with at least one dose of insulin glargine OR one dose of sitagliptin|112
1061200|NCT00851903|2573824|P1|STARTED|Overall Study||112
1061201|NCT00852124|2573836|P2|NOT COMPLETED|Overall Study||0
1061202|NCT00852124|2573837|P1|NOT COMPLETED|Overall Study||0
1061203|NCT00852124|2573836|P2|COMPLETED|Overall Study||0
1061204|NCT00852124|2573837|P1|COMPLETED|Overall Study||3
1061205|NCT00852124|2573836|P2|STARTED|Overall Study||0
1061206|NCT00852124|2573837|P1|STARTED|Overall Study||3
1061207|NCT00852137|2573844|P2|NOT COMPLETED|Overall Study||0
1061208|NCT00852137|2573845|P1|NOT COMPLETED|Overall Study||0
1061209|NCT00852137|2573844|P2|COMPLETED|Overall Study||3
1061210|NCT00852137|2573845|P1|COMPLETED|Overall Study||13
1061211|NCT00852137|2573844|P2|STARTED|Overall Study||3
1061212|NCT00852137|2573845|P1|STARTED|Overall Study||13
1061213|NCT00852397|2573868|P3|NOT COMPLETED|Overall Study||14
1061214|NCT00852397|2573869|P2|NOT COMPLETED|Overall Study||8
1061215|NCT00852397|2573870|P1|NOT COMPLETED|Overall Study||11
1061216|NCT00852397|2573868|P3|COMPLETED|Overall Study||36
1061217|NCT00852397|2573869|P2|COMPLETED|Overall Study||41
1061218|NCT00852397|2573870|P1|COMPLETED|Overall Study||41
1061219|NCT00852397|2573868|P3|Treated Participants|Overall Study||49
1061220|NCT00852397|2573869|P2|Treated Participants|Overall Study||49
1061221|NCT00852397|2573870|P1|Treated Participants|Overall Study||51
1061222|NCT00852397|2573868|P3|STARTED|Overall Study||50
1061223|NCT00852397|2573869|P2|STARTED|Overall Study||49
1061224|NCT00852397|2573870|P1|STARTED|Overall Study||52
1061225|NCT00852475|2573901|P2|NOT COMPLETED|Overall Study||4
1061226|NCT00852475|2573902|P1|NOT COMPLETED|Overall Study||3
1061227|NCT00852475|2573901|P2|COMPLETED|Overall Study||16
1061228|NCT00852475|2573902|P1|COMPLETED|Overall Study||23
1061229|NCT00852475|2573901|P2|STARTED|Overall Study||20
1061230|NCT00852475|2573902|P1|STARTED|Overall Study||26
1061231|NCT00852527|2573910|P2|NOT COMPLETED|Overall Study||0
1061232|NCT00852527|2573911|P1|NOT COMPLETED|Overall Study||0
1061233|NCT00852527|2573910|P2|COMPLETED|Overall Study||242
1061234|NCT00852527|2573911|P1|COMPLETED|Overall Study||196
1061235|NCT00852527|2573910|P2|STARTED|Overall Study||242
1061236|NCT00852527|2573911|P1|STARTED|Overall Study||196
1061237|NCT00852540|2573918|P2|NOT COMPLETED|Overall Study||18
1061238|NCT00852540|2573919|P1|NOT COMPLETED|Overall Study||36
1061239|NCT00852540|2573918|P2|COMPLETED|Overall Study||122
1061240|NCT00852540|2573919|P1|COMPLETED|Overall Study||234
1061241|NCT00852540|2573918|P2|STARTED|Overall Study||140
1061242|NCT00852540|2573919|P1|STARTED|Overall Study||270
1061243|NCT00852592|2573947|P2|NOT COMPLETED|Overall Study||4
1061244|NCT00852592|2573948|P1|NOT COMPLETED|Overall Study||3
1061245|NCT00852592|2573947|P2|COMPLETED|Overall Study||19
1061246|NCT00852592|2573948|P1|COMPLETED|Overall Study||20
1061247|NCT00852592|2573947|P2|STARTED|Overall Study||23
1061248|NCT00852592|2573948|P1|STARTED|Overall Study||23
1061249|NCT00852631|2573956|P1|NOT COMPLETED|Overall Study||11
1061250|NCT00852631|2573956|P1|COMPLETED|Overall Study||17
1061251|NCT00852631|2573956|P1|STARTED|Overall Study||28
1061252|NCT00852761|2573964|P2|NOT COMPLETED|Overall Study||0
1061253|NCT00852761|2573965|P1|NOT COMPLETED|Overall Study||0
1061254|NCT00852761|2573964|P2|COMPLETED|Overall Study||17
1061255|NCT00852761|2573965|P1|COMPLETED|Overall Study||17
1061256|NCT00852761|2573964|P2|STARTED|Overall Study||17
1061257|NCT00852761|2573965|P1|STARTED|Overall Study||17
1061258|NCT00852917|2574011|P4|NOT COMPLETED|Overall Study||93
1061259|NCT00852917|2574012|P3|NOT COMPLETED|Overall Study||58
1061260|NCT00852917|2574013|P2|NOT COMPLETED|Overall Study||46
1061261|NCT00852917|2574014|P1|NOT COMPLETED|Overall Study||44
1061262|NCT00852917|2574011|P4|COMPLETED|Overall Study||134
1061263|NCT00852917|2574012|P3|COMPLETED|Overall Study||50
1061264|NCT00852917|2574013|P2|COMPLETED|Overall Study||65
1061265|NCT00852917|2574014|P1|COMPLETED|Overall Study||62
1061266|NCT00852917|2574011|P4|STARTED|Overall Study||227
1061267|NCT00852917|2574012|P3|STARTED|Overall Study||108
1061268|NCT00852917|2574013|P2|STARTED|Overall Study||111
1061269|NCT00852917|2574014|P1|STARTED|Overall Study||106
1061270|NCT00852930|2574055|P3|NOT COMPLETED|Overall Study||2
1061271|NCT00852930|2574056|P2|NOT COMPLETED|Overall Study||1
1061272|NCT00852930|2574057|P1|NOT COMPLETED|Overall Study||1
1061273|NCT00852930|2574055|P3|COMPLETED|Overall Study||15
1061274|NCT00852930|2574056|P2|COMPLETED|Overall Study||16
1061275|NCT00852930|2574057|P1|COMPLETED|Overall Study||15
1061276|NCT00852930|2574055|P3|STARTED|Overall Study||17
1061277|NCT00852930|2574056|P2|STARTED|Overall Study||17
1061278|NCT00852930|2574057|P1|STARTED|Overall Study||16
1061279|NCT00852969|2574076|P2|NOT COMPLETED|Overall Study||2
1061280|NCT00852969|2574077|P1|NOT COMPLETED|Overall Study||0
1061281|NCT00852969|2574076|P2|COMPLETED|Overall Study||13
1061282|NCT00852969|2574077|P1|COMPLETED|Overall Study||15
1061283|NCT00852969|2574076|P2|STARTED|Overall Study||15
1061284|NCT00852969|2574077|P1|STARTED|Overall Study||15
1061285|NCT00852995|2574090|P5|NOT COMPLETED|Overall Study||4
1061286|NCT00852995|2574091|P4|NOT COMPLETED|Overall Study||5
1061287|NCT00852995|2574092|P3|NOT COMPLETED|Overall Study||5
1061288|NCT00852995|2574093|P2|NOT COMPLETED|Overall Study||1
1061289|NCT00852995|2574094|P1|NOT COMPLETED|Overall Study||8
1061290|NCT00852995|2574090|P5|COMPLETED|Overall Study||46
1061291|NCT00852995|2574091|P4|COMPLETED|Overall Study||40
1061292|NCT00852995|2574092|P3|COMPLETED|Overall Study||39
1061293|NCT00852995|2574093|P2|COMPLETED|Overall Study||42
1061294|NCT00852995|2574094|P1|COMPLETED|Overall Study||38
1061295|NCT00852995|2574090|P5|STARTED|Overall Study||50
1061296|NCT00852995|2574091|P4|STARTED|Overall Study||45
1061297|NCT00852995|2574092|P3|STARTED|Overall Study||44
1061298|NCT00852995|2574093|P2|STARTED|Overall Study||43
1061299|NCT00852995|2574094|P1|STARTED|Overall Study||46
1061300|NCT00853021|2574136|P1|NOT COMPLETED|Overall Study||5
1061301|NCT00853021|2574136|P1|COMPLETED|Overall Study||21
1061302|NCT00853021|2574136|P1|STARTED|Overall Study||26
1061303|NCT00853073|2574145|P2|NOT COMPLETED|Overall Study||2
1061304|NCT00853073|2574146|P1|NOT COMPLETED|Overall Study||3
1061305|NCT00853073|2574145|P2|COMPLETED|Overall Study||29
1061306|NCT00853073|2574146|P1|COMPLETED|Overall Study||29
1061307|NCT00853073|2574145|P2|STARTED|Overall Study||31
1061308|NCT00853073|2574146|P1|STARTED|Overall Study||32
1061309|NCT00853099|2574155|P4|NOT COMPLETED|Double-blind + Open-label Periods||147
1061310|NCT00853099|2574156|P3|NOT COMPLETED|Double-blind + Open-label Periods||0
1061311|NCT00853099|2574157|P2|NOT COMPLETED|Double-blind + Open-label Periods||0
1061312|NCT00853099|2574158|P1|NOT COMPLETED|Double-blind + Open-label Periods||0
1061313|NCT00853099|2574155|P4|COMPLETED|Double-blind + Open-label Periods||119
1061314|NCT00853099|2574156|P3|COMPLETED|Double-blind + Open-label Periods||0
1061315|NCT00853099|2574157|P2|COMPLETED|Double-blind + Open-label Periods||0
1061316|NCT00853099|2574158|P1|COMPLETED|Double-blind + Open-label Periods||0
1061317|NCT00853099|2574155|P4|STARTED|Double-blind + Open-label Periods|7 participants randomized to placebo did not receive any adalimumab; 1 participant was excluded.|266
1061318|NCT00853099|2574156|P3|STARTED|Double-blind + Open-label Periods||0
1061319|NCT00853099|2574157|P2|STARTED|Double-blind + Open-label Periods||0
1061320|NCT00853099|2574158|P1|STARTED|Double-blind + Open-label Periods||0
1061321|NCT00853099|2574155|P4|NOT COMPLETED|Double-blind Period||0
1061322|NCT00853099|2574156|P3|NOT COMPLETED|Double-blind Period||31
1061323|NCT00853099|2574157|P2|NOT COMPLETED|Double-blind Period||29
1061324|NCT00853099|2574158|P1|NOT COMPLETED|Double-blind Period||23
1061325|NCT00853099|2574155|P4|COMPLETED|Double-blind Period||0
1061326|NCT00853099|2574156|P3|COMPLETED|Double-blind Period|Participants who completed Week 52.|60
1061327|NCT00853099|2574157|P2|COMPLETED|Double-blind Period|Participants who completed Week 52.|58
1061328|NCT00853099|2574158|P1|COMPLETED|Double-blind Period|Participants who completed Week 52.|73
1061329|NCT00853099|2574155|P4|Completed Week 8|Double-blind Period||0
1061330|NCT00853099|2574156|P3|Completed Week 8|Double-blind Period||86
1061331|NCT00853099|2574157|P2|Completed Week 8|Double-blind Period||85
1061332|NCT00853099|2574158|P1|Completed Week 8|Double-blind Period||92
1061333|NCT00853099|2574155|P4|Treated|Double-blind Period||0
1061334|NCT00853099|2574156|P3|Treated|Double-blind Period|1 participant, incorrectly treated with open-label (rescue) study drug at Week 0, was excluded.|90
1061335|NCT00853099|2574157|P2|Treated|Double-blind Period||87
1061336|NCT00853099|2574158|P1|Treated|Double-blind Period||96
1061337|NCT00853099|2574155|P4|STARTED|Double-blind Period||0
1061338|NCT00853099|2574156|P3|STARTED|Double-blind Period||91
1061339|NCT00853099|2574157|P2|STARTED|Double-blind Period||87
1061340|NCT00853099|2574158|P1|STARTED|Double-blind Period||96
1061341|NCT00853151|2574202|P4|NOT COMPLETED|Overall Study||3
1061342|NCT00853151|2574203|P3|NOT COMPLETED|Overall Study||8
1061343|NCT00853151|2574204|P2|NOT COMPLETED|Overall Study||13
1061344|NCT00853151|2574205|P1|NOT COMPLETED|Overall Study||10
1061345|NCT00853151|2574202|P4|COMPLETED|Overall Study||15
1061346|NCT00853151|2574203|P3|COMPLETED|Overall Study||30
1061347|NCT00853151|2574204|P2|COMPLETED|Overall Study||24
1061348|NCT00853151|2574205|P1|COMPLETED|Overall Study||28
1061349|NCT00853151|2574202|P4|STARTED|Overall Study||18
1061350|NCT00853151|2574203|P3|STARTED|Overall Study||38
1061351|NCT00853151|2574204|P2|STARTED|Overall Study||37
1061352|NCT00853151|2574205|P1|STARTED|Overall Study||38
1061353|NCT00853229|2574349|P2|NOT COMPLETED|Phase 2: Cross Over||0
1061354|NCT00853229|2574350|P1|NOT COMPLETED|Phase 2: Cross Over||0
1061355|NCT00853229|2574349|P2|COMPLETED|Phase 2: Cross Over||0
1061356|NCT00853229|2574350|P1|COMPLETED|Phase 2: Cross Over||0
1061357|NCT00853229|2574349|P2|STARTED|Phase 2: Cross Over||0
1061358|NCT00853229|2574350|P1|STARTED|Phase 2: Cross Over||0
1061359|NCT00853229|2574349|P2|NOT COMPLETED|Phase 1: Initial Intervention||8
1061360|NCT00853229|2574350|P1|NOT COMPLETED|Phase 1: Initial Intervention||8
1061361|NCT00853229|2574349|P2|COMPLETED|Phase 1: Initial Intervention||0
1061362|NCT00853229|2574350|P1|COMPLETED|Phase 1: Initial Intervention||0
1061363|NCT00853229|2574349|P2|STARTED|Phase 1: Initial Intervention||8
1061364|NCT00853229|2574350|P1|STARTED|Phase 1: Initial Intervention||8
1061365|NCT00853242|2574363|P7|NOT COMPLETED|Overall Study||5
1061366|NCT00853242|2574364|P6|NOT COMPLETED|Overall Study||2
1061367|NCT00853242|2574365|P5|NOT COMPLETED|Overall Study||4
1061368|NCT00853242|2574366|P4|NOT COMPLETED|Overall Study||4
1061369|NCT00853242|2574367|P3|NOT COMPLETED|Overall Study||3
1061370|NCT00853242|2574368|P2|NOT COMPLETED|Overall Study||3
1061371|NCT00853242|2574369|P1|NOT COMPLETED|Overall Study||3
1061372|NCT00853242|2574363|P7|COMPLETED|Overall Study||44
1061373|NCT00853242|2574364|P6|COMPLETED|Overall Study||49
1061374|NCT00853242|2574365|P5|COMPLETED|Overall Study||46
1061375|NCT00853242|2574366|P4|COMPLETED|Overall Study||46
1061376|NCT00853242|2574367|P3|COMPLETED|Overall Study||46
1061377|NCT00853242|2574368|P2|COMPLETED|Overall Study||47
1061378|NCT00853242|2574369|P1|COMPLETED|Overall Study||47
1061379|NCT00853242|2574363|P7|Treated|Overall Study||48
1061380|NCT00853242|2574364|P6|Treated|Overall Study||51
1061381|NCT00853242|2574365|P5|Treated|Overall Study||50
1061382|NCT00853242|2574366|P4|Treated|Overall Study||50
1061383|NCT00853242|2574367|P3|Treated|Overall Study||48
1061384|NCT00853242|2574368|P2|Treated|Overall Study||49
1061385|NCT00853242|2574369|P1|Treated|Overall Study||50
1061386|NCT00853242|2574363|P7|STARTED|Overall Study||49
1061387|NCT00853242|2574364|P6|STARTED|Overall Study||51
1061388|NCT00853242|2574365|P5|STARTED|Overall Study||50
1061389|NCT00853242|2574366|P4|STARTED|Overall Study||50
1061390|NCT00853242|2574367|P3|STARTED|Overall Study||49
1061391|NCT00853242|2574368|P2|STARTED|Overall Study||50
1061392|NCT00853242|2574369|P1|STARTED|Overall Study||50
1061393|NCT00853333|2574412|P3|NOT COMPLETED|Overall Study||0
1061394|NCT00853333|2574413|P2|NOT COMPLETED|Overall Study||0
1061395|NCT00853333|2574414|P1|NOT COMPLETED|Overall Study||0
1061396|NCT00853333|2574412|P3|COMPLETED|Overall Study||31
1061397|NCT00853333|2574413|P2|COMPLETED|Overall Study||27
1061398|NCT00853333|2574414|P1|COMPLETED|Overall Study||28
1061399|NCT00853333|2574412|P3|STARTED|Overall Study||31
1061400|NCT00853333|2574413|P2|STARTED|Overall Study||27
1061401|NCT00853333|2574414|P1|STARTED|Overall Study||28
1061402|NCT00853385|2574427|P5|NOT COMPLETED|Overall Study||42
1061403|NCT00853385|2574428|P4|NOT COMPLETED|Overall Study||13
1061404|NCT00853385|2574429|P3|NOT COMPLETED|Overall Study||9
1061405|NCT00853385|2574430|P2|NOT COMPLETED|Overall Study||43
1061406|NCT00853385|2574431|P1|NOT COMPLETED|Overall Study||54
1061407|NCT00853385|2574427|P5|COMPLETED|Overall Study||162
1061408|NCT00853385|2574428|P4|COMPLETED|Overall Study||39
1061409|NCT00853385|2574429|P3|COMPLETED|Overall Study||47
1061410|NCT00853385|2574430|P2|COMPLETED|Overall Study||158
1061411|NCT00853385|2574431|P1|COMPLETED|Overall Study||150
1061412|NCT00853385|2574427|P5|STARTED|Overall Study||204
1061413|NCT00853385|2574428|P4|STARTED|Overall Study||52
1061414|NCT00853385|2574429|P3|STARTED|Overall Study||56
1061415|NCT00853385|2574430|P2|STARTED|Overall Study||201
1061416|NCT00853385|2574431|P1|STARTED|Overall Study||204
1061417|NCT00853567|2574647|P1|NOT COMPLETED|Overall Study||71
1061418|NCT00853567|2574647|P1|COMPLETED|Overall Study||0
1061419|NCT00853567|2574647|P1|STARTED|Overall Study||71
1061420|NCT00853593|2574655|P1|NOT COMPLETED|Overall Study||45
1061421|NCT00853593|2574655|P1|COMPLETED|Overall Study||152
1061422|NCT00853593|2574655|P1|Model 4396 Lead Attempted|Overall Study||164
1061423|NCT00853593|2574655|P1|Implant Attempted|Overall Study||193
1061424|NCT00853593|2574655|P1|STARTED|Overall Study||197
1061425|NCT00853606|2574680|P1|NOT COMPLETED|Overall Study||220
1061426|NCT00853606|2574680|P1|COMPLETED|Overall Study||492
1061427|NCT00853606|2574680|P1|STARTED|Overall Study||712
1061428|NCT00853658|2574689|P3|NOT COMPLETED|Overall Study||815
1061429|NCT00853658|2574690|P2|NOT COMPLETED|Overall Study||832
1061430|NCT00853658|2574691|P1|NOT COMPLETED|Overall Study||787
1061431|NCT00853658|2574689|P3|COMPLETED|Overall Study||1539
1061432|NCT00853658|2574690|P2|COMPLETED|Overall Study||1524
1061433|NCT00853658|2574691|P1|COMPLETED|Overall Study||1567
1061434|NCT00853658|2574689|P3|Safety Set|Overall Study||2345
1061435|NCT00853658|2574690|P2|Safety Set|Overall Study||2348
1061436|NCT00853658|2574691|P1|Safety Set|Overall Study||2347
1061437|NCT00853658|2574689|P3|Full Analysis Set (FAS)|Overall Study||2336
1061438|NCT00853658|2574690|P2|Full Analysis Set (FAS)|Overall Study||2340
1061439|NCT00853658|2574691|P1|Full Analysis Set (FAS)|Overall Study||2340
1061440|NCT00853658|2574689|P3|STARTED|Overall Study||2354
1061441|NCT00853658|2574690|P2|STARTED|Overall Study||2356
1061442|NCT00853658|2574691|P1|STARTED|Overall Study||2354
1061443|NCT00853723|2574708|P3|NOT COMPLETED|Overall Study||2
1061444|NCT00853723|2574709|P2|NOT COMPLETED|Overall Study||7
1061445|NCT00853723|2574710|P1|NOT COMPLETED|Overall Study||6
1061446|NCT00853723|2574708|P3|COMPLETED|Overall Study||33
1061447|NCT00853723|2574709|P2|COMPLETED|Overall Study||28
1061448|NCT00853723|2574710|P1|COMPLETED|Overall Study||29
1061449|NCT00853723|2574708|P3|STARTED|Overall Study||35
1061450|NCT00853723|2574709|P2|STARTED|Overall Study||35
1061451|NCT00853723|2574710|P1|STARTED|Overall Study||35
1061452|NCT00853749|2574756|P2|NOT COMPLETED|Overall Study||1
1061453|NCT00853749|2574757|P1|NOT COMPLETED|Overall Study||0
1061454|NCT00853749|2574756|P2|COMPLETED|Overall Study||38
1061455|NCT00853749|2574757|P1|COMPLETED|Overall Study||50
1061456|NCT00853749|2574756|P2|Vaccinated|Overall Study||39
1061457|NCT00853749|2574757|P1|Vaccinated|Overall Study||50
1061458|NCT00853749|2574756|P2|STARTED|Overall Study||39
1061459|NCT00853749|2574757|P1|STARTED|Overall Study||50
1061460|NCT00853762|2574779|P4|NOT COMPLETED|Overall Study||22
1061461|NCT00853762|2574780|P3|NOT COMPLETED|Overall Study||17
1061462|NCT00853762|2574781|P2|NOT COMPLETED|Overall Study||19
1061463|NCT00853762|2574782|P1|NOT COMPLETED|Overall Study||16
1061464|NCT00853762|2574779|P4|COMPLETED|Overall Study||0
1061465|NCT00853762|2574780|P3|COMPLETED|Overall Study||0
1061466|NCT00853762|2574781|P2|COMPLETED|Overall Study||0
1061467|NCT00853762|2574782|P1|COMPLETED|Overall Study||0
1061468|NCT00853762|2574779|P4|STARTED|Overall Study||22
1061469|NCT00853762|2574780|P3|STARTED|Overall Study||17
1061470|NCT00853762|2574781|P2|STARTED|Overall Study||19
1061471|NCT00853762|2574782|P1|STARTED|Overall Study||16
1061472|NCT00853827|2574850|P2|NOT COMPLETED|Double Blind Period (103 Weeks)||109
1061473|NCT00853827|2574851|P1|NOT COMPLETED|Double Blind Period (103 Weeks)||104
1061474|NCT00853827|2574850|P2|COMPLETED|Double Blind Period (103 Weeks)||199
1061475|NCT00853827|2574851|P1|COMPLETED|Double Blind Period (103 Weeks)||201
1061476|NCT00853827|2574850|P2|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||233
1061477|NCT00853827|2574851|P1|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||225
1061478|NCT00853827|2574850|P2|STARTED|Double Blind Period (103 Weeks)||308
1061479|NCT00853827|2574851|P1|STARTED|Double Blind Period (103 Weeks)|"Started indicates number of patients in randomized set, full analysis set (FAS) and safety set."|305
1061480|NCT00853827|2574850|P2|NOT COMPLETED|Single Blind Period (1 Week)||0
1061481|NCT00853827|2574851|P1|NOT COMPLETED|Single Blind Period (1 Week)||39
1061482|NCT00853827|2574850|P2|COMPLETED|Single Blind Period (1 Week)||0
1061483|NCT00853827|2574851|P1|COMPLETED|Single Blind Period (1 Week)|Completed patients in single blind period|613
1061484|NCT00853827|2574850|P2|STARTED|Single Blind Period (1 Week)|This arm was only used in double blind period|0
1061485|NCT00853827|2574851|P1|STARTED|Single Blind Period (1 Week)|Enrolled patients in single blind|652
1061486|NCT00853840|2574863|P2|NOT COMPLETED|Period 2||0
1061487|NCT00853840|2574864|P1|NOT COMPLETED|Period 2||0
1061488|NCT00853840|2574863|P2|COMPLETED|Period 2||9
1061489|NCT00853840|2574864|P1|COMPLETED|Period 2||9
1061490|NCT00853840|2574863|P2|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
1061491|NCT00853840|2574864|P1|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
1061492|NCT00853840|2574863|P2|Maraviroc (Days 1 - 3)|Period 2||9
1061493|NCT00853840|2574864|P1|Maraviroc (Days 1 - 3)|Period 2||9
1061494|NCT00853840|2574863|P2|STARTED|Period 2||9
1061495|NCT00853840|2574864|P1|STARTED|Period 2||9
1061496|NCT00853840|2574863|P2|NOT COMPLETED|Period 1||0
1061497|NCT00853840|2574864|P1|NOT COMPLETED|Period 1||0
1061498|NCT00853840|2574863|P2|COMPLETED|Period 1||9
1061499|NCT00853840|2574864|P1|COMPLETED|Period 1||9
1061500|NCT00853840|2574863|P2|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
1061501|NCT00853840|2574864|P1|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
1061502|NCT00853840|2574863|P2|Maraviroc (Days 1 - 4)|Period 1||9
1061503|NCT00853840|2574864|P1|Maraviroc (Days 1 - 4)|Period 1||9
1061504|NCT00853840|2574863|P2|STARTED|Period 1||9
1061505|NCT00853840|2574864|P1|STARTED|Period 1||9
1061506|NCT00853905|2574881|P2|NOT COMPLETED|Overall Study||4
1061507|NCT00853905|2574882|P1|NOT COMPLETED|Overall Study||2
1061508|NCT00853905|2574881|P2|COMPLETED|Overall Study||36
1061509|NCT00853905|2574882|P1|COMPLETED|Overall Study||35
1061510|NCT00853905|2574881|P2|STARTED|Overall Study||40
1061511|NCT00853905|2574882|P1|STARTED|Overall Study||37
1061512|NCT00853957|2574890|P2|NOT COMPLETED|Overall Study||19
1061513|NCT00853957|2574891|P1|NOT COMPLETED|Overall Study||14
1061514|NCT00853957|2574890|P2|COMPLETED|Overall Study||204
1061515|NCT00853957|2574891|P1|COMPLETED|Overall Study||206
1061516|NCT00853957|2574890|P2|STARTED|Overall Study||223
1061517|NCT00853957|2574891|P1|STARTED|Overall Study||220
1061518|NCT00853970|2574909|P2|NOT COMPLETED|Overall Study||3
1061519|NCT00853970|2574910|P1|NOT COMPLETED|Overall Study||6
1061520|NCT00853970|2574909|P2|COMPLETED|Overall Study||144
1061521|NCT00853970|2574910|P1|COMPLETED|Overall Study||146
1061522|NCT00853970|2574909|P2|STARTED|Overall Study||147
1061523|NCT00853970|2574910|P1|STARTED|Overall Study||152
1061524|NCT00853996|2574918|P1|NOT COMPLETED|Overall Study||0
1061525|NCT00853996|2574918|P1|COMPLETED|Overall Study||25
1061526|NCT00853996|2574918|P1|STARTED|Overall Study||25
1061527|NCT00854087|2574930|P2|NOT COMPLETED|Overall Study||19
1061528|NCT00854087|2574931|P1|NOT COMPLETED|Overall Study||19
1061529|NCT00854087|2574930|P2|COMPLETED|Overall Study||40
1061530|NCT00854087|2574931|P1|COMPLETED|Overall Study||40
1061531|NCT00854087|2574930|P2|STARTED|Overall Study||59
1061532|NCT00854087|2574931|P1|STARTED|Overall Study||59
1061533|NCT00854113|2574948|P11|NOT COMPLETED|Overall Study||0
1061534|NCT00854113|2574949|P10|NOT COMPLETED|Overall Study||0
1061535|NCT00854113|2574950|P9|NOT COMPLETED|Overall Study||1
1061536|NCT00854113|2574951|P8|NOT COMPLETED|Overall Study||3
1061537|NCT00854113|2574952|P7|NOT COMPLETED|Overall Study||0
1061538|NCT00854113|2574953|P6|NOT COMPLETED|Overall Study||0
1061539|NCT00854113|2574954|P5|NOT COMPLETED|Overall Study||0
1061540|NCT00854113|2574955|P4|NOT COMPLETED|Overall Study||0
1061541|NCT00854113|2574956|P3|NOT COMPLETED|Overall Study||0
1061542|NCT00854113|2574957|P2|NOT COMPLETED|Overall Study||0
1061543|NCT00854113|2574958|P1|NOT COMPLETED|Overall Study||0
1061544|NCT00854113|2574948|P11|COMPLETED|Overall Study||6
1061545|NCT00854113|2574949|P10|COMPLETED|Overall Study||8
1061546|NCT00854113|2574950|P9|COMPLETED|Overall Study||7
1061547|NCT00854113|2574951|P8|COMPLETED|Overall Study||5
1061548|NCT00854113|2574952|P7|COMPLETED|Overall Study||12
1061549|NCT00854113|2574953|P6|COMPLETED|Overall Study||6
1061550|NCT00854113|2574954|P5|COMPLETED|Overall Study||6
1061551|NCT00854113|2574955|P4|COMPLETED|Overall Study||6
1061552|NCT00854113|2574956|P3|COMPLETED|Overall Study||6
1061553|NCT00854113|2574957|P2|COMPLETED|Overall Study||6
1061554|NCT00854113|2574958|P1|COMPLETED|Overall Study||6
1061555|NCT00854113|2574948|P11|STARTED|Overall Study||6
1061556|NCT00854113|2574949|P10|STARTED|Overall Study||8
1061557|NCT00854113|2574950|P9|STARTED|Overall Study||8
1061558|NCT00854113|2574951|P8|STARTED|Overall Study||8
1061559|NCT00854113|2574952|P7|STARTED|Overall Study||12
1061560|NCT00854113|2574953|P6|STARTED|Overall Study||6
1061561|NCT00854113|2574954|P5|STARTED|Overall Study||6
1061562|NCT00854113|2574955|P4|STARTED|Overall Study||6
1061563|NCT00854113|2574956|P3|STARTED|Overall Study||6
1061564|NCT00854113|2574957|P2|STARTED|Overall Study||6
1061565|NCT00854113|2574958|P1|STARTED|Overall Study||6
1061566|NCT00859833|2575059|P1|NOT COMPLETED|Overall Study||0
1061567|NCT00859833|2575059|P1|COMPLETED|Overall Study||30
1061568|NCT00859833|2575059|P1|STARTED|Overall Study||30
1061569|NCT00859898|2575067|P3|NOT COMPLETED|Overall Study||27
1061570|NCT00859898|2575068|P2|NOT COMPLETED|Overall Study||31
1061571|NCT00859898|2575069|P1|NOT COMPLETED|Overall Study||28
1061572|NCT00859898|2575067|P3|COMPLETED|Overall Study||181
1061573|NCT00859898|2575068|P2|COMPLETED|Overall Study||188
1061574|NCT00859898|2575069|P1|COMPLETED|Overall Study||183
1061575|NCT00859898|2575067|P3|STARTED|Overall Study||208
1061576|NCT00859898|2575068|P2|STARTED|Overall Study||219
1061577|NCT00859898|2575069|P1|STARTED|Overall Study||211
1061578|NCT00859937|2575112|P2|NOT COMPLETED|Overall Study||0
1061579|NCT00859937|2575113|P1|NOT COMPLETED|Overall Study||1
1061580|NCT00859937|2575112|P2|COMPLETED|Overall Study||14
1061581|NCT00859937|2575113|P1|COMPLETED|Overall Study||40
1061582|NCT00859937|2575112|P2|STARTED|Overall Study||14
1061583|NCT00859937|2575113|P1|STARTED|Overall Study||41
1061584|NCT00859950|2575127|P2|NOT COMPLETED|Overall Study||0
1061585|NCT00859950|2575128|P1|NOT COMPLETED|Overall Study||0
1061586|NCT00859950|2575127|P2|COMPLETED|Overall Study||21
1061587|NCT00859950|2575128|P1|COMPLETED|Overall Study||49
1061588|NCT00859950|2575127|P2|STARTED|Overall Study||21
1061589|NCT00859950|2575128|P1|STARTED|Overall Study||49
1061590|NCT00860028|2575136|P2|NOT COMPLETED|Smoking Cessation Phase||2
1061591|NCT00860028|2575137|P1|NOT COMPLETED|Smoking Cessation Phase||0
1061592|NCT00860028|2575136|P2|COMPLETED|Smoking Cessation Phase||12
1061593|NCT00860028|2575137|P1|COMPLETED|Smoking Cessation Phase||13
1061594|NCT00860028|2575136|P2|STARTED|Smoking Cessation Phase||14
1061595|NCT00860028|2575137|P1|STARTED|Smoking Cessation Phase||13
1061596|NCT00860028|2575136|P2|NOT COMPLETED|Placebo Controlled Pretreatment Period||1
1061597|NCT00860028|2575137|P1|NOT COMPLETED|Placebo Controlled Pretreatment Period||2
1061598|NCT00860028|2575136|P2|COMPLETED|Placebo Controlled Pretreatment Period||14
1061599|NCT00860028|2575137|P1|COMPLETED|Placebo Controlled Pretreatment Period||13
1061600|NCT00860028|2575136|P2|STARTED|Placebo Controlled Pretreatment Period||15
1061601|NCT00860028|2575137|P1|STARTED|Placebo Controlled Pretreatment Period||15
1061602|NCT00860067|2575150|P3|NOT COMPLETED|Overall Study||9
1061603|NCT00860067|2575151|P2|NOT COMPLETED|Overall Study||9
1061604|NCT00860067|2575152|P1|NOT COMPLETED|Overall Study||51
1061605|NCT00860067|2575150|P3|COMPLETED|Overall Study||292
1061606|NCT00860067|2575151|P2|COMPLETED|Overall Study||290
1061607|NCT00860067|2575152|P1|COMPLETED|Overall Study||1149
1061608|NCT00860067|2575150|P3|STARTED|Overall Study||301
1061609|NCT00860067|2575151|P2|STARTED|Overall Study||299
1061610|NCT00860067|2575152|P1|STARTED|Overall Study||1200
1061611|NCT00860457|2575210|P1|NOT COMPLETED|Overall Study||11
1061612|NCT00860457|2575210|P1|COMPLETED|Overall Study||11
1061613|NCT00860457|2575210|P1|STARTED|Overall Study||22
1061614|NCT00860470|2575216|P2|NOT COMPLETED|Overall Study||59
1061615|NCT00860470|2575217|P1|NOT COMPLETED|Overall Study||48
1061616|NCT00860470|2575216|P2|COMPLETED|Overall Study||22346
1061617|NCT00860470|2575217|P1|COMPLETED|Overall Study||22114
1061618|NCT00860470|2575216|P2|STARTED|Overall Study||22405
1061619|NCT00860470|2575217|P1|STARTED|Overall Study||22162
1061620|NCT00860535|2575241|P1|NOT COMPLETED|Overall Study||1
1061621|NCT00860535|2575241|P1|COMPLETED|Overall Study||8
1061622|NCT00860535|2575241|P1|DISCONTINUED|Overall Study|Participant did not meet inclusion criteria and did not complete the study.|1
1061623|NCT00860535|2575241|P1|STARTED|Overall Study||9
1061630|NCT00860795|2575261|P2|NOT COMPLETED|Overall Study||0
1061631|NCT00860795|2575262|P1|NOT COMPLETED|Overall Study||0
1061632|NCT00860795|2575261|P2|COMPLETED|Overall Study||10
1061633|NCT00860795|2575262|P1|COMPLETED|Overall Study|One participant discontinued study medication on day 5, but completed safety evaluations|10
1061634|NCT00860795|2575261|P2|Number to Complete Study Medication|Overall Study||10
1061635|NCT00860795|2575262|P1|Number to Complete Study Medication|Overall Study||9
1061636|NCT00860795|2575261|P2|STARTED|Overall Study||10
1061637|NCT00860795|2575262|P1|STARTED|Overall Study||10
1061638|NCT00860847|2575282|P2|NOT COMPLETED|Overall Study||5
1061639|NCT00860847|2575283|P1|NOT COMPLETED|Overall Study||4
1061640|NCT00860847|2575282|P2|COMPLETED|Overall Study||28
1061641|NCT00860847|2575283|P1|COMPLETED|Overall Study||28
1061642|NCT00860847|2575282|P2|STARTED|Overall Study||33
1061643|NCT00860847|2575283|P1|STARTED|Overall Study||32
1061644|NCT00860951|2575289|P1|NOT COMPLETED|Overall Study||7
1061645|NCT00860951|2575289|P1|COMPLETED|Overall Study||22
1061646|NCT00860951|2575289|P1|STARTED|Overall Study||29
1061647|NCT00861146|2575297|P2|NOT COMPLETED|Overall Study||8
1061648|NCT00861146|2575298|P1|NOT COMPLETED|Overall Study||20
1061649|NCT00861146|2575297|P2|COMPLETED|Overall Study||38
1061650|NCT00861146|2575298|P1|COMPLETED|Overall Study||85
1061651|NCT00861146|2575297|P2|Week 13 Assessment|Overall Study||38
1061652|NCT00861146|2575298|P1|Week 13 Assessment|Overall Study||85
1061653|NCT00861146|2575297|P2|Week 2 Assessment|Overall Study||45
1061654|NCT00861146|2575298|P1|Week 2 Assessment|Overall Study||97
1061655|NCT00861146|2575297|P2|STARTED|Overall Study||46
1061656|NCT00861146|2575298|P1|STARTED|Overall Study||105
1061657|NCT00861198|2575308|P1|NOT COMPLETED|Overall Study||5
1061658|NCT00861198|2575308|P1|COMPLETED|Overall Study||70
1061659|NCT00861198|2575308|P1|STARTED|Overall Study||75
1061660|NCT00861263|2575312|P1|NOT COMPLETED|Overall Study||0
1061661|NCT00861263|2575312|P1|COMPLETED|Overall Study||193
1061662|NCT00861263|2575312|P1|STARTED|Overall Study||193
1061663|NCT00861341|2575316|P1|NOT COMPLETED|Overall Study||2
1061664|NCT00861341|2575316|P1|COMPLETED|Overall Study||38
1061665|NCT00861341|2575316|P1|STARTED|Overall Study||40
1061666|NCT00861471|2575321|P1|NOT COMPLETED|Overall Study||9
1061667|NCT00861471|2575321|P1|COMPLETED|Overall Study||3
1061668|NCT00861471|2575321|P1|STARTED|Overall Study||12
1061669|NCT00861601|2575332|P3|NOT COMPLETED|Overall Study||0
1061670|NCT00861601|2575333|P2|NOT COMPLETED|Overall Study||0
1061671|NCT00861601|2575334|P1|NOT COMPLETED|Overall Study||0
1061672|NCT00861601|2575332|P3|COMPLETED|Overall Study||12
1061673|NCT00861601|2575333|P2|COMPLETED|Overall Study||14
1061674|NCT00861601|2575334|P1|COMPLETED|Overall Study||12
1061675|NCT00861601|2575332|P3|STARTED|Overall Study||12
1061676|NCT00861601|2575333|P2|STARTED|Overall Study||14
1061677|NCT00861601|2575334|P1|STARTED|Overall Study||12
1061678|NCT00861614|2575386|P2|NOT COMPLETED|Overall Study||368
1061679|NCT00861614|2575387|P1|NOT COMPLETED|Overall Study||371
1061680|NCT00861614|2575386|P2|COMPLETED|Overall Study||28
1061681|NCT00861614|2575387|P1|COMPLETED|Overall Study||22
1061682|NCT00861614|2575386|P2|STARTED|Overall Study||396
1061683|NCT00861614|2575387|P1|STARTED|Overall Study||393
1061684|NCT00861692|2575417|P1|NOT COMPLETED|Overall Study||6
1061685|NCT00861692|2575417|P1|COMPLETED|Overall Study||14
1061686|NCT00861692|2575417|P1|STARTED|Overall Study||20
1061687|NCT00861705|2575431|P4|NOT COMPLETED|Overall Study||1
1061688|NCT00861705|2575432|P3|NOT COMPLETED|Overall Study||0
1061689|NCT00861705|2575433|P2|NOT COMPLETED|Overall Study||3
1061690|NCT00861705|2575434|P1|NOT COMPLETED|Overall Study||7
1061691|NCT00861705|2575431|P4|COMPLETED|Overall Study||112
1061692|NCT00861705|2575432|P3|COMPLETED|Overall Study||113
1061693|NCT00861705|2575433|P2|COMPLETED|Overall Study||110
1061694|NCT00861705|2575434|P1|COMPLETED|Overall Study||108
1061695|NCT00861705|2575431|P4|STARTED|Overall Study||113
1061696|NCT00861705|2575432|P3|STARTED|Overall Study||113
1061697|NCT00861705|2575433|P2|STARTED|Overall Study||113
1061698|NCT00861705|2575434|P1|STARTED|Overall Study||115
1061699|NCT00861744|2575454|P4|NOT COMPLETED|Overall Study||33
1061700|NCT00861744|2575455|P3|NOT COMPLETED|Overall Study||24
1061701|NCT00861744|2575456|P2|NOT COMPLETED|Overall Study||29
1061702|NCT00861744|2575457|P1|NOT COMPLETED|Overall Study||17
1061703|NCT00861744|2575454|P4|COMPLETED|Overall Study||275
1061704|NCT00861744|2575455|P3|COMPLETED|Overall Study||280
1061705|NCT00861744|2575456|P2|COMPLETED|Overall Study||275
1061706|NCT00861744|2575457|P1|COMPLETED|Overall Study||287
1061707|NCT00861744|2575454|P4|STARTED|Overall Study||308
1061708|NCT00861744|2575455|P3|STARTED|Overall Study||304
1061709|NCT00861744|2575456|P2|STARTED|Overall Study||304
1061710|NCT00861744|2575457|P1|STARTED|Overall Study||304
1061711|NCT00861757|2575639|P4|NOT COMPLETED|Overall Study||9
1061712|NCT00861757|2575640|P3|NOT COMPLETED|Overall Study||18
1061713|NCT00861757|2575641|P2|NOT COMPLETED|Overall Study||15
1061714|NCT00861757|2575642|P1|NOT COMPLETED|Overall Study||9
1061715|NCT00861757|2575639|P4|COMPLETED|Overall Study||143
1061716|NCT00861757|2575640|P3|COMPLETED|Overall Study||137
1061717|NCT00861757|2575641|P2|COMPLETED|Overall Study||136
1061718|NCT00861757|2575642|P1|COMPLETED|Overall Study||145
1061719|NCT00861757|2575639|P4|STARTED|Overall Study||152
1061720|NCT00861757|2575640|P3|STARTED|Overall Study||155
1061721|NCT00861757|2575641|P2|STARTED|Overall Study||151
1061722|NCT00861757|2575642|P1|STARTED|Overall Study||154
1061723|NCT00861913|2575696|P1|NOT COMPLETED|Overall Study||0
1061724|NCT00861913|2575696|P1|COMPLETED|Overall Study||13
1061725|NCT00861913|2575696|P1|STARTED|Overall Study||13
1061726|NCT00862082|2575706|P2|NOT COMPLETED|Overall Study||1
1061727|NCT00862082|2575707|P1|NOT COMPLETED|Overall Study||5
1061728|NCT00862082|2575706|P2|COMPLETED|Overall Study||5
1061729|NCT00862082|2575707|P1|COMPLETED|Overall Study||3
1061730|NCT00862082|2575706|P2|STARTED|Overall Study||6
1061731|NCT00862082|2575707|P1|STARTED|Overall Study||8
1061732|NCT00862121|2575752|P2|NOT COMPLETED|Overall Study||8
1061733|NCT00862121|2575753|P1|NOT COMPLETED|Overall Study||1
1061734|NCT00862121|2575752|P2|COMPLETED|Overall Study||4
1061735|NCT00862121|2575753|P1|COMPLETED|Overall Study||7
1061736|NCT00862121|2575752|P2|Safety Analysis Set|Overall Study||11
1061737|NCT00862121|2575753|P1|Safety Analysis Set|Overall Study|The participant with no evaluable post-baseline CDAI score was included in the Safety Analysis Set.|8
1061738|NCT00862121|2575752|P2|Full Analysis Set (FAS)|Overall Study|One participant randomised in error (no IMP taken).|11
1061739|NCT00862121|2575753|P1|Full Analysis Set (FAS)|Overall Study|One participant had no evaluable post-baseline CDAI score.|7
1061740|NCT00862121|2575752|P2|STARTED|Overall Study|Randomised, intent-to-treat (ITT)|12
1061741|NCT00862121|2575753|P1|STARTED|Overall Study||8
1061742|NCT00862134|2575771|P2|NOT COMPLETED|Overall Study||12
1061743|NCT00862134|2575772|P1|NOT COMPLETED|Overall Study||11
1061744|NCT00862134|2575771|P2|COMPLETED|Overall Study||11
1061745|NCT00862134|2575772|P1|COMPLETED|Overall Study||8
1061746|NCT00862134|2575771|P2|STARTED|Overall Study||23
1061747|NCT00862134|2575772|P1|STARTED|Overall Study||19
1061748|NCT00862186|2575782|P1|NOT COMPLETED|Overall Study||0
1061749|NCT00862186|2575782|P1|COMPLETED|Overall Study||15
1061750|NCT00862186|2575782|P1|STARTED|Overall Study||15
1061751|NCT00862251|2575790|P3|NOT COMPLETED|Overall Study||9
1061752|NCT00862251|2575791|P2|NOT COMPLETED|Overall Study||5
1061753|NCT00862251|2575792|P1|NOT COMPLETED|Overall Study||19
1061754|NCT00862251|2575790|P3|COMPLETED|Overall Study||315
1061755|NCT00862251|2575791|P2|COMPLETED|Overall Study||157
1061756|NCT00862251|2575792|P1|COMPLETED|Overall Study||303
1061757|NCT00862251|2575790|P3|STARTED|Overall Study||324
1061758|NCT00862251|2575791|P2|STARTED|Overall Study||162
1061759|NCT00862251|2575792|P1|STARTED|Overall Study||322
1061760|NCT00862277|2575848|P3|NOT COMPLETED|Overall Study||5
1061761|NCT00862277|2575849|P2|NOT COMPLETED|Overall Study||2
1061762|NCT00862277|2575850|P1|NOT COMPLETED|Overall Study||1
1061763|NCT00862277|2575848|P3|COMPLETED|Overall Study||100
1061764|NCT00862277|2575849|P2|COMPLETED|Overall Study||94
1061765|NCT00862277|2575850|P1|COMPLETED|Overall Study||560
1061766|NCT00862277|2575848|P3|STARTED|Overall Study||105
1061767|NCT00862277|2575849|P2|STARTED|Overall Study||96
1061768|NCT00862277|2575850|P1|STARTED|Overall Study||561
1061769|NCT00862459|2575864|P3|NOT COMPLETED|Overall Study||6
1061770|NCT00862459|2575865|P2|NOT COMPLETED|Overall Study||8
1061771|NCT00862459|2575866|P1|NOT COMPLETED|Overall Study||6
1061772|NCT00862459|2575864|P3|COMPLETED|Overall Study||66
1061773|NCT00862459|2575865|P2|COMPLETED|Overall Study||85
1061774|NCT00862459|2575866|P1|COMPLETED|Overall Study||66
1061775|NCT00862459|2575864|P3|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 68 received Gadobutrol and 69 received OptiMARK|69
1061776|NCT00862459|2575865|P2|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 90 received Gadobutrol and 88 received OptiMARK|90
1061777|NCT00862459|2575866|P1|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 67 received Gadobutrol and 70 received OptiMARK|70
1061778|NCT00862459|2575864|P3|STARTED|Overall Study||72
1061779|NCT00862459|2575865|P2|STARTED|Overall Study||93
1061780|NCT00862459|2575866|P1|STARTED|Overall Study||72
1061781|NCT00862537|2576010|P1|NOT COMPLETED|Overall Study||7
1061782|NCT00862537|2576010|P1|COMPLETED|Overall Study||11
1061783|NCT00862537|2576010|P1|STARTED|Overall Study||18
1061784|NCT00862563|2576018|P4|NOT COMPLETED|Overall Study||5
1061785|NCT00862563|2576019|P3|NOT COMPLETED|Overall Study||6
1061786|NCT00862563|2576020|P2|NOT COMPLETED|Overall Study||4
1061787|NCT00862563|2576021|P1|NOT COMPLETED|Overall Study||4
1061788|NCT00862563|2576018|P4|COMPLETED|Overall Study||19
1061789|NCT00862563|2576019|P3|COMPLETED|Overall Study||15
1061790|NCT00862563|2576020|P2|COMPLETED|Overall Study||17
1061791|NCT00862563|2576021|P1|COMPLETED|Overall Study||15
1061792|NCT00862563|2576018|P4|STARTED|Overall Study||24
1061793|NCT00862563|2576019|P3|STARTED|Overall Study||21
1061794|NCT00862563|2576020|P2|STARTED|Overall Study||21
1061795|NCT00862563|2576021|P1|STARTED|Overall Study||19
1061796|NCT00862641|2576063|P4|NOT COMPLETED|Overall Study||4
1061797|NCT00862641|2576064|P3|NOT COMPLETED|Overall Study||1
1061798|NCT00862641|2576065|P2|NOT COMPLETED|Overall Study||4
1061799|NCT00862641|2576066|P1|NOT COMPLETED|Overall Study||1
1061800|NCT00862641|2576063|P4|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|316
1061801|NCT00862641|2576064|P3|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|151
1061802|NCT00862641|2576065|P2|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|356
1061803|NCT00862641|2576066|P1|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|176
1061804|NCT00862641|2576063|P4|STARTED|Overall Study||320
1061805|NCT00862641|2576064|P3|STARTED|Overall Study||152
1061806|NCT00862641|2576065|P2|STARTED|Overall Study||360
1061807|NCT00862641|2576066|P1|STARTED|Overall Study||177
1061808|NCT00862654|2576112|P4|NOT COMPLETED|Overall Study||6
1061809|NCT00862654|2576113|P3|NOT COMPLETED|Overall Study||6
1061810|NCT00862654|2576114|P2|NOT COMPLETED|Overall Study||8
1061811|NCT00862654|2576115|P1|NOT COMPLETED|Overall Study||6
1061812|NCT00862654|2576112|P4|COMPLETED|Overall Study||74
1061813|NCT00862654|2576113|P3|COMPLETED|Overall Study||76
1061814|NCT00862654|2576114|P2|COMPLETED|Overall Study||74
1061815|NCT00862654|2576115|P1|COMPLETED|Overall Study||76
1061816|NCT00862654|2576112|P4|STARTED|Overall Study||80
1061817|NCT00862654|2576113|P3|STARTED|Overall Study||82
1061818|NCT00862654|2576114|P2|STARTED|Overall Study||82
1061819|NCT00862654|2576115|P1|STARTED|Overall Study||82
1061820|NCT00862719|2576129|P4|NOT COMPLETED|Overall Study||1
1061821|NCT00862719|2576130|P3|NOT COMPLETED|Overall Study||4
1061822|NCT00862719|2576131|P2|NOT COMPLETED|Overall Study||6
1061823|NCT00862719|2576132|P1|NOT COMPLETED|Overall Study||10
1061824|NCT00862719|2576129|P4|COMPLETED|Overall Study||0
1061825|NCT00862719|2576130|P3|COMPLETED|Overall Study||0
1061826|NCT00862719|2576131|P2|COMPLETED|Overall Study||1
1061827|NCT00862719|2576132|P1|COMPLETED|Overall Study||7
1061828|NCT00862719|2576129|P4|STARTED|Overall Study||1
1061829|NCT00862719|2576130|P3|STARTED|Overall Study||4
1061830|NCT00862719|2576131|P2|STARTED|Overall Study||7
1061831|NCT00862719|2576132|P1|STARTED|Overall Study||17
1061832|NCT00862745|2576153|P2|NOT COMPLETED|Open-label Follow-up||49
1061833|NCT00862745|2576154|P1|NOT COMPLETED|Open-label Follow-up||39
1061834|NCT00862745|2576153|P2|COMPLETED|Open-label Follow-up||225
1061835|NCT00862745|2576154|P1|COMPLETED|Open-label Follow-up||229
1061836|NCT00862745|2576153|P2|STARTED|Open-label Follow-up|10 participants elected not to enter the open-label portion of the study after completing the RCT.|274
1061837|NCT00862745|2576154|P1|STARTED|Open-label Follow-up|19 participants elected not to enter the open-label portion of the study after completing the RCT.|268
1061838|NCT00862745|2576153|P2|NOT COMPLETED|Randomized Control Trial||39
1061839|NCT00862745|2576154|P1|NOT COMPLETED|Randomized Control Trial||38
1061840|NCT00862745|2576153|P2|COMPLETED|Randomized Control Trial||284
1061841|NCT00862745|2576154|P1|COMPLETED|Randomized Control Trial||284
1061842|NCT00862745|2576153|P2|STARTED|Randomized Control Trial||323
1061843|NCT00862745|2576154|P1|STARTED|Randomized Control Trial||322
1061844|NCT00862784|2576160|P1|NOT COMPLETED|Overall Study||0
1061845|NCT00862784|2576160|P1|COMPLETED|Overall Study||48
1061846|NCT00862784|2576160|P1|Received Any Amount of Study Drug|Overall Study||48
1061847|NCT00862784|2576160|P1|STARTED|Overall Study||48
1061848|NCT00862810|2576182|P2|NOT COMPLETED|Overall Study||4
1061849|NCT00862810|2576183|P1|NOT COMPLETED|Overall Study||4
1061850|NCT00862810|2576182|P2|COMPLETED|Overall Study||35
1061851|NCT00862810|2576183|P1|COMPLETED|Overall Study||29
1061852|NCT00862810|2576182|P2|STARTED|Overall Study||39
1061853|NCT00862810|2576183|P1|STARTED|Overall Study||33
1061854|NCT00862823|2576189|P2|NOT COMPLETED|Second Intervention||0
1061855|NCT00862823|2576190|P1|NOT COMPLETED|Second Intervention||0
1061856|NCT00862823|2576189|P2|COMPLETED|Second Intervention||9
1061857|NCT00862823|2576190|P1|COMPLETED|Second Intervention||5
1061858|NCT00862823|2576189|P2|STARTED|Second Intervention||9
1061859|NCT00862823|2576190|P1|STARTED|Second Intervention||5
1061860|NCT00862823|2576189|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
1061861|NCT00862823|2576190|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
1061862|NCT00862823|2576189|P2|COMPLETED|Washout Period of 2 Weeks||9
1061863|NCT00862823|2576190|P1|COMPLETED|Washout Period of 2 Weeks||5
1061864|NCT00862823|2576189|P2|STARTED|Washout Period of 2 Weeks||9
1061865|NCT00862823|2576190|P1|STARTED|Washout Period of 2 Weeks||5
1061866|NCT00862823|2576189|P2|NOT COMPLETED|First Intervention||1
1061867|NCT00862823|2576190|P1|NOT COMPLETED|First Intervention||1
1061868|NCT00862823|2576189|P2|COMPLETED|First Intervention||9
1061869|NCT00862823|2576190|P1|COMPLETED|First Intervention||5
1061870|NCT00862823|2576189|P2|STARTED|First Intervention||10
1061871|NCT00862823|2576190|P1|STARTED|First Intervention||6
1061872|NCT00862836|2576197|P1|NOT COMPLETED|Overall Study||1
1061873|NCT00862836|2576197|P1|COMPLETED|Overall Study||14
1061874|NCT00862836|2576197|P1|Evaluable for Activity (Tumour Response)|Overall Study||10
1061875|NCT00862836|2576197|P1|Evaluable for Safety/Toxicity|Overall Study|1 patient withdrew consent before first cycle|14
1061876|NCT00862836|2576197|P1|STARTED|Overall Study||15
1061877|NCT00862849|2576208|P6|NOT COMPLETED|Intervention 6||0
1061878|NCT00862849|2576209|P5|NOT COMPLETED|Intervention 6||0
1061879|NCT00862849|2576210|P4|NOT COMPLETED|Intervention 6||0
1061880|NCT00862849|2576211|P3|NOT COMPLETED|Intervention 6||0
1061881|NCT00862849|2576212|P2|NOT COMPLETED|Intervention 6||0
1061882|NCT00862849|2576213|P1|NOT COMPLETED|Intervention 6||0
1061883|NCT00862849|2576208|P6|COMPLETED|Intervention 6||3
1061884|NCT00862849|2576209|P5|COMPLETED|Intervention 6||4
1061885|NCT00862849|2576210|P4|COMPLETED|Intervention 6||4
1061886|NCT00862849|2576211|P3|COMPLETED|Intervention 6||3
1061887|NCT00862849|2576212|P2|COMPLETED|Intervention 6||3
1061888|NCT00862849|2576213|P1|COMPLETED|Intervention 6||3
1061889|NCT00862849|2576208|P6|STARTED|Intervention 6||3
1061890|NCT00862849|2576209|P5|STARTED|Intervention 6||4
1061891|NCT00862849|2576210|P4|STARTED|Intervention 6||4
1061892|NCT00862849|2576211|P3|STARTED|Intervention 6||3
1061893|NCT00862849|2576212|P2|STARTED|Intervention 6||3
1061894|NCT00862849|2576213|P1|STARTED|Intervention 6||3
1061895|NCT00862849|2576208|P6|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
1061896|NCT00862849|2576209|P5|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
1061897|NCT00862849|2576210|P4|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
1061898|NCT00862849|2576211|P3|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
1061899|NCT00862849|2576212|P2|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
1061900|NCT00862849|2576213|P1|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
1061901|NCT00862849|2576208|P6|COMPLETED|Washout 5 (3 to 14 Days)||3
1061902|NCT00862849|2576209|P5|COMPLETED|Washout 5 (3 to 14 Days)||4
1061903|NCT00862849|2576210|P4|COMPLETED|Washout 5 (3 to 14 Days)||4
1061904|NCT00862849|2576211|P3|COMPLETED|Washout 5 (3 to 14 Days)||3
1061905|NCT00862849|2576212|P2|COMPLETED|Washout 5 (3 to 14 Days)||3
1061906|NCT00862849|2576213|P1|COMPLETED|Washout 5 (3 to 14 Days)||3
1061907|NCT00862849|2576208|P6|STARTED|Washout 5 (3 to 14 Days)||3
1061908|NCT00862849|2576209|P5|STARTED|Washout 5 (3 to 14 Days)||4
1061909|NCT00862849|2576210|P4|STARTED|Washout 5 (3 to 14 Days)||4
1061910|NCT00862849|2576211|P3|STARTED|Washout 5 (3 to 14 Days)||3
1061911|NCT00862849|2576212|P2|STARTED|Washout 5 (3 to 14 Days)||3
1061912|NCT00862849|2576213|P1|STARTED|Washout 5 (3 to 14 Days)||3
1061913|NCT00862849|2576208|P6|NOT COMPLETED|Intervention 5||0
1061914|NCT00862849|2576209|P5|NOT COMPLETED|Intervention 5||0
1061915|NCT00862849|2576210|P4|NOT COMPLETED|Intervention 5||0
1061916|NCT00862849|2576211|P3|NOT COMPLETED|Intervention 5||0
1061917|NCT00862849|2576212|P2|NOT COMPLETED|Intervention 5||0
1061918|NCT00862849|2576213|P1|NOT COMPLETED|Intervention 5||0
1061919|NCT00862849|2576208|P6|COMPLETED|Intervention 5||3
1061920|NCT00862849|2576209|P5|COMPLETED|Intervention 5||4
1061921|NCT00862849|2576210|P4|COMPLETED|Intervention 5||4
1061922|NCT00862849|2576211|P3|COMPLETED|Intervention 5||3
1061923|NCT00862849|2576212|P2|COMPLETED|Intervention 5||3
1061924|NCT00862849|2576213|P1|COMPLETED|Intervention 5||3
1061925|NCT00862849|2576208|P6|STARTED|Intervention 5||3
1061926|NCT00862849|2576209|P5|STARTED|Intervention 5||4
1061927|NCT00862849|2576210|P4|STARTED|Intervention 5||4
1061928|NCT00862849|2576211|P3|STARTED|Intervention 5||3
1061929|NCT00862849|2576212|P2|STARTED|Intervention 5||3
1061930|NCT00862849|2576213|P1|STARTED|Intervention 5||3
1061931|NCT00862849|2576208|P6|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
1061932|NCT00862849|2576209|P5|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
1061933|NCT00862849|2576210|P4|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
1061934|NCT00862849|2576211|P3|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
1061935|NCT00862849|2576212|P2|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
1061936|NCT00862849|2576213|P1|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
1061937|NCT00862849|2576208|P6|COMPLETED|Washout 4 (3 to 14 Days)||3
1061938|NCT00862849|2576209|P5|COMPLETED|Washout 4 (3 to 14 Days)||4
1061939|NCT00862849|2576210|P4|COMPLETED|Washout 4 (3 to 14 Days)||4
1061940|NCT00862849|2576211|P3|COMPLETED|Washout 4 (3 to 14 Days)||3
1061941|NCT00862849|2576212|P2|COMPLETED|Washout 4 (3 to 14 Days)||3
1061942|NCT00862849|2576213|P1|COMPLETED|Washout 4 (3 to 14 Days)||3
1061943|NCT00862849|2576208|P6|STARTED|Washout 4 (3 to 14 Days)||3
1061944|NCT00862849|2576209|P5|STARTED|Washout 4 (3 to 14 Days)||4
1061945|NCT00862849|2576210|P4|STARTED|Washout 4 (3 to 14 Days)||4
1061946|NCT00862849|2576211|P3|STARTED|Washout 4 (3 to 14 Days)||3
1061947|NCT00862849|2576212|P2|STARTED|Washout 4 (3 to 14 Days)||3
1061948|NCT00862849|2576213|P1|STARTED|Washout 4 (3 to 14 Days)||3
1061949|NCT00862849|2576208|P6|NOT COMPLETED|Intervention 4||0
1061950|NCT00862849|2576209|P5|NOT COMPLETED|Intervention 4||0
1061951|NCT00862849|2576210|P4|NOT COMPLETED|Intervention 4||0
1061952|NCT00862849|2576211|P3|NOT COMPLETED|Intervention 4||0
1061953|NCT00862849|2576212|P2|NOT COMPLETED|Intervention 4||0
1061954|NCT00862849|2576213|P1|NOT COMPLETED|Intervention 4||0
1061955|NCT00862849|2576208|P6|COMPLETED|Intervention 4||3
1061956|NCT00862849|2576209|P5|COMPLETED|Intervention 4||4
1061957|NCT00862849|2576210|P4|COMPLETED|Intervention 4||4
1061958|NCT00862849|2576211|P3|COMPLETED|Intervention 4||3
1061959|NCT00862849|2576212|P2|COMPLETED|Intervention 4||3
1061960|NCT00862849|2576213|P1|COMPLETED|Intervention 4||3
1061961|NCT00862849|2576208|P6|STARTED|Intervention 4||3
1061962|NCT00862849|2576209|P5|STARTED|Intervention 4||4
1061963|NCT00862849|2576210|P4|STARTED|Intervention 4||4
1061964|NCT00862849|2576211|P3|STARTED|Intervention 4||3
1061965|NCT00862849|2576212|P2|STARTED|Intervention 4||3
1061966|NCT00862849|2576213|P1|STARTED|Intervention 4||3
1061967|NCT00862849|2576208|P6|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
1061968|NCT00862849|2576209|P5|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
1061969|NCT00862849|2576210|P4|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
1061970|NCT00862849|2576211|P3|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
1061971|NCT00862849|2576212|P2|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
1061972|NCT00862849|2576213|P1|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
1061973|NCT00862849|2576208|P6|COMPLETED|Washout 3 (3 to 14 Days)||3
1061974|NCT00862849|2576209|P5|COMPLETED|Washout 3 (3 to 14 Days)||4
1061975|NCT00862849|2576210|P4|COMPLETED|Washout 3 (3 to 14 Days)||4
1061976|NCT00862849|2576211|P3|COMPLETED|Washout 3 (3 to 14 Days)||3
1061977|NCT00862849|2576212|P2|COMPLETED|Washout 3 (3 to 14 Days)||3
1061978|NCT00862849|2576213|P1|COMPLETED|Washout 3 (3 to 14 Days)||3
1061979|NCT00862849|2576208|P6|STARTED|Washout 3 (3 to 14 Days)||3
1061980|NCT00862849|2576209|P5|STARTED|Washout 3 (3 to 14 Days)||4
1061981|NCT00862849|2576210|P4|STARTED|Washout 3 (3 to 14 Days)||4
1061982|NCT00862849|2576211|P3|STARTED|Washout 3 (3 to 14 Days)||3
1061983|NCT00862849|2576212|P2|STARTED|Washout 3 (3 to 14 Days)||3
1061984|NCT00862849|2576213|P1|STARTED|Washout 3 (3 to 14 Days)||3
1061985|NCT00862849|2576208|P6|NOT COMPLETED|Intervention 3||0
1061986|NCT00862849|2576209|P5|NOT COMPLETED|Intervention 3||0
1061987|NCT00862849|2576210|P4|NOT COMPLETED|Intervention 3||0
1061988|NCT00862849|2576211|P3|NOT COMPLETED|Intervention 3||0
1061989|NCT00862849|2576212|P2|NOT COMPLETED|Intervention 3||0
1061990|NCT00862849|2576213|P1|NOT COMPLETED|Intervention 3||0
1061991|NCT00862849|2576208|P6|COMPLETED|Intervention 3||3
1061992|NCT00862849|2576209|P5|COMPLETED|Intervention 3||4
1061993|NCT00862849|2576210|P4|COMPLETED|Intervention 3||4
1061994|NCT00862849|2576211|P3|COMPLETED|Intervention 3||3
1061995|NCT00862849|2576212|P2|COMPLETED|Intervention 3||3
1061996|NCT00862849|2576213|P1|COMPLETED|Intervention 3||3
1061997|NCT00862849|2576208|P6|STARTED|Intervention 3||3
1061998|NCT00862849|2576209|P5|STARTED|Intervention 3||4
1061999|NCT00862849|2576210|P4|STARTED|Intervention 3||4
1062000|NCT00862849|2576211|P3|STARTED|Intervention 3||3
1062001|NCT00862849|2576212|P2|STARTED|Intervention 3||3
1062002|NCT00862849|2576213|P1|STARTED|Intervention 3||3
1062003|NCT00862849|2576208|P6|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
1062004|NCT00862849|2576209|P5|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
1062005|NCT00862849|2576210|P4|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
1062006|NCT00862849|2576211|P3|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
1062007|NCT00862849|2576212|P2|NOT COMPLETED|Washout 2 (3 to 14 Days)||1
1062008|NCT00862849|2576213|P1|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
1062009|NCT00862849|2576208|P6|COMPLETED|Washout 2 (3 to 14 Days)||3
1062010|NCT00862849|2576209|P5|COMPLETED|Washout 2 (3 to 14 Days)||4
1062011|NCT00862849|2576210|P4|COMPLETED|Washout 2 (3 to 14 Days)||4
1062012|NCT00862849|2576211|P3|COMPLETED|Washout 2 (3 to 14 Days)||3
1062013|NCT00862849|2576212|P2|COMPLETED|Washout 2 (3 to 14 Days)||3
1062014|NCT00862849|2576213|P1|COMPLETED|Washout 2 (3 to 14 Days)||3
1062015|NCT00862849|2576208|P6|STARTED|Washout 2 (3 to 14 Days)||3
1062016|NCT00862849|2576209|P5|STARTED|Washout 2 (3 to 14 Days)||4
1062017|NCT00862849|2576210|P4|STARTED|Washout 2 (3 to 14 Days)||4
1062018|NCT00862849|2576211|P3|STARTED|Washout 2 (3 to 14 Days)||3
1062019|NCT00862849|2576212|P2|STARTED|Washout 2 (3 to 14 Days)||4
1062020|NCT00862849|2576213|P1|STARTED|Washout 2 (3 to 14 Days)||3
1062021|NCT00862849|2576208|P6|NOT COMPLETED|Intervention 2||0
1062022|NCT00862849|2576209|P5|NOT COMPLETED|Intervention 2||0
1062023|NCT00862849|2576210|P4|NOT COMPLETED|Intervention 2||0
1062024|NCT00862849|2576211|P3|NOT COMPLETED|Intervention 2||0
1062025|NCT00862849|2576212|P2|NOT COMPLETED|Intervention 2||0
1062026|NCT00862849|2576213|P1|NOT COMPLETED|Intervention 2||0
1062027|NCT00862849|2576208|P6|COMPLETED|Intervention 2||3
1062028|NCT00862849|2576209|P5|COMPLETED|Intervention 2||4
1062029|NCT00862849|2576210|P4|COMPLETED|Intervention 2||4
1062030|NCT00862849|2576211|P3|COMPLETED|Intervention 2||3
1062031|NCT00862849|2576212|P2|COMPLETED|Intervention 2||4
1062032|NCT00862849|2576213|P1|COMPLETED|Intervention 2||3
1062033|NCT00862849|2576208|P6|STARTED|Intervention 2||3
1062034|NCT00862849|2576209|P5|STARTED|Intervention 2||4
1062035|NCT00862849|2576210|P4|STARTED|Intervention 2||4
1062036|NCT00862849|2576211|P3|STARTED|Intervention 2||3
1062037|NCT00862849|2576212|P2|STARTED|Intervention 2||4
1062038|NCT00862849|2576213|P1|STARTED|Intervention 2||3
1062039|NCT00862849|2576208|P6|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
1062040|NCT00862849|2576209|P5|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
1062041|NCT00862849|2576210|P4|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
1062042|NCT00862849|2576211|P3|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
1062043|NCT00862849|2576212|P2|NOT COMPLETED|Washout 1 (3 to 14 Days)||1
1062044|NCT00862849|2576213|P1|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
1062045|NCT00862849|2576208|P6|COMPLETED|Washout 1 (3 to 14 Days)||3
1062046|NCT00862849|2576209|P5|COMPLETED|Washout 1 (3 to 14 Days)||4
1062047|NCT00862849|2576210|P4|COMPLETED|Washout 1 (3 to 14 Days)||4
1062048|NCT00862849|2576211|P3|COMPLETED|Washout 1 (3 to 14 Days)||3
1062049|NCT00862849|2576212|P2|COMPLETED|Washout 1 (3 to 14 Days)||4
1062050|NCT00862849|2576213|P1|COMPLETED|Washout 1 (3 to 14 Days)||3
1062051|NCT00862849|2576208|P6|STARTED|Washout 1 (3 to 14 Days)||3
1062052|NCT00862849|2576209|P5|STARTED|Washout 1 (3 to 14 Days)||4
1062053|NCT00862849|2576210|P4|STARTED|Washout 1 (3 to 14 Days)||4
1062054|NCT00862849|2576211|P3|STARTED|Washout 1 (3 to 14 Days)||3
1062055|NCT00862849|2576212|P2|STARTED|Washout 1 (3 to 14 Days)||5
1062056|NCT00862849|2576213|P1|STARTED|Washout 1 (3 to 14 Days)||3
1062057|NCT00862849|2576208|P6|NOT COMPLETED|Intervention 1||0
1062058|NCT00862849|2576209|P5|NOT COMPLETED|Intervention 1||0
1062059|NCT00862849|2576210|P4|NOT COMPLETED|Intervention 1||0
1062060|NCT00862849|2576211|P3|NOT COMPLETED|Intervention 1||0
1062061|NCT00862849|2576212|P2|NOT COMPLETED|Intervention 1||0
1062062|NCT00862849|2576213|P1|NOT COMPLETED|Intervention 1||0
1062063|NCT00862849|2576208|P6|COMPLETED|Intervention 1||3
1062064|NCT00862849|2576209|P5|COMPLETED|Intervention 1||4
1062065|NCT00862849|2576210|P4|COMPLETED|Intervention 1||4
1062066|NCT00862849|2576211|P3|COMPLETED|Intervention 1||3
1062067|NCT00862849|2576212|P2|COMPLETED|Intervention 1||5
1062068|NCT00862849|2576213|P1|COMPLETED|Intervention 1||3
1062069|NCT00862849|2576208|P6|Received at Least One Dose of Study Drug|Intervention 1||3
1062070|NCT00862849|2576209|P5|Received at Least One Dose of Study Drug|Intervention 1||4
1062071|NCT00862849|2576210|P4|Received at Least One Dose of Study Drug|Intervention 1||4
1062072|NCT00862849|2576211|P3|Received at Least One Dose of Study Drug|Intervention 1||3
1062073|NCT00862849|2576212|P2|Received at Least One Dose of Study Drug|Intervention 1||5
1062074|NCT00862849|2576213|P1|Received at Least One Dose of Study Drug|Intervention 1||3
1062075|NCT00862849|2576208|P6|STARTED|Intervention 1||3
1062076|NCT00862849|2576209|P5|STARTED|Intervention 1||4
1062077|NCT00862849|2576210|P4|STARTED|Intervention 1||4
1062078|NCT00862849|2576211|P3|STARTED|Intervention 1||3
1062079|NCT00862849|2576212|P2|STARTED|Intervention 1||5
1062080|NCT00862849|2576213|P1|STARTED|Intervention 1||3
1062081|NCT00862940|2576238|P2|NOT COMPLETED|Overall Study||30
1062082|NCT00862940|2576239|P1|NOT COMPLETED|Overall Study||30
1062083|NCT00862940|2576238|P2|COMPLETED|Overall Study||114
1062084|NCT00862940|2576239|P1|COMPLETED|Overall Study||103
1062085|NCT00862940|2576238|P2|STARTED|Overall Study||144
1062086|NCT00862940|2576239|P1|STARTED|Overall Study||133
1062087|NCT00863057|2576255|P4|NOT COMPLETED|Period 4 (Weeks 16-20)||0
1062088|NCT00863057|2576256|P3|NOT COMPLETED|Period 4 (Weeks 16-20)||0
1062089|NCT00863057|2576257|P2|NOT COMPLETED|Period 4 (Weeks 16-20)||0
1062090|NCT00863057|2576258|P1|NOT COMPLETED|Period 4 (Weeks 16-20)||0
1062091|NCT00863057|2576255|P4|COMPLETED|Period 4 (Weeks 16-20)||2
1062092|NCT00863057|2576256|P3|COMPLETED|Period 4 (Weeks 16-20)||2
1062093|NCT00863057|2576257|P2|COMPLETED|Period 4 (Weeks 16-20)||1
1062094|NCT00863057|2576258|P1|COMPLETED|Period 4 (Weeks 16-20)||3
1062095|NCT00863057|2576255|P4|STARTED|Period 4 (Weeks 16-20)||2
1062096|NCT00863057|2576256|P3|STARTED|Period 4 (Weeks 16-20)||2
1062097|NCT00863057|2576257|P2|STARTED|Period 4 (Weeks 16-20)||1
1062098|NCT00863057|2576258|P1|STARTED|Period 4 (Weeks 16-20)||3
1062099|NCT00863057|2576255|P4|NOT COMPLETED|Period 3 (Weeks 11-15)||0
1062100|NCT00863057|2576256|P3|NOT COMPLETED|Period 3 (Weeks 11-15)||0
1062101|NCT00863057|2576257|P2|NOT COMPLETED|Period 3 (Weeks 11-15)||0
1062102|NCT00863057|2576258|P1|NOT COMPLETED|Period 3 (Weeks 11-15)||0
1062103|NCT00863057|2576255|P4|COMPLETED|Period 3 (Weeks 11-15)||2
1062104|NCT00863057|2576256|P3|COMPLETED|Period 3 (Weeks 11-15)||2
1062105|NCT00863057|2576257|P2|COMPLETED|Period 3 (Weeks 11-15)||1
1062106|NCT00863057|2576258|P1|COMPLETED|Period 3 (Weeks 11-15)||3
1062107|NCT00863057|2576255|P4|STARTED|Period 3 (Weeks 11-15)||2
1062108|NCT00863057|2576256|P3|STARTED|Period 3 (Weeks 11-15)||2
1062109|NCT00863057|2576257|P2|STARTED|Period 3 (Weeks 11-15)||1
1062110|NCT00863057|2576258|P1|STARTED|Period 3 (Weeks 11-15)||3
1062111|NCT00863057|2576255|P4|NOT COMPLETED|Period 2 (Weeks 6-10)||1
1062112|NCT00863057|2576256|P3|NOT COMPLETED|Period 2 (Weeks 6-10)||1
1062113|NCT00863057|2576257|P2|NOT COMPLETED|Period 2 (Weeks 6-10)||1
1062114|NCT00863057|2576258|P1|NOT COMPLETED|Period 2 (Weeks 6-10)||0
1062115|NCT00863057|2576255|P4|COMPLETED|Period 2 (Weeks 6-10)||2
1062116|NCT00863057|2576256|P3|COMPLETED|Period 2 (Weeks 6-10)||2
1062117|NCT00863057|2576257|P2|COMPLETED|Period 2 (Weeks 6-10)||1
1062118|NCT00863057|2576258|P1|COMPLETED|Period 2 (Weeks 6-10)||3
1062119|NCT00863057|2576255|P4|STARTED|Period 2 (Weeks 6-10)||3
1062120|NCT00863057|2576256|P3|STARTED|Period 2 (Weeks 6-10)||3
1062121|NCT00863057|2576257|P2|STARTED|Period 2 (Weeks 6-10)||2
1062122|NCT00863057|2576258|P1|STARTED|Period 2 (Weeks 6-10)||3
1062123|NCT00863057|2576255|P4|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
1062124|NCT00863057|2576256|P3|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||0
1062125|NCT00863057|2576257|P2|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||2
1062126|NCT00863057|2576258|P1|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
1062127|NCT00863057|2576255|P4|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
1062128|NCT00863057|2576256|P3|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
1062129|NCT00863057|2576257|P2|COMPLETED|Milestones Period 1 (Weeks 0-5)||2
1062130|NCT00863057|2576258|P1|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
1062131|NCT00863057|2576255|P4|STARTED|Milestones Period 1 (Weeks 0-5)||4
1062132|NCT00863057|2576256|P3|STARTED|Milestones Period 1 (Weeks 0-5)||3
1062133|NCT00863057|2576257|P2|STARTED|Milestones Period 1 (Weeks 0-5)||4
1062134|NCT00863057|2576258|P1|STARTED|Milestones Period 1 (Weeks 0-5)||4
1062135|NCT00863109|2576298|P1|NOT COMPLETED|Follow-up Period||11
1062136|NCT00863109|2576298|P1|COMPLETED|Follow-up Period||48
1062137|NCT00863109|2576298|P1|STARTED|Follow-up Period|Follow-up performed on 53 who completed Treatment Period plus 6 who discontinued treatment|59
1062138|NCT00863109|2576298|P1|NOT COMPLETED|Treatment Period||77
1062139|NCT00863109|2576298|P1|COMPLETED|Treatment Period||53
1062140|NCT00863109|2576298|P1|STARTED|Treatment Period||130
1062141|NCT00864682|2576314|P3|NOT COMPLETED|Overall Study||2
1062142|NCT00864682|2576315|P2|NOT COMPLETED|Overall Study||1
1062143|NCT00864682|2576316|P1|NOT COMPLETED|Overall Study||2
1062144|NCT00864682|2576314|P3|COMPLETED|Overall Study||51
1062145|NCT00864682|2576315|P2|COMPLETED|Overall Study||50
1062146|NCT00864682|2576316|P1|COMPLETED|Overall Study||50
1062147|NCT00864682|2576314|P3|STARTED|Overall Study||53
1062148|NCT00864682|2576315|P2|STARTED|Overall Study||51
1062149|NCT00864682|2576316|P1|STARTED|Overall Study||52
1062150|NCT00864708|2576330|P1|NOT COMPLETED|Overall Study||0
1062151|NCT00864708|2576330|P1|COMPLETED|Overall Study||1
1062152|NCT00864708|2576330|P1|STARTED|Overall Study||1
1062153|NCT00864851|2576342|P3|NOT COMPLETED|Overall Study||0
1062154|NCT00864851|2576343|P2|NOT COMPLETED|Overall Study||1
1062155|NCT00864851|2576344|P1|NOT COMPLETED|Overall Study||3
1062156|NCT00864851|2576342|P3|COMPLETED|Overall Study||5
1062157|NCT00864851|2576343|P2|COMPLETED|Overall Study||18
1062158|NCT00864851|2576344|P1|COMPLETED|Overall Study||17
1062159|NCT00864851|2576342|P3|STARTED|Overall Study||5
1062160|NCT00864851|2576343|P2|STARTED|Overall Study||19
1062161|NCT00864851|2576344|P1|STARTED|Overall Study||20
1062162|NCT00864916|2576380|P2|NOT COMPLETED|Overall Study||4
1062163|NCT00864916|2576381|P1|NOT COMPLETED|Overall Study||6
1062164|NCT00864916|2576380|P2|COMPLETED|Overall Study||5
1062165|NCT00864916|2576381|P1|COMPLETED|Overall Study||4
1062166|NCT00864916|2576380|P2|STARTED|Overall Study||9
1062167|NCT00864916|2576381|P1|STARTED|Overall Study||10
1062168|NCT00865020|2576389|P2|NOT COMPLETED|Overall Study||51
1062169|NCT00865020|2576390|P1|NOT COMPLETED|Overall Study||49
1062170|NCT00865020|2576389|P2|COMPLETED|Overall Study||357
1062171|NCT00865020|2576390|P1|COMPLETED|Overall Study||365
1062172|NCT00865020|2576389|P2|STARTED|Overall Study||408
1062173|NCT00865020|2576390|P1|STARTED|Overall Study||414
1062174|NCT00865046|2576407|P3|NOT COMPLETED|Overall Study||1
1062175|NCT00865046|2576408|P2|NOT COMPLETED|Overall Study||5
1062176|NCT00865046|2576409|P1|NOT COMPLETED|Overall Study||6
1062177|NCT00865046|2576407|P3|COMPLETED|Overall Study||62
1062178|NCT00865046|2576408|P2|COMPLETED|Overall Study||59
1062179|NCT00865046|2576409|P1|COMPLETED|Overall Study||57
1062180|NCT00865046|2576407|P3|STARTED|Overall Study||63
1062181|NCT00865046|2576408|P2|STARTED|Overall Study||64
1062182|NCT00865046|2576409|P1|STARTED|Overall Study||63
1062183|NCT00865098|2576417|P1|NOT COMPLETED|Overall Study||1
1062184|NCT00865098|2576417|P1|COMPLETED|Overall Study|Discontinued from the study due to progressive disease, after completing planned treatment schedule|21
1062185|NCT00865098|2576417|P1|STARTED|Overall Study||22
1062186|NCT00865124|2576429|P3|NOT COMPLETED|Overall Study||0
1062187|NCT00865124|2576430|P2|NOT COMPLETED|Overall Study||1
1062188|NCT00865124|2576431|P1|NOT COMPLETED|Overall Study||4
1062189|NCT00865124|2576429|P3|COMPLETED|Overall Study||17
1062190|NCT00865124|2576430|P2|COMPLETED|Overall Study||24
1062191|NCT00865124|2576431|P1|COMPLETED|Overall Study||23
1062192|NCT00865124|2576429|P3|STARTED|Overall Study||17
1062193|NCT00865124|2576430|P2|STARTED|Overall Study||25
1062194|NCT00865124|2576431|P1|STARTED|Overall Study||27
1062195|NCT00865189|2576450|P2|NOT COMPLETED|Overall Study||19
1062196|NCT00865189|2576451|P1|NOT COMPLETED|Overall Study||12
1062197|NCT00865189|2576450|P2|COMPLETED|Overall Study||26
1062198|NCT00865189|2576451|P1|COMPLETED|Overall Study||34
1062199|NCT00865189|2576450|P2|STARTED|Overall Study||45
1062200|NCT00865189|2576451|P1|STARTED|Overall Study||46
1062201|NCT00865202|2576478|P2|NOT COMPLETED|Overall Study||0
1062202|NCT00865202|2576479|P1|NOT COMPLETED|Overall Study||0
1062203|NCT00865202|2576478|P2|COMPLETED|Overall Study||149
1062204|NCT00865202|2576479|P1|COMPLETED|Overall Study||152
1062205|NCT00865202|2576478|P2|STARTED|Overall Study||149
1062206|NCT00865202|2576479|P1|STARTED|Overall Study||152
1062207|NCT00865306|2576495|P2|NOT COMPLETED|One-Year Follow-Up||0
1062208|NCT00865306|2576496|P1|NOT COMPLETED|One-Year Follow-Up||0
1062209|NCT00865306|2576495|P2|COMPLETED|One-Year Follow-Up||15
1062210|NCT00865306|2576496|P1|COMPLETED|One-Year Follow-Up||29
1062211|NCT00865306|2576495|P2|STARTED|One-Year Follow-Up|Only controls who opted for CBT after the waitlist (n=17) were included. 2 were lost (15 included).|15
1062212|NCT00865306|2576496|P1|STARTED|One-Year Follow-Up||29
1062213|NCT00865306|2576495|P2|NOT COMPLETED|Controlled Trial||2
1062214|NCT00865306|2576496|P1|NOT COMPLETED|Controlled Trial||5
1062215|NCT00865306|2576495|P2|COMPLETED|Controlled Trial||28
1062216|NCT00865306|2576496|P1|COMPLETED|Controlled Trial||29
1062217|NCT00865306|2576495|P2|STARTED|Controlled Trial||30
1062218|NCT00865306|2576496|P1|STARTED|Controlled Trial|35 assigned to CBT. One child in trial had 0 anxiety disorders, so we excluded her from analysis.|34
1062219|NCT00865345|2576506|P1|NOT COMPLETED|Overall Study||2
1062220|NCT00865345|2576506|P1|COMPLETED|Overall Study||61
1062221|NCT00865345|2576506|P1|STARTED|Overall Study||63
1062222|NCT00865514|2576511|P1|NOT COMPLETED|Overall Study||2
1062223|NCT00865514|2576511|P1|COMPLETED|Overall Study||0
1062224|NCT00865514|2576511|P1|STARTED|Overall Study||2
1062225|NCT00865709|2576518|P2|NOT COMPLETED|Long Term Follow-up||49
1062226|NCT00865709|2576519|P1|NOT COMPLETED|Long Term Follow-up||46
1062227|NCT00865709|2576518|P2|COMPLETED|Long Term Follow-up||33
1062228|NCT00865709|2576519|P1|COMPLETED|Long Term Follow-up||24
1062229|NCT00865709|2576518|P2|STARTED|Long Term Follow-up||82
1062230|NCT00865709|2576519|P1|STARTED|Long Term Follow-up||70
1062231|NCT00865709|2576518|P2|NOT COMPLETED|Active Follow-up||1
1062232|NCT00865709|2576519|P1|NOT COMPLETED|Active Follow-up||8
1062233|NCT00865709|2576518|P2|COMPLETED|Active Follow-up||15
1062234|NCT00865709|2576519|P1|COMPLETED|Active Follow-up||17
1062235|NCT00865709|2576518|P2|STARTED|Active Follow-up||16
1062236|NCT00865709|2576519|P1|STARTED|Active Follow-up||25
1062237|NCT00865709|2576518|P2|NOT COMPLETED|Treatment||18
1062238|NCT00865709|2576519|P1|NOT COMPLETED|Treatment||30
1062239|NCT00865709|2576518|P2|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|83
1062240|NCT00865709|2576519|P1|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|67
1062241|NCT00865709|2576518|P2|Received Treatment|Treatment|Safety population|101
1062242|NCT00865709|2576519|P1|Received Treatment|Treatment|Safety population|97
1062243|NCT00865709|2576518|P2|STARTED|Treatment||101
1062244|NCT00865709|2576519|P1|STARTED|Treatment||97
1062245|NCT00865904|2576540|P5|NOT COMPLETED|Overall Study||1
1062246|NCT00865904|2576541|P4|NOT COMPLETED|Overall Study||1
1062247|NCT00865904|2576542|P3|NOT COMPLETED|Overall Study||0
1062248|NCT00865904|2576543|P2|NOT COMPLETED|Overall Study||0
1062249|NCT00865904|2576544|P1|NOT COMPLETED|Overall Study||2
1062250|NCT00865904|2576540|P5|COMPLETED|Overall Study|Completed 14-day follow-up.|19
1062251|NCT00865904|2576541|P4|COMPLETED|Overall Study|Completed 14-day follow-up.|17
1062252|NCT00865904|2576542|P3|COMPLETED|Overall Study|Completed 14-day follow-up.|18
1062253|NCT00865904|2576543|P2|COMPLETED|Overall Study|Completed 14-day follow-up.|18
1062254|NCT00865904|2576544|P1|COMPLETED|Overall Study|Completed 14-day follow-up.|17
1062255|NCT00865904|2576540|P5|STARTED|Overall Study|Randomized.|20
1062256|NCT00865904|2576541|P4|STARTED|Overall Study|Randomized.|18
1062257|NCT00865904|2576542|P3|STARTED|Overall Study|Randomized.|18
1062258|NCT00865904|2576543|P2|STARTED|Overall Study|Randomized.|18
1062259|NCT00865904|2576544|P1|STARTED|Overall Study|Randomized.|19
1062260|NCT00866034|2576601|P2|NOT COMPLETED|Overall Study||8
1062261|NCT00866034|2576602|P1|NOT COMPLETED|Overall Study||16
1062262|NCT00866034|2576601|P2|COMPLETED|Overall Study||301
1062263|NCT00866034|2576602|P1|COMPLETED|Overall Study||292
1062264|NCT00866034|2576601|P2|STARTED|Overall Study||309
1062265|NCT00866034|2576602|P1|STARTED|Overall Study||308
1062266|NCT00866047|2576610|P1|NOT COMPLETED|Follow-up Period||5
1062267|NCT00866047|2576610|P1|COMPLETED|Follow-up Period|Completed survival follow-up due to death [25] or study completion [28]|53
1062268|NCT00866047|2576610|P1|STARTED|Follow-up Period|All participants were to be followed after treatment|58
1062269|NCT00866047|2576610|P1|NOT COMPLETED|Treatment Period||48
1062270|NCT00866047|2576610|P1|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|10
1062271|NCT00866047|2576610|P1|STARTED|Treatment Period||58
1062272|NCT00866177|2576626|P1|NOT COMPLETED|Overall Study||152
1062273|NCT00866177|2576626|P1|COMPLETED|Overall Study||15
1062274|NCT00866177|2576626|P1|STARTED|Overall Study||167
1062275|NCT00866281|2576632|P2|NOT COMPLETED|Overall Study||15
1062276|NCT00866281|2576633|P1|NOT COMPLETED|Overall Study||7
1062277|NCT00866281|2576632|P2|COMPLETED|Overall Study||0
1062278|NCT00866281|2576633|P1|COMPLETED|Overall Study||0
1062279|NCT00866281|2576632|P2|STARTED|Overall Study||15
1062280|NCT00866281|2576633|P1|STARTED|Overall Study||7
1062281|NCT00866294|2576652|P3|NOT COMPLETED|Overall Study||11
1062282|NCT00866294|2576653|P2|NOT COMPLETED|Overall Study||20
1062283|NCT00866294|2576654|P1|NOT COMPLETED|Overall Study||33
1062284|NCT00866294|2576652|P3|COMPLETED|Overall Study||72
1062285|NCT00866294|2576653|P2|COMPLETED|Overall Study||141
1062286|NCT00866294|2576654|P1|COMPLETED|Overall Study||139
1062287|NCT00866294|2576652|P3|STARTED|Overall Study||83
1062288|NCT00866294|2576653|P2|STARTED|Overall Study||161
1062289|NCT00866294|2576654|P1|STARTED|Overall Study||172
1062290|NCT00866307|2576681|P3|NOT COMPLETED|Consolidation/Maintenance||16
1062291|NCT00866307|2576682|P2|NOT COMPLETED|Consolidation/Maintenance||9
1062292|NCT00866307|2576683|P1|NOT COMPLETED|Consolidation/Maintenance||0
1062293|NCT00866307|2576681|P3|COMPLETED|Consolidation/Maintenance||14
1062294|NCT00866307|2576682|P2|COMPLETED|Consolidation/Maintenance||45
1062295|NCT00866307|2576683|P1|COMPLETED|Consolidation/Maintenance||0
1062296|NCT00866307|2576681|P3|STARTED|Consolidation/Maintenance||30
1062297|NCT00866307|2576682|P2|STARTED|Consolidation/Maintenance||54
1062298|NCT00866307|2576683|P1|STARTED|Consolidation/Maintenance||0
1062299|NCT00866307|2576681|P3|NOT COMPLETED|Induction||0
1062300|NCT00866307|2576682|P2|NOT COMPLETED|Induction||0
1062301|NCT00866307|2576683|P1|NOT COMPLETED|Induction||20
1062302|NCT00866307|2576681|P3|COMPLETED|Induction||0
1062303|NCT00866307|2576682|P2|COMPLETED|Induction||0
1062304|NCT00866307|2576683|P1|COMPLETED|Induction||84
1062305|NCT00866307|2576681|P3|STARTED|Induction||0
1062306|NCT00866307|2576682|P2|STARTED|Induction||0
1062307|NCT00866307|2576683|P1|STARTED|Induction||104
1062308|NCT00866320|2576690|P1|NOT COMPLETED|Overall Study||6
1062309|NCT00866320|2576690|P1|COMPLETED|Overall Study|All patients that received treatment were analyzed.|43
1062310|NCT00866320|2576690|P1|STARTED|Overall Study||49
1062347|NCT00866606|2576755|P1|NOT COMPLETED|Overall Study||4
1062348|NCT00866606|2576755|P1|COMPLETED|Overall Study||31
1062349|NCT00866606|2576755|P1|STARTED|Overall Study||35
1062350|NCT00866658|2576769|P2|NOT COMPLETED|Overall Study||21
1062351|NCT00866658|2576770|P1|NOT COMPLETED|Overall Study||13
1062352|NCT00866658|2576769|P2|COMPLETED|Overall Study||133
1062353|NCT00866658|2576770|P1|COMPLETED|Overall Study||144
1062354|NCT00866658|2576769|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||154
1062355|NCT00866658|2576770|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|157
1062356|NCT00866658|2576769|P2|Safety Population|Overall Study||154
1062357|NCT00866658|2576770|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|157
1062358|NCT00866658|2576769|P2|STARTED|Overall Study||154
1062359|NCT00866658|2576770|P1|STARTED|Overall Study|Randomized.|157
1062360|NCT00866697|2576800|P2|NOT COMPLETED|Overall Study||377
1062361|NCT00866697|2576801|P1|NOT COMPLETED|Overall Study||373
1062362|NCT00866697|2576800|P2|COMPLETED|Overall Study||95
1062363|NCT00866697|2576801|P1|COMPLETED|Overall Study||95
1062364|NCT00866697|2576800|P2|Ongoing|Overall Study||312
1062365|NCT00866697|2576801|P1|Ongoing|Overall Study||335
1062366|NCT00866697|2576800|P2|STARTED|Overall Study||472
1062367|NCT00866697|2576801|P1|STARTED|Overall Study||468
1062368|NCT00866723|2576843|P1|NOT COMPLETED|Overall Study||5
1062369|NCT00866723|2576843|P1|COMPLETED|Overall Study||0
1062370|NCT00866723|2576843|P1|STARTED|Overall Study||5
1062371|NCT00866775|2576850|P2|NOT COMPLETED|Overall Study||52
1062372|NCT00866775|2576851|P1|NOT COMPLETED|Overall Study||36
1062373|NCT00866775|2576850|P2|COMPLETED|Overall Study||76
1062374|NCT00866775|2576851|P1|COMPLETED|Overall Study||29
1062375|NCT00866775|2576850|P2|STARTED|Overall Study||128
1062376|NCT00866775|2576851|P1|STARTED|Overall Study||65
1062377|NCT00866788|2576891|P4|NOT COMPLETED|Overall Study||5
1062378|NCT00866788|2576892|P3|NOT COMPLETED|Overall Study||2
1062379|NCT00866788|2576893|P2|NOT COMPLETED|Overall Study||6
1062380|NCT00866788|2576894|P1|NOT COMPLETED|Overall Study||6
1062381|NCT00866788|2576891|P4|COMPLETED|Overall Study||16
1062382|NCT00866788|2576892|P3|COMPLETED|Overall Study||23
1062383|NCT00866788|2576893|P2|COMPLETED|Overall Study||17
1062384|NCT00866788|2576894|P1|COMPLETED|Overall Study||15
1062385|NCT00866788|2576891|P4|STARTED|Overall Study||21
1062386|NCT00866788|2576892|P3|STARTED|Overall Study||25
1062387|NCT00866788|2576893|P2|STARTED|Overall Study||23
1062388|NCT00866788|2576894|P1|STARTED|Overall Study||21
1062389|NCT00866814|2576940|P1|NOT COMPLETED|Overall Study||20
1062390|NCT00866814|2576940|P1|COMPLETED|Overall Study||99
1062391|NCT00866814|2576940|P1|STARTED|Overall Study||119
1062392|NCT00866905|2576949|P1|NOT COMPLETED|Overall Study||33
1062393|NCT00866905|2576949|P1|COMPLETED|Overall Study||135
1062394|NCT00866905|2576949|P1|STARTED|Overall Study||168
1062395|NCT00866918|2576956|P2|NOT COMPLETED|Overall Study||12
1062396|NCT00866918|2576957|P1|NOT COMPLETED|Overall Study||16
1062397|NCT00866918|2576956|P2|COMPLETED|Overall Study||27
1062398|NCT00866918|2576957|P1|COMPLETED|Overall Study||53
1062399|NCT00866918|2576956|P2|STARTED|Overall Study||39
1062400|NCT00866918|2576957|P1|STARTED|Overall Study||69
1062401|NCT00867009|2576969|P1|NOT COMPLETED|Maintenance Period||4
1062402|NCT00867009|2576969|P1|COMPLETED|Maintenance Period|Participant was considered completed if they had PD, death, or stopped receiving study drug.|47
1062403|NCT00867009|2576969|P1|STARTED|Maintenance Period||51
1062404|NCT00867009|2576969|P1|NOT COMPLETED|Induction Period||62
1062405|NCT00867009|2576969|P1|COMPLETED|Induction Period|Participants continued on the study in the Maintenance Period.|51
1062406|NCT00867009|2576969|P1|Protocol Qualified (PQ) Population|Induction Period|Stage IIIB/IV NS-NSCLC, no concurrent chemotherapy, measurable disease, ≥1 dose study drug.|109
1062407|NCT00867009|2576969|P1|Received at Least 1 Dose of Study Drug|Induction Period||113
1062408|NCT00867009|2576969|P1|STARTED|Induction Period|Participants with Stage IIIB/IV non-squamous (NS) non-small cell lung cancer (NSCLC)|113
1062409|NCT00867035|2576978|P2|NOT COMPLETED|Baseline to 1 Week||0
1062410|NCT00867035|2576979|P1|NOT COMPLETED|Baseline to 1 Week||1
1062411|NCT00867035|2576978|P2|COMPLETED|Baseline to 1 Week||8
1062412|NCT00867035|2576979|P1|COMPLETED|Baseline to 1 Week||11
1062413|NCT00867035|2576978|P2|STARTED|Baseline to 1 Week||8
1062414|NCT00867035|2576979|P1|STARTED|Baseline to 1 Week||12
1062415|NCT00867035|2576978|P2|NOT COMPLETED|Baseline to 4 Hours||0
1062416|NCT00867035|2576979|P1|NOT COMPLETED|Baseline to 4 Hours||0
1062417|NCT00867035|2576978|P2|COMPLETED|Baseline to 4 Hours||8
1062418|NCT00867035|2576979|P1|COMPLETED|Baseline to 4 Hours||12
1062419|NCT00867035|2576978|P2|STARTED|Baseline to 4 Hours||8
1062420|NCT00867035|2576979|P1|STARTED|Baseline to 4 Hours||12
1062421|NCT00867035|2576978|P2|NOT COMPLETED|Baseline to 2 Hours||0
1062422|NCT00867035|2576979|P1|NOT COMPLETED|Baseline to 2 Hours||0
1062423|NCT00867035|2576978|P2|COMPLETED|Baseline to 2 Hours||8
1062424|NCT00867035|2576979|P1|COMPLETED|Baseline to 2 Hours||12
1062425|NCT00867035|2576978|P2|STARTED|Baseline to 2 Hours||8
1062426|NCT00867035|2576979|P1|STARTED|Baseline to 2 Hours||12
1062427|NCT00867035|2576978|P2|NOT COMPLETED|Baseline to 1 Hour||1
1062428|NCT00867035|2576979|P1|NOT COMPLETED|Baseline to 1 Hour||1
1062429|NCT00867035|2576978|P2|COMPLETED|Baseline to 1 Hour||8
1062430|NCT00867035|2576979|P1|COMPLETED|Baseline to 1 Hour||12
1062431|NCT00867035|2576978|P2|STARTED|Baseline to 1 Hour||9
1062432|NCT00867035|2576979|P1|STARTED|Baseline to 1 Hour||13
1062433|NCT00867087|2577005|P1|NOT COMPLETED|Overall Study||42
1062434|NCT00867087|2577005|P1|COMPLETED|Overall Study||21
1062435|NCT00867087|2577005|P1|STARTED|Overall Study||63
1062436|NCT00860158|2577019|P1|NOT COMPLETED|Overall Study||1
1062437|NCT00860158|2577019|P1|COMPLETED|Overall Study||0
1062438|NCT00860158|2577019|P1|STARTED|Overall Study||1
1062439|NCT00860249|2577030|P3|NOT COMPLETED|Overall Study||21
1062440|NCT00860249|2577031|P2|NOT COMPLETED|Overall Study||18
1062441|NCT00860249|2577032|P1|NOT COMPLETED|Overall Study||21
1062442|NCT00860249|2577030|P3|COMPLETED|Overall Study||0
1062443|NCT00860249|2577031|P2|COMPLETED|Overall Study||0
1062444|NCT00860249|2577032|P1|COMPLETED|Overall Study||0
1062445|NCT00860249|2577030|P3|STARTED|Overall Study||21
1062446|NCT00860249|2577031|P2|STARTED|Overall Study||18
1062447|NCT00860249|2577032|P1|STARTED|Overall Study||21
1062448|NCT00860262|2577046|P3|NOT COMPLETED|Overall Study||18
1062449|NCT00860262|2577047|P2|NOT COMPLETED|Overall Study||22
1062450|NCT00860262|2577048|P1|NOT COMPLETED|Overall Study||20
1062451|NCT00860262|2577046|P3|COMPLETED|Overall Study||202
1062452|NCT00860262|2577047|P2|COMPLETED|Overall Study||195
1062453|NCT00860262|2577048|P1|COMPLETED|Overall Study||401
1062454|NCT00860262|2577046|P3|STARTED|Overall Study||220
1062455|NCT00860262|2577047|P2|STARTED|Overall Study||217
1062456|NCT00860262|2577048|P1|STARTED|Overall Study||421
1062457|NCT00860314|2577160|P2|NOT COMPLETED|Overall Study||0
1062458|NCT00860314|2577161|P1|NOT COMPLETED|Overall Study||0
1062459|NCT00860314|2577160|P2|COMPLETED|Overall Study||48
1062460|NCT00860314|2577161|P1|COMPLETED|Overall Study||48
1062461|NCT00860314|2577160|P2|STARTED|Overall Study||48
1062462|NCT00860314|2577161|P1|STARTED|Overall Study||48
1062463|NCT00860405|2577175|P2|NOT COMPLETED|Overall Study||4
1062464|NCT00860405|2577176|P1|NOT COMPLETED|Overall Study||5
1062465|NCT00860405|2577175|P2|COMPLETED|Overall Study||26
1062466|NCT00860405|2577176|P1|COMPLETED|Overall Study|completed overall study|26
1062467|NCT00860405|2577175|P2|Day 28 Follow-up Performed|Overall Study||29
1062468|NCT00860405|2577176|P1|Day 28 Follow-up Performed|Overall Study||31
1062469|NCT00860405|2577175|P2|Completed Treatment|Overall Study||29
1062470|NCT00860405|2577176|P1|Completed Treatment|Overall Study||31
1062471|NCT00860405|2577175|P2|STARTED|Overall Study||30
1062472|NCT00860405|2577176|P1|STARTED|Overall Study||31
1062473|NCT00867139|2577201|P3|NOT COMPLETED|Overall Study||1
1062474|NCT00867139|2577202|P2|NOT COMPLETED|Overall Study||0
1062475|NCT00867139|2577203|P1|NOT COMPLETED|Overall Study||0
1062476|NCT00867139|2577201|P3|COMPLETED|Overall Study|One open-labeled patient withdrew on day 5.|3
1062477|NCT00867139|2577202|P2|COMPLETED|Overall Study||1
1062478|NCT00867139|2577203|P1|COMPLETED|Overall Study||2
1062479|NCT00867139|2577201|P3|STARTED|Overall Study||4
1062480|NCT00867139|2577202|P2|STARTED|Overall Study||1
1062481|NCT00867139|2577203|P1|STARTED|Overall Study||2
1062482|NCT00867165|2577246|P2|NOT COMPLETED|Overall Study||0
1062483|NCT00867165|2577247|P1|NOT COMPLETED|Overall Study||4
1062484|NCT00867165|2577246|P2|COMPLETED|Overall Study||45
1062485|NCT00867165|2577247|P1|COMPLETED|Overall Study||89
1062486|NCT00867165|2577246|P2|STARTED|Overall Study||45
1062487|NCT00867165|2577247|P1|STARTED|Overall Study||93
1062488|NCT00867321|2577352|P6|NOT COMPLETED|Overall Study||0
1062489|NCT00867321|2577353|P5|NOT COMPLETED|Overall Study||0
1062490|NCT00867321|2577354|P4|NOT COMPLETED|Overall Study||0
1062491|NCT00867321|2577355|P3|NOT COMPLETED|Overall Study||0
1062492|NCT00867321|2577356|P2|NOT COMPLETED|Overall Study||1
1062493|NCT00867321|2577357|P1|NOT COMPLETED|Overall Study||0
1062494|NCT00867321|2577352|P6|COMPLETED|Overall Study||3
1062495|NCT00867321|2577353|P5|COMPLETED|Overall Study||5
1062496|NCT00867321|2577354|P4|COMPLETED|Overall Study||6
1062497|NCT00867321|2577355|P3|COMPLETED|Overall Study||3
1062498|NCT00867321|2577356|P2|COMPLETED|Overall Study||2
1062499|NCT00867321|2577357|P1|COMPLETED|Overall Study||4
1062500|NCT00867321|2577352|P6|STARTED|Overall Study||3
1062501|NCT00867321|2577353|P5|STARTED|Overall Study||5
1062502|NCT00867321|2577354|P4|STARTED|Overall Study||6
1062503|NCT00867321|2577355|P3|STARTED|Overall Study||3
1062504|NCT00867321|2577356|P2|STARTED|Overall Study||3
1062505|NCT00867321|2577357|P1|STARTED|Overall Study||4
1062506|NCT00867360|2577377|P2|NOT COMPLETED|Overall Study||1
1062507|NCT00867360|2577378|P1|NOT COMPLETED|Overall Study||1
1062508|NCT00867360|2577377|P2|COMPLETED|Overall Study||5
1062509|NCT00867360|2577378|P1|COMPLETED|Overall Study||3
1062510|NCT00867360|2577377|P2|STARTED|Overall Study||6
1062511|NCT00867360|2577378|P1|STARTED|Overall Study||4
1062512|NCT00867529|2577388|P1|NOT COMPLETED|Overall Study||0
1062513|NCT00867529|2577388|P1|COMPLETED|Overall Study||63
1062514|NCT00867529|2577388|P1|STARTED|Overall Study||63
1062515|NCT00867568|2577393|P1|NOT COMPLETED|Overall Study||15
1062516|NCT00867568|2577393|P1|COMPLETED|Overall Study||3
1062517|NCT00867568|2577393|P1|STARTED|Overall Study||18
1062518|NCT00867659|2577402|P1|NOT COMPLETED|Overall Study||0
1062519|NCT00867659|2577402|P1|COMPLETED|Overall Study|January 2010|20
1062520|NCT00867659|2577402|P1|STARTED|Overall Study|October 2009|20
1062521|NCT00868101|2577409|P2|NOT COMPLETED|Overall Study||0
1062522|NCT00868101|2577410|P1|NOT COMPLETED|Overall Study||0
1062523|NCT00868101|2577409|P2|COMPLETED|Overall Study||10
1062524|NCT00868101|2577410|P1|COMPLETED|Overall Study||12
1062525|NCT00868101|2577409|P2|STARTED|Overall Study||10
1062526|NCT00868101|2577410|P1|STARTED|Overall Study||12
1062533|NCT00868192|2577441|P1|NOT COMPLETED|Overall Study||4
1062534|NCT00868192|2577441|P1|COMPLETED|Overall Study||34
1062535|NCT00868192|2577441|P1|STARTED|Overall Study||38
1062536|NCT00868218|2577460|P4|NOT COMPLETED|Overall Study||0
1062537|NCT00868218|2577461|P3|NOT COMPLETED|Overall Study||0
1062538|NCT00868218|2577462|P2|NOT COMPLETED|Overall Study||0
1062539|NCT00868218|2577463|P1|NOT COMPLETED|Overall Study||0
1062540|NCT00868218|2577460|P4|COMPLETED|Overall Study||15
1062541|NCT00868218|2577461|P3|COMPLETED|Overall Study||15
1062542|NCT00868218|2577462|P2|COMPLETED|Overall Study||15
1062543|NCT00868218|2577463|P1|COMPLETED|Overall Study||15
1062544|NCT00868218|2577460|P4|STARTED|Overall Study||15
1062545|NCT00868218|2577461|P3|STARTED|Overall Study||15
1062546|NCT00868218|2577462|P2|STARTED|Overall Study||15
1062547|NCT00868218|2577463|P1|STARTED|Overall Study||15
1062548|NCT00868231|2577481|P6|NOT COMPLETED|Treatment Period 3||0
1062549|NCT00868231|2577482|P5|NOT COMPLETED|Treatment Period 3||0
1062550|NCT00868231|2577483|P4|NOT COMPLETED|Treatment Period 3||0
1062551|NCT00868231|2577484|P3|NOT COMPLETED|Treatment Period 3||1
1062552|NCT00868231|2577485|P2|NOT COMPLETED|Treatment Period 3||0
1062553|NCT00868231|2577486|P1|NOT COMPLETED|Treatment Period 3||0
1062554|NCT00868231|2577481|P6|COMPLETED|Treatment Period 3||5
1062555|NCT00868231|2577482|P5|COMPLETED|Treatment Period 3||4
1062556|NCT00868231|2577483|P4|COMPLETED|Treatment Period 3||5
1062557|NCT00868231|2577484|P3|COMPLETED|Treatment Period 3||4
1062558|NCT00868231|2577485|P2|COMPLETED|Treatment Period 3||5
1062559|NCT00868231|2577486|P1|COMPLETED|Treatment Period 3||4
1062560|NCT00868231|2577481|P6|STARTED|Treatment Period 3||5
1062561|NCT00868231|2577482|P5|STARTED|Treatment Period 3||4
1062562|NCT00868231|2577483|P4|STARTED|Treatment Period 3||5
1062563|NCT00868231|2577484|P3|STARTED|Treatment Period 3||5
1062564|NCT00868231|2577485|P2|STARTED|Treatment Period 3||5
1062565|NCT00868231|2577486|P1|STARTED|Treatment Period 3||4
1062566|NCT00868231|2577481|P6|NOT COMPLETED|Treatment Period 2||0
1062567|NCT00868231|2577482|P5|NOT COMPLETED|Treatment Period 2||0
1062568|NCT00868231|2577483|P4|NOT COMPLETED|Treatment Period 2||0
1062569|NCT00868231|2577484|P3|NOT COMPLETED|Treatment Period 2||0
1062570|NCT00868231|2577485|P2|NOT COMPLETED|Treatment Period 2||0
1062571|NCT00868231|2577486|P1|NOT COMPLETED|Treatment Period 2||1
1062572|NCT00868231|2577481|P6|COMPLETED|Treatment Period 2||5
1062573|NCT00868231|2577482|P5|COMPLETED|Treatment Period 2||4
1062574|NCT00868231|2577483|P4|COMPLETED|Treatment Period 2||5
1062575|NCT00868231|2577484|P3|COMPLETED|Treatment Period 2||5
1062576|NCT00868231|2577485|P2|COMPLETED|Treatment Period 2||5
1062577|NCT00868231|2577486|P1|COMPLETED|Treatment Period 2||4
1062578|NCT00868231|2577481|P6|STARTED|Treatment Period 2||5
1062579|NCT00868231|2577482|P5|STARTED|Treatment Period 2||4
1062580|NCT00868231|2577483|P4|STARTED|Treatment Period 2||5
1062581|NCT00868231|2577484|P3|STARTED|Treatment Period 2||5
1062582|NCT00868231|2577485|P2|STARTED|Treatment Period 2||5
1062583|NCT00868231|2577486|P1|STARTED|Treatment Period 2||5
1062584|NCT00868231|2577481|P6|NOT COMPLETED|Treatment Period 1||0
1062585|NCT00868231|2577482|P5|NOT COMPLETED|Treatment Period 1||1
1062586|NCT00868231|2577483|P4|NOT COMPLETED|Treatment Period 1||0
1062587|NCT00868231|2577484|P3|NOT COMPLETED|Treatment Period 1||0
1062588|NCT00868231|2577485|P2|NOT COMPLETED|Treatment Period 1||0
1062589|NCT00868231|2577486|P1|NOT COMPLETED|Treatment Period 1||0
1062590|NCT00868231|2577481|P6|COMPLETED|Treatment Period 1||5
1062591|NCT00868231|2577482|P5|COMPLETED|Treatment Period 1||4
1062592|NCT00868231|2577483|P4|COMPLETED|Treatment Period 1||5
1062593|NCT00868231|2577484|P3|COMPLETED|Treatment Period 1||5
1062594|NCT00868231|2577485|P2|COMPLETED|Treatment Period 1||5
1062595|NCT00868231|2577486|P1|COMPLETED|Treatment Period 1||5
1062596|NCT00868231|2577481|P6|STARTED|Treatment Period 1||5
1062597|NCT00868231|2577482|P5|STARTED|Treatment Period 1||5
1062598|NCT00868231|2577483|P4|STARTED|Treatment Period 1||5
1062599|NCT00868231|2577484|P3|STARTED|Treatment Period 1||5
1062600|NCT00868231|2577485|P2|STARTED|Treatment Period 1||5
1062601|NCT00868231|2577486|P1|STARTED|Treatment Period 1||5
1062602|NCT00868296|2577529|P2|NOT COMPLETED|Overall Study||3
1062603|NCT00868296|2577530|P1|NOT COMPLETED|Overall Study||0
1062604|NCT00868296|2577529|P2|COMPLETED|Overall Study||43
1062605|NCT00868296|2577530|P1|COMPLETED|Overall Study||12
1062606|NCT00868296|2577529|P2|STARTED|Overall Study||46
1062607|NCT00868296|2577530|P1|STARTED|Overall Study||12
1062608|NCT00868309|2577540|P2|NOT COMPLETED|Overall Study||0
1062609|NCT00868309|2577541|P1|NOT COMPLETED|Overall Study||0
1062610|NCT00868309|2577540|P2|COMPLETED|Overall Study||6
1062611|NCT00868309|2577541|P1|COMPLETED|Overall Study||6
1062612|NCT00868309|2577540|P2|STARTED|Overall Study||6
1062613|NCT00868309|2577541|P1|STARTED|Overall Study||6
1062614|NCT00868348|2577551|P2|NOT COMPLETED|Overall Study||0
1062615|NCT00868348|2577552|P1|NOT COMPLETED|Overall Study||0
1062616|NCT00868348|2577551|P2|COMPLETED|Overall Study||30
1062617|NCT00868348|2577552|P1|COMPLETED|Overall Study||30
1062618|NCT00868348|2577551|P2|STARTED|Overall Study||30
1062619|NCT00868348|2577552|P1|STARTED|Overall Study||30
1062620|NCT00868374|2577570|P2|NOT COMPLETED|Overall Study||7
1062621|NCT00868374|2577571|P1|NOT COMPLETED|Overall Study||7
1062622|NCT00868374|2577570|P2|COMPLETED|Overall Study||4
1062623|NCT00868374|2577571|P1|COMPLETED|Overall Study||5
1062624|NCT00868374|2577570|P2|STARTED|Overall Study||11
1062625|NCT00868374|2577571|P1|STARTED|Overall Study||12
1062626|NCT00868439|2577579|P2|NOT COMPLETED|Overall Study||9
1062627|NCT00868439|2577580|P1|NOT COMPLETED|Overall Study||8
1062628|NCT00868439|2577579|P2|COMPLETED|Overall Study||40
1062629|NCT00868439|2577580|P1|COMPLETED|Overall Study||48
1062630|NCT00868439|2577579|P2|STARTED|Overall Study||49
1062631|NCT00868439|2577580|P1|STARTED|Overall Study||56
1062632|NCT00868452|2577598|P2|NOT COMPLETED|Overall Study||29
1062633|NCT00868452|2577599|P1|NOT COMPLETED|Overall Study||40
1062634|NCT00868452|2577598|P2|COMPLETED|Overall Study||136
1062635|NCT00868452|2577599|P1|COMPLETED|Overall Study||143
1062636|NCT00868452|2577598|P2|STARTED|Overall Study||165
1062637|NCT00868452|2577599|P1|STARTED|Overall Study||183
1062638|NCT00868517|2577612|P3|NOT COMPLETED|Overall Study||2
1062639|NCT00868517|2577613|P2|NOT COMPLETED|Overall Study||4
1062640|NCT00868517|2577614|P1|NOT COMPLETED|Overall Study||4
1062641|NCT00868517|2577612|P3|COMPLETED|Overall Study||9
1062642|NCT00868517|2577613|P2|COMPLETED|Overall Study||8
1062643|NCT00868517|2577614|P1|COMPLETED|Overall Study||8
1062644|NCT00868517|2577612|P3|STARTED|Overall Study||11
1062645|NCT00868517|2577613|P2|STARTED|Overall Study||12
1062646|NCT00868517|2577614|P1|STARTED|Overall Study||12
1062647|NCT00868530|2577637|P1|NOT COMPLETED|Overall Study||4
1062648|NCT00868530|2577637|P1|COMPLETED|Overall Study||49
1062649|NCT00868530|2577637|P1|STARTED|Overall Study||53
1062650|NCT00868699|2577652|P3|NOT COMPLETED|Overall Study||43
1062651|NCT00868699|2577653|P2|NOT COMPLETED|Overall Study||45
1062652|NCT00868699|2577654|P1|NOT COMPLETED|Overall Study||43
1062653|NCT00868699|2577652|P3|COMPLETED|Overall Study||123
1062654|NCT00868699|2577653|P2|COMPLETED|Overall Study||124
1062655|NCT00868699|2577654|P1|COMPLETED|Overall Study||127
1062656|NCT00868699|2577652|P3|Safety Population|Overall Study||164
1062657|NCT00868699|2577653|P2|Safety Population|Overall Study||167
1062658|NCT00868699|2577654|P1|Safety Population|Overall Study||168
1062659|NCT00868699|2577652|P3|Intent-to-Treat Population|Overall Study||161
1062660|NCT00868699|2577653|P2|Intent-to-Treat Population|Overall Study||162
1062661|NCT00868699|2577654|P1|Intent-to-Treat Population|Overall Study||162
1062662|NCT00868699|2577652|P3|STARTED|Overall Study||166
1062663|NCT00868699|2577653|P2|STARTED|Overall Study||169
1062664|NCT00868699|2577654|P1|STARTED|Overall Study||170
1062665|NCT00868712|2577671|P3|NOT COMPLETED|Overall Study||0
1062666|NCT00868712|2577672|P2|NOT COMPLETED|Overall Study||0
1062667|NCT00868712|2577673|P1|NOT COMPLETED|Overall Study||0
1062668|NCT00868712|2577671|P3|COMPLETED|Overall Study||28
1062669|NCT00868712|2577672|P2|COMPLETED|Overall Study||11
1062670|NCT00868712|2577673|P1|COMPLETED|Overall Study||31
1062671|NCT00868712|2577671|P3|STARTED|Overall Study||28
1062672|NCT00868712|2577672|P2|STARTED|Overall Study||11
1062673|NCT00868712|2577673|P1|STARTED|Overall Study||31
1062674|NCT00868751|2577684|P1|NOT COMPLETED|Overall Study||1
1062675|NCT00868751|2577684|P1|COMPLETED|Overall Study||0
1062676|NCT00868751|2577684|P1|STARTED|Overall Study||1
1062677|NCT00868790|2577692|P14|NOT COMPLETED|Post-study||0
1062678|NCT00868790|2577693|P13|NOT COMPLETED|Post-study||0
1062679|NCT00868790|2577694|P12|NOT COMPLETED|Post-study||0
1062680|NCT00868790|2577695|P11|NOT COMPLETED|Post-study||0
1062681|NCT00868790|2577696|P10|NOT COMPLETED|Post-study||1
1062682|NCT00868790|2577697|P9|NOT COMPLETED|Post-study||0
1062683|NCT00868790|2577698|P8|NOT COMPLETED|Post-study||2
1062684|NCT00868790|2577699|P7|NOT COMPLETED|Post-study||0
1062685|NCT00868790|2577700|P6|NOT COMPLETED|Post-study||0
1062686|NCT00868790|2577701|P5|NOT COMPLETED|Post-study||1
1062687|NCT00868790|2577702|P4|NOT COMPLETED|Post-study||0
1062688|NCT00868790|2577703|P3|NOT COMPLETED|Post-study||0
1062689|NCT00868790|2577704|P2|NOT COMPLETED|Post-study||0
1062690|NCT00868790|2577705|P1|NOT COMPLETED|Post-study||0
1062691|NCT00868790|2577692|P14|COMPLETED|Post-study||7
1062692|NCT00868790|2577693|P13|COMPLETED|Post-study||6
1062693|NCT00868790|2577694|P12|COMPLETED|Post-study||3
1062694|NCT00868790|2577695|P11|COMPLETED|Post-study||5
1062695|NCT00868790|2577696|P10|COMPLETED|Post-study||1
1062696|NCT00868790|2577697|P9|COMPLETED|Post-study||6
1062697|NCT00868790|2577698|P8|COMPLETED|Post-study||12
1062698|NCT00868790|2577699|P7|COMPLETED|Post-study||4
1062699|NCT00868790|2577700|P6|COMPLETED|Post-study||1
1062700|NCT00868790|2577701|P5|COMPLETED|Post-study||17
1062701|NCT00868790|2577702|P4|COMPLETED|Post-study||3
1062702|NCT00868790|2577703|P3|COMPLETED|Post-study||3
1062703|NCT00868790|2577704|P2|COMPLETED|Post-study||6
1062704|NCT00868790|2577705|P1|COMPLETED|Post-study||7
1062705|NCT00868790|2577692|P14|STARTED|Post-study||7
1062706|NCT00868790|2577693|P13|STARTED|Post-study||6
1062707|NCT00868790|2577694|P12|STARTED|Post-study||3
1062708|NCT00868790|2577695|P11|STARTED|Post-study||5
1062709|NCT00868790|2577696|P10|STARTED|Post-study||2
1062710|NCT00868790|2577697|P9|STARTED|Post-study||6
1062711|NCT00868790|2577698|P8|STARTED|Post-study||14
1062712|NCT00868790|2577699|P7|STARTED|Post-study||4
1062713|NCT00868790|2577700|P6|STARTED|Post-study||1
1062714|NCT00868790|2577701|P5|STARTED|Post-study||18
1062715|NCT00868790|2577702|P4|STARTED|Post-study||3
1062716|NCT00868790|2577703|P3|STARTED|Post-study||3
1062717|NCT00868790|2577704|P2|STARTED|Post-study||6
1062718|NCT00868790|2577705|P1|STARTED|Post-study||7
1062719|NCT00868790|2577692|P14|NOT COMPLETED|Period 4||1
1062720|NCT00868790|2577693|P13|NOT COMPLETED|Period 4||1
1062721|NCT00868790|2577694|P12|NOT COMPLETED|Period 4||1
1062722|NCT00868790|2577695|P11|NOT COMPLETED|Period 4||3
1062723|NCT00868790|2577696|P10|NOT COMPLETED|Period 4||0
1062724|NCT00868790|2577697|P9|NOT COMPLETED|Period 4||2
1062725|NCT00868790|2577698|P8|NOT COMPLETED|Period 4||3
1062726|NCT00868790|2577699|P7|NOT COMPLETED|Period 4||0
1062727|NCT00868790|2577700|P6|NOT COMPLETED|Period 4||0
1062728|NCT00868790|2577701|P5|NOT COMPLETED|Period 4||0
1062729|NCT00868790|2577702|P4|NOT COMPLETED|Period 4||0
1062730|NCT00868790|2577703|P3|NOT COMPLETED|Period 4||1
1062731|NCT00868790|2577704|P2|NOT COMPLETED|Period 4||0
1062732|NCT00868790|2577705|P1|NOT COMPLETED|Period 4||2
1062733|NCT00868790|2577692|P14|COMPLETED|Period 4||7
1062734|NCT00868790|2577693|P13|COMPLETED|Period 4||6
1062735|NCT00868790|2577694|P12|COMPLETED|Period 4||3
1062736|NCT00868790|2577695|P11|COMPLETED|Period 4||5
1062737|NCT00868790|2577696|P10|COMPLETED|Period 4||2
1062738|NCT00868790|2577697|P9|COMPLETED|Period 4||6
1062739|NCT00868790|2577698|P8|COMPLETED|Period 4||14
1062740|NCT00868790|2577699|P7|COMPLETED|Period 4||4
1062741|NCT00868790|2577700|P6|COMPLETED|Period 4||1
1062742|NCT00868790|2577701|P5|COMPLETED|Period 4||18
1062743|NCT00868790|2577702|P4|COMPLETED|Period 4||3
1062744|NCT00868790|2577703|P3|COMPLETED|Period 4|One non-completion due to abnormal alanine aminotransferase/aspartate aminotransferase (ALT/AST)|3
1062745|NCT00868790|2577704|P2|COMPLETED|Period 4||6
1062746|NCT00868790|2577705|P1|COMPLETED|Period 4||7
1062747|NCT00868790|2577692|P14|STARTED|Period 4||8
1062748|NCT00868790|2577693|P13|STARTED|Period 4||7
1062749|NCT00868790|2577694|P12|STARTED|Period 4||4
1062750|NCT00868790|2577695|P11|STARTED|Period 4||8
1062751|NCT00868790|2577696|P10|STARTED|Period 4||2
1062752|NCT00868790|2577697|P9|STARTED|Period 4||8
1062753|NCT00868790|2577698|P8|STARTED|Period 4||17
1062754|NCT00868790|2577699|P7|STARTED|Period 4||4
1062755|NCT00868790|2577700|P6|STARTED|Period 4||1
1062756|NCT00868790|2577701|P5|STARTED|Period 4||18
1062757|NCT00868790|2577702|P4|STARTED|Period 4||3
1062758|NCT00868790|2577703|P3|STARTED|Period 4||4
1062759|NCT00868790|2577704|P2|STARTED|Period 4||6
1062760|NCT00868790|2577705|P1|STARTED|Period 4||9
1062761|NCT00868790|2577692|P14|NOT COMPLETED|Period 3||0
1062762|NCT00868790|2577693|P13|NOT COMPLETED|Period 3||0
1062763|NCT00868790|2577694|P12|NOT COMPLETED|Period 3||0
1062764|NCT00868790|2577695|P11|NOT COMPLETED|Period 3||1
1062765|NCT00868790|2577696|P10|NOT COMPLETED|Period 3||1
1062766|NCT00868790|2577697|P9|NOT COMPLETED|Period 3||0
1062767|NCT00868790|2577698|P8|NOT COMPLETED|Period 3||0
1062768|NCT00868790|2577699|P7|NOT COMPLETED|Period 3||0
1062769|NCT00868790|2577700|P6|NOT COMPLETED|Period 3||0
1062770|NCT00868790|2577701|P5|NOT COMPLETED|Period 3||0
1062771|NCT00868790|2577702|P4|NOT COMPLETED|Period 3||1
1062772|NCT00868790|2577703|P3|NOT COMPLETED|Period 3||0
1062773|NCT00868790|2577704|P2|NOT COMPLETED|Period 3||0
1062774|NCT00868790|2577705|P1|NOT COMPLETED|Period 3||0
1062775|NCT00868790|2577692|P14|COMPLETED|Period 3||8
1062776|NCT00868790|2577693|P13|COMPLETED|Period 3||7
1062777|NCT00868790|2577694|P12|COMPLETED|Period 3||4
1062778|NCT00868790|2577695|P11|COMPLETED|Period 3||8
1062779|NCT00868790|2577696|P10|COMPLETED|Period 3||2
1062780|NCT00868790|2577697|P9|COMPLETED|Period 3||8
1062781|NCT00868790|2577698|P8|COMPLETED|Period 3||17
1062782|NCT00868790|2577699|P7|COMPLETED|Period 3||4
1062783|NCT00868790|2577700|P6|COMPLETED|Period 3||1
1062784|NCT00868790|2577701|P5|COMPLETED|Period 3||18
1062785|NCT00868790|2577702|P4|COMPLETED|Period 3||3
1062786|NCT00868790|2577703|P3|COMPLETED|Period 3||4
1062787|NCT00868790|2577704|P2|COMPLETED|Period 3||6
1062788|NCT00868790|2577705|P1|COMPLETED|Period 3||9
1062789|NCT00868790|2577692|P14|STARTED|Period 3||8
1062790|NCT00868790|2577693|P13|STARTED|Period 3||7
1062791|NCT00868790|2577694|P12|STARTED|Period 3||4
1062792|NCT00868790|2577695|P11|STARTED|Period 3||9
1062793|NCT00868790|2577696|P10|STARTED|Period 3||3
1062794|NCT00868790|2577697|P9|STARTED|Period 3||8
1062795|NCT00868790|2577698|P8|STARTED|Period 3||17
1062796|NCT00868790|2577699|P7|STARTED|Period 3||4
1062797|NCT00868790|2577700|P6|STARTED|Period 3||1
1062798|NCT00868790|2577701|P5|STARTED|Period 3||18
1062799|NCT00868790|2577702|P4|STARTED|Period 3||4
1062800|NCT00868790|2577703|P3|STARTED|Period 3||4
1062801|NCT00868790|2577704|P2|STARTED|Period 3||6
1062802|NCT00868790|2577705|P1|STARTED|Period 3||9
1062803|NCT00868790|2577692|P14|NOT COMPLETED|Period 2||1
1062804|NCT00868790|2577693|P13|NOT COMPLETED|Period 2||0
1062805|NCT00868790|2577694|P12|NOT COMPLETED|Period 2||0
1062806|NCT00868790|2577695|P11|NOT COMPLETED|Period 2||0
1062807|NCT00868790|2577696|P10|NOT COMPLETED|Period 2||0
1062808|NCT00868790|2577697|P9|NOT COMPLETED|Period 2||2
1062809|NCT00868790|2577698|P8|NOT COMPLETED|Period 2||0
1062810|NCT00868790|2577699|P7|NOT COMPLETED|Period 2||0
1062811|NCT00868790|2577700|P6|NOT COMPLETED|Period 2||1
1062812|NCT00868790|2577701|P5|NOT COMPLETED|Period 2||0
1062813|NCT00868790|2577702|P4|NOT COMPLETED|Period 2||0
1062814|NCT00868790|2577703|P3|NOT COMPLETED|Period 2||0
1062815|NCT00868790|2577704|P2|NOT COMPLETED|Period 2||1
1062816|NCT00868790|2577705|P1|NOT COMPLETED|Period 2||0
1062817|NCT00868790|2577692|P14|COMPLETED|Period 2||8
1062818|NCT00868790|2577693|P13|COMPLETED|Period 2||7
1062819|NCT00868790|2577694|P12|COMPLETED|Period 2||4
1062820|NCT00868790|2577695|P11|COMPLETED|Period 2||9
1062821|NCT00868790|2577696|P10|COMPLETED|Period 2||3
1062822|NCT00868790|2577697|P9|COMPLETED|Period 2||8
1062823|NCT00868790|2577698|P8|COMPLETED|Period 2||17
1062824|NCT00868790|2577699|P7|COMPLETED|Period 2||4
1062825|NCT00868790|2577700|P6|COMPLETED|Period 2||1
1062826|NCT00868790|2577701|P5|COMPLETED|Period 2||18
1062827|NCT00868790|2577702|P4|COMPLETED|Period 2||4
1062828|NCT00868790|2577703|P3|COMPLETED|Period 2||4
1062829|NCT00868790|2577704|P2|COMPLETED|Period 2||6
1062830|NCT00868790|2577705|P1|COMPLETED|Period 2||9
1062831|NCT00868790|2577692|P14|STARTED|Period 2||9
1062832|NCT00868790|2577693|P13|STARTED|Period 2||7
1062833|NCT00868790|2577694|P12|STARTED|Period 2||4
1062834|NCT00868790|2577695|P11|STARTED|Period 2||9
1062835|NCT00868790|2577696|P10|STARTED|Period 2||3
1062836|NCT00868790|2577697|P9|STARTED|Period 2||10
1062837|NCT00868790|2577698|P8|STARTED|Period 2||17
1062838|NCT00868790|2577699|P7|STARTED|Period 2||4
1062839|NCT00868790|2577700|P6|STARTED|Period 2||2
1062840|NCT00868790|2577701|P5|STARTED|Period 2||18
1062841|NCT00868790|2577702|P4|STARTED|Period 2||4
1062842|NCT00868790|2577703|P3|STARTED|Period 2||4
1062843|NCT00868790|2577704|P2|STARTED|Period 2||7
1062844|NCT00868790|2577705|P1|STARTED|Period 2||9
1062845|NCT00868790|2577692|P14|NOT COMPLETED|Period 1||2
1062846|NCT00868790|2577693|P13|NOT COMPLETED|Period 1||0
1062847|NCT00868790|2577694|P12|NOT COMPLETED|Period 1||0
1062848|NCT00868790|2577695|P11|NOT COMPLETED|Period 1||0
1062849|NCT00868790|2577696|P10|NOT COMPLETED|Period 1||0
1062850|NCT00868790|2577697|P9|NOT COMPLETED|Period 1||1
1062851|NCT00868790|2577698|P8|NOT COMPLETED|Period 1||3
1062852|NCT00868790|2577699|P7|NOT COMPLETED|Period 1||0
1062853|NCT00868790|2577700|P6|NOT COMPLETED|Period 1||1
1062854|NCT00868790|2577701|P5|NOT COMPLETED|Period 1||1
1062855|NCT00868790|2577702|P4|NOT COMPLETED|Period 1||0
1062856|NCT00868790|2577703|P3|NOT COMPLETED|Period 1||0
1062857|NCT00868790|2577704|P2|NOT COMPLETED|Period 1||1
1062858|NCT00868790|2577705|P1|NOT COMPLETED|Period 1||2
1062859|NCT00868790|2577692|P14|COMPLETED|Period 1||9
1062860|NCT00868790|2577693|P13|COMPLETED|Period 1||7
1062861|NCT00868790|2577694|P12|COMPLETED|Period 1||4
1062862|NCT00868790|2577695|P11|COMPLETED|Period 1||9
1062863|NCT00868790|2577696|P10|COMPLETED|Period 1||3
1062864|NCT00868790|2577697|P9|COMPLETED|Period 1||10
1062865|NCT00868790|2577698|P8|COMPLETED|Period 1||17
1062866|NCT00868790|2577699|P7|COMPLETED|Period 1||4
1062867|NCT00868790|2577700|P6|COMPLETED|Period 1||2
1062868|NCT00868790|2577701|P5|COMPLETED|Period 1||18
1062869|NCT00868790|2577702|P4|COMPLETED|Period 1||4
1062870|NCT00868790|2577703|P3|COMPLETED|Period 1||4
1062871|NCT00868790|2577704|P2|COMPLETED|Period 1||7
1062872|NCT00868790|2577705|P1|COMPLETED|Period 1||9
1062873|NCT00868790|2577692|P14|STARTED|Period 1||11
1062874|NCT00868790|2577693|P13|STARTED|Period 1||7
1062875|NCT00868790|2577694|P12|STARTED|Period 1||4
1062876|NCT00868790|2577695|P11|STARTED|Period 1||9
1062877|NCT00868790|2577696|P10|STARTED|Period 1||3
1062878|NCT00868790|2577697|P9|STARTED|Period 1||11
1062879|NCT00868790|2577698|P8|STARTED|Period 1||20
1062880|NCT00868790|2577699|P7|STARTED|Period 1||4
1062881|NCT00868790|2577700|P6|STARTED|Period 1||3
1062882|NCT00868790|2577701|P5|STARTED|Period 1||19
1062883|NCT00868790|2577702|P4|STARTED|Period 1||4
1062884|NCT00868790|2577703|P3|STARTED|Period 1||4
1062885|NCT00868790|2577704|P2|STARTED|Period 1||8
1062886|NCT00868790|2577705|P1|STARTED|Period 1||11
1062887|NCT00868959|2577742|P1|NOT COMPLETED|Overall Study||258
1062888|NCT00868959|2577742|P1|COMPLETED|Overall Study||559
1062889|NCT00868959|2577742|P1|STARTED|Overall Study|817 represents total number of subjects who provided informed consent.|817
1062890|NCT00868998|2577748|P1|NOT COMPLETED|Overall Study||5
1062891|NCT00868998|2577748|P1|COMPLETED|Overall Study||0
1062892|NCT00868998|2577748|P1|STARTED|Overall Study||5
1062893|NCT00869050|2577753|P1|NOT COMPLETED|Overall Study||3
1062894|NCT00869050|2577753|P1|COMPLETED|Overall Study||38
1062895|NCT00869050|2577753|P1|STARTED|Overall Study||41
1062896|NCT00869089|2577758|P1|NOT COMPLETED|Overall Study||3
1062897|NCT00869089|2577758|P1|COMPLETED|Overall Study||2
1062898|NCT00869089|2577758|P1|STARTED|Overall Study||5
1062899|NCT00869128|2577762|P2|NOT COMPLETED|Overall Study||6
1062900|NCT00869128|2577763|P1|NOT COMPLETED|Overall Study||6
1062901|NCT00869128|2577762|P2|COMPLETED|Overall Study||12
1062902|NCT00869128|2577763|P1|COMPLETED|Overall Study||12
1062903|NCT00869128|2577762|P2|STARTED|Overall Study||18
1062904|NCT00869128|2577763|P1|STARTED|Overall Study||18
1062905|NCT00869141|2577769|P2|NOT COMPLETED|Overall Study||0
1062906|NCT00869141|2577770|P1|NOT COMPLETED|Overall Study||0
1062907|NCT00869141|2577769|P2|COMPLETED|Overall Study||26
1062908|NCT00869141|2577770|P1|COMPLETED|Overall Study||26
1062909|NCT00869141|2577769|P2|STARTED|Overall Study||26
1062910|NCT00869141|2577770|P1|STARTED|Overall Study||26
1062911|NCT00869167|2577782|P2|NOT COMPLETED|Overall Study||1
1062912|NCT00869167|2577783|P1|NOT COMPLETED|Overall Study||0
1062913|NCT00869167|2577782|P2|COMPLETED|Overall Study||0
1062914|NCT00869167|2577783|P1|COMPLETED|Overall Study||2
1062915|NCT00869167|2577782|P2|STARTED|Overall Study||1
1062916|NCT00869167|2577783|P1|STARTED|Overall Study||2
1062917|NCT00869258|2577797|P1|NOT COMPLETED|Overall Study||1
1062918|NCT00869258|2577797|P1|COMPLETED|Overall Study||31
1062919|NCT00869258|2577797|P1|STARTED|Overall Study||32
1062920|NCT00869323|2577801|P1|NOT COMPLETED|Maintenance Therapy||1
1062921|NCT00869323|2577801|P1|COMPLETED|Maintenance Therapy||1
1062922|NCT00869323|2577801|P1|STARTED|Maintenance Therapy|One participant removed from study after completing induction therapy due to progressive disease.|2
1062923|NCT00869323|2577801|P1|NOT COMPLETED|Induction Therapy||0
1062924|NCT00869323|2577801|P1|COMPLETED|Induction Therapy||3
1062925|NCT00869323|2577801|P1|STARTED|Induction Therapy||3
1062926|NCT00869349|2577811|P2|NOT COMPLETED|Overall Study||4
1062927|NCT00869349|2577812|P1|NOT COMPLETED|Overall Study||7
1062928|NCT00869349|2577811|P2|COMPLETED|Overall Study||36
1062929|NCT00869349|2577812|P1|COMPLETED|Overall Study||32
1062930|NCT00869349|2577811|P2|STARTED|Overall Study||40
1062931|NCT00869349|2577812|P1|STARTED|Overall Study||39
1062932|NCT00869362|2577824|P2|NOT COMPLETED|Overall Study||5
1062933|NCT00869362|2577825|P1|NOT COMPLETED|Overall Study||1
1062934|NCT00869362|2577824|P2|COMPLETED|Overall Study||11
1062935|NCT00869362|2577825|P1|COMPLETED|Overall Study||14
1062936|NCT00869362|2577824|P2|STARTED|Overall Study||16
1062937|NCT00869362|2577825|P1|STARTED|Overall Study||15
1062938|NCT00869375|2577835|P2|NOT COMPLETED|Overall Study||0
1062939|NCT00869375|2577836|P1|NOT COMPLETED|Overall Study||0
1062940|NCT00869375|2577835|P2|COMPLETED|Overall Study||3
1062941|NCT00869375|2577836|P1|COMPLETED|Overall Study||3
1062942|NCT00869375|2577835|P2|STARTED|Overall Study||3
1062943|NCT00869375|2577836|P1|STARTED|Overall Study||3
1062944|NCT00869401|2577847|P5|NOT COMPLETED|Overall Study||3
1062945|NCT00869401|2577848|P4|NOT COMPLETED|Overall Study||5
1062946|NCT00869401|2577849|P3|NOT COMPLETED|Overall Study||0
1062947|NCT00869401|2577850|P2|NOT COMPLETED|Overall Study||0
1062948|NCT00869401|2577851|P1|NOT COMPLETED|Overall Study||0
1062949|NCT00869401|2577847|P5|COMPLETED|Overall Study||63
1062950|NCT00869401|2577848|P4|COMPLETED|Overall Study||133
1062951|NCT00869401|2577849|P3|COMPLETED|Overall Study||7
1062952|NCT00869401|2577850|P2|COMPLETED|Overall Study||3
1062953|NCT00869401|2577851|P1|COMPLETED|Overall Study||3
1062954|NCT00869401|2577847|P5|STARTED|Overall Study||66
1062955|NCT00869401|2577848|P4|STARTED|Overall Study||138
1062956|NCT00869401|2577849|P3|STARTED|Overall Study||7
1062957|NCT00869401|2577850|P2|STARTED|Overall Study||3
1062958|NCT00869401|2577851|P1|STARTED|Overall Study||3
1062959|NCT00869414|2577867|P3|NOT COMPLETED|Overall Study||0
1062960|NCT00869414|2577868|P2|NOT COMPLETED|Overall Study||0
1062961|NCT00869414|2577869|P1|NOT COMPLETED|Overall Study||0
1062962|NCT00869414|2577867|P3|COMPLETED|Overall Study||0
1062963|NCT00869414|2577868|P2|COMPLETED|Overall Study||0
1062964|NCT00869414|2577869|P1|COMPLETED|Overall Study||0
1062965|NCT00869414|2577867|P3|STARTED|Overall Study||0
1062966|NCT00869414|2577868|P2|STARTED|Overall Study||0
1062967|NCT00869414|2577869|P1|STARTED|Overall Study||0
1062968|NCT00869518|2577882|P2|NOT COMPLETED|Overall Study||1
1062969|NCT00869518|2577883|P1|NOT COMPLETED|Overall Study||1
1062970|NCT00869518|2577882|P2|COMPLETED|Overall Study||5
1062971|NCT00869518|2577883|P1|COMPLETED|Overall Study||5
1062972|NCT00869518|2577882|P2|STARTED|Overall Study||6
1062973|NCT00869518|2577883|P1|STARTED|Overall Study||6
1062974|NCT00869557|2577897|P2|NOT COMPLETED|Extension Phase||3
1062975|NCT00869557|2577898|P1|NOT COMPLETED|Extension Phase||10
1062976|NCT00869557|2577897|P2|COMPLETED|Extension Phase||11
1062977|NCT00869557|2577898|P1|COMPLETED|Extension Phase||35
1062978|NCT00869557|2577897|P2|STARTED|Extension Phase|Seven participants completing randomized Atripla treatment did not enter open-label extension phase.|14
1062979|NCT00869557|2577898|P1|STARTED|Extension Phase||45
1062980|NCT00869557|2577897|P2|NOT COMPLETED|Randomized Phase||2
1062981|NCT00869557|2577898|P1|NOT COMPLETED|Randomized Phase||3
1062982|NCT00869557|2577897|P2|COMPLETED|Randomized Phase||21
1062983|NCT00869557|2577898|P1|COMPLETED|Randomized Phase||45
1062984|NCT00869557|2577897|P2|STARTED|Randomized Phase||23
1062985|NCT00869557|2577898|P1|STARTED|Randomized Phase||48
1062986|NCT00869609|2577917|P2|NOT COMPLETED|Overall Study||3
1062987|NCT00869609|2577918|P1|NOT COMPLETED|Overall Study||6
1062988|NCT00869609|2577917|P2|COMPLETED|Overall Study||26
1062989|NCT00869609|2577918|P1|COMPLETED|Overall Study||25
1062990|NCT00869609|2577917|P2|STARTED|Overall Study||29
1062991|NCT00869609|2577918|P1|STARTED|Overall Study||31
1062992|NCT00869622|2577944|P2|NOT COMPLETED|Overall Study||14
1062993|NCT00869622|2577945|P1|NOT COMPLETED|Overall Study||13
1062994|NCT00869622|2577944|P2|COMPLETED|Overall Study||26
1062995|NCT00869622|2577945|P1|COMPLETED|Overall Study||27
1062996|NCT00869622|2577944|P2|STARTED|Overall Study||40
1062997|NCT00869622|2577945|P1|STARTED|Overall Study||40
1062998|NCT00869778|2577956|P3|NOT COMPLETED|Overall Study||10
1062999|NCT00869778|2577957|P2|NOT COMPLETED|Overall Study||7
1063000|NCT00869778|2577958|P1|NOT COMPLETED|Overall Study||12
1063001|NCT00869778|2577956|P3|COMPLETED|Overall Study||110
1063002|NCT00869778|2577957|P2|COMPLETED|Overall Study||113
1063003|NCT00869778|2577958|P1|COMPLETED|Overall Study||108
1063004|NCT00869778|2577956|P3|STARTED|Overall Study||120
1063005|NCT00869778|2577957|P2|STARTED|Overall Study||120
1063006|NCT00869778|2577958|P1|STARTED|Overall Study||120
1063007|NCT00869791|2577993|P2|NOT COMPLETED|Period 2 Treatment for 7 Days||0
1063008|NCT00869791|2577994|P1|NOT COMPLETED|Period 2 Treatment for 7 Days||0
1063009|NCT00869791|2577993|P2|COMPLETED|Period 2 Treatment for 7 Days||13
1063010|NCT00869791|2577994|P1|COMPLETED|Period 2 Treatment for 7 Days||14
1063011|NCT00869791|2577993|P2|STARTED|Period 2 Treatment for 7 Days||13
1063012|NCT00869791|2577994|P1|STARTED|Period 2 Treatment for 7 Days||14
1063013|NCT00869791|2577993|P2|NOT COMPLETED|Period 1 Treatment for 7 Days||0
1063014|NCT00869791|2577994|P1|NOT COMPLETED|Period 1 Treatment for 7 Days||0
1063015|NCT00869791|2577993|P2|COMPLETED|Period 1 Treatment for 7 Days||13
1063016|NCT00869791|2577994|P1|COMPLETED|Period 1 Treatment for 7 Days||14
1063017|NCT00869791|2577993|P2|STARTED|Period 1 Treatment for 7 Days||13
1063018|NCT00869791|2577994|P1|STARTED|Period 1 Treatment for 7 Days||14
1063019|NCT00869947|2578014|P2|NOT COMPLETED|Overall Study||0
1063020|NCT00869947|2578015|P1|NOT COMPLETED|Overall Study||0
1063021|NCT00869947|2578014|P2|COMPLETED|Overall Study||8
1063022|NCT00869947|2578015|P1|COMPLETED|Overall Study||8
1063023|NCT00869947|2578014|P2|STARTED|Overall Study||8
1063024|NCT00869947|2578015|P1|STARTED|Overall Study||8
1063025|NCT00869960|2578028|P1|NOT COMPLETED|Overall Study||2
1063026|NCT00869960|2578028|P1|COMPLETED|Overall Study||22
1063027|NCT00869960|2578028|P1|STARTED|Overall Study||24
1063028|NCT00863317|2578041|P2|NOT COMPLETED|Overall Study||9
1063029|NCT00863317|2578042|P1|NOT COMPLETED|Overall Study||8
1063030|NCT00863317|2578041|P2|COMPLETED|Overall Study||64
1063031|NCT00863317|2578042|P1|COMPLETED|Overall Study||60
1063032|NCT00863317|2578041|P2|STARTED|Overall Study||73
1063033|NCT00863317|2578042|P1|STARTED|Overall Study||68
1063034|NCT00863330|2578048|P1|NOT COMPLETED|Overall Study||6
1063035|NCT00863330|2578048|P1|COMPLETED|Overall Study||0
1063036|NCT00863330|2578048|P1|STARTED|Overall Study||6
1063037|NCT00863343|2578054|P2|NOT COMPLETED|Overall Study||0
1063038|NCT00863343|2578055|P1|NOT COMPLETED|Overall Study||0
1063039|NCT00863343|2578054|P2|COMPLETED|Overall Study||374
1063040|NCT00863343|2578055|P1|COMPLETED|Overall Study||17
1063041|NCT00863343|2578054|P2|STARTED|Overall Study||374
1063042|NCT00863343|2578055|P1|STARTED|Overall Study||17
1063043|NCT00863356|2578067|P1|NOT COMPLETED|Overall Study||0
1063044|NCT00863356|2578067|P1|COMPLETED|Overall Study||20
1063045|NCT00863356|2578067|P1|STARTED|Overall Study||20
1063046|NCT00863434|2578071|P1|NOT COMPLETED|Overall Study||0
1063047|NCT00863434|2578071|P1|COMPLETED|Overall Study||2
1063048|NCT00863434|2578071|P1|STARTED|Overall Study||2
1063049|NCT00863512|2578079|P2|NOT COMPLETED|Overall Study||0
1063050|NCT00863512|2578080|P1|NOT COMPLETED|Overall Study||14
1063051|NCT00863512|2578079|P2|COMPLETED|Overall Study||17
1063052|NCT00863512|2578080|P1|COMPLETED|Overall Study||3
1063053|NCT00863512|2578079|P2|STARTED|Overall Study||17
1063054|NCT00863512|2578080|P1|STARTED|Overall Study||17
1063055|NCT00863551|2578086|P1|NOT COMPLETED|Overall Study||0
1063056|NCT00863551|2578086|P1|COMPLETED|Overall Study||12
1063057|NCT00863551|2578086|P1|STARTED|Overall Study||12
1063058|NCT00863655|2578096|P2|NOT COMPLETED|Overall Study||239
1063059|NCT00863655|2578097|P1|NOT COMPLETED|Overall Study||485
1063060|NCT00863655|2578096|P2|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
1063061|NCT00863655|2578097|P1|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
1063062|NCT00863655|2578096|P2|STARTED|Overall Study||239
1063063|NCT00863655|2578097|P1|STARTED|Overall Study||485
1063064|NCT00863707|2578126|P2|NOT COMPLETED|Overall Study||3
1063065|NCT00863707|2578127|P1|NOT COMPLETED|Overall Study||4
1063066|NCT00863707|2578126|P2|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|334
1063067|NCT00863707|2578127|P1|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|170
1063068|NCT00863707|2578126|P2|STARTED|Overall Study||337
1063069|NCT00863707|2578127|P1|STARTED|Overall Study||174
1063070|NCT00863746|2578135|P2|NOT COMPLETED|Survival Follow up||280
1063071|NCT00863746|2578136|P1|NOT COMPLETED|Survival Follow up||253
1063072|NCT00863746|2578135|P2|COMPLETED|Survival Follow up||51
1063073|NCT00863746|2578136|P1|COMPLETED|Survival Follow up||45
1063074|NCT00863746|2578135|P2|STARTED|Survival Follow up|331 patients of 339 patients (=353 randomized - 14 death) entered the survival follow-up.|331
1063075|NCT00863746|2578136|P1|STARTED|Survival Follow up|298 patients of 317 patients (= 346 randomized - 29 deaths) entered the survival follow-up|298
1063076|NCT00863746|2578135|P2|NOT COMPLETED|Treatment||35
1063077|NCT00863746|2578136|P1|NOT COMPLETED|Treatment||71
1063078|NCT00863746|2578135|P2|COMPLETED|Treatment||318
1063079|NCT00863746|2578136|P1|COMPLETED|Treatment||279
1063080|NCT00863746|2578135|P2|Participants Received Treatment|Treatment|Safety population|351
1063081|NCT00863746|2578136|P1|Participants Received Treatment|Treatment|Safety population|346
1063082|NCT00863746|2578135|P2|STARTED|Treatment||353
1063083|NCT00863746|2578136|P1|STARTED|Treatment||350
1063084|NCT00863798|2578163|P3|NOT COMPLETED|Overall Study||25
1063085|NCT00863798|2578164|P2|NOT COMPLETED|Overall Study||30
1063086|NCT00863798|2578165|P1|NOT COMPLETED|Overall Study||32
1063087|NCT00863798|2578163|P3|COMPLETED|Overall Study||202
1063088|NCT00863798|2578164|P2|COMPLETED|Overall Study||198
1063089|NCT00863798|2578165|P1|COMPLETED|Overall Study||195
1063090|NCT00863798|2578163|P3|Treated|Overall Study||224
1063091|NCT00863798|2578164|P2|Treated|Overall Study||226
1063092|NCT00863798|2578165|P1|Treated|Overall Study||223
1063093|NCT00863798|2578163|P3|STARTED|Overall Study||227
1063094|NCT00863798|2578164|P2|STARTED|Overall Study||228
1063095|NCT00863798|2578165|P1|STARTED|Overall Study||227
1063096|NCT00864032|2578215|P3|NOT COMPLETED|Overall Study||0
1063097|NCT00864032|2578216|P2|NOT COMPLETED|Overall Study||0
1063098|NCT00864032|2578217|P1|NOT COMPLETED|Overall Study||0
1063099|NCT00864032|2578215|P3|COMPLETED|Overall Study||0
1063100|NCT00864032|2578216|P2|COMPLETED|Overall Study||5
1063101|NCT00864032|2578217|P1|COMPLETED|Overall Study||3
1063102|NCT00864032|2578215|P3|STARTED|Overall Study||0
1063103|NCT00864032|2578216|P2|STARTED|Overall Study||5
1063104|NCT00864032|2578217|P1|STARTED|Overall Study||3
1063105|NCT00864084|2578223|P1|NOT COMPLETED|Overall Study||3
1063106|NCT00864084|2578223|P1|COMPLETED|Overall Study||11
1063107|NCT00864084|2578223|P1|STARTED|Overall Study||14
1063108|NCT00864123|2578248|P2|NOT COMPLETED|Overall Study||0
1063109|NCT00864123|2578249|P1|NOT COMPLETED|Overall Study||0
1063110|NCT00864123|2578248|P2|COMPLETED|Overall Study||15
1063111|NCT00864123|2578249|P1|COMPLETED|Overall Study||15
1063112|NCT00864123|2578248|P2|STARTED|Overall Study||15
1063113|NCT00864123|2578249|P1|STARTED|Overall Study||15
1063117|NCT00864253|2578276|P2|NOT COMPLETED|Overall Study||58
1063118|NCT00864253|2578277|P1|NOT COMPLETED|Overall Study||99
1063119|NCT00864253|2578276|P2|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|207
1063120|NCT00864253|2578277|P1|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|165
1063121|NCT00864253|2578276|P2|Treated|Overall Study||258
1063122|NCT00864253|2578277|P1|Treated|Overall Study||257
1063123|NCT00864253|2578276|P2|STARTED|Overall Study||265
1063124|NCT00864253|2578277|P1|STARTED|Overall Study||264
1063125|NCT00864383|2578310|P3|NOT COMPLETED|Modified Intent to Treat||85
1063126|NCT00864383|2578311|P2|NOT COMPLETED|Modified Intent to Treat||87
1063127|NCT00864383|2578312|P1|NOT COMPLETED|Modified Intent to Treat||85
1063128|NCT00864383|2578310|P3|COMPLETED|Modified Intent to Treat||551
1063129|NCT00864383|2578311|P2|COMPLETED|Modified Intent to Treat||568
1063130|NCT00864383|2578312|P1|COMPLETED|Modified Intent to Treat||555
1063131|NCT00864383|2578310|P3|STARTED|Modified Intent to Treat||636
1063132|NCT00864383|2578311|P2|STARTED|Modified Intent to Treat||655
1063133|NCT00864383|2578312|P1|STARTED|Modified Intent to Treat||640
1063134|NCT00864383|2578310|P3|NOT COMPLETED|Per- Protocol||112
1063135|NCT00864383|2578311|P2|NOT COMPLETED|Per- Protocol||141
1063136|NCT00864383|2578312|P1|NOT COMPLETED|Per- Protocol||130
1063137|NCT00864383|2578310|P3|COMPLETED|Per- Protocol||524
1063138|NCT00864383|2578311|P2|COMPLETED|Per- Protocol||514
1063139|NCT00864383|2578312|P1|COMPLETED|Per- Protocol||510
1063140|NCT00864383|2578310|P3|STARTED|Per- Protocol||636
1063141|NCT00864383|2578311|P2|STARTED|Per- Protocol||655
1063142|NCT00864383|2578312|P1|STARTED|Per- Protocol||640
1063143|NCT00864513|2578344|P1|NOT COMPLETED|Overall Study||3
1063144|NCT00864513|2578344|P1|COMPLETED|Overall Study||12
1063145|NCT00864513|2578344|P1|STARTED|Overall Study||15
1063146|NCT00864539|2578357|P6|NOT COMPLETED|Overall Study||14
1063147|NCT00864539|2578358|P5|NOT COMPLETED|Overall Study||22
1063148|NCT00864539|2578359|P4|NOT COMPLETED|Overall Study||7
1063149|NCT00864539|2578360|P3|NOT COMPLETED|Overall Study||10
1063150|NCT00864539|2578361|P2|NOT COMPLETED|Overall Study||23
1063151|NCT00864539|2578362|P1|NOT COMPLETED|Overall Study||9
1063152|NCT00864539|2578357|P6|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|71
1063153|NCT00864539|2578358|P5|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|81
1063154|NCT00864539|2578359|P4|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|89
1063155|NCT00864539|2578360|P3|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|92
1063156|NCT00864539|2578361|P2|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|72
1063157|NCT00864539|2578362|P1|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|95
1063158|NCT00864539|2578357|P6|STARTED|Overall Study||85
1063159|NCT00864539|2578358|P5|STARTED|Overall Study||103
1063160|NCT00864539|2578359|P4|STARTED|Overall Study||96
1063161|NCT00864539|2578360|P3|STARTED|Overall Study||102
1063162|NCT00864539|2578361|P2|STARTED|Overall Study||95
1063163|NCT00864539|2578362|P1|STARTED|Overall Study||104
1063164|NCT00869999|2578376|P1|NOT COMPLETED|Overall Study||2
1063165|NCT00869999|2578376|P1|COMPLETED|Overall Study||24
1063166|NCT00869999|2578376|P1|STARTED|Overall Study||26
1063167|NCT00870103|2578382|P1|NOT COMPLETED|Overall Study||4
1063168|NCT00870103|2578382|P1|COMPLETED|Overall Study||60
1063169|NCT00870103|2578382|P1|STARTED|Overall Study||64
1063170|NCT00870194|2578389|P2|NOT COMPLETED|Overall Study||14
1063171|NCT00870194|2578390|P1|NOT COMPLETED|Overall Study||26
1063172|NCT00870194|2578389|P2|COMPLETED|Overall Study||114
1063173|NCT00870194|2578390|P1|COMPLETED|Overall Study||101
1063174|NCT00870194|2578389|P2|Per Protocol Set|Overall Study||111
1063175|NCT00870194|2578390|P1|Per Protocol Set|Overall Study||97
1063176|NCT00870194|2578389|P2|STARTED|Overall Study||128
1063177|NCT00870194|2578390|P1|STARTED|Overall Study||127
1063178|NCT00870467|2578430|P6|NOT COMPLETED|Open-label||3
1063179|NCT00870467|2578431|P5|NOT COMPLETED|Open-label||5
1063180|NCT00870467|2578432|P4|NOT COMPLETED|Open-label||7
1063181|NCT00870467|2578433|P3|NOT COMPLETED|Open-label||13
1063182|NCT00870467|2578434|P2|NOT COMPLETED|Open-label||0
1063183|NCT00870467|2578435|P1|NOT COMPLETED|Open-label||0
1063184|NCT00870467|2578430|P6|COMPLETED|Open-label||21
1063185|NCT00870467|2578431|P5|COMPLETED|Open-label||5
1063186|NCT00870467|2578432|P4|COMPLETED|Open-label||120
1063187|NCT00870467|2578433|P3|COMPLETED|Open-label||132
1063188|NCT00870467|2578434|P2|COMPLETED|Open-label||0
1063189|NCT00870467|2578435|P1|COMPLETED|Open-label||0
1063190|NCT00870467|2578430|P6|STARTED|Open-label||24
1063191|NCT00870467|2578431|P5|STARTED|Open-label||10
1063192|NCT00870467|2578432|P4|STARTED|Open-label||127
1063193|NCT00870467|2578433|P3|STARTED|Open-label||145
1063194|NCT00870467|2578434|P2|STARTED|Open-label||0
1063195|NCT00870467|2578435|P1|STARTED|Open-label||0
1063196|NCT00870467|2578430|P6|NOT COMPLETED|Double-blind||0
1063197|NCT00870467|2578431|P5|NOT COMPLETED|Double-blind||0
1063198|NCT00870467|2578432|P4|NOT COMPLETED|Double-blind||0
1063199|NCT00870467|2578433|P3|NOT COMPLETED|Double-blind||0
1063200|NCT00870467|2578434|P2|NOT COMPLETED|Double-blind||12
1063201|NCT00870467|2578435|P1|NOT COMPLETED|Double-blind||16
1063202|NCT00870467|2578430|P6|COMPLETED|Double-blind||0
1063203|NCT00870467|2578431|P5|COMPLETED|Double-blind||0
1063204|NCT00870467|2578432|P4|COMPLETED|Double-blind||0
1063205|NCT00870467|2578433|P3|COMPLETED|Double-blind||0
1063206|NCT00870467|2578434|P2|COMPLETED|Double-blind|24 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|151
1063207|NCT00870467|2578435|P1|COMPLETED|Double-blind|10 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|155
1063208|NCT00870467|2578430|P6|STARTED|Double-blind||0
1063209|NCT00870467|2578431|P5|STARTED|Double-blind||0
1063210|NCT00870467|2578432|P4|STARTED|Double-blind||0
1063211|NCT00870467|2578433|P3|STARTED|Double-blind||0
1063212|NCT00870467|2578434|P2|STARTED|Double-blind||163
1063213|NCT00870467|2578435|P1|STARTED|Double-blind||171
1063214|NCT00870545|2578479|P1|NOT COMPLETED|Overall Study||17
1063215|NCT00870545|2578479|P1|COMPLETED|Overall Study||69
1063216|NCT00870545|2578479|P1|STARTED|Overall Study||86
1063217|NCT00870584|2578490|P2|NOT COMPLETED|Overall Study||13
1063218|NCT00870584|2578491|P1|NOT COMPLETED|Overall Study||16
1063219|NCT00870584|2578490|P2|COMPLETED|Overall Study||122
1063220|NCT00870584|2578491|P1|COMPLETED|Overall Study||120
1063221|NCT00870584|2578490|P2|STARTED|Overall Study||135
1063222|NCT00870584|2578491|P1|STARTED|Overall Study||136
1063223|NCT00870688|2578499|P1|NOT COMPLETED|Overall Study||4
1063224|NCT00870688|2578499|P1|COMPLETED|Overall Study||78
1063225|NCT00870688|2578499|P1|STARTED|Overall Study||82
1063226|NCT00870740|2578508|P6|NOT COMPLETED|Overall Study||17
1063227|NCT00870740|2578509|P5|NOT COMPLETED|Overall Study||11
1063228|NCT00870740|2578510|P4|NOT COMPLETED|Overall Study||12
1063229|NCT00870740|2578511|P3|NOT COMPLETED|Overall Study||10
1063230|NCT00870740|2578512|P2|NOT COMPLETED|Overall Study||9
1063231|NCT00870740|2578513|P1|NOT COMPLETED|Overall Study||12
1063232|NCT00870740|2578508|P6|COMPLETED|Overall Study||70
1063233|NCT00870740|2578509|P5|COMPLETED|Overall Study||77
1063234|NCT00870740|2578510|P4|COMPLETED|Overall Study||74
1063235|NCT00870740|2578511|P3|COMPLETED|Overall Study||76
1063236|NCT00870740|2578512|P2|COMPLETED|Overall Study||75
1063237|NCT00870740|2578513|P1|COMPLETED|Overall Study||74
1063238|NCT00870740|2578508|P6|STARTED|Overall Study|number randomized and dosed|87
1063239|NCT00870740|2578509|P5|STARTED|Overall Study|number randomized and dosed|88
1063240|NCT00870740|2578510|P4|STARTED|Overall Study|number randomized and dosed|86
1063241|NCT00870740|2578511|P3|STARTED|Overall Study|number randomized and dosed|86
1063242|NCT00870740|2578512|P2|STARTED|Overall Study|number randomized and dosed|84
1063243|NCT00870740|2578513|P1|STARTED|Overall Study|number randomized and dosed|86
1063244|NCT00870896|2578587|P1|NOT COMPLETED|Overall Study||0
1063245|NCT00870896|2578587|P1|COMPLETED|Overall Study||5
1063246|NCT00870896|2578587|P1|STARTED|Overall Study||5
1063247|NCT00871000|2578595|P2|NOT COMPLETED|Overall Study||0
1063248|NCT00871000|2578596|P1|NOT COMPLETED|Overall Study||1
1063249|NCT00871000|2578595|P2|COMPLETED|Overall Study||152
1063250|NCT00871000|2578596|P1|COMPLETED|Overall Study||150
1063251|NCT00871000|2578595|P2|STARTED|Overall Study||152
1063252|NCT00871000|2578596|P1|STARTED|Overall Study||151
1063253|NCT00871117|2578640|P2|NOT COMPLETED|Overall Study||10
1063254|NCT00871117|2578641|P1|NOT COMPLETED|Overall Study||5
1063255|NCT00871117|2578640|P2|COMPLETED|Overall Study||227
1063256|NCT00871117|2578641|P1|COMPLETED|Overall Study||234
1063257|NCT00871117|2578640|P2|STARTED|Overall Study||237
1063258|NCT00871117|2578641|P1|STARTED|Overall Study||239
1063259|NCT00871143|2578673|P2|NOT COMPLETED|Overall Study||0
1063260|NCT00871143|2578674|P1|NOT COMPLETED|Overall Study||0
1063261|NCT00871143|2578673|P2|COMPLETED|Overall Study||25
1063262|NCT00871143|2578674|P1|COMPLETED|Overall Study||21
1063263|NCT00871143|2578673|P2|STARTED|Overall Study||25
1063264|NCT00871143|2578674|P1|STARTED|Overall Study||21
1063265|NCT00871169|2578692|P1|NOT COMPLETED|Overall Study||3
1063266|NCT00871169|2578692|P1|COMPLETED|Overall Study||58
1063267|NCT00871169|2578692|P1|STARTED|Overall Study||61
1063268|NCT00871234|2578697|P1|NOT COMPLETED|Overall Study||5
1063269|NCT00871234|2578697|P1|COMPLETED|Overall Study||23
1063270|NCT00871234|2578697|P1|STARTED|Overall Study||28
1063271|NCT00871286|2578703|P2|NOT COMPLETED|Overall Study||6
1063272|NCT00871286|2578704|P1|NOT COMPLETED|Overall Study||0
1063273|NCT00871286|2578703|P2|COMPLETED|Overall Study||14
1063274|NCT00871286|2578704|P1|COMPLETED|Overall Study||20
1063275|NCT00871286|2578703|P2|STARTED|Overall Study||20
1063276|NCT00871286|2578704|P1|STARTED|Overall Study||20
1063277|NCT00871338|2578714|P2|NOT COMPLETED|After Booster||0
1063278|NCT00871338|2578715|P1|NOT COMPLETED|After Booster||0
1063279|NCT00871338|2578714|P2|COMPLETED|After Booster||135
1063280|NCT00871338|2578715|P1|COMPLETED|After Booster||139
1063281|NCT00871338|2578714|P2|STARTED|After Booster||135
1063282|NCT00871338|2578715|P1|STARTED|After Booster||139
1063283|NCT00871338|2578714|P2|NOT COMPLETED|Prior to Booster||3
1063284|NCT00871338|2578715|P1|NOT COMPLETED|Prior to Booster||2
1063285|NCT00871338|2578714|P2|COMPLETED|Prior to Booster||139
1063286|NCT00871338|2578715|P1|COMPLETED|Prior to Booster||140
1063287|NCT00871338|2578714|P2|STARTED|Prior to Booster||142
1063288|NCT00871338|2578715|P1|STARTED|Prior to Booster||142
1063289|NCT00871351|2578796|P3|NOT COMPLETED|Overall Study||0
1063290|NCT00871351|2578797|P2|NOT COMPLETED|Overall Study||1
1063291|NCT00871351|2578798|P1|NOT COMPLETED|Overall Study||4
1063292|NCT00871351|2578796|P3|COMPLETED|Overall Study||32
1063293|NCT00871351|2578797|P2|COMPLETED|Overall Study||45
1063294|NCT00871351|2578798|P1|COMPLETED|Overall Study||43
1063295|NCT00871351|2578796|P3|STARTED|Overall Study||32
1063296|NCT00871351|2578797|P2|STARTED|Overall Study||46
1063297|NCT00871351|2578798|P1|STARTED|Overall Study||47
1063298|NCT00871377|2578818|P6|NOT COMPLETED|Third Intervention (10 Weeks)||0
1063299|NCT00871377|2578819|P5|NOT COMPLETED|Third Intervention (10 Weeks)||0
1063300|NCT00871377|2578820|P4|NOT COMPLETED|Third Intervention (10 Weeks)||1
1063301|NCT00871377|2578821|P3|NOT COMPLETED|Third Intervention (10 Weeks)||0
1063302|NCT00871377|2578822|P2|NOT COMPLETED|Third Intervention (10 Weeks)||0
1063303|NCT00871377|2578823|P1|NOT COMPLETED|Third Intervention (10 Weeks)||0
1063304|NCT00871377|2578818|P6|COMPLETED|Third Intervention (10 Weeks)||3
1063305|NCT00871377|2578819|P5|COMPLETED|Third Intervention (10 Weeks)||4
1063306|NCT00871377|2578820|P4|COMPLETED|Third Intervention (10 Weeks)||3
1063307|NCT00871377|2578821|P3|COMPLETED|Third Intervention (10 Weeks)||3
1063308|NCT00871377|2578822|P2|COMPLETED|Third Intervention (10 Weeks)||4
1063309|NCT00871377|2578823|P1|COMPLETED|Third Intervention (10 Weeks)||2
1063310|NCT00871377|2578818|P6|STARTED|Third Intervention (10 Weeks)||3
1063311|NCT00871377|2578819|P5|STARTED|Third Intervention (10 Weeks)||4
1063312|NCT00871377|2578820|P4|STARTED|Third Intervention (10 Weeks)||4
1063313|NCT00871377|2578821|P3|STARTED|Third Intervention (10 Weeks)||3
1063314|NCT00871377|2578822|P2|STARTED|Third Intervention (10 Weeks)||4
1063315|NCT00871377|2578823|P1|STARTED|Third Intervention (10 Weeks)||2
1063316|NCT00871377|2578818|P6|NOT COMPLETED|Washout (6 Weeks)||1
1063317|NCT00871377|2578819|P5|NOT COMPLETED|Washout (6 Weeks)||0
1063318|NCT00871377|2578820|P4|NOT COMPLETED|Washout (6 Weeks)||0
1063319|NCT00871377|2578821|P3|NOT COMPLETED|Washout (6 Weeks)||0
1063320|NCT00871377|2578822|P2|NOT COMPLETED|Washout (6 Weeks)||0
1063321|NCT00871377|2578823|P1|NOT COMPLETED|Washout (6 Weeks)||0
1063322|NCT00871377|2578818|P6|COMPLETED|Washout (6 Weeks)||3
1063323|NCT00871377|2578819|P5|COMPLETED|Washout (6 Weeks)||4
1063324|NCT00871377|2578820|P4|COMPLETED|Washout (6 Weeks)||4
1063325|NCT00871377|2578821|P3|COMPLETED|Washout (6 Weeks)||3
1063326|NCT00871377|2578822|P2|COMPLETED|Washout (6 Weeks)||4
1063327|NCT00871377|2578823|P1|COMPLETED|Washout (6 Weeks)||2
1063328|NCT00871377|2578818|P6|STARTED|Washout (6 Weeks)||4
1063329|NCT00871377|2578819|P5|STARTED|Washout (6 Weeks)||4
1063330|NCT00871377|2578820|P4|STARTED|Washout (6 Weeks)||4
1063331|NCT00871377|2578821|P3|STARTED|Washout (6 Weeks)||3
1063332|NCT00871377|2578822|P2|STARTED|Washout (6 Weeks)||4
1063333|NCT00871377|2578823|P1|STARTED|Washout (6 Weeks)||2
1063334|NCT00871377|2578818|P6|NOT COMPLETED|Second Intervention (10 Weeks)||0
1063335|NCT00871377|2578819|P5|NOT COMPLETED|Second Intervention (10 Weeks)||0
1063336|NCT00871377|2578820|P4|NOT COMPLETED|Second Intervention (10 Weeks)||0
1063337|NCT00871377|2578821|P3|NOT COMPLETED|Second Intervention (10 Weeks)||0
1063338|NCT00871377|2578822|P2|NOT COMPLETED|Second Intervention (10 Weeks)||0
1063339|NCT00871377|2578823|P1|NOT COMPLETED|Second Intervention (10 Weeks)||0
1063340|NCT00871377|2578818|P6|COMPLETED|Second Intervention (10 Weeks)||4
1063341|NCT00871377|2578819|P5|COMPLETED|Second Intervention (10 Weeks)||4
1063342|NCT00871377|2578820|P4|COMPLETED|Second Intervention (10 Weeks)||4
1063343|NCT00871377|2578821|P3|COMPLETED|Second Intervention (10 Weeks)||3
1063344|NCT00871377|2578822|P2|COMPLETED|Second Intervention (10 Weeks)||4
1063345|NCT00871377|2578823|P1|COMPLETED|Second Intervention (10 Weeks)||2
1063346|NCT00871377|2578818|P6|STARTED|Second Intervention (10 Weeks)||4
1063347|NCT00871377|2578819|P5|STARTED|Second Intervention (10 Weeks)||4
1063348|NCT00871377|2578820|P4|STARTED|Second Intervention (10 Weeks)||4
1063349|NCT00871377|2578821|P3|STARTED|Second Intervention (10 Weeks)||3
1063350|NCT00871377|2578822|P2|STARTED|Second Intervention (10 Weeks)||4
1063351|NCT00871377|2578823|P1|STARTED|Second Intervention (10 Weeks)||2
1063352|NCT00871377|2578818|P6|NOT COMPLETED|Washout (6 Weeks)||0
1063353|NCT00871377|2578819|P5|NOT COMPLETED|Washout (6 Weeks)||0
1063354|NCT00871377|2578820|P4|NOT COMPLETED|Washout (6 Weeks)||0
1063355|NCT00871377|2578821|P3|NOT COMPLETED|Washout (6 Weeks)||0
1063356|NCT00871377|2578822|P2|NOT COMPLETED|Washout (6 Weeks)||0
1063357|NCT00871377|2578823|P1|NOT COMPLETED|Washout (6 Weeks)||1
1063358|NCT00871377|2578818|P6|COMPLETED|Washout (6 Weeks)||4
1063359|NCT00871377|2578819|P5|COMPLETED|Washout (6 Weeks)||4
1063360|NCT00871377|2578820|P4|COMPLETED|Washout (6 Weeks)||4
1063361|NCT00871377|2578821|P3|COMPLETED|Washout (6 Weeks)||3
1063362|NCT00871377|2578822|P2|COMPLETED|Washout (6 Weeks)||4
1063363|NCT00871377|2578823|P1|COMPLETED|Washout (6 Weeks)||2
1063364|NCT00871377|2578818|P6|STARTED|Washout (6 Weeks)||4
1063365|NCT00871377|2578819|P5|STARTED|Washout (6 Weeks)||4
1063366|NCT00871377|2578820|P4|STARTED|Washout (6 Weeks)||4
1063367|NCT00871377|2578821|P3|STARTED|Washout (6 Weeks)||3
1063368|NCT00871377|2578822|P2|STARTED|Washout (6 Weeks)||4
1063369|NCT00871377|2578823|P1|STARTED|Washout (6 Weeks)||3
1063370|NCT00871377|2578818|P6|NOT COMPLETED|First Intervention (10 Weeks)||1
1063371|NCT00871377|2578819|P5|NOT COMPLETED|First Intervention (10 Weeks)||0
1063372|NCT00871377|2578820|P4|NOT COMPLETED|First Intervention (10 Weeks)||0
1063373|NCT00871377|2578821|P3|NOT COMPLETED|First Intervention (10 Weeks)||1
1063374|NCT00871377|2578822|P2|NOT COMPLETED|First Intervention (10 Weeks)||0
1063375|NCT00871377|2578823|P1|NOT COMPLETED|First Intervention (10 Weeks)||0
1063376|NCT00871377|2578818|P6|COMPLETED|First Intervention (10 Weeks)||4
1063377|NCT00871377|2578819|P5|COMPLETED|First Intervention (10 Weeks)||4
1063378|NCT00871377|2578820|P4|COMPLETED|First Intervention (10 Weeks)||4
1063379|NCT00871377|2578821|P3|COMPLETED|First Intervention (10 Weeks)||3
1063380|NCT00871377|2578822|P2|COMPLETED|First Intervention (10 Weeks)||4
1063381|NCT00871377|2578823|P1|COMPLETED|First Intervention (10 Weeks)||3
1063382|NCT00871377|2578818|P6|STARTED|First Intervention (10 Weeks)||5
1063383|NCT00871377|2578819|P5|STARTED|First Intervention (10 Weeks)||4
1063384|NCT00871377|2578820|P4|STARTED|First Intervention (10 Weeks)||4
1063385|NCT00871377|2578821|P3|STARTED|First Intervention (10 Weeks)||4
1063386|NCT00871377|2578822|P2|STARTED|First Intervention (10 Weeks)||4
1063387|NCT00871377|2578823|P1|STARTED|First Intervention (10 Weeks)||3
1063388|NCT00871403|2578834|P3|NOT COMPLETED|Monotherapy Treatment Phase||1
1063389|NCT00871403|2578835|P2|NOT COMPLETED|Monotherapy Treatment Phase||13
1063390|NCT00871403|2578836|P1|NOT COMPLETED|Monotherapy Treatment Phase||0
1063391|NCT00871403|2578834|P3|COMPLETED|Monotherapy Treatment Phase||0
1063392|NCT00871403|2578835|P2|COMPLETED|Monotherapy Treatment Phase||0
1063393|NCT00871403|2578836|P1|COMPLETED|Monotherapy Treatment Phase||0
1063394|NCT00871403|2578834|P3|STARTED|Monotherapy Treatment Phase||1
1063395|NCT00871403|2578835|P2|STARTED|Monotherapy Treatment Phase||13
1063396|NCT00871403|2578836|P1|STARTED|Monotherapy Treatment Phase||0
1063397|NCT00871403|2578834|P3|NOT COMPLETED|Combination Treatment Phase||12
1063398|NCT00871403|2578835|P2|NOT COMPLETED|Combination Treatment Phase||49
1063399|NCT00871403|2578836|P1|NOT COMPLETED|Combination Treatment Phase||9
1063400|NCT00871403|2578834|P3|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|23
1063401|NCT00871403|2578835|P2|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|13
1063402|NCT00871403|2578836|P1|COMPLETED|Combination Treatment Phase|No particiapants completed Combination Treatement.|0
1063403|NCT00871403|2578834|P3|STARTED|Combination Treatment Phase||35
1063404|NCT00871403|2578835|P2|STARTED|Combination Treatment Phase||62
1063405|NCT00871403|2578836|P1|STARTED|Combination Treatment Phase||9
1063406|NCT00871429|2578849|P1|NOT COMPLETED|Overall Study||24
1063407|NCT00871429|2578849|P1|COMPLETED|Overall Study||75
1063408|NCT00871429|2578849|P1|STARTED|Overall Study||99
1063409|NCT00871494|2578857|P1|NOT COMPLETED|Overall Study||14
1063410|NCT00871494|2578857|P1|COMPLETED|Overall Study||62
1063411|NCT00871494|2578857|P1|STARTED|Overall Study||76
1063412|NCT00871624|2578866|P2|NOT COMPLETED|Overall Study||1
1063413|NCT00871624|2578867|P1|NOT COMPLETED|Overall Study||2
1063414|NCT00871624|2578866|P2|COMPLETED|Overall Study||17
1063415|NCT00871624|2578867|P1|COMPLETED|Overall Study||16
1063416|NCT00871624|2578866|P2|STARTED|Overall Study||18
1063417|NCT00871624|2578867|P1|STARTED|Overall Study||18
1063418|NCT00871689|2578873|P1|NOT COMPLETED|Overall Study||0
1063419|NCT00871689|2578873|P1|COMPLETED|Overall Study||2
1063420|NCT00871689|2578873|P1|STARTED|Overall Study||2
1063421|NCT00871715|2578887|P3|NOT COMPLETED|Overall Study||26
1063422|NCT00871715|2578888|P2|NOT COMPLETED|Overall Study||16
1063423|NCT00871715|2578889|P1|NOT COMPLETED|Overall Study||15
1063424|NCT00871715|2578887|P3|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|96
1063425|NCT00871715|2578888|P2|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
1063426|NCT00871715|2578889|P1|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
1063427|NCT00871715|2578887|P3|6-mo Follow-up|Overall Study||112
1063428|NCT00871715|2578888|P2|6-mo Follow-up|Overall Study||113
1063429|NCT00871715|2578889|P1|6-mo Follow-up|Overall Study||110
1063430|NCT00871715|2578887|P3|Post-Intervention|Overall Study||115
1063431|NCT00871715|2578888|P2|Post-Intervention|Overall Study||115
1063432|NCT00871715|2578889|P1|Post-Intervention|Overall Study||112
1063433|NCT00871715|2578887|P3|STARTED|Overall Study||122
1063434|NCT00871715|2578888|P2|STARTED|Overall Study||120
1063435|NCT00871715|2578889|P1|STARTED|Overall Study||119
1063436|NCT00871728|2578907|P1|NOT COMPLETED|Overall Study||20
1063437|NCT00871728|2578907|P1|COMPLETED|Overall Study||112
1063438|NCT00871728|2578907|P1|Treated|Overall Study||130
1063439|NCT00871728|2578907|P1|STARTED|Overall Study||132
1063440|NCT00871741|2578919|P2|NOT COMPLETED|Overall Study||7
1063441|NCT00871741|2578920|P1|NOT COMPLETED|Overall Study||9
1063442|NCT00871741|2578919|P2|COMPLETED|Overall Study||0
1063443|NCT00871741|2578920|P1|COMPLETED|Overall Study||0
1063444|NCT00871741|2578919|P2|STARTED|Overall Study||7
1063445|NCT00871741|2578920|P1|STARTED|Overall Study||9
1063446|NCT00871780|2578934|P1|NOT COMPLETED|Overall Study||27
1063447|NCT00871780|2578934|P1|COMPLETED|Overall Study||197
1063448|NCT00871780|2578934|P1|Efficacy Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab and completed at least 1 on-treatment evaluation|215
1063540|NCT00872521|2579055|P1|NOT COMPLETED|Completed 3-month Follow up||0
1063449|NCT00871780|2578934|P1|Safety Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab during the study|218
1063450|NCT00871780|2578934|P1|STARTED|Overall Study|number enrolled|224
1063451|NCT00871819|2578952|P1|NOT COMPLETED|Overall Study||0
1063452|NCT00871819|2578952|P1|COMPLETED|Overall Study||20
1063453|NCT00871819|2578952|P1|STARTED|Overall Study||20
1063454|NCT00871871|2578958|P4|NOT COMPLETED|Part II||4
1063455|NCT00871871|2578959|P3|NOT COMPLETED|Part II||4
1063456|NCT00871871|2578960|P2|NOT COMPLETED|Part II||0
1063457|NCT00871871|2578961|P1|NOT COMPLETED|Part II||0
1063458|NCT00871871|2578958|P4|COMPLETED|Part II||11
1063459|NCT00871871|2578959|P3|COMPLETED|Part II||9
1063460|NCT00871871|2578960|P2|COMPLETED|Part II||0
1063461|NCT00871871|2578961|P1|COMPLETED|Part II||0
1063462|NCT00871871|2578958|P4|STARTED|Part II||15
1063463|NCT00871871|2578959|P3|STARTED|Part II||13
1063464|NCT00871871|2578960|P2|STARTED|Part II||0
1063465|NCT00871871|2578961|P1|STARTED|Part II||0
1063466|NCT00871871|2578958|P4|NOT COMPLETED|Part I||0
1063467|NCT00871871|2578959|P3|NOT COMPLETED|Part I||0
1063468|NCT00871871|2578960|P2|NOT COMPLETED|Part I||3
1063469|NCT00871871|2578961|P1|NOT COMPLETED|Part I||3
1063470|NCT00871871|2578958|P4|COMPLETED|Part I||0
1063471|NCT00871871|2578959|P3|COMPLETED|Part I||0
1063472|NCT00871871|2578960|P2|COMPLETED|Part I||15
1063473|NCT00871871|2578961|P1|COMPLETED|Part I||15
1063474|NCT00871871|2578958|P4|STARTED|Part I||0
1063475|NCT00871871|2578959|P3|STARTED|Part I||0
1063476|NCT00871871|2578960|P2|STARTED|Part I||18
1063477|NCT00871871|2578961|P1|STARTED|Part I||18
1063478|NCT00871975|2578981|P1|NOT COMPLETED|Overall Study||22
1063479|NCT00871975|2578981|P1|COMPLETED|Overall Study||133
1063480|NCT00871975|2578981|P1|STARTED|Overall Study||155
1063481|NCT00872001|2578987|P2|NOT COMPLETED|Overall Study||131
1063482|NCT00872001|2578988|P1|NOT COMPLETED|Overall Study||136
1063483|NCT00872001|2578987|P2|COMPLETED|Overall Study||1413
1063484|NCT00872001|2578988|P1|COMPLETED|Overall Study||1400
1063485|NCT00872001|2578987|P2|STARTED|Overall Study||1544
1063486|NCT00872001|2578988|P1|STARTED|Overall Study||1536
1063487|NCT00872027|2578998|P2|NOT COMPLETED|Overall Study||0
1063488|NCT00872027|2578999|P1|NOT COMPLETED|Overall Study||0
1063489|NCT00872027|2578998|P2|COMPLETED|Overall Study||8
1063490|NCT00872027|2578999|P1|COMPLETED|Overall Study||7
1063491|NCT00872027|2578998|P2|STARTED|Overall Study||8
1063492|NCT00872027|2578999|P1|STARTED|Overall Study||7
1063493|NCT00872079|2579005|P1|NOT COMPLETED|Overall Study||0
1063494|NCT00872079|2579005|P1|COMPLETED|Overall Study||175
1063495|NCT00872079|2579005|P1|STARTED|Overall Study||175
1063496|NCT00872170|2579011|P2|NOT COMPLETED|Overall Study||0
1063497|NCT00872170|2579012|P1|NOT COMPLETED|Overall Study||1
1063498|NCT00872170|2579011|P2|COMPLETED|Overall Study||13
1063499|NCT00872170|2579012|P1|COMPLETED|Overall Study|One patient withdrew from study at week 2.|13
1063500|NCT00872170|2579011|P2|STARTED|Overall Study||13
1063501|NCT00872170|2579012|P1|STARTED|Overall Study||14
1063502|NCT00872339|2579030|P3|NOT COMPLETED|Overall Study||0
1063503|NCT00872339|2579031|P2|NOT COMPLETED|Overall Study||0
1063504|NCT00872339|2579032|P1|NOT COMPLETED|Overall Study||0
1063505|NCT00872339|2579030|P3|COMPLETED|Overall Study||37
1063506|NCT00872339|2579031|P2|COMPLETED|Overall Study||14
1063507|NCT00872339|2579032|P1|COMPLETED|Overall Study||201
1063508|NCT00872339|2579030|P3|STARTED|Overall Study||37
1063509|NCT00872339|2579031|P2|STARTED|Overall Study||14
1063510|NCT00872339|2579032|P1|STARTED|Overall Study||201
1063511|NCT00872430|2579043|P2|NOT COMPLETED|Second Intervention||0
1063512|NCT00872430|2579044|P1|NOT COMPLETED|Second Intervention||0
1063513|NCT00872430|2579043|P2|COMPLETED|Second Intervention||10
1063514|NCT00872430|2579044|P1|COMPLETED|Second Intervention||10
1063515|NCT00872430|2579043|P2|STARTED|Second Intervention||10
1063516|NCT00872430|2579044|P1|STARTED|Second Intervention||10
1063517|NCT00872430|2579043|P2|NOT COMPLETED|Washout Period||0
1063518|NCT00872430|2579044|P1|NOT COMPLETED|Washout Period||0
1063519|NCT00872430|2579043|P2|COMPLETED|Washout Period||10
1063520|NCT00872430|2579044|P1|COMPLETED|Washout Period||10
1063521|NCT00872430|2579043|P2|STARTED|Washout Period||10
1063522|NCT00872430|2579044|P1|STARTED|Washout Period||10
1063523|NCT00872430|2579043|P2|NOT COMPLETED|First Intervention||0
1063524|NCT00872430|2579044|P1|NOT COMPLETED|First Intervention||0
1063525|NCT00872430|2579043|P2|COMPLETED|First Intervention||10
1063526|NCT00872430|2579044|P1|COMPLETED|First Intervention||10
1063527|NCT00872430|2579043|P2|STARTED|First Intervention||10
1063528|NCT00872430|2579044|P1|STARTED|First Intervention||10
1063529|NCT00872521|2579053|P3|NOT COMPLETED|Secondary Endpoint Analysis||1
1063530|NCT00872521|2579054|P2|NOT COMPLETED|Secondary Endpoint Analysis||2
1063531|NCT00872521|2579055|P1|NOT COMPLETED|Secondary Endpoint Analysis||0
1063532|NCT00872521|2579053|P3|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|7
1063533|NCT00872521|2579054|P2|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|58
1063534|NCT00872521|2579055|P1|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|20
1063535|NCT00872521|2579053|P3|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|8
1063536|NCT00872521|2579054|P2|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|60
1063537|NCT00872521|2579055|P1|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|20
1063538|NCT00872521|2579053|P3|NOT COMPLETED|Completed 3-month Follow up||0
1063539|NCT00872521|2579054|P2|NOT COMPLETED|Completed 3-month Follow up||3
1063541|NCT00872521|2579053|P3|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|8
1063542|NCT00872521|2579054|P2|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|60
1063543|NCT00872521|2579055|P1|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|20
1063544|NCT00872521|2579053|P3|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|8
1063545|NCT00872521|2579054|P2|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|63
1063546|NCT00872521|2579055|P1|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|20
1063547|NCT00872521|2579053|P3|NOT COMPLETED|Primary Endpoint Analysis||1
1063548|NCT00872521|2579054|P2|NOT COMPLETED|Primary Endpoint Analysis||5
1063549|NCT00872521|2579055|P1|NOT COMPLETED|Primary Endpoint Analysis||1
1063550|NCT00872521|2579053|P3|COMPLETED|Primary Endpoint Analysis|participants analyzed|8
1063551|NCT00872521|2579054|P2|COMPLETED|Primary Endpoint Analysis|participants analyzed|63
1063552|NCT00872521|2579055|P1|COMPLETED|Primary Endpoint Analysis|participants analyzed|20
1063553|NCT00872521|2579053|P3|STARTED|Primary Endpoint Analysis|Completed PAD induction|9
1063554|NCT00872521|2579054|P2|STARTED|Primary Endpoint Analysis|Completed PAD induction|68
1063555|NCT00872521|2579055|P1|STARTED|Primary Endpoint Analysis|Completed PAD induction|21
1063556|NCT00872521|2579053|P3|NOT COMPLETED|Completed PAD Induction||0
1063557|NCT00872521|2579054|P2|NOT COMPLETED|Completed PAD Induction||4
1063558|NCT00872521|2579055|P1|NOT COMPLETED|Completed PAD Induction||5
1063559|NCT00872521|2579053|P3|COMPLETED|Completed PAD Induction|Completed PAD induction|9
1063560|NCT00872521|2579054|P2|COMPLETED|Completed PAD Induction|Completed PAD induction|68
1063561|NCT00872521|2579055|P1|COMPLETED|Completed PAD Induction|Completed PAD induction|21
1063562|NCT00872521|2579053|P3|STARTED|Completed PAD Induction|Received allocated treatment|9
1063563|NCT00872521|2579054|P2|STARTED|Completed PAD Induction|Received allocated treatment|72
1063564|NCT00872521|2579055|P1|STARTED|Completed PAD Induction|Received allocated treatment|26
1063565|NCT00872534|2579103|P2|NOT COMPLETED|Overall Study||3
1063566|NCT00872534|2579104|P1|NOT COMPLETED|Overall Study||3
1063567|NCT00872534|2579103|P2|COMPLETED|Overall Study||101
1063568|NCT00872534|2579104|P1|COMPLETED|Overall Study||97
1063569|NCT00872534|2579103|P2|STARTED|Overall Study||104
1063570|NCT00872534|2579104|P1|STARTED|Overall Study||100
1063571|NCT00872599|2579110|P2|NOT COMPLETED|Second Drug During High Salt Intake||0
1063572|NCT00872599|2579111|P1|NOT COMPLETED|Second Drug During High Salt Intake||0
1063573|NCT00872599|2579110|P2|COMPLETED|Second Drug During High Salt Intake||16
1063574|NCT00872599|2579111|P1|COMPLETED|Second Drug During High Salt Intake||15
1063575|NCT00872599|2579110|P2|STARTED|Second Drug During High Salt Intake||16
1063576|NCT00872599|2579111|P1|STARTED|Second Drug During High Salt Intake||15
1063577|NCT00872599|2579110|P2|NOT COMPLETED|Second Washout Period||1
1063578|NCT00872599|2579111|P1|NOT COMPLETED|Second Washout Period||1
1063579|NCT00872599|2579110|P2|COMPLETED|Second Washout Period||16
1063580|NCT00872599|2579111|P1|COMPLETED|Second Washout Period||15
1063581|NCT00872599|2579110|P2|STARTED|Second Washout Period||17
1063582|NCT00872599|2579111|P1|STARTED|Second Washout Period||16
1063583|NCT00872599|2579110|P2|NOT COMPLETED|First Drug During High Salt Intake||0
1063584|NCT00872599|2579111|P1|NOT COMPLETED|First Drug During High Salt Intake||0
1063585|NCT00872599|2579110|P2|COMPLETED|First Drug During High Salt Intake||17
1063586|NCT00872599|2579111|P1|COMPLETED|First Drug During High Salt Intake||16
1063587|NCT00872599|2579110|P2|STARTED|First Drug During High Salt Intake||17
1063588|NCT00872599|2579111|P1|STARTED|First Drug During High Salt Intake||16
1063589|NCT00872599|2579110|P2|NOT COMPLETED|First Washout Period After Low Salt||0
1063590|NCT00872599|2579111|P1|NOT COMPLETED|First Washout Period After Low Salt||0
1063591|NCT00872599|2579110|P2|COMPLETED|First Washout Period After Low Salt||17
1063592|NCT00872599|2579111|P1|COMPLETED|First Washout Period After Low Salt||16
1063593|NCT00872599|2579110|P2|STARTED|First Washout Period After Low Salt||17
1063594|NCT00872599|2579111|P1|STARTED|First Washout Period After Low Salt||16
1063595|NCT00872729|2579119|P1|NOT COMPLETED|Overall Study||0
1063596|NCT00872729|2579119|P1|COMPLETED|Overall Study||9
1063597|NCT00872729|2579119|P1|STARTED|Overall Study||9
1063598|NCT00872833|2579149|P2|NOT COMPLETED|Overall Study||0
1063599|NCT00872833|2579150|P1|NOT COMPLETED|Overall Study||0
1063600|NCT00872833|2579149|P2|COMPLETED|Overall Study||17
1063601|NCT00872833|2579150|P1|COMPLETED|Overall Study||15
1063602|NCT00872833|2579149|P2|STARTED|Overall Study||17
1063603|NCT00872833|2579150|P1|STARTED|Overall Study||15
1063604|NCT00872898|2579162|P2|NOT COMPLETED|Part Two - Double Blind||6
1063605|NCT00872898|2579163|P1|NOT COMPLETED|Part Two - Double Blind||11
1063606|NCT00872898|2579162|P2|COMPLETED|Part Two - Double Blind||54
1063607|NCT00872898|2579163|P1|COMPLETED|Part Two - Double Blind||50
1063608|NCT00872898|2579162|P2|STARTED|Part Two - Double Blind||60
1063609|NCT00872898|2579163|P1|STARTED|Part Two - Double Blind||61
1063610|NCT00872898|2579162|P2|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
1063611|NCT00872898|2579163|P1|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
1063612|NCT00872898|2579162|P2|COMPLETED|Part One - Open Label, Pharmacokinetics||4
1063613|NCT00872898|2579163|P1|COMPLETED|Part One - Open Label, Pharmacokinetics||0
1063614|NCT00872898|2579162|P2|STARTED|Part One - Open Label, Pharmacokinetics||4
1063615|NCT00872898|2579163|P1|STARTED|Part One - Open Label, Pharmacokinetics||0
1063616|NCT00867451|2579199|P2|NOT COMPLETED|Overall Study||0
1063617|NCT00867451|2579200|P1|NOT COMPLETED|Overall Study||0
1063618|NCT00867451|2579199|P2|COMPLETED|Overall Study||4
1063619|NCT00867451|2579200|P1|COMPLETED|Overall Study||4
1063620|NCT00867451|2579199|P2|STARTED|Overall Study||4
1063621|NCT00867451|2579200|P1|STARTED|Overall Study||4
1063622|NCT00867490|2579220|P1|NOT COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||0
1063623|NCT00867490|2579220|P1|COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||61
1063624|NCT00867490|2579220|P1|STARTED|Phase 3 - Aliskiren+HCTZ+Amlodipine|The first 60 patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg entered this phase.|61
1063625|NCT00867490|2579220|P1|NOT COMPLETED|Phase 2 - Aliskiren+HCTZ||3
1063626|NCT00867490|2579220|P1|COMPLETED|Phase 2 - Aliskiren+HCTZ||120
1063627|NCT00867490|2579220|P1|STARTED|Phase 2 - Aliskiren+HCTZ|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|123
1063628|NCT00867490|2579220|P1|NOT COMPLETED|Phase 1 - Candesartan+HCTZ||10
1063629|NCT00867490|2579220|P1|COMPLETED|Phase 1 - Candesartan+HCTZ||176
1063630|NCT00867490|2579220|P1|STARTED|Phase 1 - Candesartan+HCTZ||186
1063631|NCT00867503|2579237|P1|NOT COMPLETED|Overall Study||1
1063632|NCT00867503|2579237|P1|COMPLETED|Overall Study||9
1063633|NCT00867503|2579237|P1|STARTED|Overall Study||10
1063634|NCT00872989|2579245|P2|NOT COMPLETED|Overall Study||63
1063635|NCT00872989|2579246|P1|NOT COMPLETED|Overall Study||65
1063636|NCT00872989|2579245|P2|COMPLETED|Overall Study||0
1063637|NCT00872989|2579246|P1|COMPLETED|Overall Study||1
1063638|NCT00872989|2579245|P2|STARTED|Overall Study||63
1063639|NCT00872989|2579246|P1|STARTED|Overall Study||66
1063640|NCT00873015|2579266|P4|NOT COMPLETED|Overall Study||0
1063641|NCT00873015|2579267|P3|NOT COMPLETED|Overall Study||0
1063642|NCT00873015|2579268|P2|NOT COMPLETED|Overall Study||1
1063643|NCT00873015|2579269|P1|NOT COMPLETED|Overall Study||0
1063644|NCT00873015|2579266|P4|COMPLETED|Overall Study||3
1063645|NCT00873015|2579267|P3|COMPLETED|Overall Study||3
1063646|NCT00873015|2579268|P2|COMPLETED|Overall Study||3
1063647|NCT00873015|2579269|P1|COMPLETED|Overall Study||9
1063648|NCT00873015|2579266|P4|STARTED|Overall Study||3
1063649|NCT00873015|2579267|P3|STARTED|Overall Study||3
1063650|NCT00873015|2579268|P2|STARTED|Overall Study||4
1063651|NCT00873015|2579269|P1|STARTED|Overall Study||9
1063652|NCT00873041|2579279|P3|NOT COMPLETED|Extension Study||2
1063653|NCT00873041|2579280|P2|NOT COMPLETED|Extension Study||0
1063654|NCT00873041|2579281|P1|NOT COMPLETED|Extension Study||1
1063655|NCT00873041|2579279|P3|COMPLETED|Extension Study||46
1063656|NCT00873041|2579280|P2|COMPLETED|Extension Study||44
1063657|NCT00873041|2579281|P1|COMPLETED|Extension Study||40
1063658|NCT00873041|2579279|P3|STARTED|Extension Study||48
1063659|NCT00873041|2579280|P2|STARTED|Extension Study||44
1063660|NCT00873041|2579281|P1|STARTED|Extension Study||41
1063661|NCT00873041|2579279|P3|NOT COMPLETED|Core Study||5
1063662|NCT00873041|2579280|P2|NOT COMPLETED|Core Study||6
1063663|NCT00873041|2579281|P1|NOT COMPLETED|Core Study||7
1063664|NCT00873041|2579279|P3|COMPLETED|Core Study||51
1063665|NCT00873041|2579280|P2|COMPLETED|Core Study||49
1063666|NCT00873041|2579281|P1|COMPLETED|Core Study||48
1063667|NCT00873041|2579279|P3|STARTED|Core Study||56
1063668|NCT00873041|2579280|P2|STARTED|Core Study||55
1063669|NCT00873041|2579281|P1|STARTED|Core Study||55
1063670|NCT00873093|2579340|P5|NOT COMPLETED|Overall Study||2
1063671|NCT00873093|2579341|P4|NOT COMPLETED|Overall Study||11
1063672|NCT00873093|2579342|P3|NOT COMPLETED|Overall Study||16
1063673|NCT00873093|2579343|P2|NOT COMPLETED|Overall Study||27
1063674|NCT00873093|2579344|P1|NOT COMPLETED|Overall Study||1
1063675|NCT00873093|2579340|P5|COMPLETED|Overall Study||8
1063676|NCT00873093|2579341|P4|COMPLETED|Overall Study||12
1063677|NCT00873093|2579342|P3|COMPLETED|Overall Study||33
1063678|NCT00873093|2579343|P2|COMPLETED|Overall Study||35
1063679|NCT00873093|2579344|P1|COMPLETED|Overall Study||3
1063680|NCT00873093|2579340|P5|STARTED|Overall Study||10
1063681|NCT00873093|2579341|P4|STARTED|Overall Study||23
1063682|NCT00873093|2579342|P3|STARTED|Overall Study||49
1063683|NCT00873093|2579343|P2|STARTED|Overall Study||62
1063684|NCT00873093|2579344|P1|STARTED|Overall Study||4
1063685|NCT00873119|2579400|P2|NOT COMPLETED|Overall Study||26
1063686|NCT00873119|2579401|P1|NOT COMPLETED|Overall Study||44
1063687|NCT00873119|2579400|P2|COMPLETED|Overall Study||19
1063688|NCT00873119|2579401|P1|COMPLETED|Overall Study|Of 42 patients treated with belinostat, 23 patients received 6 or more treatment cycles.|0
1063689|NCT00873119|2579400|P2|STARTED|Overall Study||45
1063690|NCT00873119|2579401|P1|STARTED|Overall Study||44
1063691|NCT00875550|2579419|P2|NOT COMPLETED|Overall Study||10
1063692|NCT00875550|2579420|P1|NOT COMPLETED|Overall Study||12
1063693|NCT00875550|2579419|P2|COMPLETED|Overall Study||76
1063694|NCT00875550|2579420|P1|COMPLETED|Overall Study||77
1063695|NCT00875550|2579419|P2|STARTED|Overall Study||86
1063696|NCT00875550|2579420|P1|STARTED|Overall Study||89
1063697|NCT00875563|2579436|P1|NOT COMPLETED|Overall Study||24
1063698|NCT00875563|2579436|P1|COMPLETED|Overall Study||18
1063699|NCT00875563|2579436|P1|STARTED|Overall Study||42
1063700|NCT00875589|2579442|P2|NOT COMPLETED|Overall Study||0
1063701|NCT00875589|2579443|P1|NOT COMPLETED|Overall Study||0
1063702|NCT00875589|2579442|P2|COMPLETED|Overall Study||11
1063703|NCT00875589|2579443|P1|COMPLETED|Overall Study||15
1063704|NCT00875589|2579442|P2|STARTED|Overall Study||11
1063705|NCT00875589|2579443|P1|STARTED|Overall Study||15
1063706|NCT00875615|2579449|P1|NOT COMPLETED|Overall Study||1
1063707|NCT00875615|2579449|P1|COMPLETED|Overall Study||10
1063708|NCT00875615|2579449|P1|STARTED|Overall Study||11
1063709|NCT00875706|2579457|P3|NOT COMPLETED|Overall Study||0
1063710|NCT00875706|2579458|P2|NOT COMPLETED|Overall Study||0
1063711|NCT00875706|2579459|P1|NOT COMPLETED|Overall Study||1
1063712|NCT00875706|2579457|P3|COMPLETED|Overall Study||13
1063713|NCT00875706|2579458|P2|COMPLETED|Overall Study||24
1063714|NCT00875706|2579459|P1|COMPLETED|Overall Study||7
1063715|NCT00875706|2579457|P3|STARTED|Overall Study||13
1063716|NCT00875706|2579458|P2|STARTED|Overall Study||24
1063717|NCT00875706|2579459|P1|STARTED|Overall Study||8
1063718|NCT00875797|2579478|P2|NOT COMPLETED|Overall Study||3
1063719|NCT00875797|2579479|P1|NOT COMPLETED|Overall Study||6
1063720|NCT00875797|2579478|P2|COMPLETED|Overall Study||42
1063721|NCT00875797|2579479|P1|COMPLETED|Overall Study||39
1063722|NCT00875797|2579478|P2|STARTED|Overall Study||45
1063723|NCT00875797|2579479|P1|STARTED|Overall Study||45
1063724|NCT00875810|2579489|P1|NOT COMPLETED|Overall Study||46
1063725|NCT00875810|2579489|P1|COMPLETED|Overall Study||148
1063726|NCT00875810|2579489|P1|24 Months Follow up|Overall Study||148
1063727|NCT00875810|2579489|P1|12 Months Follow up|Overall Study||112
1063728|NCT00875810|2579489|P1|6 Months Follow up|Overall Study||80
1063729|NCT00875810|2579489|P1|3 Months Follow up|Overall Study||175
1063730|NCT00875810|2579489|P1|Discharged|Overall Study||177
1063731|NCT00875810|2579489|P1|Implanted|Overall Study||190
1063732|NCT00875810|2579489|P1|STARTED|Overall Study||194
1063733|NCT00875836|2579498|P2|NOT COMPLETED|Overall Study||40
1063734|NCT00875836|2579499|P1|NOT COMPLETED|Overall Study||43
1063735|NCT00875836|2579498|P2|COMPLETED|Overall Study||47
1063736|NCT00875836|2579499|P1|COMPLETED|Overall Study||45
1063737|NCT00875836|2579498|P2|STARTED|Overall Study||87
1063738|NCT00875836|2579499|P1|STARTED|Overall Study||88
1063739|NCT00875979|2579511|P2|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||47
1063740|NCT00875979|2579512|P1|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
1063741|NCT00875979|2579511|P2|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||11
1063742|NCT00875979|2579512|P1|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
1063743|NCT00875979|2579511|P2|STARTED|Dose Expansion Phase - 3.6 mg/kg||58
1063744|NCT00875979|2579512|P1|STARTED|Dose Expansion Phase - 3.6 mg/kg||0
1063745|NCT00875979|2579511|P2|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||6
1063746|NCT00875979|2579512|P1|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
1063747|NCT00875979|2579511|P2|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
1063748|NCT00875979|2579512|P1|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
1063749|NCT00875979|2579511|P2|STARTED|Dose Escalation Phase - 3.6 mg/kg||6
1063750|NCT00875979|2579512|P1|STARTED|Dose Escalation Phase - 3.6 mg/kg||0
1063751|NCT00875979|2579511|P2|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
1063752|NCT00875979|2579512|P1|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||3
1063753|NCT00875979|2579511|P2|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
1063754|NCT00875979|2579512|P1|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
1063755|NCT00875979|2579511|P2|STARTED|Dose Escalation Phase - 3.0 mg/kg||0
1063756|NCT00875979|2579512|P1|STARTED|Dose Escalation Phase - 3.0 mg/kg||3
1063757|NCT00876018|2579525|P3|NOT COMPLETED|Overall Study||3
1063758|NCT00876018|2579526|P2|NOT COMPLETED|Overall Study||5
1063759|NCT00876018|2579527|P1|NOT COMPLETED|Overall Study||5
1063760|NCT00876018|2579525|P3|COMPLETED|Overall Study||97
1063761|NCT00876018|2579526|P2|COMPLETED|Overall Study||95
1063762|NCT00876018|2579527|P1|COMPLETED|Overall Study||95
1063763|NCT00876018|2579525|P3|STARTED|Overall Study||100
1063764|NCT00876018|2579526|P2|STARTED|Overall Study||100
1063765|NCT00876018|2579527|P1|STARTED|Overall Study||100
1063766|NCT00876265|2579580|P1|NOT COMPLETED|Overall Study||12
1063767|NCT00876265|2579580|P1|COMPLETED|Overall Study||106
1063768|NCT00876265|2579580|P1|STARTED|Overall Study||118
1063769|NCT00876343|2579589|P3|NOT COMPLETED|Overall Study||12
1063770|NCT00876343|2579590|P2|NOT COMPLETED|Overall Study||17
1063771|NCT00876343|2579591|P1|NOT COMPLETED|Overall Study||17
1063772|NCT00876343|2579589|P3|COMPLETED|Overall Study||183
1063773|NCT00876343|2579590|P2|COMPLETED|Overall Study||180
1063774|NCT00876343|2579591|P1|COMPLETED|Overall Study||177
1063775|NCT00876343|2579589|P3|STARTED|Overall Study||195
1063776|NCT00876343|2579590|P2|STARTED|Overall Study||197
1063777|NCT00876343|2579591|P1|STARTED|Overall Study||194
1063778|NCT00876447|2579607|P2|NOT COMPLETED|Overall Study||81
1063779|NCT00876447|2579608|P1|NOT COMPLETED|Overall Study||80
1063780|NCT00876447|2579607|P2|COMPLETED|Overall Study||122
1063781|NCT00876447|2579608|P1|COMPLETED|Overall Study||105
1063782|NCT00876447|2579607|P2|STARTED|Overall Study||203
1063783|NCT00876447|2579608|P1|STARTED|Overall Study||185
1063784|NCT00876460|2579674|P8|NOT COMPLETED|Mono Therapy Phase||3
1063785|NCT00876460|2579675|P7|NOT COMPLETED|Mono Therapy Phase||1
1063786|NCT00876460|2579676|P6|NOT COMPLETED|Mono Therapy Phase||0
1063787|NCT00876460|2579677|P5|NOT COMPLETED|Mono Therapy Phase||2
1063788|NCT00876460|2579678|P4|NOT COMPLETED|Mono Therapy Phase||1
1063789|NCT00876460|2579679|P3|NOT COMPLETED|Mono Therapy Phase||0
1063790|NCT00876460|2579680|P2|NOT COMPLETED|Mono Therapy Phase||1
1063791|NCT00876460|2579681|P1|NOT COMPLETED|Mono Therapy Phase||0
1063792|NCT00876460|2579674|P8|COMPLETED|Mono Therapy Phase||0
1063793|NCT00876460|2579675|P7|COMPLETED|Mono Therapy Phase||0
1063794|NCT00876460|2579676|P6|COMPLETED|Mono Therapy Phase||0
1063795|NCT00876460|2579677|P5|COMPLETED|Mono Therapy Phase||0
1063796|NCT00876460|2579678|P4|COMPLETED|Mono Therapy Phase||0
1063797|NCT00876460|2579679|P3|COMPLETED|Mono Therapy Phase||0
1063798|NCT00876460|2579680|P2|COMPLETED|Mono Therapy Phase||0
1063799|NCT00876460|2579681|P1|COMPLETED|Mono Therapy Phase||0
1063800|NCT00876460|2579674|P8|STARTED|Mono Therapy Phase|Three patients started mono therapy phase after discontinued from combination therapy phase.|3
1063801|NCT00876460|2579675|P7|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
1063802|NCT00876460|2579676|P6|STARTED|Mono Therapy Phase||0
1063803|NCT00876460|2579677|P5|STARTED|Mono Therapy Phase|Two patients started mono therapy phase after discontinued from combination therapy phase.|2
1063804|NCT00876460|2579678|P4|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
1063805|NCT00876460|2579679|P3|STARTED|Mono Therapy Phase||0
1063806|NCT00876460|2579680|P2|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
1063807|NCT00876460|2579681|P1|STARTED|Mono Therapy Phase||0
1063808|NCT00876460|2579674|P8|NOT COMPLETED|Combination Therapy Phase||6
1063809|NCT00876460|2579675|P7|NOT COMPLETED|Combination Therapy Phase||8
1063810|NCT00876460|2579676|P6|NOT COMPLETED|Combination Therapy Phase||3
1063811|NCT00876460|2579677|P5|NOT COMPLETED|Combination Therapy Phase||7
1063812|NCT00876460|2579678|P4|NOT COMPLETED|Combination Therapy Phase||6
1063813|NCT00876460|2579679|P3|NOT COMPLETED|Combination Therapy Phase||3
1063814|NCT00876460|2579680|P2|NOT COMPLETED|Combination Therapy Phase||7
1063815|NCT00876460|2579681|P1|NOT COMPLETED|Combination Therapy Phase||3
1063816|NCT00876460|2579674|P8|COMPLETED|Combination Therapy Phase||0
1063817|NCT00876460|2579675|P7|COMPLETED|Combination Therapy Phase||0
1063818|NCT00876460|2579676|P6|COMPLETED|Combination Therapy Phase||0
1063819|NCT00876460|2579677|P5|COMPLETED|Combination Therapy Phase||0
1063820|NCT00876460|2579678|P4|COMPLETED|Combination Therapy Phase||0
1063821|NCT00876460|2579679|P3|COMPLETED|Combination Therapy Phase||0
1063822|NCT00876460|2579680|P2|COMPLETED|Combination Therapy Phase||0
1063823|NCT00876460|2579681|P1|COMPLETED|Combination Therapy Phase||0
1063824|NCT00876460|2579674|P8|STARTED|Combination Therapy Phase||6
1063825|NCT00876460|2579675|P7|STARTED|Combination Therapy Phase||8
1063826|NCT00876460|2579676|P6|STARTED|Combination Therapy Phase||3
1063827|NCT00876460|2579677|P5|STARTED|Combination Therapy Phase||7
1063828|NCT00876460|2579678|P4|STARTED|Combination Therapy Phase||6
1063829|NCT00876460|2579679|P3|STARTED|Combination Therapy Phase||3
1063830|NCT00876460|2579680|P2|STARTED|Combination Therapy Phase||7
1063831|NCT00876460|2579681|P1|STARTED|Combination Therapy Phase||3
1063832|NCT00876694|2579753|P2|NOT COMPLETED|Overall Study||12
1063833|NCT00876694|2579754|P1|NOT COMPLETED|Overall Study||21
1063834|NCT00876694|2579753|P2|COMPLETED|Overall Study||49
1063835|NCT00876694|2579754|P1|COMPLETED|Overall Study||104
1063836|NCT00876694|2579753|P2|STARTED|Overall Study||61
1063837|NCT00876694|2579754|P1|STARTED|Overall Study||125
1063838|NCT00876733|2579776|P4|NOT COMPLETED|Overall Study||7
1063839|NCT00876733|2579777|P3|NOT COMPLETED|Overall Study||30
1063840|NCT00876733|2579778|P2|NOT COMPLETED|Overall Study||42
1063841|NCT00876733|2579779|P1|NOT COMPLETED|Overall Study||91
1063842|NCT00876733|2579776|P4|COMPLETED|Overall Study||14
1063843|NCT00876733|2579777|P3|COMPLETED|Overall Study||63
1063844|NCT00876733|2579778|P2|COMPLETED|Overall Study||161
1063845|NCT00876733|2579779|P1|COMPLETED|Overall Study||197
1063846|NCT00876733|2579776|P4|STARTED|Overall Study||21
1063847|NCT00876733|2579777|P3|STARTED|Overall Study||93
1063848|NCT00876733|2579778|P2|STARTED|Overall Study||203
1063849|NCT00876733|2579779|P1|STARTED|Overall Study||288
1063850|NCT00876915|2579888|P3|NOT COMPLETED|Overall Study||0
1063851|NCT00876915|2579889|P2|NOT COMPLETED|Overall Study||14
1063852|NCT00876915|2579890|P1|NOT COMPLETED|Overall Study||19
1063853|NCT00876915|2579888|P3|COMPLETED|Overall Study||101
1063854|NCT00876915|2579889|P2|COMPLETED|Overall Study||34
1063855|NCT00876915|2579890|P1|COMPLETED|Overall Study||31
1063856|NCT00876915|2579888|P3|Week 8|Overall Study||0
1063857|NCT00876915|2579889|P2|Week 8|Overall Study||36
1063858|NCT00876915|2579890|P1|Week 8|Overall Study||33
1063859|NCT00876915|2579888|P3|Week 4|Overall Study||0
1063860|NCT00876915|2579889|P2|Week 4|Overall Study||45
1063861|NCT00876915|2579890|P1|Week 4|Overall Study||38
1063862|NCT00876915|2579888|P3|STARTED|Overall Study||101
1063863|NCT00876915|2579889|P2|STARTED|Overall Study||48
1063864|NCT00876915|2579890|P1|STARTED|Overall Study||50
1063865|NCT00876928|2579912|P2|NOT COMPLETED|Overall Study||5
1063866|NCT00876928|2579913|P1|NOT COMPLETED|Overall Study||3
1063867|NCT00876928|2579912|P2|COMPLETED|Overall Study||56
1063868|NCT00876928|2579913|P1|COMPLETED|Overall Study||53
1063869|NCT00876928|2579912|P2|STARTED|Overall Study||61
1063870|NCT00876928|2579913|P1|STARTED|Overall Study||56
1063871|NCT00877006|2579923|P2|NOT COMPLETED|Long-Term Follow-up Period||210
1063872|NCT00877006|2579924|P1|NOT COMPLETED|Long-Term Follow-up Period||210
1063873|NCT00877006|2579923|P2|COMPLETED|Long-Term Follow-up Period|study is ongoing|0
1063874|NCT00877006|2579924|P1|COMPLETED|Long-Term Follow-up Period|study is ongoing|0
1063875|NCT00877006|2579923|P2|STARTED|Long-Term Follow-up Period||210
1063876|NCT00877006|2579924|P1|STARTED|Long-Term Follow-up Period||210
1063877|NCT00877006|2579923|P2|NOT COMPLETED|Treatment Period||27
1063878|NCT00877006|2579924|P1|NOT COMPLETED|Treatment Period||21
1063879|NCT00877006|2579923|P2|COMPLETED|Treatment Period||196
1063880|NCT00877006|2579924|P1|COMPLETED|Treatment Period|treated for >=6 cycles|203
1063881|NCT00877006|2579923|P2|STARTED|Treatment Period||223
1063882|NCT00877006|2579924|P1|STARTED|Treatment Period||224
1063883|NCT00877032|2579957|P7|NOT COMPLETED|Overall Study||2
1063884|NCT00877032|2579958|P6|NOT COMPLETED|Overall Study||0
1063885|NCT00877032|2579959|P5|NOT COMPLETED|Overall Study||0
1063886|NCT00877032|2579960|P4|NOT COMPLETED|Overall Study||1
1063887|NCT00877032|2579961|P3|NOT COMPLETED|Overall Study||0
1063888|NCT00877032|2579962|P2|NOT COMPLETED|Overall Study||0
1063889|NCT00877032|2579963|P1|NOT COMPLETED|Overall Study||0
1063890|NCT00877032|2579957|P7|COMPLETED|Overall Study||18
1063891|NCT00877032|2579958|P6|COMPLETED|Overall Study||6
1063892|NCT00877032|2579959|P5|COMPLETED|Overall Study||6
1063893|NCT00877032|2579960|P4|COMPLETED|Overall Study||6
1063894|NCT00877032|2579961|P3|COMPLETED|Overall Study||6
1063895|NCT00877032|2579962|P2|COMPLETED|Overall Study||6
1063896|NCT00877032|2579963|P1|COMPLETED|Overall Study||6
1063897|NCT00877032|2579957|P7|Treated|Overall Study||18
1063898|NCT00877032|2579958|P6|Treated|Overall Study||6
1063899|NCT00877032|2579959|P5|Treated|Overall Study||6
1063900|NCT00877032|2579960|P4|Treated|Overall Study||6
1063901|NCT00877032|2579961|P3|Treated|Overall Study||6
1063902|NCT00877032|2579962|P2|Treated|Overall Study||6
1063903|NCT00877032|2579963|P1|Treated|Overall Study||6
1063904|NCT00877032|2579957|P7|STARTED|Overall Study||20
1063905|NCT00877032|2579958|P6|STARTED|Overall Study||6
1063906|NCT00877032|2579959|P5|STARTED|Overall Study||6
1063907|NCT00877032|2579960|P4|STARTED|Overall Study||7
1063908|NCT00877032|2579961|P3|STARTED|Overall Study||6
1063909|NCT00877032|2579962|P2|STARTED|Overall Study||6
1063910|NCT00877032|2579963|P1|STARTED|Overall Study||6
1063911|NCT00877058|2580065|P3|NOT COMPLETED|Overall Study||39
1063912|NCT00877058|2580066|P2|NOT COMPLETED|Overall Study||40
1063913|NCT00877058|2580067|P1|NOT COMPLETED|Overall Study||37
1063914|NCT00877058|2580065|P3|COMPLETED|Overall Study||75
1063915|NCT00877058|2580066|P2|COMPLETED|Overall Study||131
1063916|NCT00877058|2580067|P1|COMPLETED|Overall Study||137
1063917|NCT00877058|2580065|P3|STARTED|Overall Study||114
1063918|NCT00877058|2580066|P2|STARTED|Overall Study||171
1063919|NCT00877058|2580067|P1|STARTED|Overall Study||174
1063920|NCT00877071|2580081|P1|NOT COMPLETED|Overall Study||2
1063921|NCT00877071|2580081|P1|COMPLETED|Overall Study||0
1063922|NCT00877071|2580081|P1|STARTED|Overall Study||2
1063923|NCT00877370|2580088|P1|NOT COMPLETED|Overall Study||0
1063924|NCT00877370|2580088|P1|COMPLETED|Overall Study||8
1063925|NCT00877370|2580088|P1|STARTED|Overall Study||8
1063926|NCT00877383|2580094|P2|NOT COMPLETED|Overall Study||37
1063927|NCT00877383|2580095|P1|NOT COMPLETED|Overall Study||29
1063928|NCT00877383|2580094|P2|COMPLETED|Overall Study||533
1063929|NCT00877383|2580095|P1|COMPLETED|Overall Study||543
1063930|NCT00877383|2580094|P2|STARTED|Overall Study||570
1063931|NCT00877383|2580095|P1|STARTED|Overall Study||572
1063932|NCT00877448|2580118|P7|NOT COMPLETED|Overall Study||0
1063933|NCT00877448|2580119|P6|NOT COMPLETED|Overall Study||1
1063934|NCT00877448|2580120|P5|NOT COMPLETED|Overall Study||0
1063935|NCT00877448|2580121|P4|NOT COMPLETED|Overall Study||1
1063936|NCT00877448|2580122|P3|NOT COMPLETED|Overall Study||0
1063937|NCT00877448|2580123|P2|NOT COMPLETED|Overall Study||1
1063938|NCT00877448|2580124|P1|NOT COMPLETED|Overall Study||0
1063939|NCT00877448|2580118|P7|COMPLETED|Overall Study||3
1063940|NCT00877448|2580119|P6|COMPLETED|Overall Study||9
1063941|NCT00877448|2580120|P5|COMPLETED|Overall Study||10
1063942|NCT00877448|2580121|P4|COMPLETED|Overall Study||9
1063943|NCT00877448|2580122|P3|COMPLETED|Overall Study||10
1063944|NCT00877448|2580123|P2|COMPLETED|Overall Study||9
1063945|NCT00877448|2580124|P1|COMPLETED|Overall Study||10
1063946|NCT00877448|2580118|P7|STARTED|Overall Study||3
1063947|NCT00877448|2580119|P6|STARTED|Overall Study||10
1063948|NCT00877448|2580120|P5|STARTED|Overall Study||10
1063949|NCT00877448|2580121|P4|STARTED|Overall Study||10
1063950|NCT00877448|2580122|P3|STARTED|Overall Study||10
1063951|NCT00877448|2580123|P2|STARTED|Overall Study||10
1063952|NCT00877448|2580124|P1|STARTED|Overall Study||10
1063953|NCT00877487|2580147|P2|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||47
1063954|NCT00877487|2580148|P1|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||6
1063955|NCT00877487|2580147|P2|COMPLETED|Double-blind Randomized Withdrawal Phase||13
1063956|NCT00877487|2580148|P1|COMPLETED|Double-blind Randomized Withdrawal Phase||50
1063957|NCT00877487|2580147|P2|STARTED|Double-blind Randomized Withdrawal Phase||60
1063958|NCT00877487|2580148|P1|STARTED|Double-blind Randomized Withdrawal Phase||56
1063959|NCT00877487|2580147|P2|NOT COMPLETED|Open-label Treatment Phase||0
1063960|NCT00877487|2580148|P1|NOT COMPLETED|Open-label Treatment Phase||7
1063961|NCT00877487|2580147|P2|COMPLETED|Open-label Treatment Phase||0
1063962|NCT00877487|2580148|P1|COMPLETED|Open-label Treatment Phase||116
1063963|NCT00877487|2580147|P2|STARTED|Open-label Treatment Phase||0
1063964|NCT00877487|2580148|P1|STARTED|Open-label Treatment Phase||123
1063965|NCT00877604|2580160|P2|NOT COMPLETED|Overall Study||3
1063966|NCT00877604|2580161|P1|NOT COMPLETED|Overall Study||2
1063967|NCT00877604|2580160|P2|COMPLETED|Overall Study||14
1063968|NCT00877604|2580161|P1|COMPLETED|Overall Study||15
1063969|NCT00877604|2580160|P2|STARTED|Overall Study||17
1063970|NCT00877604|2580161|P1|STARTED|Overall Study||17
1063971|NCT00877773|2580167|P1|NOT COMPLETED|Overall Study||44
1063972|NCT00877773|2580167|P1|COMPLETED|Overall Study|No participant reached to first restaging.|0
1063973|NCT00877773|2580167|P1|STARTED|Overall Study||44
1063974|NCT00877799|2580176|P5|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||1
1063975|NCT00877799|2580177|P4|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||2
1063976|NCT00877799|2580178|P3|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
1063977|NCT00877799|2580179|P2|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
1063978|NCT00877799|2580180|P1|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
1063979|NCT00877799|2580176|P5|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||19
1063980|NCT00877799|2580177|P4|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||24
1063981|NCT00877799|2580178|P3|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
1063982|NCT00877799|2580179|P2|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
1063983|NCT00877799|2580180|P1|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
1063984|NCT00877799|2580176|P5|STARTED|Cohort 2: Immediately Post-op (Day 0)||20
1063985|NCT00877799|2580177|P4|STARTED|Cohort 2: Immediately Post-op (Day 0)||26
1063986|NCT00877799|2580178|P3|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
1063987|NCT00877799|2580179|P2|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
1063988|NCT00877799|2580180|P1|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
1063989|NCT00877799|2580176|P5|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
1063990|NCT00877799|2580177|P4|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
1063991|NCT00877799|2580178|P3|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
1063992|NCT00877799|2580179|P2|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||5
1063993|NCT00877799|2580180|P1|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
1063994|NCT00877799|2580176|P5|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
1063995|NCT00877799|2580177|P4|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
1063996|NCT00877799|2580178|P3|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||18
1063997|NCT00877799|2580179|P2|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||17
1063998|NCT00877799|2580180|P1|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||22
1063999|NCT00877799|2580176|P5|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
1064000|NCT00877799|2580177|P4|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
1064001|NCT00877799|2580178|P3|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||21
1064002|NCT00877799|2580179|P2|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||22
1064003|NCT00877799|2580180|P1|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||25
1064004|NCT00877877|2580195|P1|NOT COMPLETED|Year 10||0
1064005|NCT00877877|2580195|P1|COMPLETED|Year 10||495
1064006|NCT00877877|2580195|P1|STARTED|Year 10||495
1064007|NCT00877877|2580195|P1|NOT COMPLETED|Year 9||0
1064008|NCT00877877|2580195|P1|COMPLETED|Year 9||507
1064009|NCT00877877|2580195|P1|STARTED|Year 9||507
1064010|NCT00877877|2580195|P1|NOT COMPLETED|Year 8||0
1064011|NCT00877877|2580195|P1|COMPLETED|Year 8||522
1064012|NCT00877877|2580195|P1|STARTED|Year 8||522
1064013|NCT00877877|2580195|P1|NOT COMPLETED|Year 7||0
1064014|NCT00877877|2580195|P1|COMPLETED|Year 7||523
1064015|NCT00877877|2580195|P1|STARTED|Year 7||523
1064016|NCT00877877|2580195|P1|NOT COMPLETED|Year 6||0
1064017|NCT00877877|2580195|P1|COMPLETED|Year 6||529
1064018|NCT00877877|2580195|P1|STARTED|Year 6||529
1064019|NCT00877877|2580195|P1|NOT COMPLETED|Year 5||0
1064020|NCT00877877|2580195|P1|COMPLETED|Year 5||397
1064021|NCT00877877|2580195|P1|STARTED|Year 5||397
1064022|NCT00877890|2580223|P2|NOT COMPLETED|Overall Study||30
1064023|NCT00877890|2580224|P1|NOT COMPLETED|Overall Study||20
1064024|NCT00877890|2580223|P2|COMPLETED|Overall Study||95
1064025|NCT00877890|2580224|P1|COMPLETED|Overall Study||109
1064026|NCT00877890|2580223|P2|Intent to Treat (ITT)|Overall Study||123
1064027|NCT00877890|2580224|P1|Intent to Treat (ITT)|Overall Study||129
1064028|NCT00877890|2580223|P2|STARTED|Overall Study||125
1064029|NCT00877890|2580224|P1|STARTED|Overall Study||129
1064030|NCT00877929|2580260|P2|NOT COMPLETED|Overall Study||35
1064031|NCT00877929|2580261|P1|NOT COMPLETED|Overall Study||20
1064032|NCT00877929|2580260|P2|COMPLETED|Overall Study||319
1064033|NCT00877929|2580261|P1|COMPLETED|Overall Study||332
1064034|NCT00877929|2580260|P2|STARTED|Overall Study||354
1064035|NCT00877929|2580261|P1|STARTED|Overall Study||352
1064036|NCT00870363|2580351|P4|NOT COMPLETED|Overall Study||0
1064037|NCT00870363|2580352|P3|NOT COMPLETED|Overall Study||3
1064038|NCT00870363|2580353|P2|NOT COMPLETED|Overall Study||3
1064039|NCT00870363|2580354|P1|NOT COMPLETED|Overall Study||0
1064040|NCT00870363|2580351|P4|COMPLETED|Overall Study||12
1064041|NCT00870363|2580352|P3|COMPLETED|Overall Study||8
1064042|NCT00870363|2580353|P2|COMPLETED|Overall Study||8
1064043|NCT00870363|2580354|P1|COMPLETED|Overall Study||10
1064044|NCT00870363|2580351|P4|STARTED|Overall Study||12
1064045|NCT00870363|2580352|P3|STARTED|Overall Study||11
1064046|NCT00870363|2580353|P2|STARTED|Overall Study||11
1064047|NCT00870363|2580354|P1|STARTED|Overall Study||10
1064048|NCT00878228|2580390|P2|NOT COMPLETED|Overall Study||12
1064049|NCT00878228|2580391|P1|NOT COMPLETED|Overall Study||10
1064050|NCT00878228|2580390|P2|COMPLETED|Overall Study||37
1064051|NCT00878228|2580391|P1|COMPLETED|Overall Study||39
1064052|NCT00878228|2580390|P2|STARTED|Overall Study||49
1064053|NCT00878228|2580391|P1|STARTED|Overall Study||49
1064054|NCT00881959|2580403|P2|NOT COMPLETED|Overall Study||4
1064055|NCT00881959|2580404|P1|NOT COMPLETED|Overall Study||2
1064056|NCT00881959|2580403|P2|COMPLETED|Overall Study||38
1064057|NCT00881959|2580404|P1|COMPLETED|Overall Study||36
1064058|NCT00881959|2580403|P2|STARTED|Overall Study||42
1064059|NCT00881959|2580404|P1|STARTED|Overall Study||38
1064060|NCT00882102|2580410|P1|NOT COMPLETED|Overall Study||0
1064061|NCT00882102|2580410|P1|COMPLETED|Overall Study||40
1064062|NCT00882102|2580410|P1|STARTED|Overall Study||40
1064063|NCT00882206|2580414|P1|NOT COMPLETED|Overall Study||0
1064064|NCT00882206|2580414|P1|COMPLETED|Overall Study||13
1064065|NCT00882206|2580414|P1|STARTED|Overall Study||13
1064066|NCT00882310|2580421|P1|NOT COMPLETED|Overall Study||22
1064067|NCT00882310|2580421|P1|COMPLETED|Overall Study||15
1064068|NCT00882310|2580421|P1|STARTED|Overall Study||37
1064069|NCT00882362|2580429|P2|NOT COMPLETED|Overall Study||23
1064070|NCT00882362|2580430|P1|NOT COMPLETED|Overall Study||49
1064071|NCT00882362|2580429|P2|COMPLETED|Overall Study||10
1064072|NCT00882362|2580430|P1|COMPLETED|Overall Study||73
1064073|NCT00882362|2580429|P2|STARTED|Overall Study||33
1064074|NCT00882362|2580430|P1|STARTED|Overall Study||122
1064075|NCT00882440|2580443|P7|NOT COMPLETED|Overall Study||4
1064076|NCT00882440|2580444|P6|NOT COMPLETED|Overall Study||7
1064077|NCT00882440|2580445|P5|NOT COMPLETED|Overall Study||10
1064078|NCT00882440|2580446|P4|NOT COMPLETED|Overall Study||3
1064079|NCT00882440|2580447|P3|NOT COMPLETED|Overall Study||7
1064080|NCT00882440|2580448|P2|NOT COMPLETED|Overall Study||8
1064081|NCT00882440|2580449|P1|NOT COMPLETED|Overall Study||11
1064082|NCT00882440|2580443|P7|COMPLETED|Overall Study||79
1064083|NCT00882440|2580444|P6|COMPLETED|Overall Study||77
1064084|NCT00882440|2580445|P5|COMPLETED|Overall Study||80
1064085|NCT00882440|2580446|P4|COMPLETED|Overall Study||76
1064086|NCT00882440|2580447|P3|COMPLETED|Overall Study||75
1064087|NCT00882440|2580448|P2|COMPLETED|Overall Study||72
1064088|NCT00882440|2580449|P1|COMPLETED|Overall Study||67
1064089|NCT00882440|2580443|P7|STARTED|Overall Study||83
1064090|NCT00882440|2580444|P6|STARTED|Overall Study||84
1064091|NCT00882440|2580445|P5|STARTED|Overall Study||90
1064092|NCT00882440|2580446|P4|STARTED|Overall Study||79
1064093|NCT00882440|2580447|P3|STARTED|Overall Study||82
1064094|NCT00882440|2580448|P2|STARTED|Overall Study||80
1064095|NCT00882440|2580449|P1|STARTED|Overall Study||78
1064096|NCT00882518|2580474|P2|NOT COMPLETED|Overall Study||44
1064097|NCT00882518|2580475|P1|NOT COMPLETED|Overall Study||38
1064098|NCT00882518|2580474|P2|COMPLETED|Overall Study||148
1064099|NCT00882518|2580475|P1|COMPLETED|Overall Study||158
1064100|NCT00882518|2580474|P2|STARTED|Overall Study||192
1064101|NCT00882518|2580475|P1|STARTED|Overall Study||196
1064112|NCT00882583|2580520|P2|NOT COMPLETED|Overall Study||1
1064113|NCT00882583|2580521|P1|NOT COMPLETED|Overall Study||1
1064114|NCT00882583|2580520|P2|COMPLETED|Overall Study||11
1064115|NCT00882583|2580521|P1|COMPLETED|Overall Study||6
1064116|NCT00882583|2580520|P2|STARTED|Overall Study||12
1064117|NCT00882583|2580521|P1|STARTED|Overall Study||7
1064118|NCT00882661|2580530|P2|NOT COMPLETED|Treatment||26
1064119|NCT00882661|2580531|P1|NOT COMPLETED|Treatment||10
1064120|NCT00882661|2580530|P2|COMPLETED|Treatment||114
1064121|NCT00882661|2580531|P1|COMPLETED|Treatment||141
1064122|NCT00882661|2580530|P2|STARTED|Treatment||140
1064123|NCT00882661|2580531|P1|STARTED|Treatment||151
1064124|NCT00882661|2580530|P2|NOT COMPLETED|Investigational Training||0
1064125|NCT00882661|2580531|P1|NOT COMPLETED|Investigational Training||10
1064126|NCT00882661|2580530|P2|COMPLETED|Investigational Training||0
1064127|NCT00882661|2580531|P1|COMPLETED|Investigational Training||79
1064128|NCT00882661|2580530|P2|STARTED|Investigational Training||0
1064129|NCT00882661|2580531|P1|STARTED|Investigational Training||89
1064130|NCT00882687|2580563|P4|NOT COMPLETED|Overall Study||2
1064131|NCT00882687|2580564|P3|NOT COMPLETED|Overall Study||3
1064132|NCT00882687|2580565|P2|NOT COMPLETED|Overall Study||2
1064133|NCT00882687|2580566|P1|NOT COMPLETED|Overall Study||2
1064134|NCT00882687|2580563|P4|COMPLETED|Overall Study||13
1064135|NCT00882687|2580564|P3|COMPLETED|Overall Study||12
1064136|NCT00882687|2580565|P2|COMPLETED|Overall Study||13
1064137|NCT00882687|2580566|P1|COMPLETED|Overall Study||13
1064138|NCT00882687|2580563|P4|STARTED|Overall Study||15
1064139|NCT00882687|2580564|P3|STARTED|Overall Study||15
1064140|NCT00882687|2580565|P2|STARTED|Overall Study||15
1064141|NCT00882687|2580566|P1|STARTED|Overall Study||15
1064142|NCT00882713|2580596|P1|NOT COMPLETED|Overall Study||22
1064143|NCT00882713|2580596|P1|COMPLETED|Overall Study||172
1064144|NCT00882713|2580596|P1|STARTED|Overall Study||194
1064145|NCT00882778|2580618|P1|NOT COMPLETED|Overall Study||0
1064146|NCT00882778|2580618|P1|COMPLETED|Overall Study||86
1064147|NCT00882778|2580618|P1|STARTED|Overall Study||86
1064148|NCT00882908|2580654|P5|NOT COMPLETED|Overall Study||6
1064149|NCT00882908|2580655|P4|NOT COMPLETED|Overall Study||7
1064150|NCT00882908|2580656|P3|NOT COMPLETED|Overall Study||7
1064151|NCT00882908|2580657|P2|NOT COMPLETED|Overall Study||6
1064152|NCT00882908|2580658|P1|NOT COMPLETED|Overall Study||3
1064153|NCT00882908|2580654|P5|COMPLETED|Overall Study||71
1064154|NCT00882908|2580655|P4|COMPLETED|Overall Study||72
1064155|NCT00882908|2580656|P3|COMPLETED|Overall Study||70
1064156|NCT00882908|2580657|P2|COMPLETED|Overall Study||69
1064157|NCT00882908|2580658|P1|COMPLETED|Overall Study||75
1064158|NCT00882908|2580654|P5|STARTED|Overall Study||77
1064159|NCT00882908|2580655|P4|STARTED|Overall Study||79
1064160|NCT00882908|2580656|P3|STARTED|Overall Study||77
1064161|NCT00882908|2580657|P2|STARTED|Overall Study||75
1064162|NCT00882908|2580658|P1|STARTED|Overall Study||78
1064163|NCT00882921|2580733|P1|NOT COMPLETED|Overall Study||11
1064164|NCT00882921|2580733|P1|COMPLETED|Overall Study||15
1064165|NCT00882921|2580733|P1|STARTED|Overall Study||26
1064166|NCT00883090|2580738|P1|NOT COMPLETED|Overall Study||2
1064167|NCT00883090|2580738|P1|COMPLETED|Overall Study||13
1064332|NCT00884039|2581278|P2|STARTED|Overall Study||2
1064168|NCT00883090|2580738|P1|STARTED|Overall Study|Of the 15 participants started, 14 were administered FXIII|15
1064169|NCT00883103|2580755|P2|NOT COMPLETED|Overall Study||0
1064170|NCT00883103|2580756|P1|NOT COMPLETED|Overall Study||0
1064171|NCT00883103|2580755|P2|COMPLETED|Overall Study||68
1064172|NCT00883103|2580756|P1|COMPLETED|Overall Study||69
1064173|NCT00883103|2580755|P2|STARTED|Overall Study||68
1064174|NCT00883103|2580756|P1|STARTED|Overall Study||69
1064175|NCT00883116|2580764|P2|NOT COMPLETED|Overall Study||219
1064176|NCT00883116|2580765|P1|NOT COMPLETED|Overall Study||209
1064177|NCT00883116|2580764|P2|COMPLETED|Overall Study||29
1064178|NCT00883116|2580765|P1|COMPLETED|Overall Study||39
1064179|NCT00883116|2580764|P2|Received Treatment|Overall Study||239
1064180|NCT00883116|2580765|P1|Received Treatment|Overall Study||248
1064181|NCT00883116|2580764|P2|STARTED|Overall Study||248
1064182|NCT00883116|2580765|P1|STARTED|Overall Study||248
1064183|NCT00883129|2580780|P2|NOT COMPLETED|Overall Study||36
1064184|NCT00883129|2580781|P1|NOT COMPLETED|Overall Study||20
1064185|NCT00883129|2580780|P2|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 16 of whom had prematurely withdrawn from drug treatment.|37
1064186|NCT00883129|2580781|P1|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 4 of whom had prematurely withdrawn from drug treatment.|49
1064187|NCT00883129|2580780|P2|STARTED|Overall Study||73
1064188|NCT00883129|2580781|P1|STARTED|Overall Study||69
1064189|NCT00883168|2580807|P4|NOT COMPLETED|Overall Study||15
1064190|NCT00883168|2580808|P3|NOT COMPLETED|Overall Study||19
1064191|NCT00883168|2580809|P2|NOT COMPLETED|Overall Study||15
1064192|NCT00883168|2580810|P1|NOT COMPLETED|Overall Study||14
1064193|NCT00883168|2580807|P4|COMPLETED|Overall Study||433
1064194|NCT00883168|2580808|P3|COMPLETED|Overall Study||431
1064195|NCT00883168|2580809|P2|COMPLETED|Overall Study||430
1064196|NCT00883168|2580810|P1|COMPLETED|Overall Study||434
1064197|NCT00883168|2580807|P4|STARTED|Overall Study||448
1064198|NCT00883168|2580808|P3|STARTED|Overall Study||450
1064199|NCT00883168|2580809|P2|STARTED|Overall Study||445
1064200|NCT00883168|2580810|P1|STARTED|Overall Study||448
1064201|NCT00883181|2580828|P1|NOT COMPLETED|Overall Study||278
1064202|NCT00883181|2580828|P1|COMPLETED|Overall Study|Completed planned chemotherapy|1069
1064203|NCT00883181|2580828|P1|STARTED|Overall Study|Full analysis set|1347
1064204|NCT00883233|2581041|P4|NOT COMPLETED|Overall Study||5
1064205|NCT00883233|2581042|P3|NOT COMPLETED|Overall Study||4
1064206|NCT00883233|2581043|P2|NOT COMPLETED|Overall Study||4
1064207|NCT00883233|2581044|P1|NOT COMPLETED|Overall Study||5
1064208|NCT00883233|2581041|P4|COMPLETED|Overall Study||25
1064209|NCT00883233|2581042|P3|COMPLETED|Overall Study||25
1064210|NCT00883233|2581043|P2|COMPLETED|Overall Study||28
1064211|NCT00883233|2581044|P1|COMPLETED|Overall Study||27
1064212|NCT00883233|2581041|P4|STARTED|Overall Study||30
1064213|NCT00883233|2581042|P3|STARTED|Overall Study||29
1064214|NCT00883233|2581043|P2|STARTED|Overall Study||32
1064215|NCT00883233|2581044|P1|STARTED|Overall Study||32
1064216|NCT00883246|2581054|P1|NOT COMPLETED|Overall Study||173
1064217|NCT00883246|2581054|P1|COMPLETED|Overall Study||626
1064218|NCT00883246|2581054|P1|STARTED|Overall Study||799
1064219|NCT00883337|2581075|P3|NOT COMPLETED|Extension Treatment Period||19
1064220|NCT00883337|2581076|P2|NOT COMPLETED|Extension Treatment Period||23
1064221|NCT00883337|2581077|P1|NOT COMPLETED|Extension Treatment Period||28
1064222|NCT00883337|2581075|P3|COMPLETED|Extension Treatment Period||40
1064223|NCT00883337|2581076|P2|COMPLETED|Extension Treatment Period||66
1064224|NCT00883337|2581077|P1|COMPLETED|Extension Treatment Period||61
1064225|NCT00883337|2581075|P3|STARTED|Extension Treatment Period|12 participants completed the core period but didn't enter the extension period.|59
1064226|NCT00883337|2581076|P2|STARTED|Extension Treatment Period||89
1064227|NCT00883337|2581077|P1|STARTED|Extension Treatment Period||89
1064228|NCT00883337|2581075|P3|NOT COMPLETED|Core Treatment Period||33
1064229|NCT00883337|2581076|P2|NOT COMPLETED|Core Treatment Period||22
1064230|NCT00883337|2581077|P1|NOT COMPLETED|Core Treatment Period||20
1064231|NCT00883337|2581075|P3|COMPLETED|Core Treatment Period||71
1064232|NCT00883337|2581076|P2|COMPLETED|Core Treatment Period||89
1064233|NCT00883337|2581077|P1|COMPLETED|Core Treatment Period||89
1064234|NCT00883337|2581075|P3|Treated|Core Treatment Period|3 participants refused treatment with Rebif®|101
1064235|NCT00883337|2581076|P2|Treated|Core Treatment Period|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|111
1064236|NCT00883337|2581077|P1|Treated|Core Treatment Period||109
1064237|NCT00883337|2581075|P3|STARTED|Core Treatment Period||104
1064238|NCT00883337|2581076|P2|STARTED|Core Treatment Period||111
1064239|NCT00883337|2581077|P1|STARTED|Core Treatment Period||109
1064240|NCT00883389|2581109|P1|NOT COMPLETED|Overall Study||0
1064241|NCT00883389|2581109|P1|COMPLETED|Overall Study||26
1064242|NCT00883389|2581109|P1|STARTED|Overall Study||26
1064243|NCT00883493|2581115|P2|NOT COMPLETED|Overall Study||50
1064244|NCT00883493|2581116|P1|NOT COMPLETED|Overall Study||46
1064245|NCT00883493|2581115|P2|COMPLETED|Overall Study||159
1064246|NCT00883493|2581116|P1|COMPLETED|Overall Study||166
1064247|NCT00883493|2581115|P2|Per Protocol Analysis Population|Overall Study||155
1064248|NCT00883493|2581116|P1|Per Protocol Analysis Population|Overall Study||162
1064249|NCT00883493|2581115|P2|Intention To Treat Analysis Population|Overall Study||195
1064250|NCT00883493|2581116|P1|Intention To Treat Analysis Population|Overall Study||204
1064251|NCT00883493|2581115|P2|STARTED|Overall Study||209
1064252|NCT00883493|2581116|P1|STARTED|Overall Study||212
1064253|NCT00883558|2581140|P3|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||1
1064254|NCT00883558|2581141|P2|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
1064255|NCT00883558|2581142|P1|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
1064256|NCT00883558|2581140|P3|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||22
1064257|NCT00883558|2581141|P2|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||19
1064258|NCT00883558|2581142|P1|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
1064259|NCT00883558|2581140|P3|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||23
1064260|NCT00883558|2581141|P2|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||19
1064261|NCT00883558|2581142|P1|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||0
1064262|NCT00883558|2581140|P3|STARTED|Second Treatment Cycle (Weeks 16 to 28)||23
1064263|NCT00883558|2581141|P2|STARTED|Second Treatment Cycle (Weeks 16 to 28)||19
1064264|NCT00883558|2581142|P1|STARTED|Second Treatment Cycle (Weeks 16 to 28)||0
1064265|NCT00883558|2581140|P3|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||1
1064266|NCT00883558|2581141|P2|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||3
1064267|NCT00883558|2581142|P1|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
1064268|NCT00883558|2581140|P3|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||23
1064269|NCT00883558|2581141|P2|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||19
1064270|NCT00883558|2581142|P1|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
1064271|NCT00883558|2581140|P3|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||24
1064272|NCT00883558|2581141|P2|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||22
1064273|NCT00883558|2581142|P1|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||0
1064274|NCT00883558|2581140|P3|STARTED|First Treatment Cycle (Weeks 4 to 16)||24
1064275|NCT00883558|2581141|P2|STARTED|First Treatment Cycle (Weeks 4 to 16)||22
1064276|NCT00883558|2581142|P1|STARTED|First Treatment Cycle (Weeks 4 to 16)||0
1064277|NCT00883558|2581140|P3|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
1064278|NCT00883558|2581141|P2|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
1064279|NCT00883558|2581142|P1|NOT COMPLETED|Titration Period (Weeks 0 to 4)||2
1064280|NCT00883558|2581140|P3|COMPLETED|Titration Period (Weeks 0 to 4)||0
1064281|NCT00883558|2581141|P2|COMPLETED|Titration Period (Weeks 0 to 4)||0
1064282|NCT00883558|2581142|P1|COMPLETED|Titration Period (Weeks 0 to 4)||46
1064283|NCT00883558|2581140|P3|STARTED|Titration Period (Weeks 0 to 4)||0
1064284|NCT00883558|2581141|P2|STARTED|Titration Period (Weeks 0 to 4)||0
1064285|NCT00883558|2581142|P1|STARTED|Titration Period (Weeks 0 to 4)||48
1064286|NCT00883675|2581152|P1|NOT COMPLETED|Overall Study||0
1064287|NCT00883675|2581152|P1|COMPLETED|Overall Study||133
1064288|NCT00883675|2581152|P1|STARTED|Overall Study||133
1064289|NCT00883740|2581156|P2|NOT COMPLETED|Second Intervention||1
1064290|NCT00883740|2581157|P1|NOT COMPLETED|Second Intervention||1
1064291|NCT00883740|2581156|P2|COMPLETED|Second Intervention||50
1064292|NCT00883740|2581157|P1|COMPLETED|Second Intervention||52
1064293|NCT00883740|2581156|P2|STARTED|Second Intervention||51
1064294|NCT00883740|2581157|P1|STARTED|Second Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
1064295|NCT00883740|2581156|P2|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
1064296|NCT00883740|2581157|P1|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
1064297|NCT00883740|2581156|P2|COMPLETED|Taper and Washout Period (2 Weeks)||51
1064298|NCT00883740|2581157|P1|COMPLETED|Taper and Washout Period (2 Weeks)||54
1064299|NCT00883740|2581156|P2|STARTED|Taper and Washout Period (2 Weeks)||51
1064300|NCT00883740|2581157|P1|STARTED|Taper and Washout Period (2 Weeks)|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|54
1064301|NCT00883740|2581156|P2|NOT COMPLETED|First Intervention||8
1064302|NCT00883740|2581157|P1|NOT COMPLETED|First Intervention||7
1064303|NCT00883740|2581156|P2|COMPLETED|First Intervention||51
1064304|NCT00883740|2581157|P1|COMPLETED|First Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
1064305|NCT00883740|2581156|P2|STARTED|First Intervention||59
1064306|NCT00883740|2581157|P1|STARTED|First Intervention||60
1064307|NCT00883753|2581197|P1|NOT COMPLETED|Overall Study||107
1064308|NCT00883753|2581197|P1|COMPLETED|Overall Study||827
1064309|NCT00883753|2581197|P1|STARTED|Overall Study||934
1064310|NCT00883779|2581239|P2|NOT COMPLETED|Off-study Phase||202
1064311|NCT00883779|2581240|P1|NOT COMPLETED|Off-study Phase||209
1064312|NCT00883779|2581239|P2|COMPLETED|Off-study Phase||0
1064313|NCT00883779|2581240|P1|COMPLETED|Off-study Phase||0
1064314|NCT00883779|2581239|P2|STARTED|Off-study Phase||202
1064315|NCT00883779|2581240|P1|STARTED|Off-study Phase||209
1064316|NCT00883779|2581239|P2|NOT COMPLETED|Post-Study Treatment Phase||135
1064317|NCT00883779|2581240|P1|NOT COMPLETED|Post-Study Treatment Phase||112
1064318|NCT00883779|2581239|P2|COMPLETED|Post-Study Treatment Phase||0
1064319|NCT00883779|2581240|P1|COMPLETED|Post-Study Treatment Phase||0
1064320|NCT00883779|2581239|P2|STARTED|Post-Study Treatment Phase||135
1064321|NCT00883779|2581240|P1|STARTED|Post-Study Treatment Phase||112
1064322|NCT00883779|2581239|P2|NOT COMPLETED|Primary Study Treatment Phase||86
1064323|NCT00883779|2581240|P1|NOT COMPLETED|Primary Study Treatment Phase||105
1064324|NCT00883779|2581239|P2|COMPLETED|Primary Study Treatment Phase||140
1064325|NCT00883779|2581240|P1|COMPLETED|Primary Study Treatment Phase||120
1064326|NCT00883779|2581239|P2|STARTED|Primary Study Treatment Phase||226
1064327|NCT00883779|2581240|P1|STARTED|Primary Study Treatment Phase||225
1064328|NCT00884039|2581278|P2|NOT COMPLETED|Overall Study||1
1064329|NCT00884039|2581279|P1|NOT COMPLETED|Overall Study||2
1064330|NCT00884039|2581278|P2|COMPLETED|Overall Study||1
1064331|NCT00884039|2581279|P1|COMPLETED|Overall Study||3
1064333|NCT00884039|2581279|P1|STARTED|Overall Study||5
1064334|NCT00884065|2581287|P2|NOT COMPLETED|Overall Study||0
1064335|NCT00884065|2581288|P1|NOT COMPLETED|Overall Study||0
1064336|NCT00884065|2581287|P2|COMPLETED|Overall Study||25
1064337|NCT00884065|2581288|P1|COMPLETED|Overall Study||25
1064338|NCT00884065|2581287|P2|STARTED|Overall Study||25
1064339|NCT00884065|2581288|P1|STARTED|Overall Study||25
1064340|NCT00884117|2581304|P1|NOT COMPLETED|Overall Study||249
1064341|NCT00884117|2581304|P1|COMPLETED|Overall Study|Defined as Day 6 visit for those enrolled before Amendment D; thereafter defined as Day 10 visit.|4312
1064342|NCT00884117|2581304|P1|STARTED|Overall Study||4561
1064343|NCT00884221|2581348|P2|NOT COMPLETED|Overall Study||32
1064344|NCT00884221|2581349|P1|NOT COMPLETED|Overall Study||34
1064345|NCT00884221|2581348|P2|COMPLETED|Overall Study||343
1064346|NCT00884221|2581349|P1|COMPLETED|Overall Study||340
1064347|NCT00884221|2581348|P2|STARTED|Overall Study||375
1064348|NCT00884221|2581349|P1|STARTED|Overall Study||374
1064349|NCT00884273|2581387|P2|NOT COMPLETED|Overall Study||5
1064350|NCT00884273|2581388|P1|NOT COMPLETED|Overall Study||2
1064351|NCT00884273|2581387|P2|COMPLETED|Overall Study||93
1064352|NCT00884273|2581388|P1|COMPLETED|Overall Study||82
1064353|NCT00884273|2581387|P2|Safety Analysis Set|Overall Study||98
1064354|NCT00884273|2581388|P1|Safety Analysis Set|Overall Study||84
1064355|NCT00884273|2581387|P2|Per Protocol (PP) Analysis Set|Overall Study||92
1064356|NCT00884273|2581388|P1|Per Protocol (PP) Analysis Set|Overall Study||81
1064357|NCT00884273|2581387|P2|Full Analysis Set (FAS)|Overall Study|One participant did not have any post-dose efficacy assessment and was excluded from the FAS.|97
1064358|NCT00884273|2581388|P1|Full Analysis Set (FAS)|Overall Study|Two participants did not have any post-dose efficacy assessment and were excluded from the FAS.|82
1064359|NCT00884273|2581387|P2|STARTED|Overall Study|ITT population.|98
1064360|NCT00884273|2581388|P1|STARTED|Overall Study|Intention-to-treat (ITT) population.|84
1064361|NCT00884325|2581414|P2|NOT COMPLETED|Overall Study||4
1064362|NCT00884325|2581415|P1|NOT COMPLETED|Overall Study||3
1064363|NCT00884325|2581414|P2|COMPLETED|Overall Study||16
1064364|NCT00884325|2581415|P1|COMPLETED|Overall Study||17
1064365|NCT00884325|2581414|P2|STARTED|Overall Study||20
1064366|NCT00884325|2581415|P1|STARTED|Overall Study||20
1064367|NCT00884377|2581425|P2|NOT COMPLETED|Overall Study||1
1064368|NCT00884377|2581426|P1|NOT COMPLETED|Overall Study||2
1064369|NCT00884377|2581425|P2|COMPLETED|Overall Study||27
1064370|NCT00884377|2581426|P1|COMPLETED|Overall Study|1 received full course of therapy,withdrew consent before completion of the 12 month follow up|26
1064371|NCT00884377|2581425|P2|STARTED|Overall Study|1 was not treated due to concerns arising from the location of cutaneous leishmaniasis lesion|28
1064372|NCT00884377|2581426|P1|STARTED|Overall Study|1 not treated because infecting parasite could not be confirmed as L. major on rapid PCR testing,|28
1064373|NCT00884390|2581448|P2|NOT COMPLETED|Overall Study||8
1064374|NCT00884390|2581449|P1|NOT COMPLETED|Overall Study||23
1064375|NCT00884390|2581448|P2|COMPLETED|Overall Study||54
1064376|NCT00884390|2581449|P1|COMPLETED|Overall Study||123
1064377|NCT00884390|2581448|P2|STARTED|Overall Study||62
1064378|NCT00884390|2581449|P1|STARTED|Overall Study||146
1064379|NCT00873327|2581465|P1|NOT COMPLETED|Overall Study||0
1064380|NCT00873327|2581465|P1|COMPLETED|Overall Study||32
1064381|NCT00873327|2581465|P1|STARTED|Overall Study||32
1064382|NCT00873457|2581469|P1|NOT COMPLETED|Overall Study||0
1064383|NCT00873457|2581469|P1|COMPLETED|Overall Study||16
1064384|NCT00873457|2581469|P1|STARTED|Overall Study||16
1064385|NCT00873730|2581478|P2|NOT COMPLETED|Overall Study||5
1064386|NCT00873730|2581479|P1|NOT COMPLETED|Overall Study||6
1064387|NCT00873730|2581478|P2|COMPLETED|Overall Study||49
1064388|NCT00873730|2581479|P1|COMPLETED|Overall Study||48
1064389|NCT00873730|2581478|P2|STARTED|Overall Study||54
1064390|NCT00873730|2581479|P1|STARTED|Overall Study||54
1064391|NCT00873782|2581515|P1|NOT COMPLETED|Overall Study||0
1064392|NCT00873782|2581515|P1|COMPLETED|Overall Study||16
1064393|NCT00873782|2581515|P1|STARTED|Overall Study||16
1064394|NCT00873821|2581521|P2|NOT COMPLETED|Overall Study||0
1064395|NCT00873821|2581522|P1|NOT COMPLETED|Overall Study||0
1064396|NCT00873821|2581521|P2|COMPLETED|Overall Study||22
1064397|NCT00873821|2581522|P1|COMPLETED|Overall Study||22
1064398|NCT00873821|2581521|P2|STARTED|Overall Study||22
1064399|NCT00873821|2581522|P1|STARTED|Overall Study||22
1064400|NCT00873860|2581536|P4|NOT COMPLETED|Overall Study||1
1064401|NCT00873860|2581537|P3|NOT COMPLETED|Overall Study||3
1064402|NCT00873860|2581538|P2|NOT COMPLETED|Overall Study||0
1064403|NCT00873860|2581539|P1|NOT COMPLETED|Overall Study||4
1064404|NCT00873860|2581536|P4|COMPLETED|Overall Study||47
1064405|NCT00873860|2581537|P3|COMPLETED|Overall Study||48
1064406|NCT00873860|2581538|P2|COMPLETED|Overall Study||47
1064407|NCT00873860|2581539|P1|COMPLETED|Overall Study||44
1064408|NCT00873860|2581536|P4|Treated|Overall Study||48
1064409|NCT00873860|2581537|P3|Treated|Overall Study||51
1064410|NCT00873860|2581538|P2|Treated|Overall Study||47
1064411|NCT00873860|2581539|P1|Treated|Overall Study||47
1064412|NCT00873860|2581536|P4|STARTED|Overall Study||48
1064413|NCT00873860|2581537|P3|STARTED|Overall Study||51
1064414|NCT00873860|2581538|P2|STARTED|Overall Study||47
1064415|NCT00873860|2581539|P1|STARTED|Overall Study||48
1064416|NCT00873873|2581612|P4|NOT COMPLETED|Overall Study||0
1064417|NCT00873873|2581613|P3|NOT COMPLETED|Overall Study||0
1064418|NCT00873873|2581614|P2|NOT COMPLETED|Overall Study||0
1064419|NCT00873873|2581615|P1|NOT COMPLETED|Overall Study||0
1064420|NCT00873873|2581612|P4|COMPLETED|Overall Study||18
1064421|NCT00873873|2581613|P3|COMPLETED|Overall Study||9
1064422|NCT00873873|2581614|P2|COMPLETED|Overall Study||8
1064423|NCT00873873|2581615|P1|COMPLETED|Overall Study||20
1064424|NCT00873873|2581612|P4|STARTED|Overall Study||18
1064425|NCT00873873|2581613|P3|STARTED|Overall Study||9
1064426|NCT00873873|2581614|P2|STARTED|Overall Study||8
1064427|NCT00873873|2581615|P1|STARTED|Overall Study||20
1064428|NCT00873912|2581631|P2|NOT COMPLETED|Overall Study||0
1064429|NCT00873912|2581632|P1|NOT COMPLETED|Overall Study||3
1064430|NCT00873912|2581631|P2|COMPLETED|Overall Study||60
1064431|NCT00873912|2581632|P1|COMPLETED|Overall Study||237
1064432|NCT00873912|2581631|P2|STARTED|Overall Study||60
1064433|NCT00873912|2581632|P1|STARTED|Overall Study||240
1064434|NCT00874029|2581646|P1|NOT COMPLETED|Overall Study||21
1064435|NCT00874029|2581646|P1|COMPLETED|Overall Study||116
1064436|NCT00874029|2581646|P1|STARTED|Overall Study||137
1064437|NCT00874094|2581660|P1|NOT COMPLETED|Overall Study||0
1064438|NCT00874094|2581660|P1|COMPLETED|Overall Study||15
1064439|NCT00874094|2581660|P1|STARTED|Overall Study||15
1064458|NCT00874250|2581676|P1|NOT COMPLETED|Overall Study||51
1064459|NCT00874250|2581676|P1|COMPLETED|Overall Study||0
1064460|NCT00874250|2581676|P1|STARTED|Overall Study||51
1064461|NCT00874276|2581690|P2|NOT COMPLETED|Overall Study||1
1064462|NCT00874276|2581691|P1|NOT COMPLETED|Overall Study||1
1064463|NCT00874276|2581690|P2|COMPLETED|Overall Study||7
1064464|NCT00874276|2581691|P1|COMPLETED|Overall Study||5
1064465|NCT00874276|2581690|P2|STARTED|Overall Study||8
1064466|NCT00874276|2581691|P1|STARTED|Overall Study||6
1064467|NCT00874497|2581701|P2|NOT COMPLETED|Overall Study||18
1064468|NCT00874497|2581702|P1|NOT COMPLETED|Overall Study||28
1064469|NCT00874497|2581701|P2|COMPLETED|Overall Study||15
1064470|NCT00874497|2581702|P1|COMPLETED|Overall Study||23
1064471|NCT00874497|2581701|P2|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|33
1064472|NCT00874497|2581702|P1|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|51
1064473|NCT00874510|2581742|P2|NOT COMPLETED|Year 2||0
1064474|NCT00874510|2581743|P1|NOT COMPLETED|Year 2||0
1064475|NCT00874510|2581742|P2|COMPLETED|Year 2||87
1064476|NCT00874510|2581743|P1|COMPLETED|Year 2||92
1064477|NCT00874510|2581742|P2|STARTED|Year 2||87
1064478|NCT00874510|2581743|P1|STARTED|Year 2||92
1064479|NCT00874510|2581742|P2|NOT COMPLETED|Year 1||0
1064480|NCT00874510|2581743|P1|NOT COMPLETED|Year 1||0
1064481|NCT00874510|2581742|P2|COMPLETED|Year 1||85
1064482|NCT00874510|2581743|P1|COMPLETED|Year 1||88
1064483|NCT00874510|2581742|P2|STARTED|Year 1||85
1064484|NCT00874510|2581743|P1|STARTED|Year 1||88
1064485|NCT00874549|2581753|P4|NOT COMPLETED|Overall Study||2
1064486|NCT00874549|2581754|P3|NOT COMPLETED|Overall Study||4
1064487|NCT00874549|2581755|P2|NOT COMPLETED|Overall Study||1
1064488|NCT00874549|2581756|P1|NOT COMPLETED|Overall Study||1
1064489|NCT00874549|2581753|P4|COMPLETED|Overall Study||56
1064490|NCT00874549|2581754|P3|COMPLETED|Overall Study||47
1064491|NCT00874549|2581755|P2|COMPLETED|Overall Study||55
1064492|NCT00874549|2581756|P1|COMPLETED|Overall Study||50
1064493|NCT00874549|2581753|P4|STARTED|Overall Study||58
1064494|NCT00874549|2581754|P3|STARTED|Overall Study||51
1064495|NCT00874549|2581755|P2|STARTED|Overall Study||56
1064496|NCT00874549|2581756|P1|STARTED|Overall Study||51
1064497|NCT00874770|2581826|P4|NOT COMPLETED|Overall Study||5
1064498|NCT00874770|2581827|P3|NOT COMPLETED|Overall Study||4
1064499|NCT00874770|2581828|P2|NOT COMPLETED|Overall Study||1
1064500|NCT00874770|2581829|P1|NOT COMPLETED|Overall Study||5
1064501|NCT00874770|2581826|P4|COMPLETED|Overall Study||7
1064502|NCT00874770|2581827|P3|COMPLETED|Overall Study||8
1064503|NCT00874770|2581828|P2|COMPLETED|Overall Study||11
1064504|NCT00874770|2581829|P1|COMPLETED|Overall Study||7
1064505|NCT00874770|2581826|P4|STARTED|Overall Study||12
1064506|NCT00874770|2581827|P3|STARTED|Overall Study||12
1064507|NCT00874770|2581828|P2|STARTED|Overall Study||12
1064508|NCT00874770|2581829|P1|STARTED|Overall Study||12
1064509|NCT00874822|2581863|P1|NOT COMPLETED|Overall Study||8
1064510|NCT00874822|2581863|P1|COMPLETED|Overall Study||208
1064511|NCT00874822|2581863|P1|STARTED|Overall Study||216
1064512|NCT00874848|2581869|P2|NOT COMPLETED|Overall Study||28
1064513|NCT00874848|2581870|P1|NOT COMPLETED|Overall Study||59
1064608|NCT00875017|2581923|P6|COMPLETED|Second Intervention||5
1064514|NCT00874848|2581869|P2|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|1
1064515|NCT00874848|2581870|P1|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|0
1064516|NCT00874848|2581869|P2|Discontinued|Overall Study||28
1064517|NCT00874848|2581870|P1|Discontinued|Overall Study||59
1064518|NCT00874848|2581869|P2|STARTED|Overall Study||29
1064519|NCT00874848|2581870|P1|STARTED|Overall Study||59
1064520|NCT00874887|2581888|P2|NOT COMPLETED|Overall Study||0
1064521|NCT00874887|2581889|P1|NOT COMPLETED|Overall Study||0
1064522|NCT00874887|2581888|P2|COMPLETED|Overall Study||34
1064523|NCT00874887|2581889|P1|COMPLETED|Overall Study||32
1064524|NCT00874887|2581888|P2|STARTED|Overall Study||34
1064525|NCT00874887|2581889|P1|STARTED|Overall Study||32
1064526|NCT00874939|2581903|P1|NOT COMPLETED|Overall Study||4
1064527|NCT00874939|2581903|P1|COMPLETED|Overall Study||0
1064528|NCT00874939|2581903|P1|Treated|Overall Study||0
1064529|NCT00874939|2581903|P1|STARTED|Overall Study||4
1064530|NCT00875017|2581923|P6|NOT COMPLETED|Fourth Intervention||1
1064531|NCT00875017|2581924|P5|NOT COMPLETED|Fourth Intervention||0
1064532|NCT00875017|2581925|P4|NOT COMPLETED|Fourth Intervention||0
1064533|NCT00875017|2581926|P3|NOT COMPLETED|Fourth Intervention||0
1064534|NCT00875017|2581927|P2|NOT COMPLETED|Fourth Intervention||0
1064535|NCT00875017|2581928|P1|NOT COMPLETED|Fourth Intervention||0
1064536|NCT00875017|2581923|P6|COMPLETED|Fourth Intervention||4
1064537|NCT00875017|2581924|P5|COMPLETED|Fourth Intervention||3
1064538|NCT00875017|2581925|P4|COMPLETED|Fourth Intervention||4
1064539|NCT00875017|2581926|P3|COMPLETED|Fourth Intervention||2
1064540|NCT00875017|2581927|P2|COMPLETED|Fourth Intervention||3
1064541|NCT00875017|2581928|P1|COMPLETED|Fourth Intervention||3
1064542|NCT00875017|2581923|P6|STARTED|Fourth Intervention||5
1064543|NCT00875017|2581924|P5|STARTED|Fourth Intervention||3
1064544|NCT00875017|2581925|P4|STARTED|Fourth Intervention||4
1064545|NCT00875017|2581926|P3|STARTED|Fourth Intervention||2
1064546|NCT00875017|2581927|P2|STARTED|Fourth Intervention||3
1064547|NCT00875017|2581928|P1|STARTED|Fourth Intervention||3
1064548|NCT00875017|2581923|P6|NOT COMPLETED|Washout||0
1064549|NCT00875017|2581924|P5|NOT COMPLETED|Washout||1
1064550|NCT00875017|2581925|P4|NOT COMPLETED|Washout||0
1064551|NCT00875017|2581926|P3|NOT COMPLETED|Washout||0
1064552|NCT00875017|2581927|P2|NOT COMPLETED|Washout||0
1064553|NCT00875017|2581928|P1|NOT COMPLETED|Washout||0
1064554|NCT00875017|2581923|P6|COMPLETED|Washout||5
1064555|NCT00875017|2581924|P5|COMPLETED|Washout||3
1064556|NCT00875017|2581925|P4|COMPLETED|Washout||4
1064557|NCT00875017|2581926|P3|COMPLETED|Washout||2
1064558|NCT00875017|2581927|P2|COMPLETED|Washout||3
1064559|NCT00875017|2581928|P1|COMPLETED|Washout||3
1064560|NCT00875017|2581923|P6|STARTED|Washout||5
1064561|NCT00875017|2581924|P5|STARTED|Washout||4
1064562|NCT00875017|2581925|P4|STARTED|Washout||4
1064563|NCT00875017|2581926|P3|STARTED|Washout||2
1064564|NCT00875017|2581927|P2|STARTED|Washout||3
1064565|NCT00875017|2581928|P1|STARTED|Washout||3
1064566|NCT00875017|2581923|P6|NOT COMPLETED|Third Intervention||0
1064567|NCT00875017|2581924|P5|NOT COMPLETED|Third Intervention||0
1064568|NCT00875017|2581925|P4|NOT COMPLETED|Third Intervention||0
1064569|NCT00875017|2581926|P3|NOT COMPLETED|Third Intervention||1
1064570|NCT00875017|2581927|P2|NOT COMPLETED|Third Intervention||1
1064571|NCT00875017|2581928|P1|NOT COMPLETED|Third Intervention||0
1064572|NCT00875017|2581923|P6|COMPLETED|Third Intervention||5
1064573|NCT00875017|2581924|P5|COMPLETED|Third Intervention||4
1064574|NCT00875017|2581925|P4|COMPLETED|Third Intervention||4
1064575|NCT00875017|2581926|P3|COMPLETED|Third Intervention||2
1064576|NCT00875017|2581927|P2|COMPLETED|Third Intervention||3
1064577|NCT00875017|2581928|P1|COMPLETED|Third Intervention||3
1064578|NCT00875017|2581923|P6|STARTED|Third Intervention||5
1064579|NCT00875017|2581924|P5|STARTED|Third Intervention||4
1064580|NCT00875017|2581925|P4|STARTED|Third Intervention||4
1064581|NCT00875017|2581926|P3|STARTED|Third Intervention||3
1064582|NCT00875017|2581927|P2|STARTED|Third Intervention||4
1064583|NCT00875017|2581928|P1|STARTED|Third Intervention||3
1064584|NCT00875017|2581923|P6|NOT COMPLETED|Washout||0
1064585|NCT00875017|2581924|P5|NOT COMPLETED|Washout||0
1064586|NCT00875017|2581925|P4|NOT COMPLETED|Washout||0
1064587|NCT00875017|2581926|P3|NOT COMPLETED|Washout||0
1064588|NCT00875017|2581927|P2|NOT COMPLETED|Washout||1
1064589|NCT00875017|2581928|P1|NOT COMPLETED|Washout||0
1064590|NCT00875017|2581923|P6|COMPLETED|Washout||5
1064591|NCT00875017|2581924|P5|COMPLETED|Washout||4
1064592|NCT00875017|2581925|P4|COMPLETED|Washout||4
1064593|NCT00875017|2581926|P3|COMPLETED|Washout||3
1064594|NCT00875017|2581927|P2|COMPLETED|Washout||4
1064595|NCT00875017|2581928|P1|COMPLETED|Washout||3
1064596|NCT00875017|2581923|P6|STARTED|Washout||5
1064597|NCT00875017|2581924|P5|STARTED|Washout||4
1064598|NCT00875017|2581925|P4|STARTED|Washout||4
1064599|NCT00875017|2581926|P3|STARTED|Washout||3
1064600|NCT00875017|2581927|P2|STARTED|Washout||5
1064601|NCT00875017|2581928|P1|STARTED|Washout||3
1064602|NCT00875017|2581923|P6|NOT COMPLETED|Second Intervention||0
1064603|NCT00875017|2581924|P5|NOT COMPLETED|Second Intervention||0
1064604|NCT00875017|2581925|P4|NOT COMPLETED|Second Intervention||1
1064605|NCT00875017|2581926|P3|NOT COMPLETED|Second Intervention||0
1064606|NCT00875017|2581927|P2|NOT COMPLETED|Second Intervention||0
1064607|NCT00875017|2581928|P1|NOT COMPLETED|Second Intervention||0
1064609|NCT00875017|2581924|P5|COMPLETED|Second Intervention||4
1064610|NCT00875017|2581925|P4|COMPLETED|Second Intervention||4
1064611|NCT00875017|2581926|P3|COMPLETED|Second Intervention||3
1064612|NCT00875017|2581927|P2|COMPLETED|Second Intervention||5
1064613|NCT00875017|2581928|P1|COMPLETED|Second Intervention||3
1064614|NCT00875017|2581923|P6|STARTED|Second Intervention||5
1064615|NCT00875017|2581924|P5|STARTED|Second Intervention||4
1064616|NCT00875017|2581925|P4|STARTED|Second Intervention||5
1064617|NCT00875017|2581926|P3|STARTED|Second Intervention||3
1064618|NCT00875017|2581927|P2|STARTED|Second Intervention||5
1064619|NCT00875017|2581928|P1|STARTED|Second Intervention||3
1064620|NCT00875017|2581923|P6|NOT COMPLETED|Washout||0
1064621|NCT00875017|2581924|P5|NOT COMPLETED|Washout||0
1064622|NCT00875017|2581925|P4|NOT COMPLETED|Washout||0
1064623|NCT00875017|2581926|P3|NOT COMPLETED|Washout||1
1064624|NCT00875017|2581927|P2|NOT COMPLETED|Washout||0
1064625|NCT00875017|2581928|P1|NOT COMPLETED|Washout||0
1064626|NCT00875017|2581923|P6|COMPLETED|Washout||5
1064627|NCT00875017|2581924|P5|COMPLETED|Washout||4
1064628|NCT00875017|2581925|P4|COMPLETED|Washout||5
1064629|NCT00875017|2581926|P3|COMPLETED|Washout||3
1064630|NCT00875017|2581927|P2|COMPLETED|Washout||5
1064631|NCT00875017|2581928|P1|COMPLETED|Washout||3
1064632|NCT00875017|2581923|P6|STARTED|Washout||5
1064633|NCT00875017|2581924|P5|STARTED|Washout||4
1064634|NCT00875017|2581925|P4|STARTED|Washout||5
1064635|NCT00875017|2581926|P3|STARTED|Washout||4
1064636|NCT00875017|2581927|P2|STARTED|Washout||5
1064637|NCT00875017|2581928|P1|STARTED|Washout||3
1064638|NCT00875017|2581923|P6|NOT COMPLETED|First Intervention||0
1064639|NCT00875017|2581924|P5|NOT COMPLETED|First Intervention||1
1064640|NCT00875017|2581925|P4|NOT COMPLETED|First Intervention||1
1064641|NCT00875017|2581926|P3|NOT COMPLETED|First Intervention||1
1064642|NCT00875017|2581927|P2|NOT COMPLETED|First Intervention||0
1064643|NCT00875017|2581928|P1|NOT COMPLETED|First Intervention||2
1064644|NCT00875017|2581923|P6|COMPLETED|First Intervention||5
1064645|NCT00875017|2581924|P5|COMPLETED|First Intervention||4
1064646|NCT00875017|2581925|P4|COMPLETED|First Intervention||5
1064647|NCT00875017|2581926|P3|COMPLETED|First Intervention||4
1064648|NCT00875017|2581927|P2|COMPLETED|First Intervention||5
1064649|NCT00875017|2581928|P1|COMPLETED|First Intervention||3
1064650|NCT00875017|2581923|P6|STARTED|First Intervention||5
1064651|NCT00875017|2581924|P5|STARTED|First Intervention||5
1064652|NCT00875017|2581925|P4|STARTED|First Intervention||6
1064653|NCT00875017|2581926|P3|STARTED|First Intervention||5
1064654|NCT00875017|2581927|P2|STARTED|First Intervention||5
1064655|NCT00875017|2581928|P1|STARTED|First Intervention||5
1064656|NCT00875212|2581942|P1|NOT COMPLETED|CaGP and Fluoride Dentifrice||0
1064657|NCT00875212|2581942|P1|COMPLETED|CaGP and Fluoride Dentifrice||12
1064658|NCT00875212|2581942|P1|STARTED|CaGP and Fluoride Dentifrice||12
1064659|NCT00875212|2581942|P1|NOT COMPLETED|Fluoride Only Dentifrice||0
1064660|NCT00875212|2581942|P1|COMPLETED|Fluoride Only Dentifrice||12
1064661|NCT00875212|2581942|P1|STARTED|Fluoride Only Dentifrice||12
1064662|NCT00875212|2581942|P1|NOT COMPLETED|CaGP Only Dentifrice||0
1064663|NCT00875212|2581942|P1|COMPLETED|CaGP Only Dentifrice||12
1064664|NCT00875212|2581942|P1|STARTED|CaGP Only Dentifrice||12
1064665|NCT00875212|2581942|P1|NOT COMPLETED|Placebo Dentifrice||0
1064666|NCT00875212|2581942|P1|COMPLETED|Placebo Dentifrice|all participants completed this group|12
1064667|NCT00875212|2581942|P1|STARTED|Placebo Dentifrice||12
1064668|NCT00875329|2581953|P1|NOT COMPLETED|Overall Study||0
1064669|NCT00875329|2581953|P1|COMPLETED|Overall Study||97
1064670|NCT00875329|2581953|P1|STARTED|Overall Study||97
1064671|NCT00875394|2581960|P3|NOT COMPLETED|Overall Study||0
1064672|NCT00875394|2581961|P2|NOT COMPLETED|Overall Study||0
1064673|NCT00875394|2581962|P1|NOT COMPLETED|Overall Study||0
1064674|NCT00875394|2581960|P3|COMPLETED|Overall Study||9
1064675|NCT00875394|2581961|P2|COMPLETED|Overall Study||23
1064676|NCT00875394|2581962|P1|COMPLETED|Overall Study||36
1064677|NCT00875394|2581960|P3|STARTED|Overall Study||9
1064678|NCT00875394|2581961|P2|STARTED|Overall Study||23
1064679|NCT00875394|2581962|P1|STARTED|Overall Study||36
1064680|NCT00875420|2581975|P5|NOT COMPLETED|Overall Study||2
1064681|NCT00875420|2581976|P4|NOT COMPLETED|Overall Study||2
1064682|NCT00875420|2581977|P3|NOT COMPLETED|Overall Study||3
1064683|NCT00875420|2581978|P2|NOT COMPLETED|Overall Study||2
1064684|NCT00875420|2581979|P1|NOT COMPLETED|Overall Study||2
1064685|NCT00875420|2581975|P5|COMPLETED|Overall Study||17
1064686|NCT00875420|2581976|P4|COMPLETED|Overall Study||16
1064687|NCT00875420|2581977|P3|COMPLETED|Overall Study||18
1064688|NCT00875420|2581978|P2|COMPLETED|Overall Study||18
1064689|NCT00875420|2581979|P1|COMPLETED|Overall Study||20
1064690|NCT00875420|2581975|P5|STARTED|Overall Study||19
1064691|NCT00875420|2581976|P4|STARTED|Overall Study||18
1064692|NCT00875420|2581977|P3|STARTED|Overall Study||21
1064693|NCT00875420|2581978|P2|STARTED|Overall Study||20
1064694|NCT00875420|2581979|P1|STARTED|Overall Study||22
1064695|NCT00875433|2582006|P1|NOT COMPLETED|Overall Study||60
1064696|NCT00875433|2582006|P1|COMPLETED|Overall Study||0
1064697|NCT00875433|2582006|P1|STARTED|Overall Study|Treated|60
1064698|NCT00875485|2582033|P2|NOT COMPLETED|Challenge Dose Epoch||0
1064699|NCT00875485|2582034|P1|NOT COMPLETED|Challenge Dose Epoch||1
1064700|NCT00875485|2582033|P2|COMPLETED|Challenge Dose Epoch||11
1064701|NCT00875485|2582034|P1|COMPLETED|Challenge Dose Epoch||7
1064702|NCT00875485|2582033|P2|STARTED|Challenge Dose Epoch||11
1064703|NCT00875485|2582034|P1|STARTED|Challenge Dose Epoch||8
1064704|NCT00875485|2582033|P2|NOT COMPLETED|Year 15||0
1064705|NCT00875485|2582034|P1|NOT COMPLETED|Year 15||0
1064706|NCT00875485|2582033|P2|COMPLETED|Year 15||111
1064707|NCT00875485|2582034|P1|COMPLETED|Year 15||98
1064708|NCT00875485|2582033|P2|STARTED|Year 15||111
1064709|NCT00875485|2582034|P1|STARTED|Year 15||98
1064710|NCT00875485|2582033|P2|NOT COMPLETED|Year 14||0
1064711|NCT00875485|2582034|P1|NOT COMPLETED|Year 14||0
1064712|NCT00875485|2582033|P2|COMPLETED|Year 14||113
1064713|NCT00875485|2582034|P1|COMPLETED|Year 14||100
1064714|NCT00875485|2582033|P2|STARTED|Year 14||113
1064715|NCT00875485|2582034|P1|STARTED|Year 14||100
1064716|NCT00875485|2582033|P2|NOT COMPLETED|Year 13||0
1064717|NCT00875485|2582034|P1|NOT COMPLETED|Year 13||0
1064718|NCT00875485|2582033|P2|COMPLETED|Year 13||113
1064719|NCT00875485|2582034|P1|COMPLETED|Year 13||102
1064720|NCT00875485|2582033|P2|STARTED|Year 13||113
1064721|NCT00875485|2582034|P1|STARTED|Year 13||102
1064722|NCT00875485|2582033|P2|NOT COMPLETED|Year 12||0
1064723|NCT00875485|2582034|P1|NOT COMPLETED|Year 12||0
1064724|NCT00875485|2582033|P2|COMPLETED|Year 12||109
1064725|NCT00875485|2582034|P1|COMPLETED|Year 12||101
1064726|NCT00875485|2582033|P2|STARTED|Year 12||109
1064727|NCT00875485|2582034|P1|STARTED|Year 12||101
1064728|NCT00875485|2582033|P2|NOT COMPLETED|Year 11||0
1064729|NCT00875485|2582034|P1|NOT COMPLETED|Year 11||0
1064730|NCT00875485|2582033|P2|COMPLETED|Year 11||111
1064731|NCT00875485|2582034|P1|COMPLETED|Year 11||99
1064732|NCT00875485|2582033|P2|STARTED|Year 11||111
1064733|NCT00875485|2582034|P1|STARTED|Year 11||99
1064734|NCT00884585|2582076|P2|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||0
1064735|NCT00884585|2582077|P1|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||3
1064736|NCT00884585|2582076|P2|COMPLETED|Open-Label Maintenance (Months 9-12)||0
1064737|NCT00884585|2582077|P1|COMPLETED|Open-Label Maintenance (Months 9-12)||144
1064738|NCT00884585|2582076|P2|STARTED|Open-Label Maintenance (Months 9-12)||0
1064739|NCT00884585|2582077|P1|STARTED|Open-Label Maintenance (Months 9-12)||147
1064740|NCT00884585|2582076|P2|NOT COMPLETED|Open-Label Phase (Months 3-9)||0
1064741|NCT00884585|2582077|P1|NOT COMPLETED|Open-Label Phase (Months 3-9)||15
1064742|NCT00884585|2582076|P2|COMPLETED|Open-Label Phase (Months 3-9)||0
1064743|NCT00884585|2582077|P1|COMPLETED|Open-Label Phase (Months 3-9)||147
1064744|NCT00884585|2582076|P2|STARTED|Open-Label Phase (Months 3-9)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|0
1064745|NCT00884585|2582077|P1|STARTED|Open-Label Phase (Months 3-9)|All patients who completed the double-masked phase received COS in the open-label phase.|162
1064746|NCT00884585|2582076|P2|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||4
1064747|NCT00884585|2582077|P1|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||10
1064748|NCT00884585|2582076|P2|COMPLETED|Double-Masked Phase (Day 1-Month 3)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|83
1064749|NCT00884585|2582077|P1|COMPLETED|Double-Masked Phase (Day 1-Month 3)||79
1064750|NCT00884585|2582076|P2|STARTED|Double-Masked Phase (Day 1-Month 3)||87
1064751|NCT00884585|2582077|P1|STARTED|Double-Masked Phase (Day 1-Month 3)||89
1064752|NCT00884741|2582092|P4|NOT COMPLETED|Randomization||8
1064753|NCT00884741|2582093|P3|NOT COMPLETED|Randomization||8
1064754|NCT00884741|2582094|P2|NOT COMPLETED|Randomization||0
1064755|NCT00884741|2582095|P1|NOT COMPLETED|Randomization||0
1064756|NCT00884741|2582092|P4|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|312
1064757|NCT00884741|2582093|P3|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|309
1064758|NCT00884741|2582094|P2|COMPLETED|Randomization||0
1064759|NCT00884741|2582095|P1|COMPLETED|Randomization||0
1064760|NCT00884741|2582092|P4|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|320
1064761|NCT00884741|2582093|P3|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|317
1064762|NCT00884741|2582094|P2|STARTED|Randomization|Step 2 Registration Arm goes to a randomized arm.|0
1064763|NCT00884741|2582095|P1|STARTED|Randomization||0
1064764|NCT00884741|2582092|P4|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
1064765|NCT00884741|2582093|P3|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
1064766|NCT00884741|2582094|P2|NOT COMPLETED|Step 2 Registration: Tissue Analysis||29
1064767|NCT00884741|2582095|P1|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
1064768|NCT00884741|2582092|P4|COMPLETED|Step 2 Registration: Tissue Analysis||0
1064769|NCT00884741|2582093|P3|COMPLETED|Step 2 Registration: Tissue Analysis||0
1064770|NCT00884741|2582094|P2|COMPLETED|Step 2 Registration: Tissue Analysis||637
1064771|NCT00884741|2582095|P1|COMPLETED|Step 2 Registration: Tissue Analysis||0
1064772|NCT00884741|2582092|P4|STARTED|Step 2 Registration: Tissue Analysis||0
1064773|NCT00884741|2582093|P3|STARTED|Step 2 Registration: Tissue Analysis||0
1064774|NCT00884741|2582094|P2|STARTED|Step 2 Registration: Tissue Analysis|These patients completed the previous period on the Step 1 Registration arm.|666
1064775|NCT00884741|2582095|P1|STARTED|Step 2 Registration: Tissue Analysis|Step 1 Registration Arm goes to Step 2 Registration Arm|0
1064776|NCT00884741|2582092|P4|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
1064777|NCT00884741|2582093|P3|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
1064778|NCT00884741|2582094|P2|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
1064779|NCT00884741|2582095|P1|NOT COMPLETED|Step 1 Registration: Tissue Screening||312
1064780|NCT00884741|2582092|P4|COMPLETED|Step 1 Registration: Tissue Screening||0
1064781|NCT00884741|2582093|P3|COMPLETED|Step 1 Registration: Tissue Screening||0
1064874|NCT00885365|2582433|P2|NOT COMPLETED|4 Weeks ON Treatment||6
1064782|NCT00884741|2582094|P2|COMPLETED|Step 1 Registration: Tissue Screening||0
1064783|NCT00884741|2582095|P1|COMPLETED|Step 1 Registration: Tissue Screening||666
1064784|NCT00884741|2582092|P4|STARTED|Step 1 Registration: Tissue Screening||0
1064785|NCT00884741|2582093|P3|STARTED|Step 1 Registration: Tissue Screening||0
1064786|NCT00884741|2582094|P2|STARTED|Step 1 Registration: Tissue Screening||0
1064787|NCT00884741|2582095|P1|STARTED|Step 1 Registration: Tissue Screening||978
1064788|NCT00884832|2582108|P2|NOT COMPLETED|Overall Study||1
1064789|NCT00884832|2582109|P1|NOT COMPLETED|Overall Study||0
1064790|NCT00884832|2582108|P2|COMPLETED|Overall Study||21
1064791|NCT00884832|2582109|P1|COMPLETED|Overall Study||22
1064792|NCT00884832|2582108|P2|STARTED|Overall Study||22
1064793|NCT00884832|2582109|P1|STARTED|Overall Study||22
1064794|NCT00884897|2582141|P2|NOT COMPLETED|Overall Study||0
1064795|NCT00884897|2582142|P1|NOT COMPLETED|Overall Study||0
1064796|NCT00884897|2582141|P2|COMPLETED|Overall Study||15
1064797|NCT00884897|2582142|P1|COMPLETED|Overall Study||13
1064798|NCT00884897|2582141|P2|STARTED|Overall Study||15
1064799|NCT00884897|2582142|P1|STARTED|Overall Study||13
1064800|NCT00884910|2582150|P1|NOT COMPLETED|Overall Study||1
1064801|NCT00884910|2582150|P1|COMPLETED|Overall Study|patient diagnosed with primary pulmonary tumor during study|32
1064802|NCT00884910|2582150|P1|STARTED|Overall Study||33
1064803|NCT00884949|2582155|P1|NOT COMPLETED|Continuation Period||0
1064804|NCT00884949|2582155|P1|COMPLETED|Continuation Period||18
1064805|NCT00884949|2582155|P1|STARTED|Continuation Period||18
1064806|NCT00884949|2582155|P1|NOT COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||0
1064807|NCT00884949|2582155|P1|COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||18
1064808|NCT00884949|2582155|P1|STARTED|Weeks 25-36: 2.0 mg/kg/Week||18
1064809|NCT00884949|2582155|P1|NOT COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||0
1064810|NCT00884949|2582155|P1|COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||18
1064811|NCT00884949|2582155|P1|STARTED|Weeks 13-24: 1.0 mg/kg/Week||18
1064812|NCT00884949|2582155|P1|NOT COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||2
1064813|NCT00884949|2582155|P1|COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||18
1064814|NCT00884949|2582155|P1|STARTED|Weeks 1-12: 0.1 mg/kg/Week||20
1064815|NCT00885079|2582174|P2|NOT COMPLETED|Overall Study||4
1064816|NCT00885079|2582175|P1|NOT COMPLETED|Overall Study||2
1064817|NCT00885079|2582174|P2|COMPLETED|Overall Study||91
1064818|NCT00885079|2582175|P1|COMPLETED|Overall Study||91
1064819|NCT00885079|2582174|P2|STARTED|Overall Study||95
1064820|NCT00885079|2582175|P1|STARTED|Overall Study||93
1064821|NCT00885092|2582185|P2|NOT COMPLETED|Period 2, 7 Days||0
1064822|NCT00885092|2582186|P1|NOT COMPLETED|Period 2, 7 Days||0
1064823|NCT00885092|2582185|P2|COMPLETED|Period 2, 7 Days||20
1064824|NCT00885092|2582186|P1|COMPLETED|Period 2, 7 Days||20
1064825|NCT00885092|2582185|P2|STARTED|Period 2, 7 Days||20
1064826|NCT00885092|2582186|P1|STARTED|Period 2, 7 Days||20
1064827|NCT00885092|2582185|P2|NOT COMPLETED|Period 1, 7 Days||0
1064828|NCT00885092|2582186|P1|NOT COMPLETED|Period 1, 7 Days||0
1064829|NCT00885092|2582185|P2|COMPLETED|Period 1, 7 Days||20
1064830|NCT00885092|2582186|P1|COMPLETED|Period 1, 7 Days||20
1064831|NCT00885092|2582185|P2|STARTED|Period 1, 7 Days||20
1064832|NCT00885092|2582186|P1|STARTED|Period 1, 7 Days||20
1064833|NCT00885105|2582198|P2|NOT COMPLETED|Overall Study||10
1064834|NCT00885105|2582199|P1|NOT COMPLETED|Overall Study||1
1064835|NCT00885105|2582198|P2|COMPLETED|Overall Study||120
1064836|NCT00885105|2582199|P1|COMPLETED|Overall Study||111
1064837|NCT00885105|2582198|P2|STARTED|Overall Study||130
1064838|NCT00885105|2582199|P1|STARTED|Overall Study||112
1064839|NCT00885118|2582220|P5|NOT COMPLETED|Overall Study||1
1064840|NCT00885118|2582221|P4|NOT COMPLETED|Overall Study||0
1064841|NCT00885118|2582222|P3|NOT COMPLETED|Overall Study||1
1064842|NCT00885118|2582223|P2|NOT COMPLETED|Overall Study||0
1064843|NCT00885118|2582224|P1|NOT COMPLETED|Overall Study||1
1064844|NCT00885118|2582220|P5|COMPLETED|Overall Study||18
1064845|NCT00885118|2582221|P4|COMPLETED|Overall Study||20
1064846|NCT00885118|2582222|P3|COMPLETED|Overall Study||20
1064847|NCT00885118|2582223|P2|COMPLETED|Overall Study||19
1064848|NCT00885118|2582224|P1|COMPLETED|Overall Study||20
1064849|NCT00885118|2582220|P5|STARTED|Overall Study||19
1064850|NCT00885118|2582221|P4|STARTED|Overall Study||20
1064851|NCT00885118|2582222|P3|STARTED|Overall Study||21
1064852|NCT00885118|2582223|P2|STARTED|Overall Study||19
1064853|NCT00885118|2582224|P1|STARTED|Overall Study||21
1064854|NCT00885170|2582363|P2|NOT COMPLETED|Overall Study||23
1064855|NCT00885170|2582364|P1|NOT COMPLETED|Overall Study||38
1064856|NCT00885170|2582363|P2|COMPLETED|Overall Study||99
1064857|NCT00885170|2582364|P1|COMPLETED|Overall Study||86
1064858|NCT00885170|2582363|P2|Treated|Overall Study||121
1064859|NCT00885170|2582364|P1|Treated|Overall Study||122
1064860|NCT00885170|2582363|P2|STARTED|Overall Study||122
1064861|NCT00885170|2582364|P1|STARTED|Overall Study||124
1064862|NCT00885352|2582420|P2|NOT COMPLETED|Overall Study||20
1064863|NCT00885352|2582421|P1|NOT COMPLETED|Overall Study||8
1064864|NCT00885352|2582420|P2|COMPLETED|Overall Study||136
1064865|NCT00885352|2582421|P1|COMPLETED|Overall Study||149
1064866|NCT00885352|2582420|P2|STARTED|Overall Study||156
1064867|NCT00885352|2582421|P1|STARTED|Overall Study||157
1064868|NCT00885365|2582433|P2|NOT COMPLETED|4 Weeks OFF Treatment||0
1064869|NCT00885365|2582434|P1|NOT COMPLETED|4 Weeks OFF Treatment||0
1064870|NCT00885365|2582433|P2|COMPLETED|4 Weeks OFF Treatment||159
1064871|NCT00885365|2582434|P1|COMPLETED|4 Weeks OFF Treatment||155
1064872|NCT00885365|2582433|P2|STARTED|4 Weeks OFF Treatment||159
1064873|NCT00885365|2582434|P1|STARTED|4 Weeks OFF Treatment||155
1064875|NCT00885365|2582434|P1|NOT COMPLETED|4 Weeks ON Treatment||4
1064876|NCT00885365|2582433|P2|COMPLETED|4 Weeks ON Treatment||159
1064877|NCT00885365|2582434|P1|COMPLETED|4 Weeks ON Treatment||155
1064878|NCT00885365|2582433|P2|Safety Population|4 Weeks ON Treatment|Six participants randomized to TOBI were administered Bramitob|168
1064879|NCT00885365|2582434|P1|Safety Population|4 Weeks ON Treatment|Nine participants randomized to Bramitob were administered TOBI.|156
1064880|NCT00885365|2582433|P2|Intent-to-Treat Population|4 Weeks ON Treatment||163
1064881|NCT00885365|2582434|P1|Intent-to-Treat Population|4 Weeks ON Treatment|Participants who took 1 dose of study medication and had baseline and at least 1 post-treatment FEV1|158
1064882|NCT00885365|2582433|P2|STARTED|4 Weeks ON Treatment||165
1064883|NCT00885365|2582434|P1|STARTED|4 Weeks ON Treatment||159
1064884|NCT00885378|2582470|P2|NOT COMPLETED|Overall Study||8
1064885|NCT00885378|2582471|P1|NOT COMPLETED|Overall Study||8
1064886|NCT00885378|2582470|P2|COMPLETED|Overall Study||78
1064887|NCT00885378|2582471|P1|COMPLETED|Overall Study||66
1064888|NCT00885378|2582470|P2|STARTED|Overall Study|Number randomized.|86
1064889|NCT00885378|2582471|P1|STARTED|Overall Study|Number randomized.|74
1064890|NCT00885482|2582499|P1|NOT COMPLETED|Overall Study||4
1064891|NCT00885482|2582499|P1|COMPLETED|Overall Study||36
1064892|NCT00885482|2582499|P1|STARTED|Overall Study||40
1064893|NCT00885534|2582503|P1|NOT COMPLETED|Overall Study||1
1064894|NCT00885534|2582503|P1|COMPLETED|Overall Study||6
1064895|NCT00885534|2582503|P1|STARTED|Overall Study||7
1064896|NCT00885638|2582507|P2|NOT COMPLETED|Overall Study||0
1064897|NCT00885638|2582508|P1|NOT COMPLETED|Overall Study||0
1064898|NCT00885638|2582507|P2|COMPLETED|Overall Study||6
1064899|NCT00885638|2582508|P1|COMPLETED|Overall Study||6
1064900|NCT00885638|2582507|P2|STARTED|Overall Study||6
1064901|NCT00885638|2582508|P1|STARTED|Overall Study||6
1064902|NCT00885677|2582517|P2|NOT COMPLETED|Overall Study||178
1064903|NCT00885677|2582518|P1|NOT COMPLETED|Overall Study||183
1064904|NCT00885677|2582517|P2|COMPLETED|Overall Study||277
1064905|NCT00885677|2582518|P1|COMPLETED|Overall Study||279
1064906|NCT00885677|2582517|P2|Intention To Treat|Overall Study||428
1064907|NCT00885677|2582518|P1|Intention To Treat|Overall Study||437
1064908|NCT00885677|2582517|P2|STARTED|Overall Study||455
1064909|NCT00885677|2582518|P1|STARTED|Overall Study||462
1064910|NCT00885742|2582526|P1|NOT COMPLETED|Overall Study||0
1064911|NCT00885742|2582526|P1|COMPLETED|Overall Study||41
1064912|NCT00885742|2582526|P1|STARTED|Overall Study||41
1064913|NCT00885755|2582540|P3|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
1064914|NCT00885755|2582541|P2|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
1064915|NCT00885755|2582542|P1|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||5
1064916|NCT00885755|2582540|P3|COMPLETED|Part II: Trastuzumab + Capecitabine.||0
1064917|NCT00885755|2582541|P2|COMPLETED|Part II: Trastuzumab + Capecitabine.||1
1064918|NCT00885755|2582542|P1|COMPLETED|Part II: Trastuzumab + Capecitabine.||8
1064919|NCT00885755|2582540|P3|STARTED|Part II: Trastuzumab + Capecitabine.||0
1064920|NCT00885755|2582541|P2|STARTED|Part II: Trastuzumab + Capecitabine.||1
1064921|NCT00885755|2582542|P1|STARTED|Part II: Trastuzumab + Capecitabine.||13
1064922|NCT00885755|2582540|P3|NOT COMPLETED|Part I: Trastuzumab+Taxane||1
1064923|NCT00885755|2582541|P2|NOT COMPLETED|Part I: Trastuzumab+Taxane||0
1064924|NCT00885755|2582542|P1|NOT COMPLETED|Part I: Trastuzumab+Taxane||18
1064925|NCT00885755|2582540|P3|COMPLETED|Part I: Trastuzumab+Taxane||0
1064926|NCT00885755|2582541|P2|COMPLETED|Part I: Trastuzumab+Taxane||1
1064927|NCT00885755|2582542|P1|COMPLETED|Part I: Trastuzumab+Taxane||13
1064928|NCT00885755|2582540|P3|STARTED|Part I: Trastuzumab+Taxane||1
1064929|NCT00885755|2582541|P2|STARTED|Part I: Trastuzumab+Taxane||1
1064930|NCT00885755|2582542|P1|STARTED|Part I: Trastuzumab+Taxane||31
1064931|NCT00885768|2582567|P1|NOT COMPLETED|Overall Study||0
1064932|NCT00885768|2582567|P1|COMPLETED|Overall Study|all patients with including criteria completed the study|146
1064933|NCT00885768|2582567|P1|STARTED|Overall Study|all patients with coronary artery stenosis on angiography entered the study|146
1064934|NCT00885846|2582574|P3|NOT COMPLETED|Overall Study||2
1064935|NCT00885846|2582575|P2|NOT COMPLETED|Overall Study||5
1064936|NCT00885846|2582576|P1|NOT COMPLETED|Overall Study||2
1064937|NCT00885846|2582574|P3|COMPLETED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|8
1064938|NCT00885846|2582575|P2|COMPLETED|Overall Study|Cohort 1 = 1 Cohort 2 = 5|6
1064939|NCT00885846|2582576|P1|COMPLETED|Overall Study|Cohort 1 = 3 Cohort 2 = 6|9
1064940|NCT00885846|2582574|P3|STARTED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|10
1064941|NCT00885846|2582575|P2|STARTED|Overall Study|Cohort 1 = 6 Cohort 2 = 5|11
1064942|NCT00885846|2582576|P1|STARTED|Overall Study|Cohort 1 = 5 Cohort 2 = 6|11
1064943|NCT00886015|2582586|P2|NOT COMPLETED|Overall Study||2
1064944|NCT00886015|2582587|P1|NOT COMPLETED|Overall Study||0
1064945|NCT00886015|2582586|P2|COMPLETED|Overall Study|1669 eyes; 956 participants|1669
1064946|NCT00886015|2582587|P1|COMPLETED|Overall Study|1674 eyes; 960 participants|1674
1064947|NCT00886015|2582586|P2|STARTED|Overall Study|1671 eyes; 957 participants|1671
1064948|NCT00886015|2582587|P1|STARTED|Overall Study|1674 eyes; 960 participants|1674
1064949|NCT00886119|2582603|P2|NOT COMPLETED|Period 2||0
1064950|NCT00886119|2582604|P1|NOT COMPLETED|Period 2||0
1064951|NCT00886119|2582603|P2|COMPLETED|Period 2||22
1064952|NCT00886119|2582604|P1|COMPLETED|Period 2||23
1064953|NCT00886119|2582603|P2|STARTED|Period 2||22
1064954|NCT00886119|2582604|P1|STARTED|Period 2||23
1064955|NCT00886119|2582603|P2|NOT COMPLETED|Period 1||0
1064956|NCT00886119|2582604|P1|NOT COMPLETED|Period 1||1
1064957|NCT00886119|2582603|P2|COMPLETED|Period 1||22
1064958|NCT00886119|2582604|P1|COMPLETED|Period 1||23
1064959|NCT00886119|2582603|P2|STARTED|Period 1||22
1064960|NCT00886119|2582604|P1|STARTED|Period 1||24
1064961|NCT00886145|2582610|P1|NOT COMPLETED|Overall Study||0
1064962|NCT00886145|2582610|P1|COMPLETED|Overall Study||1
1064963|NCT00886145|2582610|P1|STARTED|Overall Study||1
1064964|NCT00886288|2582618|P2|NOT COMPLETED|Overall Study||227
1064965|NCT00886288|2582619|P1|NOT COMPLETED|Overall Study||743
1064966|NCT00886288|2582618|P2|COMPLETED|Overall Study||457
1064967|NCT00886288|2582619|P1|COMPLETED|Overall Study||1284
1064968|NCT00886288|2582618|P2|STARTED|Overall Study|Baseline Population|684
1064969|NCT00886288|2582619|P1|STARTED|Overall Study|Baseline Population|2027
1064970|NCT00886340|2582637|P2|NOT COMPLETED|Overall Study||7
1064971|NCT00886340|2582638|P1|NOT COMPLETED|Overall Study||0
1064972|NCT00886340|2582637|P2|COMPLETED|Overall Study||24
1064973|NCT00886340|2582638|P1|COMPLETED|Overall Study||27
1064974|NCT00886340|2582637|P2|STARTED|Overall Study||31
1064975|NCT00886340|2582638|P1|STARTED|Overall Study||27
1064976|NCT00886483|2582646|P2|NOT COMPLETED|Overall Study||3
1064977|NCT00886483|2582647|P1|NOT COMPLETED|Overall Study||2
1064978|NCT00886483|2582646|P2|COMPLETED|Overall Study||10
1064979|NCT00886483|2582647|P1|COMPLETED|Overall Study||24
1064980|NCT00886483|2582646|P2|Completed 20 Treatments|Overall Study||11
1064981|NCT00886483|2582647|P1|Completed 20 Treatments|Overall Study||25
1064982|NCT00886483|2582646|P2|STARTED|Overall Study||13
1064983|NCT00886483|2582647|P1|STARTED|Overall Study||26
1064984|NCT00886587|2582665|P2|NOT COMPLETED|Overall Study||2
1064985|NCT00886587|2582666|P1|NOT COMPLETED|Overall Study||4
1064986|NCT00886587|2582665|P2|COMPLETED|Overall Study||39
1064987|NCT00886587|2582666|P1|COMPLETED|Overall Study||37
1064988|NCT00886587|2582665|P2|STARTED|Overall Study||41
1064989|NCT00886587|2582666|P1|STARTED|Overall Study||41
1064990|NCT00886600|2582682|P4|NOT COMPLETED|Combination Therapy Period||0
1064991|NCT00886600|2582683|P3|NOT COMPLETED|Combination Therapy Period||2
1064992|NCT00886600|2582684|P2|NOT COMPLETED|Combination Therapy Period||0
1064993|NCT00886600|2582685|P1|NOT COMPLETED|Combination Therapy Period||0
1064994|NCT00886600|2582682|P4|COMPLETED|Combination Therapy Period||23
1064995|NCT00886600|2582683|P3|COMPLETED|Combination Therapy Period||19
1064996|NCT00886600|2582684|P2|COMPLETED|Combination Therapy Period||21
1064997|NCT00886600|2582685|P1|COMPLETED|Combination Therapy Period||28
1064998|NCT00886600|2582682|P4|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 5-(SiDBP <85); 1-(SiDBP ≥85)|23
1064999|NCT00886600|2582683|P3|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 7-(SiDBP <85); 1-(SiDBP ≥85)|21
1065000|NCT00886600|2582684|P2|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 4-(SiDBP <85); 3-(SiDBP ≥85)|21
1065001|NCT00886600|2582685|P1|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 2-(Sitting Diastolic Blood Pressure (SiDBP) <85)|28
1065002|NCT00886600|2582682|P4|NOT COMPLETED|Double-blind Monotherapy||2
1065003|NCT00886600|2582683|P3|NOT COMPLETED|Double-blind Monotherapy||1
1065004|NCT00886600|2582684|P2|NOT COMPLETED|Double-blind Monotherapy||1
1065005|NCT00886600|2582685|P1|NOT COMPLETED|Double-blind Monotherapy||2
1065006|NCT00886600|2582682|P4|COMPLETED|Double-blind Monotherapy||29
1065007|NCT00886600|2582683|P3|COMPLETED|Double-blind Monotherapy||29
1065008|NCT00886600|2582684|P2|COMPLETED|Double-blind Monotherapy|1 pt discontinued after Wk 4 due to AE starting in placebo baseline and continuing into double-blind|28
1065009|NCT00886600|2582685|P1|COMPLETED|Double-blind Monotherapy||30
1065010|NCT00886600|2582682|P4|STARTED|Double-blind Monotherapy||31
1065011|NCT00886600|2582683|P3|STARTED|Double-blind Monotherapy||30
1065012|NCT00886600|2582684|P2|STARTED|Double-blind Monotherapy||29
1065013|NCT00886600|2582685|P1|STARTED|Double-blind Monotherapy||32
1065014|NCT00886613|2582710|P3|NOT COMPLETED|Overall Study||3
1065015|NCT00886613|2582711|P2|NOT COMPLETED|Overall Study||0
1065016|NCT00886613|2582712|P1|NOT COMPLETED|Overall Study||2
1065017|NCT00886613|2582710|P3|COMPLETED|Overall Study||37
1065018|NCT00886613|2582711|P2|COMPLETED|Overall Study||39
1065019|NCT00886613|2582712|P1|COMPLETED|Overall Study||39
1065020|NCT00886613|2582710|P3|STARTED|Overall Study||40
1065021|NCT00886613|2582711|P2|STARTED|Overall Study||39
1065022|NCT00886613|2582712|P1|STARTED|Overall Study||41
1065023|NCT00886626|2582730|P2|NOT COMPLETED|Period 2 (90 Days)||0
1065024|NCT00886626|2582731|P1|NOT COMPLETED|Period 2 (90 Days)||0
1065025|NCT00886626|2582730|P2|COMPLETED|Period 2 (90 Days)||6
1065026|NCT00886626|2582731|P1|COMPLETED|Period 2 (90 Days)||5
1065027|NCT00886626|2582730|P2|STARTED|Period 2 (90 Days)||6
1065028|NCT00886626|2582731|P1|STARTED|Period 2 (90 Days)||5
1065029|NCT00886626|2582730|P2|NOT COMPLETED|Period 1 (90 Days)||0
1065030|NCT00886626|2582731|P1|NOT COMPLETED|Period 1 (90 Days)||1
1065031|NCT00886626|2582730|P2|COMPLETED|Period 1 (90 Days)||6
1065032|NCT00886626|2582731|P1|COMPLETED|Period 1 (90 Days)||5
1065033|NCT00886626|2582730|P2|STARTED|Period 1 (90 Days)||6
1065034|NCT00886626|2582731|P1|STARTED|Period 1 (90 Days)||6
1065035|NCT00886639|2582737|P1|NOT COMPLETED|Overall Study||16
1065036|NCT00886639|2582737|P1|COMPLETED|Overall Study||111
1065037|NCT00886639|2582737|P1|STARTED|Overall Study||127
1065038|NCT00886704|2582743|P2|NOT COMPLETED|Overall Study||0
1065039|NCT00886704|2582744|P1|NOT COMPLETED|Overall Study||0
1065040|NCT00886704|2582743|P2|COMPLETED|Overall Study||10
1065041|NCT00886704|2582744|P1|COMPLETED|Overall Study||40
1065042|NCT00886704|2582743|P2|STARTED|Overall Study||10
1065043|NCT00886704|2582744|P1|STARTED|Overall Study||40
1065044|NCT00886743|2582752|P1|NOT COMPLETED|Overall Study||4
1065045|NCT00886743|2582752|P1|COMPLETED|Overall Study||15
1065046|NCT00886743|2582752|P1|STARTED|Overall Study|Received treatment|19
1065047|NCT00886769|2582762|P2|NOT COMPLETED|Overall Study||37
1065048|NCT00886769|2582763|P1|NOT COMPLETED|Overall Study||6
1065049|NCT00886769|2582762|P2|COMPLETED|Overall Study||4
1065050|NCT00886769|2582763|P1|COMPLETED|Overall Study||37
1065051|NCT00886769|2582762|P2|STARTED|Overall Study||41
1065052|NCT00886769|2582763|P1|STARTED|Overall Study||43
1065053|NCT00886795|2582787|P1|NOT COMPLETED|Overall Study||1
1065054|NCT00886795|2582787|P1|COMPLETED|Overall Study||3
1065055|NCT00886795|2582787|P1|STARTED|Overall Study||4
1065056|NCT00886821|2582806|P14|NOT COMPLETED|Stage 2||1
1065057|NCT00886821|2582807|P13|NOT COMPLETED|Stage 2||5
1065058|NCT00886821|2582808|P12|NOT COMPLETED|Stage 2||1
1065059|NCT00886821|2582809|P11|NOT COMPLETED|Stage 2||0
1065060|NCT00886821|2582810|P10|NOT COMPLETED|Stage 2||0
1065061|NCT00886821|2582811|P9|NOT COMPLETED|Stage 2||0
1065062|NCT00886821|2582812|P8|NOT COMPLETED|Stage 2||0
1065063|NCT00886821|2582813|P7|NOT COMPLETED|Stage 2||0
1065064|NCT00886821|2582814|P6|NOT COMPLETED|Stage 2||0
1065065|NCT00886821|2582815|P5|NOT COMPLETED|Stage 2||0
1065066|NCT00886821|2582816|P4|NOT COMPLETED|Stage 2||0
1065067|NCT00886821|2582817|P3|NOT COMPLETED|Stage 2||0
1065068|NCT00886821|2582818|P2|NOT COMPLETED|Stage 2||0
1065069|NCT00886821|2582819|P1|NOT COMPLETED|Stage 2||0
1065070|NCT00886821|2582806|P14|COMPLETED|Stage 2||8
1065071|NCT00886821|2582807|P13|COMPLETED|Stage 2||8
1065072|NCT00886821|2582808|P12|COMPLETED|Stage 2||8
1065073|NCT00886821|2582809|P11|COMPLETED|Stage 2||9
1065074|NCT00886821|2582810|P10|COMPLETED|Stage 2||0
1065075|NCT00886821|2582811|P9|COMPLETED|Stage 2||0
1065076|NCT00886821|2582812|P8|COMPLETED|Stage 2||0
1065077|NCT00886821|2582813|P7|COMPLETED|Stage 2||0
1065078|NCT00886821|2582814|P6|COMPLETED|Stage 2||0
1065079|NCT00886821|2582815|P5|COMPLETED|Stage 2||0
1065080|NCT00886821|2582816|P4|COMPLETED|Stage 2||0
1065081|NCT00886821|2582817|P3|COMPLETED|Stage 2||0
1065082|NCT00886821|2582818|P2|COMPLETED|Stage 2||0
1065083|NCT00886821|2582819|P1|COMPLETED|Stage 2||0
1065084|NCT00886821|2582806|P14|STARTED|Stage 2||9
1065085|NCT00886821|2582807|P13|STARTED|Stage 2||13
1065086|NCT00886821|2582808|P12|STARTED|Stage 2||9
1065087|NCT00886821|2582809|P11|STARTED|Stage 2||9
1065088|NCT00886821|2582810|P10|STARTED|Stage 2||0
1065089|NCT00886821|2582811|P9|STARTED|Stage 2||0
1065090|NCT00886821|2582812|P8|STARTED|Stage 2||0
1065091|NCT00886821|2582813|P7|STARTED|Stage 2||0
1065092|NCT00886821|2582814|P6|STARTED|Stage 2||0
1065093|NCT00886821|2582815|P5|STARTED|Stage 2||0
1065094|NCT00886821|2582816|P4|STARTED|Stage 2||0
1065095|NCT00886821|2582817|P3|STARTED|Stage 2||0
1065096|NCT00886821|2582818|P2|STARTED|Stage 2||0
1065097|NCT00886821|2582819|P1|STARTED|Stage 2||0
1065098|NCT00886821|2582806|P14|NOT COMPLETED|Stage 1||0
1065099|NCT00886821|2582807|P13|NOT COMPLETED|Stage 1||0
1065100|NCT00886821|2582808|P12|NOT COMPLETED|Stage 1||0
1065101|NCT00886821|2582809|P11|NOT COMPLETED|Stage 1||0
1065102|NCT00886821|2582810|P10|NOT COMPLETED|Stage 1||0
1065103|NCT00886821|2582811|P9|NOT COMPLETED|Stage 1||0
1065104|NCT00886821|2582812|P8|NOT COMPLETED|Stage 1||0
1065105|NCT00886821|2582813|P7|NOT COMPLETED|Stage 1||0
1065106|NCT00886821|2582814|P6|NOT COMPLETED|Stage 1||0
1065107|NCT00886821|2582815|P5|NOT COMPLETED|Stage 1||0
1065108|NCT00886821|2582816|P4|NOT COMPLETED|Stage 1||0
1065109|NCT00886821|2582817|P3|NOT COMPLETED|Stage 1||0
1065110|NCT00886821|2582818|P2|NOT COMPLETED|Stage 1||0
1065111|NCT00886821|2582819|P1|NOT COMPLETED|Stage 1||0
1065112|NCT00886821|2582806|P14|COMPLETED|Stage 1||0
1065113|NCT00886821|2582807|P13|COMPLETED|Stage 1||0
1065114|NCT00886821|2582808|P12|COMPLETED|Stage 1||0
1065115|NCT00886821|2582809|P11|COMPLETED|Stage 1||0
1065116|NCT00886821|2582810|P10|COMPLETED|Stage 1||18
1065117|NCT00886821|2582811|P9|COMPLETED|Stage 1||6
1065118|NCT00886821|2582812|P8|COMPLETED|Stage 1||6
1065119|NCT00886821|2582813|P7|COMPLETED|Stage 1||6
1065120|NCT00886821|2582814|P6|COMPLETED|Stage 1||6
1065121|NCT00886821|2582815|P5|COMPLETED|Stage 1||6
1065122|NCT00886821|2582816|P4|COMPLETED|Stage 1||7
1065123|NCT00886821|2582817|P3|COMPLETED|Stage 1||6
1065124|NCT00886821|2582818|P2|COMPLETED|Stage 1||6
1065125|NCT00886821|2582819|P1|COMPLETED|Stage 1||7
1065126|NCT00886821|2582806|P14|STARTED|Stage 1||0
1065127|NCT00886821|2582807|P13|STARTED|Stage 1||0
1065128|NCT00886821|2582808|P12|STARTED|Stage 1||0
1065129|NCT00886821|2582809|P11|STARTED|Stage 1||0
1065130|NCT00886821|2582810|P10|STARTED|Stage 1||18
1065131|NCT00886821|2582811|P9|STARTED|Stage 1||6
1065132|NCT00886821|2582812|P8|STARTED|Stage 1||6
1065133|NCT00886821|2582813|P7|STARTED|Stage 1||6
1065134|NCT00886821|2582814|P6|STARTED|Stage 1||6
1065135|NCT00886821|2582815|P5|STARTED|Stage 1||6
1065136|NCT00886821|2582816|P4|STARTED|Stage 1||7
1065137|NCT00886821|2582817|P3|STARTED|Stage 1||6
1065138|NCT00886821|2582818|P2|STARTED|Stage 1||6
1065139|NCT00886821|2582819|P1|STARTED|Stage 1||7
1065140|NCT00886834|2583046|P2|NOT COMPLETED|Overall Study||3
1065141|NCT00886834|2583047|P1|NOT COMPLETED|Overall Study||0
1065142|NCT00886834|2583046|P2|COMPLETED|Overall Study||51
1065143|NCT00886834|2583047|P1|COMPLETED|Overall Study||54
1065144|NCT00886834|2583046|P2|STARTED|Overall Study||54
1065145|NCT00886834|2583047|P1|STARTED|Overall Study||54
1065146|NCT00886899|2583055|P1|NOT COMPLETED|Overall Study||0
1065147|NCT00886899|2583055|P1|COMPLETED|Overall Study||147
1065148|NCT00886899|2583055|P1|STARTED|Overall Study||147
1065149|NCT00886938|2583062|P1|NOT COMPLETED|Overall Study||2
1065150|NCT00886938|2583062|P1|COMPLETED|Overall Study||10
1065151|NCT00886938|2583062|P1|STARTED|Overall Study||12
1065152|NCT00887159|2583069|P3|NOT COMPLETED|Overall Study||56
1065153|NCT00887159|2583070|P2|NOT COMPLETED|Overall Study||56
1065154|NCT00887159|2583071|P1|NOT COMPLETED|Overall Study||29
1065155|NCT00887159|2583069|P3|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
1065156|NCT00887159|2583070|P2|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
1065157|NCT00887159|2583071|P1|COMPLETED|Overall Study||27
1065158|NCT00887159|2583069|P3|Eligible/Treated Pts With CTCs Results|Overall Study||38
1065159|NCT00887159|2583070|P2|Eligible/Treated Pts With CTCs Results|Overall Study||42
1065160|NCT00887159|2583071|P1|Eligible/Treated Pts With CTCs Results|Overall Study||40
1065161|NCT00887159|2583069|P3|Eligible and Treated Patients|Overall Study||52
1065162|NCT00887159|2583070|P2|Eligible and Treated Patients|Overall Study||52
1065163|NCT00887159|2583071|P1|Eligible and Treated Patients|Overall Study||48
1065164|NCT00887159|2583069|P3|Patients Who Started Assigned Treatment|Overall Study||52
1065165|NCT00887159|2583070|P2|Patients Who Started Assigned Treatment|Overall Study||53
1065166|NCT00887159|2583071|P1|Patients Who Started Assigned Treatment|Overall Study||53
1065167|NCT00887159|2583069|P3|STARTED|Overall Study||56
1065168|NCT00887159|2583070|P2|STARTED|Overall Study||56
1065169|NCT00887159|2583071|P1|STARTED|Overall Study||56
1065170|NCT00887198|2583089|P2|NOT COMPLETED|Overall Study||431
1065171|NCT00887198|2583090|P1|NOT COMPLETED|Overall Study||384
1065172|NCT00887198|2583089|P2|COMPLETED|Overall Study||111
1065173|NCT00887198|2583090|P1|COMPLETED|Overall Study||162
1065174|NCT00887198|2583089|P2|STARTED|Overall Study||542
1065175|NCT00887198|2583090|P1|STARTED|Overall Study||546
1065176|NCT00887224|2583121|P3|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||30
1065177|NCT00887224|2583122|P2|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||41
1065178|NCT00887224|2583123|P1|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||0
1065179|NCT00887224|2583121|P3|COMPLETED|DB Taper Phase / Post Study Follow Up||235
1065180|NCT00887224|2583122|P2|COMPLETED|DB Taper Phase / Post Study Follow Up||226
1065181|NCT00887224|2583123|P1|COMPLETED|DB Taper Phase / Post Study Follow Up||0
1065182|NCT00887224|2583121|P3|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||30
1065183|NCT00887224|2583122|P2|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up|DBp could have discontinued at anytime during DB taper period or Follow-up (7 days after last dose).|41
1065184|NCT00887224|2583123|P1|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||0
1065185|NCT00887224|2583121|P3|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||7
1065186|NCT00887224|2583122|P2|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||9
1065187|NCT00887224|2583123|P1|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||0
1065188|NCT00887224|2583121|P3|STARTED|DB Taper Phase / Post Study Follow Up||265
1065189|NCT00887224|2583122|P2|STARTED|DB Taper Phase / Post Study Follow Up|Double-blind participants (DBp) could have entered 7-day taper period at any time during DB phase.|267
1065190|NCT00887224|2583123|P1|STARTED|DB Taper Phase / Post Study Follow Up||0
1065191|NCT00887224|2583121|P3|NOT COMPLETED|Double-blind (DB) Phase||62
1065192|NCT00887224|2583122|P2|NOT COMPLETED|Double-blind (DB) Phase||100
1065193|NCT00887224|2583123|P1|NOT COMPLETED|Double-blind (DB) Phase||0
1065194|NCT00887224|2583121|P3|COMPLETED|Double-blind (DB) Phase||210
1065195|NCT00887224|2583122|P2|COMPLETED|Double-blind (DB) Phase||176
1065196|NCT00887224|2583123|P1|COMPLETED|Double-blind (DB) Phase||0
1065197|NCT00887224|2583121|P3|STARTED|Double-blind (DB) Phase||272
1065198|NCT00887224|2583122|P2|STARTED|Double-blind (DB) Phase|2 participants randomized in error to DB, then entered OL Taper; counted in OL Taper and DB phases.|276
1065199|NCT00887224|2583123|P1|STARTED|Double-blind (DB) Phase||0
1065200|NCT00887224|2583121|P3|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
1065201|NCT00887224|2583122|P2|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
1065202|NCT00887224|2583123|P1|NOT COMPLETED|OL Taper Phase / OL Follow Up||144
1065203|NCT00887224|2583121|P3|COMPLETED|OL Taper Phase / OL Follow Up||0
1065204|NCT00887224|2583122|P2|COMPLETED|OL Taper Phase / OL Follow Up||0
1065205|NCT00887224|2583123|P1|COMPLETED|OL Taper Phase / OL Follow Up||163
1065206|NCT00887224|2583121|P3|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
1065207|NCT00887224|2583122|P2|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
1065208|NCT00887224|2583123|P1|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up|Could have discontinued at any time during OL taper phase or OL Follow-up (7 days after last dose).|144
1065209|NCT00887224|2583121|P3|STARTED|OL Taper Phase / OL Follow Up||0
1065210|NCT00887224|2583122|P2|STARTED|OL Taper Phase / OL Follow Up||0
1065211|NCT00887224|2583123|P1|STARTED|OL Taper Phase / OL Follow Up|Could have entered 7-day taper period at any time during either the OLR phase or OLS phase.|307
1065212|NCT00887224|2583121|P3|NOT COMPLETED|Between OLS and DB Phases||0
1065213|NCT00887224|2583122|P2|NOT COMPLETED|Between OLS and DB Phases||0
1065214|NCT00887224|2583123|P1|NOT COMPLETED|Between OLS and DB Phases||28
1065215|NCT00887224|2583121|P3|COMPLETED|Between OLS and DB Phases||0
1065216|NCT00887224|2583122|P2|COMPLETED|Between OLS and DB Phases||0
1065217|NCT00887224|2583123|P1|COMPLETED|Between OLS and DB Phases||548
1065218|NCT00887224|2583121|P3|STARTED|Between OLS and DB Phases||0
1065219|NCT00887224|2583122|P2|STARTED|Between OLS and DB Phases||0
1065220|NCT00887224|2583123|P1|STARTED|Between OLS and DB Phases||576
1065221|NCT00887224|2583121|P3|NOT COMPLETED|Open-label Stability (OLS) Phase||0
1065222|NCT00887224|2583122|P2|NOT COMPLETED|Open-label Stability (OLS) Phase||0
1065223|NCT00887224|2583123|P1|NOT COMPLETED|Open-label Stability (OLS) Phase||83
1065224|NCT00887224|2583121|P3|COMPLETED|Open-label Stability (OLS) Phase||0
1065225|NCT00887224|2583122|P2|COMPLETED|Open-label Stability (OLS) Phase||0
1065226|NCT00887224|2583123|P1|COMPLETED|Open-label Stability (OLS) Phase||576
1065227|NCT00887224|2583121|P3|STARTED|Open-label Stability (OLS) Phase||0
1065228|NCT00887224|2583122|P2|STARTED|Open-label Stability (OLS) Phase||0
1065229|NCT00887224|2583123|P1|STARTED|Open-label Stability (OLS) Phase||659
1065230|NCT00887224|2583121|P3|NOT COMPLETED|Between OLR and OLS Phases||0
1065231|NCT00887224|2583122|P2|NOT COMPLETED|Between OLR and OLS Phases||0
1065232|NCT00887224|2583123|P1|NOT COMPLETED|Between OLR and OLS Phases||93
1065233|NCT00887224|2583121|P3|COMPLETED|Between OLR and OLS Phases||0
1065234|NCT00887224|2583122|P2|COMPLETED|Between OLR and OLS Phases||0
1065235|NCT00887224|2583123|P1|COMPLETED|Between OLR and OLS Phases||659
1065236|NCT00887224|2583121|P3|STARTED|Between OLR and OLS Phases||0
1065237|NCT00887224|2583122|P2|STARTED|Between OLR and OLS Phases||0
1065238|NCT00887224|2583123|P1|STARTED|Between OLR and OLS Phases||752
1065239|NCT00887224|2583121|P3|NOT COMPLETED|Open-label Response (OLR) Phase||0
1065240|NCT00887224|2583122|P2|NOT COMPLETED|Open-label Response (OLR) Phase||0
1065241|NCT00887224|2583123|P1|NOT COMPLETED|Open-label Response (OLR) Phase||122
1065242|NCT00887224|2583121|P3|COMPLETED|Open-label Response (OLR) Phase||0
1065243|NCT00887224|2583122|P2|COMPLETED|Open-label Response (OLR) Phase||0
1065244|NCT00887224|2583123|P1|COMPLETED|Open-label Response (OLR) Phase||752
1065245|NCT00887224|2583121|P3|STARTED|Open-label Response (OLR) Phase||0
1065246|NCT00887224|2583122|P2|STARTED|Open-label Response (OLR) Phase||0
1065247|NCT00887224|2583123|P1|STARTED|Open-label Response (OLR) Phase||874
1065248|NCT00887250|2583151|P3|NOT COMPLETED|Overall Study||13
1065249|NCT00887250|2583152|P2|NOT COMPLETED|Overall Study||12
1065250|NCT00887250|2583153|P1|NOT COMPLETED|Overall Study||18
1065251|NCT00887250|2583151|P3|COMPLETED|Overall Study||110
1065252|NCT00887250|2583152|P2|COMPLETED|Overall Study||115
1065253|NCT00887250|2583153|P1|COMPLETED|Overall Study||98
1065254|NCT00887250|2583151|P3|STARTED|Overall Study||123
1065255|NCT00887250|2583152|P2|STARTED|Overall Study||127
1065256|NCT00887250|2583153|P1|STARTED|Overall Study||116
1065257|NCT00887289|2583173|P1|NOT COMPLETED|Overall Study||95
1065258|NCT00887289|2583173|P1|COMPLETED|Overall Study||1409
1065259|NCT00887289|2583173|P1|STARTED|Overall Study||1504
1065260|NCT00887315|2583184|P2|NOT COMPLETED|Overall Study||4
1065261|NCT00887315|2583185|P1|NOT COMPLETED|Overall Study||7
1065262|NCT00887315|2583184|P2|COMPLETED|Overall Study||0
1065263|NCT00887315|2583185|P1|COMPLETED|Overall Study||0
1065264|NCT00887315|2583184|P2|STARTED|Overall Study||4
1065265|NCT00887315|2583185|P1|STARTED|Overall Study||7
1065266|NCT00878501|2583196|P3|NOT COMPLETED|Overall Study||8
1065267|NCT00878501|2583197|P2|NOT COMPLETED|Overall Study||7
1065268|NCT00878501|2583198|P1|NOT COMPLETED|Overall Study||17
1065269|NCT00878501|2583196|P3|COMPLETED|Overall Study||85
1065270|NCT00878501|2583197|P2|COMPLETED|Overall Study||37
1065271|NCT00878501|2583198|P1|COMPLETED|Overall Study||87
1065272|NCT00878501|2583196|P3|Interim Analysis|Overall Study||81
1065273|NCT00878501|2583197|P2|Interim Analysis|Overall Study||37
1065274|NCT00878501|2583198|P1|Interim Analysis|Overall Study||83
1065275|NCT00878501|2583196|P3|STARTED|Overall Study||93
1065276|NCT00878501|2583197|P2|STARTED|Overall Study||44
1065277|NCT00878501|2583198|P1|STARTED|Overall Study|One of these patients did not receive study drug since incorrectly enrolled (mis-randomisation)|104
1065278|NCT00878553|2583219|P5|NOT COMPLETED|PK Study||0
1065279|NCT00878553|2583220|P4|NOT COMPLETED|PK Study||1
1065280|NCT00878553|2583221|P3|NOT COMPLETED|PK Study||0
1065281|NCT00878553|2583222|P2|NOT COMPLETED|PK Study||0
1065282|NCT00878553|2583223|P1|NOT COMPLETED|PK Study||0
1065283|NCT00878553|2583219|P5|COMPLETED|PK Study||15
1065284|NCT00878553|2583220|P4|COMPLETED|PK Study|One patient withdrew consent after completing the Sleep Substudy and prior to starting PK substudy.|13
1065285|NCT00878553|2583221|P3|COMPLETED|PK Study||17
1065286|NCT00878553|2583222|P2|COMPLETED|PK Study||16
1065287|NCT00878553|2583223|P1|COMPLETED|PK Study|A total of 61 randomized patients completed this parallel group, single dose PK substudy.|0
1065288|NCT00878553|2583219|P5|STARTED|PK Study|During the PK period, 15 randomized participants received one bedtime dose of 20mg SKP-1041.|15
1065289|NCT00878553|2583220|P4|STARTED|PK Study|During the PK period, 14 participants were randomized to receive one bedtime dose of 15mg SKP-1041.|14
1065290|NCT00878553|2583221|P3|STARTED|PK Study|During the PK period, 17 randomized participants received one bedtime dose of 10mg SKP-1041.|17
1065291|NCT00878553|2583222|P2|STARTED|PK Study|During the PK period, 16 randomized participants received one bedtime dose of SKP-1041 placebo.|16
1065292|NCT00878553|2583223|P1|STARTED|PK Study|A total of 62 randomized patients started this parallel group, single dose PK substudy.|0
1065293|NCT00878553|2583219|P5|NOT COMPLETED|Sleep Study||0
1065294|NCT00878553|2583220|P4|NOT COMPLETED|Sleep Study||0
1065295|NCT00878553|2583221|P3|NOT COMPLETED|Sleep Study||0
1065296|NCT00878553|2583222|P2|NOT COMPLETED|Sleep Study||0
1065297|NCT00878553|2583223|P1|NOT COMPLETED|Sleep Study||5
1065298|NCT00878553|2583219|P5|COMPLETED|Sleep Study||0
1065299|NCT00878553|2583220|P4|COMPLETED|Sleep Study||0
1065300|NCT00878553|2583221|P3|COMPLETED|Sleep Study||0
1065301|NCT00878553|2583222|P2|COMPLETED|Sleep Study||0
1065302|NCT00878553|2583223|P1|COMPLETED|Sleep Study|5 patient withdraws result in greater than 5 lost patient data across groups due to CROSSOVER design|62
1065303|NCT00878553|2583219|P5|Number of Patients Receiving 20mg|Sleep Study||0
1065304|NCT00878553|2583220|P4|Number of Patients Receiving 20mg|Sleep Study||0
1065305|NCT00878553|2583221|P3|Number of Patients Receiving 20mg|Sleep Study||0
1065306|NCT00878553|2583222|P2|Number of Patients Receiving 20mg|Sleep Study||0
1065307|NCT00878553|2583223|P1|Number of Patients Receiving 20mg|Sleep Study||65
1065308|NCT00878553|2583219|P5|Number of Patients Receiving 15mg|Sleep Study||0
1065309|NCT00878553|2583220|P4|Number of Patients Receiving 15mg|Sleep Study||0
1065310|NCT00878553|2583221|P3|Number of Patients Receiving 15mg|Sleep Study||0
1065311|NCT00878553|2583222|P2|Number of Patients Receiving 15mg|Sleep Study||0
1065312|NCT00878553|2583223|P1|Number of Patients Receiving 15mg|Sleep Study||65
1065313|NCT00878553|2583219|P5|Number of Patients Receiving 10mg|Sleep Study||0
1065314|NCT00878553|2583220|P4|Number of Patients Receiving 10mg|Sleep Study||0
1065315|NCT00878553|2583221|P3|Number of Patients Receiving 10mg|Sleep Study||0
1065316|NCT00878553|2583222|P2|Number of Patients Receiving 10mg|Sleep Study||0
1065317|NCT00878553|2583223|P1|Number of Patients Receiving 10mg|Sleep Study||65
1065318|NCT00878553|2583219|P5|Number of Patients Receiving Placebo|Sleep Study||0
1065319|NCT00878553|2583220|P4|Number of Patients Receiving Placebo|Sleep Study||0
1065320|NCT00878553|2583221|P3|Number of Patients Receiving Placebo|Sleep Study||0
1065321|NCT00878553|2583222|P2|Number of Patients Receiving Placebo|Sleep Study||0
1065322|NCT00878553|2583223|P1|Number of Patients Receiving Placebo|Sleep Study||66
1065323|NCT00878553|2583219|P5|STARTED|Sleep Study||0
1065324|NCT00878553|2583220|P4|STARTED|Sleep Study||0
1065325|NCT00878553|2583221|P3|STARTED|Sleep Study||0
1065326|NCT00878553|2583222|P2|STARTED|Sleep Study||0
1065327|NCT00878553|2583223|P1|STARTED|Sleep Study|This Intention to Treat population includes all randomized patients; one dropped prior to treatment.|67
1065328|NCT00878605|2583283|P4|NOT COMPLETED|Overall Study||3
1065329|NCT00878605|2583284|P3|NOT COMPLETED|Overall Study||1
1065330|NCT00878605|2583285|P2|NOT COMPLETED|Overall Study||3
1065331|NCT00878605|2583286|P1|NOT COMPLETED|Overall Study||3
1065332|NCT00878605|2583283|P4|COMPLETED|Overall Study||6
1065333|NCT00878605|2583284|P3|COMPLETED|Overall Study||8
1065334|NCT00878605|2583285|P2|COMPLETED|Overall Study||7
1065335|NCT00878605|2583286|P1|COMPLETED|Overall Study||7
1065336|NCT00878605|2583283|P4|STARTED|Overall Study||9
1065337|NCT00878605|2583284|P3|STARTED|Overall Study||9
1065338|NCT00878605|2583285|P2|STARTED|Overall Study||10
1065339|NCT00878605|2583286|P1|STARTED|Overall Study||10
1065340|NCT00878644|2583298|P2|NOT COMPLETED|Overall Study||4
1065341|NCT00878644|2583299|P1|NOT COMPLETED|Overall Study||4
1065342|NCT00878644|2583298|P2|COMPLETED|Overall Study||136
1065343|NCT00878644|2583299|P1|COMPLETED|Overall Study||151
1065344|NCT00878644|2583298|P2|STARTED|Overall Study||140
1065345|NCT00878644|2583299|P1|STARTED|Overall Study||155
1065352|NCT00878722|2583346|P8|NOT COMPLETED|Overall Study||7
1065353|NCT00878722|2583347|P7|NOT COMPLETED|Overall Study||6
1065354|NCT00878722|2583348|P6|NOT COMPLETED|Overall Study||2
1065355|NCT00878722|2583349|P5|NOT COMPLETED|Overall Study||7
1065356|NCT00878722|2583350|P4|NOT COMPLETED|Overall Study||9
1065357|NCT00878722|2583351|P3|NOT COMPLETED|Overall Study||3
1065358|NCT00878722|2583352|P2|NOT COMPLETED|Overall Study||3
1065359|NCT00878722|2583353|P1|NOT COMPLETED|Overall Study||3
1065360|NCT00878722|2583346|P8|COMPLETED|Overall Study||0
1065361|NCT00878722|2583347|P7|COMPLETED|Overall Study||0
1065362|NCT00878722|2583348|P6|COMPLETED|Overall Study||1
1065363|NCT00878722|2583349|P5|COMPLETED|Overall Study||0
1065364|NCT00878722|2583350|P4|COMPLETED|Overall Study||0
1065365|NCT00878722|2583351|P3|COMPLETED|Overall Study||0
1065366|NCT00878722|2583352|P2|COMPLETED|Overall Study||0
1065367|NCT00878722|2583353|P1|COMPLETED|Overall Study||0
1065368|NCT00878722|2583346|P8|STARTED|Overall Study||7
1065369|NCT00878722|2583347|P7|STARTED|Overall Study||6
1065370|NCT00878722|2583348|P6|STARTED|Overall Study||3
1065371|NCT00878722|2583349|P5|STARTED|Overall Study||7
1065372|NCT00878722|2583350|P4|STARTED|Overall Study||9
1065373|NCT00878722|2583351|P3|STARTED|Overall Study||3
1065374|NCT00878722|2583352|P2|STARTED|Overall Study||3
1065375|NCT00878722|2583353|P1|STARTED|Overall Study||3
1065376|NCT00878800|2583441|P5|NOT COMPLETED|Overall Study||16
1065377|NCT00878800|2583442|P4|NOT COMPLETED|Overall Study||6
1065378|NCT00878800|2583443|P3|NOT COMPLETED|Overall Study||9
1065379|NCT00878800|2583444|P2|NOT COMPLETED|Overall Study||7
1065380|NCT00878800|2583445|P1|NOT COMPLETED|Overall Study||3
1065381|NCT00878800|2583441|P5|COMPLETED|Overall Study|Mean number of cycles administered: 6.4|0
1065382|NCT00878800|2583442|P4|COMPLETED|Overall Study|Mean number of cycles administered: 5.3|0
1065383|NCT00878800|2583443|P3|COMPLETED|Overall Study|Mean number of cycles administered: 3.0|0
1065384|NCT00878800|2583444|P2|COMPLETED|Overall Study|Mean number of cycles administered: 4.6|0
1065385|NCT00878800|2583445|P1|COMPLETED|Overall Study|Mean number of cycles administered: 4.0|0
1065386|NCT00878800|2583441|P5|STARTED|Overall Study||16
1065387|NCT00878800|2583442|P4|STARTED|Overall Study||6
1065388|NCT00878800|2583443|P3|STARTED|Overall Study||9
1065389|NCT00878800|2583444|P2|STARTED|Overall Study||7
1065390|NCT00878800|2583445|P1|STARTED|Overall Study||3
1065391|NCT00878826|2583475|P3|NOT COMPLETED|Overall Study||0
1065392|NCT00878826|2583476|P2|NOT COMPLETED|Overall Study||0
1065393|NCT00878826|2583477|P1|NOT COMPLETED|Overall Study||0
1065394|NCT00878826|2583475|P3|COMPLETED|Overall Study||2
1065395|NCT00878826|2583476|P2|COMPLETED|Overall Study||6
1065396|NCT00878826|2583477|P1|COMPLETED|Overall Study||3
1065397|NCT00878826|2583475|P3|STARTED|Overall Study||2
1065398|NCT00878826|2583476|P2|STARTED|Overall Study||6
1065399|NCT00878826|2583477|P1|STARTED|Overall Study||3
1065400|NCT00878878|2583496|P2|NOT COMPLETED|Overall Study||0
1065401|NCT00878878|2583497|P1|NOT COMPLETED|Overall Study||0
1065402|NCT00878878|2583496|P2|COMPLETED|Overall Study||15
1065403|NCT00878878|2583497|P1|COMPLETED|Overall Study||15
1065404|NCT00878878|2583496|P2|STARTED|Overall Study||15
1065405|NCT00878878|2583497|P1|STARTED|Overall Study||15
1065406|NCT00879398|2583507|P1|NOT COMPLETED|Overall Study||675
1065407|NCT00879398|2583507|P1|COMPLETED|Overall Study||2434
1065408|NCT00879398|2583507|P1|STARTED|Overall Study||3109
1065409|NCT00879411|2583517|P1|NOT COMPLETED|Overall Study||162
1065410|NCT00879411|2583517|P1|COMPLETED|Overall Study||539
1065411|NCT00879411|2583517|P1|STARTED|Overall Study||701
1065412|NCT00879619|2583523|P1|NOT COMPLETED|Overall Study||0
1065413|NCT00879619|2583523|P1|COMPLETED|Overall Study||4
1065414|NCT00879619|2583523|P1|STARTED|Overall Study||4
1065415|NCT00879645|2583536|P4|NOT COMPLETED|Overall Study||0
1065416|NCT00879645|2583537|P3|NOT COMPLETED|Overall Study||0
1065417|NCT00879645|2583538|P2|NOT COMPLETED|Overall Study||0
1065418|NCT00879645|2583539|P1|NOT COMPLETED|Overall Study||1
1065419|NCT00879645|2583536|P4|COMPLETED|Overall Study||7
1065420|NCT00879645|2583537|P3|COMPLETED|Overall Study||6
1065421|NCT00879645|2583538|P2|COMPLETED|Overall Study||6
1065422|NCT00879645|2583539|P1|COMPLETED|Overall Study||8
1065423|NCT00879645|2583536|P4|STARTED|Overall Study||7
1065424|NCT00879645|2583537|P3|STARTED|Overall Study||6
1065425|NCT00879645|2583538|P2|STARTED|Overall Study||6
1065426|NCT00879645|2583539|P1|STARTED|Overall Study||9
1065427|NCT00879684|2583557|P7|NOT COMPLETED|Stage 2: Expanded Cohort||13
1065428|NCT00879684|2583558|P6|NOT COMPLETED|Stage 2: Expanded Cohort||0
1065429|NCT00879684|2583559|P5|NOT COMPLETED|Stage 2: Expanded Cohort||0
1065430|NCT00879684|2583560|P4|NOT COMPLETED|Stage 2: Expanded Cohort||0
1065431|NCT00879684|2583561|P3|NOT COMPLETED|Stage 2: Expanded Cohort||0
1065432|NCT00879684|2583562|P2|NOT COMPLETED|Stage 2: Expanded Cohort||0
1065433|NCT00879684|2583563|P1|NOT COMPLETED|Stage 2: Expanded Cohort||0
1065434|NCT00879684|2583557|P7|COMPLETED|Stage 2: Expanded Cohort||0
1065435|NCT00879684|2583558|P6|COMPLETED|Stage 2: Expanded Cohort||0
1065436|NCT00879684|2583559|P5|COMPLETED|Stage 2: Expanded Cohort||0
1065437|NCT00879684|2583560|P4|COMPLETED|Stage 2: Expanded Cohort||0
1065438|NCT00879684|2583561|P3|COMPLETED|Stage 2: Expanded Cohort||0
1065439|NCT00879684|2583562|P2|COMPLETED|Stage 2: Expanded Cohort||0
1065440|NCT00879684|2583563|P1|COMPLETED|Stage 2: Expanded Cohort||0
1065441|NCT00879684|2583557|P7|STARTED|Stage 2: Expanded Cohort||13
1065442|NCT00879684|2583558|P6|STARTED|Stage 2: Expanded Cohort||0
1065443|NCT00879684|2583559|P5|STARTED|Stage 2: Expanded Cohort||0
1065444|NCT00879684|2583560|P4|STARTED|Stage 2: Expanded Cohort||0
1065445|NCT00879684|2583561|P3|STARTED|Stage 2: Expanded Cohort||0
1065446|NCT00879684|2583562|P2|STARTED|Stage 2: Expanded Cohort||0
1065447|NCT00879684|2583563|P1|STARTED|Stage 2: Expanded Cohort||0
1065448|NCT00879684|2583557|P7|NOT COMPLETED|Stage 1: Dose Escalation||0
1065449|NCT00879684|2583558|P6|NOT COMPLETED|Stage 1: Dose Escalation||3
1065450|NCT00879684|2583559|P5|NOT COMPLETED|Stage 1: Dose Escalation||3
1065451|NCT00879684|2583560|P4|NOT COMPLETED|Stage 1: Dose Escalation||6
1065452|NCT00879684|2583561|P3|NOT COMPLETED|Stage 1: Dose Escalation||3
1065453|NCT00879684|2583562|P2|NOT COMPLETED|Stage 1: Dose Escalation||3
1065454|NCT00879684|2583563|P1|NOT COMPLETED|Stage 1: Dose Escalation||3
1065455|NCT00879684|2583557|P7|COMPLETED|Stage 1: Dose Escalation||0
1065456|NCT00879684|2583558|P6|COMPLETED|Stage 1: Dose Escalation||0
1065457|NCT00879684|2583559|P5|COMPLETED|Stage 1: Dose Escalation||0
1065458|NCT00879684|2583560|P4|COMPLETED|Stage 1: Dose Escalation||0
1065459|NCT00879684|2583561|P3|COMPLETED|Stage 1: Dose Escalation||0
1065460|NCT00879684|2583562|P2|COMPLETED|Stage 1: Dose Escalation||0
1065461|NCT00879684|2583563|P1|COMPLETED|Stage 1: Dose Escalation||0
1065462|NCT00879684|2583557|P7|STARTED|Stage 1: Dose Escalation||0
1065463|NCT00879684|2583558|P6|STARTED|Stage 1: Dose Escalation||3
1065464|NCT00879684|2583559|P5|STARTED|Stage 1: Dose Escalation||3
1065465|NCT00879684|2583560|P4|STARTED|Stage 1: Dose Escalation||6
1065466|NCT00879684|2583561|P3|STARTED|Stage 1: Dose Escalation||3
1065467|NCT00879684|2583562|P2|STARTED|Stage 1: Dose Escalation||3
1065468|NCT00879684|2583563|P1|STARTED|Stage 1: Dose Escalation||3
1065469|NCT00879697|2583627|P2|NOT COMPLETED|Overall Study||2
1065470|NCT00879697|2583628|P1|NOT COMPLETED|Overall Study||2
1065471|NCT00879697|2583627|P2|COMPLETED|Overall Study|Two patients did not finish the trial|15
1065472|NCT00879697|2583628|P1|COMPLETED|Overall Study|Two patients did not finish the trial|15
1065473|NCT00879697|2583627|P2|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
1065474|NCT00879697|2583628|P1|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
1065475|NCT00879710|2583636|P4|NOT COMPLETED|Phase 2 6 Weeks||0
1065476|NCT00879710|2583637|P3|NOT COMPLETED|Phase 2 6 Weeks||0
1065477|NCT00879710|2583638|P2|NOT COMPLETED|Phase 2 6 Weeks||0
1065478|NCT00879710|2583639|P1|NOT COMPLETED|Phase 2 6 Weeks||0
1065479|NCT00879710|2583636|P4|COMPLETED|Phase 2 6 Weeks||13
1065480|NCT00879710|2583637|P3|COMPLETED|Phase 2 6 Weeks||10
1065481|NCT00879710|2583638|P2|COMPLETED|Phase 2 6 Weeks||14
1065482|NCT00879710|2583639|P1|COMPLETED|Phase 2 6 Weeks||10
1065483|NCT00879710|2583636|P4|STARTED|Phase 2 6 Weeks||13
1065484|NCT00879710|2583637|P3|STARTED|Phase 2 6 Weeks||10
1065485|NCT00879710|2583638|P2|STARTED|Phase 2 6 Weeks||14
1065486|NCT00879710|2583639|P1|STARTED|Phase 2 6 Weeks||10
1065487|NCT00879710|2583636|P4|NOT COMPLETED|Wash Out Period of 4 Weeks||0
1065488|NCT00879710|2583637|P3|NOT COMPLETED|Wash Out Period of 4 Weeks||0
1065489|NCT00879710|2583638|P2|NOT COMPLETED|Wash Out Period of 4 Weeks||0
1065490|NCT00879710|2583639|P1|NOT COMPLETED|Wash Out Period of 4 Weeks||0
1065491|NCT00879710|2583636|P4|COMPLETED|Wash Out Period of 4 Weeks||13
1065492|NCT00879710|2583637|P3|COMPLETED|Wash Out Period of 4 Weeks||10
1065493|NCT00879710|2583638|P2|COMPLETED|Wash Out Period of 4 Weeks||14
1065494|NCT00879710|2583639|P1|COMPLETED|Wash Out Period of 4 Weeks||10
1065495|NCT00879710|2583636|P4|STARTED|Wash Out Period of 4 Weeks||13
1065496|NCT00879710|2583637|P3|STARTED|Wash Out Period of 4 Weeks|The person who did not complete ezetimibe arm came back to complete simvastatin arm.|10
1065497|NCT00879710|2583638|P2|STARTED|Wash Out Period of 4 Weeks||14
1065498|NCT00879710|2583639|P1|STARTED|Wash Out Period of 4 Weeks||10
1065499|NCT00879710|2583636|P4|NOT COMPLETED|Phase 1 - 6 Weeks||4
1065500|NCT00879710|2583637|P3|NOT COMPLETED|Phase 1 - 6 Weeks||2
1065501|NCT00879710|2583638|P2|NOT COMPLETED|Phase 1 - 6 Weeks||3
1065502|NCT00879710|2583639|P1|NOT COMPLETED|Phase 1 - 6 Weeks||2
1065503|NCT00879710|2583636|P4|COMPLETED|Phase 1 - 6 Weeks||13
1065504|NCT00879710|2583637|P3|COMPLETED|Phase 1 - 6 Weeks||9
1065505|NCT00879710|2583638|P2|COMPLETED|Phase 1 - 6 Weeks||14
1065506|NCT00879710|2583639|P1|COMPLETED|Phase 1 - 6 Weeks||10
1065507|NCT00879710|2583636|P4|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|17
1065508|NCT00879710|2583637|P3|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|11
1065509|NCT00879710|2583638|P2|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|17
1065510|NCT00879710|2583639|P1|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|12
1065511|NCT00879775|2583649|P2|NOT COMPLETED|Overall Study||1
1065512|NCT00879775|2583650|P1|NOT COMPLETED|Overall Study||2
1065513|NCT00879775|2583649|P2|COMPLETED|Overall Study||20
1065514|NCT00879775|2583650|P1|COMPLETED|Overall Study||18
1065515|NCT00879775|2583649|P2|STARTED|Overall Study||21
1065516|NCT00879775|2583650|P1|STARTED|Overall Study||20
1065517|NCT00879814|2583668|P4|NOT COMPLETED|Overall Study||5
1065518|NCT00879814|2583669|P3|NOT COMPLETED|Overall Study||3
1065519|NCT00879814|2583670|P2|NOT COMPLETED|Overall Study||2
1065520|NCT00879814|2583671|P1|NOT COMPLETED|Overall Study||4
1065521|NCT00879814|2583668|P4|COMPLETED|Overall Study||7
1065522|NCT00879814|2583669|P3|COMPLETED|Overall Study||9
1065523|NCT00879814|2583670|P2|COMPLETED|Overall Study||10
1065524|NCT00879814|2583671|P1|COMPLETED|Overall Study||8
1065525|NCT00879814|2583668|P4|STARTED|Overall Study||12
1065526|NCT00879814|2583669|P3|STARTED|Overall Study||12
1065527|NCT00879814|2583670|P2|STARTED|Overall Study||12
1065528|NCT00879814|2583671|P1|STARTED|Overall Study||12
1065529|NCT00879879|2583777|P1|NOT COMPLETED|Overall Study||3
1065530|NCT00879879|2583777|P1|COMPLETED|Overall Study||17
1065531|NCT00879879|2583777|P1|STARTED|Overall Study||20
1065532|NCT00879970|2583784|P5|NOT COMPLETED|Period 2 Vitamin D Randomization||7
1065533|NCT00879970|2583785|P4|NOT COMPLETED|Period 2 Vitamin D Randomization||4
1065534|NCT00879970|2583786|P3|NOT COMPLETED|Period 2 Vitamin D Randomization||0
1065535|NCT00879970|2583787|P2|NOT COMPLETED|Period 2 Vitamin D Randomization||0
1065536|NCT00879970|2583788|P1|NOT COMPLETED|Period 2 Vitamin D Randomization||0
1065537|NCT00879970|2583784|P5|COMPLETED|Period 2 Vitamin D Randomization||600
1065538|NCT00879970|2583785|P4|COMPLETED|Period 2 Vitamin D Randomization||610
1065539|NCT00879970|2583786|P3|COMPLETED|Period 2 Vitamin D Randomization||0
1065540|NCT00879970|2583787|P2|COMPLETED|Period 2 Vitamin D Randomization||0
1065541|NCT00879970|2583788|P1|COMPLETED|Period 2 Vitamin D Randomization||0
1065542|NCT00879970|2583784|P5|STARTED|Period 2 Vitamin D Randomization||607
1065543|NCT00879970|2583785|P4|STARTED|Period 2 Vitamin D Randomization||614
1065544|NCT00879970|2583786|P3|STARTED|Period 2 Vitamin D Randomization||0
1065545|NCT00879970|2583787|P2|STARTED|Period 2 Vitamin D Randomization||0
1065546|NCT00879970|2583788|P1|STARTED|Period 2 Vitamin D Randomization||0
1065547|NCT00879970|2583784|P5|NOT COMPLETED|Period 1 TZD Randomization||0
1065548|NCT00879970|2583785|P4|NOT COMPLETED|Period 1 TZD Randomization||0
1065549|NCT00879970|2583786|P3|NOT COMPLETED|Period 1 TZD Randomization||6
1065550|NCT00879970|2583787|P2|NOT COMPLETED|Period 1 TZD Randomization||4
1065551|NCT00879970|2583788|P1|NOT COMPLETED|Period 1 TZD Randomization||8
1065552|NCT00879970|2583784|P5|COMPLETED|Period 1 TZD Randomization||0
1065553|NCT00879970|2583785|P4|COMPLETED|Period 1 TZD Randomization||0
1065554|NCT00879970|2583786|P3|COMPLETED|Period 1 TZD Randomization||393
1065555|NCT00879970|2583787|P2|COMPLETED|Period 1 TZD Randomization||388
1065556|NCT00879970|2583788|P1|COMPLETED|Period 1 TZD Randomization||533
1065557|NCT00879970|2583784|P5|STARTED|Period 1 TZD Randomization||0
1065558|NCT00879970|2583785|P4|STARTED|Period 1 TZD Randomization||0
1065559|NCT00879970|2583786|P3|STARTED|Period 1 TZD Randomization||399
1065560|NCT00879970|2583787|P2|STARTED|Period 1 TZD Randomization||392
1065561|NCT00879970|2583788|P1|STARTED|Period 1 TZD Randomization||541
1065562|NCT00879996|2583872|P2|NOT COMPLETED|Overall Study||13
1065563|NCT00879996|2583873|P1|NOT COMPLETED|Overall Study||15
1065564|NCT00879996|2583872|P2|COMPLETED|Overall Study||13
1065565|NCT00879996|2583873|P1|COMPLETED|Overall Study||13
1065566|NCT00879996|2583872|P2|STARTED|Overall Study||26
1065567|NCT00879996|2583873|P1|STARTED|Overall Study||28
1065568|NCT00880009|2583885|P1|NOT COMPLETED|Overall Study||16
1065569|NCT00880009|2583885|P1|COMPLETED|Overall Study||0
1065570|NCT00880009|2583885|P1|STARTED|Overall Study||16
1065571|NCT00880022|2583909|P2|NOT COMPLETED|Overall Study||3
1065572|NCT00880022|2583910|P1|NOT COMPLETED|Overall Study||2
1065573|NCT00880022|2583909|P2|COMPLETED|Overall Study||21
1065574|NCT00880022|2583910|P1|COMPLETED|Overall Study||21
1065575|NCT00880022|2583909|P2|STARTED|Overall Study||24
1065576|NCT00880022|2583910|P1|STARTED|Overall Study||23
1065577|NCT00880100|2583916|P1|NOT COMPLETED|Treatment Phase With Ultrase® MT12||3
1065578|NCT00880100|2583916|P1|COMPLETED|Treatment Phase With Ultrase® MT12||45
1065579|NCT00880100|2583916|P1|STARTED|Treatment Phase With Ultrase® MT12||48
1065580|NCT00880100|2583916|P1|NOT COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||1
1065581|NCT00880100|2583916|P1|COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||48
1065582|NCT00880100|2583916|P1|STARTED|Baseline Phase-Usual Pancreatic Enzymes||49
1065583|NCT00880165|2583929|P2|NOT COMPLETED|Overall Study||50
1065584|NCT00880165|2583930|P1|NOT COMPLETED|Overall Study||62
1065585|NCT00880165|2583929|P2|COMPLETED|Overall Study||98
1065586|NCT00880165|2583930|P1|COMPLETED|Overall Study||86
1065587|NCT00880165|2583929|P2|STARTED|Overall Study||148
1065588|NCT00880165|2583930|P1|STARTED|Overall Study||148
1065589|NCT00880191|2583942|P2|NOT COMPLETED|Overall Study||8
1065590|NCT00880191|2583943|P1|NOT COMPLETED|Overall Study||13
1065591|NCT00880191|2583942|P2|COMPLETED|Overall Study||198
1065592|NCT00880191|2583943|P1|COMPLETED|Overall Study||194
1065593|NCT00880191|2583942|P2|Available for Primary Endpoint Analysis|Overall Study||206
1065594|NCT00880191|2583943|P1|Available for Primary Endpoint Analysis|Overall Study||207
1065595|NCT00880191|2583942|P2|STARTED|Overall Study||206
1065596|NCT00880191|2583943|P1|STARTED|Overall Study||207
1065597|NCT00880230|2583961|P1|NOT COMPLETED|Overall Study||7
1065598|NCT00880230|2583961|P1|COMPLETED|Overall Study||134
1065599|NCT00880230|2583961|P1|STARTED|Overall Study||141
1065600|NCT00880256|2583981|P1|NOT COMPLETED|Overall Study||28
1065601|NCT00880256|2583981|P1|COMPLETED|Overall Study||65
1065602|NCT00880256|2583981|P1|STARTED|Overall Study||93
1065603|NCT00880269|2583988|P2|NOT COMPLETED|Overall Study||27
1065604|NCT00880269|2583989|P1|NOT COMPLETED|Overall Study||32
1065605|NCT00880269|2583988|P2|COMPLETED|Overall Study||0
1065606|NCT00880269|2583989|P1|COMPLETED|Overall Study||0
1065607|NCT00880269|2583988|P2|Discontinued Treatment|Overall Study||27
1065608|NCT00880269|2583989|P1|Discontinued Treatment|Overall Study||32
1065609|NCT00880269|2583988|P2|STARTED|Overall Study||27
1065610|NCT00880269|2583989|P1|STARTED|Overall Study||32
1065611|NCT00880334|2584007|P2|NOT COMPLETED|Overall Study||3
1065612|NCT00880334|2584008|P1|NOT COMPLETED|Overall Study||4
1065613|NCT00880334|2584007|P2|COMPLETED|Overall Study||72
1065614|NCT00880334|2584008|P1|COMPLETED|Overall Study||70
1065615|NCT00880334|2584007|P2|Eligible & Treated|Overall Study||72
1065616|NCT00880334|2584008|P1|Eligible & Treated|Overall Study||70
1065617|NCT00880334|2584007|P2|STARTED|Overall Study||75
1065618|NCT00880334|2584008|P1|STARTED|Overall Study||74
1065619|NCT00880360|2584022|P1|NOT COMPLETED|Overall Study||0
1065620|NCT00880360|2584022|P1|COMPLETED|Overall Study||19
1065621|NCT00880360|2584022|P1|STARTED|Overall Study||19
1065622|NCT00880399|2584029|P3|NOT COMPLETED|Overall Study||26
1065623|NCT00880399|2584030|P2|NOT COMPLETED|Overall Study||29
1065624|NCT00880399|2584031|P1|NOT COMPLETED|Overall Study||31
1065625|NCT00880399|2584029|P3|COMPLETED|Overall Study||81
1065626|NCT00880399|2584030|P2|COMPLETED|Overall Study||84
1065627|NCT00880399|2584031|P1|COMPLETED|Overall Study||77
1065628|NCT00880399|2584029|P3|STARTED|Overall Study||107
1065629|NCT00880399|2584030|P2|STARTED|Overall Study||113
1065630|NCT00880399|2584031|P1|STARTED|Overall Study||108
1065631|NCT00880425|2584087|P2|NOT COMPLETED|Overall Study||0
1065632|NCT00880425|2584088|P1|NOT COMPLETED|Overall Study||0
1065633|NCT00880425|2584087|P2|COMPLETED|Overall Study||27
1065634|NCT00880425|2584088|P1|COMPLETED|Overall Study||18
1065635|NCT00880425|2584087|P2|STARTED|Overall Study||27
1065636|NCT00880425|2584088|P1|STARTED|Overall Study||18
1065637|NCT00880542|2584096|P1|NOT COMPLETED|Follow-up Period||0
1065638|NCT00880542|2584096|P1|COMPLETED|Follow-up Period||7
1065639|NCT00880542|2584096|P1|STARTED|Follow-up Period|All 7 patients who started the treatment period completed the follow-up period.|7
1065640|NCT00880542|2584096|P1|NOT COMPLETED|Continued Treatment Period||0
1065641|NCT00880542|2584096|P1|COMPLETED|Continued Treatment Period||0
1065642|NCT00880542|2584096|P1|STARTED|Continued Treatment Period|None of the 3 subjects from previous period met study criteria for continuation of therapy.|0
1065643|NCT00880542|2584096|P1|NOT COMPLETED|Post Surgical Evaluation||0
1065644|NCT00880542|2584096|P1|COMPLETED|Post Surgical Evaluation|none of the 3 subjects met study criteria for continuation of therapy.|3
1065645|NCT00880542|2584096|P1|STARTED|Post Surgical Evaluation||3
1065646|NCT00880542|2584096|P1|NOT COMPLETED|REP: Surgical Resection||1
1065647|NCT00880542|2584096|P1|COMPLETED|REP: Surgical Resection||3
1065648|NCT00880542|2584096|P1|STARTED|REP: Surgical Resection||4
1065649|NCT00880542|2584096|P1|NOT COMPLETED|Response Evaluation Period(REP): PET/CT||0
1065650|NCT00880542|2584096|P1|COMPLETED|Response Evaluation Period(REP): PET/CT||4
1065651|NCT00880542|2584096|P1|STARTED|Response Evaluation Period(REP): PET/CT||4
1065652|NCT00880542|2584096|P1|NOT COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||3
1065653|NCT00880542|2584096|P1|COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||4
1065654|NCT00880542|2584096|P1|STARTED|Treatment Period (Sorafenib+Ifosfamide)||7
1065655|NCT00880555|2584104|P6|NOT COMPLETED|Overall Study||1
1065656|NCT00880555|2584105|P5|NOT COMPLETED|Overall Study||1
1065657|NCT00880555|2584106|P4|NOT COMPLETED|Overall Study||2
1065658|NCT00880555|2584107|P3|NOT COMPLETED|Overall Study||5
1065659|NCT00880555|2584108|P2|NOT COMPLETED|Overall Study||17
1065660|NCT00880555|2584109|P1|NOT COMPLETED|Overall Study||10
1065661|NCT00880555|2584104|P6|COMPLETED|Overall Study||0
1065662|NCT00880555|2584105|P5|COMPLETED|Overall Study||0
1065663|NCT00880555|2584106|P4|COMPLETED|Overall Study||0
1065664|NCT00880555|2584107|P3|COMPLETED|Overall Study||6
1065665|NCT00880555|2584108|P2|COMPLETED|Overall Study||23
1065666|NCT00880555|2584109|P1|COMPLETED|Overall Study||13
1065667|NCT00880555|2584104|P6|STARTED|Overall Study||1
1065668|NCT00880555|2584105|P5|STARTED|Overall Study||1
1065669|NCT00880555|2584106|P4|STARTED|Overall Study||2
1065670|NCT00880555|2584107|P3|STARTED|Overall Study||11
1065671|NCT00880555|2584108|P2|STARTED|Overall Study||40
1065672|NCT00880555|2584109|P1|STARTED|Overall Study||23
1065673|NCT00880568|2584129|P9|NOT COMPLETED|Overall Study||3
1065674|NCT00880568|2584130|P8|NOT COMPLETED|Overall Study||2
1065675|NCT00880568|2584131|P7|NOT COMPLETED|Overall Study||6
1065676|NCT00880568|2584132|P6|NOT COMPLETED|Overall Study||3
1065677|NCT00880568|2584133|P5|NOT COMPLETED|Overall Study||3
1065678|NCT00880568|2584134|P4|NOT COMPLETED|Overall Study||1
1065679|NCT00880568|2584135|P3|NOT COMPLETED|Overall Study||3
1065680|NCT00880568|2584136|P2|NOT COMPLETED|Overall Study||3
1065681|NCT00880568|2584137|P1|NOT COMPLETED|Overall Study||3
1065682|NCT00880568|2584129|P9|COMPLETED|Overall Study||0
1065683|NCT00880568|2584130|P8|COMPLETED|Overall Study||0
1065684|NCT00880568|2584131|P7|COMPLETED|Overall Study||0
1065685|NCT00880568|2584132|P6|COMPLETED|Overall Study||0
1065686|NCT00880568|2584133|P5|COMPLETED|Overall Study||0
1065687|NCT00880568|2584134|P4|COMPLETED|Overall Study||0
1065688|NCT00880568|2584135|P3|COMPLETED|Overall Study||0
1065689|NCT00880568|2584136|P2|COMPLETED|Overall Study||0
1065690|NCT00880568|2584137|P1|COMPLETED|Overall Study||0
1065691|NCT00880568|2584129|P9|STARTED|Overall Study||3
1065692|NCT00880568|2584130|P8|STARTED|Overall Study||2
1065693|NCT00880568|2584131|P7|STARTED|Overall Study||6
1065694|NCT00880568|2584132|P6|STARTED|Overall Study||3
1065695|NCT00880568|2584133|P5|STARTED|Overall Study||3
1065696|NCT00880568|2584134|P4|STARTED|Overall Study||1
1065697|NCT00880568|2584135|P3|STARTED|Overall Study||3
1065698|NCT00880568|2584136|P2|STARTED|Overall Study||3
1065699|NCT00880568|2584137|P1|STARTED|Overall Study||3
1065700|NCT00880581|2584180|P1|NOT COMPLETED|Cycle 2 Re-treatment||0
1065701|NCT00880581|2584180|P1|COMPLETED|Cycle 2 Re-treatment||24
1065702|NCT00880581|2584180|P1|STARTED|Cycle 2 Re-treatment|6 subjects with progessive disease were not treated and evaluated in Cycle 2|24
1065703|NCT00880581|2584180|P1|NOT COMPLETED|Cycle 1||0
1065704|NCT00880581|2584180|P1|COMPLETED|Cycle 1||30
1065705|NCT00880581|2584180|P1|STARTED|Cycle 1||30
1065706|NCT00880620|2584189|P4|NOT COMPLETED|Overall Study||24
1065707|NCT00880620|2584190|P3|NOT COMPLETED|Overall Study||21
1065708|NCT00880620|2584191|P2|NOT COMPLETED|Overall Study||15
1065709|NCT00880620|2584192|P1|NOT COMPLETED|Overall Study||21
1065710|NCT00880620|2584189|P4|COMPLETED|Overall Study||74
1065711|NCT00880620|2584190|P3|COMPLETED|Overall Study||83
1065712|NCT00880620|2584191|P2|COMPLETED|Overall Study||72
1065713|NCT00880620|2584192|P1|COMPLETED|Overall Study||71
1065714|NCT00880620|2584189|P4|Week 23|Overall Study||74
1065715|NCT00880620|2584190|P3|Week 23|Overall Study||85
1065716|NCT00880620|2584191|P2|Week 23|Overall Study||72
1065717|NCT00880620|2584192|P1|Week 23|Overall Study||71
1065718|NCT00880620|2584189|P4|Week 16|Overall Study||74
1065719|NCT00880620|2584190|P3|Week 16|Overall Study||87
1065720|NCT00880620|2584191|P2|Week 16|Overall Study||73
1065721|NCT00880620|2584192|P1|Week 16|Overall Study||74
1065722|NCT00880620|2584189|P4|Week 9|Overall Study||78
1065723|NCT00880620|2584190|P3|Week 9|Overall Study||88
1065724|NCT00880620|2584191|P2|Week 9|Overall Study||73
1065725|NCT00880620|2584192|P1|Week 9|Overall Study||80
1065726|NCT00880620|2584189|P4|Week 4|Overall Study||86
1065727|NCT00880620|2584190|P3|Week 4|Overall Study||94
1065728|NCT00880620|2584191|P2|Week 4|Overall Study||79
1065729|NCT00880620|2584192|P1|Week 4|Overall Study||88
1065730|NCT00880620|2584189|P4|STARTED|Overall Study||98
1065731|NCT00880620|2584190|P3|STARTED|Overall Study||104
1065732|NCT00880620|2584191|P2|STARTED|Overall Study||87
1065733|NCT00880620|2584192|P1|STARTED|Overall Study||92
1065734|NCT00880685|2584206|P1|NOT COMPLETED|Memantine 30mg||0
1065735|NCT00880685|2584206|P1|COMPLETED|Memantine 30mg||9
1065736|NCT00880685|2584206|P1|STARTED|Memantine 30mg||9
1065737|NCT00880685|2584206|P1|NOT COMPLETED|Memantine 20mg||1
1065738|NCT00880685|2584206|P1|COMPLETED|Memantine 20mg||9
1065739|NCT00880685|2584206|P1|STARTED|Memantine 20mg||10
1065740|NCT00880685|2584206|P1|NOT COMPLETED|Memantine 10mg||2
1065741|NCT00880685|2584206|P1|COMPLETED|Memantine 10mg||10
1065742|NCT00880685|2584206|P1|STARTED|Memantine 10mg||12
1065755|NCT00880750|2584249|P2|NOT COMPLETED|Second Intervention||2
1065756|NCT00880750|2584250|P1|NOT COMPLETED|Second Intervention||4
1065757|NCT00880750|2584249|P2|COMPLETED|Second Intervention||30
1065758|NCT00880750|2584250|P1|COMPLETED|Second Intervention||26
1065759|NCT00880750|2584249|P2|STARTED|Second Intervention||32
1065760|NCT00880750|2584250|P1|STARTED|Second Intervention||30
1065761|NCT00880750|2584249|P2|NOT COMPLETED|Washout Period||0
1065762|NCT00880750|2584250|P1|NOT COMPLETED|Washout Period||0
1065763|NCT00880750|2584249|P2|COMPLETED|Washout Period||32
1065764|NCT00880750|2584250|P1|COMPLETED|Washout Period||30
1065765|NCT00880750|2584249|P2|STARTED|Washout Period||32
1065766|NCT00880750|2584250|P1|STARTED|Washout Period||30
1065767|NCT00880750|2584249|P2|NOT COMPLETED|First Intervention||1
1065768|NCT00880750|2584250|P1|NOT COMPLETED|First Intervention||9
1065769|NCT00880750|2584249|P2|COMPLETED|First Intervention||32
1065770|NCT00880750|2584250|P1|COMPLETED|First Intervention||30
1065771|NCT00880750|2584249|P2|STARTED|First Intervention||33
1065772|NCT00880750|2584250|P1|STARTED|First Intervention||39
1065773|NCT00880763|2584268|P4|NOT COMPLETED|Extension Period (Part 2)||3
1065774|NCT00880763|2584269|P3|NOT COMPLETED|Extension Period (Part 2)||3
1065775|NCT00880763|2584270|P2|NOT COMPLETED|Extension Period (Part 2)||3
1065776|NCT00880763|2584271|P1|NOT COMPLETED|Extension Period (Part 2)||0
1065777|NCT00880763|2584268|P4|COMPLETED|Extension Period (Part 2)||19
1065778|NCT00880763|2584269|P3|COMPLETED|Extension Period (Part 2)||20
1065779|NCT00880763|2584270|P2|COMPLETED|Extension Period (Part 2)||19
1065780|NCT00880763|2584271|P1|COMPLETED|Extension Period (Part 2)||23
1065781|NCT00880763|2584268|P4|STARTED|Extension Period (Part 2)||22
1065782|NCT00880763|2584269|P3|STARTED|Extension Period (Part 2)||23
1065783|NCT00880763|2584270|P2|STARTED|Extension Period (Part 2)||22
1065784|NCT00880763|2584271|P1|STARTED|Extension Period (Part 2)||23
1065785|NCT00880763|2584268|P4|NOT COMPLETED|Initial Treatment Period (Part 1)||0
1065786|NCT00880763|2584269|P3|NOT COMPLETED|Initial Treatment Period (Part 1)||0
1065787|NCT00880763|2584270|P2|NOT COMPLETED|Initial Treatment Period (Part 1)||0
1065788|NCT00880763|2584271|P1|NOT COMPLETED|Initial Treatment Period (Part 1)||0
1065789|NCT00880763|2584268|P4|COMPLETED|Initial Treatment Period (Part 1)||22
1065790|NCT00880763|2584269|P3|COMPLETED|Initial Treatment Period (Part 1)||23
1065791|NCT00880763|2584270|P2|COMPLETED|Initial Treatment Period (Part 1)||22
1065792|NCT00880763|2584271|P1|COMPLETED|Initial Treatment Period (Part 1)||23
1065793|NCT00880763|2584268|P4|STARTED|Initial Treatment Period (Part 1)||22
1065794|NCT00880763|2584269|P3|STARTED|Initial Treatment Period (Part 1)||23
1065795|NCT00880763|2584270|P2|STARTED|Initial Treatment Period (Part 1)||22
1065796|NCT00880763|2584271|P1|STARTED|Initial Treatment Period (Part 1)||23
1065797|NCT00880906|2584303|P2|NOT COMPLETED|Overall Study||7
1065798|NCT00880906|2584304|P1|NOT COMPLETED|Overall Study||12
1065799|NCT00880906|2584303|P2|COMPLETED|Overall Study||14
1065800|NCT00880906|2584304|P1|COMPLETED|Overall Study||17
1065801|NCT00880906|2584303|P2|STARTED|Overall Study||21
1065802|NCT00880906|2584304|P1|STARTED|Overall Study||29
1065803|NCT00880919|2584313|P3|NOT COMPLETED|Overall Study||6
1065804|NCT00880919|2584314|P2|NOT COMPLETED|Overall Study||14
1065805|NCT00880919|2584315|P1|NOT COMPLETED|Overall Study||15
1065806|NCT00880919|2584313|P3|COMPLETED|Overall Study||23
1065807|NCT00880919|2584314|P2|COMPLETED|Overall Study||19
1065808|NCT00880919|2584315|P1|COMPLETED|Overall Study||18
1065809|NCT00880919|2584313|P3|STARTED|Overall Study||29
1065810|NCT00880919|2584314|P2|STARTED|Overall Study||33
1065811|NCT00880919|2584315|P1|STARTED|Overall Study||33
1065812|NCT00881205|2584349|P2|NOT COMPLETED|Overall Study||7
1065813|NCT00881205|2584350|P1|NOT COMPLETED|Overall Study||11
1065814|NCT00881205|2584349|P2|COMPLETED|Overall Study||34
1065815|NCT00881205|2584350|P1|COMPLETED|Overall Study||34
1065816|NCT00881205|2584349|P2|STARTED|Overall Study||41
1065817|NCT00881205|2584350|P1|STARTED|Overall Study||45
1065818|NCT00881335|2584359|P2|NOT COMPLETED|Overall Study||2
1065819|NCT00881335|2584360|P1|NOT COMPLETED|Overall Study||3
1065820|NCT00881335|2584359|P2|COMPLETED|Overall Study|2 participants did not complete the period|28
1065821|NCT00881335|2584360|P1|COMPLETED|Overall Study|3 participants did not complete the period|27
1065822|NCT00881335|2584359|P2|STARTED|Overall Study||30
1065823|NCT00881335|2584360|P1|STARTED|Overall Study||30
1065824|NCT00881465|2584380|P2|NOT COMPLETED|Overall Study||0
1065825|NCT00881465|2584381|P1|NOT COMPLETED|Overall Study||2
1065826|NCT00881465|2584380|P2|COMPLETED|Overall Study||15
1065827|NCT00881465|2584381|P1|COMPLETED|Overall Study||14
1065828|NCT00881465|2584380|P2|STARTED|Overall Study||15
1065829|NCT00881465|2584381|P1|STARTED|Overall Study||16
1065830|NCT00881504|2584391|P1|NOT COMPLETED|Overall Study||1
1065831|NCT00881504|2584391|P1|COMPLETED|Overall Study||8
1065832|NCT00881504|2584391|P1|STARTED|Overall Study||9
1065833|NCT00881530|2584402|P6|NOT COMPLETED|Overall Study||5
1065834|NCT00881530|2584403|P5|NOT COMPLETED|Overall Study||14
1065835|NCT00881530|2584404|P4|NOT COMPLETED|Overall Study||9
1065836|NCT00881530|2584405|P3|NOT COMPLETED|Overall Study||5
1065837|NCT00881530|2584406|P2|NOT COMPLETED|Overall Study||5
1065838|NCT00881530|2584407|P1|NOT COMPLETED|Overall Study||14
1065839|NCT00881530|2584402|P6|COMPLETED|Overall Study||51
1065840|NCT00881530|2584403|P5|COMPLETED|Overall Study||152
1065841|NCT00881530|2584404|P4|COMPLETED|Overall Study||157
1065842|NCT00881530|2584405|P3|COMPLETED|Overall Study||51
1065843|NCT00881530|2584406|P2|COMPLETED|Overall Study||104
1065844|NCT00881530|2584407|P1|COMPLETED|Overall Study||92
1065845|NCT00881530|2584402|P6|STARTED|Overall Study||56
1065846|NCT00881530|2584403|P5|STARTED|Overall Study||166
1065847|NCT00881530|2584404|P4|STARTED|Overall Study||166
1065848|NCT00881530|2584405|P3|STARTED|Overall Study||56
1065849|NCT00881530|2584406|P2|STARTED|Overall Study||109
1065850|NCT00881530|2584407|P1|STARTED|Overall Study||106
1065851|NCT00881608|2584468|P1|NOT COMPLETED|Overall Study||11
1065852|NCT00881608|2584468|P1|COMPLETED|Overall Study||0
1065853|NCT00881608|2584468|P1|STARTED|Overall Study||11
1065854|NCT00881621|2584485|P1|NOT COMPLETED|Overall Study||34
1065855|NCT00881621|2584485|P1|COMPLETED|Overall Study||17
1065856|NCT00881621|2584485|P1|STARTED|Overall Study||51
1065857|NCT00881647|2584494|P2|NOT COMPLETED|Overall Study||1
1065858|NCT00881647|2584495|P1|NOT COMPLETED|Overall Study||2
1065859|NCT00881647|2584494|P2|COMPLETED|Overall Study||15
1065860|NCT00881647|2584495|P1|COMPLETED|Overall Study||27
1065861|NCT00881647|2584494|P2|STARTED|Overall Study||16
1065862|NCT00881647|2584495|P1|STARTED|Overall Study||29
1065863|NCT00881712|2584508|P3|NOT COMPLETED|Overall Study||0
1065864|NCT00881712|2584509|P2|NOT COMPLETED|Overall Study||0
1065865|NCT00881712|2584510|P1|NOT COMPLETED|Overall Study||2
1065866|NCT00881712|2584508|P3|COMPLETED|Overall Study||0
1065867|NCT00881712|2584509|P2|COMPLETED|Overall Study||0
1065868|NCT00881712|2584510|P1|COMPLETED|Overall Study||13
1065869|NCT00881712|2584508|P3|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
1065870|NCT00881712|2584509|P2|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
1065871|NCT00881712|2584510|P1|STARTED|Overall Study||15
1065872|NCT00881751|2584532|P2|NOT COMPLETED|Overall Study||5
1065873|NCT00881751|2584533|P1|NOT COMPLETED|Overall Study||0
1065874|NCT00881751|2584532|P2|COMPLETED|Overall Study||43
1065875|NCT00881751|2584533|P1|COMPLETED|Overall Study||47
1065876|NCT00881751|2584532|P2|STARTED|Overall Study||48
1065877|NCT00881751|2584533|P1|STARTED|Overall Study||47
1065878|NCT00881868|2584547|P2|NOT COMPLETED|Overall Study||2
1065879|NCT00881868|2584548|P1|NOT COMPLETED|Overall Study||8
1065880|NCT00881868|2584547|P2|COMPLETED|Overall Study||38
1065881|NCT00881868|2584548|P1|COMPLETED|Overall Study||33
1065882|NCT00881868|2584547|P2|STARTED|Overall Study||40
1065883|NCT00881868|2584548|P1|STARTED|Overall Study||41
1065884|NCT00881894|2584562|P2|NOT COMPLETED|Overall Study||3
1065885|NCT00881894|2584563|P1|NOT COMPLETED|Overall Study||1
1065886|NCT00881894|2584562|P2|COMPLETED|Overall Study||23
1065887|NCT00881894|2584563|P1|COMPLETED|Overall Study||25
1065888|NCT00881894|2584562|P2|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|21
1065889|NCT00881894|2584563|P1|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|23
1065890|NCT00881894|2584562|P2|STARTED|Overall Study||26
1065891|NCT00881894|2584563|P1|STARTED|Overall Study||26
1065892|NCT00887341|2584595|P2|NOT COMPLETED|Overall Study||3
1065893|NCT00887341|2584596|P1|NOT COMPLETED|Overall Study||2
1065894|NCT00887341|2584595|P2|COMPLETED|Overall Study||36
1065895|NCT00887341|2584596|P1|COMPLETED|Overall Study||35
1065896|NCT00887341|2584595|P2|STARTED|Overall Study||39
1065897|NCT00887341|2584596|P1|STARTED|Overall Study||37
1065898|NCT00887354|2584632|P2|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||6
1065899|NCT00887354|2584633|P1|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||3
1065900|NCT00887354|2584632|P2|COMPLETED|Open Label Phase (Week 26 to Week 78)||59
1065901|NCT00887354|2584633|P1|COMPLETED|Open Label Phase (Week 26 to Week 78)||57
1065902|NCT00887354|2584632|P2|STARTED|Open Label Phase (Week 26 to Week 78)||65
1065903|NCT00887354|2584633|P1|STARTED|Open Label Phase (Week 26 to Week 78)||60
1065904|NCT00887354|2584632|P2|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||48
1065905|NCT00887354|2584633|P1|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||51
1065906|NCT00887354|2584632|P2|COMPLETED|Treatment Phase (Week 0 to Week 26)||65
1065907|NCT00887354|2584633|P1|COMPLETED|Treatment Phase (Week 0 to Week 26)||60
1065908|NCT00887354|2584632|P2|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||85
1065909|NCT00887354|2584633|P1|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||86
1065910|NCT00887354|2584632|P2|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||110
1065911|NCT00887354|2584633|P1|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||106
1065912|NCT00887354|2584632|P2|STARTED|Treatment Phase (Week 0 to Week 26)||113
1065913|NCT00887354|2584633|P1|STARTED|Treatment Phase (Week 0 to Week 26)||111
1065920|NCT00887471|2584662|P2|NOT COMPLETED|Overall Study||0
1065921|NCT00887471|2584663|P1|NOT COMPLETED|Overall Study||0
1065922|NCT00887471|2584662|P2|COMPLETED|Overall Study||15
1065923|NCT00887471|2584663|P1|COMPLETED|Overall Study||15
1065924|NCT00887471|2584662|P2|STARTED|Overall Study||15
1065925|NCT00887471|2584663|P1|STARTED|Overall Study||15
1065926|NCT00887484|2584671|P1|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||3
1065927|NCT00887484|2584671|P1|COMPLETED|Full Face Treatment (Weeks 5 and 8)||45
1065928|NCT00887484|2584671|P1|STARTED|Full Face Treatment (Weeks 5 and 8)||48
1065929|NCT00887484|2584671|P1|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
1065930|NCT00887484|2584671|P1|COMPLETED|Split Face Treatment (Weeks 1 and 2)||48
1065931|NCT00887484|2584671|P1|STARTED|Split Face Treatment (Weeks 1 and 2)||48
1065938|NCT00887549|2584746|P1|NOT COMPLETED|Maintenance Therapy||43
1065939|NCT00887549|2584746|P1|COMPLETED|Maintenance Therapy||0
1065940|NCT00887549|2584746|P1|STARTED|Maintenance Therapy||43
1065941|NCT00887549|2584746|P1|NOT COMPLETED|Induction Therapy||27
1065942|NCT00887549|2584746|P1|COMPLETED|Induction Therapy||43
1065943|NCT00887549|2584746|P1|STARTED|Induction Therapy||70
1065944|NCT00887562|2584756|P3|NOT COMPLETED|Overall Study||1
1065945|NCT00887562|2584757|P2|NOT COMPLETED|Overall Study||2
1065946|NCT00887562|2584758|P1|NOT COMPLETED|Overall Study||3
1065947|NCT00887562|2584756|P3|COMPLETED|Overall Study||7
1065948|NCT00887562|2584757|P2|COMPLETED|Overall Study||7
1065949|NCT00887562|2584758|P1|COMPLETED|Overall Study||7
1065950|NCT00887562|2584756|P3|STARTED|Overall Study||8
1065951|NCT00887562|2584757|P2|STARTED|Overall Study||9
1065952|NCT00887562|2584758|P1|STARTED|Overall Study||10
1065953|NCT00887575|2584772|P3|NOT COMPLETED|Phase II - Maintenance Therapy||0
1065954|NCT00887575|2584773|P2|NOT COMPLETED|Phase II - Maintenance Therapy||0
1065955|NCT00887575|2584774|P1|NOT COMPLETED|Phase II - Maintenance Therapy||2
1065956|NCT00887575|2584772|P3|COMPLETED|Phase II - Maintenance Therapy||0
1065957|NCT00887575|2584773|P2|COMPLETED|Phase II - Maintenance Therapy||0
1065958|NCT00887575|2584774|P1|COMPLETED|Phase II - Maintenance Therapy||6
1065959|NCT00887575|2584772|P3|STARTED|Phase II - Maintenance Therapy||0
1065960|NCT00887575|2584773|P2|STARTED|Phase II - Maintenance Therapy||0
1065961|NCT00887575|2584774|P1|STARTED|Phase II - Maintenance Therapy|Pts who completed 6 cycles of Neoadjuvant Therapy & underwent surgery were eligible for maintenance|8
1065962|NCT00887575|2584772|P3|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
1065963|NCT00887575|2584773|P2|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
1065964|NCT00887575|2584774|P1|NOT COMPLETED|Phase II - Neoadjuvant Therapy||25
1065965|NCT00887575|2584772|P3|COMPLETED|Phase II - Neoadjuvant Therapy||0
1065966|NCT00887575|2584773|P2|COMPLETED|Phase II - Neoadjuvant Therapy||0
1065967|NCT00887575|2584774|P1|COMPLETED|Phase II - Neoadjuvant Therapy||16
1065968|NCT00887575|2584772|P3|STARTED|Phase II - Neoadjuvant Therapy||0
1065969|NCT00887575|2584773|P2|STARTED|Phase II - Neoadjuvant Therapy||0
1065970|NCT00887575|2584774|P1|STARTED|Phase II - Neoadjuvant Therapy|Includes patients treated at MTD during Phase I, 39 additional patients enrolled, 4 were not treated|41
1065971|NCT00887575|2584772|P3|NOT COMPLETED|Phase I||3
1065972|NCT00887575|2584773|P2|NOT COMPLETED|Phase I||6
1065973|NCT00887575|2584774|P1|NOT COMPLETED|Phase I||0
1065974|NCT00887575|2584772|P3|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
1065975|NCT00887575|2584773|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
1065976|NCT00887575|2584774|P1|COMPLETED|Phase I||6
1065977|NCT00887575|2584772|P3|STARTED|Phase I||3
1065978|NCT00887575|2584773|P2|STARTED|Phase I||6
1065979|NCT00887575|2584774|P1|STARTED|Phase I||6
1065980|NCT00887588|2584784|P2|NOT COMPLETED|Extension Period||5
1065981|NCT00887588|2584785|P1|NOT COMPLETED|Extension Period||6
1065982|NCT00887588|2584784|P2|COMPLETED|Extension Period||120
1065983|NCT00887588|2584785|P1|COMPLETED|Extension Period||121
1065984|NCT00887588|2584784|P2|Arterial Stiffness Set|Extension Period||94
1065985|NCT00887588|2584785|P1|Arterial Stiffness Set|Extension Period||86
1065986|NCT00887588|2584784|P2|STARTED|Extension Period||125
1065987|NCT00887588|2584785|P1|STARTED|Extension Period||127
1065988|NCT00887588|2584784|P2|NOT COMPLETED|Core Period||21
1065989|NCT00887588|2584785|P1|NOT COMPLETED|Core Period||19
1065990|NCT00887588|2584784|P2|COMPLETED|Core Period||131
1065991|NCT00887588|2584785|P1|COMPLETED|Core Period||130
1065992|NCT00887588|2584784|P2|Arterial Stiffness Set|Core Period||94
1065993|NCT00887588|2584785|P1|Arterial Stiffness Set|Core Period||86
1065994|NCT00887588|2584784|P2|Full Analysis Set|Core Period||146
1065995|NCT00887588|2584785|P1|Full Analysis Set|Core Period||148
1065996|NCT00887588|2584784|P2|Extension Efficacy Set|Core Period||125
1065997|NCT00887588|2584785|P1|Extension Efficacy Set|Core Period||127
1065998|NCT00887588|2584784|P2|STARTED|Core Period||152
1065999|NCT00887588|2584785|P1|STARTED|Core Period||149
1066000|NCT00887640|2584837|P1|NOT COMPLETED|Overall Study||0
1066001|NCT00887640|2584837|P1|COMPLETED|Overall Study||11
1066002|NCT00887640|2584837|P1|STARTED|Overall Study||11
1066003|NCT00887653|2584850|P1|NOT COMPLETED|Overall Study||0
1066004|NCT00887653|2584850|P1|COMPLETED|Overall Study||20
1066005|NCT00887653|2584850|P1|STARTED|Overall Study||20
1066013|NCT00888654|2584862|P1|NOT COMPLETED|Overall Study||10
1066014|NCT00888654|2584862|P1|COMPLETED|Overall Study||31
1066015|NCT00888654|2584862|P1|STARTED|Overall Study||41
1066016|NCT00888849|2584868|P2|NOT COMPLETED|Overall Study||9
1066017|NCT00888849|2584869|P1|NOT COMPLETED|Overall Study||5
1066018|NCT00888849|2584868|P2|COMPLETED|Overall Study||129
1066019|NCT00888849|2584869|P1|COMPLETED|Overall Study||137
1066020|NCT00888849|2584868|P2|STARTED|Overall Study||138
1066021|NCT00888849|2584869|P1|STARTED|Overall Study||142
1066022|NCT00888940|2584881|P2|NOT COMPLETED|Overall Study||21
1066023|NCT00888940|2584882|P1|NOT COMPLETED|Overall Study||28
1066024|NCT00888940|2584881|P2|COMPLETED|Overall Study||101
1066025|NCT00888940|2584882|P1|COMPLETED|Overall Study||92
1066026|NCT00888940|2584881|P2|Completed Therapy|Overall Study||106
1066027|NCT00888940|2584882|P1|Completed Therapy|Overall Study||107
1066028|NCT00888940|2584881|P2|STARTED|Overall Study||122
1066029|NCT00888940|2584882|P1|STARTED|Overall Study||120
1066030|NCT00888979|2584890|P1|NOT COMPLETED|Overall Study||4
1066031|NCT00888979|2584890|P1|COMPLETED|Overall Study||6
1066032|NCT00888979|2584890|P1|Received the Inhaler/Counseling|Overall Study||8
1066033|NCT00888979|2584890|P1|STARTED|Overall Study||10
1066034|NCT00889187|2584896|P4|NOT COMPLETED|Overall Study||0
1066035|NCT00889187|2584897|P3|NOT COMPLETED|Overall Study||0
1066036|NCT00889187|2584898|P2|NOT COMPLETED|Overall Study||0
1066037|NCT00889187|2584899|P1|NOT COMPLETED|Overall Study||0
1066038|NCT00889187|2584896|P4|COMPLETED|Overall Study||0
1066039|NCT00889187|2584897|P3|COMPLETED|Overall Study||4
1066040|NCT00889187|2584898|P2|COMPLETED|Overall Study||3
1066041|NCT00889187|2584899|P1|COMPLETED|Overall Study||3
1066042|NCT00889187|2584896|P4|STARTED|Overall Study||0
1066043|NCT00889187|2584897|P3|STARTED|Overall Study||4
1066044|NCT00889187|2584898|P2|STARTED|Overall Study||3
1066045|NCT00889187|2584899|P1|STARTED|Overall Study||3
1066046|NCT00889200|2584909|P1|NOT COMPLETED|Overall Study||0
1066047|NCT00889200|2584909|P1|COMPLETED|Overall Study||12
1066048|NCT00889200|2584909|P1|STARTED|Overall Study||12
1066049|NCT00889252|2584915|P2|NOT COMPLETED|Overall Study||4
1066050|NCT00889252|2584916|P1|NOT COMPLETED|Overall Study||7
1066051|NCT00889252|2584915|P2|COMPLETED|Overall Study||78
1066052|NCT00889252|2584916|P1|COMPLETED|Overall Study||161
1066053|NCT00889252|2584915|P2|STARTED|Overall Study||82
1066054|NCT00889252|2584916|P1|STARTED|Overall Study||168
1066055|NCT00889265|2584958|P1|NOT COMPLETED|Overall Study||7
1066056|NCT00889265|2584958|P1|COMPLETED|Overall Study||44
1066057|NCT00889265|2584958|P1|STARTED|Overall Study|Date Enrollment Started: 07/21/2009 Date Enrollment Completed: 02/15/2011 Total enrolled: 51|51
1066058|NCT00889330|2584965|P2|NOT COMPLETED|Overall Study||0
1066059|NCT00889330|2584966|P1|NOT COMPLETED|Overall Study||0
1066060|NCT00889330|2584965|P2|COMPLETED|Overall Study||30
1066061|NCT00889330|2584966|P1|COMPLETED|Overall Study||30
1066062|NCT00889330|2584965|P2|STARTED|Overall Study||30
1066063|NCT00889330|2584966|P1|STARTED|Overall Study||30
1066064|NCT00889421|2584996|P1|NOT COMPLETED|Overall Study||3
1066065|NCT00889421|2584996|P1|COMPLETED|Overall Study||0
1066066|NCT00889421|2584996|P1|STARTED|Overall Study||3
1066067|NCT00889512|2585006|P2|NOT COMPLETED|Overall Study||0
1066068|NCT00889512|2585007|P1|NOT COMPLETED|Overall Study||0
1066069|NCT00889512|2585006|P2|COMPLETED|Overall Study||9
1066070|NCT00889512|2585007|P1|COMPLETED|Overall Study||5
1066071|NCT00889512|2585006|P2|STARTED|Overall Study||9
1066072|NCT00889512|2585007|P1|STARTED|Overall Study||5
1066073|NCT00889603|2585013|P1|NOT COMPLETED|Overall Study||37
1066074|NCT00889603|2585013|P1|COMPLETED|Overall Study||333
1066075|NCT00889603|2585013|P1|STARTED|Overall Study||370
1066076|NCT00889681|2585026|P1|NOT COMPLETED|Overall Study||3
1066077|NCT00889681|2585026|P1|COMPLETED|Overall Study||78
1066078|NCT00889681|2585026|P1|Received Treatment|Overall Study||78
1066079|NCT00889681|2585026|P1|STARTED|Overall Study||81
1066080|NCT00889707|2585035|P2|NOT COMPLETED|Overall Study||10
1066081|NCT00889707|2585036|P1|NOT COMPLETED|Overall Study||7
1066082|NCT00889707|2585035|P2|COMPLETED|Overall Study||21
1066083|NCT00889707|2585036|P1|COMPLETED|Overall Study||54
1066084|NCT00889707|2585035|P2|STARTED|Overall Study||31
1066085|NCT00889707|2585036|P1|STARTED|Overall Study||61
1066086|NCT00889720|2585044|P1|NOT COMPLETED|Overall Study||8
1066087|NCT00889720|2585044|P1|COMPLETED|Overall Study||8
1066088|NCT00889720|2585044|P1|Surgical Population|Overall Study||12
1066089|NCT00889720|2585044|P1|STARTED|Overall Study||16
1066090|NCT00889824|2585069|P1|NOT COMPLETED|Overall Study||0
1066091|NCT00889824|2585069|P1|COMPLETED|Overall Study||5
1066092|NCT00889824|2585069|P1|STARTED|Overall Study||5
1066093|NCT00889863|2585073|P2|NOT COMPLETED|Part II: Randomized Double Blind||26
1066094|NCT00889863|2585074|P1|NOT COMPLETED|Part II: Randomized Double Blind||11
1066095|NCT00889863|2585073|P2|COMPLETED|Part II: Randomized Double Blind||24
1066096|NCT00889863|2585074|P1|COMPLETED|Part II: Randomized Double Blind||39
1066097|NCT00889863|2585073|P2|STARTED|Part II: Randomized Double Blind||50
1066098|NCT00889863|2585074|P1|STARTED|Part II: Randomized Double Blind||50
1066099|NCT00889863|2585073|P2|NOT COMPLETED|Part I: Open Label||0
1066100|NCT00889863|2585074|P1|NOT COMPLETED|Part I: Open Label||77
1066101|NCT00889863|2585073|P2|COMPLETED|Part I: Open Label||0
1066102|NCT00889863|2585074|P1|COMPLETED|Part I: Open Label||100
1066103|NCT00889863|2585073|P2|Entered Part 1d|Part I: Open Label||0
1066104|NCT00889863|2585074|P1|Entered Part 1d|Part I: Open Label||103
1066105|NCT00889863|2585073|P2|Entered Part Ic|Part I: Open Label||0
1066106|NCT00889863|2585074|P1|Entered Part Ic|Part I: Open Label|Patients steroid free at study entry entered Part Id directly and did not participate in Part Ic.|92
1066107|NCT00889863|2585073|P2|Entered Part Ib|Part I: Open Label||0
1066108|NCT00889863|2585074|P1|Entered Part Ib|Part I: Open Label||142
1066109|NCT00889863|2585073|P2|Entered Part Ia|Part I: Open Label||0
1066110|NCT00889863|2585074|P1|Entered Part Ia|Part I: Open Label||145
1066111|NCT00889863|2585073|P2|STARTED|Part I: Open Label|No participants received placebo in Part I.|0
1066112|NCT00889863|2585074|P1|STARTED|Part I: Open Label||177
1066113|NCT00889915|2585100|P4|NOT COMPLETED|Overall Study||8
1066114|NCT00889915|2585101|P3|NOT COMPLETED|Overall Study||13
1066115|NCT00889915|2585102|P2|NOT COMPLETED|Overall Study||5
1066116|NCT00889915|2585103|P1|NOT COMPLETED|Overall Study||2
1066117|NCT00889915|2585100|P4|COMPLETED|Overall Study||40
1066118|NCT00889915|2585101|P3|COMPLETED|Overall Study||54
1066119|NCT00889915|2585102|P2|COMPLETED|Overall Study||71
1066120|NCT00889915|2585103|P1|COMPLETED|Overall Study||35
1066121|NCT00889915|2585100|P4|STARTED|Overall Study||48
1066122|NCT00889915|2585101|P3|STARTED|Overall Study||67
1066123|NCT00889915|2585102|P2|STARTED|Overall Study||76
1066124|NCT00889915|2585103|P1|STARTED|Overall Study||37
1066125|NCT00889928|2585121|P1|NOT COMPLETED|Overall Study||0
1066126|NCT00889928|2585121|P1|COMPLETED|Overall Study||7
1066127|NCT00889928|2585121|P1|STARTED|Overall Study||7
1066128|NCT00890084|2585125|P1|NOT COMPLETED|Overall Study||142
1066129|NCT00890084|2585125|P1|COMPLETED|Overall Study||2771
1066130|NCT00890084|2585125|P1|STARTED|Overall Study||2913
1066131|NCT00890097|2585139|P3|NOT COMPLETED|Overall Study||77
1066132|NCT00890097|2585140|P2|NOT COMPLETED|Overall Study||86
1066133|NCT00890097|2585141|P1|NOT COMPLETED|Overall Study||68
1066134|NCT00890097|2585139|P3|COMPLETED|Overall Study||184
1066135|NCT00890097|2585140|P2|COMPLETED|Overall Study||173
1066136|NCT00890097|2585141|P1|COMPLETED|Overall Study||184
1066137|NCT00890097|2585139|P3|STARTED|Overall Study||261
1066138|NCT00890097|2585140|P2|STARTED|Overall Study||259
1066139|NCT00890097|2585141|P1|STARTED|Overall Study||252
1066140|NCT00890201|2585151|P2|NOT COMPLETED|Overall Study||56
1066141|NCT00890201|2585152|P1|NOT COMPLETED|Overall Study||5
1066142|NCT00890201|2585151|P2|COMPLETED|Overall Study|103 patients without acute cholecystitis or common bile duct stones|103
1066143|NCT00890201|2585152|P1|COMPLETED|Overall Study|33 patients with gastric cancer and without gallstone disease|33
1066144|NCT00890201|2585151|P2|STARTED|Overall Study|41 patients with acute cholecystitis and 15 patients with common bile duct stones|159
1066145|NCT00890201|2585152|P1|STARTED|Overall Study|5 patients with gastric cancer and gallstone disease|38
1066146|NCT00890409|2585160|P2|NOT COMPLETED|Overall Study||21
1066147|NCT00890409|2585161|P1|NOT COMPLETED|Overall Study||20
1066148|NCT00890409|2585160|P2|COMPLETED|Overall Study||119
1066149|NCT00890409|2585161|P1|COMPLETED|Overall Study||96
1066150|NCT00890409|2585160|P2|STARTED|Overall Study||140
1066151|NCT00890409|2585161|P1|STARTED|Overall Study||116
1066152|NCT00890552|2585169|P1|NOT COMPLETED|On-treatment||10
1066153|NCT00890552|2585169|P1|COMPLETED|On-treatment||14
1066154|NCT00890552|2585169|P1|STARTED|On-treatment||24
1066155|NCT00890552|2585169|P1|NOT COMPLETED|Enrollment and Pre-treatment||1
1066156|NCT00890552|2585169|P1|COMPLETED|Enrollment and Pre-treatment||24
1066157|NCT00890552|2585169|P1|STARTED|Enrollment and Pre-treatment||25
1066158|NCT00890591|2585176|P1|NOT COMPLETED|Overall Study||20
1066159|NCT00890591|2585176|P1|COMPLETED|Overall Study||124
1066160|NCT00890591|2585176|P1|STARTED|Overall Study||144
1066161|NCT00890656|2585182|P1|NOT COMPLETED|Overall Study||0
1066162|NCT00890656|2585182|P1|COMPLETED|Overall Study||90
1066163|NCT00890656|2585182|P1|STARTED|Overall Study||90
1066164|NCT00890682|2585188|P2|NOT COMPLETED|Overall Study||2
1066165|NCT00890682|2585189|P1|NOT COMPLETED|Overall Study||4
1066166|NCT00890682|2585188|P2|COMPLETED|Overall Study||94
1066167|NCT00890682|2585189|P1|COMPLETED|Overall Study||93
1066168|NCT00890682|2585188|P2|STARTED|Overall Study||96
1066169|NCT00890682|2585189|P1|STARTED|Overall Study||97
1066170|NCT00890695|2585197|P2|NOT COMPLETED|Overall Study||0
1066171|NCT00890695|2585198|P1|NOT COMPLETED|Overall Study||1
1066172|NCT00890695|2585197|P2|COMPLETED|Overall Study||33
1066173|NCT00890695|2585198|P1|COMPLETED|Overall Study||31
1066174|NCT00890695|2585197|P2|STARTED|Overall Study||33
1066175|NCT00890695|2585198|P1|STARTED|Overall Study||32
1066176|NCT00890721|2585216|P2|NOT COMPLETED|Overall Study||1
1066177|NCT00890721|2585217|P1|NOT COMPLETED|Overall Study||1
1066178|NCT00890721|2585216|P2|COMPLETED|Overall Study||93
1066179|NCT00890721|2585217|P1|COMPLETED|Overall Study||94
1066180|NCT00890721|2585216|P2|STARTED|Overall Study||94
1066181|NCT00890721|2585217|P1|STARTED|Overall Study||95
1066182|NCT00890916|2585223|P1|NOT COMPLETED|"Rehab - NP OFF"||0
1066183|NCT00890916|2585223|P1|COMPLETED|"Rehab - NP OFF"||10
1066184|NCT00890916|2585223|P1|"Grasp Release Pre-Test OFF"|"Rehab - NP OFF"||10
1066185|NCT00890916|2585223|P1|STARTED|"Rehab - NP OFF"||10
1066186|NCT00890916|2585223|P1|NOT COMPLETED|"Rehab - NP ON"||0
1066187|NCT00890916|2585223|P1|COMPLETED|"Rehab - NP ON"||10
1066188|NCT00890916|2585223|P1|"Grasp Release Pre-Test ON"|"Rehab - NP ON"||10
1066189|NCT00890916|2585223|P1|STARTED|"Rehab - NP ON"|First IST-12 Implant.|10
1066190|NCT00890929|2585227|P1|NOT COMPLETED|Overall Study||6
1066191|NCT00890929|2585227|P1|COMPLETED|Overall Study||39
1066192|NCT00890929|2585227|P1|Initiated Treatment|Overall Study||43
1066193|NCT00890929|2585227|P1|Consented & Enrolled|Overall Study||45
1066194|NCT00890929|2585227|P1|STARTED|Overall Study||45
1066195|NCT00890981|2585241|P2|NOT COMPLETED|Overall Study||0
1066196|NCT00890981|2585242|P1|NOT COMPLETED|Overall Study||0
1066197|NCT00890981|2585241|P2|COMPLETED|Overall Study||40
1066198|NCT00890981|2585242|P1|COMPLETED|Overall Study||39
1066199|NCT00890981|2585241|P2|STARTED|Overall Study||40
1066200|NCT00890981|2585242|P1|STARTED|Overall Study||39
1066201|NCT00891020|2585275|P3|NOT COMPLETED|Long-term Extension Period||23
1066202|NCT00891020|2585276|P2|NOT COMPLETED|Long-term Extension Period||24
1066203|NCT00891020|2585277|P1|NOT COMPLETED|Long-term Extension Period||6
1066204|NCT00891020|2585275|P3|COMPLETED|Long-term Extension Period||170
1066205|NCT00891020|2585276|P2|COMPLETED|Long-term Extension Period||172
1066206|NCT00891020|2585277|P1|COMPLETED|Long-term Extension Period||49
1066207|NCT00891020|2585275|P3|STARTED|Long-term Extension Period||193
1066208|NCT00891020|2585276|P2|STARTED|Long-term Extension Period||196
1066209|NCT00891020|2585277|P1|STARTED|Long-term Extension Period||55
1066210|NCT00891020|2585275|P3|NOT COMPLETED|24 Week Treatment Period||58
1066211|NCT00891020|2585276|P2|NOT COMPLETED|24 Week Treatment Period||60
1066212|NCT00891020|2585277|P1|NOT COMPLETED|24 Week Treatment Period||37
1066213|NCT00891020|2585275|P3|COMPLETED|24 Week Treatment Period||302
1066214|NCT00891020|2585276|P2|COMPLETED|24 Week Treatment Period||303
1066215|NCT00891020|2585277|P1|COMPLETED|24 Week Treatment Period||126
1066216|NCT00891020|2585275|P3|Safety Set|24 Week Treatment Period|28 patients from Monotherapy arm received DMARD, included in 8 mg/kg +DMARD arm for safety.|381
1066217|NCT00891020|2585276|P2|Safety Set|24 Week Treatment Period|1 patient from Monotherapy arm and 1 from 8 mg/kg +DMARD, included in 4 mg/kg +DMARD arm for safety.|364
1066218|NCT00891020|2585277|P1|Safety Set|24 Week Treatment Period|4 patients from 8 mg/kg +DMARD arm did not receive DMARD, included in Monotherapy arm for safety.|138
1066219|NCT00891020|2585275|P3|Intent-to-Treat (ITT)|24 Week Treatment Period||358
1066220|NCT00891020|2585276|P2|Intent-to-Treat (ITT)|24 Week Treatment Period||362
1066221|NCT00891020|2585277|P1|Intent-to-Treat (ITT)|24 Week Treatment Period||163
1066222|NCT00891020|2585275|P3|STARTED|24 Week Treatment Period||360
1066223|NCT00891020|2585276|P2|STARTED|24 Week Treatment Period||363
1066224|NCT00891020|2585277|P1|STARTED|24 Week Treatment Period||163
1066225|NCT00878969|2585311|P3|NOT COMPLETED|Overall Study||11
1066226|NCT00878969|2585312|P2|NOT COMPLETED|Overall Study||15
1066227|NCT00878969|2585313|P1|NOT COMPLETED|Overall Study||15
1066228|NCT00878969|2585311|P3|COMPLETED|Overall Study||15
1066229|NCT00878969|2585312|P2|COMPLETED|Overall Study||12
1066230|NCT00878969|2585313|P1|COMPLETED|Overall Study||10
1066231|NCT00878969|2585311|P3|STARTED|Overall Study||26
1066232|NCT00878969|2585312|P2|STARTED|Overall Study||27
1066233|NCT00878969|2585313|P1|STARTED|Overall Study||25
1066234|NCT00879034|2585321|P1|NOT COMPLETED|Overall Study||0
1066235|NCT00879034|2585321|P1|COMPLETED|Overall Study||5
1066236|NCT00879034|2585321|P1|Received Treatment|Overall Study||4
1066237|NCT00879034|2585321|P1|STARTED|Overall Study||5
1066238|NCT00879190|2585332|P2|NOT COMPLETED|Overall Study||0
1066239|NCT00879190|2585333|P1|NOT COMPLETED|Overall Study||0
1066240|NCT00879190|2585332|P2|COMPLETED|Overall Study||49
1066241|NCT00879190|2585333|P1|COMPLETED|Overall Study||43
1066242|NCT00879190|2585332|P2|STARTED|Overall Study||49
1066243|NCT00879190|2585333|P1|STARTED|Overall Study||43
1066244|NCT00879229|2585345|P2|NOT COMPLETED|Overall Study||14
1066245|NCT00879229|2585346|P1|NOT COMPLETED|Overall Study||22
1066246|NCT00879229|2585345|P2|COMPLETED|Overall Study||1
1066247|NCT00879229|2585346|P1|COMPLETED|Overall Study||3
1066248|NCT00879229|2585345|P2|STARTED|Overall Study||15
1066249|NCT00879229|2585346|P1|STARTED|Overall Study||25
1066250|NCT00879255|2585372|P2|NOT COMPLETED|Overall Study||19
1066251|NCT00879255|2585373|P1|NOT COMPLETED|Overall Study||16
1066252|NCT00879255|2585372|P2|COMPLETED|Overall Study|Completed 6-mo follow-up|45
1066253|NCT00879255|2585373|P1|COMPLETED|Overall Study|Completed 6-mo follow-up|45
1066254|NCT00879255|2585372|P2|Completed 3-mo Follow-up|Overall Study||49
1066255|NCT00879255|2585373|P1|Completed 3-mo Follow-up|Overall Study||48
1066256|NCT00879255|2585372|P2|Completed Posttreatment Follow-up|Overall Study||55
1066257|NCT00879255|2585373|P1|Completed Posttreatment Follow-up|Overall Study||50
1066258|NCT00879255|2585372|P2|Received Allocated Intervention:|Overall Study||56
1066259|NCT00879255|2585373|P1|Received Allocated Intervention:|Overall Study||51
1066260|NCT00879255|2585372|P2|STARTED|Overall Study||64
1066261|NCT00879255|2585373|P1|STARTED|Overall Study||61
1066262|NCT00879333|2585385|P2|NOT COMPLETED|Overall Study||217
1066263|NCT00879333|2585386|P1|NOT COMPLETED|Overall Study||428
1066264|NCT00879333|2585385|P2|COMPLETED|Overall Study||0
1066265|NCT00879333|2585386|P1|COMPLETED|Overall Study|Completed=Patients Still on Treatment; At data cutoff final analysis, 11 patients were on treatment|11
1066266|NCT00879333|2585385|P2|Discontinued Study Treatment|Overall Study||217
1066267|NCT00879333|2585386|P1|Discontinued Study Treatment|Overall Study||428
1066268|NCT00879333|2585385|P2|STARTED|Overall Study||217
1066269|NCT00879333|2585386|P1|STARTED|Overall Study||439
1066270|NCT00879359|2585404|P1|NOT COMPLETED|Overall Study||0
1066271|NCT00879359|2585404|P1|COMPLETED|Overall Study||15
1066272|NCT00879359|2585404|P1|STARTED|Overall Study||15
1066273|NCT00884754|2585412|P2|NOT COMPLETED|Overall Study||0
1066274|NCT00884754|2585413|P1|NOT COMPLETED|Overall Study||0
1066275|NCT00884754|2585412|P2|COMPLETED|Overall Study||30
1066276|NCT00884754|2585413|P1|COMPLETED|Overall Study||30
1066277|NCT00884754|2585412|P2|STARTED|Overall Study||30
1066278|NCT00884754|2585413|P1|STARTED|Overall Study||30
1066279|NCT00884793|2585419|P1|NOT COMPLETED|Overall Study||1
1066280|NCT00884793|2585419|P1|COMPLETED|Overall Study||7
1066281|NCT00884793|2585419|P1|STARTED|Overall Study||8
1066282|NCT00884806|2585426|P1|NOT COMPLETED|Overall Study||0
1066283|NCT00884806|2585426|P1|COMPLETED|Overall Study||110
1066284|NCT00884806|2585426|P1|STARTED|Overall Study||110
1066285|NCT00891046|2585436|P5|NOT COMPLETED|Overall Study||39
1066286|NCT00891046|2585437|P4|NOT COMPLETED|Overall Study||3
1066287|NCT00891046|2585438|P3|NOT COMPLETED|Overall Study||23
1066288|NCT00891046|2585439|P2|NOT COMPLETED|Overall Study||9
1066289|NCT00891046|2585440|P1|NOT COMPLETED|Overall Study||12
1066290|NCT00891046|2585436|P5|COMPLETED|Overall Study||84
1066291|NCT00891046|2585437|P4|COMPLETED|Overall Study||8
1066292|NCT00891046|2585438|P3|COMPLETED|Overall Study||17
1066293|NCT00891046|2585439|P2|COMPLETED|Overall Study||54
1066294|NCT00891046|2585440|P1|COMPLETED|Overall Study||21
1066295|NCT00891046|2585436|P5|STARTED|Overall Study||123
1066296|NCT00891046|2585437|P4|STARTED|Overall Study||11
1066297|NCT00891046|2585438|P3|STARTED|Overall Study||40
1066298|NCT00891046|2585439|P2|STARTED|Overall Study||63
1066299|NCT00891046|2585440|P1|STARTED|Overall Study||33
1066300|NCT00891176|2585517|P4|NOT COMPLETED|At 6 Years of Age||0
1066301|NCT00891176|2585518|P3|NOT COMPLETED|At 6 Years of Age||0
1066302|NCT00891176|2585519|P2|NOT COMPLETED|At 6 Years of Age||0
1066303|NCT00891176|2585520|P1|NOT COMPLETED|At 6 Years of Age||0
1066304|NCT00891176|2585517|P4|COMPLETED|At 6 Years of Age||135
1066305|NCT00891176|2585518|P3|COMPLETED|At 6 Years of Age||135
1066306|NCT00891176|2585519|P2|COMPLETED|At 6 Years of Age||138
1066307|NCT00891176|2585520|P1|COMPLETED|At 6 Years of Age||131
1066308|NCT00891176|2585517|P4|STARTED|At 6 Years of Age||135
1066309|NCT00891176|2585518|P3|STARTED|At 6 Years of Age||135
1066310|NCT00891176|2585519|P2|STARTED|At 6 Years of Age||138
1066311|NCT00891176|2585520|P1|STARTED|At 6 Years of Age||131
1066312|NCT00891176|2585517|P4|NOT COMPLETED|At 4 Years of Age||0
1066313|NCT00891176|2585518|P3|NOT COMPLETED|At 4 Years of Age||0
1066314|NCT00891176|2585519|P2|NOT COMPLETED|At 4 Years of Age||0
1066315|NCT00891176|2585520|P1|NOT COMPLETED|At 4 Years of Age||0
1066316|NCT00891176|2585517|P4|COMPLETED|At 4 Years of Age||137
1066317|NCT00891176|2585518|P3|COMPLETED|At 4 Years of Age||142
1066318|NCT00891176|2585519|P2|COMPLETED|At 4 Years of Age||142
1066319|NCT00891176|2585520|P1|COMPLETED|At 4 Years of Age||140
1066320|NCT00891176|2585517|P4|STARTED|At 4 Years of Age||137
1066321|NCT00891176|2585518|P3|STARTED|At 4 Years of Age||142
1066322|NCT00891176|2585519|P2|STARTED|At 4 Years of Age||142
1066323|NCT00891176|2585520|P1|STARTED|At 4 Years of Age||140
1066324|NCT00891176|2585517|P4|NOT COMPLETED|At 3 Years of Age||0
1066325|NCT00891176|2585518|P3|NOT COMPLETED|At 3 Years of Age||0
1066326|NCT00891176|2585519|P2|NOT COMPLETED|At 3 Years of Age||0
1066327|NCT00891176|2585520|P1|NOT COMPLETED|At 3 Years of Age||0
1066328|NCT00891176|2585517|P4|COMPLETED|At 3 Years of Age||141
1066329|NCT00891176|2585518|P3|COMPLETED|At 3 Years of Age||149
1066330|NCT00891176|2585519|P2|COMPLETED|At 3 Years of Age||147
1066331|NCT00891176|2585520|P1|COMPLETED|At 3 Years of Age||144
1066332|NCT00891176|2585517|P4|STARTED|At 3 Years of Age||141
1066333|NCT00891176|2585518|P3|STARTED|At 3 Years of Age||149
1066334|NCT00891176|2585519|P2|STARTED|At 3 Years of Age||147
1066335|NCT00891176|2585520|P1|STARTED|At 3 Years of Age||144
1066336|NCT00891202|2585648|P4|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||5
1066337|NCT00891202|2585649|P3|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||7
1066338|NCT00891202|2585650|P2|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
1066339|NCT00891202|2585651|P1|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
1066340|NCT00891202|2585648|P4|COMPLETED|LTTP (Post-Week 39 up to Week 312)||15
1066341|NCT00891202|2585649|P3|COMPLETED|LTTP (Post-Week 39 up to Week 312)||12
1066342|NCT00891202|2585650|P2|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
1066343|NCT00891202|2585651|P1|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
1066344|NCT00891202|2585648|P4|STARTED|LTTP (Post-Week 39 up to Week 312)||20
1066345|NCT00891202|2585649|P3|STARTED|LTTP (Post-Week 39 up to Week 312)||19
1066346|NCT00891202|2585650|P2|STARTED|LTTP (Post-Week 39 up to Week 312)||0
1066347|NCT00891202|2585651|P1|STARTED|LTTP (Post-Week 39 up to Week 312)||0
1066348|NCT00891202|2585648|P4|NOT COMPLETED|PAP (Up To Week 39)||0
1066349|NCT00891202|2585649|P3|NOT COMPLETED|PAP (Up To Week 39)||0
1066350|NCT00891202|2585650|P2|NOT COMPLETED|PAP (Up To Week 39)||0
1066351|NCT00891202|2585651|P1|NOT COMPLETED|PAP (Up To Week 39)||1
1066352|NCT00891202|2585648|P4|COMPLETED|PAP (Up To Week 39)||0
1066353|NCT00891202|2585649|P3|COMPLETED|PAP (Up To Week 39)||0
1066354|NCT00891202|2585650|P2|COMPLETED|PAP (Up To Week 39)||20
1066355|NCT00891202|2585651|P1|COMPLETED|PAP (Up To Week 39)||19
1066356|NCT00891202|2585648|P4|STARTED|PAP (Up To Week 39)||0
1066357|NCT00891202|2585649|P3|STARTED|PAP (Up To Week 39)||0
1066358|NCT00891202|2585650|P2|STARTED|PAP (Up To Week 39)||20
1066359|NCT00891202|2585651|P1|STARTED|PAP (Up To Week 39)||20
1066360|NCT00891293|2585673|P1|NOT COMPLETED|Overall Study||84
1066361|NCT00891293|2585673|P1|COMPLETED|Overall Study||9
1066362|NCT00891293|2585673|P1|STARTED|Overall Study|93 participants were enrolled; baseline data are provided for 89 participants (Safety Population).|93
1066363|NCT00891371|2585685|P1|NOT COMPLETED|Treatment||9
1066364|NCT00891371|2585685|P1|COMPLETED|Treatment||27
1066365|NCT00891371|2585685|P1|STARTED|Treatment||36
1066366|NCT00891371|2585685|P1|NOT COMPLETED|Pre-assignment||6
1066367|NCT00891371|2585685|P1|COMPLETED|Pre-assignment||36
1066368|NCT00891371|2585685|P1|STARTED|Pre-assignment||42
1066369|NCT00891618|2585694|P1|NOT COMPLETED|Overall Study||1
1066370|NCT00891618|2585694|P1|COMPLETED|Overall Study||20
1066371|NCT00891618|2585694|P1|STARTED|Overall Study||21
1066372|NCT00891657|2585700|P2|NOT COMPLETED|Overall Study||1
1066373|NCT00891657|2585701|P1|NOT COMPLETED|Overall Study||1
1066374|NCT00891657|2585700|P2|COMPLETED|Overall Study||5
1066375|NCT00891657|2585701|P1|COMPLETED|Overall Study||8
1066376|NCT00891657|2585700|P2|STARTED|Overall Study||6
1066377|NCT00891657|2585701|P1|STARTED|Overall Study||9
1066378|NCT00891735|2585717|P4|NOT COMPLETED|Overall Study||15
1066379|NCT00891735|2585718|P3|NOT COMPLETED|Overall Study||12
1066380|NCT00891735|2585719|P2|NOT COMPLETED|Overall Study||16
1066381|NCT00891735|2585720|P1|NOT COMPLETED|Overall Study||17
1066382|NCT00891735|2585717|P4|COMPLETED|Overall Study||258
1066383|NCT00891735|2585718|P3|COMPLETED|Overall Study||263
1066384|NCT00891735|2585719|P2|COMPLETED|Overall Study||258
1066385|NCT00891735|2585720|P1|COMPLETED|Overall Study||258
1066386|NCT00891735|2585717|P4|STARTED|Overall Study||273
1066387|NCT00891735|2585718|P3|STARTED|Overall Study||275
1066388|NCT00891735|2585719|P2|STARTED|Overall Study||274
1066389|NCT00891735|2585720|P1|STARTED|Overall Study||275
1066390|NCT00891774|2585758|P1|NOT COMPLETED|Overall Study||14
1066391|NCT00891774|2585758|P1|COMPLETED|Overall Study||158
1066392|NCT00891774|2585758|P1|STARTED|Overall Study||172
1066393|NCT00891813|2585762|P1|NOT COMPLETED|Overall Study||12
1066394|NCT00891813|2585762|P1|COMPLETED|Overall Study||88
1066395|NCT00891813|2585762|P1|STARTED|Overall Study||100
1066399|NCT00891904|2585777|P1|NOT COMPLETED|Overall Study||2
1066400|NCT00891904|2585777|P1|COMPLETED|Overall Study||0
1066401|NCT00891904|2585777|P1|STARTED|Overall Study||2
1066402|NCT00891930|2585784|P1|NOT COMPLETED|Part 2: Panitumumab + Ganitumab||31
1066403|NCT00891930|2585784|P1|COMPLETED|Part 2: Panitumumab + Ganitumab||5
1066404|NCT00891930|2585784|P1|STARTED|Part 2: Panitumumab + Ganitumab||36
1066405|NCT00891930|2585784|P1|NOT COMPLETED|Part 1: Panitumumab +Irinotecan||40
1066406|NCT00891930|2585784|P1|COMPLETED|Part 1: Panitumumab +Irinotecan||36
1066407|NCT00891930|2585784|P1|Received Treatment|Part 1: Panitumumab +Irinotecan||74
1066408|NCT00891930|2585784|P1|STARTED|Part 1: Panitumumab +Irinotecan||76
1066409|NCT00891982|2585807|P2|NOT COMPLETED|Overall Study||1
1066410|NCT00891982|2585808|P1|NOT COMPLETED|Overall Study||2
1066411|NCT00891982|2585807|P2|COMPLETED|Overall Study||30
1066412|NCT00891982|2585808|P1|COMPLETED|Overall Study||28
1066413|NCT00891982|2585807|P2|STARTED|Overall Study||31
1066414|NCT00891982|2585808|P1|STARTED|Overall Study||30
1066415|NCT00891995|2585854|P2|NOT COMPLETED|Overall Study||0
1066416|NCT00891995|2585855|P1|NOT COMPLETED|Overall Study||0
1066417|NCT00891995|2585854|P2|COMPLETED|Overall Study||21
1066418|NCT00891995|2585855|P1|COMPLETED|Overall Study||50
1066419|NCT00891995|2585854|P2|STARTED|Overall Study||21
1066420|NCT00891995|2585855|P1|STARTED|Overall Study||50
1066421|NCT00892008|2585877|P1|NOT COMPLETED|Overall Study||565
1066422|NCT00892008|2585877|P1|COMPLETED|Overall Study||1713
1066423|NCT00892008|2585877|P1|STARTED|Overall Study||2278
1066424|NCT00892047|2585893|P2|NOT COMPLETED|Overall Study||7
1066425|NCT00892047|2585894|P1|NOT COMPLETED|Overall Study||4
1066426|NCT00892047|2585893|P2|COMPLETED|Overall Study||83
1066427|NCT00892047|2585894|P1|COMPLETED|Overall Study||87
1066428|NCT00892047|2585893|P2|STARTED|Overall Study||90
1066429|NCT00892047|2585894|P1|STARTED|Overall Study||91
1066430|NCT00892099|2585913|P3|NOT COMPLETED|Overall Study||7
1066431|NCT00892099|2585914|P2|NOT COMPLETED|Overall Study||1
1066432|NCT00892099|2585915|P1|NOT COMPLETED|Overall Study||5
1066433|NCT00892099|2585913|P3|COMPLETED|Overall Study||29
1066434|NCT00892099|2585914|P2|COMPLETED|Overall Study||32
1066435|NCT00892099|2585915|P1|COMPLETED|Overall Study||31
1066436|NCT00892099|2585913|P3|STARTED|Overall Study||36
1066437|NCT00892099|2585914|P2|STARTED|Overall Study||33
1066438|NCT00892099|2585915|P1|STARTED|Overall Study||36
1066439|NCT00892151|2585923|P1|NOT COMPLETED|Overall Study||1
1066440|NCT00892151|2585923|P1|COMPLETED|Overall Study||50
1066441|NCT00892151|2585923|P1|STARTED|Overall Study||51
1066442|NCT00892177|2585932|P6|NOT COMPLETED|Phase II||2
1066443|NCT00892177|2585933|P5|NOT COMPLETED|Phase II||5
1066444|NCT00892177|2585934|P4|NOT COMPLETED|Phase II||0
1066445|NCT00892177|2585935|P3|NOT COMPLETED|Phase II||0
1066446|NCT00892177|2585936|P2|NOT COMPLETED|Phase II||0
1066447|NCT00892177|2585937|P1|NOT COMPLETED|Phase II||0
1066448|NCT00892177|2585932|P6|COMPLETED|Phase II||38
1066449|NCT00892177|2585933|P5|COMPLETED|Phase II||83
1066450|NCT00892177|2585934|P4|COMPLETED|Phase II||0
1066451|NCT00892177|2585935|P3|COMPLETED|Phase II||0
1066452|NCT00892177|2585936|P2|COMPLETED|Phase II||0
1066453|NCT00892177|2585937|P1|COMPLETED|Phase II||0
1066454|NCT00892177|2585932|P6|STARTED|Phase II||40
1066455|NCT00892177|2585933|P5|STARTED|Phase II||88
1066456|NCT00892177|2585934|P4|STARTED|Phase II||0
1066457|NCT00892177|2585935|P3|STARTED|Phase II||0
1066458|NCT00892177|2585936|P2|STARTED|Phase II||0
1066459|NCT00892177|2585937|P1|STARTED|Phase II||0
1066460|NCT00892177|2585932|P6|NOT COMPLETED|Phase I: Dose Level 3||0
1066461|NCT00892177|2585933|P5|NOT COMPLETED|Phase I: Dose Level 3||0
1066462|NCT00892177|2585934|P4|NOT COMPLETED|Phase I: Dose Level 3||0
1066463|NCT00892177|2585935|P3|NOT COMPLETED|Phase I: Dose Level 3||0
1066464|NCT00892177|2585936|P2|NOT COMPLETED|Phase I: Dose Level 3||0
1066465|NCT00892177|2585937|P1|NOT COMPLETED|Phase I: Dose Level 3||0
1066466|NCT00892177|2585932|P6|COMPLETED|Phase I: Dose Level 3||0
1066467|NCT00892177|2585933|P5|COMPLETED|Phase I: Dose Level 3||0
1066468|NCT00892177|2585934|P4|COMPLETED|Phase I: Dose Level 3||6
1066469|NCT00892177|2585935|P3|COMPLETED|Phase I: Dose Level 3||0
1066470|NCT00892177|2585936|P2|COMPLETED|Phase I: Dose Level 3||0
1066471|NCT00892177|2585937|P1|COMPLETED|Phase I: Dose Level 3||0
1066472|NCT00892177|2585932|P6|STARTED|Phase I: Dose Level 3||0
1066473|NCT00892177|2585933|P5|STARTED|Phase I: Dose Level 3||0
1066474|NCT00892177|2585934|P4|STARTED|Phase I: Dose Level 3||6
1066475|NCT00892177|2585935|P3|STARTED|Phase I: Dose Level 3||0
1066476|NCT00892177|2585936|P2|STARTED|Phase I: Dose Level 3||0
1066477|NCT00892177|2585937|P1|STARTED|Phase I: Dose Level 3||0
1066478|NCT00892177|2585932|P6|NOT COMPLETED|Phase I: Dose Level 2||0
1066479|NCT00892177|2585933|P5|NOT COMPLETED|Phase I: Dose Level 2||0
1066480|NCT00892177|2585934|P4|NOT COMPLETED|Phase I: Dose Level 2||0
1066481|NCT00892177|2585935|P3|NOT COMPLETED|Phase I: Dose Level 2||0
1066482|NCT00892177|2585936|P2|NOT COMPLETED|Phase I: Dose Level 2||0
1066483|NCT00892177|2585937|P1|NOT COMPLETED|Phase I: Dose Level 2||0
1066484|NCT00892177|2585932|P6|COMPLETED|Phase I: Dose Level 2||0
1066485|NCT00892177|2585933|P5|COMPLETED|Phase I: Dose Level 2||0
1066486|NCT00892177|2585934|P4|COMPLETED|Phase I: Dose Level 2||0
1066487|NCT00892177|2585935|P3|COMPLETED|Phase I: Dose Level 2||3
1066488|NCT00892177|2585936|P2|COMPLETED|Phase I: Dose Level 2||0
1066489|NCT00892177|2585937|P1|COMPLETED|Phase I: Dose Level 2||0
1066490|NCT00892177|2585932|P6|STARTED|Phase I: Dose Level 2||0
1066491|NCT00892177|2585933|P5|STARTED|Phase I: Dose Level 2||0
1066492|NCT00892177|2585934|P4|STARTED|Phase I: Dose Level 2||0
1066493|NCT00892177|2585935|P3|STARTED|Phase I: Dose Level 2||3
1066494|NCT00892177|2585936|P2|STARTED|Phase I: Dose Level 2||0
1066495|NCT00892177|2585937|P1|STARTED|Phase I: Dose Level 2||0
1066496|NCT00892177|2585932|P6|NOT COMPLETED|Phase I: Dose Level 1||0
1066497|NCT00892177|2585933|P5|NOT COMPLETED|Phase I: Dose Level 1||0
1066498|NCT00892177|2585934|P4|NOT COMPLETED|Phase I: Dose Level 1||0
1066499|NCT00892177|2585935|P3|NOT COMPLETED|Phase I: Dose Level 1||0
1066500|NCT00892177|2585936|P2|NOT COMPLETED|Phase I: Dose Level 1||0
1066501|NCT00892177|2585937|P1|NOT COMPLETED|Phase I: Dose Level 1||0
1066502|NCT00892177|2585932|P6|COMPLETED|Phase I: Dose Level 1||0
1066503|NCT00892177|2585933|P5|COMPLETED|Phase I: Dose Level 1||0
1066504|NCT00892177|2585934|P4|COMPLETED|Phase I: Dose Level 1||0
1066505|NCT00892177|2585935|P3|COMPLETED|Phase I: Dose Level 1||0
1066506|NCT00892177|2585936|P2|COMPLETED|Phase I: Dose Level 1||4
1066507|NCT00892177|2585937|P1|COMPLETED|Phase I: Dose Level 1||0
1066508|NCT00892177|2585932|P6|STARTED|Phase I: Dose Level 1||0
1066509|NCT00892177|2585933|P5|STARTED|Phase I: Dose Level 1||0
1066510|NCT00892177|2585934|P4|STARTED|Phase I: Dose Level 1||0
1066511|NCT00892177|2585935|P3|STARTED|Phase I: Dose Level 1||0
1066512|NCT00892177|2585936|P2|STARTED|Phase I: Dose Level 1||4
1066513|NCT00892177|2585937|P1|STARTED|Phase I: Dose Level 1||0
1066514|NCT00892177|2585932|P6|NOT COMPLETED|Phase I: Dose Level 0||0
1066515|NCT00892177|2585933|P5|NOT COMPLETED|Phase I: Dose Level 0||0
1066516|NCT00892177|2585934|P4|NOT COMPLETED|Phase I: Dose Level 0||0
1066517|NCT00892177|2585935|P3|NOT COMPLETED|Phase I: Dose Level 0||0
1066518|NCT00892177|2585936|P2|NOT COMPLETED|Phase I: Dose Level 0||0
1066519|NCT00892177|2585937|P1|NOT COMPLETED|Phase I: Dose Level 0||0
1066520|NCT00892177|2585932|P6|COMPLETED|Phase I: Dose Level 0||0
1066521|NCT00892177|2585933|P5|COMPLETED|Phase I: Dose Level 0||0
1066522|NCT00892177|2585934|P4|COMPLETED|Phase I: Dose Level 0||0
1066523|NCT00892177|2585935|P3|COMPLETED|Phase I: Dose Level 0||0
1066524|NCT00892177|2585936|P2|COMPLETED|Phase I: Dose Level 0||0
1066525|NCT00892177|2585937|P1|COMPLETED|Phase I: Dose Level 0||3
1066526|NCT00892177|2585932|P6|STARTED|Phase I: Dose Level 0||0
1066527|NCT00892177|2585933|P5|STARTED|Phase I: Dose Level 0||0
1066528|NCT00892177|2585934|P4|STARTED|Phase I: Dose Level 0||0
1066529|NCT00892177|2585935|P3|STARTED|Phase I: Dose Level 0||0
1066530|NCT00892177|2585936|P2|STARTED|Phase I: Dose Level 0||0
1066531|NCT00892177|2585937|P1|STARTED|Phase I: Dose Level 0||3
1066532|NCT00892281|2585964|P2|NOT COMPLETED|Overall Study||37
1066533|NCT00892281|2585965|P1|NOT COMPLETED|Overall Study||267
1066534|NCT00892281|2585964|P2|COMPLETED|Overall Study||187
1066535|NCT00892281|2585965|P1|COMPLETED|Overall Study||930
1066536|NCT00892281|2585964|P2|STARTED|Overall Study||224
1066537|NCT00892281|2585965|P1|STARTED|Overall Study||1197
1066538|NCT00892437|2585977|P2|NOT COMPLETED|Open-Label Extension Phase||4
1066539|NCT00892437|2585978|P1|NOT COMPLETED|Open-Label Extension Phase||12
1066540|NCT00892437|2585977|P2|COMPLETED|Open-Label Extension Phase||15
1066541|NCT00892437|2585978|P1|COMPLETED|Open-Label Extension Phase||32
1066542|NCT00892437|2585977|P2|STARTED|Open-Label Extension Phase|5 participants completed the randomized phase but did not enter the open-label extension phase.|19
1066543|NCT00892437|2585978|P1|STARTED|Open-Label Extension Phase|1 participant completed the randomized phase but did not enter the open-label extension phase.|44
1066544|NCT00892437|2585977|P2|NOT COMPLETED|Randomized Phase||5
1066545|NCT00892437|2585978|P1|NOT COMPLETED|Randomized Phase||11
1066546|NCT00892437|2585977|P2|COMPLETED|Randomized Phase||24
1066547|NCT00892437|2585978|P1|COMPLETED|Randomized Phase||45
1066548|NCT00892437|2585977|P2|Randomized and Treated|Randomized Phase||29
1066549|NCT00892437|2585978|P1|Randomized and Treated|Randomized Phase||50
1066550|NCT00892437|2585977|P2|STARTED|Randomized Phase||29
1066551|NCT00892437|2585978|P1|STARTED|Randomized Phase||56
1066552|NCT00892606|2585997|P2|NOT COMPLETED|Overall Study||4
1066553|NCT00892606|2585998|P1|NOT COMPLETED|Overall Study||5
1066554|NCT00892606|2585997|P2|COMPLETED|Overall Study||33
1066555|NCT00892606|2585998|P1|COMPLETED|Overall Study||33
1066556|NCT00892606|2585997|P2|STARTED|Overall Study||37
1066557|NCT00892606|2585998|P1|STARTED|Overall Study||38
1066558|NCT00892697|2586008|P1|NOT COMPLETED|Overall Study||0
1066559|NCT00892697|2586008|P1|COMPLETED|Overall Study||15
1066560|NCT00892697|2586008|P1|STARTED|Overall Study||15
1066561|NCT00892710|2586016|P3|NOT COMPLETED|Overall Study||55
1066562|NCT00892710|2586017|P2|NOT COMPLETED|Overall Study||59
1066563|NCT00892710|2586018|P1|NOT COMPLETED|Overall Study||48
1066564|NCT00892710|2586016|P3|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
1066565|NCT00892710|2586017|P2|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
1066566|NCT00892710|2586018|P1|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
1066567|NCT00892710|2586016|P3|STARTED|Overall Study||55
1066568|NCT00892710|2586017|P2|STARTED|Overall Study||59
1066569|NCT00892710|2586018|P1|STARTED|Overall Study||48
1066570|NCT00892723|2586044|P3|NOT COMPLETED|Overall Study||2
1066571|NCT00892723|2586045|P2|NOT COMPLETED|Overall Study||4
1066572|NCT00892723|2586046|P1|NOT COMPLETED|Overall Study||2
1066573|NCT00892723|2586044|P3|COMPLETED|Overall Study||17
1066574|NCT00892723|2586045|P2|COMPLETED|Overall Study||15
1066575|NCT00892723|2586046|P1|COMPLETED|Overall Study||19
1066576|NCT00892723|2586044|P3|STARTED|Overall Study||19
1066577|NCT00892723|2586045|P2|STARTED|Overall Study||19
1066578|NCT00892723|2586046|P1|STARTED|Overall Study||21
1066585|NCT00892957|2586116|P2|NOT COMPLETED|Postoperative Day 30 Assessment||0
1066586|NCT00892957|2586117|P1|NOT COMPLETED|Postoperative Day 30 Assessment||0
1066587|NCT00892957|2586116|P2|COMPLETED|Postoperative Day 30 Assessment||66
1066588|NCT00892957|2586117|P1|COMPLETED|Postoperative Day 30 Assessment||70
1066589|NCT00892957|2586116|P2|STARTED|Postoperative Day 30 Assessment||66
1066590|NCT00892957|2586117|P1|STARTED|Postoperative Day 30 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|70
1066591|NCT00892957|2586116|P2|NOT COMPLETED|Postoperative Day 14 Assessment||0
1066592|NCT00892957|2586117|P1|NOT COMPLETED|Postoperative Day 14 Assessment||0
1066593|NCT00892957|2586116|P2|COMPLETED|Postoperative Day 14 Assessment||66
1066594|NCT00892957|2586117|P1|COMPLETED|Postoperative Day 14 Assessment||68
1066595|NCT00892957|2586116|P2|STARTED|Postoperative Day 14 Assessment||66
1066596|NCT00892957|2586117|P1|STARTED|Postoperative Day 14 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|68
1066597|NCT00892957|2586116|P2|NOT COMPLETED|Between Postoperative Day 1 and Day 14||4
1066598|NCT00892957|2586117|P1|NOT COMPLETED|Between Postoperative Day 1 and Day 14||0
1066599|NCT00892957|2586116|P2|COMPLETED|Between Postoperative Day 1 and Day 14||66
1066600|NCT00892957|2586117|P1|COMPLETED|Between Postoperative Day 1 and Day 14||70
1066601|NCT00892957|2586116|P2|STARTED|Between Postoperative Day 1 and Day 14||70
1066602|NCT00892957|2586117|P1|STARTED|Between Postoperative Day 1 and Day 14||70
1066603|NCT00892957|2586116|P2|NOT COMPLETED|Postoperative Day 1 Assessment||0
1066604|NCT00892957|2586117|P1|NOT COMPLETED|Postoperative Day 1 Assessment||0
1066605|NCT00892957|2586116|P2|COMPLETED|Postoperative Day 1 Assessment||70
1066606|NCT00892957|2586117|P1|COMPLETED|Postoperative Day 1 Assessment||70
1066607|NCT00892957|2586116|P2|STARTED|Postoperative Day 1 Assessment||70
1066608|NCT00892957|2586117|P1|STARTED|Postoperative Day 1 Assessment||70
1066609|NCT00892957|2586116|P2|NOT COMPLETED|Intraoperative Day 0||0
1066610|NCT00892957|2586117|P1|NOT COMPLETED|Intraoperative Day 0||0
1066611|NCT00892957|2586116|P2|COMPLETED|Intraoperative Day 0||70
1066612|NCT00892957|2586117|P1|COMPLETED|Intraoperative Day 0||70
1066613|NCT00892957|2586116|P2|STARTED|Intraoperative Day 0||70
1066614|NCT00892957|2586117|P1|STARTED|Intraoperative Day 0||70
1066615|NCT00893074|2586203|P1|NOT COMPLETED|Overall Study||11
1066616|NCT00893074|2586203|P1|COMPLETED|Overall Study||13
1066617|NCT00893074|2586203|P1|STARTED|Overall Study||24
1066618|NCT00893113|2586223|P2|NOT COMPLETED|Overall Study||16
1066619|NCT00893113|2586224|P1|NOT COMPLETED|Overall Study||13
1066620|NCT00893113|2586223|P2|COMPLETED|Overall Study||22
1066621|NCT00893113|2586224|P1|COMPLETED|Overall Study||23
1066622|NCT00893113|2586223|P2|STARTED|Overall Study||38
1066623|NCT00893113|2586224|P1|STARTED|Overall Study||36
1066624|NCT00893152|2586236|P2|NOT COMPLETED|Overall Study||0
1066625|NCT00893152|2586237|P1|NOT COMPLETED|Overall Study||0
1066626|NCT00893152|2586236|P2|COMPLETED|Overall Study||36
1066627|NCT00893152|2586237|P1|COMPLETED|Overall Study||47
1066628|NCT00893152|2586236|P2|STARTED|Overall Study||36
1066629|NCT00893152|2586237|P1|STARTED|Overall Study||47
1066630|NCT00893464|2586251|P8|NOT COMPLETED|Overall Study||2
1066631|NCT00893464|2586252|P7|NOT COMPLETED|Overall Study||2
1066632|NCT00893464|2586253|P6|NOT COMPLETED|Overall Study||0
1066633|NCT00893464|2586254|P5|NOT COMPLETED|Overall Study||0
1066634|NCT00893464|2586255|P4|NOT COMPLETED|Overall Study||0
1066635|NCT00893464|2586256|P3|NOT COMPLETED|Overall Study||0
1066636|NCT00893464|2586257|P2|NOT COMPLETED|Overall Study||0
1066637|NCT00893464|2586258|P1|NOT COMPLETED|Overall Study||0
1066638|NCT00893464|2586251|P8|COMPLETED|Overall Study||3
1066639|NCT00893464|2586252|P7|COMPLETED|Overall Study||8
1066640|NCT00893464|2586253|P6|COMPLETED|Overall Study||7
1066641|NCT00893464|2586254|P5|COMPLETED|Overall Study||4
1066642|NCT00893464|2586255|P4|COMPLETED|Overall Study||1
1066643|NCT00893464|2586256|P3|COMPLETED|Overall Study||1
1066644|NCT00893464|2586257|P2|COMPLETED|Overall Study||1
1066645|NCT00893464|2586258|P1|COMPLETED|Overall Study||1
1066646|NCT00893464|2586251|P8|STARTED|Overall Study||5
1066647|NCT00893464|2586252|P7|STARTED|Overall Study||10
1066648|NCT00893464|2586253|P6|STARTED|Overall Study||7
1066649|NCT00893464|2586254|P5|STARTED|Overall Study||4
1066650|NCT00893464|2586255|P4|STARTED|Overall Study||1
1066651|NCT00893464|2586256|P3|STARTED|Overall Study||1
1066652|NCT00893464|2586257|P2|STARTED|Overall Study||1
1066653|NCT00893464|2586258|P1|STARTED|Overall Study||1
1066654|NCT00893737|2586374|P1|NOT COMPLETED|Overall Study||12
1066655|NCT00893737|2586374|P1|COMPLETED|Overall Study||135
1066656|NCT00893737|2586374|P1|STARTED|Overall Study||147
1066657|NCT00893763|2586382|P2|NOT COMPLETED|Overall Study||110
1066658|NCT00893763|2586383|P1|NOT COMPLETED|Overall Study||110
1066659|NCT00893763|2586382|P2|COMPLETED|Overall Study||47
1066660|NCT00893763|2586383|P1|COMPLETED|Overall Study||47
1066661|NCT00893763|2586382|P2|STARTED|Overall Study||157
1066662|NCT00893763|2586383|P1|STARTED|Overall Study||157
1066663|NCT00893789|2586395|P4|NOT COMPLETED|Overall Study||13
1066664|NCT00893789|2586396|P3|NOT COMPLETED|Overall Study||7
1066665|NCT00893789|2586397|P2|NOT COMPLETED|Overall Study||4
1066666|NCT00893789|2586398|P1|NOT COMPLETED|Overall Study||6
1066667|NCT00893789|2586395|P4|COMPLETED|Overall Study||16
1066668|NCT00893789|2586396|P3|COMPLETED|Overall Study||22
1066669|NCT00893789|2586397|P2|COMPLETED|Overall Study||26
1066670|NCT00893789|2586398|P1|COMPLETED|Overall Study||23
1066671|NCT00893789|2586395|P4|Full Analysis Set (FAS)|Overall Study||27
1066672|NCT00893789|2586396|P3|Full Analysis Set (FAS)|Overall Study||28
1066673|NCT00893789|2586397|P2|Full Analysis Set (FAS)|Overall Study||29
1066674|NCT00893789|2586398|P1|Full Analysis Set (FAS)|Overall Study|FAS = participants in the safety analysis set with ≥1 postbaseline primary efficacy assessment.|29
1066675|NCT00893789|2586395|P4|Safety Analysis Set (SAS)|Overall Study||29
1066676|NCT00893789|2586396|P3|Safety Analysis Set (SAS)|Overall Study||29
1066677|NCT00893789|2586397|P2|Safety Analysis Set (SAS)|Overall Study||30
1066678|NCT00893789|2586398|P1|Safety Analysis Set (SAS)|Overall Study|SAS = all participants who received 1 or more doses of study drug.|29
1066679|NCT00893789|2586395|P4|STARTED|Overall Study||29
1066680|NCT00893789|2586396|P3|STARTED|Overall Study||29
1066681|NCT00893789|2586397|P2|STARTED|Overall Study||30
1066682|NCT00893789|2586398|P1|STARTED|Overall Study||29
1066683|NCT00893971|2586480|P1|NOT COMPLETED|Overall Study||3
1066684|NCT00893971|2586480|P1|COMPLETED|Overall Study||13
1066685|NCT00893971|2586480|P1|GP MDI (PT001) + FF MDI (PT005)|Overall Study||16
1066686|NCT00893971|2586480|P1|Placebo + FF MDI (PT005)|Overall Study||13
1066687|NCT00893971|2586480|P1|Placebo + GFF MDI (PT003)|Overall Study||15
1066688|NCT00893971|2586480|P1|Placebo + GP MDI (PT001)|Overall Study||15
1066689|NCT00893971|2586480|P1|STARTED|Overall Study||16
1066690|NCT00893997|2586594|P1|NOT COMPLETED|Overall Study||0
1066691|NCT00893997|2586594|P1|COMPLETED|Overall Study||10
1066692|NCT00893997|2586594|P1|STARTED|Overall Study||10
1066693|NCT00894127|2586599|P1|NOT COMPLETED|Overall Study||0
1066694|NCT00894127|2586599|P1|COMPLETED|Overall Study||128
1066695|NCT00894127|2586599|P1|STARTED|Overall Study||128
1066696|NCT00887679|2586603|P1|NOT COMPLETED|Overall Study||10
1066697|NCT00887679|2586603|P1|COMPLETED|Overall Study|20 subjects completed the study.|20
1066698|NCT00887679|2586603|P1|STARTED|Overall Study||30
1066699|NCT00887744|2586612|P1|NOT COMPLETED|Overall Study||34
1066700|NCT00887744|2586612|P1|COMPLETED|Overall Study||128
1066701|NCT00887744|2586612|P1|STARTED|Overall Study|162 patients signed an informed consent but only 157 patients were treated with the Aperius.|162
1066702|NCT00887809|2586623|P2|NOT COMPLETED|Overall Study||0
1066703|NCT00887809|2586624|P1|NOT COMPLETED|Overall Study||4
1066704|NCT00887809|2586623|P2|COMPLETED|Overall Study||10
1066705|NCT00887809|2586624|P1|COMPLETED|Overall Study||33
1066706|NCT00887809|2586623|P2|STARTED|Overall Study||10
1066707|NCT00887809|2586624|P1|STARTED|Overall Study||37
1066708|NCT00887822|2586632|P2|NOT COMPLETED|Overall Study||102
1066709|NCT00887822|2586633|P1|NOT COMPLETED|Overall Study||97
1066710|NCT00887822|2586632|P2|COMPLETED|Overall Study||0
1066711|NCT00887822|2586633|P1|COMPLETED|Overall Study||3
1066712|NCT00887822|2586632|P2|Treated (Safety Population)|Overall Study||101
1066713|NCT00887822|2586633|P1|Treated (Safety Population)|Overall Study||100
1066714|NCT00887822|2586632|P2|STARTED|Overall Study||102
1066715|NCT00887822|2586633|P1|STARTED|Overall Study||100
1066716|NCT00887913|2586663|P1|NOT COMPLETED|Overall Study||6
1066717|NCT00887913|2586663|P1|COMPLETED|Overall Study||63
1066718|NCT00887913|2586663|P1|STARTED|Overall Study||69
1066719|NCT00887965|2586669|P1|NOT COMPLETED|Overall Study||0
1066720|NCT00887965|2586669|P1|COMPLETED|Overall Study||15
1066721|NCT00887965|2586669|P1|STARTED|Overall Study||15
1066722|NCT00887978|2586701|P2|NOT COMPLETED|Overall Study||15
1066723|NCT00887978|2586702|P1|NOT COMPLETED|Overall Study||25
1066724|NCT00887978|2586701|P2|COMPLETED|Overall Study||138
1066725|NCT00887978|2586702|P1|COMPLETED|Overall Study||132
1066726|NCT00887978|2586701|P2|STARTED|Overall Study||153
1066727|NCT00887978|2586702|P1|STARTED|Overall Study||157
1066728|NCT00888134|2586738|P1|NOT COMPLETED|Follow-up||1
1066729|NCT00888134|2586738|P1|COMPLETED|Follow-up|23 died; 3 were lost-to-follow-up|26
1066730|NCT00888134|2586738|P1|STARTED|Follow-up||27
1066731|NCT00888134|2586738|P1|NOT COMPLETED|Treatment With Study Drug||1
1066732|NCT00888134|2586738|P1|COMPLETED|Treatment With Study Drug|21 had progressive disease; 5 had unacceptable toxicity; 1 finished treatment|27
1066733|NCT00888134|2586738|P1|STARTED|Treatment With Study Drug||28
1066734|NCT00888238|2586746|P3|NOT COMPLETED|Third Period of Treatment Intervention||0
1066735|NCT00888238|2586747|P2|NOT COMPLETED|Third Period of Treatment Intervention||0
1066736|NCT00888238|2586748|P1|NOT COMPLETED|Third Period of Treatment Intervention||0
1066737|NCT00888238|2586746|P3|COMPLETED|Third Period of Treatment Intervention||3
1066738|NCT00888238|2586747|P2|COMPLETED|Third Period of Treatment Intervention||4
1066739|NCT00888238|2586748|P1|COMPLETED|Third Period of Treatment Intervention||4
1066740|NCT00888238|2586746|P3|STARTED|Third Period of Treatment Intervention||3
1066741|NCT00888238|2586747|P2|STARTED|Third Period of Treatment Intervention||4
1066742|NCT00888238|2586748|P1|STARTED|Third Period of Treatment Intervention||4
1066743|NCT00888238|2586746|P3|NOT COMPLETED|Washout Period After Period 2||1
1066744|NCT00888238|2586747|P2|NOT COMPLETED|Washout Period After Period 2||0
1066745|NCT00888238|2586748|P1|NOT COMPLETED|Washout Period After Period 2||0
1066746|NCT00888238|2586746|P3|COMPLETED|Washout Period After Period 2||3
1066747|NCT00888238|2586747|P2|COMPLETED|Washout Period After Period 2||4
1066748|NCT00888238|2586748|P1|COMPLETED|Washout Period After Period 2||4
1066749|NCT00888238|2586746|P3|STARTED|Washout Period After Period 2||4
1066750|NCT00888238|2586747|P2|STARTED|Washout Period After Period 2||4
1066751|NCT00888238|2586748|P1|STARTED|Washout Period After Period 2||4
1066752|NCT00888238|2586746|P3|NOT COMPLETED|Second Period of Treatment Intervention||0
1066753|NCT00888238|2586747|P2|NOT COMPLETED|Second Period of Treatment Intervention||0
1066754|NCT00888238|2586748|P1|NOT COMPLETED|Second Period of Treatment Intervention||0
1066755|NCT00888238|2586746|P3|COMPLETED|Second Period of Treatment Intervention||4
1066756|NCT00888238|2586747|P2|COMPLETED|Second Period of Treatment Intervention||4
1066757|NCT00888238|2586748|P1|COMPLETED|Second Period of Treatment Intervention||4
1066758|NCT00888238|2586746|P3|STARTED|Second Period of Treatment Intervention||4
1066759|NCT00888238|2586747|P2|STARTED|Second Period of Treatment Intervention||4
1066760|NCT00888238|2586748|P1|STARTED|Second Period of Treatment Intervention||4
1066761|NCT00888238|2586746|P3|NOT COMPLETED|Washout Period After Period 1||0
1066762|NCT00888238|2586747|P2|NOT COMPLETED|Washout Period After Period 1||0
1066763|NCT00888238|2586748|P1|NOT COMPLETED|Washout Period After Period 1||0
1066764|NCT00888238|2586746|P3|COMPLETED|Washout Period After Period 1||4
1066765|NCT00888238|2586747|P2|COMPLETED|Washout Period After Period 1||4
1066766|NCT00888238|2586748|P1|COMPLETED|Washout Period After Period 1||4
1066767|NCT00888238|2586746|P3|STARTED|Washout Period After Period 1||4
1066768|NCT00888238|2586747|P2|STARTED|Washout Period After Period 1||4
1066769|NCT00888238|2586748|P1|STARTED|Washout Period After Period 1||4
1066770|NCT00888238|2586746|P3|NOT COMPLETED|First Period of Treatment Intervention||0
1066771|NCT00888238|2586747|P2|NOT COMPLETED|First Period of Treatment Intervention||0
1066772|NCT00888238|2586748|P1|NOT COMPLETED|First Period of Treatment Intervention||0
1066773|NCT00888238|2586746|P3|COMPLETED|First Period of Treatment Intervention||4
1066774|NCT00888238|2586747|P2|COMPLETED|First Period of Treatment Intervention||4
1066775|NCT00888238|2586748|P1|COMPLETED|First Period of Treatment Intervention||4
1066776|NCT00888238|2586746|P3|STARTED|First Period of Treatment Intervention||4
1066777|NCT00888238|2586747|P2|STARTED|First Period of Treatment Intervention||4
1066778|NCT00888238|2586748|P1|STARTED|First Period of Treatment Intervention||4
1066779|NCT00888329|2586758|P2|NOT COMPLETED|Overall Study||9
1066780|NCT00888329|2586759|P1|NOT COMPLETED|Overall Study||6
1066781|NCT00888329|2586758|P2|COMPLETED|Overall Study||122
1066782|NCT00888329|2586759|P1|COMPLETED|Overall Study||119
1066783|NCT00888329|2586758|P2|STARTED|Overall Study||131
1066784|NCT00888329|2586759|P1|STARTED|Overall Study||125
1066785|NCT00888355|2586769|P4|NOT COMPLETED|Overall Study||10
1066786|NCT00888355|2586770|P3|NOT COMPLETED|Overall Study||12
1066787|NCT00888355|2586771|P2|NOT COMPLETED|Overall Study||9
1066788|NCT00888355|2586772|P1|NOT COMPLETED|Overall Study||22
1066789|NCT00888355|2586769|P4|COMPLETED|Overall Study||96
1066790|NCT00888355|2586770|P3|COMPLETED|Overall Study||94
1066791|NCT00888355|2586771|P2|COMPLETED|Overall Study||99
1066792|NCT00888355|2586772|P1|COMPLETED|Overall Study||86
1066793|NCT00888355|2586769|P4|STARTED|Overall Study||106
1066794|NCT00888355|2586770|P3|STARTED|Overall Study||106
1066795|NCT00888355|2586771|P2|STARTED|Overall Study||108
1066796|NCT00888355|2586772|P1|STARTED|Overall Study||108
1066797|NCT00888381|2586828|P2|NOT COMPLETED|Overall Study||1
1066798|NCT00888381|2586829|P1|NOT COMPLETED|Overall Study||0
1066799|NCT00888381|2586828|P2|COMPLETED|Overall Study||59
1066800|NCT00888381|2586829|P1|COMPLETED|Overall Study||60
1066801|NCT00888381|2586828|P2|STARTED|Overall Study||60
1066802|NCT00888381|2586829|P1|STARTED|Overall Study||60
1066803|NCT00888433|2586847|P2|NOT COMPLETED|Overall Study||3
1066804|NCT00888433|2586848|P1|NOT COMPLETED|Overall Study||3
1066805|NCT00888433|2586847|P2|COMPLETED|Overall Study||51
1066806|NCT00888433|2586848|P1|COMPLETED|Overall Study||49
1066807|NCT00888433|2586847|P2|STARTED|Overall Study||54
1066808|NCT00888433|2586848|P1|STARTED|Overall Study||52
1066809|NCT00888459|2586856|P2|NOT COMPLETED|Overall Study||0
1066810|NCT00888459|2586857|P1|NOT COMPLETED|Overall Study||0
1066811|NCT00888459|2586856|P2|COMPLETED|Overall Study||30
1066812|NCT00888459|2586857|P1|COMPLETED|Overall Study||30
1066813|NCT00888459|2586856|P2|STARTED|Overall Study||30
1066814|NCT00888459|2586857|P1|STARTED|Overall Study||30
1066815|NCT00894166|2586871|P8|NOT COMPLETED|Overall Study||34
1066816|NCT00894166|2586872|P7|NOT COMPLETED|Overall Study||16
1066817|NCT00894166|2586873|P6|NOT COMPLETED|Overall Study||16
1066818|NCT00894166|2586874|P5|NOT COMPLETED|Overall Study||24
1066819|NCT00894166|2586875|P4|NOT COMPLETED|Overall Study||69
1066820|NCT00894166|2586876|P3|NOT COMPLETED|Overall Study||62
1066821|NCT00894166|2586877|P2|NOT COMPLETED|Overall Study||63
1066822|NCT00894166|2586878|P1|NOT COMPLETED|Overall Study||61
1066823|NCT00894166|2586871|P8|COMPLETED|Overall Study||0
1066824|NCT00894166|2586872|P7|COMPLETED|Overall Study||19
1066825|NCT00894166|2586873|P6|COMPLETED|Overall Study||20
1066826|NCT00894166|2586874|P5|COMPLETED|Overall Study||10
1066827|NCT00894166|2586875|P4|COMPLETED|Overall Study||45
1066828|NCT00894166|2586876|P3|COMPLETED|Overall Study||50
1066829|NCT00894166|2586877|P2|COMPLETED|Overall Study||46
1066830|NCT00894166|2586878|P1|COMPLETED|Overall Study||71
1066831|NCT00894166|2586871|P8|STARTED|Overall Study||34
1066832|NCT00894166|2586872|P7|STARTED|Overall Study||35
1066833|NCT00894166|2586873|P6|STARTED|Overall Study||36
1066834|NCT00894166|2586874|P5|STARTED|Overall Study||34
1066835|NCT00894166|2586875|P4|STARTED|Overall Study||114
1066836|NCT00894166|2586876|P3|STARTED|Overall Study||112
1066837|NCT00894166|2586877|P2|STARTED|Overall Study||109
1066838|NCT00894166|2586878|P1|STARTED|Overall Study||132
1066839|NCT00894244|2586908|P1|NOT COMPLETED|Overall Study||1
1066840|NCT00894244|2586908|P1|COMPLETED|Overall Study||24
1066841|NCT00894244|2586908|P1|STARTED|Overall Study||25
1066842|NCT00894322|2586915|P3|NOT COMPLETED|Overall Study||0
1066843|NCT00894322|2586916|P2|NOT COMPLETED|Overall Study||0
1066844|NCT00894322|2586917|P1|NOT COMPLETED|Overall Study||1
1066845|NCT00894322|2586915|P3|COMPLETED|Overall Study||12
1066846|NCT00894322|2586916|P2|COMPLETED|Overall Study||23
1066847|NCT00894322|2586917|P1|COMPLETED|Overall Study||29
1066848|NCT00894322|2586915|P3|STARTED|Overall Study||12
1066849|NCT00894322|2586916|P2|STARTED|Overall Study||23
1066850|NCT00894322|2586917|P1|STARTED|Overall Study||30
1066851|NCT00894361|2586958|P2|NOT COMPLETED|Overall Study||64
1066852|NCT00894361|2586959|P1|NOT COMPLETED|Overall Study||24
1066853|NCT00894361|2586958|P2|COMPLETED|Overall Study||136
1066854|NCT00894361|2586959|P1|COMPLETED|Overall Study||176
1066855|NCT00894361|2586958|P2|STARTED|Overall Study||200
1066856|NCT00894361|2586959|P1|STARTED|Overall Study||200
1066857|NCT00894387|2586967|P2|NOT COMPLETED|Overall Study||175
1066858|NCT00894387|2586968|P1|NOT COMPLETED|Overall Study||175
1066859|NCT00894387|2586967|P2|COMPLETED|Overall Study||643
1066860|NCT00894387|2586968|P1|COMPLETED|Overall Study|"Completed indicates patients whose treatment duration completed as per protocol"|646
1066861|NCT00894387|2586967|P2|Completed Secondary Efficacy Phase (12m)|Overall Study||640
1066862|NCT00894387|2586968|P1|Completed Secondary Efficacy Phase (12m)|Overall Study||654
1066863|NCT00894387|2586967|P2|Completed Primary Efficacy Phase (6 m)|Overall Study||707
1066864|NCT00894387|2586968|P1|Completed Primary Efficacy Phase (6 m)|Overall Study||717
1066865|NCT00894387|2586967|P2|Full Analysis Set|Overall Study||807
1066866|NCT00894387|2586968|P1|Full Analysis Set|Overall Study||808
1066867|NCT00894387|2586967|P2|Safety Set|Overall Study||810
1066868|NCT00894387|2586968|P1|Safety Set|Overall Study||808
1066869|NCT00894387|2586967|P2|STARTED|Overall Study||818
1066870|NCT00894387|2586968|P1|STARTED|Overall Study|"Started indicates all randomized patients"|821
1066871|NCT00894465|2586988|P2|NOT COMPLETED|Overall Study||0
1066872|NCT00894465|2586989|P1|NOT COMPLETED|Overall Study||0
1066873|NCT00894465|2586988|P2|COMPLETED|Overall Study||22
1066874|NCT00894465|2586989|P1|COMPLETED|Overall Study||22
1066875|NCT00894465|2586988|P2|STARTED|Overall Study||22
1066876|NCT00894465|2586989|P1|STARTED|Overall Study||22
1066877|NCT00896233|2586997|P1|NOT COMPLETED|Overall Study||1
1066878|NCT00896233|2586997|P1|COMPLETED|Overall Study||9
1066879|NCT00896233|2586997|P1|STARTED|Overall Study||10
1066880|NCT00896337|2587008|P1|NOT COMPLETED|Overall Study||25
1066881|NCT00896337|2587008|P1|COMPLETED|Overall Study||100
1066882|NCT00896337|2587008|P1|STARTED|Overall Study||125
1066883|NCT00896454|2587075|P1|NOT COMPLETED|Overall Study||33
1066884|NCT00896454|2587075|P1|COMPLETED|Overall Study||0
1066885|NCT00896454|2587075|P1|STARTED|Overall Study||33
1066886|NCT00896649|2587087|P1|NOT COMPLETED|Overall Study||5
1066887|NCT00896649|2587087|P1|COMPLETED|Overall Study||188
1066888|NCT00896649|2587087|P1|STARTED|Overall Study||193
1066889|NCT00896779|2587094|P2|NOT COMPLETED|Overall Study||1
1066890|NCT00896779|2587095|P1|NOT COMPLETED|Overall Study||0
1066891|NCT00896779|2587094|P2|COMPLETED|Overall Study||11
1066892|NCT00896779|2587095|P1|COMPLETED|Overall Study||8
1066893|NCT00896779|2587094|P2|STARTED|Overall Study||12
1066894|NCT00896779|2587095|P1|STARTED|Overall Study||8
1066895|NCT00897104|2587104|P3|NOT COMPLETED|Overall Study||8
1066896|NCT00897104|2587105|P2|NOT COMPLETED|Overall Study||71
1066897|NCT00897104|2587106|P1|NOT COMPLETED|Overall Study||64
1066898|NCT00897104|2587104|P3|COMPLETED|Overall Study|Participants who took study drug and completed the study|79
1066899|NCT00897104|2587105|P2|COMPLETED|Overall Study|Participants who took study drug and completed the study|357
1066900|NCT00897104|2587106|P1|COMPLETED|Overall Study|Participants who took study drug and completed the study|354
1066901|NCT00897104|2587104|P3|Participants Not Treated|Overall Study|Participants who did not take study drug|7
1066902|NCT00897104|2587105|P2|Participants Not Treated|Overall Study|Participants who did not take study drug|71
1066903|NCT00897104|2587106|P1|Participants Not Treated|Overall Study|Participants who did not take study drug|63
1066904|NCT00897104|2587104|P3|Participants Treated|Overall Study|Participants who took study drug|80
1066905|NCT00897104|2587105|P2|Participants Treated|Overall Study|Participants who took study drug|357
1066906|NCT00897104|2587106|P1|Participants Treated|Overall Study|Participants who took study drug|355
1066907|NCT00897104|2587104|P3|STARTED|Overall Study|Participants who were allocated study drug|87
1066908|NCT00897104|2587105|P2|STARTED|Overall Study|Participants who were allocated study drug|428
1066909|NCT00897104|2587106|P1|STARTED|Overall Study|Participants who were allocated study drug|418
1066910|NCT00897390|2587132|P1|NOT COMPLETED|Overall Study||6
1066911|NCT00897390|2587132|P1|COMPLETED|Overall Study||18
1066912|NCT00897390|2587132|P1|STARTED|Overall Study||24
1066913|NCT00897715|2587221|P2|NOT COMPLETED|Overall Study||1
1066914|NCT00897715|2587222|P1|NOT COMPLETED|Overall Study||2
1066915|NCT00897715|2587221|P2|COMPLETED|Overall Study||6
1066916|NCT00897715|2587222|P1|COMPLETED|Overall Study||6
1066917|NCT00897715|2587221|P2|STARTED|Overall Study||7
1066918|NCT00897715|2587222|P1|STARTED|Overall Study||8
1066919|NCT00897897|2587230|P1|NOT COMPLETED|Overall Study||0
1066920|NCT00897897|2587230|P1|COMPLETED|Overall Study||33
1066921|NCT00897897|2587230|P1|STARTED|Overall Study||33
1066922|NCT00897910|2587235|P1|NOT COMPLETED|Overall Study||0
1066923|NCT00897910|2587235|P1|COMPLETED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected|6
1066924|NCT00897910|2587235|P1|STARTED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected.|6
1066925|NCT00897949|2587242|P3|NOT COMPLETED|Overall Study||69
1066926|NCT00897949|2587243|P2|NOT COMPLETED|Overall Study||103
1066927|NCT00897949|2587244|P1|NOT COMPLETED|Overall Study||104
1066928|NCT00897949|2587242|P3|COMPLETED|Overall Study|Patients who took study drug and completed the study|301
1066929|NCT00897949|2587243|P2|COMPLETED|Overall Study|Patients who took study drug and completed the study|446
1066930|NCT00897949|2587244|P1|COMPLETED|Overall Study|Patients who took study drug and completed the study|450
1066931|NCT00897949|2587242|P3|Patients Treated|Overall Study|Patients who took study drug|304
1066932|NCT00897949|2587243|P2|Patients Treated|Overall Study|Patients who took study drug|456
1066933|NCT00897949|2587244|P1|Patients Treated|Overall Study|Patients who took study drug|458
1066934|NCT00897949|2587242|P3|STARTED|Overall Study|Patients who were allocated study drug|370
1066935|NCT00897949|2587243|P2|STARTED|Overall Study|Patients who were allocated study drug|549
1066936|NCT00897949|2587244|P1|STARTED|Overall Study|Patients who were allocated study drug|554
1066937|NCT00898222|2587267|P1|NOT COMPLETED|Overall Study||0
1066938|NCT00898222|2587267|P1|COMPLETED|Overall Study||4
1066939|NCT00898222|2587267|P1|STARTED|Overall Study||4
1066940|NCT00898443|2587273|P2|NOT COMPLETED|Overall Study||0
1066941|NCT00898443|2587274|P1|NOT COMPLETED|Overall Study||1
1066942|NCT00898443|2587273|P2|COMPLETED|Overall Study||8
1066943|NCT00898443|2587274|P1|COMPLETED|Overall Study||9
1066944|NCT00898443|2587273|P2|STARTED|Overall Study||8
1066945|NCT00898443|2587274|P1|STARTED|Overall Study||10
1066946|NCT00898560|2587282|P1|NOT COMPLETED|Overall Study||1
1066947|NCT00898560|2587282|P1|COMPLETED|Overall Study||19
1066948|NCT00898560|2587282|P1|STARTED|Overall Study||20
1066949|NCT00898677|2587296|P4|NOT COMPLETED|Overall Study||19
1066950|NCT00898677|2587297|P3|NOT COMPLETED|Overall Study||72
1066951|NCT00898677|2587298|P2|NOT COMPLETED|Overall Study||69
1066952|NCT00898677|2587299|P1|NOT COMPLETED|Overall Study||17
1066953|NCT00898677|2587296|P4|COMPLETED|Overall Study||159
1066954|NCT00898677|2587297|P3|COMPLETED|Overall Study||383
1066955|NCT00898677|2587298|P2|COMPLETED|Overall Study||386
1066956|NCT00898677|2587299|P1|COMPLETED|Overall Study||163
1066957|NCT00898677|2587296|P4|Patients Treated|Overall Study|Patients Not Treated: 18|160
1066958|NCT00898677|2587297|P3|Patients Treated|Overall Study|Patients Not Treated: 67|388
1066959|NCT00898677|2587298|P2|Patients Treated|Overall Study|Patients Not Treated: 68|387
1066960|NCT00898677|2587299|P1|Patients Treated|Overall Study|Patients Not Treated: 16|164
1066961|NCT00898677|2587296|P4|STARTED|Overall Study||178
1066962|NCT00898677|2587297|P3|STARTED|Overall Study||455
1066963|NCT00898677|2587298|P2|STARTED|Overall Study||455
1066964|NCT00898677|2587299|P1|STARTED|Overall Study||180
1066965|NCT00898807|2587327|P2|NOT COMPLETED|Overall Study||9
1066966|NCT00898807|2587328|P1|NOT COMPLETED|Overall Study||8
1066967|NCT00898807|2587327|P2|COMPLETED|Overall Study||83
1066968|NCT00898807|2587328|P1|COMPLETED|Overall Study||86
1066969|NCT00898807|2587327|P2|STARTED|Overall Study||92
1066970|NCT00898807|2587328|P1|STARTED|Overall Study||94
1066971|NCT00891436|2587342|P2|NOT COMPLETED|Overall Study||0
1066972|NCT00891436|2587343|P1|NOT COMPLETED|Overall Study||0
1066973|NCT00891436|2587342|P2|COMPLETED|Overall Study||10
1066974|NCT00891436|2587343|P1|COMPLETED|Overall Study||10
1066975|NCT00891436|2587342|P2|STARTED|Overall Study||10
1066976|NCT00891436|2587343|P1|STARTED|Overall Study||10
1066977|NCT00891462|2587354|P3|NOT COMPLETED|Overall Study||24
1066978|NCT00891462|2587355|P2|NOT COMPLETED|Overall Study||33
1066979|NCT00891462|2587356|P1|NOT COMPLETED|Overall Study||37
1066980|NCT00891462|2587354|P3|COMPLETED|Overall Study||166
1066981|NCT00891462|2587355|P2|COMPLETED|Overall Study||152
1066982|NCT00891462|2587356|P1|COMPLETED|Overall Study||149
1066983|NCT00891462|2587354|P3|STARTED|Overall Study||190
1066984|NCT00891462|2587355|P2|STARTED|Overall Study||185
1066985|NCT00891462|2587356|P1|STARTED|Overall Study||186
1066986|NCT00891527|2587367|P1|NOT COMPLETED|Overall Study||2
1066987|NCT00891527|2587367|P1|COMPLETED|Overall Study||48
1066988|NCT00891527|2587367|P1|STARTED|Overall Study||50
1066989|NCT00899353|2587373|P1|NOT COMPLETED|Overall Study||5
1066990|NCT00899353|2587373|P1|COMPLETED|Overall Study||11
1066991|NCT00899353|2587373|P1|STARTED|Overall Study||16
1066992|NCT00899379|2587399|P5|NOT COMPLETED|Overall Study||31
1066993|NCT00899379|2587400|P4|NOT COMPLETED|Overall Study||37
1066994|NCT00899379|2587401|P3|NOT COMPLETED|Overall Study||29
1066995|NCT00899379|2587402|P2|NOT COMPLETED|Overall Study||29
1066996|NCT00899379|2587403|P1|NOT COMPLETED|Overall Study||34
1066997|NCT00899379|2587399|P5|COMPLETED|Overall Study|Patients who took study drug and completed the study|63
1066998|NCT00899379|2587400|P4|COMPLETED|Overall Study|Patients who took study drug and completed the study|57
1066999|NCT00899379|2587401|P3|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
1067000|NCT00899379|2587402|P2|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
1067001|NCT00899379|2587403|P1|COMPLETED|Overall Study|Patients who took study drug and completed the study|61
1067002|NCT00899379|2587399|P5|Patients Not Treated|Overall Study|Patients who did not take study drug|13
1067003|NCT00899379|2587400|P4|Patients Not Treated|Overall Study|Patients who did not take study drug|17
1067004|NCT00899379|2587401|P3|Patients Not Treated|Overall Study|Patients who did not take study drug|11
1067005|NCT00899379|2587402|P2|Patients Not Treated|Overall Study|Patients who did not take study drug|13
1067006|NCT00899379|2587403|P1|Patients Not Treated|Overall Study|Patients who did not take study drug|12
1067007|NCT00899379|2587399|P5|Patients Treated|Overall Study|Patients who took study drug|81
1067008|NCT00899379|2587400|P4|Patients Treated|Overall Study|Patients who took study drug|77
1067009|NCT00899379|2587401|P3|Patients Treated|Overall Study|Patients who took study drug|84
1067010|NCT00899379|2587402|P2|Patients Treated|Overall Study|Patients who took study drug|82
1067011|NCT00899379|2587403|P1|Patients Treated|Overall Study|Patients who took study drug|83
1067012|NCT00899379|2587399|P5|STARTED|Overall Study|Patients who were allocated study drug|94
1067013|NCT00899379|2587400|P4|STARTED|Overall Study|Patients who were allocated study drug|94
1067014|NCT00899379|2587401|P3|STARTED|Overall Study|Patients who were allocated study drug|95
1067015|NCT00899379|2587402|P2|STARTED|Overall Study|Patients who were allocated study drug|95
1067016|NCT00899379|2587403|P1|STARTED|Overall Study|Patients who were allocated study drug|95
1067017|NCT00899392|2587417|P2|NOT COMPLETED|Overall Study||24
1067018|NCT00899392|2587418|P1|NOT COMPLETED|Overall Study||21
1067019|NCT00899392|2587417|P2|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|50
1067020|NCT00899392|2587418|P1|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|47
1067021|NCT00899392|2587417|P2|STARTED|Overall Study||74
1067022|NCT00899392|2587418|P1|STARTED|Overall Study||68
1067023|NCT00899470|2587430|P4|NOT COMPLETED|Fourth Therapy||0
1067024|NCT00899470|2587431|P3|NOT COMPLETED|Fourth Therapy||0
1067025|NCT00899470|2587432|P2|NOT COMPLETED|Fourth Therapy||0
1067026|NCT00899470|2587433|P1|NOT COMPLETED|Fourth Therapy||0
1067027|NCT00899470|2587430|P4|COMPLETED|Fourth Therapy||6
1067028|NCT00899470|2587431|P3|COMPLETED|Fourth Therapy||6
1067029|NCT00899470|2587432|P2|COMPLETED|Fourth Therapy||6
1067030|NCT00899470|2587433|P1|COMPLETED|Fourth Therapy||6
1067031|NCT00899470|2587430|P4|STARTED|Fourth Therapy||6
1067032|NCT00899470|2587431|P3|STARTED|Fourth Therapy||6
1067033|NCT00899470|2587432|P2|STARTED|Fourth Therapy||6
1067034|NCT00899470|2587433|P1|STARTED|Fourth Therapy||6
1067035|NCT00899470|2587430|P4|NOT COMPLETED|Third Washout||0
1067036|NCT00899470|2587431|P3|NOT COMPLETED|Third Washout||0
1067037|NCT00899470|2587432|P2|NOT COMPLETED|Third Washout||0
1067038|NCT00899470|2587433|P1|NOT COMPLETED|Third Washout||0
1067039|NCT00899470|2587430|P4|COMPLETED|Third Washout||6
1067040|NCT00899470|2587431|P3|COMPLETED|Third Washout||6
1067041|NCT00899470|2587432|P2|COMPLETED|Third Washout||6
1067042|NCT00899470|2587433|P1|COMPLETED|Third Washout||6
1067043|NCT00899470|2587430|P4|STARTED|Third Washout||6
1067044|NCT00899470|2587431|P3|STARTED|Third Washout||6
1067045|NCT00899470|2587432|P2|STARTED|Third Washout||6
1067046|NCT00899470|2587433|P1|STARTED|Third Washout||6
1067047|NCT00899470|2587430|P4|NOT COMPLETED|Third Therapy||0
1067048|NCT00899470|2587431|P3|NOT COMPLETED|Third Therapy||0
1067049|NCT00899470|2587432|P2|NOT COMPLETED|Third Therapy||0
1067050|NCT00899470|2587433|P1|NOT COMPLETED|Third Therapy||0
1067051|NCT00899470|2587430|P4|COMPLETED|Third Therapy||6
1067052|NCT00899470|2587431|P3|COMPLETED|Third Therapy||6
1067053|NCT00899470|2587432|P2|COMPLETED|Third Therapy||6
1067054|NCT00899470|2587433|P1|COMPLETED|Third Therapy||6
1067055|NCT00899470|2587430|P4|STARTED|Third Therapy||6
1067056|NCT00899470|2587431|P3|STARTED|Third Therapy||6
1067057|NCT00899470|2587432|P2|STARTED|Third Therapy||6
1067058|NCT00899470|2587433|P1|STARTED|Third Therapy||6
1067059|NCT00899470|2587430|P4|NOT COMPLETED|Second Washout||0
1067060|NCT00899470|2587431|P3|NOT COMPLETED|Second Washout||0
1067061|NCT00899470|2587432|P2|NOT COMPLETED|Second Washout||0
1067062|NCT00899470|2587433|P1|NOT COMPLETED|Second Washout||0
1067063|NCT00899470|2587430|P4|COMPLETED|Second Washout||6
1067064|NCT00899470|2587431|P3|COMPLETED|Second Washout||6
1067065|NCT00899470|2587432|P2|COMPLETED|Second Washout||6
1067066|NCT00899470|2587433|P1|COMPLETED|Second Washout||6
1067067|NCT00899470|2587430|P4|STARTED|Second Washout||6
1067068|NCT00899470|2587431|P3|STARTED|Second Washout||6
1067069|NCT00899470|2587432|P2|STARTED|Second Washout||6
1067070|NCT00899470|2587433|P1|STARTED|Second Washout||6
1067071|NCT00899470|2587430|P4|NOT COMPLETED|Second Therapy||0
1067072|NCT00899470|2587431|P3|NOT COMPLETED|Second Therapy||0
1067073|NCT00899470|2587432|P2|NOT COMPLETED|Second Therapy||0
1067074|NCT00899470|2587433|P1|NOT COMPLETED|Second Therapy||0
1067075|NCT00899470|2587430|P4|COMPLETED|Second Therapy||6
1067076|NCT00899470|2587431|P3|COMPLETED|Second Therapy||6
1067077|NCT00899470|2587432|P2|COMPLETED|Second Therapy||6
1067078|NCT00899470|2587433|P1|COMPLETED|Second Therapy||6
1067079|NCT00899470|2587430|P4|STARTED|Second Therapy||6
1067080|NCT00899470|2587431|P3|STARTED|Second Therapy||6
1067081|NCT00899470|2587432|P2|STARTED|Second Therapy||6
1067082|NCT00899470|2587433|P1|STARTED|Second Therapy||6
1067083|NCT00899470|2587430|P4|NOT COMPLETED|First Washout Period||0
1067084|NCT00899470|2587431|P3|NOT COMPLETED|First Washout Period||0
1067085|NCT00899470|2587432|P2|NOT COMPLETED|First Washout Period||0
1067086|NCT00899470|2587433|P1|NOT COMPLETED|First Washout Period||0
1067087|NCT00899470|2587430|P4|COMPLETED|First Washout Period||6
1067088|NCT00899470|2587431|P3|COMPLETED|First Washout Period||6
1067089|NCT00899470|2587432|P2|COMPLETED|First Washout Period||6
1067090|NCT00899470|2587433|P1|COMPLETED|First Washout Period||6
1067091|NCT00899470|2587430|P4|STARTED|First Washout Period||6
1067092|NCT00899470|2587431|P3|STARTED|First Washout Period||6
1067093|NCT00899470|2587432|P2|STARTED|First Washout Period||6
1067094|NCT00899470|2587433|P1|STARTED|First Washout Period||6
1067095|NCT00899470|2587430|P4|NOT COMPLETED|First Therapy||0
1067096|NCT00899470|2587431|P3|NOT COMPLETED|First Therapy||0
1067097|NCT00899470|2587432|P2|NOT COMPLETED|First Therapy||0
1067098|NCT00899470|2587433|P1|NOT COMPLETED|First Therapy||0
1067099|NCT00899470|2587430|P4|COMPLETED|First Therapy||6
1067100|NCT00899470|2587431|P3|COMPLETED|First Therapy||6
1067101|NCT00899470|2587432|P2|COMPLETED|First Therapy||6
1067102|NCT00899470|2587433|P1|COMPLETED|First Therapy||6
1067103|NCT00899470|2587430|P4|STARTED|First Therapy||6
1067104|NCT00899470|2587431|P3|STARTED|First Therapy||6
1067105|NCT00899470|2587432|P2|STARTED|First Therapy||6
1067106|NCT00899470|2587433|P1|STARTED|First Therapy||6
1067107|NCT00899574|2587509|P1|NOT COMPLETED|Overall Study||0
1067108|NCT00899574|2587509|P1|COMPLETED|Overall Study||10
1067109|NCT00899574|2587509|P1|STARTED|Overall Study||10
1067110|NCT00899600|2587516|P2|NOT COMPLETED|Overall Study||0
1067111|NCT00899600|2587517|P1|NOT COMPLETED|Overall Study||0
1067112|NCT00899600|2587516|P2|COMPLETED|Overall Study||52
1067113|NCT00899600|2587517|P1|COMPLETED|Overall Study||50
1067114|NCT00899600|2587516|P2|STARTED|Overall Study||52
1067115|NCT00899600|2587517|P1|STARTED|Overall Study||50
1067116|NCT00899678|2587526|P3|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||28
1067117|NCT00899678|2587527|P2|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||25
1067118|NCT00899678|2587528|P1|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||0
1067119|NCT00899678|2587526|P3|COMPLETED|Maintenance Period (Weeks 8 to 62)||7
1067120|NCT00899678|2587527|P2|COMPLETED|Maintenance Period (Weeks 8 to 62)||12
1067121|NCT00899678|2587528|P1|COMPLETED|Maintenance Period (Weeks 8 to 62)||0
1067122|NCT00899678|2587526|P3|STARTED|Maintenance Period (Weeks 8 to 62)||35
1067123|NCT00899678|2587527|P2|STARTED|Maintenance Period (Weeks 8 to 62)||37
1067124|NCT00899678|2587528|P1|STARTED|Maintenance Period (Weeks 8 to 62)|Induction only includes subjects that discontinued before Maintenance Period.|0
1067125|NCT00899678|2587526|P3|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
1067126|NCT00899678|2587527|P2|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
1067127|NCT00899678|2587528|P1|NOT COMPLETED|Induction Period (Weeks 0 to 6)||25
1067128|NCT00899678|2587526|P3|COMPLETED|Induction Period (Weeks 0 to 6)||35
1067129|NCT00899678|2587527|P2|COMPLETED|Induction Period (Weeks 0 to 6)||37
1067130|NCT00899678|2587528|P1|COMPLETED|Induction Period (Weeks 0 to 6)|2 subjects completed the Induction Phase, but discontinued prior to receiving any Maintenance doses.|2
1067131|NCT00899678|2587526|P3|STARTED|Induction Period (Weeks 0 to 6)||35
1067132|NCT00899678|2587527|P2|STARTED|Induction Period (Weeks 0 to 6)||37
1067133|NCT00899678|2587528|P1|STARTED|Induction Period (Weeks 0 to 6)|Induction only includes subjects that discontinued before Maintenance Period.|27
1067134|NCT00899717|2587558|P2|NOT COMPLETED|Overall Study||0
1067135|NCT00899717|2587559|P1|NOT COMPLETED|Overall Study||0
1067136|NCT00899717|2587558|P2|COMPLETED|Overall Study||11
1067137|NCT00899717|2587559|P1|COMPLETED|Overall Study||10
1067138|NCT00899717|2587558|P2|STARTED|Overall Study||11
1067139|NCT00899717|2587559|P1|STARTED|Overall Study||10
1067140|NCT00900029|2587578|P5|NOT COMPLETED|Overall Study||6
1067141|NCT00900029|2587579|P4|NOT COMPLETED|Overall Study||7
1067142|NCT00900029|2587580|P3|NOT COMPLETED|Overall Study||3
1067143|NCT00900029|2587581|P2|NOT COMPLETED|Overall Study||4
1067144|NCT00900029|2587582|P1|NOT COMPLETED|Overall Study||3
1067145|NCT00900029|2587578|P5|COMPLETED|Overall Study||38
1067146|NCT00900029|2587579|P4|COMPLETED|Overall Study||35
1067147|NCT00900029|2587580|P3|COMPLETED|Overall Study||38
1067148|NCT00900029|2587581|P2|COMPLETED|Overall Study||37
1067149|NCT00900029|2587582|P1|COMPLETED|Overall Study||35
1067150|NCT00900029|2587578|P5|STARTED|Overall Study||44
1067151|NCT00900029|2587579|P4|STARTED|Overall Study||42
1067152|NCT00900029|2587580|P3|STARTED|Overall Study||41
1067153|NCT00900029|2587581|P2|STARTED|Overall Study||41
1067154|NCT00900029|2587582|P1|STARTED|Overall Study||38
1067155|NCT00900146|2587604|P5|NOT COMPLETED|Intermediate: Period III||167
1067156|NCT00900146|2587605|P4|NOT COMPLETED|Intermediate: Period III||90
1067157|NCT00900146|2587606|P3|NOT COMPLETED|Intermediate: Period III||84
1067158|NCT00900146|2587607|P2|NOT COMPLETED|Intermediate: Period III||93
1067159|NCT00900146|2587608|P1|NOT COMPLETED|Intermediate: Period III||87
1067160|NCT00900146|2587604|P5|COMPLETED|Intermediate: Period III||0
1067161|NCT00900146|2587605|P4|COMPLETED|Intermediate: Period III||0
1067162|NCT00900146|2587606|P3|COMPLETED|Intermediate: Period III||0
1067163|NCT00900146|2587607|P2|COMPLETED|Intermediate: Period III||0
1067164|NCT00900146|2587608|P1|COMPLETED|Intermediate: Period III||0
1067165|NCT00900146|2587604|P5|Safety Set|Intermediate: Period III||166
1067166|NCT00900146|2587605|P4|Safety Set|Intermediate: Period III||90
1067167|NCT00900146|2587606|P3|Safety Set|Intermediate: Period III||84
1067168|NCT00900146|2587607|P2|Safety Set|Intermediate: Period III||92
1067169|NCT00900146|2587608|P1|Safety Set|Intermediate: Period III||86
1067170|NCT00900146|2587604|P5|STARTED|Intermediate: Period III||167
1067171|NCT00900146|2587605|P4|STARTED|Intermediate: Period III||90
1067172|NCT00900146|2587606|P3|STARTED|Intermediate: Period III||84
1067173|NCT00900146|2587607|P2|STARTED|Intermediate: Period III||93
1067174|NCT00900146|2587608|P1|STARTED|Intermediate: Period III||87
1067175|NCT00900146|2587604|P5|NOT COMPLETED|Dose Finding: Period II (4 Months)||12
1067176|NCT00900146|2587605|P4|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
1067177|NCT00900146|2587606|P3|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
1067178|NCT00900146|2587607|P2|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
1067179|NCT00900146|2587608|P1|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
1067180|NCT00900146|2587604|P5|COMPLETED|Dose Finding: Period II (4 Months)|Placebo also included 1 patient with no study completion page.|167
1067181|NCT00900146|2587605|P4|COMPLETED|Dose Finding: Period II (4 Months)||90
1067182|NCT00900146|2587606|P3|COMPLETED|Dose Finding: Period II (4 Months)||87
1067183|NCT00900146|2587607|P2|COMPLETED|Dose Finding: Period II (4 Months)||93
1067184|NCT00900146|2587608|P1|COMPLETED|Dose Finding: Period II (4 Months)||88
1067185|NCT00900146|2587604|P5|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||179
1067186|NCT00900146|2587605|P4|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
1067187|NCT00900146|2587606|P3|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
1067188|NCT00900146|2587607|P2|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||95
1067189|NCT00900146|2587608|P1|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||93
1067190|NCT00900146|2587604|P5|STARTED|Dose Finding: Period II (4 Months)||179
1067191|NCT00900146|2587605|P4|STARTED|Dose Finding: Period II (4 Months)||92
1067192|NCT00900146|2587606|P3|STARTED|Dose Finding: Period II (4 Months)||92
1067193|NCT00900146|2587607|P2|STARTED|Dose Finding: Period II (4 Months)||95
1067194|NCT00900146|2587608|P1|STARTED|Dose Finding: Period II (4 Months)||93
1067195|NCT00900159|2587722|P2|NOT COMPLETED|Second Intervention||0
1067196|NCT00900159|2587723|P1|NOT COMPLETED|Second Intervention||1
1067197|NCT00900159|2587722|P2|COMPLETED|Second Intervention||13
1067198|NCT00900159|2587723|P1|COMPLETED|Second Intervention||10
1067199|NCT00900159|2587722|P2|STARTED|Second Intervention||13
1067200|NCT00900159|2587723|P1|STARTED|Second Intervention||11
1067201|NCT00900159|2587722|P2|NOT COMPLETED|Washout||0
1067202|NCT00900159|2587723|P1|NOT COMPLETED|Washout||0
1067203|NCT00900159|2587722|P2|COMPLETED|Washout||13
1067204|NCT00900159|2587723|P1|COMPLETED|Washout||11
1067205|NCT00900159|2587722|P2|STARTED|Washout||13
1067206|NCT00900159|2587723|P1|STARTED|Washout||11
1067207|NCT00900159|2587722|P2|NOT COMPLETED|First Intervention||0
1067208|NCT00900159|2587723|P1|NOT COMPLETED|First Intervention||0
1067209|NCT00900159|2587722|P2|COMPLETED|First Intervention||13
1067210|NCT00900159|2587723|P1|COMPLETED|First Intervention||11
1067211|NCT00900159|2587722|P2|STARTED|First Intervention||13
1067212|NCT00900159|2587723|P1|STARTED|First Intervention||11
1067213|NCT00900237|2587739|P2|NOT COMPLETED|Overall Study||0
1067214|NCT00900237|2587740|P1|NOT COMPLETED|Overall Study||0
1067215|NCT00900237|2587739|P2|COMPLETED|Overall Study||7
1067216|NCT00900237|2587740|P1|COMPLETED|Overall Study||7
1067217|NCT00900237|2587739|P2|STARTED|Overall Study||7
1067218|NCT00900237|2587740|P1|STARTED|Overall Study||7
1067219|NCT00900627|2587754|P6|NOT COMPLETED|Overall Study||26
1067220|NCT00900627|2587755|P5|NOT COMPLETED|Overall Study||29
1067221|NCT00900627|2587756|P4|NOT COMPLETED|Overall Study||6
1067222|NCT00900627|2587757|P3|NOT COMPLETED|Overall Study||6
1067223|NCT00900627|2587758|P2|NOT COMPLETED|Overall Study||2
1067224|NCT00900627|2587759|P1|NOT COMPLETED|Overall Study||6
1067225|NCT00900627|2587754|P6|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|70
1067226|NCT00900627|2587755|P5|COMPLETED|Overall Study|No set completion, pts were to remain in study until withdrawn|65
1067227|NCT00900627|2587756|P4|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
1067228|NCT00900627|2587757|P3|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
1067229|NCT00900627|2587758|P2|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
1067230|NCT00900627|2587759|P1|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
1067231|NCT00900627|2587754|P6|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|96
1067232|NCT00900627|2587755|P5|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|94
1067233|NCT00900627|2587756|P4|STARTED|Overall Study||6
1067234|NCT00900627|2587757|P3|STARTED|Overall Study||6
1067235|NCT00900627|2587758|P2|STARTED|Overall Study||2
1067236|NCT00900627|2587759|P1|STARTED|Overall Study||6
1067237|NCT00900666|2587779|P2|NOT COMPLETED|Overall Study||0
1067238|NCT00900666|2587780|P1|NOT COMPLETED|Overall Study||0
1067239|NCT00900666|2587779|P2|COMPLETED|Overall Study||9
1067240|NCT00900666|2587780|P1|COMPLETED|Overall Study||10
1067241|NCT00900666|2587779|P2|STARTED|Overall Study||9
1067242|NCT00900666|2587780|P1|STARTED|Overall Study||10
1067243|NCT00900731|2587790|P2|NOT COMPLETED|Overall Study||61
1067244|NCT00900731|2587791|P1|NOT COMPLETED|Overall Study||60
1067245|NCT00900731|2587790|P2|COMPLETED|Overall Study||740
1067246|NCT00900731|2587791|P1|COMPLETED|Overall Study||737
1067247|NCT00900731|2587790|P2|Safety Set: Received Study Drug|Overall Study||799
1067248|NCT00900731|2587791|P1|Safety Set: Received Study Drug|Overall Study||794
1067249|NCT00900731|2587790|P2|STARTED|Overall Study||801
1067250|NCT00900731|2587791|P1|STARTED|Overall Study|Randomized participants|797
1067251|NCT00900757|2587811|P1|NOT COMPLETED|Overall Study||19
1067252|NCT00900757|2587811|P1|COMPLETED|Overall Study||38
1067253|NCT00900757|2587811|P1|STARTED|Overall Study||57
1067254|NCT00900796|2587819|P1|NOT COMPLETED|Phase 2||5
1067255|NCT00900796|2587819|P1|COMPLETED|Phase 2||6
1067256|NCT00900796|2587819|P1|STARTED|Phase 2||11
1067257|NCT00900796|2587819|P1|NOT COMPLETED|Between Phase 1 and Phase 2||110
1067258|NCT00900796|2587819|P1|COMPLETED|Between Phase 1 and Phase 2||11
1067259|NCT00900796|2587819|P1|STARTED|Between Phase 1 and Phase 2||121
1067260|NCT00900796|2587819|P1|NOT COMPLETED|Phase 1||11
1067261|NCT00900796|2587819|P1|COMPLETED|Phase 1||121
1067262|NCT00900796|2587819|P1|STARTED|Phase 1||132
1067263|NCT00900822|2587829|P1|NOT COMPLETED|12 Months Clinical Evaluation||0
1067264|NCT00900822|2587829|P1|COMPLETED|12 Months Clinical Evaluation||11
1067265|NCT00900822|2587829|P1|STARTED|12 Months Clinical Evaluation||11
1067266|NCT00900822|2587829|P1|NOT COMPLETED|9 Months Histological Evaluation||0
1067267|NCT00900822|2587829|P1|COMPLETED|9 Months Histological Evaluation||11
1067268|NCT00900822|2587829|P1|STARTED|9 Months Histological Evaluation||11
1067269|NCT00901017|2587839|P1|NOT COMPLETED|Overall Study||0
1067270|NCT00901017|2587839|P1|COMPLETED|Overall Study||14
1067271|NCT00901017|2587839|P1|STARTED|Overall Study||14
1067272|NCT00901186|2587855|P2|NOT COMPLETED|Overall Study||11
1067273|NCT00901186|2587856|P1|NOT COMPLETED|Overall Study||9
1067274|NCT00901186|2587855|P2|COMPLETED|Overall Study||32
1067275|NCT00901186|2587856|P1|COMPLETED|Overall Study||31
1067276|NCT00901186|2587855|P2|Intent to Treat|Overall Study|Five treated participants did not have at least a baseline and one post-treatment BCVA.|38
1067277|NCT00901186|2587856|P1|Intent to Treat|Overall Study|Four treated participants did not have at least a baseline and one post-treatment BCVA.|35
1067278|NCT00901186|2587855|P2|Safety Set|Overall Study||43
1067279|NCT00901186|2587856|P1|Safety Set|Overall Study|One participant did not receive one intravitreal RFB002 injection.|39
1067280|NCT00901186|2587855|P2|STARTED|Overall Study||43
1067281|NCT00901186|2587856|P1|STARTED|Overall Study||40
1067282|NCT00901225|2587872|P1|NOT COMPLETED|Overall Study||1
1067283|NCT00901225|2587872|P1|COMPLETED|Overall Study||20
1067284|NCT00901225|2587872|P1|STARTED|Overall Study||21
1067285|NCT00901316|2587883|P2|NOT COMPLETED|Overall Study||0
1067286|NCT00901316|2587884|P1|NOT COMPLETED|Overall Study||0
1067287|NCT00901316|2587883|P2|COMPLETED|Overall Study||495
1067288|NCT00901316|2587884|P1|COMPLETED|Overall Study||492
1067289|NCT00901316|2587883|P2|STARTED|Overall Study||495
1067290|NCT00901316|2587884|P1|STARTED|Overall Study||492
1067291|NCT00901342|2587890|P1|NOT COMPLETED|Overall Study||15
1067292|NCT00901342|2587890|P1|COMPLETED|Overall Study|89 subjects completed the study completion visit|89
1067293|NCT00901342|2587890|P1|Received at Least 1 Infusion|Overall Study||98
1067294|NCT00901342|2587890|P1|STARTED|Overall Study||104
1067295|NCT00901459|2587894|P1|NOT COMPLETED|Overall Study||6
1067296|NCT00901459|2587894|P1|COMPLETED|Overall Study||15
1067297|NCT00901459|2587894|P1|STARTED|Overall Study||21
1067298|NCT00901576|2587911|P6|NOT COMPLETED|Third Intervention||0
1067299|NCT00901576|2587912|P5|NOT COMPLETED|Third Intervention||0
1067300|NCT00901576|2587913|P4|NOT COMPLETED|Third Intervention||0
1067301|NCT00901576|2587914|P3|NOT COMPLETED|Third Intervention||0
1067302|NCT00901576|2587915|P2|NOT COMPLETED|Third Intervention||0
1067303|NCT00901576|2587916|P1|NOT COMPLETED|Third Intervention||0
1067304|NCT00901576|2587911|P6|COMPLETED|Third Intervention||5
1067305|NCT00901576|2587912|P5|COMPLETED|Third Intervention||6
1067306|NCT00901576|2587913|P4|COMPLETED|Third Intervention||5
1067307|NCT00901576|2587914|P3|COMPLETED|Third Intervention||7
1067308|NCT00901576|2587915|P2|COMPLETED|Third Intervention||7
1067309|NCT00901576|2587916|P1|COMPLETED|Third Intervention||5
1067310|NCT00901576|2587911|P6|STARTED|Third Intervention||5
1067311|NCT00901576|2587912|P5|STARTED|Third Intervention||6
1067312|NCT00901576|2587913|P4|STARTED|Third Intervention||5
1067313|NCT00901576|2587914|P3|STARTED|Third Intervention||7
1067314|NCT00901576|2587915|P2|STARTED|Third Intervention||7
1067315|NCT00901576|2587916|P1|STARTED|Third Intervention||5
1067316|NCT00901576|2587911|P6|NOT COMPLETED|Washout||0
1067317|NCT00901576|2587912|P5|NOT COMPLETED|Washout||0
1067318|NCT00901576|2587913|P4|NOT COMPLETED|Washout||0
1067319|NCT00901576|2587914|P3|NOT COMPLETED|Washout||0
1067320|NCT00901576|2587915|P2|NOT COMPLETED|Washout||0
1067321|NCT00901576|2587916|P1|NOT COMPLETED|Washout||0
1067322|NCT00901576|2587911|P6|COMPLETED|Washout||5
1067323|NCT00901576|2587912|P5|COMPLETED|Washout||6
1067324|NCT00901576|2587913|P4|COMPLETED|Washout||5
1067325|NCT00901576|2587914|P3|COMPLETED|Washout||7
1067326|NCT00901576|2587915|P2|COMPLETED|Washout||7
1067327|NCT00901576|2587916|P1|COMPLETED|Washout||5
1067328|NCT00901576|2587911|P6|STARTED|Washout||5
1067329|NCT00901576|2587912|P5|STARTED|Washout||6
1067330|NCT00901576|2587913|P4|STARTED|Washout||5
1067331|NCT00901576|2587914|P3|STARTED|Washout||7
1067332|NCT00901576|2587915|P2|STARTED|Washout||7
1067333|NCT00901576|2587916|P1|STARTED|Washout||5
1067334|NCT00901576|2587911|P6|NOT COMPLETED|Second Intervention||1
1067335|NCT00901576|2587912|P5|NOT COMPLETED|Second Intervention||0
1067336|NCT00901576|2587913|P4|NOT COMPLETED|Second Intervention||1
1067337|NCT00901576|2587914|P3|NOT COMPLETED|Second Intervention||0
1067338|NCT00901576|2587915|P2|NOT COMPLETED|Second Intervention||0
1067339|NCT00901576|2587916|P1|NOT COMPLETED|Second Intervention||1
1067340|NCT00901576|2587911|P6|COMPLETED|Second Intervention||5
1067341|NCT00901576|2587912|P5|COMPLETED|Second Intervention||6
1067342|NCT00901576|2587913|P4|COMPLETED|Second Intervention||5
1067343|NCT00901576|2587914|P3|COMPLETED|Second Intervention||7
1067344|NCT00901576|2587915|P2|COMPLETED|Second Intervention||7
1067345|NCT00901576|2587916|P1|COMPLETED|Second Intervention||5
1067346|NCT00901576|2587911|P6|STARTED|Second Intervention||6
1067347|NCT00901576|2587912|P5|STARTED|Second Intervention||6
1067348|NCT00901576|2587913|P4|STARTED|Second Intervention||6
1067349|NCT00901576|2587914|P3|STARTED|Second Intervention||7
1067350|NCT00901576|2587915|P2|STARTED|Second Intervention||7
1067351|NCT00901576|2587916|P1|STARTED|Second Intervention||6
1067352|NCT00901576|2587911|P6|NOT COMPLETED|Washout||0
1067353|NCT00901576|2587912|P5|NOT COMPLETED|Washout||0
1067354|NCT00901576|2587913|P4|NOT COMPLETED|Washout||0
1067355|NCT00901576|2587914|P3|NOT COMPLETED|Washout||0
1067356|NCT00901576|2587915|P2|NOT COMPLETED|Washout||0
1067357|NCT00901576|2587916|P1|NOT COMPLETED|Washout||0
1067358|NCT00901576|2587911|P6|COMPLETED|Washout||6
1067359|NCT00901576|2587912|P5|COMPLETED|Washout||6
1067360|NCT00901576|2587913|P4|COMPLETED|Washout||6
1067361|NCT00901576|2587914|P3|COMPLETED|Washout||7
1067362|NCT00901576|2587915|P2|COMPLETED|Washout||7
1067363|NCT00901576|2587916|P1|COMPLETED|Washout||6
1067364|NCT00901576|2587911|P6|STARTED|Washout||6
1067365|NCT00901576|2587912|P5|STARTED|Washout||6
1067366|NCT00901576|2587913|P4|STARTED|Washout||6
1067367|NCT00901576|2587914|P3|STARTED|Washout||7
1067368|NCT00901576|2587915|P2|STARTED|Washout||7
1067369|NCT00901576|2587916|P1|STARTED|Washout||6
1067370|NCT00901576|2587911|P6|NOT COMPLETED|First Intervention||0
1067371|NCT00901576|2587912|P5|NOT COMPLETED|First Intervention||0
1067372|NCT00901576|2587913|P4|NOT COMPLETED|First Intervention||0
1067373|NCT00901576|2587914|P3|NOT COMPLETED|First Intervention||0
1067374|NCT00901576|2587915|P2|NOT COMPLETED|First Intervention||0
1067375|NCT00901576|2587916|P1|NOT COMPLETED|First Intervention||0
1067376|NCT00901576|2587911|P6|COMPLETED|First Intervention||6
1067377|NCT00901576|2587912|P5|COMPLETED|First Intervention||6
1067378|NCT00901576|2587913|P4|COMPLETED|First Intervention||6
1067379|NCT00901576|2587914|P3|COMPLETED|First Intervention||7
1067380|NCT00901576|2587915|P2|COMPLETED|First Intervention||7
1067381|NCT00901576|2587916|P1|COMPLETED|First Intervention||6
1067382|NCT00901576|2587911|P6|STARTED|First Intervention||6
1067383|NCT00901576|2587912|P5|STARTED|First Intervention||6
1067384|NCT00901576|2587913|P4|STARTED|First Intervention||6
1067385|NCT00901576|2587914|P3|STARTED|First Intervention||7
1067386|NCT00901576|2587915|P2|STARTED|First Intervention||7
1067387|NCT00901576|2587916|P1|STARTED|First Intervention||6
1067388|NCT00901628|2587939|P2|NOT COMPLETED|Overall Study||10
1067389|NCT00901628|2587940|P1|NOT COMPLETED|Overall Study||4
1067390|NCT00901628|2587939|P2|COMPLETED|Overall Study||42
1067391|NCT00901628|2587940|P1|COMPLETED|Overall Study||45
1067392|NCT00901628|2587939|P2|STARTED|Overall Study||52
1067393|NCT00901628|2587940|P1|STARTED|Overall Study||49
1067394|NCT00901901|2587958|P2|NOT COMPLETED|Follow-up Period||259
1067395|NCT00901901|2587959|P1|NOT COMPLETED|Follow-up Period||246
1067396|NCT00901901|2587958|P2|COMPLETED|Follow-up Period|These participants are ongoing.|65
1067397|NCT00901901|2587959|P1|COMPLETED|Follow-up Period|These participants are ongoing.|76
1067398|NCT00901901|2587958|P2|STARTED|Follow-up Period||324
1067399|NCT00901901|2587959|P1|STARTED|Follow-up Period||322
1067400|NCT00901901|2587958|P2|NOT COMPLETED|Treatment Period||168
1067401|NCT00901901|2587959|P1|NOT COMPLETED|Treatment Period||157
1067402|NCT00901901|2587958|P2|COMPLETED|Treatment Period|17 of these participants are ongoing|190
1067403|NCT00901901|2587959|P1|COMPLETED|Treatment Period|19 of these participants are ongoing|205
1067404|NCT00901901|2587958|P2|Participants Received Treatment|Treatment Period||355
1067405|NCT00901901|2587959|P1|Participants Received Treatment|Treatment Period||362
1067406|NCT00901901|2587958|P2|STARTED|Treatment Period||358
1067407|NCT00901901|2587959|P1|STARTED|Treatment Period||362
1067408|NCT00894504|2587979|P1|NOT COMPLETED|Overall Study||71
1067409|NCT00894504|2587979|P1|COMPLETED|Overall Study||0
1067410|NCT00894504|2587979|P1|STARTED|Overall Study||71
1067411|NCT00894517|2587995|P2|NOT COMPLETED|Overall Study||5
1067412|NCT00894517|2587996|P1|NOT COMPLETED|Overall Study||2
1067413|NCT00894517|2587995|P2|COMPLETED|Overall Study||26
1067414|NCT00894517|2587996|P1|COMPLETED|Overall Study||28
1067415|NCT00894517|2587995|P2|STARTED|Overall Study||31
1067416|NCT00894517|2587996|P1|STARTED|Overall Study||30
1067417|NCT00894543|2588012|P2|NOT COMPLETED|Week 4 to Week 8||2
1067418|NCT00894543|2588013|P1|NOT COMPLETED|Week 4 to Week 8||4
1067419|NCT00894543|2588012|P2|COMPLETED|Week 4 to Week 8||97
1067420|NCT00894543|2588013|P1|COMPLETED|Week 4 to Week 8||97
1067421|NCT00894543|2588012|P2|STARTED|Week 4 to Week 8||99
1067422|NCT00894543|2588013|P1|STARTED|Week 4 to Week 8||101
1067423|NCT00894543|2588012|P2|NOT COMPLETED|Baseline to Week 4||2
1067424|NCT00894543|2588013|P1|NOT COMPLETED|Baseline to Week 4||3
1067425|NCT00894543|2588012|P2|COMPLETED|Baseline to Week 4||99
1067426|NCT00894543|2588013|P1|COMPLETED|Baseline to Week 4||101
1067427|NCT00894543|2588012|P2|STARTED|Baseline to Week 4||101
1067428|NCT00894543|2588013|P1|STARTED|Baseline to Week 4||104
1067429|NCT00894543|2588012|P2|NOT COMPLETED|Baseline||0
1067430|NCT00894543|2588013|P1|NOT COMPLETED|Baseline||0
1067431|NCT00894543|2588012|P2|COMPLETED|Baseline||101
1067432|NCT00894543|2588013|P1|COMPLETED|Baseline||104
1067433|NCT00894543|2588012|P2|STARTED|Baseline||101
1067434|NCT00894543|2588013|P1|STARTED|Baseline||104
1067435|NCT00894556|2588038|P4|NOT COMPLETED|Treatment Phase||0
1067436|NCT00894556|2588039|P3|NOT COMPLETED|Treatment Phase||1
1067437|NCT00894556|2588040|P2|NOT COMPLETED|Treatment Phase||4
1067438|NCT00894556|2588041|P1|NOT COMPLETED|Treatment Phase||4
1067439|NCT00894556|2588038|P4|COMPLETED|Treatment Phase||0
1067440|NCT00894556|2588039|P3|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|35
1067441|NCT00894556|2588040|P2|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|32
1067442|NCT00894556|2588041|P1|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|33
1067443|NCT00894556|2588038|P4|STARTED|Treatment Phase||0
1067444|NCT00894556|2588039|P3|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
1067445|NCT00894556|2588040|P2|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
1067446|NCT00894556|2588041|P1|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|37
1067447|NCT00894556|2588038|P4|NOT COMPLETED|Baseline Phase||85
1067448|NCT00894556|2588039|P3|NOT COMPLETED|Baseline Phase||0
1067449|NCT00894556|2588040|P2|NOT COMPLETED|Baseline Phase||0
1067450|NCT00894556|2588041|P1|NOT COMPLETED|Baseline Phase||0
1067451|NCT00894556|2588038|P4|COMPLETED|Baseline Phase||109
1067452|NCT00894556|2588039|P3|COMPLETED|Baseline Phase||0
1067453|NCT00894556|2588040|P2|COMPLETED|Baseline Phase||0
1067454|NCT00894556|2588041|P1|COMPLETED|Baseline Phase||0
1067455|NCT00894556|2588038|P4|STARTED|Baseline Phase||194
1067456|NCT00894556|2588039|P3|STARTED|Baseline Phase||0
1067457|NCT00894556|2588040|P2|STARTED|Baseline Phase||0
1067458|NCT00894556|2588041|P1|STARTED|Baseline Phase||0
1067459|NCT00894647|2588052|P2|NOT COMPLETED|Overall Study||14
1067460|NCT00894647|2588053|P1|NOT COMPLETED|Overall Study||10
1067461|NCT00894647|2588052|P2|COMPLETED|Overall Study||112
1067462|NCT00894647|2588053|P1|COMPLETED|Overall Study||111
1067463|NCT00894647|2588052|P2|STARTED|Overall Study||126
1067464|NCT00894647|2588053|P1|STARTED|Overall Study||121
1067465|NCT00894699|2588065|P2|NOT COMPLETED|Overall Study||0
1067466|NCT00894699|2588066|P1|NOT COMPLETED|Overall Study||0
1067467|NCT00894699|2588065|P2|COMPLETED|Overall Study||19
1067468|NCT00894699|2588066|P1|COMPLETED|Overall Study||21
1067469|NCT00894699|2588065|P2|STARTED|Overall Study||19
1067470|NCT00894699|2588066|P1|STARTED|Overall Study||21
1067471|NCT00894790|2588074|P2|NOT COMPLETED|Overall Study||2
1067472|NCT00894790|2588075|P1|NOT COMPLETED|Overall Study||1
1067473|NCT00894790|2588074|P2|COMPLETED|Overall Study||2
1067474|NCT00894790|2588075|P1|COMPLETED|Overall Study||3
1067475|NCT00894790|2588074|P2|STARTED|Overall Study||4
1067476|NCT00894790|2588075|P1|STARTED|Overall Study||4
1067477|NCT00894803|2588099|P2|NOT COMPLETED|Overall Study||5
1067478|NCT00894803|2588100|P1|NOT COMPLETED|Overall Study||20
1067479|NCT00894803|2588099|P2|COMPLETED|Overall Study||20
1067480|NCT00894803|2588100|P1|COMPLETED|Overall Study||81
1067481|NCT00894803|2588099|P2|STARTED|Overall Study||25
1067482|NCT00894803|2588100|P1|STARTED|Overall Study||101
1067483|NCT00894933|2588134|P1|NOT COMPLETED|Overall Study||4
1067484|NCT00894933|2588134|P1|COMPLETED|Overall Study||29
1067485|NCT00894933|2588134|P1|STARTED|Overall Study||33
1067486|NCT00895011|2588153|P3|NOT COMPLETED|Overall Study||8
1067487|NCT00895011|2588154|P2|NOT COMPLETED|Overall Study||14
1067488|NCT00895011|2588155|P1|NOT COMPLETED|Overall Study||24
1067489|NCT00895011|2588153|P3|COMPLETED|Overall Study||91
1067490|NCT00895011|2588154|P2|COMPLETED|Overall Study||85
1067491|NCT00895011|2588155|P1|COMPLETED|Overall Study||76
1067492|NCT00895011|2588153|P3|STARTED|Overall Study||99
1067493|NCT00895011|2588154|P2|STARTED|Overall Study||99
1067494|NCT00895011|2588155|P1|STARTED|Overall Study||100
1067495|NCT00895180|2588171|P2|NOT COMPLETED|Overall Study||0
1067496|NCT00895180|2588172|P1|NOT COMPLETED|Overall Study||0
1067497|NCT00895180|2588171|P2|COMPLETED|Overall Study||40
1067498|NCT00895180|2588172|P1|COMPLETED|Overall Study||40
1067499|NCT00895180|2588171|P2|Received at Least 1 Dose of Study Drug|Overall Study||40
1067500|NCT00895180|2588172|P1|Received at Least 1 Dose of Study Drug|Overall Study||40
1067501|NCT00895180|2588171|P2|STARTED|Overall Study||40
1067502|NCT00895180|2588172|P1|STARTED|Overall Study||40
1067503|NCT00895193|2588194|P4|NOT COMPLETED|Overall Study||0
1067504|NCT00895193|2588195|P3|NOT COMPLETED|Overall Study||0
1067505|NCT00895193|2588196|P2|NOT COMPLETED|Overall Study||0
1067506|NCT00895193|2588197|P1|NOT COMPLETED|Overall Study||0
1067507|NCT00895193|2588194|P4|COMPLETED|Overall Study||25
1067508|NCT00895193|2588195|P3|COMPLETED|Overall Study||25
1067509|NCT00895193|2588196|P2|COMPLETED|Overall Study||25
1067510|NCT00895193|2588197|P1|COMPLETED|Overall Study||25
1067511|NCT00895193|2588194|P4|STARTED|Overall Study||25
1067512|NCT00895193|2588195|P3|STARTED|Overall Study||25
1067513|NCT00895193|2588196|P2|STARTED|Overall Study||25
1067514|NCT00895193|2588197|P1|STARTED|Overall Study||25
1067515|NCT00895232|2588222|P3|NOT COMPLETED|Overall Study||5
1067516|NCT00895232|2588223|P2|NOT COMPLETED|Overall Study||4
1067517|NCT00895232|2588224|P1|NOT COMPLETED|Overall Study||3
1067518|NCT00895232|2588222|P3|COMPLETED|Overall Study||3
1067519|NCT00895232|2588223|P2|COMPLETED|Overall Study||2
1067520|NCT00895232|2588224|P1|COMPLETED|Overall Study||4
1067521|NCT00895232|2588222|P3|STARTED|Overall Study||8
1067522|NCT00895232|2588223|P2|STARTED|Overall Study||6
1067523|NCT00895232|2588224|P1|STARTED|Overall Study||7
1067524|NCT00895245|2588238|P1|NOT COMPLETED|Overall Study||6
1067525|NCT00895245|2588238|P1|COMPLETED|Overall Study||0
1067526|NCT00895245|2588238|P1|STARTED|Overall Study||6
1067527|NCT00895284|2588247|P2|NOT COMPLETED|Overall Study||0
1067528|NCT00895284|2588248|P1|NOT COMPLETED|Overall Study||0
1067529|NCT00895284|2588247|P2|COMPLETED|Overall Study||0
1067530|NCT00895284|2588248|P1|COMPLETED|Overall Study||3
1067531|NCT00895284|2588247|P2|STARTED|Overall Study||0
1067532|NCT00895284|2588248|P1|STARTED|Overall Study||3
1067533|NCT00895310|2588254|P1|NOT COMPLETED|Overall Study||1
1067534|NCT00895310|2588254|P1|COMPLETED|Overall Study||29
1067535|NCT00895310|2588254|P1|STARTED|Overall Study||30
1067536|NCT00895453|2588264|P3|NOT COMPLETED|Overall Study||23
1067537|NCT00895453|2588265|P2|NOT COMPLETED|Overall Study||25
1067538|NCT00895453|2588266|P1|NOT COMPLETED|Overall Study||25
1067539|NCT00895453|2588264|P3|COMPLETED|Overall Study||23
1067540|NCT00895453|2588265|P2|COMPLETED|Overall Study||25
1067541|NCT00895453|2588266|P1|COMPLETED|Overall Study||23
1067542|NCT00895453|2588264|P3|STARTED|Overall Study||46
1067543|NCT00895453|2588265|P2|STARTED|Overall Study||50
1067544|NCT00895453|2588266|P1|STARTED|Overall Study||48
1067545|NCT00895531|2588276|P2|NOT COMPLETED|Overall Study||0
1067546|NCT00895531|2588277|P1|NOT COMPLETED|Overall Study||0
1067547|NCT00895531|2588276|P2|COMPLETED|Overall Study||37
1067548|NCT00895531|2588277|P1|COMPLETED|Overall Study||38
1067549|NCT00895531|2588276|P2|STARTED|Overall Study||37
1067550|NCT00895531|2588277|P1|STARTED|Overall Study||38
1067551|NCT00895583|2588285|P2|NOT COMPLETED|Overall Study||12
1067552|NCT00895583|2588286|P1|NOT COMPLETED|Overall Study||44
1067553|NCT00895583|2588285|P2|COMPLETED|Overall Study||111
1067554|NCT00895583|2588286|P1|COMPLETED|Overall Study||87
1067555|NCT00895583|2588285|P2|STARTED|Overall Study||123
1067556|NCT00895583|2588286|P1|STARTED|Overall Study||131
1067557|NCT00895661|2588364|P1|NOT COMPLETED|Overall Study||3
1067558|NCT00895661|2588364|P1|COMPLETED|Overall Study||37
1067559|NCT00895661|2588364|P1|STARTED|Overall Study||40
1067560|NCT00895752|2588371|P1|NOT COMPLETED|Overall Study||0
1067561|NCT00895752|2588371|P1|COMPLETED|Overall Study||6
1067562|NCT00895752|2588371|P1|STARTED|Overall Study||6
1067563|NCT00895817|2588384|P2|NOT COMPLETED|Overall Study||0
1067564|NCT00895817|2588385|P1|NOT COMPLETED|Overall Study||0
1067565|NCT00895817|2588384|P2|COMPLETED|Overall Study||21
1067566|NCT00895817|2588385|P1|COMPLETED|Overall Study||21
1067567|NCT00895817|2588384|P2|STARTED|Overall Study||21
1067568|NCT00895817|2588385|P1|STARTED|Overall Study||21
1067569|NCT00895830|2588396|P5|NOT COMPLETED|Overall Study||0
1067570|NCT00895830|2588397|P4|NOT COMPLETED|Overall Study||0
1067571|NCT00895830|2588398|P3|NOT COMPLETED|Overall Study||0
1067572|NCT00895830|2588399|P2|NOT COMPLETED|Overall Study||0
1067573|NCT00895830|2588400|P1|NOT COMPLETED|Overall Study||0
1067574|NCT00895830|2588396|P5|COMPLETED|Overall Study||55
1067575|NCT00895830|2588397|P4|COMPLETED|Overall Study||52
1067576|NCT00895830|2588398|P3|COMPLETED|Overall Study||49
1067577|NCT00895830|2588399|P2|COMPLETED|Overall Study||50
1067578|NCT00895830|2588400|P1|COMPLETED|Overall Study||51
1067579|NCT00895830|2588396|P5|STARTED|Overall Study||55
1067580|NCT00895830|2588397|P4|STARTED|Overall Study||52
1067581|NCT00895830|2588398|P3|STARTED|Overall Study||49
1067582|NCT00895830|2588399|P2|STARTED|Overall Study||50
1067583|NCT00895830|2588400|P1|STARTED|Overall Study||51
1067584|NCT00895843|2588414|P2|NOT COMPLETED|Overall Study||12
1067585|NCT00895843|2588415|P1|NOT COMPLETED|Overall Study||12
1067586|NCT00895843|2588414|P2|COMPLETED|Overall Study||50
1067587|NCT00895843|2588415|P1|COMPLETED|Overall Study||48
1067588|NCT00895843|2588414|P2|STARTED|Overall Study||62
1067589|NCT00895843|2588415|P1|STARTED|Overall Study||60
1067590|NCT00895895|2588426|P5|NOT COMPLETED|Period 2||49
1067591|NCT00895895|2588427|P4|NOT COMPLETED|Period 2||54
1067592|NCT00895895|2588428|P3|NOT COMPLETED|Period 2||49
1067593|NCT00895895|2588429|P2|NOT COMPLETED|Period 2||53
1067594|NCT00895895|2588430|P1|NOT COMPLETED|Period 2||56
1067595|NCT00895895|2588426|P5|COMPLETED|Period 2||35
1067596|NCT00895895|2588427|P4|COMPLETED|Period 2||37
1067597|NCT00895895|2588428|P3|COMPLETED|Period 2||33
1067598|NCT00895895|2588429|P2|COMPLETED|Period 2||31
1067599|NCT00895895|2588430|P1|COMPLETED|Period 2||30
1067600|NCT00895895|2588426|P5|STARTED|Period 2||84
1067601|NCT00895895|2588427|P4|STARTED|Period 2||91
1067602|NCT00895895|2588428|P3|STARTED|Period 2||82
1067603|NCT00895895|2588429|P2|STARTED|Period 2||84
1067604|NCT00895895|2588430|P1|STARTED|Period 2||86
1067605|NCT00895895|2588426|P5|NOT COMPLETED|After Period 1, Prior to Period 2||2
1067606|NCT00895895|2588427|P4|NOT COMPLETED|After Period 1, Prior to Period 2||0
1067607|NCT00895895|2588428|P3|NOT COMPLETED|After Period 1, Prior to Period 2||2
1067608|NCT00895895|2588429|P2|NOT COMPLETED|After Period 1, Prior to Period 2||0
1067609|NCT00895895|2588430|P1|NOT COMPLETED|After Period 1, Prior to Period 2||0
1067610|NCT00895895|2588426|P5|COMPLETED|After Period 1, Prior to Period 2||84
1067611|NCT00895895|2588427|P4|COMPLETED|After Period 1, Prior to Period 2||91
1067612|NCT00895895|2588428|P3|COMPLETED|After Period 1, Prior to Period 2||82
1067613|NCT00895895|2588429|P2|COMPLETED|After Period 1, Prior to Period 2||84
1067614|NCT00895895|2588430|P1|COMPLETED|After Period 1, Prior to Period 2||86
1067615|NCT00895895|2588426|P5|STARTED|After Period 1, Prior to Period 2||86
1067616|NCT00895895|2588427|P4|STARTED|After Period 1, Prior to Period 2||91
1067617|NCT00895895|2588428|P3|STARTED|After Period 1, Prior to Period 2||84
1067618|NCT00895895|2588429|P2|STARTED|After Period 1, Prior to Period 2||84
1067619|NCT00895895|2588430|P1|STARTED|After Period 1, Prior to Period 2||86
1067620|NCT00895895|2588426|P5|NOT COMPLETED|Period 1||20
1067621|NCT00895895|2588427|P4|NOT COMPLETED|Period 1||13
1067622|NCT00895895|2588428|P3|NOT COMPLETED|Period 1||20
1067623|NCT00895895|2588429|P2|NOT COMPLETED|Period 1||21
1067624|NCT00895895|2588430|P1|NOT COMPLETED|Period 1||21
1067625|NCT00895895|2588426|P5|COMPLETED|Period 1||86
1067626|NCT00895895|2588427|P4|COMPLETED|Period 1||91
1067627|NCT00895895|2588428|P3|COMPLETED|Period 1||84
1067628|NCT00895895|2588429|P2|COMPLETED|Period 1||84
1067629|NCT00895895|2588430|P1|COMPLETED|Period 1||86
1067630|NCT00895895|2588426|P5|Randomized But Not Treated|Period 1||2
1067631|NCT00895895|2588427|P4|Randomized But Not Treated|Period 1||1
1067632|NCT00895895|2588428|P3|Randomized But Not Treated|Period 1||1
1067633|NCT00895895|2588429|P2|Randomized But Not Treated|Period 1||3
1067634|NCT00895895|2588430|P1|Randomized But Not Treated|Period 1||1
1067635|NCT00895895|2588426|P5|STARTED|Period 1||106
1067636|NCT00895895|2588427|P4|STARTED|Period 1||104
1067637|NCT00895895|2588428|P3|STARTED|Period 1||104
1067638|NCT00895895|2588429|P2|STARTED|Period 1||105
1067639|NCT00895895|2588430|P1|STARTED|Period 1||107
1067640|NCT00895934|2588544|P2|NOT COMPLETED|Overall Study||25
1067641|NCT00895934|2588545|P1|NOT COMPLETED|Overall Study||6
1067642|NCT00895934|2588544|P2|COMPLETED|Overall Study||18
1067643|NCT00895934|2588545|P1|COMPLETED|Overall Study||4
1067644|NCT00895934|2588544|P2|STARTED|Overall Study||43
1067645|NCT00895934|2588545|P1|STARTED|Overall Study||10
1067646|NCT00895947|2588553|P2|NOT COMPLETED|Overall Study||10
1067647|NCT00895947|2588554|P1|NOT COMPLETED|Overall Study||12
1067648|NCT00895947|2588553|P2|COMPLETED|Overall Study||90
1067649|NCT00895947|2588554|P1|COMPLETED|Overall Study||88
1067650|NCT00895947|2588553|P2|STARTED|Overall Study||100
1067651|NCT00895947|2588554|P1|STARTED|Overall Study||100
1067652|NCT00896025|2588570|P1|NOT COMPLETED|Overall Study||0
1067653|NCT00896025|2588570|P1|COMPLETED|Overall Study||8
1067654|NCT00896025|2588570|P1|STARTED|Overall Study||8
1067655|NCT00896038|2588576|P2|NOT COMPLETED|Overall Study||1
1067656|NCT00896038|2588577|P1|NOT COMPLETED|Overall Study||4
1067657|NCT00896038|2588576|P2|COMPLETED|Overall Study||27
1067658|NCT00896038|2588577|P1|COMPLETED|Overall Study||26
1067659|NCT00896038|2588576|P2|STARTED|Overall Study||28
1067660|NCT00896038|2588577|P1|STARTED|Overall Study||30
1067661|NCT00896051|2588617|P2|NOT COMPLETED|Overall Study||9
1067662|NCT00896051|2588618|P1|NOT COMPLETED|Overall Study||10
1067663|NCT00896051|2588617|P2|COMPLETED|Overall Study||16
1067664|NCT00896051|2588618|P1|COMPLETED|Overall Study||15
1067665|NCT00896051|2588617|P2|STARTED|Overall Study||25
1067666|NCT00896051|2588618|P1|STARTED|Overall Study||25
1067667|NCT00896064|2588660|P2|NOT COMPLETED|Overall Study||0
1067668|NCT00896064|2588661|P1|NOT COMPLETED|Overall Study||0
1067669|NCT00896064|2588660|P2|COMPLETED|Overall Study||21
1067670|NCT00896064|2588661|P1|COMPLETED|Overall Study||22
1067671|NCT00896064|2588660|P2|STARTED|Overall Study||21
1067672|NCT00896064|2588661|P1|STARTED|Overall Study||22
1067673|NCT00896168|2588691|P2|NOT COMPLETED|Overall Study||19
1067674|NCT00896168|2588692|P1|NOT COMPLETED|Overall Study||14
1067675|NCT00896168|2588691|P2|COMPLETED|Overall Study||111
1067676|NCT00896168|2588692|P1|COMPLETED|Overall Study||90
1067677|NCT00896168|2588691|P2|STARTED|Overall Study||130
1067678|NCT00896168|2588692|P1|STARTED|Overall Study||104
1067679|NCT00902161|2588722|P3|NOT COMPLETED|Period 2||0
1067680|NCT00902161|2588723|P2|NOT COMPLETED|Period 2||0
1067681|NCT00902161|2588724|P1|NOT COMPLETED|Period 2||0
1067682|NCT00902161|2588722|P3|COMPLETED|Period 2||0
1067683|NCT00902161|2588723|P2|COMPLETED|Period 2||9
1067684|NCT00902161|2588724|P1|COMPLETED|Period 2|2 participants discontinued and were replaced; 1 due to protocol deviation and 1 withdrew consent|8
1067685|NCT00902161|2588722|P3|STARTED|Period 2||0
1067686|NCT00902161|2588723|P2|STARTED|Period 2||9
1067687|NCT00902161|2588724|P1|STARTED|Period 2||8
1067688|NCT00902161|2588722|P3|NOT COMPLETED|Post-clamp Washout||0
1067689|NCT00902161|2588723|P2|NOT COMPLETED|Post-clamp Washout||0
1067690|NCT00902161|2588724|P1|NOT COMPLETED|Post-clamp Washout||0
1067691|NCT00902161|2588722|P3|COMPLETED|Post-clamp Washout|2 participants discontinued washout and were replaced; 1 due to an AE and 1 due to lack of efficacy|22
1067692|NCT00902161|2588723|P2|COMPLETED|Post-clamp Washout||0
1067693|NCT00902161|2588724|P1|COMPLETED|Post-clamp Washout||0
1067694|NCT00902161|2588722|P3|STARTED|Post-clamp Washout||22
1067695|NCT00902161|2588723|P2|STARTED|Post-clamp Washout||0
1067696|NCT00902161|2588724|P1|STARTED|Post-clamp Washout||0
1067697|NCT00902161|2588722|P3|NOT COMPLETED|Period 1||0
1067698|NCT00902161|2588723|P2|NOT COMPLETED|Period 1||0
1067699|NCT00902161|2588724|P1|NOT COMPLETED|Period 1||0
1067700|NCT00902161|2588722|P3|COMPLETED|Period 1||0
1067701|NCT00902161|2588723|P2|COMPLETED|Period 1||10
1067702|NCT00902161|2588724|P1|COMPLETED|Period 1||12
1067703|NCT00902161|2588722|P3|STARTED|Period 1||0
1067704|NCT00902161|2588723|P2|STARTED|Period 1||10
1067705|NCT00902161|2588724|P1|STARTED|Period 1||12
1067706|NCT00902161|2588722|P3|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
1067707|NCT00902161|2588723|P2|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
1067708|NCT00902161|2588724|P1|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
1067709|NCT00902161|2588722|P3|COMPLETED|Pre-study Washout/Propanolol Run-in||22
1067710|NCT00902161|2588723|P2|COMPLETED|Pre-study Washout/Propanolol Run-in||0
1067711|NCT00902161|2588724|P1|COMPLETED|Pre-study Washout/Propanolol Run-in||0
1067712|NCT00902161|2588722|P3|STARTED|Pre-study Washout/Propanolol Run-in||22
1067713|NCT00902161|2588723|P2|STARTED|Pre-study Washout/Propanolol Run-in||0
1067714|NCT00902161|2588724|P1|STARTED|Pre-study Washout/Propanolol Run-in||0
1067715|NCT00902174|2588741|P2|NOT COMPLETED|Overall Study||18
1067716|NCT00902174|2588742|P1|NOT COMPLETED|Overall Study||34
1067717|NCT00902174|2588741|P2|COMPLETED|Overall Study||81
1067718|NCT00902174|2588742|P1|COMPLETED|Overall Study||69
1067719|NCT00902174|2588741|P2|STARTED|Overall Study||99
1067720|NCT00902174|2588742|P1|STARTED|Overall Study||103
1067721|NCT00902226|2588778|P1|NOT COMPLETED|Overall Study||0
1067722|NCT00902226|2588778|P1|COMPLETED|Overall Study||30
1067723|NCT00902226|2588778|P1|STARTED|Overall Study||30
1067724|NCT00902265|2588788|P1|NOT COMPLETED|Overall Study||6
1067725|NCT00902265|2588788|P1|COMPLETED|Overall Study||132
1067726|NCT00902265|2588788|P1|Participants Who Received Treatment|Overall Study||137
1067727|NCT00902265|2588788|P1|STARTED|Overall Study||138
1067728|NCT00902668|2588800|P1|NOT COMPLETED|Overall Study||3
1067729|NCT00902668|2588800|P1|COMPLETED|Overall Study||0
1067730|NCT00902668|2588800|P1|STARTED|Overall Study||3
1067731|NCT00902746|2588804|P1|NOT COMPLETED|Overall Study||36
1067732|NCT00902746|2588804|P1|COMPLETED|Overall Study||113
1067733|NCT00902746|2588804|P1|Transfer to Step 2|Overall Study||133
1067734|NCT00902746|2588804|P1|Initiation of Study Drug Administration|Overall Study||148
1067735|NCT00902746|2588804|P1|STARTED|Overall Study||149
1067736|NCT00902850|2588811|P2|NOT COMPLETED|Overall Study||2
1067737|NCT00902850|2588812|P1|NOT COMPLETED|Overall Study||2
1067738|NCT00902850|2588811|P2|COMPLETED|Overall Study||12
1067739|NCT00902850|2588812|P1|COMPLETED|Overall Study||12
1067740|NCT00902850|2588811|P2|STARTED|Overall Study||14
1067741|NCT00902850|2588812|P1|STARTED|Overall Study||14
1067742|NCT00903006|2588822|P4|NOT COMPLETED|Overall Study||0
1067743|NCT00903006|2588823|P3|NOT COMPLETED|Overall Study||1
1067744|NCT00903006|2588824|P2|NOT COMPLETED|Overall Study||3
1067745|NCT00903006|2588825|P1|NOT COMPLETED|Overall Study||2
1067746|NCT00903006|2588822|P4|COMPLETED|Overall Study||0
1067747|NCT00903006|2588823|P3|COMPLETED|Overall Study||0
1067748|NCT00903006|2588824|P2|COMPLETED|Overall Study||0
1067749|NCT00903006|2588825|P1|COMPLETED|Overall Study||0
1067750|NCT00903006|2588822|P4|STARTED|Overall Study|Zero participants started due to smaller sample size.|0
1067751|NCT00903006|2588823|P3|STARTED|Overall Study||1
1067752|NCT00903006|2588824|P2|STARTED|Overall Study||3
1067753|NCT00903006|2588825|P1|STARTED|Overall Study||2
1067754|NCT00903032|2588837|P2|NOT COMPLETED|Overall Study||5
1067755|NCT00903032|2588838|P1|NOT COMPLETED|Overall Study||7
1067756|NCT00903032|2588837|P2|COMPLETED|Overall Study||119
1067757|NCT00903032|2588838|P1|COMPLETED|Overall Study||122
1067758|NCT00903032|2588837|P2|STARTED|Overall Study||124
1067759|NCT00903032|2588838|P1|STARTED|Overall Study||129
1067760|NCT00903162|2588844|P1|NOT COMPLETED|Overall Study||4
1067761|NCT00903162|2588844|P1|COMPLETED|Overall Study||12
1067762|NCT00903162|2588844|P1|STARTED|Overall Study||16
1067763|NCT00903175|2588852|P2|NOT COMPLETED|Period 2 - Second Line||36
1067764|NCT00903175|2588853|P1|NOT COMPLETED|Period 2 - Second Line||49
1067765|NCT00903175|2588852|P2|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|80
1067766|NCT00903175|2588853|P1|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|79
1067767|NCT00903175|2588852|P2|STARTED|Period 2 - Second Line|130 from Sunitinib 1L planned to enter 2L period and cross over to everolimus but only 116 did.|116
1067768|NCT00903175|2588853|P1|STARTED|Period 2 - Second Line|139 from everolimus 1L planned to enter 2L period and cross over to sunitinib but only 128 did.|128
1067769|NCT00903175|2588852|P2|NOT COMPLETED|Period 1 - First Line||89
1067770|NCT00903175|2588853|P1|NOT COMPLETED|Period 1 - First Line||77
1067771|NCT00903175|2588852|P2|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|142
1067772|NCT00903175|2588853|P1|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|161
1067773|NCT00903175|2588852|P2|STARTED|Period 1 - First Line||231
1067774|NCT00903175|2588853|P1|STARTED|Period 1 - First Line||238
1067775|NCT00903331|2588885|P2|NOT COMPLETED|Overall Study||18
1067776|NCT00903331|2588886|P1|NOT COMPLETED|Overall Study||5
1067777|NCT00903331|2588885|P2|COMPLETED|Overall Study||101
1067778|NCT00903331|2588886|P1|COMPLETED|Overall Study||54
1067779|NCT00903331|2588885|P2|STARTED|Overall Study||119
1067780|NCT00903331|2588886|P1|STARTED|Overall Study||59
1067781|NCT00903344|2588896|P2|NOT COMPLETED|Overall Study||3
1067782|NCT00903344|2588897|P1|NOT COMPLETED|Overall Study||5
1067783|NCT00903344|2588896|P2|COMPLETED|Overall Study||7
1067784|NCT00903344|2588897|P1|COMPLETED|Overall Study||7
1067785|NCT00903344|2588896|P2|6 Month Visit|Overall Study||10
1067786|NCT00903344|2588897|P1|6 Month Visit|Overall Study||9
1067787|NCT00903344|2588896|P2|3 Month Visit|Overall Study||10
1067788|NCT00903344|2588897|P1|3 Month Visit|Overall Study||10
1067789|NCT00903344|2588896|P2|STARTED|Overall Study||10
1067790|NCT00903344|2588897|P1|STARTED|Overall Study||12
1067791|NCT00903357|2588913|P2|NOT COMPLETED|Second Intervention||0
1067792|NCT00903357|2588914|P1|NOT COMPLETED|Second Intervention||1
1067793|NCT00903357|2588913|P2|COMPLETED|Second Intervention||22
1067794|NCT00903357|2588914|P1|COMPLETED|Second Intervention||21
1067795|NCT00903357|2588913|P2|STARTED|Second Intervention||22
1067796|NCT00903357|2588914|P1|STARTED|Second Intervention||22
1067797|NCT00903357|2588913|P2|NOT COMPLETED|Wash Out Period of 2 Weeks||1
1067798|NCT00903357|2588914|P1|NOT COMPLETED|Wash Out Period of 2 Weeks||0
1067799|NCT00903357|2588913|P2|COMPLETED|Wash Out Period of 2 Weeks||22
1067800|NCT00903357|2588914|P1|COMPLETED|Wash Out Period of 2 Weeks||22
1067801|NCT00903357|2588913|P2|STARTED|Wash Out Period of 2 Weeks||23
1067802|NCT00903357|2588914|P1|STARTED|Wash Out Period of 2 Weeks||22
1067803|NCT00903357|2588913|P2|NOT COMPLETED|First Intervention||4
1067804|NCT00903357|2588914|P1|NOT COMPLETED|First Intervention||5
1067805|NCT00903357|2588913|P2|COMPLETED|First Intervention||23
1067806|NCT00903357|2588914|P1|COMPLETED|First Intervention||22
1067807|NCT00903357|2588913|P2|STARTED|First Intervention||27
1067808|NCT00903357|2588914|P1|STARTED|First Intervention||27
1067809|NCT00903370|2588926|P2|NOT COMPLETED|Overall Study||24
1067810|NCT00903370|2588927|P1|NOT COMPLETED|Overall Study||28
1067811|NCT00903370|2588926|P2|COMPLETED|Overall Study||109
1067812|NCT00903370|2588927|P1|COMPLETED|Overall Study||99
1067813|NCT00903370|2588926|P2|STARTED|Overall Study||133
1067814|NCT00903370|2588927|P1|STARTED|Overall Study||127
1067815|NCT00903383|2588939|P4|NOT COMPLETED|Overall Study||5
1067816|NCT00903383|2588940|P3|NOT COMPLETED|Overall Study||3
1067817|NCT00903383|2588941|P2|NOT COMPLETED|Overall Study||6
1067818|NCT00903383|2588942|P1|NOT COMPLETED|Overall Study||7
1067819|NCT00903383|2588939|P4|COMPLETED|Overall Study||44
1067820|NCT00903383|2588940|P3|COMPLETED|Overall Study||47
1067821|NCT00903383|2588941|P2|COMPLETED|Overall Study||48
1067822|NCT00903383|2588942|P1|COMPLETED|Overall Study||48
1067823|NCT00903383|2588939|P4|STARTED|Overall Study||49
1067824|NCT00903383|2588940|P3|STARTED|Overall Study||50
1067825|NCT00903383|2588941|P2|STARTED|Overall Study||54
1067826|NCT00903383|2588942|P1|STARTED|Overall Study||55
1067827|NCT00903396|2588976|P4|NOT COMPLETED|Overall Study||0
1067828|NCT00903396|2588977|P3|NOT COMPLETED|Overall Study||0
1067829|NCT00903396|2588978|P2|NOT COMPLETED|Overall Study||0
1067830|NCT00903396|2588979|P1|NOT COMPLETED|Overall Study||0
1067831|NCT00903396|2588976|P4|COMPLETED|Overall Study||1
1067832|NCT00903396|2588977|P3|COMPLETED|Overall Study||3
1067833|NCT00903396|2588978|P2|COMPLETED|Overall Study||1
1067834|NCT00903396|2588979|P1|COMPLETED|Overall Study||2
1067835|NCT00903396|2588976|P4|STARTED|Overall Study||1
1067836|NCT00903396|2588977|P3|STARTED|Overall Study||3
1067837|NCT00903396|2588978|P2|STARTED|Overall Study||1
1067838|NCT00903396|2588979|P1|STARTED|Overall Study||2
1067845|NCT00903448|2589022|P2|NOT COMPLETED|Period 3: 5 Days||0
1067846|NCT00903448|2589023|P1|NOT COMPLETED|Period 3: 5 Days||0
1067847|NCT00903448|2589022|P2|COMPLETED|Period 3: 5 Days||20
1067848|NCT00903448|2589023|P1|COMPLETED|Period 3: 5 Days||20
1067849|NCT00903448|2589022|P2|STARTED|Period 3: 5 Days||20
1067850|NCT00903448|2589023|P1|STARTED|Period 3: 5 Days||20
1067851|NCT00903448|2589022|P2|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
1067852|NCT00903448|2589023|P1|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
1067853|NCT00903448|2589022|P2|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
1067854|NCT00903448|2589023|P1|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
1067855|NCT00903448|2589022|P2|STARTED|Period 2: 5 Days Then 10 Day Washout||20
1067856|NCT00903448|2589023|P1|STARTED|Period 2: 5 Days Then 10 Day Washout||20
1067857|NCT00903448|2589022|P2|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
1067858|NCT00903448|2589023|P1|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
1067859|NCT00903448|2589022|P2|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
1067860|NCT00903448|2589023|P1|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
1067861|NCT00903448|2589022|P2|STARTED|Period 1: 5 Days Then 10 Day Washout||20
1067862|NCT00903448|2589023|P1|STARTED|Period 1: 5 Days Then 10 Day Washout||20
1067863|NCT00903617|2589033|P4|NOT COMPLETED|Overall Study||1
1067864|NCT00903617|2589034|P3|NOT COMPLETED|Overall Study||5
1067865|NCT00903617|2589035|P2|NOT COMPLETED|Overall Study||5
1067866|NCT00903617|2589036|P1|NOT COMPLETED|Overall Study||3
1067867|NCT00903617|2589033|P4|COMPLETED|Overall Study||20
1067868|NCT00903617|2589034|P3|COMPLETED|Overall Study||15
1067869|NCT00903617|2589035|P2|COMPLETED|Overall Study||15
1067870|NCT00903617|2589036|P1|COMPLETED|Overall Study||16
1067871|NCT00903617|2589033|P4|STARTED|Overall Study||21
1067872|NCT00903617|2589034|P3|STARTED|Overall Study||20
1067873|NCT00903617|2589035|P2|STARTED|Overall Study||20
1067874|NCT00903617|2589036|P1|STARTED|Overall Study||19
1067875|NCT00903630|2589133|P3|NOT COMPLETED|Phase 2||1
1067876|NCT00903630|2589134|P2|NOT COMPLETED|Phase 2||0
1067877|NCT00903630|2589135|P1|NOT COMPLETED|Phase 2||0
1067878|NCT00903630|2589133|P3|COMPLETED|Phase 2|One participant was removed from the study after 2 weeks of treatment due to skin toxicity.|3
1067879|NCT00903630|2589134|P2|COMPLETED|Phase 2||0
1067880|NCT00903630|2589135|P1|COMPLETED|Phase 2||6
1067881|NCT00903630|2589133|P3|STARTED|Phase 2||4
1067882|NCT00903630|2589134|P2|STARTED|Phase 2||0
1067883|NCT00903630|2589135|P1|STARTED|Phase 2||6
1067884|NCT00903630|2589133|P3|NOT COMPLETED|Phase l||0
1067885|NCT00903630|2589134|P2|NOT COMPLETED|Phase l||0
1067886|NCT00903630|2589135|P1|NOT COMPLETED|Phase l||0
1067887|NCT00903630|2589133|P3|COMPLETED|Phase l||0
1067888|NCT00903630|2589134|P2|COMPLETED|Phase l||5
1067889|NCT00903630|2589135|P1|COMPLETED|Phase l||6
1067890|NCT00903630|2589133|P3|STARTED|Phase l||0
1067891|NCT00903630|2589134|P2|STARTED|Phase l||5
1067892|NCT00903630|2589135|P1|STARTED|Phase l||6
1067893|NCT00903682|2589151|P2|NOT COMPLETED|Overall Study||15
1067894|NCT00903682|2589152|P1|NOT COMPLETED|Overall Study||16
1067895|NCT00903682|2589151|P2|COMPLETED|Overall Study||63
1067896|NCT00903682|2589152|P1|COMPLETED|Overall Study||63
1067897|NCT00903682|2589151|P2|STARTED|Overall Study||78
1067898|NCT00903682|2589152|P1|STARTED|Overall Study||79
1067899|NCT00903695|2589172|P2|NOT COMPLETED|Overall Study||0
1067900|NCT00903695|2589173|P1|NOT COMPLETED|Overall Study||2
1067901|NCT00903695|2589172|P2|COMPLETED|Overall Study||2
1067902|NCT00903695|2589173|P1|COMPLETED|Overall Study||6
1067903|NCT00903695|2589172|P2|STARTED|Overall Study||2
1067904|NCT00903695|2589173|P1|STARTED|Overall Study||8
1067905|NCT00903877|2589193|P1|NOT COMPLETED|Overall Study||43
1067906|NCT00903877|2589193|P1|COMPLETED|Overall Study||8
1067907|NCT00903877|2589193|P1|STARTED|Overall Study||51
1067908|NCT00903929|2589197|P4|NOT COMPLETED|Overall Study||3
1067909|NCT00903929|2589198|P3|NOT COMPLETED|Overall Study||1
1067910|NCT00903929|2589199|P2|NOT COMPLETED|Overall Study||0
1067911|NCT00903929|2589200|P1|NOT COMPLETED|Overall Study||0
1067912|NCT00903929|2589197|P4|COMPLETED|Overall Study||6
1067913|NCT00903929|2589198|P3|COMPLETED|Overall Study||3
1067914|NCT00903929|2589199|P2|COMPLETED|Overall Study||3
1067915|NCT00903929|2589200|P1|COMPLETED|Overall Study||3
1067916|NCT00903929|2589197|P4|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|9
1067917|NCT00903929|2589198|P3|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|4
1067918|NCT00903929|2589199|P2|STARTED|Overall Study||3
1067919|NCT00903929|2589200|P1|STARTED|Overall Study||3
1067920|NCT00903968|2589208|P8|NOT COMPLETED|Overall Study||33
1067921|NCT00903968|2589209|P7|NOT COMPLETED|Overall Study||3
1067922|NCT00903968|2589210|P6|NOT COMPLETED|Overall Study||6
1067923|NCT00903968|2589211|P5|NOT COMPLETED|Overall Study||4
1067924|NCT00903968|2589212|P4|NOT COMPLETED|Overall Study||3
1067925|NCT00903968|2589213|P3|NOT COMPLETED|Overall Study||3
1067926|NCT00903968|2589214|P2|NOT COMPLETED|Overall Study||3
1067927|NCT00903968|2589215|P1|NOT COMPLETED|Overall Study||3
1067928|NCT00903968|2589208|P8|COMPLETED|Overall Study||0
1067929|NCT00903968|2589209|P7|COMPLETED|Overall Study||0
1067930|NCT00903968|2589210|P6|COMPLETED|Overall Study||0
1067931|NCT00903968|2589211|P5|COMPLETED|Overall Study||0
1067932|NCT00903968|2589212|P4|COMPLETED|Overall Study||0
1067933|NCT00903968|2589213|P3|COMPLETED|Overall Study||0
1067934|NCT00903968|2589214|P2|COMPLETED|Overall Study||0
1067935|NCT00903968|2589215|P1|COMPLETED|Overall Study||0
1067936|NCT00903968|2589208|P8|STARTED|Overall Study||33
1067937|NCT00903968|2589209|P7|STARTED|Overall Study||3
1067938|NCT00903968|2589210|P6|STARTED|Overall Study||6
1067939|NCT00903968|2589211|P5|STARTED|Overall Study||4
1067940|NCT00903968|2589212|P4|STARTED|Overall Study||3
1067941|NCT00903968|2589213|P3|STARTED|Overall Study||3
1067942|NCT00903968|2589214|P2|STARTED|Overall Study||3
1067943|NCT00903968|2589215|P1|STARTED|Overall Study||3
1067944|NCT00904007|2589247|P2|NOT COMPLETED|Overall Study||0
1067945|NCT00904007|2589248|P1|NOT COMPLETED|Overall Study||0
1067946|NCT00904007|2589247|P2|COMPLETED|Overall Study||56
1067947|NCT00904007|2589248|P1|COMPLETED|Overall Study||55
1067948|NCT00904007|2589247|P2|STARTED|Overall Study||56
1067949|NCT00904007|2589248|P1|STARTED|Overall Study||55
1067950|NCT00904150|2589256|P2|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
1067951|NCT00904150|2589257|P1|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
1067952|NCT00904150|2589256|P2|COMPLETED|Blood Samples (RNA): Luteal Phase||30
1067953|NCT00904150|2589257|P1|COMPLETED|Blood Samples (RNA): Luteal Phase||34
1067954|NCT00904150|2589256|P2|STARTED|Blood Samples (RNA): Luteal Phase||30
1067955|NCT00904150|2589257|P1|STARTED|Blood Samples (RNA): Luteal Phase||34
1067956|NCT00904150|2589256|P2|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
1067957|NCT00904150|2589257|P1|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
1067958|NCT00904150|2589256|P2|COMPLETED|Blood Samples (RNA): Follicular Phase||32
1067959|NCT00904150|2589257|P1|COMPLETED|Blood Samples (RNA): Follicular Phase||37
1067960|NCT00904150|2589256|P2|STARTED|Blood Samples (RNA): Follicular Phase||32
1067961|NCT00904150|2589257|P1|STARTED|Blood Samples (RNA): Follicular Phase||37
1067962|NCT00904150|2589256|P2|NOT COMPLETED|Saliva Samples (DNA)||145
1067963|NCT00904150|2589257|P1|NOT COMPLETED|Saliva Samples (DNA)||3
1067964|NCT00904150|2589256|P2|COMPLETED|Saliva Samples (DNA)||155
1067965|NCT00904150|2589257|P1|COMPLETED|Saliva Samples (DNA)||282
1067966|NCT00904150|2589256|P2|STARTED|Saliva Samples (DNA)||300
1067967|NCT00904150|2589257|P1|STARTED|Saliva Samples (DNA)||285
1067968|NCT00904189|2589275|P1|NOT COMPLETED|Overall Study||0
1067969|NCT00904189|2589275|P1|COMPLETED|Overall Study||2
1067970|NCT00904189|2589275|P1|STARTED|Overall Study||2
1067971|NCT00904215|2589280|P1|NOT COMPLETED|Overall Study||135
1067972|NCT00904215|2589280|P1|COMPLETED|Overall Study||960
1067973|NCT00904215|2589280|P1|STARTED|Overall Study||1095
1067974|NCT00904371|2589287|P1|NOT COMPLETED|Overall Study||9
1067975|NCT00904371|2589287|P1|COMPLETED|Overall Study||202
1067976|NCT00904371|2589287|P1|STARTED|Overall Study||211
1067977|NCT00904423|2589301|P1|NOT COMPLETED|Overall Study||0
1067978|NCT00904423|2589301|P1|COMPLETED|Overall Study||8
1067979|NCT00904423|2589301|P1|STARTED|Overall Study||8
1067980|NCT00904618|2589309|P1|NOT COMPLETED|Overall Study||0
1067981|NCT00904618|2589309|P1|COMPLETED|Overall Study||48
1067982|NCT00904618|2589309|P1|STARTED|Overall Study||48
1067983|NCT00904670|2589317|P2|NOT COMPLETED|Second Intervention Period||0
1067984|NCT00904670|2589318|P1|NOT COMPLETED|Second Intervention Period||0
1067985|NCT00904670|2589317|P2|COMPLETED|Second Intervention Period||22
1067986|NCT00904670|2589318|P1|COMPLETED|Second Intervention Period||17
1067987|NCT00904670|2589317|P2|STARTED|Second Intervention Period||22
1067988|NCT00904670|2589318|P1|STARTED|Second Intervention Period||17
1067989|NCT00904670|2589317|P2|NOT COMPLETED|First Intervention Period||0
1067990|NCT00904670|2589318|P1|NOT COMPLETED|First Intervention Period||0
1067991|NCT00904670|2589317|P2|COMPLETED|First Intervention Period||22
1067992|NCT00904670|2589318|P1|COMPLETED|First Intervention Period||17
1067993|NCT00904670|2589317|P2|STARTED|First Intervention Period||22
1067994|NCT00904670|2589318|P1|STARTED|First Intervention Period||17
1067995|NCT00904670|2589317|P2|NOT COMPLETED|Open Label Phase||0
1067996|NCT00904670|2589318|P1|NOT COMPLETED|Open Label Phase||6
1067997|NCT00904670|2589317|P2|COMPLETED|Open Label Phase||22
1067998|NCT00904670|2589318|P1|COMPLETED|Open Label Phase||17
1067999|NCT00904670|2589317|P2|STARTED|Open Label Phase||22
1068000|NCT00904670|2589318|P1|STARTED|Open Label Phase||23
1068001|NCT00904722|2589339|P1|NOT COMPLETED|Overall Study||1
1068002|NCT00904722|2589339|P1|COMPLETED|Overall Study||29
1068003|NCT00904722|2589339|P1|STARTED|Overall Study||30
1068004|NCT00904748|2589344|P6|NOT COMPLETED|Overall Study||0
1068005|NCT00904748|2589345|P5|NOT COMPLETED|Overall Study||1
1068006|NCT00904748|2589346|P4|NOT COMPLETED|Overall Study||2
1068007|NCT00904748|2589347|P3|NOT COMPLETED|Overall Study||1
1068008|NCT00904748|2589348|P2|NOT COMPLETED|Overall Study||1
1068009|NCT00904748|2589349|P1|NOT COMPLETED|Overall Study||1
1068010|NCT00904748|2589344|P6|COMPLETED|Overall Study||8
1068011|NCT00904748|2589345|P5|COMPLETED|Overall Study||7
1068012|NCT00904748|2589346|P4|COMPLETED|Overall Study||6
1068013|NCT00904748|2589347|P3|COMPLETED|Overall Study||7
1068014|NCT00904748|2589348|P2|COMPLETED|Overall Study||7
1068015|NCT00904748|2589349|P1|COMPLETED|Overall Study||7
1068016|NCT00904748|2589344|P6|Received Treatment|Overall Study||8
1068017|NCT00904748|2589345|P5|Received Treatment|Overall Study||7
1068018|NCT00904748|2589346|P4|Received Treatment|Overall Study||8
1068019|NCT00904748|2589347|P3|Received Treatment|Overall Study||8
1068020|NCT00904748|2589348|P2|Received Treatment|Overall Study||8
1068021|NCT00904748|2589349|P1|Received Treatment|Overall Study||8
1068022|NCT00904748|2589344|P6|STARTED|Overall Study||8
1068023|NCT00904748|2589345|P5|STARTED|Overall Study|1 participant randomized to this sequence discontinued prior to receipt of study medication.|8
1068024|NCT00904748|2589346|P4|STARTED|Overall Study||8
1068025|NCT00904748|2589347|P3|STARTED|Overall Study||8
1068026|NCT00904748|2589348|P2|STARTED|Overall Study||8
1068027|NCT00904748|2589349|P1|STARTED|Overall Study||8
1068028|NCT00904826|2589373|P1|NOT COMPLETED|Overall Study||0
1068029|NCT00904826|2589373|P1|COMPLETED|Overall Study||14
1068030|NCT00904826|2589373|P1|STARTED|Overall Study||14
1068031|NCT00904839|2589387|P3|NOT COMPLETED|Overall Study||15
1068032|NCT00904839|2589388|P2|NOT COMPLETED|Overall Study||18
1068033|NCT00904839|2589389|P1|NOT COMPLETED|Overall Study||1
1068034|NCT00904839|2589387|P3|COMPLETED|Overall Study||27
1068035|NCT00904839|2589388|P2|COMPLETED|Overall Study||64
1068036|NCT00904839|2589389|P1|COMPLETED|Overall Study||3
1068037|NCT00904839|2589387|P3|STARTED|Overall Study|Randomised|42
1068038|NCT00904839|2589388|P2|STARTED|Overall Study|11 patients were randomised to Maximum Tolerable Dose analysis set.|82
1068039|NCT00904839|2589389|P1|STARTED|Overall Study|All 4 patients were randomised to Maximum Tolerable Dose analysis set.|4
1068040|NCT00904917|2589427|P4|NOT COMPLETED|Overall Study||2
1068041|NCT00904917|2589428|P3|NOT COMPLETED|Overall Study||2
1068042|NCT00904917|2589429|P2|NOT COMPLETED|Overall Study||2
1068043|NCT00904917|2589430|P1|NOT COMPLETED|Overall Study||2
1068044|NCT00904917|2589427|P4|COMPLETED|Overall Study||6
1068045|NCT00904917|2589428|P3|COMPLETED|Overall Study||6
1068046|NCT00904917|2589429|P2|COMPLETED|Overall Study||9
1068047|NCT00904917|2589430|P1|COMPLETED|Overall Study||5
1068048|NCT00904917|2589427|P4|STARTED|Overall Study||8
1068049|NCT00904917|2589428|P3|STARTED|Overall Study||8
1068050|NCT00904917|2589429|P2|STARTED|Overall Study||11
1068051|NCT00904917|2589430|P1|STARTED|Overall Study||7
1068052|NCT00904943|2589448|P2|NOT COMPLETED|Period 2||0
1068053|NCT00904943|2589449|P1|NOT COMPLETED|Period 2||0
1068054|NCT00904943|2589448|P2|COMPLETED|Period 2||8
1068055|NCT00904943|2589449|P1|COMPLETED|Period 2||9
1068056|NCT00904943|2589448|P2|STARTED|Period 2|one subject was withdrawn prior to Pd. 2 dosing|8
1068057|NCT00904943|2589449|P1|STARTED|Period 2||9
1068058|NCT00904943|2589448|P2|NOT COMPLETED|Period 1||0
1068059|NCT00904943|2589449|P1|NOT COMPLETED|Period 1||0
1068060|NCT00904943|2589448|P2|COMPLETED|Period 1||9
1068061|NCT00904943|2589449|P1|COMPLETED|Period 1||9
1068062|NCT00904943|2589448|P2|STARTED|Period 1||9
1068063|NCT00904943|2589449|P1|STARTED|Period 1||9
1068064|NCT00904982|2589461|P4|NOT COMPLETED|Overall Study||0
1068065|NCT00904982|2589462|P3|NOT COMPLETED|Overall Study||0
1068066|NCT00904982|2589463|P2|NOT COMPLETED|Overall Study||0
1068067|NCT00904982|2589464|P1|NOT COMPLETED|Overall Study||2
1068068|NCT00904982|2589461|P4|COMPLETED|Overall Study||68
1068069|NCT00904982|2589462|P3|COMPLETED|Overall Study||67
1068070|NCT00904982|2589463|P2|COMPLETED|Overall Study||67
1068071|NCT00904982|2589464|P1|COMPLETED|Overall Study||66
1068072|NCT00904982|2589461|P4|STARTED|Overall Study||68
1068073|NCT00904982|2589462|P3|STARTED|Overall Study||67
1068074|NCT00904982|2589463|P2|STARTED|Overall Study||67
1068075|NCT00904982|2589464|P1|STARTED|Overall Study||68
1068076|NCT00904995|2589476|P2|NOT COMPLETED|Overall Study||0
1068077|NCT00904995|2589477|P1|NOT COMPLETED|Overall Study||0
1068078|NCT00904995|2589476|P2|COMPLETED|Overall Study||11
1068079|NCT00904995|2589477|P1|COMPLETED|Overall Study||10
1068080|NCT00904995|2589476|P2|STARTED|Overall Study||11
1068081|NCT00904995|2589477|P1|STARTED|Overall Study||10
1068082|NCT00905021|2589483|P1|NOT COMPLETED|Overall Study||2
1068083|NCT00905021|2589483|P1|COMPLETED|Overall Study|2 patients were off study due to AE.|2
1068084|NCT00905021|2589483|P1|STARTED|Overall Study||4
1068085|NCT00905034|2589488|P1|NOT COMPLETED|Overall Study||1
1068086|NCT00905034|2589488|P1|COMPLETED|Overall Study||36
1068087|NCT00905034|2589488|P1|STARTED|Overall Study||37
1068088|NCT00905125|2589494|P2|NOT COMPLETED|Overall Study||3
1068089|NCT00905125|2589495|P1|NOT COMPLETED|Overall Study||4
1068090|NCT00905125|2589494|P2|COMPLETED|Overall Study||53
1068091|NCT00905125|2589495|P1|COMPLETED|Overall Study||42
1068092|NCT00905125|2589494|P2|STARTED|Overall Study||56
1068093|NCT00905125|2589495|P1|STARTED|Overall Study||46
1068094|NCT00905151|2589527|P1|NOT COMPLETED|Overall Study||6
1068095|NCT00905151|2589527|P1|COMPLETED|Overall Study||200
1068096|NCT00905151|2589527|P1|STARTED|Overall Study||206
1068097|NCT00905164|2589533|P2|NOT COMPLETED|Period 2||0
1068098|NCT00905164|2589534|P1|NOT COMPLETED|Period 2||0
1068099|NCT00905164|2589533|P2|COMPLETED|Period 2||11
1068100|NCT00905164|2589534|P1|COMPLETED|Period 2||12
1068101|NCT00905164|2589533|P2|STARTED|Period 2||11
1068102|NCT00905164|2589534|P1|STARTED|Period 2||12
1068103|NCT00905164|2589533|P2|NOT COMPLETED|Period 1||1
1068104|NCT00905164|2589534|P1|NOT COMPLETED|Period 1||0
1068105|NCT00905164|2589533|P2|COMPLETED|Period 1||11
1068106|NCT00905164|2589534|P1|COMPLETED|Period 1||12
1068107|NCT00905164|2589533|P2|STARTED|Period 1||12
1068108|NCT00905164|2589534|P1|STARTED|Period 1||12
1068109|NCT00905255|2589544|P2|NOT COMPLETED|Overall Study||9
1068110|NCT00905255|2589545|P1|NOT COMPLETED|Overall Study||13
1068111|NCT00905255|2589544|P2|COMPLETED|Overall Study||27
1068112|NCT00905255|2589545|P1|COMPLETED|Overall Study||20
1068113|NCT00905255|2589544|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||36
1068114|NCT00905255|2589545|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|33
1068115|NCT00905255|2589544|P2|Safety Population|Overall Study||36
1068116|NCT00905255|2589545|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|33
1068117|NCT00905255|2589544|P2|STARTED|Overall Study||36
1068118|NCT00905255|2589545|P1|STARTED|Overall Study|Randomized.|33
1068119|NCT00905268|2589565|P4|NOT COMPLETED|Overall Study||2
1068120|NCT00905268|2589566|P3|NOT COMPLETED|Overall Study||0
1068121|NCT00905268|2589567|P2|NOT COMPLETED|Overall Study||1
1068122|NCT00905268|2589568|P1|NOT COMPLETED|Overall Study||4
1068123|NCT00905268|2589565|P4|COMPLETED|Overall Study||57
1068124|NCT00905268|2589566|P3|COMPLETED|Overall Study||59
1068125|NCT00905268|2589567|P2|COMPLETED|Overall Study||56
1068126|NCT00905268|2589568|P1|COMPLETED|Overall Study||53
1068127|NCT00905268|2589565|P4|STARTED|Overall Study||59
1068128|NCT00905268|2589566|P3|STARTED|Overall Study||59
1068129|NCT00905268|2589567|P2|STARTED|Overall Study||57
1068130|NCT00905268|2589568|P1|STARTED|Overall Study||57
1068131|NCT00905307|2589604|P6|NOT COMPLETED|Overall Study||42
1068132|NCT00905307|2589605|P5|NOT COMPLETED|Overall Study||16
1068133|NCT00905307|2589606|P4|NOT COMPLETED|Overall Study||37
1068134|NCT00905307|2589607|P3|NOT COMPLETED|Overall Study||37
1068135|NCT00905307|2589608|P2|NOT COMPLETED|Overall Study||37
1068136|NCT00905307|2589609|P1|NOT COMPLETED|Overall Study||22
1068137|NCT00905307|2589604|P6|COMPLETED|Overall Study||53
1068138|NCT00905307|2589605|P5|COMPLETED|Overall Study||34
1068139|NCT00905307|2589606|P4|COMPLETED|Overall Study||56
1068140|NCT00905307|2589607|P3|COMPLETED|Overall Study||53
1068141|NCT00905307|2589608|P2|COMPLETED|Overall Study||52
1068142|NCT00905307|2589609|P1|COMPLETED|Overall Study||20
1068143|NCT00905307|2589604|P6|STARTED|Overall Study||95
1068144|NCT00905307|2589605|P5|STARTED|Overall Study||50
1068145|NCT00905307|2589606|P4|STARTED|Overall Study||93
1068146|NCT00905307|2589607|P3|STARTED|Overall Study||90
1068147|NCT00905307|2589608|P2|STARTED|Overall Study||89
1068148|NCT00905307|2589609|P1|STARTED|Overall Study||42
1068149|NCT00905346|2589667|P2|NOT COMPLETED|Period 2||0
1068150|NCT00905346|2589668|P1|NOT COMPLETED|Period 2||0
1068151|NCT00905346|2589667|P2|COMPLETED|Period 2||11
1068152|NCT00905346|2589668|P1|COMPLETED|Period 2||10
1068153|NCT00905346|2589667|P2|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|11
1068154|NCT00905346|2589668|P1|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|10
1068155|NCT00905346|2589667|P2|NOT COMPLETED|Period 1||0
1068156|NCT00905346|2589668|P1|NOT COMPLETED|Period 1||1
1068157|NCT00905346|2589667|P2|COMPLETED|Period 1||12
1068158|NCT00905346|2589668|P1|COMPLETED|Period 1||11
1068159|NCT00905346|2589667|P2|STARTED|Period 1||12
1068160|NCT00905346|2589668|P1|STARTED|Period 1||12
1068161|NCT00905359|2589678|P2|NOT COMPLETED|Overall Study||16
1068162|NCT00905359|2589679|P1|NOT COMPLETED|Overall Study||24
1068163|NCT00905359|2589678|P2|COMPLETED|Overall Study||65
1068164|NCT00905359|2589679|P1|COMPLETED|Overall Study||58
1068165|NCT00905359|2589678|P2|24 Months Follow up|Overall Study||65
1068166|NCT00905359|2589679|P1|24 Months Follow up|Overall Study||58
1068167|NCT00905359|2589678|P2|12 Months Follow up|Overall Study||72
1068168|NCT00905359|2589679|P1|12 Months Follow up|Overall Study||68
1068169|NCT00905359|2589678|P2|STARTED|Overall Study||81
1068170|NCT00905359|2589679|P1|STARTED|Overall Study||82
1068171|NCT00905424|2589715|P2|NOT COMPLETED|Overall Study||9
1068172|NCT00905424|2589716|P1|NOT COMPLETED|Overall Study||11
1068173|NCT00905424|2589715|P2|COMPLETED|Overall Study||79
1068174|NCT00905424|2589716|P1|COMPLETED|Overall Study||78
1068175|NCT00905424|2589715|P2|STARTED|Overall Study||88
1068176|NCT00905424|2589716|P1|STARTED|Overall Study||89
1068177|NCT00905437|2589758|P2|NOT COMPLETED|Overall Study||10
1068178|NCT00905437|2589759|P1|NOT COMPLETED|Overall Study||8
1068179|NCT00905437|2589758|P2|COMPLETED|Overall Study||27
1068180|NCT00905437|2589759|P1|COMPLETED|Overall Study||27
1068181|NCT00905437|2589758|P2|STARTED|Overall Study||37
1068182|NCT00905437|2589759|P1|STARTED|Overall Study||35
1068183|NCT00905489|2589777|P1|NOT COMPLETED|Optional Extension Phase (OEP)||1
1068184|NCT00905489|2589777|P1|COMPLETED|Optional Extension Phase (OEP)||39
1068185|NCT00905489|2589777|P1|STARTED|Optional Extension Phase (OEP)|Includes only subjects who chose to continue trt with nevirapine XR after completing the PK phase.|40
1068186|NCT00905489|2589777|P1|NOT COMPLETED|Pharmaco-kinetic (PK) Phase||5
1068187|NCT00905489|2589777|P1|COMPLETED|Pharmaco-kinetic (PK) Phase||80
1068188|NCT00905489|2589777|P1|STARTED|Pharmaco-kinetic (PK) Phase||85
1068189|NCT00907335|2589826|P2|NOT COMPLETED|Overall Study||1
1068190|NCT00907335|2589827|P1|NOT COMPLETED|Overall Study||8
1068191|NCT00907335|2589826|P2|COMPLETED|Overall Study||54
1068192|NCT00907335|2589827|P1|COMPLETED|Overall Study||47
1068193|NCT00907335|2589826|P2|STARTED|Overall Study||55
1068194|NCT00907335|2589827|P1|STARTED|Overall Study||55
1068195|NCT00907374|2589845|P2|NOT COMPLETED|Overall Study||2
1068196|NCT00907374|2589846|P1|NOT COMPLETED|Overall Study||2
1068197|NCT00907374|2589845|P2|COMPLETED|Overall Study||11
1068198|NCT00907374|2589846|P1|COMPLETED|Overall Study||12
1068199|NCT00907374|2589845|P2|STARTED|Overall Study||13
1068200|NCT00907374|2589846|P1|STARTED|Overall Study||14
1068201|NCT00907426|2589861|P3|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||7
1068202|NCT00907426|2589862|P2|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||3
1068203|NCT00907426|2589863|P1|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||11
1068204|NCT00907426|2589861|P3|COMPLETED|Treatment Period 2 (6 to 12 Months)||77
1068205|NCT00907426|2589862|P2|COMPLETED|Treatment Period 2 (6 to 12 Months)||52
1068206|NCT00907426|2589863|P1|COMPLETED|Treatment Period 2 (6 to 12 Months)||184
1068207|NCT00907426|2589861|P3|STARTED|Treatment Period 2 (6 to 12 Months)||84
1068208|NCT00907426|2589862|P2|STARTED|Treatment Period 2 (6 to 12 Months)||55
1068209|NCT00907426|2589863|P1|STARTED|Treatment Period 2 (6 to 12 Months)||195
1068210|NCT00907426|2589861|P3|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||9
1068211|NCT00907426|2589862|P2|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||5
1068212|NCT00907426|2589863|P1|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||20
1068213|NCT00907426|2589861|P3|COMPLETED|Treatment Period 1 (0 to 6 Months)||84
1068214|NCT00907426|2589862|P2|COMPLETED|Treatment Period 1 (0 to 6 Months)||55
1068215|NCT00907426|2589863|P1|COMPLETED|Treatment Period 1 (0 to 6 Months)||195
1068216|NCT00907426|2589861|P3|STARTED|Treatment Period 1 (0 to 6 Months)||93
1068217|NCT00907426|2589862|P2|STARTED|Treatment Period 1 (0 to 6 Months)||60
1068218|NCT00907426|2589863|P1|STARTED|Treatment Period 1 (0 to 6 Months)||215
1068219|NCT00907478|2589881|P3|NOT COMPLETED|Overall Study||22
1068220|NCT00907478|2589882|P2|NOT COMPLETED|Overall Study||17
1068221|NCT00907478|2589883|P1|NOT COMPLETED|Overall Study||27
1068222|NCT00907478|2589881|P3|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|47
1068223|NCT00907478|2589882|P2|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|33
1068224|NCT00907478|2589883|P1|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|23
1068225|NCT00907478|2589881|P3|STARTED|Overall Study||69
1068226|NCT00907478|2589882|P2|STARTED|Overall Study||50
1068227|NCT00907478|2589883|P1|STARTED|Overall Study||50
1068228|NCT00907517|2589916|P5|NOT COMPLETED|Overall Study||5
1068229|NCT00907517|2589917|P4|NOT COMPLETED|Overall Study||4
1068230|NCT00907517|2589918|P3|NOT COMPLETED|Overall Study||4
1068231|NCT00907517|2589919|P2|NOT COMPLETED|Overall Study||3
1068232|NCT00907517|2589920|P1|NOT COMPLETED|Overall Study||3
1068233|NCT00907517|2589916|P5|COMPLETED|Overall Study||1
1068234|NCT00907517|2589917|P4|COMPLETED|Overall Study||2
1068235|NCT00907517|2589918|P3|COMPLETED|Overall Study||2
1068236|NCT00907517|2589919|P2|COMPLETED|Overall Study||0
1068237|NCT00907517|2589920|P1|COMPLETED|Overall Study||0
1068238|NCT00907517|2589916|P5|STARTED|Overall Study||6
1068239|NCT00907517|2589917|P4|STARTED|Overall Study||6
1068240|NCT00907517|2589918|P3|STARTED|Overall Study||6
1068241|NCT00907517|2589919|P2|STARTED|Overall Study||3
1068242|NCT00907517|2589920|P1|STARTED|Overall Study||3
1068243|NCT00907621|2589944|P2|NOT COMPLETED|Overall Study||4
1068244|NCT00907621|2589945|P1|NOT COMPLETED|Overall Study||7
1068245|NCT00907621|2589944|P2|COMPLETED|Overall Study||41
1068246|NCT00907621|2589945|P1|COMPLETED|Overall Study||38
1068247|NCT00907621|2589944|P2|STARTED|Overall Study||45
1068248|NCT00907621|2589945|P1|STARTED|Overall Study||45
1068249|NCT00907738|2589958|P5|NOT COMPLETED|Overall Study||2
1068250|NCT00907738|2589959|P4|NOT COMPLETED|Overall Study||4
1068251|NCT00907738|2589960|P3|NOT COMPLETED|Overall Study||7
1068252|NCT00907738|2589961|P2|NOT COMPLETED|Overall Study||1
1068253|NCT00907738|2589962|P1|NOT COMPLETED|Overall Study||13
1068254|NCT00907738|2589958|P5|COMPLETED|Overall Study||0
1068255|NCT00907738|2589959|P4|COMPLETED|Overall Study||0
1068256|NCT00907738|2589960|P3|COMPLETED|Overall Study||0
1068257|NCT00907738|2589961|P2|COMPLETED|Overall Study||0
1068258|NCT00907738|2589962|P1|COMPLETED|Overall Study||0
1068259|NCT00907738|2589958|P5|STARTED|Overall Study||2
1068260|NCT00907738|2589959|P4|STARTED|Overall Study||4
1068261|NCT00907738|2589960|P3|STARTED|Overall Study||7
1068262|NCT00907738|2589961|P2|STARTED|Overall Study||1
1068263|NCT00907738|2589962|P1|STARTED|Overall Study||13
1068264|NCT00907777|2589980|P2|NOT COMPLETED|Overall Study||1
1068265|NCT00907777|2589981|P1|NOT COMPLETED|Overall Study||0
1068266|NCT00907777|2589980|P2|COMPLETED|Overall Study||26
1068267|NCT00907777|2589981|P1|COMPLETED|Overall Study||25
1068268|NCT00907777|2589980|P2|STARTED|Overall Study||27
1068269|NCT00907777|2589981|P1|STARTED|Overall Study||25
1068270|NCT00907803|2590006|P3|NOT COMPLETED|Overall Study||0
1068271|NCT00907803|2590007|P2|NOT COMPLETED|Overall Study||3
1068272|NCT00907803|2590008|P1|NOT COMPLETED|Overall Study||3
1068273|NCT00907803|2590006|P3|COMPLETED|Overall Study||16
1068274|NCT00907803|2590007|P2|COMPLETED|Overall Study||43
1068275|NCT00907803|2590008|P1|COMPLETED|Overall Study||42
1068276|NCT00907803|2590006|P3|STARTED|Overall Study||16
1068277|NCT00907803|2590007|P2|STARTED|Overall Study||46
1068278|NCT00907803|2590008|P1|STARTED|Overall Study||45
1068279|NCT00907881|2590037|P1|NOT COMPLETED|Overall Study||85
1068280|NCT00907881|2590037|P1|COMPLETED|Overall Study||984
1068281|NCT00907881|2590037|P1|STARTED|Overall Study||1069
1068282|NCT00907907|2590046|P2|NOT COMPLETED|Period 4||0
1068283|NCT00907907|2590047|P1|NOT COMPLETED|Period 4||0
1068284|NCT00907907|2590046|P2|COMPLETED|Period 4||18
1068285|NCT00907907|2590047|P1|COMPLETED|Period 4||19
1068286|NCT00907907|2590046|P2|STARTED|Period 4|two subjects were withdrawn prior to Period 4 dosing|18
1068287|NCT00907907|2590047|P1|STARTED|Period 4|one subject withdrew prior to Period 4 dosing|19
1068288|NCT00907907|2590046|P2|NOT COMPLETED|Period 3||0
1068289|NCT00907907|2590047|P1|NOT COMPLETED|Period 3||0
1068290|NCT00907907|2590046|P2|COMPLETED|Period 3||20
1068291|NCT00907907|2590047|P1|COMPLETED|Period 3||20
1068292|NCT00907907|2590046|P2|STARTED|Period 3||20
1068293|NCT00907907|2590047|P1|STARTED|Period 3||20
1068294|NCT00907907|2590046|P2|NOT COMPLETED|Period 2||0
1068295|NCT00907907|2590047|P1|NOT COMPLETED|Period 2||0
1068296|NCT00907907|2590046|P2|COMPLETED|Period 2||20
1068297|NCT00907907|2590047|P1|COMPLETED|Period 2||20
1068298|NCT00907907|2590046|P2|STARTED|Period 2||20
1068299|NCT00907907|2590047|P1|STARTED|Period 2||20
1068300|NCT00907907|2590046|P2|NOT COMPLETED|Period 1||0
1068301|NCT00907907|2590047|P1|NOT COMPLETED|Period 1||0
1068302|NCT00907907|2590046|P2|COMPLETED|Period 1||20
1068303|NCT00907907|2590047|P1|COMPLETED|Period 1||20
1068304|NCT00907907|2590046|P2|STARTED|Period 1||20
1068305|NCT00907907|2590047|P1|STARTED|Period 1||20
1068306|NCT00908011|2590057|P2|NOT COMPLETED|Overall Study||2
1068307|NCT00908011|2590058|P1|NOT COMPLETED|Overall Study||2
1068308|NCT00908011|2590057|P2|COMPLETED|Overall Study||18
1068309|NCT00908011|2590058|P1|COMPLETED|Overall Study||21
1068310|NCT00908011|2590057|P2|STARTED|Overall Study||20
1068311|NCT00908011|2590058|P1|STARTED|Overall Study||23
1068312|NCT00908037|2590071|P12|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
1068313|NCT00908037|2590072|P11|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||4
1068314|NCT00908037|2590073|P10|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
1068315|NCT00908037|2590074|P9|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1068316|NCT00908037|2590075|P8|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1068317|NCT00908037|2590076|P7|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1068318|NCT00908037|2590077|P6|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1068319|NCT00908037|2590078|P5|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1068320|NCT00908037|2590079|P4|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1068321|NCT00908037|2590080|P3|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1068322|NCT00908037|2590081|P2|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1068323|NCT00908037|2590082|P1|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1068324|NCT00908037|2590071|P12|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||12
1068325|NCT00908037|2590072|P11|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|24
1068326|NCT00908037|2590073|P10|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||21
1068327|NCT00908037|2590074|P9|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1068328|NCT00908037|2590075|P8|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1068329|NCT00908037|2590076|P7|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1068330|NCT00908037|2590077|P6|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1068331|NCT00908037|2590078|P5|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1068332|NCT00908037|2590079|P4|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1068333|NCT00908037|2590080|P3|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1068334|NCT00908037|2590081|P2|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1068335|NCT00908037|2590082|P1|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
1068336|NCT00908037|2590071|P12|STARTED|Part 2/3(Eltrombopag Open-Label Period)||15
1068411|NCT00908037|2590074|P9|STARTED|Part1 (24 Week Dose-Finding Period)||0
1068337|NCT00908037|2590072|P11|STARTED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|28
1068338|NCT00908037|2590073|P10|STARTED|Part 2/3(Eltrombopag Open-Label Period)||24
1068339|NCT00908037|2590074|P9|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
1068340|NCT00908037|2590075|P8|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
1068341|NCT00908037|2590076|P7|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
1068342|NCT00908037|2590077|P6|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
1068343|NCT00908037|2590078|P5|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
1068344|NCT00908037|2590079|P4|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
1068345|NCT00908037|2590080|P3|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
1068346|NCT00908037|2590081|P2|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
1068347|NCT00908037|2590082|P1|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
1068348|NCT00908037|2590071|P12|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
1068349|NCT00908037|2590072|P11|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
1068350|NCT00908037|2590073|P10|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
1068351|NCT00908037|2590074|P9|NOT COMPLETED|Part 2 (7 Week Randomized Period)||5
1068352|NCT00908037|2590075|P8|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
1068353|NCT00908037|2590076|P7|NOT COMPLETED|Part 2 (7 Week Randomized Period)||4
1068354|NCT00908037|2590077|P6|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
1068355|NCT00908037|2590078|P5|NOT COMPLETED|Part 2 (7 Week Randomized Period)||3
1068356|NCT00908037|2590079|P4|NOT COMPLETED|Part 2 (7 Week Randomized Period)||1
1068357|NCT00908037|2590080|P3|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
1068358|NCT00908037|2590081|P2|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
1068359|NCT00908037|2590082|P1|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
1068360|NCT00908037|2590071|P12|COMPLETED|Part 2 (7 Week Randomized Period)||0
1068361|NCT00908037|2590072|P11|COMPLETED|Part 2 (7 Week Randomized Period)||0
1068362|NCT00908037|2590073|P10|COMPLETED|Part 2 (7 Week Randomized Period)||0
1068363|NCT00908037|2590074|P9|COMPLETED|Part 2 (7 Week Randomized Period)||5
1068364|NCT00908037|2590075|P8|COMPLETED|Part 2 (7 Week Randomized Period)||5
1068365|NCT00908037|2590076|P7|COMPLETED|Part 2 (7 Week Randomized Period)||15
1068366|NCT00908037|2590077|P6|COMPLETED|Part 2 (7 Week Randomized Period)||9
1068367|NCT00908037|2590078|P5|COMPLETED|Part 2 (7 Week Randomized Period)||13
1068368|NCT00908037|2590079|P4|COMPLETED|Part 2 (7 Week Randomized Period)||7
1068369|NCT00908037|2590080|P3|COMPLETED|Part 2 (7 Week Randomized Period)||0
1068370|NCT00908037|2590081|P2|COMPLETED|Part 2 (7 Week Randomized Period)||0
1068371|NCT00908037|2590082|P1|COMPLETED|Part 2 (7 Week Randomized Period)||0
1068372|NCT00908037|2590071|P12|STARTED|Part 2 (7 Week Randomized Period)||0
1068373|NCT00908037|2590072|P11|STARTED|Part 2 (7 Week Randomized Period)||0
1068374|NCT00908037|2590073|P10|STARTED|Part 2 (7 Week Randomized Period)||0
1068375|NCT00908037|2590074|P9|STARTED|Part 2 (7 Week Randomized Period)||10
1068376|NCT00908037|2590075|P8|STARTED|Part 2 (7 Week Randomized Period)||5
1068377|NCT00908037|2590076|P7|STARTED|Part 2 (7 Week Randomized Period)||19
1068378|NCT00908037|2590077|P6|STARTED|Part 2 (7 Week Randomized Period)||9
1068379|NCT00908037|2590078|P5|STARTED|Part 2 (7 Week Randomized Period)||16
1068380|NCT00908037|2590079|P4|STARTED|Part 2 (7 Week Randomized Period)||8
1068381|NCT00908037|2590080|P3|STARTED|Part 2 (7 Week Randomized Period)||0
1068382|NCT00908037|2590081|P2|STARTED|Part 2 (7 Week Randomized Period)||0
1068383|NCT00908037|2590082|P1|STARTED|Part 2 (7 Week Randomized Period)||0
1068384|NCT00908037|2590071|P12|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1068385|NCT00908037|2590072|P11|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1068386|NCT00908037|2590073|P10|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1068387|NCT00908037|2590074|P9|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1068388|NCT00908037|2590075|P8|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1068389|NCT00908037|2590076|P7|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1068390|NCT00908037|2590077|P6|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1068391|NCT00908037|2590078|P5|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1068392|NCT00908037|2590079|P4|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1068393|NCT00908037|2590080|P3|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1068394|NCT00908037|2590081|P2|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1068395|NCT00908037|2590082|P1|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1068396|NCT00908037|2590071|P12|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1068397|NCT00908037|2590072|P11|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1068398|NCT00908037|2590073|P10|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1068399|NCT00908037|2590074|P9|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1068400|NCT00908037|2590075|P8|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1068401|NCT00908037|2590076|P7|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1068402|NCT00908037|2590077|P6|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1068403|NCT00908037|2590078|P5|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1068404|NCT00908037|2590079|P4|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
1068405|NCT00908037|2590080|P3|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
1068406|NCT00908037|2590081|P2|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
1068407|NCT00908037|2590082|P1|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
1068408|NCT00908037|2590071|P12|STARTED|Part1 (24 Week Dose-Finding Period)||0
1068409|NCT00908037|2590072|P11|STARTED|Part1 (24 Week Dose-Finding Period)||0
1068410|NCT00908037|2590073|P10|STARTED|Part1 (24 Week Dose-Finding Period)||0
1068412|NCT00908037|2590075|P8|STARTED|Part1 (24 Week Dose-Finding Period)||0
1068413|NCT00908037|2590076|P7|STARTED|Part1 (24 Week Dose-Finding Period)||0
1068414|NCT00908037|2590077|P6|STARTED|Part1 (24 Week Dose-Finding Period)||0
1068415|NCT00908037|2590078|P5|STARTED|Part1 (24 Week Dose-Finding Period)||0
1068416|NCT00908037|2590079|P4|STARTED|Part1 (24 Week Dose-Finding Period)||0
1068417|NCT00908037|2590080|P3|STARTED|Part1 (24 Week Dose-Finding Period)||5
1068418|NCT00908037|2590081|P2|STARTED|Part1 (24 Week Dose-Finding Period)||5
1068419|NCT00908037|2590082|P1|STARTED|Part1 (24 Week Dose-Finding Period)||5
1068420|NCT00908076|2590231|P2|NOT COMPLETED|Overall Study||1
1068421|NCT00908076|2590232|P1|NOT COMPLETED|Overall Study||1
1068422|NCT00908076|2590231|P2|COMPLETED|Overall Study||26
1068423|NCT00908076|2590232|P1|COMPLETED|Overall Study||26
1068424|NCT00908076|2590231|P2|STARTED|Overall Study||27
1068425|NCT00908076|2590232|P1|STARTED|Overall Study||27
1068426|NCT00908115|2590238|P1|NOT COMPLETED|Overall Study||14
1068427|NCT00908115|2590238|P1|COMPLETED|Overall Study||1244
1068428|NCT00908115|2590238|P1|STARTED|Overall Study||1258
1068429|NCT00908128|2590246|P2|NOT COMPLETED|Period 4||0
1068430|NCT00908128|2590247|P1|NOT COMPLETED|Period 4||0
1068431|NCT00908128|2590246|P2|COMPLETED|Period 4||19
1068432|NCT00908128|2590247|P1|COMPLETED|Period 4||20
1068433|NCT00908128|2590246|P2|STARTED|Period 4|One subject withdrew prior to Period 4 dosing due to adverse events|19
1068434|NCT00908128|2590247|P1|STARTED|Period 4||20
1068435|NCT00908128|2590246|P2|NOT COMPLETED|Period 3||0
1068436|NCT00908128|2590247|P1|NOT COMPLETED|Period 3||0
1068437|NCT00908128|2590246|P2|COMPLETED|Period 3||20
1068438|NCT00908128|2590247|P1|COMPLETED|Period 3||20
1068439|NCT00908128|2590246|P2|STARTED|Period 3||20
1068440|NCT00908128|2590247|P1|STARTED|Period 3||20
1068441|NCT00908128|2590246|P2|NOT COMPLETED|Period 2||0
1068442|NCT00908128|2590247|P1|NOT COMPLETED|Period 2||0
1068443|NCT00908128|2590246|P2|COMPLETED|Period 2||20
1068444|NCT00908128|2590247|P1|COMPLETED|Period 2||20
1068445|NCT00908128|2590246|P2|STARTED|Period 2||20
1068446|NCT00908128|2590247|P1|STARTED|Period 2||20
1068447|NCT00908128|2590246|P2|NOT COMPLETED|Period 1||0
1068448|NCT00908128|2590247|P1|NOT COMPLETED|Period 1||0
1068449|NCT00908128|2590246|P2|COMPLETED|Period 1||20
1068450|NCT00908128|2590247|P1|COMPLETED|Period 1||20
1068451|NCT00908128|2590246|P2|STARTED|Period 1||20
1068452|NCT00908128|2590247|P1|STARTED|Period 1||20
1068453|NCT00908141|2590257|P2|NOT COMPLETED|Overall Study||1
1068454|NCT00908141|2590258|P1|NOT COMPLETED|Overall Study||0
1068455|NCT00908141|2590257|P2|COMPLETED|Overall Study||8
1068456|NCT00908141|2590258|P1|COMPLETED|Overall Study||8
1068457|NCT00908141|2590257|P2|STARTED|Overall Study||9
1068458|NCT00908141|2590258|P1|STARTED|Overall Study||8
1068459|NCT00908232|2590264|P4|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||0
1068460|NCT00908232|2590265|P3|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||1
1068461|NCT00908232|2590266|P2|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||3
1068462|NCT00908232|2590267|P1|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||35
1068463|NCT00908232|2590264|P4|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
1068464|NCT00908232|2590265|P3|COMPLETED|Randomization (Cycle 5) to Cycle 8||7
1068465|NCT00908232|2590266|P2|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
1068466|NCT00908232|2590267|P1|COMPLETED|Randomization (Cycle 5) to Cycle 8||63
1068467|NCT00908232|2590264|P4|STARTED|Randomization (Cycle 5) to Cycle 8||4
1068468|NCT00908232|2590265|P3|STARTED|Randomization (Cycle 5) to Cycle 8||8
1068469|NCT00908232|2590266|P2|STARTED|Randomization (Cycle 5) to Cycle 8||7
1068470|NCT00908232|2590267|P1|STARTED|Randomization (Cycle 5) to Cycle 8|Responding patients (not randomized) who received 4 more cycles of VD|98
1068471|NCT00908232|2590264|P4|NOT COMPLETED|Cycle 1 to 4||0
1068472|NCT00908232|2590265|P3|NOT COMPLETED|Cycle 1 to 4||0
1068473|NCT00908232|2590266|P2|NOT COMPLETED|Cycle 1 to 4||0
1068474|NCT00908232|2590267|P1|NOT COMPLETED|Cycle 1 to 4||28
1068475|NCT00908232|2590264|P4|COMPLETED|Cycle 1 to 4||0
1068476|NCT00908232|2590265|P3|COMPLETED|Cycle 1 to 4||0
1068477|NCT00908232|2590266|P2|COMPLETED|Cycle 1 to 4||0
1068478|NCT00908232|2590267|P1|COMPLETED|Cycle 1 to 4|Of those completed, 120 subjects were assessed for response, 117 w/ Response or SD continued.|135
1068479|NCT00908232|2590264|P4|STARTED|Cycle 1 to 4||0
1068480|NCT00908232|2590265|P3|STARTED|Cycle 1 to 4||0
1068481|NCT00908232|2590266|P2|STARTED|Cycle 1 to 4||0
1068482|NCT00908232|2590267|P1|STARTED|Cycle 1 to 4|All participants started VD treatment for 4 cycles prior to local site response assessments|163
1068483|NCT00908310|2590283|P1|NOT COMPLETED|Overall Study||60
1068484|NCT00908310|2590283|P1|COMPLETED|Overall Study||153
1068485|NCT00908310|2590283|P1|STARTED|Overall Study||213
1068486|NCT00908349|2590287|P1|NOT COMPLETED|Overall Study||35
1068487|NCT00908349|2590287|P1|COMPLETED|Overall Study||179
1068488|NCT00908349|2590287|P1|STARTED|Overall Study||214
1068489|NCT00908375|2590293|P2|NOT COMPLETED|Overall Study||10
1068490|NCT00908375|2590294|P1|NOT COMPLETED|Overall Study||10
1068491|NCT00908375|2590293|P2|COMPLETED|Overall Study||9
1068492|NCT00908375|2590294|P1|COMPLETED|Overall Study||10
1068493|NCT00908375|2590293|P2|STARTED|Overall Study||19
1068494|NCT00908375|2590294|P1|STARTED|Overall Study||20
1068498|NCT00908583|2590312|P1|NOT COMPLETED|Phase 5||3
1068499|NCT00908583|2590312|P1|COMPLETED|Phase 5||2
1068500|NCT00908583|2590312|P1|STARTED|Phase 5||5
1068501|NCT00908583|2590312|P1|NOT COMPLETED|Phase 4||2
1068502|NCT00908583|2590312|P1|COMPLETED|Phase 4||3
1068503|NCT00908583|2590312|P1|STARTED|Phase 4||5
1068504|NCT00908583|2590312|P1|NOT COMPLETED|Phase 3||2
1068505|NCT00908583|2590312|P1|COMPLETED|Phase 3||8
1068506|NCT00908583|2590312|P1|STARTED|Phase 3||10
1068507|NCT00908583|2590312|P1|NOT COMPLETED|Phase 2||2
1068508|NCT00908583|2590312|P1|COMPLETED|Phase 2||10
1068509|NCT00908583|2590312|P1|STARTED|Phase 2||12
1068510|NCT00908583|2590312|P1|NOT COMPLETED|Phase 1||5
1068511|NCT00908583|2590312|P1|COMPLETED|Phase 1||15
1068512|NCT00908583|2590312|P1|STARTED|Phase 1||20
1068513|NCT00908596|2590334|P4|NOT COMPLETED|Overall Study||37
1068514|NCT00908596|2590335|P3|NOT COMPLETED|Overall Study||74
1068515|NCT00908596|2590336|P2|NOT COMPLETED|Overall Study||13
1068516|NCT00908596|2590337|P1|NOT COMPLETED|Overall Study||47
1068517|NCT00908596|2590334|P4|COMPLETED|Overall Study||48
1068518|NCT00908596|2590335|P3|COMPLETED|Overall Study||119
1068519|NCT00908596|2590336|P2|COMPLETED|Overall Study||19
1068520|NCT00908596|2590337|P1|COMPLETED|Overall Study||0
1068521|NCT00908596|2590334|P4|STARTED|Overall Study||85
1068522|NCT00908596|2590335|P3|STARTED|Overall Study||193
1068523|NCT00908596|2590336|P2|STARTED|Overall Study||32
1068524|NCT00908596|2590337|P1|STARTED|Overall Study||47
1068525|NCT00908648|2590369|P2|NOT COMPLETED|Overall Study||0
1068526|NCT00908648|2590370|P1|NOT COMPLETED|Overall Study||0
1068527|NCT00908648|2590369|P2|COMPLETED|Overall Study||103
1068528|NCT00908648|2590370|P1|COMPLETED|Overall Study||108
1068529|NCT00908648|2590369|P2|STARTED|Overall Study||103
1068530|NCT00908648|2590370|P1|STARTED|Overall Study||108
1068531|NCT00908687|2590382|P6|NOT COMPLETED|Overall Study||6
1068532|NCT00908687|2590383|P5|NOT COMPLETED|Overall Study||4
1068533|NCT00908687|2590384|P4|NOT COMPLETED|Overall Study||3
1068534|NCT00908687|2590385|P3|NOT COMPLETED|Overall Study||3
1068535|NCT00908687|2590386|P2|NOT COMPLETED|Overall Study||1
1068536|NCT00908687|2590387|P1|NOT COMPLETED|Overall Study||1
1068537|NCT00908687|2590382|P6|COMPLETED|Overall Study||94
1068538|NCT00908687|2590383|P5|COMPLETED|Overall Study||94
1068539|NCT00908687|2590384|P4|COMPLETED|Overall Study||47
1068540|NCT00908687|2590385|P3|COMPLETED|Overall Study||99
1068541|NCT00908687|2590386|P2|COMPLETED|Overall Study||99
1068542|NCT00908687|2590387|P1|COMPLETED|Overall Study||49
1068543|NCT00908687|2590382|P6|STARTED|Overall Study||100
1068544|NCT00908687|2590383|P5|STARTED|Overall Study||98
1068545|NCT00908687|2590384|P4|STARTED|Overall Study||50
1068546|NCT00908687|2590385|P3|STARTED|Overall Study||102
1068547|NCT00908687|2590386|P2|STARTED|Overall Study||100
1068548|NCT00908687|2590387|P1|STARTED|Overall Study||50
1068549|NCT00908882|2590403|P2|NOT COMPLETED|Overall Study||30
1068550|NCT00908882|2590404|P1|NOT COMPLETED|Overall Study||28
1068551|NCT00908882|2590403|P2|COMPLETED|Overall Study||59
1068552|NCT00908882|2590404|P1|COMPLETED|Overall Study||61
1068553|NCT00908882|2590403|P2|STARTED|Overall Study||89
1068554|NCT00908882|2590404|P1|STARTED|Overall Study||89
1068555|NCT00908895|2590430|P2|NOT COMPLETED|Overall Study||6
1068556|NCT00908895|2590431|P1|NOT COMPLETED|Overall Study||4
1068557|NCT00908895|2590430|P2|COMPLETED|Overall Study||57
1068558|NCT00908895|2590431|P1|COMPLETED|Overall Study||53
1068559|NCT00908895|2590430|P2|STARTED|Overall Study||63
1068560|NCT00908895|2590431|P1|STARTED|Overall Study||57
1068561|NCT00908908|2590439|P1|NOT COMPLETED|Overall Study||0
1068562|NCT00908908|2590439|P1|COMPLETED|Overall Study||6
1068563|NCT00908908|2590439|P1|Physician Decision|Overall Study||0
1068564|NCT00908908|2590439|P1|Administrative/Other|Overall Study||0
1068565|NCT00908908|2590439|P1|Withdrawl by Subject|Overall Study||0
1068566|NCT00908908|2590439|P1|Adverse Event|Overall Study||0
1068567|NCT00908908|2590439|P1|STARTED|Overall Study||6
1068568|NCT00908960|2590448|P3|NOT COMPLETED|Overall Study||2
1068569|NCT00908960|2590449|P2|NOT COMPLETED|Overall Study||1
1068570|NCT00908960|2590450|P1|NOT COMPLETED|Overall Study||1
1068571|NCT00908960|2590448|P3|COMPLETED|Overall Study||32
1068572|NCT00908960|2590449|P2|COMPLETED|Overall Study||11
1068573|NCT00908960|2590450|P1|COMPLETED|Overall Study||23
1068574|NCT00908960|2590448|P3|STARTED|Overall Study||34
1068575|NCT00908960|2590449|P2|STARTED|Overall Study||12
1068576|NCT00908960|2590450|P1|STARTED|Overall Study||24
1068577|NCT00909038|2590458|P1|NOT COMPLETED|Overall Study||417
1068578|NCT00909038|2590458|P1|COMPLETED|Overall Study||1994
1068579|NCT00909038|2590458|P1|STARTED|Overall Study||2411
1068580|NCT00909064|2590467|P1|NOT COMPLETED|Overall Study||0
1068581|NCT00909064|2590467|P1|COMPLETED|Overall Study||114
1068582|NCT00909064|2590467|P1|STARTED|Overall Study||114
1068583|NCT00909155|2590476|P3|NOT COMPLETED|Overall Study||7
1068584|NCT00909155|2590477|P2|NOT COMPLETED|Overall Study||5
1068585|NCT00909155|2590478|P1|NOT COMPLETED|Overall Study||3
1068586|NCT00909155|2590476|P3|COMPLETED|Overall Study||14
1068587|NCT00909155|2590477|P2|COMPLETED|Overall Study||9
1068588|NCT00909155|2590478|P1|COMPLETED|Overall Study||12
1068589|NCT00909155|2590476|P3|STARTED|Overall Study||21
1068590|NCT00909155|2590477|P2|STARTED|Overall Study||14
1068591|NCT00909155|2590478|P1|STARTED|Overall Study||15
1068592|NCT00909181|2590489|P3|NOT COMPLETED|Overall Study||33
1068593|NCT00909181|2590490|P2|NOT COMPLETED|Overall Study||18
1068594|NCT00909181|2590491|P1|NOT COMPLETED|Overall Study||39
1068595|NCT00909181|2590489|P3|COMPLETED|Overall Study||169
1068596|NCT00909181|2590490|P2|COMPLETED|Overall Study||196
1068597|NCT00909181|2590491|P1|COMPLETED|Overall Study||171
1068598|NCT00909181|2590489|P3|STARTED|Overall Study||202
1068599|NCT00909181|2590490|P2|STARTED|Overall Study||214
1068600|NCT00909181|2590491|P1|STARTED|Overall Study||210
1068601|NCT00909324|2590501|P2|NOT COMPLETED|Overall Study||0
1068602|NCT00909324|2590502|P1|NOT COMPLETED|Overall Study||0
1068603|NCT00909324|2590501|P2|COMPLETED|Overall Study||90
1068604|NCT00909324|2590502|P1|COMPLETED|Overall Study||72
1068605|NCT00909324|2590501|P2|STARTED|Overall Study||90
1068606|NCT00909324|2590502|P1|STARTED|Overall Study||72
1068607|NCT00909389|2590512|P1|NOT COMPLETED|Overall Study||133
1068608|NCT00909389|2590512|P1|COMPLETED|Overall Study||4615
1068609|NCT00909389|2590512|P1|STARTED|Overall Study||4748
1068610|NCT00909428|2590519|P3|NOT COMPLETED|Overall Study||9
1068611|NCT00909428|2590520|P2|NOT COMPLETED|Overall Study||10
1068612|NCT00909428|2590521|P1|NOT COMPLETED|Overall Study||13
1068613|NCT00909428|2590519|P3|COMPLETED|Overall Study||0
1068614|NCT00909428|2590520|P2|COMPLETED|Overall Study||5
1068615|NCT00909428|2590521|P1|COMPLETED|Overall Study||5
1068616|NCT00909428|2590519|P3|STARTED|Overall Study||9
1068617|NCT00909428|2590520|P2|STARTED|Overall Study||15
1068618|NCT00909428|2590521|P1|STARTED|Overall Study||18
1068619|NCT00909480|2590530|P2|NOT COMPLETED|Overall Study||41
1068620|NCT00909480|2590531|P1|NOT COMPLETED|Overall Study||38
1068621|NCT00909480|2590530|P2|COMPLETED|Overall Study||188
1068622|NCT00909480|2590531|P1|COMPLETED|Overall Study||190
1068623|NCT00909480|2590530|P2|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|227
1068624|NCT00909480|2590531|P1|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|226
1068625|NCT00909480|2590530|P2|STARTED|Overall Study||229
1068626|NCT00909480|2590531|P1|STARTED|Overall Study||228
1068627|NCT00909532|2590565|P2|NOT COMPLETED|Overall Study||6
1068628|NCT00909532|2590566|P1|NOT COMPLETED|Overall Study||10
1068629|NCT00909532|2590565|P2|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|77
1068630|NCT00909532|2590566|P1|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|68
1068631|NCT00909532|2590565|P2|Completed Treatment Period, Week 24|Overall Study||80
1068632|NCT00909532|2590566|P1|Completed Treatment Period, Week 24|Overall Study||71
1068633|NCT00909532|2590565|P2|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor).|83
1068634|NCT00909532|2590566|P1|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo).|78
1068635|NCT00909545|2590586|P4|NOT COMPLETED|Overall Study||5
1068636|NCT00909545|2590587|P3|NOT COMPLETED|Overall Study||1
1068637|NCT00909545|2590588|P2|NOT COMPLETED|Overall Study||1
1068638|NCT00909545|2590589|P1|NOT COMPLETED|Overall Study||1
1068639|NCT00909545|2590586|P4|COMPLETED|Overall Study||19
1068640|NCT00909545|2590587|P3|COMPLETED|Overall Study||25
1068641|NCT00909545|2590588|P2|COMPLETED|Overall Study||22
1068642|NCT00909545|2590589|P1|COMPLETED|Overall Study||25
1068643|NCT00909545|2590586|P4|STARTED|Overall Study||24
1068644|NCT00909545|2590587|P3|STARTED|Overall Study||26
1068645|NCT00909545|2590588|P2|STARTED|Overall Study||23
1068646|NCT00909545|2590589|P1|STARTED|Overall Study||26
1068647|NCT00909610|2590725|P2|NOT COMPLETED|Period: Second Intervention||0
1068648|NCT00909610|2590726|P1|NOT COMPLETED|Period: Second Intervention||1
1068649|NCT00909610|2590725|P2|COMPLETED|Period: Second Intervention||33
1068650|NCT00909610|2590726|P1|COMPLETED|Period: Second Intervention||36
1068651|NCT00909610|2590725|P2|STARTED|Period: Second Intervention||33
1068652|NCT00909610|2590726|P1|STARTED|Period: Second Intervention||37
1068653|NCT00909610|2590725|P2|NOT COMPLETED|Period: Washout of 28 Days||6
1068654|NCT00909610|2590726|P1|NOT COMPLETED|Period: Washout of 28 Days||3
1068655|NCT00909610|2590725|P2|COMPLETED|Period: Washout of 28 Days||33
1068656|NCT00909610|2590726|P1|COMPLETED|Period: Washout of 28 Days||37
1068657|NCT00909610|2590725|P2|STARTED|Period: Washout of 28 Days||39
1068658|NCT00909610|2590726|P1|STARTED|Period: Washout of 28 Days||40
1068659|NCT00909610|2590725|P2|NOT COMPLETED|Period: First Intervention||1
1068660|NCT00909610|2590726|P1|NOT COMPLETED|Period: First Intervention||0
1068661|NCT00909610|2590725|P2|COMPLETED|Period: First Intervention||39
1068662|NCT00909610|2590726|P1|COMPLETED|Period: First Intervention||40
1068663|NCT00909610|2590725|P2|STARTED|Period: First Intervention||40
1068664|NCT00909610|2590726|P1|STARTED|Period: First Intervention||40
1068665|NCT00909649|2590746|P2|NOT COMPLETED|Overall Study||0
1068666|NCT00909649|2590747|P1|NOT COMPLETED|Overall Study||0
1068667|NCT00909649|2590746|P2|COMPLETED|Overall Study||25
1068668|NCT00909649|2590747|P1|COMPLETED|Overall Study||25
1068669|NCT00909649|2590746|P2|STARTED|Overall Study||25
1068670|NCT00909649|2590747|P1|STARTED|Overall Study||25
1068671|NCT00909727|2590753|P2|NOT COMPLETED|Overall Study||0
1068672|NCT00909727|2590754|P1|NOT COMPLETED|Overall Study||4
1068673|NCT00909727|2590753|P2|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|26
1068674|NCT00909727|2590754|P1|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|22
1068675|NCT00909727|2590753|P2|Completed Treatment Period, Week 24|Overall Study||26
1068676|NCT00909727|2590754|P1|Completed Treatment Period, Week 24|Overall Study||23
1068677|NCT00909727|2590753|P2|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor)|26
1068678|NCT00909727|2590754|P1|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo)|26
1068679|NCT00909753|2590770|P2|NOT COMPLETED|Period: Second Intervention||0
1068680|NCT00909753|2590771|P1|NOT COMPLETED|Period: Second Intervention||1
1068681|NCT00909753|2590770|P2|COMPLETED|Period: Second Intervention||43
1068682|NCT00909753|2590771|P1|COMPLETED|Period: Second Intervention||43
1068683|NCT00909753|2590770|P2|STARTED|Period: Second Intervention||43
1068684|NCT00909753|2590771|P1|STARTED|Period: Second Intervention||44
1068685|NCT00909753|2590770|P2|NOT COMPLETED|Period: Washout of 28 Days||3
1068686|NCT00909753|2590771|P1|NOT COMPLETED|Period: Washout of 28 Days||2
1068687|NCT00909753|2590770|P2|COMPLETED|Period: Washout of 28 Days||43
1068688|NCT00909753|2590771|P1|COMPLETED|Period: Washout of 28 Days||44
1068689|NCT00909753|2590770|P2|STARTED|Period: Washout of 28 Days||46
1068690|NCT00909753|2590771|P1|STARTED|Period: Washout of 28 Days||46
1068691|NCT00909753|2590770|P2|NOT COMPLETED|Period: First Intervention||0
1068692|NCT00909753|2590771|P1|NOT COMPLETED|Period: First Intervention||0
1068693|NCT00909753|2590770|P2|COMPLETED|Period: First Intervention||46
1068694|NCT00909753|2590771|P1|COMPLETED|Period: First Intervention||46
1068695|NCT00909753|2590770|P2|STARTED|Period: First Intervention||46
1068696|NCT00909753|2590771|P1|STARTED|Period: First Intervention||46
1068697|NCT00909779|2590791|P2|NOT COMPLETED|Overall Study||165
1068698|NCT00909779|2590792|P1|NOT COMPLETED|Overall Study||210
1068699|NCT00909779|2590791|P2|COMPLETED|Overall Study|All subjects but 42 were followed for 12 months/until death (whichever was earlier).|255
1068700|NCT00909779|2590792|P1|COMPLETED|Overall Study|All subjects but 47 were followed for 12 months/until death (whichever was earlier).|211
1068701|NCT00909779|2590791|P2|STARTED|Overall Study||420
1068702|NCT00909779|2590792|P1|STARTED|Overall Study||421
1068703|NCT00909792|2590814|P2|NOT COMPLETED|Period 2||1
1068704|NCT00909792|2590815|P1|NOT COMPLETED|Period 2||1
1068705|NCT00909792|2590814|P2|COMPLETED|Period 2||124
1068706|NCT00909792|2590815|P1|COMPLETED|Period 2||128
1068707|NCT00909792|2590814|P2|STARTED|Period 2|Two discontinuations between P1 & P2: 1 for fail inc/exc criteria; 1 for lack of efficacy.|125
1068708|NCT00909792|2590815|P1|STARTED|Period 2|One participant discontinued between Period 1 and Period 2 due to lack of efficacy.|129
1068709|NCT00909792|2590814|P2|NOT COMPLETED|Period 1||1
1068710|NCT00909792|2590815|P1|NOT COMPLETED|Period 1||0
1068711|NCT00909792|2590814|P2|COMPLETED|Period 1||127
1068712|NCT00909792|2590815|P1|COMPLETED|Period 1||130
1068713|NCT00909792|2590814|P2|STARTED|Period 1||128
1068714|NCT00909792|2590815|P1|STARTED|Period 1||130
1068715|NCT00909844|2590821|P1|NOT COMPLETED|Overall Study||4
1068716|NCT00909844|2590821|P1|COMPLETED|Overall Study||31
1068717|NCT00909844|2590821|P1|STARTED|Overall Study||35
1068718|NCT00902304|2590842|P3|NOT COMPLETED|Overall Study||110
1068719|NCT00902304|2590843|P2|NOT COMPLETED|Overall Study||71
1068720|NCT00902304|2590844|P1|NOT COMPLETED|Overall Study||58
1068721|NCT00902304|2590842|P3|COMPLETED|Overall Study||568
1068722|NCT00902304|2590843|P2|COMPLETED|Overall Study||289
1068723|NCT00902304|2590844|P1|COMPLETED|Overall Study||466
1068724|NCT00902304|2590842|P3|STARTED|Overall Study||678
1068725|NCT00902304|2590843|P2|STARTED|Overall Study||360
1068726|NCT00902304|2590844|P1|STARTED|Overall Study||524
1068727|NCT00902330|2590891|P2|NOT COMPLETED|Overall Study||5
1068728|NCT00902330|2590892|P1|NOT COMPLETED|Overall Study||4
1068729|NCT00902330|2590891|P2|COMPLETED|Overall Study||75
1068730|NCT00902330|2590892|P1|COMPLETED|Overall Study||77
1068731|NCT00902330|2590891|P2|STARTED|Overall Study||80
1068732|NCT00902330|2590892|P1|STARTED|Overall Study||81
1068733|NCT00902538|2590929|P6|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||1
1068734|NCT00902538|2590930|P5|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||2
1068735|NCT00902538|2590931|P4|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||9
1068736|NCT00902538|2590932|P3|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
1068737|NCT00902538|2590933|P2|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
1068738|NCT00902538|2590934|P1|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
1068739|NCT00902538|2590929|P6|COMPLETED|4-Randomized Double-blind 2 Treatments||196
1068740|NCT00902538|2590930|P5|COMPLETED|4-Randomized Double-blind 2 Treatments||95
1068741|NCT00902538|2590931|P4|COMPLETED|4-Randomized Double-blind 2 Treatments||458
1068742|NCT00902538|2590932|P3|COMPLETED|4-Randomized Double-blind 2 Treatments||0
1068743|NCT00902538|2590933|P2|COMPLETED|4-Randomized Double-blind 2 Treatments||0
1068744|NCT00902538|2590934|P1|COMPLETED|4-Randomized Double-blind 2 Treatments||0
1068745|NCT00902538|2590929|P6|STARTED|4-Randomized Double-blind 2 Treatments||197
1068746|NCT00902538|2590930|P5|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 non-responders were randomized to OLM 40-AML 10-HCTZ 12.5 or 25 in a 2:1 ratio|97
1068747|NCT00902538|2590931|P4|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 responders were continued on OLM 40-AML 10-HCTZ 12.5|467
1068748|NCT00902538|2590932|P3|STARTED|4-Randomized Double-blind 2 Treatments||0
1068749|NCT00902538|2590933|P2|STARTED|4-Randomized Double-blind 2 Treatments||0
1068750|NCT00902538|2590934|P1|STARTED|4-Randomized Double-blind 2 Treatments||0
1068751|NCT00902538|2590929|P6|NOT COMPLETED|3-Single-blind, Single Treatment||0
1068752|NCT00902538|2590930|P5|NOT COMPLETED|3-Single-blind, Single Treatment||0
1068753|NCT00902538|2590931|P4|NOT COMPLETED|3-Single-blind, Single Treatment||0
1068754|NCT00902538|2590932|P3|NOT COMPLETED|3-Single-blind, Single Treatment||0
1068755|NCT00902538|2590933|P2|NOT COMPLETED|3-Single-blind, Single Treatment||15
1068756|NCT00902538|2590934|P1|NOT COMPLETED|3-Single-blind, Single Treatment||0
1068757|NCT00902538|2590929|P6|COMPLETED|3-Single-blind, Single Treatment||0
1068758|NCT00902538|2590930|P5|COMPLETED|3-Single-blind, Single Treatment||0
1068759|NCT00902538|2590931|P4|COMPLETED|3-Single-blind, Single Treatment||0
1068760|NCT00902538|2590932|P3|COMPLETED|3-Single-blind, Single Treatment||0
1068761|NCT00902538|2590933|P2|COMPLETED|3-Single-blind, Single Treatment||767
1068762|NCT00902538|2590934|P1|COMPLETED|3-Single-blind, Single Treatment||0
1068763|NCT00902538|2590929|P6|STARTED|3-Single-blind, Single Treatment||0
1068764|NCT00902538|2590930|P5|STARTED|3-Single-blind, Single Treatment||0
1068765|NCT00902538|2590931|P4|STARTED|3-Single-blind, Single Treatment||0
1068766|NCT00902538|2590932|P3|STARTED|3-Single-blind, Single Treatment||0
1068767|NCT00902538|2590933|P2|STARTED|3-Single-blind, Single Treatment|Number starting is < total completing previous arm since 3 subjects did not receive at least 1 dose.|782
1068768|NCT00902538|2590934|P1|STARTED|3-Single-blind, Single Treatment||0
1068769|NCT00902538|2590929|P6|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
1068770|NCT00902538|2590930|P5|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
1068771|NCT00902538|2590931|P4|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
1068772|NCT00902538|2590932|P3|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||8
1068773|NCT00902538|2590933|P2|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||6
1068774|NCT00902538|2590934|P1|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||9
1068775|NCT00902538|2590929|P6|COMPLETED|2-Randomized Double-blind 3 Treatments||0
1068776|NCT00902538|2590930|P5|COMPLETED|2-Randomized Double-blind 3 Treatments||0
1068777|NCT00902538|2590931|P4|COMPLETED|2-Randomized Double-blind 3 Treatments||0
1068778|NCT00902538|2590932|P3|COMPLETED|2-Randomized Double-blind 3 Treatments||262
1068779|NCT00902538|2590933|P2|COMPLETED|2-Randomized Double-blind 3 Treatments||263
1068780|NCT00902538|2590934|P1|COMPLETED|2-Randomized Double-blind 3 Treatments||260
1068781|NCT00902538|2590929|P6|STARTED|2-Randomized Double-blind 3 Treatments||0
1068782|NCT00902538|2590930|P5|STARTED|2-Randomized Double-blind 3 Treatments||0
1068783|NCT00902538|2590931|P4|STARTED|2-Randomized Double-blind 3 Treatments||0
1068784|NCT00902538|2590932|P3|STARTED|2-Randomized Double-blind 3 Treatments||270
1068785|NCT00902538|2590933|P2|STARTED|2-Randomized Double-blind 3 Treatments||269
1068786|NCT00902538|2590934|P1|STARTED|2-Randomized Double-blind 3 Treatments|Only 808 began Period 2 because the others finishing Period 1 did not meet the entry criteria.|269
1068787|NCT00902538|2590929|P6|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
1068788|NCT00902538|2590930|P5|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
1068789|NCT00902538|2590931|P4|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
1068790|NCT00902538|2590932|P3|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
1068791|NCT00902538|2590933|P2|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
1068792|NCT00902538|2590934|P1|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||118
1068793|NCT00902538|2590929|P6|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
1068794|NCT00902538|2590930|P5|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
1068795|NCT00902538|2590931|P4|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
1068796|NCT00902538|2590932|P3|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
1068797|NCT00902538|2590933|P2|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
1068798|NCT00902538|2590934|P1|COMPLETED|1-Single-blind, Run-in, Single-Treatment||2086
1068799|NCT00902538|2590929|P6|STARTED|1-Single-blind, Run-in, Single-Treatment||0
1068800|NCT00902538|2590930|P5|STARTED|1-Single-blind, Run-in, Single-Treatment||0
1068801|NCT00902538|2590931|P4|STARTED|1-Single-blind, Run-in, Single-Treatment||0
1068802|NCT00902538|2590932|P3|STARTED|1-Single-blind, Run-in, Single-Treatment||0
1068803|NCT00902538|2590933|P2|STARTED|1-Single-blind, Run-in, Single-Treatment||0
1068804|NCT00902538|2590934|P1|STARTED|1-Single-blind, Run-in, Single-Treatment||2204
1068805|NCT00902564|2590964|P1|NOT COMPLETED|Overall Study||2
1068806|NCT00902564|2590964|P1|COMPLETED|Overall Study||28
1068807|NCT00902564|2590964|P1|STARTED|Overall Study||30
1068808|NCT00909857|2590978|P2|NOT COMPLETED|Overall Study||45
1068809|NCT00909857|2590979|P1|NOT COMPLETED|Overall Study||36
1068810|NCT00909857|2590978|P2|COMPLETED|Overall Study||209
1068811|NCT00909857|2590979|P1|COMPLETED|Overall Study||217
1068812|NCT00909857|2590978|P2|Treated|Overall Study||230
1068813|NCT00909857|2590979|P1|Treated|Overall Study||234
1068814|NCT00909857|2590978|P2|STARTED|Overall Study||254
1068815|NCT00909857|2590979|P1|STARTED|Overall Study||253
1068822|NCT00910000|2591138|P6|NOT COMPLETED|Overall Study||1
1068823|NCT00910000|2591139|P5|NOT COMPLETED|Overall Study||1
1068824|NCT00910000|2591140|P4|NOT COMPLETED|Overall Study||2
1068825|NCT00910000|2591141|P3|NOT COMPLETED|Overall Study||3
1068826|NCT00910000|2591142|P2|NOT COMPLETED|Overall Study||3
1068827|NCT00910000|2591143|P1|NOT COMPLETED|Overall Study||0
1068828|NCT00910000|2591138|P6|COMPLETED|Overall Study||0
1068829|NCT00910000|2591139|P5|COMPLETED|Overall Study||2
1068830|NCT00910000|2591140|P4|COMPLETED|Overall Study||0
1068831|NCT00910000|2591141|P3|COMPLETED|Overall Study||0
1068832|NCT00910000|2591142|P2|COMPLETED|Overall Study||0
1068833|NCT00910000|2591143|P1|COMPLETED|Overall Study||3
1068834|NCT00910000|2591138|P6|STARTED|Overall Study||1
1068835|NCT00910000|2591139|P5|STARTED|Overall Study||3
1068836|NCT00910000|2591140|P4|STARTED|Overall Study||2
1068837|NCT00910000|2591141|P3|STARTED|Overall Study||3
1068838|NCT00910000|2591142|P2|STARTED|Overall Study||3
1068839|NCT00910000|2591143|P1|STARTED|Overall Study||3
1068840|NCT00910039|2591159|P1|NOT COMPLETED|Overall Study||1
1068841|NCT00910039|2591159|P1|COMPLETED|Overall Study||13
1068842|NCT00910039|2591159|P1|STARTED|Overall Study||14
1068843|NCT00910091|2591172|P2|NOT COMPLETED|Treatment and Survival||4
1068844|NCT00910091|2591173|P1|NOT COMPLETED|Treatment and Survival||4
1068845|NCT00910091|2591172|P2|COMPLETED|Treatment and Survival||31
1068846|NCT00910091|2591173|P1|COMPLETED|Treatment and Survival||32
1068847|NCT00910091|2591172|P2|STARTED|Treatment and Survival||35
1068848|NCT00910091|2591173|P1|STARTED|Treatment and Survival||36
1068849|NCT00910091|2591172|P2|NOT COMPLETED|Pre-assignment||2
1068850|NCT00910091|2591173|P1|NOT COMPLETED|Pre-assignment||0
1068851|NCT00910091|2591172|P2|COMPLETED|Pre-assignment||35
1068852|NCT00910091|2591173|P1|COMPLETED|Pre-assignment||36
1068853|NCT00910091|2591172|P2|STARTED|Pre-assignment||37
1068854|NCT00910091|2591173|P1|STARTED|Pre-assignment||36
1068855|NCT00910273|2591203|P2|NOT COMPLETED|Overall Study||13
1068856|NCT00910273|2591204|P1|NOT COMPLETED|Overall Study||18
1068857|NCT00910273|2591203|P2|COMPLETED|Overall Study||3
1068858|NCT00910273|2591204|P1|COMPLETED|Overall Study||0
1068859|NCT00910273|2591203|P2|STARTED|Overall Study||16
1068860|NCT00910273|2591204|P1|STARTED|Overall Study||18
1068861|NCT00910299|2591256|P2|NOT COMPLETED|Overall Study||74
1068862|NCT00910299|2591257|P1|NOT COMPLETED|Overall Study||76
1068863|NCT00910299|2591256|P2|COMPLETED|Overall Study|1 participant died of sepsis while on study drug and was considered a “protocol completer.”|137
1068864|NCT00910299|2591257|P1|COMPLETED|Overall Study||136
1068865|NCT00910299|2591256|P2|Received at Least 1 Dose of Study Drug|Overall Study||210
1068866|NCT00910299|2591257|P1|Received at Least 1 Dose of Study Drug|Overall Study||210
1068867|NCT00910299|2591256|P2|STARTED|Overall Study||211
1068868|NCT00910299|2591257|P1|STARTED|Overall Study||212
1068869|NCT00910520|2591269|P2|NOT COMPLETED|Treatment Cycle 2||8
1068870|NCT00910520|2591270|P1|NOT COMPLETED|Treatment Cycle 2||7
1068871|NCT00910520|2591269|P2|COMPLETED|Treatment Cycle 2||215
1068872|NCT00910520|2591270|P1|COMPLETED|Treatment Cycle 2||156
1068873|NCT00910520|2591269|P2|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|223
1068874|NCT00910520|2591270|P1|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|163
1068875|NCT00910520|2591269|P2|NOT COMPLETED|Treatment Cycle 1||24
1068876|NCT00910520|2591270|P1|NOT COMPLETED|Treatment Cycle 1||20
1068877|NCT00910520|2591269|P2|COMPLETED|Treatment Cycle 1||247
1068878|NCT00910520|2591270|P1|COMPLETED|Treatment Cycle 1||257
1068879|NCT00910520|2591269|P2|STARTED|Treatment Cycle 1||271
1068880|NCT00910520|2591270|P1|STARTED|Treatment Cycle 1||277
1068881|NCT00910624|2591284|P4|NOT COMPLETED|Follow-Up Phase||0
1068882|NCT00910624|2591285|P3|NOT COMPLETED|Follow-Up Phase||4
1068883|NCT00910624|2591286|P2|NOT COMPLETED|Follow-Up Phase||4
1068884|NCT00910624|2591287|P1|NOT COMPLETED|Follow-Up Phase||6
1068885|NCT00910624|2591284|P4|COMPLETED|Follow-Up Phase||2
1068886|NCT00910624|2591285|P3|COMPLETED|Follow-Up Phase||25
1068887|NCT00910624|2591286|P2|COMPLETED|Follow-Up Phase||76
1068888|NCT00910624|2591287|P1|COMPLETED|Follow-Up Phase||42
1068889|NCT00910624|2591284|P4|STARTED|Follow-Up Phase||2
1068890|NCT00910624|2591285|P3|STARTED|Follow-Up Phase||29
1068891|NCT00910624|2591286|P2|STARTED|Follow-Up Phase||80
1068892|NCT00910624|2591287|P1|STARTED|Follow-Up Phase||48
1068893|NCT00910624|2591284|P4|NOT COMPLETED|Treatment Phase||0
1068894|NCT00910624|2591285|P3|NOT COMPLETED|Treatment Phase||9
1068895|NCT00910624|2591286|P2|NOT COMPLETED|Treatment Phase||21
1068896|NCT00910624|2591287|P1|NOT COMPLETED|Treatment Phase||30
1068897|NCT00910624|2591284|P4|COMPLETED|Treatment Phase||2
1068898|NCT00910624|2591285|P3|COMPLETED|Treatment Phase||20
1068899|NCT00910624|2591286|P2|COMPLETED|Treatment Phase||64
1068900|NCT00910624|2591287|P1|COMPLETED|Treatment Phase||22
1068901|NCT00910624|2591284|P4|STARTED|Treatment Phase||2
1068902|NCT00910624|2591285|P3|STARTED|Treatment Phase||29
1068903|NCT00910624|2591286|P2|STARTED|Treatment Phase||85
1068904|NCT00910624|2591287|P1|STARTED|Treatment Phase||52
1068905|NCT00910663|2591301|P2|NOT COMPLETED|Period 2||0
1068906|NCT00910663|2591302|P1|NOT COMPLETED|Period 2||0
1068907|NCT00910663|2591301|P2|COMPLETED|Period 2||29
1068908|NCT00910663|2591302|P1|COMPLETED|Period 2||30
1068909|NCT00910663|2591301|P2|STARTED|Period 2||29
1068910|NCT00910663|2591302|P1|STARTED|Period 2||30
1068911|NCT00910663|2591301|P2|NOT COMPLETED|Period 1||1
1068912|NCT00910663|2591302|P1|NOT COMPLETED|Period 1||0
1068913|NCT00910663|2591301|P2|COMPLETED|Period 1||29
1068914|NCT00910663|2591302|P1|COMPLETED|Period 1||30
1068915|NCT00910663|2591301|P2|STARTED|Period 1||30
1068916|NCT00910663|2591302|P1|STARTED|Period 1||30
1068917|NCT00910689|2591316|P4|NOT COMPLETED|Months 11- 16: Evaluation Period II||6
1068918|NCT00910689|2591317|P3|NOT COMPLETED|Months 11- 16: Evaluation Period II||7
1068919|NCT00910689|2591318|P2|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
1068920|NCT00910689|2591319|P1|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
1068921|NCT00910689|2591316|P4|COMPLETED|Months 11- 16: Evaluation Period II||35
1068922|NCT00910689|2591317|P3|COMPLETED|Months 11- 16: Evaluation Period II||28
1068923|NCT00910689|2591318|P2|COMPLETED|Months 11- 16: Evaluation Period II||25
1068924|NCT00910689|2591319|P1|COMPLETED|Months 11- 16: Evaluation Period II||30
1068925|NCT00910689|2591316|P4|STARTED|Months 11- 16: Evaluation Period II||41
1068926|NCT00910689|2591317|P3|STARTED|Months 11- 16: Evaluation Period II||35
1068927|NCT00910689|2591318|P2|STARTED|Months 11- 16: Evaluation Period II||35
1068928|NCT00910689|2591319|P1|STARTED|Months 11- 16: Evaluation Period II||40
1068929|NCT00910689|2591316|P4|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
1068930|NCT00910689|2591317|P3|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
1068931|NCT00910689|2591318|P2|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
1068932|NCT00910689|2591319|P1|NOT COMPLETED|Months 5 - 10: Evaluation Period I||4
1068933|NCT00910689|2591316|P4|COMPLETED|Months 5 - 10: Evaluation Period I||41
1069183|NCT00911768|2591876|P1|COMPLETED|Overall Study||44
1068934|NCT00910689|2591317|P3|COMPLETED|Months 5 - 10: Evaluation Period I||35
1068935|NCT00910689|2591318|P2|COMPLETED|Months 5 - 10: Evaluation Period I||35
1068936|NCT00910689|2591319|P1|COMPLETED|Months 5 - 10: Evaluation Period I||40
1068937|NCT00910689|2591316|P4|STARTED|Months 5 - 10: Evaluation Period I||48
1068938|NCT00910689|2591317|P3|STARTED|Months 5 - 10: Evaluation Period I||42
1068939|NCT00910689|2591318|P2|STARTED|Months 5 - 10: Evaluation Period I||42
1068940|NCT00910689|2591319|P1|STARTED|Months 5 - 10: Evaluation Period I||44
1068941|NCT00910689|2591316|P4|NOT COMPLETED|Month 2- 4: Treatment Period||11
1068942|NCT00910689|2591317|P3|NOT COMPLETED|Month 2- 4: Treatment Period||8
1068943|NCT00910689|2591318|P2|NOT COMPLETED|Month 2- 4: Treatment Period||10
1068944|NCT00910689|2591319|P1|NOT COMPLETED|Month 2- 4: Treatment Period||9
1068945|NCT00910689|2591316|P4|COMPLETED|Month 2- 4: Treatment Period||48
1068946|NCT00910689|2591317|P3|COMPLETED|Month 2- 4: Treatment Period||42
1068947|NCT00910689|2591318|P2|COMPLETED|Month 2- 4: Treatment Period||42
1068948|NCT00910689|2591319|P1|COMPLETED|Month 2- 4: Treatment Period||44
1068949|NCT00910689|2591316|P4|STARTED|Month 2- 4: Treatment Period||59
1068950|NCT00910689|2591317|P3|STARTED|Month 2- 4: Treatment Period||50
1068951|NCT00910689|2591318|P2|STARTED|Month 2- 4: Treatment Period||52
1068952|NCT00910689|2591319|P1|STARTED|Month 2- 4: Treatment Period||53
1068953|NCT00910689|2591316|P4|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||10
1068954|NCT00910689|2591317|P3|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||5
1068955|NCT00910689|2591318|P2|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||1
1068956|NCT00910689|2591319|P1|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||2
1068957|NCT00910689|2591316|P4|COMPLETED|Month 1: Optimal Acute Therapy Run in||59
1068958|NCT00910689|2591317|P3|COMPLETED|Month 1: Optimal Acute Therapy Run in||50
1068959|NCT00910689|2591318|P2|COMPLETED|Month 1: Optimal Acute Therapy Run in||52
1068960|NCT00910689|2591319|P1|COMPLETED|Month 1: Optimal Acute Therapy Run in||53
1068961|NCT00910689|2591316|P4|STARTED|Month 1: Optimal Acute Therapy Run in||69
1068962|NCT00910689|2591317|P3|STARTED|Month 1: Optimal Acute Therapy Run in||55
1068963|NCT00910689|2591318|P2|STARTED|Month 1: Optimal Acute Therapy Run in||53
1068964|NCT00910689|2591319|P1|STARTED|Month 1: Optimal Acute Therapy Run in||55
1068965|NCT00910715|2591352|P3|NOT COMPLETED|Overall Study||0
1068966|NCT00910715|2591353|P2|NOT COMPLETED|Overall Study||26
1068967|NCT00910715|2591354|P1|NOT COMPLETED|Overall Study||22
1068968|NCT00910715|2591352|P3|COMPLETED|Overall Study||81
1068969|NCT00910715|2591353|P2|COMPLETED|Overall Study||91
1068970|NCT00910715|2591354|P1|COMPLETED|Overall Study||86
1068971|NCT00910715|2591352|P3|STARTED|Overall Study||81
1068972|NCT00910715|2591353|P2|STARTED|Overall Study||117
1068973|NCT00910715|2591354|P1|STARTED|Overall Study||108
1068974|NCT00910728|2591373|P9|NOT COMPLETED|Overall Study||3
1068975|NCT00910728|2591374|P8|NOT COMPLETED|Overall Study||3
1068976|NCT00910728|2591375|P7|NOT COMPLETED|Overall Study||6
1068977|NCT00910728|2591376|P6|NOT COMPLETED|Overall Study||1
1068978|NCT00910728|2591377|P5|NOT COMPLETED|Overall Study||5
1068979|NCT00910728|2591378|P4|NOT COMPLETED|Overall Study||3
1068980|NCT00910728|2591379|P3|NOT COMPLETED|Overall Study||3
1068981|NCT00910728|2591380|P2|NOT COMPLETED|Overall Study||3
1068982|NCT00910728|2591381|P1|NOT COMPLETED|Overall Study||6
1068983|NCT00910728|2591373|P9|COMPLETED|Overall Study||0
1068984|NCT00910728|2591374|P8|COMPLETED|Overall Study||1
1068985|NCT00910728|2591375|P7|COMPLETED|Overall Study||0
1068986|NCT00910728|2591376|P6|COMPLETED|Overall Study||0
1068987|NCT00910728|2591377|P5|COMPLETED|Overall Study||1
1068988|NCT00910728|2591378|P4|COMPLETED|Overall Study||0
1068989|NCT00910728|2591379|P3|COMPLETED|Overall Study||0
1068990|NCT00910728|2591380|P2|COMPLETED|Overall Study||0
1068991|NCT00910728|2591381|P1|COMPLETED|Overall Study||0
1068992|NCT00910728|2591373|P9|STARTED|Overall Study||3
1068993|NCT00910728|2591374|P8|STARTED|Overall Study||4
1068994|NCT00910728|2591375|P7|STARTED|Overall Study||6
1068995|NCT00910728|2591376|P6|STARTED|Overall Study||1
1068996|NCT00910728|2591377|P5|STARTED|Overall Study||6
1068997|NCT00910728|2591378|P4|STARTED|Overall Study||3
1068998|NCT00910728|2591379|P3|STARTED|Overall Study||3
1068999|NCT00910728|2591380|P2|STARTED|Overall Study||3
1069000|NCT00910728|2591381|P1|STARTED|Overall Study||6
1069001|NCT00910845|2591502|P2|NOT COMPLETED|Treatment Cycle 2||9
1069002|NCT00910845|2591503|P1|NOT COMPLETED|Treatment Cycle 2||5
1069003|NCT00910845|2591502|P2|COMPLETED|Treatment Cycle 2||203
1069004|NCT00910845|2591503|P1|COMPLETED|Treatment Cycle 2||136
1069005|NCT00910845|2591502|P2|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|212
1069006|NCT00910845|2591503|P1|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|141
1069007|NCT00910845|2591502|P2|NOT COMPLETED|Treatment Cycle 1||34
1069008|NCT00910845|2591503|P1|NOT COMPLETED|Treatment Cycle 1||31
1069009|NCT00910845|2591502|P2|COMPLETED|Treatment Cycle 1||243
1069010|NCT00910845|2591503|P1|COMPLETED|Treatment Cycle 1||249
1069011|NCT00910845|2591502|P2|STARTED|Treatment Cycle 1||277
1069012|NCT00910845|2591503|P1|STARTED|Treatment Cycle 1||280
1069013|NCT00910858|2591516|P3|NOT COMPLETED|Combined Treatment Phase||4
1069014|NCT00910858|2591517|P2|NOT COMPLETED|Combined Treatment Phase||10
1069015|NCT00910858|2591518|P1|NOT COMPLETED|Combined Treatment Phase||9
1069016|NCT00910858|2591516|P3|COMPLETED|Combined Treatment Phase||0
1069017|NCT00910858|2591517|P2|COMPLETED|Combined Treatment Phase||0
1069018|NCT00910858|2591518|P1|COMPLETED|Combined Treatment Phase||0
1069184|NCT00911768|2591875|P2|STARTED|Overall Study||50
1069019|NCT00910858|2591516|P3|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|4
1069020|NCT00910858|2591517|P2|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|10
1069021|NCT00910858|2591518|P1|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|9
1069022|NCT00910858|2591516|P3|NOT COMPLETED|Monotherapy Phase||7
1069023|NCT00910858|2591517|P2|NOT COMPLETED|Monotherapy Phase||15
1069024|NCT00910858|2591518|P1|NOT COMPLETED|Monotherapy Phase||17
1069025|NCT00910858|2591516|P3|COMPLETED|Monotherapy Phase||0
1069026|NCT00910858|2591517|P2|COMPLETED|Monotherapy Phase||0
1069027|NCT00910858|2591518|P1|COMPLETED|Monotherapy Phase||0
1069028|NCT00910858|2591516|P3|Pharmacokinetic Population|Monotherapy Phase||7
1069029|NCT00910858|2591517|P2|Pharmacokinetic Population|Monotherapy Phase|Patients in the 15 mg Non-del 5q group were not included in the pharmacokinetic assessment.|0
1069030|NCT00910858|2591518|P1|Pharmacokinetic Population|Monotherapy Phase||17
1069031|NCT00910858|2591516|P3|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|7
1069032|NCT00910858|2591517|P2|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|15
1069033|NCT00910858|2591518|P1|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|17
1069034|NCT00910858|2591516|P3|STARTED|Monotherapy Phase|Includes 3 participants from the PK Phase and 4 newly enrolled participants.|7
1069035|NCT00910858|2591517|P2|STARTED|Monotherapy Phase|All 15 participants were newly enrolled into the Monotherapy Phase.|15
1069036|NCT00910858|2591518|P1|STARTED|Monotherapy Phase|Includes 8 participants from the PK Phase and 9 newly enrolled participants.|17
1069037|NCT00910858|2591516|P3|NOT COMPLETED|Pharmacokinetic Phase||0
1069038|NCT00910858|2591517|P2|NOT COMPLETED|Pharmacokinetic Phase||0
1069039|NCT00910858|2591518|P1|NOT COMPLETED|Pharmacokinetic Phase||1
1069040|NCT00910858|2591516|P3|COMPLETED|Pharmacokinetic Phase||3
1069041|NCT00910858|2591517|P2|COMPLETED|Pharmacokinetic Phase||0
1069042|NCT00910858|2591518|P1|COMPLETED|Pharmacokinetic Phase||8
1069043|NCT00910858|2591516|P3|STARTED|Pharmacokinetic Phase||3
1069044|NCT00910858|2591517|P2|STARTED|Pharmacokinetic Phase||0
1069045|NCT00910858|2591518|P1|STARTED|Pharmacokinetic Phase||9
1069046|NCT00910871|2591541|P1|NOT COMPLETED|Overall Study||54
1069047|NCT00910871|2591541|P1|COMPLETED|Overall Study||179
1069048|NCT00910871|2591541|P1|STARTED|Overall Study||233
1069049|NCT00910910|2591548|P2|NOT COMPLETED|Overall Study||224
1069050|NCT00910910|2591549|P1|NOT COMPLETED|Overall Study||225
1069051|NCT00910910|2591548|P2|COMPLETED|Overall Study|Completed includes participants who are continuing with ongoing treatment|1
1069052|NCT00910910|2591549|P1|COMPLETED|Overall Study|Completed includes participants who are continuing with ongoing treatment|0
1069053|NCT00910910|2591548|P2|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|223
1069054|NCT00910910|2591549|P1|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|224
1069055|NCT00910910|2591548|P2|STARTED|Overall Study||225
1069056|NCT00910910|2591549|P1|STARTED|Overall Study||225
1069057|NCT00910988|2591587|P4|NOT COMPLETED|Overall Study||0
1069058|NCT00910988|2591588|P3|NOT COMPLETED|Overall Study||3
1069059|NCT00910988|2591589|P2|NOT COMPLETED|Overall Study||4
1069060|NCT00910988|2591590|P1|NOT COMPLETED|Overall Study||2
1069061|NCT00910988|2591587|P4|COMPLETED|Overall Study||6
1069062|NCT00910988|2591588|P3|COMPLETED|Overall Study||5
1069063|NCT00910988|2591589|P2|COMPLETED|Overall Study||12
1069064|NCT00910988|2591590|P1|COMPLETED|Overall Study||14
1069065|NCT00910988|2591587|P4|STARTED|Overall Study||6
1069066|NCT00910988|2591588|P3|STARTED|Overall Study||8
1069067|NCT00910988|2591589|P2|STARTED|Overall Study||16
1069068|NCT00910988|2591590|P1|STARTED|Overall Study||16
1069069|NCT00911144|2591634|P2|NOT COMPLETED|Overall Study||5
1069070|NCT00911144|2591635|P1|NOT COMPLETED|Overall Study||16
1069071|NCT00911144|2591634|P2|COMPLETED|Overall Study||108
1069072|NCT00911144|2591635|P1|COMPLETED|Overall Study||319
1069073|NCT00911144|2591634|P2|STARTED|Overall Study||113
1069074|NCT00911144|2591635|P1|STARTED|Overall Study||335
1069075|NCT00911157|2591661|P2|NOT COMPLETED|Overall Study||2
1069076|NCT00911157|2591662|P1|NOT COMPLETED|Overall Study||7
1069077|NCT00911157|2591661|P2|COMPLETED|Overall Study||8
1069078|NCT00911157|2591662|P1|COMPLETED|Overall Study||22
1069079|NCT00911157|2591661|P2|STARTED|Overall Study||10
1069080|NCT00911157|2591662|P1|STARTED|Overall Study||29
1069081|NCT00911170|2591678|P2|NOT COMPLETED|Long Term Follow-Up||422
1069082|NCT00911170|2591679|P1|NOT COMPLETED|Long Term Follow-Up||423
1069083|NCT00911170|2591678|P2|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
1069084|NCT00911170|2591679|P1|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
1069085|NCT00911170|2591678|P2|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|422
1069086|NCT00911170|2591679|P1|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|423
1069087|NCT00911170|2591678|P2|NOT COMPLETED|Treatment Period||37
1069088|NCT00911170|2591679|P1|NOT COMPLETED|Treatment Period||27
1069089|NCT00911170|2591678|P2|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|386
1069090|NCT00911170|2591679|P1|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|397
1069091|NCT00911170|2591678|P2|Received Investigational Product|Treatment Period||419
1069092|NCT00911170|2591679|P1|Received Investigational Product|Treatment Period|Includes one participant who received pegfilgrastim in error.|422
1069093|NCT00911170|2591678|P2|Received Bevacizumab|Treatment Period||420
1069094|NCT00911170|2591679|P1|Received Bevacizumab|Treatment Period||423
1069095|NCT00911170|2591678|P2|Received Chemotherapy|Treatment Period|Primary Analysis Set|422
1069096|NCT00911170|2591679|P1|Received Chemotherapy|Treatment Period|Primary Analysis Set|423
1069097|NCT00911170|2591678|P2|STARTED|Treatment Period||423
1069098|NCT00911170|2591679|P1|STARTED|Treatment Period||424
1069099|NCT00911274|2591703|P2|NOT COMPLETED|Period 2||0
1069100|NCT00911274|2591704|P1|NOT COMPLETED|Period 2||0
1069101|NCT00911274|2591703|P2|COMPLETED|Period 2||26
1069102|NCT00911274|2591704|P1|COMPLETED|Period 2||27
1069103|NCT00911274|2591703|P2|STARTED|Period 2||26
1069104|NCT00911274|2591704|P1|STARTED|Period 2||27
1069105|NCT00911274|2591703|P2|NOT COMPLETED|Period 1||0
1069106|NCT00911274|2591704|P1|NOT COMPLETED|Period 1||0
1069107|NCT00911274|2591703|P2|COMPLETED|Period 1||26
1069108|NCT00911274|2591704|P1|COMPLETED|Period 1||27
1069109|NCT00911274|2591703|P2|STARTED|Period 1||26
1069110|NCT00911274|2591704|P1|STARTED|Period 1||27
1069111|NCT00911300|2591714|P2|NOT COMPLETED|Overall Study||43
1069112|NCT00911300|2591715|P1|NOT COMPLETED|Overall Study||35
1069113|NCT00911300|2591714|P2|COMPLETED|Overall Study||131
1069114|NCT00911300|2591715|P1|COMPLETED|Overall Study||140
1069115|NCT00911300|2591714|P2|STARTED|Overall Study||174
1069116|NCT00911300|2591715|P1|STARTED|Overall Study||175
1069117|NCT00911326|2591739|P1|NOT COMPLETED|Overall Study||16
1069118|NCT00911326|2591739|P1|COMPLETED|Overall Study||85
1069119|NCT00911326|2591739|P1|STARTED|Overall Study||101
1069120|NCT00911443|2591751|P5|NOT COMPLETED|Overall Study||0
1069121|NCT00911443|2591752|P4|NOT COMPLETED|Overall Study||0
1069122|NCT00911443|2591753|P3|NOT COMPLETED|Overall Study||0
1069123|NCT00911443|2591754|P2|NOT COMPLETED|Overall Study||0
1069124|NCT00911443|2591755|P1|NOT COMPLETED|Overall Study||0
1069125|NCT00911443|2591751|P5|COMPLETED|Overall Study||97
1069126|NCT00911443|2591752|P4|COMPLETED|Overall Study||99
1069127|NCT00911443|2591753|P3|COMPLETED|Overall Study||98
1069128|NCT00911443|2591754|P2|COMPLETED|Overall Study||97
1069129|NCT00911443|2591755|P1|COMPLETED|Overall Study||97
1069130|NCT00911443|2591751|P5|STARTED|Overall Study||97
1069131|NCT00911443|2591752|P4|STARTED|Overall Study||99
1069132|NCT00911443|2591753|P3|STARTED|Overall Study||98
1069133|NCT00911443|2591754|P2|STARTED|Overall Study||97
1069134|NCT00911443|2591755|P1|STARTED|Overall Study||97
1069135|NCT00911495|2591772|P1|NOT COMPLETED|Overall Study||1
1069136|NCT00911495|2591772|P1|COMPLETED|Overall Study||14
1069137|NCT00911495|2591772|P1|STARTED|Overall Study||15
1069138|NCT00911534|2591782|P2|NOT COMPLETED|Overall Study||16
1069139|NCT00911534|2591783|P1|NOT COMPLETED|Overall Study||15
1069140|NCT00911534|2591782|P2|COMPLETED|Overall Study||137
1069141|NCT00911534|2591783|P1|COMPLETED|Overall Study||132
1069142|NCT00911534|2591782|P2|STARTED|Overall Study|Randomized (treated)|153
1069143|NCT00911534|2591783|P1|STARTED|Overall Study|Randomized (treated)|147
1069144|NCT00911547|2591799|P4|NOT COMPLETED|Overall Study||16
1069145|NCT00911547|2591800|P3|NOT COMPLETED|Overall Study||22
1069146|NCT00911547|2591801|P2|NOT COMPLETED|Overall Study||42
1069147|NCT00911547|2591802|P1|NOT COMPLETED|Overall Study||11
1069148|NCT00911547|2591799|P4|COMPLETED|Overall Study||177
1069149|NCT00911547|2591800|P3|COMPLETED|Overall Study||178
1069150|NCT00911547|2591801|P2|COMPLETED|Overall Study||159
1069151|NCT00911547|2591802|P1|COMPLETED|Overall Study||37
1069152|NCT00911547|2591799|P4|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|193
1069153|NCT00911547|2591800|P3|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|200
1069154|NCT00911547|2591801|P2|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|201
1069155|NCT00911547|2591802|P1|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|48
1069156|NCT00911612|2591830|P2|NOT COMPLETED|Overall Study||0
1069157|NCT00911612|2591831|P1|NOT COMPLETED|Overall Study||0
1069158|NCT00911612|2591830|P2|COMPLETED|Overall Study||12
1069159|NCT00911612|2591831|P1|COMPLETED|Overall Study||12
1069160|NCT00911612|2591830|P2|STARTED|Overall Study||12
1069161|NCT00911612|2591831|P1|STARTED|Overall Study||12
1069162|NCT00911625|2591847|P2|NOT COMPLETED|Overall Study||0
1069163|NCT00911625|2591848|P1|NOT COMPLETED|Overall Study||7
1069164|NCT00911625|2591847|P2|COMPLETED|Overall Study||57
1069165|NCT00911625|2591848|P1|COMPLETED|Overall Study||50
1069166|NCT00911625|2591847|P2|STARTED|Overall Study||57
1069167|NCT00911625|2591848|P1|STARTED|Overall Study||57
1069168|NCT00911742|2591858|P2|NOT COMPLETED|Treatment Phase II||0
1069169|NCT00911742|2591859|P1|NOT COMPLETED|Treatment Phase II||0
1069170|NCT00911742|2591858|P2|COMPLETED|Treatment Phase II||13
1069171|NCT00911742|2591859|P1|COMPLETED|Treatment Phase II||13
1069172|NCT00911742|2591858|P2|STARTED|Treatment Phase II||13
1069173|NCT00911742|2591859|P1|STARTED|Treatment Phase II||13
1069174|NCT00911742|2591858|P2|NOT COMPLETED|Treatment Phase I||0
1069175|NCT00911742|2591859|P1|NOT COMPLETED|Treatment Phase I||0
1069176|NCT00911742|2591858|P2|COMPLETED|Treatment Phase I||13
1069177|NCT00911742|2591859|P1|COMPLETED|Treatment Phase I||13
1069178|NCT00911742|2591858|P2|STARTED|Treatment Phase I||13
1069179|NCT00911742|2591859|P1|STARTED|Treatment Phase I||13
1069180|NCT00911768|2591875|P2|NOT COMPLETED|Overall Study||4
1069181|NCT00911768|2591876|P1|NOT COMPLETED|Overall Study||6
1069182|NCT00911768|2591875|P2|COMPLETED|Overall Study||46
1069185|NCT00911768|2591876|P1|STARTED|Overall Study||50
1069186|NCT00911807|2591889|P3|NOT COMPLETED|Overall Study||23
1069187|NCT00911807|2591890|P2|NOT COMPLETED|Overall Study||18
1069188|NCT00911807|2591891|P1|NOT COMPLETED|Overall Study||17
1069189|NCT00911807|2591889|P3|COMPLETED|Overall Study||52
1069190|NCT00911807|2591890|P2|COMPLETED|Overall Study||52
1069191|NCT00911807|2591891|P1|COMPLETED|Overall Study||55
1069192|NCT00911807|2591889|P3|STARTED|Overall Study||75
1069193|NCT00911807|2591890|P2|STARTED|Overall Study||70
1069194|NCT00911807|2591891|P1|STARTED|Overall Study||72
1069195|NCT00911859|2591902|P3|NOT COMPLETED|Follow-up Period||41
1069196|NCT00911859|2591903|P2|NOT COMPLETED|Follow-up Period||46
1069197|NCT00911859|2591904|P1|NOT COMPLETED|Follow-up Period||11
1069198|NCT00911859|2591902|P3|COMPLETED|Follow-up Period||11
1069199|NCT00911859|2591903|P2|COMPLETED|Follow-up Period||7
1069200|NCT00911859|2591904|P1|COMPLETED|Follow-up Period||1
1069201|NCT00911859|2591902|P3|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|52
1069202|NCT00911859|2591903|P2|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|53
1069203|NCT00911859|2591904|P1|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|12
1069204|NCT00911859|2591902|P3|NOT COMPLETED|Maintainance Period||21
1069205|NCT00911859|2591903|P2|NOT COMPLETED|Maintainance Period||0
1069206|NCT00911859|2591904|P1|NOT COMPLETED|Maintainance Period||0
1069207|NCT00911859|2591902|P3|COMPLETED|Maintainance Period||0
1069208|NCT00911859|2591903|P2|COMPLETED|Maintainance Period||0
1069209|NCT00911859|2591904|P1|COMPLETED|Maintainance Period||0
1069210|NCT00911859|2591902|P3|STARTED|Maintainance Period|Participants who received siltuximab only during the 18-month maintenance period|21
1069211|NCT00911859|2591903|P2|STARTED|Maintainance Period||0
1069212|NCT00911859|2591904|P1|STARTED|Maintainance Period||0
1069213|NCT00911859|2591902|P3|NOT COMPLETED|Treatment Period||25
1069214|NCT00911859|2591903|P2|NOT COMPLETED|Treatment Period||21
1069215|NCT00911859|2591904|P1|NOT COMPLETED|Treatment Period||8
1069216|NCT00911859|2591902|P3|COMPLETED|Treatment Period||27
1069217|NCT00911859|2591903|P2|COMPLETED|Treatment Period||33
1069218|NCT00911859|2591904|P1|COMPLETED|Treatment Period||4
1069219|NCT00911859|2591902|P3|Received Treatment|Treatment Period||52
1069220|NCT00911859|2591903|P2|Received Treatment|Treatment Period||53
1069221|NCT00911859|2591904|P1|Received Treatment|Treatment Period||12
1069222|NCT00911859|2591902|P3|STARTED|Treatment Period||52
1069223|NCT00911859|2591903|P2|STARTED|Treatment Period||54
1069224|NCT00911859|2591904|P1|STARTED|Treatment Period||12
1069225|NCT00911898|2591928|P1|NOT COMPLETED|Overall Study||0
1069226|NCT00911898|2591928|P1|COMPLETED|Overall Study||20
1069227|NCT00911898|2591928|P1|STARTED|Overall Study||20
1069228|NCT00911937|2591934|P2|NOT COMPLETED|Overall Study||95
1069229|NCT00911937|2591935|P1|NOT COMPLETED|Overall Study||87
1069230|NCT00911937|2591934|P2|COMPLETED|Overall Study||381
1069231|NCT00911937|2591935|P1|COMPLETED|Overall Study||400
1069232|NCT00911937|2591934|P2|Treated|Overall Study||463
1069233|NCT00911937|2591935|P1|Treated|Overall Study||474
1069234|NCT00911937|2591934|P2|STARTED|Overall Study||476
1069235|NCT00911937|2591935|P1|STARTED|Overall Study||487
1069236|NCT00911989|2591995|P1|NOT COMPLETED|Overall Study||1
1069237|NCT00911989|2591995|P1|COMPLETED|Overall Study||3
1069238|NCT00911989|2591995|P1|STARTED|Overall Study||4
1069239|NCT00912002|2591999|P1|NOT COMPLETED|Overall Study||0
1069240|NCT00912002|2591999|P1|COMPLETED|Overall Study||6
1069241|NCT00912002|2591999|P1|STARTED|Overall Study||6
1069242|NCT00912015|2592009|P4|NOT COMPLETED|Overall Study||2
1069243|NCT00912015|2592010|P3|NOT COMPLETED|Overall Study||3
1069244|NCT00912015|2592011|P2|NOT COMPLETED|Overall Study||8
1069245|NCT00912015|2592012|P1|NOT COMPLETED|Overall Study||16
1069246|NCT00912015|2592009|P4|COMPLETED|Overall Study||0
1069247|NCT00912015|2592010|P3|COMPLETED|Overall Study||22
1069248|NCT00912015|2592011|P2|COMPLETED|Overall Study||62
1069249|NCT00912015|2592012|P1|COMPLETED|Overall Study||125
1069250|NCT00912015|2592009|P4|STARTED|Overall Study|Two patients took 100 mg against instructions in protocol that the minimum daily dose was 200 mg.|2
1069251|NCT00912015|2592010|P3|STARTED|Overall Study|Dose at which a patient spent the longest time.|25
1069252|NCT00912015|2592011|P2|STARTED|Overall Study|Dose at which a patient spent the longest time.|70
1069253|NCT00912015|2592012|P1|STARTED|Overall Study|Dose at which a patient spent the longest time.|141
1069254|NCT00912028|2592025|P5|NOT COMPLETED|Overall Study||3
1069255|NCT00912028|2592026|P4|NOT COMPLETED|Overall Study||1
1069256|NCT00912028|2592027|P3|NOT COMPLETED|Overall Study||0
1069257|NCT00912028|2592028|P2|NOT COMPLETED|Overall Study||3
1069258|NCT00912028|2592029|P1|NOT COMPLETED|Overall Study||5
1069259|NCT00912028|2592025|P5|COMPLETED|Overall Study||0
1069260|NCT00912028|2592026|P4|COMPLETED|Overall Study||16
1069261|NCT00912028|2592027|P3|COMPLETED|Overall Study||13
1069262|NCT00912028|2592028|P2|COMPLETED|Overall Study||0
1069263|NCT00912028|2592029|P1|COMPLETED|Overall Study||30
1069264|NCT00912028|2592025|P5|STARTED|Overall Study||3
1069265|NCT00912028|2592026|P4|STARTED|Overall Study||17
1069266|NCT00912028|2592027|P3|STARTED|Overall Study||13
1069267|NCT00912028|2592028|P2|STARTED|Overall Study||3
1069268|NCT00912028|2592029|P1|STARTED|Overall Study||35
1069269|NCT00912093|2592059|P5|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
1069270|NCT00912093|2592060|P4|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
1069271|NCT00912093|2592061|P3|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
1069272|NCT00912093|2592062|P2|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
1069273|NCT00912093|2592063|P1|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
1069274|NCT00912093|2592059|P5|COMPLETED|The Open Label Extension (OLE) Phase||4
1069275|NCT00912093|2592060|P4|COMPLETED|The Open Label Extension (OLE) Phase||2
1069276|NCT00912093|2592061|P3|COMPLETED|The Open Label Extension (OLE) Phase||3
1069277|NCT00912093|2592062|P2|COMPLETED|The Open Label Extension (OLE) Phase||35
1069278|NCT00912093|2592063|P1|COMPLETED|The Open Label Extension (OLE) Phase||38
1069279|NCT00912093|2592059|P5|STARTED|The Open Label Extension (OLE) Phase||4
1069280|NCT00912093|2592060|P4|STARTED|The Open Label Extension (OLE) Phase||2
1069281|NCT00912093|2592061|P3|STARTED|The Open Label Extension (OLE) Phase||3
1069282|NCT00912093|2592062|P2|STARTED|The Open Label Extension (OLE) Phase||35
1069283|NCT00912093|2592063|P1|STARTED|The Open Label Extension (OLE) Phase||38
1069284|NCT00912093|2592059|P5|NOT COMPLETED|The Controlled Phase||1
1069285|NCT00912093|2592060|P4|NOT COMPLETED|The Controlled Phase||0
1069286|NCT00912093|2592061|P3|NOT COMPLETED|The Controlled Phase||0
1069287|NCT00912093|2592062|P2|NOT COMPLETED|The Controlled Phase||2
1069288|NCT00912093|2592063|P1|NOT COMPLETED|The Controlled Phase||0
1069289|NCT00912093|2592059|P5|COMPLETED|The Controlled Phase||4
1069290|NCT00912093|2592060|P4|COMPLETED|The Controlled Phase||2
1069291|NCT00912093|2592061|P3|COMPLETED|The Controlled Phase||3
1069292|NCT00912093|2592062|P2|COMPLETED|The Controlled Phase||43
1069293|NCT00912093|2592063|P1|COMPLETED|The Controlled Phase||43
1069294|NCT00912093|2592059|P5|STARTED|The Controlled Phase||5
1069295|NCT00912093|2592060|P4|STARTED|The Controlled Phase||2
1069296|NCT00912093|2592061|P3|STARTED|The Controlled Phase||3
1069297|NCT00912093|2592062|P2|STARTED|The Controlled Phase||45
1069298|NCT00912093|2592063|P1|STARTED|The Controlled Phase||43
1069299|NCT00912158|2592082|P3|NOT COMPLETED|Overall Study||0
1069300|NCT00912158|2592083|P2|NOT COMPLETED|Overall Study||0
1069301|NCT00912158|2592084|P1|NOT COMPLETED|Overall Study||0
1069302|NCT00912158|2592082|P3|COMPLETED|Overall Study||41
1069303|NCT00912158|2592083|P2|COMPLETED|Overall Study||44
1069304|NCT00912158|2592084|P1|COMPLETED|Overall Study||44
1069305|NCT00912158|2592082|P3|STARTED|Overall Study||41
1069306|NCT00912158|2592083|P2|STARTED|Overall Study||44
1069307|NCT00912158|2592084|P1|STARTED|Overall Study||44
1069311|NCT00912288|2592107|P2|NOT COMPLETED|Overall Study||40
1069312|NCT00912288|2592108|P1|NOT COMPLETED|Overall Study||41
1069313|NCT00912288|2592107|P2|COMPLETED|Overall Study||2
1069314|NCT00912288|2592108|P1|COMPLETED|Overall Study||3
1069315|NCT00912288|2592107|P2|STARTED|Overall Study||42
1069316|NCT00912288|2592108|P1|STARTED|Overall Study||44
1069317|NCT00912301|2592133|P3|NOT COMPLETED|Overall Study||0
1069318|NCT00912301|2592134|P2|NOT COMPLETED|Overall Study||0
1069319|NCT00912301|2592135|P1|NOT COMPLETED|Overall Study||0
1069320|NCT00912301|2592133|P3|COMPLETED|Overall Study||13
1069321|NCT00912301|2592134|P2|COMPLETED|Overall Study||12
1069322|NCT00912301|2592135|P1|COMPLETED|Overall Study||11
1069323|NCT00912301|2592133|P3|STARTED|Overall Study||13
1069324|NCT00912301|2592134|P2|STARTED|Overall Study||12
1069325|NCT00912301|2592135|P1|STARTED|Overall Study||11
1069326|NCT00912405|2592155|P1|NOT COMPLETED|Overall Study||5
1069327|NCT00912405|2592155|P1|COMPLETED|Overall Study||45
1069328|NCT00912405|2592155|P1|STARTED|Overall Study||50
1069335|NCT00905515|2592174|P3|NOT COMPLETED|Overall Study||2
1069336|NCT00905515|2592175|P2|NOT COMPLETED|Overall Study||0
1069337|NCT00905515|2592176|P1|NOT COMPLETED|Overall Study||2
1069338|NCT00905515|2592174|P3|COMPLETED|Overall Study||20
1069339|NCT00905515|2592175|P2|COMPLETED|Overall Study||20
1069340|NCT00905515|2592176|P1|COMPLETED|Overall Study||19
1069341|NCT00905515|2592174|P3|STARTED|Overall Study||22
1069342|NCT00905515|2592175|P2|STARTED|Overall Study||20
1069343|NCT00905515|2592176|P1|STARTED|Overall Study||21
1069344|NCT00905554|2592186|P2|NOT COMPLETED|Overall Study||0
1069345|NCT00905554|2592187|P1|NOT COMPLETED|Overall Study||0
1069346|NCT00905554|2592186|P2|COMPLETED|Overall Study||114
1069347|NCT00905554|2592187|P1|COMPLETED|Overall Study||116
1069348|NCT00905554|2592186|P2|STARTED|Overall Study||114
1069349|NCT00905554|2592187|P1|STARTED|Overall Study||116
1069350|NCT00905567|2592197|P2|NOT COMPLETED|Period 2||0
1069351|NCT00905567|2592198|P1|NOT COMPLETED|Period 2||0
1069352|NCT00905567|2592197|P2|COMPLETED|Period 2||11
1069353|NCT00905567|2592198|P1|COMPLETED|Period 2||12
1069354|NCT00905567|2592197|P2|STARTED|Period 2||11
1069355|NCT00905567|2592198|P1|STARTED|Period 2||12
1069356|NCT00905567|2592197|P2|NOT COMPLETED|Washout||1
1069357|NCT00905567|2592198|P1|NOT COMPLETED|Washout||0
1069358|NCT00905567|2592197|P2|COMPLETED|Washout||11
1069359|NCT00905567|2592198|P1|COMPLETED|Washout||12
1069360|NCT00905567|2592197|P2|STARTED|Washout||12
1069361|NCT00905567|2592198|P1|STARTED|Washout||12
1069362|NCT00905567|2592197|P2|NOT COMPLETED|Period 1||0
1069363|NCT00905567|2592198|P1|NOT COMPLETED|Period 1||0
1069364|NCT00905567|2592197|P2|COMPLETED|Period 1||12
1069365|NCT00905567|2592198|P1|COMPLETED|Period 1||12
1069366|NCT00905567|2592197|P2|STARTED|Period 1||12
1069367|NCT00905567|2592198|P1|STARTED|Period 1||12
1069368|NCT00905580|2592208|P2|NOT COMPLETED|Overall Study||3
1069369|NCT00905580|2592209|P1|NOT COMPLETED|Overall Study||2
1069370|NCT00905580|2592208|P2|COMPLETED|Overall Study||47
1069371|NCT00905580|2592209|P1|COMPLETED|Overall Study||47
1069372|NCT00905580|2592208|P2|STARTED|Overall Study||50
1069373|NCT00905580|2592209|P1|STARTED|Overall Study||49
1069374|NCT00905606|2592223|P2|NOT COMPLETED|Period 2||0
1069375|NCT00905606|2592224|P1|NOT COMPLETED|Period 2||0
1069376|NCT00905606|2592223|P2|COMPLETED|Period 2||14
1069377|NCT00905606|2592224|P1|COMPLETED|Period 2||14
1069378|NCT00905606|2592223|P2|STARTED|Period 2||14
1069379|NCT00905606|2592224|P1|STARTED|Period 2||14
1069380|NCT00905606|2592223|P2|NOT COMPLETED|Washout||0
1069381|NCT00905606|2592224|P1|NOT COMPLETED|Washout||1
1069382|NCT00905606|2592223|P2|COMPLETED|Washout||14
1069383|NCT00905606|2592224|P1|COMPLETED|Washout||14
1069384|NCT00905606|2592223|P2|STARTED|Washout||14
1069385|NCT00905606|2592224|P1|STARTED|Washout||15
1069386|NCT00905606|2592223|P2|NOT COMPLETED|Period 1||1
1069387|NCT00905606|2592224|P1|NOT COMPLETED|Period 1||0
1069388|NCT00905606|2592223|P2|COMPLETED|Period 1||14
1069389|NCT00905606|2592224|P1|COMPLETED|Period 1||15
1069390|NCT00905606|2592223|P2|STARTED|Period 1||15
1069391|NCT00905606|2592224|P1|STARTED|Period 1||15
1069392|NCT00905632|2592239|P7|NOT COMPLETED|Overall Study||4
1069393|NCT00905632|2592240|P6|NOT COMPLETED|Overall Study||1
1069394|NCT00905632|2592241|P5|NOT COMPLETED|Overall Study||0
1069395|NCT00905632|2592242|P4|NOT COMPLETED|Overall Study||0
1069396|NCT00905632|2592243|P3|NOT COMPLETED|Overall Study||0
1069397|NCT00905632|2592244|P2|NOT COMPLETED|Overall Study||0
1069398|NCT00905632|2592245|P1|NOT COMPLETED|Overall Study||0
1069399|NCT00905632|2592239|P7|COMPLETED|Overall Study||7
1069400|NCT00905632|2592240|P6|COMPLETED|Overall Study||8
1069401|NCT00905632|2592241|P5|COMPLETED|Overall Study||10
1069402|NCT00905632|2592242|P4|COMPLETED|Overall Study||6
1069403|NCT00905632|2592243|P3|COMPLETED|Overall Study||7
1069404|NCT00905632|2592244|P2|COMPLETED|Overall Study||6
1069405|NCT00905632|2592245|P1|COMPLETED|Overall Study||8
1069406|NCT00905632|2592239|P7|STARTED|Overall Study||11
1069407|NCT00905632|2592240|P6|STARTED|Overall Study||9
1069408|NCT00905632|2592241|P5|STARTED|Overall Study||10
1069409|NCT00905632|2592242|P4|STARTED|Overall Study||6
1069410|NCT00905632|2592243|P3|STARTED|Overall Study||7
1069411|NCT00905632|2592244|P2|STARTED|Overall Study||6
1069412|NCT00905632|2592245|P1|STARTED|Overall Study||8
1069413|NCT00905827|2592384|P3|NOT COMPLETED|Overall Study||0
1069414|NCT00905827|2592385|P2|NOT COMPLETED|Overall Study||0
1069415|NCT00905827|2592386|P1|NOT COMPLETED|Overall Study||0
1069416|NCT00905827|2592384|P3|COMPLETED|Overall Study||73
1069417|NCT00905827|2592385|P2|COMPLETED|Overall Study||69
1069418|NCT00905827|2592386|P1|COMPLETED|Overall Study||70
1069419|NCT00905827|2592384|P3|STARTED|Overall Study||73
1069420|NCT00905827|2592385|P2|STARTED|Overall Study||69
1069421|NCT00905827|2592386|P1|STARTED|Overall Study||70
1069422|NCT00905840|2592396|P1|NOT COMPLETED|Overall Study||16
1069423|NCT00905840|2592396|P1|COMPLETED|Overall Study||75
1069424|NCT00905840|2592396|P1|STARTED|Overall Study||91
1069425|NCT00906035|2592408|P3|NOT COMPLETED|Overall Study||0
1069426|NCT00906035|2592409|P2|NOT COMPLETED|Overall Study||3
1069427|NCT00906035|2592410|P1|NOT COMPLETED|Overall Study||2
1069428|NCT00906035|2592408|P3|COMPLETED|Overall Study||8
1069429|NCT00906035|2592409|P2|COMPLETED|Overall Study|2 subjects Withdrew after Visit 1 and 1 subject Withdrew shortly after Visit 1due to an AE|6
1069430|NCT00906035|2592410|P1|COMPLETED|Overall Study|One Drop-Out; SAE day before Visit 1 and One subject Withrew prior to visit 1|6
1069431|NCT00906035|2592408|P3|STARTED|Overall Study||8
1069432|NCT00906035|2592409|P2|STARTED|Overall Study||9
1069433|NCT00906035|2592410|P1|STARTED|Overall Study||8
1069434|NCT00906074|2592426|P2|NOT COMPLETED|Overall Study||0
1069435|NCT00906074|2592427|P1|NOT COMPLETED|Overall Study||0
1069436|NCT00906074|2592426|P2|COMPLETED|Overall Study||90
1069437|NCT00906074|2592427|P1|COMPLETED|Overall Study||90
1069438|NCT00906074|2592426|P2|STARTED|Overall Study||90
1069439|NCT00906074|2592427|P1|STARTED|Overall Study||90
1069440|NCT00906087|2592451|P1|NOT COMPLETED|Final Washout Period 4 Weeks||0
1069441|NCT00906087|2592451|P1|COMPLETED|Final Washout Period 4 Weeks||12
1069442|NCT00906087|2592451|P1|STARTED|Final Washout Period 4 Weeks||12
1069443|NCT00906087|2592451|P1|NOT COMPLETED|Cosopt Treatment 6 Weeks||0
1069444|NCT00906087|2592451|P1|COMPLETED|Cosopt Treatment 6 Weeks||12
1069445|NCT00906087|2592451|P1|STARTED|Cosopt Treatment 6 Weeks||12
1069446|NCT00906087|2592451|P1|NOT COMPLETED|Initial Washout||2
1069447|NCT00906087|2592451|P1|COMPLETED|Initial Washout||12
1069448|NCT00906087|2592451|P1|Completed Washout and Continue Protocol|Initial Washout||12
1069449|NCT00906087|2592451|P1|Begin Washout|Initial Washout||13
1069450|NCT00906087|2592451|P1|Completed Screening|Initial Washout||14
1069451|NCT00906087|2592451|P1|STARTED|Initial Washout||14
1069452|NCT00906178|2592460|P2|NOT COMPLETED|Overall Study||16
1069453|NCT00906178|2592461|P1|NOT COMPLETED|Overall Study||15
1069454|NCT00906178|2592460|P2|COMPLETED|Overall Study||167
1069455|NCT00906178|2592461|P1|COMPLETED|Overall Study||168
1069456|NCT00906178|2592460|P2|STARTED|Overall Study||183
1069457|NCT00906178|2592461|P1|STARTED|Overall Study||183
1069458|NCT00906204|2592475|P2|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||3
1069459|NCT00906204|2592476|P1|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||2
1069460|NCT00906204|2592475|P2|COMPLETED|Secondary Endpoints (Long-term Safety)||48
1069461|NCT00906204|2592476|P1|COMPLETED|Secondary Endpoints (Long-term Safety)||41
1069462|NCT00906204|2592475|P2|STARTED|Secondary Endpoints (Long-term Safety)||51
1069463|NCT00906204|2592476|P1|STARTED|Secondary Endpoints (Long-term Safety)||43
1069464|NCT00906204|2592475|P2|NOT COMPLETED|Primary Endpoint (Early Safety)||1
1069465|NCT00906204|2592476|P1|NOT COMPLETED|Primary Endpoint (Early Safety)||2
1069466|NCT00906204|2592475|P2|COMPLETED|Primary Endpoint (Early Safety)||51
1069467|NCT00906204|2592476|P1|COMPLETED|Primary Endpoint (Early Safety)||43
1069468|NCT00906204|2592475|P2|STARTED|Primary Endpoint (Early Safety)||52
1069469|NCT00906204|2592476|P1|STARTED|Primary Endpoint (Early Safety)||45
1069470|NCT00906243|2592492|P1|NOT COMPLETED|Overall Study||0
1069471|NCT00906243|2592492|P1|COMPLETED|Overall Study||6
1069472|NCT00906243|2592492|P1|STARTED|Overall Study||6
1069473|NCT00906282|2592496|P1|NOT COMPLETED|Surgical Resection||0
1069474|NCT00906282|2592496|P1|COMPLETED|Surgical Resection||27
1069475|NCT00906282|2592496|P1|STARTED|Surgical Resection||27
1069476|NCT00906282|2592496|P1|NOT COMPLETED|Preoperative Chemotherapy||19
1069477|NCT00906282|2592496|P1|COMPLETED|Preoperative Chemotherapy|2 of 27 patients completed less than 4 cycles and were deemed surgical candidates.|27
1069478|NCT00906282|2592496|P1|STARTED|Preoperative Chemotherapy||46
1069479|NCT00906347|2592506|P2|NOT COMPLETED|Received Study Drug||31
1069480|NCT00906347|2592507|P1|NOT COMPLETED|Received Study Drug||40
1069481|NCT00906347|2592506|P2|COMPLETED|Received Study Drug||143
1069482|NCT00906347|2592507|P1|COMPLETED|Received Study Drug||136
1069483|NCT00906347|2592506|P2|STARTED|Received Study Drug||174
1069484|NCT00906347|2592507|P1|STARTED|Received Study Drug||176
1069485|NCT00906347|2592506|P2|NOT COMPLETED|Randomized||0
1069486|NCT00906347|2592507|P1|NOT COMPLETED|Randomized||0
1069487|NCT00906347|2592506|P2|COMPLETED|Randomized||174
1069488|NCT00906347|2592507|P1|COMPLETED|Randomized||176
1069489|NCT00906347|2592506|P2|STARTED|Randomized||174
1069490|NCT00906347|2592507|P1|STARTED|Randomized||176
1069491|NCT00906399|2592530|P7|NOT COMPLETED|Year 2||29
1069492|NCT00906399|2592531|P6|NOT COMPLETED|Year 2||47
1069493|NCT00906399|2592532|P5|NOT COMPLETED|Year 2||35
1069494|NCT00906399|2592533|P4|NOT COMPLETED|Year 2||30
1069495|NCT00906399|2592534|P3|NOT COMPLETED|Year 2||0
1069496|NCT00906399|2592535|P2|NOT COMPLETED|Year 2||0
1069497|NCT00906399|2592536|P1|NOT COMPLETED|Year 2||0
1069498|NCT00906399|2592530|P7|COMPLETED|Year 2||409
1069499|NCT00906399|2592531|P6|COMPLETED|Year 2||391
1069500|NCT00906399|2592532|P5|COMPLETED|Year 2||193
1069501|NCT00906399|2592533|P4|COMPLETED|Year 2||198
1069502|NCT00906399|2592534|P3|COMPLETED|Year 2||0
1069503|NCT00906399|2592535|P2|COMPLETED|Year 2||0
1069504|NCT00906399|2592536|P1|COMPLETED|Year 2||0
1069505|NCT00906399|2592530|P7|Completed Year 2 Study Treatment|Year 2||411
1069506|NCT00906399|2592531|P6|Completed Year 2 Study Treatment|Year 2||391
1069507|NCT00906399|2592532|P5|Completed Year 2 Study Treatment|Year 2||196
1069508|NCT00906399|2592533|P4|Completed Year 2 Study Treatment|Year 2||200
1069509|NCT00906399|2592534|P3|Completed Year 2 Study Treatment|Year 2||0
1069510|NCT00906399|2592535|P2|Completed Year 2 Study Treatment|Year 2||0
1069511|NCT00906399|2592536|P1|Completed Year 2 Study Treatment|Year 2||0
1069512|NCT00906399|2592530|P7|STARTED|Year 2||438
1069513|NCT00906399|2592531|P6|STARTED|Year 2||438
1069514|NCT00906399|2592532|P5|STARTED|Year 2||228
1069515|NCT00906399|2592533|P4|STARTED|Year 2||228
1069516|NCT00906399|2592534|P3|STARTED|Year 2||0
1069517|NCT00906399|2592535|P2|STARTED|Year 2||0
1069518|NCT00906399|2592536|P1|STARTED|Year 2||0
1069519|NCT00906399|2592530|P7|NOT COMPLETED|Year 1||0
1069520|NCT00906399|2592531|P6|NOT COMPLETED|Year 1||0
1069521|NCT00906399|2592532|P5|NOT COMPLETED|Year 1||0
1069522|NCT00906399|2592533|P4|NOT COMPLETED|Year 1||0
1069523|NCT00906399|2592534|P3|NOT COMPLETED|Year 1||76
1069524|NCT00906399|2592535|P2|NOT COMPLETED|Year 1||63
1069525|NCT00906399|2592536|P1|NOT COMPLETED|Year 1||44
1069526|NCT00906399|2592530|P7|COMPLETED|Year 1||0
1069527|NCT00906399|2592531|P6|COMPLETED|Year 1||0
1069528|NCT00906399|2592532|P5|COMPLETED|Year 1||0
1069529|NCT00906399|2592533|P4|COMPLETED|Year 1||0
1069530|NCT00906399|2592534|P3|COMPLETED|Year 1|1 participant discontinued treatment before end of study period but remained to complete follow-up.|439
1069531|NCT00906399|2592535|P2|COMPLETED|Year 1||438
1069532|NCT00906399|2592536|P1|COMPLETED|Year 1||456
1069533|NCT00906399|2592530|P7|Completed Year 1 Study Treatment|Year 1||0
1069534|NCT00906399|2592531|P6|Completed Year 1 Study Treatment|Year 1||0
1069535|NCT00906399|2592532|P5|Completed Year 1 Study Treatment|Year 1||0
1069536|NCT00906399|2592533|P4|Completed Year 1 Study Treatment|Year 1||0
1069537|NCT00906399|2592534|P3|Completed Year 1 Study Treatment|Year 1||438
1069538|NCT00906399|2592535|P2|Completed Year 1 Study Treatment|Year 1||438
1069539|NCT00906399|2592536|P1|Completed Year 1 Study Treatment|Year 1||456
1069540|NCT00906399|2592530|P7|STARTED|Year 1||0
1069541|NCT00906399|2592531|P6|STARTED|Year 1||0
1069542|NCT00906399|2592532|P5|STARTED|Year 1||0
1069543|NCT00906399|2592533|P4|STARTED|Year 1||0
1069544|NCT00906399|2592534|P3|STARTED|Year 1||515
1069545|NCT00906399|2592535|P2|STARTED|Year 1||501
1069546|NCT00906399|2592536|P1|STARTED|Year 1||500
1069547|NCT00906425|2592559|P2|NOT COMPLETED|Overall Study||72
1069548|NCT00906425|2592560|P1|NOT COMPLETED|Overall Study||73
1069643|NCT00912795|2592802|P2|NOT COMPLETED|Overall Study||58
1069549|NCT00906425|2592559|P2|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
1069550|NCT00906425|2592560|P1|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
1069551|NCT00906425|2592559|P2|2 Year|Overall Study|ITT population|58
1069552|NCT00906425|2592560|P1|2 Year|Overall Study|ITT population|62
1069553|NCT00906425|2592559|P2|1 Year|Overall Study|ITT population|60
1069554|NCT00906425|2592560|P1|1 Year|Overall Study|ITT population|67
1069555|NCT00906425|2592559|P2|6 Months|Overall Study|ITT population|64
1069556|NCT00906425|2592560|P1|6 Months|Overall Study|ITT population|69
1069557|NCT00906425|2592559|P2|STARTED|Overall Study||72
1069558|NCT00906425|2592560|P1|STARTED|Overall Study||73
1069559|NCT00906503|2592570|P1|NOT COMPLETED|Overall Study||0
1069560|NCT00906503|2592570|P1|COMPLETED|Overall Study||9
1069561|NCT00906503|2592570|P1|STARTED|Overall Study||9
1069562|NCT00906698|2592580|P6|NOT COMPLETED|Overall Study||5
1069563|NCT00906698|2592581|P5|NOT COMPLETED|Overall Study||18
1069564|NCT00906698|2592582|P4|NOT COMPLETED|Overall Study||4
1069565|NCT00906698|2592583|P3|NOT COMPLETED|Overall Study||6
1069566|NCT00906698|2592584|P2|NOT COMPLETED|Overall Study||19
1069567|NCT00906698|2592585|P1|NOT COMPLETED|Overall Study||3
1069568|NCT00906698|2592580|P6|COMPLETED|Overall Study||0
1069569|NCT00906698|2592581|P5|COMPLETED|Overall Study||0
1069570|NCT00906698|2592582|P4|COMPLETED|Overall Study||0
1069571|NCT00906698|2592583|P3|COMPLETED|Overall Study||0
1069572|NCT00906698|2592584|P2|COMPLETED|Overall Study||0
1069573|NCT00906698|2592585|P1|COMPLETED|Overall Study||0
1069574|NCT00906698|2592580|P6|STARTED|Overall Study||5
1069575|NCT00906698|2592581|P5|STARTED|Overall Study||18
1069576|NCT00906698|2592582|P4|STARTED|Overall Study||4
1069577|NCT00906698|2592583|P3|STARTED|Overall Study||6
1069578|NCT00906698|2592584|P2|STARTED|Overall Study||19
1069579|NCT00906698|2592585|P1|STARTED|Overall Study||3
1069580|NCT00906776|2592669|P2|NOT COMPLETED|Overall Study||0
1069581|NCT00906776|2592670|P1|NOT COMPLETED|Overall Study||0
1069582|NCT00906776|2592669|P2|COMPLETED|Overall Study||8
1069583|NCT00906776|2592670|P1|COMPLETED|Overall Study||11
1069584|NCT00906776|2592669|P2|STARTED|Overall Study||8
1069585|NCT00906776|2592670|P1|STARTED|Overall Study||11
1069586|NCT00906789|2592686|P1|NOT COMPLETED|Overall Study||0
1069587|NCT00906789|2592686|P1|COMPLETED|Overall Study||15
1069588|NCT00906789|2592686|P1|STARTED|Overall Study|Radiologists served as own control. Total enrollment is 15 radiologists.|15
1069589|NCT00906945|2592699|P6|NOT COMPLETED|Overall Study||2
1069590|NCT00906945|2592700|P5|NOT COMPLETED|Overall Study||1
1069591|NCT00906945|2592701|P4|NOT COMPLETED|Overall Study||1
1069592|NCT00906945|2592702|P3|NOT COMPLETED|Overall Study||0
1069593|NCT00906945|2592703|P2|NOT COMPLETED|Overall Study||0
1069594|NCT00906945|2592704|P1|NOT COMPLETED|Overall Study||0
1069595|NCT00906945|2592699|P6|COMPLETED|Overall Study||14
1069596|NCT00906945|2592700|P5|COMPLETED|Overall Study||6
1069597|NCT00906945|2592701|P4|COMPLETED|Overall Study||6
1069598|NCT00906945|2592702|P3|COMPLETED|Overall Study||3
1069599|NCT00906945|2592703|P2|COMPLETED|Overall Study||3
1069600|NCT00906945|2592704|P1|COMPLETED|Overall Study||3
1069601|NCT00906945|2592699|P6|STARTED|Overall Study||16
1069602|NCT00906945|2592700|P5|STARTED|Overall Study||7
1069603|NCT00906945|2592701|P4|STARTED|Overall Study||7
1069604|NCT00906945|2592702|P3|STARTED|Overall Study||3
1069605|NCT00906945|2592703|P2|STARTED|Overall Study||3
1069606|NCT00906945|2592704|P1|STARTED|Overall Study||3
1069607|NCT00906971|2592733|P2|NOT COMPLETED|Overall Study||3
1069608|NCT00906971|2592734|P1|NOT COMPLETED|Overall Study||8
1069609|NCT00906971|2592733|P2|COMPLETED|Overall Study||33
1069610|NCT00906971|2592734|P1|COMPLETED|Overall Study||28
1069611|NCT00906971|2592733|P2|STARTED|Overall Study||36
1069612|NCT00906971|2592734|P1|STARTED|Overall Study||36
1069613|NCT00907088|2592744|P2|NOT COMPLETED|Overall Study||30
1069614|NCT00907088|2592745|P1|NOT COMPLETED|Overall Study||20
1069615|NCT00907088|2592744|P2|COMPLETED|Overall Study||99
1069616|NCT00907088|2592745|P1|COMPLETED|Overall Study||102
1069617|NCT00907088|2592744|P2|STARTED|Overall Study||129
1069618|NCT00907088|2592745|P1|STARTED|Overall Study||122
1069619|NCT00907101|2592751|P1|NOT COMPLETED|Overall Study||0
1069620|NCT00907101|2592751|P1|COMPLETED|Overall Study||30
1069621|NCT00907101|2592751|P1|STARTED|Overall Study||30
1069625|NCT00907257|2592765|P2|NOT COMPLETED|Overall Study||12
1069626|NCT00907257|2592766|P1|NOT COMPLETED|Overall Study||13
1069627|NCT00907257|2592765|P2|COMPLETED|Overall Study||112
1069628|NCT00907257|2592766|P1|COMPLETED|Overall Study||110
1069629|NCT00907257|2592765|P2|STARTED|Overall Study||124
1069630|NCT00907257|2592766|P1|STARTED|Overall Study||123
1069631|NCT00912743|2592778|P2|NOT COMPLETED|Overall Study||20
1069632|NCT00912743|2592779|P1|NOT COMPLETED|Overall Study||13
1069633|NCT00912743|2592778|P2|COMPLETED|Overall Study||0
1069634|NCT00912743|2592779|P1|COMPLETED|Overall Study||0
1069635|NCT00912743|2592778|P2|STARTED|Overall Study||20
1069636|NCT00912743|2592779|P1|STARTED|Overall Study||13
1069637|NCT00912782|2592791|P2|NOT COMPLETED|Overall Study||5
1069638|NCT00912782|2592792|P1|NOT COMPLETED|Overall Study||3
1069639|NCT00912782|2592791|P2|COMPLETED|Overall Study||20
1069640|NCT00912782|2592792|P1|COMPLETED|Overall Study||24
1069641|NCT00912782|2592791|P2|STARTED|Overall Study||25
1069642|NCT00912782|2592792|P1|STARTED|Overall Study||27
1069644|NCT00912795|2592803|P1|NOT COMPLETED|Overall Study||47
1069645|NCT00912795|2592802|P2|COMPLETED|Overall Study||17
1069646|NCT00912795|2592803|P1|COMPLETED|Overall Study||29
1069647|NCT00912795|2592802|P2|STARTED|Overall Study||75
1069648|NCT00912795|2592803|P1|STARTED|Overall Study||76
1069649|NCT00912808|2592817|P2|NOT COMPLETED|Overall Study||1
1069650|NCT00912808|2592818|P1|NOT COMPLETED|Overall Study||3
1069651|NCT00912808|2592817|P2|COMPLETED|Overall Study||11
1069652|NCT00912808|2592818|P1|COMPLETED|Overall Study||8
1069653|NCT00912808|2592817|P2|STARTED|Overall Study||12
1069654|NCT00912808|2592818|P1|STARTED|Overall Study||11
1069655|NCT00912912|2592826|P1|NOT COMPLETED|Overall Study||4
1069656|NCT00912912|2592826|P1|COMPLETED|Overall Study||1
1069657|NCT00912912|2592826|P1|STARTED|Overall Study||5
1069658|NCT00912925|2592832|P2|NOT COMPLETED|Overall Study||0
1069659|NCT00912925|2592833|P1|NOT COMPLETED|Overall Study||0
1069660|NCT00912925|2592832|P2|COMPLETED|Overall Study||22
1069661|NCT00912925|2592833|P1|COMPLETED|Overall Study||23
1069662|NCT00912925|2592832|P2|STARTED|Overall Study||22
1069663|NCT00912925|2592833|P1|STARTED|Overall Study||23
1069664|NCT00912964|2592854|P3|NOT COMPLETED|Overall Study||54
1069665|NCT00912964|2592855|P2|NOT COMPLETED|Overall Study||46
1069666|NCT00912964|2592856|P1|NOT COMPLETED|Overall Study||66
1069667|NCT00912964|2592854|P3|COMPLETED|Overall Study||386
1069668|NCT00912964|2592855|P2|COMPLETED|Overall Study||387
1069669|NCT00912964|2592856|P1|COMPLETED|Overall Study||367
1069670|NCT00912964|2592854|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|257
1069671|NCT00912964|2592855|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|254
1069672|NCT00912964|2592856|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|262
1069673|NCT00912964|2592854|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|426
1069674|NCT00912964|2592855|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|410
1069675|NCT00912964|2592856|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|415
1069676|NCT00912964|2592854|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|440
1069677|NCT00912964|2592855|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|432
1069678|NCT00912964|2592856|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
1069679|NCT00912964|2592854|P3|STARTED|Overall Study||440
1069680|NCT00912964|2592855|P2|STARTED|Overall Study||433
1069681|NCT00912964|2592856|P1|STARTED|Overall Study||433
1069682|NCT00913003|2592980|P2|NOT COMPLETED|Overall Study||0
1069683|NCT00913003|2592981|P1|NOT COMPLETED|Overall Study||0
1069684|NCT00913003|2592980|P2|COMPLETED|Overall Study||11
1069685|NCT00913003|2592981|P1|COMPLETED|Overall Study||11
1069686|NCT00913003|2592980|P2|STARTED|Overall Study||11
1069687|NCT00913003|2592981|P1|STARTED|Overall Study||11
1069688|NCT00915148|2592991|P1|NOT COMPLETED|Overall Study||0
1069689|NCT00915148|2592991|P1|COMPLETED|Overall Study|August 2010|110
1069690|NCT00915148|2592991|P1|STARTED|Overall Study|October 2009|110
1069691|NCT00915278|2593002|P6|NOT COMPLETED|Overall Study||8
1069692|NCT00915278|2593003|P5|NOT COMPLETED|Overall Study||2
1069693|NCT00915278|2593004|P4|NOT COMPLETED|Overall Study||3
1069694|NCT00915278|2593005|P3|NOT COMPLETED|Overall Study||1
1069695|NCT00915278|2593006|P2|NOT COMPLETED|Overall Study||3
1069696|NCT00915278|2593007|P1|NOT COMPLETED|Overall Study||5
1069697|NCT00915278|2593002|P6|COMPLETED|Overall Study||1
1069698|NCT00915278|2593003|P5|COMPLETED|Overall Study||1
1069699|NCT00915278|2593004|P4|COMPLETED|Overall Study||2
1069700|NCT00915278|2593005|P3|COMPLETED|Overall Study||2
1069701|NCT00915278|2593006|P2|COMPLETED|Overall Study||2
1069702|NCT00915278|2593007|P1|COMPLETED|Overall Study||3
1069703|NCT00915278|2593002|P6|STARTED|Overall Study||9
1069704|NCT00915278|2593003|P5|STARTED|Overall Study||3
1069705|NCT00915278|2593004|P4|STARTED|Overall Study||5
1069706|NCT00915278|2593005|P3|STARTED|Overall Study||3
1069707|NCT00915278|2593006|P2|STARTED|Overall Study||5
1069708|NCT00915278|2593007|P1|STARTED|Overall Study||8
1069709|NCT00915343|2593153|P3|NOT COMPLETED|Part B - Open Label Period||2
1069710|NCT00915343|2593154|P2|NOT COMPLETED|Part B - Open Label Period||0
1069711|NCT00915343|2593155|P1|NOT COMPLETED|Part B - Open Label Period||0
1069712|NCT00915343|2593153|P3|COMPLETED|Part B - Open Label Period||57
1069713|NCT00915343|2593154|P2|COMPLETED|Part B - Open Label Period||0
1069714|NCT00915343|2593155|P1|COMPLETED|Part B - Open Label Period||0
1069715|NCT00915343|2593153|P3|STARTED|Part B - Open Label Period||59
1069716|NCT00915343|2593154|P2|STARTED|Part B - Open Label Period||0
1069717|NCT00915343|2593155|P1|STARTED|Part B - Open Label Period||0
1069718|NCT00915343|2593153|P3|NOT COMPLETED|Part A - Second Intervention Period||0
1069719|NCT00915343|2593154|P2|NOT COMPLETED|Part A - Second Intervention Period||0
1069720|NCT00915343|2593155|P1|NOT COMPLETED|Part A - Second Intervention Period||0
1069721|NCT00915343|2593153|P3|COMPLETED|Part A - Second Intervention Period||0
1069722|NCT00915343|2593154|P2|COMPLETED|Part A - Second Intervention Period||32
1069723|NCT00915343|2593155|P1|COMPLETED|Part A - Second Intervention Period||32
1069724|NCT00915343|2593153|P3|STARTED|Part A - Second Intervention Period||0
1069725|NCT00915343|2593154|P2|STARTED|Part A - Second Intervention Period||32
1069726|NCT00915343|2593155|P1|STARTED|Part A - Second Intervention Period||32
1069727|NCT00915343|2593153|P3|NOT COMPLETED|Part A - First Intervention Period||0
1069728|NCT00915343|2593154|P2|NOT COMPLETED|Part A - First Intervention Period||0
1069729|NCT00915343|2593155|P1|NOT COMPLETED|Part A - First Intervention Period||0
1069730|NCT00915343|2593153|P3|COMPLETED|Part A - First Intervention Period||0
1069731|NCT00915343|2593154|P2|COMPLETED|Part A - First Intervention Period||32
1069732|NCT00915343|2593155|P1|COMPLETED|Part A - First Intervention Period||32
1069733|NCT00915343|2593153|P3|STARTED|Part A - First Intervention Period||0
1069734|NCT00915343|2593154|P2|STARTED|Part A - First Intervention Period||32
1069735|NCT00915343|2593155|P1|STARTED|Part A - First Intervention Period||32
1069736|NCT00915356|2593239|P5|NOT COMPLETED|Overall Study||0
1069737|NCT00915356|2593240|P4|NOT COMPLETED|Overall Study||0
1069738|NCT00915356|2593241|P3|NOT COMPLETED|Overall Study||0
1069739|NCT00915356|2593242|P2|NOT COMPLETED|Overall Study||0
1069740|NCT00915356|2593243|P1|NOT COMPLETED|Overall Study||1
1069741|NCT00915356|2593239|P5|COMPLETED|Overall Study||43
1069742|NCT00915356|2593240|P4|COMPLETED|Overall Study||12
1069743|NCT00915356|2593241|P3|COMPLETED|Overall Study||45
1069744|NCT00915356|2593242|P2|COMPLETED|Overall Study||45
1069745|NCT00915356|2593243|P1|COMPLETED|Overall Study||25
1069746|NCT00915356|2593239|P5|STARTED|Overall Study||43
1069747|NCT00915356|2593240|P4|STARTED|Overall Study||12
1069748|NCT00915356|2593241|P3|STARTED|Overall Study||45
1069749|NCT00915356|2593242|P2|STARTED|Overall Study||45
1069750|NCT00915356|2593243|P1|STARTED|Overall Study||26
1069751|NCT00915473|2593307|P2|NOT COMPLETED|4-week Follow Up||5
1069752|NCT00915473|2593308|P1|NOT COMPLETED|4-week Follow Up||1
1069753|NCT00915473|2593307|P2|COMPLETED|4-week Follow Up||30
1069754|NCT00915473|2593308|P1|COMPLETED|4-week Follow Up||33
1069755|NCT00915473|2593307|P2|STARTED|4-week Follow Up||35
1069756|NCT00915473|2593308|P1|STARTED|4-week Follow Up||34
1069757|NCT00915473|2593307|P2|NOT COMPLETED|Injection||0
1069758|NCT00915473|2593308|P1|NOT COMPLETED|Injection||0
1069759|NCT00915473|2593307|P2|COMPLETED|Injection||35
1069760|NCT00915473|2593308|P1|COMPLETED|Injection||34
1069761|NCT00915473|2593307|P2|STARTED|Injection||35
1069762|NCT00915473|2593308|P1|STARTED|Injection||34
1069763|NCT00915473|2593307|P2|NOT COMPLETED|Screening||0
1069764|NCT00915473|2593308|P1|NOT COMPLETED|Screening||1
1069765|NCT00915473|2593307|P2|COMPLETED|Screening||35
1069766|NCT00915473|2593308|P1|COMPLETED|Screening||34
1069767|NCT00915473|2593307|P2|STARTED|Screening||35
1069768|NCT00915473|2593308|P1|STARTED|Screening||35
1069769|NCT00915499|2593322|P2|NOT COMPLETED|Overall Study||2
1069770|NCT00915499|2593323|P1|NOT COMPLETED|Overall Study||4
1069771|NCT00915499|2593322|P2|COMPLETED|Overall Study||31
1069772|NCT00915499|2593323|P1|COMPLETED|Overall Study||29
1069773|NCT00915499|2593322|P2|STARTED|Overall Study||33
1069774|NCT00915499|2593323|P1|STARTED|Overall Study||33
1069775|NCT00915525|2593333|P2|NOT COMPLETED|Overall Study||135
1069776|NCT00915525|2593334|P1|NOT COMPLETED|Overall Study||265
1069777|NCT00915525|2593333|P2|COMPLETED|Overall Study||151
1069778|NCT00915525|2593334|P1|COMPLETED|Overall Study||278
1069779|NCT00915525|2593333|P2|STARTED|Overall Study||286
1069780|NCT00915525|2593334|P1|STARTED|Overall Study||543
1069781|NCT00915551|2593437|P2|NOT COMPLETED|Overall Study||1
1069782|NCT00915551|2593438|P1|NOT COMPLETED|Overall Study||0
1069783|NCT00915551|2593437|P2|COMPLETED|Overall Study||135
1069784|NCT00915551|2593438|P1|COMPLETED|Overall Study||142
1069785|NCT00915551|2593437|P2|STARTED|Overall Study||136
1069786|NCT00915551|2593438|P1|STARTED|Overall Study||142
1069787|NCT00915590|2593448|P2|NOT COMPLETED|Overall Study||1
1069788|NCT00915590|2593449|P1|NOT COMPLETED|Overall Study||2
1069789|NCT00915590|2593448|P2|COMPLETED|Overall Study||4
1069790|NCT00915590|2593449|P1|COMPLETED|Overall Study||3
1069791|NCT00915590|2593448|P2|STARTED|Overall Study||5
1069792|NCT00915590|2593449|P1|STARTED|Overall Study||5
1069793|NCT00915603|2593468|P2|NOT COMPLETED|Overall Study||55
1069794|NCT00915603|2593469|P1|NOT COMPLETED|Overall Study||56
1069795|NCT00915603|2593468|P2|COMPLETED|Overall Study||0
1069796|NCT00915603|2593469|P1|COMPLETED|Overall Study||0
1069797|NCT00915603|2593468|P2|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|55
1069798|NCT00915603|2593469|P1|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|56
1069799|NCT00915655|2593483|P1|NOT COMPLETED|Overall Study||0
1069800|NCT00915655|2593483|P1|COMPLETED|Overall Study|'Completed' represents patients who have not discontinued at time of cut-off for Week 24 analysis|12
1069801|NCT00915655|2593483|P1|STARTED|Overall Study||12
1069802|NCT00915759|2593488|P1|NOT COMPLETED|Overall Study||0
1069803|NCT00915759|2593488|P1|COMPLETED|Overall Study|number of participants|40
1069804|NCT00915759|2593488|P1|STARTED|Overall Study|number of participants|40
1069805|NCT00915772|2593501|P3|NOT COMPLETED|Overall Study||29
1069806|NCT00915772|2593502|P2|NOT COMPLETED|Overall Study||46
1069807|NCT00915772|2593503|P1|NOT COMPLETED|Overall Study||36
1069808|NCT00915772|2593501|P3|COMPLETED|Overall Study||142
1069809|NCT00915772|2593502|P2|COMPLETED|Overall Study||179
1069810|NCT00915772|2593503|P1|COMPLETED|Overall Study||134
1069811|NCT00915772|2593501|P3|STARTED|Overall Study||171
1069812|NCT00915772|2593502|P2|STARTED|Overall Study||225
1069813|NCT00915772|2593503|P1|STARTED|Overall Study||170
1069814|NCT00915798|2593552|P4|NOT COMPLETED|Overall Study||0
1069815|NCT00915798|2593553|P3|NOT COMPLETED|Overall Study||0
1069816|NCT00915798|2593554|P2|NOT COMPLETED|Overall Study||0
1069817|NCT00915798|2593555|P1|NOT COMPLETED|Overall Study||0
1069818|NCT00915798|2593552|P4|COMPLETED|Overall Study||26
1069819|NCT00915798|2593553|P3|COMPLETED|Overall Study||23
1069820|NCT00915798|2593554|P2|COMPLETED|Overall Study||21
1069821|NCT00915798|2593555|P1|COMPLETED|Overall Study||19
1069822|NCT00915798|2593552|P4|STARTED|Overall Study||26
1069823|NCT00915798|2593553|P3|STARTED|Overall Study||23
1069824|NCT00915798|2593554|P2|STARTED|Overall Study||21
1069825|NCT00915798|2593555|P1|STARTED|Overall Study||19
1069826|NCT00915876|2593577|P2|NOT COMPLETED|Overall Study||1
1069827|NCT00915876|2593578|P1|NOT COMPLETED|Overall Study||0
1069828|NCT00915876|2593577|P2|COMPLETED|Overall Study||20
1069829|NCT00915876|2593578|P1|COMPLETED|Overall Study||20
1069830|NCT00915876|2593577|P2|Moving Beyond First Dose|Overall Study||20
1069831|NCT00915876|2593578|P1|Moving Beyond First Dose|Overall Study||20
1069832|NCT00915876|2593577|P2|STARTED|Overall Study||21
1069833|NCT00915876|2593578|P1|STARTED|Overall Study||20
1069834|NCT00915902|2593586|P2|NOT COMPLETED|2nd Treatment Period||1
1069835|NCT00915902|2593587|P1|NOT COMPLETED|2nd Treatment Period||0
1069836|NCT00915902|2593586|P2|COMPLETED|2nd Treatment Period||20
1069837|NCT00915902|2593587|P1|COMPLETED|2nd Treatment Period||19
1069838|NCT00915902|2593586|P2|STARTED|2nd Treatment Period||21
1069839|NCT00915902|2593587|P1|STARTED|2nd Treatment Period||19
1069840|NCT00915902|2593586|P2|NOT COMPLETED|Washout (4 Weeks)||1
1069841|NCT00915902|2593587|P1|NOT COMPLETED|Washout (4 Weeks)||0
1069842|NCT00915902|2593586|P2|COMPLETED|Washout (4 Weeks)||21
1069843|NCT00915902|2593587|P1|COMPLETED|Washout (4 Weeks)||19
1069844|NCT00915902|2593586|P2|STARTED|Washout (4 Weeks)||22
1069845|NCT00915902|2593587|P1|STARTED|Washout (4 Weeks)||19
1069846|NCT00915902|2593586|P2|NOT COMPLETED|1st Treatment Period||0
1069847|NCT00915902|2593587|P1|NOT COMPLETED|1st Treatment Period||1
1069848|NCT00915902|2593586|P2|COMPLETED|1st Treatment Period||22
1069849|NCT00915902|2593587|P1|COMPLETED|1st Treatment Period||19
1069850|NCT00915902|2593586|P2|STARTED|1st Treatment Period||22
1069851|NCT00915902|2593587|P1|STARTED|1st Treatment Period||20
1069852|NCT00916006|2593597|P2|NOT COMPLETED|Overall Study||7
1069853|NCT00916006|2593598|P1|NOT COMPLETED|Overall Study||3
1069854|NCT00916006|2593597|P2|COMPLETED|Overall Study||127
1069855|NCT00916006|2593598|P1|COMPLETED|Overall Study||132
1069856|NCT00916006|2593597|P2|STARTED|Overall Study||134
1069857|NCT00916006|2593598|P1|STARTED|Overall Study||135
1069858|NCT00916032|2593606|P2|NOT COMPLETED|Overall Study||0
1069859|NCT00916032|2593607|P1|NOT COMPLETED|Overall Study||0
1069860|NCT00916032|2593606|P2|COMPLETED|Overall Study||11
1069861|NCT00916032|2593607|P1|COMPLETED|Overall Study||12
1069862|NCT00916032|2593606|P2|STARTED|Overall Study||11
1069863|NCT00916032|2593607|P1|STARTED|Overall Study||12
1069864|NCT00916136|2593649|P2|NOT COMPLETED|Overall Study||0
1069865|NCT00916136|2593650|P1|NOT COMPLETED|Overall Study||0
1069866|NCT00916136|2593649|P2|COMPLETED|Overall Study||29
1069867|NCT00916136|2593650|P1|COMPLETED|Overall Study||37
1069868|NCT00916136|2593649|P2|STARTED|Overall Study||29
1069869|NCT00916136|2593650|P1|STARTED|Overall Study||37
1069870|NCT00916279|2593658|P1|NOT COMPLETED|Overall Study||4
1069871|NCT00916279|2593658|P1|COMPLETED|Overall Study||37
1069872|NCT00916279|2593658|P1|24 Months|Overall Study||37
1069873|NCT00916279|2593658|P1|6 Months|Overall Study||41
1069874|NCT00916279|2593658|P1|30 Days|Overall Study||41
1069875|NCT00916279|2593658|P1|STARTED|Overall Study||41
1069876|NCT00916305|2593668|P2|NOT COMPLETED|Overall Study||28
1069877|NCT00916305|2593669|P1|NOT COMPLETED|Overall Study||21
1069878|NCT00916305|2593668|P2|COMPLETED|Overall Study||9
1069879|NCT00916305|2593669|P1|COMPLETED|Overall Study||7
1069880|NCT00916305|2593668|P2|STARTED|Overall Study||37
1069881|NCT00916305|2593669|P1|STARTED|Overall Study||28
1069882|NCT00916344|2593677|P1|NOT COMPLETED|Overall Study||8
1069883|NCT00916344|2593677|P1|COMPLETED|Overall Study||167
1069884|NCT00916344|2593677|P1|STARTED|Overall Study||175
1069885|NCT00916357|2593682|P6|NOT COMPLETED|Period 3||0
1069886|NCT00916357|2593683|P5|NOT COMPLETED|Period 3||0
1069887|NCT00916357|2593684|P4|NOT COMPLETED|Period 3||0
1069888|NCT00916357|2593685|P3|NOT COMPLETED|Period 3||0
1069889|NCT00916357|2593686|P2|NOT COMPLETED|Period 3||0
1069890|NCT00916357|2593687|P1|NOT COMPLETED|Period 3||0
1069891|NCT00916357|2593682|P6|COMPLETED|Period 3||4
1069892|NCT00916357|2593683|P5|COMPLETED|Period 3||3
1069893|NCT00916357|2593684|P4|COMPLETED|Period 3||3
1069894|NCT00916357|2593685|P3|COMPLETED|Period 3||4
1069895|NCT00916357|2593686|P2|COMPLETED|Period 3||4
1069896|NCT00916357|2593687|P1|COMPLETED|Period 3||3
1069897|NCT00916357|2593682|P6|STARTED|Period 3||4
1069898|NCT00916357|2593683|P5|STARTED|Period 3||3
1069899|NCT00916357|2593684|P4|STARTED|Period 3||3
1069900|NCT00916357|2593685|P3|STARTED|Period 3||4
1069901|NCT00916357|2593686|P2|STARTED|Period 3||4
1069902|NCT00916357|2593687|P1|STARTED|Period 3||3
1069903|NCT00916357|2593682|P6|NOT COMPLETED|Washout (3 to 14 Days)||0
1069904|NCT00916357|2593683|P5|NOT COMPLETED|Washout (3 to 14 Days)||0
1069905|NCT00916357|2593684|P4|NOT COMPLETED|Washout (3 to 14 Days)||0
1069906|NCT00916357|2593685|P3|NOT COMPLETED|Washout (3 to 14 Days)||0
1069907|NCT00916357|2593686|P2|NOT COMPLETED|Washout (3 to 14 Days)||0
1069908|NCT00916357|2593687|P1|NOT COMPLETED|Washout (3 to 14 Days)||0
1069909|NCT00916357|2593682|P6|COMPLETED|Washout (3 to 14 Days)||4
1069910|NCT00916357|2593683|P5|COMPLETED|Washout (3 to 14 Days)||3
1069911|NCT00916357|2593684|P4|COMPLETED|Washout (3 to 14 Days)||3
1069912|NCT00916357|2593685|P3|COMPLETED|Washout (3 to 14 Days)||4
1069913|NCT00916357|2593686|P2|COMPLETED|Washout (3 to 14 Days)||4
1069914|NCT00916357|2593687|P1|COMPLETED|Washout (3 to 14 Days)||3
1069915|NCT00916357|2593682|P6|STARTED|Washout (3 to 14 Days)||4
1069916|NCT00916357|2593683|P5|STARTED|Washout (3 to 14 Days)||3
1069917|NCT00916357|2593684|P4|STARTED|Washout (3 to 14 Days)||3
1069918|NCT00916357|2593685|P3|STARTED|Washout (3 to 14 Days)||4
1069919|NCT00916357|2593686|P2|STARTED|Washout (3 to 14 Days)||4
1069920|NCT00916357|2593687|P1|STARTED|Washout (3 to 14 Days)||3
1069921|NCT00916357|2593682|P6|NOT COMPLETED|Period 2||0
1069922|NCT00916357|2593683|P5|NOT COMPLETED|Period 2||0
1069923|NCT00916357|2593684|P4|NOT COMPLETED|Period 2||1
1069924|NCT00916357|2593685|P3|NOT COMPLETED|Period 2||0
1069925|NCT00916357|2593686|P2|NOT COMPLETED|Period 2||0
1069926|NCT00916357|2593687|P1|NOT COMPLETED|Period 2||0
1069927|NCT00916357|2593682|P6|COMPLETED|Period 2||4
1069928|NCT00916357|2593683|P5|COMPLETED|Period 2||3
1069929|NCT00916357|2593684|P4|COMPLETED|Period 2||3
1069930|NCT00916357|2593685|P3|COMPLETED|Period 2||4
1069931|NCT00916357|2593686|P2|COMPLETED|Period 2||4
1069932|NCT00916357|2593687|P1|COMPLETED|Period 2||3
1069933|NCT00916357|2593682|P6|STARTED|Period 2||4
1069934|NCT00916357|2593683|P5|STARTED|Period 2||3
1069935|NCT00916357|2593684|P4|STARTED|Period 2||4
1069936|NCT00916357|2593685|P3|STARTED|Period 2||4
1069937|NCT00916357|2593686|P2|STARTED|Period 2||4
1069938|NCT00916357|2593687|P1|STARTED|Period 2||3
1069939|NCT00916357|2593682|P6|NOT COMPLETED|Washout (3 to 14 Days)||0
1069940|NCT00916357|2593683|P5|NOT COMPLETED|Washout (3 to 14 Days)||0
1069941|NCT00916357|2593684|P4|NOT COMPLETED|Washout (3 to 14 Days)||0
1069942|NCT00916357|2593685|P3|NOT COMPLETED|Washout (3 to 14 Days)||0
1069943|NCT00916357|2593686|P2|NOT COMPLETED|Washout (3 to 14 Days)||0
1069944|NCT00916357|2593687|P1|NOT COMPLETED|Washout (3 to 14 Days)||0
1069945|NCT00916357|2593682|P6|COMPLETED|Washout (3 to 14 Days)||4
1069946|NCT00916357|2593683|P5|COMPLETED|Washout (3 to 14 Days)||3
1069947|NCT00916357|2593684|P4|COMPLETED|Washout (3 to 14 Days)||4
1069948|NCT00916357|2593685|P3|COMPLETED|Washout (3 to 14 Days)||4
1069949|NCT00916357|2593686|P2|COMPLETED|Washout (3 to 14 Days)||4
1069950|NCT00916357|2593687|P1|COMPLETED|Washout (3 to 14 Days)||3
1069951|NCT00916357|2593682|P6|STARTED|Washout (3 to 14 Days)||4
1069952|NCT00916357|2593683|P5|STARTED|Washout (3 to 14 Days)||3
1069953|NCT00916357|2593684|P4|STARTED|Washout (3 to 14 Days)||4
1069954|NCT00916357|2593685|P3|STARTED|Washout (3 to 14 Days)||4
1069955|NCT00916357|2593686|P2|STARTED|Washout (3 to 14 Days)||4
1069956|NCT00916357|2593687|P1|STARTED|Washout (3 to 14 Days)||3
1069957|NCT00916357|2593682|P6|NOT COMPLETED|Period 1||0
1069958|NCT00916357|2593683|P5|NOT COMPLETED|Period 1||0
1069959|NCT00916357|2593684|P4|NOT COMPLETED|Period 1||0
1069960|NCT00916357|2593685|P3|NOT COMPLETED|Period 1||0
1069961|NCT00916357|2593686|P2|NOT COMPLETED|Period 1||0
1069962|NCT00916357|2593687|P1|NOT COMPLETED|Period 1||1
1069963|NCT00916357|2593682|P6|COMPLETED|Period 1||4
1069964|NCT00916357|2593683|P5|COMPLETED|Period 1||3
1069965|NCT00916357|2593684|P4|COMPLETED|Period 1||4
1069966|NCT00916357|2593685|P3|COMPLETED|Period 1||4
1069967|NCT00916357|2593686|P2|COMPLETED|Period 1||4
1069968|NCT00916357|2593687|P1|COMPLETED|Period 1||3
1069969|NCT00916357|2593682|P6|Received at Least 1 Dose of Study Drug|Period 1||4
1069970|NCT00916357|2593683|P5|Received at Least 1 Dose of Study Drug|Period 1||3
1069971|NCT00916357|2593684|P4|Received at Least 1 Dose of Study Drug|Period 1||4
1069972|NCT00916357|2593685|P3|Received at Least 1 Dose of Study Drug|Period 1||4
1069973|NCT00916357|2593686|P2|Received at Least 1 Dose of Study Drug|Period 1||4
1069974|NCT00916357|2593687|P1|Received at Least 1 Dose of Study Drug|Period 1||4
1069975|NCT00916357|2593682|P6|STARTED|Period 1||4
1069976|NCT00916357|2593683|P5|STARTED|Period 1||3
1069977|NCT00916357|2593684|P4|STARTED|Period 1||4
1069978|NCT00916357|2593685|P3|STARTED|Period 1||4
1069979|NCT00916357|2593686|P2|STARTED|Period 1||4
1069980|NCT00916357|2593687|P1|STARTED|Period 1||4
1069981|NCT00916370|2593727|P2|NOT COMPLETED|Overall Study||2
1069982|NCT00916370|2593728|P1|NOT COMPLETED|Overall Study||5
1069983|NCT00916370|2593727|P2|COMPLETED|Overall Study||102
1069984|NCT00916370|2593728|P1|COMPLETED|Overall Study||396
1069985|NCT00916370|2593727|P2|STARTED|Overall Study||104
1069986|NCT00916370|2593728|P1|STARTED|Overall Study||401
1069987|NCT00916383|2593902|P1|NOT COMPLETED|Overall Study||3
1069988|NCT00916383|2593902|P1|COMPLETED|Overall Study||46
1069989|NCT00916383|2593902|P1|STARTED|Overall Study||49
1069990|NCT00916539|2593930|P2|NOT COMPLETED|Overall Study||0
1069991|NCT00916539|2593931|P1|NOT COMPLETED|Overall Study||0
1069992|NCT00916539|2593930|P2|COMPLETED|Overall Study||31
1069993|NCT00916539|2593931|P1|COMPLETED|Overall Study||31
1069994|NCT00916539|2593930|P2|STARTED|Overall Study||31
1069995|NCT00916539|2593931|P1|STARTED|Overall Study||31
1069996|NCT00916617|2593957|P4|NOT COMPLETED|Overall Study||7
1069997|NCT00916617|2593958|P3|NOT COMPLETED|Overall Study||10
1069998|NCT00916617|2593959|P2|NOT COMPLETED|Overall Study||21
1069999|NCT00916617|2593960|P1|NOT COMPLETED|Overall Study||23
1070000|NCT00916617|2593957|P4|COMPLETED|Overall Study||0
1070001|NCT00916617|2593958|P3|COMPLETED|Overall Study||0
1070002|NCT00916617|2593959|P2|COMPLETED|Overall Study||0
1070003|NCT00916617|2593960|P1|COMPLETED|Overall Study||1
1070004|NCT00916617|2593957|P4|STARTED|Overall Study||7
1070005|NCT00916617|2593958|P3|STARTED|Overall Study||10
1070006|NCT00916617|2593959|P2|STARTED|Overall Study||21
1070007|NCT00916617|2593960|P1|STARTED|Overall Study||24
1070008|NCT00916643|2593974|P1|NOT COMPLETED|Overall Study||0
1070009|NCT00916643|2593974|P1|COMPLETED|Overall Study||113
1070010|NCT00916643|2593974|P1|STARTED|Overall Study||113
1070011|NCT00916721|2593983|P2|NOT COMPLETED|Overall Study||10
1070012|NCT00916721|2593984|P1|NOT COMPLETED|Overall Study||10
1070013|NCT00916721|2593983|P2|COMPLETED|Overall Study||29
1070014|NCT00916721|2593984|P1|COMPLETED|Overall Study||25
1070015|NCT00916721|2593983|P2|STARTED|Overall Study||39
1070016|NCT00916721|2593984|P1|STARTED|Overall Study||35
1070017|NCT00916929|2593998|P2|NOT COMPLETED|Overall Study||29
1070018|NCT00916929|2593999|P1|NOT COMPLETED|Overall Study||10
1070019|NCT00916929|2593998|P2|COMPLETED|Overall Study||53
1070020|NCT00916929|2593999|P1|COMPLETED|Overall Study||70
1070021|NCT00916929|2593998|P2|STARTED|Overall Study||82
1070022|NCT00916929|2593999|P1|STARTED|Overall Study||80
1070023|NCT00917124|2594009|P2|NOT COMPLETED|Overall Study||6
1070024|NCT00917124|2594010|P1|NOT COMPLETED|Overall Study||4
1070025|NCT00917124|2594009|P2|COMPLETED|Overall Study||94
1070026|NCT00917124|2594010|P1|COMPLETED|Overall Study||96
1070027|NCT00917124|2594009|P2|STARTED|Overall Study||100
1070028|NCT00917124|2594010|P1|STARTED|Overall Study||100
1070029|NCT00917267|2594020|P2|NOT COMPLETED|Overall Study||79
1070030|NCT00917267|2594021|P1|NOT COMPLETED|Overall Study||39
1070031|NCT00917267|2594020|P2|COMPLETED|Overall Study||266
1070032|NCT00917267|2594021|P1|COMPLETED|Overall Study||307
1070033|NCT00917267|2594020|P2|Intent to Treat (ITT)|Overall Study||338
1070034|NCT00917267|2594021|P1|Intent to Treat (ITT)|Overall Study||340
1070035|NCT00917267|2594020|P2|STARTED|Overall Study||345
1070036|NCT00917267|2594021|P1|STARTED|Overall Study||346
1070037|NCT00917384|2594049|P2|NOT COMPLETED|Overall Study||4
1070038|NCT00917384|2594050|P1|NOT COMPLETED|Overall Study||14
1070039|NCT00917384|2594049|P2|COMPLETED|Overall Study||113
1070040|NCT00917384|2594050|P1|COMPLETED|Overall Study||224
1070041|NCT00917384|2594049|P2|Received at Least 1 Dose of Study Drug|Overall Study||115
1070042|NCT00917384|2594050|P1|Received at Least 1 Dose of Study Drug|Overall Study||236
1070043|NCT00917384|2594049|P2|STARTED|Overall Study||117
1070044|NCT00917384|2594050|P1|STARTED|Overall Study||238
1070045|NCT00917501|2594074|P2|NOT COMPLETED|Overall Study||5
1070046|NCT00917501|2594075|P1|NOT COMPLETED|Overall Study||8
1070047|NCT00917501|2594074|P2|COMPLETED|Overall Study||21
1070048|NCT00917501|2594075|P1|COMPLETED|Overall Study||21
1070049|NCT00917501|2594074|P2|STARTED|Overall Study||26
1070050|NCT00917501|2594075|P1|STARTED|Overall Study||29
1070051|NCT00917579|2594081|P2|NOT COMPLETED|Period 2: 2nd Intervention||0
1070052|NCT00917579|2594082|P1|NOT COMPLETED|Period 2: 2nd Intervention||0
1070053|NCT00917579|2594081|P2|COMPLETED|Period 2: 2nd Intervention||37
1070054|NCT00917579|2594082|P1|COMPLETED|Period 2: 2nd Intervention||37
1070055|NCT00917579|2594081|P2|STARTED|Period 2: 2nd Intervention||37
1070056|NCT00917579|2594082|P1|STARTED|Period 2: 2nd Intervention||37
1070057|NCT00917579|2594081|P2|NOT COMPLETED|Washout >= 2 Weeks||0
1070058|NCT00917579|2594082|P1|NOT COMPLETED|Washout >= 2 Weeks||2
1070059|NCT00917579|2594081|P2|COMPLETED|Washout >= 2 Weeks||37
1070060|NCT00917579|2594082|P1|COMPLETED|Washout >= 2 Weeks||37
1070061|NCT00917579|2594081|P2|STARTED|Washout >= 2 Weeks||37
1070062|NCT00917579|2594082|P1|STARTED|Washout >= 2 Weeks||39
1070063|NCT00917579|2594081|P2|NOT COMPLETED|Period 1: 1st Intervention||0
1070064|NCT00917579|2594082|P1|NOT COMPLETED|Period 1: 1st Intervention||0
1070065|NCT00917579|2594081|P2|COMPLETED|Period 1: 1st Intervention||37
1070066|NCT00917579|2594082|P1|COMPLETED|Period 1: 1st Intervention||39
1070067|NCT00917579|2594081|P2|STARTED|Period 1: 1st Intervention||37
1070068|NCT00917579|2594082|P1|STARTED|Period 1: 1st Intervention||39
1070069|NCT00917644|2594096|P2|NOT COMPLETED|Period 2: Second Intervention||0
1070070|NCT00917644|2594097|P1|NOT COMPLETED|Period 2: Second Intervention||1
1070071|NCT00917644|2594096|P2|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Ref drug = 73.|37
1070072|NCT00917644|2594097|P1|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Test drug = 74.|36
1070073|NCT00917644|2594096|P2|STARTED|Period 2: Second Intervention|Washout: Reference drug (Ref) 1st, completed = 37; 2nd period: Ref drug 2nd, completed = 36.|37
1070074|NCT00917644|2594097|P1|STARTED|Period 2: Second Intervention|Washout: Test drug 1st, completed = 37; 2nd period: Test drug 2nd, completed = 37.|37
1070075|NCT00917644|2594096|P2|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||0
1070076|NCT00917644|2594097|P1|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||2
1070077|NCT00917644|2594096|P2|COMPLETED|Period: Washout Period of > = 2 Weeks||37
1070078|NCT00917644|2594097|P1|COMPLETED|Period: Washout Period of > = 2 Weeks||37
1070079|NCT00917644|2594096|P2|STARTED|Period: Washout Period of > = 2 Weeks||37
1070080|NCT00917644|2594097|P1|STARTED|Period: Washout Period of > = 2 Weeks||39
1070081|NCT00917644|2594096|P2|NOT COMPLETED|Period 1: First Intervention||0
1070082|NCT00917644|2594097|P1|NOT COMPLETED|Period 1: First Intervention||0
1070083|NCT00917644|2594096|P2|COMPLETED|Period 1: First Intervention||37
1070084|NCT00917644|2594097|P1|COMPLETED|Period 1: First Intervention||39
1070085|NCT00917644|2594096|P2|STARTED|Period 1: First Intervention||37
1070086|NCT00917644|2594097|P1|STARTED|Period 1: First Intervention||39
1070087|NCT00917735|2594113|P2|NOT COMPLETED|Overall Study||63
1070088|NCT00917735|2594114|P1|NOT COMPLETED|Overall Study||75
1070089|NCT00917735|2594113|P2|COMPLETED|Overall Study||474
1070090|NCT00917735|2594114|P1|COMPLETED|Overall Study||463
1070091|NCT00917735|2594113|P2|STARTED|Overall Study||537
1070092|NCT00917735|2594114|P1|STARTED|Overall Study||538
1070093|NCT00917852|2594124|P1|NOT COMPLETED|Overall Study||6
1070094|NCT00917852|2594124|P1|COMPLETED|Overall Study||45
1070095|NCT00917852|2594124|P1|STARTED|Overall Study||51
1070096|NCT00917865|2594129|P1|NOT COMPLETED|Overall Study||0
1070097|NCT00917865|2594129|P1|COMPLETED|Overall Study||11
1070098|NCT00917865|2594129|P1|STARTED|Overall Study||11
1070099|NCT00920621|2594144|P4|NOT COMPLETED|Overall Study||35
1070100|NCT00920621|2594145|P3|NOT COMPLETED|Overall Study||35
1070101|NCT00920621|2594146|P2|NOT COMPLETED|Overall Study||45
1070102|NCT00920621|2594147|P1|NOT COMPLETED|Overall Study||54
1070103|NCT00920621|2594144|P4|COMPLETED|Overall Study||401
1070104|NCT00920621|2594145|P3|COMPLETED|Overall Study||405
1070105|NCT00920621|2594146|P2|COMPLETED|Overall Study||391
1070106|NCT00920621|2594147|P1|COMPLETED|Overall Study||386
1070107|NCT00920621|2594144|P4|STARTED|Overall Study||436
1070108|NCT00920621|2594145|P3|STARTED|Overall Study||440
1070109|NCT00920621|2594146|P2|STARTED|Overall Study||436
1070110|NCT00920621|2594147|P1|STARTED|Overall Study||440
1070111|NCT00920647|2594175|P4|NOT COMPLETED|Overall Study||0
1070112|NCT00920647|2594176|P3|NOT COMPLETED|Overall Study||0
1070113|NCT00920647|2594177|P2|NOT COMPLETED|Overall Study||0
1070114|NCT00920647|2594178|P1|NOT COMPLETED|Overall Study||0
1070115|NCT00920647|2594175|P4|COMPLETED|Overall Study||4
1070116|NCT00920647|2594176|P3|COMPLETED|Overall Study||4
1070117|NCT00920647|2594177|P2|COMPLETED|Overall Study||4
1070118|NCT00920647|2594178|P1|COMPLETED|Overall Study||4
1070119|NCT00920647|2594175|P4|STARTED|Overall Study||4
1070120|NCT00920647|2594176|P3|STARTED|Overall Study||4
1070121|NCT00920647|2594177|P2|STARTED|Overall Study||4
1070122|NCT00920647|2594178|P1|STARTED|Overall Study||4
1070123|NCT00920686|2594229|P3|NOT COMPLETED|Overall Study||13
1070124|NCT00920686|2594230|P2|NOT COMPLETED|Overall Study||22
1070125|NCT00920686|2594231|P1|NOT COMPLETED|Overall Study||19
1070126|NCT00920686|2594229|P3|COMPLETED|Overall Study||62
1070127|NCT00920686|2594230|P2|COMPLETED|Overall Study||60
1070128|NCT00920686|2594231|P1|COMPLETED|Overall Study||63
1070129|NCT00920686|2594229|P3|STARTED|Overall Study||75
1070130|NCT00920686|2594230|P2|STARTED|Overall Study||82
1070131|NCT00920686|2594231|P1|STARTED|Overall Study||82
1070132|NCT00920699|2594254|P3|NOT COMPLETED|Overall Study||4
1070133|NCT00920699|2594255|P2|NOT COMPLETED|Overall Study||1
1070134|NCT00920699|2594256|P1|NOT COMPLETED|Overall Study||2
1070135|NCT00920699|2594254|P3|COMPLETED|Overall Study||28
1070136|NCT00920699|2594255|P2|COMPLETED|Overall Study||29
1070137|NCT00920699|2594256|P1|COMPLETED|Overall Study||27
1070138|NCT00920699|2594254|P3|STARTED|Overall Study||32
1070139|NCT00920699|2594255|P2|STARTED|Overall Study||30
1070140|NCT00920699|2594256|P1|STARTED|Overall Study||29
1070141|NCT00920790|2594270|P1|NOT COMPLETED|Overall Study||14
1070142|NCT00920790|2594270|P1|COMPLETED|Overall Study||13
1070143|NCT00920790|2594270|P1|STARTED|Overall Study||27
1070144|NCT00920816|2594283|P4|NOT COMPLETED|Overall Study||69
1070145|NCT00920816|2594284|P3|NOT COMPLETED|Overall Study||135
1070146|NCT00920816|2594285|P2|NOT COMPLETED|Overall Study||96
1070147|NCT00920816|2594286|P1|NOT COMPLETED|Overall Study||192
1070148|NCT00920816|2594283|P4|COMPLETED|Overall Study||0
1070149|NCT00920816|2594284|P3|COMPLETED|Overall Study||0
1070150|NCT00920816|2594285|P2|COMPLETED|Overall Study||0
1070151|NCT00920816|2594286|P1|COMPLETED|Overall Study||0
1070152|NCT00920816|2594283|P4|Treated|Overall Study||69
1070153|NCT00920816|2594284|P3|Treated|Overall Study||135
1070154|NCT00920816|2594285|P2|Treated|Overall Study||96
1070155|NCT00920816|2594286|P1|Treated|Overall Study||189
1070156|NCT00920816|2594283|P4|STARTED|Overall Study||69
1070157|NCT00920816|2594284|P3|STARTED|Overall Study||135
1070158|NCT00920816|2594285|P2|STARTED|Overall Study||96
1070159|NCT00920816|2594286|P1|STARTED|Overall Study||192
1070160|NCT00920855|2594327|P3|NOT COMPLETED|Overall Study||22
1070161|NCT00920855|2594328|P2|NOT COMPLETED|Overall Study||3
1070162|NCT00920855|2594329|P1|NOT COMPLETED|Overall Study||5
1070163|NCT00920855|2594327|P3|COMPLETED|Overall Study|completed eight cycles of treatment|9
1070164|NCT00920855|2594328|P2|COMPLETED|Overall Study|completed eight cycles of treatment|1
1070165|NCT00920855|2594329|P1|COMPLETED|Overall Study|completed eight cycles of treatment|0
1070166|NCT00920855|2594327|P3|Safety and Efficacy Populations|Overall Study||31
1070167|NCT00920855|2594328|P2|Safety and Efficacy Populations|Overall Study||4
1070168|NCT00920855|2594329|P1|Safety and Efficacy Populations|Overall Study||5
1070169|NCT00920855|2594327|P3|STARTED|Overall Study||31
1070170|NCT00920855|2594328|P2|STARTED|Overall Study||4
1070171|NCT00920855|2594329|P1|STARTED|Overall Study||5
1070172|NCT00920907|2594353|P2|NOT COMPLETED|Maintenance Period||13
1070173|NCT00920907|2594354|P1|NOT COMPLETED|Maintenance Period||12
1070174|NCT00920907|2594353|P2|COMPLETED|Maintenance Period|2 participants who entered Maintenance Period did not receive study drug during the period.|2
1070175|NCT00920907|2594354|P1|COMPLETED|Maintenance Period|All participants who entered Maintenance were treated with study drug.|3
1070176|NCT00920907|2594353|P2|STARTED|Maintenance Period|1 patient completed Induction phase but discontinued the study prior to start of maintenance phase.|15
1070177|NCT00920907|2594354|P1|STARTED|Maintenance Period||15
1070178|NCT00920907|2594353|P2|NOT COMPLETED|Induction Period||22
1070179|NCT00920907|2594354|P1|NOT COMPLETED|Induction Period||22
1070180|NCT00920907|2594353|P2|COMPLETED|Induction Period||16
1070181|NCT00920907|2594354|P1|COMPLETED|Induction Period||15
1070182|NCT00920907|2594353|P2|STARTED|Induction Period||38
1070183|NCT00920907|2594354|P1|STARTED|Induction Period||37
1070184|NCT00921024|2594394|P2|NOT COMPLETED|Overall Study||3
1070185|NCT00921024|2594395|P1|NOT COMPLETED|Overall Study||4
1070186|NCT00921024|2594394|P2|COMPLETED|Overall Study||39
1070187|NCT00921024|2594395|P1|COMPLETED|Overall Study||81
1070188|NCT00921024|2594394|P2|STARTED|Overall Study||42
1070189|NCT00921024|2594395|P1|STARTED|Overall Study||85
1070190|NCT00921115|2594403|P1|NOT COMPLETED|Overall Study||0
1070191|NCT00921115|2594403|P1|COMPLETED|Overall Study||42
1070192|NCT00921115|2594403|P1|STARTED|Overall Study||42
1070193|NCT00921310|2594409|P3|NOT COMPLETED|Overall Study||0
1070194|NCT00921310|2594410|P2|NOT COMPLETED|Overall Study||0
1070195|NCT00921310|2594411|P1|NOT COMPLETED|Overall Study||0
1070196|NCT00921310|2594409|P3|COMPLETED|Overall Study||4
1070197|NCT00921310|2594410|P2|COMPLETED|Overall Study||6
1070198|NCT00921310|2594411|P1|COMPLETED|Overall Study||2
1070199|NCT00921310|2594409|P3|STARTED|Overall Study||4
1070200|NCT00921310|2594410|P2|STARTED|Overall Study||6
1070201|NCT00921310|2594411|P1|STARTED|Overall Study||2
1070202|NCT00921518|2594438|P2|NOT COMPLETED|Overall Study||0
1070203|NCT00921518|2594439|P1|NOT COMPLETED|Overall Study||0
1070204|NCT00921518|2594438|P2|COMPLETED|Overall Study||44
1070205|NCT00921518|2594439|P1|COMPLETED|Overall Study||48
1070206|NCT00921518|2594438|P2|STARTED|Overall Study||44
1070207|NCT00921518|2594439|P1|STARTED|Overall Study||48
1070208|NCT00921557|2594448|P3|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
1070209|NCT00921557|2594449|P2|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
1070210|NCT00921557|2594450|P1|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||3
1070211|NCT00921557|2594448|P3|COMPLETED|Weeks 96-144 (Off Study Treatment)||16
1070212|NCT00921557|2594449|P2|COMPLETED|Weeks 96-144 (Off Study Treatment)||15
1070213|NCT00921557|2594450|P1|COMPLETED|Weeks 96-144 (Off Study Treatment)||12
1070214|NCT00921557|2594448|P3|STARTED|Weeks 96-144 (Off Study Treatment)||17
1070215|NCT00921557|2594449|P2|STARTED|Weeks 96-144 (Off Study Treatment)||16
1070216|NCT00921557|2594450|P1|STARTED|Weeks 96-144 (Off Study Treatment)||15
1070217|NCT00921557|2594448|P3|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
1070218|NCT00921557|2594449|P2|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
1070219|NCT00921557|2594450|P1|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||0
1070220|NCT00921557|2594448|P3|COMPLETED|Weeks 48-96 (on Study Treatment)||17
1070221|NCT00921557|2594449|P2|COMPLETED|Weeks 48-96 (on Study Treatment)||16
1070222|NCT00921557|2594450|P1|COMPLETED|Weeks 48-96 (on Study Treatment)||15
1070223|NCT00921557|2594448|P3|STARTED|Weeks 48-96 (on Study Treatment)||18
1070224|NCT00921557|2594449|P2|STARTED|Weeks 48-96 (on Study Treatment)||17
1070225|NCT00921557|2594450|P1|STARTED|Weeks 48-96 (on Study Treatment)||15
1070226|NCT00921557|2594448|P3|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
1070227|NCT00921557|2594449|P2|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
1070228|NCT00921557|2594450|P1|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||2
1070229|NCT00921557|2594448|P3|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|18
1070230|NCT00921557|2594449|P2|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|17
1070231|NCT00921557|2594450|P1|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|15
1070232|NCT00921557|2594448|P3|STARTED|Weeks 0-48 (on Study Treatment)||18
1070233|NCT00921557|2594449|P2|STARTED|Weeks 0-48 (on Study Treatment)||17
1070234|NCT00921557|2594450|P1|STARTED|Weeks 0-48 (on Study Treatment)||17
1070235|NCT00921687|2594510|P2|NOT COMPLETED|Overall Study||0
1070236|NCT00921687|2594511|P1|NOT COMPLETED|Overall Study||0
1070237|NCT00921687|2594510|P2|COMPLETED|Overall Study||363
1070238|NCT00921687|2594511|P1|COMPLETED|Overall Study||418
1070239|NCT00921687|2594510|P2|STARTED|Overall Study||363
1070240|NCT00921687|2594511|P1|STARTED|Overall Study|eligible patients seen in clinic between 1/1/09 and 1/1/10|418
1070241|NCT00921895|2594519|P1|NOT COMPLETED|Overall Study||0
1070242|NCT00921895|2594519|P1|COMPLETED|Overall Study||128
1070243|NCT00921895|2594519|P1|STARTED|Overall Study||128
1070244|NCT00921934|2594524|P1|NOT COMPLETED|Overall Study||0
1070245|NCT00921934|2594524|P1|COMPLETED|Overall Study||68
1070246|NCT00921934|2594524|P1|STARTED|Overall Study||68
1070247|NCT00921947|2594530|P2|NOT COMPLETED|Day 28||0
1070248|NCT00921947|2594531|P1|NOT COMPLETED|Day 28||0
1070249|NCT00921947|2594530|P2|COMPLETED|Day 28||30
1070250|NCT00921947|2594531|P1|COMPLETED|Day 28||28
1070251|NCT00921947|2594530|P2|STARTED|Day 28||30
1070252|NCT00921947|2594531|P1|STARTED|Day 28|2 subjects were lost to follow-up and did not receive the 2nd vaccination of 1.0 ug i.m.|28
1070253|NCT00921947|2594530|P2|NOT COMPLETED|Day 0||0
1070254|NCT00921947|2594531|P1|NOT COMPLETED|Day 0||0
1070255|NCT00921947|2594530|P2|COMPLETED|Day 0||30
1070256|NCT00921947|2594531|P1|COMPLETED|Day 0||30
1070257|NCT00921947|2594530|P2|STARTED|Day 0||30
1070258|NCT00921947|2594531|P1|STARTED|Day 0||30
1070259|NCT00922116|2594541|P1|NOT COMPLETED|Overall Study||15
1070260|NCT00922116|2594541|P1|COMPLETED|Overall Study||176
1070261|NCT00922116|2594541|P1|STARTED|Overall Study||191
1070262|NCT00922194|2594550|P1|NOT COMPLETED|Metformin for 12 Months or More||0
1070263|NCT00922194|2594550|P1|COMPLETED|Metformin for 12 Months or More||102
1070264|NCT00922194|2594550|P1|STARTED|Metformin for 12 Months or More|Gradually increasing dose of Extended Release Metformin|102
1070265|NCT00922194|2594550|P1|NOT COMPLETED|Metformin in Maximum Tolerated Dose||0
1070266|NCT00922194|2594550|P1|COMPLETED|Metformin in Maximum Tolerated Dose|June 2009|102
1070267|NCT00922194|2594550|P1|STARTED|Metformin in Maximum Tolerated Dose|February 2006|102
1070268|NCT00922207|2594563|P3|NOT COMPLETED|Overall Study||4
1070269|NCT00922207|2594564|P2|NOT COMPLETED|Overall Study||7
1070270|NCT00922207|2594565|P1|NOT COMPLETED|Overall Study||6
1070271|NCT00922207|2594563|P3|COMPLETED|Overall Study||90
1070272|NCT00922207|2594564|P2|COMPLETED|Overall Study||88
1070273|NCT00922207|2594565|P1|COMPLETED|Overall Study||85
1070274|NCT00922207|2594563|P3|STARTED|Overall Study||94
1070275|NCT00922207|2594564|P2|STARTED|Overall Study||95
1070276|NCT00922207|2594565|P1|STARTED|Overall Study||91
1070277|NCT00922233|2594591|P1|NOT COMPLETED|Overall Study||4
1070278|NCT00922233|2594591|P1|COMPLETED|Overall Study||68
1070279|NCT00922233|2594591|P1|STARTED|Overall Study||72
1070280|NCT00922272|2594597|P2|NOT COMPLETED|Double-blind Phase||6
1070281|NCT00922272|2594598|P1|NOT COMPLETED|Double-blind Phase||7
1070282|NCT00922272|2594597|P2|COMPLETED|Double-blind Phase||29
1070283|NCT00922272|2594598|P1|COMPLETED|Double-blind Phase||27
1070284|NCT00922272|2594597|P2|STARTED|Double-blind Phase||35
1070285|NCT00922272|2594598|P1|STARTED|Double-blind Phase||34
1070286|NCT00922272|2594597|P2|NOT COMPLETED|Open-label Phase||0
1070287|NCT00922272|2594598|P1|NOT COMPLETED|Open-label Phase||23
1070288|NCT00922272|2594597|P2|COMPLETED|Open-label Phase||0
1070289|NCT00922272|2594598|P1|COMPLETED|Open-label Phase||69
1070290|NCT00922272|2594597|P2|STARTED|Open-label Phase||0
1070291|NCT00922272|2594598|P1|STARTED|Open-label Phase||92
1070292|NCT00922428|2594654|P1|NOT COMPLETED|Overall Study||15
1070293|NCT00922428|2594654|P1|COMPLETED|Overall Study|for 11 participants no gender was given|1374
1070294|NCT00922428|2594654|P1|STARTED|Overall Study|13 patients were completely not analysed, 2 not for demographic or efficacy but for safety|1389
1070295|NCT00922623|2594683|P1|NOT COMPLETED|Overall Study||5
1070296|NCT00922623|2594683|P1|COMPLETED|Overall Study||88
1070297|NCT00922623|2594683|P1|STARTED|Overall Study||93
1070298|NCT00922636|2594694|P5|NOT COMPLETED|Overall Study||16
1070299|NCT00922636|2594695|P4|NOT COMPLETED|Overall Study||17
1070300|NCT00922636|2594696|P3|NOT COMPLETED|Overall Study||20
1070301|NCT00922636|2594697|P2|NOT COMPLETED|Overall Study||16
1070302|NCT00922636|2594698|P1|NOT COMPLETED|Overall Study||7
1070303|NCT00922636|2594694|P5|COMPLETED|Overall Study||59
1070304|NCT00922636|2594695|P4|COMPLETED|Overall Study||58
1070305|NCT00922636|2594696|P3|COMPLETED|Overall Study||56
1070306|NCT00922636|2594697|P2|COMPLETED|Overall Study||62
1070307|NCT00922636|2594698|P1|COMPLETED|Overall Study||29
1070308|NCT00922636|2594694|P5|Entered Optional Taper Phase|Overall Study||12
1070309|NCT00922636|2594695|P4|Entered Optional Taper Phase|Overall Study||7
1070310|NCT00922636|2594696|P3|Entered Optional Taper Phase|Overall Study||15
1070311|NCT00922636|2594697|P2|Entered Optional Taper Phase|Overall Study||10
1070312|NCT00922636|2594698|P1|Entered Optional Taper Phase|Overall Study||4
1070313|NCT00922636|2594694|P5|STARTED|Overall Study||75
1070314|NCT00922636|2594695|P4|STARTED|Overall Study||75
1070315|NCT00922636|2594696|P3|STARTED|Overall Study||76
1070316|NCT00922636|2594697|P2|STARTED|Overall Study||78
1070317|NCT00922636|2594698|P1|STARTED|Overall Study||36
1070318|NCT00922701|2594845|P1|NOT COMPLETED|Overall Study||0
1070319|NCT00922701|2594845|P1|COMPLETED|Overall Study||4
1070320|NCT00922701|2594845|P1|STARTED|Overall Study||4
1070321|NCT00922766|2594849|P1|NOT COMPLETED|Overall Study||7
1070322|NCT00922766|2594849|P1|COMPLETED|Overall Study||610
1070323|NCT00922766|2594849|P1|STARTED|Overall Study||617
1070324|NCT00922779|2594858|P1|NOT COMPLETED|Overall Study||2327
1070325|NCT00922779|2594858|P1|COMPLETED|Overall Study||4334
1070326|NCT00922779|2594858|P1|STARTED|Overall Study||6661
1070327|NCT00913081|2594865|P1|NOT COMPLETED|Placebo + Niacin 500 mg (1day)||0
1070328|NCT00913081|2594865|P1|COMPLETED|Placebo + Niacin 500 mg (1day)||17
1070329|NCT00913081|2594865|P1|STARTED|Placebo + Niacin 500 mg (1day)||17
1070330|NCT00913081|2594865|P1|NOT COMPLETED|Washout #3 (7days)||0
1070331|NCT00913081|2594865|P1|COMPLETED|Washout #3 (7days)||17
1070332|NCT00913081|2594865|P1|STARTED|Washout #3 (7days)||17
1070333|NCT00913081|2594865|P1|NOT COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||0
1070334|NCT00913081|2594865|P1|COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
1070335|NCT00913081|2594865|P1|STARTED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
1070336|NCT00913081|2594865|P1|NOT COMPLETED|Washout #2 (7 Days)||0
1070337|NCT00913081|2594865|P1|COMPLETED|Washout #2 (7 Days)||17
1070338|NCT00913081|2594865|P1|STARTED|Washout #2 (7 Days)||17
1070339|NCT00913081|2594865|P1|NOT COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||0
1070340|NCT00913081|2594865|P1|COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
1070341|NCT00913081|2594865|P1|STARTED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
1070342|NCT00913081|2594865|P1|NOT COMPLETED|Washout #1 (7 Days)||0
1070343|NCT00913081|2594865|P1|COMPLETED|Washout #1 (7 Days)||17
1070344|NCT00913081|2594865|P1|STARTED|Washout #1 (7 Days)||17
1070345|NCT00913081|2594865|P1|NOT COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||0
1070346|NCT00913081|2594865|P1|COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||17
1070347|NCT00913081|2594865|P1|STARTED|Quercetin 500 mg + Niacin 500 mg (1day)||17
1070348|NCT00913133|2594875|P1|NOT COMPLETED|Overall Study||0
1070349|NCT00913133|2594875|P1|COMPLETED|Overall Study||516
1070350|NCT00913133|2594875|P1|STARTED|Overall Study||516
1070351|NCT00913263|2594880|P1|NOT COMPLETED|Overall Study||0
1070352|NCT00913263|2594880|P1|COMPLETED|Overall Study||24
1070353|NCT00913263|2594880|P1|STARTED|Overall Study||24
1070354|NCT00913380|2594891|P2|NOT COMPLETED|Clinical Outcomes||6
1070355|NCT00913380|2594892|P1|NOT COMPLETED|Clinical Outcomes||6
1070356|NCT00913380|2594891|P2|COMPLETED|Clinical Outcomes||441
1070357|NCT00913380|2594892|P1|COMPLETED|Clinical Outcomes||438
1070358|NCT00913380|2594891|P2|STARTED|Clinical Outcomes||447
1070359|NCT00913380|2594892|P1|STARTED|Clinical Outcomes||444
1070360|NCT00913380|2594891|P2|NOT COMPLETED|CT Examination||0
1070361|NCT00913380|2594892|P1|NOT COMPLETED|CT Examination||0
1070362|NCT00913380|2594891|P2|COMPLETED|CT Examination||447
1070363|NCT00913380|2594892|P1|COMPLETED|CT Examination||444
1070364|NCT00913380|2594891|P2|STARTED|CT Examination||447
1070365|NCT00913380|2594892|P1|STARTED|CT Examination||444
1070366|NCT00913458|2594918|P7|NOT COMPLETED|Phase 3||8
1070367|NCT00913458|2594919|P6|NOT COMPLETED|Phase 3||18
1070368|NCT00913458|2594920|P5|NOT COMPLETED|Phase 3||22
1070369|NCT00913458|2594921|P4|NOT COMPLETED|Phase 3||0
1070370|NCT00913458|2594922|P3|NOT COMPLETED|Phase 3||0
1070371|NCT00913458|2594923|P2|NOT COMPLETED|Phase 3||0
1070372|NCT00913458|2594924|P1|NOT COMPLETED|Phase 3||0
1070373|NCT00913458|2594918|P7|COMPLETED|Phase 3||24
1070374|NCT00913458|2594919|P6|COMPLETED|Phase 3||28
1070375|NCT00913458|2594920|P5|COMPLETED|Phase 3||31
1070376|NCT00913458|2594921|P4|COMPLETED|Phase 3||0
1070377|NCT00913458|2594922|P3|COMPLETED|Phase 3||0
1070378|NCT00913458|2594923|P2|COMPLETED|Phase 3||0
1070379|NCT00913458|2594924|P1|COMPLETED|Phase 3|This arm is part of Phase 1 of the study.|0
1070380|NCT00913458|2594918|P7|STARTED|Phase 3|Participants who completed Phase 2 study|32
1070381|NCT00913458|2594919|P6|STARTED|Phase 3|Participants who completed Phase 2 study|46
1070382|NCT00913458|2594920|P5|STARTED|Phase 3|Participants who completed Phase 2 study|53
1070383|NCT00913458|2594921|P4|STARTED|Phase 3||0
1070384|NCT00913458|2594922|P3|STARTED|Phase 3||0
1070385|NCT00913458|2594923|P2|STARTED|Phase 3||0
1070386|NCT00913458|2594924|P1|STARTED|Phase 3|This arm is part of Phase 1 of the study.|0
1070387|NCT00913458|2594918|P7|NOT COMPLETED|Phase 2||0
1070388|NCT00913458|2594919|P6|NOT COMPLETED|Phase 2||0
1070389|NCT00913458|2594920|P5|NOT COMPLETED|Phase 2||0
1070390|NCT00913458|2594921|P4|NOT COMPLETED|Phase 2||33
1070391|NCT00913458|2594922|P3|NOT COMPLETED|Phase 2||19
1070392|NCT00913458|2594923|P2|NOT COMPLETED|Phase 2||10
1070393|NCT00913458|2594924|P1|NOT COMPLETED|Phase 2||0
1070394|NCT00913458|2594918|P7|COMPLETED|Phase 2||0
1070395|NCT00913458|2594919|P6|COMPLETED|Phase 2||0
1070396|NCT00913458|2594920|P5|COMPLETED|Phase 2||0
1070397|NCT00913458|2594921|P4|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|32
1070398|NCT00913458|2594922|P3|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|46
1070399|NCT00913458|2594923|P2|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|53
1070400|NCT00913458|2594924|P1|COMPLETED|Phase 2|This arm is part of Phase 1 of the study.|0
1070401|NCT00913458|2594918|P7|STARTED|Phase 2||0
1070402|NCT00913458|2594919|P6|STARTED|Phase 2||0
1070403|NCT00913458|2594920|P5|STARTED|Phase 2||0
1070404|NCT00913458|2594921|P4|STARTED|Phase 2||65
1070405|NCT00913458|2594922|P3|STARTED|Phase 2||65
1070406|NCT00913458|2594923|P2|STARTED|Phase 2||63
1070407|NCT00913458|2594924|P1|STARTED|Phase 2|This arm is part of Phase 1 of the study.|0
1070408|NCT00913458|2594918|P7|NOT COMPLETED|Phase 1||0
1070409|NCT00913458|2594919|P6|NOT COMPLETED|Phase 1||0
1070410|NCT00913458|2594920|P5|NOT COMPLETED|Phase 1||0
1070411|NCT00913458|2594921|P4|NOT COMPLETED|Phase 1||0
1070412|NCT00913458|2594922|P3|NOT COMPLETED|Phase 1||0
1070413|NCT00913458|2594923|P2|NOT COMPLETED|Phase 1||0
1070414|NCT00913458|2594924|P1|NOT COMPLETED|Phase 1||112
1070415|NCT00913458|2594918|P7|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
1070416|NCT00913458|2594919|P6|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
1070417|NCT00913458|2594920|P5|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
1070418|NCT00913458|2594921|P4|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
1070419|NCT00913458|2594922|P3|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
1070420|NCT00913458|2594923|P2|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
1070421|NCT00913458|2594924|P1|COMPLETED|Phase 1|194 continued to Phase 2 but 1 was randomized in error leaving 193 in the phase 2 analysis.|194
1070422|NCT00913458|2594918|P7|STARTED|Phase 1|This arm is part of Phase 3 study|0
1070423|NCT00913458|2594919|P6|STARTED|Phase 1|This arm is part of Phase 3 study|0
1070424|NCT00913458|2594920|P5|STARTED|Phase 1|This arm is part of Phase 3 study|0
1070425|NCT00913458|2594921|P4|STARTED|Phase 1|This arm is part of Phase 2 study|0
1070426|NCT00913458|2594922|P3|STARTED|Phase 1|This arm is part of Phase 2 study|0
1070427|NCT00913458|2594923|P2|STARTED|Phase 1|This arm is part of Phase 2 study|0
1070428|NCT00913458|2594924|P1|STARTED|Phase 1||306
1070429|NCT00913510|2595017|P2|NOT COMPLETED|Overall Study||4
1070430|NCT00913510|2595018|P1|NOT COMPLETED|Overall Study||8
1070431|NCT00913510|2595017|P2|COMPLETED|Overall Study||3
1070432|NCT00913510|2595018|P1|COMPLETED|Overall Study||5
1070433|NCT00913510|2595017|P2|STARTED|Overall Study||7
1070434|NCT00913510|2595018|P1|STARTED|Overall Study||13
1070435|NCT00913523|2595027|P3|NOT COMPLETED|Overall Study||14
1070436|NCT00913523|2595028|P2|NOT COMPLETED|Overall Study||16
1070437|NCT00913523|2595029|P1|NOT COMPLETED|Overall Study||18
1070438|NCT00913523|2595027|P3|COMPLETED|Overall Study||147
1070439|NCT00913523|2595028|P2|COMPLETED|Overall Study||143
1070440|NCT00913523|2595029|P1|COMPLETED|Overall Study||144
1070441|NCT00913523|2595027|P3|STARTED|Overall Study||161
1070442|NCT00913523|2595028|P2|STARTED|Overall Study||159
1070443|NCT00913523|2595029|P1|STARTED|Overall Study||162
1070444|NCT00913692|2595052|P1|NOT COMPLETED|Treatment Phase 2 (5 Months)||0
1070445|NCT00913692|2595052|P1|COMPLETED|Treatment Phase 2 (5 Months)||1
1070446|NCT00913692|2595052|P1|STARTED|Treatment Phase 2 (5 Months)||1
1070447|NCT00913692|2595052|P1|NOT COMPLETED|Washout (2 Weeks)||0
1070448|NCT00913692|2595052|P1|COMPLETED|Washout (2 Weeks)||1
1070449|NCT00913692|2595052|P1|STARTED|Washout (2 Weeks)||1
1070450|NCT00913692|2595052|P1|NOT COMPLETED|Treatment Phase 1 (5 Months)||1
1070451|NCT00913692|2595052|P1|COMPLETED|Treatment Phase 1 (5 Months)||1
1070452|NCT00913692|2595052|P1|STARTED|Treatment Phase 1 (5 Months)||2
1070453|NCT00913692|2595052|P1|NOT COMPLETED|Screening (4 Months)||9
1070454|NCT00913692|2595052|P1|COMPLETED|Screening (4 Months)||2
1070455|NCT00913692|2595052|P1|STARTED|Screening (4 Months)||11
1070456|NCT00913744|2595064|P2|NOT COMPLETED|Overall Study||1
1070457|NCT00913744|2595065|P1|NOT COMPLETED|Overall Study||5
1070458|NCT00913744|2595064|P2|COMPLETED|Overall Study||24
1070459|NCT00913744|2595065|P1|COMPLETED|Overall Study||70
1070460|NCT00913744|2595064|P2|STARTED|Overall Study||25
1070461|NCT00913744|2595065|P1|STARTED|Overall Study||75
1070462|NCT00913770|2595074|P3|NOT COMPLETED|Overall Study||21
1070463|NCT00913770|2595075|P2|NOT COMPLETED|Overall Study||29
1070464|NCT00913770|2595076|P1|NOT COMPLETED|Overall Study||35
1070465|NCT00913770|2595074|P3|COMPLETED|Overall Study||93
1070466|NCT00913770|2595075|P2|COMPLETED|Overall Study||82
1070467|NCT00913770|2595076|P1|COMPLETED|Overall Study||69
1070468|NCT00913770|2595074|P3|STARTED|Overall Study||114
1070469|NCT00913770|2595075|P2|STARTED|Overall Study||111
1070470|NCT00913770|2595076|P1|STARTED|Overall Study||104
1070471|NCT00913835|2595089|P2|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||3
1070472|NCT00913835|2595090|P1|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||0
1070473|NCT00913835|2595089|P2|COMPLETED|Lip Dox: Olaratumab Monotherapy||25
1070474|NCT00913835|2595090|P1|COMPLETED|Lip Dox: Olaratumab Monotherapy||0
1070475|NCT00913835|2595089|P2|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||28
1070476|NCT00913835|2595090|P1|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||0
1070477|NCT00913835|2595089|P2|STARTED|Lip Dox: Olaratumab Monotherapy||28
1070478|NCT00913835|2595090|P1|STARTED|Lip Dox: Olaratumab Monotherapy||0
1070479|NCT00913835|2595089|P2|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||7
1070480|NCT00913835|2595090|P1|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||8
1070481|NCT00913835|2595089|P2|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
1070482|NCT00913835|2595090|P1|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
1070483|NCT00913835|2595089|P2|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||61
1070484|NCT00913835|2595090|P1|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||62
1070485|NCT00913835|2595089|P2|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||62
1070486|NCT00913835|2595090|P1|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||63
1070487|NCT00913913|2595126|P1|NOT COMPLETED|Overall Study||8
1070488|NCT00913913|2595126|P1|COMPLETED|Overall Study||0
1070489|NCT00913913|2595126|P1|STARTED|Overall Study||8
1070490|NCT00914069|2595135|P2|NOT COMPLETED|Overall Study||0
1070491|NCT00914069|2595136|P1|NOT COMPLETED|Overall Study||0
1070492|NCT00914069|2595135|P2|COMPLETED|Overall Study||88
1070493|NCT00914069|2595136|P1|COMPLETED|Overall Study||84
1070494|NCT00914069|2595135|P2|STARTED|Overall Study||88
1070495|NCT00914069|2595136|P1|STARTED|Overall Study||84
1070496|NCT00914186|2595154|P4|NOT COMPLETED|Overall Study||10
1070497|NCT00914186|2595155|P3|NOT COMPLETED|Overall Study||2
1070498|NCT00914186|2595156|P2|NOT COMPLETED|Overall Study||2
1070499|NCT00914186|2595157|P1|NOT COMPLETED|Overall Study||3
1070500|NCT00914186|2595154|P4|COMPLETED|Overall Study||20
1070501|NCT00914186|2595155|P3|COMPLETED|Overall Study||29
1070502|NCT00914186|2595156|P2|COMPLETED|Overall Study||28
1070503|NCT00914186|2595157|P1|COMPLETED|Overall Study||28
1070504|NCT00914186|2595154|P4|STARTED|Overall Study||30
1070505|NCT00914186|2595155|P3|STARTED|Overall Study||31
1070506|NCT00914186|2595156|P2|STARTED|Overall Study||30
1070507|NCT00914186|2595157|P1|STARTED|Overall Study||31
1070508|NCT00914316|2595193|P4|NOT COMPLETED|Phase 2||0
1070509|NCT00914316|2595194|P3|NOT COMPLETED|Phase 2||1
1070510|NCT00914316|2595195|P2|NOT COMPLETED|Phase 2||0
1070511|NCT00914316|2595196|P1|NOT COMPLETED|Phase 2||1
1070512|NCT00914316|2595193|P4|COMPLETED|Phase 2||6
1070513|NCT00914316|2595194|P3|COMPLETED|Phase 2||2
1070514|NCT00914316|2595195|P2|COMPLETED|Phase 2||4
1070515|NCT00914316|2595196|P1|COMPLETED|Phase 2||1
1070516|NCT00914316|2595193|P4|STARTED|Phase 2||6
1070517|NCT00914316|2595194|P3|STARTED|Phase 2||3
1070518|NCT00914316|2595195|P2|STARTED|Phase 2||4
1070519|NCT00914316|2595196|P1|STARTED|Phase 2||2
1070520|NCT00914316|2595193|P4|NOT COMPLETED|Phase 1||2
1070521|NCT00914316|2595194|P3|NOT COMPLETED|Phase 1||5
1070522|NCT00914316|2595195|P2|NOT COMPLETED|Phase 1||2
1070523|NCT00914316|2595196|P1|NOT COMPLETED|Phase 1||5
1070524|NCT00914316|2595193|P4|COMPLETED|Phase 1||6
1070525|NCT00914316|2595194|P3|COMPLETED|Phase 1||3
1070526|NCT00914316|2595195|P2|COMPLETED|Phase 1||4
1070527|NCT00914316|2595196|P1|COMPLETED|Phase 1||2
1070528|NCT00914316|2595193|P4|STARTED|Phase 1||8
1070529|NCT00914316|2595194|P3|STARTED|Phase 1||8
1070530|NCT00914316|2595195|P2|STARTED|Phase 1||6
1070531|NCT00914316|2595196|P1|STARTED|Phase 1||7
1070532|NCT00914459|2595212|P2|NOT COMPLETED|Overall Study||1
1070533|NCT00914459|2595213|P1|NOT COMPLETED|Overall Study||1
1070534|NCT00914459|2595212|P2|COMPLETED|Overall Study||18
1070535|NCT00914459|2595213|P1|COMPLETED|Overall Study||17
1070536|NCT00914459|2595212|P2|STARTED|Overall Study||19
1070537|NCT00914459|2595213|P1|STARTED|Overall Study||18
1070538|NCT00914485|2595239|P1|NOT COMPLETED|Overall Study||0
1070539|NCT00914485|2595239|P1|COMPLETED|Overall Study||369
1070540|NCT00914485|2595239|P1|STARTED|Overall Study||369
1070541|NCT00914589|2595246|P3|NOT COMPLETED|Overall Study||12
1070542|NCT00914589|2595247|P2|NOT COMPLETED|Overall Study||16
1070543|NCT00914589|2595248|P1|NOT COMPLETED|Overall Study||25
1070544|NCT00914589|2595246|P3|COMPLETED|Overall Study||126
1070545|NCT00914589|2595247|P2|COMPLETED|Overall Study||127
1070546|NCT00914589|2595248|P1|COMPLETED|Overall Study||103
1070547|NCT00914589|2595246|P3|STARTED|Overall Study||138
1070548|NCT00914589|2595247|P2|STARTED|Overall Study||143
1070549|NCT00914589|2595248|P1|STARTED|Overall Study||128
1070550|NCT00914810|2595270|P2|NOT COMPLETED|Overall Study||1
1070551|NCT00914810|2595271|P1|NOT COMPLETED|Overall Study||2
1070552|NCT00914810|2595270|P2|COMPLETED|Overall Study||18
1070553|NCT00914810|2595271|P1|COMPLETED|Overall Study||18
1070554|NCT00914810|2595270|P2|STARTED|Overall Study||19
1070555|NCT00914810|2595271|P1|STARTED|Overall Study||20
1070556|NCT00914849|2595281|P2|NOT COMPLETED|Overall Study||1
1070557|NCT00914849|2595282|P1|NOT COMPLETED|Overall Study||1
1070558|NCT00914849|2595281|P2|COMPLETED|Overall Study||33
1070559|NCT00914849|2595282|P1|COMPLETED|Overall Study||33
1070560|NCT00914849|2595281|P2|STARTED|Overall Study||34
1070561|NCT00914849|2595282|P1|STARTED|Overall Study||34
1070562|NCT00914862|2595319|P5|NOT COMPLETED|Overall Study||0
1070563|NCT00914862|2595320|P4|NOT COMPLETED|Overall Study||0
1070564|NCT00914862|2595321|P3|NOT COMPLETED|Overall Study||0
1070565|NCT00914862|2595322|P2|NOT COMPLETED|Overall Study||0
1070566|NCT00914862|2595323|P1|NOT COMPLETED|Overall Study||0
1070567|NCT00914862|2595319|P5|COMPLETED|Overall Study||28
1070568|NCT00914862|2595320|P4|COMPLETED|Overall Study||8
1070569|NCT00914862|2595321|P3|COMPLETED|Overall Study||8
1070570|NCT00914862|2595322|P2|COMPLETED|Overall Study||6
1070571|NCT00914862|2595323|P1|COMPLETED|Overall Study||6
1070572|NCT00914862|2595319|P5|STARTED|Overall Study||28
1070573|NCT00914862|2595320|P4|STARTED|Overall Study||8
1070574|NCT00914862|2595321|P3|STARTED|Overall Study||8
1070575|NCT00914862|2595322|P2|STARTED|Overall Study||6
1070576|NCT00914862|2595323|P1|STARTED|Overall Study||6
1070577|NCT00914966|2595395|P1|NOT COMPLETED|Step 3: 2500 Units||0
1070578|NCT00914966|2595395|P1|COMPLETED|Step 3: 2500 Units||12
1070579|NCT00914966|2595395|P1|STARTED|Step 3: 2500 Units||12
1070580|NCT00914966|2595395|P1|NOT COMPLETED|Step 2: 2000 Units||1
1070581|NCT00914966|2595395|P1|COMPLETED|Step 2: 2000 Units||12
1070582|NCT00914966|2595395|P1|STARTED|Step 2: 2000 Units||13
1070583|NCT00914966|2595395|P1|NOT COMPLETED|Step 1: 1500 Units||2
1070584|NCT00914966|2595395|P1|COMPLETED|Step 1: 1500 Units|5/18 subjects completing Step 1 (1500 Units) entered the 3 month follow-up and did not dose escalate|18
1070585|NCT00914966|2595395|P1|STARTED|Step 1: 1500 Units||20
1070586|NCT00922935|2595410|P3|NOT COMPLETED|Overall Study||0
1070587|NCT00922935|2595411|P2|NOT COMPLETED|Overall Study||5
1070588|NCT00922935|2595412|P1|NOT COMPLETED|Overall Study||1
1070589|NCT00922935|2595410|P3|COMPLETED|Overall Study||10
1070590|NCT00922935|2595411|P2|COMPLETED|Overall Study||11
1070591|NCT00922935|2595412|P1|COMPLETED|Overall Study||9
1070592|NCT00922935|2595410|P3|STARTED|Overall Study||10
1070593|NCT00922935|2595411|P2|STARTED|Overall Study||16
1070594|NCT00922935|2595412|P1|STARTED|Overall Study||10
1070595|NCT00922987|2595420|P1|NOT COMPLETED|Overall Study||4
1070596|NCT00922987|2595420|P1|COMPLETED|Overall Study||277
1070597|NCT00922987|2595420|P1|STARTED|Overall Study||281
1070598|NCT00923091|2595440|P13|NOT COMPLETED|Period VI (Open-Label)||0
1070599|NCT00923091|2595441|P12|NOT COMPLETED|Period VI (Open-Label)||0
1070600|NCT00923091|2595442|P11|NOT COMPLETED|Period VI (Open-Label)||0
1070601|NCT00923091|2595443|P10|NOT COMPLETED|Period VI (Open-Label)||0
1070602|NCT00923091|2595444|P9|NOT COMPLETED|Period VI (Open-Label)||0
1070603|NCT00923091|2595445|P8|NOT COMPLETED|Period VI (Open-Label)||0
1070604|NCT00923091|2595446|P7|NOT COMPLETED|Period VI (Open-Label)||0
1070605|NCT00923091|2595447|P6|NOT COMPLETED|Period VI (Open-Label)||0
1070606|NCT00923091|2595448|P5|NOT COMPLETED|Period VI (Open-Label)||7
1070607|NCT00923091|2595449|P4|NOT COMPLETED|Period VI (Open-Label)||3
1070608|NCT00923091|2595450|P3|NOT COMPLETED|Period VI (Open-Label)||13
1070609|NCT00923091|2595451|P2|NOT COMPLETED|Period VI (Open-Label)||8
1070610|NCT00923091|2595452|P1|NOT COMPLETED|Period VI (Open-Label)||39
1070611|NCT00923091|2595440|P13|COMPLETED|Period VI (Open-Label)||0
1070612|NCT00923091|2595441|P12|COMPLETED|Period VI (Open-Label)||0
1070613|NCT00923091|2595442|P11|COMPLETED|Period VI (Open-Label)||0
1070614|NCT00923091|2595443|P10|COMPLETED|Period VI (Open-Label)||0
1070615|NCT00923091|2595444|P9|COMPLETED|Period VI (Open-Label)||0
1070616|NCT00923091|2595445|P8|COMPLETED|Period VI (Open-Label)||0
1070617|NCT00923091|2595446|P7|COMPLETED|Period VI (Open-Label)||0
1070618|NCT00923091|2595447|P6|COMPLETED|Period VI (Open-Label)||0
1070619|NCT00923091|2595448|P5|COMPLETED|Period VI (Open-Label)||157
1070620|NCT00923091|2595449|P4|COMPLETED|Period VI (Open-Label)||143
1070621|NCT00923091|2595450|P3|COMPLETED|Period VI (Open-Label)||467
1070622|NCT00923091|2595451|P2|COMPLETED|Period VI (Open-Label)||264
1070623|NCT00923091|2595452|P1|COMPLETED|Period VI (Open-Label)||1408
1070624|NCT00923091|2595440|P13|STARTED|Period VI (Open-Label)||0
1070625|NCT00923091|2595441|P12|STARTED|Period VI (Open-Label)||0
1070626|NCT00923091|2595442|P11|STARTED|Period VI (Open-Label)||0
1070627|NCT00923091|2595443|P10|STARTED|Period VI (Open-Label)||0
1070628|NCT00923091|2595444|P9|STARTED|Period VI (Open-Label)||0
1070629|NCT00923091|2595445|P8|STARTED|Period VI (Open-Label)||0
1070630|NCT00923091|2595446|P7|STARTED|Period VI (Open-Label)||0
1070631|NCT00923091|2595447|P6|STARTED|Period VI (Open-Label)||0
1070632|NCT00923091|2595448|P5|STARTED|Period VI (Open-Label)||164
1070633|NCT00923091|2595449|P4|STARTED|Period VI (Open-Label)||146
1070634|NCT00923091|2595450|P3|STARTED|Period VI (Open-Label)||480
1070635|NCT00923091|2595451|P2|STARTED|Period VI (Open-Label)||272
1070636|NCT00923091|2595452|P1|STARTED|Period VI (Open-Label)|1837 from Period III+2 from Period IV + 670 from Period 5 = 2509|1447
1070637|NCT00923091|2595440|P13|NOT COMPLETED|Period V (Double -Blind)||2
1070638|NCT00923091|2595441|P12|NOT COMPLETED|Period V (Double -Blind)||0
1070639|NCT00923091|2595442|P11|NOT COMPLETED|Period V (Double -Blind)||1
1070640|NCT00923091|2595443|P10|NOT COMPLETED|Period V (Double -Blind)||0
1070641|NCT00923091|2595444|P9|NOT COMPLETED|Period V (Double -Blind)||1
1070642|NCT00923091|2595445|P8|NOT COMPLETED|Period V (Double -Blind)||0
1070643|NCT00923091|2595446|P7|NOT COMPLETED|Period V (Double -Blind)||0
1070644|NCT00923091|2595447|P6|NOT COMPLETED|Period V (Double -Blind)||0
1070645|NCT00923091|2595448|P5|NOT COMPLETED|Period V (Double -Blind)||0
1070646|NCT00923091|2595449|P4|NOT COMPLETED|Period V (Double -Blind)||0
1070647|NCT00923091|2595450|P3|NOT COMPLETED|Period V (Double -Blind)||0
1070648|NCT00923091|2595451|P2|NOT COMPLETED|Period V (Double -Blind)||0
1070649|NCT00923091|2595452|P1|NOT COMPLETED|Period V (Double -Blind)||0
1070650|NCT00923091|2595440|P13|COMPLETED|Period V (Double -Blind)||73
1070651|NCT00923091|2595441|P12|COMPLETED|Period V (Double -Blind)||151
1070652|NCT00923091|2595442|P11|COMPLETED|Period V (Double -Blind)||193
1070653|NCT00923091|2595443|P10|COMPLETED|Period V (Double -Blind)||119
1070654|NCT00923091|2595444|P9|COMPLETED|Period V (Double -Blind)||134
1070655|NCT00923091|2595445|P8|COMPLETED|Period V (Double -Blind)||0
1070656|NCT00923091|2595446|P7|COMPLETED|Period V (Double -Blind)||0
1070657|NCT00923091|2595447|P6|COMPLETED|Period V (Double -Blind)||0
1070658|NCT00923091|2595448|P5|COMPLETED|Period V (Double -Blind)||0
1070659|NCT00923091|2595449|P4|COMPLETED|Period V (Double -Blind)||0
1070660|NCT00923091|2595450|P3|COMPLETED|Period V (Double -Blind)||0
1070661|NCT00923091|2595451|P2|COMPLETED|Period V (Double -Blind)||0
1070662|NCT00923091|2595452|P1|COMPLETED|Period V (Double -Blind)||0
1070663|NCT00923091|2595440|P13|STARTED|Period V (Double -Blind)||75
1070664|NCT00923091|2595441|P12|STARTED|Period V (Double -Blind)||151
1070665|NCT00923091|2595442|P11|STARTED|Period V (Double -Blind)||194
1070666|NCT00923091|2595443|P10|STARTED|Period V (Double -Blind)||119
1070667|NCT00923091|2595444|P9|STARTED|Period V (Double -Blind)||135
1070668|NCT00923091|2595445|P8|STARTED|Period V (Double -Blind)||0
1070669|NCT00923091|2595446|P7|STARTED|Period V (Double -Blind)||0
1070670|NCT00923091|2595447|P6|STARTED|Period V (Double -Blind)||0
1070671|NCT00923091|2595448|P5|STARTED|Period V (Double -Blind)||0
1070672|NCT00923091|2595449|P4|STARTED|Period V (Double -Blind)||0
1070673|NCT00923091|2595450|P3|STARTED|Period V (Double -Blind)||0
1070674|NCT00923091|2595451|P2|STARTED|Period V (Double -Blind)||0
1070675|NCT00923091|2595452|P1|STARTED|Period V (Double -Blind)|677 completed Period 4. 1 did not continue and 2 erroneously responders were not counted = 674|0
1070676|NCT00923091|2595440|P13|NOT COMPLETED|Period IV (Double-Blind)||0
1070677|NCT00923091|2595441|P12|NOT COMPLETED|Period IV (Double-Blind)||0
1070678|NCT00923091|2595442|P11|NOT COMPLETED|Period IV (Double-Blind)||0
1070679|NCT00923091|2595443|P10|NOT COMPLETED|Period IV (Double-Blind)||0
1070680|NCT00923091|2595444|P9|NOT COMPLETED|Period IV (Double-Blind)||0
1070681|NCT00923091|2595445|P8|NOT COMPLETED|Period IV (Double-Blind)||0
1070682|NCT00923091|2595446|P7|NOT COMPLETED|Period IV (Double-Blind)||0
1070683|NCT00923091|2595447|P6|NOT COMPLETED|Period IV (Double-Blind)||0
1070684|NCT00923091|2595448|P5|NOT COMPLETED|Period IV (Double-Blind)||0
1070685|NCT00923091|2595449|P4|NOT COMPLETED|Period IV (Double-Blind)||0
1070686|NCT00923091|2595450|P3|NOT COMPLETED|Period IV (Double-Blind)||0
1070687|NCT00923091|2595451|P2|NOT COMPLETED|Period IV (Double-Blind)||2
1070688|NCT00923091|2595452|P1|NOT COMPLETED|Period IV (Double-Blind)||2
1070689|NCT00923091|2595440|P13|COMPLETED|Period IV (Double-Blind)||0
1070690|NCT00923091|2595441|P12|COMPLETED|Period IV (Double-Blind)||0
1070691|NCT00923091|2595442|P11|COMPLETED|Period IV (Double-Blind)||0
1070692|NCT00923091|2595443|P10|COMPLETED|Period IV (Double-Blind)||0
1070693|NCT00923091|2595444|P9|COMPLETED|Period IV (Double-Blind)||0
1070694|NCT00923091|2595445|P8|COMPLETED|Period IV (Double-Blind)||0
1070695|NCT00923091|2595446|P7|COMPLETED|Period IV (Double-Blind)||0
1070696|NCT00923091|2595447|P6|COMPLETED|Period IV (Double-Blind)||0
1070697|NCT00923091|2595448|P5|COMPLETED|Period IV (Double-Blind)||0
1070698|NCT00923091|2595449|P4|COMPLETED|Period IV (Double-Blind)||0
1070699|NCT00923091|2595450|P3|COMPLETED|Period IV (Double-Blind)||0
1070700|NCT00923091|2595451|P2|COMPLETED|Period IV (Double-Blind)||451
1070701|NCT00923091|2595452|P1|COMPLETED|Period IV (Double-Blind)||226
1070702|NCT00923091|2595440|P13|STARTED|Period IV (Double-Blind)||0
1070703|NCT00923091|2595441|P12|STARTED|Period IV (Double-Blind)||0
1070704|NCT00923091|2595442|P11|STARTED|Period IV (Double-Blind)||0
1070705|NCT00923091|2595443|P10|STARTED|Period IV (Double-Blind)||0
1070706|NCT00923091|2595444|P9|STARTED|Period IV (Double-Blind)||0
1070707|NCT00923091|2595445|P8|STARTED|Period IV (Double-Blind)||0
1070708|NCT00923091|2595446|P7|STARTED|Period IV (Double-Blind)||0
1070709|NCT00923091|2595447|P6|STARTED|Period IV (Double-Blind)||0
1070710|NCT00923091|2595448|P5|STARTED|Period IV (Double-Blind)||0
1070711|NCT00923091|2595449|P4|STARTED|Period IV (Double-Blind)||0
1070712|NCT00923091|2595450|P3|STARTED|Period IV (Double-Blind)||0
1070713|NCT00923091|2595451|P2|STARTED|Period IV (Double-Blind)||453
1070714|NCT00923091|2595452|P1|STARTED|Period IV (Double-Blind)|2 did not continue in the study and 1837 responders went directly to Period VI. 228+453+2+1837=2520|228
1070715|NCT00923091|2595440|P13|NOT COMPLETED|Period III (Single-Blind)||0
1070716|NCT00923091|2595441|P12|NOT COMPLETED|Period III (Single-Blind)||0
1070717|NCT00923091|2595442|P11|NOT COMPLETED|Period III (Single-Blind)||0
1070718|NCT00923091|2595443|P10|NOT COMPLETED|Period III (Single-Blind)||0
1070719|NCT00923091|2595444|P9|NOT COMPLETED|Period III (Single-Blind)||0
1070720|NCT00923091|2595445|P8|NOT COMPLETED|Period III (Single-Blind)||0
1070721|NCT00923091|2595446|P7|NOT COMPLETED|Period III (Single-Blind)||0
1070722|NCT00923091|2595447|P6|NOT COMPLETED|Period III (Single-Blind)||0
1070723|NCT00923091|2595448|P5|NOT COMPLETED|Period III (Single-Blind)||0
1070724|NCT00923091|2595449|P4|NOT COMPLETED|Period III (Single-Blind)||0
1070725|NCT00923091|2595450|P3|NOT COMPLETED|Period III (Single-Blind)||0
1070726|NCT00923091|2595451|P2|NOT COMPLETED|Period III (Single-Blind)||0
1070727|NCT00923091|2595452|P1|NOT COMPLETED|Period III (Single-Blind)||20
1070728|NCT00923091|2595440|P13|COMPLETED|Period III (Single-Blind)||0
1070729|NCT00923091|2595441|P12|COMPLETED|Period III (Single-Blind)||0
1070730|NCT00923091|2595442|P11|COMPLETED|Period III (Single-Blind)||0
1070731|NCT00923091|2595443|P10|COMPLETED|Period III (Single-Blind)||0
1070732|NCT00923091|2595444|P9|COMPLETED|Period III (Single-Blind)||0
1070733|NCT00923091|2595445|P8|COMPLETED|Period III (Single-Blind)||0
1070734|NCT00923091|2595446|P7|COMPLETED|Period III (Single-Blind)||0
1070735|NCT00923091|2595447|P6|COMPLETED|Period III (Single-Blind)||0
1070736|NCT00923091|2595448|P5|COMPLETED|Period III (Single-Blind)||0
1070737|NCT00923091|2595449|P4|COMPLETED|Period III (Single-Blind)||0
1070738|NCT00923091|2595450|P3|COMPLETED|Period III (Single-Blind)||0
1070739|NCT00923091|2595451|P2|COMPLETED|Period III (Single-Blind)||0
1070740|NCT00923091|2595452|P1|COMPLETED|Period III (Single-Blind)||2520
1070741|NCT00923091|2595440|P13|STARTED|Period III (Single-Blind)||0
1070742|NCT00923091|2595441|P12|STARTED|Period III (Single-Blind)||0
1070743|NCT00923091|2595442|P11|STARTED|Period III (Single-Blind)||0
1070744|NCT00923091|2595443|P10|STARTED|Period III (Single-Blind)||0
1070745|NCT00923091|2595444|P9|STARTED|Period III (Single-Blind)||0
1070746|NCT00923091|2595445|P8|STARTED|Period III (Single-Blind)||0
1070747|NCT00923091|2595446|P7|STARTED|Period III (Single-Blind)||0
1070748|NCT00923091|2595447|P6|STARTED|Period III (Single-Blind)||0
1070749|NCT00923091|2595448|P5|STARTED|Period III (Single-Blind)||0
1070750|NCT00923091|2595449|P4|STARTED|Period III (Single-Blind)||0
1070751|NCT00923091|2595450|P3|STARTED|Period III (Single-Blind)||0
1070752|NCT00923091|2595451|P2|STARTED|Period III (Single-Blind)||0
1070753|NCT00923091|2595452|P1|STARTED|Period III (Single-Blind)|2543 completed Period 2. Three decided not to continue in the study=2540.|2540
1070754|NCT00923091|2595440|P13|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
1070755|NCT00923091|2595441|P12|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
1070756|NCT00923091|2595442|P11|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
1070757|NCT00923091|2595443|P10|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
1070758|NCT00923091|2595444|P9|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
1070759|NCT00923091|2595445|P8|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||25
1070760|NCT00923091|2595446|P7|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||18
1070761|NCT00923091|2595447|P6|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||15
1070762|NCT00923091|2595448|P5|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||21
1070763|NCT00923091|2595449|P4|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||27
1070764|NCT00923091|2595450|P3|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||13
1070765|NCT00923091|2595451|P2|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||11
1070766|NCT00923091|2595452|P1|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||16
1070767|NCT00923091|2595440|P13|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
1070768|NCT00923091|2595441|P12|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
1070769|NCT00923091|2595442|P11|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
1070770|NCT00923091|2595443|P10|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
1070771|NCT00923091|2595444|P9|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
1070772|NCT00923091|2595445|P8|COMPLETED|PeriodI-II (Randomized, Double-Blind)||311
1070773|NCT00923091|2595446|P7|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
1070774|NCT00923091|2595447|P6|COMPLETED|PeriodI-II (Randomized, Double-Blind)||322
1070775|NCT00923091|2595448|P5|COMPLETED|PeriodI-II (Randomized, Double-Blind)||315
1070776|NCT00923091|2595449|P4|COMPLETED|PeriodI-II (Randomized, Double-Blind)||309
1070777|NCT00923091|2595450|P3|COMPLETED|PeriodI-II (Randomized, Double-Blind)||323
1070778|NCT00923091|2595451|P2|COMPLETED|PeriodI-II (Randomized, Double-Blind)||325
1070779|NCT00923091|2595452|P1|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
1070780|NCT00923091|2595440|P13|STARTED|PeriodI-II (Randomized, Double-Blind)||0
1070781|NCT00923091|2595441|P12|STARTED|PeriodI-II (Randomized, Double-Blind)||0
1070782|NCT00923091|2595442|P11|STARTED|PeriodI-II (Randomized, Double-Blind)||0
1070783|NCT00923091|2595443|P10|STARTED|PeriodI-II (Randomized, Double-Blind)||0
1070784|NCT00923091|2595444|P9|STARTED|PeriodI-II (Randomized, Double-Blind)||0
1070785|NCT00923091|2595445|P8|STARTED|PeriodI-II (Randomized, Double-Blind)||336
1070786|NCT00923091|2595446|P7|STARTED|PeriodI-II (Randomized, Double-Blind)||337
1070787|NCT00923091|2595447|P6|STARTED|PeriodI-II (Randomized, Double-Blind)||337
1070788|NCT00923091|2595448|P5|STARTED|PeriodI-II (Randomized, Double-Blind)||336
1070789|NCT00923091|2595449|P4|STARTED|PeriodI-II (Randomized, Double-Blind)||336
1070790|NCT00923091|2595450|P3|STARTED|PeriodI-II (Randomized, Double-Blind)||336
1070791|NCT00923091|2595451|P2|STARTED|PeriodI-II (Randomized, Double-Blind)||336
1070792|NCT00923091|2595452|P1|STARTED|PeriodI-II (Randomized, Double-Blind)||335
1070793|NCT00923117|2595501|P2|NOT COMPLETED|Overall Study||0
1070794|NCT00923117|2595502|P1|NOT COMPLETED|Overall Study||0
1070795|NCT00923117|2595501|P2|COMPLETED|Overall Study||43
1070796|NCT00923117|2595502|P1|COMPLETED|Overall Study||44
1070797|NCT00923117|2595501|P2|STARTED|Overall Study||43
1070798|NCT00923117|2595502|P1|STARTED|Overall Study||44
1070799|NCT00923130|2595510|P1|NOT COMPLETED|Overall Study||25
1070800|NCT00923130|2595510|P1|COMPLETED|Overall Study||5
1070801|NCT00923130|2595510|P1|STARTED|Overall Study||30
1070802|NCT00923156|2595529|P3|NOT COMPLETED|Overall Study||3
1070803|NCT00923156|2595530|P2|NOT COMPLETED|Overall Study||4
1070804|NCT00923156|2595531|P1|NOT COMPLETED|Overall Study||0
1070805|NCT00923156|2595529|P3|COMPLETED|Overall Study||38
1070806|NCT00923156|2595530|P2|COMPLETED|Overall Study||38
1070807|NCT00923156|2595531|P1|COMPLETED|Overall Study||40
1070808|NCT00923156|2595529|P3|STARTED|Overall Study||41
1070809|NCT00923156|2595530|P2|STARTED|Overall Study||42
1070810|NCT00923156|2595531|P1|STARTED|Overall Study|"Started indicates randomized, safety and pharmacodynamic population"|40
1070811|NCT00923195|2595559|P2|NOT COMPLETED|Overall Study||1
1070812|NCT00923195|2595560|P1|NOT COMPLETED|Overall Study||0
1070813|NCT00923195|2595559|P2|COMPLETED|Overall Study||1
1070814|NCT00923195|2595560|P1|COMPLETED|Overall Study||2
1070815|NCT00923195|2595559|P2|STARTED|Overall Study||2
1070816|NCT00923195|2595560|P1|STARTED|Overall Study||2
1070817|NCT00923247|2595570|P2|NOT COMPLETED|Overall Study||0
1070818|NCT00923247|2595571|P1|NOT COMPLETED|Overall Study||0
1070819|NCT00923247|2595570|P2|COMPLETED|Overall Study||1
1070820|NCT00923247|2595571|P1|COMPLETED|Overall Study||21
1070821|NCT00923247|2595570|P2|STARTED|Overall Study||1
1070822|NCT00923247|2595571|P1|STARTED|Overall Study||21
1070823|NCT00923260|2595599|P2|NOT COMPLETED|Overall Study||1
1070824|NCT00923260|2595600|P1|NOT COMPLETED|Overall Study||1
1070825|NCT00923260|2595599|P2|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
1070826|NCT00923260|2595600|P1|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
1070827|NCT00923260|2595599|P2|STARTED|Overall Study||12
1070828|NCT00923260|2595600|P1|STARTED|Overall Study||12
1070829|NCT00923845|2595734|P2|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
1070830|NCT00923845|2595735|P1|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
1070831|NCT00923845|2595734|P2|COMPLETED|Allogeneic Stem Cell Therapy||10
1070832|NCT00923845|2595735|P1|COMPLETED|Allogeneic Stem Cell Therapy||0
1070833|NCT00923845|2595734|P2|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||6
1070834|NCT00923845|2595735|P1|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||0
1070835|NCT00923845|2595734|P2|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||8
1070836|NCT00923845|2595735|P1|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||0
1070837|NCT00923845|2595734|P2|STARTED|Allogeneic Stem Cell Therapy||10
1070838|NCT00923845|2595735|P1|STARTED|Allogeneic Stem Cell Therapy||0
1070839|NCT00923845|2595734|P2|NOT COMPLETED|Induction Therapy||2
1070840|NCT00923845|2595735|P1|NOT COMPLETED|Induction Therapy||0
1070841|NCT00923845|2595734|P2|COMPLETED|Induction Therapy||10
1070842|NCT00923845|2595735|P1|COMPLETED|Induction Therapy||0
1070843|NCT00923845|2595734|P2|STARTED|Induction Therapy||12
1070844|NCT00923845|2595735|P1|STARTED|Induction Therapy||0
1070845|NCT00923845|2595734|P2|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
1070846|NCT00923845|2595735|P1|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
1070847|NCT00923845|2595734|P2|COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
1070848|NCT00923845|2595735|P1|COMPLETED|Donor Hematopoietic Stem Cell Harvest||13
1070849|NCT00923845|2595734|P2|STARTED|Donor Hematopoietic Stem Cell Harvest||0
1070850|NCT00923845|2595735|P1|STARTED|Donor Hematopoietic Stem Cell Harvest||13
1070851|NCT00923845|2595734|P2|NOT COMPLETED|Donor Lymphocyte Harvest||0
1070852|NCT00923845|2595735|P1|NOT COMPLETED|Donor Lymphocyte Harvest||0
1070853|NCT00923845|2595734|P2|COMPLETED|Donor Lymphocyte Harvest||0
1070854|NCT00923845|2595735|P1|COMPLETED|Donor Lymphocyte Harvest||13
1070855|NCT00923845|2595734|P2|STARTED|Donor Lymphocyte Harvest||0
1070856|NCT00923845|2595735|P1|STARTED|Donor Lymphocyte Harvest||13
1070857|NCT00923910|2595758|P2|NOT COMPLETED|Period 2||0
1070858|NCT00923910|2595759|P1|NOT COMPLETED|Period 2||0
1070859|NCT00923910|2595758|P2|COMPLETED|Period 2||5
1070860|NCT00923910|2595759|P1|COMPLETED|Period 2||5
1070861|NCT00923910|2595758|P2|STARTED|Period 2||5
1070862|NCT00923910|2595759|P1|STARTED|Period 2||5
1070863|NCT00923910|2595758|P2|NOT COMPLETED|Period 1||0
1070864|NCT00923910|2595759|P1|NOT COMPLETED|Period 1||0
1070865|NCT00923910|2595758|P2|COMPLETED|Period 1||5
1070866|NCT00923910|2595759|P1|COMPLETED|Period 1||5
1070867|NCT00923910|2595758|P2|STARTED|Period 1||5
1070868|NCT00923910|2595759|P1|STARTED|Period 1||5
1070869|NCT00923936|2595771|P2|NOT COMPLETED|Overall Study||3
1070870|NCT00923936|2595772|P1|NOT COMPLETED|Overall Study||8
1070871|NCT00923936|2595771|P2|COMPLETED|Overall Study||3
1070872|NCT00923936|2595772|P1|COMPLETED|Overall Study||2
1070873|NCT00923936|2595771|P2|STARTED|Overall Study||6
1070874|NCT00923936|2595772|P1|STARTED|Overall Study||10
1070875|NCT00923949|2595786|P1|NOT COMPLETED|Overall Study||0
1070876|NCT00923949|2595786|P1|COMPLETED|Overall Study||1
1070877|NCT00923949|2595786|P1|STARTED|Overall Study||1
1070878|NCT00923975|2595796|P1|NOT COMPLETED|Overall Study||1
1070879|NCT00923975|2595796|P1|COMPLETED|Overall Study|One subject did not meet inclusion criteria; the data was not used in analysis.|50
1070880|NCT00923975|2595796|P1|STARTED|Overall Study||51
1070881|NCT00924001|2595803|P1|NOT COMPLETED|Overall Study||0
1070882|NCT00924001|2595803|P1|COMPLETED|Overall Study||1
1070883|NCT00924001|2595803|P1|STARTED|Overall Study||1
1070884|NCT00924040|2595809|P1|NOT COMPLETED|Overall Study||0
1070885|NCT00924040|2595809|P1|COMPLETED|Overall Study||1
1070886|NCT00924040|2595809|P1|STARTED|Overall Study||1
1070887|NCT00924053|2595825|P4|NOT COMPLETED|Overall Study||0
1070888|NCT00924053|2595826|P3|NOT COMPLETED|Overall Study||0
1070889|NCT00924053|2595827|P2|NOT COMPLETED|Overall Study||0
1070890|NCT00924053|2595828|P1|NOT COMPLETED|Overall Study||0
1070891|NCT00924053|2595825|P4|COMPLETED|Overall Study||6
1070892|NCT00924053|2595826|P3|COMPLETED|Overall Study||6
1070893|NCT00924053|2595827|P2|COMPLETED|Overall Study||6
1070894|NCT00924053|2595828|P1|COMPLETED|Overall Study||6
1070895|NCT00924053|2595825|P4|STARTED|Overall Study||6
1070896|NCT00924053|2595826|P3|STARTED|Overall Study||6
1070897|NCT00924053|2595827|P2|STARTED|Overall Study||6
1070898|NCT00924053|2595828|P1|STARTED|Overall Study||6
1070899|NCT00924066|2595874|P1|NOT COMPLETED|Overall Study||0
1070900|NCT00924066|2595874|P1|COMPLETED|Overall Study||41
1070901|NCT00924066|2595874|P1|STARTED|Overall Study||41
1070902|NCT00924118|2595881|P2|NOT COMPLETED|Overall Study||0
1070903|NCT00924118|2595882|P1|NOT COMPLETED|Overall Study||0
1070904|NCT00924118|2595881|P2|COMPLETED|Overall Study||15
1070905|NCT00924118|2595882|P1|COMPLETED|Overall Study||15
1070906|NCT00924118|2595881|P2|STARTED|Overall Study||15
1070907|NCT00924118|2595882|P1|STARTED|Overall Study||15
1070908|NCT00924170|2595892|P2|NOT COMPLETED|Overall Study||8
1070909|NCT00924170|2595893|P1|NOT COMPLETED|Overall Study||7
1070910|NCT00924170|2595892|P2|COMPLETED|Overall Study||0
1070911|NCT00924170|2595893|P1|COMPLETED|Overall Study||3
1070912|NCT00924170|2595892|P2|STARTED|Overall Study||8
1070913|NCT00924170|2595893|P1|STARTED|Overall Study||10
1070914|NCT00924209|2595931|P1|NOT COMPLETED|Overall Study||0
1070915|NCT00924209|2595931|P1|COMPLETED|Overall Study||7
1070916|NCT00924209|2595931|P1|STARTED|Overall Study||7
1070917|NCT00924287|2595936|P1|NOT COMPLETED|Overall Study||1
1070918|NCT00924287|2595936|P1|COMPLETED|Overall Study||0
1070919|NCT00924287|2595936|P1|STARTED|Overall Study||1
1070920|NCT00924313|2595942|P1|NOT COMPLETED|Overall Study||1
1070921|NCT00924313|2595942|P1|COMPLETED|Overall Study||39
1070922|NCT00924313|2595942|P1|STARTED|Overall Study||40
1070923|NCT00924352|2595954|P2|NOT COMPLETED|Overall Study||0
1070924|NCT00924352|2595955|P1|NOT COMPLETED|Overall Study||0
1070925|NCT00924352|2595954|P2|COMPLETED|Overall Study||44
1070926|NCT00924352|2595955|P1|COMPLETED|Overall Study||12
1070927|NCT00924352|2595954|P2|STARTED|Overall Study||44
1070928|NCT00924352|2595955|P1|STARTED|Overall Study||12
1070929|NCT00924404|2595970|P2|NOT COMPLETED|Overall Study||4
1070930|NCT00924404|2595971|P1|NOT COMPLETED|Overall Study||6
1070931|NCT00924404|2595970|P2|COMPLETED|Overall Study||22
1070932|NCT00924404|2595971|P1|COMPLETED|Overall Study||21
1070933|NCT00924404|2595970|P2|STARTED|Overall Study||26
1070934|NCT00924404|2595971|P1|STARTED|Overall Study||27
1070935|NCT00924443|2595977|P1|NOT COMPLETED|Overall Study||3
1070936|NCT00924443|2595977|P1|COMPLETED|Overall Study||66
1070937|NCT00924443|2595977|P1|Full Analysis Set (Received Study Drug)|Overall Study||66
1070938|NCT00924443|2595977|P1|STARTED|Overall Study||69
1070939|NCT00924469|2595987|P2|NOT COMPLETED|Overall Study||2
1070940|NCT00924469|2595988|P1|NOT COMPLETED|Overall Study||2
1070941|NCT00924469|2595987|P2|COMPLETED|Overall Study||26
1070942|NCT00924469|2595988|P1|COMPLETED|Overall Study||28
1070943|NCT00924469|2595987|P2|STARTED|Overall Study||28
1070944|NCT00924469|2595988|P1|STARTED|Overall Study||30
1070945|NCT00924482|2596010|P1|NOT COMPLETED|Overall Study||0
1070946|NCT00924482|2596010|P1|COMPLETED|Overall Study||261
1070947|NCT00924482|2596010|P1|STARTED|Overall Study||261
1070948|NCT00924508|2596015|P1|NOT COMPLETED|Overall Study||3
1070949|NCT00924508|2596015|P1|COMPLETED|Overall Study||20
1070950|NCT00924508|2596015|P1|STARTED|Overall Study||23
1070951|NCT00924560|2596025|P3|NOT COMPLETED|Overall Study||83
1070952|NCT00924560|2596026|P2|NOT COMPLETED|Overall Study||208
1070953|NCT00924560|2596027|P1|NOT COMPLETED|Overall Study||211
1070954|NCT00924560|2596025|P3|COMPLETED|Overall Study||372
1070955|NCT00924560|2596026|P2|COMPLETED|Overall Study||240
1070956|NCT00924560|2596027|P1|COMPLETED|Overall Study||247
1070957|NCT00924560|2596025|P3|Received Treatment|Overall Study||0
1070958|NCT00924560|2596026|P2|Received Treatment|Overall Study|Excludes 9 participants from one site that was closed due to audit findings.|411
1070959|NCT00924560|2596027|P1|Received Treatment|Overall Study|Excludes 7 participants at 1 site that was closed. One participant received 28-day OC in error.|422
1070960|NCT00924560|2596025|P3|STARTED|Overall Study||455
1070961|NCT00924560|2596026|P2|STARTED|Overall Study||448
1070962|NCT00924560|2596027|P1|STARTED|Overall Study||458
1070963|NCT00924638|2596073|P2|NOT COMPLETED|Overall Study||13
1070964|NCT00924638|2596074|P1|NOT COMPLETED|Overall Study||12
1070965|NCT00924638|2596073|P2|COMPLETED|Overall Study|Completed 6 months of follow-up|207
1070966|NCT00924638|2596074|P1|COMPLETED|Overall Study|Completed 6 months of follow-up|209
1070967|NCT00924638|2596073|P2|STARTED|Overall Study|Randomized to Control Arm|220
1070968|NCT00924638|2596074|P1|STARTED|Overall Study|Randomized to Continuous Monitoring Arm|221
1070969|NCT00924651|2596095|P2|NOT COMPLETED|Overall Study||25
1070970|NCT00924651|2596096|P1|NOT COMPLETED|Overall Study||25
1070971|NCT00924651|2596095|P2|COMPLETED|Overall Study||312
1070972|NCT00924651|2596096|P1|COMPLETED|Overall Study||331
1070973|NCT00924651|2596095|P2|STARTED|Overall Study||337
1070974|NCT00924651|2596096|P1|STARTED|Overall Study||356
1070981|NCT00924781|2596115|P2|NOT COMPLETED|Overall Study||10
1070982|NCT00924781|2596116|P1|NOT COMPLETED|Overall Study||12
1070983|NCT00924781|2596115|P2|COMPLETED|Overall Study||9
1070984|NCT00924781|2596116|P1|COMPLETED|Overall Study||8
1070985|NCT00924781|2596115|P2|STARTED|Overall Study||19
1070986|NCT00924781|2596116|P1|STARTED|Overall Study||20
1070987|NCT00924807|2596148|P1|NOT COMPLETED|Overall Study||0
1070988|NCT00924807|2596148|P1|COMPLETED|Overall Study||4
1070989|NCT00924807|2596148|P1|STARTED|Overall Study||4
1070990|NCT00924833|2596155|P3|NOT COMPLETED|Overall Study||0
1070991|NCT00924833|2596156|P2|NOT COMPLETED|Overall Study||0
1070992|NCT00924833|2596157|P1|NOT COMPLETED|Overall Study||0
1070993|NCT00924833|2596155|P3|COMPLETED|Overall Study|1 subject was excluded from the analysis for medical problems unrelated to the study.|9
1070994|NCT00924833|2596156|P2|COMPLETED|Overall Study|1 subject was excluded from the analysis for incomplete data.|9
1070995|NCT00924833|2596157|P1|COMPLETED|Overall Study|7 subjects analyzed (2 were excluded for poor cardiopulmonary exercise stress test quality).|9
1070996|NCT00924833|2596155|P3|STARTED|Overall Study||9
1070997|NCT00924833|2596156|P2|STARTED|Overall Study||9
1070998|NCT00924833|2596157|P1|STARTED|Overall Study||9
1070999|NCT00924898|2596171|P1|NOT COMPLETED|Overall Study||2
1071000|NCT00924898|2596171|P1|COMPLETED|Overall Study||90
1071001|NCT00924898|2596171|P1|STARTED|Overall Study||92
1071002|NCT00924950|2596180|P1|NOT COMPLETED|Overall Study||2
1071003|NCT00924950|2596180|P1|COMPLETED|Overall Study||28
1071004|NCT00924950|2596180|P1|STARTED|Overall Study||30
1071005|NCT00925015|2596188|P3|NOT COMPLETED|Overall Study||6
1071006|NCT00925015|2596189|P2|NOT COMPLETED|Overall Study||6
1071007|NCT00925015|2596190|P1|NOT COMPLETED|Overall Study||8
1071008|NCT00925015|2596188|P3|COMPLETED|Overall Study||0
1071009|NCT00925015|2596189|P2|COMPLETED|Overall Study||0
1071010|NCT00925015|2596190|P1|COMPLETED|Overall Study||0
1071011|NCT00925015|2596188|P3|STARTED|Overall Study||6
1071012|NCT00925015|2596189|P2|STARTED|Overall Study||6
1071013|NCT00925015|2596190|P1|STARTED|Overall Study||8
1071014|NCT00925132|2596246|P5|NOT COMPLETED|Overall Study||5
1071015|NCT00925132|2596247|P4|NOT COMPLETED|Overall Study||0
1071016|NCT00925132|2596248|P3|NOT COMPLETED|Overall Study||0
1071017|NCT00925132|2596249|P2|NOT COMPLETED|Overall Study||0
1071018|NCT00925132|2596250|P1|NOT COMPLETED|Overall Study||2
1071019|NCT00925132|2596246|P5|COMPLETED|Overall Study||17
1071020|NCT00925132|2596247|P4|COMPLETED|Overall Study||4
1071021|NCT00925132|2596248|P3|COMPLETED|Overall Study||4
1071022|NCT00925132|2596249|P2|COMPLETED|Overall Study||4
1071023|NCT00925132|2596250|P1|COMPLETED|Overall Study||3
1071024|NCT00925132|2596246|P5|STARTED|Overall Study||22
1071025|NCT00925132|2596247|P4|STARTED|Overall Study||4
1071026|NCT00925132|2596248|P3|STARTED|Overall Study||4
1071027|NCT00925132|2596249|P2|STARTED|Overall Study||4
1071028|NCT00925132|2596250|P1|STARTED|Overall Study||5
1071029|NCT00925288|2596258|P2|NOT COMPLETED|Overall Study||7
1071030|NCT00925288|2596259|P1|NOT COMPLETED|Overall Study||9
1071031|NCT00925288|2596258|P2|COMPLETED|Overall Study||93
1071032|NCT00925288|2596259|P1|COMPLETED|Overall Study||91
1071033|NCT00925288|2596258|P2|STARTED|Overall Study||100
1071034|NCT00925288|2596259|P1|STARTED|Overall Study||100
1071035|NCT00925353|2596271|P1|NOT COMPLETED|Overall Study||3
1071036|NCT00925353|2596271|P1|COMPLETED|Overall Study||10
1071037|NCT00925353|2596271|P1|STARTED|Overall Study||13
1071038|NCT00925522|2596275|P1|NOT COMPLETED|Overall Study||0
1071039|NCT00925522|2596275|P1|COMPLETED|Overall Study||20
1071040|NCT00925522|2596275|P1|STARTED|Overall Study||20
1071041|NCT00925548|2596281|P2|NOT COMPLETED|Overall Study||5
1071042|NCT00925548|2596282|P1|NOT COMPLETED|Overall Study||10
1071043|NCT00925548|2596281|P2|COMPLETED|Overall Study||0
1071044|NCT00925548|2596282|P1|COMPLETED|Overall Study||1
1071045|NCT00925548|2596281|P2|STARTED|Overall Study||5
1071046|NCT00925548|2596282|P1|STARTED|Overall Study||11
1071047|NCT00925587|2596310|P2|NOT COMPLETED|Overall Study||25
1071048|NCT00925587|2596311|P1|NOT COMPLETED|Overall Study||36
1071049|NCT00925587|2596310|P2|COMPLETED|Overall Study||155
1071050|NCT00925587|2596311|P1|COMPLETED|Overall Study||142
1071051|NCT00925587|2596310|P2|STARTED|Overall Study||180
1071052|NCT00925587|2596311|P1|STARTED|Overall Study||178
1071053|NCT00925600|2596425|P2|NOT COMPLETED|Overall Study||28
1071054|NCT00925600|2596426|P1|NOT COMPLETED|Overall Study||32
1071055|NCT00925600|2596425|P2|COMPLETED|Overall Study||355
1071056|NCT00925600|2596426|P1|COMPLETED|Overall Study||354
1071057|NCT00925600|2596425|P2|Received Treatment|Overall Study||382
1071058|NCT00925600|2596426|P1|Received Treatment|Overall Study|Three participants received at least 1 dose of denosumab in error|383
1071059|NCT00925600|2596425|P2|STARTED|Overall Study||383
1071060|NCT00925600|2596426|P1|STARTED|Overall Study||386
1071061|NCT00925704|2596452|P6|NOT COMPLETED|Third Intervention||1
1071062|NCT00925704|2596453|P5|NOT COMPLETED|Third Intervention||0
1071063|NCT00925704|2596454|P4|NOT COMPLETED|Third Intervention||0
1071064|NCT00925704|2596455|P3|NOT COMPLETED|Third Intervention||0
1071065|NCT00925704|2596456|P2|NOT COMPLETED|Third Intervention||0
1071066|NCT00925704|2596457|P1|NOT COMPLETED|Third Intervention||0
1071067|NCT00925704|2596452|P6|COMPLETED|Third Intervention||6
1071068|NCT00925704|2596453|P5|COMPLETED|Third Intervention||5
1071069|NCT00925704|2596454|P4|COMPLETED|Third Intervention||6
1071070|NCT00925704|2596455|P3|COMPLETED|Third Intervention||7
1071071|NCT00925704|2596456|P2|COMPLETED|Third Intervention||7
1071072|NCT00925704|2596457|P1|COMPLETED|Third Intervention||5
1071073|NCT00925704|2596452|P6|STARTED|Third Intervention||7
1071074|NCT00925704|2596453|P5|STARTED|Third Intervention||5
1071075|NCT00925704|2596454|P4|STARTED|Third Intervention||6
1071076|NCT00925704|2596455|P3|STARTED|Third Intervention||7
1071077|NCT00925704|2596456|P2|STARTED|Third Intervention||7
1071078|NCT00925704|2596457|P1|STARTED|Third Intervention||5
1071079|NCT00925704|2596452|P6|NOT COMPLETED|Washout||0
1071080|NCT00925704|2596453|P5|NOT COMPLETED|Washout||0
1071081|NCT00925704|2596454|P4|NOT COMPLETED|Washout||0
1071082|NCT00925704|2596455|P3|NOT COMPLETED|Washout||0
1071083|NCT00925704|2596456|P2|NOT COMPLETED|Washout||0
1071084|NCT00925704|2596457|P1|NOT COMPLETED|Washout||0
1071085|NCT00925704|2596452|P6|COMPLETED|Washout||7
1071086|NCT00925704|2596453|P5|COMPLETED|Washout||5
1071087|NCT00925704|2596454|P4|COMPLETED|Washout||6
1071088|NCT00925704|2596455|P3|COMPLETED|Washout||7
1071089|NCT00925704|2596456|P2|COMPLETED|Washout||7
1071090|NCT00925704|2596457|P1|COMPLETED|Washout||5
1071091|NCT00925704|2596452|P6|STARTED|Washout||7
1071092|NCT00925704|2596453|P5|STARTED|Washout||5
1071093|NCT00925704|2596454|P4|STARTED|Washout||6
1071094|NCT00925704|2596455|P3|STARTED|Washout||7
1071095|NCT00925704|2596456|P2|STARTED|Washout||7
1071096|NCT00925704|2596457|P1|STARTED|Washout||5
1071097|NCT00925704|2596452|P6|NOT COMPLETED|Second Intervention||0
1071098|NCT00925704|2596453|P5|NOT COMPLETED|Second Intervention||1
1071099|NCT00925704|2596454|P4|NOT COMPLETED|Second Intervention||0
1071100|NCT00925704|2596455|P3|NOT COMPLETED|Second Intervention||0
1071101|NCT00925704|2596456|P2|NOT COMPLETED|Second Intervention||0
1071102|NCT00925704|2596457|P1|NOT COMPLETED|Second Intervention||1
1071103|NCT00925704|2596452|P6|COMPLETED|Second Intervention||7
1071104|NCT00925704|2596453|P5|COMPLETED|Second Intervention||5
1071105|NCT00925704|2596454|P4|COMPLETED|Second Intervention||6
1071106|NCT00925704|2596455|P3|COMPLETED|Second Intervention||7
1071107|NCT00925704|2596456|P2|COMPLETED|Second Intervention||7
1071108|NCT00925704|2596457|P1|COMPLETED|Second Intervention||5
1071109|NCT00925704|2596452|P6|STARTED|Second Intervention||7
1071110|NCT00925704|2596453|P5|STARTED|Second Intervention||6
1071111|NCT00925704|2596454|P4|STARTED|Second Intervention||6
1071112|NCT00925704|2596455|P3|STARTED|Second Intervention||7
1071113|NCT00925704|2596456|P2|STARTED|Second Intervention||7
1071114|NCT00925704|2596457|P1|STARTED|Second Intervention||6
1071115|NCT00925704|2596452|P6|NOT COMPLETED|Washout||0
1071116|NCT00925704|2596453|P5|NOT COMPLETED|Washout||0
1071117|NCT00925704|2596454|P4|NOT COMPLETED|Washout||0
1071118|NCT00925704|2596455|P3|NOT COMPLETED|Washout||0
1071119|NCT00925704|2596456|P2|NOT COMPLETED|Washout||0
1071120|NCT00925704|2596457|P1|NOT COMPLETED|Washout||0
1071121|NCT00925704|2596452|P6|COMPLETED|Washout||7
1071122|NCT00925704|2596453|P5|COMPLETED|Washout||6
1071123|NCT00925704|2596454|P4|COMPLETED|Washout||6
1071124|NCT00925704|2596455|P3|COMPLETED|Washout||7
1071125|NCT00925704|2596456|P2|COMPLETED|Washout||7
1071126|NCT00925704|2596457|P1|COMPLETED|Washout||6
1071127|NCT00925704|2596452|P6|STARTED|Washout||7
1071128|NCT00925704|2596453|P5|STARTED|Washout||6
1071129|NCT00925704|2596454|P4|STARTED|Washout||6
1071130|NCT00925704|2596455|P3|STARTED|Washout||7
1071131|NCT00925704|2596456|P2|STARTED|Washout||7
1071132|NCT00925704|2596457|P1|STARTED|Washout||6
1071133|NCT00925704|2596452|P6|NOT COMPLETED|First Intervention||0
1071134|NCT00925704|2596453|P5|NOT COMPLETED|First Intervention||1
1071135|NCT00925704|2596454|P4|NOT COMPLETED|First Intervention||1
1071136|NCT00925704|2596455|P3|NOT COMPLETED|First Intervention||0
1071137|NCT00925704|2596456|P2|NOT COMPLETED|First Intervention||0
1071138|NCT00925704|2596457|P1|NOT COMPLETED|First Intervention||0
1071139|NCT00925704|2596452|P6|COMPLETED|First Intervention||7
1071140|NCT00925704|2596453|P5|COMPLETED|First Intervention||6
1071141|NCT00925704|2596454|P4|COMPLETED|First Intervention||6
1071142|NCT00925704|2596455|P3|COMPLETED|First Intervention||7
1071143|NCT00925704|2596456|P2|COMPLETED|First Intervention||7
1071144|NCT00925704|2596457|P1|COMPLETED|First Intervention||6
1071145|NCT00925704|2596452|P6|STARTED|First Intervention||7
1071146|NCT00925704|2596453|P5|STARTED|First Intervention||7
1071147|NCT00925704|2596454|P4|STARTED|First Intervention||7
1071148|NCT00925704|2596455|P3|STARTED|First Intervention||7
1071149|NCT00925704|2596456|P2|STARTED|First Intervention||7
1071150|NCT00925704|2596457|P1|STARTED|First Intervention||6
1071151|NCT00925769|2596468|P6|NOT COMPLETED|Overall Study||3
1071152|NCT00925769|2596469|P5|NOT COMPLETED|Overall Study||3
1071153|NCT00925769|2596470|P4|NOT COMPLETED|Overall Study||6
1071154|NCT00925769|2596471|P3|NOT COMPLETED|Overall Study||6
1071155|NCT00925769|2596472|P2|NOT COMPLETED|Overall Study||6
1071156|NCT00925769|2596473|P1|NOT COMPLETED|Overall Study||6
1071157|NCT00925769|2596468|P6|COMPLETED|Overall Study||0
1071158|NCT00925769|2596469|P5|COMPLETED|Overall Study||0
1071159|NCT00925769|2596470|P4|COMPLETED|Overall Study||0
1071160|NCT00925769|2596471|P3|COMPLETED|Overall Study||0
1071161|NCT00925769|2596472|P2|COMPLETED|Overall Study||0
1071162|NCT00925769|2596473|P1|COMPLETED|Overall Study||0
1071163|NCT00925769|2596468|P6|STARTED|Overall Study||3
1071164|NCT00925769|2596469|P5|STARTED|Overall Study||3
1071165|NCT00925769|2596470|P4|STARTED|Overall Study||6
1071166|NCT00925769|2596471|P3|STARTED|Overall Study||6
1071167|NCT00925769|2596472|P2|STARTED|Overall Study||6
1071168|NCT00925769|2596473|P1|STARTED|Overall Study||6
1071169|NCT00925782|2596535|P2|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
1071170|NCT00925782|2596536|P1|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
1071171|NCT00925782|2596535|P2|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
1071172|NCT00925782|2596536|P1|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
1071173|NCT00925782|2596535|P2|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
1071174|NCT00925782|2596536|P1|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
1071175|NCT00925782|2596535|P2|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
1071176|NCT00925782|2596536|P1|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
1071177|NCT00925782|2596535|P2|COMPLETED|Study Period (Day -3 to Day 0)||12
1071178|NCT00925782|2596536|P1|COMPLETED|Study Period (Day -3 to Day 0)||12
1071179|NCT00925782|2596535|P2|STARTED|Study Period (Day -3 to Day 0)||12
1071180|NCT00925782|2596536|P1|STARTED|Study Period (Day -3 to Day 0)||12
1071181|NCT00925782|2596535|P2|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
1071182|NCT00925782|2596536|P1|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
1071183|NCT00925782|2596535|P2|COMPLETED|Pretreatment (Day -30 to Day -3)||12
1071184|NCT00925782|2596536|P1|COMPLETED|Pretreatment (Day -30 to Day -3)||12
1071185|NCT00925782|2596535|P2|STARTED|Pretreatment (Day -30 to Day -3)||12
1071186|NCT00925782|2596536|P1|STARTED|Pretreatment (Day -30 to Day -3)||12
1071187|NCT00925899|2596547|P2|NOT COMPLETED|Part 2||12
1071188|NCT00925899|2596548|P1|NOT COMPLETED|Part 2||6
1071189|NCT00925899|2596547|P2|COMPLETED|Part 2||9
1071190|NCT00925899|2596548|P1|COMPLETED|Part 2||9
1071191|NCT00925899|2596547|P2|STARTED|Part 2|Nine patients withdrew because they did not wish to continue in the study|21
1071192|NCT00925899|2596548|P1|STARTED|Part 2|All patients received the same intervention in the second part of the study (20 mg melatonin)|15
1071193|NCT00925899|2596547|P2|NOT COMPLETED|Part 1||11
1071194|NCT00925899|2596548|P1|NOT COMPLETED|Part 1||11
1071195|NCT00925899|2596547|P2|COMPLETED|Part 1||27
1071196|NCT00925899|2596548|P1|COMPLETED|Part 1||23
1071197|NCT00925899|2596547|P2|STARTED|Part 1||38
1071198|NCT00925899|2596548|P1|STARTED|Part 1||34
1071199|NCT00925938|2596569|P3|NOT COMPLETED|Overall Study||0
1071200|NCT00925938|2596570|P2|NOT COMPLETED|Overall Study||0
1071201|NCT00925938|2596571|P1|NOT COMPLETED|Overall Study||0
1071202|NCT00925938|2596569|P3|COMPLETED|Overall Study||17
1071203|NCT00925938|2596570|P2|COMPLETED|Overall Study||25
1071204|NCT00925938|2596571|P1|COMPLETED|Overall Study||9
1071205|NCT00925938|2596569|P3|STARTED|Overall Study||17
1071206|NCT00925938|2596570|P2|STARTED|Overall Study||25
1071207|NCT00925938|2596571|P1|STARTED|Overall Study||9
1071208|NCT00925990|2596593|P2|NOT COMPLETED|Overall Study||11
1071209|NCT00925990|2596594|P1|NOT COMPLETED|Overall Study||5
1071210|NCT00925990|2596593|P2|COMPLETED|Overall Study||24
1071211|NCT00925990|2596594|P1|COMPLETED|Overall Study||30
1071212|NCT00925990|2596593|P2|STARTED|Overall Study||35
1071213|NCT00925990|2596594|P1|STARTED|Overall Study||35
1071214|NCT00926029|2596605|P3|NOT COMPLETED|Overall Study||1
1071215|NCT00926029|2596606|P2|NOT COMPLETED|Overall Study||1
1071216|NCT00926029|2596607|P1|NOT COMPLETED|Overall Study||2
1071217|NCT00926029|2596605|P3|COMPLETED|Overall Study||33
1071218|NCT00926029|2596606|P2|COMPLETED|Overall Study||33
1071219|NCT00926029|2596607|P1|COMPLETED|Overall Study||32
1071220|NCT00926029|2596605|P3|STARTED|Overall Study||34
1071221|NCT00926029|2596606|P2|STARTED|Overall Study||34
1071222|NCT00926029|2596607|P1|STARTED|Overall Study||34
1071223|NCT00926185|2596622|P4|NOT COMPLETED|Overall Study||10
1071224|NCT00926185|2596623|P3|NOT COMPLETED|Overall Study||10
1071225|NCT00926185|2596624|P2|NOT COMPLETED|Overall Study||6
1071226|NCT00926185|2596625|P1|NOT COMPLETED|Overall Study||3
1071227|NCT00926185|2596622|P4|COMPLETED|Overall Study||48
1071228|NCT00926185|2596623|P3|COMPLETED|Overall Study||48
1071229|NCT00926185|2596624|P2|COMPLETED|Overall Study||51
1071230|NCT00926185|2596625|P1|COMPLETED|Overall Study||54
1071231|NCT00926185|2596622|P4|STARTED|Overall Study||58
1071232|NCT00926185|2596623|P3|STARTED|Overall Study||58
1071233|NCT00926185|2596624|P2|STARTED|Overall Study||57
1071234|NCT00926185|2596625|P1|STARTED|Overall Study||57
1071235|NCT00926211|2596639|P1|NOT COMPLETED|Overall Study||1
1071236|NCT00926211|2596639|P1|COMPLETED|Overall Study||35
1071237|NCT00926211|2596639|P1|STARTED|Overall Study|One additional subject was not randomized and did not receive the treatment procedure.|36
1071238|NCT00926263|2596648|P2|NOT COMPLETED|Overall Study||0
1071239|NCT00926263|2596649|P1|NOT COMPLETED|Overall Study||0
1071240|NCT00926263|2596648|P2|COMPLETED|Overall Study||12
1071241|NCT00926263|2596649|P1|COMPLETED|Overall Study||16
1071242|NCT00926263|2596648|P2|STARTED|Overall Study||12
1071243|NCT00926263|2596649|P1|STARTED|Overall Study||16
1071244|NCT00926289|2596682|P2|NOT COMPLETED|Overall Study||36
1071245|NCT00926289|2596683|P1|NOT COMPLETED|Overall Study||25
1071246|NCT00926289|2596682|P2|COMPLETED|Overall Study||558
1071247|NCT00926289|2596683|P1|COMPLETED|Overall Study||269
1071248|NCT00926289|2596682|P2|STARTED|Overall Study|Number of treated patients|594
1071249|NCT00926289|2596683|P1|STARTED|Overall Study|Number of treated patients|294
1071250|NCT00918125|2596719|P2|NOT COMPLETED|Overall Study||0
1071251|NCT00918125|2596720|P1|NOT COMPLETED|Overall Study||0
1071252|NCT00918125|2596719|P2|COMPLETED|Overall Study||39
1071253|NCT00918125|2596720|P1|COMPLETED|Overall Study||20
1071254|NCT00918125|2596719|P2|STARTED|Overall Study||39
1071255|NCT00918125|2596720|P1|STARTED|Overall Study||20
1071256|NCT00918138|2596733|P2|NOT COMPLETED|Overall Study||1
1071257|NCT00918138|2596734|P1|NOT COMPLETED|Overall Study||2
1071258|NCT00918138|2596733|P2|COMPLETED|Overall Study||46
1071259|NCT00918138|2596734|P1|COMPLETED|Overall Study||44
1071260|NCT00918138|2596733|P2|STARTED|Overall Study||47
1071261|NCT00918138|2596734|P1|STARTED|Overall Study||46
1071262|NCT00918203|2596750|P3|NOT COMPLETED|Crossover to Olaratumab Monotherapy||3
1071263|NCT00918203|2596751|P2|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
1071264|NCT00918203|2596752|P1|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
1071265|NCT00918203|2596750|P3|COMPLETED|Crossover to Olaratumab Monotherapy||14
1071266|NCT00918203|2596751|P2|COMPLETED|Crossover to Olaratumab Monotherapy||0
1071267|NCT00918203|2596752|P1|COMPLETED|Crossover to Olaratumab Monotherapy||0
1071268|NCT00918203|2596750|P3|STARTED|Crossover to Olaratumab Monotherapy|16 participants crossed over to olaratumab after PD and 1 participant of symptomatic deterioration.|17
1071269|NCT00918203|2596751|P2|STARTED|Crossover to Olaratumab Monotherapy||0
1071270|NCT00918203|2596752|P1|STARTED|Crossover to Olaratumab Monotherapy||0
1071271|NCT00918203|2596750|P3|NOT COMPLETED|Treatment With or Without Olaratumab||0
1071272|NCT00918203|2596751|P2|NOT COMPLETED|Treatment With or Without Olaratumab||14
1071273|NCT00918203|2596752|P1|NOT COMPLETED|Treatment With or Without Olaratumab||7
1071274|NCT00918203|2596750|P3|COMPLETED|Treatment With or Without Olaratumab||0
1071275|NCT00918203|2596751|P2|COMPLETED|Treatment With or Without Olaratumab||53
1071276|NCT00918203|2596752|P1|COMPLETED|Treatment With or Without Olaratumab||63
1071277|NCT00918203|2596750|P3|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||0
1071278|NCT00918203|2596751|P2|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||64
1071279|NCT00918203|2596752|P1|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||67
1071280|NCT00918203|2596750|P3|STARTED|Treatment With or Without Olaratumab||0
1071281|NCT00918203|2596751|P2|STARTED|Treatment With or Without Olaratumab||67
1071282|NCT00918203|2596752|P1|STARTED|Treatment With or Without Olaratumab||70
1071283|NCT00918255|2596784|P3|NOT COMPLETED|Overall Study||5
1071284|NCT00918255|2596785|P2|NOT COMPLETED|Overall Study||0
1071285|NCT00918255|2596786|P1|NOT COMPLETED|Overall Study||6
1071286|NCT00918255|2596784|P3|COMPLETED|Overall Study||46
1071287|NCT00918255|2596785|P2|COMPLETED|Overall Study||52
1071288|NCT00918255|2596786|P1|COMPLETED|Overall Study||45
1071289|NCT00918255|2596784|P3|STARTED|Overall Study||51
1071290|NCT00918255|2596785|P2|STARTED|Overall Study||52
1071291|NCT00918255|2596786|P1|STARTED|Overall Study||51
1071292|NCT00918281|2596812|P1|NOT COMPLETED|Overall Study||29
1071293|NCT00918281|2596812|P1|COMPLETED|Overall Study||41
1071294|NCT00918281|2596812|P1|STARTED|Overall Study||70
1071295|NCT00918346|2596819|P2|NOT COMPLETED|Post Study Period||0
1071296|NCT00918346|2596820|P1|NOT COMPLETED|Post Study Period||0
1071297|NCT00918346|2596819|P2|COMPLETED|Post Study Period||21
1071298|NCT00918346|2596820|P1|COMPLETED|Post Study Period||21
1071299|NCT00918346|2596819|P2|STARTED|Post Study Period||21
1071300|NCT00918346|2596820|P1|STARTED|Post Study Period||21
1071301|NCT00918346|2596819|P2|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
1071302|NCT00918346|2596820|P1|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
1071303|NCT00918346|2596819|P2|COMPLETED|Second Treatment Period (4 Weeks)||21
1071304|NCT00918346|2596820|P1|COMPLETED|Second Treatment Period (4 Weeks)||21
1071305|NCT00918346|2596819|P2|STARTED|Second Treatment Period (4 Weeks)||21
1071306|NCT00918346|2596820|P1|STARTED|Second Treatment Period (4 Weeks)||21
1071307|NCT00918346|2596819|P2|NOT COMPLETED|Washout (at Least 4 Weeks)||0
1071308|NCT00918346|2596820|P1|NOT COMPLETED|Washout (at Least 4 Weeks)||0
1071309|NCT00918346|2596819|P2|COMPLETED|Washout (at Least 4 Weeks)||21
1071310|NCT00918346|2596820|P1|COMPLETED|Washout (at Least 4 Weeks)||21
1071311|NCT00918346|2596819|P2|STARTED|Washout (at Least 4 Weeks)||21
1071312|NCT00918346|2596820|P1|STARTED|Washout (at Least 4 Weeks)||21
1071313|NCT00918346|2596819|P2|NOT COMPLETED|First Treatment Period (4 Weeks)||1
1071314|NCT00918346|2596820|P1|NOT COMPLETED|First Treatment Period (4 Weeks)||0
1071315|NCT00918346|2596819|P2|COMPLETED|First Treatment Period (4 Weeks)|A patient completed the first treatment period but discontinued thereafter (did not start washout).|21
1071316|NCT00918346|2596820|P1|COMPLETED|First Treatment Period (4 Weeks)||21
1071317|NCT00918346|2596819|P2|STARTED|First Treatment Period (4 Weeks)||22
1071318|NCT00918346|2596820|P1|STARTED|First Treatment Period (4 Weeks)||21
1071319|NCT00918385|2596836|P2|NOT COMPLETED|Combination Nilutamide and Dasatinib||8
1071320|NCT00918385|2596837|P1|NOT COMPLETED|Combination Nilutamide and Dasatinib||6
1071321|NCT00918385|2596836|P2|COMPLETED|Combination Nilutamide and Dasatinib||3
1071322|NCT00918385|2596837|P1|COMPLETED|Combination Nilutamide and Dasatinib||6
1071323|NCT00918385|2596836|P2|STARTED|Combination Nilutamide and Dasatinib||11
1071324|NCT00918385|2596837|P1|STARTED|Combination Nilutamide and Dasatinib||12
1071325|NCT00918385|2596836|P2|NOT COMPLETED|Monotherapy||6
1071326|NCT00918385|2596837|P1|NOT COMPLETED|Monotherapy||2
1071327|NCT00918385|2596836|P2|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|11
1071328|NCT00918385|2596837|P1|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|12
1071329|NCT00918385|2596836|P2|STARTED|Monotherapy||17
1071330|NCT00918385|2596837|P1|STARTED|Monotherapy||14
1071331|NCT00918580|2596846|P1|NOT COMPLETED|After 6-month FU to 1-year FU||60
1071332|NCT00918580|2596846|P1|COMPLETED|After 6-month FU to 1-year FU||87
1071333|NCT00918580|2596846|P1|Continued After 6-Month FU|After 6-month FU to 1-year FU||89
1071334|NCT00918580|2596846|P1|STARTED|After 6-month FU to 1-year FU||147
1071335|NCT00918580|2596846|P1|NOT COMPLETED|Up to 6-month Follow-up(FU)||11
1071336|NCT00918580|2596846|P1|COMPLETED|Up to 6-month Follow-up(FU)|Completed include 1 participant:withdrew before Dose 2 (protocol violation) but completed 6-month FU|147
1071337|NCT00918580|2596846|P1|Vaccinated Dose 2|Up to 6-month Follow-up(FU)||146
1071338|NCT00918580|2596846|P1|Vaccinated Dose 1|Up to 6-month Follow-up(FU)||158
1071339|NCT00918580|2596846|P1|STARTED|Up to 6-month Follow-up(FU)||158
1071340|NCT00918671|2596864|P1|NOT COMPLETED|Overall Study||0
1071341|NCT00918671|2596864|P1|COMPLETED|Overall Study||60
1071342|NCT00918671|2596864|P1|STARTED|Overall Study||60
1071343|NCT00918684|2596869|P1|NOT COMPLETED|Treatment Phase||25
1071344|NCT00918684|2596869|P1|COMPLETED|Treatment Phase||65
1071345|NCT00918684|2596869|P1|STARTED|Treatment Phase||90
1071346|NCT00918684|2596869|P1|NOT COMPLETED|Two Week Drug Washout and Placebo Phase||16
1071347|NCT00918684|2596869|P1|COMPLETED|Two Week Drug Washout and Placebo Phase||90
1071348|NCT00918684|2596869|P1|STARTED|Two Week Drug Washout and Placebo Phase||106
1071349|NCT00918736|2596875|P1|NOT COMPLETED|Overall Study||4
1071350|NCT00918736|2596875|P1|COMPLETED|Overall Study|October, 2008|46
1071351|NCT00918736|2596875|P1|STARTED|Overall Study|October, 2007|50
1071352|NCT00918749|2596882|P3|NOT COMPLETED|Overall Study||7
1071353|NCT00918749|2596883|P2|NOT COMPLETED|Overall Study||3
1071354|NCT00918749|2596884|P1|NOT COMPLETED|Overall Study||7
1071355|NCT00918749|2596882|P3|COMPLETED|Overall Study||62
1071356|NCT00918749|2596883|P2|COMPLETED|Overall Study||63
1071357|NCT00918749|2596884|P1|COMPLETED|Overall Study||63
1071358|NCT00918749|2596882|P3|ITT (Intent to Treat) Population|Overall Study||69
1071359|NCT00918749|2596883|P2|ITT (Intent to Treat) Population|Overall Study||66
1071360|NCT00918749|2596884|P1|ITT (Intent to Treat) Population|Overall Study|One subject took no study drug and was not included in ITT Population|69
1071361|NCT00918749|2596882|P3|STARTED|Overall Study||69
1071362|NCT00918749|2596883|P2|STARTED|Overall Study||66
1071363|NCT00918749|2596884|P1|STARTED|Overall Study||70
1071364|NCT00918866|2596918|P2|NOT COMPLETED|Overall Study||0
1071365|NCT00918866|2596919|P1|NOT COMPLETED|Overall Study||0
1071366|NCT00918866|2596918|P2|COMPLETED|Overall Study||16
1071367|NCT00918866|2596919|P1|COMPLETED|Overall Study||16
1071368|NCT00918866|2596918|P2|STARTED|Overall Study||16
1071369|NCT00918866|2596919|P1|STARTED|Overall Study||16
1071370|NCT00918879|2596935|P2|NOT COMPLETED|Overall Study||6
1071371|NCT00918879|2596936|P1|NOT COMPLETED|Overall Study||6
1071372|NCT00918879|2596935|P2|COMPLETED|Overall Study|Completed 24 weeks of treatment|100
1071373|NCT00918879|2596936|P1|COMPLETED|Overall Study|Completed 24 weeks of treatment|101
1071374|NCT00918879|2596935|P2|STARTED|Overall Study|Randomized and treated|106
1071375|NCT00918879|2596936|P1|STARTED|Overall Study|Randomized and treated|107
1071376|NCT00918931|2596948|P1|NOT COMPLETED|Overall Study||0
1071377|NCT00918931|2596948|P1|COMPLETED|Overall Study||3
1071378|NCT00918931|2596948|P1|STARTED|Overall Study||3
1071379|NCT00918957|2596954|P2|NOT COMPLETED|Overall Study||0
1071380|NCT00918957|2596955|P1|NOT COMPLETED|Overall Study||3
1071381|NCT00918957|2596954|P2|COMPLETED|Overall Study||30
1071382|NCT00918957|2596955|P1|COMPLETED|Overall Study||29
1071383|NCT00918957|2596954|P2|STARTED|Overall Study||30
1071384|NCT00918957|2596955|P1|STARTED|Overall Study||32
1071385|NCT00919035|2596982|P1|NOT COMPLETED|Overall Study||0
1071386|NCT00919035|2596982|P1|COMPLETED|Overall Study||21
1071387|NCT00919035|2596982|P1|STARTED|Overall Study||21
1071388|NCT00919061|2596988|P1|NOT COMPLETED|Overall Study||2
1071389|NCT00919061|2596988|P1|COMPLETED|Overall Study||37
1071390|NCT00919061|2596988|P1|STARTED|Overall Study||39
1071391|NCT00919113|2596995|P2|NOT COMPLETED|Overall Study||8
1071392|NCT00919113|2596996|P1|NOT COMPLETED|Overall Study||9
1071393|NCT00919113|2596995|P2|COMPLETED|Overall Study||40
1071394|NCT00919113|2596996|P1|COMPLETED|Overall Study||41
1071395|NCT00919113|2596995|P2|Received Placebo|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
1071396|NCT00919113|2596996|P1|Received Placebo|Overall Study||0
1071397|NCT00919113|2596995|P2|Received Uracyst|Overall Study||0
1071398|NCT00919113|2596996|P1|Received Uracyst|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
1071399|NCT00919113|2596995|P2|STARTED|Overall Study||48
1071400|NCT00919113|2596996|P1|STARTED|Overall Study||50
1071401|NCT00919126|2597007|P3|NOT COMPLETED|Overall Study||1
1071402|NCT00919126|2597008|P2|NOT COMPLETED|Overall Study||5
1071403|NCT00919126|2597009|P1|NOT COMPLETED|Overall Study||1
1071404|NCT00919126|2597007|P3|COMPLETED|Overall Study||32
1071405|NCT00919126|2597008|P2|COMPLETED|Overall Study||32
1071406|NCT00919126|2597009|P1|COMPLETED|Overall Study||31
1071407|NCT00919126|2597007|P3|STARTED|Overall Study||33
1071408|NCT00919126|2597008|P2|STARTED|Overall Study||37
1071409|NCT00919126|2597009|P1|STARTED|Overall Study||32
1071410|NCT00919191|2597053|P1|NOT COMPLETED|Overall Study||0
1071411|NCT00919191|2597053|P1|COMPLETED|Overall Study||26
1071412|NCT00919191|2597053|P1|STARTED|Overall Study||26
1071413|NCT00919633|2597064|P4|NOT COMPLETED|Overall Study||21
1071414|NCT00919633|2597065|P3|NOT COMPLETED|Overall Study||23
1071415|NCT00919633|2597066|P2|NOT COMPLETED|Overall Study||15
1071416|NCT00919633|2597067|P1|NOT COMPLETED|Overall Study||22
1071417|NCT00919633|2597064|P4|COMPLETED|Overall Study||5
1071418|NCT00919633|2597065|P3|COMPLETED|Overall Study||4
1071419|NCT00919633|2597066|P2|COMPLETED|Overall Study||10
1071420|NCT00919633|2597067|P1|COMPLETED|Overall Study||6
1071421|NCT00919633|2597064|P4|STARTED|Overall Study||26
1071422|NCT00919633|2597065|P3|STARTED|Overall Study||27
1071423|NCT00919633|2597066|P2|STARTED|Overall Study||25
1071424|NCT00919633|2597067|P1|STARTED|Overall Study||28
1071425|NCT00919711|2597087|P2|NOT COMPLETED|Overall Study||13
1071426|NCT00919711|2597088|P1|NOT COMPLETED|Overall Study||33
1071427|NCT00919711|2597087|P2|COMPLETED|Overall Study||422
1071428|NCT00919711|2597088|P1|COMPLETED|Overall Study||402
1071429|NCT00919711|2597087|P2|STARTED|Overall Study||435
1071430|NCT00919711|2597088|P1|STARTED|Overall Study||435
1071431|NCT00919724|2597102|P2|NOT COMPLETED|Overall Study||0
1071432|NCT00919724|2597103|P1|NOT COMPLETED|Overall Study||0
1071433|NCT00919724|2597102|P2|COMPLETED|Overall Study||44
1071434|NCT00919724|2597103|P1|COMPLETED|Overall Study||45
1071435|NCT00919724|2597102|P2|STARTED|Overall Study||44
1071436|NCT00919724|2597103|P1|STARTED|Overall Study||45
1071437|NCT00919763|2597111|P2|NOT COMPLETED|Overall Study||4
1071438|NCT00919763|2597112|P1|NOT COMPLETED|Overall Study||12
1071439|NCT00919763|2597111|P2|COMPLETED|Overall Study||45
1071440|NCT00919763|2597112|P1|COMPLETED|Overall Study||41
1071441|NCT00919763|2597111|P2|STARTED|Overall Study||49
1071442|NCT00919763|2597112|P1|STARTED|Overall Study||53
1071443|NCT00919802|2597118|P2|NOT COMPLETED|Second Intervention - (24 Hours)||0
1071444|NCT00919802|2597119|P1|NOT COMPLETED|Second Intervention - (24 Hours)||0
1071445|NCT00919802|2597118|P2|COMPLETED|Second Intervention - (24 Hours)||13
1071446|NCT00919802|2597119|P1|COMPLETED|Second Intervention - (24 Hours)||12
1071447|NCT00919802|2597118|P2|STARTED|Second Intervention - (24 Hours)||13
1071448|NCT00919802|2597119|P1|STARTED|Second Intervention - (24 Hours)||12
1071449|NCT00919802|2597118|P2|NOT COMPLETED|First Intervention - (24 Hours)||0
1071450|NCT00919802|2597119|P1|NOT COMPLETED|First Intervention - (24 Hours)||0
1071451|NCT00919802|2597118|P2|COMPLETED|First Intervention - (24 Hours)||13
1071452|NCT00919802|2597119|P1|COMPLETED|First Intervention - (24 Hours)||12
1071453|NCT00919802|2597118|P2|STARTED|First Intervention - (24 Hours)||13
1071454|NCT00919802|2597119|P1|STARTED|First Intervention - (24 Hours)||12
1071455|NCT00919854|2597127|P1|NOT COMPLETED|Overall Study||1
1071456|NCT00919854|2597127|P1|COMPLETED|Overall Study|'Completed' represents the patients that are ongoing at the time of cut-off for the Week 24 analysis|20
1071457|NCT00919854|2597127|P1|STARTED|Overall Study||21
1071458|NCT00919867|2597142|P6|NOT COMPLETED|Third Intervention||0
1071459|NCT00919867|2597143|P5|NOT COMPLETED|Third Intervention||0
1071460|NCT00919867|2597144|P4|NOT COMPLETED|Third Intervention||0
1071461|NCT00919867|2597145|P3|NOT COMPLETED|Third Intervention||0
1071462|NCT00919867|2597146|P2|NOT COMPLETED|Third Intervention||0
1071463|NCT00919867|2597147|P1|NOT COMPLETED|Third Intervention||0
1071464|NCT00919867|2597142|P6|COMPLETED|Third Intervention||6
1071465|NCT00919867|2597143|P5|COMPLETED|Third Intervention||7
1071466|NCT00919867|2597144|P4|COMPLETED|Third Intervention||7
1071467|NCT00919867|2597145|P3|COMPLETED|Third Intervention||6
1071468|NCT00919867|2597146|P2|COMPLETED|Third Intervention||7
1071469|NCT00919867|2597147|P1|COMPLETED|Third Intervention||7
1071470|NCT00919867|2597142|P6|STARTED|Third Intervention||6
1071471|NCT00919867|2597143|P5|STARTED|Third Intervention||7
1071472|NCT00919867|2597144|P4|STARTED|Third Intervention||7
1071473|NCT00919867|2597145|P3|STARTED|Third Intervention||6
1071474|NCT00919867|2597146|P2|STARTED|Third Intervention||7
1071475|NCT00919867|2597147|P1|STARTED|Third Intervention||7
1071476|NCT00919867|2597142|P6|NOT COMPLETED|Washout||0
1071477|NCT00919867|2597143|P5|NOT COMPLETED|Washout||0
1071478|NCT00919867|2597144|P4|NOT COMPLETED|Washout||0
1071479|NCT00919867|2597145|P3|NOT COMPLETED|Washout||0
1071480|NCT00919867|2597146|P2|NOT COMPLETED|Washout||0
1071481|NCT00919867|2597147|P1|NOT COMPLETED|Washout||0
1071482|NCT00919867|2597142|P6|COMPLETED|Washout||6
1071483|NCT00919867|2597143|P5|COMPLETED|Washout||7
1071484|NCT00919867|2597144|P4|COMPLETED|Washout||7
1071485|NCT00919867|2597145|P3|COMPLETED|Washout||6
1071486|NCT00919867|2597146|P2|COMPLETED|Washout||7
1071487|NCT00919867|2597147|P1|COMPLETED|Washout||7
1071488|NCT00919867|2597142|P6|STARTED|Washout||6
1071489|NCT00919867|2597143|P5|STARTED|Washout||7
1071490|NCT00919867|2597144|P4|STARTED|Washout||7
1071491|NCT00919867|2597145|P3|STARTED|Washout||6
1071492|NCT00919867|2597146|P2|STARTED|Washout||7
1071493|NCT00919867|2597147|P1|STARTED|Washout||7
1071494|NCT00919867|2597142|P6|NOT COMPLETED|Second Intervention||0
1071495|NCT00919867|2597143|P5|NOT COMPLETED|Second Intervention||0
1071496|NCT00919867|2597144|P4|NOT COMPLETED|Second Intervention||0
1071497|NCT00919867|2597145|P3|NOT COMPLETED|Second Intervention||0
1071498|NCT00919867|2597146|P2|NOT COMPLETED|Second Intervention||0
1071499|NCT00919867|2597147|P1|NOT COMPLETED|Second Intervention||0
1071500|NCT00919867|2597142|P6|COMPLETED|Second Intervention||6
1071501|NCT00919867|2597143|P5|COMPLETED|Second Intervention||7
1071502|NCT00919867|2597144|P4|COMPLETED|Second Intervention||7
1071503|NCT00919867|2597145|P3|COMPLETED|Second Intervention||6
1071504|NCT00919867|2597146|P2|COMPLETED|Second Intervention||7
1071505|NCT00919867|2597147|P1|COMPLETED|Second Intervention||7
1071506|NCT00919867|2597142|P6|STARTED|Second Intervention||6
1071507|NCT00919867|2597143|P5|STARTED|Second Intervention||7
1071508|NCT00919867|2597144|P4|STARTED|Second Intervention||7
1071509|NCT00919867|2597145|P3|STARTED|Second Intervention||6
1071510|NCT00919867|2597146|P2|STARTED|Second Intervention||7
1071511|NCT00919867|2597147|P1|STARTED|Second Intervention||7
1071512|NCT00919867|2597142|P6|NOT COMPLETED|Washout||0
1071513|NCT00919867|2597143|P5|NOT COMPLETED|Washout||0
1071514|NCT00919867|2597144|P4|NOT COMPLETED|Washout||0
1071515|NCT00919867|2597145|P3|NOT COMPLETED|Washout||0
1071516|NCT00919867|2597146|P2|NOT COMPLETED|Washout||0
1071517|NCT00919867|2597147|P1|NOT COMPLETED|Washout||0
1071518|NCT00919867|2597142|P6|COMPLETED|Washout||6
1071519|NCT00919867|2597143|P5|COMPLETED|Washout||7
1071520|NCT00919867|2597144|P4|COMPLETED|Washout||7
1071521|NCT00919867|2597145|P3|COMPLETED|Washout||6
1071522|NCT00919867|2597146|P2|COMPLETED|Washout||7
1071523|NCT00919867|2597147|P1|COMPLETED|Washout||7
1071524|NCT00919867|2597142|P6|STARTED|Washout||6
1071525|NCT00919867|2597143|P5|STARTED|Washout||7
1071526|NCT00919867|2597144|P4|STARTED|Washout||7
1071527|NCT00919867|2597145|P3|STARTED|Washout||6
1071528|NCT00919867|2597146|P2|STARTED|Washout||7
1071529|NCT00919867|2597147|P1|STARTED|Washout||7
1071530|NCT00919867|2597142|P6|NOT COMPLETED|First Intervention||1
1071531|NCT00919867|2597143|P5|NOT COMPLETED|First Intervention||0
1071532|NCT00919867|2597144|P4|NOT COMPLETED|First Intervention||0
1071533|NCT00919867|2597145|P3|NOT COMPLETED|First Intervention||1
1071534|NCT00919867|2597146|P2|NOT COMPLETED|First Intervention||0
1071535|NCT00919867|2597147|P1|NOT COMPLETED|First Intervention||0
1071536|NCT00919867|2597142|P6|COMPLETED|First Intervention||6
1071537|NCT00919867|2597143|P5|COMPLETED|First Intervention||7
1071538|NCT00919867|2597144|P4|COMPLETED|First Intervention||7
1071539|NCT00919867|2597145|P3|COMPLETED|First Intervention||6
1071540|NCT00919867|2597146|P2|COMPLETED|First Intervention||7
1071541|NCT00919867|2597147|P1|COMPLETED|First Intervention||7
1071542|NCT00919867|2597142|P6|STARTED|First Intervention||7
1071543|NCT00919867|2597143|P5|STARTED|First Intervention||7
1071544|NCT00919867|2597144|P4|STARTED|First Intervention||7
1071545|NCT00919867|2597145|P3|STARTED|First Intervention||7
1071546|NCT00919867|2597146|P2|STARTED|First Intervention||7
1071547|NCT00919867|2597147|P1|STARTED|First Intervention||7
1071548|NCT00919893|2597170|P2|NOT COMPLETED|Overall Study||9
1071549|NCT00919893|2597171|P1|NOT COMPLETED|Overall Study||19
1071550|NCT00919893|2597170|P2|COMPLETED|Overall Study||60
1071551|NCT00919893|2597171|P1|COMPLETED|Overall Study||51
1071552|NCT00919893|2597170|P2|STARTED|Overall Study||69
1071553|NCT00919893|2597171|P1|STARTED|Overall Study||70
1071554|NCT00919932|2597179|P2|NOT COMPLETED|Overall Study||0
1071555|NCT00919932|2597180|P1|NOT COMPLETED|Overall Study||0
1071556|NCT00919932|2597179|P2|COMPLETED|Overall Study||5
1071557|NCT00919932|2597180|P1|COMPLETED|Overall Study||4
1071558|NCT00919932|2597179|P2|STARTED|Overall Study||5
1071559|NCT00919932|2597180|P1|STARTED|Overall Study||4
1071560|NCT00920023|2597188|P1|NOT COMPLETED|Overall Study||0
1071561|NCT00920023|2597188|P1|COMPLETED|Overall Study||15
1071562|NCT00920023|2597188|P1|STARTED|Overall Study||15
1071563|NCT00920075|2597193|P1|NOT COMPLETED|Post Study, 11 Pts Responded||0
1071564|NCT00920075|2597193|P1|COMPLETED|Post Study, 11 Pts Responded||11
1071565|NCT00920075|2597193|P1|STARTED|Post Study, 11 Pts Responded||11
1071566|NCT00920075|2597193|P1|NOT COMPLETED|Last Study,25 Pts Invited,11 Responded||0
1071567|NCT00920075|2597193|P1|COMPLETED|Last Study,25 Pts Invited,11 Responded||11
1071568|NCT00920075|2597193|P1|STARTED|Last Study,25 Pts Invited,11 Responded||11
1071569|NCT00920140|2597204|P5|NOT COMPLETED|Phase 2||11
1071570|NCT00920140|2597205|P4|NOT COMPLETED|Phase 2||22
1071571|NCT00920140|2597206|P3|NOT COMPLETED|Phase 2||50
1071572|NCT00920140|2597207|P2|NOT COMPLETED|Phase 2||0
1071573|NCT00920140|2597208|P1|NOT COMPLETED|Phase 2||0
1071574|NCT00920140|2597204|P5|COMPLETED|Phase 2||0
1071575|NCT00920140|2597205|P4|COMPLETED|Phase 2||0
1071576|NCT00920140|2597206|P3|COMPLETED|Phase 2||0
1071577|NCT00920140|2597207|P2|COMPLETED|Phase 2||0
1071578|NCT00920140|2597208|P1|COMPLETED|Phase 2||0
1071579|NCT00920140|2597204|P5|STARTED|Phase 2||11
1071580|NCT00920140|2597205|P4|STARTED|Phase 2||22
1071581|NCT00920140|2597206|P3|STARTED|Phase 2||50
1071582|NCT00920140|2597207|P2|STARTED|Phase 2||0
1071583|NCT00920140|2597208|P1|STARTED|Phase 2||0
1071584|NCT00920140|2597204|P5|NOT COMPLETED|Phase 1 (Dose Escalation)||0
1071585|NCT00920140|2597205|P4|NOT COMPLETED|Phase 1 (Dose Escalation)||0
1071586|NCT00920140|2597206|P3|NOT COMPLETED|Phase 1 (Dose Escalation)||0
1071587|NCT00920140|2597207|P2|NOT COMPLETED|Phase 1 (Dose Escalation)||9
1071588|NCT00920140|2597208|P1|NOT COMPLETED|Phase 1 (Dose Escalation)||5
1071589|NCT00920140|2597204|P5|COMPLETED|Phase 1 (Dose Escalation)||0
1071590|NCT00920140|2597205|P4|COMPLETED|Phase 1 (Dose Escalation)||0
1071591|NCT00920140|2597206|P3|COMPLETED|Phase 1 (Dose Escalation)||0
1071592|NCT00920140|2597207|P2|COMPLETED|Phase 1 (Dose Escalation)||0
1071593|NCT00920140|2597208|P1|COMPLETED|Phase 1 (Dose Escalation)||0
1071594|NCT00920140|2597204|P5|STARTED|Phase 1 (Dose Escalation)||0
1071595|NCT00920140|2597205|P4|STARTED|Phase 1 (Dose Escalation)||0
1071596|NCT00920140|2597206|P3|STARTED|Phase 1 (Dose Escalation)||0
1071597|NCT00920140|2597207|P2|STARTED|Phase 1 (Dose Escalation)||9
1071598|NCT00920140|2597208|P1|STARTED|Phase 1 (Dose Escalation)||5
1071599|NCT00920231|2597248|P2|NOT COMPLETED|Overall Study||0
1071600|NCT00920231|2597249|P1|NOT COMPLETED|Overall Study||0
1071601|NCT00920231|2597248|P2|COMPLETED|Overall Study||8
1071602|NCT00920231|2597249|P1|COMPLETED|Overall Study||8
1071603|NCT00920231|2597248|P2|STARTED|Overall Study||8
1071604|NCT00920231|2597249|P1|STARTED|Overall Study||8
1071605|NCT00920309|2597259|P2|NOT COMPLETED|Overall Study||0
1071606|NCT00920309|2597260|P1|NOT COMPLETED|Overall Study||0
1071607|NCT00920309|2597259|P2|COMPLETED|Overall Study||7
1071608|NCT00920309|2597260|P1|COMPLETED|Overall Study||14
1071609|NCT00920309|2597259|P2|STARTED|Overall Study||7
1071610|NCT00920309|2597260|P1|STARTED|Overall Study||14
1071611|NCT00920374|2597270|P2|NOT COMPLETED|Overall Study||0
1071612|NCT00920374|2597271|P1|NOT COMPLETED|Overall Study||0
1071613|NCT00920374|2597270|P2|COMPLETED|Overall Study||57
1071614|NCT00920374|2597271|P1|COMPLETED|Overall Study||61
1071615|NCT00920374|2597270|P2|STARTED|Overall Study||57
1071616|NCT00920374|2597271|P1|STARTED|Overall Study||61
1071617|NCT00926328|2597297|P2|NOT COMPLETED|Overall Study||14
1071618|NCT00926328|2597298|P1|NOT COMPLETED|Overall Study||12
1071619|NCT00926328|2597297|P2|COMPLETED|Overall Study||46
1071620|NCT00926328|2597298|P1|COMPLETED|Overall Study||48
1071621|NCT00926328|2597297|P2|STARTED|Overall Study||60
1071622|NCT00926328|2597298|P1|STARTED|Overall Study||60
1071623|NCT00926367|2597308|P2|NOT COMPLETED|Overall Study||3
1071624|NCT00926367|2597309|P1|NOT COMPLETED|Overall Study||2
1071625|NCT00926367|2597308|P2|COMPLETED|Overall Study||24
1071626|NCT00926367|2597309|P1|COMPLETED|Overall Study||23
1071627|NCT00926367|2597308|P2|STARTED|Overall Study||27
1071628|NCT00926367|2597309|P1|STARTED|Overall Study||25
1071629|NCT00926393|2597351|P2|NOT COMPLETED|Overall Study||3
1071630|NCT00926393|2597352|P1|NOT COMPLETED|Overall Study||2
1071631|NCT00926393|2597351|P2|COMPLETED|Overall Study||67
1071632|NCT00926393|2597352|P1|COMPLETED|Overall Study||67
1071633|NCT00926393|2597351|P2|STARTED|Overall Study||70
1071634|NCT00926393|2597352|P1|STARTED|Overall Study||69
1071635|NCT00926497|2597384|P2|NOT COMPLETED|Overall Study||0
1071636|NCT00926497|2597385|P1|NOT COMPLETED|Overall Study||0
1071637|NCT00926497|2597384|P2|COMPLETED|Overall Study||61
1071638|NCT00926497|2597385|P1|COMPLETED|Overall Study||60
1071639|NCT00926497|2597384|P2|STARTED|Overall Study||61
1071640|NCT00926497|2597385|P1|STARTED|Overall Study||60
1071641|NCT00926536|2597395|P2|NOT COMPLETED|Overall Study||2
1071642|NCT00926536|2597396|P1|NOT COMPLETED|Overall Study||1
1071643|NCT00926536|2597395|P2|COMPLETED|Overall Study||41
1071644|NCT00926536|2597396|P1|COMPLETED|Overall Study||43
1071645|NCT00926536|2597395|P2|STARTED|Overall Study||43
1071646|NCT00926536|2597396|P1|STARTED|Overall Study||44
1071647|NCT00926575|2597406|P2|NOT COMPLETED|Overall Study||17
1071648|NCT00926575|2597407|P1|NOT COMPLETED|Overall Study||16
1071649|NCT00926575|2597406|P2|COMPLETED|Overall Study||53
1071650|NCT00926575|2597407|P1|COMPLETED|Overall Study||54
1071651|NCT00926575|2597406|P2|STARTED|Overall Study||70
1071652|NCT00926575|2597407|P1|STARTED|Overall Study||70
1071653|NCT00926588|2597419|P2|NOT COMPLETED|Overall Study||4
1071654|NCT00926588|2597420|P1|NOT COMPLETED|Overall Study||8
1071655|NCT00926588|2597419|P2|COMPLETED|Overall Study||122
1071656|NCT00926588|2597420|P1|COMPLETED|Overall Study||116
1071657|NCT00926588|2597419|P2|STARTED|Overall Study||126
1071658|NCT00926588|2597420|P1|STARTED|Overall Study||124
1071659|NCT00927069|2597428|P4|NOT COMPLETED|Week 12 to Week 24||3
1071660|NCT00927069|2597429|P3|NOT COMPLETED|Week 12 to Week 24||3
1071661|NCT00927069|2597430|P2|NOT COMPLETED|Week 12 to Week 24||0
1071662|NCT00927069|2597431|P1|NOT COMPLETED|Week 12 to Week 24||2
1071663|NCT00927069|2597428|P4|COMPLETED|Week 12 to Week 24||20
1071664|NCT00927069|2597429|P3|COMPLETED|Week 12 to Week 24||28
1071665|NCT00927069|2597430|P2|COMPLETED|Week 12 to Week 24||11
1071666|NCT00927069|2597431|P1|COMPLETED|Week 12 to Week 24||16
1071667|NCT00927069|2597428|P4|STARTED|Week 12 to Week 24|23 Pts. from Group B had a dose incr. since they did not respond to 40mg adalimumab every other week|23
1071668|NCT00927069|2597429|P3|STARTED|Week 12 to Week 24|31 Pts. from Group A had a dose incr. since they did not respond to 40mg adalimumab every other week|31
1071669|NCT00927069|2597430|P2|STARTED|Week 12 to Week 24|11 patients stayed at the same dose of 40 mg Adalimumab every other week|11
1071670|NCT00927069|2597431|P1|STARTED|Week 12 to Week 24|17 patients stayed at the same dose. One patient withdrew at Week 12 and also had no dose increase|18
1071671|NCT00927069|2597428|P4|NOT COMPLETED|Week 0 to Week 12||0
1071672|NCT00927069|2597429|P3|NOT COMPLETED|Week 0 to Week 12||0
1071673|NCT00927069|2597430|P2|NOT COMPLETED|Week 0 to Week 12||1
1071674|NCT00927069|2597431|P1|NOT COMPLETED|Week 0 to Week 12||1
1071675|NCT00927069|2597428|P4|COMPLETED|Week 0 to Week 12||0
1071676|NCT00927069|2597429|P3|COMPLETED|Week 0 to Week 12||0
1071677|NCT00927069|2597430|P2|COMPLETED|Week 0 to Week 12||34
1071678|NCT00927069|2597431|P1|COMPLETED|Week 0 to Week 12||49
1071679|NCT00927069|2597428|P4|STARTED|Week 0 to Week 12||0
1071680|NCT00927069|2597429|P3|STARTED|Week 0 to Week 12||0
1071681|NCT00927069|2597430|P2|STARTED|Week 0 to Week 12||35
1071682|NCT00927069|2597431|P1|STARTED|Week 0 to Week 12||50
1071683|NCT00927082|2597445|P4|NOT COMPLETED|Overall Study||19
1071684|NCT00927082|2597446|P3|NOT COMPLETED|Overall Study||22
1071685|NCT00927082|2597447|P2|NOT COMPLETED|Overall Study||10
1071686|NCT00927082|2597448|P1|NOT COMPLETED|Overall Study||12
1071687|NCT00927082|2597445|P4|COMPLETED|Overall Study||78
1071688|NCT00927082|2597446|P3|COMPLETED|Overall Study||86
1071689|NCT00927082|2597447|P2|COMPLETED|Overall Study||77
1071690|NCT00927082|2597448|P1|COMPLETED|Overall Study||79
1071691|NCT00927082|2597445|P4|STARTED|Overall Study||97
1071692|NCT00927082|2597446|P3|STARTED|Overall Study||108
1071693|NCT00927082|2597447|P2|STARTED|Overall Study||87
1071694|NCT00927082|2597448|P1|STARTED|Overall Study||91
1071695|NCT00927095|2597513|P3|NOT COMPLETED|Overall Study||2
1071696|NCT00927095|2597514|P2|NOT COMPLETED|Overall Study||4
1071697|NCT00927095|2597515|P1|NOT COMPLETED|Overall Study||6
1071698|NCT00927095|2597513|P3|COMPLETED|Overall Study||22
1071699|NCT00927095|2597514|P2|COMPLETED|Overall Study||17
1071700|NCT00927095|2597515|P1|COMPLETED|Overall Study||16
1071701|NCT00927095|2597513|P3|STARTED|Overall Study||24
1071702|NCT00927095|2597514|P2|STARTED|Overall Study||21
1071703|NCT00927095|2597515|P1|STARTED|Overall Study||22
1071704|NCT00927160|2597525|P2|NOT COMPLETED|Overall Study||0
1071705|NCT00927160|2597526|P1|NOT COMPLETED|Overall Study||0
1071706|NCT00927160|2597525|P2|COMPLETED|Overall Study||173
1071707|NCT00927160|2597526|P1|COMPLETED|Overall Study||173
1071708|NCT00927160|2597525|P2|STARTED|Overall Study||173
1071709|NCT00927160|2597526|P1|STARTED|Overall Study||173
1071710|NCT00927186|2597536|P2|NOT COMPLETED|12 - 24 Months Extension Treatment||0
1071711|NCT00927186|2597537|P1|NOT COMPLETED|12 - 24 Months Extension Treatment||0
1071712|NCT00927186|2597536|P2|COMPLETED|12 - 24 Months Extension Treatment||11
1071713|NCT00927186|2597537|P1|COMPLETED|12 - 24 Months Extension Treatment||10
1071714|NCT00927186|2597536|P2|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|11
1071715|NCT00927186|2597537|P1|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|10
1071716|NCT00927186|2597536|P2|NOT COMPLETED|12 Months Primary Study||4
1071717|NCT00927186|2597537|P1|NOT COMPLETED|12 Months Primary Study||7
1071718|NCT00927186|2597536|P2|COMPLETED|12 Months Primary Study||31
1071719|NCT00927186|2597537|P1|COMPLETED|12 Months Primary Study||27
1071720|NCT00927186|2597536|P2|Completed 6 Months Double Blind Phase|12 Months Primary Study||31
1071721|NCT00927186|2597537|P1|Completed 6 Months Double Blind Phase|12 Months Primary Study||28
1071722|NCT00927186|2597536|P2|STARTED|12 Months Primary Study||35
1071723|NCT00927186|2597537|P1|STARTED|12 Months Primary Study||34
1071724|NCT00927251|2597653|P1|NOT COMPLETED|Overall Study||8
1071725|NCT00927251|2597653|P1|COMPLETED|Overall Study||82
1071726|NCT00927251|2597653|P1|STARTED|Overall Study||90
1071727|NCT00927264|2597659|P2|NOT COMPLETED|Overall Study||25
1071728|NCT00927264|2597660|P1|NOT COMPLETED|Overall Study||56
1071729|NCT00927264|2597659|P2|COMPLETED|Overall Study||140
1071730|NCT00927264|2597660|P1|COMPLETED|Overall Study||109
1071731|NCT00927264|2597659|P2|STARTED|Overall Study||165
1071732|NCT00927264|2597660|P1|STARTED|Overall Study||165
1071733|NCT00927355|2597676|P2|NOT COMPLETED|Overall Study||1
1071734|NCT00927355|2597677|P1|NOT COMPLETED|Overall Study||1
1071735|NCT00927355|2597676|P2|COMPLETED|Overall Study||4
1071736|NCT00927355|2597677|P1|COMPLETED|Overall Study||4
1071737|NCT00927355|2597676|P2|STARTED|Overall Study||5
1071738|NCT00927355|2597677|P1|STARTED|Overall Study||5
1071739|NCT00927368|2597698|P3|NOT COMPLETED|Overall Study||5
1071740|NCT00927368|2597699|P2|NOT COMPLETED|Overall Study||5
1071741|NCT00927368|2597700|P1|NOT COMPLETED|Overall Study||6
1071742|NCT00927368|2597698|P3|COMPLETED|Overall Study||138
1071743|NCT00927368|2597699|P2|COMPLETED|Overall Study||152
1071744|NCT00927368|2597700|P1|COMPLETED|Overall Study||147
1071745|NCT00927368|2597698|P3|STARTED|Overall Study||143
1071746|NCT00927368|2597699|P2|STARTED|Overall Study||157
1071747|NCT00927368|2597700|P1|STARTED|Overall Study||153
1071748|NCT00927394|2597719|P2|NOT COMPLETED|Overall Study||85
1071749|NCT00927394|2597720|P1|NOT COMPLETED|Overall Study||77
1071750|NCT00927394|2597719|P2|COMPLETED|Overall Study||483
1071751|NCT00927394|2597720|P1|COMPLETED|Overall Study||498
1071752|NCT00927394|2597719|P2|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||562
1071753|NCT00927394|2597720|P1|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||574
1071754|NCT00927394|2597719|P2|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study||323
1071755|NCT00927394|2597720|P1|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study|consists of all patients in FAS 2 who had both valid baseline and post-baseline ABPM assessments.|342
1071756|NCT00927394|2597719|P2|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study||398
1071757|NCT00927394|2597720|P1|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study|FAS 2= all patients randomized to Cohort 2 and who had a valid baseline assessment of 24 hours ABPM.|417
1071758|NCT00927394|2597719|P2|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study||164
1071759|NCT00927394|2597720|P1|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study|FAS 1 includes all patients in Cohort 1 to whom study treatments were given through randomization.|157
1071760|NCT00927394|2597719|P2|Combined Safety Set (Cohort 1 and 2)|Overall Study||565
1071761|NCT00927394|2597720|P1|Combined Safety Set (Cohort 1 and 2)|Overall Study||574
1071762|NCT00927394|2597719|P2|Cohort 2 (Randomized)|Overall Study||403
1071763|NCT00927394|2597720|P1|Cohort 2 (Randomized)|Overall Study|Cohort 2 includes patients with specific eligibility criteria mentioned in protocol section|418
1071764|NCT00927394|2597719|P2|Cohort 1 (Randomized)|Overall Study||165
1071765|NCT00927394|2597720|P1|Cohort 1 (Randomized)|Overall Study|Cohort 1 includes patients with specific eligibility criteria mentioned in protocol section|157
1071766|NCT00927394|2597719|P2|STARTED|Overall Study|One patient was randomized in error and was discontinued by site.|568
1071767|NCT00927394|2597720|P1|STARTED|Overall Study||575
1071768|NCT00927472|2597750|P2|NOT COMPLETED|Overall Study||22
1071769|NCT00927472|2597751|P1|NOT COMPLETED|Overall Study||11
1071770|NCT00927472|2597750|P2|COMPLETED|Overall Study||106
1071771|NCT00927472|2597751|P1|COMPLETED|Overall Study||115
1071772|NCT00927472|2597750|P2|STARTED|Overall Study||128
1071773|NCT00927472|2597751|P1|STARTED|Overall Study||126
1071774|NCT00927563|2597775|P1|NOT COMPLETED|Overall Study||2
1071775|NCT00927563|2597775|P1|COMPLETED|Overall Study||22
1071776|NCT00927563|2597775|P1|STARTED|Overall Study||24
1071777|NCT00927576|2597783|P2|NOT COMPLETED|Overall Study||0
1071778|NCT00927576|2597784|P1|NOT COMPLETED|Overall Study||0
1071779|NCT00927576|2597783|P2|COMPLETED|Overall Study||28
1071780|NCT00927576|2597784|P1|COMPLETED|Overall Study||237
1071781|NCT00927576|2597783|P2|Cognitive Testing|Overall Study||28
1071782|NCT00927576|2597784|P1|Cognitive Testing|Overall Study||237
1071783|NCT00927576|2597783|P2|STARTED|Overall Study||28
1071784|NCT00927576|2597784|P1|STARTED|Overall Study||237
1071785|NCT00927589|2597789|P1|NOT COMPLETED|Overall Study||16
1071786|NCT00927589|2597789|P1|COMPLETED|Overall Study|Participants were considered to have completed the study after receiving 3 cycles of treatment.|43
1071787|NCT00927589|2597789|P1|STARTED|Overall Study||59
1071788|NCT00927758|2597811|P6|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
1071789|NCT00927758|2597812|P5|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
1071790|NCT00927758|2597813|P4|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
1071791|NCT00927758|2597814|P3|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
1071792|NCT00927758|2597815|P2|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
1071793|NCT00927758|2597816|P1|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
1071794|NCT00927758|2597811|P6|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||2
1071795|NCT00927758|2597812|P5|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
1071796|NCT00927758|2597813|P4|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||1
1071797|NCT00927758|2597814|P3|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
1071798|NCT00927758|2597815|P2|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
1071799|NCT00927758|2597816|P1|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
1071800|NCT00927758|2597811|P6|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||2
1071801|NCT00927758|2597812|P5|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
1071802|NCT00927758|2597813|P4|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||1
1071803|NCT00927758|2597814|P3|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
1071804|NCT00927758|2597815|P2|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
1071805|NCT00927758|2597816|P1|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
1071806|NCT00927758|2597811|P6|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
1071807|NCT00927758|2597812|P5|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
1071808|NCT00927758|2597813|P4|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
1071809|NCT00927758|2597814|P3|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
1071810|NCT00927758|2597815|P2|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
1071811|NCT00927758|2597816|P1|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
1071812|NCT00927758|2597811|P6|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||2
1071813|NCT00927758|2597812|P5|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
1071814|NCT00927758|2597813|P4|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
1071815|NCT00927758|2597814|P3|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
1071816|NCT00927758|2597815|P2|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
1071817|NCT00927758|2597816|P1|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
1071818|NCT00927758|2597811|P6|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||2
1071819|NCT00927758|2597812|P5|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
1071820|NCT00927758|2597813|P4|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||1
1071821|NCT00927758|2597814|P3|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
1071822|NCT00927758|2597815|P2|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
1071823|NCT00927758|2597816|P1|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
1071824|NCT00927758|2597811|P6|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
1071825|NCT00927758|2597812|P5|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
1071826|NCT00927758|2597813|P4|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||2
1071827|NCT00927758|2597814|P3|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
1071828|NCT00927758|2597815|P2|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
1071829|NCT00927758|2597816|P1|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
1071830|NCT00927758|2597811|P6|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
1071831|NCT00927758|2597812|P5|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
1071832|NCT00927758|2597813|P4|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
1071833|NCT00927758|2597814|P3|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
1071834|NCT00927758|2597815|P2|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
1071835|NCT00927758|2597816|P1|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
1071836|NCT00927758|2597811|P6|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
1071837|NCT00927758|2597812|P5|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
1071838|NCT00927758|2597813|P4|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||2
1071839|NCT00927758|2597814|P3|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
1071840|NCT00927758|2597815|P2|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
1071841|NCT00927758|2597816|P1|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
1071842|NCT00927758|2597811|P6|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
1071843|NCT00927758|2597812|P5|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
1071844|NCT00927758|2597813|P4|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||2
1071845|NCT00927758|2597814|P3|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
1071846|NCT00927758|2597815|P2|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
1071847|NCT00927758|2597816|P1|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
1071848|NCT00927758|2597811|P6|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
1071849|NCT00927758|2597812|P5|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
1071850|NCT00927758|2597813|P4|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
1071851|NCT00927758|2597814|P3|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
1071852|NCT00927758|2597815|P2|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
1071853|NCT00927758|2597816|P1|STARTED|Treatment Cycle 1 (Day 1 - Day 7)|"Started  indicates randomized as well as safety set."|4
1071854|NCT00927823|2597824|P4|NOT COMPLETED|Continuous Dosing Period||5
1071855|NCT00927823|2597825|P3|NOT COMPLETED|Continuous Dosing Period||26
1071856|NCT00927823|2597826|P2|NOT COMPLETED|Continuous Dosing Period||3
1071857|NCT00927823|2597827|P1|NOT COMPLETED|Continuous Dosing Period||3
1071858|NCT00927823|2597824|P4|COMPLETED|Continuous Dosing Period||0
1071859|NCT00927823|2597825|P3|COMPLETED|Continuous Dosing Period||0
1071860|NCT00927823|2597826|P2|COMPLETED|Continuous Dosing Period||0
1071861|NCT00927823|2597827|P1|COMPLETED|Continuous Dosing Period||0
1071862|NCT00927823|2597824|P4|Treated|Continuous Dosing Period||5
1071863|NCT00927823|2597825|P3|Treated|Continuous Dosing Period||23
1071864|NCT00927823|2597826|P2|Treated|Continuous Dosing Period||3
1071865|NCT00927823|2597827|P1|Treated|Continuous Dosing Period||3
1071866|NCT00927823|2597824|P4|STARTED|Continuous Dosing Period||5
1071867|NCT00927823|2597825|P3|STARTED|Continuous Dosing Period||26
1071868|NCT00927823|2597826|P2|STARTED|Continuous Dosing Period||3
1071869|NCT00927823|2597827|P1|STARTED|Continuous Dosing Period||3
1071870|NCT00927823|2597824|P4|NOT COMPLETED|Lead-In Period||0
1071871|NCT00927823|2597825|P3|NOT COMPLETED|Lead-In Period||0
1071872|NCT00927823|2597826|P2|NOT COMPLETED|Lead-In Period||0
1071873|NCT00927823|2597827|P1|NOT COMPLETED|Lead-In Period||0
1071874|NCT00927823|2597824|P4|COMPLETED|Lead-In Period||5
1071875|NCT00927823|2597825|P3|COMPLETED|Lead-In Period||26
1071876|NCT00927823|2597826|P2|COMPLETED|Lead-In Period||3
1071877|NCT00927823|2597827|P1|COMPLETED|Lead-In Period||3
1071878|NCT00927823|2597824|P4|STARTED|Lead-In Period||5
1071879|NCT00927823|2597825|P3|STARTED|Lead-In Period||26
1071880|NCT00927823|2597826|P2|STARTED|Lead-In Period||3
1071881|NCT00927823|2597827|P1|STARTED|Lead-In Period||3
1071882|NCT00927849|2597894|P3|NOT COMPLETED|Overall Study||0
1071883|NCT00927849|2597895|P2|NOT COMPLETED|Overall Study||0
1071884|NCT00927849|2597896|P1|NOT COMPLETED|Overall Study||0
1071885|NCT00927849|2597894|P3|COMPLETED|Overall Study||21
1071886|NCT00927849|2597895|P2|COMPLETED|Overall Study||21
1071887|NCT00927849|2597896|P1|COMPLETED|Overall Study||21
1071888|NCT00927849|2597894|P3|STARTED|Overall Study||21
1071889|NCT00927849|2597895|P2|STARTED|Overall Study||21
1071890|NCT00927849|2597896|P1|STARTED|Overall Study||21
1071891|NCT00927862|2597906|P2|NOT COMPLETED|Overall Study||45
1071892|NCT00927862|2597907|P1|NOT COMPLETED|Overall Study||27
1071893|NCT00927862|2597906|P2|COMPLETED|Overall Study||1866
1071894|NCT00927862|2597907|P1|COMPLETED|Overall Study|477 patients evaluated in primary analyses and 488 evaluated in secondary analyses.|477
1071895|NCT00927862|2597906|P2|STARTED|Overall Study||1911
1071896|NCT00927862|2597907|P1|STARTED|Overall Study||504
1071897|NCT00927888|2597931|P2|NOT COMPLETED|Overall Study||0
1071898|NCT00927888|2597932|P1|NOT COMPLETED|Overall Study||0
1071899|NCT00927888|2597931|P2|COMPLETED|Overall Study||27
1071900|NCT00927888|2597932|P1|COMPLETED|Overall Study||29
1071901|NCT00927888|2597931|P2|STARTED|Overall Study||27
1071902|NCT00927888|2597932|P1|STARTED|Overall Study||29
1071903|NCT00927901|2597940|P4|NOT COMPLETED|Treatment Period 4||1
1071904|NCT00927901|2597941|P3|NOT COMPLETED|Treatment Period 4||1
1071905|NCT00927901|2597942|P2|NOT COMPLETED|Treatment Period 4||0
1071906|NCT00927901|2597943|P1|NOT COMPLETED|Treatment Period 4||0
1071907|NCT00927901|2597940|P4|COMPLETED|Treatment Period 4||8
1071908|NCT00927901|2597941|P3|COMPLETED|Treatment Period 4||5
1071909|NCT00927901|2597942|P2|COMPLETED|Treatment Period 4||7
1071910|NCT00927901|2597943|P1|COMPLETED|Treatment Period 4||7
1071911|NCT00927901|2597940|P4|STARTED|Treatment Period 4||9
1071912|NCT00927901|2597941|P3|STARTED|Treatment Period 4||6
1071913|NCT00927901|2597942|P2|STARTED|Treatment Period 4||7
1071914|NCT00927901|2597943|P1|STARTED|Treatment Period 4||7
1071915|NCT00927901|2597940|P4|NOT COMPLETED|Treatment Period 3||0
1071916|NCT00927901|2597941|P3|NOT COMPLETED|Treatment Period 3||0
1071917|NCT00927901|2597942|P2|NOT COMPLETED|Treatment Period 3||0
1071918|NCT00927901|2597943|P1|NOT COMPLETED|Treatment Period 3||0
1071919|NCT00927901|2597940|P4|COMPLETED|Treatment Period 3||9
1071920|NCT00927901|2597941|P3|COMPLETED|Treatment Period 3||6
1071921|NCT00927901|2597942|P2|COMPLETED|Treatment Period 3||7
1071922|NCT00927901|2597943|P1|COMPLETED|Treatment Period 3||7
1071923|NCT00927901|2597940|P4|STARTED|Treatment Period 3||9
1071924|NCT00927901|2597941|P3|STARTED|Treatment Period 3||6
1071925|NCT00927901|2597942|P2|STARTED|Treatment Period 3||7
1071926|NCT00927901|2597943|P1|STARTED|Treatment Period 3||7
1071927|NCT00927901|2597940|P4|NOT COMPLETED|Treatment Period 2||0
1071928|NCT00927901|2597941|P3|NOT COMPLETED|Treatment Period 2||0
1071929|NCT00927901|2597942|P2|NOT COMPLETED|Treatment Period 2||0
1071930|NCT00927901|2597943|P1|NOT COMPLETED|Treatment Period 2||0
1071931|NCT00927901|2597940|P4|COMPLETED|Treatment Period 2||9
1071932|NCT00927901|2597941|P3|COMPLETED|Treatment Period 2||6
1071933|NCT00927901|2597942|P2|COMPLETED|Treatment Period 2||7
1071934|NCT00927901|2597943|P1|COMPLETED|Treatment Period 2||7
1071935|NCT00927901|2597940|P4|STARTED|Treatment Period 2||9
1071936|NCT00927901|2597941|P3|STARTED|Treatment Period 2||6
1071937|NCT00927901|2597942|P2|STARTED|Treatment Period 2||7
1071938|NCT00927901|2597943|P1|STARTED|Treatment Period 2||7
1071939|NCT00927901|2597940|P4|NOT COMPLETED|Treatment Period 1||0
1071940|NCT00927901|2597941|P3|NOT COMPLETED|Treatment Period 1||1
1071941|NCT00927901|2597942|P2|NOT COMPLETED|Treatment Period 1||0
1071942|NCT00927901|2597943|P1|NOT COMPLETED|Treatment Period 1||0
1071943|NCT00927901|2597940|P4|COMPLETED|Treatment Period 1||9
1071944|NCT00927901|2597941|P3|COMPLETED|Treatment Period 1||6
1071945|NCT00927901|2597942|P2|COMPLETED|Treatment Period 1||7
1071946|NCT00927901|2597943|P1|COMPLETED|Treatment Period 1||7
1071947|NCT00927901|2597940|P4|STARTED|Treatment Period 1||9
1071948|NCT00927901|2597941|P3|STARTED|Treatment Period 1||7
1071949|NCT00927901|2597942|P2|STARTED|Treatment Period 1||7
1071950|NCT00927901|2597943|P1|STARTED|Treatment Period 1||7
1071951|NCT00927927|2597986|P15|NOT COMPLETED|Overall Study||0
1071952|NCT00927927|2597987|P14|NOT COMPLETED|Overall Study||0
1071953|NCT00927927|2597988|P13|NOT COMPLETED|Overall Study||0
1071954|NCT00927927|2597989|P12|NOT COMPLETED|Overall Study||2
1071955|NCT00927927|2597990|P11|NOT COMPLETED|Overall Study||0
1071956|NCT00927927|2597991|P10|NOT COMPLETED|Overall Study||0
1071957|NCT00927927|2597992|P9|NOT COMPLETED|Overall Study||0
1071958|NCT00927927|2597993|P8|NOT COMPLETED|Overall Study||2
1071959|NCT00927927|2597994|P7|NOT COMPLETED|Overall Study||0
1071960|NCT00927927|2597995|P6|NOT COMPLETED|Overall Study||0
1071961|NCT00927927|2597996|P5|NOT COMPLETED|Overall Study||0
1071962|NCT00927927|2597997|P4|NOT COMPLETED|Overall Study||0
1071963|NCT00927927|2597998|P3|NOT COMPLETED|Overall Study||0
1071964|NCT00927927|2597999|P2|NOT COMPLETED|Overall Study||0
1071965|NCT00927927|2598000|P1|NOT COMPLETED|Overall Study||0
1071966|NCT00927927|2597986|P15|COMPLETED|Overall Study||9
1071967|NCT00927927|2597987|P14|COMPLETED|Overall Study||5
1071968|NCT00927927|2597988|P13|COMPLETED|Overall Study||5
1071969|NCT00927927|2597989|P12|COMPLETED|Overall Study|One subject withdrew consent after being randomised but before receiving any trial product.|4
1071970|NCT00927927|2597990|P11|COMPLETED|Overall Study||5
1071971|NCT00927927|2597991|P10|COMPLETED|Overall Study||3
1071972|NCT00927927|2597992|P9|COMPLETED|Overall Study||8
1071973|NCT00927927|2597993|P8|COMPLETED|Overall Study||1
1071974|NCT00927927|2597994|P7|COMPLETED|Overall Study||3
1071975|NCT00927927|2597995|P6|COMPLETED|Overall Study||3
1071976|NCT00927927|2597996|P5|COMPLETED|Overall Study||3
1071977|NCT00927927|2597997|P4|COMPLETED|Overall Study||3
1071978|NCT00927927|2597998|P3|COMPLETED|Overall Study||3
1071979|NCT00927927|2597999|P2|COMPLETED|Overall Study||3
1071980|NCT00927927|2598000|P1|COMPLETED|Overall Study||3
1071981|NCT00927927|2597986|P15|Exposed|Overall Study||9
1071982|NCT00927927|2597987|P14|Exposed|Overall Study||5
1071983|NCT00927927|2597988|P13|Exposed|Overall Study||5
1071984|NCT00927927|2597989|P12|Exposed|Overall Study||5
1071985|NCT00927927|2597990|P11|Exposed|Overall Study||5
1071986|NCT00927927|2597991|P10|Exposed|Overall Study||3
1071987|NCT00927927|2597992|P9|Exposed|Overall Study||8
1071988|NCT00927927|2597993|P8|Exposed|Overall Study||3
1071989|NCT00927927|2597994|P7|Exposed|Overall Study||3
1071990|NCT00927927|2597995|P6|Exposed|Overall Study||3
1071991|NCT00927927|2597996|P5|Exposed|Overall Study||3
1071992|NCT00927927|2597997|P4|Exposed|Overall Study||3
1071993|NCT00927927|2597998|P3|Exposed|Overall Study||3
1071994|NCT00927927|2597999|P2|Exposed|Overall Study||3
1071995|NCT00927927|2598000|P1|Exposed|Overall Study||3
1071996|NCT00927927|2597986|P15|STARTED|Overall Study||9
1071997|NCT00927927|2597987|P14|STARTED|Overall Study||5
1071998|NCT00927927|2597988|P13|STARTED|Overall Study||5
1071999|NCT00927927|2597989|P12|STARTED|Overall Study||6
1072000|NCT00927927|2597990|P11|STARTED|Overall Study||5
1072001|NCT00927927|2597991|P10|STARTED|Overall Study||3
1072002|NCT00927927|2597992|P9|STARTED|Overall Study||8
1072003|NCT00927927|2597993|P8|STARTED|Overall Study||3
1072004|NCT00927927|2597994|P7|STARTED|Overall Study||3
1072005|NCT00927927|2597995|P6|STARTED|Overall Study||3
1072006|NCT00927927|2597996|P5|STARTED|Overall Study||3
1072007|NCT00927927|2597997|P4|STARTED|Overall Study||3
1072008|NCT00927927|2597998|P3|STARTED|Overall Study||3
1072009|NCT00927927|2597999|P2|STARTED|Overall Study||3
1072010|NCT00927927|2598000|P1|STARTED|Overall Study||3
1072011|NCT00927940|2598047|P1|NOT COMPLETED|Overall Study||1
1072012|NCT00927940|2598047|P1|COMPLETED|Overall Study|A patient died before 30 days follow up. This pasitent is excluded from primary analysis.|99
1072013|NCT00927940|2598047|P1|STARTED|Overall Study||100
1072014|NCT00927953|2598054|P2|NOT COMPLETED|Overall Study||1
1072015|NCT00927953|2598055|P1|NOT COMPLETED|Overall Study||2
1072016|NCT00927953|2598054|P2|COMPLETED|Overall Study||6
1072017|NCT00927953|2598055|P1|COMPLETED|Overall Study||4
1072018|NCT00927953|2598054|P2|STARTED|Overall Study||7
1072019|NCT00927953|2598055|P1|STARTED|Overall Study||6
1072020|NCT00927992|2598069|P1|NOT COMPLETED|Overall Study||0
1072021|NCT00927992|2598069|P1|COMPLETED|Overall Study||11
1072022|NCT00927992|2598069|P1|STARTED|Overall Study||11
1072023|NCT00928018|2598081|P2|NOT COMPLETED|Overall Study||0
1072024|NCT00928018|2598082|P1|NOT COMPLETED|Overall Study||1
1072025|NCT00928018|2598081|P2|COMPLETED|Overall Study||73
1072026|NCT00928018|2598082|P1|COMPLETED|Overall Study||65
1072027|NCT00928018|2598081|P2|STARTED|Overall Study||73
1072028|NCT00928018|2598082|P1|STARTED|Overall Study|One Arm A patient withdrew consent, treated as Arm B, but analyzed on Arm A based on intent-to-treat|66
1072029|NCT00928057|2598102|P2|NOT COMPLETED|Overall Study||4
1072030|NCT00928057|2598103|P1|NOT COMPLETED|Overall Study||2
1072031|NCT00928057|2598102|P2|COMPLETED|Overall Study||85
1072032|NCT00928057|2598103|P1|COMPLETED|Overall Study||82
1072033|NCT00928057|2598102|P2|STARTED|Overall Study||89
1072034|NCT00928057|2598103|P1|STARTED|Overall Study||84
1072035|NCT00928070|2598128|P2|NOT COMPLETED|Overall Study||57
1072036|NCT00928070|2598129|P1|NOT COMPLETED|Overall Study||63
1072037|NCT00928070|2598128|P2|COMPLETED|Overall Study||226
1072038|NCT00928070|2598129|P1|COMPLETED|Overall Study||220
1072039|NCT00928070|2598128|P2|Treated|Overall Study||281
1072040|NCT00928070|2598129|P1|Treated|Overall Study||281
1072041|NCT00928070|2598128|P2|STARTED|Overall Study||283
1072042|NCT00928070|2598129|P1|STARTED|Overall Study||283
1072043|NCT00928083|2598188|P9|NOT COMPLETED|Overall Study||0
1072044|NCT00928083|2598189|P8|NOT COMPLETED|Overall Study||0
1072045|NCT00928083|2598190|P7|NOT COMPLETED|Overall Study||0
1072046|NCT00928083|2598191|P6|NOT COMPLETED|Overall Study||0
1072047|NCT00928083|2598192|P5|NOT COMPLETED|Overall Study||1
1072048|NCT00928083|2598193|P4|NOT COMPLETED|Overall Study||1
1072049|NCT00928083|2598194|P3|NOT COMPLETED|Overall Study||0
1072050|NCT00928083|2598195|P2|NOT COMPLETED|Overall Study||0
1072051|NCT00928083|2598196|P1|NOT COMPLETED|Overall Study||4
1072052|NCT00928083|2598188|P9|COMPLETED|Overall Study||6
1072053|NCT00928083|2598189|P8|COMPLETED|Overall Study||6
1072054|NCT00928083|2598190|P7|COMPLETED|Overall Study||6
1072055|NCT00928083|2598191|P6|COMPLETED|Overall Study||6
1072056|NCT00928083|2598192|P5|COMPLETED|Overall Study||6
1072057|NCT00928083|2598193|P4|COMPLETED|Overall Study||5
1072058|NCT00928083|2598194|P3|COMPLETED|Overall Study||8
1072059|NCT00928083|2598195|P2|COMPLETED|Overall Study||8
1072060|NCT00928083|2598196|P1|COMPLETED|Overall Study||6
1072061|NCT00928083|2598188|P9|STARTED|Overall Study||6
1072062|NCT00928083|2598189|P8|STARTED|Overall Study||6
1072063|NCT00928083|2598190|P7|STARTED|Overall Study||6
1072064|NCT00928083|2598191|P6|STARTED|Overall Study||6
1072065|NCT00928083|2598192|P5|STARTED|Overall Study||7
1072066|NCT00928083|2598193|P4|STARTED|Overall Study||6
1072067|NCT00928083|2598194|P3|STARTED|Overall Study||8
1072068|NCT00928083|2598195|P2|STARTED|Overall Study||8
1072069|NCT00928083|2598196|P1|STARTED|Overall Study||10
1072070|NCT00928174|2598305|P1|NOT COMPLETED|Overall Study||5
1072071|NCT00928174|2598305|P1|COMPLETED|Overall Study|3 withdrawn before start of participation|22
1072072|NCT00928174|2598305|P1|STARTED|Overall Study||27
1072073|NCT00928187|2598312|P3|NOT COMPLETED|Overall Study||5
1072074|NCT00928187|2598313|P2|NOT COMPLETED|Overall Study||6
1072075|NCT00928187|2598314|P1|NOT COMPLETED|Overall Study||2
1072076|NCT00928187|2598312|P3|COMPLETED|Overall Study||150
1072077|NCT00928187|2598313|P2|COMPLETED|Overall Study||141
1072078|NCT00928187|2598314|P1|COMPLETED|Overall Study||150
1072079|NCT00928187|2598312|P3|Analysed|Overall Study||154
1072080|NCT00928187|2598313|P2|Analysed|Overall Study||145
1072081|NCT00928187|2598314|P1|Analysed|Overall Study||152
1072082|NCT00928187|2598312|P3|STARTED|Overall Study||155
1072083|NCT00928187|2598313|P2|STARTED|Overall Study||147
1072084|NCT00928187|2598314|P1|STARTED|Overall Study||152
1072085|NCT00928252|2598358|P1|NOT COMPLETED|Overall Study||3
1072086|NCT00928252|2598358|P1|COMPLETED|Overall Study||42
1072087|NCT00928252|2598358|P1|STARTED|Overall Study||45
1072088|NCT00928304|2598364|P2|NOT COMPLETED|Overall Study||0
1072089|NCT00928304|2598365|P1|NOT COMPLETED|Overall Study||0
1072090|NCT00928304|2598364|P2|COMPLETED|Overall Study||70
1072091|NCT00928304|2598365|P1|COMPLETED|Overall Study||39
1072092|NCT00928304|2598364|P2|STARTED|Overall Study||70
1072093|NCT00928304|2598365|P1|STARTED|Overall Study||39
1072094|NCT00928395|2598377|P1|NOT COMPLETED|Overall Study||21
1072095|NCT00928395|2598377|P1|COMPLETED|Overall Study||29
1072096|NCT00928395|2598377|P1|STARTED|Overall Study||50
1072097|NCT00928408|2598381|P1|NOT COMPLETED|Overall Study||23
1072098|NCT00928408|2598381|P1|COMPLETED|Overall Study||282
1072099|NCT00928408|2598381|P1|Full Analysis Set|Overall Study|All enrolled participants who fulfilled the study inclusion/exclusion criteria|303
1072100|NCT00928408|2598381|P1|STARTED|Overall Study|Number Enrolled|305
1072101|NCT00928421|2598410|P1|NOT COMPLETED|Overall Study||0
1072102|NCT00928421|2598410|P1|COMPLETED|Overall Study||16
1072103|NCT00928421|2598410|P1|Treated With Study Drug|Overall Study||16
1072104|NCT00928421|2598410|P1|STARTED|Overall Study||16
1072105|NCT00928434|2598417|P3|NOT COMPLETED|Overall Study||44
1072106|NCT00928434|2598418|P2|NOT COMPLETED|Overall Study||14
1072107|NCT00928434|2598419|P1|NOT COMPLETED|Overall Study||44
1072108|NCT00928434|2598417|P3|COMPLETED|Overall Study||134
1072109|NCT00928434|2598418|P2|COMPLETED|Overall Study||36
1072110|NCT00928434|2598419|P1|COMPLETED|Overall Study||131
1072111|NCT00928434|2598417|P3|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|150
1072112|NCT00928434|2598418|P2|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|41
1072113|NCT00928434|2598419|P1|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|137
1072114|NCT00928434|2598417|P3|STARTED|Overall Study|Full Analysis Set Patients|178
1072115|NCT00928434|2598418|P2|STARTED|Overall Study|Full Analysis Set Patients|50
1072116|NCT00928434|2598419|P1|STARTED|Overall Study|Full Analysis Set Patients|175
1072117|NCT00928486|2598491|P1|NOT COMPLETED|Overall Study||10
1072118|NCT00928486|2598491|P1|COMPLETED|Overall Study|Completed = those who continued responding to treatment; upon marketing approval, given lenalidomide|15
1072119|NCT00928486|2598491|P1|Efficacy Evaluable (EE)|Overall Study|EE population = given at least 1 dose of study drug, evaluated for efficacy and met eligibility|24
1072120|NCT00928486|2598491|P1|STARTED|Overall Study||25
1072121|NCT00928512|2598502|P5|NOT COMPLETED|Overall Study||15
1072122|NCT00928512|2598503|P4|NOT COMPLETED|Overall Study||21
1072123|NCT00928512|2598504|P3|NOT COMPLETED|Overall Study||11
1072124|NCT00928512|2598505|P2|NOT COMPLETED|Overall Study||6
1072125|NCT00928512|2598506|P1|NOT COMPLETED|Overall Study||10
1072126|NCT00928512|2598502|P5|COMPLETED|Overall Study||35
1072127|NCT00928512|2598503|P4|COMPLETED|Overall Study||33
1072128|NCT00928512|2598504|P3|COMPLETED|Overall Study||38
1072129|NCT00928512|2598505|P2|COMPLETED|Overall Study||37
1072130|NCT00928512|2598506|P1|COMPLETED|Overall Study||31
1072131|NCT00928512|2598502|P5|Entered/Continued to Week 20 (All)|Overall Study||45
1072132|NCT00928512|2598503|P4|Entered/Continued to Week 20 (All)|Overall Study||45
1072133|NCT00928512|2598504|P3|Entered/Continued to Week 20 (All)|Overall Study||46
1072134|NCT00928512|2598505|P2|Entered/Continued to Week 20 (All)|Overall Study||43
1072135|NCT00928512|2598506|P1|Entered/Continued to Week 20 (All)|Overall Study||37
1072136|NCT00928512|2598502|P5|Completed Week 16|Overall Study||45
1072137|NCT00928512|2598503|P4|Completed Week 16|Overall Study||48
1072138|NCT00928512|2598504|P3|Completed Week 16|Overall Study||47
1072139|NCT00928512|2598505|P2|Completed Week 16|Overall Study||43
1072140|NCT00928512|2598506|P1|Completed Week 16|Overall Study||38
1072141|NCT00928512|2598502|P5|New Groups After Reassignment|Overall Study||0
1072142|NCT00928512|2598503|P4|New Groups After Reassignment|Overall Study|2 patients in this group continued at Week 16 but did not receive any study drug at Week 20|18
1072143|NCT00928512|2598504|P3|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|23
1072144|NCT00928512|2598505|P2|New Groups After Reassignment|Overall Study||115
1072145|NCT00928512|2598506|P1|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|60
1072146|NCT00928512|2598502|P5|Not Reassigned at Week 20 (Responders)|Overall Study||0
1072147|NCT00928512|2598503|P4|Not Reassigned at Week 20 (Responders)|Overall Study||18
1072148|NCT00928512|2598504|P3|Not Reassigned at Week 20 (Responders)|Overall Study||23
1072149|NCT00928512|2598505|P2|Not Reassigned at Week 20 (Responders)|Overall Study||20
1072150|NCT00928512|2598506|P1|Not Reassigned at Week 20 (Responders)|Overall Study||37
1072151|NCT00928512|2598502|P5|Reassigned at Week 20 (Non-responders)|Overall Study|All placebo patients (responders & non-responders) were reassigned treatment to the 150 mg group.|45
1072152|NCT00928512|2598503|P4|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 25 mg group were reassigned treatment to the 150 mg group.|27
1072153|NCT00928512|2598504|P3|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 75 mg group were reassigned treatment to the 150 mg group.|23
1072154|NCT00928512|2598505|P2|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 150 mg group were reassigned treatment to the 300 mg group.|23
1072155|NCT00928512|2598506|P1|Reassigned at Week 20 (Non-responders)|Overall Study|All patients in the 300 mg group at Week 20 remained at this dose in this group.|0
1072156|NCT00928512|2598502|P5|Discontinued Prior to Week 16|Overall Study||5
1072157|NCT00928512|2598503|P4|Discontinued Prior to Week 16|Overall Study||6
1072158|NCT00928512|2598504|P3|Discontinued Prior to Week 16|Overall Study||2
1072159|NCT00928512|2598505|P2|Discontinued Prior to Week 16|Overall Study||0
1072160|NCT00928512|2598506|P1|Discontinued Prior to Week 16|Overall Study||3
1072161|NCT00928512|2598502|P5|STARTED|Overall Study||50
1072162|NCT00928512|2598503|P4|STARTED|Overall Study||54
1072163|NCT00928512|2598504|P3|STARTED|Overall Study||49
1072164|NCT00928512|2598505|P2|STARTED|Overall Study||43
1072165|NCT00928512|2598506|P1|STARTED|Overall Study||41
1072166|NCT00928642|2598607|P1|NOT COMPLETED|Overall Study||0
1072167|NCT00928642|2598607|P1|COMPLETED|Overall Study|1 subject withdrew after 1st cycle but before disease assessment. 7 of 8 are evaluable for response|8
1072168|NCT00928642|2598607|P1|STARTED|Overall Study||8
1072169|NCT00928668|2598616|P5|NOT COMPLETED|Overall Study||1
1072170|NCT00928668|2598617|P4|NOT COMPLETED|Overall Study||1
1072171|NCT00928668|2598618|P3|NOT COMPLETED|Overall Study||1
1072172|NCT00928668|2598619|P2|NOT COMPLETED|Overall Study||1
1072173|NCT00928668|2598620|P1|NOT COMPLETED|Overall Study||1
1072174|NCT00928668|2598616|P5|COMPLETED|Overall Study||5
1072175|NCT00928668|2598617|P4|COMPLETED|Overall Study||3
1072176|NCT00928668|2598618|P3|COMPLETED|Overall Study||6
1072177|NCT00928668|2598619|P2|COMPLETED|Overall Study||6
1072178|NCT00928668|2598620|P1|COMPLETED|Overall Study||6
1072179|NCT00928668|2598616|P5|STARTED|Overall Study||6
1072180|NCT00928668|2598617|P4|STARTED|Overall Study||4
1072181|NCT00928668|2598618|P3|STARTED|Overall Study||7
1072182|NCT00928668|2598619|P2|STARTED|Overall Study||7
1072183|NCT00928668|2598620|P1|STARTED|Overall Study||7
1072184|NCT00928694|2598662|P2|NOT COMPLETED|Second Intervention||0
1072185|NCT00928694|2598663|P1|NOT COMPLETED|Second Intervention||0
1072186|NCT00928694|2598662|P2|COMPLETED|Second Intervention||7
1072187|NCT00928694|2598663|P1|COMPLETED|Second Intervention||7
1072188|NCT00928694|2598662|P2|STARTED|Second Intervention||7
1072189|NCT00928694|2598663|P1|STARTED|Second Intervention||7
1072190|NCT00928694|2598662|P2|NOT COMPLETED|First Intervention||0
1072191|NCT00928694|2598663|P1|NOT COMPLETED|First Intervention||0
1072192|NCT00928694|2598662|P2|COMPLETED|First Intervention||7
1072193|NCT00928694|2598663|P1|COMPLETED|First Intervention||7
1072194|NCT00928694|2598662|P2|STARTED|First Intervention||7
1072195|NCT00928694|2598663|P1|STARTED|First Intervention||7
1072196|NCT00928720|2598674|P3|NOT COMPLETED|Overall Study||3
1072197|NCT00928720|2598675|P2|NOT COMPLETED|Overall Study||6
1072198|NCT00928720|2598676|P1|NOT COMPLETED|Overall Study||2
1072199|NCT00928720|2598674|P3|COMPLETED|Overall Study||15
1072200|NCT00928720|2598675|P2|COMPLETED|Overall Study||14
1072201|NCT00928720|2598676|P1|COMPLETED|Overall Study||17
1072202|NCT00928720|2598674|P3|STARTED|Overall Study||18
1072203|NCT00928720|2598675|P2|STARTED|Overall Study||20
1072204|NCT00928720|2598676|P1|STARTED|Overall Study||19
1072205|NCT00928746|2598684|P1|NOT COMPLETED|Overall Study||6
1072206|NCT00928746|2598684|P1|COMPLETED|Overall Study||136
1072207|NCT00928746|2598684|P1|STARTED|Overall Study||142
1072208|NCT00928772|2598707|P3|NOT COMPLETED|Overall Study||0
1072209|NCT00928772|2598708|P2|NOT COMPLETED|Overall Study||0
1072210|NCT00928772|2598709|P1|NOT COMPLETED|Overall Study||0
1072211|NCT00928772|2598707|P3|COMPLETED|Overall Study||38
1072212|NCT00928772|2598708|P2|COMPLETED|Overall Study||38
1072213|NCT00928772|2598709|P1|COMPLETED|Overall Study||39
1072214|NCT00928772|2598707|P3|STARTED|Overall Study||38
1072215|NCT00928772|2598708|P2|STARTED|Overall Study||38
1072216|NCT00928772|2598709|P1|STARTED|Overall Study||39
1072217|NCT00928889|2598728|P2|NOT COMPLETED|Overall Study||2
1072218|NCT00928889|2598729|P1|NOT COMPLETED|Overall Study||5
1072219|NCT00928889|2598728|P2|COMPLETED|Overall Study||78
1072220|NCT00928889|2598729|P1|COMPLETED|Overall Study||75
1072221|NCT00928889|2598728|P2|STARTED|Overall Study||80
1072222|NCT00928889|2598729|P1|STARTED|Overall Study||80
1072223|NCT00928954|2598753|P2|NOT COMPLETED|Overall Study||0
1072224|NCT00928954|2598754|P1|NOT COMPLETED|Overall Study||0
1072225|NCT00928954|2598753|P2|COMPLETED|Overall Study||6
1072226|NCT00928954|2598754|P1|COMPLETED|Overall Study||4
1072227|NCT00928954|2598753|P2|STARTED|Overall Study||6
1072228|NCT00928954|2598754|P1|STARTED|Overall Study||4
1072229|NCT00929071|2598762|P1|NOT COMPLETED|Overall Study||0
1072230|NCT00929071|2598762|P1|COMPLETED|Overall Study||10
1072231|NCT00929071|2598762|P1|STARTED|Overall Study||10
1072232|NCT00929110|2598772|P3|NOT COMPLETED|Overall Study||62
1072233|NCT00929110|2598773|P2|NOT COMPLETED|Overall Study||76
1072234|NCT00929110|2598774|P1|NOT COMPLETED|Overall Study||118
1072235|NCT00929110|2598772|P3|COMPLETED|Overall Study||206
1072236|NCT00929110|2598773|P2|COMPLETED|Overall Study||193
1072237|NCT00929110|2598774|P1|COMPLETED|Overall Study||411
1072238|NCT00929110|2598772|P3|STARTED|Overall Study||268
1072239|NCT00929110|2598773|P2|STARTED|Overall Study||269
1072240|NCT00929110|2598774|P1|STARTED|Overall Study||529
1072241|NCT00929162|2598841|P2|NOT COMPLETED|Overall Study||42
1072242|NCT00929162|2598842|P1|NOT COMPLETED|Overall Study||48
1072243|NCT00929162|2598841|P2|COMPLETED|Overall Study||19
1072244|NCT00929162|2598842|P1|COMPLETED|Overall Study||11
1072245|NCT00929162|2598841|P2|Patients Who Received Treatment|Overall Study||58
1072246|NCT00929162|2598842|P1|Patients Who Received Treatment|Overall Study||58
1072247|NCT00929162|2598841|P2|STARTED|Overall Study||61
1072248|NCT00929162|2598842|P1|STARTED|Overall Study||59
1072249|NCT00929201|2598852|P2|NOT COMPLETED|Period 2||0
1072250|NCT00929201|2598853|P1|NOT COMPLETED|Period 2||0
1072251|NCT00929201|2598852|P2|COMPLETED|Period 2||30
1072252|NCT00929201|2598853|P1|COMPLETED|Period 2||30
1072253|NCT00929201|2598852|P2|STARTED|Period 2||30
1072254|NCT00929201|2598853|P1|STARTED|Period 2||30
1072255|NCT00929201|2598852|P2|NOT COMPLETED|7-day Washout||0
1072256|NCT00929201|2598853|P1|NOT COMPLETED|7-day Washout||0
1072257|NCT00929201|2598852|P2|COMPLETED|7-day Washout||30
1072258|NCT00929201|2598853|P1|COMPLETED|7-day Washout||30
1072259|NCT00929201|2598852|P2|STARTED|7-day Washout||30
1072260|NCT00929201|2598853|P1|STARTED|7-day Washout||30
1072261|NCT00929201|2598852|P2|NOT COMPLETED|Period 1||1
1072262|NCT00929201|2598853|P1|NOT COMPLETED|Period 1||0
1072263|NCT00929201|2598852|P2|COMPLETED|Period 1||30
1072264|NCT00929201|2598853|P1|COMPLETED|Period 1||30
1072265|NCT00929201|2598852|P2|STARTED|Period 1||31
1072266|NCT00929201|2598853|P1|STARTED|Period 1||30
1072267|NCT00929240|2598861|P3|NOT COMPLETED|Maintenance Phase||91
1072268|NCT00929240|2598862|P2|NOT COMPLETED|Maintenance Phase||94
1072269|NCT00929240|2598863|P1|NOT COMPLETED|Maintenance Phase||0
1072270|NCT00929240|2598861|P3|COMPLETED|Maintenance Phase||0
1072271|NCT00929240|2598862|P2|COMPLETED|Maintenance Phase||0
1072272|NCT00929240|2598863|P1|COMPLETED|Maintenance Phase||0
1072273|NCT00929240|2598861|P3|STARTED|Maintenance Phase||91
1072274|NCT00929240|2598862|P2|STARTED|Maintenance Phase||94
1072275|NCT00929240|2598863|P1|STARTED|Maintenance Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
1072276|NCT00929240|2598861|P3|NOT COMPLETED|Initial Treatment Phase||0
1072277|NCT00929240|2598862|P2|NOT COMPLETED|Initial Treatment Phase||0
1072278|NCT00929240|2598863|P1|NOT COMPLETED|Initial Treatment Phase||99
1072279|NCT00929240|2598861|P3|COMPLETED|Initial Treatment Phase||0
1072280|NCT00929240|2598862|P2|COMPLETED|Initial Treatment Phase||0
1072281|NCT00929240|2598863|P1|COMPLETED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|185
1072282|NCT00929240|2598861|P3|STARTED|Initial Treatment Phase||0
1072283|NCT00929240|2598862|P2|STARTED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
1072284|NCT00929240|2598863|P1|STARTED|Initial Treatment Phase|Includes only the participants that received Initial Phase Treatment.|284
1072285|NCT00929305|2598892|P2|NOT COMPLETED|Overall Study||0
1072286|NCT00929305|2598893|P1|NOT COMPLETED|Overall Study||0
1072287|NCT00929305|2598892|P2|COMPLETED|Overall Study||43
1072288|NCT00929305|2598893|P1|COMPLETED|Overall Study||43
1072289|NCT00929305|2598892|P2|STARTED|Overall Study||43
1072290|NCT00929305|2598893|P1|STARTED|Overall Study||43
1072291|NCT00929331|2598903|P2|NOT COMPLETED|Overall Study||0
1072292|NCT00929331|2598904|P1|NOT COMPLETED|Overall Study||0
1072293|NCT00929331|2598903|P2|COMPLETED|Overall Study||55
1072294|NCT00929331|2598904|P1|COMPLETED|Overall Study||55
1072295|NCT00929331|2598903|P2|STARTED|Overall Study||55
1072296|NCT00929331|2598904|P1|STARTED|Overall Study||55
1072297|NCT00929344|2598939|P3|NOT COMPLETED|Overall Study||21
1072298|NCT00929344|2598940|P2|NOT COMPLETED|Overall Study||13
1072299|NCT00929344|2598941|P1|NOT COMPLETED|Overall Study||22
1072300|NCT00929344|2598939|P3|COMPLETED|Overall Study||29
1072301|NCT00929344|2598940|P2|COMPLETED|Overall Study||37
1072302|NCT00929344|2598941|P1|COMPLETED|Overall Study||28
1072303|NCT00929344|2598939|P3|STARTED|Overall Study||50
1072304|NCT00929344|2598940|P2|STARTED|Overall Study||50
1072305|NCT00929344|2598941|P1|STARTED|Overall Study||50
1072306|NCT00929357|2598957|P2|NOT COMPLETED|Overall Study||0
1072307|NCT00929357|2598958|P1|NOT COMPLETED|Overall Study||0
1072308|NCT00929357|2598957|P2|COMPLETED|Overall Study||64
1072309|NCT00929357|2598958|P1|COMPLETED|Overall Study||92
1072310|NCT00929357|2598957|P2|STARTED|Overall Study||64
1072311|NCT00929357|2598958|P1|STARTED|Overall Study||92
1072312|NCT00929383|2598978|P1|NOT COMPLETED|Overall Study||15
1072313|NCT00929383|2598978|P1|COMPLETED|Overall Study||67
1072314|NCT00929383|2598978|P1|STARTED|Overall Study||82
1072315|NCT00923273|2598991|P5|NOT COMPLETED|Phase II Treatment Period||0
1072316|NCT00923273|2598992|P4|NOT COMPLETED|Phase II Treatment Period||7
1072317|NCT00923273|2598993|P3|NOT COMPLETED|Phase II Treatment Period||0
1072318|NCT00923273|2598994|P2|NOT COMPLETED|Phase II Treatment Period||0
1072319|NCT00923273|2598995|P1|NOT COMPLETED|Phase II Treatment Period||0
1072320|NCT00923273|2598991|P5|COMPLETED|Phase II Treatment Period||0
1072321|NCT00923273|2598992|P4|COMPLETED|Phase II Treatment Period||20
1072322|NCT00923273|2598993|P3|COMPLETED|Phase II Treatment Period||0
1072323|NCT00923273|2598994|P2|COMPLETED|Phase II Treatment Period||0
1072324|NCT00923273|2598995|P1|COMPLETED|Phase II Treatment Period||0
1072325|NCT00923273|2598991|P5|STARTED|Phase II Treatment Period||0
1072326|NCT00923273|2598992|P4|STARTED|Phase II Treatment Period|Includes 8 subjects with prior peme;12 subjects who were peme naive; 7 subjects rolled over from phI|27
1072327|NCT00923273|2598993|P3|STARTED|Phase II Treatment Period||0
1072328|NCT00923273|2598994|P2|STARTED|Phase II Treatment Period||0
1072329|NCT00923273|2598995|P1|STARTED|Phase II Treatment Period|The phase II portion will utilize the MTD from the phase I portion.|0
1072330|NCT00923273|2598991|P5|NOT COMPLETED|Phase I Treatment Period||0
1072331|NCT00923273|2598992|P4|NOT COMPLETED|Phase I Treatment Period||0
1072332|NCT00923273|2598993|P3|NOT COMPLETED|Phase I Treatment Period||0
1072333|NCT00923273|2598994|P2|NOT COMPLETED|Phase I Treatment Period||0
1072334|NCT00923273|2598995|P1|NOT COMPLETED|Phase I Treatment Period||0
1072335|NCT00923273|2598991|P5|COMPLETED|Phase I Treatment Period||5
1072336|NCT00923273|2598992|P4|COMPLETED|Phase I Treatment Period||7
1072337|NCT00923273|2598993|P3|COMPLETED|Phase I Treatment Period||3
1072338|NCT00923273|2598994|P2|COMPLETED|Phase I Treatment Period||3
1072339|NCT00923273|2598995|P1|COMPLETED|Phase I Treatment Period||4
1072340|NCT00923273|2598991|P5|STARTED|Phase I Treatment Period|5 subjects peme naive.|5
1072341|NCT00923273|2598992|P4|STARTED|Phase I Treatment Period|3 subjects initially enrolled and 4 subjects added after dose level 5; peme naive.|7
1072342|NCT00923273|2598993|P3|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
1072343|NCT00923273|2598994|P2|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
1072344|NCT00923273|2598995|P1|STARTED|Phase I Treatment Period|The phase I portion will establish the maximum tolerated dose. 4 subjects peme naive.|4
1072354|NCT00923481|2599030|P1|NOT COMPLETED|Overall Study||0
1072355|NCT00923481|2599030|P1|COMPLETED|Overall Study||37
1072356|NCT00923481|2599030|P1|STARTED|Overall Study||37
1072357|NCT00929474|2599037|P2|NOT COMPLETED|Overall Study||9
1072358|NCT00929474|2599038|P1|NOT COMPLETED|Overall Study||8
1072359|NCT00929474|2599037|P2|COMPLETED|Overall Study||0
1072360|NCT00929474|2599038|P1|COMPLETED|Overall Study||0
1072361|NCT00929474|2599037|P2|STARTED|Overall Study||9
1072362|NCT00929474|2599038|P1|STARTED|Overall Study||8
1072363|NCT00929500|2599046|P2|NOT COMPLETED|Overall Study||0
1072364|NCT00929500|2599047|P1|NOT COMPLETED|Overall Study||4
1072365|NCT00929500|2599046|P2|COMPLETED|Overall Study||4
1072366|NCT00929500|2599047|P1|COMPLETED|Overall Study||4
1072367|NCT00929500|2599046|P2|STARTED|Overall Study||4
1072368|NCT00929500|2599047|P1|STARTED|Overall Study||8
1072369|NCT00929526|2599061|P2|NOT COMPLETED|Overall Study||29
1072370|NCT00929526|2599062|P1|NOT COMPLETED|Overall Study||17
1072371|NCT00929526|2599061|P2|COMPLETED|Overall Study||348
1072372|NCT00929526|2599062|P1|COMPLETED|Overall Study||358
1072373|NCT00929526|2599061|P2|STARTED|Overall Study||377
1072374|NCT00929526|2599062|P1|STARTED|Overall Study||375
1072375|NCT00929578|2599096|P1|NOT COMPLETED|Overall Study||0
1072376|NCT00929578|2599096|P1|COMPLETED|Overall Study||15
1072377|NCT00929578|2599096|P1|STARTED|Overall Study||15
1072378|NCT00929643|2599107|P1|NOT COMPLETED|Overall Study||2
1072379|NCT00929643|2599107|P1|COMPLETED|Overall Study||201
1072380|NCT00929643|2599107|P1|STARTED|Overall Study||203
1072381|NCT00929656|2599118|P2|NOT COMPLETED|Overall Study||1
1072382|NCT00929656|2599119|P1|NOT COMPLETED|Overall Study||0
1072383|NCT00929656|2599118|P2|COMPLETED|Overall Study||8
1072384|NCT00929656|2599119|P1|COMPLETED|Overall Study||13
1072385|NCT00929656|2599118|P2|STARTED|Overall Study||9
1072386|NCT00929656|2599119|P1|STARTED|Overall Study||13
1072387|NCT00929695|2599135|P2|NOT COMPLETED|Overall Study||6
1072388|NCT00929695|2599136|P1|NOT COMPLETED|Overall Study||8
1072389|NCT00929695|2599135|P2|COMPLETED|Overall Study||77
1072390|NCT00929695|2599136|P1|COMPLETED|Overall Study||73
1072391|NCT00929695|2599135|P2|STARTED|Overall Study||83
1072392|NCT00929695|2599136|P1|STARTED|Overall Study||81
1072393|NCT00929708|2599171|P5|NOT COMPLETED|Overall Study||6
1072394|NCT00929708|2599172|P4|NOT COMPLETED|Overall Study||6
1072395|NCT00929708|2599173|P3|NOT COMPLETED|Overall Study||3
1072396|NCT00929708|2599174|P2|NOT COMPLETED|Overall Study||3
1072397|NCT00929708|2599175|P1|NOT COMPLETED|Overall Study||4
1072398|NCT00929708|2599171|P5|COMPLETED|Overall Study||57
1072399|NCT00929708|2599172|P4|COMPLETED|Overall Study||61
1072400|NCT00929708|2599173|P3|COMPLETED|Overall Study||62
1072401|NCT00929708|2599174|P2|COMPLETED|Overall Study||66
1072402|NCT00929708|2599175|P1|COMPLETED|Overall Study||61
1072403|NCT00929708|2599171|P5|STARTED|Overall Study||63
1072404|NCT00929708|2599172|P4|STARTED|Overall Study||67
1072405|NCT00929708|2599173|P3|STARTED|Overall Study||65
1072406|NCT00929708|2599174|P2|STARTED|Overall Study||69
1072407|NCT00929708|2599175|P1|STARTED|Overall Study||65
1072408|NCT00929734|2599229|P2|NOT COMPLETED|Overall Study||3
1072409|NCT00929734|2599230|P1|NOT COMPLETED|Overall Study||2
1072410|NCT00929734|2599229|P2|COMPLETED|Overall Study||47
1072411|NCT00929734|2599230|P1|COMPLETED|Overall Study||47
1072412|NCT00929734|2599229|P2|STARTED|Overall Study||50
1072413|NCT00929734|2599230|P1|STARTED|Overall Study||49
1072414|NCT00929773|2599244|P2|NOT COMPLETED|Overall Study||0
1072415|NCT00929773|2599245|P1|NOT COMPLETED|Overall Study||0
1072416|NCT00929773|2599244|P2|COMPLETED|Overall Study||50
1072417|NCT00929773|2599245|P1|COMPLETED|Overall Study||50
1072418|NCT00929773|2599244|P2|STARTED|Overall Study||50
1072419|NCT00929773|2599245|P1|STARTED|Overall Study||50
1072426|NCT00932165|2599268|P1|NOT COMPLETED|Overall Study||1
1072427|NCT00932165|2599268|P1|COMPLETED|Overall Study||450
1072428|NCT00932165|2599268|P1|STARTED|Overall Study||451
1072429|NCT00932282|2599281|P2|NOT COMPLETED|OIT Maintenance Phase||2
1072430|NCT00932282|2599282|P1|NOT COMPLETED|OIT Maintenance Phase||1
1072431|NCT00932282|2599281|P2|COMPLETED|OIT Maintenance Phase||2
1072432|NCT00932282|2599282|P1|COMPLETED|OIT Maintenance Phase||4
1072433|NCT00932282|2599281|P2|STARTED|OIT Maintenance Phase||4
1072434|NCT00932282|2599282|P1|STARTED|OIT Maintenance Phase||5
1072435|NCT00932282|2599281|P2|NOT COMPLETED|Biweekly OIT Buildup Phase||1
1072436|NCT00932282|2599282|P1|NOT COMPLETED|Biweekly OIT Buildup Phase||1
1072437|NCT00932282|2599281|P2|COMPLETED|Biweekly OIT Buildup Phase||4
1072438|NCT00932282|2599282|P1|COMPLETED|Biweekly OIT Buildup Phase||5
1072439|NCT00932282|2599281|P2|STARTED|Biweekly OIT Buildup Phase||5
1072440|NCT00932282|2599282|P1|STARTED|Biweekly OIT Buildup Phase||6
1072441|NCT00932282|2599281|P2|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0
1072442|NCT00932282|2599282|P1|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0
1072443|NCT00932282|2599281|P2|COMPLETED|Modified OIT Rush Desensitization Phase||5
1072444|NCT00932282|2599282|P1|COMPLETED|Modified OIT Rush Desensitization Phase||6
1072445|NCT00932282|2599281|P2|STARTED|Modified OIT Rush Desensitization Phase||5
1072446|NCT00932282|2599282|P1|STARTED|Modified OIT Rush Desensitization Phase||6
1072447|NCT00932282|2599281|P2|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1
1072448|NCT00932282|2599282|P1|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1
1072449|NCT00932282|2599281|P2|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||5
1072450|NCT00932282|2599282|P1|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||6
1072451|NCT00932282|2599281|P2|STARTED|Pre-OIT Anti-IgE Therapy Phase||6
1072452|NCT00932282|2599282|P1|STARTED|Pre-OIT Anti-IgE Therapy Phase||7
1072453|NCT00932321|2599298|P2|NOT COMPLETED|Overall Study||46
1072454|NCT00932321|2599299|P1|NOT COMPLETED|Overall Study||171
1072455|NCT00932321|2599298|P2|COMPLETED|Overall Study||141
1072456|NCT00932321|2599299|P1|COMPLETED|Overall Study||580
1072457|NCT00932321|2599298|P2|MITT Population|Overall Study||181
1072458|NCT00932321|2599299|P1|MITT Population|Overall Study||705
1072459|NCT00932321|2599298|P2|STARTED|Overall Study||187
1072460|NCT00932321|2599299|P1|STARTED|Overall Study||751
1072461|NCT00932373|2599318|P11|NOT COMPLETED|Overall Study||3
1072462|NCT00932373|2599319|P10|NOT COMPLETED|Overall Study||13
1072463|NCT00932373|2599320|P9|NOT COMPLETED|Overall Study||2
1072464|NCT00932373|2599321|P8|NOT COMPLETED|Overall Study||3
1072465|NCT00932373|2599322|P7|NOT COMPLETED|Overall Study||1
1072466|NCT00932373|2599323|P6|NOT COMPLETED|Overall Study||3
1072467|NCT00932373|2599324|P5|NOT COMPLETED|Overall Study||14
1072468|NCT00932373|2599325|P4|NOT COMPLETED|Overall Study||0
1072469|NCT00932373|2599326|P3|NOT COMPLETED|Overall Study||1
1072470|NCT00932373|2599327|P2|NOT COMPLETED|Overall Study||1
1072471|NCT00932373|2599328|P1|NOT COMPLETED|Overall Study||3
1072472|NCT00932373|2599318|P11|COMPLETED|Overall Study||0
1072473|NCT00932373|2599319|P10|COMPLETED|Overall Study||3
1072474|NCT00932373|2599320|P9|COMPLETED|Overall Study||1
1072475|NCT00932373|2599321|P8|COMPLETED|Overall Study||0
1072476|NCT00932373|2599322|P7|COMPLETED|Overall Study||2
1072477|NCT00932373|2599323|P6|COMPLETED|Overall Study||0
1072478|NCT00932373|2599324|P5|COMPLETED|Overall Study||1
1072479|NCT00932373|2599325|P4|COMPLETED|Overall Study||1
1072480|NCT00932373|2599326|P3|COMPLETED|Overall Study||0
1072481|NCT00932373|2599327|P2|COMPLETED|Overall Study||0
1072482|NCT00932373|2599328|P1|COMPLETED|Overall Study||0
1072483|NCT00932373|2599318|P11|STARTED|Overall Study||3
1072484|NCT00932373|2599319|P10|STARTED|Overall Study||16
1072485|NCT00932373|2599320|P9|STARTED|Overall Study||3
1072486|NCT00932373|2599321|P8|STARTED|Overall Study||3
1072487|NCT00932373|2599322|P7|STARTED|Overall Study||3
1072488|NCT00932373|2599323|P6|STARTED|Overall Study||3
1072489|NCT00932373|2599324|P5|STARTED|Overall Study||15
1072490|NCT00932373|2599325|P4|STARTED|Overall Study||1
1072491|NCT00932373|2599326|P3|STARTED|Overall Study||1
1072492|NCT00932373|2599327|P2|STARTED|Overall Study||1
1072493|NCT00932373|2599328|P1|STARTED|Overall Study||3
1072494|NCT00932399|2599430|P2|NOT COMPLETED|Overall Study||0
1072495|NCT00932399|2599431|P1|NOT COMPLETED|Overall Study||0
1072496|NCT00932399|2599430|P2|COMPLETED|Overall Study||3790
1072497|NCT00932399|2599431|P1|COMPLETED|Overall Study||759
1072498|NCT00932399|2599430|P2|STARTED|Overall Study||3790
1072499|NCT00932399|2599431|P1|STARTED|Overall Study||759
1072500|NCT00932425|2599439|P2|NOT COMPLETED|Overall Study||2
1072501|NCT00932425|2599440|P1|NOT COMPLETED|Overall Study||0
1072502|NCT00932425|2599439|P2|COMPLETED|Overall Study||18
1072503|NCT00932425|2599440|P1|COMPLETED|Overall Study||20
1072504|NCT00932425|2599439|P2|STARTED|Overall Study||20
1072505|NCT00932425|2599440|P1|STARTED|Overall Study||20
1072506|NCT00932451|2599453|P1|NOT COMPLETED|Overall Study||822
1072507|NCT00932451|2599453|P1|COMPLETED|Overall Study||244
1072508|NCT00932451|2599453|P1|STARTED|Overall Study||1066
1072509|NCT00932477|2599475|P6|NOT COMPLETED|Treatment 3||0
1072510|NCT00932477|2599476|P5|NOT COMPLETED|Treatment 3||0
1072511|NCT00932477|2599477|P4|NOT COMPLETED|Treatment 3||0
1072512|NCT00932477|2599478|P3|NOT COMPLETED|Treatment 3||0
1072513|NCT00932477|2599479|P2|NOT COMPLETED|Treatment 3||0
1072514|NCT00932477|2599480|P1|NOT COMPLETED|Treatment 3||0
1072515|NCT00932477|2599475|P6|COMPLETED|Treatment 3||8
1072516|NCT00932477|2599476|P5|COMPLETED|Treatment 3||8
1072517|NCT00932477|2599477|P4|COMPLETED|Treatment 3||7
1072518|NCT00932477|2599478|P3|COMPLETED|Treatment 3||9
1072519|NCT00932477|2599479|P2|COMPLETED|Treatment 3||8
1072520|NCT00932477|2599480|P1|COMPLETED|Treatment 3||7
1072521|NCT00932477|2599475|P6|STARTED|Treatment 3||8
1072522|NCT00932477|2599476|P5|STARTED|Treatment 3||8
1072523|NCT00932477|2599477|P4|STARTED|Treatment 3||7
1072524|NCT00932477|2599478|P3|STARTED|Treatment 3||9
1072525|NCT00932477|2599479|P2|STARTED|Treatment 3||8
1072526|NCT00932477|2599480|P1|STARTED|Treatment 3||7
1072527|NCT00932477|2599475|P6|NOT COMPLETED|Treatment 2||0
1072528|NCT00932477|2599476|P5|NOT COMPLETED|Treatment 2||0
1072529|NCT00932477|2599477|P4|NOT COMPLETED|Treatment 2||0
1072530|NCT00932477|2599478|P3|NOT COMPLETED|Treatment 2||0
1072531|NCT00932477|2599479|P2|NOT COMPLETED|Treatment 2||0
1072532|NCT00932477|2599480|P1|NOT COMPLETED|Treatment 2||0
1072533|NCT00932477|2599475|P6|COMPLETED|Treatment 2||8
1072534|NCT00932477|2599476|P5|COMPLETED|Treatment 2||8
1072535|NCT00932477|2599477|P4|COMPLETED|Treatment 2||7
1072536|NCT00932477|2599478|P3|COMPLETED|Treatment 2||9
1072537|NCT00932477|2599479|P2|COMPLETED|Treatment 2||8
1072538|NCT00932477|2599480|P1|COMPLETED|Treatment 2||7
1072539|NCT00932477|2599475|P6|STARTED|Treatment 2||8
1072540|NCT00932477|2599476|P5|STARTED|Treatment 2||8
1072541|NCT00932477|2599477|P4|STARTED|Treatment 2||7
1072542|NCT00932477|2599478|P3|STARTED|Treatment 2||9
1072543|NCT00932477|2599479|P2|STARTED|Treatment 2||8
1072544|NCT00932477|2599480|P1|STARTED|Treatment 2||7
1072545|NCT00932477|2599475|P6|NOT COMPLETED|Treatment 1||0
1072546|NCT00932477|2599476|P5|NOT COMPLETED|Treatment 1||0
1072547|NCT00932477|2599477|P4|NOT COMPLETED|Treatment 1||0
1072548|NCT00932477|2599478|P3|NOT COMPLETED|Treatment 1||0
1072549|NCT00932477|2599479|P2|NOT COMPLETED|Treatment 1||0
1072550|NCT00932477|2599480|P1|NOT COMPLETED|Treatment 1||0
1072551|NCT00932477|2599475|P6|COMPLETED|Treatment 1||8
1072552|NCT00932477|2599476|P5|COMPLETED|Treatment 1||8
1072553|NCT00932477|2599477|P4|COMPLETED|Treatment 1||7
1072554|NCT00932477|2599478|P3|COMPLETED|Treatment 1||9
1072555|NCT00932477|2599479|P2|COMPLETED|Treatment 1||8
1072556|NCT00932477|2599480|P1|COMPLETED|Treatment 1||7
1072557|NCT00932477|2599475|P6|STARTED|Treatment 1||8
1072558|NCT00932477|2599476|P5|STARTED|Treatment 1||8
1072559|NCT00932477|2599477|P4|STARTED|Treatment 1||7
1072560|NCT00932477|2599478|P3|STARTED|Treatment 1||9
1072561|NCT00932477|2599479|P2|STARTED|Treatment 1||8
1072562|NCT00932477|2599480|P1|STARTED|Treatment 1||7
1072563|NCT00932620|2599499|P2|NOT COMPLETED|Overall Study||0
1072564|NCT00932620|2599500|P1|NOT COMPLETED|Overall Study||0
1072565|NCT00932620|2599499|P2|COMPLETED|Overall Study||50
1072566|NCT00932620|2599500|P1|COMPLETED|Overall Study||50
1072567|NCT00932620|2599499|P2|STARTED|Overall Study||50
1072568|NCT00932620|2599500|P1|STARTED|Overall Study||50
1072569|NCT00932646|2599508|P4|NOT COMPLETED|Overall Study||1
1072570|NCT00932646|2599509|P3|NOT COMPLETED|Overall Study||4
1072571|NCT00932646|2599510|P2|NOT COMPLETED|Overall Study||3
1072572|NCT00932646|2599511|P1|NOT COMPLETED|Overall Study||5
1072573|NCT00932646|2599508|P4|COMPLETED|Overall Study||24
1072574|NCT00932646|2599509|P3|COMPLETED|Overall Study||21
1072575|NCT00932646|2599510|P2|COMPLETED|Overall Study||22
1072576|NCT00932646|2599511|P1|COMPLETED|Overall Study||20
1072577|NCT00932646|2599508|P4|STARTED|Overall Study||25
1072578|NCT00932646|2599509|P3|STARTED|Overall Study||25
1072579|NCT00932646|2599510|P2|STARTED|Overall Study||25
1072580|NCT00932646|2599511|P1|STARTED|Overall Study||25
1072581|NCT00932659|2599565|P1|NOT COMPLETED|Overall Study||0
1072582|NCT00932659|2599565|P1|COMPLETED|Overall Study||8
1072583|NCT00932659|2599565|P1|STARTED|Overall Study||8
1072584|NCT00932893|2599572|P2|NOT COMPLETED|Overall Study||170
1072585|NCT00932893|2599573|P1|NOT COMPLETED|Overall Study||133
1072586|NCT00932893|2599572|P2|COMPLETED|Overall Study||4
1072587|NCT00932893|2599573|P1|COMPLETED|Overall Study||40
1072588|NCT00932893|2599572|P2|Treated|Overall Study||171
1072589|NCT00932893|2599573|P1|Treated|Overall Study||172
1072590|NCT00932893|2599572|P2|STARTED|Overall Study||174
1072591|NCT00932893|2599573|P1|STARTED|Overall Study||173
1072592|NCT00933166|2599604|P1|NOT COMPLETED|Overall Study||18
1072593|NCT00933166|2599604|P1|COMPLETED|Overall Study||151
1072594|NCT00933166|2599604|P1|STARTED|Overall Study||169
1072595|NCT00933244|2599611|P3|NOT COMPLETED|Overall Study||3
1072596|NCT00933244|2599612|P2|NOT COMPLETED|Overall Study||1
1072597|NCT00933244|2599613|P1|NOT COMPLETED|Overall Study||5
1072598|NCT00933244|2599611|P3|COMPLETED|Overall Study||73
1072599|NCT00933244|2599612|P2|COMPLETED|Overall Study||74
1072600|NCT00933244|2599613|P1|COMPLETED|Overall Study||74
1072601|NCT00933244|2599611|P3|STARTED|Overall Study||76
1072602|NCT00933244|2599612|P2|STARTED|Overall Study||75
1072603|NCT00933244|2599613|P1|STARTED|Overall Study||79
1072604|NCT00933270|2599630|P1|NOT COMPLETED|Overall Study||87
1072605|NCT00933270|2599630|P1|COMPLETED|Overall Study||177
1072606|NCT00933270|2599630|P1|STARTED|Overall Study|ITT population|264
1072607|NCT00933335|2599723|P2|NOT COMPLETED|Overall Study||16
1072608|NCT00933335|2599724|P1|NOT COMPLETED|Overall Study||2
1072609|NCT00933335|2599723|P2|COMPLETED|Overall Study||20
1072610|NCT00933335|2599724|P1|COMPLETED|Overall Study||0
1072611|NCT00933335|2599723|P2|STARTED|Overall Study|35/36 participants who received 3 cycles of fludarabine later received a DD and TD of TST/I 131 TST.|36
1072612|NCT00933335|2599724|P1|STARTED|Overall Study||2
1072613|NCT00933491|2599796|P2|NOT COMPLETED|Overall Study||0
1072614|NCT00933491|2599797|P1|NOT COMPLETED|Overall Study||0
1072615|NCT00933491|2599796|P2|COMPLETED|Overall Study||18
1072616|NCT00933491|2599797|P1|COMPLETED|Overall Study||14
1072617|NCT00933491|2599796|P2|STARTED|Overall Study||18
1072618|NCT00933491|2599797|P1|STARTED|Overall Study||14
1072619|NCT00933543|2599807|P2|NOT COMPLETED|Overall Study||7
1072620|NCT00933543|2599808|P1|NOT COMPLETED|Overall Study||3
1072621|NCT00933543|2599807|P2|COMPLETED|Overall Study||46
1072622|NCT00933543|2599808|P1|COMPLETED|Overall Study||51
1072623|NCT00933543|2599807|P2|STARTED|Overall Study||53
1072624|NCT00933543|2599808|P1|STARTED|Overall Study||54
1072625|NCT00933608|2599866|P2|NOT COMPLETED|Overall Study||2
1072626|NCT00933608|2599867|P1|NOT COMPLETED|Overall Study||5
1072627|NCT00933608|2599866|P2|COMPLETED|Overall Study||8
1072628|NCT00933608|2599867|P1|COMPLETED|Overall Study||2
1072629|NCT00933608|2599866|P2|STARTED|Overall Study||10
1072630|NCT00933608|2599867|P1|STARTED|Overall Study||7
1072631|NCT00933686|2599875|P2|NOT COMPLETED|Overall Study||11
1072632|NCT00933686|2599876|P1|NOT COMPLETED|Overall Study||10
1072633|NCT00933686|2599875|P2|COMPLETED|Overall Study||47
1072634|NCT00933686|2599876|P1|COMPLETED|Overall Study||45
1072635|NCT00933686|2599875|P2|STARTED|Overall Study||58
1072636|NCT00933686|2599876|P1|STARTED|Overall Study||55
1072637|NCT00933933|2599899|P3|NOT COMPLETED|Pediatric From 2 to 21 Years||0
1072638|NCT00933933|2599900|P2|NOT COMPLETED|Pediatric From 2 to 21 Years||0
1072639|NCT00933933|2599901|P1|NOT COMPLETED|Pediatric From 2 to 21 Years||0
1072640|NCT00933933|2599899|P3|COMPLETED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women|0
1072641|NCT00933933|2599900|P2|COMPLETED|Pediatric From 2 to 21 Years||64
1072642|NCT00933933|2599901|P1|COMPLETED|Pediatric From 2 to 21 Years||588
1072643|NCT00933933|2599899|P3|STARTED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women.|0
1072644|NCT00933933|2599900|P2|STARTED|Pediatric From 2 to 21 Years||64
1072645|NCT00933933|2599901|P1|STARTED|Pediatric From 2 to 21 Years||588
1072646|NCT00933933|2599899|P3|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
1072647|NCT00933933|2599900|P2|NOT COMPLETED|Pregnant Females Between 16-44 Years||2
1072648|NCT00933933|2599901|P1|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
1072649|NCT00933933|2599899|P3|COMPLETED|Pregnant Females Between 16-44 Years||203
1072650|NCT00933933|2599900|P2|COMPLETED|Pregnant Females Between 16-44 Years||65
1072651|NCT00933933|2599901|P1|COMPLETED|Pregnant Females Between 16-44 Years||448
1072652|NCT00933933|2599899|P3|STARTED|Pregnant Females Between 16-44 Years||203
1072653|NCT00933933|2599900|P2|STARTED|Pregnant Females Between 16-44 Years||67
1072654|NCT00933933|2599901|P1|STARTED|Pregnant Females Between 16-44 Years||448
1072655|NCT00933933|2599899|P3|NOT COMPLETED|General Population From 16 to 89 Years||0
1072656|NCT00933933|2599900|P2|NOT COMPLETED|General Population From 16 to 89 Years||20
1072657|NCT00933933|2599901|P1|NOT COMPLETED|General Population From 16 to 89 Years||0
1072658|NCT00933933|2599899|P3|COMPLETED|General Population From 16 to 89 Years||1206
1072659|NCT00933933|2599900|P2|COMPLETED|General Population From 16 to 89 Years||1267
1072660|NCT00933933|2599901|P1|COMPLETED|General Population From 16 to 89 Years||6164
1072661|NCT00933933|2599899|P3|STARTED|General Population From 16 to 89 Years||1206
1072662|NCT00933933|2599900|P2|STARTED|General Population From 16 to 89 Years||1287
1072663|NCT00933933|2599901|P1|STARTED|General Population From 16 to 89 Years||6164
1072664|NCT00934050|2599923|P6|NOT COMPLETED|Enrolled After 15 Dec 2009||4
1072665|NCT00934050|2599924|P5|NOT COMPLETED|Enrolled After 15 Dec 2009||7
1072666|NCT00934050|2599925|P4|NOT COMPLETED|Enrolled After 15 Dec 2009||0
1072667|NCT00934050|2599926|P3|NOT COMPLETED|Enrolled After 15 Dec 2009||0
1072668|NCT00934050|2599927|P2|NOT COMPLETED|Enrolled After 15 Dec 2009||0
1072669|NCT00934050|2599928|P1|NOT COMPLETED|Enrolled After 15 Dec 2009||0
1072670|NCT00934050|2599923|P6|COMPLETED|Enrolled After 15 Dec 2009||23
1072671|NCT00934050|2599924|P5|COMPLETED|Enrolled After 15 Dec 2009||19
1072672|NCT00934050|2599925|P4|COMPLETED|Enrolled After 15 Dec 2009||0
1072673|NCT00934050|2599926|P3|COMPLETED|Enrolled After 15 Dec 2009||0
1072674|NCT00934050|2599927|P2|COMPLETED|Enrolled After 15 Dec 2009||0
1072675|NCT00934050|2599928|P1|COMPLETED|Enrolled After 15 Dec 2009||0
1072676|NCT00934050|2599923|P6|STARTED|Enrolled After 15 Dec 2009||27
1072677|NCT00934050|2599924|P5|STARTED|Enrolled After 15 Dec 2009||26
1072678|NCT00934050|2599925|P4|STARTED|Enrolled After 15 Dec 2009||0
1072679|NCT00934050|2599926|P3|STARTED|Enrolled After 15 Dec 2009||0
1072680|NCT00934050|2599927|P2|STARTED|Enrolled After 15 Dec 2009||0
1072681|NCT00934050|2599928|P1|STARTED|Enrolled After 15 Dec 2009||0
1072682|NCT00934050|2599923|P6|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
1072683|NCT00934050|2599924|P5|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
1072684|NCT00934050|2599925|P4|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||14
1072685|NCT00934050|2599926|P3|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
1072686|NCT00934050|2599927|P2|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
1072687|NCT00934050|2599928|P1|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
1072688|NCT00934050|2599923|P6|COMPLETED|Enrolled Prior to 15 Dec 2009||0
1072689|NCT00934050|2599924|P5|COMPLETED|Enrolled Prior to 15 Dec 2009||0
1072690|NCT00934050|2599925|P4|COMPLETED|Enrolled Prior to 15 Dec 2009||0
1072691|NCT00934050|2599926|P3|COMPLETED|Enrolled Prior to 15 Dec 2009||0
1072692|NCT00934050|2599927|P2|COMPLETED|Enrolled Prior to 15 Dec 2009||0
1072693|NCT00934050|2599928|P1|COMPLETED|Enrolled Prior to 15 Dec 2009||0
1072694|NCT00934050|2599923|P6|STARTED|Enrolled Prior to 15 Dec 2009||0
1072695|NCT00934050|2599924|P5|STARTED|Enrolled Prior to 15 Dec 2009||0
1072696|NCT00934050|2599925|P4|STARTED|Enrolled Prior to 15 Dec 2009||14
1072697|NCT00934050|2599926|P3|STARTED|Enrolled Prior to 15 Dec 2009||12
1072698|NCT00934050|2599927|P2|STARTED|Enrolled Prior to 15 Dec 2009||12
1072699|NCT00934050|2599928|P1|STARTED|Enrolled Prior to 15 Dec 2009||12
1072700|NCT00934102|2599938|P3|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
1072701|NCT00934102|2599939|P2|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
1072702|NCT00934102|2599940|P1|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
1072703|NCT00934102|2599938|P3|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
1072704|NCT00934102|2599939|P2|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
1072705|NCT00934102|2599940|P1|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
1072706|NCT00934102|2599938|P3|STARTED|Period 2, 7 Days/6 Nights of Wear||15
1072707|NCT00934102|2599939|P2|STARTED|Period 2, 7 Days/6 Nights of Wear||15
1072708|NCT00934102|2599940|P1|STARTED|Period 2, 7 Days/6 Nights of Wear||15
1072709|NCT00934102|2599938|P3|NOT COMPLETED|Period 1, One Night of Wear||0
1072710|NCT00934102|2599939|P2|NOT COMPLETED|Period 1, One Night of Wear||0
1072711|NCT00934102|2599940|P1|NOT COMPLETED|Period 1, One Night of Wear||1
1072712|NCT00934102|2599938|P3|COMPLETED|Period 1, One Night of Wear||15
1072713|NCT00934102|2599939|P2|COMPLETED|Period 1, One Night of Wear||15
1072714|NCT00934102|2599940|P1|COMPLETED|Period 1, One Night of Wear||15
1072715|NCT00934102|2599938|P3|STARTED|Period 1, One Night of Wear||15
1072716|NCT00934102|2599939|P2|STARTED|Period 1, One Night of Wear||15
1072717|NCT00934102|2599940|P1|STARTED|Period 1, One Night of Wear||16
1072718|NCT00934128|2599950|P2|NOT COMPLETED|Second Intervention (2 Hours)||3
1072719|NCT00934128|2599951|P1|NOT COMPLETED|Second Intervention (2 Hours)||0
1072720|NCT00934128|2599950|P2|COMPLETED|Second Intervention (2 Hours)||5
1072721|NCT00934128|2599951|P1|COMPLETED|Second Intervention (2 Hours)||3
1072722|NCT00934128|2599950|P2|STARTED|Second Intervention (2 Hours)||8
1072723|NCT00934128|2599951|P1|STARTED|Second Intervention (2 Hours)||3
1072724|NCT00934128|2599950|P2|NOT COMPLETED|Washout Period (1 Hour)||5
1072725|NCT00934128|2599951|P1|NOT COMPLETED|Washout Period (1 Hour)||7
1072726|NCT00934128|2599950|P2|COMPLETED|Washout Period (1 Hour)||8
1072727|NCT00934128|2599951|P1|COMPLETED|Washout Period (1 Hour)||3
1072728|NCT00934128|2599950|P2|STARTED|Washout Period (1 Hour)||13
1072729|NCT00934128|2599951|P1|STARTED|Washout Period (1 Hour)||10
1072730|NCT00934128|2599950|P2|NOT COMPLETED|First Intervention (2 Hours)||2
1072731|NCT00934128|2599951|P1|NOT COMPLETED|First Intervention (2 Hours)||5
1072732|NCT00934128|2599950|P2|COMPLETED|First Intervention (2 Hours)||13
1072733|NCT00934128|2599951|P1|COMPLETED|First Intervention (2 Hours)||10
1072734|NCT00934128|2599950|P2|STARTED|First Intervention (2 Hours)||15
1072735|NCT00934128|2599951|P1|STARTED|First Intervention (2 Hours)||15
1072736|NCT00934141|2599963|P4|NOT COMPLETED|Overall Study||3
1072737|NCT00934141|2599964|P3|NOT COMPLETED|Overall Study||0
1072738|NCT00934141|2599965|P2|NOT COMPLETED|Overall Study||3
1072739|NCT00934141|2599966|P1|NOT COMPLETED|Overall Study||4
1072740|NCT00934141|2599963|P4|COMPLETED|Overall Study||51
1072741|NCT00934141|2599964|P3|COMPLETED|Overall Study||48
1072742|NCT00934141|2599965|P2|COMPLETED|Overall Study||47
1072743|NCT00934141|2599966|P1|COMPLETED|Overall Study||45
1072744|NCT00934141|2599963|P4|STARTED|Overall Study||54
1072745|NCT00934141|2599964|P3|STARTED|Overall Study||48
1072746|NCT00934141|2599965|P2|STARTED|Overall Study||50
1072747|NCT00934141|2599966|P1|STARTED|Overall Study||49
1072748|NCT00934180|2599990|P2|NOT COMPLETED|Second Intervention||0
1072749|NCT00934180|2599991|P1|NOT COMPLETED|Second Intervention||0
1072750|NCT00934180|2599990|P2|COMPLETED|Second Intervention||12
1072751|NCT00934180|2599991|P1|COMPLETED|Second Intervention||12
1072752|NCT00934180|2599990|P2|STARTED|Second Intervention||12
1072753|NCT00934180|2599991|P1|STARTED|Second Intervention||12
1072754|NCT00934180|2599990|P2|NOT COMPLETED|First Intervention||0
1072755|NCT00934180|2599991|P1|NOT COMPLETED|First Intervention||0
1072756|NCT00934180|2599990|P2|COMPLETED|First Intervention||12
1072757|NCT00934180|2599991|P1|COMPLETED|First Intervention||12
1072758|NCT00934180|2599990|P2|STARTED|First Intervention||12
1072759|NCT00934180|2599991|P1|STARTED|First Intervention||12
1072760|NCT00934362|2600001|P2|NOT COMPLETED|Overall Study||0
1072761|NCT00934362|2600002|P1|NOT COMPLETED|Overall Study||1
1072762|NCT00934362|2600001|P2|COMPLETED|Overall Study||8
1072763|NCT00934362|2600002|P1|COMPLETED|Overall Study||7
1072764|NCT00934362|2600001|P2|STARTED|Overall Study||8
1072765|NCT00934362|2600002|P1|STARTED|Overall Study||8
1072766|NCT00934375|2600012|P2|NOT COMPLETED|Overall Study||22
1072767|NCT00934375|2600013|P1|NOT COMPLETED|Overall Study||13
1072768|NCT00934375|2600012|P2|COMPLETED|Overall Study||55
1072769|NCT00934375|2600013|P1|COMPLETED|Overall Study||55
1072770|NCT00934375|2600012|P2|STARTED|Overall Study||77
1072771|NCT00934375|2600013|P1|STARTED|Overall Study||68
1072772|NCT00934440|2600019|P1|NOT COMPLETED|Overall Study||1
1072773|NCT00934440|2600019|P1|COMPLETED|Overall Study||10
1072774|NCT00934440|2600019|P1|STARTED|Overall Study||11
1072775|NCT00934544|2600026|P2|NOT COMPLETED|Overall Study||42
1072776|NCT00934544|2600027|P1|NOT COMPLETED|Overall Study||55
1072777|NCT00934544|2600026|P2|COMPLETED|Overall Study|Participants ongoing in the randomized treatment phase for the BAT group|31
1072778|NCT00934544|2600027|P1|COMPLETED|Overall Study|Participants ongoing in the randomized treatment phase for INC424/INCB018424 group|91
1072779|NCT00934544|2600026|P2|STARTED|Overall Study||73
1072780|NCT00934544|2600027|P1|STARTED|Overall Study||146
1072781|NCT00934596|2600043|P2|NOT COMPLETED|Overall Study||0
1072782|NCT00934596|2600044|P1|NOT COMPLETED|Overall Study||0
1072783|NCT00934596|2600043|P2|COMPLETED|Overall Study||10
1072784|NCT00934596|2600044|P1|COMPLETED|Overall Study||10
1072785|NCT00934596|2600043|P2|STARTED|Overall Study||10
1072786|NCT00934596|2600044|P1|STARTED|Overall Study|Twenty patients were prospectively randomly assigned to the two arms|10
1072787|NCT00934622|2600072|P1|NOT COMPLETED|Overall Study||8
1072788|NCT00934622|2600072|P1|COMPLETED|Overall Study||68
1072789|NCT00934622|2600072|P1|STARTED|Overall Study||76
1072790|NCT00934635|2600086|P9|NOT COMPLETED|Overall Study||0
1072791|NCT00934635|2600087|P8|NOT COMPLETED|Overall Study||0
1072792|NCT00934635|2600088|P7|NOT COMPLETED|Overall Study||0
1072793|NCT00934635|2600089|P6|NOT COMPLETED|Overall Study||0
1072794|NCT00934635|2600090|P5|NOT COMPLETED|Overall Study||0
1072795|NCT00934635|2600091|P4|NOT COMPLETED|Overall Study||0
1072796|NCT00934635|2600092|P3|NOT COMPLETED|Overall Study||0
1072797|NCT00934635|2600093|P2|NOT COMPLETED|Overall Study||0
1072798|NCT00934635|2600094|P1|NOT COMPLETED|Overall Study||0
1072799|NCT00934635|2600086|P9|COMPLETED|Overall Study||1
1072800|NCT00934635|2600087|P8|COMPLETED|Overall Study||0
1072801|NCT00934635|2600088|P7|COMPLETED|Overall Study||0
1072802|NCT00934635|2600089|P6|COMPLETED|Overall Study||0
1072803|NCT00934635|2600090|P5|COMPLETED|Overall Study||0
1072804|NCT00934635|2600091|P4|COMPLETED|Overall Study||0
1072805|NCT00934635|2600092|P3|COMPLETED|Overall Study||0
1072806|NCT00934635|2600093|P2|COMPLETED|Overall Study||1
1072807|NCT00934635|2600094|P1|COMPLETED|Overall Study||0
1072808|NCT00934635|2600086|P9|STARTED|Overall Study||1
1072809|NCT00934635|2600087|P8|STARTED|Overall Study||0
1072810|NCT00934635|2600088|P7|STARTED|Overall Study||0
1072811|NCT00934635|2600089|P6|STARTED|Overall Study||0
1072812|NCT00934635|2600090|P5|STARTED|Overall Study||0
1072813|NCT00934635|2600091|P4|STARTED|Overall Study||0
1072814|NCT00934635|2600092|P3|STARTED|Overall Study||0
1072815|NCT00934635|2600093|P2|STARTED|Overall Study||1
1072816|NCT00934635|2600094|P1|STARTED|Overall Study||0
1072817|NCT00926783|2600116|P2|NOT COMPLETED|Overall Study||3
1072818|NCT00926783|2600117|P1|NOT COMPLETED|Overall Study||3
1072819|NCT00926783|2600116|P2|COMPLETED|Overall Study||38
1072820|NCT00926783|2600117|P1|COMPLETED|Overall Study||39
1072821|NCT00926783|2600116|P2|STARTED|Overall Study||41
1072822|NCT00926783|2600117|P1|STARTED|Overall Study||42
1072823|NCT00926796|2600135|P2|NOT COMPLETED|Overall Study||106
1072824|NCT00926796|2600136|P1|NOT COMPLETED|Overall Study||107
1072825|NCT00926796|2600135|P2|COMPLETED|Overall Study|Number eligible and in the full analysis set|199
1072826|NCT00926796|2600136|P1|COMPLETED|Overall Study|Number eligible and in the full analysis set|202
1072827|NCT00926796|2600135|P2|STARTED|Overall Study|Number randomized|305
1072828|NCT00926796|2600136|P1|STARTED|Overall Study|Number randomized|309
1072829|NCT00926887|2600157|P2|NOT COMPLETED|Overall Study||0
1072830|NCT00926887|2600158|P1|NOT COMPLETED|Overall Study||0
1072831|NCT00926887|2600157|P2|COMPLETED|Overall Study||50
1072832|NCT00926887|2600158|P1|COMPLETED|Overall Study||54
1072833|NCT00926887|2600157|P2|STARTED|Overall Study||50
1072834|NCT00926887|2600158|P1|STARTED|Overall Study||54
1072835|NCT00926952|2600168|P1|NOT COMPLETED|Overall Study||0
1072836|NCT00926952|2600168|P1|COMPLETED|Overall Study||20
1072837|NCT00926952|2600168|P1|STARTED|Overall Study||20
1072838|NCT00934648|2600180|P1|NOT COMPLETED|Overall Study||9
1072839|NCT00934648|2600180|P1|COMPLETED|Overall Study||6
1072840|NCT00934648|2600180|P1|STARTED|Overall Study||15
1072841|NCT00934791|2600189|P2|NOT COMPLETED|Overall Study||0
1072842|NCT00934791|2600190|P1|NOT COMPLETED|Overall Study||1
1072843|NCT00934791|2600189|P2|COMPLETED|Overall Study||0
1072844|NCT00934791|2600190|P1|COMPLETED|Overall Study||0
1072845|NCT00934791|2600189|P2|STARTED|Overall Study||0
1072846|NCT00934791|2600190|P1|STARTED|Overall Study||1
1072847|NCT00934843|2600198|P2|NOT COMPLETED|Overall Study||1
1072848|NCT00934843|2600199|P1|NOT COMPLETED|Overall Study||0
1072849|NCT00934843|2600198|P2|COMPLETED|Overall Study|1 subject discontinued intervention, surgery plan changed and did not require CPB|39
1072850|NCT00934843|2600199|P1|COMPLETED|Overall Study||37
1072851|NCT00934843|2600198|P2|STARTED|Overall Study||40
1072852|NCT00934843|2600199|P1|STARTED|Overall Study||37
1072853|NCT00934856|2600219|P6|NOT COMPLETED|Extension Part||5
1072854|NCT00934856|2600220|P5|NOT COMPLETED|Extension Part||4
1072855|NCT00934856|2600221|P4|NOT COMPLETED|Extension Part||2
1072856|NCT00934856|2600222|P3|NOT COMPLETED|Extension Part||0
1072857|NCT00934856|2600223|P2|NOT COMPLETED|Extension Part||0
1072858|NCT00934856|2600224|P1|NOT COMPLETED|Extension Part||0
1072859|NCT00934856|2600219|P6|COMPLETED|Extension Part||19
1072860|NCT00934856|2600220|P5|COMPLETED|Extension Part||24
1072861|NCT00934856|2600221|P4|COMPLETED|Extension Part||2
1072862|NCT00934856|2600222|P3|COMPLETED|Extension Part||0
1072863|NCT00934856|2600223|P2|COMPLETED|Extension Part||0
1072864|NCT00934856|2600224|P1|COMPLETED|Extension Part||0
1072865|NCT00934856|2600219|P6|STARTED|Extension Part|New participants were enrolled in the extension part.|24
1072866|NCT00934856|2600220|P5|STARTED|Extension Part|New participants were enrolled in the extension part.|28
1072867|NCT00934856|2600221|P4|STARTED|Extension Part|New participants were enrolled in the extension part.|4
1072868|NCT00934856|2600222|P3|STARTED|Extension Part||0
1072869|NCT00934856|2600223|P2|STARTED|Extension Part||0
1072870|NCT00934856|2600224|P1|STARTED|Extension Part||0
1072871|NCT00934856|2600219|P6|NOT COMPLETED|Feasibility Part||3
1072872|NCT00934856|2600220|P5|NOT COMPLETED|Feasibility Part||0
1072873|NCT00934856|2600221|P4|NOT COMPLETED|Feasibility Part||5
1072874|NCT00934856|2600222|P3|NOT COMPLETED|Feasibility Part||3
1072875|NCT00934856|2600223|P2|NOT COMPLETED|Feasibility Part||5
1072876|NCT00934856|2600224|P1|NOT COMPLETED|Feasibility Part||5
1072877|NCT00934856|2600219|P6|COMPLETED|Feasibility Part||6
1072878|NCT00934856|2600220|P5|COMPLETED|Feasibility Part||12
1072879|NCT00934856|2600221|P4|COMPLETED|Feasibility Part||1
1072880|NCT00934856|2600222|P3|COMPLETED|Feasibility Part||0
1072881|NCT00934856|2600223|P2|COMPLETED|Feasibility Part||1
1072882|NCT00934856|2600224|P1|COMPLETED|Feasibility Part||1
1072883|NCT00934856|2600219|P6|STARTED|Feasibility Part||9
1072884|NCT00934856|2600220|P5|STARTED|Feasibility Part||12
1072885|NCT00934856|2600221|P4|STARTED|Feasibility Part||6
1072886|NCT00934856|2600222|P3|STARTED|Feasibility Part||3
1072887|NCT00934856|2600223|P2|STARTED|Feasibility Part||6
1072888|NCT00934856|2600224|P1|STARTED|Feasibility Part||6
1072889|NCT00934921|2600322|P2|NOT COMPLETED|Second Intervention||0
1072890|NCT00934921|2600323|P1|NOT COMPLETED|Second Intervention||0
1072891|NCT00934921|2600322|P2|COMPLETED|Second Intervention||12
1072892|NCT00934921|2600323|P1|COMPLETED|Second Intervention||12
1072893|NCT00934921|2600322|P2|STARTED|Second Intervention||12
1072894|NCT00934921|2600323|P1|STARTED|Second Intervention||12
1072895|NCT00934921|2600322|P2|NOT COMPLETED|First Intervention||0
1072896|NCT00934921|2600323|P1|NOT COMPLETED|First Intervention||0
1072897|NCT00934921|2600322|P2|COMPLETED|First Intervention||12
1072898|NCT00934921|2600323|P1|COMPLETED|First Intervention||12
1072899|NCT00934921|2600322|P2|STARTED|First Intervention||12
1072900|NCT00934921|2600323|P1|STARTED|First Intervention||12
1072901|NCT00934947|2600333|P2|NOT COMPLETED|Overall Study||2
1072902|NCT00934947|2600334|P1|NOT COMPLETED|Overall Study||0
1072903|NCT00934947|2600333|P2|COMPLETED|Overall Study||20
1072904|NCT00934947|2600334|P1|COMPLETED|Overall Study||23
1072905|NCT00934947|2600333|P2|STARTED|Overall Study||22
1072906|NCT00934947|2600334|P1|STARTED|Overall Study||23
1072907|NCT00935493|2600343|P3|NOT COMPLETED|Overall Study||1
1072908|NCT00935493|2600344|P2|NOT COMPLETED|Overall Study||2
1072909|NCT00935493|2600345|P1|NOT COMPLETED|Overall Study||1
1072910|NCT00935493|2600343|P3|COMPLETED|Overall Study||40
1072911|NCT00935493|2600344|P2|COMPLETED|Overall Study||39
1072912|NCT00935493|2600345|P1|COMPLETED|Overall Study||40
1072913|NCT00935493|2600343|P3|STARTED|Overall Study||41
1072914|NCT00935493|2600344|P2|STARTED|Overall Study||41
1072915|NCT00935493|2600345|P1|STARTED|Overall Study||41
1072916|NCT00935532|2600361|P2|NOT COMPLETED|Overall Study||11
1072917|NCT00935532|2600362|P1|NOT COMPLETED|Overall Study||22
1072918|NCT00935532|2600361|P2|COMPLETED|Overall Study||201
1072919|NCT00935532|2600362|P1|COMPLETED|Overall Study||193
1072920|NCT00935532|2600361|P2|STARTED|Overall Study||212
1072921|NCT00935532|2600362|P1|STARTED|Overall Study||215
1072922|NCT00935584|2600390|P2|NOT COMPLETED|Overall Study||4
1072923|NCT00935584|2600391|P1|NOT COMPLETED|Overall Study||49
1072924|NCT00935584|2600390|P2|COMPLETED|Overall Study||19
1072925|NCT00935584|2600391|P1|COMPLETED|Overall Study||77
1072926|NCT00935584|2600390|P2|STARTED|Overall Study||23
1072927|NCT00935584|2600391|P1|STARTED|Overall Study|Out of 128 participants consented, 2 patients had no data collected, as the clinic was cancelled.|126
1072928|NCT00935649|2600401|P1|NOT COMPLETED|Overall Study||5
1072929|NCT00935649|2600401|P1|COMPLETED|Overall Study||134
1072930|NCT00935649|2600401|P1|STARTED|Overall Study||139
1072931|NCT00935701|2600409|P1|NOT COMPLETED|Overall Study||1
1072932|NCT00935701|2600409|P1|COMPLETED|Overall Study||9
1072933|NCT00935701|2600409|P1|Transition Acupressure to Acupuncture|Overall Study||9
1072934|NCT00935701|2600409|P1|STARTED|Overall Study||10
1072935|NCT00935766|2600418|P2|NOT COMPLETED|Overall Study||7
1072936|NCT00935766|2600419|P1|NOT COMPLETED|Overall Study||7
1072937|NCT00935766|2600418|P2|COMPLETED|Overall Study||27
1072938|NCT00935766|2600419|P1|COMPLETED|Overall Study||35
1072939|NCT00935766|2600418|P2|STARTED|Overall Study||34
1072940|NCT00935766|2600419|P1|STARTED|Overall Study||42
1072941|NCT00935792|2600432|P3|NOT COMPLETED|Overall Study||0
1072942|NCT00935792|2600433|P2|NOT COMPLETED|Overall Study||3
1072943|NCT00935792|2600434|P1|NOT COMPLETED|Overall Study||1
1072944|NCT00935792|2600432|P3|COMPLETED|Overall Study||12
1072945|NCT00935792|2600433|P2|COMPLETED|Overall Study||6
1072946|NCT00935792|2600434|P1|COMPLETED|Overall Study||6
1072947|NCT00935792|2600432|P3|STARTED|Overall Study||12
1072948|NCT00935792|2600433|P2|STARTED|Overall Study||9
1072949|NCT00935792|2600434|P1|STARTED|Overall Study||7
1072950|NCT00935818|2600451|P2|NOT COMPLETED|Overall Study||100
1072951|NCT00935818|2600452|P1|NOT COMPLETED|Overall Study||91
1072952|NCT00935818|2600451|P2|COMPLETED|Overall Study||157
1072953|NCT00935818|2600452|P1|COMPLETED|Overall Study||158
1072954|NCT00935818|2600451|P2|End of Medication Phase|Overall Study||184
1072955|NCT00935818|2600452|P1|End of Medication Phase|Overall Study||182
1072956|NCT00935818|2600451|P2|STARTED|Overall Study||257
1072957|NCT00935818|2600452|P1|STARTED|Overall Study||249
1072958|NCT00935857|2600472|P2|NOT COMPLETED|Overall Study||0
1072959|NCT00935857|2600473|P1|NOT COMPLETED|Overall Study||0
1072960|NCT00935857|2600472|P2|COMPLETED|Overall Study||16
1072961|NCT00935857|2600473|P1|COMPLETED|Overall Study||14
1072962|NCT00935857|2600472|P2|STARTED|Overall Study||16
1072963|NCT00935857|2600473|P1|STARTED|Overall Study||14
1072964|NCT00935883|2600485|P2|NOT COMPLETED|Follow-Up Period||0
1072965|NCT00935883|2600486|P1|NOT COMPLETED|Follow-Up Period||0
1072966|NCT00935883|2600485|P2|COMPLETED|Follow-Up Period||38
1072967|NCT00935883|2600486|P1|COMPLETED|Follow-Up Period||19
1072968|NCT00935883|2600485|P2|STARTED|Follow-Up Period||38
1072969|NCT00935883|2600486|P1|STARTED|Follow-Up Period||19
1072970|NCT00935883|2600485|P2|NOT COMPLETED|Treatment Period||2
1072971|NCT00935883|2600486|P1|NOT COMPLETED|Treatment Period||1
1072972|NCT00935883|2600485|P2|COMPLETED|Treatment Period||38
1072973|NCT00935883|2600486|P1|COMPLETED|Treatment Period||19
1072974|NCT00935883|2600485|P2|STARTED|Treatment Period||40
1072975|NCT00935883|2600486|P1|STARTED|Treatment Period||20
1072976|NCT00936065|2600501|P3|NOT COMPLETED|Overall Study||7
1072977|NCT00936065|2600502|P2|NOT COMPLETED|Overall Study||4
1072978|NCT00936065|2600503|P1|NOT COMPLETED|Overall Study||4
1072979|NCT00936065|2600501|P3|COMPLETED|Overall Study||12
1072980|NCT00936065|2600502|P2|COMPLETED|Overall Study||16
1072981|NCT00936065|2600503|P1|COMPLETED|Overall Study||17
1072982|NCT00936065|2600501|P3|Study Assessments Performed|Overall Study||18
1072983|NCT00936065|2600502|P2|Study Assessments Performed|Overall Study||19
1072984|NCT00936065|2600503|P1|Study Assessments Performed|Overall Study||21
1072985|NCT00936065|2600501|P3|Received Treatment|Overall Study||18
1072986|NCT00936065|2600502|P2|Received Treatment|Overall Study||20
1072987|NCT00936065|2600503|P1|Received Treatment|Overall Study||21
1072988|NCT00936065|2600501|P3|STARTED|Overall Study||19
1072989|NCT00936065|2600502|P2|STARTED|Overall Study||20
1072990|NCT00936065|2600503|P1|STARTED|Overall Study||21
1072991|NCT00936117|2600607|P1|NOT COMPLETED|Overall Study||10
1072992|NCT00936117|2600607|P1|COMPLETED|Overall Study|Completed 42 days on study drug|10
1072993|NCT00936117|2600607|P1|STARTED|Overall Study||20
1072994|NCT00936208|2600614|P2|NOT COMPLETED|Overall Study||22
1072995|NCT00936208|2600615|P1|NOT COMPLETED|Overall Study||37
1072996|NCT00936208|2600614|P2|COMPLETED|Overall Study||1574
1072997|NCT00936208|2600615|P1|COMPLETED|Overall Study||1462
1072998|NCT00936208|2600614|P2|STARTED|Overall Study||1596
1072999|NCT00936208|2600615|P1|STARTED|Overall Study||1499
1073000|NCT00936221|2600635|P2|NOT COMPLETED|Overall Study||1
1073001|NCT00936221|2600636|P1|NOT COMPLETED|Overall Study||1
1073002|NCT00936221|2600635|P2|COMPLETED|Overall Study|10 patients ongoing at data cutoff + 35 patients who had died.|45
1073003|NCT00936221|2600636|P1|COMPLETED|Overall Study|13 patients ongoing cutoff + 31 patients who had died.|44
1073004|NCT00936221|2600635|P2|Received Treatment|Overall Study||45
1073005|NCT00936221|2600636|P1|Received Treatment|Overall Study||44
1073006|NCT00936221|2600635|P2|STARTED|Overall Study||46
1073007|NCT00936221|2600636|P1|STARTED|Overall Study||45
1073008|NCT00936351|2600650|P2|NOT COMPLETED|Overall Study||2
1073009|NCT00936351|2600651|P1|NOT COMPLETED|Overall Study||3
1073010|NCT00936351|2600650|P2|COMPLETED|Overall Study||14
1073011|NCT00936351|2600651|P1|COMPLETED|Overall Study||15
1073012|NCT00936351|2600650|P2|STARTED|Overall Study||16
1073013|NCT00936351|2600651|P1|STARTED|Overall Study||18
1073014|NCT00936377|2600664|P3|NOT COMPLETED|Overall Study||0
1073015|NCT00936377|2600665|P2|NOT COMPLETED|Overall Study||0
1073016|NCT00936377|2600666|P1|NOT COMPLETED|Overall Study||0
1073017|NCT00936377|2600664|P3|COMPLETED|Overall Study||8
1073018|NCT00936377|2600665|P2|COMPLETED|Overall Study||8
1073019|NCT00936377|2600666|P1|COMPLETED|Overall Study||8
1073020|NCT00936377|2600664|P3|STARTED|Overall Study||8
1073021|NCT00936377|2600665|P2|STARTED|Overall Study||8
1073022|NCT00936377|2600666|P1|STARTED|Overall Study||8
1073023|NCT00936455|2600697|P2|NOT COMPLETED|Overall Study||0
1073024|NCT00936455|2600698|P1|NOT COMPLETED|Overall Study||0
1073025|NCT00936455|2600697|P2|COMPLETED|Overall Study||38
1073026|NCT00936455|2600698|P1|COMPLETED|Overall Study||37
1073027|NCT00936455|2600697|P2|STARTED|Overall Study||38
1073028|NCT00936455|2600698|P1|STARTED|Overall Study||37
1073029|NCT00936481|2600712|P2|NOT COMPLETED|Overall Study||0
1073030|NCT00936481|2600713|P1|NOT COMPLETED|Overall Study||0
1073031|NCT00936481|2600712|P2|COMPLETED|Overall Study||17
1073032|NCT00936481|2600713|P1|COMPLETED|Overall Study||17
1073033|NCT00936481|2600712|P2|STARTED|Overall Study||17
1073034|NCT00936481|2600713|P1|STARTED|Overall Study||17
1073035|NCT00936585|2600721|P1|NOT COMPLETED|Overall Study||0
1073036|NCT00936585|2600721|P1|COMPLETED|Overall Study||2
1073037|NCT00936585|2600721|P1|STARTED|Overall Study||2
1073038|NCT00936598|2600727|P2|NOT COMPLETED|Overall Study||0
1073039|NCT00936598|2600728|P1|NOT COMPLETED|Overall Study||2
1073040|NCT00936598|2600727|P2|COMPLETED|Overall Study||1
1073041|NCT00936598|2600728|P1|COMPLETED|Overall Study||2
1073042|NCT00936598|2600727|P2|STARTED|Overall Study||1
1073043|NCT00936598|2600728|P1|STARTED|Overall Study||4
1073044|NCT00936702|2600738|P1|NOT COMPLETED|Overall Study||46
1073045|NCT00936702|2600738|P1|COMPLETED|Overall Study||0
1073046|NCT00936702|2600738|P1|STARTED|Overall Study||46
1073047|NCT00936715|2600746|P1|NOT COMPLETED|Overall Study||6
1073048|NCT00936715|2600746|P1|COMPLETED|Overall Study||18
1073049|NCT00936715|2600746|P1|STARTED|Overall Study||24
1073050|NCT00936741|2600750|P1|NOT COMPLETED|Overall Study||9
1073051|NCT00936741|2600750|P1|COMPLETED|Overall Study||21
1073052|NCT00936741|2600750|P1|STARTED|Overall Study||30
1073053|NCT00936897|2600757|P2|NOT COMPLETED|Overall Study||60
1073054|NCT00936897|2600758|P1|NOT COMPLETED|Overall Study||19
1073055|NCT00936897|2600757|P2|COMPLETED|Overall Study||356
1073056|NCT00936897|2600758|P1|COMPLETED|Overall Study||398
1073057|NCT00936897|2600757|P2|STARTED|Overall Study|Randomized|416
1073058|NCT00936897|2600758|P1|STARTED|Overall Study|Randomized|417
1073062|NCT00936975|2600777|P1|NOT COMPLETED|Overall Study||6
1073063|NCT00936975|2600777|P1|COMPLETED|Overall Study||12
1073064|NCT00936975|2600777|P1|STARTED|Overall Study||18
1073065|NCT00937040|2600788|P2|NOT COMPLETED|Overall Study||37
1073066|NCT00937040|2600789|P1|NOT COMPLETED|Overall Study||41
1073067|NCT00937040|2600788|P2|COMPLETED|Overall Study||141
1073068|NCT00937040|2600789|P1|COMPLETED|Overall Study||138
1073069|NCT00937040|2600788|P2|STARTED|Overall Study||178
1073070|NCT00937040|2600789|P1|STARTED|Overall Study||179
1073071|NCT00937105|2600833|P2|NOT COMPLETED|Overall Study||39
1073072|NCT00937105|2600834|P1|NOT COMPLETED|Overall Study||40
1073073|NCT00937105|2600833|P2|COMPLETED|Overall Study||70
1073074|NCT00937105|2600834|P1|COMPLETED|Overall Study||69
1073075|NCT00937105|2600833|P2|STARTED|Overall Study||109
1073076|NCT00937105|2600834|P1|STARTED|Overall Study||109
1073077|NCT00937118|2600849|P1|NOT COMPLETED|Overall Study||0
1073078|NCT00937118|2600849|P1|COMPLETED|Overall Study||41
1073079|NCT00937118|2600849|P1|STARTED|Overall Study||41
1073080|NCT00937157|2600856|P1|NOT COMPLETED|Overall Study||4
1073081|NCT00937157|2600856|P1|COMPLETED|Overall Study||8
1073082|NCT00937157|2600856|P1|STARTED|Overall Study||12
1073083|NCT00937235|2600862|P2|NOT COMPLETED|Overall Study||0
1073084|NCT00937235|2600863|P1|NOT COMPLETED|Overall Study||0
1073085|NCT00937235|2600862|P2|COMPLETED|Overall Study||70
1073086|NCT00937235|2600863|P1|COMPLETED|Overall Study||72
1073087|NCT00937235|2600862|P2|STARTED|Overall Study||70
1073088|NCT00937235|2600863|P1|STARTED|Overall Study||72
1073089|NCT00937391|2600885|P1|NOT COMPLETED|Stage 2||1
1073090|NCT00937391|2600885|P1|COMPLETED|Stage 2|The number completed includes participants within the FAS and Per Protocol Set (PPS)|33
1073091|NCT00937391|2600885|P1|Treated|Stage 2|Valid for Full Analysis Set; participants administered correct Magnevist dose based on body weight|34
1073092|NCT00937391|2600885|P1|STARTED|Stage 2|Stage 1 and Stage 2 are independent each enrolling a different set of participants|34
1073093|NCT00937391|2600885|P1|NOT COMPLETED|Stage 1||0
1073094|NCT00937391|2600885|P1|COMPLETED|Stage 1||20
1073095|NCT00937391|2600885|P1|Treated|Stage 1|Valid for Full Analysis Set (FAS); includes all participants administered Magnevist Injection|20
1073096|NCT00937391|2600885|P1|STARTED|Stage 1||20
1073097|NCT00937495|2600936|P1|NOT COMPLETED|Overall Study||2
1073098|NCT00937495|2600936|P1|COMPLETED|Overall Study||14
1073099|NCT00937495|2600936|P1|STARTED|Overall Study||16
1073100|NCT00937521|2600950|P8|NOT COMPLETED|Booster Phase||2
1073101|NCT00937521|2600951|P7|NOT COMPLETED|Booster Phase||5
1073102|NCT00937521|2600952|P6|NOT COMPLETED|Booster Phase||5
1073103|NCT00937521|2600953|P5|NOT COMPLETED|Booster Phase||5
1073104|NCT00937521|2600954|P4|NOT COMPLETED|Booster Phase||3
1073105|NCT00937521|2600955|P3|NOT COMPLETED|Booster Phase||5
1073106|NCT00937521|2600956|P2|NOT COMPLETED|Booster Phase||2
1073107|NCT00937521|2600957|P1|NOT COMPLETED|Booster Phase||3
1073108|NCT00937521|2600950|P8|COMPLETED|Booster Phase||159
1073109|NCT00937521|2600951|P7|COMPLETED|Booster Phase||160
1073110|NCT00937521|2600952|P6|COMPLETED|Booster Phase||160
1073111|NCT00937521|2600953|P5|COMPLETED|Booster Phase||163
1073112|NCT00937521|2600954|P4|COMPLETED|Booster Phase||167
1073113|NCT00937521|2600955|P3|COMPLETED|Booster Phase||164
1073114|NCT00937521|2600956|P2|COMPLETED|Booster Phase||161
1073115|NCT00937521|2600957|P1|COMPLETED|Booster Phase||152
1073116|NCT00937521|2600950|P8|Premature Withdrawal|Booster Phase||2
1073117|NCT00937521|2600951|P7|Premature Withdrawal|Booster Phase||5
1073118|NCT00937521|2600952|P6|Premature Withdrawal|Booster Phase||5
1073119|NCT00937521|2600953|P5|Premature Withdrawal|Booster Phase||5
1073120|NCT00937521|2600954|P4|Premature Withdrawal|Booster Phase||3
1073121|NCT00937521|2600955|P3|Premature Withdrawal|Booster Phase||5
1073122|NCT00937521|2600956|P2|Premature Withdrawal|Booster Phase||2
1073123|NCT00937521|2600957|P1|Premature Withdrawal|Booster Phase||3
1073124|NCT00937521|2600950|P8|STARTED|Booster Phase||161
1073125|NCT00937521|2600951|P7|STARTED|Booster Phase||165
1073126|NCT00937521|2600952|P6|STARTED|Booster Phase||165
1073127|NCT00937521|2600953|P5|STARTED|Booster Phase||168
1073128|NCT00937521|2600954|P4|STARTED|Booster Phase||170
1073129|NCT00937521|2600955|P3|STARTED|Booster Phase||169
1073130|NCT00937521|2600956|P2|STARTED|Booster Phase||163
1073131|NCT00937521|2600957|P1|STARTED|Booster Phase||155
1073132|NCT00937521|2600950|P8|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
1073133|NCT00937521|2600951|P7|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
1073134|NCT00937521|2600952|P6|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
1073135|NCT00937521|2600953|P5|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
1073136|NCT00937521|2600954|P4|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
1073137|NCT00937521|2600955|P3|NOT COMPLETED|Overall Study - Prior to Booster Dose||6
1073138|NCT00937521|2600956|P2|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
1073139|NCT00937521|2600957|P1|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
1073140|NCT00937521|2600950|P8|COMPLETED|Overall Study - Prior to Booster Dose||183
1073141|NCT00937521|2600951|P7|COMPLETED|Overall Study - Prior to Booster Dose||181
1073142|NCT00937521|2600952|P6|COMPLETED|Overall Study - Prior to Booster Dose||187
1073143|NCT00937521|2600953|P5|COMPLETED|Overall Study - Prior to Booster Dose||188
1073144|NCT00937521|2600954|P4|COMPLETED|Overall Study - Prior to Booster Dose||187
1073145|NCT00937521|2600955|P3|COMPLETED|Overall Study - Prior to Booster Dose||186
1073146|NCT00937521|2600956|P2|COMPLETED|Overall Study - Prior to Booster Dose||185
1073147|NCT00937521|2600957|P1|COMPLETED|Overall Study - Prior to Booster Dose||185
1073148|NCT00937521|2600950|P8|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
1073149|NCT00937521|2600951|P7|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
1073150|NCT00937521|2600952|P6|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
1073151|NCT00937521|2600953|P5|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
1073152|NCT00937521|2600954|P4|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
1073153|NCT00937521|2600955|P3|Premature Withdrawal|Overall Study - Prior to Booster Dose||6
1073154|NCT00937521|2600956|P2|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
1073155|NCT00937521|2600957|P1|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
1073156|NCT00937521|2600950|P8|STARTED|Overall Study - Prior to Booster Dose||184
1073157|NCT00937521|2600951|P7|STARTED|Overall Study - Prior to Booster Dose||186
1073158|NCT00937521|2600952|P6|STARTED|Overall Study - Prior to Booster Dose||188
1073159|NCT00937521|2600953|P5|STARTED|Overall Study - Prior to Booster Dose||191
1073160|NCT00937521|2600954|P4|STARTED|Overall Study - Prior to Booster Dose||188
1073161|NCT00937521|2600955|P3|STARTED|Overall Study - Prior to Booster Dose||192
1073162|NCT00937521|2600956|P2|STARTED|Overall Study - Prior to Booster Dose||190
1073163|NCT00937521|2600957|P1|STARTED|Overall Study - Prior to Booster Dose||188
1073164|NCT00937547|2601066|P3|NOT COMPLETED|Overall Study||7
1073165|NCT00937547|2601067|P2|NOT COMPLETED|Overall Study||6
1073166|NCT00937547|2601068|P1|NOT COMPLETED|Overall Study||1
1073167|NCT00937547|2601066|P3|COMPLETED|Overall Study||142
1073168|NCT00937547|2601067|P2|COMPLETED|Overall Study||78
1073169|NCT00937547|2601068|P1|COMPLETED|Overall Study||95
1073170|NCT00937547|2601066|P3|Histological Samples|Overall Study||142
1073171|NCT00937547|2601067|P2|Histological Samples|Overall Study||78
1073172|NCT00937547|2601068|P1|Histological Samples|Overall Study||95
1073173|NCT00937547|2601066|P3|STARTED|Overall Study||149
1073174|NCT00937547|2601067|P2|STARTED|Overall Study||84
1073175|NCT00937547|2601068|P1|STARTED|Overall Study||96
1073176|NCT00937560|2601097|P1|NOT COMPLETED|Maintenance Treatment||18
1073177|NCT00937560|2601097|P1|COMPLETED|Maintenance Treatment||150
1073178|NCT00937560|2601097|P1|STARTED|Maintenance Treatment||168
1073179|NCT00937560|2601097|P1|NOT COMPLETED|Initial Treatment||21
1073180|NCT00937560|2601097|P1|COMPLETED|Initial Treatment||169
1073181|NCT00937560|2601097|P1|Received Treatment|Initial Treatment||189
1073182|NCT00937560|2601097|P1|STARTED|Initial Treatment||190
1073183|NCT00937768|2601107|P2|NOT COMPLETED|Overall Study||8
1073184|NCT00937768|2601108|P1|NOT COMPLETED|Overall Study||8
1073185|NCT00937768|2601107|P2|COMPLETED|Overall Study||0
1073186|NCT00937768|2601108|P1|COMPLETED|Overall Study||0
1073187|NCT00937768|2601107|P2|STARTED|Overall Study||8
1073188|NCT00937768|2601108|P1|STARTED|Overall Study||8
1073189|NCT00937794|2601114|P1|NOT COMPLETED|Overall Study||0
1073190|NCT00937794|2601114|P1|COMPLETED|Overall Study||33
1073191|NCT00937794|2601114|P1|STARTED|Overall Study||33
1073192|NCT00937833|2601121|P2|NOT COMPLETED|Overall Study||17
1073193|NCT00937833|2601122|P1|NOT COMPLETED|Overall Study||15
1073194|NCT00937833|2601121|P2|COMPLETED|Overall Study||60
1073195|NCT00937833|2601122|P1|COMPLETED|Overall Study||58
1073196|NCT00937833|2601121|P2|STARTED|Overall Study||77
1073197|NCT00937833|2601122|P1|STARTED|Overall Study||73
1073198|NCT00929864|2601130|P2|NOT COMPLETED|Overall Study||83
1073199|NCT00929864|2601131|P1|NOT COMPLETED|Overall Study||66
1073200|NCT00929864|2601130|P2|COMPLETED|Overall Study||245
1073201|NCT00929864|2601131|P1|COMPLETED|Overall Study||252
1073202|NCT00929864|2601130|P2|STARTED|Overall Study||328
1073203|NCT00929864|2601131|P1|STARTED|Overall Study||318
1073204|NCT00929981|2601149|P1|NOT COMPLETED|Overall Study||0
1073205|NCT00929981|2601149|P1|COMPLETED|Overall Study||80
1073206|NCT00929981|2601149|P1|STARTED|Overall Study||80
1073207|NCT00930176|2601159|P1|NOT COMPLETED|Overall Study||1
1073208|NCT00930176|2601159|P1|COMPLETED|Overall Study||15
1073209|NCT00930176|2601159|P1|STARTED|Overall Study||16
1073210|NCT00930293|2601166|P2|NOT COMPLETED|Overall Study||7
1073211|NCT00930293|2601167|P1|NOT COMPLETED|Overall Study||7
1073212|NCT00930293|2601166|P2|COMPLETED|Overall Study||19
1073213|NCT00930293|2601167|P1|COMPLETED|Overall Study||17
1073214|NCT00930293|2601166|P2|STARTED|Overall Study||26
1073215|NCT00930293|2601167|P1|STARTED|Overall Study||24
1073216|NCT00930553|2601175|P1|NOT COMPLETED|Overall Study||223
1073217|NCT00930553|2601175|P1|COMPLETED|Overall Study||1091
1073218|NCT00930553|2601175|P1|Participants Entered From CAMMS324|Overall Study||685
1073219|NCT00930553|2601175|P1|Participants Entered From CAMMS323|Overall Study||488
1073220|NCT00930553|2601175|P1|Participants Entered From CAMMS223|Overall Study||141
1073221|NCT00930553|2601175|P1|STARTED|Overall Study||1314
1073222|NCT00930644|2601241|P1|NOT COMPLETED|Overall Study||23
1073223|NCT00930644|2601241|P1|COMPLETED|Overall Study||65
1073224|NCT00930644|2601241|P1|STARTED|Overall Study||88
1073225|NCT00930722|2601254|P1|NOT COMPLETED|Overall Study||27
1073226|NCT00930722|2601254|P1|COMPLETED|Overall Study||302
1073227|NCT00930722|2601254|P1|STARTED|Overall Study||329
1073228|NCT00930761|2601271|P2|NOT COMPLETED|Overall Study||3
1073229|NCT00930761|2601272|P1|NOT COMPLETED|Overall Study||4
1073230|NCT00930761|2601271|P2|COMPLETED|Overall Study||48
1073231|NCT00930761|2601272|P1|COMPLETED|Overall Study||46
1073232|NCT00930761|2601271|P2|STARTED|Overall Study||51
1073233|NCT00930761|2601272|P1|STARTED|Overall Study||50
1073234|NCT00930774|2601288|P4|NOT COMPLETED|Overall Study||0
1073235|NCT00930774|2601289|P3|NOT COMPLETED|Overall Study||2
1073236|NCT00930774|2601290|P2|NOT COMPLETED|Overall Study||9
1073237|NCT00930774|2601291|P1|NOT COMPLETED|Overall Study||1
1073238|NCT00930774|2601288|P4|COMPLETED|Overall Study||25
1073239|NCT00930774|2601289|P3|COMPLETED|Overall Study||22
1073240|NCT00930774|2601290|P2|COMPLETED|Overall Study||16
1073241|NCT00930774|2601291|P1|COMPLETED|Overall Study||24
1073242|NCT00930774|2601288|P4|STARTED|Overall Study||25
1073243|NCT00930774|2601289|P3|STARTED|Overall Study||24
1073244|NCT00930774|2601290|P2|STARTED|Overall Study||25
1073245|NCT00930774|2601291|P1|STARTED|Overall Study||25
1073246|NCT00930787|2601331|P2|NOT COMPLETED|Overall Study||0
1073247|NCT00930787|2601332|P1|NOT COMPLETED|Overall Study||0
1073248|NCT00930787|2601331|P2|COMPLETED|Overall Study||9
1073249|NCT00930787|2601332|P1|COMPLETED|Overall Study||14
1073250|NCT00930787|2601331|P2|STARTED|Overall Study||9
1073251|NCT00930787|2601332|P1|STARTED|Overall Study||14
1073252|NCT00930813|2601340|P2|NOT COMPLETED|Overall Study||14
1073253|NCT00930813|2601341|P1|NOT COMPLETED|Overall Study||8
1073254|NCT00930813|2601340|P2|COMPLETED|Overall Study||38
1073255|NCT00930813|2601341|P1|COMPLETED|Overall Study||41
1073256|NCT00930813|2601340|P2|STARTED|Overall Study||52
1073257|NCT00930813|2601341|P1|STARTED|Overall Study||49
1073258|NCT00930930|2601351|P2|NOT COMPLETED|Overall Study||9
1073259|NCT00930930|2601352|P1|NOT COMPLETED|Overall Study||21
1073260|NCT00930930|2601351|P2|COMPLETED|Overall Study||40
1073261|NCT00930930|2601352|P1|COMPLETED|Overall Study||75
1073262|NCT00930930|2601351|P2|STARTED|Overall Study||49
1073263|NCT00930930|2601352|P1|STARTED|Overall Study||96
1073264|NCT00930969|2601364|P1|NOT COMPLETED|Overall Study||38
1073265|NCT00930969|2601364|P1|COMPLETED|Overall Study||137
1073266|NCT00930969|2601364|P1|STARTED|Overall Study||175
1073267|NCT00930982|2601374|P2|NOT COMPLETED|Overall Study||29
1073268|NCT00930982|2601375|P1|NOT COMPLETED|Overall Study||21
1073269|NCT00930982|2601374|P2|COMPLETED|Overall Study||35
1073270|NCT00930982|2601375|P1|COMPLETED|Overall Study||39
1073271|NCT00930982|2601374|P2|STARTED|Overall Study||64
1073272|NCT00930982|2601375|P1|STARTED|Overall Study||60
1073273|NCT00931164|2601409|P1|NOT COMPLETED|Overall Study||0
1073274|NCT00931164|2601409|P1|COMPLETED|Overall Study||6
1073275|NCT00931164|2601409|P1|STARTED|Overall Study||6
1073276|NCT00931242|2601415|P2|NOT COMPLETED|Overall Study||2
1073277|NCT00931242|2601416|P1|NOT COMPLETED|Overall Study||5
1073278|NCT00931242|2601415|P2|COMPLETED|Overall Study||0
1073279|NCT00931242|2601416|P1|COMPLETED|Overall Study||5
1073280|NCT00931242|2601415|P2|STARTED|Overall Study||2
1073281|NCT00931242|2601416|P1|STARTED|Overall Study||10
1073282|NCT00931268|2601422|P1|NOT COMPLETED|Overall Study||6
1073283|NCT00931268|2601422|P1|COMPLETED|Overall Study||4
1073284|NCT00931268|2601422|P1|STARTED|Overall Study||10
1073285|NCT00931307|2601432|P1|NOT COMPLETED|Overall Study||13
1073286|NCT00931307|2601432|P1|COMPLETED|Overall Study||9
1073287|NCT00931307|2601432|P1|STARTED|Overall Study||22
1073288|NCT00931359|2601438|P2|NOT COMPLETED|Overall Study||13
1073289|NCT00931359|2601439|P1|NOT COMPLETED|Overall Study||6
1073290|NCT00931359|2601438|P2|COMPLETED|Overall Study||68
1073291|NCT00931359|2601439|P1|COMPLETED|Overall Study||33
1073292|NCT00931359|2601438|P2|STARTED|Overall Study||81
1073293|NCT00931359|2601439|P1|STARTED|Overall Study||39
1073294|NCT00931385|2601451|P4|NOT COMPLETED|Overall Study||5
1073295|NCT00931385|2601452|P3|NOT COMPLETED|Overall Study||1
1073296|NCT00931385|2601453|P2|NOT COMPLETED|Overall Study||2
1073297|NCT00931385|2601454|P1|NOT COMPLETED|Overall Study||2
1073298|NCT00931385|2601451|P4|COMPLETED|Overall Study||21
1073299|NCT00931385|2601452|P3|COMPLETED|Overall Study||24
1073300|NCT00931385|2601453|P2|COMPLETED|Overall Study||21
1073301|NCT00931385|2601454|P1|COMPLETED|Overall Study||23
1073302|NCT00931385|2601451|P4|STARTED|Overall Study||26
1073303|NCT00931385|2601452|P3|STARTED|Overall Study||25
1073304|NCT00931385|2601453|P2|STARTED|Overall Study||23
1073305|NCT00931385|2601454|P1|STARTED|Overall Study||25
1073306|NCT00931411|2601510|P2|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||1
1073307|NCT00931411|2601511|P1|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||0
1073308|NCT00931411|2601510|P2|COMPLETED|After Crossover - 14 Days (up to Day 56)||34
1073309|NCT00931411|2601511|P1|COMPLETED|After Crossover - 14 Days (up to Day 56)||31
1073310|NCT00931411|2601510|P2|STARTED|After Crossover - 14 Days (up to Day 56)||35
1073311|NCT00931411|2601511|P1|STARTED|After Crossover - 14 Days (up to Day 56)||31
1073312|NCT00931411|2601510|P2|NOT COMPLETED|First Intervention - 42 Days||3
1073313|NCT00931411|2601511|P1|NOT COMPLETED|First Intervention - 42 Days||4
1073314|NCT00931411|2601510|P2|COMPLETED|First Intervention - 42 Days||35
1073315|NCT00931411|2601511|P1|COMPLETED|First Intervention - 42 Days||31
1073316|NCT00931411|2601510|P2|STARTED|First Intervention - 42 Days||38
1073317|NCT00931411|2601511|P1|STARTED|First Intervention - 42 Days||35
1073318|NCT00931463|2601534|P2|NOT COMPLETED|Overall Study||5
1073319|NCT00931463|2601535|P1|NOT COMPLETED|Overall Study||17
1073320|NCT00931463|2601534|P2|COMPLETED|Overall Study||265
1073321|NCT00931463|2601535|P1|COMPLETED|Overall Study||254
1073322|NCT00931463|2601534|P2|STARTED|Overall Study||270
1073323|NCT00931463|2601535|P1|STARTED|Overall Study||271
1073324|NCT00931489|2601554|P5|NOT COMPLETED|Overall Study||0
1073325|NCT00931489|2601555|P4|NOT COMPLETED|Overall Study||0
1073326|NCT00931489|2601556|P3|NOT COMPLETED|Overall Study||0
1073327|NCT00931489|2601557|P2|NOT COMPLETED|Overall Study||0
1073328|NCT00931489|2601558|P1|NOT COMPLETED|Overall Study||0
1073329|NCT00931489|2601554|P5|COMPLETED|Overall Study||7
1073330|NCT00931489|2601555|P4|COMPLETED|Overall Study||39
1073331|NCT00931489|2601556|P3|COMPLETED|Overall Study|3 subjects enrolled in Group 1 (responders) were moved to Group 3 (non-responders)|5
1073332|NCT00931489|2601557|P2|COMPLETED|Overall Study||40
1073333|NCT00931489|2601558|P1|COMPLETED|Overall Study||40
1073334|NCT00931489|2601554|P5|STARTED|Overall Study||7
1073335|NCT00931489|2601555|P4|STARTED|Overall Study||39
1073336|NCT00931489|2601556|P3|STARTED|Overall Study||5
1073337|NCT00931489|2601557|P2|STARTED|Overall Study||40
1073338|NCT00931489|2601558|P1|STARTED|Overall Study||40
1073339|NCT00931515|2601573|P2|NOT COMPLETED|Overall Study||5
1073340|NCT00931515|2601574|P1|NOT COMPLETED|Overall Study||2
1073341|NCT00931515|2601573|P2|COMPLETED|Overall Study||10
1073342|NCT00931515|2601574|P1|COMPLETED|Overall Study||13
1073343|NCT00931515|2601573|P2|STARTED|Overall Study||15
1073344|NCT00931515|2601574|P1|STARTED|Overall Study||15
1073345|NCT00931528|2601582|P2|NOT COMPLETED|Overall Study||60
1073346|NCT00931528|2601583|P1|NOT COMPLETED|Overall Study||41
1073347|NCT00931528|2601582|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|61
1073348|NCT00931528|2601583|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|80
1073349|NCT00931528|2601582|P2|STARTED|Overall Study||121
1073350|NCT00931528|2601583|P1|STARTED|Overall Study||121
1073357|NCT00931710|2601600|P2|NOT COMPLETED|Overall Study||38
1073358|NCT00931710|2601601|P1|NOT COMPLETED|Overall Study||34
1073359|NCT00931710|2601600|P2|COMPLETED|Overall Study||209
1073360|NCT00931710|2601601|P1|COMPLETED|Overall Study||207
1073361|NCT00931710|2601600|P2|STARTED|Overall Study||247
1073362|NCT00931710|2601601|P1|STARTED|Overall Study||241
1073363|NCT00931723|2601619|P2|NOT COMPLETED|Overall Study||39
1073364|NCT00931723|2601620|P1|NOT COMPLETED|Overall Study||26
1073365|NCT00931723|2601619|P2|COMPLETED|Overall Study||144
1073366|NCT00931723|2601620|P1|COMPLETED|Overall Study||147
1073367|NCT00931723|2601619|P2|STARTED|Overall Study||183
1073368|NCT00931723|2601620|P1|STARTED|Overall Study||173
1073369|NCT00931801|2601669|P3|NOT COMPLETED|Overall Study||4
1073370|NCT00931801|2601670|P2|NOT COMPLETED|Overall Study||1
1073371|NCT00931801|2601671|P1|NOT COMPLETED|Overall Study||1
1073372|NCT00931801|2601669|P3|COMPLETED|Overall Study||10
1073373|NCT00931801|2601670|P2|COMPLETED|Overall Study||14
1073374|NCT00931801|2601671|P1|COMPLETED|Overall Study||13
1073375|NCT00931801|2601669|P3|STARTED|Overall Study||14
1073376|NCT00931801|2601670|P2|STARTED|Overall Study||15
1073377|NCT00931801|2601671|P1|STARTED|Overall Study||14
1073378|NCT00931879|2601694|P2|NOT COMPLETED|Overall Study||3
1073379|NCT00931879|2601695|P1|NOT COMPLETED|Overall Study||3
1073380|NCT00931879|2601694|P2|COMPLETED|Overall Study||19
1073381|NCT00931879|2601695|P1|COMPLETED|Overall Study||19
1073382|NCT00931879|2601694|P2|STARTED|Overall Study||22
1073383|NCT00931879|2601695|P1|STARTED|Overall Study||22
1073384|NCT00931918|2601719|P2|NOT COMPLETED|Overall Study||17
1073385|NCT00931918|2601720|P1|NOT COMPLETED|Overall Study||17
1073386|NCT00931918|2601719|P2|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
1073387|NCT00931918|2601720|P1|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
1073388|NCT00931918|2601719|P2|Safety Population: Received Study Drug|Overall Study||101
1073389|NCT00931918|2601720|P1|Safety Population: Received Study Drug|Overall Study||100
1073390|NCT00931918|2601719|P2|STARTED|Overall Study||103
1073391|NCT00931918|2601720|P1|STARTED|Overall Study||103
1073392|NCT00931996|2601744|P1|NOT COMPLETED|Overall Study||7
1073393|NCT00931996|2601744|P1|COMPLETED|Overall Study||5
1073394|NCT00931996|2601744|P1|STARTED|Overall Study||12
1073395|NCT00932022|2601750|P2|NOT COMPLETED|Overall Study||4
1073396|NCT00932022|2601751|P1|NOT COMPLETED|Overall Study||5
1073397|NCT00932022|2601750|P2|COMPLETED|Overall Study||59
1073398|NCT00932022|2601751|P1|COMPLETED|Overall Study||59
1073399|NCT00932022|2601750|P2|STARTED|Overall Study||63
1073400|NCT00932022|2601751|P1|STARTED|Overall Study||64
1073401|NCT00932035|2601767|P2|NOT COMPLETED|Overall Study||0
1073402|NCT00932035|2601768|P1|NOT COMPLETED|Overall Study||0
1073403|NCT00932035|2601767|P2|COMPLETED|Overall Study||21
1073404|NCT00932035|2601768|P1|COMPLETED|Overall Study||18
1073405|NCT00932035|2601767|P2|STARTED|Overall Study||21
1073406|NCT00932035|2601768|P1|STARTED|Overall Study||18
1073407|NCT00932113|2601780|P2|NOT COMPLETED|Overall Study||0
1073408|NCT00932113|2601781|P1|NOT COMPLETED|Overall Study||1
1073409|NCT00932113|2601780|P2|COMPLETED|Overall Study||15
1073410|NCT00932113|2601781|P1|COMPLETED|Overall Study||14
1073411|NCT00932113|2601780|P2|STARTED|Overall Study||15
1073412|NCT00932113|2601781|P1|STARTED|Overall Study||15
1073413|NCT00932126|2601797|P8|NOT COMPLETED|Overall Study||10
1073414|NCT00932126|2601798|P7|NOT COMPLETED|Overall Study||5
1073415|NCT00932126|2601799|P6|NOT COMPLETED|Overall Study||3
1073416|NCT00932126|2601800|P5|NOT COMPLETED|Overall Study||5
1073417|NCT00932126|2601801|P4|NOT COMPLETED|Overall Study||3
1073418|NCT00932126|2601802|P3|NOT COMPLETED|Overall Study||3
1073419|NCT00932126|2601803|P2|NOT COMPLETED|Overall Study||3
1073420|NCT00932126|2601804|P1|NOT COMPLETED|Overall Study||3
1073421|NCT00932126|2601797|P8|COMPLETED|Overall Study||0
1073422|NCT00932126|2601798|P7|COMPLETED|Overall Study||0
1073423|NCT00932126|2601799|P6|COMPLETED|Overall Study||0
1073424|NCT00932126|2601800|P5|COMPLETED|Overall Study||0
1073425|NCT00932126|2601801|P4|COMPLETED|Overall Study||0
1073426|NCT00932126|2601802|P3|COMPLETED|Overall Study||0
1073427|NCT00932126|2601803|P2|COMPLETED|Overall Study||0
1073428|NCT00932126|2601804|P1|COMPLETED|Overall Study||0
1073429|NCT00932126|2601797|P8|STARTED|Overall Study||10
1073430|NCT00932126|2601798|P7|STARTED|Overall Study||5
1073431|NCT00932126|2601799|P6|STARTED|Overall Study||3
1073432|NCT00932126|2601800|P5|STARTED|Overall Study||5
1073433|NCT00932126|2601801|P4|STARTED|Overall Study||3
1073434|NCT00932126|2601802|P3|STARTED|Overall Study||3
1073435|NCT00932126|2601803|P2|STARTED|Overall Study||3
1073436|NCT00932126|2601804|P1|STARTED|Overall Study||3
1073440|NCT00937950|2601847|P1|NOT COMPLETED|Overall Study||216
1073441|NCT00937950|2601847|P1|COMPLETED|Overall Study||1787
1073442|NCT00937950|2601847|P1|STARTED|Overall Study||2003
1073443|NCT00938015|2601863|P1|NOT COMPLETED|Overall Study||147
1073444|NCT00938015|2601863|P1|COMPLETED|Overall Study||156
1073445|NCT00938015|2601863|P1|STARTED|Overall Study||303
1073446|NCT00938041|2601879|P1|NOT COMPLETED|Overall Study||27
1073447|NCT00938041|2601879|P1|COMPLETED|Overall Study||5
1073448|NCT00938041|2601879|P1|STARTED|Overall Study||32
1073449|NCT00940875|2601890|P2|NOT COMPLETED|Post-Study Treatment||3
1073450|NCT00940875|2601891|P1|NOT COMPLETED|Post-Study Treatment||0
1073451|NCT00940875|2601890|P2|COMPLETED|Post-Study Treatment||1
1073452|NCT00940875|2601891|P1|COMPLETED|Post-Study Treatment||0
1073453|NCT00940875|2601890|P2|STARTED|Post-Study Treatment||4
1073454|NCT00940875|2601891|P1|STARTED|Post-Study Treatment||0
1073455|NCT00940875|2601890|P2|NOT COMPLETED|Treatment Phase||19
1073456|NCT00940875|2601891|P1|NOT COMPLETED|Treatment Phase||26
1073457|NCT00940875|2601890|P2|COMPLETED|Treatment Phase||4
1073458|NCT00940875|2601891|P1|COMPLETED|Treatment Phase||5
1073459|NCT00940875|2601890|P2|STARTED|Treatment Phase|3 participants randomized to G+E arm received only gemcitabine and were analyzed in Gemcitabine arm|23
1073460|NCT00940875|2601891|P1|STARTED|Treatment Phase|Disposition analysis includes 3 participants randomized to G+E but received only gemcitabine|31
1073461|NCT00940888|2601909|P1|NOT COMPLETED|Overall Study||835
1073462|NCT00940888|2601909|P1|COMPLETED|Overall Study|Subjects that completed the 60 month follow up visit|866
1073463|NCT00940888|2601909|P1|STARTED|Overall Study|Total number of subjects consented|1701
1073464|NCT00940901|2601916|P2|NOT COMPLETED|Week 9-16 (Phase 2)||3
1073465|NCT00940901|2601917|P1|NOT COMPLETED|Week 9-16 (Phase 2)||2
1073466|NCT00940901|2601916|P2|COMPLETED|Week 9-16 (Phase 2)||4
1073467|NCT00940901|2601917|P1|COMPLETED|Week 9-16 (Phase 2)||4
1073468|NCT00940901|2601916|P2|STARTED|Week 9-16 (Phase 2)||7
1073469|NCT00940901|2601917|P1|STARTED|Week 9-16 (Phase 2)||6
1073470|NCT00940901|2601916|P2|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
1073471|NCT00940901|2601917|P1|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
1073472|NCT00940901|2601916|P2|COMPLETED|Weeks 1-8 (Phase 1)||7
1073473|NCT00940901|2601917|P1|COMPLETED|Weeks 1-8 (Phase 1)||6
1073474|NCT00940901|2601916|P2|STARTED|Weeks 1-8 (Phase 1)||7
1073475|NCT00940901|2601917|P1|STARTED|Weeks 1-8 (Phase 1)||6
1073476|NCT00940927|2601927|P1|NOT COMPLETED|Overall Study||0
1073477|NCT00940927|2601927|P1|COMPLETED|Overall Study||81
1073478|NCT00940927|2601927|P1|STARTED|Overall Study||81
1073479|NCT00940992|2601935|P3|NOT COMPLETED|Overall Study||2
1073480|NCT00940992|2601936|P2|NOT COMPLETED|Overall Study||2
1073481|NCT00940992|2601937|P1|NOT COMPLETED|Overall Study||4
1073482|NCT00940992|2601935|P3|COMPLETED|Overall Study||28
1073483|NCT00940992|2601936|P2|COMPLETED|Overall Study||28
1073484|NCT00940992|2601937|P1|COMPLETED|Overall Study||28
1073485|NCT00940992|2601935|P3|STARTED|Overall Study||30
1073486|NCT00940992|2601936|P2|STARTED|Overall Study||30
1073487|NCT00940992|2601937|P1|STARTED|Overall Study||32
1073488|NCT00941031|2601952|P7|NOT COMPLETED|Maintenance Period||43
1073489|NCT00941031|2601953|P6|NOT COMPLETED|Maintenance Period||6
1073490|NCT00941031|2601954|P5|NOT COMPLETED|Maintenance Period||9
1073491|NCT00941031|2601955|P4|NOT COMPLETED|Maintenance Period||0
1073492|NCT00941031|2601956|P3|NOT COMPLETED|Maintenance Period||0
1073493|NCT00941031|2601957|P2|NOT COMPLETED|Maintenance Period||0
1073494|NCT00941031|2601958|P1|NOT COMPLETED|Maintenance Period||0
1073495|NCT00941031|2601952|P7|COMPLETED|Maintenance Period||204
1073496|NCT00941031|2601953|P6|COMPLETED|Maintenance Period||61
1073497|NCT00941031|2601954|P5|COMPLETED|Maintenance Period||56
1073498|NCT00941031|2601955|P4|COMPLETED|Maintenance Period|Non Responders treated with an open label regimen.|0
1073499|NCT00941031|2601956|P3|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
1073500|NCT00941031|2601957|P2|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
1073501|NCT00941031|2601958|P1|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
1073502|NCT00941031|2601952|P7|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|247
1073503|NCT00941031|2601953|P6|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|67
1073504|NCT00941031|2601954|P5|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|65
1073505|NCT00941031|2601955|P4|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|0
1073506|NCT00941031|2601956|P3|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
1073507|NCT00941031|2601957|P2|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
1073508|NCT00941031|2601958|P1|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
1073509|NCT00941031|2601952|P7|NOT COMPLETED|Induction Period||0
1073510|NCT00941031|2601953|P6|NOT COMPLETED|Induction Period||0
1073511|NCT00941031|2601954|P5|NOT COMPLETED|Induction Period||0
1073512|NCT00941031|2601955|P4|NOT COMPLETED|Induction Period||9
1073513|NCT00941031|2601956|P3|NOT COMPLETED|Induction Period||6
1073514|NCT00941031|2601957|P2|NOT COMPLETED|Induction Period||4
1073515|NCT00941031|2601958|P1|NOT COMPLETED|Induction Period||5
1073516|NCT00941031|2601952|P7|COMPLETED|Induction Period||0
1073517|NCT00941031|2601953|P6|COMPLETED|Induction Period||0
1073518|NCT00941031|2601954|P5|COMPLETED|Induction Period||0
1073519|NCT00941031|2601955|P4|COMPLETED|Induction Period||58
1073520|NCT00941031|2601956|P3|COMPLETED|Induction Period||127
1073521|NCT00941031|2601957|P2|COMPLETED|Induction Period||134
1073522|NCT00941031|2601958|P1|COMPLETED|Induction Period||61
1073523|NCT00941031|2601952|P7|STARTED|Induction Period||0
1073524|NCT00941031|2601953|P6|STARTED|Induction Period||0
1073525|NCT00941031|2601954|P5|STARTED|Induction Period||0
1073526|NCT00941031|2601955|P4|STARTED|Induction Period||67
1073527|NCT00941031|2601956|P3|STARTED|Induction Period||133
1073528|NCT00941031|2601957|P2|STARTED|Induction Period||138
1073529|NCT00941031|2601958|P1|STARTED|Induction Period||66
1073530|NCT00941070|2601981|P1|NOT COMPLETED|Overall Study||1
1073531|NCT00941070|2601981|P1|COMPLETED|Overall Study||25
1073532|NCT00941070|2601981|P1|STARTED|Overall Study||26
1073533|NCT00941304|2602000|P5|NOT COMPLETED|Overall Study||0
1073534|NCT00941304|2602001|P4|NOT COMPLETED|Overall Study||0
1073535|NCT00941304|2602002|P3|NOT COMPLETED|Overall Study||0
1073536|NCT00941304|2602003|P2|NOT COMPLETED|Overall Study||0
1073537|NCT00941304|2602004|P1|NOT COMPLETED|Overall Study||1
1073538|NCT00941304|2602000|P5|COMPLETED|Overall Study||31
1073539|NCT00941304|2602001|P4|COMPLETED|Overall Study||30
1073540|NCT00941304|2602002|P3|COMPLETED|Overall Study||31
1073541|NCT00941304|2602003|P2|COMPLETED|Overall Study||30
1073542|NCT00941304|2602004|P1|COMPLETED|Overall Study||30
1073543|NCT00941304|2602000|P5|STARTED|Overall Study||31
1073544|NCT00941304|2602001|P4|STARTED|Overall Study||30
1073545|NCT00941304|2602002|P3|STARTED|Overall Study||31
1073546|NCT00941304|2602003|P2|STARTED|Overall Study||30
1073547|NCT00941304|2602004|P1|STARTED|Overall Study||31
1073554|NCT00941603|2602083|P6|NOT COMPLETED|Overall Study||3
1073555|NCT00941603|2602084|P5|NOT COMPLETED|Overall Study||4
1073556|NCT00941603|2602085|P4|NOT COMPLETED|Overall Study||4
1073557|NCT00941603|2602086|P3|NOT COMPLETED|Overall Study||5
1073558|NCT00941603|2602087|P2|NOT COMPLETED|Overall Study||16
1073559|NCT00941603|2602088|P1|NOT COMPLETED|Overall Study||11
1073560|NCT00941603|2602083|P6|COMPLETED|Overall Study||94
1073561|NCT00941603|2602084|P5|COMPLETED|Overall Study||101
1073562|NCT00941603|2602085|P4|COMPLETED|Overall Study||100
1073563|NCT00941603|2602086|P3|COMPLETED|Overall Study||99
1073564|NCT00941603|2602087|P2|COMPLETED|Overall Study||89
1073565|NCT00941603|2602088|P1|COMPLETED|Overall Study||93
1073566|NCT00941603|2602083|P6|STARTED|Overall Study||97
1073567|NCT00941603|2602084|P5|STARTED|Overall Study||105
1073568|NCT00941603|2602085|P4|STARTED|Overall Study||104
1073569|NCT00941603|2602086|P3|STARTED|Overall Study||104
1073570|NCT00941603|2602087|P2|STARTED|Overall Study||105
1073571|NCT00941603|2602088|P1|STARTED|Overall Study||104
1073572|NCT00941655|2602110|P2|NOT COMPLETED|Overall Study||5
1073573|NCT00941655|2602111|P1|NOT COMPLETED|Overall Study||5
1073574|NCT00941655|2602110|P2|COMPLETED|Overall Study||2
1073575|NCT00941655|2602111|P1|COMPLETED|Overall Study||3
1073576|NCT00941655|2602110|P2|STARTED|Overall Study||7
1073577|NCT00941655|2602111|P1|STARTED|Overall Study||8
1073578|NCT00941668|2602132|P2|NOT COMPLETED|Overall Study||25
1073579|NCT00941668|2602133|P1|NOT COMPLETED|Overall Study||24
1073580|NCT00941668|2602132|P2|COMPLETED|Overall Study||0
1073581|NCT00941668|2602133|P1|COMPLETED|Overall Study||0
1073582|NCT00941668|2602132|P2|STARTED|Overall Study||25
1073583|NCT00941668|2602133|P1|STARTED|Overall Study||24
1073584|NCT00941681|2602144|P3|NOT COMPLETED|Overall Study||0
1073585|NCT00941681|2602145|P2|NOT COMPLETED|Overall Study||1
1073586|NCT00941681|2602146|P1|NOT COMPLETED|Overall Study||0
1073587|NCT00941681|2602144|P3|COMPLETED|Overall Study||12
1073588|NCT00941681|2602145|P2|COMPLETED|Overall Study||10
1073589|NCT00941681|2602146|P1|COMPLETED|Overall Study||12
1073590|NCT00941681|2602144|P3|STARTED|Overall Study||12
1073591|NCT00941681|2602145|P2|STARTED|Overall Study||11
1073592|NCT00941681|2602146|P1|STARTED|Overall Study||12
1073593|NCT00941720|2602169|P1|NOT COMPLETED|Overall Study||14
1073594|NCT00941720|2602169|P1|COMPLETED|Overall Study||57
1073595|NCT00941720|2602169|P1|STARTED|Overall Study||71
1073596|NCT00941733|2602177|P2|NOT COMPLETED|Overall Study||28
1073597|NCT00941733|2602178|P1|NOT COMPLETED|Overall Study||74
1073598|NCT00941733|2602177|P2|COMPLETED|Overall Study|1 year follow-up|91
1073599|NCT00941733|2602178|P1|COMPLETED|Overall Study|1 year follow-up|165
1073600|NCT00941733|2602177|P2|STARTED|Overall Study||119
1073601|NCT00941733|2602178|P1|STARTED|Overall Study||239
1073602|NCT00941798|2602220|P2|NOT COMPLETED|Overall Study||185
1073603|NCT00941798|2602221|P1|NOT COMPLETED|Overall Study||194
1073604|NCT00941798|2602220|P2|COMPLETED|Overall Study||578
1073605|NCT00941798|2602221|P1|COMPLETED|Overall Study||561
1073606|NCT00941798|2602220|P2|Full Analysis Set|Overall Study||759
1073607|NCT00941798|2602221|P1|Full Analysis Set|Overall Study||749
1073608|NCT00941798|2602220|P2|STARTED|Overall Study||763
1073609|NCT00941798|2602221|P1|STARTED|Overall Study||755
1073610|NCT00941863|2602254|P5|NOT COMPLETED|Continued After PCD||19
1073611|NCT00941863|2602255|P4|NOT COMPLETED|Continued After PCD||0
1073612|NCT00941863|2602256|P3|NOT COMPLETED|Continued After PCD||0
1073613|NCT00941863|2602257|P2|NOT COMPLETED|Continued After PCD||0
1073614|NCT00941863|2602258|P1|NOT COMPLETED|Continued After PCD||0
1073615|NCT00941863|2602254|P5|COMPLETED|Continued After PCD||6
1073616|NCT00941863|2602255|P4|COMPLETED|Continued After PCD||0
1073617|NCT00941863|2602256|P3|COMPLETED|Continued After PCD||0
1073618|NCT00941863|2602257|P2|COMPLETED|Continued After PCD||0
1073619|NCT00941863|2602258|P1|COMPLETED|Continued After PCD||0
1073620|NCT00941863|2602254|P5|STARTED|Continued After PCD|25 of 119 participants from the Expansion Phase, were still on the treatment as of 31 May 2005.|25
1073621|NCT00941863|2602255|P4|STARTED|Continued After PCD||0
1073622|NCT00941863|2602256|P3|STARTED|Continued After PCD||0
1073623|NCT00941863|2602257|P2|STARTED|Continued After PCD||0
1073624|NCT00941863|2602258|P1|STARTED|Continued After PCD||0
1073625|NCT00941863|2602254|P5|NOT COMPLETED|Until Primary Completion Date (PCD)||94
1073626|NCT00941863|2602255|P4|NOT COMPLETED|Until Primary Completion Date (PCD)||17
1073627|NCT00941863|2602256|P3|NOT COMPLETED|Until Primary Completion Date (PCD)||12
1073628|NCT00941863|2602257|P2|NOT COMPLETED|Until Primary Completion Date (PCD)||3
1073629|NCT00941863|2602258|P1|NOT COMPLETED|Until Primary Completion Date (PCD)||7
1073630|NCT00941863|2602254|P5|COMPLETED|Until Primary Completion Date (PCD)||25
1073631|NCT00941863|2602255|P4|COMPLETED|Until Primary Completion Date (PCD)||0
1073632|NCT00941863|2602256|P3|COMPLETED|Until Primary Completion Date (PCD)||0
1073633|NCT00941863|2602257|P2|COMPLETED|Until Primary Completion Date (PCD)||0
1073634|NCT00941863|2602258|P1|COMPLETED|Until Primary Completion Date (PCD)||0
1073635|NCT00941863|2602254|P5|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||94
1073636|NCT00941863|2602255|P4|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||17
1073637|NCT00941863|2602256|P3|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||12
1073638|NCT00941863|2602257|P2|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||3
1073639|NCT00941863|2602258|P1|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||7
1073640|NCT00941863|2602254|P5|STARTED|Until Primary Completion Date (PCD)||119
1073641|NCT00941863|2602255|P4|STARTED|Until Primary Completion Date (PCD)||17
1073642|NCT00941863|2602256|P3|STARTED|Until Primary Completion Date (PCD)||12
1073643|NCT00941863|2602257|P2|STARTED|Until Primary Completion Date (PCD)||3
1073644|NCT00941863|2602258|P1|STARTED|Until Primary Completion Date (PCD)||7
1073645|NCT00941889|2602285|P2|NOT COMPLETED|Overall Study||12
1073646|NCT00941889|2602286|P1|NOT COMPLETED|Overall Study||12
1073647|NCT00941889|2602285|P2|COMPLETED|Overall Study||3
1073648|NCT00941889|2602286|P1|COMPLETED|Overall Study||5
1073649|NCT00941889|2602285|P2|STARTED|Overall Study||15
1073650|NCT00941889|2602286|P1|STARTED|Overall Study||17
1073651|NCT00941928|2602292|P1|NOT COMPLETED|Overall Study||2
1073652|NCT00941928|2602292|P1|COMPLETED|Overall Study||0
1073653|NCT00941928|2602292|P1|STARTED|Overall Study||2
1073654|NCT00941993|2602296|P1|NOT COMPLETED|Overall Study||0
1073655|NCT00941993|2602296|P1|COMPLETED|Overall Study||109
1073656|NCT00941993|2602296|P1|STARTED|Overall Study||109
1073657|NCT00942084|2602304|P1|NOT COMPLETED|Overall Study||2
1073658|NCT00942084|2602304|P1|COMPLETED|Overall Study|There were 2 infant deaths. None determined to be related to study drug.|30
1073659|NCT00942084|2602304|P1|STARTED|Overall Study||32
1073660|NCT00942149|2602313|P1|NOT COMPLETED|Overall Study||0
1073661|NCT00942149|2602313|P1|COMPLETED|Overall Study||20
1073662|NCT00942149|2602313|P1|STARTED|Overall Study||20
1073663|NCT00942175|2602321|P4|NOT COMPLETED|Overall Study||2
1073664|NCT00942175|2602322|P3|NOT COMPLETED|Overall Study||2
1073665|NCT00942175|2602323|P2|NOT COMPLETED|Overall Study||4
1073666|NCT00942175|2602324|P1|NOT COMPLETED|Overall Study||2
1073667|NCT00942175|2602321|P4|COMPLETED|Overall Study||38
1073668|NCT00942175|2602322|P3|COMPLETED|Overall Study||38
1073669|NCT00942175|2602323|P2|COMPLETED|Overall Study||36
1073670|NCT00942175|2602324|P1|COMPLETED|Overall Study||38
1073671|NCT00942175|2602321|P4|STARTED|Overall Study||40
1073672|NCT00942175|2602322|P3|STARTED|Overall Study||40
1073673|NCT00942175|2602323|P2|STARTED|Overall Study||40
1073674|NCT00942175|2602324|P1|STARTED|Overall Study||40
1073675|NCT00942266|2602376|P2|NOT COMPLETED|Overall Study||15
1073676|NCT00942266|2602377|P1|NOT COMPLETED|Overall Study||43
1073677|NCT00942266|2602376|P2|COMPLETED|Overall Study||0
1073678|NCT00942266|2602377|P1|COMPLETED|Overall Study||0
1073679|NCT00942266|2602376|P2|STARTED|Overall Study||15
1073680|NCT00942266|2602377|P1|STARTED|Overall Study||43
1073681|NCT00942409|2602395|P1|NOT COMPLETED|Overall Study||3
1073682|NCT00942409|2602395|P1|COMPLETED|Overall Study||2
1073683|NCT00942409|2602395|P1|STARTED|Overall Study||5
1073684|NCT00942422|2602399|P1|NOT COMPLETED|Overall Study||3
1073685|NCT00942422|2602399|P1|COMPLETED|Overall Study||5
1073686|NCT00942422|2602399|P1|STARTED|Overall Study||8
1073687|NCT00942448|2602407|P4|NOT COMPLETED|Overall Study||0
1073688|NCT00942448|2602408|P3|NOT COMPLETED|Overall Study||0
1073689|NCT00942448|2602409|P2|NOT COMPLETED|Overall Study||0
1073690|NCT00942448|2602410|P1|NOT COMPLETED|Overall Study||0
1073691|NCT00942448|2602407|P4|COMPLETED|Overall Study||75
1073692|NCT00942448|2602408|P3|COMPLETED|Overall Study||78
1073693|NCT00942448|2602409|P2|COMPLETED|Overall Study||76
1073694|NCT00942448|2602410|P1|COMPLETED|Overall Study||77
1073695|NCT00942448|2602407|P4|STARTED|Overall Study||75
1073696|NCT00942448|2602408|P3|STARTED|Overall Study||78
1073697|NCT00942448|2602409|P2|STARTED|Overall Study||76
1073698|NCT00942448|2602410|P1|STARTED|Overall Study||77
1073699|NCT00942604|2602474|P2|NOT COMPLETED|Overall Study||4
1073700|NCT00942604|2602475|P1|NOT COMPLETED|Overall Study||2
1073701|NCT00942604|2602474|P2|COMPLETED|Overall Study||99
1073702|NCT00942604|2602475|P1|COMPLETED|Overall Study||98
1073703|NCT00942604|2602474|P2|STARTED|Overall Study||103
1073704|NCT00942604|2602475|P1|STARTED|Overall Study||100
1073705|NCT00942734|2602483|P1|NOT COMPLETED|Overall Study||8
1073706|NCT00942734|2602483|P1|COMPLETED|Overall Study||35
1073707|NCT00942734|2602483|P1|STARTED|Overall Study||43
1073708|NCT00942786|2602487|P1|NOT COMPLETED|Overall Study||0
1073709|NCT00942786|2602487|P1|COMPLETED|Overall Study|date of last follow-up|297
1073710|NCT00942786|2602487|P1|STARTED|Overall Study||297
1073711|NCT00942825|2602496|P2|NOT COMPLETED|Overall Study||0
1073712|NCT00942825|2602497|P1|NOT COMPLETED|Overall Study||0
1073713|NCT00942825|2602496|P2|COMPLETED|Overall Study||98
1073714|NCT00942825|2602497|P1|COMPLETED|Overall Study||97
1073715|NCT00942825|2602496|P2|STARTED|Overall Study||98
1073716|NCT00942825|2602497|P1|STARTED|Overall Study||97
1073717|NCT00942851|2602505|P2|NOT COMPLETED|Overall Study||1
1073718|NCT00942851|2602506|P1|NOT COMPLETED|Overall Study||0
1073719|NCT00942851|2602505|P2|COMPLETED|Overall Study||11
1073720|NCT00942851|2602506|P1|COMPLETED|Overall Study||12
1073721|NCT00942851|2602505|P2|STARTED|Overall Study||12
1073722|NCT00942851|2602506|P1|STARTED|Overall Study||12
1073723|NCT00942903|2602516|P1|NOT COMPLETED|Overall Study||0
1073724|NCT00942903|2602516|P1|COMPLETED|Overall Study||20
1073725|NCT00942903|2602516|P1|STARTED|Overall Study||20
1073726|NCT00942968|2602521|P1|NOT COMPLETED|Overall Study||229
1073727|NCT00942968|2602521|P1|COMPLETED|Overall Study||109
1073728|NCT00942968|2602521|P1|Treated|Overall Study||334
1073729|NCT00942968|2602521|P1|STARTED|Overall Study||338
1073730|NCT00942994|2602544|P2|NOT COMPLETED|Overall Study||19
1073731|NCT00942994|2602545|P1|NOT COMPLETED|Overall Study||16
1073732|NCT00942994|2602544|P2|COMPLETED|Overall Study||190
1073733|NCT00942994|2602545|P1|COMPLETED|Overall Study||187
1073734|NCT00942994|2602544|P2|STARTED|Overall Study||209
1073735|NCT00942994|2602545|P1|STARTED|Overall Study||203
1073736|NCT00943072|2602563|P2|NOT COMPLETED|Overall Study||14
1073737|NCT00943072|2602564|P1|NOT COMPLETED|Overall Study||5
1073738|NCT00943072|2602563|P2|COMPLETED|Overall Study|60 Participants completed Week 24, From FAS; 50 Participants completed up to Week 100, From SAF|60
1073739|NCT00943072|2602564|P1|COMPLETED|Overall Study|110 Participants completed Week 24, From FAS; 102 Participants completed up to Week 100, From SAF|110
1073740|NCT00943072|2602563|P2|Full Analysis Set (FAS) Population|Overall Study||73
1073741|NCT00943072|2602564|P1|Full Analysis Set (FAS) Population|Overall Study|FAS population used for analysis of Primary and Secondary Outcome Measures|114
1073742|NCT00943072|2602563|P2|Participants Received Treatment|Overall Study||74
1073743|NCT00943072|2602564|P1|Participants Received Treatment|Overall Study|Safety population (SAF)|114
1073744|NCT00943072|2602563|P2|STARTED|Overall Study||74
1073745|NCT00943072|2602564|P1|STARTED|Overall Study||115
1073746|NCT00943098|2602582|P2|NOT COMPLETED|Overall Study||0
1073747|NCT00943098|2602583|P1|NOT COMPLETED|Overall Study||0
1073748|NCT00943098|2602582|P2|COMPLETED|Overall Study||72
1073749|NCT00943098|2602583|P1|COMPLETED|Overall Study||70
1073750|NCT00943098|2602582|P2|STARTED|Overall Study|1 patient was excluded from the ITT and therefore the baseline population is 71|72
1073751|NCT00943098|2602583|P1|STARTED|Overall Study||70
1073752|NCT00943111|2602617|P3|NOT COMPLETED|5 Years Long-term Treatment Period||75
1073753|NCT00943111|2602618|P2|NOT COMPLETED|5 Years Long-term Treatment Period||0
1073754|NCT00943111|2602619|P1|NOT COMPLETED|5 Years Long-term Treatment Period||0
1073755|NCT00943111|2602617|P3|COMPLETED|5 Years Long-term Treatment Period||77
1073756|NCT00943111|2602618|P2|COMPLETED|5 Years Long-term Treatment Period||0
1073757|NCT00943111|2602619|P1|COMPLETED|5 Years Long-term Treatment Period||0
1073758|NCT00943111|2602617|P3|STARTED|5 Years Long-term Treatment Period|Participants from both the arms of PAP who completed PAP and remained on-study|152
1073759|NCT00943111|2602618|P2|STARTED|5 Years Long-term Treatment Period||0
1073760|NCT00943111|2602619|P1|STARTED|5 Years Long-term Treatment Period||0
1073761|NCT00943111|2602617|P3|NOT COMPLETED|52-Weeks Primary Analysis Period||0
1073762|NCT00943111|2602618|P2|NOT COMPLETED|52-Weeks Primary Analysis Period||2
1073763|NCT00943111|2602619|P1|NOT COMPLETED|52-Weeks Primary Analysis Period||2
1073764|NCT00943111|2602617|P3|COMPLETED|52-Weeks Primary Analysis Period||0
1073765|NCT00943111|2602618|P2|COMPLETED|52-Weeks Primary Analysis Period||52
1073766|NCT00943111|2602619|P1|COMPLETED|52-Weeks Primary Analysis Period||104
1073767|NCT00943111|2602617|P3|Treated|52-Weeks Primary Analysis Period||0
1073768|NCT00943111|2602618|P2|Treated|52-Weeks Primary Analysis Period||53
1073769|NCT00943111|2602619|P1|Treated|52-Weeks Primary Analysis Period||106
1073770|NCT00943111|2602617|P3|STARTED|52-Weeks Primary Analysis Period||0
1073771|NCT00943111|2602618|P2|STARTED|52-Weeks Primary Analysis Period||54
1073772|NCT00943111|2602619|P1|STARTED|52-Weeks Primary Analysis Period||106
1073773|NCT00943124|2602650|P2|NOT COMPLETED|Period 2||0
1073774|NCT00943124|2602651|P1|NOT COMPLETED|Period 2||0
1073775|NCT00943124|2602650|P2|COMPLETED|Period 2||108
1073776|NCT00943124|2602651|P1|COMPLETED|Period 2||108
1073777|NCT00943124|2602650|P2|STARTED|Period 2||108
1073778|NCT00943124|2602651|P1|STARTED|Period 2||108
1073779|NCT00943124|2602650|P2|NOT COMPLETED|Period 1||2
1073780|NCT00943124|2602651|P1|NOT COMPLETED|Period 1||2
1073781|NCT00943124|2602650|P2|COMPLETED|Period 1||108
1073782|NCT00943124|2602651|P1|COMPLETED|Period 1||108
1073783|NCT00943124|2602650|P2|STARTED|Period 1||110
1073784|NCT00943124|2602651|P1|STARTED|Period 1||110
1073785|NCT00943150|2602673|P2|NOT COMPLETED|Overall Study||0
1073786|NCT00943150|2602674|P1|NOT COMPLETED|Overall Study||0
1073787|NCT00943150|2602673|P2|COMPLETED|Overall Study||10
1073788|NCT00943150|2602674|P1|COMPLETED|Overall Study||10
1073789|NCT00943150|2602673|P2|STARTED|Overall Study||10
1073790|NCT00943150|2602674|P1|STARTED|Overall Study||10
1073791|NCT00943202|2602699|P4|NOT COMPLETED|Overall Study||1
1073792|NCT00943202|2602700|P3|NOT COMPLETED|Overall Study||0
1073793|NCT00943202|2602701|P2|NOT COMPLETED|Overall Study||2
1073794|NCT00943202|2602702|P1|NOT COMPLETED|Overall Study||1
1073795|NCT00943202|2602699|P4|COMPLETED|Overall Study||131
1073796|NCT00943202|2602700|P3|COMPLETED|Overall Study||133
1073797|NCT00943202|2602701|P2|COMPLETED|Overall Study||131
1073798|NCT00943202|2602702|P1|COMPLETED|Overall Study||132
1073799|NCT00943202|2602699|P4|STARTED|Overall Study||132
1073800|NCT00943202|2602700|P3|STARTED|Overall Study||133
1073801|NCT00943202|2602701|P2|STARTED|Overall Study||133
1073802|NCT00943202|2602702|P1|STARTED|Overall Study||133
1073803|NCT00935064|2602918|P2|NOT COMPLETED|Overall Study||0
1073804|NCT00935064|2602919|P1|NOT COMPLETED|Overall Study||0
1073805|NCT00935064|2602918|P2|COMPLETED|Overall Study||30
1073806|NCT00935064|2602919|P1|COMPLETED|Overall Study||30
1073807|NCT00935064|2602918|P2|STARTED|Overall Study||30
1073808|NCT00935064|2602919|P1|STARTED|Overall Study||30
1073809|NCT00935220|2602933|P1|NOT COMPLETED|Overall Study||2
1073810|NCT00935220|2602933|P1|COMPLETED|Overall Study||39
1073811|NCT00935220|2602933|P1|STARTED|Overall Study||41
1073812|NCT00935259|2602945|P2|NOT COMPLETED|Period 2||0
1073813|NCT00935259|2602946|P1|NOT COMPLETED|Period 2||0
1073814|NCT00935259|2602945|P2|COMPLETED|Period 2||14
1073815|NCT00935259|2602946|P1|COMPLETED|Period 2||15
1073816|NCT00935259|2602945|P2|STARTED|Period 2||14
1073817|NCT00935259|2602946|P1|STARTED|Period 2||15
1073818|NCT00935259|2602945|P2|NOT COMPLETED|Period 1||1
1073819|NCT00935259|2602946|P1|NOT COMPLETED|Period 1||1
1073820|NCT00935259|2602945|P2|COMPLETED|Period 1||14
1073821|NCT00935259|2602946|P1|COMPLETED|Period 1||15
1073822|NCT00935259|2602945|P2|STARTED|Period 1||15
1073823|NCT00935259|2602946|P1|STARTED|Period 1||16
1073824|NCT00935272|2602962|P2|NOT COMPLETED|Overall Study||6
1073825|NCT00935272|2602963|P1|NOT COMPLETED|Overall Study||19
1073826|NCT00935272|2602962|P2|COMPLETED|Overall Study||39
1073827|NCT00935272|2602963|P1|COMPLETED|Overall Study||116
1073828|NCT00935272|2602962|P2|STARTED|Overall Study||45
1073829|NCT00935272|2602963|P1|STARTED|Overall Study||135
1073830|NCT00935311|2602975|P3|NOT COMPLETED|Overall Study||0
1073831|NCT00935311|2602976|P2|NOT COMPLETED|Overall Study||0
1073832|NCT00935311|2602977|P1|NOT COMPLETED|Overall Study||0
1073833|NCT00935311|2602975|P3|COMPLETED|Overall Study||40
1073834|NCT00935311|2602976|P2|COMPLETED|Overall Study||39
1073835|NCT00935311|2602977|P1|COMPLETED|Overall Study||43
1073836|NCT00935311|2602975|P3|STARTED|Overall Study||40
1073837|NCT00935311|2602976|P2|STARTED|Overall Study||39
1073838|NCT00935311|2602977|P1|STARTED|Overall Study||43
1073839|NCT00943384|2602994|P1|NOT COMPLETED|Overall Study||49
1073840|NCT00943384|2602994|P1|COMPLETED|Overall Study|evaluated at the Month 24 visit with complete or partial data|55
1073841|NCT00943384|2602994|P1|Treated on Protocol|Overall Study|5 subjects were treated off protocol due to intraoperative decisions made by the surgeon|76
1073842|NCT00943384|2602994|P1|Treated|Overall Study|81 subjects were eligible and willing to participate in the study and were treated|81
1073843|NCT00943384|2602994|P1|STARTED|Overall Study|104 subjects consented and underwent additional screening to determine eligibility to participate|104
1073844|NCT00943397|2603010|P2|NOT COMPLETED|Overall Study||72
1073845|NCT00943397|2603011|P1|NOT COMPLETED|Overall Study||15
1073846|NCT00943397|2603010|P2|COMPLETED|Overall Study|Site terminated - Merck administrative decision (52); Patient moved (1); Discontinued for other (3)|86
1073847|NCT00943397|2603011|P1|COMPLETED|Overall Study|Site terminated - Merck administrative decision (11); Discontinued for other (1)|17
1073848|NCT00943397|2603010|P2|STARTED|Overall Study||158
1073849|NCT00943397|2603011|P1|STARTED|Overall Study||32
1073850|NCT00943436|2603019|P2|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
1073851|NCT00943436|2603020|P1|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
1073852|NCT00943436|2603019|P2|COMPLETED|Rest Session: 45 Minutes of Reading||10
1073853|NCT00943436|2603020|P1|COMPLETED|Rest Session: 45 Minutes of Reading||10
1073854|NCT00943436|2603019|P2|STARTED|Rest Session: 45 Minutes of Reading||10
1073855|NCT00943436|2603020|P1|STARTED|Rest Session: 45 Minutes of Reading||10
1073856|NCT00943436|2603019|P2|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
1073857|NCT00943436|2603020|P1|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
1073858|NCT00943436|2603019|P2|COMPLETED|Exercise Session: 45 Minutes of Activity||10
1073859|NCT00943436|2603020|P1|COMPLETED|Exercise Session: 45 Minutes of Activity||10
1073860|NCT00943436|2603019|P2|STARTED|Exercise Session: 45 Minutes of Activity||10
1073861|NCT00943436|2603020|P1|STARTED|Exercise Session: 45 Minutes of Activity||10
1073862|NCT00943488|2603042|P2|NOT COMPLETED|Overall Study||2
1073863|NCT00943488|2603043|P1|NOT COMPLETED|Overall Study||1
1073864|NCT00943488|2603042|P2|COMPLETED|Overall Study||202
1073865|NCT00943488|2603043|P1|COMPLETED|Overall Study||203
1073866|NCT00943488|2603042|P2|STARTED|Overall Study||204
1073867|NCT00943488|2603043|P1|STARTED|Overall Study||204
1073868|NCT00943579|2603099|P2|NOT COMPLETED|Overall Study||5
1073869|NCT00943579|2603100|P1|NOT COMPLETED|Overall Study||6
1073870|NCT00943579|2603099|P2|COMPLETED|Overall Study||15
1073871|NCT00943579|2603100|P1|COMPLETED|Overall Study||15
1073872|NCT00943579|2603099|P2|STARTED|Overall Study||20
1073873|NCT00943579|2603100|P1|STARTED|Overall Study||21
1073874|NCT00943592|2603112|P1|NOT COMPLETED|Overall Study||3
1073875|NCT00943592|2603112|P1|COMPLETED|Overall Study|None of the three deaths were attributed to the conditioning regimen|79
1073876|NCT00943592|2603112|P1|Maximum Tolerated Dose|Overall Study|74 patients received the Maximum Tolerated Dose|74
1073877|NCT00943592|2603112|P1|STARTED|Overall Study||82
1073878|NCT00943605|2603125|P2|NOT COMPLETED|Overall Study||30
1073879|NCT00943605|2603126|P1|NOT COMPLETED|Overall Study||30
1073880|NCT00943605|2603125|P2|COMPLETED|Overall Study||0
1073881|NCT00943605|2603126|P1|COMPLETED|Overall Study||0
1073882|NCT00943605|2603125|P2|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
1073883|NCT00943605|2603126|P1|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
1073884|NCT00943631|2603138|P2|NOT COMPLETED|Overall Study||2
1073885|NCT00943631|2603139|P1|NOT COMPLETED|Overall Study||4
1073886|NCT00943631|2603138|P2|COMPLETED|Overall Study||202
1073887|NCT00943631|2603139|P1|COMPLETED|Overall Study||198
1073888|NCT00943631|2603138|P2|STARTED|Overall Study||204
1073889|NCT00943631|2603139|P1|STARTED|Overall Study||202
1073890|NCT00943670|2603189|P1|NOT COMPLETED|Trastuzumab Emtansine + Pertuzumab||18
1073891|NCT00943670|2603189|P1|COMPLETED|Trastuzumab Emtansine + Pertuzumab|Completed treatment defined as receiving a total of 17 cycles of therapy in both treatment periods.|2
1073892|NCT00943670|2603189|P1|STARTED|Trastuzumab Emtansine + Pertuzumab|Patients with early progressive disease who elected to receive T-DM1 and pertuzumab.|20
1073893|NCT00943670|2603189|P1|NOT COMPLETED|Single-agent Trastuzumab Emtansine||42
1073894|NCT00943670|2603189|P1|COMPLETED|Single-agent Trastuzumab Emtansine|Completed single-agent treatment defined as receiving 17 cycles of trastuzumab emtansine therapy.|9
1073895|NCT00943670|2603189|P1|Treated|Single-agent Trastuzumab Emtansine||51
1073896|NCT00943670|2603189|P1|STARTED|Single-agent Trastuzumab Emtansine||51
1073897|NCT00943761|2603225|P2|NOT COMPLETED|Overall Study||1
1073898|NCT00943761|2603226|P1|NOT COMPLETED|Overall Study||4
1073899|NCT00943761|2603225|P2|COMPLETED|Overall Study||23
1073900|NCT00943761|2603226|P1|COMPLETED|Overall Study||17
1073901|NCT00943761|2603225|P2|STARTED|Overall Study||24
1073902|NCT00943761|2603226|P1|STARTED|Overall Study||21
1073903|NCT00943787|2603238|P1|NOT COMPLETED|Overall Study||7
1073904|NCT00943787|2603238|P1|COMPLETED|Overall Study||34
1073905|NCT00943787|2603238|P1|STARTED|Overall Study||41
1073906|NCT00943826|2603245|P2|NOT COMPLETED|After Primary Overall Survival Analysis||20
1073907|NCT00943826|2603246|P1|NOT COMPLETED|After Primary Overall Survival Analysis||27
1073908|NCT00943826|2603245|P2|COMPLETED|After Primary Overall Survival Analysis||0
1073909|NCT00943826|2603246|P1|COMPLETED|After Primary Overall Survival Analysis||0
1073910|NCT00943826|2603245|P2|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|20
1073911|NCT00943826|2603246|P1|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|27
1073912|NCT00943826|2603245|P2|NOT COMPLETED|Monotherapy Phase||16
1073913|NCT00943826|2603246|P1|NOT COMPLETED|Monotherapy Phase||65
1073914|NCT00943826|2603245|P2|COMPLETED|Monotherapy Phase||143
1073915|NCT00943826|2603246|P1|COMPLETED|Monotherapy Phase||204
1073916|NCT00943826|2603245|P2|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|159
1073917|NCT00943826|2603246|P1|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|269
1073918|NCT00943826|2603245|P2|NOT COMPLETED|Maintenance Phase||39
1073919|NCT00943826|2603246|P1|NOT COMPLETED|Maintenance Phase||43
1073920|NCT00943826|2603245|P2|COMPLETED|Maintenance Phase||331
1073921|NCT00943826|2603246|P1|COMPLETED|Maintenance Phase||353
1073922|NCT00943826|2603245|P2|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|370
1073923|NCT00943826|2603246|P1|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|396
1073924|NCT00943826|2603245|P2|NOT COMPLETED|Concurrent Phase||42
1073925|NCT00943826|2603246|P1|NOT COMPLETED|Concurrent Phase||61
1073926|NCT00943826|2603245|P2|COMPLETED|Concurrent Phase||421
1073927|NCT00943826|2603246|P1|COMPLETED|Concurrent Phase||397
1073928|NCT00943826|2603245|P2|Treated|Concurrent Phase||459
1073929|NCT00943826|2603246|P1|Treated|Concurrent Phase||452
1073930|NCT00943826|2603245|P2|STARTED|Concurrent Phase||463
1073931|NCT00943826|2603246|P1|STARTED|Concurrent Phase||458
1073932|NCT00943852|2603264|P10|NOT COMPLETED|Fifth Period of Treatment Intervention||0
1073933|NCT00943852|2603265|P9|NOT COMPLETED|Fifth Period of Treatment Intervention||0
1073934|NCT00943852|2603266|P8|NOT COMPLETED|Fifth Period of Treatment Intervention||0
1073935|NCT00943852|2603267|P7|NOT COMPLETED|Fifth Period of Treatment Intervention||0
1073936|NCT00943852|2603268|P6|NOT COMPLETED|Fifth Period of Treatment Intervention||0
1073937|NCT00943852|2603269|P5|NOT COMPLETED|Fifth Period of Treatment Intervention||0
1073938|NCT00943852|2603270|P4|NOT COMPLETED|Fifth Period of Treatment Intervention||0
1073939|NCT00943852|2603271|P3|NOT COMPLETED|Fifth Period of Treatment Intervention||0
1073940|NCT00943852|2603272|P2|NOT COMPLETED|Fifth Period of Treatment Intervention||0
1073941|NCT00943852|2603273|P1|NOT COMPLETED|Fifth Period of Treatment Intervention||0
1073942|NCT00943852|2603264|P10|COMPLETED|Fifth Period of Treatment Intervention||1
1073943|NCT00943852|2603265|P9|COMPLETED|Fifth Period of Treatment Intervention||1
1073944|NCT00943852|2603266|P8|COMPLETED|Fifth Period of Treatment Intervention||0
1073945|NCT00943852|2603267|P7|COMPLETED|Fifth Period of Treatment Intervention||0
1073946|NCT00943852|2603268|P6|COMPLETED|Fifth Period of Treatment Intervention||0
1073947|NCT00943852|2603269|P5|COMPLETED|Fifth Period of Treatment Intervention||1
1073948|NCT00943852|2603270|P4|COMPLETED|Fifth Period of Treatment Intervention||0
1073949|NCT00943852|2603271|P3|COMPLETED|Fifth Period of Treatment Intervention||0
1073950|NCT00943852|2603272|P2|COMPLETED|Fifth Period of Treatment Intervention||1
1073951|NCT00943852|2603273|P1|COMPLETED|Fifth Period of Treatment Intervention||1
1073952|NCT00943852|2603264|P10|STARTED|Fifth Period of Treatment Intervention||1
1073953|NCT00943852|2603265|P9|STARTED|Fifth Period of Treatment Intervention||1
1073954|NCT00943852|2603266|P8|STARTED|Fifth Period of Treatment Intervention||0
1073955|NCT00943852|2603267|P7|STARTED|Fifth Period of Treatment Intervention||0
1073956|NCT00943852|2603268|P6|STARTED|Fifth Period of Treatment Intervention||0
1073957|NCT00943852|2603269|P5|STARTED|Fifth Period of Treatment Intervention||1
1073958|NCT00943852|2603270|P4|STARTED|Fifth Period of Treatment Intervention||0
1073959|NCT00943852|2603271|P3|STARTED|Fifth Period of Treatment Intervention||0
1073960|NCT00943852|2603272|P2|STARTED|Fifth Period of Treatment Intervention||1
1073961|NCT00943852|2603273|P1|STARTED|Fifth Period of Treatment Intervention||1
1073962|NCT00943852|2603264|P10|NOT COMPLETED|Washout Period After Period 4 Treatment||0
1073963|NCT00943852|2603265|P9|NOT COMPLETED|Washout Period After Period 4 Treatment||0
1073964|NCT00943852|2603266|P8|NOT COMPLETED|Washout Period After Period 4 Treatment||1
1073965|NCT00943852|2603267|P7|NOT COMPLETED|Washout Period After Period 4 Treatment||1
1073966|NCT00943852|2603268|P6|NOT COMPLETED|Washout Period After Period 4 Treatment||0
1073967|NCT00943852|2603269|P5|NOT COMPLETED|Washout Period After Period 4 Treatment||0
1073968|NCT00943852|2603270|P4|NOT COMPLETED|Washout Period After Period 4 Treatment||1
1073969|NCT00943852|2603271|P3|NOT COMPLETED|Washout Period After Period 4 Treatment||1
1073970|NCT00943852|2603272|P2|NOT COMPLETED|Washout Period After Period 4 Treatment||0
1073971|NCT00943852|2603273|P1|NOT COMPLETED|Washout Period After Period 4 Treatment||1
1073972|NCT00943852|2603264|P10|COMPLETED|Washout Period After Period 4 Treatment||1
1073973|NCT00943852|2603265|P9|COMPLETED|Washout Period After Period 4 Treatment||1
1073974|NCT00943852|2603266|P8|COMPLETED|Washout Period After Period 4 Treatment||0
1073975|NCT00943852|2603267|P7|COMPLETED|Washout Period After Period 4 Treatment||0
1073976|NCT00943852|2603268|P6|COMPLETED|Washout Period After Period 4 Treatment||0
1073977|NCT00943852|2603269|P5|COMPLETED|Washout Period After Period 4 Treatment||1
1073978|NCT00943852|2603270|P4|COMPLETED|Washout Period After Period 4 Treatment||0
1073979|NCT00943852|2603271|P3|COMPLETED|Washout Period After Period 4 Treatment||0
1073980|NCT00943852|2603272|P2|COMPLETED|Washout Period After Period 4 Treatment||1
1073981|NCT00943852|2603273|P1|COMPLETED|Washout Period After Period 4 Treatment||1
1073982|NCT00943852|2603264|P10|STARTED|Washout Period After Period 4 Treatment||1
1073983|NCT00943852|2603265|P9|STARTED|Washout Period After Period 4 Treatment||1
1073984|NCT00943852|2603266|P8|STARTED|Washout Period After Period 4 Treatment||1
1073985|NCT00943852|2603267|P7|STARTED|Washout Period After Period 4 Treatment||1
1073986|NCT00943852|2603268|P6|STARTED|Washout Period After Period 4 Treatment||0
1073987|NCT00943852|2603269|P5|STARTED|Washout Period After Period 4 Treatment||1
1073988|NCT00943852|2603270|P4|STARTED|Washout Period After Period 4 Treatment||1
1073989|NCT00943852|2603271|P3|STARTED|Washout Period After Period 4 Treatment||1
1073990|NCT00943852|2603272|P2|STARTED|Washout Period After Period 4 Treatment||1
1073991|NCT00943852|2603273|P1|STARTED|Washout Period After Period 4 Treatment||2
1073992|NCT00943852|2603264|P10|NOT COMPLETED|Fourth Period of Treatment Intervention||0
1073993|NCT00943852|2603265|P9|NOT COMPLETED|Fourth Period of Treatment Intervention||0
1073994|NCT00943852|2603266|P8|NOT COMPLETED|Fourth Period of Treatment Intervention||0
1073995|NCT00943852|2603267|P7|NOT COMPLETED|Fourth Period of Treatment Intervention||0
1073996|NCT00943852|2603268|P6|NOT COMPLETED|Fourth Period of Treatment Intervention||0
1073997|NCT00943852|2603269|P5|NOT COMPLETED|Fourth Period of Treatment Intervention||0
1073998|NCT00943852|2603270|P4|NOT COMPLETED|Fourth Period of Treatment Intervention||0
1073999|NCT00943852|2603271|P3|NOT COMPLETED|Fourth Period of Treatment Intervention||0
1074000|NCT00943852|2603272|P2|NOT COMPLETED|Fourth Period of Treatment Intervention||0
1074001|NCT00943852|2603273|P1|NOT COMPLETED|Fourth Period of Treatment Intervention||0
1074002|NCT00943852|2603264|P10|COMPLETED|Fourth Period of Treatment Intervention||1
1074003|NCT00943852|2603265|P9|COMPLETED|Fourth Period of Treatment Intervention||1
1074004|NCT00943852|2603266|P8|COMPLETED|Fourth Period of Treatment Intervention||1
1074005|NCT00943852|2603267|P7|COMPLETED|Fourth Period of Treatment Intervention||1
1074006|NCT00943852|2603268|P6|COMPLETED|Fourth Period of Treatment Intervention||0
1074007|NCT00943852|2603269|P5|COMPLETED|Fourth Period of Treatment Intervention||1
1074008|NCT00943852|2603270|P4|COMPLETED|Fourth Period of Treatment Intervention||1
1074009|NCT00943852|2603271|P3|COMPLETED|Fourth Period of Treatment Intervention||1
1074010|NCT00943852|2603272|P2|COMPLETED|Fourth Period of Treatment Intervention||1
1074011|NCT00943852|2603273|P1|COMPLETED|Fourth Period of Treatment Intervention||2
1074012|NCT00943852|2603264|P10|STARTED|Fourth Period of Treatment Intervention||1
1074013|NCT00943852|2603265|P9|STARTED|Fourth Period of Treatment Intervention||1
1074014|NCT00943852|2603266|P8|STARTED|Fourth Period of Treatment Intervention||1
1074015|NCT00943852|2603267|P7|STARTED|Fourth Period of Treatment Intervention||1
1074016|NCT00943852|2603268|P6|STARTED|Fourth Period of Treatment Intervention||0
1074017|NCT00943852|2603269|P5|STARTED|Fourth Period of Treatment Intervention||1
1074018|NCT00943852|2603270|P4|STARTED|Fourth Period of Treatment Intervention||1
1074019|NCT00943852|2603271|P3|STARTED|Fourth Period of Treatment Intervention||1
1074020|NCT00943852|2603272|P2|STARTED|Fourth Period of Treatment Intervention||1
1074021|NCT00943852|2603273|P1|STARTED|Fourth Period of Treatment Intervention||2
1074022|NCT00943852|2603264|P10|NOT COMPLETED|Washout Period After Period 3 Treatment||0
1074023|NCT00943852|2603265|P9|NOT COMPLETED|Washout Period After Period 3 Treatment||0
1074024|NCT00943852|2603266|P8|NOT COMPLETED|Washout Period After Period 3 Treatment||0
1074025|NCT00943852|2603267|P7|NOT COMPLETED|Washout Period After Period 3 Treatment||1
1074026|NCT00943852|2603268|P6|NOT COMPLETED|Washout Period After Period 3 Treatment||0
1074027|NCT00943852|2603269|P5|NOT COMPLETED|Washout Period After Period 3 Treatment||0
1074028|NCT00943852|2603270|P4|NOT COMPLETED|Washout Period After Period 3 Treatment||0
1074029|NCT00943852|2603271|P3|NOT COMPLETED|Washout Period After Period 3 Treatment||0
1074030|NCT00943852|2603272|P2|NOT COMPLETED|Washout Period After Period 3 Treatment||0
1074031|NCT00943852|2603273|P1|NOT COMPLETED|Washout Period After Period 3 Treatment||0
1074032|NCT00943852|2603264|P10|COMPLETED|Washout Period After Period 3 Treatment||1
1074033|NCT00943852|2603265|P9|COMPLETED|Washout Period After Period 3 Treatment||1
1074034|NCT00943852|2603266|P8|COMPLETED|Washout Period After Period 3 Treatment||1
1074035|NCT00943852|2603267|P7|COMPLETED|Washout Period After Period 3 Treatment||1
1074036|NCT00943852|2603268|P6|COMPLETED|Washout Period After Period 3 Treatment||0
1074037|NCT00943852|2603269|P5|COMPLETED|Washout Period After Period 3 Treatment||1
1074038|NCT00943852|2603270|P4|COMPLETED|Washout Period After Period 3 Treatment||1
1074039|NCT00943852|2603271|P3|COMPLETED|Washout Period After Period 3 Treatment||1
1074040|NCT00943852|2603272|P2|COMPLETED|Washout Period After Period 3 Treatment||1
1074041|NCT00943852|2603273|P1|COMPLETED|Washout Period After Period 3 Treatment||2
1074042|NCT00943852|2603264|P10|STARTED|Washout Period After Period 3 Treatment||1
1074043|NCT00943852|2603265|P9|STARTED|Washout Period After Period 3 Treatment||1
1074044|NCT00943852|2603266|P8|STARTED|Washout Period After Period 3 Treatment||1
1074045|NCT00943852|2603267|P7|STARTED|Washout Period After Period 3 Treatment||2
1074046|NCT00943852|2603268|P6|STARTED|Washout Period After Period 3 Treatment||0
1074047|NCT00943852|2603269|P5|STARTED|Washout Period After Period 3 Treatment||1
1074048|NCT00943852|2603270|P4|STARTED|Washout Period After Period 3 Treatment||1
1074049|NCT00943852|2603271|P3|STARTED|Washout Period After Period 3 Treatment||1
1074050|NCT00943852|2603272|P2|STARTED|Washout Period After Period 3 Treatment||1
1074051|NCT00943852|2603273|P1|STARTED|Washout Period After Period 3 Treatment||2
1074052|NCT00943852|2603264|P10|NOT COMPLETED|Third Period of Treatment Intervention||0
1074053|NCT00943852|2603265|P9|NOT COMPLETED|Third Period of Treatment Intervention||0
1074054|NCT00943852|2603266|P8|NOT COMPLETED|Third Period of Treatment Intervention||0
1074055|NCT00943852|2603267|P7|NOT COMPLETED|Third Period of Treatment Intervention||0
1074056|NCT00943852|2603268|P6|NOT COMPLETED|Third Period of Treatment Intervention||0
1074057|NCT00943852|2603269|P5|NOT COMPLETED|Third Period of Treatment Intervention||0
1074058|NCT00943852|2603270|P4|NOT COMPLETED|Third Period of Treatment Intervention||0
1074059|NCT00943852|2603271|P3|NOT COMPLETED|Third Period of Treatment Intervention||0
1074060|NCT00943852|2603272|P2|NOT COMPLETED|Third Period of Treatment Intervention||0
1074061|NCT00943852|2603273|P1|NOT COMPLETED|Third Period of Treatment Intervention||0
1074062|NCT00943852|2603264|P10|COMPLETED|Third Period of Treatment Intervention||1
1074063|NCT00943852|2603265|P9|COMPLETED|Third Period of Treatment Intervention||1
1074064|NCT00943852|2603266|P8|COMPLETED|Third Period of Treatment Intervention||1
1074065|NCT00943852|2603267|P7|COMPLETED|Third Period of Treatment Intervention||2
1074066|NCT00943852|2603268|P6|COMPLETED|Third Period of Treatment Intervention||0
1074067|NCT00943852|2603269|P5|COMPLETED|Third Period of Treatment Intervention||1
1074068|NCT00943852|2603270|P4|COMPLETED|Third Period of Treatment Intervention||1
1074069|NCT00943852|2603271|P3|COMPLETED|Third Period of Treatment Intervention||1
1074070|NCT00943852|2603272|P2|COMPLETED|Third Period of Treatment Intervention||1
1074071|NCT00943852|2603273|P1|COMPLETED|Third Period of Treatment Intervention||2
1074072|NCT00943852|2603264|P10|STARTED|Third Period of Treatment Intervention||1
1074073|NCT00943852|2603265|P9|STARTED|Third Period of Treatment Intervention||1
1074074|NCT00943852|2603266|P8|STARTED|Third Period of Treatment Intervention||1
1074075|NCT00943852|2603267|P7|STARTED|Third Period of Treatment Intervention||2
1074076|NCT00943852|2603268|P6|STARTED|Third Period of Treatment Intervention||0
1074077|NCT00943852|2603269|P5|STARTED|Third Period of Treatment Intervention||1
1074078|NCT00943852|2603270|P4|STARTED|Third Period of Treatment Intervention||1
1074079|NCT00943852|2603271|P3|STARTED|Third Period of Treatment Intervention||1
1074080|NCT00943852|2603272|P2|STARTED|Third Period of Treatment Intervention||1
1074081|NCT00943852|2603273|P1|STARTED|Third Period of Treatment Intervention||2
1074082|NCT00943852|2603264|P10|NOT COMPLETED|Washout Period After Period 2 Treatment||0
1074083|NCT00943852|2603265|P9|NOT COMPLETED|Washout Period After Period 2 Treatment||0
1074084|NCT00943852|2603266|P8|NOT COMPLETED|Washout Period After Period 2 Treatment||0
1074085|NCT00943852|2603267|P7|NOT COMPLETED|Washout Period After Period 2 Treatment||0
1074086|NCT00943852|2603268|P6|NOT COMPLETED|Washout Period After Period 2 Treatment||1
1074087|NCT00943852|2603269|P5|NOT COMPLETED|Washout Period After Period 2 Treatment||0
1074088|NCT00943852|2603270|P4|NOT COMPLETED|Washout Period After Period 2 Treatment||0
1074089|NCT00943852|2603271|P3|NOT COMPLETED|Washout Period After Period 2 Treatment||0
1074090|NCT00943852|2603272|P2|NOT COMPLETED|Washout Period After Period 2 Treatment||0
1074091|NCT00943852|2603273|P1|NOT COMPLETED|Washout Period After Period 2 Treatment||0
1074092|NCT00943852|2603264|P10|COMPLETED|Washout Period After Period 2 Treatment||1
1074093|NCT00943852|2603265|P9|COMPLETED|Washout Period After Period 2 Treatment||1
1074094|NCT00943852|2603266|P8|COMPLETED|Washout Period After Period 2 Treatment||1
1074095|NCT00943852|2603267|P7|COMPLETED|Washout Period After Period 2 Treatment||2
1074096|NCT00943852|2603268|P6|COMPLETED|Washout Period After Period 2 Treatment||0
1074097|NCT00943852|2603269|P5|COMPLETED|Washout Period After Period 2 Treatment||1
1074098|NCT00943852|2603270|P4|COMPLETED|Washout Period After Period 2 Treatment||1
1074099|NCT00943852|2603271|P3|COMPLETED|Washout Period After Period 2 Treatment||1
1074100|NCT00943852|2603272|P2|COMPLETED|Washout Period After Period 2 Treatment||1
1074101|NCT00943852|2603273|P1|COMPLETED|Washout Period After Period 2 Treatment||2
1074102|NCT00943852|2603264|P10|STARTED|Washout Period After Period 2 Treatment||1
1074103|NCT00943852|2603265|P9|STARTED|Washout Period After Period 2 Treatment||1
1074104|NCT00943852|2603266|P8|STARTED|Washout Period After Period 2 Treatment||1
1074105|NCT00943852|2603267|P7|STARTED|Washout Period After Period 2 Treatment||2
1074106|NCT00943852|2603268|P6|STARTED|Washout Period After Period 2 Treatment||1
1074107|NCT00943852|2603269|P5|STARTED|Washout Period After Period 2 Treatment||1
1074108|NCT00943852|2603270|P4|STARTED|Washout Period After Period 2 Treatment||1
1074109|NCT00943852|2603271|P3|STARTED|Washout Period After Period 2 Treatment||1
1074110|NCT00943852|2603272|P2|STARTED|Washout Period After Period 2 Treatment||1
1074111|NCT00943852|2603273|P1|STARTED|Washout Period After Period 2 Treatment||2
1074112|NCT00943852|2603264|P10|NOT COMPLETED|Second Period of Treatment Intervention||0
1074113|NCT00943852|2603265|P9|NOT COMPLETED|Second Period of Treatment Intervention||0
1074114|NCT00943852|2603266|P8|NOT COMPLETED|Second Period of Treatment Intervention||0
1074115|NCT00943852|2603267|P7|NOT COMPLETED|Second Period of Treatment Intervention||0
1074116|NCT00943852|2603268|P6|NOT COMPLETED|Second Period of Treatment Intervention||0
1074117|NCT00943852|2603269|P5|NOT COMPLETED|Second Period of Treatment Intervention||0
1074118|NCT00943852|2603270|P4|NOT COMPLETED|Second Period of Treatment Intervention||0
1074119|NCT00943852|2603271|P3|NOT COMPLETED|Second Period of Treatment Intervention||0
1074120|NCT00943852|2603272|P2|NOT COMPLETED|Second Period of Treatment Intervention||0
1074121|NCT00943852|2603273|P1|NOT COMPLETED|Second Period of Treatment Intervention||0
1074122|NCT00943852|2603264|P10|COMPLETED|Second Period of Treatment Intervention||1
1074123|NCT00943852|2603265|P9|COMPLETED|Second Period of Treatment Intervention||1
1074124|NCT00943852|2603266|P8|COMPLETED|Second Period of Treatment Intervention||1
1074125|NCT00943852|2603267|P7|COMPLETED|Second Period of Treatment Intervention||2
1074126|NCT00943852|2603268|P6|COMPLETED|Second Period of Treatment Intervention||1
1074127|NCT00943852|2603269|P5|COMPLETED|Second Period of Treatment Intervention||1
1074128|NCT00943852|2603270|P4|COMPLETED|Second Period of Treatment Intervention||1
1074129|NCT00943852|2603271|P3|COMPLETED|Second Period of Treatment Intervention||1
1074130|NCT00943852|2603272|P2|COMPLETED|Second Period of Treatment Intervention||1
1074131|NCT00943852|2603273|P1|COMPLETED|Second Period of Treatment Intervention||2
1074132|NCT00943852|2603264|P10|STARTED|Second Period of Treatment Intervention||1
1074133|NCT00943852|2603265|P9|STARTED|Second Period of Treatment Intervention||1
1074134|NCT00943852|2603266|P8|STARTED|Second Period of Treatment Intervention||1
1074135|NCT00943852|2603267|P7|STARTED|Second Period of Treatment Intervention||2
1074136|NCT00943852|2603268|P6|STARTED|Second Period of Treatment Intervention||1
1074137|NCT00943852|2603269|P5|STARTED|Second Period of Treatment Intervention||1
1074138|NCT00943852|2603270|P4|STARTED|Second Period of Treatment Intervention||1
1074139|NCT00943852|2603271|P3|STARTED|Second Period of Treatment Intervention||1
1074140|NCT00943852|2603272|P2|STARTED|Second Period of Treatment Intervention||1
1074141|NCT00943852|2603273|P1|STARTED|Second Period of Treatment Intervention||2
1074142|NCT00943852|2603264|P10|NOT COMPLETED|Washout Period After Period 1 Treatment||0
1074143|NCT00943852|2603265|P9|NOT COMPLETED|Washout Period After Period 1 Treatment||0
1074144|NCT00943852|2603266|P8|NOT COMPLETED|Washout Period After Period 1 Treatment||0
1074145|NCT00943852|2603267|P7|NOT COMPLETED|Washout Period After Period 1 Treatment||0
1074146|NCT00943852|2603268|P6|NOT COMPLETED|Washout Period After Period 1 Treatment||0
1074147|NCT00943852|2603269|P5|NOT COMPLETED|Washout Period After Period 1 Treatment||0
1074148|NCT00943852|2603270|P4|NOT COMPLETED|Washout Period After Period 1 Treatment||1
1074149|NCT00943852|2603271|P3|NOT COMPLETED|Washout Period After Period 1 Treatment||0
1074150|NCT00943852|2603272|P2|NOT COMPLETED|Washout Period After Period 1 Treatment||0
1074151|NCT00943852|2603273|P1|NOT COMPLETED|Washout Period After Period 1 Treatment||0
1074152|NCT00943852|2603264|P10|COMPLETED|Washout Period After Period 1 Treatment||1
1074153|NCT00943852|2603265|P9|COMPLETED|Washout Period After Period 1 Treatment||1
1074154|NCT00943852|2603266|P8|COMPLETED|Washout Period After Period 1 Treatment||1
1074155|NCT00943852|2603267|P7|COMPLETED|Washout Period After Period 1 Treatment||2
1074156|NCT00943852|2603268|P6|COMPLETED|Washout Period After Period 1 Treatment||1
1074157|NCT00943852|2603269|P5|COMPLETED|Washout Period After Period 1 Treatment||1
1074158|NCT00943852|2603270|P4|COMPLETED|Washout Period After Period 1 Treatment||1
1074159|NCT00943852|2603271|P3|COMPLETED|Washout Period After Period 1 Treatment||1
1074160|NCT00943852|2603272|P2|COMPLETED|Washout Period After Period 1 Treatment||1
1074161|NCT00943852|2603273|P1|COMPLETED|Washout Period After Period 1 Treatment||2
1074162|NCT00943852|2603264|P10|STARTED|Washout Period After Period 1 Treatment||1
1074163|NCT00943852|2603265|P9|STARTED|Washout Period After Period 1 Treatment||1
1074164|NCT00943852|2603266|P8|STARTED|Washout Period After Period 1 Treatment||1
1074165|NCT00943852|2603267|P7|STARTED|Washout Period After Period 1 Treatment||2
1074166|NCT00943852|2603268|P6|STARTED|Washout Period After Period 1 Treatment||1
1074167|NCT00943852|2603269|P5|STARTED|Washout Period After Period 1 Treatment||1
1074168|NCT00943852|2603270|P4|STARTED|Washout Period After Period 1 Treatment||2
1074169|NCT00943852|2603271|P3|STARTED|Washout Period After Period 1 Treatment||1
1074170|NCT00943852|2603272|P2|STARTED|Washout Period After Period 1 Treatment||1
1074171|NCT00943852|2603273|P1|STARTED|Washout Period After Period 1 Treatment||2
1074172|NCT00943852|2603264|P10|NOT COMPLETED|First Period of Treatment Intervention||0
1074173|NCT00943852|2603265|P9|NOT COMPLETED|First Period of Treatment Intervention||0
1074174|NCT00943852|2603266|P8|NOT COMPLETED|First Period of Treatment Intervention||0
1074175|NCT00943852|2603267|P7|NOT COMPLETED|First Period of Treatment Intervention||0
1074176|NCT00943852|2603268|P6|NOT COMPLETED|First Period of Treatment Intervention||0
1074177|NCT00943852|2603269|P5|NOT COMPLETED|First Period of Treatment Intervention||0
1074178|NCT00943852|2603270|P4|NOT COMPLETED|First Period of Treatment Intervention||0
1074179|NCT00943852|2603271|P3|NOT COMPLETED|First Period of Treatment Intervention||0
1074180|NCT00943852|2603272|P2|NOT COMPLETED|First Period of Treatment Intervention||0
1074181|NCT00943852|2603273|P1|NOT COMPLETED|First Period of Treatment Intervention||0
1074182|NCT00943852|2603264|P10|COMPLETED|First Period of Treatment Intervention||1
1074183|NCT00943852|2603265|P9|COMPLETED|First Period of Treatment Intervention||1
1074184|NCT00943852|2603266|P8|COMPLETED|First Period of Treatment Intervention||1
1074185|NCT00943852|2603267|P7|COMPLETED|First Period of Treatment Intervention||2
1074186|NCT00943852|2603268|P6|COMPLETED|First Period of Treatment Intervention||1
1074187|NCT00943852|2603269|P5|COMPLETED|First Period of Treatment Intervention||1
1074188|NCT00943852|2603270|P4|COMPLETED|First Period of Treatment Intervention||2
1074189|NCT00943852|2603271|P3|COMPLETED|First Period of Treatment Intervention||1
1074190|NCT00943852|2603272|P2|COMPLETED|First Period of Treatment Intervention||1
1074191|NCT00943852|2603273|P1|COMPLETED|First Period of Treatment Intervention||2
1074192|NCT00943852|2603264|P10|STARTED|First Period of Treatment Intervention||1
1074193|NCT00943852|2603265|P9|STARTED|First Period of Treatment Intervention||1
1074194|NCT00943852|2603266|P8|STARTED|First Period of Treatment Intervention||1
1074195|NCT00943852|2603267|P7|STARTED|First Period of Treatment Intervention||2
1074196|NCT00943852|2603268|P6|STARTED|First Period of Treatment Intervention||1
1074197|NCT00943852|2603269|P5|STARTED|First Period of Treatment Intervention||1
1074198|NCT00943852|2603270|P4|STARTED|First Period of Treatment Intervention||2
1074199|NCT00943852|2603271|P3|STARTED|First Period of Treatment Intervention||1
1074200|NCT00943852|2603272|P2|STARTED|First Period of Treatment Intervention||1
1074201|NCT00943852|2603273|P1|STARTED|First Period of Treatment Intervention||2
1074202|NCT00943878|2603288|P4|NOT COMPLETED|Overall Study||2
1074203|NCT00943878|2603289|P3|NOT COMPLETED|Overall Study||6
1074204|NCT00943878|2603290|P2|NOT COMPLETED|Overall Study||2
1074205|NCT00943878|2603291|P1|NOT COMPLETED|Overall Study||2
1074206|NCT00943878|2603288|P4|COMPLETED|Overall Study||198
1074207|NCT00943878|2603289|P3|COMPLETED|Overall Study||197
1074208|NCT00943878|2603290|P2|COMPLETED|Overall Study||198
1074209|NCT00943878|2603291|P1|COMPLETED|Overall Study||200
1074210|NCT00943878|2603288|P4|STARTED|Overall Study||200
1074211|NCT00943878|2603289|P3|STARTED|Overall Study||203
1074212|NCT00943878|2603290|P2|STARTED|Overall Study||200
1074213|NCT00943878|2603291|P1|STARTED|Overall Study||202
1074214|NCT00943917|2603428|P15|NOT COMPLETED|Stage II Continuation||4
1074215|NCT00943917|2603429|P14|NOT COMPLETED|Stage II Continuation||3
1074216|NCT00943917|2603430|P13|NOT COMPLETED|Stage II Continuation||3
1074217|NCT00943917|2603431|P12|NOT COMPLETED|Stage II Continuation||2
1074218|NCT00943917|2603432|P11|NOT COMPLETED|Stage II Continuation||0
1074219|NCT00943917|2603433|P10|NOT COMPLETED|Stage II Continuation||1
1074220|NCT00943917|2603434|P9|NOT COMPLETED|Stage II Continuation||0
1074221|NCT00943917|2603435|P8|NOT COMPLETED|Stage II Continuation||0
1074222|NCT00943917|2603436|P7|NOT COMPLETED|Stage II Continuation||0
1074223|NCT00943917|2603437|P6|NOT COMPLETED|Stage II Continuation||0
1074224|NCT00943917|2603438|P5|NOT COMPLETED|Stage II Continuation||0
1074225|NCT00943917|2603439|P4|NOT COMPLETED|Stage II Continuation||0
1074226|NCT00943917|2603440|P3|NOT COMPLETED|Stage II Continuation||0
1074227|NCT00943917|2603441|P2|NOT COMPLETED|Stage II Continuation||0
1074228|NCT00943917|2603442|P1|NOT COMPLETED|Stage II Continuation||0
1074229|NCT00943917|2603428|P15|COMPLETED|Stage II Continuation||8
1074230|NCT00943917|2603429|P14|COMPLETED|Stage II Continuation||12
1074231|NCT00943917|2603430|P13|COMPLETED|Stage II Continuation||13
1074232|NCT00943917|2603431|P12|COMPLETED|Stage II Continuation||11
1074233|NCT00943917|2603432|P11|COMPLETED|Stage II Continuation||15
1074234|NCT00943917|2603433|P10|COMPLETED|Stage II Continuation||14
1074235|NCT00943917|2603434|P9|COMPLETED|Stage II Continuation||0
1074236|NCT00943917|2603435|P8|COMPLETED|Stage II Continuation||0
1074237|NCT00943917|2603436|P7|COMPLETED|Stage II Continuation||0
1074238|NCT00943917|2603437|P6|COMPLETED|Stage II Continuation||0
1074239|NCT00943917|2603438|P5|COMPLETED|Stage II Continuation||0
1074240|NCT00943917|2603439|P4|COMPLETED|Stage II Continuation||0
1074241|NCT00943917|2603440|P3|COMPLETED|Stage II Continuation||0
1074242|NCT00943917|2603441|P2|COMPLETED|Stage II Continuation||0
1074243|NCT00943917|2603442|P1|COMPLETED|Stage II Continuation||0
1074244|NCT00943917|2603428|P15|STARTED|Stage II Continuation||12
1074245|NCT00943917|2603429|P14|STARTED|Stage II Continuation||15
1074246|NCT00943917|2603430|P13|STARTED|Stage II Continuation||16
1074247|NCT00943917|2603431|P12|STARTED|Stage II Continuation||13
1074248|NCT00943917|2603432|P11|STARTED|Stage II Continuation||15
1074249|NCT00943917|2603433|P10|STARTED|Stage II Continuation||15
1074250|NCT00943917|2603434|P9|STARTED|Stage II Continuation||0
1074251|NCT00943917|2603435|P8|STARTED|Stage II Continuation||0
1074252|NCT00943917|2603436|P7|STARTED|Stage II Continuation||0
1074253|NCT00943917|2603437|P6|STARTED|Stage II Continuation||0
1074254|NCT00943917|2603438|P5|STARTED|Stage II Continuation||0
1074255|NCT00943917|2603439|P4|STARTED|Stage II Continuation||0
1074256|NCT00943917|2603440|P3|STARTED|Stage II Continuation||0
1074257|NCT00943917|2603441|P2|STARTED|Stage II Continuation||0
1074258|NCT00943917|2603442|P1|STARTED|Stage II Continuation||0
1074259|NCT00943917|2603428|P15|NOT COMPLETED|Stage II||0
1074260|NCT00943917|2603429|P14|NOT COMPLETED|Stage II||0
1074261|NCT00943917|2603430|P13|NOT COMPLETED|Stage II||0
1074262|NCT00943917|2603431|P12|NOT COMPLETED|Stage II||0
1074263|NCT00943917|2603432|P11|NOT COMPLETED|Stage II||0
1074264|NCT00943917|2603433|P10|NOT COMPLETED|Stage II||0
1074265|NCT00943917|2603434|P9|NOT COMPLETED|Stage II||1
1074266|NCT00943917|2603435|P8|NOT COMPLETED|Stage II||0
1074267|NCT00943917|2603436|P7|NOT COMPLETED|Stage II||3
1074268|NCT00943917|2603437|P6|NOT COMPLETED|Stage II||3
1074269|NCT00943917|2603438|P5|NOT COMPLETED|Stage II||0
1074270|NCT00943917|2603439|P4|NOT COMPLETED|Stage II||0
1074271|NCT00943917|2603440|P3|NOT COMPLETED|Stage II||0
1074272|NCT00943917|2603441|P2|NOT COMPLETED|Stage II||0
1074273|NCT00943917|2603442|P1|NOT COMPLETED|Stage II||0
1074274|NCT00943917|2603428|P15|COMPLETED|Stage II||0
1074275|NCT00943917|2603429|P14|COMPLETED|Stage II||0
1074276|NCT00943917|2603430|P13|COMPLETED|Stage II||0
1074277|NCT00943917|2603431|P12|COMPLETED|Stage II||0
1074278|NCT00943917|2603432|P11|COMPLETED|Stage II||0
1074279|NCT00943917|2603433|P10|COMPLETED|Stage II||0
1074280|NCT00943917|2603434|P9|COMPLETED|Stage II||20
1074281|NCT00943917|2603435|P8|COMPLETED|Stage II||23
1074282|NCT00943917|2603436|P7|COMPLETED|Stage II||20
1074283|NCT00943917|2603437|P6|COMPLETED|Stage II||20
1074284|NCT00943917|2603438|P5|COMPLETED|Stage II||21
1074285|NCT00943917|2603439|P4|COMPLETED|Stage II||20
1074286|NCT00943917|2603440|P3|COMPLETED|Stage II||0
1074287|NCT00943917|2603441|P2|COMPLETED|Stage II||0
1074288|NCT00943917|2603442|P1|COMPLETED|Stage II||0
1074289|NCT00943917|2603428|P15|STARTED|Stage II||0
1074290|NCT00943917|2603429|P14|STARTED|Stage II||0
1074291|NCT00943917|2603430|P13|STARTED|Stage II||0
1074292|NCT00943917|2603431|P12|STARTED|Stage II||0
1074293|NCT00943917|2603432|P11|STARTED|Stage II||0
1074294|NCT00943917|2603433|P10|STARTED|Stage II||0
1074295|NCT00943917|2603434|P9|STARTED|Stage II||21
1074296|NCT00943917|2603435|P8|STARTED|Stage II||23
1074297|NCT00943917|2603436|P7|STARTED|Stage II||23
1074298|NCT00943917|2603437|P6|STARTED|Stage II||23
1074299|NCT00943917|2603438|P5|STARTED|Stage II||21
1074300|NCT00943917|2603439|P4|STARTED|Stage II||20
1074301|NCT00943917|2603440|P3|STARTED|Stage II||0
1074302|NCT00943917|2603441|P2|STARTED|Stage II||0
1074303|NCT00943917|2603442|P1|STARTED|Stage II||0
1074304|NCT00943917|2603428|P15|NOT COMPLETED|Stage I||0
1074305|NCT00943917|2603429|P14|NOT COMPLETED|Stage I||0
1074306|NCT00943917|2603430|P13|NOT COMPLETED|Stage I||0
1074307|NCT00943917|2603431|P12|NOT COMPLETED|Stage I||0
1074308|NCT00943917|2603432|P11|NOT COMPLETED|Stage I||0
1074309|NCT00943917|2603433|P10|NOT COMPLETED|Stage I||0
1074310|NCT00943917|2603434|P9|NOT COMPLETED|Stage I||0
1074311|NCT00943917|2603435|P8|NOT COMPLETED|Stage I||0
1074312|NCT00943917|2603436|P7|NOT COMPLETED|Stage I||0
1074313|NCT00943917|2603437|P6|NOT COMPLETED|Stage I||0
1074314|NCT00943917|2603438|P5|NOT COMPLETED|Stage I||0
1074315|NCT00943917|2603439|P4|NOT COMPLETED|Stage I||0
1074316|NCT00943917|2603440|P3|NOT COMPLETED|Stage I||6
1074317|NCT00943917|2603441|P2|NOT COMPLETED|Stage I||3
1074318|NCT00943917|2603442|P1|NOT COMPLETED|Stage I||4
1074319|NCT00943917|2603428|P15|COMPLETED|Stage I||0
1074320|NCT00943917|2603429|P14|COMPLETED|Stage I||0
1074321|NCT00943917|2603430|P13|COMPLETED|Stage I||0
1074322|NCT00943917|2603431|P12|COMPLETED|Stage I||0
1074323|NCT00943917|2603432|P11|COMPLETED|Stage I||0
1074324|NCT00943917|2603433|P10|COMPLETED|Stage I||0
1074325|NCT00943917|2603434|P9|COMPLETED|Stage I||0
1074326|NCT00943917|2603435|P8|COMPLETED|Stage I||0
1074327|NCT00943917|2603436|P7|COMPLETED|Stage I||0
1074328|NCT00943917|2603437|P6|COMPLETED|Stage I||0
1074329|NCT00943917|2603438|P5|COMPLETED|Stage I||0
1074330|NCT00943917|2603439|P4|COMPLETED|Stage I||0
1074331|NCT00943917|2603440|P3|COMPLETED|Stage I||47
1074332|NCT00943917|2603441|P2|COMPLETED|Stage I||48
1074333|NCT00943917|2603442|P1|COMPLETED|Stage I||47
1074334|NCT00943917|2603428|P15|STARTED|Stage I||0
1074335|NCT00943917|2603429|P14|STARTED|Stage I||0
1074336|NCT00943917|2603430|P13|STARTED|Stage I||0
1074337|NCT00943917|2603431|P12|STARTED|Stage I||0
1074338|NCT00943917|2603432|P11|STARTED|Stage I||0
1074339|NCT00943917|2603433|P10|STARTED|Stage I||0
1074340|NCT00943917|2603434|P9|STARTED|Stage I||0
1074341|NCT00943917|2603435|P8|STARTED|Stage I||0
1074342|NCT00943917|2603436|P7|STARTED|Stage I||0
1074343|NCT00943917|2603437|P6|STARTED|Stage I||0
1074344|NCT00943917|2603438|P5|STARTED|Stage I||0
1074345|NCT00943917|2603439|P4|STARTED|Stage I||0
1074346|NCT00943917|2603440|P3|STARTED|Stage I||53
1074347|NCT00943917|2603441|P2|STARTED|Stage I||51
1074348|NCT00943917|2603442|P1|STARTED|Stage I||51
1074349|NCT00944021|2603494|P5|NOT COMPLETED|Overall Study||0
1074350|NCT00944021|2603495|P4|NOT COMPLETED|Overall Study||0
1074351|NCT00944021|2603496|P3|NOT COMPLETED|Overall Study||0
1074352|NCT00944021|2603497|P2|NOT COMPLETED|Overall Study||0
1074353|NCT00944021|2603498|P1|NOT COMPLETED|Overall Study||1
1074354|NCT00944021|2603494|P5|COMPLETED|Overall Study||8
1074355|NCT00944021|2603495|P4|COMPLETED|Overall Study||16
1074356|NCT00944021|2603496|P3|COMPLETED|Overall Study||15
1074357|NCT00944021|2603497|P2|COMPLETED|Overall Study||15
1074358|NCT00944021|2603498|P1|COMPLETED|Overall Study||14
1074359|NCT00944021|2603494|P5|STARTED|Overall Study||8
1074360|NCT00944021|2603495|P4|STARTED|Overall Study||16
1074361|NCT00944021|2603496|P3|STARTED|Overall Study||15
1074362|NCT00944021|2603497|P2|STARTED|Overall Study||15
1074363|NCT00944021|2603498|P1|STARTED|Overall Study||15
1074364|NCT00944034|2603567|P12|NOT COMPLETED|Overall Study||4
1074365|NCT00944034|2603568|P11|NOT COMPLETED|Overall Study||1
1074366|NCT00944034|2603569|P10|NOT COMPLETED|Overall Study||10
1074367|NCT00944034|2603570|P9|NOT COMPLETED|Overall Study||10
1074368|NCT00944034|2603571|P8|NOT COMPLETED|Overall Study||5
1074369|NCT00944034|2603572|P7|NOT COMPLETED|Overall Study||4
1074370|NCT00944034|2603573|P6|NOT COMPLETED|Overall Study||20
1074371|NCT00944034|2603574|P5|NOT COMPLETED|Overall Study||14
1074372|NCT00944034|2603575|P4|NOT COMPLETED|Overall Study||4
1074373|NCT00944034|2603576|P3|NOT COMPLETED|Overall Study||9
1074374|NCT00944034|2603577|P2|NOT COMPLETED|Overall Study||7
1074375|NCT00944034|2603578|P1|NOT COMPLETED|Overall Study||5
1074376|NCT00944034|2603567|P12|COMPLETED|Overall Study||52
1074377|NCT00944034|2603568|P11|COMPLETED|Overall Study||50
1074378|NCT00944034|2603569|P10|COMPLETED|Overall Study||236
1074379|NCT00944034|2603570|P9|COMPLETED|Overall Study||63
1074380|NCT00944034|2603571|P8|COMPLETED|Overall Study||73
1074381|NCT00944034|2603572|P7|COMPLETED|Overall Study||102
1074382|NCT00944034|2603573|P6|COMPLETED|Overall Study||123
1074383|NCT00944034|2603574|P5|COMPLETED|Overall Study||150
1074384|NCT00944034|2603575|P4|COMPLETED|Overall Study||170
1074385|NCT00944034|2603576|P3|COMPLETED|Overall Study||143
1074386|NCT00944034|2603577|P2|COMPLETED|Overall Study||150
1074387|NCT00944034|2603578|P1|COMPLETED|Overall Study||183
1074388|NCT00944034|2603567|P12|STARTED|Overall Study||56
1074389|NCT00944034|2603568|P11|STARTED|Overall Study||51
1074390|NCT00944034|2603569|P10|STARTED|Overall Study||246
1074391|NCT00944034|2603570|P9|STARTED|Overall Study||73
1074392|NCT00944034|2603571|P8|STARTED|Overall Study||78
1074393|NCT00944034|2603572|P7|STARTED|Overall Study||106
1074394|NCT00944034|2603573|P6|STARTED|Overall Study||143
1074395|NCT00944034|2603574|P5|STARTED|Overall Study||164
1074396|NCT00944034|2603575|P4|STARTED|Overall Study||174
1074397|NCT00944034|2603576|P3|STARTED|Overall Study||152
1074398|NCT00944034|2603577|P2|STARTED|Overall Study||157
1074399|NCT00944034|2603578|P1|STARTED|Overall Study||188
1074400|NCT00944073|2603645|P2|NOT COMPLETED|Overall Study||4
1074401|NCT00944073|2603646|P1|NOT COMPLETED|Overall Study||5
1074402|NCT00944073|2603645|P2|COMPLETED|Overall Study||287
1074403|NCT00944073|2603646|P1|COMPLETED|Overall Study||287
1074404|NCT00944073|2603645|P2|STARTED|Overall Study||291
1074405|NCT00944073|2603646|P1|STARTED|Overall Study||292
1074406|NCT00944125|2603724|P2|NOT COMPLETED|6 Months to Study Completion||2
1074407|NCT00944125|2603725|P1|NOT COMPLETED|6 Months to Study Completion||0
1074408|NCT00944125|2603724|P2|COMPLETED|6 Months to Study Completion||18
1074409|NCT00944125|2603725|P1|COMPLETED|6 Months to Study Completion||19
1074410|NCT00944125|2603724|P2|STARTED|6 Months to Study Completion||20
1074411|NCT00944125|2603725|P1|STARTED|6 Months to Study Completion||19
1074412|NCT00944125|2603724|P2|NOT COMPLETED|3 to 6 Months||2
1074413|NCT00944125|2603725|P1|NOT COMPLETED|3 to 6 Months||0
1074414|NCT00944125|2603724|P2|COMPLETED|3 to 6 Months||20
1074415|NCT00944125|2603725|P1|COMPLETED|3 to 6 Months||19
1074416|NCT00944125|2603724|P2|STARTED|3 to 6 Months||22
1074417|NCT00944125|2603725|P1|STARTED|3 to 6 Months||19
1074418|NCT00944125|2603724|P2|NOT COMPLETED|Baseline to 3 Months||0
1074419|NCT00944125|2603725|P1|NOT COMPLETED|Baseline to 3 Months||0
1074420|NCT00944125|2603724|P2|COMPLETED|Baseline to 3 Months||22
1074421|NCT00944125|2603725|P1|COMPLETED|Baseline to 3 Months||19
1074422|NCT00944125|2603724|P2|STARTED|Baseline to 3 Months||22
1074423|NCT00944125|2603725|P1|STARTED|Baseline to 3 Months||19
1074424|NCT00944229|2603731|P1|NOT COMPLETED|Overall Study||25
1074425|NCT00944229|2603731|P1|COMPLETED|Overall Study||33
1074426|NCT00944229|2603731|P1|STARTED|Overall Study||58
1074427|NCT00944450|2603737|P2|NOT COMPLETED|Period 2||0
1074428|NCT00944450|2603738|P1|NOT COMPLETED|Period 2||0
1074429|NCT00944450|2603737|P2|COMPLETED|Period 2||6
1074430|NCT00944450|2603738|P1|COMPLETED|Period 2||6
1074431|NCT00944450|2603737|P2|STARTED|Period 2||6
1074432|NCT00944450|2603738|P1|STARTED|Period 2||6
1074433|NCT00944450|2603737|P2|NOT COMPLETED|Period 1||0
1074434|NCT00944450|2603738|P1|NOT COMPLETED|Period 1||0
1074435|NCT00944450|2603737|P2|COMPLETED|Period 1||6
1074436|NCT00944450|2603738|P1|COMPLETED|Period 1||6
1074437|NCT00944450|2603737|P2|STARTED|Period 1||6
1074438|NCT00944450|2603738|P1|STARTED|Period 1||6
1074439|NCT00944554|2603748|P2|NOT COMPLETED|Overall Study||29
1074440|NCT00944554|2603749|P1|NOT COMPLETED|Overall Study||28
1074441|NCT00944554|2603748|P2|COMPLETED|Overall Study||25
1074442|NCT00944554|2603749|P1|COMPLETED|Overall Study||22
1074443|NCT00944554|2603748|P2|STARTED|Overall Study||54
1074444|NCT00944554|2603749|P1|STARTED|Overall Study||50
1074445|NCT00944645|2603755|P2|NOT COMPLETED|Period 2||9
1074446|NCT00944645|2603756|P1|NOT COMPLETED|Period 2||8
1074447|NCT00944645|2603755|P2|COMPLETED|Period 2||85
1074448|NCT00944645|2603756|P1|COMPLETED|Period 2||86
1074449|NCT00944645|2603755|P2|STARTED|Period 2||94
1074450|NCT00944645|2603756|P1|STARTED|Period 2||94
1074451|NCT00944645|2603755|P2|NOT COMPLETED|Period 1||0
1074452|NCT00944645|2603756|P1|NOT COMPLETED|Period 1||0
1074453|NCT00944645|2603755|P2|COMPLETED|Period 1||94
1074454|NCT00944645|2603756|P1|COMPLETED|Period 1||94
1074455|NCT00944645|2603755|P2|STARTED|Period 1||94
1074456|NCT00944645|2603756|P1|STARTED|Period 1||94
1074457|NCT00944671|2603774|P6|NOT COMPLETED|Period III||0
1074458|NCT00944671|2603775|P5|NOT COMPLETED|Period III||0
1074459|NCT00944671|2603776|P4|NOT COMPLETED|Period III||0
1074460|NCT00944671|2603777|P3|NOT COMPLETED|Period III||0
1074461|NCT00944671|2603778|P2|NOT COMPLETED|Period III||0
1074462|NCT00944671|2603779|P1|NOT COMPLETED|Period III||0
1074463|NCT00944671|2603774|P6|COMPLETED|Period III||4
1074464|NCT00944671|2603775|P5|COMPLETED|Period III||4
1074465|NCT00944671|2603776|P4|COMPLETED|Period III||4
1074466|NCT00944671|2603777|P3|COMPLETED|Period III||4
1074467|NCT00944671|2603778|P2|COMPLETED|Period III||4
1074468|NCT00944671|2603779|P1|COMPLETED|Period III||4
1074469|NCT00944671|2603774|P6|STARTED|Period III||4
1074470|NCT00944671|2603775|P5|STARTED|Period III||4
1074471|NCT00944671|2603776|P4|STARTED|Period III||4
1074472|NCT00944671|2603777|P3|STARTED|Period III||4
1074473|NCT00944671|2603778|P2|STARTED|Period III||4
1074474|NCT00944671|2603779|P1|STARTED|Period III||4
1074475|NCT00944671|2603774|P6|NOT COMPLETED|Period II||0
1074476|NCT00944671|2603775|P5|NOT COMPLETED|Period II||0
1074477|NCT00944671|2603776|P4|NOT COMPLETED|Period II||0
1074478|NCT00944671|2603777|P3|NOT COMPLETED|Period II||0
1074479|NCT00944671|2603778|P2|NOT COMPLETED|Period II||0
1074480|NCT00944671|2603779|P1|NOT COMPLETED|Period II||0
1074481|NCT00944671|2603774|P6|COMPLETED|Period II||4
1074482|NCT00944671|2603775|P5|COMPLETED|Period II||4
1074483|NCT00944671|2603776|P4|COMPLETED|Period II||4
1074484|NCT00944671|2603777|P3|COMPLETED|Period II||4
1074485|NCT00944671|2603778|P2|COMPLETED|Period II||4
1074486|NCT00944671|2603779|P1|COMPLETED|Period II||4
1074487|NCT00944671|2603774|P6|STARTED|Period II||4
1074488|NCT00944671|2603775|P5|STARTED|Period II||4
1074489|NCT00944671|2603776|P4|STARTED|Period II||4
1074490|NCT00944671|2603777|P3|STARTED|Period II||4
1074491|NCT00944671|2603778|P2|STARTED|Period II||4
1074492|NCT00944671|2603779|P1|STARTED|Period II||4
1074493|NCT00944671|2603774|P6|NOT COMPLETED|Period I||0
1074494|NCT00944671|2603775|P5|NOT COMPLETED|Period I||0
1074495|NCT00944671|2603776|P4|NOT COMPLETED|Period I||0
1074496|NCT00944671|2603777|P3|NOT COMPLETED|Period I||0
1074497|NCT00944671|2603778|P2|NOT COMPLETED|Period I||0
1074498|NCT00944671|2603779|P1|NOT COMPLETED|Period I||0
1074499|NCT00944671|2603774|P6|COMPLETED|Period I||4
1074500|NCT00944671|2603775|P5|COMPLETED|Period I||4
1074501|NCT00944671|2603776|P4|COMPLETED|Period I||4
1074502|NCT00944671|2603777|P3|COMPLETED|Period I||4
1074503|NCT00944671|2603778|P2|COMPLETED|Period I||4
1074504|NCT00944671|2603779|P1|COMPLETED|Period I||4
1074505|NCT00944671|2603774|P6|STARTED|Period I||4
1074506|NCT00944671|2603775|P5|STARTED|Period I||4
1074507|NCT00944671|2603776|P4|STARTED|Period I||4
1074508|NCT00944671|2603777|P3|STARTED|Period I||4
1074509|NCT00944671|2603778|P2|STARTED|Period I||4
1074510|NCT00944671|2603779|P1|STARTED|Period I||4
1074511|NCT00944697|2603794|P2|NOT COMPLETED|Overall Study||5
1074512|NCT00944697|2603795|P1|NOT COMPLETED|Overall Study||2
1074513|NCT00944697|2603794|P2|COMPLETED|Overall Study||43
1074514|NCT00944697|2603795|P1|COMPLETED|Overall Study||48
1074515|NCT00944697|2603794|P2|STARTED|Overall Study||48
1074516|NCT00944697|2603795|P1|STARTED|Overall Study||50
1074517|NCT00944710|2603803|P2|NOT COMPLETED|Additional Post 10-week Primary Outcome||11
1074518|NCT00944710|2603804|P1|NOT COMPLETED|Additional Post 10-week Primary Outcome||17
1074519|NCT00944710|2603803|P2|COMPLETED|Additional Post 10-week Primary Outcome||22
1074520|NCT00944710|2603804|P1|COMPLETED|Additional Post 10-week Primary Outcome||23
1074521|NCT00944710|2603803|P2|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||26
1074522|NCT00944710|2603804|P1|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||24
1074523|NCT00944710|2603803|P2|STARTED|Additional Post 10-week Primary Outcome||33
1074524|NCT00944710|2603804|P1|STARTED|Additional Post 10-week Primary Outcome||40
1074525|NCT00944710|2603803|P2|NOT COMPLETED|12-week Visit (Off-treatment)||0
1074526|NCT00944710|2603804|P1|NOT COMPLETED|12-week Visit (Off-treatment)||0
1074527|NCT00944710|2603803|P2|COMPLETED|12-week Visit (Off-treatment)||33
1074528|NCT00944710|2603804|P1|COMPLETED|12-week Visit (Off-treatment)||40
1074529|NCT00944710|2603803|P2|STARTED|12-week Visit (Off-treatment)||33
1074530|NCT00944710|2603804|P1|STARTED|12-week Visit (Off-treatment)||40
1074531|NCT00944710|2603803|P2|NOT COMPLETED|10-week Primary Outcome||0
1074532|NCT00944710|2603804|P1|NOT COMPLETED|10-week Primary Outcome||0
1074533|NCT00944710|2603803|P2|COMPLETED|10-week Primary Outcome||33
1074534|NCT00944710|2603804|P1|COMPLETED|10-week Primary Outcome||40
1074535|NCT00944710|2603803|P2|STARTED|10-week Primary Outcome||33
1074536|NCT00944710|2603804|P1|STARTED|10-week Primary Outcome||40
1074537|NCT00944749|2603860|P1|NOT COMPLETED|Overall Study||1
1074538|NCT00944749|2603860|P1|COMPLETED|Overall Study||22
1074539|NCT00944749|2603860|P1|STARTED|Overall Study||23
1074540|NCT00945035|2603865|P2|NOT COMPLETED|Period 2||0
1074541|NCT00945035|2603866|P1|NOT COMPLETED|Period 2||0
1074542|NCT00945035|2603865|P2|COMPLETED|Period 2||18
1074543|NCT00945035|2603866|P1|COMPLETED|Period 2||18
1074544|NCT00945035|2603865|P2|STARTED|Period 2||18
1074545|NCT00945035|2603866|P1|STARTED|Period 2||18
1074546|NCT00945035|2603865|P2|NOT COMPLETED|Period 1||0
1074547|NCT00945035|2603866|P1|NOT COMPLETED|Period 1||0
1074548|NCT00945035|2603865|P2|COMPLETED|Period 1||18
1074549|NCT00945035|2603866|P1|COMPLETED|Period 1||18
1074550|NCT00945035|2603865|P2|STARTED|Period 1||18
1074551|NCT00945035|2603866|P1|STARTED|Period 1||18
1074552|NCT00945100|2603876|P2|NOT COMPLETED|Post-10 Week Primary Outcome||7
1074553|NCT00945100|2603877|P1|NOT COMPLETED|Post-10 Week Primary Outcome||4
1074554|NCT00945100|2603876|P2|COMPLETED|Post-10 Week Primary Outcome||56
1074555|NCT00945100|2603877|P1|COMPLETED|Post-10 Week Primary Outcome||51
1074556|NCT00945100|2603876|P2|STARTED|Post-10 Week Primary Outcome|20 participants were not eligible for Post 10 week Primary Outcome phase|63
1074557|NCT00945100|2603877|P1|STARTED|Post-10 Week Primary Outcome|27 participants were not eligible for Post 10 week Primary Outcome phase|55
1074558|NCT00945100|2603876|P2|NOT COMPLETED|10-week Primary Outcome||3
1074559|NCT00945100|2603877|P1|NOT COMPLETED|10-week Primary Outcome||1
1074560|NCT00945100|2603876|P2|COMPLETED|10-week Primary Outcome||83
1074561|NCT00945100|2603877|P1|COMPLETED|10-week Primary Outcome||82
1074562|NCT00945100|2603876|P2|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|20
1074563|NCT00945100|2603877|P1|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|27
1074564|NCT00945100|2603876|P2|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|63
1074565|NCT00945100|2603877|P1|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|55
1074566|NCT00945100|2603876|P2|STARTED|10-week Primary Outcome||86
1074567|NCT00945100|2603877|P1|STARTED|10-week Primary Outcome||83
1074568|NCT00945139|2603941|P1|NOT COMPLETED|Overall Study||0
1074569|NCT00945139|2603941|P1|COMPLETED|Overall Study||46
1074570|NCT00945139|2603941|P1|STARTED|Overall Study||46
1074571|NCT00945243|2603950|P1|NOT COMPLETED|Overall Study||3
1074572|NCT00945243|2603950|P1|COMPLETED|Overall Study||8
1074573|NCT00945243|2603950|P1|STARTED|Overall Study|Enrolled and Treated Per Protocol|11
1074574|NCT00945256|2603961|P5|NOT COMPLETED|Overall Study||1
1074575|NCT00945256|2603962|P4|NOT COMPLETED|Overall Study||9
1074576|NCT00945256|2603963|P3|NOT COMPLETED|Overall Study||8
1074577|NCT00945256|2603964|P2|NOT COMPLETED|Overall Study||2
1074578|NCT00945256|2603965|P1|NOT COMPLETED|Overall Study||4
1074579|NCT00945256|2603961|P5|COMPLETED|Overall Study||7
1074580|NCT00945256|2603962|P4|COMPLETED|Overall Study||7
1074581|NCT00945256|2603963|P3|COMPLETED|Overall Study||7
1074582|NCT00945256|2603964|P2|COMPLETED|Overall Study||8
1074583|NCT00945256|2603965|P1|COMPLETED|Overall Study||9
1074584|NCT00945256|2603961|P5|STARTED|Overall Study||8
1074585|NCT00945256|2603962|P4|STARTED|Overall Study||16
1074586|NCT00945256|2603963|P3|STARTED|Overall Study||15
1074587|NCT00945256|2603964|P2|STARTED|Overall Study||10
1074588|NCT00945256|2603965|P1|STARTED|Overall Study||13
1074589|NCT00945295|2603979|P2|NOT COMPLETED|Overall Study||2
1074590|NCT00945295|2603980|P1|NOT COMPLETED|Overall Study||0
1074591|NCT00945295|2603979|P2|COMPLETED|Overall Study||14
1074592|NCT00945295|2603980|P1|COMPLETED|Overall Study||15
1074593|NCT00945295|2603979|P2|STARTED|Overall Study||16
1074594|NCT00945295|2603980|P1|STARTED|Overall Study||15
1074595|NCT00945321|2603988|P6|NOT COMPLETED|Period 4||1
1074596|NCT00945321|2603989|P5|NOT COMPLETED|Period 4||0
1074597|NCT00945321|2603990|P4|NOT COMPLETED|Period 4||0
1074598|NCT00945321|2603991|P3|NOT COMPLETED|Period 4||0
1074599|NCT00945321|2603992|P2|NOT COMPLETED|Period 4||0
1074600|NCT00945321|2603993|P1|NOT COMPLETED|Period 4||0
1074601|NCT00945321|2603988|P6|COMPLETED|Period 4||6
1074602|NCT00945321|2603989|P5|COMPLETED|Period 4||6
1074603|NCT00945321|2603990|P4|COMPLETED|Period 4||7
1074604|NCT00945321|2603991|P3|COMPLETED|Period 4||7
1074605|NCT00945321|2603992|P2|COMPLETED|Period 4||7
1074606|NCT00945321|2603993|P1|COMPLETED|Period 4||7
1074607|NCT00945321|2603988|P6|STARTED|Period 4||7
1074608|NCT00945321|2603989|P5|STARTED|Period 4||6
1074609|NCT00945321|2603990|P4|STARTED|Period 4||7
1074610|NCT00945321|2603991|P3|STARTED|Period 4||7
1074611|NCT00945321|2603992|P2|STARTED|Period 4||7
1074612|NCT00945321|2603993|P1|STARTED|Period 4||7
1074613|NCT00945321|2603988|P6|NOT COMPLETED|Period 3||0
1074614|NCT00945321|2603989|P5|NOT COMPLETED|Period 3||0
1074615|NCT00945321|2603990|P4|NOT COMPLETED|Period 3||0
1074616|NCT00945321|2603991|P3|NOT COMPLETED|Period 3||0
1074617|NCT00945321|2603992|P2|NOT COMPLETED|Period 3||0
1074618|NCT00945321|2603993|P1|NOT COMPLETED|Period 3||0
1074619|NCT00945321|2603988|P6|COMPLETED|Period 3||7
1074620|NCT00945321|2603989|P5|COMPLETED|Period 3||6
1074621|NCT00945321|2603990|P4|COMPLETED|Period 3||7
1074622|NCT00945321|2603991|P3|COMPLETED|Period 3||7
1074623|NCT00945321|2603992|P2|COMPLETED|Period 3||7
1074624|NCT00945321|2603993|P1|COMPLETED|Period 3||7
1074625|NCT00945321|2603988|P6|STARTED|Period 3||7
1074626|NCT00945321|2603989|P5|STARTED|Period 3||6
1074627|NCT00945321|2603990|P4|STARTED|Period 3||7
1074628|NCT00945321|2603991|P3|STARTED|Period 3||7
1074629|NCT00945321|2603992|P2|STARTED|Period 3||7
1074630|NCT00945321|2603993|P1|STARTED|Period 3||7
1074631|NCT00945321|2603988|P6|NOT COMPLETED|Period 2||0
1074632|NCT00945321|2603989|P5|NOT COMPLETED|Period 2||0
1074633|NCT00945321|2603990|P4|NOT COMPLETED|Period 2||0
1074634|NCT00945321|2603991|P3|NOT COMPLETED|Period 2||0
1074635|NCT00945321|2603992|P2|NOT COMPLETED|Period 2||0
1074636|NCT00945321|2603993|P1|NOT COMPLETED|Period 2||0
1074637|NCT00945321|2603988|P6|COMPLETED|Period 2||7
1074638|NCT00945321|2603989|P5|COMPLETED|Period 2||6
1074639|NCT00945321|2603990|P4|COMPLETED|Period 2||7
1074640|NCT00945321|2603991|P3|COMPLETED|Period 2||7
1074641|NCT00945321|2603992|P2|COMPLETED|Period 2||7
1074642|NCT00945321|2603993|P1|COMPLETED|Period 2||7
1074643|NCT00945321|2603988|P6|STARTED|Period 2||7
1074644|NCT00945321|2603989|P5|STARTED|Period 2||6
1074645|NCT00945321|2603990|P4|STARTED|Period 2||7
1074646|NCT00945321|2603991|P3|STARTED|Period 2||7
1074647|NCT00945321|2603992|P2|STARTED|Period 2||7
1074648|NCT00945321|2603993|P1|STARTED|Period 2||7
1074649|NCT00945321|2603988|P6|NOT COMPLETED|Period 1||0
1074650|NCT00945321|2603989|P5|NOT COMPLETED|Period 1||1
1074651|NCT00945321|2603990|P4|NOT COMPLETED|Period 1||0
1074652|NCT00945321|2603991|P3|NOT COMPLETED|Period 1||0
1074653|NCT00945321|2603992|P2|NOT COMPLETED|Period 1||0
1074654|NCT00945321|2603993|P1|NOT COMPLETED|Period 1||0
1074655|NCT00945321|2603988|P6|COMPLETED|Period 1||7
1074656|NCT00945321|2603989|P5|COMPLETED|Period 1||6
1074657|NCT00945321|2603990|P4|COMPLETED|Period 1||7
1074658|NCT00945321|2603991|P3|COMPLETED|Period 1||7
1074659|NCT00945321|2603992|P2|COMPLETED|Period 1||7
1074660|NCT00945321|2603993|P1|COMPLETED|Period 1||7
1074661|NCT00945321|2603988|P6|STARTED|Period 1||7
1074662|NCT00945321|2603989|P5|STARTED|Period 1||7
1074663|NCT00945321|2603990|P4|STARTED|Period 1||7
1074664|NCT00945321|2603991|P3|STARTED|Period 1||7
1074665|NCT00945321|2603992|P2|STARTED|Period 1||7
1074666|NCT00945321|2603993|P1|STARTED|Period 1||7
1074667|NCT00945334|2604015|P2|NOT COMPLETED|Overall Study||3
1074668|NCT00945334|2604016|P1|NOT COMPLETED|Overall Study||3
1074669|NCT00945334|2604015|P2|COMPLETED|Overall Study||15
1074670|NCT00945334|2604016|P1|COMPLETED|Overall Study||16
1074671|NCT00945334|2604015|P2|STARTED|Overall Study||18
1074672|NCT00945334|2604016|P1|STARTED|Overall Study||19
1074673|NCT00945477|2604024|P1|NOT COMPLETED|Overall Study||6
1074674|NCT00945477|2604024|P1|COMPLETED|Overall Study||5
1074675|NCT00945477|2604024|P1|STARTED|Overall Study||11
1074676|NCT00945555|2604029|P1|NOT COMPLETED|Overall Study||28
1074677|NCT00945555|2604029|P1|COMPLETED|Overall Study||236
1074678|NCT00945555|2604029|P1|STARTED|Overall Study||264
1074679|NCT00945750|2604046|P6|NOT COMPLETED|Period III||0
1074680|NCT00945750|2604047|P5|NOT COMPLETED|Period III||0
1074681|NCT00945750|2604048|P4|NOT COMPLETED|Period III||0
1074682|NCT00945750|2604049|P3|NOT COMPLETED|Period III||0
1074683|NCT00945750|2604050|P2|NOT COMPLETED|Period III||0
1074684|NCT00945750|2604051|P1|NOT COMPLETED|Period III||0
1074685|NCT00945750|2604046|P6|COMPLETED|Period III||5
1074686|NCT00945750|2604047|P5|COMPLETED|Period III||5
1074687|NCT00945750|2604048|P4|COMPLETED|Period III||5
1074688|NCT00945750|2604049|P3|COMPLETED|Period III||5
1074689|NCT00945750|2604050|P2|COMPLETED|Period III||5
1074690|NCT00945750|2604051|P1|COMPLETED|Period III||5
1074691|NCT00945750|2604046|P6|STARTED|Period III||5
1074692|NCT00945750|2604047|P5|STARTED|Period III||5
1074693|NCT00945750|2604048|P4|STARTED|Period III||5
1074694|NCT00945750|2604049|P3|STARTED|Period III||5
1074695|NCT00945750|2604050|P2|STARTED|Period III||5
1074696|NCT00945750|2604051|P1|STARTED|Period III||5
1074697|NCT00945750|2604046|P6|NOT COMPLETED|Period II||0
1074698|NCT00945750|2604047|P5|NOT COMPLETED|Period II||0
1074699|NCT00945750|2604048|P4|NOT COMPLETED|Period II||0
1074700|NCT00945750|2604049|P3|NOT COMPLETED|Period II||0
1074701|NCT00945750|2604050|P2|NOT COMPLETED|Period II||0
1074702|NCT00945750|2604051|P1|NOT COMPLETED|Period II||0
1074703|NCT00945750|2604046|P6|COMPLETED|Period II||5
1074704|NCT00945750|2604047|P5|COMPLETED|Period II||5
1074705|NCT00945750|2604048|P4|COMPLETED|Period II||5
1074706|NCT00945750|2604049|P3|COMPLETED|Period II||5
1074707|NCT00945750|2604050|P2|COMPLETED|Period II||5
1074708|NCT00945750|2604051|P1|COMPLETED|Period II||5
1074709|NCT00945750|2604046|P6|STARTED|Period II||5
1074710|NCT00945750|2604047|P5|STARTED|Period II||5
1074711|NCT00945750|2604048|P4|STARTED|Period II||5
1074712|NCT00945750|2604049|P3|STARTED|Period II||5
1074713|NCT00945750|2604050|P2|STARTED|Period II||5
1074714|NCT00945750|2604051|P1|STARTED|Period II||5
1074715|NCT00945750|2604046|P6|NOT COMPLETED|Period I||0
1074716|NCT00945750|2604047|P5|NOT COMPLETED|Period I||0
1074717|NCT00945750|2604048|P4|NOT COMPLETED|Period I||0
1074718|NCT00945750|2604049|P3|NOT COMPLETED|Period I||0
1074719|NCT00945750|2604050|P2|NOT COMPLETED|Period I||0
1074720|NCT00945750|2604051|P1|NOT COMPLETED|Period I||0
1074721|NCT00945750|2604046|P6|COMPLETED|Period I||5
1074722|NCT00945750|2604047|P5|COMPLETED|Period I||5
1074723|NCT00945750|2604048|P4|COMPLETED|Period I||5
1074724|NCT00945750|2604049|P3|COMPLETED|Period I||5
1074725|NCT00945750|2604050|P2|COMPLETED|Period I||5
1074726|NCT00945750|2604051|P1|COMPLETED|Period I||5
1074727|NCT00945750|2604046|P6|STARTED|Period I||5
1074728|NCT00945750|2604047|P5|STARTED|Period I||5
1074729|NCT00945750|2604048|P4|STARTED|Period I||5
1074730|NCT00945750|2604049|P3|STARTED|Period I||5
1074731|NCT00945750|2604050|P2|STARTED|Period I||5
1074732|NCT00945750|2604051|P1|STARTED|Period I||5
1074733|NCT00945815|2604064|P1|NOT COMPLETED|Overall Study||8
1074734|NCT00945815|2604064|P1|COMPLETED|Overall Study||27
1074735|NCT00945815|2604064|P1|Eligible and Began Protocol Therapy|Overall Study||31
1074736|NCT00945815|2604064|P1|Eligible|Overall Study||32
1074737|NCT00945815|2604064|P1|STARTED|Overall Study||35
1074738|NCT00945854|2604071|P2|NOT COMPLETED|Overall Study||4
1074739|NCT00945854|2604072|P1|NOT COMPLETED|Overall Study||2
1074740|NCT00945854|2604071|P2|COMPLETED|Overall Study||26
1074741|NCT00945854|2604072|P1|COMPLETED|Overall Study||28
1074742|NCT00945854|2604071|P2|STARTED|Overall Study||30
1074743|NCT00945854|2604072|P1|STARTED|Overall Study||30
1074744|NCT00945893|2604084|P2|NOT COMPLETED|Overall Study||10
1074745|NCT00945893|2604085|P1|NOT COMPLETED|Overall Study||3
1074746|NCT00945893|2604084|P2|COMPLETED|Overall Study||230
1074747|NCT00945893|2604085|P1|COMPLETED|Overall Study||57
1074748|NCT00945893|2604084|P2|Day 15 Post Dose 2|Overall Study||226
1074749|NCT00945893|2604085|P1|Day 15 Post Dose 2|Overall Study||54
1074750|NCT00945893|2604084|P2|Day 15 Post Dose 1|Overall Study||238
1074751|NCT00945893|2604085|P1|Day 15 Post Dose 1|Overall Study||60
1074752|NCT00945893|2604084|P2|STARTED|Overall Study||240
1074753|NCT00945893|2604085|P1|STARTED|Overall Study||60
1074754|NCT00945906|2604149|P1|NOT COMPLETED|Overall Study||7
1074755|NCT00945906|2604149|P1|COMPLETED|Overall Study||54
1074756|NCT00945906|2604149|P1|STARTED|Overall Study||61
1074757|NCT00945945|2604160|P2|NOT COMPLETED|Overall Study||55
1074758|NCT00945945|2604161|P1|NOT COMPLETED|Overall Study||36
1074759|NCT00945945|2604160|P2|COMPLETED|Overall Study||162
1074760|NCT00945945|2604161|P1|COMPLETED|Overall Study||171
1074761|NCT00945945|2604160|P2|STARTED|Overall Study||217
1074762|NCT00945945|2604161|P1|STARTED|Overall Study||207
1074763|NCT00945958|2604187|P1|NOT COMPLETED|Overall Study||12
1074764|NCT00945958|2604187|P1|COMPLETED|Overall Study||149
1074765|NCT00945958|2604187|P1|STARTED|Overall Study||161
1074766|NCT00946088|2604194|P2|NOT COMPLETED|Overall Study||1
1074767|NCT00946088|2604195|P1|NOT COMPLETED|Overall Study||0
1074768|NCT00946088|2604194|P2|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|2
1074769|NCT00946088|2604195|P1|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|4
1074770|NCT00946088|2604194|P2|STARTED|Overall Study||3
1074771|NCT00946088|2604195|P1|STARTED|Overall Study||4
1074772|NCT00946101|2604219|P2|NOT COMPLETED|Overall Study||2
1074773|NCT00946101|2604220|P1|NOT COMPLETED|Overall Study||4
1074774|NCT00946101|2604219|P2|COMPLETED|Overall Study||63
1074775|NCT00946101|2604220|P1|COMPLETED|Overall Study||257
1074776|NCT00946101|2604219|P2|Day 15 Post Dose 2|Overall Study||63
1074777|NCT00946101|2604220|P1|Day 15 Post Dose 2|Overall Study||254
1074778|NCT00946101|2604219|P2|Day 15 Post Dose 1|Overall Study||64
1074779|NCT00946101|2604220|P1|Day 15 Post Dose 1|Overall Study||260
1074780|NCT00946101|2604219|P2|STARTED|Overall Study||65
1074781|NCT00946101|2604220|P1|STARTED|Overall Study|Intent to Treat population, enrolled and randomized|261
1074782|NCT00946114|2604286|P2|NOT COMPLETED|Overall Study||2
1074783|NCT00946114|2604287|P1|NOT COMPLETED|Overall Study||8
1074784|NCT00946114|2604286|P2|COMPLETED|Overall Study||10
1074785|NCT00946114|2604287|P1|COMPLETED|Overall Study||12
1074786|NCT00946114|2604286|P2|STARTED|Overall Study||12
1074787|NCT00946114|2604287|P1|STARTED|Overall Study||20
1074788|NCT00938366|2604295|P2|NOT COMPLETED|Overall Study||0
1074789|NCT00938366|2604296|P1|NOT COMPLETED|Overall Study||1
1074790|NCT00938366|2604295|P2|COMPLETED|Overall Study||9
1074791|NCT00938366|2604296|P1|COMPLETED|Overall Study||8
1074792|NCT00938366|2604295|P2|STARTED|Overall Study||9
1074793|NCT00938366|2604296|P1|STARTED|Overall Study||9
1074794|NCT00938392|2604318|P2|NOT COMPLETED|Overall Study||4
1074795|NCT00938392|2604319|P1|NOT COMPLETED|Overall Study||2
1074796|NCT00938392|2604318|P2|COMPLETED|Overall Study||358
1074797|NCT00938392|2604319|P1|COMPLETED|Overall Study||360
1074798|NCT00938392|2604318|P2|STARTED|Overall Study||362
1074799|NCT00938392|2604319|P1|STARTED|Overall Study||362
1074800|NCT00938431|2604346|P3|NOT COMPLETED|Overall Study||8
1074801|NCT00938431|2604347|P2|NOT COMPLETED|Overall Study||9
1074802|NCT00938431|2604348|P1|NOT COMPLETED|Overall Study||6
1074803|NCT00938431|2604346|P3|COMPLETED|Overall Study||1
1074804|NCT00938431|2604347|P2|COMPLETED|Overall Study||14
1074805|NCT00938431|2604348|P1|COMPLETED|Overall Study||9
1074806|NCT00938431|2604346|P3|STARTED|Overall Study||9
1074807|NCT00938431|2604347|P2|STARTED|Overall Study||23
1074808|NCT00938431|2604348|P1|STARTED|Overall Study||15
1074809|NCT00938457|2604373|P1|NOT COMPLETED|Overall Study||0
1074810|NCT00938457|2604373|P1|COMPLETED|Overall Study||3
1074811|NCT00938457|2604373|P1|STARTED|Overall Study||3
1074812|NCT00938470|2604388|P2|NOT COMPLETED|Overall Study||3
1074813|NCT00938470|2604389|P1|NOT COMPLETED|Overall Study||7
1074814|NCT00938470|2604388|P2|COMPLETED|Overall Study||25
1074815|NCT00938470|2604389|P1|COMPLETED|Overall Study||27
1074816|NCT00938470|2604388|P2|STARTED|Overall Study||28
1074817|NCT00938470|2604389|P1|STARTED|Overall Study||34
1074818|NCT00938548|2604405|P2|NOT COMPLETED|Overall Study||0
1074819|NCT00938548|2604406|P1|NOT COMPLETED|Overall Study||0
1074820|NCT00938548|2604405|P2|COMPLETED|Overall Study||35
1074821|NCT00938548|2604406|P1|COMPLETED|Overall Study||35
1074822|NCT00938548|2604405|P2|STARTED|Overall Study||35
1074823|NCT00938548|2604406|P1|STARTED|Overall Study||35
1074824|NCT00938639|2604418|P2|NOT COMPLETED|Overall Study||4
1074825|NCT00938639|2604419|P1|NOT COMPLETED|Overall Study||3
1074826|NCT00938639|2604418|P2|COMPLETED|Overall Study||116
1074827|NCT00938639|2604419|P1|COMPLETED|Overall Study||117
1074828|NCT00938639|2604418|P2|STARTED|Overall Study||120
1074829|NCT00938639|2604419|P1|STARTED|Overall Study||120
1074830|NCT00938704|2604489|P2|NOT COMPLETED|Overall Study||0
1074831|NCT00938704|2604490|P1|NOT COMPLETED|Overall Study||0
1074832|NCT00938704|2604489|P2|COMPLETED|Overall Study||37
1074833|NCT00938704|2604490|P1|COMPLETED|Overall Study||33
1074834|NCT00938704|2604489|P2|STARTED|Overall Study||37
1074835|NCT00938704|2604490|P1|STARTED|Overall Study||33
1074836|NCT00938717|2604506|P2|NOT COMPLETED|Overall Study||108
1074837|NCT00938717|2604507|P1|NOT COMPLETED|Overall Study||98
1074838|NCT00938717|2604506|P2|COMPLETED|Overall Study||294
1074839|NCT00938717|2604507|P1|COMPLETED|Overall Study||305
1074840|NCT00938717|2604506|P2|STARTED|Overall Study||402
1074841|NCT00938717|2604507|P1|STARTED|Overall Study||403
1074842|NCT00938782|2604541|P2|NOT COMPLETED|Overall Study||0
1074843|NCT00938782|2604542|P1|NOT COMPLETED|Overall Study||0
1074844|NCT00938782|2604541|P2|COMPLETED|Overall Study|Upon discharge from PACU|35
1074845|NCT00938782|2604542|P1|COMPLETED|Overall Study|Upon discharge from PACU|32
1074846|NCT00938782|2604541|P2|STARTED|Overall Study|Monitoring started pre-induction of anesthesia|35
1074847|NCT00938782|2604542|P1|STARTED|Overall Study|Pre-induction of anesthesia|32
1074848|NCT00938860|2604550|P2|NOT COMPLETED|Overall Study||17
1074849|NCT00938860|2604551|P1|NOT COMPLETED|Overall Study||25
1074850|NCT00938860|2604550|P2|COMPLETED|Overall Study||25
1074851|NCT00938860|2604551|P1|COMPLETED|Overall Study||25
1074852|NCT00938860|2604550|P2|Efficacy Population|Overall Study||41
1074853|NCT00938860|2604551|P1|Efficacy Population|Overall Study||40
1074854|NCT00938860|2604550|P2|STARTED|Overall Study||42
1074855|NCT00938860|2604551|P1|STARTED|Overall Study|Intent-to-Treat (ITT) population. ITT population consisted of all randomized patients|50
1074856|NCT00938886|2604575|P2|NOT COMPLETED|Overall Study||10
1074857|NCT00938886|2604576|P1|NOT COMPLETED|Overall Study||7
1074858|NCT00938886|2604575|P2|COMPLETED|Overall Study||65
1074859|NCT00938886|2604576|P1|COMPLETED|Overall Study||68
1074860|NCT00938886|2604575|P2|Attended 1 Counseling Session|Overall Study||70
1074861|NCT00938886|2604576|P1|Attended 1 Counseling Session|Overall Study||70
1074862|NCT00938886|2604575|P2|STARTED|Overall Study||75
1074863|NCT00938886|2604576|P1|STARTED|Overall Study||75
1074864|NCT00938964|2604586|P2|NOT COMPLETED|Overall Study||28
1074865|NCT00938964|2604587|P1|NOT COMPLETED|Overall Study||30
1074866|NCT00938964|2604586|P2|COMPLETED|Overall Study||209
1074867|NCT00938964|2604587|P1|COMPLETED|Overall Study||211
1074868|NCT00938964|2604586|P2|STARTED|Overall Study||237
1074869|NCT00938964|2604587|P1|STARTED|Overall Study||241
1074870|NCT00939003|2604627|P2|NOT COMPLETED|Open-label Treatment Period||29
1074871|NCT00939003|2604628|P1|NOT COMPLETED|Open-label Treatment Period||29
1074872|NCT00939003|2604627|P2|COMPLETED|Open-label Treatment Period||62
1074873|NCT00939003|2604628|P1|COMPLETED|Open-label Treatment Period||66
1074874|NCT00939003|2604627|P2|STARTED|Open-label Treatment Period||91
1074875|NCT00939003|2604628|P1|STARTED|Open-label Treatment Period||95
1074876|NCT00939003|2604627|P2|NOT COMPLETED|Double-blind Treatment Period||4
1074877|NCT00939003|2604628|P1|NOT COMPLETED|Double-blind Treatment Period||2
1074878|NCT00939003|2604627|P2|COMPLETED|Double-blind Treatment Period||91
1074879|NCT00939003|2604628|P1|COMPLETED|Double-blind Treatment Period||95
1074880|NCT00939003|2604627|P2|STARTED|Double-blind Treatment Period||95
1074881|NCT00939003|2604628|P1|STARTED|Double-blind Treatment Period||97
1074882|NCT00939029|2604665|P2|NOT COMPLETED|Overall Study||12
1074883|NCT00939029|2604666|P1|NOT COMPLETED|Overall Study||6
1074884|NCT00939029|2604665|P2|COMPLETED|Overall Study||15
1074885|NCT00939029|2604666|P1|COMPLETED|Overall Study||19
1074886|NCT00939029|2604665|P2|STARTED|Overall Study||27
1074887|NCT00939029|2604666|P1|STARTED|Overall Study||25
1074888|NCT00939055|2604678|P2|NOT COMPLETED|Overall Study||0
1074889|NCT00939055|2604679|P1|NOT COMPLETED|Overall Study||4
1074890|NCT00939055|2604678|P2|COMPLETED|Overall Study||39
1074891|NCT00939055|2604679|P1|COMPLETED|Overall Study||69
1074892|NCT00939055|2604678|P2|STARTED|Overall Study||39
1074893|NCT00939055|2604679|P1|STARTED|Overall Study||73
1074894|NCT00939094|2604689|P2|NOT COMPLETED|Overall Study||10
1074895|NCT00939094|2604690|P1|NOT COMPLETED|Overall Study||14
1074896|NCT00939094|2604689|P2|COMPLETED|Overall Study||35
1074897|NCT00939094|2604690|P1|COMPLETED|Overall Study||28
1074898|NCT00939094|2604689|P2|STARTED|Overall Study||45
1074899|NCT00939094|2604690|P1|STARTED|Overall Study||42
1074900|NCT00939107|2604712|P2|NOT COMPLETED|Overall Study||12
1074901|NCT00939107|2604713|P1|NOT COMPLETED|Overall Study||14
1074902|NCT00939107|2604712|P2|COMPLETED|Overall Study||163
1074903|NCT00939107|2604713|P1|COMPLETED|Overall Study||161
1074904|NCT00939107|2604712|P2|12 Months Follow-up|Overall Study||163
1074905|NCT00939107|2604713|P1|12 Months Follow-up|Overall Study||161
1074906|NCT00939107|2604712|P2|STARTED|Overall Study||175
1074907|NCT00939107|2604713|P1|STARTED|Overall Study||175
1074908|NCT00939120|2604727|P2|NOT COMPLETED|Overall Study||5
1074909|NCT00939120|2604728|P1|NOT COMPLETED|Overall Study||8
1074910|NCT00939120|2604727|P2|COMPLETED|Overall Study||18
1074911|NCT00939120|2604728|P1|COMPLETED|Overall Study||15
1074912|NCT00939120|2604727|P2|STARTED|Overall Study||23
1074913|NCT00939120|2604728|P1|STARTED|Overall Study||23
1074914|NCT00939159|2604750|P1|NOT COMPLETED|Overall Study||0
1074915|NCT00939159|2604750|P1|COMPLETED|Overall Study||13
1074916|NCT00939159|2604750|P1|STARTED|Overall Study||13
1074917|NCT00939185|2604754|P1|NOT COMPLETED|Overall Study||25
1074918|NCT00939185|2604754|P1|COMPLETED|Overall Study||375
1074919|NCT00939185|2604754|P1|Received Treatment|Overall Study||390
1074920|NCT00939185|2604754|P1|STARTED|Overall Study||400
1074921|NCT00939211|2604761|P1|NOT COMPLETED|Placebo||0
1074922|NCT00939211|2604761|P1|COMPLETED|Placebo||28
1074923|NCT00939211|2604761|P1|STARTED|Placebo||28
1074924|NCT00939211|2604761|P1|NOT COMPLETED|Spiriva 18 Mcg First, Then Placebo||0
1074925|NCT00939211|2604761|P1|COMPLETED|Spiriva 18 Mcg First, Then Placebo||28
1074926|NCT00939211|2604761|P1|STARTED|Spiriva 18 Mcg First, Then Placebo||28
1074927|NCT00939211|2604761|P1|NOT COMPLETED|AZD9164 1200 Mcg First, Then Placebo||0
1074928|NCT00939211|2604761|P1|COMPLETED|AZD9164 1200 Mcg First, Then Placebo||28
1074929|NCT00939211|2604761|P1|STARTED|AZD9164 1200 Mcg First, Then Placebo||28
1074930|NCT00939211|2604761|P1|NOT COMPLETED|AZD9164 400 Mcg First, Then Placebo||0
1074931|NCT00939211|2604761|P1|COMPLETED|AZD9164 400 Mcg First, Then Placebo||28
1074932|NCT00939211|2604761|P1|STARTED|AZD9164 400 Mcg First, Then Placebo||28
1074933|NCT00939211|2604761|P1|NOT COMPLETED|AZD9164 100 Mcg First, Then Placebo||0
1074934|NCT00939211|2604761|P1|COMPLETED|AZD9164 100 Mcg First, Then Placebo||28
1074935|NCT00939211|2604761|P1|STARTED|AZD9164 100 Mcg First, Then Placebo|Cross-over study|28
1074936|NCT00939341|2604823|P1|NOT COMPLETED|Overall Study||66
1074937|NCT00939341|2604823|P1|COMPLETED|Overall Study|862 participants entered into the 12-week treatment,66 discontinued, 796 completed the treatment.|796
1074938|NCT00939341|2604823|P1|STARTED|Overall Study|1022 participants were enrolled. There were 160 screen failures, 862 proceeded to treatment period.|862
1074939|NCT00939367|2604843|P2|NOT COMPLETED|Second Intervention||0
1074940|NCT00939367|2604844|P1|NOT COMPLETED|Second Intervention||0
1074941|NCT00939367|2604843|P2|COMPLETED|Second Intervention||15
1074942|NCT00939367|2604844|P1|COMPLETED|Second Intervention||15
1074943|NCT00939367|2604843|P2|STARTED|Second Intervention||15
1074944|NCT00939367|2604844|P1|STARTED|Second Intervention||15
1074945|NCT00939367|2604843|P2|NOT COMPLETED|First Intervention||0
1074946|NCT00939367|2604844|P1|NOT COMPLETED|First Intervention||0
1074947|NCT00939367|2604843|P2|COMPLETED|First Intervention||15
1074948|NCT00939367|2604844|P1|COMPLETED|First Intervention||15
1074949|NCT00939367|2604843|P2|STARTED|First Intervention||15
1074950|NCT00939367|2604844|P1|STARTED|First Intervention||15
1074957|NCT00939471|2604877|P1|NOT COMPLETED|Overall Study||11
1074958|NCT00939471|2604877|P1|COMPLETED|Overall Study||33
1074959|NCT00939471|2604877|P1|STARTED|Overall Study||44
1074960|NCT00939484|2604891|P3|NOT COMPLETED|Overall Study||3
1074961|NCT00939484|2604892|P2|NOT COMPLETED|Overall Study||20
1074962|NCT00939484|2604893|P1|NOT COMPLETED|Overall Study||8
1074963|NCT00939484|2604891|P3|COMPLETED|Overall Study||0
1074964|NCT00939484|2604892|P2|COMPLETED|Overall Study||0
1074965|NCT00939484|2604893|P1|COMPLETED|Overall Study||0
1074966|NCT00939484|2604891|P3|STARTED|Overall Study||3
1074967|NCT00939484|2604892|P2|STARTED|Overall Study||20
1074968|NCT00939484|2604893|P1|STARTED|Overall Study||8
1074969|NCT00939510|2604906|P1|NOT COMPLETED|Overall Study||1
1074970|NCT00939510|2604906|P1|COMPLETED|Overall Study||31
1074971|NCT00939510|2604906|P1|STARTED|Overall Study||32
1074972|NCT00939536|2604914|P2|NOT COMPLETED|Second Intervention||0
1074973|NCT00939536|2604915|P1|NOT COMPLETED|Second Intervention||0
1074974|NCT00939536|2604914|P2|COMPLETED|Second Intervention||12
1074975|NCT00939536|2604915|P1|COMPLETED|Second Intervention||12
1074976|NCT00939536|2604914|P2|STARTED|Second Intervention||12
1074977|NCT00939536|2604915|P1|STARTED|Second Intervention||12
1074978|NCT00939536|2604914|P2|NOT COMPLETED|First Intervention||0
1074979|NCT00939536|2604915|P1|NOT COMPLETED|First Intervention||0
1074980|NCT00939536|2604914|P2|COMPLETED|First Intervention||12
1074981|NCT00939536|2604915|P1|COMPLETED|First Intervention||12
1074982|NCT00939536|2604914|P2|STARTED|First Intervention||12
1074983|NCT00939536|2604915|P1|STARTED|First Intervention||12
1074984|NCT00939562|2604925|P2|NOT COMPLETED|Period 2||0
1074985|NCT00939562|2604926|P1|NOT COMPLETED|Period 2||0
1074986|NCT00939562|2604925|P2|COMPLETED|Period 2||12
1074987|NCT00939562|2604926|P1|COMPLETED|Period 2||12
1074988|NCT00939562|2604925|P2|STARTED|Period 2||12
1074989|NCT00939562|2604926|P1|STARTED|Period 2||12
1074990|NCT00939562|2604925|P2|NOT COMPLETED|Period 1||0
1074991|NCT00939562|2604926|P1|NOT COMPLETED|Period 1||0
1074992|NCT00939562|2604925|P2|COMPLETED|Period 1||12
1074993|NCT00939562|2604926|P1|COMPLETED|Period 1||12
1074994|NCT00939562|2604925|P2|STARTED|Period 1||12
1074995|NCT00939562|2604926|P1|STARTED|Period 1||12
1074996|NCT00939627|2604936|P3|NOT COMPLETED|Overall Study||0
1074997|NCT00939627|2604937|P2|NOT COMPLETED|Overall Study||28
1074998|NCT00939627|2604938|P1|NOT COMPLETED|Overall Study||27
1074999|NCT00939627|2604936|P3|COMPLETED|Overall Study||0
1075000|NCT00939627|2604937|P2|COMPLETED|Overall Study||0
1075001|NCT00939627|2604938|P1|COMPLETED|Overall Study||0
1075002|NCT00939627|2604936|P3|STARTED|Overall Study||0
1075003|NCT00939627|2604937|P2|STARTED|Overall Study||28
1075004|NCT00939627|2604938|P1|STARTED|Overall Study||27
1075005|NCT00939692|2604954|P2|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||1
1075006|NCT00939692|2604955|P1|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||0
1075007|NCT00939692|2604954|P2|COMPLETED|Period 2 - Second Intervent - 5 Days||12
1075008|NCT00939692|2604955|P1|COMPLETED|Period 2 - Second Intervent - 5 Days||12
1075009|NCT00939692|2604954|P2|STARTED|Period 2 - Second Intervent - 5 Days||13
1075010|NCT00939692|2604955|P1|STARTED|Period 2 - Second Intervent - 5 Days||12
1075011|NCT00939692|2604954|P2|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
1075012|NCT00939692|2604955|P1|NOT COMPLETED|Period 1 - First Intervention - 5 Days||1
1075013|NCT00939692|2604954|P2|COMPLETED|Period 1 - First Intervention - 5 Days||13
1075014|NCT00939692|2604955|P1|COMPLETED|Period 1 - First Intervention - 5 Days||12
1075015|NCT00939692|2604954|P2|STARTED|Period 1 - First Intervention - 5 Days||13
1075016|NCT00939692|2604955|P1|STARTED|Period 1 - First Intervention - 5 Days||13
1075017|NCT00939705|2604967|P2|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
1075018|NCT00939705|2604968|P1|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
1075019|NCT00939705|2604967|P2|COMPLETED|Period 3 - Second Intervent - 5 Days||9
1075020|NCT00939705|2604968|P1|COMPLETED|Period 3 - Second Intervent - 5 Days||9
1075021|NCT00939705|2604967|P2|STARTED|Period 3 - Second Intervent - 5 Days||9
1075022|NCT00939705|2604968|P1|STARTED|Period 3 - Second Intervent - 5 Days||9
1075023|NCT00939705|2604967|P2|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
1075024|NCT00939705|2604968|P1|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
1075025|NCT00939705|2604967|P2|COMPLETED|Period 2 - Washout Period - 21 Days||9
1075026|NCT00939705|2604968|P1|COMPLETED|Period 2 - Washout Period - 21 Days||9
1075027|NCT00939705|2604967|P2|STARTED|Period 2 - Washout Period - 21 Days||9
1075028|NCT00939705|2604968|P1|STARTED|Period 2 - Washout Period - 21 Days||9
1075029|NCT00939705|2604967|P2|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
1075030|NCT00939705|2604968|P1|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
1075031|NCT00939705|2604967|P2|COMPLETED|Period 1 - First Intervention - 5 Days||9
1075032|NCT00939705|2604968|P1|COMPLETED|Period 1 - First Intervention - 5 Days||9
1075033|NCT00939705|2604967|P2|STARTED|Period 1 - First Intervention - 5 Days||9
1075034|NCT00939705|2604968|P1|STARTED|Period 1 - First Intervention - 5 Days||9
1075035|NCT00939731|2604978|P2|NOT COMPLETED|Second Intervention Period||0
1075036|NCT00939731|2604979|P1|NOT COMPLETED|Second Intervention Period||0
1075037|NCT00939731|2604978|P2|COMPLETED|Second Intervention Period||12
1075038|NCT00939731|2604979|P1|COMPLETED|Second Intervention Period||12
1075039|NCT00939731|2604978|P2|STARTED|Second Intervention Period||12
1075040|NCT00939731|2604979|P1|STARTED|Second Intervention Period||12
1075041|NCT00939731|2604978|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1075136|NCT00946309|2605206|P2|COMPLETED|Overall Study||19
1075042|NCT00939731|2604979|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1075043|NCT00939731|2604978|P2|COMPLETED|Washout Period (at Least 14 Days)||12
1075044|NCT00939731|2604979|P1|COMPLETED|Washout Period (at Least 14 Days)||12
1075045|NCT00939731|2604978|P2|STARTED|Washout Period (at Least 14 Days)||12
1075046|NCT00939731|2604979|P1|STARTED|Washout Period (at Least 14 Days)||12
1075047|NCT00939731|2604978|P2|NOT COMPLETED|First Intervention Period||0
1075048|NCT00939731|2604979|P1|NOT COMPLETED|First Intervention Period||0
1075049|NCT00939731|2604978|P2|COMPLETED|First Intervention Period||12
1075050|NCT00939731|2604979|P1|COMPLETED|First Intervention Period||12
1075051|NCT00939731|2604978|P2|STARTED|First Intervention Period||12
1075052|NCT00939731|2604979|P1|STARTED|First Intervention Period||12
1075053|NCT00939783|2604997|P1|NOT COMPLETED|Overall Study||649
1075054|NCT00939783|2604997|P1|COMPLETED|Overall Study||0
1075055|NCT00939783|2604997|P1|Treated|Overall Study||648
1075056|NCT00939783|2604997|P1|STARTED|Overall Study||649
1075057|NCT00939796|2605004|P1|NOT COMPLETED|Overall Study||0
1075058|NCT00939796|2605004|P1|COMPLETED|Overall Study||16
1075059|NCT00939796|2605004|P1|STARTED|Overall Study||16
1075060|NCT00939809|2605010|P1|NOT COMPLETED|Overall Study||3
1075061|NCT00939809|2605010|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|28
1075062|NCT00939809|2605010|P1|STARTED|Overall Study||31
1075063|NCT00939874|2605018|P1|NOT COMPLETED|Overall Study||20
1075064|NCT00939874|2605018|P1|COMPLETED|Overall Study||32
1075065|NCT00939874|2605018|P1|Completed Week 48|Overall Study||37
1075066|NCT00939874|2605018|P1|STARTED|Overall Study||52
1075067|NCT00939900|2605025|P2|NOT COMPLETED|Overall Study||7
1075068|NCT00939900|2605026|P1|NOT COMPLETED|Overall Study||2
1075069|NCT00939900|2605025|P2|COMPLETED|Overall Study||48
1075070|NCT00939900|2605026|P1|COMPLETED|Overall Study||53
1075071|NCT00939900|2605025|P2|STARTED|Overall Study||55
1075072|NCT00939900|2605026|P1|STARTED|Overall Study||55
1075073|NCT00939952|2605032|P1|NOT COMPLETED|Overall Study||0
1075074|NCT00939952|2605032|P1|COMPLETED|Overall Study||7
1075075|NCT00939952|2605032|P1|STARTED|Overall Study||7
1075076|NCT00939991|2605044|P2|NOT COMPLETED|Overall Study||0
1075077|NCT00939991|2605045|P1|NOT COMPLETED|Overall Study||0
1075078|NCT00939991|2605044|P2|COMPLETED|Overall Study||39
1075079|NCT00939991|2605045|P1|COMPLETED|Overall Study||9
1075080|NCT00939991|2605044|P2|STARTED|Overall Study||39
1075081|NCT00939991|2605045|P1|STARTED|Overall Study||9
1075082|NCT00940017|2605055|P1|NOT COMPLETED|Overall Study||4
1075083|NCT00940017|2605055|P1|COMPLETED|Overall Study||20
1075084|NCT00940017|2605055|P1|Subjects Treated|Overall Study||21
1075085|NCT00940017|2605055|P1|STARTED|Overall Study||24
1075086|NCT00940108|2605078|P4|NOT COMPLETED|Overall Study||5
1075087|NCT00940108|2605079|P3|NOT COMPLETED|Overall Study||3
1075088|NCT00940108|2605080|P2|NOT COMPLETED|Overall Study||9
1075089|NCT00940108|2605081|P1|NOT COMPLETED|Overall Study||5
1075090|NCT00940108|2605078|P4|COMPLETED|Overall Study||99
1075091|NCT00940108|2605079|P3|COMPLETED|Overall Study||100
1075092|NCT00940108|2605080|P2|COMPLETED|Overall Study||71
1075093|NCT00940108|2605081|P1|COMPLETED|Overall Study||77
1075094|NCT00940108|2605078|P4|STARTED|Overall Study||104
1075095|NCT00940108|2605079|P3|STARTED|Overall Study||103
1075096|NCT00940108|2605080|P2|STARTED|Overall Study||80
1075097|NCT00940108|2605081|P1|STARTED|Overall Study||82
1075098|NCT00940290|2605135|P4|NOT COMPLETED|Overall Study||0
1075099|NCT00940290|2605136|P3|NOT COMPLETED|Overall Study||0
1075100|NCT00940290|2605137|P2|NOT COMPLETED|Overall Study||0
1075101|NCT00940290|2605138|P1|NOT COMPLETED|Overall Study||0
1075102|NCT00940290|2605135|P4|COMPLETED|Overall Study||54
1075103|NCT00940290|2605136|P3|COMPLETED|Overall Study||55
1075104|NCT00940290|2605137|P2|COMPLETED|Overall Study||53
1075105|NCT00940290|2605138|P1|COMPLETED|Overall Study||54
1075106|NCT00940290|2605135|P4|STARTED|Overall Study||54
1075107|NCT00940290|2605136|P3|STARTED|Overall Study||55
1075108|NCT00940290|2605137|P2|STARTED|Overall Study||53
1075109|NCT00940290|2605138|P1|STARTED|Overall Study||54
1075110|NCT00940485|2605150|P2|NOT COMPLETED|Overall Study||7
1075111|NCT00940485|2605151|P1|NOT COMPLETED|Overall Study||15
1075112|NCT00940485|2605150|P2|COMPLETED|Overall Study||93
1075113|NCT00940485|2605151|P1|COMPLETED|Overall Study||82
1075114|NCT00940485|2605150|P2|STARTED|Overall Study||100
1075115|NCT00940485|2605151|P1|STARTED|Overall Study||97
1075116|NCT00940537|2605177|P2|NOT COMPLETED|Overall Study||0
1075117|NCT00940537|2605178|P1|NOT COMPLETED|Overall Study||0
1075118|NCT00940537|2605177|P2|COMPLETED|Overall Study||9
1075119|NCT00940537|2605178|P1|COMPLETED|Overall Study||5
1075120|NCT00940537|2605177|P2|STARTED|Overall Study||9
1075121|NCT00940537|2605178|P1|STARTED|Overall Study||5
1075122|NCT00940576|2605187|P2|NOT COMPLETED|Overall Study||0
1075123|NCT00940576|2605188|P1|NOT COMPLETED|Overall Study||0
1075124|NCT00940576|2605187|P2|COMPLETED|Overall Study||9
1075125|NCT00940576|2605188|P1|COMPLETED|Overall Study||8
1075126|NCT00940576|2605187|P2|STARTED|Overall Study||9
1075127|NCT00940576|2605188|P1|STARTED|Overall Study||8
1075128|NCT00946296|2605197|P2|NOT COMPLETED|Overall Study||0
1075129|NCT00946296|2605198|P1|NOT COMPLETED|Overall Study||3
1075130|NCT00946296|2605197|P2|COMPLETED|Overall Study||15
1075131|NCT00946296|2605198|P1|COMPLETED|Overall Study||18
1075132|NCT00946296|2605197|P2|STARTED|Overall Study||15
1075133|NCT00946296|2605198|P1|STARTED|Overall Study||21
1075134|NCT00946309|2605206|P2|NOT COMPLETED|Overall Study||4
1075135|NCT00946309|2605207|P1|NOT COMPLETED|Overall Study||1
1075137|NCT00946309|2605207|P1|COMPLETED|Overall Study||21
1075138|NCT00946309|2605206|P2|STARTED|Overall Study||23
1075139|NCT00946309|2605207|P1|STARTED|Overall Study||22
1075140|NCT00946322|2605223|P1|NOT COMPLETED|Post-treatment||2
1075141|NCT00946322|2605223|P1|COMPLETED|Post-treatment||9
1075142|NCT00946322|2605223|P1|STARTED|Post-treatment||11
1075143|NCT00946322|2605223|P1|NOT COMPLETED|Pre-treatment||1
1075144|NCT00946322|2605223|P1|COMPLETED|Pre-treatment||11
1075145|NCT00946322|2605223|P1|STARTED|Pre-treatment||12
1075146|NCT00946348|2605236|P2|NOT COMPLETED|Overall Study||0
1075147|NCT00946348|2605237|P1|NOT COMPLETED|Overall Study||0
1075148|NCT00946348|2605236|P2|COMPLETED|Overall Study||6
1075149|NCT00946348|2605237|P1|COMPLETED|Overall Study||6
1075150|NCT00946348|2605236|P2|STARTED|Overall Study||6
1075151|NCT00946348|2605237|P1|STARTED|Overall Study||6
1075152|NCT00946478|2605245|P2|NOT COMPLETED|Overall Study||0
1075153|NCT00946478|2605246|P1|NOT COMPLETED|Overall Study||0
1075154|NCT00946478|2605245|P2|COMPLETED|Overall Study||20
1075155|NCT00946478|2605246|P1|COMPLETED|Overall Study||20
1075156|NCT00946478|2605245|P2|STARTED|Overall Study||20
1075157|NCT00946478|2605246|P1|STARTED|Overall Study||20
1075158|NCT00946530|2605256|P4|NOT COMPLETED|Overall Study||4
1075159|NCT00946530|2605257|P3|NOT COMPLETED|Overall Study||1
1075160|NCT00946530|2605258|P2|NOT COMPLETED|Overall Study||4
1075161|NCT00946530|2605259|P1|NOT COMPLETED|Overall Study||1
1075162|NCT00946530|2605256|P4|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|23
1075163|NCT00946530|2605257|P3|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
1075164|NCT00946530|2605258|P2|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver completed to the Dim Light (Control) arm|23
1075165|NCT00946530|2605259|P1|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
1075166|NCT00946530|2605256|P4|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
1075167|NCT00946530|2605257|P3|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
1075168|NCT00946530|2605258|P2|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
1075169|NCT00946530|2605259|P1|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
1075170|NCT00948389|2605278|P5|NOT COMPLETED|Overall Study||1
1075171|NCT00948389|2605279|P4|NOT COMPLETED|Overall Study||9
1075172|NCT00948389|2605280|P3|NOT COMPLETED|Overall Study||7
1075173|NCT00948389|2605281|P2|NOT COMPLETED|Overall Study||3
1075174|NCT00948389|2605282|P1|NOT COMPLETED|Overall Study||6
1075175|NCT00948389|2605278|P5|COMPLETED|Overall Study||0
1075176|NCT00948389|2605279|P4|COMPLETED|Overall Study||0
1075177|NCT00948389|2605280|P3|COMPLETED|Overall Study||0
1075178|NCT00948389|2605281|P2|COMPLETED|Overall Study||0
1075179|NCT00948389|2605282|P1|COMPLETED|Overall Study||0
1075180|NCT00948389|2605278|P5|STARTED|Overall Study||1
1075181|NCT00948389|2605279|P4|STARTED|Overall Study||9
1075182|NCT00948389|2605280|P3|STARTED|Overall Study||7
1075183|NCT00948389|2605281|P2|STARTED|Overall Study||3
1075184|NCT00948389|2605282|P1|STARTED|Overall Study||6
1075185|NCT00948441|2605321|P2|NOT COMPLETED|Overall Study||4
1075186|NCT00948441|2605322|P1|NOT COMPLETED|Overall Study||1
1075187|NCT00948441|2605321|P2|COMPLETED|Overall Study||4
1075188|NCT00948441|2605322|P1|COMPLETED|Overall Study||7
1075189|NCT00948441|2605321|P2|STARTED|Overall Study||8
1075190|NCT00948441|2605322|P1|STARTED|Overall Study||8
1075191|NCT00948506|2605332|P2|NOT COMPLETED|Overall Study||1
1075192|NCT00948506|2605333|P1|NOT COMPLETED|Overall Study||3
1075193|NCT00948506|2605332|P2|COMPLETED|Overall Study||8
1075194|NCT00948506|2605333|P1|COMPLETED|Overall Study||8
1075195|NCT00948506|2605332|P2|STARTED|Overall Study||9
1075196|NCT00948506|2605333|P1|STARTED|Overall Study||11
1075197|NCT00948610|2605344|P2|NOT COMPLETED|Overall Study||1
1075198|NCT00948610|2605345|P1|NOT COMPLETED|Overall Study||1
1075199|NCT00948610|2605344|P2|COMPLETED|Overall Study||9
1075200|NCT00948610|2605345|P1|COMPLETED|Overall Study||9
1075201|NCT00948610|2605344|P2|STARTED|Overall Study||10
1075202|NCT00948610|2605345|P1|STARTED|Overall Study||10
1075203|NCT00948675|2605355|P2|NOT COMPLETED|Overall Study||4
1075204|NCT00948675|2605356|P1|NOT COMPLETED|Overall Study||7
1075205|NCT00948675|2605355|P2|COMPLETED|Overall Study||175
1075206|NCT00948675|2605356|P1|COMPLETED|Overall Study||175
1075207|NCT00948675|2605355|P2|STARTED|Overall Study||179
1075208|NCT00948675|2605356|P1|STARTED|Overall Study||182
1075209|NCT00948688|2605370|P2|NOT COMPLETED|Period 2: 100 mg Vorinostat||1
1075210|NCT00948688|2605371|P1|NOT COMPLETED|Period 2: 100 mg Vorinostat||0
1075211|NCT00948688|2605370|P2|COMPLETED|Period 2: 100 mg Vorinostat||5
1075212|NCT00948688|2605371|P1|COMPLETED|Period 2: 100 mg Vorinostat||0
1075213|NCT00948688|2605370|P2|STARTED|Period 2: 100 mg Vorinostat||6
1075214|NCT00948688|2605371|P1|STARTED|Period 2: 100 mg Vorinostat||0
1075215|NCT00948688|2605370|P2|NOT COMPLETED|Period 1: 200 mg Vorinostat||0
1075216|NCT00948688|2605371|P1|NOT COMPLETED|Period 1: 200 mg Vorinostat||2
1075217|NCT00948688|2605370|P2|COMPLETED|Period 1: 200 mg Vorinostat||0
1075218|NCT00948688|2605371|P1|COMPLETED|Period 1: 200 mg Vorinostat||2
1075219|NCT00948688|2605370|P2|STARTED|Period 1: 200 mg Vorinostat||0
1075220|NCT00948688|2605371|P1|STARTED|Period 1: 200 mg Vorinostat||4
1075221|NCT00948766|2605385|P2|NOT COMPLETED|Extension Study||0
1075222|NCT00948766|2605386|P1|NOT COMPLETED|Extension Study||91
1075223|NCT00948766|2605385|P2|COMPLETED|Extension Study||0
1075224|NCT00948766|2605386|P1|COMPLETED|Extension Study||306
1075225|NCT00948766|2605385|P2|Exposed to Study Medication|Extension Study||0
1075226|NCT00948766|2605386|P1|Exposed to Study Medication|Extension Study||396
1075227|NCT00948766|2605385|P2|STARTED|Extension Study|No patients received this treatment in the extension study.|0
1075228|NCT00948766|2605386|P1|STARTED|Extension Study|397 of the 463 patients who completed the core study entered the extension study.|397
1075229|NCT00948766|2605385|P2|NOT COMPLETED|Core Study||126
1075230|NCT00948766|2605386|P1|NOT COMPLETED|Core Study||127
1075231|NCT00948766|2605385|P2|COMPLETED|Core Study||234
1075232|NCT00948766|2605386|P1|COMPLETED|Core Study||229
1075233|NCT00948766|2605385|P2|Exposed to Study Medication|Core Study||359
1075234|NCT00948766|2605386|P1|Exposed to Study Medication|Core Study||355
1075235|NCT00948766|2605385|P2|STARTED|Core Study||360
1075236|NCT00948766|2605386|P1|STARTED|Core Study||356
1075237|NCT00948792|2605402|P1|NOT COMPLETED|Overall Study||0
1075238|NCT00948792|2605402|P1|COMPLETED|Overall Study||21
1075239|NCT00948792|2605402|P1|STARTED|Overall Study||21
1075240|NCT00948818|2605414|P2|NOT COMPLETED|Overall Study||94
1075241|NCT00948818|2605415|P1|NOT COMPLETED|Overall Study||62
1075242|NCT00948818|2605414|P2|COMPLETED|Overall Study||312
1075243|NCT00948818|2605415|P1|COMPLETED|Overall Study||335
1075244|NCT00948818|2605414|P2|STARTED|Overall Study||406
1075245|NCT00948818|2605415|P1|STARTED|Overall Study||397
1075246|NCT00948857|2605452|P2|NOT COMPLETED|Overall Study||0
1075247|NCT00948857|2605453|P1|NOT COMPLETED|Overall Study||1
1075248|NCT00948857|2605452|P2|COMPLETED|Overall Study||2
1075249|NCT00948857|2605453|P1|COMPLETED|Overall Study|3 completed and 1 dropped out.|2
1075250|NCT00948857|2605452|P2|STARTED|Overall Study||2
1075251|NCT00948857|2605453|P1|STARTED|Overall Study||3
1075252|NCT00948896|2605467|P8|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
1075253|NCT00948896|2605468|P7|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
1075254|NCT00948896|2605469|P6|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
1075255|NCT00948896|2605470|P5|NOT COMPLETED|24 Months of Age to 36 Months of Age||1
1075256|NCT00948896|2605471|P4|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
1075257|NCT00948896|2605472|P3|NOT COMPLETED|24 Months of Age to 36 Months of Age||5
1075258|NCT00948896|2605473|P2|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
1075259|NCT00948896|2605474|P1|NOT COMPLETED|24 Months of Age to 36 Months of Age||3
1075260|NCT00948896|2605467|P8|COMPLETED|24 Months of Age to 36 Months of Age||45
1075261|NCT00948896|2605468|P7|COMPLETED|24 Months of Age to 36 Months of Age||43
1075262|NCT00948896|2605469|P6|COMPLETED|24 Months of Age to 36 Months of Age||40
1075263|NCT00948896|2605470|P5|COMPLETED|24 Months of Age to 36 Months of Age||43
1075264|NCT00948896|2605471|P4|COMPLETED|24 Months of Age to 36 Months of Age||85
1075265|NCT00948896|2605472|P3|COMPLETED|24 Months of Age to 36 Months of Age||85
1075266|NCT00948896|2605473|P2|COMPLETED|24 Months of Age to 36 Months of Age||83
1075267|NCT00948896|2605474|P1|COMPLETED|24 Months of Age to 36 Months of Age||87
1075268|NCT00948896|2605467|P8|STARTED|24 Months of Age to 36 Months of Age||45
1075269|NCT00948896|2605468|P7|STARTED|24 Months of Age to 36 Months of Age||43
1075270|NCT00948896|2605469|P6|STARTED|24 Months of Age to 36 Months of Age||42
1075271|NCT00948896|2605470|P5|STARTED|24 Months of Age to 36 Months of Age||44
1075272|NCT00948896|2605471|P4|STARTED|24 Months of Age to 36 Months of Age||87
1075273|NCT00948896|2605472|P3|STARTED|24 Months of Age to 36 Months of Age||90
1075274|NCT00948896|2605473|P2|STARTED|24 Months of Age to 36 Months of Age||85
1075275|NCT00948896|2605474|P1|STARTED|24 Months of Age to 36 Months of Age||90
1075276|NCT00948896|2605467|P8|NOT COMPLETED|Randomization to 24 Months of Age||2
1075277|NCT00948896|2605468|P7|NOT COMPLETED|Randomization to 24 Months of Age||4
1075278|NCT00948896|2605469|P6|NOT COMPLETED|Randomization to 24 Months of Age||4
1075279|NCT00948896|2605470|P5|NOT COMPLETED|Randomization to 24 Months of Age||2
1075280|NCT00948896|2605471|P4|NOT COMPLETED|Randomization to 24 Months of Age||11
1075281|NCT00948896|2605472|P3|NOT COMPLETED|Randomization to 24 Months of Age||9
1075282|NCT00948896|2605473|P2|NOT COMPLETED|Randomization to 24 Months of Age||13
1075283|NCT00948896|2605474|P1|NOT COMPLETED|Randomization to 24 Months of Age||8
1075284|NCT00948896|2605467|P8|COMPLETED|Randomization to 24 Months of Age||45
1075285|NCT00948896|2605468|P7|COMPLETED|Randomization to 24 Months of Age||43
1075286|NCT00948896|2605469|P6|COMPLETED|Randomization to 24 Months of Age||42
1075287|NCT00948896|2605470|P5|COMPLETED|Randomization to 24 Months of Age||44
1075288|NCT00948896|2605471|P4|COMPLETED|Randomization to 24 Months of Age||87
1075289|NCT00948896|2605472|P3|COMPLETED|Randomization to 24 Months of Age||90
1075290|NCT00948896|2605473|P2|COMPLETED|Randomization to 24 Months of Age||85
1075291|NCT00948896|2605474|P1|COMPLETED|Randomization to 24 Months of Age||90
1075292|NCT00948896|2605467|P8|STARTED|Randomization to 24 Months of Age||47
1075293|NCT00948896|2605468|P7|STARTED|Randomization to 24 Months of Age||47
1075294|NCT00948896|2605469|P6|STARTED|Randomization to 24 Months of Age||46
1075295|NCT00948896|2605470|P5|STARTED|Randomization to 24 Months of Age||46
1075296|NCT00948896|2605471|P4|STARTED|Randomization to 24 Months of Age||98
1075297|NCT00948896|2605472|P3|STARTED|Randomization to 24 Months of Age||99
1075298|NCT00948896|2605473|P2|STARTED|Randomization to 24 Months of Age||98
1075299|NCT00948896|2605474|P1|STARTED|Randomization to 24 Months of Age||98
1075300|NCT00949078|2605510|P2|NOT COMPLETED|Overall Study||0
1075301|NCT00949078|2605511|P1|NOT COMPLETED|Overall Study||0
1075302|NCT00949078|2605510|P2|COMPLETED|Overall Study||9
1075303|NCT00949078|2605511|P1|COMPLETED|Overall Study||5
1075304|NCT00949078|2605510|P2|STARTED|Overall Study||9
1075305|NCT00949078|2605511|P1|STARTED|Overall Study||5
1075306|NCT00949117|2605535|P2|NOT COMPLETED|Overall Study||5
1075307|NCT00949117|2605536|P1|NOT COMPLETED|Overall Study||3
1075308|NCT00949117|2605535|P2|COMPLETED|Overall Study||0
1075309|NCT00949117|2605536|P1|COMPLETED|Overall Study||1
1075310|NCT00949117|2605535|P2|STARTED|Overall Study||5
1075311|NCT00949117|2605536|P1|STARTED|Overall Study||4
1075312|NCT00949533|2605552|P2|NOT COMPLETED|Overall Study||1
1075313|NCT00949533|2605553|P1|NOT COMPLETED|Overall Study||0
1075314|NCT00949533|2605552|P2|COMPLETED|Overall Study||17
1075315|NCT00949533|2605553|P1|COMPLETED|Overall Study||19
1075316|NCT00949533|2605552|P2|STARTED|Overall Study||18
1075317|NCT00949533|2605553|P1|STARTED|Overall Study||19
1075318|NCT00949650|2605567|P2|NOT COMPLETED|Overall Study||55
1075319|NCT00949650|2605568|P1|NOT COMPLETED|Overall Study||165
1075320|NCT00949650|2605567|P2|COMPLETED|Overall Study|6 courses of chemotherapy completed|60
1075321|NCT00949650|2605568|P1|COMPLETED|Overall Study|On-treatment at primary endpoint analysis cut-off date (09 February 2012).|65
1075322|NCT00949650|2605567|P2|STARTED|Overall Study|Randomized patients|115
1075323|NCT00949650|2605568|P1|STARTED|Overall Study|Randomized patients|230
1075324|NCT00949702|2605604|P1|NOT COMPLETED|Overall Study||48
1075325|NCT00949702|2605604|P1|COMPLETED|Overall Study||84
1075326|NCT00949702|2605604|P1|STARTED|Overall Study||132
1075327|NCT00949715|2605621|P2|NOT COMPLETED|Overall Study||0
1075328|NCT00949715|2605622|P1|NOT COMPLETED|Overall Study||4
1075329|NCT00949715|2605621|P2|COMPLETED|Overall Study||33
1075330|NCT00949715|2605622|P1|COMPLETED|Overall Study||28
1075331|NCT00949715|2605621|P2|STARTED|Overall Study||33
1075332|NCT00949715|2605622|P1|STARTED|Overall Study||32
1075333|NCT00949884|2605636|P3|NOT COMPLETED|Overall Study||58
1075334|NCT00949884|2605637|P2|NOT COMPLETED|Overall Study||15
1075335|NCT00949884|2605638|P1|NOT COMPLETED|Overall Study||50
1075336|NCT00949884|2605636|P3|COMPLETED|Overall Study||411
1075337|NCT00949884|2605637|P2|COMPLETED|Overall Study||37
1075338|NCT00949884|2605638|P1|COMPLETED|Overall Study||370
1075339|NCT00949884|2605636|P3|STARTED|Overall Study||469
1075340|NCT00949884|2605637|P2|STARTED|Overall Study||52
1075341|NCT00949884|2605638|P1|STARTED|Overall Study||420
1075342|NCT00949910|2605691|P1|NOT COMPLETED|Overall Study||6576
1075343|NCT00949910|2605691|P1|COMPLETED|Overall Study||10
1075344|NCT00949910|2605691|P1|STARTED|Overall Study||6586
1075345|NCT00949975|2605705|P4|NOT COMPLETED|Overall Study||28
1075346|NCT00949975|2605706|P3|NOT COMPLETED|Overall Study||19
1075347|NCT00949975|2605707|P2|NOT COMPLETED|Overall Study||29
1075348|NCT00949975|2605708|P1|NOT COMPLETED|Overall Study||27
1075349|NCT00949975|2605705|P4|COMPLETED|Overall Study||190
1075350|NCT00949975|2605706|P3|COMPLETED|Overall Study||183
1075351|NCT00949975|2605707|P2|COMPLETED|Overall Study||177
1075352|NCT00949975|2605708|P1|COMPLETED|Overall Study||185
1075353|NCT00949975|2605705|P4|STARTED|Overall Study||218
1075354|NCT00949975|2605706|P3|STARTED|Overall Study||202
1075355|NCT00949975|2605707|P2|STARTED|Overall Study||206
1075356|NCT00949975|2605708|P1|STARTED|Overall Study||212
1075357|NCT00950183|2605826|P1|NOT COMPLETED|Overall Study||36
1075358|NCT00950183|2605826|P1|COMPLETED|Overall Study||0
1075359|NCT00950183|2605826|P1|STARTED|Overall Study||36
1075360|NCT00950235|2605836|P2|NOT COMPLETED|Overall Study||4
1075361|NCT00950235|2605837|P1|NOT COMPLETED|Overall Study||2
1075362|NCT00950235|2605836|P2|COMPLETED|Overall Study||54
1075363|NCT00950235|2605837|P1|COMPLETED|Overall Study||58
1075364|NCT00950235|2605836|P2|STARTED|Overall Study||58
1075365|NCT00950235|2605837|P1|STARTED|Overall Study||60
1075388|NCT00950352|2605905|P2|NOT COMPLETED|Overall Study||11
1075389|NCT00950352|2605906|P1|NOT COMPLETED|Overall Study||42
1075390|NCT00950352|2605905|P2|COMPLETED|Overall Study||21
1075391|NCT00950352|2605906|P1|COMPLETED|Overall Study||30
1075392|NCT00950352|2605905|P2|STARTED|Overall Study||32
1075393|NCT00950352|2605906|P1|STARTED|Overall Study||72
1075394|NCT00950599|2605920|P10|NOT COMPLETED|Follow-Up Period||2
1075395|NCT00950599|2605921|P9|NOT COMPLETED|Follow-Up Period||13
1075396|NCT00950599|2605922|P8|NOT COMPLETED|Follow-Up Period||0
1075397|NCT00950599|2605923|P7|NOT COMPLETED|Follow-Up Period||0
1075398|NCT00950599|2605924|P6|NOT COMPLETED|Follow-Up Period||0
1075399|NCT00950599|2605925|P5|NOT COMPLETED|Follow-Up Period||0
1075400|NCT00950599|2605926|P4|NOT COMPLETED|Follow-Up Period||0
1075401|NCT00950599|2605927|P3|NOT COMPLETED|Follow-Up Period||0
1075402|NCT00950599|2605928|P2|NOT COMPLETED|Follow-Up Period||0
1075403|NCT00950599|2605929|P1|NOT COMPLETED|Follow-Up Period||0
1075404|NCT00950599|2605920|P10|COMPLETED|Follow-Up Period||78
1075405|NCT00950599|2605921|P9|COMPLETED|Follow-Up Period||296
1075406|NCT00950599|2605922|P8|COMPLETED|Follow-Up Period||0
1075407|NCT00950599|2605923|P7|COMPLETED|Follow-Up Period||0
1075408|NCT00950599|2605924|P6|COMPLETED|Follow-Up Period||0
1075409|NCT00950599|2605925|P5|COMPLETED|Follow-Up Period||0
1075410|NCT00950599|2605926|P4|COMPLETED|Follow-Up Period||0
1075411|NCT00950599|2605927|P3|COMPLETED|Follow-Up Period||0
1075412|NCT00950599|2605928|P2|COMPLETED|Follow-Up Period||0
1075413|NCT00950599|2605929|P1|COMPLETED|Follow-Up Period||0
1075414|NCT00950599|2605920|P10|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|80
1075415|NCT00950599|2605921|P9|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|309
1075416|NCT00950599|2605922|P8|STARTED|Follow-Up Period||0
1075417|NCT00950599|2605923|P7|STARTED|Follow-Up Period||0
1075418|NCT00950599|2605924|P6|STARTED|Follow-Up Period||0
1075419|NCT00950599|2605925|P5|STARTED|Follow-Up Period||0
1075420|NCT00950599|2605926|P4|STARTED|Follow-Up Period||0
1075421|NCT00950599|2605927|P3|STARTED|Follow-Up Period||0
1075422|NCT00950599|2605928|P2|STARTED|Follow-Up Period||0
1075423|NCT00950599|2605929|P1|STARTED|Follow-Up Period||0
1075424|NCT00950599|2605920|P10|NOT COMPLETED|Double-Blind Treatment Period||0
1075425|NCT00950599|2605921|P9|NOT COMPLETED|Double-Blind Treatment Period||0
1075426|NCT00950599|2605922|P8|NOT COMPLETED|Double-Blind Treatment Period||6
1075427|NCT00950599|2605923|P7|NOT COMPLETED|Double-Blind Treatment Period||0
1075428|NCT00950599|2605924|P6|NOT COMPLETED|Double-Blind Treatment Period||12
1075429|NCT00950599|2605925|P5|NOT COMPLETED|Double-Blind Treatment Period||7
1075430|NCT00950599|2605926|P4|NOT COMPLETED|Double-Blind Treatment Period||11
1075431|NCT00950599|2605927|P3|NOT COMPLETED|Double-Blind Treatment Period||9
1075432|NCT00950599|2605928|P2|NOT COMPLETED|Double-Blind Treatment Period||10
1075433|NCT00950599|2605929|P1|NOT COMPLETED|Double-Blind Treatment Period||7
1075434|NCT00950599|2605920|P10|COMPLETED|Double-Blind Treatment Period||0
1075435|NCT00950599|2605921|P9|COMPLETED|Double-Blind Treatment Period||0
1075436|NCT00950599|2605922|P8|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|35
1075437|NCT00950599|2605923|P7|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|44
1075438|NCT00950599|2605924|P6|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|55
1075439|NCT00950599|2605925|P5|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|45
1075440|NCT00950599|2605926|P4|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|43
1075441|NCT00950599|2605927|P3|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|54
1075442|NCT00950599|2605928|P2|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|37
1075443|NCT00950599|2605929|P1|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|48
1075444|NCT00950599|2605920|P10|STARTED|Double-Blind Treatment Period||0
1075445|NCT00950599|2605921|P9|STARTED|Double-Blind Treatment Period||0
1075446|NCT00950599|2605922|P8|STARTED|Double-Blind Treatment Period||41
1075447|NCT00950599|2605923|P7|STARTED|Double-Blind Treatment Period||44
1075448|NCT00950599|2605924|P6|STARTED|Double-Blind Treatment Period||67
1075449|NCT00950599|2605925|P5|STARTED|Double-Blind Treatment Period||52
1075450|NCT00950599|2605926|P4|STARTED|Double-Blind Treatment Period||54
1075451|NCT00950599|2605927|P3|STARTED|Double-Blind Treatment Period||63
1075452|NCT00950599|2605928|P2|STARTED|Double-Blind Treatment Period||47
1075453|NCT00950599|2605929|P1|STARTED|Double-Blind Treatment Period||55
1075454|NCT00950612|2606493|P2|NOT COMPLETED|Overall Study||0
1075455|NCT00950612|2606494|P1|NOT COMPLETED|Overall Study||0
1075456|NCT00950612|2606493|P2|COMPLETED|Overall Study||20
1075457|NCT00950612|2606494|P1|COMPLETED|Overall Study||40
1075458|NCT00950612|2606493|P2|STARTED|Overall Study||20
1075459|NCT00950612|2606494|P1|STARTED|Overall Study||40
1075460|NCT00950651|2606532|P2|NOT COMPLETED|Overall Study||35
1075461|NCT00950651|2606533|P1|NOT COMPLETED|Overall Study||31
1075462|NCT00950651|2606532|P2|COMPLETED|Overall Study||181
1075463|NCT00950651|2606533|P1|COMPLETED|Overall Study||184
1075464|NCT00950651|2606532|P2|STARTED|Overall Study|216 patients randomized but one never took study medication|216
1075465|NCT00950651|2606533|P1|STARTED|Overall Study||215
1075466|NCT00950664|2606581|P2|NOT COMPLETED|Second Intervention||48
1075467|NCT00950664|2606582|P1|NOT COMPLETED|Second Intervention||46
1075468|NCT00950664|2606581|P2|COMPLETED|Second Intervention||0
1075469|NCT00950664|2606582|P1|COMPLETED|Second Intervention||0
1075470|NCT00950664|2606581|P2|STARTED|Second Intervention||48
1075471|NCT00950664|2606582|P1|STARTED|Second Intervention||46
1075472|NCT00950664|2606581|P2|NOT COMPLETED|Washout Period of 4 Weeks||0
1075473|NCT00950664|2606582|P1|NOT COMPLETED|Washout Period of 4 Weeks||0
1075474|NCT00950664|2606581|P2|COMPLETED|Washout Period of 4 Weeks||48
1075475|NCT00950664|2606582|P1|COMPLETED|Washout Period of 4 Weeks||46
1075476|NCT00950664|2606581|P2|STARTED|Washout Period of 4 Weeks||48
1075477|NCT00950664|2606582|P1|STARTED|Washout Period of 4 Weeks||46
1075478|NCT00950664|2606581|P2|NOT COMPLETED|First Intervention||5
1075479|NCT00950664|2606582|P1|NOT COMPLETED|First Intervention||3
1075480|NCT00950664|2606581|P2|COMPLETED|First Intervention||48
1075481|NCT00950664|2606582|P1|COMPLETED|First Intervention||46
1075482|NCT00950664|2606581|P2|STARTED|First Intervention||53
1075483|NCT00950664|2606582|P1|STARTED|First Intervention||49
1075484|NCT00950690|2606600|P1|NOT COMPLETED|Overall Study||244
1075485|NCT00950690|2606600|P1|COMPLETED|Overall Study||1105
1075486|NCT00950690|2606600|P1|STARTED|Overall Study||1349
1075487|NCT00950729|2606605|P1|NOT COMPLETED|Driving With Aircast||0
1075488|NCT00950729|2606605|P1|COMPLETED|Driving With Aircast||48
1075489|NCT00950729|2606605|P1|STARTED|Driving With Aircast||48
1075490|NCT00950729|2606605|P1|NOT COMPLETED|Driving With Plaster Cast||0
1075491|NCT00950729|2606605|P1|COMPLETED|Driving With Plaster Cast||48
1075492|NCT00950729|2606605|P1|STARTED|Driving With Plaster Cast||48
1075493|NCT00950729|2606605|P1|NOT COMPLETED|Driving With Running Shoes||0
1075494|NCT00950729|2606605|P1|COMPLETED|Driving With Running Shoes|June 2007|48
1075495|NCT00950729|2606605|P1|STARTED|Driving With Running Shoes|March 2007|48
1075496|NCT00950742|2606612|P2|NOT COMPLETED|Overall Study||2
1075497|NCT00950742|2606613|P1|NOT COMPLETED|Overall Study||16
1075498|NCT00950742|2606612|P2|COMPLETED|Overall Study||0
1075499|NCT00950742|2606613|P1|COMPLETED|Overall Study||0
1075500|NCT00950742|2606612|P2|STARTED|Overall Study|entered and treated|2
1075501|NCT00950742|2606613|P1|STARTED|Overall Study|entered and treated|16
1075502|NCT00950755|2606629|P1|NOT COMPLETED|Long-Term Follow-Up||9
1075503|NCT00950755|2606629|P1|COMPLETED|Long-Term Follow-Up||9
1075504|NCT00950755|2606629|P1|STARTED|Long-Term Follow-Up|18 of the 41 participants withdrawing from Study BEX104505 enrolled in the LTFU study.|18
1075505|NCT00950755|2606629|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||41
1075506|NCT00950755|2606629|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
1075507|NCT00950755|2606629|P1|STARTED|Dosimetric and Therapeutic Treatment||41
1075508|NCT00950807|2606653|P10|NOT COMPLETED|Treatment Period 3||1
1075509|NCT00950807|2606654|P9|NOT COMPLETED|Treatment Period 3||0
1075510|NCT00950807|2606655|P8|NOT COMPLETED|Treatment Period 3||1
1075511|NCT00950807|2606656|P7|NOT COMPLETED|Treatment Period 3||1
1075512|NCT00950807|2606657|P6|NOT COMPLETED|Treatment Period 3||0
1075513|NCT00950807|2606658|P5|NOT COMPLETED|Treatment Period 3||0
1075514|NCT00950807|2606659|P4|NOT COMPLETED|Treatment Period 3||0
1075515|NCT00950807|2606660|P3|NOT COMPLETED|Treatment Period 3||0
1075516|NCT00950807|2606661|P2|NOT COMPLETED|Treatment Period 3||0
1075517|NCT00950807|2606662|P1|NOT COMPLETED|Treatment Period 3||1
1075518|NCT00950807|2606653|P10|COMPLETED|Treatment Period 3||10
1075519|NCT00950807|2606654|P9|COMPLETED|Treatment Period 3||9
1075520|NCT00950807|2606655|P8|COMPLETED|Treatment Period 3||9
1075521|NCT00950807|2606656|P7|COMPLETED|Treatment Period 3||11
1075522|NCT00950807|2606657|P6|COMPLETED|Treatment Period 3||9
1075523|NCT00950807|2606658|P5|COMPLETED|Treatment Period 3||12
1075524|NCT00950807|2606659|P4|COMPLETED|Treatment Period 3||11
1075525|NCT00950807|2606660|P3|COMPLETED|Treatment Period 3||10
1075526|NCT00950807|2606661|P2|COMPLETED|Treatment Period 3||9
1075527|NCT00950807|2606662|P1|COMPLETED|Treatment Period 3||45
1075528|NCT00950807|2606653|P10|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
1075529|NCT00950807|2606654|P9|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
1075530|NCT00950807|2606655|P8|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
1075531|NCT00950807|2606656|P7|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
1075532|NCT00950807|2606657|P6|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
1075533|NCT00950807|2606658|P5|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
1075534|NCT00950807|2606659|P4|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
1075535|NCT00950807|2606660|P3|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
1075536|NCT00950807|2606661|P2|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
1075537|NCT00950807|2606662|P1|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|46
1075538|NCT00950807|2606653|P10|NOT COMPLETED|Washout Period 2||0
1075539|NCT00950807|2606654|P9|NOT COMPLETED|Washout Period 2||0
1075540|NCT00950807|2606655|P8|NOT COMPLETED|Washout Period 2||1
1075541|NCT00950807|2606656|P7|NOT COMPLETED|Washout Period 2||1
1075542|NCT00950807|2606657|P6|NOT COMPLETED|Washout Period 2||0
1075543|NCT00950807|2606658|P5|NOT COMPLETED|Washout Period 2||1
1075544|NCT00950807|2606659|P4|NOT COMPLETED|Washout Period 2||1
1075545|NCT00950807|2606660|P3|NOT COMPLETED|Washout Period 2||0
1075546|NCT00950807|2606661|P2|NOT COMPLETED|Washout Period 2||1
1075547|NCT00950807|2606662|P1|NOT COMPLETED|Washout Period 2||4
1075548|NCT00950807|2606653|P10|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
1075549|NCT00950807|2606654|P9|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
1075550|NCT00950807|2606655|P8|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
1075551|NCT00950807|2606656|P7|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|8
1075552|NCT00950807|2606657|P6|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
1075553|NCT00950807|2606658|P5|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|12
1075554|NCT00950807|2606659|P4|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
1075555|NCT00950807|2606660|P3|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|10
1075556|NCT00950807|2606661|P2|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
1075557|NCT00950807|2606662|P1|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|47
1075558|NCT00950807|2606653|P10|STARTED|Washout Period 2||11
1075559|NCT00950807|2606654|P9|STARTED|Washout Period 2||11
1075560|NCT00950807|2606655|P8|STARTED|Washout Period 2||10
1075561|NCT00950807|2606656|P7|STARTED|Washout Period 2||9
1075562|NCT00950807|2606657|P6|STARTED|Washout Period 2||9
1075563|NCT00950807|2606658|P5|STARTED|Washout Period 2||13
1075564|NCT00950807|2606659|P4|STARTED|Washout Period 2||12
1075565|NCT00950807|2606660|P3|STARTED|Washout Period 2||10
1075566|NCT00950807|2606661|P2|STARTED|Washout Period 2||12
1075567|NCT00950807|2606662|P1|STARTED|Washout Period 2||51
1075568|NCT00950807|2606653|P10|NOT COMPLETED|Treatment Period 2||0
1075569|NCT00950807|2606654|P9|NOT COMPLETED|Treatment Period 2||0
1075570|NCT00950807|2606655|P8|NOT COMPLETED|Treatment Period 2||3
1075571|NCT00950807|2606656|P7|NOT COMPLETED|Treatment Period 2||1
1075572|NCT00950807|2606657|P6|NOT COMPLETED|Treatment Period 2||1
1075573|NCT00950807|2606658|P5|NOT COMPLETED|Treatment Period 2||0
1075574|NCT00950807|2606659|P4|NOT COMPLETED|Treatment Period 2||1
1075575|NCT00950807|2606660|P3|NOT COMPLETED|Treatment Period 2||0
1075576|NCT00950807|2606661|P2|NOT COMPLETED|Treatment Period 2||1
1075577|NCT00950807|2606662|P1|NOT COMPLETED|Treatment Period 2||2
1075578|NCT00950807|2606653|P10|COMPLETED|Treatment Period 2||11
1075579|NCT00950807|2606654|P9|COMPLETED|Treatment Period 2||11
1075580|NCT00950807|2606655|P8|COMPLETED|Treatment Period 2||10
1075581|NCT00950807|2606656|P7|COMPLETED|Treatment Period 2||9
1075582|NCT00950807|2606657|P6|COMPLETED|Treatment Period 2||9
1075583|NCT00950807|2606658|P5|COMPLETED|Treatment Period 2||13
1075584|NCT00950807|2606659|P4|COMPLETED|Treatment Period 2||12
1075585|NCT00950807|2606660|P3|COMPLETED|Treatment Period 2||10
1075586|NCT00950807|2606661|P2|COMPLETED|Treatment Period 2||12
1075587|NCT00950807|2606662|P1|COMPLETED|Treatment Period 2||51
1075588|NCT00950807|2606653|P10|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
1075589|NCT00950807|2606654|P9|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
1075590|NCT00950807|2606655|P8|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
1075591|NCT00950807|2606656|P7|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
1075592|NCT00950807|2606657|P6|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
1075593|NCT00950807|2606658|P5|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
1075594|NCT00950807|2606659|P4|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
1075595|NCT00950807|2606660|P3|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
1075596|NCT00950807|2606661|P2|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
1075597|NCT00950807|2606662|P1|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|53
1075598|NCT00950807|2606653|P10|NOT COMPLETED|Washout Period 1||0
1075599|NCT00950807|2606654|P9|NOT COMPLETED|Washout Period 1||1
1075600|NCT00950807|2606655|P8|NOT COMPLETED|Washout Period 1||1
1075601|NCT00950807|2606656|P7|NOT COMPLETED|Washout Period 1||2
1075602|NCT00950807|2606657|P6|NOT COMPLETED|Washout Period 1||0
1075603|NCT00950807|2606658|P5|NOT COMPLETED|Washout Period 1||1
1075604|NCT00950807|2606659|P4|NOT COMPLETED|Washout Period 1||1
1075605|NCT00950807|2606660|P3|NOT COMPLETED|Washout Period 1||0
1075606|NCT00950807|2606661|P2|NOT COMPLETED|Washout Period 1||0
1075607|NCT00950807|2606662|P1|NOT COMPLETED|Washout Period 1||5
1075608|NCT00950807|2606653|P10|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
1075609|NCT00950807|2606654|P9|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
1075610|NCT00950807|2606655|P8|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
1075611|NCT00950807|2606656|P7|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|10
1075612|NCT00950807|2606657|P6|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
1075613|NCT00950807|2606658|P5|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
1075614|NCT00950807|2606659|P4|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
1075615|NCT00950807|2606660|P3|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
1075616|NCT00950807|2606661|P2|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
1075617|NCT00950807|2606662|P1|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|51
1075618|NCT00950807|2606653|P10|STARTED|Washout Period 1||13
1075619|NCT00950807|2606654|P9|STARTED|Washout Period 1||12
1075620|NCT00950807|2606655|P8|STARTED|Washout Period 1||14
1075621|NCT00950807|2606656|P7|STARTED|Washout Period 1||12
1075622|NCT00950807|2606657|P6|STARTED|Washout Period 1||11
1075623|NCT00950807|2606658|P5|STARTED|Washout Period 1||12
1075624|NCT00950807|2606659|P4|STARTED|Washout Period 1||12
1075625|NCT00950807|2606660|P3|STARTED|Washout Period 1||13
1075626|NCT00950807|2606661|P2|STARTED|Washout Period 1||13
1075627|NCT00950807|2606662|P1|STARTED|Washout Period 1||56
1075628|NCT00950807|2606653|P10|NOT COMPLETED|Treatment Period 1||0
1075629|NCT00950807|2606654|P9|NOT COMPLETED|Treatment Period 1||1
1075630|NCT00950807|2606655|P8|NOT COMPLETED|Treatment Period 1||0
1075631|NCT00950807|2606656|P7|NOT COMPLETED|Treatment Period 1||0
1075632|NCT00950807|2606657|P6|NOT COMPLETED|Treatment Period 1||2
1075633|NCT00950807|2606658|P5|NOT COMPLETED|Treatment Period 1||1
1075634|NCT00950807|2606659|P4|NOT COMPLETED|Treatment Period 1||0
1075635|NCT00950807|2606660|P3|NOT COMPLETED|Treatment Period 1||1
1075636|NCT00950807|2606661|P2|NOT COMPLETED|Treatment Period 1||0
1075637|NCT00950807|2606662|P1|NOT COMPLETED|Treatment Period 1||3
1075638|NCT00950807|2606653|P10|COMPLETED|Treatment Period 1||13
1075639|NCT00950807|2606654|P9|COMPLETED|Treatment Period 1||12
1075640|NCT00950807|2606655|P8|COMPLETED|Treatment Period 1||14
1075641|NCT00950807|2606656|P7|COMPLETED|Treatment Period 1||12
1075642|NCT00950807|2606657|P6|COMPLETED|Treatment Period 1||11
1075643|NCT00950807|2606658|P5|COMPLETED|Treatment Period 1||12
1075644|NCT00950807|2606659|P4|COMPLETED|Treatment Period 1||12
1075645|NCT00950807|2606660|P3|COMPLETED|Treatment Period 1||13
1075646|NCT00950807|2606661|P2|COMPLETED|Treatment Period 1||13
1075647|NCT00950807|2606662|P1|COMPLETED|Treatment Period 1||56
1075648|NCT00950807|2606653|P10|STARTED|Treatment Period 1||13
1075649|NCT00950807|2606654|P9|STARTED|Treatment Period 1||13
1075650|NCT00950807|2606655|P8|STARTED|Treatment Period 1||14
1075651|NCT00950807|2606656|P7|STARTED|Treatment Period 1||12
1075652|NCT00950807|2606657|P6|STARTED|Treatment Period 1||13
1075653|NCT00950807|2606658|P5|STARTED|Treatment Period 1||13
1075654|NCT00950807|2606659|P4|STARTED|Treatment Period 1||12
1075655|NCT00950807|2606660|P3|STARTED|Treatment Period 1||14
1075656|NCT00950807|2606661|P2|STARTED|Treatment Period 1||13
1075657|NCT00950807|2606662|P1|STARTED|Treatment Period 1||59
1075658|NCT00938314|2606708|P4|NOT COMPLETED|Cohort 3||1
1075659|NCT00938314|2606709|P3|NOT COMPLETED|Cohort 3||4
1075660|NCT00938314|2606710|P2|NOT COMPLETED|Cohort 3||0
1075661|NCT00938314|2606711|P1|NOT COMPLETED|Cohort 3||0
1075662|NCT00938314|2606708|P4|COMPLETED|Cohort 3||7
1075663|NCT00938314|2606709|P3|COMPLETED|Cohort 3||20
1075664|NCT00938314|2606710|P2|COMPLETED|Cohort 3||0
1075665|NCT00938314|2606711|P1|COMPLETED|Cohort 3||0
1075666|NCT00938314|2606708|P4|STARTED|Cohort 3||8
1075667|NCT00938314|2606709|P3|STARTED|Cohort 3||24
1075668|NCT00938314|2606710|P2|STARTED|Cohort 3||0
1075669|NCT00938314|2606711|P1|STARTED|Cohort 3||0
1075670|NCT00938314|2606708|P4|NOT COMPLETED|Cohort 2||2
1075671|NCT00938314|2606709|P3|NOT COMPLETED|Cohort 2||0
1075672|NCT00938314|2606710|P2|NOT COMPLETED|Cohort 2||6
1075673|NCT00938314|2606711|P1|NOT COMPLETED|Cohort 2||0
1075674|NCT00938314|2606708|P4|COMPLETED|Cohort 2||6
1075675|NCT00938314|2606709|P3|COMPLETED|Cohort 2||0
1075676|NCT00938314|2606710|P2|COMPLETED|Cohort 2||18
1075677|NCT00938314|2606711|P1|COMPLETED|Cohort 2||0
1075678|NCT00938314|2606708|P4|STARTED|Cohort 2||8
1075679|NCT00938314|2606709|P3|STARTED|Cohort 2||0
1075680|NCT00938314|2606710|P2|STARTED|Cohort 2||24
1075681|NCT00938314|2606711|P1|STARTED|Cohort 2||0
1075682|NCT00938314|2606708|P4|NOT COMPLETED|Cohort 1||2
1075683|NCT00938314|2606709|P3|NOT COMPLETED|Cohort 1||0
1075684|NCT00938314|2606710|P2|NOT COMPLETED|Cohort 1||0
1075685|NCT00938314|2606711|P1|NOT COMPLETED|Cohort 1||2
1075686|NCT00938314|2606708|P4|COMPLETED|Cohort 1||6
1075687|NCT00938314|2606709|P3|COMPLETED|Cohort 1||0
1075688|NCT00938314|2606710|P2|COMPLETED|Cohort 1||0
1075689|NCT00938314|2606711|P1|COMPLETED|Cohort 1||22
1075690|NCT00938314|2606708|P4|STARTED|Cohort 1||8
1075691|NCT00938314|2606709|P3|STARTED|Cohort 1||0
1075692|NCT00938314|2606710|P2|STARTED|Cohort 1||0
1075693|NCT00938314|2606711|P1|STARTED|Cohort 1||24
1075694|NCT00938327|2606765|P1|NOT COMPLETED|Overall Study||60
1075695|NCT00938327|2606765|P1|COMPLETED|Overall Study||272
1075696|NCT00938327|2606765|P1|STARTED|Overall Study||332
1075697|NCT00943683|2606774|P2|NOT COMPLETED|Overall Study||6
1075698|NCT00943683|2606775|P1|NOT COMPLETED|Overall Study||7
1075699|NCT00943683|2606774|P2|COMPLETED|Overall Study||169
1075700|NCT00943683|2606775|P1|COMPLETED|Overall Study||74
1075701|NCT00943683|2606774|P2|STARTED|Overall Study||175
1075702|NCT00943683|2606775|P1|STARTED|Overall Study||81
1075733|NCT00943735|2606818|P1|NOT COMPLETED|Overall Study||32
1075734|NCT00943735|2606818|P1|COMPLETED|Overall Study||742
1075735|NCT00943735|2606818|P1|Per Protocol Population|Overall Study||500
1075736|NCT00943735|2606818|P1|STARTED|Overall Study||774
1075737|NCT00950833|2606854|P3|NOT COMPLETED|Overall Study||0
1075738|NCT00950833|2606855|P2|NOT COMPLETED|Overall Study||0
1075739|NCT00950833|2606856|P1|NOT COMPLETED|Overall Study||0
1075740|NCT00950833|2606854|P3|COMPLETED|Overall Study||223
1075741|NCT00950833|2606855|P2|COMPLETED|Overall Study||108
1075742|NCT00950833|2606856|P1|COMPLETED|Overall Study||112
1075743|NCT00950833|2606854|P3|STARTED|Overall Study||223
1075744|NCT00950833|2606855|P2|STARTED|Overall Study||108
1075745|NCT00950833|2606856|P1|STARTED|Overall Study||112
1075746|NCT00950859|2606912|P2|NOT COMPLETED|Overall Study||10
1075747|NCT00950859|2606913|P1|NOT COMPLETED|Overall Study||16
1075748|NCT00950859|2606912|P2|COMPLETED|Overall Study||14
1075749|NCT00950859|2606913|P1|COMPLETED|Overall Study||11
1075750|NCT00950859|2606912|P2|STARTED|Overall Study||24
1075751|NCT00950859|2606913|P1|STARTED|Overall Study||27
1075752|NCT00950872|2606953|P1|NOT COMPLETED|Overall Study||3
1075753|NCT00950872|2606953|P1|COMPLETED|Overall Study||26
1075754|NCT00950872|2606953|P1|STARTED|Overall Study||29
1075755|NCT00950911|2606962|P2|NOT COMPLETED|Overall Study||15
1075756|NCT00950911|2606963|P1|NOT COMPLETED|Overall Study||12
1075757|NCT00950911|2606962|P2|COMPLETED|Overall Study||3
1075758|NCT00950911|2606963|P1|COMPLETED|Overall Study||5
1075759|NCT00950911|2606962|P2|STARTED|Overall Study||18
1075760|NCT00950911|2606963|P1|STARTED|Overall Study||17
1075761|NCT00950937|2606971|P2|NOT COMPLETED|Overall Study||0
1075762|NCT00950937|2606972|P1|NOT COMPLETED|Overall Study||0
1075763|NCT00950937|2606971|P2|COMPLETED|Overall Study||14
1075764|NCT00950937|2606972|P1|COMPLETED|Overall Study||14
1075765|NCT00950937|2606971|P2|STARTED|Overall Study||14
1075766|NCT00950937|2606972|P1|STARTED|Overall Study||14
1075767|NCT00950963|2606990|P2|NOT COMPLETED|Overall Study||24
1075768|NCT00950963|2606991|P1|NOT COMPLETED|Overall Study||29
1075769|NCT00950963|2606990|P2|COMPLETED|Overall Study||357
1075770|NCT00950963|2606991|P1|COMPLETED|Overall Study||352
1075771|NCT00950963|2606990|P2|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
1075772|NCT00950963|2606991|P1|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
1075773|NCT00951015|2607009|P4|NOT COMPLETED|Overall Study||18
1075774|NCT00951015|2607010|P3|NOT COMPLETED|Overall Study||51
1075775|NCT00951015|2607011|P2|NOT COMPLETED|Overall Study||51
1075776|NCT00951015|2607012|P1|NOT COMPLETED|Overall Study||53
1075777|NCT00951015|2607009|P4|COMPLETED|Overall Study||32
1075778|NCT00951015|2607010|P3|COMPLETED|Overall Study||0
1075779|NCT00951015|2607011|P2|COMPLETED|Overall Study||0
1075780|NCT00951015|2607012|P1|COMPLETED|Overall Study||0
1075781|NCT00951015|2607009|P4|Ongoing|Overall Study||8
1075782|NCT00951015|2607010|P3|Ongoing|Overall Study||46
1075783|NCT00951015|2607011|P2|Ongoing|Overall Study||45
1075784|NCT00951015|2607012|P1|Ongoing|Overall Study||47
1075785|NCT00951015|2607009|P4|STARTED|Overall Study||50
1075786|NCT00951015|2607010|P3|STARTED|Overall Study||51
1075787|NCT00951015|2607011|P2|STARTED|Overall Study||51
1075788|NCT00951015|2607012|P1|STARTED|Overall Study||53
1075789|NCT00951093|2607106|P1|NOT COMPLETED|6 Months After GBP||0
1075790|NCT00951093|2607106|P1|COMPLETED|6 Months After GBP||53
1075791|NCT00951093|2607106|P1|STARTED|6 Months After GBP||53
1075792|NCT00951093|2607106|P1|NOT COMPLETED|Before GBP||0
1075793|NCT00951093|2607106|P1|COMPLETED|Before GBP||53
1075794|NCT00951093|2607106|P1|STARTED|Before GBP||53
1075795|NCT00951275|2607130|P1|NOT COMPLETED|Overall Study||13
1075796|NCT00951275|2607130|P1|COMPLETED|Overall Study||92
1075797|NCT00951275|2607130|P1|STARTED|Overall Study||105
1075798|NCT00951379|2607162|P2|NOT COMPLETED|Overall Study||2
1075799|NCT00951379|2607163|P1|NOT COMPLETED|Overall Study||6
1075800|NCT00951379|2607162|P2|COMPLETED|Overall Study||23
1075801|NCT00951379|2607163|P1|COMPLETED|Overall Study||21
1075802|NCT00951379|2607162|P2|STARTED|Overall Study||25
1075803|NCT00951379|2607163|P1|STARTED|Overall Study||27
1075804|NCT00951483|2607207|P2|NOT COMPLETED|Overall Study||0
1075805|NCT00951483|2607208|P1|NOT COMPLETED|Overall Study||19
1075806|NCT00951483|2607207|P2|COMPLETED|Overall Study||44
1075807|NCT00951483|2607208|P1|COMPLETED|Overall Study||28
1075808|NCT00951483|2607207|P2|STARTED|Overall Study||44
1075809|NCT00951483|2607208|P1|STARTED|Overall Study||47
1075810|NCT00951509|2607226|P1|NOT COMPLETED|Overall Study||2
1075811|NCT00951509|2607226|P1|COMPLETED|Overall Study||29
1075812|NCT00951509|2607226|P1|Driving Condition 5|Overall Study||30
1075813|NCT00951509|2607226|P1|Driving Condition 4|Overall Study||28
1075814|NCT00951509|2607226|P1|Driving Condition 3|Overall Study||25
1075815|NCT00951509|2607226|P1|Driving Condition 2|Overall Study||29
1075816|NCT00951509|2607226|P1|Driving Condition 1|Overall Study||29
1075817|NCT00951509|2607226|P1|STARTED|Overall Study||31
1075818|NCT00951561|2607234|P4|NOT COMPLETED|Overall Study||1
1075819|NCT00951561|2607235|P3|NOT COMPLETED|Overall Study||3
1075820|NCT00951561|2607236|P2|NOT COMPLETED|Overall Study||0
1075821|NCT00951561|2607237|P1|NOT COMPLETED|Overall Study||0
1075822|NCT00951561|2607234|P4|COMPLETED|Overall Study|1 subject dropped after period 2|26
1075823|NCT00951561|2607235|P3|COMPLETED|Overall Study|3 subjects dropped after period 2|18
1075824|NCT00951561|2607236|P2|COMPLETED|Overall Study||29
1075825|NCT00951561|2607237|P1|COMPLETED|Overall Study||25
1075826|NCT00951561|2607234|P4|STARTED|Overall Study||27
1075827|NCT00951561|2607235|P3|STARTED|Overall Study|1 subject used Vipon periods 1 & 2 instead of Ibuprofen period 2.|21
1075828|NCT00951561|2607236|P2|STARTED|Overall Study||29
1075829|NCT00951561|2607237|P1|STARTED|Overall Study|Randomized Vipon or Ibuprofen period 1, crossover period 2, randomized period 3, crossover period 4|25
1075830|NCT00951665|2607248|P6|NOT COMPLETED|Phase 2a||7
1075831|NCT00951665|2607249|P5|NOT COMPLETED|Phase 2a||12
1075832|NCT00951665|2607250|P4|NOT COMPLETED|Phase 2a||0
1075833|NCT00951665|2607251|P3|NOT COMPLETED|Phase 2a||0
1075834|NCT00951665|2607252|P2|NOT COMPLETED|Phase 2a||0
1075835|NCT00951665|2607253|P1|NOT COMPLETED|Phase 2a||0
1075836|NCT00951665|2607248|P6|COMPLETED|Phase 2a||15
1075837|NCT00951665|2607249|P5|COMPLETED|Phase 2a||10
1075838|NCT00951665|2607250|P4|COMPLETED|Phase 2a||0
1075839|NCT00951665|2607251|P3|COMPLETED|Phase 2a||0
1075840|NCT00951665|2607252|P2|COMPLETED|Phase 2a||0
1075841|NCT00951665|2607253|P1|COMPLETED|Phase 2a||0
1075842|NCT00951665|2607248|P6|STARTED|Phase 2a||22
1075843|NCT00951665|2607249|P5|STARTED|Phase 2a||22
1075844|NCT00951665|2607250|P4|STARTED|Phase 2a||0
1075845|NCT00951665|2607251|P3|STARTED|Phase 2a||0
1075846|NCT00951665|2607252|P2|STARTED|Phase 2a||0
1075847|NCT00951665|2607253|P1|STARTED|Phase 2a||0
1075848|NCT00951665|2607248|P6|NOT COMPLETED|Phase 1b||0
1075849|NCT00951665|2607249|P5|NOT COMPLETED|Phase 1b||0
1075850|NCT00951665|2607250|P4|NOT COMPLETED|Phase 1b||1
1075851|NCT00951665|2607251|P3|NOT COMPLETED|Phase 1b||17
1075852|NCT00951665|2607252|P2|NOT COMPLETED|Phase 1b||4
1075853|NCT00951665|2607253|P1|NOT COMPLETED|Phase 1b||22
1075854|NCT00951665|2607248|P6|COMPLETED|Phase 1b||0
1075855|NCT00951665|2607249|P5|COMPLETED|Phase 1b||0
1075856|NCT00951665|2607250|P4|COMPLETED|Phase 1b||2
1075857|NCT00951665|2607251|P3|COMPLETED|Phase 1b||4
1075858|NCT00951665|2607252|P2|COMPLETED|Phase 1b||6
1075859|NCT00951665|2607253|P1|COMPLETED|Phase 1b||7
1075860|NCT00951665|2607248|P6|Started Treatment|Phase 1b||0
1075861|NCT00951665|2607249|P5|Started Treatment|Phase 1b||0
1075862|NCT00951665|2607250|P4|Started Treatment|Phase 1b||3
1075863|NCT00951665|2607251|P3|Started Treatment|Phase 1b||21
1075864|NCT00951665|2607252|P2|Started Treatment|Phase 1b||10
1075865|NCT00951665|2607253|P1|Started Treatment|Phase 1b||26
1075866|NCT00951665|2607248|P6|STARTED|Phase 1b||0
1075867|NCT00951665|2607249|P5|STARTED|Phase 1b||0
1075868|NCT00951665|2607250|P4|STARTED|Phase 1b||3
1075869|NCT00951665|2607251|P3|STARTED|Phase 1b||21
1075870|NCT00951665|2607252|P2|STARTED|Phase 1b||10
1075871|NCT00951665|2607253|P1|STARTED|Phase 1b||29
1075872|NCT00951808|2607354|P3|NOT COMPLETED|Overall Study||4
1075873|NCT00951808|2607355|P2|NOT COMPLETED|Overall Study||0
1075874|NCT00951808|2607356|P1|NOT COMPLETED|Overall Study||0
1075875|NCT00951808|2607354|P3|COMPLETED|Overall Study|Four subjects withdrew from the study.|223
1075876|NCT00951808|2607355|P2|COMPLETED|Overall Study||6
1075877|NCT00951808|2607356|P1|COMPLETED|Overall Study||4
1075878|NCT00951808|2607354|P3|STARTED|Overall Study||227
1075879|NCT00951808|2607355|P2|STARTED|Overall Study||6
1075880|NCT00951808|2607356|P1|STARTED|Overall Study||4
1075881|NCT00951821|2607364|P2|NOT COMPLETED|Overall Study||0
1075882|NCT00951821|2607365|P1|NOT COMPLETED|Overall Study||0
1075883|NCT00951821|2607364|P2|COMPLETED|Overall Study||8
1075884|NCT00951821|2607365|P1|COMPLETED|Overall Study||16
1075885|NCT00951821|2607364|P2|STARTED|Overall Study||8
1075886|NCT00951821|2607365|P1|STARTED|Overall Study||16
1075887|NCT00951899|2607375|P2|NOT COMPLETED|Overall Study||0
1075888|NCT00951899|2607376|P1|NOT COMPLETED|Overall Study||0
1075889|NCT00951899|2607375|P2|COMPLETED|Overall Study||19
1075890|NCT00951899|2607376|P1|COMPLETED|Overall Study||19
1075891|NCT00951899|2607375|P2|STARTED|Overall Study||19
1075892|NCT00951899|2607376|P1|STARTED|Overall Study||19
1075893|NCT00951912|2607401|P3|NOT COMPLETED|Overall Study||2
1075894|NCT00951912|2607402|P2|NOT COMPLETED|Overall Study||5
1075895|NCT00951912|2607403|P1|NOT COMPLETED|Overall Study||7
1075896|NCT00951912|2607401|P3|COMPLETED|Overall Study||54
1075897|NCT00951912|2607402|P2|COMPLETED|Overall Study||50
1075898|NCT00951912|2607403|P1|COMPLETED|Overall Study||47
1075899|NCT00951912|2607401|P3|STARTED|Overall Study||56
1075900|NCT00951912|2607402|P2|STARTED|Overall Study||55
1075901|NCT00951912|2607403|P1|STARTED|Overall Study||54
1075902|NCT00952068|2607453|P1|NOT COMPLETED|Overall Study||7
1075903|NCT00952068|2607453|P1|COMPLETED|Overall Study||40
1075904|NCT00952068|2607453|P1|STARTED|Overall Study||47
1075905|NCT00952081|2607461|P1|NOT COMPLETED|Overall Study||0
1075906|NCT00952081|2607461|P1|COMPLETED|Overall Study||22
1075907|NCT00952081|2607461|P1|STARTED|Overall Study||22
1075908|NCT00952120|2607468|P3|NOT COMPLETED|Overall Study||0
1075909|NCT00952120|2607469|P2|NOT COMPLETED|Overall Study||0
1075910|NCT00952120|2607470|P1|NOT COMPLETED|Overall Study||0
1075911|NCT00952120|2607468|P3|COMPLETED|Overall Study||5
1075912|NCT00952120|2607469|P2|COMPLETED|Overall Study||47
1075913|NCT00952120|2607470|P1|COMPLETED|Overall Study||52
1075914|NCT00952120|2607468|P3|STARTED|Overall Study||5
1075915|NCT00952120|2607469|P2|STARTED|Overall Study||47
1075916|NCT00952120|2607470|P1|STARTED|Overall Study||52
1075917|NCT00952133|2607480|P2|NOT COMPLETED|Overall Study||0
1075918|NCT00952133|2607481|P1|NOT COMPLETED|Overall Study||0
1075919|NCT00952133|2607480|P2|COMPLETED|Overall Study||59
1075920|NCT00952133|2607481|P1|COMPLETED|Overall Study||59
1075921|NCT00952133|2607480|P2|STARTED|Overall Study||59
1075922|NCT00952133|2607481|P1|STARTED|Overall Study||59
1075923|NCT00952211|2607491|P2|NOT COMPLETED|Overall Study||0
1075924|NCT00952211|2607492|P1|NOT COMPLETED|Overall Study||0
1075925|NCT00952211|2607491|P2|COMPLETED|Overall Study||0
1075926|NCT00952211|2607492|P1|COMPLETED|Overall Study||3
1075927|NCT00952211|2607491|P2|STARTED|Overall Study||0
1075928|NCT00952211|2607492|P1|STARTED|Overall Study||3
1075929|NCT00952276|2607505|P5|NOT COMPLETED|Overall Study||0
1075930|NCT00952276|2607506|P4|NOT COMPLETED|Overall Study||1
1075931|NCT00952276|2607507|P3|NOT COMPLETED|Overall Study||0
1075932|NCT00952276|2607508|P2|NOT COMPLETED|Overall Study||0
1075933|NCT00952276|2607509|P1|NOT COMPLETED|Overall Study||1
1075934|NCT00952276|2607505|P5|COMPLETED|Overall Study||63
1075935|NCT00952276|2607506|P4|COMPLETED|Overall Study||120
1075936|NCT00952276|2607507|P3|COMPLETED|Overall Study||122
1075937|NCT00952276|2607508|P2|COMPLETED|Overall Study||115
1075938|NCT00952276|2607509|P1|COMPLETED|Overall Study||126
1075939|NCT00952276|2607505|P5|STARTED|Overall Study||63
1075940|NCT00952276|2607506|P4|STARTED|Overall Study||121
1075941|NCT00952276|2607507|P3|STARTED|Overall Study||122
1075942|NCT00952276|2607508|P2|STARTED|Overall Study||115
1075943|NCT00952276|2607509|P1|STARTED|Overall Study||127
1075944|NCT00952289|2607558|P2|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||54
1075945|NCT00952289|2607559|P1|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
1075946|NCT00952289|2607558|P2|COMPLETED|Patients Who Crossed Over to Ruxolitinib|Number of cross over subjects who were still in the study as of 25 JAN 2013|57
1075947|NCT00952289|2607559|P1|COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
1075948|NCT00952289|2607558|P2|STARTED|Patients Who Crossed Over to Ruxolitinib||111
1075949|NCT00952289|2607559|P1|STARTED|Patients Who Crossed Over to Ruxolitinib||0
1075950|NCT00952289|2607558|P2|NOT COMPLETED|All Participants||40
1075951|NCT00952289|2607559|P1|NOT COMPLETED|All Participants||21
1075952|NCT00952289|2607558|P2|COMPLETED|All Participants|Includes patients in the study as of 2 November 2010 (78) + those who crossed over to Ruxolitinib.|114
1075953|NCT00952289|2607559|P1|COMPLETED|All Participants|Represents the number of patients who were still in the study as of 02 November 2010|134
1075954|NCT00952289|2607558|P2|Safety Population|All Participants|Randomized patients who are documented to have received at least 1 dose of study medication.|151
1075955|NCT00952289|2607559|P1|Safety Population|All Participants||155
1075956|NCT00952289|2607558|P2|STARTED|All Participants||154
1075957|NCT00952289|2607559|P1|STARTED|All Participants||155
1075970|NCT00952367|2607606|P1|NOT COMPLETED|Overall Study||6
1075971|NCT00952367|2607606|P1|COMPLETED|Overall Study||3635
1075972|NCT00952367|2607606|P1|STARTED|Overall Study||3641
1075973|NCT00952393|2607619|P1|NOT COMPLETED|Overall Study||0
1075974|NCT00952393|2607619|P1|COMPLETED|Overall Study||10
1075975|NCT00952393|2607619|P1|STARTED|Overall Study|10|10
1075976|NCT00952419|2607626|P3|NOT COMPLETED|Overall Study||0
1075977|NCT00952419|2607627|P2|NOT COMPLETED|Overall Study||10
1075978|NCT00952419|2607628|P1|NOT COMPLETED|Overall Study||6
1075979|NCT00952419|2607626|P3|COMPLETED|Overall Study||51
1075980|NCT00952419|2607627|P2|COMPLETED|Overall Study||198
1075981|NCT00952419|2607628|P1|COMPLETED|Overall Study||209
1075982|NCT00952419|2607626|P3|STARTED|Overall Study||51
1075983|NCT00952419|2607627|P2|STARTED|Overall Study||208
1075984|NCT00952419|2607628|P1|STARTED|Overall Study||215
1075985|NCT00952484|2607663|P3|NOT COMPLETED|Overall Study||0
1075986|NCT00952484|2607664|P2|NOT COMPLETED|Overall Study||1
1075987|NCT00952484|2607665|P1|NOT COMPLETED|Overall Study||0
1075988|NCT00952484|2607663|P3|COMPLETED|Overall Study||16
1075989|NCT00952484|2607664|P2|COMPLETED|Overall Study||6
1075990|NCT00952484|2607665|P1|COMPLETED|Overall Study||6
1075991|NCT00952484|2607663|P3|STARTED|Overall Study||16
1075992|NCT00952484|2607664|P2|STARTED|Overall Study||7
1075993|NCT00952484|2607665|P1|STARTED|Overall Study||6
1075994|NCT00952523|2607689|P1|NOT COMPLETED|Overall Study||7
1075995|NCT00952523|2607689|P1|COMPLETED|Overall Study||155
1075996|NCT00952523|2607689|P1|STARTED|Overall Study||162
1075997|NCT00952588|2607697|P2|NOT COMPLETED|Overall Study||24
1075998|NCT00952588|2607698|P1|NOT COMPLETED|Overall Study||36
1075999|NCT00952588|2607697|P2|COMPLETED|Overall Study||2
1076000|NCT00952588|2607698|P1|COMPLETED|Overall Study||12
1076001|NCT00952588|2607697|P2|STARTED|Overall Study||26
1076002|NCT00952588|2607698|P1|STARTED|Overall Study||48
1076003|NCT00952614|2607716|P1|NOT COMPLETED|Overall Study||7
1076004|NCT00952614|2607716|P1|COMPLETED|Overall Study|3 subjects died from unrelated causes, 3 were lost to follow-up & 1 had both eyes included in study.|23
1076005|NCT00952614|2607716|P1|Participants Started Treatment|Overall Study|29 subjects signed consent; 1 agreed for both eyes to enroll. 30 eyes rec'd drug delivery implant|30
1076006|NCT00952614|2607716|P1|STARTED|Overall Study||30
1076007|NCT00952653|2607721|P1|NOT COMPLETED|Period 2: Coadministration DVS SR, MDZ||0
1076008|NCT00952653|2607721|P1|COMPLETED|Period 2: Coadministration DVS SR, MDZ||28
1076009|NCT00952653|2607721|P1|STARTED|Period 2: Coadministration DVS SR, MDZ||28
1076010|NCT00952653|2607721|P1|NOT COMPLETED|Period 1: MDZ Alone||0
1076011|NCT00952653|2607721|P1|COMPLETED|Period 1: MDZ Alone||28
1076012|NCT00952653|2607721|P1|STARTED|Period 1: MDZ Alone||28
1076013|NCT00952705|2607749|P3|NOT COMPLETED|Overall Study||10
1076014|NCT00952705|2607750|P2|NOT COMPLETED|Overall Study||10
1076015|NCT00952705|2607751|P1|NOT COMPLETED|Overall Study||33
1076016|NCT00952705|2607749|P3|COMPLETED|Overall Study||288
1076017|NCT00952705|2607750|P2|COMPLETED|Overall Study||290
1076018|NCT00952705|2607751|P1|COMPLETED|Overall Study||1169
1076019|NCT00952705|2607749|P3|STARTED|Overall Study||298
1076020|NCT00952705|2607750|P2|STARTED|Overall Study||300
1076021|NCT00952705|2607751|P1|STARTED|Overall Study|Three not treated with Q/LAIV-BFS (1 treated with FluMist/B/Yamagata; 2 withdrew prior to dosing).|1202
1076022|NCT00952731|2607815|P2|NOT COMPLETED|Overall Study||0
1076023|NCT00952731|2607816|P1|NOT COMPLETED|Overall Study||1
1076024|NCT00952731|2607815|P2|COMPLETED|Overall Study||14
1076025|NCT00952731|2607816|P1|COMPLETED|Overall Study||12
1076026|NCT00952731|2607815|P2|Follow-up|Overall Study||14
1076027|NCT00952731|2607816|P1|Follow-up|Overall Study||12
1076028|NCT00952731|2607815|P2|Surgery|Overall Study||14
1076029|NCT00952731|2607816|P1|Surgery|Overall Study||12
1076030|NCT00952731|2607815|P2|Treatment & Pre-Surgery|Overall Study||14
1076031|NCT00952731|2607816|P1|Treatment & Pre-Surgery|Overall Study||12
1076032|NCT00952731|2607815|P2|Randomization|Overall Study||14
1076033|NCT00952731|2607816|P1|Randomization|Overall Study||13
1076034|NCT00952731|2607815|P2|STARTED|Overall Study||14
1076035|NCT00952731|2607816|P1|STARTED|Overall Study||13
1076036|NCT00952822|2607832|P4|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
1076037|NCT00952822|2607833|P3|NOT COMPLETED|2nd Pharmacokinetic Evaluation||1
1076038|NCT00952822|2607834|P2|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
1076039|NCT00952822|2607835|P1|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
1076040|NCT00952822|2607832|P4|COMPLETED|2nd Pharmacokinetic Evaluation||4
1076041|NCT00952822|2607833|P3|COMPLETED|2nd Pharmacokinetic Evaluation||10
1076042|NCT00952822|2607834|P2|COMPLETED|2nd Pharmacokinetic Evaluation||17
1076043|NCT00952822|2607835|P1|COMPLETED|2nd Pharmacokinetic Evaluation||9
1076044|NCT00952822|2607832|P4|STARTED|2nd Pharmacokinetic Evaluation||4
1076045|NCT00952822|2607833|P3|STARTED|2nd Pharmacokinetic Evaluation||11
1076046|NCT00952822|2607834|P2|STARTED|2nd Pharmacokinetic Evaluation||17
1076047|NCT00952822|2607835|P1|STARTED|2nd Pharmacokinetic Evaluation||9
1076048|NCT00952822|2607832|P4|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
1076049|NCT00952822|2607833|P3|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
1076050|NCT00952822|2607834|P2|NOT COMPLETED|1st Pharmacokinetic Evaluation||1
1076051|NCT00952822|2607835|P1|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
1076052|NCT00952822|2607832|P4|COMPLETED|1st Pharmacokinetic Evaluation||4
1076053|NCT00952822|2607833|P3|COMPLETED|1st Pharmacokinetic Evaluation||11
1076054|NCT00952822|2607834|P2|COMPLETED|1st Pharmacokinetic Evaluation||17
1076055|NCT00952822|2607835|P1|COMPLETED|1st Pharmacokinetic Evaluation||9
1076056|NCT00952822|2607832|P4|STARTED|1st Pharmacokinetic Evaluation||4
1076057|NCT00952822|2607833|P3|STARTED|1st Pharmacokinetic Evaluation||11
1076058|NCT00952822|2607834|P2|STARTED|1st Pharmacokinetic Evaluation||18
1076059|NCT00952822|2607835|P1|STARTED|1st Pharmacokinetic Evaluation||9
1076060|NCT00952848|2607865|P1|NOT COMPLETED|Overall Study||4
1076061|NCT00952848|2607865|P1|COMPLETED|Overall Study||14
1076062|NCT00952848|2607865|P1|STARTED|Overall Study||18
1076063|NCT00953017|2607876|P4|NOT COMPLETED|Overall Study||5
1076064|NCT00953017|2607877|P3|NOT COMPLETED|Overall Study||6
1076065|NCT00953017|2607878|P2|NOT COMPLETED|Overall Study||6
1076066|NCT00953017|2607879|P1|NOT COMPLETED|Overall Study||5
1076067|NCT00953017|2607876|P4|COMPLETED|Overall Study||101
1076068|NCT00953017|2607877|P3|COMPLETED|Overall Study||100
1076069|NCT00953017|2607878|P2|COMPLETED|Overall Study||101
1076070|NCT00953017|2607879|P1|COMPLETED|Overall Study||101
1076071|NCT00953017|2607876|P4|STARTED|Overall Study||106
1076072|NCT00953017|2607877|P3|STARTED|Overall Study||106
1076073|NCT00953017|2607878|P2|STARTED|Overall Study||107
1076074|NCT00953017|2607879|P1|STARTED|Overall Study||106
1076075|NCT00953043|2607903|P2|NOT COMPLETED|Overall Study||2
1076076|NCT00953043|2607904|P1|NOT COMPLETED|Overall Study||4
1076077|NCT00953043|2607903|P2|COMPLETED|Overall Study||28
1076078|NCT00953043|2607904|P1|COMPLETED|Overall Study||26
1076079|NCT00953043|2607903|P2|STARTED|Overall Study||30
1076080|NCT00953043|2607904|P1|STARTED|Overall Study||30
1076081|NCT00953056|2607930|P6|NOT COMPLETED|Overall Study||4
1076082|NCT00953056|2607931|P5|NOT COMPLETED|Overall Study||2
1076083|NCT00953056|2607932|P4|NOT COMPLETED|Overall Study||0
1076084|NCT00953056|2607933|P3|NOT COMPLETED|Overall Study||0
1076085|NCT00953056|2607934|P2|NOT COMPLETED|Overall Study||0
1076086|NCT00953056|2607935|P1|NOT COMPLETED|Overall Study||0
1076087|NCT00953056|2607930|P6|COMPLETED|Overall Study||20
1076088|NCT00953056|2607931|P5|COMPLETED|Overall Study|One participant received placebo at the second dose in error, but completed the study.|22
1076089|NCT00953056|2607932|P4|COMPLETED|Overall Study||24
1076090|NCT00953056|2607933|P3|COMPLETED|Overall Study||24
1076091|NCT00953056|2607934|P2|COMPLETED|Overall Study||24
1076092|NCT00953056|2607935|P1|COMPLETED|Overall Study||24
1076093|NCT00953056|2607930|P6|STARTED|Overall Study||24
1076094|NCT00953056|2607931|P5|STARTED|Overall Study||24
1076095|NCT00953056|2607932|P4|STARTED|Overall Study||24
1076096|NCT00953056|2607933|P3|STARTED|Overall Study||24
1076097|NCT00953056|2607934|P2|STARTED|Overall Study||24
1076098|NCT00953056|2607935|P1|STARTED|Overall Study||24
1076099|NCT00953121|2607960|P3|NOT COMPLETED|Overall Study||0
1076100|NCT00953121|2607961|P2|NOT COMPLETED|Overall Study||0
1076101|NCT00953121|2607962|P1|NOT COMPLETED|Overall Study||0
1076102|NCT00953121|2607960|P3|COMPLETED|Overall Study||25
1076103|NCT00953121|2607961|P2|COMPLETED|Overall Study||39
1076104|NCT00953121|2607962|P1|COMPLETED|Overall Study||40
1076105|NCT00953121|2607960|P3|STARTED|Overall Study||25
1076106|NCT00953121|2607961|P2|STARTED|Overall Study||39
1076107|NCT00953121|2607962|P1|STARTED|Overall Study||40
1076108|NCT00953147|2607985|P3|NOT COMPLETED|Overall Study||42
1076109|NCT00953147|2607986|P2|NOT COMPLETED|Overall Study||66
1076110|NCT00953147|2607987|P1|NOT COMPLETED|Overall Study||37
1076111|NCT00953147|2607985|P3|COMPLETED|Overall Study||265
1076112|NCT00953147|2607986|P2|COMPLETED|Overall Study||439
1076113|NCT00953147|2607987|P1|COMPLETED|Overall Study||261
1076114|NCT00953147|2607985|P3|STARTED|Overall Study||307
1076115|NCT00953147|2607986|P2|STARTED|Overall Study||505
1076116|NCT00953147|2607987|P1|STARTED|Overall Study||298
1076117|NCT00953160|2608034|P1|NOT COMPLETED|Overall Study||27
1076118|NCT00953160|2608034|P1|COMPLETED|Overall Study||49
1076119|NCT00953160|2608034|P1|STARTED|Overall Study||76
1076120|NCT00953199|2608042|P2|NOT COMPLETED|Overall Study||0
1076121|NCT00953199|2608043|P1|NOT COMPLETED|Overall Study||0
1076122|NCT00953199|2608042|P2|COMPLETED|Overall Study||252
1076123|NCT00953199|2608043|P1|COMPLETED|Overall Study||254
1076124|NCT00953199|2608042|P2|STARTED|Overall Study||252
1076125|NCT00953199|2608043|P1|STARTED|Overall Study||254
1076132|NCT00953290|2608062|P1|NOT COMPLETED|Overall Study||0
1076133|NCT00953290|2608062|P1|COMPLETED|Overall Study||4
1076134|NCT00953290|2608062|P1|STARTED|Overall Study||4
1076135|NCT00953329|2608069|P1|NOT COMPLETED|Overall Study||1
1076136|NCT00953329|2608069|P1|COMPLETED|Overall Study||0
1076137|NCT00953329|2608069|P1|STARTED|Overall Study||1
1076138|NCT00953407|2608078|P5|NOT COMPLETED|Overall Study||1
1076139|NCT00953407|2608079|P4|NOT COMPLETED|Overall Study||2
1076140|NCT00953407|2608080|P3|NOT COMPLETED|Overall Study||1
1076141|NCT00953407|2608081|P2|NOT COMPLETED|Overall Study||1
1076142|NCT00953407|2608082|P1|NOT COMPLETED|Overall Study||1
1076143|NCT00953407|2608078|P5|COMPLETED|Overall Study||23
1076144|NCT00953407|2608079|P4|COMPLETED|Overall Study||23
1076145|NCT00953407|2608080|P3|COMPLETED|Overall Study||25
1076146|NCT00953407|2608081|P2|COMPLETED|Overall Study||24
1076147|NCT00953407|2608082|P1|COMPLETED|Overall Study||25
1076148|NCT00953407|2608078|P5|STARTED|Overall Study||24
1076149|NCT00953407|2608079|P4|STARTED|Overall Study||25
1076150|NCT00953407|2608080|P3|STARTED|Overall Study||26
1076151|NCT00953407|2608081|P2|STARTED|Overall Study||25
1076152|NCT00953407|2608082|P1|STARTED|Overall Study||26
1076153|NCT00953524|2608098|P4|NOT COMPLETED|Overall Study||8
1076154|NCT00953524|2608099|P3|NOT COMPLETED|Overall Study||14
1076155|NCT00953524|2608100|P2|NOT COMPLETED|Overall Study||15
1076156|NCT00953524|2608101|P1|NOT COMPLETED|Overall Study||22
1076157|NCT00953524|2608098|P4|COMPLETED|Overall Study||91
1076158|NCT00953524|2608099|P3|COMPLETED|Overall Study||233
1076159|NCT00953524|2608100|P2|COMPLETED|Overall Study||239
1076160|NCT00953524|2608101|P1|COMPLETED|Overall Study||227
1076161|NCT00953524|2608098|P4|STARTED|Overall Study||99
1076162|NCT00953524|2608099|P3|STARTED|Overall Study||247
1076163|NCT00953524|2608100|P2|STARTED|Overall Study||254
1076164|NCT00953524|2608101|P1|STARTED|Overall Study||249
1076165|NCT00953615|2608139|P1|NOT COMPLETED|Overall Study||1
1076166|NCT00953615|2608139|P1|COMPLETED|Overall Study||0
1076167|NCT00953615|2608139|P1|STARTED|Overall Study||1
1076168|NCT00953654|2608149|P3|NOT COMPLETED|Overall Study||0
1076169|NCT00953654|2608150|P2|NOT COMPLETED|Overall Study||0
1076170|NCT00953654|2608151|P1|NOT COMPLETED|Overall Study||0
1076171|NCT00953654|2608149|P3|COMPLETED|Overall Study||10
1076172|NCT00953654|2608150|P2|COMPLETED|Overall Study||10
1076173|NCT00953654|2608151|P1|COMPLETED|Overall Study||10
1076174|NCT00953654|2608149|P3|STARTED|Overall Study||10
1076175|NCT00953654|2608150|P2|STARTED|Overall Study||10
1076176|NCT00953654|2608151|P1|STARTED|Overall Study||10
1076177|NCT00953667|2608162|P1|NOT COMPLETED|Overall Study||123
1076178|NCT00953667|2608162|P1|COMPLETED|Overall Study||277
1076179|NCT00953667|2608162|P1|STARTED|Overall Study||400
1076180|NCT00953680|2608167|P2|NOT COMPLETED|Period 2||0
1076181|NCT00953680|2608168|P1|NOT COMPLETED|Period 2||0
1076182|NCT00953680|2608167|P2|COMPLETED|Period 2||38
1076183|NCT00953680|2608168|P1|COMPLETED|Period 2||38
1076184|NCT00953680|2608167|P2|STARTED|Period 2||38
1076185|NCT00953680|2608168|P1|STARTED|Period 2||38
1076186|NCT00953680|2608167|P2|NOT COMPLETED|Period 1||1
1076187|NCT00953680|2608168|P1|NOT COMPLETED|Period 1||0
1076188|NCT00953680|2608167|P2|COMPLETED|Period 1||38
1076189|NCT00953680|2608168|P1|COMPLETED|Period 1||38
1076190|NCT00953680|2608167|P2|STARTED|Period 1||39
1076191|NCT00953680|2608168|P1|STARTED|Period 1||38
1076192|NCT00953706|2608182|P4|NOT COMPLETED|Part B (96-Week Open-Label Extension)||33
1076193|NCT00953706|2608183|P3|NOT COMPLETED|Part B (96-Week Open-Label Extension)||5
1076194|NCT00953706|2608184|P2|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
1076195|NCT00953706|2608185|P1|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
1076196|NCT00953706|2608182|P4|COMPLETED|Part B (96-Week Open-Label Extension)||0
1076197|NCT00953706|2608183|P3|COMPLETED|Part B (96-Week Open-Label Extension)||0
1076198|NCT00953706|2608184|P2|COMPLETED|Part B (96-Week Open-Label Extension)||0
1076199|NCT00953706|2608185|P1|COMPLETED|Part B (96-Week Open-Label Extension)||0
1076200|NCT00953706|2608182|P4|STARTED|Part B (96-Week Open-Label Extension)||33
1076201|NCT00953706|2608183|P3|STARTED|Part B (96-Week Open-Label Extension)||5
1076202|NCT00953706|2608184|P2|STARTED|Part B (96-Week Open-Label Extension)||0
1076203|NCT00953706|2608185|P1|STARTED|Part B (96-Week Open-Label Extension)||0
1076204|NCT00953706|2608182|P4|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
1076205|NCT00953706|2608183|P3|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
1076206|NCT00953706|2608184|P2|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||8
1076207|NCT00953706|2608185|P1|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||2
1076208|NCT00953706|2608182|P4|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
1076209|NCT00953706|2608183|P3|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
1076210|NCT00953706|2608184|P2|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 33 participants continued in Part B.|104
1076211|NCT00953706|2608185|P1|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 5 participants continued in Part B.|26
1076212|NCT00953706|2608182|P4|STARTED|Part A (16-Week Double-Blind Treatment)||0
1076213|NCT00953706|2608183|P3|STARTED|Part A (16-Week Double-Blind Treatment)||0
1076214|NCT00953706|2608184|P2|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (ivacaftor)|112
1076215|NCT00953706|2608185|P1|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (placebo)|28
1076216|NCT00953719|2608219|P2|NOT COMPLETED|Overall Study||5
1076217|NCT00953719|2608220|P1|NOT COMPLETED|Overall Study||19
1076218|NCT00953719|2608219|P2|COMPLETED|Overall Study||69
1076219|NCT00953719|2608220|P1|COMPLETED|Overall Study||150
1076220|NCT00953719|2608219|P2|STARTED|Overall Study||74
1076221|NCT00953719|2608220|P1|STARTED|Overall Study||169
1076222|NCT00946920|2608242|P2|NOT COMPLETED|Overall Study||44
1076223|NCT00946920|2608243|P1|NOT COMPLETED|Overall Study||110
1076224|NCT00946920|2608242|P2|COMPLETED|Overall Study||239
1076225|NCT00946920|2608243|P1|COMPLETED|Overall Study||455
1076226|NCT00946920|2608242|P2|Full Analysis Set (FAS)|Overall Study|Received at least one dose of goserelin and had at least one post-dosing efficacy assessment.|282
1076227|NCT00946920|2608243|P1|Full Analysis Set (FAS)|Overall Study|Received at least one dose of degarelix and had at least one post-dosing efficacy assessment.|565
1076228|NCT00946920|2608242|P2|STARTED|Overall Study|Received at least one dose of goserelin acetate.|283
1076229|NCT00946920|2608243|P1|STARTED|Overall Study|Received at least one dose of degarelix.|565
1076230|NCT00946985|2608258|P1|NOT COMPLETED|Relapse Prevention Phase (24 Months)||2
1076231|NCT00946985|2608258|P1|COMPLETED|Relapse Prevention Phase (24 Months)||0
1076232|NCT00946985|2608258|P1|STARTED|Relapse Prevention Phase (24 Months)|Both randomized patients were discontinued when the sponsor terminated the trial early.|2
1076233|NCT00946985|2608258|P1|NOT COMPLETED|Stabilization Phase (25 Weeks)||160
1076234|NCT00946985|2608258|P1|COMPLETED|Stabilization Phase (25 Weeks)||2
1076235|NCT00946985|2608258|P1|STARTED|Stabilization Phase (25 Weeks)||162
1076236|NCT00947011|2608262|P1|NOT COMPLETED|Overall Study||12
1076237|NCT00947011|2608262|P1|COMPLETED|Overall Study||0
1076238|NCT00947011|2608262|P1|STARTED|Overall Study||12
1076239|NCT00947115|2608273|P3|NOT COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||15
1076240|NCT00947115|2608274|P2|NOT COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||22
1076241|NCT00947115|2608275|P1|NOT COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||17
1076242|NCT00947115|2608273|P3|COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||156
1076243|NCT00947115|2608274|P2|COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||172
1076244|NCT00947115|2608275|P1|COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||142
1076245|NCT00947115|2608273|P3|STARTED|Year 0 (Month 0) - Year 10 (Month 120)||171
1076246|NCT00947115|2608274|P2|STARTED|Year 0 (Month 0) - Year 10 (Month 120)||194
1076247|NCT00947115|2608275|P1|STARTED|Year 0 (Month 0) - Year 10 (Month 120)||159
1076248|NCT00947115|2608273|P3|NOT COMPLETED|Year 10 (Month 120)||0
1076249|NCT00947115|2608274|P2|NOT COMPLETED|Year 10 (Month 120)||0
1076250|NCT00947115|2608275|P1|NOT COMPLETED|Year 10 (Month 120)||0
1076251|NCT00947115|2608273|P3|COMPLETED|Year 10 (Month 120)||156
1076252|NCT00947115|2608274|P2|COMPLETED|Year 10 (Month 120)||172
1076253|NCT00947115|2608275|P1|COMPLETED|Year 10 (Month 120)||142
1076254|NCT00947115|2608273|P3|STARTED|Year 10 (Month 120)||156
1076255|NCT00947115|2608274|P2|STARTED|Year 10 (Month 120)||172
1076256|NCT00947115|2608275|P1|STARTED|Year 10 (Month 120)||142
1076257|NCT00947115|2608273|P3|NOT COMPLETED|Year 9 (Month 108)||0
1076258|NCT00947115|2608274|P2|NOT COMPLETED|Year 9 (Month 108)||0
1076259|NCT00947115|2608275|P1|NOT COMPLETED|Year 9 (Month 108)||0
1076260|NCT00947115|2608273|P3|COMPLETED|Year 9 (Month 108)||157
1076261|NCT00947115|2608274|P2|COMPLETED|Year 9 (Month 108)||180
1076262|NCT00947115|2608275|P1|COMPLETED|Year 9 (Month 108)||146
1076263|NCT00947115|2608273|P3|STARTED|Year 9 (Month 108)||157
1076264|NCT00947115|2608274|P2|STARTED|Year 9 (Month 108)||180
1076265|NCT00947115|2608275|P1|STARTED|Year 9 (Month 108)||146
1076266|NCT00947115|2608273|P3|NOT COMPLETED|Year 8 (Month 96)||0
1076267|NCT00947115|2608274|P2|NOT COMPLETED|Year 8 (Month 96)||0
1076268|NCT00947115|2608275|P1|NOT COMPLETED|Year 8 (Month 96)||0
1076269|NCT00947115|2608273|P3|COMPLETED|Year 8 (Month 96)||141
1076270|NCT00947115|2608274|P2|COMPLETED|Year 8 (Month 96)||152
1076271|NCT00947115|2608275|P1|COMPLETED|Year 8 (Month 96)||137
1076272|NCT00947115|2608273|P3|STARTED|Year 8 (Month 96)||141
1076273|NCT00947115|2608274|P2|STARTED|Year 8 (Month 96)||152
1076274|NCT00947115|2608275|P1|STARTED|Year 8 (Month 96)||137
1076275|NCT00947115|2608273|P3|NOT COMPLETED|Year 7 (Month 84)||0
1076276|NCT00947115|2608274|P2|NOT COMPLETED|Year 7 (Month 84)||0
1076277|NCT00947115|2608275|P1|NOT COMPLETED|Year 7 (Month 84)||0
1076278|NCT00947115|2608273|P3|COMPLETED|Year 7 (Month 84)||160
1076279|NCT00947115|2608274|P2|COMPLETED|Year 7 (Month 84)||165
1076280|NCT00947115|2608275|P1|COMPLETED|Year 7 (Month 84)||149
1076281|NCT00947115|2608273|P3|STARTED|Year 7 (Month 84)||160
1076282|NCT00947115|2608274|P2|STARTED|Year 7 (Month 84)||165
1076283|NCT00947115|2608275|P1|STARTED|Year 7 (Month 84)||149
1076284|NCT00947115|2608273|P3|NOT COMPLETED|Year 6 (Month 72)||0
1076285|NCT00947115|2608274|P2|NOT COMPLETED|Year 6 (Month 72)||0
1076286|NCT00947115|2608275|P1|NOT COMPLETED|Year 6 (Month 72)||0
1076287|NCT00947115|2608273|P3|COMPLETED|Year 6 (Month 72)||164
1076288|NCT00947115|2608274|P2|COMPLETED|Year 6 (Month 72)||177
1076289|NCT00947115|2608275|P1|COMPLETED|Year 6 (Month 72)||147
1076290|NCT00947115|2608273|P3|STARTED|Year 6 (Month 72)||164
1076291|NCT00947115|2608274|P2|STARTED|Year 6 (Month 72)||177
1076292|NCT00947115|2608275|P1|STARTED|Year 6 (Month 72)||147
1076293|NCT00947115|2608273|P3|NOT COMPLETED|Year 5 (Month 60)||0
1076294|NCT00947115|2608274|P2|NOT COMPLETED|Year 5 (Month 60)||0
1076295|NCT00947115|2608275|P1|NOT COMPLETED|Year 5 (Month 60)||0
1076296|NCT00947115|2608273|P3|COMPLETED|Year 5 (Month 60)||170
1076297|NCT00947115|2608274|P2|COMPLETED|Year 5 (Month 60)||184
1076298|NCT00947115|2608275|P1|COMPLETED|Year 5 (Month 60)||153
1076299|NCT00947115|2608273|P3|STARTED|Year 5 (Month 60)||170
1076300|NCT00947115|2608274|P2|STARTED|Year 5 (Month 60)||184
1076301|NCT00947115|2608275|P1|STARTED|Year 5 (Month 60)||153
1076302|NCT00947154|2608337|P1|NOT COMPLETED|Overall Study||1
1076303|NCT00947154|2608337|P1|COMPLETED|Overall Study||11
1076304|NCT00947154|2608337|P1|STARTED|Overall Study||12
1076305|NCT00947167|2608344|P1|NOT COMPLETED|Erlotinib Added to Pertuzumab||0
1076306|NCT00947167|2608344|P1|COMPLETED|Erlotinib Added to Pertuzumab||3
1076307|NCT00947167|2608344|P1|STARTED|Erlotinib Added to Pertuzumab||3
1076308|NCT00947167|2608344|P1|NOT COMPLETED|Pertuzumab Alone||0
1076309|NCT00947167|2608344|P1|COMPLETED|Pertuzumab Alone||4
1076310|NCT00947167|2608344|P1|STARTED|Pertuzumab Alone||4
1076311|NCT00947219|2608352|P3|NOT COMPLETED|Overall Study||4
1076312|NCT00947219|2608353|P2|NOT COMPLETED|Overall Study||4
1076313|NCT00947219|2608354|P1|NOT COMPLETED|Overall Study||6
1076314|NCT00947219|2608352|P3|COMPLETED|Overall Study||22
1076315|NCT00947219|2608353|P2|COMPLETED|Overall Study||21
1076316|NCT00947219|2608354|P1|COMPLETED|Overall Study||22
1076317|NCT00947219|2608352|P3|STARTED|Overall Study||26
1076318|NCT00947219|2608353|P2|STARTED|Overall Study||25
1076319|NCT00947219|2608354|P1|STARTED|Overall Study||28
1076320|NCT00947271|2608366|P4|NOT COMPLETED|12 Months Post Intervention||62
1076321|NCT00947271|2608367|P3|NOT COMPLETED|12 Months Post Intervention||59
1076322|NCT00947271|2608368|P2|NOT COMPLETED|12 Months Post Intervention||60
1076323|NCT00947271|2608369|P1|NOT COMPLETED|12 Months Post Intervention||71
1076324|NCT00947271|2608366|P4|COMPLETED|12 Months Post Intervention||188
1076325|NCT00947271|2608367|P3|COMPLETED|12 Months Post Intervention||195
1076326|NCT00947271|2608368|P2|COMPLETED|12 Months Post Intervention||192
1076327|NCT00947271|2608369|P1|COMPLETED|12 Months Post Intervention||183
1076328|NCT00947271|2608366|P4|STARTED|12 Months Post Intervention||250
1076329|NCT00947271|2608367|P3|STARTED|12 Months Post Intervention||254
1076330|NCT00947271|2608368|P2|STARTED|12 Months Post Intervention||252
1076331|NCT00947271|2608369|P1|STARTED|12 Months Post Intervention||254
1076332|NCT00947271|2608366|P4|NOT COMPLETED|9 Months Post Intervention||59
1076333|NCT00947271|2608367|P3|NOT COMPLETED|9 Months Post Intervention||61
1076334|NCT00947271|2608368|P2|NOT COMPLETED|9 Months Post Intervention||60
1076335|NCT00947271|2608369|P1|NOT COMPLETED|9 Months Post Intervention||70
1076336|NCT00947271|2608366|P4|COMPLETED|9 Months Post Intervention||191
1076337|NCT00947271|2608367|P3|COMPLETED|9 Months Post Intervention||193
1076338|NCT00947271|2608368|P2|COMPLETED|9 Months Post Intervention||192
1076339|NCT00947271|2608369|P1|COMPLETED|9 Months Post Intervention||184
1076340|NCT00947271|2608366|P4|STARTED|9 Months Post Intervention||250
1076341|NCT00947271|2608367|P3|STARTED|9 Months Post Intervention||254
1076342|NCT00947271|2608368|P2|STARTED|9 Months Post Intervention||252
1076343|NCT00947271|2608369|P1|STARTED|9 Months Post Intervention||254
1076344|NCT00947271|2608366|P4|NOT COMPLETED|6 Months Post Intervention||54
1076345|NCT00947271|2608367|P3|NOT COMPLETED|6 Months Post Intervention||58
1076346|NCT00947271|2608368|P2|NOT COMPLETED|6 Months Post Intervention||53
1076347|NCT00947271|2608369|P1|NOT COMPLETED|6 Months Post Intervention||55
1076348|NCT00947271|2608366|P4|COMPLETED|6 Months Post Intervention||196
1076349|NCT00947271|2608367|P3|COMPLETED|6 Months Post Intervention||196
1076350|NCT00947271|2608368|P2|COMPLETED|6 Months Post Intervention||199
1076351|NCT00947271|2608369|P1|COMPLETED|6 Months Post Intervention||199
1076352|NCT00947271|2608366|P4|STARTED|6 Months Post Intervention||250
1076353|NCT00947271|2608367|P3|STARTED|6 Months Post Intervention||254
1076354|NCT00947271|2608368|P2|STARTED|6 Months Post Intervention||252
1076355|NCT00947271|2608369|P1|STARTED|6 Months Post Intervention||254
1076356|NCT00947271|2608366|P4|NOT COMPLETED|3 Months Post Intervention||44
1076357|NCT00947271|2608367|P3|NOT COMPLETED|3 Months Post Intervention||36
1076358|NCT00947271|2608368|P2|NOT COMPLETED|3 Months Post Intervention||48
1076359|NCT00947271|2608369|P1|NOT COMPLETED|3 Months Post Intervention||52
1076360|NCT00947271|2608366|P4|COMPLETED|3 Months Post Intervention||206
1076361|NCT00947271|2608367|P3|COMPLETED|3 Months Post Intervention||218
1076362|NCT00947271|2608368|P2|COMPLETED|3 Months Post Intervention||204
1076363|NCT00947271|2608369|P1|COMPLETED|3 Months Post Intervention||202
1076364|NCT00947271|2608366|P4|STARTED|3 Months Post Intervention||250
1076365|NCT00947271|2608367|P3|STARTED|3 Months Post Intervention||254
1076366|NCT00947271|2608368|P2|STARTED|3 Months Post Intervention||252
1076367|NCT00947271|2608369|P1|STARTED|3 Months Post Intervention||254
1076368|NCT00947284|2608395|P2|NOT COMPLETED|Overall Study||3
1076369|NCT00947284|2608396|P1|NOT COMPLETED|Overall Study||0
1076370|NCT00947284|2608395|P2|COMPLETED|Overall Study||0
1076371|NCT00947284|2608396|P1|COMPLETED|Overall Study||0
1076372|NCT00947284|2608395|P2|STARTED|Overall Study||3
1076373|NCT00947284|2608396|P1|STARTED|Overall Study||0
1076374|NCT00947297|2608400|P1|NOT COMPLETED|Overall Study||7
1076375|NCT00947297|2608400|P1|COMPLETED|Overall Study||53
1076376|NCT00947297|2608400|P1|STARTED|Overall Study||60
1076377|NCT00947310|2608410|P3|NOT COMPLETED|Overall Study||0
1076378|NCT00947310|2608411|P2|NOT COMPLETED|Overall Study||0
1076379|NCT00947310|2608412|P1|NOT COMPLETED|Overall Study||0
1076380|NCT00947310|2608410|P3|COMPLETED|Overall Study||486
1076381|NCT00947310|2608411|P2|COMPLETED|Overall Study||500
1076382|NCT00947310|2608412|P1|COMPLETED|Overall Study||514
1076383|NCT00947310|2608410|P3|STARTED|Overall Study||486
1076384|NCT00947310|2608411|P2|STARTED|Overall Study||500
1076385|NCT00947310|2608412|P1|STARTED|Overall Study||514
1076386|NCT00947349|2608430|P4|NOT COMPLETED|Overall Study Standard of Care||2
1076387|NCT00947349|2608431|P3|NOT COMPLETED|Overall Study Standard of Care||2
1076388|NCT00947349|2608432|P2|NOT COMPLETED|Overall Study Standard of Care||0
1076389|NCT00947349|2608433|P1|NOT COMPLETED|Overall Study Standard of Care||0
1076390|NCT00947349|2608430|P4|COMPLETED|Overall Study Standard of Care||4
1076391|NCT00947349|2608431|P3|COMPLETED|Overall Study Standard of Care||4
1076392|NCT00947349|2608432|P2|COMPLETED|Overall Study Standard of Care||5
1076393|NCT00947349|2608433|P1|COMPLETED|Overall Study Standard of Care||4
1076394|NCT00947349|2608430|P4|STARTED|Overall Study Standard of Care||6
1076395|NCT00947349|2608431|P3|STARTED|Overall Study Standard of Care||6
1076396|NCT00947349|2608432|P2|STARTED|Overall Study Standard of Care||5
1076397|NCT00947349|2608433|P1|STARTED|Overall Study Standard of Care||4
1076398|NCT00947349|2608430|P4|NOT COMPLETED|Triple Treatment Combination Period||0
1076399|NCT00947349|2608431|P3|NOT COMPLETED|Triple Treatment Combination Period||0
1076400|NCT00947349|2608432|P2|NOT COMPLETED|Triple Treatment Combination Period||1
1076401|NCT00947349|2608433|P1|NOT COMPLETED|Triple Treatment Combination Period||0
1076402|NCT00947349|2608430|P4|COMPLETED|Triple Treatment Combination Period||6
1076403|NCT00947349|2608431|P3|COMPLETED|Triple Treatment Combination Period||6
1076404|NCT00947349|2608432|P2|COMPLETED|Triple Treatment Combination Period||5
1076405|NCT00947349|2608433|P1|COMPLETED|Triple Treatment Combination Period||4
1076406|NCT00947349|2608430|P4|STARTED|Triple Treatment Combination Period||6
1076407|NCT00947349|2608431|P3|STARTED|Triple Treatment Combination Period||6
1076408|NCT00947349|2608432|P2|STARTED|Triple Treatment Combination Period||6
1076409|NCT00947349|2608433|P1|STARTED|Triple Treatment Combination Period||4
1076410|NCT00947427|2608567|P2|NOT COMPLETED|Overall Study||4
1076411|NCT00947427|2608568|P1|NOT COMPLETED|Overall Study||1
1076412|NCT00947427|2608567|P2|COMPLETED|Overall Study||45
1076413|NCT00947427|2608568|P1|COMPLETED|Overall Study||21
1076414|NCT00947427|2608567|P2|STARTED|Overall Study|2 participants discontinued prior to any study drug administration|49
1076415|NCT00947427|2608568|P1|STARTED|Overall Study||22
1076416|NCT00947505|2608576|P2|NOT COMPLETED|Overall Study||2
1076417|NCT00947505|2608577|P1|NOT COMPLETED|Overall Study||9
1076418|NCT00947505|2608576|P2|COMPLETED|Overall Study||14
1076419|NCT00947505|2608577|P1|COMPLETED|Overall Study||24
1076420|NCT00947505|2608576|P2|STARTED|Overall Study||16
1076421|NCT00947505|2608577|P1|STARTED|Overall Study||33
1076422|NCT00947518|2608586|P3|NOT COMPLETED|Overall Study||0
1076423|NCT00947518|2608587|P2|NOT COMPLETED|Overall Study||0
1076424|NCT00947518|2608588|P1|NOT COMPLETED|Overall Study||0
1076425|NCT00947518|2608586|P3|COMPLETED|Overall Study||20
1076426|NCT00947518|2608587|P2|COMPLETED|Overall Study||20
1076427|NCT00947518|2608588|P1|COMPLETED|Overall Study||20
1076428|NCT00947518|2608586|P3|STARTED|Overall Study||20
1076429|NCT00947518|2608587|P2|STARTED|Overall Study||20
1076430|NCT00947518|2608588|P1|STARTED|Overall Study||20
1076431|NCT00947531|2608601|P2|NOT COMPLETED|Overall Study||11
1076432|NCT00947531|2608602|P1|NOT COMPLETED|Overall Study||14
1076433|NCT00947531|2608601|P2|COMPLETED|Overall Study||110
1076434|NCT00947531|2608602|P1|COMPLETED|Overall Study||107
1076435|NCT00947531|2608601|P2|STARTED|Overall Study||121
1076436|NCT00947531|2608602|P1|STARTED|Overall Study||121
1076437|NCT00947544|2608608|P2|NOT COMPLETED|Safety-Extension Period (12 Months)||0
1076438|NCT00947544|2608609|P1|NOT COMPLETED|Safety-Extension Period (12 Months)||1
1076439|NCT00947544|2608608|P2|COMPLETED|Safety-Extension Period (12 Months)||6
1076440|NCT00947544|2608609|P1|COMPLETED|Safety-Extension Period (12 Months)||10
1076441|NCT00947544|2608608|P2|STARTED|Safety-Extension Period (12 Months)|New participants were enrolled due to DSMB approval.|6
1076442|NCT00947544|2608609|P1|STARTED|Safety-Extension Period (12 Months)||11
1076443|NCT00947544|2608608|P2|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
1076444|NCT00947544|2608609|P1|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
1076445|NCT00947544|2608608|P2|COMPLETED|Switch-Over Period (2 Weeks)||0
1076446|NCT00947544|2608609|P1|COMPLETED|Switch-Over Period (2 Weeks)||11
1076447|NCT00947544|2608608|P2|STARTED|Switch-Over Period (2 Weeks)||0
1076448|NCT00947544|2608609|P1|STARTED|Switch-Over Period (2 Weeks)||11
1076449|NCT00947661|2608635|P2|NOT COMPLETED|Overall Study||15
1076450|NCT00947661|2608636|P1|NOT COMPLETED|Overall Study||13
1076451|NCT00947661|2608635|P2|COMPLETED|Overall Study||274
1076452|NCT00947661|2608636|P1|COMPLETED|Overall Study||276
1076453|NCT00947661|2608635|P2|STARTED|Overall Study||289
1076454|NCT00947661|2608636|P1|STARTED|Overall Study||289
1076455|NCT00947752|2608644|P2|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
1076456|NCT00947752|2608645|P1|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
1076457|NCT00947752|2608644|P2|COMPLETED|Crossover to 2nd 14-day Treatment Period||76
1076458|NCT00947752|2608645|P1|COMPLETED|Crossover to 2nd 14-day Treatment Period||71
1076459|NCT00947752|2608644|P2|STARTED|Crossover to 2nd 14-day Treatment Period||76
1076460|NCT00947752|2608645|P1|STARTED|Crossover to 2nd 14-day Treatment Period||71
1076461|NCT00947752|2608644|P2|NOT COMPLETED|1st 14-day Treatment Period||0
1076462|NCT00947752|2608645|P1|NOT COMPLETED|1st 14-day Treatment Period||0
1076463|NCT00947752|2608644|P2|COMPLETED|1st 14-day Treatment Period||71
1076464|NCT00947752|2608645|P1|COMPLETED|1st 14-day Treatment Period||76
1076465|NCT00947752|2608644|P2|STARTED|1st 14-day Treatment Period||71
1076466|NCT00947752|2608645|P1|STARTED|1st 14-day Treatment Period||76
1076467|NCT00947752|2608644|P2|NOT COMPLETED|7-Day Run-in Treatment Period||0
1076468|NCT00947752|2608645|P1|NOT COMPLETED|7-Day Run-in Treatment Period||0
1076469|NCT00947752|2608644|P2|COMPLETED|7-Day Run-in Treatment Period||0
1076470|NCT00947752|2608645|P1|COMPLETED|7-Day Run-in Treatment Period||147
1076471|NCT00947752|2608644|P2|STARTED|7-Day Run-in Treatment Period||0
1076472|NCT00947752|2608645|P1|STARTED|7-Day Run-in Treatment Period|All subjects started with a daily does of F1 for 7 days|147
1076473|NCT00947765|2608655|P2|NOT COMPLETED|Overall Study||0
1076474|NCT00947765|2608656|P1|NOT COMPLETED|Overall Study||0
1076475|NCT00947765|2608655|P2|COMPLETED|Overall Study||30
1076476|NCT00947765|2608656|P1|COMPLETED|Overall Study||30
1076477|NCT00947765|2608655|P2|STARTED|Overall Study||30
1076478|NCT00947765|2608656|P1|STARTED|Overall Study||30
1076479|NCT00947791|2608678|P2|NOT COMPLETED|Overall Study||0
1076480|NCT00947791|2608679|P1|NOT COMPLETED|Overall Study||0
1076481|NCT00947791|2608678|P2|COMPLETED|Overall Study||1
1076482|NCT00947791|2608679|P1|COMPLETED|Overall Study||0
1076483|NCT00947791|2608678|P2|STARTED|Overall Study||1
1076484|NCT00947791|2608679|P1|STARTED|Overall Study||0
1076485|NCT00947856|2608697|P2|NOT COMPLETED|Follow-up Period||23
1076486|NCT00947856|2608698|P1|NOT COMPLETED|Follow-up Period||51
1076487|NCT00947856|2608697|P2|COMPLETED|Follow-up Period|Completed survival follow-up due to death|9
1076488|NCT00947856|2608698|P1|COMPLETED|Follow-up Period||27
1076489|NCT00947856|2608697|P2|STARTED|Follow-up Period|All participants were followed after treatment; thus, number started will not match number completed|32
1076490|NCT00947856|2608698|P1|STARTED|Follow-up Period||78
1076491|NCT00947856|2608697|P2|NOT COMPLETED|Treatment Period||32
1076492|NCT00947856|2608698|P1|NOT COMPLETED|Treatment Period||78
1076493|NCT00947856|2608697|P2|COMPLETED|Treatment Period|Patients treated until disease progression, unacceptable toxicity or study closure|0
1076494|NCT00947856|2608698|P1|COMPLETED|Treatment Period||0
1076495|NCT00947856|2608697|P2|STARTED|Treatment Period|Two patients in extension arm re-enrolled in retreatment arm and are represented in both arms|32
1076496|NCT00947856|2608698|P1|STARTED|Treatment Period||78
1076497|NCT00947882|2608729|P4|NOT COMPLETED|Overall Study||82
1076498|NCT00947882|2608730|P3|NOT COMPLETED|Overall Study||79
1076499|NCT00947882|2608731|P2|NOT COMPLETED|Overall Study||77
1076500|NCT00947882|2608732|P1|NOT COMPLETED|Overall Study||74
1076501|NCT00947882|2608729|P4|COMPLETED|Overall Study||20
1076502|NCT00947882|2608730|P3|COMPLETED|Overall Study||22
1076503|NCT00947882|2608731|P2|COMPLETED|Overall Study||24
1076504|NCT00947882|2608732|P1|COMPLETED|Overall Study|End of Trial, Month 12: Patients who had completed the 12-month period when the trial was stopped.|26
1076505|NCT00947882|2608729|P4|Visit 12, Month 6|Overall Study||95
1076506|NCT00947882|2608730|P3|Visit 12, Month 6|Overall Study||90
1076507|NCT00947882|2608731|P2|Visit 12, Month 6|Overall Study||91
1076508|NCT00947882|2608732|P1|Visit 12, Month 6|Overall Study|The trial was stopped when all patients had completed Visit 12, scheduled 6 months after the dosing.|93
1076509|NCT00947882|2608729|P4|Safety Analysis Set|Overall Study||105
1076510|NCT00947882|2608730|P3|Safety Analysis Set|Overall Study||100
1076511|NCT00947882|2608731|P2|Safety Analysis Set|Overall Study||101
1076512|NCT00947882|2608732|P1|Safety Analysis Set|Overall Study|Safety Analysis Set: Received a dose of Investigational Medicinal Product (IMP).|98
1076513|NCT00947882|2608729|P4|Actual Treatment|Overall Study||105
1076514|NCT00947882|2608730|P3|Actual Treatment|Overall Study|1 patient randomised to 20 mg degarelix received 30 mg degarelix|100
1076515|NCT00947882|2608731|P2|Actual Treatment|Overall Study||101
1076516|NCT00947882|2608732|P1|Actual Treatment|Overall Study|2 placebo patients received 30 mg degarelix|98
1076517|NCT00947882|2608729|P4|Full Analysis Set (FAS)|Overall Study||102
1076518|NCT00947882|2608730|P3|Full Analysis Set (FAS)|Overall Study|1 patient received 20 mg degarelix but had no post-baseline IPSS value and was excluded from the FAS|100
1076519|NCT00947882|2608731|P2|Full Analysis Set (FAS)|Overall Study||101
1076520|NCT00947882|2608732|P1|Full Analysis Set (FAS)|Overall Study|FAS: Received a dose of IMP and completed at least one post-baseline IPSS questionnaire.|100
1076521|NCT00947882|2608729|P4|STARTED|Overall Study||102
1076522|NCT00947882|2608730|P3|STARTED|Overall Study||101
1076523|NCT00947882|2608731|P2|STARTED|Overall Study||101
1076524|NCT00947882|2608732|P1|STARTED|Overall Study|Started: Randomised.|100
1076525|NCT00948064|2608761|P3|NOT COMPLETED|Phase II||1
1076526|NCT00948064|2608762|P2|NOT COMPLETED|Phase II||1
1076527|NCT00948064|2608763|P1|NOT COMPLETED|Phase II||0
1076528|NCT00948064|2608761|P3|COMPLETED|Phase II||26
1076529|NCT00948064|2608762|P2|COMPLETED|Phase II||51
1076530|NCT00948064|2608763|P1|COMPLETED|Phase II||0
1076531|NCT00948064|2608761|P3|STARTED|Phase II||27
1076532|NCT00948064|2608762|P2|STARTED|Phase II||52
1076533|NCT00948064|2608763|P1|STARTED|Phase II||0
1076534|NCT00948064|2608761|P3|NOT COMPLETED|Phase I||0
1076535|NCT00948064|2608762|P2|NOT COMPLETED|Phase I||0
1076536|NCT00948064|2608763|P1|NOT COMPLETED|Phase I||1
1076537|NCT00948064|2608761|P3|COMPLETED|Phase I||0
1076538|NCT00948064|2608762|P2|COMPLETED|Phase I||0
1076539|NCT00948064|2608763|P1|COMPLETED|Phase I||30
1076540|NCT00948064|2608761|P3|STARTED|Phase I||0
1076541|NCT00948064|2608762|P2|STARTED|Phase I||0
1076542|NCT00948064|2608763|P1|STARTED|Phase I||31
1076543|NCT00948090|2608776|P4|NOT COMPLETED|Overall Study||11
1076544|NCT00948090|2608777|P3|NOT COMPLETED|Overall Study||56
1076545|NCT00948090|2608778|P2|NOT COMPLETED|Overall Study||1
1076546|NCT00948090|2608779|P1|NOT COMPLETED|Overall Study||43
1076547|NCT00948090|2608776|P4|COMPLETED|Overall Study||7
1076548|NCT00948090|2608777|P3|COMPLETED|Overall Study||67
1076549|NCT00948090|2608778|P2|COMPLETED|Overall Study||0
1076550|NCT00948090|2608779|P1|COMPLETED|Overall Study||22
1076551|NCT00948090|2608776|P4|STARTED|Overall Study||18
1076552|NCT00948090|2608777|P3|STARTED|Overall Study||123
1076553|NCT00948090|2608778|P2|STARTED|Overall Study||1
1076554|NCT00948090|2608779|P1|STARTED|Overall Study||65
1076555|NCT00948155|2608800|P2|NOT COMPLETED|Second Intervention 21 Days||3
1076556|NCT00948155|2608801|P1|NOT COMPLETED|Second Intervention 21 Days||2
1076557|NCT00948155|2608800|P2|COMPLETED|Second Intervention 21 Days||8
1076558|NCT00948155|2608801|P1|COMPLETED|Second Intervention 21 Days||9
1076559|NCT00948155|2608800|P2|STARTED|Second Intervention 21 Days||11
1076560|NCT00948155|2608801|P1|STARTED|Second Intervention 21 Days||11
1076561|NCT00948155|2608800|P2|NOT COMPLETED|Washout 14 Days||2
1076562|NCT00948155|2608801|P1|NOT COMPLETED|Washout 14 Days||1
1076563|NCT00948155|2608800|P2|COMPLETED|Washout 14 Days||11
1076564|NCT00948155|2608801|P1|COMPLETED|Washout 14 Days||11
1076565|NCT00948155|2608800|P2|STARTED|Washout 14 Days||13
1076566|NCT00948155|2608801|P1|STARTED|Washout 14 Days||12
1076567|NCT00948155|2608800|P2|NOT COMPLETED|First Intervention 21 Days||2
1076568|NCT00948155|2608801|P1|NOT COMPLETED|First Intervention 21 Days||2
1076569|NCT00948155|2608800|P2|COMPLETED|First Intervention 21 Days||13
1076570|NCT00948155|2608801|P1|COMPLETED|First Intervention 21 Days||12
1076571|NCT00948155|2608800|P2|STARTED|First Intervention 21 Days||15
1076572|NCT00948155|2608801|P1|STARTED|First Intervention 21 Days||14
1076573|NCT00948246|2608821|P1|NOT COMPLETED|Overall Study||24
1076574|NCT00948246|2608821|P1|COMPLETED|Overall Study||86
1076575|NCT00948246|2608821|P1|STARTED|Overall Study||110
1076576|NCT00953849|2608832|P4|NOT COMPLETED|Overall Study||0
1076577|NCT00953849|2608833|P3|NOT COMPLETED|Overall Study||0
1076578|NCT00953849|2608834|P2|NOT COMPLETED|Overall Study||0
1076579|NCT00953849|2608835|P1|NOT COMPLETED|Overall Study||0
1076580|NCT00953849|2608832|P4|COMPLETED|Overall Study||5
1076581|NCT00953849|2608833|P3|COMPLETED|Overall Study||4
1076582|NCT00953849|2608834|P2|COMPLETED|Overall Study||6
1076583|NCT00953849|2608835|P1|COMPLETED|Overall Study||6
1076584|NCT00953849|2608832|P4|STARTED|Overall Study||5
1076585|NCT00953849|2608833|P3|STARTED|Overall Study||4
1076586|NCT00953849|2608834|P2|STARTED|Overall Study||6
1076587|NCT00953849|2608835|P1|STARTED|Overall Study||6
1076588|NCT00953862|2608857|P1|NOT COMPLETED|Overall Study||6
1076589|NCT00953862|2608857|P1|COMPLETED|Overall Study||12
1076590|NCT00953862|2608857|P1|STARTED|Overall Study||18
1076591|NCT00953927|2608865|P2|NOT COMPLETED|Overall Study||95
1076592|NCT00953927|2608866|P1|NOT COMPLETED|Overall Study||105
1076593|NCT00953927|2608865|P2|COMPLETED|Overall Study||1303
1076594|NCT00953927|2608866|P1|COMPLETED|Overall Study||1294
1076595|NCT00953927|2608865|P2|STARTED|Overall Study||1398
1076596|NCT00953927|2608866|P1|STARTED|Overall Study||1399
1076597|NCT00954109|2608884|P1|NOT COMPLETED|Overall Study||0
1076598|NCT00954109|2608884|P1|COMPLETED|Overall Study||11
1076599|NCT00954109|2608884|P1|STARTED|Overall Study||11
1076600|NCT00954122|2608889|P1|NOT COMPLETED|Overall Study||7
1076601|NCT00954122|2608889|P1|COMPLETED|Overall Study||28
1076602|NCT00954122|2608889|P1|STARTED|Overall Study||35
1076603|NCT00956943|2608901|P2|NOT COMPLETED|Overall Study||10
1076604|NCT00956943|2608902|P1|NOT COMPLETED|Overall Study||9
1076605|NCT00956943|2608901|P2|COMPLETED|Overall Study||34
1076606|NCT00956943|2608902|P1|COMPLETED|Overall Study||34
1076607|NCT00956943|2608901|P2|Baseline|Overall Study||44
1076608|NCT00956943|2608902|P1|Baseline|Overall Study||43
1076609|NCT00956943|2608901|P2|STARTED|Overall Study||44
1076610|NCT00956943|2608902|P1|STARTED|Overall Study||43
1076611|NCT00957008|2608914|P4|NOT COMPLETED|Overall Study||24
1076612|NCT00957008|2608915|P3|NOT COMPLETED|Overall Study||17
1076613|NCT00957008|2608916|P2|NOT COMPLETED|Overall Study||12
1076614|NCT00957008|2608917|P1|NOT COMPLETED|Overall Study||21
1076615|NCT00957008|2608914|P4|COMPLETED|Overall Study||26
1076616|NCT00957008|2608915|P3|COMPLETED|Overall Study||32
1076617|NCT00957008|2608916|P2|COMPLETED|Overall Study||37
1076618|NCT00957008|2608917|P1|COMPLETED|Overall Study||28
1076619|NCT00957008|2608914|P4|STARTED|Overall Study||50
1076620|NCT00957008|2608915|P3|STARTED|Overall Study||49
1076621|NCT00957008|2608916|P2|STARTED|Overall Study||49
1076622|NCT00957008|2608917|P1|STARTED|Overall Study||49
1076623|NCT00957021|2608931|P1|NOT COMPLETED|Overall Study||117
1076624|NCT00957021|2608931|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2 yr primary outcome interval.|237
1076625|NCT00957021|2608931|P1|STARTED|Overall Study||354
1076626|NCT00957034|2608943|P3|NOT COMPLETED|Overall Study||6
1076627|NCT00957034|2608944|P2|NOT COMPLETED|Overall Study||4
1076628|NCT00957034|2608945|P1|NOT COMPLETED|Overall Study||6
1076629|NCT00957034|2608943|P3|COMPLETED|Overall Study||1
1076630|NCT00957034|2608944|P2|COMPLETED|Overall Study||0
1076631|NCT00957034|2608945|P1|COMPLETED|Overall Study||0
1076632|NCT00957034|2608943|P3|STARTED|Overall Study||7
1076633|NCT00957034|2608944|P2|STARTED|Overall Study||4
1076634|NCT00957034|2608945|P1|STARTED|Overall Study||6
1076635|NCT00957047|2608972|P5|NOT COMPLETED|PART II||102
1076636|NCT00957047|2608973|P4|NOT COMPLETED|PART II||0
1076637|NCT00957047|2608974|P3|NOT COMPLETED|PART II||0
1076638|NCT00957047|2608975|P2|NOT COMPLETED|PART II||0
1076639|NCT00957047|2608976|P1|NOT COMPLETED|PART II||0
1076640|NCT00957047|2608972|P5|COMPLETED|PART II||223
1076641|NCT00957047|2608973|P4|COMPLETED|PART II||0
1076642|NCT00957047|2608974|P3|COMPLETED|PART II||0
1076643|NCT00957047|2608975|P2|COMPLETED|PART II||0
1076644|NCT00957047|2608976|P1|COMPLETED|PART II||0
1076645|NCT00957047|2608972|P5|Terminated Prematurely|PART II|Terminated Prematurely during 1-year Open-Label Period|102
1076646|NCT00957047|2608973|P4|Terminated Prematurely|PART II||0
1076647|NCT00957047|2608974|P3|Terminated Prematurely|PART II||0
1076648|NCT00957047|2608975|P2|Terminated Prematurely|PART II||0
1076649|NCT00957047|2608976|P1|Terminated Prematurely|PART II||0
1076650|NCT00957047|2608972|P5|STARTED|PART II|325 patients who completed Part I were enrolled in Part II.|325
1076651|NCT00957047|2608973|P4|STARTED|PART II||0
1076652|NCT00957047|2608974|P3|STARTED|PART II||0
1076653|NCT00957047|2608975|P2|STARTED|PART II||0
1076654|NCT00957047|2608976|P1|STARTED|PART II||0
1076655|NCT00957047|2608972|P5|NOT COMPLETED|PART I||0
1076656|NCT00957047|2608973|P4|NOT COMPLETED|PART I||30
1076657|NCT00957047|2608974|P3|NOT COMPLETED|PART I||21
1076658|NCT00957047|2608975|P2|NOT COMPLETED|PART I||13
1076659|NCT00957047|2608976|P1|NOT COMPLETED|PART I||6
1076660|NCT00957047|2608972|P5|COMPLETED|PART I||0
1076661|NCT00957047|2608973|P4|COMPLETED|PART I||68
1076662|NCT00957047|2608974|P3|COMPLETED|PART I||80
1076663|NCT00957047|2608975|P2|COMPLETED|PART I||83
1076664|NCT00957047|2608976|P1|COMPLETED|PART I||94
1076665|NCT00957047|2608972|P5|Per-Protocol Population|PART I||0
1076666|NCT00957047|2608973|P4|Per-Protocol Population|PART I||54
1076667|NCT00957047|2608974|P3|Per-Protocol Population|PART I||75
1076668|NCT00957047|2608975|P2|Per-Protocol Population|PART I||70
1076669|NCT00957047|2608976|P1|Per-Protocol Population|PART I||81
1076670|NCT00957047|2608972|P5|Intention-to-treat (ITT) Population|PART I||0
1076671|NCT00957047|2608973|P4|Intention-to-treat (ITT) Population|PART I||97
1076672|NCT00957047|2608974|P3|Intention-to-treat (ITT) Population|PART I||100
1076673|NCT00957047|2608975|P2|Intention-to-treat (ITT) Population|PART I||96
1076674|NCT00957047|2608976|P1|Intention-to-treat (ITT) Population|PART I||100
1076675|NCT00957047|2608972|P5|Randomized/Safety Population|PART I||0
1076676|NCT00957047|2608973|P4|Randomized/Safety Population|PART I||98
1076677|NCT00957047|2608974|P3|Randomized/Safety Population|PART I||101
1076678|NCT00957047|2608975|P2|Randomized/Safety Population|PART I||96
1076679|NCT00957047|2608976|P1|Randomized/Safety Population|PART I||100
1076680|NCT00957047|2608972|P5|STARTED|PART I||0
1076681|NCT00957047|2608973|P4|STARTED|PART I||98
1076682|NCT00957047|2608974|P3|STARTED|PART I||101
1076683|NCT00957047|2608975|P2|STARTED|PART I||96
1076684|NCT00957047|2608976|P1|STARTED|PART I||100
1076685|NCT00957242|2608996|P2|NOT COMPLETED|Overall Study||0
1076686|NCT00957242|2608997|P1|NOT COMPLETED|Overall Study||0
1076687|NCT00957242|2608996|P2|COMPLETED|Overall Study||72
1076688|NCT00957242|2608997|P1|COMPLETED|Overall Study||73
1076689|NCT00957242|2608996|P2|STARTED|Overall Study||72
1076690|NCT00957242|2608997|P1|STARTED|Overall Study||73
1076691|NCT00957268|2609030|P5|NOT COMPLETED|Overall Study||0
1076692|NCT00957268|2609031|P4|NOT COMPLETED|Overall Study||0
1076693|NCT00957268|2609032|P3|NOT COMPLETED|Overall Study||1
1076694|NCT00957268|2609033|P2|NOT COMPLETED|Overall Study||0
1076695|NCT00957268|2609034|P1|NOT COMPLETED|Overall Study||0
1076696|NCT00957268|2609030|P5|COMPLETED|Overall Study||22
1076697|NCT00957268|2609031|P4|COMPLETED|Overall Study||7
1076698|NCT00957268|2609032|P3|COMPLETED|Overall Study||7
1076699|NCT00957268|2609033|P2|COMPLETED|Overall Study||4
1076700|NCT00957268|2609034|P1|COMPLETED|Overall Study||5
1076701|NCT00957268|2609030|P5|STARTED|Overall Study||22
1076702|NCT00957268|2609031|P4|STARTED|Overall Study||7
1076703|NCT00957268|2609032|P3|STARTED|Overall Study||8
1076704|NCT00957268|2609033|P2|STARTED|Overall Study||4
1076705|NCT00957268|2609034|P1|STARTED|Overall Study||5
1076706|NCT00957333|2609096|P1|NOT COMPLETED|Overall Study||0
1076707|NCT00957333|2609096|P1|COMPLETED|Overall Study||44
1076708|NCT00957333|2609096|P1|STARTED|Overall Study||44
1076709|NCT00957372|2609103|P4|NOT COMPLETED|PART II||44
1076710|NCT00957372|2609104|P3|NOT COMPLETED|PART II||0
1076711|NCT00957372|2609105|P2|NOT COMPLETED|PART II||0
1076712|NCT00957372|2609106|P1|NOT COMPLETED|PART II||0
1076713|NCT00957372|2609103|P4|COMPLETED|PART II||150
1076714|NCT00957372|2609104|P3|COMPLETED|PART II||0
1076715|NCT00957372|2609105|P2|COMPLETED|PART II||0
1076716|NCT00957372|2609106|P1|COMPLETED|PART II||0
1076717|NCT00957372|2609103|P4|Per-Protocol Population|PART II||108
1076718|NCT00957372|2609104|P3|Per-Protocol Population|PART II||0
1076719|NCT00957372|2609105|P2|Per-Protocol Population|PART II||0
1076720|NCT00957372|2609106|P1|Per-Protocol Population|PART II||0
1076721|NCT00957372|2609103|P4|Intention-to-treat (ITT) Population|PART II||191
1076722|NCT00957372|2609104|P3|Intention-to-treat (ITT) Population|PART II||0
1076723|NCT00957372|2609105|P2|Intention-to-treat (ITT) Population|PART II||0
1076724|NCT00957372|2609106|P1|Intention-to-treat (ITT) Population|PART II||0
1076725|NCT00957372|2609103|P4|Safety Population|PART II||194
1076726|NCT00957372|2609104|P3|Safety Population|PART II||0
1076727|NCT00957372|2609105|P2|Safety Population|PART II||0
1076728|NCT00957372|2609106|P1|Safety Population|PART II||0
1076729|NCT00957372|2609103|P4|STARTED|PART II||194
1076730|NCT00957372|2609104|P3|STARTED|PART II||0
1076731|NCT00957372|2609105|P2|STARTED|PART II||0
1076732|NCT00957372|2609106|P1|STARTED|PART II||0
1076733|NCT00957372|2609103|P4|NOT COMPLETED|PART I||0
1076734|NCT00957372|2609104|P3|NOT COMPLETED|PART I||1
1076735|NCT00957372|2609105|P2|NOT COMPLETED|PART I||0
1076736|NCT00957372|2609106|P1|NOT COMPLETED|PART I||0
1076737|NCT00957372|2609103|P4|COMPLETED|PART I||0
1076738|NCT00957372|2609104|P3|COMPLETED|PART I||87
1076739|NCT00957372|2609105|P2|COMPLETED|PART I||85
1076740|NCT00957372|2609106|P1|COMPLETED|PART I||80
1076741|NCT00957372|2609103|P4|Randomized But Not Treated|PART I||0
1076742|NCT00957372|2609104|P3|Randomized But Not Treated|PART I||1
1076743|NCT00957372|2609105|P2|Randomized But Not Treated|PART I||0
1076744|NCT00957372|2609106|P1|Randomized But Not Treated|PART I||0
1076745|NCT00957372|2609103|P4|Per-Protocol Population|PART I||0
1076746|NCT00957372|2609104|P3|Per-Protocol Population|PART I||51
1076747|NCT00957372|2609105|P2|Per-Protocol Population|PART I||47
1076748|NCT00957372|2609106|P1|Per-Protocol Population|PART I||35
1076749|NCT00957372|2609103|P4|Intention-to-Treat Population|PART I||0
1076750|NCT00957372|2609104|P3|Intention-to-Treat Population|PART I||84
1076751|NCT00957372|2609105|P2|Intention-to-Treat Population|PART I||84
1076752|NCT00957372|2609106|P1|Intention-to-Treat Population|PART I||77
1076753|NCT00957372|2609103|P4|Safety Population|PART I||0
1076754|NCT00957372|2609104|P3|Safety Population|PART I||87
1076755|NCT00957372|2609105|P2|Safety Population|PART I||85
1076756|NCT00957372|2609106|P1|Safety Population|PART I||80
1076757|NCT00957372|2609103|P4|STARTED|PART I||0
1076758|NCT00957372|2609104|P3|STARTED|PART I||88
1076759|NCT00957372|2609105|P2|STARTED|PART I||85
1076760|NCT00957372|2609106|P1|STARTED|PART I||80
1076761|NCT00957424|2609122|P1|NOT COMPLETED|Overall Study||23
1076762|NCT00957424|2609122|P1|COMPLETED|Overall Study||44
1076763|NCT00957424|2609122|P1|Follow-up #2|Overall Study||50
1076764|NCT00957424|2609122|P1|Follow-up #1|Overall Study||59
1076765|NCT00957424|2609122|P1|STARTED|Overall Study||67
1076766|NCT00957528|2609132|P3|NOT COMPLETED|Overall Study||1
1076767|NCT00957528|2609133|P2|NOT COMPLETED|Overall Study||1
1076768|NCT00957528|2609134|P1|NOT COMPLETED|Overall Study||0
1076769|NCT00957528|2609132|P3|COMPLETED|Overall Study||8
1076770|NCT00957528|2609133|P2|COMPLETED|Overall Study||8
1076771|NCT00957528|2609134|P1|COMPLETED|Overall Study||8
1076772|NCT00957528|2609132|P3|STARTED|Overall Study||9
1076773|NCT00957528|2609133|P2|STARTED|Overall Study||9
1076774|NCT00957528|2609134|P1|STARTED|Overall Study||8
1076775|NCT00957580|2609160|P3|NOT COMPLETED|Overall Study||0
1076776|NCT00957580|2609161|P2|NOT COMPLETED|Overall Study||2
1076777|NCT00957580|2609162|P1|NOT COMPLETED|Overall Study||0
1076778|NCT00957580|2609160|P3|COMPLETED|Overall Study||15
1076779|NCT00957580|2609161|P2|COMPLETED|Overall Study||31
1076780|NCT00957580|2609162|P1|COMPLETED|Overall Study||33
1076781|NCT00957580|2609160|P3|Treated|Overall Study||15
1076782|NCT00957580|2609161|P2|Treated|Overall Study||32
1076783|NCT00957580|2609162|P1|Treated|Overall Study||33
1076784|NCT00957580|2609160|P3|STARTED|Overall Study||15
1076785|NCT00957580|2609161|P2|STARTED|Overall Study||33
1076786|NCT00957580|2609162|P1|STARTED|Overall Study||33
1076787|NCT00957593|2609308|P2|NOT COMPLETED|Overall Study||0
1076788|NCT00957593|2609309|P1|NOT COMPLETED|Overall Study||0
1076789|NCT00957593|2609308|P2|COMPLETED|Overall Study||125
1076790|NCT00957593|2609309|P1|COMPLETED|Overall Study||127
1076791|NCT00957593|2609308|P2|STARTED|Overall Study||125
1076792|NCT00957593|2609309|P1|STARTED|Overall Study||127
1076793|NCT00957658|2609315|P1|NOT COMPLETED|Overall Study||65
1076794|NCT00957658|2609315|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|169
1076795|NCT00957658|2609315|P1|STARTED|Overall Study||234
1076796|NCT00957684|2609332|P5|NOT COMPLETED|PART II||75
1076797|NCT00957684|2609333|P4|NOT COMPLETED|PART II||0
1076798|NCT00957684|2609334|P3|NOT COMPLETED|PART II||0
1076799|NCT00957684|2609335|P2|NOT COMPLETED|PART II||0
1076800|NCT00957684|2609336|P1|NOT COMPLETED|PART II||0
1076801|NCT00957684|2609332|P5|COMPLETED|PART II||239
1076802|NCT00957684|2609333|P4|COMPLETED|PART II||0
1076803|NCT00957684|2609334|P3|COMPLETED|PART II||0
1076804|NCT00957684|2609335|P2|COMPLETED|PART II||0
1076805|NCT00957684|2609336|P1|COMPLETED|PART II||0
1076806|NCT00957684|2609332|P5|Patients Entered Part II|PART II||314
1076807|NCT00957684|2609333|P4|Patients Entered Part II|PART II||0
1076808|NCT00957684|2609334|P3|Patients Entered Part II|PART II||0
1076809|NCT00957684|2609335|P2|Patients Entered Part II|PART II||0
1076810|NCT00957684|2609336|P1|Patients Entered Part II|PART II||0
1076811|NCT00957684|2609332|P5|STARTED|PART II||314
1076812|NCT00957684|2609333|P4|STARTED|PART II||0
1076813|NCT00957684|2609334|P3|STARTED|PART II||0
1076814|NCT00957684|2609335|P2|STARTED|PART II||0
1076815|NCT00957684|2609336|P1|STARTED|PART II||0
1076816|NCT00957684|2609332|P5|NOT COMPLETED|PART I||0
1076817|NCT00957684|2609333|P4|NOT COMPLETED|PART I||18
1076818|NCT00957684|2609334|P3|NOT COMPLETED|PART I||10
1076819|NCT00957684|2609335|P2|NOT COMPLETED|PART I||13
1076820|NCT00957684|2609336|P1|NOT COMPLETED|PART I||31
1076821|NCT00957684|2609332|P5|COMPLETED|PART I||0
1076822|NCT00957684|2609333|P4|COMPLETED|PART I||84
1076823|NCT00957684|2609334|P3|COMPLETED|PART I||90
1076824|NCT00957684|2609335|P2|COMPLETED|PART I||85
1076825|NCT00957684|2609336|P1|COMPLETED|PART I||71
1076826|NCT00957684|2609332|P5|Per-protocol (PP)Population|PART I||0
1076827|NCT00957684|2609333|P4|Per-protocol (PP)Population|PART I||91
1076828|NCT00957684|2609334|P3|Per-protocol (PP)Population|PART I||94
1076829|NCT00957684|2609335|P2|Per-protocol (PP)Population|PART I||86
1076830|NCT00957684|2609336|P1|Per-protocol (PP)Population|PART I||72
1076831|NCT00957684|2609332|P5|Intention-to-treat (ITT) Population|PART I||0
1076832|NCT00957684|2609333|P4|Intention-to-treat (ITT) Population|PART I||102
1076833|NCT00957684|2609334|P3|Intention-to-treat (ITT) Population|PART I||99
1076834|NCT00957684|2609335|P2|Intention-to-treat (ITT) Population|PART I||98
1076835|NCT00957684|2609336|P1|Intention-to-treat (ITT) Population|PART I||98
1076836|NCT00957684|2609332|P5|Randomised (Safety Population)|PART I||0
1076837|NCT00957684|2609333|P4|Randomised (Safety Population)|PART I||102
1076838|NCT00957684|2609334|P3|Randomised (Safety Population)|PART I||100
1076839|NCT00957684|2609335|P2|Randomised (Safety Population)|PART I||98
1076840|NCT00957684|2609336|P1|Randomised (Safety Population)|PART I||102
1076841|NCT00957684|2609332|P5|STARTED|PART I||0
1076842|NCT00957684|2609333|P4|STARTED|PART I||102
1076843|NCT00957684|2609334|P3|STARTED|PART I||100
1076844|NCT00957684|2609335|P2|STARTED|PART I||98
1076845|NCT00957684|2609336|P1|STARTED|PART I||102
1076849|NCT00957905|2609359|P2|NOT COMPLETED|Part B||4
1076850|NCT00957905|2609360|P1|NOT COMPLETED|Part B||0
1076851|NCT00957905|2609359|P2|COMPLETED|Part B||25
1076852|NCT00957905|2609360|P1|COMPLETED|Part B||0
1076853|NCT00957905|2609359|P2|STARTED|Part B||29
1076854|NCT00957905|2609360|P1|STARTED|Part B||0
1076855|NCT00957905|2609359|P2|NOT COMPLETED|Part A||0
1076856|NCT00957905|2609360|P1|NOT COMPLETED|Part A||0
1076857|NCT00957905|2609359|P2|COMPLETED|Part A||0
1076858|NCT00957905|2609360|P1|COMPLETED|Part A||7
1076859|NCT00957905|2609359|P2|STARTED|Part A||0
1076860|NCT00957905|2609360|P1|STARTED|Part A||7
1076861|NCT00957944|2609368|P2|NOT COMPLETED|Second Intervention- 24 Hours||0
1076862|NCT00957944|2609369|P1|NOT COMPLETED|Second Intervention- 24 Hours||0
1076863|NCT00957944|2609368|P2|COMPLETED|Second Intervention- 24 Hours||19
1076864|NCT00957944|2609369|P1|COMPLETED|Second Intervention- 24 Hours||20
1076865|NCT00957944|2609368|P2|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours|One subject that fullfilled predefined criteria for patch adhesiveness was excluded from the PKS|18
1076866|NCT00957944|2609369|P1|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours||20
1076867|NCT00957944|2609368|P2|STARTED|Second Intervention- 24 Hours||19
1076868|NCT00957944|2609369|P1|STARTED|Second Intervention- 24 Hours||20
1076869|NCT00957944|2609368|P2|NOT COMPLETED|Washout Period of at Least 5 Days||0
1076870|NCT00957944|2609369|P1|NOT COMPLETED|Washout Period of at Least 5 Days||0
1076871|NCT00957944|2609368|P2|COMPLETED|Washout Period of at Least 5 Days||19
1076872|NCT00957944|2609369|P1|COMPLETED|Washout Period of at Least 5 Days||20
1076873|NCT00957944|2609368|P2|STARTED|Washout Period of at Least 5 Days||19
1076874|NCT00957944|2609369|P1|STARTED|Washout Period of at Least 5 Days||20
1076875|NCT00957944|2609368|P2|NOT COMPLETED|First Intervention- 24 Hours||1
1076876|NCT00957944|2609369|P1|NOT COMPLETED|First Intervention- 24 Hours||0
1076877|NCT00957944|2609368|P2|COMPLETED|First Intervention- 24 Hours||19
1076878|NCT00957944|2609369|P1|COMPLETED|First Intervention- 24 Hours||20
1076879|NCT00957944|2609368|P2|STARTED|First Intervention- 24 Hours||20
1076880|NCT00957944|2609369|P1|STARTED|First Intervention- 24 Hours||20
1076881|NCT00957996|2609405|P2|NOT COMPLETED|Overall Study||28
1076882|NCT00957996|2609406|P1|NOT COMPLETED|Overall Study||26
1076883|NCT00957996|2609405|P2|COMPLETED|Overall Study||89
1076884|NCT00957996|2609406|P1|COMPLETED|Overall Study||91
1076885|NCT00957996|2609405|P2|STARTED|Overall Study||117
1076886|NCT00957996|2609406|P1|STARTED|Overall Study||117
1076887|NCT00958009|2609436|P1|NOT COMPLETED|Overall Study||2
1076888|NCT00958009|2609436|P1|COMPLETED|Overall Study||107
1076889|NCT00958009|2609436|P1|STARTED|Overall Study||109
1076890|NCT00958035|2609443|P2|NOT COMPLETED|Overall Study||4
1076891|NCT00958035|2609444|P1|NOT COMPLETED|Overall Study||3
1076892|NCT00958035|2609443|P2|COMPLETED|Overall Study||39
1076893|NCT00958035|2609444|P1|COMPLETED|Overall Study||43
1076894|NCT00958035|2609443|P2|STARTED|Overall Study||43
1076895|NCT00958035|2609444|P1|STARTED|Overall Study||46
1076896|NCT00958074|2609452|P2|NOT COMPLETED|Overall Study||1
1076897|NCT00958074|2609453|P1|NOT COMPLETED|Overall Study||0
1076898|NCT00958074|2609452|P2|COMPLETED|Overall Study||6
1076899|NCT00958074|2609453|P1|COMPLETED|Overall Study||4
1076900|NCT00958074|2609452|P2|STARTED|Overall Study||7
1076901|NCT00958074|2609453|P1|STARTED|Overall Study||4
1076902|NCT00958126|2609467|P8|NOT COMPLETED|Overall Study||0
1076903|NCT00958126|2609468|P7|NOT COMPLETED|Overall Study||1
1076904|NCT00958126|2609469|P6|NOT COMPLETED|Overall Study||1
1076905|NCT00958126|2609470|P5|NOT COMPLETED|Overall Study||0
1076906|NCT00958126|2609471|P4|NOT COMPLETED|Overall Study||11
1076907|NCT00958126|2609472|P3|NOT COMPLETED|Overall Study||10
1076908|NCT00958126|2609473|P2|NOT COMPLETED|Overall Study||9
1076909|NCT00958126|2609474|P1|NOT COMPLETED|Overall Study||1
1076910|NCT00958126|2609467|P8|COMPLETED|Overall Study||202
1076911|NCT00958126|2609468|P7|COMPLETED|Overall Study||199
1076912|NCT00958126|2609469|P6|COMPLETED|Overall Study||202
1076913|NCT00958126|2609470|P5|COMPLETED|Overall Study||50
1076914|NCT00958126|2609471|P4|COMPLETED|Overall Study||192
1076915|NCT00958126|2609472|P3|COMPLETED|Overall Study||191
1076916|NCT00958126|2609473|P2|COMPLETED|Overall Study||196
1076917|NCT00958126|2609474|P1|COMPLETED|Overall Study||48
1076918|NCT00958126|2609467|P8|STARTED|Overall Study||202
1076919|NCT00958126|2609468|P7|STARTED|Overall Study||200
1076920|NCT00958126|2609469|P6|STARTED|Overall Study||203
1076921|NCT00958126|2609470|P5|STARTED|Overall Study||50
1076922|NCT00958126|2609471|P4|STARTED|Overall Study||203
1076923|NCT00958126|2609472|P3|STARTED|Overall Study||201
1076924|NCT00958126|2609473|P2|STARTED|Overall Study||205
1076925|NCT00958126|2609474|P1|STARTED|Overall Study||49
1076926|NCT00958165|2609544|P1|NOT COMPLETED|Overall Study||14
1076927|NCT00958165|2609544|P1|COMPLETED|Overall Study|Of the 72 treated participants, 67 completed follow-up and were evaluable for effectiveness.|67
1076928|NCT00958165|2609544|P1|Treated|Overall Study||72
1076929|NCT00958165|2609544|P1|STARTED|Overall Study|81 enrolled participants resulted in 72 eligible participants that were treated.|81
1076930|NCT00958191|2609548|P1|NOT COMPLETED|Overall Study||112
1076931|NCT00958191|2609548|P1|COMPLETED|Overall Study|Number of participants with 5 year primary endpoint data|110
1076932|NCT00958191|2609548|P1|STARTED|Overall Study||222
1076933|NCT00958217|2609563|P2|NOT COMPLETED|Overall Study||25
1076934|NCT00958217|2609564|P1|NOT COMPLETED|Overall Study||24
1076935|NCT00958217|2609563|P2|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
1076936|NCT00958217|2609564|P1|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
1076937|NCT00958217|2609563|P2|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|57
1076938|NCT00958217|2609564|P1|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|56
1076939|NCT00958217|2609563|P2|STARTED|Overall Study||62
1076940|NCT00958217|2609564|P1|STARTED|Overall Study||61
1076941|NCT00958243|2609581|P6|NOT COMPLETED|Overall Study||10
1076942|NCT00958243|2609582|P5|NOT COMPLETED|Overall Study||9
1076943|NCT00958243|2609583|P4|NOT COMPLETED|Overall Study||3
1076944|NCT00958243|2609584|P3|NOT COMPLETED|Overall Study||14
1076945|NCT00958243|2609585|P2|NOT COMPLETED|Overall Study||6
1076946|NCT00958243|2609586|P1|NOT COMPLETED|Overall Study||2
1076947|NCT00958243|2609581|P6|COMPLETED|Overall Study||99
1076948|NCT00958243|2609582|P5|COMPLETED|Overall Study||100
1076949|NCT00958243|2609583|P4|COMPLETED|Overall Study||25
1076950|NCT00958243|2609584|P3|COMPLETED|Overall Study||82
1076951|NCT00958243|2609585|P2|COMPLETED|Overall Study||99
1076952|NCT00958243|2609586|P1|COMPLETED|Overall Study||24
1076953|NCT00958243|2609581|P6|STARTED|Overall Study||109
1076954|NCT00958243|2609582|P5|STARTED|Overall Study||109
1076955|NCT00958243|2609583|P4|STARTED|Overall Study||28
1076956|NCT00958243|2609584|P3|STARTED|Overall Study||96
1076957|NCT00958243|2609585|P2|STARTED|Overall Study||105
1076958|NCT00958243|2609586|P1|STARTED|Overall Study||26
1076959|NCT00958256|2609642|P1|NOT COMPLETED|Overall Study||3
1076960|NCT00958256|2609642|P1|COMPLETED|Overall Study||18
1076961|NCT00958256|2609642|P1|STARTED|Overall Study||21
1076962|NCT00958282|2609648|P2|NOT COMPLETED|Overall Study||6
1076963|NCT00958282|2609649|P1|NOT COMPLETED|Overall Study||10
1076964|NCT00958282|2609648|P2|COMPLETED|Overall Study||15
1076965|NCT00958282|2609649|P1|COMPLETED|Overall Study||12
1076966|NCT00958282|2609648|P2|STARTED|Overall Study||21
1076967|NCT00958282|2609649|P1|STARTED|Overall Study||22
1076968|NCT00958308|2609660|P3|NOT COMPLETED|Overall Study||0
1076969|NCT00958308|2609661|P2|NOT COMPLETED|Overall Study||0
1076970|NCT00958308|2609662|P1|NOT COMPLETED|Overall Study||0
1076971|NCT00958308|2609660|P3|COMPLETED|Overall Study||86
1076972|NCT00958308|2609661|P2|COMPLETED|Overall Study||85
1076973|NCT00958308|2609662|P1|COMPLETED|Overall Study||84
1076974|NCT00958308|2609660|P3|STARTED|Overall Study||86
1076975|NCT00958308|2609661|P2|STARTED|Overall Study||85
1076976|NCT00958308|2609662|P1|STARTED|Overall Study||84
1076977|NCT00958334|2609673|P3|NOT COMPLETED|Overall Study||13
1076978|NCT00958334|2609674|P2|NOT COMPLETED|Overall Study||17
1076979|NCT00958334|2609675|P1|NOT COMPLETED|Overall Study||14
1076980|NCT00958334|2609673|P3|COMPLETED|Overall Study||8
1076981|NCT00958334|2609674|P2|COMPLETED|Overall Study||5
1076982|NCT00958334|2609675|P1|COMPLETED|Overall Study||8
1076983|NCT00958334|2609673|P3|STARTED|Overall Study||21
1076984|NCT00958334|2609674|P2|STARTED|Overall Study||22
1076985|NCT00958334|2609675|P1|STARTED|Overall Study||22
1076986|NCT00958347|2609683|P1|NOT COMPLETED|Overall Study||226
1076987|NCT00958347|2609683|P1|COMPLETED|Overall Study|11 revisions total, one was a bilateral participant with the other hip counted as not completed.|0
1076988|NCT00958347|2609683|P1|STARTED|Overall Study||226
1076989|NCT00958360|2609689|P2|NOT COMPLETED|Overall Study||10
1076990|NCT00958360|2609690|P1|NOT COMPLETED|Overall Study||11
1076991|NCT00958360|2609689|P2|COMPLETED|Overall Study||150
1076992|NCT00958360|2609690|P1|COMPLETED|Overall Study||152
1076993|NCT00958360|2609689|P2|STARTED|Overall Study||160
1076994|NCT00958360|2609690|P1|STARTED|Overall Study||163
1076995|NCT00958438|2609707|P3|NOT COMPLETED|Overall Study||6
1076996|NCT00958438|2609708|P2|NOT COMPLETED|Overall Study||10
1076997|NCT00958438|2609709|P1|NOT COMPLETED|Overall Study||10
1076998|NCT00958438|2609707|P3|COMPLETED|Overall Study||78
1076999|NCT00958438|2609708|P2|COMPLETED|Overall Study||72
1077000|NCT00958438|2609709|P1|COMPLETED|Overall Study||72
1077001|NCT00958438|2609707|P3|STARTED|Overall Study||84
1077002|NCT00958438|2609708|P2|STARTED|Overall Study||82
1077003|NCT00958438|2609709|P1|STARTED|Overall Study||82
1077004|NCT00958477|2609736|P4|NOT COMPLETED|Overall Study||0
1077005|NCT00958477|2609737|P3|NOT COMPLETED|Overall Study||0
1077006|NCT00958477|2609738|P2|NOT COMPLETED|Overall Study||0
1077007|NCT00958477|2609739|P1|NOT COMPLETED|Overall Study||0
1077008|NCT00958477|2609736|P4|COMPLETED|Overall Study||6
1077009|NCT00958477|2609737|P3|COMPLETED|Overall Study||6
1077010|NCT00958477|2609738|P2|COMPLETED|Overall Study||6
1077011|NCT00958477|2609739|P1|COMPLETED|Overall Study||8
1077012|NCT00958477|2609736|P4|STARTED|Overall Study||6
1077013|NCT00958477|2609737|P3|STARTED|Overall Study||6
1077014|NCT00958477|2609738|P2|STARTED|Overall Study||6
1077015|NCT00958477|2609739|P1|STARTED|Overall Study||8
1077016|NCT00958568|2609885|P4|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||106
1077017|NCT00958568|2609886|P3|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||82
1077018|NCT00958568|2609887|P2|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
1077019|NCT00958568|2609888|P1|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
1077020|NCT00958568|2609885|P4|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||117
1077021|NCT00958568|2609886|P3|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||139
1077022|NCT00958568|2609887|P2|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
1077023|NCT00958568|2609888|P1|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
1077024|NCT00958568|2609885|P4|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||223
1077025|NCT00958568|2609886|P3|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||221
1077026|NCT00958568|2609887|P2|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
1077027|NCT00958568|2609888|P1|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
1077028|NCT00958568|2609885|P4|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
1077029|NCT00958568|2609886|P3|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
1077030|NCT00958568|2609887|P2|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||211
1077031|NCT00958568|2609888|P1|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
1077032|NCT00958568|2609885|P4|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
1077033|NCT00958568|2609886|P3|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
1077034|NCT00958568|2609887|P2|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||444
1077035|NCT00958568|2609888|P1|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
1077036|NCT00958568|2609885|P4|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
1077037|NCT00958568|2609886|P3|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
1077038|NCT00958568|2609887|P2|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||655
1077039|NCT00958568|2609888|P1|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
1077040|NCT00958568|2609885|P4|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
1077041|NCT00958568|2609886|P3|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
1077042|NCT00958568|2609887|P2|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
1077043|NCT00958568|2609888|P1|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||237
1077044|NCT00958568|2609885|P4|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
1077045|NCT00958568|2609886|P3|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
1077046|NCT00958568|2609887|P2|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
1077047|NCT00958568|2609888|P1|COMPLETED|SPII (Wk 0-8, Acute Open-label)||655
1077048|NCT00958568|2609885|P4|STARTED|SPII (Wk 0-8, Acute Open-label)||0
1077049|NCT00958568|2609886|P3|STARTED|SPII (Wk 0-8, Acute Open-label)||0
1077050|NCT00958568|2609887|P2|STARTED|SPII (Wk 0-8, Acute Open-label)||0
1077051|NCT00958568|2609888|P1|STARTED|SPII (Wk 0-8, Acute Open-label)||892
1077052|NCT00958776|2609971|P2|NOT COMPLETED|Overall Study||29
1077053|NCT00958776|2609972|P1|NOT COMPLETED|Overall Study||16
1077054|NCT00958776|2609971|P2|COMPLETED|Overall Study||239
1077055|NCT00958776|2609972|P1|COMPLETED|Overall Study||121
1077056|NCT00958776|2609971|P2|STARTED|Overall Study||268
1077057|NCT00958776|2609972|P1|STARTED|Overall Study||137
1077058|NCT00958789|2610002|P1|NOT COMPLETED|Overall Study||51
1077059|NCT00958789|2610002|P1|COMPLETED|Overall Study|Participant status at the 2 year primary outcome interval determined Completed/Not Completed counts.|130
1077060|NCT00958789|2610002|P1|STARTED|Overall Study||181
1077061|NCT00958828|2610006|P2|NOT COMPLETED|Period 2, 1 Week of Wear||1
1077062|NCT00958828|2610007|P1|NOT COMPLETED|Period 2, 1 Week of Wear||0
1077063|NCT00958828|2610006|P2|COMPLETED|Period 2, 1 Week of Wear||87
1077064|NCT00958828|2610007|P1|COMPLETED|Period 2, 1 Week of Wear||89
1077065|NCT00958828|2610006|P2|STARTED|Period 2, 1 Week of Wear||88
1077066|NCT00958828|2610007|P1|STARTED|Period 2, 1 Week of Wear||89
1077067|NCT00958828|2610006|P2|NOT COMPLETED|Period 1, 1 Week of Wear||1
1077068|NCT00958828|2610007|P1|NOT COMPLETED|Period 1, 1 Week of Wear||0
1077069|NCT00958828|2610006|P2|COMPLETED|Period 1, 1 Week of Wear||88
1077070|NCT00958828|2610007|P1|COMPLETED|Period 1, 1 Week of Wear||89
1077071|NCT00958828|2610006|P2|STARTED|Period 1, 1 Week of Wear||89
1077072|NCT00958828|2610007|P1|STARTED|Period 1, 1 Week of Wear||89
1077073|NCT00958841|2610013|P1|NOT COMPLETED|Overall Study||96
1077074|NCT00958841|2610013|P1|COMPLETED|Overall Study|Completed = Completed extension|22
1077075|NCT00958841|2610013|P1|Entered in Extension|Overall Study||63
1077076|NCT00958841|2610013|P1|Completed Month 6 (M6)|Overall Study||90
1077077|NCT00958841|2610013|P1|STARTED|Overall Study||118
1077078|NCT00958880|2610033|P2|NOT COMPLETED|Overall Study||2
1077079|NCT00958880|2610034|P1|NOT COMPLETED|Overall Study||2
1077080|NCT00958880|2610033|P2|COMPLETED|Overall Study||18
1077081|NCT00958880|2610034|P1|COMPLETED|Overall Study||18
1077082|NCT00958880|2610033|P2|STARTED|Overall Study||20
1077083|NCT00958880|2610034|P1|STARTED|Overall Study||20
1077084|NCT00958893|2610042|P1|NOT COMPLETED|Overall Study||4
1077085|NCT00958893|2610042|P1|COMPLETED|Overall Study||0
1077086|NCT00958893|2610042|P1|STARTED|Overall Study||4
1077087|NCT00958919|2610046|P2|NOT COMPLETED|Second Intervention||0
1077088|NCT00958919|2610047|P1|NOT COMPLETED|Second Intervention||0
1077089|NCT00958919|2610046|P2|COMPLETED|Second Intervention||7
1077090|NCT00958919|2610047|P1|COMPLETED|Second Intervention||7
1077091|NCT00958919|2610046|P2|STARTED|Second Intervention||7
1077092|NCT00958919|2610047|P1|STARTED|Second Intervention||7
1077093|NCT00958919|2610046|P2|NOT COMPLETED|First Intervention||0
1077094|NCT00958919|2610047|P1|NOT COMPLETED|First Intervention||0
1077095|NCT00958919|2610046|P2|COMPLETED|First Intervention||7
1077096|NCT00958919|2610047|P1|COMPLETED|First Intervention||7
1077097|NCT00958919|2610046|P2|STARTED|First Intervention||7
1077098|NCT00958919|2610047|P1|STARTED|First Intervention||7
1077099|NCT00959049|2610067|P6|NOT COMPLETED|Overall Study||1
1077100|NCT00959049|2610068|P5|NOT COMPLETED|Overall Study||9
1077101|NCT00959049|2610069|P4|NOT COMPLETED|Overall Study||11
1077102|NCT00959049|2610070|P3|NOT COMPLETED|Overall Study||1
1077103|NCT00959049|2610071|P2|NOT COMPLETED|Overall Study||7
1077104|NCT00959049|2610072|P1|NOT COMPLETED|Overall Study||18
1077105|NCT00959049|2610067|P6|COMPLETED|Overall Study||249
1077106|NCT00959049|2610068|P5|COMPLETED|Overall Study||248
1077107|NCT00959049|2610069|P4|COMPLETED|Overall Study||217
1077108|NCT00959049|2610070|P3|COMPLETED|Overall Study||253
1077109|NCT00959049|2610071|P2|COMPLETED|Overall Study||247
1077110|NCT00959049|2610072|P1|COMPLETED|Overall Study||213
1077111|NCT00959049|2610067|P6|STARTED|Overall Study||250
1077112|NCT00959049|2610068|P5|STARTED|Overall Study||257
1077113|NCT00959049|2610069|P4|STARTED|Overall Study||228
1077114|NCT00959049|2610070|P3|STARTED|Overall Study||254
1077115|NCT00959049|2610071|P2|STARTED|Overall Study||254
1077116|NCT00959049|2610072|P1|STARTED|Overall Study||231
1077117|NCT00959192|2610126|P4|NOT COMPLETED|Overall Study||1
1077118|NCT00959192|2610127|P3|NOT COMPLETED|Overall Study||3
1077119|NCT00959192|2610128|P2|NOT COMPLETED|Overall Study||1
1077120|NCT00959192|2610129|P1|NOT COMPLETED|Overall Study||2
1077121|NCT00959192|2610126|P4|COMPLETED|Overall Study||7
1077122|NCT00959192|2610127|P3|COMPLETED|Overall Study||6
1077123|NCT00959192|2610128|P2|COMPLETED|Overall Study||8
1077124|NCT00959192|2610129|P1|COMPLETED|Overall Study||4
1077125|NCT00959192|2610126|P4|STARTED|Overall Study||8
1077126|NCT00959192|2610127|P3|STARTED|Overall Study||9
1077127|NCT00959192|2610128|P2|STARTED|Overall Study||9
1077128|NCT00959192|2610129|P1|STARTED|Overall Study||6
1077129|NCT00959374|2610171|P1|NOT COMPLETED|Overall Study||23
1077130|NCT00959374|2610171|P1|COMPLETED|Overall Study||218
1077131|NCT00959374|2610171|P1|STARTED|Overall Study|Of the 241 enrolled subjects, 229 were randomized and treated|241
1077132|NCT00951171|2610183|P2|NOT COMPLETED|Overall Study||0
1077133|NCT00951171|2610184|P1|NOT COMPLETED|Overall Study||2
1077134|NCT00951171|2610183|P2|COMPLETED|Overall Study|2 of the cervical occlusion group transferred to standard group because of pain during attempted IUI|55
1077135|NCT00951171|2610184|P1|COMPLETED|Overall Study||38
1077136|NCT00951171|2610183|P2|Pregnancy|Overall Study||7
1077137|NCT00951171|2610184|P1|Pregnancy|Overall Study||1
1077138|NCT00951171|2610183|P2|STARTED|Overall Study||55
1077139|NCT00951171|2610184|P1|STARTED|Overall Study||40
1077140|NCT00959647|2610190|P1|NOT COMPLETED|Overall Study||19
1077141|NCT00959647|2610190|P1|COMPLETED|Overall Study||0
1077142|NCT00959647|2610190|P1|STARTED|Overall Study||19
1077143|NCT00959699|2610197|P2|NOT COMPLETED|Follow-up Period||6
1077144|NCT00959699|2610198|P1|NOT COMPLETED|Follow-up Period||6
1077145|NCT00959699|2610197|P2|COMPLETED|Follow-up Period||56
1077146|NCT00959699|2610198|P1|COMPLETED|Follow-up Period||27
1077147|NCT00959699|2610197|P2|STARTED|Follow-up Period|2 participants didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|62
1077148|NCT00959699|2610198|P1|STARTED|Follow-up Period|1 participant didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|33
1077149|NCT00959699|2610197|P2|NOT COMPLETED|Treatment Period||25
1077150|NCT00959699|2610198|P1|NOT COMPLETED|Treatment Period||23
1077151|NCT00959699|2610197|P2|COMPLETED|Treatment Period||40
1077152|NCT00959699|2610198|P1|COMPLETED|Treatment Period|At TW24, 4 participants not achieving undetectable HCV-RNA crossed-over and received boceprevir.|11
1077153|NCT00959699|2610197|P2|Treated|Treatment Period||64
1077154|NCT00959699|2610198|P1|Treated|Treatment Period||34
1077155|NCT00959699|2610197|P2|STARTED|Treatment Period||65
1077156|NCT00959699|2610198|P1|STARTED|Treatment Period||34
1077157|NCT00959751|2610217|P2|NOT COMPLETED|Overall Study||12
1077158|NCT00959751|2610218|P1|NOT COMPLETED|Overall Study||9
1077159|NCT00959751|2610217|P2|COMPLETED|Overall Study||86
1077160|NCT00959751|2610218|P1|COMPLETED|Overall Study||88
1077161|NCT00959751|2610217|P2|STARTED|Overall Study||98
1077162|NCT00959751|2610218|P1|STARTED|Overall Study||97
1077163|NCT00959764|2610241|P3|NOT COMPLETED|Overall Study||36
1077164|NCT00959764|2610242|P2|NOT COMPLETED|Overall Study||57
1077165|NCT00959764|2610243|P1|NOT COMPLETED|Overall Study||95
1077166|NCT00959764|2610241|P3|COMPLETED|Overall Study||73
1077167|NCT00959764|2610242|P2|COMPLETED|Overall Study||128
1077168|NCT00959764|2610243|P1|COMPLETED|Overall Study||176
1077169|NCT00959764|2610241|P3|STARTED|Overall Study||109
1077170|NCT00959764|2610242|P2|STARTED|Overall Study||185
1077171|NCT00959764|2610243|P1|STARTED|Overall Study||271
1077172|NCT00961116|2610257|P2|NOT COMPLETED|Second Intervention||0
1077173|NCT00961116|2610258|P1|NOT COMPLETED|Second Intervention||0
1077174|NCT00961116|2610257|P2|COMPLETED|Second Intervention||24
1077175|NCT00961116|2610258|P1|COMPLETED|Second Intervention||25
1077176|NCT00961116|2610257|P2|STARTED|Second Intervention||24
1077177|NCT00961116|2610258|P1|STARTED|Second Intervention||25
1077178|NCT00961116|2610257|P2|NOT COMPLETED|Washout Period of 7 Days||3
1077179|NCT00961116|2610258|P1|NOT COMPLETED|Washout Period of 7 Days||2
1077180|NCT00961116|2610257|P2|COMPLETED|Washout Period of 7 Days||24
1077181|NCT00961116|2610258|P1|COMPLETED|Washout Period of 7 Days||25
1077182|NCT00961116|2610257|P2|STARTED|Washout Period of 7 Days||27
1077183|NCT00961116|2610258|P1|STARTED|Washout Period of 7 Days||27
1077184|NCT00961116|2610257|P2|NOT COMPLETED|First Intervention||0
1077185|NCT00961116|2610258|P1|NOT COMPLETED|First Intervention||0
1077186|NCT00961116|2610257|P2|COMPLETED|First Intervention||27
1077187|NCT00961116|2610258|P1|COMPLETED|First Intervention||27
1077188|NCT00961116|2610257|P2|STARTED|First Intervention||27
1077189|NCT00961116|2610258|P1|STARTED|First Intervention||27
1077190|NCT00961181|2610268|P1|NOT COMPLETED|Overall Study||5
1077191|NCT00961181|2610268|P1|COMPLETED|Overall Study||76
1077192|NCT00961181|2610268|P1|STARTED|Overall Study||81
1077193|NCT00961220|2610281|P1|NOT COMPLETED|Overall Study||7
1077194|NCT00961220|2610281|P1|COMPLETED|Overall Study||10
1077195|NCT00961220|2610281|P1|STARTED|Overall Study||17
1077196|NCT00961233|2610299|P2|NOT COMPLETED|Overall Study||1
1077197|NCT00961233|2610300|P1|NOT COMPLETED|Overall Study||2
1077198|NCT00961233|2610299|P2|COMPLETED|Overall Study||11
1077199|NCT00961233|2610300|P1|COMPLETED|Overall Study||11
1077200|NCT00961233|2610299|P2|STARTED|Overall Study||12
1077201|NCT00961233|2610300|P1|STARTED|Overall Study||13
1077202|NCT00961259|2610308|P3|NOT COMPLETED|Third Intervention||0
1077203|NCT00961259|2610309|P2|NOT COMPLETED|Third Intervention||0
1077204|NCT00961259|2610310|P1|NOT COMPLETED|Third Intervention||0
1077205|NCT00961259|2610308|P3|COMPLETED|Third Intervention||18
1077206|NCT00961259|2610309|P2|COMPLETED|Third Intervention||17
1077207|NCT00961259|2610310|P1|COMPLETED|Third Intervention||18
1077208|NCT00961259|2610308|P3|STARTED|Third Intervention||18
1077209|NCT00961259|2610309|P2|STARTED|Third Intervention||17
1077210|NCT00961259|2610310|P1|STARTED|Third Intervention||18
1077211|NCT00961259|2610308|P3|NOT COMPLETED|Washout Period of 7 Days||0
1077212|NCT00961259|2610309|P2|NOT COMPLETED|Washout Period of 7 Days||0
1077213|NCT00961259|2610310|P1|NOT COMPLETED|Washout Period of 7 Days||0
1077214|NCT00961259|2610308|P3|COMPLETED|Washout Period of 7 Days||18
1077215|NCT00961259|2610309|P2|COMPLETED|Washout Period of 7 Days||17
1077216|NCT00961259|2610310|P1|COMPLETED|Washout Period of 7 Days||18
1077217|NCT00961259|2610308|P3|STARTED|Washout Period of 7 Days||18
1077218|NCT00961259|2610309|P2|STARTED|Washout Period of 7 Days||17
1077219|NCT00961259|2610310|P1|STARTED|Washout Period of 7 Days||18
1077220|NCT00961259|2610308|P3|NOT COMPLETED|Second Intervention||0
1077221|NCT00961259|2610309|P2|NOT COMPLETED|Second Intervention||0
1077222|NCT00961259|2610310|P1|NOT COMPLETED|Second Intervention||0
1077223|NCT00961259|2610308|P3|COMPLETED|Second Intervention||18
1077224|NCT00961259|2610309|P2|COMPLETED|Second Intervention||17
1077225|NCT00961259|2610310|P1|COMPLETED|Second Intervention||18
1077226|NCT00961259|2610308|P3|STARTED|Second Intervention||18
1077227|NCT00961259|2610309|P2|STARTED|Second Intervention||17
1077228|NCT00961259|2610310|P1|STARTED|Second Intervention||18
1077229|NCT00961259|2610308|P3|NOT COMPLETED|Washout Period of 7 Days||0
1077230|NCT00961259|2610309|P2|NOT COMPLETED|Washout Period of 7 Days||1
1077231|NCT00961259|2610310|P1|NOT COMPLETED|Washout Period of 7 Days||0
1077232|NCT00961259|2610308|P3|COMPLETED|Washout Period of 7 Days||18
1077233|NCT00961259|2610309|P2|COMPLETED|Washout Period of 7 Days|dropped due to concomitant medication used prior to admission.|17
1077234|NCT00961259|2610310|P1|COMPLETED|Washout Period of 7 Days||18
1077235|NCT00961259|2610308|P3|STARTED|Washout Period of 7 Days||18
1077236|NCT00961259|2610309|P2|STARTED|Washout Period of 7 Days||18
1077237|NCT00961259|2610310|P1|STARTED|Washout Period of 7 Days||18
1077238|NCT00961259|2610308|P3|NOT COMPLETED|First Intervention||0
1077239|NCT00961259|2610309|P2|NOT COMPLETED|First Intervention||0
1077240|NCT00961259|2610310|P1|NOT COMPLETED|First Intervention||0
1077241|NCT00961259|2610308|P3|COMPLETED|First Intervention||18
1077242|NCT00961259|2610309|P2|COMPLETED|First Intervention||18
1077243|NCT00961259|2610310|P1|COMPLETED|First Intervention||18
1077244|NCT00961259|2610308|P3|STARTED|First Intervention||18
1077245|NCT00961259|2610309|P2|STARTED|First Intervention||18
1077246|NCT00961259|2610310|P1|STARTED|First Intervention||18
1077247|NCT00961298|2610327|P1|NOT COMPLETED|12 Weeks Duloxetine Treatment Phase||3
1077248|NCT00961298|2610327|P1|COMPLETED|12 Weeks Duloxetine Treatment Phase||11
1077249|NCT00961298|2610327|P1|STARTED|12 Weeks Duloxetine Treatment Phase||14
1077250|NCT00961298|2610327|P1|NOT COMPLETED|Two Week Placebo Run in||1
1077251|NCT00961298|2610327|P1|COMPLETED|Two Week Placebo Run in||14
1077252|NCT00961298|2610327|P1|STARTED|Two Week Placebo Run in||15
1077253|NCT00961311|2610334|P1|NOT COMPLETED|Overall Study||0
1077254|NCT00961311|2610334|P1|COMPLETED|Overall Study||51
1077255|NCT00961311|2610334|P1|STARTED|Overall Study||51
1077256|NCT00961350|2610343|P2|NOT COMPLETED|Overall Study||67
1077257|NCT00961350|2610344|P1|NOT COMPLETED|Overall Study||47
1077258|NCT00961350|2610343|P2|COMPLETED|Overall Study||198
1077259|NCT00961350|2610344|P1|COMPLETED|Overall Study||218
1077260|NCT00961350|2610343|P2|Safety Population|Overall Study||265
1077261|NCT00961350|2610344|P1|Safety Population|Overall Study|1. One sub rand to PA32540 took EC-Aspirin|264
1077262|NCT00961350|2610343|P2|Intent-to-Treat Population (ITT)|Overall Study||265
1077263|NCT00961350|2610344|P1|Intent-to-Treat Population (ITT)|Overall Study||265
1077264|NCT00961350|2610343|P2|STARTED|Overall Study||265
1077265|NCT00961350|2610344|P1|STARTED|Overall Study||265
1077266|NCT00961402|2610360|P2|NOT COMPLETED|Overall Study||5
1077267|NCT00961402|2610361|P1|NOT COMPLETED|Overall Study||1
1077268|NCT00961402|2610360|P2|COMPLETED|Overall Study||61
1077269|NCT00961402|2610361|P1|COMPLETED|Overall Study||63
1077270|NCT00961402|2610360|P2|Randomized|Overall Study||66
1077271|NCT00961402|2610361|P1|Randomized|Overall Study||64
1077272|NCT00961402|2610360|P2|STARTED|Overall Study||66
1077273|NCT00961402|2610361|P1|STARTED|Overall Study||64
1077274|NCT00961415|2610375|P3|NOT COMPLETED|Maintenance Treatment Phase||45
1077275|NCT00961415|2610376|P2|NOT COMPLETED|Maintenance Treatment Phase||48
1077276|NCT00961415|2610377|P1|NOT COMPLETED|Maintenance Treatment Phase||0
1077277|NCT00961415|2610375|P3|COMPLETED|Maintenance Treatment Phase||83
1077278|NCT00961415|2610376|P2|COMPLETED|Maintenance Treatment Phase||77
1077279|NCT00961415|2610377|P1|COMPLETED|Maintenance Treatment Phase||0
1077280|NCT00961415|2610375|P3|STARTED|Maintenance Treatment Phase||128
1077281|NCT00961415|2610376|P2|STARTED|Maintenance Treatment Phase||125
1077282|NCT00961415|2610377|P1|STARTED|Maintenance Treatment Phase||0
1077283|NCT00961415|2610375|P3|NOT COMPLETED|Induction Treatment Phase||0
1077284|NCT00961415|2610376|P2|NOT COMPLETED|Induction Treatment Phase||0
1077285|NCT00961415|2610377|P1|NOT COMPLETED|Induction Treatment Phase||123
1077286|NCT00961415|2610375|P3|COMPLETED|Induction Treatment Phase||0
1077287|NCT00961415|2610376|P2|COMPLETED|Induction Treatment Phase||0
1077288|NCT00961415|2610377|P1|COMPLETED|Induction Treatment Phase||253
1077289|NCT00961415|2610375|P3|STARTED|Induction Treatment Phase||0
1077290|NCT00961415|2610376|P2|STARTED|Induction Treatment Phase||0
1077291|NCT00961415|2610377|P1|STARTED|Induction Treatment Phase||376
1077292|NCT00961441|2610402|P2|NOT COMPLETED|Overall Study||0
1077293|NCT00961441|2610403|P1|NOT COMPLETED|Overall Study||0
1077294|NCT00961441|2610402|P2|COMPLETED|Overall Study||13
1077295|NCT00961441|2610403|P1|COMPLETED|Overall Study||12
1077296|NCT00961441|2610402|P2|Pharmacokinetic (PK-PP) Population|Overall Study|Two subjects were excluded due to study medication noncompliance, one due to wrong dosing regimen.|10
1077297|NCT00961441|2610403|P1|Pharmacokinetic (PK-PP) Population|Overall Study||12
1077298|NCT00961441|2610402|P2|STARTED|Overall Study||13
1077299|NCT00961441|2610403|P1|STARTED|Overall Study||12
1077300|NCT00961532|2610417|P1|NOT COMPLETED|Overall Study||0
1077301|NCT00961532|2610417|P1|COMPLETED|Overall Study||14
1077302|NCT00961532|2610417|P1|STARTED|Overall Study||14
1077303|NCT00961571|2610422|P1|NOT COMPLETED|Overall Study||39
1077304|NCT00961571|2610422|P1|COMPLETED|Overall Study|high percentage of patient drop-off study prior cancer progression|11
1077305|NCT00961571|2610422|P1|STARTED|Overall Study||50
1077306|NCT00961636|2610429|P3|NOT COMPLETED|Overall Study||32
1077307|NCT00961636|2610430|P2|NOT COMPLETED|Overall Study||131
1077308|NCT00961636|2610431|P1|NOT COMPLETED|Overall Study||107
1077309|NCT00961636|2610429|P3|COMPLETED|Overall Study||201
1077310|NCT00961636|2610430|P2|COMPLETED|Overall Study||325
1077311|NCT00961636|2610431|P1|COMPLETED|Overall Study||356
1077312|NCT00961636|2610429|P3|STARTED|Overall Study||233
1077313|NCT00961636|2610430|P2|STARTED|Overall Study||456
1077314|NCT00961636|2610431|P1|STARTED|Overall Study||463
1077315|NCT00961649|2610446|P4|NOT COMPLETED|Overall Study||4
1077316|NCT00961649|2610447|P3|NOT COMPLETED|Overall Study||5
1077317|NCT00961649|2610448|P2|NOT COMPLETED|Overall Study||4
1077318|NCT00961649|2610449|P1|NOT COMPLETED|Overall Study||9
1077319|NCT00961649|2610446|P4|COMPLETED|Overall Study||37
1077320|NCT00961649|2610447|P3|COMPLETED|Overall Study||39
1077321|NCT00961649|2610448|P2|COMPLETED|Overall Study||40
1077322|NCT00961649|2610449|P1|COMPLETED|Overall Study||32
1077323|NCT00961649|2610446|P4|STARTED|Overall Study||41
1077324|NCT00961649|2610447|P3|STARTED|Overall Study||44
1077325|NCT00961649|2610448|P2|STARTED|Overall Study||44
1077326|NCT00961649|2610449|P1|STARTED|Overall Study||41
1077327|NCT00961662|2610463|P3|NOT COMPLETED|Overall Study||19
1077328|NCT00961662|2610464|P2|NOT COMPLETED|Overall Study||19
1077329|NCT00961662|2610465|P1|NOT COMPLETED|Overall Study||22
1077330|NCT00961662|2610463|P3|COMPLETED|Overall Study||34
1077331|NCT00961662|2610464|P2|COMPLETED|Overall Study||32
1077332|NCT00961662|2610465|P1|COMPLETED|Overall Study||35
1077333|NCT00961662|2610463|P3|STARTED|Overall Study||53
1077334|NCT00961662|2610464|P2|STARTED|Overall Study||51
1077335|NCT00961662|2610465|P1|STARTED|Overall Study||57
1077336|NCT00961805|2610475|P2|NOT COMPLETED|Overall Study||0
1077337|NCT00961805|2610476|P1|NOT COMPLETED|Overall Study||0
1077338|NCT00961805|2610475|P2|COMPLETED|Overall Study||40
1077339|NCT00961805|2610476|P1|COMPLETED|Overall Study||40
1077340|NCT00961805|2610475|P2|STARTED|Overall Study||40
1077341|NCT00961805|2610476|P1|STARTED|Overall Study||40
1077342|NCT00961896|2610507|P3|NOT COMPLETED|Overall Study||1
1077343|NCT00961896|2610508|P2|NOT COMPLETED|Overall Study||0
1077344|NCT00961896|2610509|P1|NOT COMPLETED|Overall Study||0
1077345|NCT00961896|2610507|P3|COMPLETED|Overall Study||6
1077346|NCT00961896|2610508|P2|COMPLETED|Overall Study||3
1077347|NCT00961896|2610509|P1|COMPLETED|Overall Study||8
1077348|NCT00961896|2610507|P3|STARTED|Overall Study||7
1077349|NCT00961896|2610508|P2|STARTED|Overall Study||3
1077350|NCT00961896|2610509|P1|STARTED|Overall Study||8
1077351|NCT00962000|2610528|P2|NOT COMPLETED|Period 4 - 1 Week||0
1077352|NCT00962000|2610529|P1|NOT COMPLETED|Period 4 - 1 Week||0
1077353|NCT00962000|2610528|P2|COMPLETED|Period 4 - 1 Week||21
1077354|NCT00962000|2610529|P1|COMPLETED|Period 4 - 1 Week||21
1077355|NCT00962000|2610528|P2|STARTED|Period 4 - 1 Week||21
1077356|NCT00962000|2610529|P1|STARTED|Period 4 - 1 Week||21
1077357|NCT00962000|2610528|P2|NOT COMPLETED|Period 3 - 1 Week||0
1077358|NCT00962000|2610529|P1|NOT COMPLETED|Period 3 - 1 Week||0
1077359|NCT00962000|2610528|P2|COMPLETED|Period 3 - 1 Week||21
1077360|NCT00962000|2610529|P1|COMPLETED|Period 3 - 1 Week||21
1077361|NCT00962000|2610528|P2|STARTED|Period 3 - 1 Week||21
1077362|NCT00962000|2610529|P1|STARTED|Period 3 - 1 Week||21
1077363|NCT00962000|2610528|P2|NOT COMPLETED|Period 2 - 1 Week||0
1077364|NCT00962000|2610529|P1|NOT COMPLETED|Period 2 - 1 Week||0
1077365|NCT00962000|2610528|P2|COMPLETED|Period 2 - 1 Week||21
1077366|NCT00962000|2610529|P1|COMPLETED|Period 2 - 1 Week||21
1077367|NCT00962000|2610528|P2|STARTED|Period 2 - 1 Week||21
1077368|NCT00962000|2610529|P1|STARTED|Period 2 - 1 Week||21
1077369|NCT00962000|2610528|P2|NOT COMPLETED|Period 1 - 1 Week||0
1077370|NCT00962000|2610529|P1|NOT COMPLETED|Period 1 - 1 Week||0
1077371|NCT00962000|2610528|P2|COMPLETED|Period 1 - 1 Week||21
1077372|NCT00962000|2610529|P1|COMPLETED|Period 1 - 1 Week||21
1077373|NCT00962000|2610528|P2|STARTED|Period 1 - 1 Week||21
1077374|NCT00962000|2610529|P1|STARTED|Period 1 - 1 Week||21
1077375|NCT00962013|2610539|P1|NOT COMPLETED|Overall Study||68
1077376|NCT00962013|2610539|P1|COMPLETED|Overall Study|Number of participants with 5 year primary endpoint data|52
1077377|NCT00962013|2610539|P1|STARTED|Overall Study||120
1077378|NCT00962065|2610551|P3|NOT COMPLETED|Overall Study||0
1077379|NCT00962065|2610552|P2|NOT COMPLETED|Overall Study||0
1077380|NCT00962065|2610553|P1|NOT COMPLETED|Overall Study||0
1077381|NCT00962065|2610551|P3|COMPLETED|Overall Study||12
1077382|NCT00962065|2610552|P2|COMPLETED|Overall Study||12
1077383|NCT00962065|2610553|P1|COMPLETED|Overall Study||12
1077384|NCT00962065|2610551|P3|STARTED|Overall Study||12
1077385|NCT00962065|2610552|P2|STARTED|Overall Study||12
1077386|NCT00962065|2610553|P1|STARTED|Overall Study||12
1077387|NCT00962104|2610578|P2|NOT COMPLETED|Overall Study||25
1077388|NCT00962104|2610579|P1|NOT COMPLETED|Overall Study||40
1077389|NCT00962104|2610578|P2|COMPLETED|Overall Study||171
1077390|NCT00962104|2610579|P1|COMPLETED|Overall Study||155
1077391|NCT00962104|2610578|P2|Full Analysis Set|Overall Study|1 participant was excluded because that participant failed to take the assigned study medication.|195
1077392|NCT00962104|2610579|P1|Full Analysis Set|Overall Study|2 participants were excluded because they failed to take the assigned study medication.|193
1077393|NCT00962104|2610578|P2|STARTED|Overall Study||196
1077394|NCT00962104|2610579|P1|STARTED|Overall Study||195
1077395|NCT00962208|2610607|P2|NOT COMPLETED|Overall Study||10
1077396|NCT00962208|2610608|P1|NOT COMPLETED|Overall Study||14
1077397|NCT00962208|2610607|P2|COMPLETED|Overall Study||41
1077398|NCT00962208|2610608|P1|COMPLETED|Overall Study||37
1077399|NCT00962208|2610607|P2|STARTED|Overall Study||51
1077400|NCT00962208|2610608|P1|STARTED|Overall Study||51
1077401|NCT00962247|2610614|P1|NOT COMPLETED|50% Reduction of Sedentary Activity||0
1077402|NCT00962247|2610614|P1|COMPLETED|50% Reduction of Sedentary Activity||56
1077403|NCT00962247|2610614|P1|STARTED|50% Reduction of Sedentary Activity||56
1077404|NCT00962247|2610614|P1|NOT COMPLETED|25% Reduction of Sedentary Activity||5
1077405|NCT00962247|2610614|P1|COMPLETED|25% Reduction of Sedentary Activity||56
1077406|NCT00962247|2610614|P1|STARTED|25% Reduction of Sedentary Activity||61
1077407|NCT00962247|2610614|P1|NOT COMPLETED|Usual Sedentary||18
1077408|NCT00962247|2610614|P1|COMPLETED|Usual Sedentary||61
1077409|NCT00962247|2610614|P1|STARTED|Usual Sedentary||79
1077410|NCT00962390|2610627|P4|NOT COMPLETED|Overall Study||1
1077411|NCT00962390|2610628|P3|NOT COMPLETED|Overall Study||4
1077412|NCT00962390|2610629|P2|NOT COMPLETED|Overall Study||3
1077413|NCT00962390|2610630|P1|NOT COMPLETED|Overall Study||4
1077414|NCT00962390|2610627|P4|COMPLETED|Overall Study||28
1077415|NCT00962390|2610628|P3|COMPLETED|Overall Study||25
1077416|NCT00962390|2610629|P2|COMPLETED|Overall Study||26
1077417|NCT00962390|2610630|P1|COMPLETED|Overall Study||25
1077418|NCT00962390|2610627|P4|STARTED|Overall Study||29
1077419|NCT00962390|2610628|P3|STARTED|Overall Study||29
1077420|NCT00962390|2610629|P2|STARTED|Overall Study||29
1077421|NCT00962390|2610630|P1|STARTED|Overall Study||29
1077422|NCT00962585|2610696|P4|NOT COMPLETED|Overall Study||0
1077423|NCT00962585|2610697|P3|NOT COMPLETED|Overall Study||3
1077424|NCT00962585|2610698|P2|NOT COMPLETED|Overall Study||2
1077425|NCT00962585|2610699|P1|NOT COMPLETED|Overall Study||6
1077426|NCT00962585|2610696|P4|COMPLETED|Overall Study||42
1077427|NCT00962585|2610697|P3|COMPLETED|Overall Study||39
1077428|NCT00962585|2610698|P2|COMPLETED|Overall Study||40
1077429|NCT00962585|2610699|P1|COMPLETED|Overall Study||37
1077430|NCT00962585|2610696|P4|STARTED|Overall Study||42
1077431|NCT00962585|2610697|P3|STARTED|Overall Study||42
1077432|NCT00962585|2610698|P2|STARTED|Overall Study||42
1077433|NCT00962585|2610699|P1|STARTED|Overall Study||43
1077434|NCT00962598|2610759|P2|NOT COMPLETED|Overall Study||6
1077435|NCT00962598|2610760|P1|NOT COMPLETED|Overall Study||6
1077436|NCT00962598|2610759|P2|COMPLETED|Overall Study||18
1077437|NCT00962598|2610760|P1|COMPLETED|Overall Study||21
1077438|NCT00962598|2610759|P2|STARTED|Overall Study||24
1077439|NCT00962598|2610760|P1|STARTED|Overall Study||27
1077440|NCT00962650|2610768|P1|NOT COMPLETED|Overall Study||2
1077441|NCT00962650|2610768|P1|COMPLETED|Overall Study||8
1077442|NCT00962650|2610768|P1|STARTED|Overall Study||10
1077443|NCT00962741|2610772|P1|NOT COMPLETED|Overall Study||8
1077444|NCT00962741|2610772|P1|COMPLETED|Overall Study||119
1077445|NCT00962741|2610772|P1|STARTED|Overall Study||127
1077446|NCT00962754|2610865|P2|NOT COMPLETED|Overall Study||0
1077447|NCT00962754|2610866|P1|NOT COMPLETED|Overall Study||0
1077448|NCT00962754|2610865|P2|COMPLETED|Overall Study||84
1077449|NCT00962754|2610866|P1|COMPLETED|Overall Study||86
1077450|NCT00962754|2610865|P2|STARTED|Overall Study||84
1077451|NCT00962754|2610866|P1|STARTED|Overall Study||86
1077452|NCT00962780|2610878|P2|NOT COMPLETED|Overall Study||14
1077453|NCT00962780|2610879|P1|NOT COMPLETED|Overall Study||10
1077454|NCT00962780|2610878|P2|COMPLETED|Overall Study||138
1077455|NCT00962780|2610879|P1|COMPLETED|Overall Study||141
1077456|NCT00962780|2610878|P2|Vaccinated 23vPS Dose|Overall Study||139
1077457|NCT00962780|2610879|P1|Vaccinated 23vPS Dose|Overall Study||143
1077458|NCT00962780|2610878|P2|Vaccinated 13vPnC Dose 3|Overall Study||142
1077459|NCT00962780|2610879|P1|Vaccinated 13vPnC Dose 3|Overall Study||144
1077460|NCT00962780|2610878|P2|Vaccinated 13vPnC Dose 2|Overall Study||145
1077461|NCT00962780|2610879|P1|Vaccinated 13vPnC Dose 2|Overall Study||145
1077462|NCT00962780|2610878|P2|Vaccinated 13vPnC Dose 1|Overall Study||151
1077463|NCT00962780|2610879|P1|Vaccinated 13vPnC Dose 1|Overall Study||150
1077464|NCT00962780|2610878|P2|STARTED|Overall Study||152
1077465|NCT00962780|2610879|P1|STARTED|Overall Study||151
1077466|NCT00962871|2610945|P4|NOT COMPLETED|Overall Study||0
1077467|NCT00962871|2610946|P3|NOT COMPLETED|Overall Study||0
1077468|NCT00962871|2610947|P2|NOT COMPLETED|Overall Study||0
1077469|NCT00962871|2610948|P1|NOT COMPLETED|Overall Study||0
1077470|NCT00962871|2610945|P4|COMPLETED|Overall Study||6
1077471|NCT00962871|2610946|P3|COMPLETED|Overall Study||12
1077472|NCT00962871|2610947|P2|COMPLETED|Overall Study||6
1077473|NCT00962871|2610948|P1|COMPLETED|Overall Study||6
1077474|NCT00962871|2610945|P4|STARTED|Overall Study||6
1077475|NCT00962871|2610946|P3|STARTED|Overall Study||12
1077476|NCT00962871|2610947|P2|STARTED|Overall Study||6
1077477|NCT00962871|2610948|P1|STARTED|Overall Study||6
1077478|NCT00963157|2610967|P5|NOT COMPLETED|Overall Study||2
1077479|NCT00963157|2610968|P4|NOT COMPLETED|Overall Study||7
1077480|NCT00963157|2610969|P3|NOT COMPLETED|Overall Study||5
1077481|NCT00963157|2610970|P2|NOT COMPLETED|Overall Study||4
1077482|NCT00963157|2610971|P1|NOT COMPLETED|Overall Study||5
1077483|NCT00963157|2610967|P5|COMPLETED|Overall Study||151
1077484|NCT00963157|2610968|P4|COMPLETED|Overall Study||150
1077485|NCT00963157|2610969|P3|COMPLETED|Overall Study||155
1077486|NCT00963157|2610970|P2|COMPLETED|Overall Study||159
1077487|NCT00963157|2610971|P1|COMPLETED|Overall Study||151
1077488|NCT00963157|2610967|P5|STARTED|Overall Study||153
1077489|NCT00963157|2610968|P4|STARTED|Overall Study||157
1077490|NCT00963157|2610969|P3|STARTED|Overall Study||160
1077491|NCT00963157|2610970|P2|STARTED|Overall Study||163
1077492|NCT00963157|2610971|P1|STARTED|Overall Study||156
1077493|NCT00963235|2611163|P1|NOT COMPLETED|Overall Study||60
1077494|NCT00963235|2611163|P1|COMPLETED|Overall Study||271
1077495|NCT00963235|2611163|P1|Completed Dose 3 1-month Blood Draw|Overall Study||277
1077496|NCT00963235|2611163|P1|Vaccinated Dose 3|Overall Study||279
1077497|NCT00963235|2611163|P1|Vaccinated Dose 2|Overall Study||300
1077498|NCT00963235|2611163|P1|Vaccinated Dose 1|Overall Study||329
1077499|NCT00963235|2611163|P1|STARTED|Overall Study||331
1077500|NCT00963430|2611184|P2|NOT COMPLETED|Overall Study||3
1077501|NCT00963430|2611185|P1|NOT COMPLETED|Overall Study||1
1077502|NCT00963430|2611184|P2|COMPLETED|Overall Study||57
1077503|NCT00963430|2611185|P1|COMPLETED|Overall Study||59
1077504|NCT00963430|2611184|P2|STARTED|Overall Study||60
1077505|NCT00963430|2611185|P1|STARTED|Overall Study||60
1077506|NCT00963469|2611226|P3|NOT COMPLETED|Overall Study||10
1077507|NCT00963469|2611227|P2|NOT COMPLETED|Overall Study||28
1077508|NCT00963469|2611228|P1|NOT COMPLETED|Overall Study||41
1077509|NCT00963469|2611226|P3|COMPLETED|Overall Study||170
1077510|NCT00963469|2611227|P2|COMPLETED|Overall Study||420
1077511|NCT00963469|2611228|P1|COMPLETED|Overall Study||410
1077512|NCT00963469|2611226|P3|STARTED|Overall Study||180
1077513|NCT00963469|2611227|P2|STARTED|Overall Study||448
1077514|NCT00963469|2611228|P1|STARTED|Overall Study||451
1077515|NCT00963482|2611256|P2|NOT COMPLETED|Overall Study||17
1077516|NCT00963482|2611257|P1|NOT COMPLETED|Overall Study||28
1077517|NCT00963482|2611256|P2|COMPLETED|Overall Study||33
1077518|NCT00963482|2611257|P1|COMPLETED|Overall Study||25
1077519|NCT00963482|2611256|P2|STARTED|Overall Study||50
1077520|NCT00963482|2611257|P1|STARTED|Overall Study||53
1077521|NCT00963508|2611265|P2|NOT COMPLETED|Overall Study||28
1077522|NCT00963508|2611266|P1|NOT COMPLETED|Overall Study||10
1077523|NCT00963508|2611265|P2|COMPLETED|Overall Study||169
1077524|NCT00963508|2611266|P1|COMPLETED|Overall Study||196
1077525|NCT00963508|2611265|P2|STARTED|Overall Study||197
1077526|NCT00963508|2611266|P1|STARTED|Overall Study||206
1077527|NCT00963560|2611277|P3|NOT COMPLETED|Overall Study||0
1077528|NCT00963560|2611278|P2|NOT COMPLETED|Overall Study||3
1077529|NCT00963560|2611279|P1|NOT COMPLETED|Overall Study||3
1077530|NCT00963560|2611277|P3|COMPLETED|Overall Study||41
1077531|NCT00963560|2611278|P2|COMPLETED|Overall Study||41
1077532|NCT00963560|2611279|P1|COMPLETED|Overall Study||44
1077533|NCT00963560|2611277|P3|STARTED|Overall Study||41
1077534|NCT00963560|2611278|P2|STARTED|Overall Study||44
1077535|NCT00963560|2611279|P1|STARTED|Overall Study||47
1077536|NCT00963599|2611291|P4|NOT COMPLETED|Overall Study||14
1077537|NCT00963599|2611292|P3|NOT COMPLETED|Overall Study||9
1077538|NCT00963599|2611293|P2|NOT COMPLETED|Overall Study||6
1077539|NCT00963599|2611294|P1|NOT COMPLETED|Overall Study||6
1077540|NCT00963599|2611291|P4|COMPLETED|Overall Study||288
1077541|NCT00963599|2611292|P3|COMPLETED|Overall Study||292
1077542|NCT00963599|2611293|P2|COMPLETED|Overall Study||149
1077543|NCT00963599|2611294|P1|COMPLETED|Overall Study||143
1077544|NCT00963599|2611291|P4|STARTED|Overall Study||302
1077545|NCT00963599|2611292|P3|STARTED|Overall Study||301
1077546|NCT00963599|2611293|P2|STARTED|Overall Study||155
1077547|NCT00963599|2611294|P1|STARTED|Overall Study||149
1077548|NCT00954447|2611350|P2|NOT COMPLETED|Overall Study||88
1077549|NCT00954447|2611351|P1|NOT COMPLETED|Overall Study||110
1077550|NCT00954447|2611350|P2|COMPLETED|Overall Study||543
1077551|NCT00954447|2611351|P1|COMPLETED|Overall Study||520
1077552|NCT00954447|2611350|P2|STARTED|Overall Study||631
1077553|NCT00954447|2611351|P1|STARTED|Overall Study||630
1077554|NCT00954512|2611393|P6|NOT COMPLETED|Overall Study||4
1077555|NCT00954512|2611394|P5|NOT COMPLETED|Overall Study||4
1077556|NCT00954512|2611395|P4|NOT COMPLETED|Overall Study||2
1077557|NCT00954512|2611396|P3|NOT COMPLETED|Overall Study||0
1077558|NCT00954512|2611397|P2|NOT COMPLETED|Overall Study||3
1077559|NCT00954512|2611398|P1|NOT COMPLETED|Overall Study||2
1077560|NCT00954512|2611393|P6|COMPLETED|Overall Study||0
1077561|NCT00954512|2611394|P5|COMPLETED|Overall Study||0
1077562|NCT00954512|2611395|P4|COMPLETED|Overall Study||0
1077563|NCT00954512|2611396|P3|COMPLETED|Overall Study||0
1077564|NCT00954512|2611397|P2|COMPLETED|Overall Study||0
1077565|NCT00954512|2611398|P1|COMPLETED|Overall Study||0
1077566|NCT00954512|2611393|P6|STARTED|Overall Study||4
1077567|NCT00954512|2611394|P5|STARTED|Overall Study||4
1077568|NCT00954512|2611395|P4|STARTED|Overall Study||2
1077569|NCT00954512|2611396|P3|STARTED|Overall Study||0
1077570|NCT00954512|2611397|P2|STARTED|Overall Study||3
1077571|NCT00954512|2611398|P1|STARTED|Overall Study||2
1077572|NCT00954538|2611419|P6|NOT COMPLETED|Part III||0
1077573|NCT00954538|2611420|P5|NOT COMPLETED|Part III||1
1077574|NCT00954538|2611421|P4|NOT COMPLETED|Part III||0
1077575|NCT00954538|2611422|P3|NOT COMPLETED|Part III||0
1077576|NCT00954538|2611423|P2|NOT COMPLETED|Part III||0
1077577|NCT00954538|2611424|P1|NOT COMPLETED|Part III||0
1077578|NCT00954538|2611419|P6|COMPLETED|Part III||2
1077579|NCT00954538|2611420|P5|COMPLETED|Part III|The subject who did not complete received 1 dose of study drug|5
1077580|NCT00954538|2611421|P4|COMPLETED|Part III||4
1077581|NCT00954538|2611422|P3|COMPLETED|Part III||0
1077582|NCT00954538|2611423|P2|COMPLETED|Part III||0
1077583|NCT00954538|2611424|P1|COMPLETED|Part III||0
1077584|NCT00954538|2611419|P6|STARTED|Part III|These subjects did not participate in Part I and did participate in Part II and III|2
1077585|NCT00954538|2611420|P5|STARTED|Part III|These subjects did not participate in Part I or II|6
1077586|NCT00954538|2611421|P4|STARTED|Part III|These subjects did not participate in Part I or II|4
1077587|NCT00954538|2611422|P3|STARTED|Part III||0
1077588|NCT00954538|2611423|P2|STARTED|Part III||0
1077589|NCT00954538|2611424|P1|STARTED|Part III||0
1077590|NCT00954538|2611419|P6|NOT COMPLETED|Part II||0
1077591|NCT00954538|2611420|P5|NOT COMPLETED|Part II||0
1077592|NCT00954538|2611421|P4|NOT COMPLETED|Part II||0
1077593|NCT00954538|2611422|P3|NOT COMPLETED|Part II||0
1077594|NCT00954538|2611423|P2|NOT COMPLETED|Part II||0
1077595|NCT00954538|2611424|P1|NOT COMPLETED|Part II||0
1077596|NCT00954538|2611419|P6|COMPLETED|Part II||2
1077597|NCT00954538|2611420|P5|COMPLETED|Part II||0
1077598|NCT00954538|2611421|P4|COMPLETED|Part II||0
1077599|NCT00954538|2611422|P3|COMPLETED|Part II||3
1077600|NCT00954538|2611423|P2|COMPLETED|Part II||1
1077601|NCT00954538|2611424|P1|COMPLETED|Part II||0
1077602|NCT00954538|2611419|P6|STARTED|Part II|These subjects did not participate in Part I and did participate in Part II and III|2
1077603|NCT00954538|2611420|P5|STARTED|Part II||0
1077604|NCT00954538|2611421|P4|STARTED|Part II||0
1077605|NCT00954538|2611422|P3|STARTED|Part II|These subjects did not participate in Part I or III|3
1077606|NCT00954538|2611423|P2|STARTED|Part II|This subject did not participate in Part I or III|1
1077607|NCT00954538|2611424|P1|STARTED|Part II||0
1077608|NCT00954538|2611419|P6|NOT COMPLETED|Part I||0
1077609|NCT00954538|2611420|P5|NOT COMPLETED|Part I||0
1077610|NCT00954538|2611421|P4|NOT COMPLETED|Part I||0
1077611|NCT00954538|2611422|P3|NOT COMPLETED|Part I||0
1077612|NCT00954538|2611423|P2|NOT COMPLETED|Part I||0
1077613|NCT00954538|2611424|P1|NOT COMPLETED|Part I||0
1077614|NCT00954538|2611419|P6|COMPLETED|Part I||0
1077615|NCT00954538|2611420|P5|COMPLETED|Part I||0
1077616|NCT00954538|2611421|P4|COMPLETED|Part I||0
1077617|NCT00954538|2611422|P3|COMPLETED|Part I||0
1077618|NCT00954538|2611423|P2|COMPLETED|Part I||0
1077619|NCT00954538|2611424|P1|COMPLETED|Part I||3
1077620|NCT00954538|2611419|P6|STARTED|Part I||0
1077621|NCT00954538|2611420|P5|STARTED|Part I||0
1077622|NCT00954538|2611421|P4|STARTED|Part I||0
1077623|NCT00954538|2611422|P3|STARTED|Part I||0
1077624|NCT00954538|2611423|P2|STARTED|Part I||0
1077625|NCT00954538|2611424|P1|STARTED|Part I|These subjects did not participate in Part II or III|3
1077626|NCT00954681|2611435|P1|NOT COMPLETED|Overall Study||5
1077627|NCT00954681|2611435|P1|COMPLETED|Overall Study||10
1077628|NCT00954681|2611435|P1|STARTED|Overall Study||15
1077629|NCT00954707|2611439|P1|NOT COMPLETED|Overall Study||167
1077630|NCT00954707|2611439|P1|COMPLETED|Overall Study|2342 Subjects completed 12-month Phase 1 follow-up; 167 subjects didn't complete the Phase 1.|2342
1077631|NCT00954707|2611439|P1|STARTED|Overall Study||2509
1077632|NCT00954733|2611455|P1|NOT COMPLETED|Overall Study||1
1077633|NCT00954733|2611455|P1|COMPLETED|Overall Study||39
1077634|NCT00954733|2611455|P1|STARTED|Overall Study||40
1077635|NCT00954824|2611459|P1|NOT COMPLETED|Overall Study||50
1077636|NCT00954824|2611459|P1|COMPLETED|Overall Study||50
1077637|NCT00954824|2611459|P1|STARTED|Overall Study||100
1077638|NCT00954915|2611463|P1|NOT COMPLETED|Overall Study||0
1077639|NCT00954915|2611463|P1|COMPLETED|Overall Study||1
1077640|NCT00954915|2611463|P1|STARTED|Overall Study||1
1077641|NCT00954941|2611469|P2|NOT COMPLETED|Overall Study||7
1077642|NCT00954941|2611470|P1|NOT COMPLETED|Overall Study||8
1077643|NCT00954941|2611469|P2|COMPLETED|Overall Study||41
1077644|NCT00954941|2611470|P1|COMPLETED|Overall Study||42
1077645|NCT00954941|2611469|P2|STARTED|Overall Study||48
1077646|NCT00954941|2611470|P1|STARTED|Overall Study||50
1077647|NCT00954993|2611478|P1|NOT COMPLETED|Period 2||0
1077648|NCT00954993|2611478|P1|COMPLETED|Period 2||3
1077649|NCT00954993|2611478|P1|STARTED|Period 2||3
1077650|NCT00954993|2611478|P1|NOT COMPLETED|Washout||0
1077651|NCT00954993|2611478|P1|COMPLETED|Washout||3
1077652|NCT00954993|2611478|P1|STARTED|Washout||3
1077653|NCT00954993|2611478|P1|NOT COMPLETED|Period 1||0
1077654|NCT00954993|2611478|P1|COMPLETED|Period 1||3
1077655|NCT00954993|2611478|P1|STARTED|Period 1||3
1077656|NCT00955032|2611490|P2|NOT COMPLETED|Overall Study||0
1077657|NCT00955032|2611491|P1|NOT COMPLETED|Overall Study||0
1077658|NCT00955032|2611490|P2|COMPLETED|Overall Study||8
1077659|NCT00955032|2611491|P1|COMPLETED|Overall Study||16
1077660|NCT00955032|2611490|P2|STARTED|Overall Study||8
1077661|NCT00955032|2611491|P1|STARTED|Overall Study||16
1077662|NCT00955110|2611511|P1|NOT COMPLETED|Treatment Phase||6
1077663|NCT00955110|2611511|P1|COMPLETED|Treatment Phase||35
1077664|NCT00955110|2611511|P1|Oxycodone CR 60 mg|Treatment Phase||40
1077665|NCT00955110|2611511|P1|Oxycodone CR 30 mg|Treatment Phase||40
1077666|NCT00955110|2611511|P1|Oxymorphone ER 30 mg|Treatment Phase||38
1077667|NCT00955110|2611511|P1|Oxymorphone ER 15 mg|Treatment Phase||37
1077668|NCT00955110|2611511|P1|Placebo|Treatment Phase||38
1077669|NCT00955110|2611511|P1|STARTED|Treatment Phase||41
1077670|NCT00955110|2611511|P1|NOT COMPLETED|Qualification Phase||24
1077671|NCT00955110|2611511|P1|COMPLETED|Qualification Phase||54
1077672|NCT00955110|2611511|P1|STARTED|Qualification Phase||78
1077673|NCT00955266|2611525|P2|NOT COMPLETED|Overall Study||0
1077674|NCT00955266|2611526|P1|NOT COMPLETED|Overall Study||0
1077675|NCT00955266|2611525|P2|COMPLETED|Overall Study||4
1077676|NCT00955266|2611526|P1|COMPLETED|Overall Study||4
1077677|NCT00955266|2611525|P2|STARTED|Overall Study||4
1077678|NCT00955266|2611526|P1|STARTED|Overall Study||4
1077679|NCT00955279|2611543|P3|NOT COMPLETED|Overall Study||8
1077680|NCT00955279|2611544|P2|NOT COMPLETED|Overall Study||4
1077681|NCT00955279|2611545|P1|NOT COMPLETED|Overall Study||3
1077682|NCT00955279|2611543|P3|COMPLETED|Overall Study||52
1077683|NCT00955279|2611544|P2|COMPLETED|Overall Study||51
1077684|NCT00955279|2611545|P1|COMPLETED|Overall Study||55
1077685|NCT00955279|2611543|P3|STARTED|Overall Study||60
1077686|NCT00955279|2611544|P2|STARTED|Overall Study||55
1077687|NCT00955279|2611545|P1|STARTED|Overall Study||58
1077688|NCT00955305|2611567|P2|NOT COMPLETED|Overall Study||87
1077689|NCT00955305|2611568|P1|NOT COMPLETED|Overall Study||88
1077690|NCT00955305|2611567|P2|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
1077691|NCT00955305|2611568|P1|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
1077692|NCT00955305|2611567|P2|Eligible and Treated|Overall Study||75
1077693|NCT00955305|2611568|P1|Eligible and Treated|Overall Study||78
1077694|NCT00955305|2611567|P2|Treated|Overall Study||82
1077695|NCT00955305|2611568|P1|Treated|Overall Study||83
1077696|NCT00955305|2611567|P2|STARTED|Overall Study||87
1077697|NCT00955305|2611568|P1|STARTED|Overall Study||88
1077698|NCT00955357|2611580|P2|NOT COMPLETED|Maintenance Phase||45
1077699|NCT00955357|2611581|P1|NOT COMPLETED|Maintenance Phase||12
1077700|NCT00955357|2611580|P2|COMPLETED|Maintenance Phase||249
1077701|NCT00955357|2611581|P1|COMPLETED|Maintenance Phase||68
1077702|NCT00955357|2611580|P2|STARTED|Maintenance Phase||294
1077703|NCT00955357|2611581|P1|STARTED|Maintenance Phase||80
1077704|NCT00955357|2611580|P2|NOT COMPLETED|Titration Phase||66
1077705|NCT00955357|2611581|P1|NOT COMPLETED|Titration Phase||16
1077706|NCT00955357|2611580|P2|COMPLETED|Titration Phase||294
1077707|NCT00955357|2611581|P1|COMPLETED|Titration Phase||80
1077708|NCT00955357|2611580|P2|STARTED|Titration Phase||360
1077709|NCT00955357|2611581|P1|STARTED|Titration Phase||96
1077710|NCT00955474|2611589|P2|NOT COMPLETED|Overall Study||5
1077711|NCT00955474|2611590|P1|NOT COMPLETED|Overall Study||7
1077712|NCT00955474|2611589|P2|COMPLETED|Overall Study||8
1077713|NCT00955474|2611590|P1|COMPLETED|Overall Study||5
1077714|NCT00955474|2611589|P2|STARTED|Overall Study||13
1077715|NCT00955474|2611590|P1|STARTED|Overall Study||12
1077716|NCT00955487|2611626|P6|NOT COMPLETED|Overall Study||0
1077717|NCT00955487|2611627|P5|NOT COMPLETED|Overall Study||0
1077718|NCT00955487|2611628|P4|NOT COMPLETED|Overall Study||0
1077719|NCT00955487|2611629|P3|NOT COMPLETED|Overall Study||0
1077720|NCT00955487|2611630|P2|NOT COMPLETED|Overall Study||0
1077721|NCT00955487|2611631|P1|NOT COMPLETED|Overall Study||0
1077722|NCT00955487|2611626|P6|COMPLETED|Overall Study||35
1077723|NCT00955487|2611627|P5|COMPLETED|Overall Study||32
1077724|NCT00955487|2611628|P4|COMPLETED|Overall Study||21
1077725|NCT00955487|2611629|P3|COMPLETED|Overall Study||17
1077726|NCT00955487|2611630|P2|COMPLETED|Overall Study||9
1077727|NCT00955487|2611631|P1|COMPLETED|Overall Study||10
1077728|NCT00955487|2611626|P6|STARTED|Overall Study||35
1077729|NCT00955487|2611627|P5|STARTED|Overall Study||32
1077730|NCT00955487|2611628|P4|STARTED|Overall Study||21
1077731|NCT00955487|2611629|P3|STARTED|Overall Study||17
1077732|NCT00955487|2611630|P2|STARTED|Overall Study||9
1077733|NCT00955487|2611631|P1|STARTED|Overall Study||10
1077734|NCT00955513|2611666|P3|NOT COMPLETED|Overall Study||3
1077735|NCT00955513|2611667|P2|NOT COMPLETED|Overall Study||2
1077736|NCT00955513|2611668|P1|NOT COMPLETED|Overall Study||1
1077737|NCT00955513|2611666|P3|COMPLETED|Overall Study||79
1077738|NCT00955513|2611667|P2|COMPLETED|Overall Study||78
1077739|NCT00955513|2611668|P1|COMPLETED|Overall Study||79
1077740|NCT00955513|2611666|P3|STARTED|Overall Study||82
1077741|NCT00955513|2611667|P2|STARTED|Overall Study||80
1077742|NCT00955513|2611668|P1|STARTED|Overall Study||80
1077743|NCT00955617|2611676|P2|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
1077744|NCT00955617|2611677|P1|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
1077745|NCT00955617|2611676|P2|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
1077746|NCT00955617|2611677|P1|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
1077747|NCT00955617|2611676|P2|STARTED|Second MRA (Between Day 1 and Day 51)||10
1077748|NCT00955617|2611677|P1|STARTED|Second MRA (Between Day 1 and Day 51)||10
1077749|NCT00955617|2611676|P2|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
1077750|NCT00955617|2611677|P1|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
1077751|NCT00955617|2611676|P2|COMPLETED|First MRA (Between Day0 and Day21)||10
1077752|NCT00955617|2611677|P1|COMPLETED|First MRA (Between Day0 and Day21)||10
1077753|NCT00955617|2611676|P2|STARTED|First MRA (Between Day0 and Day21)||10
1077754|NCT00955617|2611677|P1|STARTED|First MRA (Between Day0 and Day21)||10
1077755|NCT00955721|2611689|P2|NOT COMPLETED|Overall Study||0
1077756|NCT00955721|2611690|P1|NOT COMPLETED|Overall Study||3
1077757|NCT00955721|2611689|P2|COMPLETED|Overall Study||0
1077758|NCT00955721|2611690|P1|COMPLETED|Overall Study||6
1077759|NCT00955721|2611689|P2|STARTED|Overall Study||0
1077760|NCT00955721|2611690|P1|STARTED|Overall Study||9
1077761|NCT00955747|2611700|P2|NOT COMPLETED|Overall Study||69
1077762|NCT00955747|2611701|P1|NOT COMPLETED|Overall Study||69
1077763|NCT00955747|2611700|P2|COMPLETED|Overall Study||172
1077764|NCT00955747|2611701|P1|COMPLETED|Overall Study||184
1077765|NCT00955747|2611700|P2|STARTED|Overall Study||241
1077766|NCT00955747|2611701|P1|STARTED|Overall Study||253
1077767|NCT00955825|2611709|P2|NOT COMPLETED|Overall Study||17
1077768|NCT00955825|2611710|P1|NOT COMPLETED|Overall Study||26
1077769|NCT00955825|2611709|P2|COMPLETED|Overall Study||223
1077770|NCT00955825|2611710|P1|COMPLETED|Overall Study||207
1077771|NCT00955825|2611709|P2|STARTED|Overall Study||240
1077772|NCT00955825|2611710|P1|STARTED|Overall Study||233
1077773|NCT00955903|2611719|P3|NOT COMPLETED|Overall Study||7
1077774|NCT00955903|2611720|P2|NOT COMPLETED|Overall Study||3
1077775|NCT00955903|2611721|P1|NOT COMPLETED|Overall Study||6
1077776|NCT00955903|2611719|P3|COMPLETED|Overall Study||48
1077777|NCT00955903|2611720|P2|COMPLETED|Overall Study||51
1077778|NCT00955903|2611721|P1|COMPLETED|Overall Study||49
1077779|NCT00955903|2611719|P3|STARTED|Overall Study||55
1077780|NCT00955903|2611720|P2|STARTED|Overall Study||54
1077781|NCT00955903|2611721|P1|STARTED|Overall Study||55
1077782|NCT00955916|2611735|P1|NOT COMPLETED|Overall Study||0
1077783|NCT00955916|2611735|P1|COMPLETED|Overall Study||38
1077784|NCT00955916|2611735|P1|STARTED|Overall Study||38
1077785|NCT00955955|2611744|P3|NOT COMPLETED|Overall Study||0
1077786|NCT00955955|2611745|P2|NOT COMPLETED|Overall Study||0
1077787|NCT00955955|2611746|P1|NOT COMPLETED|Overall Study||2
1077788|NCT00955955|2611744|P3|COMPLETED|Overall Study||28
1077789|NCT00955955|2611745|P2|COMPLETED|Overall Study||28
1077790|NCT00955955|2611746|P1|COMPLETED|Overall Study||17
1077791|NCT00955955|2611744|P3|STARTED|Overall Study||28
1077792|NCT00955955|2611745|P2|STARTED|Overall Study||28
1077793|NCT00955955|2611746|P1|STARTED|Overall Study||19
1077794|NCT00956020|2611760|P1|NOT COMPLETED|Overall Study||0
1077795|NCT00956020|2611760|P1|COMPLETED|Overall Study||4
1077796|NCT00956020|2611760|P1|STARTED|Overall Study||4
1077797|NCT00956085|2611775|P1|NOT COMPLETED|Overall Study||0
1077798|NCT00956085|2611775|P1|COMPLETED|Overall Study||12
1077799|NCT00956085|2611775|P1|STARTED|Overall Study||12
1077800|NCT00956254|2611779|P1|NOT COMPLETED|Overall Study||0
1077801|NCT00956254|2611779|P1|COMPLETED|Overall Study||18
1077802|NCT00956254|2611779|P1|STARTED|Overall Study||18
1077803|NCT00956293|2611791|P3|NOT COMPLETED|Follow-up Period||0
1077804|NCT00956293|2611792|P2|NOT COMPLETED|Follow-up Period||32
1077805|NCT00956293|2611793|P1|NOT COMPLETED|Follow-up Period||20
1077806|NCT00956293|2611791|P3|COMPLETED|Follow-up Period||0
1077807|NCT00956293|2611792|P2|COMPLETED|Follow-up Period||0
1077808|NCT00956293|2611793|P1|COMPLETED|Follow-up Period||0
1077809|NCT00956293|2611791|P3|STARTED|Follow-up Period||0
1077810|NCT00956293|2611792|P2|STARTED|Follow-up Period||32
1077811|NCT00956293|2611793|P1|STARTED|Follow-up Period||20
1077812|NCT00956293|2611791|P3|NOT COMPLETED|Main Period (Randomization)||0
1077813|NCT00956293|2611792|P2|NOT COMPLETED|Main Period (Randomization)||27
1077814|NCT00956293|2611793|P1|NOT COMPLETED|Main Period (Randomization)||1
1077815|NCT00956293|2611791|P3|COMPLETED|Main Period (Randomization)||0
1077816|NCT00956293|2611792|P2|COMPLETED|Main Period (Randomization)||26
1077817|NCT00956293|2611793|P1|COMPLETED|Main Period (Randomization)||23
1077818|NCT00956293|2611791|P3|Randomized Safety Set|Main Period (Randomization)||0
1077819|NCT00956293|2611792|P2|Randomized Safety Set|Main Period (Randomization)||51
1077820|NCT00956293|2611793|P1|Randomized Safety Set|Main Period (Randomization)||24
1077821|NCT00956293|2611791|P3|Full Analysis Set|Main Period (Randomization)||0
1077822|NCT00956293|2611792|P2|Full Analysis Set|Main Period (Randomization)|Two participants, randomized to this arm, did not receive everolimus.|51
1077823|NCT00956293|2611793|P1|Full Analysis Set|Main Period (Randomization)||24
1077824|NCT00956293|2611791|P3|STARTED|Main Period (Randomization)||0
1077825|NCT00956293|2611792|P2|STARTED|Main Period (Randomization)||53
1077826|NCT00956293|2611793|P1|STARTED|Main Period (Randomization)||24
1077827|NCT00956293|2611791|P3|NOT COMPLETED|Main Period (Pre-randomization)||130
1077828|NCT00956293|2611792|P2|NOT COMPLETED|Main Period (Pre-randomization)||0
1077829|NCT00956293|2611793|P1|NOT COMPLETED|Main Period (Pre-randomization)||0
1077830|NCT00956293|2611791|P3|COMPLETED|Main Period (Pre-randomization)||77
1077831|NCT00956293|2611792|P2|COMPLETED|Main Period (Pre-randomization)||0
1077832|NCT00956293|2611793|P1|COMPLETED|Main Period (Pre-randomization)||0
1077833|NCT00956293|2611791|P3|Enrolled Safety Set|Main Period (Pre-randomization)||203
1077834|NCT00956293|2611792|P2|Enrolled Safety Set|Main Period (Pre-randomization)||0
1077835|NCT00956293|2611793|P1|Enrolled Safety Set|Main Period (Pre-randomization)||0
1077836|NCT00956293|2611791|P3|STARTED|Main Period (Pre-randomization)||207
1077837|NCT00956293|2611792|P2|STARTED|Main Period (Pre-randomization)||0
1077838|NCT00956293|2611793|P1|STARTED|Main Period (Pre-randomization)||0
1077839|NCT00956540|2611821|P4|NOT COMPLETED|Overall Study||4
1077840|NCT00956540|2611822|P3|NOT COMPLETED|Overall Study||3
1077841|NCT00956540|2611823|P2|NOT COMPLETED|Overall Study||4
1077842|NCT00956540|2611824|P1|NOT COMPLETED|Overall Study||3
1077843|NCT00956540|2611821|P4|COMPLETED|Overall Study||41
1077844|NCT00956540|2611822|P3|COMPLETED|Overall Study||43
1077845|NCT00956540|2611823|P2|COMPLETED|Overall Study||46
1077846|NCT00956540|2611824|P1|COMPLETED|Overall Study||51
1077847|NCT00956540|2611821|P4|STARTED|Overall Study||45
1077848|NCT00956540|2611822|P3|STARTED|Overall Study||46
1077849|NCT00956540|2611823|P2|STARTED|Overall Study||50
1077850|NCT00956540|2611824|P1|STARTED|Overall Study||54
1077851|NCT00956592|2611836|P2|NOT COMPLETED|Overall Study||3
1077852|NCT00956592|2611837|P1|NOT COMPLETED|Overall Study||1
1077853|NCT00956592|2611836|P2|COMPLETED|Overall Study||147
1077854|NCT00956592|2611837|P1|COMPLETED|Overall Study||149
1077855|NCT00956592|2611836|P2|STARTED|Overall Study||150
1077856|NCT00956592|2611837|P1|STARTED|Overall Study||150
1077857|NCT00956631|2611843|P1|NOT COMPLETED|Overall Study||16
1077858|NCT00956631|2611843|P1|COMPLETED|Overall Study||62
1077859|NCT00956631|2611843|P1|STARTED|Overall Study||78
1077860|NCT00956657|2611851|P2|NOT COMPLETED|Overall Study||0
1077861|NCT00956657|2611852|P1|NOT COMPLETED|Overall Study||0
1077862|NCT00956657|2611851|P2|COMPLETED|Overall Study||13
1077863|NCT00956657|2611852|P1|COMPLETED|Overall Study||18
1077864|NCT00956657|2611851|P2|STARTED|Overall Study||13
1077865|NCT00956657|2611852|P1|STARTED|Overall Study||18
1077866|NCT00956709|2611860|P2|NOT COMPLETED|Overall Study||0
1077867|NCT00956709|2611861|P1|NOT COMPLETED|Overall Study||0
1077868|NCT00956709|2611860|P2|COMPLETED|Overall Study||19
1077869|NCT00956709|2611861|P1|COMPLETED|Overall Study||16
1077870|NCT00956709|2611860|P2|STARTED|Overall Study||19
1077871|NCT00956709|2611861|P1|STARTED|Overall Study||16
1077872|NCT00956761|2611871|P1|NOT COMPLETED|Overall Study||0
1077873|NCT00956761|2611871|P1|COMPLETED|Overall Study||63
1077874|NCT00956761|2611871|P1|STARTED|Overall Study||63
1077875|NCT00956813|2611880|P2|NOT COMPLETED|Continuation Phase||0
1077876|NCT00956813|2611881|P1|NOT COMPLETED|Continuation Phase||0
1077877|NCT00956813|2611880|P2|COMPLETED|Continuation Phase||0
1077878|NCT00956813|2611881|P1|COMPLETED|Continuation Phase||80
1077879|NCT00956813|2611880|P2|STARTED|Continuation Phase||0
1077880|NCT00956813|2611881|P1|STARTED|Continuation Phase||80
1077881|NCT00956813|2611880|P2|NOT COMPLETED|Flaxseed and Placebo||5
1077882|NCT00956813|2611881|P1|NOT COMPLETED|Flaxseed and Placebo||8
1077883|NCT00956813|2611880|P2|COMPLETED|Flaxseed and Placebo||100
1077884|NCT00956813|2611881|P1|COMPLETED|Flaxseed and Placebo||97
1077885|NCT00956813|2611880|P2|STARTED|Flaxseed and Placebo||105
1077886|NCT00956813|2611881|P1|STARTED|Flaxseed and Placebo||105
1077887|NCT00956839|2611899|P3|NOT COMPLETED|Overall Study||3
1077888|NCT00956839|2611900|P2|NOT COMPLETED|Overall Study||0
1077889|NCT00956839|2611901|P1|NOT COMPLETED|Overall Study||3
1077890|NCT00956839|2611899|P3|COMPLETED|Overall Study||10
1077891|NCT00956839|2611900|P2|COMPLETED|Overall Study||13
1077892|NCT00956839|2611901|P1|COMPLETED|Overall Study||11
1077893|NCT00956839|2611899|P3|STARTED|Overall Study||13
1077894|NCT00956839|2611900|P2|STARTED|Overall Study||13
1077895|NCT00956839|2611901|P1|STARTED|Overall Study||14
1077896|NCT00963638|2611914|P2|NOT COMPLETED|Overall Study||0
1077897|NCT00963638|2611915|P1|NOT COMPLETED|Overall Study||0
1077898|NCT00963638|2611914|P2|COMPLETED|Overall Study||20
1077899|NCT00963638|2611915|P1|COMPLETED|Overall Study||20
1077900|NCT00963638|2611914|P2|STARTED|Overall Study||20
1077901|NCT00963638|2611915|P1|STARTED|Overall Study||20
1077902|NCT00963677|2611923|P2|NOT COMPLETED|Overall Study||2
1077903|NCT00963677|2611924|P1|NOT COMPLETED|Overall Study||0
1077904|NCT00963677|2611923|P2|COMPLETED|Overall Study|Two patients were excluded from the study due to the difficult ventilation with facemask ventilation|18
1077905|NCT00963677|2611924|P1|COMPLETED|Overall Study||35
1077906|NCT00963677|2611923|P2|STARTED|Overall Study|Patients with predicted difficult intubation but not ventilation|20
1077907|NCT00963677|2611924|P1|STARTED|Overall Study|Patients without predicted difficult intubation|35
1077908|NCT00963807|2611932|P1|NOT COMPLETED|Overall Study||18
1077909|NCT00963807|2611932|P1|COMPLETED|Overall Study||8
1077910|NCT00963807|2611932|P1|Completed Post-Cycle 2 FDG Imaging|Overall Study||8
1077911|NCT00963807|2611932|P1|Completed Post-Cycle 2 FLT Imaging|Overall Study||9
1077912|NCT00963807|2611932|P1|Completed Post-Cycle 1 Imaging|Overall Study||9
1077913|NCT00963807|2611932|P1|Completed Baseline Imaging|Overall Study||11
1077914|NCT00963807|2611932|P1|STARTED|Overall Study||26
1077915|NCT00963820|2611941|P12|NOT COMPLETED|Expansion Phase||4
1077916|NCT00963820|2611942|P11|NOT COMPLETED|Expansion Phase||5
1077917|NCT00963820|2611943|P10|NOT COMPLETED|Expansion Phase||9
1077918|NCT00963820|2611944|P9|NOT COMPLETED|Expansion Phase||10
1077919|NCT00963820|2611945|P8|NOT COMPLETED|Expansion Phase||0
1077920|NCT00963820|2611946|P7|NOT COMPLETED|Expansion Phase||0
1077921|NCT00963820|2611947|P6|NOT COMPLETED|Expansion Phase||0
1077922|NCT00963820|2611948|P5|NOT COMPLETED|Expansion Phase||0
1077923|NCT00963820|2611949|P4|NOT COMPLETED|Expansion Phase||0
1077924|NCT00963820|2611950|P3|NOT COMPLETED|Expansion Phase||0
1077925|NCT00963820|2611951|P2|NOT COMPLETED|Expansion Phase||0
1077926|NCT00963820|2611952|P1|NOT COMPLETED|Expansion Phase||0
1077927|NCT00963820|2611941|P12|COMPLETED|Expansion Phase||0
1077928|NCT00963820|2611942|P11|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
1077929|NCT00963820|2611943|P10|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
1077930|NCT00963820|2611944|P9|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
1077931|NCT00963820|2611945|P8|COMPLETED|Expansion Phase||0
1077932|NCT00963820|2611946|P7|COMPLETED|Expansion Phase||0
1077933|NCT00963820|2611947|P6|COMPLETED|Expansion Phase||0
1077934|NCT00963820|2611948|P5|COMPLETED|Expansion Phase||0
1077935|NCT00963820|2611949|P4|COMPLETED|Expansion Phase||0
1077936|NCT00963820|2611950|P3|COMPLETED|Expansion Phase||0
1077937|NCT00963820|2611951|P2|COMPLETED|Expansion Phase||0
1077938|NCT00963820|2611952|P1|COMPLETED|Expansion Phase||0
1077939|NCT00963820|2611941|P12|STARTED|Expansion Phase|Includes participants with last dose of carfilzomib 21 to 60 days before 1st ixazomib citrate dose.|4
1077940|NCT00963820|2611942|P11|STARTED|Expansion Phase|Includes only participants who are proteasome inhibitor (PI)-naïve.|6
1077941|NCT00963820|2611943|P10|STARTED|Expansion Phase|Includes 1 participant from the dose escalation cohort 2.97 mg/m^2.|10
1077942|NCT00963820|2611944|P9|STARTED|Expansion Phase|Includes 2 participants from the dose escalation cohort 2.97 mg/m^2.|11
1077943|NCT00963820|2611945|P8|STARTED|Expansion Phase||0
1077944|NCT00963820|2611946|P7|STARTED|Expansion Phase||0
1077945|NCT00963820|2611947|P6|STARTED|Expansion Phase||0
1077946|NCT00963820|2611948|P5|STARTED|Expansion Phase||0
1077947|NCT00963820|2611949|P4|STARTED|Expansion Phase||0
1077948|NCT00963820|2611950|P3|STARTED|Expansion Phase||0
1077949|NCT00963820|2611951|P2|STARTED|Expansion Phase||0
1077950|NCT00963820|2611952|P1|STARTED|Expansion Phase|Dose escalation cohorts were not part of the Expansion Phase except as noted in comments.|0
1077951|NCT00963820|2611941|P12|NOT COMPLETED|Dose Escalation Phase||0
1077952|NCT00963820|2611942|P11|NOT COMPLETED|Dose Escalation Phase||0
1077953|NCT00963820|2611943|P10|NOT COMPLETED|Dose Escalation Phase||0
1077954|NCT00963820|2611944|P9|NOT COMPLETED|Dose Escalation Phase||0
1077955|NCT00963820|2611945|P8|NOT COMPLETED|Dose Escalation Phase||5
1077956|NCT00963820|2611946|P7|NOT COMPLETED|Dose Escalation Phase||8
1077957|NCT00963820|2611947|P6|NOT COMPLETED|Dose Escalation Phase||3
1077958|NCT00963820|2611948|P5|NOT COMPLETED|Dose Escalation Phase||4
1077959|NCT00963820|2611949|P4|NOT COMPLETED|Dose Escalation Phase||3
1077960|NCT00963820|2611950|P3|NOT COMPLETED|Dose Escalation Phase||3
1077961|NCT00963820|2611951|P2|NOT COMPLETED|Dose Escalation Phase||3
1077962|NCT00963820|2611952|P1|NOT COMPLETED|Dose Escalation Phase||3
1077963|NCT00963820|2611941|P12|COMPLETED|Dose Escalation Phase||0
1077964|NCT00963820|2611942|P11|COMPLETED|Dose Escalation Phase||0
1077965|NCT00963820|2611943|P10|COMPLETED|Dose Escalation Phase||0
1077966|NCT00963820|2611944|P9|COMPLETED|Dose Escalation Phase||0
1077967|NCT00963820|2611945|P8|COMPLETED|Dose Escalation Phase||0
1077968|NCT00963820|2611946|P7|COMPLETED|Dose Escalation Phase||0
1077969|NCT00963820|2611947|P6|COMPLETED|Dose Escalation Phase||0
1077970|NCT00963820|2611948|P5|COMPLETED|Dose Escalation Phase||0
1077971|NCT00963820|2611949|P4|COMPLETED|Dose Escalation Phase||0
1077972|NCT00963820|2611950|P3|COMPLETED|Dose Escalation Phase||0
1077973|NCT00963820|2611951|P2|COMPLETED|Dose Escalation Phase||0
1077974|NCT00963820|2611952|P1|COMPLETED|Dose Escalation Phase||0
1077975|NCT00963820|2611941|P12|STARTED|Dose Escalation Phase||0
1077976|NCT00963820|2611942|P11|STARTED|Dose Escalation Phase||0
1077977|NCT00963820|2611943|P10|STARTED|Dose Escalation Phase||0
1077978|NCT00963820|2611944|P9|STARTED|Dose Escalation Phase|Expansion cohorts were not part of Dose Escalation except as noted in comments.|0
1077979|NCT00963820|2611945|P8|STARTED|Dose Escalation Phase||5
1077980|NCT00963820|2611946|P7|STARTED|Dose Escalation Phase||8
1077981|NCT00963820|2611947|P6|STARTED|Dose Escalation Phase||3
1077982|NCT00963820|2611948|P5|STARTED|Dose Escalation Phase||4
1077983|NCT00963820|2611949|P4|STARTED|Dose Escalation Phase||3
1077984|NCT00963820|2611950|P3|STARTED|Dose Escalation Phase||3
1077985|NCT00963820|2611951|P2|STARTED|Dose Escalation Phase||3
1077986|NCT00963820|2611952|P1|STARTED|Dose Escalation Phase||3
1077987|NCT00963859|2612088|P1|NOT COMPLETED|Overall Study||0
1077988|NCT00963859|2612088|P1|COMPLETED|Overall Study||11
1077989|NCT00963859|2612088|P1|STARTED|Overall Study||11
1077990|NCT00963872|2612095|P2|NOT COMPLETED|Overall Study||1
1077991|NCT00963872|2612096|P1|NOT COMPLETED|Overall Study||1
1077992|NCT00963872|2612095|P2|COMPLETED|Overall Study||5
1077993|NCT00963872|2612096|P1|COMPLETED|Overall Study||24
1077994|NCT00963872|2612095|P2|STARTED|Overall Study||6
1077995|NCT00963872|2612096|P1|STARTED|Overall Study||25
1077996|NCT00963924|2612142|P2|NOT COMPLETED|Overall Study||3
1077997|NCT00963924|2612143|P1|NOT COMPLETED|Overall Study||1
1077998|NCT00963924|2612142|P2|COMPLETED|Overall Study||15
1077999|NCT00963924|2612143|P1|COMPLETED|Overall Study||17
1078000|NCT00963924|2612142|P2|STARTED|Overall Study||18
1078001|NCT00963924|2612143|P1|STARTED|Overall Study||18
1078002|NCT00963937|2612162|P3|NOT COMPLETED|Overall Study||4
1078003|NCT00963937|2612163|P2|NOT COMPLETED|Overall Study||11
1078004|NCT00963937|2612164|P1|NOT COMPLETED|Overall Study||19
1078005|NCT00963937|2612162|P3|COMPLETED|Overall Study||41
1078006|NCT00963937|2612163|P2|COMPLETED|Overall Study||33
1078007|NCT00963937|2612164|P1|COMPLETED|Overall Study||70
1078008|NCT00963937|2612162|P3|STARTED|Overall Study||45
1078009|NCT00963937|2612163|P2|STARTED|Overall Study||44
1078010|NCT00963937|2612164|P1|STARTED|Overall Study||89
1078011|NCT00964444|2612200|P1|NOT COMPLETED|Overall Study||0
1078012|NCT00964444|2612200|P1|COMPLETED|Overall Study||10
1078013|NCT00964444|2612200|P1|STARTED|Overall Study||10
1078014|NCT00964496|2612206|P2|NOT COMPLETED|Overall Study||1
1078015|NCT00964496|2612207|P1|NOT COMPLETED|Overall Study||2
1078016|NCT00964496|2612206|P2|COMPLETED|Overall Study||26
1078017|NCT00964496|2612207|P1|COMPLETED|Overall Study||26
1078018|NCT00964496|2612206|P2|STARTED|Overall Study||27
1078019|NCT00964496|2612207|P1|STARTED|Overall Study||28
1078020|NCT00964548|2612227|P2|NOT COMPLETED|Overall Study||0
1078021|NCT00964548|2612228|P1|NOT COMPLETED|Overall Study||0
1078022|NCT00964548|2612227|P2|COMPLETED|Overall Study||5
1078023|NCT00964548|2612228|P1|COMPLETED|Overall Study||5
1078024|NCT00964548|2612227|P2|STARTED|Overall Study||5
1078025|NCT00964548|2612228|P1|STARTED|Overall Study||5
1078026|NCT00964678|2612238|P1|NOT COMPLETED|Overall Study||4
1078027|NCT00964678|2612238|P1|COMPLETED|Overall Study||6
1078028|NCT00964678|2612238|P1|STARTED|Overall Study||10
1078029|NCT00964743|2612245|P1|NOT COMPLETED|Overall Study||2
1078030|NCT00964743|2612245|P1|COMPLETED|Overall Study||0
1078031|NCT00964743|2612245|P1|STARTED|Overall Study||2
1078032|NCT00964795|2612253|P1|NOT COMPLETED|Overall Study||307
1078033|NCT00964795|2612253|P1|COMPLETED|Overall Study|Prior to amendment 4, 16 participants completed up to Week 120. No participants completed Week 180.|16
1078034|NCT00964795|2612253|P1|Number of Participants Treated|Overall Study||320
1078035|NCT00964795|2612253|P1|STARTED|Overall Study|randomized|323
1078036|NCT00964860|2612262|P2|NOT COMPLETED|Overall Study||1
1078037|NCT00964860|2612263|P1|NOT COMPLETED|Overall Study||0
1078038|NCT00964860|2612262|P2|COMPLETED|Overall Study||29
1078039|NCT00964860|2612263|P1|COMPLETED|Overall Study||30
1078040|NCT00964860|2612262|P2|STARTED|Overall Study||30
1078041|NCT00964860|2612263|P1|STARTED|Overall Study||30
1078042|NCT00964886|2612275|P4|NOT COMPLETED|Overall Study||9
1078043|NCT00964886|2612276|P3|NOT COMPLETED|Overall Study||16
1078044|NCT00964886|2612277|P2|NOT COMPLETED|Overall Study||7
1078045|NCT00964886|2612278|P1|NOT COMPLETED|Overall Study||11
1078046|NCT00964886|2612275|P4|COMPLETED|Overall Study||24
1078047|NCT00964886|2612276|P3|COMPLETED|Overall Study||21
1078048|NCT00964886|2612277|P2|COMPLETED|Overall Study||27
1078049|NCT00964886|2612278|P1|COMPLETED|Overall Study||27
1078050|NCT00964886|2612275|P4|STARTED|Overall Study||33
1078051|NCT00964886|2612276|P3|STARTED|Overall Study||37
1078052|NCT00964886|2612277|P2|STARTED|Overall Study||34
1078053|NCT00964886|2612278|P1|STARTED|Overall Study||38
1078054|NCT00965081|2612294|P2|NOT COMPLETED|Overall Study||43
1078055|NCT00965081|2612295|P1|NOT COMPLETED|Overall Study||34
1078056|NCT00965081|2612294|P2|COMPLETED|Overall Study||110
1078057|NCT00965081|2612295|P1|COMPLETED|Overall Study|In addition, 16/17 rescue participants completed study on protocol-specified study medication.|121
1078058|NCT00965081|2612294|P2|STARTED|Overall Study||153
1078059|NCT00965081|2612295|P1|STARTED|Overall Study|2 randomized participants had no post-baseline measures and are not included in outcome measures.|155
1078060|NCT00965094|2612320|P2|NOT COMPLETED|Overall Study||1
1078061|NCT00965094|2612321|P1|NOT COMPLETED|Overall Study||5
1078062|NCT00965094|2612320|P2|COMPLETED|Overall Study||16
1078063|NCT00965094|2612321|P1|COMPLETED|Overall Study||14
1078064|NCT00965094|2612320|P2|STARTED|Overall Study||17
1078065|NCT00965094|2612321|P1|STARTED|Overall Study||19
1078066|NCT00965146|2612335|P1|NOT COMPLETED|Overall Study||210
1078067|NCT00965146|2612335|P1|COMPLETED|Overall Study|Study was terminated prior to reaching 15 year endpoint.|0
1078068|NCT00965146|2612335|P1|STARTED|Overall Study||210
1078069|NCT00965185|2612341|P2|NOT COMPLETED|Overall Study||1
1078070|NCT00965185|2612342|P1|NOT COMPLETED|Overall Study||2
1078071|NCT00965185|2612341|P2|COMPLETED|Overall Study||20
1078072|NCT00965185|2612342|P1|COMPLETED|Overall Study||17
1078073|NCT00965185|2612341|P2|9 Month Visit|Overall Study||21
1078074|NCT00965185|2612342|P1|9 Month Visit|Overall Study||18
1078075|NCT00965185|2612341|P2|6 Month Visit|Overall Study||21
1078076|NCT00965185|2612342|P1|6 Month Visit|Overall Study||18
1078077|NCT00965185|2612341|P2|3 Month Visit|Overall Study||21
1078078|NCT00965185|2612342|P1|3 Month Visit|Overall Study||18
1078079|NCT00965185|2612341|P2|1 Month Visit|Overall Study||21
1078080|NCT00965185|2612342|P1|1 Month Visit|Overall Study||18
1078081|NCT00965185|2612341|P2|STARTED|Overall Study||21
1078082|NCT00965185|2612342|P1|STARTED|Overall Study||19
1078083|NCT00965237|2612358|P2|NOT COMPLETED|Period 2, One Week of Wear||0
1078084|NCT00965237|2612359|P1|NOT COMPLETED|Period 2, One Week of Wear||0
1078085|NCT00965237|2612358|P2|COMPLETED|Period 2, One Week of Wear||8
1078086|NCT00965237|2612359|P1|COMPLETED|Period 2, One Week of Wear||8
1078087|NCT00965237|2612358|P2|STARTED|Period 2, One Week of Wear||8
1078088|NCT00965237|2612359|P1|STARTED|Period 2, One Week of Wear||8
1078089|NCT00965237|2612358|P2|NOT COMPLETED|Period 1, One Week of Wear||0
1078090|NCT00965237|2612359|P1|NOT COMPLETED|Period 1, One Week of Wear||0
1078091|NCT00965237|2612358|P2|COMPLETED|Period 1, One Week of Wear||8
1078092|NCT00965237|2612359|P1|COMPLETED|Period 1, One Week of Wear||8
1078093|NCT00965237|2612358|P2|STARTED|Period 1, One Week of Wear||8
1078094|NCT00965237|2612359|P1|STARTED|Period 1, One Week of Wear||8
1078095|NCT00965250|2612367|P2|NOT COMPLETED|Overall Study||0
1078096|NCT00965250|2612368|P1|NOT COMPLETED|Overall Study||0
1078097|NCT00965250|2612367|P2|COMPLETED|Overall Study||12
1078098|NCT00965250|2612368|P1|COMPLETED|Overall Study||37
1078099|NCT00965250|2612367|P2|STARTED|Overall Study||12
1078100|NCT00965250|2612368|P1|STARTED|Overall Study||37
1078101|NCT00965341|2612388|P2|NOT COMPLETED|Overall Study||8
1078102|NCT00965341|2612389|P1|NOT COMPLETED|Overall Study||6
1078103|NCT00965341|2612388|P2|COMPLETED|Overall Study||16
1078104|NCT00965341|2612389|P1|COMPLETED|Overall Study||13
1078105|NCT00965341|2612388|P2|STARTED|Overall Study||24
1078106|NCT00965341|2612389|P1|STARTED|Overall Study||19
1078113|NCT00965484|2612416|P1|NOT COMPLETED|Overall Study||2
1078114|NCT00965484|2612416|P1|COMPLETED|Overall Study||134
1078115|NCT00965484|2612416|P1|STARTED|Overall Study||136
1078116|NCT00965497|2612423|P1|NOT COMPLETED|Overall Study||1
1078117|NCT00965497|2612423|P1|COMPLETED|Overall Study||13
1078118|NCT00965497|2612423|P1|STARTED|Overall Study||14
1078119|NCT00965523|2612428|P1|NOT COMPLETED|Study 224||6
1078120|NCT00965523|2612428|P1|COMPLETED|Study 224||0
1078121|NCT00965523|2612428|P1|STARTED|Study 224|Six subjects continued into Study 224 from Study 221.|6
1078122|NCT00965523|2612428|P1|NOT COMPLETED|Study 221||7
1078123|NCT00965523|2612428|P1|COMPLETED|Study 221||74
1078124|NCT00965523|2612428|P1|STARTED|Study 221|Study 221 (Safety Analysis Set).|81
1078125|NCT00965562|2612436|P3|NOT COMPLETED|Overall Study||3
1078126|NCT00965562|2612437|P2|NOT COMPLETED|Overall Study||4
1078127|NCT00965562|2612438|P1|NOT COMPLETED|Overall Study||3
1078128|NCT00965562|2612436|P3|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
1078129|NCT00965562|2612437|P2|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
1078130|NCT00965562|2612438|P1|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
1078131|NCT00965562|2612436|P3|Women Who Participated Full Follow up|Overall Study|2 patients discontinued intervention: 2 patient requests|11
1078132|NCT00965562|2612437|P2|Women Who Participated Full Follow up|Overall Study|3 patients discontinued intervention: 1 out of contact, 2 patient requests|10
1078133|NCT00965562|2612438|P1|Women Who Participated Full Follow up|Overall Study|7 patients discontinued intervention: 2 out of contact, 4 patient requests, 1 suspended by IRB|6
1078134|NCT00965562|2612436|P3|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 3 out of contact|13
1078135|NCT00965562|2612437|P2|Women With at Least 2 Follow up Visits|Overall Study|4 patients with no follow up visits: 2 out of contact, 2 patient requests|13
1078136|NCT00965562|2612438|P1|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 1 out of contact, 2 patient requests|13
1078137|NCT00965562|2612436|P3|STARTED|Overall Study||16
1078138|NCT00965562|2612437|P2|STARTED|Overall Study||17
1078139|NCT00965562|2612438|P1|STARTED|Overall Study||16
1078140|NCT00965718|2612476|P1|NOT COMPLETED|Overall Study||4
1078141|NCT00965718|2612476|P1|COMPLETED|Overall Study||16
1078142|NCT00965718|2612476|P1|STARTED|Overall Study||20
1078143|NCT00965731|2612488|P2|NOT COMPLETED|Overall Study||20
1078144|NCT00965731|2612489|P1|NOT COMPLETED|Overall Study||7
1078145|NCT00965731|2612488|P2|COMPLETED|Overall Study||0
1078146|NCT00965731|2612489|P1|COMPLETED|Overall Study||0
1078147|NCT00965731|2612488|P2|STARTED|Overall Study|Dose level given only after lower dose was successfully administered|20
1078148|NCT00965731|2612489|P1|STARTED|Overall Study||7
1078149|NCT00965757|2612555|P4|NOT COMPLETED|Extension Phase||24
1078150|NCT00965757|2612556|P3|NOT COMPLETED|Extension Phase||33
1078151|NCT00965757|2612557|P2|NOT COMPLETED|Extension Phase||0
1078152|NCT00965757|2612558|P1|NOT COMPLETED|Extension Phase||0
1078153|NCT00965757|2612555|P4|COMPLETED|Extension Phase||64
1078154|NCT00965757|2612556|P3|COMPLETED|Extension Phase||132
1078155|NCT00965757|2612557|P2|COMPLETED|Extension Phase||0
1078156|NCT00965757|2612558|P1|COMPLETED|Extension Phase||0
1078157|NCT00965757|2612555|P4|STARTED|Extension Phase||88
1078158|NCT00965757|2612556|P3|STARTED|Extension Phase||165
1078159|NCT00965757|2612557|P2|STARTED|Extension Phase||0
1078160|NCT00965757|2612558|P1|STARTED|Extension Phase||0
1078161|NCT00965757|2612555|P4|NOT COMPLETED|Double-blind Phase||0
1078162|NCT00965757|2612556|P3|NOT COMPLETED|Double-blind Phase||0
1078163|NCT00965757|2612557|P2|NOT COMPLETED|Double-blind Phase||18
1078164|NCT00965757|2612558|P1|NOT COMPLETED|Double-blind Phase||17
1078165|NCT00965757|2612555|P4|COMPLETED|Double-blind Phase||0
1078166|NCT00965757|2612556|P3|COMPLETED|Double-blind Phase||0
1078167|NCT00965757|2612557|P2|COMPLETED|Double-blind Phase||70
1078168|NCT00965757|2612558|P1|COMPLETED|Double-blind Phase||148
1078169|NCT00965757|2612555|P4|STARTED|Double-blind Phase||0
1078170|NCT00965757|2612556|P3|STARTED|Double-blind Phase||0
1078171|NCT00965757|2612557|P2|STARTED|Double-blind Phase||88
1078172|NCT00965757|2612558|P1|STARTED|Double-blind Phase||165
1078173|NCT00965848|2612590|P3|NOT COMPLETED|Overall Study||10
1078174|NCT00965848|2612591|P2|NOT COMPLETED|Overall Study||2
1078175|NCT00965848|2612592|P1|NOT COMPLETED|Overall Study||29
1078176|NCT00965848|2612590|P3|COMPLETED|Overall Study||117
1078177|NCT00965848|2612591|P2|COMPLETED|Overall Study||32
1078178|NCT00965848|2612592|P1|COMPLETED|Overall Study||78
1078179|NCT00965848|2612590|P3|STARTED|Overall Study||127
1078180|NCT00965848|2612591|P2|STARTED|Overall Study||34
1078181|NCT00965848|2612592|P1|STARTED|Overall Study||107
1078182|NCT00966186|2612611|P2|NOT COMPLETED|Overall Study||0
1078183|NCT00966186|2612612|P1|NOT COMPLETED|Overall Study||0
1078184|NCT00966186|2612611|P2|COMPLETED|Overall Study||60
1078185|NCT00966186|2612612|P1|COMPLETED|Overall Study||60
1078186|NCT00966186|2612611|P2|STARTED|Overall Study||60
1078187|NCT00966186|2612612|P1|STARTED|Overall Study||60
1078188|NCT00966238|2612624|P6|NOT COMPLETED|Overall Study||0
1078189|NCT00966238|2612625|P5|NOT COMPLETED|Overall Study||0
1078190|NCT00966238|2612626|P4|NOT COMPLETED|Overall Study||0
1078191|NCT00966238|2612627|P3|NOT COMPLETED|Overall Study||0
1078192|NCT00966238|2612628|P2|NOT COMPLETED|Overall Study||0
1078193|NCT00966238|2612629|P1|NOT COMPLETED|Overall Study||0
1078194|NCT00966238|2612624|P6|COMPLETED|Overall Study||20
1078195|NCT00966238|2612625|P5|COMPLETED|Overall Study||20
1078196|NCT00966238|2612626|P4|COMPLETED|Overall Study||20
1078197|NCT00966238|2612627|P3|COMPLETED|Overall Study||20
1078198|NCT00966238|2612628|P2|COMPLETED|Overall Study||20
1078199|NCT00966238|2612629|P1|COMPLETED|Overall Study||20
1078200|NCT00966238|2612624|P6|STARTED|Overall Study||20
1078201|NCT00966238|2612625|P5|STARTED|Overall Study||20
1078202|NCT00966238|2612626|P4|STARTED|Overall Study||20
1078203|NCT00966238|2612627|P3|STARTED|Overall Study||20
1078204|NCT00966238|2612628|P2|STARTED|Overall Study||20
1078205|NCT00966238|2612629|P1|STARTED|Overall Study||20
1078206|NCT00966264|2612651|P2|NOT COMPLETED|Overall Study||3
1078207|NCT00966264|2612652|P1|NOT COMPLETED|Overall Study||4
1078208|NCT00966264|2612651|P2|COMPLETED|Overall Study|5 years results|114
1078209|NCT00966264|2612652|P1|COMPLETED|Overall Study|5 years results|115
1078210|NCT00966264|2612651|P2|STARTED|Overall Study||117
1078211|NCT00966264|2612652|P1|STARTED|Overall Study||119
1078212|NCT00966277|2612660|P2|NOT COMPLETED|Overall Study||4
1078213|NCT00966277|2612661|P1|NOT COMPLETED|Overall Study||4
1078214|NCT00966277|2612660|P2|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|33
1078215|NCT00966277|2612661|P1|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|34
1078216|NCT00966277|2612660|P2|STARTED|Overall Study||37
1078217|NCT00966277|2612661|P1|STARTED|Overall Study||38
1078227|NCT00966550|2612688|P2|NOT COMPLETED|Overall Study||0
1078228|NCT00966550|2612689|P1|NOT COMPLETED|Overall Study||0
1078229|NCT00966550|2612688|P2|COMPLETED|Overall Study||12
1078230|NCT00966550|2612689|P1|COMPLETED|Overall Study||13
1078231|NCT00966550|2612688|P2|STARTED|Overall Study||12
1078232|NCT00966550|2612689|P1|STARTED|Overall Study||13
1078233|NCT00966641|2612695|P2|NOT COMPLETED|Second Intervention||0
1078234|NCT00966641|2612696|P1|NOT COMPLETED|Second Intervention||0
1078235|NCT00966641|2612695|P2|COMPLETED|Second Intervention||17
1078236|NCT00966641|2612696|P1|COMPLETED|Second Intervention||17
1078237|NCT00966641|2612695|P2|STARTED|Second Intervention||17
1078238|NCT00966641|2612696|P1|STARTED|Second Intervention||17
1078239|NCT00966641|2612695|P2|NOT COMPLETED|First Intervention||0
1078240|NCT00966641|2612696|P1|NOT COMPLETED|First Intervention||0
1078241|NCT00966641|2612695|P2|COMPLETED|First Intervention||17
1078242|NCT00966641|2612696|P1|COMPLETED|First Intervention||17
1078243|NCT00966641|2612695|P2|STARTED|First Intervention||17
1078244|NCT00966641|2612696|P1|STARTED|First Intervention||17
1078245|NCT00966654|2612702|P1|NOT COMPLETED|Overall Study||12
1078246|NCT00966654|2612702|P1|COMPLETED|Overall Study||0
1078247|NCT00966654|2612702|P1|STARTED|Overall Study||12
1078248|NCT00966823|2612710|P1|NOT COMPLETED|Overall Study||1
1078249|NCT00966823|2612710|P1|COMPLETED|Overall Study||2
1078250|NCT00966823|2612710|P1|STARTED|Overall Study||3
1078251|NCT00966875|2612727|P9|NOT COMPLETED|Part B||18
1078252|NCT00966875|2612728|P8|NOT COMPLETED|Part B||19
1078253|NCT00966875|2612729|P7|NOT COMPLETED|Part B||22
1078254|NCT00966875|2612730|P6|NOT COMPLETED|Part B||6
1078255|NCT00966875|2612731|P5|NOT COMPLETED|Part B||7
1078256|NCT00966875|2612732|P4|NOT COMPLETED|Part B||3
1078257|NCT00966875|2612733|P3|NOT COMPLETED|Part B||6
1078258|NCT00966875|2612734|P2|NOT COMPLETED|Part B||3
1078259|NCT00966875|2612735|P1|NOT COMPLETED|Part B||5
1078260|NCT00966875|2612727|P9|COMPLETED|Part B||32
1078261|NCT00966875|2612728|P8|COMPLETED|Part B||38
1078262|NCT00966875|2612729|P7|COMPLETED|Part B||29
1078263|NCT00966875|2612730|P6|COMPLETED|Part B||26
1078264|NCT00966875|2612731|P5|COMPLETED|Part B||44
1078265|NCT00966875|2612732|P4|COMPLETED|Part B||31
1078266|NCT00966875|2612733|P3|COMPLETED|Part B||27
1078267|NCT00966875|2612734|P2|COMPLETED|Part B||33
1078268|NCT00966875|2612735|P1|COMPLETED|Part B||41
1078269|NCT00966875|2612727|P9|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|50
1078270|NCT00966875|2612728|P8|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|57
1078271|NCT00966875|2612729|P7|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
1078272|NCT00966875|2612730|P6|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|32
1078273|NCT00966875|2612731|P5|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
1078274|NCT00966875|2612732|P4|STARTED|Part B||34
1078275|NCT00966875|2612733|P3|STARTED|Part B||33
1078276|NCT00966875|2612734|P2|STARTED|Part B||36
1078277|NCT00966875|2612735|P1|STARTED|Part B|Two (2) participants who completed Part A did not enter Part B.|46
1078278|NCT00966875|2612727|P9|NOT COMPLETED|Part A||8
1078279|NCT00966875|2612728|P8|NOT COMPLETED|Part A||7
1078280|NCT00966875|2612729|P7|NOT COMPLETED|Part A||12
1078281|NCT00966875|2612730|P6|NOT COMPLETED|Part A||4
1078282|NCT00966875|2612731|P5|NOT COMPLETED|Part A||5
1078283|NCT00966875|2612732|P4|NOT COMPLETED|Part A||3
1078284|NCT00966875|2612733|P3|NOT COMPLETED|Part A||2
1078285|NCT00966875|2612734|P2|NOT COMPLETED|Part A||4
1078286|NCT00966875|2612735|P1|NOT COMPLETED|Part A||6
1078287|NCT00966875|2612727|P9|COMPLETED|Part A||51
1078288|NCT00966875|2612728|P8|COMPLETED|Part A||58
1078289|NCT00966875|2612729|P7|COMPLETED|Part A||52
1078290|NCT00966875|2612730|P6|COMPLETED|Part A||33
1078291|NCT00966875|2612731|P5|COMPLETED|Part A||52
1078292|NCT00966875|2612732|P4|COMPLETED|Part A||34
1078293|NCT00966875|2612733|P3|COMPLETED|Part A||33
1078294|NCT00966875|2612734|P2|COMPLETED|Part A||36
1078295|NCT00966875|2612735|P1|COMPLETED|Part A||48
1078296|NCT00966875|2612727|P9|Received ≥1 Doses of Study Drug|Part A||59
1078297|NCT00966875|2612728|P8|Received ≥1 Doses of Study Drug|Part A||65
1078298|NCT00966875|2612729|P7|Received ≥1 Doses of Study Drug|Part A||64
1078299|NCT00966875|2612730|P6|Received ≥1 Doses of Study Drug|Part A||37
1078300|NCT00966875|2612731|P5|Received ≥1 Doses of Study Drug|Part A||57
1078301|NCT00966875|2612732|P4|Received ≥1 Doses of Study Drug|Part A||37
1078302|NCT00966875|2612733|P3|Received ≥1 Doses of Study Drug|Part A||35
1078303|NCT00966875|2612734|P2|Received ≥1 Doses of Study Drug|Part A||40
1078304|NCT00966875|2612735|P1|Received ≥1 Doses of Study Drug|Part A||54
1078305|NCT00966875|2612727|P9|STARTED|Part A||59
1078306|NCT00966875|2612728|P8|STARTED|Part A||65
1078307|NCT00966875|2612729|P7|STARTED|Part A||64
1078308|NCT00966875|2612730|P6|STARTED|Part A||37
1078309|NCT00966875|2612731|P5|STARTED|Part A||57
1078310|NCT00966875|2612732|P4|STARTED|Part A||37
1078311|NCT00966875|2612733|P3|STARTED|Part A||35
1078312|NCT00966875|2612734|P2|STARTED|Part A||40
1078313|NCT00966875|2612735|P1|STARTED|Part A||54
1078314|NCT00966940|2613056|P2|NOT COMPLETED|Period 2, Second 6 Weeks||0
1078315|NCT00966940|2613057|P1|NOT COMPLETED|Period 2, Second 6 Weeks||0
1078316|NCT00966940|2613056|P2|COMPLETED|Period 2, Second 6 Weeks||23
1078317|NCT00966940|2613057|P1|COMPLETED|Period 2, Second 6 Weeks||25
1078318|NCT00966940|2613056|P2|STARTED|Period 2, Second 6 Weeks||23
1078319|NCT00966940|2613057|P1|STARTED|Period 2, Second 6 Weeks||25
1078320|NCT00966940|2613056|P2|NOT COMPLETED|Period 1, First 6 Weeks||0
1078321|NCT00966940|2613057|P1|NOT COMPLETED|Period 1, First 6 Weeks||3
1078322|NCT00966940|2613056|P2|COMPLETED|Period 1, First 6 Weeks||23
1078323|NCT00966940|2613057|P1|COMPLETED|Period 1, First 6 Weeks||25
1078324|NCT00966940|2613056|P2|STARTED|Period 1, First 6 Weeks||23
1078325|NCT00966940|2613057|P1|STARTED|Period 1, First 6 Weeks||28
1078326|NCT00966953|2613079|P4|NOT COMPLETED|4th Intervention Order||0
1078327|NCT00966953|2613080|P3|NOT COMPLETED|4th Intervention Order||0
1078328|NCT00966953|2613081|P2|NOT COMPLETED|4th Intervention Order||0
1078329|NCT00966953|2613082|P1|NOT COMPLETED|4th Intervention Order||0
1078330|NCT00966953|2613079|P4|COMPLETED|4th Intervention Order||7
1078331|NCT00966953|2613080|P3|COMPLETED|4th Intervention Order||6
1078332|NCT00966953|2613081|P2|COMPLETED|4th Intervention Order||6
1078333|NCT00966953|2613082|P1|COMPLETED|4th Intervention Order||6
1078334|NCT00966953|2613079|P4|STARTED|4th Intervention Order||7
1078335|NCT00966953|2613080|P3|STARTED|4th Intervention Order||6
1078336|NCT00966953|2613081|P2|STARTED|4th Intervention Order||6
1078337|NCT00966953|2613082|P1|STARTED|4th Intervention Order||6
1078338|NCT00966953|2613079|P4|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
1078339|NCT00966953|2613080|P3|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
1078340|NCT00966953|2613081|P2|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
1078341|NCT00966953|2613082|P1|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
1078342|NCT00966953|2613079|P4|COMPLETED|1 Week Washout After 3rd Intervention||7
1078343|NCT00966953|2613080|P3|COMPLETED|1 Week Washout After 3rd Intervention||6
1078344|NCT00966953|2613081|P2|COMPLETED|1 Week Washout After 3rd Intervention||6
1078345|NCT00966953|2613082|P1|COMPLETED|1 Week Washout After 3rd Intervention||6
1078346|NCT00966953|2613079|P4|STARTED|1 Week Washout After 3rd Intervention||7
1078347|NCT00966953|2613080|P3|STARTED|1 Week Washout After 3rd Intervention||6
1078348|NCT00966953|2613081|P2|STARTED|1 Week Washout After 3rd Intervention||6
1078349|NCT00966953|2613082|P1|STARTED|1 Week Washout After 3rd Intervention||6
1078350|NCT00966953|2613079|P4|NOT COMPLETED|3rd Intervention Order||0
1078351|NCT00966953|2613080|P3|NOT COMPLETED|3rd Intervention Order||0
1078352|NCT00966953|2613081|P2|NOT COMPLETED|3rd Intervention Order||0
1078353|NCT00966953|2613082|P1|NOT COMPLETED|3rd Intervention Order||0
1078354|NCT00966953|2613079|P4|COMPLETED|3rd Intervention Order||7
1078355|NCT00966953|2613080|P3|COMPLETED|3rd Intervention Order||6
1078356|NCT00966953|2613081|P2|COMPLETED|3rd Intervention Order||6
1078357|NCT00966953|2613082|P1|COMPLETED|3rd Intervention Order||6
1078358|NCT00966953|2613079|P4|STARTED|3rd Intervention Order||7
1078359|NCT00966953|2613080|P3|STARTED|3rd Intervention Order||6
1078360|NCT00966953|2613081|P2|STARTED|3rd Intervention Order||6
1078361|NCT00966953|2613082|P1|STARTED|3rd Intervention Order||6
1078362|NCT00966953|2613079|P4|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
1078363|NCT00966953|2613080|P3|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
1078364|NCT00966953|2613081|P2|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
1078365|NCT00966953|2613082|P1|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
1078366|NCT00966953|2613079|P4|COMPLETED|1 Week Washout After 2nd Intervention||7
1078367|NCT00966953|2613080|P3|COMPLETED|1 Week Washout After 2nd Intervention||6
1078368|NCT00966953|2613081|P2|COMPLETED|1 Week Washout After 2nd Intervention||6
1078369|NCT00966953|2613082|P1|COMPLETED|1 Week Washout After 2nd Intervention||6
1078370|NCT00966953|2613079|P4|STARTED|1 Week Washout After 2nd Intervention||7
1078371|NCT00966953|2613080|P3|STARTED|1 Week Washout After 2nd Intervention||6
1078372|NCT00966953|2613081|P2|STARTED|1 Week Washout After 2nd Intervention||6
1078373|NCT00966953|2613082|P1|STARTED|1 Week Washout After 2nd Intervention||6
1078374|NCT00966953|2613079|P4|NOT COMPLETED|2nd Intervention||0
1078375|NCT00966953|2613080|P3|NOT COMPLETED|2nd Intervention||0
1078376|NCT00966953|2613081|P2|NOT COMPLETED|2nd Intervention||0
1078377|NCT00966953|2613082|P1|NOT COMPLETED|2nd Intervention||0
1078378|NCT00966953|2613079|P4|COMPLETED|2nd Intervention||7
1078379|NCT00966953|2613080|P3|COMPLETED|2nd Intervention||6
1078380|NCT00966953|2613081|P2|COMPLETED|2nd Intervention||6
1078381|NCT00966953|2613082|P1|COMPLETED|2nd Intervention||6
1078382|NCT00966953|2613079|P4|STARTED|2nd Intervention||7
1078383|NCT00966953|2613080|P3|STARTED|2nd Intervention||6
1078384|NCT00966953|2613081|P2|STARTED|2nd Intervention||6
1078385|NCT00966953|2613082|P1|STARTED|2nd Intervention||6
1078386|NCT00966953|2613079|P4|NOT COMPLETED|1 Week Washout After 1st Intervention||0
1078387|NCT00966953|2613080|P3|NOT COMPLETED|1 Week Washout After 1st Intervention||0
1078388|NCT00966953|2613081|P2|NOT COMPLETED|1 Week Washout After 1st Intervention||0
1078389|NCT00966953|2613082|P1|NOT COMPLETED|1 Week Washout After 1st Intervention||0
1078390|NCT00966953|2613079|P4|COMPLETED|1 Week Washout After 1st Intervention||7
1078391|NCT00966953|2613080|P3|COMPLETED|1 Week Washout After 1st Intervention||6
1078392|NCT00966953|2613081|P2|COMPLETED|1 Week Washout After 1st Intervention||6
1078393|NCT00966953|2613082|P1|COMPLETED|1 Week Washout After 1st Intervention||6
1078394|NCT00966953|2613079|P4|STARTED|1 Week Washout After 1st Intervention||7
1078395|NCT00966953|2613080|P3|STARTED|1 Week Washout After 1st Intervention||6
1078396|NCT00966953|2613081|P2|STARTED|1 Week Washout After 1st Intervention||6
1078397|NCT00966953|2613082|P1|STARTED|1 Week Washout After 1st Intervention||6
1078398|NCT00966953|2613079|P4|NOT COMPLETED|1st Intervention||0
1078399|NCT00966953|2613080|P3|NOT COMPLETED|1st Intervention||0
1078400|NCT00966953|2613081|P2|NOT COMPLETED|1st Intervention||0
1078401|NCT00966953|2613082|P1|NOT COMPLETED|1st Intervention||0
1078402|NCT00966953|2613079|P4|COMPLETED|1st Intervention||7
1078403|NCT00966953|2613080|P3|COMPLETED|1st Intervention||6
1078404|NCT00966953|2613081|P2|COMPLETED|1st Intervention||6
1078405|NCT00966953|2613082|P1|COMPLETED|1st Intervention||6
1078406|NCT00966953|2613079|P4|STARTED|1st Intervention||7
1078407|NCT00966953|2613080|P3|STARTED|1st Intervention||6
1078408|NCT00966953|2613081|P2|STARTED|1st Intervention||6
1078409|NCT00966953|2613082|P1|STARTED|1st Intervention||6
1078410|NCT00954187|2613090|P2|NOT COMPLETED|Overall Study||0
1078411|NCT00954187|2613091|P1|NOT COMPLETED|Overall Study||0
1078412|NCT00954187|2613090|P2|COMPLETED|Overall Study||0
1078413|NCT00954187|2613091|P1|COMPLETED|Overall Study||0
1078414|NCT00954187|2613090|P2|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
1078415|NCT00954187|2613091|P1|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
1078416|NCT00954356|2613099|P2|NOT COMPLETED|Overall Study||0
1078417|NCT00954356|2613100|P1|NOT COMPLETED|Overall Study||0
1078418|NCT00954356|2613099|P2|COMPLETED|Overall Study||20
1078419|NCT00954356|2613100|P1|COMPLETED|Overall Study||41
1078420|NCT00954356|2613099|P2|STARTED|Overall Study||20
1078421|NCT00954356|2613100|P1|STARTED|Overall Study||41
1078422|NCT00954421|2613128|P1|NOT COMPLETED|VIM=ON VO=OFF at 6 Months||1
1078423|NCT00954421|2613128|P1|COMPLETED|VIM=ON VO=OFF at 6 Months||11
1078424|NCT00954421|2613128|P1|STARTED|VIM=ON VO=OFF at 6 Months||12
1078425|NCT00954421|2613128|P1|NOT COMPLETED|VIM=OFF VO=ON at 6 Months||0
1078426|NCT00954421|2613128|P1|COMPLETED|VIM=OFF VO=ON at 6 Months||12
1078427|NCT00954421|2613128|P1|STARTED|VIM=OFF VO=ON at 6 Months||12
1078428|NCT00954421|2613128|P1|NOT COMPLETED|VIM=OFF VO=OFF at 6 Months||0
1078429|NCT00954421|2613128|P1|COMPLETED|VIM=OFF VO=OFF at 6 Months||12
1078430|NCT00954421|2613128|P1|STARTED|VIM=OFF VO=OFF at 6 Months||12
1078431|NCT00954421|2613128|P1|NOT COMPLETED|VIM=ON VO=ON at 6 Months||0
1078432|NCT00954421|2613128|P1|COMPLETED|VIM=ON VO=ON at 6 Months||12
1078433|NCT00954421|2613128|P1|STARTED|VIM=ON VO=ON at 6 Months|This is the point of evaluation: Order of assessment was random for periods 4-7|12
1078434|NCT00954421|2613128|P1|NOT COMPLETED|6 Months of DBS||1
1078435|NCT00954421|2613128|P1|COMPLETED|6 Months of DBS||12
1078436|NCT00954421|2613128|P1|STARTED|6 Months of DBS||13
1078437|NCT00954421|2613128|P1|NOT COMPLETED|Baseline||0
1078438|NCT00954421|2613128|P1|COMPLETED|Baseline||13
1078439|NCT00954421|2613128|P1|STARTED|Baseline||13
1078440|NCT00954421|2613128|P1|NOT COMPLETED|Screening||3
1078441|NCT00954421|2613128|P1|COMPLETED|Screening||13
1078442|NCT00954421|2613128|P1|STARTED|Screening||16
1078443|NCT00959894|2613134|P1|NOT COMPLETED|Overall Study||16
1078444|NCT00959894|2613134|P1|COMPLETED|Overall Study||63
1078445|NCT00959894|2613134|P1|STARTED|Overall Study|One (1) additional subject became ineligible on the day of entry and never started study medication.|79
1078446|NCT00959907|2613164|P2|NOT COMPLETED|Overall Study||1
1078447|NCT00959907|2613165|P1|NOT COMPLETED|Overall Study||3
1078448|NCT00959907|2613164|P2|COMPLETED|Overall Study||28
1078449|NCT00959907|2613165|P1|COMPLETED|Overall Study||27
1078450|NCT00959907|2613164|P2|STARTED|Overall Study||29
1078451|NCT00959907|2613165|P1|STARTED|Overall Study||30
1078452|NCT00959920|2613177|P2|NOT COMPLETED|Overall Study||1
1078453|NCT00959920|2613178|P1|NOT COMPLETED|Overall Study||0
1078454|NCT00959920|2613177|P2|COMPLETED|Overall Study||66
1078455|NCT00959920|2613178|P1|COMPLETED|Overall Study||72
1078456|NCT00959920|2613177|P2|STARTED|Overall Study||67
1078457|NCT00959920|2613178|P1|STARTED|Overall Study||72
1078458|NCT00959946|2613194|P8|NOT COMPLETED|Overall Study||2
1078459|NCT00959946|2613195|P7|NOT COMPLETED|Overall Study||2
1078460|NCT00959946|2613196|P6|NOT COMPLETED|Overall Study||9
1078461|NCT00959946|2613197|P5|NOT COMPLETED|Overall Study||4
1078462|NCT00959946|2613198|P4|NOT COMPLETED|Overall Study||5
1078463|NCT00959946|2613199|P3|NOT COMPLETED|Overall Study||4
1078464|NCT00959946|2613200|P2|NOT COMPLETED|Overall Study||4
1078465|NCT00959946|2613201|P1|NOT COMPLETED|Overall Study||2
1078466|NCT00959946|2613194|P8|COMPLETED|Overall Study||0
1078467|NCT00959946|2613195|P7|COMPLETED|Overall Study||0
1078468|NCT00959946|2613196|P6|COMPLETED|Overall Study||0
1078469|NCT00959946|2613197|P5|COMPLETED|Overall Study||0
1078470|NCT00959946|2613198|P4|COMPLETED|Overall Study||0
1078471|NCT00959946|2613199|P3|COMPLETED|Overall Study||0
1078472|NCT00959946|2613200|P2|COMPLETED|Overall Study||0
1078473|NCT00959946|2613201|P1|COMPLETED|Overall Study||0
1078474|NCT00959946|2613194|P8|STARTED|Overall Study||2
1078475|NCT00959946|2613195|P7|STARTED|Overall Study||2
1078476|NCT00959946|2613196|P6|STARTED|Overall Study||9
1078477|NCT00959946|2613197|P5|STARTED|Overall Study||4
1078478|NCT00959946|2613198|P4|STARTED|Overall Study||5
1078479|NCT00959946|2613199|P3|STARTED|Overall Study||4
1078480|NCT00959946|2613200|P2|STARTED|Overall Study||4
1078481|NCT00959946|2613201|P1|STARTED|Overall Study||2
1078482|NCT00959985|2613256|P4|NOT COMPLETED|Overall Study||0
1078483|NCT00959985|2613257|P3|NOT COMPLETED|Overall Study||0
1078484|NCT00959985|2613258|P2|NOT COMPLETED|Overall Study||0
1078485|NCT00959985|2613259|P1|NOT COMPLETED|Overall Study||0
1078486|NCT00959985|2613256|P4|COMPLETED|Overall Study||4
1078487|NCT00959985|2613257|P3|COMPLETED|Overall Study||4
1078488|NCT00959985|2613258|P2|COMPLETED|Overall Study||7
1078489|NCT00959985|2613259|P1|COMPLETED|Overall Study||8
1078490|NCT00959985|2613256|P4|STARTED|Overall Study||4
1078491|NCT00959985|2613257|P3|STARTED|Overall Study||4
1078492|NCT00959985|2613258|P2|STARTED|Overall Study||7
1078493|NCT00959985|2613259|P1|STARTED|Overall Study||8
1078494|NCT00960063|2613300|P3|NOT COMPLETED|Overall Study||3
1078495|NCT00960063|2613301|P2|NOT COMPLETED|Overall Study||0
1078496|NCT00960063|2613302|P1|NOT COMPLETED|Overall Study||1
1078497|NCT00960063|2613300|P3|COMPLETED|Overall Study||0
1078498|NCT00960063|2613301|P2|COMPLETED|Overall Study||0
1078499|NCT00960063|2613302|P1|COMPLETED|Overall Study||0
1078500|NCT00960063|2613300|P3|STARTED|Overall Study||3
1078501|NCT00960063|2613301|P2|STARTED|Overall Study||0
1078502|NCT00960063|2613302|P1|STARTED|Overall Study||1
1078503|NCT00960076|2613342|P2|NOT COMPLETED|Overall Study||25
1078504|NCT00960076|2613343|P1|NOT COMPLETED|Overall Study||8
1078505|NCT00960076|2613342|P2|COMPLETED|Overall Study|Completing 18 weeks of treatment|119
1078506|NCT00960076|2613343|P1|COMPLETED|Overall Study|Completing 18 weeks of treatment|130
1078507|NCT00960076|2613342|P2|STARTED|Overall Study|Randomized and treated|144
1078508|NCT00960076|2613343|P1|STARTED|Overall Study|Randomized and treated|138
1078509|NCT00960115|2613357|P2|NOT COMPLETED|Overall Study||15
1078510|NCT00960115|2613358|P1|NOT COMPLETED|Overall Study||19
1078511|NCT00960115|2613357|P2|COMPLETED|Overall Study||43
1078512|NCT00960115|2613358|P1|COMPLETED|Overall Study||95
1078513|NCT00960115|2613357|P2|STARTED|Overall Study||58
1078514|NCT00960115|2613358|P1|STARTED|Overall Study||114
1078515|NCT00960141|2613373|P3|NOT COMPLETED|Overall Study||7
1078516|NCT00960141|2613374|P2|NOT COMPLETED|Overall Study||17
1078517|NCT00960141|2613375|P1|NOT COMPLETED|Overall Study||10
1078518|NCT00960141|2613373|P3|COMPLETED|Overall Study||163
1078519|NCT00960141|2613374|P2|COMPLETED|Overall Study||309
1078520|NCT00960141|2613375|P1|COMPLETED|Overall Study||323
1078521|NCT00960141|2613373|P3|STARTED|Overall Study||170
1078522|NCT00960141|2613374|P2|STARTED|Overall Study||326
1078523|NCT00960141|2613375|P1|STARTED|Overall Study||333
1078524|NCT00960154|2613400|P2|NOT COMPLETED|Overall Study||25
1078525|NCT00960154|2613401|P1|NOT COMPLETED|Overall Study||25
1078526|NCT00960154|2613400|P2|COMPLETED|Overall Study||0
1078527|NCT00960154|2613401|P1|COMPLETED|Overall Study||0
1078528|NCT00960154|2613400|P2|STARTED|Overall Study||25
1078529|NCT00960154|2613401|P1|STARTED|Overall Study||25
1078530|NCT00960193|2613409|P1|NOT COMPLETED|Colchicine With Seville Orange Juice||0
1078531|NCT00960193|2613409|P1|COMPLETED|Colchicine With Seville Orange Juice||23
1078532|NCT00960193|2613409|P1|STARTED|Colchicine With Seville Orange Juice||23
1078533|NCT00960193|2613409|P1|NOT COMPLETED|Seville Orange Juice Alone||0
1078534|NCT00960193|2613409|P1|COMPLETED|Seville Orange Juice Alone||23
1078535|NCT00960193|2613409|P1|STARTED|Seville Orange Juice Alone||23
1078536|NCT00960193|2613409|P1|NOT COMPLETED|14 Day Washout Period||1
1078537|NCT00960193|2613409|P1|COMPLETED|14 Day Washout Period||23
1078538|NCT00960193|2613409|P1|STARTED|14 Day Washout Period||24
1078539|NCT00960193|2613409|P1|NOT COMPLETED|Colchicine Alone||0
1078540|NCT00960193|2613409|P1|COMPLETED|Colchicine Alone||24
1078541|NCT00960193|2613409|P1|STARTED|Colchicine Alone||24
1078542|NCT00960206|2613423|P3|NOT COMPLETED|Overall Study||12
1078543|NCT00960206|2613424|P2|NOT COMPLETED|Overall Study||27
1078544|NCT00960206|2613425|P1|NOT COMPLETED|Overall Study||40
1078545|NCT00960206|2613423|P3|COMPLETED|Overall Study||77
1078546|NCT00960206|2613424|P2|COMPLETED|Overall Study||158
1078547|NCT00960206|2613425|P1|COMPLETED|Overall Study||150
1078548|NCT00960206|2613423|P3|STARTED|Overall Study||89
1078549|NCT00960206|2613424|P2|STARTED|Overall Study||185
1078550|NCT00960206|2613425|P1|STARTED|Overall Study||190
1078551|NCT00960297|2613443|P1|NOT COMPLETED|Overall Study||3
1078552|NCT00960297|2613443|P1|COMPLETED|Overall Study||1
1078553|NCT00960297|2613443|P1|STARTED|Overall Study||4
1078554|NCT00960323|2613447|P1|NOT COMPLETED|Colchicine and Atorvastatin||0
1078555|NCT00960323|2613447|P1|COMPLETED|Colchicine and Atorvastatin||23
1078556|NCT00960323|2613447|P1|STARTED|Colchicine and Atorvastatin||23
1078557|NCT00960323|2613447|P1|NOT COMPLETED|Atorvastatin Alone||1
1078558|NCT00960323|2613447|P1|COMPLETED|Atorvastatin Alone||23
1078559|NCT00960323|2613447|P1|STARTED|Atorvastatin Alone||24
1078560|NCT00960323|2613447|P1|NOT COMPLETED|14 Day Washout Period||0
1078561|NCT00960323|2613447|P1|COMPLETED|14 Day Washout Period||24
1078562|NCT00960323|2613447|P1|STARTED|14 Day Washout Period||24
1078563|NCT00960323|2613447|P1|NOT COMPLETED|Colchicine Alone||0
1078564|NCT00960323|2613447|P1|COMPLETED|Colchicine Alone||24
1078565|NCT00960323|2613447|P1|STARTED|Colchicine Alone||24
1078566|NCT00960375|2613460|P2|NOT COMPLETED|Overall Study||22
1078567|NCT00960375|2613461|P1|NOT COMPLETED|Overall Study||20
1078568|NCT00960375|2613460|P2|COMPLETED|Overall Study||65
1078569|NCT00960375|2613461|P1|COMPLETED|Overall Study||72
1078570|NCT00960375|2613460|P2|STARTED|Overall Study||87
1078571|NCT00960375|2613461|P1|STARTED|Overall Study||92
1078572|NCT00960440|2613473|P4|NOT COMPLETED|Overall Study||18
1078573|NCT00960440|2613474|P3|NOT COMPLETED|Overall Study||13
1078574|NCT00960440|2613475|P2|NOT COMPLETED|Overall Study||31
1078575|NCT00960440|2613476|P1|NOT COMPLETED|Overall Study||26
1078576|NCT00960440|2613473|P4|COMPLETED|Overall Study||48
1078577|NCT00960440|2613474|P3|COMPLETED|Overall Study||53
1078578|NCT00960440|2613475|P2|COMPLETED|Overall Study||103
1078579|NCT00960440|2613476|P1|COMPLETED|Overall Study||107
1078580|NCT00960440|2613473|P4|STARTED|Overall Study||66
1078581|NCT00960440|2613474|P3|STARTED|Overall Study||66
1078582|NCT00960440|2613475|P2|STARTED|Overall Study||134
1078583|NCT00960440|2613476|P1|STARTED|Overall Study||133
1078584|NCT00960531|2613656|P10|NOT COMPLETED|Overall Study||1
1078585|NCT00960531|2613657|P9|NOT COMPLETED|Overall Study||14
1078586|NCT00960531|2613658|P8|NOT COMPLETED|Overall Study||4
1078587|NCT00960531|2613659|P7|NOT COMPLETED|Overall Study||24
1078588|NCT00960531|2613660|P6|NOT COMPLETED|Overall Study||3
1078589|NCT00960531|2613661|P5|NOT COMPLETED|Overall Study||2
1078590|NCT00960531|2613662|P4|NOT COMPLETED|Overall Study||8
1078591|NCT00960531|2613663|P3|NOT COMPLETED|Overall Study||26
1078592|NCT00960531|2613664|P2|NOT COMPLETED|Overall Study||1
1078593|NCT00960531|2613665|P1|NOT COMPLETED|Overall Study||10
1078594|NCT00960531|2613656|P10|COMPLETED|Overall Study|Completed study|3
1078595|NCT00960531|2613657|P9|COMPLETED|Overall Study|Completed study|2
1078596|NCT00960531|2613658|P8|COMPLETED|Overall Study|Completed study|2
1078597|NCT00960531|2613659|P7|COMPLETED|Overall Study|Completed study|3
1078598|NCT00960531|2613660|P6|COMPLETED|Overall Study|Completed study|6
1078599|NCT00960531|2613661|P5|COMPLETED|Overall Study|Completed study|3
1078600|NCT00960531|2613662|P4|COMPLETED|Overall Study|Completed study|17
1078601|NCT00960531|2613663|P3|COMPLETED|Overall Study|Completed study|15
1078602|NCT00960531|2613664|P2|COMPLETED|Overall Study|Completed study|5
1078603|NCT00960531|2613665|P1|COMPLETED|Overall Study|Completed study|11
1078604|NCT00960531|2613656|P10|Completed Treatment|Overall Study||4
1078605|NCT00960531|2613657|P9|Completed Treatment|Overall Study||2
1078606|NCT00960531|2613658|P8|Completed Treatment|Overall Study||3
1078607|NCT00960531|2613659|P7|Completed Treatment|Overall Study||4
1078608|NCT00960531|2613660|P6|Completed Treatment|Overall Study||7
1078609|NCT00960531|2613661|P5|Completed Treatment|Overall Study||3
1078610|NCT00960531|2613662|P4|Completed Treatment|Overall Study||17
1078611|NCT00960531|2613663|P3|Completed Treatment|Overall Study||15
1078612|NCT00960531|2613664|P2|Completed Treatment|Overall Study||5
1078613|NCT00960531|2613665|P1|Completed Treatment|Overall Study||12
1078614|NCT00960531|2613656|P10|Treated|Overall Study||4
1078615|NCT00960531|2613657|P9|Treated|Overall Study||16
1078616|NCT00960531|2613658|P8|Treated|Overall Study||6
1078617|NCT00960531|2613659|P7|Treated|Overall Study||27
1078618|NCT00960531|2613660|P6|Treated|Overall Study||9
1078619|NCT00960531|2613661|P5|Treated|Overall Study||5
1078620|NCT00960531|2613662|P4|Treated|Overall Study||24
1078621|NCT00960531|2613663|P3|Treated|Overall Study||41
1078622|NCT00960531|2613664|P2|Treated|Overall Study||6
1078623|NCT00960531|2613665|P1|Treated|Overall Study||21
1078624|NCT00960531|2613656|P10|STARTED|Overall Study|Started=Randomized|4
1078625|NCT00960531|2613657|P9|STARTED|Overall Study|Started=Randomized|16
1078626|NCT00960531|2613658|P8|STARTED|Overall Study|Started=Randomized|6
1078627|NCT00960531|2613659|P7|STARTED|Overall Study|Started=Randomized|27
1078628|NCT00960531|2613660|P6|STARTED|Overall Study|Started=Randomized|9
1078629|NCT00960531|2613661|P5|STARTED|Overall Study|Started=Randomized|5
1078630|NCT00960531|2613662|P4|STARTED|Overall Study|Started=Randomized.|25
1078631|NCT00960531|2613663|P3|STARTED|Overall Study|Started=Randomized|41
1078632|NCT00960531|2613664|P2|STARTED|Overall Study|Started=Randomized|6
1078633|NCT00960531|2613665|P1|STARTED|Overall Study|Started=Randomized|21
1078634|NCT00960570|2613709|P1|NOT COMPLETED|Efavirenz and Fenofibric Acid||0
1078635|NCT00960570|2613709|P1|COMPLETED|Efavirenz and Fenofibric Acid||25
1078636|NCT00960570|2613709|P1|STARTED|Efavirenz and Fenofibric Acid||25
1078637|NCT00960570|2613709|P1|NOT COMPLETED|1 Day Period Between Dosing||3
1078638|NCT00960570|2613709|P1|COMPLETED|1 Day Period Between Dosing||25
1078639|NCT00960570|2613709|P1|STARTED|1 Day Period Between Dosing||28
1078640|NCT00960570|2613709|P1|NOT COMPLETED|Fenofibric Acid Alone||0
1078641|NCT00960570|2613709|P1|COMPLETED|Fenofibric Acid Alone||28
1078642|NCT00960570|2613709|P1|STARTED|Fenofibric Acid Alone||28
1078643|NCT00960570|2613709|P1|NOT COMPLETED|21 Day Washout Period||2
1078644|NCT00960570|2613709|P1|COMPLETED|21 Day Washout Period||28
1078645|NCT00960570|2613709|P1|STARTED|21 Day Washout Period||30
1078646|NCT00960570|2613709|P1|NOT COMPLETED|Efavirenz Alone||0
1078647|NCT00960570|2613709|P1|COMPLETED|Efavirenz Alone||30
1078648|NCT00960570|2613709|P1|STARTED|Efavirenz Alone||30
1078649|NCT00960622|2613722|P2|NOT COMPLETED|Overall Study||3
1078650|NCT00960622|2613723|P1|NOT COMPLETED|Overall Study||0
1078651|NCT00960622|2613722|P2|COMPLETED|Overall Study||7
1078652|NCT00960622|2613723|P1|COMPLETED|Overall Study||10
1078653|NCT00960622|2613722|P2|STARTED|Overall Study||10
1078654|NCT00960622|2613723|P1|STARTED|Overall Study||10
1078655|NCT00960661|2613731|P3|NOT COMPLETED|Interventional Phase||46
1078656|NCT00960661|2613732|P2|NOT COMPLETED|Interventional Phase||52
1078657|NCT00960661|2613733|P1|NOT COMPLETED|Interventional Phase||0
1078658|NCT00960661|2613731|P3|COMPLETED|Interventional Phase||275
1078659|NCT00960661|2613732|P2|COMPLETED|Interventional Phase||264
1078660|NCT00960661|2613733|P1|COMPLETED|Interventional Phase||0
1078661|NCT00960661|2613731|P3|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|263
1078662|NCT00960661|2613732|P2|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|247
1078663|NCT00960661|2613733|P1|Per Protocol Population|Interventional Phase||0
1078664|NCT00960661|2613731|P3|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|312
1078665|NCT00960661|2613732|P2|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|315
1078666|NCT00960661|2613733|P1|Intent to Treat Population|Interventional Phase||0
1078667|NCT00960661|2613731|P3|STARTED|Interventional Phase||321
1078668|NCT00960661|2613732|P2|STARTED|Interventional Phase||316
1078669|NCT00960661|2613733|P1|STARTED|Interventional Phase||0
1078670|NCT00960661|2613731|P3|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
1078671|NCT00960661|2613732|P2|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
1078672|NCT00960661|2613733|P1|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||399
1078673|NCT00960661|2613731|P3|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
1078674|NCT00960661|2613732|P2|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
1078675|NCT00960661|2613733|P1|COMPLETED|Basal Insulin Optimization Phase (BIO)||637
1078676|NCT00960661|2613731|P3|STARTED|Basal Insulin Optimization Phase (BIO)||0
1078677|NCT00960661|2613732|P2|STARTED|Basal Insulin Optimization Phase (BIO)||0
1078678|NCT00960661|2613733|P1|STARTED|Basal Insulin Optimization Phase (BIO)||1036
1078679|NCT00960687|2613763|P2|NOT COMPLETED|Second Intervention||0
1078680|NCT00960687|2613764|P1|NOT COMPLETED|Second Intervention||0
1078681|NCT00960687|2613763|P2|COMPLETED|Second Intervention||24
1078682|NCT00960687|2613764|P1|COMPLETED|Second Intervention||23
1078683|NCT00960687|2613763|P2|STARTED|Second Intervention||24
1078684|NCT00960687|2613764|P1|STARTED|Second Intervention||23
1078685|NCT00960687|2613763|P2|NOT COMPLETED|Washout Period of 7 Days||3
1078686|NCT00960687|2613764|P1|NOT COMPLETED|Washout Period of 7 Days||4
1078687|NCT00960687|2613763|P2|COMPLETED|Washout Period of 7 Days|two subjects withdrew due to adverse events and one subject withdrew for personal reasons.|24
1078688|NCT00960687|2613764|P1|COMPLETED|Washout Period of 7 Days|three subjects withdrew due to adverse events and one subject withdrew for personal reasons.|23
1078689|NCT00960687|2613763|P2|STARTED|Washout Period of 7 Days||27
1078690|NCT00960687|2613764|P1|STARTED|Washout Period of 7 Days||27
1078691|NCT00960687|2613763|P2|NOT COMPLETED|First Intervention||0
1078692|NCT00960687|2613764|P1|NOT COMPLETED|First Intervention||0
1078693|NCT00960687|2613763|P2|COMPLETED|First Intervention||27
1078694|NCT00960687|2613764|P1|COMPLETED|First Intervention||27
1078695|NCT00960687|2613763|P2|STARTED|First Intervention||27
1078696|NCT00960687|2613764|P1|STARTED|First Intervention||27
1078697|NCT00960843|2613776|P2|NOT COMPLETED|Overall Study||5
1078698|NCT00960843|2613777|P1|NOT COMPLETED|Overall Study||2
1078699|NCT00960843|2613776|P2|COMPLETED|Overall Study||21
1078700|NCT00960843|2613777|P1|COMPLETED|Overall Study||23
1078701|NCT00960843|2613776|P2|STARTED|Overall Study||26
1078702|NCT00960843|2613777|P1|STARTED|Overall Study||25
1078703|NCT00960856|2613787|P4|NOT COMPLETED|Period IV||0
1078704|NCT00960856|2613788|P3|NOT COMPLETED|Period IV||0
1078705|NCT00960856|2613789|P2|NOT COMPLETED|Period IV||0
1078706|NCT00960856|2613790|P1|NOT COMPLETED|Period IV||0
1078707|NCT00960856|2613787|P4|COMPLETED|Period IV||9
1078708|NCT00960856|2613788|P3|COMPLETED|Period IV||8
1078709|NCT00960856|2613789|P2|COMPLETED|Period IV||7
1078710|NCT00960856|2613790|P1|COMPLETED|Period IV||10
1078711|NCT00960856|2613787|P4|STARTED|Period IV||9
1078712|NCT00960856|2613788|P3|STARTED|Period IV||8
1078713|NCT00960856|2613789|P2|STARTED|Period IV||7
1078714|NCT00960856|2613790|P1|STARTED|Period IV||10
1078715|NCT00960856|2613787|P4|NOT COMPLETED|Washout Period of 7 Days||0
1078716|NCT00960856|2613788|P3|NOT COMPLETED|Washout Period of 7 Days||1
1078717|NCT00960856|2613789|P2|NOT COMPLETED|Washout Period of 7 Days||0
1078718|NCT00960856|2613790|P1|NOT COMPLETED|Washout Period of 7 Days||0
1078719|NCT00960856|2613787|P4|COMPLETED|Washout Period of 7 Days||9
1078720|NCT00960856|2613788|P3|COMPLETED|Washout Period of 7 Days||8
1078721|NCT00960856|2613789|P2|COMPLETED|Washout Period of 7 Days||7
1078722|NCT00960856|2613790|P1|COMPLETED|Washout Period of 7 Days||10
1078723|NCT00960856|2613787|P4|STARTED|Washout Period of 7 Days||9
1078724|NCT00960856|2613788|P3|STARTED|Washout Period of 7 Days||9
1078725|NCT00960856|2613789|P2|STARTED|Washout Period of 7 Days||7
1078726|NCT00960856|2613790|P1|STARTED|Washout Period of 7 Days||10
1078727|NCT00960856|2613787|P4|NOT COMPLETED|Period III||0
1078728|NCT00960856|2613788|P3|NOT COMPLETED|Period III||0
1078729|NCT00960856|2613789|P2|NOT COMPLETED|Period III||0
1078730|NCT00960856|2613790|P1|NOT COMPLETED|Period III||0
1078731|NCT00960856|2613787|P4|COMPLETED|Period III||9
1078732|NCT00960856|2613788|P3|COMPLETED|Period III||9
1078733|NCT00960856|2613789|P2|COMPLETED|Period III||7
1078734|NCT00960856|2613790|P1|COMPLETED|Period III||10
1078735|NCT00960856|2613787|P4|STARTED|Period III||9
1078736|NCT00960856|2613788|P3|STARTED|Period III||9
1078737|NCT00960856|2613789|P2|STARTED|Period III||7
1078738|NCT00960856|2613790|P1|STARTED|Period III||10
1078739|NCT00960856|2613787|P4|NOT COMPLETED|Washout Period of 7 Days||0
1078740|NCT00960856|2613788|P3|NOT COMPLETED|Washout Period of 7 Days||0
1078741|NCT00960856|2613789|P2|NOT COMPLETED|Washout Period of 7 Days||0
1078742|NCT00960856|2613790|P1|NOT COMPLETED|Washout Period of 7 Days||0
1078743|NCT00960856|2613787|P4|COMPLETED|Washout Period of 7 Days||9
1078744|NCT00960856|2613788|P3|COMPLETED|Washout Period of 7 Days||9
1078745|NCT00960856|2613789|P2|COMPLETED|Washout Period of 7 Days||7
1078746|NCT00960856|2613790|P1|COMPLETED|Washout Period of 7 Days||10
1078747|NCT00960856|2613787|P4|STARTED|Washout Period of 7 Days||9
1078748|NCT00960856|2613788|P3|STARTED|Washout Period of 7 Days||9
1078749|NCT00960856|2613789|P2|STARTED|Washout Period of 7 Days||7
1078750|NCT00960856|2613790|P1|STARTED|Washout Period of 7 Days||10
1078751|NCT00960856|2613787|P4|NOT COMPLETED|Period II||0
1078752|NCT00960856|2613788|P3|NOT COMPLETED|Period II||0
1078753|NCT00960856|2613789|P2|NOT COMPLETED|Period II||0
1078754|NCT00960856|2613790|P1|NOT COMPLETED|Period II||0
1078755|NCT00960856|2613787|P4|COMPLETED|Period II||9
1078756|NCT00960856|2613788|P3|COMPLETED|Period II||9
1078757|NCT00960856|2613789|P2|COMPLETED|Period II||7
1078758|NCT00960856|2613790|P1|COMPLETED|Period II||10
1078759|NCT00960856|2613787|P4|STARTED|Period II||9
1078760|NCT00960856|2613788|P3|STARTED|Period II||9
1078761|NCT00960856|2613789|P2|STARTED|Period II||7
1078762|NCT00960856|2613790|P1|STARTED|Period II||10
1078763|NCT00960856|2613787|P4|NOT COMPLETED|Washout Period of 7 Days||0
1078764|NCT00960856|2613788|P3|NOT COMPLETED|Washout Period of 7 Days||0
1078765|NCT00960856|2613789|P2|NOT COMPLETED|Washout Period of 7 Days||2
1078766|NCT00960856|2613790|P1|NOT COMPLETED|Washout Period of 7 Days||0
1078767|NCT00960856|2613787|P4|COMPLETED|Washout Period of 7 Days||9
1078768|NCT00960856|2613788|P3|COMPLETED|Washout Period of 7 Days||9
1078769|NCT00960856|2613789|P2|COMPLETED|Washout Period of 7 Days|personal reasons|7
1078770|NCT00960856|2613790|P1|COMPLETED|Washout Period of 7 Days||10
1078771|NCT00960856|2613787|P4|STARTED|Washout Period of 7 Days||9
1078772|NCT00960856|2613788|P3|STARTED|Washout Period of 7 Days||9
1078773|NCT00960856|2613789|P2|STARTED|Washout Period of 7 Days||9
1078774|NCT00960856|2613790|P1|STARTED|Washout Period of 7 Days||10
1078775|NCT00960856|2613787|P4|NOT COMPLETED|Period I||0
1078776|NCT00960856|2613788|P3|NOT COMPLETED|Period I||0
1078777|NCT00960856|2613789|P2|NOT COMPLETED|Period I||0
1078778|NCT00960856|2613790|P1|NOT COMPLETED|Period I||0
1078779|NCT00960856|2613787|P4|COMPLETED|Period I||9
1078780|NCT00960856|2613788|P3|COMPLETED|Period I||9
1078781|NCT00960856|2613789|P2|COMPLETED|Period I||9
1078782|NCT00960856|2613790|P1|COMPLETED|Period I||10
1078783|NCT00960856|2613787|P4|STARTED|Period I||9
1078784|NCT00960856|2613788|P3|STARTED|Period I||9
1078785|NCT00960856|2613789|P2|STARTED|Period I||9
1078786|NCT00960856|2613790|P1|STARTED|Period I||10
1078787|NCT00960869|2613810|P2|NOT COMPLETED|Overall Study||62
1078788|NCT00960869|2613811|P1|NOT COMPLETED|Overall Study||53
1078789|NCT00960869|2613810|P2|COMPLETED|Overall Study||198
1078790|NCT00960869|2613811|P1|COMPLETED|Overall Study||206
1078791|NCT00960869|2613810|P2|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|259
1078792|NCT00960869|2613811|P1|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|257
1078793|NCT00960869|2613810|P2|Intent-to-Treat Population (ITT)|Overall Study||260
1078794|NCT00960869|2613811|P1|Intent-to-Treat Population (ITT)|Overall Study||259
1078795|NCT00960869|2613810|P2|STARTED|Overall Study||260
1078796|NCT00960869|2613811|P1|STARTED|Overall Study||259
1078797|NCT00960934|2613831|P6|NOT COMPLETED|Overall Study||64
1078798|NCT00960934|2613832|P5|NOT COMPLETED|Overall Study||64
1078799|NCT00960934|2613833|P4|NOT COMPLETED|Overall Study||64
1078800|NCT00960934|2613834|P3|NOT COMPLETED|Overall Study||64
1078801|NCT00960934|2613835|P2|NOT COMPLETED|Overall Study||63
1078802|NCT00960934|2613836|P1|NOT COMPLETED|Overall Study||64
1078803|NCT00960934|2613831|P6|COMPLETED|Overall Study||0
1078804|NCT00960934|2613832|P5|COMPLETED|Overall Study||0
1078805|NCT00960934|2613833|P4|COMPLETED|Overall Study||0
1078806|NCT00960934|2613834|P3|COMPLETED|Overall Study||0
1078807|NCT00960934|2613835|P2|COMPLETED|Overall Study||0
1078808|NCT00960934|2613836|P1|COMPLETED|Overall Study||0
1078809|NCT00960934|2613831|P6|Number Treated|Overall Study|1 participant was randomized but not treated|63
1078810|NCT00960934|2613832|P5|Number Treated|Overall Study|1 participant was randomized but not treated|63
1078811|NCT00960934|2613833|P4|Number Treated|Overall Study||64
1078812|NCT00960934|2613834|P3|Number Treated|Overall Study||64
1078813|NCT00960934|2613835|P2|Number Treated|Overall Study|1 participant was randomized but not treated|62
1078814|NCT00960934|2613836|P1|Number Treated|Overall Study||64
1078815|NCT00960934|2613831|P6|STARTED|Overall Study||64
1078816|NCT00960934|2613832|P5|STARTED|Overall Study||64
1078817|NCT00960934|2613833|P4|STARTED|Overall Study||64
1078818|NCT00960934|2613834|P3|STARTED|Overall Study||64
1078819|NCT00960934|2613835|P2|STARTED|Overall Study||63
1078820|NCT00960934|2613836|P1|STARTED|Overall Study||64
1078821|NCT00960986|2613950|P4|NOT COMPLETED|Period 3 (7-week Therapy Period)||25
1078822|NCT00960986|2613951|P3|NOT COMPLETED|Period 3 (7-week Therapy Period)||20
1078823|NCT00960986|2613952|P2|NOT COMPLETED|Period 3 (7-week Therapy Period)||23
1078824|NCT00960986|2613953|P1|NOT COMPLETED|Period 3 (7-week Therapy Period)||30
1078825|NCT00960986|2613950|P4|COMPLETED|Period 3 (7-week Therapy Period)||36
1078826|NCT00960986|2613951|P3|COMPLETED|Period 3 (7-week Therapy Period)||39
1078827|NCT00960986|2613952|P2|COMPLETED|Period 3 (7-week Therapy Period)||36
1078828|NCT00960986|2613953|P1|COMPLETED|Period 3 (7-week Therapy Period)||26
1078829|NCT00960986|2613950|P4|STARTED|Period 3 (7-week Therapy Period)||61
1078830|NCT00960986|2613951|P3|STARTED|Period 3 (7-week Therapy Period)||59
1078831|NCT00960986|2613952|P2|STARTED|Period 3 (7-week Therapy Period)||59
1078832|NCT00960986|2613953|P1|STARTED|Period 3 (7-week Therapy Period)||56
1078833|NCT00960986|2613950|P4|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
1078834|NCT00960986|2613951|P3|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
1078835|NCT00960986|2613952|P2|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
1078836|NCT00960986|2613953|P1|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
1078837|NCT00960986|2613950|P4|COMPLETED|Period 2 (1-week Initial Dosing Period)||61
1078838|NCT00960986|2613951|P3|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
1078839|NCT00960986|2613952|P2|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
1078840|NCT00960986|2613953|P1|COMPLETED|Period 2 (1-week Initial Dosing Period)||56
1078841|NCT00960986|2613950|P4|STARTED|Period 2 (1-week Initial Dosing Period)||61
1078926|NCT00968201|2614220|P2|COMPLETED|Base Study - (Period II)||0
1078842|NCT00960986|2613951|P3|STARTED|Period 2 (1-week Initial Dosing Period)||59
1078843|NCT00960986|2613952|P2|STARTED|Period 2 (1-week Initial Dosing Period)||59
1078844|NCT00960986|2613953|P1|STARTED|Period 2 (1-week Initial Dosing Period)||56
1078845|NCT00960986|2613950|P4|NOT COMPLETED|Period 1 (Screening and Washout)||3
1078846|NCT00960986|2613951|P3|NOT COMPLETED|Period 1 (Screening and Washout)||4
1078847|NCT00960986|2613952|P2|NOT COMPLETED|Period 1 (Screening and Washout)||4
1078848|NCT00960986|2613953|P1|NOT COMPLETED|Period 1 (Screening and Washout)||3
1078849|NCT00960986|2613950|P4|COMPLETED|Period 1 (Screening and Washout)||61
1078850|NCT00960986|2613951|P3|COMPLETED|Period 1 (Screening and Washout)||59
1078851|NCT00960986|2613952|P2|COMPLETED|Period 1 (Screening and Washout)||59
1078852|NCT00960986|2613953|P1|COMPLETED|Period 1 (Screening and Washout)||56
1078853|NCT00960986|2613950|P4|STARTED|Period 1 (Screening and Washout)||64
1078854|NCT00960986|2613951|P3|STARTED|Period 1 (Screening and Washout)||63
1078855|NCT00960986|2613952|P2|STARTED|Period 1 (Screening and Washout)||63
1078856|NCT00960986|2613953|P1|STARTED|Period 1 (Screening and Washout)||59
1078857|NCT00960999|2614025|P2|NOT COMPLETED|Overall Study||2
1078858|NCT00960999|2614026|P1|NOT COMPLETED|Overall Study||8
1078859|NCT00960999|2614025|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|45
1078860|NCT00960999|2614026|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|39
1078861|NCT00960999|2614025|P2|STARTED|Overall Study||47
1078862|NCT00960999|2614026|P1|STARTED|Overall Study||47
1078863|NCT00961051|2614034|P2|NOT COMPLETED|Overall Study||14
1078864|NCT00961051|2614035|P1|NOT COMPLETED|Overall Study||12
1078865|NCT00961051|2614034|P2|COMPLETED|Overall Study||79
1078866|NCT00961051|2614035|P1|COMPLETED|Overall Study||165
1078867|NCT00961051|2614034|P2|STARTED|Overall Study||93
1078868|NCT00961051|2614035|P1|STARTED|Overall Study||177
1078869|NCT00966992|2614045|P2|NOT COMPLETED|Overall Study||0
1078870|NCT00966992|2614046|P1|NOT COMPLETED|Overall Study||0
1078871|NCT00966992|2614045|P2|COMPLETED|Overall Study||0
1078872|NCT00966992|2614046|P1|COMPLETED|Overall Study||3
1078873|NCT00966992|2614045|P2|STARTED|Overall Study||0
1078874|NCT00966992|2614046|P1|STARTED|Overall Study||3
1078875|NCT00967005|2614064|P2|NOT COMPLETED|Overall Study||10
1078876|NCT00967005|2614065|P1|NOT COMPLETED|Overall Study||7
1078877|NCT00967005|2614064|P2|COMPLETED|Overall Study||5
1078878|NCT00967005|2614065|P1|COMPLETED|Overall Study||6
1078879|NCT00967005|2614064|P2|Treatment Completion|Overall Study||10
1078880|NCT00967005|2614065|P1|Treatment Completion|Overall Study||10
1078881|NCT00967005|2614064|P2|STARTED|Overall Study||15
1078882|NCT00967005|2614065|P1|STARTED|Overall Study||13
1078883|NCT00967018|2614117|P1|NOT COMPLETED|Overall Study||21
1078884|NCT00967018|2614117|P1|COMPLETED|Overall Study||56
1078885|NCT00967018|2614117|P1|STARTED|Overall Study||77
1078886|NCT00967044|2614124|P1|NOT COMPLETED|Overall Study||0
1078887|NCT00967044|2614124|P1|COMPLETED|Overall Study||30
1078888|NCT00967044|2614124|P1|STARTED|Overall Study||30
1078889|NCT00967226|2614130|P2|NOT COMPLETED|Overall Study||6
1078890|NCT00967226|2614131|P1|NOT COMPLETED|Overall Study||2
1078891|NCT00967226|2614130|P2|COMPLETED|Overall Study||2
1078892|NCT00967226|2614131|P1|COMPLETED|Overall Study||9
1078893|NCT00967226|2614130|P2|STARTED|Overall Study||8
1078894|NCT00967226|2614131|P1|STARTED|Overall Study||11
1078895|NCT00967993|2614161|P1|NOT COMPLETED|Overall Study||4
1078896|NCT00967993|2614161|P1|COMPLETED|Overall Study||18
1078897|NCT00967993|2614161|P1|STARTED|Overall Study||22
1078898|NCT00968019|2614165|P1|NOT COMPLETED|Overall Study||15
1078899|NCT00968019|2614165|P1|COMPLETED|Overall Study||303
1078900|NCT00968019|2614165|P1|STARTED|Overall Study||318
1078901|NCT00968032|2614186|P1|NOT COMPLETED|Overall Study||2
1078902|NCT00968032|2614186|P1|COMPLETED|Overall Study|"1 patient not receiving investigational device due to failure in usage
1 patient denied latest FU"|61
1078903|NCT00968032|2614186|P1|STARTED|Overall Study||63
1078904|NCT00968071|2614190|P1|NOT COMPLETED|Overall Study||0
1078905|NCT00968071|2614190|P1|COMPLETED|Overall Study||71
1078906|NCT00968071|2614190|P1|STARTED|Overall Study||71
1078907|NCT00968149|2614196|P2|NOT COMPLETED|Overall Study||6
1078908|NCT00968149|2614197|P1|NOT COMPLETED|Overall Study||11
1078909|NCT00968149|2614196|P2|COMPLETED|Overall Study||127
1078910|NCT00968149|2614197|P1|COMPLETED|Overall Study||269
1078911|NCT00968149|2614196|P2|STARTED|Overall Study||133
1078912|NCT00968149|2614197|P1|STARTED|Overall Study||280
1078913|NCT00968201|2614219|P3|NOT COMPLETED|Extension Study - (Period III)||280
1078914|NCT00968201|2614220|P2|NOT COMPLETED|Extension Study - (Period III)||124
1078915|NCT00968201|2614221|P1|NOT COMPLETED|Extension Study - (Period III)||0
1078916|NCT00968201|2614219|P3|COMPLETED|Extension Study - (Period III)||84
1078917|NCT00968201|2614220|P2|COMPLETED|Extension Study - (Period III)||33
1078918|NCT00968201|2614221|P1|COMPLETED|Extension Study - (Period III)||0
1078919|NCT00968201|2614219|P3|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|364
1078920|NCT00968201|2614220|P2|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|157
1078921|NCT00968201|2614221|P1|STARTED|Extension Study - (Period III)||0
1078922|NCT00968201|2614219|P3|NOT COMPLETED|Base Study - (Period II)||45
1078923|NCT00968201|2614220|P2|NOT COMPLETED|Base Study - (Period II)||0
1078924|NCT00968201|2614221|P1|NOT COMPLETED|Base Study - (Period II)||26
1078925|NCT00968201|2614219|P3|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|416
1078927|NCT00968201|2614221|P1|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|202
1078928|NCT00968201|2614219|P3|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to montelukast.|461
1078929|NCT00968201|2614220|P2|STARTED|Base Study - (Period II)||0
1078930|NCT00968201|2614221|P1|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to placebo.|228
1078931|NCT00968227|2614280|P1|NOT COMPLETED|Overall Study||0
1078932|NCT00968227|2614280|P1|COMPLETED|Overall Study||56
1078933|NCT00968227|2614280|P1|STARTED|Overall Study||56
1078934|NCT00968617|2614285|P1|NOT COMPLETED|Overall Study||6
1078935|NCT00968617|2614285|P1|COMPLETED|Overall Study||1
1078936|NCT00968617|2614285|P1|STARTED|Overall Study||7
1078937|NCT00968669|2614301|P4|NOT COMPLETED|Overall Study||9
1078938|NCT00968669|2614302|P3|NOT COMPLETED|Overall Study||11
1078939|NCT00968669|2614303|P2|NOT COMPLETED|Overall Study||18
1078940|NCT00968669|2614304|P1|NOT COMPLETED|Overall Study||18
1078941|NCT00968669|2614301|P4|COMPLETED|Overall Study||72
1078942|NCT00968669|2614302|P3|COMPLETED|Overall Study||72
1078943|NCT00968669|2614303|P2|COMPLETED|Overall Study||63
1078944|NCT00968669|2614304|P1|COMPLETED|Overall Study||64
1078945|NCT00968669|2614301|P4|STARTED|Overall Study||81
1078946|NCT00968669|2614302|P3|STARTED|Overall Study||83
1078947|NCT00968669|2614303|P2|STARTED|Overall Study||81
1078948|NCT00968669|2614304|P1|STARTED|Overall Study||82
1078949|NCT00968708|2614396|P2|NOT COMPLETED|Overall Study||298
1078950|NCT00968708|2614397|P1|NOT COMPLETED|Overall Study||318
1078951|NCT00968708|2614396|P2|COMPLETED|Overall Study||2403
1078952|NCT00968708|2614397|P1|COMPLETED|Overall Study||2361
1078953|NCT00968708|2614396|P2|Treated|Overall Study||2698
1078954|NCT00968708|2614397|P1|Treated|Overall Study||2676
1078955|NCT00968708|2614396|P2|STARTED|Overall Study||2701
1078956|NCT00968708|2614397|P1|STARTED|Overall Study||2679
1078957|NCT00968799|2614405|P1|NOT COMPLETED|Overall Study||2
1078958|NCT00968799|2614405|P1|COMPLETED|Overall Study||4
1078959|NCT00968799|2614405|P1|STARTED|Overall Study||6
1078960|NCT00968812|2614416|P3|NOT COMPLETED|Overall Study||168
1078961|NCT00968812|2614417|P2|NOT COMPLETED|Overall Study||162
1078962|NCT00968812|2614418|P1|NOT COMPLETED|Overall Study||140
1078963|NCT00968812|2614416|P3|COMPLETED|Overall Study||314
1078964|NCT00968812|2614417|P2|COMPLETED|Overall Study||323
1078965|NCT00968812|2614418|P1|COMPLETED|Overall Study||343
1078966|NCT00968812|2614416|P3|STARTED|Overall Study||482
1078967|NCT00968812|2614417|P2|STARTED|Overall Study||485
1078968|NCT00968812|2614418|P1|STARTED|Overall Study||483
1078969|NCT00968838|2614440|P2|NOT COMPLETED|Overall Study||0
1078970|NCT00968838|2614441|P1|NOT COMPLETED|Overall Study||0
1078971|NCT00968838|2614440|P2|COMPLETED|Overall Study||58
1078972|NCT00968838|2614441|P1|COMPLETED|Overall Study||50
1078973|NCT00968838|2614440|P2|STARTED|Overall Study||58
1078974|NCT00968838|2614441|P1|STARTED|Overall Study||50
1078975|NCT00968890|2614449|P2|NOT COMPLETED|Overall Study||0
1078976|NCT00968890|2614450|P1|NOT COMPLETED|Overall Study||0
1078977|NCT00968890|2614449|P2|COMPLETED|Overall Study||84
1078978|NCT00968890|2614450|P1|COMPLETED|Overall Study||84
1078979|NCT00968890|2614449|P2|STARTED|Overall Study||84
1078980|NCT00968890|2614450|P1|STARTED|Overall Study||84
1078981|NCT00968981|2614481|P3|NOT COMPLETED|Overall Study||22
1078982|NCT00968981|2614482|P2|NOT COMPLETED|Overall Study||22
1078983|NCT00968981|2614483|P1|NOT COMPLETED|Overall Study||22
1078984|NCT00968981|2614481|P3|COMPLETED|Overall Study||0
1078985|NCT00968981|2614482|P2|COMPLETED|Overall Study||0
1078986|NCT00968981|2614483|P1|COMPLETED|Overall Study||1
1078987|NCT00968981|2614481|P3|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|22
1078988|NCT00968981|2614482|P2|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|21
1078989|NCT00968981|2614483|P1|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|20
1078990|NCT00968981|2614481|P3|STARTED|Overall Study||22
1078991|NCT00968981|2614482|P2|STARTED|Overall Study||22
1078992|NCT00968981|2614483|P1|STARTED|Overall Study||23
1078993|NCT00969124|2614519|P1|NOT COMPLETED|Overall Study||30
1078994|NCT00969124|2614519|P1|COMPLETED|Overall Study||298
1078995|NCT00969124|2614519|P1|STARTED|Overall Study||328
1078996|NCT00969150|2614527|P2|NOT COMPLETED|Overall Study||40
1078997|NCT00969150|2614528|P1|NOT COMPLETED|Overall Study||33
1078998|NCT00969150|2614527|P2|COMPLETED|Overall Study||135
1078999|NCT00969150|2614528|P1|COMPLETED|Overall Study||149
1079000|NCT00969150|2614527|P2|STARTED|Overall Study||175
1079001|NCT00969150|2614528|P1|STARTED|Overall Study||182
1079002|NCT00969228|2614538|P2|NOT COMPLETED|Overall Study||14
1079003|NCT00969228|2614539|P1|NOT COMPLETED|Overall Study||43
1079004|NCT00969228|2614538|P2|COMPLETED|Overall Study||162
1079005|NCT00969228|2614539|P1|COMPLETED|Overall Study||465
1079006|NCT00969228|2614538|P2|STARTED|Overall Study||176
1079007|NCT00969228|2614539|P1|STARTED|Overall Study||508
1079008|NCT00969280|2614557|P2|NOT COMPLETED|Overall Study||3
1079009|NCT00969280|2614558|P1|NOT COMPLETED|Overall Study||2
1079010|NCT00969280|2614557|P2|COMPLETED|Overall Study||18
1079011|NCT00969280|2614558|P1|COMPLETED|Overall Study||19
1079012|NCT00969280|2614557|P2|STARTED|Overall Study||21
1079013|NCT00969280|2614558|P1|STARTED|Overall Study||21
1079014|NCT00969436|2614567|P3|NOT COMPLETED|Overall Study||11
1079015|NCT00969436|2614568|P2|NOT COMPLETED|Overall Study||21
1079016|NCT00969436|2614569|P1|NOT COMPLETED|Overall Study||25
1079017|NCT00969436|2614567|P3|COMPLETED|Overall Study||79
1079018|NCT00969436|2614568|P2|COMPLETED|Overall Study||159
1079019|NCT00969436|2614569|P1|COMPLETED|Overall Study||155
1079020|NCT00969436|2614567|P3|STARTED|Overall Study||90
1079021|NCT00969436|2614568|P2|STARTED|Overall Study||180
1079022|NCT00969436|2614569|P1|STARTED|Overall Study||180
1079023|NCT00969501|2614601|P1|NOT COMPLETED|Overall Study||5
1079024|NCT00969501|2614601|P1|COMPLETED|Overall Study||27
1079025|NCT00969501|2614601|P1|STARTED|Overall Study||32
1079026|NCT00969540|2614607|P2|NOT COMPLETED|Overall Study||1
1079027|NCT00969540|2614608|P1|NOT COMPLETED|Overall Study||1
1079028|NCT00969540|2614607|P2|COMPLETED|Overall Study||3
1079029|NCT00969540|2614608|P1|COMPLETED|Overall Study||3
1079030|NCT00969540|2614607|P2|STARTED|Overall Study||4
1079031|NCT00969540|2614608|P1|STARTED|Overall Study||4
1079032|NCT00969618|2614626|P1|NOT COMPLETED|Overall Study||78
1079033|NCT00969618|2614626|P1|COMPLETED|Overall Study||133
1079034|NCT00969618|2614626|P1|STARTED|Overall Study||211
1079035|NCT00969709|2614641|P4|NOT COMPLETED|Overall Study||63
1079036|NCT00969709|2614642|P3|NOT COMPLETED|Overall Study||58
1079037|NCT00969709|2614643|P2|NOT COMPLETED|Overall Study||48
1079038|NCT00969709|2614644|P1|NOT COMPLETED|Overall Study||38
1079039|NCT00969709|2614641|P4|COMPLETED|Overall Study||117
1079040|NCT00969709|2614642|P3|COMPLETED|Overall Study||121
1079041|NCT00969709|2614643|P2|COMPLETED|Overall Study||130
1079042|NCT00969709|2614644|P1|COMPLETED|Overall Study||138
1079043|NCT00969709|2614641|P4|STARTED|Overall Study||180
1079044|NCT00969709|2614642|P3|STARTED|Overall Study||179
1079045|NCT00969709|2614643|P2|STARTED|Overall Study||178
1079046|NCT00969709|2614644|P1|STARTED|Overall Study||176
1079047|NCT00969878|2614660|P2|NOT COMPLETED|Overall Study||26
1079048|NCT00969878|2614661|P1|NOT COMPLETED|Overall Study||30
1079049|NCT00969878|2614660|P2|COMPLETED|Overall Study||126
1079050|NCT00969878|2614661|P1|COMPLETED|Overall Study||118
1079051|NCT00969878|2614660|P2|STARTED|Overall Study||152
1079052|NCT00969878|2614661|P1|STARTED|Overall Study||148
1079053|NCT00970216|2614669|P1|NOT COMPLETED|Overall Study||80
1079054|NCT00970216|2614669|P1|COMPLETED|Overall Study||80
1079055|NCT00970216|2614669|P1|STARTED|Overall Study||160
1079056|NCT00964028|2614675|P2|NOT COMPLETED|Overall Study||1
1079057|NCT00964028|2614676|P1|NOT COMPLETED|Overall Study||0
1079058|NCT00964028|2614675|P2|COMPLETED|Overall Study||24
1079059|NCT00964028|2614676|P1|COMPLETED|Overall Study||25
1079060|NCT00964028|2614675|P2|STARTED|Overall Study||25
1079061|NCT00964028|2614676|P1|STARTED|Overall Study||25
1079062|NCT00964119|2614688|P1|NOT COMPLETED|Overall Study||0
1079063|NCT00964119|2614688|P1|COMPLETED|Overall Study||15
1079064|NCT00964119|2614688|P1|STARTED|Overall Study||15
1079065|NCT00964223|2614692|P1|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||1
1079066|NCT00964223|2614692|P1|COMPLETED|Full Face Treatment (Weeks 5 and 8)||27
1079067|NCT00964223|2614692|P1|STARTED|Full Face Treatment (Weeks 5 and 8)||28
1079068|NCT00964223|2614692|P1|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
1079069|NCT00964223|2614692|P1|COMPLETED|Split Face Treatment (Weeks 1 and 2)||28
1079070|NCT00964223|2614692|P1|STARTED|Split Face Treatment (Weeks 1 and 2)||28
1079071|NCT00964366|2614759|P2|NOT COMPLETED|Overall Study||1
1079072|NCT00964366|2614760|P1|NOT COMPLETED|Overall Study||1
1079073|NCT00964366|2614759|P2|COMPLETED|Overall Study||24
1079074|NCT00964366|2614760|P1|COMPLETED|Overall Study||27
1079075|NCT00964366|2614759|P2|STARTED|Overall Study||25
1079076|NCT00964366|2614760|P1|STARTED|Overall Study|27 of the 28 enrolled were eligible after screening.|28
1079077|NCT00964392|2614776|P2|NOT COMPLETED|Overall Study||190
1079078|NCT00964392|2614777|P1|NOT COMPLETED|Overall Study||53
1079079|NCT00964392|2614776|P2|COMPLETED|Overall Study||92
1079080|NCT00964392|2614777|P1|COMPLETED|Overall Study||72
1079081|NCT00964392|2614776|P2|STARTED|Overall Study|Both safety and efficacy cohort: Total 292 (10 LEP Excluded)|282
1079082|NCT00964392|2614777|P1|STARTED|Overall Study|Both safety and efficacy cohort: Total 128 (3 MEP Excluded)|125
1079083|NCT00964431|2614789|P4|NOT COMPLETED|Overall Study||0
1079084|NCT00964431|2614790|P3|NOT COMPLETED|Overall Study||0
1079085|NCT00964431|2614791|P2|NOT COMPLETED|Overall Study||0
1079086|NCT00964431|2614792|P1|NOT COMPLETED|Overall Study||0
1079087|NCT00964431|2614789|P4|COMPLETED|Overall Study||51
1079088|NCT00964431|2614790|P3|COMPLETED|Overall Study||51
1079089|NCT00964431|2614791|P2|COMPLETED|Overall Study||51
1079090|NCT00964431|2614792|P1|COMPLETED|Overall Study||50
1079091|NCT00964431|2614789|P4|STARTED|Overall Study||51
1079092|NCT00964431|2614790|P3|STARTED|Overall Study||51
1079093|NCT00964431|2614791|P2|STARTED|Overall Study||51
1079094|NCT00964431|2614792|P1|STARTED|Overall Study||50
1079095|NCT00970268|2614804|P2|NOT COMPLETED|Overall Study||49
1079096|NCT00970268|2614805|P1|NOT COMPLETED|Overall Study||43
1079097|NCT00970268|2614804|P2|COMPLETED|Overall Study||103
1079098|NCT00970268|2614805|P1|COMPLETED|Overall Study||96
1079099|NCT00970268|2614804|P2|STARTED|Overall Study||152
1079100|NCT00970268|2614805|P1|STARTED|Overall Study||139
1079101|NCT00970281|2614821|P2|NOT COMPLETED|Overall Study||16
1079102|NCT00970281|2614822|P1|NOT COMPLETED|Overall Study||2
1079103|NCT00970281|2614821|P2|COMPLETED|Overall Study||29
1079104|NCT00970281|2614822|P1|COMPLETED|Overall Study||44
1079105|NCT00970281|2614821|P2|Full Analysis Set|Overall Study||45
1079106|NCT00970281|2614822|P1|Full Analysis Set|Overall Study|1 participant in the olanzapine arm discontinued before the first intramuscular (IM) injection.|45
1079107|NCT00970281|2614821|P2|STARTED|Overall Study||45
1079108|NCT00970281|2614822|P1|STARTED|Overall Study||46
1079109|NCT00970294|2614838|P1|NOT COMPLETED|Overall Study||5
1079110|NCT00970294|2614838|P1|COMPLETED|Overall Study||6
1079111|NCT00970294|2614838|P1|STARTED|Overall Study||11
1079112|NCT00970307|2614847|P3|NOT COMPLETED|Overall Study||2
1079113|NCT00970307|2614848|P2|NOT COMPLETED|Overall Study||3
1079114|NCT00970307|2614849|P1|NOT COMPLETED|Overall Study||3
1079115|NCT00970307|2614847|P3|COMPLETED|Overall Study||139
1079116|NCT00970307|2614848|P2|COMPLETED|Overall Study||136
1079117|NCT00970307|2614849|P1|COMPLETED|Overall Study||138
1079118|NCT00970307|2614847|P3|STARTED|Overall Study||141
1079119|NCT00970307|2614848|P2|STARTED|Overall Study||139
1079120|NCT00970307|2614849|P1|STARTED|Overall Study||141
1079121|NCT00970320|2614928|P5|NOT COMPLETED|Overall Study||540
1079122|NCT00970320|2614929|P4|NOT COMPLETED|Overall Study||14
1079123|NCT00970320|2614930|P3|NOT COMPLETED|Overall Study||13
1079124|NCT00970320|2614931|P2|NOT COMPLETED|Overall Study||11
1079125|NCT00970320|2614932|P1|NOT COMPLETED|Overall Study||0
1079126|NCT00970320|2614928|P5|COMPLETED|Overall Study||1031
1079127|NCT00970320|2614929|P4|COMPLETED|Overall Study||36
1079128|NCT00970320|2614930|P3|COMPLETED|Overall Study||35
1079129|NCT00970320|2614931|P2|COMPLETED|Overall Study||13
1079130|NCT00970320|2614932|P1|COMPLETED|Overall Study||25
1079131|NCT00970320|2614928|P5|STARTED|Overall Study||1571
1079132|NCT00970320|2614929|P4|STARTED|Overall Study||50
1079133|NCT00970320|2614930|P3|STARTED|Overall Study||48
1079134|NCT00970320|2614931|P2|STARTED|Overall Study||24
1079135|NCT00970320|2614932|P1|STARTED|Overall Study||25
1079136|NCT00970359|2614944|P1|NOT COMPLETED|Overall Study||4
1079137|NCT00970359|2614944|P1|COMPLETED|Overall Study||20
1079138|NCT00970359|2614944|P1|STARTED|Overall Study||24
1079139|NCT00970489|2614952|P2|NOT COMPLETED|Overall Study||41
1079140|NCT00970489|2614953|P1|NOT COMPLETED|Overall Study||54
1079141|NCT00970489|2614952|P2|COMPLETED|Overall Study||717
1079142|NCT00970489|2614953|P1|COMPLETED|Overall Study||704
1079143|NCT00970489|2614952|P2|STARTED|Overall Study||758
1079144|NCT00970489|2614953|P1|STARTED|Overall Study||758
1079145|NCT00970502|2614965|P1|NOT COMPLETED|Overall Study||1
1079146|NCT00970502|2614965|P1|COMPLETED|Overall Study||14
1079147|NCT00970502|2614965|P1|STARTED|Overall Study||15
1079148|NCT00970606|2614976|P2|NOT COMPLETED|Overall Study||0
1079149|NCT00970606|2614977|P1|NOT COMPLETED|Overall Study||0
1079150|NCT00970606|2614976|P2|COMPLETED|Overall Study||3
1079151|NCT00970606|2614977|P1|COMPLETED|Overall Study||4
1079152|NCT00970606|2614976|P2|STARTED|Overall Study||3
1079153|NCT00970606|2614977|P1|STARTED|Overall Study||4
1079154|NCT00970632|2614986|P3|NOT COMPLETED|Overall Study||18
1079155|NCT00970632|2614987|P2|NOT COMPLETED|Overall Study||15
1079156|NCT00970632|2614988|P1|NOT COMPLETED|Overall Study||24
1079157|NCT00970632|2614986|P3|COMPLETED|Overall Study||150
1079158|NCT00970632|2614987|P2|COMPLETED|Overall Study||156
1079159|NCT00970632|2614988|P1|COMPLETED|Overall Study||148
1079160|NCT00970632|2614986|P3|STARTED|Overall Study||168
1079161|NCT00970632|2614987|P2|STARTED|Overall Study||171
1079162|NCT00970632|2614988|P1|STARTED|Overall Study||172
1079163|NCT00970684|2615044|P1|NOT COMPLETED|Overall Study||10
1079164|NCT00970684|2615044|P1|COMPLETED|Overall Study||3
1079165|NCT00970684|2615044|P1|STARTED|Overall Study||13
1079166|NCT00970736|2615050|P1|NOT COMPLETED|Overall Study||2
1079167|NCT00970736|2615050|P1|COMPLETED|Overall Study||18
1079168|NCT00970736|2615050|P1|STARTED|Overall Study||20
1079169|NCT00970814|2615058|P2|NOT COMPLETED|Overall Study||14
1079170|NCT00970814|2615059|P1|NOT COMPLETED|Overall Study||8
1079171|NCT00970814|2615058|P2|COMPLETED|Overall Study||50
1079172|NCT00970814|2615059|P1|COMPLETED|Overall Study||58
1079173|NCT00970814|2615058|P2|STARTED|Overall Study||64
1079174|NCT00970814|2615059|P1|STARTED|Overall Study||66
1079175|NCT00970853|2615071|P2|NOT COMPLETED|Overall Study||0
1079176|NCT00970853|2615072|P1|NOT COMPLETED|Overall Study||0
1079177|NCT00970853|2615071|P2|COMPLETED|Overall Study||98
1079178|NCT00970853|2615072|P1|COMPLETED|Overall Study||89
1079179|NCT00970853|2615071|P2|STARTED|Overall Study||98
1079180|NCT00970853|2615072|P1|STARTED|Overall Study||89
1079181|NCT00970944|2615096|P2|NOT COMPLETED|Overall Study||2
1079182|NCT00970944|2615097|P1|NOT COMPLETED|Overall Study||1
1079183|NCT00970944|2615096|P2|COMPLETED|Overall Study||95
1079184|NCT00970944|2615097|P1|COMPLETED|Overall Study||86
1079185|NCT00970944|2615096|P2|STARTED|Overall Study||97
1079186|NCT00970944|2615097|P1|STARTED|Overall Study||87
1079187|NCT00971048|2615109|P4|NOT COMPLETED|Overall Study||2
1079188|NCT00971048|2615110|P3|NOT COMPLETED|Overall Study||1
1079189|NCT00971048|2615111|P2|NOT COMPLETED|Overall Study||2
1079190|NCT00971048|2615112|P1|NOT COMPLETED|Overall Study||1
1079191|NCT00971048|2615109|P4|COMPLETED|Overall Study||11
1079192|NCT00971048|2615110|P3|COMPLETED|Overall Study||11
1079193|NCT00971048|2615111|P2|COMPLETED|Overall Study||31
1079194|NCT00971048|2615112|P1|COMPLETED|Overall Study||29
1079195|NCT00971048|2615109|P4|STARTED|Overall Study||13
1079196|NCT00971048|2615110|P3|STARTED|Overall Study||12
1079197|NCT00971048|2615111|P2|STARTED|Overall Study||33
1079198|NCT00971048|2615112|P1|STARTED|Overall Study||30
1079199|NCT00971204|2615134|P1|NOT COMPLETED|Overall Study||24
1079200|NCT00971204|2615134|P1|COMPLETED|Overall Study|86 participants were treated and of these 86, 76 completed the study.|76
1079201|NCT00971204|2615134|P1|Treated|Overall Study||86
1079202|NCT00971204|2615134|P1|STARTED|Overall Study|100 enrolled participants|100
1079203|NCT00971243|2615143|P5|NOT COMPLETED|Open-label Period||6
1079204|NCT00971243|2615144|P4|NOT COMPLETED|Open-label Period||10
1079205|NCT00971243|2615145|P3|NOT COMPLETED|Open-label Period||5
1079206|NCT00971243|2615146|P2|NOT COMPLETED|Open-label Period||10
1079207|NCT00971243|2615147|P1|NOT COMPLETED|Open-label Period||8
1079208|NCT00971243|2615143|P5|COMPLETED|Open-label Period||64
1079209|NCT00971243|2615144|P4|COMPLETED|Open-label Period||64
1079210|NCT00971243|2615145|P3|COMPLETED|Open-label Period||66
1079211|NCT00971243|2615146|P2|COMPLETED|Open-label Period||71
1079212|NCT00971243|2615147|P1|COMPLETED|Open-label Period||60
1079213|NCT00971243|2615143|P5|STARTED|Open-label Period||70
1079214|NCT00971243|2615144|P4|STARTED|Open-label Period||74
1079215|NCT00971243|2615145|P3|STARTED|Open-label Period|One Subject did not entered the Open-label Period because of the withdrawal of consent.|71
1079216|NCT00971243|2615146|P2|STARTED|Open-label Period|One Subject did not entered because of the failure of inclusion/exclusion criteria.|81
1079217|NCT00971243|2615147|P1|STARTED|Open-label Period||68
1079218|NCT00971243|2615143|P5|NOT COMPLETED|Double Blind Period||18
1079219|NCT00971243|2615144|P4|NOT COMPLETED|Double Blind Period||14
1079220|NCT00971243|2615145|P3|NOT COMPLETED|Double Blind Period||19
1079221|NCT00971243|2615146|P2|NOT COMPLETED|Double Blind Period||11
1079222|NCT00971243|2615147|P1|NOT COMPLETED|Double Blind Period||19
1079223|NCT00971243|2615143|P5|COMPLETED|Double Blind Period||70
1079224|NCT00971243|2615144|P4|COMPLETED|Double Blind Period||74
1079225|NCT00971243|2615145|P3|COMPLETED|Double Blind Period||72
1079226|NCT00971243|2615146|P2|COMPLETED|Double Blind Period||82
1079227|NCT00971243|2615147|P1|COMPLETED|Double Blind Period||68
1079228|NCT00971243|2615143|P5|STARTED|Double Blind Period||88
1079229|NCT00971243|2615144|P4|STARTED|Double Blind Period|One subject who did not receive any study drug was excluded from the ITT|88
1079230|NCT00971243|2615145|P3|STARTED|Double Blind Period||91
1079231|NCT00971243|2615146|P2|STARTED|Double Blind Period||93
1079232|NCT00971243|2615147|P1|STARTED|Double Blind Period||87
1079233|NCT00971282|2615164|P1|NOT COMPLETED|Overall Study||0
1079234|NCT00971282|2615164|P1|COMPLETED|Overall Study||30
1079235|NCT00971282|2615164|P1|STARTED|Overall Study||30
1079236|NCT00971295|2615178|P2|NOT COMPLETED|Overall Study||1
1079237|NCT00971295|2615179|P1|NOT COMPLETED|Overall Study||0
1079238|NCT00971295|2615178|P2|COMPLETED|Overall Study||9
1079239|NCT00971295|2615179|P1|COMPLETED|Overall Study||10
1079240|NCT00971295|2615178|P2|STARTED|Overall Study||10
1079241|NCT00971295|2615179|P1|STARTED|Overall Study||10
1079242|NCT00971425|2615191|P2|NOT COMPLETED|Overall Study||2
1079243|NCT00971425|2615192|P1|NOT COMPLETED|Overall Study||1
1079244|NCT00971425|2615191|P2|COMPLETED|Overall Study||71
1079245|NCT00971425|2615192|P1|COMPLETED|Overall Study||71
1079246|NCT00971425|2615191|P2|STARTED|Overall Study||73
1079247|NCT00971425|2615192|P1|STARTED|Overall Study||72
1079248|NCT00971620|2615228|P2|NOT COMPLETED|Overall Study||0
1079249|NCT00971620|2615229|P1|NOT COMPLETED|Overall Study||0
1079250|NCT00971620|2615228|P2|COMPLETED|Overall Study||9
1079251|NCT00971620|2615229|P1|COMPLETED|Overall Study||9
1079252|NCT00971620|2615228|P2|STARTED|Overall Study||9
1079253|NCT00971620|2615229|P1|STARTED|Overall Study||9
1079254|NCT00971633|2615259|P6|NOT COMPLETED|Period 3||0
1079255|NCT00971633|2615260|P5|NOT COMPLETED|Period 3||0
1079256|NCT00971633|2615261|P4|NOT COMPLETED|Period 3||0
1079257|NCT00971633|2615262|P3|NOT COMPLETED|Period 3||0
1079258|NCT00971633|2615263|P2|NOT COMPLETED|Period 3||0
1079259|NCT00971633|2615264|P1|NOT COMPLETED|Period 3||0
1079260|NCT00971633|2615259|P6|COMPLETED|Period 3||2
1079261|NCT00971633|2615260|P5|COMPLETED|Period 3||2
1079262|NCT00971633|2615261|P4|COMPLETED|Period 3||2
1079263|NCT00971633|2615262|P3|COMPLETED|Period 3||2
1079264|NCT00971633|2615263|P2|COMPLETED|Period 3||2
1079265|NCT00971633|2615264|P1|COMPLETED|Period 3||2
1079266|NCT00971633|2615259|P6|STARTED|Period 3||2
1079267|NCT00971633|2615260|P5|STARTED|Period 3||2
1079268|NCT00971633|2615261|P4|STARTED|Period 3||2
1079269|NCT00971633|2615262|P3|STARTED|Period 3||2
1079270|NCT00971633|2615263|P2|STARTED|Period 3||2
1079271|NCT00971633|2615264|P1|STARTED|Period 3||2
1079272|NCT00971633|2615259|P6|NOT COMPLETED|Period 2||0
1079273|NCT00971633|2615260|P5|NOT COMPLETED|Period 2||0
1079274|NCT00971633|2615261|P4|NOT COMPLETED|Period 2||0
1079275|NCT00971633|2615262|P3|NOT COMPLETED|Period 2||0
1079276|NCT00971633|2615263|P2|NOT COMPLETED|Period 2||0
1079277|NCT00971633|2615264|P1|NOT COMPLETED|Period 2||0
1079278|NCT00971633|2615259|P6|COMPLETED|Period 2||2
1079279|NCT00971633|2615260|P5|COMPLETED|Period 2||2
1079280|NCT00971633|2615261|P4|COMPLETED|Period 2||2
1079281|NCT00971633|2615262|P3|COMPLETED|Period 2||2
1079282|NCT00971633|2615263|P2|COMPLETED|Period 2||2
1079283|NCT00971633|2615264|P1|COMPLETED|Period 2||2
1079284|NCT00971633|2615259|P6|STARTED|Period 2||2
1079285|NCT00971633|2615260|P5|STARTED|Period 2||2
1079286|NCT00971633|2615261|P4|STARTED|Period 2||2
1079287|NCT00971633|2615262|P3|STARTED|Period 2||2
1079288|NCT00971633|2615263|P2|STARTED|Period 2||2
1079289|NCT00971633|2615264|P1|STARTED|Period 2||2
1079290|NCT00971633|2615259|P6|NOT COMPLETED|Period 1||0
1079291|NCT00971633|2615260|P5|NOT COMPLETED|Period 1||0
1079292|NCT00971633|2615261|P4|NOT COMPLETED|Period 1||0
1079293|NCT00971633|2615262|P3|NOT COMPLETED|Period 1||0
1079294|NCT00971633|2615263|P2|NOT COMPLETED|Period 1||0
1079295|NCT00971633|2615264|P1|NOT COMPLETED|Period 1||0
1079296|NCT00971633|2615259|P6|COMPLETED|Period 1||2
1079297|NCT00971633|2615260|P5|COMPLETED|Period 1||2
1079298|NCT00971633|2615261|P4|COMPLETED|Period 1||2
1079299|NCT00971633|2615262|P3|COMPLETED|Period 1||2
1079300|NCT00971633|2615263|P2|COMPLETED|Period 1||2
1079301|NCT00971633|2615264|P1|COMPLETED|Period 1||2
1079302|NCT00971633|2615259|P6|STARTED|Period 1||2
1079303|NCT00971633|2615260|P5|STARTED|Period 1||2
1079304|NCT00971633|2615261|P4|STARTED|Period 1||2
1079305|NCT00971633|2615262|P3|STARTED|Period 1||2
1079306|NCT00971633|2615263|P2|STARTED|Period 1||2
1079307|NCT00971633|2615264|P1|STARTED|Period 1||2
1079308|NCT00971750|2615275|P1|NOT COMPLETED|Overall Study||0
1079309|NCT00971750|2615275|P1|COMPLETED|Overall Study||253
1079310|NCT00971750|2615275|P1|STARTED|Overall Study||253
1079311|NCT00971789|2615284|P1|NOT COMPLETED|Overall Study||0
1079312|NCT00971789|2615284|P1|COMPLETED|Overall Study||18
1079313|NCT00971789|2615284|P1|STARTED|Overall Study||18
1079314|NCT00971841|2615289|P1|NOT COMPLETED|Overall Study||0
1079315|NCT00971841|2615289|P1|COMPLETED|Overall Study||1
1079316|NCT00971841|2615289|P1|STARTED|Overall Study||1
1079317|NCT00971932|2615294|P1|NOT COMPLETED|Overall Study||7
1079318|NCT00971932|2615294|P1|COMPLETED|Overall Study||26
1079319|NCT00971932|2615294|P1|STARTED|Overall Study|Number of participants treated.|33
1079320|NCT00971997|2615304|P1|NOT COMPLETED|Overall Study||19
1079321|NCT00971997|2615304|P1|COMPLETED|Overall Study||116
1079322|NCT00971997|2615304|P1|STARTED|Overall Study||135
1079323|NCT00972023|2615322|P1|NOT COMPLETED|Overall Study||1
1079324|NCT00972023|2615322|P1|COMPLETED|Overall Study||0
1079325|NCT00972023|2615322|P1|STARTED|Overall Study||1
1079326|NCT00972088|2615329|P1|NOT COMPLETED|Overall Study||0
1079327|NCT00972088|2615329|P1|COMPLETED|Overall Study||26
1079328|NCT00972088|2615329|P1|STARTED|Overall Study||26
1079329|NCT00972153|2615336|P3|NOT COMPLETED|Overall Study||0
1079330|NCT00972153|2615337|P2|NOT COMPLETED|Overall Study||1
1079331|NCT00972153|2615338|P1|NOT COMPLETED|Overall Study||0
1079332|NCT00972153|2615336|P3|COMPLETED|Overall Study||12
1079333|NCT00972153|2615337|P2|COMPLETED|Overall Study|One case excluded due to technical problem with measuring equipment.|11
1079334|NCT00972153|2615338|P1|COMPLETED|Overall Study||12
1079335|NCT00972153|2615336|P3|STARTED|Overall Study||12
1079336|NCT00972153|2615337|P2|STARTED|Overall Study||12
1079337|NCT00972153|2615338|P1|STARTED|Overall Study||12
1079338|NCT00972205|2615349|P1|NOT COMPLETED|Overall Study||0
1079339|NCT00972205|2615349|P1|COMPLETED|Overall Study||12
1079340|NCT00972205|2615349|P1|STARTED|Overall Study||12
1079341|NCT00972244|2615361|P5|NOT COMPLETED|Overall Study||9
1079342|NCT00972244|2615362|P4|NOT COMPLETED|Overall Study||0
1079343|NCT00972244|2615363|P3|NOT COMPLETED|Overall Study||2
1079344|NCT00972244|2615364|P2|NOT COMPLETED|Overall Study||5
1079345|NCT00972244|2615365|P1|NOT COMPLETED|Overall Study||5
1079346|NCT00972244|2615361|P5|COMPLETED|Overall Study||45
1079347|NCT00972244|2615362|P4|COMPLETED|Overall Study||52
1079348|NCT00972244|2615363|P3|COMPLETED|Overall Study||56
1079349|NCT00972244|2615364|P2|COMPLETED|Overall Study||51
1079350|NCT00972244|2615365|P1|COMPLETED|Overall Study||54
1079351|NCT00972244|2615361|P5|STARTED|Overall Study||54
1079352|NCT00972244|2615362|P4|STARTED|Overall Study||52
1079353|NCT00972244|2615363|P3|STARTED|Overall Study||58
1079354|NCT00972244|2615364|P2|STARTED|Overall Study||56
1079355|NCT00972244|2615365|P1|STARTED|Overall Study||59
1079356|NCT00972283|2615389|P2|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||8
1079357|NCT00972283|2615390|P1|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||27
1079358|NCT00972283|2615389|P2|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||183
1079359|NCT00972283|2615390|P1|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||539
1079360|NCT00972283|2615389|P2|STARTED|Extension: Week 53 to 78 (NN1250-3667)|20 subjects did not continue into the extension from main trial|191
1079361|NCT00972283|2615390|P1|STARTED|Extension: Week 53 to 78 (NN1250-3667)|52 subjects did not continue into the extension from main trial|566
1079362|NCT00972283|2615389|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||40
1079363|NCT00972283|2615390|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||137
1079364|NCT00972283|2615389|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||211
1079365|NCT00972283|2615390|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||618
1079366|NCT00972283|2615389|P2|Exposed|Main: Week 0 to 52 (NN1250-3582)||251
1079367|NCT00972283|2615390|P1|Exposed|Main: Week 0 to 52 (NN1250-3582)|2 subjects were withdrawn prior to exposure to trial products|753
1079368|NCT00972283|2615389|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|3 subjects were excluded due to closure of a site|248
1079369|NCT00972283|2615390|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|11 subjects were excluded due to closure of a site|744
1079370|NCT00972283|2615389|P2|STARTED|Main: Week 0 to 52 (NN1250-3582)||251
1079371|NCT00972283|2615390|P1|STARTED|Main: Week 0 to 52 (NN1250-3582)||755
1079372|NCT00972322|2615414|P2|NOT COMPLETED|Overall Study||3
1079373|NCT00972322|2615415|P1|NOT COMPLETED|Overall Study||3
1079374|NCT00972322|2615414|P2|COMPLETED|Overall Study||25
1079375|NCT00972322|2615415|P1|COMPLETED|Overall Study||25
1079376|NCT00972322|2615414|P2|STARTED|Overall Study||28
1079377|NCT00972322|2615415|P1|STARTED|Overall Study||28
1079378|NCT00972335|2615425|P1|NOT COMPLETED|Overall Study||17
1079379|NCT00972335|2615425|P1|COMPLETED|Overall Study|Patients were on study until an event or condition occured which required them to come off study|0
1079380|NCT00972335|2615425|P1|STARTED|Overall Study|One patient was enrolled but showed no evidence of disease at study entry and was not treated|17
1079381|NCT00972374|2615433|P3|NOT COMPLETED|Overall Study||1
1079382|NCT00972374|2615434|P2|NOT COMPLETED|Overall Study||0
1079383|NCT00972374|2615435|P1|NOT COMPLETED|Overall Study||2
1079384|NCT00972374|2615433|P3|COMPLETED|Overall Study||13
1079385|NCT00972374|2615434|P2|COMPLETED|Overall Study||15
1079386|NCT00972374|2615435|P1|COMPLETED|Overall Study||13
1079387|NCT00972374|2615433|P3|STARTED|Overall Study||14
1079388|NCT00972374|2615434|P2|STARTED|Overall Study||15
1079389|NCT00972374|2615435|P1|STARTED|Overall Study||15
1079398|NCT00972504|2615462|P1|NOT COMPLETED|Overall Study||3
1079399|NCT00972504|2615462|P1|COMPLETED|Overall Study||51
1079400|NCT00972504|2615462|P1|STARTED|Overall Study||54
1079401|NCT00972530|2615494|P2|NOT COMPLETED|Overall Study||0
1079402|NCT00972530|2615495|P1|NOT COMPLETED|Overall Study||0
1079403|NCT00972530|2615494|P2|COMPLETED|Overall Study||46
1079404|NCT00972530|2615495|P1|COMPLETED|Overall Study||44
1079405|NCT00972530|2615494|P2|STARTED|Overall Study||46
1079406|NCT00972530|2615495|P1|STARTED|Overall Study||44
1079407|NCT00972543|2615503|P2|NOT COMPLETED|Overall Study||1
1079408|NCT00972543|2615504|P1|NOT COMPLETED|Overall Study||5
1079409|NCT00972543|2615503|P2|COMPLETED|Overall Study||0
1079410|NCT00972543|2615504|P1|COMPLETED|Overall Study||0
1079411|NCT00972543|2615503|P2|STARTED|Overall Study||1
1079412|NCT00972543|2615504|P1|STARTED|Overall Study||5
1079413|NCT00972595|2615578|P2|NOT COMPLETED|Period 2||0
1079414|NCT00972595|2615579|P1|NOT COMPLETED|Period 2||0
1079415|NCT00972595|2615578|P2|COMPLETED|Period 2||22
1079416|NCT00972595|2615579|P1|COMPLETED|Period 2||22
1079417|NCT00972595|2615578|P2|STARTED|Period 2||22
1079418|NCT00972595|2615579|P1|STARTED|Period 2||22
1079419|NCT00972595|2615578|P2|NOT COMPLETED|Period 1||0
1079420|NCT00972595|2615579|P1|NOT COMPLETED|Period 1||1
1079421|NCT00972595|2615578|P2|COMPLETED|Period 1||22
1079422|NCT00972595|2615579|P1|COMPLETED|Period 1||22
1079423|NCT00972595|2615578|P2|STARTED|Period 1||22
1079424|NCT00972595|2615579|P1|STARTED|Period 1||23
1079425|NCT00972621|2615589|P2|NOT COMPLETED|Overall Study||1
1079426|NCT00972621|2615590|P1|NOT COMPLETED|Overall Study||0
1079427|NCT00972621|2615589|P2|COMPLETED|Overall Study|One subject discontinued due to lens exchange.|199
1079428|NCT00972621|2615590|P1|COMPLETED|Overall Study||200
1079429|NCT00972621|2615589|P2|STARTED|Overall Study||200
1079430|NCT00972621|2615590|P1|STARTED|Overall Study||200
1079431|NCT00972725|2615600|P2|NOT COMPLETED|Overall Study||0
1079432|NCT00972725|2615601|P1|NOT COMPLETED|Overall Study||0
1079433|NCT00972725|2615600|P2|COMPLETED|Overall Study||15
1079434|NCT00972725|2615601|P1|COMPLETED|Overall Study||13
1079435|NCT00972725|2615600|P2|STARTED|Overall Study||15
1079436|NCT00972725|2615601|P1|STARTED|Overall Study||13
1079437|NCT00972738|2615684|P3|NOT COMPLETED|Overall Study||29
1079438|NCT00972738|2615685|P2|NOT COMPLETED|Overall Study||6
1079439|NCT00972738|2615686|P1|NOT COMPLETED|Overall Study||21
1079440|NCT00972738|2615684|P3|COMPLETED|Overall Study||492
1079441|NCT00972738|2615685|P2|COMPLETED|Overall Study||165
1079442|NCT00972738|2615686|P1|COMPLETED|Overall Study||501
1079443|NCT00972738|2615684|P3|STARTED|Overall Study||521
1079444|NCT00972738|2615685|P2|STARTED|Overall Study||171
1079445|NCT00972738|2615686|P1|STARTED|Overall Study||522
1079446|NCT00972777|2615711|P2|NOT COMPLETED|Overall Study||14
1079447|NCT00972777|2615712|P1|NOT COMPLETED|Overall Study||14
1079448|NCT00972777|2615711|P2|COMPLETED|Overall Study||229
1079449|NCT00972777|2615712|P1|COMPLETED|Overall Study||217
1079450|NCT00972777|2615711|P2|STARTED|Overall Study||243
1079451|NCT00972777|2615712|P1|STARTED|Overall Study||231
1079452|NCT00972816|2615732|P8|NOT COMPLETED|Overall Study||9
1079453|NCT00972816|2615733|P7|NOT COMPLETED|Overall Study||10
1079454|NCT00972816|2615734|P6|NOT COMPLETED|Overall Study||11
1079455|NCT00972816|2615735|P5|NOT COMPLETED|Overall Study||12
1079456|NCT00972816|2615736|P4|NOT COMPLETED|Overall Study||8
1079457|NCT00972816|2615737|P3|NOT COMPLETED|Overall Study||9
1079458|NCT00972816|2615738|P2|NOT COMPLETED|Overall Study||11
1079459|NCT00972816|2615739|P1|NOT COMPLETED|Overall Study||17
1079460|NCT00972816|2615732|P8|COMPLETED|Overall Study||161
1079461|NCT00972816|2615733|P7|COMPLETED|Overall Study||159
1079462|NCT00972816|2615734|P6|COMPLETED|Overall Study||158
1079463|NCT00972816|2615735|P5|COMPLETED|Overall Study||157
1079464|NCT00972816|2615736|P4|COMPLETED|Overall Study||161
1079465|NCT00972816|2615737|P3|COMPLETED|Overall Study||160
1079466|NCT00972816|2615738|P2|COMPLETED|Overall Study||158
1079467|NCT00972816|2615739|P1|COMPLETED|Overall Study||156
1079468|NCT00972816|2615732|P8|STARTED|Overall Study||170
1079469|NCT00972816|2615733|P7|STARTED|Overall Study||169
1079470|NCT00972816|2615734|P6|STARTED|Overall Study||169
1079471|NCT00972816|2615735|P5|STARTED|Overall Study||169
1079472|NCT00972816|2615736|P4|STARTED|Overall Study||169
1079473|NCT00972816|2615737|P3|STARTED|Overall Study||169
1079474|NCT00972816|2615738|P2|STARTED|Overall Study||169
1079475|NCT00972816|2615739|P1|STARTED|Overall Study||173
1079476|NCT00972959|2615821|P1|NOT COMPLETED|Overall Study||0
1079477|NCT00972959|2615821|P1|COMPLETED|Overall Study||17
1079478|NCT00972959|2615821|P1|STARTED|Overall Study||17
1079479|NCT00967330|2615838|P2|NOT COMPLETED|Overall Study||60
1079480|NCT00967330|2615839|P1|NOT COMPLETED|Overall Study||122
1079481|NCT00967330|2615838|P2|COMPLETED|Overall Study||0
1079482|NCT00967330|2615839|P1|COMPLETED|Overall Study||0
1079483|NCT00967330|2615838|P2|STARTED|Overall Study||60
1079484|NCT00967330|2615839|P1|STARTED|Overall Study||122
1079485|NCT00967447|2615867|P1|NOT COMPLETED|Overall Study||0
1079486|NCT00967447|2615867|P1|COMPLETED|Overall Study|there are no collected data in CRF|2
1079487|NCT00967447|2615867|P1|STARTED|Overall Study|there are no collected data in CRF|2
1079488|NCT00967473|2615874|P1|NOT COMPLETED|Overall Study||0
1079489|NCT00967473|2615874|P1|COMPLETED|Overall Study||15
1079490|NCT00967473|2615874|P1|STARTED|Overall Study||15
1079491|NCT00967486|2615882|P2|NOT COMPLETED|Overall Study||0
1079492|NCT00967486|2615883|P1|NOT COMPLETED|Overall Study||0
1079493|NCT00967486|2615882|P2|COMPLETED|Overall Study||102
1079494|NCT00967486|2615883|P1|COMPLETED|Overall Study||98
1079495|NCT00967486|2615882|P2|STARTED|Overall Study||102
1079496|NCT00967486|2615883|P1|STARTED|Overall Study||98
1079497|NCT00967551|2615891|P2|NOT COMPLETED|Overall Study||0
1079498|NCT00967551|2615892|P1|NOT COMPLETED|Overall Study||0
1079499|NCT00967551|2615891|P2|COMPLETED|Overall Study||75
1079500|NCT00967551|2615892|P1|COMPLETED|Overall Study||68
1079501|NCT00967551|2615891|P2|STARTED|Overall Study||75
1079502|NCT00967551|2615892|P1|STARTED|Overall Study||68
1079503|NCT00967668|2615903|P3|NOT COMPLETED|Overall Study||69
1079504|NCT00967668|2615904|P2|NOT COMPLETED|Overall Study||56
1079505|NCT00967668|2615905|P1|NOT COMPLETED|Overall Study||71
1079506|NCT00967668|2615903|P3|COMPLETED|Overall Study||90
1079507|NCT00967668|2615904|P2|COMPLETED|Overall Study||104
1079508|NCT00967668|2615905|P1|COMPLETED|Overall Study||91
1079509|NCT00967668|2615903|P3|18-mo Assessment|Overall Study||92
1079510|NCT00967668|2615904|P2|18-mo Assessment|Overall Study||102
1079511|NCT00967668|2615905|P1|18-mo Assessment|Overall Study||95
1079512|NCT00967668|2615903|P3|Completed Year 1 - 12-mo Assessment|Overall Study||119
1079513|NCT00967668|2615904|P2|Completed Year 1 - 12-mo Assessment|Overall Study||122
1079514|NCT00967668|2615905|P1|Completed Year 1 - 12-mo Assessment|Overall Study||120
1079515|NCT00967668|2615903|P3|3-mo Assessment|Overall Study||115
1079516|NCT00967668|2615904|P2|3-mo Assessment|Overall Study||127
1079517|NCT00967668|2615905|P1|3-mo Assessment|Overall Study||131
1079518|NCT00967668|2615903|P3|STARTED|Overall Study||159
1079519|NCT00967668|2615904|P2|STARTED|Overall Study||160
1079520|NCT00967668|2615905|P1|STARTED|Overall Study||162
1079521|NCT00967694|2615916|P1|NOT COMPLETED|Overall Study||6
1079522|NCT00967694|2615916|P1|COMPLETED|Overall Study|5 discontinued during N2O administration due to agitation ⁄ dysphoria, one due to nausea⁄vomiting.|20
1079523|NCT00967694|2615916|P1|STARTED|Overall Study||26
1079524|NCT00973349|2615936|P16|NOT COMPLETED|Overall Study||2
1079525|NCT00973349|2615937|P15|NOT COMPLETED|Overall Study||2
1079526|NCT00973349|2615938|P14|NOT COMPLETED|Overall Study||0
1079527|NCT00973349|2615939|P13|NOT COMPLETED|Overall Study||1
1079528|NCT00973349|2615940|P12|NOT COMPLETED|Overall Study||2
1079529|NCT00973349|2615941|P11|NOT COMPLETED|Overall Study||0
1079530|NCT00973349|2615942|P10|NOT COMPLETED|Overall Study||6
1079531|NCT00973349|2615943|P9|NOT COMPLETED|Overall Study||4
1079532|NCT00973349|2615944|P8|NOT COMPLETED|Overall Study||3
1079533|NCT00973349|2615945|P7|NOT COMPLETED|Overall Study||2
1079534|NCT00973349|2615946|P6|NOT COMPLETED|Overall Study||4
1079535|NCT00973349|2615947|P5|NOT COMPLETED|Overall Study||5
1079536|NCT00973349|2615948|P4|NOT COMPLETED|Overall Study||5
1079537|NCT00973349|2615949|P3|NOT COMPLETED|Overall Study||5
1079538|NCT00973349|2615950|P2|NOT COMPLETED|Overall Study||3
1079539|NCT00973349|2615951|P1|NOT COMPLETED|Overall Study||4
1079540|NCT00973349|2615936|P16|COMPLETED|Overall Study||165
1079541|NCT00973349|2615937|P15|COMPLETED|Overall Study||168
1079542|NCT00973349|2615938|P14|COMPLETED|Overall Study||171
1079543|NCT00973349|2615939|P13|COMPLETED|Overall Study||168
1079544|NCT00973349|2615940|P12|COMPLETED|Overall Study||167
1079545|NCT00973349|2615941|P11|COMPLETED|Overall Study||174
1079546|NCT00973349|2615942|P10|COMPLETED|Overall Study||163
1079547|NCT00973349|2615943|P9|COMPLETED|Overall Study||167
1079548|NCT00973349|2615944|P8|COMPLETED|Overall Study||166
1079549|NCT00973349|2615945|P7|COMPLETED|Overall Study||172
1079550|NCT00973349|2615946|P6|COMPLETED|Overall Study||165
1079551|NCT00973349|2615947|P5|COMPLETED|Overall Study||165
1079552|NCT00973349|2615948|P4|COMPLETED|Overall Study||163
1079553|NCT00973349|2615949|P3|COMPLETED|Overall Study||166
1079554|NCT00973349|2615950|P2|COMPLETED|Overall Study||165
1079555|NCT00973349|2615951|P1|COMPLETED|Overall Study||166
1079556|NCT00973349|2615936|P16|STARTED|Overall Study||167
1079557|NCT00973349|2615937|P15|STARTED|Overall Study||170
1079558|NCT00973349|2615938|P14|STARTED|Overall Study||171
1079559|NCT00973349|2615939|P13|STARTED|Overall Study||169
1079560|NCT00973349|2615940|P12|STARTED|Overall Study||169
1079561|NCT00973349|2615941|P11|STARTED|Overall Study||174
1079562|NCT00973349|2615942|P10|STARTED|Overall Study||169
1079563|NCT00973349|2615943|P9|STARTED|Overall Study||171
1079564|NCT00973349|2615944|P8|STARTED|Overall Study||169
1079565|NCT00973349|2615945|P7|STARTED|Overall Study||174
1079566|NCT00973349|2615946|P6|STARTED|Overall Study||169
1079567|NCT00973349|2615947|P5|STARTED|Overall Study||170
1079568|NCT00973349|2615948|P4|STARTED|Overall Study||168
1079569|NCT00973349|2615949|P3|STARTED|Overall Study||171
1079570|NCT00973349|2615950|P2|STARTED|Overall Study||168
1079571|NCT00973349|2615951|P1|STARTED|Overall Study||170
1079572|NCT00973362|2616051|P2|NOT COMPLETED|3-Year Follow-up||0
1079573|NCT00973362|2616052|P1|NOT COMPLETED|3-Year Follow-up||17
1079574|NCT00973362|2616051|P2|COMPLETED|3-Year Follow-up||0
1079575|NCT00973362|2616052|P1|COMPLETED|3-Year Follow-up||10854
1079576|NCT00973362|2616051|P2|STARTED|3-Year Follow-up|ASC-US study arm did not have a follow-up period|0
1079577|NCT00973362|2616052|P1|STARTED|3-Year Follow-up||10871
1079578|NCT00973362|2616051|P2|NOT COMPLETED|Baseline Evaluation||223
1079579|NCT00973362|2616052|P1|NOT COMPLETED|Baseline Evaluation||773
1079580|NCT00973362|2616051|P2|COMPLETED|Baseline Evaluation||1029
1079581|NCT00973362|2616052|P1|COMPLETED|Baseline Evaluation||10871
1079582|NCT00973362|2616051|P2|Conclusive Disease Status|Baseline Evaluation||939
1079583|NCT00973362|2616052|P1|Conclusive Disease Status|Baseline Evaluation||819
1079584|NCT00973362|2616051|P2|Evaluable for Analysis|Baseline Evaluation||958
1079585|NCT00973362|2616052|P1|Evaluable for Analysis|Baseline Evaluation||10871
1079586|NCT00973362|2616051|P2|STARTED|Baseline Evaluation||1252
1079587|NCT00973362|2616052|P1|STARTED|Baseline Evaluation||11644
1079588|NCT00975975|2616061|P1|NOT COMPLETED|Overall Study||6
1079589|NCT00975975|2616061|P1|COMPLETED|Overall Study||11
1079590|NCT00975975|2616061|P1|STARTED|Overall Study||17
1079591|NCT00976027|2616069|P2|NOT COMPLETED|Overall Study||215
1079592|NCT00976027|2616070|P1|NOT COMPLETED|Overall Study||411
1079593|NCT00976027|2616069|P2|COMPLETED|Overall Study||2835
1079594|NCT00976027|2616070|P1|COMPLETED|Overall Study||5697
1079595|NCT00976027|2616069|P2|STARTED|Overall Study||3050
1079596|NCT00976027|2616070|P1|STARTED|Overall Study||6108
1079597|NCT00976183|2616082|P1|NOT COMPLETED|Overall Study||0
1079598|NCT00976183|2616082|P1|COMPLETED|Overall Study|The study was closed on 05/30/12 due to adverse events. We did not complete enrollment|18
1079599|NCT00976183|2616082|P1|STARTED|Overall Study||18
1079600|NCT00976209|2616089|P2|NOT COMPLETED|Treatment Period 2||2
1079601|NCT00976209|2616090|P1|NOT COMPLETED|Treatment Period 2||0
1079602|NCT00976209|2616089|P2|COMPLETED|Treatment Period 2||161
1079603|NCT00976209|2616090|P1|COMPLETED|Treatment Period 2||158
1079604|NCT00976209|2616089|P2|STARTED|Treatment Period 2||163
1079605|NCT00976209|2616090|P1|STARTED|Treatment Period 2||158
1079606|NCT00976209|2616089|P2|NOT COMPLETED|Wash-out Period||2
1079607|NCT00976209|2616090|P1|NOT COMPLETED|Wash-out Period||4
1079608|NCT00976209|2616089|P2|COMPLETED|Wash-out Period||163
1079609|NCT00976209|2616090|P1|COMPLETED|Wash-out Period||158
1079610|NCT00976209|2616089|P2|STARTED|Wash-out Period||165
1079611|NCT00976209|2616090|P1|STARTED|Wash-out Period||162
1079612|NCT00976209|2616089|P2|NOT COMPLETED|Treatment Period 1||1
1079613|NCT00976209|2616090|P1|NOT COMPLETED|Treatment Period 1||3
1079614|NCT00976209|2616089|P2|COMPLETED|Treatment Period 1||165
1079615|NCT00976209|2616090|P1|COMPLETED|Treatment Period 1||162
1079616|NCT00976209|2616089|P2|STARTED|Treatment Period 1||166
1079617|NCT00976209|2616090|P1|STARTED|Treatment Period 1||165
1079621|NCT00976274|2616104|P2|NOT COMPLETED|Overall Study||8
1079622|NCT00976274|2616105|P1|NOT COMPLETED|Overall Study||7
1079623|NCT00976274|2616104|P2|COMPLETED|Overall Study||21
1079624|NCT00976274|2616105|P1|COMPLETED|Overall Study||24
1079625|NCT00976274|2616104|P2|STARTED|Overall Study||29
1079626|NCT00976274|2616105|P1|STARTED|Overall Study||31
1079627|NCT00976339|2616115|P2|NOT COMPLETED|Overall Study||0
1079628|NCT00976339|2616116|P1|NOT COMPLETED|Overall Study||0
1079629|NCT00976339|2616115|P2|COMPLETED|Overall Study||10
1079630|NCT00976339|2616116|P1|COMPLETED|Overall Study||10
1079631|NCT00976339|2616115|P2|STARTED|Overall Study||10
1079632|NCT00976339|2616116|P1|STARTED|Overall Study||10
1079633|NCT00976391|2616126|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||34
1079634|NCT00976391|2616127|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||29
1079635|NCT00976391|2616126|P2|COMPLETED|Follow-up Period (8 Weeks)||247
1079636|NCT00976391|2616127|P1|COMPLETED|Follow-up Period (8 Weeks)||256
1079637|NCT00976391|2616126|P2|STARTED|Follow-up Period (8 Weeks)||281
1079638|NCT00976391|2616127|P1|STARTED|Follow-up Period (8 Weeks)||285
1079639|NCT00976391|2616126|P2|NOT COMPLETED|Treatment Period (52 Weeks)||39
1079640|NCT00976391|2616127|P1|NOT COMPLETED|Treatment Period (52 Weeks)||42
1079641|NCT00976391|2616126|P2|COMPLETED|Treatment Period (52 Weeks)||242
1079642|NCT00976391|2616127|P1|COMPLETED|Treatment Period (52 Weeks)||243
1079643|NCT00976391|2616126|P2|STARTED|Treatment Period (52 Weeks)||281
1079644|NCT00976391|2616127|P1|STARTED|Treatment Period (52 Weeks)||285
1079645|NCT00976404|2616149|P2|NOT COMPLETED|Overall Study||0
1079646|NCT00976404|2616150|P1|NOT COMPLETED|Overall Study||0
1079647|NCT00976404|2616149|P2|COMPLETED|Overall Study||14
1079648|NCT00976404|2616150|P1|COMPLETED|Overall Study||14
1079649|NCT00976404|2616149|P2|STARTED|Overall Study||14
1079650|NCT00976404|2616150|P1|STARTED|Overall Study||14
1079651|NCT00976456|2616166|P2|NOT COMPLETED|Overall Study||38
1079652|NCT00976456|2616167|P1|NOT COMPLETED|Overall Study||43
1079653|NCT00976456|2616166|P2|COMPLETED|Overall Study||98
1079654|NCT00976456|2616167|P1|COMPLETED|Overall Study||92
1079655|NCT00976456|2616166|P2|STARTED|Overall Study||136
1079656|NCT00976456|2616167|P1|STARTED|Overall Study||135
1079657|NCT00976482|2616175|P1|NOT COMPLETED|Overall Study||259
1079658|NCT00976482|2616175|P1|COMPLETED|Overall Study||1486
1079659|NCT00976482|2616175|P1|Eligible for Last Follow up|Overall Study||1487
1079660|NCT00976482|2616175|P1|STARTED|Overall Study||1745
1079661|NCT00976495|2616182|P3|NOT COMPLETED|Overall Study||0
1079662|NCT00976495|2616183|P2|NOT COMPLETED|Overall Study||1
1079663|NCT00976495|2616184|P1|NOT COMPLETED|Overall Study||0
1079664|NCT00976495|2616182|P3|COMPLETED|Overall Study||26
1079665|NCT00976495|2616183|P2|COMPLETED|Overall Study||23
1079666|NCT00976495|2616184|P1|COMPLETED|Overall Study||25
1079667|NCT00976495|2616182|P3|STARTED|Overall Study||26
1079668|NCT00976495|2616183|P2|STARTED|Overall Study||24
1079669|NCT00976495|2616184|P1|STARTED|Overall Study||25
1079670|NCT00976508|2616203|P2|NOT COMPLETED|Overall Study||6
1079671|NCT00976508|2616204|P1|NOT COMPLETED|Overall Study||14
1079672|NCT00976508|2616203|P2|COMPLETED|Overall Study||0
1079673|NCT00976508|2616204|P1|COMPLETED|Overall Study|These subjects withdrew from last study treatment due to progressive disease.|3
1079674|NCT00976508|2616203|P2|STARTED|Overall Study||6
1079675|NCT00976508|2616204|P1|STARTED|Overall Study|18 subjects were enrolled; 17 subjects were treated; 1 subject was not eligible.|17
1079676|NCT00976521|2616238|P4|NOT COMPLETED|Overall Study||19
1079677|NCT00976521|2616239|P3|NOT COMPLETED|Overall Study||9
1079678|NCT00976521|2616240|P2|NOT COMPLETED|Overall Study||12
1079679|NCT00976521|2616241|P1|NOT COMPLETED|Overall Study||9
1079680|NCT00976521|2616238|P4|COMPLETED|Overall Study||93
1079681|NCT00976521|2616239|P3|COMPLETED|Overall Study||102
1079682|NCT00976521|2616240|P2|COMPLETED|Overall Study||99
1079683|NCT00976521|2616241|P1|COMPLETED|Overall Study||109
1079684|NCT00976521|2616238|P4|STARTED|Overall Study||112
1079685|NCT00976521|2616239|P3|STARTED|Overall Study||111
1079686|NCT00976521|2616240|P2|STARTED|Overall Study||111
1079687|NCT00976521|2616241|P1|STARTED|Overall Study||118
1079688|NCT00976573|2616255|P2|NOT COMPLETED|Overall Study||3
1079689|NCT00976573|2616256|P1|NOT COMPLETED|Overall Study||4
1079690|NCT00976573|2616255|P2|COMPLETED|Overall Study||71
1079691|NCT00976573|2616256|P1|COMPLETED|Overall Study||71
1079692|NCT00976573|2616255|P2|STARTED|Overall Study||74
1079693|NCT00976573|2616256|P1|STARTED|Overall Study||75
1079694|NCT00976599|2616270|P2|NOT COMPLETED|Overall Study||0
1079695|NCT00976599|2616271|P1|NOT COMPLETED|Overall Study||0
1079696|NCT00976599|2616270|P2|COMPLETED|Overall Study||14
1079697|NCT00976599|2616271|P1|COMPLETED|Overall Study||15
1079698|NCT00976599|2616270|P2|STARTED|Overall Study||14
1079699|NCT00976599|2616271|P1|STARTED|Overall Study||15
1079700|NCT00976664|2616459|P2|NOT COMPLETED|Overall Study||1
1079701|NCT00976664|2616460|P1|NOT COMPLETED|Overall Study||3
1079702|NCT00976664|2616459|P2|COMPLETED|Overall Study||24
1079703|NCT00976664|2616460|P1|COMPLETED|Overall Study||22
1079704|NCT00976664|2616459|P2|STARTED|Overall Study||25
1079705|NCT00976664|2616460|P1|STARTED|Overall Study||25
1079706|NCT00976677|2616470|P2|NOT COMPLETED|Overall Study||5
1079707|NCT00976677|2616471|P1|NOT COMPLETED|Overall Study||5
1079708|NCT00976677|2616470|P2|COMPLETED|Overall Study||0
1079709|NCT00976677|2616471|P1|COMPLETED|Overall Study||0
1079710|NCT00976677|2616470|P2|STARTED|Overall Study||5
1079711|NCT00976677|2616471|P1|STARTED|Overall Study||5
1079712|NCT00976703|2616479|P2|NOT COMPLETED|Overall Study||3
1079713|NCT00976703|2616480|P1|NOT COMPLETED|Overall Study||3
1079714|NCT00976703|2616479|P2|COMPLETED|Overall Study||95
1079715|NCT00976703|2616480|P1|COMPLETED|Overall Study||96
1079716|NCT00976703|2616479|P2|STARTED|Overall Study||98
1079717|NCT00976703|2616480|P1|STARTED|Overall Study||99
1079718|NCT00976716|2616492|P1|NOT COMPLETED|Overall Study||1
1079719|NCT00976716|2616492|P1|COMPLETED|Overall Study||79
1079720|NCT00976716|2616492|P1|STARTED|Overall Study||80
1079721|NCT00976911|2616510|P2|NOT COMPLETED|Overall Study||179
1079722|NCT00976911|2616511|P1|NOT COMPLETED|Overall Study||182
1079723|NCT00976911|2616510|P2|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
1079724|NCT00976911|2616511|P1|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
1079725|NCT00976911|2616510|P2|STARTED|Overall Study||179
1079726|NCT00976911|2616511|P1|STARTED|Overall Study||182
1079727|NCT00976937|2616531|P2|NOT COMPLETED|Overall Study||11
1079728|NCT00976937|2616532|P1|NOT COMPLETED|Overall Study||16
1079729|NCT00976937|2616531|P2|COMPLETED|Overall Study||150
1079730|NCT00976937|2616532|P1|COMPLETED|Overall Study||142
1079731|NCT00976937|2616531|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||161
1079732|NCT00976937|2616532|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All randomized patients who received at least 1 dose of study drug.|158
1079733|NCT00976937|2616531|P2|Treated/Safety Population|Overall Study||161
1079734|NCT00976937|2616532|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|158
1079735|NCT00976937|2616531|P2|STARTED|Overall Study||161
1079736|NCT00976937|2616532|P1|STARTED|Overall Study|Randomized|158
1079737|NCT00976950|2616572|P1|NOT COMPLETED|Overall Study||6
1079738|NCT00976950|2616572|P1|COMPLETED|Overall Study||36
1079739|NCT00976950|2616572|P1|STARTED|Overall Study||42
1079740|NCT00976989|2616581|P3|NOT COMPLETED|Overall Study||17
1079741|NCT00976989|2616582|P2|NOT COMPLETED|Overall Study||12
1079742|NCT00976989|2616583|P1|NOT COMPLETED|Overall Study||13
1079743|NCT00976989|2616581|P3|COMPLETED|Overall Study||60
1079744|NCT00976989|2616582|P2|COMPLETED|Overall Study||63
1079745|NCT00976989|2616583|P1|COMPLETED|Overall Study||60
1079746|NCT00976989|2616581|P3|STARTED|Overall Study||77
1079747|NCT00976989|2616582|P2|STARTED|Overall Study||75
1079748|NCT00976989|2616583|P1|STARTED|Overall Study||73
1079749|NCT00977080|2616628|P4|NOT COMPLETED|Overall Study||17
1079750|NCT00977080|2616629|P3|NOT COMPLETED|Overall Study||16
1079751|NCT00977080|2616630|P2|NOT COMPLETED|Overall Study||20
1079752|NCT00977080|2616631|P1|NOT COMPLETED|Overall Study||12
1079753|NCT00977080|2616628|P4|COMPLETED|Overall Study||53
1079754|NCT00977080|2616629|P3|COMPLETED|Overall Study||56
1079755|NCT00977080|2616630|P2|COMPLETED|Overall Study||44
1079756|NCT00977080|2616631|P1|COMPLETED|Overall Study||50
1079757|NCT00977080|2616628|P4|STARTED|Overall Study||70
1079758|NCT00977080|2616629|P3|STARTED|Overall Study||72
1079759|NCT00977080|2616630|P2|STARTED|Overall Study||64
1079760|NCT00977080|2616631|P1|STARTED|Overall Study||62
1079761|NCT00977106|2616663|P2|NOT COMPLETED|Overall Study||11
1079762|NCT00977106|2616664|P1|NOT COMPLETED|Overall Study||10
1079763|NCT00977106|2616663|P2|COMPLETED|Overall Study||45
1079764|NCT00977106|2616664|P1|COMPLETED|Overall Study||37
1079765|NCT00977106|2616663|P2|STARTED|Overall Study|Includes 3 participants who were randomized to placebo, but received tocilizumab.|56
1079766|NCT00977106|2616664|P1|STARTED|Overall Study||47
1079767|NCT00977171|2616752|P1|NOT COMPLETED|Overall Study||0
1079768|NCT00977171|2616752|P1|COMPLETED|Overall Study||3
1079769|NCT00977171|2616752|P1|STARTED|Overall Study||3
1079770|NCT00977184|2616758|P2|NOT COMPLETED|Overall Study||0
1079771|NCT00977184|2616759|P1|NOT COMPLETED|Overall Study||0
1079772|NCT00977184|2616758|P2|COMPLETED|Overall Study||13
1079773|NCT00977184|2616759|P1|COMPLETED|Overall Study||13
1079774|NCT00977184|2616758|P2|STARTED|Overall Study||13
1079775|NCT00977184|2616759|P1|STARTED|Overall Study||13
1079776|NCT00977197|2616787|P2|NOT COMPLETED|Overall Study||9
1079777|NCT00977197|2616788|P1|NOT COMPLETED|Overall Study||9
1079778|NCT00977197|2616787|P2|COMPLETED|Overall Study||35
1079779|NCT00977197|2616788|P1|COMPLETED|Overall Study||32
1079780|NCT00977197|2616787|P2|STARTED|Overall Study||44
1079781|NCT00977197|2616788|P1|STARTED|Overall Study||41
1079782|NCT00977314|2616818|P2|NOT COMPLETED|Overall Study||0
1079783|NCT00977314|2616819|P1|NOT COMPLETED|Overall Study||2
1079784|NCT00977314|2616818|P2|COMPLETED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
1079785|NCT00977314|2616819|P1|COMPLETED|Overall Study||28
1079786|NCT00977314|2616818|P2|STARTED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
1079787|NCT00977314|2616819|P1|STARTED|Overall Study||30
1079788|NCT00977379|2616827|P2|NOT COMPLETED|Overall Study||12
1079789|NCT00977379|2616828|P1|NOT COMPLETED|Overall Study||12
1079790|NCT00977379|2616827|P2|COMPLETED|Overall Study||0
1079791|NCT00977379|2616828|P1|COMPLETED|Overall Study||0
1079792|NCT00977379|2616827|P2|Treated|Overall Study||11
1079793|NCT00977379|2616828|P1|Treated|Overall Study||12
1079794|NCT00977379|2616827|P2|STARTED|Overall Study|Randomized|12
1079795|NCT00977379|2616828|P1|STARTED|Overall Study|Randomized|12
1079796|NCT00977470|2616864|P2|NOT COMPLETED|Overall Study||38
1079797|NCT00977470|2616865|P1|NOT COMPLETED|Overall Study||38
1079798|NCT00977470|2616864|P2|COMPLETED|Overall Study||0
1079799|NCT00977470|2616865|P1|COMPLETED|Overall Study||0
1079800|NCT00977470|2616864|P2|STARTED|Overall Study||38
1079801|NCT00977470|2616865|P1|STARTED|Overall Study||38
1079802|NCT00977548|2616883|P1|NOT COMPLETED|Overall Study||13
1079803|NCT00977548|2616883|P1|COMPLETED|Overall Study||26
1079804|NCT00977548|2616883|P1|STARTED|Overall Study||39
1079805|NCT00977561|2616892|P2|NOT COMPLETED|Overall Study||4
1079806|NCT00977561|2616893|P1|NOT COMPLETED|Overall Study||5
1079807|NCT00977561|2616892|P2|COMPLETED|Overall Study||0
1079808|NCT00977561|2616893|P1|COMPLETED|Overall Study||0
1079809|NCT00977561|2616892|P2|STARTED|Overall Study||4
1079810|NCT00977561|2616893|P1|STARTED|Overall Study||5
1079811|NCT00977613|2616920|P1|NOT COMPLETED|Overall Study||16
1079812|NCT00977613|2616920|P1|COMPLETED|Overall Study||34
1079813|NCT00977613|2616920|P1|STARTED|Overall Study||50
1079814|NCT00977665|2616926|P2|NOT COMPLETED|Overall Study||15
1079815|NCT00977665|2616927|P1|NOT COMPLETED|Overall Study||21
1079816|NCT00977665|2616926|P2|COMPLETED|Overall Study||75
1079817|NCT00977665|2616927|P1|COMPLETED|Overall Study||63
1079818|NCT00977665|2616926|P2|STARTED|Overall Study||90
1079819|NCT00977665|2616927|P1|STARTED|Overall Study||84
1079820|NCT00977704|2616959|P1|NOT COMPLETED|Overall Study||0
1079821|NCT00977704|2616959|P1|COMPLETED|Overall Study||20
1079822|NCT00977704|2616959|P1|STARTED|Overall Study||20
1079823|NCT00977769|2616966|P3|NOT COMPLETED|Overall Study||0
1079824|NCT00977769|2616967|P2|NOT COMPLETED|Overall Study||0
1079825|NCT00977769|2616968|P1|NOT COMPLETED|Overall Study||0
1079826|NCT00977769|2616966|P3|COMPLETED|Overall Study||25
1079827|NCT00977769|2616967|P2|COMPLETED|Overall Study||26
1079828|NCT00977769|2616968|P1|COMPLETED|Overall Study||25
1079829|NCT00977769|2616966|P3|STARTED|Overall Study||25
1079830|NCT00977769|2616967|P2|STARTED|Overall Study||26
1079831|NCT00977769|2616968|P1|STARTED|Overall Study||25
1079832|NCT00977808|2616982|P1|NOT COMPLETED|Overall Study||1
1079833|NCT00977808|2616982|P1|COMPLETED|Overall Study||11
1079834|NCT00977808|2616982|P1|Completion of Closed-Loop Admission|Overall Study||11
1079835|NCT00977808|2616982|P1|Completion of Open-Loop Admission|Overall Study||12
1079836|NCT00977808|2616982|P1|STARTED|Overall Study||12
1079837|NCT00977938|2616991|P4|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||3
1079838|NCT00977938|2616992|P3|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||12
1079839|NCT00977938|2616993|P2|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||58
1079840|NCT00977938|2616994|P1|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||51
1079841|NCT00977938|2616991|P4|COMPLETED|Observation (30-33 mo. Post Procedure)||781
1079842|NCT00977938|2616992|P3|COMPLETED|Observation (30-33 mo. Post Procedure)||784
1079843|NCT00977938|2616993|P2|COMPLETED|Observation (30-33 mo. Post Procedure)||4658
1079844|NCT00977938|2616994|P1|COMPLETED|Observation (30-33 mo. Post Procedure)||4732
1079845|NCT00977938|2616991|P4|STARTED|Observation (30-33 mo. Post Procedure)||784
1079846|NCT00977938|2616992|P3|STARTED|Observation (30-33 mo. Post Procedure)||796
1079847|NCT00977938|2616993|P2|STARTED|Observation (30-33 mo. Post Procedure)||4716
1079848|NCT00977938|2616994|P1|STARTED|Observation (30-33 mo. Post Procedure)||4783
1079849|NCT00977938|2616991|P4|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||61
1079850|NCT00977938|2616992|P3|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||46
1079851|NCT00977938|2616993|P2|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||225
1079852|NCT00977938|2616994|P1|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||237
1079853|NCT00977938|2616991|P4|COMPLETED|Treatment (12-30 mo. Post Procedure)||784
1079854|NCT00977938|2616992|P3|COMPLETED|Treatment (12-30 mo. Post Procedure)||796
1079855|NCT00977938|2616993|P2|COMPLETED|Treatment (12-30 mo. Post Procedure)||4716
1079856|NCT00977938|2616994|P1|COMPLETED|Treatment (12-30 mo. Post Procedure)||4783
1079857|NCT00977938|2616991|P4|STARTED|Treatment (12-30 mo. Post Procedure)||845
1079858|NCT00977938|2616992|P3|STARTED|Treatment (12-30 mo. Post Procedure)||842
1079859|NCT00977938|2616993|P2|STARTED|Treatment (12-30 mo. Post Procedure)||4941
1079860|NCT00977938|2616994|P1|STARTED|Treatment (12-30 mo. Post Procedure)||5020
1079861|NCT00978029|2617031|P3|NOT COMPLETED|Overall Study||6
1079862|NCT00978029|2617032|P2|NOT COMPLETED|Overall Study||3
1079863|NCT00978029|2617033|P1|NOT COMPLETED|Overall Study||1
1079864|NCT00978029|2617031|P3|COMPLETED|Overall Study||59
1079865|NCT00978029|2617032|P2|COMPLETED|Overall Study||63
1079866|NCT00978029|2617033|P1|COMPLETED|Overall Study||64
1079867|NCT00978029|2617031|P3|STARTED|Overall Study||65
1079868|NCT00978029|2617032|P2|STARTED|Overall Study||66
1079869|NCT00978029|2617033|P1|STARTED|Overall Study||65
1079870|NCT00978042|2617058|P2|NOT COMPLETED|Received Repeat Treatment||3
1079871|NCT00978042|2617059|P1|NOT COMPLETED|Received Repeat Treatment||43
1079872|NCT00978042|2617058|P2|COMPLETED|Received Repeat Treatment||23
1079873|NCT00978042|2617059|P1|COMPLETED|Received Repeat Treatment|Completed=Completed Repeat Treatment Follow-up|98
1079874|NCT00978042|2617058|P2|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|26
1079875|NCT00978042|2617059|P1|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|141
1079876|NCT00978042|2617058|P2|NOT COMPLETED|Initial Treatment Period||15
1079877|NCT00978042|2617059|P1|NOT COMPLETED|Initial Treatment Period||61
1079878|NCT00978042|2617058|P2|COMPLETED|Initial Treatment Period||32
1079879|NCT00978042|2617059|P1|COMPLETED|Initial Treatment Period|Completed 24-month Follow-Up|174
1079880|NCT00978042|2617058|P2|MITT_treated With VOLUMA XC|Initial Treatment Period||35
1079881|NCT00978042|2617059|P1|MITT_treated With VOLUMA XC|Initial Treatment Period||235
1079882|NCT00978042|2617058|P2|STARTED|Initial Treatment Period||47
1079883|NCT00978042|2617059|P1|STARTED|Initial Treatment Period||235
1079884|NCT00978120|2617073|P4|NOT COMPLETED|Overall Study||2
1079885|NCT00978120|2617074|P3|NOT COMPLETED|Overall Study||3
1079886|NCT00978120|2617075|P2|NOT COMPLETED|Overall Study||0
1079887|NCT00978120|2617076|P1|NOT COMPLETED|Overall Study||2
1079888|NCT00978120|2617073|P4|COMPLETED|Overall Study||84
1079889|NCT00978120|2617074|P3|COMPLETED|Overall Study||84
1079890|NCT00978120|2617075|P2|COMPLETED|Overall Study||107
1079891|NCT00978120|2617076|P1|COMPLETED|Overall Study||108
1079892|NCT00978120|2617073|P4|STARTED|Overall Study||86
1079893|NCT00978120|2617074|P3|STARTED|Overall Study||87
1079894|NCT00978120|2617075|P2|STARTED|Overall Study||107
1079895|NCT00978120|2617076|P1|STARTED|Overall Study||110
1079896|NCT00978341|2617126|P2|NOT COMPLETED|Second Intervention||0
1079897|NCT00978341|2617127|P1|NOT COMPLETED|Second Intervention||0
1079898|NCT00978341|2617126|P2|COMPLETED|Second Intervention||7
1079899|NCT00978341|2617127|P1|COMPLETED|Second Intervention||7
1079900|NCT00978341|2617126|P2|STARTED|Second Intervention||7
1079901|NCT00978341|2617127|P1|STARTED|Second Intervention||7
1079902|NCT00978341|2617126|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
1079903|NCT00978341|2617127|P1|NOT COMPLETED|Washout Period of 2 Weeks||1
1079904|NCT00978341|2617126|P2|COMPLETED|Washout Period of 2 Weeks||7
1079905|NCT00978341|2617127|P1|COMPLETED|Washout Period of 2 Weeks||7
1079906|NCT00978341|2617126|P2|STARTED|Washout Period of 2 Weeks||7
1079907|NCT00978341|2617127|P1|STARTED|Washout Period of 2 Weeks||8
1079908|NCT00978341|2617126|P2|NOT COMPLETED|First Intervention||0
1079909|NCT00978341|2617127|P1|NOT COMPLETED|First Intervention||0
1079910|NCT00978341|2617126|P2|COMPLETED|First Intervention||7
1079911|NCT00978341|2617127|P1|COMPLETED|First Intervention||8
1079912|NCT00978341|2617126|P2|STARTED|First Intervention||7
1079913|NCT00978341|2617127|P1|STARTED|First Intervention||8
1079914|NCT00978380|2617145|P1|NOT COMPLETED|Overall Study||19
1079915|NCT00978380|2617145|P1|COMPLETED|Overall Study||44
1079916|NCT00978380|2617145|P1|STARTED|Overall Study||63
1079917|NCT00978432|2617154|P3|NOT COMPLETED|Overall Study||5
1079918|NCT00978432|2617155|P2|NOT COMPLETED|Overall Study||1
1079919|NCT00978432|2617156|P1|NOT COMPLETED|Overall Study||3
1079920|NCT00978432|2617154|P3|COMPLETED|Overall Study||13
1079921|NCT00978432|2617155|P2|COMPLETED|Overall Study||4
1079922|NCT00978432|2617156|P1|COMPLETED|Overall Study||7
1079923|NCT00978432|2617154|P3|STARTED|Overall Study||18
1079924|NCT00978432|2617155|P2|STARTED|Overall Study||5
1079925|NCT00978432|2617156|P1|STARTED|Overall Study||10
1079926|NCT00978445|2617176|P2|NOT COMPLETED|Overall Study||1
1079927|NCT00978445|2617177|P1|NOT COMPLETED|Overall Study||2
1079928|NCT00978445|2617176|P2|COMPLETED|Overall Study||12
1079929|NCT00978445|2617177|P1|COMPLETED|Overall Study||10
1079930|NCT00978445|2617176|P2|STARTED|Overall Study||13
1079931|NCT00978445|2617177|P1|STARTED|Overall Study||12
1079932|NCT00978562|2617184|P1|NOT COMPLETED|Overall Study||0
1079933|NCT00978562|2617184|P1|COMPLETED|Overall Study||7
1079934|NCT00978562|2617184|P1|STARTED|Overall Study||7
1079935|NCT00978627|2617191|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||9
1079936|NCT00978627|2617192|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||21
1079937|NCT00978627|2617191|P2|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||113
1079938|NCT00978627|2617192|P1|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||233
1079939|NCT00978627|2617191|P2|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Thirty four subjects from main trial did not continue into extension trial|122
1079940|NCT00978627|2617192|P1|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Sixty six subjects from main trial did not continue into extension trial|254
1079941|NCT00978627|2617191|P2|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||26
1079942|NCT00978627|2617192|P1|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||46
1079943|NCT00978627|2617191|P2|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||156
1079944|NCT00978627|2617192|P1|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||320
1079945|NCT00978627|2617191|P2|Exposed|Main: Week 0 to 26 (NN5401-3594)|Two subjects withdrew prior to exposure to trial products|180
1079946|NCT00978627|2617192|P1|Exposed|Main: Week 0 to 26 (NN5401-3594)|Four subjects withdrew prior to exposure to trial products|362
1079947|NCT00978627|2617191|P2|STARTED|Main: Week 0 to 26 (NN5401-3594)||182
1079948|NCT00978627|2617192|P1|STARTED|Main: Week 0 to 26 (NN5401-3594)||366
1079949|NCT00978731|2617218|P4|NOT COMPLETED|Overall Study||4
1079950|NCT00978731|2617219|P3|NOT COMPLETED|Overall Study||5
1079951|NCT00978731|2617220|P2|NOT COMPLETED|Overall Study||15
1079952|NCT00978731|2617221|P1|NOT COMPLETED|Overall Study||22
1079953|NCT00978731|2617218|P4|COMPLETED|Overall Study||0
1079954|NCT00978731|2617219|P3|COMPLETED|Overall Study||0
1079955|NCT00978731|2617220|P2|COMPLETED|Overall Study||0
1079956|NCT00978731|2617221|P1|COMPLETED|Overall Study||0
1079957|NCT00978731|2617218|P4|STARTED|Overall Study||4
1079958|NCT00978731|2617219|P3|STARTED|Overall Study||5
1079959|NCT00978731|2617220|P2|STARTED|Overall Study||15
1079960|NCT00978731|2617221|P1|STARTED|Overall Study||22
1079961|NCT00978757|2617261|P2|NOT COMPLETED|Overall Study||3
1079962|NCT00978757|2617262|P1|NOT COMPLETED|Overall Study||1
1079963|NCT00978757|2617261|P2|COMPLETED|Overall Study|Junio 2008|17
1079964|NCT00978757|2617262|P1|COMPLETED|Overall Study|Junio 2008|21
1079965|NCT00978757|2617261|P2|STARTED|Overall Study|Junio 2001|20
1079966|NCT00978757|2617262|P1|STARTED|Overall Study|Junio 2001|22
1079967|NCT00979017|2617268|P1|NOT COMPLETED|Overall Study||0
1079968|NCT00979017|2617268|P1|COMPLETED|Overall Study||41
1079969|NCT00979017|2617268|P1|STARTED|Overall Study||41
1079970|NCT00979069|2617278|P2|NOT COMPLETED|Overall Study||2
1079971|NCT00979069|2617279|P1|NOT COMPLETED|Overall Study||0
1079972|NCT00979069|2617278|P2|COMPLETED|Overall Study||8
1079973|NCT00979069|2617279|P1|COMPLETED|Overall Study||10
1079974|NCT00979069|2617278|P2|STARTED|Overall Study||10
1079975|NCT00979069|2617279|P1|STARTED|Overall Study||10
1079976|NCT00979121|2617287|P2|NOT COMPLETED|Overall Study||0
1079977|NCT00979121|2617288|P1|NOT COMPLETED|Overall Study||0
1079978|NCT00979121|2617287|P2|COMPLETED|Overall Study||366
1079979|NCT00979121|2617288|P1|COMPLETED|Overall Study||379
1079980|NCT00979121|2617287|P2|STARTED|Overall Study||366
1079981|NCT00979121|2617288|P1|STARTED|Overall Study||379
1079982|NCT00979199|2617304|P1|NOT COMPLETED|Overall Study||222
1079983|NCT00979199|2617304|P1|COMPLETED|Overall Study||475
1079984|NCT00979199|2617304|P1|STARTED|Overall Study||697
1079985|NCT00979212|2617310|P2|NOT COMPLETED|Overall Study||8
1079986|NCT00979212|2617311|P1|NOT COMPLETED|Overall Study||2
1079987|NCT00979212|2617310|P2|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|39
1079988|NCT00979212|2617311|P1|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|22
1079989|NCT00979212|2617310|P2|STARTED|Overall Study||47
1079990|NCT00979212|2617311|P1|STARTED|Overall Study||24
1079991|NCT00979420|2617333|P4|NOT COMPLETED|Overall Study||2
1079992|NCT00979420|2617334|P3|NOT COMPLETED|Overall Study||1
1079993|NCT00979420|2617335|P2|NOT COMPLETED|Overall Study||0
1079994|NCT00979420|2617336|P1|NOT COMPLETED|Overall Study||7
1079995|NCT00979420|2617333|P4|COMPLETED|Overall Study||59
1079996|NCT00979420|2617334|P3|COMPLETED|Overall Study||59
1079997|NCT00979420|2617335|P2|COMPLETED|Overall Study||57
1079998|NCT00979420|2617336|P1|COMPLETED|Overall Study||171
1079999|NCT00979420|2617333|P4|STARTED|Overall Study||61
1080000|NCT00979420|2617334|P3|STARTED|Overall Study||60
1080001|NCT00979420|2617335|P2|STARTED|Overall Study||57
1080002|NCT00979420|2617336|P1|STARTED|Overall Study||178
1080003|NCT00979459|2617404|P2|NOT COMPLETED|Second Intervention||0
1080004|NCT00979459|2617405|P1|NOT COMPLETED|Second Intervention||0
1080005|NCT00979459|2617404|P2|COMPLETED|Second Intervention||6
1080006|NCT00979459|2617405|P1|COMPLETED|Second Intervention||6
1080007|NCT00979459|2617404|P2|STARTED|Second Intervention||6
1080008|NCT00979459|2617405|P1|STARTED|Second Intervention||6
1080009|NCT00979459|2617404|P2|NOT COMPLETED|7-day Washout Period||0
1080010|NCT00979459|2617405|P1|NOT COMPLETED|7-day Washout Period||0
1080011|NCT00979459|2617404|P2|COMPLETED|7-day Washout Period||6
1080012|NCT00979459|2617405|P1|COMPLETED|7-day Washout Period||6
1080013|NCT00979459|2617404|P2|STARTED|7-day Washout Period||6
1080014|NCT00979459|2617405|P1|STARTED|7-day Washout Period||6
1080015|NCT00979459|2617404|P2|NOT COMPLETED|First Intervention||0
1080016|NCT00979459|2617405|P1|NOT COMPLETED|First Intervention||0
1080017|NCT00979459|2617404|P2|COMPLETED|First Intervention||6
1080018|NCT00979459|2617405|P1|COMPLETED|First Intervention||6
1080019|NCT00979459|2617404|P2|STARTED|First Intervention||6
1080020|NCT00979459|2617405|P1|STARTED|First Intervention||6
1080021|NCT00979576|2617420|P3|NOT COMPLETED|Combination Followed by Monotherapy||1
1080022|NCT00979576|2617421|P2|NOT COMPLETED|Combination Followed by Monotherapy||2
1080023|NCT00979576|2617422|P1|NOT COMPLETED|Combination Followed by Monotherapy||0
1080024|NCT00979576|2617420|P3|COMPLETED|Combination Followed by Monotherapy||0
1080025|NCT00979576|2617421|P2|COMPLETED|Combination Followed by Monotherapy||0
1080026|NCT00979576|2617422|P1|COMPLETED|Combination Followed by Monotherapy||0
1080027|NCT00979576|2617420|P3|STARTED|Combination Followed by Monotherapy||1
1080028|NCT00979576|2617421|P2|STARTED|Combination Followed by Monotherapy||2
1080029|NCT00979576|2617422|P1|STARTED|Combination Followed by Monotherapy||0
1080030|NCT00979576|2617420|P3|NOT COMPLETED|Combination Treatment Phase||9
1080031|NCT00979576|2617421|P2|NOT COMPLETED|Combination Treatment Phase||6
1080032|NCT00979576|2617422|P1|NOT COMPLETED|Combination Treatment Phase||3
1080033|NCT00979576|2617420|P3|COMPLETED|Combination Treatment Phase||0
1080034|NCT00979576|2617421|P2|COMPLETED|Combination Treatment Phase||0
1080035|NCT00979576|2617422|P1|COMPLETED|Combination Treatment Phase||0
1080036|NCT00979576|2617420|P3|STARTED|Combination Treatment Phase||9
1080037|NCT00979576|2617421|P2|STARTED|Combination Treatment Phase||6
1080038|NCT00979576|2617422|P1|STARTED|Combination Treatment Phase||3
1080039|NCT00979602|2617455|P2|NOT COMPLETED|Overall Study||133
1080040|NCT00979602|2617456|P1|NOT COMPLETED|Overall Study||145
1080041|NCT00979602|2617455|P2|COMPLETED|Overall Study||1890
1080042|NCT00979602|2617456|P1|COMPLETED|Overall Study||1880
1080043|NCT00979602|2617455|P2|STARTED|Overall Study||2023
1080044|NCT00979602|2617456|P1|STARTED|Overall Study||2025
1080045|NCT00979615|2617626|P2|NOT COMPLETED|Overall Study||8
1080046|NCT00979615|2617627|P1|NOT COMPLETED|Overall Study||6
1080047|NCT00979615|2617626|P2|COMPLETED|Overall Study||58
1080048|NCT00979615|2617627|P1|COMPLETED|Overall Study||57
1080049|NCT00979615|2617626|P2|STARTED|Overall Study||66
1080050|NCT00979615|2617627|P1|STARTED|Overall Study||63
1080051|NCT00979628|2617644|P3|NOT COMPLETED|Overall Study||6
1080052|NCT00979628|2617645|P2|NOT COMPLETED|Overall Study||9
1080053|NCT00979628|2617646|P1|NOT COMPLETED|Overall Study||9
1080054|NCT00979628|2617644|P3|COMPLETED|Overall Study||74
1080055|NCT00979628|2617645|P2|COMPLETED|Overall Study||133
1080056|NCT00979628|2617646|P1|COMPLETED|Overall Study||144
1080057|NCT00979628|2617644|P3|STARTED|Overall Study||80
1080058|NCT00979628|2617645|P2|STARTED|Overall Study||142
1080059|NCT00979628|2617646|P1|STARTED|Overall Study||153
1080060|NCT00979654|2617654|P1|NOT COMPLETED|Overall Study||36
1080061|NCT00979654|2617654|P1|COMPLETED|Overall Study||67
1080062|NCT00979654|2617654|P1|STARTED|Overall Study||103
1080063|NCT00979875|2617666|P6|NOT COMPLETED|Intervention 3||0
1080064|NCT00979875|2617667|P5|NOT COMPLETED|Intervention 3||0
1080065|NCT00979875|2617668|P4|NOT COMPLETED|Intervention 3||0
1080066|NCT00979875|2617669|P3|NOT COMPLETED|Intervention 3||0
1080067|NCT00979875|2617670|P2|NOT COMPLETED|Intervention 3||0
1080068|NCT00979875|2617671|P1|NOT COMPLETED|Intervention 3||0
1080069|NCT00979875|2617666|P6|COMPLETED|Intervention 3||2
1080070|NCT00979875|2617667|P5|COMPLETED|Intervention 3||3
1080071|NCT00979875|2617668|P4|COMPLETED|Intervention 3||2
1080072|NCT00979875|2617669|P3|COMPLETED|Intervention 3||3
1080073|NCT00979875|2617670|P2|COMPLETED|Intervention 3||2
1080074|NCT00979875|2617671|P1|COMPLETED|Intervention 3||2
1080075|NCT00979875|2617666|P6|STARTED|Intervention 3||2
1080076|NCT00979875|2617667|P5|STARTED|Intervention 3||3
1080077|NCT00979875|2617668|P4|STARTED|Intervention 3||2
1080078|NCT00979875|2617669|P3|STARTED|Intervention 3||3
1080079|NCT00979875|2617670|P2|STARTED|Intervention 3||2
1080080|NCT00979875|2617671|P1|STARTED|Intervention 3||2
1080081|NCT00979875|2617666|P6|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
1080082|NCT00979875|2617667|P5|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
1080083|NCT00979875|2617668|P4|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
1080084|NCT00979875|2617669|P3|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
1080085|NCT00979875|2617670|P2|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
1080086|NCT00979875|2617671|P1|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
1080087|NCT00979875|2617666|P6|COMPLETED|Washout 2 (3 to 14 Days)||2
1080088|NCT00979875|2617667|P5|COMPLETED|Washout 2 (3 to 14 Days)||3
1080089|NCT00979875|2617668|P4|COMPLETED|Washout 2 (3 to 14 Days)||2
1080090|NCT00979875|2617669|P3|COMPLETED|Washout 2 (3 to 14 Days)||3
1080091|NCT00979875|2617670|P2|COMPLETED|Washout 2 (3 to 14 Days)||2
1080092|NCT00979875|2617671|P1|COMPLETED|Washout 2 (3 to 14 Days)||2
1080093|NCT00979875|2617666|P6|STARTED|Washout 2 (3 to 14 Days)||2
1080094|NCT00979875|2617667|P5|STARTED|Washout 2 (3 to 14 Days)||3
1080095|NCT00979875|2617668|P4|STARTED|Washout 2 (3 to 14 Days)||2
1080096|NCT00979875|2617669|P3|STARTED|Washout 2 (3 to 14 Days)||3
1080097|NCT00979875|2617670|P2|STARTED|Washout 2 (3 to 14 Days)||2
1080098|NCT00979875|2617671|P1|STARTED|Washout 2 (3 to 14 Days)||2
1080099|NCT00979875|2617666|P6|NOT COMPLETED|Intervention 2||0
1080100|NCT00979875|2617667|P5|NOT COMPLETED|Intervention 2||0
1080101|NCT00979875|2617668|P4|NOT COMPLETED|Intervention 2||0
1080102|NCT00979875|2617669|P3|NOT COMPLETED|Intervention 2||0
1080103|NCT00979875|2617670|P2|NOT COMPLETED|Intervention 2||0
1080104|NCT00979875|2617671|P1|NOT COMPLETED|Intervention 2||0
1080105|NCT00979875|2617666|P6|COMPLETED|Intervention 2||2
1080106|NCT00979875|2617667|P5|COMPLETED|Intervention 2||3
1080107|NCT00979875|2617668|P4|COMPLETED|Intervention 2||2
1080108|NCT00979875|2617669|P3|COMPLETED|Intervention 2||3
1080109|NCT00979875|2617670|P2|COMPLETED|Intervention 2||2
1080110|NCT00979875|2617671|P1|COMPLETED|Intervention 2||2
1080111|NCT00979875|2617666|P6|STARTED|Intervention 2||2
1080112|NCT00979875|2617667|P5|STARTED|Intervention 2||3
1080113|NCT00979875|2617668|P4|STARTED|Intervention 2||2
1080114|NCT00979875|2617669|P3|STARTED|Intervention 2||3
1080115|NCT00979875|2617670|P2|STARTED|Intervention 2||2
1080116|NCT00979875|2617671|P1|STARTED|Intervention 2||2
1080117|NCT00979875|2617666|P6|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
1080118|NCT00979875|2617667|P5|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
1080119|NCT00979875|2617668|P4|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
1080120|NCT00979875|2617669|P3|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
1080121|NCT00979875|2617670|P2|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
1080122|NCT00979875|2617671|P1|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
1080123|NCT00979875|2617666|P6|COMPLETED|Washout 1 (3 to 14 Days)||2
1080124|NCT00979875|2617667|P5|COMPLETED|Washout 1 (3 to 14 Days)||3
1080125|NCT00979875|2617668|P4|COMPLETED|Washout 1 (3 to 14 Days)||2
1080126|NCT00979875|2617669|P3|COMPLETED|Washout 1 (3 to 14 Days)||3
1080127|NCT00979875|2617670|P2|COMPLETED|Washout 1 (3 to 14 Days)||2
1080128|NCT00979875|2617671|P1|COMPLETED|Washout 1 (3 to 14 Days)||2
1080129|NCT00979875|2617666|P6|STARTED|Washout 1 (3 to 14 Days)||2
1080130|NCT00979875|2617667|P5|STARTED|Washout 1 (3 to 14 Days)||3
1080131|NCT00979875|2617668|P4|STARTED|Washout 1 (3 to 14 Days)||2
1080132|NCT00979875|2617669|P3|STARTED|Washout 1 (3 to 14 Days)||3
1080133|NCT00979875|2617670|P2|STARTED|Washout 1 (3 to 14 Days)||2
1080134|NCT00979875|2617671|P1|STARTED|Washout 1 (3 to 14 Days)||2
1080135|NCT00979875|2617666|P6|NOT COMPLETED|Intervention 1||0
1080136|NCT00979875|2617667|P5|NOT COMPLETED|Intervention 1||0
1080137|NCT00979875|2617668|P4|NOT COMPLETED|Intervention 1||0
1080138|NCT00979875|2617669|P3|NOT COMPLETED|Intervention 1||0
1080139|NCT00979875|2617670|P2|NOT COMPLETED|Intervention 1||0
1080140|NCT00979875|2617671|P1|NOT COMPLETED|Intervention 1||0
1080141|NCT00979875|2617666|P6|COMPLETED|Intervention 1||2
1080142|NCT00979875|2617667|P5|COMPLETED|Intervention 1||3
1080143|NCT00979875|2617668|P4|COMPLETED|Intervention 1||2
1080144|NCT00979875|2617669|P3|COMPLETED|Intervention 1||3
1080145|NCT00979875|2617670|P2|COMPLETED|Intervention 1||2
1080146|NCT00979875|2617671|P1|COMPLETED|Intervention 1||2
1080147|NCT00979875|2617666|P6|Received at Least 1 Dose of Study Drug|Intervention 1||2
1080148|NCT00979875|2617667|P5|Received at Least 1 Dose of Study Drug|Intervention 1||3
1080149|NCT00979875|2617668|P4|Received at Least 1 Dose of Study Drug|Intervention 1||2
1080150|NCT00979875|2617669|P3|Received at Least 1 Dose of Study Drug|Intervention 1||3
1080151|NCT00979875|2617670|P2|Received at Least 1 Dose of Study Drug|Intervention 1||2
1080152|NCT00979875|2617671|P1|Received at Least 1 Dose of Study Drug|Intervention 1||2
1080153|NCT00979875|2617666|P6|STARTED|Intervention 1||2
1080154|NCT00979875|2617667|P5|STARTED|Intervention 1||3
1080155|NCT00979875|2617668|P4|STARTED|Intervention 1||2
1080156|NCT00979875|2617669|P3|STARTED|Intervention 1||3
1080157|NCT00979875|2617670|P2|STARTED|Intervention 1||2
1080158|NCT00979875|2617671|P1|STARTED|Intervention 1||2
1080159|NCT00979901|2617719|P4|NOT COMPLETED|Overall Study||116
1080160|NCT00979901|2617720|P3|NOT COMPLETED|Overall Study||29
1080161|NCT00979901|2617721|P2|NOT COMPLETED|Overall Study||12
1080162|NCT00979901|2617722|P1|NOT COMPLETED|Overall Study||18
1080163|NCT00979901|2617719|P4|COMPLETED|Overall Study||159
1080164|NCT00979901|2617720|P3|COMPLETED|Overall Study||573
1080165|NCT00979901|2617721|P2|COMPLETED|Overall Study||336
1080166|NCT00979901|2617722|P1|COMPLETED|Overall Study||334
1080167|NCT00979901|2617719|P4|STARTED|Overall Study||275
1080168|NCT00979901|2617720|P3|STARTED|Overall Study||602
1080169|NCT00979901|2617721|P2|STARTED|Overall Study||348
1080170|NCT00979901|2617722|P1|STARTED|Overall Study||352
1080171|NCT00979940|2617748|P2|NOT COMPLETED|Overall Study||0
1080172|NCT00979940|2617749|P1|NOT COMPLETED|Overall Study||0
1080173|NCT00979940|2617748|P2|COMPLETED|Overall Study||28
1080174|NCT00979940|2617749|P1|COMPLETED|Overall Study||32
1080175|NCT00979940|2617748|P2|STARTED|Overall Study||28
1080176|NCT00979940|2617749|P1|STARTED|Overall Study||32
1080177|NCT00979953|2617759|P4|NOT COMPLETED|Overall Study||7
1080178|NCT00979953|2617760|P3|NOT COMPLETED|Overall Study||22
1080179|NCT00979953|2617761|P2|NOT COMPLETED|Overall Study||5
1080180|NCT00979953|2617762|P1|NOT COMPLETED|Overall Study||8
1080181|NCT00979953|2617759|P4|COMPLETED|Overall Study||97
1080182|NCT00979953|2617760|P3|COMPLETED|Overall Study||82
1080183|NCT00979953|2617761|P2|COMPLETED|Overall Study||94
1080184|NCT00979953|2617762|P1|COMPLETED|Overall Study||93
1080185|NCT00979953|2617759|P4|Received at Least 1 Dose of Study Drug|Overall Study||104
1080186|NCT00979953|2617760|P3|Received at Least 1 Dose of Study Drug|Overall Study||104
1080187|NCT00979953|2617761|P2|Received at Least 1 Dose of Study Drug|Overall Study||99
1080188|NCT00979953|2617762|P1|Received at Least 1 Dose of Study Drug|Overall Study||101
1080189|NCT00979953|2617759|P4|STARTED|Overall Study||104
1080190|NCT00979953|2617760|P3|STARTED|Overall Study||104
1080191|NCT00979953|2617761|P2|STARTED|Overall Study||99
1080192|NCT00979953|2617762|P1|STARTED|Overall Study||101
1080193|NCT00979992|2617772|P1|NOT COMPLETED|Overall Study||5
1080194|NCT00979992|2617772|P1|COMPLETED|Overall Study||30
1080195|NCT00979992|2617772|P1|STARTED|Overall Study||35
1080196|NCT00980005|2617782|P2|NOT COMPLETED|Overall Study||63
1080197|NCT00980005|2617783|P1|NOT COMPLETED|Overall Study||47
1080198|NCT00980005|2617782|P2|COMPLETED|Overall Study||998
1080199|NCT00980005|2617783|P1|COMPLETED|Overall Study||1008
1080200|NCT00980005|2617782|P2|STARTED|Overall Study||1061
1080201|NCT00980005|2617783|P1|STARTED|Overall Study||1055
1080202|NCT00980044|2617826|P3|NOT COMPLETED|Overall Study||5
1080203|NCT00980044|2617827|P2|NOT COMPLETED|Overall Study||7
1080204|NCT00980044|2617828|P1|NOT COMPLETED|Overall Study||5
1080205|NCT00980044|2617826|P3|COMPLETED|Overall Study||12
1080206|NCT00980044|2617827|P2|COMPLETED|Overall Study||12
1080207|NCT00980044|2617828|P1|COMPLETED|Overall Study||12
1080208|NCT00980044|2617826|P3|STARTED|Overall Study||17
1080209|NCT00980044|2617827|P2|STARTED|Overall Study||19
1080210|NCT00980044|2617828|P1|STARTED|Overall Study||17
1080211|NCT00980148|2617847|P2|NOT COMPLETED|Overall Study||128
1080212|NCT00980148|2617848|P1|NOT COMPLETED|Overall Study||129
1080213|NCT00980148|2617847|P2|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
1080214|NCT00980148|2617848|P1|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
1080215|NCT00980148|2617847|P2|STARTED|Overall Study||283
1080216|NCT00980148|2617848|P1|STARTED|Overall Study||284
1080217|NCT00980174|2617856|P2|NOT COMPLETED|Overall Study||10
1080218|NCT00980174|2617857|P1|NOT COMPLETED|Overall Study||4
1080219|NCT00980174|2617856|P2|COMPLETED|Overall Study||111
1080220|NCT00980174|2617857|P1|COMPLETED|Overall Study||117
1080221|NCT00980174|2617856|P2|STARTED|Overall Study||121
1080222|NCT00980174|2617857|P1|STARTED|Overall Study||121
1080223|NCT00980200|2617873|P5|NOT COMPLETED|7-day Treatment Period 5||0
1080224|NCT00980200|2617874|P4|NOT COMPLETED|7-day Treatment Period 5||0
1080225|NCT00980200|2617875|P3|NOT COMPLETED|7-day Treatment Period 5||0
1080226|NCT00980200|2617876|P2|NOT COMPLETED|7-day Treatment Period 5||0
1080227|NCT00980200|2617877|P1|NOT COMPLETED|7-day Treatment Period 5||0
1080228|NCT00980200|2617873|P5|COMPLETED|7-day Treatment Period 5||14
1080229|NCT00980200|2617874|P4|COMPLETED|7-day Treatment Period 5||16
1080230|NCT00980200|2617875|P3|COMPLETED|7-day Treatment Period 5||15
1080231|NCT00980200|2617876|P2|COMPLETED|7-day Treatment Period 5||12
1080232|NCT00980200|2617877|P1|COMPLETED|7-day Treatment Period 5||15
1080233|NCT00980200|2617873|P5|STARTED|7-day Treatment Period 5||14
1080234|NCT00980200|2617874|P4|STARTED|7-day Treatment Period 5||16
1080235|NCT00980200|2617875|P3|STARTED|7-day Treatment Period 5||15
1080236|NCT00980200|2617876|P2|STARTED|7-day Treatment Period 5||12
1080237|NCT00980200|2617877|P1|STARTED|7-day Treatment Period 5||15
1080238|NCT00980200|2617873|P5|NOT COMPLETED|7-day Washout Period 4||0
1080239|NCT00980200|2617874|P4|NOT COMPLETED|7-day Washout Period 4||0
1080240|NCT00980200|2617875|P3|NOT COMPLETED|7-day Washout Period 4||0
1080241|NCT00980200|2617876|P2|NOT COMPLETED|7-day Washout Period 4||0
1080242|NCT00980200|2617877|P1|NOT COMPLETED|7-day Washout Period 4||0
1080243|NCT00980200|2617873|P5|COMPLETED|7-day Washout Period 4||14
1080244|NCT00980200|2617874|P4|COMPLETED|7-day Washout Period 4||16
1080245|NCT00980200|2617875|P3|COMPLETED|7-day Washout Period 4||15
1080246|NCT00980200|2617876|P2|COMPLETED|7-day Washout Period 4||12
1080247|NCT00980200|2617877|P1|COMPLETED|7-day Washout Period 4||15
1080248|NCT00980200|2617873|P5|STARTED|7-day Washout Period 4||14
1080249|NCT00980200|2617874|P4|STARTED|7-day Washout Period 4||16
1080250|NCT00980200|2617875|P3|STARTED|7-day Washout Period 4||15
1080251|NCT00980200|2617876|P2|STARTED|7-day Washout Period 4||12
1080252|NCT00980200|2617877|P1|STARTED|7-day Washout Period 4||15
1080253|NCT00980200|2617873|P5|NOT COMPLETED|7-day Treatment Period 4||0
1080254|NCT00980200|2617874|P4|NOT COMPLETED|7-day Treatment Period 4||0
1080255|NCT00980200|2617875|P3|NOT COMPLETED|7-day Treatment Period 4||0
1080256|NCT00980200|2617876|P2|NOT COMPLETED|7-day Treatment Period 4||0
1080257|NCT00980200|2617877|P1|NOT COMPLETED|7-day Treatment Period 4||0
1080258|NCT00980200|2617873|P5|COMPLETED|7-day Treatment Period 4||14
1080259|NCT00980200|2617874|P4|COMPLETED|7-day Treatment Period 4||16
1080260|NCT00980200|2617875|P3|COMPLETED|7-day Treatment Period 4||15
1080261|NCT00980200|2617876|P2|COMPLETED|7-day Treatment Period 4||12
1080262|NCT00980200|2617877|P1|COMPLETED|7-day Treatment Period 4||15
1080263|NCT00980200|2617873|P5|STARTED|7-day Treatment Period 4||14
1080264|NCT00980200|2617874|P4|STARTED|7-day Treatment Period 4||16
1080265|NCT00980200|2617875|P3|STARTED|7-day Treatment Period 4||15
1080266|NCT00980200|2617876|P2|STARTED|7-day Treatment Period 4||12
1080267|NCT00980200|2617877|P1|STARTED|7-day Treatment Period 4||15
1080268|NCT00980200|2617873|P5|NOT COMPLETED|7-day Washout Period 3||0
1080269|NCT00980200|2617874|P4|NOT COMPLETED|7-day Washout Period 3||0
1080270|NCT00980200|2617875|P3|NOT COMPLETED|7-day Washout Period 3||0
1080271|NCT00980200|2617876|P2|NOT COMPLETED|7-day Washout Period 3||0
1080272|NCT00980200|2617877|P1|NOT COMPLETED|7-day Washout Period 3||0
1080273|NCT00980200|2617873|P5|COMPLETED|7-day Washout Period 3||14
1080274|NCT00980200|2617874|P4|COMPLETED|7-day Washout Period 3||16
1080275|NCT00980200|2617875|P3|COMPLETED|7-day Washout Period 3||15
1080276|NCT00980200|2617876|P2|COMPLETED|7-day Washout Period 3||12
1080277|NCT00980200|2617877|P1|COMPLETED|7-day Washout Period 3||15
1080278|NCT00980200|2617873|P5|STARTED|7-day Washout Period 3||14
1080279|NCT00980200|2617874|P4|STARTED|7-day Washout Period 3||16
1080280|NCT00980200|2617875|P3|STARTED|7-day Washout Period 3||15
1080281|NCT00980200|2617876|P2|STARTED|7-day Washout Period 3||12
1080282|NCT00980200|2617877|P1|STARTED|7-day Washout Period 3||15
1080283|NCT00980200|2617873|P5|NOT COMPLETED|7-day Treatment Period 3||1
1080284|NCT00980200|2617874|P4|NOT COMPLETED|7-day Treatment Period 3||0
1080285|NCT00980200|2617875|P3|NOT COMPLETED|7-day Treatment Period 3||0
1080286|NCT00980200|2617876|P2|NOT COMPLETED|7-day Treatment Period 3||1
1080287|NCT00980200|2617877|P1|NOT COMPLETED|7-day Treatment Period 3||0
1080288|NCT00980200|2617873|P5|COMPLETED|7-day Treatment Period 3||14
1080289|NCT00980200|2617874|P4|COMPLETED|7-day Treatment Period 3||16
1080290|NCT00980200|2617875|P3|COMPLETED|7-day Treatment Period 3||15
1080291|NCT00980200|2617876|P2|COMPLETED|7-day Treatment Period 3||12
1080292|NCT00980200|2617877|P1|COMPLETED|7-day Treatment Period 3||15
1080293|NCT00980200|2617873|P5|STARTED|7-day Treatment Period 3||15
1080294|NCT00980200|2617874|P4|STARTED|7-day Treatment Period 3||16
1080295|NCT00980200|2617875|P3|STARTED|7-day Treatment Period 3||15
1080296|NCT00980200|2617876|P2|STARTED|7-day Treatment Period 3||13
1080297|NCT00980200|2617877|P1|STARTED|7-day Treatment Period 3||15
1080298|NCT00980200|2617873|P5|NOT COMPLETED|7-day Washout Period 2||0
1080299|NCT00980200|2617874|P4|NOT COMPLETED|7-day Washout Period 2||0
1080300|NCT00980200|2617875|P3|NOT COMPLETED|7-day Washout Period 2||0
1080301|NCT00980200|2617876|P2|NOT COMPLETED|7-day Washout Period 2||0
1080302|NCT00980200|2617877|P1|NOT COMPLETED|7-day Washout Period 2||0
1080303|NCT00980200|2617873|P5|COMPLETED|7-day Washout Period 2||15
1080304|NCT00980200|2617874|P4|COMPLETED|7-day Washout Period 2||16
1080305|NCT00980200|2617875|P3|COMPLETED|7-day Washout Period 2||15
1080306|NCT00980200|2617876|P2|COMPLETED|7-day Washout Period 2||13
1080307|NCT00980200|2617877|P1|COMPLETED|7-day Washout Period 2||15
1080308|NCT00980200|2617873|P5|STARTED|7-day Washout Period 2||15
1080309|NCT00980200|2617874|P4|STARTED|7-day Washout Period 2||16
1080310|NCT00980200|2617875|P3|STARTED|7-day Washout Period 2||15
1080311|NCT00980200|2617876|P2|STARTED|7-day Washout Period 2||13
1080312|NCT00980200|2617877|P1|STARTED|7-day Washout Period 2||15
1080313|NCT00980200|2617873|P5|NOT COMPLETED|7-day Treatment Period 2||0
1080314|NCT00980200|2617874|P4|NOT COMPLETED|7-day Treatment Period 2||0
1080315|NCT00980200|2617875|P3|NOT COMPLETED|7-day Treatment Period 2||0
1080316|NCT00980200|2617876|P2|NOT COMPLETED|7-day Treatment Period 2||0
1080317|NCT00980200|2617877|P1|NOT COMPLETED|7-day Treatment Period 2||0
1080318|NCT00980200|2617873|P5|COMPLETED|7-day Treatment Period 2||15
1080319|NCT00980200|2617874|P4|COMPLETED|7-day Treatment Period 2||16
1080320|NCT00980200|2617875|P3|COMPLETED|7-day Treatment Period 2||15
1080321|NCT00980200|2617876|P2|COMPLETED|7-day Treatment Period 2||13
1080322|NCT00980200|2617877|P1|COMPLETED|7-day Treatment Period 2||15
1080323|NCT00980200|2617873|P5|STARTED|7-day Treatment Period 2||15
1080324|NCT00980200|2617874|P4|STARTED|7-day Treatment Period 2||16
1080325|NCT00980200|2617875|P3|STARTED|7-day Treatment Period 2||15
1080326|NCT00980200|2617876|P2|STARTED|7-day Treatment Period 2||13
1080327|NCT00980200|2617877|P1|STARTED|7-day Treatment Period 2||15
1080328|NCT00980200|2617873|P5|NOT COMPLETED|7-day Washout Period 1||0
1080329|NCT00980200|2617874|P4|NOT COMPLETED|7-day Washout Period 1||0
1080330|NCT00980200|2617875|P3|NOT COMPLETED|7-day Washout Period 1||0
1080331|NCT00980200|2617876|P2|NOT COMPLETED|7-day Washout Period 1||0
1080332|NCT00980200|2617877|P1|NOT COMPLETED|7-day Washout Period 1||0
1080333|NCT00980200|2617873|P5|COMPLETED|7-day Washout Period 1||15
1080334|NCT00980200|2617874|P4|COMPLETED|7-day Washout Period 1||16
1080335|NCT00980200|2617875|P3|COMPLETED|7-day Washout Period 1||15
1080336|NCT00980200|2617876|P2|COMPLETED|7-day Washout Period 1||13
1080337|NCT00980200|2617877|P1|COMPLETED|7-day Washout Period 1||15
1080338|NCT00980200|2617873|P5|STARTED|7-day Washout Period 1||15
1080339|NCT00980200|2617874|P4|STARTED|7-day Washout Period 1||16
1080340|NCT00980200|2617875|P3|STARTED|7-day Washout Period 1||15
1080341|NCT00980200|2617876|P2|STARTED|7-day Washout Period 1||13
1080342|NCT00980200|2617877|P1|STARTED|7-day Washout Period 1||15
1080343|NCT00980200|2617873|P5|NOT COMPLETED|7-day Treatment Period 1||0
1080344|NCT00980200|2617874|P4|NOT COMPLETED|7-day Treatment Period 1||0
1080345|NCT00980200|2617875|P3|NOT COMPLETED|7-day Treatment Period 1||0
1080346|NCT00980200|2617876|P2|NOT COMPLETED|7-day Treatment Period 1||1
1080347|NCT00980200|2617877|P1|NOT COMPLETED|7-day Treatment Period 1||0
1080348|NCT00980200|2617873|P5|COMPLETED|7-day Treatment Period 1||15
1080349|NCT00980200|2617874|P4|COMPLETED|7-day Treatment Period 1||16
1080350|NCT00980200|2617875|P3|COMPLETED|7-day Treatment Period 1||15
1080351|NCT00980200|2617876|P2|COMPLETED|7-day Treatment Period 1||13
1080352|NCT00980200|2617877|P1|COMPLETED|7-day Treatment Period 1||15
1080353|NCT00980200|2617873|P5|STARTED|7-day Treatment Period 1||15
1080354|NCT00980200|2617874|P4|STARTED|7-day Treatment Period 1||16
1080355|NCT00980200|2617875|P3|STARTED|7-day Treatment Period 1||15
1080356|NCT00980200|2617876|P2|STARTED|7-day Treatment Period 1||14
1080357|NCT00980200|2617877|P1|STARTED|7-day Treatment Period 1||15
1080358|NCT00980278|2617896|P2|NOT COMPLETED|Overall Study||0
1080359|NCT00980278|2617897|P1|NOT COMPLETED|Overall Study||2
1080360|NCT00980278|2617896|P2|COMPLETED|Overall Study||13
1080361|NCT00980278|2617897|P1|COMPLETED|Overall Study||11
1080362|NCT00980278|2617896|P2|STARTED|Overall Study||13
1080363|NCT00980278|2617897|P1|STARTED|Overall Study||13
1080364|NCT00980330|2617918|P7|NOT COMPLETED|Overall Study||7
1080365|NCT00980330|2617919|P6|NOT COMPLETED|Overall Study||4
1080366|NCT00980330|2617920|P5|NOT COMPLETED|Overall Study||5
1080367|NCT00980330|2617921|P4|NOT COMPLETED|Overall Study||5
1080368|NCT00980330|2617922|P3|NOT COMPLETED|Overall Study||8
1080369|NCT00980330|2617923|P2|NOT COMPLETED|Overall Study||5
1080370|NCT00980330|2617924|P1|NOT COMPLETED|Overall Study||5
1080371|NCT00980330|2617918|P7|COMPLETED|Overall Study||59
1080372|NCT00980330|2617919|P6|COMPLETED|Overall Study||61
1080373|NCT00980330|2617920|P5|COMPLETED|Overall Study||63
1080374|NCT00980330|2617921|P4|COMPLETED|Overall Study||61
1080375|NCT00980330|2617922|P3|COMPLETED|Overall Study||58
1080376|NCT00980330|2617923|P2|COMPLETED|Overall Study||60
1080377|NCT00980330|2617924|P1|COMPLETED|Overall Study||61
1080378|NCT00980330|2617918|P7|STARTED|Overall Study||66
1080379|NCT00980330|2617919|P6|STARTED|Overall Study||65
1080380|NCT00980330|2617920|P5|STARTED|Overall Study||68
1080381|NCT00980330|2617921|P4|STARTED|Overall Study||66
1080382|NCT00980330|2617922|P3|STARTED|Overall Study||66
1080383|NCT00980330|2617923|P2|STARTED|Overall Study||65
1080384|NCT00980330|2617924|P1|STARTED|Overall Study||66
1080385|NCT00980343|2618024|P2|NOT COMPLETED|Overall Study||3
1080386|NCT00980343|2618025|P1|NOT COMPLETED|Overall Study||1
1080387|NCT00980343|2618024|P2|COMPLETED|Overall Study||20
1080388|NCT00980343|2618025|P1|COMPLETED|Overall Study||20
1080389|NCT00980343|2618024|P2|STARTED|Overall Study||23
1080390|NCT00980343|2618025|P1|STARTED|Overall Study||21
1080391|NCT00980590|2618044|P2|NOT COMPLETED|Overall Study||0
1080392|NCT00980590|2618045|P1|NOT COMPLETED|Overall Study||0
1080393|NCT00980590|2618044|P2|COMPLETED|Overall Study||50
1080394|NCT00980590|2618045|P1|COMPLETED|Overall Study||50
1080395|NCT00980590|2618044|P2|STARTED|Overall Study||50
1080396|NCT00980590|2618045|P1|STARTED|Overall Study||50
1080397|NCT00980642|2618059|P2|NOT COMPLETED|Overall Study||0
1080398|NCT00980642|2618060|P1|NOT COMPLETED|Overall Study||0
1080399|NCT00980642|2618059|P2|COMPLETED|Overall Study||20
1080400|NCT00980642|2618060|P1|COMPLETED|Overall Study||36
1080401|NCT00980642|2618059|P2|STARTED|Overall Study||20
1080402|NCT00980642|2618060|P1|STARTED|Overall Study||36
1080403|NCT00980655|2618072|P2|NOT COMPLETED|Overall Study||51
1080404|NCT00980655|2618073|P1|NOT COMPLETED|Overall Study||16
1080405|NCT00980655|2618072|P2|COMPLETED|Overall Study||139
1080406|NCT00980655|2618073|P1|COMPLETED|Overall Study||45
1080407|NCT00980655|2618072|P2|Vaccinated 23vPS Dose|Overall Study||140
1080408|NCT00980655|2618073|P1|Vaccinated 23vPS Dose|Overall Study||45
1080409|NCT00980655|2618072|P2|Vaccinated 13vPnC Dose 4|Overall Study||146
1080410|NCT00980655|2618073|P1|Vaccinated 13vPnC Dose 4|Overall Study||46
1080411|NCT00980655|2618072|P2|Vaccinated 13vPnC Dose 3|Overall Study||167
1080412|NCT00980655|2618073|P1|Vaccinated 13vPnC Dose 3|Overall Study||54
1080413|NCT00980655|2618072|P2|Vaccinated 13vPnC Dose 2|Overall Study||176
1080414|NCT00980655|2618073|P1|Vaccinated 13vPnC Dose 2|Overall Study||55
1080415|NCT00980655|2618072|P2|Vaccinated 13vPnC Dose 1|Overall Study||188
1080416|NCT00980655|2618073|P1|Vaccinated 13vPnC Dose 1|Overall Study||59
1080417|NCT00980655|2618072|P2|STARTED|Overall Study||190
1080418|NCT00980655|2618073|P1|STARTED|Overall Study||61
1080419|NCT00980681|2618119|P1|NOT COMPLETED|Dotarem MRA||0
1080420|NCT00980681|2618119|P1|COMPLETED|Dotarem MRA||10
1080421|NCT00980681|2618119|P1|STARTED|Dotarem MRA|Out of the 13 enrolled patients, three did not receive treatment|10
1080422|NCT00980681|2618119|P1|NOT COMPLETED|TOF MRA||0
1080423|NCT00980681|2618119|P1|COMPLETED|TOF MRA||10
1080424|NCT00980681|2618119|P1|STARTED|TOF MRA|Out of the 13 enrolled patients, three did not receive treatment|10
1080425|NCT00980746|2618131|P6|NOT COMPLETED|Overall Study||18
1080426|NCT00980746|2618132|P5|NOT COMPLETED|Overall Study||17
1080427|NCT00980746|2618133|P4|NOT COMPLETED|Overall Study||36
1080428|NCT00980746|2618134|P3|NOT COMPLETED|Overall Study||20
1080429|NCT00980746|2618135|P2|NOT COMPLETED|Overall Study||22
1080430|NCT00980746|2618136|P1|NOT COMPLETED|Overall Study||27
1080431|NCT00980746|2618131|P6|COMPLETED|Overall Study||78
1080432|NCT00980746|2618132|P5|COMPLETED|Overall Study||75
1080433|NCT00980746|2618133|P4|COMPLETED|Overall Study||64
1080434|NCT00980746|2618134|P3|COMPLETED|Overall Study||75
1080435|NCT00980746|2618135|P2|COMPLETED|Overall Study||67
1080436|NCT00980746|2618136|P1|COMPLETED|Overall Study||58
1080437|NCT00980746|2618131|P6|Per-protocol|Overall Study||74
1080438|NCT00980746|2618132|P5|Per-protocol|Overall Study||73
1080439|NCT00980746|2618133|P4|Per-protocol|Overall Study||62
1080440|NCT00980746|2618134|P3|Per-protocol|Overall Study||73
1080441|NCT00980746|2618135|P2|Per-protocol|Overall Study||66
1080442|NCT00980746|2618136|P1|Per-protocol|Overall Study||55
1080443|NCT00980746|2618131|P6|Safety Population|Overall Study||96
1080444|NCT00980746|2618132|P5|Safety Population|Overall Study||92
1080445|NCT00980746|2618133|P4|Safety Population|Overall Study||100
1080446|NCT00980746|2618134|P3|Safety Population|Overall Study||95
1080447|NCT00980746|2618135|P2|Safety Population|Overall Study||89
1080448|NCT00980746|2618136|P1|Safety Population|Overall Study||85
1080449|NCT00980746|2618131|P6|Randomized|Overall Study||96
1080450|NCT00980746|2618132|P5|Randomized|Overall Study||92
1080451|NCT00980746|2618133|P4|Randomized|Overall Study||100
1080452|NCT00980746|2618134|P3|Randomized|Overall Study||95
1080453|NCT00980746|2618135|P2|Randomized|Overall Study||89
1080454|NCT00980746|2618136|P1|Randomized|Overall Study||85
1080455|NCT00980746|2618131|P6|STARTED|Overall Study||96
1080456|NCT00980746|2618132|P5|STARTED|Overall Study||92
1080457|NCT00980746|2618133|P4|STARTED|Overall Study||100
1080458|NCT00980746|2618134|P3|STARTED|Overall Study||95
1080459|NCT00980746|2618135|P2|STARTED|Overall Study||89
1080460|NCT00980746|2618136|P1|STARTED|Overall Study||85
1080461|NCT00980798|2618152|P2|NOT COMPLETED|Overall Study||55
1080462|NCT00980798|2618153|P1|NOT COMPLETED|Overall Study||33
1080463|NCT00980798|2618152|P2|COMPLETED|Overall Study||84
1080464|NCT00980798|2618153|P1|COMPLETED|Overall Study||116
1080465|NCT00980798|2618152|P2|STARTED|Overall Study||139
1080466|NCT00980798|2618153|P1|STARTED|Overall Study||149
1080467|NCT00980980|2618164|P3|NOT COMPLETED|Overall Study||0
1080468|NCT00980980|2618165|P2|NOT COMPLETED|Overall Study||1
1080469|NCT00980980|2618166|P1|NOT COMPLETED|Overall Study||0
1080470|NCT00980980|2618164|P3|COMPLETED|Overall Study||13
1080471|NCT00980980|2618165|P2|COMPLETED|Overall Study||13
1080472|NCT00980980|2618166|P1|COMPLETED|Overall Study||16
1080473|NCT00980980|2618164|P3|STARTED|Overall Study||13
1080474|NCT00980980|2618165|P2|STARTED|Overall Study||14
1080475|NCT00980980|2618166|P1|STARTED|Overall Study||16
1080476|NCT00981019|2618195|P1|NOT COMPLETED|Overall Study||477
1080477|NCT00981019|2618195|P1|COMPLETED|Overall Study||301
1080478|NCT00981019|2618195|P1|STARTED|Overall Study||778
1080479|NCT00981045|2618201|P2|NOT COMPLETED|Overall Study||9
1080480|NCT00981045|2618202|P1|NOT COMPLETED|Overall Study||14
1080481|NCT00981045|2618201|P2|COMPLETED|Overall Study||1285
1080482|NCT00981045|2618202|P1|COMPLETED|Overall Study||1276
1080483|NCT00981045|2618201|P2|STARTED|Overall Study||1294
1080484|NCT00981045|2618202|P1|STARTED|Overall Study||1290
1080485|NCT00981058|2618212|P2|NOT COMPLETED|Overall Study||97
1080486|NCT00981058|2618213|P1|NOT COMPLETED|Overall Study||120
1080487|NCT00981058|2618212|P2|COMPLETED|Overall Study||451
1080488|NCT00981058|2618213|P1|COMPLETED|Overall Study||425
1080489|NCT00981058|2618212|P2|Death Due to Any Cause|Overall Study||442
1080490|NCT00981058|2618213|P1|Death Due to Any Cause|Overall Study||418
1080491|NCT00981058|2618212|P2|Received at Least 1 Dose of Study Drug|Overall Study||541
1080492|NCT00981058|2618213|P1|Received at Least 1 Dose of Study Drug|Overall Study||538
1080493|NCT00981058|2618212|P2|STARTED|Overall Study||548
1080494|NCT00981058|2618213|P1|STARTED|Overall Study||545
1080495|NCT00981084|2618235|P2|NOT COMPLETED|Post Intervention (Data Analysis)||1
1080496|NCT00981084|2618236|P1|NOT COMPLETED|Post Intervention (Data Analysis)||2
1080497|NCT00981084|2618235|P2|COMPLETED|Post Intervention (Data Analysis)||16
1080498|NCT00981084|2618236|P1|COMPLETED|Post Intervention (Data Analysis)||14
1080499|NCT00981084|2618235|P2|STARTED|Post Intervention (Data Analysis)||17
1080500|NCT00981084|2618236|P1|STARTED|Post Intervention (Data Analysis)||16
1080501|NCT00981084|2618235|P2|NOT COMPLETED|Second Intervention (One Day)||0
1080502|NCT00981084|2618236|P1|NOT COMPLETED|Second Intervention (One Day)||0
1080503|NCT00981084|2618235|P2|COMPLETED|Second Intervention (One Day)||17
1080504|NCT00981084|2618236|P1|COMPLETED|Second Intervention (One Day)||16
1080505|NCT00981084|2618235|P2|STARTED|Second Intervention (One Day)||17
1080506|NCT00981084|2618236|P1|STARTED|Second Intervention (One Day)||16
1080507|NCT00981084|2618235|P2|NOT COMPLETED|Washout Period (7 Days)||0
1080508|NCT00981084|2618236|P1|NOT COMPLETED|Washout Period (7 Days)||0
1080509|NCT00981084|2618235|P2|COMPLETED|Washout Period (7 Days)||17
1080510|NCT00981084|2618236|P1|COMPLETED|Washout Period (7 Days)||16
1080511|NCT00981084|2618235|P2|STARTED|Washout Period (7 Days)||17
1080512|NCT00981084|2618236|P1|STARTED|Washout Period (7 Days)||16
1080513|NCT00981084|2618235|P2|NOT COMPLETED|First Intervention (One Day)||0
1080514|NCT00981084|2618236|P1|NOT COMPLETED|First Intervention (One Day)||0
1080515|NCT00981084|2618235|P2|COMPLETED|First Intervention (One Day)||17
1080516|NCT00981084|2618236|P1|COMPLETED|First Intervention (One Day)||16
1080517|NCT00981084|2618235|P2|STARTED|First Intervention (One Day)||17
1080518|NCT00981084|2618236|P1|STARTED|First Intervention (One Day)||16
1080519|NCT00981175|2618253|P2|NOT COMPLETED|Booster Dose Vaccination||3
1080520|NCT00981175|2618254|P1|NOT COMPLETED|Booster Dose Vaccination||2
1080521|NCT00981175|2618253|P2|COMPLETED|Booster Dose Vaccination||40
1080522|NCT00981175|2618254|P1|COMPLETED|Booster Dose Vaccination||53
1080523|NCT00981175|2618253|P2|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|43
1080524|NCT00981175|2618254|P1|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|55
1080525|NCT00981175|2618253|P2|NOT COMPLETED|Primary Dose Vaccination||2
1080526|NCT00981175|2618254|P1|NOT COMPLETED|Primary Dose Vaccination||3
1080527|NCT00981175|2618253|P2|COMPLETED|Primary Dose Vaccination||99
1080528|NCT00981175|2618254|P1|COMPLETED|Primary Dose Vaccination||98
1080529|NCT00981175|2618253|P2|STARTED|Primary Dose Vaccination||101
1080530|NCT00981175|2618254|P1|STARTED|Primary Dose Vaccination||101
1080531|NCT00981214|2618277|P1|NOT COMPLETED|Overall Study||0
1080532|NCT00981214|2618277|P1|COMPLETED|Overall Study||19
1080533|NCT00981214|2618277|P1|STARTED|Overall Study||19
1080534|NCT00981227|2618297|P6|NOT COMPLETED|Overall Study||18
1080535|NCT00981227|2618298|P5|NOT COMPLETED|Overall Study||30
1080536|NCT00981227|2618299|P4|NOT COMPLETED|Overall Study||21
1080537|NCT00981227|2618300|P3|NOT COMPLETED|Overall Study||21
1080538|NCT00981227|2618301|P2|NOT COMPLETED|Overall Study||19
1080539|NCT00981227|2618302|P1|NOT COMPLETED|Overall Study||22
1080540|NCT00981227|2618297|P6|COMPLETED|Overall Study||75
1080541|NCT00981227|2618298|P5|COMPLETED|Overall Study||60
1080542|NCT00981227|2618299|P4|COMPLETED|Overall Study||73
1080543|NCT00981227|2618300|P3|COMPLETED|Overall Study||73
1080544|NCT00981227|2618301|P2|COMPLETED|Overall Study||75
1080545|NCT00981227|2618302|P1|COMPLETED|Overall Study||80
1080546|NCT00981227|2618297|P6|Per–Protocol|Overall Study||70
1080547|NCT00981227|2618298|P5|Per–Protocol|Overall Study||50
1080548|NCT00981227|2618299|P4|Per–Protocol|Overall Study||68
1080549|NCT00981227|2618300|P3|Per–Protocol|Overall Study||67
1080550|NCT00981227|2618301|P2|Per–Protocol|Overall Study||72
1080551|NCT00981227|2618302|P1|Per–Protocol|Overall Study||69
1080552|NCT00981227|2618297|P6|Safety Population|Overall Study||93
1080553|NCT00981227|2618298|P5|Safety Population|Overall Study||90
1080554|NCT00981227|2618299|P4|Safety Population|Overall Study||94
1080555|NCT00981227|2618300|P3|Safety Population|Overall Study||94
1080556|NCT00981227|2618301|P2|Safety Population|Overall Study||94
1080557|NCT00981227|2618302|P1|Safety Population|Overall Study||102
1080558|NCT00981227|2618297|P6|Randomized|Overall Study||93
1080559|NCT00981227|2618298|P5|Randomized|Overall Study||90
1080560|NCT00981227|2618299|P4|Randomized|Overall Study||94
1080561|NCT00981227|2618300|P3|Randomized|Overall Study||94
1080562|NCT00981227|2618301|P2|Randomized|Overall Study||94
1080563|NCT00981227|2618302|P1|Randomized|Overall Study||102
1080564|NCT00981227|2618297|P6|STARTED|Overall Study||93
1080565|NCT00981227|2618298|P5|STARTED|Overall Study||90
1080566|NCT00981227|2618299|P4|STARTED|Overall Study||94
1080567|NCT00981227|2618300|P3|STARTED|Overall Study||94
1080568|NCT00981227|2618301|P2|STARTED|Overall Study||94
1080569|NCT00981227|2618302|P1|STARTED|Overall Study||102
1080570|NCT00981292|2618326|P6|NOT COMPLETED|Day 3||1
1080571|NCT00981292|2618327|P5|NOT COMPLETED|Day 3||0
1080572|NCT00981292|2618328|P4|NOT COMPLETED|Day 3||0
1080573|NCT00981292|2618329|P3|NOT COMPLETED|Day 3||0
1080574|NCT00981292|2618330|P2|NOT COMPLETED|Day 3||0
1080575|NCT00981292|2618331|P1|NOT COMPLETED|Day 3||0
1080576|NCT00981292|2618326|P6|COMPLETED|Day 3||4
1080577|NCT00981292|2618327|P5|COMPLETED|Day 3||4
1080578|NCT00981292|2618328|P4|COMPLETED|Day 3||4
1080579|NCT00981292|2618329|P3|COMPLETED|Day 3||6
1080580|NCT00981292|2618330|P2|COMPLETED|Day 3||4
1080581|NCT00981292|2618331|P1|COMPLETED|Day 3||4
1080582|NCT00981292|2618326|P6|STARTED|Day 3||5
1080583|NCT00981292|2618327|P5|STARTED|Day 3||4
1080584|NCT00981292|2618328|P4|STARTED|Day 3||4
1080585|NCT00981292|2618329|P3|STARTED|Day 3||6
1080586|NCT00981292|2618330|P2|STARTED|Day 3||4
1080587|NCT00981292|2618331|P1|STARTED|Day 3||4
1080588|NCT00981292|2618326|P6|NOT COMPLETED|Day 2||0
1080589|NCT00981292|2618327|P5|NOT COMPLETED|Day 2||0
1080590|NCT00981292|2618328|P4|NOT COMPLETED|Day 2||0
1080591|NCT00981292|2618329|P3|NOT COMPLETED|Day 2||0
1080592|NCT00981292|2618330|P2|NOT COMPLETED|Day 2||0
1080593|NCT00981292|2618331|P1|NOT COMPLETED|Day 2||2
1080594|NCT00981292|2618326|P6|COMPLETED|Day 2||5
1080595|NCT00981292|2618327|P5|COMPLETED|Day 2||4
1080596|NCT00981292|2618328|P4|COMPLETED|Day 2||4
1080597|NCT00981292|2618329|P3|COMPLETED|Day 2||6
1080598|NCT00981292|2618330|P2|COMPLETED|Day 2||4
1080599|NCT00981292|2618331|P1|COMPLETED|Day 2||4
1080600|NCT00981292|2618326|P6|STARTED|Day 2||5
1080601|NCT00981292|2618327|P5|STARTED|Day 2||4
1080602|NCT00981292|2618328|P4|STARTED|Day 2||4
1080603|NCT00981292|2618329|P3|STARTED|Day 2||6
1080604|NCT00981292|2618330|P2|STARTED|Day 2||4
1080605|NCT00981292|2618331|P1|STARTED|Day 2||6
1080606|NCT00981292|2618326|P6|NOT COMPLETED|Day 1||2
1080607|NCT00981292|2618327|P5|NOT COMPLETED|Day 1||0
1080608|NCT00981292|2618328|P4|NOT COMPLETED|Day 1||0
1080609|NCT00981292|2618329|P3|NOT COMPLETED|Day 1||0
1080610|NCT00981292|2618330|P2|NOT COMPLETED|Day 1||0
1080611|NCT00981292|2618331|P1|NOT COMPLETED|Day 1||1
1080612|NCT00981292|2618326|P6|COMPLETED|Day 1||5
1080613|NCT00981292|2618327|P5|COMPLETED|Day 1||4
1080614|NCT00981292|2618328|P4|COMPLETED|Day 1||4
1080615|NCT00981292|2618329|P3|COMPLETED|Day 1||6
1080616|NCT00981292|2618330|P2|COMPLETED|Day 1||4
1080617|NCT00981292|2618331|P1|COMPLETED|Day 1||6
1080618|NCT00981292|2618326|P6|STARTED|Day 1||7
1080619|NCT00981292|2618327|P5|STARTED|Day 1||4
1080620|NCT00981292|2618328|P4|STARTED|Day 1||4
1080621|NCT00981292|2618329|P3|STARTED|Day 1||6
1080622|NCT00981292|2618330|P2|STARTED|Day 1||4
1080623|NCT00981292|2618331|P1|STARTED|Day 1||7
1080624|NCT00981305|2618350|P2|NOT COMPLETED|Overall Study||10
1080625|NCT00981305|2618351|P1|NOT COMPLETED|Overall Study||19
1080626|NCT00981305|2618350|P2|COMPLETED|Overall Study||57
1080627|NCT00981305|2618351|P1|COMPLETED|Overall Study||50
1080628|NCT00981305|2618350|P2|STARTED|Overall Study||67
1080629|NCT00981305|2618351|P1|STARTED|Overall Study||69
1080630|NCT00981370|2618363|P1|NOT COMPLETED|Overall Study||0
1080631|NCT00981370|2618363|P1|COMPLETED|Overall Study||0
1080632|NCT00981370|2618363|P1|STARTED|Overall Study||0
1080633|NCT00981409|2618369|P2|NOT COMPLETED|Overall Study||1
1080634|NCT00981409|2618370|P1|NOT COMPLETED|Overall Study||6
1080635|NCT00981409|2618369|P2|COMPLETED|Overall Study||10
1080636|NCT00981409|2618370|P1|COMPLETED|Overall Study||24
1080637|NCT00981409|2618369|P2|STARTED|Overall Study||11
1080638|NCT00981409|2618370|P1|STARTED|Overall Study||30
1080639|NCT00981435|2618387|P3|NOT COMPLETED|Overall Study||0
1080640|NCT00981435|2618388|P2|NOT COMPLETED|Overall Study||0
1080641|NCT00981435|2618389|P1|NOT COMPLETED|Overall Study||0
1080642|NCT00981435|2618387|P3|COMPLETED|Overall Study||37
1080643|NCT00981435|2618388|P2|COMPLETED|Overall Study||29
1080644|NCT00981435|2618389|P1|COMPLETED|Overall Study||31
1080645|NCT00981435|2618387|P3|STARTED|Overall Study||37
1080646|NCT00981435|2618388|P2|STARTED|Overall Study||29
1080647|NCT00981435|2618389|P1|STARTED|Overall Study||31
1080648|NCT00981461|2618402|P2|NOT COMPLETED|Overall Study||2
1080649|NCT00981461|2618403|P1|NOT COMPLETED|Overall Study||5
1080650|NCT00981461|2618402|P2|COMPLETED|Overall Study||22
1080651|NCT00981461|2618403|P1|COMPLETED|Overall Study||43
1080652|NCT00981461|2618402|P2|STARTED|Overall Study||24
1080653|NCT00981461|2618403|P1|STARTED|Overall Study||48
1080660|NCT00973622|2618430|P2|NOT COMPLETED|Overall Study||5
1080661|NCT00973622|2618431|P1|NOT COMPLETED|Overall Study||31
1080662|NCT00973622|2618430|P2|COMPLETED|Overall Study|Completed three sessions of rTMS|14
1080663|NCT00973622|2618431|P1|COMPLETED|Overall Study|Completed three sessions of rTMS|16
1080664|NCT00973622|2618430|P2|STARTED|Overall Study|21 passed telephone interview; 19 passed the in-person interview, were enrolled, and sent for MRI.|19
1080665|NCT00973622|2618431|P1|STARTED|Overall Study|75 passed telephone interview; 28 passed in-person interview, were enrolled, and sent for MRI.|47
1080666|NCT00973700|2618442|P5|NOT COMPLETED|Overall Study||10
1080667|NCT00973700|2618443|P4|NOT COMPLETED|Overall Study||18
1080668|NCT00973700|2618444|P3|NOT COMPLETED|Overall Study||10
1080669|NCT00973700|2618445|P2|NOT COMPLETED|Overall Study||2
1080670|NCT00973700|2618446|P1|NOT COMPLETED|Overall Study||7
1080671|NCT00973700|2618442|P5|COMPLETED|Overall Study||158
1080672|NCT00973700|2618443|P4|COMPLETED|Overall Study||318
1080673|NCT00973700|2618444|P3|COMPLETED|Overall Study||158
1080674|NCT00973700|2618445|P2|COMPLETED|Overall Study||54
1080675|NCT00973700|2618446|P1|COMPLETED|Overall Study||49
1080676|NCT00973700|2618442|P5|STARTED|Overall Study||168
1080677|NCT00973700|2618443|P4|STARTED|Overall Study||336
1080678|NCT00973700|2618444|P3|STARTED|Overall Study||168
1080679|NCT00973700|2618445|P2|STARTED|Overall Study||56
1080680|NCT00973700|2618446|P1|STARTED|Overall Study||56
1080681|NCT00973739|2618493|P1|NOT COMPLETED|Overall Study||4
1080682|NCT00973739|2618493|P1|COMPLETED|Overall Study||17
1080683|NCT00973739|2618493|P1|STARTED|Overall Study||21
1080684|NCT00973752|2618500|P1|NOT COMPLETED|Overall Study||0
1080685|NCT00973752|2618500|P1|COMPLETED|Overall Study||30
1080686|NCT00973752|2618500|P1|STARTED|Overall Study||30
1080687|NCT00973765|2618506|P2|NOT COMPLETED|Overall Study||14
1080688|NCT00973765|2618507|P1|NOT COMPLETED|Overall Study||8
1080689|NCT00973765|2618506|P2|COMPLETED|Overall Study|102|102
1080690|NCT00973765|2618507|P1|COMPLETED|Overall Study|88|88
1080691|NCT00973765|2618506|P2|STARTED|Overall Study|116|116
1080692|NCT00973765|2618507|P1|STARTED|Overall Study|96|96
1080693|NCT00973921|2618513|P1|NOT COMPLETED|Overall Study||9
1080694|NCT00973921|2618513|P1|COMPLETED|Overall Study||31
1080695|NCT00973921|2618513|P1|STARTED|Overall Study||40
1080696|NCT00974051|2618520|P3|NOT COMPLETED|Overall Study||0
1080697|NCT00974051|2618521|P2|NOT COMPLETED|Overall Study||0
1080698|NCT00974051|2618522|P1|NOT COMPLETED|Overall Study||0
1080699|NCT00974051|2618520|P3|COMPLETED|Overall Study||6
1080700|NCT00974051|2618521|P2|COMPLETED|Overall Study||4
1080701|NCT00974051|2618522|P1|COMPLETED|Overall Study||6
1080702|NCT00974051|2618520|P3|STARTED|Overall Study||6
1080703|NCT00974051|2618521|P2|STARTED|Overall Study||4
1080704|NCT00974051|2618522|P1|STARTED|Overall Study||6
1080705|NCT00974090|2618542|P2|NOT COMPLETED|Period 2: Open-label Period||10
1080706|NCT00974090|2618543|P1|NOT COMPLETED|Period 2: Open-label Period||8
1080707|NCT00974090|2618542|P2|COMPLETED|Period 2: Open-label Period||85
1080708|NCT00974090|2618543|P1|COMPLETED|Period 2: Open-label Period||87
1080709|NCT00974090|2618542|P2|STARTED|Period 2: Open-label Period||95
1080710|NCT00974090|2618543|P1|STARTED|Period 2: Open-label Period||95
1080711|NCT00974090|2618542|P2|NOT COMPLETED|Period 1: Double Blind Period||1
1080712|NCT00974090|2618543|P1|NOT COMPLETED|Period 1: Double Blind Period||3
1080713|NCT00974090|2618542|P2|COMPLETED|Period 1: Double Blind Period||95
1080714|NCT00974090|2618543|P1|COMPLETED|Period 1: Double Blind Period||95
1080715|NCT00974090|2618542|P2|STARTED|Period 1: Double Blind Period||96
1080716|NCT00974090|2618543|P1|STARTED|Period 1: Double Blind Period||98
1080717|NCT00974220|2618559|P2|NOT COMPLETED|Treatment Period 2||0
1080718|NCT00974220|2618560|P1|NOT COMPLETED|Treatment Period 2||0
1080719|NCT00974220|2618559|P2|COMPLETED|Treatment Period 2||5
1080720|NCT00974220|2618560|P1|COMPLETED|Treatment Period 2||7
1080721|NCT00974220|2618559|P2|STARTED|Treatment Period 2||5
1080722|NCT00974220|2618560|P1|STARTED|Treatment Period 2||7
1080723|NCT00974220|2618559|P2|NOT COMPLETED|Treatment Period 1||2
1080724|NCT00974220|2618560|P1|NOT COMPLETED|Treatment Period 1||2
1080725|NCT00974220|2618559|P2|COMPLETED|Treatment Period 1||5
1080726|NCT00974220|2618560|P1|COMPLETED|Treatment Period 1||7
1080727|NCT00974220|2618559|P2|STARTED|Treatment Period 1||7
1080728|NCT00974220|2618560|P1|STARTED|Treatment Period 1||9
1080729|NCT00974233|2618568|P1|NOT COMPLETED|Maintenance Lenalidomide||13
1080730|NCT00974233|2618568|P1|COMPLETED|Maintenance Lenalidomide||6
1080731|NCT00974233|2618568|P1|STARTED|Maintenance Lenalidomide||19
1080732|NCT00974233|2618568|P1|NOT COMPLETED|Induction Chemoimmunotherapy||15
1080733|NCT00974233|2618568|P1|COMPLETED|Induction Chemoimmunotherapy||19
1080734|NCT00974233|2618568|P1|STARTED|Induction Chemoimmunotherapy||34
1080735|NCT00974246|2618581|P1|NOT COMPLETED|Overall Study||0
1080736|NCT00974246|2618581|P1|COMPLETED|Overall Study||27
1080737|NCT00974246|2618581|P1|STARTED|Overall Study||27
1080738|NCT00974311|2618589|P2|NOT COMPLETED|Overall Study||236
1080739|NCT00974311|2618590|P1|NOT COMPLETED|Overall Study||546
1080826|NCT00975130|2618811|P2|COMPLETED|Study Part 2||212
1080740|NCT00974311|2618589|P2|COMPLETED|Overall Study|Indicates participants continuing long-term follow-up as of 25 September 2011.|163
1080741|NCT00974311|2618590|P1|COMPLETED|Overall Study|Indicates participants continuing long-term follow-up as of 25 September 2011.|254
1080742|NCT00974311|2618589|P2|STARTED|Overall Study||399
1080743|NCT00974311|2618590|P1|STARTED|Overall Study||800
1080744|NCT00974363|2618612|P2|NOT COMPLETED|Overall Study||0
1080745|NCT00974363|2618613|P1|NOT COMPLETED|Overall Study||0
1080746|NCT00974363|2618612|P2|COMPLETED|Overall Study||168
1080747|NCT00974363|2618613|P1|COMPLETED|Overall Study||521
1080748|NCT00974363|2618612|P2|STARTED|Overall Study||168
1080749|NCT00974363|2618613|P1|STARTED|Overall Study||521
1080750|NCT00974376|2618635|P2|NOT COMPLETED|Overall Study||33
1080751|NCT00974376|2618636|P1|NOT COMPLETED|Overall Study||34
1080752|NCT00974376|2618635|P2|COMPLETED|Overall Study||42
1080753|NCT00974376|2618636|P1|COMPLETED|Overall Study||41
1080754|NCT00974376|2618635|P2|STARTED|Overall Study||75
1080755|NCT00974376|2618636|P1|STARTED|Overall Study||75
1080756|NCT00974480|2618645|P3|NOT COMPLETED|Overall Study||10
1080757|NCT00974480|2618646|P2|NOT COMPLETED|Overall Study||7
1080758|NCT00974480|2618647|P1|NOT COMPLETED|Overall Study||11
1080759|NCT00974480|2618645|P3|COMPLETED|Overall Study||30
1080760|NCT00974480|2618646|P2|COMPLETED|Overall Study||33
1080761|NCT00974480|2618647|P1|COMPLETED|Overall Study||29
1080762|NCT00974480|2618645|P3|STARTED|Overall Study||40
1080763|NCT00974480|2618646|P2|STARTED|Overall Study||40
1080764|NCT00974480|2618647|P1|STARTED|Overall Study||40
1080765|NCT00974571|2618688|P3|NOT COMPLETED|Overall Study||83
1080766|NCT00974571|2618689|P2|NOT COMPLETED|Overall Study||16
1080767|NCT00974571|2618690|P1|NOT COMPLETED|Overall Study||68
1080768|NCT00974571|2618688|P3|COMPLETED|Overall Study||530
1080769|NCT00974571|2618689|P2|COMPLETED|Overall Study||106
1080770|NCT00974571|2618690|P1|COMPLETED|Overall Study||562
1080771|NCT00974571|2618688|P3|STARTED|Overall Study||613
1080772|NCT00974571|2618689|P2|STARTED|Overall Study||122
1080773|NCT00974571|2618690|P1|STARTED|Overall Study||630
1080774|NCT00974675|2618714|P4|NOT COMPLETED|Overall Study||2
1080775|NCT00974675|2618715|P3|NOT COMPLETED|Overall Study||2
1080776|NCT00974675|2618716|P2|NOT COMPLETED|Overall Study||1
1080777|NCT00974675|2618717|P1|NOT COMPLETED|Overall Study||2
1080778|NCT00974675|2618714|P4|COMPLETED|Overall Study||2
1080779|NCT00974675|2618715|P3|COMPLETED|Overall Study||1
1080780|NCT00974675|2618716|P2|COMPLETED|Overall Study||7
1080781|NCT00974675|2618717|P1|COMPLETED|Overall Study||6
1080782|NCT00974675|2618714|P4|STARTED|Overall Study||4
1080783|NCT00974675|2618715|P3|STARTED|Overall Study||3
1080784|NCT00974675|2618716|P2|STARTED|Overall Study||8
1080785|NCT00974675|2618717|P1|STARTED|Overall Study||8
1080786|NCT00974818|2618765|P2|NOT COMPLETED|Overall Study||0
1080787|NCT00974818|2618766|P1|NOT COMPLETED|Overall Study||0
1080788|NCT00974818|2618765|P2|COMPLETED|Overall Study||25
1080789|NCT00974818|2618766|P1|COMPLETED|Overall Study||25
1080790|NCT00974818|2618765|P2|STARTED|Overall Study||25
1080791|NCT00974818|2618766|P1|STARTED|Overall Study||25
1080792|NCT00974974|2618774|P2|NOT COMPLETED|Maintenance - Double Blind Treatment||10
1080793|NCT00974974|2618775|P1|NOT COMPLETED|Maintenance - Double Blind Treatment||15
1080794|NCT00974974|2618774|P2|COMPLETED|Maintenance - Double Blind Treatment||182
1080795|NCT00974974|2618775|P1|COMPLETED|Maintenance - Double Blind Treatment||186
1080796|NCT00974974|2618774|P2|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|192
1080797|NCT00974974|2618775|P1|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|201
1080798|NCT00974974|2618774|P2|NOT COMPLETED|IPX066 Dose Conversion||0
1080799|NCT00974974|2618775|P1|NOT COMPLETED|IPX066 Dose Conversion||57
1080800|NCT00974974|2618774|P2|COMPLETED|IPX066 Dose Conversion||0
1080801|NCT00974974|2618775|P1|COMPLETED|IPX066 Dose Conversion||393
1080802|NCT00974974|2618774|P2|STARTED|IPX066 Dose Conversion|IR is not applicable in IPX066 dose conversion.|0
1080803|NCT00974974|2618775|P1|STARTED|IPX066 Dose Conversion|All subjects who completed IR Dose adjustment entered into IPX066 dose conversion.|450
1080804|NCT00974974|2618774|P2|NOT COMPLETED|IR CD-LD Dose Adjustment||21
1080805|NCT00974974|2618775|P1|NOT COMPLETED|IR CD-LD Dose Adjustment||0
1080806|NCT00974974|2618774|P2|COMPLETED|IR CD-LD Dose Adjustment||450
1080807|NCT00974974|2618775|P1|COMPLETED|IR CD-LD Dose Adjustment||0
1080808|NCT00974974|2618774|P2|STARTED|IR CD-LD Dose Adjustment||471
1080809|NCT00974974|2618775|P1|STARTED|IR CD-LD Dose Adjustment||0
1080810|NCT00975000|2618787|P2|NOT COMPLETED|Overall Study||5
1080811|NCT00975000|2618788|P1|NOT COMPLETED|Overall Study||5
1080812|NCT00975000|2618787|P2|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
1080813|NCT00975000|2618788|P1|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
1080814|NCT00975000|2618787|P2|Completed Maintenance Phase|Overall Study||52
1080815|NCT00975000|2618788|P1|Completed Maintenance Phase|Overall Study||52
1080816|NCT00975000|2618787|P2|Completed Efficacy Assessment Phase|Overall Study||54
1080817|NCT00975000|2618788|P1|Completed Efficacy Assessment Phase|Overall Study||54
1080818|NCT00975000|2618787|P2|Completed Titration Phase|Overall Study||55
1080819|NCT00975000|2618788|P1|Completed Titration Phase|Overall Study||54
1080820|NCT00975000|2618787|P2|STARTED|Overall Study||57
1080821|NCT00975000|2618788|P1|STARTED|Overall Study||57
1080822|NCT00975130|2618810|P3|NOT COMPLETED|Study Part 2||17
1080823|NCT00975130|2618811|P2|NOT COMPLETED|Study Part 2||38
1080824|NCT00975130|2618812|P1|NOT COMPLETED|Study Part 2||0
1080825|NCT00975130|2618810|P3|COMPLETED|Study Part 2||238
1080827|NCT00975130|2618812|P1|COMPLETED|Study Part 2||0
1080828|NCT00975130|2618810|P3|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|255
1080829|NCT00975130|2618811|P2|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|250
1080830|NCT00975130|2618812|P1|STARTED|Study Part 2||0
1080831|NCT00975130|2618810|P3|NOT COMPLETED|Study Part 1||0
1080832|NCT00975130|2618811|P2|NOT COMPLETED|Study Part 1||0
1080833|NCT00975130|2618812|P1|NOT COMPLETED|Study Part 1||280
1080834|NCT00975130|2618810|P3|COMPLETED|Study Part 1||0
1080835|NCT00975130|2618811|P2|COMPLETED|Study Part 1||0
1080836|NCT00975130|2618812|P1|COMPLETED|Study Part 1||3086
1080837|NCT00975130|2618810|P3|STARTED|Study Part 1||0
1080838|NCT00975130|2618811|P2|STARTED|Study Part 1||0
1080839|NCT00975130|2618812|P1|STARTED|Study Part 1||3366
1080840|NCT00975143|2618996|P2|NOT COMPLETED|Overall Study||60
1080841|NCT00975143|2618997|P1|NOT COMPLETED|Overall Study||70
1080842|NCT00975143|2618996|P2|COMPLETED|Overall Study||401
1080843|NCT00975143|2618997|P1|COMPLETED|Overall Study||394
1080844|NCT00975143|2618996|P2|Completed Treatment (Week 20)|Overall Study||410
1080845|NCT00975143|2618997|P1|Completed Treatment (Week 20)|Overall Study||403
1080846|NCT00975143|2618996|P2|STARTED|Overall Study||461
1080847|NCT00975143|2618997|P1|STARTED|Overall Study||464
1080848|NCT00975156|2619009|P2|NOT COMPLETED|Overall Study||1
1080849|NCT00975156|2619010|P1|NOT COMPLETED|Overall Study||0
1080850|NCT00975156|2619009|P2|COMPLETED|Overall Study||9
1080851|NCT00975156|2619010|P1|COMPLETED|Overall Study||11
1080852|NCT00975156|2619009|P2|STARTED|Overall Study||10
1080853|NCT00975156|2619010|P1|STARTED|Overall Study||11
1080854|NCT00975195|2619022|P2|NOT COMPLETED|Overall Study||233
1080855|NCT00975195|2619023|P1|NOT COMPLETED|Overall Study||228
1080856|NCT00975195|2619022|P2|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1011
1080857|NCT00975195|2619023|P1|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1016
1080858|NCT00975195|2619022|P2|STARTED|Overall Study||1244
1080859|NCT00975195|2619023|P1|STARTED|Overall Study||1244
1080860|NCT00975221|2619083|P2|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||1
1080861|NCT00975221|2619084|P1|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||2
1080862|NCT00975221|2619083|P2|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
1080863|NCT00975221|2619084|P1|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
1080864|NCT00975221|2619083|P2|STARTED|Open-label Extension Phase (Weeks 29-52)||28
1080865|NCT00975221|2619084|P1|STARTED|Open-label Extension Phase (Weeks 29-52)|1 participant who completed the EAP did not enter the open-label phase|29
1080866|NCT00975221|2619083|P2|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||1
1080867|NCT00975221|2619084|P1|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||0
1080868|NCT00975221|2619083|P2|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||28
1080869|NCT00975221|2619084|P1|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||30
1080870|NCT00975221|2619083|P2|STARTED|Efficacy Assessment Phase (Weeks 13-28)||29
1080871|NCT00975221|2619084|P1|STARTED|Efficacy Assessment Phase (Weeks 13-28)|1 participant who completed the Titration Phase did not enter the EAP|30
1080872|NCT00975221|2619083|P2|NOT COMPLETED|Titration Phase (Weeks 1-12)||4
1080873|NCT00975221|2619084|P1|NOT COMPLETED|Titration Phase (Weeks 1-12)||3
1080874|NCT00975221|2619083|P2|COMPLETED|Titration Phase (Weeks 1-12)||29
1080875|NCT00975221|2619084|P1|COMPLETED|Titration Phase (Weeks 1-12)||31
1080876|NCT00975221|2619083|P2|Received Study Drug|Titration Phase (Weeks 1-12)||33
1080877|NCT00975221|2619084|P1|Received Study Drug|Titration Phase (Weeks 1-12)||34
1080878|NCT00975221|2619083|P2|STARTED|Titration Phase (Weeks 1-12)||33
1080879|NCT00975221|2619084|P1|STARTED|Titration Phase (Weeks 1-12)||34
1080880|NCT00975286|2619100|P2|NOT COMPLETED|Overall Study||29
1080881|NCT00975286|2619101|P1|NOT COMPLETED|Overall Study||12
1080882|NCT00975286|2619100|P2|COMPLETED|Overall Study||194
1080883|NCT00975286|2619101|P1|COMPLETED|Overall Study||211
1080884|NCT00975286|2619100|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||223
1080885|NCT00975286|2619101|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|223
1080886|NCT00975286|2619100|P2|Safety Population|Overall Study||223
1080887|NCT00975286|2619101|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|223
1080888|NCT00975286|2619100|P2|STARTED|Overall Study||223
1080889|NCT00975286|2619101|P1|STARTED|Overall Study|Randomized.|223
1080890|NCT00975416|2619133|P2|NOT COMPLETED|Overall Study||5
1080891|NCT00975416|2619134|P1|NOT COMPLETED|Overall Study||3
1080892|NCT00975416|2619133|P2|COMPLETED|Overall Study||11
1080893|NCT00975416|2619134|P1|COMPLETED|Overall Study||11
1080894|NCT00975416|2619133|P2|STARTED|Overall Study||16
1080895|NCT00975416|2619134|P1|STARTED|Overall Study||14
1080896|NCT00975481|2619141|P6|NOT COMPLETED|Sixth Intervention Period||0
1080897|NCT00975481|2619142|P5|NOT COMPLETED|Sixth Intervention Period||0
1080898|NCT00975481|2619143|P4|NOT COMPLETED|Sixth Intervention Period||0
1080899|NCT00975481|2619144|P3|NOT COMPLETED|Sixth Intervention Period||0
1080900|NCT00975481|2619145|P2|NOT COMPLETED|Sixth Intervention Period||0
1080901|NCT00975481|2619146|P1|NOT COMPLETED|Sixth Intervention Period||0
1080902|NCT00975481|2619141|P6|COMPLETED|Sixth Intervention Period||6
1080903|NCT00975481|2619142|P5|COMPLETED|Sixth Intervention Period||5
1080904|NCT00975481|2619143|P4|COMPLETED|Sixth Intervention Period||5
1080905|NCT00975481|2619144|P3|COMPLETED|Sixth Intervention Period||4
1080906|NCT00975481|2619145|P2|COMPLETED|Sixth Intervention Period||5
1080907|NCT00975481|2619146|P1|COMPLETED|Sixth Intervention Period||4
1080908|NCT00975481|2619141|P6|STARTED|Sixth Intervention Period||6
1080909|NCT00975481|2619142|P5|STARTED|Sixth Intervention Period||5
1080910|NCT00975481|2619143|P4|STARTED|Sixth Intervention Period||5
1080911|NCT00975481|2619144|P3|STARTED|Sixth Intervention Period||4
1080912|NCT00975481|2619145|P2|STARTED|Sixth Intervention Period||5
1080913|NCT00975481|2619146|P1|STARTED|Sixth Intervention Period||4
1080914|NCT00975481|2619141|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1080915|NCT00975481|2619142|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1080916|NCT00975481|2619143|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1080917|NCT00975481|2619144|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1080918|NCT00975481|2619145|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1080919|NCT00975481|2619146|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1080920|NCT00975481|2619141|P6|COMPLETED|Washout Period (at Least 7 Days)||6
1080921|NCT00975481|2619142|P5|COMPLETED|Washout Period (at Least 7 Days)||5
1080922|NCT00975481|2619143|P4|COMPLETED|Washout Period (at Least 7 Days)||5
1080923|NCT00975481|2619144|P3|COMPLETED|Washout Period (at Least 7 Days)||4
1080924|NCT00975481|2619145|P2|COMPLETED|Washout Period (at Least 7 Days)||5
1080925|NCT00975481|2619146|P1|COMPLETED|Washout Period (at Least 7 Days)||4
1080926|NCT00975481|2619141|P6|STARTED|Washout Period (at Least 7 Days)||6
1080927|NCT00975481|2619142|P5|STARTED|Washout Period (at Least 7 Days)||5
1080928|NCT00975481|2619143|P4|STARTED|Washout Period (at Least 7 Days)||5
1080929|NCT00975481|2619144|P3|STARTED|Washout Period (at Least 7 Days)||4
1080930|NCT00975481|2619145|P2|STARTED|Washout Period (at Least 7 Days)||5
1080931|NCT00975481|2619146|P1|STARTED|Washout Period (at Least 7 Days)||4
1080932|NCT00975481|2619141|P6|NOT COMPLETED|Fifth Intervention Period||0
1080933|NCT00975481|2619142|P5|NOT COMPLETED|Fifth Intervention Period||1
1080934|NCT00975481|2619143|P4|NOT COMPLETED|Fifth Intervention Period||0
1080935|NCT00975481|2619144|P3|NOT COMPLETED|Fifth Intervention Period||0
1080936|NCT00975481|2619145|P2|NOT COMPLETED|Fifth Intervention Period||0
1080937|NCT00975481|2619146|P1|NOT COMPLETED|Fifth Intervention Period||0
1080938|NCT00975481|2619141|P6|COMPLETED|Fifth Intervention Period||6
1080939|NCT00975481|2619142|P5|COMPLETED|Fifth Intervention Period||5
1080940|NCT00975481|2619143|P4|COMPLETED|Fifth Intervention Period||5
1080941|NCT00975481|2619144|P3|COMPLETED|Fifth Intervention Period||4
1080942|NCT00975481|2619145|P2|COMPLETED|Fifth Intervention Period||5
1080943|NCT00975481|2619146|P1|COMPLETED|Fifth Intervention Period||4
1080944|NCT00975481|2619141|P6|STARTED|Fifth Intervention Period||6
1080945|NCT00975481|2619142|P5|STARTED|Fifth Intervention Period||6
1080946|NCT00975481|2619143|P4|STARTED|Fifth Intervention Period||5
1080947|NCT00975481|2619144|P3|STARTED|Fifth Intervention Period||4
1080948|NCT00975481|2619145|P2|STARTED|Fifth Intervention Period||5
1080949|NCT00975481|2619146|P1|STARTED|Fifth Intervention Period||4
1080950|NCT00975481|2619141|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1080951|NCT00975481|2619142|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1080952|NCT00975481|2619143|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1080953|NCT00975481|2619144|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1080954|NCT00975481|2619145|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1080955|NCT00975481|2619146|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1080956|NCT00975481|2619141|P6|COMPLETED|Washout Period (at Least 7 Days)||6
1080957|NCT00975481|2619142|P5|COMPLETED|Washout Period (at Least 7 Days)||6
1080958|NCT00975481|2619143|P4|COMPLETED|Washout Period (at Least 7 Days)||5
1080959|NCT00975481|2619144|P3|COMPLETED|Washout Period (at Least 7 Days)||4
1080960|NCT00975481|2619145|P2|COMPLETED|Washout Period (at Least 7 Days)||5
1080961|NCT00975481|2619146|P1|COMPLETED|Washout Period (at Least 7 Days)||4
1080962|NCT00975481|2619141|P6|STARTED|Washout Period (at Least 7 Days)||6
1080963|NCT00975481|2619142|P5|STARTED|Washout Period (at Least 7 Days)||6
1080964|NCT00975481|2619143|P4|STARTED|Washout Period (at Least 7 Days)||5
1080965|NCT00975481|2619144|P3|STARTED|Washout Period (at Least 7 Days)||4
1080966|NCT00975481|2619145|P2|STARTED|Washout Period (at Least 7 Days)||5
1080967|NCT00975481|2619146|P1|STARTED|Washout Period (at Least 7 Days)||4
1080968|NCT00975481|2619141|P6|NOT COMPLETED|Fourth Intervention Period||0
1080969|NCT00975481|2619142|P5|NOT COMPLETED|Fourth Intervention Period||0
1080970|NCT00975481|2619143|P4|NOT COMPLETED|Fourth Intervention Period||1
1080971|NCT00975481|2619144|P3|NOT COMPLETED|Fourth Intervention Period||1
1080972|NCT00975481|2619145|P2|NOT COMPLETED|Fourth Intervention Period||0
1080973|NCT00975481|2619146|P1|NOT COMPLETED|Fourth Intervention Period||0
1080974|NCT00975481|2619141|P6|COMPLETED|Fourth Intervention Period||6
1080975|NCT00975481|2619142|P5|COMPLETED|Fourth Intervention Period||6
1080976|NCT00975481|2619143|P4|COMPLETED|Fourth Intervention Period||5
1080977|NCT00975481|2619144|P3|COMPLETED|Fourth Intervention Period||4
1080978|NCT00975481|2619145|P2|COMPLETED|Fourth Intervention Period||5
1080979|NCT00975481|2619146|P1|COMPLETED|Fourth Intervention Period||4
1080980|NCT00975481|2619141|P6|STARTED|Fourth Intervention Period||6
1080981|NCT00975481|2619142|P5|STARTED|Fourth Intervention Period||6
1080982|NCT00975481|2619143|P4|STARTED|Fourth Intervention Period||6
1080983|NCT00975481|2619144|P3|STARTED|Fourth Intervention Period||5
1080984|NCT00975481|2619145|P2|STARTED|Fourth Intervention Period||5
1080985|NCT00975481|2619146|P1|STARTED|Fourth Intervention Period||4
1080986|NCT00975481|2619141|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1080987|NCT00975481|2619142|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1080988|NCT00975481|2619143|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1080989|NCT00975481|2619144|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1080990|NCT00975481|2619145|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1080991|NCT00975481|2619146|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1080992|NCT00975481|2619141|P6|COMPLETED|Washout Period (at Least 7 Days)||6
1080993|NCT00975481|2619142|P5|COMPLETED|Washout Period (at Least 7 Days)||6
1080994|NCT00975481|2619143|P4|COMPLETED|Washout Period (at Least 7 Days)||6
1080995|NCT00975481|2619144|P3|COMPLETED|Washout Period (at Least 7 Days)||5
1080996|NCT00975481|2619145|P2|COMPLETED|Washout Period (at Least 7 Days)||5
1080997|NCT00975481|2619146|P1|COMPLETED|Washout Period (at Least 7 Days)||4
1080998|NCT00975481|2619141|P6|STARTED|Washout Period (at Least 7 Days)||6
1080999|NCT00975481|2619142|P5|STARTED|Washout Period (at Least 7 Days)||6
1081000|NCT00975481|2619143|P4|STARTED|Washout Period (at Least 7 Days)||6
1081001|NCT00975481|2619144|P3|STARTED|Washout Period (at Least 7 Days)||5
1081002|NCT00975481|2619145|P2|STARTED|Washout Period (at Least 7 Days)||5
1081003|NCT00975481|2619146|P1|STARTED|Washout Period (at Least 7 Days)||4
1081004|NCT00975481|2619141|P6|NOT COMPLETED|Third Intervention Period||0
1081005|NCT00975481|2619142|P5|NOT COMPLETED|Third Intervention Period||0
1081006|NCT00975481|2619143|P4|NOT COMPLETED|Third Intervention Period||0
1081007|NCT00975481|2619144|P3|NOT COMPLETED|Third Intervention Period||0
1081008|NCT00975481|2619145|P2|NOT COMPLETED|Third Intervention Period||0
1081009|NCT00975481|2619146|P1|NOT COMPLETED|Third Intervention Period||0
1081010|NCT00975481|2619141|P6|COMPLETED|Third Intervention Period||6
1081011|NCT00975481|2619142|P5|COMPLETED|Third Intervention Period||6
1081012|NCT00975481|2619143|P4|COMPLETED|Third Intervention Period||6
1081013|NCT00975481|2619144|P3|COMPLETED|Third Intervention Period||5
1081014|NCT00975481|2619145|P2|COMPLETED|Third Intervention Period||5
1081015|NCT00975481|2619146|P1|COMPLETED|Third Intervention Period||4
1081016|NCT00975481|2619141|P6|STARTED|Third Intervention Period||6
1081017|NCT00975481|2619142|P5|STARTED|Third Intervention Period||6
1081018|NCT00975481|2619143|P4|STARTED|Third Intervention Period||6
1081019|NCT00975481|2619144|P3|STARTED|Third Intervention Period||5
1081020|NCT00975481|2619145|P2|STARTED|Third Intervention Period||5
1081021|NCT00975481|2619146|P1|STARTED|Third Intervention Period||4
1081022|NCT00975481|2619141|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1081023|NCT00975481|2619142|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1081024|NCT00975481|2619143|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1081025|NCT00975481|2619144|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1081026|NCT00975481|2619145|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1081027|NCT00975481|2619146|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1081028|NCT00975481|2619141|P6|COMPLETED|Washout Period (at Least 7 Days)||6
1081029|NCT00975481|2619142|P5|COMPLETED|Washout Period (at Least 7 Days)||6
1081030|NCT00975481|2619143|P4|COMPLETED|Washout Period (at Least 7 Days)||6
1081031|NCT00975481|2619144|P3|COMPLETED|Washout Period (at Least 7 Days)||5
1081032|NCT00975481|2619145|P2|COMPLETED|Washout Period (at Least 7 Days)||5
1081033|NCT00975481|2619146|P1|COMPLETED|Washout Period (at Least 7 Days)||4
1081034|NCT00975481|2619141|P6|STARTED|Washout Period (at Least 7 Days)||6
1081035|NCT00975481|2619142|P5|STARTED|Washout Period (at Least 7 Days)||6
1081036|NCT00975481|2619143|P4|STARTED|Washout Period (at Least 7 Days)||6
1081037|NCT00975481|2619144|P3|STARTED|Washout Period (at Least 7 Days)||5
1081038|NCT00975481|2619145|P2|STARTED|Washout Period (at Least 7 Days)||5
1081039|NCT00975481|2619146|P1|STARTED|Washout Period (at Least 7 Days)||4
1081040|NCT00975481|2619141|P6|NOT COMPLETED|Second Intervention Period||0
1081041|NCT00975481|2619142|P5|NOT COMPLETED|Second Intervention Period||0
1081042|NCT00975481|2619143|P4|NOT COMPLETED|Second Intervention Period||0
1081043|NCT00975481|2619144|P3|NOT COMPLETED|Second Intervention Period||1
1081044|NCT00975481|2619145|P2|NOT COMPLETED|Second Intervention Period||1
1081045|NCT00975481|2619146|P1|NOT COMPLETED|Second Intervention Period||2
1081046|NCT00975481|2619141|P6|COMPLETED|Second Intervention Period||6
1081047|NCT00975481|2619142|P5|COMPLETED|Second Intervention Period||6
1081048|NCT00975481|2619143|P4|COMPLETED|Second Intervention Period||6
1081049|NCT00975481|2619144|P3|COMPLETED|Second Intervention Period||5
1081050|NCT00975481|2619145|P2|COMPLETED|Second Intervention Period||5
1081051|NCT00975481|2619146|P1|COMPLETED|Second Intervention Period||4
1081052|NCT00975481|2619141|P6|STARTED|Second Intervention Period||6
1081053|NCT00975481|2619142|P5|STARTED|Second Intervention Period||6
1081054|NCT00975481|2619143|P4|STARTED|Second Intervention Period||6
1081055|NCT00975481|2619144|P3|STARTED|Second Intervention Period||6
1081056|NCT00975481|2619145|P2|STARTED|Second Intervention Period||6
1081057|NCT00975481|2619146|P1|STARTED|Second Intervention Period||6
1081058|NCT00975481|2619141|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1081059|NCT00975481|2619142|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1081060|NCT00975481|2619143|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1081061|NCT00975481|2619144|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1081062|NCT00975481|2619145|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1081063|NCT00975481|2619146|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1081064|NCT00975481|2619141|P6|COMPLETED|Washout Period (at Least 7 Days)||6
1081065|NCT00975481|2619142|P5|COMPLETED|Washout Period (at Least 7 Days)||6
1081066|NCT00975481|2619143|P4|COMPLETED|Washout Period (at Least 7 Days)||6
1081067|NCT00975481|2619144|P3|COMPLETED|Washout Period (at Least 7 Days)||6
1081068|NCT00975481|2619145|P2|COMPLETED|Washout Period (at Least 7 Days)||6
1081069|NCT00975481|2619146|P1|COMPLETED|Washout Period (at Least 7 Days)||6
1081070|NCT00975481|2619141|P6|STARTED|Washout Period (at Least 7 Days)||6
1081071|NCT00975481|2619142|P5|STARTED|Washout Period (at Least 7 Days)||6
1081072|NCT00975481|2619143|P4|STARTED|Washout Period (at Least 7 Days)||6
1081073|NCT00975481|2619144|P3|STARTED|Washout Period (at Least 7 Days)||6
1081074|NCT00975481|2619145|P2|STARTED|Washout Period (at Least 7 Days)||6
1081075|NCT00975481|2619146|P1|STARTED|Washout Period (at Least 7 Days)||6
1081076|NCT00975481|2619141|P6|NOT COMPLETED|First Intervention Period||0
1081077|NCT00975481|2619142|P5|NOT COMPLETED|First Intervention Period||0
1081078|NCT00975481|2619143|P4|NOT COMPLETED|First Intervention Period||0
1081079|NCT00975481|2619144|P3|NOT COMPLETED|First Intervention Period||0
1081080|NCT00975481|2619145|P2|NOT COMPLETED|First Intervention Period||0
1081081|NCT00975481|2619146|P1|NOT COMPLETED|First Intervention Period||0
1081082|NCT00975481|2619141|P6|COMPLETED|First Intervention Period||6
1081083|NCT00975481|2619142|P5|COMPLETED|First Intervention Period||6
1081084|NCT00975481|2619143|P4|COMPLETED|First Intervention Period||6
1081085|NCT00975481|2619144|P3|COMPLETED|First Intervention Period||6
1081086|NCT00975481|2619145|P2|COMPLETED|First Intervention Period||6
1081087|NCT00975481|2619146|P1|COMPLETED|First Intervention Period||6
1081088|NCT00975481|2619141|P6|STARTED|First Intervention Period||6
1081089|NCT00975481|2619142|P5|STARTED|First Intervention Period||6
1081090|NCT00975481|2619143|P4|STARTED|First Intervention Period||6
1081091|NCT00975481|2619144|P3|STARTED|First Intervention Period||6
1081092|NCT00975481|2619145|P2|STARTED|First Intervention Period||6
1081093|NCT00975481|2619146|P1|STARTED|First Intervention Period||6
1081094|NCT00975507|2619246|P2|NOT COMPLETED|Overall Study||4
1081095|NCT00975507|2619247|P1|NOT COMPLETED|Overall Study||20
1081096|NCT00975507|2619246|P2|COMPLETED|Overall Study||153
1081097|NCT00975507|2619247|P1|COMPLETED|Overall Study||303
1081098|NCT00975507|2619246|P2|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects receiving M-M-R™ II + VARIVAX™ at Visit 1 were not vaccinated at Visit 2|0
1081099|NCT00975507|2619247|P1|Vaccinated at Visit 2|Overall Study||310
1081100|NCT00975507|2619246|P2|Vaccinated at Visit 1|Overall Study||157
1081101|NCT00975507|2619247|P1|Vaccinated at Visit 1|Overall Study||323
1081102|NCT00975507|2619246|P2|STARTED|Overall Study||157
1081103|NCT00975507|2619247|P1|STARTED|Overall Study||323
1081104|NCT00975585|2619269|P2|NOT COMPLETED|Overall Study||12
1081105|NCT00975585|2619270|P1|NOT COMPLETED|Overall Study||7
1081106|NCT00975585|2619269|P2|COMPLETED|Overall Study||183
1081107|NCT00975585|2619270|P1|COMPLETED|Overall Study||177
1081108|NCT00975585|2619269|P2|STARTED|Overall Study||195
1081109|NCT00975585|2619270|P1|STARTED|Overall Study||184
1081110|NCT00975611|2619288|P1|NOT COMPLETED|Overall Study||17
1081111|NCT00975611|2619288|P1|COMPLETED|Overall Study||5
1081112|NCT00975611|2619288|P1|STARTED|Overall Study||22
1081113|NCT00975637|2619297|P5|NOT COMPLETED|Overall Study||2
1081114|NCT00975637|2619298|P4|NOT COMPLETED|Overall Study||6
1081115|NCT00975637|2619299|P3|NOT COMPLETED|Overall Study||2
1081116|NCT00975637|2619300|P2|NOT COMPLETED|Overall Study||1
1081117|NCT00975637|2619301|P1|NOT COMPLETED|Overall Study||3
1081118|NCT00975637|2619297|P5|COMPLETED|Overall Study||37
1081119|NCT00975637|2619298|P4|COMPLETED|Overall Study||32
1081120|NCT00975637|2619299|P3|COMPLETED|Overall Study||40
1081121|NCT00975637|2619300|P2|COMPLETED|Overall Study||38
1081122|NCT00975637|2619301|P1|COMPLETED|Overall Study||37
1081123|NCT00975637|2619297|P5|STARTED|Overall Study||39
1081124|NCT00975637|2619298|P4|STARTED|Overall Study||38
1081125|NCT00975637|2619299|P3|STARTED|Overall Study||42
1081126|NCT00975637|2619300|P2|STARTED|Overall Study||39
1081127|NCT00975637|2619301|P1|STARTED|Overall Study||40
1081128|NCT00975689|2619320|P2|NOT COMPLETED|Overall Study||3
1081129|NCT00975689|2619321|P1|NOT COMPLETED|Overall Study||2
1081130|NCT00975689|2619320|P2|COMPLETED|Overall Study||15
1081131|NCT00975689|2619321|P1|COMPLETED|Overall Study||15
1081132|NCT00975689|2619320|P2|STARTED|Overall Study||18
1081133|NCT00975689|2619321|P1|STARTED|Overall Study||17
1081134|NCT00975715|2619329|P2|NOT COMPLETED|Maintenance Period||1
1081135|NCT00975715|2619330|P1|NOT COMPLETED|Maintenance Period||2
1081136|NCT00975715|2619329|P2|COMPLETED|Maintenance Period||50
1081137|NCT00975715|2619330|P1|COMPLETED|Maintenance Period||39
1081138|NCT00975715|2619329|P2|STARTED|Maintenance Period||51
1081139|NCT00975715|2619330|P1|STARTED|Maintenance Period||41
1081140|NCT00975715|2619329|P2|NOT COMPLETED|Titration Period||0
1081141|NCT00975715|2619330|P1|NOT COMPLETED|Titration Period||7
1081142|NCT00975715|2619329|P2|COMPLETED|Titration Period||51
1081143|NCT00975715|2619330|P1|COMPLETED|Titration Period||41
1081144|NCT00975715|2619329|P2|STARTED|Titration Period||51
1081145|NCT00975715|2619330|P1|STARTED|Titration Period||48
1081146|NCT00975780|2619346|P2|NOT COMPLETED|Follow Up||157
1081147|NCT00975780|2619347|P1|NOT COMPLETED|Follow Up||102
1081148|NCT00975780|2619346|P2|COMPLETED|Follow Up||277
1081149|NCT00975780|2619347|P1|COMPLETED|Follow Up||298
1081150|NCT00975780|2619346|P2|STARTED|Follow Up||434
1081151|NCT00975780|2619347|P1|STARTED|Follow Up||400
1081152|NCT00975780|2619346|P2|NOT COMPLETED|Allocation||0
1081153|NCT00975780|2619347|P1|NOT COMPLETED|Allocation||0
1081154|NCT00975780|2619346|P2|COMPLETED|Allocation||434
1081155|NCT00975780|2619347|P1|COMPLETED|Allocation||400
1081156|NCT00975780|2619346|P2|STARTED|Allocation||434
1081157|NCT00975780|2619347|P1|STARTED|Allocation||400
1081158|NCT00975806|2619358|P3|NOT COMPLETED|Overall Study||4
1081159|NCT00975806|2619359|P2|NOT COMPLETED|Overall Study||7
1081160|NCT00975806|2619360|P1|NOT COMPLETED|Overall Study||5
1081161|NCT00975806|2619358|P3|COMPLETED|Overall Study|Participants were prematurely discontinued|0
1081162|NCT00975806|2619359|P2|COMPLETED|Overall Study|Participants were prematurely discontinued|0
1081163|NCT00975806|2619360|P1|COMPLETED|Overall Study|Participants were prematurely discontinued|0
1081164|NCT00975806|2619358|P3|STARTED|Overall Study||4
1081165|NCT00975806|2619359|P2|STARTED|Overall Study||7
1081166|NCT00975806|2619360|P1|STARTED|Overall Study||5
1081167|NCT00975923|2619384|P2|NOT COMPLETED|Overall Study||1
1081168|NCT00975923|2619385|P1|NOT COMPLETED|Overall Study||0
1081169|NCT00975923|2619384|P2|COMPLETED|Overall Study|1 hospital was sold, yielding 29 hospitals in the Tool Kit Group|29
1081170|NCT00975923|2619385|P1|COMPLETED|Overall Study||30
1081171|NCT00975923|2619384|P2|STARTED|Overall Study||30
1081172|NCT00975923|2619385|P1|STARTED|Overall Study||30
1081173|NCT00981630|2619397|P4|NOT COMPLETED|Overall Study||0
1081174|NCT00981630|2619398|P3|NOT COMPLETED|Overall Study||0
1081175|NCT00981630|2619399|P2|NOT COMPLETED|Overall Study||0
1081176|NCT00981630|2619400|P1|NOT COMPLETED|Overall Study||0
1081177|NCT00981630|2619397|P4|COMPLETED|Overall Study||32
1081178|NCT00981630|2619398|P3|COMPLETED|Overall Study||32
1081179|NCT00981630|2619399|P2|COMPLETED|Overall Study||32
1081180|NCT00981630|2619400|P1|COMPLETED|Overall Study||32
1081181|NCT00981630|2619397|P4|STARTED|Overall Study||32
1081182|NCT00981630|2619398|P3|STARTED|Overall Study||32
1081183|NCT00981630|2619399|P2|STARTED|Overall Study||32
1081184|NCT00981630|2619400|P1|STARTED|Overall Study||32
1081185|NCT00981669|2619432|P2|NOT COMPLETED|Overall Study||0
1081186|NCT00981669|2619433|P1|NOT COMPLETED|Overall Study||1
1081187|NCT00981669|2619432|P2|COMPLETED|Overall Study||40
1081188|NCT00981669|2619433|P1|COMPLETED|Overall Study||39
1081189|NCT00981669|2619432|P2|STARTED|Overall Study||40
1081190|NCT00981669|2619433|P1|STARTED|Overall Study||40
1081191|NCT00981812|2619441|P1|NOT COMPLETED|Overall Study||0
1081192|NCT00981812|2619441|P1|COMPLETED|Overall Study||20
1081193|NCT00981812|2619441|P1|STARTED|Overall Study||20
1081194|NCT00981825|2619447|P2|NOT COMPLETED|Second Intervention||0
1081195|NCT00981825|2619448|P1|NOT COMPLETED|Second Intervention||0
1081196|NCT00981825|2619447|P2|COMPLETED|Second Intervention||11
1081197|NCT00981825|2619448|P1|COMPLETED|Second Intervention||11
1081198|NCT00981825|2619447|P2|STARTED|Second Intervention||11
1081199|NCT00981825|2619448|P1|STARTED|Second Intervention||11
1081200|NCT00981825|2619447|P2|NOT COMPLETED|Washout After 1st Intervention||0
1081201|NCT00981825|2619448|P1|NOT COMPLETED|Washout After 1st Intervention||0
1081202|NCT00981825|2619447|P2|COMPLETED|Washout After 1st Intervention||11
1081203|NCT00981825|2619448|P1|COMPLETED|Washout After 1st Intervention||11
1081204|NCT00981825|2619447|P2|STARTED|Washout After 1st Intervention||11
1081205|NCT00981825|2619448|P1|STARTED|Washout After 1st Intervention||11
1081206|NCT00981825|2619447|P2|NOT COMPLETED|First Intervention||0
1081207|NCT00981825|2619448|P1|NOT COMPLETED|First Intervention||0
1081208|NCT00981825|2619447|P2|COMPLETED|First Intervention||11
1081209|NCT00981825|2619448|P1|COMPLETED|First Intervention||11
1081210|NCT00981825|2619447|P2|STARTED|First Intervention||11
1081211|NCT00981825|2619448|P1|STARTED|First Intervention||11
1081212|NCT00982735|2619454|P1|NOT COMPLETED|Overall Study||230
1081213|NCT00982735|2619454|P1|COMPLETED|Overall Study||757
1081214|NCT00982735|2619454|P1|STARTED|Overall Study||987
1081215|NCT00982995|2619460|P1|NOT COMPLETED|Overall Study||0
1081216|NCT00982995|2619460|P1|COMPLETED|Overall Study||3
1081217|NCT00982995|2619460|P1|STARTED|Overall Study||3
1081218|NCT00983073|2619465|P1|NOT COMPLETED|Maintenance Period||16
1081219|NCT00983073|2619465|P1|COMPLETED|Maintenance Period||144
1081220|NCT00983073|2619465|P1|STARTED|Maintenance Period||160
1081221|NCT00983073|2619465|P1|NOT COMPLETED|Titration and Optimal Dose Period||40
1081222|NCT00983073|2619465|P1|COMPLETED|Titration and Optimal Dose Period||160
1081223|NCT00983073|2619465|P1|STARTED|Titration and Optimal Dose Period||200
1081224|NCT00983073|2619465|P1|NOT COMPLETED|Observation Period||24
1081225|NCT00983073|2619465|P1|COMPLETED|Observation Period|24 participants not eligible to be dosed.|200
1081226|NCT00983073|2619465|P1|STARTED|Observation Period||224
1081227|NCT00983216|2619486|P1|NOT COMPLETED|Colchicine With Ketoconazole||0
1081228|NCT00983216|2619486|P1|COMPLETED|Colchicine With Ketoconazole||24
1081229|NCT00983216|2619486|P1|STARTED|Colchicine With Ketoconazole||24
1081230|NCT00983216|2619486|P1|NOT COMPLETED|Ketoconazole Alone||0
1081231|NCT00983216|2619486|P1|COMPLETED|Ketoconazole Alone||24
1081232|NCT00983216|2619486|P1|STARTED|Ketoconazole Alone||24
1081233|NCT00983216|2619486|P1|NOT COMPLETED|14 Day Washout Period||0
1081234|NCT00983216|2619486|P1|COMPLETED|14 Day Washout Period||24
1081235|NCT00983216|2619486|P1|STARTED|14 Day Washout Period||24
1081236|NCT00983216|2619486|P1|NOT COMPLETED|Colchicine Alone||0
1081237|NCT00983216|2619486|P1|COMPLETED|Colchicine Alone||24
1081238|NCT00983216|2619486|P1|STARTED|Colchicine Alone||24
1081239|NCT00983242|2619497|P1|NOT COMPLETED|Colchicine With Verapamil HCl ER||0
1081240|NCT00983242|2619497|P1|COMPLETED|Colchicine With Verapamil HCl ER||24
1081241|NCT00983242|2619497|P1|STARTED|Colchicine With Verapamil HCl ER||24
1081242|NCT00983242|2619497|P1|NOT COMPLETED|Verapamil HCl ER Alone||0
1081243|NCT00983242|2619497|P1|COMPLETED|Verapamil HCl ER Alone||24
1081244|NCT00983242|2619497|P1|STARTED|Verapamil HCl ER Alone||24
1081245|NCT00983242|2619497|P1|NOT COMPLETED|14 Day Washout Period||0
1081246|NCT00983242|2619497|P1|COMPLETED|14 Day Washout Period||24
1081247|NCT00983242|2619497|P1|STARTED|14 Day Washout Period||24
1081248|NCT00983242|2619497|P1|NOT COMPLETED|Colchicine Alone||0
1081249|NCT00983242|2619497|P1|COMPLETED|Colchicine Alone||24
1081250|NCT00983242|2619497|P1|STARTED|Colchicine Alone||24
1081251|NCT00983281|2619510|P2|NOT COMPLETED|Overall Study||0
1081252|NCT00983281|2619511|P1|NOT COMPLETED|Overall Study||0
1081253|NCT00983281|2619510|P2|COMPLETED|Overall Study||909
1081254|NCT00983281|2619511|P1|COMPLETED|Overall Study||805
1081255|NCT00983281|2619510|P2|STARTED|Overall Study||909
1081256|NCT00983281|2619511|P1|STARTED|Overall Study||805
1081257|NCT00983294|2619517|P1|NOT COMPLETED|Colchicine With Azithromycin||1
1081258|NCT00983294|2619517|P1|COMPLETED|Colchicine With Azithromycin|withdrawn by sponsor on Day 21 due to vomiting on Day 15, prior to azithromycin dosing(1)|21
1081259|NCT00983294|2619517|P1|STARTED|Colchicine With Azithromycin||22
1081260|NCT00983294|2619517|P1|NOT COMPLETED|Azithromycin Alone||0
1081261|NCT00983294|2619517|P1|COMPLETED|Azithromycin Alone||22
1081262|NCT00983294|2619517|P1|STARTED|Azithromycin Alone||22
1081263|NCT00983294|2619517|P1|NOT COMPLETED|14 Day Washout Period||2
1081264|NCT00983294|2619517|P1|COMPLETED|14 Day Washout Period|two subjects withdrew consent due to personal reasons|22
1081265|NCT00983294|2619517|P1|STARTED|14 Day Washout Period||24
1081266|NCT00983294|2619517|P1|NOT COMPLETED|Colchicine Alone||0
1081267|NCT00983294|2619517|P1|COMPLETED|Colchicine Alone||24
1081268|NCT00983294|2619517|P1|STARTED|Colchicine Alone||24
1081269|NCT00983346|2619528|P1|NOT COMPLETED|Overall Study||0
1081270|NCT00983346|2619528|P1|COMPLETED|Overall Study||17
1081271|NCT00983346|2619528|P1|STARTED|Overall Study||17
1081272|NCT00983359|2619532|P1|NOT COMPLETED|Overall Study||1
1081273|NCT00983359|2619532|P1|COMPLETED|Overall Study||39
1081274|NCT00983359|2619532|P1|Not Eligible for Analysis|Overall Study||1
1081275|NCT00983359|2619532|P1|STARTED|Overall Study||40
1081276|NCT00983372|2619540|P1|NOT COMPLETED|Colchicine With Diltiazem ER||0
1081277|NCT00983372|2619540|P1|COMPLETED|Colchicine With Diltiazem ER||20
1081278|NCT00983372|2619540|P1|STARTED|Colchicine With Diltiazem ER||20
1081279|NCT00983372|2619540|P1|NOT COMPLETED|Diltiazem ER Alone||3
1081280|NCT00983372|2619540|P1|COMPLETED|Diltiazem ER Alone|two subjects dropped due to missed diltiazem ER dose; one subject dropped due to vomitting|20
1081281|NCT00983372|2619540|P1|STARTED|Diltiazem ER Alone||23
1081282|NCT00983372|2619540|P1|NOT COMPLETED|14 Day Washout Period||1
1081283|NCT00983372|2619540|P1|COMPLETED|14 Day Washout Period|subject withdrew consent due to schedule conflict - during washout period or diltiazem alone|23
1081284|NCT00983372|2619540|P1|STARTED|14 Day Washout Period||24
1081285|NCT00983372|2619540|P1|NOT COMPLETED|Colchicine Alone||0
1081286|NCT00983372|2619540|P1|COMPLETED|Colchicine Alone||24
1081287|NCT00983372|2619540|P1|STARTED|Colchicine Alone||24
1081288|NCT00983385|2619551|P1|NOT COMPLETED|Maintenance Period||23
1081289|NCT00983385|2619551|P1|COMPLETED|Maintenance Period||117
1081290|NCT00983385|2619551|P1|STARTED|Maintenance Period||140
1081291|NCT00983385|2619551|P1|NOT COMPLETED|Titration and Optimal Dose Period||36
1081292|NCT00983385|2619551|P1|COMPLETED|Titration and Optimal Dose Period||140
1081293|NCT00983385|2619551|P1|STARTED|Titration and Optimal Dose Period||176
1081294|NCT00983385|2619551|P1|NOT COMPLETED|Observation Period||32
1081295|NCT00983385|2619551|P1|COMPLETED|Observation Period||176
1081296|NCT00983385|2619551|P1|STARTED|Observation Period||208
1081297|NCT00983437|2619596|P1|NOT COMPLETED|Overall Study||47
1081298|NCT00983437|2619596|P1|COMPLETED|Overall Study|Completed 12 months of treatment with armodafinil.|0
1081299|NCT00983437|2619596|P1|Full Analysis Set (FAS)|Overall Study|Participants had to have at least 1 postbaseline efficacy assessment to be evaluable for efficacy.|45
1081300|NCT00983437|2619596|P1|Safety Analysis Set (SAS)|Overall Study|Participants who received at least 1 dose of study drug were evaluable for safety.|47
1081301|NCT00983437|2619596|P1|STARTED|Overall Study||47
1081302|NCT00983476|2619618|P3|NOT COMPLETED|Overall Study||0
1081303|NCT00983476|2619619|P2|NOT COMPLETED|Overall Study||22
1081304|NCT00983476|2619620|P1|NOT COMPLETED|Overall Study||17
1081305|NCT00983476|2619618|P3|COMPLETED|Overall Study||88
1081306|NCT00983476|2619619|P2|COMPLETED|Overall Study||71
1081307|NCT00983476|2619620|P1|COMPLETED|Overall Study||78
1081308|NCT00983476|2619618|P3|6 Month Follow up Assessment|Overall Study||74
1081309|NCT00983476|2619619|P2|6 Month Follow up Assessment|Overall Study||62
1081310|NCT00983476|2619620|P1|6 Month Follow up Assessment|Overall Study||71
1081311|NCT00983476|2619618|P3|STARTED|Overall Study||88
1081312|NCT00983476|2619619|P2|STARTED|Overall Study||93
1081313|NCT00983476|2619620|P1|STARTED|Overall Study||95
1081314|NCT00983489|2619655|P3|NOT COMPLETED|Overall Study||312
1081315|NCT00983489|2619656|P2|NOT COMPLETED|Overall Study||285
1081316|NCT00983489|2619657|P1|NOT COMPLETED|Overall Study||185
1081317|NCT00983489|2619655|P3|COMPLETED|Overall Study||135
1081318|NCT00983489|2619656|P2|COMPLETED|Overall Study||168
1081319|NCT00983489|2619657|P1|COMPLETED|Overall Study||326
1081320|NCT00983489|2619655|P3|STARTED|Overall Study||447
1081321|NCT00983489|2619656|P2|STARTED|Overall Study||453
1081322|NCT00983489|2619657|P1|STARTED|Overall Study||511
1081323|NCT00983515|2619665|P1|NOT COMPLETED|Colchicine With Ritonavir||1
1081324|NCT00983515|2619665|P1|COMPLETED|Colchicine With Ritonavir|pharmacokinetic data included since parameters could be estimated for both dosing conditions|17
1081325|NCT00983515|2619665|P1|STARTED|Colchicine With Ritonavir||18
1081326|NCT00983515|2619665|P1|NOT COMPLETED|Ritonavir Alone||6
1081327|NCT00983515|2619665|P1|COMPLETED|Ritonavir Alone||18
1081328|NCT00983515|2619665|P1|STARTED|Ritonavir Alone||24
1081329|NCT00983515|2619665|P1|NOT COMPLETED|14 Day Washout Period||0
1081330|NCT00983515|2619665|P1|COMPLETED|14 Day Washout Period||24
1081331|NCT00983515|2619665|P1|STARTED|14 Day Washout Period||24
1081332|NCT00983515|2619665|P1|NOT COMPLETED|Colchicine Alone||0
1081333|NCT00983515|2619665|P1|COMPLETED|Colchicine Alone||24
1081334|NCT00983515|2619665|P1|STARTED|Colchicine Alone||24
1081335|NCT00983541|2619676|P1|NOT COMPLETED|Overall Study||0
1081336|NCT00983541|2619676|P1|COMPLETED|Overall Study||1
1081337|NCT00983541|2619676|P1|STARTED|Overall Study||1
1081338|NCT00983645|2619688|P2|NOT COMPLETED|Overall Study||0
1081339|NCT00983645|2619689|P1|NOT COMPLETED|Overall Study||0
1081340|NCT00983645|2619688|P2|COMPLETED|Overall Study||7
1081341|NCT00983645|2619689|P1|COMPLETED|Overall Study||8
1081342|NCT00983645|2619688|P2|STARTED|Overall Study||7
1081343|NCT00983645|2619689|P1|STARTED|Overall Study||8
1081344|NCT00983749|2619703|P2|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||3
1081345|NCT00983749|2619704|P1|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||1
1081346|NCT00983749|2619703|P2|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||7
1081347|NCT00983749|2619704|P1|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||12
1081348|NCT00983749|2619703|P2|STARTED|Follow-up Phase (Hospital DC to 30 Days)||10
1081349|NCT00983749|2619704|P1|STARTED|Follow-up Phase (Hospital DC to 30 Days)||13
1081350|NCT00983749|2619703|P2|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
1081351|NCT00983749|2619704|P1|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
1081352|NCT00983749|2619703|P2|COMPLETED|Acute Phase (Enrollment to Hospital DC)||10
1081353|NCT00983749|2619704|P1|COMPLETED|Acute Phase (Enrollment to Hospital DC)||13
1081354|NCT00983749|2619703|P2|STARTED|Acute Phase (Enrollment to Hospital DC)||10
1081355|NCT00983749|2619704|P1|STARTED|Acute Phase (Enrollment to Hospital DC)||13
1081356|NCT00983801|2619712|P1|NOT COMPLETED|Overall Study||0
1081357|NCT00983801|2619712|P1|COMPLETED|Overall Study|Participants who were taken off treatment.|52
1081358|NCT00983801|2619712|P1|STARTED|Overall Study|Participants who received treatment.|52
1081359|NCT00983827|2619724|P1|NOT COMPLETED|Overall Study||1
1081360|NCT00983827|2619724|P1|COMPLETED|Overall Study||7
1081361|NCT00983827|2619724|P1|STARTED|Overall Study||8
1081362|NCT00983853|2619734|P6|NOT COMPLETED|Overall Study||1
1081363|NCT00983853|2619735|P5|NOT COMPLETED|Overall Study||3
1081364|NCT00983853|2619736|P4|NOT COMPLETED|Overall Study||2
1081365|NCT00983853|2619737|P3|NOT COMPLETED|Overall Study||3
1081366|NCT00983853|2619738|P2|NOT COMPLETED|Overall Study||2
1081367|NCT00983853|2619739|P1|NOT COMPLETED|Overall Study||1
1081368|NCT00983853|2619734|P6|COMPLETED|Overall Study||7
1081369|NCT00983853|2619735|P5|COMPLETED|Overall Study||12
1081370|NCT00983853|2619736|P4|COMPLETED|Overall Study||6
1081371|NCT00983853|2619737|P3|COMPLETED|Overall Study||14
1081372|NCT00983853|2619738|P2|COMPLETED|Overall Study||5
1081373|NCT00983853|2619739|P1|COMPLETED|Overall Study||6
1081374|NCT00983853|2619734|P6|STARTED|Overall Study||8
1081375|NCT00983853|2619735|P5|STARTED|Overall Study||15
1081376|NCT00983853|2619736|P4|STARTED|Overall Study||8
1081377|NCT00983853|2619737|P3|STARTED|Overall Study|1 subject was randomized but not dosed|17
1081378|NCT00983853|2619738|P2|STARTED|Overall Study|1 subject was randomized but not dosed|7
1081379|NCT00983853|2619739|P1|STARTED|Overall Study||7
1081380|NCT00983892|2619769|P2|NOT COMPLETED|Overall Study||12
1081381|NCT00983892|2619770|P1|NOT COMPLETED|Overall Study||10
1081382|NCT00983892|2619769|P2|COMPLETED|Overall Study||56
1081383|NCT00983892|2619770|P1|COMPLETED|Overall Study||56
1081384|NCT00983892|2619769|P2|STARTED|Overall Study||68
1081385|NCT00983892|2619770|P1|STARTED|Overall Study||66
1081386|NCT00983905|2619776|P1|NOT COMPLETED|Theophylline With Colchicine||0
1081387|NCT00983905|2619776|P1|COMPLETED|Theophylline With Colchicine||27
1081388|NCT00983905|2619776|P1|STARTED|Theophylline With Colchicine||27
1081389|NCT00983905|2619776|P1|NOT COMPLETED|Colchicine Alone||2
1081390|NCT00983905|2619776|P1|COMPLETED|Colchicine Alone|withdrawn by sponsor due to: diarrhea(1); vomiting and diarrhea(1)|27
1081391|NCT00983905|2619776|P1|STARTED|Colchicine Alone||29
1081392|NCT00983905|2619776|P1|NOT COMPLETED|4 Day Washout Period||0
1081393|NCT00983905|2619776|P1|COMPLETED|4 Day Washout Period||29
1081394|NCT00983905|2619776|P1|STARTED|4 Day Washout Period||29
1081395|NCT00983905|2619776|P1|NOT COMPLETED|Theophylline Alone||1
1081396|NCT00983905|2619776|P1|COMPLETED|Theophylline Alone|withdrawn by sponsor due to vomiting(1)|29
1081397|NCT00983905|2619776|P1|STARTED|Theophylline Alone||30
1081398|NCT00983918|2619791|P4|NOT COMPLETED|Overall Study||2
1081399|NCT00983918|2619792|P3|NOT COMPLETED|Overall Study||2
1081400|NCT00983918|2619793|P2|NOT COMPLETED|Overall Study||2
1081401|NCT00983918|2619794|P1|NOT COMPLETED|Overall Study||0
1081402|NCT00983918|2619791|P4|COMPLETED|Overall Study||18
1081403|NCT00983918|2619792|P3|COMPLETED|Overall Study||18
1081404|NCT00983918|2619793|P2|COMPLETED|Overall Study||18
1081405|NCT00983918|2619794|P1|COMPLETED|Overall Study||20
1081406|NCT00983918|2619791|P4|STARTED|Overall Study||20
1081407|NCT00983918|2619792|P3|STARTED|Overall Study||20
1081408|NCT00983918|2619793|P2|STARTED|Overall Study||20
1081409|NCT00983918|2619794|P1|STARTED|Overall Study||20
1081410|NCT00983931|2619804|P1|NOT COMPLETED|Colchicine With Cyclosporine||0
1081411|NCT00983931|2619804|P1|COMPLETED|Colchicine With Cyclosporine||23
1081412|NCT00983931|2619804|P1|STARTED|Colchicine With Cyclosporine||23
1081413|NCT00983931|2619804|P1|NOT COMPLETED|14 Day Washout Period||1
1081414|NCT00983931|2619804|P1|COMPLETED|14 Day Washout Period|one subject withdrawn due to creatine kinase out of range|23
1081415|NCT00983931|2619804|P1|STARTED|14 Day Washout Period||24
1081416|NCT00983931|2619804|P1|NOT COMPLETED|Colchicine Alone||0
1081417|NCT00983931|2619804|P1|COMPLETED|Colchicine Alone||24
1081418|NCT00983931|2619804|P1|STARTED|Colchicine Alone||24
1081419|NCT00983957|2619814|P1|NOT COMPLETED|Overall Study||2
1081420|NCT00983957|2619814|P1|COMPLETED|Overall Study||18
1081421|NCT00983957|2619814|P1|Treatment C|Overall Study||18
1081422|NCT00983957|2619814|P1|Treatment B|Overall Study||20
1081423|NCT00983957|2619814|P1|Treatment A|Overall Study||20
1081424|NCT00983957|2619814|P1|STARTED|Overall Study||20
1081425|NCT00983983|2619851|P3|NOT COMPLETED|Overall Study||1
1081426|NCT00983983|2619852|P2|NOT COMPLETED|Overall Study||1
1081427|NCT00983983|2619853|P1|NOT COMPLETED|Overall Study||2
1081428|NCT00983983|2619851|P3|COMPLETED|Overall Study||6
1081429|NCT00983983|2619852|P2|COMPLETED|Overall Study||8
1081430|NCT00983983|2619853|P1|COMPLETED|Overall Study||6
1081431|NCT00983983|2619851|P3|STARTED|Overall Study||7
1081432|NCT00983983|2619852|P2|STARTED|Overall Study||9
1081433|NCT00983983|2619853|P1|STARTED|Overall Study||8
1081434|NCT00984009|2619870|P1|NOT COMPLETED|Colchicine With Grapefruit Juice||0
1081435|NCT00984009|2619870|P1|COMPLETED|Colchicine With Grapefruit Juice||21
1081436|NCT00984009|2619870|P1|STARTED|Colchicine With Grapefruit Juice||21
1081437|NCT00984009|2619870|P1|NOT COMPLETED|Grapefruit Juice Alone||1
1081438|NCT00984009|2619870|P1|COMPLETED|Grapefruit Juice Alone|one subject dropped due to missed a.m. serving of grapefruit juice on Day 16|21
1081439|NCT00984009|2619870|P1|STARTED|Grapefruit Juice Alone||22
1081440|NCT00984009|2619870|P1|NOT COMPLETED|14 Day Washout Period||0
1081441|NCT00984009|2619870|P1|COMPLETED|14 Day Washout Period||22
1081442|NCT00984009|2619870|P1|STARTED|14 Day Washout Period||22
1081443|NCT00984009|2619870|P1|NOT COMPLETED|Colchicine Alone||0
1081444|NCT00984009|2619870|P1|COMPLETED|Colchicine Alone||22
1081445|NCT00984009|2619870|P1|STARTED|Colchicine Alone||22
1081446|NCT00984022|2619883|P2|NOT COMPLETED|Overall Study||14
1081447|NCT00984022|2619884|P1|NOT COMPLETED|Overall Study||10
1081448|NCT00984022|2619883|P2|COMPLETED|Overall Study||35
1081449|NCT00984022|2619884|P1|COMPLETED|Overall Study||33
1081450|NCT00984022|2619883|P2|STARTED|Overall Study||49
1081451|NCT00984022|2619884|P1|STARTED|Overall Study||43
1081452|NCT00984061|2619894|P1|NOT COMPLETED|Colchicine With Clarithromycin||0
1081453|NCT00984061|2619894|P1|COMPLETED|Colchicine With Clarithromycin||23
1081454|NCT00984061|2619894|P1|STARTED|Colchicine With Clarithromycin||23
1081455|NCT00984061|2619894|P1|NOT COMPLETED|Clarithromycin Alone||1
1081456|NCT00984061|2619894|P1|COMPLETED|Clarithromycin Alone|One subject was dropped due to noncompliance with outpatient clarithromycin regimen.|23
1081457|NCT00984061|2619894|P1|STARTED|Clarithromycin Alone||24
1081458|NCT00984061|2619894|P1|NOT COMPLETED|21 Day Washout Period||0
1081459|NCT00984061|2619894|P1|COMPLETED|21 Day Washout Period||24
1081460|NCT00984061|2619894|P1|STARTED|21 Day Washout Period||24
1081461|NCT00984061|2619894|P1|NOT COMPLETED|Colchicine Alone||0
1081462|NCT00984061|2619894|P1|COMPLETED|Colchicine Alone||24
1081463|NCT00984061|2619894|P1|STARTED|Colchicine Alone||24
1081464|NCT00984126|2619909|P4|NOT COMPLETED|Overall Study||59
1081465|NCT00984126|2619910|P3|NOT COMPLETED|Overall Study||7
1081466|NCT00984126|2619911|P2|NOT COMPLETED|Overall Study||8
1081467|NCT00984126|2619912|P1|NOT COMPLETED|Overall Study||7
1081468|NCT00984126|2619909|P4|COMPLETED|Overall Study||76
1081469|NCT00984126|2619910|P3|COMPLETED|Overall Study||16
1081470|NCT00984126|2619911|P2|COMPLETED|Overall Study||20
1081471|NCT00984126|2619912|P1|COMPLETED|Overall Study||20
1081472|NCT00984126|2619909|P4|STARTED|Overall Study||135
1081473|NCT00984126|2619910|P3|STARTED|Overall Study||23
1081474|NCT00984126|2619911|P2|STARTED|Overall Study||28
1081475|NCT00984126|2619912|P1|STARTED|Overall Study||27
1081476|NCT00984139|2619937|P1|NOT COMPLETED|Overall Study||0
1081477|NCT00984139|2619937|P1|COMPLETED|Overall Study||306
1081478|NCT00984139|2619937|P1|STARTED|Overall Study||306
1081491|NCT00984204|2619969|P1|NOT COMPLETED|Overall Study||15
1081492|NCT00984204|2619969|P1|COMPLETED|Overall Study|"Seven subjects of the ten Lack of efficacy were acute failures that had no block after 30 min"|173
1081493|NCT00984204|2619969|P1|STARTED|Overall Study||188
1081494|NCT00984256|2619977|P2|NOT COMPLETED|Overall Study||1
1081495|NCT00984256|2619978|P1|NOT COMPLETED|Overall Study||0
1081496|NCT00984256|2619977|P2|COMPLETED|Overall Study||29
1081497|NCT00984256|2619978|P1|COMPLETED|Overall Study||6
1081498|NCT00984256|2619977|P2|STARTED|Overall Study||30
1081499|NCT00984256|2619978|P1|STARTED|Overall Study||6
1081500|NCT00984282|2620000|P2|NOT COMPLETED|Long Term Follow-up||117
1081501|NCT00984282|2620001|P1|NOT COMPLETED|Long Term Follow-up||114
1081502|NCT00984282|2620000|P2|COMPLETED|Long Term Follow-up||0
1081503|NCT00984282|2620001|P1|COMPLETED|Long Term Follow-up||0
1081504|NCT00984282|2620000|P2|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|117
1081505|NCT00984282|2620001|P1|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|114
1081506|NCT00984282|2620000|P2|NOT COMPLETED|Open-label Treatment||161
1081507|NCT00984282|2620001|P1|NOT COMPLETED|Open-label Treatment||86
1081508|NCT00984282|2620000|P2|COMPLETED|Open-label Treatment||0
1081509|NCT00984282|2620001|P1|COMPLETED|Open-label Treatment||0
1081510|NCT00984282|2620000|P2|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG4 (RG= Reporting Group for Safety Data)|161
1081511|NCT00984282|2620001|P1|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG3 (RG= Reporting Group for Safety Data)|86
1081512|NCT00984282|2620000|P2|STARTED|Open-label Treatment||161
1081513|NCT00984282|2620001|P1|STARTED|Open-label Treatment||86
1081514|NCT00984282|2620000|P2|NOT COMPLETED|Double Blind Treatment||38
1081515|NCT00984282|2620001|P1|NOT COMPLETED|Double Blind Treatment||104
1081516|NCT00984282|2620000|P2|COMPLETED|Double Blind Treatment||172
1081517|NCT00984282|2620001|P1|COMPLETED|Double Blind Treatment||103
1081518|NCT00984282|2620000|P2|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG2 (RG= Reporting Group for Safety Data)|209
1081519|NCT00984282|2620001|P1|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG1 (RG= Reporting Group for Safety Data)|207
1081520|NCT00984282|2620000|P2|STARTED|Double Blind Treatment||210
1081521|NCT00984282|2620001|P1|STARTED|Double Blind Treatment||207
1081522|NCT00984295|2620025|P3|NOT COMPLETED|Overall Study||37
1081523|NCT00984295|2620026|P2|NOT COMPLETED|Overall Study||32
1081524|NCT00984295|2620027|P1|NOT COMPLETED|Overall Study||65
1081525|NCT00984295|2620025|P3|COMPLETED|Overall Study||442
1081526|NCT00984295|2620026|P2|COMPLETED|Overall Study||453
1081527|NCT00984295|2620027|P1|COMPLETED|Overall Study||884
1081528|NCT00984295|2620025|P3|Visit 2|Overall Study||453
1081529|NCT00984295|2620026|P2|Visit 2|Overall Study||468
1081530|NCT00984295|2620027|P1|Visit 2|Overall Study||909
1081531|NCT00984295|2620025|P3|Visit 1|Overall Study||479
1081532|NCT00984295|2620026|P2|Visit 1|Overall Study||485
1081533|NCT00984295|2620027|P1|Visit 1|Overall Study||949
1081534|NCT00984295|2620025|P3|STARTED|Overall Study||479
1081535|NCT00984295|2620026|P2|STARTED|Overall Study||485
1081536|NCT00984295|2620027|P1|STARTED|Overall Study|2 patients were incorrectly vaccinated and are excluded from this table.|949
1081537|NCT00984308|2620094|P2|NOT COMPLETED|Overall Study||6
1081538|NCT00984308|2620095|P1|NOT COMPLETED|Overall Study||18
1081539|NCT00984308|2620094|P2|COMPLETED|Overall Study||109
1081540|NCT00984308|2620095|P1|COMPLETED|Overall Study||92
1081541|NCT00984308|2620094|P2|STARTED|Overall Study||115
1081542|NCT00984308|2620095|P1|STARTED|Overall Study||110
1081543|NCT00984334|2620110|P5|NOT COMPLETED|Overall Study||1
1081544|NCT00984334|2620111|P4|NOT COMPLETED|Overall Study||1
1081545|NCT00984334|2620112|P3|NOT COMPLETED|Overall Study||0
1081546|NCT00984334|2620113|P2|NOT COMPLETED|Overall Study||1
1081547|NCT00984334|2620114|P1|NOT COMPLETED|Overall Study||1
1081548|NCT00984334|2620110|P5|COMPLETED|Overall Study||7
1081549|NCT00984334|2620111|P4|COMPLETED|Overall Study||7
1081550|NCT00984334|2620112|P3|COMPLETED|Overall Study||8
1081551|NCT00984334|2620113|P2|COMPLETED|Overall Study||7
1081552|NCT00984334|2620114|P1|COMPLETED|Overall Study||7
1081553|NCT00984334|2620110|P5|STARTED|Overall Study||8
1081554|NCT00984334|2620111|P4|STARTED|Overall Study||8
1081555|NCT00984334|2620112|P3|STARTED|Overall Study||8
1081556|NCT00984334|2620113|P2|STARTED|Overall Study||8
1081557|NCT00984334|2620114|P1|STARTED|Overall Study||8
1081558|NCT00984490|2620126|P1|NOT COMPLETED|Overall Study||0
1081559|NCT00984490|2620126|P1|COMPLETED|Overall Study||5
1081560|NCT00984490|2620126|P1|STARTED|Overall Study||5
1081561|NCT00984542|2620131|P1|NOT COMPLETED|Overall Study||41
1081562|NCT00984542|2620131|P1|COMPLETED|Overall Study||9
1081563|NCT00984542|2620131|P1|STARTED|Overall Study||50
1081564|NCT00984568|2620141|P2|NOT COMPLETED|Overall Study||6
1081565|NCT00984568|2620142|P1|NOT COMPLETED|Overall Study||8
1081566|NCT00984568|2620141|P2|COMPLETED|Overall Study||7
1081567|NCT00984568|2620142|P1|COMPLETED|Overall Study||7
1081568|NCT00984568|2620141|P2|STARTED|Overall Study||13
1081569|NCT00984568|2620142|P1|STARTED|Overall Study||15
1081570|NCT00984594|2620152|P2|NOT COMPLETED|Overall Study||1
1081571|NCT00984594|2620153|P1|NOT COMPLETED|Overall Study||1
1081572|NCT00984594|2620152|P2|COMPLETED|Overall Study||1
1081573|NCT00984594|2620153|P1|COMPLETED|Overall Study||1
1081574|NCT00984594|2620152|P2|STARTED|Overall Study|One patient withdrew consent and left the study before treatment.|2
1081575|NCT00984594|2620153|P1|STARTED|Overall Study||2
1081576|NCT00984620|2620169|P2|NOT COMPLETED|Overall Study||12
1081577|NCT00984620|2620170|P1|NOT COMPLETED|Overall Study||6
1081578|NCT00984620|2620169|P2|COMPLETED|Overall Study||67
1081579|NCT00984620|2620170|P1|COMPLETED|Overall Study||75
1081580|NCT00984620|2620169|P2|STARTED|Overall Study||79
1081581|NCT00984620|2620170|P1|STARTED|Overall Study||81
1081606|NCT00984698|2620240|P2|NOT COMPLETED|Overall Study||8
1081607|NCT00984698|2620241|P1|NOT COMPLETED|Overall Study||3
1081608|NCT00984698|2620240|P2|COMPLETED|Overall Study||14
1081609|NCT00984698|2620241|P1|COMPLETED|Overall Study||18
1081610|NCT00984698|2620240|P2|STARTED|Overall Study||22
1081611|NCT00984698|2620241|P1|STARTED|Overall Study||21
1081612|NCT00984815|2620249|P1|NOT COMPLETED|Overall Study||30
1081613|NCT00984815|2620249|P1|COMPLETED|Overall Study||56
1081614|NCT00984815|2620249|P1|STARTED|Overall Study||86
1081615|NCT00984867|2620258|P2|NOT COMPLETED|Overall Study||17
1081616|NCT00984867|2620259|P1|NOT COMPLETED|Overall Study||23
1081617|NCT00984867|2620258|P2|COMPLETED|Overall Study||208
1081618|NCT00984867|2620259|P1|COMPLETED|Overall Study||203
1081619|NCT00984867|2620258|P2|STARTED|Overall Study|Of the 225 randomized and treated participants only 223 were included in the full analysis set.|225
1081620|NCT00984867|2620259|P1|STARTED|Overall Study|Of the 226 randomized and treated participants only 224 were included in the full analysis set.|226
1081621|NCT00985010|2620279|P2|NOT COMPLETED|Overall Study||0
1081622|NCT00985010|2620280|P1|NOT COMPLETED|Overall Study||0
1081623|NCT00985010|2620279|P2|COMPLETED|Overall Study||5
1081624|NCT00985010|2620280|P1|COMPLETED|Overall Study||4
1081625|NCT00985010|2620279|P2|STARTED|Overall Study||5
1081626|NCT00985010|2620280|P1|STARTED|Overall Study||4
1081627|NCT00985114|2620290|P2|NOT COMPLETED|Overall Study||2
1081628|NCT00985114|2620291|P1|NOT COMPLETED|Overall Study||1
1081629|NCT00985114|2620290|P2|COMPLETED|Overall Study||37
1081630|NCT00985114|2620291|P1|COMPLETED|Overall Study||33
1081631|NCT00985114|2620290|P2|Diet + Lifestyle Counseling Cross-over|Overall Study|Received device for intended period of 12 months with 6 months follow up|28
1081632|NCT00985114|2620291|P1|Diet + Lifestyle Counseling Cross-over|Overall Study||0
1081633|NCT00985114|2620290|P2|STARTED|Overall Study||39
1081634|NCT00985114|2620291|P1|STARTED|Overall Study|38 randomized, 34 received the device|34
1081635|NCT00985140|2620297|P1|NOT COMPLETED|Overall Study||0
1081636|NCT00985140|2620297|P1|COMPLETED|Overall Study||15
1081637|NCT00985140|2620297|P1|STARTED|Overall Study||15
1081638|NCT00985153|2620305|P4|NOT COMPLETED|Overall Study||47
1081639|NCT00985153|2620306|P3|NOT COMPLETED|Overall Study||44
1081640|NCT00985153|2620307|P2|NOT COMPLETED|Overall Study||44
1081641|NCT00985153|2620308|P1|NOT COMPLETED|Overall Study||35
1081642|NCT00985153|2620305|P4|COMPLETED|Overall Study||965
1081643|NCT00985153|2620306|P3|COMPLETED|Overall Study||918
1081644|NCT00985153|2620307|P2|COMPLETED|Overall Study||924
1081645|NCT00985153|2620308|P1|COMPLETED|Overall Study||950
1081646|NCT00985153|2620305|P4|Vaccinated at Visit 1|Overall Study||1012
1081647|NCT00985153|2620306|P3|Vaccinated at Visit 1|Overall Study||962
1081648|NCT00985153|2620307|P2|Vaccinated at Visit 1|Overall Study||968
1081649|NCT00985153|2620308|P1|Vaccinated at Visit 1|Overall Study||985
1081650|NCT00985153|2620305|P4|STARTED|Overall Study||1012
1081651|NCT00985153|2620306|P3|STARTED|Overall Study||962
1081652|NCT00985153|2620307|P2|STARTED|Overall Study||968
1081653|NCT00985153|2620308|P1|STARTED|Overall Study||985
1081654|NCT00985166|2620353|P3|NOT COMPLETED|Overall Study||7
1081655|NCT00985166|2620354|P2|NOT COMPLETED|Overall Study||4
1081656|NCT00985166|2620355|P1|NOT COMPLETED|Overall Study||9
1081657|NCT00985166|2620353|P3|COMPLETED|Overall Study||188
1081658|NCT00985166|2620354|P2|COMPLETED|Overall Study||201
1081659|NCT00985166|2620355|P1|COMPLETED|Overall Study||392
1081660|NCT00985166|2620353|P3|Vaccinated at Visit 1|Overall Study||195
1081661|NCT00985166|2620354|P2|Vaccinated at Visit 1|Overall Study||205
1081662|NCT00985166|2620355|P1|Vaccinated at Visit 1|Overall Study||399
1081663|NCT00985166|2620353|P3|STARTED|Overall Study||195
1081664|NCT00985166|2620354|P2|STARTED|Overall Study||205
1081665|NCT00985166|2620355|P1|STARTED|Overall Study|Two randomized subjects withdrew consent before vaccination: no demographic information available.|401
1081666|NCT00985192|2620371|P1|NOT COMPLETED|Overall Study||4
1081667|NCT00985192|2620371|P1|COMPLETED|Overall Study||45
1081668|NCT00985192|2620371|P1|STARTED|Overall Study||49
1081669|NCT00985231|2620382|P2|NOT COMPLETED|Overall Study||3
1081670|NCT00985231|2620383|P1|NOT COMPLETED|Overall Study||3
1081671|NCT00985231|2620382|P2|COMPLETED|Overall Study||129
1081672|NCT00985231|2620383|P1|COMPLETED|Overall Study||130
1081673|NCT00985231|2620382|P2|STARTED|Overall Study||132
1081674|NCT00985231|2620383|P1|STARTED|Overall Study||133
1081675|NCT00985257|2620391|P1|NOT COMPLETED|Overall Study||0
1081676|NCT00985257|2620391|P1|COMPLETED|Overall Study||123
1081677|NCT00985257|2620391|P1|STARTED|Overall Study||123
1081678|NCT00985439|2620399|P4|NOT COMPLETED|Overall Study||0
1081679|NCT00985439|2620400|P3|NOT COMPLETED|Overall Study||1
1081680|NCT00985439|2620401|P2|NOT COMPLETED|Overall Study||0
1081681|NCT00985439|2620402|P1|NOT COMPLETED|Overall Study||0
1081682|NCT00985439|2620399|P4|COMPLETED|Overall Study||51
1081683|NCT00985439|2620400|P3|COMPLETED|Overall Study||50
1081684|NCT00985439|2620401|P2|COMPLETED|Overall Study||51
1081685|NCT00985439|2620402|P1|COMPLETED|Overall Study||49
1081686|NCT00985439|2620399|P4|STARTED|Overall Study||51
1081687|NCT00985439|2620400|P3|STARTED|Overall Study||51
1081688|NCT00985439|2620401|P2|STARTED|Overall Study||51
1081689|NCT00985439|2620402|P1|STARTED|Overall Study||49
1081690|NCT00985491|2620412|P1|NOT COMPLETED|Overall Study||19
1081691|NCT00985491|2620412|P1|COMPLETED|Overall Study|43 subjects received a device, 27 subjects completed 12 month implant period|27
1081692|NCT00985491|2620412|P1|Received Device|Overall Study||43
1081693|NCT00985491|2620412|P1|STARTED|Overall Study|46 subjects underwent an attempted implantation procedure|46
1081694|NCT00985504|2620419|P2|NOT COMPLETED|Optimization Period||23
1081695|NCT00985504|2620420|P1|NOT COMPLETED|Optimization Period||26
1081696|NCT00985504|2620419|P2|COMPLETED|Optimization Period||204
1081697|NCT00985504|2620420|P1|COMPLETED|Optimization Period||203
1081698|NCT00985504|2620419|P2|STARTED|Optimization Period||227
1081699|NCT00985504|2620420|P1|STARTED|Optimization Period||229
1081700|NCT00985504|2620419|P2|NOT COMPLETED|Acute Treatment Period||12
1081701|NCT00985504|2620420|P1|NOT COMPLETED|Acute Treatment Period||15
1081702|NCT00985504|2620419|P2|COMPLETED|Acute Treatment Period||227
1081703|NCT00985504|2620420|P1|COMPLETED|Acute Treatment Period||229
1081704|NCT00985504|2620419|P2|STARTED|Acute Treatment Period||239
1081705|NCT00985504|2620420|P1|STARTED|Acute Treatment Period||244
1081706|NCT00988429|2620449|P3|NOT COMPLETED|Overall Study||69
1081707|NCT00988429|2620450|P2|NOT COMPLETED|Overall Study||43
1081708|NCT00988429|2620451|P1|NOT COMPLETED|Overall Study||37
1081709|NCT00988429|2620449|P3|COMPLETED|Overall Study||142
1081710|NCT00988429|2620450|P2|COMPLETED|Overall Study||173
1081711|NCT00988429|2620451|P1|COMPLETED|Overall Study||189
1081712|NCT00988429|2620449|P3|Intention-to-treat (ITT) Population|Overall Study||205
1081713|NCT00988429|2620450|P2|Intention-to-treat (ITT) Population|Overall Study||215
1081714|NCT00988429|2620451|P1|Intention-to-treat (ITT) Population|Overall Study||220
1081715|NCT00988429|2620449|P3|Safety Population|Overall Study||210
1081716|NCT00988429|2620450|P2|Safety Population|Overall Study||216
1081717|NCT00988429|2620451|P1|Safety Population|Overall Study||224
1081718|NCT00988429|2620449|P3|STARTED|Overall Study||211
1081719|NCT00988429|2620450|P2|STARTED|Overall Study||216
1081720|NCT00988429|2620451|P1|STARTED|Overall Study||226
1081721|NCT00988442|2620464|P2|NOT COMPLETED|Overall Study||28
1081722|NCT00988442|2620465|P1|NOT COMPLETED|Overall Study||30
1081723|NCT00988442|2620464|P2|COMPLETED|Overall Study||1
1081724|NCT00988442|2620465|P1|COMPLETED|Overall Study||0
1081725|NCT00988442|2620464|P2|STARTED|Overall Study||29
1081726|NCT00988442|2620465|P1|STARTED|Overall Study||30
1081727|NCT00988533|2620525|P1|NOT COMPLETED|Overall Study||3
1081728|NCT00988533|2620525|P1|COMPLETED|Overall Study||27
1081729|NCT00988533|2620525|P1|STARTED|Overall Study||30
1081730|NCT00988637|2620539|P2|NOT COMPLETED|Overall Study||3
1081731|NCT00988637|2620540|P1|NOT COMPLETED|Overall Study||3
1081732|NCT00988637|2620539|P2|COMPLETED|Overall Study||65
1081733|NCT00988637|2620540|P1|COMPLETED|Overall Study||67
1081734|NCT00988637|2620539|P2|STARTED|Overall Study||68
1081735|NCT00988637|2620540|P1|STARTED|Overall Study||70
1081736|NCT00988832|2620570|P1|NOT COMPLETED|Overall Study||0
1081737|NCT00988832|2620570|P1|COMPLETED|Overall Study||380
1081738|NCT00988832|2620570|P1|STARTED|Overall Study||380
1081739|NCT00988858|2620605|P1|NOT COMPLETED|Overall Study||10
1081740|NCT00988858|2620605|P1|COMPLETED|Overall Study||45
1081741|NCT00988858|2620605|P1|STARTED|Overall Study||55
1081742|NCT00988884|2620619|P2|NOT COMPLETED|Overall Study||36
1081743|NCT00988884|2620620|P1|NOT COMPLETED|Overall Study||35
1081744|NCT00988884|2620619|P2|COMPLETED|Overall Study||584
1081745|NCT00988884|2620620|P1|COMPLETED|Overall Study||586
1081746|NCT00988884|2620619|P2|STARTED|Overall Study||620
1081747|NCT00988884|2620620|P1|STARTED|Overall Study||621
1081748|NCT00989014|2620646|P4|NOT COMPLETED|Overall Study||0
1081749|NCT00989014|2620647|P3|NOT COMPLETED|Overall Study||0
1081750|NCT00989014|2620648|P2|NOT COMPLETED|Overall Study||0
1081751|NCT00989014|2620649|P1|NOT COMPLETED|Overall Study||0
1081752|NCT00989014|2620646|P4|COMPLETED|Overall Study||32
1081753|NCT00989014|2620647|P3|COMPLETED|Overall Study||28
1081754|NCT00989014|2620648|P2|COMPLETED|Overall Study||31
1081755|NCT00989014|2620649|P1|COMPLETED|Overall Study||31
1081756|NCT00989014|2620646|P4|STARTED|Overall Study||32
1081757|NCT00989014|2620647|P3|STARTED|Overall Study||28
1081758|NCT00989014|2620648|P2|STARTED|Overall Study||31
1081759|NCT00989014|2620649|P1|STARTED|Overall Study||31
1081760|NCT00989092|2620661|P2|NOT COMPLETED|Overall Study||28
1081761|NCT00989092|2620662|P1|NOT COMPLETED|Overall Study||90
1081762|NCT00989092|2620661|P2|COMPLETED|Overall Study||31
1081763|NCT00989092|2620662|P1|COMPLETED|Overall Study||138
1081764|NCT00989092|2620661|P2|Treated With Darbepoetin Alfa|Overall Study||33
1081765|NCT00989092|2620662|P1|Treated With Darbepoetin Alfa|Overall Study||226
1081766|NCT00989092|2620661|P2|STARTED|Overall Study||59
1081767|NCT00989092|2620662|P1|STARTED|Overall Study||228
1081768|NCT00989157|2620697|P2|NOT COMPLETED|Overall Study||0
1081769|NCT00989157|2620698|P1|NOT COMPLETED|Overall Study||0
1081770|NCT00989157|2620697|P2|COMPLETED|Overall Study||10
1081771|NCT00989157|2620698|P1|COMPLETED|Overall Study||10
1081772|NCT00989157|2620697|P2|STARTED|Overall Study||10
1081773|NCT00989157|2620698|P1|STARTED|Overall Study||10
1081774|NCT00989196|2620712|P2|NOT COMPLETED|Treatment Period||0
1081775|NCT00989196|2620713|P1|NOT COMPLETED|Treatment Period||1
1081776|NCT00989196|2620712|P2|COMPLETED|Treatment Period||12
1081777|NCT00989196|2620713|P1|COMPLETED|Treatment Period||9
1081778|NCT00989196|2620712|P2|STARTED|Treatment Period||12
1081779|NCT00989196|2620713|P1|STARTED|Treatment Period||10
1081780|NCT00989196|2620712|P2|NOT COMPLETED|PK Crossover Period||0
1081781|NCT00989196|2620713|P1|NOT COMPLETED|PK Crossover Period||0
1081782|NCT00989196|2620712|P2|COMPLETED|PK Crossover Period||12
1081783|NCT00989196|2620713|P1|COMPLETED|PK Crossover Period||10
1081784|NCT00989196|2620712|P2|STARTED|PK Crossover Period||12
1081785|NCT00989196|2620713|P1|STARTED|PK Crossover Period||10
1081786|NCT00989235|2620734|P2|NOT COMPLETED|Overall Study||6
1081787|NCT00989235|2620735|P1|NOT COMPLETED|Overall Study||3
1081788|NCT00989235|2620734|P2|COMPLETED|Overall Study||44
1081789|NCT00989235|2620735|P1|COMPLETED|Overall Study||55
1081790|NCT00989235|2620734|P2|Number Completing Double-Blind Treatment|Overall Study||41
1081791|NCT00989235|2620735|P1|Number Completing Double-Blind Treatment|Overall Study||51
1081792|NCT00989235|2620734|P2|Number Rescued to Open-Label Treatment|Overall Study|Of these, 1 was discontinued from open-label treatment (lost to follow-up).|4
1081793|NCT00989235|2620735|P1|Number Rescued to Open-Label Treatment|Overall Study||4
1081794|NCT00989235|2620734|P2|STARTED|Overall Study||50
1081795|NCT00989235|2620735|P1|STARTED|Overall Study||58
1081796|NCT00989586|2620782|P2|NOT COMPLETED|Overall Study||0
1081797|NCT00989586|2620783|P1|NOT COMPLETED|Overall Study||0
1081798|NCT00989586|2620782|P2|COMPLETED|Overall Study||17
1081799|NCT00989586|2620783|P1|COMPLETED|Overall Study||18
1081800|NCT00989586|2620782|P2|STARTED|Overall Study||17
1081801|NCT00989586|2620783|P1|STARTED|Overall Study||18
1081802|NCT00989664|2620796|P1|NOT COMPLETED|Long-Term Follow-Up||3
1081803|NCT00989664|2620796|P1|COMPLETED|Long-Term Follow-Up||11
1081804|NCT00989664|2620796|P1|STARTED|Long-Term Follow-Up|14 of the 61 participants withdrawing from Study BEX104504 enrolled in the LTFU study.|14
1081805|NCT00989664|2620796|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||61
1081806|NCT00989664|2620796|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
1081807|NCT00989664|2620796|P1|STARTED|Dosimetric and Therapeutic Treatment||61
1081808|NCT00989768|2620824|P1|NOT COMPLETED|Overall Study||1
1081809|NCT00989768|2620824|P1|COMPLETED|Overall Study||28
1081810|NCT00989768|2620824|P1|STARTED|Overall Study|All patients received both treatments. They are their own controls|29
1081811|NCT00989833|2620838|P3|NOT COMPLETED|Overall Study||2
1081812|NCT00989833|2620839|P2|NOT COMPLETED|Overall Study||3
1081813|NCT00989833|2620840|P1|NOT COMPLETED|Overall Study||2
1081814|NCT00989833|2620838|P3|COMPLETED|Overall Study||21
1081815|NCT00989833|2620839|P2|COMPLETED|Overall Study||19
1081816|NCT00989833|2620840|P1|COMPLETED|Overall Study||19
1081817|NCT00989833|2620838|P3|STARTED|Overall Study||23
1081818|NCT00989833|2620839|P2|STARTED|Overall Study||22
1081819|NCT00989833|2620840|P1|STARTED|Overall Study||21
1081820|NCT00989911|2620869|P1|NOT COMPLETED|Overall Study||3
1081821|NCT00989911|2620869|P1|COMPLETED|Overall Study||7
1081822|NCT00989911|2620869|P1|STARTED|Overall Study||10
1081823|NCT00989950|2620877|P4|NOT COMPLETED|Randomized Phase||0
1081824|NCT00989950|2620878|P3|NOT COMPLETED|Randomized Phase||0
1081825|NCT00989950|2620879|P2|NOT COMPLETED|Randomized Phase||1
1081826|NCT00989950|2620880|P1|NOT COMPLETED|Randomized Phase||1
1081827|NCT00989950|2620877|P4|COMPLETED|Randomized Phase||7
1081828|NCT00989950|2620878|P3|COMPLETED|Randomized Phase||4
1081829|NCT00989950|2620879|P2|COMPLETED|Randomized Phase||8
1081830|NCT00989950|2620880|P1|COMPLETED|Randomized Phase||5
1081831|NCT00989950|2620877|P4|STARTED|Randomized Phase||7
1081832|NCT00989950|2620878|P3|STARTED|Randomized Phase||4
1081833|NCT00989950|2620879|P2|STARTED|Randomized Phase||9
1081834|NCT00989950|2620880|P1|STARTED|Randomized Phase||6
1081835|NCT00989950|2620877|P4|NOT COMPLETED|Open Label Dose Optimization||0
1081836|NCT00989950|2620878|P3|NOT COMPLETED|Open Label Dose Optimization||0
1081837|NCT00989950|2620879|P2|NOT COMPLETED|Open Label Dose Optimization||0
1081838|NCT00989950|2620880|P1|NOT COMPLETED|Open Label Dose Optimization||0
1081839|NCT00989950|2620877|P4|COMPLETED|Open Label Dose Optimization||7
1081840|NCT00989950|2620878|P3|COMPLETED|Open Label Dose Optimization||4
1081841|NCT00989950|2620879|P2|COMPLETED|Open Label Dose Optimization||9
1081842|NCT00989950|2620880|P1|COMPLETED|Open Label Dose Optimization||6
1081843|NCT00989950|2620877|P4|STARTED|Open Label Dose Optimization||7
1081844|NCT00989950|2620878|P3|STARTED|Open Label Dose Optimization||4
1081845|NCT00989950|2620879|P2|STARTED|Open Label Dose Optimization||9
1081846|NCT00989950|2620880|P1|STARTED|Open Label Dose Optimization||6
1081847|NCT00989989|2620893|P3|NOT COMPLETED|Overall Study||23
1081848|NCT00989989|2620894|P2|NOT COMPLETED|Overall Study||10
1081849|NCT00989989|2620895|P1|NOT COMPLETED|Overall Study||18
1081850|NCT00989989|2620893|P3|COMPLETED|Overall Study||108
1081851|NCT00989989|2620894|P2|COMPLETED|Overall Study||123
1081852|NCT00989989|2620895|P1|COMPLETED|Overall Study||114
1081853|NCT00989989|2620893|P3|STARTED|Overall Study||131
1081854|NCT00989989|2620894|P2|STARTED|Overall Study||133
1081855|NCT00989989|2620895|P1|STARTED|Overall Study||132
1081856|NCT00990093|2620933|P2|NOT COMPLETED|Test Period 2 (15-28 Days)||1
1081857|NCT00990093|2620934|P1|NOT COMPLETED|Test Period 2 (15-28 Days)||2
1081858|NCT00990093|2620933|P2|COMPLETED|Test Period 2 (15-28 Days)||14
1081859|NCT00990093|2620934|P1|COMPLETED|Test Period 2 (15-28 Days)||13
1081860|NCT00990093|2620933|P2|STARTED|Test Period 2 (15-28 Days)||15
1081861|NCT00990093|2620934|P1|STARTED|Test Period 2 (15-28 Days)||15
1081862|NCT00990093|2620933|P2|NOT COMPLETED|Test Period 1 (1-14 Days)||2
1081863|NCT00990093|2620934|P1|NOT COMPLETED|Test Period 1 (1-14 Days)||4
1081864|NCT00990093|2620933|P2|COMPLETED|Test Period 1 (1-14 Days)||15
1081865|NCT00990093|2620934|P1|COMPLETED|Test Period 1 (1-14 Days)||15
1081866|NCT00990093|2620933|P2|STARTED|Test Period 1 (1-14 Days)||17
1081867|NCT00990093|2620934|P1|STARTED|Test Period 1 (1-14 Days)||19
1081868|NCT00990106|2620942|P2|NOT COMPLETED|Overall Study||12
1081869|NCT00990106|2620943|P1|NOT COMPLETED|Overall Study||9
1081870|NCT00990106|2620942|P2|COMPLETED|Overall Study||23
1081871|NCT00990106|2620943|P1|COMPLETED|Overall Study||23
1081872|NCT00990106|2620942|P2|STARTED|Overall Study||35
1081873|NCT00990106|2620943|P1|STARTED|Overall Study||32
1081874|NCT00990184|2620953|P1|NOT COMPLETED|Overall Study||1
1081875|NCT00990184|2620953|P1|COMPLETED|Overall Study||20
1081876|NCT00990184|2620953|P1|STARTED|Overall Study||21
1081877|NCT00990340|2620961|P2|NOT COMPLETED|Second 14-day Treatment||0
1081878|NCT00990340|2620962|P1|NOT COMPLETED|Second 14-day Treatment||0
1081879|NCT00990340|2620961|P2|COMPLETED|Second 14-day Treatment||21
1081880|NCT00990340|2620962|P1|COMPLETED|Second 14-day Treatment||21
1081881|NCT00990340|2620961|P2|STARTED|Second 14-day Treatment||21
1081882|NCT00990340|2620962|P1|STARTED|Second 14-day Treatment||21
1081883|NCT00990340|2620961|P2|NOT COMPLETED|First 14-day Treatment||4
1081884|NCT00990340|2620962|P1|NOT COMPLETED|First 14-day Treatment||6
1081885|NCT00990340|2620961|P2|COMPLETED|First 14-day Treatment||21
1081886|NCT00990340|2620962|P1|COMPLETED|First 14-day Treatment||21
1081887|NCT00990340|2620961|P2|STARTED|First 14-day Treatment||25
1081888|NCT00990340|2620962|P1|STARTED|First 14-day Treatment||27
1081889|NCT00990509|2620978|P2|NOT COMPLETED|Overall Study||1
1081890|NCT00990509|2620979|P1|NOT COMPLETED|Overall Study||0
1081891|NCT00990509|2620978|P2|COMPLETED|Overall Study||8
1081892|NCT00990509|2620979|P1|COMPLETED|Overall Study||5
1081893|NCT00990509|2620978|P2|STARTED|Overall Study||9
1081894|NCT00990509|2620979|P1|STARTED|Overall Study||5
1081895|NCT00990561|2620991|P4|NOT COMPLETED|Period 2||2
1081896|NCT00990561|2620992|P3|NOT COMPLETED|Period 2||0
1081897|NCT00990561|2620993|P2|NOT COMPLETED|Period 2||0
1081898|NCT00990561|2620994|P1|NOT COMPLETED|Period 2||0
1081899|NCT00990561|2620991|P4|COMPLETED|Period 2||17
1081900|NCT00990561|2620992|P3|COMPLETED|Period 2||20
1081901|NCT00990561|2620993|P2|COMPLETED|Period 2||0
1081902|NCT00990561|2620994|P1|COMPLETED|Period 2||0
1081903|NCT00990561|2620991|P4|STARTED|Period 2||19
1081904|NCT00990561|2620992|P3|STARTED|Period 2||20
1081905|NCT00990561|2620993|P2|STARTED|Period 2||0
1081906|NCT00990561|2620994|P1|STARTED|Period 2||0
1081907|NCT00990561|2620991|P4|NOT COMPLETED|Period 1||0
1081908|NCT00990561|2620992|P3|NOT COMPLETED|Period 1||0
1081909|NCT00990561|2620993|P2|NOT COMPLETED|Period 1||1
1081910|NCT00990561|2620994|P1|NOT COMPLETED|Period 1||0
1081911|NCT00990561|2620991|P4|COMPLETED|Period 1||0
1081912|NCT00990561|2620992|P3|COMPLETED|Period 1||0
1081913|NCT00990561|2620993|P2|COMPLETED|Period 1||19
1081914|NCT00990561|2620994|P1|COMPLETED|Period 1||20
1081915|NCT00990561|2620991|P4|STARTED|Period 1||0
1081916|NCT00990561|2620992|P3|STARTED|Period 1||0
1081917|NCT00990561|2620993|P2|STARTED|Period 1||20
1081918|NCT00990561|2620994|P1|STARTED|Period 1||20
1081919|NCT00990652|2621000|P1|NOT COMPLETED|Post-sugery Bortezomib + Temozolomide||1
1081920|NCT00990652|2621000|P1|COMPLETED|Post-sugery Bortezomib + Temozolomide||8
1081921|NCT00990652|2621000|P1|STARTED|Post-sugery Bortezomib + Temozolomide||9
1081922|NCT00990652|2621000|P1|NOT COMPLETED|Surgical Resection||0
1081923|NCT00990652|2621000|P1|COMPLETED|Surgical Resection||9
1081924|NCT00990652|2621000|P1|STARTED|Surgical Resection||9
1081925|NCT00990652|2621000|P1|NOT COMPLETED|Pre-surgical Bortezomib||1
1081926|NCT00990652|2621000|P1|COMPLETED|Pre-surgical Bortezomib||9
1081927|NCT00990652|2621000|P1|STARTED|Pre-surgical Bortezomib||10
1081928|NCT00990704|2621010|P2|NOT COMPLETED|Overall Study||2
1081929|NCT00990704|2621011|P1|NOT COMPLETED|Overall Study||1
1081930|NCT00990704|2621010|P2|COMPLETED|Overall Study||31
1081931|NCT00990704|2621011|P1|COMPLETED|Overall Study||13
1081932|NCT00990704|2621010|P2|STARTED|Overall Study||33
1081933|NCT00990704|2621011|P1|STARTED|Overall Study||14
1081934|NCT00990769|2621033|P2|NOT COMPLETED|Overall Study||0
1081935|NCT00990769|2621034|P1|NOT COMPLETED|Overall Study||0
1081936|NCT00990769|2621033|P2|COMPLETED|Overall Study||18
1081937|NCT00990769|2621034|P1|COMPLETED|Overall Study||22
1081938|NCT00990769|2621033|P2|STARTED|Overall Study|Signed consent and assigned to Low-normal BIS|18
1081939|NCT00990769|2621034|P1|STARTED|Overall Study|Signed consent and assigned to High-normal BIS|22
1081940|NCT00990782|2621044|P1|NOT COMPLETED|Overall Study||5
1081941|NCT00990782|2621044|P1|COMPLETED|Overall Study||88
1081942|NCT00990782|2621044|P1|STARTED|Overall Study||93
1081943|NCT00990821|2621063|P14|NOT COMPLETED|Overall Study||1
1081944|NCT00990821|2621064|P13|NOT COMPLETED|Overall Study||2
1081945|NCT00990821|2621065|P12|NOT COMPLETED|Overall Study||5
1081946|NCT00990821|2621066|P11|NOT COMPLETED|Overall Study||3
1081947|NCT00990821|2621067|P10|NOT COMPLETED|Overall Study||1
1081948|NCT00990821|2621068|P9|NOT COMPLETED|Overall Study||0
1081949|NCT00990821|2621069|P8|NOT COMPLETED|Overall Study||0
1081950|NCT00990821|2621070|P7|NOT COMPLETED|Overall Study||1
1081951|NCT00990821|2621071|P6|NOT COMPLETED|Overall Study||3
1081952|NCT00990821|2621072|P5|NOT COMPLETED|Overall Study||3
1081953|NCT00990821|2621073|P4|NOT COMPLETED|Overall Study||0
1081954|NCT00990821|2621074|P3|NOT COMPLETED|Overall Study||0
1081955|NCT00990821|2621075|P2|NOT COMPLETED|Overall Study||2
1081956|NCT00990821|2621076|P1|NOT COMPLETED|Overall Study||0
1081957|NCT00990821|2621063|P14|COMPLETED|Overall Study||11
1081958|NCT00990821|2621064|P13|COMPLETED|Overall Study||10
1081959|NCT00990821|2621065|P12|COMPLETED|Overall Study||9
1081960|NCT00990821|2621066|P11|COMPLETED|Overall Study||9
1081961|NCT00990821|2621067|P10|COMPLETED|Overall Study||13
1081962|NCT00990821|2621068|P9|COMPLETED|Overall Study||12
1081963|NCT00990821|2621069|P8|COMPLETED|Overall Study||14
1081964|NCT00990821|2621070|P7|COMPLETED|Overall Study||11
1081965|NCT00990821|2621071|P6|COMPLETED|Overall Study||14
1081966|NCT00990821|2621072|P5|COMPLETED|Overall Study||14
1081967|NCT00990821|2621073|P4|COMPLETED|Overall Study||8
1081968|NCT00990821|2621074|P3|COMPLETED|Overall Study||14
1081969|NCT00990821|2621075|P2|COMPLETED|Overall Study||14
1081970|NCT00990821|2621076|P1|COMPLETED|Overall Study||14
1081971|NCT00990821|2621063|P14|STARTED|Overall Study||12
1081972|NCT00990821|2621064|P13|STARTED|Overall Study||12
1081973|NCT00990821|2621065|P12|STARTED|Overall Study||14
1081974|NCT00990821|2621066|P11|STARTED|Overall Study||12
1081975|NCT00990821|2621067|P10|STARTED|Overall Study||14
1081976|NCT00990821|2621068|P9|STARTED|Overall Study||12
1081977|NCT00990821|2621069|P8|STARTED|Overall Study||14
1081978|NCT00990821|2621070|P7|STARTED|Overall Study||12
1081979|NCT00990821|2621071|P6|STARTED|Overall Study||17
1081980|NCT00990821|2621072|P5|STARTED|Overall Study||17
1081981|NCT00990821|2621073|P4|STARTED|Overall Study||8
1081982|NCT00990821|2621074|P3|STARTED|Overall Study||14
1081983|NCT00990821|2621075|P2|STARTED|Overall Study||16
1081984|NCT00990821|2621076|P1|STARTED|Overall Study||14
1081985|NCT00982007|2621097|P4|NOT COMPLETED|Overall Study||6
1081986|NCT00982007|2621098|P3|NOT COMPLETED|Overall Study||0
1081987|NCT00982007|2621099|P2|NOT COMPLETED|Overall Study||4
1081988|NCT00982007|2621100|P1|NOT COMPLETED|Overall Study||4
1081989|NCT00982007|2621097|P4|COMPLETED|Overall Study||245
1081990|NCT00982007|2621098|P3|COMPLETED|Overall Study||253
1081991|NCT00982007|2621099|P2|COMPLETED|Overall Study||253
1081992|NCT00982007|2621100|P1|COMPLETED|Overall Study||246
1081993|NCT00982007|2621097|P4|STARTED|Overall Study||251
1081994|NCT00982007|2621098|P3|STARTED|Overall Study||253
1081995|NCT00982007|2621099|P2|STARTED|Overall Study||257
1081996|NCT00982007|2621100|P1|STARTED|Overall Study||250
1081997|NCT00982020|2621112|P2|NOT COMPLETED|Overall Study||64
1081998|NCT00982020|2621113|P1|NOT COMPLETED|Overall Study||57
1081999|NCT00982020|2621112|P2|COMPLETED|Overall Study||37
1082000|NCT00982020|2621113|P1|COMPLETED|Overall Study||45
1082001|NCT00982020|2621112|P2|Received at Least 1 Dose of Study Drug|Overall Study||101
1082002|NCT00982020|2621113|P1|Received at Least 1 Dose of Study Drug|Overall Study||102
1082003|NCT00982020|2621112|P2|STARTED|Overall Study||101
1082004|NCT00982020|2621113|P1|STARTED|Overall Study||102
1082005|NCT00982033|2621135|P2|NOT COMPLETED|Overall Study||0
1082006|NCT00982033|2621136|P1|NOT COMPLETED|Overall Study||0
1082007|NCT00982033|2621135|P2|COMPLETED|Overall Study||27
1082008|NCT00982033|2621136|P1|COMPLETED|Overall Study||25
1082009|NCT00982033|2621135|P2|STARTED|Overall Study||27
1082010|NCT00982033|2621136|P1|STARTED|Overall Study||25
1082011|NCT00982111|2621144|P2|NOT COMPLETED|Overall Study||66
1082012|NCT00982111|2621145|P1|NOT COMPLETED|Overall Study||75
1082013|NCT00982111|2621144|P2|COMPLETED|Overall Study||252
1082014|NCT00982111|2621145|P1|COMPLETED|Overall Study||240
1082015|NCT00982111|2621144|P2|On Study at Conclusion, Off Treatment|Overall Study||6
1082016|NCT00982111|2621145|P1|On Study at Conclusion, Off Treatment|Overall Study||4
1082017|NCT00982111|2621144|P2|Death Due to Any Cause|Overall Study||246
1082018|NCT00982111|2621145|P1|Death Due to Any Cause|Overall Study||236
1082019|NCT00982111|2621144|P2|Received at Least 1 Dose of Study Drug|Overall Study||312
1082020|NCT00982111|2621145|P1|Received at Least 1 Dose of Study Drug|Overall Study||304
1082021|NCT00982111|2621144|P2|STARTED|Overall Study||318
1082022|NCT00982111|2621145|P1|STARTED|Overall Study||315
1082023|NCT00982137|2621171|P4|NOT COMPLETED|Overall Study||1
1082024|NCT00982137|2621172|P3|NOT COMPLETED|Overall Study||0
1082025|NCT00982137|2621173|P2|NOT COMPLETED|Overall Study||1
1082026|NCT00982137|2621174|P1|NOT COMPLETED|Overall Study||0
1082027|NCT00982137|2621171|P4|COMPLETED|Overall Study||17
1082028|NCT00982137|2621172|P3|COMPLETED|Overall Study||18
1082029|NCT00982137|2621173|P2|COMPLETED|Overall Study||35
1082030|NCT00982137|2621174|P1|COMPLETED|Overall Study||36
1082031|NCT00982137|2621171|P4|STARTED|Overall Study||18
1082032|NCT00982137|2621172|P3|STARTED|Overall Study||18
1082033|NCT00982137|2621173|P2|STARTED|Overall Study||36
1082034|NCT00982137|2621174|P1|STARTED|Overall Study||36
1082035|NCT00982189|2621208|P4|NOT COMPLETED|Overall Study||0
1082036|NCT00982189|2621209|P3|NOT COMPLETED|Overall Study||0
1082037|NCT00982189|2621210|P2|NOT COMPLETED|Overall Study||0
1082038|NCT00982189|2621211|P1|NOT COMPLETED|Overall Study||0
1082039|NCT00982189|2621208|P4|COMPLETED|Overall Study||9
1082040|NCT00982189|2621209|P3|COMPLETED|Overall Study||9
1082041|NCT00982189|2621210|P2|COMPLETED|Overall Study||9
1082042|NCT00982189|2621211|P1|COMPLETED|Overall Study||10
1082043|NCT00982189|2621208|P4|STARTED|Overall Study||9
1082044|NCT00982189|2621209|P3|STARTED|Overall Study||9
1082045|NCT00982189|2621210|P2|STARTED|Overall Study||9
1082046|NCT00982189|2621211|P1|STARTED|Overall Study||10
1082047|NCT00982228|2621231|P2|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||5
1082048|NCT00982228|2621232|P1|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||21
1082049|NCT00982228|2621231|P2|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||113
1082050|NCT00982228|2621232|P1|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||330
1082051|NCT00982228|2621231|P2|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Nineteen subjects from the main trial did not continue into the extension|118
1082052|NCT00982228|2621232|P1|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Fifty-three subjects from the main trial did not continue into the extension|351
1082053|NCT00982228|2621231|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||20
1082054|NCT00982228|2621232|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||68
1082055|NCT00982228|2621231|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||137
1082056|NCT00982228|2621232|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||404
1082057|NCT00982228|2621231|P2|Exposed|Main: Week 0 to 52 (NN1250-3583)|Three subjects withdrew prior to exposure to trial drug|154
1082058|NCT00982228|2621232|P1|Exposed|Main: Week 0 to 52 (NN1250-3583)||472
1082059|NCT00982228|2621231|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||157
1082060|NCT00982228|2621232|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||472
1082061|NCT00982228|2621231|P2|STARTED|Main: Week 0 to 52 (NN1250-3583)||157
1082062|NCT00982228|2621232|P1|STARTED|Main: Week 0 to 52 (NN1250-3583)||472
1082063|NCT00982280|2621256|P1|NOT COMPLETED|Maintenance Period||1
1082064|NCT00982280|2621256|P1|COMPLETED|Maintenance Period||54
1082065|NCT00982280|2621256|P1|STARTED|Maintenance Period||55
1082066|NCT00982280|2621256|P1|NOT COMPLETED|Titration and Optimal Dose Period||8
1082067|NCT00982280|2621256|P1|COMPLETED|Titration and Optimal Dose Period||55
1082068|NCT00982280|2621256|P1|STARTED|Titration and Optimal Dose Period||63
1082069|NCT00982280|2621256|P1|NOT COMPLETED|Observation Period||19
1082070|NCT00982280|2621256|P1|COMPLETED|Observation Period||63
1082071|NCT00982280|2621256|P1|STARTED|Observation Period||82
1082072|NCT00982345|2621279|P1|NOT COMPLETED|Overall Study||2
1082073|NCT00982345|2621279|P1|COMPLETED|Overall Study||18
1082074|NCT00982345|2621279|P1|STARTED|Overall Study||20
1082075|NCT00982410|2621285|P2|NOT COMPLETED|12-month Follow-up Assessment||9
1082076|NCT00982410|2621286|P1|NOT COMPLETED|12-month Follow-up Assessment||9
1082077|NCT00982410|2621285|P2|COMPLETED|12-month Follow-up Assessment||55
1082078|NCT00982410|2621286|P1|COMPLETED|12-month Follow-up Assessment||56
1082079|NCT00982410|2621285|P2|STARTED|12-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
1082080|NCT00982410|2621286|P1|STARTED|12-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
1082081|NCT00982410|2621285|P2|NOT COMPLETED|6-month Follow-up Assessment||11
1082082|NCT00982410|2621286|P1|NOT COMPLETED|6-month Follow-up Assessment||6
1082083|NCT00982410|2621285|P2|COMPLETED|6-month Follow-up Assessment||53
1082084|NCT00982410|2621286|P1|COMPLETED|6-month Follow-up Assessment||59
1082085|NCT00982410|2621285|P2|STARTED|6-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
1082086|NCT00982410|2621286|P1|STARTED|6-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
1082087|NCT00982410|2621285|P2|NOT COMPLETED|3-month Follow-up Assessment||13
1082088|NCT00982410|2621286|P1|NOT COMPLETED|3-month Follow-up Assessment||9
1082089|NCT00982410|2621285|P2|COMPLETED|3-month Follow-up Assessment||53
1082090|NCT00982410|2621286|P1|COMPLETED|3-month Follow-up Assessment||56
1082091|NCT00982410|2621285|P2|STARTED|3-month Follow-up Assessment||66
1082092|NCT00982410|2621286|P1|STARTED|3-month Follow-up Assessment||65
1082093|NCT00982423|2621310|P2|NOT COMPLETED|Overall Study||0
1082094|NCT00982423|2621311|P1|NOT COMPLETED|Overall Study||0
1082095|NCT00982423|2621310|P2|COMPLETED|Overall Study||19
1082096|NCT00982423|2621311|P1|COMPLETED|Overall Study||13
1082097|NCT00982423|2621310|P2|STARTED|Overall Study||19
1082098|NCT00982423|2621311|P1|STARTED|Overall Study||13
1082099|NCT00982488|2621332|P5|NOT COMPLETED|Overall Study||1
1082100|NCT00982488|2621333|P4|NOT COMPLETED|Overall Study||3
1082101|NCT00982488|2621334|P3|NOT COMPLETED|Overall Study||34
1082102|NCT00982488|2621335|P2|NOT COMPLETED|Overall Study||14
1082103|NCT00982488|2621336|P1|NOT COMPLETED|Overall Study||185
1082104|NCT00982488|2621332|P5|COMPLETED|Overall Study|Still receiving treatment|0
1082105|NCT00982488|2621333|P4|COMPLETED|Overall Study|Still receiving treatment|0
1082106|NCT00982488|2621334|P3|COMPLETED|Overall Study|Still receiving treatment|0
1082107|NCT00982488|2621335|P2|COMPLETED|Overall Study|Still receiving treatment|0
1082108|NCT00982488|2621336|P1|COMPLETED|Overall Study|Still receiving treatment|0
1082109|NCT00982488|2621332|P5|STARTED|Overall Study|Received treatment|1
1082110|NCT00982488|2621333|P4|STARTED|Overall Study|Received treatment|3
1082111|NCT00982488|2621334|P3|STARTED|Overall Study|Received treatment|34
1082112|NCT00982488|2621335|P2|STARTED|Overall Study|Received treatment|14
1082113|NCT00982488|2621336|P1|STARTED|Overall Study|Received treatment|185
1082114|NCT00982553|2621348|P1|NOT COMPLETED|Overall Study||0
1082115|NCT00982553|2621348|P1|COMPLETED|Overall Study||14
1082116|NCT00982553|2621348|P1|STARTED|Overall Study||14
1082117|NCT00982592|2621357|P2|NOT COMPLETED|Overall Study||33
1082118|NCT00982592|2621358|P1|NOT COMPLETED|Overall Study||31
1082119|NCT00982592|2621357|P2|COMPLETED|Overall Study|patients who were off treatment due to disease progression|27
1082120|NCT00982592|2621358|P1|COMPLETED|Overall Study|patients who were off treatment due to disease progression|33
1082121|NCT00982592|2621357|P2|Treatment Received|Overall Study||52
1082122|NCT00982592|2621358|P1|Treatment Received|Overall Study||63
1082123|NCT00982592|2621357|P2|STARTED|Overall Study||60
1082124|NCT00982592|2621358|P1|STARTED|Overall Study||64
1082125|NCT00982644|2621374|P2|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||20
1082126|NCT00982644|2621375|P1|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||46
1082127|NCT00982644|2621374|P2|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||154
1082128|NCT00982644|2621375|P1|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||505
1082129|NCT00982644|2621374|P2|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Twenty-three subjects did not continue into extension trial|174
1082130|NCT00982644|2621375|P1|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Fifty-six subjects did not continue into extension trial|551
1082131|NCT00982644|2621374|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||60
1082132|NCT00982644|2621375|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||166
1082133|NCT00982644|2621374|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||197
1082134|NCT00982644|2621375|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||607
1082135|NCT00982644|2621374|P2|Exposed|Main: Week 0 to 52 (NN1250-3579)||257
1082136|NCT00982644|2621375|P1|Exposed|Main: Week 0 to 52 (NN1250-3579)|7 subjects were withdrawn prior to exposure to trial products|766
1082137|NCT00982644|2621374|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||257
1082138|NCT00982644|2621375|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||773
1082139|NCT00982644|2621374|P2|STARTED|Main: Week 0 to 52 (NN1250-3579)||257
1082140|NCT00982644|2621375|P1|STARTED|Main: Week 0 to 52 (NN1250-3579)||773
1082141|NCT00982657|2621401|P4|NOT COMPLETED|Overall Study||9
1082142|NCT00982657|2621402|P3|NOT COMPLETED|Overall Study||2
1082143|NCT00982657|2621403|P2|NOT COMPLETED|Overall Study||0
1082144|NCT00982657|2621404|P1|NOT COMPLETED|Overall Study||1
1082145|NCT00982657|2621401|P4|COMPLETED|Overall Study||7
1082146|NCT00982657|2621402|P3|COMPLETED|Overall Study||1
1082147|NCT00982657|2621403|P2|COMPLETED|Overall Study||3
1082148|NCT00982657|2621404|P1|COMPLETED|Overall Study||11
1082149|NCT00982657|2621401|P4|STARTED|Overall Study||16
1082150|NCT00982657|2621402|P3|STARTED|Overall Study||3
1082151|NCT00982657|2621403|P2|STARTED|Overall Study||3
1082152|NCT00982657|2621404|P1|STARTED|Overall Study||12
1082153|NCT00990964|2621443|P1|NOT COMPLETED|Overall Study||212
1082154|NCT00990964|2621443|P1|COMPLETED|Overall Study|Total number of subjects with successful Attain Family lead using Attain Family catheter|1802
1082155|NCT00990964|2621443|P1|Attain Family Study System Attempt|Overall Study|Total number of subjects with an Attain Family lead attempt after an Attain Family catheter attempt|1917
1082156|NCT00990964|2621443|P1|STARTED|Overall Study|Total number of subjects enrolled|2014
1082157|NCT00991081|2621450|P3|NOT COMPLETED|Phase II, Randomized Control Trial||4
1082158|NCT00991081|2621451|P2|NOT COMPLETED|Phase II, Randomized Control Trial||2
1082159|NCT00991081|2621452|P1|NOT COMPLETED|Phase II, Randomized Control Trial||0
1082160|NCT00991081|2621450|P3|COMPLETED|Phase II, Randomized Control Trial||15
1082161|NCT00991081|2621451|P2|COMPLETED|Phase II, Randomized Control Trial||15
1082162|NCT00991081|2621452|P1|COMPLETED|Phase II, Randomized Control Trial||0
1082163|NCT00991081|2621450|P3|Received First Clinical Call|Phase II, Randomized Control Trial||17
1082164|NCT00991081|2621451|P2|Received First Clinical Call|Phase II, Randomized Control Trial||16
1082165|NCT00991081|2621452|P1|Received First Clinical Call|Phase II, Randomized Control Trial||0
1082166|NCT00991081|2621450|P3|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|19
1082167|NCT00991081|2621451|P2|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|17
1082168|NCT00991081|2621452|P1|STARTED|Phase II, Randomized Control Trial||0
1082169|NCT00991081|2621450|P3|NOT COMPLETED|Phase I, Formative Research||0
1082170|NCT00991081|2621451|P2|NOT COMPLETED|Phase I, Formative Research||0
1082171|NCT00991081|2621452|P1|NOT COMPLETED|Phase I, Formative Research||0
1082172|NCT00991081|2621450|P3|COMPLETED|Phase I, Formative Research||0
1082173|NCT00991081|2621451|P2|COMPLETED|Phase I, Formative Research||0
1082174|NCT00991081|2621452|P1|COMPLETED|Phase I, Formative Research|The 10 smokers interviewed were not enrolled in the Phase II RCT.|20
1082175|NCT00991081|2621450|P3|STARTED|Phase I, Formative Research||0
1082176|NCT00991081|2621451|P2|STARTED|Phase I, Formative Research||0
1082177|NCT00991081|2621452|P1|STARTED|Phase I, Formative Research||20
1082178|NCT00991185|2621484|P1|NOT COMPLETED|Overall Study||0
1082179|NCT00991185|2621484|P1|COMPLETED|Overall Study||8
1082180|NCT00991185|2621484|P1|STARTED|Overall Study||8
1082181|NCT00991809|2621490|P2|NOT COMPLETED|Overall Study||6
1082182|NCT00991809|2621491|P1|NOT COMPLETED|Overall Study||4
1082183|NCT00991809|2621490|P2|COMPLETED|Overall Study||4
1082184|NCT00991809|2621491|P1|COMPLETED|Overall Study||8
1082185|NCT00991809|2621490|P2|STARTED|Overall Study||10
1082186|NCT00991809|2621491|P1|STARTED|Overall Study||12
1082187|NCT00991887|2621501|P2|NOT COMPLETED|Overall Study||1
1082188|NCT00991887|2621502|P1|NOT COMPLETED|Overall Study||2
1082189|NCT00991887|2621501|P2|COMPLETED|Overall Study||21
1082190|NCT00991887|2621502|P1|COMPLETED|Overall Study||24
1082191|NCT00991887|2621501|P2|STARTED|Overall Study||22
1082192|NCT00991887|2621502|P1|STARTED|Overall Study||26
1082193|NCT00991939|2621510|P2|NOT COMPLETED|Overall Study||2
1082194|NCT00991939|2621511|P1|NOT COMPLETED|Overall Study||5
1082195|NCT00991939|2621510|P2|COMPLETED|Overall Study||1
1082196|NCT00991939|2621511|P1|COMPLETED|Overall Study||0
1082197|NCT00991939|2621510|P2|STARTED|Overall Study||3
1082198|NCT00991939|2621511|P1|STARTED|Overall Study||5
1082199|NCT00991952|2621545|P2|NOT COMPLETED|Overall Study||1
1082200|NCT00991952|2621546|P1|NOT COMPLETED|Overall Study||0
1082201|NCT00991952|2621545|P2|COMPLETED|Overall Study||5
1082202|NCT00991952|2621546|P1|COMPLETED|Overall Study||13
1082203|NCT00991952|2621545|P2|STARTED|Overall Study||6
1082204|NCT00991952|2621546|P1|STARTED|Overall Study||13
1082205|NCT00992017|2621552|P1|NOT COMPLETED|Overall Study||10
1082206|NCT00992017|2621552|P1|COMPLETED|Overall Study||118
1082207|NCT00992017|2621552|P1|Received Only One Study Vaccination|Overall Study|Reasons: delivered and LFU; moved; no transportation; ineligible - blood transfusion at delivery|4
1082208|NCT00992017|2621552|P1|Received Both Study Vaccinations|Overall Study||124
1082209|NCT00992017|2621552|P1|STARTED|Overall Study|Two additional women were enrolled but left the clinic before vaccine was administered.|128
1082210|NCT00992056|2621567|P2|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
1082211|NCT00992056|2621568|P1|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
1082212|NCT00992056|2621567|P2|COMPLETED|Treatment Period 2 (6 Weeks)||10
1082213|NCT00992056|2621568|P1|COMPLETED|Treatment Period 2 (6 Weeks)||10
1082214|NCT00992056|2621567|P2|STARTED|Treatment Period 2 (6 Weeks)||10
1082215|NCT00992056|2621568|P1|STARTED|Treatment Period 2 (6 Weeks)||10
1082216|NCT00992056|2621567|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
1082217|NCT00992056|2621568|P1|NOT COMPLETED|Washout Period (2 Weeks)||1
1082218|NCT00992056|2621567|P2|COMPLETED|Washout Period (2 Weeks)||10
1082219|NCT00992056|2621568|P1|COMPLETED|Washout Period (2 Weeks)||10
1082220|NCT00992056|2621567|P2|STARTED|Washout Period (2 Weeks)||10
1082221|NCT00992056|2621568|P1|STARTED|Washout Period (2 Weeks)||11
1082222|NCT00992056|2621567|P2|NOT COMPLETED|Treatment Period 1 (6 Weeks)||2
1082223|NCT00992056|2621568|P1|NOT COMPLETED|Treatment Period 1 (6 Weeks)||1
1082224|NCT00992056|2621567|P2|COMPLETED|Treatment Period 1 (6 Weeks)||10
1082225|NCT00992056|2621568|P1|COMPLETED|Treatment Period 1 (6 Weeks)|February 2012|11
1082226|NCT00992056|2621567|P2|STARTED|Treatment Period 1 (6 Weeks)||12
1082227|NCT00992056|2621568|P1|STARTED|Treatment Period 1 (6 Weeks)||12
1082228|NCT00992108|2621576|P2|NOT COMPLETED|Overall Study||1
1082229|NCT00992108|2621577|P1|NOT COMPLETED|Overall Study||0
1082230|NCT00992108|2621576|P2|COMPLETED|Overall Study||9
1082231|NCT00992108|2621577|P1|COMPLETED|Overall Study||7
1082232|NCT00992108|2621576|P2|STARTED|Overall Study||10
1082233|NCT00992108|2621577|P1|STARTED|Overall Study||7
1082234|NCT00992186|2621589|P1|NOT COMPLETED|Overall Study||46
1082235|NCT00992186|2621589|P1|COMPLETED|Overall Study||0
1082236|NCT00992186|2621589|P1|STARTED|Overall Study||46
1082285|NCT00992394|2621653|P2|NOT COMPLETED|Overall Study||14
1082286|NCT00992394|2621654|P1|NOT COMPLETED|Overall Study||24
1082287|NCT00992394|2621653|P2|COMPLETED|Overall Study||72
1082288|NCT00992394|2621654|P1|COMPLETED|Overall Study||64
1082289|NCT00992394|2621653|P2|mITT Population|Overall Study||84
1082290|NCT00992394|2621654|P1|mITT Population|Overall Study||86
1082291|NCT00992394|2621653|P2|Safety Population|Overall Study||84
1082292|NCT00992394|2621654|P1|Safety Population|Overall Study||87
1082293|NCT00992394|2621653|P2|STARTED|Overall Study||86
1082294|NCT00992394|2621654|P1|STARTED|Overall Study||88
1082295|NCT00992407|2621698|P2|NOT COMPLETED|Overall Study||24
1082296|NCT00992407|2621699|P1|NOT COMPLETED|Overall Study||31
1082297|NCT00992407|2621698|P2|COMPLETED|Overall Study||14
1082298|NCT00992407|2621699|P1|COMPLETED|Overall Study||6
1082299|NCT00992407|2621698|P2|Treated|Overall Study||25
1082300|NCT00992407|2621699|P1|Treated|Overall Study||20
1082301|NCT00992407|2621698|P2|STARTED|Overall Study||38
1082302|NCT00992407|2621699|P1|STARTED|Overall Study||37
1082303|NCT00992433|2621749|P2|NOT COMPLETED|Overall Study||7
1082304|NCT00992433|2621750|P1|NOT COMPLETED|Overall Study||4
1082305|NCT00992433|2621749|P2|COMPLETED|Overall Study||90
1082306|NCT00992433|2621750|P1|COMPLETED|Overall Study||91
1082307|NCT00992433|2621749|P2|STARTED|Overall Study||97
1082308|NCT00992433|2621750|P1|STARTED|Overall Study||95
1082309|NCT00992446|2621812|P1|NOT COMPLETED|Overall Study||8
1082310|NCT00992446|2621812|P1|COMPLETED|Overall Study||19
1082311|NCT00992446|2621812|P1|STARTED|Overall Study||27
1082312|NCT00992459|2621819|P2|NOT COMPLETED|Overall Study||1
1082313|NCT00992459|2621820|P1|NOT COMPLETED|Overall Study||1
1082314|NCT00992459|2621819|P2|COMPLETED|Overall Study|Totals enrolled and completed in Arm B HPN 100 treatment + NaPBA Placebo are not mutually exclusive.|23
1082315|NCT00992459|2621820|P1|COMPLETED|Overall Study|Totals enrolled and completed in Arm A NaPBA treatment + HPN 100 Placebo are not mutually exclusive.|21
1082316|NCT00992459|2621819|P2|STARTED|Overall Study|All patients received NaPBA placebo in Arm B (+ concomitant active HPN 100)|24
1082317|NCT00992459|2621820|P1|STARTED|Overall Study|All patients received HPN 100 placebo in Arm A (+ concomitant active NaPBA)|22
1082318|NCT00992589|2621844|P4|NOT COMPLETED|Double-Blind Phase||10
1082319|NCT00992589|2621845|P3|NOT COMPLETED|Double-Blind Phase||13
1082320|NCT00992589|2621846|P2|NOT COMPLETED|Double-Blind Phase||13
1082321|NCT00992589|2621847|P1|NOT COMPLETED|Double-Blind Phase||0
1082322|NCT00992589|2621844|P4|COMPLETED|Double-Blind Phase||78
1082323|NCT00992589|2621845|P3|COMPLETED|Double-Blind Phase||77
1082324|NCT00992589|2621846|P2|COMPLETED|Double-Blind Phase||76
1082325|NCT00992589|2621847|P1|COMPLETED|Double-Blind Phase||0
1082326|NCT00992589|2621844|P4|STARTED|Double-Blind Phase||88
1082327|NCT00992589|2621845|P3|STARTED|Double-Blind Phase||90
1082328|NCT00992589|2621846|P2|STARTED|Double-Blind Phase||89
1082329|NCT00992589|2621847|P1|STARTED|Double-Blind Phase||0
1082330|NCT00992589|2621844|P4|NOT COMPLETED|Open-Label Phase||0
1082331|NCT00992589|2621845|P3|NOT COMPLETED|Open-Label Phase||0
1082332|NCT00992589|2621846|P2|NOT COMPLETED|Open-Label Phase||0
1082333|NCT00992589|2621847|P1|NOT COMPLETED|Open-Label Phase||77
1082334|NCT00992589|2621844|P4|COMPLETED|Open-Label Phase||0
1082335|NCT00992589|2621845|P3|COMPLETED|Open-Label Phase||0
1082336|NCT00992589|2621846|P2|COMPLETED|Open-Label Phase||0
1082337|NCT00992589|2621847|P1|COMPLETED|Open-Label Phase||267
1082338|NCT00992589|2621844|P4|STARTED|Open-Label Phase||0
1082339|NCT00992589|2621845|P3|STARTED|Open-Label Phase||0
1082340|NCT00992589|2621846|P2|STARTED|Open-Label Phase||0
1082341|NCT00992589|2621847|P1|STARTED|Open-Label Phase||344
1082342|NCT00992602|2621889|P1|NOT COMPLETED|Overall Study||3
1082343|NCT00992602|2621889|P1|COMPLETED|Overall Study||0
1082344|NCT00992602|2621889|P1|STARTED|Overall Study||3
1082345|NCT00992719|2621897|P3|NOT COMPLETED|Overall Study||0
1082346|NCT00992719|2621898|P2|NOT COMPLETED|Overall Study||1
1082347|NCT00992719|2621899|P1|NOT COMPLETED|Overall Study||1
1082348|NCT00992719|2621897|P3|COMPLETED|Overall Study||28
1082349|NCT00992719|2621898|P2|COMPLETED|Overall Study||27
1082350|NCT00992719|2621899|P1|COMPLETED|Overall Study||27
1082351|NCT00992719|2621897|P3|STARTED|Overall Study||28
1082352|NCT00992719|2621898|P2|STARTED|Overall Study||28
1082353|NCT00992719|2621899|P1|STARTED|Overall Study||28
1082354|NCT00992784|2621936|P3|NOT COMPLETED|Overall Study||1
1082355|NCT00992784|2621937|P2|NOT COMPLETED|Overall Study||2
1082356|NCT00992784|2621938|P1|NOT COMPLETED|Overall Study||3
1082357|NCT00992784|2621936|P3|COMPLETED|Overall Study||85
1082358|NCT00992784|2621937|P2|COMPLETED|Overall Study||102
1082359|NCT00992784|2621938|P1|COMPLETED|Overall Study||177
1082360|NCT00992784|2621936|P3|STARTED|Overall Study||86
1082361|NCT00992784|2621937|P2|STARTED|Overall Study||104
1082362|NCT00992784|2621938|P1|STARTED|Overall Study||180
1082363|NCT00992836|2622006|P1|NOT COMPLETED|Overall Study||5
1082364|NCT00992836|2622006|P1|COMPLETED|Overall Study||150
1082365|NCT00992836|2622006|P1|Received Both Study Vaccinations|Overall Study||150
1082366|NCT00992836|2622006|P1|STARTED|Overall Study||155
1082367|NCT00992927|2622020|P2|NOT COMPLETED|Overall Study||0
1082368|NCT00992927|2622021|P1|NOT COMPLETED|Overall Study||0
1082369|NCT00992927|2622020|P2|COMPLETED|Overall Study||22
1082370|NCT00992927|2622021|P1|COMPLETED|Overall Study||32
1082371|NCT00992927|2622020|P2|STARTED|Overall Study||22
1082372|NCT00992927|2622021|P1|STARTED|Overall Study||32
1082373|NCT00992992|2622029|P1|NOT COMPLETED|Overall Study||25
1082374|NCT00992992|2622029|P1|COMPLETED|Overall Study||0
1082375|NCT00992992|2622029|P1|STARTED|Overall Study||25
1082376|NCT00993044|2622049|P1|NOT COMPLETED|Irinotecan 50 mg||1
1082377|NCT00993044|2622049|P1|COMPLETED|Irinotecan 50 mg||6
1082378|NCT00993044|2622049|P1|STARTED|Irinotecan 50 mg||7
1082379|NCT00993044|2622049|P1|NOT COMPLETED|Irinotecan 30 mg||0
1082380|NCT00993044|2622049|P1|COMPLETED|Irinotecan 30 mg||6
1082381|NCT00993044|2622049|P1|STARTED|Irinotecan 30 mg||6
1082382|NCT00993148|2622054|P1|NOT COMPLETED|Overall Study||3
1082383|NCT00993148|2622054|P1|COMPLETED|Overall Study||22
1082384|NCT00993148|2622054|P1|STARTED|Overall Study||25
1082385|NCT00993187|2622068|P2|NOT COMPLETED|Overall Study||37
1082386|NCT00993187|2622069|P1|NOT COMPLETED|Overall Study||26
1082387|NCT00993187|2622068|P2|COMPLETED|Overall Study||108
1082388|NCT00993187|2622069|P1|COMPLETED|Overall Study||121
1082389|NCT00993187|2622068|P2|Received at Least 1 Dose of Study Drug|Overall Study||144
1082390|NCT00993187|2622069|P1|Received at Least 1 Dose of Study Drug|Overall Study||146
1082391|NCT00993187|2622068|P2|STARTED|Overall Study||145
1082392|NCT00993187|2622069|P1|STARTED|Overall Study||147
1082393|NCT00993200|2622089|P2|NOT COMPLETED|Overall Study||0
1082394|NCT00993200|2622090|P1|NOT COMPLETED|Overall Study||0
1082395|NCT00993200|2622089|P2|COMPLETED|Overall Study||13
1082396|NCT00993200|2622090|P1|COMPLETED|Overall Study||13
1082397|NCT00993200|2622089|P2|STARTED|Overall Study||13
1082398|NCT00993200|2622090|P1|STARTED|Overall Study||13
1082399|NCT00993265|2622102|P2|NOT COMPLETED|Overall Study||0
1082400|NCT00993265|2622103|P1|NOT COMPLETED|Overall Study||4
1082401|NCT00993265|2622102|P2|COMPLETED|Overall Study||19
1082402|NCT00993265|2622103|P1|COMPLETED|Overall Study||16
1082403|NCT00993265|2622102|P2|STARTED|Overall Study||19
1082404|NCT00993265|2622103|P1|STARTED|Overall Study||20
1082405|NCT00993291|2622121|P1|NOT COMPLETED|Overall Study||1
1082406|NCT00993291|2622121|P1|COMPLETED|Overall Study||19
1082407|NCT00993291|2622121|P1|STARTED|Overall Study||20
1082408|NCT00993317|2622127|P2|NOT COMPLETED|Overall Study||25
1082409|NCT00993317|2622128|P1|NOT COMPLETED|Overall Study||21
1082410|NCT00993317|2622127|P2|COMPLETED|Overall Study||60
1082411|NCT00993317|2622128|P1|COMPLETED|Overall Study||21
1082412|NCT00993317|2622127|P2|STARTED|Overall Study||85
1082413|NCT00993317|2622128|P1|STARTED|Overall Study||42
1082414|NCT00993421|2622153|P7|NOT COMPLETED|Overall Study||42
1082415|NCT00993421|2622154|P6|NOT COMPLETED|Overall Study||46
1082416|NCT00993421|2622155|P5|NOT COMPLETED|Overall Study||46
1082417|NCT00993421|2622156|P4|NOT COMPLETED|Overall Study||45
1082418|NCT00993421|2622157|P3|NOT COMPLETED|Overall Study||43
1082419|NCT00993421|2622158|P2|NOT COMPLETED|Overall Study||45
1082420|NCT00993421|2622159|P1|NOT COMPLETED|Overall Study||44
1082421|NCT00993421|2622153|P7|COMPLETED|Overall Study||4
1082422|NCT00993421|2622154|P6|COMPLETED|Overall Study||4
1082423|NCT00993421|2622155|P5|COMPLETED|Overall Study||6
1082424|NCT00993421|2622156|P4|COMPLETED|Overall Study||4
1082425|NCT00993421|2622157|P3|COMPLETED|Overall Study||5
1082426|NCT00993421|2622158|P2|COMPLETED|Overall Study||4
1082427|NCT00993421|2622159|P1|COMPLETED|Overall Study||5
1082428|NCT00993421|2622153|P7|STARTED|Overall Study||46
1082429|NCT00993421|2622154|P6|STARTED|Overall Study||50
1082430|NCT00993421|2622155|P5|STARTED|Overall Study||52
1082431|NCT00993421|2622156|P4|STARTED|Overall Study||49
1082432|NCT00993421|2622157|P3|STARTED|Overall Study||48
1082433|NCT00993421|2622158|P2|STARTED|Overall Study||49
1082434|NCT00993421|2622159|P1|STARTED|Overall Study||49
1082435|NCT00993447|2622310|P2|NOT COMPLETED|Overall Study||19
1082436|NCT00993447|2622311|P1|NOT COMPLETED|Overall Study||37
1082437|NCT00993447|2622310|P2|COMPLETED|Overall Study||180
1082438|NCT00993447|2622311|P1|COMPLETED|Overall Study||364
1082439|NCT00993447|2622310|P2|STARTED|Overall Study||199
1082440|NCT00993447|2622311|P1|STARTED|Overall Study||401
1082441|NCT00993473|2622343|P2|NOT COMPLETED|Overall Study||10
1082442|NCT00993473|2622344|P1|NOT COMPLETED|Overall Study||4
1082443|NCT00993473|2622343|P2|COMPLETED|Overall Study||54
1082444|NCT00993473|2622344|P1|COMPLETED|Overall Study||57
1082445|NCT00993473|2622343|P2|STARTED|Overall Study|64 patients randomized to NPH but only 63 patients treated with NPH due to a dispensation's error|64
1082446|NCT00993473|2622344|P1|STARTED|Overall Study|61 patients randomized to Lantus but 62 patients treated with Lantus due to a dispensation's error|61
1082447|NCT00993499|2622386|P6|NOT COMPLETED|Discontinued After Starting Course 3||3
1082448|NCT00993499|2622387|P5|NOT COMPLETED|Discontinued After Starting Course 3||3
1082449|NCT00993499|2622388|P4|NOT COMPLETED|Discontinued After Starting Course 3||2
1082450|NCT00993499|2622389|P3|NOT COMPLETED|Discontinued After Starting Course 3||6
1082451|NCT00993499|2622390|P2|NOT COMPLETED|Discontinued After Starting Course 3||5
1082452|NCT00993499|2622391|P1|NOT COMPLETED|Discontinued After Starting Course 3||8
1082453|NCT00993499|2622386|P6|COMPLETED|Discontinued After Starting Course 3||0
1082454|NCT00993499|2622387|P5|COMPLETED|Discontinued After Starting Course 3||0
1082455|NCT00993499|2622388|P4|COMPLETED|Discontinued After Starting Course 3||1
1082456|NCT00993499|2622389|P3|COMPLETED|Discontinued After Starting Course 3||3
1082457|NCT00993499|2622390|P2|COMPLETED|Discontinued After Starting Course 3||4
1082458|NCT00993499|2622391|P1|COMPLETED|Discontinued After Starting Course 3||4
1082459|NCT00993499|2622386|P6|STARTED|Discontinued After Starting Course 3||3
1082460|NCT00993499|2622387|P5|STARTED|Discontinued After Starting Course 3||3
1082461|NCT00993499|2622388|P4|STARTED|Discontinued After Starting Course 3||3
1082462|NCT00993499|2622389|P3|STARTED|Discontinued After Starting Course 3||9
1082463|NCT00993499|2622390|P2|STARTED|Discontinued After Starting Course 3||9
1082464|NCT00993499|2622391|P1|STARTED|Discontinued After Starting Course 3||12
1082465|NCT00993499|2622386|P6|NOT COMPLETED|Discontinued Before Starting Course 3||0
1082466|NCT00993499|2622387|P5|NOT COMPLETED|Discontinued Before Starting Course 3||0
1082467|NCT00993499|2622388|P4|NOT COMPLETED|Discontinued Before Starting Course 3||1
1082468|NCT00993499|2622389|P3|NOT COMPLETED|Discontinued Before Starting Course 3||3
1082469|NCT00993499|2622390|P2|NOT COMPLETED|Discontinued Before Starting Course 3||4
1082470|NCT00993499|2622391|P1|NOT COMPLETED|Discontinued Before Starting Course 3||4
1082471|NCT00993499|2622386|P6|COMPLETED|Discontinued Before Starting Course 3||3
1082472|NCT00993499|2622387|P5|COMPLETED|Discontinued Before Starting Course 3||3
1082473|NCT00993499|2622388|P4|COMPLETED|Discontinued Before Starting Course 3||2
1082474|NCT00993499|2622389|P3|COMPLETED|Discontinued Before Starting Course 3||6
1082475|NCT00993499|2622390|P2|COMPLETED|Discontinued Before Starting Course 3||5
1082476|NCT00993499|2622391|P1|COMPLETED|Discontinued Before Starting Course 3||8
1082477|NCT00993499|2622386|P6|STARTED|Discontinued Before Starting Course 3||3
1082478|NCT00993499|2622387|P5|STARTED|Discontinued Before Starting Course 3||3
1082479|NCT00993499|2622388|P4|STARTED|Discontinued Before Starting Course 3||3
1082480|NCT00993499|2622389|P3|STARTED|Discontinued Before Starting Course 3||9
1082481|NCT00993499|2622390|P2|STARTED|Discontinued Before Starting Course 3||9
1082482|NCT00993499|2622391|P1|STARTED|Discontinued Before Starting Course 3||12
1082483|NCT00993499|2622386|P6|NOT COMPLETED|Run-in Period (8 Days)||0
1082484|NCT00993499|2622387|P5|NOT COMPLETED|Run-in Period (8 Days)||0
1082485|NCT00993499|2622388|P4|NOT COMPLETED|Run-in Period (8 Days)||0
1082486|NCT00993499|2622389|P3|NOT COMPLETED|Run-in Period (8 Days)||1
1082487|NCT00993499|2622390|P2|NOT COMPLETED|Run-in Period (8 Days)||3
1082488|NCT00993499|2622391|P1|NOT COMPLETED|Run-in Period (8 Days)||1
1082489|NCT00993499|2622386|P6|COMPLETED|Run-in Period (8 Days)||3
1082490|NCT00993499|2622387|P5|COMPLETED|Run-in Period (8 Days)||3
1082491|NCT00993499|2622388|P4|COMPLETED|Run-in Period (8 Days)||3
1082492|NCT00993499|2622389|P3|COMPLETED|Run-in Period (8 Days)||9
1082493|NCT00993499|2622390|P2|COMPLETED|Run-in Period (8 Days)||9
1082494|NCT00993499|2622391|P1|COMPLETED|Run-in Period (8 Days)||12
1082495|NCT00993499|2622386|P6|STARTED|Run-in Period (8 Days)||3
1082496|NCT00993499|2622387|P5|STARTED|Run-in Period (8 Days)||3
1082497|NCT00993499|2622388|P4|STARTED|Run-in Period (8 Days)||3
1082498|NCT00993499|2622389|P3|STARTED|Run-in Period (8 Days)||10
1082499|NCT00993499|2622390|P2|STARTED|Run-in Period (8 Days)||12
1082500|NCT00993499|2622391|P1|STARTED|Run-in Period (8 Days)||13
1082501|NCT00993616|2622471|P1|NOT COMPLETED|Overall Study||2
1082502|NCT00993616|2622471|P1|COMPLETED|Overall Study|Number of eligible and evaluable participants|27
1082503|NCT00993616|2622471|P1|STARTED|Overall Study||29
1082504|NCT00993655|2622478|P3|NOT COMPLETED|Overall Study||0
1082505|NCT00993655|2622479|P2|NOT COMPLETED|Overall Study||0
1082506|NCT00993655|2622480|P1|NOT COMPLETED|Overall Study||0
1082507|NCT00993655|2622478|P3|COMPLETED|Overall Study||102
1082508|NCT00993655|2622479|P2|COMPLETED|Overall Study||72
1082509|NCT00993655|2622480|P1|COMPLETED|Overall Study||101
1082510|NCT00993655|2622478|P3|STARTED|Overall Study||102
1082511|NCT00993655|2622479|P2|STARTED|Overall Study||72
1082512|NCT00993655|2622480|P1|STARTED|Overall Study||101
1082513|NCT00993668|2622496|P2|NOT COMPLETED|Open-Label Period||15
1082514|NCT00993668|2622497|P1|NOT COMPLETED|Open-Label Period||23
1082515|NCT00993668|2622496|P2|COMPLETED|Open-Label Period||91
1082516|NCT00993668|2622497|P1|COMPLETED|Open-Label Period||86
1082517|NCT00993668|2622496|P2|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|106
1082518|NCT00993668|2622497|P1|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|109
1082519|NCT00993668|2622496|P2|NOT COMPLETED|Single-Blind Period||3
1082520|NCT00993668|2622497|P1|NOT COMPLETED|Single-Blind Period||4
1082521|NCT00993668|2622496|P2|COMPLETED|Single-Blind Period||107
1082522|NCT00993668|2622497|P1|COMPLETED|Single-Blind Period||110
1082523|NCT00993668|2622496|P2|STARTED|Single-Blind Period||110
1082524|NCT00993668|2622497|P1|STARTED|Single-Blind Period||114
1082525|NCT00993824|2622524|P2|NOT COMPLETED|Overall Study||0
1082526|NCT00993824|2622525|P1|NOT COMPLETED|Overall Study||0
1082527|NCT00993824|2622524|P2|COMPLETED|Overall Study||10
1082528|NCT00993824|2622525|P1|COMPLETED|Overall Study||11
1082529|NCT00993824|2622524|P2|STARTED|Overall Study||10
1082530|NCT00993824|2622525|P1|STARTED|Overall Study||11
1082531|NCT00993915|2622537|P1|NOT COMPLETED|Overall Study||9
1082532|NCT00993915|2622537|P1|COMPLETED|Overall Study||678
1082533|NCT00993915|2622537|P1|STARTED|Overall Study||687
1082534|NCT00993928|2622548|P2|NOT COMPLETED|Overall Study||7
1082535|NCT00993928|2622549|P1|NOT COMPLETED|Overall Study||5
1082536|NCT00993928|2622548|P2|COMPLETED|Overall Study||38
1082537|NCT00993928|2622549|P1|COMPLETED|Overall Study||43
1082538|NCT00993928|2622548|P2|STARTED|Overall Study||45
1082539|NCT00993928|2622549|P1|STARTED|Overall Study||48
1082540|NCT00993954|2622565|P2|NOT COMPLETED|Overall Study||2
1082541|NCT00993954|2622566|P1|NOT COMPLETED|Overall Study||21
1082542|NCT00993954|2622565|P2|COMPLETED|Overall Study||121
1082543|NCT00993954|2622566|P1|COMPLETED|Overall Study||124
1082544|NCT00993954|2622565|P2|STARTED|Overall Study||123
1082545|NCT00993954|2622566|P1|STARTED|Overall Study||145
1082546|NCT00994110|2622579|P2|NOT COMPLETED|Overall Study||74
1082547|NCT00994110|2622580|P1|NOT COMPLETED|Overall Study||65
1082548|NCT00994110|2622579|P2|COMPLETED|Overall Study||148
1082549|NCT00994110|2622580|P1|COMPLETED|Overall Study||152
1082550|NCT00994110|2622579|P2|STARTED|Overall Study||222
1082551|NCT00994110|2622580|P1|STARTED|Overall Study||217
1082552|NCT00994123|2622589|P3|NOT COMPLETED|Overall Study||0
1082553|NCT00994123|2622590|P2|NOT COMPLETED|Overall Study||0
1082554|NCT00994123|2622591|P1|NOT COMPLETED|Overall Study||0
1082555|NCT00994123|2622589|P3|COMPLETED|Overall Study||44
1082556|NCT00994123|2622590|P2|COMPLETED|Overall Study||85
1082557|NCT00994123|2622591|P1|COMPLETED|Overall Study||33
1082558|NCT00994123|2622589|P3|STARTED|Overall Study||44
1082559|NCT00994123|2622590|P2|STARTED|Overall Study||85
1082560|NCT00994123|2622591|P1|STARTED|Overall Study||33
1082561|NCT00994175|2622610|P2|NOT COMPLETED|Second Intervention||0
1082562|NCT00994175|2622611|P1|NOT COMPLETED|Second Intervention||0
1082563|NCT00994175|2622610|P2|COMPLETED|Second Intervention||8
1082564|NCT00994175|2622611|P1|COMPLETED|Second Intervention||4
1082565|NCT00994175|2622610|P2|STARTED|Second Intervention||8
1082566|NCT00994175|2622611|P1|STARTED|Second Intervention||4
1082567|NCT00994175|2622610|P2|NOT COMPLETED|First Intervention||1
1082568|NCT00994175|2622611|P1|NOT COMPLETED|First Intervention||2
1082569|NCT00994175|2622610|P2|COMPLETED|First Intervention||8
1082570|NCT00994175|2622611|P1|COMPLETED|First Intervention||4
1082571|NCT00994175|2622610|P2|STARTED|First Intervention||9
1082572|NCT00994175|2622611|P1|STARTED|First Intervention||6
1082573|NCT00994214|2622623|P4|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
1082574|NCT00994214|2622624|P3|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||2
1082575|NCT00994214|2622625|P2|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
1082576|NCT00994214|2622626|P1|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||4
1082577|NCT00994214|2622623|P4|COMPLETED|ITT (Intention-to-Treat) - Part B||0
1082578|NCT00994214|2622624|P3|COMPLETED|ITT (Intention-to-Treat) - Part B||0
1082579|NCT00994214|2622625|P2|COMPLETED|ITT (Intention-to-Treat) - Part B||0
1082580|NCT00994214|2622626|P1|COMPLETED|ITT (Intention-to-Treat) - Part B||0
1082581|NCT00994214|2622623|P4|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||3
1082582|NCT00994214|2622624|P3|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||2
1082583|NCT00994214|2622625|P2|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
1082584|NCT00994214|2622626|P1|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
1082585|NCT00994214|2622623|P4|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
1082586|NCT00994214|2622624|P3|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
1082587|NCT00994214|2622625|P2|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||3
1082588|NCT00994214|2622626|P1|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||1
1082589|NCT00994214|2622623|P4|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
1082590|NCT00994214|2622624|P3|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
1082591|NCT00994214|2622625|P2|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
1082592|NCT00994214|2622626|P1|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||3
1082593|NCT00994214|2622623|P4|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
1082594|NCT00994214|2622624|P3|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
1082595|NCT00994214|2622625|P2|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
1082596|NCT00994214|2622626|P1|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
1082597|NCT00994214|2622623|P4|STARTED|ITT (Intention-to-Treat) - Part B|2 subjects did not enter Part B Arm D|3
1082598|NCT00994214|2622624|P3|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm C|2
1082599|NCT00994214|2622625|P2|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm B|3
1082600|NCT00994214|2622626|P1|STARTED|ITT (Intention-to-Treat) - Part B|1 subject did not enter Part B Arm A|4
1082601|NCT00994214|2622623|P4|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||15
1082602|NCT00994214|2622624|P3|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
1082603|NCT00994214|2622625|P2|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
1082604|NCT00994214|2622626|P1|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||14
1082605|NCT00994214|2622623|P4|COMPLETED|ITT (Intention-to-Treat) - Part A||5
1082606|NCT00994214|2622624|P3|COMPLETED|ITT (Intention-to-Treat) - Part A||5
1082607|NCT00994214|2622625|P2|COMPLETED|ITT (Intention-to-Treat) - Part A||6
1082608|NCT00994214|2622626|P1|COMPLETED|ITT (Intention-to-Treat) - Part A||5
1082609|NCT00994214|2622623|P4|STARTED|ITT (Intention-to-Treat) - Part A||20
1082610|NCT00994214|2622624|P3|STARTED|ITT (Intention-to-Treat) - Part A||18
1082611|NCT00994214|2622625|P2|STARTED|ITT (Intention-to-Treat) - Part A||19
1082612|NCT00994214|2622626|P1|STARTED|ITT (Intention-to-Treat) - Part A||19
1082613|NCT00985543|2622670|P1|NOT COMPLETED|Overall Study||0
1082614|NCT00985543|2622670|P1|COMPLETED|Overall Study||22
1082615|NCT00985543|2622670|P1|STARTED|Overall Study||22
1082616|NCT00985673|2622685|P6|NOT COMPLETED|Overall Study||6
1082617|NCT00985673|2622686|P5|NOT COMPLETED|Overall Study||8
1082618|NCT00985673|2622687|P4|NOT COMPLETED|Overall Study||12
1082619|NCT00985673|2622688|P3|NOT COMPLETED|Overall Study||12
1082620|NCT00985673|2622689|P2|NOT COMPLETED|Overall Study||11
1082621|NCT00985673|2622690|P1|NOT COMPLETED|Overall Study||7
1082622|NCT00985673|2622685|P6|COMPLETED|Overall Study||96
1082623|NCT00985673|2622686|P5|COMPLETED|Overall Study||93
1082624|NCT00985673|2622687|P4|COMPLETED|Overall Study||88
1082625|NCT00985673|2622688|P3|COMPLETED|Overall Study||90
1082626|NCT00985673|2622689|P2|COMPLETED|Overall Study||93
1082627|NCT00985673|2622690|P1|COMPLETED|Overall Study||95
1082628|NCT00985673|2622685|P6|STARTED|Overall Study||102
1082629|NCT00985673|2622686|P5|STARTED|Overall Study||101
1082630|NCT00985673|2622687|P4|STARTED|Overall Study||100
1082631|NCT00985673|2622688|P3|STARTED|Overall Study||102
1082632|NCT00985673|2622689|P2|STARTED|Overall Study||104
1082633|NCT00985673|2622690|P1|STARTED|Overall Study||102
1082634|NCT00985686|2622945|P4|NOT COMPLETED|Overall Study||2
1082635|NCT00985686|2622946|P3|NOT COMPLETED|Overall Study||0
1082636|NCT00985686|2622947|P2|NOT COMPLETED|Overall Study||1
1082637|NCT00985686|2622948|P1|NOT COMPLETED|Overall Study||1
1082638|NCT00985686|2622945|P4|COMPLETED|Overall Study||14
1082639|NCT00985686|2622946|P3|COMPLETED|Overall Study||13
1082640|NCT00985686|2622947|P2|COMPLETED|Overall Study||15
1082641|NCT00985686|2622948|P1|COMPLETED|Overall Study||17
1082642|NCT00985686|2622945|P4|Visit 4: Data Collection at 24 Weeks|Overall Study||14
1082643|NCT00985686|2622946|P3|Visit 4: Data Collection at 24 Weeks|Overall Study||13
1082644|NCT00985686|2622947|P2|Visit 4: Data Collection at 24 Weeks|Overall Study||15
1082645|NCT00985686|2622948|P1|Visit 4: Data Collection at 24 Weeks|Overall Study||17
1082646|NCT00985686|2622945|P4|Visit 3: Data Collection at 16 Weeks|Overall Study||16
1082647|NCT00985686|2622946|P3|Visit 3: Data Collection at 16 Weeks|Overall Study||13
1082648|NCT00985686|2622947|P2|Visit 3: Data Collection at 16 Weeks|Overall Study||15
1082649|NCT00985686|2622948|P1|Visit 3: Data Collection at 16 Weeks|Overall Study||17
1082650|NCT00985686|2622945|P4|Visit 2: Data Collection at 8 Weeks|Overall Study||16
1082651|NCT00985686|2622946|P3|Visit 2: Data Collection at 8 Weeks|Overall Study||13
1082652|NCT00985686|2622947|P2|Visit 2: Data Collection at 8 Weeks|Overall Study||15
1082653|NCT00985686|2622948|P1|Visit 2: Data Collection at 8 Weeks|Overall Study||18
1082654|NCT00985686|2622945|P4|Visit 1: Baseline Data Collection|Overall Study||16
1082655|NCT00985686|2622946|P3|Visit 1: Baseline Data Collection|Overall Study||13
1082656|NCT00985686|2622947|P2|Visit 1: Baseline Data Collection|Overall Study||15
1082657|NCT00985686|2622948|P1|Visit 1: Baseline Data Collection|Overall Study||18
1082658|NCT00985686|2622945|P4|STARTED|Overall Study||16
1082659|NCT00985686|2622946|P3|STARTED|Overall Study||13
1082660|NCT00985686|2622947|P2|STARTED|Overall Study||16
1082661|NCT00985686|2622948|P1|STARTED|Overall Study||18
1082662|NCT00985712|2622958|P2|NOT COMPLETED|Overall Study||7
1082663|NCT00985712|2622959|P1|NOT COMPLETED|Overall Study||6
1082664|NCT00985712|2622958|P2|COMPLETED|Overall Study||123
1082665|NCT00985712|2622959|P1|COMPLETED|Overall Study||127
1082666|NCT00985712|2622958|P2|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|129
1082667|NCT00985712|2622959|P1|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|128
1082668|NCT00985712|2622958|P2|Received at Least One Dose of Study Drug|Overall Study||130
1082669|NCT00985712|2622959|P1|Received at Least One Dose of Study Drug|Overall Study||131
1082670|NCT00985712|2622958|P2|STARTED|Overall Study||130
1082671|NCT00985712|2622959|P1|STARTED|Overall Study||133
1082672|NCT00985725|2622975|P2|NOT COMPLETED|Overall Study||13
1082673|NCT00985725|2622976|P1|NOT COMPLETED|Overall Study||11
1082674|NCT00985725|2622975|P2|COMPLETED|Overall Study||59
1082675|NCT00985725|2622976|P1|COMPLETED|Overall Study||60
1082676|NCT00985725|2622975|P2|STARTED|Overall Study||72
1082677|NCT00985725|2622976|P1|STARTED|Overall Study||71
1082678|NCT00985738|2623012|P2|NOT COMPLETED|Overall Study||8
1082679|NCT00985738|2623013|P1|NOT COMPLETED|Overall Study||8
1082680|NCT00985738|2623012|P2|COMPLETED|Overall Study||0
1082681|NCT00985738|2623013|P1|COMPLETED|Overall Study||0
1082682|NCT00985738|2623012|P2|STARTED|Overall Study||8
1082683|NCT00985738|2623013|P1|STARTED|Overall Study||8
1082684|NCT00985751|2623024|P5|NOT COMPLETED|Overall Study||1
1082685|NCT00985751|2623025|P4|NOT COMPLETED|Overall Study||0
1082686|NCT00985751|2623026|P3|NOT COMPLETED|Overall Study||0
1082687|NCT00985751|2623027|P2|NOT COMPLETED|Overall Study||0
1082688|NCT00985751|2623028|P1|NOT COMPLETED|Overall Study||0
1082689|NCT00985751|2623024|P5|COMPLETED|Overall Study||50
1082690|NCT00985751|2623025|P4|COMPLETED|Overall Study||51
1082691|NCT00985751|2623026|P3|COMPLETED|Overall Study||52
1082692|NCT00985751|2623027|P2|COMPLETED|Overall Study||52
1082693|NCT00985751|2623028|P1|COMPLETED|Overall Study||51
1082694|NCT00985751|2623024|P5|STARTED|Overall Study||51
1082695|NCT00985751|2623025|P4|STARTED|Overall Study||51
1082696|NCT00985751|2623026|P3|STARTED|Overall Study||52
1082697|NCT00985751|2623027|P2|STARTED|Overall Study||52
1082698|NCT00985751|2623028|P1|STARTED|Overall Study||51
1082699|NCT00985790|2623091|P2|NOT COMPLETED|Overall Study||8
1082700|NCT00985790|2623092|P1|NOT COMPLETED|Overall Study||7
1082701|NCT00985790|2623091|P2|COMPLETED|Overall Study||293
1082702|NCT00985790|2623092|P1|COMPLETED|Overall Study||291
1082703|NCT00985790|2623091|P2|STARTED|Overall Study|97 were primed and 204 were unprimed subjects.|301
1082704|NCT00985790|2623092|P1|STARTED|Overall Study|95 were primed and 203 were unprimed subjects.|298
1082705|NCT00985946|2623128|P1|NOT COMPLETED|Overall Study||7
1082706|NCT00985946|2623128|P1|COMPLETED|Overall Study||8
1082707|NCT00985946|2623128|P1|STARTED|Overall Study|Eighty-seven percent (n=13) were evaluable for response.|15
1082708|NCT00985959|2623139|P3|NOT COMPLETED|Overall Study||59
1082709|NCT00985959|2623140|P2|NOT COMPLETED|Overall Study||3
1082710|NCT00985959|2623141|P1|NOT COMPLETED|Overall Study||3
1082711|NCT00985959|2623139|P3|COMPLETED|Overall Study||28
1082712|NCT00985959|2623140|P2|COMPLETED|Overall Study|Completed all 9 cycles|3
1082713|NCT00985959|2623141|P1|COMPLETED|Overall Study|Completed all 9 cycles|3
1082714|NCT00985959|2623139|P3|STARTED|Overall Study|Number of participants treated|87
1082715|NCT00985959|2623140|P2|STARTED|Overall Study|Number of participants treated|6
1082716|NCT00985959|2623141|P1|STARTED|Overall Study|Number of participants treated|6
1082717|NCT00985985|2623168|P4|NOT COMPLETED|Overall Study||13
1082718|NCT00985985|2623169|P3|NOT COMPLETED|Overall Study||11
1082719|NCT00985985|2623170|P2|NOT COMPLETED|Overall Study||24
1082720|NCT00985985|2623171|P1|NOT COMPLETED|Overall Study||24
1082721|NCT00985985|2623168|P4|COMPLETED|Overall Study||107
1082722|NCT00985985|2623169|P3|COMPLETED|Overall Study||109
1082723|NCT00985985|2623170|P2|COMPLETED|Overall Study||218
1082724|NCT00985985|2623171|P1|COMPLETED|Overall Study||217
1082725|NCT00985985|2623168|P4|Full Analysis Set (FAS) Population|Overall Study|One participant withdrew consent and was not included as the FAS population.|119
1082726|NCT00985985|2623169|P3|Full Analysis Set (FAS) Population|Overall Study||120
1082727|NCT00985985|2623170|P2|Full Analysis Set (FAS) Population|Overall Study||242
1082728|NCT00985985|2623171|P1|Full Analysis Set (FAS) Population|Overall Study||241
1082729|NCT00985985|2623168|P4|Safety Population|Overall Study||118
1082730|NCT00985985|2623169|P3|Safety Population|Overall Study||119
1082731|NCT00985985|2623170|P2|Safety Population|Overall Study||242
1082732|NCT00985985|2623171|P1|Safety Population|Overall Study||241
1082733|NCT00985985|2623168|P4|STARTED|Overall Study||120
1082734|NCT00985985|2623169|P3|STARTED|Overall Study||120
1082735|NCT00985985|2623170|P2|STARTED|Overall Study||242
1082736|NCT00985985|2623171|P1|STARTED|Overall Study||241
1082737|NCT00986102|2623213|P4|NOT COMPLETED|Overall Study||1
1082738|NCT00986102|2623214|P3|NOT COMPLETED|Overall Study||0
1082739|NCT00986102|2623215|P2|NOT COMPLETED|Overall Study||2
1082740|NCT00986102|2623216|P1|NOT COMPLETED|Overall Study||1
1082741|NCT00986102|2623213|P4|COMPLETED|Overall Study||66
1082742|NCT00986102|2623214|P3|COMPLETED|Overall Study||19
1082743|NCT00986102|2623215|P2|COMPLETED|Overall Study||75
1082744|NCT00986102|2623216|P1|COMPLETED|Overall Study||52
1082745|NCT00986102|2623213|P4|STARTED|Overall Study|Number of participants who received study medication|67
1082746|NCT00986102|2623214|P3|STARTED|Overall Study|Number of participants who received study medication|19
1082747|NCT00986102|2623215|P2|STARTED|Overall Study|Number of participants who received study medication|77
1082748|NCT00986102|2623216|P1|STARTED|Overall Study|Number of participants who received study medication|53
1082749|NCT00986154|2623264|P2|NOT COMPLETED|Overall Study||194
1082750|NCT00986154|2623265|P1|NOT COMPLETED|Overall Study||206
1082751|NCT00986154|2623264|P2|COMPLETED|Overall Study||3955
1082752|NCT00986154|2623265|P1|COMPLETED|Overall Study||3937
1082753|NCT00986154|2623264|P2|Safety Analysis Set (Received Drug)|Overall Study||4122
1082754|NCT00986154|2623265|P1|Safety Analysis Set (Received Drug)|Overall Study||4118
1082755|NCT00986154|2623264|P2|STARTED|Overall Study||4149
1082756|NCT00986154|2623265|P1|STARTED|Overall Study||4143
1082757|NCT00986180|2623277|P2|NOT COMPLETED|Overall Study||56
1082758|NCT00986180|2623278|P1|NOT COMPLETED|Overall Study||44
1082759|NCT00986180|2623277|P2|COMPLETED|Overall Study||268
1082760|NCT00986180|2623278|P1|COMPLETED|Overall Study||277
1082761|NCT00986180|2623277|P2|STARTED|Overall Study||324
1082762|NCT00986180|2623278|P1|STARTED|Overall Study||321
1082763|NCT00986232|2623358|P4|NOT COMPLETED|Overall Study||20
1082764|NCT00986232|2623359|P3|NOT COMPLETED|Overall Study||35
1082765|NCT00986232|2623360|P2|NOT COMPLETED|Overall Study||50
1082766|NCT00986232|2623361|P1|NOT COMPLETED|Overall Study||51
1082767|NCT00986232|2623358|P4|COMPLETED|Overall Study||370
1082768|NCT00986232|2623359|P3|COMPLETED|Overall Study||346
1082769|NCT00986232|2623360|P2|COMPLETED|Overall Study||343
1082770|NCT00986232|2623361|P1|COMPLETED|Overall Study||336
1082771|NCT00986232|2623358|P4|Vaccination Visit 2|Overall Study||0
1082772|NCT00986232|2623359|P3|Vaccination Visit 2|Overall Study||360
1082773|NCT00986232|2623360|P2|Vaccination Visit 2|Overall Study||365
1082774|NCT00986232|2623361|P1|Vaccination Visit 2|Overall Study||360
1082775|NCT00986232|2623358|P4|Vaccination Visit 1|Overall Study||390
1082776|NCT00986232|2623359|P3|Vaccination Visit 1|Overall Study||381
1082777|NCT00986232|2623360|P2|Vaccination Visit 1|Overall Study||393
1082778|NCT00986232|2623361|P1|Vaccination Visit 1|Overall Study||387
1082779|NCT00986232|2623358|P4|STARTED|Overall Study|Excludes 1 patient who was randomized to receive M-M-R™ II + PUVV, but was not vaccinated.|390
1082780|NCT00986232|2623359|P3|STARTED|Overall Study||381
1082781|NCT00986232|2623360|P2|STARTED|Overall Study|Excludes 1 patient who was randomized to receive ProQuad (Middle Dose), but was not vaccinated.|393
1082782|NCT00986232|2623361|P1|STARTED|Overall Study||387
1082783|NCT00986245|2623433|P2|NOT COMPLETED|Second Intervention||1
1082784|NCT00986245|2623434|P1|NOT COMPLETED|Second Intervention||2
1082785|NCT00986245|2623433|P2|COMPLETED|Second Intervention||32
1082786|NCT00986245|2623434|P1|COMPLETED|Second Intervention||29
1082787|NCT00986245|2623433|P2|STARTED|Second Intervention||33
1082788|NCT00986245|2623434|P1|STARTED|Second Intervention||31
1082789|NCT00986245|2623433|P2|NOT COMPLETED|First Intervention||8
1082790|NCT00986245|2623434|P1|NOT COMPLETED|First Intervention||10
1082791|NCT00986245|2623433|P2|COMPLETED|First Intervention||33
1082792|NCT00986245|2623434|P1|COMPLETED|First Intervention||31
1082793|NCT00986245|2623433|P2|STARTED|First Intervention||41
1082794|NCT00986245|2623434|P1|STARTED|First Intervention||41
1082795|NCT00986258|2623467|P1|NOT COMPLETED|Maintenance Period||9
1082796|NCT00986258|2623467|P1|COMPLETED|Maintenance Period||93
1082797|NCT00986258|2623467|P1|STARTED|Maintenance Period||102
1082798|NCT00986258|2623467|P1|NOT COMPLETED|Titration and Optimal Dose Period||23
1082799|NCT00986258|2623467|P1|COMPLETED|Titration and Optimal Dose Period||102
1082800|NCT00986258|2623467|P1|STARTED|Titration and Optimal Dose Period||125
1082801|NCT00986258|2623467|P1|NOT COMPLETED|Observation Period||11
1082802|NCT00986258|2623467|P1|COMPLETED|Observation Period||125
1082803|NCT00986258|2623467|P1|STARTED|Observation Period||136
1082804|NCT00986349|2623495|P1|NOT COMPLETED|Overall Study||7
1082805|NCT00986349|2623495|P1|COMPLETED|Overall Study||16
1082806|NCT00986349|2623495|P1|Early Explant|Overall Study||4
1082807|NCT00986349|2623495|P1|Successful Implant Procedure|Overall Study|successful device implant procedure|20
1082808|NCT00986349|2623495|P1|STARTED|Overall Study|attempted implant procedures|23
1082809|NCT00986362|2623510|P2|NOT COMPLETED|Overall Study||1
1082810|NCT00986362|2623511|P1|NOT COMPLETED|Overall Study||2
1082811|NCT00986362|2623510|P2|COMPLETED|Overall Study|7 eyes completed the study (in 7 subjects).|7
1082812|NCT00986362|2623511|P1|COMPLETED|Overall Study|14 eyes completed the study (in 14 subjects).|14
1082813|NCT00986362|2623510|P2|STARTED|Overall Study|8 eyes randomized and treated (in 8 subjects).|8
1082814|NCT00986362|2623511|P1|STARTED|Overall Study|16 eyes randomized and treated (in 15 subjects).|16
1082815|NCT00986401|2623519|P2|NOT COMPLETED|Period 2||0
1082816|NCT00986401|2623520|P1|NOT COMPLETED|Period 2||0
1082817|NCT00986401|2623519|P2|COMPLETED|Period 2||21
1082818|NCT00986401|2623520|P1|COMPLETED|Period 2||22
1082819|NCT00986401|2623519|P2|STARTED|Period 2||21
1082820|NCT00986401|2623520|P1|STARTED|Period 2||22
1082821|NCT00986401|2623519|P2|NOT COMPLETED|Period 1||1
1082822|NCT00986401|2623520|P1|NOT COMPLETED|Period 1||0
1082823|NCT00986401|2623519|P2|COMPLETED|Period 1||21
1082824|NCT00986401|2623520|P1|COMPLETED|Period 1||22
1082825|NCT00986401|2623519|P2|STARTED|Period 1||22
1082826|NCT00986401|2623520|P1|STARTED|Period 1||22
1082827|NCT00986427|2623531|P2|NOT COMPLETED|Overall Study||0
1082828|NCT00986427|2623532|P1|NOT COMPLETED|Overall Study||4
1082829|NCT00986427|2623531|P2|COMPLETED|Overall Study||12
1082830|NCT00986427|2623532|P1|COMPLETED|Overall Study||8
1082831|NCT00986427|2623531|P2|STARTED|Overall Study||12
1082832|NCT00986427|2623532|P1|STARTED|Overall Study||12
1082833|NCT00986453|2623546|P1|NOT COMPLETED|Overall Study||2
1082834|NCT00986453|2623546|P1|COMPLETED|Overall Study||43
1082835|NCT00986453|2623546|P1|STARTED|Overall Study||45
1082836|NCT00986479|2623562|P2|NOT COMPLETED|Period 2||0
1082837|NCT00986479|2623563|P1|NOT COMPLETED|Period 2||0
1082838|NCT00986479|2623562|P2|COMPLETED|Period 2||10
1082839|NCT00986479|2623563|P1|COMPLETED|Period 2||10
1082840|NCT00986479|2623562|P2|STARTED|Period 2||10
1082841|NCT00986479|2623563|P1|STARTED|Period 2||10
1082842|NCT00986479|2623562|P2|NOT COMPLETED|Period 1||0
1082843|NCT00986479|2623563|P1|NOT COMPLETED|Period 1||2
1082844|NCT00986479|2623562|P2|COMPLETED|Period 1||10
1082845|NCT00986479|2623563|P1|COMPLETED|Period 1||10
1082846|NCT00986479|2623562|P2|STARTED|Period 1||10
1082847|NCT00986479|2623563|P1|STARTED|Period 1||12
1082848|NCT00986544|2623595|P2|NOT COMPLETED|Overall Study||0
1082849|NCT00986544|2623596|P1|NOT COMPLETED|Overall Study||0
1082850|NCT00986544|2623595|P2|COMPLETED|Overall Study||53
1082851|NCT00986544|2623596|P1|COMPLETED|Overall Study||53
1082852|NCT00986544|2623595|P2|STARTED|Overall Study||53
1082853|NCT00986544|2623596|P1|STARTED|Overall Study||53
1082854|NCT00986570|2623604|P1|NOT COMPLETED|Overall Study||7
1082855|NCT00986570|2623604|P1|COMPLETED|Overall Study||114
1082856|NCT00986570|2623604|P1|STARTED|Overall Study||121
1082857|NCT00986583|2623610|P2|NOT COMPLETED|Overall Study||0
1082858|NCT00986583|2623611|P1|NOT COMPLETED|Overall Study||0
1082859|NCT00986583|2623610|P2|COMPLETED|Overall Study||32
1082860|NCT00986583|2623611|P1|COMPLETED|Overall Study||38
1082861|NCT00986583|2623610|P2|STARTED|Overall Study||32
1082862|NCT00986583|2623611|P1|STARTED|Overall Study||38
1082863|NCT00986674|2623630|P3|NOT COMPLETED|Overall Study||48
1082864|NCT00986674|2623631|P2|NOT COMPLETED|Overall Study||45
1082865|NCT00986674|2623632|P1|NOT COMPLETED|Overall Study||47
1082866|NCT00986674|2623630|P3|COMPLETED|Overall Study||0
1082867|NCT00986674|2623631|P2|COMPLETED|Overall Study||0
1082868|NCT00986674|2623632|P1|COMPLETED|Overall Study||0
1082869|NCT00986674|2623630|P3|Eligible and Treated|Overall Study||47
1082870|NCT00986674|2623631|P2|Eligible and Treated|Overall Study||41
1082871|NCT00986674|2623632|P1|Eligible and Treated|Overall Study||39
1082872|NCT00986674|2623630|P3|Treated|Overall Study||47
1082873|NCT00986674|2623631|P2|Treated|Overall Study||42
1082874|NCT00986674|2623632|P1|Treated|Overall Study||43
1082875|NCT00986674|2623630|P3|STARTED|Overall Study||48
1082876|NCT00986674|2623631|P2|STARTED|Overall Study||45
1082877|NCT00986674|2623632|P1|STARTED|Overall Study||47
1082878|NCT00986856|2623648|P2|NOT COMPLETED|Overall Study||0
1082879|NCT00986856|2623649|P1|NOT COMPLETED|Overall Study||0
1082880|NCT00986856|2623648|P2|COMPLETED|Overall Study||16
1082881|NCT00986856|2623649|P1|COMPLETED|Overall Study||42
1082882|NCT00986856|2623648|P2|STARTED|Overall Study||16
1082883|NCT00986856|2623649|P1|STARTED|Overall Study||42
1082884|NCT00986921|2623671|P2|NOT COMPLETED|Overall Study||0
1082885|NCT00986921|2623672|P1|NOT COMPLETED|Overall Study||1
1082886|NCT00986921|2623671|P2|COMPLETED|Overall Study||25
1082887|NCT00986921|2623672|P1|COMPLETED|Overall Study||24
1082888|NCT00986921|2623671|P2|STARTED|Overall Study||25
1082889|NCT00986921|2623672|P1|STARTED|Overall Study||25
1082890|NCT00986947|2623682|P1|NOT COMPLETED|Overall Study||20
1082891|NCT00986947|2623682|P1|COMPLETED|Overall Study||0
1082892|NCT00986947|2623682|P1|STARTED|Overall Study||20
1082893|NCT00986960|2623689|P2|NOT COMPLETED|Overall Study||0
1082894|NCT00986960|2623690|P1|NOT COMPLETED|Overall Study||0
1082895|NCT00986960|2623689|P2|COMPLETED|Overall Study||0
1082896|NCT00986960|2623690|P1|COMPLETED|Overall Study||0
1082897|NCT00986960|2623689|P2|STARTED|Overall Study||0
1082898|NCT00986960|2623690|P1|STARTED|Overall Study||0
1082899|NCT00986973|2623696|P1|NOT COMPLETED|Overall Study||1
1082900|NCT00986973|2623696|P1|COMPLETED|Overall Study|One subject was withdrawn from the study due to poor compliance with KUVAN therapy.|5
1082901|NCT00986973|2623696|P1|STARTED|Overall Study||6
1082902|NCT00986986|2623708|P2|NOT COMPLETED|Overall Study||1
1082903|NCT00986986|2623709|P1|NOT COMPLETED|Overall Study||0
1082904|NCT00986986|2623708|P2|COMPLETED|Overall Study||9
1082905|NCT00986986|2623709|P1|COMPLETED|Overall Study||10
1082906|NCT00986986|2623708|P2|STARTED|Overall Study||10
1082907|NCT00986986|2623709|P1|STARTED|Overall Study||10
1082908|NCT00986999|2623719|P1|NOT COMPLETED|Overall Study||1
1082909|NCT00986999|2623719|P1|COMPLETED|Overall Study||6
1082910|NCT00986999|2623719|P1|STARTED|Overall Study||7
1082911|NCT00987337|2623731|P3|NOT COMPLETED|Overall Study||51
1082912|NCT00987337|2623732|P2|NOT COMPLETED|Overall Study||55
1082913|NCT00987337|2623733|P1|NOT COMPLETED|Overall Study||57
1082914|NCT00987337|2623731|P3|COMPLETED|Overall Study||45
1082915|NCT00987337|2623732|P2|COMPLETED|Overall Study||41
1082916|NCT00987337|2623733|P1|COMPLETED|Overall Study||39
1082917|NCT00987337|2623731|P3|STARTED|Overall Study||96
1082918|NCT00987337|2623732|P2|STARTED|Overall Study||96
1082919|NCT00987337|2623733|P1|STARTED|Overall Study||96
1082920|NCT00987402|2623779|P2|NOT COMPLETED|Overall Study||98
1082921|NCT00987402|2623780|P1|NOT COMPLETED|Overall Study||86
1082922|NCT00987402|2623779|P2|COMPLETED|Overall Study|98 patients did not have sufficient data|1537
1082923|NCT00987402|2623780|P1|COMPLETED|Overall Study|86 patients did not have some data, and could not be evaluated|1596
1082924|NCT00987402|2623779|P2|STARTED|Overall Study|January 2007 with crossover every 2 months|1635
1082925|NCT00987402|2623780|P1|STARTED|Overall Study|January 2007, with crossover every 2 months|1682
1082926|NCT00987415|2623788|P2|NOT COMPLETED|Overall Study||9
1082927|NCT00987415|2623789|P1|NOT COMPLETED|Overall Study||9
1082928|NCT00987415|2623788|P2|COMPLETED|Overall Study||116
1082929|NCT00987415|2623789|P1|COMPLETED|Overall Study||119
1082930|NCT00987415|2623788|P2|STARTED|Overall Study||125
1082931|NCT00987415|2623789|P1|STARTED|Overall Study||128
1082932|NCT00987467|2623803|P1|NOT COMPLETED|Overall Study||2
1082933|NCT00987467|2623803|P1|COMPLETED|Overall Study||10
1082934|NCT00987467|2623803|P1|STARTED|Overall Study||12
1082935|NCT00987558|2623808|P2|NOT COMPLETED|Overall Study||5
1082936|NCT00987558|2623809|P1|NOT COMPLETED|Overall Study||1
1082937|NCT00987558|2623808|P2|COMPLETED|Overall Study||12
1082938|NCT00987558|2623809|P1|COMPLETED|Overall Study||12
1082939|NCT00987558|2623808|P2|Eslicarbazepine Acetate + Simvastatin|Overall Study||17
1082940|NCT00987558|2623809|P1|Eslicarbazepine Acetate + Simvastatin|Overall Study||13
1082941|NCT00987558|2623808|P2|Washout|Overall Study||12
1082942|NCT00987558|2623809|P1|Washout|Overall Study||13
1082943|NCT00987558|2623808|P2|Simvastatin|Overall Study||12
1082944|NCT00987558|2623809|P1|Simvastatin|Overall Study||13
1082945|NCT00987558|2623808|P2|STARTED|Overall Study||17
1082946|NCT00987558|2623809|P1|STARTED|Overall Study||13
1082947|NCT00987623|2623824|P2|NOT COMPLETED|Overall Study||3
1082948|NCT00987623|2623825|P1|NOT COMPLETED|Overall Study||5
1082949|NCT00987623|2623824|P2|COMPLETED|Overall Study||151
1082950|NCT00987623|2623825|P1|COMPLETED|Overall Study||140
1082951|NCT00987623|2623824|P2|STARTED|Overall Study||154
1082952|NCT00987623|2623825|P1|STARTED|Overall Study||145
1082953|NCT00987727|2623833|P2|NOT COMPLETED|Overall Study||7
1082954|NCT00987727|2623834|P1|NOT COMPLETED|Overall Study||5
1082955|NCT00987727|2623833|P2|COMPLETED|Overall Study||34
1082956|NCT00987727|2623834|P1|COMPLETED|Overall Study||36
1082957|NCT00987727|2623833|P2|STARTED|Overall Study||41
1082958|NCT00987727|2623834|P1|STARTED|Overall Study||41
1082959|NCT00987831|2623845|P3|NOT COMPLETED|Overall Study||0
1082960|NCT00987831|2623846|P2|NOT COMPLETED|Overall Study||3
1082961|NCT00987831|2623847|P1|NOT COMPLETED|Overall Study||1
1082962|NCT00987831|2623845|P3|COMPLETED|Overall Study|Anyone who entered this arm completed it the same day|62
1082963|NCT00987831|2623846|P2|COMPLETED|Overall Study|all controls returned for two visits|52
1082964|NCT00987831|2623847|P1|COMPLETED|Overall Study|40 patients completed in 6 months. 1 patient did not meet completion definition in 12 months.|40
1082965|NCT00987831|2623845|P3|STARTED|Overall Study|Anyone who entered this arm completed it the same day|62
1082966|NCT00987831|2623846|P2|STARTED|Overall Study|52 healthy controls donated biomarkers on two occasions in order to verify biomarkers ranges|55
1082967|NCT00987831|2623847|P1|STARTED|Overall Study|41 patients improved after depomedrol, if not improved, treated and moved to Group B|41
1082968|NCT00987935|2623865|P9|NOT COMPLETED|Overall Study||32
1082969|NCT00987935|2623866|P8|NOT COMPLETED|Overall Study||62
1082970|NCT00987935|2623867|P7|NOT COMPLETED|Overall Study||15
1082971|NCT00987935|2623868|P6|NOT COMPLETED|Overall Study||3
1082972|NCT00987935|2623869|P5|NOT COMPLETED|Overall Study||7
1082973|NCT00987935|2623870|P4|NOT COMPLETED|Overall Study||3
1082974|NCT00987935|2623871|P3|NOT COMPLETED|Overall Study||3
1082975|NCT00987935|2623872|P2|NOT COMPLETED|Overall Study||3
1082976|NCT00987935|2623873|P1|NOT COMPLETED|Overall Study||4
1082977|NCT00987935|2623865|P9|COMPLETED|Overall Study||0
1082978|NCT00987935|2623866|P8|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
1082979|NCT00987935|2623867|P7|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
1082980|NCT00987935|2623868|P6|COMPLETED|Overall Study||0
1082981|NCT00987935|2623869|P5|COMPLETED|Overall Study||0
1082982|NCT00987935|2623870|P4|COMPLETED|Overall Study||0
1082983|NCT00987935|2623871|P3|COMPLETED|Overall Study||0
1082984|NCT00987935|2623872|P2|COMPLETED|Overall Study||0
1082985|NCT00987935|2623873|P1|COMPLETED|Overall Study||0
1082986|NCT00987935|2623865|P9|STARTED|Overall Study||32
1082987|NCT00987935|2623866|P8|STARTED|Overall Study||63
1082988|NCT00987935|2623867|P7|STARTED|Overall Study||16
1082989|NCT00987935|2623868|P6|STARTED|Overall Study||3
1082990|NCT00987935|2623869|P5|STARTED|Overall Study||7
1082991|NCT00987935|2623870|P4|STARTED|Overall Study||3
1082992|NCT00987935|2623871|P3|STARTED|Overall Study||3
1082993|NCT00987935|2623872|P2|STARTED|Overall Study||3
1082994|NCT00987935|2623873|P1|STARTED|Overall Study||4
1082995|NCT00987948|2623926|P1|NOT COMPLETED|Overall Study||3
1082996|NCT00987948|2623926|P1|COMPLETED|Overall Study||12
1082997|NCT00987948|2623926|P1|STARTED|Overall Study||15
1082998|NCT00988065|2623934|P3|NOT COMPLETED|Overall Study||15
1082999|NCT00988065|2623935|P2|NOT COMPLETED|Overall Study||23
1083000|NCT00988065|2623936|P1|NOT COMPLETED|Overall Study||13
1083001|NCT00988065|2623934|P3|COMPLETED|Overall Study||135
1083002|NCT00988065|2623935|P2|COMPLETED|Overall Study||127
1083003|NCT00988065|2623936|P1|COMPLETED|Overall Study||135
1083004|NCT00988065|2623934|P3|Received Third Randomized Dose|Overall Study||135
1083005|NCT00988065|2623935|P2|Received Third Randomized Dose|Overall Study||127
1083006|NCT00988065|2623936|P1|Received Third Randomized Dose|Overall Study||135
1083007|NCT00988065|2623934|P3|Received Second Randomized Dose|Overall Study||145
1083008|NCT00988065|2623935|P2|Received Second Randomized Dose|Overall Study||135
1083009|NCT00988065|2623936|P1|Received Second Randomized Dose|Overall Study||139
1083010|NCT00988065|2623934|P3|Received First Randomized Dose|Overall Study||150
1083011|NCT00988065|2623935|P2|Received First Randomized Dose|Overall Study||150
1083012|NCT00988065|2623936|P1|Received First Randomized Dose|Overall Study||148
1083013|NCT00988065|2623934|P3|STARTED|Overall Study|Randomized to double-blind treatment|150
1083014|NCT00988065|2623935|P2|STARTED|Overall Study|Randomized to double-blind treatment|150
1083015|NCT00988065|2623936|P1|STARTED|Overall Study|Randomized to double-blind treatment|148
1083016|NCT00988091|2623958|P2|NOT COMPLETED|Open-label Period||33
1083017|NCT00988091|2623959|P1|NOT COMPLETED|Open-label Period||21
1083018|NCT00988091|2623958|P2|COMPLETED|Open-label Period||192
1083019|NCT00988091|2623959|P1|COMPLETED|Open-label Period||208
1083020|NCT00988091|2623958|P2|STARTED|Open-label Period|Participation in the Open-label period was optional.|225
1083021|NCT00988091|2623959|P1|STARTED|Open-label Period|Participation in the Open-label period was optional.|229
1083022|NCT00988091|2623958|P2|NOT COMPLETED|Double-blind Period||47
1083023|NCT00988091|2623959|P1|NOT COMPLETED|Double-blind Period||43
1083024|NCT00988091|2623958|P2|COMPLETED|Double-blind Period||251
1083025|NCT00988091|2623959|P1|COMPLETED|Double-blind Period||255
1083026|NCT00988091|2623958|P2|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|295
1083027|NCT00988091|2623959|P1|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|294
1083028|NCT00988091|2623958|P2|STARTED|Double-blind Period||298
1083029|NCT00988091|2623959|P1|STARTED|Double-blind Period||298
1083030|NCT00988117|2623978|P1|NOT COMPLETED|9.5 mg/24 Hours From Week 4 to 12||2
1083031|NCT00988117|2623978|P1|COMPLETED|9.5 mg/24 Hours From Week 4 to 12||12
1083032|NCT00988117|2623978|P1|STARTED|9.5 mg/24 Hours From Week 4 to 12||14
1083033|NCT00988117|2623978|P1|NOT COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||1
1083034|NCT00988117|2623978|P1|COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||14
1083035|NCT00988117|2623978|P1|STARTED|4.6 mg/24 Hours From Baseline to Week 4||15
1083036|NCT00988143|2623988|P3|NOT COMPLETED|Overall Study||0
1083037|NCT00988143|2623989|P2|NOT COMPLETED|Overall Study||0
1083038|NCT00988143|2623990|P1|NOT COMPLETED|Overall Study||0
1083039|NCT00988143|2623988|P3|COMPLETED|Overall Study||190
1083040|NCT00988143|2623989|P2|COMPLETED|Overall Study||190
1083041|NCT00988143|2623990|P1|COMPLETED|Overall Study||220
1083042|NCT00988143|2623988|P3|STARTED|Overall Study||190
1083043|NCT00988143|2623989|P2|STARTED|Overall Study||190
1083044|NCT00988143|2623990|P1|STARTED|Overall Study||220
1083045|NCT00988156|2624024|P2|NOT COMPLETED|Overall Study||20
1083046|NCT00988156|2624025|P1|NOT COMPLETED|Overall Study||17
1083047|NCT00988156|2624024|P2|COMPLETED|Overall Study||135
1083048|NCT00988156|2624025|P1|COMPLETED|Overall Study||132
1083049|NCT00988156|2624024|P2|Safety Set|Overall Study||134
1083050|NCT00988156|2624025|P1|Safety Set|Overall Study||129
1083051|NCT00988156|2624024|P2|Per Protocol Set (PP)|Overall Study||97
1083052|NCT00988156|2624025|P1|Per Protocol Set (PP)|Overall Study||101
1083053|NCT00988156|2624024|P2|Intention-to-Treat Set (ITT)|Overall Study||134
1083054|NCT00988156|2624025|P1|Intention-to-Treat Set (ITT)|Overall Study||129
1083055|NCT00988156|2624024|P2|STARTED|Overall Study||155
1083056|NCT00988156|2624025|P1|STARTED|Overall Study||149
1083057|NCT00988169|2624033|P1|NOT COMPLETED|Overall Study||1
1083058|NCT00988169|2624033|P1|COMPLETED|Overall Study||5
1083059|NCT00988169|2624033|P1|STARTED|Overall Study||6
1083060|NCT00988208|2624039|P2|NOT COMPLETED|Overall Study||438
1083061|NCT00988208|2624040|P1|NOT COMPLETED|Overall Study||431
1083062|NCT00988208|2624039|P2|COMPLETED|Overall Study|DPL Completed = kept on treatment with docetaxel/prednisone; Lenalidomide discontinued in DPL arm|95
1083063|NCT00988208|2624040|P1|COMPLETED|Overall Study|DP Completed = kept on treatment with docetaxel/prednisone; Placebo was discontinued in DP arm|95
1083064|NCT00988208|2624039|P2|Treated|Overall Study||525
1083065|NCT00988208|2624040|P1|Treated|Overall Study||521
1083066|NCT00988208|2624039|P2|STARTED|Overall Study||533
1083067|NCT00988208|2624040|P1|STARTED|Overall Study||526
1083068|NCT00988221|2624055|P4|NOT COMPLETED|Part III||0
1083069|NCT00988221|2624056|P3|NOT COMPLETED|Part III||3
1083070|NCT00988221|2624057|P2|NOT COMPLETED|Part III||1
1083071|NCT00988221|2624058|P1|NOT COMPLETED|Part III||1
1083072|NCT00988221|2624055|P4|COMPLETED|Part III||0
1083073|NCT00988221|2624056|P3|COMPLETED|Part III||103
1083074|NCT00988221|2624057|P2|COMPLETED|Part III||23
1083075|NCT00988221|2624058|P1|COMPLETED|Part III||29
1083076|NCT00988221|2624055|P4|STARTED|Part III|No patients received placebo in Part III of this study.|0
1083077|NCT00988221|2624056|P3|STARTED|Part III||106
1083078|NCT00988221|2624057|P2|STARTED|Part III||24
1083079|NCT00988221|2624058|P1|STARTED|Part III||30
1083080|NCT00988221|2624055|P4|NOT COMPLETED|Part II||3
1083081|NCT00988221|2624056|P3|NOT COMPLETED|Part II||3
1083082|NCT00988221|2624057|P2|NOT COMPLETED|Part II||0
1083083|NCT00988221|2624058|P1|NOT COMPLETED|Part II||1
1083084|NCT00988221|2624055|P4|COMPLETED|Part II||81
1083085|NCT00988221|2624056|P3|COMPLETED|Part II|One participant who did not complete Part II was available to continue in the study and did.|52
1083086|NCT00988221|2624057|P2|COMPLETED|Part II||11
1083087|NCT00988221|2624058|P1|COMPLETED|Part II||15
1083088|NCT00988221|2624055|P4|STARTED|Part II||84
1083089|NCT00988221|2624056|P3|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|55
1083090|NCT00988221|2624057|P2|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|11
1083091|NCT00988221|2624058|P1|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|16
1083092|NCT00988221|2624055|P4|NOT COMPLETED|Part I||0
1083093|NCT00988221|2624056|P3|NOT COMPLETED|Part I||8
1083094|NCT00988221|2624057|P2|NOT COMPLETED|Part I||10
1083095|NCT00988221|2624058|P1|NOT COMPLETED|Part I||4
1083096|NCT00988221|2624055|P4|COMPLETED|Part I||0
1083097|NCT00988221|2624056|P3|COMPLETED|Part I||111
1083098|NCT00988221|2624057|P2|COMPLETED|Part I||24
1083099|NCT00988221|2624058|P1|COMPLETED|Part I||31
1083100|NCT00988221|2624055|P4|STARTED|Part I|No patients received placebo in Part I of this study.|0
1083101|NCT00988221|2624056|P3|STARTED|Part I||119
1083102|NCT00988221|2624057|P2|STARTED|Part I||34
1083103|NCT00988221|2624058|P1|STARTED|Part I||35
1083104|NCT00988247|2624231|P2|NOT COMPLETED|Overall Study||26
1083105|NCT00988247|2624232|P1|NOT COMPLETED|Overall Study||83
1083106|NCT00988247|2624231|P2|COMPLETED|Overall Study||85
1083107|NCT00988247|2624232|P1|COMPLETED|Overall Study||335
1083108|NCT00988247|2624231|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|110
1083109|NCT00988247|2624232|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|414
1083110|NCT00988247|2624231|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|111
1083111|NCT00988247|2624232|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|415
1083112|NCT00988247|2624231|P2|STARTED|Overall Study||111
1083113|NCT00988247|2624232|P1|STARTED|Overall Study||418
1083114|NCT00988325|2624251|P3|NOT COMPLETED|Overall Study||0
1083115|NCT00988325|2624252|P2|NOT COMPLETED|Overall Study||0
1083116|NCT00988325|2624253|P1|NOT COMPLETED|Overall Study||0
1083117|NCT00988325|2624251|P3|COMPLETED|Overall Study||5
1083118|NCT00988325|2624252|P2|COMPLETED|Overall Study||20
1083119|NCT00988325|2624253|P1|COMPLETED|Overall Study||40
1083120|NCT00988325|2624251|P3|STARTED|Overall Study||5
1083121|NCT00988325|2624252|P2|STARTED|Overall Study||20
1083122|NCT00988325|2624253|P1|STARTED|Overall Study||40
1083123|NCT00988351|2624311|P2|NOT COMPLETED|Overall Study||12
1083124|NCT00988351|2624312|P1|NOT COMPLETED|Overall Study||19
1083125|NCT00988351|2624311|P2|COMPLETED|Overall Study||66
1083126|NCT00988351|2624312|P1|COMPLETED|Overall Study||59
1083127|NCT00988351|2624311|P2|Using CPAP or APAP|Overall Study|3 not using APAP (less than 1/2 hour per night)|66
1083128|NCT00988351|2624312|P1|Using CPAP or APAP|Overall Study|5 not using CPAP (use < 1/2 hour per night)|59
1083129|NCT00988351|2624311|P2|Clinic Visit|Overall Study|9 lost to follow-up or no show for clinic|69
1083130|NCT00988351|2624312|P1|Clinic Visit|Overall Study|6 lost to follow-up or no show for clinic|64
1083131|NCT00988351|2624311|P2|PAP Setup|Overall Study|APAP treatment started|78
1083132|NCT00988351|2624312|P1|PAP Setup|Overall Study|CPAP treatment started|70
1083133|NCT00988351|2624311|P2|CPAP Titration|Overall Study|no titration needed|78
1083134|NCT00988351|2624312|P1|CPAP Titration|Overall Study|8 declined CPAP treatment|78
1083135|NCT00988351|2624311|P2|STARTED|Overall Study||78
1083136|NCT00988351|2624312|P1|STARTED|Overall Study||78
1083137|NCT00994240|2624328|P2|NOT COMPLETED|Overall Study||5
1083138|NCT00994240|2624329|P1|NOT COMPLETED|Overall Study||6
1083139|NCT00994240|2624328|P2|COMPLETED|Overall Study||39
1083140|NCT00994240|2624329|P1|COMPLETED|Overall Study||35
1083141|NCT00994240|2624328|P2|STARTED|Overall Study||44
1083142|NCT00994240|2624329|P1|STARTED|Overall Study||41
1083143|NCT00994279|2624337|P2|NOT COMPLETED|Overall Study||5
1083144|NCT00994279|2624338|P1|NOT COMPLETED|Overall Study||4
1083145|NCT00994279|2624337|P2|COMPLETED|Overall Study||13
1083146|NCT00994279|2624338|P1|COMPLETED|Overall Study||18
1083147|NCT00994279|2624337|P2|STARTED|Overall Study||18
1083148|NCT00994279|2624338|P1|STARTED|Overall Study||22
1083149|NCT00994318|2624349|P3|NOT COMPLETED|Overall Study||67
1083150|NCT00994318|2624350|P2|NOT COMPLETED|Overall Study||18
1083151|NCT00994318|2624351|P1|NOT COMPLETED|Overall Study||22
1083152|NCT00994318|2624349|P3|COMPLETED|Overall Study||250
1083153|NCT00994318|2624350|P2|COMPLETED|Overall Study||136
1083154|NCT00994318|2624351|P1|COMPLETED|Overall Study||133
1083155|NCT00994318|2624349|P3|STARTED|Overall Study||317
1083156|NCT00994318|2624350|P2|STARTED|Overall Study||154
1083157|NCT00994318|2624351|P1|STARTED|Overall Study||155
1083158|NCT00994422|2624361|P2|NOT COMPLETED|Overall Study||1
1083159|NCT00994422|2624362|P1|NOT COMPLETED|Overall Study||7
1083160|NCT00994422|2624361|P2|COMPLETED|Overall Study||54
1083161|NCT00994422|2624362|P1|COMPLETED|Overall Study||185
1083162|NCT00994422|2624361|P2|STARTED|Overall Study||55
1083163|NCT00994422|2624362|P1|STARTED|Overall Study||192
1083164|NCT00994448|2624374|P2|NOT COMPLETED|Overall Study||2
1083165|NCT00994448|2624375|P1|NOT COMPLETED|Overall Study||8
1083166|NCT00994448|2624374|P2|COMPLETED|Overall Study||5
1083167|NCT00994448|2624375|P1|COMPLETED|Overall Study||4
1083168|NCT00994448|2624374|P2|STARTED|Overall Study||7
1083169|NCT00994448|2624375|P1|STARTED|Overall Study||12
1083170|NCT00994461|2624384|P3|NOT COMPLETED|Overall Study||0
1083171|NCT00994461|2624385|P2|NOT COMPLETED|Overall Study||1
1083172|NCT00994461|2624386|P1|NOT COMPLETED|Overall Study||2
1083173|NCT00994461|2624384|P3|COMPLETED|Overall Study||37
1083174|NCT00994461|2624385|P2|COMPLETED|Overall Study||75
1083175|NCT00994461|2624386|P1|COMPLETED|Overall Study||74
1083176|NCT00994461|2624384|P3|STARTED|Overall Study|One subject was randomized but did not receive study drug.|37
1083177|NCT00994461|2624385|P2|STARTED|Overall Study||76
1083178|NCT00994461|2624386|P1|STARTED|Overall Study||76
1083179|NCT00996892|2624412|P20|NOT COMPLETED|Expansion Stage 2A||45
1083180|NCT00996892|2624413|P19|NOT COMPLETED|Expansion Stage 2A||0
1083181|NCT00996892|2624414|P18|NOT COMPLETED|Expansion Stage 2A||0
1083182|NCT00996892|2624415|P17|NOT COMPLETED|Expansion Stage 2A||0
1083183|NCT00996892|2624416|P16|NOT COMPLETED|Expansion Stage 2A||0
1083184|NCT00996892|2624417|P15|NOT COMPLETED|Expansion Stage 2A||0
1083185|NCT00996892|2624418|P14|NOT COMPLETED|Expansion Stage 2A||0
1083186|NCT00996892|2624419|P13|NOT COMPLETED|Expansion Stage 2A||0
1083187|NCT00996892|2624420|P12|NOT COMPLETED|Expansion Stage 2A||0
1083188|NCT00996892|2624421|P11|NOT COMPLETED|Expansion Stage 2A||0
1083189|NCT00996892|2624422|P10|NOT COMPLETED|Expansion Stage 2A||0
1083190|NCT00996892|2624423|P9|NOT COMPLETED|Expansion Stage 2A||0
1083191|NCT00996892|2624424|P8|NOT COMPLETED|Expansion Stage 2A||0
1083192|NCT00996892|2624425|P7|NOT COMPLETED|Expansion Stage 2A||0
1083193|NCT00996892|2624426|P6|NOT COMPLETED|Expansion Stage 2A||0
1083194|NCT00996892|2624427|P5|NOT COMPLETED|Expansion Stage 2A||0
1083195|NCT00996892|2624428|P4|NOT COMPLETED|Expansion Stage 2A||0
1083196|NCT00996892|2624429|P3|NOT COMPLETED|Expansion Stage 2A||0
1083197|NCT00996892|2624430|P2|NOT COMPLETED|Expansion Stage 2A||0
1083198|NCT00996892|2624431|P1|NOT COMPLETED|Expansion Stage 2A||0
1083199|NCT00996892|2624412|P20|COMPLETED|Expansion Stage 2A||0
1083200|NCT00996892|2624413|P19|COMPLETED|Expansion Stage 2A||0
1083201|NCT00996892|2624414|P18|COMPLETED|Expansion Stage 2A||0
1083202|NCT00996892|2624415|P17|COMPLETED|Expansion Stage 2A||0
1083203|NCT00996892|2624416|P16|COMPLETED|Expansion Stage 2A||0
1083204|NCT00996892|2624417|P15|COMPLETED|Expansion Stage 2A||0
1083205|NCT00996892|2624418|P14|COMPLETED|Expansion Stage 2A||0
1083206|NCT00996892|2624419|P13|COMPLETED|Expansion Stage 2A||0
1083207|NCT00996892|2624420|P12|COMPLETED|Expansion Stage 2A||0
1083208|NCT00996892|2624421|P11|COMPLETED|Expansion Stage 2A||0
1083209|NCT00996892|2624422|P10|COMPLETED|Expansion Stage 2A||0
1083210|NCT00996892|2624423|P9|COMPLETED|Expansion Stage 2A||0
1083211|NCT00996892|2624424|P8|COMPLETED|Expansion Stage 2A||0
1083212|NCT00996892|2624425|P7|COMPLETED|Expansion Stage 2A||0
1083213|NCT00996892|2624426|P6|COMPLETED|Expansion Stage 2A||0
1083214|NCT00996892|2624427|P5|COMPLETED|Expansion Stage 2A||0
1083215|NCT00996892|2624428|P4|COMPLETED|Expansion Stage 2A||0
1083216|NCT00996892|2624429|P3|COMPLETED|Expansion Stage 2A||0
1083217|NCT00996892|2624430|P2|COMPLETED|Expansion Stage 2A||0
1083218|NCT00996892|2624431|P1|COMPLETED|Expansion Stage 2A||0
1083219|NCT00996892|2624412|P20|STARTED|Expansion Stage 2A||45
1083220|NCT00996892|2624413|P19|STARTED|Expansion Stage 2A||0
1083221|NCT00996892|2624414|P18|STARTED|Expansion Stage 2A||0
1083222|NCT00996892|2624415|P17|STARTED|Expansion Stage 2A||0
1083223|NCT00996892|2624416|P16|STARTED|Expansion Stage 2A||0
1083224|NCT00996892|2624417|P15|STARTED|Expansion Stage 2A||0
1083225|NCT00996892|2624418|P14|STARTED|Expansion Stage 2A||0
1083226|NCT00996892|2624419|P13|STARTED|Expansion Stage 2A||0
1083227|NCT00996892|2624420|P12|STARTED|Expansion Stage 2A||0
1083228|NCT00996892|2624421|P11|STARTED|Expansion Stage 2A||0
1083229|NCT00996892|2624422|P10|STARTED|Expansion Stage 2A||0
1083230|NCT00996892|2624423|P9|STARTED|Expansion Stage 2A||0
1083231|NCT00996892|2624424|P8|STARTED|Expansion Stage 2A||0
1083232|NCT00996892|2624425|P7|STARTED|Expansion Stage 2A||0
1083233|NCT00996892|2624426|P6|STARTED|Expansion Stage 2A||0
1083234|NCT00996892|2624427|P5|STARTED|Expansion Stage 2A||0
1083235|NCT00996892|2624428|P4|STARTED|Expansion Stage 2A||0
1083236|NCT00996892|2624429|P3|STARTED|Expansion Stage 2A||0
1083237|NCT00996892|2624430|P2|STARTED|Expansion Stage 2A||0
1083238|NCT00996892|2624431|P1|STARTED|Expansion Stage 2A||0
1083239|NCT00996892|2624412|P20|NOT COMPLETED|Expansion Stage 2||0
1083240|NCT00996892|2624413|P19|NOT COMPLETED|Expansion Stage 2||35
1083241|NCT00996892|2624414|P18|NOT COMPLETED|Expansion Stage 2||0
1083242|NCT00996892|2624415|P17|NOT COMPLETED|Expansion Stage 2||0
1083243|NCT00996892|2624416|P16|NOT COMPLETED|Expansion Stage 2||0
1083244|NCT00996892|2624417|P15|NOT COMPLETED|Expansion Stage 2||0
1083245|NCT00996892|2624418|P14|NOT COMPLETED|Expansion Stage 2||0
1083246|NCT00996892|2624419|P13|NOT COMPLETED|Expansion Stage 2||0
1083247|NCT00996892|2624420|P12|NOT COMPLETED|Expansion Stage 2||0
1083248|NCT00996892|2624421|P11|NOT COMPLETED|Expansion Stage 2||0
1083249|NCT00996892|2624422|P10|NOT COMPLETED|Expansion Stage 2||0
1083250|NCT00996892|2624423|P9|NOT COMPLETED|Expansion Stage 2||0
1083251|NCT00996892|2624424|P8|NOT COMPLETED|Expansion Stage 2||0
1083252|NCT00996892|2624425|P7|NOT COMPLETED|Expansion Stage 2||0
1083253|NCT00996892|2624426|P6|NOT COMPLETED|Expansion Stage 2||0
1083254|NCT00996892|2624427|P5|NOT COMPLETED|Expansion Stage 2||0
1083255|NCT00996892|2624428|P4|NOT COMPLETED|Expansion Stage 2||0
1083256|NCT00996892|2624429|P3|NOT COMPLETED|Expansion Stage 2||0
1083257|NCT00996892|2624430|P2|NOT COMPLETED|Expansion Stage 2||0
1083258|NCT00996892|2624431|P1|NOT COMPLETED|Expansion Stage 2||0
1083259|NCT00996892|2624412|P20|COMPLETED|Expansion Stage 2||0
1083260|NCT00996892|2624413|P19|COMPLETED|Expansion Stage 2||0
1083261|NCT00996892|2624414|P18|COMPLETED|Expansion Stage 2||0
1083262|NCT00996892|2624415|P17|COMPLETED|Expansion Stage 2||0
1083263|NCT00996892|2624416|P16|COMPLETED|Expansion Stage 2||0
1083264|NCT00996892|2624417|P15|COMPLETED|Expansion Stage 2||0
1083265|NCT00996892|2624418|P14|COMPLETED|Expansion Stage 2||0
1083266|NCT00996892|2624419|P13|COMPLETED|Expansion Stage 2||0
1083267|NCT00996892|2624420|P12|COMPLETED|Expansion Stage 2||0
1083268|NCT00996892|2624421|P11|COMPLETED|Expansion Stage 2||0
1083269|NCT00996892|2624422|P10|COMPLETED|Expansion Stage 2||0
1083270|NCT00996892|2624423|P9|COMPLETED|Expansion Stage 2||0
1083271|NCT00996892|2624424|P8|COMPLETED|Expansion Stage 2||0
1083272|NCT00996892|2624425|P7|COMPLETED|Expansion Stage 2||0
1083273|NCT00996892|2624426|P6|COMPLETED|Expansion Stage 2||0
1083274|NCT00996892|2624427|P5|COMPLETED|Expansion Stage 2||0
1083275|NCT00996892|2624428|P4|COMPLETED|Expansion Stage 2||0
1083276|NCT00996892|2624429|P3|COMPLETED|Expansion Stage 2||0
1083277|NCT00996892|2624430|P2|COMPLETED|Expansion Stage 2||0
1083278|NCT00996892|2624431|P1|COMPLETED|Expansion Stage 2||0
1083279|NCT00996892|2624412|P20|STARTED|Expansion Stage 2||0
1083280|NCT00996892|2624413|P19|STARTED|Expansion Stage 2||35
1083281|NCT00996892|2624414|P18|STARTED|Expansion Stage 2||0
1083282|NCT00996892|2624415|P17|STARTED|Expansion Stage 2||0
1083283|NCT00996892|2624416|P16|STARTED|Expansion Stage 2||0
1083284|NCT00996892|2624417|P15|STARTED|Expansion Stage 2||0
1083285|NCT00996892|2624418|P14|STARTED|Expansion Stage 2||0
1083286|NCT00996892|2624419|P13|STARTED|Expansion Stage 2||0
1083287|NCT00996892|2624420|P12|STARTED|Expansion Stage 2||0
1083288|NCT00996892|2624421|P11|STARTED|Expansion Stage 2||0
1083289|NCT00996892|2624422|P10|STARTED|Expansion Stage 2||0
1083290|NCT00996892|2624423|P9|STARTED|Expansion Stage 2||0
1083291|NCT00996892|2624424|P8|STARTED|Expansion Stage 2||0
1083292|NCT00996892|2624425|P7|STARTED|Expansion Stage 2||0
1083293|NCT00996892|2624426|P6|STARTED|Expansion Stage 2||0
1083294|NCT00996892|2624427|P5|STARTED|Expansion Stage 2||0
1083295|NCT00996892|2624428|P4|STARTED|Expansion Stage 2||0
1083296|NCT00996892|2624429|P3|STARTED|Expansion Stage 2||0
1083297|NCT00996892|2624430|P2|STARTED|Expansion Stage 2||0
1083298|NCT00996892|2624431|P1|STARTED|Expansion Stage 2||0
1083299|NCT00996892|2624412|P20|NOT COMPLETED|Dose-Escalation Stage 1B||0
1083300|NCT00996892|2624413|P19|NOT COMPLETED|Dose-Escalation Stage 1B||0
1083301|NCT00996892|2624414|P18|NOT COMPLETED|Dose-Escalation Stage 1B||5
1083302|NCT00996892|2624415|P17|NOT COMPLETED|Dose-Escalation Stage 1B||3
1083303|NCT00996892|2624416|P16|NOT COMPLETED|Dose-Escalation Stage 1B||3
1083304|NCT00996892|2624417|P15|NOT COMPLETED|Dose-Escalation Stage 1B||4
1083305|NCT00996892|2624418|P14|NOT COMPLETED|Dose-Escalation Stage 1B||0
1083306|NCT00996892|2624419|P13|NOT COMPLETED|Dose-Escalation Stage 1B||0
1083307|NCT00996892|2624420|P12|NOT COMPLETED|Dose-Escalation Stage 1B||0
1083308|NCT00996892|2624421|P11|NOT COMPLETED|Dose-Escalation Stage 1B||0
1083309|NCT00996892|2624422|P10|NOT COMPLETED|Dose-Escalation Stage 1B||0
1083310|NCT00996892|2624423|P9|NOT COMPLETED|Dose-Escalation Stage 1B||0
1083311|NCT00996892|2624424|P8|NOT COMPLETED|Dose-Escalation Stage 1B||0
1083312|NCT00996892|2624425|P7|NOT COMPLETED|Dose-Escalation Stage 1B||0
1083313|NCT00996892|2624426|P6|NOT COMPLETED|Dose-Escalation Stage 1B||0
1083314|NCT00996892|2624427|P5|NOT COMPLETED|Dose-Escalation Stage 1B||0
1083315|NCT00996892|2624428|P4|NOT COMPLETED|Dose-Escalation Stage 1B||0
1083316|NCT00996892|2624429|P3|NOT COMPLETED|Dose-Escalation Stage 1B||0
1083317|NCT00996892|2624430|P2|NOT COMPLETED|Dose-Escalation Stage 1B||0
1083318|NCT00996892|2624431|P1|NOT COMPLETED|Dose-Escalation Stage 1B||0
1083319|NCT00996892|2624412|P20|COMPLETED|Dose-Escalation Stage 1B||0
1083320|NCT00996892|2624413|P19|COMPLETED|Dose-Escalation Stage 1B||0
1083321|NCT00996892|2624414|P18|COMPLETED|Dose-Escalation Stage 1B||0
1083322|NCT00996892|2624415|P17|COMPLETED|Dose-Escalation Stage 1B||0
1083323|NCT00996892|2624416|P16|COMPLETED|Dose-Escalation Stage 1B||0
1083324|NCT00996892|2624417|P15|COMPLETED|Dose-Escalation Stage 1B||0
1083325|NCT00996892|2624418|P14|COMPLETED|Dose-Escalation Stage 1B||0
1083326|NCT00996892|2624419|P13|COMPLETED|Dose-Escalation Stage 1B||0
1083327|NCT00996892|2624420|P12|COMPLETED|Dose-Escalation Stage 1B||0
1083328|NCT00996892|2624421|P11|COMPLETED|Dose-Escalation Stage 1B||0
1083329|NCT00996892|2624422|P10|COMPLETED|Dose-Escalation Stage 1B||0
1083330|NCT00996892|2624423|P9|COMPLETED|Dose-Escalation Stage 1B||0
1083331|NCT00996892|2624424|P8|COMPLETED|Dose-Escalation Stage 1B||0
1083332|NCT00996892|2624425|P7|COMPLETED|Dose-Escalation Stage 1B||0
1083333|NCT00996892|2624426|P6|COMPLETED|Dose-Escalation Stage 1B||0
1083334|NCT00996892|2624427|P5|COMPLETED|Dose-Escalation Stage 1B||0
1083335|NCT00996892|2624428|P4|COMPLETED|Dose-Escalation Stage 1B||0
1083336|NCT00996892|2624429|P3|COMPLETED|Dose-Escalation Stage 1B||0
1083337|NCT00996892|2624430|P2|COMPLETED|Dose-Escalation Stage 1B||0
1083338|NCT00996892|2624431|P1|COMPLETED|Dose-Escalation Stage 1B||0
1083339|NCT00996892|2624412|P20|STARTED|Dose-Escalation Stage 1B||0
1083340|NCT00996892|2624413|P19|STARTED|Dose-Escalation Stage 1B||0
1083341|NCT00996892|2624414|P18|STARTED|Dose-Escalation Stage 1B||5
1083342|NCT00996892|2624415|P17|STARTED|Dose-Escalation Stage 1B||3
1083343|NCT00996892|2624416|P16|STARTED|Dose-Escalation Stage 1B||3
1083344|NCT00996892|2624417|P15|STARTED|Dose-Escalation Stage 1B||4
1083345|NCT00996892|2624418|P14|STARTED|Dose-Escalation Stage 1B||0
1083346|NCT00996892|2624419|P13|STARTED|Dose-Escalation Stage 1B||0
1083347|NCT00996892|2624420|P12|STARTED|Dose-Escalation Stage 1B||0
1083348|NCT00996892|2624421|P11|STARTED|Dose-Escalation Stage 1B||0
1083349|NCT00996892|2624422|P10|STARTED|Dose-Escalation Stage 1B||0
1083350|NCT00996892|2624423|P9|STARTED|Dose-Escalation Stage 1B||0
1083351|NCT00996892|2624424|P8|STARTED|Dose-Escalation Stage 1B||0
1083352|NCT00996892|2624425|P7|STARTED|Dose-Escalation Stage 1B||0
1083353|NCT00996892|2624426|P6|STARTED|Dose-Escalation Stage 1B||0
1083354|NCT00996892|2624427|P5|STARTED|Dose-Escalation Stage 1B||0
1083355|NCT00996892|2624428|P4|STARTED|Dose-Escalation Stage 1B||0
1083356|NCT00996892|2624429|P3|STARTED|Dose-Escalation Stage 1B||0
1083357|NCT00996892|2624430|P2|STARTED|Dose-Escalation Stage 1B||0
1083358|NCT00996892|2624431|P1|STARTED|Dose-Escalation Stage 1B||0
1083359|NCT00996892|2624412|P20|NOT COMPLETED|Dose-Escalation Stage 1A||0
1083360|NCT00996892|2624413|P19|NOT COMPLETED|Dose-Escalation Stage 1A||0
1083361|NCT00996892|2624414|P18|NOT COMPLETED|Dose-Escalation Stage 1A||0
1083362|NCT00996892|2624415|P17|NOT COMPLETED|Dose-Escalation Stage 1A||0
1083363|NCT00996892|2624416|P16|NOT COMPLETED|Dose-Escalation Stage 1A||0
1083364|NCT00996892|2624417|P15|NOT COMPLETED|Dose-Escalation Stage 1A||0
1083365|NCT00996892|2624418|P14|NOT COMPLETED|Dose-Escalation Stage 1A||5
1083366|NCT00996892|2624419|P13|NOT COMPLETED|Dose-Escalation Stage 1A||8
1083367|NCT00996892|2624420|P12|NOT COMPLETED|Dose-Escalation Stage 1A||9
1083368|NCT00996892|2624421|P11|NOT COMPLETED|Dose-Escalation Stage 1A||7
1083369|NCT00996892|2624422|P10|NOT COMPLETED|Dose-Escalation Stage 1A||4
1083370|NCT00996892|2624423|P9|NOT COMPLETED|Dose-Escalation Stage 1A||3
1083371|NCT00996892|2624424|P8|NOT COMPLETED|Dose-Escalation Stage 1A||3
1083372|NCT00996892|2624425|P7|NOT COMPLETED|Dose-Escalation Stage 1A||0
1083373|NCT00996892|2624426|P6|NOT COMPLETED|Dose-Escalation Stage 1A||0
1083374|NCT00996892|2624427|P5|NOT COMPLETED|Dose-Escalation Stage 1A||0
1083375|NCT00996892|2624428|P4|NOT COMPLETED|Dose-Escalation Stage 1A||0
1083376|NCT00996892|2624429|P3|NOT COMPLETED|Dose-Escalation Stage 1A||0
1083377|NCT00996892|2624430|P2|NOT COMPLETED|Dose-Escalation Stage 1A||0
1083378|NCT00996892|2624431|P1|NOT COMPLETED|Dose-Escalation Stage 1A||0
1083379|NCT00996892|2624412|P20|COMPLETED|Dose-Escalation Stage 1A||0
1083380|NCT00996892|2624413|P19|COMPLETED|Dose-Escalation Stage 1A||0
1083381|NCT00996892|2624414|P18|COMPLETED|Dose-Escalation Stage 1A||0
1083382|NCT00996892|2624415|P17|COMPLETED|Dose-Escalation Stage 1A||0
1083383|NCT00996892|2624416|P16|COMPLETED|Dose-Escalation Stage 1A||0
1083384|NCT00996892|2624417|P15|COMPLETED|Dose-Escalation Stage 1A||0
1083385|NCT00996892|2624418|P14|COMPLETED|Dose-Escalation Stage 1A||0
1083386|NCT00996892|2624419|P13|COMPLETED|Dose-Escalation Stage 1A||0
1083387|NCT00996892|2624420|P12|COMPLETED|Dose-Escalation Stage 1A||0
1083388|NCT00996892|2624421|P11|COMPLETED|Dose-Escalation Stage 1A||0
1083389|NCT00996892|2624422|P10|COMPLETED|Dose-Escalation Stage 1A||0
1083390|NCT00996892|2624423|P9|COMPLETED|Dose-Escalation Stage 1A||0
1083391|NCT00996892|2624424|P8|COMPLETED|Dose-Escalation Stage 1A||0
1083392|NCT00996892|2624425|P7|COMPLETED|Dose-Escalation Stage 1A||0
1083393|NCT00996892|2624426|P6|COMPLETED|Dose-Escalation Stage 1A||0
1083394|NCT00996892|2624427|P5|COMPLETED|Dose-Escalation Stage 1A||0
1083395|NCT00996892|2624428|P4|COMPLETED|Dose-Escalation Stage 1A||0
1083396|NCT00996892|2624429|P3|COMPLETED|Dose-Escalation Stage 1A||0
1083397|NCT00996892|2624430|P2|COMPLETED|Dose-Escalation Stage 1A||0
1083398|NCT00996892|2624431|P1|COMPLETED|Dose-Escalation Stage 1A||0
1083399|NCT00996892|2624412|P20|STARTED|Dose-Escalation Stage 1A||0
1083400|NCT00996892|2624413|P19|STARTED|Dose-Escalation Stage 1A||0
1083401|NCT00996892|2624414|P18|STARTED|Dose-Escalation Stage 1A||0
1083402|NCT00996892|2624415|P17|STARTED|Dose-Escalation Stage 1A||0
1083403|NCT00996892|2624416|P16|STARTED|Dose-Escalation Stage 1A||0
1083404|NCT00996892|2624417|P15|STARTED|Dose-Escalation Stage 1A||0
1083405|NCT00996892|2624418|P14|STARTED|Dose-Escalation Stage 1A||5
1083406|NCT00996892|2624419|P13|STARTED|Dose-Escalation Stage 1A||8
1083407|NCT00996892|2624420|P12|STARTED|Dose-Escalation Stage 1A||9
1083408|NCT00996892|2624421|P11|STARTED|Dose-Escalation Stage 1A||7
1083409|NCT00996892|2624422|P10|STARTED|Dose-Escalation Stage 1A||4
1083410|NCT00996892|2624423|P9|STARTED|Dose-Escalation Stage 1A||3
1083411|NCT00996892|2624424|P8|STARTED|Dose-Escalation Stage 1A||3
1083412|NCT00996892|2624425|P7|STARTED|Dose-Escalation Stage 1A||0
1083413|NCT00996892|2624426|P6|STARTED|Dose-Escalation Stage 1A||0
1083414|NCT00996892|2624427|P5|STARTED|Dose-Escalation Stage 1A||0
1083415|NCT00996892|2624428|P4|STARTED|Dose-Escalation Stage 1A||0
1083416|NCT00996892|2624429|P3|STARTED|Dose-Escalation Stage 1A||0
1083417|NCT00996892|2624430|P2|STARTED|Dose-Escalation Stage 1A||0
1083418|NCT00996892|2624431|P1|STARTED|Dose-Escalation Stage 1A||0
1083419|NCT00996892|2624412|P20|NOT COMPLETED|Dose-Escalation Stage 1||0
1083420|NCT00996892|2624413|P19|NOT COMPLETED|Dose-Escalation Stage 1||0
1083421|NCT00996892|2624414|P18|NOT COMPLETED|Dose-Escalation Stage 1||0
1083422|NCT00996892|2624415|P17|NOT COMPLETED|Dose-Escalation Stage 1||0
1083423|NCT00996892|2624416|P16|NOT COMPLETED|Dose-Escalation Stage 1||0
1083424|NCT00996892|2624417|P15|NOT COMPLETED|Dose-Escalation Stage 1||0
1083425|NCT00996892|2624418|P14|NOT COMPLETED|Dose-Escalation Stage 1||0
1083426|NCT00996892|2624419|P13|NOT COMPLETED|Dose-Escalation Stage 1||0
1083427|NCT00996892|2624420|P12|NOT COMPLETED|Dose-Escalation Stage 1||0
1083428|NCT00996892|2624421|P11|NOT COMPLETED|Dose-Escalation Stage 1||0
1083429|NCT00996892|2624422|P10|NOT COMPLETED|Dose-Escalation Stage 1||0
1083430|NCT00996892|2624423|P9|NOT COMPLETED|Dose-Escalation Stage 1||0
1083431|NCT00996892|2624424|P8|NOT COMPLETED|Dose-Escalation Stage 1||0
1083432|NCT00996892|2624425|P7|NOT COMPLETED|Dose-Escalation Stage 1||4
1083433|NCT00996892|2624426|P6|NOT COMPLETED|Dose-Escalation Stage 1||10
1083434|NCT00996892|2624427|P5|NOT COMPLETED|Dose-Escalation Stage 1||11
1083435|NCT00996892|2624428|P4|NOT COMPLETED|Dose-Escalation Stage 1||9
1083436|NCT00996892|2624429|P3|NOT COMPLETED|Dose-Escalation Stage 1||3
1083437|NCT00996892|2624430|P2|NOT COMPLETED|Dose-Escalation Stage 1||3
1083438|NCT00996892|2624431|P1|NOT COMPLETED|Dose-Escalation Stage 1||4
1083439|NCT00996892|2624412|P20|COMPLETED|Dose-Escalation Stage 1||0
1083440|NCT00996892|2624413|P19|COMPLETED|Dose-Escalation Stage 1||0
1083441|NCT00996892|2624414|P18|COMPLETED|Dose-Escalation Stage 1||0
1083442|NCT00996892|2624415|P17|COMPLETED|Dose-Escalation Stage 1||0
1083443|NCT00996892|2624416|P16|COMPLETED|Dose-Escalation Stage 1||0
1083444|NCT00996892|2624417|P15|COMPLETED|Dose-Escalation Stage 1||0
1083445|NCT00996892|2624418|P14|COMPLETED|Dose-Escalation Stage 1||0
1083446|NCT00996892|2624419|P13|COMPLETED|Dose-Escalation Stage 1||0
1083447|NCT00996892|2624420|P12|COMPLETED|Dose-Escalation Stage 1||0
1083448|NCT00996892|2624421|P11|COMPLETED|Dose-Escalation Stage 1||0
1083449|NCT00996892|2624422|P10|COMPLETED|Dose-Escalation Stage 1||0
1083450|NCT00996892|2624423|P9|COMPLETED|Dose-Escalation Stage 1||0
1083451|NCT00996892|2624424|P8|COMPLETED|Dose-Escalation Stage 1||0
1083452|NCT00996892|2624425|P7|COMPLETED|Dose-Escalation Stage 1||0
1083453|NCT00996892|2624426|P6|COMPLETED|Dose-Escalation Stage 1||0
1083454|NCT00996892|2624427|P5|COMPLETED|Dose-Escalation Stage 1||0
1083455|NCT00996892|2624428|P4|COMPLETED|Dose-Escalation Stage 1||0
1083456|NCT00996892|2624429|P3|COMPLETED|Dose-Escalation Stage 1||0
1083457|NCT00996892|2624430|P2|COMPLETED|Dose-Escalation Stage 1||0
1083458|NCT00996892|2624431|P1|COMPLETED|Dose-Escalation Stage 1||0
1083459|NCT00996892|2624412|P20|STARTED|Dose-Escalation Stage 1||0
1083460|NCT00996892|2624413|P19|STARTED|Dose-Escalation Stage 1||0
1083461|NCT00996892|2624414|P18|STARTED|Dose-Escalation Stage 1||0
1083462|NCT00996892|2624415|P17|STARTED|Dose-Escalation Stage 1||0
1083463|NCT00996892|2624416|P16|STARTED|Dose-Escalation Stage 1||0
1083464|NCT00996892|2624417|P15|STARTED|Dose-Escalation Stage 1||0
1083465|NCT00996892|2624418|P14|STARTED|Dose-Escalation Stage 1||0
1083466|NCT00996892|2624419|P13|STARTED|Dose-Escalation Stage 1||0
1083467|NCT00996892|2624420|P12|STARTED|Dose-Escalation Stage 1||0
1083468|NCT00996892|2624421|P11|STARTED|Dose-Escalation Stage 1||0
1083469|NCT00996892|2624422|P10|STARTED|Dose-Escalation Stage 1||0
1083470|NCT00996892|2624423|P9|STARTED|Dose-Escalation Stage 1||0
1083471|NCT00996892|2624424|P8|STARTED|Dose-Escalation Stage 1||0
1083472|NCT00996892|2624425|P7|STARTED|Dose-Escalation Stage 1||4
1083473|NCT00996892|2624426|P6|STARTED|Dose-Escalation Stage 1||10
1083474|NCT00996892|2624427|P5|STARTED|Dose-Escalation Stage 1||11
1083475|NCT00996892|2624428|P4|STARTED|Dose-Escalation Stage 1||9
1083476|NCT00996892|2624429|P3|STARTED|Dose-Escalation Stage 1||3
1083477|NCT00996892|2624430|P2|STARTED|Dose-Escalation Stage 1||3
1083478|NCT00996892|2624431|P1|STARTED|Dose-Escalation Stage 1||4
1083479|NCT00996918|2625025|P5|NOT COMPLETED|Overall Study||4
1083480|NCT00996918|2625026|P4|NOT COMPLETED|Overall Study||56
1083481|NCT00996918|2625027|P3|NOT COMPLETED|Overall Study||37
1083482|NCT00996918|2625028|P2|NOT COMPLETED|Overall Study||66
1083483|NCT00996918|2625029|P1|NOT COMPLETED|Overall Study||39
1083484|NCT00996918|2625025|P5|COMPLETED|Overall Study||0
1083485|NCT00996918|2625026|P4|COMPLETED|Overall Study||0
1083486|NCT00996918|2625027|P3|COMPLETED|Overall Study||0
1083487|NCT00996918|2625028|P2|COMPLETED|Overall Study||0
1083488|NCT00996918|2625029|P1|COMPLETED|Overall Study||0
1083489|NCT00996918|2625025|P5|Treated|Overall Study||4
1083490|NCT00996918|2625026|P4|Treated|Overall Study||56
1083491|NCT00996918|2625027|P3|Treated|Overall Study||37
1083492|NCT00996918|2625028|P2|Treated|Overall Study||66
1083493|NCT00996918|2625029|P1|Treated|Overall Study||39
1083494|NCT00996918|2625025|P5|STARTED|Overall Study||4
1083495|NCT00996918|2625026|P4|STARTED|Overall Study||56
1083496|NCT00996918|2625027|P3|STARTED|Overall Study||37
1083497|NCT00996918|2625028|P2|STARTED|Overall Study||66
1083498|NCT00996918|2625029|P1|STARTED|Overall Study||39
1083499|NCT00996931|2625073|P1|NOT COMPLETED|Overall Study||0
1083500|NCT00996931|2625073|P1|COMPLETED|Overall Study||6
1083501|NCT00996931|2625073|P1|STARTED|Overall Study||6
1083502|NCT00996944|2625080|P2|NOT COMPLETED|Long-term Treatment Period||5
1083503|NCT00996944|2625081|P1|NOT COMPLETED|Long-term Treatment Period||12
1083504|NCT00996944|2625080|P2|COMPLETED|Long-term Treatment Period||0
1083505|NCT00996944|2625081|P1|COMPLETED|Long-term Treatment Period||0
1083506|NCT00996944|2625080|P2|STARTED|Long-term Treatment Period||5
1083507|NCT00996944|2625081|P1|STARTED|Long-term Treatment Period||12
1083508|NCT00996944|2625080|P2|NOT COMPLETED|Double-blind Treatment Period||7
1083509|NCT00996944|2625081|P1|NOT COMPLETED|Double-blind Treatment Period||10
1083510|NCT00996944|2625080|P2|COMPLETED|Double-blind Treatment Period||5
1083511|NCT00996944|2625081|P1|COMPLETED|Double-blind Treatment Period||12
1083512|NCT00996944|2625080|P2|STARTED|Double-blind Treatment Period||12
1083513|NCT00996944|2625081|P1|STARTED|Double-blind Treatment Period||22
1083514|NCT00996996|2625123|P1|NOT COMPLETED|Overall Study||33
1083515|NCT00996996|2625123|P1|COMPLETED|Overall Study|These participants completed 12 years of follow-up.|44
1083516|NCT00996996|2625123|P1|STARTED|Overall Study||77
1083517|NCT00997035|2625157|P2|NOT COMPLETED|3-month Follow-up Visit||6
1083518|NCT00997035|2625158|P1|NOT COMPLETED|3-month Follow-up Visit||12
1083519|NCT00997035|2625157|P2|COMPLETED|3-month Follow-up Visit||107
1083520|NCT00997035|2625158|P1|COMPLETED|3-month Follow-up Visit||100
1083521|NCT00997035|2625157|P2|STARTED|3-month Follow-up Visit||113
1083522|NCT00997035|2625158|P1|STARTED|3-month Follow-up Visit||112
1083523|NCT00997035|2625157|P2|NOT COMPLETED|3-week Followup Visit||6
1083524|NCT00997035|2625158|P1|NOT COMPLETED|3-week Followup Visit||9
1083525|NCT00997035|2625157|P2|COMPLETED|3-week Followup Visit||113
1083526|NCT00997035|2625158|P1|COMPLETED|3-week Followup Visit||112
1083527|NCT00997035|2625157|P2|STARTED|3-week Followup Visit||119
1083528|NCT00997035|2625158|P1|STARTED|3-week Followup Visit||121
1083529|NCT00997113|2625180|P2|NOT COMPLETED|Overall Study||0
1083530|NCT00997113|2625181|P1|NOT COMPLETED|Overall Study||0
1083531|NCT00997113|2625180|P2|COMPLETED|Overall Study||10
1083532|NCT00997113|2625181|P1|COMPLETED|Overall Study||10
1083533|NCT00997113|2625180|P2|STARTED|Overall Study||10
1083534|NCT00997113|2625181|P1|STARTED|Overall Study||10
1083535|NCT00997126|2625193|P2|NOT COMPLETED|Overall Study||11
1083536|NCT00997126|2625194|P1|NOT COMPLETED|Overall Study||7
1083537|NCT00997126|2625193|P2|COMPLETED|Overall Study||52
1083538|NCT00997126|2625194|P1|COMPLETED|Overall Study||56
1083539|NCT00997126|2625193|P2|STARTED|Overall Study||63
1083540|NCT00997126|2625194|P1|STARTED|Overall Study||63
1083541|NCT00997139|2625208|P1|NOT COMPLETED|Overall Study||186
1083542|NCT00997139|2625208|P1|COMPLETED|Overall Study||30
1083543|NCT00997139|2625208|P1|Treated for Positive Baseline Culture|Overall Study||30
1083544|NCT00997139|2625208|P1|STARTED|Overall Study||216
1083545|NCT00997204|2625216|P2|NOT COMPLETED|Self-administration Phase||1
1083546|NCT00997204|2625217|P1|NOT COMPLETED|Self-administration Phase||0
1083547|NCT00997204|2625216|P2|COMPLETED|Self-administration Phase||77
1083548|NCT00997204|2625217|P1|COMPLETED|Self-administration Phase||19
1083549|NCT00997204|2625216|P2|STARTED|Self-administration Phase|1 subject did not self-administered icatibant but had a HCP to perform. the data were not included.|78
1083550|NCT00997204|2625217|P1|STARTED|Self-administration Phase||19
1083551|NCT00997204|2625216|P2|NOT COMPLETED|Naive Treatment Phase||79
1083552|NCT00997204|2625217|P1|NOT COMPLETED|Naive Treatment Phase||6
1083553|NCT00997204|2625216|P2|COMPLETED|Naive Treatment Phase||0
1083554|NCT00997204|2625217|P1|COMPLETED|Naive Treatment Phase||19
1083555|NCT00997204|2625216|P2|STARTED|Naive Treatment Phase|Non-naive patients participated in the study but they were not treated in the naive treatment phase|79
1083556|NCT00997204|2625217|P1|STARTED|Naive Treatment Phase||25
1083557|NCT00997243|2625228|P1|NOT COMPLETED|Overall Study||7
1083558|NCT00997243|2625228|P1|COMPLETED|Overall Study||0
1083559|NCT00997243|2625228|P1|STARTED|Overall Study||7
1083560|NCT00997321|2625240|P2|NOT COMPLETED|Overall Study||3
1083561|NCT00997321|2625241|P1|NOT COMPLETED|Overall Study||0
1083562|NCT00997321|2625240|P2|COMPLETED|Overall Study||47
1083563|NCT00997321|2625241|P1|COMPLETED|Overall Study||50
1083564|NCT00997321|2625240|P2|STARTED|Overall Study||50
1083565|NCT00997321|2625241|P1|STARTED|Overall Study||50
1083566|NCT00997334|2625253|P1|NOT COMPLETED|Overall Study||25
1083567|NCT00997334|2625253|P1|COMPLETED|Overall Study||35
1083568|NCT00997334|2625253|P1|Evaluable|Overall Study|Patients with tissue available for re-biopsy at time of progression|35
1083569|NCT00997334|2625253|P1|Eligible for Repeat Biopsy|Overall Study|Patients who experience disease progression on treatment were eligible for repeat biopsy|44
1083570|NCT00997334|2625253|P1|STARTED|Overall Study||60
1083571|NCT00997373|2625262|P2|NOT COMPLETED|Overall Study||0
1083572|NCT00997373|2625263|P1|NOT COMPLETED|Overall Study||15
1083573|NCT00997373|2625262|P2|COMPLETED|Overall Study||15
1083574|NCT00997373|2625263|P1|COMPLETED|Overall Study||13
1083575|NCT00997373|2625262|P2|Completed Hysterectomy|Overall Study||15
1083576|NCT00997373|2625263|P1|Completed Hysterectomy|Overall Study||17
1083577|NCT00997373|2625262|P2|Received Letrozole|Overall Study||0
1083578|NCT00997373|2625263|P1|Received Letrozole|Overall Study||23
1083579|NCT00997373|2625262|P2|STARTED|Overall Study||15
1083580|NCT00997373|2625263|P1|STARTED|Overall Study||28
1083581|NCT00997425|2625269|P1|NOT COMPLETED|Overall Study||0
1083582|NCT00997425|2625269|P1|COMPLETED|Overall Study||19
1083583|NCT00997425|2625269|P1|STARTED|Overall Study||19
1083584|NCT00997438|2625277|P3|NOT COMPLETED|Overall Study||4
1083585|NCT00997438|2625278|P2|NOT COMPLETED|Overall Study||3
1083586|NCT00997438|2625279|P1|NOT COMPLETED|Overall Study||5
1083587|NCT00997438|2625277|P3|COMPLETED|Overall Study||20
1083588|NCT00997438|2625278|P2|COMPLETED|Overall Study||21
1083589|NCT00997438|2625279|P1|COMPLETED|Overall Study||16
1083590|NCT00997438|2625277|P3|STARTED|Overall Study||24
1083591|NCT00997438|2625278|P2|STARTED|Overall Study||24
1083592|NCT00997438|2625279|P1|STARTED|Overall Study||21
1083593|NCT00997503|2625314|P1|NOT COMPLETED|Overall Study||273
1083594|NCT00997503|2625314|P1|COMPLETED|Overall Study||3926
1083595|NCT00997503|2625314|P1|12 Months|Overall Study|4059 subjects evaluable at 12-months (cardiac death/MI within 365 days or completed follow-up)|4059
1083596|NCT00997503|2625314|P1|STARTED|Overall Study||4199
1083597|NCT00997516|2625356|P2|NOT COMPLETED|Long-term Follow-up (After 6 Months)||2
1083598|NCT00997516|2625357|P1|NOT COMPLETED|Long-term Follow-up (After 6 Months)||6
1083599|NCT00997516|2625356|P2|COMPLETED|Long-term Follow-up (After 6 Months)||36
1083600|NCT00997516|2625357|P1|COMPLETED|Long-term Follow-up (After 6 Months)||31
1083601|NCT00997516|2625356|P2|STARTED|Long-term Follow-up (After 6 Months)||38
1083602|NCT00997516|2625357|P1|STARTED|Long-term Follow-up (After 6 Months)||37
1083603|NCT00997516|2625356|P2|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
1083604|NCT00997516|2625357|P1|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
1083605|NCT00997516|2625356|P2|COMPLETED|Short-term Follow-up (Post Operative)||38
1083606|NCT00997516|2625357|P1|COMPLETED|Short-term Follow-up (Post Operative)||37
1083607|NCT00997516|2625356|P2|STARTED|Short-term Follow-up (Post Operative)||38
1083608|NCT00997516|2625357|P1|STARTED|Short-term Follow-up (Post Operative)||37
1083609|NCT00997555|2625387|P2|NOT COMPLETED|Overall Study||0
1083610|NCT00997555|2625388|P1|NOT COMPLETED|Overall Study||0
1083611|NCT00997555|2625387|P2|COMPLETED|Overall Study||15
1083612|NCT00997555|2625388|P1|COMPLETED|Overall Study||13
1083613|NCT00997555|2625387|P2|STARTED|Overall Study||15
1083614|NCT00997555|2625388|P1|STARTED|Overall Study||13
1083615|NCT00997594|2625406|P2|NOT COMPLETED|Overall Study||0
1083616|NCT00997594|2625407|P1|NOT COMPLETED|Overall Study||0
1083617|NCT00997594|2625406|P2|COMPLETED|Overall Study||9
1083618|NCT00997594|2625407|P1|COMPLETED|Overall Study||9
1083619|NCT00997594|2625406|P2|Completion of Ablation Procedure|Overall Study||9
1083620|NCT00997594|2625407|P1|Completion of Ablation Procedure|Overall Study||9
1083621|NCT00997594|2625406|P2|STARTED|Overall Study||9
1083622|NCT00997594|2625407|P1|STARTED|Overall Study||9
1083623|NCT00997672|2625415|P2|NOT COMPLETED|Overall Study||4
1083624|NCT00997672|2625416|P1|NOT COMPLETED|Overall Study||4
1083625|NCT00997672|2625415|P2|COMPLETED|Overall Study||1
1083626|NCT00997672|2625416|P1|COMPLETED|Overall Study||0
1083627|NCT00997672|2625415|P2|STARTED|Overall Study||5
1083628|NCT00997672|2625416|P1|STARTED|Overall Study||4
1083629|NCT00997932|2625422|P1|NOT COMPLETED|Overall Study||2
1083630|NCT00997932|2625422|P1|COMPLETED|Overall Study||27
1083631|NCT00997932|2625422|P1|STARTED|Overall Study||29
1083632|NCT00997984|2625430|P3|NOT COMPLETED|Overall Study||26
1083633|NCT00997984|2625431|P2|NOT COMPLETED|Overall Study||34
1083634|NCT00997984|2625432|P1|NOT COMPLETED|Overall Study||37
1083635|NCT00997984|2625430|P3|COMPLETED|Overall Study||88
1083636|NCT00997984|2625431|P2|COMPLETED|Overall Study||79
1083637|NCT00997984|2625432|P1|COMPLETED|Overall Study||76
1083638|NCT00997984|2625430|P3|STARTED|Overall Study||114
1083639|NCT00997984|2625431|P2|STARTED|Overall Study||113
1083640|NCT00997984|2625432|P1|STARTED|Overall Study||113
1083641|NCT00998023|2625500|P2|NOT COMPLETED|Overall Study||0
1083642|NCT00998023|2625501|P1|NOT COMPLETED|Overall Study||0
1083643|NCT00998023|2625500|P2|COMPLETED|Overall Study||32
1083644|NCT00998023|2625501|P1|COMPLETED|Overall Study||32
1083645|NCT00998023|2625500|P2|STARTED|Overall Study||32
1083646|NCT00998023|2625501|P1|STARTED|Overall Study||32
1083647|NCT00998049|2625509|P1|NOT COMPLETED|Overall Study||0
1083648|NCT00998049|2625509|P1|COMPLETED|Overall Study||39
1083649|NCT00998049|2625509|P1|STARTED|Overall Study||39
1083650|NCT00998205|2625518|P1|NOT COMPLETED|Overall Study||0
1083651|NCT00998205|2625518|P1|COMPLETED|Overall Study||16
1083652|NCT00998205|2625518|P1|STARTED|Overall Study||16
1083653|NCT00998296|2625534|P11|NOT COMPLETED|Overall Study||7
1083654|NCT00998296|2625535|P10|NOT COMPLETED|Overall Study||18
1083655|NCT00998296|2625536|P9|NOT COMPLETED|Overall Study||2
1083656|NCT00998296|2625537|P8|NOT COMPLETED|Overall Study||2
1083657|NCT00998296|2625538|P7|NOT COMPLETED|Overall Study||1
1083658|NCT00998296|2625539|P6|NOT COMPLETED|Overall Study||0
1083659|NCT00998296|2625540|P5|NOT COMPLETED|Overall Study||2
1083660|NCT00998296|2625541|P4|NOT COMPLETED|Overall Study||0
1083661|NCT00998296|2625542|P3|NOT COMPLETED|Overall Study||0
1083662|NCT00998296|2625543|P2|NOT COMPLETED|Overall Study||1
1083663|NCT00998296|2625544|P1|NOT COMPLETED|Overall Study||0
1083664|NCT00998296|2625534|P11|COMPLETED|Overall Study||0
1083665|NCT00998296|2625535|P10|COMPLETED|Overall Study||0
1083666|NCT00998296|2625536|P9|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
1083667|NCT00998296|2625537|P8|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
1083668|NCT00998296|2625538|P7|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
1083669|NCT00998296|2625539|P6|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
1083670|NCT00998296|2625540|P5|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
1083671|NCT00998296|2625541|P4|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
1083672|NCT00998296|2625542|P3|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
1083673|NCT00998296|2625543|P2|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|2
1083674|NCT00998296|2625544|P1|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
1083675|NCT00998296|2625534|P11|STARTED|Overall Study||7
1083676|NCT00998296|2625535|P10|STARTED|Overall Study||18
1083677|NCT00998296|2625536|P9|STARTED|Overall Study||6
1083678|NCT00998296|2625537|P8|STARTED|Overall Study||6
1083679|NCT00998296|2625538|P7|STARTED|Overall Study||7
1083680|NCT00998296|2625539|P6|STARTED|Overall Study||3
1083681|NCT00998296|2625540|P5|STARTED|Overall Study||8
1083682|NCT00998296|2625541|P4|STARTED|Overall Study||3
1083683|NCT00998296|2625542|P3|STARTED|Overall Study||3
1083684|NCT00998296|2625543|P2|STARTED|Overall Study||3
1083685|NCT00998296|2625544|P1|STARTED|Overall Study||6
1083686|NCT00998309|2625611|P1|NOT COMPLETED|Overall Study||4
1083687|NCT00998309|2625611|P1|COMPLETED|Overall Study||498
1083688|NCT00998309|2625611|P1|STARTED|Overall Study||502
1083689|NCT00998335|2625669|P2|NOT COMPLETED|Randomized Period (Months 3 to 6)||2
1083690|NCT00998335|2625670|P1|NOT COMPLETED|Randomized Period (Months 3 to 6)||0
1083691|NCT00998335|2625669|P2|COMPLETED|Randomized Period (Months 3 to 6)||20
1083692|NCT00998335|2625670|P1|COMPLETED|Randomized Period (Months 3 to 6)||8
1083693|NCT00998335|2625669|P2|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|22
1083694|NCT00998335|2625670|P1|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|8
1083695|NCT00998335|2625669|P2|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
1083696|NCT00998335|2625670|P1|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
1083697|NCT00998335|2625669|P2|COMPLETED|Initial Treatment (Months 0 - 3)||0
1083698|NCT00998335|2625670|P1|COMPLETED|Initial Treatment (Months 0 - 3)||30
1083699|NCT00998335|2625669|P2|STARTED|Initial Treatment (Months 0 - 3)||0
1083700|NCT00998335|2625670|P1|STARTED|Initial Treatment (Months 0 - 3)||30
1083701|NCT00998374|2625700|P2|NOT COMPLETED|Overall Study||11
1083702|NCT00998374|2625701|P1|NOT COMPLETED|Overall Study||12
1083703|NCT00998374|2625700|P2|COMPLETED|Overall Study||12
1083704|NCT00998374|2625701|P1|COMPLETED|Overall Study||27
1083705|NCT00998374|2625700|P2|STARTED|Overall Study||23
1083706|NCT00998374|2625701|P1|STARTED|Overall Study||39
1083707|NCT00998426|2625713|P1|NOT COMPLETED|Overall Study||0
1083708|NCT00998426|2625713|P1|COMPLETED|Overall Study||5
1083709|NCT00998426|2625713|P1|Blood Glucose Monitoring|Overall Study||5
1083710|NCT00998426|2625713|P1|STARTED|Overall Study||5
1083711|NCT00998517|2625721|P3|NOT COMPLETED|Overall Study||0
1083712|NCT00998517|2625722|P2|NOT COMPLETED|Overall Study||0
1083713|NCT00998517|2625723|P1|NOT COMPLETED|Overall Study||0
1083714|NCT00998517|2625721|P3|COMPLETED|Overall Study||918
1083715|NCT00998517|2625722|P2|COMPLETED|Overall Study||906
1083716|NCT00998517|2625723|P1|COMPLETED|Overall Study||888
1083717|NCT00998517|2625721|P3|STARTED|Overall Study||918
1083718|NCT00998517|2625722|P2|STARTED|Overall Study||906
1083719|NCT00998517|2625723|P1|STARTED|Overall Study||888
1083720|NCT00998582|2625751|P2|NOT COMPLETED|Overall Study||0
1083721|NCT00998582|2625752|P1|NOT COMPLETED|Overall Study||0
1083722|NCT00998582|2625751|P2|COMPLETED|Overall Study||14
1083723|NCT00998582|2625752|P1|COMPLETED|Overall Study||13
1083724|NCT00998582|2625751|P2|STARTED|Overall Study||14
1083725|NCT00998582|2625752|P1|STARTED|Overall Study||13
1083726|NCT00998660|2625763|P1|NOT COMPLETED|Overall Study||13
1083727|NCT00998660|2625763|P1|COMPLETED|Overall Study|87 subjects reached the final study visit at Month 6.|87
1083728|NCT00998660|2625763|P1|Month 3 Visit|Overall Study||87
1083729|NCT00998660|2625763|P1|Implanted|Overall Study||93
1083730|NCT00998660|2625763|P1|STARTED|Overall Study||100
1083731|NCT00998738|2625767|P1|NOT COMPLETED|Overall Study||1
1083732|NCT00998738|2625767|P1|COMPLETED|Overall Study||0
1083733|NCT00998738|2625767|P1|STARTED|Overall Study||1
1083734|NCT00998764|2625781|P2|NOT COMPLETED|Overall Study||274
1083735|NCT00998764|2625782|P1|NOT COMPLETED|Overall Study||216
1083736|NCT00998764|2625781|P2|COMPLETED|Overall Study||2
1083737|NCT00998764|2625782|P1|COMPLETED|Overall Study||0
1083738|NCT00998764|2625781|P2|Treated|Overall Study||275
1083739|NCT00998764|2625782|P1|Treated|Overall Study||215
1083740|NCT00998764|2625781|P2|STARTED|Overall Study||276
1083741|NCT00998764|2625782|P1|STARTED|Overall Study||216
1083742|NCT00998868|2625804|P1|NOT COMPLETED|Overall Study||0
1083743|NCT00998868|2625804|P1|COMPLETED|Overall Study||51
1083744|NCT00998868|2625804|P1|STARTED|Overall Study|>=10 for each muscle strength per MRC scale, after excluding the cases following exclusion criteria|51
1083745|NCT00998881|2625813|P2|NOT COMPLETED|Overall Study||2
1083746|NCT00998881|2625814|P1|NOT COMPLETED|Overall Study||8
1083747|NCT00998881|2625813|P2|COMPLETED|Overall Study||97
1083748|NCT00998881|2625814|P1|COMPLETED|Overall Study||96
1083749|NCT00998881|2625813|P2|STARTED|Overall Study||99
1083750|NCT00998881|2625814|P1|STARTED|Overall Study||104
1083751|NCT00998985|2625840|P14|NOT COMPLETED|Overall Study||0
1083752|NCT00998985|2625841|P13|NOT COMPLETED|Overall Study||0
1083753|NCT00998985|2625842|P12|NOT COMPLETED|Overall Study||0
1083754|NCT00998985|2625843|P11|NOT COMPLETED|Overall Study||0
1083755|NCT00998985|2625844|P10|NOT COMPLETED|Overall Study||0
1083756|NCT00998985|2625845|P9|NOT COMPLETED|Overall Study||1
1083757|NCT00998985|2625846|P8|NOT COMPLETED|Overall Study||0
1083758|NCT00998985|2625847|P7|NOT COMPLETED|Overall Study||0
1083759|NCT00998985|2625848|P6|NOT COMPLETED|Overall Study||1
1083760|NCT00998985|2625849|P5|NOT COMPLETED|Overall Study||0
1083761|NCT00998985|2625850|P4|NOT COMPLETED|Overall Study||0
1083762|NCT00998985|2625851|P3|NOT COMPLETED|Overall Study||0
1083763|NCT00998985|2625852|P2|NOT COMPLETED|Overall Study||0
1083764|NCT00998985|2625853|P1|NOT COMPLETED|Overall Study||0
1083765|NCT00998985|2625840|P14|COMPLETED|Overall Study||15
1083766|NCT00998985|2625841|P13|COMPLETED|Overall Study||5
1083767|NCT00998985|2625842|P12|COMPLETED|Overall Study||5
1083768|NCT00998985|2625843|P11|COMPLETED|Overall Study||5
1083769|NCT00998985|2625844|P10|COMPLETED|Overall Study||5
1083770|NCT00998985|2625845|P9|COMPLETED|Overall Study||5
1083771|NCT00998985|2625846|P8|COMPLETED|Overall Study||5
1083772|NCT00998985|2625847|P7|COMPLETED|Overall Study||5
1083773|NCT00998985|2625848|P6|COMPLETED|Overall Study||4
1083774|NCT00998985|2625849|P5|COMPLETED|Overall Study||5
1083775|NCT00998985|2625850|P4|COMPLETED|Overall Study||5
1083776|NCT00998985|2625851|P3|COMPLETED|Overall Study||15
1083777|NCT00998985|2625852|P2|COMPLETED|Overall Study||5
1083778|NCT00998985|2625853|P1|COMPLETED|Overall Study||5
1083779|NCT00998985|2625840|P14|STARTED|Overall Study||15
1083780|NCT00998985|2625841|P13|STARTED|Overall Study||5
1083781|NCT00998985|2625842|P12|STARTED|Overall Study||5
1083782|NCT00998985|2625843|P11|STARTED|Overall Study||5
1083783|NCT00998985|2625844|P10|STARTED|Overall Study||5
1083784|NCT00998985|2625845|P9|STARTED|Overall Study||6
1083785|NCT00998985|2625846|P8|STARTED|Overall Study||5
1083786|NCT00998985|2625847|P7|STARTED|Overall Study||5
1083787|NCT00998985|2625848|P6|STARTED|Overall Study||5
1083788|NCT00998985|2625849|P5|STARTED|Overall Study||5
1083789|NCT00998985|2625850|P4|STARTED|Overall Study||5
1083790|NCT00998985|2625851|P3|STARTED|Overall Study||15
1083791|NCT00998985|2625852|P2|STARTED|Overall Study||5
1083792|NCT00998985|2625853|P1|STARTED|Overall Study||5
1083793|NCT00999037|2625921|P2|NOT COMPLETED|Overall Study||0
1083794|NCT00999037|2625922|P1|NOT COMPLETED|Overall Study||0
1083795|NCT00999037|2625921|P2|COMPLETED|Overall Study||9
1083796|NCT00999037|2625922|P1|COMPLETED|Overall Study||9
1083797|NCT00999037|2625921|P2|STARTED|Overall Study|20|9
1083798|NCT00999037|2625922|P1|STARTED|Overall Study||9
1083799|NCT00999141|2625932|P1|NOT COMPLETED|Overall Study||0
1083800|NCT00999141|2625932|P1|COMPLETED|Overall Study||75
1083801|NCT00999141|2625932|P1|STARTED|Overall Study|Randomized and treated|75
1083802|NCT00999167|2626016|P3|NOT COMPLETED|Part B: Randomized, Placebo Controlled||21
1083803|NCT00999167|2626017|P2|NOT COMPLETED|Part B: Randomized, Placebo Controlled||35
1083804|NCT00999167|2626018|P1|NOT COMPLETED|Part B: Randomized, Placebo Controlled||0
1083805|NCT00999167|2626016|P3|COMPLETED|Part B: Randomized, Placebo Controlled||67
1083806|NCT00999167|2626017|P2|COMPLETED|Part B: Randomized, Placebo Controlled||55
1083807|NCT00999167|2626018|P1|COMPLETED|Part B: Randomized, Placebo Controlled||0
1083808|NCT00999167|2626016|P3|STARTED|Part B: Randomized, Placebo Controlled||88
1083809|NCT00999167|2626017|P2|STARTED|Part B: Randomized, Placebo Controlled|4 subjects who participated in Part A enrolled in Part B and remainder were newly enrolled|90
1083810|NCT00999167|2626018|P1|STARTED|Part B: Randomized, Placebo Controlled||0
1083811|NCT00999167|2626016|P3|NOT COMPLETED|Part A: Open Label Safety run-in||0
1083812|NCT00999167|2626017|P2|NOT COMPLETED|Part A: Open Label Safety run-in||0
1083813|NCT00999167|2626018|P1|NOT COMPLETED|Part A: Open Label Safety run-in||7
1083814|NCT00999167|2626016|P3|COMPLETED|Part A: Open Label Safety run-in||0
1083815|NCT00999167|2626017|P2|COMPLETED|Part A: Open Label Safety run-in||0
1083816|NCT00999167|2626018|P1|COMPLETED|Part A: Open Label Safety run-in||8
1083817|NCT00999167|2626016|P3|Received 9 mL BID|Part A: Open Label Safety run-in||0
1083818|NCT00999167|2626017|P2|Received 9 mL BID|Part A: Open Label Safety run-in||0
1083819|NCT00999167|2626018|P1|Received 9 mL BID|Part A: Open Label Safety run-in||15
1083820|NCT00999167|2626016|P3|STARTED|Part A: Open Label Safety run-in||0
1083821|NCT00999167|2626017|P2|STARTED|Part A: Open Label Safety run-in||0
1083822|NCT00999167|2626018|P1|STARTED|Part A: Open Label Safety run-in||15
1083823|NCT00985829|2626032|P1|NOT COMPLETED|Overall Study||0
1083824|NCT00985829|2626032|P1|COMPLETED|Overall Study||28
1083825|NCT00985829|2626032|P1|STARTED|Overall Study||28
1083826|NCT00991276|2626047|P6|NOT COMPLETED|Third Intervention Period||1
1083827|NCT00991276|2626048|P5|NOT COMPLETED|Third Intervention Period||0
1083828|NCT00991276|2626049|P4|NOT COMPLETED|Third Intervention Period||1
1083829|NCT00991276|2626050|P3|NOT COMPLETED|Third Intervention Period||1
1083830|NCT00991276|2626051|P2|NOT COMPLETED|Third Intervention Period||0
1083831|NCT00991276|2626052|P1|NOT COMPLETED|Third Intervention Period||1
1083832|NCT00991276|2626047|P6|COMPLETED|Third Intervention Period||10
1083833|NCT00991276|2626048|P5|COMPLETED|Third Intervention Period||10
1083834|NCT00991276|2626049|P4|COMPLETED|Third Intervention Period||8
1083835|NCT00991276|2626050|P3|COMPLETED|Third Intervention Period||13
1083836|NCT00991276|2626051|P2|COMPLETED|Third Intervention Period||8
1083837|NCT00991276|2626052|P1|COMPLETED|Third Intervention Period||13
1083838|NCT00991276|2626047|P6|STARTED|Third Intervention Period||11
1083839|NCT00991276|2626048|P5|STARTED|Third Intervention Period||10
1083840|NCT00991276|2626049|P4|STARTED|Third Intervention Period||9
1083841|NCT00991276|2626050|P3|STARTED|Third Intervention Period||14
1083842|NCT00991276|2626051|P2|STARTED|Third Intervention Period||8
1083843|NCT00991276|2626052|P1|STARTED|Third Intervention Period||14
1083844|NCT00991276|2626047|P6|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
1083845|NCT00991276|2626048|P5|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
1083846|NCT00991276|2626049|P4|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
1083847|NCT00991276|2626050|P3|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
1083848|NCT00991276|2626051|P2|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
1083849|NCT00991276|2626052|P1|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
1083850|NCT00991276|2626047|P6|COMPLETED|Placebo Wash-out Period (7 Days)||11
1083851|NCT00991276|2626048|P5|COMPLETED|Placebo Wash-out Period (7 Days)||10
1083852|NCT00991276|2626049|P4|COMPLETED|Placebo Wash-out Period (7 Days)||9
1083853|NCT00991276|2626050|P3|COMPLETED|Placebo Wash-out Period (7 Days)||14
1083854|NCT00991276|2626051|P2|COMPLETED|Placebo Wash-out Period (7 Days)||8
1083855|NCT00991276|2626052|P1|COMPLETED|Placebo Wash-out Period (7 Days)||14
1083856|NCT00991276|2626047|P6|STARTED|Placebo Wash-out Period (7 Days)||11
1083857|NCT00991276|2626048|P5|STARTED|Placebo Wash-out Period (7 Days)||10
1083858|NCT00991276|2626049|P4|STARTED|Placebo Wash-out Period (7 Days)||9
1083859|NCT00991276|2626050|P3|STARTED|Placebo Wash-out Period (7 Days)||14
1083860|NCT00991276|2626051|P2|STARTED|Placebo Wash-out Period (7 Days)||8
1083861|NCT00991276|2626052|P1|STARTED|Placebo Wash-out Period (7 Days)||14
1083862|NCT00991276|2626047|P6|NOT COMPLETED|Second Intervention Period||1
1083863|NCT00991276|2626048|P5|NOT COMPLETED|Second Intervention Period||1
1083864|NCT00991276|2626049|P4|NOT COMPLETED|Second Intervention Period||2
1083865|NCT00991276|2626050|P3|NOT COMPLETED|Second Intervention Period||0
1083866|NCT00991276|2626051|P2|NOT COMPLETED|Second Intervention Period||2
1083867|NCT00991276|2626052|P1|NOT COMPLETED|Second Intervention Period||1
1083868|NCT00991276|2626047|P6|COMPLETED|Second Intervention Period||11
1083869|NCT00991276|2626048|P5|COMPLETED|Second Intervention Period||10
1083870|NCT00991276|2626049|P4|COMPLETED|Second Intervention Period||9
1083871|NCT00991276|2626050|P3|COMPLETED|Second Intervention Period||14
1083872|NCT00991276|2626051|P2|COMPLETED|Second Intervention Period||8
1083873|NCT00991276|2626052|P1|COMPLETED|Second Intervention Period||14
1083874|NCT00991276|2626047|P6|STARTED|Second Intervention Period||12
1083875|NCT00991276|2626048|P5|STARTED|Second Intervention Period||11
1083876|NCT00991276|2626049|P4|STARTED|Second Intervention Period||11
1083877|NCT00991276|2626050|P3|STARTED|Second Intervention Period||14
1083878|NCT00991276|2626051|P2|STARTED|Second Intervention Period||10
1083879|NCT00991276|2626052|P1|STARTED|Second Intervention Period||15
1083880|NCT00991276|2626047|P6|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
1083881|NCT00991276|2626048|P5|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
1083882|NCT00991276|2626049|P4|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
1083883|NCT00991276|2626050|P3|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
1083884|NCT00991276|2626051|P2|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
1083885|NCT00991276|2626052|P1|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
1083886|NCT00991276|2626047|P6|COMPLETED|Placebo Wash-out Period (7 Days)||12
1083887|NCT00991276|2626048|P5|COMPLETED|Placebo Wash-out Period (7 Days)||11
1083888|NCT00991276|2626049|P4|COMPLETED|Placebo Wash-out Period (7 Days)||11
1083889|NCT00991276|2626050|P3|COMPLETED|Placebo Wash-out Period (7 Days)||14
1083890|NCT00991276|2626051|P2|COMPLETED|Placebo Wash-out Period (7 Days)||10
1083891|NCT00991276|2626052|P1|COMPLETED|Placebo Wash-out Period (7 Days)||15
1083892|NCT00991276|2626047|P6|STARTED|Placebo Wash-out Period (7 Days)||12
1083893|NCT00991276|2626048|P5|STARTED|Placebo Wash-out Period (7 Days)||11
1083894|NCT00991276|2626049|P4|STARTED|Placebo Wash-out Period (7 Days)||11
1083895|NCT00991276|2626050|P3|STARTED|Placebo Wash-out Period (7 Days)||14
1083896|NCT00991276|2626051|P2|STARTED|Placebo Wash-out Period (7 Days)||10
1083897|NCT00991276|2626052|P1|STARTED|Placebo Wash-out Period (7 Days)||15
1083898|NCT00991276|2626047|P6|NOT COMPLETED|First Intervention Period||1
1083899|NCT00991276|2626048|P5|NOT COMPLETED|First Intervention Period||4
1083900|NCT00991276|2626049|P4|NOT COMPLETED|First Intervention Period||4
1083901|NCT00991276|2626050|P3|NOT COMPLETED|First Intervention Period||0
1083902|NCT00991276|2626051|P2|NOT COMPLETED|First Intervention Period||3
1083903|NCT00991276|2626052|P1|NOT COMPLETED|First Intervention Period||0
1083904|NCT00991276|2626047|P6|COMPLETED|First Intervention Period||12
1083905|NCT00991276|2626048|P5|COMPLETED|First Intervention Period||11
1083906|NCT00991276|2626049|P4|COMPLETED|First Intervention Period||11
1083907|NCT00991276|2626050|P3|COMPLETED|First Intervention Period||14
1083908|NCT00991276|2626051|P2|COMPLETED|First Intervention Period||10
1083909|NCT00991276|2626052|P1|COMPLETED|First Intervention Period||15
1083910|NCT00991276|2626047|P6|STARTED|First Intervention Period||13
1083911|NCT00991276|2626048|P5|STARTED|First Intervention Period||15
1083912|NCT00991276|2626049|P4|STARTED|First Intervention Period||15
1083913|NCT00991276|2626050|P3|STARTED|First Intervention Period||14
1083914|NCT00991276|2626051|P2|STARTED|First Intervention Period||13
1083915|NCT00991276|2626052|P1|STARTED|First Intervention Period||15
1083916|NCT00991289|2626150|P1|NOT COMPLETED|Overall Study||12
1083917|NCT00991289|2626150|P1|COMPLETED|Overall Study|Completed study.|55
1083918|NCT00991289|2626150|P1|COMPLETED Week 16|Overall Study|Completed 16 weeks of the study (the primary endpoint time point). The study continued to Week 76.|61
1083919|NCT00991289|2626150|P1|STARTED|Overall Study|68 participants enrolled, one was found to have been ineligible and was excluded.|67
1083920|NCT00991302|2626166|P2|NOT COMPLETED|Overall Study||13
1083921|NCT00991302|2626167|P1|NOT COMPLETED|Overall Study||14
1083922|NCT00991302|2626166|P2|COMPLETED|Overall Study||73
1083923|NCT00991302|2626167|P1|COMPLETED|Overall Study||72
1083924|NCT00991302|2626166|P2|STARTED|Overall Study||86
1083925|NCT00991302|2626167|P1|STARTED|Overall Study||86
1083926|NCT00991341|2626185|P2|NOT COMPLETED|Overall Study||179
1083927|NCT00991341|2626186|P1|NOT COMPLETED|Overall Study||204
1083928|NCT00991341|2626185|P2|COMPLETED|Overall Study||560
1083929|NCT00991341|2626186|P1|COMPLETED|Overall Study||538
1083930|NCT00991341|2626185|P2|STARTED|Overall Study||739
1083931|NCT00991341|2626186|P1|STARTED|Overall Study||742
1083932|NCT00991458|2626225|P3|NOT COMPLETED|Overall Study||25
1083933|NCT00991458|2626226|P2|NOT COMPLETED|Overall Study||28
1083934|NCT00991458|2626227|P1|NOT COMPLETED|Overall Study||20
1083935|NCT00991458|2626225|P3|COMPLETED|Overall Study||180
1083936|NCT00991458|2626226|P2|COMPLETED|Overall Study||181
1083937|NCT00991458|2626227|P1|COMPLETED|Overall Study||187
1083938|NCT00991458|2626225|P3|STARTED|Overall Study||205
1083939|NCT00991458|2626226|P2|STARTED|Overall Study||209
1083940|NCT00991458|2626227|P1|STARTED|Overall Study||207
1083941|NCT00991510|2626246|P2|NOT COMPLETED|Period III (Days 29-112)||1
1083942|NCT00991510|2626247|P1|NOT COMPLETED|Period III (Days 29-112)||1
1083943|NCT00991510|2626246|P2|COMPLETED|Period III (Days 29-112)||20
1083944|NCT00991510|2626247|P1|COMPLETED|Period III (Days 29-112)||20
1083945|NCT00991510|2626246|P2|STARTED|Period III (Days 29-112)||21
1083946|NCT00991510|2626247|P1|STARTED|Period III (Days 29-112)||21
1083947|NCT00991510|2626246|P2|NOT COMPLETED|Period II (Days 15-28)||0
1083948|NCT00991510|2626247|P1|NOT COMPLETED|Period II (Days 15-28)||0
1083949|NCT00991510|2626246|P2|COMPLETED|Period II (Days 15-28)||21
1083950|NCT00991510|2626247|P1|COMPLETED|Period II (Days 15-28)||21
1083951|NCT00991510|2626246|P2|STARTED|Period II (Days 15-28)||21
1083952|NCT00991510|2626247|P1|STARTED|Period II (Days 15-28)||21
1083953|NCT00991510|2626246|P2|NOT COMPLETED|Period I (Days 1-14)||0
1083954|NCT00991510|2626247|P1|NOT COMPLETED|Period I (Days 1-14)||1
1083955|NCT00991510|2626246|P2|COMPLETED|Period I (Days 1-14)||21
1083956|NCT00991510|2626247|P1|COMPLETED|Period I (Days 1-14)||21
1083957|NCT00991510|2626246|P2|STARTED|Period I (Days 1-14)||21
1083958|NCT00991510|2626247|P1|STARTED|Period I (Days 1-14)||22
1083959|NCT00999466|2626272|P3|NOT COMPLETED|Main Part||4
1083960|NCT00999466|2626273|P2|NOT COMPLETED|Main Part||4
1083961|NCT00999466|2626274|P1|NOT COMPLETED|Main Part||0
1083962|NCT00999466|2626272|P3|COMPLETED|Main Part||21
1083963|NCT00999466|2626273|P2|COMPLETED|Main Part||22
1083964|NCT00999466|2626274|P1|COMPLETED|Main Part||0
1083965|NCT00999466|2626272|P3|STARTED|Main Part||25
1083966|NCT00999466|2626273|P2|STARTED|Main Part||26
1083967|NCT00999466|2626274|P1|STARTED|Main Part|AZD8848 nasal spray 30 μg group was not participated in the Main part|0
1083968|NCT00999466|2626272|P3|NOT COMPLETED|Pilot Part||0
1083969|NCT00999466|2626273|P2|NOT COMPLETED|Pilot Part||0
1083970|NCT00999466|2626274|P1|NOT COMPLETED|Pilot Part||0
1083971|NCT00999466|2626272|P3|COMPLETED|Pilot Part||3
1083972|NCT00999466|2626273|P2|COMPLETED|Pilot Part||0
1083973|NCT00999466|2626274|P1|COMPLETED|Pilot Part||6
1083974|NCT00999466|2626272|P3|STARTED|Pilot Part||3
1083975|NCT00999466|2626273|P2|STARTED|Pilot Part|AZD8848 nasal spray 60 μg group was not participated in the Pilot part|0
1083976|NCT00999466|2626274|P1|STARTED|Pilot Part||6
1083977|NCT00999544|2626549|P1|NOT COMPLETED|Overall Study||1
1083978|NCT00999544|2626549|P1|COMPLETED|Overall Study||8
1083979|NCT00999544|2626549|P1|STARTED|Overall Study||9
1083980|NCT00999596|2626582|P1|NOT COMPLETED|Overall Study||101
1083981|NCT00999596|2626582|P1|COMPLETED|Overall Study|Not all patient images were used for the reader evaluation based on new FDA Guidelines|6
1083982|NCT00999596|2626582|P1|New FDA Guideline Released|Overall Study|FDA Guidance: Class II Special Controls Guidance Document: Full-Field Digital Mammography System|6
1083983|NCT00999596|2626582|P1|STARTED|Overall Study||107
1083984|NCT01000610|2626587|P1|NOT COMPLETED|Overall Study||6
1083985|NCT01000610|2626587|P1|COMPLETED|Overall Study||12
1083986|NCT01000610|2626587|P1|STARTED|Overall Study||18
1083987|NCT01000649|2626598|P4|NOT COMPLETED|Overall Study||6
1083988|NCT01000649|2626599|P3|NOT COMPLETED|Overall Study||2
1083989|NCT01000649|2626600|P2|NOT COMPLETED|Overall Study||3
1083990|NCT01000649|2626601|P1|NOT COMPLETED|Overall Study||5
1083991|NCT01000649|2626598|P4|COMPLETED|Overall Study||15
1083992|NCT01000649|2626599|P3|COMPLETED|Overall Study||0
1083993|NCT01000649|2626600|P2|COMPLETED|Overall Study||16
1083994|NCT01000649|2626601|P1|COMPLETED|Overall Study||5
1083995|NCT01000649|2626598|P4|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|21
1083996|NCT01000649|2626599|P3|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|2
1083997|NCT01000649|2626600|P2|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|20
1083998|NCT01000649|2626601|P1|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|10
1083999|NCT01000649|2626598|P4|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|21
1084000|NCT01000649|2626599|P3|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|2
1084001|NCT01000649|2626600|P2|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|19
1084002|NCT01000649|2626601|P1|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|10
1084003|NCT01000662|2626684|P2|NOT COMPLETED|Overall Study||8
1084004|NCT01000662|2626685|P1|NOT COMPLETED|Overall Study||4
1084005|NCT01000662|2626684|P2|COMPLETED|Overall Study||198
1084006|NCT01000662|2626685|P1|COMPLETED|Overall Study||202
1084007|NCT01000662|2626684|P2|STARTED|Overall Study||206
1084008|NCT01000662|2626685|P1|STARTED|Overall Study||206
1084009|NCT01000727|2626693|P2|NOT COMPLETED|Overall Study||176
1084010|NCT01000727|2626694|P1|NOT COMPLETED|Overall Study||175
1084011|NCT01000727|2626693|P2|COMPLETED|Overall Study||6328
1084012|NCT01000727|2626694|P1|COMPLETED|Overall Study||6347
1084013|NCT01000727|2626693|P2|STARTED|Overall Study||6504
1084014|NCT01000727|2626694|P1|STARTED|Overall Study||6522
1084015|NCT01000805|2626724|P2|NOT COMPLETED|Overall Study||62
1084016|NCT01000805|2626725|P1|NOT COMPLETED|Overall Study||70
1084017|NCT01000805|2626724|P2|COMPLETED|Overall Study||204
1084018|NCT01000805|2626725|P1|COMPLETED|Overall Study||192
1084019|NCT01000805|2626724|P2|STARTED|Overall Study||266
1084020|NCT01000805|2626725|P1|STARTED|Overall Study||262
1084021|NCT01000818|2626757|P1|NOT COMPLETED|Omeprazole + Raltegravir||0
1084022|NCT01000818|2626757|P1|COMPLETED|Omeprazole + Raltegravir||18
1084023|NCT01000818|2626757|P1|STARTED|Omeprazole + Raltegravir||18
1084024|NCT01000818|2626757|P1|NOT COMPLETED|Famotidine + Raltegravir||0
1084025|NCT01000818|2626757|P1|COMPLETED|Famotidine + Raltegravir||18
1084026|NCT01000818|2626757|P1|STARTED|Famotidine + Raltegravir||18
1084027|NCT01000818|2626757|P1|NOT COMPLETED|Raltegravir||0
1084028|NCT01000818|2626757|P1|COMPLETED|Raltegravir||18
1084029|NCT01000818|2626757|P1|STARTED|Raltegravir||18
1084030|NCT01000961|2626766|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
1084031|NCT01000961|2626767|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
1084032|NCT01000961|2626766|P2|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|20
1084033|NCT01000961|2626767|P1|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|21
1084034|NCT01000961|2626766|P2|STARTED|Second Intervention (3 Weeks)||20
1084035|NCT01000961|2626767|P1|STARTED|Second Intervention (3 Weeks)||21
1084036|NCT01000961|2626766|P2|NOT COMPLETED|First Intervention (3 Weeks)||2
1084037|NCT01000961|2626767|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
1084038|NCT01000961|2626766|P2|COMPLETED|First Intervention (3 Weeks)||20
1084039|NCT01000961|2626767|P1|COMPLETED|First Intervention (3 Weeks)||21
1084040|NCT01000961|2626766|P2|STARTED|First Intervention (3 Weeks)||22
1084041|NCT01000961|2626767|P1|STARTED|First Intervention (3 Weeks)||21
1084042|NCT01000961|2626766|P2|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
1084043|NCT01000961|2626767|P1|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
1084044|NCT01000961|2626766|P2|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||22
1084045|NCT01000961|2626767|P1|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||21
1084046|NCT01000961|2626766|P2|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|22
1084047|NCT01000961|2626767|P1|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|21
1084048|NCT01000974|2626782|P3|NOT COMPLETED|Booster Vaccination Phase||14
1084049|NCT01000974|2626783|P2|NOT COMPLETED|Booster Vaccination Phase||12
1084050|NCT01000974|2626784|P1|NOT COMPLETED|Booster Vaccination Phase||67
1084051|NCT01000974|2626782|P3|COMPLETED|Booster Vaccination Phase||386
1084052|NCT01000974|2626783|P2|COMPLETED|Booster Vaccination Phase||423
1084053|NCT01000974|2626784|P1|COMPLETED|Booster Vaccination Phase||2270
1084054|NCT01000974|2626782|P3|STARTED|Booster Vaccination Phase||400
1084055|NCT01000974|2626783|P2|STARTED|Booster Vaccination Phase||435
1084056|NCT01000974|2626784|P1|STARTED|Booster Vaccination Phase||2337
1084057|NCT01000974|2626782|P3|NOT COMPLETED|Primary Vaccination Phase||63
1084058|NCT01000974|2626783|P2|NOT COMPLETED|Primary Vaccination Phase||50
1084059|NCT01000974|2626784|P1|NOT COMPLETED|Primary Vaccination Phase||338
1084060|NCT01000974|2626782|P3|COMPLETED|Primary Vaccination Phase||457
1084061|NCT01000974|2626783|P2|COMPLETED|Primary Vaccination Phase||470
1084062|NCT01000974|2626784|P1|COMPLETED|Primary Vaccination Phase||2625
1084063|NCT01000974|2626782|P3|STARTED|Primary Vaccination Phase||520
1084064|NCT01000974|2626783|P2|STARTED|Primary Vaccination Phase||520
1084065|NCT01000974|2626784|P1|STARTED|Primary Vaccination Phase||2963
1084066|NCT01001052|2626891|P2|NOT COMPLETED|Overall Study||0
1084067|NCT01001052|2626892|P1|NOT COMPLETED|Overall Study||0
1084068|NCT01001052|2626891|P2|COMPLETED|Overall Study||18
1084069|NCT01001052|2626892|P1|COMPLETED|Overall Study||20
1084070|NCT01001052|2626891|P2|STARTED|Overall Study||18
1084071|NCT01001052|2626892|P1|STARTED|Overall Study||20
1084072|NCT01001078|2626904|P2|NOT COMPLETED|Overall Study||0
1084073|NCT01001078|2626905|P1|NOT COMPLETED|Overall Study||0
1084074|NCT01001078|2626904|P2|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 2|50
1084075|NCT01001078|2626905|P1|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 5|50
1084076|NCT01001078|2626904|P2|Lost to Followup Interview|Overall Study|Could not be interviewed.|2
1084077|NCT01001078|2626905|P1|Lost to Followup Interview|Overall Study|Could not be interviewed.|5
1084078|NCT01001078|2626904|P2|Intubated|Overall Study||1
1084079|NCT01001078|2626905|P1|Intubated|Overall Study||2
1084080|NCT01001078|2626904|P2|Received Crossover|Overall Study||3
1084081|NCT01001078|2626905|P1|Received Crossover|Overall Study||2
1084082|NCT01001078|2626904|P2|Received Allocated Intervention|Overall Study||46
1084083|NCT01001078|2626905|P1|Received Allocated Intervention|Overall Study||46
1084084|NCT01001078|2626904|P2|STARTED|Overall Study||50
1084085|NCT01001078|2626905|P1|STARTED|Overall Study||50
1084086|NCT01001104|2626925|P4|NOT COMPLETED|Overall Study||3
1084087|NCT01001104|2626926|P3|NOT COMPLETED|Overall Study||1
1084088|NCT01001104|2626927|P2|NOT COMPLETED|Overall Study||1
1084089|NCT01001104|2626928|P1|NOT COMPLETED|Overall Study||2
1084090|NCT01001104|2626925|P4|COMPLETED|Overall Study||34
1084091|NCT01001104|2626926|P3|COMPLETED|Overall Study||35
1084092|NCT01001104|2626927|P2|COMPLETED|Overall Study||36
1084093|NCT01001104|2626928|P1|COMPLETED|Overall Study||33
1084094|NCT01001104|2626925|P4|STARTED|Overall Study||37
1084095|NCT01001104|2626926|P3|STARTED|Overall Study||36
1084096|NCT01001104|2626927|P2|STARTED|Overall Study||37
1084097|NCT01001104|2626928|P1|STARTED|Overall Study||35
1084098|NCT01001169|2626975|P2|NOT COMPLETED|Overall Study||1
1084099|NCT01001169|2626976|P1|NOT COMPLETED|Overall Study||2
1084100|NCT01001169|2626975|P2|COMPLETED|Overall Study||29
1084101|NCT01001169|2626976|P1|COMPLETED|Overall Study||28
1084102|NCT01001169|2626975|P2|STARTED|Overall Study||30
1084103|NCT01001169|2626976|P1|STARTED|Overall Study||30
1084104|NCT01001195|2627084|P4|NOT COMPLETED|Overall Study||0
1084105|NCT01001195|2627085|P3|NOT COMPLETED|Overall Study||0
1084106|NCT01001195|2627086|P2|NOT COMPLETED|Overall Study||2
1084107|NCT01001195|2627087|P1|NOT COMPLETED|Overall Study||2
1084108|NCT01001195|2627084|P4|COMPLETED|Overall Study||41
1084109|NCT01001195|2627085|P3|COMPLETED|Overall Study||44
1084110|NCT01001195|2627086|P2|COMPLETED|Overall Study||39
1084111|NCT01001195|2627087|P1|COMPLETED|Overall Study||37
1084112|NCT01001195|2627084|P4|STARTED|Overall Study||41
1084113|NCT01001195|2627085|P3|STARTED|Overall Study||44
1084114|NCT01001195|2627086|P2|STARTED|Overall Study||41
1084115|NCT01001195|2627087|P1|STARTED|Overall Study||39
1084116|NCT01001208|2627099|P2|NOT COMPLETED|Overall Study||33
1084117|NCT01001208|2627100|P1|NOT COMPLETED|Overall Study||28
1084118|NCT01001208|2627099|P2|COMPLETED|Overall Study||206
1084119|NCT01001208|2627100|P1|COMPLETED|Overall Study||211
1084120|NCT01001208|2627099|P2|STARTED|Overall Study||239
1084121|NCT01001208|2627100|P1|STARTED|Overall Study||239
1084122|NCT01001221|2627128|P5|NOT COMPLETED|Overall Study||0
1084123|NCT01001221|2627129|P4|NOT COMPLETED|Overall Study||6
1084124|NCT01001221|2627130|P3|NOT COMPLETED|Overall Study||3
1084125|NCT01001221|2627131|P2|NOT COMPLETED|Overall Study||5
1084126|NCT01001221|2627132|P1|NOT COMPLETED|Overall Study||5
1084127|NCT01001221|2627128|P5|COMPLETED|Overall Study||0
1084128|NCT01001221|2627129|P4|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
1084129|NCT01001221|2627130|P3|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
1084130|NCT01001221|2627131|P2|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
1084131|NCT01001221|2627132|P1|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
1084132|NCT01001221|2627128|P5|Completed 1st Treatment Cycle|Overall Study||0
1084133|NCT01001221|2627129|P4|Completed 1st Treatment Cycle|Overall Study||6
1084134|NCT01001221|2627130|P3|Completed 1st Treatment Cycle|Overall Study||2
1084135|NCT01001221|2627131|P2|Completed 1st Treatment Cycle|Overall Study||5
1084136|NCT01001221|2627132|P1|Completed 1st Treatment Cycle|Overall Study||5
1084137|NCT01001221|2627128|P5|Treated|Overall Study||0
1084138|NCT01001221|2627129|P4|Treated|Overall Study||6
1084139|NCT01001221|2627130|P3|Treated|Overall Study||2
1084140|NCT01001221|2627131|P2|Treated|Overall Study||5
1084141|NCT01001221|2627132|P1|Treated|Overall Study||5
1084142|NCT01001221|2627128|P5|STARTED|Overall Study|Inability to determine the MTD during study part 1|0
1084143|NCT01001221|2627129|P4|STARTED|Overall Study||6
1084144|NCT01001221|2627130|P3|STARTED|Overall Study||3
1084145|NCT01001221|2627131|P2|STARTED|Overall Study||5
1084146|NCT01001221|2627132|P1|STARTED|Overall Study||5
1084147|NCT01001234|2627310|P5|NOT COMPLETED|Overall Study||0
1084148|NCT01001234|2627311|P4|NOT COMPLETED|Overall Study||25
1084149|NCT01001234|2627312|P3|NOT COMPLETED|Overall Study||32
1084150|NCT01001234|2627313|P2|NOT COMPLETED|Overall Study||26
1084151|NCT01001234|2627314|P1|NOT COMPLETED|Overall Study||405
1084152|NCT01001234|2627310|P5|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|40
1084153|NCT01001234|2627311|P4|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|385
1084154|NCT01001234|2627312|P3|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|377
1084155|NCT01001234|2627313|P2|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|5
1084156|NCT01001234|2627314|P1|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|87
1084157|NCT01001234|2627310|P5|Participants Not Treated|Overall Study|Participants who did not take study drug|0
1084158|NCT01001234|2627311|P4|Participants Not Treated|Overall Study|Participants who did not take study drug|5
1084159|NCT01001234|2627312|P3|Participants Not Treated|Overall Study|Participants who did not take study drug|9
1084160|NCT01001234|2627313|P2|Participants Not Treated|Overall Study|Participants who did not take study drug|23
1084161|NCT01001234|2627314|P1|Participants Not Treated|Overall Study|Participants who did not take study drug|368
1084162|NCT01001234|2627310|P5|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|40
1084163|NCT01001234|2627311|P4|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|405
1084164|NCT01001234|2627312|P3|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|400
1084165|NCT01001234|2627313|P2|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|8
1084166|NCT01001234|2627314|P1|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|124
1084167|NCT01001234|2627310|P5|STARTED|Overall Study|Participants who were randomized to study drug|40
1084168|NCT01001234|2627311|P4|STARTED|Overall Study|Participants who were randomized to study drug|410
1084169|NCT01001234|2627312|P3|STARTED|Overall Study|Participants who were randomized to study drug|409
1084170|NCT01001234|2627313|P2|STARTED|Overall Study|Participants who were randomized to study drug|31
1084171|NCT01001234|2627314|P1|STARTED|Overall Study|Participants who were randomized to study drug|492
1084172|NCT01001299|2627326|P1|NOT COMPLETED|Overall Study||25
1084173|NCT01001299|2627326|P1|COMPLETED|Overall Study||0
1084174|NCT01001299|2627326|P1|STARTED|Overall Study||25
1084175|NCT01001325|2627352|P2|NOT COMPLETED|Overall Study||10
1084176|NCT01001325|2627353|P1|NOT COMPLETED|Overall Study||18
1084177|NCT01001325|2627352|P2|COMPLETED|Overall Study||224
1084178|NCT01001325|2627353|P1|COMPLETED|Overall Study||216
1084179|NCT01001325|2627352|P2|STARTED|Overall Study||234
1084180|NCT01001325|2627353|P1|STARTED|Overall Study||234
1084181|NCT01001377|2627361|P2|NOT COMPLETED|Overall Study||421
1084182|NCT01001377|2627362|P1|NOT COMPLETED|Overall Study||426
1084183|NCT01001377|2627361|P2|COMPLETED|Overall Study|Indicates participants continuing in study|85
1084184|NCT01001377|2627362|P1|COMPLETED|Overall Study|Indicates participants continuing in study|78
1084185|NCT01001377|2627361|P2|Received Treatment|Overall Study||499
1084186|NCT01001377|2627362|P1|Received Treatment|Overall Study||500
1084187|NCT01001377|2627361|P2|STARTED|Overall Study||506
1084188|NCT01001377|2627362|P1|STARTED|Overall Study||504
1084189|NCT01001390|2627390|P2|NOT COMPLETED|Overall Study||0
1084190|NCT01001390|2627391|P1|NOT COMPLETED|Overall Study||2
1084191|NCT01001390|2627390|P2|COMPLETED|Overall Study||0
1084192|NCT01001390|2627391|P1|COMPLETED|Overall Study||0
1084193|NCT01001390|2627390|P2|STARTED|Overall Study||0
1084194|NCT01001390|2627391|P1|STARTED|Overall Study||2
1084195|NCT01001403|2627399|P2|NOT COMPLETED|Overall Study||0
1084196|NCT01001403|2627400|P1|NOT COMPLETED|Overall Study||0
1084197|NCT01001403|2627399|P2|COMPLETED|Overall Study||31
1084198|NCT01001403|2627400|P1|COMPLETED|Overall Study||31
1084199|NCT01001403|2627399|P2|STARTED|Overall Study||31
1084200|NCT01001403|2627400|P1|STARTED|Overall Study||31
1084201|NCT01001429|2627408|P2|NOT COMPLETED|Overall Study||1
1084202|NCT01001429|2627409|P1|NOT COMPLETED|Overall Study||0
1084203|NCT01001429|2627408|P2|COMPLETED|Overall Study||37
1084204|NCT01001429|2627409|P1|COMPLETED|Overall Study||39
1084205|NCT01001429|2627408|P2|STARTED|Overall Study||38
1084206|NCT01001429|2627409|P1|STARTED|Overall Study||39
1084207|NCT01001494|2627442|P3|NOT COMPLETED|Overall Study||41
1084208|NCT01001494|2627443|P2|NOT COMPLETED|Overall Study||17
1084209|NCT01001494|2627444|P1|NOT COMPLETED|Overall Study||24
1084210|NCT01001494|2627442|P3|COMPLETED|Overall Study||232
1084211|NCT01001494|2627443|P2|COMPLETED|Overall Study||252
1084212|NCT01001494|2627444|P1|COMPLETED|Overall Study||253
1084213|NCT01001494|2627442|P3|STARTED|Overall Study|276 patients were randomized, but baseline data was missing from 3 patients in one center|273
1084214|NCT01001494|2627443|P2|STARTED|Overall Study|272 patients were randomized, but baseline data was missing from 3 patients in one center|269
1084215|NCT01001494|2627444|P1|STARTED|Overall Study|280 patients were randomized, but baseline data was missing from 3 patients in one center|277
1084216|NCT01001520|2627464|P2|NOT COMPLETED|Medication Period 2||3
1084217|NCT01001520|2627465|P1|NOT COMPLETED|Medication Period 2||0
1084218|NCT01001520|2627464|P2|COMPLETED|Medication Period 2||13
1084219|NCT01001520|2627465|P1|COMPLETED|Medication Period 2||16
1084220|NCT01001520|2627464|P2|STARTED|Medication Period 2||16
1084221|NCT01001520|2627465|P1|STARTED|Medication Period 2||16
1084222|NCT01001520|2627464|P2|NOT COMPLETED|Washout Period||1
1084223|NCT01001520|2627465|P1|NOT COMPLETED|Washout Period||2
1084224|NCT01001520|2627464|P2|COMPLETED|Washout Period||16
1084225|NCT01001520|2627465|P1|COMPLETED|Washout Period||16
1084226|NCT01001520|2627464|P2|STARTED|Washout Period||17
1084227|NCT01001520|2627465|P1|STARTED|Washout Period||18
1084228|NCT01001520|2627464|P2|NOT COMPLETED|Medication Period 1||7
1084229|NCT01001520|2627465|P1|NOT COMPLETED|Medication Period 1||4
1084230|NCT01001520|2627464|P2|COMPLETED|Medication Period 1||17
1084231|NCT01001520|2627465|P1|COMPLETED|Medication Period 1||18
1084232|NCT01001520|2627464|P2|STARTED|Medication Period 1||24
1084233|NCT01001520|2627465|P1|STARTED|Medication Period 1||22
1084234|NCT01001546|2627491|P2|NOT COMPLETED|Overall Study||0
1084235|NCT01001546|2627492|P1|NOT COMPLETED|Overall Study||0
1084236|NCT01001546|2627491|P2|COMPLETED|Overall Study||207
1084237|NCT01001546|2627492|P1|COMPLETED|Overall Study||206
1084238|NCT01001546|2627491|P2|STARTED|Overall Study||207
1084239|NCT01001546|2627492|P1|STARTED|Overall Study||206
1084240|NCT01001559|2627500|P2|NOT COMPLETED|Overall Study||0
1084241|NCT01001559|2627501|P1|NOT COMPLETED|Overall Study||0
1084242|NCT01001559|2627500|P2|COMPLETED|Overall Study||147
1084243|NCT01001559|2627501|P1|COMPLETED|Overall Study||95
1084244|NCT01001559|2627500|P2|STARTED|Overall Study||147
1084245|NCT01001559|2627501|P1|STARTED|Overall Study||95
1084246|NCT01001572|2627515|P3|NOT COMPLETED|Double-Blind Treatment Phase||19
1084247|NCT01001572|2627516|P2|NOT COMPLETED|Double-Blind Treatment Phase||10
1084248|NCT01001572|2627517|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
1084249|NCT01001572|2627515|P3|COMPLETED|Double-Blind Treatment Phase||306
1084250|NCT01001572|2627516|P2|COMPLETED|Double-Blind Treatment Phase||319
1084251|NCT01001572|2627517|P1|COMPLETED|Double-Blind Treatment Phase||0
1084252|NCT01001572|2627515|P3|Full Analysis Set (FAS)|Double-Blind Treatment Phase|Two patients were excluded from full analysis set for having no post-baseline efficacy assessment.|323
1084253|NCT01001572|2627516|P2|Full Analysis Set (FAS)|Double-Blind Treatment Phase|One patient was excluded from full analysis set for having no post-baseline efficacy assessment.|328
1084254|NCT01001572|2627517|P1|Full Analysis Set (FAS)|Double-Blind Treatment Phase||0
1084255|NCT01001572|2627515|P3|STARTED|Double-Blind Treatment Phase||325
1084256|NCT01001572|2627516|P2|STARTED|Double-Blind Treatment Phase||329
1084257|NCT01001572|2627517|P1|STARTED|Double-Blind Treatment Phase|This arm is only used for single blind period. So, no enrollment during double blind period.|0
1084258|NCT01001572|2627515|P3|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
1084259|NCT01001572|2627516|P2|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
1084260|NCT01001572|2627517|P1|NOT COMPLETED|Single-Blind Valsartan 160 mg||278
1084261|NCT01001572|2627515|P3|COMPLETED|Single-Blind Valsartan 160 mg||0
1084262|NCT01001572|2627516|P2|COMPLETED|Single-Blind Valsartan 160 mg||0
1084263|NCT01001572|2627517|P1|COMPLETED|Single-Blind Valsartan 160 mg||654
1084264|NCT01001572|2627515|P3|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
1084265|NCT01001572|2627516|P2|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
1084266|NCT01001572|2627517|P1|STARTED|Single-Blind Valsartan 160 mg||932
1084267|NCT01001702|2627531|P1|NOT COMPLETED|Overall Study||72
1084268|NCT01001702|2627531|P1|COMPLETED|Overall Study||13
1084269|NCT01001702|2627531|P1|STARTED|Overall Study||85
1084270|NCT01001767|2627544|P2|NOT COMPLETED|Overall Study||0
1084271|NCT01001767|2627545|P1|NOT COMPLETED|Overall Study||4
1084272|NCT01001767|2627544|P2|COMPLETED|Overall Study||17
1084273|NCT01001767|2627545|P1|COMPLETED|Overall Study||14
1084274|NCT01001767|2627544|P2|STARTED|Overall Study||17
1084275|NCT01001767|2627545|P1|STARTED|Overall Study||18
1084276|NCT01001806|2627554|P3|NOT COMPLETED|Overall Study||4
1084277|NCT01001806|2627555|P2|NOT COMPLETED|Overall Study||1
1084278|NCT01001806|2627556|P1|NOT COMPLETED|Overall Study||0
1084279|NCT01001806|2627554|P3|COMPLETED|Overall Study||38
1084280|NCT01001806|2627555|P2|COMPLETED|Overall Study||41
1084281|NCT01001806|2627556|P1|COMPLETED|Overall Study||42
1084282|NCT01001806|2627554|P3|STARTED|Overall Study||42
1084283|NCT01001806|2627555|P2|STARTED|Overall Study||42
1084284|NCT01001806|2627556|P1|STARTED|Overall Study||42
1084285|NCT01001832|2627566|P2|NOT COMPLETED|Follow-up Period||21
1084286|NCT01001832|2627567|P1|NOT COMPLETED|Follow-up Period||18
1084287|NCT01001832|2627566|P2|COMPLETED|Follow-up Period||30
1084288|NCT01001832|2627567|P1|COMPLETED|Follow-up Period||34
1084289|NCT01001832|2627566|P2|STARTED|Follow-up Period||51
1084290|NCT01001832|2627567|P1|STARTED|Follow-up Period||52
1084291|NCT01001832|2627566|P2|NOT COMPLETED|Long-term Period||5
1084292|NCT01001832|2627567|P1|NOT COMPLETED|Long-term Period||4
1084293|NCT01001832|2627566|P2|COMPLETED|Long-term Period||51
1084294|NCT01001832|2627567|P1|COMPLETED|Long-term Period||52
1084295|NCT01001832|2627566|P2|STARTED|Long-term Period||56
1084296|NCT01001832|2627567|P1|STARTED|Long-term Period|1 participant completed the short term period but discontinued before start of the Long-term Period.|56
1084297|NCT01001832|2627566|P2|NOT COMPLETED|Short-term Period||3
1084298|NCT01001832|2627567|P1|NOT COMPLETED|Short-term Period||2
1084299|NCT01001832|2627566|P2|COMPLETED|Short-term Period||56
1084300|NCT01001832|2627567|P1|COMPLETED|Short-term Period||57
1084301|NCT01001832|2627566|P2|STARTED|Short-term Period||59
1084302|NCT01001832|2627567|P1|STARTED|Short-term Period||59
1084309|NCT01002105|2627623|P2|NOT COMPLETED|Overall Study||21
1084310|NCT01002105|2627624|P1|NOT COMPLETED|Overall Study||19
1084311|NCT01002105|2627623|P2|COMPLETED|Overall Study||11
1084312|NCT01002105|2627624|P1|COMPLETED|Overall Study||13
1084313|NCT01002105|2627623|P2|STARTED|Overall Study||32
1084314|NCT01002105|2627624|P1|STARTED|Overall Study||32
1084315|NCT01002118|2627640|P1|NOT COMPLETED|Overall Study||0
1084316|NCT01002118|2627640|P1|COMPLETED|Overall Study||1
1084317|NCT01002118|2627640|P1|Randomized Only Patient|Overall Study||1
1084318|NCT01002118|2627640|P1|STARTED|Overall Study||1
1084319|NCT01002287|2627648|P2|NOT COMPLETED|Overall Study||0
1084320|NCT01002287|2627649|P1|NOT COMPLETED|Overall Study||0
1084321|NCT01002287|2627648|P2|COMPLETED|Overall Study||3
1084322|NCT01002287|2627649|P1|COMPLETED|Overall Study||8
1084323|NCT01002287|2627648|P2|STARTED|Overall Study||3
1084324|NCT01002287|2627649|P1|STARTED|Overall Study||8
1084325|NCT01002339|2627664|P3|NOT COMPLETED|Overall Study||5
1084326|NCT01002339|2627665|P2|NOT COMPLETED|Overall Study||1
1084327|NCT01002339|2627666|P1|NOT COMPLETED|Overall Study||0
1084328|NCT01002339|2627664|P3|COMPLETED|Overall Study||42
1084329|NCT01002339|2627665|P2|COMPLETED|Overall Study||42
1084330|NCT01002339|2627666|P1|COMPLETED|Overall Study||44
1084331|NCT01002339|2627664|P3|STARTED|Overall Study||47
1084332|NCT01002339|2627665|P2|STARTED|Overall Study||43
1084333|NCT01002339|2627666|P1|STARTED|Overall Study||44
1084334|NCT01002456|2627721|P2|NOT COMPLETED|Overall Study||0
1084335|NCT01002456|2627722|P1|NOT COMPLETED|Overall Study||0
1084336|NCT01002456|2627721|P2|COMPLETED|Overall Study||122
1084337|NCT01002456|2627722|P1|COMPLETED|Overall Study||98
1084338|NCT01002456|2627721|P2|STARTED|Overall Study||122
1084339|NCT01002456|2627722|P1|STARTED|Overall Study||98
1084340|NCT01002482|2627732|P2|NOT COMPLETED|Overall Study||21
1084341|NCT01002482|2627733|P1|NOT COMPLETED|Overall Study||15
1084342|NCT01002482|2627732|P2|COMPLETED|Overall Study||1312
1084343|NCT01002482|2627733|P1|COMPLETED|Overall Study||1336
1084344|NCT01002482|2627732|P2|STARTED|Overall Study||1333
1084345|NCT01002482|2627733|P1|STARTED|Overall Study||1351
1084346|NCT01002573|2627755|P2|NOT COMPLETED|Overall Study||7
1084347|NCT01002573|2627756|P1|NOT COMPLETED|Overall Study||11
1084348|NCT01002573|2627755|P2|COMPLETED|Overall Study||53
1084349|NCT01002573|2627756|P1|COMPLETED|Overall Study||47
1084350|NCT01002573|2627755|P2|STARTED|Overall Study||60
1084351|NCT01002573|2627756|P1|STARTED|Overall Study||58
1084358|NCT01002989|2627811|P1|NOT COMPLETED|Overall Study||5
1084359|NCT01002989|2627811|P1|COMPLETED|Overall Study||93
1084360|NCT01002989|2627811|P1|STARTED|Overall Study||98
1084361|NCT01003067|2627820|P2|NOT COMPLETED|Overall Study||24
1084362|NCT01003067|2627821|P1|NOT COMPLETED|Overall Study||33
1084363|NCT01003067|2627820|P2|COMPLETED|Overall Study||107
1084364|NCT01003067|2627821|P1|COMPLETED|Overall Study||103
1084365|NCT01003067|2627820|P2|STARTED|Overall Study||131
1084366|NCT01003067|2627821|P1|STARTED|Overall Study||136
1084367|NCT00994604|2627827|P1|NOT COMPLETED|Overall Study||6
1084368|NCT00994604|2627827|P1|COMPLETED|Overall Study||45
1084369|NCT00994604|2627827|P1|STARTED|Overall Study||51
1084370|NCT00994643|2627834|P1|NOT COMPLETED|Overall Study||2
1084371|NCT00994643|2627834|P1|COMPLETED|Overall Study||10
1084372|NCT00994643|2627834|P1|STARTED|Overall Study||12
1084373|NCT00994682|2627840|P2|NOT COMPLETED|Pioglitazone Open Label||7
1084374|NCT00994682|2627841|P1|NOT COMPLETED|Pioglitazone Open Label||13
1084375|NCT00994682|2627840|P2|COMPLETED|Pioglitazone Open Label||34
1084376|NCT00994682|2627841|P1|COMPLETED|Pioglitazone Open Label||29
1084377|NCT00994682|2627840|P2|STARTED|Pioglitazone Open Label||41
1084378|NCT00994682|2627841|P1|STARTED|Pioglitazone Open Label||42
1084379|NCT00994682|2627840|P2|NOT COMPLETED|Double Bilnd||9
1084380|NCT00994682|2627841|P1|NOT COMPLETED|Double Bilnd||9
1084381|NCT00994682|2627840|P2|COMPLETED|Double Bilnd||41
1084382|NCT00994682|2627841|P1|COMPLETED|Double Bilnd||42
1084383|NCT00994682|2627840|P2|STARTED|Double Bilnd||50
1084384|NCT00994682|2627841|P1|STARTED|Double Bilnd||51
1084385|NCT00994760|2627885|P1|NOT COMPLETED|Overall Study||24
1084386|NCT00994760|2627885|P1|COMPLETED|Overall Study||107
1084387|NCT00994760|2627885|P1|STARTED|Overall Study||131
1084388|NCT00994929|2627924|P1|NOT COMPLETED|Overall Study||0
1084389|NCT00994929|2627924|P1|COMPLETED|Overall Study||9
1084390|NCT00994929|2627924|P1|STARTED|Overall Study||9
1084391|NCT00995007|2627932|P2|NOT COMPLETED|Overall Study||2
1084392|NCT00995007|2627933|P1|NOT COMPLETED|Overall Study||17
1084393|NCT00995007|2627932|P2|COMPLETED|Overall Study||54
1084394|NCT00995007|2627933|P1|COMPLETED|Overall Study||39
1084395|NCT00995007|2627932|P2|Crossover to Vandetanib|Overall Study||0
1084396|NCT00995007|2627933|P1|Crossover to Vandetanib|Overall Study||42
1084397|NCT00995007|2627932|P2|STARTED|Overall Study||56
1084398|NCT00995007|2627933|P1|STARTED|Overall Study||56
1084399|NCT00995020|2627951|P2|NOT COMPLETED|Overall Study||7
1084400|NCT00995020|2627952|P1|NOT COMPLETED|Overall Study||3
1084401|NCT00995020|2627951|P2|COMPLETED|Overall Study|"Reasons for not completed:
margin analysis not performed specimen fragmentation thermal damage"|45
1084402|NCT00995020|2627952|P1|COMPLETED|Overall Study|"Reasons for not completed:
margin analysis not performed specimen fragmentation thermal damage"|48
1084403|NCT00995020|2627951|P2|STARTED|Overall Study||52
1084404|NCT00995020|2627952|P1|STARTED|Overall Study||51
1084405|NCT00995085|2627960|P1|NOT COMPLETED|Overall Study||5
1084406|NCT00995085|2627960|P1|COMPLETED|Overall Study||38
1084407|NCT00995085|2627960|P1|STARTED|Overall Study||43
1084408|NCT00995345|2627969|P5|NOT COMPLETED|Overall Study||5
1084409|NCT00995345|2627970|P4|NOT COMPLETED|Overall Study||5
1084410|NCT00995345|2627971|P3|NOT COMPLETED|Overall Study||7
1084411|NCT00995345|2627972|P2|NOT COMPLETED|Overall Study||7
1084412|NCT00995345|2627973|P1|NOT COMPLETED|Overall Study||11
1084413|NCT00995345|2627969|P5|COMPLETED|Overall Study||75
1084414|NCT00995345|2627970|P4|COMPLETED|Overall Study||76
1084415|NCT00995345|2627971|P3|COMPLETED|Overall Study||73
1084416|NCT00995345|2627972|P2|COMPLETED|Overall Study||74
1084417|NCT00995345|2627973|P1|COMPLETED|Overall Study||70
1084418|NCT00995345|2627969|P5|STARTED|Overall Study||80
1084419|NCT00995345|2627970|P4|STARTED|Overall Study||81
1084420|NCT00995345|2627971|P3|STARTED|Overall Study||80
1084421|NCT00995345|2627972|P2|STARTED|Overall Study||81
1084422|NCT00995345|2627973|P1|STARTED|Overall Study||81
1084423|NCT00995371|2628002|P2|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
1084424|NCT00995371|2628003|P1|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
1084425|NCT00995371|2628002|P2|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 17 completed Wk 6 Intent to Treat analysis prior to x-over. After x-over 12 reported Wk 26|12
1084426|NCT00995371|2628003|P1|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 21 completed Wk 6 Intent to Treat analysis. Sixteen reported Week 26 outcomes.|16
1084427|NCT00995371|2628002|P2|STARTED|After ESI Cross-over to Mild, 26 Weeks||17
1084428|NCT00995371|2628003|P1|STARTED|After ESI Cross-over to Mild, 26 Weeks||21
1084429|NCT00995371|2628002|P2|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
1084430|NCT00995371|2628003|P1|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
1084431|NCT00995371|2628002|P2|COMPLETED|Prior to ESI Cross-over, 6 Weeks||17
1084432|NCT00995371|2628003|P1|COMPLETED|Prior to ESI Cross-over, 6 Weeks||21
1084433|NCT00995371|2628002|P2|STARTED|Prior to ESI Cross-over, 6 Weeks||17
1084434|NCT00995371|2628003|P1|STARTED|Prior to ESI Cross-over, 6 Weeks||21
1084435|NCT00995410|2628016|P1|NOT COMPLETED|Overall Study||88
1084436|NCT00995410|2628016|P1|COMPLETED|Overall Study||292
1084437|NCT00995410|2628016|P1|Treated|Overall Study||379
1084438|NCT00995410|2628016|P1|STARTED|Overall Study||380
1084439|NCT00995436|2628024|P3|NOT COMPLETED|Overall Study||0
1084440|NCT00995436|2628025|P2|NOT COMPLETED|Overall Study||5
1084441|NCT00995436|2628026|P1|NOT COMPLETED|Overall Study||2
1084442|NCT00995436|2628024|P3|COMPLETED|Overall Study||26
1084443|NCT00995436|2628025|P2|COMPLETED|Overall Study||22
1084444|NCT00995436|2628026|P1|COMPLETED|Overall Study||23
1084445|NCT00995436|2628024|P3|STARTED|Overall Study||26
1084446|NCT00995436|2628025|P2|STARTED|Overall Study||27
1084447|NCT00995436|2628026|P1|STARTED|Overall Study|25|25
1084448|NCT00995449|2628038|P4|NOT COMPLETED|Overall Study||0
1084449|NCT00995449|2628039|P3|NOT COMPLETED|Overall Study||2
1084450|NCT00995449|2628040|P2|NOT COMPLETED|Overall Study||0
1084451|NCT00995449|2628041|P1|NOT COMPLETED|Overall Study||0
1084452|NCT00995449|2628038|P4|COMPLETED|Overall Study||2
1084453|NCT00995449|2628039|P3|COMPLETED|Overall Study||5
1084454|NCT00995449|2628040|P2|COMPLETED|Overall Study||0
1084455|NCT00995449|2628041|P1|COMPLETED|Overall Study||0
1084456|NCT00995449|2628038|P4|STARTED|Overall Study||2
1084457|NCT00995449|2628039|P3|STARTED|Overall Study||7
1084458|NCT00995449|2628040|P2|STARTED|Overall Study||0
1084459|NCT00995449|2628041|P1|STARTED|Overall Study||0
1084460|NCT00995488|2628049|P1|NOT COMPLETED|Overall Study||1
1084461|NCT00995488|2628049|P1|COMPLETED|Overall Study||15
1084462|NCT00995488|2628049|P1|STARTED|Overall Study||16
1084463|NCT00995501|2628062|P8|NOT COMPLETED|Overall Study||0
1084464|NCT00995501|2628063|P7|NOT COMPLETED|Overall Study||0
1084465|NCT00995501|2628064|P6|NOT COMPLETED|Overall Study||0
1084466|NCT00995501|2628065|P5|NOT COMPLETED|Overall Study||0
1084467|NCT00995501|2628066|P4|NOT COMPLETED|Overall Study||0
1084468|NCT00995501|2628067|P3|NOT COMPLETED|Overall Study||0
1084469|NCT00995501|2628068|P2|NOT COMPLETED|Overall Study||0
1084470|NCT00995501|2628069|P1|NOT COMPLETED|Overall Study||0
1084471|NCT00995501|2628062|P8|COMPLETED|Overall Study||46
1084472|NCT00995501|2628063|P7|COMPLETED|Overall Study||49
1084473|NCT00995501|2628064|P6|COMPLETED|Overall Study||44
1084474|NCT00995501|2628065|P5|COMPLETED|Overall Study||46
1084475|NCT00995501|2628066|P4|COMPLETED|Overall Study||46
1084476|NCT00995501|2628067|P3|COMPLETED|Overall Study||47
1084477|NCT00995501|2628068|P2|COMPLETED|Overall Study||51
1084478|NCT00995501|2628069|P1|COMPLETED|Overall Study||52
1084479|NCT00995501|2628062|P8|STARTED|Overall Study||46
1084480|NCT00995501|2628063|P7|STARTED|Overall Study||49
1084481|NCT00995501|2628064|P6|STARTED|Overall Study||44
1084482|NCT00995501|2628065|P5|STARTED|Overall Study||46
1084483|NCT00995501|2628066|P4|STARTED|Overall Study||46
1084484|NCT00995501|2628067|P3|STARTED|Overall Study||47
1084485|NCT00995501|2628068|P2|STARTED|Overall Study||51
1084486|NCT00995501|2628069|P1|STARTED|Overall Study||52
1084487|NCT00995553|2628097|P2|NOT COMPLETED|Overall Study||6
1084488|NCT00995553|2628098|P1|NOT COMPLETED|Overall Study||2
1084489|NCT00995553|2628097|P2|COMPLETED|Overall Study||35
1084490|NCT00995553|2628098|P1|COMPLETED|Overall Study||38
1084491|NCT00995553|2628097|P2|STARTED|Overall Study||41
1084492|NCT00995553|2628098|P1|STARTED|Overall Study||40
1084493|NCT00995566|2628106|P1|NOT COMPLETED|Overall Study||54
1084494|NCT00995566|2628106|P1|COMPLETED|Overall Study||0
1084495|NCT00995566|2628106|P1|STARTED|Overall Study||54
1084496|NCT00995670|2628121|P3|NOT COMPLETED|Overall Study||3
1084497|NCT00995670|2628122|P2|NOT COMPLETED|Overall Study||0
1084498|NCT00995670|2628123|P1|NOT COMPLETED|Overall Study||1
1084499|NCT00995670|2628121|P3|COMPLETED|Overall Study|These 17 volunteers underwent 33 studies on the effect of statins, glucose, and glucose & statins.|14
1084500|NCT00995670|2628122|P2|COMPLETED|Overall Study|These 16 subjects underwent a total of 25 studies on the effect of Vitamin C.|16
1084501|NCT00995670|2628123|P1|COMPLETED|Overall Study|These 26 subjects underwent a total of 58 studies to determine the effect of dose of glucose on I/R.|25
1084502|NCT00995670|2628121|P3|STARTED|Overall Study||17
1084503|NCT00995670|2628122|P2|STARTED|Overall Study||16
1084504|NCT00995670|2628123|P1|STARTED|Overall Study||26
1084505|NCT00995709|2628134|P3|NOT COMPLETED|Overall Study||5
1084506|NCT00995709|2628135|P2|NOT COMPLETED|Overall Study||9
1084507|NCT00995709|2628136|P1|NOT COMPLETED|Overall Study||7
1084508|NCT00995709|2628134|P3|COMPLETED|Overall Study||34
1084509|NCT00995709|2628135|P2|COMPLETED|Overall Study|patient in the 300 mg monthly group was randomized,was not eligible,never received study medication|31
1084510|NCT00995709|2628136|P1|COMPLETED|Overall Study||32
1084511|NCT00995709|2628134|P3|STARTED|Overall Study||39
1084512|NCT00995709|2628135|P2|STARTED|Overall Study||40
1084513|NCT00995709|2628136|P1|STARTED|Overall Study||39
1084526|NCT00995761|2628176|P1|NOT COMPLETED|Overall Study||0
1084527|NCT00995761|2628176|P1|COMPLETED|Overall Study||48
1084528|NCT00995761|2628176|P1|STARTED|Overall Study||48
1084529|NCT00995774|2628182|P2|NOT COMPLETED|Training Period 2||0
1084530|NCT00995774|2628183|P1|NOT COMPLETED|Training Period 2||2
1084531|NCT00995774|2628182|P2|COMPLETED|Training Period 2||5
1084532|NCT00995774|2628183|P1|COMPLETED|Training Period 2||5
1084533|NCT00995774|2628182|P2|STARTED|Training Period 2||5
1084534|NCT00995774|2628183|P1|STARTED|Training Period 2||7
1084535|NCT00995774|2628182|P2|NOT COMPLETED|Washout Period||0
1084536|NCT00995774|2628183|P1|NOT COMPLETED|Washout Period||0
1084537|NCT00995774|2628182|P2|COMPLETED|Washout Period||5
1084538|NCT00995774|2628183|P1|COMPLETED|Washout Period||7
1084539|NCT00995774|2628182|P2|STARTED|Washout Period||5
1084540|NCT00995774|2628183|P1|STARTED|Washout Period||7
1084541|NCT00995774|2628182|P2|NOT COMPLETED|Training Period 1||0
1084542|NCT00995774|2628183|P1|NOT COMPLETED|Training Period 1||0
1084543|NCT00995774|2628182|P2|COMPLETED|Training Period 1||5
1084544|NCT00995774|2628183|P1|COMPLETED|Training Period 1||7
1084545|NCT00995774|2628182|P2|STARTED|Training Period 1||5
1084546|NCT00995774|2628183|P1|STARTED|Training Period 1||7
1084547|NCT00995865|2628194|P3|NOT COMPLETED|Overall Study||1
1084548|NCT00995865|2628195|P2|NOT COMPLETED|Overall Study||0
1084549|NCT00995865|2628196|P1|NOT COMPLETED|Overall Study||2
1084550|NCT00995865|2628194|P3|COMPLETED|Overall Study||11
1084551|NCT00995865|2628195|P2|COMPLETED|Overall Study||24
1084552|NCT00995865|2628196|P1|COMPLETED|Overall Study||22
1084553|NCT00995865|2628194|P3|STARTED|Overall Study||12
1084554|NCT00995865|2628195|P2|STARTED|Overall Study||24
1084555|NCT00995865|2628196|P1|STARTED|Overall Study||24
1084556|NCT00995904|2628216|P6|NOT COMPLETED|Follow-up Visit (Final Visit)||0
1084557|NCT00995904|2628217|P5|NOT COMPLETED|Follow-up Visit (Final Visit)||0
1084558|NCT00995904|2628218|P4|NOT COMPLETED|Follow-up Visit (Final Visit)||0
1084559|NCT00995904|2628219|P3|NOT COMPLETED|Follow-up Visit (Final Visit)||0
1084560|NCT00995904|2628220|P2|NOT COMPLETED|Follow-up Visit (Final Visit)||0
1084561|NCT00995904|2628221|P1|NOT COMPLETED|Follow-up Visit (Final Visit)||0
1084562|NCT00995904|2628216|P6|COMPLETED|Follow-up Visit (Final Visit)||3
1084563|NCT00995904|2628217|P5|COMPLETED|Follow-up Visit (Final Visit)||5
1084564|NCT00995904|2628218|P4|COMPLETED|Follow-up Visit (Final Visit)||5
1084565|NCT00995904|2628219|P3|COMPLETED|Follow-up Visit (Final Visit)||4
1084566|NCT00995904|2628220|P2|COMPLETED|Follow-up Visit (Final Visit)||3
1084567|NCT00995904|2628221|P1|COMPLETED|Follow-up Visit (Final Visit)||4
1084568|NCT00995904|2628216|P6|STARTED|Follow-up Visit (Final Visit)||3
1084569|NCT00995904|2628217|P5|STARTED|Follow-up Visit (Final Visit)||5
1084570|NCT00995904|2628218|P4|STARTED|Follow-up Visit (Final Visit)||5
1084571|NCT00995904|2628219|P3|STARTED|Follow-up Visit (Final Visit)||4
1084572|NCT00995904|2628220|P2|STARTED|Follow-up Visit (Final Visit)||3
1084573|NCT00995904|2628221|P1|STARTED|Follow-up Visit (Final Visit)||4
1084574|NCT00995904|2628216|P6|NOT COMPLETED|Visit 4||0
1084575|NCT00995904|2628217|P5|NOT COMPLETED|Visit 4||0
1084576|NCT00995904|2628218|P4|NOT COMPLETED|Visit 4||0
1084577|NCT00995904|2628219|P3|NOT COMPLETED|Visit 4||0
1084578|NCT00995904|2628220|P2|NOT COMPLETED|Visit 4||0
1084579|NCT00995904|2628221|P1|NOT COMPLETED|Visit 4||0
1084580|NCT00995904|2628216|P6|COMPLETED|Visit 4||3
1084581|NCT00995904|2628217|P5|COMPLETED|Visit 4||5
1084582|NCT00995904|2628218|P4|COMPLETED|Visit 4||5
1084583|NCT00995904|2628219|P3|COMPLETED|Visit 4||4
1084584|NCT00995904|2628220|P2|COMPLETED|Visit 4||3
1084585|NCT00995904|2628221|P1|COMPLETED|Visit 4||4
1084586|NCT00995904|2628216|P6|STARTED|Visit 4||3
1084587|NCT00995904|2628217|P5|STARTED|Visit 4||5
1084588|NCT00995904|2628218|P4|STARTED|Visit 4||5
1084589|NCT00995904|2628219|P3|STARTED|Visit 4||4
1084590|NCT00995904|2628220|P2|STARTED|Visit 4||3
1084591|NCT00995904|2628221|P1|STARTED|Visit 4||4
1084592|NCT00995904|2628216|P6|NOT COMPLETED|Visit 3||0
1084593|NCT00995904|2628217|P5|NOT COMPLETED|Visit 3||0
1084594|NCT00995904|2628218|P4|NOT COMPLETED|Visit 3||0
1084595|NCT00995904|2628219|P3|NOT COMPLETED|Visit 3||0
1084596|NCT00995904|2628220|P2|NOT COMPLETED|Visit 3||0
1084597|NCT00995904|2628221|P1|NOT COMPLETED|Visit 3||0
1084598|NCT00995904|2628216|P6|COMPLETED|Visit 3||3
1084599|NCT00995904|2628217|P5|COMPLETED|Visit 3||5
1084600|NCT00995904|2628218|P4|COMPLETED|Visit 3||5
1084601|NCT00995904|2628219|P3|COMPLETED|Visit 3||4
1084602|NCT00995904|2628220|P2|COMPLETED|Visit 3||3
1084603|NCT00995904|2628221|P1|COMPLETED|Visit 3||4
1084604|NCT00995904|2628216|P6|STARTED|Visit 3|One subject was withdrawn from the study after completion of Visit 2 but prior to Visit 3.|3
1084605|NCT00995904|2628217|P5|STARTED|Visit 3||5
1084606|NCT00995904|2628218|P4|STARTED|Visit 3||5
1084607|NCT00995904|2628219|P3|STARTED|Visit 3||4
1084608|NCT00995904|2628220|P2|STARTED|Visit 3||3
1084609|NCT00995904|2628221|P1|STARTED|Visit 3||4
1084610|NCT00995904|2628216|P6|NOT COMPLETED|Visit 2 (Randomization)||0
1084611|NCT00995904|2628217|P5|NOT COMPLETED|Visit 2 (Randomization)||0
1084612|NCT00995904|2628218|P4|NOT COMPLETED|Visit 2 (Randomization)||0
1084613|NCT00995904|2628219|P3|NOT COMPLETED|Visit 2 (Randomization)||0
1084614|NCT00995904|2628220|P2|NOT COMPLETED|Visit 2 (Randomization)||0
1084615|NCT00995904|2628221|P1|NOT COMPLETED|Visit 2 (Randomization)||0
1084616|NCT00995904|2628216|P6|COMPLETED|Visit 2 (Randomization)||4
1084617|NCT00995904|2628217|P5|COMPLETED|Visit 2 (Randomization)||5
1084618|NCT00995904|2628218|P4|COMPLETED|Visit 2 (Randomization)||5
1084619|NCT00995904|2628219|P3|COMPLETED|Visit 2 (Randomization)||4
1084620|NCT00995904|2628220|P2|COMPLETED|Visit 2 (Randomization)||3
1084621|NCT00995904|2628221|P1|COMPLETED|Visit 2 (Randomization)||4
1084622|NCT00995904|2628216|P6|STARTED|Visit 2 (Randomization)||4
1084623|NCT00995904|2628217|P5|STARTED|Visit 2 (Randomization)||5
1084624|NCT00995904|2628218|P4|STARTED|Visit 2 (Randomization)||5
1084625|NCT00995904|2628219|P3|STARTED|Visit 2 (Randomization)||4
1084626|NCT00995904|2628220|P2|STARTED|Visit 2 (Randomization)||3
1084627|NCT00995904|2628221|P1|STARTED|Visit 2 (Randomization)||4
1084628|NCT00995930|2628237|P2|NOT COMPLETED|Overall Study||28
1084629|NCT00995930|2628238|P1|NOT COMPLETED|Overall Study||21
1084630|NCT00995930|2628237|P2|COMPLETED|Overall Study||67
1084631|NCT00995930|2628238|P1|COMPLETED|Overall Study||73
1084632|NCT00995930|2628237|P2|Imaging Analysis Set|Overall Study||92
1084633|NCT00995930|2628238|P1|Imaging Analysis Set|Overall Study||92
1084634|NCT00995930|2628237|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||92
1084635|NCT00995930|2628238|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||92
1084636|NCT00995930|2628237|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||95
1084637|NCT00995930|2628238|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||0
1084638|NCT00995930|2628237|P2|Safety Analysis Set|Overall Study||95
1084639|NCT00995930|2628238|P1|Safety Analysis Set|Overall Study||94
1084640|NCT00995930|2628237|P2|STARTED|Overall Study||95
1084641|NCT00995930|2628238|P1|STARTED|Overall Study||94
1084642|NCT00996034|2628267|P1|NOT COMPLETED|Overall Study||3
1084643|NCT00996034|2628267|P1|COMPLETED|Overall Study||11
1084644|NCT00996034|2628267|P1|STARTED|Overall Study||14
1084645|NCT00996125|2628273|P2|NOT COMPLETED|Overall Study||11
1084646|NCT00996125|2628274|P1|NOT COMPLETED|Overall Study||5
1084647|NCT00996125|2628273|P2|COMPLETED|Overall Study||365
1084648|NCT00996125|2628274|P1|COMPLETED|Overall Study||369
1084649|NCT00996125|2628273|P2|STARTED|Overall Study||376
1084650|NCT00996125|2628274|P1|STARTED|Overall Study||374
1084651|NCT00996164|2628296|P2|NOT COMPLETED|Overall Study||101
1084652|NCT00996164|2628297|P1|NOT COMPLETED|Overall Study||135
1084653|NCT00996164|2628296|P2|COMPLETED|Overall Study||446
1084654|NCT00996164|2628297|P1|COMPLETED|Overall Study||408
1084655|NCT00996164|2628296|P2|STARTED|Overall Study||547
1084656|NCT00996164|2628297|P1|STARTED|Overall Study||543
1084657|NCT00996203|2628305|P1|NOT COMPLETED|Overall Study||7
1084658|NCT00996203|2628305|P1|COMPLETED|Overall Study||194
1084659|NCT00996203|2628305|P1|STARTED|Overall Study||201
1084660|NCT00996216|2628324|P1|NOT COMPLETED|Part 2 (Antiviral Treatment Phase)||4
1084661|NCT00996216|2628324|P1|COMPLETED|Part 2 (Antiviral Treatment Phase)||21
1084662|NCT00996216|2628324|P1|STARTED|Part 2 (Antiviral Treatment Phase)|One participant who completed Part 1 didn’t qualify to begin antiviral treatment in Part 2.|25
1084663|NCT00996216|2628324|P1|NOT COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||1
1084664|NCT00996216|2628324|P1|COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||26
1084665|NCT00996216|2628324|P1|STARTED|Part 1 (Pre-Antiviral Treatment Phase)||27
1084684|NCT00996333|2628416|P1|NOT COMPLETED|Overall Study||13
1084685|NCT00996333|2628416|P1|COMPLETED|Overall Study||33
1084686|NCT00996333|2628416|P1|STARTED|Overall Study||46
1084687|NCT00996346|2628425|P3|NOT COMPLETED|Overall Study||0
1084688|NCT00996346|2628426|P2|NOT COMPLETED|Overall Study||0
1084689|NCT00996346|2628427|P1|NOT COMPLETED|Overall Study||0
1084690|NCT00996346|2628425|P3|COMPLETED|Overall Study||3
1084691|NCT00996346|2628426|P2|COMPLETED|Overall Study||8
1084692|NCT00996346|2628427|P1|COMPLETED|Overall Study||6
1084693|NCT00996346|2628425|P3|STARTED|Overall Study||3
1084694|NCT00996346|2628426|P2|STARTED|Overall Study||8
1084695|NCT00996346|2628427|P1|STARTED|Overall Study||6
1084696|NCT00996372|2628436|P2|NOT COMPLETED|Overall Study||84
1084697|NCT00996372|2628437|P1|NOT COMPLETED|Overall Study||103
1084698|NCT00996372|2628436|P2|COMPLETED|Overall Study||397
1084699|NCT00996372|2628437|P1|COMPLETED|Overall Study||365
1084700|NCT00996372|2628436|P2|STARTED|Overall Study||481
1084701|NCT00996372|2628437|P1|STARTED|Overall Study||468
1084702|NCT00996437|2628449|P2|NOT COMPLETED|Overall Study||7
1084703|NCT00996437|2628450|P1|NOT COMPLETED|Overall Study||5
1084704|NCT00996437|2628449|P2|COMPLETED|Overall Study||129
1084705|NCT00996437|2628450|P1|COMPLETED|Overall Study||120
1084706|NCT00996437|2628449|P2|STARTED|Overall Study||136
1084707|NCT00996437|2628450|P1|STARTED|Overall Study||125
1084708|NCT00996476|2628475|P5|NOT COMPLETED|Overall Study||2
1084709|NCT00996476|2628476|P4|NOT COMPLETED|Overall Study||0
1084710|NCT00996476|2628477|P3|NOT COMPLETED|Overall Study||1
1084711|NCT00996476|2628478|P2|NOT COMPLETED|Overall Study||3
1084712|NCT00996476|2628479|P1|NOT COMPLETED|Overall Study||1
1084713|NCT00996476|2628475|P5|COMPLETED|Overall Study||11
1084714|NCT00996476|2628476|P4|COMPLETED|Overall Study||13
1084715|NCT00996476|2628477|P3|COMPLETED|Overall Study||12
1084716|NCT00996476|2628478|P2|COMPLETED|Overall Study||23
1084717|NCT00996476|2628479|P1|COMPLETED|Overall Study||26
1084718|NCT00996476|2628475|P5|STARTED|Overall Study||13
1084719|NCT00996476|2628476|P4|STARTED|Overall Study||13
1084720|NCT00996476|2628477|P3|STARTED|Overall Study||13
1084721|NCT00996476|2628478|P2|STARTED|Overall Study||26
1084722|NCT00996476|2628479|P1|STARTED|Overall Study||27
1084723|NCT00996502|2628545|P1|NOT COMPLETED|Overall Study||0
1084724|NCT00996502|2628545|P1|COMPLETED|Overall Study||4
1084725|NCT00996502|2628545|P1|STARTED|Overall Study||4
1084726|NCT00996580|2628549|P1|NOT COMPLETED|Overall Study||1453
1084727|NCT00996580|2628549|P1|COMPLETED|Overall Study||2144
1084728|NCT00996580|2628549|P1|Pregnancy Intent-to-Treat Population|Overall Study||3019
1084729|NCT00996580|2628549|P1|STARTED|Overall Study||3597
1084730|NCT00996593|2628577|P1|NOT COMPLETED|Long-Term Follow-Up||3
1084731|NCT00996593|2628577|P1|COMPLETED|Long-Term Follow-Up||6
1084732|NCT00996593|2628577|P1|STARTED|Long-Term Follow-Up|9 of the 40 participants withdrawing from Study BEX104507 enrolled in long-term follow-up study.|9
1084733|NCT00996593|2628577|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||43
1084734|NCT00996593|2628577|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
1084735|NCT00996593|2628577|P1|STARTED|Dosimetric and Therapeutic Treatment||43
1084736|NCT00996606|2628605|P1|NOT COMPLETED|Overall Study||8
1084737|NCT00996606|2628605|P1|COMPLETED|Overall Study||50
1084738|NCT00996606|2628605|P1|STARTED|Overall Study||58
1084739|NCT00996632|2628701|P2|NOT COMPLETED|Overall Study||0
1084740|NCT00996632|2628702|P1|NOT COMPLETED|Overall Study||0
1084741|NCT00996632|2628701|P2|COMPLETED|Overall Study||56
1084742|NCT00996632|2628702|P1|COMPLETED|Overall Study||38
1084743|NCT00996632|2628701|P2|STARTED|Overall Study||56
1084744|NCT00996632|2628702|P1|STARTED|Overall Study||38
1084745|NCT00996658|2628712|P2|NOT COMPLETED|Overall Study||21
1084746|NCT00996658|2628713|P1|NOT COMPLETED|Overall Study||16
1084747|NCT00996658|2628712|P2|COMPLETED|Overall Study||165
1084748|NCT00996658|2628713|P1|COMPLETED|Overall Study||76
1084749|NCT00996658|2628712|P2|STARTED|Overall Study||186
1084750|NCT00996658|2628713|P1|STARTED|Overall Study||92
1084751|NCT00996736|2628741|P2|NOT COMPLETED|Overall Study||18
1084752|NCT00996736|2628742|P1|NOT COMPLETED|Overall Study||21
1084753|NCT00996736|2628741|P2|COMPLETED|Overall Study||143
1084754|NCT00996736|2628742|P1|COMPLETED|Overall Study||141
1084755|NCT00996736|2628741|P2|3-month Visit|Overall Study||146
1084756|NCT00996736|2628742|P1|3-month Visit|Overall Study||146
1084757|NCT00996736|2628741|P2|3-week Visit|Overall Study|144 visited within pre-specified 3-week window (2.5-5 weeks); 7 had a second visit not within window|151
1084758|NCT00996736|2628742|P1|3-week Visit|Overall Study|149 visited within pre-specified 3-week window (2.5-5 weeks); 6 had a second visit not within window|155
1084759|NCT00996736|2628741|P2|STARTED|Overall Study||161
1084760|NCT00996736|2628742|P1|STARTED|Overall Study||162
1084761|NCT00996775|2628762|P2|NOT COMPLETED|Overall Study||14
1084762|NCT00996775|2628763|P1|NOT COMPLETED|Overall Study||11
1084763|NCT00996775|2628762|P2|COMPLETED|Overall Study||75
1084764|NCT00996775|2628763|P1|COMPLETED|Overall Study||67
1084765|NCT00996775|2628762|P2|STARTED|Overall Study||89
1084766|NCT00996775|2628763|P1|STARTED|Overall Study||78
1084767|NCT00996801|2628775|P6|NOT COMPLETED|Overall Study||19
1084768|NCT00996801|2628776|P5|NOT COMPLETED|Overall Study||88
1084769|NCT00996801|2628777|P4|NOT COMPLETED|Overall Study||31
1084770|NCT00996801|2628778|P3|NOT COMPLETED|Overall Study||23
1084771|NCT00996801|2628779|P2|NOT COMPLETED|Overall Study||16
1084772|NCT00996801|2628780|P1|NOT COMPLETED|Overall Study||20
1084773|NCT00996801|2628775|P6|COMPLETED|Overall Study||68
1084774|NCT00996801|2628776|P5|COMPLETED|Overall Study||0
1084775|NCT00996801|2628777|P4|COMPLETED|Overall Study||56
1084776|NCT00996801|2628778|P3|COMPLETED|Overall Study||65
1084777|NCT00996801|2628779|P2|COMPLETED|Overall Study||72
1084778|NCT00996801|2628780|P1|COMPLETED|Overall Study||68
1084779|NCT00996801|2628775|P6|STARTED|Overall Study||87
1084780|NCT00996801|2628776|P5|STARTED|Overall Study|15-mg arm was discontinued as a result of Protocol Amendment 1.|88
1084781|NCT00996801|2628777|P4|STARTED|Overall Study||87
1084782|NCT00996801|2628778|P3|STARTED|Overall Study||88
1084783|NCT00996801|2628779|P2|STARTED|Overall Study||88
1084784|NCT00996801|2628780|P1|STARTED|Overall Study||88
1084785|NCT01003080|2628883|P2|NOT COMPLETED|Overall Study||0
1084786|NCT01003080|2628884|P1|NOT COMPLETED|Overall Study||0
1084787|NCT01003080|2628883|P2|COMPLETED|Overall Study||61
1084788|NCT01003080|2628884|P1|COMPLETED|Overall Study||50
1084789|NCT01003080|2628883|P2|STARTED|Overall Study||61
1084790|NCT01003080|2628884|P1|STARTED|Overall Study||50
1084791|NCT01003106|2628894|P8|NOT COMPLETED|Month 6-Month 36||0
1084792|NCT01003106|2628895|P7|NOT COMPLETED|Month 6-Month 36||1
1084793|NCT01003106|2628896|P6|NOT COMPLETED|Month 6-Month 36||0
1084794|NCT01003106|2628897|P5|NOT COMPLETED|Month 6-Month 36||0
1084795|NCT01003106|2628898|P4|NOT COMPLETED|Month 6-Month 36||0
1084796|NCT01003106|2628899|P3|NOT COMPLETED|Month 6-Month 36||1
1084797|NCT01003106|2628900|P2|NOT COMPLETED|Month 6-Month 36||0
1084798|NCT01003106|2628901|P1|NOT COMPLETED|Month 6-Month 36||0
1084799|NCT01003106|2628894|P8|COMPLETED|Month 6-Month 36||18
1084800|NCT01003106|2628895|P7|COMPLETED|Month 6-Month 36||19
1084801|NCT01003106|2628896|P6|COMPLETED|Month 6-Month 36||0
1084802|NCT01003106|2628897|P5|COMPLETED|Month 6-Month 36||0
1084803|NCT01003106|2628898|P4|COMPLETED|Month 6-Month 36||20
1084804|NCT01003106|2628899|P3|COMPLETED|Month 6-Month 36||18
1084805|NCT01003106|2628900|P2|COMPLETED|Month 6-Month 36||0
1084806|NCT01003106|2628901|P1|COMPLETED|Month 6-Month 36||0
1084807|NCT01003106|2628894|P8|STARTED|Month 6-Month 36||18
1084808|NCT01003106|2628895|P7|STARTED|Month 6-Month 36||20
1084809|NCT01003106|2628896|P6|STARTED|Month 6-Month 36||0
1084810|NCT01003106|2628897|P5|STARTED|Month 6-Month 36||0
1084811|NCT01003106|2628898|P4|STARTED|Month 6-Month 36||20
1084812|NCT01003106|2628899|P3|STARTED|Month 6-Month 36||19
1084813|NCT01003106|2628900|P2|STARTED|Month 6-Month 36||0
1084814|NCT01003106|2628901|P1|STARTED|Month 6-Month 36||0
1084815|NCT01003106|2628894|P8|NOT COMPLETED|Baseline to Month 6||0
1084816|NCT01003106|2628895|P7|NOT COMPLETED|Baseline to Month 6||0
1084817|NCT01003106|2628896|P6|NOT COMPLETED|Baseline to Month 6||0
1084818|NCT01003106|2628897|P5|NOT COMPLETED|Baseline to Month 6||0
1084819|NCT01003106|2628898|P4|NOT COMPLETED|Baseline to Month 6||0
1084820|NCT01003106|2628899|P3|NOT COMPLETED|Baseline to Month 6||0
1084821|NCT01003106|2628900|P2|NOT COMPLETED|Baseline to Month 6||0
1084822|NCT01003106|2628901|P1|NOT COMPLETED|Baseline to Month 6||0
1084823|NCT01003106|2628894|P8|COMPLETED|Baseline to Month 6||0
1084824|NCT01003106|2628895|P7|COMPLETED|Baseline to Month 6||0
1084825|NCT01003106|2628896|P6|COMPLETED|Baseline to Month 6||20
1084826|NCT01003106|2628897|P5|COMPLETED|Baseline to Month 6||19
1084827|NCT01003106|2628898|P4|COMPLETED|Baseline to Month 6||0
1084828|NCT01003106|2628899|P3|COMPLETED|Baseline to Month 6||0
1084829|NCT01003106|2628900|P2|COMPLETED|Baseline to Month 6||20
1084830|NCT01003106|2628901|P1|COMPLETED|Baseline to Month 6||22
1084831|NCT01003106|2628894|P8|STARTED|Baseline to Month 6||0
1084832|NCT01003106|2628895|P7|STARTED|Baseline to Month 6||0
1084833|NCT01003106|2628896|P6|STARTED|Baseline to Month 6||20
1084834|NCT01003106|2628897|P5|STARTED|Baseline to Month 6||19
1084835|NCT01003106|2628898|P4|STARTED|Baseline to Month 6||0
1084836|NCT01003106|2628899|P3|STARTED|Baseline to Month 6||0
1084837|NCT01003106|2628900|P2|STARTED|Baseline to Month 6||20
1084838|NCT01003106|2628901|P1|STARTED|Baseline to Month 6||22
1084839|NCT01003184|2628925|P2|NOT COMPLETED|Overall Study||12
1084840|NCT01003184|2628926|P1|NOT COMPLETED|Overall Study||19
1084841|NCT01003184|2628925|P2|COMPLETED|Overall Study||99
1084842|NCT01003184|2628926|P1|COMPLETED|Overall Study||92
1084843|NCT01003184|2628925|P2|Full Analysis Set (FAS)|Overall Study||105
1084844|NCT01003184|2628926|P1|Full Analysis Set (FAS)|Overall Study||111
1084845|NCT01003184|2628925|P2|STARTED|Overall Study||111
1084846|NCT01003184|2628926|P1|STARTED|Overall Study||111
1084847|NCT01003210|2628960|P2|NOT COMPLETED|Overall Study||3
1084848|NCT01003210|2628961|P1|NOT COMPLETED|Overall Study||1
1084849|NCT01003210|2628960|P2|COMPLETED|Overall Study||102
1084850|NCT01003210|2628961|P1|COMPLETED|Overall Study||104
1084851|NCT01003210|2628960|P2|STARTED|Overall Study||105
1084852|NCT01003210|2628961|P1|STARTED|Overall Study||105
1084853|NCT01003275|2628971|P2|NOT COMPLETED|Overall Study||0
1084854|NCT01003275|2628972|P1|NOT COMPLETED|Overall Study||1
1084855|NCT01003275|2628971|P2|COMPLETED|Overall Study||11
1084856|NCT01003275|2628972|P1|COMPLETED|Overall Study||10
1084857|NCT01003275|2628971|P2|STARTED|Overall Study||11
1084858|NCT01003275|2628972|P1|STARTED|Overall Study||11
1084859|NCT01003288|2628980|P1|NOT COMPLETED|Overall Study||0
1084860|NCT01003288|2628980|P1|COMPLETED|Overall Study||255
1084861|NCT01003288|2628980|P1|STARTED|Overall Study||255
1084862|NCT01003301|2628987|P2|NOT COMPLETED|Overall Study||0
1084863|NCT01003301|2628988|P1|NOT COMPLETED|Overall Study||0
1084864|NCT01003301|2628987|P2|COMPLETED|Overall Study||9
1084865|NCT01003301|2628988|P1|COMPLETED|Overall Study||10
1084866|NCT01003301|2628987|P2|STARTED|Overall Study||9
1084867|NCT01003301|2628988|P1|STARTED|Overall Study||10
1084868|NCT01003886|2628994|P1|NOT COMPLETED|Overall Study||230
1084869|NCT01003886|2628994|P1|COMPLETED|Overall Study||759
1084870|NCT01003886|2628994|P1|STARTED|Overall Study||989
1084871|NCT01003899|2629003|P1|NOT COMPLETED|Overall Study||47
1084872|NCT01003899|2629003|P1|COMPLETED|Overall Study||0
1084873|NCT01003899|2629003|P1|STARTED|Overall Study|enrolled|47
1084874|NCT01003938|2629012|P1|NOT COMPLETED|Overall Study||0
1084875|NCT01003938|2629012|P1|COMPLETED|Overall Study||6
1084876|NCT01003938|2629012|P1|STARTED|Overall Study||6
1084877|NCT01003990|2629024|P3|NOT COMPLETED|Overall Study||43
1084878|NCT01003990|2629025|P2|NOT COMPLETED|Overall Study||51
1084879|NCT01003990|2629026|P1|NOT COMPLETED|Overall Study||92
1084880|NCT01003990|2629024|P3|COMPLETED|Overall Study||53
1084881|NCT01003990|2629025|P2|COMPLETED|Overall Study||103
1084882|NCT01003990|2629026|P1|COMPLETED|Overall Study||367
1084883|NCT01003990|2629024|P3|STARTED|Overall Study||96
1084884|NCT01003990|2629025|P2|STARTED|Overall Study||154
1084885|NCT01003990|2629026|P1|STARTED|Overall Study||459
1084913|NCT01004146|2629081|P2|NOT COMPLETED|Overall Study||5
1084914|NCT01004146|2629082|P1|NOT COMPLETED|Overall Study||4
1084915|NCT01004146|2629081|P2|COMPLETED|Overall Study||20
1084916|NCT01004146|2629082|P1|COMPLETED|Overall Study||21
1084917|NCT01004146|2629081|P2|Have Incentive Spirometry Data|Overall Study||20
1084918|NCT01004146|2629082|P1|Have Incentive Spirometry Data|Overall Study||21
1084919|NCT01004146|2629081|P2|STARTED|Overall Study||25
1084920|NCT01004146|2629082|P1|STARTED|Overall Study||25
1084921|NCT01004159|2629088|P1|NOT COMPLETED|Overall Study||20
1084922|NCT01004159|2629088|P1|COMPLETED|Overall Study||0
1084923|NCT01004159|2629088|P1|STARTED|Overall Study||20
1084924|NCT01004172|2629093|P1|NOT COMPLETED|Overall Study||38
1084925|NCT01004172|2629093|P1|COMPLETED|Overall Study||0
1084926|NCT01004172|2629093|P1|STARTED|Overall Study||38
1084927|NCT01004185|2629101|P2|NOT COMPLETED|Overall Study||9
1084928|NCT01004185|2629102|P1|NOT COMPLETED|Overall Study||9
1084929|NCT01004185|2629101|P2|COMPLETED|Overall Study||11
1084930|NCT01004185|2629102|P1|COMPLETED|Overall Study||10
1084931|NCT01004185|2629101|P2|STARTED|Overall Study||20
1084932|NCT01004185|2629102|P1|STARTED|Overall Study||19
1084933|NCT01004250|2629110|P1|NOT COMPLETED|Follow-Up (FU) Period||1
1084934|NCT01004250|2629110|P1|COMPLETED|Follow-Up (FU) Period||100
1084935|NCT01004250|2629110|P1|STARTED|Follow-Up (FU) Period|Did not enter FU:Death-4pts Ind,1pts Maint; Pt Withdrew-1 pts Ind,1pts Maint; Lost to FU-1 pts Maint|101
1084936|NCT01004250|2629110|P1|NOT COMPLETED|Maintenance Therapy Period||26
1084937|NCT01004250|2629110|P1|COMPLETED|Maintenance Therapy Period||46
1084938|NCT01004250|2629110|P1|Death (Any Cause) or Disease Progression|Maintenance Therapy Period|Pts with death or disease progression considered to have completed phase.|46
1084939|NCT01004250|2629110|P1|STARTED|Maintenance Therapy Period|Did not enter Maint: 21 pts due to death or disease progression; 1 pts had performance status 2.|72
1084940|NCT01004250|2629110|P1|NOT COMPLETED|Induction Therapy Period||15
1084941|NCT01004250|2629110|P1|COMPLETED|Induction Therapy Period||94
1084942|NCT01004250|2629110|P1|Death (Any Cause) or Disease Progression|Induction Therapy Period|Participants (pts) with death or disease progression considered to have completed phase.|21
1084943|NCT01004250|2629110|P1|Received at Least One Dose of Study Drug|Induction Therapy Period||109
1084944|NCT01004250|2629110|P1|STARTED|Induction Therapy Period||109
1084945|NCT01004263|2629120|P1|NOT COMPLETED|Overall Study||179
1084946|NCT01004263|2629120|P1|COMPLETED|Overall Study||427
1084947|NCT01004263|2629120|P1|STARTED|Overall Study|Participants who took study drug|606
1084948|NCT01004354|2629128|P1|NOT COMPLETED|Overall Study||0
1084949|NCT01004354|2629128|P1|COMPLETED|Overall Study||12
1084950|NCT01004354|2629128|P1|STARTED|Overall Study||12
1084951|NCT01004393|2629132|P1|NOT COMPLETED|Overall Study||0
1084952|NCT01004393|2629132|P1|COMPLETED|Overall Study||12
1084953|NCT01004393|2629132|P1|STARTED|Overall Study||12
1084954|NCT01004432|2629143|P5|NOT COMPLETED|OL Study Extension (Week 52 - 76)||18
1084955|NCT01004432|2629144|P4|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
1084956|NCT01004432|2629145|P3|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
1084957|NCT01004432|2629146|P2|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
1084958|NCT01004432|2629147|P1|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
1084959|NCT01004432|2629143|P5|COMPLETED|OL Study Extension (Week 52 - 76)||194
1084960|NCT01004432|2629144|P4|COMPLETED|OL Study Extension (Week 52 - 76)||0
1084961|NCT01004432|2629145|P3|COMPLETED|OL Study Extension (Week 52 - 76)||0
1084962|NCT01004432|2629146|P2|COMPLETED|OL Study Extension (Week 52 - 76)||0
1084963|NCT01004432|2629147|P1|COMPLETED|OL Study Extension (Week 52 - 76)||0
1084964|NCT01004432|2629143|P5|STARTED|OL Study Extension (Week 52 - 76)||212
1084965|NCT01004432|2629144|P4|STARTED|OL Study Extension (Week 52 - 76)||0
1084966|NCT01004432|2629145|P3|STARTED|OL Study Extension (Week 52 - 76)||0
1084967|NCT01004432|2629146|P2|STARTED|OL Study Extension (Week 52 - 76)||0
1084968|NCT01004432|2629147|P1|STARTED|OL Study Extension (Week 52 - 76)||0
1084969|NCT01004432|2629143|P5|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
1084970|NCT01004432|2629144|P4|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||58
1084971|NCT01004432|2629145|P3|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||37
1084972|NCT01004432|2629146|P2|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||10
1084973|NCT01004432|2629147|P1|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
1084974|NCT01004432|2629143|P5|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
1084975|NCT01004432|2629144|P4|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||126
1084976|NCT01004432|2629145|P3|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||54
1084977|NCT01004432|2629146|P2|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||65
1084978|NCT01004432|2629147|P1|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
1084979|NCT01004432|2629143|P5|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
1084980|NCT01004432|2629144|P4|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||184
1084981|NCT01004432|2629145|P3|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||91
1084982|NCT01004432|2629146|P2|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||75
1084983|NCT01004432|2629147|P1|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
1084984|NCT01004432|2629143|P5|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
1084985|NCT01004432|2629144|P4|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
1084986|NCT01004432|2629145|P3|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
1085077|NCT01004770|2629231|P2|NOT COMPLETED|Overall Study||0
1084987|NCT01004432|2629146|P2|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
1084988|NCT01004432|2629147|P1|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||83
1084989|NCT01004432|2629143|P5|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
1084990|NCT01004432|2629144|P4|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
1084991|NCT01004432|2629145|P3|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
1084992|NCT01004432|2629146|P2|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
1084993|NCT01004432|2629147|P1|COMPLETED|Open-label (OL) Period (Week 0 – 16)|1 Participant died after completing open-label period. Discontinuation was noted as adverse event.|350
1084994|NCT01004432|2629143|P5|STARTED|Open-label (OL) Period (Week 0 – 16)||0
1084995|NCT01004432|2629144|P4|STARTED|Open-label (OL) Period (Week 0 – 16)||0
1084996|NCT01004432|2629145|P3|STARTED|Open-label (OL) Period (Week 0 – 16)||0
1084997|NCT01004432|2629146|P2|STARTED|Open-label (OL) Period (Week 0 – 16)||0
1084998|NCT01004432|2629147|P1|STARTED|Open-label (OL) Period (Week 0 – 16)||433
1084999|NCT01004510|2629167|P1|NOT COMPLETED|Overall Study||1
1085000|NCT01004510|2629167|P1|COMPLETED|Overall Study||2
1085001|NCT01004510|2629167|P1|STARTED|Overall Study||3
1085002|NCT01004614|2629175|P4|NOT COMPLETED|Second Intervention||0
1085003|NCT01004614|2629176|P3|NOT COMPLETED|Second Intervention||0
1085004|NCT01004614|2629177|P2|NOT COMPLETED|Second Intervention||0
1085005|NCT01004614|2629178|P1|NOT COMPLETED|Second Intervention||0
1085006|NCT01004614|2629175|P4|COMPLETED|Second Intervention||12
1085007|NCT01004614|2629176|P3|COMPLETED|Second Intervention||12
1085008|NCT01004614|2629177|P2|COMPLETED|Second Intervention||11
1085009|NCT01004614|2629178|P1|COMPLETED|Second Intervention||12
1085010|NCT01004614|2629175|P4|STARTED|Second Intervention||12
1085011|NCT01004614|2629176|P3|STARTED|Second Intervention||12
1085012|NCT01004614|2629177|P2|STARTED|Second Intervention||11
1085013|NCT01004614|2629178|P1|STARTED|Second Intervention||12
1085014|NCT01004614|2629175|P4|NOT COMPLETED|Washout||0
1085015|NCT01004614|2629176|P3|NOT COMPLETED|Washout||0
1085016|NCT01004614|2629177|P2|NOT COMPLETED|Washout||1
1085017|NCT01004614|2629178|P1|NOT COMPLETED|Washout||0
1085018|NCT01004614|2629175|P4|COMPLETED|Washout||12
1085019|NCT01004614|2629176|P3|COMPLETED|Washout||12
1085020|NCT01004614|2629177|P2|COMPLETED|Washout||11
1085021|NCT01004614|2629178|P1|COMPLETED|Washout||12
1085022|NCT01004614|2629175|P4|STARTED|Washout||12
1085023|NCT01004614|2629176|P3|STARTED|Washout||12
1085024|NCT01004614|2629177|P2|STARTED|Washout||12
1085025|NCT01004614|2629178|P1|STARTED|Washout||12
1085026|NCT01004614|2629175|P4|NOT COMPLETED|First Intervention||0
1085027|NCT01004614|2629176|P3|NOT COMPLETED|First Intervention||0
1085028|NCT01004614|2629177|P2|NOT COMPLETED|First Intervention||0
1085029|NCT01004614|2629178|P1|NOT COMPLETED|First Intervention||0
1085030|NCT01004614|2629175|P4|COMPLETED|First Intervention||12
1085031|NCT01004614|2629176|P3|COMPLETED|First Intervention||12
1085032|NCT01004614|2629177|P2|COMPLETED|First Intervention||12
1085033|NCT01004614|2629178|P1|COMPLETED|First Intervention||12
1085034|NCT01004614|2629175|P4|STARTED|First Intervention||12
1085035|NCT01004614|2629176|P3|STARTED|First Intervention||12
1085036|NCT01004614|2629177|P2|STARTED|First Intervention||12
1085037|NCT01004614|2629178|P1|STARTED|First Intervention||12
1085038|NCT01004705|2629212|P3|NOT COMPLETED|Period 2 (12 Weeks)||4
1085039|NCT01004705|2629213|P2|NOT COMPLETED|Period 2 (12 Weeks)||0
1085040|NCT01004705|2629214|P1|NOT COMPLETED|Period 2 (12 Weeks)||0
1085041|NCT01004705|2629212|P3|COMPLETED|Period 2 (12 Weeks)||9
1085042|NCT01004705|2629213|P2|COMPLETED|Period 2 (12 Weeks)||13
1085043|NCT01004705|2629214|P1|COMPLETED|Period 2 (12 Weeks)||0
1085044|NCT01004705|2629212|P3|STARTED|Period 2 (12 Weeks)||13
1085045|NCT01004705|2629213|P2|STARTED|Period 2 (12 Weeks)||13
1085046|NCT01004705|2629214|P1|STARTED|Period 2 (12 Weeks)||0
1085047|NCT01004705|2629212|P3|NOT COMPLETED|Washout Period (6 Weeks)||0
1085048|NCT01004705|2629213|P2|NOT COMPLETED|Washout Period (6 Weeks)||0
1085049|NCT01004705|2629214|P1|NOT COMPLETED|Washout Period (6 Weeks)||0
1085050|NCT01004705|2629212|P3|COMPLETED|Washout Period (6 Weeks)||13
1085051|NCT01004705|2629213|P2|COMPLETED|Washout Period (6 Weeks)||13
1085052|NCT01004705|2629214|P1|COMPLETED|Washout Period (6 Weeks)||0
1085053|NCT01004705|2629212|P3|STARTED|Washout Period (6 Weeks)||13
1085054|NCT01004705|2629213|P2|STARTED|Washout Period (6 Weeks)||13
1085055|NCT01004705|2629214|P1|STARTED|Washout Period (6 Weeks)||0
1085056|NCT01004705|2629212|P3|NOT COMPLETED|Period 1 (12 Weeks)||5
1085057|NCT01004705|2629213|P2|NOT COMPLETED|Period 1 (12 Weeks)||5
1085058|NCT01004705|2629214|P1|NOT COMPLETED|Period 1 (12 Weeks)||0
1085059|NCT01004705|2629212|P3|COMPLETED|Period 1 (12 Weeks)||13
1085060|NCT01004705|2629213|P2|COMPLETED|Period 1 (12 Weeks)||13
1085061|NCT01004705|2629214|P1|COMPLETED|Period 1 (12 Weeks)||0
1085062|NCT01004705|2629212|P3|STARTED|Period 1 (12 Weeks)||18
1085063|NCT01004705|2629213|P2|STARTED|Period 1 (12 Weeks)||18
1085064|NCT01004705|2629214|P1|STARTED|Period 1 (12 Weeks)||0
1085065|NCT01004705|2629212|P3|NOT COMPLETED|Run-In||0
1085066|NCT01004705|2629213|P2|NOT COMPLETED|Run-In||0
1085067|NCT01004705|2629214|P1|NOT COMPLETED|Run-In||8
1085068|NCT01004705|2629212|P3|COMPLETED|Run-In||0
1085069|NCT01004705|2629213|P2|COMPLETED|Run-In||0
1085070|NCT01004705|2629214|P1|COMPLETED|Run-In||36
1085071|NCT01004705|2629212|P3|STARTED|Run-In||0
1085072|NCT01004705|2629213|P2|STARTED|Run-In||0
1085073|NCT01004705|2629214|P1|STARTED|Run-In||44
1085074|NCT01004770|2629228|P5|NOT COMPLETED|Overall Study||0
1085075|NCT01004770|2629229|P4|NOT COMPLETED|Overall Study||0
1085076|NCT01004770|2629230|P3|NOT COMPLETED|Overall Study||0
1085078|NCT01004770|2629232|P1|NOT COMPLETED|Overall Study||0
1085079|NCT01004770|2629228|P5|COMPLETED|Overall Study||10
1085080|NCT01004770|2629229|P4|COMPLETED|Overall Study||10
1085081|NCT01004770|2629230|P3|COMPLETED|Overall Study||10
1085082|NCT01004770|2629231|P2|COMPLETED|Overall Study||10
1085083|NCT01004770|2629232|P1|COMPLETED|Overall Study||10
1085084|NCT01004770|2629228|P5|STARTED|Overall Study||10
1085085|NCT01004770|2629229|P4|STARTED|Overall Study||10
1085086|NCT01004770|2629230|P3|STARTED|Overall Study||10
1085087|NCT01004770|2629231|P2|STARTED|Overall Study||10
1085088|NCT01004770|2629232|P1|STARTED|Overall Study||10
1085089|NCT01004822|2629272|P8|NOT COMPLETED|Overall Study||5
1085090|NCT01004822|2629273|P7|NOT COMPLETED|Overall Study||4
1085091|NCT01004822|2629274|P6|NOT COMPLETED|Overall Study||4
1085092|NCT01004822|2629275|P5|NOT COMPLETED|Overall Study||4
1085093|NCT01004822|2629276|P4|NOT COMPLETED|Overall Study||4
1085094|NCT01004822|2629277|P3|NOT COMPLETED|Overall Study||4
1085095|NCT01004822|2629278|P2|NOT COMPLETED|Overall Study||3
1085096|NCT01004822|2629279|P1|NOT COMPLETED|Overall Study||3
1085097|NCT01004822|2629272|P8|COMPLETED|Overall Study||0
1085098|NCT01004822|2629273|P7|COMPLETED|Overall Study||0
1085099|NCT01004822|2629274|P6|COMPLETED|Overall Study||0
1085100|NCT01004822|2629275|P5|COMPLETED|Overall Study||0
1085101|NCT01004822|2629276|P4|COMPLETED|Overall Study||0
1085102|NCT01004822|2629277|P3|COMPLETED|Overall Study||0
1085103|NCT01004822|2629278|P2|COMPLETED|Overall Study||0
1085104|NCT01004822|2629279|P1|COMPLETED|Overall Study||0
1085105|NCT01004822|2629272|P8|Treated|Overall Study||5
1085106|NCT01004822|2629273|P7|Treated|Overall Study||4
1085107|NCT01004822|2629274|P6|Treated|Overall Study||4
1085108|NCT01004822|2629275|P5|Treated|Overall Study||4
1085109|NCT01004822|2629276|P4|Treated|Overall Study||4
1085110|NCT01004822|2629277|P3|Treated|Overall Study||3
1085111|NCT01004822|2629278|P2|Treated|Overall Study||3
1085112|NCT01004822|2629279|P1|Treated|Overall Study||3
1085113|NCT01004822|2629272|P8|STARTED|Overall Study||5
1085114|NCT01004822|2629273|P7|STARTED|Overall Study||4
1085115|NCT01004822|2629274|P6|STARTED|Overall Study||4
1085116|NCT01004822|2629275|P5|STARTED|Overall Study||4
1085117|NCT01004822|2629276|P4|STARTED|Overall Study||4
1085118|NCT01004822|2629277|P3|STARTED|Overall Study||4
1085119|NCT01004822|2629278|P2|STARTED|Overall Study||3
1085120|NCT01004822|2629279|P1|STARTED|Overall Study||3
1085121|NCT01004848|2629390|P2|NOT COMPLETED|Overall Study||45
1085122|NCT01004848|2629391|P1|NOT COMPLETED|Overall Study||55
1085123|NCT01004848|2629390|P2|COMPLETED|Overall Study||147
1085124|NCT01004848|2629391|P1|COMPLETED|Overall Study||155
1085125|NCT01004848|2629390|P2|STARTED|Overall Study||192
1085126|NCT01004848|2629391|P1|STARTED|Overall Study||210
1085127|NCT01004874|2629421|P1|NOT COMPLETED|Overall Study||0
1085128|NCT01004874|2629421|P1|COMPLETED|Overall Study||80
1085129|NCT01004874|2629421|P1|STARTED|Overall Study||80
1085130|NCT01004939|2629430|P1|NOT COMPLETED|Overall Study||0
1085131|NCT01004939|2629430|P1|COMPLETED|Overall Study||120
1085132|NCT01004939|2629430|P1|STARTED|Overall Study||120
1085133|NCT01004991|2629471|P1|NOT COMPLETED|Overall Study||0
1085134|NCT01004991|2629471|P1|COMPLETED|Overall Study||12
1085135|NCT01004991|2629471|P1|STARTED|Overall Study||12
1085136|NCT01005251|2629480|P5|NOT COMPLETED|Overall Study||18
1085137|NCT01005251|2629481|P4|NOT COMPLETED|Overall Study||12
1085138|NCT01005251|2629482|P3|NOT COMPLETED|Overall Study||22
1085139|NCT01005251|2629483|P2|NOT COMPLETED|Overall Study||16
1085140|NCT01005251|2629484|P1|NOT COMPLETED|Overall Study||13
1085141|NCT01005251|2629480|P5|COMPLETED|Overall Study||122
1085142|NCT01005251|2629481|P4|COMPLETED|Overall Study||114
1085143|NCT01005251|2629482|P3|COMPLETED|Overall Study||114
1085144|NCT01005251|2629483|P2|COMPLETED|Overall Study||109
1085145|NCT01005251|2629484|P1|COMPLETED|Overall Study||121
1085146|NCT01005251|2629480|P5|STARTED|Overall Study||140
1085147|NCT01005251|2629481|P4|STARTED|Overall Study||126
1085148|NCT01005251|2629482|P3|STARTED|Overall Study||136
1085149|NCT01005251|2629483|P2|STARTED|Overall Study||125
1085150|NCT01005251|2629484|P1|STARTED|Overall Study||134
1085151|NCT01005290|2629501|P3|NOT COMPLETED|Period 2 (5 Weeks)||2
1085152|NCT01005290|2629502|P2|NOT COMPLETED|Period 2 (5 Weeks)||0
1085153|NCT01005290|2629503|P1|NOT COMPLETED|Period 2 (5 Weeks)||0
1085154|NCT01005290|2629501|P3|COMPLETED|Period 2 (5 Weeks)||7
1085155|NCT01005290|2629502|P2|COMPLETED|Period 2 (5 Weeks)||13
1085156|NCT01005290|2629503|P1|COMPLETED|Period 2 (5 Weeks)||0
1085157|NCT01005290|2629501|P3|STARTED|Period 2 (5 Weeks)||9
1085158|NCT01005290|2629502|P2|STARTED|Period 2 (5 Weeks)||13
1085159|NCT01005290|2629503|P1|STARTED|Period 2 (5 Weeks)||0
1085160|NCT01005290|2629501|P3|NOT COMPLETED|Washout Period (2 Weeks)||0
1085161|NCT01005290|2629502|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
1085162|NCT01005290|2629503|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
1085163|NCT01005290|2629501|P3|COMPLETED|Washout Period (2 Weeks)||9
1085164|NCT01005290|2629502|P2|COMPLETED|Washout Period (2 Weeks)||13
1085165|NCT01005290|2629503|P1|COMPLETED|Washout Period (2 Weeks)||0
1085166|NCT01005290|2629501|P3|STARTED|Washout Period (2 Weeks)||9
1085167|NCT01005290|2629502|P2|STARTED|Washout Period (2 Weeks)||13
1085168|NCT01005290|2629503|P1|STARTED|Washout Period (2 Weeks)||0
1085169|NCT01005290|2629501|P3|NOT COMPLETED|Period 1 (5 Weeks)||9
1085170|NCT01005290|2629502|P2|NOT COMPLETED|Period 1 (5 Weeks)||7
1085171|NCT01005290|2629503|P1|NOT COMPLETED|Period 1 (5 Weeks)||0
1085172|NCT01005290|2629501|P3|COMPLETED|Period 1 (5 Weeks)||9
1085173|NCT01005290|2629502|P2|COMPLETED|Period 1 (5 Weeks)||13
1085174|NCT01005290|2629503|P1|COMPLETED|Period 1 (5 Weeks)||0
1085175|NCT01005290|2629501|P3|STARTED|Period 1 (5 Weeks)||18
1085176|NCT01005290|2629502|P2|STARTED|Period 1 (5 Weeks)||20
1085177|NCT01005290|2629503|P1|STARTED|Period 1 (5 Weeks)||0
1085178|NCT01005290|2629501|P3|NOT COMPLETED|Run-In||0
1085179|NCT01005290|2629502|P2|NOT COMPLETED|Run-In||0
1085180|NCT01005290|2629503|P1|NOT COMPLETED|Run-In||14
1085181|NCT01005290|2629501|P3|COMPLETED|Run-In||0
1085182|NCT01005290|2629502|P2|COMPLETED|Run-In||0
1085183|NCT01005290|2629503|P1|COMPLETED|Run-In||38
1085184|NCT01005290|2629501|P3|STARTED|Run-In||0
1085185|NCT01005290|2629502|P2|STARTED|Run-In||0
1085186|NCT01005290|2629503|P1|STARTED|Run-In||52
1085187|NCT01005316|2629514|P4|NOT COMPLETED|Overall Study||108
1085188|NCT01005316|2629515|P3|NOT COMPLETED|Overall Study||11
1085189|NCT01005316|2629516|P2|NOT COMPLETED|Overall Study||76
1085190|NCT01005316|2629517|P1|NOT COMPLETED|Overall Study||50
1085191|NCT01005316|2629514|P4|COMPLETED|Overall Study||19
1085192|NCT01005316|2629515|P3|COMPLETED|Overall Study||5
1085193|NCT01005316|2629516|P2|COMPLETED|Overall Study||21
1085194|NCT01005316|2629517|P1|COMPLETED|Overall Study||0
1085195|NCT01005316|2629514|P4|STARTED|Overall Study||127
1085196|NCT01005316|2629515|P3|STARTED|Overall Study||16
1085197|NCT01005316|2629516|P2|STARTED|Overall Study||97
1085198|NCT01005316|2629517|P1|STARTED|Overall Study||50
1085199|NCT01005329|2629569|P1|NOT COMPLETED|Overall Study||4
1085200|NCT01005329|2629569|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|30
1085201|NCT01005329|2629569|P1|STARTED|Overall Study||34
1085202|NCT01005355|2629576|P3|NOT COMPLETED|Overall Study||0
1085203|NCT01005355|2629577|P2|NOT COMPLETED|Overall Study||0
1085204|NCT01005355|2629578|P1|NOT COMPLETED|Overall Study||0
1085205|NCT01005355|2629576|P3|COMPLETED|Overall Study||6
1085206|NCT01005355|2629577|P2|COMPLETED|Overall Study||6
1085207|NCT01005355|2629578|P1|COMPLETED|Overall Study||3
1085208|NCT01005355|2629576|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
1085209|NCT01005355|2629577|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
1085210|NCT01005355|2629578|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
1085211|NCT01005355|2629576|P3|STARTED|Overall Study||6
1085212|NCT01005355|2629577|P2|STARTED|Overall Study||6
1085213|NCT01005355|2629578|P1|STARTED|Overall Study||3
1085214|NCT01005459|2629615|P2|NOT COMPLETED|Overall Study||0
1085215|NCT01005459|2629616|P1|NOT COMPLETED|Overall Study||0
1085216|NCT01005459|2629615|P2|COMPLETED|Overall Study||23
1085217|NCT01005459|2629616|P1|COMPLETED|Overall Study||23
1085218|NCT01005459|2629615|P2|STARTED|Overall Study||23
1085219|NCT01005459|2629616|P1|STARTED|Overall Study||23
1085220|NCT01005602|2629624|P2|NOT COMPLETED|Overall Study||0
1085221|NCT01005602|2629625|P1|NOT COMPLETED|Overall Study||1
1085222|NCT01005602|2629624|P2|COMPLETED|Overall Study||66
1085223|NCT01005602|2629625|P1|COMPLETED|Overall Study|One patient completed the trial but was excluded from data analyses due to unreliable clinical data.|65
1085224|NCT01005602|2629624|P2|STARTED|Overall Study||66
1085225|NCT01005602|2629625|P1|STARTED|Overall Study||66
1085226|NCT01005680|2629647|P2|NOT COMPLETED|Overall Study||11
1085227|NCT01005680|2629648|P1|NOT COMPLETED|Overall Study||6
1085228|NCT01005680|2629647|P2|COMPLETED|Overall Study||119
1085229|NCT01005680|2629648|P1|COMPLETED|Overall Study||120
1085230|NCT01005680|2629647|P2|Received at Least 1 Dose of Study Drug|Overall Study||127
1085231|NCT01005680|2629648|P1|Received at Least 1 Dose of Study Drug|Overall Study||125
1085232|NCT01005680|2629647|P2|STARTED|Overall Study||130
1085233|NCT01005680|2629648|P1|STARTED|Overall Study||126
1085234|NCT01005706|2629672|P2|NOT COMPLETED|Overall Study||0
1085235|NCT01005706|2629673|P1|NOT COMPLETED|Overall Study||0
1085236|NCT01005706|2629672|P2|COMPLETED|Overall Study||17
1085237|NCT01005706|2629673|P1|COMPLETED|Overall Study||23
1085238|NCT01005706|2629672|P2|STARTED|Overall Study||17
1085239|NCT01005706|2629673|P1|STARTED|Overall Study||23
1085240|NCT01005719|2629679|P6|NOT COMPLETED|Period 3||0
1085241|NCT01005719|2629680|P5|NOT COMPLETED|Period 3||0
1085242|NCT01005719|2629681|P4|NOT COMPLETED|Period 3||0
1085243|NCT01005719|2629682|P3|NOT COMPLETED|Period 3||0
1085244|NCT01005719|2629683|P2|NOT COMPLETED|Period 3||0
1085245|NCT01005719|2629684|P1|NOT COMPLETED|Period 3||0
1085246|NCT01005719|2629679|P6|COMPLETED|Period 3||9
1085247|NCT01005719|2629680|P5|COMPLETED|Period 3||10
1085248|NCT01005719|2629681|P4|COMPLETED|Period 3||10
1085249|NCT01005719|2629682|P3|COMPLETED|Period 3||10
1085250|NCT01005719|2629683|P2|COMPLETED|Period 3||10
1085251|NCT01005719|2629684|P1|COMPLETED|Period 3||10
1085252|NCT01005719|2629679|P6|STARTED|Period 3||9
1085253|NCT01005719|2629680|P5|STARTED|Period 3||10
1085254|NCT01005719|2629681|P4|STARTED|Period 3||10
1085255|NCT01005719|2629682|P3|STARTED|Period 3||10
1085256|NCT01005719|2629683|P2|STARTED|Period 3||10
1085257|NCT01005719|2629684|P1|STARTED|Period 3||10
1085258|NCT01005719|2629679|P6|NOT COMPLETED|Period 2||1
1085259|NCT01005719|2629680|P5|NOT COMPLETED|Period 2||1
1085260|NCT01005719|2629681|P4|NOT COMPLETED|Period 2||0
1085261|NCT01005719|2629682|P3|NOT COMPLETED|Period 2||0
1085262|NCT01005719|2629683|P2|NOT COMPLETED|Period 2||0
1085263|NCT01005719|2629684|P1|NOT COMPLETED|Period 2||0
1085264|NCT01005719|2629679|P6|COMPLETED|Period 2||9
1085265|NCT01005719|2629680|P5|COMPLETED|Period 2||10
1085266|NCT01005719|2629681|P4|COMPLETED|Period 2||10
1085267|NCT01005719|2629682|P3|COMPLETED|Period 2||10
1085268|NCT01005719|2629683|P2|COMPLETED|Period 2||10
1085269|NCT01005719|2629684|P1|COMPLETED|Period 2||10
1085270|NCT01005719|2629679|P6|STARTED|Period 2||10
1085271|NCT01005719|2629680|P5|STARTED|Period 2||11
1085272|NCT01005719|2629681|P4|STARTED|Period 2||10
1085273|NCT01005719|2629682|P3|STARTED|Period 2||10
1085274|NCT01005719|2629683|P2|STARTED|Period 2||10
1085275|NCT01005719|2629684|P1|STARTED|Period 2||10
1085276|NCT01005719|2629679|P6|NOT COMPLETED|Period 1||1
1085277|NCT01005719|2629680|P5|NOT COMPLETED|Period 1||0
1085278|NCT01005719|2629681|P4|NOT COMPLETED|Period 1||1
1085279|NCT01005719|2629682|P3|NOT COMPLETED|Period 1||0
1085280|NCT01005719|2629683|P2|NOT COMPLETED|Period 1||0
1085281|NCT01005719|2629684|P1|NOT COMPLETED|Period 1||0
1085282|NCT01005719|2629679|P6|COMPLETED|Period 1||10
1085283|NCT01005719|2629680|P5|COMPLETED|Period 1||11
1085284|NCT01005719|2629681|P4|COMPLETED|Period 1||10
1085285|NCT01005719|2629682|P3|COMPLETED|Period 1||10
1085286|NCT01005719|2629683|P2|COMPLETED|Period 1||10
1085287|NCT01005719|2629684|P1|COMPLETED|Period 1||10
1085288|NCT01005719|2629679|P6|STARTED|Period 1||11
1085289|NCT01005719|2629680|P5|STARTED|Period 1||11
1085290|NCT01005719|2629681|P4|STARTED|Period 1||11
1085291|NCT01005719|2629682|P3|STARTED|Period 1||10
1085292|NCT01005719|2629683|P2|STARTED|Period 1||10
1085293|NCT01005719|2629684|P1|STARTED|Period 1||10
1085294|NCT01005732|2629740|P1|NOT COMPLETED|Overall Study||11
1085295|NCT01005732|2629740|P1|COMPLETED|Overall Study||43
1085296|NCT01005732|2629740|P1|STARTED|Overall Study||54
1085297|NCT01005745|2629756|P1|NOT COMPLETED|Overall Study||6
1085298|NCT01005745|2629756|P1|COMPLETED|Overall Study||13
1085299|NCT01005745|2629756|P1|STARTED|Overall Study||19
1085300|NCT01005875|2629761|P1|NOT COMPLETED|Overall Study||3
1085301|NCT01005875|2629761|P1|COMPLETED|Overall Study||2
1085302|NCT01005875|2629761|P1|STARTED|Overall Study||5
1085303|NCT01005888|2629773|P2|NOT COMPLETED|Second Intervention||1
1085304|NCT01005888|2629774|P1|NOT COMPLETED|Second Intervention||1
1085305|NCT01005888|2629773|P2|COMPLETED|Second Intervention||10
1085306|NCT01005888|2629774|P1|COMPLETED|Second Intervention||10
1085307|NCT01005888|2629773|P2|STARTED|Second Intervention||11
1085308|NCT01005888|2629774|P1|STARTED|Second Intervention||11
1085309|NCT01005888|2629773|P2|NOT COMPLETED|First Intervention||1
1085310|NCT01005888|2629774|P1|NOT COMPLETED|First Intervention||1
1085311|NCT01005888|2629773|P2|COMPLETED|First Intervention||11
1085312|NCT01005888|2629774|P1|COMPLETED|First Intervention||11
1085313|NCT01005888|2629773|P2|STARTED|First Intervention||12
1085314|NCT01005888|2629774|P1|STARTED|First Intervention||12
1085315|NCT01005901|2629796|P2|NOT COMPLETED|Overall Study||58
1085316|NCT01005901|2629797|P1|NOT COMPLETED|Overall Study||102
1085317|NCT01005901|2629796|P2|COMPLETED|Overall Study||212
1085318|NCT01005901|2629797|P1|COMPLETED|Overall Study||450
1085319|NCT01005901|2629796|P2|Full Analysis Set|Overall Study||260
1085320|NCT01005901|2629797|P1|Full Analysis Set|Overall Study||534
1085321|NCT01005901|2629796|P2|Safety Population|Overall Study||267
1085322|NCT01005901|2629797|P1|Safety Population|Overall Study||550
1085323|NCT01005901|2629796|P2|STARTED|Overall Study||270
1085324|NCT01005901|2629797|P1|STARTED|Overall Study||552
1085325|NCT01005914|2629835|P1|NOT COMPLETED|Overall Study||10
1085326|NCT01005914|2629835|P1|COMPLETED|Overall Study||1
1085327|NCT01005914|2629835|P1|STARTED|Overall Study||11
1085463|NCT01006018|2629866|P3|NOT COMPLETED|Overall Study||0
1085464|NCT01006018|2629867|P2|NOT COMPLETED|Overall Study||0
1085465|NCT01006018|2629868|P1|NOT COMPLETED|Overall Study||0
1085466|NCT01006018|2629866|P3|COMPLETED|Overall Study||0
1085467|NCT01006018|2629867|P2|COMPLETED|Overall Study||0
1085468|NCT01006018|2629868|P1|COMPLETED|Overall Study||0
1085469|NCT01006018|2629866|P3|STARTED|Overall Study||0
1085470|NCT01006018|2629867|P2|STARTED|Overall Study||0
1085471|NCT01006018|2629868|P1|STARTED|Overall Study||0
1085472|NCT01006122|2629876|P2|NOT COMPLETED|Second Double-blind Intervention Period||7
1085473|NCT01006122|2629877|P1|NOT COMPLETED|Second Double-blind Intervention Period||2
1085474|NCT01006122|2629876|P2|COMPLETED|Second Double-blind Intervention Period||24
1085475|NCT01006122|2629877|P1|COMPLETED|Second Double-blind Intervention Period||29
1085476|NCT01006122|2629876|P2|STARTED|Second Double-blind Intervention Period||31
1085477|NCT01006122|2629877|P1|STARTED|Second Double-blind Intervention Period||31
1085478|NCT01006122|2629876|P2|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
1085479|NCT01006122|2629877|P1|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
1085480|NCT01006122|2629876|P2|COMPLETED|Wash-out Period (at Least 7 Days)||31
1085481|NCT01006122|2629877|P1|COMPLETED|Wash-out Period (at Least 7 Days)||31
1085482|NCT01006122|2629876|P2|STARTED|Wash-out Period (at Least 7 Days)||31
1085483|NCT01006122|2629877|P1|STARTED|Wash-out Period (at Least 7 Days)||31
1085484|NCT01006122|2629876|P2|NOT COMPLETED|First Double-blind Intervention Period||17
1085485|NCT01006122|2629877|P1|NOT COMPLETED|First Double-blind Intervention Period||16
1085486|NCT01006122|2629876|P2|COMPLETED|First Double-blind Intervention Period||31
1085487|NCT01006122|2629877|P1|COMPLETED|First Double-blind Intervention Period||31
1085488|NCT01006122|2629876|P2|STARTED|First Double-blind Intervention Period||48
1085489|NCT01006122|2629877|P1|STARTED|First Double-blind Intervention Period||47
1085490|NCT01006135|2629915|P1|NOT COMPLETED|Overall Study||140
1085491|NCT01006135|2629915|P1|COMPLETED|Overall Study||4712
1085492|NCT01006135|2629915|P1|STARTED|Overall Study||4852
1085493|NCT00999661|2629922|P1|NOT COMPLETED|Overall Study||70
1085494|NCT00999661|2629922|P1|COMPLETED|Overall Study||161
1085495|NCT00999661|2629922|P1|STARTED|Overall Study||231
1085496|NCT00999687|2629928|P1|NOT COMPLETED|Second Intervention||3
1085497|NCT00999687|2629928|P1|COMPLETED|Second Intervention||27
1085498|NCT00999687|2629928|P1|STARTED|Second Intervention|From week 13 to 24, all participants applied INOE to both hands twice daily.|30
1085499|NCT00999687|2629928|P1|NOT COMPLETED|First Intervention||1
1085500|NCT00999687|2629928|P1|COMPLETED|First Intervention||30
1085501|NCT00999687|2629928|P1|STARTED|First Intervention|16 used the INOE on the right hand,15 used the INOE on the left hand.|31
1085502|NCT00999804|2629937|P2|NOT COMPLETED|Overall Study||5
1085503|NCT00999804|2629938|P1|NOT COMPLETED|Overall Study||21
1085504|NCT00999804|2629937|P2|COMPLETED|Overall Study||38
1085505|NCT00999804|2629938|P1|COMPLETED|Overall Study||64
1085506|NCT00999804|2629937|P2|STARTED|Overall Study||43
1085507|NCT00999804|2629938|P1|STARTED|Overall Study||85
1085508|NCT00999830|2629952|P2|NOT COMPLETED|Overall Study||0
1085509|NCT00999830|2629953|P1|NOT COMPLETED|Overall Study||0
1085510|NCT00999830|2629952|P2|COMPLETED|Overall Study||13
1085511|NCT00999830|2629953|P1|COMPLETED|Overall Study||14
1085512|NCT00999830|2629952|P2|STARTED|Overall Study||13
1085513|NCT00999830|2629953|P1|STARTED|Overall Study||14
1085514|NCT00999908|2629963|P3|NOT COMPLETED|Treatment Period 3||0
1085515|NCT00999908|2629964|P2|NOT COMPLETED|Treatment Period 3||0
1085516|NCT00999908|2629965|P1|NOT COMPLETED|Treatment Period 3||0
1085517|NCT00999908|2629963|P3|COMPLETED|Treatment Period 3||19
1085518|NCT00999908|2629964|P2|COMPLETED|Treatment Period 3||16
1085519|NCT00999908|2629965|P1|COMPLETED|Treatment Period 3||16
1085520|NCT00999908|2629963|P3|STARTED|Treatment Period 3||19
1085521|NCT00999908|2629964|P2|STARTED|Treatment Period 3||16
1085522|NCT00999908|2629965|P1|STARTED|Treatment Period 3||16
1085523|NCT00999908|2629963|P3|NOT COMPLETED|Treatment Period 2||0
1085524|NCT00999908|2629964|P2|NOT COMPLETED|Treatment Period 2||0
1085525|NCT00999908|2629965|P1|NOT COMPLETED|Treatment Period 2||1
1085526|NCT00999908|2629963|P3|COMPLETED|Treatment Period 2||19
1085527|NCT00999908|2629964|P2|COMPLETED|Treatment Period 2||16
1085528|NCT00999908|2629965|P1|COMPLETED|Treatment Period 2||16
1085529|NCT00999908|2629963|P3|STARTED|Treatment Period 2||19
1085530|NCT00999908|2629964|P2|STARTED|Treatment Period 2||16
1085531|NCT00999908|2629965|P1|STARTED|Treatment Period 2||17
1085532|NCT00999908|2629963|P3|NOT COMPLETED|Treatment Period 1||0
1085533|NCT00999908|2629964|P2|NOT COMPLETED|Treatment Period 1||0
1085534|NCT00999908|2629965|P1|NOT COMPLETED|Treatment Period 1||2
1085535|NCT00999908|2629963|P3|COMPLETED|Treatment Period 1||19
1085536|NCT00999908|2629964|P2|COMPLETED|Treatment Period 1||16
1085537|NCT00999908|2629965|P1|COMPLETED|Treatment Period 1||17
1085538|NCT00999908|2629963|P3|STARTED|Treatment Period 1||19
1085539|NCT00999908|2629964|P2|STARTED|Treatment Period 1||16
1085540|NCT00999908|2629965|P1|STARTED|Treatment Period 1||19
1085541|NCT00999921|2629981|P2|NOT COMPLETED|Overall Study||19
1085542|NCT00999921|2629982|P1|NOT COMPLETED|Overall Study||10
1085543|NCT00999921|2629981|P2|COMPLETED|Overall Study||110
1085544|NCT00999921|2629982|P1|COMPLETED|Overall Study||117
1085545|NCT00999921|2629981|P2|STARTED|Overall Study||129
1085546|NCT00999921|2629982|P1|STARTED|Overall Study||127
1085547|NCT01000025|2629994|P2|NOT COMPLETED|Overall Study||238
1085548|NCT01000025|2629995|P1|NOT COMPLETED|Overall Study||468
1085549|NCT01000025|2629994|P2|COMPLETED|Overall Study||2
1085550|NCT01000025|2629995|P1|COMPLETED|Overall Study||12
1085551|NCT01000025|2629994|P2|STARTED|Overall Study||240
1085552|NCT01000025|2629995|P1|STARTED|Overall Study||480
1085553|NCT01000064|2630011|P2|NOT COMPLETED|Overall Study||1
1085554|NCT01000064|2630012|P1|NOT COMPLETED|Overall Study||1
1085555|NCT01000064|2630011|P2|COMPLETED|Overall Study||5
1085556|NCT01000064|2630012|P1|COMPLETED|Overall Study||6
1085557|NCT01000064|2630011|P2|STARTED|Overall Study||6
1085558|NCT01000064|2630012|P1|STARTED|Overall Study||7
1085559|NCT01000155|2630033|P1|NOT COMPLETED|Overall Study||2
1085560|NCT01000155|2630033|P1|COMPLETED|Overall Study||3
1085561|NCT01000155|2630033|P1|STARTED|Overall Study||5
1085562|NCT01000285|2630041|P1|NOT COMPLETED|Overall Study||0
1085563|NCT01000285|2630041|P1|COMPLETED|Overall Study||18
1085564|NCT01000285|2630041|P1|STARTED|Overall Study||18
1085565|NCT01000311|2630063|P2|NOT COMPLETED|Overall Study||70
1085566|NCT01000311|2630064|P1|NOT COMPLETED|Overall Study||45
1085567|NCT01000311|2630063|P2|COMPLETED|Overall Study||201
1085568|NCT01000311|2630064|P1|COMPLETED|Overall Study||213
1085569|NCT01000311|2630063|P2|STARTED|Overall Study||271
1085570|NCT01000311|2630064|P1|STARTED|Overall Study||258
1085571|NCT01000324|2630092|P1|NOT COMPLETED|Year 20||0
1085572|NCT01000324|2630092|P1|COMPLETED|Year 20||28
1085573|NCT01000324|2630092|P1|STARTED|Year 20||28
1085574|NCT01000324|2630092|P1|NOT COMPLETED|Year 19||0
1085575|NCT01000324|2630092|P1|COMPLETED|Year 19||28
1085576|NCT01000324|2630092|P1|STARTED|Year 19||28
1085577|NCT01000324|2630092|P1|NOT COMPLETED|Year 18||0
1085578|NCT01000324|2630092|P1|COMPLETED|Year 18||29
1085579|NCT01000324|2630092|P1|STARTED|Year 18||29
1085580|NCT01000324|2630092|P1|NOT COMPLETED|Year 17||0
1085581|NCT01000324|2630092|P1|COMPLETED|Year 17||32
1085582|NCT01000324|2630092|P1|STARTED|Year 17||32
1085583|NCT01000324|2630092|P1|NOT COMPLETED|Year 16||0
1085584|NCT01000324|2630092|P1|COMPLETED|Year 16||40
1085585|NCT01000324|2630092|P1|STARTED|Year 16||40
1085586|NCT01000337|2630104|P2|NOT COMPLETED|Overall Study||3
1085587|NCT01000337|2630105|P1|NOT COMPLETED|Overall Study||4
1085588|NCT01000337|2630104|P2|COMPLETED|Overall Study||30
1085589|NCT01000337|2630105|P1|COMPLETED|Overall Study||30
1085590|NCT01000337|2630104|P2|STARTED|Overall Study||33
1085591|NCT01000337|2630105|P1|STARTED|Overall Study||34
1085592|NCT01000376|2630113|P2|NOT COMPLETED|Cycle 1 Day 15||0
1085593|NCT01000376|2630114|P1|NOT COMPLETED|Cycle 1 Day 15||0
1085594|NCT01000376|2630113|P2|COMPLETED|Cycle 1 Day 15||6
1085595|NCT01000376|2630114|P1|COMPLETED|Cycle 1 Day 15||4
1085596|NCT01000376|2630113|P2|STARTED|Cycle 1 Day 15||6
1085597|NCT01000376|2630114|P1|STARTED|Cycle 1 Day 15||4
1085598|NCT01000376|2630113|P2|NOT COMPLETED|Cycle 1 Day 1||0
1085599|NCT01000376|2630114|P1|NOT COMPLETED|Cycle 1 Day 1||2
1085600|NCT01000376|2630113|P2|COMPLETED|Cycle 1 Day 1||6
1085601|NCT01000376|2630114|P1|COMPLETED|Cycle 1 Day 1||4
1085602|NCT01000376|2630113|P2|STARTED|Cycle 1 Day 1||6
1085603|NCT01000376|2630114|P1|STARTED|Cycle 1 Day 1||6
1085604|NCT01000480|2630122|P1|NOT COMPLETED|Follow-Up Period||0
1085605|NCT01000480|2630122|P1|COMPLETED|Follow-Up Period||88
1085606|NCT01000480|2630122|P1|STARTED|Follow-Up Period|One pt lost to follow-up during induction, 1 pt died in concurrent therapy, both not enter follow-up|88
1085607|NCT01000480|2630122|P1|NOT COMPLETED|Concurrent Therapy Phase||10
1085608|NCT01000480|2630122|P1|COMPLETED|Concurrent Therapy Phase||65
1085609|NCT01000480|2630122|P1|Death (Any Cause) or Disease Progression|Concurrent Therapy Phase|Pts who died (any cause) or had disease progression considered to have completed the phase.|1
1085610|NCT01000480|2630122|P1|STARTED|Concurrent Therapy Phase|Eight participants (pts) who completed Induction Phase, not eligible for Concurrent Therapy Phase.|75
1085611|NCT01000480|2630122|P1|NOT COMPLETED|Induction Phase||7
1085612|NCT01000480|2630122|P1|COMPLETED|Induction Phase||83
1085613|NCT01000480|2630122|P1|Death (Any Cause) or Disease Progression|Induction Phase|Participants who died (any cause) or had disease progression considered to have completed phase.|8
1085614|NCT01000480|2630122|P1|Received at Least 1 Dose of Either Drug|Induction Phase||90
1085615|NCT01000480|2630122|P1|STARTED|Induction Phase||90
1085616|NCT01000493|2630130|P2|NOT COMPLETED|Overall Study||55
1085617|NCT01000493|2630131|P1|NOT COMPLETED|Overall Study||39
1085618|NCT01000493|2630130|P2|COMPLETED|Overall Study||14
1085619|NCT01000493|2630131|P1|COMPLETED|Overall Study||21
1085620|NCT01000493|2630130|P2|STARTED|Overall Study||69
1085621|NCT01000493|2630131|P1|STARTED|Overall Study||60
1085634|NCT01006291|2630233|P3|NOT COMPLETED|Overall Study||27
1085635|NCT01006291|2630234|P2|NOT COMPLETED|Overall Study||24
1085636|NCT01006291|2630235|P1|NOT COMPLETED|Overall Study||26
1085637|NCT01006291|2630233|P3|COMPLETED|Overall Study||203
1085638|NCT01006291|2630234|P2|COMPLETED|Overall Study||204
1085639|NCT01006291|2630235|P1|COMPLETED|Overall Study||203
1085640|NCT01006291|2630233|P3|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|229
1085641|NCT01006291|2630234|P2|Exposed|Overall Study|2 subjects received IDeg OD FF|226
1085642|NCT01006291|2630235|P1|Exposed|Overall Study|1 subject withdrew before exposure to drug. 2 subjects randomised to IDeg OD received IDeg OD FF|230
1085643|NCT01006291|2630233|P3|STARTED|Overall Study||230
1085644|NCT01006291|2630234|P2|STARTED|Overall Study||228
1085645|NCT01006291|2630235|P1|STARTED|Overall Study||229
1085646|NCT01006356|2630252|P1|NOT COMPLETED|Overall Study||42
1085647|NCT01006356|2630252|P1|COMPLETED|Overall Study||99
1085648|NCT01006356|2630252|P1|STARTED|Overall Study||141
1085649|NCT01006889|2630264|P1|NOT COMPLETED|Overall Study||3
1085650|NCT01006889|2630264|P1|COMPLETED|Overall Study||17
1085651|NCT01006889|2630264|P1|STARTED|Overall Study||20
1085652|NCT01006980|2630277|P2|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||84
1085653|NCT01006980|2630278|P1|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
1085654|NCT01006980|2630277|P2|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
1085655|NCT01006980|2630278|P1|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
1085656|NCT01006980|2630277|P2|STARTED|Crossover: Dacarbazine to Vemurafenib|Participants who crossed over from dacarbazine to vemurafenib treatment.|84
1085657|NCT01006980|2630278|P1|STARTED|Crossover: Dacarbazine to Vemurafenib||0
1085658|NCT01006980|2630277|P2|NOT COMPLETED|Vemurafenib and Dacarbazine||338
1085659|NCT01006980|2630278|P1|NOT COMPLETED|Vemurafenib and Dacarbazine||337
1085660|NCT01006980|2630277|P2|COMPLETED|Vemurafenib and Dacarbazine||0
1085661|NCT01006980|2630278|P1|COMPLETED|Vemurafenib and Dacarbazine||0
1085662|NCT01006980|2630277|P2|Treated|Vemurafenib and Dacarbazine||293
1085663|NCT01006980|2630278|P1|Treated|Vemurafenib and Dacarbazine||336
1085664|NCT01006980|2630277|P2|STARTED|Vemurafenib and Dacarbazine||338
1085665|NCT01006980|2630278|P1|STARTED|Vemurafenib and Dacarbazine||337
1085666|NCT01007110|2630300|P2|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||5
1085667|NCT01007110|2630301|P1|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
1085668|NCT01007110|2630300|P2|COMPLETED|Neonatal Behavioral Assessment Scale (NB||15
1085669|NCT01007110|2630301|P1|COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
1085670|NCT01007110|2630300|P2|STARTED|Neonatal Behavioral Assessment Scale (NB||20
1085671|NCT01007110|2630301|P1|STARTED|Neonatal Behavioral Assessment Scale (NB||24
1085672|NCT01007110|2630300|P2|NOT COMPLETED|Follow-Up at 36 Weeks||2
1085673|NCT01007110|2630301|P1|NOT COMPLETED|Follow-Up at 36 Weeks||0
1085674|NCT01007110|2630300|P2|COMPLETED|Follow-Up at 36 Weeks||20
1085675|NCT01007110|2630301|P1|COMPLETED|Follow-Up at 36 Weeks||24
1085676|NCT01007110|2630300|P2|STARTED|Follow-Up at 36 Weeks||22
1085677|NCT01007110|2630301|P1|STARTED|Follow-Up at 36 Weeks||24
1085678|NCT01007110|2630300|P2|NOT COMPLETED|Follow-Up at 32 Weeks||1
1085679|NCT01007110|2630301|P1|NOT COMPLETED|Follow-Up at 32 Weeks||1
1085680|NCT01007110|2630300|P2|COMPLETED|Follow-Up at 32 Weeks||22
1085681|NCT01007110|2630301|P1|COMPLETED|Follow-Up at 32 Weeks||24
1085682|NCT01007110|2630300|P2|STARTED|Follow-Up at 32 Weeks||23
1085683|NCT01007110|2630301|P1|STARTED|Follow-Up at 32 Weeks||25
1085684|NCT01007110|2630300|P2|NOT COMPLETED|Follow-Up at 24 Weeks||4
1085685|NCT01007110|2630301|P1|NOT COMPLETED|Follow-Up at 24 Weeks||0
1085686|NCT01007110|2630300|P2|COMPLETED|Follow-Up at 24 Weeks||23
1085687|NCT01007110|2630301|P1|COMPLETED|Follow-Up at 24 Weeks||25
1085688|NCT01007110|2630300|P2|STARTED|Follow-Up at 24 Weeks||27
1085689|NCT01007110|2630301|P1|STARTED|Follow-Up at 24 Weeks||25
1085690|NCT01007110|2630300|P2|NOT COMPLETED|Allocation||8
1085691|NCT01007110|2630301|P1|NOT COMPLETED|Allocation||7
1085692|NCT01007110|2630300|P2|COMPLETED|Allocation||27
1085693|NCT01007110|2630301|P1|COMPLETED|Allocation||25
1085694|NCT01007110|2630300|P2|STARTED|Allocation||35
1085695|NCT01007110|2630301|P1|STARTED|Allocation||32
1085696|NCT01007123|2630319|P4|NOT COMPLETED|Overall Study||6
1085697|NCT01007123|2630320|P3|NOT COMPLETED|Overall Study||11
1085698|NCT01007123|2630321|P2|NOT COMPLETED|Overall Study||6
1085699|NCT01007123|2630322|P1|NOT COMPLETED|Overall Study||6
1085700|NCT01007123|2630319|P4|COMPLETED|Overall Study||41
1085701|NCT01007123|2630320|P3|COMPLETED|Overall Study||37
1085702|NCT01007123|2630321|P2|COMPLETED|Overall Study||41
1085703|NCT01007123|2630322|P1|COMPLETED|Overall Study||42
1085704|NCT01007123|2630319|P4|STARTED|Overall Study||47
1085705|NCT01007123|2630320|P3|STARTED|Overall Study||48
1085706|NCT01007123|2630321|P2|STARTED|Overall Study||47
1085707|NCT01007123|2630322|P1|STARTED|Overall Study||48
1085708|NCT01007149|2630353|P2|NOT COMPLETED|Overall Study||1
1085709|NCT01007149|2630354|P1|NOT COMPLETED|Overall Study||0
1085710|NCT01007149|2630353|P2|COMPLETED|Overall Study||20
1085711|NCT01007149|2630354|P1|COMPLETED|Overall Study||20
1085712|NCT01007149|2630353|P2|STARTED|Overall Study||21
1085713|NCT01007149|2630354|P1|STARTED|Overall Study||20
1085714|NCT01007253|2630376|P4|NOT COMPLETED|Fourth Intervention||0
1085715|NCT01007253|2630377|P3|NOT COMPLETED|Fourth Intervention||0
1085716|NCT01007253|2630378|P2|NOT COMPLETED|Fourth Intervention||0
1085717|NCT01007253|2630379|P1|NOT COMPLETED|Fourth Intervention||0
1085718|NCT01007253|2630376|P4|COMPLETED|Fourth Intervention||5
1085719|NCT01007253|2630377|P3|COMPLETED|Fourth Intervention||5
1085720|NCT01007253|2630378|P2|COMPLETED|Fourth Intervention||5
1085721|NCT01007253|2630379|P1|COMPLETED|Fourth Intervention||5
1085722|NCT01007253|2630376|P4|STARTED|Fourth Intervention||5
1085723|NCT01007253|2630377|P3|STARTED|Fourth Intervention||5
1085724|NCT01007253|2630378|P2|STARTED|Fourth Intervention||5
1085725|NCT01007253|2630379|P1|STARTED|Fourth Intervention||5
1085726|NCT01007253|2630376|P4|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
1085727|NCT01007253|2630377|P3|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
1085728|NCT01007253|2630378|P2|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
1085729|NCT01007253|2630379|P1|NOT COMPLETED|Washout Period (2 Weeks) # 3||1
1085730|NCT01007253|2630376|P4|COMPLETED|Washout Period (2 Weeks) # 3||5
1085731|NCT01007253|2630377|P3|COMPLETED|Washout Period (2 Weeks) # 3||5
1085732|NCT01007253|2630378|P2|COMPLETED|Washout Period (2 Weeks) # 3||5
1085733|NCT01007253|2630379|P1|COMPLETED|Washout Period (2 Weeks) # 3||5
1085734|NCT01007253|2630376|P4|STARTED|Washout Period (2 Weeks) # 3||5
1085735|NCT01007253|2630377|P3|STARTED|Washout Period (2 Weeks) # 3||5
1085736|NCT01007253|2630378|P2|STARTED|Washout Period (2 Weeks) # 3||5
1085737|NCT01007253|2630379|P1|STARTED|Washout Period (2 Weeks) # 3||6
1085738|NCT01007253|2630376|P4|NOT COMPLETED|Third Intervention||0
1085739|NCT01007253|2630377|P3|NOT COMPLETED|Third Intervention||0
1085740|NCT01007253|2630378|P2|NOT COMPLETED|Third Intervention||0
1085741|NCT01007253|2630379|P1|NOT COMPLETED|Third Intervention||0
1085742|NCT01007253|2630376|P4|COMPLETED|Third Intervention||5
1085743|NCT01007253|2630377|P3|COMPLETED|Third Intervention||5
1085744|NCT01007253|2630378|P2|COMPLETED|Third Intervention||5
1085745|NCT01007253|2630379|P1|COMPLETED|Third Intervention||6
1085746|NCT01007253|2630376|P4|STARTED|Third Intervention||5
1085747|NCT01007253|2630377|P3|STARTED|Third Intervention||5
1085748|NCT01007253|2630378|P2|STARTED|Third Intervention||5
1085749|NCT01007253|2630379|P1|STARTED|Third Intervention||6
1085750|NCT01007253|2630376|P4|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
1085751|NCT01007253|2630377|P3|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
1085752|NCT01007253|2630378|P2|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
1085753|NCT01007253|2630379|P1|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
1085754|NCT01007253|2630376|P4|COMPLETED|Washout Period (2 Weeks) # 2||5
1085755|NCT01007253|2630377|P3|COMPLETED|Washout Period (2 Weeks) # 2||5
1085756|NCT01007253|2630378|P2|COMPLETED|Washout Period (2 Weeks) # 2||5
1085757|NCT01007253|2630379|P1|COMPLETED|Washout Period (2 Weeks) # 2||6
1085758|NCT01007253|2630376|P4|STARTED|Washout Period (2 Weeks) # 2||5
1085759|NCT01007253|2630377|P3|STARTED|Washout Period (2 Weeks) # 2||5
1085760|NCT01007253|2630378|P2|STARTED|Washout Period (2 Weeks) # 2||5
1085761|NCT01007253|2630379|P1|STARTED|Washout Period (2 Weeks) # 2||6
1085762|NCT01007253|2630376|P4|NOT COMPLETED|Second Intervention||0
1085763|NCT01007253|2630377|P3|NOT COMPLETED|Second Intervention||0
1085764|NCT01007253|2630378|P2|NOT COMPLETED|Second Intervention||0
1085765|NCT01007253|2630379|P1|NOT COMPLETED|Second Intervention||0
1085766|NCT01007253|2630376|P4|COMPLETED|Second Intervention||5
1085767|NCT01007253|2630377|P3|COMPLETED|Second Intervention||5
1085768|NCT01007253|2630378|P2|COMPLETED|Second Intervention||5
1085769|NCT01007253|2630379|P1|COMPLETED|Second Intervention||6
1085770|NCT01007253|2630376|P4|STARTED|Second Intervention||5
1085771|NCT01007253|2630377|P3|STARTED|Second Intervention||5
1085772|NCT01007253|2630378|P2|STARTED|Second Intervention||5
1085773|NCT01007253|2630379|P1|STARTED|Second Intervention||6
1085774|NCT01007253|2630376|P4|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
1085775|NCT01007253|2630377|P3|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
1085776|NCT01007253|2630378|P2|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
1085777|NCT01007253|2630379|P1|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
1085778|NCT01007253|2630376|P4|COMPLETED|Washout Period (2 Weeks) # 1||5
1085779|NCT01007253|2630377|P3|COMPLETED|Washout Period (2 Weeks) # 1||5
1085780|NCT01007253|2630378|P2|COMPLETED|Washout Period (2 Weeks) # 1||5
1085781|NCT01007253|2630379|P1|COMPLETED|Washout Period (2 Weeks) # 1||6
1085782|NCT01007253|2630376|P4|STARTED|Washout Period (2 Weeks) # 1||5
1085783|NCT01007253|2630377|P3|STARTED|Washout Period (2 Weeks) # 1||5
1085784|NCT01007253|2630378|P2|STARTED|Washout Period (2 Weeks) # 1||5
1085785|NCT01007253|2630379|P1|STARTED|Washout Period (2 Weeks) # 1||6
1085786|NCT01007253|2630376|P4|NOT COMPLETED|First Intervention||0
1085787|NCT01007253|2630377|P3|NOT COMPLETED|First Intervention||0
1085788|NCT01007253|2630378|P2|NOT COMPLETED|First Intervention||0
1085789|NCT01007253|2630379|P1|NOT COMPLETED|First Intervention||0
1085790|NCT01007253|2630376|P4|COMPLETED|First Intervention||5
1085791|NCT01007253|2630377|P3|COMPLETED|First Intervention||5
1085792|NCT01007253|2630378|P2|COMPLETED|First Intervention||5
1085793|NCT01007253|2630379|P1|COMPLETED|First Intervention||6
1085794|NCT01007253|2630376|P4|STARTED|First Intervention||5
1085795|NCT01007253|2630377|P3|STARTED|First Intervention||5
1085796|NCT01007253|2630378|P2|STARTED|First Intervention||5
1085797|NCT01007253|2630379|P1|STARTED|First Intervention||6
1085798|NCT01007396|2630409|P1|NOT COMPLETED|Overall Study||47
1085799|NCT01007396|2630409|P1|COMPLETED|Overall Study||275
1085800|NCT01007396|2630409|P1|STARTED|Overall Study||322
1085801|NCT01007435|2630418|P4|NOT COMPLETED|Overall Study||56
1085802|NCT01007435|2630419|P3|NOT COMPLETED|Overall Study||64
1085803|NCT01007435|2630420|P2|NOT COMPLETED|Overall Study||59
1085804|NCT01007435|2630421|P1|NOT COMPLETED|Overall Study||63
1085805|NCT01007435|2630418|P4|COMPLETED|Overall Study||236
1085806|NCT01007435|2630419|P3|COMPLETED|Overall Study||227
1085807|NCT01007435|2630420|P2|COMPLETED|Overall Study||231
1085808|NCT01007435|2630421|P1|COMPLETED|Overall Study||226
1085809|NCT01007435|2630418|P4|STARTED|Overall Study||292
1085810|NCT01007435|2630419|P3|STARTED|Overall Study||291
1085811|NCT01007435|2630420|P2|STARTED|Overall Study||290
1085812|NCT01007435|2630421|P1|STARTED|Overall Study||289
1085813|NCT01007552|2630463|P1|NOT COMPLETED|Overall Study||1
1085814|NCT01007552|2630463|P1|COMPLETED|Overall Study||49
1085815|NCT01007552|2630463|P1|STARTED|Overall Study||50
1085816|NCT01007643|2630475|P2|NOT COMPLETED|Overall Study||0
1085817|NCT01007643|2630476|P1|NOT COMPLETED|Overall Study||0
1085818|NCT01007643|2630475|P2|COMPLETED|Overall Study||14
1085819|NCT01007643|2630476|P1|COMPLETED|Overall Study||8
1085820|NCT01007643|2630475|P2|STARTED|Overall Study||14
1085821|NCT01007643|2630476|P1|STARTED|Overall Study||8
1085822|NCT01007656|2630482|P1|NOT COMPLETED|Overall Study||0
1085823|NCT01007656|2630482|P1|COMPLETED|Overall Study||31
1085824|NCT01007656|2630482|P1|STARTED|Overall Study||31
1085825|NCT01007812|2630500|P2|NOT COMPLETED|Period 2, One Week||0
1085826|NCT01007812|2630501|P1|NOT COMPLETED|Period 2, One Week||0
1085827|NCT01007812|2630500|P2|COMPLETED|Period 2, One Week||24
1085828|NCT01007812|2630501|P1|COMPLETED|Period 2, One Week||24
1085829|NCT01007812|2630500|P2|STARTED|Period 2, One Week||24
1085830|NCT01007812|2630501|P1|STARTED|Period 2, One Week||24
1085831|NCT01007812|2630500|P2|NOT COMPLETED|Period 1, One Week||1
1085832|NCT01007812|2630501|P1|NOT COMPLETED|Period 1, One Week||1
1085833|NCT01007812|2630500|P2|COMPLETED|Period 1, One Week||24
1085834|NCT01007812|2630501|P1|COMPLETED|Period 1, One Week||24
1085835|NCT01007812|2630500|P2|STARTED|Period 1, One Week||25
1085836|NCT01007812|2630501|P1|STARTED|Period 1, One Week||25
1085837|NCT01007838|2630511|P4|NOT COMPLETED|Overall Study||0
1085838|NCT01007838|2630512|P3|NOT COMPLETED|Overall Study||0
1085839|NCT01007838|2630513|P2|NOT COMPLETED|Overall Study||0
1085840|NCT01007838|2630514|P1|NOT COMPLETED|Overall Study||3
1085841|NCT01007838|2630511|P4|COMPLETED|Overall Study||4
1085842|NCT01007838|2630512|P3|COMPLETED|Overall Study||5
1085843|NCT01007838|2630513|P2|COMPLETED|Overall Study||11
1085844|NCT01007838|2630514|P1|COMPLETED|Overall Study||9
1085845|NCT01007838|2630511|P4|STARTED|Overall Study||4
1085846|NCT01007838|2630512|P3|STARTED|Overall Study||5
1085847|NCT01007838|2630513|P2|STARTED|Overall Study||11
1085848|NCT01007838|2630514|P1|STARTED|Overall Study||12
1085849|NCT01007916|2630524|P2|NOT COMPLETED|Period 2, 4 Weeks of Wear||0
1085850|NCT01007916|2630525|P1|NOT COMPLETED|Period 2, 4 Weeks of Wear||1
1085851|NCT01007916|2630524|P2|COMPLETED|Period 2, 4 Weeks of Wear||25
1085852|NCT01007916|2630525|P1|COMPLETED|Period 2, 4 Weeks of Wear||21
1085853|NCT01007916|2630524|P2|STARTED|Period 2, 4 Weeks of Wear|One participant completed Period 1 but did not start Period 2 due to failing inclusion criteria.|25
1085854|NCT01007916|2630525|P1|STARTED|Period 2, 4 Weeks of Wear||22
1085855|NCT01007916|2630524|P2|NOT COMPLETED|Period 1, 4 Weeks of Wear||0
1085856|NCT01007916|2630525|P1|NOT COMPLETED|Period 1, 4 Weeks of Wear||1
1085857|NCT01007916|2630524|P2|COMPLETED|Period 1, 4 Weeks of Wear||26
1085858|NCT01007916|2630525|P1|COMPLETED|Period 1, 4 Weeks of Wear||22
1085859|NCT01007916|2630524|P2|STARTED|Period 1, 4 Weeks of Wear||26
1085860|NCT01007916|2630525|P1|STARTED|Period 1, 4 Weeks of Wear||23
1085861|NCT01007942|2630533|P2|NOT COMPLETED|Overall Study||278
1085862|NCT01007942|2630534|P1|NOT COMPLETED|Overall Study||281
1085863|NCT01007942|2630533|P2|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|7
1085864|NCT01007942|2630534|P1|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|3
1085865|NCT01007942|2630533|P2|STARTED|Overall Study||285
1085866|NCT01007942|2630534|P1|STARTED|Overall Study||284
1085867|NCT01008280|2630558|P2|NOT COMPLETED|Overall Study||19
1085868|NCT01008280|2630559|P1|NOT COMPLETED|Overall Study||21
1085869|NCT01008280|2630558|P2|COMPLETED|Overall Study||73
1085870|NCT01008280|2630559|P1|COMPLETED|Overall Study||67
1085871|NCT01008280|2630558|P2|STARTED|Overall Study||92
1085872|NCT01008280|2630559|P1|STARTED|Overall Study||88
1085873|NCT01008449|2630571|P2|NOT COMPLETED|Overall Study||19
1085874|NCT01008449|2630572|P1|NOT COMPLETED|Overall Study||29
1085875|NCT01008449|2630571|P2|COMPLETED|Overall Study||179
1085876|NCT01008449|2630572|P1|COMPLETED|Overall Study||171
1085877|NCT01008449|2630571|P2|STARTED|Overall Study||198
1085878|NCT01008449|2630572|P1|STARTED|Overall Study||200
1085879|NCT01008475|2630599|P7|NOT COMPLETED|Overall Study||4
1085880|NCT01008475|2630600|P6|NOT COMPLETED|Overall Study||6
1085881|NCT01008475|2630601|P5|NOT COMPLETED|Overall Study||5
1085882|NCT01008475|2630602|P4|NOT COMPLETED|Overall Study||0
1085883|NCT01008475|2630603|P3|NOT COMPLETED|Overall Study||0
1085884|NCT01008475|2630604|P2|NOT COMPLETED|Overall Study||0
1085885|NCT01008475|2630605|P1|NOT COMPLETED|Overall Study||0
1085886|NCT01008475|2630599|P7|COMPLETED|Overall Study||67
1085887|NCT01008475|2630600|P6|COMPLETED|Overall Study||67
1085888|NCT01008475|2630601|P5|COMPLETED|Overall Study||67
1085889|NCT01008475|2630602|P4|COMPLETED|Overall Study||3
1085890|NCT01008475|2630603|P3|COMPLETED|Overall Study||7
1085891|NCT01008475|2630604|P2|COMPLETED|Overall Study||3
1085892|NCT01008475|2630605|P1|COMPLETED|Overall Study||3
1085893|NCT01008475|2630599|P7|Safety Analysis Set|Overall Study||69
1085894|NCT01008475|2630600|P6|Safety Analysis Set|Overall Study||72
1085895|NCT01008475|2630601|P5|Safety Analysis Set|Overall Study|1 subject randomized to EMD525797 1000 mg group received only SoC. Hence, reported under SOC group.|73
1085896|NCT01008475|2630602|P4|Safety Analysis Set|Overall Study||3
1085897|NCT01008475|2630603|P3|Safety Analysis Set|Overall Study||7
1085898|NCT01008475|2630604|P2|Safety Analysis Set|Overall Study||3
1085899|NCT01008475|2630605|P1|Safety Analysis Set|Overall Study||3
1085900|NCT01008475|2630599|P7|STARTED|Overall Study||71
1085901|NCT01008475|2630600|P6|STARTED|Overall Study||73
1085902|NCT01008475|2630601|P5|STARTED|Overall Study||72
1085903|NCT01008475|2630602|P4|STARTED|Overall Study||3
1085904|NCT01008475|2630603|P3|STARTED|Overall Study||7
1085905|NCT01008475|2630604|P2|STARTED|Overall Study||3
1085906|NCT01008475|2630605|P1|STARTED|Overall Study||3
1085907|NCT01008553|2630633|P3|NOT COMPLETED|Period 2 (Double-Blind Period)||51
1085908|NCT01008553|2630634|P2|NOT COMPLETED|Period 2 (Double-Blind Period)||37
1085909|NCT01008553|2630635|P1|NOT COMPLETED|Period 2 (Double-Blind Period)||0
1085910|NCT01008553|2630633|P3|COMPLETED|Period 2 (Double-Blind Period)||28
1085911|NCT01008553|2630634|P2|COMPLETED|Period 2 (Double-Blind Period)||47
1085912|NCT01008553|2630635|P1|COMPLETED|Period 2 (Double-Blind Period)||0
1085913|NCT01008553|2630633|P3|STARTED|Period 2 (Double-Blind Period)||79
1085914|NCT01008553|2630634|P2|STARTED|Period 2 (Double-Blind Period)||84
1085915|NCT01008553|2630635|P1|STARTED|Period 2 (Double-Blind Period)||0
1085916|NCT01008553|2630633|P3|NOT COMPLETED|Period 1 (Titration Period)||0
1085917|NCT01008553|2630634|P2|NOT COMPLETED|Period 1 (Titration Period)||0
1085918|NCT01008553|2630635|P1|NOT COMPLETED|Period 1 (Titration Period)||95
1085919|NCT01008553|2630633|P3|COMPLETED|Period 1 (Titration Period)||0
1085920|NCT01008553|2630634|P2|COMPLETED|Period 1 (Titration Period)||0
1085921|NCT01008553|2630635|P1|COMPLETED|Period 1 (Titration Period)||163
1085922|NCT01008553|2630633|P3|STARTED|Period 1 (Titration Period)||0
1085923|NCT01008553|2630634|P2|STARTED|Period 1 (Titration Period)||0
1085924|NCT01008553|2630635|P1|STARTED|Period 1 (Titration Period)||258
1085925|NCT01008605|2630660|P1|NOT COMPLETED|Overall Study||0
1085926|NCT01008605|2630660|P1|COMPLETED|Overall Study||48
1085927|NCT01008605|2630660|P1|STARTED|Overall Study||48
1085928|NCT01008618|2630684|P3|NOT COMPLETED|Period 2 (Double-Blind Period)||38
1085929|NCT01008618|2630685|P2|NOT COMPLETED|Period 2 (Double-Blind Period)||36
1085930|NCT01008618|2630686|P1|NOT COMPLETED|Period 2 (Double-Blind Period)||0
1085931|NCT01008618|2630684|P3|COMPLETED|Period 2 (Double-Blind Period)||39
1085932|NCT01008618|2630685|P2|COMPLETED|Period 2 (Double-Blind Period)||37
1085933|NCT01008618|2630686|P1|COMPLETED|Period 2 (Double-Blind Period)||0
1085934|NCT01008618|2630684|P3|STARTED|Period 2 (Double-Blind Period)||77
1085935|NCT01008618|2630685|P2|STARTED|Period 2 (Double-Blind Period)||73
1085936|NCT01008618|2630686|P1|STARTED|Period 2 (Double-Blind Period)||0
1085937|NCT01008618|2630684|P3|NOT COMPLETED|Period 1 (Titration Period)||0
1085938|NCT01008618|2630685|P2|NOT COMPLETED|Period 1 (Titration Period)||0
1085939|NCT01008618|2630686|P1|NOT COMPLETED|Period 1 (Titration Period)||68
1085940|NCT01008618|2630684|P3|COMPLETED|Period 1 (Titration Period)||0
1085941|NCT01008618|2630685|P2|COMPLETED|Period 1 (Titration Period)||0
1085942|NCT01008618|2630686|P1|COMPLETED|Period 1 (Titration Period)||150
1085943|NCT01008618|2630684|P3|STARTED|Period 1 (Titration Period)||0
1085944|NCT01008618|2630685|P2|STARTED|Period 1 (Titration Period)||0
1085945|NCT01008618|2630686|P1|STARTED|Period 1 (Titration Period)||218
1085946|NCT01008696|2630713|P2|NOT COMPLETED|Overall Study||17
1085947|NCT01008696|2630714|P1|NOT COMPLETED|Overall Study||17
1085948|NCT01008696|2630713|P2|COMPLETED|Overall Study||92
1085949|NCT01008696|2630714|P1|COMPLETED|Overall Study||91
1085950|NCT01008696|2630713|P2|STARTED|Overall Study||109
1085951|NCT01008696|2630714|P1|STARTED|Overall Study||108
1085952|NCT01008722|2630726|P2|NOT COMPLETED|Overall Study||0
1085953|NCT01008722|2630727|P1|NOT COMPLETED|Overall Study||0
1085954|NCT01008722|2630726|P2|COMPLETED|Overall Study||71
1085955|NCT01008722|2630727|P1|COMPLETED|Overall Study||36
1085956|NCT01008722|2630726|P2|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|71
1085957|NCT01008722|2630727|P1|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|36
1085958|NCT01008904|2630735|P1|NOT COMPLETED|Overall Study||4
1085959|NCT01008904|2630735|P1|COMPLETED|Overall Study||25
1085960|NCT01008904|2630735|P1|STARTED|Overall Study||29
1085961|NCT01008943|2630740|P1|NOT COMPLETED|Overall Study||1
1085962|NCT01008943|2630740|P1|COMPLETED|Overall Study||15
1085963|NCT01008943|2630740|P1|STARTED|Overall Study||16
1085964|NCT01008969|2630747|P1|NOT COMPLETED|Overall Study||0
1085965|NCT01008969|2630747|P1|COMPLETED|Overall Study||10
1085966|NCT01008969|2630747|P1|STARTED|Overall Study||10
1085967|NCT01008995|2630754|P4|NOT COMPLETED|After Controlled Period||1
1085968|NCT01008995|2630755|P3|NOT COMPLETED|After Controlled Period||2
1085969|NCT01008995|2630756|P2|NOT COMPLETED|After Controlled Period||0
1085970|NCT01008995|2630757|P1|NOT COMPLETED|After Controlled Period||0
1085971|NCT01008995|2630754|P4|COMPLETED|After Controlled Period||156
1085972|NCT01008995|2630755|P3|COMPLETED|After Controlled Period||156
1085973|NCT01008995|2630756|P2|COMPLETED|After Controlled Period||0
1085974|NCT01008995|2630757|P1|COMPLETED|After Controlled Period||0
1085975|NCT01008995|2630754|P4|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|157
1085976|NCT01008995|2630755|P3|STARTED|After Controlled Period|1 placebo participant discontinued after completing the CP and did not receive ustekinumab 45 mg.|158
1085977|NCT01008995|2630756|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
1085978|NCT01008995|2630757|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
1085979|NCT01008995|2630754|P4|NOT COMPLETED|Controlled Period||0
1085980|NCT01008995|2630755|P3|NOT COMPLETED|Controlled Period||0
1085981|NCT01008995|2630756|P2|NOT COMPLETED|Controlled Period||3
1085982|NCT01008995|2630757|P1|NOT COMPLETED|Controlled Period||3
1085983|NCT01008995|2630754|P4|COMPLETED|Controlled Period||0
1085984|NCT01008995|2630755|P3|COMPLETED|Controlled Period||0
1085985|NCT01008995|2630756|P2|COMPLETED|Controlled Period||157
1085986|NCT01008995|2630757|P1|COMPLETED|Controlled Period||159
1085987|NCT01008995|2630754|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
1085988|NCT01008995|2630755|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
1085989|NCT01008995|2630756|P2|STARTED|Controlled Period||160
1085990|NCT01008995|2630757|P1|STARTED|Controlled Period||162
1085991|NCT01009034|2630769|P1|NOT COMPLETED|Overall Study||4
1085992|NCT01009034|2630769|P1|COMPLETED|Overall Study||10
1085993|NCT01009034|2630769|P1|STARTED|Overall Study||14
1085994|NCT01009047|2630777|P2|NOT COMPLETED|Overall Study||26
1085995|NCT01009047|2630778|P1|NOT COMPLETED|Overall Study||28
1085996|NCT01009047|2630777|P2|COMPLETED|Overall Study||89
1085997|NCT01009047|2630778|P1|COMPLETED|Overall Study||85
1085998|NCT01009047|2630777|P2|STARTED|Overall Study||115
1085999|NCT01009047|2630778|P1|STARTED|Overall Study||113
1086000|NCT01009060|2630802|P2|NOT COMPLETED|Overall Study||5
1086001|NCT01009060|2630803|P1|NOT COMPLETED|Overall Study||4
1086002|NCT01009060|2630802|P2|COMPLETED|Overall Study||20
1086003|NCT01009060|2630803|P1|COMPLETED|Overall Study||21
1086004|NCT01009060|2630802|P2|STARTED|Overall Study||25
1086005|NCT01009060|2630803|P1|STARTED|Overall Study||25
1086006|NCT01009086|2630842|P3|NOT COMPLETED|Overall Study||34
1086007|NCT01009086|2630843|P2|NOT COMPLETED|Overall Study||47
1086008|NCT01009086|2630844|P1|NOT COMPLETED|Overall Study||44
1086009|NCT01009086|2630842|P3|COMPLETED|Overall Study||170
1086010|NCT01009086|2630843|P2|COMPLETED|Overall Study||158
1086011|NCT01009086|2630844|P1|COMPLETED|Overall Study||162
1086012|NCT01009086|2630842|P3|STARTED|Overall Study||204
1086013|NCT01009086|2630843|P2|STARTED|Overall Study||205
1086014|NCT01009086|2630844|P1|STARTED|Overall Study||206
1086015|NCT01009099|2630879|P2|NOT COMPLETED|Overall Study||4
1086016|NCT01009099|2630880|P1|NOT COMPLETED|Overall Study||5
1086017|NCT01009099|2630879|P2|COMPLETED|Overall Study||57
1086018|NCT01009099|2630880|P1|COMPLETED|Overall Study||53
1086019|NCT01009099|2630879|P2|STARTED|Overall Study||61
1086020|NCT01009099|2630880|P1|STARTED|Overall Study||58
1086021|NCT01009138|2630888|P2|NOT COMPLETED|Overall Study||20
1086022|NCT01009138|2630889|P1|NOT COMPLETED|Overall Study||13
1086023|NCT01009138|2630888|P2|COMPLETED|Overall Study||88
1086024|NCT01009138|2630889|P1|COMPLETED|Overall Study||93
1086025|NCT01009138|2630888|P2|STARTED|Overall Study||108
1086026|NCT01009138|2630889|P1|STARTED|Overall Study||106
1086027|NCT01009203|2630917|P1|NOT COMPLETED|Overall Study||7
1086028|NCT01009203|2630917|P1|COMPLETED|Overall Study||6
1086029|NCT01009203|2630917|P1|Received Treatment|Overall Study|One patient withdrew consent before treatment started.|12
1086030|NCT01009203|2630917|P1|STARTED|Overall Study||13
1086031|NCT01009333|2630924|P6|NOT COMPLETED|Week 3||0
1086032|NCT01009333|2630925|P5|NOT COMPLETED|Week 3||0
1086033|NCT01009333|2630926|P4|NOT COMPLETED|Week 3||0
1086034|NCT01009333|2630927|P3|NOT COMPLETED|Week 3||0
1086035|NCT01009333|2630928|P2|NOT COMPLETED|Week 3||0
1086036|NCT01009333|2630929|P1|NOT COMPLETED|Week 3||0
1086037|NCT01009333|2630924|P6|COMPLETED|Week 3||2
1086038|NCT01009333|2630925|P5|COMPLETED|Week 3||2
1086039|NCT01009333|2630926|P4|COMPLETED|Week 3||2
1086040|NCT01009333|2630927|P3|COMPLETED|Week 3||2
1086041|NCT01009333|2630928|P2|COMPLETED|Week 3||2
1086042|NCT01009333|2630929|P1|COMPLETED|Week 3||2
1086043|NCT01009333|2630924|P6|STARTED|Week 3||2
1086044|NCT01009333|2630925|P5|STARTED|Week 3||2
1086045|NCT01009333|2630926|P4|STARTED|Week 3||2
1086046|NCT01009333|2630927|P3|STARTED|Week 3||2
1086047|NCT01009333|2630928|P2|STARTED|Week 3||2
1086048|NCT01009333|2630929|P1|STARTED|Week 3||2
1086049|NCT01009333|2630924|P6|NOT COMPLETED|Week 2||0
1086050|NCT01009333|2630925|P5|NOT COMPLETED|Week 2||0
1086051|NCT01009333|2630926|P4|NOT COMPLETED|Week 2||0
1086052|NCT01009333|2630927|P3|NOT COMPLETED|Week 2||0
1086053|NCT01009333|2630928|P2|NOT COMPLETED|Week 2||0
1086054|NCT01009333|2630929|P1|NOT COMPLETED|Week 2||0
1086055|NCT01009333|2630924|P6|COMPLETED|Week 2||2
1086056|NCT01009333|2630925|P5|COMPLETED|Week 2||2
1086057|NCT01009333|2630926|P4|COMPLETED|Week 2||2
1086058|NCT01009333|2630927|P3|COMPLETED|Week 2||2
1086059|NCT01009333|2630928|P2|COMPLETED|Week 2||2
1086060|NCT01009333|2630929|P1|COMPLETED|Week 2||2
1086061|NCT01009333|2630924|P6|STARTED|Week 2||2
1086062|NCT01009333|2630925|P5|STARTED|Week 2||2
1086063|NCT01009333|2630926|P4|STARTED|Week 2||2
1086064|NCT01009333|2630927|P3|STARTED|Week 2||2
1086065|NCT01009333|2630928|P2|STARTED|Week 2||2
1086066|NCT01009333|2630929|P1|STARTED|Week 2||2
1086067|NCT01009333|2630924|P6|NOT COMPLETED|Week 1||0
1086068|NCT01009333|2630925|P5|NOT COMPLETED|Week 1||0
1086069|NCT01009333|2630926|P4|NOT COMPLETED|Week 1||0
1086070|NCT01009333|2630927|P3|NOT COMPLETED|Week 1||0
1086071|NCT01009333|2630928|P2|NOT COMPLETED|Week 1||0
1086072|NCT01009333|2630929|P1|NOT COMPLETED|Week 1||0
1086073|NCT01009333|2630924|P6|COMPLETED|Week 1||2
1086074|NCT01009333|2630925|P5|COMPLETED|Week 1||2
1086075|NCT01009333|2630926|P4|COMPLETED|Week 1||2
1086076|NCT01009333|2630927|P3|COMPLETED|Week 1||2
1086077|NCT01009333|2630928|P2|COMPLETED|Week 1|1 participant did not progress to the second period due to a protocol violation.|3
1086078|NCT01009333|2630929|P1|COMPLETED|Week 1||2
1086079|NCT01009333|2630924|P6|STARTED|Week 1||2
1086080|NCT01009333|2630925|P5|STARTED|Week 1||2
1086081|NCT01009333|2630926|P4|STARTED|Week 1||2
1086082|NCT01009333|2630927|P3|STARTED|Week 1||2
1086083|NCT01009333|2630928|P2|STARTED|Week 1||3
1086084|NCT01009333|2630929|P1|STARTED|Week 1||2
1086085|NCT01009346|2630943|P1|NOT COMPLETED|Overall Study||4
1086086|NCT01009346|2630943|P1|COMPLETED|Overall Study||5
1086087|NCT01009346|2630943|P1|Toxicity|Overall Study||8
1086088|NCT01009346|2630943|P1|STARTED|Overall Study||9
1086089|NCT01009463|2630951|P5|NOT COMPLETED|52-week, Double-blind Treatment Period||101
1086090|NCT01009463|2630952|P4|NOT COMPLETED|52-week, Double-blind Treatment Period||91
1086091|NCT01009463|2630953|P3|NOT COMPLETED|52-week, Double-blind Treatment Period||93
1086092|NCT01009463|2630954|P2|NOT COMPLETED|52-week, Double-blind Treatment Period||115
1086093|NCT01009463|2630955|P1|NOT COMPLETED|52-week, Double-blind Treatment Period||0
1086094|NCT01009463|2630951|P5|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|301
1086095|NCT01009463|2630952|P4|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|312
1086096|NCT01009463|2630953|P3|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|315
1086097|NCT01009463|2630954|P2|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|294
1086098|NCT01009463|2630955|P1|COMPLETED|52-week, Double-blind Treatment Period||0
1086099|NCT01009463|2630951|P5|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|303
1086100|NCT01009463|2630952|P4|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|314
1086101|NCT01009463|2630953|P3|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|318
1086102|NCT01009463|2630954|P2|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|295
1086103|NCT01009463|2630955|P1|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
1086104|NCT01009463|2630951|P5|STARTED|52-week, Double-blind Treatment Period||402
1086105|NCT01009463|2630952|P4|STARTED|52-week, Double-blind Treatment Period||403
1086106|NCT01009463|2630953|P3|STARTED|52-week, Double-blind Treatment Period||408
1086107|NCT01009463|2630954|P2|STARTED|52-week, Double-blind Treatment Period||409
1086108|NCT01009463|2630955|P1|STARTED|52-week, Double-blind Treatment Period||0
1086109|NCT01009463|2630951|P5|NOT COMPLETED|4-week, Open-label Run-In Period||0
1086110|NCT01009463|2630952|P4|NOT COMPLETED|4-week, Open-label Run-In Period||0
1086111|NCT01009463|2630953|P3|NOT COMPLETED|4-week, Open-label Run-In Period||0
1086112|NCT01009463|2630954|P2|NOT COMPLETED|4-week, Open-label Run-In Period||0
1086113|NCT01009463|2630955|P1|NOT COMPLETED|4-week, Open-label Run-In Period||449
1086114|NCT01009463|2630951|P5|COMPLETED|4-week, Open-label Run-In Period||0
1086115|NCT01009463|2630952|P4|COMPLETED|4-week, Open-label Run-In Period||0
1086116|NCT01009463|2630953|P3|COMPLETED|4-week, Open-label Run-In Period||0
1086117|NCT01009463|2630954|P2|COMPLETED|4-week, Open-label Run-In Period||0
1086118|NCT01009463|2630955|P1|COMPLETED|4-week, Open-label Run-In Period||1622
1086119|NCT01009463|2630951|P5|STARTED|4-week, Open-label Run-In Period||0
1086120|NCT01009463|2630952|P4|STARTED|4-week, Open-label Run-In Period||0
1086121|NCT01009463|2630953|P3|STARTED|4-week, Open-label Run-In Period||0
1086122|NCT01009463|2630954|P2|STARTED|4-week, Open-label Run-In Period||0
1086123|NCT01009463|2630955|P1|STARTED|4-week, Open-label Run-In Period||2071
1086127|NCT01009554|2630986|P2|NOT COMPLETED|Overall Study||7
1086128|NCT01009554|2630987|P1|NOT COMPLETED|Overall Study||2
1086129|NCT01009554|2630986|P2|COMPLETED|Overall Study||41
1086130|NCT01009554|2630987|P1|COMPLETED|Overall Study||46
1086131|NCT01009554|2630986|P2|STARTED|Overall Study||48
1086132|NCT01009554|2630987|P1|STARTED|Overall Study||48
1086133|NCT01009580|2631121|P2|NOT COMPLETED|Overall Study||35
1086134|NCT01009580|2631122|P1|NOT COMPLETED|Overall Study||27
1086135|NCT01009580|2631121|P2|COMPLETED|Overall Study||188
1086136|NCT01009580|2631122|P1|COMPLETED|Overall Study||197
1086137|NCT01009580|2631121|P2|Exposed|Overall Study|One subject was randomised in error and withdrew prior to exposure to drug|222
1086138|NCT01009580|2631122|P1|Exposed|Overall Study||224
1086139|NCT01009580|2631121|P2|STARTED|Overall Study||223
1086140|NCT01009580|2631122|P1|STARTED|Overall Study||224
1086141|NCT01012167|2631137|P3|NOT COMPLETED|Overall Study||4
1086142|NCT01012167|2631138|P2|NOT COMPLETED|Overall Study||2
1086143|NCT01012167|2631139|P1|NOT COMPLETED|Overall Study||2
1086144|NCT01012167|2631137|P3|COMPLETED|Overall Study||17
1086145|NCT01012167|2631138|P2|COMPLETED|Overall Study||18
1086146|NCT01012167|2631139|P1|COMPLETED|Overall Study||15
1086147|NCT01012167|2631137|P3|Exposed to Study Drug|Overall Study||20
1086148|NCT01012167|2631138|P2|Exposed to Study Drug|Overall Study||20
1086149|NCT01012167|2631139|P1|Exposed to Study Drug|Overall Study||16
1086150|NCT01012167|2631137|P3|Withdrawn Prior to Study Drug Exposure|Overall Study||1
1086151|NCT01012167|2631138|P2|Withdrawn Prior to Study Drug Exposure|Overall Study||0
1086152|NCT01012167|2631139|P1|Withdrawn Prior to Study Drug Exposure|Overall Study||1
1086153|NCT01012167|2631137|P3|STARTED|Overall Study||21
1086154|NCT01012167|2631138|P2|STARTED|Overall Study||20
1086155|NCT01012167|2631139|P1|STARTED|Overall Study||17
1086156|NCT01012219|2631393|P1|NOT COMPLETED|Period 3||0
1086157|NCT01012219|2631393|P1|COMPLETED|Period 3||20
1086158|NCT01012219|2631393|P1|STARTED|Period 3|of the 36 who started Period 1|20
1086159|NCT01012219|2631393|P1|NOT COMPLETED|Period 2||1
1086160|NCT01012219|2631393|P1|COMPLETED|Period 2||34
1086161|NCT01012219|2631393|P1|STARTED|Period 2|Number who completed Period 1|35
1086162|NCT01012219|2631393|P1|NOT COMPLETED|Period 1||1
1086163|NCT01012219|2631393|P1|COMPLETED|Period 1||35
1086164|NCT01012219|2631393|P1|STARTED|Period 1|Number randomized|36
1086165|NCT01012245|2631404|P1|NOT COMPLETED|Overall Study||2427
1086166|NCT01012245|2631404|P1|COMPLETED|Overall Study|More than 1 discontinuation (DC) reason possible per subject. See outcome measure Reasons for DC.|26385
1086167|NCT01012245|2631404|P1|STARTED|Overall Study||28812
1086168|NCT01012258|2631441|P1|NOT COMPLETED|Overall Study||66
1086169|NCT01012258|2631441|P1|COMPLETED|Overall Study||0
1086170|NCT01012258|2631441|P1|STARTED|Overall Study||66
1086171|NCT01012297|2631449|P2|NOT COMPLETED|Overall Study||0
1086172|NCT01012297|2631450|P1|NOT COMPLETED|Overall Study||0
1086173|NCT01012297|2631449|P2|COMPLETED|Overall Study||53
1086174|NCT01012297|2631450|P1|COMPLETED|Overall Study||54
1086175|NCT01012297|2631449|P2|STARTED|Overall Study||53
1086176|NCT01012297|2631450|P1|STARTED|Overall Study||54
1086177|NCT01012323|2631462|P1|NOT COMPLETED|Overall Study||1
1086178|NCT01012323|2631462|P1|COMPLETED|Overall Study||50
1086179|NCT01012323|2631462|P1|STARTED|Overall Study||51
1086180|NCT01012336|2631484|P1|NOT COMPLETED|Overall Study||0
1086181|NCT01012336|2631484|P1|COMPLETED|Overall Study||85
1086182|NCT01012336|2631484|P1|STARTED|Overall Study||85
1086183|NCT01012362|2631493|P5|NOT COMPLETED|Overall Study||0
1086184|NCT01012362|2631494|P4|NOT COMPLETED|Overall Study||0
1086185|NCT01012362|2631495|P3|NOT COMPLETED|Overall Study||0
1086186|NCT01012362|2631496|P2|NOT COMPLETED|Overall Study||0
1086187|NCT01012362|2631497|P1|NOT COMPLETED|Overall Study||0
1086188|NCT01012362|2631493|P5|COMPLETED|Overall Study||9
1086189|NCT01012362|2631494|P4|COMPLETED|Overall Study||4
1086190|NCT01012362|2631495|P3|COMPLETED|Overall Study||3
1086191|NCT01012362|2631496|P2|COMPLETED|Overall Study||6
1086192|NCT01012362|2631497|P1|COMPLETED|Overall Study||9
1086193|NCT01012362|2631493|P5|STARTED|Overall Study||9
1086194|NCT01012362|2631494|P4|STARTED|Overall Study||4
1086195|NCT01012362|2631495|P3|STARTED|Overall Study||3
1086196|NCT01012362|2631496|P2|STARTED|Overall Study||6
1086197|NCT01012362|2631497|P1|STARTED|Overall Study||9
1086198|NCT01012388|2631513|P1|NOT COMPLETED|Overall Study||0
1086199|NCT01012388|2631513|P1|COMPLETED|Overall Study||100
1086200|NCT01012388|2631513|P1|STARTED|Overall Study||100
1086201|NCT01012414|2631518|P1|NOT COMPLETED|Overall Study||10
1086202|NCT01012414|2631518|P1|COMPLETED|Overall Study|No subjects completed the study.|0
1086203|NCT01012414|2631518|P1|STARTED|Overall Study||10
1086204|NCT01012440|2631525|P1|NOT COMPLETED|Overall Study||2
1086205|NCT01012440|2631525|P1|COMPLETED|Overall Study||3
1086206|NCT01012440|2631525|P1|STARTED|Overall Study||5
1086210|NCT01012622|2631533|P1|NOT COMPLETED|Overall Study||31
1086211|NCT01012622|2631533|P1|COMPLETED|Overall Study||111
1086212|NCT01012622|2631533|P1|STARTED|Overall Study||142
1086213|NCT01012661|2631552|P1|NOT COMPLETED|Overall Study||0
1086214|NCT01012661|2631552|P1|COMPLETED|Overall Study||50
1086215|NCT01012661|2631552|P1|STARTED|Overall Study||50
1086216|NCT01012674|2631560|P1|NOT COMPLETED|Overall Study||24
1086217|NCT01012674|2631560|P1|COMPLETED|Overall Study||187
1086218|NCT01012674|2631560|P1|STARTED|Overall Study||211
1086219|NCT01012713|2631572|P1|NOT COMPLETED|Overall Study||3
1086220|NCT01012713|2631572|P1|COMPLETED|Overall Study||27
1086221|NCT01012713|2631572|P1|STARTED|Overall Study||30
1086222|NCT01012739|2631578|P4|NOT COMPLETED|Treatment Period 4||0
1086223|NCT01012739|2631579|P3|NOT COMPLETED|Treatment Period 4||0
1086224|NCT01012739|2631580|P2|NOT COMPLETED|Treatment Period 4||0
1086225|NCT01012739|2631581|P1|NOT COMPLETED|Treatment Period 4||0
1086226|NCT01012739|2631578|P4|COMPLETED|Treatment Period 4||7
1086227|NCT01012739|2631579|P3|COMPLETED|Treatment Period 4||9
1086228|NCT01012739|2631580|P2|COMPLETED|Treatment Period 4||8
1086229|NCT01012739|2631581|P1|COMPLETED|Treatment Period 4||9
1086230|NCT01012739|2631578|P4|STARTED|Treatment Period 4||7
1086231|NCT01012739|2631579|P3|STARTED|Treatment Period 4||9
1086232|NCT01012739|2631580|P2|STARTED|Treatment Period 4||8
1086233|NCT01012739|2631581|P1|STARTED|Treatment Period 4||9
1086234|NCT01012739|2631578|P4|NOT COMPLETED|Treatment Period 3||0
1086235|NCT01012739|2631579|P3|NOT COMPLETED|Treatment Period 3||0
1086236|NCT01012739|2631580|P2|NOT COMPLETED|Treatment Period 3||0
1086237|NCT01012739|2631581|P1|NOT COMPLETED|Treatment Period 3||0
1086238|NCT01012739|2631578|P4|COMPLETED|Treatment Period 3||7
1086239|NCT01012739|2631579|P3|COMPLETED|Treatment Period 3||9
1086240|NCT01012739|2631580|P2|COMPLETED|Treatment Period 3||8
1086241|NCT01012739|2631581|P1|COMPLETED|Treatment Period 3||9
1086242|NCT01012739|2631578|P4|STARTED|Treatment Period 3||7
1086243|NCT01012739|2631579|P3|STARTED|Treatment Period 3||9
1086244|NCT01012739|2631580|P2|STARTED|Treatment Period 3||8
1086245|NCT01012739|2631581|P1|STARTED|Treatment Period 3||9
1086246|NCT01012739|2631578|P4|NOT COMPLETED|Treatment Period 2||1
1086247|NCT01012739|2631579|P3|NOT COMPLETED|Treatment Period 2||0
1086248|NCT01012739|2631580|P2|NOT COMPLETED|Treatment Period 2||0
1086249|NCT01012739|2631581|P1|NOT COMPLETED|Treatment Period 2||0
1086250|NCT01012739|2631578|P4|COMPLETED|Treatment Period 2||7
1086251|NCT01012739|2631579|P3|COMPLETED|Treatment Period 2||9
1086252|NCT01012739|2631580|P2|COMPLETED|Treatment Period 2||8
1086253|NCT01012739|2631581|P1|COMPLETED|Treatment Period 2||9
1086254|NCT01012739|2631578|P4|STARTED|Treatment Period 2||8
1086255|NCT01012739|2631579|P3|STARTED|Treatment Period 2||9
1086256|NCT01012739|2631580|P2|STARTED|Treatment Period 2||8
1086257|NCT01012739|2631581|P1|STARTED|Treatment Period 2||9
1086258|NCT01012739|2631578|P4|NOT COMPLETED|Treatment Period 1||1
1086259|NCT01012739|2631579|P3|NOT COMPLETED|Treatment Period 1||0
1086260|NCT01012739|2631580|P2|NOT COMPLETED|Treatment Period 1||0
1086261|NCT01012739|2631581|P1|NOT COMPLETED|Treatment Period 1||0
1086262|NCT01012739|2631578|P4|COMPLETED|Treatment Period 1||8
1086263|NCT01012739|2631579|P3|COMPLETED|Treatment Period 1||9
1086264|NCT01012739|2631580|P2|COMPLETED|Treatment Period 1||8
1086265|NCT01012739|2631581|P1|COMPLETED|Treatment Period 1||9
1086266|NCT01012739|2631578|P4|STARTED|Treatment Period 1||9
1086267|NCT01012739|2631579|P3|STARTED|Treatment Period 1||9
1086268|NCT01012739|2631580|P2|STARTED|Treatment Period 1||8
1086269|NCT01012739|2631581|P1|STARTED|Treatment Period 1||9
1086270|NCT01012765|2631609|P6|NOT COMPLETED|Treatment Period 3||0
1086271|NCT01012765|2631610|P5|NOT COMPLETED|Treatment Period 3||0
1086272|NCT01012765|2631611|P4|NOT COMPLETED|Treatment Period 3||0
1086273|NCT01012765|2631612|P3|NOT COMPLETED|Treatment Period 3||0
1086274|NCT01012765|2631613|P2|NOT COMPLETED|Treatment Period 3||0
1086275|NCT01012765|2631614|P1|NOT COMPLETED|Treatment Period 3||0
1086276|NCT01012765|2631609|P6|COMPLETED|Treatment Period 3||24
1086277|NCT01012765|2631610|P5|COMPLETED|Treatment Period 3||18
1086278|NCT01012765|2631611|P4|COMPLETED|Treatment Period 3||15
1086279|NCT01012765|2631612|P3|COMPLETED|Treatment Period 3||18
1086280|NCT01012765|2631613|P2|COMPLETED|Treatment Period 3||19
1086281|NCT01012765|2631614|P1|COMPLETED|Treatment Period 3||16
1086282|NCT01012765|2631609|P6|STARTED|Treatment Period 3||24
1086283|NCT01012765|2631610|P5|STARTED|Treatment Period 3||18
1086284|NCT01012765|2631611|P4|STARTED|Treatment Period 3||15
1086285|NCT01012765|2631612|P3|STARTED|Treatment Period 3||18
1086286|NCT01012765|2631613|P2|STARTED|Treatment Period 3||19
1086287|NCT01012765|2631614|P1|STARTED|Treatment Period 3||16
1086288|NCT01012765|2631609|P6|NOT COMPLETED|Treatment Period 2||1
1086289|NCT01012765|2631610|P5|NOT COMPLETED|Treatment Period 2||1
1086290|NCT01012765|2631611|P4|NOT COMPLETED|Treatment Period 2||0
1086291|NCT01012765|2631612|P3|NOT COMPLETED|Treatment Period 2||3
1086292|NCT01012765|2631613|P2|NOT COMPLETED|Treatment Period 2||2
1086293|NCT01012765|2631614|P1|NOT COMPLETED|Treatment Period 2||1
1086294|NCT01012765|2631609|P6|COMPLETED|Treatment Period 2||24
1086295|NCT01012765|2631610|P5|COMPLETED|Treatment Period 2||18
1086296|NCT01012765|2631611|P4|COMPLETED|Treatment Period 2||15
1086297|NCT01012765|2631612|P3|COMPLETED|Treatment Period 2||18
1086298|NCT01012765|2631613|P2|COMPLETED|Treatment Period 2||19
1086299|NCT01012765|2631614|P1|COMPLETED|Treatment Period 2||16
1086300|NCT01012765|2631609|P6|STARTED|Treatment Period 2||25
1086301|NCT01012765|2631610|P5|STARTED|Treatment Period 2||19
1086302|NCT01012765|2631611|P4|STARTED|Treatment Period 2||15
1086303|NCT01012765|2631612|P3|STARTED|Treatment Period 2||21
1086304|NCT01012765|2631613|P2|STARTED|Treatment Period 2||21
1086305|NCT01012765|2631614|P1|STARTED|Treatment Period 2||17
1086306|NCT01012765|2631609|P6|NOT COMPLETED|Treatment Period 1||0
1086307|NCT01012765|2631610|P5|NOT COMPLETED|Treatment Period 1||3
1086308|NCT01012765|2631611|P4|NOT COMPLETED|Treatment Period 1||3
1086309|NCT01012765|2631612|P3|NOT COMPLETED|Treatment Period 1||2
1086310|NCT01012765|2631613|P2|NOT COMPLETED|Treatment Period 1||0
1086311|NCT01012765|2631614|P1|NOT COMPLETED|Treatment Period 1||3
1086312|NCT01012765|2631609|P6|COMPLETED|Treatment Period 1||25
1086313|NCT01012765|2631610|P5|COMPLETED|Treatment Period 1||19
1086314|NCT01012765|2631611|P4|COMPLETED|Treatment Period 1||15
1086315|NCT01012765|2631612|P3|COMPLETED|Treatment Period 1||21
1086316|NCT01012765|2631613|P2|COMPLETED|Treatment Period 1||21
1086317|NCT01012765|2631614|P1|COMPLETED|Treatment Period 1||17
1086318|NCT01012765|2631609|P6|STARTED|Treatment Period 1||25
1086319|NCT01012765|2631610|P5|STARTED|Treatment Period 1||22
1086320|NCT01012765|2631611|P4|STARTED|Treatment Period 1||18
1086321|NCT01012765|2631612|P3|STARTED|Treatment Period 1||23
1086322|NCT01012765|2631613|P2|STARTED|Treatment Period 1||21
1086323|NCT01012765|2631614|P1|STARTED|Treatment Period 1||20
1086324|NCT01012947|2631648|P5|NOT COMPLETED|Overall Study||142
1086325|NCT01012947|2631649|P4|NOT COMPLETED|Overall Study||118
1086326|NCT01012947|2631650|P3|NOT COMPLETED|Overall Study||130
1086327|NCT01012947|2631651|P2|NOT COMPLETED|Overall Study||135
1086328|NCT01012947|2631652|P1|NOT COMPLETED|Overall Study||131
1086329|NCT01012947|2631648|P5|COMPLETED|Overall Study||94
1086330|NCT01012947|2631649|P4|COMPLETED|Overall Study||93
1086331|NCT01012947|2631650|P3|COMPLETED|Overall Study||111
1086332|NCT01012947|2631651|P2|COMPLETED|Overall Study||80
1086333|NCT01012947|2631652|P1|COMPLETED|Overall Study||81
1086334|NCT01012947|2631648|P5|STARTED|Overall Study||236
1086335|NCT01012947|2631649|P4|STARTED|Overall Study||211
1086336|NCT01012947|2631650|P3|STARTED|Overall Study||241
1086337|NCT01012947|2631651|P2|STARTED|Overall Study||215
1086338|NCT01012947|2631652|P1|STARTED|Overall Study||212
1086339|NCT01012973|2631666|P2|NOT COMPLETED|Overall Study||19
1086340|NCT01012973|2631667|P1|NOT COMPLETED|Overall Study||16
1086341|NCT01012973|2631666|P2|COMPLETED|Overall Study||52
1086342|NCT01012973|2631667|P1|COMPLETED|Overall Study||90
1086343|NCT01012973|2631666|P2|Completed Week 52, From FAS|Overall Study||52
1086344|NCT01012973|2631667|P1|Completed Week 52, From FAS|Overall Study||91
1086345|NCT01012973|2631666|P2|Completed Week 24, From FAS|Overall Study||57
1086346|NCT01012973|2631667|P1|Completed Week 24, From FAS|Overall Study||97
1086347|NCT01012973|2631666|P2|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|68
1086348|NCT01012973|2631667|P1|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|103
1086349|NCT01012973|2631666|P2|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|68
1086350|NCT01012973|2631667|P1|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|104
1086351|NCT01012973|2631666|P2|STARTED|Overall Study||71
1086352|NCT01012973|2631667|P1|STARTED|Overall Study||106
1086353|NCT01012999|2631687|P1|NOT COMPLETED|Overall Study||1
1086354|NCT01012999|2631687|P1|COMPLETED|Overall Study||15
1086355|NCT01012999|2631687|P1|STARTED|Overall Study||16
1086356|NCT01013194|2631693|P2|NOT COMPLETED|Overall Study||0
1086357|NCT01013194|2631694|P1|NOT COMPLETED|Overall Study||0
1086358|NCT01013194|2631693|P2|COMPLETED|Overall Study|Retrospectively contemporary matched-pair group|16
1086359|NCT01013194|2631694|P1|COMPLETED|Overall Study|Consecutive patients|9
1086360|NCT01013194|2631693|P2|STARTED|Overall Study||16
1086361|NCT01013194|2631694|P1|STARTED|Overall Study||9
1086362|NCT01013207|2631704|P1|NOT COMPLETED|CPAP Post Nexus (S9)||6
1086363|NCT01013207|2631704|P1|COMPLETED|CPAP Post Nexus (S9)||44
1086364|NCT01013207|2631704|P1|STARTED|CPAP Post Nexus (S9)||50
1086365|NCT01013207|2631704|P1|NOT COMPLETED|Nexus (S9)||0
1086366|NCT01013207|2631704|P1|COMPLETED|Nexus (S9)||50
1086367|NCT01013207|2631704|P1|STARTED|Nexus (S9)||50
1086368|NCT01013207|2631704|P1|NOT COMPLETED|CPAP Pre Nexus (S9)||0
1086369|NCT01013207|2631704|P1|COMPLETED|CPAP Pre Nexus (S9)||50
1086370|NCT01013207|2631704|P1|STARTED|CPAP Pre Nexus (S9)||50
1086371|NCT01013597|2631709|P1|NOT COMPLETED|Overall Study||1
1086372|NCT01013597|2631709|P1|COMPLETED|Overall Study||12
1086373|NCT01013597|2631709|P1|STARTED|Overall Study||13
1086374|NCT01013701|2631719|P1|NOT COMPLETED|Overall Study||7
1086375|NCT01013701|2631719|P1|COMPLETED|Overall Study||0
1086376|NCT01013701|2631719|P1|STARTED|Overall Study||7
1086377|NCT01013740|2631728|P2|NOT COMPLETED|Overall Study||19
1086378|NCT01013740|2631729|P1|NOT COMPLETED|Overall Study||11
1086379|NCT01013740|2631728|P2|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|56
1086380|NCT01013740|2631729|P1|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|26
1086381|NCT01013740|2631728|P2|Ongoing|Overall Study||0
1086382|NCT01013740|2631729|P1|Ongoing|Overall Study||0
1086383|NCT01013740|2631728|P2|STARTED|Overall Study|29 participants experiencing PD in the RP elected to enroll in the optional CP.|75
1086384|NCT01013740|2631729|P1|STARTED|Overall Study|13 participants (par.) experiencing PD in the RP elected to enroll in the optional CP.|37
1086385|NCT01013753|2631753|P1|NOT COMPLETED|Overall Study||16
1086386|NCT01013753|2631753|P1|COMPLETED|Overall Study||182
1086387|NCT01013753|2631753|P1|Received Form 12 mcg Bid|Overall Study||125
1086388|NCT01013753|2631753|P1|Received Olo 20 mcg qd|Overall Study||124
1086389|NCT01013753|2631753|P1|Received Olo 10 mcg qd|Overall Study||127
1086390|NCT01013753|2631753|P1|Received Olo 5 mcg qd|Overall Study||130
1086391|NCT01013753|2631753|P1|Received Olo 2 mcg qd|Overall Study||121
1086392|NCT01013753|2631753|P1|Received Placebo|Overall Study||125
1086393|NCT01013753|2631753|P1|STARTED|Overall Study|Entered and treated|198
1086394|NCT01013792|2631949|P2|NOT COMPLETED|Overall Study||5
1086395|NCT01013792|2631950|P1|NOT COMPLETED|Overall Study||2
1086396|NCT01013792|2631949|P2|COMPLETED|Overall Study||11
1086397|NCT01013792|2631950|P1|COMPLETED|Overall Study||12
1086398|NCT01013792|2631949|P2|STARTED|Overall Study||16
1086399|NCT01013792|2631950|P1|STARTED|Overall Study||14
1086400|NCT01013844|2631958|P2|NOT COMPLETED|Overall Study||0
1086401|NCT01013844|2631959|P1|NOT COMPLETED|Overall Study||0
1086402|NCT01013844|2631958|P2|COMPLETED|Overall Study||65
1086403|NCT01013844|2631959|P1|COMPLETED|Overall Study||65
1086404|NCT01013844|2631958|P2|STARTED|Overall Study||65
1086405|NCT01013844|2631959|P1|STARTED|Overall Study||65
1086406|NCT01013870|2631983|P2|NOT COMPLETED|Overall Study||3
1086407|NCT01013870|2631984|P1|NOT COMPLETED|Overall Study||1
1086408|NCT01013870|2631983|P2|COMPLETED|Overall Study||21
1086409|NCT01013870|2631984|P1|COMPLETED|Overall Study||27
1086410|NCT01013870|2631983|P2|STARTED|Overall Study||24
1086411|NCT01013870|2631984|P1|STARTED|Overall Study||28
1086412|NCT01013883|2632008|P2|NOT COMPLETED|Overall Study||2
1086413|NCT01013883|2632009|P1|NOT COMPLETED|Overall Study||2
1086414|NCT01013883|2632008|P2|COMPLETED|Overall Study||241
1086415|NCT01013883|2632009|P1|COMPLETED|Overall Study||268
1086416|NCT01013883|2632008|P2|STARTED|Overall Study||243
1086417|NCT01013883|2632009|P1|STARTED|Overall Study||270
1086418|NCT01013961|2632021|P2|NOT COMPLETED|Overall Study||3
1086419|NCT01013961|2632022|P1|NOT COMPLETED|Overall Study||3
1086420|NCT01013961|2632021|P2|COMPLETED|Overall Study||12
1086421|NCT01013961|2632022|P1|COMPLETED|Overall Study||13
1086422|NCT01013961|2632021|P2|STARTED|Overall Study||15
1086423|NCT01013961|2632022|P1|STARTED|Overall Study||16
1086424|NCT01014013|2632040|P2|NOT COMPLETED|Overall Study||56
1086425|NCT01014013|2632041|P1|NOT COMPLETED|Overall Study||51
1086426|NCT01014013|2632040|P2|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of Ceftriaxone parentheral therapy|80
1086427|NCT01014013|2632041|P1|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of MK0826 parentheral therapy|84
1086428|NCT01014013|2632040|P2|Completed Parenteral Therapy|Overall Study|Patients completing Ceftriaxone as a single daily dose of 2.0g intravenous infusion at least 3 days|88
1086429|NCT01014013|2632041|P1|Completed Parenteral Therapy|Overall Study|"Patients completing MK0826 as a single daily dose of 1.0g intravenous
infusion at least 3 days"|87
1086430|NCT01014013|2632040|P2|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of Ceftriaxone parenteral therapy|135
1086431|NCT01014013|2632041|P1|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of MK0826 parenteral therapy|132
1086432|NCT01014013|2632040|P2|STARTED|Overall Study||136
1086433|NCT01014013|2632041|P1|STARTED|Overall Study||135
1086434|NCT01014091|2632057|P6|NOT COMPLETED|Overall Study||0
1086435|NCT01014091|2632058|P5|NOT COMPLETED|Overall Study||0
1086436|NCT01014091|2632059|P4|NOT COMPLETED|Overall Study||0
1086437|NCT01014091|2632060|P3|NOT COMPLETED|Overall Study||0
1086438|NCT01014091|2632061|P2|NOT COMPLETED|Overall Study||0
1086439|NCT01014091|2632062|P1|NOT COMPLETED|Overall Study||0
1086440|NCT01014091|2632057|P6|COMPLETED|Overall Study||12
1086441|NCT01014091|2632058|P5|COMPLETED|Overall Study||6
1086442|NCT01014091|2632059|P4|COMPLETED|Overall Study||15
1086443|NCT01014091|2632060|P3|COMPLETED|Overall Study||5
1086444|NCT01014091|2632061|P2|COMPLETED|Overall Study||13
1086445|NCT01014091|2632062|P1|COMPLETED|Overall Study||7
1086446|NCT01014091|2632057|P6|STARTED|Overall Study||12
1086447|NCT01014091|2632058|P5|STARTED|Overall Study||6
1086448|NCT01014091|2632059|P4|STARTED|Overall Study||15
1086449|NCT01014091|2632060|P3|STARTED|Overall Study||5
1086450|NCT01014091|2632061|P2|STARTED|Overall Study||13
1086451|NCT01014091|2632062|P1|STARTED|Overall Study||7
1086452|NCT01014143|2632139|P3|NOT COMPLETED|Third Intervention||0
1086453|NCT01014143|2632140|P2|NOT COMPLETED|Third Intervention||0
1086454|NCT01014143|2632141|P1|NOT COMPLETED|Third Intervention||0
1086455|NCT01014143|2632139|P3|COMPLETED|Third Intervention||9
1086456|NCT01014143|2632140|P2|COMPLETED|Third Intervention||9
1086457|NCT01014143|2632141|P1|COMPLETED|Third Intervention||8
1086458|NCT01014143|2632139|P3|STARTED|Third Intervention||9
1086459|NCT01014143|2632140|P2|STARTED|Third Intervention||9
1086460|NCT01014143|2632141|P1|STARTED|Third Intervention||8
1086461|NCT01014143|2632139|P3|NOT COMPLETED|Washout After 2nd Intervention||0
1086462|NCT01014143|2632140|P2|NOT COMPLETED|Washout After 2nd Intervention||0
1086463|NCT01014143|2632141|P1|NOT COMPLETED|Washout After 2nd Intervention||0
1086464|NCT01014143|2632139|P3|COMPLETED|Washout After 2nd Intervention||9
1086465|NCT01014143|2632140|P2|COMPLETED|Washout After 2nd Intervention||9
1086466|NCT01014143|2632141|P1|COMPLETED|Washout After 2nd Intervention||8
1086467|NCT01014143|2632139|P3|STARTED|Washout After 2nd Intervention||9
1086468|NCT01014143|2632140|P2|STARTED|Washout After 2nd Intervention||9
1086469|NCT01014143|2632141|P1|STARTED|Washout After 2nd Intervention||8
1086470|NCT01014143|2632139|P3|NOT COMPLETED|Second Intervention||0
1086471|NCT01014143|2632140|P2|NOT COMPLETED|Second Intervention||0
1086472|NCT01014143|2632141|P1|NOT COMPLETED|Second Intervention||2
1086473|NCT01014143|2632139|P3|COMPLETED|Second Intervention||9
1086474|NCT01014143|2632140|P2|COMPLETED|Second Intervention||9
1086475|NCT01014143|2632141|P1|COMPLETED|Second Intervention||8
1086476|NCT01014143|2632139|P3|STARTED|Second Intervention||9
1086477|NCT01014143|2632140|P2|STARTED|Second Intervention||9
1086478|NCT01014143|2632141|P1|STARTED|Second Intervention||10
1086479|NCT01014143|2632139|P3|NOT COMPLETED|Washout Period After 1st Intervention||0
1086480|NCT01014143|2632140|P2|NOT COMPLETED|Washout Period After 1st Intervention||0
1086481|NCT01014143|2632141|P1|NOT COMPLETED|Washout Period After 1st Intervention||0
1086482|NCT01014143|2632139|P3|COMPLETED|Washout Period After 1st Intervention||9
1086483|NCT01014143|2632140|P2|COMPLETED|Washout Period After 1st Intervention||9
1086484|NCT01014143|2632141|P1|COMPLETED|Washout Period After 1st Intervention||10
1086485|NCT01014143|2632139|P3|STARTED|Washout Period After 1st Intervention||9
1086486|NCT01014143|2632140|P2|STARTED|Washout Period After 1st Intervention||9
1086487|NCT01014143|2632141|P1|STARTED|Washout Period After 1st Intervention||10
1086488|NCT01014143|2632139|P3|NOT COMPLETED|First Intervention||0
1086489|NCT01014143|2632140|P2|NOT COMPLETED|First Intervention||0
1086490|NCT01014143|2632141|P1|NOT COMPLETED|First Intervention||0
1086491|NCT01014143|2632139|P3|COMPLETED|First Intervention||9
1086492|NCT01014143|2632140|P2|COMPLETED|First Intervention||9
1086493|NCT01014143|2632141|P1|COMPLETED|First Intervention||10
1086494|NCT01014143|2632139|P3|STARTED|First Intervention||9
1086495|NCT01014143|2632140|P2|STARTED|First Intervention||9
1086496|NCT01014143|2632141|P1|STARTED|First Intervention||10
1086497|NCT01014169|2632151|P2|NOT COMPLETED|Overall Study||13
1086498|NCT01014169|2632152|P1|NOT COMPLETED|Overall Study||7
1086499|NCT01014169|2632151|P2|COMPLETED|Overall Study||48
1086500|NCT01014169|2632152|P1|COMPLETED|Overall Study||58
1086501|NCT01014169|2632151|P2|STARTED|Overall Study||61
1086502|NCT01014169|2632152|P1|STARTED|Overall Study||65
1086503|NCT01014208|2632164|P2|NOT COMPLETED|Overall Study||100
1086504|NCT01014208|2632165|P1|NOT COMPLETED|Overall Study||94
1086505|NCT01014208|2632164|P2|COMPLETED|Overall Study||122
1086506|NCT01014208|2632165|P1|COMPLETED|Overall Study||131
1086507|NCT01014208|2632164|P2|Intent-to-Treat Population|Overall Study||222
1086508|NCT01014208|2632165|P1|Intent-to-Treat Population|Overall Study||223
1086509|NCT01014208|2632164|P2|STARTED|Overall Study||222
1086510|NCT01014208|2632165|P1|STARTED|Overall Study||225
1086511|NCT01014351|2632191|P1|NOT COMPLETED|Overall Study||37
1086512|NCT01014351|2632191|P1|COMPLETED|Overall Study||33
1086513|NCT01014351|2632191|P1|STARTED|Overall Study||70
1086514|NCT01014442|2632199|P2|NOT COMPLETED|Overall Study||19
1086515|NCT01014442|2632200|P1|NOT COMPLETED|Overall Study||7
1086516|NCT01014442|2632199|P2|COMPLETED|Overall Study||16
1086517|NCT01014442|2632200|P1|COMPLETED|Overall Study||26
1086518|NCT01014442|2632199|P2|STARTED|Overall Study||35
1086519|NCT01014442|2632200|P1|STARTED|Overall Study||33
1086520|NCT01014455|2632314|P2|NOT COMPLETED|Overall Study||0
1086521|NCT01014455|2632315|P1|NOT COMPLETED|Overall Study||0
1086522|NCT01014455|2632314|P2|COMPLETED|Overall Study||87
1086523|NCT01014455|2632315|P1|COMPLETED|Overall Study||82
1086524|NCT01014455|2632314|P2|STARTED|Overall Study||87
1086525|NCT01014455|2632315|P1|STARTED|Overall Study||82
1086526|NCT01014585|2632325|P4|NOT COMPLETED|Overall Study||30
1086527|NCT01014585|2632326|P3|NOT COMPLETED|Overall Study||23
1086528|NCT01014585|2632327|P2|NOT COMPLETED|Overall Study||25
1086529|NCT01014585|2632328|P1|NOT COMPLETED|Overall Study||20
1086530|NCT01014585|2632325|P4|COMPLETED|Overall Study||99
1086531|NCT01014585|2632326|P3|COMPLETED|Overall Study||37
1086532|NCT01014585|2632327|P2|COMPLETED|Overall Study||75
1086533|NCT01014585|2632328|P1|COMPLETED|Overall Study||31
1086534|NCT01014585|2632325|P4|STARTED|Overall Study||129
1086535|NCT01014585|2632326|P3|STARTED|Overall Study||60
1086536|NCT01014585|2632327|P2|STARTED|Overall Study||100
1086537|NCT01014585|2632328|P1|STARTED|Overall Study||51
1086538|NCT01014624|2632348|P2|NOT COMPLETED|Overall Study||1
1086539|NCT01014624|2632349|P1|NOT COMPLETED|Overall Study||2
1086540|NCT01014624|2632348|P2|COMPLETED|Overall Study||26
1086541|NCT01014624|2632349|P1|COMPLETED|Overall Study||27
1086542|NCT01014624|2632348|P2|STARTED|Overall Study||27
1086543|NCT01014624|2632349|P1|STARTED|Overall Study||29
1086544|NCT01006590|2632371|P2|NOT COMPLETED|Overall Study||32
1086545|NCT01006590|2632372|P1|NOT COMPLETED|Overall Study||28
1086546|NCT01006590|2632371|P2|COMPLETED|Overall Study|Completed 24 weeks of treatment|107
1086547|NCT01006590|2632372|P1|COMPLETED|Overall Study|Completed 24 weeks of treatment|119
1086548|NCT01006590|2632371|P2|STARTED|Overall Study|Randomised and treated|139
1086549|NCT01006590|2632372|P1|STARTED|Overall Study|Randomised and treated|147
1086550|NCT01006603|2632390|P2|NOT COMPLETED|Overall Study||75
1086551|NCT01006603|2632391|P1|NOT COMPLETED|Overall Study||71
1086552|NCT01006603|2632390|P2|COMPLETED|Overall Study||285
1086553|NCT01006603|2632391|P1|COMPLETED|Overall Study||289
1086554|NCT01006603|2632390|P2|STARTED|Overall Study|Completed lead-in period and were randomised|360
1086555|NCT01006603|2632391|P1|STARTED|Overall Study|Completed lead-in period and were randomised|360
1086556|NCT01006616|2632413|P4|NOT COMPLETED|Period 2 (18 Months)||82
1086557|NCT01006616|2632414|P3|NOT COMPLETED|Period 2 (18 Months)||55
1086558|NCT01006616|2632415|P2|NOT COMPLETED|Period 2 (18 Months)||63
1086559|NCT01006616|2632416|P1|NOT COMPLETED|Period 2 (18 Months)||75
1086560|NCT01006616|2632413|P4|COMPLETED|Period 2 (18 Months)||0
1086561|NCT01006616|2632414|P3|COMPLETED|Period 2 (18 Months)||0
1086562|NCT01006616|2632415|P2|COMPLETED|Period 2 (18 Months)||0
1086563|NCT01006616|2632416|P1|COMPLETED|Period 2 (18 Months)||0
1086564|NCT01006616|2632413|P4|Treated|Period 2 (18 Months)||82
1086565|NCT01006616|2632414|P3|Treated|Period 2 (18 Months)||55
1086566|NCT01006616|2632415|P2|Treated|Period 2 (18 Months)||63
1086567|NCT01006616|2632416|P1|Treated|Period 2 (18 Months)||75
1086568|NCT01006616|2632413|P4|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|82
1086569|NCT01006616|2632414|P3|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|55
1086570|NCT01006616|2632415|P2|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|63
1086571|NCT01006616|2632416|P1|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|75
1086572|NCT01006616|2632413|P4|NOT COMPLETED|Period 1 (6 Months)||27
1086573|NCT01006616|2632414|P3|NOT COMPLETED|Period 1 (6 Months)||51
1086574|NCT01006616|2632415|P2|NOT COMPLETED|Period 1 (6 Months)||54
1086575|NCT01006616|2632416|P1|NOT COMPLETED|Period 1 (6 Months)||26
1086576|NCT01006616|2632413|P4|COMPLETED|Period 1 (6 Months)||128
1086577|NCT01006616|2632414|P3|COMPLETED|Period 1 (6 Months)||102
1086578|NCT01006616|2632415|P2|COMPLETED|Period 1 (6 Months)||102
1086579|NCT01006616|2632416|P1|COMPLETED|Period 1 (6 Months)||126
1086580|NCT01006616|2632413|P4|Treated|Period 1 (6 Months)||154
1086581|NCT01006616|2632414|P3|Treated|Period 1 (6 Months)||152
1086582|NCT01006616|2632415|P2|Treated|Period 1 (6 Months)||156
1086583|NCT01006616|2632416|P1|Treated|Period 1 (6 Months)||152
1086584|NCT01006616|2632413|P4|STARTED|Period 1 (6 Months)||155
1086585|NCT01006616|2632414|P3|STARTED|Period 1 (6 Months)||153
1086586|NCT01006616|2632415|P2|STARTED|Period 1 (6 Months)||156
1086587|NCT01006616|2632416|P1|STARTED|Period 1 (6 Months)||152
1086588|NCT01006629|2632550|P1|NOT COMPLETED|Overall Study||6
1086589|NCT01006629|2632550|P1|COMPLETED|Overall Study||94
1086590|NCT01006629|2632550|P1|STARTED|Overall Study||100
1086591|NCT01006655|2632563|P2|NOT COMPLETED|Second Intervention||0
1086592|NCT01006655|2632564|P1|NOT COMPLETED|Second Intervention||0
1086593|NCT01006655|2632563|P2|COMPLETED|Second Intervention||10
1086594|NCT01006655|2632564|P1|COMPLETED|Second Intervention||11
1086595|NCT01006655|2632563|P2|STARTED|Second Intervention||10
1086596|NCT01006655|2632564|P1|STARTED|Second Intervention||11
1086597|NCT01006655|2632563|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
1086598|NCT01006655|2632564|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
1086599|NCT01006655|2632563|P2|COMPLETED|Washout Period of 2 Weeks||10
1086600|NCT01006655|2632564|P1|COMPLETED|Washout Period of 2 Weeks||11
1086601|NCT01006655|2632563|P2|STARTED|Washout Period of 2 Weeks||10
1086602|NCT01006655|2632564|P1|STARTED|Washout Period of 2 Weeks||11
1086603|NCT01006655|2632563|P2|NOT COMPLETED|First Intervention||0
1086604|NCT01006655|2632564|P1|NOT COMPLETED|First Intervention||0
1086605|NCT01006655|2632563|P2|COMPLETED|First Intervention||10
1086606|NCT01006655|2632564|P1|COMPLETED|First Intervention||11
1086607|NCT01006655|2632563|P2|STARTED|First Intervention||10
1086608|NCT01006655|2632564|P1|STARTED|First Intervention||11
1086609|NCT01014689|2632572|P2|NOT COMPLETED|Overall Study||13
1086610|NCT01014689|2632573|P1|NOT COMPLETED|Overall Study||13
1086611|NCT01014689|2632572|P2|COMPLETED|Overall Study||174
1086612|NCT01014689|2632573|P1|COMPLETED|Overall Study||178
1086613|NCT01014689|2632572|P2|STARTED|Overall Study||187
1086614|NCT01014689|2632573|P1|STARTED|Overall Study||191
1086615|NCT01014728|2632583|P2|NOT COMPLETED|Overall Study||0
1086616|NCT01014728|2632584|P1|NOT COMPLETED|Overall Study||0
1086617|NCT01014728|2632583|P2|COMPLETED|Overall Study||15
1086618|NCT01014728|2632584|P1|COMPLETED|Overall Study||18
1086619|NCT01014728|2632583|P2|STARTED|Overall Study||15
1086620|NCT01014728|2632584|P1|STARTED|Overall Study||18
1086621|NCT01014741|2632596|P2|NOT COMPLETED|Overall Study||5
1086622|NCT01014741|2632597|P1|NOT COMPLETED|Overall Study||11
1086623|NCT01014741|2632596|P2|COMPLETED|Overall Study||90
1086624|NCT01014741|2632597|P1|COMPLETED|Overall Study||94
1086625|NCT01014741|2632596|P2|STARTED|Overall Study||95
1086626|NCT01014741|2632597|P1|STARTED|Overall Study||105
1086627|NCT01014871|2632609|P1|NOT COMPLETED|Overall Study||0
1086628|NCT01014871|2632609|P1|COMPLETED|Overall Study||30
1086629|NCT01014871|2632609|P1|STARTED|Overall Study||30
1086630|NCT01014910|2632617|P2|NOT COMPLETED|Overall Study||2
1086631|NCT01014910|2632618|P1|NOT COMPLETED|Overall Study||0
1086632|NCT01014910|2632617|P2|COMPLETED|Overall Study||79
1086633|NCT01014910|2632618|P1|COMPLETED|Overall Study||80
1086634|NCT01014910|2632617|P2|STARTED|Overall Study||81
1086635|NCT01014910|2632618|P1|STARTED|Overall Study||80
1086636|NCT01014936|2632629|P3|NOT COMPLETED|Overall Study||0
1086637|NCT01014936|2632630|P2|NOT COMPLETED|Overall Study||0
1086638|NCT01014936|2632631|P1|NOT COMPLETED|Overall Study||0
1086639|NCT01014936|2632629|P3|COMPLETED|Overall Study||62
1086640|NCT01014936|2632630|P2|COMPLETED|Overall Study||45
1086641|NCT01014936|2632631|P1|COMPLETED|Overall Study||42
1086642|NCT01014936|2632629|P3|STARTED|Overall Study||62
1086643|NCT01014936|2632630|P2|STARTED|Overall Study||45
1086644|NCT01014936|2632631|P1|STARTED|Overall Study||42
1086645|NCT01016483|2633125|P4|NOT COMPLETED|Phase II||0
1086646|NCT01016483|2633126|P3|NOT COMPLETED|Phase II||0
1086647|NCT01016483|2633127|P2|NOT COMPLETED|Phase II||0
1086648|NCT01016483|2633128|P1|NOT COMPLETED|Phase II||0
1086649|NCT01016483|2633125|P4|COMPLETED|Phase II||44
1086650|NCT01016483|2633126|P3|COMPLETED|Phase II||44
1086651|NCT01016483|2633127|P2|COMPLETED|Phase II||0
1086652|NCT01016483|2633128|P1|COMPLETED|Phase II||0
1086653|NCT01016483|2633125|P4|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|45
1086654|NCT01016483|2633126|P3|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|42
1086655|NCT01016483|2633127|P2|Treated (Safety Analysis Set [SAF])|Phase II||0
1086656|NCT01016483|2633128|P1|Treated (Safety Analysis Set [SAF])|Phase II||0
1086657|NCT01016483|2633125|P4|STARTED|Phase II|Subjects presented as randomized (ITT Analysis Set).|44
1086658|NCT01016483|2633126|P3|STARTED|Phase II|Subjects presented as randomized (Intention-to-Treat [ITT] Analysis Set).|44
1086659|NCT01016483|2633127|P2|STARTED|Phase II||0
1086660|NCT01016483|2633128|P1|STARTED|Phase II||0
1086661|NCT01016483|2633125|P4|NOT COMPLETED|Safety Run-in Part||0
1086662|NCT01016483|2633126|P3|NOT COMPLETED|Safety Run-in Part||0
1086663|NCT01016483|2633127|P2|NOT COMPLETED|Safety Run-in Part||0
1086664|NCT01016483|2633128|P1|NOT COMPLETED|Safety Run-in Part||0
1086665|NCT01016483|2633125|P4|COMPLETED|Safety Run-in Part||0
1086666|NCT01016483|2633126|P3|COMPLETED|Safety Run-in Part||0
1086667|NCT01016483|2633127|P2|COMPLETED|Safety Run-in Part||26
1086668|NCT01016483|2633128|P1|COMPLETED|Safety Run-in Part||27
1086669|NCT01016483|2633125|P4|STARTED|Safety Run-in Part||0
1086670|NCT01016483|2633126|P3|STARTED|Safety Run-in Part||0
1086671|NCT01016483|2633127|P2|STARTED|Safety Run-in Part||26
1086672|NCT01016483|2633128|P1|STARTED|Safety Run-in Part||27
1086673|NCT01016600|2633238|P4|NOT COMPLETED|Overall Study||0
1086674|NCT01016600|2633239|P3|NOT COMPLETED|Overall Study||0
1086675|NCT01016600|2633240|P2|NOT COMPLETED|Overall Study||0
1086676|NCT01016600|2633241|P1|NOT COMPLETED|Overall Study||1
1086677|NCT01016600|2633238|P4|COMPLETED|Overall Study||12
1086678|NCT01016600|2633239|P3|COMPLETED|Overall Study||6
1086679|NCT01016600|2633240|P2|COMPLETED|Overall Study||4
1086680|NCT01016600|2633241|P1|COMPLETED|Overall Study||8
1086681|NCT01016600|2633238|P4|STARTED|Overall Study||12
1086682|NCT01016600|2633239|P3|STARTED|Overall Study||6
1086683|NCT01016600|2633240|P2|STARTED|Overall Study||4
1086684|NCT01016600|2633241|P1|STARTED|Overall Study||9
1086685|NCT01016652|2633306|P2|NOT COMPLETED|Period 2||0
1086686|NCT01016652|2633307|P1|NOT COMPLETED|Period 2||0
1086687|NCT01016652|2633306|P2|COMPLETED|Period 2||24
1086688|NCT01016652|2633307|P1|COMPLETED|Period 2||25
1086689|NCT01016652|2633306|P2|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|24
1086690|NCT01016652|2633307|P1|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|25
1086691|NCT01016652|2633306|P2|NOT COMPLETED|Period 1||0
1086692|NCT01016652|2633307|P1|NOT COMPLETED|Period 1||0
1086693|NCT01016652|2633306|P2|COMPLETED|Period 1||24
1086694|NCT01016652|2633307|P1|COMPLETED|Period 1||25
1086695|NCT01016652|2633306|P2|STARTED|Period 1||24
1086696|NCT01016652|2633307|P1|STARTED|Period 1||25
1086697|NCT01016678|2633323|P5|NOT COMPLETED|Overall Study||6
1086698|NCT01016678|2633324|P4|NOT COMPLETED|Overall Study||0
1086699|NCT01016678|2633325|P3|NOT COMPLETED|Overall Study||4
1086700|NCT01016678|2633326|P2|NOT COMPLETED|Overall Study||3
1086701|NCT01016678|2633327|P1|NOT COMPLETED|Overall Study||2
1086702|NCT01016678|2633323|P5|COMPLETED|Overall Study||13
1086703|NCT01016678|2633324|P4|COMPLETED|Overall Study||19
1086704|NCT01016678|2633325|P3|COMPLETED|Overall Study||15
1086705|NCT01016678|2633326|P2|COMPLETED|Overall Study||14
1086706|NCT01016678|2633327|P1|COMPLETED|Overall Study||18
1086707|NCT01016678|2633323|P5|STARTED|Overall Study||19
1086708|NCT01016678|2633324|P4|STARTED|Overall Study||19
1086709|NCT01016678|2633325|P3|STARTED|Overall Study||19
1086710|NCT01016678|2633326|P2|STARTED|Overall Study||17
1086711|NCT01016678|2633327|P1|STARTED|Overall Study||20
1086712|NCT01016691|2633350|P3|NOT COMPLETED|Overall Study||0
1086713|NCT01016691|2633351|P2|NOT COMPLETED|Overall Study||0
1086714|NCT01016691|2633352|P1|NOT COMPLETED|Overall Study||0
1086715|NCT01016691|2633350|P3|COMPLETED|Overall Study||18
1086716|NCT01016691|2633351|P2|COMPLETED|Overall Study||12
1086717|NCT01016691|2633352|P1|COMPLETED|Overall Study||17
1086718|NCT01016691|2633350|P3|STARTED|Overall Study||18
1086719|NCT01016691|2633351|P2|STARTED|Overall Study||12
1086720|NCT01016691|2633352|P1|STARTED|Overall Study||17
1086721|NCT01016834|2633360|P1|NOT COMPLETED|Overall Study||22
1086722|NCT01016834|2633360|P1|COMPLETED|Overall Study||220
1086723|NCT01016834|2633360|P1|STARTED|Overall Study||242
1086724|NCT01016847|2633368|P2|NOT COMPLETED|Overall Study||0
1086725|NCT01016847|2633369|P1|NOT COMPLETED|Overall Study||0
1086726|NCT01016847|2633368|P2|COMPLETED|Overall Study||2
1086727|NCT01016847|2633369|P1|COMPLETED|Overall Study||1
1086728|NCT01016847|2633368|P2|STARTED|Overall Study||2
1086729|NCT01016847|2633369|P1|STARTED|Overall Study||1
1086730|NCT01016873|2633388|P3|NOT COMPLETED|36 Months||6
1086731|NCT01016873|2633389|P2|NOT COMPLETED|36 Months||4
1086732|NCT01016873|2633390|P1|NOT COMPLETED|36 Months||11
1086733|NCT01016873|2633388|P3|COMPLETED|36 Months||67
1086734|NCT01016873|2633389|P2|COMPLETED|36 Months||64
1086735|NCT01016873|2633390|P1|COMPLETED|36 Months||58
1086736|NCT01016873|2633388|P3|STARTED|36 Months||73
1086737|NCT01016873|2633389|P2|STARTED|36 Months||68
1086738|NCT01016873|2633390|P1|STARTED|36 Months||69
1086739|NCT01016873|2633388|P3|NOT COMPLETED|24 Months||6
1086740|NCT01016873|2633389|P2|NOT COMPLETED|24 Months||4
1086741|NCT01016873|2633390|P1|NOT COMPLETED|24 Months||5
1086742|NCT01016873|2633388|P3|COMPLETED|24 Months||73
1086743|NCT01016873|2633389|P2|COMPLETED|24 Months||68
1086744|NCT01016873|2633390|P1|COMPLETED|24 Months||69
1086745|NCT01016873|2633388|P3|STARTED|24 Months||79
1086746|NCT01016873|2633389|P2|STARTED|24 Months||72
1086747|NCT01016873|2633390|P1|STARTED|24 Months||74
1086748|NCT01016873|2633388|P3|NOT COMPLETED|12 Months||1
1086749|NCT01016873|2633389|P2|NOT COMPLETED|12 Months||3
1086750|NCT01016873|2633390|P1|NOT COMPLETED|12 Months||1
1086751|NCT01016873|2633388|P3|COMPLETED|12 Months||79
1086752|NCT01016873|2633389|P2|COMPLETED|12 Months||72
1086753|NCT01016873|2633390|P1|COMPLETED|12 Months||74
1086754|NCT01016873|2633388|P3|STARTED|12 Months||80
1086755|NCT01016873|2633389|P2|STARTED|12 Months||75
1086756|NCT01016873|2633390|P1|STARTED|12 Months||75
1086757|NCT01016912|2633424|P5|NOT COMPLETED|Follow-up Period||0
1086758|NCT01016912|2633425|P4|NOT COMPLETED|Follow-up Period||1
1086759|NCT01016912|2633426|P3|NOT COMPLETED|Follow-up Period||1
1086760|NCT01016912|2633427|P2|NOT COMPLETED|Follow-up Period||0
1086761|NCT01016912|2633428|P1|NOT COMPLETED|Follow-up Period||0
1086762|NCT01016912|2633424|P5|COMPLETED|Follow-up Period||9
1086763|NCT01016912|2633425|P4|COMPLETED|Follow-up Period||8
1086764|NCT01016912|2633426|P3|COMPLETED|Follow-up Period||9
1086765|NCT01016912|2633427|P2|COMPLETED|Follow-up Period||9
1086766|NCT01016912|2633428|P1|COMPLETED|Follow-up Period||8
1086767|NCT01016912|2633424|P5|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
1086768|NCT01016912|2633425|P4|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
1086769|NCT01016912|2633426|P3|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|10
1086770|NCT01016912|2633427|P2|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
1086771|NCT01016912|2633428|P1|STARTED|Follow-up Period||8
1086772|NCT01016912|2633424|P5|NOT COMPLETED|End of Treatment Period||4
1086773|NCT01016912|2633425|P4|NOT COMPLETED|End of Treatment Period||4
1086774|NCT01016912|2633426|P3|NOT COMPLETED|End of Treatment Period||1
1086775|NCT01016912|2633427|P2|NOT COMPLETED|End of Treatment Period||3
1086776|NCT01016912|2633428|P1|NOT COMPLETED|End of Treatment Period||0
1086777|NCT01016912|2633424|P5|COMPLETED|End of Treatment Period||5
1086778|NCT01016912|2633425|P4|COMPLETED|End of Treatment Period||5
1086779|NCT01016912|2633426|P3|COMPLETED|End of Treatment Period||9
1086780|NCT01016912|2633427|P2|COMPLETED|End of Treatment Period||6
1086781|NCT01016912|2633428|P1|COMPLETED|End of Treatment Period||8
1086782|NCT01016912|2633424|P5|Received Treatment|End of Treatment Period||9
1086783|NCT01016912|2633425|P4|Received Treatment|End of Treatment Period||9
1086784|NCT01016912|2633426|P3|Received Treatment|End of Treatment Period||10
1086785|NCT01016912|2633427|P2|Received Treatment|End of Treatment Period||9
1086786|NCT01016912|2633428|P1|Received Treatment|End of Treatment Period||8
1086787|NCT01016912|2633424|P5|STARTED|End of Treatment Period||9
1086788|NCT01016912|2633425|P4|STARTED|End of Treatment Period||9
1086789|NCT01016912|2633426|P3|STARTED|End of Treatment Period||10
1086790|NCT01016912|2633427|P2|STARTED|End of Treatment Period||9
1086791|NCT01016912|2633428|P1|STARTED|End of Treatment Period||8
1086792|NCT01016938|2633470|P1|NOT COMPLETED|Overall Study||9
1086793|NCT01016938|2633470|P1|COMPLETED|Overall Study||7
1086794|NCT01016938|2633470|P1|STARTED|Overall Study||16
1086795|NCT01016964|2633477|P2|NOT COMPLETED|Overall Study||3
1086796|NCT01016964|2633478|P1|NOT COMPLETED|Overall Study||3
1086797|NCT01016964|2633477|P2|COMPLETED|Overall Study||39
1086798|NCT01016964|2633478|P1|COMPLETED|Overall Study||18
1086799|NCT01016964|2633477|P2|STARTED|Overall Study||42
1086800|NCT01016964|2633478|P1|STARTED|Overall Study||21
1086801|NCT01016977|2633486|P2|NOT COMPLETED|Overall Study||2
1086802|NCT01016977|2633487|P1|NOT COMPLETED|Overall Study||3
1086803|NCT01016977|2633486|P2|COMPLETED|Overall Study||18
1086804|NCT01016977|2633487|P1|COMPLETED|Overall Study||17
1086805|NCT01016977|2633486|P2|STARTED|Overall Study||20
1086806|NCT01016977|2633487|P1|STARTED|Overall Study||20
1086807|NCT01017003|2633521|P1|NOT COMPLETED|Colchicine 0.6 mg Final Dose||0
1086808|NCT01017003|2633521|P1|COMPLETED|Colchicine 0.6 mg Final Dose||13
1086809|NCT01017003|2633521|P1|STARTED|Colchicine 0.6 mg Final Dose||13
1086810|NCT01017003|2633521|P1|NOT COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||0
1086811|NCT01017003|2633521|P1|COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||13
1086812|NCT01017003|2633521|P1|STARTED|Colchicine 0.6 mg Twice Daily x 10 Days||13
1086813|NCT01017003|2633521|P1|NOT COMPLETED|14 Day Washout Period||0
1086814|NCT01017003|2633521|P1|COMPLETED|14 Day Washout Period||13
1086815|NCT01017003|2633521|P1|STARTED|14 Day Washout Period||13
1086816|NCT01017003|2633521|P1|NOT COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||0
1086817|NCT01017003|2633521|P1|COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||13
1086818|NCT01017003|2633521|P1|STARTED|Single Dose Colchicine 0.6 mg, Day 1||13
1086819|NCT01017029|2633533|P2|NOT COMPLETED|Overall Study||2
1086820|NCT01017029|2633534|P1|NOT COMPLETED|Overall Study||4
1086821|NCT01017029|2633533|P2|COMPLETED|Overall Study||90
1086822|NCT01017029|2633534|P1|COMPLETED|Overall Study||85
1086823|NCT01017029|2633533|P2|STARTED|Overall Study||92
1086824|NCT01017029|2633534|P1|STARTED|Overall Study||89
1086825|NCT01017042|2633550|P1|NOT COMPLETED|Overall Study||0
1086826|NCT01017042|2633550|P1|COMPLETED|Overall Study||13
1086827|NCT01017042|2633550|P1|STARTED|Overall Study||13
1086828|NCT01017120|2633563|P2|NOT COMPLETED|Overall Study||35
1086829|NCT01017120|2633564|P1|NOT COMPLETED|Overall Study||66
1086830|NCT01017120|2633563|P2|COMPLETED|Overall Study||334
1086831|NCT01017120|2633564|P1|COMPLETED|Overall Study||307
1086832|NCT01017120|2633563|P2|STARTED|Overall Study||369
1086833|NCT01017120|2633564|P1|STARTED|Overall Study||373
1086834|NCT01017146|2633614|P2|NOT COMPLETED|Overall Study||39
1086835|NCT01017146|2633615|P1|NOT COMPLETED|Overall Study||66
1086836|NCT01017146|2633614|P2|COMPLETED|Overall Study||333
1086837|NCT01017146|2633615|P1|COMPLETED|Overall Study||306
1086838|NCT01017146|2633614|P2|STARTED|Overall Study||372
1086839|NCT01017146|2633615|P1|STARTED|Overall Study||372
1086840|NCT01017237|2633653|P2|NOT COMPLETED|Overall Study||2
1086841|NCT01017237|2633654|P1|NOT COMPLETED|Overall Study||5
1086842|NCT01017237|2633653|P2|COMPLETED|Overall Study||6
1086843|NCT01017237|2633654|P1|COMPLETED|Overall Study||5
1086844|NCT01017237|2633653|P2|STARTED|Overall Study||8
1086845|NCT01017237|2633654|P1|STARTED|Overall Study||10
1086846|NCT01017250|2633706|P1|NOT COMPLETED|Overall Study||0
1086847|NCT01017250|2633706|P1|COMPLETED|Overall Study||15
1086848|NCT01017250|2633706|P1|2-month MRI|Overall Study|1 participant did not return for the 2 month MRI at treating facility. Resides out of state.|14
1086849|NCT01017250|2633706|P1|STARTED|Overall Study||15
1086850|NCT01017263|2633726|P1|NOT COMPLETED|Overall Study||12
1086851|NCT01017263|2633726|P1|COMPLETED|Overall Study|A total of 14 participants screened: 2 qualified and received drug the remaining 12 failed screen|2
1086852|NCT01017263|2633726|P1|STARTED|Overall Study||14
1086853|NCT01017497|2633730|P1|NOT COMPLETED|Overall Study||0
1086854|NCT01017497|2633730|P1|COMPLETED|Overall Study||49
1086855|NCT01017497|2633730|P1|STARTED|Overall Study||49
1086856|NCT01017536|2633745|P2|NOT COMPLETED|Overall Study||0
1086857|NCT01017536|2633746|P1|NOT COMPLETED|Overall Study||0
1086858|NCT01017536|2633745|P2|COMPLETED|Overall Study||13
1086859|NCT01017536|2633746|P1|COMPLETED|Overall Study||13
1086860|NCT01017536|2633745|P2|STARTED|Overall Study||13
1086861|NCT01017536|2633746|P1|STARTED|Overall Study||13
1086862|NCT01017549|2633756|P1|NOT COMPLETED|One-year Follow-up||7
1086863|NCT01017549|2633756|P1|COMPLETED|One-year Follow-up||36
1086864|NCT01017549|2633756|P1|STARTED|One-year Follow-up||43
1086865|NCT01017549|2633756|P1|NOT COMPLETED|Eligibility Through 6 Month Follow-up||1
1086866|NCT01017549|2633756|P1|COMPLETED|Eligibility Through 6 Month Follow-up|6 month follow-up complete Oct 2008; data through 6 months and 1 year are published.|43
1086867|NCT01017549|2633756|P1|STARTED|Eligibility Through 6 Month Follow-up||44
1086868|NCT01017575|2633766|P5|NOT COMPLETED|Overall Study||3
1086869|NCT01017575|2633767|P4|NOT COMPLETED|Overall Study||1
1086870|NCT01017575|2633768|P3|NOT COMPLETED|Overall Study||0
1086871|NCT01017575|2633769|P2|NOT COMPLETED|Overall Study||2
1086872|NCT01017575|2633770|P1|NOT COMPLETED|Overall Study||1
1086873|NCT01017575|2633766|P5|COMPLETED|Overall Study||6
1086874|NCT01017575|2633767|P4|COMPLETED|Overall Study||7
1086875|NCT01017575|2633768|P3|COMPLETED|Overall Study||8
1086876|NCT01017575|2633769|P2|COMPLETED|Overall Study||7
1086877|NCT01017575|2633770|P1|COMPLETED|Overall Study||7
1086878|NCT01017575|2633766|P5|STARTED|Overall Study||9
1086879|NCT01017575|2633767|P4|STARTED|Overall Study||8
1086880|NCT01017575|2633768|P3|STARTED|Overall Study||8
1086881|NCT01017575|2633769|P2|STARTED|Overall Study||9
1086882|NCT01017575|2633770|P1|STARTED|Overall Study||8
1086883|NCT01017601|2633809|P2|NOT COMPLETED|Overall Study||13
1086884|NCT01017601|2633810|P1|NOT COMPLETED|Overall Study||12
1086885|NCT01017601|2633809|P2|COMPLETED|Overall Study||11
1086886|NCT01017601|2633810|P1|COMPLETED|Overall Study||14
1086887|NCT01017601|2633809|P2|STARTED|Overall Study||24
1086888|NCT01017601|2633810|P1|STARTED|Overall Study||26
1086889|NCT01017653|2633832|P1|NOT COMPLETED|Overall Study||0
1086890|NCT01017653|2633832|P1|COMPLETED|Overall Study||16
1086891|NCT01017653|2633832|P1|STARTED|Overall Study||16
1086892|NCT01017731|2633842|P1|NOT COMPLETED|Overall Study||8
1086893|NCT01017731|2633842|P1|COMPLETED|Overall Study||60
1086894|NCT01017731|2633842|P1|Received at Least 1 Dose of Study Drug|Overall Study||66
1086895|NCT01017731|2633842|P1|STARTED|Overall Study||68
1086896|NCT01017874|2633861|P2|NOT COMPLETED|Overall Study||26
1086897|NCT01017874|2633862|P1|NOT COMPLETED|Overall Study||30
1086898|NCT01017874|2633861|P2|COMPLETED|Overall Study||92
1086899|NCT01017874|2633862|P1|COMPLETED|Overall Study||88
1086900|NCT01017874|2633861|P2|Received at Least 1 Dose of Study Drug|Overall Study||118
1086901|NCT01017874|2633862|P1|Received at Least 1 Dose of Study Drug|Overall Study||114
1086902|NCT01017874|2633861|P2|STARTED|Overall Study||118
1086903|NCT01017874|2633862|P1|STARTED|Overall Study||118
1086904|NCT01017952|2633884|P5|NOT COMPLETED|52-week, Double-blind Treatment Period||103
1086905|NCT01017952|2633885|P4|NOT COMPLETED|52-week, Double-blind Treatment Period||112
1086906|NCT01017952|2633886|P3|NOT COMPLETED|52-week, Double-blind Treatment Period||109
1086907|NCT01017952|2633887|P2|NOT COMPLETED|52-week, Double-blind Treatment Period||125
1086908|NCT01017952|2633888|P1|NOT COMPLETED|52-week, Double-blind Treatment Period||0
1086909|NCT01017952|2633884|P5|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|306
1086910|NCT01017952|2633885|P4|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|291
1086911|NCT01017952|2633886|P3|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|303
1086912|NCT01017952|2633887|P2|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|284
1086913|NCT01017952|2633888|P1|COMPLETED|52-week, Double-blind Treatment Period||0
1086914|NCT01017952|2633884|P5|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|307
1086915|NCT01017952|2633885|P4|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|293
1086916|NCT01017952|2633886|P3|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|305
1086917|NCT01017952|2633887|P2|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|285
1086918|NCT01017952|2633888|P1|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
1086919|NCT01017952|2633884|P5|STARTED|52-week, Double-blind Treatment Period||409
1086920|NCT01017952|2633885|P4|STARTED|52-week, Double-blind Treatment Period||403
1086921|NCT01017952|2633886|P3|STARTED|52-week, Double-blind Treatment Period||412
1086922|NCT01017952|2633887|P2|STARTED|52-week, Double-blind Treatment Period||409
1086923|NCT01017952|2633888|P1|STARTED|52-week, Double-blind Treatment Period||0
1086924|NCT01017952|2633884|P5|NOT COMPLETED|4-week, Open-label Run-In Period||0
1086925|NCT01017952|2633885|P4|NOT COMPLETED|4-week, Open-label Run-In Period||0
1086926|NCT01017952|2633886|P3|NOT COMPLETED|4-week, Open-label Run-In Period||0
1086927|NCT01017952|2633887|P2|NOT COMPLETED|4-week, Open-label Run-In Period||0
1086928|NCT01017952|2633888|P1|NOT COMPLETED|4-week, Open-label Run-In Period||459
1086929|NCT01017952|2633884|P5|COMPLETED|4-week, Open-label Run-In Period||0
1086930|NCT01017952|2633885|P4|COMPLETED|4-week, Open-label Run-In Period||0
1086931|NCT01017952|2633886|P3|COMPLETED|4-week, Open-label Run-In Period||0
1086932|NCT01017952|2633887|P2|COMPLETED|4-week, Open-label Run-In Period||0
1086933|NCT01017952|2633888|P1|COMPLETED|4-week, Open-label Run-In Period||1633
1086934|NCT01017952|2633884|P5|STARTED|4-week, Open-label Run-In Period||0
1086935|NCT01017952|2633885|P4|STARTED|4-week, Open-label Run-In Period||0
1086936|NCT01017952|2633886|P3|STARTED|4-week, Open-label Run-In Period||0
1086937|NCT01017952|2633887|P2|STARTED|4-week, Open-label Run-In Period||0
1086938|NCT01017952|2633888|P1|STARTED|4-week, Open-label Run-In Period||2092
1086939|NCT01018030|2633913|P3|NOT COMPLETED|Overall Study||13
1086940|NCT01018030|2633914|P2|NOT COMPLETED|Overall Study||11
1086941|NCT01018030|2633915|P1|NOT COMPLETED|Overall Study||19
1086942|NCT01018030|2633913|P3|COMPLETED|Overall Study||239
1086943|NCT01018030|2633914|P2|COMPLETED|Overall Study||232
1086944|NCT01018030|2633915|P1|COMPLETED|Overall Study||227
1086945|NCT01018030|2633913|P3|STARTED|Overall Study||252
1086946|NCT01018030|2633914|P2|STARTED|Overall Study||243
1086947|NCT01018030|2633915|P1|STARTED|Overall Study||246
1086948|NCT01018056|2633965|P3|NOT COMPLETED|Overall Study||1
1086949|NCT01018056|2633966|P2|NOT COMPLETED|Overall Study||2
1086950|NCT01018056|2633967|P1|NOT COMPLETED|Overall Study||3
1086951|NCT01018056|2633965|P3|COMPLETED|Overall Study||5
1086952|NCT01018056|2633966|P2|COMPLETED|Overall Study||10
1086953|NCT01018056|2633967|P1|COMPLETED|Overall Study||9
1086954|NCT01018056|2633965|P3|STARTED|Overall Study||6
1086955|NCT01018056|2633966|P2|STARTED|Overall Study||12
1086956|NCT01018056|2633967|P1|STARTED|Overall Study||12
1086957|NCT01018095|2634001|P2|NOT COMPLETED|Overall Study||62
1086958|NCT01018095|2634002|P1|NOT COMPLETED|Overall Study||56
1086959|NCT01018095|2634001|P2|COMPLETED|Overall Study||73
1086960|NCT01018095|2634002|P1|COMPLETED|Overall Study||79
1086961|NCT01018095|2634001|P2|STARTED|Overall Study||135
1086962|NCT01018095|2634002|P1|STARTED|Overall Study||135
1086963|NCT01018134|2634016|P6|NOT COMPLETED|Overall Study||0
1086964|NCT01018134|2634017|P5|NOT COMPLETED|Overall Study||0
1086965|NCT01018134|2634018|P4|NOT COMPLETED|Overall Study||0
1086966|NCT01018134|2634019|P3|NOT COMPLETED|Overall Study||1
1086967|NCT01018134|2634020|P2|NOT COMPLETED|Overall Study||1
1086968|NCT01018134|2634021|P1|NOT COMPLETED|Overall Study||0
1086969|NCT01018134|2634016|P6|COMPLETED|Overall Study||15
1086970|NCT01018134|2634017|P5|COMPLETED|Overall Study||15
1086971|NCT01018134|2634018|P4|COMPLETED|Overall Study||29
1086972|NCT01018134|2634019|P3|COMPLETED|Overall Study||29
1086973|NCT01018134|2634020|P2|COMPLETED|Overall Study||30
1086974|NCT01018134|2634021|P1|COMPLETED|Overall Study||30
1086975|NCT01018134|2634016|P6|STARTED|Overall Study||15
1086976|NCT01018134|2634017|P5|STARTED|Overall Study||15
1086977|NCT01018134|2634018|P4|STARTED|Overall Study|30 enrolled patients, one who did not use the study medication was excluded from all analyses|29
1086978|NCT01018134|2634019|P3|STARTED|Overall Study||30
1086979|NCT01018134|2634020|P2|STARTED|Overall Study||31
1086980|NCT01018134|2634021|P1|STARTED|Overall Study||30
1086981|NCT01018186|2634062|P4|NOT COMPLETED|52-week Double-blind Treatment Period||29
1086982|NCT01018186|2634063|P3|NOT COMPLETED|52-week Double-blind Treatment Period||41
1086983|NCT01018186|2634064|P2|NOT COMPLETED|52-week Double-blind Treatment Period||40
1086984|NCT01018186|2634065|P1|NOT COMPLETED|52-week Double-blind Treatment Period||0
1086985|NCT01018186|2634062|P4|COMPLETED|52-week Double-blind Treatment Period||71
1086986|NCT01018186|2634063|P3|COMPLETED|52-week Double-blind Treatment Period||161
1086987|NCT01018186|2634064|P2|COMPLETED|52-week Double-blind Treatment Period||161
1086988|NCT01018186|2634065|P1|COMPLETED|52-week Double-blind Treatment Period||0
1086989|NCT01018186|2634062|P4|STARTED|52-week Double-blind Treatment Period||100
1086990|NCT01018186|2634063|P3|STARTED|52-week Double-blind Treatment Period||202
1086991|NCT01018186|2634064|P2|STARTED|52-week Double-blind Treatment Period||201
1086992|NCT01018186|2634065|P1|STARTED|52-week Double-blind Treatment Period||0
1086993|NCT01018186|2634062|P4|NOT COMPLETED|2-week Run-in Period||0
1086994|NCT01018186|2634063|P3|NOT COMPLETED|2-week Run-in Period||0
1086995|NCT01018186|2634064|P2|NOT COMPLETED|2-week Run-in Period||0
1086996|NCT01018186|2634065|P1|NOT COMPLETED|2-week Run-in Period||114
1086997|NCT01018186|2634062|P4|COMPLETED|2-week Run-in Period||0
1086998|NCT01018186|2634063|P3|COMPLETED|2-week Run-in Period||0
1086999|NCT01018186|2634064|P2|COMPLETED|2-week Run-in Period||0
1087000|NCT01018186|2634065|P1|COMPLETED|2-week Run-in Period||503
1087001|NCT01018186|2634062|P4|STARTED|2-week Run-in Period||0
1087002|NCT01018186|2634063|P3|STARTED|2-week Run-in Period||0
1087003|NCT01018186|2634064|P2|STARTED|2-week Run-in Period||0
1087004|NCT01018186|2634065|P1|STARTED|2-week Run-in Period||617
1087005|NCT01018264|2634153|P2|NOT COMPLETED|Overall Study||1
1087006|NCT01018264|2634154|P1|NOT COMPLETED|Overall Study||1
1087007|NCT01018264|2634153|P2|COMPLETED|Overall Study||12
1087008|NCT01018264|2634154|P1|COMPLETED|Overall Study||9
1087009|NCT01018264|2634153|P2|STARTED|Overall Study||13
1087010|NCT01018264|2634154|P1|STARTED|Overall Study||10
1087011|NCT01018394|2634170|P2|NOT COMPLETED|Overall Study||8
1087012|NCT01018394|2634171|P1|NOT COMPLETED|Overall Study||9
1087013|NCT01018394|2634170|P2|COMPLETED|Overall Study||33
1087014|NCT01018394|2634171|P1|COMPLETED|Overall Study||31
1087015|NCT01018394|2634170|P2|STARTED|Overall Study||41
1087016|NCT01018394|2634171|P1|STARTED|Overall Study||40
1087017|NCT01018420|2634181|P2|NOT COMPLETED|Overall Study||0
1087018|NCT01018420|2634182|P1|NOT COMPLETED|Overall Study||0
1087019|NCT01018420|2634181|P2|COMPLETED|Overall Study||3
1087020|NCT01018420|2634182|P1|COMPLETED|Overall Study||15
1087021|NCT01018420|2634181|P2|STARTED|Overall Study||3
1087022|NCT01018420|2634182|P1|STARTED|Overall Study||15
1087023|NCT01018511|2634211|P4|NOT COMPLETED|Overall Study||33
1087024|NCT01018511|2634212|P3|NOT COMPLETED|Overall Study||40
1087025|NCT01018511|2634213|P2|NOT COMPLETED|Overall Study||32
1087026|NCT01018511|2634214|P1|NOT COMPLETED|Overall Study||26
1087027|NCT01018511|2634211|P4|COMPLETED|Overall Study||294
1087028|NCT01018511|2634212|P3|COMPLETED|Overall Study||299
1087029|NCT01018511|2634213|P2|COMPLETED|Overall Study||295
1087030|NCT01018511|2634214|P1|COMPLETED|Overall Study||315
1087031|NCT01018511|2634211|P4|Randomized and Treated|Overall Study||324
1087032|NCT01018511|2634212|P3|Randomized and Treated|Overall Study||338
1087033|NCT01018511|2634213|P2|Randomized and Treated|Overall Study||326
1087034|NCT01018511|2634214|P1|Randomized and Treated|Overall Study||341
1087035|NCT01018511|2634211|P4|STARTED|Overall Study||327
1087036|NCT01018511|2634212|P3|STARTED|Overall Study||339
1087037|NCT01018511|2634213|P2|STARTED|Overall Study||327
1087038|NCT01018511|2634214|P1|STARTED|Overall Study||341
1087039|NCT01018680|2634383|P2|NOT COMPLETED|Overall Study||75
1087040|NCT01018680|2634384|P1|NOT COMPLETED|Overall Study||61
1087041|NCT01018680|2634383|P2|COMPLETED|Overall Study||189
1087042|NCT01018680|2634384|P1|COMPLETED|Overall Study||199
1087043|NCT01018680|2634383|P2|STARTED|Overall Study||264
1087044|NCT01018680|2634384|P1|STARTED|Overall Study||260
1087045|NCT01018732|2634427|P3|NOT COMPLETED|Overall Study||4
1087046|NCT01018732|2634428|P2|NOT COMPLETED|Overall Study||2
1087047|NCT01018732|2634429|P1|NOT COMPLETED|Overall Study||1
1087048|NCT01018732|2634427|P3|COMPLETED|Overall Study||50
1087049|NCT01018732|2634428|P2|COMPLETED|Overall Study||49
1087050|NCT01018732|2634429|P1|COMPLETED|Overall Study||49
1087051|NCT01018732|2634427|P3|STARTED|Overall Study||54
1087052|NCT01018732|2634428|P2|STARTED|Overall Study||51
1087053|NCT01018732|2634429|P1|STARTED|Overall Study||50
1087054|NCT01009762|2634463|P2|NOT COMPLETED|Overall Study||0
1087055|NCT01009762|2634464|P1|NOT COMPLETED|Overall Study||0
1087056|NCT01009762|2634463|P2|COMPLETED|Overall Study|10 participants received vaccine|10
1087057|NCT01009762|2634464|P1|COMPLETED|Overall Study|according to randomization this one participant received placebo|1
1087058|NCT01009762|2634463|P2|Primary Outcome|Overall Study|no SAE, no treatment related side effects DLT grade 3 or more|0
1087059|NCT01009762|2634464|P1|Primary Outcome|Overall Study|no Serious Adverse Events (SAE), no treatment related side effects DLT grade 3 or more|0
1087060|NCT01009762|2634463|P2|STARTED|Overall Study||10
1087061|NCT01009762|2634464|P1|STARTED|Overall Study||1
1087062|NCT01009840|2634474|P1|NOT COMPLETED|Overall Study||14
1087063|NCT01009840|2634474|P1|COMPLETED|Overall Study||16
1087064|NCT01009840|2634474|P1|STARTED|Overall Study||30
1087065|NCT01009931|2634487|P1|NOT COMPLETED|Overall Study||1
1087066|NCT01009931|2634487|P1|COMPLETED|Overall Study||0
1087067|NCT01009931|2634487|P1|STARTED|Overall Study||1
1087068|NCT01009983|2634493|P1|NOT COMPLETED|Overall Study||1
1087069|NCT01009983|2634493|P1|COMPLETED|Overall Study||13
1087070|NCT01009983|2634493|P1|STARTED|Overall Study||14
1087071|NCT01010009|2634500|P3|NOT COMPLETED|Overall Study||0
1087072|NCT01010009|2634501|P2|NOT COMPLETED|Overall Study||0
1087073|NCT01010009|2634502|P1|NOT COMPLETED|Overall Study||0
1087074|NCT01010009|2634500|P3|COMPLETED|Overall Study||8
1087075|NCT01010009|2634501|P2|COMPLETED|Overall Study||8
1087076|NCT01010009|2634502|P1|COMPLETED|Overall Study||8
1087077|NCT01010009|2634500|P3|STARTED|Overall Study||8
1087078|NCT01010009|2634501|P2|STARTED|Overall Study||8
1087079|NCT01010009|2634502|P1|STARTED|Overall Study||8
1087080|NCT01010061|2634518|P2|NOT COMPLETED|Overall Study||95
1087081|NCT01010061|2634519|P1|NOT COMPLETED|Overall Study||133
1087082|NCT01010061|2634518|P2|COMPLETED|Overall Study||23
1087083|NCT01010061|2634519|P1|COMPLETED|Overall Study|Completed=Completed treatment.|105
1087084|NCT01010061|2634518|P2|Received Study Drug|Overall Study||116
1087085|NCT01010061|2634519|P1|Received Study Drug|Overall Study||236
1087086|NCT01010061|2634518|P2|STARTED|Overall Study||118
1087087|NCT01010061|2634519|P1|STARTED|Overall Study||238
1087088|NCT01010204|2634552|P2|NOT COMPLETED|Overall Study||9
1087089|NCT01010204|2634553|P1|NOT COMPLETED|Overall Study||7
1087090|NCT01010204|2634552|P2|COMPLETED|Overall Study||20
1087091|NCT01010204|2634553|P1|COMPLETED|Overall Study||24
1087092|NCT01010204|2634552|P2|STARTED|Overall Study||29
1087093|NCT01010204|2634553|P1|STARTED|Overall Study||31
1087094|NCT01010230|2634563|P2|NOT COMPLETED|Overall Study||7
1087095|NCT01010230|2634564|P1|NOT COMPLETED|Overall Study||10
1087096|NCT01010230|2634563|P2|COMPLETED|Overall Study||26
1087097|NCT01010230|2634564|P1|COMPLETED|Overall Study||22
1087098|NCT01010230|2634563|P2|STARTED|Overall Study||33
1087099|NCT01010230|2634564|P1|STARTED|Overall Study||32
1087100|NCT01010282|2634597|P3|NOT COMPLETED|Overall Study||19
1087101|NCT01010282|2634598|P2|NOT COMPLETED|Overall Study||7
1087102|NCT01010282|2634599|P1|NOT COMPLETED|Overall Study||6
1087103|NCT01010282|2634597|P3|COMPLETED|Overall Study||77
1087104|NCT01010282|2634598|P2|COMPLETED|Overall Study||88
1087105|NCT01010282|2634599|P1|COMPLETED|Overall Study||91
1087106|NCT01010282|2634597|P3|STARTED|Overall Study||96
1087107|NCT01010282|2634598|P2|STARTED|Overall Study||95
1087108|NCT01010282|2634599|P1|STARTED|Overall Study||97
1087109|NCT01010399|2634619|P1|NOT COMPLETED|Overall Study||5
1087110|NCT01010399|2634619|P1|COMPLETED|Overall Study||31
1087111|NCT01010399|2634619|P1|STARTED|Overall Study||36
1087112|NCT01010477|2634626|P2|NOT COMPLETED|Overall Study||3
1087113|NCT01010477|2634627|P1|NOT COMPLETED|Overall Study||6
1087114|NCT01010477|2634626|P2|COMPLETED|Overall Study||22
1087115|NCT01010477|2634627|P1|COMPLETED|Overall Study||21
1087116|NCT01010477|2634626|P2|STARTED|Overall Study||25
1087117|NCT01010477|2634627|P1|STARTED|Overall Study||27
1087118|NCT01010503|2634633|P1|NOT COMPLETED|Overall Study||2
1087119|NCT01010503|2634633|P1|COMPLETED|Overall Study||30
1087120|NCT01010503|2634633|P1|STARTED|Overall Study||32
1087121|NCT01010555|2634651|P2|NOT COMPLETED|Second Four Weeks of Wear||0
1087122|NCT01010555|2634652|P1|NOT COMPLETED|Second Four Weeks of Wear||0
1087123|NCT01010555|2634651|P2|COMPLETED|Second Four Weeks of Wear||9
1087124|NCT01010555|2634652|P1|COMPLETED|Second Four Weeks of Wear||10
1087125|NCT01010555|2634651|P2|STARTED|Second Four Weeks of Wear||9
1087126|NCT01010555|2634652|P1|STARTED|Second Four Weeks of Wear||10
1087127|NCT01010555|2634651|P2|NOT COMPLETED|First Four Weeks of Wear||0
1087128|NCT01010555|2634652|P1|NOT COMPLETED|First Four Weeks of Wear||0
1087129|NCT01010555|2634651|P2|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Non-compliance with visit schedule.|10
1087130|NCT01010555|2634652|P1|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Relocation.|11
1087131|NCT01010555|2634651|P2|STARTED|First Four Weeks of Wear||10
1087132|NCT01010555|2634652|P1|STARTED|First Four Weeks of Wear||11
1087133|NCT01010568|2634662|P1|NOT COMPLETED|Overall Study||5
1087134|NCT01010568|2634662|P1|COMPLETED|Overall Study||5
1087135|NCT01010568|2634662|P1|STARTED|Overall Study||10
1087136|NCT01010633|2634670|P2|NOT COMPLETED|Overall Study||5
1087137|NCT01010633|2634671|P1|NOT COMPLETED|Overall Study||4
1087138|NCT01010633|2634670|P2|COMPLETED|Overall Study||198
1087139|NCT01010633|2634671|P1|COMPLETED|Overall Study||199
1087140|NCT01010633|2634670|P2|STARTED|Overall Study||203
1087141|NCT01010633|2634671|P1|STARTED|Overall Study||203
1087142|NCT01010750|2634687|P6|NOT COMPLETED|Third Intervention||0
1087143|NCT01010750|2634688|P5|NOT COMPLETED|Third Intervention||0
1087144|NCT01010750|2634689|P4|NOT COMPLETED|Third Intervention||0
1087145|NCT01010750|2634690|P3|NOT COMPLETED|Third Intervention||0
1087146|NCT01010750|2634691|P2|NOT COMPLETED|Third Intervention||0
1087147|NCT01010750|2634692|P1|NOT COMPLETED|Third Intervention||0
1087148|NCT01010750|2634687|P6|COMPLETED|Third Intervention||3
1087149|NCT01010750|2634688|P5|COMPLETED|Third Intervention||2
1087150|NCT01010750|2634689|P4|COMPLETED|Third Intervention||3
1087151|NCT01010750|2634690|P3|COMPLETED|Third Intervention||3
1087152|NCT01010750|2634691|P2|COMPLETED|Third Intervention||3
1087153|NCT01010750|2634692|P1|COMPLETED|Third Intervention||3
1087154|NCT01010750|2634687|P6|STARTED|Third Intervention||3
1087155|NCT01010750|2634688|P5|STARTED|Third Intervention||2
1087156|NCT01010750|2634689|P4|STARTED|Third Intervention||3
1087157|NCT01010750|2634690|P3|STARTED|Third Intervention||3
1087158|NCT01010750|2634691|P2|STARTED|Third Intervention||3
1087159|NCT01010750|2634692|P1|STARTED|Third Intervention||3
1087160|NCT01010750|2634687|P6|NOT COMPLETED|Second Intervention||0
1087161|NCT01010750|2634688|P5|NOT COMPLETED|Second Intervention||0
1087162|NCT01010750|2634689|P4|NOT COMPLETED|Second Intervention||0
1087163|NCT01010750|2634690|P3|NOT COMPLETED|Second Intervention||0
1087164|NCT01010750|2634691|P2|NOT COMPLETED|Second Intervention||1
1087165|NCT01010750|2634692|P1|NOT COMPLETED|Second Intervention||0
1087166|NCT01010750|2634687|P6|COMPLETED|Second Intervention||3
1087167|NCT01010750|2634688|P5|COMPLETED|Second Intervention||2
1087168|NCT01010750|2634689|P4|COMPLETED|Second Intervention||3
1087169|NCT01010750|2634690|P3|COMPLETED|Second Intervention||3
1087170|NCT01010750|2634691|P2|COMPLETED|Second Intervention||3
1087171|NCT01010750|2634692|P1|COMPLETED|Second Intervention||3
1087172|NCT01010750|2634687|P6|STARTED|Second Intervention||3
1087173|NCT01010750|2634688|P5|STARTED|Second Intervention||2
1087174|NCT01010750|2634689|P4|STARTED|Second Intervention||3
1087175|NCT01010750|2634690|P3|STARTED|Second Intervention||3
1087176|NCT01010750|2634691|P2|STARTED|Second Intervention||4
1087177|NCT01010750|2634692|P1|STARTED|Second Intervention||3
1087178|NCT01010750|2634687|P6|NOT COMPLETED|First Intervention||0
1087179|NCT01010750|2634688|P5|NOT COMPLETED|First Intervention||0
1087180|NCT01010750|2634689|P4|NOT COMPLETED|First Intervention||0
1087181|NCT01010750|2634690|P3|NOT COMPLETED|First Intervention||0
1087182|NCT01010750|2634691|P2|NOT COMPLETED|First Intervention||0
1087183|NCT01010750|2634692|P1|NOT COMPLETED|First Intervention||0
1087184|NCT01010750|2634687|P6|COMPLETED|First Intervention||3
1087185|NCT01010750|2634688|P5|COMPLETED|First Intervention||2
1087186|NCT01010750|2634689|P4|COMPLETED|First Intervention||3
1087187|NCT01010750|2634690|P3|COMPLETED|First Intervention||3
1087188|NCT01010750|2634691|P2|COMPLETED|First Intervention||4
1087189|NCT01010750|2634692|P1|COMPLETED|First Intervention||3
1087190|NCT01010750|2634687|P6|STARTED|First Intervention||3
1087191|NCT01010750|2634688|P5|STARTED|First Intervention||2
1087192|NCT01010750|2634689|P4|STARTED|First Intervention||3
1087193|NCT01010750|2634690|P3|STARTED|First Intervention||3
1087194|NCT01010750|2634691|P2|STARTED|First Intervention||4
1087195|NCT01010750|2634692|P1|STARTED|First Intervention||3
1087196|NCT01010776|2634715|P1|NOT COMPLETED|Extension Phase||3
1087197|NCT01010776|2634715|P1|COMPLETED|Extension Phase||156
1087198|NCT01010776|2634715|P1|STARTED|Extension Phase||159
1087199|NCT01010776|2634715|P1|NOT COMPLETED|In-Between Main Phase & Extension Phase||15
1087200|NCT01010776|2634715|P1|COMPLETED|In-Between Main Phase & Extension Phase||159
1087201|NCT01010776|2634715|P1|STARTED|In-Between Main Phase & Extension Phase||174
1087202|NCT01010776|2634715|P1|NOT COMPLETED|Main Phase||49
1087203|NCT01010776|2634715|P1|COMPLETED|Main Phase||174
1087204|NCT01010776|2634715|P1|Treated|Main Phase||218
1087205|NCT01010776|2634715|P1|STARTED|Main Phase||223
1087206|NCT01010867|2634737|P1|NOT COMPLETED|Overall Study||1
1087207|NCT01010867|2634737|P1|COMPLETED|Overall Study||30
1087208|NCT01010867|2634737|P1|STARTED|Overall Study||31
1087209|NCT01010906|2634750|P6|NOT COMPLETED|Overall Study||0
1087210|NCT01010906|2634751|P5|NOT COMPLETED|Overall Study||0
1087211|NCT01010906|2634752|P4|NOT COMPLETED|Overall Study||0
1087212|NCT01010906|2634753|P3|NOT COMPLETED|Overall Study||0
1087213|NCT01010906|2634754|P2|NOT COMPLETED|Overall Study||0
1087214|NCT01010906|2634755|P1|NOT COMPLETED|Overall Study||0
1087215|NCT01010906|2634750|P6|COMPLETED|Overall Study||10
1087216|NCT01010906|2634751|P5|COMPLETED|Overall Study||10
1087217|NCT01010906|2634752|P4|COMPLETED|Overall Study||10
1087218|NCT01010906|2634753|P3|COMPLETED|Overall Study||10
1087219|NCT01010906|2634754|P2|COMPLETED|Overall Study||10
1087220|NCT01010906|2634755|P1|COMPLETED|Overall Study||10
1087221|NCT01010906|2634750|P6|STARTED|Overall Study||10
1087222|NCT01010906|2634751|P5|STARTED|Overall Study||10
1087223|NCT01010906|2634752|P4|STARTED|Overall Study||10
1087224|NCT01010906|2634753|P3|STARTED|Overall Study||10
1087225|NCT01010906|2634754|P2|STARTED|Overall Study||10
1087226|NCT01010906|2634755|P1|STARTED|Overall Study||10
1087227|NCT01010932|2634775|P1|NOT COMPLETED|Overall Study||22
1087228|NCT01010932|2634775|P1|COMPLETED|Overall Study||200
1087229|NCT01010932|2634775|P1|STARTED|Overall Study||222
1087230|NCT01010971|2634790|P3|NOT COMPLETED|Overall Study||13
1087231|NCT01010971|2634791|P2|NOT COMPLETED|Overall Study||8
1087232|NCT01010971|2634792|P1|NOT COMPLETED|Overall Study||3
1087233|NCT01010971|2634790|P3|COMPLETED|Overall Study||207
1087234|NCT01010971|2634791|P2|COMPLETED|Overall Study||218
1087235|NCT01010971|2634792|P1|COMPLETED|Overall Study||222
1087236|NCT01010971|2634790|P3|STARTED|Overall Study||220
1087237|NCT01010971|2634791|P2|STARTED|Overall Study||226
1087238|NCT01010971|2634792|P1|STARTED|Overall Study||225
1087239|NCT01011049|2634881|P4|NOT COMPLETED|Overall Study||0
1087240|NCT01011049|2634882|P3|NOT COMPLETED|Overall Study||4
1087241|NCT01011049|2634883|P2|NOT COMPLETED|Overall Study||2
1087242|NCT01011049|2634884|P1|NOT COMPLETED|Overall Study||1
1087243|NCT01011049|2634881|P4|COMPLETED|Overall Study||246
1087244|NCT01011049|2634882|P3|COMPLETED|Overall Study||239
1087245|NCT01011049|2634883|P2|COMPLETED|Overall Study||250
1087246|NCT01011049|2634884|P1|COMPLETED|Overall Study||506
1087247|NCT01011049|2634881|P4|STARTED|Overall Study||246
1087248|NCT01011049|2634882|P3|STARTED|Overall Study||243
1087249|NCT01011049|2634883|P2|STARTED|Overall Study||252
1087250|NCT01011049|2634884|P1|STARTED|Overall Study||507
1087251|NCT01011075|2634906|P1|NOT COMPLETED|Overall Study||0
1087252|NCT01011075|2634906|P1|COMPLETED|Overall Study||34
1087253|NCT01011075|2634906|P1|STARTED|Overall Study||34
1087254|NCT01011153|2634916|P3|NOT COMPLETED|Overall Study||9
1087255|NCT01011153|2634917|P2|NOT COMPLETED|Overall Study||11
1087256|NCT01011153|2634918|P1|NOT COMPLETED|Overall Study||8
1087257|NCT01011153|2634916|P3|COMPLETED|Overall Study||45
1087258|NCT01011153|2634917|P2|COMPLETED|Overall Study||64
1087259|NCT01011153|2634918|P1|COMPLETED|Overall Study||46
1087260|NCT01011153|2634916|P3|STARTED|Overall Study||54
1087261|NCT01011153|2634917|P2|STARTED|Overall Study||75
1087262|NCT01011153|2634918|P1|STARTED|Overall Study||54
1087263|NCT01011179|2634938|P2|NOT COMPLETED|Overall Study||2
1087264|NCT01011179|2634939|P1|NOT COMPLETED|Overall Study||4
1087265|NCT01011179|2634938|P2|COMPLETED|Overall Study||20
1087266|NCT01011179|2634939|P1|COMPLETED|Overall Study||20
1087267|NCT01011179|2634938|P2|STARTED|Overall Study||22
1087268|NCT01011179|2634939|P1|STARTED|Overall Study||24
1087269|NCT01011283|2634947|P2|NOT COMPLETED|Overall Study||11
1087270|NCT01011283|2634948|P1|NOT COMPLETED|Overall Study||11
1087271|NCT01011283|2634947|P2|COMPLETED|Overall Study||2
1087272|NCT01011283|2634948|P1|COMPLETED|Overall Study||2
1087273|NCT01011283|2634947|P2|STARTED|Overall Study||13
1087274|NCT01011283|2634948|P1|STARTED|Overall Study||13
1087275|NCT01011309|2634959|P3|NOT COMPLETED|Overall Study||5
1087276|NCT01011309|2634960|P2|NOT COMPLETED|Overall Study||3
1087277|NCT01011309|2634961|P1|NOT COMPLETED|Overall Study||2
1087278|NCT01011309|2634959|P3|COMPLETED|Overall Study||16
1087279|NCT01011309|2634960|P2|COMPLETED|Overall Study||7
1087280|NCT01011309|2634961|P1|COMPLETED|Overall Study||12
1087281|NCT01011309|2634959|P3|STARTED|Overall Study||21
1087282|NCT01011309|2634960|P2|STARTED|Overall Study||10
1087283|NCT01011309|2634961|P1|STARTED|Overall Study||14
1087284|NCT01011387|2634975|P1|NOT COMPLETED|Overall Study||6
1087285|NCT01011387|2634975|P1|COMPLETED|Overall Study||10
1087286|NCT01011387|2634975|P1|STARTED|Overall Study||16
1087287|NCT01011465|2634987|P8|NOT COMPLETED|Overall Study||0
1087288|NCT01011465|2634988|P7|NOT COMPLETED|Overall Study||1
1087289|NCT01011465|2634989|P6|NOT COMPLETED|Overall Study||0
1087290|NCT01011465|2634990|P5|NOT COMPLETED|Overall Study||1
1087291|NCT01011465|2634991|P4|NOT COMPLETED|Overall Study||0
1087292|NCT01011465|2634992|P3|NOT COMPLETED|Overall Study||0
1087293|NCT01011465|2634993|P2|NOT COMPLETED|Overall Study||1
1087294|NCT01011465|2634994|P1|NOT COMPLETED|Overall Study||2
1087295|NCT01011465|2634987|P8|COMPLETED|Overall Study||32
1087296|NCT01011465|2634988|P7|COMPLETED|Overall Study||51
1087297|NCT01011465|2634989|P6|COMPLETED|Overall Study||29
1087298|NCT01011465|2634990|P5|COMPLETED|Overall Study||46
1087299|NCT01011465|2634991|P4|COMPLETED|Overall Study||18
1087300|NCT01011465|2634992|P3|COMPLETED|Overall Study||36
1087301|NCT01011465|2634993|P2|COMPLETED|Overall Study||19
1087302|NCT01011465|2634994|P1|COMPLETED|Overall Study||34
1087303|NCT01011465|2634987|P8|STARTED|Overall Study||32
1087304|NCT01011465|2634988|P7|STARTED|Overall Study||52
1087305|NCT01011465|2634989|P6|STARTED|Overall Study||29
1087306|NCT01011465|2634990|P5|STARTED|Overall Study||47
1087307|NCT01011465|2634991|P4|STARTED|Overall Study||18
1087308|NCT01011465|2634992|P3|STARTED|Overall Study||36
1087309|NCT01011465|2634993|P2|STARTED|Overall Study||20
1087310|NCT01011465|2634994|P1|STARTED|Overall Study||36
1087311|NCT01011556|2635026|P4|NOT COMPLETED|Overall Study||13
1087312|NCT01011556|2635027|P3|NOT COMPLETED|Overall Study||10
1087313|NCT01011556|2635028|P2|NOT COMPLETED|Overall Study||8
1087314|NCT01011556|2635029|P1|NOT COMPLETED|Overall Study||6
1087315|NCT01011556|2635026|P4|COMPLETED|Overall Study||51
1087316|NCT01011556|2635027|P3|COMPLETED|Overall Study||45
1087317|NCT01011556|2635028|P2|COMPLETED|Overall Study||48
1087318|NCT01011556|2635029|P1|COMPLETED|Overall Study||52
1087319|NCT01011556|2635026|P4|Received at Least 1 Dose of Study Drug|Overall Study||64
1087320|NCT01011556|2635027|P3|Received at Least 1 Dose of Study Drug|Overall Study||54
1087321|NCT01011556|2635028|P2|Received at Least 1 Dose of Study Drug|Overall Study||56
1087322|NCT01011556|2635029|P1|Received at Least 1 Dose of Study Drug|Overall Study||57
1087323|NCT01011556|2635026|P4|STARTED|Overall Study||64
1087324|NCT01011556|2635027|P3|STARTED|Overall Study||55
1087325|NCT01011556|2635028|P2|STARTED|Overall Study||56
1087326|NCT01011556|2635029|P1|STARTED|Overall Study||58
1087327|NCT01011634|2635101|P2|NOT COMPLETED|Overall Study||1
1087328|NCT01011634|2635102|P1|NOT COMPLETED|Overall Study||0
1087329|NCT01011634|2635101|P2|COMPLETED|Overall Study||8
1087330|NCT01011634|2635102|P1|COMPLETED|Overall Study||9
1087331|NCT01011634|2635101|P2|STARTED|Overall Study||9
1087332|NCT01011634|2635102|P1|STARTED|Overall Study||9
1087333|NCT01011673|2635112|P2|NOT COMPLETED|24 Hour Follow-up||3
1087334|NCT01011673|2635113|P1|NOT COMPLETED|24 Hour Follow-up||3
1087335|NCT01011673|2635112|P2|COMPLETED|24 Hour Follow-up||57
1087336|NCT01011673|2635113|P1|COMPLETED|24 Hour Follow-up||57
1087337|NCT01011673|2635112|P2|STARTED|24 Hour Follow-up||60
1087338|NCT01011673|2635113|P1|STARTED|24 Hour Follow-up||60
1087339|NCT01011673|2635112|P2|NOT COMPLETED|Emergency Department Portion||0
1087340|NCT01011673|2635113|P1|NOT COMPLETED|Emergency Department Portion||0
1087341|NCT01011673|2635112|P2|COMPLETED|Emergency Department Portion||60
1087342|NCT01011673|2635113|P1|COMPLETED|Emergency Department Portion||60
1087343|NCT01011673|2635112|P2|STARTED|Emergency Department Portion||60
1087344|NCT01011673|2635113|P1|STARTED|Emergency Department Portion||60
1087345|NCT01011673|2635112|P2|NOT COMPLETED|Randomized||1
1087346|NCT01011673|2635113|P1|NOT COMPLETED|Randomized||2
1087347|NCT01011673|2635112|P2|COMPLETED|Randomized|1 patient was randomized but not included in analyses bc they did not truly meet study criteria.|60
1087348|NCT01011673|2635113|P1|COMPLETED|Randomized|2 patients were randomized but not included in analyses bc they did not truly meet study criteria.|60
1087349|NCT01011673|2635112|P2|STARTED|Randomized||61
1087350|NCT01011673|2635113|P1|STARTED|Randomized||62
1087351|NCT01011738|2635124|P3|NOT COMPLETED|Overall Study||17
1087352|NCT01011738|2635125|P2|NOT COMPLETED|Overall Study||294
1087353|NCT01011738|2635126|P1|NOT COMPLETED|Overall Study||324
1087354|NCT01011738|2635124|P3|COMPLETED|Overall Study||36
1087355|NCT01011738|2635125|P2|COMPLETED|Overall Study||618
1087356|NCT01011738|2635126|P1|COMPLETED|Overall Study||553
1087357|NCT01011738|2635124|P3|STARTED|Overall Study||53
1087358|NCT01011738|2635125|P2|STARTED|Overall Study||912
1087359|NCT01011738|2635126|P1|STARTED|Overall Study||877
1087360|NCT01011816|2635166|P2|NOT COMPLETED|78-Week Extended Follow-up||28
1087361|NCT01011816|2635167|P1|NOT COMPLETED|78-Week Extended Follow-up||72
1087362|NCT01011816|2635166|P2|COMPLETED|78-Week Extended Follow-up||26
1087363|NCT01011816|2635167|P1|COMPLETED|78-Week Extended Follow-up||85
1087364|NCT01011816|2635166|P2|STARTED|78-Week Extended Follow-up||54
1087365|NCT01011816|2635167|P1|STARTED|78-Week Extended Follow-up||157
1087366|NCT01011816|2635166|P2|NOT COMPLETED|26-Week Primary Endpoint||2
1087367|NCT01011816|2635167|P1|NOT COMPLETED|26-Week Primary Endpoint||7
1087368|NCT01011816|2635166|P2|COMPLETED|26-Week Primary Endpoint||54
1087369|NCT01011816|2635167|P1|COMPLETED|26-Week Primary Endpoint||157
1087370|NCT01011816|2635166|P2|STARTED|26-Week Primary Endpoint||56
1087371|NCT01011816|2635167|P1|STARTED|26-Week Primary Endpoint||164
1087372|NCT01011829|2635179|P2|NOT COMPLETED|Overall Study||9
1087373|NCT01011829|2635180|P1|NOT COMPLETED|Overall Study||4
1087374|NCT01011829|2635179|P2|COMPLETED|Overall Study||1
1087375|NCT01011829|2635180|P1|COMPLETED|Overall Study||6
1087376|NCT01011829|2635179|P2|STARTED|Overall Study||10
1087377|NCT01011829|2635180|P1|STARTED|Overall Study||10
1087378|NCT01011868|2635191|P3|NOT COMPLETED|After Week 78 Follow-up||44
1087379|NCT01011868|2635192|P2|NOT COMPLETED|After Week 78 Follow-up||38
1087380|NCT01011868|2635193|P1|NOT COMPLETED|After Week 78 Follow-up||52
1087381|NCT01011868|2635191|P3|COMPLETED|After Week 78 Follow-up||111
1087382|NCT01011868|2635192|P2|COMPLETED|After Week 78 Follow-up||131
1087383|NCT01011868|2635193|P1|COMPLETED|After Week 78 Follow-up||118
1087384|NCT01011868|2635191|P3|STARTED|After Week 78 Follow-up||155
1087385|NCT01011868|2635192|P2|STARTED|After Week 78 Follow-up||169
1087386|NCT01011868|2635193|P1|STARTED|After Week 78 Follow-up||170
1087387|NCT01011868|2635191|P3|NOT COMPLETED|After Week 18 Follow-up||26
1087388|NCT01011868|2635192|P2|NOT COMPLETED|After Week 18 Follow-up||16
1087389|NCT01011868|2635193|P1|NOT COMPLETED|After Week 18 Follow-up||23
1087390|NCT01011868|2635191|P3|COMPLETED|After Week 18 Follow-up||129
1087391|NCT01011868|2635192|P2|COMPLETED|After Week 18 Follow-up||153
1087392|NCT01011868|2635193|P1|COMPLETED|After Week 18 Follow-up||147
1087393|NCT01011868|2635191|P3|STARTED|After Week 18 Follow-up||155
1087394|NCT01011868|2635192|P2|STARTED|After Week 18 Follow-up||169
1087395|NCT01011868|2635193|P1|STARTED|After Week 18 Follow-up||170
1087396|NCT01011894|2635228|P1|NOT COMPLETED|Overall Study||0
1087397|NCT01011894|2635228|P1|COMPLETED|Overall Study||26
1087398|NCT01011894|2635228|P1|STARTED|Overall Study||26
1087399|NCT01011907|2635234|P2|NOT COMPLETED|Overall Study||15
1087400|NCT01011907|2635235|P1|NOT COMPLETED|Overall Study||14
1087401|NCT01011907|2635234|P2|COMPLETED|Overall Study||18
1087402|NCT01011907|2635235|P1|COMPLETED|Overall Study||17
1087403|NCT01011907|2635234|P2|STARTED|Overall Study||33
1087404|NCT01011907|2635235|P1|STARTED|Overall Study||31
1087405|NCT01011933|2635245|P1|NOT COMPLETED|Overall Study||4
1087406|NCT01011933|2635245|P1|COMPLETED|Overall Study|total eligible and evaluable|50
1087407|NCT01011933|2635245|P1|STARTED|Overall Study|total enrolled|54
1087408|NCT01011946|2635252|P1|NOT COMPLETED|Overall Study||3
1087409|NCT01011946|2635252|P1|COMPLETED|Overall Study||33
1087410|NCT01011946|2635252|P1|STARTED|Overall Study||36
1087411|NCT01012037|2635259|P3|NOT COMPLETED|Overall Study||10
1087412|NCT01012037|2635260|P2|NOT COMPLETED|Overall Study||16
1087413|NCT01012037|2635261|P1|NOT COMPLETED|Overall Study||1
1087414|NCT01012037|2635259|P3|COMPLETED|Overall Study||214
1087415|NCT01012037|2635260|P2|COMPLETED|Overall Study||207
1087416|NCT01012037|2635261|P1|COMPLETED|Overall Study||43
1087417|NCT01012037|2635259|P3|STARTED|Overall Study||224
1087418|NCT01012037|2635260|P2|STARTED|Overall Study||223
1087419|NCT01012037|2635261|P1|STARTED|Overall Study||44
1087420|NCT01018810|2635301|P5|NOT COMPLETED|Overall Study||1
1087421|NCT01018810|2635302|P4|NOT COMPLETED|Overall Study||1
1087422|NCT01018810|2635303|P3|NOT COMPLETED|Overall Study||1
1087423|NCT01018810|2635304|P2|NOT COMPLETED|Overall Study||1
1087424|NCT01018810|2635305|P1|NOT COMPLETED|Overall Study||2
1087425|NCT01018810|2635301|P5|COMPLETED|Overall Study||0
1087426|NCT01018810|2635302|P4|COMPLETED|Overall Study||0
1087427|NCT01018810|2635303|P3|COMPLETED|Overall Study||0
1087428|NCT01018810|2635304|P2|COMPLETED|Overall Study||0
1087429|NCT01018810|2635305|P1|COMPLETED|Overall Study||2
1087430|NCT01018810|2635301|P5|STARTED|Overall Study||1
1087431|NCT01018810|2635302|P4|STARTED|Overall Study||1
1087432|NCT01018810|2635303|P3|STARTED|Overall Study||1
1087433|NCT01018810|2635304|P2|STARTED|Overall Study||1
1087434|NCT01018810|2635305|P1|STARTED|Overall Study||4
1087435|NCT01018862|2635365|P3|NOT COMPLETED|Overall Study||16
1087436|NCT01018862|2635366|P2|NOT COMPLETED|Overall Study||10
1087437|NCT01018862|2635367|P1|NOT COMPLETED|Overall Study||13
1087438|NCT01018862|2635365|P3|COMPLETED|Overall Study||146
1087439|NCT01018862|2635366|P2|COMPLETED|Overall Study||156
1087440|NCT01018862|2635367|P1|COMPLETED|Overall Study||148
1087441|NCT01018862|2635365|P3|STARTED|Overall Study||162
1087442|NCT01018862|2635366|P2|STARTED|Overall Study||166
1087443|NCT01018862|2635367|P1|STARTED|Overall Study||161
1087444|NCT01018953|2635384|P1|NOT COMPLETED|Overall Study||8
1087445|NCT01018953|2635384|P1|COMPLETED|Overall Study||0
1087446|NCT01018953|2635384|P1|BIM 23A760 4 mg|Overall Study||3
1087447|NCT01018953|2635384|P1|BIM 23A760 2 mg|Overall Study||2
1087448|NCT01018953|2635384|P1|BIM 23A760 1 mg|Overall Study||3
1087449|NCT01018953|2635384|P1|STARTED|Overall Study||8
1087450|NCT01018979|2635396|P2|NOT COMPLETED|Overall Study||10
1087451|NCT01018979|2635397|P1|NOT COMPLETED|Overall Study||3
1087452|NCT01018979|2635396|P2|COMPLETED|Overall Study||3
1087453|NCT01018979|2635397|P1|COMPLETED|Overall Study||4
1087454|NCT01018979|2635396|P2|Received at Least One Dose|Overall Study||12
1087455|NCT01018979|2635397|P1|Received at Least One Dose|Overall Study||7
1087456|NCT01018979|2635396|P2|STARTED|Overall Study|A total of 20 subjects were randomized.|13
1087457|NCT01018979|2635397|P1|STARTED|Overall Study||7
1087458|NCT01018992|2635429|P2|NOT COMPLETED|Overall Study||16
1087459|NCT01018992|2635430|P1|NOT COMPLETED|Overall Study||16
1087460|NCT01018992|2635429|P2|COMPLETED|Overall Study||49
1087461|NCT01018992|2635430|P1|COMPLETED|Overall Study||47
1087462|NCT01018992|2635429|P2|STARTED|Overall Study||65
1087463|NCT01018992|2635430|P1|STARTED|Overall Study||63
1087464|NCT01022567|2635444|P2|NOT COMPLETED|Overall Study||15
1087465|NCT01022567|2635445|P1|NOT COMPLETED|Overall Study||1
1087466|NCT01022567|2635444|P2|COMPLETED|Overall Study||242
1087467|NCT01022567|2635445|P1|COMPLETED|Overall Study||272
1087468|NCT01022567|2635444|P2|STARTED|Overall Study||257
1087469|NCT01022567|2635445|P1|STARTED|Overall Study||273
1087470|NCT01022762|2635453|P2|NOT COMPLETED|Overall Study||28
1087471|NCT01022762|2635454|P1|NOT COMPLETED|Overall Study||22
1087472|NCT01022762|2635453|P2|COMPLETED|Overall Study||194
1087473|NCT01022762|2635454|P1|COMPLETED|Overall Study||196
1087474|NCT01022762|2635453|P2|Exposed to Trial Drug|Overall Study|Four participants were not exposed to the treatment due to non-compliance or lost to follow-up|218
1087475|NCT01022762|2635454|P1|Exposed to Trial Drug|Overall Study|One participant was not exposed to the treatment due to fulfillment of exclusion criteria|217
1087476|NCT01022762|2635453|P2|STARTED|Overall Study||222
1087477|NCT01022762|2635454|P1|STARTED|Overall Study||218
1087478|NCT01022996|2635480|P1|NOT COMPLETED|Overall Study||57
1087479|NCT01022996|2635480|P1|COMPLETED|Overall Study||0
1087480|NCT01022996|2635480|P1|STARTED|Overall Study||57
1087481|NCT01023022|2635489|P1|NOT COMPLETED|Overall Study||14
1087482|NCT01023022|2635489|P1|COMPLETED|Overall Study||162
1087483|NCT01023022|2635489|P1|STARTED|Overall Study|Previous No.: 178 subjects incl. 2 pts who withdraw their approval for processing personal data|176
1087484|NCT01023035|2635498|P3|NOT COMPLETED|Follow-up Period (up to Week 72)||39
1087485|NCT01023035|2635499|P2|NOT COMPLETED|Follow-up Period (up to Week 72)||28
1087486|NCT01023035|2635500|P1|NOT COMPLETED|Follow-up Period (up to Week 72)||28
1087487|NCT01023035|2635498|P3|COMPLETED|Follow-up Period (up to Week 72)||108
1087488|NCT01023035|2635499|P2|COMPLETED|Follow-up Period (up to Week 72)||207
1087489|NCT01023035|2635500|P1|COMPLETED|Follow-up Period (up to Week 72)||210
1087490|NCT01023035|2635498|P3|STARTED|Follow-up Period (up to Week 72)||147
1087491|NCT01023035|2635499|P2|STARTED|Follow-up Period (up to Week 72)||235
1087492|NCT01023035|2635500|P1|STARTED|Follow-up Period (up to Week 72)||238
1087493|NCT01023035|2635498|P3|NOT COMPLETED|Treatment Period||118
1087494|NCT01023035|2635499|P2|NOT COMPLETED|Treatment Period||85
1087495|NCT01023035|2635500|P1|NOT COMPLETED|Treatment Period||72
1087496|NCT01023035|2635498|P3|COMPLETED|Treatment Period||69
1087497|NCT01023035|2635499|P2|COMPLETED|Treatment Period||166
1087498|NCT01023035|2635500|P1|COMPLETED|Treatment Period||177
1087499|NCT01023035|2635498|P3|STARTED|Treatment Period||187
1087500|NCT01023035|2635499|P2|STARTED|Treatment Period||251
1087501|NCT01023035|2635500|P1|STARTED|Treatment Period||249
1087502|NCT01023061|2635510|P1|NOT COMPLETED|Overall Study||2
1087503|NCT01023061|2635510|P1|COMPLETED|Overall Study||22
1087504|NCT01023061|2635510|P1|STARTED|Overall Study||24
1087505|NCT01023074|2635519|P3|NOT COMPLETED|Overall Study||0
1087506|NCT01023074|2635520|P2|NOT COMPLETED|Overall Study||0
1087507|NCT01023074|2635521|P1|NOT COMPLETED|Overall Study||0
1087508|NCT01023074|2635519|P3|COMPLETED|Overall Study||13
1087509|NCT01023074|2635520|P2|COMPLETED|Overall Study||13
1087510|NCT01023074|2635521|P1|COMPLETED|Overall Study||26
1087511|NCT01023074|2635519|P3|STARTED|Overall Study||13
1087512|NCT01023074|2635520|P2|STARTED|Overall Study||13
1087513|NCT01023074|2635521|P1|STARTED|Overall Study||26
1087514|NCT01023178|2635538|P3|NOT COMPLETED|Overall Study||3
1087515|NCT01023178|2635539|P2|NOT COMPLETED|Overall Study||2
1087516|NCT01023178|2635540|P1|NOT COMPLETED|Overall Study||2
1087517|NCT01023178|2635538|P3|COMPLETED|Overall Study||4
1087518|NCT01023178|2635539|P2|COMPLETED|Overall Study||6
1087519|NCT01023178|2635540|P1|COMPLETED|Overall Study||3
1087520|NCT01023178|2635538|P3|STARTED|Overall Study||7
1087521|NCT01023178|2635539|P2|STARTED|Overall Study||8
1087522|NCT01023178|2635540|P1|STARTED|Overall Study||5
1087523|NCT01023217|2635550|P2|NOT COMPLETED|Overall Study||0
1087524|NCT01023217|2635551|P1|NOT COMPLETED|Overall Study||1
1087525|NCT01023217|2635550|P2|COMPLETED|Overall Study||45
1087526|NCT01023217|2635551|P1|COMPLETED|Overall Study||44
1087527|NCT01023217|2635550|P2|STARTED|Overall Study||45
1087528|NCT01023217|2635551|P1|STARTED|Overall Study||45
1087529|NCT01023256|2635561|P4|NOT COMPLETED|Overall Study||5
1087530|NCT01023256|2635562|P3|NOT COMPLETED|Overall Study||1
1087531|NCT01023256|2635563|P2|NOT COMPLETED|Overall Study||3
1087532|NCT01023256|2635564|P1|NOT COMPLETED|Overall Study||4
1087533|NCT01023256|2635561|P4|COMPLETED|Overall Study||22
1087534|NCT01023256|2635562|P3|COMPLETED|Overall Study||23
1087535|NCT01023256|2635563|P2|COMPLETED|Overall Study||19
1087536|NCT01023256|2635564|P1|COMPLETED|Overall Study||21
1087537|NCT01023256|2635561|P4|STARTED|Overall Study||27
1087538|NCT01023256|2635562|P3|STARTED|Overall Study||24
1087539|NCT01023256|2635563|P2|STARTED|Overall Study||22
1087540|NCT01023256|2635564|P1|STARTED|Overall Study||25
1087541|NCT01023308|2635606|P2|NOT COMPLETED|Overall Study||279
1087542|NCT01023308|2635607|P1|NOT COMPLETED|Overall Study||285
1087543|NCT01023308|2635606|P2|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
1087544|NCT01023308|2635607|P1|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
1087545|NCT01023308|2635606|P2|STARTED|Overall Study||381
1087546|NCT01023308|2635607|P1|STARTED|Overall Study||387
1087547|NCT01023516|2635635|P2|NOT COMPLETED|Overall Study||18
1087548|NCT01023516|2635636|P1|NOT COMPLETED|Overall Study||24
1087549|NCT01023516|2635635|P2|COMPLETED|Overall Study||284
1087550|NCT01023516|2635636|P1|COMPLETED|Overall Study||289
1087551|NCT01023516|2635635|P2|STARTED|Overall Study||302
1087552|NCT01023516|2635636|P1|STARTED|Overall Study||313
1087553|NCT01023568|2635719|P3|NOT COMPLETED|Overall Study||0
1087554|NCT01023568|2635720|P2|NOT COMPLETED|Overall Study||0
1087555|NCT01023568|2635721|P1|NOT COMPLETED|Overall Study||0
1087556|NCT01023568|2635719|P3|COMPLETED|Overall Study||45
1087557|NCT01023568|2635720|P2|COMPLETED|Overall Study||44
1087558|NCT01023568|2635721|P1|COMPLETED|Overall Study||45
1087559|NCT01023568|2635719|P3|STARTED|Overall Study||45
1087560|NCT01023568|2635720|P2|STARTED|Overall Study||44
1087561|NCT01023568|2635721|P1|STARTED|Overall Study||45
1087562|NCT01023581|2635748|P7|NOT COMPLETED|Overall Study||20
1087563|NCT01023581|2635749|P6|NOT COMPLETED|Overall Study||19
1087564|NCT01023581|2635750|P5|NOT COMPLETED|Overall Study||16
1087565|NCT01023581|2635751|P4|NOT COMPLETED|Overall Study||20
1087566|NCT01023581|2635752|P3|NOT COMPLETED|Overall Study||42
1087567|NCT01023581|2635753|P2|NOT COMPLETED|Overall Study||23
1087568|NCT01023581|2635754|P1|NOT COMPLETED|Overall Study||35
1087569|NCT01023581|2635748|P7|COMPLETED|Overall Study||94
1087570|NCT01023581|2635749|P6|COMPLETED|Overall Study||92
1087571|NCT01023581|2635750|P5|COMPLETED|Overall Study||95
1087572|NCT01023581|2635751|P4|COMPLETED|Overall Study||94
1087573|NCT01023581|2635752|P3|COMPLETED|Overall Study||71
1087574|NCT01023581|2635753|P2|COMPLETED|Overall Study||89
1087575|NCT01023581|2635754|P1|COMPLETED|Overall Study|The number of completed patients represents those who completed study drug.|74
1087576|NCT01023581|2635748|P7|Received Study Treatment|Overall Study||114
1087577|NCT01023581|2635749|P6|Received Study Treatment|Overall Study||106
1087578|NCT01023581|2635750|P5|Received Study Treatment|Overall Study||111
1087579|NCT01023581|2635751|P4|Received Study Treatment|Overall Study||109
1087580|NCT01023581|2635752|P3|Received Study Treatment|Overall Study||110
1087581|NCT01023581|2635753|P2|Received Study Treatment|Overall Study||112
1087582|NCT01023581|2635754|P1|Received Study Treatment|Overall Study||106
1087583|NCT01023581|2635748|P7|STARTED|Overall Study||114
1087584|NCT01023581|2635749|P6|STARTED|Overall Study||111
1087585|NCT01023581|2635750|P5|STARTED|Overall Study||111
1087586|NCT01023581|2635751|P4|STARTED|Overall Study||114
1087587|NCT01023581|2635752|P3|STARTED|Overall Study||113
1087588|NCT01023581|2635753|P2|STARTED|Overall Study||112
1087589|NCT01023581|2635754|P1|STARTED|Overall Study||109
1087590|NCT01023659|2635787|P3|NOT COMPLETED|Overall Study||99
1087591|NCT01023659|2635788|P2|NOT COMPLETED|Overall Study||228
1087592|NCT01023659|2635789|P1|NOT COMPLETED|Overall Study||73
1087593|NCT01023659|2635787|P3|COMPLETED|Overall Study||165
1087594|NCT01023659|2635788|P2|COMPLETED|Overall Study||137
1087595|NCT01023659|2635789|P1|COMPLETED|Overall Study||185
1087596|NCT01023659|2635787|P3|STARTED|Overall Study||264
1087597|NCT01023659|2635788|P2|STARTED|Overall Study||365
1087598|NCT01023659|2635789|P1|STARTED|Overall Study||258
1087599|NCT01023672|2635798|P1|NOT COMPLETED|Overall Study||3
1087600|NCT01023672|2635798|P1|COMPLETED|Overall Study||17
1087601|NCT01023672|2635798|P1|STARTED|Overall Study||20
1087602|NCT01023711|2635802|P1|NOT COMPLETED|Overall Study||0
1087603|NCT01023711|2635802|P1|COMPLETED|Overall Study||107
1087604|NCT01023711|2635802|P1|STARTED|Overall Study||107
1087605|NCT01023724|2635809|P2|NOT COMPLETED|Overall Study||3
1087606|NCT01023724|2635810|P1|NOT COMPLETED|Overall Study||4
1087607|NCT01023724|2635809|P2|COMPLETED|Overall Study||22
1087608|NCT01023724|2635810|P1|COMPLETED|Overall Study||21
1087609|NCT01023724|2635809|P2|STARTED|Overall Study||25
1087610|NCT01023724|2635810|P1|STARTED|Overall Study||25
1087611|NCT01023776|2635816|P1|NOT COMPLETED|Overall Study||0
1087612|NCT01023776|2635816|P1|COMPLETED|Overall Study||20
1087613|NCT01023776|2635816|P1|STARTED|Overall Study|Subjects received 2 dose of vaccine 0.1 ml in each nostril intra nasally 28 days apart|20
1087614|NCT01023815|2635825|P4|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
1087615|NCT01023815|2635826|P3|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||8
1087616|NCT01023815|2635827|P2|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
1087617|NCT01023815|2635828|P1|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||0
1087618|NCT01023815|2635825|P4|COMPLETED|Randomized Period (Day 90 to Month 12)||68
1087619|NCT01023815|2635826|P3|COMPLETED|Randomized Period (Day 90 to Month 12)||60
1087620|NCT01023815|2635827|P2|COMPLETED|Randomized Period (Day 90 to Month 12)||42
1087621|NCT01023815|2635828|P1|COMPLETED|Randomized Period (Day 90 to Month 12)||0
1087622|NCT01023815|2635825|P4|STARTED|Randomized Period (Day 90 to Month 12)||71
1087623|NCT01023815|2635826|P3|STARTED|Randomized Period (Day 90 to Month 12)||68
1087624|NCT01023815|2635827|P2|STARTED|Randomized Period (Day 90 to Month 12)|Randomized patients to Group A, B and C are also intent to treat population.|45
1087625|NCT01023815|2635828|P1|STARTED|Randomized Period (Day 90 to Month 12)||0
1087626|NCT01023815|2635825|P4|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
1087627|NCT01023815|2635826|P3|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
1087628|NCT01023815|2635827|P2|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
1087629|NCT01023815|2635828|P1|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||144
1087630|NCT01023815|2635825|P4|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
1087631|NCT01023815|2635826|P3|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
1087632|NCT01023815|2635827|P2|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
1087633|NCT01023815|2635828|P1|COMPLETED|Pre-randomization Period (Day 1 to 90)||184
1087634|NCT01023815|2635825|P4|STARTED|Pre-randomization Period (Day 1 to 90)||0
1087635|NCT01023815|2635826|P3|STARTED|Pre-randomization Period (Day 1 to 90)||0
1087636|NCT01023815|2635827|P2|STARTED|Pre-randomization Period (Day 1 to 90)||0
1087637|NCT01023815|2635828|P1|STARTED|Pre-randomization Period (Day 1 to 90)|Out of 330 enrolled, 2 patients never received everolimus.|328
1087638|NCT01023841|2635849|P2|NOT COMPLETED|Overall Study||0
1087639|NCT01023841|2635850|P1|NOT COMPLETED|Overall Study||1
1087640|NCT01023841|2635849|P2|COMPLETED|Overall Study||23
1087641|NCT01023841|2635850|P1|COMPLETED|Overall Study||47
1087642|NCT01023841|2635849|P2|STARTED|Overall Study||23
1087643|NCT01023841|2635850|P1|STARTED|Overall Study||48
1087644|NCT01024036|2635866|P2|NOT COMPLETED|Unblinded Treatment||0
1087645|NCT01024036|2635867|P1|NOT COMPLETED|Unblinded Treatment||3
1087646|NCT01024036|2635866|P2|COMPLETED|Unblinded Treatment||0
1087647|NCT01024036|2635867|P1|COMPLETED|Unblinded Treatment||10
1087648|NCT01024036|2635866|P2|STARTED|Unblinded Treatment|No participants received Placebo+BSC during unblinded treatment period|0
1087649|NCT01024036|2635867|P1|STARTED|Unblinded Treatment|Only 13 participants from Placebo+BSC group received siltuximab+BSC in unblinded treatment period|13
1087650|NCT01024036|2635866|P2|NOT COMPLETED|Blinded Treatment||20
1087651|NCT01024036|2635867|P1|NOT COMPLETED|Blinded Treatment||22
1087652|NCT01024036|2635866|P2|COMPLETED|Blinded Treatment||6
1087653|NCT01024036|2635867|P1|COMPLETED|Blinded Treatment||31
1087654|NCT01024036|2635866|P2|STARTED|Blinded Treatment||26
1087655|NCT01024036|2635867|P1|STARTED|Blinded Treatment||53
1087656|NCT01024244|2635900|P5|NOT COMPLETED|Overall Study||14
1087657|NCT01024244|2635901|P4|NOT COMPLETED|Overall Study||13
1087658|NCT01024244|2635902|P3|NOT COMPLETED|Overall Study||14
1087659|NCT01024244|2635903|P2|NOT COMPLETED|Overall Study||11
1087660|NCT01024244|2635904|P1|NOT COMPLETED|Overall Study||17
1087661|NCT01024244|2635900|P5|COMPLETED|Overall Study||1
1087662|NCT01024244|2635901|P4|COMPLETED|Overall Study||1
1087663|NCT01024244|2635902|P3|COMPLETED|Overall Study||1
1087664|NCT01024244|2635903|P2|COMPLETED|Overall Study||1
1087665|NCT01024244|2635904|P1|COMPLETED|Overall Study||5
1087666|NCT01024244|2635900|P5|STARTED|Overall Study||15
1087667|NCT01024244|2635901|P4|STARTED|Overall Study||14
1087668|NCT01024244|2635902|P3|STARTED|Overall Study||15
1087669|NCT01024244|2635903|P2|STARTED|Overall Study||12
1087670|NCT01024244|2635904|P1|STARTED|Overall Study||22
1087671|NCT01024309|2636018|P2|NOT COMPLETED|Overall Study||4
1087672|NCT01024309|2636019|P1|NOT COMPLETED|Overall Study||8
1087673|NCT01024309|2636018|P2|COMPLETED|Overall Study||27
1087674|NCT01024309|2636019|P1|COMPLETED|Overall Study||27
1087675|NCT01024309|2636018|P2|STARTED|Overall Study||31
1087676|NCT01024309|2636019|P1|STARTED|Overall Study||35
1087677|NCT01024335|2636043|P2|NOT COMPLETED|Overall Study||26
1087678|NCT01024335|2636044|P1|NOT COMPLETED|Overall Study||13
1087679|NCT01024335|2636043|P2|COMPLETED|Overall Study||14
1087680|NCT01024335|2636044|P1|COMPLETED|Overall Study||7
1087681|NCT01024335|2636043|P2|STARTED|Overall Study||40
1087682|NCT01024335|2636044|P1|STARTED|Overall Study||20
1087683|NCT01024465|2636052|P1|NOT COMPLETED|Overall Study||3
1087684|NCT01024465|2636052|P1|COMPLETED|Overall Study||23
1087685|NCT01024465|2636052|P1|STARTED|Overall Study||26
1087686|NCT01024608|2636058|P2|NOT COMPLETED|Overall Study||4
1087687|NCT01024608|2636059|P1|NOT COMPLETED|Overall Study||4
1087688|NCT01024608|2636058|P2|COMPLETED|Overall Study||167
1087689|NCT01024608|2636059|P1|COMPLETED|Overall Study||165
1087690|NCT01024608|2636058|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|171
1087691|NCT01024608|2636059|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|167
1087692|NCT01024608|2636058|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|171
1087693|NCT01024608|2636059|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|167
1087694|NCT01024608|2636058|P2|STARTED|Overall Study||171
1087695|NCT01024608|2636059|P1|STARTED|Overall Study||169
1087696|NCT01024738|2636074|P3|NOT COMPLETED|Third Intervention:||0
1087697|NCT01024738|2636075|P2|NOT COMPLETED|Third Intervention:||0
1087698|NCT01024738|2636076|P1|NOT COMPLETED|Third Intervention:||0
1087699|NCT01024738|2636074|P3|COMPLETED|Third Intervention:||8
1087700|NCT01024738|2636075|P2|COMPLETED|Third Intervention:||7
1087701|NCT01024738|2636076|P1|COMPLETED|Third Intervention:||7
1087702|NCT01024738|2636074|P3|STARTED|Third Intervention:||8
1087703|NCT01024738|2636075|P2|STARTED|Third Intervention:||7
1087704|NCT01024738|2636076|P1|STARTED|Third Intervention:||7
1087705|NCT01024738|2636074|P3|NOT COMPLETED|Washout After 2nd Intervention||0
1087706|NCT01024738|2636075|P2|NOT COMPLETED|Washout After 2nd Intervention||0
1087707|NCT01024738|2636076|P1|NOT COMPLETED|Washout After 2nd Intervention||0
1087708|NCT01024738|2636074|P3|COMPLETED|Washout After 2nd Intervention||8
1087709|NCT01024738|2636075|P2|COMPLETED|Washout After 2nd Intervention||7
1087710|NCT01024738|2636076|P1|COMPLETED|Washout After 2nd Intervention||7
1087711|NCT01024738|2636074|P3|STARTED|Washout After 2nd Intervention||8
1087712|NCT01024738|2636075|P2|STARTED|Washout After 2nd Intervention||7
1087713|NCT01024738|2636076|P1|STARTED|Washout After 2nd Intervention||7
1087714|NCT01024738|2636074|P3|NOT COMPLETED|Second Intervention:||0
1087715|NCT01024738|2636075|P2|NOT COMPLETED|Second Intervention:||0
1087716|NCT01024738|2636076|P1|NOT COMPLETED|Second Intervention:||0
1087717|NCT01024738|2636074|P3|COMPLETED|Second Intervention:||8
1087718|NCT01024738|2636075|P2|COMPLETED|Second Intervention:||7
1087719|NCT01024738|2636076|P1|COMPLETED|Second Intervention:||7
1087720|NCT01024738|2636074|P3|STARTED|Second Intervention:||8
1087721|NCT01024738|2636075|P2|STARTED|Second Intervention:||7
1087722|NCT01024738|2636076|P1|STARTED|Second Intervention:||7
1087723|NCT01024738|2636074|P3|NOT COMPLETED|Washout After 1st Intervention||0
1087724|NCT01024738|2636075|P2|NOT COMPLETED|Washout After 1st Intervention||0
1087725|NCT01024738|2636076|P1|NOT COMPLETED|Washout After 1st Intervention||0
1087726|NCT01024738|2636074|P3|COMPLETED|Washout After 1st Intervention||8
1087727|NCT01024738|2636075|P2|COMPLETED|Washout After 1st Intervention||7
1087728|NCT01024738|2636076|P1|COMPLETED|Washout After 1st Intervention||7
1087729|NCT01024738|2636074|P3|STARTED|Washout After 1st Intervention||8
1087730|NCT01024738|2636075|P2|STARTED|Washout After 1st Intervention||7
1087731|NCT01024738|2636076|P1|STARTED|Washout After 1st Intervention||7
1087732|NCT01024738|2636074|P3|NOT COMPLETED|First Intervention:||0
1087733|NCT01024738|2636075|P2|NOT COMPLETED|First Intervention:||0
1087734|NCT01024738|2636076|P1|NOT COMPLETED|First Intervention:||0
1087735|NCT01024738|2636074|P3|COMPLETED|First Intervention:||8
1087736|NCT01024738|2636075|P2|COMPLETED|First Intervention:||7
1087737|NCT01024738|2636076|P1|COMPLETED|First Intervention:||7
1087738|NCT01024738|2636074|P3|STARTED|First Intervention:||8
1087739|NCT01024738|2636075|P2|STARTED|First Intervention:||7
1087740|NCT01024738|2636076|P1|STARTED|First Intervention:||7
1087741|NCT01024751|2636086|P2|NOT COMPLETED|Eligible Participants||3
1087742|NCT01024751|2636087|P1|NOT COMPLETED|Eligible Participants||0
1087743|NCT01024751|2636086|P2|COMPLETED|Eligible Participants||149
1087744|NCT01024751|2636087|P1|COMPLETED|Eligible Participants||153
1087745|NCT01024751|2636086|P2|STARTED|Eligible Participants||152
1087746|NCT01024751|2636087|P1|STARTED|Eligible Participants||153
1087747|NCT01024751|2636086|P2|NOT COMPLETED|Enrolled Participants||4
1087748|NCT01024751|2636087|P1|NOT COMPLETED|Enrolled Participants||3
1087749|NCT01024751|2636086|P2|COMPLETED|Enrolled Participants||152
1087750|NCT01024751|2636087|P1|COMPLETED|Enrolled Participants||153
1087751|NCT01024751|2636086|P2|STARTED|Enrolled Participants||156
1087752|NCT01024751|2636087|P1|STARTED|Enrolled Participants||156
1087753|NCT01024855|2636095|P1|NOT COMPLETED|Overall Study||1
1087754|NCT01024855|2636095|P1|COMPLETED|Overall Study|One subject of the 30 seen for baseline did not meet the inclusion/exclusion criteria|29
1087755|NCT01024855|2636095|P1|STARTED|Overall Study|30 subjects enrolled in a paired/split-eye evaluation; each subject used both study treatments|30
1087756|NCT01024946|2636100|P1|NOT COMPLETED|Overall Study||5
1087757|NCT01024946|2636100|P1|COMPLETED|Overall Study||6
1087758|NCT01024946|2636100|P1|STARTED|Overall Study||11
1087759|NCT01024959|2636104|P1|NOT COMPLETED|Overall Study||41
1087760|NCT01024959|2636104|P1|COMPLETED|Overall Study||466
1087761|NCT01024959|2636104|P1|STARTED|Overall Study||507
1087762|NCT01024972|2636115|P2|NOT COMPLETED|Overall Study||0
1087763|NCT01024972|2636116|P1|NOT COMPLETED|Overall Study||0
1087764|NCT01024972|2636115|P2|COMPLETED|Overall Study||15
1087765|NCT01024972|2636116|P1|COMPLETED|Overall Study||16
1087766|NCT01024972|2636115|P2|STARTED|Overall Study||15
1087767|NCT01024972|2636116|P1|STARTED|Overall Study||16
1087768|NCT01009619|2636128|P2|NOT COMPLETED|Overall Study||0
1087769|NCT01009619|2636129|P1|NOT COMPLETED|Overall Study||0
1087770|NCT01009619|2636128|P2|COMPLETED|Overall Study||43
1087771|NCT01009619|2636129|P1|COMPLETED|Overall Study||40
1087772|NCT01009619|2636128|P2|STARTED|Overall Study||43
1087773|NCT01009619|2636129|P1|STARTED|Overall Study||40
1087774|NCT01009645|2636151|P4|NOT COMPLETED|Overall Study||5
1087775|NCT01009645|2636152|P3|NOT COMPLETED|Overall Study||4
1087776|NCT01009645|2636153|P2|NOT COMPLETED|Overall Study||8
1087777|NCT01009645|2636154|P1|NOT COMPLETED|Overall Study||2
1087778|NCT01009645|2636151|P4|COMPLETED|Overall Study||26
1087779|NCT01009645|2636152|P3|COMPLETED|Overall Study||28
1087780|NCT01009645|2636153|P2|COMPLETED|Overall Study||23
1087781|NCT01009645|2636154|P1|COMPLETED|Overall Study||29
1087782|NCT01009645|2636151|P4|STARTED|Overall Study||31
1087783|NCT01009645|2636152|P3|STARTED|Overall Study||32
1087784|NCT01009645|2636153|P2|STARTED|Overall Study||31
1087785|NCT01009645|2636154|P1|STARTED|Overall Study||31
1087786|NCT01014975|2636168|P3|NOT COMPLETED|Overall Study||6
1087787|NCT01014975|2636169|P2|NOT COMPLETED|Overall Study||3
1087788|NCT01014975|2636170|P1|NOT COMPLETED|Overall Study||4
1087789|NCT01014975|2636168|P3|COMPLETED|Overall Study||10
1087790|NCT01014975|2636169|P2|COMPLETED|Overall Study||13
1087791|NCT01014975|2636170|P1|COMPLETED|Overall Study||4
1087792|NCT01014975|2636168|P3|STARTED|Overall Study||16
1087793|NCT01014975|2636169|P2|STARTED|Overall Study||16
1087794|NCT01014975|2636170|P1|STARTED|Overall Study||8
1087795|NCT01014988|2636184|P6|NOT COMPLETED|Overall Study||3
1087796|NCT01014988|2636185|P5|NOT COMPLETED|Overall Study||1
1087797|NCT01014988|2636186|P4|NOT COMPLETED|Overall Study||0
1087798|NCT01014988|2636187|P3|NOT COMPLETED|Overall Study||2
1087799|NCT01014988|2636188|P2|NOT COMPLETED|Overall Study||0
1087800|NCT01014988|2636189|P1|NOT COMPLETED|Overall Study||23
1087801|NCT01014988|2636184|P6|COMPLETED|Overall Study||11
1087802|NCT01014988|2636185|P5|COMPLETED|Overall Study||26
1087803|NCT01014988|2636186|P4|COMPLETED|Overall Study||12
1087804|NCT01014988|2636187|P3|COMPLETED|Overall Study||9
1087805|NCT01014988|2636188|P2|COMPLETED|Overall Study||7
1087806|NCT01014988|2636189|P1|COMPLETED|Overall Study||107
1087807|NCT01014988|2636184|P6|STARTED|Overall Study||14
1087808|NCT01014988|2636185|P5|STARTED|Overall Study||27
1087809|NCT01014988|2636186|P4|STARTED|Overall Study||12
1087810|NCT01014988|2636187|P3|STARTED|Overall Study||11
1087811|NCT01014988|2636188|P2|STARTED|Overall Study||7
1087812|NCT01014988|2636189|P1|STARTED|Overall Study||130
1087819|NCT01015131|2636382|P1|NOT COMPLETED|Overall Study||8
1087820|NCT01015131|2636382|P1|COMPLETED|Overall Study||36
1087821|NCT01015131|2636382|P1|STARTED|Overall Study||44
1087822|NCT01015170|2636396|P1|NOT COMPLETED|Overall Study||239
1087823|NCT01015170|2636396|P1|COMPLETED|Overall Study||215
1087824|NCT01015170|2636396|P1|STARTED|Overall Study||454
1087825|NCT01015287|2636404|P2|NOT COMPLETED|Overall Study||79
1087826|NCT01015287|2636405|P1|NOT COMPLETED|Overall Study||72
1087827|NCT01015287|2636404|P2|COMPLETED|Overall Study||1958
1087828|NCT01015287|2636405|P1|COMPLETED|Overall Study||1924
1087829|NCT01015287|2636404|P2|Received at Least 1 Dose of Study Drug|Overall Study||2037
1087830|NCT01015287|2636405|P1|Received at Least 1 Dose of Study Drug|Overall Study||1996
1087831|NCT01015287|2636404|P2|STARTED|Overall Study||2037
1087832|NCT01015287|2636405|P1|STARTED|Overall Study||1996
1087833|NCT01015326|2636433|P2|NOT COMPLETED|Overall Study||2
1087834|NCT01015326|2636434|P1|NOT COMPLETED|Overall Study||1
1087835|NCT01015326|2636433|P2|COMPLETED|Overall Study||18
1087836|NCT01015326|2636434|P1|COMPLETED|Overall Study||11
1087837|NCT01015326|2636433|P2|STARTED|Overall Study||20
1087838|NCT01015326|2636434|P1|STARTED|Overall Study||12
1087839|NCT01015443|2636442|P2|NOT COMPLETED|Overall Study||0
1087840|NCT01015443|2636443|P1|NOT COMPLETED|Overall Study||0
1087841|NCT01015443|2636442|P2|COMPLETED|Overall Study||94
1087842|NCT01015443|2636443|P1|COMPLETED|Overall Study||191
1087843|NCT01015443|2636442|P2|Treated|Overall Study||93
1087844|NCT01015443|2636443|P1|Treated|Overall Study||191
1087845|NCT01015443|2636442|P2|STARTED|Overall Study||94
1087846|NCT01015443|2636443|P1|STARTED|Overall Study||191
1087847|NCT01015534|2636461|P2|NOT COMPLETED|Overall Study||0
1087848|NCT01015534|2636462|P1|NOT COMPLETED|Overall Study||1
1087849|NCT01015534|2636461|P2|COMPLETED|Overall Study||27
1087850|NCT01015534|2636462|P1|COMPLETED|Overall Study||27
1087851|NCT01015534|2636461|P2|STARTED|Overall Study||27
1087852|NCT01015534|2636462|P1|STARTED|Overall Study||28
1087853|NCT01015560|2636474|P1|NOT COMPLETED|Overall Study||3
1087854|NCT01015560|2636474|P1|COMPLETED|Overall Study||41
1087855|NCT01015560|2636474|P1|Eligible and Analyzable|Overall Study||43
1087856|NCT01015560|2636474|P1|STARTED|Overall Study||44
1087857|NCT01015638|2636480|P2|NOT COMPLETED|Overall Study||0
1087858|NCT01015638|2636481|P1|NOT COMPLETED|Overall Study||1
1087859|NCT01015638|2636480|P2|COMPLETED|Overall Study||19
1087860|NCT01015638|2636481|P1|COMPLETED|Overall Study||16
1087861|NCT01015638|2636480|P2|STARTED|Overall Study||19
1087862|NCT01015638|2636481|P1|STARTED|Overall Study||17
1087863|NCT01015677|2636512|P3|NOT COMPLETED|Overall Study||0
1087864|NCT01015677|2636513|P2|NOT COMPLETED|Overall Study||4
1087865|NCT01015677|2636514|P1|NOT COMPLETED|Overall Study||1
1087866|NCT01015677|2636512|P3|COMPLETED|Overall Study||33
1087867|NCT01015677|2636513|P2|COMPLETED|Overall Study||28
1087868|NCT01015677|2636514|P1|COMPLETED|Overall Study||33
1087869|NCT01015677|2636512|P3|STARTED|Overall Study||33
1087870|NCT01015677|2636513|P2|STARTED|Overall Study||32
1087871|NCT01015677|2636514|P1|STARTED|Overall Study||34
1087872|NCT01015703|2636539|P5|NOT COMPLETED|Overall Study||0
1087873|NCT01015703|2636540|P4|NOT COMPLETED|Overall Study||0
1087874|NCT01015703|2636541|P3|NOT COMPLETED|Overall Study||0
1087875|NCT01015703|2636542|P2|NOT COMPLETED|Overall Study||1
1087876|NCT01015703|2636543|P1|NOT COMPLETED|Overall Study||2
1087877|NCT01015703|2636539|P5|COMPLETED|Overall Study||10
1087878|NCT01015703|2636540|P4|COMPLETED|Overall Study||10
1087879|NCT01015703|2636541|P3|COMPLETED|Overall Study||10
1087880|NCT01015703|2636542|P2|COMPLETED|Overall Study||9
1087881|NCT01015703|2636543|P1|COMPLETED|Overall Study||8
1087882|NCT01015703|2636539|P5|STARTED|Overall Study||10
1087883|NCT01015703|2636540|P4|STARTED|Overall Study||10
1087884|NCT01015703|2636541|P3|STARTED|Overall Study||10
1087885|NCT01015703|2636542|P2|STARTED|Overall Study||10
1087886|NCT01015703|2636543|P1|STARTED|Overall Study||10
1087887|NCT01015781|2636557|P2|NOT COMPLETED|Overall Study||29
1087888|NCT01015781|2636558|P1|NOT COMPLETED|Overall Study||37
1087889|NCT01015781|2636557|P2|COMPLETED|Overall Study||121
1087890|NCT01015781|2636558|P1|COMPLETED|Overall Study||113
1087891|NCT01015781|2636557|P2|STARTED|Overall Study||150
1087892|NCT01015781|2636558|P1|STARTED|Overall Study||150
1087902|NCT01015820|2636579|P2|NOT COMPLETED|Overall Study||0
1087903|NCT01015820|2636580|P1|NOT COMPLETED|Overall Study||1
1087904|NCT01015820|2636579|P2|COMPLETED|Overall Study||15
1087905|NCT01015820|2636580|P1|COMPLETED|Overall Study||14
1087906|NCT01015820|2636579|P2|STARTED|Overall Study||15
1087907|NCT01015820|2636580|P1|STARTED|Overall Study||15
1087908|NCT01015976|2636588|P2|NOT COMPLETED|Overall Study||0
1087909|NCT01015976|2636589|P1|NOT COMPLETED|Overall Study||0
1087910|NCT01015976|2636588|P2|COMPLETED|Overall Study||5
1087911|NCT01015976|2636589|P1|COMPLETED|Overall Study||5
1087912|NCT01015976|2636588|P2|STARTED|Overall Study||5
1087913|NCT01015976|2636589|P1|STARTED|Overall Study||5
1087914|NCT01016015|2636593|P1|NOT COMPLETED|Overall Study||19
1087915|NCT01016015|2636593|P1|COMPLETED|Overall Study||159
1087916|NCT01016015|2636593|P1|STARTED|Overall Study||178
1087917|NCT01016067|2636599|P2|NOT COMPLETED|Overall Study||4
1087918|NCT01016067|2636600|P1|NOT COMPLETED|Overall Study||2
1087919|NCT01016067|2636599|P2|COMPLETED|Overall Study||8
1087920|NCT01016067|2636600|P1|COMPLETED|Overall Study||9
1087921|NCT01016067|2636599|P2|STARTED|Overall Study||12
1087922|NCT01016067|2636600|P1|STARTED|Overall Study||11
1087923|NCT01016106|2636620|P2|NOT COMPLETED|Overall Study||0
1087924|NCT01016106|2636621|P1|NOT COMPLETED|Overall Study||0
1087925|NCT01016106|2636620|P2|COMPLETED|Overall Study||18
1087926|NCT01016106|2636621|P1|COMPLETED|Overall Study||17
1087927|NCT01016106|2636620|P2|STARTED|Overall Study||18
1087928|NCT01016106|2636621|P1|STARTED|Overall Study||17
1087929|NCT01016132|2636627|P1|NOT COMPLETED|Overall Study||1
1087930|NCT01016132|2636627|P1|COMPLETED|Overall Study||151
1087931|NCT01016132|2636627|P1|STARTED|Overall Study||152
1087932|NCT01025037|2636631|P1|NOT COMPLETED|Overall Study||11
1087933|NCT01025037|2636631|P1|COMPLETED|Overall Study||50
1087934|NCT01025037|2636631|P1|STARTED|Overall Study||61
1087935|NCT01025076|2636640|P1|NOT COMPLETED|Overall Study||0
1087936|NCT01025076|2636640|P1|COMPLETED|Overall Study||14
1087937|NCT01025076|2636640|P1|STARTED|Overall Study||14
1087938|NCT01025154|2636644|P1|NOT COMPLETED|Overall Study||2
1087939|NCT01025154|2636644|P1|COMPLETED|Overall Study||57
1087940|NCT01025154|2636644|P1|STARTED|Overall Study||59
1087941|NCT01025193|2636649|P1|NOT COMPLETED|Overall Study||4
1087942|NCT01025193|2636649|P1|COMPLETED|Overall Study|one patient was transplanted 2 weeks after 8 month belimumab dose and did not receive further doses.|4
1087943|NCT01025193|2636649|P1|STARTED|Overall Study||8
1087944|NCT01025232|2636661|P2|NOT COMPLETED|Overall Study||6
1087945|NCT01025232|2636662|P1|NOT COMPLETED|Overall Study||3
1087946|NCT01025232|2636661|P2|COMPLETED|Overall Study||36
1087947|NCT01025232|2636662|P1|COMPLETED|Overall Study||43
1087948|NCT01025232|2636661|P2|STARTED|Overall Study||42
1087949|NCT01025232|2636662|P1|STARTED|Overall Study||46
1087950|NCT01025271|2636680|P1|NOT COMPLETED|Overall Study||0
1087951|NCT01025271|2636680|P1|COMPLETED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
1087952|NCT01025271|2636680|P1|STARTED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
1087968|NCT01026012|2636746|P1|NOT COMPLETED|Overall Study||0
1087969|NCT01026012|2636746|P1|COMPLETED|Overall Study||40
1087970|NCT01026012|2636746|P1|STARTED|Overall Study||40
1087971|NCT01026038|2636753|P3|NOT COMPLETED|Overall Study||0
1087972|NCT01026038|2636754|P2|NOT COMPLETED|Overall Study||1
1087973|NCT01026038|2636755|P1|NOT COMPLETED|Overall Study||1
1087974|NCT01026038|2636753|P3|COMPLETED|Overall Study||67
1087975|NCT01026038|2636754|P2|COMPLETED|Overall Study||64
1087976|NCT01026038|2636755|P1|COMPLETED|Overall Study||129
1087977|NCT01026038|2636753|P3|STARTED|Overall Study||67
1087978|NCT01026038|2636754|P2|STARTED|Overall Study||65
1087979|NCT01026038|2636755|P1|STARTED|Overall Study||130
1087980|NCT01026103|2636790|P1|NOT COMPLETED|Overall Study||2
1087981|NCT01026103|2636790|P1|COMPLETED|Overall Study||28
1087982|NCT01026103|2636790|P1|Consented|Overall Study||30
1087983|NCT01026103|2636790|P1|STARTED|Overall Study||30
1087984|NCT01026142|2636799|P2|NOT COMPLETED|Overall Study||121
1087985|NCT01026142|2636800|P1|NOT COMPLETED|Overall Study||139
1087986|NCT01026142|2636799|P2|COMPLETED|Overall Study||107
1087987|NCT01026142|2636800|P1|COMPLETED|Overall Study||79
1087988|NCT01026142|2636799|P2|STARTED|Overall Study||228
1087989|NCT01026142|2636800|P1|STARTED|Overall Study||218
1087990|NCT01026181|2636825|P3|NOT COMPLETED|Overall Study||0
1087991|NCT01026181|2636826|P2|NOT COMPLETED|Overall Study||0
1087992|NCT01026181|2636827|P1|NOT COMPLETED|Overall Study||0
1087993|NCT01026181|2636825|P3|COMPLETED|Overall Study||48
1087994|NCT01026181|2636826|P2|COMPLETED|Overall Study||51
1087995|NCT01026181|2636827|P1|COMPLETED|Overall Study||51
1087996|NCT01026181|2636825|P3|STARTED|Overall Study||48
1087997|NCT01026181|2636826|P2|STARTED|Overall Study||51
1087998|NCT01026181|2636827|P1|STARTED|Overall Study||51
1087999|NCT01026194|2636840|P2|NOT COMPLETED|Period 2：Open-label Period||10
1088000|NCT01026194|2636841|P1|NOT COMPLETED|Period 2：Open-label Period||7
1088001|NCT01026194|2636840|P2|COMPLETED|Period 2：Open-label Period||88
1088002|NCT01026194|2636841|P1|COMPLETED|Period 2：Open-label Period||91
1088003|NCT01026194|2636840|P2|STARTED|Period 2：Open-label Period||98
1088004|NCT01026194|2636841|P1|STARTED|Period 2：Open-label Period||98
1088005|NCT01026194|2636840|P2|NOT COMPLETED|Period 1：Double Blind Period||5
1088006|NCT01026194|2636841|P1|NOT COMPLETED|Period 1：Double Blind Period||3
1088007|NCT01026194|2636840|P2|COMPLETED|Period 1：Double Blind Period||98
1088008|NCT01026194|2636841|P1|COMPLETED|Period 1：Double Blind Period||98
1088009|NCT01026194|2636840|P2|STARTED|Period 1：Double Blind Period||103
1088010|NCT01026194|2636841|P1|STARTED|Period 1：Double Blind Period||101
1088011|NCT01026220|2636855|P3|NOT COMPLETED|Consolidation Maintenance||14
1088012|NCT01026220|2636856|P2|NOT COMPLETED|Consolidation Maintenance||6
1088013|NCT01026220|2636857|P1|NOT COMPLETED|Consolidation Maintenance||0
1088014|NCT01026220|2636855|P3|COMPLETED|Consolidation Maintenance||66
1088015|NCT01026220|2636856|P2|COMPLETED|Consolidation Maintenance||75
1088016|NCT01026220|2636857|P1|COMPLETED|Consolidation Maintenance||0
1088017|NCT01026220|2636855|P3|STARTED|Consolidation Maintenance||80
1088018|NCT01026220|2636856|P2|STARTED|Consolidation Maintenance||81
1088019|NCT01026220|2636857|P1|STARTED|Consolidation Maintenance||0
1088020|NCT01026220|2636855|P3|NOT COMPLETED|Induction||0
1088021|NCT01026220|2636856|P2|NOT COMPLETED|Induction||0
1088022|NCT01026220|2636857|P1|NOT COMPLETED|Induction||25
1088023|NCT01026220|2636855|P3|COMPLETED|Induction||0
1088024|NCT01026220|2636856|P2|COMPLETED|Induction||0
1088025|NCT01026220|2636857|P1|COMPLETED|Induction||141
1088026|NCT01026220|2636855|P3|STARTED|Induction||0
1088027|NCT01026220|2636856|P2|STARTED|Induction||0
1088028|NCT01026220|2636857|P1|STARTED|Induction||166
1088029|NCT01026324|2636882|P3|NOT COMPLETED|Follow up/Survival||0
1088030|NCT01026324|2636883|P2|NOT COMPLETED|Follow up/Survival||0
1088031|NCT01026324|2636884|P1|NOT COMPLETED|Follow up/Survival||1
1088032|NCT01026324|2636882|P3|COMPLETED|Follow up/Survival||4
1088033|NCT01026324|2636883|P2|COMPLETED|Follow up/Survival||3
1088034|NCT01026324|2636884|P1|COMPLETED|Follow up/Survival||4
1088035|NCT01026324|2636882|P3|Follow up Discontinuation (Death)|Follow up/Survival||4
1088036|NCT01026324|2636883|P2|Follow up Discontinuation (Death)|Follow up/Survival||3
1088037|NCT01026324|2636884|P1|Follow up Discontinuation (Death)|Follow up/Survival||4
1088038|NCT01026324|2636882|P3|STARTED|Follow up/Survival||4
1088039|NCT01026324|2636883|P2|STARTED|Follow up/Survival||3
1088040|NCT01026324|2636884|P1|STARTED|Follow up/Survival||5
1088041|NCT01026324|2636882|P3|NOT COMPLETED|Treatment Allocation||0
1088042|NCT01026324|2636883|P2|NOT COMPLETED|Treatment Allocation||0
1088043|NCT01026324|2636884|P1|NOT COMPLETED|Treatment Allocation||0
1088044|NCT01026324|2636882|P3|COMPLETED|Treatment Allocation||4
1088045|NCT01026324|2636883|P2|COMPLETED|Treatment Allocation||3
1088046|NCT01026324|2636884|P1|COMPLETED|Treatment Allocation||5
1088047|NCT01026324|2636882|P3|Discontinued Intervention (Withdrew)|Treatment Allocation||0
1088048|NCT01026324|2636883|P2|Discontinued Intervention (Withdrew)|Treatment Allocation||0
1088049|NCT01026324|2636884|P1|Discontinued Intervention (Withdrew)|Treatment Allocation||1
1088050|NCT01026324|2636882|P3|Discontinuted Intervention (Progression)|Treatment Allocation||4
1088051|NCT01026324|2636883|P2|Discontinuted Intervention (Progression)|Treatment Allocation||3
1088052|NCT01026324|2636884|P1|Discontinuted Intervention (Progression)|Treatment Allocation||3
1088053|NCT01026324|2636882|P3|Discontinued Intervention (Toxicity)|Treatment Allocation||0
1088054|NCT01026324|2636883|P2|Discontinued Intervention (Toxicity)|Treatment Allocation||0
1088055|NCT01026324|2636884|P1|Discontinued Intervention (Toxicity)|Treatment Allocation||1
1088056|NCT01026324|2636882|P3|STARTED|Treatment Allocation||4
1088057|NCT01026324|2636883|P2|STARTED|Treatment Allocation||3
1088058|NCT01026324|2636884|P1|STARTED|Treatment Allocation||5
1088059|NCT01026389|2636896|P2|NOT COMPLETED|Overall Study||5
1088060|NCT01026389|2636897|P1|NOT COMPLETED|Overall Study||5
1088061|NCT01026389|2636896|P2|COMPLETED|Overall Study||88
1088062|NCT01026389|2636897|P1|COMPLETED|Overall Study||88
1088063|NCT01026389|2636896|P2|STARTED|Overall Study||93
1088064|NCT01026389|2636897|P1|STARTED|Overall Study||93
1088065|NCT01026402|2636926|P17|NOT COMPLETED|Overall Study||0
1088066|NCT01026402|2636927|P16|NOT COMPLETED|Overall Study||0
1088067|NCT01026402|2636928|P15|NOT COMPLETED|Overall Study||0
1088068|NCT01026402|2636929|P14|NOT COMPLETED|Overall Study||0
1088069|NCT01026402|2636930|P13|NOT COMPLETED|Overall Study||0
1088070|NCT01026402|2636931|P12|NOT COMPLETED|Overall Study||0
1088071|NCT01026402|2636932|P11|NOT COMPLETED|Overall Study||0
1088072|NCT01026402|2636933|P10|NOT COMPLETED|Overall Study||0
1088073|NCT01026402|2636934|P9|NOT COMPLETED|Overall Study||0
1088074|NCT01026402|2636935|P8|NOT COMPLETED|Overall Study||0
1088075|NCT01026402|2636936|P7|NOT COMPLETED|Overall Study||0
1088076|NCT01026402|2636937|P6|NOT COMPLETED|Overall Study||0
1088077|NCT01026402|2636938|P5|NOT COMPLETED|Overall Study||0
1088078|NCT01026402|2636939|P4|NOT COMPLETED|Overall Study||0
1088079|NCT01026402|2636940|P3|NOT COMPLETED|Overall Study||0
1088080|NCT01026402|2636941|P2|NOT COMPLETED|Overall Study||0
1088081|NCT01026402|2636942|P1|NOT COMPLETED|Overall Study||0
1088082|NCT01026402|2636926|P17|COMPLETED|Overall Study||4
1088083|NCT01026402|2636927|P16|COMPLETED|Overall Study||5
1088084|NCT01026402|2636928|P15|COMPLETED|Overall Study||3
1088085|NCT01026402|2636929|P14|COMPLETED|Overall Study||6
1088086|NCT01026402|2636930|P13|COMPLETED|Overall Study||8
1088087|NCT01026402|2636931|P12|COMPLETED|Overall Study||8
1088088|NCT01026402|2636932|P11|COMPLETED|Overall Study||7
1088089|NCT01026402|2636933|P10|COMPLETED|Overall Study||3
1088090|NCT01026402|2636934|P9|COMPLETED|Overall Study||7
1088091|NCT01026402|2636935|P8|COMPLETED|Overall Study||3
1088092|NCT01026402|2636936|P7|COMPLETED|Overall Study||8
1088093|NCT01026402|2636937|P6|COMPLETED|Overall Study||5
1088094|NCT01026402|2636938|P5|COMPLETED|Overall Study||3
1088095|NCT01026402|2636939|P4|COMPLETED|Overall Study||18
1088096|NCT01026402|2636940|P3|COMPLETED|Overall Study||33
1088097|NCT01026402|2636941|P2|COMPLETED|Overall Study||8
1088098|NCT01026402|2636942|P1|COMPLETED|Overall Study||6
1088099|NCT01026402|2636926|P17|STARTED|Overall Study||4
1088100|NCT01026402|2636927|P16|STARTED|Overall Study||5
1088101|NCT01026402|2636928|P15|STARTED|Overall Study||3
1088102|NCT01026402|2636929|P14|STARTED|Overall Study||6
1088103|NCT01026402|2636930|P13|STARTED|Overall Study||8
1088104|NCT01026402|2636931|P12|STARTED|Overall Study||8
1088105|NCT01026402|2636932|P11|STARTED|Overall Study||7
1088106|NCT01026402|2636933|P10|STARTED|Overall Study||3
1088107|NCT01026402|2636934|P9|STARTED|Overall Study||7
1088108|NCT01026402|2636935|P8|STARTED|Overall Study||3
1088109|NCT01026402|2636936|P7|STARTED|Overall Study||8
1088110|NCT01026402|2636937|P6|STARTED|Overall Study||5
1088111|NCT01026402|2636938|P5|STARTED|Overall Study||3
1088112|NCT01026402|2636939|P4|STARTED|Overall Study||18
1088113|NCT01026402|2636940|P3|STARTED|Overall Study||33
1088114|NCT01026402|2636941|P2|STARTED|Overall Study||8
1088115|NCT01026402|2636942|P1|STARTED|Overall Study||6
1088116|NCT01026454|2637252|P2|NOT COMPLETED|Second Intervention||1
1088117|NCT01026454|2637253|P1|NOT COMPLETED|Second Intervention||1
1088118|NCT01026454|2637252|P2|COMPLETED|Second Intervention||13
1088119|NCT01026454|2637253|P1|COMPLETED|Second Intervention||16
1088120|NCT01026454|2637252|P2|STARTED|Second Intervention||14
1088121|NCT01026454|2637253|P1|STARTED|Second Intervention||17
1088122|NCT01026454|2637252|P2|NOT COMPLETED|Washout||0
1088123|NCT01026454|2637253|P1|NOT COMPLETED|Washout||0
1088124|NCT01026454|2637252|P2|COMPLETED|Washout||14
1088125|NCT01026454|2637253|P1|COMPLETED|Washout||18
1088126|NCT01026454|2637252|P2|STARTED|Washout||14
1088127|NCT01026454|2637253|P1|STARTED|Washout||18
1088128|NCT01026454|2637252|P2|NOT COMPLETED|First Intervention||0
1088129|NCT01026454|2637253|P1|NOT COMPLETED|First Intervention||0
1088130|NCT01026454|2637252|P2|COMPLETED|First Intervention||14
1088131|NCT01026454|2637253|P1|COMPLETED|First Intervention||18
1088132|NCT01026454|2637252|P2|STARTED|First Intervention||14
1088133|NCT01026454|2637253|P1|STARTED|First Intervention||18
1088134|NCT01026493|2637267|P8|NOT COMPLETED|Overall Study||1
1088135|NCT01026493|2637268|P7|NOT COMPLETED|Overall Study||4
1088136|NCT01026493|2637269|P6|NOT COMPLETED|Overall Study||3
1088137|NCT01026493|2637270|P5|NOT COMPLETED|Overall Study||2
1088138|NCT01026493|2637271|P4|NOT COMPLETED|Overall Study||0
1088139|NCT01026493|2637272|P3|NOT COMPLETED|Overall Study||0
1088140|NCT01026493|2637273|P2|NOT COMPLETED|Overall Study||1
1088141|NCT01026493|2637274|P1|NOT COMPLETED|Overall Study||0
1088142|NCT01026493|2637267|P8|COMPLETED|Overall Study||37
1088143|NCT01026493|2637268|P7|COMPLETED|Overall Study||32
1088144|NCT01026493|2637269|P6|COMPLETED|Overall Study||73
1088145|NCT01026493|2637270|P5|COMPLETED|Overall Study||73
1088146|NCT01026493|2637271|P4|COMPLETED|Overall Study||8
1088147|NCT01026493|2637272|P3|COMPLETED|Overall Study||9
1088148|NCT01026493|2637273|P2|COMPLETED|Overall Study||6
1088149|NCT01026493|2637274|P1|COMPLETED|Overall Study||8
1088150|NCT01026493|2637267|P8|STARTED|Overall Study||38
1088151|NCT01026493|2637268|P7|STARTED|Overall Study||36
1088152|NCT01026493|2637269|P6|STARTED|Overall Study||76
1088153|NCT01026493|2637270|P5|STARTED|Overall Study||75
1088154|NCT01026493|2637271|P4|STARTED|Overall Study||8
1088155|NCT01026493|2637272|P3|STARTED|Overall Study||9
1088156|NCT01026493|2637273|P2|STARTED|Overall Study||7
1088157|NCT01026493|2637274|P1|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|8
1088158|NCT01026792|2637300|P1|NOT COMPLETED|Overall Study||1
1088159|NCT01026792|2637300|P1|COMPLETED|Overall Study||37
1088160|NCT01026792|2637300|P1|STARTED|Overall Study||38
1088161|NCT01026805|2637304|P1|NOT COMPLETED|Overall Study||0
1088162|NCT01026805|2637304|P1|COMPLETED|Overall Study||11
1088163|NCT01026805|2637304|P1|STARTED|Overall Study||11
1088164|NCT01026818|2637317|P4|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||3
1088165|NCT01026818|2637318|P3|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||5
1088166|NCT01026818|2637319|P2|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||7
1088167|NCT01026818|2637320|P1|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||0
1088168|NCT01026818|2637317|P4|COMPLETED|OL Period (Month 10.5 - 13.5)||105
1088169|NCT01026818|2637318|P3|COMPLETED|OL Period (Month 10.5 - 13.5)||112
1088170|NCT01026818|2637319|P2|COMPLETED|OL Period (Month 10.5 - 13.5)||98
1088171|NCT01026818|2637320|P1|COMPLETED|OL Period (Month 10.5 - 13.5)||0
1088172|NCT01026818|2637317|P4|STARTED|OL Period (Month 10.5 - 13.5)||108
1088173|NCT01026818|2637318|P3|STARTED|OL Period (Month 10.5 - 13.5)||117
1088174|NCT01026818|2637319|P2|STARTED|OL Period (Month 10.5 - 13.5)||105
1088175|NCT01026818|2637320|P1|STARTED|OL Period (Month 10.5 - 13.5)||0
1088176|NCT01026818|2637317|P4|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||7
1088177|NCT01026818|2637318|P3|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||5
1088178|NCT01026818|2637319|P2|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||9
1088179|NCT01026818|2637320|P1|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
1088180|NCT01026818|2637317|P4|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||108
1088181|NCT01026818|2637318|P3|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||117
1088182|NCT01026818|2637319|P2|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||105
1088183|NCT01026818|2637320|P1|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
1088184|NCT01026818|2637317|P4|STARTED|Drug-Free Washout Period (Month 9-10.5)||115
1088185|NCT01026818|2637318|P3|STARTED|Drug-Free Washout Period (Month 9-10.5)||122
1088186|NCT01026818|2637319|P2|STARTED|Drug-Free Washout Period (Month 9-10.5)||114
1088187|NCT01026818|2637320|P1|STARTED|Drug-Free Washout Period (Month 9-10.5)||0
1088188|NCT01026818|2637317|P4|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||26
1088189|NCT01026818|2637318|P3|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||21
1088190|NCT01026818|2637319|P2|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||25
1088191|NCT01026818|2637320|P1|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||0
1088192|NCT01026818|2637317|P4|COMPLETED|DB Treatment Period (Month 0 - 9)||115
1088193|NCT01026818|2637318|P3|COMPLETED|DB Treatment Period (Month 0 - 9)||122
1088194|NCT01026818|2637319|P2|COMPLETED|DB Treatment Period (Month 0 - 9)||114
1088195|NCT01026818|2637320|P1|COMPLETED|DB Treatment Period (Month 0 - 9)||0
1088196|NCT01026818|2637317|P4|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||141
1088197|NCT01026818|2637318|P3|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||143
1088198|NCT01026818|2637319|P2|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||139
1088199|NCT01026818|2637320|P1|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||0
1088200|NCT01026818|2637317|P4|STARTED|DB Treatment Period (Month 0 - 9)||141
1088201|NCT01026818|2637318|P3|STARTED|DB Treatment Period (Month 0 - 9)||143
1088202|NCT01026818|2637319|P2|STARTED|DB Treatment Period (Month 0 - 9)||139
1088203|NCT01026818|2637320|P1|STARTED|DB Treatment Period (Month 0 - 9)||0
1088204|NCT01026818|2637317|P4|NOT COMPLETED|Screening Period||0
1088205|NCT01026818|2637318|P3|NOT COMPLETED|Screening Period||0
1088206|NCT01026818|2637319|P2|NOT COMPLETED|Screening Period||0
1088207|NCT01026818|2637320|P1|NOT COMPLETED|Screening Period||160
1088208|NCT01026818|2637317|P4|COMPLETED|Screening Period||0
1088209|NCT01026818|2637318|P3|COMPLETED|Screening Period||0
1088210|NCT01026818|2637319|P2|COMPLETED|Screening Period||0
1088211|NCT01026818|2637320|P1|COMPLETED|Screening Period||423
1088212|NCT01026818|2637317|P4|STARTED|Screening Period||0
1088213|NCT01026818|2637318|P3|STARTED|Screening Period||0
1088214|NCT01026818|2637319|P2|STARTED|Screening Period||0
1088215|NCT01026818|2637320|P1|STARTED|Screening Period||583
1088216|NCT01026831|2637400|P2|NOT COMPLETED|Overall Study||11
1088217|NCT01026831|2637401|P1|NOT COMPLETED|Overall Study||14
1088218|NCT01026831|2637400|P2|COMPLETED|Overall Study||312
1088219|NCT01026831|2637401|P1|COMPLETED|Overall Study||306
1088220|NCT01026831|2637400|P2|STARTED|Overall Study|randomized|323
1088221|NCT01026831|2637401|P1|STARTED|Overall Study|randomized|320
1088222|NCT01026844|2637411|P2|NOT COMPLETED|Overall Study||0
1088223|NCT01026844|2637412|P1|NOT COMPLETED|Overall Study||0
1088224|NCT01026844|2637411|P2|COMPLETED|Overall Study||8
1088225|NCT01026844|2637412|P1|COMPLETED|Overall Study||19
1088226|NCT01026844|2637411|P2|STARTED|Overall Study||8
1088227|NCT01026844|2637412|P1|STARTED|Overall Study||19
1088228|NCT01026909|2637426|P2|NOT COMPLETED|Overall Study||0
1088229|NCT01026909|2637427|P1|NOT COMPLETED|Overall Study||0
1088230|NCT01026909|2637426|P2|COMPLETED|Overall Study||2
1088231|NCT01026909|2637427|P1|COMPLETED|Overall Study||1
1088232|NCT01026909|2637426|P2|STARTED|Overall Study||2
1088233|NCT01026909|2637427|P1|STARTED|Overall Study||1
1088234|NCT01026948|2637435|P1|NOT COMPLETED|Overall Study||8
1088235|NCT01026948|2637435|P1|COMPLETED|Overall Study|8 Women were recalled because of signal loss|62
1088236|NCT01026948|2637435|P1|STARTED|Overall Study||70
1088237|NCT01026974|2637444|P4|NOT COMPLETED|Overall Study||3
1088238|NCT01026974|2637445|P3|NOT COMPLETED|Overall Study||12
1088239|NCT01026974|2637446|P2|NOT COMPLETED|Overall Study||2
1088240|NCT01026974|2637447|P1|NOT COMPLETED|Overall Study||1
1088241|NCT01026974|2637444|P4|COMPLETED|Overall Study||46
1088242|NCT01026974|2637445|P3|COMPLETED|Overall Study||29
1088243|NCT01026974|2637446|P2|COMPLETED|Overall Study||12
1088244|NCT01026974|2637447|P1|COMPLETED|Overall Study||15
1088245|NCT01026974|2637444|P4|STARTED|Overall Study||49
1088246|NCT01026974|2637445|P3|STARTED|Overall Study||41
1088247|NCT01026974|2637446|P2|STARTED|Overall Study||14
1088248|NCT01026974|2637447|P1|STARTED|Overall Study||16
1088249|NCT01027000|2637504|P1|NOT COMPLETED|Overall Study||0
1088250|NCT01027000|2637504|P1|COMPLETED|Overall Study||68
1088251|NCT01027000|2637504|P1|STARTED|Overall Study||68
1088252|NCT01027195|2637510|P2|NOT COMPLETED|Overall Study||0
1088253|NCT01027195|2637511|P1|NOT COMPLETED|Overall Study||0
1088254|NCT01027195|2637510|P2|COMPLETED|Overall Study||69
1088255|NCT01027195|2637511|P1|COMPLETED|Overall Study||71
1088256|NCT01027195|2637510|P2|STARTED|Overall Study||69
1088257|NCT01027195|2637511|P1|STARTED|Overall Study||71
1088258|NCT01027273|2637533|P2|NOT COMPLETED|Overall Study||33
1088259|NCT01027273|2637534|P1|NOT COMPLETED|Overall Study||59
1088260|NCT01027273|2637533|P2|COMPLETED|Overall Study||266
1088261|NCT01027273|2637534|P1|COMPLETED|Overall Study||242
1088262|NCT01027273|2637533|P2|STARTED|Overall Study||299
1088263|NCT01027273|2637534|P1|STARTED|Overall Study||301
1088264|NCT01027286|2637552|P2|NOT COMPLETED|Overall Study||1
1088265|NCT01027286|2637553|P1|NOT COMPLETED|Overall Study||1
1088266|NCT01027286|2637552|P2|COMPLETED|Overall Study||49
1088267|NCT01027286|2637553|P1|COMPLETED|Overall Study||49
1088268|NCT01027286|2637552|P2|12 Week Postoperative|Overall Study||49
1088269|NCT01027286|2637553|P1|12 Week Postoperative|Overall Study||49
1088270|NCT01027286|2637552|P2|4 Week Postoperative|Overall Study||50
1088271|NCT01027286|2637553|P1|4 Week Postoperative|Overall Study||49
1088272|NCT01027286|2637552|P2|Day of Surgery|Overall Study||50
1088273|NCT01027286|2637553|P1|Day of Surgery|Overall Study||50
1088274|NCT01027286|2637552|P2|Preoperative|Overall Study||50
1088275|NCT01027286|2637553|P1|Preoperative|Overall Study||50
1088276|NCT01027286|2637552|P2|STARTED|Overall Study||50
1088277|NCT01027286|2637553|P1|STARTED|Overall Study||50
1088278|NCT01027351|2637577|P6|NOT COMPLETED|Overall Study||5
1088279|NCT01027351|2637578|P5|NOT COMPLETED|Overall Study||11
1088280|NCT01027351|2637579|P4|NOT COMPLETED|Overall Study||2
1088281|NCT01027351|2637580|P3|NOT COMPLETED|Overall Study||1
1088282|NCT01027351|2637581|P2|NOT COMPLETED|Overall Study||1
1088283|NCT01027351|2637582|P1|NOT COMPLETED|Overall Study||3
1088284|NCT01027351|2637577|P6|COMPLETED|Overall Study||45
1088285|NCT01027351|2637578|P5|COMPLETED|Overall Study||32
1088286|NCT01027351|2637579|P4|COMPLETED|Overall Study||6
1088287|NCT01027351|2637580|P3|COMPLETED|Overall Study||13
1088288|NCT01027351|2637581|P2|COMPLETED|Overall Study||18
1088289|NCT01027351|2637582|P1|COMPLETED|Overall Study||26
1088290|NCT01027351|2637577|P6|STARTED|Overall Study||50
1088291|NCT01027351|2637578|P5|STARTED|Overall Study||43
1088292|NCT01027351|2637579|P4|STARTED|Overall Study||8
1088293|NCT01027351|2637580|P3|STARTED|Overall Study||14
1088294|NCT01027351|2637581|P2|STARTED|Overall Study||19
1088295|NCT01027351|2637582|P1|STARTED|Overall Study||29
1088296|NCT01027364|2637668|P4|NOT COMPLETED|Overall Study||1
1088297|NCT01027364|2637669|P3|NOT COMPLETED|Overall Study||1
1088298|NCT01027364|2637670|P2|NOT COMPLETED|Overall Study||2
1088299|NCT01027364|2637671|P1|NOT COMPLETED|Overall Study||4
1088300|NCT01027364|2637668|P4|COMPLETED|Overall Study|11 participants total completed Arm 4 (3: compl. Arm 4 only; 7: cont. to Arm 1; 1: cont. to Arm 3)|3
1088301|NCT01027364|2637669|P3|COMPLETED|Overall Study||26
1088302|NCT01027364|2637670|P2|COMPLETED|Overall Study||27
1088303|NCT01027364|2637671|P1|COMPLETED|Overall Study||59
1088304|NCT01027364|2637668|P4|Started Arm 4 Then Joined Another Arm|Overall Study||0
1088305|NCT01027364|2637669|P3|Started Arm 4 Then Joined Another Arm|Overall Study||0
1088306|NCT01027364|2637670|P2|Started Arm 4 Then Joined Another Arm|Overall Study||0
1088307|NCT01027364|2637671|P1|Started Arm 4 Then Joined Another Arm|Overall Study||2
1088308|NCT01027364|2637668|P4|Joined Arm 4 for Surgery Then Returned|Overall Study||0
1088309|NCT01027364|2637669|P3|Joined Arm 4 for Surgery Then Returned|Overall Study||1
1088310|NCT01027364|2637670|P2|Joined Arm 4 for Surgery Then Returned|Overall Study||0
1088311|NCT01027364|2637671|P1|Joined Arm 4 for Surgery Then Returned|Overall Study||5
1088312|NCT01027364|2637668|P4|Enrolled in Sequential PK Subgroup|Overall Study||0
1088313|NCT01027364|2637669|P3|Enrolled in Sequential PK Subgroup|Overall Study||0
1088314|NCT01027364|2637670|P2|Enrolled in Sequential PK Subgroup|Overall Study||0
1088315|NCT01027364|2637671|P1|Enrolled in Sequential PK Subgroup|Overall Study||22
1088316|NCT01027364|2637668|P4|STARTED|Overall Study|12 total participants in Arm 4 (6 started in Arm 4; 5 joined from Arm 1; 1 joined from Arm 3)|4
1088317|NCT01027364|2637669|P3|STARTED|Overall Study||27
1088318|NCT01027364|2637670|P2|STARTED|Overall Study||29
1088319|NCT01027364|2637671|P1|STARTED|Overall Study||63
1088320|NCT01027468|2637760|P1|NOT COMPLETED|Overall Study||0
1088321|NCT01027468|2637760|P1|COMPLETED|Overall Study||160
1088322|NCT01027468|2637760|P1|STARTED|Overall Study||160
1088323|NCT01027598|2637766|P2|NOT COMPLETED|Overall Study||67
1088324|NCT01027598|2637767|P1|NOT COMPLETED|Overall Study||134
1088325|NCT01027598|2637766|P2|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
1088326|NCT01027598|2637767|P1|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
1088327|NCT01027598|2637766|P2|STARTED|Overall Study||67
1088328|NCT01027598|2637767|P1|STARTED|Overall Study|One patient was enrolled but not treated|134
1088329|NCT01027650|2637785|P8|NOT COMPLETED|Overall Study||0
1088330|NCT01027650|2637786|P7|NOT COMPLETED|Overall Study||1
1088331|NCT01027650|2637787|P6|NOT COMPLETED|Overall Study||2
1088332|NCT01027650|2637788|P5|NOT COMPLETED|Overall Study||2
1088333|NCT01027650|2637789|P4|NOT COMPLETED|Overall Study||0
1088334|NCT01027650|2637790|P3|NOT COMPLETED|Overall Study||0
1088335|NCT01027650|2637791|P2|NOT COMPLETED|Overall Study||0
1088336|NCT01027650|2637792|P1|NOT COMPLETED|Overall Study||0
1088337|NCT01027650|2637785|P8|COMPLETED|Overall Study||24
1088338|NCT01027650|2637786|P7|COMPLETED|Overall Study||24
1088339|NCT01027650|2637787|P6|COMPLETED|Overall Study||24
1088340|NCT01027650|2637788|P5|COMPLETED|Overall Study||23
1088341|NCT01027650|2637789|P4|COMPLETED|Overall Study||3
1088342|NCT01027650|2637790|P3|COMPLETED|Overall Study||6
1088343|NCT01027650|2637791|P2|COMPLETED|Overall Study||6
1088344|NCT01027650|2637792|P1|COMPLETED|Overall Study||6
1088345|NCT01027650|2637785|P8|STARTED|Overall Study||24
1088346|NCT01027650|2637786|P7|STARTED|Overall Study||25
1088347|NCT01027650|2637787|P6|STARTED|Overall Study||26
1088348|NCT01027650|2637788|P5|STARTED|Overall Study||25
1088349|NCT01027650|2637789|P4|STARTED|Overall Study||3
1088350|NCT01027650|2637790|P3|STARTED|Overall Study||6
1088351|NCT01027650|2637791|P2|STARTED|Overall Study||6
1088352|NCT01027650|2637792|P1|STARTED|Overall Study||6
1088353|NCT01027780|2637836|P2|NOT COMPLETED|Overall Study||1
1088354|NCT01027780|2637837|P1|NOT COMPLETED|Overall Study||0
1088355|NCT01027780|2637836|P2|COMPLETED|Overall Study||102
1088356|NCT01027780|2637837|P1|COMPLETED|Overall Study||105
1088357|NCT01027780|2637836|P2|STARTED|Overall Study||103
1088358|NCT01027780|2637837|P1|STARTED|Overall Study||105
1088359|NCT01027819|2637849|P2|NOT COMPLETED|Overall Study||0
1088360|NCT01027819|2637850|P1|NOT COMPLETED|Overall Study||0
1088361|NCT01027819|2637849|P2|COMPLETED|Overall Study||40
1088362|NCT01027819|2637850|P1|COMPLETED|Overall Study||40
1088363|NCT01027819|2637849|P2|STARTED|Overall Study||40
1088364|NCT01027819|2637850|P1|STARTED|Overall Study||40
1088365|NCT01027884|2637858|P2|NOT COMPLETED|Overall Study||7
1088366|NCT01027884|2637859|P1|NOT COMPLETED|Overall Study||4
1088367|NCT01027884|2637858|P2|COMPLETED|Overall Study||25
1088368|NCT01027884|2637859|P1|COMPLETED|Overall Study||30
1088369|NCT01027884|2637858|P2|STARTED|Overall Study||32
1088370|NCT01027884|2637859|P1|STARTED|Overall Study||34
1088371|NCT01027897|2637873|P1|NOT COMPLETED|Overall Study||2
1088372|NCT01027897|2637873|P1|COMPLETED|Overall Study||28
1088373|NCT01027897|2637873|P1|STARTED|Overall Study||30
1088374|NCT01027910|2637881|P2|NOT COMPLETED|Overall Study||0
1088375|NCT01027910|2637882|P1|NOT COMPLETED|Overall Study||0
1088376|NCT01027910|2637881|P2|COMPLETED|Overall Study||14
1088377|NCT01027910|2637882|P1|COMPLETED|Overall Study||6
1088378|NCT01027910|2637881|P2|STARTED|Overall Study||14
1088379|NCT01027910|2637882|P1|STARTED|Overall Study||6
1088380|NCT01028014|2637900|P6|NOT COMPLETED|Overall Study||2
1088381|NCT01028014|2637901|P5|NOT COMPLETED|Overall Study||1
1088382|NCT01028014|2637902|P4|NOT COMPLETED|Overall Study||1
1088383|NCT01028014|2637903|P3|NOT COMPLETED|Overall Study||0
1088384|NCT01028014|2637904|P2|NOT COMPLETED|Overall Study||2
1088385|NCT01028014|2637905|P1|NOT COMPLETED|Overall Study||1
1088386|NCT01028014|2637900|P6|COMPLETED|Overall Study||4
1088387|NCT01028014|2637901|P5|COMPLETED|Overall Study||9
1088388|NCT01028014|2637902|P4|COMPLETED|Overall Study||9
1088389|NCT01028014|2637903|P3|COMPLETED|Overall Study||10
1088390|NCT01028014|2637904|P2|COMPLETED|Overall Study||8
1088391|NCT01028014|2637905|P1|COMPLETED|Overall Study||9
1088392|NCT01028014|2637900|P6|STARTED|Overall Study||6
1088393|NCT01028014|2637901|P5|STARTED|Overall Study||10
1088394|NCT01028014|2637902|P4|STARTED|Overall Study||10
1088395|NCT01028014|2637903|P3|STARTED|Overall Study||10
1088396|NCT01028014|2637904|P2|STARTED|Overall Study||10
1088397|NCT01028014|2637905|P1|STARTED|Overall Study||10
1088398|NCT01028027|2637933|P2|NOT COMPLETED|Overall Study||13
1088399|NCT01028027|2637934|P1|NOT COMPLETED|Overall Study||16
1088400|NCT01028027|2637933|P2|COMPLETED|Overall Study||164
1088401|NCT01028027|2637934|P1|COMPLETED|Overall Study||164
1088402|NCT01028027|2637933|P2|STARTED|Overall Study||177
1088403|NCT01028027|2637934|P1|STARTED|Overall Study||180
1088404|NCT01028053|2637950|P1|NOT COMPLETED|Overall Study||133
1088405|NCT01028053|2637950|P1|COMPLETED|Overall Study||232
1088406|NCT01028053|2637950|P1|STARTED|Overall Study||365
1088407|NCT01028131|2637960|P4|NOT COMPLETED|Overall Study||4
1088408|NCT01028131|2637961|P3|NOT COMPLETED|Overall Study||6
1088409|NCT01028131|2637962|P2|NOT COMPLETED|Overall Study||3
1088410|NCT01028131|2637963|P1|NOT COMPLETED|Overall Study||3
1088411|NCT01028131|2637960|P4|COMPLETED|Overall Study||26
1088412|NCT01028131|2637961|P3|COMPLETED|Overall Study||22
1088413|NCT01028131|2637962|P2|COMPLETED|Overall Study||23
1088414|NCT01028131|2637963|P1|COMPLETED|Overall Study||23
1088415|NCT01028131|2637960|P4|Completed Intervention/Control Session|Overall Study||30
1088416|NCT01028131|2637961|P3|Completed Intervention/Control Session|Overall Study||28
1088417|NCT01028131|2637962|P2|Completed Intervention/Control Session|Overall Study||26
1088418|NCT01028131|2637963|P1|Completed Intervention/Control Session|Overall Study||26
1088419|NCT01028131|2637960|P4|STARTED|Overall Study||30
1088420|NCT01028131|2637961|P3|STARTED|Overall Study||28
1088421|NCT01028131|2637962|P2|STARTED|Overall Study||26
1088422|NCT01028131|2637963|P1|STARTED|Overall Study||26
1088423|NCT01028222|2637979|P2|NOT COMPLETED|Overall Study||13
1088424|NCT01028222|2637980|P1|NOT COMPLETED|Overall Study||38
1088425|NCT01028222|2637979|P2|COMPLETED|Overall Study||0
1088426|NCT01028222|2637980|P1|COMPLETED|Overall Study||4
1088427|NCT01028222|2637979|P2|Cross Over From DTIC to Nilotinib|Overall Study||10
1088428|NCT01028222|2637980|P1|Cross Over From DTIC to Nilotinib|Overall Study||0
1088429|NCT01028222|2637979|P2|STARTED|Overall Study||13
1088430|NCT01028222|2637980|P1|STARTED|Overall Study||42
1088431|NCT01028300|2638001|P1|NOT COMPLETED|Overall Study||4
1088432|NCT01028300|2638001|P1|COMPLETED|Overall Study||0
1088433|NCT01028300|2638001|P1|STARTED|Overall Study||4
1088434|NCT01028352|2638008|P1|NOT COMPLETED|Overall Study||6
1088435|NCT01028352|2638008|P1|COMPLETED|Overall Study||29
1088436|NCT01028352|2638008|P1|STARTED|Overall Study||35
1088437|NCT01028378|2638013|P1|NOT COMPLETED|Overall Study||17
1088438|NCT01028378|2638013|P1|COMPLETED|Overall Study|195 participants (230 eyes) with myopia|195
1088439|NCT01028378|2638013|P1|STARTED|Overall Study|212 participants (249 eyes) with myopia|212
1088440|NCT01028391|2638027|P2|NOT COMPLETED|Overall Study||11
1088441|NCT01028391|2638028|P1|NOT COMPLETED|Overall Study||14
1088442|NCT01028391|2638027|P2|COMPLETED|Overall Study||142
1088443|NCT01028391|2638028|P1|COMPLETED|Overall Study||150
1088444|NCT01028391|2638027|P2|STARTED|Overall Study||153
1088445|NCT01028391|2638028|P1|STARTED|Overall Study||164
1088446|NCT01019135|2638039|P3|NOT COMPLETED|Overall Study||31
1088447|NCT01019135|2638040|P2|NOT COMPLETED|Overall Study||19
1088448|NCT01019135|2638041|P1|NOT COMPLETED|Overall Study||20
1088449|NCT01019135|2638039|P3|COMPLETED|Overall Study||24
1088450|NCT01019135|2638040|P2|COMPLETED|Overall Study||40
1088451|NCT01019135|2638041|P1|COMPLETED|Overall Study||35
1088452|NCT01019135|2638039|P3|STARTED|Overall Study||55
1088453|NCT01019135|2638040|P2|STARTED|Overall Study||59
1088454|NCT01019135|2638041|P1|STARTED|Overall Study||55
1088455|NCT01019317|2638067|P1|NOT COMPLETED|Overall Study||4
1088456|NCT01019317|2638067|P1|COMPLETED|Overall Study||147
1088457|NCT01019317|2638067|P1|STARTED|Overall Study||151
1088458|NCT01019369|2638073|P2|NOT COMPLETED|Overall Study||7
1088459|NCT01019369|2638074|P1|NOT COMPLETED|Overall Study||10
1088460|NCT01019369|2638073|P2|COMPLETED|Overall Study||39
1088461|NCT01019369|2638074|P1|COMPLETED|Overall Study||76
1088462|NCT01019369|2638073|P2|STARTED|Overall Study||46
1088463|NCT01019369|2638074|P1|STARTED|Overall Study||86
1088464|NCT01019486|2638083|P3|NOT COMPLETED|Overall Study||1
1088465|NCT01019486|2638084|P2|NOT COMPLETED|Overall Study||1
1088466|NCT01019486|2638085|P1|NOT COMPLETED|Overall Study||1
1088467|NCT01019486|2638083|P3|COMPLETED|Overall Study||15
1088468|NCT01019486|2638084|P2|COMPLETED|Overall Study||4
1088469|NCT01019486|2638085|P1|COMPLETED|Overall Study||4
1088470|NCT01019486|2638083|P3|STARTED|Overall Study||16
1088471|NCT01019486|2638084|P2|STARTED|Overall Study||5
1088472|NCT01019486|2638085|P1|STARTED|Overall Study||5
1088473|NCT01019694|2638100|P3|NOT COMPLETED|Overall Study||47
1088474|NCT01019694|2638101|P2|NOT COMPLETED|Overall Study||38
1088475|NCT01019694|2638102|P1|NOT COMPLETED|Overall Study||24
1088476|NCT01019694|2638100|P3|COMPLETED|Overall Study||110
1088477|NCT01019694|2638101|P2|COMPLETED|Overall Study||118
1088478|NCT01019694|2638102|P1|COMPLETED|Overall Study||133
1088479|NCT01019694|2638100|P3|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
1088480|NCT01019694|2638101|P2|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|156
1088481|NCT01019694|2638102|P1|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
1088482|NCT01019707|2638224|P2|NOT COMPLETED|Second Phase||0
1088483|NCT01019707|2638225|P1|NOT COMPLETED|Second Phase||0
1088484|NCT01019707|2638224|P2|COMPLETED|Second Phase||1
1088485|NCT01019707|2638225|P1|COMPLETED|Second Phase||3
1088486|NCT01019707|2638224|P2|STARTED|Second Phase||1
1088487|NCT01019707|2638225|P1|STARTED|Second Phase||3
1088488|NCT01019707|2638224|P2|NOT COMPLETED|Washout||2
1088489|NCT01019707|2638225|P1|NOT COMPLETED|Washout||0
1088490|NCT01019707|2638224|P2|COMPLETED|Washout||1
1088491|NCT01019707|2638225|P1|COMPLETED|Washout||3
1088492|NCT01019707|2638224|P2|STARTED|Washout||3
1088493|NCT01019707|2638225|P1|STARTED|Washout||3
1088494|NCT01019707|2638224|P2|NOT COMPLETED|First Phase||0
1088495|NCT01019707|2638225|P1|NOT COMPLETED|First Phase||0
1088496|NCT01019707|2638224|P2|COMPLETED|First Phase||3
1088497|NCT01019707|2638225|P1|COMPLETED|First Phase||3
1088498|NCT01019707|2638224|P2|STARTED|First Phase||3
1088499|NCT01019707|2638225|P1|STARTED|First Phase||3
1088500|NCT01019928|2638237|P2|NOT COMPLETED|Period 3||0
1088501|NCT01019928|2638238|P1|NOT COMPLETED|Period 3||0
1088502|NCT01019928|2638237|P2|COMPLETED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
1088503|NCT01019928|2638238|P1|COMPLETED|Period 3||7
1088504|NCT01019928|2638237|P2|STARTED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
1088505|NCT01019928|2638238|P1|STARTED|Period 3||7
1088506|NCT01019928|2638237|P2|NOT COMPLETED|Period 2||1
1088507|NCT01019928|2638238|P1|NOT COMPLETED|Period 2||0
1088508|NCT01019928|2638237|P2|COMPLETED|Period 2|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
1088509|NCT01019928|2638238|P1|COMPLETED|Period 2||7
1088510|NCT01019928|2638237|P2|STARTED|Period 2||7
1088511|NCT01019928|2638238|P1|STARTED|Period 2||7
1088512|NCT01019928|2638237|P2|NOT COMPLETED|Period 1||0
1088513|NCT01019928|2638238|P1|NOT COMPLETED|Period 1||0
1088514|NCT01019928|2638237|P2|COMPLETED|Period 1||7
1088515|NCT01019928|2638238|P1|COMPLETED|Period 1||7
1088516|NCT01019928|2638237|P2|STARTED|Period 1||7
1088517|NCT01019928|2638238|P1|STARTED|Period 1||7
1088518|NCT01019980|2638280|P2|NOT COMPLETED|Overall Study||0
1088519|NCT01019980|2638281|P1|NOT COMPLETED|Overall Study||2
1088520|NCT01019980|2638280|P2|COMPLETED|Overall Study||0
1088521|NCT01019980|2638281|P1|COMPLETED|Overall Study||0
1088522|NCT01019980|2638280|P2|Discontinued|Overall Study||0
1088523|NCT01019980|2638281|P1|Discontinued|Overall Study||2
1088524|NCT01019980|2638280|P2|STARTED|Overall Study||0
1088525|NCT01019980|2638281|P1|STARTED|Overall Study|2 patients entered study but did not receive any drug since it was not available in the region.|2
1088526|NCT01020006|2638290|P3|NOT COMPLETED|Overall Study||16
1088527|NCT01020006|2638291|P2|NOT COMPLETED|Overall Study||18
1088528|NCT01020006|2638292|P1|NOT COMPLETED|Overall Study||8
1088529|NCT01020006|2638290|P3|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
1088530|NCT01020006|2638291|P2|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
1088531|NCT01020006|2638292|P1|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
1088532|NCT01020006|2638290|P3|STARTED|Overall Study||16
1088533|NCT01020006|2638291|P2|STARTED|Overall Study||18
1088534|NCT01020006|2638292|P1|STARTED|Overall Study||8
1088535|NCT01020123|2638307|P7|NOT COMPLETED|Extention Period||1
1088536|NCT01020123|2638308|P6|NOT COMPLETED|Extention Period||2
1088537|NCT01020123|2638309|P5|NOT COMPLETED|Extention Period||0
1088538|NCT01020123|2638310|P4|NOT COMPLETED|Extention Period||1
1088539|NCT01020123|2638311|P3|NOT COMPLETED|Extention Period||2
1088540|NCT01020123|2638312|P2|NOT COMPLETED|Extention Period||2
1088541|NCT01020123|2638313|P1|NOT COMPLETED|Extention Period||3
1088542|NCT01020123|2638307|P7|COMPLETED|Extention Period||18
1088543|NCT01020123|2638308|P6|COMPLETED|Extention Period||36
1088544|NCT01020123|2638309|P5|COMPLETED|Extention Period||31
1088545|NCT01020123|2638310|P4|COMPLETED|Extention Period||12
1088546|NCT01020123|2638311|P3|COMPLETED|Extention Period||17
1088547|NCT01020123|2638312|P2|COMPLETED|Extention Period||33
1088548|NCT01020123|2638313|P1|COMPLETED|Extention Period||37
1088549|NCT01020123|2638307|P7|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
1088550|NCT01020123|2638308|P6|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|38
1088551|NCT01020123|2638309|P5|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|31
1088552|NCT01020123|2638310|P4|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|13
1088553|NCT01020123|2638311|P3|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
1088554|NCT01020123|2638312|P2|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|35
1088555|NCT01020123|2638313|P1|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|40
1088556|NCT01020123|2638307|P7|NOT COMPLETED|Main Period||11
1088557|NCT01020123|2638308|P6|NOT COMPLETED|Main Period||11
1088558|NCT01020123|2638309|P5|NOT COMPLETED|Main Period||11
1088559|NCT01020123|2638310|P4|NOT COMPLETED|Main Period||7
1088560|NCT01020123|2638311|P3|NOT COMPLETED|Main Period||8
1088561|NCT01020123|2638312|P2|NOT COMPLETED|Main Period||14
1088562|NCT01020123|2638313|P1|NOT COMPLETED|Main Period||17
1088563|NCT01020123|2638307|P7|COMPLETED|Main Period||61
1088564|NCT01020123|2638308|P6|COMPLETED|Main Period||83
1088565|NCT01020123|2638309|P5|COMPLETED|Main Period||77
1088566|NCT01020123|2638310|P4|COMPLETED|Main Period||33
1088567|NCT01020123|2638311|P3|COMPLETED|Main Period||44
1088568|NCT01020123|2638312|P2|COMPLETED|Main Period||77
1088569|NCT01020123|2638313|P1|COMPLETED|Main Period||76
1088570|NCT01020123|2638307|P7|STARTED|Main Period||72
1088571|NCT01020123|2638308|P6|STARTED|Main Period||94
1088572|NCT01020123|2638309|P5|STARTED|Main Period||88
1088573|NCT01020123|2638310|P4|STARTED|Main Period||40
1088574|NCT01020123|2638311|P3|STARTED|Main Period||52
1088575|NCT01020123|2638312|P2|STARTED|Main Period||91
1088576|NCT01020123|2638313|P1|STARTED|Main Period||93
1088577|NCT01020305|2638506|P1|NOT COMPLETED|Overall Study||2
1088578|NCT01020305|2638506|P1|COMPLETED|Overall Study||3
1088579|NCT01020305|2638506|P1|STARTED|Overall Study||5
1088580|NCT01020448|2638510|P1|NOT COMPLETED|Treatment||26
1088581|NCT01020448|2638510|P1|COMPLETED|Treatment||299
1088582|NCT01020448|2638510|P1|STARTED|Treatment|One patient was excluded from the safety population as no post-baseline assessment was available|325
1088583|NCT01020448|2638510|P1|NOT COMPLETED|Pre-assignment||13
1088584|NCT01020448|2638510|P1|COMPLETED|Pre-assignment||326
1088585|NCT01020448|2638510|P1|STARTED|Pre-assignment||339
1088586|NCT01020474|2638521|P2|NOT COMPLETED|Overall Study||17
1088587|NCT01020474|2638522|P1|NOT COMPLETED|Overall Study||10
1088588|NCT01020474|2638521|P2|COMPLETED|Overall Study||36
1088589|NCT01020474|2638522|P1|COMPLETED|Overall Study||44
1088590|NCT01020474|2638521|P2|STARTED|Overall Study||53
1088591|NCT01020474|2638522|P1|STARTED|Overall Study||54
1088592|NCT01020487|2638545|P3|NOT COMPLETED|Part 2 Open-label Period||1
1088593|NCT01020487|2638546|P2|NOT COMPLETED|Part 2 Open-label Period||4
1088594|NCT01020487|2638547|P1|NOT COMPLETED|Part 2 Open-label Period||0
1088595|NCT01020487|2638545|P3|COMPLETED|Part 2 Open-label Period||12
1088596|NCT01020487|2638546|P2|COMPLETED|Part 2 Open-label Period||12
1088597|NCT01020487|2638547|P1|COMPLETED|Part 2 Open-label Period||0
1088598|NCT01020487|2638545|P3|STARTED|Part 2 Open-label Period||13
1088599|NCT01020487|2638546|P2|STARTED|Part 2 Open-label Period||16
1088600|NCT01020487|2638547|P1|STARTED|Part 2 Open-label Period||0
1088601|NCT01020487|2638545|P3|NOT COMPLETED|Part 2 Double-blind Treatment Period||6
1088602|NCT01020487|2638546|P2|NOT COMPLETED|Part 2 Double-blind Treatment Period||2
1088603|NCT01020487|2638547|P1|NOT COMPLETED|Part 2 Double-blind Treatment Period||0
1088604|NCT01020487|2638545|P3|COMPLETED|Part 2 Double-blind Treatment Period||13
1088605|NCT01020487|2638546|P2|COMPLETED|Part 2 Double-blind Treatment Period||16
1088606|NCT01020487|2638547|P1|COMPLETED|Part 2 Double-blind Treatment Period||0
1088607|NCT01020487|2638545|P3|Received Treatment|Part 2 Double-blind Treatment Period||18
1088608|NCT01020487|2638546|P2|Received Treatment|Part 2 Double-blind Treatment Period||18
1088609|NCT01020487|2638547|P1|Received Treatment|Part 2 Double-blind Treatment Period||0
1088610|NCT01020487|2638545|P3|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|19
1088611|NCT01020487|2638546|P2|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|18
1088612|NCT01020487|2638547|P1|STARTED|Part 2 Double-blind Treatment Period||0
1088613|NCT01020487|2638545|P3|NOT COMPLETED|Part 1||0
1088614|NCT01020487|2638546|P2|NOT COMPLETED|Part 1||0
1088615|NCT01020487|2638547|P1|NOT COMPLETED|Part 1||0
1088616|NCT01020487|2638545|P3|COMPLETED|Part 1||0
1088617|NCT01020487|2638546|P2|COMPLETED|Part 1||0
1088618|NCT01020487|2638547|P1|COMPLETED|Part 1||12
1088619|NCT01020487|2638545|P3|STARTED|Part 1||0
1088620|NCT01020487|2638546|P2|STARTED|Part 1||0
1088621|NCT01020487|2638547|P1|STARTED|Part 1||12
1088622|NCT01020526|2638568|P1|NOT COMPLETED|Overall Study||14
1088623|NCT01020526|2638568|P1|COMPLETED|Overall Study||49
1088624|NCT01020526|2638568|P1|STARTED|Overall Study||63
1088625|NCT01020591|2638574|P2|NOT COMPLETED|Overall Study||0
1088626|NCT01020591|2638575|P1|NOT COMPLETED|Overall Study||0
1088627|NCT01020591|2638574|P2|COMPLETED|Overall Study||15
1088628|NCT01020591|2638575|P1|COMPLETED|Overall Study||15
1088629|NCT01020591|2638574|P2|STARTED|Overall Study||15
1088630|NCT01020591|2638575|P1|STARTED|Overall Study||15
1088631|NCT01020747|2638583|P1|NOT COMPLETED|Overall Study||1
1088632|NCT01020747|2638583|P1|COMPLETED|Overall Study||19
1088633|NCT01020747|2638583|P1|STARTED|Overall Study||20
1088634|NCT01020773|2638590|P2|NOT COMPLETED|Overall Study||3
1088635|NCT01020773|2638591|P1|NOT COMPLETED|Overall Study||4
1088636|NCT01020773|2638590|P2|COMPLETED|Overall Study||29
1088637|NCT01020773|2638591|P1|COMPLETED|Overall Study||31
1088638|NCT01020773|2638590|P2|STARTED|Overall Study||32
1088639|NCT01020773|2638591|P1|STARTED|Overall Study||35
1088640|NCT01020786|2638597|P1|NOT COMPLETED|Maintenance Period||60
1088641|NCT01020786|2638597|P1|COMPLETED|Maintenance Period||0
1088642|NCT01020786|2638597|P1|STARTED|Maintenance Period||60
1088643|NCT01020786|2638597|P1|NOT COMPLETED|Induction Period||49
1088644|NCT01020786|2638597|P1|COMPLETED|Induction Period|Completed induction therapy. Completed=starting the maintenance therapy.|60
1088645|NCT01020786|2638597|P1|STARTED|Induction Period||109
1088646|NCT01020799|2638612|P3|NOT COMPLETED|Overall Study||7
1088647|NCT01020799|2638613|P2|NOT COMPLETED|Overall Study||14
1088648|NCT01020799|2638614|P1|NOT COMPLETED|Overall Study||19
1088649|NCT01020799|2638612|P3|COMPLETED|Overall Study||43
1088650|NCT01020799|2638613|P2|COMPLETED|Overall Study||85
1088651|NCT01020799|2638614|P1|COMPLETED|Overall Study||79
1088652|NCT01020799|2638612|P3|Full Analysis Set|Overall Study||49
1088653|NCT01020799|2638613|P2|Full Analysis Set|Overall Study||94
1088654|NCT01020799|2638614|P1|Full Analysis Set|Overall Study||91
1088655|NCT01020799|2638612|P3|Patients Received Treatment|Overall Study||50
1088656|NCT01020799|2638613|P2|Patients Received Treatment|Overall Study||99
1088657|NCT01020799|2638614|P1|Patients Received Treatment|Overall Study||96
1088658|NCT01020799|2638612|P3|STARTED|Overall Study||50
1088659|NCT01020799|2638613|P2|STARTED|Overall Study||99
1088660|NCT01020799|2638614|P1|STARTED|Overall Study||98
1088661|NCT01020812|2638637|P1|NOT COMPLETED|Overall Study||3
1088662|NCT01020812|2638637|P1|COMPLETED|Overall Study||8
1088663|NCT01020812|2638637|P1|STARTED|Overall Study||11
1088664|NCT01020838|2638644|P1|NOT COMPLETED|Overall Study||183
1088665|NCT01020838|2638644|P1|COMPLETED|Overall Study||35
1088666|NCT01020838|2638644|P1|Second Annual Repeat Injection|Overall Study|Patients returning for second follow-up administration and PET-scan.|34
1088667|NCT01020838|2638644|P1|First Annual Repeat Injection|Overall Study|Patients returning for first follow-up administration and PET-scan.|91
1088668|NCT01020838|2638644|P1|Final Analysis Set (Whole Brain)|Overall Study|Final analysis set comparing PET scans with different histopathological evaluations.|97
1088669|NCT01020838|2638644|P1|Interim Analysis Set (Primary Efficacy)|Overall Study|Primary efficacy analysis of initial study period (tissue-scan matched regional analysis)|41
1088670|NCT01020838|2638644|P1|Safety Analysis Set|Overall Study|Two patients were excluded from this population because injection of florbetaben was not done.|216
1088671|NCT01020838|2638644|P1|STARTED|Overall Study||218
1088672|NCT01020877|2638661|P2|NOT COMPLETED|Second Intervention||0
1088673|NCT01020877|2638662|P1|NOT COMPLETED|Second Intervention||1
1088674|NCT01020877|2638661|P2|COMPLETED|Second Intervention||19
1088675|NCT01020877|2638662|P1|COMPLETED|Second Intervention||18
1088676|NCT01020877|2638661|P2|STARTED|Second Intervention||19
1088677|NCT01020877|2638662|P1|STARTED|Second Intervention||19
1088678|NCT01020877|2638661|P2|NOT COMPLETED|Washout of 7 Days||0
1088679|NCT01020877|2638662|P1|NOT COMPLETED|Washout of 7 Days||0
1088680|NCT01020877|2638661|P2|COMPLETED|Washout of 7 Days||19
1088681|NCT01020877|2638662|P1|COMPLETED|Washout of 7 Days||19
1088682|NCT01020877|2638661|P2|STARTED|Washout of 7 Days||19
1088683|NCT01020877|2638662|P1|STARTED|Washout of 7 Days||19
1088684|NCT01020877|2638661|P2|NOT COMPLETED|First Intervention||0
1088685|NCT01020877|2638662|P1|NOT COMPLETED|First Intervention||0
1088686|NCT01020877|2638661|P2|COMPLETED|First Intervention||19
1088687|NCT01020877|2638662|P1|COMPLETED|First Intervention||19
1088688|NCT01020877|2638661|P2|STARTED|First Intervention||19
1088689|NCT01020877|2638662|P1|STARTED|First Intervention||19
1088690|NCT01020903|2638674|P2|NOT COMPLETED|Overall Study||0
1088691|NCT01020903|2638675|P1|NOT COMPLETED|Overall Study||0
1088692|NCT01020903|2638674|P2|COMPLETED|Overall Study|Please be advised that the investigator of the study entitled left the institution in 2011.|100
1088693|NCT01020903|2638675|P1|COMPLETED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
1088694|NCT01020903|2638674|P2|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
1088695|NCT01020903|2638675|P1|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
1088696|NCT01020981|2638683|P2|NOT COMPLETED|Overall Study||90
1088697|NCT01020981|2638684|P1|NOT COMPLETED|Overall Study||84
1088698|NCT01020981|2638683|P2|COMPLETED|Overall Study||60
1088699|NCT01020981|2638684|P1|COMPLETED|Overall Study||66
1088700|NCT01020981|2638683|P2|STARTED|Overall Study||150
1088701|NCT01020981|2638684|P1|STARTED|Overall Study||150
1088702|NCT01021007|2638696|P2|NOT COMPLETED|Overall Study||4
1088703|NCT01021007|2638697|P1|NOT COMPLETED|Overall Study||2
1088704|NCT01021007|2638696|P2|COMPLETED|Overall Study||33
1088705|NCT01021007|2638697|P1|COMPLETED|Overall Study||34
1088706|NCT01021007|2638696|P2|STARTED|Overall Study||37
1088707|NCT01021007|2638697|P1|STARTED|Overall Study||36
1088708|NCT01021020|2638707|P1|NOT COMPLETED|Period III||0
1088709|NCT01021020|2638707|P1|COMPLETED|Period III||25
1088710|NCT01021020|2638707|P1|STARTED|Period III||25
1088711|NCT01021020|2638707|P1|NOT COMPLETED|14 Day Washout Period B||0
1088712|NCT01021020|2638707|P1|COMPLETED|14 Day Washout Period B||25
1088713|NCT01021020|2638707|P1|STARTED|14 Day Washout Period B||25
1088714|NCT01021020|2638707|P1|NOT COMPLETED|Period II||0
1088715|NCT01021020|2638707|P1|COMPLETED|Period II||25
1088716|NCT01021020|2638707|P1|STARTED|Period II||25
1088717|NCT01021020|2638707|P1|NOT COMPLETED|14 Day Washout Period A||1
1088718|NCT01021020|2638707|P1|COMPLETED|14 Day Washout Period A|Colchicine/Probenecid-medical investigator dropped due to abnormal check-in lab results.|25
1088719|NCT01021020|2638707|P1|STARTED|14 Day Washout Period A||26
1088720|NCT01021020|2638707|P1|NOT COMPLETED|Period I||2
1088721|NCT01021020|2638707|P1|COMPLETED|Period I|Colchicine(fasted)-subject took Claritin-D 12hour.Colchicine(fed)arm-subject had schedule conflict.|26
1088722|NCT01021020|2638707|P1|STARTED|Period I||28
1088723|NCT01021111|2638721|P1|NOT COMPLETED|Overall Study||0
1088724|NCT01021111|2638721|P1|COMPLETED|Overall Study||17
1088725|NCT01021111|2638721|P1|STARTED|Overall Study||17
1088726|NCT01021215|2638728|P2|NOT COMPLETED|Overall Study||0
1088727|NCT01021215|2638729|P1|NOT COMPLETED|Overall Study||3
1088728|NCT01021215|2638728|P2|COMPLETED|Overall Study||20
1088729|NCT01021215|2638729|P1|COMPLETED|Overall Study||57
1088730|NCT01021215|2638728|P2|Received Allocated Intervention|Overall Study||20
1088731|NCT01021215|2638729|P1|Received Allocated Intervention|Overall Study||60
1088732|NCT01021215|2638728|P2|STARTED|Overall Study||20
1088733|NCT01021215|2638729|P1|STARTED|Overall Study||60
1088734|NCT01021293|2638741|P2|NOT COMPLETED|Overall Study||24
1088735|NCT01021293|2638742|P1|NOT COMPLETED|Overall Study||12
1088736|NCT01021293|2638741|P2|COMPLETED|Overall Study||526
1088737|NCT01021293|2638742|P1|COMPLETED|Overall Study||538
1088738|NCT01021293|2638741|P2|STARTED|Overall Study||550
1088739|NCT01021293|2638742|P1|STARTED|Overall Study||550
1088740|NCT01021306|2638763|P4|NOT COMPLETED|6 Month (Follow-up)||3
1088741|NCT01021306|2638764|P3|NOT COMPLETED|6 Month (Follow-up)||0
1088742|NCT01021306|2638765|P2|NOT COMPLETED|6 Month (Follow-up)||1
1088743|NCT01021306|2638766|P1|NOT COMPLETED|6 Month (Follow-up)||3
1088744|NCT01021306|2638763|P4|COMPLETED|6 Month (Follow-up)||14
1088745|NCT01021306|2638764|P3|COMPLETED|6 Month (Follow-up)||14
1088746|NCT01021306|2638765|P2|COMPLETED|6 Month (Follow-up)||13
1088747|NCT01021306|2638766|P1|COMPLETED|6 Month (Follow-up)||11
1088748|NCT01021306|2638763|P4|STARTED|6 Month (Follow-up)||17
1088749|NCT01021306|2638764|P3|STARTED|6 Month (Follow-up)||14
1088750|NCT01021306|2638765|P2|STARTED|6 Month (Follow-up)||14
1088751|NCT01021306|2638766|P1|STARTED|6 Month (Follow-up)||14
1088752|NCT01021306|2638763|P4|NOT COMPLETED|2 Month (Primary Outcome)||4
1088753|NCT01021306|2638764|P3|NOT COMPLETED|2 Month (Primary Outcome)||5
1088754|NCT01021306|2638765|P2|NOT COMPLETED|2 Month (Primary Outcome)||6
1088755|NCT01021306|2638766|P1|NOT COMPLETED|2 Month (Primary Outcome)||6
1088756|NCT01021306|2638763|P4|COMPLETED|2 Month (Primary Outcome)||17
1088757|NCT01021306|2638764|P3|COMPLETED|2 Month (Primary Outcome)||14
1088758|NCT01021306|2638765|P2|COMPLETED|2 Month (Primary Outcome)||14
1088759|NCT01021306|2638766|P1|COMPLETED|2 Month (Primary Outcome)||14
1088760|NCT01021306|2638763|P4|STARTED|2 Month (Primary Outcome)||21
1088761|NCT01021306|2638764|P3|STARTED|2 Month (Primary Outcome)||19
1088762|NCT01021306|2638765|P2|STARTED|2 Month (Primary Outcome)||20
1088763|NCT01021306|2638766|P1|STARTED|2 Month (Primary Outcome)||20
1088764|NCT01021332|2638784|P1|NOT COMPLETED|Overall Study||106
1088765|NCT01021332|2638784|P1|COMPLETED|Overall Study||960
1088766|NCT01021332|2638784|P1|Full Analysis Set (FAS)|Overall Study||1009
1088767|NCT01021332|2638784|P1|Safety Analysis Set (SAF)|Overall Study||1066
1088768|NCT01021332|2638784|P1|STARTED|Overall Study|Took ≥ 1 dose of FDC open-label study drug|1066
1088769|NCT01021423|2638820|P2|NOT COMPLETED|Overall Study||5
1088770|NCT01021423|2638821|P1|NOT COMPLETED|Overall Study||4
1088771|NCT01021423|2638820|P2|COMPLETED|Overall Study||0
1088772|NCT01021423|2638821|P1|COMPLETED|Overall Study||0
1088773|NCT01021423|2638820|P2|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to disease progression|5
1088774|NCT01021423|2638821|P1|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to an AE|4
1088775|NCT01021553|2638840|P3|NOT COMPLETED|Overall Study||3
1088776|NCT01021553|2638841|P2|NOT COMPLETED|Overall Study||5
1088777|NCT01021553|2638842|P1|NOT COMPLETED|Overall Study||4
1088778|NCT01021553|2638840|P3|COMPLETED|Overall Study||25
1088779|NCT01021553|2638841|P2|COMPLETED|Overall Study||17
1088780|NCT01021553|2638842|P1|COMPLETED|Overall Study||23
1088781|NCT01021553|2638840|P3|STARTED|Overall Study||28
1088782|NCT01021553|2638841|P2|STARTED|Overall Study||22
1088783|NCT01021553|2638842|P1|STARTED|Overall Study||27
1088784|NCT01021618|2638896|P2|NOT COMPLETED|Overall Study||0
1088785|NCT01021618|2638897|P1|NOT COMPLETED|Overall Study||0
1088786|NCT01021618|2638896|P2|COMPLETED|Overall Study||96
1088787|NCT01021618|2638897|P1|COMPLETED|Overall Study||44
1088788|NCT01021618|2638896|P2|STARTED|Overall Study||96
1088789|NCT01021618|2638897|P1|STARTED|Overall Study||44
1088790|NCT01021683|2638905|P1|NOT COMPLETED|Overall Study||71
1088791|NCT01021683|2638905|P1|COMPLETED|Overall Study||132
1088792|NCT01021683|2638905|P1|STARTED|Overall Study||203
1088793|NCT01021761|2638920|P3|NOT COMPLETED|Overall Study||0
1088794|NCT01021761|2638921|P2|NOT COMPLETED|Overall Study||4
1088795|NCT01021761|2638922|P1|NOT COMPLETED|Overall Study||1
1088796|NCT01021761|2638920|P3|COMPLETED|Overall Study||42
1088797|NCT01021761|2638921|P2|COMPLETED|Overall Study||38
1088798|NCT01021761|2638922|P1|COMPLETED|Overall Study||41
1088799|NCT01021761|2638920|P3|STARTED|Overall Study||42
1088800|NCT01021761|2638921|P2|STARTED|Overall Study||42
1088801|NCT01021761|2638922|P1|STARTED|Overall Study||42
1088802|NCT01021813|2638932|P5|NOT COMPLETED|DB Randomized Discontinuation Phase||5
1088803|NCT01021813|2638933|P4|NOT COMPLETED|DB Randomized Discontinuation Phase||5
1088804|NCT01021813|2638934|P3|NOT COMPLETED|DB Randomized Discontinuation Phase||4
1088805|NCT01021813|2638935|P2|NOT COMPLETED|DB Randomized Discontinuation Phase||0
1088806|NCT01021813|2638936|P1|NOT COMPLETED|DB Randomized Discontinuation Phase||0
1088807|NCT01021813|2638932|P5|COMPLETED|DB Randomized Discontinuation Phase||157
1088808|NCT01021813|2638933|P4|COMPLETED|DB Randomized Discontinuation Phase||161
1088809|NCT01021813|2638934|P3|COMPLETED|DB Randomized Discontinuation Phase||152
1088810|NCT01021813|2638935|P2|COMPLETED|DB Randomized Discontinuation Phase||0
1088811|NCT01021813|2638936|P1|COMPLETED|DB Randomized Discontinuation Phase||0
1088812|NCT01021813|2638932|P5|STARTED|DB Randomized Discontinuation Phase||162
1088813|NCT01021813|2638933|P4|STARTED|DB Randomized Discontinuation Phase||166
1088814|NCT01021813|2638934|P3|STARTED|DB Randomized Discontinuation Phase||156
1088815|NCT01021813|2638935|P2|STARTED|DB Randomized Discontinuation Phase||0
1088816|NCT01021813|2638936|P1|STARTED|DB Randomized Discontinuation Phase||0
1088817|NCT01021813|2638932|P5|NOT COMPLETED|DB Treatment Phase||0
1088818|NCT01021813|2638933|P4|NOT COMPLETED|DB Treatment Phase||0
1088819|NCT01021813|2638934|P3|NOT COMPLETED|DB Treatment Phase||0
1088820|NCT01021813|2638935|P2|NOT COMPLETED|DB Treatment Phase||97
1088821|NCT01021813|2638936|P1|NOT COMPLETED|DB Treatment Phase||200
1088822|NCT01021813|2638932|P5|COMPLETED|DB Treatment Phase||0
1088823|NCT01021813|2638933|P4|COMPLETED|DB Treatment Phase||0
1088824|NCT01021813|2638934|P3|COMPLETED|DB Treatment Phase||0
1088825|NCT01021813|2638935|P2|COMPLETED|DB Treatment Phase||162
1088826|NCT01021813|2638936|P1|COMPLETED|DB Treatment Phase||322
1088827|NCT01021813|2638932|P5|Treated|DB Treatment Phase||0
1088828|NCT01021813|2638933|P4|Treated|DB Treatment Phase||0
1088829|NCT01021813|2638934|P3|Treated|DB Treatment Phase||0
1088830|NCT01021813|2638935|P2|Treated|DB Treatment Phase||258
1088831|NCT01021813|2638936|P1|Treated|DB Treatment Phase||521
1088832|NCT01021813|2638932|P5|STARTED|DB Treatment Phase||0
1088833|NCT01021813|2638933|P4|STARTED|DB Treatment Phase||0
1088834|NCT01021813|2638934|P3|STARTED|DB Treatment Phase||0
1088835|NCT01021813|2638935|P2|STARTED|DB Treatment Phase||259
1088836|NCT01021813|2638936|P1|STARTED|DB Treatment Phase||522
1088837|NCT01021852|2638983|P8|NOT COMPLETED|Treatment Period 2||2
1088838|NCT01021852|2638984|P7|NOT COMPLETED|Treatment Period 2||3
1088839|NCT01021852|2638985|P6|NOT COMPLETED|Treatment Period 2||1
1088840|NCT01021852|2638986|P5|NOT COMPLETED|Treatment Period 2||2
1088841|NCT01021852|2638987|P4|NOT COMPLETED|Treatment Period 2||0
1088842|NCT01021852|2638988|P3|NOT COMPLETED|Treatment Period 2||1
1088843|NCT01021852|2638989|P2|NOT COMPLETED|Treatment Period 2||1
1088844|NCT01021852|2638990|P1|NOT COMPLETED|Treatment Period 2||0
1088845|NCT01021852|2638983|P8|COMPLETED|Treatment Period 2||38
1088846|NCT01021852|2638984|P7|COMPLETED|Treatment Period 2||37
1088847|NCT01021852|2638985|P6|COMPLETED|Treatment Period 2||37
1088848|NCT01021852|2638986|P5|COMPLETED|Treatment Period 2||37
1088849|NCT01021852|2638987|P4|COMPLETED|Treatment Period 2||37
1088850|NCT01021852|2638988|P3|COMPLETED|Treatment Period 2||38
1088851|NCT01021852|2638989|P2|COMPLETED|Treatment Period 2||38
1088852|NCT01021852|2638990|P1|COMPLETED|Treatment Period 2||37
1088853|NCT01021852|2638983|P8|STARTED|Treatment Period 2||40
1088854|NCT01021852|2638984|P7|STARTED|Treatment Period 2||40
1088855|NCT01021852|2638985|P6|STARTED|Treatment Period 2||38
1088856|NCT01021852|2638986|P5|STARTED|Treatment Period 2||39
1088857|NCT01021852|2638987|P4|STARTED|Treatment Period 2||37
1088858|NCT01021852|2638988|P3|STARTED|Treatment Period 2||39
1088859|NCT01021852|2638989|P2|STARTED|Treatment Period 2||39
1088860|NCT01021852|2638990|P1|STARTED|Treatment Period 2||37
1088861|NCT01021852|2638983|P8|NOT COMPLETED|Washout Period-No Drug||0
1088862|NCT01021852|2638984|P7|NOT COMPLETED|Washout Period-No Drug||0
1088863|NCT01021852|2638985|P6|NOT COMPLETED|Washout Period-No Drug||1
1088864|NCT01021852|2638986|P5|NOT COMPLETED|Washout Period-No Drug||0
1088865|NCT01021852|2638987|P4|NOT COMPLETED|Washout Period-No Drug||0
1088866|NCT01021852|2638988|P3|NOT COMPLETED|Washout Period-No Drug||0
1088867|NCT01021852|2638989|P2|NOT COMPLETED|Washout Period-No Drug||0
1088868|NCT01021852|2638990|P1|NOT COMPLETED|Washout Period-No Drug||1
1088869|NCT01021852|2638983|P8|COMPLETED|Washout Period-No Drug||40
1088870|NCT01021852|2638984|P7|COMPLETED|Washout Period-No Drug||40
1088871|NCT01021852|2638985|P6|COMPLETED|Washout Period-No Drug||38
1088872|NCT01021852|2638986|P5|COMPLETED|Washout Period-No Drug||39
1088873|NCT01021852|2638987|P4|COMPLETED|Washout Period-No Drug||37
1088874|NCT01021852|2638988|P3|COMPLETED|Washout Period-No Drug||39
1088875|NCT01021852|2638989|P2|COMPLETED|Washout Period-No Drug||39
1088876|NCT01021852|2638990|P1|COMPLETED|Washout Period-No Drug||37
1088877|NCT01021852|2638983|P8|STARTED|Washout Period-No Drug||40
1088878|NCT01021852|2638984|P7|STARTED|Washout Period-No Drug||40
1088879|NCT01021852|2638985|P6|STARTED|Washout Period-No Drug|Includes 1 participant who completed Treatment Period 1 but missed Placebo Washout.|39
1088880|NCT01021852|2638986|P5|STARTED|Washout Period-No Drug||39
1088881|NCT01021852|2638987|P4|STARTED|Washout Period-No Drug||37
1088882|NCT01021852|2638988|P3|STARTED|Washout Period-No Drug||39
1088883|NCT01021852|2638989|P2|STARTED|Washout Period-No Drug||39
1088884|NCT01021852|2638990|P1|STARTED|Washout Period-No Drug|Includes 1 participant who discontinued Treatment Period 1 (AE) and missed Placebo Washout.|38
1088885|NCT01021852|2638983|P8|NOT COMPLETED|Washout Period-Placebo||0
1088886|NCT01021852|2638984|P7|NOT COMPLETED|Washout Period-Placebo||1
1088887|NCT01021852|2638985|P6|NOT COMPLETED|Washout Period-Placebo||1
1088888|NCT01021852|2638986|P5|NOT COMPLETED|Washout Period-Placebo||1
1088889|NCT01021852|2638987|P4|NOT COMPLETED|Washout Period-Placebo||1
1088890|NCT01021852|2638988|P3|NOT COMPLETED|Washout Period-Placebo||0
1088891|NCT01021852|2638989|P2|NOT COMPLETED|Washout Period-Placebo||0
1088892|NCT01021852|2638990|P1|NOT COMPLETED|Washout Period-Placebo||0
1088893|NCT01021852|2638983|P8|COMPLETED|Washout Period-Placebo||40
1088894|NCT01021852|2638984|P7|COMPLETED|Washout Period-Placebo||40
1088895|NCT01021852|2638985|P6|COMPLETED|Washout Period-Placebo||38
1088896|NCT01021852|2638986|P5|COMPLETED|Washout Period-Placebo||39
1088897|NCT01021852|2638987|P4|COMPLETED|Washout Period-Placebo||37
1088898|NCT01021852|2638988|P3|COMPLETED|Washout Period-Placebo||39
1088899|NCT01021852|2638989|P2|COMPLETED|Washout Period-Placebo||39
1088900|NCT01021852|2638990|P1|COMPLETED|Washout Period-Placebo||37
1088901|NCT01021852|2638983|P8|STARTED|Washout Period-Placebo||40
1088902|NCT01021852|2638984|P7|STARTED|Washout Period-Placebo||41
1088903|NCT01021852|2638985|P6|STARTED|Washout Period-Placebo|Excludes 1 participant who completed Treatment Period 1 but missed Placebo Washout|39
1088904|NCT01021852|2638986|P5|STARTED|Washout Period-Placebo|Includes 1 participant that discontinued Treatment Period 1 (AE).|40
1088905|NCT01021852|2638987|P4|STARTED|Washout Period-Placebo||38
1088906|NCT01021852|2638988|P3|STARTED|Washout Period-Placebo||39
1088907|NCT01021852|2638989|P2|STARTED|Washout Period-Placebo||39
1088908|NCT01021852|2638990|P1|STARTED|Washout Period-Placebo||37
1088909|NCT01021852|2638983|P8|NOT COMPLETED|Treatment Period 1||1
1088910|NCT01021852|2638984|P7|NOT COMPLETED|Treatment Period 1||0
1088911|NCT01021852|2638985|P6|NOT COMPLETED|Treatment Period 1||2
1088912|NCT01021852|2638986|P5|NOT COMPLETED|Treatment Period 1||3
1088913|NCT01021852|2638987|P4|NOT COMPLETED|Treatment Period 1||2
1088914|NCT01021852|2638988|P3|NOT COMPLETED|Treatment Period 1||2
1088915|NCT01021852|2638989|P2|NOT COMPLETED|Treatment Period 1||1
1088916|NCT01021852|2638990|P1|NOT COMPLETED|Treatment Period 1||3
1088917|NCT01021852|2638983|P8|COMPLETED|Treatment Period 1||40
1088918|NCT01021852|2638984|P7|COMPLETED|Treatment Period 1||41
1088919|NCT01021852|2638985|P6|COMPLETED|Treatment Period 1||39
1088920|NCT01021852|2638986|P5|COMPLETED|Treatment Period 1||39
1088921|NCT01021852|2638987|P4|COMPLETED|Treatment Period 1||38
1088922|NCT01021852|2638988|P3|COMPLETED|Treatment Period 1||39
1088923|NCT01021852|2638989|P2|COMPLETED|Treatment Period 1||39
1088924|NCT01021852|2638990|P1|COMPLETED|Treatment Period 1||37
1088925|NCT01021852|2638983|P8|Treated|Treatment Period 1||41
1088926|NCT01021852|2638984|P7|Treated|Treatment Period 1||41
1088927|NCT01021852|2638985|P6|Treated|Treatment Period 1|1 participant discontinued Treatment Period 1 (AE) but continued in Placebo Washout|41
1088928|NCT01021852|2638986|P5|Treated|Treatment Period 1||42
1088929|NCT01021852|2638987|P4|Treated|Treatment Period 1||38
1088930|NCT01021852|2638988|P3|Treated|Treatment Period 1||41
1088931|NCT01021852|2638989|P2|Treated|Treatment Period 1||40
1088932|NCT01021852|2638990|P1|Treated|Treatment Period 1||40
1088933|NCT01021852|2638983|P8|STARTED|Treatment Period 1||41
1088934|NCT01021852|2638984|P7|STARTED|Treatment Period 1||41
1088935|NCT01021852|2638985|P6|STARTED|Treatment Period 1||41
1088936|NCT01021852|2638986|P5|STARTED|Treatment Period 1||42
1088937|NCT01021852|2638987|P4|STARTED|Treatment Period 1||40
1088938|NCT01021852|2638988|P3|STARTED|Treatment Period 1||41
1088939|NCT01021852|2638989|P2|STARTED|Treatment Period 1||40
1088940|NCT01021852|2638990|P1|STARTED|Treatment Period 1||40
1088941|NCT01021878|2639026|P2|NOT COMPLETED|Overall Study||10
1088942|NCT01021878|2639027|P1|NOT COMPLETED|Overall Study||16
1088943|NCT01021878|2639026|P2|COMPLETED|Overall Study||17
1088944|NCT01021878|2639027|P1|COMPLETED|Overall Study||17
1088945|NCT01021878|2639026|P2|Completed Follow-up|Overall Study||17
1088946|NCT01021878|2639027|P1|Completed Follow-up|Overall Study||17
1088947|NCT01021878|2639026|P2|STARTED|Overall Study||27
1088948|NCT01021878|2639027|P1|STARTED|Overall Study||33
1088949|NCT01022073|2639043|P2|NOT COMPLETED|Overall Study||18
1088950|NCT01022073|2639044|P1|NOT COMPLETED|Overall Study||19
1088951|NCT01022073|2639043|P2|COMPLETED|Overall Study||52
1088952|NCT01022073|2639044|P1|COMPLETED|Overall Study||67
1088953|NCT01022073|2639043|P2|STARTED|Overall Study||70
1088954|NCT01022073|2639044|P1|STARTED|Overall Study||86
1088955|NCT01022112|2639055|P5|NOT COMPLETED|Overall Study||10
1088956|NCT01022112|2639056|P4|NOT COMPLETED|Overall Study||3
1088957|NCT01022112|2639057|P3|NOT COMPLETED|Overall Study||3
1088958|NCT01022112|2639058|P2|NOT COMPLETED|Overall Study||3
1088959|NCT01022112|2639059|P1|NOT COMPLETED|Overall Study||3
1088960|NCT01022112|2639055|P5|COMPLETED|Overall Study||65
1088961|NCT01022112|2639056|P4|COMPLETED|Overall Study||72
1088962|NCT01022112|2639057|P3|COMPLETED|Overall Study||74
1088963|NCT01022112|2639058|P2|COMPLETED|Overall Study||71
1088964|NCT01022112|2639059|P1|COMPLETED|Overall Study||79
1088965|NCT01022112|2639055|P5|STARTED|Overall Study||75
1088966|NCT01022112|2639056|P4|STARTED|Overall Study||75
1088967|NCT01022112|2639057|P3|STARTED|Overall Study||77
1088968|NCT01022112|2639058|P2|STARTED|Overall Study||74
1088969|NCT01022112|2639059|P1|STARTED|Overall Study||82
1088970|NCT01022190|2639071|P1|NOT COMPLETED|Overall Study||0
1088971|NCT01022190|2639071|P1|COMPLETED|Overall Study||42
1088972|NCT01022190|2639071|P1|STARTED|Overall Study||42
1088973|NCT01022203|2639077|P2|NOT COMPLETED|Follow-Up Assessment||2
1088974|NCT01022203|2639078|P1|NOT COMPLETED|Follow-Up Assessment||2
1088975|NCT01022203|2639077|P2|COMPLETED|Follow-Up Assessment||40
1088976|NCT01022203|2639078|P1|COMPLETED|Follow-Up Assessment||42
1088977|NCT01022203|2639077|P2|STARTED|Follow-Up Assessment||42
1088978|NCT01022203|2639078|P1|STARTED|Follow-Up Assessment||44
1088979|NCT01022203|2639077|P2|NOT COMPLETED|Post Treatment Assessment||14
1088980|NCT01022203|2639078|P1|NOT COMPLETED|Post Treatment Assessment||14
1088981|NCT01022203|2639077|P2|COMPLETED|Post Treatment Assessment||42
1088982|NCT01022203|2639078|P1|COMPLETED|Post Treatment Assessment||44
1088983|NCT01022203|2639077|P2|STARTED|Post Treatment Assessment||56
1088984|NCT01022203|2639078|P1|STARTED|Post Treatment Assessment||58
1088985|NCT01022203|2639077|P2|NOT COMPLETED|PreTreatment Assessment||0
1088986|NCT01022203|2639078|P1|NOT COMPLETED|PreTreatment Assessment||0
1088987|NCT01022203|2639077|P2|COMPLETED|PreTreatment Assessment||56
1088988|NCT01022203|2639078|P1|COMPLETED|PreTreatment Assessment||58
1088989|NCT01022203|2639077|P2|STARTED|PreTreatment Assessment||56
1088990|NCT01022203|2639078|P1|STARTED|PreTreatment Assessment||58
1088991|NCT01022242|2639090|P2|NOT COMPLETED|Overall Study||19
1088992|NCT01022242|2639091|P1|NOT COMPLETED|Overall Study||21
1088993|NCT01022242|2639090|P2|COMPLETED|Overall Study||46
1088994|NCT01022242|2639091|P1|COMPLETED|Overall Study||49
1088995|NCT01022242|2639090|P2|STARTED|Overall Study|67 pat rand to PXL01. 2 got incorrect mix of PXL01. 65 patients treated with the correct PXL01 mix.|65
1088996|NCT01022242|2639091|P1|STARTED|Overall Study|71 pat rand to placebo. 1 got incorrect mix of placebo. 70 patients treated with the correct mix.|70
1088997|NCT01022307|2639099|P2|NOT COMPLETED|Overall Study||4
1088998|NCT01022307|2639100|P1|NOT COMPLETED|Overall Study||0
1088999|NCT01022307|2639099|P2|COMPLETED|Overall Study|Some TBI patients could not undergo MR scanning due to contraindications.|24
1089000|NCT01022307|2639100|P1|COMPLETED|Overall Study||184
1089001|NCT01022307|2639099|P2|STARTED|Overall Study||28
1089002|NCT01022307|2639100|P1|STARTED|Overall Study||184
1089003|NCT01022398|2639108|P2|NOT COMPLETED|Overall Study||2
1089004|NCT01022398|2639109|P1|NOT COMPLETED|Overall Study||2
1089005|NCT01022398|2639108|P2|COMPLETED|Overall Study||0
1089006|NCT01022398|2639109|P1|COMPLETED|Overall Study||0
1089007|NCT01022398|2639108|P2|STARTED|Overall Study||2
1089008|NCT01022398|2639109|P1|STARTED|Overall Study||2
1089009|NCT01022502|2639114|P1|NOT COMPLETED|Overall Study||3
1089010|NCT01022502|2639114|P1|COMPLETED|Overall Study|3 participants withdrew at week 4,5,6,respectively.|35
1089011|NCT01022502|2639114|P1|STARTED|Overall Study|19 used the refined ointment on the right site, 19 used the crude ointment on the left site.|38
1089012|NCT01028651|2639128|P1|NOT COMPLETED|Overall Study||3
1089013|NCT01028651|2639128|P1|COMPLETED|Overall Study||10
1089014|NCT01028651|2639128|P1|STARTED|Overall Study||13
1089015|NCT01028677|2639151|P2|NOT COMPLETED|Overall Study||1
1089016|NCT01028677|2639152|P1|NOT COMPLETED|Overall Study||2
1089017|NCT01028677|2639151|P2|COMPLETED|Overall Study||6
1089018|NCT01028677|2639152|P1|COMPLETED|Overall Study||8
1089019|NCT01028677|2639151|P2|STARTED|Overall Study||7
1089020|NCT01028677|2639152|P1|STARTED|Overall Study||10
1089021|NCT01033383|2639172|P4|NOT COMPLETED|Overall Study||0
1089022|NCT01033383|2639173|P3|NOT COMPLETED|Overall Study||0
1089023|NCT01033383|2639174|P2|NOT COMPLETED|Overall Study||0
1089024|NCT01033383|2639175|P1|NOT COMPLETED|Overall Study||0
1089025|NCT01033383|2639172|P4|COMPLETED|Overall Study||20
1089026|NCT01033383|2639173|P3|COMPLETED|Overall Study||20
1089027|NCT01033383|2639174|P2|COMPLETED|Overall Study||20
1089028|NCT01033383|2639175|P1|COMPLETED|Overall Study||20
1089029|NCT01033383|2639172|P4|STARTED|Overall Study||20
1089030|NCT01033383|2639173|P3|STARTED|Overall Study||20
1089031|NCT01033383|2639174|P2|STARTED|Overall Study||20
1089032|NCT01033383|2639175|P1|STARTED|Overall Study||20
1089033|NCT01033448|2639193|P1|NOT COMPLETED|Overall Study||12
1089034|NCT01033448|2639193|P1|COMPLETED|Overall Study||47
1089035|NCT01033448|2639193|P1|STARTED|Overall Study||59
1089036|NCT01033487|2639201|P10|NOT COMPLETED|Fifth Intervention Period||0
1089037|NCT01033487|2639202|P9|NOT COMPLETED|Fifth Intervention Period||0
1089038|NCT01033487|2639203|P8|NOT COMPLETED|Fifth Intervention Period||0
1089039|NCT01033487|2639204|P7|NOT COMPLETED|Fifth Intervention Period||0
1089040|NCT01033487|2639205|P6|NOT COMPLETED|Fifth Intervention Period||0
1089041|NCT01033487|2639206|P5|NOT COMPLETED|Fifth Intervention Period||0
1089042|NCT01033487|2639207|P4|NOT COMPLETED|Fifth Intervention Period||0
1089043|NCT01033487|2639208|P3|NOT COMPLETED|Fifth Intervention Period||0
1089044|NCT01033487|2639209|P2|NOT COMPLETED|Fifth Intervention Period||0
1089045|NCT01033487|2639210|P1|NOT COMPLETED|Fifth Intervention Period||0
1089046|NCT01033487|2639201|P10|COMPLETED|Fifth Intervention Period||2
1089047|NCT01033487|2639202|P9|COMPLETED|Fifth Intervention Period||1
1089048|NCT01033487|2639203|P8|COMPLETED|Fifth Intervention Period||3
1089049|NCT01033487|2639204|P7|COMPLETED|Fifth Intervention Period||2
1089050|NCT01033487|2639205|P6|COMPLETED|Fifth Intervention Period||2
1089051|NCT01033487|2639206|P5|COMPLETED|Fifth Intervention Period||2
1089052|NCT01033487|2639207|P4|COMPLETED|Fifth Intervention Period||2
1089053|NCT01033487|2639208|P3|COMPLETED|Fifth Intervention Period||2
1089054|NCT01033487|2639209|P2|COMPLETED|Fifth Intervention Period||3
1089055|NCT01033487|2639210|P1|COMPLETED|Fifth Intervention Period||2
1089056|NCT01033487|2639201|P10|STARTED|Fifth Intervention Period||2
1089057|NCT01033487|2639202|P9|STARTED|Fifth Intervention Period||1
1089058|NCT01033487|2639203|P8|STARTED|Fifth Intervention Period||3
1089059|NCT01033487|2639204|P7|STARTED|Fifth Intervention Period||2
1089060|NCT01033487|2639205|P6|STARTED|Fifth Intervention Period||2
1089061|NCT01033487|2639206|P5|STARTED|Fifth Intervention Period||2
1089062|NCT01033487|2639207|P4|STARTED|Fifth Intervention Period||2
1089063|NCT01033487|2639208|P3|STARTED|Fifth Intervention Period||2
1089064|NCT01033487|2639209|P2|STARTED|Fifth Intervention Period||3
1089065|NCT01033487|2639210|P1|STARTED|Fifth Intervention Period||2
1089066|NCT01033487|2639201|P10|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
1089067|NCT01033487|2639202|P9|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
1089068|NCT01033487|2639203|P8|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
1089069|NCT01033487|2639204|P7|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
1089070|NCT01033487|2639205|P6|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
1089071|NCT01033487|2639206|P5|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
1089072|NCT01033487|2639207|P4|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
1089073|NCT01033487|2639208|P3|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
1089074|NCT01033487|2639209|P2|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
1089075|NCT01033487|2639210|P1|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
1089076|NCT01033487|2639201|P10|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
1089077|NCT01033487|2639202|P9|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||1
1089078|NCT01033487|2639203|P8|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
1089079|NCT01033487|2639204|P7|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
1089080|NCT01033487|2639205|P6|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
1089081|NCT01033487|2639206|P5|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
1089082|NCT01033487|2639207|P4|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
1089083|NCT01033487|2639208|P3|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
1089084|NCT01033487|2639209|P2|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
1089085|NCT01033487|2639210|P1|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
1089086|NCT01033487|2639201|P10|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
1089087|NCT01033487|2639202|P9|STARTED|Between Period 4 and 5 (At Least 7 Days)||1
1089088|NCT01033487|2639203|P8|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
1089089|NCT01033487|2639204|P7|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
1089090|NCT01033487|2639205|P6|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
1089091|NCT01033487|2639206|P5|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
1089092|NCT01033487|2639207|P4|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
1089093|NCT01033487|2639208|P3|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
1089094|NCT01033487|2639209|P2|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
1089095|NCT01033487|2639210|P1|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
1089096|NCT01033487|2639201|P10|NOT COMPLETED|Fourth Intervention Period||0
1089097|NCT01033487|2639202|P9|NOT COMPLETED|Fourth Intervention Period||1
1089098|NCT01033487|2639203|P8|NOT COMPLETED|Fourth Intervention Period||0
1089099|NCT01033487|2639204|P7|NOT COMPLETED|Fourth Intervention Period||0
1089100|NCT01033487|2639205|P6|NOT COMPLETED|Fourth Intervention Period||0
1089101|NCT01033487|2639206|P5|NOT COMPLETED|Fourth Intervention Period||0
1089102|NCT01033487|2639207|P4|NOT COMPLETED|Fourth Intervention Period||0
1089103|NCT01033487|2639208|P3|NOT COMPLETED|Fourth Intervention Period||0
1089104|NCT01033487|2639209|P2|NOT COMPLETED|Fourth Intervention Period||0
1089105|NCT01033487|2639210|P1|NOT COMPLETED|Fourth Intervention Period||0
1089106|NCT01033487|2639201|P10|COMPLETED|Fourth Intervention Period||2
1089107|NCT01033487|2639202|P9|COMPLETED|Fourth Intervention Period||1
1089108|NCT01033487|2639203|P8|COMPLETED|Fourth Intervention Period||3
1089109|NCT01033487|2639204|P7|COMPLETED|Fourth Intervention Period||2
1089110|NCT01033487|2639205|P6|COMPLETED|Fourth Intervention Period||2
1089111|NCT01033487|2639206|P5|COMPLETED|Fourth Intervention Period||2
1089112|NCT01033487|2639207|P4|COMPLETED|Fourth Intervention Period||2
1089113|NCT01033487|2639208|P3|COMPLETED|Fourth Intervention Period||2
1089114|NCT01033487|2639209|P2|COMPLETED|Fourth Intervention Period||3
1089115|NCT01033487|2639210|P1|COMPLETED|Fourth Intervention Period||2
1089116|NCT01033487|2639201|P10|STARTED|Fourth Intervention Period||2
1089117|NCT01033487|2639202|P9|STARTED|Fourth Intervention Period||2
1089118|NCT01033487|2639203|P8|STARTED|Fourth Intervention Period||3
1089119|NCT01033487|2639204|P7|STARTED|Fourth Intervention Period||2
1089120|NCT01033487|2639205|P6|STARTED|Fourth Intervention Period||2
1089121|NCT01033487|2639206|P5|STARTED|Fourth Intervention Period||2
1089122|NCT01033487|2639207|P4|STARTED|Fourth Intervention Period||2
1089123|NCT01033487|2639208|P3|STARTED|Fourth Intervention Period||2
1089124|NCT01033487|2639209|P2|STARTED|Fourth Intervention Period||3
1089125|NCT01033487|2639210|P1|STARTED|Fourth Intervention Period||2
1089126|NCT01033487|2639201|P10|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
1089127|NCT01033487|2639202|P9|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
1089128|NCT01033487|2639203|P8|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
1089129|NCT01033487|2639204|P7|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
1089130|NCT01033487|2639205|P6|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
1089131|NCT01033487|2639206|P5|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
1089132|NCT01033487|2639207|P4|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
1089133|NCT01033487|2639208|P3|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
1089134|NCT01033487|2639209|P2|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
1089135|NCT01033487|2639210|P1|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
1089136|NCT01033487|2639201|P10|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
1089137|NCT01033487|2639202|P9|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
1089138|NCT01033487|2639203|P8|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
1089139|NCT01033487|2639204|P7|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
1089140|NCT01033487|2639205|P6|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
1089141|NCT01033487|2639206|P5|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
1089142|NCT01033487|2639207|P4|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
1089143|NCT01033487|2639208|P3|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
1089144|NCT01033487|2639209|P2|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
1089145|NCT01033487|2639210|P1|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
1089146|NCT01033487|2639201|P10|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
1089147|NCT01033487|2639202|P9|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
1089148|NCT01033487|2639203|P8|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
1089149|NCT01033487|2639204|P7|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
1089150|NCT01033487|2639205|P6|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
1089151|NCT01033487|2639206|P5|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
1089152|NCT01033487|2639207|P4|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
1089153|NCT01033487|2639208|P3|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
1089154|NCT01033487|2639209|P2|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
1089155|NCT01033487|2639210|P1|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
1089156|NCT01033487|2639201|P10|NOT COMPLETED|Third Intervention Period||0
1089157|NCT01033487|2639202|P9|NOT COMPLETED|Third Intervention Period||0
1089158|NCT01033487|2639203|P8|NOT COMPLETED|Third Intervention Period||0
1089159|NCT01033487|2639204|P7|NOT COMPLETED|Third Intervention Period||0
1089160|NCT01033487|2639205|P6|NOT COMPLETED|Third Intervention Period||0
1089161|NCT01033487|2639206|P5|NOT COMPLETED|Third Intervention Period||0
1089162|NCT01033487|2639207|P4|NOT COMPLETED|Third Intervention Period||0
1089163|NCT01033487|2639208|P3|NOT COMPLETED|Third Intervention Period||0
1089164|NCT01033487|2639209|P2|NOT COMPLETED|Third Intervention Period||0
1089165|NCT01033487|2639210|P1|NOT COMPLETED|Third Intervention Period||0
1089166|NCT01033487|2639201|P10|COMPLETED|Third Intervention Period||2
1089167|NCT01033487|2639202|P9|COMPLETED|Third Intervention Period||2
1089168|NCT01033487|2639203|P8|COMPLETED|Third Intervention Period||3
1089169|NCT01033487|2639204|P7|COMPLETED|Third Intervention Period||2
1089170|NCT01033487|2639205|P6|COMPLETED|Third Intervention Period||2
1089171|NCT01033487|2639206|P5|COMPLETED|Third Intervention Period||2
1089172|NCT01033487|2639207|P4|COMPLETED|Third Intervention Period||2
1089173|NCT01033487|2639208|P3|COMPLETED|Third Intervention Period||2
1089174|NCT01033487|2639209|P2|COMPLETED|Third Intervention Period||3
1089175|NCT01033487|2639210|P1|COMPLETED|Third Intervention Period||2
1089176|NCT01033487|2639201|P10|STARTED|Third Intervention Period||2
1089177|NCT01033487|2639202|P9|STARTED|Third Intervention Period||2
1089178|NCT01033487|2639203|P8|STARTED|Third Intervention Period||3
1089179|NCT01033487|2639204|P7|STARTED|Third Intervention Period||2
1089180|NCT01033487|2639205|P6|STARTED|Third Intervention Period||2
1089181|NCT01033487|2639206|P5|STARTED|Third Intervention Period||2
1089182|NCT01033487|2639207|P4|STARTED|Third Intervention Period||2
1089183|NCT01033487|2639208|P3|STARTED|Third Intervention Period||2
1089184|NCT01033487|2639209|P2|STARTED|Third Intervention Period||3
1089185|NCT01033487|2639210|P1|STARTED|Third Intervention Period||2
1089186|NCT01033487|2639201|P10|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
1089187|NCT01033487|2639202|P9|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
1089188|NCT01033487|2639203|P8|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
1089189|NCT01033487|2639204|P7|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
1089190|NCT01033487|2639205|P6|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
1089191|NCT01033487|2639206|P5|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
1089192|NCT01033487|2639207|P4|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
1089193|NCT01033487|2639208|P3|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
1089194|NCT01033487|2639209|P2|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
1089195|NCT01033487|2639210|P1|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
1089196|NCT01033487|2639201|P10|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
1089197|NCT01033487|2639202|P9|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
1089198|NCT01033487|2639203|P8|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
1089199|NCT01033487|2639204|P7|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
1089200|NCT01033487|2639205|P6|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
1089201|NCT01033487|2639206|P5|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
1089202|NCT01033487|2639207|P4|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
1089203|NCT01033487|2639208|P3|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
1089204|NCT01033487|2639209|P2|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
1089205|NCT01033487|2639210|P1|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
1089206|NCT01033487|2639201|P10|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
1089207|NCT01033487|2639202|P9|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
1089208|NCT01033487|2639203|P8|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
1089209|NCT01033487|2639204|P7|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
1089210|NCT01033487|2639205|P6|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
1089211|NCT01033487|2639206|P5|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
1089212|NCT01033487|2639207|P4|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
1089213|NCT01033487|2639208|P3|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
1089214|NCT01033487|2639209|P2|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
1089215|NCT01033487|2639210|P1|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
1089216|NCT01033487|2639201|P10|NOT COMPLETED|Second Intervention Period||0
1089217|NCT01033487|2639202|P9|NOT COMPLETED|Second Intervention Period||0
1089218|NCT01033487|2639203|P8|NOT COMPLETED|Second Intervention Period||0
1089219|NCT01033487|2639204|P7|NOT COMPLETED|Second Intervention Period||0
1089220|NCT01033487|2639205|P6|NOT COMPLETED|Second Intervention Period||0
1089221|NCT01033487|2639206|P5|NOT COMPLETED|Second Intervention Period||0
1089222|NCT01033487|2639207|P4|NOT COMPLETED|Second Intervention Period||0
1089223|NCT01033487|2639208|P3|NOT COMPLETED|Second Intervention Period||0
1089224|NCT01033487|2639209|P2|NOT COMPLETED|Second Intervention Period||0
1089225|NCT01033487|2639210|P1|NOT COMPLETED|Second Intervention Period||0
1089226|NCT01033487|2639201|P10|COMPLETED|Second Intervention Period||2
1089227|NCT01033487|2639202|P9|COMPLETED|Second Intervention Period||2
1089228|NCT01033487|2639203|P8|COMPLETED|Second Intervention Period||3
1089229|NCT01033487|2639204|P7|COMPLETED|Second Intervention Period||2
1089230|NCT01033487|2639205|P6|COMPLETED|Second Intervention Period||2
1089231|NCT01033487|2639206|P5|COMPLETED|Second Intervention Period||2
1089232|NCT01033487|2639207|P4|COMPLETED|Second Intervention Period||2
1089233|NCT01033487|2639208|P3|COMPLETED|Second Intervention Period||2
1089234|NCT01033487|2639209|P2|COMPLETED|Second Intervention Period||3
1089235|NCT01033487|2639210|P1|COMPLETED|Second Intervention Period||2
1089236|NCT01033487|2639201|P10|STARTED|Second Intervention Period||2
1089237|NCT01033487|2639202|P9|STARTED|Second Intervention Period||2
1089238|NCT01033487|2639203|P8|STARTED|Second Intervention Period||3
1089239|NCT01033487|2639204|P7|STARTED|Second Intervention Period||2
1089240|NCT01033487|2639205|P6|STARTED|Second Intervention Period||2
1089241|NCT01033487|2639206|P5|STARTED|Second Intervention Period||2
1089242|NCT01033487|2639207|P4|STARTED|Second Intervention Period||2
1089243|NCT01033487|2639208|P3|STARTED|Second Intervention Period||2
1089244|NCT01033487|2639209|P2|STARTED|Second Intervention Period||3
1089245|NCT01033487|2639210|P1|STARTED|Second Intervention Period||2
1089246|NCT01033487|2639201|P10|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
1089247|NCT01033487|2639202|P9|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
1089248|NCT01033487|2639203|P8|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
1089249|NCT01033487|2639204|P7|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
1089250|NCT01033487|2639205|P6|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
1089251|NCT01033487|2639206|P5|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
1089252|NCT01033487|2639207|P4|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
1089253|NCT01033487|2639208|P3|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
1089254|NCT01033487|2639209|P2|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
1089255|NCT01033487|2639210|P1|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
1089256|NCT01033487|2639201|P10|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
1089257|NCT01033487|2639202|P9|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
1089258|NCT01033487|2639203|P8|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
1089259|NCT01033487|2639204|P7|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
1089260|NCT01033487|2639205|P6|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
1089261|NCT01033487|2639206|P5|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
1089262|NCT01033487|2639207|P4|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
1089263|NCT01033487|2639208|P3|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
1089264|NCT01033487|2639209|P2|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
1089265|NCT01033487|2639210|P1|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
1089266|NCT01033487|2639201|P10|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
1089267|NCT01033487|2639202|P9|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
1089268|NCT01033487|2639203|P8|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
1089269|NCT01033487|2639204|P7|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
1089270|NCT01033487|2639205|P6|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
1089271|NCT01033487|2639206|P5|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
1089272|NCT01033487|2639207|P4|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
1089273|NCT01033487|2639208|P3|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
1089274|NCT01033487|2639209|P2|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
1089275|NCT01033487|2639210|P1|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
1089276|NCT01033487|2639201|P10|NOT COMPLETED|First Intervention Period||0
1089277|NCT01033487|2639202|P9|NOT COMPLETED|First Intervention Period||0
1089278|NCT01033487|2639203|P8|NOT COMPLETED|First Intervention Period||0
1089279|NCT01033487|2639204|P7|NOT COMPLETED|First Intervention Period||0
1089280|NCT01033487|2639205|P6|NOT COMPLETED|First Intervention Period||0
1089281|NCT01033487|2639206|P5|NOT COMPLETED|First Intervention Period||0
1089282|NCT01033487|2639207|P4|NOT COMPLETED|First Intervention Period||0
1089283|NCT01033487|2639208|P3|NOT COMPLETED|First Intervention Period||0
1089284|NCT01033487|2639209|P2|NOT COMPLETED|First Intervention Period||0
1089285|NCT01033487|2639210|P1|NOT COMPLETED|First Intervention Period||0
1089286|NCT01033487|2639201|P10|COMPLETED|First Intervention Period||2
1089287|NCT01033487|2639202|P9|COMPLETED|First Intervention Period||2
1089288|NCT01033487|2639203|P8|COMPLETED|First Intervention Period||3
1089289|NCT01033487|2639204|P7|COMPLETED|First Intervention Period||2
1089290|NCT01033487|2639205|P6|COMPLETED|First Intervention Period||2
1089291|NCT01033487|2639206|P5|COMPLETED|First Intervention Period||2
1089292|NCT01033487|2639207|P4|COMPLETED|First Intervention Period||2
1089293|NCT01033487|2639208|P3|COMPLETED|First Intervention Period||2
1089294|NCT01033487|2639209|P2|COMPLETED|First Intervention Period||3
1089295|NCT01033487|2639210|P1|COMPLETED|First Intervention Period||2
1089296|NCT01033487|2639201|P10|STARTED|First Intervention Period||2
1089297|NCT01033487|2639202|P9|STARTED|First Intervention Period||2
1089298|NCT01033487|2639203|P8|STARTED|First Intervention Period||3
1089299|NCT01033487|2639204|P7|STARTED|First Intervention Period||2
1089300|NCT01033487|2639205|P6|STARTED|First Intervention Period||2
1089301|NCT01033487|2639206|P5|STARTED|First Intervention Period||2
1089302|NCT01033487|2639207|P4|STARTED|First Intervention Period||2
1089303|NCT01033487|2639208|P3|STARTED|First Intervention Period||2
1089304|NCT01033487|2639209|P2|STARTED|First Intervention Period||3
1089305|NCT01033487|2639210|P1|STARTED|First Intervention Period||2
1089306|NCT01033565|2639264|P1|NOT COMPLETED|Overall Study||0
1089307|NCT01033565|2639264|P1|COMPLETED|Overall Study||1
1089308|NCT01033565|2639264|P1|STARTED|Overall Study||1
1089309|NCT01033734|2639268|P1|NOT COMPLETED|Overall Study||1
1089310|NCT01033734|2639268|P1|COMPLETED|Overall Study||7
1089311|NCT01033734|2639268|P1|STARTED|Overall Study||8
1089312|NCT01033747|2639322|P2|NOT COMPLETED|Overall Study||15
1089313|NCT01033747|2639323|P1|NOT COMPLETED|Overall Study||37
1089314|NCT01033747|2639322|P2|COMPLETED|Overall Study||4
1089315|NCT01033747|2639323|P1|COMPLETED|Overall Study||14
1089316|NCT01033747|2639322|P2|STARTED|Overall Study||19
1089317|NCT01033747|2639323|P1|STARTED|Overall Study||51
1089318|NCT01033825|2639338|P7|NOT COMPLETED|Overall Study||0
1089319|NCT01033825|2639339|P6|NOT COMPLETED|Overall Study||0
1089320|NCT01033825|2639340|P5|NOT COMPLETED|Overall Study||2
1089321|NCT01033825|2639341|P4|NOT COMPLETED|Overall Study||2
1089322|NCT01033825|2639342|P3|NOT COMPLETED|Overall Study||2
1089323|NCT01033825|2639343|P2|NOT COMPLETED|Overall Study||3
1089324|NCT01033825|2639344|P1|NOT COMPLETED|Overall Study||3
1089325|NCT01033825|2639338|P7|COMPLETED|Overall Study||18
1089326|NCT01033825|2639339|P6|COMPLETED|Overall Study||18
1089327|NCT01033825|2639340|P5|COMPLETED|Overall Study||56
1089328|NCT01033825|2639341|P4|COMPLETED|Overall Study||46
1089329|NCT01033825|2639342|P3|COMPLETED|Overall Study||55
1089330|NCT01033825|2639343|P2|COMPLETED|Overall Study||57
1089331|NCT01033825|2639344|P1|COMPLETED|Overall Study||48
1089332|NCT01033825|2639338|P7|STARTED|Overall Study||18
1089333|NCT01033825|2639339|P6|STARTED|Overall Study||18
1089334|NCT01033825|2639340|P5|STARTED|Overall Study||58
1089335|NCT01033825|2639341|P4|STARTED|Overall Study||48
1089336|NCT01033825|2639342|P3|STARTED|Overall Study||57
1089337|NCT01033825|2639343|P2|STARTED|Overall Study||60
1089338|NCT01033825|2639344|P1|STARTED|Overall Study||51
1089339|NCT01033851|2639565|P2|NOT COMPLETED|Overall Study||7
1089340|NCT01033851|2639566|P1|NOT COMPLETED|Overall Study||3
1089341|NCT01033851|2639565|P2|COMPLETED|Overall Study||34
1089342|NCT01033851|2639566|P1|COMPLETED|Overall Study||45
1089343|NCT01033851|2639565|P2|STARTED|Overall Study||41
1089344|NCT01033851|2639566|P1|STARTED|Overall Study||48
1089345|NCT01033864|2639576|P2|NOT COMPLETED|Overall Study||0
1089346|NCT01033864|2639577|P1|NOT COMPLETED|Overall Study||0
1089347|NCT01033864|2639576|P2|COMPLETED|Overall Study||11
1089348|NCT01033864|2639577|P1|COMPLETED|Overall Study||12
1089349|NCT01033864|2639576|P2|STARTED|Overall Study||11
1089350|NCT01033864|2639577|P1|STARTED|Overall Study||12
1089351|NCT01033942|2639603|P3|NOT COMPLETED|Overall Study||1
1089352|NCT01033942|2639604|P2|NOT COMPLETED|Overall Study||4
1089353|NCT01033942|2639605|P1|NOT COMPLETED|Overall Study||2
1089354|NCT01033942|2639603|P3|COMPLETED|Overall Study||18
1089355|NCT01033942|2639604|P2|COMPLETED|Overall Study||15
1089356|NCT01033942|2639605|P1|COMPLETED|Overall Study||18
1089357|NCT01033942|2639603|P3|STARTED|Overall Study||19
1089358|NCT01033942|2639604|P2|STARTED|Overall Study||19
1089359|NCT01033942|2639605|P1|STARTED|Overall Study||20
1089360|NCT01034111|2639875|P1|NOT COMPLETED|Overall Study||0
1089361|NCT01034111|2639875|P1|COMPLETED|Overall Study||30
1089362|NCT01034111|2639875|P1|STARTED|Overall Study||30
1089363|NCT01034137|2639883|P3|NOT COMPLETED|Overall Study||30
1089364|NCT01034137|2639884|P2|NOT COMPLETED|Overall Study||22
1089365|NCT01034137|2639885|P1|NOT COMPLETED|Overall Study||28
1089366|NCT01034137|2639883|P3|COMPLETED|Overall Study||78
1089367|NCT01034137|2639884|P2|COMPLETED|Overall Study||81
1089368|NCT01034137|2639885|P1|COMPLETED|Overall Study||78
1089369|NCT01034137|2639883|P3|STARTED|Overall Study||108
1089370|NCT01034137|2639884|P2|STARTED|Overall Study||103
1089371|NCT01034137|2639885|P1|STARTED|Overall Study||106
1089372|NCT01034163|2640018|P2|NOT COMPLETED|Overall Study||14
1089373|NCT01034163|2640019|P1|NOT COMPLETED|Overall Study||27
1089374|NCT01034163|2640018|P2|COMPLETED|Overall Study||0
1089375|NCT01034163|2640019|P1|COMPLETED|Overall Study||0
1089376|NCT01034163|2640018|P2|In Open Label Phase After Unblinding|Overall Study||0
1089377|NCT01034163|2640019|P1|In Open Label Phase After Unblinding|Overall Study||5
1089378|NCT01034163|2640018|P2|Safety Set|Overall Study||12
1089379|NCT01034163|2640019|P1|Safety Set|Overall Study||26
1089380|NCT01034163|2640018|P2|Untreated (Not in Safety Set)|Overall Study||2
1089381|NCT01034163|2640019|P1|Untreated (Not in Safety Set)|Overall Study||1
1089382|NCT01034163|2640018|P2|STARTED|Overall Study||14
1089383|NCT01034163|2640019|P1|STARTED|Overall Study||27
1089384|NCT01034176|2640027|P2|NOT COMPLETED|Overall Study||2
1089385|NCT01034176|2640028|P1|NOT COMPLETED|Overall Study||2
1089386|NCT01034176|2640027|P2|COMPLETED|Overall Study||19
1089387|NCT01034176|2640028|P1|COMPLETED|Overall Study||20
1089388|NCT01034176|2640027|P2|STARTED|Overall Study||21
1089389|NCT01034176|2640028|P1|STARTED|Overall Study||22
1089390|NCT01034306|2640038|P2|NOT COMPLETED|Overall Study||3
1089391|NCT01034306|2640039|P1|NOT COMPLETED|Overall Study||5
1089392|NCT01034306|2640038|P2|COMPLETED|Overall Study||34
1089393|NCT01034306|2640039|P1|COMPLETED|Overall Study||37
1089394|NCT01034306|2640038|P2|STARTED|Overall Study||37
1089395|NCT01034306|2640039|P1|STARTED|Overall Study||42
1089396|NCT01034358|2640045|P1|NOT COMPLETED|Overall Study||2
1089397|NCT01034358|2640045|P1|COMPLETED|Overall Study|One patient was found after enrollment to have already received one prior dose of the HPV vaccine.|13
1089398|NCT01034358|2640045|P1|STARTED|Overall Study||15
1089399|NCT01034397|2640051|P2|NOT COMPLETED|Overall Study||2
1089400|NCT01034397|2640052|P1|NOT COMPLETED|Overall Study||7
1089401|NCT01034397|2640051|P2|COMPLETED|Overall Study||17
1089402|NCT01034397|2640052|P1|COMPLETED|Overall Study||28
1089403|NCT01034397|2640051|P2|STARTED|Overall Study||19
1089404|NCT01034397|2640052|P1|STARTED|Overall Study||35
1089405|NCT01034462|2640203|P2|NOT COMPLETED|Overall Study||54
1089406|NCT01034462|2640204|P1|NOT COMPLETED|Overall Study||45
1089407|NCT01034462|2640203|P2|COMPLETED|Overall Study||163
1089408|NCT01034462|2640204|P1|COMPLETED|Overall Study||172
1089409|NCT01034462|2640203|P2|STARTED|Overall Study||217
1089410|NCT01034462|2640204|P1|STARTED|Overall Study||217
1089411|NCT01034540|2640214|P2|NOT COMPLETED|Overall Study||1
1089412|NCT01034540|2640215|P1|NOT COMPLETED|Overall Study||0
1089413|NCT01034540|2640214|P2|COMPLETED|Overall Study||11
1089414|NCT01034540|2640215|P1|COMPLETED|Overall Study||11
1089415|NCT01034540|2640214|P2|Completed 1st Treatment Intervention|Overall Study||11
1089416|NCT01034540|2640215|P1|Completed 1st Treatment Intervention|Overall Study||11
1089417|NCT01034540|2640214|P2|STARTED|Overall Study||12
1089418|NCT01034540|2640215|P1|STARTED|Overall Study||11
1089419|NCT01034553|2640223|P6|NOT COMPLETED|Overall Study||0
1089420|NCT01034553|2640224|P5|NOT COMPLETED|Overall Study||0
1089421|NCT01034553|2640225|P4|NOT COMPLETED|Overall Study||0
1089422|NCT01034553|2640226|P3|NOT COMPLETED|Overall Study||0
1089423|NCT01034553|2640227|P2|NOT COMPLETED|Overall Study||0
1089424|NCT01034553|2640228|P1|NOT COMPLETED|Overall Study||0
1089425|NCT01034553|2640223|P6|COMPLETED|Overall Study||7
1089426|NCT01034553|2640224|P5|COMPLETED|Overall Study||6
1089427|NCT01034553|2640225|P4|COMPLETED|Overall Study||3
1089428|NCT01034553|2640226|P3|COMPLETED|Overall Study||3
1089429|NCT01034553|2640227|P2|COMPLETED|Overall Study||4
1089430|NCT01034553|2640228|P1|COMPLETED|Overall Study||3
1089431|NCT01034553|2640223|P6|STARTED|Overall Study||7
1089432|NCT01034553|2640224|P5|STARTED|Overall Study||6
1089433|NCT01034553|2640225|P4|STARTED|Overall Study||3
1089434|NCT01034553|2640226|P3|STARTED|Overall Study||3
1089435|NCT01034553|2640227|P2|STARTED|Overall Study||4
1089436|NCT01034553|2640228|P1|STARTED|Overall Study||3
1089437|NCT01034579|2640244|P2|NOT COMPLETED|Overall Study||0
1089438|NCT01034579|2640245|P1|NOT COMPLETED|Overall Study||0
1089439|NCT01034579|2640244|P2|COMPLETED|Overall Study||166
1089440|NCT01034579|2640245|P1|COMPLETED|Overall Study||158
1089441|NCT01034579|2640244|P2|STARTED|Overall Study||166
1089442|NCT01034579|2640245|P1|STARTED|Overall Study||158
1089443|NCT01034592|2640259|P1|NOT COMPLETED|Overall Study||0
1089444|NCT01034592|2640259|P1|COMPLETED|Overall Study||2
1089445|NCT01034592|2640259|P1|STARTED|Overall Study||2
1089446|NCT01034631|2640272|P3|NOT COMPLETED|Phase II||2
1089447|NCT01034631|2640273|P2|NOT COMPLETED|Phase II||1
1089448|NCT01034631|2640274|P1|NOT COMPLETED|Phase II||0
1089449|NCT01034631|2640272|P3|COMPLETED|Phase II||67
1089450|NCT01034631|2640273|P2|COMPLETED|Phase II||69
1089451|NCT01034631|2640274|P1|COMPLETED|Phase II||0
1089452|NCT01034631|2640272|P3|STARTED|Phase II||69
1089453|NCT01034631|2640273|P2|STARTED|Phase II||70
1089454|NCT01034631|2640274|P1|STARTED|Phase II|No Phase I Participants were enrolled during this time period.|0
1089455|NCT01034631|2640272|P3|NOT COMPLETED|Phase I||0
1089456|NCT01034631|2640273|P2|NOT COMPLETED|Phase I||0
1089457|NCT01034631|2640274|P1|NOT COMPLETED|Phase I||3
1089458|NCT01034631|2640272|P3|COMPLETED|Phase I||0
1089459|NCT01034631|2640273|P2|COMPLETED|Phase I||0
1089460|NCT01034631|2640274|P1|COMPLETED|Phase I||12
1089461|NCT01034631|2640272|P3|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
1089462|NCT01034631|2640273|P2|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
1089463|NCT01034631|2640274|P1|STARTED|Phase I||15
1089464|NCT01034657|2640293|P3|NOT COMPLETED|Randomized Phase||1
1089465|NCT01034657|2640294|P2|NOT COMPLETED|Randomized Phase||6
1089466|NCT01034657|2640295|P1|NOT COMPLETED|Randomized Phase||5
1089467|NCT01034657|2640293|P3|COMPLETED|Randomized Phase||0
1089468|NCT01034657|2640294|P2|COMPLETED|Randomized Phase||0
1089469|NCT01034657|2640295|P1|COMPLETED|Randomized Phase||1
1089470|NCT01034657|2640293|P3|STARTED|Randomized Phase||1
1089471|NCT01034657|2640294|P2|STARTED|Randomized Phase||6
1089472|NCT01034657|2640295|P1|STARTED|Randomized Phase||6
1089473|NCT01034657|2640293|P3|NOT COMPLETED|Core Phase||0
1089474|NCT01034657|2640294|P2|NOT COMPLETED|Core Phase||0
1089475|NCT01034657|2640295|P1|NOT COMPLETED|Core Phase||14
1089476|NCT01034657|2640293|P3|COMPLETED|Core Phase||0
1089477|NCT01034657|2640294|P2|COMPLETED|Core Phase||0
1089478|NCT01034657|2640295|P1|COMPLETED|Core Phase||20
1089479|NCT01034657|2640293|P3|STARTED|Core Phase||0
1089480|NCT01034657|2640294|P2|STARTED|Core Phase||0
1089481|NCT01034657|2640295|P1|STARTED|Core Phase||34
1089482|NCT01034709|2640335|P2|NOT COMPLETED|Overall Study||16
1089483|NCT01034709|2640336|P1|NOT COMPLETED|Overall Study||9
1089484|NCT01034709|2640335|P2|COMPLETED|Overall Study||42
1089485|NCT01034709|2640336|P1|COMPLETED|Overall Study||44
1089486|NCT01034709|2640335|P2|STARTED|Overall Study||58
1089487|NCT01034709|2640336|P1|STARTED|Overall Study||53
1089488|NCT01035047|2640344|P2|NOT COMPLETED|Overall Study||0
1089489|NCT01035047|2640345|P1|NOT COMPLETED|Overall Study||0
1089490|NCT01035047|2640344|P2|COMPLETED|Overall Study||53
1089491|NCT01035047|2640345|P1|COMPLETED|Overall Study||52
1089492|NCT01035047|2640344|P2|STARTED|Overall Study||53
1089493|NCT01035047|2640345|P1|STARTED|Overall Study||52
1089494|NCT01035060|2640361|P2|NOT COMPLETED|Overall Study||14
1089495|NCT01035060|2640362|P1|NOT COMPLETED|Overall Study||24
1089496|NCT01035060|2640361|P2|COMPLETED|Overall Study||15
1089497|NCT01035060|2640362|P1|COMPLETED|Overall Study||15
1089498|NCT01035060|2640361|P2|STARTED|Overall Study||29
1089499|NCT01035060|2640362|P1|STARTED|Overall Study||39
1089500|NCT01035138|2640371|P3|NOT COMPLETED|Overall Study||47
1089501|NCT01035138|2640372|P2|NOT COMPLETED|Overall Study||60
1089502|NCT01035138|2640373|P1|NOT COMPLETED|Overall Study||73
1089503|NCT01035138|2640371|P3|COMPLETED|Overall Study||0
1089504|NCT01035138|2640372|P2|COMPLETED|Overall Study||0
1089505|NCT01035138|2640373|P1|COMPLETED|Overall Study||0
1089506|NCT01035138|2640371|P3|STARTED|Overall Study||47
1089507|NCT01035138|2640372|P2|STARTED|Overall Study||60
1089508|NCT01035138|2640373|P1|STARTED|Overall Study||73
1089509|NCT01035229|2640429|P2|NOT COMPLETED|Overall Study||184
1089510|NCT01035229|2640430|P1|NOT COMPLETED|Overall Study||362
1089511|NCT01035229|2640429|P2|COMPLETED|Overall Study||0
1089512|NCT01035229|2640430|P1|COMPLETED|Overall Study||0
1089513|NCT01035229|2640429|P2|STARTED|Overall Study||184
1089514|NCT01035229|2640430|P1|STARTED|Overall Study||362
1089515|NCT01035255|2640450|P2|NOT COMPLETED|Overall Study||862
1089516|NCT01035255|2640451|P1|NOT COMPLETED|Overall Study||741
1089517|NCT01035255|2640450|P2|COMPLETED|Overall Study||3371
1089518|NCT01035255|2640451|P1|COMPLETED|Overall Study||3468
1089519|NCT01035255|2640450|P2|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4212
1089520|NCT01035255|2640451|P1|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4187
1089521|NCT01035255|2640450|P2|Mis-randomized|Overall Study||2
1089522|NCT01035255|2640451|P1|Mis-randomized|Overall Study||4
1089523|NCT01035255|2640450|P2|GCP Violations|Overall Study||19
1089524|NCT01035255|2640451|P1|GCP Violations|Overall Study||18
1089525|NCT01035255|2640450|P2|STARTED|Overall Study||4233
1089526|NCT01035255|2640451|P1|STARTED|Overall Study||4209
1089527|NCT01035333|2640467|P1|NOT COMPLETED|Overall Study||10
1089528|NCT01035333|2640467|P1|COMPLETED|Overall Study||9
1089529|NCT01035333|2640467|P1|STARTED|Overall Study||19
1089530|NCT01035346|2640474|P2|NOT COMPLETED|Overall Study||0
1089531|NCT01035346|2640475|P1|NOT COMPLETED|Overall Study||0
1089532|NCT01035346|2640474|P2|COMPLETED|Overall Study||9
1089533|NCT01035346|2640475|P1|COMPLETED|Overall Study||7
1089534|NCT01035346|2640474|P2|STARTED|Overall Study||9
1089535|NCT01035346|2640475|P1|STARTED|Overall Study||7
1089536|NCT01035658|2640497|P4|NOT COMPLETED|Overall Study||0
1089537|NCT01035658|2640498|P3|NOT COMPLETED|Overall Study||0
1089538|NCT01035658|2640499|P2|NOT COMPLETED|Overall Study||0
1089539|NCT01035658|2640500|P1|NOT COMPLETED|Overall Study||0
1089540|NCT01035658|2640497|P4|COMPLETED|Overall Study||6
1089541|NCT01035658|2640498|P3|COMPLETED|Overall Study||3
1089542|NCT01035658|2640499|P2|COMPLETED|Overall Study||8
1089543|NCT01035658|2640500|P1|COMPLETED|Overall Study||5
1089544|NCT01035658|2640497|P4|STARTED|Overall Study||6
1089545|NCT01035658|2640498|P3|STARTED|Overall Study||3
1089546|NCT01035658|2640499|P2|STARTED|Overall Study||8
1089547|NCT01035658|2640500|P1|STARTED|Overall Study||5
1089548|NCT01035749|2640527|P4|NOT COMPLETED|Overall Study||0
1089549|NCT01035749|2640528|P3|NOT COMPLETED|Overall Study||0
1089550|NCT01035749|2640529|P2|NOT COMPLETED|Overall Study||0
1089551|NCT01035749|2640530|P1|NOT COMPLETED|Overall Study||0
1089552|NCT01035749|2640527|P4|COMPLETED|Overall Study||110
1089553|NCT01035749|2640528|P3|COMPLETED|Overall Study||68
1089554|NCT01035749|2640529|P2|COMPLETED|Overall Study||66
1089555|NCT01035749|2640530|P1|COMPLETED|Overall Study||66
1089556|NCT01035749|2640527|P4|STARTED|Overall Study||110
1089557|NCT01035749|2640528|P3|STARTED|Overall Study||68
1089558|NCT01035749|2640529|P2|STARTED|Overall Study||66
1089559|NCT01035749|2640530|P1|STARTED|Overall Study||66
1089560|NCT01035788|2640650|P2|NOT COMPLETED|Overall Study||14
1089561|NCT01035788|2640651|P1|NOT COMPLETED|Overall Study||6
1089562|NCT01035788|2640650|P2|COMPLETED|Overall Study||9
1089563|NCT01035788|2640651|P1|COMPLETED|Overall Study||17
1089564|NCT01035788|2640650|P2|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
1089565|NCT01035788|2640651|P1|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
1089566|NCT01035905|2640659|P2|NOT COMPLETED|Overall Study||1
1089567|NCT01035905|2640660|P1|NOT COMPLETED|Overall Study||1
1089568|NCT01035905|2640659|P2|COMPLETED|Overall Study||30
1089569|NCT01035905|2640660|P1|COMPLETED|Overall Study||31
1089570|NCT01035905|2640659|P2|STARTED|Overall Study||31
1089571|NCT01035905|2640660|P1|STARTED|Overall Study||32
1089572|NCT01035944|2640670|P4|NOT COMPLETED|Overall Study||0
1089573|NCT01035944|2640671|P3|NOT COMPLETED|Overall Study||1
1089574|NCT01035944|2640672|P2|NOT COMPLETED|Overall Study||1
1089575|NCT01035944|2640673|P1|NOT COMPLETED|Overall Study||3
1089576|NCT01035944|2640670|P4|COMPLETED|Overall Study||4
1089577|NCT01035944|2640671|P3|COMPLETED|Overall Study||4
1089578|NCT01035944|2640672|P2|COMPLETED|Overall Study||13
1089579|NCT01035944|2640673|P1|COMPLETED|Overall Study||11
1089580|NCT01035944|2640670|P4|STARTED|Overall Study||4
1089581|NCT01035944|2640671|P3|STARTED|Overall Study||5
1089582|NCT01035944|2640672|P2|STARTED|Overall Study||14
1089583|NCT01035944|2640673|P1|STARTED|Overall Study||14
1089584|NCT01020019|2640685|P2|NOT COMPLETED|Overall Study||29
1089585|NCT01020019|2640686|P1|NOT COMPLETED|Overall Study||26
1089586|NCT01020019|2640685|P2|COMPLETED|Overall Study||32
1089587|NCT01020019|2640686|P1|COMPLETED|Overall Study||35
1089588|NCT01020019|2640685|P2|STARTED|Overall Study||61
1089589|NCT01020019|2640686|P1|STARTED|Overall Study||61
1089590|NCT01025492|2640692|P1|NOT COMPLETED|Overall Study||0
1089591|NCT01025492|2640692|P1|COMPLETED|Overall Study||24
1089592|NCT01025492|2640692|P1|STARTED|Overall Study||24
1089593|NCT01025635|2640698|P2|NOT COMPLETED|Overall Study||25
1089594|NCT01025635|2640699|P1|NOT COMPLETED|Overall Study||23
1089595|NCT01025635|2640698|P2|COMPLETED|Overall Study||178
1089596|NCT01025635|2640699|P1|COMPLETED|Overall Study||175
1089597|NCT01025635|2640698|P2|STARTED|Overall Study||203
1089598|NCT01025635|2640699|P1|STARTED|Overall Study||198
1089599|NCT01025817|2640713|P2|NOT COMPLETED|Completed Study||22
1089600|NCT01025817|2640714|P1|NOT COMPLETED|Completed Study||16
1089601|NCT01025817|2640713|P2|COMPLETED|Completed Study|Completed study phase|282
1089602|NCT01025817|2640714|P1|COMPLETED|Completed Study|Completed study phase|293
1089603|NCT01025817|2640713|P2|STARTED|Completed Study||304
1089604|NCT01025817|2640714|P1|STARTED|Completed Study||309
1089605|NCT01025817|2640713|P2|NOT COMPLETED|Completed Study Medication||72
1089606|NCT01025817|2640714|P1|NOT COMPLETED|Completed Study Medication||105
1089607|NCT01025817|2640713|P2|COMPLETED|Completed Study Medication||232
1089608|NCT01025817|2640714|P1|COMPLETED|Completed Study Medication||204
1089609|NCT01025817|2640713|P2|STARTED|Completed Study Medication||304
1089610|NCT01025817|2640714|P1|STARTED|Completed Study Medication||309
1089611|NCT01025830|2640732|P2|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
1089612|NCT01025830|2640733|P1|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
1089613|NCT01025830|2640732|P2|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
1089614|NCT01025830|2640733|P1|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
1089615|NCT01025830|2640732|P2|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
1089616|NCT01025830|2640733|P1|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
1089617|NCT01025830|2640732|P2|NOT COMPLETED|Washout Period of 30 Days||0
1089618|NCT01025830|2640733|P1|NOT COMPLETED|Washout Period of 30 Days||0
1089619|NCT01025830|2640732|P2|COMPLETED|Washout Period of 30 Days||12
1089620|NCT01025830|2640733|P1|COMPLETED|Washout Period of 30 Days||8
1089621|NCT01025830|2640732|P2|STARTED|Washout Period of 30 Days||12
1089622|NCT01025830|2640733|P1|STARTED|Washout Period of 30 Days||8
1089623|NCT01025830|2640732|P2|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
1089624|NCT01025830|2640733|P1|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
1089625|NCT01025830|2640732|P2|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
1089626|NCT01025830|2640733|P1|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
1089627|NCT01025830|2640732|P2|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
1089628|NCT01025830|2640733|P1|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
1089629|NCT01025843|2640760|P10|NOT COMPLETED|Period 5||0
1089630|NCT01025843|2640761|P9|NOT COMPLETED|Period 5||0
1089631|NCT01025843|2640762|P8|NOT COMPLETED|Period 5||0
1089632|NCT01025843|2640763|P7|NOT COMPLETED|Period 5||0
1089633|NCT01025843|2640764|P6|NOT COMPLETED|Period 5||0
1089634|NCT01025843|2640765|P5|NOT COMPLETED|Period 5||0
1089635|NCT01025843|2640766|P4|NOT COMPLETED|Period 5||0
1089636|NCT01025843|2640767|P3|NOT COMPLETED|Period 5||0
1089637|NCT01025843|2640768|P2|NOT COMPLETED|Period 5||0
1089638|NCT01025843|2640769|P1|NOT COMPLETED|Period 5||0
1089639|NCT01025843|2640760|P10|COMPLETED|Period 5||2
1089640|NCT01025843|2640761|P9|COMPLETED|Period 5||2
1089641|NCT01025843|2640762|P8|COMPLETED|Period 5||2
1089642|NCT01025843|2640763|P7|COMPLETED|Period 5||2
1089643|NCT01025843|2640764|P6|COMPLETED|Period 5||2
1089644|NCT01025843|2640765|P5|COMPLETED|Period 5||2
1089645|NCT01025843|2640766|P4|COMPLETED|Period 5||1
1089646|NCT01025843|2640767|P3|COMPLETED|Period 5||1
1089647|NCT01025843|2640768|P2|COMPLETED|Period 5||2
1089648|NCT01025843|2640769|P1|COMPLETED|Period 5||2
1089649|NCT01025843|2640760|P10|STARTED|Period 5||2
1089650|NCT01025843|2640761|P9|STARTED|Period 5||2
1089651|NCT01025843|2640762|P8|STARTED|Period 5||2
1089652|NCT01025843|2640763|P7|STARTED|Period 5||2
1089653|NCT01025843|2640764|P6|STARTED|Period 5||2
1089654|NCT01025843|2640765|P5|STARTED|Period 5||2
1089655|NCT01025843|2640766|P4|STARTED|Period 5||1
1089656|NCT01025843|2640767|P3|STARTED|Period 5||1
1089657|NCT01025843|2640768|P2|STARTED|Period 5||2
1089658|NCT01025843|2640769|P1|STARTED|Period 5||2
1089659|NCT01025843|2640760|P10|NOT COMPLETED|Washout 4||0
1089660|NCT01025843|2640761|P9|NOT COMPLETED|Washout 4||0
1089661|NCT01025843|2640762|P8|NOT COMPLETED|Washout 4||0
1089662|NCT01025843|2640763|P7|NOT COMPLETED|Washout 4||0
1089663|NCT01025843|2640764|P6|NOT COMPLETED|Washout 4||0
1089664|NCT01025843|2640765|P5|NOT COMPLETED|Washout 4||0
1089665|NCT01025843|2640766|P4|NOT COMPLETED|Washout 4||1
1089666|NCT01025843|2640767|P3|NOT COMPLETED|Washout 4||1
1089667|NCT01025843|2640768|P2|NOT COMPLETED|Washout 4||0
1089668|NCT01025843|2640769|P1|NOT COMPLETED|Washout 4||0
1089669|NCT01025843|2640760|P10|COMPLETED|Washout 4||2
1089670|NCT01025843|2640761|P9|COMPLETED|Washout 4||2
1089671|NCT01025843|2640762|P8|COMPLETED|Washout 4||2
1089672|NCT01025843|2640763|P7|COMPLETED|Washout 4||2
1089673|NCT01025843|2640764|P6|COMPLETED|Washout 4||2
1089674|NCT01025843|2640765|P5|COMPLETED|Washout 4||2
1089675|NCT01025843|2640766|P4|COMPLETED|Washout 4||1
1089676|NCT01025843|2640767|P3|COMPLETED|Washout 4||1
1089677|NCT01025843|2640768|P2|COMPLETED|Washout 4||2
1089678|NCT01025843|2640769|P1|COMPLETED|Washout 4||2
1089679|NCT01025843|2640760|P10|STARTED|Washout 4||2
1089680|NCT01025843|2640761|P9|STARTED|Washout 4||2
1089681|NCT01025843|2640762|P8|STARTED|Washout 4||2
1089682|NCT01025843|2640763|P7|STARTED|Washout 4||2
1089683|NCT01025843|2640764|P6|STARTED|Washout 4||2
1089684|NCT01025843|2640765|P5|STARTED|Washout 4||2
1089685|NCT01025843|2640766|P4|STARTED|Washout 4||2
1089686|NCT01025843|2640767|P3|STARTED|Washout 4||2
1089687|NCT01025843|2640768|P2|STARTED|Washout 4||2
1089688|NCT01025843|2640769|P1|STARTED|Washout 4||2
1089689|NCT01025843|2640760|P10|NOT COMPLETED|Period 4||0
1089690|NCT01025843|2640761|P9|NOT COMPLETED|Period 4||0
1089691|NCT01025843|2640762|P8|NOT COMPLETED|Period 4||0
1089692|NCT01025843|2640763|P7|NOT COMPLETED|Period 4||0
1089693|NCT01025843|2640764|P6|NOT COMPLETED|Period 4||0
1089694|NCT01025843|2640765|P5|NOT COMPLETED|Period 4||0
1089695|NCT01025843|2640766|P4|NOT COMPLETED|Period 4||0
1089696|NCT01025843|2640767|P3|NOT COMPLETED|Period 4||0
1089697|NCT01025843|2640768|P2|NOT COMPLETED|Period 4||0
1089698|NCT01025843|2640769|P1|NOT COMPLETED|Period 4||0
1089699|NCT01025843|2640760|P10|COMPLETED|Period 4||2
1089700|NCT01025843|2640761|P9|COMPLETED|Period 4||2
1089701|NCT01025843|2640762|P8|COMPLETED|Period 4||2
1089702|NCT01025843|2640763|P7|COMPLETED|Period 4||2
1089703|NCT01025843|2640764|P6|COMPLETED|Period 4||2
1089704|NCT01025843|2640765|P5|COMPLETED|Period 4||2
1089705|NCT01025843|2640766|P4|COMPLETED|Period 4||2
1089706|NCT01025843|2640767|P3|COMPLETED|Period 4||2
1089707|NCT01025843|2640768|P2|COMPLETED|Period 4||2
1089708|NCT01025843|2640769|P1|COMPLETED|Period 4||2
1089709|NCT01025843|2640760|P10|STARTED|Period 4||2
1089710|NCT01025843|2640761|P9|STARTED|Period 4||2
1089711|NCT01025843|2640762|P8|STARTED|Period 4||2
1089712|NCT01025843|2640763|P7|STARTED|Period 4||2
1089713|NCT01025843|2640764|P6|STARTED|Period 4||2
1089714|NCT01025843|2640765|P5|STARTED|Period 4||2
1089715|NCT01025843|2640766|P4|STARTED|Period 4||2
1089716|NCT01025843|2640767|P3|STARTED|Period 4||2
1089717|NCT01025843|2640768|P2|STARTED|Period 4||2
1089718|NCT01025843|2640769|P1|STARTED|Period 4||2
1089719|NCT01025843|2640760|P10|NOT COMPLETED|Washout 3||0
1089720|NCT01025843|2640761|P9|NOT COMPLETED|Washout 3||0
1089721|NCT01025843|2640762|P8|NOT COMPLETED|Washout 3||0
1089722|NCT01025843|2640763|P7|NOT COMPLETED|Washout 3||0
1089723|NCT01025843|2640764|P6|NOT COMPLETED|Washout 3||0
1089724|NCT01025843|2640765|P5|NOT COMPLETED|Washout 3||0
1089725|NCT01025843|2640766|P4|NOT COMPLETED|Washout 3||0
1089726|NCT01025843|2640767|P3|NOT COMPLETED|Washout 3||0
1089727|NCT01025843|2640768|P2|NOT COMPLETED|Washout 3||0
1089728|NCT01025843|2640769|P1|NOT COMPLETED|Washout 3||0
1089729|NCT01025843|2640760|P10|COMPLETED|Washout 3||2
1089730|NCT01025843|2640761|P9|COMPLETED|Washout 3||2
1089731|NCT01025843|2640762|P8|COMPLETED|Washout 3||2
1089732|NCT01025843|2640763|P7|COMPLETED|Washout 3||2
1089733|NCT01025843|2640764|P6|COMPLETED|Washout 3||2
1089734|NCT01025843|2640765|P5|COMPLETED|Washout 3||2
1089735|NCT01025843|2640766|P4|COMPLETED|Washout 3||2
1089736|NCT01025843|2640767|P3|COMPLETED|Washout 3||2
1089737|NCT01025843|2640768|P2|COMPLETED|Washout 3||2
1089738|NCT01025843|2640769|P1|COMPLETED|Washout 3||2
1089739|NCT01025843|2640760|P10|STARTED|Washout 3||2
1089740|NCT01025843|2640761|P9|STARTED|Washout 3||2
1089741|NCT01025843|2640762|P8|STARTED|Washout 3||2
1089742|NCT01025843|2640763|P7|STARTED|Washout 3||2
1089743|NCT01025843|2640764|P6|STARTED|Washout 3||2
1089744|NCT01025843|2640765|P5|STARTED|Washout 3||2
1089745|NCT01025843|2640766|P4|STARTED|Washout 3||2
1089746|NCT01025843|2640767|P3|STARTED|Washout 3||2
1089747|NCT01025843|2640768|P2|STARTED|Washout 3||2
1089748|NCT01025843|2640769|P1|STARTED|Washout 3||2
1089749|NCT01025843|2640760|P10|NOT COMPLETED|Period 3||0
1089750|NCT01025843|2640761|P9|NOT COMPLETED|Period 3||0
1089751|NCT01025843|2640762|P8|NOT COMPLETED|Period 3||0
1089752|NCT01025843|2640763|P7|NOT COMPLETED|Period 3||0
1089753|NCT01025843|2640764|P6|NOT COMPLETED|Period 3||0
1089754|NCT01025843|2640765|P5|NOT COMPLETED|Period 3||0
1089755|NCT01025843|2640766|P4|NOT COMPLETED|Period 3||0
1089756|NCT01025843|2640767|P3|NOT COMPLETED|Period 3||0
1089757|NCT01025843|2640768|P2|NOT COMPLETED|Period 3||0
1089758|NCT01025843|2640769|P1|NOT COMPLETED|Period 3||0
1089759|NCT01025843|2640760|P10|COMPLETED|Period 3||2
1089760|NCT01025843|2640761|P9|COMPLETED|Period 3||2
1089761|NCT01025843|2640762|P8|COMPLETED|Period 3||2
1089762|NCT01025843|2640763|P7|COMPLETED|Period 3||2
1089763|NCT01025843|2640764|P6|COMPLETED|Period 3||2
1089764|NCT01025843|2640765|P5|COMPLETED|Period 3||2
1089765|NCT01025843|2640766|P4|COMPLETED|Period 3||2
1089766|NCT01025843|2640767|P3|COMPLETED|Period 3||2
1089767|NCT01025843|2640768|P2|COMPLETED|Period 3||2
1089768|NCT01025843|2640769|P1|COMPLETED|Period 3||2
1089769|NCT01025843|2640760|P10|STARTED|Period 3||2
1089770|NCT01025843|2640761|P9|STARTED|Period 3||2
1089771|NCT01025843|2640762|P8|STARTED|Period 3||2
1089772|NCT01025843|2640763|P7|STARTED|Period 3||2
1089773|NCT01025843|2640764|P6|STARTED|Period 3||2
1089774|NCT01025843|2640765|P5|STARTED|Period 3||2
1089775|NCT01025843|2640766|P4|STARTED|Period 3||2
1089776|NCT01025843|2640767|P3|STARTED|Period 3||2
1089777|NCT01025843|2640768|P2|STARTED|Period 3||2
1089778|NCT01025843|2640769|P1|STARTED|Period 3||2
1089779|NCT01025843|2640760|P10|NOT COMPLETED|Washout 2||0
1089780|NCT01025843|2640761|P9|NOT COMPLETED|Washout 2||0
1089781|NCT01025843|2640762|P8|NOT COMPLETED|Washout 2||0
1089782|NCT01025843|2640763|P7|NOT COMPLETED|Washout 2||0
1089783|NCT01025843|2640764|P6|NOT COMPLETED|Washout 2||0
1089784|NCT01025843|2640765|P5|NOT COMPLETED|Washout 2||0
1089785|NCT01025843|2640766|P4|NOT COMPLETED|Washout 2||0
1089786|NCT01025843|2640767|P3|NOT COMPLETED|Washout 2||0
1089787|NCT01025843|2640768|P2|NOT COMPLETED|Washout 2||0
1089788|NCT01025843|2640769|P1|NOT COMPLETED|Washout 2||0
1089789|NCT01025843|2640760|P10|COMPLETED|Washout 2||2
1089790|NCT01025843|2640761|P9|COMPLETED|Washout 2||2
1089791|NCT01025843|2640762|P8|COMPLETED|Washout 2||2
1089792|NCT01025843|2640763|P7|COMPLETED|Washout 2||2
1089793|NCT01025843|2640764|P6|COMPLETED|Washout 2||2
1089794|NCT01025843|2640765|P5|COMPLETED|Washout 2||2
1089795|NCT01025843|2640766|P4|COMPLETED|Washout 2||2
1089796|NCT01025843|2640767|P3|COMPLETED|Washout 2||2
1089797|NCT01025843|2640768|P2|COMPLETED|Washout 2||2
1089798|NCT01025843|2640769|P1|COMPLETED|Washout 2||2
1089799|NCT01025843|2640760|P10|STARTED|Washout 2||2
1089800|NCT01025843|2640761|P9|STARTED|Washout 2||2
1089801|NCT01025843|2640762|P8|STARTED|Washout 2||2
1089802|NCT01025843|2640763|P7|STARTED|Washout 2||2
1089803|NCT01025843|2640764|P6|STARTED|Washout 2||2
1089804|NCT01025843|2640765|P5|STARTED|Washout 2||2
1089805|NCT01025843|2640766|P4|STARTED|Washout 2||2
1089806|NCT01025843|2640767|P3|STARTED|Washout 2||2
1089807|NCT01025843|2640768|P2|STARTED|Washout 2||2
1089808|NCT01025843|2640769|P1|STARTED|Washout 2||2
1089809|NCT01025843|2640760|P10|NOT COMPLETED|Period 2||0
1089810|NCT01025843|2640761|P9|NOT COMPLETED|Period 2||0
1089811|NCT01025843|2640762|P8|NOT COMPLETED|Period 2||0
1089812|NCT01025843|2640763|P7|NOT COMPLETED|Period 2||0
1089813|NCT01025843|2640764|P6|NOT COMPLETED|Period 2||0
1089814|NCT01025843|2640765|P5|NOT COMPLETED|Period 2||0
1089815|NCT01025843|2640766|P4|NOT COMPLETED|Period 2||0
1089816|NCT01025843|2640767|P3|NOT COMPLETED|Period 2||0
1089817|NCT01025843|2640768|P2|NOT COMPLETED|Period 2||0
1089818|NCT01025843|2640769|P1|NOT COMPLETED|Period 2||0
1089819|NCT01025843|2640760|P10|COMPLETED|Period 2||2
1089820|NCT01025843|2640761|P9|COMPLETED|Period 2||2
1089821|NCT01025843|2640762|P8|COMPLETED|Period 2||2
1089822|NCT01025843|2640763|P7|COMPLETED|Period 2||2
1089823|NCT01025843|2640764|P6|COMPLETED|Period 2||2
1089824|NCT01025843|2640765|P5|COMPLETED|Period 2||2
1089825|NCT01025843|2640766|P4|COMPLETED|Period 2||2
1089826|NCT01025843|2640767|P3|COMPLETED|Period 2||2
1089827|NCT01025843|2640768|P2|COMPLETED|Period 2||2
1089828|NCT01025843|2640769|P1|COMPLETED|Period 2||2
1089829|NCT01025843|2640760|P10|STARTED|Period 2||2
1089830|NCT01025843|2640761|P9|STARTED|Period 2||2
1089831|NCT01025843|2640762|P8|STARTED|Period 2||2
1089832|NCT01025843|2640763|P7|STARTED|Period 2||2
1089833|NCT01025843|2640764|P6|STARTED|Period 2||2
1089834|NCT01025843|2640765|P5|STARTED|Period 2||2
1089835|NCT01025843|2640766|P4|STARTED|Period 2||2
1089836|NCT01025843|2640767|P3|STARTED|Period 2||2
1089837|NCT01025843|2640768|P2|STARTED|Period 2||2
1089838|NCT01025843|2640769|P1|STARTED|Period 2||2
1089839|NCT01025843|2640760|P10|NOT COMPLETED|Washout 1||0
1089840|NCT01025843|2640761|P9|NOT COMPLETED|Washout 1||0
1089841|NCT01025843|2640762|P8|NOT COMPLETED|Washout 1||0
1089842|NCT01025843|2640763|P7|NOT COMPLETED|Washout 1||0
1089843|NCT01025843|2640764|P6|NOT COMPLETED|Washout 1||0
1089844|NCT01025843|2640765|P5|NOT COMPLETED|Washout 1||0
1089845|NCT01025843|2640766|P4|NOT COMPLETED|Washout 1||0
1089846|NCT01025843|2640767|P3|NOT COMPLETED|Washout 1||0
1089847|NCT01025843|2640768|P2|NOT COMPLETED|Washout 1||0
1089848|NCT01025843|2640769|P1|NOT COMPLETED|Washout 1||0
1089849|NCT01025843|2640760|P10|COMPLETED|Washout 1||2
1089850|NCT01025843|2640761|P9|COMPLETED|Washout 1||2
1089851|NCT01025843|2640762|P8|COMPLETED|Washout 1||2
1089852|NCT01025843|2640763|P7|COMPLETED|Washout 1||2
1089853|NCT01025843|2640764|P6|COMPLETED|Washout 1||2
1089854|NCT01025843|2640765|P5|COMPLETED|Washout 1||2
1089855|NCT01025843|2640766|P4|COMPLETED|Washout 1||2
1089856|NCT01025843|2640767|P3|COMPLETED|Washout 1||2
1089857|NCT01025843|2640768|P2|COMPLETED|Washout 1||2
1089858|NCT01025843|2640769|P1|COMPLETED|Washout 1||2
1089859|NCT01025843|2640760|P10|STARTED|Washout 1||2
1089860|NCT01025843|2640761|P9|STARTED|Washout 1||2
1089861|NCT01025843|2640762|P8|STARTED|Washout 1||2
1089862|NCT01025843|2640763|P7|STARTED|Washout 1||2
1089863|NCT01025843|2640764|P6|STARTED|Washout 1||2
1089864|NCT01025843|2640765|P5|STARTED|Washout 1||2
1089865|NCT01025843|2640766|P4|STARTED|Washout 1||2
1089866|NCT01025843|2640767|P3|STARTED|Washout 1||2
1089867|NCT01025843|2640768|P2|STARTED|Washout 1||2
1089868|NCT01025843|2640769|P1|STARTED|Washout 1||2
1089869|NCT01025843|2640760|P10|NOT COMPLETED|Period 1||0
1089870|NCT01025843|2640761|P9|NOT COMPLETED|Period 1||0
1089871|NCT01025843|2640762|P8|NOT COMPLETED|Period 1||0
1089872|NCT01025843|2640763|P7|NOT COMPLETED|Period 1||0
1089873|NCT01025843|2640764|P6|NOT COMPLETED|Period 1||0
1089874|NCT01025843|2640765|P5|NOT COMPLETED|Period 1||0
1089875|NCT01025843|2640766|P4|NOT COMPLETED|Period 1||0
1089876|NCT01025843|2640767|P3|NOT COMPLETED|Period 1||0
1089877|NCT01025843|2640768|P2|NOT COMPLETED|Period 1||0
1089878|NCT01025843|2640769|P1|NOT COMPLETED|Period 1||0
1089879|NCT01025843|2640760|P10|COMPLETED|Period 1||2
1089880|NCT01025843|2640761|P9|COMPLETED|Period 1||2
1089881|NCT01025843|2640762|P8|COMPLETED|Period 1||2
1089882|NCT01025843|2640763|P7|COMPLETED|Period 1||2
1089883|NCT01025843|2640764|P6|COMPLETED|Period 1||2
1089884|NCT01025843|2640765|P5|COMPLETED|Period 1||2
1089885|NCT01025843|2640766|P4|COMPLETED|Period 1||2
1089886|NCT01025843|2640767|P3|COMPLETED|Period 1||2
1089887|NCT01025843|2640768|P2|COMPLETED|Period 1||2
1089888|NCT01025843|2640769|P1|COMPLETED|Period 1||2
1089889|NCT01025843|2640760|P10|STARTED|Period 1||2
1089890|NCT01025843|2640761|P9|STARTED|Period 1||2
1089891|NCT01025843|2640762|P8|STARTED|Period 1||2
1089892|NCT01025843|2640763|P7|STARTED|Period 1||2
1089893|NCT01025843|2640764|P6|STARTED|Period 1||2
1089894|NCT01025843|2640765|P5|STARTED|Period 1||2
1089895|NCT01025843|2640766|P4|STARTED|Period 1||2
1089896|NCT01025843|2640767|P3|STARTED|Period 1||2
1089897|NCT01025843|2640768|P2|STARTED|Period 1||2
1089898|NCT01025843|2640769|P1|STARTED|Period 1||2
1089899|NCT01036009|2640845|P2|NOT COMPLETED|Overall Study||0
1089900|NCT01036009|2640846|P1|NOT COMPLETED|Overall Study||0
1089901|NCT01036009|2640845|P2|COMPLETED|Overall Study||26
1089902|NCT01036009|2640846|P1|COMPLETED|Overall Study||17
1089903|NCT01036009|2640845|P2|STARTED|Overall Study||26
1089904|NCT01036009|2640846|P1|STARTED|Overall Study||17
1089905|NCT01036022|2640866|P6|NOT COMPLETED|Overall Study||3
1089906|NCT01036022|2640867|P5|NOT COMPLETED|Overall Study||3
1089907|NCT01036022|2640868|P4|NOT COMPLETED|Overall Study||2
1089908|NCT01036022|2640869|P3|NOT COMPLETED|Overall Study||4
1089909|NCT01036022|2640870|P2|NOT COMPLETED|Overall Study||4
1089910|NCT01036022|2640871|P1|NOT COMPLETED|Overall Study||2
1089911|NCT01036022|2640866|P6|COMPLETED|Overall Study||13
1089912|NCT01036022|2640867|P5|COMPLETED|Overall Study||9
1089913|NCT01036022|2640868|P4|COMPLETED|Overall Study||10
1089914|NCT01036022|2640869|P3|COMPLETED|Overall Study||8
1089915|NCT01036022|2640870|P2|COMPLETED|Overall Study||7
1089916|NCT01036022|2640871|P1|COMPLETED|Overall Study||13
1089917|NCT01036022|2640866|P6|STARTED|Overall Study||16
1089918|NCT01036022|2640867|P5|STARTED|Overall Study||12
1089919|NCT01036022|2640868|P4|STARTED|Overall Study||12
1089920|NCT01036022|2640869|P3|STARTED|Overall Study||12
1089921|NCT01036022|2640870|P2|STARTED|Overall Study||11
1089922|NCT01036022|2640871|P1|STARTED|Overall Study||15
1089923|NCT01036165|2640971|P1|NOT COMPLETED|Overall Study||15
1089924|NCT01036165|2640971|P1|COMPLETED|Overall Study||88
1089925|NCT01036165|2640971|P1|STARTED|Overall Study||103
1089932|NCT01036438|2641005|P2|NOT COMPLETED|Overall Study||10
1089933|NCT01036438|2641006|P1|NOT COMPLETED|Overall Study||10
1089934|NCT01036438|2641005|P2|COMPLETED|Overall Study||90
1089935|NCT01036438|2641006|P1|COMPLETED|Overall Study||91
1089936|NCT01036438|2641005|P2|STARTED|Overall Study||100
1089937|NCT01036438|2641006|P1|STARTED|Overall Study||101
1089938|NCT01036490|2641014|P2|NOT COMPLETED|Overall Study||0
1089939|NCT01036490|2641015|P1|NOT COMPLETED|Overall Study||4
1089940|NCT01036490|2641014|P2|COMPLETED|Overall Study||18
1089941|NCT01036490|2641015|P1|COMPLETED|Overall Study||14
1089942|NCT01036490|2641014|P2|STARTED|Overall Study||18
1089943|NCT01036490|2641015|P1|STARTED|Overall Study||18
1089944|NCT01036529|2641033|P2|NOT COMPLETED|Overall Study||15
1089945|NCT01036529|2641034|P1|NOT COMPLETED|Overall Study||13
1089946|NCT01036529|2641033|P2|COMPLETED|Overall Study||0
1089947|NCT01036529|2641034|P1|COMPLETED|Overall Study||0
1089948|NCT01036529|2641033|P2|Crossover to Other Group|Overall Study||1
1089949|NCT01036529|2641034|P1|Crossover to Other Group|Overall Study||1
1089950|NCT01036529|2641033|P2|Requested Crossover|Overall Study||2
1089951|NCT01036529|2641034|P1|Requested Crossover|Overall Study||1
1089952|NCT01036529|2641033|P2|12 Month Follow-up|Overall Study||3
1089953|NCT01036529|2641034|P1|12 Month Follow-up|Overall Study||4
1089954|NCT01036529|2641033|P2|6 Month Follow-up|Overall Study||7
1089955|NCT01036529|2641034|P1|6 Month Follow-up|Overall Study||6
1089956|NCT01036529|2641033|P2|3 Month Follow-up|Overall Study||9
1089957|NCT01036529|2641034|P1|3 Month Follow-up|Overall Study||7
1089958|NCT01036529|2641033|P2|Index Procedure|Overall Study|Index Procedure: Surgery|11
1089959|NCT01036529|2641034|P1|Index Procedure|Overall Study|Index Procedure: Trial Stimulation|10
1089960|NCT01036529|2641033|P2|Baseline Visit|Overall Study||13
1089961|NCT01036529|2641034|P1|Baseline Visit|Overall Study||10
1089962|NCT01036529|2641033|P2|STARTED|Overall Study||15
1089963|NCT01036529|2641034|P1|STARTED|Overall Study||13
1089964|NCT01038128|2641040|P1|NOT COMPLETED|Overall Study||4
1089965|NCT01038128|2641040|P1|COMPLETED|Overall Study||1
1089966|NCT01038128|2641040|P1|Baseline Visit|Overall Study||3
1089967|NCT01038128|2641040|P1|STARTED|Overall Study||5
1089968|NCT01038323|2641051|P3|NOT COMPLETED|Overall Study||4
1089969|NCT01038323|2641052|P2|NOT COMPLETED|Overall Study||2
1089970|NCT01038323|2641053|P1|NOT COMPLETED|Overall Study||3
1089971|NCT01038323|2641051|P3|COMPLETED|Overall Study||15
1089972|NCT01038323|2641052|P2|COMPLETED|Overall Study||17
1089973|NCT01038323|2641053|P1|COMPLETED|Overall Study||17
1089974|NCT01038323|2641051|P3|STARTED|Overall Study||19
1089975|NCT01038323|2641052|P2|STARTED|Overall Study||19
1089976|NCT01038323|2641053|P1|STARTED|Overall Study||20
1089977|NCT01038336|2641070|P3|NOT COMPLETED|Overall Study||0
1089978|NCT01038336|2641071|P2|NOT COMPLETED|Overall Study||0
1089979|NCT01038336|2641072|P1|NOT COMPLETED|Overall Study||0
1089980|NCT01038336|2641070|P3|COMPLETED|Overall Study||44
1089981|NCT01038336|2641071|P2|COMPLETED|Overall Study||42
1089982|NCT01038336|2641072|P1|COMPLETED|Overall Study||43
1089983|NCT01038336|2641070|P3|STARTED|Overall Study||44
1089984|NCT01038336|2641071|P2|STARTED|Overall Study||42
1089985|NCT01038336|2641072|P1|STARTED|Overall Study||43
1089986|NCT01038609|2641106|P5|NOT COMPLETED|Overall Study||1
1089987|NCT01038609|2641107|P4|NOT COMPLETED|Overall Study||1
1089988|NCT01038609|2641108|P3|NOT COMPLETED|Overall Study||1
1089989|NCT01038609|2641109|P2|NOT COMPLETED|Overall Study||1
1089990|NCT01038609|2641110|P1|NOT COMPLETED|Overall Study||1
1089991|NCT01038609|2641106|P5|COMPLETED|Overall Study||50
1089992|NCT01038609|2641107|P4|COMPLETED|Overall Study||47
1089993|NCT01038609|2641108|P3|COMPLETED|Overall Study||48
1089994|NCT01038609|2641109|P2|COMPLETED|Overall Study||51
1089995|NCT01038609|2641110|P1|COMPLETED|Overall Study||49
1089996|NCT01038609|2641106|P5|STARTED|Overall Study||51
1089997|NCT01038609|2641107|P4|STARTED|Overall Study||48
1089998|NCT01038609|2641108|P3|STARTED|Overall Study||49
1089999|NCT01038609|2641109|P2|STARTED|Overall Study||52
1090000|NCT01038609|2641110|P1|STARTED|Overall Study||50
1090001|NCT01038635|2641161|P9|NOT COMPLETED|Overall Study||2
1090002|NCT01038635|2641162|P8|NOT COMPLETED|Overall Study||5
1090003|NCT01038635|2641163|P7|NOT COMPLETED|Overall Study||2
1090004|NCT01038635|2641164|P6|NOT COMPLETED|Overall Study||0
1090005|NCT01038635|2641165|P5|NOT COMPLETED|Overall Study||1
1090006|NCT01038635|2641166|P4|NOT COMPLETED|Overall Study||0
1090007|NCT01038635|2641167|P3|NOT COMPLETED|Overall Study||0
1090008|NCT01038635|2641168|P2|NOT COMPLETED|Overall Study||0
1090009|NCT01038635|2641169|P1|NOT COMPLETED|Overall Study||2
1090010|NCT01038635|2641161|P9|COMPLETED|Overall Study||38
1090011|NCT01038635|2641162|P8|COMPLETED|Overall Study||15
1090012|NCT01038635|2641163|P7|COMPLETED|Overall Study||5
1090013|NCT01038635|2641164|P6|COMPLETED|Overall Study||3
1090014|NCT01038635|2641165|P5|COMPLETED|Overall Study||3
1090015|NCT01038635|2641166|P4|COMPLETED|Overall Study||3
1090016|NCT01038635|2641167|P3|COMPLETED|Overall Study||3
1090017|NCT01038635|2641168|P2|COMPLETED|Overall Study||3
1090018|NCT01038635|2641169|P1|COMPLETED|Overall Study||3
1090019|NCT01038635|2641161|P9|STARTED|Overall Study||40
1090020|NCT01038635|2641162|P8|STARTED|Overall Study||20
1090021|NCT01038635|2641163|P7|STARTED|Overall Study||7
1090022|NCT01038635|2641164|P6|STARTED|Overall Study||3
1090023|NCT01038635|2641165|P5|STARTED|Overall Study||4
1090024|NCT01038635|2641166|P4|STARTED|Overall Study||3
1090025|NCT01038635|2641167|P3|STARTED|Overall Study||3
1090026|NCT01038635|2641168|P2|STARTED|Overall Study||3
1090027|NCT01038635|2641169|P1|STARTED|Overall Study||5
1090028|NCT01038713|2641193|P3|NOT COMPLETED|Overall Study||1
1090029|NCT01038713|2641194|P2|NOT COMPLETED|Overall Study||3
1090030|NCT01038713|2641195|P1|NOT COMPLETED|Overall Study||5
1090031|NCT01038713|2641193|P3|COMPLETED|Overall Study||16
1090032|NCT01038713|2641194|P2|COMPLETED|Overall Study||17
1090033|NCT01038713|2641195|P1|COMPLETED|Overall Study||21
1090034|NCT01038713|2641193|P3|STARTED|Overall Study||17
1090035|NCT01038713|2641194|P2|STARTED|Overall Study||20
1090036|NCT01038713|2641195|P1|STARTED|Overall Study||26
1090037|NCT01038752|2641217|P2|NOT COMPLETED|Overall Study||5
1090038|NCT01038752|2641218|P1|NOT COMPLETED|Overall Study||5
1090039|NCT01038752|2641217|P2|COMPLETED|Overall Study||1
1090040|NCT01038752|2641218|P1|COMPLETED|Overall Study||3
1090041|NCT01038752|2641217|P2|STARTED|Overall Study||6
1090042|NCT01038752|2641218|P1|STARTED|Overall Study||8
1090043|NCT01038869|2641238|P1|NOT COMPLETED|Overall Study||7
1090044|NCT01038869|2641238|P1|COMPLETED|Overall Study||13
1090045|NCT01038869|2641238|P1|STARTED|Overall Study||20
1090046|NCT01038921|2641248|P2|NOT COMPLETED|Overall Study||0
1090047|NCT01038921|2641249|P1|NOT COMPLETED|Overall Study||2
1090048|NCT01038921|2641248|P2|COMPLETED|Overall Study||20
1090049|NCT01038921|2641249|P1|COMPLETED|Overall Study|2 subjects withdrew|17
1090143|NCT01028911|2641533|P2|COMPLETED|Overall Study||2
1090050|NCT01038921|2641248|P2|STARTED|Overall Study|20 subjects received placebo first (10 weeks), washout (6 weeks), melatonin second ( 10 weeks)|20
1090051|NCT01038921|2641249|P1|STARTED|Overall Study|19 subjects received melatonin first(10 weeks), washout (6 weeks), placebo second (10 weeks)|19
1090052|NCT01039207|2641255|P1|NOT COMPLETED|Overall Study||0
1090053|NCT01039207|2641255|P1|COMPLETED|Overall Study||31
1090054|NCT01039207|2641255|P1|STARTED|Overall Study||31
1090055|NCT01039376|2641265|P2|NOT COMPLETED|Overall Study||202
1090056|NCT01039376|2641266|P1|NOT COMPLETED|Overall Study||206
1090057|NCT01039376|2641265|P2|COMPLETED|Overall Study||34
1090058|NCT01039376|2641266|P1|COMPLETED|Overall Study||32
1090059|NCT01039376|2641265|P2|Ongoing|Overall Study||182
1090060|NCT01039376|2641266|P1|Ongoing|Overall Study||189
1090061|NCT01039376|2641265|P2|STARTED|Overall Study||236
1090062|NCT01039376|2641266|P1|STARTED|Overall Study||238
1090063|NCT01039428|2641326|P2|NOT COMPLETED|Overall Study||0
1090064|NCT01039428|2641327|P1|NOT COMPLETED|Overall Study||2
1090065|NCT01039428|2641326|P2|COMPLETED|Overall Study||28
1090066|NCT01039428|2641327|P1|COMPLETED|Overall Study||33
1090067|NCT01039428|2641326|P2|STARTED|Overall Study||28
1090068|NCT01039428|2641327|P1|STARTED|Overall Study||35
1090069|NCT01039519|2641349|P1|NOT COMPLETED|Survival Follow-up||27
1090070|NCT01039519|2641349|P1|COMPLETED|Survival Follow-up||0
1090071|NCT01039519|2641349|P1|STARTED|Survival Follow-up||27
1090072|NCT01039519|2641349|P1|NOT COMPLETED|Treatment||27
1090073|NCT01039519|2641349|P1|COMPLETED|Treatment|Reason not completed represents reason for terminating treatment.|0
1090074|NCT01039519|2641349|P1|STARTED|Treatment||27
1090075|NCT01039584|2641361|P3|NOT COMPLETED|Overall Study||57
1090076|NCT01039584|2641362|P2|NOT COMPLETED|Overall Study||97
1090077|NCT01039584|2641363|P1|NOT COMPLETED|Overall Study||103
1090078|NCT01039584|2641361|P3|COMPLETED|Overall Study||65
1090079|NCT01039584|2641362|P2|COMPLETED|Overall Study||146
1090080|NCT01039584|2641363|P1|COMPLETED|Overall Study||143
1090081|NCT01039584|2641361|P3|STARTED|Overall Study||122
1090082|NCT01039584|2641362|P2|STARTED|Overall Study||243
1090083|NCT01039584|2641363|P1|STARTED|Overall Study||246
1090084|NCT01039675|2641379|P2|NOT COMPLETED|Overall Study||7
1090085|NCT01039675|2641380|P1|NOT COMPLETED|Overall Study||0
1090086|NCT01039675|2641379|P2|COMPLETED|Overall Study||35
1090087|NCT01039675|2641380|P1|COMPLETED|Overall Study||9
1090088|NCT01039675|2641379|P2|STARTED|Overall Study||42
1090089|NCT01039675|2641380|P1|STARTED|Overall Study||9
1090090|NCT01039792|2641392|P2|NOT COMPLETED|Overall Study||1
1090091|NCT01039792|2641393|P1|NOT COMPLETED|Overall Study||6
1090092|NCT01039792|2641392|P2|COMPLETED|Overall Study||27
1090093|NCT01039792|2641393|P1|COMPLETED|Overall Study||23
1090094|NCT01039792|2641392|P2|STARTED|Overall Study||28
1090095|NCT01039792|2641393|P1|STARTED|Overall Study||29
1090096|NCT01040052|2641399|P1|NOT COMPLETED|Overall Study||0
1090097|NCT01040052|2641399|P1|COMPLETED|Overall Study||30
1090098|NCT01040052|2641399|P1|STARTED|Overall Study||30
1090099|NCT01040130|2641403|P6|NOT COMPLETED|Overall Study||4
1090100|NCT01040130|2641404|P5|NOT COMPLETED|Overall Study||0
1090101|NCT01040130|2641405|P4|NOT COMPLETED|Overall Study||5
1090102|NCT01040130|2641406|P3|NOT COMPLETED|Overall Study||2
1090103|NCT01040130|2641407|P2|NOT COMPLETED|Overall Study||3
1090104|NCT01040130|2641408|P1|NOT COMPLETED|Overall Study||3
1090105|NCT01040130|2641403|P6|COMPLETED|Overall Study||22
1090106|NCT01040130|2641404|P5|COMPLETED|Overall Study||25
1090107|NCT01040130|2641405|P4|COMPLETED|Overall Study||20
1090108|NCT01040130|2641406|P3|COMPLETED|Overall Study||23
1090109|NCT01040130|2641407|P2|COMPLETED|Overall Study||22
1090110|NCT01040130|2641408|P1|COMPLETED|Overall Study|Number of patients who did not discontinue from the trial.|22
1090111|NCT01040130|2641403|P6|STARTED|Overall Study||26
1090112|NCT01040130|2641404|P5|STARTED|Overall Study||25
1090113|NCT01040130|2641405|P4|STARTED|Overall Study||25
1090114|NCT01040130|2641406|P3|STARTED|Overall Study||25
1090115|NCT01040130|2641407|P2|STARTED|Overall Study||25
1090116|NCT01040130|2641408|P1|STARTED|Overall Study|Number of patients entered and treated|25
1090117|NCT01040169|2641487|P2|NOT COMPLETED|Overall Study||8
1090118|NCT01040169|2641488|P1|NOT COMPLETED|Overall Study||3
1090119|NCT01040169|2641487|P2|COMPLETED|Overall Study||36
1090120|NCT01040169|2641488|P1|COMPLETED|Overall Study||32
1090121|NCT01040169|2641487|P2|STARTED|Overall Study||44
1090122|NCT01040169|2641488|P1|STARTED|Overall Study||35
1090123|NCT01040208|2641499|P3|NOT COMPLETED|Overall Study||3
1090124|NCT01040208|2641500|P2|NOT COMPLETED|Overall Study||13
1090125|NCT01040208|2641501|P1|NOT COMPLETED|Overall Study||6
1090126|NCT01040208|2641499|P3|COMPLETED|Overall Study||35
1090127|NCT01040208|2641500|P2|COMPLETED|Overall Study||15
1090128|NCT01040208|2641501|P1|COMPLETED|Overall Study||39
1090129|NCT01040208|2641499|P3|STARTED|Overall Study||38
1090130|NCT01040208|2641500|P2|STARTED|Overall Study||28
1090131|NCT01040208|2641501|P1|STARTED|Overall Study||45
1090132|NCT01040260|2641517|P2|NOT COMPLETED|Overall Study||11
1090133|NCT01040260|2641518|P1|NOT COMPLETED|Overall Study||15
1090134|NCT01040260|2641517|P2|COMPLETED|Overall Study||39
1090135|NCT01040260|2641518|P1|COMPLETED|Overall Study||38
1090136|NCT01040260|2641517|P2|STARTED|Overall Study||50
1090137|NCT01040260|2641518|P1|STARTED|Overall Study||53
1090138|NCT01028820|2641524|P1|NOT COMPLETED|Overall Study||1
1090139|NCT01028820|2641524|P1|COMPLETED|Overall Study||12
1090140|NCT01028820|2641524|P1|STARTED|Overall Study||13
1090141|NCT01028911|2641533|P2|NOT COMPLETED|Overall Study||0
1090142|NCT01028911|2641534|P1|NOT COMPLETED|Overall Study||0
1090144|NCT01028911|2641534|P1|COMPLETED|Overall Study||7
1090145|NCT01028911|2641533|P2|STARTED|Overall Study||2
1090146|NCT01028911|2641534|P1|STARTED|Overall Study||7
1090147|NCT01029054|2641599|P3|NOT COMPLETED|Phase II||0
1090148|NCT01029054|2641600|P2|NOT COMPLETED|Phase II||0
1090149|NCT01029054|2641601|P1|NOT COMPLETED|Phase II||0
1090150|NCT01029054|2641599|P3|COMPLETED|Phase II||18
1090151|NCT01029054|2641600|P2|COMPLETED|Phase II||0
1090152|NCT01029054|2641601|P1|COMPLETED|Phase II||0
1090153|NCT01029054|2641599|P3|STARTED|Phase II|35 participants were enrolled in Ph I. 18 additional participants were enrolled in Ph II at the MTD.|18
1090154|NCT01029054|2641600|P2|STARTED|Phase II||0
1090155|NCT01029054|2641601|P1|STARTED|Phase II||0
1090156|NCT01029054|2641599|P3|NOT COMPLETED|Phase I||0
1090157|NCT01029054|2641600|P2|NOT COMPLETED|Phase I||0
1090158|NCT01029054|2641601|P1|NOT COMPLETED|Phase I||0
1090159|NCT01029054|2641599|P3|COMPLETED|Phase I||18
1090160|NCT01029054|2641600|P2|COMPLETED|Phase I||13
1090161|NCT01029054|2641601|P1|COMPLETED|Phase I||4
1090162|NCT01029054|2641599|P3|STARTED|Phase I||18
1090163|NCT01029054|2641600|P2|STARTED|Phase I||13
1090164|NCT01029054|2641601|P1|STARTED|Phase I||4
1090165|NCT01029262|2641609|P2|NOT COMPLETED|Overall Study||145
1090166|NCT01029262|2641610|P1|NOT COMPLETED|Overall Study||78
1090167|NCT01029262|2641609|P2|COMPLETED|Overall Study|Completed participants are those who were continuing to receive study drug at time of data cut-off|15
1090168|NCT01029262|2641610|P1|COMPLETED|Overall Study|Completed participants are those who were continuing to receive study drug at time of data cut-off|1
1090169|NCT01029262|2641609|P2|STARTED|Overall Study||160
1090170|NCT01029262|2641610|P1|STARTED|Overall Study||79
1090171|NCT01029340|2641671|P6|NOT COMPLETED|Part C Follow up Period||0
1090172|NCT01029340|2641672|P5|NOT COMPLETED|Part C Follow up Period||0
1090173|NCT01029340|2641673|P4|NOT COMPLETED|Part C Follow up Period||0
1090174|NCT01029340|2641674|P3|NOT COMPLETED|Part C Follow up Period||0
1090175|NCT01029340|2641675|P2|NOT COMPLETED|Part C Follow up Period||0
1090176|NCT01029340|2641676|P1|NOT COMPLETED|Part C Follow up Period||0
1090177|NCT01029340|2641671|P6|COMPLETED|Part C Follow up Period||0
1090178|NCT01029340|2641672|P5|COMPLETED|Part C Follow up Period||5
1090179|NCT01029340|2641673|P4|COMPLETED|Part C Follow up Period||0
1090180|NCT01029340|2641674|P3|COMPLETED|Part C Follow up Period||0
1090181|NCT01029340|2641675|P2|COMPLETED|Part C Follow up Period||0
1090182|NCT01029340|2641676|P1|COMPLETED|Part C Follow up Period||0
1090183|NCT01029340|2641671|P6|STARTED|Part C Follow up Period||0
1090184|NCT01029340|2641672|P5|STARTED|Part C Follow up Period||5
1090185|NCT01029340|2641673|P4|STARTED|Part C Follow up Period||0
1090186|NCT01029340|2641674|P3|STARTED|Part C Follow up Period||0
1090187|NCT01029340|2641675|P2|STARTED|Part C Follow up Period||0
1090188|NCT01029340|2641676|P1|STARTED|Part C Follow up Period||0
1090189|NCT01029340|2641671|P6|NOT COMPLETED|Part C Treatment Period||0
1090190|NCT01029340|2641672|P5|NOT COMPLETED|Part C Treatment Period||0
1090191|NCT01029340|2641673|P4|NOT COMPLETED|Part C Treatment Period||0
1090192|NCT01029340|2641674|P3|NOT COMPLETED|Part C Treatment Period||0
1090193|NCT01029340|2641675|P2|NOT COMPLETED|Part C Treatment Period||0
1090194|NCT01029340|2641676|P1|NOT COMPLETED|Part C Treatment Period||0
1090195|NCT01029340|2641671|P6|COMPLETED|Part C Treatment Period||0
1090196|NCT01029340|2641672|P5|COMPLETED|Part C Treatment Period||5
1090197|NCT01029340|2641673|P4|COMPLETED|Part C Treatment Period||0
1090198|NCT01029340|2641674|P3|COMPLETED|Part C Treatment Period||0
1090199|NCT01029340|2641675|P2|COMPLETED|Part C Treatment Period||0
1090200|NCT01029340|2641676|P1|COMPLETED|Part C Treatment Period||0
1090201|NCT01029340|2641671|P6|Participants Received Treatment|Part C Treatment Period||0
1090202|NCT01029340|2641672|P5|Participants Received Treatment|Part C Treatment Period||5
1090203|NCT01029340|2641673|P4|Participants Received Treatment|Part C Treatment Period||0
1090204|NCT01029340|2641674|P3|Participants Received Treatment|Part C Treatment Period||0
1090205|NCT01029340|2641675|P2|Participants Received Treatment|Part C Treatment Period||0
1090206|NCT01029340|2641676|P1|Participants Received Treatment|Part C Treatment Period||0
1090207|NCT01029340|2641671|P6|STARTED|Part C Treatment Period||0
1090208|NCT01029340|2641672|P5|STARTED|Part C Treatment Period||5
1090209|NCT01029340|2641673|P4|STARTED|Part C Treatment Period||0
1090210|NCT01029340|2641674|P3|STARTED|Part C Treatment Period||0
1090211|NCT01029340|2641675|P2|STARTED|Part C Treatment Period||0
1090212|NCT01029340|2641676|P1|STARTED|Part C Treatment Period||0
1090213|NCT01029340|2641671|P6|NOT COMPLETED|Extension Period||12
1090214|NCT01029340|2641672|P5|NOT COMPLETED|Extension Period||0
1090215|NCT01029340|2641673|P4|NOT COMPLETED|Extension Period||0
1090216|NCT01029340|2641674|P3|NOT COMPLETED|Extension Period||0
1090217|NCT01029340|2641675|P2|NOT COMPLETED|Extension Period||0
1090218|NCT01029340|2641676|P1|NOT COMPLETED|Extension Period||0
1090219|NCT01029340|2641671|P6|COMPLETED|Extension Period||43
1090220|NCT01029340|2641672|P5|COMPLETED|Extension Period||0
1090221|NCT01029340|2641673|P4|COMPLETED|Extension Period||0
1090222|NCT01029340|2641674|P3|COMPLETED|Extension Period||0
1090223|NCT01029340|2641675|P2|COMPLETED|Extension Period||0
1090224|NCT01029340|2641676|P1|COMPLETED|Extension Period||0
1090225|NCT01029340|2641671|P6|STARTED|Extension Period||55
1090226|NCT01029340|2641672|P5|STARTED|Extension Period||0
1090227|NCT01029340|2641673|P4|STARTED|Extension Period||0
1090228|NCT01029340|2641674|P3|STARTED|Extension Period||0
1090229|NCT01029340|2641675|P2|STARTED|Extension Period||0
1090230|NCT01029340|2641676|P1|STARTED|Extension Period||0
1090231|NCT01029340|2641671|P6|NOT COMPLETED|Part B Follow up Period||0
1090232|NCT01029340|2641672|P5|NOT COMPLETED|Part B Follow up Period||0
1090233|NCT01029340|2641673|P4|NOT COMPLETED|Part B Follow up Period||0
1090234|NCT01029340|2641674|P3|NOT COMPLETED|Part B Follow up Period||0
1090235|NCT01029340|2641675|P2|NOT COMPLETED|Part B Follow up Period||0
1090236|NCT01029340|2641676|P1|NOT COMPLETED|Part B Follow up Period||0
1090237|NCT01029340|2641671|P6|COMPLETED|Part B Follow up Period||0
1090238|NCT01029340|2641672|P5|COMPLETED|Part B Follow up Period||0
1090239|NCT01029340|2641673|P4|COMPLETED|Part B Follow up Period||32
1090240|NCT01029340|2641674|P3|COMPLETED|Part B Follow up Period||29
1090241|NCT01029340|2641675|P2|COMPLETED|Part B Follow up Period||0
1090242|NCT01029340|2641676|P1|COMPLETED|Part B Follow up Period||0
1090243|NCT01029340|2641671|P6|STARTED|Part B Follow up Period||0
1090244|NCT01029340|2641672|P5|STARTED|Part B Follow up Period||0
1090245|NCT01029340|2641673|P4|STARTED|Part B Follow up Period||32
1090246|NCT01029340|2641674|P3|STARTED|Part B Follow up Period||29
1090247|NCT01029340|2641675|P2|STARTED|Part B Follow up Period||0
1090248|NCT01029340|2641676|P1|STARTED|Part B Follow up Period||0
1090249|NCT01029340|2641671|P6|NOT COMPLETED|Part B Treatment Period||0
1090250|NCT01029340|2641672|P5|NOT COMPLETED|Part B Treatment Period||0
1090251|NCT01029340|2641673|P4|NOT COMPLETED|Part B Treatment Period||0
1090252|NCT01029340|2641674|P3|NOT COMPLETED|Part B Treatment Period||2
1090253|NCT01029340|2641675|P2|NOT COMPLETED|Part B Treatment Period||0
1090254|NCT01029340|2641676|P1|NOT COMPLETED|Part B Treatment Period||0
1090255|NCT01029340|2641671|P6|COMPLETED|Part B Treatment Period||0
1090256|NCT01029340|2641672|P5|COMPLETED|Part B Treatment Period||0
1090257|NCT01029340|2641673|P4|COMPLETED|Part B Treatment Period||32
1090258|NCT01029340|2641674|P3|COMPLETED|Part B Treatment Period||29
1090259|NCT01029340|2641675|P2|COMPLETED|Part B Treatment Period||0
1090260|NCT01029340|2641676|P1|COMPLETED|Part B Treatment Period||0
1090261|NCT01029340|2641671|P6|Participants Received Treatment|Part B Treatment Period||0
1090262|NCT01029340|2641672|P5|Participants Received Treatment|Part B Treatment Period||0
1090263|NCT01029340|2641673|P4|Participants Received Treatment|Part B Treatment Period||32
1090264|NCT01029340|2641674|P3|Participants Received Treatment|Part B Treatment Period||30
1090265|NCT01029340|2641675|P2|Participants Received Treatment|Part B Treatment Period||0
1090266|NCT01029340|2641676|P1|Participants Received Treatment|Part B Treatment Period||0
1090267|NCT01029340|2641671|P6|STARTED|Part B Treatment Period||0
1090268|NCT01029340|2641672|P5|STARTED|Part B Treatment Period||0
1090269|NCT01029340|2641673|P4|STARTED|Part B Treatment Period|Enrolled 7 participants from Arm 1 and 4 participants from Arm 2|32
1090270|NCT01029340|2641674|P3|STARTED|Part B Treatment Period|Enrolled 4 participants from Arm 1 and 7 participants from Arm 2|31
1090271|NCT01029340|2641675|P2|STARTED|Part B Treatment Period||0
1090272|NCT01029340|2641676|P1|STARTED|Part B Treatment Period||0
1090273|NCT01029340|2641671|P6|NOT COMPLETED|Part A Follow up Period||0
1090274|NCT01029340|2641672|P5|NOT COMPLETED|Part A Follow up Period||0
1090275|NCT01029340|2641673|P4|NOT COMPLETED|Part A Follow up Period||0
1090276|NCT01029340|2641674|P3|NOT COMPLETED|Part A Follow up Period||0
1090277|NCT01029340|2641675|P2|NOT COMPLETED|Part A Follow up Period||0
1090278|NCT01029340|2641676|P1|NOT COMPLETED|Part A Follow up Period||0
1090279|NCT01029340|2641671|P6|COMPLETED|Part A Follow up Period||0
1090280|NCT01029340|2641672|P5|COMPLETED|Part A Follow up Period||0
1090281|NCT01029340|2641673|P4|COMPLETED|Part A Follow up Period||0
1090282|NCT01029340|2641674|P3|COMPLETED|Part A Follow up Period||0
1090283|NCT01029340|2641675|P2|COMPLETED|Part A Follow up Period||14
1090284|NCT01029340|2641676|P1|COMPLETED|Part A Follow up Period||14
1090285|NCT01029340|2641671|P6|STARTED|Part A Follow up Period||0
1090286|NCT01029340|2641672|P5|STARTED|Part A Follow up Period||0
1090287|NCT01029340|2641673|P4|STARTED|Part A Follow up Period||0
1090288|NCT01029340|2641674|P3|STARTED|Part A Follow up Period||0
1090289|NCT01029340|2641675|P2|STARTED|Part A Follow up Period||14
1090290|NCT01029340|2641676|P1|STARTED|Part A Follow up Period||14
1090291|NCT01029340|2641671|P6|NOT COMPLETED|Part A Treatment Period||0
1090292|NCT01029340|2641672|P5|NOT COMPLETED|Part A Treatment Period||0
1090293|NCT01029340|2641673|P4|NOT COMPLETED|Part A Treatment Period||0
1090294|NCT01029340|2641674|P3|NOT COMPLETED|Part A Treatment Period||0
1090295|NCT01029340|2641675|P2|NOT COMPLETED|Part A Treatment Period||0
1090296|NCT01029340|2641676|P1|NOT COMPLETED|Part A Treatment Period||0
1090297|NCT01029340|2641671|P6|COMPLETED|Part A Treatment Period||0
1090298|NCT01029340|2641672|P5|COMPLETED|Part A Treatment Period||0
1090299|NCT01029340|2641673|P4|COMPLETED|Part A Treatment Period||0
1090300|NCT01029340|2641674|P3|COMPLETED|Part A Treatment Period||0
1090301|NCT01029340|2641675|P2|COMPLETED|Part A Treatment Period||14
1090302|NCT01029340|2641676|P1|COMPLETED|Part A Treatment Period||14
1090303|NCT01029340|2641671|P6|Safety Population|Part A Treatment Period||0
1090304|NCT01029340|2641672|P5|Safety Population|Part A Treatment Period||0
1090305|NCT01029340|2641673|P4|Safety Population|Part A Treatment Period||0
1090306|NCT01029340|2641674|P3|Safety Population|Part A Treatment Period||0
1090307|NCT01029340|2641675|P2|Safety Population|Part A Treatment Period||14
1090308|NCT01029340|2641676|P1|Safety Population|Part A Treatment Period|One excluded because receiving Kogenate FS twice.|13
1090309|NCT01029340|2641671|P6|Participants Received Treatment|Part A Treatment Period||0
1090310|NCT01029340|2641672|P5|Participants Received Treatment|Part A Treatment Period||0
1090311|NCT01029340|2641673|P4|Participants Received Treatment|Part A Treatment Period||0
1090312|NCT01029340|2641674|P3|Participants Received Treatment|Part A Treatment Period||0
1090313|NCT01029340|2641675|P2|Participants Received Treatment|Part A Treatment Period||14
1090314|NCT01029340|2641676|P1|Participants Received Treatment|Part A Treatment Period||14
1090315|NCT01029340|2641671|P6|STARTED|Part A Treatment Period||0
1090316|NCT01029340|2641672|P5|STARTED|Part A Treatment Period||0
1090317|NCT01029340|2641673|P4|STARTED|Part A Treatment Period||0
1090318|NCT01029340|2641674|P3|STARTED|Part A Treatment Period||0
1090319|NCT01029340|2641675|P2|STARTED|Part A Treatment Period||14
1090320|NCT01029340|2641676|P1|STARTED|Part A Treatment Period||14
1090321|NCT01029366|2641707|P2|NOT COMPLETED|Overall Study||2
1090322|NCT01029366|2641708|P1|NOT COMPLETED|Overall Study||4
1090323|NCT01029366|2641707|P2|COMPLETED|Overall Study||6
1090324|NCT01029366|2641708|P1|COMPLETED|Overall Study||14
1090325|NCT01029366|2641707|P2|STARTED|Overall Study||8
1090326|NCT01029366|2641708|P1|STARTED|Overall Study||18
1090327|NCT01029392|2641717|P2|NOT COMPLETED|Overall Study||11
1090328|NCT01029392|2641718|P1|NOT COMPLETED|Overall Study||20
1090329|NCT01029392|2641717|P2|COMPLETED|Overall Study||27
1090330|NCT01029392|2641718|P1|COMPLETED|Overall Study||17
1090331|NCT01029392|2641717|P2|STARTED|Overall Study||38
1090332|NCT01029392|2641718|P1|STARTED|Overall Study||37
1090333|NCT01029405|2641730|P4|NOT COMPLETED|Overall Study||5
1090334|NCT01029405|2641731|P3|NOT COMPLETED|Overall Study||4
1090335|NCT01029405|2641732|P2|NOT COMPLETED|Overall Study||3
1090336|NCT01029405|2641733|P1|NOT COMPLETED|Overall Study||2
1090337|NCT01029405|2641730|P4|COMPLETED|Overall Study||32
1090338|NCT01029405|2641731|P3|COMPLETED|Overall Study||31
1090339|NCT01029405|2641732|P2|COMPLETED|Overall Study||34
1090340|NCT01029405|2641733|P1|COMPLETED|Overall Study||34
1090341|NCT01029405|2641730|P4|STARTED|Overall Study||37
1090342|NCT01029405|2641731|P3|STARTED|Overall Study||35
1090343|NCT01029405|2641732|P2|STARTED|Overall Study||37
1090344|NCT01029405|2641733|P1|STARTED|Overall Study||36
1090345|NCT01029535|2641743|P1|NOT COMPLETED|Overall Study||31
1090346|NCT01029535|2641743|P1|COMPLETED|Overall Study||72
1090347|NCT01029535|2641743|P1|STARTED|Overall Study||103
1090348|NCT01029652|2641770|P2|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||3
1090349|NCT01029652|2641771|P1|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||1
1090350|NCT01029652|2641770|P2|COMPLETED|Extension Study 2 (25-72 Weeks)||63
1090351|NCT01029652|2641771|P1|COMPLETED|Extension Study 2 (25-72 Weeks)||68
1090352|NCT01029652|2641770|P2|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|39
1090353|NCT01029652|2641771|P1|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab over 72 weeks study duration overall|69
1090354|NCT01029652|2641770|P2|STARTED|Extension Study 2 (25-72 Weeks)||66
1090355|NCT01029652|2641771|P1|STARTED|Extension Study 2 (25-72 Weeks)||69
1090356|NCT01029652|2641770|P2|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||5
1090357|NCT01029652|2641771|P1|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||3
1090358|NCT01029652|2641770|P2|COMPLETED|Extension Study 1 (12-24 Weeks)||80
1090359|NCT01029652|2641771|P1|COMPLETED|Extension Study 1 (12-24 Weeks)||87
1090360|NCT01029652|2641770|P2|STARTED|Extension Study 1 (12-24 Weeks)||85
1090361|NCT01029652|2641771|P1|STARTED|Extension Study 1 (12-24 Weeks)||90
1090362|NCT01029652|2641770|P2|NOT COMPLETED|Core Study (0-12 Weeks)||10
1090363|NCT01029652|2641771|P1|NOT COMPLETED|Core Study (0-12 Weeks)||6
1090364|NCT01029652|2641770|P2|COMPLETED|Core Study (0-12 Weeks)||105
1090365|NCT01029652|2641771|P1|COMPLETED|Core Study (0-12 Weeks)||109
1090366|NCT01029652|2641770|P2|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||115
1090367|NCT01029652|2641771|P1|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||113
1090368|NCT01029652|2641770|P2|STARTED|Core Study (0-12 Weeks)||115
1090369|NCT01029652|2641771|P1|STARTED|Core Study (0-12 Weeks)||115
1090370|NCT01029704|2641854|P5|NOT COMPLETED|Overall Study||0
1090371|NCT01029704|2641855|P4|NOT COMPLETED|Overall Study||0
1090372|NCT01029704|2641856|P3|NOT COMPLETED|Overall Study||0
1090373|NCT01029704|2641857|P2|NOT COMPLETED|Overall Study||0
1090374|NCT01029704|2641858|P1|NOT COMPLETED|Overall Study||0
1090375|NCT01029704|2641854|P5|COMPLETED|Overall Study||26
1090376|NCT01029704|2641855|P4|COMPLETED|Overall Study||28
1090377|NCT01029704|2641856|P3|COMPLETED|Overall Study||23
1090378|NCT01029704|2641857|P2|COMPLETED|Overall Study||24
1090379|NCT01029704|2641858|P1|COMPLETED|Overall Study||28
1090380|NCT01029704|2641854|P5|STARTED|Overall Study||26
1090381|NCT01029704|2641855|P4|STARTED|Overall Study||28
1090382|NCT01029704|2641856|P3|STARTED|Overall Study||23
1090383|NCT01029704|2641857|P2|STARTED|Overall Study||24
1090384|NCT01029704|2641858|P1|STARTED|Overall Study||28
1090385|NCT01029730|2641885|P1|NOT COMPLETED|Maintenance Therapy||23
1090386|NCT01029730|2641885|P1|COMPLETED|Maintenance Therapy||14
1090387|NCT01029730|2641885|P1|STARTED|Maintenance Therapy|Two patients complete study treatment but declined subsequent maintenance therapy|37
1090388|NCT01029730|2641885|P1|NOT COMPLETED|Combination Therapy||16
1090389|NCT01029730|2641885|P1|COMPLETED|Combination Therapy|Patients remained on-study until completing 6 cycles or coming off-treatment for any other reason|39
1090390|NCT01029730|2641885|P1|STARTED|Combination Therapy||55
1090391|NCT01029795|2641894|P2|NOT COMPLETED|Overall Study||22
1090392|NCT01029795|2641895|P1|NOT COMPLETED|Overall Study||16
1090393|NCT01029795|2641894|P2|COMPLETED|Overall Study||0
1090394|NCT01029795|2641895|P1|COMPLETED|Overall Study||0
1090395|NCT01029795|2641894|P2|STARTED|Overall Study||22
1090396|NCT01029795|2641895|P1|STARTED|Overall Study||16
1090397|NCT01029886|2641949|P2|NOT COMPLETED|Overall Study||60
1090398|NCT01029886|2641950|P1|NOT COMPLETED|Overall Study||61
1090399|NCT01029886|2641949|P2|COMPLETED|Overall Study||391
1090400|NCT01029886|2641950|P1|COMPLETED|Overall Study||400
1090401|NCT01029886|2641949|P2|Intent to Treat (ITT)|Overall Study||450
1090402|NCT01029886|2641950|P1|Intent to Treat (ITT)|Overall Study||461
1090403|NCT01029886|2641949|P2|STARTED|Overall Study||451
1090404|NCT01029886|2641950|P1|STARTED|Overall Study||461
1090405|NCT01029925|2641976|P1|NOT COMPLETED|Completion of Cycle 2 (56 Days)||1
1090406|NCT01029925|2641976|P1|COMPLETED|Completion of Cycle 2 (56 Days)||2
1090407|NCT01029925|2641976|P1|STARTED|Completion of Cycle 2 (56 Days)||3
1090408|NCT01029925|2641976|P1|NOT COMPLETED|Completion of Cycle 1 (28 Days)||4
1090409|NCT01029925|2641976|P1|COMPLETED|Completion of Cycle 1 (28 Days)||3
1090410|NCT01029925|2641976|P1|STARTED|Completion of Cycle 1 (28 Days)||7
1090411|NCT01030458|2641982|P2|NOT COMPLETED|Overall Study||32
1090412|NCT01030458|2641983|P1|NOT COMPLETED|Overall Study||27
1090413|NCT01030458|2641982|P2|COMPLETED|Overall Study||57
1090414|NCT01030458|2641983|P1|COMPLETED|Overall Study||67
1090415|NCT01030458|2641982|P2|STARTED|Overall Study||89
1090416|NCT01030458|2641983|P1|STARTED|Overall Study||94
1090417|NCT01030653|2641997|P2|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
1090418|NCT01030653|2641998|P1|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
1090419|NCT01030653|2641997|P2|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
1090420|NCT01030653|2641998|P1|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
1090421|NCT01030653|2641997|P2|STARTED|Loading Dose & 2nd Maintenance Regimen||4
1090422|NCT01030653|2641998|P1|STARTED|Loading Dose & 2nd Maintenance Regimen||4
1090423|NCT01030653|2641997|P2|NOT COMPLETED|7-Day Washout Period||0
1090424|NCT01030653|2641998|P1|NOT COMPLETED|7-Day Washout Period||0
1090425|NCT01030653|2641997|P2|COMPLETED|7-Day Washout Period||4
1090426|NCT01030653|2641998|P1|COMPLETED|7-Day Washout Period||4
1090427|NCT01030653|2641997|P2|STARTED|7-Day Washout Period||4
1090428|NCT01030653|2641998|P1|STARTED|7-Day Washout Period||4
1090429|NCT01030653|2641997|P2|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
1090430|NCT01030653|2641998|P1|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
1090431|NCT01030653|2641997|P2|COMPLETED|Loading Dose & First Maintenance Regimen||4
1090432|NCT01030653|2641998|P1|COMPLETED|Loading Dose & First Maintenance Regimen||4
1090433|NCT01030653|2641997|P2|STARTED|Loading Dose & First Maintenance Regimen||4
1090434|NCT01030653|2641998|P1|STARTED|Loading Dose & First Maintenance Regimen||4
1090435|NCT01030666|2642009|P2|NOT COMPLETED|Overall Study||2
1090436|NCT01030666|2642010|P1|NOT COMPLETED|Overall Study||3
1090437|NCT01030666|2642009|P2|COMPLETED|Overall Study||31
1090438|NCT01030666|2642010|P1|COMPLETED|Overall Study||25
1090439|NCT01030666|2642009|P2|STARTED|Overall Study||33
1090440|NCT01030666|2642010|P1|STARTED|Overall Study||28
1090441|NCT01030718|2642021|P3|NOT COMPLETED|Study CA180-036 Only||5
1090442|NCT01030718|2642022|P2|NOT COMPLETED|Study CA180-036 Only||7
1090443|NCT01030718|2642023|P1|NOT COMPLETED|Study CA180-036 Only||3
1090444|NCT01030718|2642021|P3|COMPLETED|Study CA180-036 Only||1
1090445|NCT01030718|2642022|P2|COMPLETED|Study CA180-036 Only||2
1090446|NCT01030718|2642023|P1|COMPLETED|Study CA180-036 Only||26
1090447|NCT01030718|2642021|P3|STARTED|Study CA180-036 Only||6
1090448|NCT01030718|2642022|P2|STARTED|Study CA180-036 Only||9
1090449|NCT01030718|2642023|P1|STARTED|Study CA180-036 Only||29
1090450|NCT01030718|2642021|P3|NOT COMPLETED|Studies CA180-031 and -036 Combined||12
1090451|NCT01030718|2642022|P2|NOT COMPLETED|Studies CA180-031 and -036 Combined||9
1090452|NCT01030718|2642023|P1|NOT COMPLETED|Studies CA180-031 and -036 Combined||4
1090453|NCT01030718|2642021|P3|COMPLETED|Studies CA180-031 and -036 Combined||1
1090454|NCT01030718|2642022|P2|COMPLETED|Studies CA180-031 and -036 Combined||2
1090455|NCT01030718|2642023|P1|COMPLETED|Studies CA180-031 and -036 Combined||26
1090456|NCT01030718|2642021|P3|STARTED|Studies CA180-031 and -036 Combined||13
1090457|NCT01030718|2642022|P2|STARTED|Studies CA180-031 and -036 Combined||11
1090458|NCT01030718|2642023|P1|STARTED|Studies CA180-031 and -036 Combined||30
1090459|NCT01030757|2642082|P1|NOT COMPLETED|Overall Study||0
1090460|NCT01030757|2642082|P1|COMPLETED|Overall Study||2
1090461|NCT01030757|2642082|P1|STARTED|Overall Study||2
1090462|NCT01030822|2642090|P3|NOT COMPLETED|Overall Study||26
1090463|NCT01030822|2642091|P2|NOT COMPLETED|Overall Study||24
1090464|NCT01030822|2642092|P1|NOT COMPLETED|Overall Study||31
1090465|NCT01030822|2642090|P3|COMPLETED|Overall Study||61
1090466|NCT01030822|2642091|P2|COMPLETED|Overall Study||71
1090467|NCT01030822|2642092|P1|COMPLETED|Overall Study||69
1090468|NCT01030822|2642090|P3|STARTED|Overall Study||87
1090469|NCT01030822|2642091|P2|STARTED|Overall Study||95
1090470|NCT01030822|2642092|P1|STARTED|Overall Study||100
1090471|NCT01030952|2642141|P2|NOT COMPLETED|Overall Study||3
1090472|NCT01030952|2642142|P1|NOT COMPLETED|Overall Study||2
1090473|NCT01030952|2642141|P2|COMPLETED|Overall Study||49
1090474|NCT01030952|2642142|P1|COMPLETED|Overall Study||49
1090475|NCT01030952|2642141|P2|STARTED|Overall Study||52
1090476|NCT01030952|2642142|P1|STARTED|Overall Study||51
1090477|NCT01030965|2642180|P4|NOT COMPLETED|Overall Study||7
1090478|NCT01030965|2642181|P3|NOT COMPLETED|Overall Study||4
1090479|NCT01030965|2642182|P2|NOT COMPLETED|Overall Study||6
1090480|NCT01030965|2642183|P1|NOT COMPLETED|Overall Study||4
1090481|NCT01030965|2642180|P4|COMPLETED|Overall Study||64
1090482|NCT01030965|2642181|P3|COMPLETED|Overall Study||68
1090483|NCT01030965|2642182|P2|COMPLETED|Overall Study||65
1090484|NCT01030965|2642183|P1|COMPLETED|Overall Study||67
1090485|NCT01030965|2642180|P4|STARTED|Overall Study||71
1090486|NCT01030965|2642181|P3|STARTED|Overall Study||72
1090487|NCT01030965|2642182|P2|STARTED|Overall Study||71
1090488|NCT01030965|2642183|P1|STARTED|Overall Study||71
1090489|NCT01031004|2642203|P2|NOT COMPLETED|Overall Study||1
1090490|NCT01031004|2642204|P1|NOT COMPLETED|Overall Study||1
1090491|NCT01031004|2642203|P2|COMPLETED|Overall Study||24
1090492|NCT01031004|2642204|P1|COMPLETED|Overall Study||24
1090493|NCT01031004|2642203|P2|STARTED|Overall Study||25
1090494|NCT01031004|2642204|P1|STARTED|Overall Study||25
1090495|NCT01031043|2642244|P1|NOT COMPLETED|Overall Study||1
1090496|NCT01031043|2642244|P1|COMPLETED|Overall Study||4
1090497|NCT01031043|2642244|P1|STARTED|Overall Study||5
1090498|NCT01031095|2642250|P2|NOT COMPLETED|Overall Study||0
1090499|NCT01031095|2642251|P1|NOT COMPLETED|Overall Study||0
1090500|NCT01031095|2642250|P2|COMPLETED|Overall Study||100
1090501|NCT01031095|2642251|P1|COMPLETED|Overall Study||100
1090502|NCT01031095|2642250|P2|STARTED|Overall Study||100
1090503|NCT01031095|2642251|P1|STARTED|Overall Study||100
1090504|NCT01031134|2642259|P2|NOT COMPLETED|Overall Study||10
1090505|NCT01031134|2642260|P1|NOT COMPLETED|Overall Study||11
1090506|NCT01031134|2642259|P2|COMPLETED|Overall Study||78
1090507|NCT01031134|2642260|P1|COMPLETED|Overall Study||103
1090508|NCT01031134|2642259|P2|STARTED|Overall Study||88
1090509|NCT01031134|2642260|P1|STARTED|Overall Study||114
1090510|NCT01031381|2642268|P1|NOT COMPLETED|Overall Study||9
1090511|NCT01031381|2642268|P1|COMPLETED|Overall Study||50
1090512|NCT01031381|2642268|P1|STARTED|Overall Study||59
1090513|NCT01031446|2642273|P1|NOT COMPLETED|Overall Study||55
1090514|NCT01031446|2642273|P1|COMPLETED|Overall Study||0
1090515|NCT01031446|2642273|P1|STARTED|Overall Study||55
1090516|NCT01031498|2642285|P3|NOT COMPLETED|Overall Study||2
1090517|NCT01031498|2642286|P2|NOT COMPLETED|Overall Study||3
1090518|NCT01031498|2642287|P1|NOT COMPLETED|Overall Study||2
1090519|NCT01031498|2642285|P3|COMPLETED|Overall Study||48
1090520|NCT01031498|2642286|P2|COMPLETED|Overall Study||48
1090521|NCT01031498|2642287|P1|COMPLETED|Overall Study||47
1090522|NCT01031498|2642285|P3|STARTED|Overall Study|2 patients were not evaluable in arm 3.|50
1090523|NCT01031498|2642286|P2|STARTED|Overall Study|3 patients were not evaluable in arm 2|51
1090524|NCT01031498|2642287|P1|STARTED|Overall Study|2 patients were not evaluable in arm 1.|49
1090525|NCT01031550|2642297|P2|NOT COMPLETED|Overall Study||0
1090526|NCT01031550|2642298|P1|NOT COMPLETED|Overall Study||0
1090527|NCT01031550|2642297|P2|COMPLETED|Overall Study||3
1090528|NCT01031550|2642298|P1|COMPLETED|Overall Study||5
1090529|NCT01031550|2642297|P2|STARTED|Overall Study||3
1090530|NCT01031550|2642298|P1|STARTED|Overall Study||5
1090531|NCT01031628|2642314|P4|NOT COMPLETED|Overall Study||0
1090532|NCT01031628|2642315|P3|NOT COMPLETED|Overall Study||3
1090533|NCT01031628|2642316|P2|NOT COMPLETED|Overall Study||1
1090534|NCT01031628|2642317|P1|NOT COMPLETED|Overall Study||0
1090535|NCT01031628|2642314|P4|COMPLETED|Overall Study||0
1090536|NCT01031628|2642315|P3|COMPLETED|Overall Study||0
1090537|NCT01031628|2642316|P2|COMPLETED|Overall Study||0
1090538|NCT01031628|2642317|P1|COMPLETED|Overall Study||0
1090539|NCT01031628|2642314|P4|STARTED|Overall Study||0
1090540|NCT01031628|2642315|P3|STARTED|Overall Study||3
1090541|NCT01031628|2642316|P2|STARTED|Overall Study||1
1090542|NCT01031628|2642317|P1|STARTED|Overall Study||0
1090543|NCT01031680|2642329|P2|NOT COMPLETED|Overall Study||58
1090544|NCT01031680|2642330|P1|NOT COMPLETED|Overall Study||57
1090545|NCT01031680|2642329|P2|COMPLETED|Overall Study||404
1090546|NCT01031680|2642330|P1|COMPLETED|Overall Study||403
1090547|NCT01031680|2642329|P2|STARTED|Overall Study|Of the 462 randomized participants only 459 were included in the full analysis set.|462
1090548|NCT01031680|2642330|P1|STARTED|Overall Study|Of the 460 randomized participants only 455 were included in the full analysis set.|460
1090549|NCT01031706|2642348|P2|NOT COMPLETED|Overall Study||1
1090550|NCT01031706|2642349|P1|NOT COMPLETED|Overall Study||2
1090551|NCT01031706|2642348|P2|COMPLETED|Overall Study||8
1090552|NCT01031706|2642349|P1|COMPLETED|Overall Study||12
1090553|NCT01031706|2642348|P2|STARTED|Overall Study||9
1090554|NCT01031706|2642349|P1|STARTED|Overall Study||14
1090555|NCT01031810|2642357|P1|NOT COMPLETED|Overall Study||4
1090556|NCT01031810|2642357|P1|COMPLETED|Overall Study||9
1090557|NCT01031810|2642357|P1|STARTED|Overall Study||13
1090558|NCT01031914|2642366|P1|NOT COMPLETED|Overall Study||0
1090559|NCT01031914|2642366|P1|COMPLETED|Overall Study||36
1090560|NCT01031914|2642366|P1|STARTED|Overall Study||36
1090561|NCT01031953|2642370|P1|NOT COMPLETED|Overall Study||0
1090562|NCT01031953|2642370|P1|COMPLETED|Overall Study||11
1090563|NCT01031953|2642370|P1|STARTED|Overall Study||11
1090564|NCT01031979|2642383|P2|NOT COMPLETED|Overall Study||4
1090565|NCT01031979|2642384|P1|NOT COMPLETED|Overall Study||5
1090566|NCT01031979|2642383|P2|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|8
1090567|NCT01031979|2642384|P1|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|9
1090568|NCT01031979|2642383|P2|Completed Primary Outcome Measure|Overall Study||12
1090569|NCT01031979|2642384|P1|Completed Primary Outcome Measure|Overall Study||12
1090570|NCT01031979|2642383|P2|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|12
1090571|NCT01031979|2642384|P1|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|14
1090572|NCT01032018|2642398|P2|NOT COMPLETED|Overall Study||6
1090573|NCT01032018|2642399|P1|NOT COMPLETED|Overall Study||6
1090574|NCT01032018|2642398|P2|COMPLETED|Overall Study||67
1090575|NCT01032018|2642399|P1|COMPLETED|Overall Study||71
1090576|NCT01032018|2642398|P2|STARTED|Overall Study||73
1090577|NCT01032018|2642399|P1|STARTED|Overall Study||77
1090578|NCT01032044|2642409|P2|NOT COMPLETED|Overall Study||20
1090579|NCT01032044|2642410|P1|NOT COMPLETED|Overall Study||25
1090580|NCT01032044|2642409|P2|COMPLETED|Overall Study||62
1090581|NCT01032044|2642410|P1|COMPLETED|Overall Study||57
1090582|NCT01032044|2642409|P2|Procedure|Overall Study||75
1090583|NCT01032044|2642410|P1|Procedure|Overall Study||74
1090584|NCT01032044|2642409|P2|STARTED|Overall Study||82
1090585|NCT01032044|2642410|P1|STARTED|Overall Study||82
1090586|NCT01032070|2642418|P2|NOT COMPLETED|Overall Study||12
1090587|NCT01032070|2642419|P1|NOT COMPLETED|Overall Study||13
1090588|NCT01032070|2642418|P2|COMPLETED|Overall Study||0
1090589|NCT01032070|2642419|P1|COMPLETED|Overall Study||0
1090590|NCT01032070|2642418|P2|STARTED|Overall Study||12
1090591|NCT01032070|2642419|P1|STARTED|Overall Study||13
1090592|NCT01032135|2642451|P7|NOT COMPLETED|8 Week Randomization||18
1090593|NCT01032135|2642452|P6|NOT COMPLETED|8 Week Randomization||17
1090594|NCT01032135|2642453|P5|NOT COMPLETED|8 Week Randomization||9
1090595|NCT01032135|2642454|P4|NOT COMPLETED|8 Week Randomization||11
1090596|NCT01032135|2642455|P3|NOT COMPLETED|8 Week Randomization||0
1090597|NCT01032135|2642456|P2|NOT COMPLETED|8 Week Randomization||0
1090598|NCT01032135|2642457|P1|NOT COMPLETED|8 Week Randomization||26
1090599|NCT01032135|2642451|P7|COMPLETED|8 Week Randomization||36
1090600|NCT01032135|2642452|P6|COMPLETED|8 Week Randomization||31
1090601|NCT01032135|2642453|P5|COMPLETED|8 Week Randomization||34
1090602|NCT01032135|2642454|P4|COMPLETED|8 Week Randomization||30
1090603|NCT01032135|2642455|P3|COMPLETED|8 Week Randomization||0
1090604|NCT01032135|2642456|P2|COMPLETED|8 Week Randomization||0
1090605|NCT01032135|2642457|P1|COMPLETED|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|201
1090606|NCT01032135|2642451|P7|12 Week Follow up|8 Week Randomization||41
1090607|NCT01032135|2642452|P6|12 Week Follow up|8 Week Randomization||36
1090608|NCT01032135|2642453|P5|12 Week Follow up|8 Week Randomization||38
1090609|NCT01032135|2642454|P4|12 Week Follow up|8 Week Randomization||34
1090610|NCT01032135|2642455|P3|12 Week Follow up|8 Week Randomization||0
1090611|NCT01032135|2642456|P2|12 Week Follow up|8 Week Randomization||0
1090612|NCT01032135|2642457|P1|12 Week Follow up|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|217
1090613|NCT01032135|2642451|P7|STARTED|8 Week Randomization||54
1090614|NCT01032135|2642452|P6|STARTED|8 Week Randomization||48
1090615|NCT01032135|2642453|P5|STARTED|8 Week Randomization||43
1090616|NCT01032135|2642454|P4|STARTED|8 Week Randomization||41
1090617|NCT01032135|2642455|P3|STARTED|8 Week Randomization||0
1090618|NCT01032135|2642456|P2|STARTED|8 Week Randomization||0
1090619|NCT01032135|2642457|P1|STARTED|8 Week Randomization||227
1090620|NCT01032135|2642451|P7|NOT COMPLETED|2 Week Randomization||0
1090621|NCT01032135|2642452|P6|NOT COMPLETED|2 Week Randomization||0
1090622|NCT01032135|2642453|P5|NOT COMPLETED|2 Week Randomization||0
1090623|NCT01032135|2642454|P4|NOT COMPLETED|2 Week Randomization||0
1090624|NCT01032135|2642455|P3|NOT COMPLETED|2 Week Randomization||0
1090625|NCT01032135|2642456|P2|NOT COMPLETED|2 Week Randomization||0
1090626|NCT01032135|2642457|P1|NOT COMPLETED|2 Week Randomization||0
1090627|NCT01032135|2642451|P7|COMPLETED|2 Week Randomization||0
1090628|NCT01032135|2642452|P6|COMPLETED|2 Week Randomization||0
1090629|NCT01032135|2642453|P5|COMPLETED|2 Week Randomization||0
1090630|NCT01032135|2642454|P4|COMPLETED|2 Week Randomization||0
1090631|NCT01032135|2642455|P3|COMPLETED|2 Week Randomization||96
1090632|NCT01032135|2642456|P2|COMPLETED|2 Week Randomization||93
1090633|NCT01032135|2642457|P1|COMPLETED|2 Week Randomization||311
1090634|NCT01032135|2642451|P7|STARTED|2 Week Randomization||0
1090635|NCT01032135|2642452|P6|STARTED|2 Week Randomization||0
1090636|NCT01032135|2642453|P5|STARTED|2 Week Randomization||0
1090637|NCT01032135|2642454|P4|STARTED|2 Week Randomization||0
1090638|NCT01032135|2642455|P3|STARTED|2 Week Randomization||96
1090639|NCT01032135|2642456|P2|STARTED|2 Week Randomization||93
1090640|NCT01032135|2642457|P1|STARTED|2 Week Randomization||311
1090641|NCT01032174|2642676|P2|NOT COMPLETED|Overall Study||1
1090642|NCT01032174|2642677|P1|NOT COMPLETED|Overall Study||0
1090643|NCT01032174|2642676|P2|COMPLETED|Overall Study||59
1090644|NCT01032174|2642677|P1|COMPLETED|Overall Study||63
1090645|NCT01032174|2642676|P2|STARTED|Overall Study||60
1090646|NCT01032174|2642677|P1|STARTED|Overall Study||63
1090647|NCT01032200|2642689|P2|NOT COMPLETED|Overall Study||7
1090648|NCT01032200|2642690|P1|NOT COMPLETED|Overall Study||4
1090649|NCT01032200|2642689|P2|COMPLETED|Overall Study||21
1090650|NCT01032200|2642690|P1|COMPLETED|Overall Study||22
1090651|NCT01032200|2642689|P2|STARTED|Overall Study||28
1090652|NCT01032200|2642690|P1|STARTED|Overall Study||26
1090653|NCT01032265|2642706|P2|NOT COMPLETED|Overall Study||17
1090654|NCT01032265|2642707|P1|NOT COMPLETED|Overall Study||13
1090655|NCT01032265|2642706|P2|COMPLETED|Overall Study||107
1090656|NCT01032265|2642707|P1|COMPLETED|Overall Study||113
1090657|NCT01032265|2642706|P2|STARTED|Overall Study||124
1090658|NCT01032265|2642707|P1|STARTED|Overall Study||126
1090659|NCT01032291|2642728|P3|NOT COMPLETED|Proof of Concept||3
1090660|NCT01032291|2642729|P2|NOT COMPLETED|Proof of Concept||8
1090661|NCT01032291|2642730|P1|NOT COMPLETED|Proof of Concept||0
1090748|NCT01032915|2642931|P2|COMPLETED|Overall Study||20
1090662|NCT01032291|2642728|P3|COMPLETED|Proof of Concept|Participants with disease progression|18
1090663|NCT01032291|2642729|P2|COMPLETED|Proof of Concept|Participants with disease progression|14
1090664|NCT01032291|2642730|P1|COMPLETED|Proof of Concept||0
1090665|NCT01032291|2642728|P3|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
1090666|NCT01032291|2642729|P2|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
1090667|NCT01032291|2642730|P1|Intent to Treat and Safety Populations|Proof of Concept||0
1090668|NCT01032291|2642728|P3|STARTED|Proof of Concept||21
1090669|NCT01032291|2642729|P2|STARTED|Proof of Concept||22
1090670|NCT01032291|2642730|P1|STARTED|Proof of Concept||0
1090671|NCT01032291|2642728|P3|NOT COMPLETED|Safety Lead-in||0
1090672|NCT01032291|2642729|P2|NOT COMPLETED|Safety Lead-in||0
1090673|NCT01032291|2642730|P1|NOT COMPLETED|Safety Lead-in||2
1090674|NCT01032291|2642728|P3|COMPLETED|Safety Lead-in||0
1090675|NCT01032291|2642729|P2|COMPLETED|Safety Lead-in||0
1090676|NCT01032291|2642730|P1|COMPLETED|Safety Lead-in|Participants with disease progression|6
1090677|NCT01032291|2642728|P3|STARTED|Safety Lead-in||0
1090678|NCT01032291|2642729|P2|STARTED|Safety Lead-in||0
1090679|NCT01032291|2642730|P1|STARTED|Safety Lead-in||8
1090680|NCT01032382|2642756|P2|NOT COMPLETED|Overall Study||5
1090681|NCT01032382|2642757|P1|NOT COMPLETED|Overall Study||5
1090682|NCT01032382|2642756|P2|COMPLETED|Overall Study||9
1090683|NCT01032382|2642757|P1|COMPLETED|Overall Study||11
1090684|NCT01032382|2642756|P2|STARTED|Overall Study||14
1090685|NCT01032382|2642757|P1|STARTED|Overall Study||16
1090686|NCT01032538|2642783|P1|NOT COMPLETED|Overall Study||0
1090687|NCT01032538|2642783|P1|COMPLETED|Overall Study|Knees|99
1090688|NCT01032538|2642783|P1|STARTED|Overall Study|Knees|99
1090689|NCT01032694|2642791|P2|NOT COMPLETED|Overall Study||0
1090690|NCT01032694|2642792|P1|NOT COMPLETED|Overall Study||0
1090691|NCT01032694|2642791|P2|COMPLETED|Overall Study||10
1090692|NCT01032694|2642792|P1|COMPLETED|Overall Study||20
1090693|NCT01032694|2642791|P2|STARTED|Overall Study||10
1090694|NCT01032694|2642792|P1|STARTED|Overall Study||20
1090695|NCT01032733|2642804|P2|NOT COMPLETED|Overall Study||1
1090696|NCT01032733|2642805|P1|NOT COMPLETED|Overall Study||1
1090697|NCT01032733|2642804|P2|COMPLETED|Overall Study||16
1090698|NCT01032733|2642805|P1|COMPLETED|Overall Study||16
1090699|NCT01032733|2642804|P2|STARTED|Overall Study||17
1090700|NCT01032733|2642805|P1|STARTED|Overall Study||17
1090701|NCT01032759|2642821|P2|NOT COMPLETED|Overall Study||3
1090702|NCT01032759|2642822|P1|NOT COMPLETED|Overall Study||1
1090703|NCT01032759|2642821|P2|COMPLETED|Overall Study||28
1090704|NCT01032759|2642822|P1|COMPLETED|Overall Study||31
1090705|NCT01032759|2642821|P2|Completed 48 Hour Assessment|Overall Study||28
1090706|NCT01032759|2642822|P1|Completed 48 Hour Assessment|Overall Study||31
1090707|NCT01032759|2642821|P2|Completed 24 Hour Assessment|Overall Study||30
1090708|NCT01032759|2642822|P1|Completed 24 Hour Assessment|Overall Study||32
1090709|NCT01032759|2642821|P2|STARTED|Overall Study||31
1090710|NCT01032759|2642822|P1|STARTED|Overall Study||32
1090711|NCT01032837|2642844|P4|NOT COMPLETED|Overall Study||3
1090712|NCT01032837|2642845|P3|NOT COMPLETED|Overall Study||1
1090713|NCT01032837|2642846|P2|NOT COMPLETED|Overall Study||3
1090714|NCT01032837|2642847|P1|NOT COMPLETED|Overall Study||0
1090715|NCT01032837|2642844|P4|COMPLETED|Overall Study|Represents patients who completed treatment.|22
1090716|NCT01032837|2642845|P3|COMPLETED|Overall Study|Represents patients who completed treatment.|24
1090717|NCT01032837|2642846|P2|COMPLETED|Overall Study|Represents patients who completed treatment.|23
1090718|NCT01032837|2642847|P1|COMPLETED|Overall Study|Represents patients who completed treatment.|26
1090719|NCT01032837|2642844|P4|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|24
1090720|NCT01032837|2642845|P3|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|25
1090721|NCT01032837|2642846|P2|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
1090722|NCT01032837|2642847|P1|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
1090723|NCT01032837|2642844|P4|STARTED|Overall Study||25
1090724|NCT01032837|2642845|P3|STARTED|Overall Study||25
1090725|NCT01032837|2642846|P2|STARTED|Overall Study||26
1090726|NCT01032837|2642847|P1|STARTED|Overall Study||26
1090727|NCT01032850|2642893|P1|NOT COMPLETED|Overall Study||2
1090728|NCT01032850|2642893|P1|COMPLETED|Overall Study||13
1090729|NCT01032850|2642893|P1|STARTED|Overall Study||15
1090730|NCT01032889|2642903|P3|NOT COMPLETED|Overall Study||3
1090731|NCT01032889|2642904|P2|NOT COMPLETED|Overall Study||15
1090732|NCT01032889|2642905|P1|NOT COMPLETED|Overall Study||8
1090733|NCT01032889|2642903|P3|COMPLETED|Overall Study||42
1090734|NCT01032889|2642904|P2|COMPLETED|Overall Study||28
1090735|NCT01032889|2642905|P1|COMPLETED|Overall Study||33
1090736|NCT01032889|2642903|P3|Received Treatment|Overall Study||45
1090737|NCT01032889|2642904|P2|Received Treatment|Overall Study||43
1090738|NCT01032889|2642905|P1|Received Treatment|Overall Study||41
1090739|NCT01032889|2642903|P3|STARTED|Overall Study||45
1090740|NCT01032889|2642904|P2|STARTED|Overall Study||43
1090741|NCT01032889|2642905|P1|STARTED|Overall Study||41
1090742|NCT01032915|2642929|P4|NOT COMPLETED|Overall Study||7
1090743|NCT01032915|2642930|P3|NOT COMPLETED|Overall Study||7
1090744|NCT01032915|2642931|P2|NOT COMPLETED|Overall Study||11
1090745|NCT01032915|2642932|P1|NOT COMPLETED|Overall Study||8
1090746|NCT01032915|2642929|P4|COMPLETED|Overall Study||27
1090747|NCT01032915|2642930|P3|COMPLETED|Overall Study||24
1090749|NCT01032915|2642932|P1|COMPLETED|Overall Study||21
1090750|NCT01032915|2642929|P4|STARTED|Overall Study||34
1090751|NCT01032915|2642930|P3|STARTED|Overall Study||31
1090752|NCT01032915|2642931|P2|STARTED|Overall Study||31
1090753|NCT01032915|2642932|P1|STARTED|Overall Study||29
1090754|NCT01032928|2642954|P1|NOT COMPLETED|Overall Study||0
1090755|NCT01032928|2642954|P1|COMPLETED|Overall Study||30
1090756|NCT01032928|2642954|P1|STARTED|Overall Study||30
1090757|NCT01032993|2642968|P2|NOT COMPLETED|Overall Study||0
1090758|NCT01032993|2642969|P1|NOT COMPLETED|Overall Study||0
1090759|NCT01032993|2642968|P2|COMPLETED|Overall Study||20
1090760|NCT01032993|2642969|P1|COMPLETED|Overall Study||19
1090761|NCT01032993|2642968|P2|STARTED|Overall Study||20
1090762|NCT01032993|2642969|P1|STARTED|Overall Study||19
1090763|NCT01033019|2642983|P2|NOT COMPLETED|Overall Study||0
1090764|NCT01033019|2642984|P1|NOT COMPLETED|Overall Study||1
1090765|NCT01033019|2642983|P2|COMPLETED|Overall Study||8
1090766|NCT01033019|2642984|P1|COMPLETED|Overall Study||15
1090767|NCT01033019|2642983|P2|STARTED|Overall Study||8
1090768|NCT01033019|2642984|P1|STARTED|Overall Study||16
1090769|NCT01033032|2642991|P4|NOT COMPLETED|Phase II||0
1090770|NCT01033032|2642992|P3|NOT COMPLETED|Phase II||66
1090771|NCT01033032|2642993|P2|NOT COMPLETED|Phase II||0
1090772|NCT01033032|2642994|P1|NOT COMPLETED|Phase II||0
1090773|NCT01033032|2642991|P4|COMPLETED|Phase II||0
1090774|NCT01033032|2642992|P3|COMPLETED|Phase II|Patients continued recieving treatment until disease progression or unacceptable toxicity|0
1090775|NCT01033032|2642993|P2|COMPLETED|Phase II||0
1090776|NCT01033032|2642994|P1|COMPLETED|Phase II||0
1090777|NCT01033032|2642991|P4|STARTED|Phase II||0
1090778|NCT01033032|2642992|P3|STARTED|Phase II|Includes patients treated at MTD during Phase I (3 patients); 63 additional patients enrolled|66
1090779|NCT01033032|2642993|P2|STARTED|Phase II||0
1090780|NCT01033032|2642994|P1|STARTED|Phase II||0
1090781|NCT01033032|2642991|P4|NOT COMPLETED|Phase I||6
1090782|NCT01033032|2642992|P3|NOT COMPLETED|Phase I||0
1090783|NCT01033032|2642993|P2|NOT COMPLETED|Phase I||3
1090784|NCT01033032|2642994|P1|NOT COMPLETED|Phase I||3
1090785|NCT01033032|2642991|P4|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
1090786|NCT01033032|2642992|P3|COMPLETED|Phase I||3
1090787|NCT01033032|2642993|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
1090788|NCT01033032|2642994|P1|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
1090789|NCT01033032|2642991|P4|STARTED|Phase I||6
1090790|NCT01033032|2642992|P3|STARTED|Phase I||3
1090791|NCT01033032|2642993|P2|STARTED|Phase I||3
1090792|NCT01033032|2642994|P1|STARTED|Phase I||3
1090793|NCT01033071|2643004|P3|NOT COMPLETED|Overall Study||47
1090794|NCT01033071|2643005|P2|NOT COMPLETED|Overall Study||77
1090795|NCT01033071|2643006|P1|NOT COMPLETED|Overall Study||55
1090796|NCT01033071|2643004|P3|COMPLETED|Overall Study||317
1090797|NCT01033071|2643005|P2|COMPLETED|Overall Study||275
1090798|NCT01033071|2643006|P1|COMPLETED|Overall Study||300
1090799|NCT01033071|2643004|P3|STARTED|Overall Study||364
1090800|NCT01033071|2643005|P2|STARTED|Overall Study||352
1090801|NCT01033071|2643006|P1|STARTED|Overall Study||355
1090808|NCT01040351|2643076|P2|NOT COMPLETED|Overall Study||2
1090809|NCT01040351|2643077|P1|NOT COMPLETED|Overall Study||1
1090810|NCT01040351|2643076|P2|COMPLETED|Overall Study|May 2010|53
1090811|NCT01040351|2643077|P1|COMPLETED|Overall Study|May 2010|54
1090812|NCT01040351|2643076|P2|STARTED|Overall Study|October 2006|55
1090813|NCT01040351|2643077|P1|STARTED|Overall Study|October 2006|55
1090814|NCT01040403|2643085|P1|NOT COMPLETED|Overall Study||20
1090815|NCT01040403|2643085|P1|COMPLETED|Overall Study|All treatment periods|213
1090816|NCT01040403|2643085|P1|Completed T+O 5/10|Overall Study||107
1090817|NCT01040403|2643085|P1|Completed T+O 2.5/10|Overall Study||110
1090818|NCT01040403|2643085|P1|Completed T+O 1.25/10|Overall Study||106
1090819|NCT01040403|2643085|P1|Completed Olo 10|Overall Study||109
1090820|NCT01040403|2643085|P1|Completed T+O 5/5|Overall Study||106
1090821|NCT01040403|2643085|P1|Completed T+O 2.5/5|Overall Study||111
1090822|NCT01040403|2643085|P1|Completed T+O 1.25/5|Overall Study||105
1090823|NCT01040403|2643085|P1|Completed Olo 5|Overall Study||106
1090824|NCT01040403|2643085|P1|STARTED|Overall Study||233
1090825|NCT01040624|2643273|P2|NOT COMPLETED|Overall Study||0
1090826|NCT01040624|2643274|P1|NOT COMPLETED|Overall Study||0
1090827|NCT01040624|2643273|P2|COMPLETED|Overall Study||19
1090828|NCT01040624|2643274|P1|COMPLETED|Overall Study||58
1090829|NCT01040624|2643273|P2|STARTED|Overall Study||19
1090830|NCT01040624|2643274|P1|STARTED|Overall Study||58
1090831|NCT01041859|2643282|P3|NOT COMPLETED|Double-Blind Maintenance||45
1090832|NCT01041859|2643283|P2|NOT COMPLETED|Double-Blind Maintenance||46
1090833|NCT01041859|2643284|P1|NOT COMPLETED|Double-Blind Maintenance||0
1090834|NCT01041859|2643282|P3|COMPLETED|Double-Blind Maintenance||107
1090835|NCT01041859|2643283|P2|COMPLETED|Double-Blind Maintenance||120
1090836|NCT01041859|2643284|P1|COMPLETED|Double-Blind Maintenance||0
1090837|NCT01041859|2643282|P3|STARTED|Double-Blind Maintenance|152 randomized, all were treated.|152
1090927|NCT01042236|2643364|P3|COMPLETED|Treatment Period 1||3
1090838|NCT01041859|2643283|P2|STARTED|Double-Blind Maintenance|168 were randomized, 2 were not treated (1 randomized in error, 1 withdrew consent).|166
1090839|NCT01041859|2643284|P1|STARTED|Double-Blind Maintenance||0
1090840|NCT01041859|2643282|P3|NOT COMPLETED|Open-Label Titration||0
1090841|NCT01041859|2643283|P2|NOT COMPLETED|Open-Label Titration||0
1090842|NCT01041859|2643284|P1|NOT COMPLETED|Open-Label Titration||101
1090843|NCT01041859|2643282|P3|COMPLETED|Open-Label Titration||0
1090844|NCT01041859|2643283|P2|COMPLETED|Open-Label Titration||0
1090845|NCT01041859|2643284|P1|COMPLETED|Open-Label Titration|Of 358 completed subjects, 320 were randomized to the Double-Blind Maintenance Period.|358
1090846|NCT01041859|2643282|P3|STARTED|Open-Label Titration||0
1090847|NCT01041859|2643283|P2|STARTED|Open-Label Titration||0
1090848|NCT01041859|2643284|P1|STARTED|Open-Label Titration|Of 460 total enrollment, one subject enrolled twice; this subject's second enrollment is excluded.|459
1090849|NCT01041976|2643301|P2|NOT COMPLETED|Overall Study||4
1090850|NCT01041976|2643302|P1|NOT COMPLETED|Overall Study||5
1090851|NCT01041976|2643301|P2|COMPLETED|Overall Study||38
1090852|NCT01041976|2643302|P1|COMPLETED|Overall Study||37
1090853|NCT01041976|2643301|P2|18 Month Follow-up|Overall Study||38
1090854|NCT01041976|2643302|P1|18 Month Follow-up|Overall Study||37
1090855|NCT01041976|2643301|P2|12 Month Follow-up|Overall Study||38
1090856|NCT01041976|2643302|P1|12 Month Follow-up|Overall Study||37
1090857|NCT01041976|2643301|P2|6 Month Follow-up|Overall Study||41
1090858|NCT01041976|2643302|P1|6 Month Follow-up|Overall Study||39
1090859|NCT01041976|2643301|P2|STARTED|Overall Study||42
1090860|NCT01041976|2643302|P1|STARTED|Overall Study||42
1090861|NCT01042093|2643314|P4|NOT COMPLETED|Overall Study||4
1090862|NCT01042093|2643315|P3|NOT COMPLETED|Overall Study||2
1090863|NCT01042093|2643316|P2|NOT COMPLETED|Overall Study||2
1090864|NCT01042093|2643317|P1|NOT COMPLETED|Overall Study||2
1090865|NCT01042093|2643314|P4|COMPLETED|Overall Study||36
1090866|NCT01042093|2643315|P3|COMPLETED|Overall Study||38
1090867|NCT01042093|2643316|P2|COMPLETED|Overall Study||38
1090868|NCT01042093|2643317|P1|COMPLETED|Overall Study||38
1090869|NCT01042093|2643314|P4|STARTED|Overall Study||40
1090870|NCT01042093|2643315|P3|STARTED|Overall Study||40
1090871|NCT01042093|2643316|P2|STARTED|Overall Study||40
1090872|NCT01042093|2643317|P1|STARTED|Overall Study||40
1090873|NCT01042145|2643337|P2|NOT COMPLETED|Overall Study||1
1090874|NCT01042145|2643338|P1|NOT COMPLETED|Overall Study||1
1090875|NCT01042145|2643337|P2|COMPLETED|Overall Study||45
1090876|NCT01042145|2643338|P1|COMPLETED|Overall Study||40
1090877|NCT01042145|2643337|P2|STARTED|Overall Study||46
1090878|NCT01042145|2643338|P1|STARTED|Overall Study||41
1090879|NCT01042158|2643354|P1|NOT COMPLETED|Overall Study||1
1090880|NCT01042158|2643354|P1|COMPLETED|Overall Study||24
1090881|NCT01042158|2643354|P1|STARTED|Overall Study||25
1090882|NCT01042236|2643361|P6|NOT COMPLETED|Treatment Period 3||0
1090883|NCT01042236|2643362|P5|NOT COMPLETED|Treatment Period 3||0
1090884|NCT01042236|2643363|P4|NOT COMPLETED|Treatment Period 3||2
1090885|NCT01042236|2643364|P3|NOT COMPLETED|Treatment Period 3||0
1090886|NCT01042236|2643365|P2|NOT COMPLETED|Treatment Period 3||0
1090887|NCT01042236|2643366|P1|NOT COMPLETED|Treatment Period 3||0
1090888|NCT01042236|2643361|P6|COMPLETED|Treatment Period 3||3
1090889|NCT01042236|2643362|P5|COMPLETED|Treatment Period 3||3
1090890|NCT01042236|2643363|P4|COMPLETED|Treatment Period 3||3
1090891|NCT01042236|2643364|P3|COMPLETED|Treatment Period 3||3
1090892|NCT01042236|2643365|P2|COMPLETED|Treatment Period 3||3
1090893|NCT01042236|2643366|P1|COMPLETED|Treatment Period 3||3
1090894|NCT01042236|2643361|P6|STARTED|Treatment Period 3||3
1090895|NCT01042236|2643362|P5|STARTED|Treatment Period 3||3
1090896|NCT01042236|2643363|P4|STARTED|Treatment Period 3||5
1090897|NCT01042236|2643364|P3|STARTED|Treatment Period 3||3
1090898|NCT01042236|2643365|P2|STARTED|Treatment Period 3||3
1090899|NCT01042236|2643366|P1|STARTED|Treatment Period 3||3
1090900|NCT01042236|2643361|P6|NOT COMPLETED|Treatment Period 2||0
1090901|NCT01042236|2643362|P5|NOT COMPLETED|Treatment Period 2||0
1090902|NCT01042236|2643363|P4|NOT COMPLETED|Treatment Period 2||0
1090903|NCT01042236|2643364|P3|NOT COMPLETED|Treatment Period 2||0
1090904|NCT01042236|2643365|P2|NOT COMPLETED|Treatment Period 2||0
1090905|NCT01042236|2643366|P1|NOT COMPLETED|Treatment Period 2||0
1090906|NCT01042236|2643361|P6|COMPLETED|Treatment Period 2||3
1090907|NCT01042236|2643362|P5|COMPLETED|Treatment Period 2||3
1090908|NCT01042236|2643363|P4|COMPLETED|Treatment Period 2||5
1090909|NCT01042236|2643364|P3|COMPLETED|Treatment Period 2||3
1090910|NCT01042236|2643365|P2|COMPLETED|Treatment Period 2||3
1090911|NCT01042236|2643366|P1|COMPLETED|Treatment Period 2||3
1090912|NCT01042236|2643361|P6|STARTED|Treatment Period 2||3
1090913|NCT01042236|2643362|P5|STARTED|Treatment Period 2||3
1090914|NCT01042236|2643363|P4|STARTED|Treatment Period 2||5
1090915|NCT01042236|2643364|P3|STARTED|Treatment Period 2||3
1090916|NCT01042236|2643365|P2|STARTED|Treatment Period 2||3
1090917|NCT01042236|2643366|P1|STARTED|Treatment Period 2||3
1090918|NCT01042236|2643361|P6|NOT COMPLETED|Treatment Period 1||0
1090919|NCT01042236|2643362|P5|NOT COMPLETED|Treatment Period 1||1
1090920|NCT01042236|2643363|P4|NOT COMPLETED|Treatment Period 1||0
1090921|NCT01042236|2643364|P3|NOT COMPLETED|Treatment Period 1||0
1090922|NCT01042236|2643365|P2|NOT COMPLETED|Treatment Period 1||1
1090923|NCT01042236|2643366|P1|NOT COMPLETED|Treatment Period 1||0
1090924|NCT01042236|2643361|P6|COMPLETED|Treatment Period 1||3
1090925|NCT01042236|2643362|P5|COMPLETED|Treatment Period 1||3
1090926|NCT01042236|2643363|P4|COMPLETED|Treatment Period 1||5
1090928|NCT01042236|2643365|P2|COMPLETED|Treatment Period 1||3
1090929|NCT01042236|2643366|P1|COMPLETED|Treatment Period 1||3
1090930|NCT01042236|2643361|P6|STARTED|Treatment Period 1||3
1090931|NCT01042236|2643362|P5|STARTED|Treatment Period 1||4
1090932|NCT01042236|2643363|P4|STARTED|Treatment Period 1||5
1090933|NCT01042236|2643364|P3|STARTED|Treatment Period 1||3
1090934|NCT01042236|2643365|P2|STARTED|Treatment Period 1||4
1090935|NCT01042236|2643366|P1|STARTED|Treatment Period 1||3
1090936|NCT01042288|2643403|P1|NOT COMPLETED|Overall Study||69
1090937|NCT01042288|2643403|P1|COMPLETED|Overall Study|Patients remained on maintenance until disease progression, toxicity or other reason to come off|0
1090938|NCT01042288|2643403|P1|Maintenance|Overall Study||27
1090939|NCT01042288|2643403|P1|STARTED|Overall Study||69
1090940|NCT01042366|2643414|P3|NOT COMPLETED|Overall Study||0
1090941|NCT01042366|2643415|P2|NOT COMPLETED|Overall Study||0
1090942|NCT01042366|2643416|P1|NOT COMPLETED|Overall Study||0
1090943|NCT01042366|2643414|P3|COMPLETED|Overall Study||4
1090944|NCT01042366|2643415|P2|COMPLETED|Overall Study||6
1090945|NCT01042366|2643416|P1|COMPLETED|Overall Study||5
1090946|NCT01042366|2643414|P3|STARTED|Overall Study||4
1090947|NCT01042366|2643415|P2|STARTED|Overall Study||6
1090948|NCT01042366|2643416|P1|STARTED|Overall Study||5
1090949|NCT01042392|2643427|P4|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
1090950|NCT01042392|2643428|P3|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||4
1090951|NCT01042392|2643429|P2|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
1090952|NCT01042392|2643430|P1|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||2
1090953|NCT01042392|2643427|P4|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||121
1090954|NCT01042392|2643428|P3|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||115
1090955|NCT01042392|2643429|P2|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||117
1090956|NCT01042392|2643430|P1|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||127
1090957|NCT01042392|2643427|P4|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||82
1090958|NCT01042392|2643428|P3|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||93
1090959|NCT01042392|2643429|P2|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||73
1090960|NCT01042392|2643430|P1|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)|PPMD excluded patients violated protocol instructions for period 3 (duration and treatment intake)|98
1090961|NCT01042392|2643427|P4|STARTED|Period III (Unblinded,Controlled, 1 Day)||122
1090962|NCT01042392|2643428|P3|STARTED|Period III (Unblinded,Controlled, 1 Day)||119
1090963|NCT01042392|2643429|P2|STARTED|Period III (Unblinded,Controlled, 1 Day)||118
1090964|NCT01042392|2643430|P1|STARTED|Period III (Unblinded,Controlled, 1 Day)||129
1090965|NCT01042392|2643427|P4|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
1090966|NCT01042392|2643428|P3|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||8
1090967|NCT01042392|2643429|P2|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
1090968|NCT01042392|2643430|P1|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||10
1090969|NCT01042392|2643427|P4|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
1090970|NCT01042392|2643428|P3|COMPLETED|Period II(Randomized,Double Blinded,8wk)||241
1090971|NCT01042392|2643429|P2|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
1090972|NCT01042392|2643430|P1|COMPLETED|Period II(Randomized,Double Blinded,8wk)||247
1090973|NCT01042392|2643427|P4|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
1090974|NCT01042392|2643428|P3|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||222
1090975|NCT01042392|2643429|P2|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
1090976|NCT01042392|2643430|P1|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)|ITT excluded patients from centers where 90% of BP measurements were rounded to 5 or 0|222
1090977|NCT01042392|2643427|P4|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
1090978|NCT01042392|2643428|P3|STARTED|Period II(Randomized,Double Blinded,8wk)||249
1090979|NCT01042392|2643429|P2|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
1090980|NCT01042392|2643430|P1|STARTED|Period II(Randomized,Double Blinded,8wk)||257
1090981|NCT01042496|2643458|P2|NOT COMPLETED|Overall Study||0
1090982|NCT01042496|2643459|P1|NOT COMPLETED|Overall Study||0
1090983|NCT01042496|2643458|P2|COMPLETED|Overall Study||33
1090984|NCT01042496|2643459|P1|COMPLETED|Overall Study||29
1090985|NCT01042496|2643458|P2|STARTED|Overall Study||33
1090986|NCT01042496|2643459|P1|STARTED|Overall Study||29
1090987|NCT01042509|2643475|P1|NOT COMPLETED|Overall Study||0
1090988|NCT01042509|2643475|P1|COMPLETED|Overall Study||15
1090989|NCT01042509|2643475|P1|STARTED|Overall Study||15
1090993|NCT01042600|2643490|P2|NOT COMPLETED|Overall Study||0
1090994|NCT01042600|2643491|P1|NOT COMPLETED|Overall Study||1
1090995|NCT01042600|2643490|P2|COMPLETED|Overall Study||30
1090996|NCT01042600|2643491|P1|COMPLETED|Overall Study||30
1090997|NCT01042600|2643490|P2|STARTED|Overall Study||30
1090998|NCT01042600|2643491|P1|STARTED|Overall Study||31
1090999|NCT01042613|2643501|P2|NOT COMPLETED|Overall Study||0
1091000|NCT01042613|2643502|P1|NOT COMPLETED|Overall Study||0
1091001|NCT01042613|2643501|P2|COMPLETED|Overall Study||74
1091002|NCT01042613|2643502|P1|COMPLETED|Overall Study||72
1091003|NCT01042613|2643501|P2|STARTED|Overall Study||74
1091004|NCT01042613|2643502|P1|STARTED|Overall Study||72
1091005|NCT01042678|2643515|P6|NOT COMPLETED|Overall Study||0
1091006|NCT01042678|2643516|P5|NOT COMPLETED|Overall Study||0
1091007|NCT01042678|2643517|P4|NOT COMPLETED|Overall Study||0
1091008|NCT01042678|2643518|P3|NOT COMPLETED|Overall Study||0
1091009|NCT01042678|2643519|P2|NOT COMPLETED|Overall Study||0
1091010|NCT01042678|2643520|P1|NOT COMPLETED|Overall Study||1
1091011|NCT01042678|2643515|P6|COMPLETED|Overall Study||0
1091012|NCT01042678|2643516|P5|COMPLETED|Overall Study||0
1091013|NCT01042678|2643517|P4|COMPLETED|Overall Study||0
1091014|NCT01042678|2643518|P3|COMPLETED|Overall Study||6
1091015|NCT01042678|2643519|P2|COMPLETED|Overall Study||6
1091016|NCT01042678|2643520|P1|COMPLETED|Overall Study||5
1091017|NCT01042678|2643515|P6|STARTED|Overall Study||0
1091018|NCT01042678|2643516|P5|STARTED|Overall Study||0
1091019|NCT01042678|2643517|P4|STARTED|Overall Study||0
1091020|NCT01042678|2643518|P3|STARTED|Overall Study||6
1091021|NCT01042678|2643519|P2|STARTED|Overall Study||6
1091022|NCT01042678|2643520|P1|STARTED|Overall Study||6
1091023|NCT01042795|2643543|P1|NOT COMPLETED|Follow up - 22 Months After Drug Start||2
1091024|NCT01042795|2643543|P1|COMPLETED|Follow up - 22 Months After Drug Start||0
1091025|NCT01042795|2643543|P1|STARTED|Follow up - 22 Months After Drug Start||2
1091026|NCT01042795|2643543|P1|NOT COMPLETED|Dosing Period - 16 Weeks of Daily Doses||5
1091027|NCT01042795|2643543|P1|COMPLETED|Dosing Period - 16 Weeks of Daily Doses||2
1091028|NCT01042795|2643543|P1|STARTED|Dosing Period - 16 Weeks of Daily Doses||7
1091029|NCT01042938|2643549|P2|NOT COMPLETED|Overall Study||2
1091030|NCT01042938|2643550|P1|NOT COMPLETED|Overall Study||3
1091031|NCT01042938|2643549|P2|COMPLETED|Overall Study||16
1091032|NCT01042938|2643550|P1|COMPLETED|Overall Study||14
1091033|NCT01042938|2643549|P2|STARTED|Overall Study|1 withdrew before radiation; 1 non-compliance.|18
1091034|NCT01042938|2643550|P1|STARTED|Overall Study|1 withdrew before radiation; 1 ineligible due to other clinical trial; 1 non-compliance.|17
1091035|NCT01042977|2643564|P2|NOT COMPLETED|Overall Study||55
1091036|NCT01042977|2643565|P1|NOT COMPLETED|Overall Study||41
1091037|NCT01042977|2643564|P2|COMPLETED|Overall Study||428
1091038|NCT01042977|2643565|P1|COMPLETED|Overall Study||441
1091039|NCT01042977|2643564|P2|STARTED|Overall Study|Of the 483 participants only 482 were included in the full analysis set.|483
1091040|NCT01042977|2643565|P1|STARTED|Overall Study|Of 482 part. 480 were included in full analysis set. Thereof, 1 part. treated but not randomized.|482
1091041|NCT01043094|2643585|P2|NOT COMPLETED|Overall Study||0
1091042|NCT01043094|2643586|P1|NOT COMPLETED|Overall Study||0
1091043|NCT01043094|2643585|P2|COMPLETED|Overall Study||8
1091044|NCT01043094|2643586|P1|COMPLETED|Overall Study||8
1091045|NCT01043094|2643585|P2|STARTED|Overall Study||8
1091046|NCT01043094|2643586|P1|STARTED|Overall Study||8
1091047|NCT01043133|2643596|P2|NOT COMPLETED|Overall Study||2
1091048|NCT01043133|2643597|P1|NOT COMPLETED|Overall Study||1
1091049|NCT01043133|2643596|P2|COMPLETED|Overall Study||78
1091050|NCT01043133|2643597|P1|COMPLETED|Overall Study||74
1091051|NCT01043133|2643596|P2|STARTED|Overall Study||80
1091052|NCT01043133|2643597|P1|STARTED|Overall Study||75
1091053|NCT01043146|2643611|P6|NOT COMPLETED|Overall Study||0
1091054|NCT01043146|2643612|P5|NOT COMPLETED|Overall Study||0
1091055|NCT01043146|2643613|P4|NOT COMPLETED|Overall Study||0
1091056|NCT01043146|2643614|P3|NOT COMPLETED|Overall Study||0
1091057|NCT01043146|2643615|P2|NOT COMPLETED|Overall Study||0
1091058|NCT01043146|2643616|P1|NOT COMPLETED|Overall Study||0
1091059|NCT01043146|2643611|P6|COMPLETED|Overall Study||8
1091060|NCT01043146|2643612|P5|COMPLETED|Overall Study||8
1091061|NCT01043146|2643613|P4|COMPLETED|Overall Study||8
1091062|NCT01043146|2643614|P3|COMPLETED|Overall Study||8
1091063|NCT01043146|2643615|P2|COMPLETED|Overall Study||8
1091064|NCT01043146|2643616|P1|COMPLETED|Overall Study||10
1091065|NCT01043146|2643611|P6|STARTED|Overall Study||8
1091066|NCT01043146|2643612|P5|STARTED|Overall Study||8
1091067|NCT01043146|2643613|P4|STARTED|Overall Study||8
1091068|NCT01043146|2643614|P3|STARTED|Overall Study||8
1091069|NCT01043146|2643615|P2|STARTED|Overall Study||8
1091070|NCT01043146|2643616|P1|STARTED|Overall Study||10
1091071|NCT01043185|2643630|P10|NOT COMPLETED|Period 7 - Fourth Intervention||0
1091072|NCT01043185|2643631|P9|NOT COMPLETED|Period 7 - Fourth Intervention||0
1091073|NCT01043185|2643632|P8|NOT COMPLETED|Period 7 - Fourth Intervention||0
1091074|NCT01043185|2643633|P7|NOT COMPLETED|Period 7 - Fourth Intervention||0
1091075|NCT01043185|2643634|P6|NOT COMPLETED|Period 7 - Fourth Intervention||0
1091076|NCT01043185|2643635|P5|NOT COMPLETED|Period 7 - Fourth Intervention||0
1091077|NCT01043185|2643636|P4|NOT COMPLETED|Period 7 - Fourth Intervention||0
1091078|NCT01043185|2643637|P3|NOT COMPLETED|Period 7 - Fourth Intervention||0
1091079|NCT01043185|2643638|P2|NOT COMPLETED|Period 7 - Fourth Intervention||0
1091080|NCT01043185|2643639|P1|NOT COMPLETED|Period 7 - Fourth Intervention||0
1091081|NCT01043185|2643630|P10|COMPLETED|Period 7 - Fourth Intervention||3
1091082|NCT01043185|2643631|P9|COMPLETED|Period 7 - Fourth Intervention||2
1091083|NCT01043185|2643632|P8|COMPLETED|Period 7 - Fourth Intervention||3
1091084|NCT01043185|2643633|P7|COMPLETED|Period 7 - Fourth Intervention||3
1091085|NCT01043185|2643634|P6|COMPLETED|Period 7 - Fourth Intervention||3
1091086|NCT01043185|2643635|P5|COMPLETED|Period 7 - Fourth Intervention||2
1091087|NCT01043185|2643636|P4|COMPLETED|Period 7 - Fourth Intervention||2
1091088|NCT01043185|2643637|P3|COMPLETED|Period 7 - Fourth Intervention||3
1091089|NCT01043185|2643638|P2|COMPLETED|Period 7 - Fourth Intervention||2
1091090|NCT01043185|2643639|P1|COMPLETED|Period 7 - Fourth Intervention||3
1091091|NCT01043185|2643630|P10|STARTED|Period 7 - Fourth Intervention||3
1091092|NCT01043185|2643631|P9|STARTED|Period 7 - Fourth Intervention||2
1091093|NCT01043185|2643632|P8|STARTED|Period 7 - Fourth Intervention||3
1091094|NCT01043185|2643633|P7|STARTED|Period 7 - Fourth Intervention||3
1091095|NCT01043185|2643634|P6|STARTED|Period 7 - Fourth Intervention||3
1091096|NCT01043185|2643635|P5|STARTED|Period 7 - Fourth Intervention||2
1091097|NCT01043185|2643636|P4|STARTED|Period 7 - Fourth Intervention||2
1091098|NCT01043185|2643637|P3|STARTED|Period 7 - Fourth Intervention||3
1091099|NCT01043185|2643638|P2|STARTED|Period 7 - Fourth Intervention||2
1091100|NCT01043185|2643639|P1|STARTED|Period 7 - Fourth Intervention||3
1091101|NCT01043185|2643630|P10|NOT COMPLETED|Period 6 - Third Washout Period||0
1091102|NCT01043185|2643631|P9|NOT COMPLETED|Period 6 - Third Washout Period||1
1091103|NCT01043185|2643632|P8|NOT COMPLETED|Period 6 - Third Washout Period||0
1091104|NCT01043185|2643633|P7|NOT COMPLETED|Period 6 - Third Washout Period||0
1091105|NCT01043185|2643634|P6|NOT COMPLETED|Period 6 - Third Washout Period||0
1091106|NCT01043185|2643635|P5|NOT COMPLETED|Period 6 - Third Washout Period||0
1091107|NCT01043185|2643636|P4|NOT COMPLETED|Period 6 - Third Washout Period||0
1091108|NCT01043185|2643637|P3|NOT COMPLETED|Period 6 - Third Washout Period||0
1091109|NCT01043185|2643638|P2|NOT COMPLETED|Period 6 - Third Washout Period||0
1091110|NCT01043185|2643639|P1|NOT COMPLETED|Period 6 - Third Washout Period||0
1091111|NCT01043185|2643630|P10|COMPLETED|Period 6 - Third Washout Period||3
1091112|NCT01043185|2643631|P9|COMPLETED|Period 6 - Third Washout Period||2
1091113|NCT01043185|2643632|P8|COMPLETED|Period 6 - Third Washout Period||3
1091114|NCT01043185|2643633|P7|COMPLETED|Period 6 - Third Washout Period||3
1091115|NCT01043185|2643634|P6|COMPLETED|Period 6 - Third Washout Period||3
1091116|NCT01043185|2643635|P5|COMPLETED|Period 6 - Third Washout Period||2
1091117|NCT01043185|2643636|P4|COMPLETED|Period 6 - Third Washout Period||2
1091118|NCT01043185|2643637|P3|COMPLETED|Period 6 - Third Washout Period||3
1091119|NCT01043185|2643638|P2|COMPLETED|Period 6 - Third Washout Period||2
1091120|NCT01043185|2643639|P1|COMPLETED|Period 6 - Third Washout Period||3
1091121|NCT01043185|2643630|P10|STARTED|Period 6 - Third Washout Period||3
1091122|NCT01043185|2643631|P9|STARTED|Period 6 - Third Washout Period||3
1091123|NCT01043185|2643632|P8|STARTED|Period 6 - Third Washout Period||3
1091124|NCT01043185|2643633|P7|STARTED|Period 6 - Third Washout Period||3
1091125|NCT01043185|2643634|P6|STARTED|Period 6 - Third Washout Period||3
1091126|NCT01043185|2643635|P5|STARTED|Period 6 - Third Washout Period||2
1091127|NCT01043185|2643636|P4|STARTED|Period 6 - Third Washout Period||2
1091128|NCT01043185|2643637|P3|STARTED|Period 6 - Third Washout Period||3
1091129|NCT01043185|2643638|P2|STARTED|Period 6 - Third Washout Period||2
1091130|NCT01043185|2643639|P1|STARTED|Period 6 - Third Washout Period||3
1091131|NCT01043185|2643630|P10|NOT COMPLETED|Period 5 - Third Intervention||0
1091132|NCT01043185|2643631|P9|NOT COMPLETED|Period 5 - Third Intervention||0
1091133|NCT01043185|2643632|P8|NOT COMPLETED|Period 5 - Third Intervention||0
1091134|NCT01043185|2643633|P7|NOT COMPLETED|Period 5 - Third Intervention||0
1091135|NCT01043185|2643634|P6|NOT COMPLETED|Period 5 - Third Intervention||0
1091136|NCT01043185|2643635|P5|NOT COMPLETED|Period 5 - Third Intervention||0
1091137|NCT01043185|2643636|P4|NOT COMPLETED|Period 5 - Third Intervention||0
1091138|NCT01043185|2643637|P3|NOT COMPLETED|Period 5 - Third Intervention||0
1091139|NCT01043185|2643638|P2|NOT COMPLETED|Period 5 - Third Intervention||0
1091140|NCT01043185|2643639|P1|NOT COMPLETED|Period 5 - Third Intervention||0
1091141|NCT01043185|2643630|P10|COMPLETED|Period 5 - Third Intervention||3
1091142|NCT01043185|2643631|P9|COMPLETED|Period 5 - Third Intervention||3
1091143|NCT01043185|2643632|P8|COMPLETED|Period 5 - Third Intervention||3
1091144|NCT01043185|2643633|P7|COMPLETED|Period 5 - Third Intervention||3
1091145|NCT01043185|2643634|P6|COMPLETED|Period 5 - Third Intervention||3
1091146|NCT01043185|2643635|P5|COMPLETED|Period 5 - Third Intervention||2
1091147|NCT01043185|2643636|P4|COMPLETED|Period 5 - Third Intervention||2
1091148|NCT01043185|2643637|P3|COMPLETED|Period 5 - Third Intervention||3
1091149|NCT01043185|2643638|P2|COMPLETED|Period 5 - Third Intervention||2
1091150|NCT01043185|2643639|P1|COMPLETED|Period 5 - Third Intervention||3
1091151|NCT01043185|2643630|P10|STARTED|Period 5 - Third Intervention||3
1091152|NCT01043185|2643631|P9|STARTED|Period 5 - Third Intervention||3
1091153|NCT01043185|2643632|P8|STARTED|Period 5 - Third Intervention||3
1091154|NCT01043185|2643633|P7|STARTED|Period 5 - Third Intervention||3
1091155|NCT01043185|2643634|P6|STARTED|Period 5 - Third Intervention||3
1091156|NCT01043185|2643635|P5|STARTED|Period 5 - Third Intervention||2
1091157|NCT01043185|2643636|P4|STARTED|Period 5 - Third Intervention||2
1091158|NCT01043185|2643637|P3|STARTED|Period 5 - Third Intervention||3
1091159|NCT01043185|2643638|P2|STARTED|Period 5 - Third Intervention||2
1091160|NCT01043185|2643639|P1|STARTED|Period 5 - Third Intervention||3
1091161|NCT01043185|2643630|P10|NOT COMPLETED|Period 4 - Second Washout Period||0
1091162|NCT01043185|2643631|P9|NOT COMPLETED|Period 4 - Second Washout Period||0
1091163|NCT01043185|2643632|P8|NOT COMPLETED|Period 4 - Second Washout Period||0
1091164|NCT01043185|2643633|P7|NOT COMPLETED|Period 4 - Second Washout Period||0
1091165|NCT01043185|2643634|P6|NOT COMPLETED|Period 4 - Second Washout Period||0
1091166|NCT01043185|2643635|P5|NOT COMPLETED|Period 4 - Second Washout Period||0
1091167|NCT01043185|2643636|P4|NOT COMPLETED|Period 4 - Second Washout Period||0
1091168|NCT01043185|2643637|P3|NOT COMPLETED|Period 4 - Second Washout Period||0
1091169|NCT01043185|2643638|P2|NOT COMPLETED|Period 4 - Second Washout Period||0
1091170|NCT01043185|2643639|P1|NOT COMPLETED|Period 4 - Second Washout Period||0
1091171|NCT01043185|2643630|P10|COMPLETED|Period 4 - Second Washout Period||3
1091172|NCT01043185|2643631|P9|COMPLETED|Period 4 - Second Washout Period||3
1091173|NCT01043185|2643632|P8|COMPLETED|Period 4 - Second Washout Period||3
1091174|NCT01043185|2643633|P7|COMPLETED|Period 4 - Second Washout Period||3
1091175|NCT01043185|2643634|P6|COMPLETED|Period 4 - Second Washout Period||3
1091176|NCT01043185|2643635|P5|COMPLETED|Period 4 - Second Washout Period||2
1091177|NCT01043185|2643636|P4|COMPLETED|Period 4 - Second Washout Period||2
1091178|NCT01043185|2643637|P3|COMPLETED|Period 4 - Second Washout Period||3
1091179|NCT01043185|2643638|P2|COMPLETED|Period 4 - Second Washout Period||2
1091180|NCT01043185|2643639|P1|COMPLETED|Period 4 - Second Washout Period||3
1091181|NCT01043185|2643630|P10|STARTED|Period 4 - Second Washout Period||3
1091182|NCT01043185|2643631|P9|STARTED|Period 4 - Second Washout Period||3
1091183|NCT01043185|2643632|P8|STARTED|Period 4 - Second Washout Period||3
1091184|NCT01043185|2643633|P7|STARTED|Period 4 - Second Washout Period||3
1091185|NCT01043185|2643634|P6|STARTED|Period 4 - Second Washout Period||3
1091186|NCT01043185|2643635|P5|STARTED|Period 4 - Second Washout Period||2
1091187|NCT01043185|2643636|P4|STARTED|Period 4 - Second Washout Period||2
1091188|NCT01043185|2643637|P3|STARTED|Period 4 - Second Washout Period||3
1091189|NCT01043185|2643638|P2|STARTED|Period 4 - Second Washout Period||2
1091190|NCT01043185|2643639|P1|STARTED|Period 4 - Second Washout Period||3
1091191|NCT01043185|2643630|P10|NOT COMPLETED|Period 3 - Second Intervention||0
1091192|NCT01043185|2643631|P9|NOT COMPLETED|Period 3 - Second Intervention||0
1091193|NCT01043185|2643632|P8|NOT COMPLETED|Period 3 - Second Intervention||0
1091194|NCT01043185|2643633|P7|NOT COMPLETED|Period 3 - Second Intervention||0
1091195|NCT01043185|2643634|P6|NOT COMPLETED|Period 3 - Second Intervention||0
1091196|NCT01043185|2643635|P5|NOT COMPLETED|Period 3 - Second Intervention||0
1091197|NCT01043185|2643636|P4|NOT COMPLETED|Period 3 - Second Intervention||0
1091198|NCT01043185|2643637|P3|NOT COMPLETED|Period 3 - Second Intervention||0
1091199|NCT01043185|2643638|P2|NOT COMPLETED|Period 3 - Second Intervention||0
1091200|NCT01043185|2643639|P1|NOT COMPLETED|Period 3 - Second Intervention||0
1091201|NCT01043185|2643630|P10|COMPLETED|Period 3 - Second Intervention||3
1091202|NCT01043185|2643631|P9|COMPLETED|Period 3 - Second Intervention||3
1091203|NCT01043185|2643632|P8|COMPLETED|Period 3 - Second Intervention||3
1091204|NCT01043185|2643633|P7|COMPLETED|Period 3 - Second Intervention||3
1091205|NCT01043185|2643634|P6|COMPLETED|Period 3 - Second Intervention||3
1091206|NCT01043185|2643635|P5|COMPLETED|Period 3 - Second Intervention||2
1091207|NCT01043185|2643636|P4|COMPLETED|Period 3 - Second Intervention||2
1091208|NCT01043185|2643637|P3|COMPLETED|Period 3 - Second Intervention||3
1091209|NCT01043185|2643638|P2|COMPLETED|Period 3 - Second Intervention||2
1091210|NCT01043185|2643639|P1|COMPLETED|Period 3 - Second Intervention||3
1091211|NCT01043185|2643630|P10|STARTED|Period 3 - Second Intervention||3
1091212|NCT01043185|2643631|P9|STARTED|Period 3 - Second Intervention||3
1091213|NCT01043185|2643632|P8|STARTED|Period 3 - Second Intervention||3
1091214|NCT01043185|2643633|P7|STARTED|Period 3 - Second Intervention||3
1091215|NCT01043185|2643634|P6|STARTED|Period 3 - Second Intervention||3
1091216|NCT01043185|2643635|P5|STARTED|Period 3 - Second Intervention||2
1091217|NCT01043185|2643636|P4|STARTED|Period 3 - Second Intervention||2
1091218|NCT01043185|2643637|P3|STARTED|Period 3 - Second Intervention||3
1091219|NCT01043185|2643638|P2|STARTED|Period 3 - Second Intervention||2
1091220|NCT01043185|2643639|P1|STARTED|Period 3 - Second Intervention||3
1091221|NCT01043185|2643630|P10|NOT COMPLETED|Period 2 - First Washout Period||0
1091222|NCT01043185|2643631|P9|NOT COMPLETED|Period 2 - First Washout Period||0
1091223|NCT01043185|2643632|P8|NOT COMPLETED|Period 2 - First Washout Period||0
1091224|NCT01043185|2643633|P7|NOT COMPLETED|Period 2 - First Washout Period||0
1091225|NCT01043185|2643634|P6|NOT COMPLETED|Period 2 - First Washout Period||0
1091226|NCT01043185|2643635|P5|NOT COMPLETED|Period 2 - First Washout Period||0
1091227|NCT01043185|2643636|P4|NOT COMPLETED|Period 2 - First Washout Period||0
1091228|NCT01043185|2643637|P3|NOT COMPLETED|Period 2 - First Washout Period||0
1091229|NCT01043185|2643638|P2|NOT COMPLETED|Period 2 - First Washout Period||0
1091230|NCT01043185|2643639|P1|NOT COMPLETED|Period 2 - First Washout Period||0
1091231|NCT01043185|2643630|P10|COMPLETED|Period 2 - First Washout Period||3
1091232|NCT01043185|2643631|P9|COMPLETED|Period 2 - First Washout Period||3
1091233|NCT01043185|2643632|P8|COMPLETED|Period 2 - First Washout Period||3
1091234|NCT01043185|2643633|P7|COMPLETED|Period 2 - First Washout Period||3
1091235|NCT01043185|2643634|P6|COMPLETED|Period 2 - First Washout Period||3
1091236|NCT01043185|2643635|P5|COMPLETED|Period 2 - First Washout Period||2
1091237|NCT01043185|2643636|P4|COMPLETED|Period 2 - First Washout Period||2
1091238|NCT01043185|2643637|P3|COMPLETED|Period 2 - First Washout Period||3
1091239|NCT01043185|2643638|P2|COMPLETED|Period 2 - First Washout Period||2
1091240|NCT01043185|2643639|P1|COMPLETED|Period 2 - First Washout Period||3
1091241|NCT01043185|2643630|P10|STARTED|Period 2 - First Washout Period||3
1091242|NCT01043185|2643631|P9|STARTED|Period 2 - First Washout Period||3
1091243|NCT01043185|2643632|P8|STARTED|Period 2 - First Washout Period||3
1091244|NCT01043185|2643633|P7|STARTED|Period 2 - First Washout Period||3
1091245|NCT01043185|2643634|P6|STARTED|Period 2 - First Washout Period||3
1091246|NCT01043185|2643635|P5|STARTED|Period 2 - First Washout Period||2
1091247|NCT01043185|2643636|P4|STARTED|Period 2 - First Washout Period||2
1091248|NCT01043185|2643637|P3|STARTED|Period 2 - First Washout Period||3
1091249|NCT01043185|2643638|P2|STARTED|Period 2 - First Washout Period||2
1091250|NCT01043185|2643639|P1|STARTED|Period 2 - First Washout Period||3
1091251|NCT01043185|2643630|P10|NOT COMPLETED|Period 1 - First Intervention||0
1091252|NCT01043185|2643631|P9|NOT COMPLETED|Period 1 - First Intervention||0
1091253|NCT01043185|2643632|P8|NOT COMPLETED|Period 1 - First Intervention||0
1091254|NCT01043185|2643633|P7|NOT COMPLETED|Period 1 - First Intervention||0
1091255|NCT01043185|2643634|P6|NOT COMPLETED|Period 1 - First Intervention||0
1091256|NCT01043185|2643635|P5|NOT COMPLETED|Period 1 - First Intervention||0
1091257|NCT01043185|2643636|P4|NOT COMPLETED|Period 1 - First Intervention||0
1091258|NCT01043185|2643637|P3|NOT COMPLETED|Period 1 - First Intervention||0
1091259|NCT01043185|2643638|P2|NOT COMPLETED|Period 1 - First Intervention||0
1091260|NCT01043185|2643639|P1|NOT COMPLETED|Period 1 - First Intervention||0
1091261|NCT01043185|2643630|P10|COMPLETED|Period 1 - First Intervention||3
1091262|NCT01043185|2643631|P9|COMPLETED|Period 1 - First Intervention||3
1091263|NCT01043185|2643632|P8|COMPLETED|Period 1 - First Intervention||3
1091264|NCT01043185|2643633|P7|COMPLETED|Period 1 - First Intervention||3
1091265|NCT01043185|2643634|P6|COMPLETED|Period 1 - First Intervention||3
1091266|NCT01043185|2643635|P5|COMPLETED|Period 1 - First Intervention||2
1091267|NCT01043185|2643636|P4|COMPLETED|Period 1 - First Intervention||2
1091268|NCT01043185|2643637|P3|COMPLETED|Period 1 - First Intervention||3
1091269|NCT01043185|2643638|P2|COMPLETED|Period 1 - First Intervention||2
1091270|NCT01043185|2643639|P1|COMPLETED|Period 1 - First Intervention||3
1091271|NCT01043185|2643630|P10|STARTED|Period 1 - First Intervention||3
1091272|NCT01043185|2643631|P9|STARTED|Period 1 - First Intervention||3
1091273|NCT01043185|2643632|P8|STARTED|Period 1 - First Intervention||3
1091274|NCT01043185|2643633|P7|STARTED|Period 1 - First Intervention||3
1091275|NCT01043185|2643634|P6|STARTED|Period 1 - First Intervention||3
1091276|NCT01043185|2643635|P5|STARTED|Period 1 - First Intervention||2
1091277|NCT01043185|2643636|P4|STARTED|Period 1 - First Intervention||2
1091278|NCT01043185|2643637|P3|STARTED|Period 1 - First Intervention||3
1091279|NCT01043185|2643638|P2|STARTED|Period 1 - First Intervention||2
1091280|NCT01043185|2643639|P1|STARTED|Period 1 - First Intervention||3
1091281|NCT01043393|2643668|P2|NOT COMPLETED|Overall Study||0
1091282|NCT01043393|2643669|P1|NOT COMPLETED|Overall Study||0
1091283|NCT01043393|2643668|P2|COMPLETED|Overall Study||12
1091284|NCT01043393|2643669|P1|COMPLETED|Overall Study||12
1091285|NCT01043393|2643668|P2|STARTED|Overall Study||12
1091286|NCT01043393|2643669|P1|STARTED|Overall Study||12
1091287|NCT01043432|2643683|P4|NOT COMPLETED|Overall Study||0
1091288|NCT01043432|2643684|P3|NOT COMPLETED|Overall Study||0
1091289|NCT01043432|2643685|P2|NOT COMPLETED|Overall Study||0
1091290|NCT01043432|2643686|P1|NOT COMPLETED|Overall Study||0
1091291|NCT01043432|2643683|P4|COMPLETED|Overall Study||48
1091292|NCT01043432|2643684|P3|COMPLETED|Overall Study||12
1091293|NCT01043432|2643685|P2|COMPLETED|Overall Study||51
1091294|NCT01043432|2643686|P1|COMPLETED|Overall Study||22
1091295|NCT01043432|2643683|P4|STARTED|Overall Study||48
1091296|NCT01043432|2643684|P3|STARTED|Overall Study||12
1091297|NCT01043432|2643685|P2|STARTED|Overall Study||51
1091298|NCT01043432|2643686|P1|STARTED|Overall Study||22
1091299|NCT01043523|2643693|P1|NOT COMPLETED|Overall Study||0
1091300|NCT01043523|2643693|P1|COMPLETED|Overall Study||52
1091301|NCT01043523|2643693|P1|Participants With Unenhanced Images|Overall Study||51
1091302|NCT01043523|2643693|P1|STARTED|Overall Study||52
1091303|NCT01043640|2643718|P1|NOT COMPLETED|Overall Study||0
1091304|NCT01043640|2643718|P1|COMPLETED|Overall Study||46
1091305|NCT01043640|2643718|P1|STARTED|Overall Study||46
1091306|NCT01043653|2643733|P1|NOT COMPLETED|Overall Study||64
1091307|NCT01043653|2643733|P1|COMPLETED|Overall Study||186
1091308|NCT01043653|2643733|P1|STARTED|Overall Study||250
1091309|NCT01043705|2643741|P3|NOT COMPLETED|Overall Study||80
1091310|NCT01043705|2643742|P2|NOT COMPLETED|Overall Study||131
1091311|NCT01043705|2643743|P1|NOT COMPLETED|Overall Study||107
1091312|NCT01043705|2643741|P3|COMPLETED|Overall Study||498
1091313|NCT01043705|2643742|P2|COMPLETED|Overall Study||447
1091314|NCT01043705|2643743|P1|COMPLETED|Overall Study||352
1091315|NCT01043705|2643741|P3|STARTED|Overall Study||578
1091316|NCT01043705|2643742|P2|STARTED|Overall Study||578
1091317|NCT01043705|2643743|P1|STARTED|Overall Study||459
1091318|NCT01043874|2643753|P1|NOT COMPLETED|Overall Study||6
1091319|NCT01043874|2643753|P1|COMPLETED|Overall Study||39
1091320|NCT01043874|2643753|P1|STARTED|Overall Study||45
1091321|NCT01043926|2643762|P4|NOT COMPLETED|Overall Study||0
1091322|NCT01043926|2643763|P3|NOT COMPLETED|Overall Study||0
1091323|NCT01043926|2643764|P2|NOT COMPLETED|Overall Study||0
1091324|NCT01043926|2643765|P1|NOT COMPLETED|Overall Study||0
1091325|NCT01043926|2643762|P4|COMPLETED|Overall Study||0
1091326|NCT01043926|2643763|P3|COMPLETED|Overall Study||0
1091327|NCT01043926|2643764|P2|COMPLETED|Overall Study||8
1091328|NCT01043926|2643765|P1|COMPLETED|Overall Study||8
1091329|NCT01043926|2643762|P4|STARTED|Overall Study||0
1091330|NCT01043926|2643763|P3|STARTED|Overall Study||0
1091331|NCT01043926|2643764|P2|STARTED|Overall Study||8
1091332|NCT01043926|2643765|P1|STARTED|Overall Study||8
1091333|NCT01043939|2643779|P2|NOT COMPLETED|Second Intervention||0
1091334|NCT01043939|2643780|P1|NOT COMPLETED|Second Intervention||0
1091335|NCT01043939|2643779|P2|COMPLETED|Second Intervention||12
1091336|NCT01043939|2643780|P1|COMPLETED|Second Intervention||12
1091337|NCT01043939|2643779|P2|STARTED|Second Intervention||12
1091338|NCT01043939|2643780|P1|STARTED|Second Intervention||12
1091339|NCT01043939|2643779|P2|NOT COMPLETED|Washout Period||0
1091340|NCT01043939|2643780|P1|NOT COMPLETED|Washout Period||0
1091341|NCT01043939|2643779|P2|COMPLETED|Washout Period||12
1091342|NCT01043939|2643780|P1|COMPLETED|Washout Period||12
1091343|NCT01043939|2643779|P2|STARTED|Washout Period||12
1091344|NCT01043939|2643780|P1|STARTED|Washout Period||12
1091345|NCT01043939|2643779|P2|NOT COMPLETED|First Intervention||0
1091346|NCT01043939|2643780|P1|NOT COMPLETED|First Intervention||0
1091347|NCT01043939|2643779|P2|COMPLETED|First Intervention||12
1091348|NCT01043939|2643780|P1|COMPLETED|First Intervention||12
1091349|NCT01043939|2643779|P2|STARTED|First Intervention||12
1091350|NCT01043939|2643780|P1|STARTED|First Intervention||12
1091351|NCT01044030|2643794|P2|NOT COMPLETED|Overall Study||20
1091352|NCT01044030|2643795|P1|NOT COMPLETED|Overall Study||19
1091353|NCT01044030|2643794|P2|COMPLETED|Overall Study||146
1091354|NCT01044030|2643795|P1|COMPLETED|Overall Study||141
1091355|NCT01044030|2643794|P2|STARTED|Overall Study||166
1091356|NCT01044030|2643795|P1|STARTED|Overall Study||160
1091357|NCT01044056|2643808|P3|NOT COMPLETED|Overall Study||0
1091358|NCT01044056|2643809|P2|NOT COMPLETED|Overall Study||0
1091359|NCT01044056|2643810|P1|NOT COMPLETED|Overall Study||0
1091360|NCT01044056|2643808|P3|COMPLETED|Overall Study||8
1091361|NCT01044056|2643809|P2|COMPLETED|Overall Study||8
1091362|NCT01044056|2643810|P1|COMPLETED|Overall Study||8
1091363|NCT01044056|2643808|P3|STARTED|Overall Study||8
1091364|NCT01044056|2643809|P2|STARTED|Overall Study||8
1091365|NCT01044056|2643810|P1|STARTED|Overall Study||8
1091366|NCT01044212|2643829|P2|NOT COMPLETED|Overall Study||7
1091367|NCT01044212|2643830|P1|NOT COMPLETED|Overall Study||5
1091368|NCT01044212|2643829|P2|COMPLETED|Overall Study||30
1091369|NCT01044212|2643830|P1|COMPLETED|Overall Study||30
1091370|NCT01044212|2643829|P2|STARTED|Overall Study||37
1091371|NCT01044212|2643830|P1|STARTED|Overall Study||35
1091372|NCT01044264|2643843|P3|NOT COMPLETED|Overall Study||92
1091373|NCT01044264|2643844|P2|NOT COMPLETED|Overall Study||94
1091374|NCT01044264|2643845|P1|NOT COMPLETED|Overall Study||90
1091375|NCT01044264|2643843|P3|COMPLETED|Overall Study||108
1091376|NCT01044264|2643844|P2|COMPLETED|Overall Study||108
1091377|NCT01044264|2643845|P1|COMPLETED|Overall Study||110
1091378|NCT01044264|2643843|P3|STARTED|Overall Study||200
1091379|NCT01044264|2643844|P2|STARTED|Overall Study||202
1091380|NCT01044264|2643845|P1|STARTED|Overall Study||200
1091381|NCT01036724|2643855|P2|NOT COMPLETED|Overall Study||8
1091382|NCT01036724|2643856|P1|NOT COMPLETED|Overall Study||6
1091383|NCT01036724|2643855|P2|COMPLETED|Overall Study||47
1091384|NCT01036724|2643856|P1|COMPLETED|Overall Study||46
1091385|NCT01036724|2643855|P2|STARTED|Overall Study||55
1091386|NCT01036724|2643856|P1|STARTED|Overall Study||52
1091387|NCT01036763|2643864|P1|NOT COMPLETED|Overall Study||93
1091388|NCT01036763|2643864|P1|COMPLETED|Overall Study||1171
1091389|NCT01036763|2643864|P1|STARTED|Overall Study||1264
1091390|NCT01036802|2643876|P2|NOT COMPLETED|Overall Study||0
1091391|NCT01036802|2643877|P1|NOT COMPLETED|Overall Study||0
1091392|NCT01036802|2643876|P2|COMPLETED|Overall Study|Patient was taken off study after 7 months as she required hip replacement surgery.|1
1091393|NCT01036802|2643877|P1|COMPLETED|Overall Study||2
1091394|NCT01036802|2643876|P2|STARTED|Overall Study||1
1091395|NCT01036802|2643877|P1|STARTED|Overall Study||2
1091396|NCT01037088|2643895|P1|NOT COMPLETED|Overall Study||3
1091397|NCT01037088|2643895|P1|COMPLETED|Overall Study||36
1091398|NCT01037088|2643895|P1|Received Placebo|Overall Study||38
1091399|NCT01037088|2643895|P1|Received 1.29% THC|Overall Study||37
1091400|NCT01037088|2643895|P1|Received 3.53% THC|Overall Study||36
1091401|NCT01037088|2643895|P1|STARTED|Overall Study||39
1091402|NCT01037114|2643903|P1|NOT COMPLETED|Year 20||1
1091403|NCT01037114|2643903|P1|COMPLETED|Year 20|One subject returned at Y20 but did not do lab test because subject met a study exclusion criteria.|44
1091404|NCT01037114|2643903|P1|STARTED|Year 20||45
1091405|NCT01037114|2643903|P1|NOT COMPLETED|Year 19||0
1091406|NCT01037114|2643903|P1|COMPLETED|Year 19||45
1091407|NCT01037114|2643903|P1|STARTED|Year 19||45
1091408|NCT01037114|2643903|P1|NOT COMPLETED|Year 18||0
1091409|NCT01037114|2643903|P1|COMPLETED|Year 18||44
1091410|NCT01037114|2643903|P1|STARTED|Year 18||44
1091411|NCT01037114|2643903|P1|NOT COMPLETED|Year 17||0
1091412|NCT01037114|2643903|P1|COMPLETED|Year 17||48
1091413|NCT01037114|2643903|P1|STARTED|Year 17||48
1091414|NCT01037114|2643903|P1|NOT COMPLETED|Year 16||0
1091415|NCT01037114|2643903|P1|COMPLETED|Year 16||49
1091416|NCT01037114|2643903|P1|STARTED|Year 16||49
1091417|NCT01037127|2643918|P2|NOT COMPLETED|Overall Study||21
1091418|NCT01037127|2643919|P1|NOT COMPLETED|Overall Study||5
1091419|NCT01037127|2643918|P2|COMPLETED|Overall Study||36
1091420|NCT01037127|2643919|P1|COMPLETED|Overall Study||35
1091421|NCT01037127|2643918|P2|STARTED|Overall Study||57
1091422|NCT01037127|2643919|P1|STARTED|Overall Study||40
1091423|NCT01037192|2643953|P2|NOT COMPLETED|Overall Study||0
1091424|NCT01037192|2643954|P1|NOT COMPLETED|Overall Study||0
1091425|NCT01037192|2643953|P2|COMPLETED|Overall Study||1
1091426|NCT01037192|2643954|P1|COMPLETED|Overall Study||3
1091427|NCT01037192|2643953|P2|STARTED|Overall Study||1
1091428|NCT01037192|2643954|P1|STARTED|Overall Study||3
1091429|NCT01037218|2643966|P4|NOT COMPLETED|Overall Study||16
1091430|NCT01037218|2643967|P3|NOT COMPLETED|Overall Study||21
1091431|NCT01037218|2643968|P2|NOT COMPLETED|Overall Study||21
1091432|NCT01037218|2643969|P1|NOT COMPLETED|Overall Study||16
1091433|NCT01037218|2643966|P4|COMPLETED|Overall Study||134
1091434|NCT01037218|2643967|P3|COMPLETED|Overall Study||134
1091435|NCT01037218|2643968|P2|COMPLETED|Overall Study||128
1091436|NCT01037218|2643969|P1|COMPLETED|Overall Study||131
1091437|NCT01037218|2643966|P4|mITT Population|Overall Study||141
1091438|NCT01037218|2643967|P3|mITT Population|Overall Study||147
1091439|NCT01037218|2643968|P2|mITT Population|Overall Study||140
1091440|NCT01037218|2643969|P1|mITT Population|Overall Study||141
1091441|NCT01037218|2643966|P4|Safety Population|Overall Study||150
1091442|NCT01037218|2643967|P3|Safety Population|Overall Study||154
1091443|NCT01037218|2643968|P2|Safety Population|Overall Study||148
1091444|NCT01037218|2643969|P1|Safety Population|Overall Study||147
1091445|NCT01037218|2643966|P4|STARTED|Overall Study||150
1091446|NCT01037218|2643967|P3|STARTED|Overall Study||155
1091447|NCT01037218|2643968|P2|STARTED|Overall Study||149
1091448|NCT01037218|2643969|P1|STARTED|Overall Study||147
1091449|NCT01037244|2644031|P4|NOT COMPLETED|Overall Study||14
1091450|NCT01037244|2644032|P3|NOT COMPLETED|Overall Study||14
1091451|NCT01037244|2644033|P2|NOT COMPLETED|Overall Study||14
1091452|NCT01037244|2644034|P1|NOT COMPLETED|Overall Study||13
1091453|NCT01037244|2644031|P4|COMPLETED|Overall Study||140
1091454|NCT01037244|2644032|P3|COMPLETED|Overall Study||144
1091455|NCT01037244|2644033|P2|COMPLETED|Overall Study||138
1091456|NCT01037244|2644034|P1|COMPLETED|Overall Study||141
1091457|NCT01037244|2644031|P4|Safety Population|Overall Study||152
1091458|NCT01037244|2644032|P3|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|159
1091459|NCT01037244|2644033|P2|Safety Population|Overall Study||150
1091460|NCT01037244|2644034|P1|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|155
1091461|NCT01037244|2644031|P4|mITT (Modified Intent-to-Treat)|Overall Study||153
1091462|NCT01037244|2644032|P3|mITT (Modified Intent-to-Treat)|Overall Study||154
1091463|NCT01037244|2644033|P2|mITT (Modified Intent-to-Treat)|Overall Study||148
1091464|NCT01037244|2644034|P1|mITT (Modified Intent-to-Treat)|Overall Study||150
1091465|NCT01037244|2644031|P4|STARTED|Overall Study||154
1091466|NCT01037244|2644032|P3|STARTED|Overall Study||158
1091467|NCT01037244|2644033|P2|STARTED|Overall Study||152
1091468|NCT01037244|2644034|P1|STARTED|Overall Study||154
1091469|NCT01037309|2644098|P9|NOT COMPLETED|Intravenous Period 7 - 9||0
1091470|NCT01037309|2644099|P8|NOT COMPLETED|Intravenous Period 7 - 9||0
1091471|NCT01037309|2644100|P7|NOT COMPLETED|Intravenous Period 7 - 9||0
1091472|NCT01037309|2644101|P6|NOT COMPLETED|Intravenous Period 7 - 9||0
1091473|NCT01037309|2644102|P5|NOT COMPLETED|Intravenous Period 7 - 9||0
1091474|NCT01037309|2644103|P4|NOT COMPLETED|Intravenous Period 7 - 9||0
1091475|NCT01037309|2644104|P3|NOT COMPLETED|Intravenous Period 7 - 9||0
1091476|NCT01037309|2644105|P2|NOT COMPLETED|Intravenous Period 7 - 9||0
1091477|NCT01037309|2644106|P1|NOT COMPLETED|Intravenous Period 7 - 9||0
1091478|NCT01037309|2644098|P9|COMPLETED|Intravenous Period 7 - 9||3
1091479|NCT01037309|2644099|P8|COMPLETED|Intravenous Period 7 - 9||3
1091480|NCT01037309|2644100|P7|COMPLETED|Intravenous Period 7 - 9||3
1091481|NCT01037309|2644101|P6|COMPLETED|Intravenous Period 7 - 9||0
1091482|NCT01037309|2644102|P5|COMPLETED|Intravenous Period 7 - 9||0
1091483|NCT01037309|2644103|P4|COMPLETED|Intravenous Period 7 - 9||0
1091484|NCT01037309|2644104|P3|COMPLETED|Intravenous Period 7 - 9||0
1091485|NCT01037309|2644105|P2|COMPLETED|Intravenous Period 7 - 9||0
1091486|NCT01037309|2644106|P1|COMPLETED|Intravenous Period 7 - 9||0
1091487|NCT01037309|2644098|P9|STARTED|Intravenous Period 7 - 9||3
1091488|NCT01037309|2644099|P8|STARTED|Intravenous Period 7 - 9||3
1091489|NCT01037309|2644100|P7|STARTED|Intravenous Period 7 - 9||3
1091490|NCT01037309|2644101|P6|STARTED|Intravenous Period 7 - 9||0
1091491|NCT01037309|2644102|P5|STARTED|Intravenous Period 7 - 9||0
1091492|NCT01037309|2644103|P4|STARTED|Intravenous Period 7 - 9||0
1091493|NCT01037309|2644104|P3|STARTED|Intravenous Period 7 - 9||0
1091494|NCT01037309|2644105|P2|STARTED|Intravenous Period 7 - 9||0
1091495|NCT01037309|2644106|P1|STARTED|Intravenous Period 7 - 9||0
1091496|NCT01037309|2644098|P9|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
1091497|NCT01037309|2644099|P8|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
1091498|NCT01037309|2644100|P7|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
1091499|NCT01037309|2644101|P6|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
1091500|NCT01037309|2644102|P5|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
1091501|NCT01037309|2644103|P4|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
1091502|NCT01037309|2644104|P3|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
1091503|NCT01037309|2644105|P2|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
1091504|NCT01037309|2644106|P1|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
1091505|NCT01037309|2644098|P9|COMPLETED|Subcutaneous Cohort 1 - 6||0
1091506|NCT01037309|2644099|P8|COMPLETED|Subcutaneous Cohort 1 - 6||0
1091507|NCT01037309|2644100|P7|COMPLETED|Subcutaneous Cohort 1 - 6||0
1091508|NCT01037309|2644101|P6|COMPLETED|Subcutaneous Cohort 1 - 6||3
1091509|NCT01037309|2644102|P5|COMPLETED|Subcutaneous Cohort 1 - 6||3
1091510|NCT01037309|2644103|P4|COMPLETED|Subcutaneous Cohort 1 - 6||3
1091511|NCT01037309|2644104|P3|COMPLETED|Subcutaneous Cohort 1 - 6||3
1091512|NCT01037309|2644105|P2|COMPLETED|Subcutaneous Cohort 1 - 6||3
1091513|NCT01037309|2644106|P1|COMPLETED|Subcutaneous Cohort 1 - 6||3
1091514|NCT01037309|2644098|P9|STARTED|Subcutaneous Cohort 1 - 6||0
1091515|NCT01037309|2644099|P8|STARTED|Subcutaneous Cohort 1 - 6||0
1091516|NCT01037309|2644100|P7|STARTED|Subcutaneous Cohort 1 - 6||0
1091517|NCT01037309|2644101|P6|STARTED|Subcutaneous Cohort 1 - 6||3
1091518|NCT01037309|2644102|P5|STARTED|Subcutaneous Cohort 1 - 6||3
1091519|NCT01037309|2644103|P4|STARTED|Subcutaneous Cohort 1 - 6||3
1091520|NCT01037309|2644104|P3|STARTED|Subcutaneous Cohort 1 - 6||3
1091521|NCT01037309|2644105|P2|STARTED|Subcutaneous Cohort 1 - 6||3
1091522|NCT01037309|2644106|P1|STARTED|Subcutaneous Cohort 1 - 6||3
1091523|NCT01037452|2644139|P4|NOT COMPLETED|Overall Study||0
1091524|NCT01037452|2644140|P3|NOT COMPLETED|Overall Study||0
1091525|NCT01037452|2644141|P2|NOT COMPLETED|Overall Study||0
1091526|NCT01037452|2644142|P1|NOT COMPLETED|Overall Study||0
1091527|NCT01037452|2644139|P4|COMPLETED|Overall Study||30
1091528|NCT01037452|2644140|P3|COMPLETED|Overall Study||30
1091529|NCT01037452|2644141|P2|COMPLETED|Overall Study||30
1091530|NCT01037452|2644142|P1|COMPLETED|Overall Study||30
1091531|NCT01037452|2644139|P4|STARTED|Overall Study||30
1091532|NCT01037452|2644140|P3|STARTED|Overall Study||30
1091533|NCT01037452|2644141|P2|STARTED|Overall Study||30
1091534|NCT01037452|2644142|P1|STARTED|Overall Study||30
1091535|NCT01044290|2644167|P3|NOT COMPLETED|Follow-Up 2||2
1091536|NCT01044290|2644168|P2|NOT COMPLETED|Follow-Up 2||2
1091537|NCT01044290|2644169|P1|NOT COMPLETED|Follow-Up 2||0
1091538|NCT01044290|2644167|P3|COMPLETED|Follow-Up 2||69
1091539|NCT01044290|2644168|P2|COMPLETED|Follow-Up 2||67
1091540|NCT01044290|2644169|P1|COMPLETED|Follow-Up 2||70
1091541|NCT01044290|2644167|P3|Completed F2 Interview|Follow-Up 2||64
1091542|NCT01044290|2644168|P2|Completed F2 Interview|Follow-Up 2||57
1091543|NCT01044290|2644169|P1|Completed F2 Interview|Follow-Up 2||64
1091544|NCT01044290|2644167|P3|STARTED|Follow-Up 2||71
1091545|NCT01044290|2644168|P2|STARTED|Follow-Up 2||69
1091546|NCT01044290|2644169|P1|STARTED|Follow-Up 2||70
1091547|NCT01044290|2644167|P3|NOT COMPLETED|Follow-up 1||1
1091548|NCT01044290|2644168|P2|NOT COMPLETED|Follow-up 1||5
1091549|NCT01044290|2644169|P1|NOT COMPLETED|Follow-up 1||5
1091550|NCT01044290|2644167|P3|COMPLETED|Follow-up 1||71
1091551|NCT01044290|2644168|P2|COMPLETED|Follow-up 1||69
1091552|NCT01044290|2644169|P1|COMPLETED|Follow-up 1||70
1091553|NCT01044290|2644167|P3|Completed F1 Interview|Follow-up 1||61
1091554|NCT01044290|2644168|P2|Completed F1 Interview|Follow-up 1||60
1091555|NCT01044290|2644169|P1|Completed F1 Interview|Follow-up 1||61
1091556|NCT01044290|2644167|P3|STARTED|Follow-up 1||72
1091557|NCT01044290|2644168|P2|STARTED|Follow-up 1||74
1091558|NCT01044290|2644169|P1|STARTED|Follow-up 1||75
1091559|NCT01044290|2644167|P3|NOT COMPLETED|Randomization||0
1091560|NCT01044290|2644168|P2|NOT COMPLETED|Randomization||0
1091561|NCT01044290|2644169|P1|NOT COMPLETED|Randomization||0
1091562|NCT01044290|2644167|P3|COMPLETED|Randomization||72
1091563|NCT01044290|2644168|P2|COMPLETED|Randomization||74
1091564|NCT01044290|2644169|P1|COMPLETED|Randomization||75
1091565|NCT01044290|2644167|P3|Randomized|Randomization||72
1091566|NCT01044290|2644168|P2|Randomized|Randomization||74
1091567|NCT01044290|2644169|P1|Randomized|Randomization||75
1091568|NCT01044290|2644167|P3|STARTED|Randomization||72
1091569|NCT01044290|2644168|P2|STARTED|Randomization||74
1091570|NCT01044290|2644169|P1|STARTED|Randomization||75
1091571|NCT01044303|2644192|P1|NOT COMPLETED|Overall Study||2
1091572|NCT01044303|2644192|P1|COMPLETED|Overall Study||30
1091573|NCT01044303|2644192|P1|STARTED|Overall Study||32
1091574|NCT01044459|2644201|P2|NOT COMPLETED|Overall Study||131
1091575|NCT01044459|2644202|P1|NOT COMPLETED|Overall Study||133
1091576|NCT01044459|2644201|P2|COMPLETED|Overall Study||162
1091577|NCT01044459|2644202|P1|COMPLETED|Overall Study||179
1091578|NCT01044459|2644201|P2|STARTED|Overall Study||293
1091579|NCT01044459|2644202|P1|STARTED|Overall Study||312
1091580|NCT01044498|2644212|P2|NOT COMPLETED|Overall Study||2
1091581|NCT01044498|2644213|P1|NOT COMPLETED|Overall Study||3
1091582|NCT01044498|2644212|P2|COMPLETED|Overall Study||21
1091583|NCT01044498|2644213|P1|COMPLETED|Overall Study||20
1091584|NCT01044498|2644212|P2|STARTED|Overall Study||23
1091585|NCT01044498|2644213|P1|STARTED|Overall Study||23
1091586|NCT01044537|2644244|P7|NOT COMPLETED|Overall Study||0
1091587|NCT01044537|2644245|P6|NOT COMPLETED|Overall Study||0
1091588|NCT01044537|2644246|P5|NOT COMPLETED|Overall Study||0
1091589|NCT01044537|2644247|P4|NOT COMPLETED|Overall Study||0
1091590|NCT01044537|2644248|P3|NOT COMPLETED|Overall Study||0
1091591|NCT01044537|2644249|P2|NOT COMPLETED|Overall Study||0
1091592|NCT01044537|2644250|P1|NOT COMPLETED|Overall Study||0
1091593|NCT01044537|2644244|P7|COMPLETED|Overall Study||16
1091594|NCT01044537|2644245|P6|COMPLETED|Overall Study||5
1091595|NCT01044537|2644246|P5|COMPLETED|Overall Study||5
1091596|NCT01044537|2644247|P4|COMPLETED|Overall Study||6
1091597|NCT01044537|2644248|P3|COMPLETED|Overall Study||6
1091598|NCT01044537|2644249|P2|COMPLETED|Overall Study||6
1091599|NCT01044537|2644250|P1|COMPLETED|Overall Study||6
1091600|NCT01044537|2644244|P7|STARTED|Overall Study||16
1091601|NCT01044537|2644245|P6|STARTED|Overall Study||5
1091602|NCT01044537|2644246|P5|STARTED|Overall Study||5
1091603|NCT01044537|2644247|P4|STARTED|Overall Study||6
1091604|NCT01044537|2644248|P3|STARTED|Overall Study||6
1091605|NCT01044537|2644249|P2|STARTED|Overall Study||6
1091606|NCT01044537|2644250|P1|STARTED|Overall Study||6
1091607|NCT01044589|2644359|P2|NOT COMPLETED|Overall Study||5
1091608|NCT01044589|2644360|P1|NOT COMPLETED|Overall Study||3
1091609|NCT01044589|2644359|P2|COMPLETED|Overall Study||2
1091610|NCT01044589|2644360|P1|COMPLETED|Overall Study||3
1091611|NCT01044589|2644359|P2|STARTED|Overall Study||7
1091612|NCT01044589|2644360|P1|STARTED|Overall Study||6
1091613|NCT01045694|2644368|P1|NOT COMPLETED|Overall Study||2
1091614|NCT01045694|2644368|P1|COMPLETED|Overall Study||6
1091615|NCT01045694|2644368|P1|STARTED|Overall Study||8
1091616|NCT01045707|2644376|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||12
1091617|NCT01045707|2644377|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||13
1091618|NCT01045707|2644376|P2|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||209
1091619|NCT01045707|2644377|P1|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||179
1091706|NCT01046084|2644498|P2|STARTED|First Intervention||25
1091620|NCT01045707|2644376|P2|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Eleven subjects from main trial did not continue into the extension|221
1091621|NCT01045707|2644377|P1|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Twenty seven subjects from main trial did not continue into the extension|192
1091622|NCT01045707|2644376|P2|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||32
1091623|NCT01045707|2644377|P1|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||47
1091624|NCT01045707|2644376|P2|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||232
1091625|NCT01045707|2644377|P1|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||219
1091626|NCT01045707|2644376|P2|Exposed|Main: Week 0 to 26 (NN5401-3590)|Three subjects withdrew prior to exposure to trial drug|261
1091627|NCT01045707|2644377|P1|Exposed|Main: Week 0 to 26 (NN5401-3590)|One subject withdrew prior to exposure to trial drug|265
1091628|NCT01045707|2644376|P2|STARTED|Main: Week 0 to 26 (NN5401-3590)||264
1091629|NCT01045707|2644377|P1|STARTED|Main: Week 0 to 26 (NN5401-3590)||266
1091630|NCT01045798|2644395|P2|NOT COMPLETED|Overall Study||4
1091631|NCT01045798|2644396|P1|NOT COMPLETED|Overall Study||2
1091632|NCT01045798|2644395|P2|COMPLETED|Overall Study||5
1091633|NCT01045798|2644396|P1|COMPLETED|Overall Study||4
1091634|NCT01045798|2644395|P2|STARTED|Overall Study||9
1091635|NCT01045798|2644396|P1|STARTED|Overall Study||6
1091636|NCT01045967|2644404|P2|NOT COMPLETED|Second Intervention||1
1091637|NCT01045967|2644405|P1|NOT COMPLETED|Second Intervention||0
1091638|NCT01045967|2644404|P2|COMPLETED|Second Intervention||27
1091639|NCT01045967|2644405|P1|COMPLETED|Second Intervention||28
1091640|NCT01045967|2644404|P2|STARTED|Second Intervention|Subject was dropped prior to dosing in Period II due to positive drug screen.|28
1091641|NCT01045967|2644405|P1|STARTED|Second Intervention||28
1091642|NCT01045967|2644404|P2|NOT COMPLETED|Washout of 7 Days||0
1091643|NCT01045967|2644405|P1|NOT COMPLETED|Washout of 7 Days||0
1091644|NCT01045967|2644404|P2|COMPLETED|Washout of 7 Days||28
1091645|NCT01045967|2644405|P1|COMPLETED|Washout of 7 Days||28
1091646|NCT01045967|2644404|P2|STARTED|Washout of 7 Days||28
1091647|NCT01045967|2644405|P1|STARTED|Washout of 7 Days||28
1091648|NCT01045967|2644404|P2|NOT COMPLETED|First Intervention||0
1091649|NCT01045967|2644405|P1|NOT COMPLETED|First Intervention||0
1091650|NCT01045967|2644404|P2|COMPLETED|First Intervention||28
1091651|NCT01045967|2644405|P1|COMPLETED|First Intervention||28
1091652|NCT01045967|2644404|P2|STARTED|First Intervention||28
1091653|NCT01045967|2644405|P1|STARTED|First Intervention||28
1091654|NCT01045993|2644419|P4|NOT COMPLETED|Overall Study||0
1091655|NCT01045993|2644420|P3|NOT COMPLETED|Overall Study||0
1091656|NCT01045993|2644421|P2|NOT COMPLETED|Overall Study||1
1091657|NCT01045993|2644422|P1|NOT COMPLETED|Overall Study||0
1091658|NCT01045993|2644419|P4|COMPLETED|Overall Study||25
1091659|NCT01045993|2644420|P3|COMPLETED|Overall Study||5
1091660|NCT01045993|2644421|P2|COMPLETED|Overall Study||4
1091661|NCT01045993|2644422|P1|COMPLETED|Overall Study||26
1091662|NCT01045993|2644419|P4|STARTED|Overall Study||25
1091663|NCT01045993|2644420|P3|STARTED|Overall Study||5
1091664|NCT01045993|2644421|P2|STARTED|Overall Study||5
1091665|NCT01045993|2644422|P1|STARTED|Overall Study||26
1091666|NCT01046084|2644498|P2|NOT COMPLETED|Fourth Intervention||0
1091667|NCT01046084|2644499|P1|NOT COMPLETED|Fourth Intervention||0
1091668|NCT01046084|2644498|P2|COMPLETED|Fourth Intervention||25
1091669|NCT01046084|2644499|P1|COMPLETED|Fourth Intervention||23
1091670|NCT01046084|2644498|P2|STARTED|Fourth Intervention||25
1091671|NCT01046084|2644499|P1|STARTED|Fourth Intervention||23
1091672|NCT01046084|2644498|P2|NOT COMPLETED|Third Washout of 7 Days||0
1091673|NCT01046084|2644499|P1|NOT COMPLETED|Third Washout of 7 Days||2
1091674|NCT01046084|2644498|P2|COMPLETED|Third Washout of 7 Days||25
1091675|NCT01046084|2644499|P1|COMPLETED|Third Washout of 7 Days||23
1091676|NCT01046084|2644498|P2|STARTED|Third Washout of 7 Days||25
1091677|NCT01046084|2644499|P1|STARTED|Third Washout of 7 Days||25
1091678|NCT01046084|2644498|P2|NOT COMPLETED|Third Intervention||0
1091679|NCT01046084|2644499|P1|NOT COMPLETED|Third Intervention||0
1091680|NCT01046084|2644498|P2|COMPLETED|Third Intervention||25
1091681|NCT01046084|2644499|P1|COMPLETED|Third Intervention||25
1091682|NCT01046084|2644498|P2|STARTED|Third Intervention||25
1091683|NCT01046084|2644499|P1|STARTED|Third Intervention||25
1091684|NCT01046084|2644498|P2|NOT COMPLETED|Second Washout of 7 Days||0
1091685|NCT01046084|2644499|P1|NOT COMPLETED|Second Washout of 7 Days||0
1091686|NCT01046084|2644498|P2|COMPLETED|Second Washout of 7 Days||25
1091687|NCT01046084|2644499|P1|COMPLETED|Second Washout of 7 Days||25
1091688|NCT01046084|2644498|P2|STARTED|Second Washout of 7 Days||25
1091689|NCT01046084|2644499|P1|STARTED|Second Washout of 7 Days||25
1091690|NCT01046084|2644498|P2|NOT COMPLETED|Second Intervention||0
1091691|NCT01046084|2644499|P1|NOT COMPLETED|Second Intervention||0
1091692|NCT01046084|2644498|P2|COMPLETED|Second Intervention||25
1091693|NCT01046084|2644499|P1|COMPLETED|Second Intervention||25
1091694|NCT01046084|2644498|P2|STARTED|Second Intervention||25
1091695|NCT01046084|2644499|P1|STARTED|Second Intervention||25
1091696|NCT01046084|2644498|P2|NOT COMPLETED|First Washout of 7 Days||0
1091697|NCT01046084|2644499|P1|NOT COMPLETED|First Washout of 7 Days||0
1091698|NCT01046084|2644498|P2|COMPLETED|First Washout of 7 Days||25
1091699|NCT01046084|2644499|P1|COMPLETED|First Washout of 7 Days||25
1091700|NCT01046084|2644498|P2|STARTED|First Washout of 7 Days||25
1091701|NCT01046084|2644499|P1|STARTED|First Washout of 7 Days||25
1091702|NCT01046084|2644498|P2|NOT COMPLETED|First Intervention||0
1091703|NCT01046084|2644499|P1|NOT COMPLETED|First Intervention||0
1091704|NCT01046084|2644498|P2|COMPLETED|First Intervention||25
1091705|NCT01046084|2644499|P1|COMPLETED|First Intervention||25
1091707|NCT01046084|2644499|P1|STARTED|First Intervention||25
1091708|NCT01046110|2644511|P2|NOT COMPLETED|Overall Study||55
1091709|NCT01046110|2644512|P1|NOT COMPLETED|Overall Study||55
1091710|NCT01046110|2644511|P2|COMPLETED|Overall Study||174
1091711|NCT01046110|2644512|P1|COMPLETED|Overall Study||174
1091712|NCT01046110|2644511|P2|Exposed|Overall Study|1 subject was randomised in error|228
1091713|NCT01046110|2644512|P1|Exposed|Overall Study|2 subjects were randomised in error and 1 subject did not want to take insulin|226
1091714|NCT01046110|2644511|P2|STARTED|Overall Study||229
1091715|NCT01046110|2644512|P1|STARTED|Overall Study||229
1091716|NCT01046136|2644522|P2|NOT COMPLETED|Overall Study||8
1091717|NCT01046136|2644523|P1|NOT COMPLETED|Overall Study||4
1091718|NCT01046136|2644522|P2|COMPLETED|Overall Study||182
1091719|NCT01046136|2644523|P1|COMPLETED|Overall Study||184
1091720|NCT01046136|2644522|P2|STARTED|Overall Study||190
1091721|NCT01046136|2644523|P1|STARTED|Overall Study||188
1091722|NCT01046253|2644535|P2|NOT COMPLETED|Fourth Intervention||0
1091723|NCT01046253|2644536|P1|NOT COMPLETED|Fourth Intervention||0
1091724|NCT01046253|2644535|P2|COMPLETED|Fourth Intervention||23
1091725|NCT01046253|2644536|P1|COMPLETED|Fourth Intervention||25
1091726|NCT01046253|2644535|P2|STARTED|Fourth Intervention||23
1091727|NCT01046253|2644536|P1|STARTED|Fourth Intervention||25
1091728|NCT01046253|2644535|P2|NOT COMPLETED|Third Washout of 7 Days||0
1091729|NCT01046253|2644536|P1|NOT COMPLETED|Third Washout of 7 Days||0
1091730|NCT01046253|2644535|P2|COMPLETED|Third Washout of 7 Days||23
1091731|NCT01046253|2644536|P1|COMPLETED|Third Washout of 7 Days||25
1091732|NCT01046253|2644535|P2|STARTED|Third Washout of 7 Days||23
1091733|NCT01046253|2644536|P1|STARTED|Third Washout of 7 Days||25
1091734|NCT01046253|2644535|P2|NOT COMPLETED|Third Intervention||0
1091735|NCT01046253|2644536|P1|NOT COMPLETED|Third Intervention||0
1091736|NCT01046253|2644535|P2|COMPLETED|Third Intervention||23
1091737|NCT01046253|2644536|P1|COMPLETED|Third Intervention||25
1091738|NCT01046253|2644535|P2|STARTED|Third Intervention||23
1091739|NCT01046253|2644536|P1|STARTED|Third Intervention||25
1091740|NCT01046253|2644535|P2|NOT COMPLETED|Second Washout of 7 Days||0
1091741|NCT01046253|2644536|P1|NOT COMPLETED|Second Washout of 7 Days||0
1091742|NCT01046253|2644535|P2|COMPLETED|Second Washout of 7 Days||23
1091743|NCT01046253|2644536|P1|COMPLETED|Second Washout of 7 Days||25
1091744|NCT01046253|2644535|P2|STARTED|Second Washout of 7 Days||23
1091745|NCT01046253|2644536|P1|STARTED|Second Washout of 7 Days||25
1091746|NCT01046253|2644535|P2|NOT COMPLETED|Second Intervention||2
1091747|NCT01046253|2644536|P1|NOT COMPLETED|Second Intervention||0
1091748|NCT01046253|2644535|P2|COMPLETED|Second Intervention||23
1091749|NCT01046253|2644536|P1|COMPLETED|Second Intervention||25
1091750|NCT01046253|2644535|P2|STARTED|Second Intervention||25
1091751|NCT01046253|2644536|P1|STARTED|Second Intervention||25
1091752|NCT01046253|2644535|P2|NOT COMPLETED|First Washout of 7 Days||0
1091753|NCT01046253|2644536|P1|NOT COMPLETED|First Washout of 7 Days||0
1091754|NCT01046253|2644535|P2|COMPLETED|First Washout of 7 Days||25
1091755|NCT01046253|2644536|P1|COMPLETED|First Washout of 7 Days||25
1091756|NCT01046253|2644535|P2|STARTED|First Washout of 7 Days||25
1091757|NCT01046253|2644536|P1|STARTED|First Washout of 7 Days||25
1091758|NCT01046253|2644535|P2|NOT COMPLETED|First Intervention||0
1091759|NCT01046253|2644536|P1|NOT COMPLETED|First Intervention||0
1091760|NCT01046253|2644535|P2|COMPLETED|First Intervention||25
1091761|NCT01046253|2644536|P1|COMPLETED|First Intervention||25
1091762|NCT01046253|2644535|P2|STARTED|First Intervention||25
1091763|NCT01046253|2644536|P1|STARTED|First Intervention||25
1091764|NCT01046396|2644546|P1|NOT COMPLETED|Overall Study||5
1091765|NCT01046396|2644546|P1|COMPLETED|Overall Study||64
1091766|NCT01046396|2644546|P1|STARTED|Overall Study||69
1091767|NCT01046565|2644555|P1|NOT COMPLETED|Overall Study||9
1091768|NCT01046565|2644555|P1|COMPLETED|Overall Study||66
1091769|NCT01046565|2644555|P1|STARTED|Overall Study||75
1091770|NCT01046643|2644566|P4|NOT COMPLETED|Second Period Treatment or Placebo||0
1091771|NCT01046643|2644567|P3|NOT COMPLETED|Second Period Treatment or Placebo||0
1091772|NCT01046643|2644568|P2|NOT COMPLETED|Second Period Treatment or Placebo||0
1091773|NCT01046643|2644569|P1|NOT COMPLETED|Second Period Treatment or Placebo||0
1091774|NCT01046643|2644566|P4|COMPLETED|Second Period Treatment or Placebo||7
1091775|NCT01046643|2644567|P3|COMPLETED|Second Period Treatment or Placebo||7
1091776|NCT01046643|2644568|P2|COMPLETED|Second Period Treatment or Placebo||6
1091777|NCT01046643|2644569|P1|COMPLETED|Second Period Treatment or Placebo||9
1091778|NCT01046643|2644566|P4|STARTED|Second Period Treatment or Placebo||7
1091779|NCT01046643|2644567|P3|STARTED|Second Period Treatment or Placebo||7
1091780|NCT01046643|2644568|P2|STARTED|Second Period Treatment or Placebo||6
1091781|NCT01046643|2644569|P1|STARTED|Second Period Treatment or Placebo||9
1091782|NCT01046643|2644566|P4|NOT COMPLETED|Washout Period||0
1091783|NCT01046643|2644567|P3|NOT COMPLETED|Washout Period||0
1091784|NCT01046643|2644568|P2|NOT COMPLETED|Washout Period||0
1091785|NCT01046643|2644569|P1|NOT COMPLETED|Washout Period||0
1091786|NCT01046643|2644566|P4|COMPLETED|Washout Period||7
1091787|NCT01046643|2644567|P3|COMPLETED|Washout Period||7
1091788|NCT01046643|2644568|P2|COMPLETED|Washout Period||6
1091789|NCT01046643|2644569|P1|COMPLETED|Washout Period||9
1091790|NCT01046643|2644566|P4|STARTED|Washout Period||7
1091791|NCT01046643|2644567|P3|STARTED|Washout Period||7
1091792|NCT01046643|2644568|P2|STARTED|Washout Period||6
1091793|NCT01046643|2644569|P1|STARTED|Washout Period||9
1091794|NCT01046643|2644566|P4|NOT COMPLETED|First Period Treatment or Placebo||0
1091795|NCT01046643|2644567|P3|NOT COMPLETED|First Period Treatment or Placebo||0
1091796|NCT01046643|2644568|P2|NOT COMPLETED|First Period Treatment or Placebo||1
1091797|NCT01046643|2644569|P1|NOT COMPLETED|First Period Treatment or Placebo||0
1091798|NCT01046643|2644566|P4|COMPLETED|First Period Treatment or Placebo||7
1091799|NCT01046643|2644567|P3|COMPLETED|First Period Treatment or Placebo||7
1091800|NCT01046643|2644568|P2|COMPLETED|First Period Treatment or Placebo||6
1091801|NCT01046643|2644569|P1|COMPLETED|First Period Treatment or Placebo||9
1091802|NCT01046643|2644566|P4|STARTED|First Period Treatment or Placebo||7
1091803|NCT01046643|2644567|P3|STARTED|First Period Treatment or Placebo||7
1091804|NCT01046643|2644568|P2|STARTED|First Period Treatment or Placebo||7
1091805|NCT01046643|2644569|P1|STARTED|First Period Treatment or Placebo||9
1091806|NCT01046682|2644593|P2|NOT COMPLETED|Overall Study||0
1091807|NCT01046682|2644594|P1|NOT COMPLETED|Overall Study||2
1091808|NCT01046682|2644593|P2|COMPLETED|Overall Study||20
1091809|NCT01046682|2644594|P1|COMPLETED|Overall Study||18
1091810|NCT01046682|2644593|P2|STARTED|Overall Study||20
1091811|NCT01046682|2644594|P1|STARTED|Overall Study||20
1091812|NCT01046695|2644602|P2|NOT COMPLETED|Overall Study||2
1091813|NCT01046695|2644603|P1|NOT COMPLETED|Overall Study||0
1091814|NCT01046695|2644602|P2|COMPLETED|Overall Study||20
1091815|NCT01046695|2644603|P1|COMPLETED|Overall Study||20
1091816|NCT01046695|2644602|P2|STARTED|Overall Study||22
1091817|NCT01046695|2644603|P1|STARTED|Overall Study||20
1091818|NCT01046877|2644613|P1|NOT COMPLETED|Overall Study||18
1091819|NCT01046877|2644613|P1|COMPLETED|Overall Study||7
1091820|NCT01046877|2644613|P1|Completed Study Late|Overall Study|One completed (evidencing extrusions) at 23.5 mos. Missed 9 mo visit. Exam not possible at 12 mo.|1
1091821|NCT01046877|2644613|P1|Completed on Schedule|Overall Study|Final visit = the earlier of 24 months post-procedure or 12 months after extrusion.|6
1091822|NCT01046877|2644613|P1|STARTED|Overall Study||25
1091823|NCT01046903|2644627|P1|NOT COMPLETED|Overall Study||28
1091824|NCT01046903|2644627|P1|COMPLETED|Overall Study||475
1091825|NCT01046903|2644627|P1|STARTED|Overall Study||503
1091826|NCT01047189|2644642|P2|NOT COMPLETED|Overall Study||0
1091827|NCT01047189|2644643|P1|NOT COMPLETED|Overall Study||4
1091828|NCT01047189|2644642|P2|COMPLETED|Overall Study||13
1091829|NCT01047189|2644643|P1|COMPLETED|Overall Study||9
1091830|NCT01047189|2644642|P2|STARTED|Overall Study||13
1091831|NCT01047189|2644643|P1|STARTED|Overall Study||13
1091832|NCT01047241|2644651|P1|NOT COMPLETED|Overall Study||0
1091833|NCT01047241|2644651|P1|COMPLETED|Overall Study||50
1091834|NCT01047241|2644651|P1|STARTED|Overall Study||50
1091835|NCT01047293|2644660|P4|NOT COMPLETED|Overall Study||0
1091836|NCT01047293|2644661|P3|NOT COMPLETED|Overall Study||0
1091837|NCT01047293|2644662|P2|NOT COMPLETED|Overall Study||1
1091838|NCT01047293|2644663|P1|NOT COMPLETED|Overall Study||1
1091839|NCT01047293|2644660|P4|COMPLETED|Overall Study||26
1091840|NCT01047293|2644661|P3|COMPLETED|Overall Study||9
1091841|NCT01047293|2644662|P2|COMPLETED|Overall Study||7
1091842|NCT01047293|2644663|P1|COMPLETED|Overall Study||3
1091843|NCT01047293|2644660|P4|STARTED|Overall Study||26
1091844|NCT01047293|2644661|P3|STARTED|Overall Study||9
1091845|NCT01047293|2644662|P2|STARTED|Overall Study||8
1091846|NCT01047293|2644663|P1|STARTED|Overall Study||4
1091847|NCT01047306|2644672|P2|NOT COMPLETED|Overall Study||0
1091848|NCT01047306|2644673|P1|NOT COMPLETED|Overall Study||3
1091849|NCT01047306|2644672|P2|COMPLETED|Overall Study||6
1091850|NCT01047306|2644673|P1|COMPLETED|Overall Study||16
1091851|NCT01047306|2644672|P2|Discontinued From the Study|Overall Study||0
1091852|NCT01047306|2644673|P1|Discontinued From the Study|Overall Study||3
1091853|NCT01047306|2644672|P2|STARTED|Overall Study||6
1091854|NCT01047306|2644673|P1|STARTED|Overall Study||19
1091855|NCT01047332|2644749|P2|NOT COMPLETED|Overall Study||64
1091856|NCT01047332|2644750|P1|NOT COMPLETED|Overall Study||57
1091857|NCT01047332|2644749|P2|COMPLETED|Overall Study|Alive at final follow-up|4
1091858|NCT01047332|2644750|P1|COMPLETED|Overall Study|Alive at final follow-up|4
1091859|NCT01047332|2644749|P2|STARTED|Overall Study||68
1091860|NCT01047332|2644750|P1|STARTED|Overall Study||61
1091861|NCT01047345|2644764|P3|NOT COMPLETED|Extension||6
1091862|NCT01047345|2644765|P2|NOT COMPLETED|Extension||0
1091863|NCT01047345|2644766|P1|NOT COMPLETED|Extension||0
1091864|NCT01047345|2644764|P3|COMPLETED|Extension||96
1091865|NCT01047345|2644765|P2|COMPLETED|Extension||0
1091866|NCT01047345|2644766|P1|COMPLETED|Extension||0
1091867|NCT01047345|2644764|P3|Vaccination 6|Extension|1 participant received 6th vaccination outside the context of study but completed the study.|95
1091868|NCT01047345|2644765|P2|Vaccination 6|Extension||0
1091869|NCT01047345|2644766|P1|Vaccination 6|Extension||0
1091870|NCT01047345|2644764|P3|Vaccination 5|Extension||99
1091871|NCT01047345|2644765|P2|Vaccination 5|Extension||0
1091872|NCT01047345|2644766|P1|Vaccination 5|Extension||0
1091873|NCT01047345|2644764|P3|Vaccination 4|Extension||102
1091874|NCT01047345|2644765|P2|Vaccination 4|Extension||0
1091875|NCT01047345|2644766|P1|Vaccination 4|Extension||0
1091876|NCT01047345|2644764|P3|STARTED|Extension|Not all eligible participants elected to participate in extension|102
1091877|NCT01047345|2644765|P2|STARTED|Extension||0
1091878|NCT01047345|2644766|P1|STARTED|Extension||0
1091879|NCT01047345|2644764|P3|NOT COMPLETED|Base Study||0
1091880|NCT01047345|2644765|P2|NOT COMPLETED|Base Study||6
1091881|NCT01047345|2644766|P1|NOT COMPLETED|Base Study||22
1091882|NCT01047345|2644764|P3|COMPLETED|Base Study||0
1091883|NCT01047345|2644765|P2|COMPLETED|Base Study||300
1091977|NCT01040728|2645016|P1|STARTED|Overall Study||31
1091884|NCT01047345|2644766|P1|COMPLETED|Base Study|Includes 1 participant for whom completion status is unknown|596
1091885|NCT01047345|2644764|P3|Vaccination 3|Base Study||0
1091886|NCT01047345|2644765|P2|Vaccination 3|Base Study||300
1091887|NCT01047345|2644766|P1|Vaccination 3|Base Study||597
1091888|NCT01047345|2644764|P3|Vaccination 2|Base Study||0
1091889|NCT01047345|2644765|P2|Vaccination 2|Base Study||304
1091890|NCT01047345|2644766|P1|Vaccination 2|Base Study||604
1091891|NCT01047345|2644764|P3|Vaccination 1|Base Study||0
1091892|NCT01047345|2644765|P2|Vaccination 1|Base Study||306
1091893|NCT01047345|2644766|P1|Vaccination 1|Base Study||615
1091894|NCT01047345|2644764|P3|STARTED|Base Study||0
1091895|NCT01047345|2644765|P2|STARTED|Base Study||306
1091896|NCT01047345|2644766|P1|STARTED|Base Study||618
1091897|NCT01047358|2644786|P1|NOT COMPLETED|Overall Study||0
1091898|NCT01047358|2644786|P1|COMPLETED|Overall Study|At least one safety assessment (Safety Population)|206
1091899|NCT01047358|2644786|P1|STARTED|Overall Study||206
1091900|NCT01047436|2644795|P2|NOT COMPLETED|Overall Study||0
1091901|NCT01047436|2644796|P1|NOT COMPLETED|Overall Study||1
1091902|NCT01047436|2644795|P2|COMPLETED|Overall Study||15
1091903|NCT01047436|2644796|P1|COMPLETED|Overall Study||15
1091904|NCT01047436|2644795|P2|STARTED|Overall Study||15
1091905|NCT01047436|2644796|P1|STARTED|Overall Study||16
1091906|NCT01047475|2644814|P2|NOT COMPLETED|Overall Study||7
1091907|NCT01047475|2644815|P1|NOT COMPLETED|Overall Study||5
1091908|NCT01047475|2644814|P2|COMPLETED|Overall Study||31
1091909|NCT01047475|2644815|P1|COMPLETED|Overall Study||29
1091910|NCT01047475|2644814|P2|STARTED|Overall Study||38
1091911|NCT01047475|2644815|P1|STARTED|Overall Study||34
1091912|NCT01047527|2644824|P3|NOT COMPLETED|Overall Study||65
1091913|NCT01047527|2644825|P2|NOT COMPLETED|Overall Study||61
1091914|NCT01047527|2644826|P1|NOT COMPLETED|Overall Study||85
1091915|NCT01047527|2644824|P3|COMPLETED|Overall Study||107
1091916|NCT01047527|2644825|P2|COMPLETED|Overall Study||112
1091917|NCT01047527|2644826|P1|COMPLETED|Overall Study||95
1091918|NCT01047527|2644824|P3|24 Weeks|Overall Study||119
1091919|NCT01047527|2644825|P2|24 Weeks|Overall Study||123
1091920|NCT01047527|2644826|P1|24 Weeks|Overall Study||111
1091921|NCT01047527|2644824|P3|8 Weeks|Overall Study||138
1091922|NCT01047527|2644825|P2|8 Weeks|Overall Study||142
1091923|NCT01047527|2644826|P1|8 Weeks|Overall Study||148
1091924|NCT01047527|2644824|P3|STARTED|Overall Study||172
1091925|NCT01047527|2644825|P2|STARTED|Overall Study||173
1091926|NCT01047527|2644826|P1|STARTED|Overall Study||180
1091927|NCT01047553|2644837|P2|NOT COMPLETED|Overall Study||9
1091928|NCT01047553|2644838|P1|NOT COMPLETED|Overall Study||17
1091929|NCT01047553|2644837|P2|COMPLETED|Overall Study||117
1091930|NCT01047553|2644838|P1|COMPLETED|Overall Study||108
1091931|NCT01047553|2644837|P2|STARTED|Overall Study||126
1091932|NCT01047553|2644838|P1|STARTED|Overall Study||125
1091933|NCT01047709|2644920|P2|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
1091934|NCT01047709|2644921|P1|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
1091935|NCT01047709|2644920|P2|COMPLETED|Control/Positioning ad Lib (1 Night)||9
1091936|NCT01047709|2644921|P1|COMPLETED|Control/Positioning ad Lib (1 Night)||9
1091937|NCT01047709|2644920|P2|STARTED|Control/Positioning ad Lib (1 Night)||9
1091938|NCT01047709|2644921|P1|STARTED|Control/Positioning ad Lib (1 Night)||9
1091939|NCT01047709|2644920|P2|NOT COMPLETED|Positional Therapy (1 Night)||0
1091940|NCT01047709|2644921|P1|NOT COMPLETED|Positional Therapy (1 Night)||0
1091941|NCT01047709|2644920|P2|COMPLETED|Positional Therapy (1 Night)||9
1091942|NCT01047709|2644921|P1|COMPLETED|Positional Therapy (1 Night)||9
1091943|NCT01047709|2644920|P2|STARTED|Positional Therapy (1 Night)||9
1091944|NCT01047709|2644921|P1|STARTED|Positional Therapy (1 Night)||9
1091945|NCT01047839|2644930|P3|NOT COMPLETED|Overall Study||6
1091946|NCT01047839|2644931|P2|NOT COMPLETED|Overall Study||0
1091947|NCT01047839|2644932|P1|NOT COMPLETED|Overall Study||2
1091948|NCT01047839|2644930|P3|COMPLETED|Overall Study||53
1091949|NCT01047839|2644931|P2|COMPLETED|Overall Study||29
1091950|NCT01047839|2644932|P1|COMPLETED|Overall Study||10
1091951|NCT01047839|2644930|P3|STARTED|Overall Study||59
1091952|NCT01047839|2644931|P2|STARTED|Overall Study||29
1091953|NCT01047839|2644932|P1|STARTED|Overall Study||12
1091954|NCT01040689|2644940|P4|NOT COMPLETED|Overall Study||4
1091955|NCT01040689|2644941|P3|NOT COMPLETED|Overall Study||4
1091956|NCT01040689|2644942|P2|NOT COMPLETED|Overall Study||2
1091957|NCT01040689|2644943|P1|NOT COMPLETED|Overall Study||3
1091958|NCT01040689|2644940|P4|COMPLETED|Overall Study||23
1091959|NCT01040689|2644941|P3|COMPLETED|Overall Study||23
1091960|NCT01040689|2644942|P2|COMPLETED|Overall Study||25
1091961|NCT01040689|2644943|P1|COMPLETED|Overall Study||24
1091962|NCT01040689|2644940|P4|STARTED|Overall Study||27
1091963|NCT01040689|2644941|P3|STARTED|Overall Study||27
1091964|NCT01040689|2644942|P2|STARTED|Overall Study||27
1091965|NCT01040689|2644943|P1|STARTED|Overall Study||27
1091966|NCT01040728|2645013|P4|NOT COMPLETED|Overall Study||6
1091967|NCT01040728|2645014|P3|NOT COMPLETED|Overall Study||1
1091968|NCT01040728|2645015|P2|NOT COMPLETED|Overall Study||11
1091969|NCT01040728|2645016|P1|NOT COMPLETED|Overall Study||4
1091970|NCT01040728|2645013|P4|COMPLETED|Overall Study||24
1091971|NCT01040728|2645014|P3|COMPLETED|Overall Study||30
1091972|NCT01040728|2645015|P2|COMPLETED|Overall Study||19
1091973|NCT01040728|2645016|P1|COMPLETED|Overall Study||27
1091974|NCT01040728|2645013|P4|STARTED|Overall Study||30
1091975|NCT01040728|2645014|P3|STARTED|Overall Study||31
1091976|NCT01040728|2645015|P2|STARTED|Overall Study||30
1091978|NCT01040780|2645088|P2|NOT COMPLETED|Overall Study||3
1091979|NCT01040780|2645089|P1|NOT COMPLETED|Overall Study||1
1091980|NCT01040780|2645088|P2|COMPLETED|Overall Study||196
1091981|NCT01040780|2645089|P1|COMPLETED|Overall Study||199
1091982|NCT01040780|2645088|P2|STARTED|Overall Study||199
1091983|NCT01040780|2645089|P1|STARTED|Overall Study||200
1091984|NCT01040793|2645103|P6|NOT COMPLETED|Overall Study||1
1091985|NCT01040793|2645104|P5|NOT COMPLETED|Overall Study||4
1091986|NCT01040793|2645105|P4|NOT COMPLETED|Overall Study||4
1091987|NCT01040793|2645106|P3|NOT COMPLETED|Overall Study||3
1091988|NCT01040793|2645107|P2|NOT COMPLETED|Overall Study||5
1091989|NCT01040793|2645108|P1|NOT COMPLETED|Overall Study||6
1091990|NCT01040793|2645103|P6|COMPLETED|Overall Study||26
1091991|NCT01040793|2645104|P5|COMPLETED|Overall Study||22
1091992|NCT01040793|2645105|P4|COMPLETED|Overall Study||22
1091993|NCT01040793|2645106|P3|COMPLETED|Overall Study||23
1091994|NCT01040793|2645107|P2|COMPLETED|Overall Study||21
1091995|NCT01040793|2645108|P1|COMPLETED|Overall Study||20
1091996|NCT01040793|2645103|P6|STARTED|Overall Study||27
1091997|NCT01040793|2645104|P5|STARTED|Overall Study||26
1091998|NCT01040793|2645105|P4|STARTED|Overall Study||26
1091999|NCT01040793|2645106|P3|STARTED|Overall Study||26
1092000|NCT01040793|2645107|P2|STARTED|Overall Study||26
1092001|NCT01040793|2645108|P1|STARTED|Overall Study|Entered and treated|26
1092002|NCT01040819|2645187|P2|NOT COMPLETED|Overall Study||0
1092003|NCT01040819|2645188|P1|NOT COMPLETED|Overall Study||0
1092004|NCT01040819|2645187|P2|COMPLETED|Overall Study||12
1092005|NCT01040819|2645188|P1|COMPLETED|Overall Study||13
1092006|NCT01040819|2645187|P2|STARTED|Overall Study||12
1092007|NCT01040819|2645188|P1|STARTED|Overall Study||13
1092008|NCT01040832|2645196|P2|NOT COMPLETED|Overall Study||37
1092009|NCT01040832|2645197|P1|NOT COMPLETED|Overall Study||46
1092010|NCT01040832|2645196|P2|COMPLETED|Overall Study||16
1092011|NCT01040832|2645197|P1|COMPLETED|Overall Study||8
1092012|NCT01040832|2645196|P2|STARTED|Overall Study||53
1092013|NCT01040832|2645197|P1|STARTED|Overall Study|One participant was treated with study drug 'Cetuximab Plus EMD 1201081' but was not randomized|54
1092014|NCT01040845|2645213|P2|NOT COMPLETED|Overall Study||1
1092015|NCT01040845|2645214|P1|NOT COMPLETED|Overall Study||2
1092016|NCT01040845|2645213|P2|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1)|14
1092017|NCT01040845|2645214|P1|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1); dropped by physician due to positive drug screen (1)|13
1092018|NCT01040845|2645213|P2|STARTED|Overall Study||15
1092019|NCT01040845|2645214|P1|STARTED|Overall Study||15
1092020|NCT01040858|2645229|P2|NOT COMPLETED|Overall Study||0
1092021|NCT01040858|2645230|P1|NOT COMPLETED|Overall Study||9
1092022|NCT01040858|2645229|P2|COMPLETED|Overall Study||69
1092023|NCT01040858|2645230|P1|COMPLETED|Overall Study||50
1092024|NCT01040858|2645229|P2|STARTED|Overall Study||69
1092025|NCT01040858|2645230|P1|STARTED|Overall Study||59
1092026|NCT01040871|2645260|P2|NOT COMPLETED|Overall Study||7
1092027|NCT01040871|2645261|P1|NOT COMPLETED|Overall Study||13
1092028|NCT01040871|2645260|P2|COMPLETED|Overall Study||73
1092029|NCT01040871|2645261|P1|COMPLETED|Overall Study||71
1092030|NCT01040871|2645260|P2|STARTED|Overall Study|Intent to Treat, Randomized|80
1092031|NCT01040871|2645261|P1|STARTED|Overall Study|Intent to Treat, Randomized|84
1092032|NCT01041209|2645281|P2|NOT COMPLETED|Overall Study||0
1092033|NCT01041209|2645282|P1|NOT COMPLETED|Overall Study||0
1092034|NCT01041209|2645281|P2|COMPLETED|Overall Study||60
1092035|NCT01041209|2645282|P1|COMPLETED|Overall Study||60
1092036|NCT01041209|2645281|P2|STARTED|Overall Study||60
1092037|NCT01041209|2645282|P1|STARTED|Overall Study||60
1092038|NCT01041287|2645292|P2|NOT COMPLETED|Treatment Period 2 (3 Months)||5
1092039|NCT01041287|2645293|P1|NOT COMPLETED|Treatment Period 2 (3 Months)||3
1092040|NCT01041287|2645292|P2|COMPLETED|Treatment Period 2 (3 Months)||14
1092041|NCT01041287|2645293|P1|COMPLETED|Treatment Period 2 (3 Months)||16
1092042|NCT01041287|2645292|P2|STARTED|Treatment Period 2 (3 Months)||19
1092043|NCT01041287|2645293|P1|STARTED|Treatment Period 2 (3 Months)||19
1092044|NCT01041287|2645292|P2|NOT COMPLETED|Treatment Period 1 (3 Months)||0
1092045|NCT01041287|2645293|P1|NOT COMPLETED|Treatment Period 1 (3 Months)||0
1092046|NCT01041287|2645292|P2|COMPLETED|Treatment Period 1 (3 Months)||19
1092047|NCT01041287|2645293|P1|COMPLETED|Treatment Period 1 (3 Months)||19
1092048|NCT01041287|2645292|P2|STARTED|Treatment Period 1 (3 Months)||19
1092049|NCT01041287|2645293|P1|STARTED|Treatment Period 1 (3 Months)||19
1092050|NCT01041404|2645305|P2|NOT COMPLETED|Overall Study||294
1092051|NCT01041404|2645306|P1|NOT COMPLETED|Overall Study||290
1092052|NCT01041404|2645305|P2|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
1092053|NCT01041404|2645306|P1|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
1092054|NCT01041404|2645305|P2|Alive in Follow-up|Overall Study||41
1092055|NCT01041404|2645306|P1|Alive in Follow-up|Overall Study||40
1092056|NCT01041404|2645305|P2|Lost to Follow-up|Overall Study||10
1092057|NCT01041404|2645306|P1|Lost to Follow-up|Overall Study||12
1092058|NCT01041404|2645305|P2|Died in Follow-up|Overall Study||200
1092059|NCT01041404|2645306|P1|Died in Follow-up|Overall Study||199
1092060|NCT01041404|2645305|P2|Entered Follow-Up|Overall Study||251
1092061|NCT01041404|2645306|P1|Entered Follow-Up|Overall Study||251
1092062|NCT01041404|2645305|P2|STARTED|Overall Study||294
1092063|NCT01041404|2645306|P1|STARTED|Overall Study||290
1092064|NCT01041417|2645347|P2|NOT COMPLETED|Overall Study||3
1092065|NCT01041417|2645348|P1|NOT COMPLETED|Overall Study||7
1092066|NCT01041417|2645347|P2|COMPLETED|Overall Study||76
1092067|NCT01041417|2645348|P1|COMPLETED|Overall Study||73
1092068|NCT01041417|2645347|P2|STARTED|Overall Study||79
1092069|NCT01041417|2645348|P1|STARTED|Overall Study||80
1092070|NCT01041573|2645388|P4|NOT COMPLETED|Overall Study||2
1092071|NCT01041573|2645389|P3|NOT COMPLETED|Overall Study||7
1092072|NCT01041573|2645390|P2|NOT COMPLETED|Overall Study||13
1092073|NCT01041573|2645391|P1|NOT COMPLETED|Overall Study||5
1092074|NCT01041573|2645388|P4|COMPLETED|Overall Study||62
1092075|NCT01041573|2645389|P3|COMPLETED|Overall Study||387
1092076|NCT01041573|2645390|P2|COMPLETED|Overall Study||858
1092077|NCT01041573|2645391|P1|COMPLETED|Overall Study||535
1092078|NCT01041573|2645388|P4|STARTED|Overall Study||64
1092079|NCT01041573|2645389|P3|STARTED|Overall Study||394
1092080|NCT01041573|2645390|P2|STARTED|Overall Study||871
1092081|NCT01041573|2645391|P1|STARTED|Overall Study||540
1092082|NCT01041638|2645401|P1|NOT COMPLETED|Overall Study||27
1092083|NCT01041638|2645401|P1|COMPLETED|Overall Study||78
1092084|NCT01041638|2645401|P1|STARTED|Overall Study||105
1092085|NCT01048099|2645405|P1|NOT COMPLETED|Treatment Per Protocol||14
1092086|NCT01048099|2645405|P1|COMPLETED|Treatment Per Protocol|Patients continued treatment until disease progression or coming off-study for any other reason|0
1092087|NCT01048099|2645405|P1|STARTED|Treatment Per Protocol||14
1092088|NCT01048099|2645405|P1|NOT COMPLETED|Pts w/ HER2 Overexpression/Activation||10
1092089|NCT01048099|2645405|P1|COMPLETED|Pts w/ HER2 Overexpression/Activation|Patients who proceeded to treatment|14
1092090|NCT01048099|2645405|P1|STARTED|Pts w/ HER2 Overexpression/Activation|Patients with detected HER2 activation and/or overexpression|24
1092091|NCT01048099|2645405|P1|NOT COMPLETED|Patients Evaluated by PRO Onc Assay||202
1092092|NCT01048099|2645405|P1|COMPLETED|Patients Evaluated by PRO Onc Assay|Patients evaluated by PRO Onc Assay with HER2 overexpression/activation detected|24
1092093|NCT01048099|2645405|P1|STARTED|Patients Evaluated by PRO Onc Assay|Patients with CTCs who were evaluated by PRO Onc Assay|226
1092094|NCT01048099|2645405|P1|NOT COMPLETED|Patients Enrolled and Blood Collected||57
1092095|NCT01048099|2645405|P1|COMPLETED|Patients Enrolled and Blood Collected|Patients with circulating tumor cells (CTCs)|226
1092096|NCT01048099|2645405|P1|STARTED|Patients Enrolled and Blood Collected|Patients enrolled|283
1092097|NCT01048125|2645415|P2|NOT COMPLETED|Overall Study||0
1092098|NCT01048125|2645416|P1|NOT COMPLETED|Overall Study||0
1092099|NCT01048125|2645415|P2|COMPLETED|Overall Study||0
1092100|NCT01048125|2645416|P1|COMPLETED|Overall Study||0
1092101|NCT01048125|2645415|P2|STARTED|Overall Study||0
1092102|NCT01048125|2645416|P1|STARTED|Overall Study||0
1092103|NCT01048242|2645424|P2|NOT COMPLETED|Overall Study||2
1092104|NCT01048242|2645425|P1|NOT COMPLETED|Overall Study||4
1092105|NCT01048242|2645424|P2|COMPLETED|Overall Study||13
1092106|NCT01048242|2645425|P1|COMPLETED|Overall Study||8
1092107|NCT01048242|2645424|P2|STARTED|Overall Study||15
1092108|NCT01048242|2645425|P1|STARTED|Overall Study||12
1092109|NCT01048333|2645431|P6|NOT COMPLETED|Treatment Period 3||0
1092110|NCT01048333|2645432|P5|NOT COMPLETED|Treatment Period 3||0
1092111|NCT01048333|2645433|P4|NOT COMPLETED|Treatment Period 3||0
1092112|NCT01048333|2645434|P3|NOT COMPLETED|Treatment Period 3||0
1092113|NCT01048333|2645435|P2|NOT COMPLETED|Treatment Period 3||0
1092114|NCT01048333|2645436|P1|NOT COMPLETED|Treatment Period 3||0
1092115|NCT01048333|2645431|P6|COMPLETED|Treatment Period 3||18
1092116|NCT01048333|2645432|P5|COMPLETED|Treatment Period 3||17
1092117|NCT01048333|2645433|P4|COMPLETED|Treatment Period 3||18
1092118|NCT01048333|2645434|P3|COMPLETED|Treatment Period 3||16
1092119|NCT01048333|2645435|P2|COMPLETED|Treatment Period 3||18
1092120|NCT01048333|2645436|P1|COMPLETED|Treatment Period 3||21
1092121|NCT01048333|2645431|P6|STARTED|Treatment Period 3||18
1092122|NCT01048333|2645432|P5|STARTED|Treatment Period 3||17
1092123|NCT01048333|2645433|P4|STARTED|Treatment Period 3||18
1092124|NCT01048333|2645434|P3|STARTED|Treatment Period 3||16
1092125|NCT01048333|2645435|P2|STARTED|Treatment Period 3||18
1092126|NCT01048333|2645436|P1|STARTED|Treatment Period 3||21
1092127|NCT01048333|2645431|P6|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
1092128|NCT01048333|2645432|P5|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
1092129|NCT01048333|2645433|P4|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
1092130|NCT01048333|2645434|P3|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
1092131|NCT01048333|2645435|P2|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||1
1092132|NCT01048333|2645436|P1|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
1092133|NCT01048333|2645431|P6|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
1092134|NCT01048333|2645432|P5|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||17
1092135|NCT01048333|2645433|P4|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
1092136|NCT01048333|2645434|P3|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||16
1092137|NCT01048333|2645435|P2|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
1092138|NCT01048333|2645436|P1|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||21
1092139|NCT01048333|2645431|P6|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
1092140|NCT01048333|2645432|P5|STARTED|Wash-Out Period 2 of 2 - 7 Days||17
1092141|NCT01048333|2645433|P4|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
1092142|NCT01048333|2645434|P3|STARTED|Wash-Out Period 2 of 2 - 7 Days||16
1092143|NCT01048333|2645435|P2|STARTED|Wash-Out Period 2 of 2 - 7 Days||19
1092144|NCT01048333|2645436|P1|STARTED|Wash-Out Period 2 of 2 - 7 Days||21
1092145|NCT01048333|2645431|P6|NOT COMPLETED|Treatment Period 2||0
1092146|NCT01048333|2645432|P5|NOT COMPLETED|Treatment Period 2||0
1092147|NCT01048333|2645433|P4|NOT COMPLETED|Treatment Period 2||0
1092148|NCT01048333|2645434|P3|NOT COMPLETED|Treatment Period 2||0
1092149|NCT01048333|2645435|P2|NOT COMPLETED|Treatment Period 2||0
1092150|NCT01048333|2645436|P1|NOT COMPLETED|Treatment Period 2||0
1092151|NCT01048333|2645431|P6|COMPLETED|Treatment Period 2||18
1092152|NCT01048333|2645432|P5|COMPLETED|Treatment Period 2||17
1092153|NCT01048333|2645433|P4|COMPLETED|Treatment Period 2||18
1092154|NCT01048333|2645434|P3|COMPLETED|Treatment Period 2||16
1092155|NCT01048333|2645435|P2|COMPLETED|Treatment Period 2||19
1092156|NCT01048333|2645436|P1|COMPLETED|Treatment Period 2||21
1092157|NCT01048333|2645431|P6|STARTED|Treatment Period 2||18
1092158|NCT01048333|2645432|P5|STARTED|Treatment Period 2||17
1092159|NCT01048333|2645433|P4|STARTED|Treatment Period 2||18
1092160|NCT01048333|2645434|P3|STARTED|Treatment Period 2||16
1092161|NCT01048333|2645435|P2|STARTED|Treatment Period 2||19
1092162|NCT01048333|2645436|P1|STARTED|Treatment Period 2||21
1092163|NCT01048333|2645431|P6|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
1092164|NCT01048333|2645432|P5|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
1092165|NCT01048333|2645433|P4|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
1092166|NCT01048333|2645434|P3|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
1092167|NCT01048333|2645435|P2|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
1092168|NCT01048333|2645436|P1|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
1092169|NCT01048333|2645431|P6|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
1092170|NCT01048333|2645432|P5|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||17
1092171|NCT01048333|2645433|P4|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
1092172|NCT01048333|2645434|P3|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||16
1092173|NCT01048333|2645435|P2|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||19
1092174|NCT01048333|2645436|P1|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||21
1092175|NCT01048333|2645431|P6|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
1092176|NCT01048333|2645432|P5|STARTED|Wash-Out Period 1 of 2 - 7 Days||17
1092177|NCT01048333|2645433|P4|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
1092178|NCT01048333|2645434|P3|STARTED|Wash-Out Period 1 of 2 - 7 Days||16
1092179|NCT01048333|2645435|P2|STARTED|Wash-Out Period 1 of 2 - 7 Days||19
1092180|NCT01048333|2645436|P1|STARTED|Wash-Out Period 1 of 2 - 7 Days||21
1092181|NCT01048333|2645431|P6|NOT COMPLETED|Treatment Period 1||0
1092182|NCT01048333|2645432|P5|NOT COMPLETED|Treatment Period 1||0
1092183|NCT01048333|2645433|P4|NOT COMPLETED|Treatment Period 1||0
1092184|NCT01048333|2645434|P3|NOT COMPLETED|Treatment Period 1||0
1092185|NCT01048333|2645435|P2|NOT COMPLETED|Treatment Period 1||0
1092186|NCT01048333|2645436|P1|NOT COMPLETED|Treatment Period 1||0
1092187|NCT01048333|2645431|P6|COMPLETED|Treatment Period 1||18
1092188|NCT01048333|2645432|P5|COMPLETED|Treatment Period 1||17
1092189|NCT01048333|2645433|P4|COMPLETED|Treatment Period 1||18
1092190|NCT01048333|2645434|P3|COMPLETED|Treatment Period 1||16
1092191|NCT01048333|2645435|P2|COMPLETED|Treatment Period 1||19
1092192|NCT01048333|2645436|P1|COMPLETED|Treatment Period 1||21
1092193|NCT01048333|2645431|P6|STARTED|Treatment Period 1||18
1092194|NCT01048333|2645432|P5|STARTED|Treatment Period 1||17
1092195|NCT01048333|2645433|P4|STARTED|Treatment Period 1||18
1092196|NCT01048333|2645434|P3|STARTED|Treatment Period 1||16
1092197|NCT01048333|2645435|P2|STARTED|Treatment Period 1||19
1092198|NCT01048333|2645436|P1|STARTED|Treatment Period 1||21
1092199|NCT01048697|2645456|P1|NOT COMPLETED|Overall Study||0
1092200|NCT01048697|2645456|P1|COMPLETED|Overall Study||18
1092201|NCT01048697|2645456|P1|STARTED|Overall Study||18
1092202|NCT01048723|2645460|P1|NOT COMPLETED|Overall Study||0
1092203|NCT01048723|2645460|P1|COMPLETED|Overall Study||2
1092204|NCT01048723|2645460|P1|STARTED|Overall Study||2
1092205|NCT01048788|2645470|P3|NOT COMPLETED|Overall Study||2
1092206|NCT01048788|2645471|P2|NOT COMPLETED|Overall Study||2
1092207|NCT01048788|2645472|P1|NOT COMPLETED|Overall Study||5
1092208|NCT01048788|2645470|P3|COMPLETED|Overall Study||11
1092209|NCT01048788|2645471|P2|COMPLETED|Overall Study||28
1092210|NCT01048788|2645472|P1|COMPLETED|Overall Study||3
1092211|NCT01048788|2645470|P3|STARTED|Overall Study||13
1092212|NCT01048788|2645471|P2|STARTED|Overall Study||30
1092213|NCT01048788|2645472|P1|STARTED|Overall Study||8
1092214|NCT01048866|2645482|P2|NOT COMPLETED|Overall Study||5
1092215|NCT01048866|2645483|P1|NOT COMPLETED|Overall Study||4
1092216|NCT01048866|2645482|P2|COMPLETED|Overall Study||92
1092217|NCT01048866|2645483|P1|COMPLETED|Overall Study||97
1092218|NCT01048866|2645482|P2|STARTED|Overall Study||97
1092219|NCT01048866|2645483|P1|STARTED|Overall Study||101
1092220|NCT01048879|2645528|P3|NOT COMPLETED|Overall Study||0
1092221|NCT01048879|2645529|P2|NOT COMPLETED|Overall Study||0
1092222|NCT01048879|2645530|P1|NOT COMPLETED|Overall Study||0
1092223|NCT01048879|2645528|P3|COMPLETED|Overall Study||5
1092224|NCT01048879|2645529|P2|COMPLETED|Overall Study||9
1092225|NCT01048879|2645530|P1|COMPLETED|Overall Study||1
1092226|NCT01048879|2645528|P3|STARTED|Overall Study||5
1092227|NCT01048879|2645529|P2|STARTED|Overall Study||9
1092228|NCT01048879|2645530|P1|STARTED|Overall Study||1
1092229|NCT01048944|2645545|P4|NOT COMPLETED|Overall Study||2
1092230|NCT01048944|2645546|P3|NOT COMPLETED|Overall Study||10
1092231|NCT01048944|2645547|P2|NOT COMPLETED|Overall Study||10
1092232|NCT01048944|2645548|P1|NOT COMPLETED|Overall Study||8
1092233|NCT01048944|2645545|P4|COMPLETED|Overall Study||19
1092234|NCT01048944|2645546|P3|COMPLETED|Overall Study||25
1092235|NCT01048944|2645547|P2|COMPLETED|Overall Study||28
1092236|NCT01048944|2645548|P1|COMPLETED|Overall Study||24
1092237|NCT01048944|2645545|P4|STARTED|Overall Study||21
1092238|NCT01048944|2645546|P3|STARTED|Overall Study||35
1092239|NCT01048944|2645547|P2|STARTED|Overall Study||38
1092240|NCT01048944|2645548|P1|STARTED|Overall Study||32
1092241|NCT01049009|2645564|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
1092242|NCT01049009|2645565|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
1092243|NCT01049009|2645564|P2|COMPLETED|Treatment Period 2 (12 Weeks)||8
1092244|NCT01049009|2645565|P1|COMPLETED|Treatment Period 2 (12 Weeks)||11
1092245|NCT01049009|2645564|P2|STARTED|Treatment Period 2 (12 Weeks)||18
1092246|NCT01049009|2645565|P1|STARTED|Treatment Period 2 (12 Weeks)||21
1092247|NCT01049009|2645564|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
1092248|NCT01049009|2645565|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
1092249|NCT01049009|2645564|P2|COMPLETED|Treatment Period 1 (12 Weeks)||18
1092250|NCT01049009|2645565|P1|COMPLETED|Treatment Period 1 (12 Weeks)||21
1092251|NCT01049009|2645564|P2|STARTED|Treatment Period 1 (12 Weeks)||21
1092252|NCT01049009|2645565|P1|STARTED|Treatment Period 1 (12 Weeks)||23
1092253|NCT01049217|2645575|P2|NOT COMPLETED|Overall Study||63
1092254|NCT01049217|2645576|P1|NOT COMPLETED|Overall Study||56
1092255|NCT01049217|2645575|P2|COMPLETED|Overall Study||131
1092256|NCT01049217|2645576|P1|COMPLETED|Overall Study||127
1092257|NCT01049217|2645575|P2|Treated|Overall Study||192
1092258|NCT01049217|2645576|P1|Treated|Overall Study||183
1092259|NCT01049217|2645575|P2|STARTED|Overall Study||194
1092260|NCT01049217|2645576|P1|STARTED|Overall Study||183
1092261|NCT01049243|2645646|P1|NOT COMPLETED|Overall Study||2
1092262|NCT01049243|2645646|P1|COMPLETED|Overall Study||18
1092263|NCT01049243|2645646|P1|STARTED|Overall Study||20
1092264|NCT01049308|2645650|P1|NOT COMPLETED|Pill Counts||83
1092265|NCT01049308|2645650|P1|COMPLETED|Pill Counts||168
1092266|NCT01049308|2645650|P1|STARTED|Pill Counts||251
1092267|NCT01049308|2645650|P1|NOT COMPLETED|Evaluation of Cognitive Impairment||0
1092268|NCT01049308|2645650|P1|COMPLETED|Evaluation of Cognitive Impairment||251
1092269|NCT01049308|2645650|P1|STARTED|Evaluation of Cognitive Impairment||251
1092270|NCT01049334|2645659|P2|NOT COMPLETED|Overall Study||7
1092271|NCT01049334|2645660|P1|NOT COMPLETED|Overall Study||9
1092272|NCT01049334|2645659|P2|COMPLETED|Overall Study||95
1092273|NCT01049334|2645660|P1|COMPLETED|Overall Study||93
1092274|NCT01049334|2645659|P2|STARTED|Overall Study||102
1092275|NCT01049334|2645660|P1|STARTED|Overall Study||102
1092276|NCT01049360|2645696|P20|NOT COMPLETED|Period 4||0
1092277|NCT01049360|2645697|P19|NOT COMPLETED|Period 4||0
1092278|NCT01049360|2645698|P18|NOT COMPLETED|Period 4||1
1092279|NCT01049360|2645699|P17|NOT COMPLETED|Period 4||0
1092280|NCT01049360|2645700|P16|NOT COMPLETED|Period 4||0
1092281|NCT01049360|2645701|P15|NOT COMPLETED|Period 4||0
1092282|NCT01049360|2645702|P14|NOT COMPLETED|Period 4||0
1092283|NCT01049360|2645703|P13|NOT COMPLETED|Period 4||0
1092284|NCT01049360|2645704|P12|NOT COMPLETED|Period 4||0
1092285|NCT01049360|2645705|P11|NOT COMPLETED|Period 4||0
1092286|NCT01049360|2645706|P10|NOT COMPLETED|Period 4||0
1092287|NCT01049360|2645707|P9|NOT COMPLETED|Period 4||0
1092288|NCT01049360|2645708|P8|NOT COMPLETED|Period 4||0
1092289|NCT01049360|2645709|P7|NOT COMPLETED|Period 4||0
1092290|NCT01049360|2645710|P6|NOT COMPLETED|Period 4||0
1092291|NCT01049360|2645711|P5|NOT COMPLETED|Period 4||0
1092292|NCT01049360|2645712|P4|NOT COMPLETED|Period 4||1
1092293|NCT01049360|2645713|P3|NOT COMPLETED|Period 4||0
1092294|NCT01049360|2645714|P2|NOT COMPLETED|Period 4||0
1092295|NCT01049360|2645715|P1|NOT COMPLETED|Period 4||0
1092296|NCT01049360|2645696|P20|COMPLETED|Period 4||5
1092297|NCT01049360|2645697|P19|COMPLETED|Period 4||5
1092298|NCT01049360|2645698|P18|COMPLETED|Period 4||5
1092299|NCT01049360|2645699|P17|COMPLETED|Period 4||5
1092300|NCT01049360|2645700|P16|COMPLETED|Period 4||6
1092301|NCT01049360|2645701|P15|COMPLETED|Period 4||5
1092302|NCT01049360|2645702|P14|COMPLETED|Period 4||6
1092303|NCT01049360|2645703|P13|COMPLETED|Period 4||4
1092304|NCT01049360|2645704|P12|COMPLETED|Period 4||6
1092305|NCT01049360|2645705|P11|COMPLETED|Period 4||5
1092306|NCT01049360|2645706|P10|COMPLETED|Period 4||6
1092307|NCT01049360|2645707|P9|COMPLETED|Period 4||4
1092308|NCT01049360|2645708|P8|COMPLETED|Period 4||4
1092309|NCT01049360|2645709|P7|COMPLETED|Period 4||6
1092310|NCT01049360|2645710|P6|COMPLETED|Period 4||5
1092311|NCT01049360|2645711|P5|COMPLETED|Period 4||7
1092312|NCT01049360|2645712|P4|COMPLETED|Period 4||3
1092313|NCT01049360|2645713|P3|COMPLETED|Period 4||7
1092314|NCT01049360|2645714|P2|COMPLETED|Period 4||4
1092315|NCT01049360|2645715|P1|COMPLETED|Period 4||6
1092316|NCT01049360|2645696|P20|STARTED|Period 4||5
1092317|NCT01049360|2645697|P19|STARTED|Period 4||5
1092318|NCT01049360|2645698|P18|STARTED|Period 4||6
1092319|NCT01049360|2645699|P17|STARTED|Period 4||5
1092320|NCT01049360|2645700|P16|STARTED|Period 4||6
1092321|NCT01049360|2645701|P15|STARTED|Period 4||5
1092322|NCT01049360|2645702|P14|STARTED|Period 4||6
1092323|NCT01049360|2645703|P13|STARTED|Period 4||4
1092324|NCT01049360|2645704|P12|STARTED|Period 4||6
1092325|NCT01049360|2645705|P11|STARTED|Period 4||5
1092326|NCT01049360|2645706|P10|STARTED|Period 4||6
1092327|NCT01049360|2645707|P9|STARTED|Period 4||4
1092328|NCT01049360|2645708|P8|STARTED|Period 4||4
1092329|NCT01049360|2645709|P7|STARTED|Period 4||6
1092330|NCT01049360|2645710|P6|STARTED|Period 4||5
1092331|NCT01049360|2645711|P5|STARTED|Period 4||7
1092332|NCT01049360|2645712|P4|STARTED|Period 4||4
1092333|NCT01049360|2645713|P3|STARTED|Period 4||7
1092334|NCT01049360|2645714|P2|STARTED|Period 4||4
1092335|NCT01049360|2645715|P1|STARTED|Period 4||6
1092336|NCT01049360|2645696|P20|NOT COMPLETED|Period 3||0
1092337|NCT01049360|2645697|P19|NOT COMPLETED|Period 3||0
1092338|NCT01049360|2645698|P18|NOT COMPLETED|Period 3||0
1092339|NCT01049360|2645699|P17|NOT COMPLETED|Period 3||0
1092340|NCT01049360|2645700|P16|NOT COMPLETED|Period 3||0
1092341|NCT01049360|2645701|P15|NOT COMPLETED|Period 3||0
1092342|NCT01049360|2645702|P14|NOT COMPLETED|Period 3||0
1092343|NCT01049360|2645703|P13|NOT COMPLETED|Period 3||0
1092344|NCT01049360|2645704|P12|NOT COMPLETED|Period 3||0
1092345|NCT01049360|2645705|P11|NOT COMPLETED|Period 3||0
1092346|NCT01049360|2645706|P10|NOT COMPLETED|Period 3||0
1092347|NCT01049360|2645707|P9|NOT COMPLETED|Period 3||0
1092348|NCT01049360|2645708|P8|NOT COMPLETED|Period 3||0
1092349|NCT01049360|2645709|P7|NOT COMPLETED|Period 3||0
1092350|NCT01049360|2645710|P6|NOT COMPLETED|Period 3||0
1092351|NCT01049360|2645711|P5|NOT COMPLETED|Period 3||0
1092352|NCT01049360|2645712|P4|NOT COMPLETED|Period 3||0
1092353|NCT01049360|2645713|P3|NOT COMPLETED|Period 3||0
1092354|NCT01049360|2645714|P2|NOT COMPLETED|Period 3||0
1092355|NCT01049360|2645715|P1|NOT COMPLETED|Period 3||0
1092356|NCT01049360|2645696|P20|COMPLETED|Period 3||5
1092357|NCT01049360|2645697|P19|COMPLETED|Period 3||5
1092358|NCT01049360|2645698|P18|COMPLETED|Period 3||6
1092359|NCT01049360|2645699|P17|COMPLETED|Period 3||5
1092360|NCT01049360|2645700|P16|COMPLETED|Period 3||6
1092361|NCT01049360|2645701|P15|COMPLETED|Period 3||5
1092362|NCT01049360|2645702|P14|COMPLETED|Period 3||6
1092363|NCT01049360|2645703|P13|COMPLETED|Period 3||4
1092364|NCT01049360|2645704|P12|COMPLETED|Period 3||6
1092365|NCT01049360|2645705|P11|COMPLETED|Period 3||5
1092366|NCT01049360|2645706|P10|COMPLETED|Period 3||6
1092367|NCT01049360|2645707|P9|COMPLETED|Period 3||4
1092368|NCT01049360|2645708|P8|COMPLETED|Period 3||4
1092369|NCT01049360|2645709|P7|COMPLETED|Period 3||6
1092370|NCT01049360|2645710|P6|COMPLETED|Period 3||5
1092371|NCT01049360|2645711|P5|COMPLETED|Period 3||7
1092372|NCT01049360|2645712|P4|COMPLETED|Period 3||4
1092373|NCT01049360|2645713|P3|COMPLETED|Period 3||7
1092374|NCT01049360|2645714|P2|COMPLETED|Period 3||4
1092375|NCT01049360|2645715|P1|COMPLETED|Period 3||6
1092376|NCT01049360|2645696|P20|STARTED|Period 3||5
1092377|NCT01049360|2645697|P19|STARTED|Period 3||5
1092378|NCT01049360|2645698|P18|STARTED|Period 3||6
1092379|NCT01049360|2645699|P17|STARTED|Period 3||5
1092380|NCT01049360|2645700|P16|STARTED|Period 3||6
1092381|NCT01049360|2645701|P15|STARTED|Period 3||5
1092382|NCT01049360|2645702|P14|STARTED|Period 3||6
1092383|NCT01049360|2645703|P13|STARTED|Period 3||4
1092384|NCT01049360|2645704|P12|STARTED|Period 3||6
1092385|NCT01049360|2645705|P11|STARTED|Period 3||5
1092386|NCT01049360|2645706|P10|STARTED|Period 3||6
1092387|NCT01049360|2645707|P9|STARTED|Period 3||4
1092388|NCT01049360|2645708|P8|STARTED|Period 3||4
1092389|NCT01049360|2645709|P7|STARTED|Period 3||6
1092390|NCT01049360|2645710|P6|STARTED|Period 3||5
1092391|NCT01049360|2645711|P5|STARTED|Period 3||7
1092392|NCT01049360|2645712|P4|STARTED|Period 3||4
1092393|NCT01049360|2645713|P3|STARTED|Period 3||7
1092394|NCT01049360|2645714|P2|STARTED|Period 3||4
1092395|NCT01049360|2645715|P1|STARTED|Period 3||6
1092396|NCT01049360|2645696|P20|NOT COMPLETED|Period 2||2
1092397|NCT01049360|2645697|P19|NOT COMPLETED|Period 2||0
1092398|NCT01049360|2645698|P18|NOT COMPLETED|Period 2||0
1092399|NCT01049360|2645699|P17|NOT COMPLETED|Period 2||0
1092400|NCT01049360|2645700|P16|NOT COMPLETED|Period 2||1
1092401|NCT01049360|2645701|P15|NOT COMPLETED|Period 2||2
1092402|NCT01049360|2645702|P14|NOT COMPLETED|Period 2||0
1092403|NCT01049360|2645703|P13|NOT COMPLETED|Period 2||0
1092404|NCT01049360|2645704|P12|NOT COMPLETED|Period 2||0
1092405|NCT01049360|2645705|P11|NOT COMPLETED|Period 2||0
1092406|NCT01049360|2645706|P10|NOT COMPLETED|Period 2||0
1092407|NCT01049360|2645707|P9|NOT COMPLETED|Period 2||1
1092408|NCT01049360|2645708|P8|NOT COMPLETED|Period 2||0
1092409|NCT01049360|2645709|P7|NOT COMPLETED|Period 2||0
1092410|NCT01049360|2645710|P6|NOT COMPLETED|Period 2||1
1092411|NCT01049360|2645711|P5|NOT COMPLETED|Period 2||0
1092412|NCT01049360|2645712|P4|NOT COMPLETED|Period 2||2
1092413|NCT01049360|2645713|P3|NOT COMPLETED|Period 2||0
1092414|NCT01049360|2645714|P2|NOT COMPLETED|Period 2||1
1092415|NCT01049360|2645715|P1|NOT COMPLETED|Period 2||0
1092416|NCT01049360|2645696|P20|COMPLETED|Period 2||5
1092417|NCT01049360|2645697|P19|COMPLETED|Period 2||5
1092418|NCT01049360|2645698|P18|COMPLETED|Period 2||6
1092419|NCT01049360|2645699|P17|COMPLETED|Period 2||5
1092420|NCT01049360|2645700|P16|COMPLETED|Period 2||6
1092421|NCT01049360|2645701|P15|COMPLETED|Period 2||5
1092422|NCT01049360|2645702|P14|COMPLETED|Period 2||6
1092423|NCT01049360|2645703|P13|COMPLETED|Period 2||4
1092424|NCT01049360|2645704|P12|COMPLETED|Period 2||6
1092425|NCT01049360|2645705|P11|COMPLETED|Period 2||5
1092426|NCT01049360|2645706|P10|COMPLETED|Period 2||6
1092427|NCT01049360|2645707|P9|COMPLETED|Period 2||4
1092428|NCT01049360|2645708|P8|COMPLETED|Period 2||4
1092429|NCT01049360|2645709|P7|COMPLETED|Period 2||6
1092430|NCT01049360|2645710|P6|COMPLETED|Period 2||5
1092431|NCT01049360|2645711|P5|COMPLETED|Period 2||7
1092432|NCT01049360|2645712|P4|COMPLETED|Period 2||4
1092433|NCT01049360|2645713|P3|COMPLETED|Period 2||7
1092434|NCT01049360|2645714|P2|COMPLETED|Period 2||4
1092435|NCT01049360|2645715|P1|COMPLETED|Period 2||6
1092436|NCT01049360|2645696|P20|STARTED|Period 2||7
1092437|NCT01049360|2645697|P19|STARTED|Period 2||5
1092438|NCT01049360|2645698|P18|STARTED|Period 2||6
1092439|NCT01049360|2645699|P17|STARTED|Period 2||5
1092440|NCT01049360|2645700|P16|STARTED|Period 2||7
1092441|NCT01049360|2645701|P15|STARTED|Period 2||7
1092442|NCT01049360|2645702|P14|STARTED|Period 2||6
1092443|NCT01049360|2645703|P13|STARTED|Period 2||4
1092444|NCT01049360|2645704|P12|STARTED|Period 2||6
1092445|NCT01049360|2645705|P11|STARTED|Period 2||5
1092446|NCT01049360|2645706|P10|STARTED|Period 2||6
1092447|NCT01049360|2645707|P9|STARTED|Period 2||5
1092448|NCT01049360|2645708|P8|STARTED|Period 2||4
1092449|NCT01049360|2645709|P7|STARTED|Period 2||6
1092450|NCT01049360|2645710|P6|STARTED|Period 2||6
1092451|NCT01049360|2645711|P5|STARTED|Period 2||7
1092452|NCT01049360|2645712|P4|STARTED|Period 2||6
1092453|NCT01049360|2645713|P3|STARTED|Period 2||7
1092454|NCT01049360|2645714|P2|STARTED|Period 2||5
1092455|NCT01049360|2645715|P1|STARTED|Period 2||6
1092456|NCT01049360|2645696|P20|NOT COMPLETED|Period 1||0
1092457|NCT01049360|2645697|P19|NOT COMPLETED|Period 1||1
1092458|NCT01049360|2645698|P18|NOT COMPLETED|Period 1||0
1092459|NCT01049360|2645699|P17|NOT COMPLETED|Period 1||1
1092460|NCT01049360|2645700|P16|NOT COMPLETED|Period 1||0
1092461|NCT01049360|2645701|P15|NOT COMPLETED|Period 1||0
1092462|NCT01049360|2645702|P14|NOT COMPLETED|Period 1||1
1092463|NCT01049360|2645703|P13|NOT COMPLETED|Period 1||2
1092464|NCT01049360|2645704|P12|NOT COMPLETED|Period 1||0
1092465|NCT01049360|2645705|P11|NOT COMPLETED|Period 1||1
1092466|NCT01049360|2645706|P10|NOT COMPLETED|Period 1||0
1092467|NCT01049360|2645707|P9|NOT COMPLETED|Period 1||2
1092468|NCT01049360|2645708|P8|NOT COMPLETED|Period 1||2
1092469|NCT01049360|2645709|P7|NOT COMPLETED|Period 1||0
1092470|NCT01049360|2645710|P6|NOT COMPLETED|Period 1||0
1092471|NCT01049360|2645711|P5|NOT COMPLETED|Period 1||0
1092472|NCT01049360|2645712|P4|NOT COMPLETED|Period 1||1
1092473|NCT01049360|2645713|P3|NOT COMPLETED|Period 1||0
1092474|NCT01049360|2645714|P2|NOT COMPLETED|Period 1||1
1092475|NCT01049360|2645715|P1|NOT COMPLETED|Period 1||0
1092476|NCT01049360|2645696|P20|COMPLETED|Period 1||7
1092477|NCT01049360|2645697|P19|COMPLETED|Period 1||5
1092478|NCT01049360|2645698|P18|COMPLETED|Period 1||6
1092479|NCT01049360|2645699|P17|COMPLETED|Period 1||5
1092480|NCT01049360|2645700|P16|COMPLETED|Period 1||7
1092481|NCT01049360|2645701|P15|COMPLETED|Period 1||7
1092482|NCT01049360|2645702|P14|COMPLETED|Period 1||6
1092483|NCT01049360|2645703|P13|COMPLETED|Period 1||4
1092484|NCT01049360|2645704|P12|COMPLETED|Period 1||6
1092485|NCT01049360|2645705|P11|COMPLETED|Period 1||5
1092486|NCT01049360|2645706|P10|COMPLETED|Period 1||6
1092487|NCT01049360|2645707|P9|COMPLETED|Period 1||5
1092488|NCT01049360|2645708|P8|COMPLETED|Period 1||4
1092489|NCT01049360|2645709|P7|COMPLETED|Period 1||6
1092490|NCT01049360|2645710|P6|COMPLETED|Period 1||6
1092491|NCT01049360|2645711|P5|COMPLETED|Period 1||7
1092492|NCT01049360|2645712|P4|COMPLETED|Period 1||6
1092493|NCT01049360|2645713|P3|COMPLETED|Period 1||7
1092494|NCT01049360|2645714|P2|COMPLETED|Period 1||5
1092495|NCT01049360|2645715|P1|COMPLETED|Period 1||6
1092496|NCT01049360|2645696|P20|STARTED|Period 1||7
1092497|NCT01049360|2645697|P19|STARTED|Period 1||6
1092498|NCT01049360|2645698|P18|STARTED|Period 1||6
1092499|NCT01049360|2645699|P17|STARTED|Period 1||6
1092500|NCT01049360|2645700|P16|STARTED|Period 1||7
1092501|NCT01049360|2645701|P15|STARTED|Period 1||7
1092502|NCT01049360|2645702|P14|STARTED|Period 1||7
1092503|NCT01049360|2645703|P13|STARTED|Period 1||6
1092504|NCT01049360|2645704|P12|STARTED|Period 1||6
1092505|NCT01049360|2645705|P11|STARTED|Period 1||6
1092506|NCT01049360|2645706|P10|STARTED|Period 1||6
1092507|NCT01049360|2645707|P9|STARTED|Period 1||7
1092508|NCT01049360|2645708|P8|STARTED|Period 1||6
1092509|NCT01049360|2645709|P7|STARTED|Period 1||6
1092510|NCT01049360|2645710|P6|STARTED|Period 1||6
1092511|NCT01049360|2645711|P5|STARTED|Period 1||7
1092512|NCT01049360|2645712|P4|STARTED|Period 1||7
1092513|NCT01049360|2645713|P3|STARTED|Period 1||7
1092514|NCT01049360|2645714|P2|STARTED|Period 1||6
1092515|NCT01049360|2645715|P1|STARTED|Period 1||6
1092516|NCT01049373|2645739|P2|NOT COMPLETED|Overall Study||44
1092517|NCT01049373|2645740|P1|NOT COMPLETED|Overall Study||39
1092518|NCT01049373|2645739|P2|COMPLETED|Overall Study||65
1092519|NCT01049373|2645740|P1|COMPLETED|Overall Study||73
1092520|NCT01049373|2645739|P2|STARTED|Overall Study||109
1092521|NCT01049373|2645740|P1|STARTED|Overall Study||112
1092522|NCT01049503|2645760|P6|NOT COMPLETED|Overall Study||8
1092523|NCT01049503|2645761|P5|NOT COMPLETED|Overall Study||27
1092524|NCT01049503|2645762|P4|NOT COMPLETED|Overall Study||26
1092525|NCT01049503|2645763|P3|NOT COMPLETED|Overall Study||24
1092526|NCT01049503|2645764|P2|NOT COMPLETED|Overall Study||12
1092527|NCT01049503|2645765|P1|NOT COMPLETED|Overall Study||11
1092528|NCT01049503|2645760|P6|COMPLETED|Overall Study||40
1092529|NCT01049503|2645761|P5|COMPLETED|Overall Study||29
1092530|NCT01049503|2645762|P4|COMPLETED|Overall Study||29
1092531|NCT01049503|2645763|P3|COMPLETED|Overall Study||32
1092532|NCT01049503|2645764|P2|COMPLETED|Overall Study||36
1092533|NCT01049503|2645765|P1|COMPLETED|Overall Study||41
1092534|NCT01049503|2645760|P6|STARTED|Overall Study||48
1092535|NCT01049503|2645761|P5|STARTED|Overall Study||56
1092536|NCT01049503|2645762|P4|STARTED|Overall Study||55
1092537|NCT01049503|2645763|P3|STARTED|Overall Study||56
1092538|NCT01049503|2645764|P2|STARTED|Overall Study||48
1092539|NCT01049503|2645765|P1|STARTED|Overall Study||52
1092540|NCT01049581|2645796|P2|NOT COMPLETED|Overall Study||1
1092541|NCT01049581|2645797|P1|NOT COMPLETED|Overall Study||2
1092542|NCT01049581|2645796|P2|COMPLETED|Overall Study||13
1092543|NCT01049581|2645797|P1|COMPLETED|Overall Study||11
1092544|NCT01049581|2645796|P2|STARTED|Overall Study||14
1092545|NCT01049581|2645797|P1|STARTED|Overall Study||13
1092546|NCT01049776|2645806|P1|NOT COMPLETED|Overall Study||20
1092547|NCT01049776|2645806|P1|COMPLETED|Overall Study||12
1092548|NCT01049776|2645806|P1|STARTED|Overall Study||32
1092549|NCT01049802|2645812|P2|NOT COMPLETED|Overall Study||0
1092550|NCT01049802|2645813|P1|NOT COMPLETED|Overall Study||0
1092551|NCT01049802|2645812|P2|COMPLETED|Overall Study||10
1092552|NCT01049802|2645813|P1|COMPLETED|Overall Study||20
1092553|NCT01049802|2645812|P2|STARTED|Overall Study||10
1092554|NCT01049802|2645813|P1|STARTED|Overall Study||20
1092555|NCT01049945|2645829|P6|NOT COMPLETED|Overall Study||0
1092556|NCT01049945|2645830|P5|NOT COMPLETED|Overall Study||0
1092557|NCT01049945|2645831|P4|NOT COMPLETED|Overall Study||0
1092558|NCT01049945|2645832|P3|NOT COMPLETED|Overall Study||0
1092559|NCT01049945|2645833|P2|NOT COMPLETED|Overall Study||0
1092560|NCT01049945|2645834|P1|NOT COMPLETED|Overall Study||0
1092561|NCT01049945|2645829|P6|COMPLETED|Overall Study||49
1092562|NCT01049945|2645830|P5|COMPLETED|Overall Study||3
1092563|NCT01049945|2645831|P4|COMPLETED|Overall Study||6
1092564|NCT01049945|2645832|P3|COMPLETED|Overall Study||3
1092565|NCT01049945|2645833|P2|COMPLETED|Overall Study||6
1092566|NCT01049945|2645834|P1|COMPLETED|Overall Study||3
1092567|NCT01049945|2645829|P6|STARTED|Overall Study||49
1092568|NCT01049945|2645830|P5|STARTED|Overall Study||3
1092569|NCT01049945|2645831|P4|STARTED|Overall Study||6
1092570|NCT01049945|2645832|P3|STARTED|Overall Study||3
1092571|NCT01049945|2645833|P2|STARTED|Overall Study||6
1092572|NCT01049945|2645834|P1|STARTED|Overall Study||3
1092573|NCT01049984|2645850|P2|NOT COMPLETED|Overall Study||19
1092574|NCT01049984|2645851|P1|NOT COMPLETED|Overall Study||19
1092575|NCT01049984|2645850|P2|COMPLETED|Overall Study||146
1092576|NCT01049984|2645851|P1|COMPLETED|Overall Study||144
1092577|NCT01049984|2645850|P2|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|162
1092578|NCT01049984|2645851|P1|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|159
1092579|NCT01049984|2645850|P2|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|164
1092580|NCT01049984|2645851|P1|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|162
1092581|NCT01049984|2645850|P2|STARTED|Overall Study||165
1092582|NCT01049984|2645851|P1|STARTED|Overall Study||163
1092583|NCT01050062|2645869|P2|NOT COMPLETED|Overall Study||112
1092584|NCT01050062|2645870|P1|NOT COMPLETED|Overall Study||271
1092585|NCT01050062|2645869|P2|COMPLETED|Overall Study||243
1092586|NCT01050062|2645870|P1|COMPLETED|Overall Study||799
1092587|NCT01050062|2645869|P2|STARTED|Overall Study||355
1092588|NCT01050062|2645870|P1|STARTED|Overall Study||1070
1092589|NCT01050153|2645892|P2|NOT COMPLETED|Overall Study||0
1092590|NCT01050153|2645893|P1|NOT COMPLETED|Overall Study||0
1092591|NCT01050153|2645892|P2|COMPLETED|Overall Study||25
1092592|NCT01050153|2645893|P1|COMPLETED|Overall Study||25
1092593|NCT01050153|2645892|P2|STARTED|Overall Study||25
1092594|NCT01050153|2645893|P1|STARTED|Overall Study||25
1092595|NCT01050205|2645919|P2|NOT COMPLETED|Overall Study||4
1092596|NCT01050205|2645920|P1|NOT COMPLETED|Overall Study||11
1092597|NCT01050205|2645919|P2|COMPLETED|Overall Study||71
1092598|NCT01050205|2645920|P1|COMPLETED|Overall Study||137
1092599|NCT01050205|2645919|P2|STARTED|Overall Study||75
1092600|NCT01050205|2645920|P1|STARTED|Overall Study||148
1092601|NCT01050218|2645948|P1|NOT COMPLETED|Overall Study||95
1092602|NCT01050218|2645948|P1|COMPLETED|Overall Study||142
1092603|NCT01050218|2645948|P1|STARTED|Overall Study||237
1092604|NCT01050257|2645955|P3|NOT COMPLETED|Overall Study||7
1092605|NCT01050257|2645956|P2|NOT COMPLETED|Overall Study||13
1092606|NCT01050257|2645957|P1|NOT COMPLETED|Overall Study||11
1092607|NCT01050257|2645955|P3|COMPLETED|Overall Study||8
1092608|NCT01050257|2645956|P2|COMPLETED|Overall Study||40
1092609|NCT01050257|2645957|P1|COMPLETED|Overall Study|Completed 5 days of treatment either IV or Oral|39
1092610|NCT01050257|2645955|P3|Switched to Oral Treatment|Overall Study||3
1092611|NCT01050257|2645956|P2|Switched to Oral Treatment|Overall Study||31
1092612|NCT01050257|2645957|P1|Switched to Oral Treatment|Overall Study||28
1092613|NCT01050257|2645955|P3|Intent-to-treat Infected Confirmed|Overall Study||10
1092614|NCT01050257|2645956|P2|Intent-to-treat Infected Confirmed|Overall Study||32
1092615|NCT01050257|2645957|P1|Intent-to-treat Infected Confirmed|Overall Study||30
1092616|NCT01050257|2645955|P3|Safety Population: Actual Dose Received|Overall Study||14
1092617|NCT01050257|2645956|P2|Safety Population: Actual Dose Received|Overall Study|One participant randomized to 100 mg actually received the 200 mg doses.|51
1092618|NCT01050257|2645957|P1|Safety Population: Actual Dose Received|Overall Study||48
1092619|NCT01050257|2645955|P3|Received Treatment|Overall Study||14
1092620|NCT01050257|2645956|P2|Received Treatment|Overall Study||50
1092621|NCT01050257|2645957|P1|Received Treatment|Overall Study||49
1092622|NCT01050257|2645955|P3|STARTED|Overall Study||15
1092623|NCT01050257|2645956|P2|STARTED|Overall Study||53
1092624|NCT01050257|2645957|P1|STARTED|Overall Study||50
1092625|NCT01050530|2645994|P2|NOT COMPLETED|Overall Study||10
1092626|NCT01050530|2645995|P1|NOT COMPLETED|Overall Study||8
1092627|NCT01050530|2645994|P2|COMPLETED|Overall Study||70
1092628|NCT01050530|2645995|P1|COMPLETED|Overall Study||74
1092629|NCT01050530|2645994|P2|STARTED|Overall Study||80
1092630|NCT01050530|2645995|P1|STARTED|Overall Study||82
1092631|NCT01050543|2646005|P2|NOT COMPLETED|Overall Study||4
1092632|NCT01050543|2646006|P1|NOT COMPLETED|Overall Study||4
1092633|NCT01050543|2646005|P2|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
1092634|NCT01050543|2646006|P1|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
1092635|NCT01050543|2646005|P2|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
1092636|NCT01050543|2646006|P1|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
1092637|NCT01050569|2646015|P3|NOT COMPLETED|Overall Study||33
1092638|NCT01050569|2646016|P2|NOT COMPLETED|Overall Study||24
1092639|NCT01050569|2646017|P1|NOT COMPLETED|Overall Study||38
1092640|NCT01050569|2646015|P3|COMPLETED|Overall Study||47
1092641|NCT01050569|2646016|P2|COMPLETED|Overall Study||52
1092642|NCT01050569|2646017|P1|COMPLETED|Overall Study||41
1092643|NCT01050569|2646015|P3|STARTED|Overall Study||80
1092644|NCT01050569|2646016|P2|STARTED|Overall Study||76
1092645|NCT01050569|2646017|P1|STARTED|Overall Study||79
1092646|NCT01050582|2646036|P2|NOT COMPLETED|Overall Study||0
1092647|NCT01050582|2646037|P1|NOT COMPLETED|Overall Study||0
1092648|NCT01050582|2646036|P2|COMPLETED|Overall Study||51
1092649|NCT01050582|2646037|P1|COMPLETED|Overall Study||133
1092650|NCT01050582|2646036|P2|STARTED|Overall Study||51
1092651|NCT01050582|2646037|P1|STARTED|Overall Study||133
1092652|NCT01050634|2646047|P1|NOT COMPLETED|Overall Study||128
1092653|NCT01050634|2646047|P1|COMPLETED|Overall Study||852
1092654|NCT01050634|2646047|P1|Received Treatment|Overall Study||924
1092655|NCT01050634|2646047|P1|STARTED|Overall Study||980
1092656|NCT01050660|2646057|P2|NOT COMPLETED|Overall Study||0
1092657|NCT01050660|2646058|P1|NOT COMPLETED|Overall Study||0
1092658|NCT01050660|2646057|P2|COMPLETED|Overall Study||69
1092659|NCT01050660|2646058|P1|COMPLETED|Overall Study||67
1092660|NCT01050660|2646057|P2|STARTED|Overall Study||69
1092661|NCT01050660|2646058|P1|STARTED|Overall Study||67
1092662|NCT01050673|2646084|P2|NOT COMPLETED|Overall Study||5
1092663|NCT01050673|2646085|P1|NOT COMPLETED|Overall Study||4
1092664|NCT01050673|2646084|P2|COMPLETED|Overall Study||14
1092665|NCT01050673|2646085|P1|COMPLETED|Overall Study||17
1092666|NCT01050673|2646084|P2|STARTED|Overall Study||19
1092667|NCT01050673|2646085|P1|STARTED|Overall Study||21
1092668|NCT01050764|2646107|P1|NOT COMPLETED|Overall Study||3
1092669|NCT01050764|2646107|P1|COMPLETED|Overall Study||7
1092670|NCT01050764|2646107|P1|Received Infusion of T-con Cells|Overall Study||7
1092671|NCT01050764|2646107|P1|Received Infusion of T-reg Cells|Overall Study||7
1092672|NCT01050764|2646107|P1|Received HSCT Graft|Overall Study||8
1092673|NCT01050764|2646107|P1|STARTED|Overall Study||10
1092674|NCT01050790|2646116|P1|NOT COMPLETED|Overall Study||1
1092675|NCT01050790|2646116|P1|COMPLETED|Overall Study||16
1092676|NCT01050790|2646116|P1|STARTED|Overall Study||17
1092677|NCT01050816|2646126|P1|NOT COMPLETED|Overall Study||4
1092678|NCT01050816|2646126|P1|COMPLETED|Overall Study||26
1092679|NCT01050816|2646126|P1|STARTED|Overall Study||30
1092680|NCT01050946|2646132|P1|NOT COMPLETED|Overall Study||0
1092681|NCT01050946|2646132|P1|COMPLETED|Overall Study|Patient signed consent 2/3/2011. Patient had their transplant 2/15/2011. Patient died 9/2/2011|1
1092682|NCT01050946|2646132|P1|STARTED|Overall Study||1
1092683|NCT01050998|2646147|P5|NOT COMPLETED|Overall Study||14
1092684|NCT01050998|2646148|P4|NOT COMPLETED|Overall Study||3
1092685|NCT01050998|2646149|P3|NOT COMPLETED|Overall Study||3
1092686|NCT01050998|2646150|P2|NOT COMPLETED|Overall Study||2
1092687|NCT01050998|2646151|P1|NOT COMPLETED|Overall Study||4
1092688|NCT01050998|2646147|P5|COMPLETED|Overall Study||82
1092689|NCT01050998|2646148|P4|COMPLETED|Overall Study||45
1092690|NCT01050998|2646149|P3|COMPLETED|Overall Study||46
1092691|NCT01050998|2646150|P2|COMPLETED|Overall Study||47
1092692|NCT01050998|2646151|P1|COMPLETED|Overall Study||44
1092693|NCT01050998|2646147|P5|STARTED|Overall Study||96
1092694|NCT01050998|2646148|P4|STARTED|Overall Study||48
1092695|NCT01050998|2646149|P3|STARTED|Overall Study||49
1092696|NCT01050998|2646150|P2|STARTED|Overall Study||49
1092697|NCT01050998|2646151|P1|STARTED|Overall Study||48
1092698|NCT01044693|2646475|P16|NOT COMPLETED|Overall Study||0
1092699|NCT01044693|2646476|P15|NOT COMPLETED|Overall Study||0
1092700|NCT01044693|2646477|P14|NOT COMPLETED|Overall Study||0
1092701|NCT01044693|2646478|P13|NOT COMPLETED|Overall Study||0
1092702|NCT01044693|2646479|P12|NOT COMPLETED|Overall Study||0
1092703|NCT01044693|2646480|P11|NOT COMPLETED|Overall Study||0
1092704|NCT01044693|2646481|P10|NOT COMPLETED|Overall Study||0
1092705|NCT01044693|2646482|P9|NOT COMPLETED|Overall Study||0
1092706|NCT01044693|2646483|P8|NOT COMPLETED|Overall Study||0
1092707|NCT01044693|2646484|P7|NOT COMPLETED|Overall Study||0
1092708|NCT01044693|2646485|P6|NOT COMPLETED|Overall Study||0
1092709|NCT01044693|2646486|P5|NOT COMPLETED|Overall Study||0
1092710|NCT01044693|2646487|P4|NOT COMPLETED|Overall Study||0
1092711|NCT01044693|2646488|P3|NOT COMPLETED|Overall Study||0
1092712|NCT01044693|2646489|P2|NOT COMPLETED|Overall Study||0
1092713|NCT01044693|2646490|P1|NOT COMPLETED|Overall Study||0
1092714|NCT01044693|2646475|P16|COMPLETED|Overall Study||1
1092715|NCT01044693|2646476|P15|COMPLETED|Overall Study||1
1092716|NCT01044693|2646477|P14|COMPLETED|Overall Study||1
1092717|NCT01044693|2646478|P13|COMPLETED|Overall Study||2
1092718|NCT01044693|2646479|P12|COMPLETED|Overall Study||1
1092719|NCT01044693|2646480|P11|COMPLETED|Overall Study||1
1092720|NCT01044693|2646481|P10|COMPLETED|Overall Study||1
1092721|NCT01044693|2646482|P9|COMPLETED|Overall Study||1
1092722|NCT01044693|2646483|P8|COMPLETED|Overall Study||1
1092723|NCT01044693|2646484|P7|COMPLETED|Overall Study||1
1092724|NCT01044693|2646485|P6|COMPLETED|Overall Study||2
1092725|NCT01044693|2646486|P5|COMPLETED|Overall Study||1
1092726|NCT01044693|2646487|P4|COMPLETED|Overall Study||1
1092727|NCT01044693|2646488|P3|COMPLETED|Overall Study||1
1092728|NCT01044693|2646489|P2|COMPLETED|Overall Study||1
1092729|NCT01044693|2646490|P1|COMPLETED|Overall Study||3
1092730|NCT01044693|2646475|P16|STARTED|Overall Study||1
1092731|NCT01044693|2646476|P15|STARTED|Overall Study||1
1092732|NCT01044693|2646477|P14|STARTED|Overall Study||1
1092733|NCT01044693|2646478|P13|STARTED|Overall Study||2
1092734|NCT01044693|2646479|P12|STARTED|Overall Study||1
1092735|NCT01044693|2646480|P11|STARTED|Overall Study||1
1092736|NCT01044693|2646481|P10|STARTED|Overall Study||1
1092737|NCT01044693|2646482|P9|STARTED|Overall Study||1
1092738|NCT01044693|2646483|P8|STARTED|Overall Study||1
1092739|NCT01044693|2646484|P7|STARTED|Overall Study||1
1092740|NCT01044693|2646485|P6|STARTED|Overall Study||2
1092741|NCT01044693|2646486|P5|STARTED|Overall Study||1
1092742|NCT01044693|2646487|P4|STARTED|Overall Study||1
1092743|NCT01044693|2646488|P3|STARTED|Overall Study||1
1092744|NCT01044693|2646489|P2|STARTED|Overall Study||1
1092745|NCT01044693|2646490|P1|STARTED|Overall Study||3
1092746|NCT01044706|2646514|P2|NOT COMPLETED|Overall Study||0
1092747|NCT01044706|2646515|P1|NOT COMPLETED|Overall Study||0
1092748|NCT01044706|2646514|P2|COMPLETED|Overall Study||30
1092749|NCT01044706|2646515|P1|COMPLETED|Overall Study||30
1092750|NCT01044706|2646514|P2|STARTED|Overall Study||30
1092751|NCT01044706|2646515|P1|STARTED|Overall Study||30
1092752|NCT01044732|2646525|P2|NOT COMPLETED|Overall Study||50
1092753|NCT01044732|2646526|P1|NOT COMPLETED|Overall Study||49
1092754|NCT01044732|2646525|P2|COMPLETED|Overall Study||176
1092755|NCT01044732|2646526|P1|COMPLETED|Overall Study||173
1092756|NCT01044732|2646525|P2|STARTED|Overall Study||226
1092757|NCT01044732|2646526|P1|STARTED|Overall Study||222
1092758|NCT01044758|2646541|P7|NOT COMPLETED|Overall Study||10
1092759|NCT01044758|2646542|P6|NOT COMPLETED|Overall Study||3
1092760|NCT01044758|2646543|P5|NOT COMPLETED|Overall Study||2
1092761|NCT01044758|2646544|P4|NOT COMPLETED|Overall Study||2
1092762|NCT01044758|2646545|P3|NOT COMPLETED|Overall Study||4
1092763|NCT01044758|2646546|P2|NOT COMPLETED|Overall Study||0
1092764|NCT01044758|2646547|P1|NOT COMPLETED|Overall Study||4
1092765|NCT01044758|2646541|P7|COMPLETED|Overall Study||17
1092766|NCT01044758|2646542|P6|COMPLETED|Overall Study||8
1092767|NCT01044758|2646543|P5|COMPLETED|Overall Study||9
1092768|NCT01044758|2646544|P4|COMPLETED|Overall Study||10
1092769|NCT01044758|2646545|P3|COMPLETED|Overall Study||7
1092770|NCT01044758|2646546|P2|COMPLETED|Overall Study||12
1092771|NCT01044758|2646547|P1|COMPLETED|Overall Study||8
1092772|NCT01044758|2646541|P7|STARTED|Overall Study||27
1092773|NCT01044758|2646542|P6|STARTED|Overall Study||11
1092774|NCT01044758|2646543|P5|STARTED|Overall Study||11
1092775|NCT01044758|2646544|P4|STARTED|Overall Study||12
1092776|NCT01044758|2646545|P3|STARTED|Overall Study||11
1092777|NCT01044758|2646546|P2|STARTED|Overall Study||12
1092778|NCT01044758|2646547|P1|STARTED|Overall Study||12
1092779|NCT01044771|2646570|P1|NOT COMPLETED|Overall Study||0
1092780|NCT01044771|2646570|P1|COMPLETED|Overall Study||20
1092781|NCT01044771|2646570|P1|STARTED|Overall Study||20
1092782|NCT01044862|2646578|P3|NOT COMPLETED|Overall Study||52
1092783|NCT01044862|2646579|P2|NOT COMPLETED|Overall Study||49
1092784|NCT01044862|2646580|P1|NOT COMPLETED|Overall Study||53
1092785|NCT01044862|2646578|P3|COMPLETED|Overall Study||249
1092786|NCT01044862|2646579|P2|COMPLETED|Overall Study||251
1092787|NCT01044862|2646580|P1|COMPLETED|Overall Study||246
1092788|NCT01044862|2646578|P3|STARTED|Overall Study||301
1092789|NCT01044862|2646579|P2|STARTED|Overall Study||300
1092790|NCT01044862|2646580|P1|STARTED|Overall Study||299
1092791|NCT01045031|2646599|P2|NOT COMPLETED|Overall Study||6
1092792|NCT01045031|2646600|P1|NOT COMPLETED|Overall Study||9
1092793|NCT01045031|2646599|P2|COMPLETED|Overall Study||50
1092794|NCT01045031|2646600|P1|COMPLETED|Overall Study||49
1092795|NCT01045031|2646599|P2|STARTED|Overall Study||56
1092796|NCT01045031|2646600|P1|STARTED|Overall Study||58
1092797|NCT01045057|2646610|P1|NOT COMPLETED|Overall Study||0
1092798|NCT01045057|2646610|P1|COMPLETED|Overall Study||27
1092799|NCT01045057|2646610|P1|STARTED|Overall Study||27
1092800|NCT01045096|2646620|P3|NOT COMPLETED|Overall Study||0
1092801|NCT01045096|2646621|P2|NOT COMPLETED|Overall Study||0
1092802|NCT01045096|2646622|P1|NOT COMPLETED|Overall Study||3
1092803|NCT01045096|2646620|P3|COMPLETED|Overall Study||12
1092804|NCT01045096|2646621|P2|COMPLETED|Overall Study||12
1092805|NCT01045096|2646622|P1|COMPLETED|Overall Study||9
1092806|NCT01045096|2646620|P3|Pharmacokinetic Set|Overall Study||11
1092807|NCT01045096|2646621|P2|Pharmacokinetic Set|Overall Study||11
1092808|NCT01045096|2646622|P1|Pharmacokinetic Set|Overall Study|All patients with at least one estimable PK parameter for dexlansoprazole on Day 7.|9
1092809|NCT01045096|2646620|P3|STARTED|Overall Study||12
1092810|NCT01045096|2646621|P2|STARTED|Overall Study||12
1092811|NCT01045096|2646622|P1|STARTED|Overall Study||12
1092812|NCT01045122|2646648|P2|NOT COMPLETED|Propofol Then Dexmedetomidine||0
1092813|NCT01045122|2646649|P1|NOT COMPLETED|Propofol Then Dexmedetomidine||0
1092814|NCT01045122|2646648|P2|COMPLETED|Propofol Then Dexmedetomidine||6
1092815|NCT01045122|2646649|P1|COMPLETED|Propofol Then Dexmedetomidine||5
1092816|NCT01045122|2646648|P2|STARTED|Propofol Then Dexmedetomidine||6
1092817|NCT01045122|2646649|P1|STARTED|Propofol Then Dexmedetomidine||5
1092818|NCT01045122|2646648|P2|NOT COMPLETED|Dexmedetomidine Then Propofol||0
1092819|NCT01045122|2646649|P1|NOT COMPLETED|Dexmedetomidine Then Propofol||0
1092820|NCT01045122|2646648|P2|COMPLETED|Dexmedetomidine Then Propofol||6
1092821|NCT01045122|2646649|P1|COMPLETED|Dexmedetomidine Then Propofol||5
1092822|NCT01045122|2646648|P2|STARTED|Dexmedetomidine Then Propofol||6
1092823|NCT01045122|2646649|P1|STARTED|Dexmedetomidine Then Propofol||5
1092824|NCT01045161|2646658|P3|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||32
1092825|NCT01045161|2646659|P2|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
1092826|NCT01045161|2646660|P1|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
1092827|NCT01045161|2646658|P3|COMPLETED|Part B - 40 Additional Weeks Open Label||115
1092828|NCT01045161|2646659|P2|COMPLETED|Part B - 40 Additional Weeks Open Label||118
1092829|NCT01045161|2646660|P1|COMPLETED|Part B - 40 Additional Weeks Open Label||111
1092830|NCT01045161|2646658|P3|STARTED|Part B - 40 Additional Weeks Open Label||147
1092831|NCT01045161|2646659|P2|STARTED|Part B - 40 Additional Weeks Open Label||154
1092832|NCT01045161|2646660|P1|STARTED|Part B - 40 Additional Weeks Open Label||147
1092833|NCT01045161|2646658|P3|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||30
1092834|NCT01045161|2646659|P2|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||29
1092835|NCT01045161|2646660|P1|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||31
1092836|NCT01045161|2646658|P3|COMPLETED|Part A - 12 Weeks Double Blind Treatment||148
1092837|NCT01045161|2646659|P2|COMPLETED|Part A - 12 Weeks Double Blind Treatment||155
1092838|NCT01045161|2646660|P1|COMPLETED|Part A - 12 Weeks Double Blind Treatment||151
1092839|NCT01045161|2646658|P3|STARTED|Part A - 12 Weeks Double Blind Treatment||178
1092840|NCT01045161|2646659|P2|STARTED|Part A - 12 Weeks Double Blind Treatment||184
1092841|NCT01045161|2646660|P1|STARTED|Part A - 12 Weeks Double Blind Treatment||182
1092842|NCT01045187|2646680|P1|NOT COMPLETED|Overall Study||0
1092843|NCT01045187|2646680|P1|COMPLETED|Overall Study||15
1092844|NCT01045187|2646680|P1|STARTED|Overall Study||15
1092845|NCT01045265|2646684|P1|NOT COMPLETED|Overall Study||0
1092846|NCT01045265|2646684|P1|COMPLETED|Overall Study||16
1092847|NCT01045265|2646684|P1|STARTED|Overall Study||16
1092848|NCT01045421|2646697|P11|NOT COMPLETED|Phase 2||2
1092849|NCT01045421|2646698|P10|NOT COMPLETED|Phase 2||3
1092850|NCT01045421|2646699|P9|NOT COMPLETED|Phase 2||2
1092851|NCT01045421|2646700|P8|NOT COMPLETED|Phase 2||5
1092852|NCT01045421|2646701|P7|NOT COMPLETED|Phase 2||0
1092853|NCT01045421|2646702|P6|NOT COMPLETED|Phase 2||0
1092854|NCT01045421|2646703|P5|NOT COMPLETED|Phase 2||0
1092855|NCT01045421|2646704|P4|NOT COMPLETED|Phase 2||0
1092856|NCT01045421|2646705|P3|NOT COMPLETED|Phase 2||0
1092857|NCT01045421|2646706|P2|NOT COMPLETED|Phase 2||0
1092858|NCT01045421|2646707|P1|NOT COMPLETED|Phase 2||0
1092859|NCT01045421|2646697|P11|COMPLETED|Phase 2||58
1092860|NCT01045421|2646698|P10|COMPLETED|Phase 2||23
1092861|NCT01045421|2646699|P9|COMPLETED|Phase 2||53
1092862|NCT01045421|2646700|P8|COMPLETED|Phase 2||50
1092863|NCT01045421|2646701|P7|COMPLETED|Phase 2||53
1092864|NCT01045421|2646702|P6|COMPLETED|Phase 2||0
1092865|NCT01045421|2646703|P5|COMPLETED|Phase 2||0
1092866|NCT01045421|2646704|P4|COMPLETED|Phase 2||0
1092867|NCT01045421|2646705|P3|COMPLETED|Phase 2||0
1092868|NCT01045421|2646706|P2|COMPLETED|Phase 2||0
1092869|NCT01045421|2646707|P1|COMPLETED|Phase 2||0
1092870|NCT01045421|2646697|P11|STARTED|Phase 2||60
1092871|NCT01045421|2646698|P10|STARTED|Phase 2||26
1092872|NCT01045421|2646699|P9|STARTED|Phase 2||55
1092873|NCT01045421|2646700|P8|STARTED|Phase 2||55
1092874|NCT01045421|2646701|P7|STARTED|Phase 2||53
1092875|NCT01045421|2646702|P6|STARTED|Phase 2||0
1092876|NCT01045421|2646703|P5|STARTED|Phase 2||0
1092877|NCT01045421|2646704|P4|STARTED|Phase 2||0
1092878|NCT01045421|2646705|P3|STARTED|Phase 2||0
1092879|NCT01045421|2646706|P2|STARTED|Phase 2||0
1092880|NCT01045421|2646707|P1|STARTED|Phase 2||0
1092881|NCT01045421|2646697|P11|NOT COMPLETED|Phase 1||0
1092882|NCT01045421|2646698|P10|NOT COMPLETED|Phase 1||0
1092883|NCT01045421|2646699|P9|NOT COMPLETED|Phase 1||0
1092884|NCT01045421|2646700|P8|NOT COMPLETED|Phase 1||0
1092885|NCT01045421|2646701|P7|NOT COMPLETED|Phase 1||0
1092886|NCT01045421|2646702|P6|NOT COMPLETED|Phase 1||0
1092887|NCT01045421|2646703|P5|NOT COMPLETED|Phase 1||1
1092888|NCT01045421|2646704|P4|NOT COMPLETED|Phase 1||1
1092889|NCT01045421|2646705|P3|NOT COMPLETED|Phase 1||0
1092890|NCT01045421|2646706|P2|NOT COMPLETED|Phase 1||0
1092891|NCT01045421|2646707|P1|NOT COMPLETED|Phase 1||0
1092892|NCT01045421|2646697|P11|COMPLETED|Phase 1||0
1092893|NCT01045421|2646698|P10|COMPLETED|Phase 1||0
1092894|NCT01045421|2646699|P9|COMPLETED|Phase 1||0
1092895|NCT01045421|2646700|P8|COMPLETED|Phase 1||0
1092896|NCT01045421|2646701|P7|COMPLETED|Phase 1||0
1092897|NCT01045421|2646702|P6|COMPLETED|Phase 1||1
1092898|NCT01045421|2646703|P5|COMPLETED|Phase 1||2
1092899|NCT01045421|2646704|P4|COMPLETED|Phase 1||11
1092900|NCT01045421|2646705|P3|COMPLETED|Phase 1||4
1092901|NCT01045421|2646706|P2|COMPLETED|Phase 1||3
1092902|NCT01045421|2646707|P1|COMPLETED|Phase 1||1
1092903|NCT01045421|2646697|P11|STARTED|Phase 1||0
1092904|NCT01045421|2646698|P10|STARTED|Phase 1||0
1092905|NCT01045421|2646699|P9|STARTED|Phase 1||0
1092906|NCT01045421|2646700|P8|STARTED|Phase 1||0
1092907|NCT01045421|2646701|P7|STARTED|Phase 1||0
1092908|NCT01045421|2646702|P6|STARTED|Phase 1||1
1092909|NCT01045421|2646703|P5|STARTED|Phase 1||3
1092910|NCT01045421|2646704|P4|STARTED|Phase 1||12
1092911|NCT01045421|2646705|P3|STARTED|Phase 1||4
1092912|NCT01045421|2646706|P2|STARTED|Phase 1||3
1092913|NCT01045421|2646707|P1|STARTED|Phase 1||1
1092914|NCT01045447|2646789|P2|NOT COMPLETED|Overall Study||28
1092915|NCT01045447|2646790|P1|NOT COMPLETED|Overall Study||36
1092916|NCT01045447|2646789|P2|COMPLETED|Overall Study||205
1092917|NCT01045447|2646790|P1|COMPLETED|Overall Study||196
1092918|NCT01045447|2646789|P2|Exposed|Overall Study||233
1092919|NCT01045447|2646790|P1|Exposed|Overall Study|Two subjects withdrew prior to exposure to trial drug|230
1092920|NCT01045447|2646789|P2|STARTED|Overall Study||233
1092921|NCT01045447|2646790|P1|STARTED|Overall Study||232
1092922|NCT01045551|2646798|P1|NOT COMPLETED|Overall Study||0
1092923|NCT01045551|2646798|P1|COMPLETED|Overall Study||10
1092924|NCT01045551|2646798|P1|STARTED|Overall Study||10
1092925|NCT01051323|2646808|P1|NOT COMPLETED|Overall Study||539
1092926|NCT01051323|2646808|P1|COMPLETED|Overall Study||1041
1092927|NCT01051323|2646808|P1|Received at Least One Dose|Overall Study||1547
1092928|NCT01051323|2646808|P1|STARTED|Overall Study||1580
1092929|NCT01051440|2646832|P2|NOT COMPLETED|Overall Study||0
1092930|NCT01051440|2646833|P1|NOT COMPLETED|Overall Study||0
1092931|NCT01051440|2646832|P2|COMPLETED|Overall Study||1
1092932|NCT01051440|2646833|P1|COMPLETED|Overall Study||1
1092933|NCT01051440|2646832|P2|STARTED|Overall Study||1
1092934|NCT01051440|2646833|P1|STARTED|Overall Study||1
1092935|NCT01051466|2646845|P2|NOT COMPLETED|Overall Study||5
1092936|NCT01051466|2646846|P1|NOT COMPLETED|Overall Study||8
1092937|NCT01051466|2646845|P2|COMPLETED|Overall Study||23
1092938|NCT01051466|2646846|P1|COMPLETED|Overall Study||24
1092939|NCT01051466|2646845|P2|STARTED|Overall Study||28
1092940|NCT01051466|2646846|P1|STARTED|Overall Study||32
1092941|NCT01052116|2646880|P2|NOT COMPLETED|Overall Study||27
1092942|NCT01052116|2646881|P1|NOT COMPLETED|Overall Study||14
1092943|NCT01052116|2646880|P2|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|166
1092944|NCT01052116|2646881|P1|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|179
1092945|NCT01052116|2646880|P2|STARTED|Overall Study||193
1092946|NCT01052116|2646881|P1|STARTED|Overall Study||193
1092947|NCT01052207|2646889|P2|NOT COMPLETED|Overall Study||0
1092948|NCT01052207|2646890|P1|NOT COMPLETED|Overall Study||0
1092949|NCT01052207|2646889|P2|COMPLETED|Overall Study||42
1092950|NCT01052207|2646890|P1|COMPLETED|Overall Study||60
1092951|NCT01052207|2646889|P2|STARTED|Overall Study||42
1092952|NCT01052207|2646890|P1|STARTED|Overall Study||60
1092953|NCT01052272|2646900|P4|NOT COMPLETED|Overall Study||7
1092954|NCT01052272|2646901|P3|NOT COMPLETED|Overall Study||8
1092955|NCT01052272|2646902|P2|NOT COMPLETED|Overall Study||7
1092956|NCT01052272|2646903|P1|NOT COMPLETED|Overall Study||5
1092957|NCT01052272|2646900|P4|COMPLETED|Overall Study||11
1092958|NCT01052272|2646901|P3|COMPLETED|Overall Study||10
1092959|NCT01052272|2646902|P2|COMPLETED|Overall Study||11
1092960|NCT01052272|2646903|P1|COMPLETED|Overall Study||13
1092961|NCT01052272|2646900|P4|STARTED|Overall Study||18
1092962|NCT01052272|2646901|P3|STARTED|Overall Study||18
1092963|NCT01052272|2646902|P2|STARTED|Overall Study||18
1092964|NCT01052272|2646903|P1|STARTED|Overall Study||18
1092965|NCT01052428|2646939|P2|NOT COMPLETED|Overall Study||1
1092966|NCT01052428|2646940|P1|NOT COMPLETED|Overall Study||1
1092967|NCT01052428|2646939|P2|COMPLETED|Overall Study||18
1092968|NCT01052428|2646940|P1|COMPLETED|Overall Study||18
1092969|NCT01052428|2646939|P2|STARTED|Overall Study||19
1092970|NCT01052428|2646940|P1|STARTED|Overall Study||19
1092971|NCT01052480|2646960|P2|NOT COMPLETED|Overall Study||17
1092972|NCT01052480|2646961|P1|NOT COMPLETED|Overall Study||8
1092973|NCT01052480|2646960|P2|COMPLETED|Overall Study||32
1092974|NCT01052480|2646961|P1|COMPLETED|Overall Study||41
1092975|NCT01052480|2646960|P2|STARTED|Overall Study||49
1092976|NCT01052480|2646961|P1|STARTED|Overall Study||49
1092977|NCT01052545|2647011|P2|NOT COMPLETED|Overall Study||0
1092978|NCT01052545|2647012|P1|NOT COMPLETED|Overall Study||0
1092979|NCT01052545|2647011|P2|COMPLETED|Overall Study||731
1092980|NCT01052545|2647012|P1|COMPLETED|Overall Study||867
1092981|NCT01052545|2647011|P2|STARTED|Overall Study||731
1092982|NCT01052545|2647012|P1|STARTED|Overall Study||867
1092983|NCT01052662|2647027|P3|NOT COMPLETED|Overall Study||22
1092984|NCT01052662|2647028|P2|NOT COMPLETED|Overall Study||22
1092985|NCT01052662|2647029|P1|NOT COMPLETED|Overall Study||22
1092986|NCT01052662|2647027|P3|COMPLETED|Overall Study||10
1092987|NCT01052662|2647028|P2|COMPLETED|Overall Study||5
1092988|NCT01052662|2647029|P1|COMPLETED|Overall Study||6
1092989|NCT01052662|2647027|P3|Discontinuation Phase|Overall Study||10
1092990|NCT01052662|2647028|P2|Discontinuation Phase|Overall Study||5
1092991|NCT01052662|2647029|P1|Discontinuation Phase|Overall Study||6
1092992|NCT01052662|2647027|P3|Stabilization Phase|Overall Study||26
1092993|NCT01052662|2647028|P2|Stabilization Phase|Overall Study||21
1092994|NCT01052662|2647029|P1|Stabilization Phase|Overall Study||21
1092995|NCT01052662|2647027|P3|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|32
1092996|NCT01052662|2647028|P2|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|27
1092997|NCT01052662|2647029|P1|STARTED|Overall Study|1 subject excluded from Intent-to-treat sample for final analysis due to pharmacy issue.|28
1092998|NCT01052701|2647045|P2|NOT COMPLETED|Overall Study||0
1092999|NCT01052701|2647046|P1|NOT COMPLETED|Overall Study||0
1093000|NCT01052701|2647045|P2|COMPLETED|Overall Study||12
1093001|NCT01052701|2647046|P1|COMPLETED|Overall Study||14
1093002|NCT01052701|2647045|P2|STARTED|Overall Study||12
1093003|NCT01052701|2647046|P1|STARTED|Overall Study||14
1093004|NCT01052714|2647056|P3|NOT COMPLETED|Overall Study||2
1093005|NCT01052714|2647057|P2|NOT COMPLETED|Overall Study||29
1093006|NCT01052714|2647058|P1|NOT COMPLETED|Overall Study||25
1093007|NCT01052714|2647056|P3|COMPLETED|Overall Study||15
1093008|NCT01052714|2647057|P2|COMPLETED|Overall Study||33
1093009|NCT01052714|2647058|P1|COMPLETED|Overall Study||17
1093010|NCT01052714|2647056|P3|STARTED|Overall Study||17
1093011|NCT01052714|2647057|P2|STARTED|Overall Study||62
1093012|NCT01052714|2647058|P1|STARTED|Overall Study||42
1093013|NCT01052831|2647100|P2|NOT COMPLETED|Overall Study||1
1093014|NCT01052831|2647101|P1|NOT COMPLETED|Overall Study||4
1093015|NCT01052831|2647100|P2|COMPLETED|Overall Study||23
1093016|NCT01052831|2647101|P1|COMPLETED|Overall Study||22
1093017|NCT01052831|2647100|P2|STARTED|Overall Study||24
1093018|NCT01052831|2647101|P1|STARTED|Overall Study||26
1093019|NCT01052844|2647111|P2|NOT COMPLETED|Overall Study||1
1093020|NCT01052844|2647112|P1|NOT COMPLETED|Overall Study||0
1093021|NCT01052844|2647111|P2|COMPLETED|Overall Study||39
1093022|NCT01052844|2647112|P1|COMPLETED|Overall Study||40
1093023|NCT01052844|2647111|P2|STARTED|Overall Study||40
1093024|NCT01052844|2647112|P1|STARTED|Overall Study||40
1093025|NCT01052948|2647124|P4|NOT COMPLETED|Overall Study||0
1093026|NCT01052948|2647125|P3|NOT COMPLETED|Overall Study||0
1093027|NCT01052948|2647126|P2|NOT COMPLETED|Overall Study||0
1093028|NCT01052948|2647127|P1|NOT COMPLETED|Overall Study||0
1093029|NCT01052948|2647124|P4|COMPLETED|Overall Study||29311
1093030|NCT01052948|2647125|P3|COMPLETED|Overall Study||15147
1093031|NCT01052948|2647126|P2|COMPLETED|Overall Study||14669
1093032|NCT01052948|2647127|P1|COMPLETED|Overall Study||27812
1093033|NCT01052948|2647124|P4|STARTED|Overall Study||29311
1093034|NCT01052948|2647125|P3|STARTED|Overall Study||15147
1093035|NCT01052948|2647126|P2|STARTED|Overall Study||14669
1093036|NCT01052948|2647127|P1|STARTED|Overall Study||27812
1093037|NCT01053000|2647149|P2|NOT COMPLETED|Overall Study||0
1093038|NCT01053000|2647150|P1|NOT COMPLETED|Overall Study||0
1093039|NCT01053000|2647149|P2|COMPLETED|Overall Study||5
1093040|NCT01053000|2647150|P1|COMPLETED|Overall Study||5
1093041|NCT01053000|2647149|P2|STARTED|Overall Study||5
1093042|NCT01053000|2647150|P1|STARTED|Overall Study||5
1093043|NCT01053078|2647158|P2|NOT COMPLETED|Overall Study||3
1093044|NCT01053078|2647159|P1|NOT COMPLETED|Overall Study||4
1093045|NCT01053078|2647158|P2|COMPLETED|Overall Study||12
1093046|NCT01053078|2647159|P1|COMPLETED|Overall Study||10
1093047|NCT01053078|2647158|P2|STARTED|Overall Study||15
1093048|NCT01053078|2647159|P1|STARTED|Overall Study||14
1093049|NCT01053156|2647167|P2|NOT COMPLETED|Second Intervention (Week 13-24)||5
1093050|NCT01053156|2647168|P1|NOT COMPLETED|Second Intervention (Week 13-24)||2
1093051|NCT01053156|2647167|P2|COMPLETED|Second Intervention (Week 13-24)||22
1093052|NCT01053156|2647168|P1|COMPLETED|Second Intervention (Week 13-24)||26
1093053|NCT01053156|2647167|P2|STARTED|Second Intervention (Week 13-24)||27
1093054|NCT01053156|2647168|P1|STARTED|Second Intervention (Week 13-24)||28
1093055|NCT01053156|2647167|P2|NOT COMPLETED|First Intervention (Week 1-12)||6
1093056|NCT01053156|2647168|P1|NOT COMPLETED|First Intervention (Week 1-12)||5
1093057|NCT01053156|2647167|P2|COMPLETED|First Intervention (Week 1-12)||27
1093058|NCT01053156|2647168|P1|COMPLETED|First Intervention (Week 1-12)||28
1093059|NCT01053156|2647167|P2|STARTED|First Intervention (Week 1-12)||33
1093060|NCT01053156|2647168|P1|STARTED|First Intervention (Week 1-12)||33
1093061|NCT01053247|2647207|P3|NOT COMPLETED|Overall Study||28
1093062|NCT01053247|2647208|P2|NOT COMPLETED|Overall Study||19
1093063|NCT01053247|2647209|P1|NOT COMPLETED|Overall Study||20
1093064|NCT01053247|2647207|P3|COMPLETED|Overall Study||236
1093065|NCT01053247|2647208|P2|COMPLETED|Overall Study||241
1093066|NCT01053247|2647209|P1|COMPLETED|Overall Study||249
1093067|NCT01053247|2647207|P3|STARTED|Overall Study||264
1093068|NCT01053247|2647208|P2|STARTED|Overall Study||260
1093069|NCT01053247|2647209|P1|STARTED|Overall Study||269
1093070|NCT01053312|2647217|P1|NOT COMPLETED|Overall Study||0
1093071|NCT01053312|2647217|P1|COMPLETED|Overall Study||7
1093072|NCT01053312|2647217|P1|STARTED|Overall Study||7
1093073|NCT01053429|2647235|P1|NOT COMPLETED|Overall Study||373
1093074|NCT01053429|2647235|P1|COMPLETED|Overall Study||3018
1093075|NCT01053429|2647235|P1|STARTED|Overall Study||3391
1093076|NCT01053507|2647246|P2|NOT COMPLETED|Overall Study||1
1093077|NCT01053507|2647247|P1|NOT COMPLETED|Overall Study||3
1093078|NCT01053507|2647246|P2|COMPLETED|Overall Study||11
1093079|NCT01053507|2647247|P1|COMPLETED|Overall Study||8
1093080|NCT01053507|2647246|P2|STARTED|Overall Study||12
1093081|NCT01053507|2647247|P1|STARTED|Overall Study||11
1093082|NCT01053663|2647264|P1|NOT COMPLETED|Overall Study||6
1093083|NCT01053663|2647264|P1|COMPLETED|Overall Study||3
1093084|NCT01053663|2647264|P1|STARTED|Overall Study||9
1093085|NCT01053741|2647307|P2|NOT COMPLETED|2nd Study Intervention||1
1093086|NCT01053741|2647308|P1|NOT COMPLETED|2nd Study Intervention||0
1093087|NCT01053741|2647307|P2|COMPLETED|2nd Study Intervention||5
1093088|NCT01053741|2647308|P1|COMPLETED|2nd Study Intervention||5
1093089|NCT01053741|2647307|P2|STARTED|2nd Study Intervention||6
1093090|NCT01053741|2647308|P1|STARTED|2nd Study Intervention||5
1093091|NCT01053741|2647307|P2|NOT COMPLETED|14 Day Washout||0
1093092|NCT01053741|2647308|P1|NOT COMPLETED|14 Day Washout||0
1093093|NCT01053741|2647307|P2|COMPLETED|14 Day Washout||6
1093094|NCT01053741|2647308|P1|COMPLETED|14 Day Washout||5
1093095|NCT01053741|2647307|P2|STARTED|14 Day Washout||6
1093096|NCT01053741|2647308|P1|STARTED|14 Day Washout||5
1093097|NCT01053741|2647307|P2|NOT COMPLETED|1st Intervention||0
1093098|NCT01053741|2647308|P1|NOT COMPLETED|1st Intervention||0
1093099|NCT01053741|2647307|P2|COMPLETED|1st Intervention||6
1093100|NCT01053741|2647308|P1|COMPLETED|1st Intervention||5
1093101|NCT01053741|2647307|P2|STARTED|1st Intervention||6
1093102|NCT01053741|2647308|P1|STARTED|1st Intervention||5
1093103|NCT01053819|2647314|P1|NOT COMPLETED|Overall Study||0
1093104|NCT01053819|2647314|P1|COMPLETED|Overall Study||6
1093105|NCT01053819|2647314|P1|STARTED|Overall Study||6
1093106|NCT01053897|2647318|P1|NOT COMPLETED|Overall Study||0
1093107|NCT01053897|2647318|P1|COMPLETED|Overall Study||5
1093108|NCT01053897|2647318|P1|STARTED|Overall Study||5
1093109|NCT01053988|2647335|P6|NOT COMPLETED|24-week, Double-blind Treatment Period||55
1093110|NCT01053988|2647336|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||59
1093111|NCT01053988|2647337|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||63
1093112|NCT01053988|2647338|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||61
1093113|NCT01053988|2647339|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||69
1093114|NCT01053988|2647340|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
1093115|NCT01053988|2647335|P6|COMPLETED|24-week, Double-blind Treatment Period||151
1093116|NCT01053988|2647336|P5|COMPLETED|24-week, Double-blind Treatment Period||147
1093117|NCT01053988|2647337|P4|COMPLETED|24-week, Double-blind Treatment Period||142
1093118|NCT01053988|2647338|P3|COMPLETED|24-week, Double-blind Treatment Period||145
1093119|NCT01053988|2647339|P2|COMPLETED|24-week, Double-blind Treatment Period||138
1093120|NCT01053988|2647340|P1|COMPLETED|24-week, Double-blind Treatment Period||0
1093121|NCT01053988|2647335|P6|STARTED|24-week, Double-blind Treatment Period||206
1093122|NCT01053988|2647336|P5|STARTED|24-week, Double-blind Treatment Period||206
1093123|NCT01053988|2647337|P4|STARTED|24-week, Double-blind Treatment Period||205
1093124|NCT01053988|2647338|P3|STARTED|24-week, Double-blind Treatment Period||206
1093125|NCT01053988|2647339|P2|STARTED|24-week, Double-blind Treatment Period||207
1093126|NCT01053988|2647340|P1|STARTED|24-week, Double-blind Treatment Period||0
1093127|NCT01053988|2647335|P6|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1093128|NCT01053988|2647336|P5|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1093129|NCT01053988|2647337|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1093130|NCT01053988|2647338|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1093131|NCT01053988|2647339|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1093132|NCT01053988|2647340|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||360
1093133|NCT01053988|2647335|P6|COMPLETED|2-week, Single-blind Run-In Period||0
1093134|NCT01053988|2647336|P5|COMPLETED|2-week, Single-blind Run-In Period||0
1093135|NCT01053988|2647337|P4|COMPLETED|2-week, Single-blind Run-In Period||0
1093136|NCT01053988|2647338|P3|COMPLETED|2-week, Single-blind Run-In Period||0
1093137|NCT01053988|2647339|P2|COMPLETED|2-week, Single-blind Run-In Period||0
1093138|NCT01053988|2647340|P1|COMPLETED|2-week, Single-blind Run-In Period||1030
1093139|NCT01053988|2647335|P6|STARTED|2-week, Single-blind Run-In Period||0
1093140|NCT01053988|2647336|P5|STARTED|2-week, Single-blind Run-In Period||0
1093141|NCT01053988|2647337|P4|STARTED|2-week, Single-blind Run-In Period||0
1093142|NCT01053988|2647338|P3|STARTED|2-week, Single-blind Run-In Period||0
1093143|NCT01053988|2647339|P2|STARTED|2-week, Single-blind Run-In Period||0
1093144|NCT01053988|2647340|P1|STARTED|2-week, Single-blind Run-In Period||1390
1093145|NCT01054079|2647372|P1|NOT COMPLETED|Overall Study||0
1093146|NCT01054079|2647372|P1|COMPLETED|Overall Study|while all 20 patients received at least some of the intervention, some did not get proper PSA tests.|20
1093147|NCT01054079|2647372|P1|# Recieved Proper PSA Testing|Overall Study||10
1093148|NCT01054079|2647372|P1|STARTED|Overall Study||20
1093149|NCT01054170|2647378|P2|NOT COMPLETED|Overall Study||6
1093150|NCT01054170|2647379|P1|NOT COMPLETED|Overall Study||4
1093151|NCT01054170|2647378|P2|COMPLETED|Overall Study||21
1093152|NCT01054170|2647379|P1|COMPLETED|Overall Study||21
1093153|NCT01054170|2647378|P2|STARTED|Overall Study||27
1093154|NCT01054170|2647379|P1|STARTED|Overall Study||25
1093155|NCT01054183|2647433|P2|NOT COMPLETED|Overall Study||0
1093156|NCT01054183|2647434|P1|NOT COMPLETED|Overall Study||0
1093157|NCT01054183|2647433|P2|COMPLETED|Overall Study||12
1093158|NCT01054183|2647434|P1|COMPLETED|Overall Study||10
1093159|NCT01054183|2647433|P2|STARTED|Overall Study||12
1093160|NCT01054183|2647434|P1|STARTED|Overall Study||10
1093161|NCT01054222|2647442|P1|NOT COMPLETED|Overall Study||11
1093162|NCT01054222|2647442|P1|COMPLETED|Overall Study||20
1093163|NCT01054222|2647442|P1|STARTED|Overall Study||31
1093164|NCT01054339|2647464|P3|NOT COMPLETED|Overall Study||0
1093165|NCT01054339|2647465|P2|NOT COMPLETED|Overall Study||0
1093166|NCT01054339|2647466|P1|NOT COMPLETED|Overall Study||0
1093167|NCT01054339|2647464|P3|COMPLETED|Overall Study||3
1093168|NCT01054339|2647465|P2|COMPLETED|Overall Study||3
1093169|NCT01054339|2647466|P1|COMPLETED|Overall Study||3
1093170|NCT01054339|2647464|P3|STARTED|Overall Study||3
1093171|NCT01054339|2647465|P2|STARTED|Overall Study||3
1093172|NCT01054339|2647466|P1|STARTED|Overall Study||3
1093173|NCT01054404|2647482|P2|NOT COMPLETED|Overall Study||0
1093174|NCT01054404|2647483|P1|NOT COMPLETED|Overall Study||0
1093175|NCT01054404|2647482|P2|COMPLETED|Overall Study||13
1093176|NCT01054404|2647483|P1|COMPLETED|Overall Study||10
1093177|NCT01054404|2647482|P2|STARTED|Overall Study||13
1093178|NCT01054404|2647483|P1|STARTED|Overall Study||10
1093179|NCT01054560|2647491|P2|NOT COMPLETED|Overall Study||28
1093180|NCT01054560|2647492|P1|NOT COMPLETED|Overall Study||13
1093181|NCT01054560|2647491|P2|COMPLETED|Overall Study||27
1093182|NCT01054560|2647492|P1|COMPLETED|Overall Study||45
1093183|NCT01054560|2647491|P2|STARTED|Overall Study||55
1093184|NCT01054560|2647492|P1|STARTED|Overall Study||58
1093185|NCT01054573|2647518|P4|NOT COMPLETED|Overall Study||2
1093186|NCT01054573|2647519|P3|NOT COMPLETED|Overall Study||3
1093187|NCT01054573|2647520|P2|NOT COMPLETED|Overall Study||4
1093188|NCT01054573|2647521|P1|NOT COMPLETED|Overall Study||1
1093189|NCT01054573|2647518|P4|COMPLETED|Overall Study||25
1093190|NCT01054573|2647519|P3|COMPLETED|Overall Study||19
1093191|NCT01054573|2647520|P2|COMPLETED|Overall Study||28
1093192|NCT01054573|2647521|P1|COMPLETED|Overall Study||8
1093193|NCT01054573|2647518|P4|STARTED|Overall Study||27
1093194|NCT01054573|2647519|P3|STARTED|Overall Study||22
1093195|NCT01054573|2647520|P2|STARTED|Overall Study||32
1093196|NCT01054573|2647521|P1|STARTED|Overall Study||9
1093197|NCT01048424|2647567|P2|NOT COMPLETED|Overall Study||0
1093198|NCT01048424|2647568|P1|NOT COMPLETED|Overall Study||2
1093199|NCT01048424|2647567|P2|COMPLETED|Overall Study||10
1093200|NCT01048424|2647568|P1|COMPLETED|Overall Study||8
1093201|NCT01048424|2647567|P2|STARTED|Overall Study||10
1093202|NCT01048424|2647568|P1|STARTED|Overall Study||10
1093203|NCT01048502|2647594|P4|NOT COMPLETED|Overall Study||4
1093204|NCT01048502|2647595|P3|NOT COMPLETED|Overall Study||5
1093205|NCT01048502|2647596|P2|NOT COMPLETED|Overall Study||7
1093206|NCT01048502|2647597|P1|NOT COMPLETED|Overall Study||4
1093207|NCT01048502|2647594|P4|COMPLETED|Overall Study||21
1093208|NCT01048502|2647595|P3|COMPLETED|Overall Study||23
1093209|NCT01048502|2647596|P2|COMPLETED|Overall Study||16
1093210|NCT01048502|2647597|P1|COMPLETED|Overall Study||20
1093211|NCT01048502|2647594|P4|STARTED|Overall Study||25
1093212|NCT01048502|2647595|P3|STARTED|Overall Study||28
1093213|NCT01048502|2647596|P2|STARTED|Overall Study||23
1093214|NCT01048502|2647597|P1|STARTED|Overall Study||24
1093215|NCT01048541|2647608|P2|NOT COMPLETED|Overall Study||0
1093216|NCT01048541|2647609|P1|NOT COMPLETED|Overall Study||1
1093217|NCT01048541|2647608|P2|COMPLETED|Overall Study||19
1093218|NCT01048541|2647609|P1|COMPLETED|Overall Study||17
1093219|NCT01048541|2647608|P2|STARTED|Overall Study||19
1093220|NCT01048541|2647609|P1|STARTED|Overall Study||18
1093221|NCT01048593|2647618|P3|NOT COMPLETED|Overall Study||0
1093222|NCT01048593|2647619|P2|NOT COMPLETED|Overall Study||0
1093223|NCT01048593|2647620|P1|NOT COMPLETED|Overall Study||0
1093224|NCT01048593|2647618|P3|COMPLETED|Overall Study||1
1093225|NCT01048593|2647619|P2|COMPLETED|Overall Study||2
1093226|NCT01048593|2647620|P1|COMPLETED|Overall Study||3
1093227|NCT01048593|2647618|P3|STARTED|Overall Study||1
1093228|NCT01048593|2647619|P2|STARTED|Overall Study||2
1093229|NCT01048593|2647620|P1|STARTED|Overall Study||3
1093230|NCT01048606|2647632|P4|NOT COMPLETED|Overall Study||5
1093231|NCT01048606|2647633|P3|NOT COMPLETED|Overall Study||10
1093232|NCT01048606|2647634|P2|NOT COMPLETED|Overall Study||7
1093233|NCT01048606|2647635|P1|NOT COMPLETED|Overall Study||12
1093234|NCT01048606|2647632|P4|COMPLETED|Overall Study||5
1093235|NCT01048606|2647633|P3|COMPLETED|Overall Study||16
1093236|NCT01048606|2647634|P2|COMPLETED|Overall Study||8
1093237|NCT01048606|2647635|P1|COMPLETED|Overall Study||16
1093238|NCT01048606|2647632|P4|STARTED|Overall Study||10
1093239|NCT01048606|2647633|P3|STARTED|Overall Study||26
1093240|NCT01048606|2647634|P2|STARTED|Overall Study||15
1093241|NCT01048606|2647635|P1|STARTED|Overall Study||28
1093242|NCT01048658|2647647|P2|NOT COMPLETED|Overall Study||0
1093243|NCT01048658|2647648|P1|NOT COMPLETED|Overall Study||0
1093244|NCT01048658|2647647|P2|COMPLETED|Overall Study||80
1093245|NCT01048658|2647648|P1|COMPLETED|Overall Study||80
1093246|NCT01048658|2647647|P2|STARTED|Overall Study||80
1093247|NCT01048658|2647648|P1|STARTED|Overall Study||80
1093248|NCT01048671|2647665|P3|NOT COMPLETED|Overall Study||1
1093249|NCT01048671|2647666|P2|NOT COMPLETED|Overall Study||1
1093250|NCT01048671|2647667|P1|NOT COMPLETED|Overall Study||0
1093251|NCT01048671|2647665|P3|COMPLETED|Overall Study||151
1093252|NCT01048671|2647666|P2|COMPLETED|Overall Study||263
1093253|NCT01048671|2647667|P1|COMPLETED|Overall Study||66
1093254|NCT01048671|2647665|P3|STARTED|Overall Study||152
1093255|NCT01048671|2647666|P2|STARTED|Overall Study||264
1093256|NCT01048671|2647667|P1|STARTED|Overall Study||66
1093257|NCT01054586|2647692|P4|NOT COMPLETED|Overall Study||0
1093258|NCT01054586|2647693|P3|NOT COMPLETED|Overall Study||0
1093259|NCT01054586|2647694|P2|NOT COMPLETED|Overall Study||0
1093260|NCT01054586|2647695|P1|NOT COMPLETED|Overall Study||0
1093261|NCT01054586|2647692|P4|COMPLETED|Overall Study||101
1093262|NCT01054586|2647693|P3|COMPLETED|Overall Study||8
1093263|NCT01054586|2647694|P2|COMPLETED|Overall Study||15
1093264|NCT01054586|2647695|P1|COMPLETED|Overall Study||43
1093265|NCT01054586|2647692|P4|STARTED|Overall Study||101
1093266|NCT01054586|2647693|P3|STARTED|Overall Study||8
1093267|NCT01054586|2647694|P2|STARTED|Overall Study||15
1093268|NCT01054586|2647695|P1|STARTED|Overall Study||43
1093269|NCT01054599|2647785|P2|NOT COMPLETED|Overall Study||7
1093270|NCT01054599|2647786|P1|NOT COMPLETED|Overall Study||4
1093271|NCT01054599|2647785|P2|COMPLETED|Overall Study||9
1093272|NCT01054599|2647786|P1|COMPLETED|Overall Study||9
1093273|NCT01054599|2647785|P2|STARTED|Overall Study||16
1093274|NCT01054599|2647786|P1|STARTED|Overall Study||13
1093275|NCT01054625|2647797|P3|NOT COMPLETED|Overall Study||1
1093276|NCT01054625|2647798|P2|NOT COMPLETED|Overall Study||3
1093277|NCT01054625|2647799|P1|NOT COMPLETED|Overall Study||2
1093278|NCT01054625|2647797|P3|COMPLETED|Overall Study||9
1093279|NCT01054625|2647798|P2|COMPLETED|Overall Study||9
1093280|NCT01054625|2647799|P1|COMPLETED|Overall Study||6
1093281|NCT01054625|2647797|P3|STARTED|Overall Study||10
1093282|NCT01054625|2647798|P2|STARTED|Overall Study||12
1093283|NCT01054625|2647799|P1|STARTED|Overall Study|A total of 31 patients were enrolled, 1 patient died before receiving any zalutumumab|8
1093284|NCT01054703|2647825|P1|NOT COMPLETED|Overall Study||0
1093285|NCT01054703|2647825|P1|COMPLETED|Overall Study||14
1093286|NCT01054703|2647825|P1|STARTED|Overall Study||14
1093287|NCT01054729|2647833|P4|NOT COMPLETED|Overall Study||3
1093288|NCT01054729|2647834|P3|NOT COMPLETED|Overall Study||6
1093289|NCT01054729|2647835|P2|NOT COMPLETED|Overall Study||5
1093290|NCT01054729|2647836|P1|NOT COMPLETED|Overall Study||4
1093291|NCT01054729|2647833|P4|COMPLETED|Overall Study||11
1093292|NCT01054729|2647834|P3|COMPLETED|Overall Study||9
1093293|NCT01054729|2647835|P2|COMPLETED|Overall Study||14
1093294|NCT01054729|2647836|P1|COMPLETED|Overall Study||12
1093295|NCT01054729|2647833|P4|Randomized and Treated|Overall Study||14
1093296|NCT01054729|2647834|P3|Randomized and Treated|Overall Study||15
1093297|NCT01054729|2647835|P2|Randomized and Treated|Overall Study||18
1093298|NCT01054729|2647836|P1|Randomized and Treated|Overall Study||16
1093299|NCT01054729|2647833|P4|STARTED|Overall Study||14
1093300|NCT01054729|2647834|P3|STARTED|Overall Study||15
1093301|NCT01054729|2647835|P2|STARTED|Overall Study||19
1093302|NCT01054729|2647836|P1|STARTED|Overall Study||16
1093303|NCT01054742|2647897|P1|NOT COMPLETED|Overall Study||0
1093304|NCT01054742|2647897|P1|COMPLETED|Overall Study||2
1093305|NCT01054742|2647897|P1|STARTED|Overall Study||2
1093306|NCT01054820|2647901|P1|NOT COMPLETED|Overall Study||2
1093307|NCT01054820|2647901|P1|COMPLETED|Overall Study||121
1093308|NCT01054820|2647901|P1|STARTED|Overall Study||123
1093309|NCT01054846|2647917|P2|NOT COMPLETED|Overall Study||17
1093310|NCT01054846|2647918|P1|NOT COMPLETED|Overall Study||76
1093311|NCT01054846|2647917|P2|COMPLETED|Overall Study||51
1093312|NCT01054846|2647918|P1|COMPLETED|Overall Study||246
1093313|NCT01054846|2647917|P2|STARTED|Overall Study||68
1093314|NCT01054846|2647918|P1|STARTED|Overall Study||322
1093315|NCT01054885|2647931|P7|NOT COMPLETED|24-week, Double-blind Treatment Period||47
1093316|NCT01054885|2647932|P6|NOT COMPLETED|24-week, Double-blind Treatment Period||60
1093317|NCT01054885|2647933|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||42
1093318|NCT01054885|2647934|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||43
1093319|NCT01054885|2647935|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||49
1093320|NCT01054885|2647936|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||59
1093321|NCT01054885|2647937|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
1093322|NCT01054885|2647931|P7|COMPLETED|24-week, Double-blind Treatment Period||158
1093323|NCT01054885|2647932|P6|COMPLETED|24-week, Double-blind Treatment Period||144
1093324|NCT01054885|2647933|P5|COMPLETED|24-week, Double-blind Treatment Period||161
1093325|NCT01054885|2647934|P4|COMPLETED|24-week, Double-blind Treatment Period||160
1093326|NCT01054885|2647935|P3|COMPLETED|24-week, Double-blind Treatment Period||155
1093327|NCT01054885|2647936|P2|COMPLETED|24-week, Double-blind Treatment Period||146
1093328|NCT01054885|2647937|P1|COMPLETED|24-week, Double-blind Treatment Period||0
1093329|NCT01054885|2647931|P7|STARTED|24-week, Double-blind Treatment Period||205
1093330|NCT01054885|2647932|P6|STARTED|24-week, Double-blind Treatment Period||204
1093331|NCT01054885|2647933|P5|STARTED|24-week, Double-blind Treatment Period||203
1093332|NCT01054885|2647934|P4|STARTED|24-week, Double-blind Treatment Period||203
1093333|NCT01054885|2647935|P3|STARTED|24-week, Double-blind Treatment Period||204
1093334|NCT01054885|2647936|P2|STARTED|24-week, Double-blind Treatment Period||205
1093335|NCT01054885|2647937|P1|STARTED|24-week, Double-blind Treatment Period||0
1093336|NCT01054885|2647931|P7|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1093337|NCT01054885|2647932|P6|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1093338|NCT01054885|2647933|P5|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1093339|NCT01054885|2647934|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1093340|NCT01054885|2647935|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1093341|NCT01054885|2647936|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1093342|NCT01054885|2647937|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||351
1093343|NCT01054885|2647931|P7|COMPLETED|2-week, Single-blind Run-In Period||0
1093344|NCT01054885|2647932|P6|COMPLETED|2-week, Single-blind Run-In Period||0
1093345|NCT01054885|2647933|P5|COMPLETED|2-week, Single-blind Run-In Period||0
1093346|NCT01054885|2647934|P4|COMPLETED|2-week, Single-blind Run-In Period||0
1093347|NCT01054885|2647935|P3|COMPLETED|2-week, Single-blind Run-In Period||0
1093348|NCT01054885|2647936|P2|COMPLETED|2-week, Single-blind Run-In Period||0
1093349|NCT01054885|2647937|P1|COMPLETED|2-week, Single-blind Run-In Period||1226
1093350|NCT01054885|2647931|P7|STARTED|2-week, Single-blind Run-In Period||0
1093351|NCT01054885|2647932|P6|STARTED|2-week, Single-blind Run-In Period||0
1093352|NCT01054885|2647933|P5|STARTED|2-week, Single-blind Run-In Period||0
1093353|NCT01054885|2647934|P4|STARTED|2-week, Single-blind Run-In Period||0
1093354|NCT01054885|2647935|P3|STARTED|2-week, Single-blind Run-In Period||0
1093355|NCT01054885|2647936|P2|STARTED|2-week, Single-blind Run-In Period||0
1093356|NCT01054885|2647937|P1|STARTED|2-week, Single-blind Run-In Period||1577
1093357|NCT01054911|2647975|P1|NOT COMPLETED|Overall Study||0
1093358|NCT01054911|2647975|P1|COMPLETED|Overall Study||5
1093359|NCT01054911|2647975|P1|STARTED|Overall Study||5
1093360|NCT01055769|2647982|P2|NOT COMPLETED|Second Intervention||0
1093361|NCT01055769|2647983|P1|NOT COMPLETED|Second Intervention||0
1093362|NCT01055769|2647982|P2|COMPLETED|Second Intervention||10
1093363|NCT01055769|2647983|P1|COMPLETED|Second Intervention||10
1093364|NCT01055769|2647982|P2|STARTED|Second Intervention||10
1093365|NCT01055769|2647983|P1|STARTED|Second Intervention||10
1093366|NCT01055769|2647982|P2|NOT COMPLETED|Washout Period of Atleast 4 Days||0
1093367|NCT01055769|2647983|P1|NOT COMPLETED|Washout Period of Atleast 4 Days||0
1093368|NCT01055769|2647982|P2|COMPLETED|Washout Period of Atleast 4 Days||10
1093369|NCT01055769|2647983|P1|COMPLETED|Washout Period of Atleast 4 Days||10
1093370|NCT01055769|2647982|P2|STARTED|Washout Period of Atleast 4 Days||10
1093371|NCT01055769|2647983|P1|STARTED|Washout Period of Atleast 4 Days||10
1093372|NCT01055769|2647982|P2|NOT COMPLETED|First Intervention||0
1093373|NCT01055769|2647983|P1|NOT COMPLETED|First Intervention||0
1093374|NCT01055769|2647982|P2|COMPLETED|First Intervention||10
1093375|NCT01055769|2647983|P1|COMPLETED|First Intervention||10
1093376|NCT01055769|2647982|P2|STARTED|First Intervention||10
1093377|NCT01055769|2647983|P1|STARTED|First Intervention||10
1093378|NCT01055782|2647999|P2|NOT COMPLETED|Overall Study||0
1093379|NCT01055782|2648000|P1|NOT COMPLETED|Overall Study||0
1093380|NCT01055782|2647999|P2|COMPLETED|Overall Study||449
1093381|NCT01055782|2648000|P1|COMPLETED|Overall Study||555
1093382|NCT01055782|2647999|P2|STARTED|Overall Study||449
1093383|NCT01055782|2648000|P1|STARTED|Overall Study||555
1093384|NCT01055834|2648010|P2|NOT COMPLETED|Treatment Period III||0
1093385|NCT01055834|2648011|P1|NOT COMPLETED|Treatment Period III||0
1093386|NCT01055834|2648010|P2|COMPLETED|Treatment Period III||14
1093387|NCT01055834|2648011|P1|COMPLETED|Treatment Period III||0
1093388|NCT01055834|2648010|P2|STARTED|Treatment Period III|14 of 21 participants in Group B who were treated in Period II participated in Period III.|14
1093389|NCT01055834|2648011|P1|STARTED|Treatment Period III|Participants from Group A did not continue into Period III.|0
1093390|NCT01055834|2648010|P2|NOT COMPLETED|Treatment Period II||0
1093391|NCT01055834|2648011|P1|NOT COMPLETED|Treatment Period II||0
1093392|NCT01055834|2648010|P2|COMPLETED|Treatment Period II||21
1093393|NCT01055834|2648011|P1|COMPLETED|Treatment Period II||20
1093394|NCT01055834|2648010|P2|STARTED|Treatment Period II||21
1093395|NCT01055834|2648011|P1|STARTED|Treatment Period II||20
1093396|NCT01055834|2648010|P2|NOT COMPLETED|Treatment Period I||0
1093397|NCT01055834|2648011|P1|NOT COMPLETED|Treatment Period I||1
1093398|NCT01055834|2648010|P2|COMPLETED|Treatment Period I||21
1093399|NCT01055834|2648011|P1|COMPLETED|Treatment Period I||20
1093400|NCT01055834|2648010|P2|STARTED|Treatment Period I||21
1093401|NCT01055834|2648011|P1|STARTED|Treatment Period I||21
1093402|NCT01055886|2648025|P2|NOT COMPLETED|Overall Study||11
1093403|NCT01055886|2648026|P1|NOT COMPLETED|Overall Study||5
1093404|NCT01055886|2648025|P2|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|21
1093405|NCT01055886|2648026|P1|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|28
1093406|NCT01055886|2648025|P2|Reached Pre-quit Period|Overall Study|1 lost to contact|31
1093407|NCT01055886|2648026|P1|Reached Pre-quit Period|Overall Study|2 withdrawals, 1 lost to contact|30
1093408|NCT01055886|2648025|P2|STARTED|Overall Study||32
1093409|NCT01055886|2648026|P1|STARTED|Overall Study||33
1093410|NCT01056016|2648038|P2|NOT COMPLETED|Overall Study||1
1093411|NCT01056016|2648039|P1|NOT COMPLETED|Overall Study||2
1093412|NCT01056016|2648038|P2|COMPLETED|Overall Study||26
1093413|NCT01056016|2648039|P1|COMPLETED|Overall Study||20
1093414|NCT01056016|2648038|P2|STARTED|Overall Study|27 pediatricians were at 4 practices; practices were unit of randomization|27
1093415|NCT01056016|2648039|P1|STARTED|Overall Study|22 pediatricians were at 4 practices; practices were unit of randomization|22
1093416|NCT01056107|2648049|P4|NOT COMPLETED|Overall Study||0
1093417|NCT01056107|2648050|P3|NOT COMPLETED|Overall Study||3
1093418|NCT01056107|2648051|P2|NOT COMPLETED|Overall Study||1
1093419|NCT01056107|2648052|P1|NOT COMPLETED|Overall Study||0
1093420|NCT01056107|2648049|P4|COMPLETED|Overall Study||12
1093421|NCT01056107|2648050|P3|COMPLETED|Overall Study||9
1093422|NCT01056107|2648051|P2|COMPLETED|Overall Study||10
1093423|NCT01056107|2648052|P1|COMPLETED|Overall Study||11
1093424|NCT01056107|2648049|P4|STARTED|Overall Study||12
1093425|NCT01056107|2648050|P3|STARTED|Overall Study||12
1093426|NCT01056107|2648051|P2|STARTED|Overall Study||11
1093427|NCT01056107|2648052|P1|STARTED|Overall Study||11
1093428|NCT01056198|2648100|P2|NOT COMPLETED|Overall Study||0
1093429|NCT01056198|2648101|P1|NOT COMPLETED|Overall Study||0
1093430|NCT01056198|2648100|P2|COMPLETED|Overall Study||24
1093431|NCT01056198|2648101|P1|COMPLETED|Overall Study||24
1093432|NCT01056198|2648100|P2|STARTED|Overall Study||24
1093433|NCT01056198|2648101|P1|STARTED|Overall Study||24
1093434|NCT01056263|2648113|P1|NOT COMPLETED|Overall Study||52
1093435|NCT01056263|2648113|P1|COMPLETED|Overall Study||0
1093436|NCT01056263|2648113|P1|STARTED|Overall Study||52
1093437|NCT01056276|2648119|P2|NOT COMPLETED|Maintenance Therapy||28
1093438|NCT01056276|2648120|P1|NOT COMPLETED|Maintenance Therapy||0
1093439|NCT01056276|2648119|P2|COMPLETED|Maintenance Therapy|14 patients are continuing maintenance therapy.|0
1093440|NCT01056276|2648120|P1|COMPLETED|Maintenance Therapy||0
1093441|NCT01056276|2648119|P2|STARTED|Maintenance Therapy|5 patients completed 8 cycles but did not have maintenance therapy.|28
1093531|NCT01056523|2648325|P5|NOT COMPLETED|Overall Study||0
1093442|NCT01056276|2648120|P1|STARTED|Maintenance Therapy|Original regimen did not include maintenance therapy.|0
1093443|NCT01056276|2648119|P2|NOT COMPLETED|Treatment Period-Cycles 1-8||8
1093444|NCT01056276|2648120|P1|NOT COMPLETED|Treatment Period-Cycles 1-8||13
1093445|NCT01056276|2648119|P2|COMPLETED|Treatment Period-Cycles 1-8||33
1093446|NCT01056276|2648120|P1|COMPLETED|Treatment Period-Cycles 1-8||5
1093447|NCT01056276|2648119|P2|STARTED|Treatment Period-Cycles 1-8||41
1093448|NCT01056276|2648120|P1|STARTED|Treatment Period-Cycles 1-8||18
1093449|NCT01056289|2648134|P4|NOT COMPLETED|Double-blind Phase||10
1093450|NCT01056289|2648135|P3|NOT COMPLETED|Double-blind Phase||13
1093451|NCT01056289|2648136|P2|NOT COMPLETED|Double-blind Phase||4
1093452|NCT01056289|2648137|P1|NOT COMPLETED|Double-blind Phase||0
1093453|NCT01056289|2648134|P4|COMPLETED|Double-blind Phase||138
1093454|NCT01056289|2648135|P3|COMPLETED|Double-blind Phase||127
1093455|NCT01056289|2648136|P2|COMPLETED|Double-blind Phase||69
1093456|NCT01056289|2648137|P1|COMPLETED|Double-blind Phase||0
1093457|NCT01056289|2648134|P4|STARTED|Double-blind Phase||148
1093458|NCT01056289|2648135|P3|STARTED|Double-blind Phase||140
1093459|NCT01056289|2648136|P2|STARTED|Double-blind Phase||73
1093460|NCT01056289|2648137|P1|STARTED|Double-blind Phase||0
1093461|NCT01056289|2648134|P4|NOT COMPLETED|Open-label Phase||0
1093462|NCT01056289|2648135|P3|NOT COMPLETED|Open-label Phase||0
1093463|NCT01056289|2648136|P2|NOT COMPLETED|Open-label Phase||0
1093464|NCT01056289|2648137|P1|NOT COMPLETED|Open-label Phase||119
1093465|NCT01056289|2648134|P4|COMPLETED|Open-label Phase||0
1093466|NCT01056289|2648135|P3|COMPLETED|Open-label Phase||0
1093467|NCT01056289|2648136|P2|COMPLETED|Open-label Phase||0
1093468|NCT01056289|2648137|P1|COMPLETED|Open-label Phase|Participants transitioned to Double-blind phase|361
1093469|NCT01056289|2648134|P4|STARTED|Open-label Phase||0
1093470|NCT01056289|2648135|P3|STARTED|Open-label Phase||0
1093471|NCT01056289|2648136|P2|STARTED|Open-label Phase||0
1093472|NCT01056289|2648137|P1|STARTED|Open-label Phase||480
1093473|NCT01056315|2648154|P2|NOT COMPLETED|Overall Study||11
1093474|NCT01056315|2648155|P1|NOT COMPLETED|Overall Study||14
1093475|NCT01056315|2648154|P2|COMPLETED|Overall Study||12
1093476|NCT01056315|2648155|P1|COMPLETED|Overall Study||13
1093477|NCT01056315|2648154|P2|STARTED|Overall Study||23
1093478|NCT01056315|2648155|P1|STARTED|Overall Study||27
1093479|NCT01056328|2648191|P2|NOT COMPLETED|Overall Study||16
1093480|NCT01056328|2648192|P1|NOT COMPLETED|Overall Study||17
1093481|NCT01056328|2648191|P2|COMPLETED|Overall Study||144
1093482|NCT01056328|2648192|P1|COMPLETED|Overall Study||147
1093483|NCT01056328|2648191|P2|STARTED|Overall Study||160
1093484|NCT01056328|2648192|P1|STARTED|Overall Study||164
1093485|NCT01056341|2648211|P5|NOT COMPLETED|Overall Study||14
1093486|NCT01056341|2648212|P4|NOT COMPLETED|Overall Study||36
1093487|NCT01056341|2648213|P3|NOT COMPLETED|Overall Study||15
1093488|NCT01056341|2648214|P2|NOT COMPLETED|Overall Study||36
1093489|NCT01056341|2648215|P1|NOT COMPLETED|Overall Study||36
1093490|NCT01056341|2648211|P5|COMPLETED|Overall Study||88
1093491|NCT01056341|2648212|P4|COMPLETED|Overall Study||65
1093492|NCT01056341|2648213|P3|COMPLETED|Overall Study||88
1093493|NCT01056341|2648214|P2|COMPLETED|Overall Study||63
1093494|NCT01056341|2648215|P1|COMPLETED|Overall Study||19
1093495|NCT01056341|2648211|P5|Interim Analysis|Overall Study||43
1093496|NCT01056341|2648212|P4|Interim Analysis|Overall Study||40
1093497|NCT01056341|2648213|P3|Interim Analysis|Overall Study||41
1093498|NCT01056341|2648214|P2|Interim Analysis|Overall Study||41
1093499|NCT01056341|2648215|P1|Interim Analysis|Overall Study||25
1093500|NCT01056341|2648211|P5|STARTED|Overall Study||102
1093501|NCT01056341|2648212|P4|STARTED|Overall Study||101
1093502|NCT01056341|2648213|P3|STARTED|Overall Study||103
1093503|NCT01056341|2648214|P2|STARTED|Overall Study||99
1093504|NCT01056341|2648215|P1|STARTED|Overall Study||55
1093505|NCT01056380|2648236|P2|NOT COMPLETED|Overall Study||3
1093506|NCT01056380|2648237|P1|NOT COMPLETED|Overall Study||2
1093507|NCT01056380|2648236|P2|COMPLETED|Overall Study||39
1093508|NCT01056380|2648237|P1|COMPLETED|Overall Study||35
1093509|NCT01056380|2648236|P2|STARTED|Overall Study||42
1093510|NCT01056380|2648237|P1|STARTED|Overall Study||37
1093511|NCT01056484|2648261|P2|NOT COMPLETED|Follow up - Non-randomized||2
1093512|NCT01056484|2648262|P1|NOT COMPLETED|Follow up - Non-randomized||0
1093513|NCT01056484|2648261|P2|COMPLETED|Follow up - Non-randomized||56
1093514|NCT01056484|2648262|P1|COMPLETED|Follow up - Non-randomized||57
1093515|NCT01056484|2648261|P2|STARTED|Follow up - Non-randomized|Out of the enrolled control subjects (N=59), 58 completed Period 1 and entered into Period 2.|58
1093516|NCT01056484|2648262|P1|STARTED|Follow up - Non-randomized|Out of the enrolled experimental subjects (N=64), 57 completed Period 1 and entered into Period 2.|57
1093517|NCT01056484|2648261|P2|NOT COMPLETED|Randomized Controlled Trial||1
1093518|NCT01056484|2648262|P1|NOT COMPLETED|Randomized Controlled Trial||7
1093519|NCT01056484|2648261|P2|COMPLETED|Randomized Controlled Trial||58
1093520|NCT01056484|2648262|P1|COMPLETED|Randomized Controlled Trial||57
1093521|NCT01056484|2648261|P2|STARTED|Randomized Controlled Trial||59
1093522|NCT01056484|2648262|P1|STARTED|Randomized Controlled Trial||64
1093523|NCT01056510|2648278|P2|NOT COMPLETED|Overall Study||64
1093524|NCT01056510|2648279|P1|NOT COMPLETED|Overall Study||54
1093525|NCT01056510|2648278|P2|COMPLETED|Overall Study||115
1093526|NCT01056510|2648279|P1|COMPLETED|Overall Study||124
1093527|NCT01056510|2648278|P2|STARTED|Overall Study||179
1093528|NCT01056510|2648279|P1|STARTED|Overall Study||178
1093529|NCT01056523|2648323|P7|NOT COMPLETED|Overall Study||1
1093530|NCT01056523|2648324|P6|NOT COMPLETED|Overall Study||0
1093532|NCT01056523|2648326|P4|NOT COMPLETED|Overall Study||3
1093533|NCT01056523|2648327|P3|NOT COMPLETED|Overall Study||2
1093534|NCT01056523|2648328|P2|NOT COMPLETED|Overall Study||0
1093535|NCT01056523|2648329|P1|NOT COMPLETED|Overall Study||1
1093536|NCT01056523|2648323|P7|COMPLETED|Overall Study||4
1093537|NCT01056523|2648324|P6|COMPLETED|Overall Study||3
1093538|NCT01056523|2648325|P5|COMPLETED|Overall Study||3
1093539|NCT01056523|2648326|P4|COMPLETED|Overall Study||3
1093540|NCT01056523|2648327|P3|COMPLETED|Overall Study||3
1093541|NCT01056523|2648328|P2|COMPLETED|Overall Study||3
1093542|NCT01056523|2648329|P1|COMPLETED|Overall Study||3
1093543|NCT01056523|2648323|P7|STARTED|Overall Study||5
1093544|NCT01056523|2648324|P6|STARTED|Overall Study||3
1093545|NCT01056523|2648325|P5|STARTED|Overall Study||3
1093546|NCT01056523|2648326|P4|STARTED|Overall Study||6
1093547|NCT01056523|2648327|P3|STARTED|Overall Study||5
1093548|NCT01056523|2648328|P2|STARTED|Overall Study||3
1093549|NCT01056523|2648329|P1|STARTED|Overall Study||4
1093550|NCT01056601|2648337|P1|NOT COMPLETED|Overall Study||0
1093551|NCT01056601|2648337|P1|COMPLETED|Overall Study||7
1093552|NCT01056601|2648337|P1|STARTED|Overall Study||7
1093553|NCT01056640|2648345|P2|NOT COMPLETED|Overall Study||12
1093554|NCT01056640|2648346|P1|NOT COMPLETED|Overall Study||26
1093555|NCT01056640|2648345|P2|COMPLETED|Overall Study||91
1093556|NCT01056640|2648346|P1|COMPLETED|Overall Study||76
1093557|NCT01056640|2648345|P2|STARTED|Overall Study||103
1093558|NCT01056640|2648346|P1|STARTED|Overall Study||102
1093559|NCT01056653|2648355|P3|NOT COMPLETED|Overall Study||2
1093560|NCT01056653|2648356|P2|NOT COMPLETED|Overall Study||0
1093561|NCT01056653|2648357|P1|NOT COMPLETED|Overall Study||0
1093562|NCT01056653|2648355|P3|COMPLETED|Overall Study|2 were lost to follow-up because one mother left the country and one father was too busy.|42
1093563|NCT01056653|2648356|P2|COMPLETED|Overall Study||23
1093564|NCT01056653|2648357|P1|COMPLETED|Overall Study||46
1093565|NCT01056653|2648355|P3|STARTED|Overall Study||44
1093566|NCT01056653|2648356|P2|STARTED|Overall Study||23
1093567|NCT01056653|2648357|P1|STARTED|Overall Study||46
1093568|NCT01056718|2648371|P1|NOT COMPLETED|Overall Study||3
1093569|NCT01056718|2648371|P1|COMPLETED|Overall Study||50
1093570|NCT01056718|2648371|P1|STARTED|Overall Study||53
1093571|NCT01056822|2648403|P2|NOT COMPLETED|Overall Study||7
1093572|NCT01056822|2648404|P1|NOT COMPLETED|Overall Study||8
1093573|NCT01056822|2648403|P2|COMPLETED|Overall Study||35
1093574|NCT01056822|2648404|P1|COMPLETED|Overall Study||39
1093575|NCT01056822|2648403|P2|Safety (SAF) Population: NO|Overall Study||2
1093576|NCT01056822|2648404|P1|Safety (SAF) Population: NO|Overall Study||1
1093577|NCT01056822|2648403|P2|Safety (SAF) Population: YES|Overall Study||40
1093578|NCT01056822|2648404|P1|Safety (SAF) Population: YES|Overall Study||46
1093579|NCT01056822|2648403|P2|Per-protocol (PP) Population: NO|Overall Study||17
1093580|NCT01056822|2648404|P1|Per-protocol (PP) Population: NO|Overall Study||18
1093581|NCT01056822|2648403|P2|Per-protocol (PP) Population: YES|Overall Study||25
1093582|NCT01056822|2648404|P1|Per-protocol (PP) Population: YES|Overall Study||29
1093583|NCT01056822|2648403|P2|Intention-to-treat (ITT) Population: NO|Overall Study||4
1093584|NCT01056822|2648404|P1|Intention-to-treat (ITT) Population: NO|Overall Study||4
1093585|NCT01056822|2648403|P2|Intention-to-treat (ITT) Population: YES|Overall Study||38
1093586|NCT01056822|2648404|P1|Intention-to-treat (ITT) Population: YES|Overall Study||43
1093587|NCT01056822|2648403|P2|STARTED|Overall Study||42
1093588|NCT01056822|2648404|P1|STARTED|Overall Study||47
1093589|NCT01056913|2648453|P1|NOT COMPLETED|Overall Study||0
1093590|NCT01056913|2648453|P1|COMPLETED|Overall Study||62
1093591|NCT01056913|2648453|P1|STARTED|Overall Study||62
1093592|NCT01057017|2648457|P1|NOT COMPLETED|Overall Study||0
1093593|NCT01057017|2648457|P1|COMPLETED|Overall Study||5
1093594|NCT01057017|2648457|P1|STARTED|Overall Study||5
1093595|NCT01057121|2648463|P5|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
1093596|NCT01057121|2648464|P4|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
1093597|NCT01057121|2648465|P3|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
1093598|NCT01057121|2648466|P2|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
1093599|NCT01057121|2648467|P1|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
1093600|NCT01057121|2648463|P5|COMPLETED|Phase II: 25 mg/Day Lenalidomide||23
1093601|NCT01057121|2648464|P4|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
1093602|NCT01057121|2648465|P3|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
1093603|NCT01057121|2648466|P2|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
1093604|NCT01057121|2648467|P1|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
1093605|NCT01057121|2648463|P5|STARTED|Phase II: 25 mg/Day Lenalidomide||23
1093606|NCT01057121|2648464|P4|STARTED|Phase II: 25 mg/Day Lenalidomide||0
1093607|NCT01057121|2648465|P3|STARTED|Phase II: 25 mg/Day Lenalidomide||0
1093608|NCT01057121|2648466|P2|STARTED|Phase II: 25 mg/Day Lenalidomide||0
1093609|NCT01057121|2648467|P1|STARTED|Phase II: 25 mg/Day Lenalidomide||0
1093610|NCT01057121|2648463|P5|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
1093611|NCT01057121|2648464|P4|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
1093612|NCT01057121|2648465|P3|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
1093613|NCT01057121|2648466|P2|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
1093614|NCT01057121|2648467|P1|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
1093615|NCT01057121|2648463|P5|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
1093616|NCT01057121|2648464|P4|COMPLETED|Phase I: 25 mg/Day Lenalidomide||6
1093617|NCT01057121|2648465|P3|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
1093618|NCT01057121|2648466|P2|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
1093619|NCT01057121|2648467|P1|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
1093620|NCT01057121|2648463|P5|STARTED|Phase I: 25 mg/Day Lenalidomide||0
1093621|NCT01057121|2648464|P4|STARTED|Phase I: 25 mg/Day Lenalidomide||6
1093622|NCT01057121|2648465|P3|STARTED|Phase I: 25 mg/Day Lenalidomide||0
1093623|NCT01057121|2648466|P2|STARTED|Phase I: 25 mg/Day Lenalidomide||0
1093624|NCT01057121|2648467|P1|STARTED|Phase I: 25 mg/Day Lenalidomide||0
1093625|NCT01057121|2648463|P5|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
1093626|NCT01057121|2648464|P4|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
1093627|NCT01057121|2648465|P3|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
1093628|NCT01057121|2648466|P2|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
1093629|NCT01057121|2648467|P1|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
1093630|NCT01057121|2648463|P5|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
1093631|NCT01057121|2648464|P4|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
1093632|NCT01057121|2648465|P3|COMPLETED|Phase I: 20 mg/Day Lenalidomide||3
1093633|NCT01057121|2648466|P2|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
1093634|NCT01057121|2648467|P1|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
1093635|NCT01057121|2648463|P5|STARTED|Phase I: 20 mg/Day Lenalidomide||0
1093636|NCT01057121|2648464|P4|STARTED|Phase I: 20 mg/Day Lenalidomide||0
1093637|NCT01057121|2648465|P3|STARTED|Phase I: 20 mg/Day Lenalidomide||3
1093638|NCT01057121|2648466|P2|STARTED|Phase I: 20 mg/Day Lenalidomide||0
1093639|NCT01057121|2648467|P1|STARTED|Phase I: 20 mg/Day Lenalidomide||0
1093640|NCT01057121|2648463|P5|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
1093641|NCT01057121|2648464|P4|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
1093642|NCT01057121|2648465|P3|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
1093643|NCT01057121|2648466|P2|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
1093644|NCT01057121|2648467|P1|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
1093645|NCT01057121|2648463|P5|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
1093646|NCT01057121|2648464|P4|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
1093647|NCT01057121|2648465|P3|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
1093648|NCT01057121|2648466|P2|COMPLETED|Phase I: 15 mg/Day Lenolidomide||3
1093649|NCT01057121|2648467|P1|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
1093650|NCT01057121|2648463|P5|STARTED|Phase I: 15 mg/Day Lenolidomide||0
1093651|NCT01057121|2648464|P4|STARTED|Phase I: 15 mg/Day Lenolidomide||0
1093652|NCT01057121|2648465|P3|STARTED|Phase I: 15 mg/Day Lenolidomide||0
1093653|NCT01057121|2648466|P2|STARTED|Phase I: 15 mg/Day Lenolidomide||3
1093654|NCT01057121|2648467|P1|STARTED|Phase I: 15 mg/Day Lenolidomide||0
1093655|NCT01057121|2648463|P5|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
1093656|NCT01057121|2648464|P4|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
1093657|NCT01057121|2648465|P3|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
1093658|NCT01057121|2648466|P2|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
1093659|NCT01057121|2648467|P1|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
1093660|NCT01057121|2648463|P5|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
1093661|NCT01057121|2648464|P4|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
1093662|NCT01057121|2648465|P3|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
1093663|NCT01057121|2648466|P2|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
1093664|NCT01057121|2648467|P1|COMPLETED|Phase I: 10 mg/Day Lenalidomide||3
1093665|NCT01057121|2648463|P5|STARTED|Phase I: 10 mg/Day Lenalidomide||0
1093666|NCT01057121|2648464|P4|STARTED|Phase I: 10 mg/Day Lenalidomide||0
1093667|NCT01057121|2648465|P3|STARTED|Phase I: 10 mg/Day Lenalidomide||0
1093668|NCT01057121|2648466|P2|STARTED|Phase I: 10 mg/Day Lenalidomide||0
1093669|NCT01057121|2648467|P1|STARTED|Phase I: 10 mg/Day Lenalidomide||3
1093670|NCT01057225|2648496|P6|NOT COMPLETED|Overall Study||0
1093671|NCT01057225|2648497|P5|NOT COMPLETED|Overall Study||0
1093672|NCT01057225|2648498|P4|NOT COMPLETED|Overall Study||0
1093673|NCT01057225|2648499|P3|NOT COMPLETED|Overall Study||0
1093674|NCT01057225|2648500|P2|NOT COMPLETED|Overall Study||0
1093675|NCT01057225|2648501|P1|NOT COMPLETED|Overall Study||0
1093676|NCT01057225|2648496|P6|COMPLETED|Overall Study||23
1093677|NCT01057225|2648497|P5|COMPLETED|Overall Study||22
1093678|NCT01057225|2648498|P4|COMPLETED|Overall Study||7
1093679|NCT01057225|2648499|P3|COMPLETED|Overall Study||6
1093680|NCT01057225|2648500|P2|COMPLETED|Overall Study||3
1093681|NCT01057225|2648501|P1|COMPLETED|Overall Study||3
1093682|NCT01057225|2648496|P6|STARTED|Overall Study||23
1093683|NCT01057225|2648497|P5|STARTED|Overall Study||22
1093684|NCT01057225|2648498|P4|STARTED|Overall Study||7
1093685|NCT01057225|2648499|P3|STARTED|Overall Study||6
1093686|NCT01057225|2648500|P2|STARTED|Overall Study||3
1093687|NCT01057225|2648501|P1|STARTED|Overall Study||3
1093688|NCT01057251|2648523|P2|NOT COMPLETED|Overall Study||29
1093689|NCT01057251|2648524|P1|NOT COMPLETED|Overall Study||28
1093690|NCT01057251|2648523|P2|COMPLETED|Overall Study||114
1093691|NCT01057251|2648524|P1|COMPLETED|Overall Study||262
1093692|NCT01057251|2648523|P2|STARTED|Overall Study|The safety population is 142, as one patient was randomized, but never received study drug.|143
1093693|NCT01057251|2648524|P1|STARTED|Overall Study||290
1093694|NCT01057277|2648532|P1|NOT COMPLETED|Overall Study||0
1093695|NCT01057277|2648532|P1|COMPLETED|Overall Study||3
1093696|NCT01057277|2648532|P1|STARTED|Overall Study||3
1093697|NCT01057394|2648536|P2|NOT COMPLETED|Overall Study||2
1093698|NCT01057394|2648537|P1|NOT COMPLETED|Overall Study||0
1093699|NCT01057394|2648536|P2|COMPLETED|Overall Study|19 treated participants|19
1093700|NCT01057394|2648537|P1|COMPLETED|Overall Study||0
1093701|NCT01057394|2648536|P2|STARTED|Overall Study|21 enrolled participants|21
1093702|NCT01057394|2648537|P1|STARTED|Overall Study||0
1093703|NCT01057433|2648541|P1|NOT COMPLETED|Overall Study||1
1093704|NCT01057433|2648541|P1|COMPLETED|Overall Study||23
1093705|NCT01057433|2648541|P1|STARTED|Overall Study||24
1093706|NCT01057589|2648545|P1|NOT COMPLETED|Overall Study||66
1093707|NCT01057589|2648545|P1|COMPLETED|Overall Study||0
1093708|NCT01057589|2648545|P1|STARTED|Overall Study||66
1093709|NCT01057693|2648554|P3|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||36
1093710|NCT01057693|2648555|P2|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||22
1093711|NCT01057693|2648556|P1|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
1093712|NCT01057693|2648554|P3|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||113
1093713|NCT01057693|2648555|P2|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||125
1093714|NCT01057693|2648556|P1|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
1093715|NCT01057693|2648554|P3|Treated|Double-Blind Phase (Week 7 to Week 19)||147
1093716|NCT01057693|2648555|P2|Treated|Double-Blind Phase (Week 7 to Week 19)||147
1093717|NCT01057693|2648556|P1|Treated|Double-Blind Phase (Week 7 to Week 19)||0
1093718|NCT01057693|2648554|P3|STARTED|Double-Blind Phase (Week 7 to Week 19)||149
1093719|NCT01057693|2648555|P2|STARTED|Double-Blind Phase (Week 7 to Week 19)||147
1093720|NCT01057693|2648556|P1|STARTED|Double-Blind Phase (Week 7 to Week 19)||0
1093721|NCT01057693|2648554|P3|NOT COMPLETED|Between Single-Blind and Double-Blind||0
1093722|NCT01057693|2648555|P2|NOT COMPLETED|Between Single-Blind and Double-Blind||0
1093723|NCT01057693|2648556|P1|NOT COMPLETED|Between Single-Blind and Double-Blind||270
1093724|NCT01057693|2648554|P3|COMPLETED|Between Single-Blind and Double-Blind||0
1093725|NCT01057693|2648555|P2|COMPLETED|Between Single-Blind and Double-Blind||0
1093726|NCT01057693|2648556|P1|COMPLETED|Between Single-Blind and Double-Blind||296
1093727|NCT01057693|2648554|P3|STARTED|Between Single-Blind and Double-Blind||0
1093728|NCT01057693|2648555|P2|STARTED|Between Single-Blind and Double-Blind||0
1093729|NCT01057693|2648556|P1|STARTED|Between Single-Blind and Double-Blind||566
1093730|NCT01057693|2648554|P3|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
1093731|NCT01057693|2648555|P2|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
1093732|NCT01057693|2648556|P1|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||99
1093733|NCT01057693|2648554|P3|COMPLETED|Single-Blind Phase (Up to Week 6)||0
1093734|NCT01057693|2648555|P2|COMPLETED|Single-Blind Phase (Up to Week 6)||0
1093735|NCT01057693|2648556|P1|COMPLETED|Single-Blind Phase (Up to Week 6)||566
1093736|NCT01057693|2648554|P3|STARTED|Single-Blind Phase (Up to Week 6)||0
1093737|NCT01057693|2648555|P2|STARTED|Single-Blind Phase (Up to Week 6)||0
1093738|NCT01057693|2648556|P1|STARTED|Single-Blind Phase (Up to Week 6)||665
1093739|NCT01057810|2648604|P2|NOT COMPLETED|Overall Study||398
1093740|NCT01057810|2648605|P1|NOT COMPLETED|Overall Study||198
1093741|NCT01057810|2648604|P2|COMPLETED|Overall Study||1
1093742|NCT01057810|2648605|P1|COMPLETED|Overall Study||1
1093743|NCT01057810|2648604|P2|STARTED|Overall Study||399
1093744|NCT01057810|2648605|P1|STARTED|Overall Study||199
1093751|NCT01057888|2648635|P3|NOT COMPLETED|Overall Study||0
1093752|NCT01057888|2648636|P2|NOT COMPLETED|Overall Study||0
1093753|NCT01057888|2648637|P1|NOT COMPLETED|Overall Study||0
1093754|NCT01057888|2648635|P3|COMPLETED|Overall Study||2494
1093755|NCT01057888|2648636|P2|COMPLETED|Overall Study||2406
1093756|NCT01057888|2648637|P1|COMPLETED|Overall Study||2504
1093757|NCT01057888|2648635|P3|STARTED|Overall Study||2494
1093758|NCT01057888|2648636|P2|STARTED|Overall Study||2406
1093759|NCT01057888|2648637|P1|STARTED|Overall Study||2504
1093760|NCT01057901|2648648|P2|NOT COMPLETED|Overall Study||246
1093761|NCT01057901|2648649|P1|NOT COMPLETED|Overall Study||260
1093762|NCT01057901|2648648|P2|COMPLETED|Overall Study||126
1093763|NCT01057901|2648649|P1|COMPLETED|Overall Study||116
1093764|NCT01057901|2648648|P2|STARTED|Overall Study||372
1093765|NCT01057901|2648649|P1|STARTED|Overall Study||376
1093766|NCT01058005|2648660|P3|NOT COMPLETED|Overall Study||20
1093767|NCT01058005|2648661|P2|NOT COMPLETED|Overall Study||25
1093768|NCT01058005|2648662|P1|NOT COMPLETED|Overall Study||38
1093769|NCT01058005|2648660|P3|COMPLETED|Overall Study||1
1093770|NCT01058005|2648661|P2|COMPLETED|Overall Study||0
1093771|NCT01058005|2648662|P1|COMPLETED|Overall Study||0
1093772|NCT01058005|2648660|P3|Dosed With Study Treatment|Overall Study||17
1093773|NCT01058005|2648661|P2|Dosed With Study Treatment|Overall Study||22
1093774|NCT01058005|2648662|P1|Dosed With Study Treatment|Overall Study||36
1093775|NCT01058005|2648660|P3|STARTED|Overall Study||21
1093776|NCT01058005|2648661|P2|STARTED|Overall Study||25
1093777|NCT01058005|2648662|P1|STARTED|Overall Study||38
1093778|NCT01058070|2648670|P1|NOT COMPLETED|Overall Study||11
1093779|NCT01058070|2648670|P1|COMPLETED|Overall Study||33
1093780|NCT01058070|2648670|P1|STARTED|Overall Study||44
1093781|NCT01058096|2648677|P2|NOT COMPLETED|Safety Follow-up||4
1093782|NCT01058096|2648678|P1|NOT COMPLETED|Safety Follow-up||4
1093783|NCT01058096|2648677|P2|COMPLETED|Safety Follow-up||130
1093784|NCT01058096|2648678|P1|COMPLETED|Safety Follow-up||129
1093785|NCT01058096|2648677|P2|STARTED|Safety Follow-up||134
1093786|NCT01058096|2648678|P1|STARTED|Safety Follow-up|Not all participants continued to Safety Follow-up.|133
1093787|NCT01058096|2648677|P2|NOT COMPLETED|Double-blind Treatment Phase||50
1093788|NCT01058096|2648678|P1|NOT COMPLETED|Double-blind Treatment Phase||48
1093789|NCT01058096|2648677|P2|COMPLETED|Double-blind Treatment Phase||108
1093790|NCT01058096|2648678|P1|COMPLETED|Double-blind Treatment Phase||106
1093791|NCT01058096|2648677|P2|STARTED|Double-blind Treatment Phase||158
1093792|NCT01058096|2648678|P1|STARTED|Double-blind Treatment Phase||154
1093793|NCT01051557|2648693|P7|NOT COMPLETED|Overall Study||6
1093794|NCT01051557|2648694|P6|NOT COMPLETED|Overall Study||6
1093795|NCT01051557|2648695|P5|NOT COMPLETED|Overall Study||7
1093796|NCT01051557|2648696|P4|NOT COMPLETED|Overall Study||3
1093797|NCT01051557|2648697|P3|NOT COMPLETED|Overall Study||6
1093798|NCT01051557|2648698|P2|NOT COMPLETED|Overall Study||3
1093799|NCT01051557|2648699|P1|NOT COMPLETED|Overall Study||4
1093800|NCT01051557|2648693|P7|COMPLETED|Overall Study||0
1093801|NCT01051557|2648694|P6|COMPLETED|Overall Study||0
1093802|NCT01051557|2648695|P5|COMPLETED|Overall Study||1
1093803|NCT01051557|2648696|P4|COMPLETED|Overall Study||0
1093804|NCT01051557|2648697|P3|COMPLETED|Overall Study||0
1093805|NCT01051557|2648698|P2|COMPLETED|Overall Study||0
1093806|NCT01051557|2648699|P1|COMPLETED|Overall Study||0
1093807|NCT01051557|2648693|P7|STARTED|Overall Study||6
1093808|NCT01051557|2648694|P6|STARTED|Overall Study||6
1093809|NCT01051557|2648695|P5|STARTED|Overall Study||8
1093810|NCT01051557|2648696|P4|STARTED|Overall Study||3
1093811|NCT01051557|2648697|P3|STARTED|Overall Study||6
1093812|NCT01051557|2648698|P2|STARTED|Overall Study||3
1093813|NCT01051557|2648699|P1|STARTED|Overall Study||4
1093814|NCT01051570|2648709|P1|NOT COMPLETED|Overall Study||0
1093815|NCT01051570|2648709|P1|COMPLETED|Overall Study||26
1093816|NCT01051570|2648709|P1|STARTED|Overall Study||26
1093817|NCT01051739|2648715|P2|NOT COMPLETED|Overall Study||13
1093818|NCT01051739|2648716|P1|NOT COMPLETED|Overall Study||28
1093819|NCT01051739|2648715|P2|COMPLETED|Overall Study||47
1093820|NCT01051739|2648716|P1|COMPLETED|Overall Study||92
1093821|NCT01051739|2648715|P2|STARTED|Overall Study||60
1093822|NCT01051739|2648716|P1|STARTED|Overall Study||120
1093823|NCT01051778|2648724|P2|NOT COMPLETED|Overall Study||0
1093824|NCT01051778|2648725|P1|NOT COMPLETED|Overall Study||0
1093825|NCT01051778|2648724|P2|COMPLETED|Overall Study|November 2009|30
1093826|NCT01051778|2648725|P1|COMPLETED|Overall Study|November 2009|30
1093827|NCT01051778|2648724|P2|STARTED|Overall Study|June 2006|30
1093828|NCT01051778|2648725|P1|STARTED|Overall Study|June 2006|30
1093829|NCT01051817|2648733|P2|NOT COMPLETED|Overall Study||9
1093830|NCT01051817|2648734|P1|NOT COMPLETED|Overall Study||3
1093831|NCT01051817|2648733|P2|COMPLETED|Overall Study||26
1093832|NCT01051817|2648734|P1|COMPLETED|Overall Study||35
1093833|NCT01051817|2648733|P2|STARTED|Overall Study||35
1093834|NCT01051817|2648734|P1|STARTED|Overall Study||38
1093835|NCT01051856|2648746|P2|NOT COMPLETED|Overall Study||0
1093836|NCT01051856|2648747|P1|NOT COMPLETED|Overall Study||1
1093837|NCT01051856|2648746|P2|COMPLETED|Overall Study||35
1093838|NCT01051856|2648747|P1|COMPLETED|Overall Study||32
1093839|NCT01051856|2648746|P2|STARTED|Overall Study||35
1093840|NCT01051856|2648747|P1|STARTED|Overall Study||33
1093841|NCT01051921|2648755|P1|NOT COMPLETED|Overall Study||30
1093842|NCT01051921|2648755|P1|COMPLETED|Overall Study||37
1093843|NCT01051921|2648755|P1|STARTED|Overall Study||67
1093844|NCT01051986|2648762|P2|NOT COMPLETED|Overall Study||4
1093845|NCT01051986|2648763|P1|NOT COMPLETED|Overall Study||5
1093846|NCT01051986|2648762|P2|COMPLETED|Overall Study||108
1093847|NCT01051986|2648763|P1|COMPLETED|Overall Study||107
1093848|NCT01051986|2648762|P2|STARTED|Overall Study||112
1093849|NCT01051986|2648763|P1|STARTED|Overall Study||112
1093850|NCT01052038|2648780|P3|NOT COMPLETED|Overall Study||4
1093851|NCT01052038|2648781|P2|NOT COMPLETED|Overall Study||6
1093852|NCT01052038|2648782|P1|NOT COMPLETED|Overall Study||4
1093853|NCT01052038|2648780|P3|COMPLETED|Overall Study||36
1093854|NCT01052038|2648781|P2|COMPLETED|Overall Study||34
1093855|NCT01052038|2648782|P1|COMPLETED|Overall Study||36
1093856|NCT01052038|2648780|P3|STARTED|Overall Study||40
1093857|NCT01052038|2648781|P2|STARTED|Overall Study||40
1093858|NCT01052038|2648782|P1|STARTED|Overall Study||40
1093859|NCT01052077|2648804|P4|NOT COMPLETED|Phase A+||21
1093860|NCT01052077|2648805|P3|NOT COMPLETED|Phase A+||0
1093861|NCT01052077|2648806|P2|NOT COMPLETED|Phase A+||0
1093862|NCT01052077|2648807|P1|NOT COMPLETED|Phase A+||0
1093863|NCT01052077|2648804|P4|COMPLETED|Phase A+||230
1093864|NCT01052077|2648805|P3|COMPLETED|Phase A+||0
1093865|NCT01052077|2648806|P2|COMPLETED|Phase A+||0
1093866|NCT01052077|2648807|P1|COMPLETED|Phase A+||0
1093867|NCT01052077|2648804|P4|STARTED|Phase A+||251
1093868|NCT01052077|2648805|P3|STARTED|Phase A+||0
1093869|NCT01052077|2648806|P2|STARTED|Phase A+||0
1093870|NCT01052077|2648807|P1|STARTED|Phase A+||0
1093871|NCT01052077|2648804|P4|NOT COMPLETED|Phase B||0
1093872|NCT01052077|2648805|P3|NOT COMPLETED|Phase B||16
1093873|NCT01052077|2648806|P2|NOT COMPLETED|Phase B||18
1093874|NCT01052077|2648807|P1|NOT COMPLETED|Phase B||0
1093875|NCT01052077|2648804|P4|COMPLETED|Phase B||0
1093876|NCT01052077|2648805|P3|COMPLETED|Phase B||171
1093877|NCT01052077|2648806|P2|COMPLETED|Phase B||167
1093878|NCT01052077|2648807|P1|COMPLETED|Phase B||0
1093879|NCT01052077|2648804|P4|STARTED|Phase B||0
1093880|NCT01052077|2648805|P3|STARTED|Phase B||187
1093881|NCT01052077|2648806|P2|STARTED|Phase B||185
1093882|NCT01052077|2648807|P1|STARTED|Phase B||0
1093883|NCT01052077|2648804|P4|NOT COMPLETED|Phase A||0
1093884|NCT01052077|2648805|P3|NOT COMPLETED|Phase A||0
1093885|NCT01052077|2648806|P2|NOT COMPLETED|Phase A||0
1093886|NCT01052077|2648807|P1|NOT COMPLETED|Phase A||146
1093887|NCT01052077|2648804|P4|COMPLETED|Phase A||0
1093888|NCT01052077|2648805|P3|COMPLETED|Phase A||0
1093889|NCT01052077|2648806|P2|COMPLETED|Phase A||0
1093890|NCT01052077|2648807|P1|COMPLETED|Phase A||623
1093891|NCT01052077|2648804|P4|STARTED|Phase A||0
1093892|NCT01052077|2648805|P3|STARTED|Phase A||0
1093893|NCT01052077|2648806|P2|STARTED|Phase A||0
1093894|NCT01052077|2648807|P1|STARTED|Phase A||769
1093895|NCT01058265|2648833|P2|NOT COMPLETED|Overall Study||12
1093896|NCT01058265|2648834|P1|NOT COMPLETED|Overall Study||11
1093897|NCT01058265|2648833|P2|COMPLETED|Overall Study||13
1093898|NCT01058265|2648834|P1|COMPLETED|Overall Study||11
1093899|NCT01058265|2648833|P2|STARTED|Overall Study||25
1093900|NCT01058265|2648834|P1|STARTED|Overall Study||22
1093901|NCT01058304|2648844|P2|NOT COMPLETED|Overall Study||33
1093902|NCT01058304|2648845|P1|NOT COMPLETED|Overall Study||27
1093903|NCT01058304|2648844|P2|COMPLETED|Overall Study||128
1093904|NCT01058304|2648845|P1|COMPLETED|Overall Study||132
1093905|NCT01058304|2648844|P2|STARTED|Overall Study||161
1093906|NCT01058304|2648845|P1|STARTED|Overall Study||159
1093907|NCT01058356|2648853|P1|NOT COMPLETED|Overall Study||42
1093908|NCT01058356|2648853|P1|COMPLETED|Overall Study||172
1093909|NCT01058356|2648853|P1|STARTED|Overall Study||214
1093910|NCT01058421|2648860|P2|NOT COMPLETED|6 Month Outcomes||26
1093911|NCT01058421|2648861|P1|NOT COMPLETED|6 Month Outcomes||19
1093912|NCT01058421|2648860|P2|COMPLETED|6 Month Outcomes||24
1093913|NCT01058421|2648861|P1|COMPLETED|6 Month Outcomes||27
1093914|NCT01058421|2648860|P2|STARTED|6 Month Outcomes|61 (subjects started Period 1) minus 11 (deceased subjects in Periods 1 & 2) = 50 started Period 3.|50
1093915|NCT01058421|2648861|P1|STARTED|6 Month Outcomes|55 (subjects started Period 1) minus 13 (deceased subjects in Periods 1 & 2) = 46 started Period 3.|46
1093916|NCT01058421|2648860|P2|NOT COMPLETED|3 Month Outcomes||26
1093917|NCT01058421|2648861|P1|NOT COMPLETED|3 Month Outcomes||20
1093918|NCT01058421|2648860|P2|COMPLETED|3 Month Outcomes||29
1093919|NCT01058421|2648861|P1|COMPLETED|3 Month Outcomes||29
1093920|NCT01058421|2648860|P2|STARTED|3 Month Outcomes|61 (Subjects started Period 1) minus 6 (deceased subjects during Period 1) = 55 started Period 2.|55
1093921|NCT01058421|2648861|P1|STARTED|3 Month Outcomes|59 (Subjects started Period 1) minus 10 (deceased subjects during Period 1) = 49 started Period 2.|49
1093922|NCT01058421|2648860|P2|NOT COMPLETED|1 Month Outcomes||42
1093923|NCT01058421|2648861|P1|NOT COMPLETED|1 Month Outcomes||39
1093924|NCT01058421|2648860|P2|COMPLETED|1 Month Outcomes||19
1093925|NCT01058421|2648861|P1|COMPLETED|1 Month Outcomes||20
1093926|NCT01058421|2648860|P2|STARTED|1 Month Outcomes||61
1093927|NCT01058421|2648861|P1|STARTED|1 Month Outcomes||59
1093928|NCT01060072|2648885|P2|NOT COMPLETED|Overall Study||5
1093929|NCT01060072|2648886|P1|NOT COMPLETED|Overall Study||2
1093930|NCT01060072|2648885|P2|COMPLETED|Overall Study||196
1093931|NCT01060072|2648886|P1|COMPLETED|Overall Study||204
1093932|NCT01060072|2648885|P2|STARTED|Overall Study||201
1093933|NCT01060072|2648886|P1|STARTED|Overall Study||206
1093934|NCT01060111|2648903|P3|NOT COMPLETED|Overall Study||35
1093935|NCT01060111|2648904|P2|NOT COMPLETED|Overall Study||23
1093936|NCT01060111|2648905|P1|NOT COMPLETED|Overall Study||27
1093937|NCT01060111|2648903|P3|COMPLETED|Overall Study||45
1093938|NCT01060111|2648904|P2|COMPLETED|Overall Study||61
1093939|NCT01060111|2648905|P1|COMPLETED|Overall Study||54
1093940|NCT01060111|2648903|P3|Treated|Overall Study||79
1093941|NCT01060111|2648904|P2|Treated|Overall Study||83
1093942|NCT01060111|2648905|P1|Treated|Overall Study||81
1093943|NCT01060111|2648903|P3|STARTED|Overall Study||80
1093944|NCT01060111|2648904|P2|STARTED|Overall Study||84
1093945|NCT01060111|2648905|P1|STARTED|Overall Study||81
1093946|NCT01060124|2648922|P1|NOT COMPLETED|Overall Study||37
1093947|NCT01060124|2648922|P1|COMPLETED|Overall Study||66
1093948|NCT01060124|2648922|P1|STARTED|Overall Study||103
1093949|NCT01060150|2648930|P1|NOT COMPLETED|Overall Study||23
1093950|NCT01060150|2648930|P1|COMPLETED|Overall Study||92
1093951|NCT01060150|2648930|P1|Treated|Overall Study||113
1093952|NCT01060150|2648930|P1|STARTED|Overall Study||115
1093953|NCT01060540|2648947|P2|NOT COMPLETED|Overall Study||65
1093954|NCT01060540|2648948|P1|NOT COMPLETED|Overall Study||64
1093955|NCT01060540|2648947|P2|COMPLETED|Overall Study||233
1093956|NCT01060540|2648948|P1|COMPLETED|Overall Study||239
1093957|NCT01060540|2648947|P2|STARTED|Overall Study||298
1093958|NCT01060540|2648948|P1|STARTED|Overall Study||303
1093959|NCT01060553|2648962|P2|NOT COMPLETED|Overall Study||10
1093960|NCT01060553|2648963|P1|NOT COMPLETED|Overall Study||9
1093961|NCT01060553|2648962|P2|COMPLETED|Overall Study||5
1093962|NCT01060553|2648963|P1|COMPLETED|Overall Study|5 subjects completed more than half the sessions and midpoint outcome measures were obtained|6
1093963|NCT01060553|2648962|P2|STARTED|Overall Study||15
1093964|NCT01060553|2648963|P1|STARTED|Overall Study||15
1093965|NCT01060592|2648970|P2|NOT COMPLETED|12m||18
1093966|NCT01060592|2648971|P1|NOT COMPLETED|12m||0
1093967|NCT01060592|2648970|P2|COMPLETED|12m|Historic data was not available at 12m for 18 of the historic controls|31
1093968|NCT01060592|2648971|P1|COMPLETED|12m||35
1093969|NCT01060592|2648970|P2|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|49
1093970|NCT01060592|2648971|P1|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|35
1093971|NCT01060592|2648970|P2|NOT COMPLETED|4-6w||10
1093972|NCT01060592|2648971|P1|NOT COMPLETED|4-6w||12
1093973|NCT01060592|2648970|P2|COMPLETED|4-6w||39
1093974|NCT01060592|2648971|P1|COMPLETED|4-6w||23
1093975|NCT01060592|2648970|P2|STARTED|4-6w||49
1093976|NCT01060592|2648971|P1|STARTED|4-6w||35
1093977|NCT01060670|2648987|P2|NOT COMPLETED|Follow up Phase||35
1093978|NCT01060670|2648988|P1|NOT COMPLETED|Follow up Phase||22
1093979|NCT01060670|2648987|P2|COMPLETED|Follow up Phase||82
1093980|NCT01060670|2648988|P1|COMPLETED|Follow up Phase||106
1093981|NCT01060670|2648987|P2|Withdrew From Follow up Phase|Follow up Phase||35
1093982|NCT01060670|2648988|P1|Withdrew From Follow up Phase|Follow up Phase||22
1093983|NCT01060670|2648987|P2|Recurrence|Follow up Phase||9
1093984|NCT01060670|2648988|P1|Recurrence|Follow up Phase||14
1093985|NCT01060670|2648987|P2|STARTED|Follow up Phase||117
1093986|NCT01060670|2648988|P1|STARTED|Follow up Phase||128
1093987|NCT01060670|2648987|P2|NOT COMPLETED|Treatment Phase||36
1093988|NCT01060670|2648988|P1|NOT COMPLETED|Treatment Phase||26
1093989|NCT01060670|2648987|P2|COMPLETED|Treatment Phase||117
1093990|NCT01060670|2648988|P1|COMPLETED|Treatment Phase||128
1093991|NCT01060670|2648987|P2|Withdrew From Treatment|Treatment Phase||36
1093992|NCT01060670|2648988|P1|Withdrew From Treatment|Treatment Phase||26
1093993|NCT01060670|2648987|P2|Did Not Heal by Treatment Visit 17|Treatment Phase||68
1093994|NCT01060670|2648988|P1|Did Not Heal by Treatment Visit 17|Treatment Phase||49
1093995|NCT01060670|2648987|P2|Healed at End of Treatment Phase|Treatment Phase||49
1093996|NCT01060670|2648988|P1|Healed at End of Treatment Phase|Treatment Phase||79
1093997|NCT01060670|2648987|P2|STARTED|Treatment Phase||153
1093998|NCT01060670|2648988|P1|STARTED|Treatment Phase||154
1093999|NCT01060670|2648987|P2|NOT COMPLETED|Run In||238
1094000|NCT01060670|2648988|P1|NOT COMPLETED|Run In||0
1094001|NCT01060670|2648987|P2|COMPLETED|Run In||307
1094002|NCT01060670|2648988|P1|COMPLETED|Run In||0
1094003|NCT01060670|2648987|P2|STARTED|Run In||545
1094004|NCT01060670|2648988|P1|STARTED|Run In||0
1094005|NCT01061008|2649008|P2|NOT COMPLETED|Overall Study||6
1094006|NCT01061008|2649009|P1|NOT COMPLETED|Overall Study||6
1094007|NCT01061008|2649008|P2|COMPLETED|Overall Study||9
1094008|NCT01061008|2649009|P1|COMPLETED|Overall Study||10
1094009|NCT01061008|2649008|P2|STARTED|Overall Study||15
1094010|NCT01061008|2649009|P1|STARTED|Overall Study||16
1094011|NCT01061034|2649015|P1|NOT COMPLETED|Aspirin Plus Omeprazole||0
1094012|NCT01061034|2649015|P1|COMPLETED|Aspirin Plus Omeprazole||9
1094013|NCT01061034|2649015|P1|STARTED|Aspirin Plus Omeprazole||9
1094014|NCT01061034|2649015|P1|NOT COMPLETED|Aspirin||0
1094015|NCT01061034|2649015|P1|COMPLETED|Aspirin||9
1094016|NCT01061034|2649015|P1|STARTED|Aspirin||9
1094017|NCT01061177|2649020|P1|NOT COMPLETED|Overall Study||208
1094018|NCT01061177|2649020|P1|COMPLETED|Overall Study||881
1094019|NCT01061177|2649020|P1|ITT_CyR (Ph+ Patients Only)|Overall Study||983
1094020|NCT01061177|2649020|P1|ITT_MR (b2a2 &/or b3a2 +ve Pts Only)|Overall Study||1056
1094021|NCT01061177|2649020|P1|STARTED|Overall Study||1089
1094022|NCT01061333|2649039|P2|NOT COMPLETED|Period 7: Mometasone||0
1094023|NCT01061333|2649040|P1|NOT COMPLETED|Period 7: Mometasone||0
1094024|NCT01061333|2649039|P2|COMPLETED|Period 7: Mometasone||7
1094025|NCT01061333|2649040|P1|COMPLETED|Period 7: Mometasone||8
1094026|NCT01061333|2649039|P2|STARTED|Period 7: Mometasone||7
1094027|NCT01061333|2649040|P1|STARTED|Period 7: Mometasone||8
1094028|NCT01061333|2649039|P2|NOT COMPLETED|Period 6: 20-day Washout||0
1094029|NCT01061333|2649040|P1|NOT COMPLETED|Period 6: 20-day Washout||0
1094030|NCT01061333|2649039|P2|COMPLETED|Period 6: 20-day Washout||7
1094031|NCT01061333|2649040|P1|COMPLETED|Period 6: 20-day Washout||8
1094032|NCT01061333|2649039|P2|STARTED|Period 6: 20-day Washout||7
1094033|NCT01061333|2649040|P1|STARTED|Period 6: 20-day Washout||8
1094034|NCT01061333|2649039|P2|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
1094035|NCT01061333|2649040|P1|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
1094036|NCT01061333|2649039|P2|COMPLETED|Period 5: Nedocromil-Montelukast X-over||7
1094037|NCT01061333|2649040|P1|COMPLETED|Period 5: Nedocromil-Montelukast X-over||8
1094038|NCT01061333|2649039|P2|STARTED|Period 5: Nedocromil-Montelukast X-over||7
1094039|NCT01061333|2649040|P1|STARTED|Period 5: Nedocromil-Montelukast X-over||8
1094040|NCT01061333|2649039|P2|NOT COMPLETED|Period 4: 20-day Washout||1
1094041|NCT01061333|2649040|P1|NOT COMPLETED|Period 4: 20-day Washout||0
1094042|NCT01061333|2649039|P2|COMPLETED|Period 4: 20-day Washout||7
1094043|NCT01061333|2649040|P1|COMPLETED|Period 4: 20-day Washout||8
1094044|NCT01061333|2649039|P2|STARTED|Period 4: 20-day Washout||8
1094045|NCT01061333|2649040|P1|STARTED|Period 4: 20-day Washout||8
1094046|NCT01061333|2649039|P2|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
1094047|NCT01061333|2649040|P1|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
1094048|NCT01061333|2649039|P2|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
1094049|NCT01061333|2649040|P1|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
1094050|NCT01061333|2649039|P2|STARTED|Period 3: Nedocromil-Montelukast X-over||8
1094051|NCT01061333|2649040|P1|STARTED|Period 3: Nedocromil-Montelukast X-over||8
1094052|NCT01061333|2649039|P2|NOT COMPLETED|Period 2: 20-day Washout||0
1094053|NCT01061333|2649040|P1|NOT COMPLETED|Period 2: 20-day Washout||0
1094054|NCT01061333|2649039|P2|COMPLETED|Period 2: 20-day Washout||8
1094055|NCT01061333|2649040|P1|COMPLETED|Period 2: 20-day Washout||8
1094056|NCT01061333|2649039|P2|STARTED|Period 2: 20-day Washout||8
1094057|NCT01061333|2649040|P1|STARTED|Period 2: 20-day Washout||8
1094058|NCT01061333|2649039|P2|NOT COMPLETED|Period 1: Placebo Run-in||0
1094059|NCT01061333|2649040|P1|NOT COMPLETED|Period 1: Placebo Run-in||0
1094060|NCT01061333|2649039|P2|COMPLETED|Period 1: Placebo Run-in||8
1094061|NCT01061333|2649040|P1|COMPLETED|Period 1: Placebo Run-in||8
1094062|NCT01061333|2649039|P2|STARTED|Period 1: Placebo Run-in||8
1094063|NCT01061333|2649040|P1|STARTED|Period 1: Placebo Run-in||8
1094064|NCT01061359|2649078|P1|NOT COMPLETED|Overall Study||1302
1094065|NCT01061359|2649078|P1|COMPLETED|Overall Study|Completed 5 years of follow-up: 668 Disease free and 2 Relapsed|670
1094066|NCT01061359|2649078|P1|STARTED|Overall Study||1972
1094067|NCT01061385|2649086|P2|NOT COMPLETED|Overall Study||1
1094068|NCT01061385|2649087|P1|NOT COMPLETED|Overall Study||1
1094069|NCT01061385|2649086|P2|COMPLETED|Overall Study||8
1094070|NCT01061385|2649087|P1|COMPLETED|Overall Study||20
1094071|NCT01061385|2649086|P2|STARTED|Overall Study||9
1094072|NCT01061385|2649087|P1|STARTED|Overall Study||21
1094073|NCT01061476|2649095|P1|NOT COMPLETED|Overall Study||0
1094074|NCT01061476|2649095|P1|COMPLETED|Overall Study||12
1094075|NCT01061476|2649095|P1|STARTED|Overall Study||12
1094076|NCT01061567|2649099|P1|NOT COMPLETED|Overall Study||76
1094077|NCT01061567|2649099|P1|COMPLETED|Overall Study||1738
1094078|NCT01061567|2649099|P1|STARTED|Overall Study||1814
1094079|NCT01061606|2649108|P1|NOT COMPLETED|Overall Study||8
1094080|NCT01061606|2649108|P1|COMPLETED|Overall Study||0
1094081|NCT01061606|2649108|P1|STARTED|Overall Study||8
1094088|NCT01061710|2649132|P1|NOT COMPLETED|Overall Study||14
1094089|NCT01061710|2649132|P1|COMPLETED|Overall Study||6
1094090|NCT01061710|2649132|P1|STARTED|Overall Study||20
1094091|NCT01061723|2649146|P6|NOT COMPLETED|Overall Study||9
1094092|NCT01061723|2649147|P5|NOT COMPLETED|Overall Study||3
1094093|NCT01061723|2649148|P4|NOT COMPLETED|Overall Study||8
1094094|NCT01061723|2649149|P3|NOT COMPLETED|Overall Study||10
1094095|NCT01061723|2649150|P2|NOT COMPLETED|Overall Study||6
1094096|NCT01061723|2649151|P1|NOT COMPLETED|Overall Study||4
1094097|NCT01061723|2649146|P6|COMPLETED|Overall Study||41
1094098|NCT01061723|2649147|P5|COMPLETED|Overall Study||47
1094099|NCT01061723|2649148|P4|COMPLETED|Overall Study||44
1094100|NCT01061723|2649149|P3|COMPLETED|Overall Study||40
1094101|NCT01061723|2649150|P2|COMPLETED|Overall Study||43
1094102|NCT01061723|2649151|P1|COMPLETED|Overall Study||46
1094103|NCT01061723|2649146|P6|Treated|Overall Study||49
1094104|NCT01061723|2649147|P5|Treated|Overall Study||50
1094105|NCT01061723|2649148|P4|Treated|Overall Study||52
1094106|NCT01061723|2649149|P3|Treated|Overall Study||50
1094107|NCT01061723|2649150|P2|Treated|Overall Study||49
1094108|NCT01061723|2649151|P1|Treated|Overall Study||50
1094109|NCT01061723|2649146|P6|STARTED|Overall Study||50
1094110|NCT01061723|2649147|P5|STARTED|Overall Study||50
1094111|NCT01061723|2649148|P4|STARTED|Overall Study||52
1094112|NCT01061723|2649149|P3|STARTED|Overall Study||50
1094113|NCT01061723|2649150|P2|STARTED|Overall Study||49
1094114|NCT01061723|2649151|P1|STARTED|Overall Study||50
1094115|NCT01061736|2649241|P10|NOT COMPLETED|Overall Study||74
1094116|NCT01061736|2649242|P9|NOT COMPLETED|Overall Study||97
1094117|NCT01061736|2649243|P8|NOT COMPLETED|Overall Study||94
1094118|NCT01061736|2649244|P7|NOT COMPLETED|Overall Study||84
1094119|NCT01061736|2649245|P6|NOT COMPLETED|Overall Study||3
1094120|NCT01061736|2649246|P5|NOT COMPLETED|Overall Study||7
1094121|NCT01061736|2649247|P4|NOT COMPLETED|Overall Study||3
1094122|NCT01061736|2649248|P3|NOT COMPLETED|Overall Study||6
1094123|NCT01061736|2649249|P2|NOT COMPLETED|Overall Study||4
1094124|NCT01061736|2649250|P1|NOT COMPLETED|Overall Study||13
1094125|NCT01061736|2649241|P10|COMPLETED|Overall Study||354
1094126|NCT01061736|2649242|P9|COMPLETED|Overall Study||330
1094127|NCT01061736|2649243|P8|COMPLETED|Overall Study||336
1094128|NCT01061736|2649244|P7|COMPLETED|Overall Study||0
1094129|NCT01061736|2649245|P6|COMPLETED|Overall Study||49
1094130|NCT01061736|2649246|P5|COMPLETED|Overall Study||45
1094131|NCT01061736|2649247|P4|COMPLETED|Overall Study||48
1094132|NCT01061736|2649248|P3|COMPLETED|Overall Study||45
1094133|NCT01061736|2649249|P2|COMPLETED|Overall Study||46
1094134|NCT01061736|2649250|P1|COMPLETED|Overall Study||37
1094135|NCT01061736|2649241|P10|Rescued|Overall Study|Included both participants who completed and did not complete the study.|168
1094136|NCT01061736|2649242|P9|Rescued|Overall Study|Included both participants who completed and did not complete the study.|55
1094137|NCT01061736|2649243|P8|Rescued|Overall Study|Included both participants who completed and did not complete the study.|61
1094138|NCT01061736|2649244|P7|Rescued|Overall Study||0
1094139|NCT01061736|2649245|P6|Rescued|Overall Study||0
1094140|NCT01061736|2649246|P5|Rescued|Overall Study||0
1094141|NCT01061736|2649247|P4|Rescued|Overall Study||0
1094142|NCT01061736|2649248|P3|Rescued|Overall Study||0
1094143|NCT01061736|2649249|P2|Rescued|Overall Study||0
1094144|NCT01061736|2649250|P1|Rescued|Overall Study||0
1094145|NCT01061736|2649241|P10|Treated|Overall Study||428
1094146|NCT01061736|2649242|P9|Treated|Overall Study||426
1094147|NCT01061736|2649243|P8|Treated|Overall Study||428
1094148|NCT01061736|2649244|P7|Treated|Overall Study||84
1094149|NCT01061736|2649245|P6|Treated|Overall Study||52
1094150|NCT01061736|2649246|P5|Treated|Overall Study||51
1094151|NCT01061736|2649247|P4|Treated|Overall Study||51
1094152|NCT01061736|2649248|P3|Treated|Overall Study||51
1094153|NCT01061736|2649249|P2|Treated|Overall Study||50
1094154|NCT01061736|2649250|P1|Treated|Overall Study||50
1094155|NCT01061736|2649241|P10|STARTED|Overall Study||428
1094156|NCT01061736|2649242|P9|STARTED|Overall Study||427
1094157|NCT01061736|2649243|P8|STARTED|Overall Study||430
1094158|NCT01061736|2649244|P7|STARTED|Overall Study||84
1094159|NCT01061736|2649245|P6|STARTED|Overall Study||52
1094160|NCT01061736|2649246|P5|STARTED|Overall Study||52
1094161|NCT01061736|2649247|P4|STARTED|Overall Study||51
1094162|NCT01061736|2649248|P3|STARTED|Overall Study||51
1094163|NCT01061736|2649249|P2|STARTED|Overall Study||50
1094164|NCT01061736|2649250|P1|STARTED|Overall Study||50
1094165|NCT01061775|2649283|P1|NOT COMPLETED|Overall Study||3
1094166|NCT01061775|2649283|P1|COMPLETED|Overall Study||16
1094167|NCT01061775|2649283|P1|STARTED|Overall Study||19
1094168|NCT01061866|2649290|P1|NOT COMPLETED|Overall Study||2
1094169|NCT01061866|2649290|P1|COMPLETED|Overall Study||5
1094170|NCT01061866|2649290|P1|STARTED|Overall Study||7
1094171|NCT01062061|2649294|P1|NOT COMPLETED|Overall Study||27
1094172|NCT01062061|2649294|P1|COMPLETED|Overall Study||727
1094173|NCT01062061|2649294|P1|STARTED|Overall Study||754
1094174|NCT01062074|2649308|P1|NOT COMPLETED|Overall Study||0
1094175|NCT01062074|2649308|P1|COMPLETED|Overall Study||3605
1094176|NCT01062074|2649308|P1|STARTED|Overall Study||3605
1094177|NCT01062113|2649316|P3|NOT COMPLETED|Overall Study||31
1094178|NCT01062113|2649317|P2|NOT COMPLETED|Overall Study||22
1094179|NCT01062113|2649318|P1|NOT COMPLETED|Overall Study||40
1094180|NCT01062113|2649316|P3|COMPLETED|Overall Study||27
1094181|NCT01062113|2649317|P2|COMPLETED|Overall Study||42
1094182|NCT01062113|2649318|P1|COMPLETED|Overall Study||93
1094183|NCT01062113|2649316|P3|STARTED|Overall Study||58
1094184|NCT01062113|2649317|P2|STARTED|Overall Study||64
1094185|NCT01062113|2649318|P1|STARTED|Overall Study||133
1094186|NCT01062165|2649331|P1|NOT COMPLETED|Overall Study||0
1094187|NCT01062165|2649331|P1|COMPLETED|Overall Study||18
1094188|NCT01062165|2649331|P1|STARTED|Overall Study||18
1094189|NCT01062230|2649335|P1|NOT COMPLETED|Overall Study||0
1094190|NCT01062230|2649335|P1|COMPLETED|Overall Study||6
1094191|NCT01062230|2649335|P1|STARTED|Overall Study||6
1094192|NCT01062256|2649342|P3|NOT COMPLETED|Overall Study||4
1094193|NCT01062256|2649343|P2|NOT COMPLETED|Overall Study||7
1094194|NCT01062256|2649344|P1|NOT COMPLETED|Overall Study||3
1094195|NCT01062256|2649342|P3|COMPLETED|Overall Study||103
1094196|NCT01062256|2649343|P2|COMPLETED|Overall Study||96
1094197|NCT01062256|2649344|P1|COMPLETED|Overall Study||52
1094198|NCT01062256|2649342|P3|STARTED|Overall Study||107
1094199|NCT01062256|2649343|P2|STARTED|Overall Study||103
1094200|NCT01062256|2649344|P1|STARTED|Overall Study||55
1094201|NCT01062269|2649367|P1|NOT COMPLETED|Overall Study||0
1094202|NCT01062269|2649367|P1|COMPLETED|Overall Study||42
1094203|NCT01062269|2649367|P1|STARTED|Overall Study||42
1094204|NCT01062308|2649380|P2|NOT COMPLETED|Overall Study||10
1094205|NCT01062308|2649381|P1|NOT COMPLETED|Overall Study||16
1094206|NCT01062308|2649380|P2|COMPLETED|Overall Study||72
1094207|NCT01062308|2649381|P1|COMPLETED|Overall Study||64
1094208|NCT01062308|2649380|P2|STARTED|Overall Study||82
1094209|NCT01062308|2649381|P1|STARTED|Overall Study||80
1094216|NCT01054976|2649404|P1|NOT COMPLETED|Overall Study||35
1094217|NCT01054976|2649404|P1|COMPLETED|Overall Study||57
1094218|NCT01054976|2649404|P1|STARTED|Overall Study||92
1094219|NCT01055132|2649412|P2|NOT COMPLETED|Period 2 (5-9 Days)||1
1094220|NCT01055132|2649413|P1|NOT COMPLETED|Period 2 (5-9 Days)||0
1094221|NCT01055132|2649412|P2|COMPLETED|Period 2 (5-9 Days)||32
1094222|NCT01055132|2649413|P1|COMPLETED|Period 2 (5-9 Days)||35
1094223|NCT01055132|2649412|P2|STARTED|Period 2 (5-9 Days)||33
1094224|NCT01055132|2649413|P1|STARTED|Period 2 (5-9 Days)||35
1094225|NCT01055132|2649412|P2|NOT COMPLETED|Period 1 (5-9 Days)||0
1094226|NCT01055132|2649413|P1|NOT COMPLETED|Period 1 (5-9 Days)||1
1094227|NCT01055132|2649412|P2|COMPLETED|Period 1 (5-9 Days)||33
1094228|NCT01055132|2649413|P1|COMPLETED|Period 1 (5-9 Days)||35
1094229|NCT01055132|2649412|P2|STARTED|Period 1 (5-9 Days)||33
1094230|NCT01055132|2649413|P1|STARTED|Period 1 (5-9 Days)||36
1094231|NCT01055171|2649426|P2|NOT COMPLETED|Overall Study||7
1094232|NCT01055171|2649427|P1|NOT COMPLETED|Overall Study||11
1094233|NCT01055171|2649426|P2|COMPLETED|Overall Study|Received the sugar pill and completed all visits including the one-week follow-up.|21
1094234|NCT01055171|2649427|P1|COMPLETED|Overall Study|Received the medication and completed all visits including the one-week follow-up.|18
1094235|NCT01055171|2649426|P2|Test Procedure Completion|Overall Study|Received the placebo and completed the first test session.|23
1094236|NCT01055171|2649427|P1|Test Procedure Completion|Overall Study|Received the medication and completed the first test session.|21
1094237|NCT01055171|2649426|P2|Retrieval Completion|Overall Study|Received the sugar pill and completed the retrieval session.|24
1094238|NCT01055171|2649427|P1|Retrieval Completion|Overall Study|Received the medication and completed the retrieval session.|25
1094239|NCT01055171|2649426|P2|STARTED|Overall Study|Randomized to receive placebo.|28
1094240|NCT01055171|2649427|P1|STARTED|Overall Study|Randomized to receive medication.|29
1094241|NCT01055184|2649441|P1|NOT COMPLETED|Overall Study||0
1094242|NCT01055184|2649441|P1|COMPLETED|Overall Study||34
1094243|NCT01055184|2649441|P1|STARTED|Overall Study||34
1094244|NCT01055197|2649447|P2|NOT COMPLETED|Overall Study||2
1094245|NCT01055197|2649448|P1|NOT COMPLETED|Overall Study||9
1094246|NCT01055197|2649447|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
1094247|NCT01055197|2649448|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|42
1094248|NCT01055197|2649447|P2|STARTED|Overall Study||46
1094249|NCT01055197|2649448|P1|STARTED|Overall Study||51
1094250|NCT01055223|2649454|P1|NOT COMPLETED|Overall Study||0
1094251|NCT01055223|2649454|P1|COMPLETED|Overall Study||98483
1094252|NCT01055223|2649454|P1|STARTED|Overall Study||98483
1094253|NCT01055262|2649482|P1|NOT COMPLETED|Overall Study||9
1094254|NCT01055262|2649482|P1|COMPLETED|Overall Study||160
1094255|NCT01055262|2649482|P1|STARTED|Overall Study||169
1094256|NCT01055314|2649495|P2|NOT COMPLETED|Overall Study||38
1094257|NCT01055314|2649496|P1|NOT COMPLETED|Overall Study||45
1094258|NCT01055314|2649495|P2|COMPLETED|Overall Study||37
1094259|NCT01055314|2649496|P1|COMPLETED|Overall Study||55
1094260|NCT01055314|2649495|P2|STARTED|Overall Study||75
1094261|NCT01055314|2649496|P1|STARTED|Overall Study||100
1094262|NCT01055457|2649518|P10|NOT COMPLETED|Overall Study||1
1094263|NCT01055457|2649519|P9|NOT COMPLETED|Overall Study||0
1094264|NCT01055457|2649520|P8|NOT COMPLETED|Overall Study||1
1094265|NCT01055457|2649521|P7|NOT COMPLETED|Overall Study||1
1094266|NCT01055457|2649522|P6|NOT COMPLETED|Overall Study||3
1094267|NCT01055457|2649523|P5|NOT COMPLETED|Overall Study||3
1094268|NCT01055457|2649524|P4|NOT COMPLETED|Overall Study||3
1094269|NCT01055457|2649525|P3|NOT COMPLETED|Overall Study||2
1094270|NCT01055457|2649526|P2|NOT COMPLETED|Overall Study||1
1094271|NCT01055457|2649527|P1|NOT COMPLETED|Overall Study||1
1094272|NCT01055457|2649518|P10|COMPLETED|Overall Study||19
1094273|NCT01055457|2649519|P9|COMPLETED|Overall Study||20
1094274|NCT01055457|2649520|P8|COMPLETED|Overall Study||18
1094275|NCT01055457|2649521|P7|COMPLETED|Overall Study||18
1094276|NCT01055457|2649522|P6|COMPLETED|Overall Study||15
1094277|NCT01055457|2649523|P5|COMPLETED|Overall Study||38
1094278|NCT01055457|2649524|P4|COMPLETED|Overall Study||37
1094279|NCT01055457|2649525|P3|COMPLETED|Overall Study||36
1094280|NCT01055457|2649526|P2|COMPLETED|Overall Study||39
1094281|NCT01055457|2649527|P1|COMPLETED|Overall Study||39
1094282|NCT01055457|2649518|P10|STARTED|Overall Study||20
1094283|NCT01055457|2649519|P9|STARTED|Overall Study||20
1094284|NCT01055457|2649520|P8|STARTED|Overall Study||19
1094285|NCT01055457|2649521|P7|STARTED|Overall Study||19
1094286|NCT01055457|2649522|P6|STARTED|Overall Study||18
1094287|NCT01055457|2649523|P5|STARTED|Overall Study||41
1094288|NCT01055457|2649524|P4|STARTED|Overall Study||40
1094289|NCT01055457|2649525|P3|STARTED|Overall Study||38
1094290|NCT01055457|2649526|P2|STARTED|Overall Study||40
1094291|NCT01055457|2649527|P1|STARTED|Overall Study||40
1094292|NCT01055613|2649561|P2|NOT COMPLETED|Overall Study||4
1094293|NCT01055613|2649562|P1|NOT COMPLETED|Overall Study||9
1094294|NCT01055613|2649561|P2|COMPLETED|Overall Study||96
1094295|NCT01055613|2649562|P1|COMPLETED|Overall Study||191
1094296|NCT01055613|2649561|P2|STARTED|Overall Study||100
1094297|NCT01055613|2649562|P1|STARTED|Overall Study||200
1094298|NCT01055639|2649572|P2|NOT COMPLETED|Overall Study||29
1094299|NCT01055639|2649573|P1|NOT COMPLETED|Overall Study||21
1094300|NCT01055639|2649572|P2|COMPLETED|Overall Study||31
1094301|NCT01055639|2649573|P1|COMPLETED|Overall Study||45
1094302|NCT01055639|2649572|P2|STARTED|Overall Study||60
1094303|NCT01055639|2649573|P1|STARTED|Overall Study||66
1094304|NCT01055704|2649599|P4|NOT COMPLETED|Overall Study||0
1094305|NCT01055704|2649600|P3|NOT COMPLETED|Overall Study||0
1094306|NCT01055704|2649601|P2|NOT COMPLETED|Overall Study||0
1094307|NCT01055704|2649602|P1|NOT COMPLETED|Overall Study||0
1094308|NCT01055704|2649599|P4|COMPLETED|Overall Study||8
1094309|NCT01055704|2649600|P3|COMPLETED|Overall Study||16
1094310|NCT01055704|2649601|P2|COMPLETED|Overall Study||8
1094311|NCT01055704|2649602|P1|COMPLETED|Overall Study||16
1094312|NCT01055704|2649599|P4|STARTED|Overall Study||8
1094313|NCT01055704|2649600|P3|STARTED|Overall Study||16
1094314|NCT01055704|2649601|P2|STARTED|Overall Study||8
1094315|NCT01055704|2649602|P1|STARTED|Overall Study||16
1094316|NCT01062763|2649642|P2|NOT COMPLETED|Overall Study||4
1094317|NCT01062763|2649643|P1|NOT COMPLETED|Overall Study||3
1094318|NCT01062763|2649642|P2|COMPLETED|Overall Study||57
1094319|NCT01062763|2649643|P1|COMPLETED|Overall Study||55
1094320|NCT01062763|2649642|P2|STARTED|Overall Study||61
1094321|NCT01062763|2649643|P1|STARTED|Overall Study|119 randomized.|58
1094322|NCT01062841|2649655|P2|NOT COMPLETED|Overall Study||53
1094323|NCT01062841|2649656|P1|NOT COMPLETED|Overall Study||49
1094324|NCT01062841|2649655|P2|COMPLETED|Overall Study||162
1094325|NCT01062841|2649656|P1|COMPLETED|Overall Study||154
1094326|NCT01062841|2649655|P2|STARTED|Overall Study||215
1094327|NCT01062841|2649656|P1|STARTED|Overall Study||203
1094328|NCT01065350|2649686|P2|NOT COMPLETED|Overall Study||1
1094329|NCT01065350|2649687|P1|NOT COMPLETED|Overall Study||0
1094330|NCT01065350|2649686|P2|COMPLETED|Overall Study||41
1094331|NCT01065350|2649687|P1|COMPLETED|Overall Study||43
1094332|NCT01065350|2649686|P2|STARTED|Overall Study||42
1094333|NCT01065350|2649687|P1|STARTED|Overall Study||43
1094334|NCT01065428|2649721|P2|NOT COMPLETED|Overall Study||0
1094335|NCT01065428|2649722|P1|NOT COMPLETED|Overall Study||0
1094336|NCT01065428|2649721|P2|COMPLETED|Overall Study||35
1094337|NCT01065428|2649722|P1|COMPLETED|Overall Study||17
1094338|NCT01065428|2649721|P2|STARTED|Overall Study||35
1094339|NCT01065428|2649722|P1|STARTED|Overall Study||17
1094340|NCT01065454|2649734|P4|NOT COMPLETED|Follow up||44
1094341|NCT01065454|2649735|P3|NOT COMPLETED|Follow up||17
1094342|NCT01065454|2649736|P2|NOT COMPLETED|Follow up||24
1094343|NCT01065454|2649737|P1|NOT COMPLETED|Follow up||39
1094344|NCT01065454|2649734|P4|COMPLETED|Follow up||13
1094345|NCT01065454|2649735|P3|COMPLETED|Follow up||6
1094346|NCT01065454|2649736|P2|COMPLETED|Follow up||4
1094347|NCT01065454|2649737|P1|COMPLETED|Follow up||15
1094348|NCT01065454|2649734|P4|Entering Follow-up|Follow up||51
1094349|NCT01065454|2649735|P3|Entering Follow-up|Follow up||23
1094350|NCT01065454|2649736|P2|Entering Follow-up|Follow up||27
1094351|NCT01065454|2649737|P1|Entering Follow-up|Follow up||49
1094352|NCT01065454|2649734|P4|STARTED|Follow up||57
1094353|NCT01065454|2649735|P3|STARTED|Follow up||23
1094354|NCT01065454|2649736|P2|STARTED|Follow up||28
1094355|NCT01065454|2649737|P1|STARTED|Follow up||54
1094356|NCT01065454|2649734|P4|NOT COMPLETED|Treatment||12
1094357|NCT01065454|2649735|P3|NOT COMPLETED|Treatment||9
1094358|NCT01065454|2649736|P2|NOT COMPLETED|Treatment||5
1094359|NCT01065454|2649737|P1|NOT COMPLETED|Treatment||13
1094360|NCT01065454|2649734|P4|COMPLETED|Treatment||57
1094361|NCT01065454|2649735|P3|COMPLETED|Treatment||23
1094362|NCT01065454|2649736|P2|COMPLETED|Treatment||28
1094363|NCT01065454|2649737|P1|COMPLETED|Treatment||54
1094364|NCT01065454|2649734|P4|STARTED|Treatment||69
1094365|NCT01065454|2649735|P3|STARTED|Treatment||32
1094366|NCT01065454|2649736|P2|STARTED|Treatment||33
1094367|NCT01065454|2649737|P1|STARTED|Treatment||67
1094368|NCT01065506|2649849|P2|NOT COMPLETED|Overall Study||38
1094369|NCT01065506|2649850|P1|NOT COMPLETED|Overall Study||32
1094370|NCT01065506|2649849|P2|COMPLETED|Overall Study||34
1094371|NCT01065506|2649850|P1|COMPLETED|Overall Study||32
1094372|NCT01065506|2649849|P2|4-Month Follow-Up|Overall Study||34
1094373|NCT01065506|2649850|P1|4-Month Follow-Up|Overall Study||35
1094374|NCT01065506|2649849|P2|End of Treatment|Overall Study||37
1094375|NCT01065506|2649850|P1|End of Treatment|Overall Study||44
1094376|NCT01065506|2649849|P2|STARTED|Overall Study||72
1094377|NCT01065506|2649850|P1|STARTED|Overall Study||64
1094378|NCT01065558|2649856|P1|NOT COMPLETED|Overall Study||0
1094379|NCT01065558|2649856|P1|COMPLETED|Overall Study||5
1094380|NCT01065558|2649856|P1|STARTED|Overall Study||5
1094381|NCT01065597|2649861|P1|NOT COMPLETED|Overall Study||1
1094382|NCT01065597|2649861|P1|COMPLETED|Overall Study||12
1094383|NCT01065597|2649861|P1|STARTED|Overall Study||13
1094384|NCT01065714|2649868|P1|NOT COMPLETED|Overall Study||0
1094385|NCT01065714|2649868|P1|COMPLETED|Overall Study||20
1094386|NCT01065714|2649868|P1|STARTED|Overall Study|"This was a split body Study. All participants used both Hydrogel and Eucerin"|20
1094387|NCT01065766|2649875|P1|NOT COMPLETED|Overall Study||32
1094388|NCT01065766|2649875|P1|COMPLETED|Overall Study||4033
1094389|NCT01065766|2649875|P1|STARTED|Overall Study||4065
1094390|NCT01065779|2649887|P1|NOT COMPLETED|Overall Study||82
1094391|NCT01065779|2649887|P1|COMPLETED|Overall Study||798
1094392|NCT01065779|2649887|P1|STARTED|Overall Study||880
1094393|NCT01065818|2649898|P1|NOT COMPLETED|Overall Study||2
1094394|NCT01065818|2649898|P1|COMPLETED|Overall Study||4
1094395|NCT01065818|2649898|P1|STARTED|Overall Study||6
1094396|NCT01065844|2649902|P1|NOT COMPLETED|Overall Study||5
1094397|NCT01065844|2649902|P1|COMPLETED|Overall Study||10
1094398|NCT01065844|2649902|P1|STARTED|Overall Study||15
1094399|NCT01066000|2649906|P1|NOT COMPLETED|Overall Study||9
1094400|NCT01066000|2649906|P1|COMPLETED|Overall Study||24
1094401|NCT01066000|2649906|P1|STARTED|Overall Study||33
1094402|NCT01066039|2649917|P1|NOT COMPLETED|Overall Study||44
1094403|NCT01066039|2649917|P1|COMPLETED|Overall Study||158
1094404|NCT01066039|2649917|P1|Treated|Overall Study||200
1094405|NCT01066039|2649917|P1|STARTED|Overall Study||202
1094406|NCT01066104|2649932|P2|NOT COMPLETED|Overall Study||1
1094407|NCT01066104|2649933|P1|NOT COMPLETED|Overall Study||2
1094408|NCT01066104|2649932|P2|COMPLETED|Overall Study||12
1094409|NCT01066104|2649933|P1|COMPLETED|Overall Study||12
1094410|NCT01066104|2649932|P2|STARTED|Overall Study||13
1094411|NCT01066104|2649933|P1|STARTED|Overall Study||14
1094412|NCT01066143|2649941|P1|NOT COMPLETED|Overall Study||8
1094413|NCT01066143|2649941|P1|COMPLETED|Overall Study||0
1094414|NCT01066143|2649941|P1|STARTED|Overall Study||8
1094415|NCT01066156|2649945|P1|NOT COMPLETED|Overall Study||10
1094416|NCT01066156|2649945|P1|COMPLETED|Overall Study||24
1094417|NCT01066156|2649945|P1|STARTED|Overall Study||34
1094418|NCT01066520|2649952|P3|NOT COMPLETED|Overall Study||0
1094419|NCT01066520|2649953|P2|NOT COMPLETED|Overall Study||0
1094420|NCT01066520|2649954|P1|NOT COMPLETED|Overall Study||0
1094421|NCT01066520|2649952|P3|COMPLETED|Overall Study||137
1094422|NCT01066520|2649953|P2|COMPLETED|Overall Study||140
1094423|NCT01066520|2649954|P1|COMPLETED|Overall Study||143
1094424|NCT01066520|2649952|P3|STARTED|Overall Study||137
1094425|NCT01066520|2649953|P2|STARTED|Overall Study||140
1094426|NCT01066520|2649954|P1|STARTED|Overall Study||143
1094427|NCT01066546|2649968|P1|NOT COMPLETED|Overall Study||5
1094428|NCT01066546|2649968|P1|COMPLETED|Overall Study||0
1094429|NCT01066546|2649968|P1|STARTED|Overall Study||5
1094430|NCT01066585|2649981|P2|NOT COMPLETED|Overall Study||3
1094431|NCT01066585|2649982|P1|NOT COMPLETED|Overall Study||1
1094432|NCT01066585|2649981|P2|COMPLETED|Overall Study||196
1094433|NCT01066585|2649982|P1|COMPLETED|Overall Study||210
1094434|NCT01066585|2649981|P2|STARTED|Overall Study||199
1094435|NCT01066585|2649982|P1|STARTED|Overall Study||211
1094436|NCT01066624|2649997|P3|NOT COMPLETED|Overall Study||0
1094437|NCT01066624|2649998|P2|NOT COMPLETED|Overall Study||0
1094438|NCT01066624|2649999|P1|NOT COMPLETED|Overall Study||0
1094439|NCT01066624|2649997|P3|COMPLETED|Overall Study||39
1094440|NCT01066624|2649998|P2|COMPLETED|Overall Study||40
1094441|NCT01066624|2649999|P1|COMPLETED|Overall Study||38
1094442|NCT01066624|2649997|P3|STARTED|Overall Study||39
1094443|NCT01066624|2649998|P2|STARTED|Overall Study||40
1094444|NCT01066624|2649999|P1|STARTED|Overall Study||38
1094445|NCT01066780|2650007|P2|NOT COMPLETED|Overall Study||1
1094446|NCT01066780|2650008|P1|NOT COMPLETED|Overall Study||1
1094447|NCT01066780|2650007|P2|COMPLETED|Overall Study||23
1094448|NCT01066780|2650008|P1|COMPLETED|Overall Study||23
1094449|NCT01066780|2650007|P2|STARTED|Overall Study||24
1094450|NCT01066780|2650008|P1|STARTED|Overall Study||24
1094451|NCT01066793|2650018|P6|NOT COMPLETED|Overall Study||1
1094452|NCT01066793|2650019|P5|NOT COMPLETED|Overall Study||0
1094453|NCT01066793|2650020|P4|NOT COMPLETED|Overall Study||49
1094454|NCT01066793|2650021|P3|NOT COMPLETED|Overall Study||115
1094455|NCT01066793|2650022|P2|NOT COMPLETED|Overall Study||77
1094456|NCT01066793|2650023|P1|NOT COMPLETED|Overall Study||374
1094457|NCT01066793|2650018|P6|COMPLETED|Overall Study||4
1094458|NCT01066793|2650019|P5|COMPLETED|Overall Study||11
1094459|NCT01066793|2650020|P4|COMPLETED|Overall Study||94
1094460|NCT01066793|2650021|P3|COMPLETED|Overall Study||369
1094461|NCT01066793|2650022|P2|COMPLETED|Overall Study||495
1094462|NCT01066793|2650023|P1|COMPLETED|Overall Study||754
1094463|NCT01066793|2650018|P6|STARTED|Overall Study||5
1094464|NCT01066793|2650019|P5|STARTED|Overall Study||11
1094465|NCT01066793|2650020|P4|STARTED|Overall Study||143
1094466|NCT01066793|2650021|P3|STARTED|Overall Study||484
1094467|NCT01066793|2650022|P2|STARTED|Overall Study||572
1094468|NCT01066793|2650023|P1|STARTED|Overall Study||1128
1094469|NCT01066819|2650169|P6|NOT COMPLETED|Overall Study||6
1094470|NCT01066819|2650170|P5|NOT COMPLETED|Overall Study||4
1094471|NCT01066819|2650171|P4|NOT COMPLETED|Overall Study||17
1094472|NCT01066819|2650172|P3|NOT COMPLETED|Overall Study||146
1094473|NCT01066819|2650173|P2|NOT COMPLETED|Overall Study||171
1094474|NCT01066819|2650174|P1|NOT COMPLETED|Overall Study||689
1094475|NCT01066819|2650169|P6|COMPLETED|Overall Study||7
1094476|NCT01066819|2650170|P5|COMPLETED|Overall Study||3
1094477|NCT01066819|2650171|P4|COMPLETED|Overall Study||8
1094478|NCT01066819|2650172|P3|COMPLETED|Overall Study||111
1094479|NCT01066819|2650173|P2|COMPLETED|Overall Study||177
1094480|NCT01066819|2650174|P1|COMPLETED|Overall Study||317
1094481|NCT01066819|2650169|P6|STARTED|Overall Study||13
1094482|NCT01066819|2650170|P5|STARTED|Overall Study||7
1094483|NCT01066819|2650171|P4|STARTED|Overall Study||25
1094484|NCT01066819|2650172|P3|STARTED|Overall Study||257
1094485|NCT01066819|2650173|P2|STARTED|Overall Study||348
1094486|NCT01066819|2650174|P1|STARTED|Overall Study||1006
1094487|NCT01066871|2650313|P4|NOT COMPLETED|Overall Study||5
1094488|NCT01066871|2650314|P3|NOT COMPLETED|Overall Study||6
1094489|NCT01066871|2650315|P2|NOT COMPLETED|Overall Study||5
1094490|NCT01066871|2650316|P1|NOT COMPLETED|Overall Study||4
1094491|NCT01066871|2650313|P4|COMPLETED|Overall Study||13
1094492|NCT01066871|2650314|P3|COMPLETED|Overall Study||12
1094493|NCT01066871|2650315|P2|COMPLETED|Overall Study||13
1094494|NCT01066871|2650316|P1|COMPLETED|Overall Study||16
1094495|NCT01066871|2650313|P4|STARTED|Overall Study||18
1094496|NCT01066871|2650314|P3|STARTED|Overall Study||18
1094497|NCT01066871|2650315|P2|STARTED|Overall Study||18
1094498|NCT01066871|2650316|P1|STARTED|Overall Study||20
1094499|NCT01066897|2650376|P2|NOT COMPLETED|Overall Study||0
1094500|NCT01066897|2650377|P1|NOT COMPLETED|Overall Study||2
1094501|NCT01066897|2650376|P2|COMPLETED|Overall Study||9
1094502|NCT01066897|2650377|P1|COMPLETED|Overall Study||5
1094503|NCT01066897|2650376|P2|STARTED|Overall Study||9
1094504|NCT01066897|2650377|P1|STARTED|Overall Study||7
1094505|NCT01066923|2650391|P4|NOT COMPLETED|Overall Study||8
1094506|NCT01066923|2650392|P3|NOT COMPLETED|Overall Study||8
1094507|NCT01066923|2650393|P2|NOT COMPLETED|Overall Study||3
1094508|NCT01066923|2650394|P1|NOT COMPLETED|Overall Study||3
1094509|NCT01066923|2650391|P4|COMPLETED|Overall Study||23
1094510|NCT01066923|2650392|P3|COMPLETED|Overall Study||25
1094511|NCT01066923|2650393|P2|COMPLETED|Overall Study||29
1094512|NCT01066923|2650394|P1|COMPLETED|Overall Study||25
1094513|NCT01066923|2650391|P4|Retinal Imaging|Overall Study||0
1094514|NCT01066923|2650392|P3|Retinal Imaging|Overall Study||0
1094515|NCT01066923|2650393|P2|Retinal Imaging|Overall Study||0
1094516|NCT01066923|2650394|P1|Retinal Imaging|Overall Study||0
1094517|NCT01066923|2650391|P4|Activation of Coagulation|Overall Study||0
1094518|NCT01066923|2650392|P3|Activation of Coagulation|Overall Study||0
1094519|NCT01066923|2650393|P2|Activation of Coagulation|Overall Study||0
1094520|NCT01066923|2650394|P1|Activation of Coagulation|Overall Study||0
1094521|NCT01066923|2650391|P4|Vascular Function|Overall Study||13
1094522|NCT01066923|2650392|P3|Vascular Function|Overall Study||12
1094523|NCT01066923|2650393|P2|Vascular Function|Overall Study||14
1094524|NCT01066923|2650394|P1|Vascular Function|Overall Study||13
1094525|NCT01066923|2650391|P4|Platelet Closure Time|Overall Study||23
1094526|NCT01066923|2650392|P3|Platelet Closure Time|Overall Study||25
1094527|NCT01066923|2650393|P2|Platelet Closure Time|Overall Study||29
1094528|NCT01066923|2650394|P1|Platelet Closure Time|Overall Study||25
1094529|NCT01066923|2650391|P4|STARTED|Overall Study||31
1094530|NCT01066923|2650392|P3|STARTED|Overall Study||33
1094531|NCT01066923|2650393|P2|STARTED|Overall Study||32
1094532|NCT01066923|2650394|P1|STARTED|Overall Study||28
1094533|NCT01067105|2650408|P1|NOT COMPLETED|Overall Study||141
1094534|NCT01067105|2650408|P1|COMPLETED|Overall Study||683
1094535|NCT01067105|2650408|P1|STARTED|Overall Study||824
1094536|NCT01067326|2650427|P2|NOT COMPLETED|Overall Study||3
1094537|NCT01067326|2650428|P1|NOT COMPLETED|Overall Study||2
1094538|NCT01067326|2650427|P2|COMPLETED|Overall Study||5
1094539|NCT01067326|2650428|P1|COMPLETED|Overall Study||12
1094540|NCT01067326|2650427|P2|STARTED|Overall Study||8
1094541|NCT01067326|2650428|P1|STARTED|Overall Study||14
1094542|NCT01067339|2650442|P2|NOT COMPLETED|Overall Study||5
1094543|NCT01067339|2650443|P1|NOT COMPLETED|Overall Study||6
1094544|NCT01067339|2650442|P2|COMPLETED|Overall Study||29
1094545|NCT01067339|2650443|P1|COMPLETED|Overall Study||25
1094546|NCT01067339|2650442|P2|STARTED|Overall Study||34
1094547|NCT01067339|2650443|P1|STARTED|Overall Study||31
1094548|NCT01067352|2650454|P3|NOT COMPLETED|Overall Study||1
1094549|NCT01067352|2650455|P2|NOT COMPLETED|Overall Study||3
1094550|NCT01067352|2650456|P1|NOT COMPLETED|Overall Study||1
1094551|NCT01067352|2650454|P3|COMPLETED|Overall Study||9
1094552|NCT01067352|2650455|P2|COMPLETED|Overall Study||3
1094553|NCT01067352|2650456|P1|COMPLETED|Overall Study||8
1094554|NCT01067352|2650454|P3|STARTED|Overall Study||10
1094555|NCT01067352|2650455|P2|STARTED|Overall Study||6
1094556|NCT01067352|2650456|P1|STARTED|Overall Study||9
1094557|NCT01067456|2650472|P2|NOT COMPLETED|Overall Study||0
1094558|NCT01067456|2650473|P1|NOT COMPLETED|Overall Study||0
1094559|NCT01067456|2650472|P2|COMPLETED|Overall Study||29
1094560|NCT01067456|2650473|P1|COMPLETED|Overall Study||30
1094561|NCT01067456|2650472|P2|STARTED|Overall Study||29
1094562|NCT01067456|2650473|P1|STARTED|Overall Study||30
1094563|NCT01058642|2650483|P4|NOT COMPLETED|Treatment Period 2||0
1094564|NCT01058642|2650484|P3|NOT COMPLETED|Treatment Period 2||0
1094565|NCT01058642|2650485|P2|NOT COMPLETED|Treatment Period 2||0
1094566|NCT01058642|2650486|P1|NOT COMPLETED|Treatment Period 2||0
1094567|NCT01058642|2650483|P4|COMPLETED|Treatment Period 2||7
1094568|NCT01058642|2650484|P3|COMPLETED|Treatment Period 2||9
1094569|NCT01058642|2650485|P2|COMPLETED|Treatment Period 2||11
1094570|NCT01058642|2650486|P1|COMPLETED|Treatment Period 2||7
1094571|NCT01058642|2650483|P4|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
1094572|NCT01058642|2650484|P3|Received at Least 1 Dose of Study Drug|Treatment Period 2||9
1094573|NCT01058642|2650485|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2||11
1094574|NCT01058642|2650486|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
1094575|NCT01058642|2650483|P4|STARTED|Treatment Period 2||7
1094576|NCT01058642|2650484|P3|STARTED|Treatment Period 2||9
1094577|NCT01058642|2650485|P2|STARTED|Treatment Period 2||11
1094578|NCT01058642|2650486|P1|STARTED|Treatment Period 2||7
1094579|NCT01058642|2650483|P4|NOT COMPLETED|Washout Period||0
1094580|NCT01058642|2650484|P3|NOT COMPLETED|Washout Period||0
1094581|NCT01058642|2650485|P2|NOT COMPLETED|Washout Period||0
1094582|NCT01058642|2650486|P1|NOT COMPLETED|Washout Period||0
1094583|NCT01058642|2650483|P4|COMPLETED|Washout Period||7
1094584|NCT01058642|2650484|P3|COMPLETED|Washout Period||9
1094585|NCT01058642|2650485|P2|COMPLETED|Washout Period||11
1094586|NCT01058642|2650486|P1|COMPLETED|Washout Period||7
1094587|NCT01058642|2650483|P4|STARTED|Washout Period||7
1094588|NCT01058642|2650484|P3|STARTED|Washout Period||9
1094589|NCT01058642|2650485|P2|STARTED|Washout Period||11
1094590|NCT01058642|2650486|P1|STARTED|Washout Period||7
1094591|NCT01058642|2650483|P4|NOT COMPLETED|Treatment Period 1||2
1094592|NCT01058642|2650484|P3|NOT COMPLETED|Treatment Period 1||2
1094593|NCT01058642|2650485|P2|NOT COMPLETED|Treatment Period 1||1
1094594|NCT01058642|2650486|P1|NOT COMPLETED|Treatment Period 1||2
1094595|NCT01058642|2650483|P4|COMPLETED|Treatment Period 1||7
1094596|NCT01058642|2650484|P3|COMPLETED|Treatment Period 1||9
1094597|NCT01058642|2650485|P2|COMPLETED|Treatment Period 1||11
1094598|NCT01058642|2650486|P1|COMPLETED|Treatment Period 1||7
1094599|NCT01058642|2650483|P4|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
1094600|NCT01058642|2650484|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1||11
1094601|NCT01058642|2650485|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||12
1094602|NCT01058642|2650486|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
1094603|NCT01058642|2650483|P4|STARTED|Treatment Period 1||9
1094604|NCT01058642|2650484|P3|STARTED|Treatment Period 1||11
1094605|NCT01058642|2650485|P2|STARTED|Treatment Period 1||12
1094606|NCT01058642|2650486|P1|STARTED|Treatment Period 1||9
1094607|NCT01058655|2650498|P4|NOT COMPLETED|Overall Study||42
1094608|NCT01058655|2650499|P3|NOT COMPLETED|Overall Study||8
1094609|NCT01058655|2650500|P2|NOT COMPLETED|Overall Study||3
1094610|NCT01058655|2650501|P1|NOT COMPLETED|Overall Study||3
1094611|NCT01058655|2650498|P4|COMPLETED|Overall Study||0
1094612|NCT01058655|2650499|P3|COMPLETED|Overall Study||0
1094613|NCT01058655|2650500|P2|COMPLETED|Overall Study||0
1094614|NCT01058655|2650501|P1|COMPLETED|Overall Study||0
1094615|NCT01058655|2650498|P4|Evaluable|Overall Study||40
1094616|NCT01058655|2650499|P3|Evaluable|Overall Study||6
1094617|NCT01058655|2650500|P2|Evaluable|Overall Study||3
1094618|NCT01058655|2650501|P1|Evaluable|Overall Study||3
1094619|NCT01058655|2650498|P4|STARTED|Overall Study||42
1094620|NCT01058655|2650499|P3|STARTED|Overall Study||8
1094621|NCT01058655|2650500|P2|STARTED|Overall Study||3
1094622|NCT01058655|2650501|P1|STARTED|Overall Study||3
1094623|NCT01058668|2650518|P3|NOT COMPLETED|Safety Follow-up||7
1094624|NCT01058668|2650519|P2|NOT COMPLETED|Safety Follow-up||0
1094625|NCT01058668|2650520|P1|NOT COMPLETED|Safety Follow-up||5
1094626|NCT01058668|2650518|P3|COMPLETED|Safety Follow-up||141
1094627|NCT01058668|2650519|P2|COMPLETED|Safety Follow-up||146
1094628|NCT01058668|2650520|P1|COMPLETED|Safety Follow-up||139
1094629|NCT01058668|2650518|P3|STARTED|Safety Follow-up||148
1094630|NCT01058668|2650519|P2|STARTED|Safety Follow-up||146
1094631|NCT01058668|2650520|P1|STARTED|Safety Follow-up|Not all participants entered the Safety-Follow-up|144
1094632|NCT01058668|2650518|P3|NOT COMPLETED|Double-blind Treatment Phase||50
1094633|NCT01058668|2650519|P2|NOT COMPLETED|Double-blind Treatment Phase||38
1094634|NCT01058668|2650520|P1|NOT COMPLETED|Double-blind Treatment Phase||39
1094635|NCT01058668|2650518|P3|COMPLETED|Double-blind Treatment Phase||119
1094636|NCT01058668|2650519|P2|COMPLETED|Double-blind Treatment Phase||129
1094637|NCT01058668|2650520|P1|COMPLETED|Double-blind Treatment Phase||122
1094638|NCT01058668|2650518|P3|STARTED|Double-blind Treatment Phase||169
1094639|NCT01058668|2650519|P2|STARTED|Double-blind Treatment Phase||167
1094640|NCT01058668|2650520|P1|STARTED|Double-blind Treatment Phase||161
1094641|NCT01058863|2650531|P1|NOT COMPLETED|Overall Study||4
1094642|NCT01058863|2650531|P1|COMPLETED|Overall Study||68
1094643|NCT01058863|2650531|P1|Treated With Placebo Inhaler|Overall Study||69
1094644|NCT01058863|2650531|P1|Treated With ProAir® HFA 180 mcg|Overall Study||68
1094645|NCT01058863|2650531|P1|Treated With ProAir® HFA 90 mcg|Overall Study||70
1094646|NCT01058863|2650531|P1|Treated With Albuterol Spiromax® 180 mcg|Overall Study||68
1094647|NCT01058863|2650531|P1|Treated With Albuterol Spiromax® 90 mcg|Overall Study||68
1094648|NCT01058863|2650531|P1|Safety and ITT Populations|Overall Study|One patient was randomized in error and never received the study drug.|71
1094649|NCT01058863|2650531|P1|STARTED|Overall Study||72
1094650|NCT01058941|2650551|P2|NOT COMPLETED|Overall Study||11
1094651|NCT01058941|2650552|P1|NOT COMPLETED|Overall Study||9
1094652|NCT01058941|2650551|P2|COMPLETED|Overall Study||22
1094653|NCT01058941|2650552|P1|COMPLETED|Overall Study||25
1094654|NCT01058941|2650551|P2|STARTED|Overall Study||33
1094655|NCT01058941|2650552|P1|STARTED|Overall Study||34
1094656|NCT01058993|2650560|P1|NOT COMPLETED|Overall Study||0
1094657|NCT01058993|2650560|P1|COMPLETED|Overall Study||6
1094658|NCT01058993|2650560|P1|STARTED|Overall Study||6
1094659|NCT01059071|2650564|P4|NOT COMPLETED|Overall Study||6
1094660|NCT01059071|2650565|P3|NOT COMPLETED|Overall Study||2
1094661|NCT01059071|2650566|P2|NOT COMPLETED|Overall Study||4
1094662|NCT01059071|2650567|P1|NOT COMPLETED|Overall Study||2
1094663|NCT01059071|2650564|P4|COMPLETED|Overall Study||3
1094664|NCT01059071|2650565|P3|COMPLETED|Overall Study||1
1094665|NCT01059071|2650566|P2|COMPLETED|Overall Study||1
1094666|NCT01059071|2650567|P1|COMPLETED|Overall Study||2
1094667|NCT01059071|2650564|P4|STARTED|Overall Study||9
1094668|NCT01059071|2650565|P3|STARTED|Overall Study||3
1094669|NCT01059071|2650566|P2|STARTED|Overall Study||5
1094670|NCT01059071|2650567|P1|STARTED|Overall Study||4
1094671|NCT01059175|2650581|P2|NOT COMPLETED|Overall Study||20
1094672|NCT01059175|2650582|P1|NOT COMPLETED|Overall Study||21
1094673|NCT01059175|2650581|P2|COMPLETED|Overall Study|17 patients deceased 3 patients were prematurely exited|21
1094674|NCT01059175|2650582|P1|COMPLETED|Overall Study|17 patients deceased 4 additional patients were prematurely exited|22
1094675|NCT01059175|2650581|P2|STARTED|Overall Study||41
1094676|NCT01059175|2650582|P1|STARTED|Overall Study||43
1094677|NCT01059305|2650604|P1|NOT COMPLETED|Overall Study||0
1094678|NCT01059305|2650604|P1|COMPLETED|Overall Study||10
1094679|NCT01059305|2650604|P1|STARTED|Overall Study||10
1094680|NCT01059344|2650610|P2|NOT COMPLETED|Overall Study||46
1094681|NCT01059344|2650611|P1|NOT COMPLETED|Overall Study||22
1094682|NCT01059344|2650610|P2|COMPLETED|Overall Study||95
1094683|NCT01059344|2650611|P1|COMPLETED|Overall Study||118
1094684|NCT01059344|2650610|P2|STARTED|Overall Study||141
1094685|NCT01059344|2650611|P1|STARTED|Overall Study||140
1094686|NCT01059526|2650631|P2|NOT COMPLETED|Overall Study||22
1094687|NCT01059526|2650632|P1|NOT COMPLETED|Overall Study||30
1094688|NCT01059526|2650631|P2|COMPLETED|Overall Study||18
1094689|NCT01059526|2650632|P1|COMPLETED|Overall Study||11
1094690|NCT01059526|2650631|P2|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|23
1094691|NCT01059526|2650632|P1|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|21
1094692|NCT01059526|2650631|P2|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|40
1094693|NCT01059526|2650632|P1|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|41
1094694|NCT01059565|2650642|P2|NOT COMPLETED|24-Week Open-Label Phase||3
1094695|NCT01059565|2650643|P1|NOT COMPLETED|24-Week Open-Label Phase||5
1094696|NCT01059565|2650642|P2|COMPLETED|24-Week Open-Label Phase||42
1094697|NCT01059565|2650643|P1|COMPLETED|24-Week Open-Label Phase||34
1094698|NCT01059565|2650642|P2|STARTED|24-Week Open-Label Phase||45
1094699|NCT01059565|2650643|P1|STARTED|24-Week Open-Label Phase||39
1094700|NCT01059565|2650642|P2|NOT COMPLETED|24-Week Randomized Phase||7
1094701|NCT01059565|2650643|P1|NOT COMPLETED|24-Week Randomized Phase||10
1094702|NCT01059565|2650642|P2|COMPLETED|24-Week Randomized Phase||45
1094703|NCT01059565|2650643|P1|COMPLETED|24-Week Randomized Phase||39
1094704|NCT01059565|2650642|P2|Randomized and Treated|24-Week Randomized Phase||52
1094705|NCT01059565|2650643|P1|Randomized and Treated|24-Week Randomized Phase||48
1094706|NCT01059565|2650642|P2|STARTED|24-Week Randomized Phase||52
1094707|NCT01059565|2650643|P1|STARTED|24-Week Randomized Phase||49
1094708|NCT01059617|2650681|P4|NOT COMPLETED|Overall Study||6
1094709|NCT01059617|2650682|P3|NOT COMPLETED|Overall Study||8
1094710|NCT01059617|2650683|P2|NOT COMPLETED|Overall Study||1
1094711|NCT01059617|2650684|P1|NOT COMPLETED|Overall Study||7
1094712|NCT01059617|2650681|P4|COMPLETED|Overall Study||27
1094713|NCT01059617|2650682|P3|COMPLETED|Overall Study||25
1094714|NCT01059617|2650683|P2|COMPLETED|Overall Study||33
1094715|NCT01059617|2650684|P1|COMPLETED|Overall Study||26
1094716|NCT01059617|2650681|P4|STARTED|Overall Study||33
1094717|NCT01059617|2650682|P3|STARTED|Overall Study||33
1094718|NCT01059617|2650683|P2|STARTED|Overall Study||34
1094719|NCT01059617|2650684|P1|STARTED|Overall Study||33
1094720|NCT01059630|2650854|P2|NOT COMPLETED|Maintenance Period (up to 2 Years)||108
1094721|NCT01059630|2650855|P1|NOT COMPLETED|Maintenance Period (up to 2 Years)||0
1094722|NCT01059630|2650854|P2|COMPLETED|Maintenance Period (up to 2 Years)||35
1094723|NCT01059630|2650855|P1|COMPLETED|Maintenance Period (up to 2 Years)||0
1094724|NCT01059630|2650854|P2|STARTED|Maintenance Period (up to 2 Years)|Of all participants who completed induction, 13 participants did not start maintenance.|143
1094725|NCT01059630|2650855|P1|STARTED|Maintenance Period (up to 2 Years)|Maintenance was not planned for this arm.|0
1094726|NCT01059630|2650854|P2|NOT COMPLETED|Induction Period (6 Months)||38
1094727|NCT01059630|2650855|P1|NOT COMPLETED|Induction Period (6 Months)||73
1094728|NCT01059630|2650854|P2|COMPLETED|Induction Period (6 Months)||156
1094729|NCT01059630|2650855|P1|COMPLETED|Induction Period (6 Months)||129
1094730|NCT01059630|2650854|P2|Treated|Induction Period (6 Months)||194
1094731|NCT01059630|2650855|P1|Treated|Induction Period (6 Months)||198
1094732|NCT01059630|2650854|P2|STARTED|Induction Period (6 Months)||194
1094733|NCT01059630|2650855|P1|STARTED|Induction Period (6 Months)||202
1094734|NCT01059760|2650913|P2|NOT COMPLETED|Overall Study||0
1094735|NCT01059760|2650914|P1|NOT COMPLETED|Overall Study||0
1094736|NCT01059760|2650913|P2|COMPLETED|Overall Study||14
1094737|NCT01059760|2650914|P1|COMPLETED|Overall Study||16
1094738|NCT01059760|2650913|P2|STARTED|Overall Study||14
1094739|NCT01059760|2650914|P1|STARTED|Overall Study||16
1094740|NCT01059773|2651022|P2|NOT COMPLETED|Overall Study||24
1094741|NCT01059773|2651023|P1|NOT COMPLETED|Overall Study||20
1094742|NCT01059773|2651022|P2|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|221
1094743|NCT01059773|2651023|P1|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|224
1094744|NCT01059773|2651022|P2|STARTED|Overall Study||245
1094745|NCT01059773|2651023|P1|STARTED|Overall Study||244
1094746|NCT01059799|2651055|P2|NOT COMPLETED|Overall Study||10
1094747|NCT01059799|2651056|P1|NOT COMPLETED|Overall Study||31
1094748|NCT01059799|2651055|P2|COMPLETED|Overall Study||136
1094749|NCT01059799|2651056|P1|COMPLETED|Overall Study||258
1094750|NCT01059799|2651055|P2|Exposed|Overall Study||146
1094751|NCT01059799|2651056|P1|Exposed|Overall Study|Five subjects withdrew before exposure to trial drug|284
1094752|NCT01059799|2651055|P2|STARTED|Overall Study||146
1094753|NCT01059799|2651056|P1|STARTED|Overall Study||289
1094754|NCT01059812|2651070|P2|NOT COMPLETED|Overall Study||16
1094755|NCT01059812|2651071|P1|NOT COMPLETED|Overall Study||37
1094756|NCT01059812|2651070|P2|COMPLETED|Overall Study||126
1094757|NCT01059812|2651071|P1|COMPLETED|Overall Study||245
1094758|NCT01059812|2651070|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|141
1094759|NCT01059812|2651071|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|279
1094760|NCT01059812|2651070|P2|STARTED|Overall Study||142
1094761|NCT01059812|2651071|P1|STARTED|Overall Study||282
1094762|NCT01059825|2651091|P7|NOT COMPLETED|Treatment Period||0
1094763|NCT01059825|2651092|P6|NOT COMPLETED|Treatment Period||3
1094764|NCT01059825|2651093|P5|NOT COMPLETED|Treatment Period||8
1094765|NCT01059825|2651094|P4|NOT COMPLETED|Treatment Period||11
1094766|NCT01059825|2651095|P3|NOT COMPLETED|Treatment Period||6
1094767|NCT01059825|2651096|P2|NOT COMPLETED|Treatment Period||4
1094768|NCT01059825|2651097|P1|NOT COMPLETED|Treatment Period||10
1094769|NCT01059825|2651091|P7|COMPLETED|Treatment Period||0
1094770|NCT01059825|2651092|P6|COMPLETED|Treatment Period||52
1094771|NCT01059825|2651093|P5|COMPLETED|Treatment Period||47
1094772|NCT01059825|2651094|P4|COMPLETED|Treatment Period||44
1094773|NCT01059825|2651095|P3|COMPLETED|Treatment Period||49
1094774|NCT01059825|2651096|P2|COMPLETED|Treatment Period||50
1094775|NCT01059825|2651097|P1|COMPLETED|Treatment Period||44
1094776|NCT01059825|2651091|P7|STARTED|Treatment Period|Participants who completed run-in were randomized to 1 of 6 treatment groups.|0
1094777|NCT01059825|2651092|P6|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
1094778|NCT01059825|2651093|P5|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
1094779|NCT01059825|2651094|P4|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
1094780|NCT01059825|2651095|P3|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
1094781|NCT01059825|2651096|P2|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54
1094782|NCT01059825|2651097|P1|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54
1094783|NCT01059825|2651091|P7|NOT COMPLETED|Enrolled, Run-in Period||47
1094784|NCT01059825|2651092|P6|NOT COMPLETED|Enrolled, Run-in Period||0
1094785|NCT01059825|2651093|P5|NOT COMPLETED|Enrolled, Run-in Period||0
1094786|NCT01059825|2651094|P4|NOT COMPLETED|Enrolled, Run-in Period||0
1094787|NCT01059825|2651095|P3|NOT COMPLETED|Enrolled, Run-in Period||0
1094788|NCT01059825|2651096|P2|NOT COMPLETED|Enrolled, Run-in Period||0
1094789|NCT01059825|2651097|P1|NOT COMPLETED|Enrolled, Run-in Period||0
1094790|NCT01059825|2651091|P7|COMPLETED|Enrolled, Run-in Period||328
1094791|NCT01059825|2651092|P6|COMPLETED|Enrolled, Run-in Period||0
1094792|NCT01059825|2651093|P5|COMPLETED|Enrolled, Run-in Period||0
1094793|NCT01059825|2651094|P4|COMPLETED|Enrolled, Run-in Period||0
1094794|NCT01059825|2651095|P3|COMPLETED|Enrolled, Run-in Period||0
1094795|NCT01059825|2651096|P2|COMPLETED|Enrolled, Run-in Period||0
1094796|NCT01059825|2651097|P1|COMPLETED|Enrolled, Run-in Period||0
1094797|NCT01059825|2651091|P7|STARTED|Enrolled, Run-in Period||375
1094798|NCT01059825|2651092|P6|STARTED|Enrolled, Run-in Period||0
1094799|NCT01059825|2651093|P5|STARTED|Enrolled, Run-in Period||0
1094800|NCT01059825|2651094|P4|STARTED|Enrolled, Run-in Period||0
1094801|NCT01059825|2651095|P3|STARTED|Enrolled, Run-in Period||0
1094802|NCT01059825|2651096|P2|STARTED|Enrolled, Run-in Period||0
1094803|NCT01059825|2651097|P1|STARTED|Enrolled, Run-in Period||0
1094804|NCT01059851|2651284|P6|NOT COMPLETED|Overall Study||0
1094805|NCT01059851|2651285|P5|NOT COMPLETED|Overall Study||0
1094806|NCT01059851|2651286|P4|NOT COMPLETED|Overall Study||0
1094807|NCT01059851|2651287|P3|NOT COMPLETED|Overall Study||0
1094808|NCT01059851|2651288|P2|NOT COMPLETED|Overall Study||0
1094809|NCT01059851|2651289|P1|NOT COMPLETED|Overall Study||0
1094810|NCT01059851|2651284|P6|COMPLETED|Overall Study||0
1094811|NCT01059851|2651285|P5|COMPLETED|Overall Study||0
1094812|NCT01059851|2651286|P4|COMPLETED|Overall Study||0
1094813|NCT01059851|2651287|P3|COMPLETED|Overall Study||0
1094814|NCT01059851|2651288|P2|COMPLETED|Overall Study||8
1094815|NCT01059851|2651289|P1|COMPLETED|Overall Study||8
1094816|NCT01059851|2651284|P6|STARTED|Overall Study||0
1094817|NCT01059851|2651285|P5|STARTED|Overall Study||0
1094818|NCT01059851|2651286|P4|STARTED|Overall Study||0
1094819|NCT01059851|2651287|P3|STARTED|Overall Study||0
1094820|NCT01059851|2651288|P2|STARTED|Overall Study||8
1094821|NCT01059851|2651289|P1|STARTED|Overall Study||8
1094822|NCT01059864|2651303|P3|NOT COMPLETED|Double-Blind Treatment Phase||3
1094823|NCT01059864|2651304|P2|NOT COMPLETED|Double-Blind Treatment Phase||3
1094824|NCT01059864|2651305|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
1094825|NCT01059864|2651303|P3|COMPLETED|Double-Blind Treatment Phase||45
1094826|NCT01059864|2651304|P2|COMPLETED|Double-Blind Treatment Phase||47
1094827|NCT01059864|2651305|P1|COMPLETED|Double-Blind Treatment Phase||0
1094828|NCT01059864|2651303|P3|Treated|Double-Blind Treatment Phase||47
1094829|NCT01059864|2651304|P2|Treated|Double-Blind Treatment Phase||50
1094830|NCT01059864|2651305|P1|Treated|Double-Blind Treatment Phase||0
1094831|NCT01059864|2651303|P3|STARTED|Double-Blind Treatment Phase||48
1094832|NCT01059864|2651304|P2|STARTED|Double-Blind Treatment Phase||50
1094833|NCT01059864|2651305|P1|STARTED|Double-Blind Treatment Phase||0
1094834|NCT01059864|2651303|P3|NOT COMPLETED|Open-Label Run-In Phase||0
1094835|NCT01059864|2651304|P2|NOT COMPLETED|Open-Label Run-In Phase||0
1094836|NCT01059864|2651305|P1|NOT COMPLETED|Open-Label Run-In Phase||13
1094837|NCT01059864|2651303|P3|COMPLETED|Open-Label Run-In Phase||0
1094838|NCT01059864|2651304|P2|COMPLETED|Open-Label Run-In Phase||0
1094839|NCT01059864|2651305|P1|COMPLETED|Open-Label Run-In Phase||98
1094840|NCT01059864|2651303|P3|STARTED|Open-Label Run-In Phase||0
1094841|NCT01059864|2651304|P2|STARTED|Open-Label Run-In Phase||0
1094842|NCT01059864|2651305|P1|STARTED|Open-Label Run-In Phase||111
1094843|NCT01059903|2651354|P2|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
1094844|NCT01059903|2651355|P1|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
1094845|NCT01059903|2651354|P2|COMPLETED|Period 3: Second Intervention- 24 Hours||24
1094846|NCT01059903|2651355|P1|COMPLETED|Period 3: Second Intervention- 24 Hours||24
1094847|NCT01059903|2651354|P2|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Two subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|22
1094848|NCT01059903|2651355|P1|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Six subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|18
1094849|NCT01059903|2651354|P2|STARTED|Period 3: Second Intervention- 24 Hours||24
1094850|NCT01059903|2651355|P1|STARTED|Period 3: Second Intervention- 24 Hours||24
1094851|NCT01059903|2651354|P2|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
1094852|NCT01059903|2651355|P1|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
1094853|NCT01059903|2651354|P2|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
1094854|NCT01059903|2651355|P1|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
1094855|NCT01059903|2651354|P2|STARTED|Period 2: Washout Period (>= 5 Days)||24
1094856|NCT01059903|2651355|P1|STARTED|Period 2: Washout Period (>= 5 Days)||24
1094857|NCT01059903|2651354|P2|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
1094858|NCT01059903|2651355|P1|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
1094859|NCT01059903|2651354|P2|COMPLETED|Period 1: First Intervention- 24 Hours||24
1094860|NCT01059903|2651355|P1|COMPLETED|Period 1: First Intervention- 24 Hours||24
1094861|NCT01059903|2651354|P2|STARTED|Period 1: First Intervention- 24 Hours||25
1094862|NCT01059903|2651355|P1|STARTED|Period 1: First Intervention- 24 Hours||25
1094863|NCT01059994|2651393|P4|NOT COMPLETED|Overall Study||1
1094864|NCT01059994|2651394|P3|NOT COMPLETED|Overall Study||0
1094865|NCT01059994|2651395|P2|NOT COMPLETED|Overall Study||0
1094866|NCT01059994|2651396|P1|NOT COMPLETED|Overall Study||0
1094867|NCT01059994|2651393|P4|COMPLETED|Overall Study||3
1094868|NCT01059994|2651394|P3|COMPLETED|Overall Study||3
1094869|NCT01059994|2651395|P2|COMPLETED|Overall Study||2
1094870|NCT01059994|2651396|P1|COMPLETED|Overall Study||3
1094871|NCT01059994|2651393|P4|STARTED|Overall Study||4
1094872|NCT01059994|2651394|P3|STARTED|Overall Study||3
1094873|NCT01059994|2651395|P2|STARTED|Overall Study||2
1094874|NCT01059994|2651396|P1|STARTED|Overall Study||3
1094875|NCT01060007|2651410|P1|NOT COMPLETED|Overall Study||4
1094876|NCT01060007|2651410|P1|COMPLETED|Overall Study||76
1094877|NCT01060007|2651410|P1|STARTED|Overall Study||80
1094878|NCT01060059|2651426|P2|NOT COMPLETED|Overall Study||67
1094879|NCT01060059|2651427|P1|NOT COMPLETED|Overall Study||67
1094880|NCT01060059|2651426|P2|COMPLETED|Overall Study||371
1094881|NCT01060059|2651427|P1|COMPLETED|Overall Study||377
1094882|NCT01060059|2651426|P2|STARTED|Overall Study||438
1094883|NCT01060059|2651427|P1|STARTED|Overall Study||444
1094884|NCT01067716|2651480|P3|NOT COMPLETED|Overall Study||0
1094885|NCT01067716|2651481|P2|NOT COMPLETED|Overall Study||0
1094886|NCT01067716|2651482|P1|NOT COMPLETED|Overall Study||0
1094887|NCT01067716|2651480|P3|COMPLETED|Overall Study|15 eyes|9
1094888|NCT01067716|2651481|P2|COMPLETED|Overall Study|25 eyes|13
1094889|NCT01067716|2651482|P1|COMPLETED|Overall Study|110 eyes|57
1094890|NCT01067716|2651480|P3|STARTED|Overall Study|15 eyes|9
1094891|NCT01067716|2651481|P2|STARTED|Overall Study|25 eyes|13
1094892|NCT01067716|2651482|P1|STARTED|Overall Study|110 eyes|57
1094893|NCT01067768|2651501|P2|NOT COMPLETED|Overall Study||0
1094894|NCT01067768|2651502|P1|NOT COMPLETED|Overall Study||0
1094895|NCT01067768|2651501|P2|COMPLETED|Overall Study||605
1094896|NCT01067768|2651502|P1|COMPLETED|Overall Study||604
1094897|NCT01067768|2651501|P2|STARTED|Overall Study||605
1094898|NCT01067768|2651502|P1|STARTED|Overall Study||604
1094899|NCT01067781|2651514|P4|NOT COMPLETED|Up to Day 720||101
1094900|NCT01067781|2651515|P3|NOT COMPLETED|Up to Day 720||97
1094901|NCT01067781|2651516|P2|NOT COMPLETED|Up to Day 720||195
1094902|NCT01067781|2651517|P1|NOT COMPLETED|Up to Day 720||200
1094903|NCT01067781|2651514|P4|COMPLETED|Up to Day 720|all subects followed till Day180; if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
1094904|NCT01067781|2651515|P3|COMPLETED|Up to Day 720|all subects followed till Day180; if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
1094905|NCT01067781|2651516|P2|COMPLETED|Up to Day 720|all subects followed till Day180; if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|4
1094906|NCT01067781|2651517|P1|COMPLETED|Up to Day 720|all subects followed till Day180; if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|3
1094907|NCT01067781|2651514|P4|STARTED|Up to Day 720||101
1094908|NCT01067781|2651515|P3|STARTED|Up to Day 720||97
1094909|NCT01067781|2651516|P2|STARTED|Up to Day 720||199
1094910|NCT01067781|2651517|P1|STARTED|Up to Day 720||203
1094911|NCT01067781|2651514|P4|NOT COMPLETED|Up to Day 180||12
1094912|NCT01067781|2651515|P3|NOT COMPLETED|Up to Day 180||8
1094913|NCT01067781|2651516|P2|NOT COMPLETED|Up to Day 180||31
1094914|NCT01067781|2651517|P1|NOT COMPLETED|Up to Day 180||30
1094915|NCT01067781|2651514|P4|COMPLETED|Up to Day 180||89
1094916|NCT01067781|2651515|P3|COMPLETED|Up to Day 180||89
1094917|NCT01067781|2651516|P2|COMPLETED|Up to Day 180||168
1094918|NCT01067781|2651517|P1|COMPLETED|Up to Day 180||173
1094919|NCT01067781|2651514|P4|STARTED|Up to Day 180||101
1094920|NCT01067781|2651515|P3|STARTED|Up to Day 180||97
1094921|NCT01067781|2651516|P2|STARTED|Up to Day 180||199
1094922|NCT01067781|2651517|P1|STARTED|Up to Day 180||203
1094923|NCT01067846|2651527|P2|NOT COMPLETED|Overall Study||19
1094924|NCT01067846|2651528|P1|NOT COMPLETED|Overall Study||19
1094925|NCT01067846|2651527|P2|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|11
1094926|NCT01067846|2651528|P1|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|10
1094927|NCT01067846|2651527|P2|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
1094928|NCT01067846|2651528|P1|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
1094929|NCT01067846|2651527|P2|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|30
1094930|NCT01067846|2651528|P1|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|29
1094931|NCT01068158|2651538|P2|NOT COMPLETED|Overall Study||4
1094932|NCT01068158|2651539|P1|NOT COMPLETED|Overall Study||8
1094933|NCT01068158|2651538|P2|COMPLETED|Overall Study||198
1094934|NCT01068158|2651539|P1|COMPLETED|Overall Study||161
1094935|NCT01068158|2651538|P2|STARTED|Overall Study||202
1094936|NCT01068158|2651539|P1|STARTED|Overall Study||169
1094937|NCT01068262|2651555|P4|NOT COMPLETED|Overall Study||0
1094938|NCT01068262|2651556|P3|NOT COMPLETED|Overall Study||1
1094939|NCT01068262|2651557|P2|NOT COMPLETED|Overall Study||1
1094940|NCT01068262|2651558|P1|NOT COMPLETED|Overall Study||3
1094941|NCT01068262|2651555|P4|COMPLETED|Overall Study||2
1094942|NCT01068262|2651556|P3|COMPLETED|Overall Study||9
1094943|NCT01068262|2651557|P2|COMPLETED|Overall Study||8
1094944|NCT01068262|2651558|P1|COMPLETED|Overall Study||20
1094945|NCT01068262|2651555|P4|STARTED|Overall Study||2
1094946|NCT01068262|2651556|P3|STARTED|Overall Study||10
1094947|NCT01068262|2651557|P2|STARTED|Overall Study||9
1094948|NCT01068262|2651558|P1|STARTED|Overall Study||23
1094949|NCT01068418|2651586|P1|NOT COMPLETED|Overall Study||12
1094950|NCT01068418|2651586|P1|COMPLETED|Overall Study|14 participants completed all study procedures.|14
1094951|NCT01068418|2651586|P1|Medication Washout|Overall Study|9 participants were disempaneled during the medication washout phase due to noncompliance or high BP|17
1094952|NCT01068418|2651586|P1|STARTED|Overall Study|26 participants found to be eligible|26
1094953|NCT01068509|2651594|P3|NOT COMPLETED|Overall Study||21
1094954|NCT01068509|2651595|P2|NOT COMPLETED|Overall Study||22
1094955|NCT01068509|2651596|P1|NOT COMPLETED|Overall Study||6
1094956|NCT01068509|2651594|P3|COMPLETED|Overall Study||6
1094957|NCT01068509|2651595|P2|COMPLETED|Overall Study||7
1094958|NCT01068509|2651596|P1|COMPLETED|Overall Study||1
1094959|NCT01068509|2651594|P3|STARTED|Overall Study||27
1094960|NCT01068509|2651595|P2|STARTED|Overall Study||29
1094961|NCT01068509|2651596|P1|STARTED|Overall Study||7
1094962|NCT01068548|2651611|P2|NOT COMPLETED|Overall Study||0
1094963|NCT01068548|2651612|P1|NOT COMPLETED|Overall Study||0
1094964|NCT01068548|2651611|P2|COMPLETED|Overall Study||63
1094965|NCT01068548|2651612|P1|COMPLETED|Overall Study||66
1094966|NCT01068548|2651611|P2|STARTED|Overall Study||63
1094967|NCT01068548|2651612|P1|STARTED|Overall Study||66
1094968|NCT01068600|2651620|P2|NOT COMPLETED|Overall Study||17
1094969|NCT01068600|2651621|P1|NOT COMPLETED|Overall Study||11
1094970|NCT01068600|2651620|P2|COMPLETED|Overall Study||142
1094971|NCT01068600|2651621|P1|COMPLETED|Overall Study||148
1094972|NCT01068600|2651620|P2|STARTED|Overall Study||159
1094973|NCT01068600|2651621|P1|STARTED|Overall Study||159
1094974|NCT01068626|2651631|P2|NOT COMPLETED|Overall Study||2
1094975|NCT01068626|2651632|P1|NOT COMPLETED|Overall Study||3
1094976|NCT01068626|2651631|P2|COMPLETED|Overall Study||27
1094977|NCT01068626|2651632|P1|COMPLETED|Overall Study||27
1094978|NCT01068626|2651631|P2|STARTED|Overall Study||29
1094979|NCT01068626|2651632|P1|STARTED|Overall Study||30
1094980|NCT01068652|2651650|P2|NOT COMPLETED|Overall Study||15
1094981|NCT01068652|2651651|P1|NOT COMPLETED|Overall Study||18
1094982|NCT01068652|2651650|P2|COMPLETED|Overall Study||188
1094983|NCT01068652|2651651|P1|COMPLETED|Overall Study||182
1094984|NCT01068652|2651650|P2|STARTED|Overall Study||203
1094985|NCT01068652|2651651|P1|STARTED|Overall Study||200
1094986|NCT01068665|2651691|P2|NOT COMPLETED|Overall Study||29
1094987|NCT01068665|2651692|P1|NOT COMPLETED|Overall Study||30
1094988|NCT01068665|2651691|P2|COMPLETED|Overall Study||201
1094989|NCT01068665|2651692|P1|COMPLETED|Overall Study||200
1094990|NCT01068665|2651691|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|228
1094991|NCT01068665|2651692|P1|Exposed|Overall Study||228
1094992|NCT01068665|2651691|P2|Full Analysis Set|Overall Study|One subject was withdrawn because the subject was randomised in error.|229
1094993|NCT01068665|2651692|P1|Full Analysis Set|Overall Study|Two subjects were withdrawn because the subjects were randomised in error.|228
1094994|NCT01068665|2651691|P2|STARTED|Overall Study||230
1094995|NCT01068665|2651692|P1|STARTED|Overall Study||230
1094996|NCT01068678|2651702|P2|NOT COMPLETED|Overall Study||24
1094997|NCT01068678|2651703|P1|NOT COMPLETED|Overall Study||38
1094998|NCT01068678|2651702|P2|COMPLETED|Overall Study||206
1094999|NCT01068678|2651703|P1|COMPLETED|Overall Study||192
1095000|NCT01068678|2651702|P2|Exposed|Overall Study|one subject withdrew prior to exposure to trial product|229
1095001|NCT01068678|2651703|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial product.|227
1095002|NCT01068678|2651702|P2|STARTED|Overall Study||230
1095003|NCT01068678|2651703|P1|STARTED|Overall Study||230
1095004|NCT01068717|2651711|P4|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
1095005|NCT01068717|2651712|P3|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
1095006|NCT01068717|2651713|P2|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
1095007|NCT01068717|2651714|P1|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
1095008|NCT01068717|2651711|P4|COMPLETED|Period 4: Treatment Schedule Phase 4||7
1095009|NCT01068717|2651712|P3|COMPLETED|Period 4: Treatment Schedule Phase 4||7
1095010|NCT01068717|2651713|P2|COMPLETED|Period 4: Treatment Schedule Phase 4||6
1095011|NCT01068717|2651714|P1|COMPLETED|Period 4: Treatment Schedule Phase 4||7
1095012|NCT01068717|2651711|P4|STARTED|Period 4: Treatment Schedule Phase 4||7
1095013|NCT01068717|2651712|P3|STARTED|Period 4: Treatment Schedule Phase 4||7
1095014|NCT01068717|2651713|P2|STARTED|Period 4: Treatment Schedule Phase 4||6
1095015|NCT01068717|2651714|P1|STARTED|Period 4: Treatment Schedule Phase 4|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
1095016|NCT01068717|2651711|P4|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
1095017|NCT01068717|2651712|P3|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
1095018|NCT01068717|2651713|P2|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
1095019|NCT01068717|2651714|P1|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
1095020|NCT01068717|2651711|P4|COMPLETED|Period 3: Treatment Schedule Phase 3||7
1095021|NCT01068717|2651712|P3|COMPLETED|Period 3: Treatment Schedule Phase 3||7
1095022|NCT01068717|2651713|P2|COMPLETED|Period 3: Treatment Schedule Phase 3||6
1095023|NCT01068717|2651714|P1|COMPLETED|Period 3: Treatment Schedule Phase 3||7
1095024|NCT01068717|2651711|P4|STARTED|Period 3: Treatment Schedule Phase 3||7
1095025|NCT01068717|2651712|P3|STARTED|Period 3: Treatment Schedule Phase 3||7
1095026|NCT01068717|2651713|P2|STARTED|Period 3: Treatment Schedule Phase 3||6
1095027|NCT01068717|2651714|P1|STARTED|Period 3: Treatment Schedule Phase 3|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
1095028|NCT01068717|2651711|P4|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
1095029|NCT01068717|2651712|P3|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
1095030|NCT01068717|2651713|P2|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
1095031|NCT01068717|2651714|P1|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
1095032|NCT01068717|2651711|P4|COMPLETED|Period 2: Treatment Schedule Phase 2||7
1095033|NCT01068717|2651712|P3|COMPLETED|Period 2: Treatment Schedule Phase 2||7
1095034|NCT01068717|2651713|P2|COMPLETED|Period 2: Treatment Schedule Phase 2||6
1095035|NCT01068717|2651714|P1|COMPLETED|Period 2: Treatment Schedule Phase 2||6
1095036|NCT01068717|2651711|P4|STARTED|Period 2: Treatment Schedule Phase 2||7
1095037|NCT01068717|2651712|P3|STARTED|Period 2: Treatment Schedule Phase 2||7
1095038|NCT01068717|2651713|P2|STARTED|Period 2: Treatment Schedule Phase 2||6
1095039|NCT01068717|2651714|P1|STARTED|Period 2: Treatment Schedule Phase 2||6
1095040|NCT01068717|2651711|P4|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
1095041|NCT01068717|2651712|P3|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
1095042|NCT01068717|2651713|P2|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
1095043|NCT01068717|2651714|P1|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||1
1095044|NCT01068717|2651711|P4|COMPLETED|Period 1: Treatment Schedule Phase 1||7
1095045|NCT01068717|2651712|P3|COMPLETED|Period 1: Treatment Schedule Phase 1||7
1095046|NCT01068717|2651713|P2|COMPLETED|Period 1: Treatment Schedule Phase 1||6
1095047|NCT01068717|2651714|P1|COMPLETED|Period 1: Treatment Schedule Phase 1|Patient who withdrew returned for Treatment Periods 3 and 4.|6
1095048|NCT01068717|2651711|P4|STARTED|Period 1: Treatment Schedule Phase 1||7
1095049|NCT01068717|2651712|P3|STARTED|Period 1: Treatment Schedule Phase 1||7
1095050|NCT01068717|2651713|P2|STARTED|Period 1: Treatment Schedule Phase 1||6
1095051|NCT01068717|2651714|P1|STARTED|Period 1: Treatment Schedule Phase 1||7
1095052|NCT01068730|2651768|P4|NOT COMPLETED|Period 4||0
1095053|NCT01068730|2651769|P3|NOT COMPLETED|Period 4||0
1095054|NCT01068730|2651770|P2|NOT COMPLETED|Period 4||1
1095055|NCT01068730|2651771|P1|NOT COMPLETED|Period 4||0
1095056|NCT01068730|2651768|P4|COMPLETED|Period 4||7
1095057|NCT01068730|2651769|P3|COMPLETED|Period 4||7
1095058|NCT01068730|2651770|P2|COMPLETED|Period 4||6
1095059|NCT01068730|2651771|P1|COMPLETED|Period 4||6
1095060|NCT01068730|2651768|P4|STARTED|Period 4||7
1095061|NCT01068730|2651769|P3|STARTED|Period 4||7
1095062|NCT01068730|2651770|P2|STARTED|Period 4||7
1095063|NCT01068730|2651771|P1|STARTED|Period 4||6
1095064|NCT01068730|2651768|P4|NOT COMPLETED|Period 3||0
1095065|NCT01068730|2651769|P3|NOT COMPLETED|Period 3||0
1095066|NCT01068730|2651770|P2|NOT COMPLETED|Period 3||0
1095067|NCT01068730|2651771|P1|NOT COMPLETED|Period 3||1
1095068|NCT01068730|2651768|P4|COMPLETED|Period 3||7
1095069|NCT01068730|2651769|P3|COMPLETED|Period 3||7
1095070|NCT01068730|2651770|P2|COMPLETED|Period 3||7
1095071|NCT01068730|2651771|P1|COMPLETED|Period 3||6
1095072|NCT01068730|2651768|P4|STARTED|Period 3||7
1095073|NCT01068730|2651769|P3|STARTED|Period 3||7
1095074|NCT01068730|2651770|P2|STARTED|Period 3||7
1095075|NCT01068730|2651771|P1|STARTED|Period 3||7
1095076|NCT01068730|2651768|P4|NOT COMPLETED|Period 2||0
1095077|NCT01068730|2651769|P3|NOT COMPLETED|Period 2||0
1095078|NCT01068730|2651770|P2|NOT COMPLETED|Period 2||0
1095079|NCT01068730|2651771|P1|NOT COMPLETED|Period 2||0
1095080|NCT01068730|2651768|P4|COMPLETED|Period 2||7
1095081|NCT01068730|2651769|P3|COMPLETED|Period 2||7
1095082|NCT01068730|2651770|P2|COMPLETED|Period 2||7
1095083|NCT01068730|2651771|P1|COMPLETED|Period 2||7
1095084|NCT01068730|2651768|P4|STARTED|Period 2||7
1095085|NCT01068730|2651769|P3|STARTED|Period 2||7
1095086|NCT01068730|2651770|P2|STARTED|Period 2||7
1095087|NCT01068730|2651771|P1|STARTED|Period 2||7
1095088|NCT01068730|2651768|P4|NOT COMPLETED|Period 1||0
1095089|NCT01068730|2651769|P3|NOT COMPLETED|Period 1||0
1095090|NCT01068730|2651770|P2|NOT COMPLETED|Period 1||0
1095091|NCT01068730|2651771|P1|NOT COMPLETED|Period 1||0
1095092|NCT01068730|2651768|P4|COMPLETED|Period 1||7
1095093|NCT01068730|2651769|P3|COMPLETED|Period 1||7
1095094|NCT01068730|2651770|P2|COMPLETED|Period 1||7
1095095|NCT01068730|2651771|P1|COMPLETED|Period 1||7
1095096|NCT01068730|2651768|P4|STARTED|Period 1||7
1095097|NCT01068730|2651769|P3|STARTED|Period 1||7
1095098|NCT01068730|2651770|P2|STARTED|Period 1||7
1095099|NCT01068730|2651771|P1|STARTED|Period 1||7
1095100|NCT01068743|2651825|P4|NOT COMPLETED|Period 4||0
1095101|NCT01068743|2651826|P3|NOT COMPLETED|Period 4||0
1095102|NCT01068743|2651827|P2|NOT COMPLETED|Period 4||0
1095103|NCT01068743|2651828|P1|NOT COMPLETED|Period 4||0
1095104|NCT01068743|2651825|P4|COMPLETED|Period 4||6
1095105|NCT01068743|2651826|P3|COMPLETED|Period 4||6
1095106|NCT01068743|2651827|P2|COMPLETED|Period 4||5
1095107|NCT01068743|2651828|P1|COMPLETED|Period 4||6
1095108|NCT01068743|2651825|P4|STARTED|Period 4||6
1095109|NCT01068743|2651826|P3|STARTED|Period 4||6
1095110|NCT01068743|2651827|P2|STARTED|Period 4||5
1095111|NCT01068743|2651828|P1|STARTED|Period 4||6
1095112|NCT01068743|2651825|P4|NOT COMPLETED|Period 3||0
1095113|NCT01068743|2651826|P3|NOT COMPLETED|Period 3||0
1095114|NCT01068743|2651827|P2|NOT COMPLETED|Period 3||1
1095115|NCT01068743|2651828|P1|NOT COMPLETED|Period 3||0
1095116|NCT01068743|2651825|P4|COMPLETED|Period 3||6
1095117|NCT01068743|2651826|P3|COMPLETED|Period 3||6
1095118|NCT01068743|2651827|P2|COMPLETED|Period 3||5
1095119|NCT01068743|2651828|P1|COMPLETED|Period 3||6
1095120|NCT01068743|2651825|P4|STARTED|Period 3||6
1095121|NCT01068743|2651826|P3|STARTED|Period 3||6
1095122|NCT01068743|2651827|P2|STARTED|Period 3||6
1095123|NCT01068743|2651828|P1|STARTED|Period 3||6
1095124|NCT01068743|2651825|P4|NOT COMPLETED|Period 2||0
1095125|NCT01068743|2651826|P3|NOT COMPLETED|Period 2||0
1095126|NCT01068743|2651827|P2|NOT COMPLETED|Period 2||0
1095127|NCT01068743|2651828|P1|NOT COMPLETED|Period 2||0
1095128|NCT01068743|2651825|P4|COMPLETED|Period 2||6
1095129|NCT01068743|2651826|P3|COMPLETED|Period 2||6
1095130|NCT01068743|2651827|P2|COMPLETED|Period 2||6
1095131|NCT01068743|2651828|P1|COMPLETED|Period 2||6
1095132|NCT01068743|2651825|P4|STARTED|Period 2||6
1095133|NCT01068743|2651826|P3|STARTED|Period 2||6
1095134|NCT01068743|2651827|P2|STARTED|Period 2||6
1095135|NCT01068743|2651828|P1|STARTED|Period 2||6
1095136|NCT01068743|2651825|P4|NOT COMPLETED|Period 1||0
1095137|NCT01068743|2651826|P3|NOT COMPLETED|Period 1||0
1095138|NCT01068743|2651827|P2|NOT COMPLETED|Period 1||0
1095139|NCT01068743|2651828|P1|NOT COMPLETED|Period 1||0
1095140|NCT01068743|2651825|P4|COMPLETED|Period 1||6
1095141|NCT01068743|2651826|P3|COMPLETED|Period 1||6
1095142|NCT01068743|2651827|P2|COMPLETED|Period 1||6
1095143|NCT01068743|2651828|P1|COMPLETED|Period 1||6
1095144|NCT01068743|2651825|P4|STARTED|Period 1||6
1095145|NCT01068743|2651826|P3|STARTED|Period 1||6
1095146|NCT01068743|2651827|P2|STARTED|Period 1||6
1095147|NCT01068743|2651828|P1|STARTED|Period 1||6
1095148|NCT01068769|2651902|P1|NOT COMPLETED|Overall Study||1
1095149|NCT01068769|2651902|P1|COMPLETED|Overall Study||33
1095150|NCT01068769|2651902|P1|STARTED|Overall Study||34
1095151|NCT01068821|2651909|P2|NOT COMPLETED|Overall Study||0
1095152|NCT01068821|2651910|P1|NOT COMPLETED|Overall Study||1
1095153|NCT01068821|2651909|P2|COMPLETED|Overall Study||29
1095154|NCT01068821|2651910|P1|COMPLETED|Overall Study|1 patient had slide measured, but her patient ID not listed; couldn't do postoperative followup.|30
1095155|NCT01068821|2651909|P2|STARTED|Overall Study||29
1095156|NCT01068821|2651910|P1|STARTED|Overall Study||31
1095157|NCT01068860|2651928|P10|NOT COMPLETED|Overall Study||4
1095158|NCT01068860|2651929|P9|NOT COMPLETED|Overall Study||0
1095159|NCT01068860|2651930|P8|NOT COMPLETED|Overall Study||0
1095160|NCT01068860|2651931|P7|NOT COMPLETED|Overall Study||0
1095161|NCT01068860|2651932|P6|NOT COMPLETED|Overall Study||2
1095162|NCT01068860|2651933|P5|NOT COMPLETED|Overall Study||0
1095163|NCT01068860|2651934|P4|NOT COMPLETED|Overall Study||1
1095164|NCT01068860|2651935|P3|NOT COMPLETED|Overall Study||0
1095165|NCT01068860|2651936|P2|NOT COMPLETED|Overall Study||1
1095166|NCT01068860|2651937|P1|NOT COMPLETED|Overall Study||0
1095167|NCT01068860|2651928|P10|COMPLETED|Overall Study||23
1095168|NCT01068860|2651929|P9|COMPLETED|Overall Study||28
1095169|NCT01068860|2651930|P8|COMPLETED|Overall Study||15
1095170|NCT01068860|2651931|P7|COMPLETED|Overall Study||28
1095171|NCT01068860|2651932|P6|COMPLETED|Overall Study||14
1095172|NCT01068860|2651933|P5|COMPLETED|Overall Study||32
1095173|NCT01068860|2651934|P4|COMPLETED|Overall Study||16
1095174|NCT01068860|2651935|P3|COMPLETED|Overall Study||33
1095175|NCT01068860|2651936|P2|COMPLETED|Overall Study||16
1095176|NCT01068860|2651937|P1|COMPLETED|Overall Study||33
1095177|NCT01068860|2651928|P10|STARTED|Overall Study||27
1095178|NCT01068860|2651929|P9|STARTED|Overall Study||28
1095179|NCT01068860|2651930|P8|STARTED|Overall Study||15
1095180|NCT01068860|2651931|P7|STARTED|Overall Study||28
1095181|NCT01068860|2651932|P6|STARTED|Overall Study||16
1095182|NCT01068860|2651933|P5|STARTED|Overall Study||32
1095183|NCT01068860|2651934|P4|STARTED|Overall Study||17
1095184|NCT01068860|2651935|P3|STARTED|Overall Study||33
1095185|NCT01068860|2651936|P2|STARTED|Overall Study||17
1095186|NCT01068860|2651937|P1|STARTED|Overall Study||33
1095187|NCT01068912|2652112|P3|NOT COMPLETED|Overall Study||15
1095188|NCT01068912|2652113|P2|NOT COMPLETED|Overall Study||22
1095189|NCT01068912|2652114|P1|NOT COMPLETED|Overall Study||11
1095190|NCT01068912|2652112|P3|COMPLETED|Overall Study||186
1095191|NCT01068912|2652113|P2|COMPLETED|Overall Study||173
1095192|NCT01068912|2652114|P1|COMPLETED|Overall Study||123
1095193|NCT01068912|2652112|P3|STARTED|Overall Study||201
1095194|NCT01068912|2652113|P2|STARTED|Overall Study||195
1095195|NCT01068912|2652114|P1|STARTED|Overall Study||134
1095196|NCT01068964|2652124|P2|NOT COMPLETED|Overall Study||10
1095197|NCT01068964|2652125|P1|NOT COMPLETED|Overall Study||8
1095198|NCT01068964|2652124|P2|COMPLETED|Overall Study||104
1095199|NCT01068964|2652125|P1|COMPLETED|Overall Study||113
1095200|NCT01068964|2652124|P2|STARTED|Overall Study||114
1095201|NCT01068964|2652125|P1|STARTED|Overall Study||121
1095202|NCT01069003|2652134|P3|NOT COMPLETED|Overall Study||475
1095203|NCT01069003|2652135|P2|NOT COMPLETED|Overall Study||54
1095204|NCT01069003|2652136|P1|NOT COMPLETED|Overall Study||46
1095205|NCT01069003|2652134|P3|COMPLETED|Overall Study||976
1095206|NCT01069003|2652135|P2|COMPLETED|Overall Study||358
1095207|NCT01069003|2652136|P1|COMPLETED|Overall Study||353
1095208|NCT01069003|2652134|P3|STARTED|Overall Study||1451
1095209|NCT01069003|2652135|P2|STARTED|Overall Study||412
1095210|NCT01069003|2652136|P1|STARTED|Overall Study||399
1095211|NCT01069120|2652152|P1|NOT COMPLETED|Overall Study||27
1095212|NCT01069120|2652152|P1|COMPLETED|Overall Study||0
1095213|NCT01069120|2652152|P1|STARTED|Overall Study||27
1095214|NCT01069172|2652158|P2|NOT COMPLETED|Overall Study||0
1095215|NCT01069172|2652159|P1|NOT COMPLETED|Overall Study||1
1095216|NCT01069172|2652158|P2|COMPLETED|Overall Study|30 eyes|30
1095217|NCT01069172|2652159|P1|COMPLETED|Overall Study|29 eyes|29
1095218|NCT01069172|2652158|P2|STARTED|Overall Study|30 eyes|30
1095219|NCT01069172|2652159|P1|STARTED|Overall Study|30 eyes|30
1095220|NCT01069185|2652169|P2|NOT COMPLETED|Overall Study||0
1095221|NCT01069185|2652170|P1|NOT COMPLETED|Overall Study||0
1095222|NCT01069185|2652169|P2|COMPLETED|Overall Study||45
1095223|NCT01069185|2652170|P1|COMPLETED|Overall Study||47
1095224|NCT01069185|2652169|P2|STARTED|Overall Study||45
1095225|NCT01069185|2652170|P1|STARTED|Overall Study||47
1095226|NCT01069289|2652180|P2|NOT COMPLETED|Overall Study||56
1095227|NCT01069289|2652181|P1|NOT COMPLETED|Overall Study||42
1095228|NCT01069289|2652180|P2|COMPLETED|Overall Study||601
1095229|NCT01069289|2652181|P1|COMPLETED|Overall Study||594
1095230|NCT01069289|2652180|P2|STARTED|Overall Study||657
1095231|NCT01069289|2652181|P1|STARTED|Overall Study||636
1095232|NCT01069341|2652219|P1|NOT COMPLETED|Overall Study||1
1095233|NCT01069341|2652219|P1|COMPLETED|Overall Study||3
1095234|NCT01069341|2652219|P1|STARTED|Overall Study||4
1095235|NCT01069419|2652230|P1|NOT COMPLETED|Overall Study||715
1095236|NCT01069419|2652230|P1|COMPLETED|Overall Study||402
1095237|NCT01069419|2652230|P1|Full Analysis Set|Overall Study||851
1095238|NCT01069419|2652230|P1|Safety Set|Overall Study||1111
1095239|NCT01069419|2652230|P1|STARTED|Overall Study||1117
1095240|NCT01069484|2652239|P2|NOT COMPLETED|Overall Study||3
1095241|NCT01069484|2652240|P1|NOT COMPLETED|Overall Study||12
1095242|NCT01069484|2652239|P2|COMPLETED|Overall Study|27 in the stratum with major levator ani muscle defects and 58 in the stratum without such defects.|85
1095243|NCT01069484|2652240|P1|COMPLETED|Overall Study|24 in the stratum with major levator ani muscle defects and 51 in the stratum without such defects.|75
1095244|NCT01069484|2652239|P2|STARTED|Overall Study|28 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|88
1095245|NCT01069484|2652240|P1|STARTED|Overall Study|27 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|87
1095246|NCT01069523|2652250|P2|NOT COMPLETED|Overall Study||7
1095247|NCT01069523|2652251|P1|NOT COMPLETED|Overall Study||4
1095248|NCT01069523|2652250|P2|COMPLETED|Overall Study||9
1095249|NCT01069523|2652251|P1|COMPLETED|Overall Study||9
1095250|NCT01069523|2652250|P2|STARTED|Overall Study||16
1095251|NCT01069523|2652251|P1|STARTED|Overall Study||13
1095252|NCT01069562|2652261|P2|NOT COMPLETED|Overall Study||0
1095253|NCT01069562|2652262|P1|NOT COMPLETED|Overall Study||0
1095254|NCT01069562|2652261|P2|COMPLETED|Overall Study||20
1095255|NCT01069562|2652262|P1|COMPLETED|Overall Study||20
1095256|NCT01069562|2652261|P2|STARTED|Overall Study||20
1095257|NCT01069562|2652262|P1|STARTED|Overall Study||20
1095258|NCT01069627|2652286|P1|NOT COMPLETED|Overall Study||20
1095259|NCT01069627|2652286|P1|COMPLETED|Overall Study||0
1095260|NCT01069627|2652286|P1|STARTED|Overall Study||20
1095261|NCT01069861|2652307|P1|NOT COMPLETED|Overall Study||3
1095262|NCT01069861|2652307|P1|COMPLETED|Overall Study||1
1095263|NCT01069861|2652307|P1|STARTED|Overall Study||4
1095264|NCT01069900|2652322|P2|NOT COMPLETED|Overall Study||4
1095265|NCT01069900|2652323|P1|NOT COMPLETED|Overall Study||18
1095266|NCT01069900|2652322|P2|COMPLETED|Overall Study||149
1095267|NCT01069900|2652323|P1|COMPLETED|Overall Study||287
1095268|NCT01069900|2652322|P2|Treated|Overall Study||150
1095269|NCT01069900|2652323|P1|Treated|Overall Study||301
1095270|NCT01069900|2652322|P2|STARTED|Overall Study||153
1095271|NCT01069900|2652323|P1|STARTED|Overall Study||305
1095272|NCT01069939|2652369|P2|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||32
1095273|NCT01069939|2652370|P1|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||31
1095274|NCT01069939|2652369|P2|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
1095275|NCT01069939|2652370|P1|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
1095276|NCT01069939|2652369|P2|STARTED|At Data Cut Off Date (26 Feb 2011)||214
1095277|NCT01069939|2652370|P1|STARTED|At Data Cut Off Date (26 Feb 2011)||213
1095278|NCT01069939|2652369|P2|NOT COMPLETED|Randomised and Included in the Analyses||77
1095279|NCT01069939|2652370|P1|NOT COMPLETED|Randomised and Included in the Analyses||49
1095280|NCT01069939|2652369|P2|COMPLETED|Randomised and Included in the Analyses||137
1095281|NCT01069939|2652370|P1|COMPLETED|Randomised and Included in the Analyses||164
1095282|NCT01069939|2652369|P2|STARTED|Randomised and Included in the Analyses||214
1095283|NCT01069939|2652370|P1|STARTED|Randomised and Included in the Analyses||213
1095284|NCT01070043|2652396|P3|NOT COMPLETED|Double-Blind Treatment||2
1095285|NCT01070043|2652397|P2|NOT COMPLETED|Double-Blind Treatment||0
1095286|NCT01070043|2652398|P1|NOT COMPLETED|Double-Blind Treatment||0
1095287|NCT01070043|2652396|P3|COMPLETED|Double-Blind Treatment||19
1095288|NCT01070043|2652397|P2|COMPLETED|Double-Blind Treatment||21
1095289|NCT01070043|2652398|P1|COMPLETED|Double-Blind Treatment||0
1095290|NCT01070043|2652396|P3|STARTED|Double-Blind Treatment||21
1095291|NCT01070043|2652397|P2|STARTED|Double-Blind Treatment||21
1095292|NCT01070043|2652398|P1|STARTED|Double-Blind Treatment||0
1095293|NCT01070043|2652396|P3|NOT COMPLETED|Run-In Phase||0
1095294|NCT01070043|2652397|P2|NOT COMPLETED|Run-In Phase||0
1095295|NCT01070043|2652398|P1|NOT COMPLETED|Run-In Phase||18
1095296|NCT01070043|2652396|P3|COMPLETED|Run-In Phase||0
1095297|NCT01070043|2652397|P2|COMPLETED|Run-In Phase||0
1095298|NCT01070043|2652398|P1|COMPLETED|Run-In Phase||42
1095299|NCT01070043|2652396|P3|STARTED|Run-In Phase|This monotherapy (Valsartan 160 mg) treatment arm is used only for double-blind phase.|0
1095300|NCT01070043|2652397|P2|STARTED|Run-In Phase|This combination therapy arm is used only for double-blind phase.|0
1095301|NCT01070043|2652398|P1|STARTED|Run-In Phase||60
1095302|NCT01070173|2652415|P3|NOT COMPLETED|Overall Study||0
1095303|NCT01070173|2652416|P2|NOT COMPLETED|Overall Study||0
1095304|NCT01070173|2652417|P1|NOT COMPLETED|Overall Study||0
1095305|NCT01070173|2652415|P3|COMPLETED|Overall Study||11
1095306|NCT01070173|2652416|P2|COMPLETED|Overall Study||8
1095307|NCT01070173|2652417|P1|COMPLETED|Overall Study||33
1095308|NCT01070173|2652415|P3|STARTED|Overall Study||11
1095309|NCT01070173|2652416|P2|STARTED|Overall Study||8
1095310|NCT01070173|2652417|P1|STARTED|Overall Study||33
1095311|NCT01070303|2652430|P1|NOT COMPLETED|Overall Study||89
1095312|NCT01070303|2652430|P1|COMPLETED|Overall Study||88
1095313|NCT01070303|2652430|P1|STARTED|Overall Study||177
1095314|NCT01070316|2652486|P1|NOT COMPLETED|Extension Phase||4
1095315|NCT01070316|2652486|P1|COMPLETED|Extension Phase||14
1095316|NCT01070316|2652486|P1|STARTED|Extension Phase|Two participants did not qualify for Extension Phase as defined by protocol|18
1095317|NCT01070316|2652486|P1|NOT COMPLETED|Main Phase||0
1095318|NCT01070316|2652486|P1|COMPLETED|Main Phase||20
1095319|NCT01070316|2652486|P1|STARTED|Main Phase||20
1095320|NCT01070329|2652493|P2|NOT COMPLETED|Overall Study||49
1095321|NCT01070329|2652494|P1|NOT COMPLETED|Overall Study||52
1095322|NCT01070329|2652493|P2|COMPLETED|Overall Study||217
1095323|NCT01070329|2652494|P1|COMPLETED|Overall Study||209
1095324|NCT01070329|2652493|P2|STARTED|Overall Study||266
1095325|NCT01070329|2652494|P1|STARTED|Overall Study||261
1095326|NCT01070381|2652526|P2|NOT COMPLETED|Period 2, 1 Week of Wear||1
1095327|NCT01070381|2652527|P1|NOT COMPLETED|Period 2, 1 Week of Wear||1
1095328|NCT01070381|2652526|P2|COMPLETED|Period 2, 1 Week of Wear||106
1095329|NCT01070381|2652527|P1|COMPLETED|Period 2, 1 Week of Wear||108
1095330|NCT01070381|2652526|P2|STARTED|Period 2, 1 Week of Wear||107
1095331|NCT01070381|2652527|P1|STARTED|Period 2, 1 Week of Wear||109
1095332|NCT01070381|2652526|P2|NOT COMPLETED|Period 1, 1 Week of Wear||0
1095333|NCT01070381|2652527|P1|NOT COMPLETED|Period 1, 1 Week of Wear||0
1095334|NCT01070381|2652526|P2|COMPLETED|Period 1, 1 Week of Wear||107
1095335|NCT01070381|2652527|P1|COMPLETED|Period 1, 1 Week of Wear|One subject could not continue into Period 2 due to product unavailability.|109
1095336|NCT01070381|2652526|P2|STARTED|Period 1, 1 Week of Wear||107
1095337|NCT01070381|2652527|P1|STARTED|Period 1, 1 Week of Wear|One subject could not be dispensed into Period 1 product. Subject started Period 2 wear.|109
1095338|NCT01070394|2652533|P1|NOT COMPLETED|Overall Study||7
1095339|NCT01070394|2652533|P1|COMPLETED|Overall Study||33
1095340|NCT01070394|2652533|P1|STARTED|Overall Study||40
1095341|NCT01063036|2652544|P1|NOT COMPLETED|Post Dosing Follow-up Through 24 Weeks||39
1095342|NCT01063036|2652544|P1|COMPLETED|Post Dosing Follow-up Through 24 Weeks||46
1095343|NCT01063036|2652544|P1|STARTED|Post Dosing Follow-up Through 24 Weeks|2 included did not complete treatment; 3 completed treatment but not included (lost to follow-up).|85
1095344|NCT01063036|2652544|P1|NOT COMPLETED|Participants Treated With Study Drug||6
1095345|NCT01063036|2652544|P1|COMPLETED|Participants Treated With Study Drug||86
1095346|NCT01063036|2652544|P1|STARTED|Participants Treated With Study Drug||92
1095347|NCT01063049|2652561|P3|NOT COMPLETED|Overall Study||0
1095348|NCT01063049|2652562|P2|NOT COMPLETED|Overall Study||0
1095349|NCT01063049|2652563|P1|NOT COMPLETED|Overall Study||0
1095350|NCT01063049|2652561|P3|COMPLETED|Overall Study||200
1095351|NCT01063049|2652562|P2|COMPLETED|Overall Study||200
1095352|NCT01063049|2652563|P1|COMPLETED|Overall Study||200
1095353|NCT01063049|2652561|P3|STARTED|Overall Study||200
1095354|NCT01063049|2652562|P2|STARTED|Overall Study||200
1095355|NCT01063049|2652563|P1|STARTED|Overall Study||200
1095356|NCT01063062|2652576|P2|NOT COMPLETED|Overall Study||12
1095357|NCT01063062|2652577|P1|NOT COMPLETED|Overall Study||8
1095358|NCT01063062|2652576|P2|COMPLETED|Overall Study||65
1095359|NCT01063062|2652577|P1|COMPLETED|Overall Study||22
1095360|NCT01063062|2652576|P2|Received Study Drug|Overall Study||76
1095361|NCT01063062|2652577|P1|Received Study Drug|Overall Study||29
1095362|NCT01063062|2652576|P2|STARTED|Overall Study||77
1095363|NCT01063062|2652577|P1|STARTED|Overall Study||30
1095364|NCT01063075|2652615|P4|NOT COMPLETED|Overall Study||1
1095365|NCT01063075|2652616|P3|NOT COMPLETED|Overall Study||5
1095366|NCT01063075|2652617|P2|NOT COMPLETED|Overall Study||2
1095367|NCT01063075|2652618|P1|NOT COMPLETED|Overall Study||1
1095368|NCT01063075|2652615|P4|COMPLETED|Overall Study||14
1095369|NCT01063075|2652616|P3|COMPLETED|Overall Study||9
1095370|NCT01063075|2652617|P2|COMPLETED|Overall Study||1
1095371|NCT01063075|2652618|P1|COMPLETED|Overall Study||1
1095372|NCT01063075|2652615|P4|STARTED|Overall Study||15
1095373|NCT01063075|2652616|P3|STARTED|Overall Study||14
1095374|NCT01063075|2652617|P2|STARTED|Overall Study||3
1095375|NCT01063075|2652618|P1|STARTED|Overall Study||2
1095376|NCT01063153|2652636|P2|NOT COMPLETED|Overall Study||12
1095377|NCT01063153|2652637|P1|NOT COMPLETED|Overall Study||2
1095378|NCT01063153|2652636|P2|COMPLETED|Overall Study||26
1095379|NCT01063153|2652637|P1|COMPLETED|Overall Study||31
1095380|NCT01063153|2652636|P2|STARTED|Overall Study||38
1095381|NCT01063153|2652637|P1|STARTED|Overall Study||33
1095382|NCT01063348|2652649|P2|NOT COMPLETED|Overall Study||10
1095383|NCT01063348|2652650|P1|NOT COMPLETED|Overall Study||3
1095384|NCT01063348|2652649|P2|COMPLETED|Overall Study||21
1095385|NCT01063348|2652650|P1|COMPLETED|Overall Study||32
1095386|NCT01063348|2652649|P2|STARTED|Overall Study||31
1095387|NCT01063348|2652650|P1|STARTED|Overall Study||35
1095388|NCT01063517|2652660|P2|NOT COMPLETED|Overall Study||60
1095389|NCT01063517|2652661|P1|NOT COMPLETED|Overall Study||58
1095390|NCT01063517|2652660|P2|COMPLETED|Overall Study||2
1095391|NCT01063517|2652661|P1|COMPLETED|Overall Study||4
1095392|NCT01063517|2652660|P2|Received Randomised Treatment|Overall Study||62
1095393|NCT01063517|2652661|P1|Received Randomised Treatment|Overall Study||61
1095394|NCT01063517|2652660|P2|STARTED|Overall Study||62
1095395|NCT01063517|2652661|P1|STARTED|Overall Study||62
1095396|NCT01063595|2652699|P2|NOT COMPLETED|Second Intervention||0
1095397|NCT01063595|2652700|P1|NOT COMPLETED|Second Intervention||0
1095398|NCT01063595|2652699|P2|COMPLETED|Second Intervention||24
1095399|NCT01063595|2652700|P1|COMPLETED|Second Intervention||29
1095400|NCT01063595|2652699|P2|STARTED|Second Intervention||24
1095401|NCT01063595|2652700|P1|STARTED|Second Intervention||29
1095402|NCT01063595|2652699|P2|NOT COMPLETED|First Intervention||5
1095403|NCT01063595|2652700|P1|NOT COMPLETED|First Intervention||2
1095404|NCT01063595|2652699|P2|COMPLETED|First Intervention||24
1095405|NCT01063595|2652700|P1|COMPLETED|First Intervention||29
1095406|NCT01063595|2652699|P2|STARTED|First Intervention||29
1095407|NCT01063595|2652700|P1|STARTED|First Intervention||31
1095408|NCT01063595|2652699|P2|NOT COMPLETED|Enrolled in Study and Randomized||2
1095409|NCT01063595|2652700|P1|NOT COMPLETED|Enrolled in Study and Randomized||1
1095410|NCT01063595|2652699|P2|COMPLETED|Enrolled in Study and Randomized||29
1095411|NCT01063595|2652700|P1|COMPLETED|Enrolled in Study and Randomized||31
1095412|NCT01063595|2652699|P2|Received Treatment|Enrolled in Study and Randomized||29
1095413|NCT01063595|2652700|P1|Received Treatment|Enrolled in Study and Randomized||31
1095414|NCT01063595|2652699|P2|STARTED|Enrolled in Study and Randomized||31
1095415|NCT01063595|2652700|P1|STARTED|Enrolled in Study and Randomized||32
1095416|NCT01063712|2652710|P1|NOT COMPLETED|Overall Study||0
1095417|NCT01063712|2652710|P1|COMPLETED|Overall Study||29
1095418|NCT01063712|2652710|P1|STARTED|Overall Study||29
1095419|NCT01063764|2652715|P1|NOT COMPLETED|2nd Period (Week 22 to the End of Study)||20
1095420|NCT01063764|2652715|P1|COMPLETED|2nd Period (Week 22 to the End of Study)||35
1095421|NCT01063764|2652715|P1|STARTED|2nd Period (Week 22 to the End of Study)|7 subjects who completed Period 1 did not enter the Second Period.|55
1095422|NCT01063764|2652715|P1|NOT COMPLETED|1st Period (From Week 8 to Week 22)||11
1095423|NCT01063764|2652715|P1|COMPLETED|1st Period (From Week 8 to Week 22)|62 subjects completed the First Period, but 7 of these subjects did not enter the Second Period.|62
1095424|NCT01063764|2652715|P1|STARTED|1st Period (From Week 8 to Week 22)||73
1095425|NCT01063855|2652731|P2|NOT COMPLETED|Overall Study||29
1095426|NCT01063855|2652732|P1|NOT COMPLETED|Overall Study||37
1095427|NCT01063855|2652731|P2|COMPLETED|Overall Study||221
1095428|NCT01063855|2652732|P1|COMPLETED|Overall Study||208
1095429|NCT01063855|2652731|P2|STARTED|Overall Study||250
1095430|NCT01063855|2652732|P1|STARTED|Overall Study||245
1095431|NCT01063868|2652756|P2|NOT COMPLETED|Overall Study||12
1095432|NCT01063868|2652757|P1|NOT COMPLETED|Overall Study||35
1095433|NCT01063868|2652756|P2|COMPLETED|Overall Study||0
1095434|NCT01063868|2652757|P1|COMPLETED|Overall Study||0
1095435|NCT01063868|2652756|P2|STARTED|Overall Study||12
1095436|NCT01063868|2652757|P1|STARTED|Overall Study||35
1095437|NCT01063881|2652766|P3|NOT COMPLETED|Overall Study||1
1095438|NCT01063881|2652767|P2|NOT COMPLETED|Overall Study||11
1095439|NCT01063881|2652768|P1|NOT COMPLETED|Overall Study||55
1095440|NCT01063881|2652766|P3|COMPLETED|Overall Study||12
1095441|NCT01063881|2652767|P2|COMPLETED|Overall Study||114
1095442|NCT01063881|2652768|P1|COMPLETED|Overall Study||92
1095443|NCT01063881|2652766|P3|STARTED|Overall Study||13
1095444|NCT01063881|2652767|P2|STARTED|Overall Study||125
1095445|NCT01063881|2652768|P1|STARTED|Overall Study||147
1095446|NCT01063907|2652790|P2|NOT COMPLETED|Overall Study||0
1095447|NCT01063907|2652791|P1|NOT COMPLETED|Overall Study||0
1095448|NCT01063907|2652790|P2|COMPLETED|Overall Study||80
1095449|NCT01063907|2652791|P1|COMPLETED|Overall Study||15
1095450|NCT01063907|2652790|P2|STARTED|Overall Study||80
1095451|NCT01063907|2652791|P1|STARTED|Overall Study||15
1095452|NCT01064076|2652821|P1|NOT COMPLETED|Overall Study||18
1095453|NCT01064076|2652821|P1|COMPLETED|Overall Study|303 subjects completed a minimum of 180 days of follow up|303
1095454|NCT01064076|2652821|P1|STARTED|Overall Study|321 subjects underwent an implant procedure for the S-ICD System|321
1095455|NCT01064167|2652828|P2|NOT COMPLETED|Overall Study||15
1095456|NCT01064167|2652829|P1|NOT COMPLETED|Overall Study||14
1095457|NCT01064167|2652828|P2|COMPLETED|Overall Study||115
1095458|NCT01064167|2652829|P1|COMPLETED|Overall Study||116
1095459|NCT01064167|2652828|P2|STARTED|Overall Study||130
1095460|NCT01064167|2652829|P1|STARTED|Overall Study||130
1095461|NCT01064284|2652839|P2|NOT COMPLETED|Overall Study||17
1095462|NCT01064284|2652840|P1|NOT COMPLETED|Overall Study||18
1095463|NCT01064284|2652839|P2|COMPLETED|Overall Study||109
1095464|NCT01064284|2652840|P1|COMPLETED|Overall Study||107
1095465|NCT01064284|2652839|P2|STARTED|Overall Study|Taking into account the analyzed patients only|126
1095466|NCT01064284|2652840|P1|STARTED|Overall Study|Taking into account the analyzed patients only|125
1095467|NCT01064297|2652863|P3|NOT COMPLETED|Overall Study||133
1095468|NCT01064297|2652864|P2|NOT COMPLETED|Overall Study||48
1095469|NCT01064297|2652865|P1|NOT COMPLETED|Overall Study||791
1095470|NCT01064297|2652863|P3|COMPLETED|Overall Study||497
1095471|NCT01064297|2652864|P2|COMPLETED|Overall Study||171
1095472|NCT01064297|2652865|P1|COMPLETED|Overall Study||1776
1095473|NCT01064297|2652863|P3|STARTED|Overall Study||630
1095474|NCT01064297|2652864|P2|STARTED|Overall Study||219
1095475|NCT01064297|2652865|P1|STARTED|Overall Study||2567
1095476|NCT01064310|2652911|P3|NOT COMPLETED|Open Label Pazopinib||84
1095477|NCT01064310|2652912|P2|NOT COMPLETED|Open Label Pazopinib||0
1095478|NCT01064310|2652913|P1|NOT COMPLETED|Open Label Pazopinib||0
1095479|NCT01064310|2652911|P3|COMPLETED|Open Label Pazopinib||0
1095480|NCT01064310|2652912|P2|COMPLETED|Open Label Pazopinib||0
1095481|NCT01064310|2652913|P1|COMPLETED|Open Label Pazopinib||0
1095482|NCT01064310|2652911|P3|STARTED|Open Label Pazopinib||84
1095483|NCT01064310|2652912|P2|STARTED|Open Label Pazopinib||0
1095484|NCT01064310|2652913|P1|STARTED|Open Label Pazopinib||0
1095485|NCT01064310|2652911|P3|NOT COMPLETED|Period 2||0
1095486|NCT01064310|2652912|P2|NOT COMPLETED|Period 2||6
1095487|NCT01064310|2652913|P1|NOT COMPLETED|Period 2||4
1095488|NCT01064310|2652911|P3|COMPLETED|Period 2||0
1095489|NCT01064310|2652912|P2|COMPLETED|Period 2||62
1095490|NCT01064310|2652913|P1|COMPLETED|Period 2||64
1095491|NCT01064310|2652911|P3|STARTED|Period 2||0
1095492|NCT01064310|2652912|P2|STARTED|Period 2||68
1095493|NCT01064310|2652913|P1|STARTED|Period 2||68
1095494|NCT01064310|2652911|P3|NOT COMPLETED|Period 1||0
1095495|NCT01064310|2652912|P2|NOT COMPLETED|Period 1||18
1095496|NCT01064310|2652913|P1|NOT COMPLETED|Period 1||14
1095497|NCT01064310|2652911|P3|COMPLETED|Period 1||0
1095498|NCT01064310|2652912|P2|COMPLETED|Period 1||68
1095499|NCT01064310|2652913|P1|COMPLETED|Period 1||68
1095500|NCT01064310|2652911|P3|STARTED|Period 1||0
1095501|NCT01064310|2652912|P2|STARTED|Period 1||86
1095502|NCT01064310|2652913|P1|STARTED|Period 1||82
1095503|NCT01064323|2652940|P1|NOT COMPLETED|Overall Study||0
1095504|NCT01064323|2652940|P1|COMPLETED|Overall Study||10
1095505|NCT01064323|2652940|P1|STARTED|Overall Study||10
1095506|NCT01064362|2652964|P2|NOT COMPLETED|Overall Study||0
1095507|NCT01064362|2652965|P1|NOT COMPLETED|Overall Study||0
1095508|NCT01064362|2652964|P2|COMPLETED|Overall Study||11883
1095509|NCT01064362|2652965|P1|COMPLETED|Overall Study||1559
1095510|NCT01064362|2652964|P2|STARTED|Overall Study||11883
1095511|NCT01064362|2652965|P1|STARTED|Overall Study||1559
1095512|NCT01064401|2652975|P2|NOT COMPLETED|Overall Study||195
1095513|NCT01064401|2652976|P1|NOT COMPLETED|Overall Study||228
1095514|NCT01064401|2652975|P2|COMPLETED|Overall Study||724
1095515|NCT01064401|2652976|P1|COMPLETED|Overall Study||694
1095516|NCT01064401|2652975|P2|STARTED|Overall Study||919
1095517|NCT01064401|2652976|P1|STARTED|Overall Study||922
1095518|NCT01064414|2652993|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
1095519|NCT01064414|2652994|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
1095520|NCT01064414|2652995|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
1095521|NCT01064414|2652993|P3|COMPLETED|Extension Period: Week 26 to Week 52||76
1095522|NCT01064414|2652994|P2|COMPLETED|Extension Period: Week 26 to Week 52||67
1095523|NCT01064414|2652995|P1|COMPLETED|Extension Period: Week 26 to Week 52||64
1095524|NCT01064414|2652993|P3|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|81
1095525|NCT01064414|2652994|P2|STARTED|Extension Period: Week 26 to Week 52|3 pts completed core but did not enter ext. Reason: other (not specified) (3).|72
1095526|NCT01064414|2652995|P1|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|76
1095527|NCT01064414|2652993|P3|NOT COMPLETED|Core Period: Baseline to Week 26||7
1095528|NCT01064414|2652994|P2|NOT COMPLETED|Core Period: Baseline to Week 26||15
1095529|NCT01064414|2652995|P1|NOT COMPLETED|Core Period: Baseline to Week 26||13
1095530|NCT01064414|2652993|P3|COMPLETED|Core Period: Baseline to Week 26||82
1095531|NCT01064414|2652994|P2|COMPLETED|Core Period: Baseline to Week 26||75
1095532|NCT01064414|2652995|P1|COMPLETED|Core Period: Baseline to Week 26||77
1095533|NCT01064414|2652993|P3|STARTED|Core Period: Baseline to Week 26||89
1095534|NCT01064414|2652994|P2|STARTED|Core Period: Baseline to Week 26||90
1095535|NCT01064414|2652995|P1|STARTED|Core Period: Baseline to Week 26||90
1095536|NCT01064622|2653015|P2|NOT COMPLETED|Crossover of Arm I||0
1095537|NCT01064622|2653016|P1|NOT COMPLETED|Crossover of Arm I||0
1095538|NCT01064622|2653015|P2|COMPLETED|Crossover of Arm I||0
1095539|NCT01064622|2653016|P1|COMPLETED|Crossover of Arm I||22
1095540|NCT01064622|2653015|P2|STARTED|Crossover of Arm I||0
1095541|NCT01064622|2653016|P1|STARTED|Crossover of Arm I|Among 53 patients, 45 had disease progression; however 23 elected not to crossover to vismodegib.|22
1095542|NCT01064622|2653015|P2|NOT COMPLETED|Randomized Phase II||3
1095543|NCT01064622|2653016|P1|NOT COMPLETED|Randomized Phase II||2
1095544|NCT01064622|2653015|P2|COMPLETED|Randomized Phase II||53
1095545|NCT01064622|2653016|P1|COMPLETED|Randomized Phase II||53
1095546|NCT01064622|2653015|P2|STARTED|Randomized Phase II||56
1095547|NCT01064622|2653016|P1|STARTED|Randomized Phase II||55
1095548|NCT01064622|2653015|P2|NOT COMPLETED|Lead-in Phase I||0
1095549|NCT01064622|2653016|P1|NOT COMPLETED|Lead-in Phase I||0
1095550|NCT01064622|2653015|P2|COMPLETED|Lead-in Phase I||7
1095551|NCT01064622|2653016|P1|COMPLETED|Lead-in Phase I||0
1095552|NCT01064622|2653015|P2|STARTED|Lead-in Phase I||7
1095553|NCT01064622|2653016|P1|STARTED|Lead-in Phase I||0
1095554|NCT01064687|2653041|P4|NOT COMPLETED|Overall Study||17
1095555|NCT01064687|2653042|P3|NOT COMPLETED|Overall Study||41
1095556|NCT01064687|2653043|P2|NOT COMPLETED|Overall Study||26
1095557|NCT01064687|2653044|P1|NOT COMPLETED|Overall Study||34
1095558|NCT01064687|2653041|P4|COMPLETED|Overall Study||124
1095559|NCT01064687|2653042|P3|COMPLETED|Overall Study||237
1095560|NCT01064687|2653043|P2|COMPLETED|Overall Study||254
1095561|NCT01064687|2653044|P1|COMPLETED|Overall Study||245
1095562|NCT01064687|2653041|P4|Completed 26 Weeks|Overall Study||124
1095563|NCT01064687|2653042|P3|Completed 26 Weeks|Overall Study||252
1095564|NCT01064687|2653043|P2|Completed 26 Weeks|Overall Study||263
1095565|NCT01064687|2653044|P1|Completed 26 Weeks|Overall Study||260
1095566|NCT01064687|2653041|P4|Received at Least 1 Dose of Study Drug|Overall Study||141
1095567|NCT01064687|2653042|P3|Received at Least 1 Dose of Study Drug|Overall Study||276
1095568|NCT01064687|2653043|P2|Received at Least 1 Dose of Study Drug|Overall Study||280
1095569|NCT01064687|2653044|P1|Received at Least 1 Dose of Study Drug|Overall Study||279
1095570|NCT01064687|2653041|P4|STARTED|Overall Study||141
1095571|NCT01064687|2653042|P3|STARTED|Overall Study|Of 278 participants randomized to Exenatide, 2 chose not to take study drug.|278
1095572|NCT01064687|2653043|P2|STARTED|Overall Study||280
1095573|NCT01064687|2653044|P1|STARTED|Overall Study||279
1095574|NCT01064739|2653221|P1|NOT COMPLETED|Fixed Sodium Diet + Fava Beans||1
1095575|NCT01064739|2653221|P1|COMPLETED|Fixed Sodium Diet + Fava Beans|1 participant withdrew with blood in his urine on the fava bean study day.|13
1095576|NCT01064739|2653221|P1|STARTED|Fixed Sodium Diet + Fava Beans||14
1095577|NCT01064739|2653221|P1|NOT COMPLETED|Fixed Sodium Study Diet||0
1095578|NCT01064739|2653221|P1|COMPLETED|Fixed Sodium Study Diet||14
1095579|NCT01064739|2653221|P1|STARTED|Fixed Sodium Study Diet|14 participants consumed the fixed-sodium study diet prior to the fava bean supplement study day.|14
1095580|NCT01064817|2653279|P2|NOT COMPLETED|Study Completion||0
1095581|NCT01064817|2653280|P1|NOT COMPLETED|Study Completion||2
1095582|NCT01064817|2653279|P2|COMPLETED|Study Completion||62
1095583|NCT01064817|2653280|P1|COMPLETED|Study Completion||60
1095584|NCT01064817|2653279|P2|STARTED|Study Completion||62
1095585|NCT01064817|2653280|P1|STARTED|Study Completion||62
1095586|NCT01064817|2653279|P2|NOT COMPLETED|All Study Treatment Days 1-9||0
1095587|NCT01064817|2653280|P1|NOT COMPLETED|All Study Treatment Days 1-9||0
1095588|NCT01064817|2653279|P2|COMPLETED|All Study Treatment Days 1-9||62
1095589|NCT01064817|2653280|P1|COMPLETED|All Study Treatment Days 1-9||62
1095590|NCT01064817|2653279|P2|STARTED|All Study Treatment Days 1-9||62
1095591|NCT01064817|2653280|P1|STARTED|All Study Treatment Days 1-9||62
1095592|NCT01064830|2653294|P2|NOT COMPLETED|Overall Study||4
1095593|NCT01064830|2653295|P1|NOT COMPLETED|Overall Study||2
1095594|NCT01064830|2653294|P2|COMPLETED|Overall Study||7
1095595|NCT01064830|2653295|P1|COMPLETED|Overall Study||8
1095596|NCT01064830|2653294|P2|STARTED|Overall Study||11
1095597|NCT01064830|2653295|P1|STARTED|Overall Study||10
1095598|NCT01064856|2653305|P4|NOT COMPLETED|Open-label (OL) Period||20
1095599|NCT01064856|2653306|P3|NOT COMPLETED|Open-label (OL) Period||26
1095600|NCT01064856|2653307|P2|NOT COMPLETED|Open-label (OL) Period||0
1095601|NCT01064856|2653308|P1|NOT COMPLETED|Open-label (OL) Period||0
1095602|NCT01064856|2653305|P4|COMPLETED|Open-label (OL) Period||61
1095603|NCT01064856|2653306|P3|COMPLETED|Open-label (OL) Period||56
1095604|NCT01064856|2653307|P2|COMPLETED|Open-label (OL) Period||0
1095605|NCT01064856|2653308|P1|COMPLETED|Open-label (OL) Period||0
1095606|NCT01064856|2653305|P4|STARTED|Open-label (OL) Period||81
1095607|NCT01064856|2653306|P3|STARTED|Open-label (OL) Period||82
1095608|NCT01064856|2653307|P2|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
1095609|NCT01064856|2653308|P1|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
1095610|NCT01064856|2653305|P4|NOT COMPLETED|Double-blind (DB) Period||0
1095611|NCT01064856|2653306|P3|NOT COMPLETED|Double-blind (DB) Period||0
1095612|NCT01064856|2653307|P2|NOT COMPLETED|Double-blind (DB) Period||0
1095613|NCT01064856|2653308|P1|NOT COMPLETED|Double-blind (DB) Period||2
1095614|NCT01064856|2653305|P4|COMPLETED|Double-blind (DB) Period||0
1095615|NCT01064856|2653306|P3|COMPLETED|Double-blind (DB) Period||0
1095616|NCT01064856|2653307|P2|COMPLETED|Double-blind (DB) Period||81
1095617|NCT01064856|2653308|P1|COMPLETED|Double-blind (DB) Period||82
1095618|NCT01064856|2653305|P4|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
1095619|NCT01064856|2653306|P3|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
1095620|NCT01064856|2653307|P2|STARTED|Double-blind (DB) Period||81
1095621|NCT01064856|2653308|P1|STARTED|Double-blind (DB) Period||84
1095622|NCT01064882|2653342|P3|NOT COMPLETED|Overall Study||2
1095623|NCT01064882|2653343|P2|NOT COMPLETED|Overall Study||2
1095624|NCT01064882|2653344|P1|NOT COMPLETED|Overall Study||2
1095625|NCT01064882|2653342|P3|COMPLETED|Overall Study||32
1095626|NCT01064882|2653343|P2|COMPLETED|Overall Study||32
1095627|NCT01064882|2653344|P1|COMPLETED|Overall Study||34
1095628|NCT01064882|2653342|P3|STARTED|Overall Study||34
1095629|NCT01064882|2653343|P2|STARTED|Overall Study||34
1095630|NCT01064882|2653344|P1|STARTED|Overall Study||36
1095631|NCT01064947|2653370|P1|NOT COMPLETED|Overall Study||41
1095632|NCT01064947|2653370|P1|COMPLETED|Overall Study||29
1095633|NCT01064947|2653370|P1|STARTED|Overall Study||70
1095634|NCT01065051|2653380|P2|NOT COMPLETED|Overall Study||0
1095635|NCT01065051|2653381|P1|NOT COMPLETED|Overall Study||0
1095636|NCT01065051|2653380|P2|COMPLETED|Overall Study||0
1095637|NCT01065051|2653381|P1|COMPLETED|Overall Study||1
1095638|NCT01065051|2653380|P2|STARTED|Overall Study||0
1095639|NCT01065051|2653381|P1|STARTED|Overall Study||1
1095640|NCT01070550|2653413|P6|NOT COMPLETED|Overall Study||7
1095641|NCT01070550|2653414|P5|NOT COMPLETED|Overall Study||1
1095642|NCT01070550|2653415|P4|NOT COMPLETED|Overall Study||77
1095643|NCT01070550|2653416|P3|NOT COMPLETED|Overall Study||216
1095644|NCT01070550|2653417|P2|NOT COMPLETED|Overall Study||62
1095645|NCT01070550|2653418|P1|NOT COMPLETED|Overall Study||1285
1095646|NCT01070550|2653413|P6|COMPLETED|Overall Study||35
1095647|NCT01070550|2653414|P5|COMPLETED|Overall Study||20
1095648|NCT01070550|2653415|P4|COMPLETED|Overall Study||124
1095649|NCT01070550|2653416|P3|COMPLETED|Overall Study||528
1095650|NCT01070550|2653417|P2|COMPLETED|Overall Study||254
1095651|NCT01070550|2653418|P1|COMPLETED|Overall Study||2071
1095652|NCT01070550|2653413|P6|STARTED|Overall Study||42
1095653|NCT01070550|2653414|P5|STARTED|Overall Study||21
1095654|NCT01070550|2653415|P4|STARTED|Overall Study||201
1095655|NCT01070550|2653416|P3|STARTED|Overall Study||744
1095656|NCT01070550|2653417|P2|STARTED|Overall Study||316
1095657|NCT01070550|2653418|P1|STARTED|Overall Study||3356
1095658|NCT01070693|2653560|P2|NOT COMPLETED|Overall Study||39
1095659|NCT01070693|2653561|P1|NOT COMPLETED|Overall Study||28
1095660|NCT01070693|2653560|P2|COMPLETED|Overall Study||110
1095661|NCT01070693|2653561|P1|COMPLETED|Overall Study||122
1095662|NCT01070693|2653560|P2|STARTED|Overall Study||149
1095663|NCT01070693|2653561|P1|STARTED|Overall Study||150
1095664|NCT01070771|2653567|P1|NOT COMPLETED|Overall Study||3
1095665|NCT01070771|2653567|P1|COMPLETED|Overall Study|August 2012|200
1095666|NCT01070771|2653567|P1|STARTED|Overall Study|September 2008|203
1095667|NCT01070784|2653574|P2|NOT COMPLETED|Overall Study||18
1095668|NCT01070784|2653575|P1|NOT COMPLETED|Overall Study||20
1095669|NCT01070784|2653574|P2|COMPLETED|Overall Study||112
1095670|NCT01070784|2653575|P1|COMPLETED|Overall Study||110
1095671|NCT01070784|2653574|P2|STARTED|Overall Study||130
1095672|NCT01070784|2653575|P1|STARTED|Overall Study||130
1095673|NCT01070810|2653665|P2|NOT COMPLETED|Overall Study||0
1095674|NCT01070810|2653666|P1|NOT COMPLETED|Overall Study||0
1095675|NCT01070810|2653665|P2|COMPLETED|Overall Study||43
1095676|NCT01070810|2653666|P1|COMPLETED|Overall Study||45
1095677|NCT01070810|2653665|P2|STARTED|Overall Study||43
1095678|NCT01070810|2653666|P1|STARTED|Overall Study||45
1095679|NCT01071915|2653680|P1|NOT COMPLETED|Overall Study||9
1095680|NCT01071915|2653680|P1|COMPLETED|Overall Study||148
1095681|NCT01071915|2653680|P1|Safety Analysis Set|Overall Study||156
1095682|NCT01071915|2653680|P1|Full Analysis Set (FAS)|Overall Study||155
1095683|NCT01071915|2653680|P1|STARTED|Overall Study|Intention to Treat Analysis Set|157
1095684|NCT01071993|2653692|P2|NOT COMPLETED|Overall Study||0
1095685|NCT01071993|2653693|P1|NOT COMPLETED|Overall Study||0
1095686|NCT01071993|2653692|P2|COMPLETED|Overall Study||0
1095687|NCT01071993|2653693|P1|COMPLETED|Overall Study||0
1095688|NCT01071993|2653692|P2|STARTED|Overall Study||0
1095689|NCT01071993|2653693|P1|STARTED|Overall Study||0
1095690|NCT01072006|2653703|P4|NOT COMPLETED|Overall Study||0
1095691|NCT01072006|2653704|P3|NOT COMPLETED|Overall Study||0
1095692|NCT01072006|2653705|P2|NOT COMPLETED|Overall Study||0
1095693|NCT01072006|2653706|P1|NOT COMPLETED|Overall Study||0
1095694|NCT01072006|2653703|P4|COMPLETED|Overall Study||11
1095695|NCT01072006|2653704|P3|COMPLETED|Overall Study||0
1095696|NCT01072006|2653705|P2|COMPLETED|Overall Study||5
1095697|NCT01072006|2653706|P1|COMPLETED|Overall Study||14
1095698|NCT01072006|2653703|P4|STARTED|Overall Study||11
1095699|NCT01072006|2653704|P3|STARTED|Overall Study||0
1095700|NCT01072006|2653705|P2|STARTED|Overall Study||5
1095701|NCT01072006|2653706|P1|STARTED|Overall Study||14
1095702|NCT01072032|2653725|P2|NOT COMPLETED|Overall Study||9
1095703|NCT01072032|2653726|P1|NOT COMPLETED|Overall Study||8
1095704|NCT01072032|2653725|P2|COMPLETED|Overall Study||5
1095705|NCT01072032|2653726|P1|COMPLETED|Overall Study||5
1095706|NCT01072032|2653725|P2|STARTED|Overall Study||14
1095707|NCT01072032|2653726|P1|STARTED|Overall Study||13
1095708|NCT01072136|2653738|P2|NOT COMPLETED|Overall Study||31
1095709|NCT01072136|2653739|P1|NOT COMPLETED|Overall Study||23
1095710|NCT01072136|2653738|P2|COMPLETED|Overall Study||12
1095711|NCT01072136|2653739|P1|COMPLETED|Overall Study||21
1095712|NCT01072136|2653738|P2|Met All Enrollment Criteria|Overall Study||25
1095713|NCT01072136|2653739|P1|Met All Enrollment Criteria|Overall Study|Some eligibility test results were not available until after randomization.|30
1095714|NCT01072136|2653738|P2|STARTED|Overall Study||43
1095715|NCT01072136|2653739|P1|STARTED|Overall Study||44
1095716|NCT01072149|2653761|P18|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1095717|NCT01072149|2653762|P17|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1095718|NCT01072149|2653763|P16|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1095719|NCT01072149|2653764|P15|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1095720|NCT01072149|2653765|P14|NOT COMPLETED|Treatment Period 3 (28 Days)||1
1095721|NCT01072149|2653766|P13|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1095722|NCT01072149|2653767|P12|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1095723|NCT01072149|2653768|P11|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1095724|NCT01072149|2653769|P10|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1095725|NCT01072149|2653770|P9|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1095726|NCT01072149|2653771|P8|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1095727|NCT01072149|2653772|P7|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1095728|NCT01072149|2653773|P6|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1095729|NCT01072149|2653774|P5|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1095730|NCT01072149|2653775|P4|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1095731|NCT01072149|2653776|P3|NOT COMPLETED|Treatment Period 3 (28 Days)||1
1095732|NCT01072149|2653777|P2|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1095733|NCT01072149|2653778|P1|NOT COMPLETED|Treatment Period 3 (28 Days)||0
1095734|NCT01072149|2653761|P18|COMPLETED|Treatment Period 3 (28 Days)||2
1095735|NCT01072149|2653762|P17|COMPLETED|Treatment Period 3 (28 Days)||3
1095736|NCT01072149|2653763|P16|COMPLETED|Treatment Period 3 (28 Days)||1
1095737|NCT01072149|2653764|P15|COMPLETED|Treatment Period 3 (28 Days)||3
1095738|NCT01072149|2653765|P14|COMPLETED|Treatment Period 3 (28 Days)||2
1095739|NCT01072149|2653766|P13|COMPLETED|Treatment Period 3 (28 Days)||2
1095740|NCT01072149|2653767|P12|COMPLETED|Treatment Period 3 (28 Days)||3
1095741|NCT01072149|2653768|P11|COMPLETED|Treatment Period 3 (28 Days)||2
1095742|NCT01072149|2653769|P10|COMPLETED|Treatment Period 3 (28 Days)||3
1095743|NCT01072149|2653770|P9|COMPLETED|Treatment Period 3 (28 Days)||3
1095744|NCT01072149|2653771|P8|COMPLETED|Treatment Period 3 (28 Days)||2
1095745|NCT01072149|2653772|P7|COMPLETED|Treatment Period 3 (28 Days)||3
1095746|NCT01072149|2653773|P6|COMPLETED|Treatment Period 3 (28 Days)||3
1095747|NCT01072149|2653774|P5|COMPLETED|Treatment Period 3 (28 Days)||3
1095748|NCT01072149|2653775|P4|COMPLETED|Treatment Period 3 (28 Days)||3
1095749|NCT01072149|2653776|P3|COMPLETED|Treatment Period 3 (28 Days)||0
1095750|NCT01072149|2653777|P2|COMPLETED|Treatment Period 3 (28 Days)||2
1095751|NCT01072149|2653778|P1|COMPLETED|Treatment Period 3 (28 Days)||2
1095752|NCT01072149|2653761|P18|STARTED|Treatment Period 3 (28 Days)||2
1095753|NCT01072149|2653762|P17|STARTED|Treatment Period 3 (28 Days)||3
1095754|NCT01072149|2653763|P16|STARTED|Treatment Period 3 (28 Days)||1
1095755|NCT01072149|2653764|P15|STARTED|Treatment Period 3 (28 Days)||3
1095756|NCT01072149|2653765|P14|STARTED|Treatment Period 3 (28 Days)||3
1095757|NCT01072149|2653766|P13|STARTED|Treatment Period 3 (28 Days)||2
1095758|NCT01072149|2653767|P12|STARTED|Treatment Period 3 (28 Days)||3
1095759|NCT01072149|2653768|P11|STARTED|Treatment Period 3 (28 Days)||2
1095760|NCT01072149|2653769|P10|STARTED|Treatment Period 3 (28 Days)||3
1095761|NCT01072149|2653770|P9|STARTED|Treatment Period 3 (28 Days)||3
1095762|NCT01072149|2653771|P8|STARTED|Treatment Period 3 (28 Days)||2
1095763|NCT01072149|2653772|P7|STARTED|Treatment Period 3 (28 Days)||3
1095764|NCT01072149|2653773|P6|STARTED|Treatment Period 3 (28 Days)||3
1095765|NCT01072149|2653774|P5|STARTED|Treatment Period 3 (28 Days)||3
1095766|NCT01072149|2653775|P4|STARTED|Treatment Period 3 (28 Days)||3
1095767|NCT01072149|2653776|P3|STARTED|Treatment Period 3 (28 Days)||1
1095768|NCT01072149|2653777|P2|STARTED|Treatment Period 3 (28 Days)||2
1095769|NCT01072149|2653778|P1|STARTED|Treatment Period 3 (28 Days)||2
1095770|NCT01072149|2653761|P18|NOT COMPLETED|Washout Period 2 (14 Days)||0
1095771|NCT01072149|2653762|P17|NOT COMPLETED|Washout Period 2 (14 Days)||0
1095772|NCT01072149|2653763|P16|NOT COMPLETED|Washout Period 2 (14 Days)||2
1095773|NCT01072149|2653764|P15|NOT COMPLETED|Washout Period 2 (14 Days)||0
1095774|NCT01072149|2653765|P14|NOT COMPLETED|Washout Period 2 (14 Days)||0
1095775|NCT01072149|2653766|P13|NOT COMPLETED|Washout Period 2 (14 Days)||1
1095776|NCT01072149|2653767|P12|NOT COMPLETED|Washout Period 2 (14 Days)||0
1095777|NCT01072149|2653768|P11|NOT COMPLETED|Washout Period 2 (14 Days)||0
1095778|NCT01072149|2653769|P10|NOT COMPLETED|Washout Period 2 (14 Days)||0
1095779|NCT01072149|2653770|P9|NOT COMPLETED|Washout Period 2 (14 Days)||0
1095780|NCT01072149|2653771|P8|NOT COMPLETED|Washout Period 2 (14 Days)||0
1095781|NCT01072149|2653772|P7|NOT COMPLETED|Washout Period 2 (14 Days)||0
1095782|NCT01072149|2653773|P6|NOT COMPLETED|Washout Period 2 (14 Days)||0
1095783|NCT01072149|2653774|P5|NOT COMPLETED|Washout Period 2 (14 Days)||0
1095784|NCT01072149|2653775|P4|NOT COMPLETED|Washout Period 2 (14 Days)||0
1095785|NCT01072149|2653776|P3|NOT COMPLETED|Washout Period 2 (14 Days)||0
1095786|NCT01072149|2653777|P2|NOT COMPLETED|Washout Period 2 (14 Days)||0
1095787|NCT01072149|2653778|P1|NOT COMPLETED|Washout Period 2 (14 Days)||1
1095788|NCT01072149|2653761|P18|COMPLETED|Washout Period 2 (14 Days)||2
1095789|NCT01072149|2653762|P17|COMPLETED|Washout Period 2 (14 Days)||3
1095790|NCT01072149|2653763|P16|COMPLETED|Washout Period 2 (14 Days)||1
1095791|NCT01072149|2653764|P15|COMPLETED|Washout Period 2 (14 Days)||3
1095792|NCT01072149|2653765|P14|COMPLETED|Washout Period 2 (14 Days)||3
1095793|NCT01072149|2653766|P13|COMPLETED|Washout Period 2 (14 Days)||2
1095794|NCT01072149|2653767|P12|COMPLETED|Washout Period 2 (14 Days)||3
1095795|NCT01072149|2653768|P11|COMPLETED|Washout Period 2 (14 Days)||2
1095796|NCT01072149|2653769|P10|COMPLETED|Washout Period 2 (14 Days)||3
1095797|NCT01072149|2653770|P9|COMPLETED|Washout Period 2 (14 Days)||3
1095798|NCT01072149|2653771|P8|COMPLETED|Washout Period 2 (14 Days)||2
1095799|NCT01072149|2653772|P7|COMPLETED|Washout Period 2 (14 Days)||3
1095800|NCT01072149|2653773|P6|COMPLETED|Washout Period 2 (14 Days)||3
1095801|NCT01072149|2653774|P5|COMPLETED|Washout Period 2 (14 Days)||3
1095802|NCT01072149|2653775|P4|COMPLETED|Washout Period 2 (14 Days)||3
1095803|NCT01072149|2653776|P3|COMPLETED|Washout Period 2 (14 Days)||1
1095804|NCT01072149|2653777|P2|COMPLETED|Washout Period 2 (14 Days)||2
1095805|NCT01072149|2653778|P1|COMPLETED|Washout Period 2 (14 Days)||2
1095806|NCT01072149|2653761|P18|STARTED|Washout Period 2 (14 Days)||2
1095807|NCT01072149|2653762|P17|STARTED|Washout Period 2 (14 Days)||3
1095808|NCT01072149|2653763|P16|STARTED|Washout Period 2 (14 Days)||3
1095809|NCT01072149|2653764|P15|STARTED|Washout Period 2 (14 Days)||3
1095810|NCT01072149|2653765|P14|STARTED|Washout Period 2 (14 Days)||3
1095811|NCT01072149|2653766|P13|STARTED|Washout Period 2 (14 Days)||3
1095812|NCT01072149|2653767|P12|STARTED|Washout Period 2 (14 Days)||3
1095813|NCT01072149|2653768|P11|STARTED|Washout Period 2 (14 Days)||2
1095814|NCT01072149|2653769|P10|STARTED|Washout Period 2 (14 Days)||3
1095815|NCT01072149|2653770|P9|STARTED|Washout Period 2 (14 Days)||3
1095816|NCT01072149|2653771|P8|STARTED|Washout Period 2 (14 Days)||2
1095817|NCT01072149|2653772|P7|STARTED|Washout Period 2 (14 Days)||3
1095818|NCT01072149|2653773|P6|STARTED|Washout Period 2 (14 Days)||3
1095819|NCT01072149|2653774|P5|STARTED|Washout Period 2 (14 Days)||3
1095820|NCT01072149|2653775|P4|STARTED|Washout Period 2 (14 Days)||3
1095821|NCT01072149|2653776|P3|STARTED|Washout Period 2 (14 Days)||1
1095822|NCT01072149|2653777|P2|STARTED|Washout Period 2 (14 Days)||2
1095823|NCT01072149|2653778|P1|STARTED|Washout Period 2 (14 Days)||3
1095824|NCT01072149|2653761|P18|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1095825|NCT01072149|2653762|P17|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1095826|NCT01072149|2653763|P16|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1095827|NCT01072149|2653764|P15|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1095828|NCT01072149|2653765|P14|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1095829|NCT01072149|2653766|P13|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1095830|NCT01072149|2653767|P12|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1095831|NCT01072149|2653768|P11|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1095832|NCT01072149|2653769|P10|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1095833|NCT01072149|2653770|P9|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1095834|NCT01072149|2653771|P8|NOT COMPLETED|Treatment Period 2 (28 Days)||1
1095835|NCT01072149|2653772|P7|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1095836|NCT01072149|2653773|P6|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1095837|NCT01072149|2653774|P5|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1095838|NCT01072149|2653775|P4|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1095839|NCT01072149|2653776|P3|NOT COMPLETED|Treatment Period 2 (28 Days)||1
1095840|NCT01072149|2653777|P2|NOT COMPLETED|Treatment Period 2 (28 Days)||1
1095841|NCT01072149|2653778|P1|NOT COMPLETED|Treatment Period 2 (28 Days)||0
1095842|NCT01072149|2653761|P18|COMPLETED|Treatment Period 2 (28 Days)||2
1095843|NCT01072149|2653762|P17|COMPLETED|Treatment Period 2 (28 Days)||3
1095844|NCT01072149|2653763|P16|COMPLETED|Treatment Period 2 (28 Days)||3
1095845|NCT01072149|2653764|P15|COMPLETED|Treatment Period 2 (28 Days)||3
1095846|NCT01072149|2653765|P14|COMPLETED|Treatment Period 2 (28 Days)||3
1095847|NCT01072149|2653766|P13|COMPLETED|Treatment Period 2 (28 Days)||3
1095848|NCT01072149|2653767|P12|COMPLETED|Treatment Period 2 (28 Days)||3
1095849|NCT01072149|2653768|P11|COMPLETED|Treatment Period 2 (28 Days)||2
1095850|NCT01072149|2653769|P10|COMPLETED|Treatment Period 2 (28 Days)||3
1095851|NCT01072149|2653770|P9|COMPLETED|Treatment Period 2 (28 Days)||3
1095852|NCT01072149|2653771|P8|COMPLETED|Treatment Period 2 (28 Days)||2
1095853|NCT01072149|2653772|P7|COMPLETED|Treatment Period 2 (28 Days)||3
1095854|NCT01072149|2653773|P6|COMPLETED|Treatment Period 2 (28 Days)||3
1095855|NCT01072149|2653774|P5|COMPLETED|Treatment Period 2 (28 Days)||3
1095856|NCT01072149|2653775|P4|COMPLETED|Treatment Period 2 (28 Days)||3
1095857|NCT01072149|2653776|P3|COMPLETED|Treatment Period 2 (28 Days)||1
1095858|NCT01072149|2653777|P2|COMPLETED|Treatment Period 2 (28 Days)||2
1095859|NCT01072149|2653778|P1|COMPLETED|Treatment Period 2 (28 Days)||3
1095860|NCT01072149|2653761|P18|STARTED|Treatment Period 2 (28 Days)||2
1095861|NCT01072149|2653762|P17|STARTED|Treatment Period 2 (28 Days)||3
1095862|NCT01072149|2653763|P16|STARTED|Treatment Period 2 (28 Days)||3
1095863|NCT01072149|2653764|P15|STARTED|Treatment Period 2 (28 Days)||3
1095864|NCT01072149|2653765|P14|STARTED|Treatment Period 2 (28 Days)||3
1095865|NCT01072149|2653766|P13|STARTED|Treatment Period 2 (28 Days)||3
1095866|NCT01072149|2653767|P12|STARTED|Treatment Period 2 (28 Days)||3
1095867|NCT01072149|2653768|P11|STARTED|Treatment Period 2 (28 Days)||2
1095868|NCT01072149|2653769|P10|STARTED|Treatment Period 2 (28 Days)||3
1095869|NCT01072149|2653770|P9|STARTED|Treatment Period 2 (28 Days)||3
1095870|NCT01072149|2653771|P8|STARTED|Treatment Period 2 (28 Days)||3
1095871|NCT01072149|2653772|P7|STARTED|Treatment Period 2 (28 Days)||3
1095872|NCT01072149|2653773|P6|STARTED|Treatment Period 2 (28 Days)||3
1095873|NCT01072149|2653774|P5|STARTED|Treatment Period 2 (28 Days)||3
1095874|NCT01072149|2653775|P4|STARTED|Treatment Period 2 (28 Days)||3
1095875|NCT01072149|2653776|P3|STARTED|Treatment Period 2 (28 Days)||2
1095876|NCT01072149|2653777|P2|STARTED|Treatment Period 2 (28 Days)||3
1095877|NCT01072149|2653778|P1|STARTED|Treatment Period 2 (28 Days)||3
1095878|NCT01072149|2653761|P18|NOT COMPLETED|Washout Period 1 (14 Days)||0
1095879|NCT01072149|2653762|P17|NOT COMPLETED|Washout Period 1 (14 Days)||0
1095880|NCT01072149|2653763|P16|NOT COMPLETED|Washout Period 1 (14 Days)||0
1095881|NCT01072149|2653764|P15|NOT COMPLETED|Washout Period 1 (14 Days)||0
1095882|NCT01072149|2653765|P14|NOT COMPLETED|Washout Period 1 (14 Days)||0
1095883|NCT01072149|2653766|P13|NOT COMPLETED|Washout Period 1 (14 Days)||0
1095884|NCT01072149|2653767|P12|NOT COMPLETED|Washout Period 1 (14 Days)||0
1095885|NCT01072149|2653768|P11|NOT COMPLETED|Washout Period 1 (14 Days)||0
1095886|NCT01072149|2653769|P10|NOT COMPLETED|Washout Period 1 (14 Days)||0
1095887|NCT01072149|2653770|P9|NOT COMPLETED|Washout Period 1 (14 Days)||0
1095888|NCT01072149|2653771|P8|NOT COMPLETED|Washout Period 1 (14 Days)||0
1095889|NCT01072149|2653772|P7|NOT COMPLETED|Washout Period 1 (14 Days)||0
1095890|NCT01072149|2653773|P6|NOT COMPLETED|Washout Period 1 (14 Days)||0
1095891|NCT01072149|2653774|P5|NOT COMPLETED|Washout Period 1 (14 Days)||0
1095892|NCT01072149|2653775|P4|NOT COMPLETED|Washout Period 1 (14 Days)||0
1095893|NCT01072149|2653776|P3|NOT COMPLETED|Washout Period 1 (14 Days)||0
1095894|NCT01072149|2653777|P2|NOT COMPLETED|Washout Period 1 (14 Days)||0
1095895|NCT01072149|2653778|P1|NOT COMPLETED|Washout Period 1 (14 Days)||0
1095896|NCT01072149|2653761|P18|COMPLETED|Washout Period 1 (14 Days)||2
1095897|NCT01072149|2653762|P17|COMPLETED|Washout Period 1 (14 Days)||3
1095898|NCT01072149|2653763|P16|COMPLETED|Washout Period 1 (14 Days)||3
1095899|NCT01072149|2653764|P15|COMPLETED|Washout Period 1 (14 Days)||3
1095900|NCT01072149|2653765|P14|COMPLETED|Washout Period 1 (14 Days)||3
1095901|NCT01072149|2653766|P13|COMPLETED|Washout Period 1 (14 Days)||3
1095902|NCT01072149|2653767|P12|COMPLETED|Washout Period 1 (14 Days)||3
1095903|NCT01072149|2653768|P11|COMPLETED|Washout Period 1 (14 Days)||2
1095904|NCT01072149|2653769|P10|COMPLETED|Washout Period 1 (14 Days)||3
1095905|NCT01072149|2653770|P9|COMPLETED|Washout Period 1 (14 Days)||3
1095906|NCT01072149|2653771|P8|COMPLETED|Washout Period 1 (14 Days)||3
1095907|NCT01072149|2653772|P7|COMPLETED|Washout Period 1 (14 Days)||3
1095908|NCT01072149|2653773|P6|COMPLETED|Washout Period 1 (14 Days)||3
1095909|NCT01072149|2653774|P5|COMPLETED|Washout Period 1 (14 Days)||3
1095910|NCT01072149|2653775|P4|COMPLETED|Washout Period 1 (14 Days)||3
1095911|NCT01072149|2653776|P3|COMPLETED|Washout Period 1 (14 Days)||2
1095912|NCT01072149|2653777|P2|COMPLETED|Washout Period 1 (14 Days)||3
1095913|NCT01072149|2653778|P1|COMPLETED|Washout Period 1 (14 Days)||3
1095914|NCT01072149|2653761|P18|STARTED|Washout Period 1 (14 Days)||2
1095915|NCT01072149|2653762|P17|STARTED|Washout Period 1 (14 Days)||3
1095916|NCT01072149|2653763|P16|STARTED|Washout Period 1 (14 Days)||3
1095917|NCT01072149|2653764|P15|STARTED|Washout Period 1 (14 Days)||3
1095918|NCT01072149|2653765|P14|STARTED|Washout Period 1 (14 Days)||3
1095919|NCT01072149|2653766|P13|STARTED|Washout Period 1 (14 Days)||3
1095920|NCT01072149|2653767|P12|STARTED|Washout Period 1 (14 Days)||3
1095921|NCT01072149|2653768|P11|STARTED|Washout Period 1 (14 Days)||2
1095922|NCT01072149|2653769|P10|STARTED|Washout Period 1 (14 Days)||3
1095923|NCT01072149|2653770|P9|STARTED|Washout Period 1 (14 Days)||3
1095924|NCT01072149|2653771|P8|STARTED|Washout Period 1 (14 Days)||3
1095925|NCT01072149|2653772|P7|STARTED|Washout Period 1 (14 Days)||3
1095926|NCT01072149|2653773|P6|STARTED|Washout Period 1 (14 Days)||3
1095927|NCT01072149|2653774|P5|STARTED|Washout Period 1 (14 Days)||3
1095928|NCT01072149|2653775|P4|STARTED|Washout Period 1 (14 Days)||3
1095929|NCT01072149|2653776|P3|STARTED|Washout Period 1 (14 Days)||2
1095930|NCT01072149|2653777|P2|STARTED|Washout Period 1 (14 Days)||3
1095931|NCT01072149|2653778|P1|STARTED|Washout Period 1 (14 Days)||3
1095932|NCT01072149|2653761|P18|NOT COMPLETED|Treatment Period 1 (28 Days)||1
1095933|NCT01072149|2653762|P17|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1095934|NCT01072149|2653763|P16|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1095935|NCT01072149|2653764|P15|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1095936|NCT01072149|2653765|P14|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1095937|NCT01072149|2653766|P13|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1095938|NCT01072149|2653767|P12|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1095939|NCT01072149|2653768|P11|NOT COMPLETED|Treatment Period 1 (28 Days)||1
1095940|NCT01072149|2653769|P10|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1095941|NCT01072149|2653770|P9|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1095942|NCT01072149|2653771|P8|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1095943|NCT01072149|2653772|P7|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1095944|NCT01072149|2653773|P6|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1095945|NCT01072149|2653774|P5|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1095946|NCT01072149|2653775|P4|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1095947|NCT01072149|2653776|P3|NOT COMPLETED|Treatment Period 1 (28 Days)||1
1095948|NCT01072149|2653777|P2|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1095949|NCT01072149|2653778|P1|NOT COMPLETED|Treatment Period 1 (28 Days)||0
1095950|NCT01072149|2653761|P18|COMPLETED|Treatment Period 1 (28 Days)||2
1095951|NCT01072149|2653762|P17|COMPLETED|Treatment Period 1 (28 Days)||3
1095952|NCT01072149|2653763|P16|COMPLETED|Treatment Period 1 (28 Days)||3
1095953|NCT01072149|2653764|P15|COMPLETED|Treatment Period 1 (28 Days)||3
1095954|NCT01072149|2653765|P14|COMPLETED|Treatment Period 1 (28 Days)||3
1095955|NCT01072149|2653766|P13|COMPLETED|Treatment Period 1 (28 Days)||3
1095956|NCT01072149|2653767|P12|COMPLETED|Treatment Period 1 (28 Days)||3
1095957|NCT01072149|2653768|P11|COMPLETED|Treatment Period 1 (28 Days)||2
1095958|NCT01072149|2653769|P10|COMPLETED|Treatment Period 1 (28 Days)||3
1095959|NCT01072149|2653770|P9|COMPLETED|Treatment Period 1 (28 Days)||3
1095960|NCT01072149|2653771|P8|COMPLETED|Treatment Period 1 (28 Days)||3
1095961|NCT01072149|2653772|P7|COMPLETED|Treatment Period 1 (28 Days)||3
1095962|NCT01072149|2653773|P6|COMPLETED|Treatment Period 1 (28 Days)||3
1095963|NCT01072149|2653774|P5|COMPLETED|Treatment Period 1 (28 Days)||3
1095964|NCT01072149|2653775|P4|COMPLETED|Treatment Period 1 (28 Days)||3
1095965|NCT01072149|2653776|P3|COMPLETED|Treatment Period 1 (28 Days)||2
1095966|NCT01072149|2653777|P2|COMPLETED|Treatment Period 1 (28 Days)||3
1095967|NCT01072149|2653778|P1|COMPLETED|Treatment Period 1 (28 Days)||3
1095968|NCT01072149|2653761|P18|STARTED|Treatment Period 1 (28 Days)||3
1095969|NCT01072149|2653762|P17|STARTED|Treatment Period 1 (28 Days)||3
1095970|NCT01072149|2653763|P16|STARTED|Treatment Period 1 (28 Days)||3
1095971|NCT01072149|2653764|P15|STARTED|Treatment Period 1 (28 Days)||3
1095972|NCT01072149|2653765|P14|STARTED|Treatment Period 1 (28 Days)||3
1095973|NCT01072149|2653766|P13|STARTED|Treatment Period 1 (28 Days)||3
1095974|NCT01072149|2653767|P12|STARTED|Treatment Period 1 (28 Days)||3
1095975|NCT01072149|2653768|P11|STARTED|Treatment Period 1 (28 Days)||3
1095976|NCT01072149|2653769|P10|STARTED|Treatment Period 1 (28 Days)||3
1095977|NCT01072149|2653770|P9|STARTED|Treatment Period 1 (28 Days)||3
1095978|NCT01072149|2653771|P8|STARTED|Treatment Period 1 (28 Days)||3
1095979|NCT01072149|2653772|P7|STARTED|Treatment Period 1 (28 Days)||3
1095980|NCT01072149|2653773|P6|STARTED|Treatment Period 1 (28 Days)||3
1095981|NCT01072149|2653774|P5|STARTED|Treatment Period 1 (28 Days)||3
1095982|NCT01072149|2653775|P4|STARTED|Treatment Period 1 (28 Days)||3
1095983|NCT01072149|2653776|P3|STARTED|Treatment Period 1 (28 Days)||3
1095984|NCT01072149|2653777|P2|STARTED|Treatment Period 1 (28 Days)||3
1095985|NCT01072149|2653778|P1|STARTED|Treatment Period 1 (28 Days)||3
1095986|NCT01072175|2653808|P13|NOT COMPLETED|Part D (HPMC Capsules)||39
1095987|NCT01072175|2653809|P12|NOT COMPLETED|Part D (HPMC Capsules)||43
1095988|NCT01072175|2653810|P11|NOT COMPLETED|Part D (HPMC Capsules)||16
1095989|NCT01072175|2653811|P10|NOT COMPLETED|Part D (HPMC Capsules)||12
1095990|NCT01072175|2653812|P9|NOT COMPLETED|Part D (HPMC Capsules)||0
1095991|NCT01072175|2653813|P8|NOT COMPLETED|Part D (HPMC Capsules)||0
1095992|NCT01072175|2653814|P7|NOT COMPLETED|Part D (HPMC Capsules)||0
1095993|NCT01072175|2653815|P6|NOT COMPLETED|Part D (HPMC Capsules)||0
1095994|NCT01072175|2653816|P5|NOT COMPLETED|Part D (HPMC Capsules)||0
1095995|NCT01072175|2653817|P4|NOT COMPLETED|Part D (HPMC Capsules)||0
1095996|NCT01072175|2653818|P3|NOT COMPLETED|Part D (HPMC Capsules)||0
1095997|NCT01072175|2653819|P2|NOT COMPLETED|Part D (HPMC Capsules)||0
1095998|NCT01072175|2653820|P1|NOT COMPLETED|Part D (HPMC Capsules)||0
1095999|NCT01072175|2653808|P13|COMPLETED|Part D (HPMC Capsules)||0
1096000|NCT01072175|2653809|P12|COMPLETED|Part D (HPMC Capsules)||0
1096001|NCT01072175|2653810|P11|COMPLETED|Part D (HPMC Capsules)||0
1096002|NCT01072175|2653811|P10|COMPLETED|Part D (HPMC Capsules)||0
1096003|NCT01072175|2653812|P9|COMPLETED|Part D (HPMC Capsules)||0
1096004|NCT01072175|2653813|P8|COMPLETED|Part D (HPMC Capsules)||0
1096005|NCT01072175|2653814|P7|COMPLETED|Part D (HPMC Capsules)||0
1096006|NCT01072175|2653815|P6|COMPLETED|Part D (HPMC Capsules)||0
1096007|NCT01072175|2653816|P5|COMPLETED|Part D (HPMC Capsules)||0
1096008|NCT01072175|2653817|P4|COMPLETED|Part D (HPMC Capsules)||0
1096009|NCT01072175|2653818|P3|COMPLETED|Part D (HPMC Capsules)||0
1096010|NCT01072175|2653819|P2|COMPLETED|Part D (HPMC Capsules)||0
1096011|NCT01072175|2653820|P1|COMPLETED|Part D (HPMC Capsules)||0
1096012|NCT01072175|2653808|P13|Ongoing|Part D (HPMC Capsules)||34
1096013|NCT01072175|2653809|P12|Ongoing|Part D (HPMC Capsules)||34
1096014|NCT01072175|2653810|P11|Ongoing|Part D (HPMC Capsules)||12
1096015|NCT01072175|2653811|P10|Ongoing|Part D (HPMC Capsules)||10
1096016|NCT01072175|2653812|P9|Ongoing|Part D (HPMC Capsules)||0
1096017|NCT01072175|2653813|P8|Ongoing|Part D (HPMC Capsules)||0
1096018|NCT01072175|2653814|P7|Ongoing|Part D (HPMC Capsules)||0
1096019|NCT01072175|2653815|P6|Ongoing|Part D (HPMC Capsules)||0
1096020|NCT01072175|2653816|P5|Ongoing|Part D (HPMC Capsules)||0
1096021|NCT01072175|2653817|P4|Ongoing|Part D (HPMC Capsules)||0
1096022|NCT01072175|2653818|P3|Ongoing|Part D (HPMC Capsules)||0
1096023|NCT01072175|2653819|P2|Ongoing|Part D (HPMC Capsules)||0
1096024|NCT01072175|2653820|P1|Ongoing|Part D (HPMC Capsules)||0
1096025|NCT01072175|2653808|P13|STARTED|Part D (HPMC Capsules)||39
1096026|NCT01072175|2653809|P12|STARTED|Part D (HPMC Capsules)||43
1096027|NCT01072175|2653810|P11|STARTED|Part D (HPMC Capsules)||16
1096028|NCT01072175|2653811|P10|STARTED|Part D (HPMC Capsules)||12
1096029|NCT01072175|2653812|P9|STARTED|Part D (HPMC Capsules)||0
1096030|NCT01072175|2653813|P8|STARTED|Part D (HPMC Capsules)||0
1096031|NCT01072175|2653814|P7|STARTED|Part D (HPMC Capsules)||0
1096032|NCT01072175|2653815|P6|STARTED|Part D (HPMC Capsules)||0
1096033|NCT01072175|2653816|P5|STARTED|Part D (HPMC Capsules)||0
1096034|NCT01072175|2653817|P4|STARTED|Part D (HPMC Capsules)||0
1096035|NCT01072175|2653818|P3|STARTED|Part D (HPMC Capsules)||0
1096036|NCT01072175|2653819|P2|STARTED|Part D (HPMC Capsules)||0
1096037|NCT01072175|2653820|P1|STARTED|Part D (HPMC Capsules)||0
1096038|NCT01072175|2653808|P13|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1096039|NCT01072175|2653809|P12|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1096040|NCT01072175|2653810|P11|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1096041|NCT01072175|2653811|P10|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1096042|NCT01072175|2653812|P9|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||43
1096043|NCT01072175|2653813|P8|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1096044|NCT01072175|2653814|P7|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1096045|NCT01072175|2653815|P6|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1096046|NCT01072175|2653816|P5|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1096047|NCT01072175|2653817|P4|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1096048|NCT01072175|2653818|P3|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1096049|NCT01072175|2653819|P2|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1096050|NCT01072175|2653820|P1|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1096051|NCT01072175|2653808|P13|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1096052|NCT01072175|2653809|P12|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1096053|NCT01072175|2653810|P11|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1096054|NCT01072175|2653811|P10|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1096055|NCT01072175|2653812|P9|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1096056|NCT01072175|2653813|P8|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1096057|NCT01072175|2653814|P7|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1096058|NCT01072175|2653815|P6|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1096059|NCT01072175|2653816|P5|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1096060|NCT01072175|2653817|P4|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1096061|NCT01072175|2653818|P3|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1096062|NCT01072175|2653819|P2|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1096063|NCT01072175|2653820|P1|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
1096064|NCT01072175|2653808|P13|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
1096065|NCT01072175|2653809|P12|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
1096066|NCT01072175|2653810|P11|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
1096067|NCT01072175|2653811|P10|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
1096068|NCT01072175|2653812|P9|Ongoing|Part C (Phase II: Crossover Phase [CP])||28
1096069|NCT01072175|2653813|P8|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
1096070|NCT01072175|2653814|P7|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
1096071|NCT01072175|2653815|P6|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
1096072|NCT01072175|2653816|P5|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
1096073|NCT01072175|2653817|P4|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
1096074|NCT01072175|2653818|P3|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
1096075|NCT01072175|2653819|P2|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
1096076|NCT01072175|2653820|P1|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
1096077|NCT01072175|2653808|P13|STARTED|Part C (Phase II: Crossover Phase [CP])||0
1096078|NCT01072175|2653809|P12|STARTED|Part C (Phase II: Crossover Phase [CP])||0
1096079|NCT01072175|2653810|P11|STARTED|Part C (Phase II: Crossover Phase [CP])||0
1096080|NCT01072175|2653811|P10|STARTED|Part C (Phase II: Crossover Phase [CP])||0
1096081|NCT01072175|2653812|P9|STARTED|Part C (Phase II: Crossover Phase [CP])||43
1096082|NCT01072175|2653813|P8|STARTED|Part C (Phase II: Crossover Phase [CP])||0
1096083|NCT01072175|2653814|P7|STARTED|Part C (Phase II: Crossover Phase [CP])||0
1096084|NCT01072175|2653815|P6|STARTED|Part C (Phase II: Crossover Phase [CP])||0
1096085|NCT01072175|2653816|P5|STARTED|Part C (Phase II: Crossover Phase [CP])||0
1096086|NCT01072175|2653817|P4|STARTED|Part C (Phase II: Crossover Phase [CP])||0
1096087|NCT01072175|2653818|P3|STARTED|Part C (Phase II: Crossover Phase [CP])||0
1096088|NCT01072175|2653819|P2|STARTED|Part C (Phase II: Crossover Phase [CP])||0
1096089|NCT01072175|2653820|P1|STARTED|Part C (Phase II: Crossover Phase [CP])||0
1096090|NCT01072175|2653808|P13|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
1096091|NCT01072175|2653809|P12|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
1096092|NCT01072175|2653810|P11|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
1096093|NCT01072175|2653811|P10|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
1096094|NCT01072175|2653812|P9|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
1096095|NCT01072175|2653813|P8|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
1096096|NCT01072175|2653814|P7|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
1096097|NCT01072175|2653815|P6|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
1096098|NCT01072175|2653816|P5|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
1096099|NCT01072175|2653817|P4|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
1096100|NCT01072175|2653818|P3|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
1096101|NCT01072175|2653819|P2|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
1096102|NCT01072175|2653820|P1|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
1096103|NCT01072175|2653808|P13|COMPLETED|Part C (Phase II: Randomized Phase)||0
1096104|NCT01072175|2653809|P12|COMPLETED|Part C (Phase II: Randomized Phase)||0
1096105|NCT01072175|2653810|P11|COMPLETED|Part C (Phase II: Randomized Phase)||0
1096106|NCT01072175|2653811|P10|COMPLETED|Part C (Phase II: Randomized Phase)||0
1096107|NCT01072175|2653812|P9|COMPLETED|Part C (Phase II: Randomized Phase)||0
1096108|NCT01072175|2653813|P8|COMPLETED|Part C (Phase II: Randomized Phase)||0
1096109|NCT01072175|2653814|P7|COMPLETED|Part C (Phase II: Randomized Phase)||0
1096110|NCT01072175|2653815|P6|COMPLETED|Part C (Phase II: Randomized Phase)||0
1096111|NCT01072175|2653816|P5|COMPLETED|Part C (Phase II: Randomized Phase)||0
1096112|NCT01072175|2653817|P4|COMPLETED|Part C (Phase II: Randomized Phase)||0
1096113|NCT01072175|2653818|P3|COMPLETED|Part C (Phase II: Randomized Phase)||0
1096114|NCT01072175|2653819|P2|COMPLETED|Part C (Phase II: Randomized Phase)||0
1096115|NCT01072175|2653820|P1|COMPLETED|Part C (Phase II: Randomized Phase)||0
1096116|NCT01072175|2653808|P13|Ongoing|Part C (Phase II: Randomized Phase)||0
1096117|NCT01072175|2653809|P12|Ongoing|Part C (Phase II: Randomized Phase)||0
1096118|NCT01072175|2653810|P11|Ongoing|Part C (Phase II: Randomized Phase)||0
1096119|NCT01072175|2653811|P10|Ongoing|Part C (Phase II: Randomized Phase)||0
1096120|NCT01072175|2653812|P9|Ongoing|Part C (Phase II: Randomized Phase)||0
1096121|NCT01072175|2653813|P8|Ongoing|Part C (Phase II: Randomized Phase)||40
1096122|NCT01072175|2653814|P7|Ongoing|Part C (Phase II: Randomized Phase)||32
1096123|NCT01072175|2653815|P6|Ongoing|Part C (Phase II: Randomized Phase)||35
1096124|NCT01072175|2653816|P5|Ongoing|Part C (Phase II: Randomized Phase)||0
1096125|NCT01072175|2653817|P4|Ongoing|Part C (Phase II: Randomized Phase)||0
1096126|NCT01072175|2653818|P3|Ongoing|Part C (Phase II: Randomized Phase)||0
1096127|NCT01072175|2653819|P2|Ongoing|Part C (Phase II: Randomized Phase)||0
1096128|NCT01072175|2653820|P1|Ongoing|Part C (Phase II: Randomized Phase)||0
1096129|NCT01072175|2653808|P13|STARTED|Part C (Phase II: Randomized Phase)||0
1096130|NCT01072175|2653809|P12|STARTED|Part C (Phase II: Randomized Phase)||0
1096131|NCT01072175|2653810|P11|STARTED|Part C (Phase II: Randomized Phase)||0
1096132|NCT01072175|2653811|P10|STARTED|Part C (Phase II: Randomized Phase)||0
1096133|NCT01072175|2653812|P9|STARTED|Part C (Phase II: Randomized Phase)||0
1096134|NCT01072175|2653813|P8|STARTED|Part C (Phase II: Randomized Phase)||54
1096135|NCT01072175|2653814|P7|STARTED|Part C (Phase II: Randomized Phase)||54
1096136|NCT01072175|2653815|P6|STARTED|Part C (Phase II: Randomized Phase)||54
1096137|NCT01072175|2653816|P5|STARTED|Part C (Phase II: Randomized Phase)||0
1096138|NCT01072175|2653817|P4|STARTED|Part C (Phase II: Randomized Phase)||0
1096139|NCT01072175|2653818|P3|STARTED|Part C (Phase II: Randomized Phase)||0
1096140|NCT01072175|2653819|P2|STARTED|Part C (Phase II: Randomized Phase)||0
1096141|NCT01072175|2653820|P1|STARTED|Part C (Phase II: Randomized Phase)||0
1096142|NCT01072175|2653808|P13|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
1096143|NCT01072175|2653809|P12|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
1096144|NCT01072175|2653810|P11|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
1096145|NCT01072175|2653811|P10|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
1096146|NCT01072175|2653812|P9|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
1096147|NCT01072175|2653813|P8|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
1096148|NCT01072175|2653814|P7|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
1096149|NCT01072175|2653815|P6|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
1096150|NCT01072175|2653816|P5|NOT COMPLETED|Part B (Dose Escalation and Expansion)||79
1096151|NCT01072175|2653817|P4|NOT COMPLETED|Part B (Dose Escalation and Expansion)||27
1096152|NCT01072175|2653818|P3|NOT COMPLETED|Part B (Dose Escalation and Expansion)||23
1096153|NCT01072175|2653819|P2|NOT COMPLETED|Part B (Dose Escalation and Expansion)||6
1096154|NCT01072175|2653820|P1|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
1096155|NCT01072175|2653808|P13|COMPLETED|Part B (Dose Escalation and Expansion)||0
1096156|NCT01072175|2653809|P12|COMPLETED|Part B (Dose Escalation and Expansion)||0
1096157|NCT01072175|2653810|P11|COMPLETED|Part B (Dose Escalation and Expansion)||0
1096158|NCT01072175|2653811|P10|COMPLETED|Part B (Dose Escalation and Expansion)||0
1096159|NCT01072175|2653812|P9|COMPLETED|Part B (Dose Escalation and Expansion)||0
1096160|NCT01072175|2653813|P8|COMPLETED|Part B (Dose Escalation and Expansion)||0
1096161|NCT01072175|2653814|P7|COMPLETED|Part B (Dose Escalation and Expansion)||0
1096162|NCT01072175|2653815|P6|COMPLETED|Part B (Dose Escalation and Expansion)||0
1096163|NCT01072175|2653816|P5|COMPLETED|Part B (Dose Escalation and Expansion)||0
1096164|NCT01072175|2653817|P4|COMPLETED|Part B (Dose Escalation and Expansion)||0
1096165|NCT01072175|2653818|P3|COMPLETED|Part B (Dose Escalation and Expansion)||0
1096166|NCT01072175|2653819|P2|COMPLETED|Part B (Dose Escalation and Expansion)||0
1096167|NCT01072175|2653820|P1|COMPLETED|Part B (Dose Escalation and Expansion)||0
1096168|NCT01072175|2653808|P13|Ongoing|Part B (Dose Escalation and Expansion)||0
1096169|NCT01072175|2653809|P12|Ongoing|Part B (Dose Escalation and Expansion)||0
1096170|NCT01072175|2653810|P11|Ongoing|Part B (Dose Escalation and Expansion)||0
1096171|NCT01072175|2653811|P10|Ongoing|Part B (Dose Escalation and Expansion)||0
1096172|NCT01072175|2653812|P9|Ongoing|Part B (Dose Escalation and Expansion)||0
1096173|NCT01072175|2653813|P8|Ongoing|Part B (Dose Escalation and Expansion)||0
1096174|NCT01072175|2653814|P7|Ongoing|Part B (Dose Escalation and Expansion)||0
1096175|NCT01072175|2653815|P6|Ongoing|Part B (Dose Escalation and Expansion)||0
1096176|NCT01072175|2653816|P5|Ongoing|Part B (Dose Escalation and Expansion)||28
1096177|NCT01072175|2653817|P4|Ongoing|Part B (Dose Escalation and Expansion)||9
1096178|NCT01072175|2653818|P3|Ongoing|Part B (Dose Escalation and Expansion)||10
1096179|NCT01072175|2653819|P2|Ongoing|Part B (Dose Escalation and Expansion)||2
1096180|NCT01072175|2653820|P1|Ongoing|Part B (Dose Escalation and Expansion)||0
1096181|NCT01072175|2653808|P13|STARTED|Part B (Dose Escalation and Expansion)||0
1096182|NCT01072175|2653809|P12|STARTED|Part B (Dose Escalation and Expansion)||0
1096183|NCT01072175|2653810|P11|STARTED|Part B (Dose Escalation and Expansion)||0
1096184|NCT01072175|2653811|P10|STARTED|Part B (Dose Escalation and Expansion)||0
1096185|NCT01072175|2653812|P9|STARTED|Part B (Dose Escalation and Expansion)||0
1096186|NCT01072175|2653813|P8|STARTED|Part B (Dose Escalation and Expansion)||0
1096187|NCT01072175|2653814|P7|STARTED|Part B (Dose Escalation and Expansion)||0
1096188|NCT01072175|2653815|P6|STARTED|Part B (Dose Escalation and Expansion)||0
1096189|NCT01072175|2653816|P5|STARTED|Part B (Dose Escalation and Expansion)||79
1096190|NCT01072175|2653817|P4|STARTED|Part B (Dose Escalation and Expansion)||27
1096191|NCT01072175|2653818|P3|STARTED|Part B (Dose Escalation and Expansion)||23
1096192|NCT01072175|2653819|P2|STARTED|Part B (Dose Escalation and Expansion)||6
1096193|NCT01072175|2653820|P1|STARTED|Part B (Dose Escalation and Expansion)||0
1096194|NCT01072175|2653808|P13|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
1096195|NCT01072175|2653809|P12|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
1096196|NCT01072175|2653810|P11|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
1096197|NCT01072175|2653811|P10|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
1096198|NCT01072175|2653812|P9|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
1096199|NCT01072175|2653813|P8|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
1096200|NCT01072175|2653814|P7|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
1096201|NCT01072175|2653815|P6|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
1096202|NCT01072175|2653816|P5|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
1096203|NCT01072175|2653817|P4|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
1096204|NCT01072175|2653818|P3|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
1096205|NCT01072175|2653819|P2|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
1096206|NCT01072175|2653820|P1|NOT COMPLETED|Part A (Drug-Drug Interaction)||8
1096207|NCT01072175|2653808|P13|COMPLETED|Part A (Drug-Drug Interaction)||0
1096208|NCT01072175|2653809|P12|COMPLETED|Part A (Drug-Drug Interaction)||0
1096209|NCT01072175|2653810|P11|COMPLETED|Part A (Drug-Drug Interaction)||0
1096210|NCT01072175|2653811|P10|COMPLETED|Part A (Drug-Drug Interaction)||0
1096211|NCT01072175|2653812|P9|COMPLETED|Part A (Drug-Drug Interaction)||0
1096212|NCT01072175|2653813|P8|COMPLETED|Part A (Drug-Drug Interaction)||0
1096213|NCT01072175|2653814|P7|COMPLETED|Part A (Drug-Drug Interaction)||0
1096214|NCT01072175|2653815|P6|COMPLETED|Part A (Drug-Drug Interaction)||0
1096215|NCT01072175|2653816|P5|COMPLETED|Part A (Drug-Drug Interaction)||0
1096216|NCT01072175|2653817|P4|COMPLETED|Part A (Drug-Drug Interaction)||0
1096217|NCT01072175|2653818|P3|COMPLETED|Part A (Drug-Drug Interaction)||0
1096218|NCT01072175|2653819|P2|COMPLETED|Part A (Drug-Drug Interaction)||0
1096219|NCT01072175|2653820|P1|COMPLETED|Part A (Drug-Drug Interaction)||0
1096220|NCT01072175|2653808|P13|STARTED|Part A (Drug-Drug Interaction)||0
1096221|NCT01072175|2653809|P12|STARTED|Part A (Drug-Drug Interaction)||0
1096222|NCT01072175|2653810|P11|STARTED|Part A (Drug-Drug Interaction)||0
1096223|NCT01072175|2653811|P10|STARTED|Part A (Drug-Drug Interaction)||0
1096224|NCT01072175|2653812|P9|STARTED|Part A (Drug-Drug Interaction)||0
1096225|NCT01072175|2653813|P8|STARTED|Part A (Drug-Drug Interaction)||0
1096226|NCT01072175|2653814|P7|STARTED|Part A (Drug-Drug Interaction)||0
1096227|NCT01072175|2653815|P6|STARTED|Part A (Drug-Drug Interaction)||0
1096228|NCT01072175|2653816|P5|STARTED|Part A (Drug-Drug Interaction)||0
1096229|NCT01072175|2653817|P4|STARTED|Part A (Drug-Drug Interaction)||0
1096230|NCT01072175|2653818|P3|STARTED|Part A (Drug-Drug Interaction)||0
1096231|NCT01072175|2653819|P2|STARTED|Part A (Drug-Drug Interaction)||0
1096232|NCT01072175|2653820|P1|STARTED|Part A (Drug-Drug Interaction)||8
1096233|NCT01072188|2654005|P2|NOT COMPLETED|Overall Study||0
1096234|NCT01072188|2654006|P1|NOT COMPLETED|Overall Study||0
1096235|NCT01072188|2654005|P2|COMPLETED|Overall Study||23
1096236|NCT01072188|2654006|P1|COMPLETED|Overall Study||22
1096237|NCT01072188|2654005|P2|STARTED|Overall Study||23
1096238|NCT01072188|2654006|P1|STARTED|Overall Study||22
1096239|NCT01072201|2654016|P2|NOT COMPLETED|Overall Study||1
1096240|NCT01072201|2654017|P1|NOT COMPLETED|Overall Study||0
1096241|NCT01072201|2654016|P2|COMPLETED|Overall Study||29
1096242|NCT01072201|2654017|P1|COMPLETED|Overall Study||30
1096243|NCT01072201|2654016|P2|STARTED|Overall Study||30
1096244|NCT01072201|2654017|P1|STARTED|Overall Study||30
1096245|NCT01072331|2654030|P3|NOT COMPLETED|Overall Study||0
1096246|NCT01072331|2654031|P2|NOT COMPLETED|Overall Study||0
1096247|NCT01072331|2654032|P1|NOT COMPLETED|Overall Study||0
1096248|NCT01072331|2654030|P3|COMPLETED|Overall Study||32
1096249|NCT01072331|2654031|P2|COMPLETED|Overall Study||33
1096250|NCT01072331|2654032|P1|COMPLETED|Overall Study||34
1096251|NCT01072331|2654030|P3|STARTED|Overall Study||32
1096252|NCT01072331|2654031|P2|STARTED|Overall Study||33
1096253|NCT01072331|2654032|P1|STARTED|Overall Study||34
1096254|NCT01072344|2654051|P2|NOT COMPLETED|Overall Study||18
1096255|NCT01072344|2654052|P1|NOT COMPLETED|Overall Study||11
1096256|NCT01072344|2654051|P2|COMPLETED|Overall Study||29
1096257|NCT01072344|2654052|P1|COMPLETED|Overall Study||35
1096258|NCT01072344|2654051|P2|STARTED|Overall Study||47
1096259|NCT01072344|2654052|P1|STARTED|Overall Study||46
1096260|NCT01072357|2654068|P2|NOT COMPLETED|Overall Study||1
1096261|NCT01072357|2654069|P1|NOT COMPLETED|Overall Study||0
1096262|NCT01072357|2654068|P2|COMPLETED|Overall Study||14
1096263|NCT01072357|2654069|P1|COMPLETED|Overall Study||15
1096264|NCT01072357|2654068|P2|STARTED|Overall Study||15
1096265|NCT01072357|2654069|P1|STARTED|Overall Study||15
1096266|NCT01072396|2654079|P2|NOT COMPLETED|Period Two||3
1096267|NCT01072396|2654080|P1|NOT COMPLETED|Period Two||1
1096268|NCT01072396|2654079|P2|COMPLETED|Period Two||57
1096269|NCT01072396|2654080|P1|COMPLETED|Period Two||57
1096270|NCT01072396|2654079|P2|STARTED|Period Two||60
1096271|NCT01072396|2654080|P1|STARTED|Period Two||58
1096272|NCT01072396|2654079|P2|NOT COMPLETED|Washout Period||1
1096273|NCT01072396|2654080|P1|NOT COMPLETED|Washout Period||0
1096274|NCT01072396|2654079|P2|COMPLETED|Washout Period||60
1096275|NCT01072396|2654080|P1|COMPLETED|Washout Period||58
1096276|NCT01072396|2654079|P2|STARTED|Washout Period||61
1096277|NCT01072396|2654080|P1|STARTED|Washout Period||58
1096278|NCT01072396|2654079|P2|NOT COMPLETED|Period One||2
1096279|NCT01072396|2654080|P1|NOT COMPLETED|Period One||5
1096280|NCT01072396|2654079|P2|COMPLETED|Period One||61
1096281|NCT01072396|2654080|P1|COMPLETED|Period One||58
1096282|NCT01072396|2654079|P2|STARTED|Period One||63
1096283|NCT01072396|2654080|P1|STARTED|Period One||63
1096284|NCT01072409|2654090|P1|NOT COMPLETED|Overall Study||7
1096285|NCT01072409|2654090|P1|COMPLETED|Overall Study||38
1096286|NCT01072409|2654090|P1|STARTED|Overall Study||45
1096287|NCT01072448|2654096|P2|NOT COMPLETED|Overall Study||30
1096288|NCT01072448|2654097|P1|NOT COMPLETED|Overall Study||19
1096289|NCT01072448|2654096|P2|COMPLETED|Overall Study||130
1096290|NCT01072448|2654097|P1|COMPLETED|Overall Study||144
1096291|NCT01072448|2654096|P2|STARTED|Overall Study||160
1096292|NCT01072448|2654097|P1|STARTED|Overall Study||163
1096293|NCT01072500|2654107|P2|NOT COMPLETED|Overall Study||14
1096294|NCT01072500|2654108|P1|NOT COMPLETED|Overall Study||24
1096295|NCT01072500|2654107|P2|COMPLETED|Overall Study||803
1096296|NCT01072500|2654108|P1|COMPLETED|Overall Study||794
1096297|NCT01072500|2654107|P2|STARTED|Overall Study||817
1096298|NCT01072500|2654108|P1|STARTED|Overall Study||818
1096299|NCT01072526|2654116|P2|NOT COMPLETED|Overall Study||0
1096300|NCT01072526|2654117|P1|NOT COMPLETED|Overall Study||0
1096301|NCT01072526|2654116|P2|COMPLETED|Overall Study||0
1096302|NCT01072526|2654117|P1|COMPLETED|Overall Study|Study completed in September 2008(recruited 6 patients total of 20 anticipated)|6
1096303|NCT01072526|2654116|P2|STARTED|Overall Study||0
1096304|NCT01072526|2654117|P1|STARTED|Overall Study|Study started in December 2007 (recruited 6 patients total of 20 anticipated)|6
1096305|NCT01072539|2654130|P1|NOT COMPLETED|Overall Study||3
1096306|NCT01072539|2654130|P1|COMPLETED|Overall Study|Refer to the Safety Analysis Set. Data for completion were not collected.|3169
1096307|NCT01072539|2654130|P1|STARTED|Overall Study||3172
1096308|NCT01072617|2654138|P1|NOT COMPLETED|Overall Study||0
1096309|NCT01072617|2654138|P1|COMPLETED|Overall Study||8
1096310|NCT01072617|2654138|P1|STARTED|Overall Study||8
1096311|NCT01072630|2654148|P3|NOT COMPLETED|Overall Study||13
1096312|NCT01072630|2654149|P2|NOT COMPLETED|Overall Study||60
1096313|NCT01072630|2654150|P1|NOT COMPLETED|Overall Study||55
1096314|NCT01072630|2654148|P3|COMPLETED|Overall Study||17
1096315|NCT01072630|2654149|P2|COMPLETED|Overall Study||172
1096316|NCT01072630|2654150|P1|COMPLETED|Overall Study||175
1096317|NCT01072630|2654148|P3|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|28
1096318|NCT01072630|2654149|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|230
1096405|NCT01073566|2654440|P2|STARTED|Period 2 (6 Weeks)||19
1096319|NCT01072630|2654150|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|224
1096320|NCT01072630|2654148|P3|Safety Population|Overall Study|Treated participants.|30
1096321|NCT01072630|2654149|P2|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|231
1096322|NCT01072630|2654150|P1|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|229
1096323|NCT01072630|2654148|P3|STARTED|Overall Study||30
1096324|NCT01072630|2654149|P2|STARTED|Overall Study||232
1096325|NCT01072630|2654150|P1|STARTED|Overall Study||230
1096326|NCT01072643|2654224|P1|NOT COMPLETED|Overall Study||0
1096327|NCT01072643|2654224|P1|COMPLETED|Overall Study||4
1096328|NCT01072643|2654224|P1|STARTED|Overall Study||4
1096329|NCT01072656|2654233|P2|NOT COMPLETED|Second Intervention||0
1096330|NCT01072656|2654234|P1|NOT COMPLETED|Second Intervention||0
1096331|NCT01072656|2654233|P2|COMPLETED|Second Intervention||4
1096332|NCT01072656|2654234|P1|COMPLETED|Second Intervention||5
1096333|NCT01072656|2654233|P2|STARTED|Second Intervention||4
1096334|NCT01072656|2654234|P1|STARTED|Second Intervention||5
1096335|NCT01072656|2654233|P2|NOT COMPLETED|First Intervention||0
1096336|NCT01072656|2654234|P1|NOT COMPLETED|First Intervention||0
1096337|NCT01072656|2654233|P2|COMPLETED|First Intervention||4
1096338|NCT01072656|2654234|P1|COMPLETED|First Intervention||5
1096339|NCT01072656|2654233|P2|STARTED|First Intervention||4
1096340|NCT01072656|2654234|P1|STARTED|First Intervention||5
1096341|NCT01072669|2654246|P2|NOT COMPLETED|Overall Study||0
1096342|NCT01072669|2654247|P1|NOT COMPLETED|Overall Study||0
1096343|NCT01072669|2654246|P2|COMPLETED|Overall Study||5
1096344|NCT01072669|2654247|P1|COMPLETED|Overall Study||15
1096345|NCT01072669|2654246|P2|STARTED|Overall Study||5
1096346|NCT01072669|2654247|P1|STARTED|Overall Study||15
1096347|NCT01072773|2654253|P1|NOT COMPLETED|Overall Study||0
1096348|NCT01072773|2654253|P1|COMPLETED|Overall Study||2
1096349|NCT01072773|2654253|P1|STARTED|Overall Study||2
1096350|NCT01072877|2654267|P5|NOT COMPLETED|Overall Study||0
1096351|NCT01072877|2654268|P4|NOT COMPLETED|Overall Study||2
1096352|NCT01072877|2654269|P3|NOT COMPLETED|Overall Study||0
1096353|NCT01072877|2654270|P2|NOT COMPLETED|Overall Study||1
1096354|NCT01072877|2654271|P1|NOT COMPLETED|Overall Study||1
1096355|NCT01072877|2654267|P5|COMPLETED|Overall Study||63
1096356|NCT01072877|2654268|P4|COMPLETED|Overall Study||50
1096357|NCT01072877|2654269|P3|COMPLETED|Overall Study||51
1096358|NCT01072877|2654270|P2|COMPLETED|Overall Study||56
1096359|NCT01072877|2654271|P1|COMPLETED|Overall Study||55
1096360|NCT01072877|2654267|P5|STARTED|Overall Study||63
1096361|NCT01072877|2654268|P4|STARTED|Overall Study||52
1096362|NCT01072877|2654269|P3|STARTED|Overall Study||51
1096363|NCT01072877|2654270|P2|STARTED|Overall Study||57
1096364|NCT01072877|2654271|P1|STARTED|Overall Study||56
1096365|NCT01072929|2654296|P3|NOT COMPLETED|Overall Study||9
1096366|NCT01072929|2654297|P2|NOT COMPLETED|Overall Study||51
1096367|NCT01072929|2654298|P1|NOT COMPLETED|Overall Study||44
1096368|NCT01072929|2654296|P3|COMPLETED|Overall Study||24
1096369|NCT01072929|2654297|P2|COMPLETED|Overall Study||150
1096370|NCT01072929|2654298|P1|COMPLETED|Overall Study||155
1096371|NCT01072929|2654296|P3|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|31
1096372|NCT01072929|2654297|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
1096373|NCT01072929|2654298|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
1096374|NCT01072929|2654296|P3|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|32
1096375|NCT01072929|2654297|P2|Safety Population|Overall Study|Treated participants. Three participants were randomized but not treated.|198
1096376|NCT01072929|2654298|P1|Safety Population|Overall Study|Treated participants|199
1096377|NCT01072929|2654296|P3|STARTED|Overall Study||33
1096378|NCT01072929|2654297|P2|STARTED|Overall Study||201
1096379|NCT01072929|2654298|P1|STARTED|Overall Study||199
1096380|NCT01073163|2654372|P1|NOT COMPLETED|Overall Study||3
1096381|NCT01073163|2654372|P1|COMPLETED|Overall Study|Patients completed study|51
1096382|NCT01073163|2654372|P1|Treated With >=6 Cycles|Overall Study||49
1096383|NCT01073163|2654372|P1|Treated With <6 Cycles|Overall Study||4
1096384|NCT01073163|2654372|P1|Enrolled But Not Treated|Overall Study||1
1096385|NCT01073163|2654372|P1|STARTED|Overall Study||54
1096386|NCT01073267|2654392|P1|NOT COMPLETED|Overall Study||3
1096387|NCT01073267|2654392|P1|COMPLETED|Overall Study||1
1096388|NCT01073267|2654392|P1|STARTED|Overall Study||4
1096389|NCT01073293|2654398|P2|NOT COMPLETED|Overall Study||11
1096390|NCT01073293|2654399|P1|NOT COMPLETED|Overall Study||5
1096391|NCT01073293|2654398|P2|COMPLETED|Overall Study||517
1096392|NCT01073293|2654399|P1|COMPLETED|Overall Study||521
1096393|NCT01073293|2654398|P2|STARTED|Overall Study||528
1096394|NCT01073293|2654399|P1|STARTED|Overall Study||526
1096395|NCT01073449|2654421|P1|NOT COMPLETED|Overall Study||0
1096396|NCT01073449|2654421|P1|COMPLETED|Overall Study||3362
1096397|NCT01073449|2654421|P1|STARTED|Overall Study||3362
1096398|NCT01073462|2654427|P1|NOT COMPLETED|Overall Study||41
1096399|NCT01073462|2654427|P1|COMPLETED|Overall Study||26
1096400|NCT01073462|2654427|P1|STARTED|Overall Study||67
1096401|NCT01073566|2654440|P2|NOT COMPLETED|Period 2 (6 Weeks)||0
1096402|NCT01073566|2654441|P1|NOT COMPLETED|Period 2 (6 Weeks)||1
1096403|NCT01073566|2654440|P2|COMPLETED|Period 2 (6 Weeks)||19
1096404|NCT01073566|2654441|P1|COMPLETED|Period 2 (6 Weeks)||18
1096406|NCT01073566|2654441|P1|STARTED|Period 2 (6 Weeks)||19
1096407|NCT01073566|2654440|P2|NOT COMPLETED|Period 1 (6 Weeks)||0
1096408|NCT01073566|2654441|P1|NOT COMPLETED|Period 1 (6 Weeks)||0
1096409|NCT01073566|2654440|P2|COMPLETED|Period 1 (6 Weeks)||19
1096410|NCT01073566|2654441|P1|COMPLETED|Period 1 (6 Weeks)||19
1096411|NCT01073566|2654440|P2|STARTED|Period 1 (6 Weeks)||19
1096412|NCT01073566|2654441|P1|STARTED|Period 1 (6 Weeks)||19
1096413|NCT01073605|2654456|P3|NOT COMPLETED|Overall Study||61
1096414|NCT01073605|2654457|P2|NOT COMPLETED|Overall Study||67
1096415|NCT01073605|2654458|P1|NOT COMPLETED|Overall Study||62
1096416|NCT01073605|2654456|P3|COMPLETED|Overall Study|Corresponds to follow-up until final height|8
1096417|NCT01073605|2654457|P2|COMPLETED|Overall Study|Corresponds to follow-up until final height|4
1096418|NCT01073605|2654458|P1|COMPLETED|Overall Study|Corresponds to follow-up until final height|6
1096419|NCT01073605|2654456|P3|Received Treatment|Overall Study||68
1096420|NCT01073605|2654457|P2|Received Treatment|Overall Study||70
1096421|NCT01073605|2654458|P1|Received Treatment|Overall Study||68
1096422|NCT01073605|2654456|P3|STARTED|Overall Study||69
1096423|NCT01073605|2654457|P2|STARTED|Overall Study||71
1096424|NCT01073605|2654458|P1|STARTED|Overall Study||68
1096425|NCT01073618|2654502|P1|NOT COMPLETED|Overall Study||307
1096426|NCT01073618|2654502|P1|COMPLETED|Overall Study||385
1096427|NCT01073618|2654502|P1|STARTED|Overall Study||692
1096428|NCT01073631|2654507|P1|NOT COMPLETED|Overall Study||169
1096429|NCT01073631|2654507|P1|COMPLETED|Overall Study||374
1096430|NCT01073631|2654507|P1|STARTED|Overall Study||543
1096431|NCT01073657|2654514|P2|NOT COMPLETED|Overall Study||0
1096432|NCT01073657|2654515|P1|NOT COMPLETED|Overall Study||0
1096433|NCT01073657|2654514|P2|COMPLETED|Overall Study||16
1096434|NCT01073657|2654515|P1|COMPLETED|Overall Study||17
1096435|NCT01073657|2654514|P2|STARTED|Overall Study||16
1096436|NCT01073657|2654515|P1|STARTED|Overall Study||17
1096437|NCT01073865|2654523|P2|NOT COMPLETED|Overall Study||39
1096438|NCT01073865|2654524|P1|NOT COMPLETED|Overall Study||28
1096439|NCT01073865|2654523|P2|COMPLETED|Overall Study|Number of patients completed the study|74
1096440|NCT01073865|2654524|P1|COMPLETED|Overall Study|Number of patients completed the study|81
1096441|NCT01073865|2654523|P2|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|113
1096442|NCT01073865|2654524|P1|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|108
1096443|NCT01073865|2654523|P2|STARTED|Overall Study|Number of patients randomised|113
1096444|NCT01073865|2654524|P1|STARTED|Overall Study|Number of patients randomised|109
1096445|NCT01073930|2654536|P2|NOT COMPLETED|Overall Study||6
1096446|NCT01073930|2654537|P1|NOT COMPLETED|Overall Study||3
1096447|NCT01073930|2654536|P2|COMPLETED|Overall Study||295
1096448|NCT01073930|2654537|P1|COMPLETED|Overall Study||304
1096449|NCT01073930|2654536|P2|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|297
1096450|NCT01073930|2654537|P1|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|304
1096451|NCT01073930|2654536|P2|Safety Population (Treated)|Overall Study||298
1096452|NCT01073930|2654537|P1|Safety Population (Treated)|Overall Study||305
1096453|NCT01073930|2654536|P2|STARTED|Overall Study||301
1096454|NCT01073930|2654537|P1|STARTED|Overall Study||307
1096455|NCT01073943|2654561|P2|NOT COMPLETED|Overall Study||8
1096456|NCT01073943|2654562|P1|NOT COMPLETED|Overall Study||13
1096457|NCT01073943|2654561|P2|COMPLETED|Overall Study||295
1096458|NCT01073943|2654562|P1|COMPLETED|Overall Study||287
1096459|NCT01073943|2654561|P2|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|300
1096460|NCT01073943|2654562|P1|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|294
1096461|NCT01073943|2654561|P2|Safety Population (Treated)|Overall Study||302
1096462|NCT01073943|2654562|P1|Safety Population (Treated)|Overall Study||296
1096463|NCT01073943|2654561|P2|STARTED|Overall Study||303
1096464|NCT01073943|2654562|P1|STARTED|Overall Study||300
1096465|NCT01074008|2654595|P9|NOT COMPLETED|Overall Study||4
1096466|NCT01074008|2654596|P8|NOT COMPLETED|Overall Study||0
1096467|NCT01074008|2654597|P7|NOT COMPLETED|Overall Study||1
1096468|NCT01074008|2654598|P6|NOT COMPLETED|Overall Study||0
1096469|NCT01074008|2654599|P5|NOT COMPLETED|Overall Study||2
1096470|NCT01074008|2654600|P4|NOT COMPLETED|Overall Study||1
1096471|NCT01074008|2654601|P3|NOT COMPLETED|Overall Study||2
1096472|NCT01074008|2654602|P2|NOT COMPLETED|Overall Study||3
1096473|NCT01074008|2654603|P1|NOT COMPLETED|Overall Study||1
1096474|NCT01074008|2654595|P9|COMPLETED|Overall Study||7
1096475|NCT01074008|2654596|P8|COMPLETED|Overall Study||8
1096476|NCT01074008|2654597|P7|COMPLETED|Overall Study||7
1096477|NCT01074008|2654598|P6|COMPLETED|Overall Study||7
1096478|NCT01074008|2654599|P5|COMPLETED|Overall Study||6
1096479|NCT01074008|2654600|P4|COMPLETED|Overall Study||7
1096480|NCT01074008|2654601|P3|COMPLETED|Overall Study||6
1096481|NCT01074008|2654602|P2|COMPLETED|Overall Study||5
1096482|NCT01074008|2654603|P1|COMPLETED|Overall Study||7
1096483|NCT01074008|2654595|P9|Completed Direct-acting Antiviral Agent|Overall Study||5
1096484|NCT01074008|2654596|P8|Completed Direct-acting Antiviral Agent|Overall Study||7
1096485|NCT01074008|2654597|P7|Completed Direct-acting Antiviral Agent|Overall Study||8
1096486|NCT01074008|2654598|P6|Completed Direct-acting Antiviral Agent|Overall Study||5
1096487|NCT01074008|2654599|P5|Completed Direct-acting Antiviral Agent|Overall Study||8
1096488|NCT01074008|2654600|P4|Completed Direct-acting Antiviral Agent|Overall Study||8
1096489|NCT01074008|2654601|P3|Completed Direct-acting Antiviral Agent|Overall Study||7
1096490|NCT01074008|2654602|P2|Completed Direct-acting Antiviral Agent|Overall Study||7
1096491|NCT01074008|2654603|P1|Completed Direct-acting Antiviral Agent|Overall Study||8
1096492|NCT01074008|2654595|P9|STARTED|Overall Study||11
1096493|NCT01074008|2654596|P8|STARTED|Overall Study||8
1096494|NCT01074008|2654597|P7|STARTED|Overall Study||8
1096495|NCT01074008|2654598|P6|STARTED|Overall Study||7
1096496|NCT01074008|2654599|P5|STARTED|Overall Study||8
1096497|NCT01074008|2654600|P4|STARTED|Overall Study||8
1096498|NCT01074008|2654601|P3|STARTED|Overall Study||8
1096499|NCT01074008|2654602|P2|STARTED|Overall Study||8
1096500|NCT01074008|2654603|P1|STARTED|Overall Study||8
1096501|NCT01074034|2654711|P1|NOT COMPLETED|Overall Study||6
1096502|NCT01074034|2654711|P1|COMPLETED|Overall Study||205
1096503|NCT01074034|2654711|P1|STARTED|Overall Study||211
1096504|NCT01074047|2654718|P2|NOT COMPLETED|Extension Phase||0
1096505|NCT01074047|2654719|P1|NOT COMPLETED|Extension Phase||22
1096506|NCT01074047|2654718|P2|COMPLETED|Extension Phase||0
1096507|NCT01074047|2654719|P1|COMPLETED|Extension Phase||0
1096508|NCT01074047|2654718|P2|Safety Population|Extension Phase||0
1096509|NCT01074047|2654719|P1|Safety Population|Extension Phase|Participants who enrolled in the extension phase|22
1096510|NCT01074047|2654718|P2|STARTED|Extension Phase||0
1096511|NCT01074047|2654719|P1|STARTED|Extension Phase|2 participants did not enroll in the extension period.|22
1096512|NCT01074047|2654718|P2|NOT COMPLETED|Survival Follow-Up Phase||136
1096513|NCT01074047|2654719|P1|NOT COMPLETED|Survival Follow-Up Phase||124
1096514|NCT01074047|2654718|P2|COMPLETED|Survival Follow-Up Phase||27
1096515|NCT01074047|2654719|P1|COMPLETED|Survival Follow-Up Phase||16
1096516|NCT01074047|2654718|P2|STARTED|Survival Follow-Up Phase||163
1096517|NCT01074047|2654719|P1|STARTED|Survival Follow-Up Phase||140
1096518|NCT01074047|2654718|P2|NOT COMPLETED|Treatment Phase||234
1096519|NCT01074047|2654719|P1|NOT COMPLETED|Treatment Phase||217
1096520|NCT01074047|2654718|P2|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|13
1096521|NCT01074047|2654719|P1|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|24
1096522|NCT01074047|2654718|P2|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|191
1096523|NCT01074047|2654719|P1|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|179
1096524|NCT01074047|2654718|P2|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|235
1096525|NCT01074047|2654719|P1|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|236
1096526|NCT01074047|2654718|P2|Treated Population|Treatment Phase|7 patients not treated with any drug regimen|240
1096527|NCT01074047|2654719|P1|Treated Population|Treatment Phase|5 patients not treated with any drug regimen|236
1096528|NCT01074047|2654718|P2|STARTED|Treatment Phase||247
1096529|NCT01074047|2654719|P1|STARTED|Treatment Phase||241
1096530|NCT01074099|2654795|P2|NOT COMPLETED|Overall Study||0
1096531|NCT01074099|2654796|P1|NOT COMPLETED|Overall Study||0
1096532|NCT01074099|2654795|P2|COMPLETED|Overall Study||3
1096533|NCT01074099|2654796|P1|COMPLETED|Overall Study||2
1096534|NCT01074099|2654795|P2|STARTED|Overall Study||3
1096535|NCT01074099|2654796|P1|STARTED|Overall Study||2
1096536|NCT01074125|2654807|P3|NOT COMPLETED|Overall Study||12
1096537|NCT01074125|2654808|P2|NOT COMPLETED|Overall Study||5
1096538|NCT01074125|2654809|P1|NOT COMPLETED|Overall Study||12
1096539|NCT01074125|2654807|P3|COMPLETED|Overall Study||36
1096540|NCT01074125|2654808|P2|COMPLETED|Overall Study||47
1096541|NCT01074125|2654809|P1|COMPLETED|Overall Study||39
1096542|NCT01074125|2654807|P3|STARTED|Overall Study||48
1096543|NCT01074125|2654808|P2|STARTED|Overall Study||52
1096544|NCT01074125|2654809|P1|STARTED|Overall Study||51
1096545|NCT01074164|2654825|P2|NOT COMPLETED|Overall Study||1
1096546|NCT01074164|2654826|P1|NOT COMPLETED|Overall Study||3
1096547|NCT01074164|2654825|P2|COMPLETED|Overall Study||7
1096548|NCT01074164|2654826|P1|COMPLETED|Overall Study||4
1096549|NCT01074164|2654825|P2|STARTED|Overall Study||8
1096550|NCT01074164|2654826|P1|STARTED|Overall Study||7
1096551|NCT01074216|2654844|P1|NOT COMPLETED|Overall Study||13
1096552|NCT01074216|2654844|P1|COMPLETED|Overall Study||41
1096553|NCT01074216|2654844|P1|STARTED|Overall Study||54
1096554|NCT01074229|2654851|P3|NOT COMPLETED|Overall Study||4
1096555|NCT01074229|2654852|P2|NOT COMPLETED|Overall Study||3
1096556|NCT01074229|2654853|P1|NOT COMPLETED|Overall Study||2
1096557|NCT01074229|2654851|P3|COMPLETED|Overall Study||21
1096558|NCT01074229|2654852|P2|COMPLETED|Overall Study||22
1096559|NCT01074229|2654853|P1|COMPLETED|Overall Study||23
1096560|NCT01074229|2654851|P3|STARTED|Overall Study||25
1096561|NCT01074229|2654852|P2|STARTED|Overall Study||25
1096562|NCT01074229|2654853|P1|STARTED|Overall Study||25
1096563|NCT01074242|2654864|P1|NOT COMPLETED|Overall Study||403
1096564|NCT01074242|2654864|P1|COMPLETED|Overall Study||3395
1096565|NCT01074242|2654864|P1|Received at Least 1 Dose of Vaccine|Overall Study||3395
1096566|NCT01074242|2654864|P1|STARTED|Overall Study||3798
1096567|NCT01074255|2654869|P1|NOT COMPLETED|Overall Study||2
1096568|NCT01074255|2654869|P1|COMPLETED|Overall Study||3139
1096569|NCT01074255|2654869|P1|Treated|Overall Study||3139
1096570|NCT01074255|2654869|P1|STARTED|Overall Study||3141
1096571|NCT01074268|2654875|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||7
1096572|NCT01074268|2654876|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||6
1096573|NCT01074268|2654875|P2|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||115
1096574|NCT01074268|2654876|P1|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||242
1096575|NCT01074268|2654875|P2|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Sixteen subjects from main trial did not continue into the extension|122
1096576|NCT01074268|2654876|P1|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Thirty five subjects from main trial did not continue into the extension|248
1096577|NCT01074268|2654875|P2|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||15
1096578|NCT01074268|2654876|P1|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||20
1096579|NCT01074268|2654875|P2|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||138
1096580|NCT01074268|2654876|P1|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||283
1096581|NCT01074268|2654875|P2|Exposed|Main: Week 0 to 26 (NN1250-3585)|One subject withdrew prior to exposure to trial drugs|152
1096582|NCT01074268|2654876|P1|Exposed|Main: Week 0 to 26 (NN1250-3585)|Two subjects withdrew prior to exposure to trial drugs|301
1096583|NCT01074268|2654875|P2|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)||153
1096584|NCT01074268|2654876|P1|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)|One subject was withdrawn because the subject was randomised in error (screening failure)|302
1096585|NCT01074268|2654875|P2|STARTED|Main: Week 0 to 26 (NN1250-3585)||153
1096586|NCT01074268|2654876|P1|STARTED|Main: Week 0 to 26 (NN1250-3585)||303
1096587|NCT01074307|2654904|P2|NOT COMPLETED|Overall Study||12
1096588|NCT01074307|2654905|P1|NOT COMPLETED|Overall Study||22
1096589|NCT01074307|2654904|P2|COMPLETED|Overall Study||102
1096590|NCT01074307|2654905|P1|COMPLETED|Overall Study||44
1096591|NCT01074307|2654904|P2|STARTED|Overall Study||114
1096592|NCT01074307|2654905|P1|STARTED|Overall Study||66
1096593|NCT01067976|2654925|P1|NOT COMPLETED|Overall Study||22
1096594|NCT01067976|2654925|P1|COMPLETED|Overall Study|study course completed|424
1096595|NCT01067976|2654925|P1|Fulfilled Requirements of FAS Population|Overall Study||390
1096596|NCT01067976|2654925|P1|Received Treatment|Overall Study|treatment started|426
1096597|NCT01067976|2654925|P1|STARTED|Overall Study|screened and enrolled|446
1096598|NCT01074437|2654986|P2|NOT COMPLETED|Overall Study||0
1096599|NCT01074437|2654987|P1|NOT COMPLETED|Overall Study||0
1096600|NCT01074437|2654986|P2|COMPLETED|Overall Study||5
1096601|NCT01074437|2654987|P1|COMPLETED|Overall Study||4
1096602|NCT01074437|2654986|P2|STARTED|Overall Study||5
1096603|NCT01074437|2654987|P1|STARTED|Overall Study||4
1096604|NCT01074450|2654995|P2|NOT COMPLETED|Second Intervention||1
1096605|NCT01074450|2654996|P1|NOT COMPLETED|Second Intervention||1
1096606|NCT01074450|2654995|P2|COMPLETED|Second Intervention|Influenze Symptoms Present at Check in.|9
1096607|NCT01074450|2654996|P1|COMPLETED|Second Intervention|Positive Drug Screen at Check in.|11
1096608|NCT01074450|2654995|P2|STARTED|Second Intervention||10
1096609|NCT01074450|2654996|P1|STARTED|Second Intervention||12
1096610|NCT01074450|2654995|P2|NOT COMPLETED|Washout of 7 Days||0
1096611|NCT01074450|2654996|P1|NOT COMPLETED|Washout of 7 Days||0
1096612|NCT01074450|2654995|P2|COMPLETED|Washout of 7 Days||10
1096613|NCT01074450|2654996|P1|COMPLETED|Washout of 7 Days||12
1096614|NCT01074450|2654995|P2|STARTED|Washout of 7 Days||10
1096615|NCT01074450|2654996|P1|STARTED|Washout of 7 Days||12
1096616|NCT01074450|2654995|P2|NOT COMPLETED|First Intervention||2
1096617|NCT01074450|2654996|P1|NOT COMPLETED|First Intervention||0
1096618|NCT01074450|2654995|P2|COMPLETED|First Intervention||10
1096619|NCT01074450|2654996|P1|COMPLETED|First Intervention||12
1096620|NCT01074450|2654995|P2|STARTED|First Intervention||12
1096621|NCT01074450|2654996|P1|STARTED|First Intervention||12
1096622|NCT01074463|2655008|P2|NOT COMPLETED|Second Intervention||0
1096623|NCT01074463|2655009|P1|NOT COMPLETED|Second Intervention||0
1096624|NCT01074463|2655008|P2|COMPLETED|Second Intervention||12
1096625|NCT01074463|2655009|P1|COMPLETED|Second Intervention||12
1096626|NCT01074463|2655008|P2|STARTED|Second Intervention||12
1096627|NCT01074463|2655009|P1|STARTED|Second Intervention||12
1096628|NCT01074463|2655008|P2|NOT COMPLETED|Washout of 7 Days||0
1096629|NCT01074463|2655009|P1|NOT COMPLETED|Washout of 7 Days||0
1096630|NCT01074463|2655008|P2|COMPLETED|Washout of 7 Days||12
1096631|NCT01074463|2655009|P1|COMPLETED|Washout of 7 Days||12
1096632|NCT01074463|2655008|P2|STARTED|Washout of 7 Days||12
1096633|NCT01074463|2655009|P1|STARTED|Washout of 7 Days||12
1096634|NCT01074463|2655008|P2|NOT COMPLETED|First Intervention||0
1096635|NCT01074463|2655009|P1|NOT COMPLETED|First Intervention||0
1096636|NCT01074463|2655008|P2|COMPLETED|First Intervention||12
1096637|NCT01074463|2655009|P1|COMPLETED|First Intervention||12
1096638|NCT01074463|2655008|P2|STARTED|First Intervention||12
1096639|NCT01074463|2655009|P1|STARTED|First Intervention||12
1096640|NCT01074502|2655019|P1|NOT COMPLETED|Overall Study||1
1096641|NCT01074502|2655019|P1|COMPLETED|Overall Study||2
1096642|NCT01074502|2655019|P1|STARTED|Overall Study||3
1096643|NCT01074554|2655030|P2|NOT COMPLETED|Overall Study||4
1096644|NCT01074554|2655031|P1|NOT COMPLETED|Overall Study||3
1096645|NCT01074554|2655030|P2|COMPLETED|Overall Study||11
1096646|NCT01074554|2655031|P1|COMPLETED|Overall Study||11
1096647|NCT01074554|2655030|P2|STARTED|Overall Study||15
1096648|NCT01074554|2655031|P1|STARTED|Overall Study||14
1096649|NCT01074658|2655041|P1|NOT COMPLETED|Overall Study||19
1096650|NCT01074658|2655041|P1|COMPLETED|Overall Study||996
1096651|NCT01074658|2655041|P1|Attempted Implant|Overall Study||996
1096652|NCT01074658|2655041|P1|STARTED|Overall Study||1015
1096653|NCT01075074|2655050|P3|NOT COMPLETED|Overall Study||2
1096654|NCT01075074|2655051|P2|NOT COMPLETED|Overall Study||2
1096655|NCT01075074|2655052|P1|NOT COMPLETED|Overall Study||1
1096656|NCT01075074|2655050|P3|COMPLETED|Overall Study||23
1096657|NCT01075074|2655051|P2|COMPLETED|Overall Study||23
1096658|NCT01075074|2655052|P1|COMPLETED|Overall Study||24
1096659|NCT01075074|2655050|P3|STARTED|Overall Study||25
1096660|NCT01075074|2655051|P2|STARTED|Overall Study||25
1096661|NCT01075074|2655052|P1|STARTED|Overall Study||25
1096662|NCT01075087|2655071|P2|NOT COMPLETED|Overall Study||0
1096663|NCT01075087|2655072|P1|NOT COMPLETED|Overall Study||0
1096664|NCT01075087|2655071|P2|COMPLETED|Overall Study||10
1096665|NCT01075087|2655072|P1|COMPLETED|Overall Study||9
1096666|NCT01075087|2655071|P2|STARTED|Overall Study||10
1096667|NCT01075087|2655072|P1|STARTED|Overall Study||9
1096668|NCT01075100|2655082|P2|NOT COMPLETED|Overall Study||53
1096669|NCT01075100|2655083|P1|NOT COMPLETED|Overall Study||49
1096670|NCT01075100|2655082|P2|COMPLETED|Overall Study||1
1096671|NCT01075100|2655083|P1|COMPLETED|Overall Study||0
1096672|NCT01075100|2655082|P2|STARTED|Overall Study||54
1096673|NCT01075100|2655083|P1|STARTED|Overall Study||49
1096674|NCT01075152|2655101|P2|NOT COMPLETED|Overall Study||0
1096675|NCT01075152|2655102|P1|NOT COMPLETED|Overall Study||1
1096676|NCT01075152|2655101|P2|COMPLETED|Overall Study||89
1096677|NCT01075152|2655102|P1|COMPLETED|Overall Study||87
1096678|NCT01075152|2655101|P2|STARTED|Overall Study|randomized|89
1096679|NCT01075152|2655102|P1|STARTED|Overall Study|randomized|88
1096680|NCT01075178|2655128|P2|NOT COMPLETED|Subject Chart Review||9
1096681|NCT01075178|2655129|P1|NOT COMPLETED|Subject Chart Review||9
1096682|NCT01075178|2655128|P2|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
1096683|NCT01075178|2655129|P1|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
1096684|NCT01075178|2655128|P2|STARTED|Subject Chart Review|subjects matched|1018
1096685|NCT01075178|2655129|P1|STARTED|Subject Chart Review|subjects matched|1018
1096686|NCT01075178|2655128|P2|NOT COMPLETED|Subject Matching||403
1096687|NCT01075178|2655129|P1|NOT COMPLETED|Subject Matching||130
1096688|NCT01075178|2655128|P2|COMPLETED|Subject Matching|subjects matched|1018
1096689|NCT01075178|2655129|P1|COMPLETED|Subject Matching|subjects matched|1018
1096690|NCT01075178|2655128|P2|STARTED|Subject Matching|eligible for matching|1421
1096691|NCT01075178|2655129|P1|STARTED|Subject Matching|eligible for matching|1148
1096692|NCT01075191|2655141|P1|NOT COMPLETED|Overall Study||18
1096693|NCT01075191|2655141|P1|COMPLETED|Overall Study||42
1096694|NCT01075191|2655141|P1|Discontinued Year 3|Overall Study||5
1096695|NCT01075191|2655141|P1|Discontinued Year 2|Overall Study||6
1096696|NCT01075191|2655141|P1|Discontinued Year 1|Overall Study||7
1096697|NCT01075191|2655141|P1|STARTED|Overall Study|65 participants were enrolled; 5 protocol violations were excluded from all analyses except safety.|60
1096698|NCT01075204|2655150|P1|NOT COMPLETED|Overall Study||0
1096699|NCT01075204|2655150|P1|COMPLETED|Overall Study||335
1096700|NCT01075204|2655150|P1|STARTED|Overall Study||335
1096701|NCT01075217|2655169|P2|NOT COMPLETED|Overall Study||1
1096702|NCT01075217|2655170|P1|NOT COMPLETED|Overall Study||2
1096703|NCT01075217|2655169|P2|COMPLETED|Overall Study||84
1096704|NCT01075217|2655170|P1|COMPLETED|Overall Study||82
1096705|NCT01075217|2655169|P2|STARTED|Overall Study|86 patients randomized to receive Visipaque; 1 of the patients did not meet entry requirements|85
1096706|NCT01075217|2655170|P1|STARTED|Overall Study|88 patients randomized to receive Isovue; 4 of the patients did not meet entry requirements|84
1096707|NCT01075243|2655189|P3|NOT COMPLETED|Overall Study||0
1096708|NCT01075243|2655190|P2|NOT COMPLETED|Overall Study||3
1096709|NCT01075243|2655191|P1|NOT COMPLETED|Overall Study||6
1096710|NCT01075243|2655189|P3|COMPLETED|Overall Study||80
1096711|NCT01075243|2655190|P2|COMPLETED|Overall Study||155
1096712|NCT01075243|2655191|P1|COMPLETED|Overall Study||157
1096713|NCT01075243|2655189|P3|STARTED|Overall Study||80
1096714|NCT01075243|2655190|P2|STARTED|Overall Study||158
1096715|NCT01075243|2655191|P1|STARTED|Overall Study||163
1096716|NCT01075256|2655244|P3|NOT COMPLETED|Overall Study||0
1096717|NCT01075256|2655245|P2|NOT COMPLETED|Overall Study||0
1096718|NCT01075256|2655246|P1|NOT COMPLETED|Overall Study||1
1096719|NCT01075256|2655244|P3|COMPLETED|Overall Study||65
1096720|NCT01075256|2655245|P2|COMPLETED|Overall Study||66
1096721|NCT01075256|2655246|P1|COMPLETED|Overall Study||63
1096722|NCT01075256|2655244|P3|STARTED|Overall Study||65
1096723|NCT01075256|2655245|P2|STARTED|Overall Study||66
1096724|NCT01075256|2655246|P1|STARTED|Overall Study||64
1096725|NCT01075282|2655278|P3|NOT COMPLETED|Overall Study||27
1096726|NCT01075282|2655279|P2|NOT COMPLETED|Overall Study||29
1096727|NCT01075282|2655280|P1|NOT COMPLETED|Overall Study||31
1096728|NCT01075282|2655278|P3|COMPLETED|Overall Study||238
1096729|NCT01075282|2655279|P2|COMPLETED|Overall Study||243
1096730|NCT01075282|2655280|P1|COMPLETED|Overall Study||242
1096731|NCT01075282|2655278|P3|Received at Least One Dose of Study Drug|Overall Study||262
1096732|NCT01075282|2655279|P2|Received at Least One Dose of Study Drug|Overall Study||272
1096733|NCT01075282|2655280|P1|Received at Least One Dose of Study Drug|Overall Study||273
1096734|NCT01075282|2655278|P3|STARTED|Overall Study|Of 265 participants randomized to Insulin Glargine, 3 chose not to take study drug.|265
1096735|NCT01075282|2655279|P2|STARTED|Overall Study||272
1096736|NCT01075282|2655280|P1|STARTED|Overall Study||273
1096737|NCT01075347|2655362|P2|NOT COMPLETED|Overall Study||0
1096738|NCT01075347|2655363|P1|NOT COMPLETED|Overall Study||0
1096739|NCT01075347|2655362|P2|COMPLETED|Overall Study||83
1096740|NCT01075347|2655363|P1|COMPLETED|Overall Study||82
1096741|NCT01075347|2655362|P2|STARTED|Overall Study||83
1096742|NCT01075347|2655363|P1|STARTED|Overall Study||82
1096743|NCT01075399|2655371|P1|NOT COMPLETED|Overall Study||8
1096744|NCT01075399|2655371|P1|COMPLETED|Overall Study|42 of 50 patients received at least one dose and 39 of 50 patients completed two pre-treatment scan|42
1096745|NCT01075399|2655371|P1|STARTED|Overall Study|A total of 50 patients were enrolled into the study.|50
1096746|NCT01075646|2655379|P4|NOT COMPLETED|Overall Study||2
1096747|NCT01075646|2655380|P3|NOT COMPLETED|Overall Study||1
1096748|NCT01075646|2655381|P2|NOT COMPLETED|Overall Study||3
1096749|NCT01075646|2655382|P1|NOT COMPLETED|Overall Study||4
1096750|NCT01075646|2655379|P4|COMPLETED|Overall Study||44
1096751|NCT01075646|2655380|P3|COMPLETED|Overall Study||52
1096752|NCT01075646|2655381|P2|COMPLETED|Overall Study||31
1096753|NCT01075646|2655382|P1|COMPLETED|Overall Study||29
1096754|NCT01075646|2655379|P4|STARTED|Overall Study||46
1096755|NCT01075646|2655380|P3|STARTED|Overall Study||53
1096756|NCT01075646|2655381|P2|STARTED|Overall Study||34
1096757|NCT01075646|2655382|P1|STARTED|Overall Study||33
1096758|NCT01075685|2655414|P2|NOT COMPLETED|Overall Study||226
1096759|NCT01075685|2655415|P1|NOT COMPLETED|Overall Study||592
1096760|NCT01075685|2655414|P2|COMPLETED|Overall Study||188
1096761|NCT01075685|2655415|P1|COMPLETED|Overall Study||151
1096762|NCT01075685|2655414|P2|Completed Baseline Measures|Overall Study||263
1096763|NCT01075685|2655415|P1|Completed Baseline Measures|Overall Study||225
1096764|NCT01075685|2655414|P2|Met Inclusion Criteria|Overall Study||413
1096765|NCT01075685|2655415|P1|Met Inclusion Criteria|Overall Study||734
1096766|NCT01075685|2655414|P2|STARTED|Overall Study||414
1096767|NCT01075685|2655415|P1|STARTED|Overall Study||743
1096768|NCT01075763|2655429|P2|NOT COMPLETED|Overall Study||4
1096769|NCT01075763|2655430|P1|NOT COMPLETED|Overall Study||4
1096770|NCT01075763|2655429|P2|COMPLETED|Overall Study||15
1096771|NCT01075763|2655430|P1|COMPLETED|Overall Study||19
1096772|NCT01075763|2655429|P2|STARTED|Overall Study||19
1096773|NCT01075763|2655430|P1|STARTED|Overall Study||23
1096774|NCT01075815|2655454|P2|NOT COMPLETED|Overall Study||4
1096775|NCT01075815|2655455|P1|NOT COMPLETED|Overall Study||10
1096776|NCT01075815|2655454|P2|COMPLETED|Overall Study||31
1096777|NCT01075815|2655455|P1|COMPLETED|Overall Study||30
1096778|NCT01075815|2655454|P2|STARTED|Overall Study|Number of participants treated.|35
1096779|NCT01075815|2655455|P1|STARTED|Overall Study|Number of participants treated.|40
1096780|NCT01075958|2655491|P1|NOT COMPLETED|Overall Study||44
1096781|NCT01075958|2655491|P1|COMPLETED|Overall Study||239
1096782|NCT01075958|2655491|P1|STARTED|Overall Study||283
1096783|NCT01075971|2655505|P1|NOT COMPLETED|Overall Study||0
1096784|NCT01075971|2655505|P1|COMPLETED|Overall Study||52
1096785|NCT01075971|2655505|P1|STARTED|Overall Study||52
1096786|NCT01075984|2655514|P5|NOT COMPLETED|Follow-up Phase||47
1096787|NCT01075984|2655515|P4|NOT COMPLETED|Follow-up Phase||2
1096788|NCT01075984|2655516|P3|NOT COMPLETED|Follow-up Phase||1
1096789|NCT01075984|2655517|P2|NOT COMPLETED|Follow-up Phase||0
1096790|NCT01075984|2655518|P1|NOT COMPLETED|Follow-up Phase||0
1096791|NCT01075984|2655514|P5|COMPLETED|Follow-up Phase||165
1096792|NCT01075984|2655515|P4|COMPLETED|Follow-up Phase||19
1096793|NCT01075984|2655516|P3|COMPLETED|Follow-up Phase||19
1096794|NCT01075984|2655517|P2|COMPLETED|Follow-up Phase||10
1096795|NCT01075984|2655518|P1|COMPLETED|Follow-up Phase||10
1096796|NCT01075984|2655514|P5|STARTED|Follow-up Phase|One participant withdrew consent before the start of the follow-up phase.|212
1096797|NCT01075984|2655515|P4|STARTED|Follow-up Phase|Three participants did not start the follow-up phase: one died and two were lost to follow-up.|21
1096798|NCT01075984|2655516|P3|STARTED|Follow-up Phase|One participant did not start the follow-up phase for reasons unrelated to study procedures.|20
1096799|NCT01075984|2655517|P2|STARTED|Follow-up Phase||10
1096800|NCT01075984|2655518|P1|STARTED|Follow-up Phase||10
1096801|NCT01075984|2655514|P5|NOT COMPLETED|Treatment Phase||60
1096802|NCT01075984|2655515|P4|NOT COMPLETED|Treatment Phase||7
1096803|NCT01075984|2655516|P3|NOT COMPLETED|Treatment Phase||7
1096804|NCT01075984|2655517|P2|NOT COMPLETED|Treatment Phase||1
1096805|NCT01075984|2655518|P1|NOT COMPLETED|Treatment Phase||0
1096806|NCT01075984|2655514|P5|COMPLETED|Treatment Phase||153
1096807|NCT01075984|2655515|P4|COMPLETED|Treatment Phase||17
1096808|NCT01075984|2655516|P3|COMPLETED|Treatment Phase||14
1096809|NCT01075984|2655517|P2|COMPLETED|Treatment Phase||10
1096810|NCT01075984|2655518|P1|COMPLETED|Treatment Phase||10
1096811|NCT01075984|2655514|P5|STARTED|Treatment Phase||213
1096812|NCT01075984|2655515|P4|STARTED|Treatment Phase||24
1096813|NCT01075984|2655516|P3|STARTED|Treatment Phase||21
1096814|NCT01075984|2655517|P2|STARTED|Treatment Phase||11
1096815|NCT01075984|2655518|P1|STARTED|Treatment Phase||10
1096816|NCT01076036|2655572|P1|NOT COMPLETED|Overall Study||2
1096817|NCT01076036|2655572|P1|COMPLETED|Overall Study||8
1096818|NCT01076036|2655572|P1|Complete CorPath Procedures|Overall Study||8
1096819|NCT01076036|2655572|P1|# of Procedures|Overall Study||8
1096820|NCT01076036|2655572|P1|STARTED|Overall Study||10
1096821|NCT01076075|2655579|P2|NOT COMPLETED|Overall Study||47
1096822|NCT01076075|2655580|P1|NOT COMPLETED|Overall Study||41
1096823|NCT01076075|2655579|P2|COMPLETED|Overall Study||167
1096824|NCT01076075|2655580|P1|COMPLETED|Overall Study||172
1096825|NCT01076075|2655579|P2|Completed Phase A|Overall Study||189
1096826|NCT01076075|2655580|P1|Completed Phase A|Overall Study||199
1096827|NCT01076075|2655579|P2|STARTED|Overall Study|2 participants were excluded from safety and efficacy analyses due to one site's non-compliance|214
1096828|NCT01076075|2655580|P1|STARTED|Overall Study|3 participants were excluded from safety and efficacy analyses due to one site's non-compliance|213
1096829|NCT01076088|2655600|P6|NOT COMPLETED|Overall Study||23
1096830|NCT01076088|2655601|P5|NOT COMPLETED|Overall Study||16
1096831|NCT01076088|2655602|P4|NOT COMPLETED|Overall Study||15
1096832|NCT01076088|2655603|P3|NOT COMPLETED|Overall Study||17
1096833|NCT01076088|2655604|P2|NOT COMPLETED|Overall Study||18
1096834|NCT01076088|2655605|P1|NOT COMPLETED|Overall Study||11
1096835|NCT01076088|2655600|P6|COMPLETED|Overall Study||104
1096836|NCT01076088|2655601|P5|COMPLETED|Overall Study||104
1096837|NCT01076088|2655602|P4|COMPLETED|Overall Study||109
1096838|NCT01076088|2655603|P3|COMPLETED|Overall Study||109
1096839|NCT01076088|2655604|P2|COMPLETED|Overall Study||107
1096840|NCT01076088|2655605|P1|COMPLETED|Overall Study||111
1096841|NCT01076088|2655600|P6|STARTED|Overall Study||127
1096842|NCT01076088|2655601|P5|STARTED|Overall Study||120
1096843|NCT01076088|2655602|P4|STARTED|Overall Study||124
1096844|NCT01076088|2655603|P3|STARTED|Overall Study||126
1096845|NCT01076088|2655604|P2|STARTED|Overall Study||125
1096846|NCT01076088|2655605|P1|STARTED|Overall Study||122
1096847|NCT01076153|2655631|P1|NOT COMPLETED|Overall Study||11
1096848|NCT01076153|2655631|P1|COMPLETED|Overall Study||749
1096849|NCT01076153|2655631|P1|STARTED|Overall Study||760
1096850|NCT01076166|2655639|P1|NOT COMPLETED|Overall Study||9
1096851|NCT01076166|2655639|P1|COMPLETED|Overall Study||328
1096852|NCT01076166|2655639|P1|STARTED|Overall Study||337
1096853|NCT01076179|2655646|P1|NOT COMPLETED|Overall Study||1
1096854|NCT01076179|2655646|P1|COMPLETED|Overall Study||501
1096855|NCT01076179|2655646|P1|STARTED|Overall Study||502
1096856|NCT01076192|2655669|P1|NOT COMPLETED|Overall Study||197
1096857|NCT01076192|2655669|P1|COMPLETED|Overall Study||350
1096858|NCT01076192|2655669|P1|STARTED|Overall Study||547
1096859|NCT01076244|2655684|P1|NOT COMPLETED|Overall Study||4
1096860|NCT01076244|2655684|P1|COMPLETED|Overall Study||42
1096861|NCT01076244|2655684|P1|STARTED|Overall Study||46
1096862|NCT01076270|2655691|P1|NOT COMPLETED|Overall Study||0
1096863|NCT01076270|2655691|P1|COMPLETED|Overall Study||1
1096864|NCT01076270|2655691|P1|STARTED|Overall Study||1
1096865|NCT01076283|2655698|P2|NOT COMPLETED|Overall Study||0
1096866|NCT01076283|2655699|P1|NOT COMPLETED|Overall Study||1
1096867|NCT01076283|2655698|P2|COMPLETED|Overall Study||7
1096868|NCT01076283|2655699|P1|COMPLETED|Overall Study||6
1096869|NCT01076283|2655698|P2|STARTED|Overall Study||7
1096870|NCT01076283|2655699|P1|STARTED|Overall Study||7
1096871|NCT01076296|2655707|P8|NOT COMPLETED|Overall Study||0
1096872|NCT01076296|2655708|P7|NOT COMPLETED|Overall Study||0
1096873|NCT01076296|2655709|P6|NOT COMPLETED|Overall Study||0
1096874|NCT01076296|2655710|P5|NOT COMPLETED|Overall Study||0
1096875|NCT01076296|2655711|P4|NOT COMPLETED|Overall Study||0
1096876|NCT01076296|2655712|P3|NOT COMPLETED|Overall Study||0
1096877|NCT01076296|2655713|P2|NOT COMPLETED|Overall Study||0
1096878|NCT01076296|2655714|P1|NOT COMPLETED|Overall Study||0
1096879|NCT01076296|2655707|P8|COMPLETED|Overall Study||199
1096880|NCT01076296|2655708|P7|COMPLETED|Overall Study||51
1096881|NCT01076296|2655709|P6|COMPLETED|Overall Study||191
1096882|NCT01076296|2655710|P5|COMPLETED|Overall Study||59
1096883|NCT01076296|2655711|P4|COMPLETED|Overall Study||199
1096884|NCT01076296|2655712|P3|COMPLETED|Overall Study||51
1096885|NCT01076296|2655713|P2|COMPLETED|Overall Study||196
1096886|NCT01076296|2655714|P1|COMPLETED|Overall Study||54
1096887|NCT01076296|2655707|P8|STARTED|Overall Study||199
1096888|NCT01076296|2655708|P7|STARTED|Overall Study||51
1096889|NCT01076296|2655709|P6|STARTED|Overall Study||191
1096890|NCT01076296|2655710|P5|STARTED|Overall Study||59
1096891|NCT01076296|2655711|P4|STARTED|Overall Study||199
1096892|NCT01076296|2655712|P3|STARTED|Overall Study||51
1096893|NCT01076296|2655713|P2|STARTED|Overall Study||196
1096894|NCT01076296|2655714|P1|STARTED|Overall Study||54
1096895|NCT01076335|2655732|P1|NOT COMPLETED|Overall Study||4
1096896|NCT01076335|2655732|P1|COMPLETED|Overall Study||36
1096897|NCT01076335|2655732|P1|STARTED|Overall Study||40
1096898|NCT01076348|2655736|P1|NOT COMPLETED|Overall Study||22
1096899|NCT01076348|2655736|P1|COMPLETED|Overall Study||51
1096900|NCT01076348|2655736|P1|STARTED|Overall Study||73
1096901|NCT01076361|2655740|P1|NOT COMPLETED|Overall Study||21
1096902|NCT01076361|2655740|P1|COMPLETED|Overall Study|Follow-up data was not available for 21 participants (22 leads)|349
1096903|NCT01076361|2655740|P1|STARTED|Overall Study|631 leads were implanted in 370 patients. 22 leads in 21 patients were excluded from analysis.|370
1096904|NCT01076452|2655746|P2|NOT COMPLETED|Overall Study||14
1096905|NCT01076452|2655747|P1|NOT COMPLETED|Overall Study||24
1096906|NCT01076452|2655746|P2|COMPLETED|Overall Study||138
1096907|NCT01076452|2655747|P1|COMPLETED|Overall Study||123
1096908|NCT01076452|2655746|P2|STARTED|Overall Study||152
1096909|NCT01076452|2655747|P1|STARTED|Overall Study||147
1096910|NCT01076504|2655759|P1|NOT COMPLETED|Overall Study||80
1096911|NCT01076504|2655759|P1|COMPLETED|Overall Study|Patients remained on study until disease progression or withdrawal for any other reason|0
1096912|NCT01076504|2655759|P1|STARTED|Overall Study||80
1096913|NCT01076647|2655769|P2|NOT COMPLETED|Overall Study||25
1096914|NCT01076647|2655770|P1|NOT COMPLETED|Overall Study||25
1096915|NCT01076647|2655769|P2|COMPLETED|Overall Study||209
1096916|NCT01076647|2655770|P1|COMPLETED|Overall Study||208
1096917|NCT01076647|2655769|P2|STARTED|Overall Study||234
1096918|NCT01076647|2655770|P1|STARTED|Overall Study||233
1096931|NCT01076959|2655795|P1|NOT COMPLETED|Overall Study||2250
1096932|NCT01076959|2655795|P1|COMPLETED|Overall Study||5490
1096933|NCT01076959|2655795|P1|STARTED|Overall Study||7740
1096934|NCT01076972|2655812|P1|NOT COMPLETED|Overall Study||0
1096935|NCT01076972|2655812|P1|COMPLETED|Overall Study||1184
1096936|NCT01076972|2655812|P1|STARTED|Overall Study||1184
1096937|NCT01076985|2655827|P1|NOT COMPLETED|Overall Study||0
1096938|NCT01076985|2655827|P1|COMPLETED|Overall Study||24
1096939|NCT01076985|2655827|P1|STARTED|Overall Study||24
1096940|NCT01077024|2655835|P2|NOT COMPLETED|Overall Study||28
1096941|NCT01077024|2655836|P1|NOT COMPLETED|Overall Study||31
1096942|NCT01077024|2655835|P2|COMPLETED|Overall Study||243
1096943|NCT01077024|2655836|P1|COMPLETED|Overall Study||236
1096944|NCT01077024|2655835|P2|STARTED|Overall Study||271
1096945|NCT01077024|2655836|P1|STARTED|Overall Study||267
1096946|NCT01077050|2655854|P1|NOT COMPLETED|Overall Study||9
1096947|NCT01077050|2655854|P1|COMPLETED|Overall Study||1942
1096948|NCT01077050|2655854|P1|STARTED|Overall Study||1951
1096949|NCT01077063|2655860|P2|NOT COMPLETED|Overall Study||3
1096950|NCT01077063|2655861|P1|NOT COMPLETED|Overall Study||4
1096951|NCT01077063|2655860|P2|COMPLETED|Overall Study||0
1096952|NCT01077063|2655861|P1|COMPLETED|Overall Study||0
1096953|NCT01077063|2655860|P2|STARTED|Overall Study||3
1096954|NCT01077063|2655861|P1|STARTED|Overall Study||4
1096955|NCT01077076|2655867|P6|NOT COMPLETED|Third Intervention||1
1096956|NCT01077076|2655868|P5|NOT COMPLETED|Third Intervention||0
1096957|NCT01077076|2655869|P4|NOT COMPLETED|Third Intervention||0
1096958|NCT01077076|2655870|P3|NOT COMPLETED|Third Intervention||0
1096959|NCT01077076|2655871|P2|NOT COMPLETED|Third Intervention||0
1096960|NCT01077076|2655872|P1|NOT COMPLETED|Third Intervention||0
1096961|NCT01077076|2655867|P6|COMPLETED|Third Intervention||4
1096962|NCT01077076|2655868|P5|COMPLETED|Third Intervention||5
1096963|NCT01077076|2655869|P4|COMPLETED|Third Intervention||5
1096964|NCT01077076|2655870|P3|COMPLETED|Third Intervention||5
1096965|NCT01077076|2655871|P2|COMPLETED|Third Intervention||5
1096966|NCT01077076|2655872|P1|COMPLETED|Third Intervention||4
1096967|NCT01077076|2655867|P6|STARTED|Third Intervention||5
1096968|NCT01077076|2655868|P5|STARTED|Third Intervention||5
1096969|NCT01077076|2655869|P4|STARTED|Third Intervention||5
1096970|NCT01077076|2655870|P3|STARTED|Third Intervention||5
1096971|NCT01077076|2655871|P2|STARTED|Third Intervention||5
1096972|NCT01077076|2655872|P1|STARTED|Third Intervention||4
1096973|NCT01077076|2655867|P6|NOT COMPLETED|Washout Period of 2 Weeks||0
1096974|NCT01077076|2655868|P5|NOT COMPLETED|Washout Period of 2 Weeks||0
1096975|NCT01077076|2655869|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
1096976|NCT01077076|2655870|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
1096977|NCT01077076|2655871|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
1096978|NCT01077076|2655872|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
1096979|NCT01077076|2655867|P6|COMPLETED|Washout Period of 2 Weeks||5
1096980|NCT01077076|2655868|P5|COMPLETED|Washout Period of 2 Weeks||5
1096981|NCT01077076|2655869|P4|COMPLETED|Washout Period of 2 Weeks||5
1096982|NCT01077076|2655870|P3|COMPLETED|Washout Period of 2 Weeks||5
1096983|NCT01077076|2655871|P2|COMPLETED|Washout Period of 2 Weeks||5
1096984|NCT01077076|2655872|P1|COMPLETED|Washout Period of 2 Weeks||4
1096985|NCT01077076|2655867|P6|STARTED|Washout Period of 2 Weeks||5
1096986|NCT01077076|2655868|P5|STARTED|Washout Period of 2 Weeks||5
1096987|NCT01077076|2655869|P4|STARTED|Washout Period of 2 Weeks||5
1096988|NCT01077076|2655870|P3|STARTED|Washout Period of 2 Weeks||5
1096989|NCT01077076|2655871|P2|STARTED|Washout Period of 2 Weeks||5
1096990|NCT01077076|2655872|P1|STARTED|Washout Period of 2 Weeks||4
1096991|NCT01077076|2655867|P6|NOT COMPLETED|Second Intervention||0
1096992|NCT01077076|2655868|P5|NOT COMPLETED|Second Intervention||0
1096993|NCT01077076|2655869|P4|NOT COMPLETED|Second Intervention||0
1096994|NCT01077076|2655870|P3|NOT COMPLETED|Second Intervention||0
1096995|NCT01077076|2655871|P2|NOT COMPLETED|Second Intervention||0
1096996|NCT01077076|2655872|P1|NOT COMPLETED|Second Intervention||0
1096997|NCT01077076|2655867|P6|COMPLETED|Second Intervention||5
1096998|NCT01077076|2655868|P5|COMPLETED|Second Intervention||5
1096999|NCT01077076|2655869|P4|COMPLETED|Second Intervention||5
1097000|NCT01077076|2655870|P3|COMPLETED|Second Intervention||5
1097001|NCT01077076|2655871|P2|COMPLETED|Second Intervention||5
1097002|NCT01077076|2655872|P1|COMPLETED|Second Intervention||4
1097003|NCT01077076|2655867|P6|STARTED|Second Intervention||5
1097004|NCT01077076|2655868|P5|STARTED|Second Intervention||5
1097005|NCT01077076|2655869|P4|STARTED|Second Intervention||5
1097006|NCT01077076|2655870|P3|STARTED|Second Intervention||5
1097007|NCT01077076|2655871|P2|STARTED|Second Intervention||5
1097008|NCT01077076|2655872|P1|STARTED|Second Intervention||4
1097009|NCT01077076|2655867|P6|NOT COMPLETED|Washout Period of 2 Weeks||0
1097010|NCT01077076|2655868|P5|NOT COMPLETED|Washout Period of 2 Weeks||0
1097011|NCT01077076|2655869|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
1097012|NCT01077076|2655870|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
1097013|NCT01077076|2655871|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
1097014|NCT01077076|2655872|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
1097015|NCT01077076|2655867|P6|COMPLETED|Washout Period of 2 Weeks||5
1097016|NCT01077076|2655868|P5|COMPLETED|Washout Period of 2 Weeks||5
1097017|NCT01077076|2655869|P4|COMPLETED|Washout Period of 2 Weeks||5
1097018|NCT01077076|2655870|P3|COMPLETED|Washout Period of 2 Weeks||5
1097019|NCT01077076|2655871|P2|COMPLETED|Washout Period of 2 Weeks||5
1097020|NCT01077076|2655872|P1|COMPLETED|Washout Period of 2 Weeks||4
1097021|NCT01077076|2655867|P6|STARTED|Washout Period of 2 Weeks||5
1097022|NCT01077076|2655868|P5|STARTED|Washout Period of 2 Weeks||5
1097023|NCT01077076|2655869|P4|STARTED|Washout Period of 2 Weeks||5
1097024|NCT01077076|2655870|P3|STARTED|Washout Period of 2 Weeks||5
1097025|NCT01077076|2655871|P2|STARTED|Washout Period of 2 Weeks||5
1097026|NCT01077076|2655872|P1|STARTED|Washout Period of 2 Weeks||4
1097027|NCT01077076|2655867|P6|NOT COMPLETED|First Intervention||0
1097028|NCT01077076|2655868|P5|NOT COMPLETED|First Intervention||0
1097029|NCT01077076|2655869|P4|NOT COMPLETED|First Intervention||0
1097030|NCT01077076|2655870|P3|NOT COMPLETED|First Intervention||0
1097031|NCT01077076|2655871|P2|NOT COMPLETED|First Intervention||0
1097032|NCT01077076|2655872|P1|NOT COMPLETED|First Intervention||1
1097033|NCT01077076|2655867|P6|COMPLETED|First Intervention||5
1097034|NCT01077076|2655868|P5|COMPLETED|First Intervention||5
1097035|NCT01077076|2655869|P4|COMPLETED|First Intervention||5
1097036|NCT01077076|2655870|P3|COMPLETED|First Intervention||5
1097037|NCT01077076|2655871|P2|COMPLETED|First Intervention||5
1097038|NCT01077076|2655872|P1|COMPLETED|First Intervention||4
1097039|NCT01077076|2655867|P6|STARTED|First Intervention||5
1097040|NCT01077076|2655868|P5|STARTED|First Intervention||5
1097041|NCT01077076|2655869|P4|STARTED|First Intervention||5
1097042|NCT01077076|2655870|P3|STARTED|First Intervention||5
1097043|NCT01077076|2655871|P2|STARTED|First Intervention||5
1097044|NCT01077076|2655872|P1|STARTED|First Intervention||5
1097045|NCT01077128|2655880|P1|NOT COMPLETED|Overall Study||67
1097046|NCT01077128|2655880|P1|COMPLETED|Overall Study||433
1097047|NCT01077128|2655880|P1|STARTED|Overall Study||500
1097048|NCT01077193|2655938|P1|NOT COMPLETED|Overall Study||44
1097049|NCT01077193|2655938|P1|COMPLETED|Overall Study||0
1097050|NCT01077193|2655938|P1|STARTED|Overall Study||44
1097051|NCT01077258|2655942|P1|NOT COMPLETED|Overall Study||2568
1097052|NCT01077258|2655942|P1|COMPLETED|Overall Study||1640
1097053|NCT01077258|2655942|P1|STARTED|Overall Study||4208
1097054|NCT01077271|2655982|P1|NOT COMPLETED|Overall Study||22
1097055|NCT01077271|2655982|P1|COMPLETED|Overall Study||102
1097056|NCT01077271|2655982|P1|Number of Participants Analyzed|Overall Study||120
1097057|NCT01077271|2655982|P1|Participants Treated With Palivizumab|Overall Study||120
1097058|NCT01077271|2655982|P1|STARTED|Overall Study||124
1097059|NCT01077284|2656023|P3|NOT COMPLETED|Overall Study||3
1097060|NCT01077284|2656024|P2|NOT COMPLETED|Overall Study||5
1097061|NCT01077284|2656025|P1|NOT COMPLETED|Overall Study||5
1097062|NCT01077284|2656023|P3|COMPLETED|Overall Study||30
1097063|NCT01077284|2656024|P2|COMPLETED|Overall Study||28
1097064|NCT01077284|2656025|P1|COMPLETED|Overall Study||28
1097065|NCT01077284|2656023|P3|STARTED|Overall Study||33
1097066|NCT01077284|2656024|P2|STARTED|Overall Study||33
1097067|NCT01077284|2656025|P1|STARTED|Overall Study||33
1097068|NCT01077310|2656044|P2|NOT COMPLETED|Overall Study||0
1097069|NCT01077310|2656045|P1|NOT COMPLETED|Overall Study||0
1097070|NCT01077310|2656044|P2|COMPLETED|Overall Study||33
1097071|NCT01077310|2656045|P1|COMPLETED|Overall Study||67
1097072|NCT01077310|2656044|P2|STARTED|Overall Study||33
1097073|NCT01077310|2656045|P1|STARTED|Overall Study||67
1097074|NCT01077323|2656068|P3|NOT COMPLETED|Overall Study||11912089
1097075|NCT01077323|2656069|P2|NOT COMPLETED|Overall Study||386263
1097076|NCT01077323|2656070|P1|NOT COMPLETED|Overall Study||11378
1097077|NCT01077323|2656068|P3|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|103511
1097078|NCT01077323|2656069|P2|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|234536
1097079|NCT01077323|2656070|P1|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|25719
1097080|NCT01077323|2656068|P3|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|12015600
1097081|NCT01077323|2656069|P2|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|620799
1097082|NCT01077323|2656070|P1|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|37097
1097083|NCT01077362|2656090|P3|NOT COMPLETED|Overall Study||24
1097084|NCT01077362|2656091|P2|NOT COMPLETED|Overall Study||19
1097085|NCT01077362|2656092|P1|NOT COMPLETED|Overall Study||31
1097086|NCT01077362|2656090|P3|COMPLETED|Overall Study||81
1097087|NCT01077362|2656091|P2|COMPLETED|Overall Study||84
1097088|NCT01077362|2656092|P1|COMPLETED|Overall Study||73
1097089|NCT01077362|2656090|P3|STARTED|Overall Study||105
1097090|NCT01077362|2656091|P2|STARTED|Overall Study||103
1097091|NCT01077362|2656092|P1|STARTED|Overall Study||104
1097092|NCT01077375|2656127|P2|NOT COMPLETED|Overall Study||35
1097093|NCT01077375|2656128|P1|NOT COMPLETED|Overall Study||10
1097094|NCT01077375|2656127|P2|COMPLETED|Overall Study||51
1097095|NCT01077375|2656128|P1|COMPLETED|Overall Study||11
1097096|NCT01077375|2656127|P2|STARTED|Overall Study|One randomized patient not taking study drug was excluded from the Double-blind Safety Population.|86
1097097|NCT01077375|2656128|P1|STARTED|Overall Study||21
1097098|NCT01077401|2656138|P2|NOT COMPLETED|Overall Study||21
1097099|NCT01077401|2656139|P1|NOT COMPLETED|Overall Study||18
1097100|NCT01077401|2656138|P2|COMPLETED|Overall Study||54
1097101|NCT01077401|2656139|P1|COMPLETED|Overall Study||59
1097102|NCT01077401|2656138|P2|STARTED|Overall Study||75
1097103|NCT01077401|2656139|P1|STARTED|Overall Study||77
1097104|NCT01070888|2656151|P2|NOT COMPLETED|Second Intervention (14 Days)||0
1097105|NCT01070888|2656152|P1|NOT COMPLETED|Second Intervention (14 Days)||0
1097106|NCT01070888|2656151|P2|COMPLETED|Second Intervention (14 Days)||2
1097107|NCT01070888|2656152|P1|COMPLETED|Second Intervention (14 Days)||1
1097108|NCT01070888|2656151|P2|STARTED|Second Intervention (14 Days)||2
1097109|NCT01070888|2656152|P1|STARTED|Second Intervention (14 Days)||1
1097110|NCT01070888|2656151|P2|NOT COMPLETED|Washout (14 Days)||0
1097111|NCT01070888|2656152|P1|NOT COMPLETED|Washout (14 Days)||1
1097112|NCT01070888|2656151|P2|COMPLETED|Washout (14 Days)||2
1097113|NCT01070888|2656152|P1|COMPLETED|Washout (14 Days)||1
1097114|NCT01070888|2656151|P2|STARTED|Washout (14 Days)||2
1097115|NCT01070888|2656152|P1|STARTED|Washout (14 Days)||2
1097116|NCT01070888|2656151|P2|NOT COMPLETED|First Intervention (14 Days)||2
1097117|NCT01070888|2656152|P1|NOT COMPLETED|First Intervention (14 Days)||0
1097118|NCT01070888|2656151|P2|COMPLETED|First Intervention (14 Days)||2
1097119|NCT01070888|2656152|P1|COMPLETED|First Intervention (14 Days)||2
1097120|NCT01070888|2656151|P2|STARTED|First Intervention (14 Days)||4
1097121|NCT01070888|2656152|P1|STARTED|First Intervention (14 Days)||2
1097122|NCT01070953|2656158|P1|NOT COMPLETED|Participants for Efficacy Evaluation||227
1097123|NCT01070953|2656158|P1|COMPLETED|Participants for Efficacy Evaluation||3309
1097124|NCT01070953|2656158|P1|STARTED|Participants for Efficacy Evaluation||3536
1097125|NCT01070953|2656158|P1|NOT COMPLETED|Participants for Safety Evaluation||931
1097126|NCT01070953|2656158|P1|COMPLETED|Participants for Safety Evaluation||3536
1097127|NCT01070953|2656158|P1|STARTED|Participants for Safety Evaluation||4467
1097128|NCT01070966|2656169|P1|NOT COMPLETED|Participants for Efficacy Evaluation||82
1097129|NCT01070966|2656169|P1|COMPLETED|Participants for Efficacy Evaluation||1929
1097130|NCT01070966|2656169|P1|STARTED|Participants for Efficacy Evaluation||2011
1097131|NCT01070966|2656169|P1|NOT COMPLETED|Participants for Safety Evaluation||78
1097132|NCT01070966|2656169|P1|COMPLETED|Participants for Safety Evaluation||2011
1097133|NCT01070966|2656169|P1|STARTED|Participants for Safety Evaluation||2089
1097134|NCT01070979|2656183|P3|NOT COMPLETED|Overall Study||13
1097135|NCT01070979|2656184|P2|NOT COMPLETED|Overall Study||12
1097136|NCT01070979|2656185|P1|NOT COMPLETED|Overall Study||11
1097137|NCT01070979|2656183|P3|COMPLETED|Overall Study||72
1097138|NCT01070979|2656184|P2|COMPLETED|Overall Study||73
1097139|NCT01070979|2656185|P1|COMPLETED|Overall Study||68
1097140|NCT01070979|2656183|P3|STARTED|Overall Study||85
1097141|NCT01070979|2656184|P2|STARTED|Overall Study||85
1097142|NCT01070979|2656185|P1|STARTED|Overall Study||79
1097143|NCT01071044|2656213|P2|NOT COMPLETED|Overall Study||0
1097144|NCT01071044|2656214|P1|NOT COMPLETED|Overall Study||2
1097145|NCT01071044|2656213|P2|COMPLETED|Overall Study||11
1097146|NCT01071044|2656214|P1|COMPLETED|Overall Study||13
1097147|NCT01071044|2656213|P2|STARTED|Overall Study||11
1097148|NCT01071044|2656214|P1|STARTED|Overall Study||15
1097149|NCT01071070|2656234|P2|NOT COMPLETED|Overall Study||3
1097150|NCT01071070|2656235|P1|NOT COMPLETED|Overall Study||4
1097151|NCT01071070|2656234|P2|COMPLETED|Overall Study||105
1097152|NCT01071070|2656235|P1|COMPLETED|Overall Study||104
1097153|NCT01071070|2656234|P2|STARTED|Overall Study||108
1097154|NCT01071070|2656235|P1|STARTED|Overall Study||108
1097155|NCT01071083|2656262|P5|NOT COMPLETED|Overall Study||8
1097156|NCT01071083|2656263|P4|NOT COMPLETED|Overall Study||2
1097157|NCT01071083|2656264|P3|NOT COMPLETED|Overall Study||5
1097158|NCT01071083|2656265|P2|NOT COMPLETED|Overall Study||2
1097159|NCT01071083|2656266|P1|NOT COMPLETED|Overall Study||7
1097160|NCT01071083|2656262|P5|COMPLETED|Overall Study||46
1097161|NCT01071083|2656263|P4|COMPLETED|Overall Study||15
1097162|NCT01071083|2656264|P3|COMPLETED|Overall Study||12
1097163|NCT01071083|2656265|P2|COMPLETED|Overall Study||43
1097164|NCT01071083|2656266|P1|COMPLETED|Overall Study||35
1097165|NCT01071083|2656262|P5|STARTED|Overall Study||54
1097166|NCT01071083|2656263|P4|STARTED|Overall Study||17
1097167|NCT01071083|2656264|P3|STARTED|Overall Study||17
1097168|NCT01071083|2656265|P2|STARTED|Overall Study||45
1097169|NCT01071083|2656266|P1|STARTED|Overall Study||42
1097170|NCT01071096|2656283|P2|NOT COMPLETED|Second Intervention (90 Days)||0
1097171|NCT01071096|2656284|P1|NOT COMPLETED|Second Intervention (90 Days)||0
1097172|NCT01071096|2656283|P2|COMPLETED|Second Intervention (90 Days)||10
1097173|NCT01071096|2656284|P1|COMPLETED|Second Intervention (90 Days)||9
1097174|NCT01071096|2656283|P2|STARTED|Second Intervention (90 Days)||10
1097175|NCT01071096|2656284|P1|STARTED|Second Intervention (90 Days)||9
1097176|NCT01071096|2656283|P2|NOT COMPLETED|Washout Period (30 Days)||0
1097177|NCT01071096|2656284|P1|NOT COMPLETED|Washout Period (30 Days)||0
1097178|NCT01071096|2656283|P2|COMPLETED|Washout Period (30 Days)||10
1097179|NCT01071096|2656284|P1|COMPLETED|Washout Period (30 Days)||9
1097180|NCT01071096|2656283|P2|STARTED|Washout Period (30 Days)||10
1097181|NCT01071096|2656284|P1|STARTED|Washout Period (30 Days)||9
1097182|NCT01071096|2656283|P2|NOT COMPLETED|First Intervention (90 Days)||0
1097183|NCT01071096|2656284|P1|NOT COMPLETED|First Intervention (90 Days)||1
1097184|NCT01071096|2656283|P2|COMPLETED|First Intervention (90 Days)||10
1097185|NCT01071096|2656284|P1|COMPLETED|First Intervention (90 Days)||9
1097186|NCT01071096|2656283|P2|STARTED|First Intervention (90 Days)||10
1097187|NCT01071096|2656284|P1|STARTED|First Intervention (90 Days)||10
1097188|NCT01071200|2656305|P2|NOT COMPLETED|Overall Study||3
1097189|NCT01071200|2656306|P1|NOT COMPLETED|Overall Study||7
1097190|NCT01071200|2656305|P2|COMPLETED|Overall Study||63
1097191|NCT01071200|2656306|P1|COMPLETED|Overall Study||60
1097192|NCT01071200|2656305|P2|STARTED|Overall Study||66
1097193|NCT01071200|2656306|P1|STARTED|Overall Study||67
1097194|NCT01071252|2656343|P5|NOT COMPLETED|Overall Study||11
1097195|NCT01071252|2656344|P4|NOT COMPLETED|Overall Study||7
1097196|NCT01071252|2656345|P3|NOT COMPLETED|Overall Study||4
1097197|NCT01071252|2656346|P2|NOT COMPLETED|Overall Study||10
1097198|NCT01071252|2656347|P1|NOT COMPLETED|Overall Study||15
1097199|NCT01071252|2656343|P5|COMPLETED|Overall Study||11
1097200|NCT01071252|2656344|P4|COMPLETED|Overall Study||20
1097201|NCT01071252|2656345|P3|COMPLETED|Overall Study||17
1097202|NCT01071252|2656346|P2|COMPLETED|Overall Study||16
1097203|NCT01071252|2656347|P1|COMPLETED|Overall Study||14
1097204|NCT01071252|2656343|P5|STARTED|Overall Study||22
1097205|NCT01071252|2656344|P4|STARTED|Overall Study||27
1097206|NCT01071252|2656345|P3|STARTED|Overall Study||21
1097207|NCT01071252|2656346|P2|STARTED|Overall Study||26
1097208|NCT01071252|2656347|P1|STARTED|Overall Study||29
1097209|NCT01071278|2656373|P1|NOT COMPLETED|Overall Study||713
1097210|NCT01071278|2656373|P1|COMPLETED|Overall Study||1677
1097211|NCT01071278|2656373|P1|STARTED|Overall Study||2390
1097212|NCT01071395|2656381|P2|NOT COMPLETED|Overall Study||2
1097213|NCT01071395|2656382|P1|NOT COMPLETED|Overall Study||5
1097214|NCT01071395|2656381|P2|COMPLETED|Overall Study||30
1097215|NCT01071395|2656382|P1|COMPLETED|Overall Study||31
1097216|NCT01071395|2656381|P2|STARTED|Overall Study||32
1097217|NCT01071395|2656382|P1|STARTED|Overall Study||36
1097221|NCT01071538|2656396|P1|NOT COMPLETED|Overall Study||2
1097222|NCT01071538|2656396|P1|COMPLETED|Overall Study||13
1097223|NCT01071538|2656396|P1|STARTED|Overall Study||15
1097224|NCT01071798|2656406|P1|NOT COMPLETED|Subpopulation Who Received Two Cycles||15
1097225|NCT01071798|2656406|P1|COMPLETED|Subpopulation Who Received Two Cycles||805
1097226|NCT01071798|2656406|P1|Baseline and Safety Analysis Set|Subpopulation Who Received Two Cycles||820
1097227|NCT01071798|2656406|P1|STARTED|Subpopulation Who Received Two Cycles||820
1097228|NCT01071798|2656406|P1|NOT COMPLETED|Participants Who Received One Cycle||65
1097229|NCT01071798|2656406|P1|COMPLETED|Participants Who Received One Cycle||1588
1097230|NCT01071798|2656406|P1|Baseline and Safety Analysis Set|Participants Who Received One Cycle||1653
1097231|NCT01071798|2656406|P1|STARTED|Participants Who Received One Cycle||1653
1097232|NCT01077544|2656428|P2|NOT COMPLETED|Overall Study||5
1097233|NCT01077544|2656429|P1|NOT COMPLETED|Overall Study||3
1097234|NCT01077544|2656428|P2|COMPLETED|Overall Study||2
1097235|NCT01077544|2656429|P1|COMPLETED|Overall Study||5
1097236|NCT01077544|2656428|P2|STARTED|Overall Study||7
1097237|NCT01077544|2656429|P1|STARTED|Overall Study||8
1097238|NCT01077596|2656467|P12|NOT COMPLETED|Overall Study||0
1097239|NCT01077596|2656468|P11|NOT COMPLETED|Overall Study||0
1097240|NCT01077596|2656469|P10|NOT COMPLETED|Overall Study||0
1097241|NCT01077596|2656470|P9|NOT COMPLETED|Overall Study||0
1097242|NCT01077596|2656471|P8|NOT COMPLETED|Overall Study||0
1097243|NCT01077596|2656472|P7|NOT COMPLETED|Overall Study||0
1097244|NCT01077596|2656473|P6|NOT COMPLETED|Overall Study||0
1097245|NCT01077596|2656474|P5|NOT COMPLETED|Overall Study||0
1097246|NCT01077596|2656475|P4|NOT COMPLETED|Overall Study||0
1097247|NCT01077596|2656476|P3|NOT COMPLETED|Overall Study||0
1097248|NCT01077596|2656477|P2|NOT COMPLETED|Overall Study||0
1097249|NCT01077596|2656478|P1|NOT COMPLETED|Overall Study||0
1097250|NCT01077596|2656467|P12|COMPLETED|Overall Study||22150
1097251|NCT01077596|2656468|P11|COMPLETED|Overall Study||2215
1097252|NCT01077596|2656469|P10|COMPLETED|Overall Study||28420
1097253|NCT01077596|2656470|P9|COMPLETED|Overall Study||2842
1097254|NCT01077596|2656471|P8|COMPLETED|Overall Study||837
1097255|NCT01077596|2656472|P7|COMPLETED|Overall Study||308
1097256|NCT01077596|2656473|P6|COMPLETED|Overall Study||882
1097257|NCT01077596|2656474|P5|COMPLETED|Overall Study||294
1097258|NCT01077596|2656475|P4|COMPLETED|Overall Study||1370
1097259|NCT01077596|2656476|P3|COMPLETED|Overall Study||457
1097260|NCT01077596|2656477|P2|COMPLETED|Overall Study||1050
1097261|NCT01077596|2656478|P1|COMPLETED|Overall Study||350
1097262|NCT01077596|2656467|P12|STARTED|Overall Study||22150
1097263|NCT01077596|2656468|P11|STARTED|Overall Study||2215
1097264|NCT01077596|2656469|P10|STARTED|Overall Study||28420
1097265|NCT01077596|2656470|P9|STARTED|Overall Study||2842
1097266|NCT01077596|2656471|P8|STARTED|Overall Study||837
1097267|NCT01077596|2656472|P7|STARTED|Overall Study||308
1097268|NCT01077596|2656473|P6|STARTED|Overall Study||882
1097269|NCT01077596|2656474|P5|STARTED|Overall Study||294
1097270|NCT01077596|2656475|P4|STARTED|Overall Study||1370
1097271|NCT01077596|2656476|P3|STARTED|Overall Study||457
1097272|NCT01077596|2656477|P2|STARTED|Overall Study||1050
1097273|NCT01077596|2656478|P1|STARTED|Overall Study||350
1097274|NCT01077622|2656527|P1|NOT COMPLETED|Overall Study||3
1097275|NCT01077622|2656527|P1|COMPLETED|Overall Study||7
1097276|NCT01077622|2656527|P1|STARTED|Overall Study||10
1097277|NCT01077713|2656575|P2|NOT COMPLETED|Overall Study||36
1097278|NCT01077713|2656576|P1|NOT COMPLETED|Overall Study||36
1097279|NCT01077713|2656575|P2|COMPLETED|Overall Study||6
1097280|NCT01077713|2656576|P1|COMPLETED|Overall Study||8
1097281|NCT01077713|2656575|P2|STARTED|Overall Study||42
1097282|NCT01077713|2656576|P1|STARTED|Overall Study||44
1097283|NCT01077739|2656602|P2|NOT COMPLETED|Overall Study||10
1097284|NCT01077739|2656603|P1|NOT COMPLETED|Overall Study||5
1097285|NCT01077739|2656602|P2|COMPLETED|Overall Study||40
1097286|NCT01077739|2656603|P1|COMPLETED|Overall Study||20
1097287|NCT01077739|2656602|P2|STARTED|Overall Study||50
1097288|NCT01077739|2656603|P1|STARTED|Overall Study||25
1097289|NCT01077804|2656615|P1|NOT COMPLETED|Overall Study||199
1097290|NCT01077804|2656615|P1|COMPLETED|Overall Study||7386
1097291|NCT01077804|2656615|P1|STARTED|Overall Study||7585
1097292|NCT01077817|2656622|P1|NOT COMPLETED|Overall Study||0
1097293|NCT01077817|2656622|P1|COMPLETED|Overall Study||684815
1097294|NCT01077817|2656622|P1|STARTED|Overall Study|STARTED and COMPLETED is the number of participants meeting incl./excl. criteria in the GPRD.|684815
1097295|NCT01077830|2656635|P2|NOT COMPLETED|Overall Study||0
1097296|NCT01077830|2656636|P1|NOT COMPLETED|Overall Study||0
1097297|NCT01077830|2656635|P2|COMPLETED|Overall Study||682
1097298|NCT01077830|2656636|P1|COMPLETED|Overall Study||677
1097299|NCT01077830|2656635|P2|STARTED|Overall Study||682
1097300|NCT01077830|2656636|P1|STARTED|Overall Study||677
1097301|NCT01077856|2656649|P3|NOT COMPLETED|Overall Study||0
1097302|NCT01077856|2656650|P2|NOT COMPLETED|Overall Study||0
1097303|NCT01077856|2656651|P1|NOT COMPLETED|Overall Study||0
1097304|NCT01077856|2656649|P3|COMPLETED|Overall Study||15713
1097305|NCT01077856|2656650|P2|COMPLETED|Overall Study||16604
1097306|NCT01077856|2656651|P1|COMPLETED|Overall Study||22199
1097307|NCT01077856|2656649|P3|STARTED|Overall Study||15713
1097308|NCT01077856|2656650|P2|STARTED|Overall Study||16604
1097309|NCT01077856|2656651|P1|STARTED|Overall Study||22199
1097310|NCT01078441|2656830|P1|NOT COMPLETED|Overall Study||1
1097311|NCT01078441|2656830|P1|COMPLETED|Overall Study||1
1097312|NCT01078441|2656830|P1|STARTED|Overall Study||2
1097313|NCT01078454|2656836|P2|NOT COMPLETED|Overall Study||2
1097314|NCT01078454|2656837|P1|NOT COMPLETED|Overall Study||1
1097315|NCT01078454|2656836|P2|COMPLETED|Overall Study||3
1097316|NCT01078454|2656837|P1|COMPLETED|Overall Study||5
1097317|NCT01078454|2656836|P2|STARTED|Overall Study||5
1097318|NCT01078454|2656837|P1|STARTED|Overall Study||6
1097319|NCT01078545|2656843|P1|NOT COMPLETED|Overall Study||26
1097320|NCT01078545|2656843|P1|COMPLETED|Overall Study||703
1097321|NCT01078545|2656843|P1|Per Protocol Population|Overall Study||661
1097322|NCT01078545|2656843|P1|Intent-to-treat Population|Overall Study||729
1097323|NCT01078545|2656843|P1|STARTED|Overall Study||729
1097324|NCT01078571|2656851|P1|NOT COMPLETED|Overall Study||115
1097325|NCT01078571|2656851|P1|COMPLETED|Overall Study||590
1097326|NCT01078571|2656851|P1|Intent-to-treat (ITT) Population|Overall Study||591
1097327|NCT01078571|2656851|P1|Safety Population|Overall Study||675
1097328|NCT01078571|2656851|P1|STARTED|Overall Study||705
1097329|NCT01078584|2656867|P1|NOT COMPLETED|Overall Study||3010
1097330|NCT01078584|2656867|P1|COMPLETED|Overall Study||4983
1097331|NCT01078584|2656867|P1|Participants Conducted Visit 4(12-month)|Overall Study||4983
1097332|NCT01078584|2656867|P1|Participants Conducted Visit 3 (6-month)|Overall Study||5833
1097333|NCT01078584|2656867|P1|Participants Conducted Visit 2 (3-month)|Overall Study||7125
1097334|NCT01078584|2656867|P1|STARTED|Overall Study||7993
1097335|NCT01078623|2656948|P20|NOT COMPLETED|Treatment Period 4||0
1097336|NCT01078623|2656949|P19|NOT COMPLETED|Treatment Period 4||0
1097337|NCT01078623|2656950|P18|NOT COMPLETED|Treatment Period 4||0
1097338|NCT01078623|2656951|P17|NOT COMPLETED|Treatment Period 4||0
1097339|NCT01078623|2656952|P16|NOT COMPLETED|Treatment Period 4||1
1097340|NCT01078623|2656953|P15|NOT COMPLETED|Treatment Period 4||0
1097341|NCT01078623|2656954|P14|NOT COMPLETED|Treatment Period 4||0
1097342|NCT01078623|2656955|P13|NOT COMPLETED|Treatment Period 4||0
1097343|NCT01078623|2656956|P12|NOT COMPLETED|Treatment Period 4||0
1097344|NCT01078623|2656957|P11|NOT COMPLETED|Treatment Period 4||0
1097345|NCT01078623|2656958|P10|NOT COMPLETED|Treatment Period 4||0
1097346|NCT01078623|2656959|P9|NOT COMPLETED|Treatment Period 4||0
1097347|NCT01078623|2656960|P8|NOT COMPLETED|Treatment Period 4||0
1097348|NCT01078623|2656961|P7|NOT COMPLETED|Treatment Period 4||0
1097349|NCT01078623|2656962|P6|NOT COMPLETED|Treatment Period 4||0
1097350|NCT01078623|2656963|P5|NOT COMPLETED|Treatment Period 4||0
1097351|NCT01078623|2656964|P4|NOT COMPLETED|Treatment Period 4||0
1097352|NCT01078623|2656965|P3|NOT COMPLETED|Treatment Period 4||1
1097353|NCT01078623|2656966|P2|NOT COMPLETED|Treatment Period 4||0
1097354|NCT01078623|2656967|P1|NOT COMPLETED|Treatment Period 4||0
1097355|NCT01078623|2656948|P20|COMPLETED|Treatment Period 4||7
1097356|NCT01078623|2656949|P19|COMPLETED|Treatment Period 4||6
1097357|NCT01078623|2656950|P18|COMPLETED|Treatment Period 4||7
1097358|NCT01078623|2656951|P17|COMPLETED|Treatment Period 4||7
1097359|NCT01078623|2656952|P16|COMPLETED|Treatment Period 4||6
1097360|NCT01078623|2656953|P15|COMPLETED|Treatment Period 4||7
1097361|NCT01078623|2656954|P14|COMPLETED|Treatment Period 4||6
1097362|NCT01078623|2656955|P13|COMPLETED|Treatment Period 4||7
1097363|NCT01078623|2656956|P12|COMPLETED|Treatment Period 4||7
1097364|NCT01078623|2656957|P11|COMPLETED|Treatment Period 4||6
1097365|NCT01078623|2656958|P10|COMPLETED|Treatment Period 4||6
1097366|NCT01078623|2656959|P9|COMPLETED|Treatment Period 4||5
1097367|NCT01078623|2656960|P8|COMPLETED|Treatment Period 4||6
1097368|NCT01078623|2656961|P7|COMPLETED|Treatment Period 4||5
1097369|NCT01078623|2656962|P6|COMPLETED|Treatment Period 4||4
1097370|NCT01078623|2656963|P5|COMPLETED|Treatment Period 4||6
1097371|NCT01078623|2656964|P4|COMPLETED|Treatment Period 4||6
1097372|NCT01078623|2656965|P3|COMPLETED|Treatment Period 4||5
1097373|NCT01078623|2656966|P2|COMPLETED|Treatment Period 4||5
1097374|NCT01078623|2656967|P1|COMPLETED|Treatment Period 4||5
1097375|NCT01078623|2656948|P20|STARTED|Treatment Period 4||7
1097376|NCT01078623|2656949|P19|STARTED|Treatment Period 4||6
1097377|NCT01078623|2656950|P18|STARTED|Treatment Period 4||7
1097378|NCT01078623|2656951|P17|STARTED|Treatment Period 4||7
1097379|NCT01078623|2656952|P16|STARTED|Treatment Period 4||7
1097380|NCT01078623|2656953|P15|STARTED|Treatment Period 4||7
1097381|NCT01078623|2656954|P14|STARTED|Treatment Period 4||6
1097382|NCT01078623|2656955|P13|STARTED|Treatment Period 4||7
1097383|NCT01078623|2656956|P12|STARTED|Treatment Period 4||7
1097384|NCT01078623|2656957|P11|STARTED|Treatment Period 4||6
1097385|NCT01078623|2656958|P10|STARTED|Treatment Period 4||6
1097386|NCT01078623|2656959|P9|STARTED|Treatment Period 4||5
1097387|NCT01078623|2656960|P8|STARTED|Treatment Period 4||6
1097388|NCT01078623|2656961|P7|STARTED|Treatment Period 4||5
1097389|NCT01078623|2656962|P6|STARTED|Treatment Period 4||4
1097390|NCT01078623|2656963|P5|STARTED|Treatment Period 4||6
1097391|NCT01078623|2656964|P4|STARTED|Treatment Period 4||6
1097392|NCT01078623|2656965|P3|STARTED|Treatment Period 4||6
1097393|NCT01078623|2656966|P2|STARTED|Treatment Period 4||5
1097394|NCT01078623|2656967|P1|STARTED|Treatment Period 4||5
1097395|NCT01078623|2656948|P20|NOT COMPLETED|Treatment Period 3||0
1097396|NCT01078623|2656949|P19|NOT COMPLETED|Treatment Period 3||0
1097397|NCT01078623|2656950|P18|NOT COMPLETED|Treatment Period 3||0
1097398|NCT01078623|2656951|P17|NOT COMPLETED|Treatment Period 3||0
1097399|NCT01078623|2656952|P16|NOT COMPLETED|Treatment Period 3||0
1097400|NCT01078623|2656953|P15|NOT COMPLETED|Treatment Period 3||0
1097401|NCT01078623|2656954|P14|NOT COMPLETED|Treatment Period 3||1
1097402|NCT01078623|2656955|P13|NOT COMPLETED|Treatment Period 3||0
1097403|NCT01078623|2656956|P12|NOT COMPLETED|Treatment Period 3||0
1097404|NCT01078623|2656957|P11|NOT COMPLETED|Treatment Period 3||0
1097405|NCT01078623|2656958|P10|NOT COMPLETED|Treatment Period 3||0
1097406|NCT01078623|2656959|P9|NOT COMPLETED|Treatment Period 3||0
1097407|NCT01078623|2656960|P8|NOT COMPLETED|Treatment Period 3||0
1097408|NCT01078623|2656961|P7|NOT COMPLETED|Treatment Period 3||0
1097409|NCT01078623|2656962|P6|NOT COMPLETED|Treatment Period 3||0
1097410|NCT01078623|2656963|P5|NOT COMPLETED|Treatment Period 3||1
1097411|NCT01078623|2656964|P4|NOT COMPLETED|Treatment Period 3||0
1097412|NCT01078623|2656965|P3|NOT COMPLETED|Treatment Period 3||0
1097413|NCT01078623|2656966|P2|NOT COMPLETED|Treatment Period 3||0
1097414|NCT01078623|2656967|P1|NOT COMPLETED|Treatment Period 3||0
1097415|NCT01078623|2656948|P20|COMPLETED|Treatment Period 3||7
1097416|NCT01078623|2656949|P19|COMPLETED|Treatment Period 3||6
1097417|NCT01078623|2656950|P18|COMPLETED|Treatment Period 3||7
1097418|NCT01078623|2656951|P17|COMPLETED|Treatment Period 3||7
1097419|NCT01078623|2656952|P16|COMPLETED|Treatment Period 3||7
1097420|NCT01078623|2656953|P15|COMPLETED|Treatment Period 3||7
1097421|NCT01078623|2656954|P14|COMPLETED|Treatment Period 3||6
1097422|NCT01078623|2656955|P13|COMPLETED|Treatment Period 3||7
1097423|NCT01078623|2656956|P12|COMPLETED|Treatment Period 3||7
1097424|NCT01078623|2656957|P11|COMPLETED|Treatment Period 3||6
1097425|NCT01078623|2656958|P10|COMPLETED|Treatment Period 3||6
1097426|NCT01078623|2656959|P9|COMPLETED|Treatment Period 3||5
1097427|NCT01078623|2656960|P8|COMPLETED|Treatment Period 3||6
1097428|NCT01078623|2656961|P7|COMPLETED|Treatment Period 3||5
1097429|NCT01078623|2656962|P6|COMPLETED|Treatment Period 3||4
1097430|NCT01078623|2656963|P5|COMPLETED|Treatment Period 3||6
1097431|NCT01078623|2656964|P4|COMPLETED|Treatment Period 3||6
1097432|NCT01078623|2656965|P3|COMPLETED|Treatment Period 3||6
1097433|NCT01078623|2656966|P2|COMPLETED|Treatment Period 3||5
1097434|NCT01078623|2656967|P1|COMPLETED|Treatment Period 3||5
1097435|NCT01078623|2656948|P20|STARTED|Treatment Period 3||7
1097436|NCT01078623|2656949|P19|STARTED|Treatment Period 3||6
1097437|NCT01078623|2656950|P18|STARTED|Treatment Period 3||7
1097438|NCT01078623|2656951|P17|STARTED|Treatment Period 3||7
1097439|NCT01078623|2656952|P16|STARTED|Treatment Period 3||7
1097440|NCT01078623|2656953|P15|STARTED|Treatment Period 3||7
1097441|NCT01078623|2656954|P14|STARTED|Treatment Period 3||7
1097442|NCT01078623|2656955|P13|STARTED|Treatment Period 3||7
1097443|NCT01078623|2656956|P12|STARTED|Treatment Period 3||7
1097444|NCT01078623|2656957|P11|STARTED|Treatment Period 3||6
1097445|NCT01078623|2656958|P10|STARTED|Treatment Period 3||6
1097446|NCT01078623|2656959|P9|STARTED|Treatment Period 3||5
1097447|NCT01078623|2656960|P8|STARTED|Treatment Period 3||6
1097448|NCT01078623|2656961|P7|STARTED|Treatment Period 3||5
1097449|NCT01078623|2656962|P6|STARTED|Treatment Period 3||4
1097450|NCT01078623|2656963|P5|STARTED|Treatment Period 3||7
1097451|NCT01078623|2656964|P4|STARTED|Treatment Period 3||6
1097452|NCT01078623|2656965|P3|STARTED|Treatment Period 3||6
1097453|NCT01078623|2656966|P2|STARTED|Treatment Period 3||5
1097454|NCT01078623|2656967|P1|STARTED|Treatment Period 3||5
1097455|NCT01078623|2656948|P20|NOT COMPLETED|Treatment Period 2||0
1097456|NCT01078623|2656949|P19|NOT COMPLETED|Treatment Period 2||1
1097457|NCT01078623|2656950|P18|NOT COMPLETED|Treatment Period 2||0
1097458|NCT01078623|2656951|P17|NOT COMPLETED|Treatment Period 2||0
1097459|NCT01078623|2656952|P16|NOT COMPLETED|Treatment Period 2||0
1097460|NCT01078623|2656953|P15|NOT COMPLETED|Treatment Period 2||0
1097461|NCT01078623|2656954|P14|NOT COMPLETED|Treatment Period 2||0
1097462|NCT01078623|2656955|P13|NOT COMPLETED|Treatment Period 2||0
1097463|NCT01078623|2656956|P12|NOT COMPLETED|Treatment Period 2||0
1097464|NCT01078623|2656957|P11|NOT COMPLETED|Treatment Period 2||0
1097465|NCT01078623|2656958|P10|NOT COMPLETED|Treatment Period 2||0
1097466|NCT01078623|2656959|P9|NOT COMPLETED|Treatment Period 2||0
1097467|NCT01078623|2656960|P8|NOT COMPLETED|Treatment Period 2||0
1097468|NCT01078623|2656961|P7|NOT COMPLETED|Treatment Period 2||1
1097469|NCT01078623|2656962|P6|NOT COMPLETED|Treatment Period 2||1
1097470|NCT01078623|2656963|P5|NOT COMPLETED|Treatment Period 2||0
1097471|NCT01078623|2656964|P4|NOT COMPLETED|Treatment Period 2||0
1097472|NCT01078623|2656965|P3|NOT COMPLETED|Treatment Period 2||0
1097473|NCT01078623|2656966|P2|NOT COMPLETED|Treatment Period 2||0
1097474|NCT01078623|2656967|P1|NOT COMPLETED|Treatment Period 2||0
1097475|NCT01078623|2656948|P20|COMPLETED|Treatment Period 2||7
1097476|NCT01078623|2656949|P19|COMPLETED|Treatment Period 2||6
1097477|NCT01078623|2656950|P18|COMPLETED|Treatment Period 2||7
1097478|NCT01078623|2656951|P17|COMPLETED|Treatment Period 2||7
1097479|NCT01078623|2656952|P16|COMPLETED|Treatment Period 2||7
1097480|NCT01078623|2656953|P15|COMPLETED|Treatment Period 2||7
1097481|NCT01078623|2656954|P14|COMPLETED|Treatment Period 2||7
1097482|NCT01078623|2656955|P13|COMPLETED|Treatment Period 2||7
1097483|NCT01078623|2656956|P12|COMPLETED|Treatment Period 2||7
1097484|NCT01078623|2656957|P11|COMPLETED|Treatment Period 2||6
1097485|NCT01078623|2656958|P10|COMPLETED|Treatment Period 2||6
1097486|NCT01078623|2656959|P9|COMPLETED|Treatment Period 2||5
1097487|NCT01078623|2656960|P8|COMPLETED|Treatment Period 2||6
1097488|NCT01078623|2656961|P7|COMPLETED|Treatment Period 2||5
1097489|NCT01078623|2656962|P6|COMPLETED|Treatment Period 2||4
1097490|NCT01078623|2656963|P5|COMPLETED|Treatment Period 2||7
1097491|NCT01078623|2656964|P4|COMPLETED|Treatment Period 2||6
1097492|NCT01078623|2656965|P3|COMPLETED|Treatment Period 2||6
1097493|NCT01078623|2656966|P2|COMPLETED|Treatment Period 2||5
1097494|NCT01078623|2656967|P1|COMPLETED|Treatment Period 2||5
1097495|NCT01078623|2656948|P20|STARTED|Treatment Period 2||7
1097496|NCT01078623|2656949|P19|STARTED|Treatment Period 2||7
1097497|NCT01078623|2656950|P18|STARTED|Treatment Period 2||7
1097498|NCT01078623|2656951|P17|STARTED|Treatment Period 2||7
1097499|NCT01078623|2656952|P16|STARTED|Treatment Period 2||7
1097500|NCT01078623|2656953|P15|STARTED|Treatment Period 2||7
1097501|NCT01078623|2656954|P14|STARTED|Treatment Period 2||7
1097502|NCT01078623|2656955|P13|STARTED|Treatment Period 2||7
1097503|NCT01078623|2656956|P12|STARTED|Treatment Period 2||7
1097504|NCT01078623|2656957|P11|STARTED|Treatment Period 2||6
1097505|NCT01078623|2656958|P10|STARTED|Treatment Period 2||6
1097506|NCT01078623|2656959|P9|STARTED|Treatment Period 2||5
1097507|NCT01078623|2656960|P8|STARTED|Treatment Period 2||6
1097508|NCT01078623|2656961|P7|STARTED|Treatment Period 2||6
1097509|NCT01078623|2656962|P6|STARTED|Treatment Period 2||5
1097510|NCT01078623|2656963|P5|STARTED|Treatment Period 2||7
1097511|NCT01078623|2656964|P4|STARTED|Treatment Period 2||6
1097512|NCT01078623|2656965|P3|STARTED|Treatment Period 2||6
1097513|NCT01078623|2656966|P2|STARTED|Treatment Period 2||5
1097514|NCT01078623|2656967|P1|STARTED|Treatment Period 2||5
1097515|NCT01078623|2656948|P20|NOT COMPLETED|Treatment Period 1||0
1097516|NCT01078623|2656949|P19|NOT COMPLETED|Treatment Period 1||0
1097517|NCT01078623|2656950|P18|NOT COMPLETED|Treatment Period 1||0
1097518|NCT01078623|2656951|P17|NOT COMPLETED|Treatment Period 1||0
1097519|NCT01078623|2656952|P16|NOT COMPLETED|Treatment Period 1||0
1097520|NCT01078623|2656953|P15|NOT COMPLETED|Treatment Period 1||0
1097521|NCT01078623|2656954|P14|NOT COMPLETED|Treatment Period 1||0
1097522|NCT01078623|2656955|P13|NOT COMPLETED|Treatment Period 1||0
1097523|NCT01078623|2656956|P12|NOT COMPLETED|Treatment Period 1||0
1097524|NCT01078623|2656957|P11|NOT COMPLETED|Treatment Period 1||1
1097525|NCT01078623|2656958|P10|NOT COMPLETED|Treatment Period 1||1
1097526|NCT01078623|2656959|P9|NOT COMPLETED|Treatment Period 1||1
1097527|NCT01078623|2656960|P8|NOT COMPLETED|Treatment Period 1||1
1097528|NCT01078623|2656961|P7|NOT COMPLETED|Treatment Period 1||1
1097529|NCT01078623|2656962|P6|NOT COMPLETED|Treatment Period 1||1
1097530|NCT01078623|2656963|P5|NOT COMPLETED|Treatment Period 1||0
1097531|NCT01078623|2656964|P4|NOT COMPLETED|Treatment Period 1||0
1097532|NCT01078623|2656965|P3|NOT COMPLETED|Treatment Period 1||1
1097533|NCT01078623|2656966|P2|NOT COMPLETED|Treatment Period 1||1
1097534|NCT01078623|2656967|P1|NOT COMPLETED|Treatment Period 1||1
1097535|NCT01078623|2656948|P20|COMPLETED|Treatment Period 1||7
1097536|NCT01078623|2656949|P19|COMPLETED|Treatment Period 1||7
1097537|NCT01078623|2656950|P18|COMPLETED|Treatment Period 1||7
1097538|NCT01078623|2656951|P17|COMPLETED|Treatment Period 1||7
1097539|NCT01078623|2656952|P16|COMPLETED|Treatment Period 1||7
1097540|NCT01078623|2656953|P15|COMPLETED|Treatment Period 1||7
1097541|NCT01078623|2656954|P14|COMPLETED|Treatment Period 1||7
1097542|NCT01078623|2656955|P13|COMPLETED|Treatment Period 1||7
1097543|NCT01078623|2656956|P12|COMPLETED|Treatment Period 1||7
1097544|NCT01078623|2656957|P11|COMPLETED|Treatment Period 1||6
1097545|NCT01078623|2656958|P10|COMPLETED|Treatment Period 1||6
1097546|NCT01078623|2656959|P9|COMPLETED|Treatment Period 1||5
1097547|NCT01078623|2656960|P8|COMPLETED|Treatment Period 1||6
1097548|NCT01078623|2656961|P7|COMPLETED|Treatment Period 1||6
1097549|NCT01078623|2656962|P6|COMPLETED|Treatment Period 1||5
1097550|NCT01078623|2656963|P5|COMPLETED|Treatment Period 1||7
1097551|NCT01078623|2656964|P4|COMPLETED|Treatment Period 1||6
1097552|NCT01078623|2656965|P3|COMPLETED|Treatment Period 1||6
1097553|NCT01078623|2656966|P2|COMPLETED|Treatment Period 1||5
1097554|NCT01078623|2656967|P1|COMPLETED|Treatment Period 1||5
1097555|NCT01078623|2656948|P20|STARTED|Treatment Period 1||7
1097556|NCT01078623|2656949|P19|STARTED|Treatment Period 1||7
1097557|NCT01078623|2656950|P18|STARTED|Treatment Period 1||7
1097558|NCT01078623|2656951|P17|STARTED|Treatment Period 1||7
1097559|NCT01078623|2656952|P16|STARTED|Treatment Period 1||7
1097560|NCT01078623|2656953|P15|STARTED|Treatment Period 1||7
1097561|NCT01078623|2656954|P14|STARTED|Treatment Period 1||7
1097562|NCT01078623|2656955|P13|STARTED|Treatment Period 1||7
1097563|NCT01078623|2656956|P12|STARTED|Treatment Period 1||7
1097564|NCT01078623|2656957|P11|STARTED|Treatment Period 1||7
1097565|NCT01078623|2656958|P10|STARTED|Treatment Period 1||7
1097566|NCT01078623|2656959|P9|STARTED|Treatment Period 1||6
1097567|NCT01078623|2656960|P8|STARTED|Treatment Period 1||7
1097568|NCT01078623|2656961|P7|STARTED|Treatment Period 1||7
1097569|NCT01078623|2656962|P6|STARTED|Treatment Period 1||6
1097570|NCT01078623|2656963|P5|STARTED|Treatment Period 1||7
1097571|NCT01078623|2656964|P4|STARTED|Treatment Period 1||6
1097572|NCT01078623|2656965|P3|STARTED|Treatment Period 1||7
1097573|NCT01078623|2656966|P2|STARTED|Treatment Period 1||6
1097574|NCT01078623|2656967|P1|STARTED|Treatment Period 1||6
1097575|NCT01078662|2656994|P5|NOT COMPLETED|Overall Study||11
1097576|NCT01078662|2656995|P4|NOT COMPLETED|Overall Study||7
1097577|NCT01078662|2656996|P3|NOT COMPLETED|Overall Study||21
1097578|NCT01078662|2656997|P2|NOT COMPLETED|Overall Study||168
1097579|NCT01078662|2656998|P1|NOT COMPLETED|Overall Study||58
1097580|NCT01078662|2656994|P5|COMPLETED|Overall Study||1
1097581|NCT01078662|2656995|P4|COMPLETED|Overall Study||1
1097582|NCT01078662|2656996|P3|COMPLETED|Overall Study||2
1097583|NCT01078662|2656997|P2|COMPLETED|Overall Study||25
1097584|NCT01078662|2656998|P1|COMPLETED|Overall Study||4
1097585|NCT01078662|2656994|P5|STARTED|Overall Study||12
1097586|NCT01078662|2656995|P4|STARTED|Overall Study||8
1097587|NCT01078662|2656996|P3|STARTED|Overall Study||23
1097588|NCT01078662|2656997|P2|STARTED|Overall Study||193
1097589|NCT01078662|2656998|P1|STARTED|Overall Study||62
1097590|NCT01078675|2657039|P2|NOT COMPLETED|Overall Study||6
1097591|NCT01078675|2657040|P1|NOT COMPLETED|Overall Study||68
1097592|NCT01078675|2657039|P2|COMPLETED|Overall Study|Healthy siblings did not participate in investigational product administration.|59
1097593|NCT01078675|2657040|P1|COMPLETED|Overall Study||182
1097594|NCT01078675|2657039|P2|Patients Treated|Overall Study||0
1097595|NCT01078675|2657040|P1|Patients Treated|Overall Study||198
1097596|NCT01078675|2657039|P2|STARTED|Overall Study||65
1097597|NCT01078675|2657040|P1|STARTED|Overall Study||250
1097598|NCT01078753|2657059|P2|NOT COMPLETED|Treatment Period II||0
1097599|NCT01078753|2657060|P1|NOT COMPLETED|Treatment Period II||0
1097600|NCT01078753|2657059|P2|COMPLETED|Treatment Period II||44
1097601|NCT01078753|2657060|P1|COMPLETED|Treatment Period II||45
1097602|NCT01078753|2657059|P2|Full Analysis Set|Treatment Period II||44
1097603|NCT01078753|2657060|P1|Full Analysis Set|Treatment Period II|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
1097604|NCT01078753|2657059|P2|STARTED|Treatment Period II||44
1097605|NCT01078753|2657060|P1|STARTED|Treatment Period II|Desmopressin 120 µg - 4 participants Desmopressin 240 µg - 41 participants|45
1097606|NCT01078753|2657059|P2|NOT COMPLETED|Treatment Period I||0
1097607|NCT01078753|2657060|P1|NOT COMPLETED|Treatment Period I||0
1097608|NCT01078753|2657059|P2|COMPLETED|Treatment Period I||44
1097609|NCT01078753|2657060|P1|COMPLETED|Treatment Period I||45
1097610|NCT01078753|2657059|P2|Full Analysis Set|Treatment Period I||44
1097611|NCT01078753|2657060|P1|Full Analysis Set|Treatment Period I|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
1097612|NCT01078753|2657059|P2|STARTED|Treatment Period I||44
1097613|NCT01078753|2657060|P1|STARTED|Treatment Period I||45
1097614|NCT01078805|2657070|P1|NOT COMPLETED|Overall Study||2050
1097615|NCT01078805|2657070|P1|COMPLETED|Overall Study||2117
1097616|NCT01078805|2657070|P1|Modified Intent-To-Treat|Overall Study|≥1 dose of study drug (SD) and didn't discontinue SD more than 3 consecutive months during treatment|3720
1097617|NCT01078805|2657070|P1|Took at Least 1 Dose of Study Drug|Overall Study||4085
1097618|NCT01078805|2657070|P1|STARTED|Overall Study||4167
1097619|NCT01078844|2657082|P1|NOT COMPLETED|Overall Study||4
1097620|NCT01078844|2657082|P1|COMPLETED|Overall Study||0
1097621|NCT01078844|2657082|P1|STARTED|Overall Study||4
1097637|NCT01078922|2657113|P1|NOT COMPLETED|Overall Study||1
1097638|NCT01078922|2657113|P1|COMPLETED|Overall Study||10
1097639|NCT01078922|2657113|P1|STARTED|Overall Study||11
1097640|NCT01078974|2657118|P1|NOT COMPLETED|Overall Study||3
1097641|NCT01078974|2657118|P1|COMPLETED|Overall Study||4
1097642|NCT01078974|2657118|P1|STARTED|Overall Study||7
1097643|NCT01079130|2657129|P6|NOT COMPLETED|Overall Study||5
1097644|NCT01079130|2657130|P5|NOT COMPLETED|Overall Study||8
1097645|NCT01079130|2657131|P4|NOT COMPLETED|Overall Study||5
1097646|NCT01079130|2657132|P3|NOT COMPLETED|Overall Study||1
1097647|NCT01079130|2657133|P2|NOT COMPLETED|Overall Study||7
1097648|NCT01079130|2657134|P1|NOT COMPLETED|Overall Study||2
1097649|NCT01079130|2657129|P6|COMPLETED|Overall Study||80
1097650|NCT01079130|2657130|P5|COMPLETED|Overall Study||78
1097651|NCT01079130|2657131|P4|COMPLETED|Overall Study||81
1097652|NCT01079130|2657132|P3|COMPLETED|Overall Study||83
1097653|NCT01079130|2657133|P2|COMPLETED|Overall Study||78
1097654|NCT01079130|2657134|P1|COMPLETED|Overall Study||83
1097655|NCT01079130|2657129|P6|Full Analysis Set (FAS)|Overall Study||84
1097656|NCT01079130|2657130|P5|Full Analysis Set (FAS)|Overall Study||84
1097657|NCT01079130|2657131|P4|Full Analysis Set (FAS)|Overall Study||85
1097658|NCT01079130|2657132|P3|Full Analysis Set (FAS)|Overall Study||83
1097659|NCT01079130|2657133|P2|Full Analysis Set (FAS)|Overall Study|2 patients (1 in 37.5 µg;1 in 75 µg group) randomized more than once and were excluded from the FAS.|80
1097660|NCT01079130|2657134|P1|Full Analysis Set (FAS)|Overall Study||84
1097661|NCT01079130|2657129|P6|Safety Set: Received Study Drug|Overall Study||84
1097662|NCT01079130|2657130|P5|Safety Set: Received Study Drug|Overall Study||84
1097663|NCT01079130|2657131|P4|Safety Set: Received Study Drug|Overall Study||85
1097664|NCT01079130|2657132|P3|Safety Set: Received Study Drug|Overall Study||84
1097665|NCT01079130|2657133|P2|Safety Set: Received Study Drug|Overall Study||81
1097666|NCT01079130|2657134|P1|Safety Set: Received Study Drug|Overall Study||84
1097667|NCT01079130|2657129|P6|STARTED|Overall Study||85
1097668|NCT01079130|2657130|P5|STARTED|Overall Study||86
1097669|NCT01079130|2657131|P4|STARTED|Overall Study||86
1097670|NCT01079130|2657132|P3|STARTED|Overall Study||84
1097671|NCT01079130|2657133|P2|STARTED|Overall Study||85
1097672|NCT01079130|2657134|P1|STARTED|Overall Study||85
1097673|NCT01079143|2657158|P4|NOT COMPLETED|Overall Study||5
1097674|NCT01079143|2657159|P3|NOT COMPLETED|Overall Study||5
1097675|NCT01079143|2657160|P2|NOT COMPLETED|Overall Study||17
1097676|NCT01079143|2657161|P1|NOT COMPLETED|Overall Study||9
1097677|NCT01079143|2657158|P4|COMPLETED|Overall Study||54
1097678|NCT01079143|2657159|P3|COMPLETED|Overall Study||34
1097679|NCT01079143|2657160|P2|COMPLETED|Overall Study||43
1097680|NCT01079143|2657161|P1|COMPLETED|Overall Study||27
1097681|NCT01079143|2657158|P4|M3 and M12 Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
1097682|NCT01079143|2657159|P3|M3 and M12 Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
1097683|NCT01079143|2657160|P2|M3 and M12 Biopsies|Overall Study||43
1097684|NCT01079143|2657161|P1|M3 and M12 Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
1097685|NCT01079143|2657158|P4|Month 12 (M12) Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
1097686|NCT01079143|2657159|P3|Month 12 (M12) Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
1097687|NCT01079143|2657160|P2|Month 12 (M12) Biopsies|Overall Study||43
1097688|NCT01079143|2657161|P1|Month 12 (M12) Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
1097689|NCT01079143|2657158|P4|Month 3 (M3) Biopsies|Overall Study||59
1097690|NCT01079143|2657159|P3|Month 3 (M3) Biopsies|Overall Study||39
1097691|NCT01079143|2657160|P2|Month 3 (M3) Biopsies|Overall Study|1 patient was excluded due to an IF/TA Grade of III at the M3 Biopsy|59
1097692|NCT01079143|2657161|P1|Month 3 (M3) Biopsies|Overall Study||36
1097693|NCT01079143|2657158|P4|Exposed|Overall Study||59
1097694|NCT01079143|2657159|P3|Exposed|Overall Study||39
1097695|NCT01079143|2657160|P2|Exposed|Overall Study||60
1097696|NCT01079143|2657161|P1|Exposed|Overall Study||36
1097697|NCT01079143|2657158|P4|STARTED|Overall Study||59
1097698|NCT01079143|2657159|P3|STARTED|Overall Study||39
1097699|NCT01079143|2657160|P2|STARTED|Overall Study||60
1097700|NCT01079143|2657161|P1|STARTED|Overall Study||36
1097701|NCT01079182|2657229|P1|NOT COMPLETED|Overall Study||2719
1097702|NCT01079182|2657229|P1|COMPLETED|Overall Study||1962
1097703|NCT01079182|2657229|P1|STARTED|Overall Study||4681
1097704|NCT01079195|2657256|P1|NOT COMPLETED|Overall Study||1431
1097705|NCT01079195|2657256|P1|COMPLETED|Overall Study||14442
1097706|NCT01079195|2657256|P1|STARTED|Overall Study||15873
1097707|NCT01079234|2657265|P4|NOT COMPLETED|Extension: Week 27 to 52||16
1097708|NCT01079234|2657266|P3|NOT COMPLETED|Extension: Week 27 to 52||11
1097709|NCT01079234|2657267|P2|NOT COMPLETED|Extension: Week 27 to 52||0
1097710|NCT01079234|2657268|P1|NOT COMPLETED|Extension: Week 27 to 52||0
1097711|NCT01079234|2657265|P4|COMPLETED|Extension: Week 27 to 52||223
1097712|NCT01079234|2657266|P3|COMPLETED|Extension: Week 27 to 52||122
1097713|NCT01079234|2657267|P2|COMPLETED|Extension: Week 27 to 52||0
1097714|NCT01079234|2657268|P1|COMPLETED|Extension: Week 27 to 52||0
1097715|NCT01079234|2657265|P4|STARTED|Extension: Week 27 to 52|Thirty eight subjects did not continue into extension trial.|239
1097716|NCT01079234|2657266|P3|STARTED|Extension: Week 27 to 52|Nineteen subjects from main trial did not continue into extension trial|133
1097717|NCT01079234|2657267|P2|STARTED|Extension: Week 27 to 52||0
1097718|NCT01079234|2657268|P1|STARTED|Extension: Week 27 to 52||0
1097719|NCT01079234|2657265|P4|NOT COMPLETED|Main: Week 0 to 26||0
1097720|NCT01079234|2657266|P3|NOT COMPLETED|Main: Week 0 to 26||12
1097721|NCT01079234|2657267|P2|NOT COMPLETED|Main: Week 0 to 26||26
1097722|NCT01079234|2657268|P1|NOT COMPLETED|Main: Week 0 to 26||26
1097723|NCT01079234|2657265|P4|COMPLETED|Main: Week 0 to 26||0
1097724|NCT01079234|2657266|P3|COMPLETED|Main: Week 0 to 26||152
1097725|NCT01079234|2657267|P2|COMPLETED|Main: Week 0 to 26||139
1097726|NCT01079234|2657268|P1|COMPLETED|Main: Week 0 to 26||138
1097727|NCT01079234|2657265|P4|Exposed|Main: Week 0 to 26||0
1097728|NCT01079234|2657266|P3|Exposed|Main: Week 0 to 26|Three subjects withdrew prior to exposure to trial drug.|161
1097729|NCT01079234|2657267|P2|Exposed|Main: Week 0 to 26||165
1097730|NCT01079234|2657268|P1|Exposed|Main: Week 0 to 26||164
1097731|NCT01079234|2657265|P4|STARTED|Main: Week 0 to 26||0
1097732|NCT01079234|2657266|P3|STARTED|Main: Week 0 to 26||164
1097733|NCT01079234|2657267|P2|STARTED|Main: Week 0 to 26||165
1097734|NCT01079234|2657268|P1|STARTED|Main: Week 0 to 26||164
1097735|NCT01079299|2657288|P2|NOT COMPLETED|Overall Study||0
1097736|NCT01079299|2657289|P1|NOT COMPLETED|Overall Study||0
1097737|NCT01079299|2657288|P2|COMPLETED|Overall Study||25
1097738|NCT01079299|2657289|P1|COMPLETED|Overall Study||27
1097739|NCT01079299|2657288|P2|STARTED|Overall Study||25
1097740|NCT01079299|2657289|P1|STARTED|Overall Study||27
1097741|NCT01079390|2657298|P3|NOT COMPLETED|Overall Study||4
1097742|NCT01079390|2657299|P2|NOT COMPLETED|Overall Study||5
1097743|NCT01079390|2657300|P1|NOT COMPLETED|Overall Study||5
1097744|NCT01079390|2657298|P3|COMPLETED|Overall Study||10
1097745|NCT01079390|2657299|P2|COMPLETED|Overall Study||10
1097746|NCT01079390|2657300|P1|COMPLETED|Overall Study||10
1097747|NCT01079390|2657298|P3|STARTED|Overall Study||14
1097748|NCT01079390|2657299|P2|STARTED|Overall Study||15
1097749|NCT01079390|2657300|P1|STARTED|Overall Study||15
1097750|NCT01079598|2657310|P1|NOT COMPLETED|Overall Study||0
1097751|NCT01079598|2657310|P1|COMPLETED|Overall Study||8
1097752|NCT01079598|2657310|P1|STARTED|Overall Study||8
1097769|NCT01079832|2657340|P1|NOT COMPLETED|Overall Study||1
1097770|NCT01079832|2657340|P1|COMPLETED|Overall Study||49
1097771|NCT01079832|2657340|P1|STARTED|Overall Study||50
1097772|NCT01079936|2657352|P5|NOT COMPLETED|Phase II||1
1097773|NCT01079936|2657353|P4|NOT COMPLETED|Phase II||0
1097774|NCT01079936|2657354|P3|NOT COMPLETED|Phase II||1
1097775|NCT01079936|2657355|P2|NOT COMPLETED|Phase II||0
1097776|NCT01079936|2657356|P1|NOT COMPLETED|Phase II||0
1097777|NCT01079936|2657352|P5|COMPLETED|Phase II||25
1097778|NCT01079936|2657353|P4|COMPLETED|Phase II||24
1097779|NCT01079936|2657354|P3|COMPLETED|Phase II||5
1097780|NCT01079936|2657355|P2|COMPLETED|Phase II||3
1097781|NCT01079936|2657356|P1|COMPLETED|Phase II||0
1097782|NCT01079936|2657352|P5|STARTED|Phase II||26
1097783|NCT01079936|2657353|P4|STARTED|Phase II||24
1097784|NCT01079936|2657354|P3|STARTED|Phase II||6
1097785|NCT01079936|2657355|P2|STARTED|Phase II||3
1097786|NCT01079936|2657356|P1|STARTED|Phase II||0
1097787|NCT01079936|2657352|P5|NOT COMPLETED|Phase I: MTD||0
1097788|NCT01079936|2657353|P4|NOT COMPLETED|Phase I: MTD||0
1097789|NCT01079936|2657354|P3|NOT COMPLETED|Phase I: MTD||0
1097790|NCT01079936|2657355|P2|NOT COMPLETED|Phase I: MTD||0
1097791|NCT01079936|2657356|P1|NOT COMPLETED|Phase I: MTD||4
1097792|NCT01079936|2657352|P5|COMPLETED|Phase I: MTD||0
1097793|NCT01079936|2657353|P4|COMPLETED|Phase I: MTD||0
1097794|NCT01079936|2657354|P3|COMPLETED|Phase I: MTD||0
1097795|NCT01079936|2657355|P2|COMPLETED|Phase I: MTD||0
1097796|NCT01079936|2657356|P1|COMPLETED|Phase I: MTD|The 12 Phase I participants were randomized across 4 dose arms for Phase II.|12
1097797|NCT01079936|2657352|P5|STARTED|Phase I: MTD||0
1097798|NCT01079936|2657353|P4|STARTED|Phase I: MTD||0
1097799|NCT01079936|2657354|P3|STARTED|Phase I: MTD||0
1097800|NCT01079936|2657355|P2|STARTED|Phase I: MTD||0
1097801|NCT01079936|2657356|P1|STARTED|Phase I: MTD||16
1097802|NCT01079949|2657377|P2|NOT COMPLETED|Overall Study||13
1097803|NCT01079949|2657378|P1|NOT COMPLETED|Overall Study||15
1097804|NCT01079949|2657377|P2|COMPLETED|Overall Study||34
1097805|NCT01079949|2657378|P1|COMPLETED|Overall Study||31
1097806|NCT01079949|2657377|P2|STARTED|Overall Study||47
1097807|NCT01079949|2657378|P1|STARTED|Overall Study||46
1097808|NCT01079962|2657422|P2|NOT COMPLETED|Overall Study||15
1097809|NCT01079962|2657423|P1|NOT COMPLETED|Overall Study||15
1097810|NCT01079962|2657422|P2|COMPLETED|Overall Study||89
1097811|NCT01079962|2657423|P1|COMPLETED|Overall Study||90
1097812|NCT01079962|2657422|P2|STARTED|Overall Study||104
1097813|NCT01079962|2657423|P1|STARTED|Overall Study||105
1097814|NCT01079988|2657454|P5|NOT COMPLETED|Overall Study||1
1097815|NCT01079988|2657455|P4|NOT COMPLETED|Overall Study||3
1097816|NCT01079988|2657456|P3|NOT COMPLETED|Overall Study||0
1097817|NCT01079988|2657457|P2|NOT COMPLETED|Overall Study||0
1097818|NCT01079988|2657458|P1|NOT COMPLETED|Overall Study||1
1097819|NCT01079988|2657454|P5|COMPLETED|Overall Study||1
1097820|NCT01079988|2657455|P4|COMPLETED|Overall Study||17
1097821|NCT01079988|2657456|P3|COMPLETED|Overall Study||8
1097822|NCT01079988|2657457|P2|COMPLETED|Overall Study||1
1097823|NCT01079988|2657458|P1|COMPLETED|Overall Study||9
1097824|NCT01079988|2657454|P5|STARTED|Overall Study||2
1097825|NCT01079988|2657455|P4|STARTED|Overall Study||20
1097826|NCT01079988|2657456|P3|STARTED|Overall Study||8
1097827|NCT01079988|2657457|P2|STARTED|Overall Study||1
1097828|NCT01079988|2657458|P1|STARTED|Overall Study||10
1097829|NCT01080118|2657477|P4|NOT COMPLETED|Overall Study||0
1097830|NCT01080118|2657478|P3|NOT COMPLETED|Overall Study||0
1097831|NCT01080118|2657479|P2|NOT COMPLETED|Overall Study||0
1097832|NCT01080118|2657480|P1|NOT COMPLETED|Overall Study||0
1097833|NCT01080118|2657477|P4|COMPLETED|Overall Study||30
1097834|NCT01080118|2657478|P3|COMPLETED|Overall Study||30
1097835|NCT01080118|2657479|P2|COMPLETED|Overall Study||15
1097836|NCT01080118|2657480|P1|COMPLETED|Overall Study||15
1097837|NCT01080118|2657477|P4|STARTED|Overall Study||30
1097838|NCT01080118|2657478|P3|STARTED|Overall Study||30
1097839|NCT01080118|2657479|P2|STARTED|Overall Study||15
1097840|NCT01080118|2657480|P1|STARTED|Overall Study||15
1097841|NCT01080131|2657490|P2|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||11
1097842|NCT01080131|2657491|P1|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||8
1097843|NCT01080131|2657490|P2|COMPLETED|Extension Study 2 (25-72 Weeks)||54
1097844|NCT01080131|2657491|P1|COMPLETED|Extension Study 2 (25-72 Weeks)||64
1097845|NCT01080131|2657490|P2|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|41
1097846|NCT01080131|2657491|P1|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab at any time during the 72 weeks|62
1097847|NCT01080131|2657490|P2|STARTED|Extension Study 2 (25-72 Weeks)||65
1097848|NCT01080131|2657491|P1|STARTED|Extension Study 2 (25-72 Weeks)||72
1097849|NCT01080131|2657490|P2|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||4
1097850|NCT01080131|2657491|P1|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||6
1097851|NCT01080131|2657490|P2|COMPLETED|Extension Study 1 (12 -24 Weeks)||72
1097852|NCT01080131|2657491|P1|COMPLETED|Extension Study 1 (12 -24 Weeks)||78
1097853|NCT01080131|2657490|P2|STARTED|Extension Study 1 (12 -24 Weeks)||76
1097854|NCT01080131|2657491|P1|STARTED|Extension Study 1 (12 -24 Weeks)||84
1097855|NCT01080131|2657490|P2|NOT COMPLETED|Core Study (0- 12 Weeks)||11
1097856|NCT01080131|2657491|P1|NOT COMPLETED|Core Study (0- 12 Weeks)||13
1097857|NCT01080131|2657490|P2|COMPLETED|Core Study (0- 12 Weeks)||103
1097858|NCT01080131|2657491|P1|COMPLETED|Core Study (0- 12 Weeks)||99
1097859|NCT01080131|2657490|P2|STARTED|Core Study (0- 12 Weeks)||114
1097860|NCT01080131|2657491|P1|STARTED|Core Study (0- 12 Weeks)||112
1097861|NCT01080209|2657575|P7|NOT COMPLETED|Overall Study||7
1097862|NCT01080209|2657576|P6|NOT COMPLETED|Overall Study||0
1097863|NCT01080209|2657577|P5|NOT COMPLETED|Overall Study||0
1097864|NCT01080209|2657578|P4|NOT COMPLETED|Overall Study||5
1097865|NCT01080209|2657579|P3|NOT COMPLETED|Overall Study||5
1097866|NCT01080209|2657580|P2|NOT COMPLETED|Overall Study||11
1097867|NCT01080209|2657581|P1|NOT COMPLETED|Overall Study||6
1097868|NCT01080209|2657575|P7|COMPLETED|Overall Study||44
1097869|NCT01080209|2657576|P6|COMPLETED|Overall Study||2
1097870|NCT01080209|2657577|P5|COMPLETED|Overall Study||6
1097871|NCT01080209|2657578|P4|COMPLETED|Overall Study||37
1097872|NCT01080209|2657579|P3|COMPLETED|Overall Study||28
1097873|NCT01080209|2657580|P2|COMPLETED|Overall Study||42
1097874|NCT01080209|2657581|P1|COMPLETED|Overall Study||22
1097875|NCT01080209|2657575|P7|STARTED|Overall Study||51
1097876|NCT01080209|2657576|P6|STARTED|Overall Study||2
1097877|NCT01080209|2657577|P5|STARTED|Overall Study||6
1097878|NCT01080209|2657578|P4|STARTED|Overall Study||42
1097879|NCT01080209|2657579|P3|STARTED|Overall Study||33
1097880|NCT01080209|2657580|P2|STARTED|Overall Study||53
1097881|NCT01080209|2657581|P1|STARTED|Overall Study||28
1097882|NCT01080248|2657604|P1|NOT COMPLETED|Overall Study||0
1097883|NCT01080248|2657604|P1|COMPLETED|Overall Study||2
1097884|NCT01080248|2657604|P1|STARTED|Overall Study||2
1097885|NCT01080261|2657611|P1|NOT COMPLETED|Overall Study||0
1097886|NCT01080261|2657611|P1|COMPLETED|Overall Study||60
1097887|NCT01080261|2657611|P1|STARTED|Overall Study||60
1097888|NCT01080300|2657628|P2|NOT COMPLETED|Overall Study||104
1097889|NCT01080300|2657629|P1|NOT COMPLETED|Overall Study||94
1097890|NCT01080300|2657628|P2|COMPLETED|Overall Study||191
1097891|NCT01080300|2657629|P1|COMPLETED|Overall Study||206
1097892|NCT01080300|2657628|P2|STARTED|Overall Study|298 subjects were randomized, but only 295 received study treatment.|295
1097893|NCT01080300|2657629|P1|STARTED|Overall Study|302 subjects were randomized, but only 300 received study treatment.|300
1097894|NCT01080326|2657637|P1|NOT COMPLETED|Overall Study||4
1097895|NCT01080326|2657637|P1|COMPLETED|Overall Study||3
1097896|NCT01080326|2657637|P1|STARTED|Overall Study||7
1097897|NCT01080391|2657643|P2|NOT COMPLETED|Overall Study||13
1097898|NCT01080391|2657644|P1|NOT COMPLETED|Overall Study||23
1097899|NCT01080391|2657643|P2|COMPLETED|Overall Study|Participants are ongoing as of 16 June 2014 or who have died on study.|383
1097900|NCT01080391|2657644|P1|COMPLETED|Overall Study|Participants are ongoing as of 16 June 2014 or who have died on study.|373
1097901|NCT01080391|2657643|P2|Treated|Overall Study||392
1097902|NCT01080391|2657644|P1|Treated|Overall Study||389
1097903|NCT01080391|2657643|P2|STARTED|Overall Study||396
1097904|NCT01080391|2657644|P1|STARTED|Overall Study||396
1097905|NCT01080625|2657665|P3|NOT COMPLETED|Overall Study||1
1097906|NCT01080625|2657666|P2|NOT COMPLETED|Overall Study||2
1097907|NCT01080625|2657667|P1|NOT COMPLETED|Overall Study||0
1097908|NCT01080625|2657665|P3|COMPLETED|Overall Study||31
1097909|NCT01080625|2657666|P2|COMPLETED|Overall Study||31
1097910|NCT01080625|2657667|P1|COMPLETED|Overall Study||31
1097911|NCT01080625|2657665|P3|STARTED|Overall Study||32
1097912|NCT01080625|2657666|P2|STARTED|Overall Study||33
1097913|NCT01080625|2657667|P1|STARTED|Overall Study||31
1097914|NCT01080677|2657678|P3|NOT COMPLETED|Overall Study||0
1097915|NCT01080677|2657679|P2|NOT COMPLETED|Overall Study||0
1097916|NCT01080677|2657680|P1|NOT COMPLETED|Overall Study||0
1097917|NCT01080677|2657678|P3|COMPLETED|Overall Study||20
1097918|NCT01080677|2657679|P2|COMPLETED|Overall Study||20
1097919|NCT01080677|2657680|P1|COMPLETED|Overall Study||20
1097920|NCT01080677|2657678|P3|STARTED|Overall Study||20
1097921|NCT01080677|2657679|P2|STARTED|Overall Study||20
1097922|NCT01080677|2657680|P1|STARTED|Overall Study||20
1097923|NCT01080768|2657699|P2|NOT COMPLETED|Overall Study||1
1097924|NCT01080768|2657700|P1|NOT COMPLETED|Overall Study||2
1097925|NCT01080768|2657699|P2|COMPLETED|Overall Study||16
1097926|NCT01080768|2657700|P1|COMPLETED|Overall Study||12
1097927|NCT01080768|2657699|P2|STARTED|Overall Study||17
1097928|NCT01080768|2657700|P1|STARTED|Overall Study||14
1097929|NCT01080794|2657710|P4|NOT COMPLETED|Overall Study||2
1097930|NCT01080794|2657711|P3|NOT COMPLETED|Overall Study||2
1097931|NCT01080794|2657712|P2|NOT COMPLETED|Overall Study||2
1097932|NCT01080794|2657713|P1|NOT COMPLETED|Overall Study||5
1097933|NCT01080794|2657710|P4|COMPLETED|Overall Study||13
1097934|NCT01080794|2657711|P3|COMPLETED|Overall Study||10
1097935|NCT01080794|2657712|P2|COMPLETED|Overall Study||12
1097936|NCT01080794|2657713|P1|COMPLETED|Overall Study||15
1097937|NCT01080794|2657710|P4|STARTED|Overall Study||15
1097938|NCT01080794|2657711|P3|STARTED|Overall Study||12
1097939|NCT01080794|2657712|P2|STARTED|Overall Study||14
1097940|NCT01080794|2657713|P1|STARTED|Overall Study||20
1097941|NCT01080807|2657761|P2|NOT COMPLETED|Overall Study||23
1097942|NCT01080807|2657762|P1|NOT COMPLETED|Overall Study||35
1097943|NCT01080807|2657761|P2|COMPLETED|Overall Study||167
1097944|NCT01080807|2657762|P1|COMPLETED|Overall Study||158
1097945|NCT01080807|2657761|P2|STARTED|Overall Study|Three patients randomly assigned to the placebo treatment group did not receive study drug.|190
1097946|NCT01080807|2657762|P1|STARTED|Overall Study|Nine patients randomly assigned to the armodafinil treatment group did not receive study drug.|193
1097947|NCT01074931|2657816|P1|NOT COMPLETED|Overall Study||6
1097948|NCT01074931|2657816|P1|COMPLETED|Overall Study||92
1097949|NCT01074931|2657816|P1|STARTED|Overall Study||98
1097950|NCT01074944|2657828|P5|NOT COMPLETED|Extended Treatment (up to 42 Months)||5
1097951|NCT01074944|2657829|P4|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
1097952|NCT01074944|2657830|P3|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
1097953|NCT01074944|2657831|P2|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
1097954|NCT01074944|2657832|P1|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
1097955|NCT01074944|2657828|P5|COMPLETED|Extended Treatment (up to 42 Months)||20
1097956|NCT01074944|2657829|P4|COMPLETED|Extended Treatment (up to 42 Months)||0
1097957|NCT01074944|2657830|P3|COMPLETED|Extended Treatment (up to 42 Months)||0
1097958|NCT01074944|2657831|P2|COMPLETED|Extended Treatment (up to 42 Months)||0
1097959|NCT01074944|2657832|P1|COMPLETED|Extended Treatment (up to 42 Months)||0
1097960|NCT01074944|2657828|P5|STARTED|Extended Treatment (up to 42 Months)|Participants who were failed to meet the randomization criteria during the lead-in period.|25
1097961|NCT01074944|2657829|P4|STARTED|Extended Treatment (up to 42 Months)||0
1097962|NCT01074944|2657830|P3|STARTED|Extended Treatment (up to 42 Months)||0
1097963|NCT01074944|2657831|P2|STARTED|Extended Treatment (up to 42 Months)||0
1097964|NCT01074944|2657832|P1|STARTED|Extended Treatment (up to 42 Months)||0
1097965|NCT01074944|2657828|P5|NOT COMPLETED|Long Term Treatment||0
1097966|NCT01074944|2657829|P4|NOT COMPLETED|Long Term Treatment||26
1097967|NCT01074944|2657830|P3|NOT COMPLETED|Long Term Treatment||0
1097968|NCT01074944|2657831|P2|NOT COMPLETED|Long Term Treatment||0
1097969|NCT01074944|2657832|P1|NOT COMPLETED|Long Term Treatment||0
1097970|NCT01074944|2657828|P5|COMPLETED|Long Term Treatment||0
1097971|NCT01074944|2657829|P4|COMPLETED|Long Term Treatment||95
1097972|NCT01074944|2657830|P3|COMPLETED|Long Term Treatment||0
1097973|NCT01074944|2657831|P2|COMPLETED|Long Term Treatment||0
1097974|NCT01074944|2657832|P1|COMPLETED|Long Term Treatment||0
1097975|NCT01074944|2657828|P5|STARTED|Long Term Treatment||0
1097976|NCT01074944|2657829|P4|STARTED|Long Term Treatment|Participants who completed PAP (114) including those who considered as treatment failure in PAP (7).|121
1097977|NCT01074944|2657830|P3|STARTED|Long Term Treatment||0
1097978|NCT01074944|2657831|P2|STARTED|Long Term Treatment||0
1097979|NCT01074944|2657832|P1|STARTED|Long Term Treatment||0
1097980|NCT01074944|2657828|P5|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
1097981|NCT01074944|2657829|P4|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
1097982|NCT01074944|2657830|P3|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||6
1097983|NCT01074944|2657831|P2|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||11
1097984|NCT01074944|2657832|P1|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
1097985|NCT01074944|2657828|P5|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
1097986|NCT01074944|2657829|P4|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
1097987|NCT01074944|2657830|P3|COMPLETED|Primary Analysis Period (up to 52 Weeks)||60
1097988|NCT01074944|2657831|P2|COMPLETED|Primary Analysis Period (up to 52 Weeks)||54
1097989|NCT01074944|2657832|P1|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
1097990|NCT01074944|2657828|P5|STARTED|Primary Analysis Period (up to 52 Weeks)||0
1097991|NCT01074944|2657829|P4|STARTED|Primary Analysis Period (up to 52 Weeks)||0
1098075|NCT01081912|2658112|P1|NOT COMPLETED|Conversion/Titration||208
1097992|NCT01074944|2657830|P3|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|66
1097993|NCT01074944|2657831|P2|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|65
1097994|NCT01074944|2657832|P1|STARTED|Primary Analysis Period (up to 52 Weeks)||0
1097995|NCT01074944|2657828|P5|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
1097996|NCT01074944|2657829|P4|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
1097997|NCT01074944|2657830|P3|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
1097998|NCT01074944|2657831|P2|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
1097999|NCT01074944|2657832|P1|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||13
1098000|NCT01074944|2657828|P5|COMPLETED|Lead-in Period (up to 78 Weeks)||0
1098001|NCT01074944|2657829|P4|COMPLETED|Lead-in Period (up to 78 Weeks)||0
1098002|NCT01074944|2657830|P3|COMPLETED|Lead-in Period (up to 78 Weeks)||0
1098003|NCT01074944|2657831|P2|COMPLETED|Lead-in Period (up to 78 Weeks)||0
1098004|NCT01074944|2657832|P1|COMPLETED|Lead-in Period (up to 78 Weeks)||157
1098005|NCT01074944|2657828|P5|STARTED|Lead-in Period (up to 78 Weeks)||0
1098006|NCT01074944|2657829|P4|STARTED|Lead-in Period (up to 78 Weeks)||0
1098007|NCT01074944|2657830|P3|STARTED|Lead-in Period (up to 78 Weeks)||0
1098008|NCT01074944|2657831|P2|STARTED|Lead-in Period (up to 78 Weeks)||0
1098009|NCT01074944|2657832|P1|STARTED|Lead-in Period (up to 78 Weeks)|LIP conducted to assess randomization criteria of all participants in single reporting arm.|170
1098010|NCT01081041|2657889|P3|NOT COMPLETED|Overall Study||2
1098011|NCT01081041|2657890|P2|NOT COMPLETED|Overall Study||4
1098012|NCT01081041|2657891|P1|NOT COMPLETED|Overall Study||0
1098013|NCT01081041|2657889|P3|COMPLETED|Overall Study||71
1098014|NCT01081041|2657890|P2|COMPLETED|Overall Study||77
1098015|NCT01081041|2657891|P1|COMPLETED|Overall Study||33
1098016|NCT01081041|2657889|P3|Received at Least 1 Dose of Study Drug|Overall Study||71
1098017|NCT01081041|2657890|P2|Received at Least 1 Dose of Study Drug|Overall Study||77
1098018|NCT01081041|2657891|P1|Received at Least 1 Dose of Study Drug|Overall Study||33
1098019|NCT01081041|2657889|P3|STARTED|Overall Study||73
1098020|NCT01081041|2657890|P2|STARTED|Overall Study||81
1098021|NCT01081041|2657891|P1|STARTED|Overall Study||33
1098022|NCT01081132|2657921|P2|NOT COMPLETED|Overall Study||52
1098023|NCT01081132|2657922|P1|NOT COMPLETED|Overall Study||55
1098024|NCT01081132|2657921|P2|COMPLETED|Overall Study||105
1098025|NCT01081132|2657922|P1|COMPLETED|Overall Study||102
1098026|NCT01081132|2657921|P2|STARTED|Overall Study||157
1098027|NCT01081132|2657922|P1|STARTED|Overall Study||157
1098028|NCT01081145|2657960|P2|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||106
1098029|NCT01081145|2657961|P1|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||81
1098030|NCT01081145|2657960|P2|COMPLETED|Double-Blind Randomized-Withdrawal Phase||53
1098031|NCT01081145|2657961|P1|COMPLETED|Double-Blind Randomized-Withdrawal Phase||76
1098032|NCT01081145|2657960|P2|STARTED|Double-Blind Randomized-Withdrawal Phase||159
1098033|NCT01081145|2657961|P1|STARTED|Double-Blind Randomized-Withdrawal Phase||157
1098034|NCT01081145|2657960|P2|NOT COMPLETED|Open-Label Phase||0
1098035|NCT01081145|2657961|P1|NOT COMPLETED|Open-Label Phase||212
1098036|NCT01081145|2657960|P2|COMPLETED|Open-Label Phase||0
1098037|NCT01081145|2657961|P1|COMPLETED|Open-Label Phase||316
1098038|NCT01081145|2657960|P2|STARTED|Open-Label Phase||0
1098039|NCT01081145|2657961|P1|STARTED|Open-Label Phase||528
1098040|NCT01081249|2657987|P2|NOT COMPLETED|Overall Study||1
1098041|NCT01081249|2657988|P1|NOT COMPLETED|Overall Study||0
1098042|NCT01081249|2657987|P2|COMPLETED|Overall Study||6
1098043|NCT01081249|2657988|P1|COMPLETED|Overall Study||11
1098044|NCT01081249|2657987|P2|Second Psychotherapy Appointment (1 Day)|Overall Study||6
1098045|NCT01081249|2657988|P1|Second Psychotherapy Appointment (1 Day)|Overall Study||11
1098046|NCT01081249|2657987|P2|Washout (5-10 Days)|Overall Study||6
1098047|NCT01081249|2657988|P1|Washout (5-10 Days)|Overall Study||11
1098048|NCT01081249|2657987|P2|First Psychotherapy Appointment (1 Day)|Overall Study||6
1098049|NCT01081249|2657988|P1|First Psychotherapy Appointment (1 Day)|Overall Study||11
1098050|NCT01081249|2657987|P2|STARTED|Overall Study||7
1098051|NCT01081249|2657988|P1|STARTED|Overall Study||11
1098052|NCT01081301|2657994|P1|NOT COMPLETED|Overall Study||14
1098053|NCT01081301|2657994|P1|COMPLETED|Overall Study||22
1098054|NCT01081301|2657994|P1|STARTED|Overall Study||36
1098055|NCT01081873|2658032|P1|NOT COMPLETED|Overall Study||298
1098056|NCT01081873|2658032|P1|COMPLETED|Overall Study||2416
1098057|NCT01081873|2658032|P1|STARTED|Overall Study|3 patients were excluded from this and all analyses due to no available data from Baseline.|2714
1098058|NCT01081886|2658101|P2|NOT COMPLETED|Overall Study||13
1098059|NCT01081886|2658102|P1|NOT COMPLETED|Overall Study||11
1098060|NCT01081886|2658101|P2|COMPLETED|Overall Study||0
1098061|NCT01081886|2658102|P1|COMPLETED|Overall Study||0
1098062|NCT01081886|2658101|P2|STARTED|Overall Study||13
1098063|NCT01081886|2658102|P1|STARTED|Overall Study||11
1098064|NCT01081912|2658110|P3|NOT COMPLETED|Maintenance Treatment||92
1098065|NCT01081912|2658111|P2|NOT COMPLETED|Maintenance Treatment||27
1098066|NCT01081912|2658112|P1|NOT COMPLETED|Maintenance Treatment||0
1098067|NCT01081912|2658110|P3|COMPLETED|Maintenance Treatment||59
1098068|NCT01081912|2658111|P2|COMPLETED|Maintenance Treatment||124
1098069|NCT01081912|2658112|P1|COMPLETED|Maintenance Treatment||0
1098070|NCT01081912|2658110|P3|STARTED|Maintenance Treatment||151
1098071|NCT01081912|2658111|P2|STARTED|Maintenance Treatment||151
1098072|NCT01081912|2658112|P1|STARTED|Maintenance Treatment||0
1098073|NCT01081912|2658110|P3|NOT COMPLETED|Conversion/Titration||0
1098074|NCT01081912|2658111|P2|NOT COMPLETED|Conversion/Titration||0
1098076|NCT01081912|2658110|P3|COMPLETED|Conversion/Titration||0
1098077|NCT01081912|2658111|P2|COMPLETED|Conversion/Titration||0
1098078|NCT01081912|2658112|P1|COMPLETED|Conversion/Titration||302
1098079|NCT01081912|2658110|P3|STARTED|Conversion/Titration||0
1098080|NCT01081912|2658111|P2|STARTED|Conversion/Titration||0
1098081|NCT01081912|2658112|P1|STARTED|Conversion/Titration||510
1098082|NCT01081951|2658121|P2|NOT COMPLETED|Overall Study||55
1098083|NCT01081951|2658122|P1|NOT COMPLETED|Overall Study||56
1098084|NCT01081951|2658121|P2|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off), either on-treatment or in survival follow-up|26
1098085|NCT01081951|2658122|P1|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off),either on-treatment or in survival follow-up|25
1098086|NCT01081951|2658121|P2|Ongoing Study Treatment at Data Cut-off|Overall Study||0
1098087|NCT01081951|2658122|P1|Ongoing Study Treatment at Data Cut-off|Overall Study||11
1098088|NCT01081951|2658121|P2|Entered Maintenance Phase|Overall Study||55
1098089|NCT01081951|2658122|P1|Entered Maintenance Phase|Overall Study||66
1098090|NCT01081951|2658121|P2|Received Study Treatment|Overall Study||75
1098091|NCT01081951|2658122|P1|Received Study Treatment|Overall Study||81
1098092|NCT01081951|2658121|P2|STARTED|Overall Study||81
1098093|NCT01081951|2658122|P1|STARTED|Overall Study||81
1098094|NCT01082081|2658135|P3|NOT COMPLETED|Overall Study||2
1098095|NCT01082081|2658136|P2|NOT COMPLETED|Overall Study||1
1098096|NCT01082081|2658137|P1|NOT COMPLETED|Overall Study||0
1098097|NCT01082081|2658135|P3|COMPLETED|Overall Study||58
1098098|NCT01082081|2658136|P2|COMPLETED|Overall Study||118
1098099|NCT01082081|2658137|P1|COMPLETED|Overall Study||121
1098100|NCT01082081|2658135|P3|STARTED|Overall Study||60
1098101|NCT01082081|2658136|P2|STARTED|Overall Study||119
1098102|NCT01082081|2658137|P1|STARTED|Overall Study||121
1098103|NCT01082159|2658187|P1|NOT COMPLETED|Overall Study||9
1098104|NCT01082159|2658187|P1|COMPLETED|Overall Study||46
1098105|NCT01082159|2658187|P1|STARTED|Overall Study||55
1098106|NCT01082211|2658193|P1|NOT COMPLETED|Overall Study||7
1098107|NCT01082211|2658193|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
1098108|NCT01082211|2658193|P1|STARTED|Overall Study||65
1098109|NCT01082328|2658204|P1|NOT COMPLETED|Overall Study||1
1098110|NCT01082328|2658204|P1|COMPLETED|Overall Study||58
1098111|NCT01082328|2658204|P1|STARTED|Overall Study||59
1098112|NCT01082367|2658215|P2|NOT COMPLETED|Follow-up (F-U) Period||1
1098113|NCT01082367|2658216|P1|NOT COMPLETED|Follow-up (F-U) Period||2
1098114|NCT01082367|2658215|P2|COMPLETED|Follow-up (F-U) Period||9
1098115|NCT01082367|2658216|P1|COMPLETED|Follow-up (F-U) Period||17
1098116|NCT01082367|2658215|P2|Treated in F-U|Follow-up (F-U) Period||5
1098117|NCT01082367|2658216|P1|Treated in F-U|Follow-up (F-U) Period||5
1098118|NCT01082367|2658215|P2|STARTED|Follow-up (F-U) Period||10
1098119|NCT01082367|2658216|P1|STARTED|Follow-up (F-U) Period||19
1098120|NCT01082367|2658215|P2|NOT COMPLETED|Double-blind Period||13
1098121|NCT01082367|2658216|P1|NOT COMPLETED|Double-blind Period||5
1098122|NCT01082367|2658215|P2|COMPLETED|Double-blind Period||12
1098123|NCT01082367|2658216|P1|COMPLETED|Double-blind Period||21
1098124|NCT01082367|2658215|P2|Stage 4:no tx for Patients Not in co|Double-blind Period||0
1098125|NCT01082367|2658216|P1|Stage 4:no tx for Patients Not in co|Double-blind Period||0
1098126|NCT01082367|2658215|P2|Stage 3: Cross-over (co) tx|Double-blind Period||6
1098127|NCT01082367|2658216|P1|Stage 3: Cross-over (co) tx|Double-blind Period||13
1098128|NCT01082367|2658215|P2|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||0
1098129|NCT01082367|2658216|P1|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||9
1098130|NCT01082367|2658215|P2|Entered OL TOBI|Double-blind Period||18
1098131|NCT01082367|2658216|P1|Entered OL TOBI|Double-blind Period||4
1098132|NCT01082367|2658215|P2|Stage 2:no tx|Double-blind Period||0
1098133|NCT01082367|2658216|P1|Stage 2:no tx|Double-blind Period||0
1098134|NCT01082367|2658215|P2|Stage 1:1st Treatment (tx) Cycle|Double-blind Period|1 participant discontinued after cycle 1 due to an SAE|25
1098135|NCT01082367|2658216|P1|Stage 1:1st Treatment (tx) Cycle|Double-blind Period||26
1098136|NCT01082367|2658215|P2|STARTED|Double-blind Period||25
1098137|NCT01082367|2658216|P1|STARTED|Double-blind Period||26
1098138|NCT01082380|2658230|P1|NOT COMPLETED|Overall Study||0
1098139|NCT01082380|2658230|P1|COMPLETED|Overall Study||6
1098140|NCT01082380|2658230|P1|STARTED|Overall Study||6
1098141|NCT01082575|2658263|P1|NOT COMPLETED|Overall Study||0
1098142|NCT01082575|2658263|P1|COMPLETED|Overall Study||100
1098143|NCT01082575|2658263|P1|STARTED|Overall Study||100
1098144|NCT01082588|2658270|P2|NOT COMPLETED|Overall Study||5
1098145|NCT01082588|2658271|P1|NOT COMPLETED|Overall Study||6
1098146|NCT01082588|2658270|P2|COMPLETED|Overall Study||25
1098147|NCT01082588|2658271|P1|COMPLETED|Overall Study||24
1098148|NCT01082588|2658270|P2|STARTED|Overall Study||30
1098149|NCT01082588|2658271|P1|STARTED|Overall Study||30
1098150|NCT01082614|2658291|P2|NOT COMPLETED|Overall Study||5
1098151|NCT01082614|2658292|P1|NOT COMPLETED|Overall Study||3
1098152|NCT01082614|2658291|P2|COMPLETED|Overall Study||18
1098153|NCT01082614|2658292|P1|COMPLETED|Overall Study||20
1098154|NCT01082614|2658291|P2|STARTED|Overall Study||23
1098155|NCT01082614|2658292|P1|STARTED|Overall Study||23
1098156|NCT01082640|2658301|P3|NOT COMPLETED|Overall Study||8
1098157|NCT01082640|2658302|P2|NOT COMPLETED|Overall Study||15
1098158|NCT01082640|2658303|P1|NOT COMPLETED|Overall Study||17
1098159|NCT01082640|2658301|P3|COMPLETED|Overall Study||24
1098160|NCT01082640|2658302|P2|COMPLETED|Overall Study||17
1098161|NCT01082640|2658303|P1|COMPLETED|Overall Study||15
1098162|NCT01082640|2658301|P3|STARTED|Overall Study||32
1098163|NCT01082640|2658302|P2|STARTED|Overall Study||32
1098164|NCT01082640|2658303|P1|STARTED|Overall Study||32
1098165|NCT01082874|2658327|P4|NOT COMPLETED|Overall Study||13
1098166|NCT01082874|2658328|P3|NOT COMPLETED|Overall Study||11
1098167|NCT01082874|2658329|P2|NOT COMPLETED|Overall Study||12
1098168|NCT01082874|2658330|P1|NOT COMPLETED|Overall Study||11
1098169|NCT01082874|2658327|P4|COMPLETED|Overall Study||2489
1098170|NCT01082874|2658328|P3|COMPLETED|Overall Study||2488
1098171|NCT01082874|2658329|P2|COMPLETED|Overall Study||2498
1098172|NCT01082874|2658330|P1|COMPLETED|Overall Study||2488
1098173|NCT01082874|2658327|P4|STARTED|Overall Study||2502
1098174|NCT01082874|2658328|P3|STARTED|Overall Study||2499
1098175|NCT01082874|2658329|P2|STARTED|Overall Study||2510
1098176|NCT01082874|2658330|P1|STARTED|Overall Study||2499
1098177|NCT01082939|2658340|P1|NOT COMPLETED|Overall Study||0
1098178|NCT01082939|2658340|P1|COMPLETED|Overall Study||80
1098179|NCT01082939|2658340|P1|STARTED|Overall Study||80
1098180|NCT01082952|2658346|P2|NOT COMPLETED|Overall Study||0
1098181|NCT01082952|2658347|P1|NOT COMPLETED|Overall Study||0
1098182|NCT01082952|2658346|P2|COMPLETED|Overall Study||6
1098183|NCT01082952|2658347|P1|COMPLETED|Overall Study||6
1098184|NCT01082952|2658346|P2|STARTED|Overall Study||6
1098185|NCT01082952|2658347|P1|STARTED|Overall Study||6
1098186|NCT01082965|2658357|P2|NOT COMPLETED|Overall Study||2
1098187|NCT01082965|2658358|P1|NOT COMPLETED|Overall Study||1
1098188|NCT01082965|2658357|P2|COMPLETED|Overall Study||6
1098189|NCT01082965|2658358|P1|COMPLETED|Overall Study||9
1098190|NCT01082965|2658357|P2|STARTED|Overall Study||8
1098191|NCT01082965|2658358|P1|STARTED|Overall Study||10
1098192|NCT01083121|2658376|P1|NOT COMPLETED|Overall Study||81
1098193|NCT01083121|2658376|P1|COMPLETED|Overall Study|Participants included in the analysis|1698
1098194|NCT01083121|2658376|P1|STARTED|Overall Study|Participants who were enrolled in the study|1779
1098195|NCT01083160|2658384|P1|NOT COMPLETED|Overall Study||1
1098196|NCT01083160|2658384|P1|COMPLETED|Overall Study||81
1098197|NCT01083160|2658384|P1|Evaluable Population|Overall Study||71
1098198|NCT01083160|2658384|P1|STARTED|Overall Study||82
1098199|NCT01083173|2658391|P2|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||377
1098200|NCT01083173|2658392|P1|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||0
1098201|NCT01083173|2658391|P2|COMPLETED|Long-term Surveillance: Effectiveness Gr||102
1098202|NCT01083173|2658392|P1|COMPLETED|Long-term Surveillance: Effectiveness Gr||0
1098203|NCT01083173|2658391|P2|STARTED|Long-term Surveillance: Effectiveness Gr||479
1098204|NCT01083173|2658392|P1|STARTED|Long-term Surveillance: Effectiveness Gr||0
1098205|NCT01083173|2658391|P2|NOT COMPLETED|Long-term Surveillance: Safety Group||116
1098206|NCT01083173|2658392|P1|NOT COMPLETED|Long-term Surveillance: Safety Group||0
1098207|NCT01083173|2658391|P2|COMPLETED|Long-term Surveillance: Safety Group||479
1098208|NCT01083173|2658392|P1|COMPLETED|Long-term Surveillance: Safety Group||0
1098209|NCT01083173|2658391|P2|STARTED|Long-term Surveillance: Safety Group||595
1098210|NCT01083173|2658392|P1|STARTED|Long-term Surveillance: Safety Group||0
1098211|NCT01083173|2658391|P2|NOT COMPLETED|Main Surveillance: Effectiveness Group||0
1098212|NCT01083173|2658392|P1|NOT COMPLETED|Main Surveillance: Effectiveness Group||382
1098213|NCT01083173|2658391|P2|COMPLETED|Main Surveillance: Effectiveness Group||0
1098214|NCT01083173|2658392|P1|COMPLETED|Main Surveillance: Effectiveness Group||198
1098215|NCT01083173|2658391|P2|STARTED|Main Surveillance: Effectiveness Group||0
1098216|NCT01083173|2658392|P1|STARTED|Main Surveillance: Effectiveness Group||580
1098217|NCT01083173|2658391|P2|NOT COMPLETED|Main Surveillance: Safety Group||0
1098218|NCT01083173|2658392|P1|NOT COMPLETED|Main Surveillance: Safety Group||15
1098219|NCT01083173|2658391|P2|COMPLETED|Main Surveillance: Safety Group||0
1098220|NCT01083173|2658392|P1|COMPLETED|Main Surveillance: Safety Group||580
1098221|NCT01083173|2658391|P2|STARTED|Main Surveillance: Safety Group||0
1098222|NCT01083173|2658392|P1|STARTED|Main Surveillance: Safety Group||595
1098223|NCT01083186|2658410|P1|NOT COMPLETED|Overall Study||94
1098224|NCT01083186|2658410|P1|COMPLETED|Overall Study||406
1098225|NCT01083186|2658410|P1|STARTED|Overall Study||500
1098226|NCT01083199|2658451|P1|NOT COMPLETED|Overall Study||0
1098227|NCT01083199|2658451|P1|COMPLETED|Overall Study||10
1098228|NCT01083199|2658451|P1|STARTED|Overall Study||10
1098229|NCT01083316|2658456|P1|NOT COMPLETED|Overall Study||3
1098230|NCT01083316|2658456|P1|COMPLETED|Overall Study||32
1098231|NCT01083316|2658456|P1|STARTED|Overall Study||35
1098232|NCT01083472|2658464|P2|NOT COMPLETED|Overall Study||0
1098233|NCT01083472|2658465|P1|NOT COMPLETED|Overall Study||0
1098234|NCT01083472|2658464|P2|COMPLETED|Overall Study||19
1098235|NCT01083472|2658465|P1|COMPLETED|Overall Study||18
1098236|NCT01083472|2658464|P2|STARTED|Overall Study||19
1098237|NCT01083472|2658465|P1|STARTED|Overall Study||18
1098238|NCT01083485|2658473|P2|NOT COMPLETED|Overall Study||3
1098239|NCT01083485|2658474|P1|NOT COMPLETED|Overall Study||7
1098240|NCT01083485|2658473|P2|COMPLETED|Overall Study||64
1098241|NCT01083485|2658474|P1|COMPLETED|Overall Study||63
1098242|NCT01083485|2658473|P2|STARTED|Overall Study||67
1098243|NCT01083485|2658474|P1|STARTED|Overall Study||70
1098244|NCT01083576|2658484|P2|NOT COMPLETED|Overall Study||1
1098245|NCT01083576|2658485|P1|NOT COMPLETED|Overall Study||6
1098246|NCT01083576|2658484|P2|COMPLETED|Overall Study||14
1098247|NCT01083576|2658485|P1|COMPLETED|Overall Study||9
1098248|NCT01083576|2658484|P2|STARTED|Overall Study||15
1098249|NCT01083576|2658485|P1|STARTED|Overall Study||15
1098250|NCT01083602|2658513|P1|NOT COMPLETED|Overall Study||55
1098251|NCT01083602|2658513|P1|COMPLETED|Overall Study||0
1098252|NCT01083602|2658513|P1|STARTED|Overall Study||55
1098253|NCT01083641|2658522|P1|NOT COMPLETED|Overall Study||2
1098254|NCT01083641|2658522|P1|COMPLETED|Overall Study||15
1098255|NCT01083641|2658522|P1|STARTED|Overall Study||17
1098256|NCT01083654|2658531|P2|NOT COMPLETED|Overall Study||0
1098257|NCT01083654|2658532|P1|NOT COMPLETED|Overall Study||0
1098258|NCT01083654|2658531|P2|COMPLETED|Overall Study||50
1098259|NCT01083654|2658532|P1|COMPLETED|Overall Study||53
1098260|NCT01083654|2658531|P2|STARTED|Overall Study||50
1098261|NCT01083654|2658532|P1|STARTED|Overall Study||53
1098262|NCT01083667|2658538|P1|NOT COMPLETED|Overall Study||10
1098263|NCT01083667|2658538|P1|COMPLETED|Overall Study|22 completed to visit 9, the last visit on study.|22
1098264|NCT01083667|2658538|P1|STARTED|Overall Study|enrolled|32
1098265|NCT01083680|2658543|P1|NOT COMPLETED|Overall Study||3844
1098266|NCT01083680|2658543|P1|COMPLETED|Overall Study||263
1098267|NCT01083680|2658543|P1|Full Analysis Set (FAS), Efficacy|Overall Study||1621
1098268|NCT01083680|2658543|P1|STARTED|Overall Study||4107
1098269|NCT01083693|2658555|P3|NOT COMPLETED|Overall Study||7
1098270|NCT01083693|2658556|P2|NOT COMPLETED|Overall Study||6
1098271|NCT01083693|2658557|P1|NOT COMPLETED|Overall Study||20
1098272|NCT01083693|2658555|P3|COMPLETED|Overall Study||33
1098273|NCT01083693|2658556|P2|COMPLETED|Overall Study||22
1098274|NCT01083693|2658557|P1|COMPLETED|Overall Study||73
1098275|NCT01083693|2658555|P3|STARTED|Overall Study||40
1098276|NCT01083693|2658556|P2|STARTED|Overall Study||28
1098277|NCT01083693|2658557|P1|STARTED|Overall Study||93
1098278|NCT01083706|2658592|P1|NOT COMPLETED|Overall Study||0
1098279|NCT01083706|2658592|P1|COMPLETED|Overall Study||39
1098280|NCT01083706|2658592|P1|STARTED|Overall Study||39
1098281|NCT01083732|2658601|P3|NOT COMPLETED|Overall Study||0
1098282|NCT01083732|2658602|P2|NOT COMPLETED|Overall Study||0
1098283|NCT01083732|2658603|P1|NOT COMPLETED|Overall Study||0
1098284|NCT01083732|2658601|P3|COMPLETED|Overall Study||3
1098285|NCT01083732|2658602|P2|COMPLETED|Overall Study||9
1098286|NCT01083732|2658603|P1|COMPLETED|Overall Study||6
1098287|NCT01083732|2658601|P3|STARTED|Overall Study||3
1098288|NCT01083732|2658602|P2|STARTED|Overall Study||9
1098289|NCT01083732|2658603|P1|STARTED|Overall Study||6
1098290|NCT01083758|2658654|P1|NOT COMPLETED|Overall Study||2
1098291|NCT01083758|2658654|P1|COMPLETED|Overall Study||29
1098292|NCT01083758|2658654|P1|STARTED|Overall Study||31
1098293|NCT01083771|2658685|P1|NOT COMPLETED|Overall Study||5
1098294|NCT01083771|2658685|P1|COMPLETED|Overall Study||16
1098295|NCT01083771|2658685|P1|STARTED|Overall Study||21
1098296|NCT01083810|2658693|P3|NOT COMPLETED|Overall Study||20
1098297|NCT01083810|2658694|P2|NOT COMPLETED|Overall Study||45
1098298|NCT01083810|2658695|P1|NOT COMPLETED|Overall Study||65
1098299|NCT01083810|2658693|P3|COMPLETED|Overall Study||35
1098300|NCT01083810|2658694|P2|COMPLETED|Overall Study||47
1098301|NCT01083810|2658695|P1|COMPLETED|Overall Study||72
1098302|NCT01083810|2658693|P3|STARTED|Overall Study||55
1098303|NCT01083810|2658694|P2|STARTED|Overall Study||92
1098304|NCT01083810|2658695|P1|STARTED|Overall Study||137
1098305|NCT01083849|2658718|P2|NOT COMPLETED|Overall Study||111
1098306|NCT01083849|2658719|P1|NOT COMPLETED|Overall Study||60
1098307|NCT01083849|2658718|P2|COMPLETED|Overall Study||527
1098308|NCT01083849|2658719|P1|COMPLETED|Overall Study||61
1098309|NCT01083849|2658718|P2|STARTED|Overall Study||638
1098310|NCT01083849|2658719|P1|STARTED|Overall Study||121
1098311|NCT01083901|2658742|P3|NOT COMPLETED|Overall Study||2
1098312|NCT01083901|2658743|P2|NOT COMPLETED|Overall Study||2
1098313|NCT01083901|2658744|P1|NOT COMPLETED|Overall Study||1
1098314|NCT01083901|2658742|P3|COMPLETED|Overall Study||11
1098315|NCT01083901|2658743|P2|COMPLETED|Overall Study||6
1098316|NCT01083901|2658744|P1|COMPLETED|Overall Study||12
1098317|NCT01083901|2658742|P3|STARTED|Overall Study||13
1098318|NCT01083901|2658743|P2|STARTED|Overall Study||8
1098319|NCT01083901|2658744|P1|STARTED|Overall Study||13
1098320|NCT01083979|2658761|P1|NOT COMPLETED|Overall Study||0
1098321|NCT01083979|2658761|P1|COMPLETED|Overall Study||1
1098322|NCT01083979|2658761|P1|STARTED|Overall Study||1
1098323|NCT01084005|2658768|P2|NOT COMPLETED|Overall Study||16
1098324|NCT01084005|2658769|P1|NOT COMPLETED|Overall Study||5
1098325|NCT01084005|2658768|P2|COMPLETED|Overall Study||146
1098326|NCT01084005|2658769|P1|COMPLETED|Overall Study||74
1098327|NCT01084005|2658768|P2|STARTED|Overall Study||162
1098328|NCT01084005|2658769|P1|STARTED|Overall Study||79
1098329|NCT01084083|2658797|P1|NOT COMPLETED|Overall Study||12
1098330|NCT01084083|2658797|P1|COMPLETED|Overall Study||78
1098331|NCT01084083|2658797|P1|CR and Treated With 5400 cGy IMRT|Overall Study|This is the primary study population for the primary endpoint (24-month PFS).|44
1098332|NCT01084083|2658797|P1|CR to Induction Therapy|Overall Study||56
1098333|NCT01084083|2658797|P1|Eligible and Treated|Overall Study|This is the eligible and treated patients for secondary efficacy endpoints|80
1098334|NCT01084083|2658797|P1|Eligible|Overall Study||81
1098335|NCT01084083|2658797|P1|Treated|Overall Study|This is the all treated patients for toxicity analysis|89
1098336|NCT01084083|2658797|P1|STARTED|Overall Study||90
1098337|NCT01084135|2658807|P2|NOT COMPLETED|20 Week||1
1098338|NCT01084135|2658808|P1|NOT COMPLETED|20 Week||0
1098339|NCT01084135|2658807|P2|COMPLETED|20 Week||10
1098340|NCT01084135|2658808|P1|COMPLETED|20 Week||12
1098341|NCT01084135|2658807|P2|STARTED|20 Week||11
1098342|NCT01084135|2658808|P1|STARTED|20 Week||12
1098343|NCT01084135|2658807|P2|NOT COMPLETED|12 Week||0
1098344|NCT01084135|2658808|P1|NOT COMPLETED|12 Week||0
1098345|NCT01084135|2658807|P2|COMPLETED|12 Week||4
1098346|NCT01084135|2658808|P1|COMPLETED|12 Week||4
1098347|NCT01084135|2658807|P2|STARTED|12 Week||4
1098348|NCT01084135|2658808|P1|STARTED|12 Week||4
1098349|NCT01084148|2658820|P2|NOT COMPLETED|Overall Study||16
1098350|NCT01084148|2658821|P1|NOT COMPLETED|Overall Study||30
1098351|NCT01084148|2658820|P2|COMPLETED|Overall Study||102
1098352|NCT01084148|2658821|P1|COMPLETED|Overall Study||88
1098353|NCT01084148|2658820|P2|STARTED|Overall Study|Among those 118 patients randomized into V0034 CR 01B vehicle arm, one patient not treated.|118
1098354|NCT01084148|2658821|P1|STARTED|Overall Study||118
1098355|NCT01084174|2658829|P2|NOT COMPLETED|Overall Study||4
1098356|NCT01084174|2658830|P1|NOT COMPLETED|Overall Study||1
1098357|NCT01084174|2658829|P2|COMPLETED|Overall Study||7
1098358|NCT01084174|2658830|P1|COMPLETED|Overall Study||9
1098359|NCT01084174|2658829|P2|STARTED|Overall Study||11
1098360|NCT01084174|2658830|P1|STARTED|Overall Study||10
1098361|NCT01084239|2658850|P2|NOT COMPLETED|28-Day Follow-up||9
1098362|NCT01084239|2658851|P1|NOT COMPLETED|28-Day Follow-up||4
1098363|NCT01084239|2658850|P2|COMPLETED|28-Day Follow-up||490
1098364|NCT01084239|2658851|P1|COMPLETED|28-Day Follow-up||497
1098365|NCT01084239|2658850|P2|STARTED|28-Day Follow-up||499
1098366|NCT01084239|2658851|P1|STARTED|28-Day Follow-up|All 501 patients enrolled were evaluated for follow-up at 28 days.|501
1098367|NCT01084239|2658850|P2|NOT COMPLETED|Randomization - Index Hospitalization||0
1098368|NCT01084239|2658851|P1|NOT COMPLETED|Randomization - Index Hospitalization||0
1098369|NCT01084239|2658850|P2|COMPLETED|Randomization - Index Hospitalization||499
1098370|NCT01084239|2658851|P1|COMPLETED|Randomization - Index Hospitalization||501
1098371|NCT01084239|2658850|P2|STARTED|Randomization - Index Hospitalization||499
1098372|NCT01084239|2658851|P1|STARTED|Randomization - Index Hospitalization||501
1098373|NCT01084265|2658867|P1|NOT COMPLETED|Overall Study||0
1098374|NCT01084265|2658867|P1|COMPLETED|Overall Study||31
1098375|NCT01084265|2658867|P1|STARTED|Overall Study||31
1098391|NCT01077921|2658971|P2|NOT COMPLETED|Second Intervention||1
1098392|NCT01077921|2658972|P1|NOT COMPLETED|Second Intervention||0
1098393|NCT01077921|2658971|P2|COMPLETED|Second Intervention||9
1098394|NCT01077921|2658972|P1|COMPLETED|Second Intervention||13
1098395|NCT01077921|2658971|P2|STARTED|Second Intervention||10
1098396|NCT01077921|2658972|P1|STARTED|Second Intervention||13
1098397|NCT01077921|2658971|P2|NOT COMPLETED|Washout||2
1098398|NCT01077921|2658972|P1|NOT COMPLETED|Washout||0
1098399|NCT01077921|2658971|P2|COMPLETED|Washout||10
1098400|NCT01077921|2658972|P1|COMPLETED|Washout||13
1098401|NCT01077921|2658971|P2|STARTED|Washout||12
1098402|NCT01077921|2658972|P1|STARTED|Washout||13
1098403|NCT01077921|2658971|P2|NOT COMPLETED|First Intervention||1
1098404|NCT01077921|2658972|P1|NOT COMPLETED|First Intervention||1
1098405|NCT01077921|2658971|P2|COMPLETED|First Intervention||12
1098406|NCT01077921|2658972|P1|COMPLETED|First Intervention||13
1098407|NCT01077921|2658971|P2|STARTED|First Intervention||13
1098408|NCT01077921|2658972|P1|STARTED|First Intervention||14
1098409|NCT01077960|2659002|P1|NOT COMPLETED|Overall Study||16
1098410|NCT01077960|2659002|P1|COMPLETED|Overall Study|Modified Intent To Treat (ITT) Population|110
1098411|NCT01077960|2659002|P1|STARTED|Overall Study|130 subjects consented to participate, 129 enrolled in the study, and 126 received study drug|126
1098412|NCT01077973|2659014|P3|NOT COMPLETED|Overall Study||0
1098413|NCT01077973|2659015|P2|NOT COMPLETED|Overall Study||0
1098414|NCT01077973|2659016|P1|NOT COMPLETED|Overall Study||0
1098415|NCT01077973|2659014|P3|COMPLETED|Overall Study||80
1098416|NCT01077973|2659015|P2|COMPLETED|Overall Study||79
1098417|NCT01077973|2659016|P1|COMPLETED|Overall Study||41
1098418|NCT01077973|2659014|P3|STARTED|Overall Study||80
1098419|NCT01077973|2659015|P2|STARTED|Overall Study||79
1098420|NCT01077973|2659016|P1|STARTED|Overall Study||41
1098421|NCT01078090|2659064|P1|NOT COMPLETED|Overall Study||4593
1098422|NCT01078090|2659064|P1|COMPLETED|Overall Study||1152
1098423|NCT01078090|2659064|P1|STARTED|Overall Study||5745
1098424|NCT01078116|2659105|P1|NOT COMPLETED|Overall Study||48
1098425|NCT01078116|2659105|P1|COMPLETED|Overall Study||76
1098426|NCT01078116|2659105|P1|STARTED|Overall Study|121 participants were included in analysis (3 were excluded due to missing case report form data).|124
1098427|NCT01078155|2659113|P1|NOT COMPLETED|Overall Study||44
1098428|NCT01078155|2659113|P1|COMPLETED|Overall Study||87
1098429|NCT01078155|2659113|P1|STARTED|Overall Study||131
1098430|NCT01078207|2659129|P1|NOT COMPLETED|Overall Study||0
1098431|NCT01078207|2659129|P1|COMPLETED|Overall Study||100
1098432|NCT01078207|2659129|P1|STARTED|Overall Study||100
1098433|NCT01078220|2659134|P1|NOT COMPLETED|Overall Study||0
1098434|NCT01078220|2659134|P1|COMPLETED|Overall Study||189629
1098435|NCT01078220|2659134|P1|STARTED|Overall Study||189629
1098436|NCT01078233|2659150|P6|NOT COMPLETED|Overall Study||0
1098437|NCT01078233|2659151|P5|NOT COMPLETED|Overall Study||0
1098438|NCT01078233|2659152|P4|NOT COMPLETED|Overall Study||0
1098439|NCT01078233|2659153|P3|NOT COMPLETED|Overall Study||0
1098440|NCT01078233|2659154|P2|NOT COMPLETED|Overall Study||0
1098441|NCT01078233|2659155|P1|NOT COMPLETED|Overall Study||0
1098442|NCT01078233|2659150|P6|COMPLETED|Overall Study||154
1098443|NCT01078233|2659151|P5|COMPLETED|Overall Study||3199
1098444|NCT01078233|2659152|P4|COMPLETED|Overall Study||631
1098445|NCT01078233|2659153|P3|COMPLETED|Overall Study||1681
1098446|NCT01078233|2659154|P2|COMPLETED|Overall Study||296
1098447|NCT01078233|2659155|P1|COMPLETED|Overall Study||656
1098448|NCT01078233|2659150|P6|STARTED|Overall Study||154
1098449|NCT01078233|2659151|P5|STARTED|Overall Study||3199
1098450|NCT01078233|2659152|P4|STARTED|Overall Study||631
1098451|NCT01078233|2659153|P3|STARTED|Overall Study||1681
1098452|NCT01078233|2659154|P2|STARTED|Overall Study||296
1098453|NCT01078233|2659155|P1|STARTED|Overall Study||656
1098454|NCT01078246|2659179|P7|NOT COMPLETED|Overall Study||0
1098455|NCT01078246|2659180|P6|NOT COMPLETED|Overall Study||0
1098456|NCT01078246|2659181|P5|NOT COMPLETED|Overall Study||0
1098457|NCT01078246|2659182|P4|NOT COMPLETED|Overall Study||0
1098458|NCT01078246|2659183|P3|NOT COMPLETED|Overall Study||0
1098459|NCT01078246|2659184|P2|NOT COMPLETED|Overall Study||0
1098460|NCT01078246|2659185|P1|NOT COMPLETED|Overall Study||0
1098461|NCT01078246|2659179|P7|COMPLETED|Overall Study||22
1098462|NCT01078246|2659180|P6|COMPLETED|Overall Study||231
1098463|NCT01078246|2659181|P5|COMPLETED|Overall Study||3310
1098464|NCT01078246|2659182|P4|COMPLETED|Overall Study||152
1098465|NCT01078246|2659183|P3|COMPLETED|Overall Study||1963
1098466|NCT01078246|2659184|P2|COMPLETED|Overall Study||405
1098467|NCT01078246|2659185|P1|COMPLETED|Overall Study||1041
1098468|NCT01078246|2659179|P7|STARTED|Overall Study||22
1098469|NCT01078246|2659180|P6|STARTED|Overall Study||231
1098470|NCT01078246|2659181|P5|STARTED|Overall Study||3310
1098471|NCT01078246|2659182|P4|STARTED|Overall Study||152
1098472|NCT01078246|2659183|P3|STARTED|Overall Study||1963
1098473|NCT01078246|2659184|P2|STARTED|Overall Study||405
1098474|NCT01078246|2659185|P1|STARTED|Overall Study||1041
1098475|NCT01078298|2659213|P2|NOT COMPLETED|Overall Study||90
1098476|NCT01078298|2659214|P1|NOT COMPLETED|Overall Study||81
1098477|NCT01078298|2659213|P2|COMPLETED|Overall Study||179
1098478|NCT01078298|2659214|P1|COMPLETED|Overall Study||175
1098479|NCT01078298|2659213|P2|STARTED|Overall Study||269
1098480|NCT01078298|2659214|P1|STARTED|Overall Study||256
1098481|NCT01078363|2659242|P2|NOT COMPLETED|Overall Study||0
1098482|NCT01078363|2659243|P1|NOT COMPLETED|Overall Study||0
1098483|NCT01078363|2659242|P2|COMPLETED|Overall Study||49
1098484|NCT01078363|2659243|P1|COMPLETED|Overall Study||47
1098485|NCT01078363|2659242|P2|STARTED|Overall Study||49
1098486|NCT01078363|2659243|P1|STARTED|Overall Study||47
1098487|NCT01078376|2659263|P4|NOT COMPLETED|Overall Study||0
1098488|NCT01078376|2659264|P3|NOT COMPLETED|Overall Study||0
1098489|NCT01078376|2659265|P2|NOT COMPLETED|Overall Study||0
1098490|NCT01078376|2659266|P1|NOT COMPLETED|Overall Study||0
1098491|NCT01078376|2659263|P4|COMPLETED|Overall Study||3
1098492|NCT01078376|2659264|P3|COMPLETED|Overall Study||8
1098493|NCT01078376|2659265|P2|COMPLETED|Overall Study||9
1098494|NCT01078376|2659266|P1|COMPLETED|Overall Study||9
1098495|NCT01078376|2659263|P4|STARTED|Overall Study||3
1098496|NCT01078376|2659264|P3|STARTED|Overall Study||8
1098497|NCT01078376|2659265|P2|STARTED|Overall Study||9
1098498|NCT01078376|2659266|P1|STARTED|Overall Study||9
1098499|NCT01078389|2659387|P2|NOT COMPLETED|Overall Study||67
1098500|NCT01078389|2659388|P1|NOT COMPLETED|Overall Study||64
1098501|NCT01078389|2659387|P2|COMPLETED|Overall Study||90
1098502|NCT01078389|2659388|P1|COMPLETED|Overall Study||93
1098503|NCT01078389|2659387|P2|STARTED|Overall Study||157
1098504|NCT01078389|2659388|P1|STARTED|Overall Study||157
1098505|NCT01078402|2659405|P3|NOT COMPLETED|Overall Study||68
1098506|NCT01078402|2659406|P2|NOT COMPLETED|Overall Study||29
1098507|NCT01078402|2659407|P1|NOT COMPLETED|Overall Study||107
1098508|NCT01078402|2659405|P3|COMPLETED|Overall Study||166
1098509|NCT01078402|2659406|P2|COMPLETED|Overall Study||95
1098510|NCT01078402|2659407|P1|COMPLETED|Overall Study||324
1098511|NCT01078402|2659405|P3|STARTED|Overall Study||234
1098512|NCT01078402|2659406|P2|STARTED|Overall Study||124
1098513|NCT01078402|2659407|P1|STARTED|Overall Study||431
1098514|NCT01084538|2659436|P1|NOT COMPLETED|Overall Study||68
1098515|NCT01084538|2659436|P1|COMPLETED|Overall Study||113
1098516|NCT01084538|2659436|P1|STARTED|Overall Study||181
1098517|NCT01084551|2659446|P3|NOT COMPLETED|Overall Study||8
1098518|NCT01084551|2659447|P2|NOT COMPLETED|Overall Study||14
1098519|NCT01084551|2659448|P1|NOT COMPLETED|Overall Study||9
1098520|NCT01084551|2659446|P3|COMPLETED|Overall Study||86
1098521|NCT01084551|2659447|P2|COMPLETED|Overall Study||81
1098522|NCT01084551|2659448|P1|COMPLETED|Overall Study||86
1098523|NCT01084551|2659446|P3|STARTED|Overall Study||94
1098524|NCT01084551|2659447|P2|STARTED|Overall Study||95
1098525|NCT01084551|2659448|P1|STARTED|Overall Study||95
1098526|NCT01084603|2659486|P1|NOT COMPLETED|Oral Nicotine 4||0
1098527|NCT01084603|2659486|P1|COMPLETED|Oral Nicotine 4||39
1098528|NCT01084603|2659486|P1|STARTED|Oral Nicotine 4||39
1098529|NCT01084603|2659486|P1|NOT COMPLETED|Washout Period 4||1
1098530|NCT01084603|2659486|P1|COMPLETED|Washout Period 4||39
1098531|NCT01084603|2659486|P1|STARTED|Washout Period 4||40
1098532|NCT01084603|2659486|P1|NOT COMPLETED|Oral Nicotine 2||0
1098533|NCT01084603|2659486|P1|COMPLETED|Oral Nicotine 2||40
1098534|NCT01084603|2659486|P1|STARTED|Oral Nicotine 2||40
1098535|NCT01084603|2659486|P1|NOT COMPLETED|Washout Period 3||0
1098536|NCT01084603|2659486|P1|COMPLETED|Washout Period 3||40
1098537|NCT01084603|2659486|P1|STARTED|Washout Period 3||40
1098538|NCT01084603|2659486|P1|NOT COMPLETED|Oral Nicotine 1||1
1098539|NCT01084603|2659486|P1|COMPLETED|Oral Nicotine 1||40
1098540|NCT01084603|2659486|P1|STARTED|Oral Nicotine 1||41
1098541|NCT01084603|2659486|P1|NOT COMPLETED|Washout Period 2||0
1098542|NCT01084603|2659486|P1|COMPLETED|Washout Period 2||41
1098543|NCT01084603|2659486|P1|STARTED|Washout Period 2||41
1098544|NCT01084603|2659486|P1|NOT COMPLETED|Nicorette® Gum||1
1098545|NCT01084603|2659486|P1|COMPLETED|Nicorette® Gum||41
1098546|NCT01084603|2659486|P1|STARTED|Nicorette® Gum||42
1098547|NCT01084603|2659486|P1|NOT COMPLETED|Washout Period 1||0
1098548|NCT01084603|2659486|P1|COMPLETED|Washout Period 1||42
1098549|NCT01084603|2659486|P1|STARTED|Washout Period 1||42
1098550|NCT01084603|2659486|P1|NOT COMPLETED|NiQuitinTM Lozenge||1
1098551|NCT01084603|2659486|P1|COMPLETED|NiQuitinTM Lozenge||42
1098552|NCT01084603|2659486|P1|STARTED|NiQuitinTM Lozenge||43
1098553|NCT01084603|2659486|P1|NOT COMPLETED|Baseline||2
1098554|NCT01084603|2659486|P1|COMPLETED|Baseline||43
1098555|NCT01084603|2659486|P1|STARTED|Baseline||45
1098556|NCT01084668|2659519|P1|NOT COMPLETED|Overall Study||9
1098557|NCT01084668|2659519|P1|COMPLETED|Overall Study||33
1098558|NCT01084668|2659519|P1|STARTED|Overall Study|Three participants who took Humira prior to study entry have been excluded from the database.|42
1098577|NCT01086410|2659546|P4|NOT COMPLETED|Overall Study||2
1098578|NCT01086410|2659547|P3|NOT COMPLETED|Overall Study||1
1098579|NCT01086410|2659548|P2|NOT COMPLETED|Overall Study||2
1098580|NCT01086410|2659549|P1|NOT COMPLETED|Overall Study||3
1098581|NCT01086410|2659546|P4|COMPLETED|Overall Study||13
1098582|NCT01086410|2659547|P3|COMPLETED|Overall Study||55
1098583|NCT01086410|2659548|P2|COMPLETED|Overall Study||54
1098584|NCT01086410|2659549|P1|COMPLETED|Overall Study||55
1098585|NCT01086410|2659546|P4|STARTED|Overall Study||15
1098586|NCT01086410|2659547|P3|STARTED|Overall Study||56
1098587|NCT01086410|2659548|P2|STARTED|Overall Study||56
1098588|NCT01086410|2659549|P1|STARTED|Overall Study||58
1098589|NCT01086423|2659646|P3|NOT COMPLETED|Overall Study||9
1098590|NCT01086423|2659647|P2|NOT COMPLETED|Overall Study||3
1098591|NCT01086423|2659648|P1|NOT COMPLETED|Overall Study||10
1098592|NCT01086423|2659646|P3|COMPLETED|Overall Study||321
1098593|NCT01086423|2659647|P2|COMPLETED|Overall Study||321
1098594|NCT01086423|2659648|P1|COMPLETED|Overall Study||320
1098595|NCT01086423|2659646|P3|STARTED|Overall Study||330
1098596|NCT01086423|2659647|P2|STARTED|Overall Study||324
1098597|NCT01086423|2659648|P1|STARTED|Overall Study||330
1098598|NCT01086475|2659691|P2|NOT COMPLETED|Overall Study||0
1098599|NCT01086475|2659692|P1|NOT COMPLETED|Overall Study||0
1098600|NCT01086475|2659691|P2|COMPLETED|Overall Study||33
1098601|NCT01086475|2659692|P1|COMPLETED|Overall Study||34
1098602|NCT01086475|2659691|P2|STARTED|Overall Study||33
1098603|NCT01086475|2659692|P1|STARTED|Overall Study||34
1098604|NCT01086605|2659704|P2|NOT COMPLETED|Overall Study||0
1098605|NCT01086605|2659705|P1|NOT COMPLETED|Overall Study||0
1098606|NCT01086605|2659704|P2|COMPLETED|Overall Study||22
1098607|NCT01086605|2659705|P1|COMPLETED|Overall Study||24
1098608|NCT01086605|2659704|P2|STARTED|Overall Study||22
1098609|NCT01086605|2659705|P1|STARTED|Overall Study||24
1098610|NCT01086761|2659725|P6|NOT COMPLETED|Overall Study||0
1098611|NCT01086761|2659726|P5|NOT COMPLETED|Overall Study||0
1098612|NCT01086761|2659727|P4|NOT COMPLETED|Overall Study||0
1098613|NCT01086761|2659728|P3|NOT COMPLETED|Overall Study||0
1098614|NCT01086761|2659729|P2|NOT COMPLETED|Overall Study||0
1098615|NCT01086761|2659730|P1|NOT COMPLETED|Overall Study||0
1098616|NCT01086761|2659725|P6|COMPLETED|Overall Study||0
1098617|NCT01086761|2659726|P5|COMPLETED|Overall Study||4
1098618|NCT01086761|2659727|P4|COMPLETED|Overall Study||6
1098619|NCT01086761|2659728|P3|COMPLETED|Overall Study||6
1098620|NCT01086761|2659729|P2|COMPLETED|Overall Study||7
1098621|NCT01086761|2659730|P1|COMPLETED|Overall Study||9
1098622|NCT01086761|2659725|P6|STARTED|Overall Study||0
1098623|NCT01086761|2659726|P5|STARTED|Overall Study||4
1098624|NCT01086761|2659727|P4|STARTED|Overall Study||6
1098625|NCT01086761|2659728|P3|STARTED|Overall Study||6
1098626|NCT01086761|2659729|P2|STARTED|Overall Study||7
1098627|NCT01086761|2659730|P1|STARTED|Overall Study||9
1098628|NCT01086852|2659768|P1|NOT COMPLETED|Overall Study||0
1098629|NCT01086852|2659768|P1|COMPLETED|Overall Study||4
1098630|NCT01086852|2659768|P1|STARTED|Overall Study||4
1098631|NCT01086969|2659782|P3|NOT COMPLETED|Overall Study||0
1098632|NCT01086969|2659783|P2|NOT COMPLETED|Overall Study||2
1098633|NCT01086969|2659784|P1|NOT COMPLETED|Overall Study||1
1098634|NCT01086969|2659782|P3|COMPLETED|Overall Study||100
1098635|NCT01086969|2659783|P2|COMPLETED|Overall Study||98
1098636|NCT01086969|2659784|P1|COMPLETED|Overall Study||99
1098637|NCT01086969|2659782|P3|STARTED|Overall Study||100
1098638|NCT01086969|2659783|P2|STARTED|Overall Study||100
1098639|NCT01086969|2659784|P1|STARTED|Overall Study||100
1098640|NCT01087489|2659801|P2|NOT COMPLETED|Overall Study||3
1098641|NCT01087489|2659802|P1|NOT COMPLETED|Overall Study||0
1098642|NCT01087489|2659801|P2|COMPLETED|Overall Study||31
1098643|NCT01087489|2659802|P1|COMPLETED|Overall Study||19
1098644|NCT01087489|2659801|P2|STARTED|Overall Study||34
1098645|NCT01087489|2659802|P1|STARTED|Overall Study||19
1098646|NCT01087502|2659814|P2|NOT COMPLETED|Up to Final Analysis (Week 52)||23
1098647|NCT01087502|2659815|P1|NOT COMPLETED|Up to Final Analysis (Week 52)||33
1098648|NCT01087502|2659814|P2|COMPLETED|Up to Final Analysis (Week 52)||95
1098649|NCT01087502|2659815|P1|COMPLETED|Up to Final Analysis (Week 52)||90
1098650|NCT01087502|2659814|P2|STARTED|Up to Final Analysis (Week 52)||118
1098651|NCT01087502|2659815|P1|STARTED|Up to Final Analysis (Week 52)||123
1098652|NCT01087502|2659814|P2|NOT COMPLETED|Up to Interim Analysis (Week 12)||8
1098653|NCT01087502|2659815|P1|NOT COMPLETED|Up to Interim Analysis (Week 12)||9
1098654|NCT01087502|2659814|P2|COMPLETED|Up to Interim Analysis (Week 12)||110
1098655|NCT01087502|2659815|P1|COMPLETED|Up to Interim Analysis (Week 12)||114
1098656|NCT01087502|2659814|P2|STARTED|Up to Interim Analysis (Week 12)||118
1098657|NCT01087502|2659815|P1|STARTED|Up to Interim Analysis (Week 12)||123
1098658|NCT01087528|2659834|P1|NOT COMPLETED|Overall Study||7
1098659|NCT01087528|2659834|P1|COMPLETED|Overall Study|withdrawn from the study prior to any procedure|44
1098660|NCT01087528|2659834|P1|STARTED|Overall Study||51
1098661|NCT01087541|2659840|P2|NOT COMPLETED|Overall Study||0
1098662|NCT01087541|2659841|P1|NOT COMPLETED|Overall Study||0
1098663|NCT01087541|2659840|P2|COMPLETED|Overall Study||3523
1098664|NCT01087541|2659841|P1|COMPLETED|Overall Study||3307
1098665|NCT01087541|2659840|P2|STARTED|Overall Study||3523
1098666|NCT01087541|2659841|P1|STARTED|Overall Study||3307
1098667|NCT01087723|2659859|P2|NOT COMPLETED|Overall Study||20
1098668|NCT01087723|2659860|P1|NOT COMPLETED|Overall Study||14
1098669|NCT01087723|2659859|P2|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1089
1098670|NCT01087723|2659860|P1|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1075
1098671|NCT01087723|2659859|P2|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1094
1098672|NCT01087723|2659860|P1|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1099
1098673|NCT01087723|2659859|P2|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1109
1098674|NCT01087723|2659860|P1|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1089
1098675|NCT01087736|2659884|P2|NOT COMPLETED|Overall Study||2
1098676|NCT01087736|2659885|P1|NOT COMPLETED|Overall Study||1
1098677|NCT01087736|2659884|P2|COMPLETED|Overall Study||14
1098678|NCT01087736|2659885|P1|COMPLETED|Overall Study||13
1098679|NCT01087736|2659884|P2|STARTED|Overall Study||16
1098680|NCT01087736|2659885|P1|STARTED|Overall Study||14
1098681|NCT01087762|2659896|P5|NOT COMPLETED|Open-Label Period (Weeks 48-204)||57
1098682|NCT01087762|2659897|P4|NOT COMPLETED|Open-Label Period (Weeks 48-204)||59
1098683|NCT01087762|2659898|P3|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
1098684|NCT01087762|2659899|P2|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
1098685|NCT01087762|2659900|P1|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
1098686|NCT01087762|2659896|P5|COMPLETED|Open-Label Period (Weeks 48-204)||100
1098687|NCT01087762|2659897|P4|COMPLETED|Open-Label Period (Weeks 48-204)||99
1098688|NCT01087762|2659898|P3|COMPLETED|Open-Label Period (Weeks 48-204)||0
1098689|NCT01087762|2659899|P2|COMPLETED|Open-Label Period (Weeks 48-204)||0
1098690|NCT01087762|2659900|P1|COMPLETED|Open-Label Period (Weeks 48-204)||0
1098691|NCT01087762|2659896|P5|STARTED|Open-Label Period (Weeks 48-204)||157
1098692|NCT01087762|2659897|P4|STARTED|Open-Label Period (Weeks 48-204)||158
1098693|NCT01087762|2659898|P3|STARTED|Open-Label Period (Weeks 48-204)||0
1098694|NCT01087762|2659899|P2|STARTED|Open-Label Period (Weeks 48-204)||0
1098695|NCT01087762|2659900|P1|STARTED|Open-Label Period (Weeks 48-204)||0
1098696|NCT01087762|2659896|P5|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
1098697|NCT01087762|2659897|P4|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
1098698|NCT01087762|2659898|P3|NOT COMPLETED|Double Blind Period (Weeks 0-24)||9
1098699|NCT01087762|2659899|P2|NOT COMPLETED|Double Blind Period (Weeks 0-24)||6
1098700|NCT01087762|2659900|P1|NOT COMPLETED|Double Blind Period (Weeks 0-24)||12
1098701|NCT01087762|2659896|P5|COMPLETED|Double Blind Period (Weeks 0-24)||0
1098702|NCT01087762|2659897|P4|COMPLETED|Double Blind Period (Weeks 0-24)||0
1098703|NCT01087762|2659898|P3|COMPLETED|Double Blind Period (Weeks 0-24)||98
1098704|NCT01087762|2659899|P2|COMPLETED|Double Blind Period (Weeks 0-24)||105
1098705|NCT01087762|2659900|P1|COMPLETED|Double Blind Period (Weeks 0-24)||95
1098706|NCT01087762|2659896|P5|STARTED|Double Blind Period (Weeks 0-24)||0
1098707|NCT01087762|2659897|P4|STARTED|Double Blind Period (Weeks 0-24)||0
1098708|NCT01087762|2659898|P3|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
1098709|NCT01087762|2659899|P2|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|111
1098710|NCT01087762|2659900|P1|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
1098711|NCT01087788|2659949|P3|NOT COMPLETED|Open-Label Period (OL-P)||28
1098712|NCT01087788|2659950|P2|NOT COMPLETED|Open-Label Period (OL-P)||24
1098713|NCT01087788|2659951|P1|NOT COMPLETED|Open-Label Period (OL-P)||30
1098714|NCT01087788|2659949|P3|COMPLETED|Open-Label Period (OL-P)||86
1098715|NCT01087788|2659950|P2|COMPLETED|Open-Label Period (OL-P)||97
1098716|NCT01087788|2659951|P1|COMPLETED|Open-Label Period (OL-P)||81
1098717|NCT01087788|2659949|P3|STARTED|Open-Label Period (OL-P)||114
1098718|NCT01087788|2659950|P2|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|121
1098719|NCT01087788|2659951|P1|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|111
1098720|NCT01087788|2659949|P3|NOT COMPLETED|24-weeks Dose-blind Period||6
1098721|NCT01087788|2659950|P2|NOT COMPLETED|24-weeks Dose-blind Period||5
1098722|NCT01087788|2659951|P1|NOT COMPLETED|24-weeks Dose-blind Period||7
1098723|NCT01087788|2659949|P3|COMPLETED|24-weeks Dose-blind Period||114
1098724|NCT01087788|2659950|P2|COMPLETED|24-weeks Dose-blind Period||123
1098725|NCT01087788|2659951|P1|COMPLETED|24-weeks Dose-blind Period||113
1098726|NCT01087788|2659949|P3|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
1098727|NCT01087788|2659950|P2|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
1098728|NCT01087788|2659951|P1|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 400mg Q2W at week 16 (29 subjects) and at week 24 (31 subjects)|60
1098729|NCT01087788|2659949|P3|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
1098730|NCT01087788|2659950|P2|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
1098731|NCT01087788|2659951|P1|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 200mg Q2W at week 16 (30 subjects) and at week 24 (30 subjects)|60
1098732|NCT01087788|2659949|P3|STARTED|24-weeks Dose-blind Period||120
1098733|NCT01087788|2659950|P2|STARTED|24-weeks Dose-blind Period||128
1098734|NCT01087788|2659951|P1|STARTED|24-weeks Dose-blind Period||120
1098735|NCT01087788|2659949|P3|NOT COMPLETED|24-weeks Double-blind Period||15
1098736|NCT01087788|2659950|P2|NOT COMPLETED|24-weeks Double-blind Period||10
1098737|NCT01087788|2659951|P1|NOT COMPLETED|24-weeks Double-blind Period||16
1098738|NCT01087788|2659949|P3|COMPLETED|24-weeks Double-blind Period||120
1098739|NCT01087788|2659950|P2|COMPLETED|24-weeks Double-blind Period||128
1098740|NCT01087788|2659951|P1|COMPLETED|24-weeks Double-blind Period||120
1098741|NCT01087788|2659949|P3|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
1098742|NCT01087788|2659950|P2|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
1098743|NCT01087788|2659951|P1|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|29 subjects left the Placebo group and were re-randomized to CZP 400 mg Q4W on Week 16.|29
1098744|NCT01087788|2659949|P3|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
1098745|NCT01087788|2659950|P2|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
1098746|NCT01087788|2659951|P1|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|30 subjects left the Placebo group and were re-randomized to CZP 200 mg Q2W on Week 16.|30
1098747|NCT01087788|2659949|P3|STARTED|24-weeks Double-blind Period||135
1098748|NCT01087788|2659950|P2|STARTED|24-weeks Double-blind Period||138
1098749|NCT01087788|2659951|P1|STARTED|24-weeks Double-blind Period||136
1098750|NCT01087801|2659980|P2|NOT COMPLETED|Overall Study||5
1098751|NCT01087801|2659981|P1|NOT COMPLETED|Overall Study||4
1098752|NCT01087801|2659980|P2|COMPLETED|Overall Study||29
1098753|NCT01087801|2659981|P1|COMPLETED|Overall Study||26
1098754|NCT01087801|2659980|P2|STARTED|Overall Study||34
1098755|NCT01087801|2659981|P1|STARTED|Overall Study||30
1098756|NCT01087814|2659989|P2|NOT COMPLETED|Second Intervention (5 Days)||0
1098757|NCT01087814|2659990|P1|NOT COMPLETED|Second Intervention (5 Days)||1
1098758|NCT01087814|2659989|P2|COMPLETED|Second Intervention (5 Days)||6
1098759|NCT01087814|2659990|P1|COMPLETED|Second Intervention (5 Days)||4
1098760|NCT01087814|2659989|P2|STARTED|Second Intervention (5 Days)||6
1098761|NCT01087814|2659990|P1|STARTED|Second Intervention (5 Days)||5
1098762|NCT01087814|2659989|P2|NOT COMPLETED|First Intervention (5 Days)||1
1098763|NCT01087814|2659990|P1|NOT COMPLETED|First Intervention (5 Days)||3
1098764|NCT01087814|2659989|P2|COMPLETED|First Intervention (5 Days)||6
1098765|NCT01087814|2659990|P1|COMPLETED|First Intervention (5 Days)||5
1098766|NCT01087814|2659989|P2|STARTED|First Intervention (5 Days)||7
1098767|NCT01087814|2659990|P1|STARTED|First Intervention (5 Days)||8
1098768|NCT01087905|2660004|P8|NOT COMPLETED|Overall Study||29
1098769|NCT01087905|2660005|P7|NOT COMPLETED|Overall Study||23
1098770|NCT01087905|2660006|P6|NOT COMPLETED|Overall Study||28
1098771|NCT01087905|2660007|P5|NOT COMPLETED|Overall Study||31
1098772|NCT01087905|2660008|P4|NOT COMPLETED|Overall Study||36
1098773|NCT01087905|2660009|P3|NOT COMPLETED|Overall Study||22
1098774|NCT01087905|2660010|P2|NOT COMPLETED|Overall Study||32
1098775|NCT01087905|2660011|P1|NOT COMPLETED|Overall Study||29
1098776|NCT01087905|2660004|P8|COMPLETED|Overall Study||98
1098777|NCT01087905|2660005|P7|COMPLETED|Overall Study||98
1098778|NCT01087905|2660006|P6|COMPLETED|Overall Study||99
1098779|NCT01087905|2660007|P5|COMPLETED|Overall Study||91
1098780|NCT01087905|2660008|P4|COMPLETED|Overall Study||86
1098781|NCT01087905|2660009|P3|COMPLETED|Overall Study||101
1098782|NCT01087905|2660010|P2|COMPLETED|Overall Study||94
1098783|NCT01087905|2660011|P1|COMPLETED|Overall Study||90
1098784|NCT01087905|2660004|P8|STARTED|Overall Study||127
1098785|NCT01087905|2660005|P7|STARTED|Overall Study||121
1098786|NCT01087905|2660006|P6|STARTED|Overall Study||127
1098787|NCT01087905|2660007|P5|STARTED|Overall Study||122
1098788|NCT01087905|2660008|P4|STARTED|Overall Study||122
1098789|NCT01087905|2660009|P3|STARTED|Overall Study||123
1098790|NCT01087905|2660010|P2|STARTED|Overall Study||126
1098791|NCT01087905|2660011|P1|STARTED|Overall Study||119
1098792|NCT01087918|2660033|P2|NOT COMPLETED|Overall Study||0
1098793|NCT01087918|2660034|P1|NOT COMPLETED|Overall Study||0
1098794|NCT01087918|2660033|P2|COMPLETED|Overall Study||4
1098795|NCT01087918|2660034|P1|COMPLETED|Overall Study||5
1098796|NCT01087918|2660033|P2|STARTED|Overall Study||4
1098797|NCT01087918|2660034|P1|STARTED|Overall Study||5
1098798|NCT01087944|2660060|P2|NOT COMPLETED|Period 2 (Week 4-6)||2
1098799|NCT01087944|2660061|P1|NOT COMPLETED|Period 2 (Week 4-6)||0
1098800|NCT01087944|2660060|P2|COMPLETED|Period 2 (Week 4-6)||28
1098801|NCT01087944|2660061|P1|COMPLETED|Period 2 (Week 4-6)||29
1098802|NCT01087944|2660060|P2|STARTED|Period 2 (Week 4-6)||30
1098803|NCT01087944|2660061|P1|STARTED|Period 2 (Week 4-6)||29
1098804|NCT01087944|2660060|P2|NOT COMPLETED|Period 1 (Week 1-3)||0
1098805|NCT01087944|2660061|P1|NOT COMPLETED|Period 1 (Week 1-3)||1
1098806|NCT01087944|2660060|P2|COMPLETED|Period 1 (Week 1-3)||30
1098807|NCT01087944|2660061|P1|COMPLETED|Period 1 (Week 1-3)||29
1098808|NCT01087944|2660060|P2|STARTED|Period 1 (Week 1-3)||30
1098809|NCT01087944|2660061|P1|STARTED|Period 1 (Week 1-3)||30
1098810|NCT01087957|2660091|P2|NOT COMPLETED|Overall Study||55
1098811|NCT01087957|2660092|P1|NOT COMPLETED|Overall Study||41
1098812|NCT01087957|2660091|P2|COMPLETED|Overall Study||187
1098813|NCT01087957|2660092|P1|COMPLETED|Overall Study||212
1098814|NCT01087957|2660091|P2|STARTED|Overall Study||242
1098815|NCT01087957|2660092|P1|STARTED|Overall Study||253
1098816|NCT01087970|2660118|P1|NOT COMPLETED|Overall Study||2
1098817|NCT01087970|2660118|P1|COMPLETED|Overall Study||67
1098818|NCT01087970|2660118|P1|Received Carboplatin|Overall Study||63
1098819|NCT01087970|2660118|P1|Efficacy Population|Overall Study|All treated participants excluding those from a noncompliant study site.|58
1098820|NCT01087970|2660118|P1|Completed 6 Cycles|Overall Study||69
1098821|NCT01087970|2660118|P1|Received ≥1 Dose of Any Study Drug|Overall Study||69
1098822|NCT01087970|2660118|P1|STARTED|Overall Study||69
1098823|NCT01087996|2660130|P2|NOT COMPLETED|Overall Study||0
1098824|NCT01087996|2660131|P1|NOT COMPLETED|Overall Study||0
1098825|NCT01087996|2660130|P2|COMPLETED|Overall Study||15
1098826|NCT01087996|2660131|P1|COMPLETED|Overall Study||15
1098827|NCT01087996|2660130|P2|STARTED|Overall Study||15
1098828|NCT01087996|2660131|P1|STARTED|Overall Study||15
1098829|NCT01088295|2660153|P1|NOT COMPLETED|Overall Study||1
1098830|NCT01088295|2660153|P1|COMPLETED|Overall Study||35
1098831|NCT01088295|2660153|P1|STARTED|Overall Study||36
1098832|NCT01088399|2660160|P3|NOT COMPLETED|Overall Study||281
1098833|NCT01088399|2660161|P2|NOT COMPLETED|Overall Study||1347
1098834|NCT01088399|2660162|P1|NOT COMPLETED|Overall Study||7121
1098835|NCT01088399|2660160|P3|COMPLETED|Overall Study||21
1098836|NCT01088399|2660161|P2|COMPLETED|Overall Study||308
1098837|NCT01088399|2660162|P1|COMPLETED|Overall Study||1595
1098838|NCT01088399|2660160|P3|STARTED|Overall Study||302
1098839|NCT01088399|2660161|P2|STARTED|Overall Study||1655
1098840|NCT01088399|2660162|P1|STARTED|Overall Study||8716
1098841|NCT01088438|2660187|P2|NOT COMPLETED|Overall Study||36
1098842|NCT01088438|2660188|P1|NOT COMPLETED|Overall Study||29
1098843|NCT01088438|2660187|P2|COMPLETED|Overall Study||59
1098844|NCT01088438|2660188|P1|COMPLETED|Overall Study||65
1098845|NCT01088438|2660187|P2|STARTED|Overall Study||95
1098846|NCT01088438|2660188|P1|STARTED|Overall Study||94
1098847|NCT01088464|2660201|P3|NOT COMPLETED|Overall Study||0
1098848|NCT01088464|2660202|P2|NOT COMPLETED|Overall Study||0
1098849|NCT01088464|2660203|P1|NOT COMPLETED|Overall Study||0
1098850|NCT01088464|2660201|P3|COMPLETED|Overall Study||6
1098851|NCT01088464|2660202|P2|COMPLETED|Overall Study||6
1098852|NCT01088464|2660203|P1|COMPLETED|Overall Study||3
1098853|NCT01088464|2660201|P3|Received Any Quantity of Study Drug|Overall Study||6
1098854|NCT01088464|2660202|P2|Received Any Quantity of Study Drug|Overall Study||6
1098855|NCT01088464|2660203|P1|Received Any Quantity of Study Drug|Overall Study||3
1098856|NCT01088464|2660201|P3|STARTED|Overall Study||6
1098857|NCT01088464|2660202|P2|STARTED|Overall Study||6
1098858|NCT01088464|2660203|P1|STARTED|Overall Study||3
1098859|NCT01088503|2660256|P3|NOT COMPLETED|Overall Study||17
1098860|NCT01088503|2660257|P2|NOT COMPLETED|Overall Study||685
1098861|NCT01088503|2660258|P1|NOT COMPLETED|Overall Study||182
1098862|NCT01088503|2660256|P3|COMPLETED|Overall Study||241
1098863|NCT01088503|2660257|P2|COMPLETED|Overall Study||8161
1098864|NCT01088503|2660258|P1|COMPLETED|Overall Study||2941
1098865|NCT01088503|2660256|P3|STARTED|Overall Study||258
1098866|NCT01088503|2660257|P2|STARTED|Overall Study||8846
1098867|NCT01088503|2660258|P1|STARTED|Overall Study||3123
1098868|NCT01088529|2660281|P2|NOT COMPLETED|Overall Study||1
1098869|NCT01088529|2660282|P1|NOT COMPLETED|Overall Study||0
1098870|NCT01088529|2660281|P2|COMPLETED|Overall Study||21
1098871|NCT01088529|2660282|P1|COMPLETED|Overall Study||44
1098872|NCT01088529|2660281|P2|Received Treatment|Overall Study||21
1098873|NCT01088529|2660282|P1|Received Treatment|Overall Study||44
1098874|NCT01088529|2660281|P2|STARTED|Overall Study||22
1098875|NCT01088529|2660282|P1|STARTED|Overall Study||44
1098876|NCT01088646|2660292|P1|NOT COMPLETED|Overall Study||0
1098877|NCT01088646|2660292|P1|COMPLETED|Overall Study||25
1098878|NCT01088646|2660292|P1|STARTED|Overall Study||25
1098879|NCT01088672|2660296|P1|NOT COMPLETED|Overall Study||0
1098880|NCT01088672|2660296|P1|COMPLETED|Overall Study||60
1098881|NCT01088672|2660296|P1|STARTED|Overall Study||60
1098882|NCT01088711|2660306|P4|NOT COMPLETED|Overall Study||0
1098883|NCT01088711|2660307|P3|NOT COMPLETED|Overall Study||0
1098884|NCT01088711|2660308|P2|NOT COMPLETED|Overall Study||0
1098885|NCT01088711|2660309|P1|NOT COMPLETED|Overall Study||0
1098886|NCT01088711|2660306|P4|COMPLETED|Overall Study||2
1098887|NCT01088711|2660307|P3|COMPLETED|Overall Study||6
1098888|NCT01088711|2660308|P2|COMPLETED|Overall Study||6
1098889|NCT01088711|2660309|P1|COMPLETED|Overall Study||18
1098890|NCT01088711|2660306|P4|STARTED|Overall Study||2
1098891|NCT01088711|2660307|P3|STARTED|Overall Study||6
1098892|NCT01088711|2660308|P2|STARTED|Overall Study||6
1098893|NCT01088711|2660309|P1|STARTED|Overall Study||18
1098894|NCT01081626|2660335|P2|NOT COMPLETED|Overall Study||61
1098895|NCT01081626|2660336|P1|NOT COMPLETED|Overall Study||60
1098896|NCT01081626|2660335|P2|COMPLETED|Overall Study||94
1098897|NCT01081626|2660336|P1|COMPLETED|Overall Study||95
1098898|NCT01081626|2660335|P2|Assessed for Efficacy|Overall Study||125
1098899|NCT01081626|2660336|P1|Assessed for Efficacy|Overall Study||122
1098900|NCT01081626|2660335|P2|STARTED|Overall Study||155
1098901|NCT01081626|2660336|P1|STARTED|Overall Study||155
1098902|NCT01081665|2660362|P1|NOT COMPLETED|Overall Study||95
1098903|NCT01081665|2660362|P1|COMPLETED|Overall Study||142
1098904|NCT01081665|2660362|P1|Evaluable Population|Overall Study|Participants with baseline and at least 2 post-baseline parathormone measurements at 24 months.|212
1098905|NCT01081665|2660362|P1|Full Analysis Set|Overall Study||237
1098906|NCT01081665|2660362|P1|STARTED|Overall Study||237
1098907|NCT01081769|2660374|P2|NOT COMPLETED|CORE Intent-To-Treat||97
1098908|NCT01081769|2660375|P1|NOT COMPLETED|CORE Intent-To-Treat||80
1098909|NCT01081769|2660374|P2|COMPLETED|CORE Intent-To-Treat||266
1098910|NCT01081769|2660375|P1|COMPLETED|CORE Intent-To-Treat||272
1098911|NCT01081769|2660374|P2|STARTED|CORE Intent-To-Treat||363
1098912|NCT01081769|2660375|P1|STARTED|CORE Intent-To-Treat||352
1098913|NCT01081769|2660374|P2|NOT COMPLETED|Whole Intent-to-Treat||25
1098914|NCT01081769|2660375|P1|NOT COMPLETED|Whole Intent-to-Treat||24
1098915|NCT01081769|2660374|P2|COMPLETED|Whole Intent-to-Treat||363
1098916|NCT01081769|2660375|P1|COMPLETED|Whole Intent-to-Treat||352
1098917|NCT01081769|2660374|P2|STARTED|Whole Intent-to-Treat||388
1098918|NCT01081769|2660375|P1|STARTED|Whole Intent-to-Treat||376
1098919|NCT01081795|2660412|P3|NOT COMPLETED|Overall Study||30
1098920|NCT01081795|2660413|P2|NOT COMPLETED|Overall Study||35
1098921|NCT01081795|2660414|P1|NOT COMPLETED|Overall Study||33
1098922|NCT01081795|2660412|P3|COMPLETED|Overall Study||97
1098923|NCT01081795|2660413|P2|COMPLETED|Overall Study||95
1098924|NCT01081795|2660414|P1|COMPLETED|Overall Study||97
1098925|NCT01081795|2660412|P3|STARTED|Overall Study||127
1098926|NCT01081795|2660413|P2|STARTED|Overall Study||130
1098927|NCT01081795|2660414|P1|STARTED|Overall Study||130
1098928|NCT01081834|2660454|P5|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
1098929|NCT01081834|2660455|P4|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
1098930|NCT01081834|2660456|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
1098931|NCT01081834|2660457|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
1098932|NCT01081834|2660458|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||20
1098933|NCT01081834|2660454|P5|COMPLETED|Extension Period: Week 26 to Week 52||0
1098934|NCT01081834|2660455|P4|COMPLETED|Extension Period: Week 26 to Week 52||0
1098935|NCT01081834|2660456|P3|COMPLETED|Extension Period: Week 26 to Week 52||165
1098936|NCT01081834|2660457|P2|COMPLETED|Extension Period: Week 26 to Week 52||152
1098937|NCT01081834|2660458|P1|COMPLETED|Extension Period: Week 26 to Week 52||135
1098938|NCT01081834|2660454|P5|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
1098939|NCT01081834|2660455|P4|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
1098940|NCT01081834|2660456|P3|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued last day of core: AE (1), lost f/u (1), PV (1), NS (1), physician decision (1).|170
1098941|NCT01081834|2660457|P2|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued on last day of core: adverse event (AE) (1), protocol violation (PV) (1).|170
1098942|NCT01081834|2660458|P1|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued on last day of core: lack of efficacy on rescue (2), not specified (NS) (3).|155
1098943|NCT01081834|2660454|P5|NOT COMPLETED|Core Period: Baseline to Week 26||4
1098944|NCT01081834|2660455|P4|NOT COMPLETED|Core Period: Baseline to Week 26||7
1098945|NCT01081834|2660456|P3|NOT COMPLETED|Core Period: Baseline to Week 26||22
1098946|NCT01081834|2660457|P2|NOT COMPLETED|Core Period: Baseline to Week 26||23
1098947|NCT01081834|2660458|P1|NOT COMPLETED|Core Period: Baseline to Week 26||32
1098948|NCT01081834|2660454|P5|COMPLETED|Core Period: Baseline to Week 26||40
1098949|NCT01081834|2660455|P4|COMPLETED|Core Period: Baseline to Week 26||40
1098950|NCT01081834|2660456|P3|COMPLETED|Core Period: Baseline to Week 26||175
1098951|NCT01081834|2660457|P2|COMPLETED|Core Period: Baseline to Week 26||172
1098952|NCT01081834|2660458|P1|COMPLETED|Core Period: Baseline to Week 26||160
1098953|NCT01081834|2660454|P5|STARTED|Core Period: Baseline to Week 26||44
1098954|NCT01081834|2660455|P4|STARTED|Core Period: Baseline to Week 26||47
1098955|NCT01081834|2660456|P3|STARTED|Core Period: Baseline to Week 26||197
1098956|NCT01081834|2660457|P2|STARTED|Core Period: Baseline to Week 26||195
1098957|NCT01081834|2660458|P1|STARTED|Core Period: Baseline to Week 26||192
1098958|NCT01088984|2660518|P2|NOT COMPLETED|Phase 2||32
1098959|NCT01088984|2660519|P1|NOT COMPLETED|Phase 2||0
1098960|NCT01088984|2660518|P2|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
1098961|NCT01088984|2660519|P1|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
1098962|NCT01088984|2660518|P2|STARTED|Phase 2||32
1098963|NCT01088984|2660519|P1|STARTED|Phase 2||0
1098964|NCT01088984|2660518|P2|NOT COMPLETED|Phase 1||6
1098965|NCT01088984|2660519|P1|NOT COMPLETED|Phase 1||5
1098966|NCT01088984|2660518|P2|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
1098967|NCT01088984|2660519|P1|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
1098968|NCT01088984|2660518|P2|STARTED|Phase 1||6
1098969|NCT01088984|2660519|P1|STARTED|Phase 1||5
1098970|NCT01088997|2660539|P2|NOT COMPLETED|Overall Study||3
1098971|NCT01088997|2660540|P1|NOT COMPLETED|Overall Study||3
1098972|NCT01088997|2660539|P2|COMPLETED|Overall Study||2
1098973|NCT01088997|2660540|P1|COMPLETED|Overall Study||4
1098974|NCT01088997|2660539|P2|STARTED|Overall Study||5
1098975|NCT01088997|2660540|P1|STARTED|Overall Study||7
1098976|NCT01089023|2660549|P1|NOT COMPLETED|Overall Study||7
1098977|NCT01089023|2660549|P1|COMPLETED|Overall Study||88
1098978|NCT01089023|2660549|P1|STARTED|Overall Study||95
1098979|NCT01089062|2660567|P6|NOT COMPLETED|Follow-up Visit (Final Visit)||0
1098980|NCT01089062|2660568|P5|NOT COMPLETED|Follow-up Visit (Final Visit)||0
1098981|NCT01089062|2660569|P4|NOT COMPLETED|Follow-up Visit (Final Visit)||0
1098982|NCT01089062|2660570|P3|NOT COMPLETED|Follow-up Visit (Final Visit)||0
1098983|NCT01089062|2660571|P2|NOT COMPLETED|Follow-up Visit (Final Visit)||0
1098984|NCT01089062|2660572|P1|NOT COMPLETED|Follow-up Visit (Final Visit)||0
1098985|NCT01089062|2660567|P6|COMPLETED|Follow-up Visit (Final Visit)||3
1098986|NCT01089062|2660568|P5|COMPLETED|Follow-up Visit (Final Visit)||3
1098987|NCT01089062|2660569|P4|COMPLETED|Follow-up Visit (Final Visit)||3
1098988|NCT01089062|2660570|P3|COMPLETED|Follow-up Visit (Final Visit)||3
1098989|NCT01089062|2660571|P2|COMPLETED|Follow-up Visit (Final Visit)||3
1098990|NCT01089062|2660572|P1|COMPLETED|Follow-up Visit (Final Visit)||3
1098991|NCT01089062|2660567|P6|STARTED|Follow-up Visit (Final Visit)||3
1098992|NCT01089062|2660568|P5|STARTED|Follow-up Visit (Final Visit)||3
1098993|NCT01089062|2660569|P4|STARTED|Follow-up Visit (Final Visit)||3
1098994|NCT01089062|2660570|P3|STARTED|Follow-up Visit (Final Visit)||3
1098995|NCT01089062|2660571|P2|STARTED|Follow-up Visit (Final Visit)||3
1098996|NCT01089062|2660572|P1|STARTED|Follow-up Visit (Final Visit)||3
1098997|NCT01089062|2660567|P6|NOT COMPLETED|Visit 4||0
1098998|NCT01089062|2660568|P5|NOT COMPLETED|Visit 4||0
1098999|NCT01089062|2660569|P4|NOT COMPLETED|Visit 4||0
1099000|NCT01089062|2660570|P3|NOT COMPLETED|Visit 4||0
1099001|NCT01089062|2660571|P2|NOT COMPLETED|Visit 4||0
1099002|NCT01089062|2660572|P1|NOT COMPLETED|Visit 4||0
1099003|NCT01089062|2660567|P6|COMPLETED|Visit 4||3
1099004|NCT01089062|2660568|P5|COMPLETED|Visit 4||3
1099005|NCT01089062|2660569|P4|COMPLETED|Visit 4||3
1099006|NCT01089062|2660570|P3|COMPLETED|Visit 4||3
1099007|NCT01089062|2660571|P2|COMPLETED|Visit 4||3
1099008|NCT01089062|2660572|P1|COMPLETED|Visit 4||3
1099009|NCT01089062|2660567|P6|STARTED|Visit 4||3
1099010|NCT01089062|2660568|P5|STARTED|Visit 4||3
1099011|NCT01089062|2660569|P4|STARTED|Visit 4||3
1099012|NCT01089062|2660570|P3|STARTED|Visit 4||3
1099013|NCT01089062|2660571|P2|STARTED|Visit 4||3
1099014|NCT01089062|2660572|P1|STARTED|Visit 4||3
1099015|NCT01089062|2660567|P6|NOT COMPLETED|Visit 3||0
1099016|NCT01089062|2660568|P5|NOT COMPLETED|Visit 3||0
1099017|NCT01089062|2660569|P4|NOT COMPLETED|Visit 3||1
1099018|NCT01089062|2660570|P3|NOT COMPLETED|Visit 3||0
1099019|NCT01089062|2660571|P2|NOT COMPLETED|Visit 3||0
1099020|NCT01089062|2660572|P1|NOT COMPLETED|Visit 3||0
1099021|NCT01089062|2660567|P6|COMPLETED|Visit 3||3
1099022|NCT01089062|2660568|P5|COMPLETED|Visit 3||3
1099023|NCT01089062|2660569|P4|COMPLETED|Visit 3||3
1099024|NCT01089062|2660570|P3|COMPLETED|Visit 3||3
1099025|NCT01089062|2660571|P2|COMPLETED|Visit 3||3
1099026|NCT01089062|2660572|P1|COMPLETED|Visit 3||3
1099027|NCT01089062|2660567|P6|STARTED|Visit 3||3
1099028|NCT01089062|2660568|P5|STARTED|Visit 3||3
1099029|NCT01089062|2660569|P4|STARTED|Visit 3||4
1099030|NCT01089062|2660570|P3|STARTED|Visit 3||3
1099031|NCT01089062|2660571|P2|STARTED|Visit 3||3
1099032|NCT01089062|2660572|P1|STARTED|Visit 3||3
1099033|NCT01089062|2660567|P6|NOT COMPLETED|Visit 2 (Randomization)||1
1099034|NCT01089062|2660568|P5|NOT COMPLETED|Visit 2 (Randomization)||1
1099035|NCT01089062|2660569|P4|NOT COMPLETED|Visit 2 (Randomization)||0
1099036|NCT01089062|2660570|P3|NOT COMPLETED|Visit 2 (Randomization)||1
1099037|NCT01089062|2660571|P2|NOT COMPLETED|Visit 2 (Randomization)||1
1099038|NCT01089062|2660572|P1|NOT COMPLETED|Visit 2 (Randomization)||1
1099039|NCT01089062|2660567|P6|COMPLETED|Visit 2 (Randomization)||3
1099040|NCT01089062|2660568|P5|COMPLETED|Visit 2 (Randomization)||3
1099041|NCT01089062|2660569|P4|COMPLETED|Visit 2 (Randomization)||4
1099042|NCT01089062|2660570|P3|COMPLETED|Visit 2 (Randomization)||3
1099043|NCT01089062|2660571|P2|COMPLETED|Visit 2 (Randomization)||3
1099044|NCT01089062|2660572|P1|COMPLETED|Visit 2 (Randomization)||3
1099045|NCT01089062|2660567|P6|STARTED|Visit 2 (Randomization)||4
1099046|NCT01089062|2660568|P5|STARTED|Visit 2 (Randomization)||4
1099047|NCT01089062|2660569|P4|STARTED|Visit 2 (Randomization)||4
1099048|NCT01089062|2660570|P3|STARTED|Visit 2 (Randomization)||4
1099049|NCT01089062|2660571|P2|STARTED|Visit 2 (Randomization)||4
1099050|NCT01089062|2660572|P1|STARTED|Visit 2 (Randomization)||4
1099051|NCT01089127|2660601|P6|NOT COMPLETED|Overall Study||3
1099052|NCT01089127|2660602|P5|NOT COMPLETED|Overall Study||2
1099053|NCT01089127|2660603|P4|NOT COMPLETED|Overall Study||1
1099054|NCT01089127|2660604|P3|NOT COMPLETED|Overall Study||2
1099055|NCT01089127|2660605|P2|NOT COMPLETED|Overall Study||5
1099056|NCT01089127|2660606|P1|NOT COMPLETED|Overall Study||8
1099057|NCT01089127|2660601|P6|COMPLETED|Overall Study||88
1099058|NCT01089127|2660602|P5|COMPLETED|Overall Study||90
1099059|NCT01089127|2660603|P4|COMPLETED|Overall Study||91
1099060|NCT01089127|2660604|P3|COMPLETED|Overall Study||92
1099061|NCT01089127|2660605|P2|COMPLETED|Overall Study||86
1099062|NCT01089127|2660606|P1|COMPLETED|Overall Study||84
1099063|NCT01089127|2660601|P6|Exposed to Study Drug|Overall Study||91
1099064|NCT01089127|2660602|P5|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|91
1099065|NCT01089127|2660603|P4|Exposed to Study Drug|Overall Study||92
1099066|NCT01089127|2660604|P3|Exposed to Study Drug|Overall Study||94
1099067|NCT01089127|2660605|P2|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|90
1099068|NCT01089127|2660606|P1|Exposed to Study Drug|Overall Study|3 randomized patients in this group were not exposed to study treatment.|89
1099069|NCT01089127|2660601|P6|STARTED|Overall Study||91
1099070|NCT01089127|2660602|P5|STARTED|Overall Study||92
1099071|NCT01089127|2660603|P4|STARTED|Overall Study||92
1099072|NCT01089127|2660604|P3|STARTED|Overall Study||94
1099073|NCT01089127|2660605|P2|STARTED|Overall Study||91
1099074|NCT01089127|2660606|P1|STARTED|Overall Study||92
1099075|NCT01090011|2660626|P1|NOT COMPLETED|Overall Study||171
1099076|NCT01090011|2660626|P1|COMPLETED|Overall Study||0
1099077|NCT01090011|2660626|P1|STARTED|Overall Study||171
1099078|NCT01090050|2660696|P2|NOT COMPLETED|Overall Study||7
1099079|NCT01090050|2660697|P1|NOT COMPLETED|Overall Study||1
1099080|NCT01090050|2660696|P2|COMPLETED|Overall Study||5
1099081|NCT01090050|2660697|P1|COMPLETED|Overall Study||15
1099082|NCT01090050|2660696|P2|STARTED|Overall Study||12
1099083|NCT01090050|2660697|P1|STARTED|Overall Study||16
1099084|NCT01090063|2660717|P1|NOT COMPLETED|Treatment||4
1099085|NCT01090063|2660717|P1|COMPLETED|Treatment||20
1099086|NCT01090063|2660717|P1|STARTED|Treatment||24
1099087|NCT01090063|2660717|P1|NOT COMPLETED|Screen||4
1099088|NCT01090063|2660717|P1|COMPLETED|Screen||24
1099089|NCT01090063|2660717|P1|STARTED|Screen||28
1099090|NCT01090076|2660733|P2|NOT COMPLETED|Overall Study||2
1099091|NCT01090076|2660734|P1|NOT COMPLETED|Overall Study||1
1099092|NCT01090076|2660733|P2|COMPLETED|Overall Study||12
1099093|NCT01090076|2660734|P1|COMPLETED|Overall Study||11
1099094|NCT01090076|2660733|P2|STARTED|Overall Study||14
1099095|NCT01090076|2660734|P1|STARTED|Overall Study||12
1099096|NCT01090102|2660746|P2|NOT COMPLETED|Second 12 Weeks||1
1099097|NCT01090102|2660747|P1|NOT COMPLETED|Second 12 Weeks||0
1099098|NCT01090102|2660746|P2|COMPLETED|Second 12 Weeks||15
1099099|NCT01090102|2660747|P1|COMPLETED|Second 12 Weeks||11
1099100|NCT01090102|2660746|P2|STARTED|Second 12 Weeks||16
1099101|NCT01090102|2660747|P1|STARTED|Second 12 Weeks||11
1099102|NCT01090102|2660746|P2|NOT COMPLETED|First 12 Weeks||2
1099103|NCT01090102|2660747|P1|NOT COMPLETED|First 12 Weeks||4
1099104|NCT01090102|2660746|P2|COMPLETED|First 12 Weeks||16
1099105|NCT01090102|2660747|P1|COMPLETED|First 12 Weeks||11
1099106|NCT01090102|2660746|P2|STARTED|First 12 Weeks||18
1099107|NCT01090102|2660747|P1|STARTED|First 12 Weeks||15
1099108|NCT01090180|2660757|P2|NOT COMPLETED|Overall Study||8
1099109|NCT01090180|2660758|P1|NOT COMPLETED|Overall Study||11
1099110|NCT01090180|2660757|P2|COMPLETED|Overall Study||21
1099111|NCT01090180|2660758|P1|COMPLETED|Overall Study||22
1099112|NCT01090180|2660757|P2|STARTED|Overall Study||29
1099113|NCT01090180|2660758|P1|STARTED|Overall Study||33
1099114|NCT01090310|2660770|P4|NOT COMPLETED|Extension Study||20
1099115|NCT01090310|2660771|P3|NOT COMPLETED|Extension Study||15
1099116|NCT01090310|2660772|P2|NOT COMPLETED|Extension Study||16
1099117|NCT01090310|2660773|P1|NOT COMPLETED|Extension Study||14
1099118|NCT01090310|2660770|P4|COMPLETED|Extension Study||1
1099119|NCT01090310|2660771|P3|COMPLETED|Extension Study||1
1099120|NCT01090310|2660772|P2|COMPLETED|Extension Study||0
1099121|NCT01090310|2660773|P1|COMPLETED|Extension Study||3
1099122|NCT01090310|2660770|P4|STARTED|Extension Study||21
1099123|NCT01090310|2660771|P3|STARTED|Extension Study||16
1099124|NCT01090310|2660772|P2|STARTED|Extension Study||16
1099125|NCT01090310|2660773|P1|STARTED|Extension Study||17
1099126|NCT01090310|2660770|P4|NOT COMPLETED|Core Study||7
1099127|NCT01090310|2660771|P3|NOT COMPLETED|Core Study||7
1099128|NCT01090310|2660772|P2|NOT COMPLETED|Core Study||11
1099129|NCT01090310|2660773|P1|NOT COMPLETED|Core Study||8
1099130|NCT01090310|2660770|P4|COMPLETED|Core Study||27
1099131|NCT01090310|2660771|P3|COMPLETED|Core Study||24
1099132|NCT01090310|2660772|P2|COMPLETED|Core Study||20
1099133|NCT01090310|2660773|P1|COMPLETED|Core Study||21
1099134|NCT01090310|2660770|P4|STARTED|Core Study||34
1099135|NCT01090310|2660771|P3|STARTED|Core Study||31
1099136|NCT01090310|2660772|P2|STARTED|Core Study||31
1099137|NCT01090310|2660773|P1|STARTED|Core Study||29
1099138|NCT01090323|2660801|P2|NOT COMPLETED|Overall Study||34
1099139|NCT01090323|2660802|P1|NOT COMPLETED|Overall Study||89
1099140|NCT01090323|2660801|P2|COMPLETED|Overall Study||19
1099141|NCT01090323|2660802|P1|COMPLETED|Overall Study||43
1099142|NCT01090323|2660801|P2|STARTED|Overall Study||53
1099143|NCT01090323|2660802|P1|STARTED|Overall Study||132
1099186|NCT01090453|2660854|P2|NOT COMPLETED|Overall Study||14
1099187|NCT01090453|2660855|P1|NOT COMPLETED|Overall Study||13
1099188|NCT01090453|2660854|P2|COMPLETED|Overall Study||228
1099189|NCT01090453|2660855|P1|COMPLETED|Overall Study||225
1099190|NCT01090453|2660854|P2|STARTED|Overall Study||242
1099191|NCT01090453|2660855|P1|STARTED|Overall Study||238
1099192|NCT01090479|2660901|P2|NOT COMPLETED|Overall Study||0
1099193|NCT01090479|2660902|P1|NOT COMPLETED|Overall Study||0
1099194|NCT01090479|2660901|P2|COMPLETED|Overall Study||50
1099195|NCT01090479|2660902|P1|COMPLETED|Overall Study||50
1099196|NCT01090479|2660901|P2|STARTED|Overall Study||50
1099197|NCT01090479|2660902|P1|STARTED|Overall Study||50
1099198|NCT01090739|2660908|P1|NOT COMPLETED|36 Month Follow-up||23
1099199|NCT01090739|2660908|P1|COMPLETED|36 Month Follow-up||115
1099200|NCT01090739|2660908|P1|STARTED|36 Month Follow-up||138
1099201|NCT01090739|2660908|P1|NOT COMPLETED|24 Month Follow-up||9
1099202|NCT01090739|2660908|P1|COMPLETED|24 Month Follow-up||138
1099203|NCT01090739|2660908|P1|STARTED|24 Month Follow-up||147
1099204|NCT01090739|2660908|P1|NOT COMPLETED|12 Month Follow-up||5
1099205|NCT01090739|2660908|P1|COMPLETED|12 Month Follow-up||147
1099206|NCT01090739|2660908|P1|STARTED|12 Month Follow-up||152
1099207|NCT01090739|2660908|P1|NOT COMPLETED|Enrollment||55
1099208|NCT01090739|2660908|P1|COMPLETED|Enrollment||152
1099209|NCT01090739|2660908|P1|STARTED|Enrollment|Subject enrollment = signed informed consent form|207
1099210|NCT01090752|2660927|P2|NOT COMPLETED|Overall Study||0
1099211|NCT01090752|2660928|P1|NOT COMPLETED|Overall Study||0
1099212|NCT01090752|2660927|P2|COMPLETED|Overall Study||8
1099213|NCT01090752|2660928|P1|COMPLETED|Overall Study||8
1099214|NCT01090752|2660927|P2|STARTED|Overall Study||8
1099215|NCT01090752|2660928|P1|STARTED|Overall Study||8
1099216|NCT01090765|2660944|P6|NOT COMPLETED|Overall Study||1
1099217|NCT01090765|2660945|P5|NOT COMPLETED|Overall Study||2
1099218|NCT01090765|2660946|P4|NOT COMPLETED|Overall Study||1
1099219|NCT01090765|2660947|P3|NOT COMPLETED|Overall Study||0
1099220|NCT01090765|2660948|P2|NOT COMPLETED|Overall Study||0
1099221|NCT01090765|2660949|P1|NOT COMPLETED|Overall Study||0
1099222|NCT01090765|2660944|P6|COMPLETED|Overall Study||3
1099223|NCT01090765|2660945|P5|COMPLETED|Overall Study||4
1099224|NCT01090765|2660946|P4|COMPLETED|Overall Study||1
1099225|NCT01090765|2660947|P3|COMPLETED|Overall Study||3
1099226|NCT01090765|2660948|P2|COMPLETED|Overall Study||3
1099227|NCT01090765|2660949|P1|COMPLETED|Overall Study||3
1099228|NCT01090765|2660944|P6|STARTED|Overall Study||4
1099229|NCT01090765|2660945|P5|STARTED|Overall Study||6
1099230|NCT01090765|2660946|P4|STARTED|Overall Study||2
1099231|NCT01090765|2660947|P3|STARTED|Overall Study||3
1099232|NCT01090765|2660948|P2|STARTED|Overall Study||3
1099233|NCT01090765|2660949|P1|STARTED|Overall Study||3
1099234|NCT01090973|2660964|P1|NOT COMPLETED|Overall Study||1
1099235|NCT01090973|2660964|P1|COMPLETED|Overall Study||0
1099236|NCT01090973|2660964|P1|STARTED|Overall Study||1
1099237|NCT01091103|2660974|P1|NOT COMPLETED|Overall Study||4
1099238|NCT01091103|2660974|P1|COMPLETED|Overall Study|Patients on study drug and completed Week 9 visit assessments.|56
1099239|NCT01091103|2660974|P1|STARTED|Overall Study||60
1099240|NCT01091116|2660999|P5|NOT COMPLETED|Overall Study||11
1099241|NCT01091116|2661000|P4|NOT COMPLETED|Overall Study||4
1099242|NCT01091116|2661001|P3|NOT COMPLETED|Overall Study||11
1099243|NCT01091116|2661002|P2|NOT COMPLETED|Overall Study||8
1099244|NCT01091116|2661003|P1|NOT COMPLETED|Overall Study||6
1099245|NCT01091116|2660999|P5|COMPLETED|Overall Study||73
1099246|NCT01091116|2661000|P4|COMPLETED|Overall Study||80
1099247|NCT01091116|2661001|P3|COMPLETED|Overall Study||73
1099248|NCT01091116|2661002|P2|COMPLETED|Overall Study||80
1099249|NCT01091116|2661003|P1|COMPLETED|Overall Study||77
1099250|NCT01091116|2660999|P5|STARTED|Overall Study||84
1099251|NCT01091116|2661000|P4|STARTED|Overall Study||84
1099252|NCT01091116|2661001|P3|STARTED|Overall Study||84
1099253|NCT01091116|2661002|P2|STARTED|Overall Study||88
1099254|NCT01091116|2661003|P1|STARTED|Overall Study||83
1099255|NCT01091155|2661055|P1|NOT COMPLETED|Overall Study||9
1099256|NCT01091155|2661055|P1|COMPLETED|Overall Study||279
1099257|NCT01091155|2661055|P1|STARTED|Overall Study||288
1099258|NCT01091246|2661062|P3|NOT COMPLETED|Overall Study||13
1099259|NCT01091246|2661063|P2|NOT COMPLETED|Overall Study||16
1099260|NCT01091246|2661064|P1|NOT COMPLETED|Overall Study||35
1099261|NCT01091246|2661062|P3|COMPLETED|Overall Study||450
1099262|NCT01091246|2661063|P2|COMPLETED|Overall Study||448
1099263|NCT01091246|2661064|P1|COMPLETED|Overall Study||1350
1099264|NCT01091246|2661062|P3|STARTED|Overall Study||463
1099265|NCT01091246|2661063|P2|STARTED|Overall Study||464
1099266|NCT01091246|2661064|P1|STARTED|Overall Study||1385
1099267|NCT01091259|2661138|P1|NOT COMPLETED|Overall Study||5
1099268|NCT01091259|2661138|P1|COMPLETED|Overall Study|Number of patients who had at least 2 cycles of treatments|24
1099269|NCT01091259|2661138|P1|STARTED|Overall Study||29
1099270|NCT01091454|2661146|P1|NOT COMPLETED|Overall Study||1
1099271|NCT01091454|2661146|P1|COMPLETED|Overall Study||47
1099272|NCT01091454|2661146|P1|STARTED|Overall Study||48
1099273|NCT01091519|2661157|P2|NOT COMPLETED|Overall Study||73
1099274|NCT01091519|2661158|P1|NOT COMPLETED|Overall Study||55
1099275|NCT01091519|2661157|P2|COMPLETED|Overall Study||362
1099276|NCT01091519|2661158|P1|COMPLETED|Overall Study||291
1099277|NCT01091519|2661157|P2|Treated|Overall Study||431
1099278|NCT01091519|2661158|P1|Treated|Overall Study||342
1099279|NCT01091519|2661157|P2|STARTED|Overall Study||435
1099280|NCT01091519|2661158|P1|STARTED|Overall Study||346
1099281|NCT01091662|2661172|P2|NOT COMPLETED|Overall Study||34
1099282|NCT01091662|2661173|P1|NOT COMPLETED|Overall Study||17
1099283|NCT01091662|2661172|P2|COMPLETED|Overall Study||80
1099284|NCT01091662|2661173|P1|COMPLETED|Overall Study||41
1099285|NCT01091662|2661172|P2|STARTED|Overall Study||114
1099286|NCT01091662|2661173|P1|STARTED|Overall Study||58
1099287|NCT01091675|2661209|P1|NOT COMPLETED|Overall Study||34
1099288|NCT01091675|2661209|P1|COMPLETED|Overall Study||23
1099289|NCT01091675|2661209|P1|STARTED|Overall Study|7 patients leave the study due to hypertension, 27 patients withdrew due to lack of efficacy|57
1099290|NCT01091948|2661215|P2|NOT COMPLETED|Overall Study||0
1099291|NCT01091948|2661216|P1|NOT COMPLETED|Overall Study||0
1099292|NCT01091948|2661215|P2|COMPLETED|Overall Study||38
1099293|NCT01091948|2661216|P1|COMPLETED|Overall Study||37
1099294|NCT01091948|2661215|P2|STARTED|Overall Study||38
1099295|NCT01091948|2661216|P1|STARTED|Overall Study||37
1099296|NCT01091974|2661238|P4|NOT COMPLETED|Overall Study||7
1099297|NCT01091974|2661239|P3|NOT COMPLETED|Overall Study||6
1099298|NCT01091974|2661240|P2|NOT COMPLETED|Overall Study||5
1099299|NCT01091974|2661241|P1|NOT COMPLETED|Overall Study||5
1099300|NCT01091974|2661238|P4|COMPLETED|Overall Study||17
1099301|NCT01091974|2661239|P3|COMPLETED|Overall Study||19
1099302|NCT01091974|2661240|P2|COMPLETED|Overall Study||18
1099303|NCT01091974|2661241|P1|COMPLETED|Overall Study||19
1099304|NCT01091974|2661238|P4|STARTED|Overall Study||24
1099305|NCT01091974|2661239|P3|STARTED|Overall Study||25
1099306|NCT01091974|2661240|P2|STARTED|Overall Study||23
1099307|NCT01091974|2661241|P1|STARTED|Overall Study||24
1099308|NCT01092338|2661257|P2|NOT COMPLETED|Overall Study||1
1099309|NCT01092338|2661258|P1|NOT COMPLETED|Overall Study||1
1099310|NCT01092338|2661257|P2|COMPLETED|Overall Study||21
1099311|NCT01092338|2661258|P1|COMPLETED|Overall Study||21
1099312|NCT01092338|2661257|P2|STARTED|Overall Study||22
1099313|NCT01092338|2661258|P1|STARTED|Overall Study||22
1099314|NCT01084707|2661266|P1|NOT COMPLETED|Overall Study||6
1099315|NCT01084707|2661266|P1|COMPLETED|Overall Study||34
1099316|NCT01084707|2661266|P1|STARTED|Overall Study||40
1099317|NCT01084759|2661300|P1|NOT COMPLETED|Overall Study||2
1099318|NCT01084759|2661300|P1|COMPLETED|Overall Study||14
1099319|NCT01084759|2661300|P1|STARTED|Overall Study||16
1099320|NCT01085006|2661308|P2|NOT COMPLETED|Overall Study||0
1099321|NCT01085006|2661309|P1|NOT COMPLETED|Overall Study||0
1099322|NCT01085006|2661308|P2|COMPLETED|Overall Study||50
1099323|NCT01085006|2661309|P1|COMPLETED|Overall Study||50
1099324|NCT01085006|2661308|P2|STARTED|Overall Study||50
1099325|NCT01085006|2661309|P1|STARTED|Overall Study||50
1099326|NCT01085045|2661315|P1|NOT COMPLETED|Part B||15
1099327|NCT01085045|2661315|P1|COMPLETED|Part B||89
1099328|NCT01085045|2661315|P1|GP MDI 36 µg (PT001)|Part B||0
1099329|NCT01085045|2661315|P1|Foradil 12 µg|Part B||41
1099330|NCT01085045|2661315|P1|Placebo MDI|Part B||47
1099331|NCT01085045|2661315|P1|FF MDI 7.2 µg (PT005)|Part B||43
1099332|NCT01085045|2661315|P1|FF MDI 9.6 µg (PT005)|Part B||43
1099333|NCT01085045|2661315|P1|Spiriva 18 µg|Part B||0
1099334|NCT01085045|2661315|P1|GFF MDI 36/9.6 µg|Part B||0
1099335|NCT01085045|2661315|P1|GFF MDI 72/9.6mcg (PT003)|Part B||0
1099336|NCT01085045|2661315|P1|STARTED|Part B||104
1099337|NCT01085045|2661315|P1|NOT COMPLETED|Part A||18
1099338|NCT01085045|2661315|P1|COMPLETED|Part A||104
1099339|NCT01085045|2661315|P1|Foradil 12 µg|Part A||14
1099340|NCT01085045|2661315|P1|Placebo MDI|Part A||5
1099341|NCT01085045|2661315|P1|FF MDI 7.2 µg (PT005)|Part A||21
1099342|NCT01085045|2661315|P1|FF MDI 9.6 µg (PT005)|Part A||20
1099343|NCT01085045|2661315|P1|Spiriva 18 µg|Part A||58
1099344|NCT01085045|2661315|P1|GP MDI 36 µg (PT001)|Part A||40
1099345|NCT01085045|2661315|P1|GFF MDI 36/9.6 µg (PT003)|Part A||42
1099346|NCT01085045|2661315|P1|GFF MDI 72/9.6mcg|Part A||40
1099347|NCT01085045|2661315|P1|STARTED|Part A||122
1099348|NCT01085136|2661415|P3|NOT COMPLETED|Part B||26
1099349|NCT01085136|2661416|P2|NOT COMPLETED|Part B||51
1099350|NCT01085136|2661417|P1|NOT COMPLETED|Part B||0
1099351|NCT01085136|2661415|P3|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|42
1099352|NCT01085136|2661416|P2|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|87
1099353|NCT01085136|2661417|P1|COMPLETED|Part B|Afatinib monotherapy not administered in Part B|0
1099354|NCT01085136|2661415|P3|STARTED|Part B||68
1099355|NCT01085136|2661416|P2|STARTED|Part B||138
1099356|NCT01085136|2661417|P1|STARTED|Part B|Afatinib monotherapy not administered in Part B|0
1099357|NCT01085136|2661415|P3|NOT COMPLETED|Part A||0
1099358|NCT01085136|2661416|P2|NOT COMPLETED|Part A||0
1099359|NCT01085136|2661417|P1|NOT COMPLETED|Part A||323
1099360|NCT01085136|2661415|P3|COMPLETED|Part A||0
1099361|NCT01085136|2661416|P2|COMPLETED|Part A||0
1099362|NCT01085136|2661417|P1|COMPLETED|Part A|Randomized to Part B & completed trial as per protocol, had PD, clinical progression.|831
1099363|NCT01085136|2661415|P3|Randomized to Part B|Part A||0
1099364|NCT01085136|2661416|P2|Randomized to Part B|Part A||0
1099365|NCT01085136|2661417|P1|Randomized to Part B|Part A|Discontinued Part A -Randomized to Part B|206
1099366|NCT01085136|2661415|P3|STARTED|Part A||0
1099367|NCT01085136|2661416|P2|STARTED|Part A|Only Afatinib monotherapy administered in Part A|0
1099368|NCT01085136|2661417|P1|STARTED|Part A||1154
1099369|NCT01085201|2661438|P5|NOT COMPLETED|Overall Study||0
1099370|NCT01085201|2661439|P4|NOT COMPLETED|Overall Study||0
1099371|NCT01085201|2661440|P3|NOT COMPLETED|Overall Study||2
1099372|NCT01085201|2661441|P2|NOT COMPLETED|Overall Study||1
1099373|NCT01085201|2661442|P1|NOT COMPLETED|Overall Study||3
1099374|NCT01085201|2661438|P5|COMPLETED|Overall Study||3
1099375|NCT01085201|2661439|P4|COMPLETED|Overall Study||6
1099376|NCT01085201|2661440|P3|COMPLETED|Overall Study||3
1099377|NCT01085201|2661441|P2|COMPLETED|Overall Study||6
1099378|NCT01085201|2661442|P1|COMPLETED|Overall Study||15
1099379|NCT01085201|2661438|P5|STARTED|Overall Study||3
1099380|NCT01085201|2661439|P4|STARTED|Overall Study||6
1099381|NCT01085201|2661440|P3|STARTED|Overall Study||5
1099382|NCT01085201|2661441|P2|STARTED|Overall Study||7
1099383|NCT01085201|2661442|P1|STARTED|Overall Study||18
1099384|NCT01085214|2661464|P1|NOT COMPLETED|Overall Study||1
1099385|NCT01085214|2661464|P1|COMPLETED|Overall Study||36
1099386|NCT01085214|2661464|P1|STARTED|Overall Study||37
1099387|NCT01085318|2661473|P2|NOT COMPLETED|Overall Study||0
1099388|NCT01085318|2661474|P1|NOT COMPLETED|Overall Study||2
1099389|NCT01085318|2661473|P2|COMPLETED|Overall Study||15
1099390|NCT01085318|2661474|P1|COMPLETED|Overall Study||21
1099391|NCT01085318|2661473|P2|STARTED|Overall Study||15
1099392|NCT01085318|2661474|P1|STARTED|Overall Study||23
1099393|NCT01085331|2661486|P2|NOT COMPLETED|Overall Study||0
1099394|NCT01085331|2661487|P1|NOT COMPLETED|Overall Study||0
1099395|NCT01085331|2661486|P2|COMPLETED|Overall Study||6
1099396|NCT01085331|2661487|P1|COMPLETED|Overall Study||10
1099397|NCT01085331|2661486|P2|STARTED|Overall Study||6
1099398|NCT01085331|2661487|P1|STARTED|Overall Study||10
1099399|NCT01085357|2661526|P2|NOT COMPLETED|Overall Study||6
1099400|NCT01085357|2661527|P1|NOT COMPLETED|Overall Study||19
1099401|NCT01085357|2661526|P2|COMPLETED|Overall Study||125
1099402|NCT01085357|2661527|P1|COMPLETED|Overall Study||355
1099403|NCT01085357|2661526|P2|STARTED|Overall Study||131
1099404|NCT01085357|2661527|P1|STARTED|Overall Study||374
1099405|NCT01085500|2661539|P2|NOT COMPLETED|Overall Study||0
1099406|NCT01085500|2661540|P1|NOT COMPLETED|Overall Study||0
1099407|NCT01085500|2661539|P2|COMPLETED|Overall Study||24
1099408|NCT01085500|2661540|P1|COMPLETED|Overall Study||26
1099409|NCT01085500|2661539|P2|STARTED|Overall Study||24
1099410|NCT01085500|2661540|P1|STARTED|Overall Study||26
1099411|NCT01085513|2661552|P2|NOT COMPLETED|Overall Study||0
1099412|NCT01085513|2661553|P1|NOT COMPLETED|Overall Study||0
1099413|NCT01085513|2661552|P2|COMPLETED|Overall Study||68
1099414|NCT01085513|2661553|P1|COMPLETED|Overall Study|recruitment was premature terminated|75
1099415|NCT01085513|2661552|P2|STARTED|Overall Study||68
1099416|NCT01085513|2661553|P1|STARTED|Overall Study||75
1099417|NCT01085539|2661559|P1|NOT COMPLETED|100Sat Secs-100 Second Alarm Evaluation||0
1099418|NCT01085539|2661559|P1|COMPLETED|100Sat Secs-100 Second Alarm Evaluation||50
1099419|NCT01085539|2661559|P1|STARTED|100Sat Secs-100 Second Alarm Evaluation||50
1099420|NCT01085539|2661559|P1|NOT COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||0
1099421|NCT01085539|2661559|P1|COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||50
1099422|NCT01085539|2661559|P1|STARTED|50 Sat Secs--50 Second Alarm Evaluation||50
1099423|NCT01085539|2661559|P1|NOT COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||0
1099424|NCT01085539|2661559|P1|COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||50
1099425|NCT01085539|2661559|P1|STARTED|25 Sat Secs--25 Second Alarm Evaluation||50
1099426|NCT01085539|2661559|P1|NOT COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||0
1099427|NCT01085539|2661559|P1|COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||50
1099428|NCT01085539|2661559|P1|STARTED|10 Sat Secs--10 Second Alarm Evaluation||50
1099429|NCT01085539|2661559|P1|NOT COMPLETED|Sat Secs Off--No Alarm Evaluation||0
1099430|NCT01085539|2661559|P1|COMPLETED|Sat Secs Off--No Alarm Evaluation||50
1099431|NCT01085539|2661559|P1|STARTED|Sat Secs Off--No Alarm Evaluation||50
1099432|NCT01085591|2661566|P3|NOT COMPLETED|Overall Study||7
1099433|NCT01085591|2661567|P2|NOT COMPLETED|Overall Study||6
1099434|NCT01085591|2661568|P1|NOT COMPLETED|Overall Study||3
1099435|NCT01085591|2661566|P3|COMPLETED|Overall Study||63
1099436|NCT01085591|2661567|P2|COMPLETED|Overall Study||65
1099437|NCT01085591|2661568|P1|COMPLETED|Overall Study||66
1099438|NCT01085591|2661566|P3|Received at Least 1 Dose of Study Drug|Overall Study||70
1099439|NCT01085591|2661567|P2|Received at Least 1 Dose of Study Drug|Overall Study||69
1099440|NCT01085591|2661568|P1|Received at Least 1 Dose of Study Drug|Overall Study||68
1099441|NCT01085591|2661566|P3|STARTED|Overall Study||70
1099442|NCT01085591|2661567|P2|STARTED|Overall Study||71
1099443|NCT01085591|2661568|P1|STARTED|Overall Study||69
1099444|NCT01085643|2661591|P1|NOT COMPLETED|Overall Study||0
1099445|NCT01085643|2661591|P1|COMPLETED|Overall Study||4
1099446|NCT01085643|2661591|P1|STARTED|Overall Study||4
1099447|NCT01085682|2661602|P2|NOT COMPLETED|Overall Study||25
1099448|NCT01085682|2661603|P1|NOT COMPLETED|Overall Study||25
1099449|NCT01085682|2661602|P2|COMPLETED|Overall Study||3
1099450|NCT01085682|2661603|P1|COMPLETED|Overall Study||6
1099451|NCT01085682|2661602|P2|STARTED|Overall Study||28
1099452|NCT01085682|2661603|P1|STARTED|Overall Study||31
1099453|NCT01085734|2661611|P2|NOT COMPLETED|Overall Study||4
1099454|NCT01085734|2661612|P1|NOT COMPLETED|Overall Study||1
1099455|NCT01085734|2661611|P2|COMPLETED|Overall Study||11
1099456|NCT01085734|2661612|P1|COMPLETED|Overall Study||14
1099457|NCT01085734|2661611|P2|STARTED|Overall Study||15
1099458|NCT01085734|2661612|P1|STARTED|Overall Study||15
1099459|NCT01085760|2661626|P4|NOT COMPLETED|Overall Study||3
1099460|NCT01085760|2661627|P3|NOT COMPLETED|Overall Study||2
1099461|NCT01085760|2661628|P2|NOT COMPLETED|Overall Study||1
1099462|NCT01085760|2661629|P1|NOT COMPLETED|Overall Study||1
1099463|NCT01085760|2661626|P4|COMPLETED|Overall Study||6
1099464|NCT01085760|2661627|P3|COMPLETED|Overall Study||7
1099465|NCT01085760|2661628|P2|COMPLETED|Overall Study||8
1099466|NCT01085760|2661629|P1|COMPLETED|Overall Study||7
1099467|NCT01085760|2661626|P4|STARTED|Overall Study||9
1099468|NCT01085760|2661627|P3|STARTED|Overall Study||9
1099469|NCT01085760|2661628|P2|STARTED|Overall Study||9
1099470|NCT01085760|2661629|P1|STARTED|Overall Study||8
1099471|NCT01085786|2661653|P2|NOT COMPLETED|Overall Study||0
1099472|NCT01085786|2661654|P1|NOT COMPLETED|Overall Study||0
1099473|NCT01085786|2661653|P2|COMPLETED|Overall Study||117
1099474|NCT01085786|2661654|P1|COMPLETED|Overall Study||123
1099475|NCT01085786|2661653|P2|STARTED|Overall Study||117
1099476|NCT01085786|2661654|P1|STARTED|Overall Study||123
1099477|NCT01085825|2661662|P2|NOT COMPLETED|Overall Study||1
1099478|NCT01085825|2661663|P1|NOT COMPLETED|Overall Study||1
1099479|NCT01085825|2661662|P2|COMPLETED|Overall Study||247
1099480|NCT01085825|2661663|P1|COMPLETED|Overall Study||251
1099481|NCT01085825|2661662|P2|STARTED|Overall Study||248
1099482|NCT01085825|2661663|P1|STARTED|Overall Study|1st participant enrolled|252
1099483|NCT01085903|2661671|P3|NOT COMPLETED|Overall Study||0
1099484|NCT01085903|2661672|P2|NOT COMPLETED|Overall Study||0
1099485|NCT01085903|2661673|P1|NOT COMPLETED|Overall Study||0
1099486|NCT01085903|2661671|P3|COMPLETED|Overall Study||3
1099487|NCT01085903|2661672|P2|COMPLETED|Overall Study||4
1099488|NCT01085903|2661673|P1|COMPLETED|Overall Study||21
1099489|NCT01085903|2661671|P3|STARTED|Overall Study||3
1099490|NCT01085903|2661672|P2|STARTED|Overall Study||4
1099491|NCT01085903|2661673|P1|STARTED|Overall Study||21
1099492|NCT01085968|2661699|P2|NOT COMPLETED|Overall Study||4
1099493|NCT01085968|2661700|P1|NOT COMPLETED|Overall Study||10
1099494|NCT01085968|2661699|P2|COMPLETED|Overall Study||21
1099495|NCT01085968|2661700|P1|COMPLETED|Overall Study||19
1099496|NCT01085968|2661699|P2|STARTED|Overall Study||25
1099497|NCT01085968|2661700|P1|STARTED|Overall Study||29
1099498|NCT01086033|2661714|P1|NOT COMPLETED|Overall Study||304
1099499|NCT01086033|2661714|P1|COMPLETED|Overall Study||262
1099500|NCT01086033|2661714|P1|STARTED|Overall Study||566
1099501|NCT01086215|2661730|P4|NOT COMPLETED|Overall Study||3
1099502|NCT01086215|2661731|P3|NOT COMPLETED|Overall Study||26
1099503|NCT01086215|2661732|P2|NOT COMPLETED|Overall Study||47
1099504|NCT01086215|2661733|P1|NOT COMPLETED|Overall Study||36
1099505|NCT01086215|2661730|P4|COMPLETED|Overall Study||11
1099506|NCT01086215|2661731|P3|COMPLETED|Overall Study||47
1099507|NCT01086215|2661732|P2|COMPLETED|Overall Study||154
1099508|NCT01086215|2661733|P1|COMPLETED|Overall Study||176
1099509|NCT01086215|2661730|P4|12 Month Follow Up|Overall Study|0 LTF; 1 Death|11
1099510|NCT01086215|2661731|P3|12 Month Follow Up|Overall Study|9 LTF; 4 Deaths|47
1099511|NCT01086215|2661732|P2|12 Month Follow Up|Overall Study|16 LTF; 2 Deaths|154
1099512|NCT01086215|2661733|P1|12 Month Follow Up|Overall Study|10 LTF; 6 Deaths|176
1099513|NCT01086215|2661730|P4|6 Month Follow Up|Overall Study|1 LTF; 0 Deaths|12
1099514|NCT01086215|2661731|P3|6 Month Follow Up|Overall Study|4 LTF; 0 Deaths|60
1099515|NCT01086215|2661732|P2|6 Month Follow Up|Overall Study|13 LTF; 2 Deaths|172
1099516|NCT01086215|2661733|P1|6 Month Follow Up|Overall Study|5 LTF; 4 Deaths|192
1099517|NCT01086215|2661730|P4|3 Month Follow Up|Overall Study|1 LTF; 0 Deaths|13
1099518|NCT01086215|2661731|P3|3 Month Follow Up|Overall Study|5 LTF; 4 Deaths|64
1099519|NCT01086215|2661732|P2|3 Month Follow Up|Overall Study|10 LTF; 4 Deaths|187
1099520|NCT01086215|2661733|P1|3 Month Follow Up|Overall Study|7 LTF; 4 Deaths|201
1099521|NCT01086215|2661730|P4|STARTED|Overall Study||14
1099522|NCT01086215|2661731|P3|STARTED|Overall Study||73
1099523|NCT01086215|2661732|P2|STARTED|Overall Study||201
1099524|NCT01086215|2661733|P1|STARTED|Overall Study||212
1099525|NCT01092416|2661751|P1|NOT COMPLETED|12-Month Follow-up||25
1099526|NCT01092416|2661751|P1|COMPLETED|12-Month Follow-up||413
1099527|NCT01092416|2661751|P1|STARTED|12-Month Follow-up||438
1099528|NCT01092416|2661751|P1|NOT COMPLETED|30-Day Follow-up||10
1099529|NCT01092416|2661751|P1|COMPLETED|30-Day Follow-up||430
1099530|NCT01092416|2661751|P1|STARTED|30-Day Follow-up||440
1099531|NCT01092416|2661751|P1|NOT COMPLETED|Enrollment||3
1099532|NCT01092416|2661751|P1|COMPLETED|Enrollment||440
1099533|NCT01092416|2661751|P1|STARTED|Enrollment||443
1099534|NCT01092442|2661762|P2|NOT COMPLETED|Overall Study||0
1099535|NCT01092442|2661763|P1|NOT COMPLETED|Overall Study||0
1099536|NCT01092442|2661762|P2|COMPLETED|Overall Study||60
1099537|NCT01092442|2661763|P1|COMPLETED|Overall Study||80
1099538|NCT01092442|2661762|P2|STARTED|Overall Study||60
1099539|NCT01092442|2661763|P1|STARTED|Overall Study||80
1099540|NCT01092507|2661779|P2|NOT COMPLETED|Overall Study||0
1099541|NCT01092507|2661780|P1|NOT COMPLETED|Overall Study||2
1099542|NCT01092507|2661779|P2|COMPLETED|Overall Study||150
1099543|NCT01092507|2661780|P1|COMPLETED|Overall Study||147
1099544|NCT01092507|2661779|P2|STARTED|Overall Study||150
1099545|NCT01092507|2661780|P1|STARTED|Overall Study||149
1099546|NCT01092546|2661798|P1|NOT COMPLETED|Overall Study||4
1099547|NCT01092546|2661798|P1|COMPLETED|Overall Study||12
1099548|NCT01092546|2661798|P1|STARTED|Overall Study||16
1099549|NCT01092559|2661803|P1|NOT COMPLETED|Overall Study||0
1099550|NCT01092559|2661803|P1|COMPLETED|Overall Study||10
1099551|NCT01092559|2661803|P1|STARTED|Overall Study||10
1099552|NCT01092637|2661810|P2|NOT COMPLETED|Overall Study||49
1099553|NCT01092637|2661811|P1|NOT COMPLETED|Overall Study||47
1099554|NCT01092637|2661810|P2|COMPLETED|Overall Study||86
1099555|NCT01092637|2661811|P1|COMPLETED|Overall Study||98
1099556|NCT01092637|2661810|P2|STARTED|Overall Study||135
1099557|NCT01092637|2661811|P1|STARTED|Overall Study||145
1099558|NCT01092663|2661823|P2|NOT COMPLETED|Overall Study||4
1099559|NCT01092663|2661824|P1|NOT COMPLETED|Overall Study||7
1099560|NCT01092663|2661823|P2|COMPLETED|Overall Study||26
1099561|NCT01092663|2661824|P1|COMPLETED|Overall Study||24
1099562|NCT01092663|2661823|P2|STARTED|Overall Study||30
1099563|NCT01092663|2661824|P1|STARTED|Overall Study||31
1099564|NCT01092702|2661870|P1|NOT COMPLETED|Overall Study||9
1099565|NCT01092702|2661870|P1|COMPLETED|Overall Study||23
1099566|NCT01092702|2661870|P1|STARTED|Overall Study||32
1099567|NCT01095094|2661874|P1|NOT COMPLETED|Overall Study||3
1099568|NCT01095094|2661874|P1|COMPLETED|Overall Study||16
1099569|NCT01095094|2661874|P1|STARTED|Overall Study||19
1099570|NCT01095250|2661883|P4|NOT COMPLETED|Overall Study||5
1099571|NCT01095250|2661884|P3|NOT COMPLETED|Overall Study||8
1099572|NCT01095250|2661885|P2|NOT COMPLETED|Overall Study||10
1099573|NCT01095250|2661886|P1|NOT COMPLETED|Overall Study||8
1099574|NCT01095250|2661883|P4|COMPLETED|Overall Study||0
1099575|NCT01095250|2661884|P3|COMPLETED|Overall Study||0
1099576|NCT01095250|2661885|P2|COMPLETED|Overall Study||0
1099577|NCT01095250|2661886|P1|COMPLETED|Overall Study||0
1099578|NCT01095250|2661883|P4|STARTED|Overall Study||5
1099579|NCT01095250|2661884|P3|STARTED|Overall Study||8
1099580|NCT01095250|2661885|P2|STARTED|Overall Study||10
1099581|NCT01095250|2661886|P1|STARTED|Overall Study||8
1099582|NCT01095497|2661918|P2|NOT COMPLETED|Subcutaneous CINRYZE||0
1099583|NCT01095497|2661919|P1|NOT COMPLETED|Subcutaneous CINRYZE||1
1099584|NCT01095497|2661918|P2|COMPLETED|Subcutaneous CINRYZE||12
1099585|NCT01095497|2661919|P1|COMPLETED|Subcutaneous CINRYZE||12
1099586|NCT01095497|2661918|P2|STARTED|Subcutaneous CINRYZE||12
1099587|NCT01095497|2661919|P1|STARTED|Subcutaneous CINRYZE||13
1099588|NCT01095497|2661918|P2|NOT COMPLETED|Intravenous CINRYZE||0
1099589|NCT01095497|2661919|P1|NOT COMPLETED|Intravenous CINRYZE||1
1099590|NCT01095497|2661918|P2|COMPLETED|Intravenous CINRYZE||12
1099591|NCT01095497|2661919|P1|COMPLETED|Intravenous CINRYZE||13
1099592|NCT01095497|2661918|P2|STARTED|Intravenous CINRYZE||12
1099593|NCT01095497|2661919|P1|STARTED|Intravenous CINRYZE||14
1099594|NCT01095510|2661930|P4|NOT COMPLETED|Overall Study||0
1099595|NCT01095510|2661931|P3|NOT COMPLETED|Overall Study||0
1099596|NCT01095510|2661932|P2|NOT COMPLETED|Overall Study||0
1099597|NCT01095510|2661933|P1|NOT COMPLETED|Overall Study||0
1099598|NCT01095510|2661930|P4|COMPLETED|Overall Study||3
1099599|NCT01095510|2661931|P3|COMPLETED|Overall Study||3
1099600|NCT01095510|2661932|P2|COMPLETED|Overall Study||0
1099601|NCT01095510|2661933|P1|COMPLETED|Overall Study||3
1099602|NCT01095510|2661930|P4|STARTED|Overall Study||3
1099603|NCT01095510|2661931|P3|STARTED|Overall Study||3
1099604|NCT01095510|2661932|P2|STARTED|Overall Study||0
1099605|NCT01095510|2661933|P1|STARTED|Overall Study||3
1099606|NCT01095653|2661953|P3|NOT COMPLETED|Overall Study||16
1099607|NCT01095653|2661954|P2|NOT COMPLETED|Overall Study||15
1099608|NCT01095653|2661955|P1|NOT COMPLETED|Overall Study||19
1099609|NCT01095653|2661953|P3|COMPLETED|Overall Study||117
1099610|NCT01095653|2661954|P2|COMPLETED|Overall Study||113
1099611|NCT01095653|2661955|P1|COMPLETED|Overall Study||113
1099612|NCT01095653|2661953|P3|STARTED|Overall Study||133
1099613|NCT01095653|2661954|P2|STARTED|Overall Study||128
1099614|NCT01095653|2661955|P1|STARTED|Overall Study||132
1099615|NCT01095666|2661978|P3|NOT COMPLETED|Overall Study||7
1099616|NCT01095666|2661979|P2|NOT COMPLETED|Overall Study||11
1099617|NCT01095666|2661980|P1|NOT COMPLETED|Overall Study||17
1099618|NCT01095666|2661978|P3|COMPLETED|Overall Study||145
1099619|NCT01095666|2661979|P2|COMPLETED|Overall Study||136
1099620|NCT01095666|2661980|P1|COMPLETED|Overall Study||128
1099621|NCT01095666|2661978|P3|STARTED|Overall Study||152
1099622|NCT01095666|2661979|P2|STARTED|Overall Study||147
1099623|NCT01095666|2661980|P1|STARTED|Overall Study||145
1099624|NCT01095757|2662000|P1|NOT COMPLETED|Overall Study||0
1099625|NCT01095757|2662000|P1|COMPLETED|Overall Study||45
1099626|NCT01095757|2662000|P1|STARTED|Overall Study||45
1099627|NCT01095796|2662011|P2|NOT COMPLETED|Overall Study||289
1099628|NCT01095796|2662012|P1|NOT COMPLETED|Overall Study||295
1099629|NCT01095796|2662011|P2|COMPLETED|Overall Study||65
1099630|NCT01095796|2662012|P1|COMPLETED|Overall Study||58
1099631|NCT01095796|2662011|P2|STARTED|Overall Study||354
1099632|NCT01095796|2662012|P1|STARTED|Overall Study||353
1099633|NCT01095835|2662033|P3|NOT COMPLETED|Overall Study||8
1099634|NCT01095835|2662034|P2|NOT COMPLETED|Overall Study||12
1099635|NCT01095835|2662035|P1|NOT COMPLETED|Overall Study||10
1099636|NCT01095835|2662033|P3|COMPLETED|Overall Study||17
1099637|NCT01095835|2662034|P2|COMPLETED|Overall Study||40
1099638|NCT01095835|2662035|P1|COMPLETED|Overall Study||41
1099639|NCT01095835|2662033|P3|STARTED|Overall Study||25
1099640|NCT01095835|2662034|P2|STARTED|Overall Study||52
1099641|NCT01095835|2662035|P1|STARTED|Overall Study||51
1099642|NCT01095887|2662071|P1|NOT COMPLETED|Overall Study||0
1099643|NCT01095887|2662071|P1|COMPLETED|Overall Study||6
1099644|NCT01095887|2662071|P1|STARTED|Overall Study||6
1099645|NCT01095978|2662075|P1|NOT COMPLETED|Overall Study||3
1099646|NCT01095978|2662075|P1|COMPLETED|Overall Study||2819
1099647|NCT01095978|2662075|P1|STARTED|Overall Study||2822
1099648|NCT01096017|2662102|P2|NOT COMPLETED|Treatment Period 2||1
1099649|NCT01096017|2662103|P1|NOT COMPLETED|Treatment Period 2||1
1099650|NCT01096017|2662102|P2|COMPLETED|Treatment Period 2||11
1099651|NCT01096017|2662103|P1|COMPLETED|Treatment Period 2||11
1099652|NCT01096017|2662102|P2|STARTED|Treatment Period 2||12
1099653|NCT01096017|2662103|P1|STARTED|Treatment Period 2||12
1099654|NCT01096017|2662102|P2|NOT COMPLETED|Washout 1 - 14 Days||0
1099655|NCT01096017|2662103|P1|NOT COMPLETED|Washout 1 - 14 Days||0
1099656|NCT01096017|2662102|P2|COMPLETED|Washout 1 - 14 Days||12
1099657|NCT01096017|2662103|P1|COMPLETED|Washout 1 - 14 Days||12
1099658|NCT01096017|2662102|P2|STARTED|Washout 1 - 14 Days||12
1099659|NCT01096017|2662103|P1|STARTED|Washout 1 - 14 Days||12
1099660|NCT01096017|2662102|P2|NOT COMPLETED|Treatment Period 1||0
1099661|NCT01096017|2662103|P1|NOT COMPLETED|Treatment Period 1||0
1099662|NCT01096017|2662102|P2|COMPLETED|Treatment Period 1||12
1099663|NCT01096017|2662103|P1|COMPLETED|Treatment Period 1||12
1099664|NCT01096017|2662102|P2|STARTED|Treatment Period 1||12
1099665|NCT01096017|2662103|P1|STARTED|Treatment Period 1||12
1099666|NCT01096056|2662133|P2|NOT COMPLETED|Overall Study||1
1099667|NCT01096056|2662134|P1|NOT COMPLETED|Overall Study||0
1099668|NCT01096056|2662133|P2|COMPLETED|Overall Study||19
1099669|NCT01096056|2662134|P1|COMPLETED|Overall Study||20
1099670|NCT01096056|2662133|P2|Completed at Day 42|Overall Study||20
1099671|NCT01096056|2662134|P1|Completed at Day 42|Overall Study||20
1099672|NCT01096056|2662133|P2|STARTED|Overall Study||20
1099673|NCT01096056|2662134|P1|STARTED|Overall Study||20
1099674|NCT01096186|2662166|P1|NOT COMPLETED|Overall Study||50
1099675|NCT01096186|2662166|P1|COMPLETED|Overall Study||567
1099676|NCT01096186|2662166|P1|STARTED|Overall Study||617
1099677|NCT01096316|2662174|P2|NOT COMPLETED|Overall Study||9
1099678|NCT01096316|2662175|P1|NOT COMPLETED|Overall Study||15
1099679|NCT01096316|2662174|P2|COMPLETED|Overall Study||94
1099680|NCT01096316|2662175|P1|COMPLETED|Overall Study||87
1099681|NCT01096316|2662174|P2|STARTED|Overall Study||103
1099682|NCT01096316|2662175|P1|STARTED|Overall Study||102
1099683|NCT01096342|2662185|P1|NOT COMPLETED|Overall Study||1
1099684|NCT01096342|2662185|P1|COMPLETED|Overall Study||15
1099685|NCT01096342|2662185|P1|STARTED|Overall Study||16
1099686|NCT01096446|2662193|P2|NOT COMPLETED|Overall Study||0
1099687|NCT01096446|2662194|P1|NOT COMPLETED|Overall Study||3
1099688|NCT01096446|2662193|P2|COMPLETED|Overall Study||10
1099689|NCT01096446|2662194|P1|COMPLETED|Overall Study|One infant was SGA; one infant had a congenital anomaly; and one discontinued medical management|9
1099690|NCT01096446|2662193|P2|STARTED|Overall Study||10
1099691|NCT01096446|2662194|P1|STARTED|Overall Study||12
1099692|NCT01096550|2662201|P2|NOT COMPLETED|Overall Study||29
1099693|NCT01096550|2662202|P1|NOT COMPLETED|Overall Study||37
1099694|NCT01096550|2662201|P2|COMPLETED|Overall Study||146
1099695|NCT01096550|2662202|P1|COMPLETED|Overall Study||133
1099696|NCT01096550|2662201|P2|STARTED|Overall Study||175
1099697|NCT01096550|2662202|P1|STARTED|Overall Study||170
1099698|NCT01096589|2662212|P4|NOT COMPLETED|Overall Study||3
1099699|NCT01096589|2662213|P3|NOT COMPLETED|Overall Study||4
1099700|NCT01096589|2662214|P2|NOT COMPLETED|Overall Study||2
1099701|NCT01096589|2662215|P1|NOT COMPLETED|Overall Study||4
1099702|NCT01096589|2662212|P4|COMPLETED|Overall Study||15
1099703|NCT01096589|2662213|P3|COMPLETED|Overall Study||18
1099704|NCT01096589|2662214|P2|COMPLETED|Overall Study||18
1099705|NCT01096589|2662215|P1|COMPLETED|Overall Study||18
1099706|NCT01096589|2662212|P4|STARTED|Overall Study||18
1099707|NCT01096589|2662213|P3|STARTED|Overall Study||22
1099708|NCT01096589|2662214|P2|STARTED|Overall Study||20
1099709|NCT01096589|2662215|P1|STARTED|Overall Study||22
1099710|NCT01096680|2662230|P5|NOT COMPLETED|Overall Study||0
1099711|NCT01096680|2662231|P4|NOT COMPLETED|Overall Study||0
1099712|NCT01096680|2662232|P3|NOT COMPLETED|Overall Study||0
1099713|NCT01096680|2662233|P2|NOT COMPLETED|Overall Study||0
1099714|NCT01096680|2662234|P1|NOT COMPLETED|Overall Study||0
1099715|NCT01096680|2662230|P5|COMPLETED|Overall Study||27
1099716|NCT01096680|2662231|P4|COMPLETED|Overall Study||27
1099717|NCT01096680|2662232|P3|COMPLETED|Overall Study||27
1099718|NCT01096680|2662233|P2|COMPLETED|Overall Study||27
1099719|NCT01096680|2662234|P1|COMPLETED|Overall Study||27
1099720|NCT01096680|2662230|P5|STARTED|Overall Study||27
1099721|NCT01096680|2662231|P4|STARTED|Overall Study||27
1099722|NCT01096680|2662232|P3|STARTED|Overall Study||27
1099723|NCT01096680|2662233|P2|STARTED|Overall Study||27
1099724|NCT01096680|2662234|P1|STARTED|Overall Study||27
1099725|NCT01096771|2662268|P2|NOT COMPLETED|Overall Study||0
1099726|NCT01096771|2662269|P1|NOT COMPLETED|Overall Study||0
1099727|NCT01096771|2662268|P2|COMPLETED|Overall Study||7
1099728|NCT01096771|2662269|P1|COMPLETED|Overall Study||7
1099729|NCT01096771|2662268|P2|STARTED|Overall Study||7
1099730|NCT01096771|2662269|P1|STARTED|Overall Study||7
1099731|NCT01096784|2662295|P2|NOT COMPLETED|Overall Study||14
1099732|NCT01096784|2662296|P1|NOT COMPLETED|Overall Study||15
1099733|NCT01096784|2662295|P2|COMPLETED|Overall Study||46
1099734|NCT01096784|2662296|P1|COMPLETED|Overall Study||46
1099735|NCT01096784|2662295|P2|STARTED|Overall Study||60
1099736|NCT01096784|2662296|P1|STARTED|Overall Study||61
1099737|NCT01096810|2662328|P1|NOT COMPLETED|Overall Study||0
1099738|NCT01096810|2662328|P1|COMPLETED|Overall Study||20
1099739|NCT01096810|2662328|P1|STARTED|Overall Study||20
1099740|NCT01096823|2662336|P2|NOT COMPLETED|Overall Study||1
1099741|NCT01096823|2662337|P1|NOT COMPLETED|Overall Study||3
1099742|NCT01096823|2662336|P2|COMPLETED|Overall Study||15
1099743|NCT01096823|2662337|P1|COMPLETED|Overall Study||11
1099744|NCT01096823|2662336|P2|STARTED|Overall Study||16
1099745|NCT01096823|2662337|P1|STARTED|Overall Study||14
1099746|NCT01096875|2662351|P2|NOT COMPLETED|Overall Study||1
1099747|NCT01096875|2662352|P1|NOT COMPLETED|Overall Study||0
1099748|NCT01096875|2662351|P2|COMPLETED|Overall Study||29
1099749|NCT01096875|2662352|P1|COMPLETED|Overall Study||30
1099750|NCT01096875|2662351|P2|STARTED|Overall Study||30
1099751|NCT01096875|2662352|P1|STARTED|Overall Study||30
1099752|NCT01097005|2662364|P1|NOT COMPLETED|Overall Study||365
1099753|NCT01097005|2662364|P1|COMPLETED|Overall Study||101
1099754|NCT01097005|2662364|P1|Analysis of CGI|Overall Study|number of participants who were measured for Clinical Global Improvement (CGI)|249
1099755|NCT01097005|2662364|P1|Analysis of Bacilli Negative Conversion|Overall Study|number of participants who were analysed for bacilli negative conversion|285
1099756|NCT01097005|2662364|P1|Analysis of NTM Lung Disease|Overall Study|number of participants who contributed to the Baseline data|340
1099757|NCT01097005|2662364|P1|Analysis of Safety|Overall Study|number of participants who could be measured for Adverse Events|441
1099758|NCT01097005|2662364|P1|STARTED|Overall Study|number of participants who were enrolled for this study.|466
1099759|NCT01097057|2662370|P1|NOT COMPLETED|Overall Study||3
1099760|NCT01097057|2662370|P1|COMPLETED|Overall Study||17
1099761|NCT01097057|2662370|P1|STARTED|Overall Study||20
1099762|NCT01097304|2662377|P1|NOT COMPLETED|Overall Study||7
1099763|NCT01097304|2662377|P1|COMPLETED|Overall Study||29
1099764|NCT01097304|2662377|P1|STARTED|Overall Study||36
1099765|NCT01097343|2662381|P2|NOT COMPLETED|Second Intervention- 30 Days||0
1099766|NCT01097343|2662382|P1|NOT COMPLETED|Second Intervention- 30 Days||0
1099767|NCT01097343|2662381|P2|COMPLETED|Second Intervention- 30 Days||25
1099768|NCT01097343|2662382|P1|COMPLETED|Second Intervention- 30 Days||25
1099769|NCT01097343|2662381|P2|STARTED|Second Intervention- 30 Days||25
1099770|NCT01097343|2662382|P1|STARTED|Second Intervention- 30 Days||25
1099771|NCT01097343|2662381|P2|NOT COMPLETED|First Intervention- 30 Days||0
1099772|NCT01097343|2662382|P1|NOT COMPLETED|First Intervention- 30 Days||0
1099773|NCT01097343|2662381|P2|COMPLETED|First Intervention- 30 Days||25
1099774|NCT01097343|2662382|P1|COMPLETED|First Intervention- 30 Days||25
1099775|NCT01097343|2662381|P2|STARTED|First Intervention- 30 Days||25
1099776|NCT01097343|2662382|P1|STARTED|First Intervention- 30 Days||25
1099777|NCT01097421|2662388|P1|NOT COMPLETED|Overall Study||14
1099778|NCT01097421|2662388|P1|COMPLETED|Overall Study||314
1099779|NCT01097421|2662388|P1|STARTED|Overall Study||328
1099780|NCT01097460|2662398|P1|NOT COMPLETED|Overall Study||0
1099781|NCT01097460|2662398|P1|COMPLETED|Overall Study||16
1099782|NCT01097460|2662398|P1|STARTED|Overall Study||16
1099783|NCT01089231|2662406|P4|NOT COMPLETED|Overall Study||1
1099784|NCT01089231|2662407|P3|NOT COMPLETED|Overall Study||2
1099785|NCT01089231|2662408|P2|NOT COMPLETED|Overall Study||2
1099786|NCT01089231|2662409|P1|NOT COMPLETED|Overall Study||4
1099787|NCT01089231|2662406|P4|COMPLETED|Overall Study|1 subject excluded (low RNA yield)|9
1099788|NCT01089231|2662407|P3|COMPLETED|Overall Study|2 subject excluded (1 use of not allowed drugs; 1 low RNA yield)|8
1099789|NCT01089231|2662408|P2|COMPLETED|Overall Study|2 subjects excluded (1 highly elevated TG and TC data; 1 elevated inflammation (CRP level))|8
1099790|NCT01089231|2662409|P1|COMPLETED|Overall Study|4 subjects excluded (2 alcohol use / TG level changes; 1 use of not allowed drugs; 1 low RNA yield)|6
1099791|NCT01089231|2662406|P4|STARTED|Overall Study||10
1099792|NCT01089231|2662407|P3|STARTED|Overall Study||10
1099793|NCT01089231|2662408|P2|STARTED|Overall Study||10
1099794|NCT01089231|2662409|P1|STARTED|Overall Study||10
1099795|NCT01089361|2662429|P2|NOT COMPLETED|Overall Study||0
1099796|NCT01089361|2662430|P1|NOT COMPLETED|Overall Study||1
1099797|NCT01089361|2662429|P2|COMPLETED|Overall Study||10
1099798|NCT01089361|2662430|P1|COMPLETED|Overall Study||8
1099799|NCT01089361|2662429|P2|STARTED|Overall Study||10
1099800|NCT01089361|2662430|P1|STARTED|Overall Study||9
1099801|NCT01089413|2662451|P1|NOT COMPLETED|Overall Study||201
1099802|NCT01089413|2662451|P1|COMPLETED|Overall Study||0
1099803|NCT01089413|2662451|P1|Received Bevacizumab in First Line|Overall Study||199
1099804|NCT01089413|2662451|P1|STARTED|Overall Study||201
1099805|NCT01089504|2662470|P2|NOT COMPLETED|Overall Study||1
1099806|NCT01089504|2662471|P1|NOT COMPLETED|Overall Study||3
1099807|NCT01089504|2662470|P2|COMPLETED|Overall Study||4
1099808|NCT01089504|2662471|P1|COMPLETED|Overall Study||5
1099809|NCT01089504|2662470|P2|STARTED|Overall Study||5
1099810|NCT01089504|2662471|P1|STARTED|Overall Study||8
1099811|NCT01089517|2662484|P3|NOT COMPLETED|Overall Study||5
1099812|NCT01089517|2662485|P2|NOT COMPLETED|Overall Study||5
1099813|NCT01089517|2662486|P1|NOT COMPLETED|Overall Study||4
1099814|NCT01089517|2662484|P3|COMPLETED|Overall Study||147
1099815|NCT01089517|2662485|P2|COMPLETED|Overall Study||144
1099816|NCT01089517|2662486|P1|COMPLETED|Overall Study||144
1099817|NCT01089517|2662484|P3|STARTED|Overall Study||152
1099818|NCT01089517|2662485|P2|STARTED|Overall Study||149
1099819|NCT01089517|2662486|P1|STARTED|Overall Study||148
1099820|NCT01089543|2662504|P4|NOT COMPLETED|Overall Study||2
1099821|NCT01089543|2662505|P3|NOT COMPLETED|Overall Study||3
1099822|NCT01089543|2662506|P2|NOT COMPLETED|Overall Study||4
1099823|NCT01089543|2662507|P1|NOT COMPLETED|Overall Study||3
1099824|NCT01089543|2662504|P4|COMPLETED|Overall Study||83
1099825|NCT01089543|2662505|P3|COMPLETED|Overall Study||81
1099826|NCT01089543|2662506|P2|COMPLETED|Overall Study||81
1099827|NCT01089543|2662507|P1|COMPLETED|Overall Study||81
1099828|NCT01089543|2662504|P4|STARTED|Overall Study||85
1099829|NCT01089543|2662505|P3|STARTED|Overall Study||84
1099830|NCT01089543|2662506|P2|STARTED|Overall Study||85
1099831|NCT01089543|2662507|P1|STARTED|Overall Study||84
1099832|NCT01089556|2662523|P6|NOT COMPLETED|Study Period III (Weeks 9-16)||7
1099833|NCT01089556|2662524|P5|NOT COMPLETED|Study Period III (Weeks 9-16)||12
1099834|NCT01089556|2662525|P4|NOT COMPLETED|Study Period III (Weeks 9-16)||9
1099835|NCT01089556|2662526|P3|NOT COMPLETED|Study Period III (Weeks 9-16)||14
1099836|NCT01089556|2662527|P2|NOT COMPLETED|Study Period III (Weeks 9-16)||0
1099837|NCT01089556|2662528|P1|NOT COMPLETED|Study Period III (Weeks 9-16)||0
1099838|NCT01089556|2662523|P6|COMPLETED|Study Period III (Weeks 9-16)||92
1099839|NCT01089556|2662524|P5|COMPLETED|Study Period III (Weeks 9-16)||83
1099840|NCT01089556|2662525|P4|COMPLETED|Study Period III (Weeks 9-16)||66
1099841|NCT01089556|2662526|P3|COMPLETED|Study Period III (Weeks 9-16)||60
1099842|NCT01089556|2662527|P2|COMPLETED|Study Period III (Weeks 9-16)||0
1099843|NCT01089556|2662528|P1|COMPLETED|Study Period III (Weeks 9-16)||0
1099844|NCT01089556|2662523|P6|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|97
1099845|NCT01089556|2662524|P5|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|94
1099846|NCT01089556|2662525|P4|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|75
1099847|NCT01089556|2662526|P3|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|73
1099848|NCT01089556|2662527|P2|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
1099849|NCT01089556|2662528|P1|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
1099850|NCT01089556|2662523|P6|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 1 responders entered SPIII|99
1099851|NCT01089556|2662524|P5|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|95
1099852|NCT01089556|2662525|P4|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 3 responders entered SPIII|75
1099853|NCT01089556|2662526|P3|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|74
1099854|NCT01089556|2662527|P2|STARTED|Study Period III (Weeks 9-16)||0
1099855|NCT01089556|2662528|P1|STARTED|Study Period III (Weeks 9-16)||0
1099856|NCT01089556|2662523|P6|NOT COMPLETED|Study Period II (Weeks 1-8)||0
1099857|NCT01089556|2662524|P5|NOT COMPLETED|Study Period II (Weeks 1-8)||0
1099858|NCT01089556|2662525|P4|NOT COMPLETED|Study Period II (Weeks 1-8)||0
1099859|NCT01089556|2662526|P3|NOT COMPLETED|Study Period II (Weeks 1-8)||0
1099860|NCT01089556|2662527|P2|NOT COMPLETED|Study Period II (Weeks 1-8)||74
1099861|NCT01089556|2662528|P1|NOT COMPLETED|Study Period II (Weeks 1-8)||71
1099862|NCT01089556|2662523|P6|COMPLETED|Study Period II (Weeks 1-8)||0
1099863|NCT01089556|2662524|P5|COMPLETED|Study Period II (Weeks 1-8)||0
1099864|NCT01089556|2662525|P4|COMPLETED|Study Period II (Weeks 1-8)||0
1099865|NCT01089556|2662526|P3|COMPLETED|Study Period II (Weeks 1-8)||0
1099866|NCT01089556|2662527|P2|COMPLETED|Study Period II (Weeks 1-8)||333
1099867|NCT01089556|2662528|P1|COMPLETED|Study Period II (Weeks 1-8)||333
1099868|NCT01089556|2662523|P6|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
1099869|NCT01089556|2662524|P5|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
1099870|NCT01089556|2662525|P4|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
1099871|NCT01089556|2662526|P3|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
1099872|NCT01089556|2662527|P2|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||205
1099873|NCT01089556|2662528|P1|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||158
1099874|NCT01089556|2662523|P6|Safety Population|Study Period II (Weeks 1-8)||0
1099875|NCT01089556|2662524|P5|Safety Population|Study Period II (Weeks 1-8)||0
1099876|NCT01089556|2662525|P4|Safety Population|Study Period II (Weeks 1-8)||0
1099877|NCT01089556|2662526|P3|Safety Population|Study Period II (Weeks 1-8)||0
1099878|NCT01089556|2662527|P2|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|403
1099879|NCT01089556|2662528|P1|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|401
1099880|NCT01089556|2662523|P6|STARTED|Study Period II (Weeks 1-8)||0
1099881|NCT01089556|2662524|P5|STARTED|Study Period II (Weeks 1-8)||0
1099882|NCT01089556|2662525|P4|STARTED|Study Period II (Weeks 1-8)||0
1099883|NCT01089556|2662526|P3|STARTED|Study Period II (Weeks 1-8)||0
1099884|NCT01089556|2662527|P2|STARTED|Study Period II (Weeks 1-8)||407
1099885|NCT01089556|2662528|P1|STARTED|Study Period II (Weeks 1-8)||404
1099886|NCT01089569|2662601|P3|NOT COMPLETED|Overall Study||4
1099887|NCT01089569|2662602|P2|NOT COMPLETED|Overall Study||3
1099888|NCT01089569|2662603|P1|NOT COMPLETED|Overall Study||4
1099889|NCT01089569|2662601|P3|COMPLETED|Overall Study||16
1099890|NCT01089569|2662602|P2|COMPLETED|Overall Study||17
1099891|NCT01089569|2662603|P1|COMPLETED|Overall Study||16
1099892|NCT01089569|2662601|P3|STARTED|Overall Study||20
1099893|NCT01089569|2662602|P2|STARTED|Overall Study||20
1099894|NCT01089569|2662603|P1|STARTED|Overall Study||20
1099895|NCT01089582|2662629|P1|NOT COMPLETED|Overall Study||30
1099896|NCT01089582|2662629|P1|COMPLETED|Overall Study|1 subject died during the study; 1 subject died following permanent discontinuation from the study.|573
1099897|NCT01089582|2662629|P1|STARTED|Overall Study||603
1099898|NCT01089595|2662641|P2|NOT COMPLETED|Overall Study||0
1099899|NCT01089595|2662642|P1|NOT COMPLETED|Overall Study||0
1099900|NCT01089595|2662641|P2|COMPLETED|Overall Study||3
1099901|NCT01089595|2662642|P1|COMPLETED|Overall Study||2
1099902|NCT01089595|2662641|P2|STARTED|Overall Study||3
1099903|NCT01089595|2662642|P1|STARTED|Overall Study||2
1099904|NCT01089608|2662652|P2|NOT COMPLETED|Overall Study||6
1099905|NCT01089608|2662653|P1|NOT COMPLETED|Overall Study||0
1099906|NCT01089608|2662652|P2|COMPLETED|Overall Study||44
1099907|NCT01089608|2662653|P1|COMPLETED|Overall Study||43
1099908|NCT01089608|2662652|P2|STARTED|Overall Study||50
1099909|NCT01089608|2662653|P1|STARTED|Overall Study||43
1099910|NCT01089751|2662661|P2|NOT COMPLETED|Overall Study||27
1099911|NCT01089751|2662662|P1|NOT COMPLETED|Overall Study||34
1099912|NCT01089751|2662661|P2|COMPLETED|Overall Study||132
1099913|NCT01089751|2662662|P1|COMPLETED|Overall Study||129
1099914|NCT01089751|2662661|P2|STARTED|Overall Study||159
1099915|NCT01089751|2662662|P1|STARTED|Overall Study||163
1099916|NCT01097616|2662685|P8|NOT COMPLETED|DB RO Phase||1
1099917|NCT01097616|2662686|P7|NOT COMPLETED|DB RO Phase||1
1099918|NCT01097616|2662687|P6|NOT COMPLETED|DB RO Phase||2
1099919|NCT01097616|2662688|P5|NOT COMPLETED|DB RO Phase||1
1099920|NCT01097616|2662689|P4|NOT COMPLETED|DB RO Phase||1
1099921|NCT01097616|2662690|P3|NOT COMPLETED|DB RO Phase||0
1099922|NCT01097616|2662691|P2|NOT COMPLETED|DB RO Phase||0
1099923|NCT01097616|2662692|P1|NOT COMPLETED|DB RO Phase||0
1099924|NCT01097616|2662685|P8|COMPLETED|DB RO Phase||326
1099925|NCT01097616|2662686|P7|COMPLETED|DB RO Phase||161
1099926|NCT01097616|2662687|P6|COMPLETED|DB RO Phase||159
1099927|NCT01097616|2662688|P5|COMPLETED|DB RO Phase||111
1099928|NCT01097616|2662689|P4|COMPLETED|DB RO Phase||100
1099929|NCT01097616|2662690|P3|COMPLETED|DB RO Phase||0
1099930|NCT01097616|2662691|P2|COMPLETED|DB RO Phase||0
1099931|NCT01097616|2662692|P1|COMPLETED|DB RO Phase||0
1099932|NCT01097616|2662685|P8|STARTED|DB RO Phase||327
1099933|NCT01097616|2662686|P7|STARTED|DB RO Phase||162
1099934|NCT01097616|2662687|P6|STARTED|DB RO Phase|1 entered RO but was not treated during RO|161
1099935|NCT01097616|2662688|P5|STARTED|DB RO Phase|1 was randomized to this group but actually received suvorexant LD during RO|112
1099936|NCT01097616|2662689|P4|STARTED|DB RO Phase||101
1099937|NCT01097616|2662690|P3|STARTED|DB RO Phase||0
1099938|NCT01097616|2662691|P2|STARTED|DB RO Phase||0
1099939|NCT01097616|2662692|P1|STARTED|DB RO Phase||0
1099940|NCT01097616|2662685|P8|NOT COMPLETED|Optional DB EXT Phase||0
1099941|NCT01097616|2662686|P7|NOT COMPLETED|Optional DB EXT Phase||0
1099942|NCT01097616|2662687|P6|NOT COMPLETED|Optional DB EXT Phase||0
1099943|NCT01097616|2662688|P5|NOT COMPLETED|Optional DB EXT Phase||0
1099944|NCT01097616|2662689|P4|NOT COMPLETED|Optional DB EXT Phase||0
1099945|NCT01097616|2662690|P3|NOT COMPLETED|Optional DB EXT Phase||10
1099946|NCT01097616|2662691|P2|NOT COMPLETED|Optional DB EXT Phase||21
1099947|NCT01097616|2662692|P1|NOT COMPLETED|Optional DB EXT Phase||15
1099948|NCT01097616|2662685|P8|COMPLETED|Optional DB EXT Phase||0
1099949|NCT01097616|2662686|P7|COMPLETED|Optional DB EXT Phase||0
1099950|NCT01097616|2662687|P6|COMPLETED|Optional DB EXT Phase||0
1099951|NCT01097616|2662688|P5|COMPLETED|Optional DB EXT Phase||0
1099952|NCT01097616|2662689|P4|COMPLETED|Optional DB EXT Phase||0
1099953|NCT01097616|2662690|P3|COMPLETED|Optional DB EXT Phase|All 141 continued into RO|141
1099954|NCT01097616|2662691|P2|COMPLETED|Optional DB EXT Phase|All 151 continued into RO|151
1099955|NCT01097616|2662692|P1|COMPLETED|Optional DB EXT Phase|All 85 continued into RO|85
1099956|NCT01097616|2662685|P8|STARTED|Optional DB EXT Phase||0
1099957|NCT01097616|2662686|P7|STARTED|Optional DB EXT Phase||0
1099958|NCT01097616|2662687|P6|STARTED|Optional DB EXT Phase||0
1099959|NCT01097616|2662688|P5|STARTED|Optional DB EXT Phase||0
1099960|NCT01097616|2662689|P4|STARTED|Optional DB EXT Phase||0
1099961|NCT01097616|2662690|P3|STARTED|Optional DB EXT Phase||151
1099962|NCT01097616|2662691|P2|STARTED|Optional DB EXT Phase||172
1099963|NCT01097616|2662692|P1|STARTED|Optional DB EXT Phase||100
1099964|NCT01097616|2662685|P8|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1099965|NCT01097616|2662686|P7|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1099966|NCT01097616|2662687|P6|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1099967|NCT01097616|2662688|P5|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1099968|NCT01097616|2662689|P4|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1099969|NCT01097616|2662690|P3|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||44
1099970|NCT01097616|2662691|P2|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||38
1099971|NCT01097616|2662692|P1|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||24
1099972|NCT01097616|2662685|P8|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1099973|NCT01097616|2662686|P7|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1099974|NCT01097616|2662687|P6|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1099975|NCT01097616|2662688|P5|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1099976|NCT01097616|2662689|P4|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1099977|NCT01097616|2662690|P3|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|151 continued into EXT, 186 continued directly into RO, 4 did not continue into either Phase|341
1099978|NCT01097616|2662691|P2|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|172 continued into EXT, 172 continued directly into RO, 1 did not continue into either Phase|345
1099979|NCT01097616|2662692|P1|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|100 continued into EXT, 128 continued directly into RO, 2 did not continue into either Phase|230
1099980|NCT01097616|2662685|P8|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
1099981|NCT01097616|2662686|P7|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
1099982|NCT01097616|2662687|P6|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
1099983|NCT01097616|2662688|P5|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
1099984|NCT01097616|2662689|P4|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
1099985|NCT01097616|2662690|P3|Treated|Double-Blind (DB) Treatment (TRT) Phase||384
1099986|NCT01097616|2662691|P2|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
1099987|NCT01097616|2662692|P1|Treated|Double-Blind (DB) Treatment (TRT) Phase||254
1099988|NCT01097616|2662685|P8|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
1099989|NCT01097616|2662686|P7|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
1099990|NCT01097616|2662687|P6|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
1099991|NCT01097616|2662688|P5|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
1099992|NCT01097616|2662689|P4|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
1099993|NCT01097616|2662690|P3|STARTED|Double-Blind (DB) Treatment (TRT) Phase||385
1099994|NCT01097616|2662691|P2|STARTED|Double-Blind (DB) Treatment (TRT) Phase||383
1099995|NCT01097616|2662692|P1|STARTED|Double-Blind (DB) Treatment (TRT) Phase||254
1099996|NCT01097629|2662766|P8|NOT COMPLETED|DB RO Phase||1
1099997|NCT01097629|2662767|P7|NOT COMPLETED|DB RO Phase||3
1099998|NCT01097629|2662768|P6|NOT COMPLETED|DB RO Phase||1
1099999|NCT01097629|2662769|P5|NOT COMPLETED|DB RO Phase||0
1100000|NCT01097629|2662770|P4|NOT COMPLETED|DB RO Phase||1
1100001|NCT01097629|2662771|P3|NOT COMPLETED|DB RO Phase||0
1100002|NCT01097629|2662772|P2|NOT COMPLETED|DB RO Phase||0
1100003|NCT01097629|2662773|P1|NOT COMPLETED|DB RO Phase||0
1100004|NCT01097629|2662766|P8|COMPLETED|DB RO Phase||326
1100005|NCT01097629|2662767|P7|COMPLETED|DB RO Phase||168
1100006|NCT01097629|2662768|P6|COMPLETED|DB RO Phase||172
1100007|NCT01097629|2662769|P5|COMPLETED|DB RO Phase||108
1100008|NCT01097629|2662770|P4|COMPLETED|DB RO Phase||96
1100009|NCT01097629|2662771|P3|COMPLETED|DB RO Phase||0
1100010|NCT01097629|2662772|P2|COMPLETED|DB RO Phase||0
1100011|NCT01097629|2662773|P1|COMPLETED|DB RO Phase||0
1100012|NCT01097629|2662766|P8|STARTED|DB RO Phase||327
1100013|NCT01097629|2662767|P7|STARTED|DB RO Phase||171
1100014|NCT01097629|2662768|P6|STARTED|DB RO Phase||173
1100015|NCT01097629|2662769|P5|STARTED|DB RO Phase||108
1100016|NCT01097629|2662770|P4|STARTED|DB RO Phase||97
1100017|NCT01097629|2662771|P3|STARTED|DB RO Phase||0
1100018|NCT01097629|2662772|P2|STARTED|DB RO Phase||0
1100019|NCT01097629|2662773|P1|STARTED|DB RO Phase||0
1100020|NCT01097629|2662766|P8|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1100021|NCT01097629|2662767|P7|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1100022|NCT01097629|2662768|P6|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1100023|NCT01097629|2662769|P5|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1100024|NCT01097629|2662770|P4|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1100025|NCT01097629|2662771|P3|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||57
1100026|NCT01097629|2662772|P2|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||46
1100027|NCT01097629|2662773|P1|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||35
1100028|NCT01097629|2662766|P8|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1100029|NCT01097629|2662767|P7|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1100030|NCT01097629|2662768|P6|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1100031|NCT01097629|2662769|P5|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1100032|NCT01097629|2662770|P4|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
1100033|NCT01097629|2662771|P3|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|3 did not continue into RO|330
1100034|NCT01097629|2662772|P2|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|2 did not continue into RO|346
1100035|NCT01097629|2662773|P1|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||205
1100036|NCT01097629|2662766|P8|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
1100037|NCT01097629|2662767|P7|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
1100038|NCT01097629|2662768|P6|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
1100039|NCT01097629|2662769|P5|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
1100040|NCT01097629|2662770|P4|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
1100041|NCT01097629|2662771|P3|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
1100042|NCT01097629|2662772|P2|Treated|Double-Blind (DB) Treatment (TRT) Phase||387
1100043|NCT01097629|2662773|P1|Treated|Double-Blind (DB) Treatment (TRT) Phase||239
1100044|NCT01097629|2662766|P8|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
1100045|NCT01097629|2662767|P7|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
1100046|NCT01097629|2662768|P6|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
1100047|NCT01097629|2662769|P5|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
1100048|NCT01097629|2662770|P4|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
1100049|NCT01097629|2662771|P3|STARTED|Double-Blind (DB) Treatment (TRT) Phase||387
1100050|NCT01097629|2662772|P2|STARTED|Double-Blind (DB) Treatment (TRT) Phase||392
1100051|NCT01097629|2662773|P1|STARTED|Double-Blind (DB) Treatment (TRT) Phase||240
1100052|NCT01097655|2662821|P1|NOT COMPLETED|Overall Study||10
1100053|NCT01097655|2662821|P1|COMPLETED|Overall Study|participants included for analysis|3039
1100054|NCT01097655|2662821|P1|STARTED|Overall Study||3049
1100055|NCT01097668|2662830|P2|NOT COMPLETED|Overall Study||2
1100056|NCT01097668|2662831|P1|NOT COMPLETED|Overall Study||2
1100057|NCT01097668|2662830|P2|COMPLETED|Overall Study||20
1100058|NCT01097668|2662831|P1|COMPLETED|Overall Study||19
1100059|NCT01097668|2662830|P2|Week 48|Overall Study||20
1100060|NCT01097668|2662831|P1|Week 48|Overall Study||19
1100061|NCT01097668|2662830|P2|Week 20|Overall Study|Patient evaluability time point = week 20|22
1100062|NCT01097668|2662831|P1|Week 20|Overall Study|Patient evaluability time point = week 20|21
1100063|NCT01097668|2662830|P2|STARTED|Overall Study||22
1100064|NCT01097668|2662831|P1|STARTED|Overall Study||21
1100065|NCT01097694|2662843|P2|NOT COMPLETED|Overall Study||4
1100066|NCT01097694|2662844|P1|NOT COMPLETED|Overall Study||8
1100067|NCT01097694|2662843|P2|COMPLETED|Overall Study||26
1100068|NCT01097694|2662844|P1|COMPLETED|Overall Study||24
1100069|NCT01097694|2662843|P2|STARTED|Overall Study||30
1100070|NCT01097694|2662844|P1|STARTED|Overall Study||32
1100071|NCT01097785|2662906|P2|NOT COMPLETED|Cycle 3 (30 Days)||0
1100072|NCT01097785|2662907|P1|NOT COMPLETED|Cycle 3 (30 Days)||0
1100073|NCT01097785|2662906|P2|COMPLETED|Cycle 3 (30 Days)||6
1100074|NCT01097785|2662907|P1|COMPLETED|Cycle 3 (30 Days)||6
1100075|NCT01097785|2662906|P2|STARTED|Cycle 3 (30 Days)||6
1100076|NCT01097785|2662907|P1|STARTED|Cycle 3 (30 Days)||6
1100077|NCT01097785|2662906|P2|NOT COMPLETED|Washout (2 Weeks)||0
1100078|NCT01097785|2662907|P1|NOT COMPLETED|Washout (2 Weeks)||0
1100079|NCT01097785|2662906|P2|COMPLETED|Washout (2 Weeks)||6
1100080|NCT01097785|2662907|P1|COMPLETED|Washout (2 Weeks)||6
1100081|NCT01097785|2662906|P2|STARTED|Washout (2 Weeks)||6
1100082|NCT01097785|2662907|P1|STARTED|Washout (2 Weeks)||6
1100083|NCT01097785|2662906|P2|NOT COMPLETED|Cycle 1 (30 Days)||0
1100084|NCT01097785|2662907|P1|NOT COMPLETED|Cycle 1 (30 Days)||0
1100085|NCT01097785|2662906|P2|COMPLETED|Cycle 1 (30 Days)||6
1100086|NCT01097785|2662907|P1|COMPLETED|Cycle 1 (30 Days)||6
1100087|NCT01097785|2662906|P2|STARTED|Cycle 1 (30 Days)||6
1100088|NCT01097785|2662907|P1|STARTED|Cycle 1 (30 Days)||6
1100089|NCT01097863|2662918|P3|NOT COMPLETED|Overall Study||2
1100090|NCT01097863|2662919|P2|NOT COMPLETED|Overall Study||0
1100091|NCT01097863|2662920|P1|NOT COMPLETED|Overall Study||1
1100092|NCT01097863|2662918|P3|COMPLETED|Overall Study||89
1100093|NCT01097863|2662919|P2|COMPLETED|Overall Study||98
1100094|NCT01097863|2662920|P1|COMPLETED|Overall Study||89
1100095|NCT01097863|2662918|P3|STARTED|Overall Study||91
1100096|NCT01097863|2662919|P2|STARTED|Overall Study||98
1100097|NCT01097863|2662920|P1|STARTED|Overall Study||90
1100098|NCT01098032|2662930|P2|NOT COMPLETED|Overall Study||1
1100099|NCT01098032|2662931|P1|NOT COMPLETED|Overall Study||1
1100100|NCT01098032|2662930|P2|COMPLETED|Overall Study||146
1100101|NCT01098032|2662931|P1|COMPLETED|Overall Study||146
1100102|NCT01098032|2662930|P2|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
1100103|NCT01098032|2662931|P1|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
1100107|NCT01098097|2662948|P1|NOT COMPLETED|Overall Study||82
1100108|NCT01098097|2662948|P1|COMPLETED|Overall Study|Participants completing the study received at least 12 weeks of treatment|881
1100109|NCT01098097|2662948|P1|STARTED|Overall Study||963
1100110|NCT01098110|2662960|P3|NOT COMPLETED|Overall Study||94
1100111|NCT01098110|2662961|P2|NOT COMPLETED|Overall Study||73
1100112|NCT01098110|2662962|P1|NOT COMPLETED|Overall Study||62
1100113|NCT01098110|2662960|P3|COMPLETED|Overall Study||80
1100114|NCT01098110|2662961|P2|COMPLETED|Overall Study||109
1100115|NCT01098110|2662962|P1|COMPLETED|Overall Study||114
1100116|NCT01098110|2662960|P3|Treated|Overall Study|Received at least one dose of trial medication|174
1100117|NCT01098110|2662961|P2|Treated|Overall Study|Received at least one dose of trial medication|181
1100118|NCT01098110|2662962|P1|Treated|Overall Study|Received at least one dose of trial medication|175
1100119|NCT01098110|2662960|P3|STARTED|Overall Study|Randomized participants|174
1100120|NCT01098110|2662961|P2|STARTED|Overall Study|Randomized participants|182
1100121|NCT01098110|2662962|P1|STARTED|Overall Study|Randomized participants|176
1100122|NCT01098162|2663003|P1|NOT COMPLETED|Overall Study||112
1100123|NCT01098162|2663003|P1|COMPLETED|Overall Study||461
1100124|NCT01098162|2663003|P1|STARTED|Overall Study||573
1100125|NCT01098240|2663012|P3|NOT COMPLETED|Double-Blind Phase||22
1100126|NCT01098240|2663013|P2|NOT COMPLETED|Double-Blind Phase||17
1100127|NCT01098240|2663014|P1|NOT COMPLETED|Double-Blind Phase||0
1100128|NCT01098240|2663012|P3|COMPLETED|Double-Blind Phase||63
1100129|NCT01098240|2663013|P2|COMPLETED|Double-Blind Phase||60
1100130|NCT01098240|2663014|P1|COMPLETED|Double-Blind Phase||0
1100131|NCT01098240|2663012|P3|STARTED|Double-Blind Phase||85
1100132|NCT01098240|2663013|P2|STARTED|Double-Blind Phase||77
1100133|NCT01098240|2663014|P1|STARTED|Double-Blind Phase||0
1100134|NCT01098240|2663012|P3|NOT COMPLETED|Open-Label Phase||0
1100135|NCT01098240|2663013|P2|NOT COMPLETED|Open-Label Phase||0
1100136|NCT01098240|2663014|P1|NOT COMPLETED|Open-Label Phase||135
1100137|NCT01098240|2663012|P3|COMPLETED|Open-Label Phase||0
1100138|NCT01098240|2663013|P2|COMPLETED|Open-Label Phase||0
1100139|NCT01098240|2663014|P1|COMPLETED|Open-Label Phase||162
1100140|NCT01098240|2663012|P3|STARTED|Open-Label Phase||0
1100141|NCT01098240|2663013|P2|STARTED|Open-Label Phase||0
1100142|NCT01098240|2663014|P1|STARTED|Open-Label Phase||297
1100143|NCT01098253|2663046|P2|NOT COMPLETED|Overall Study||0
1100144|NCT01098253|2663047|P1|NOT COMPLETED|Overall Study||2
1100145|NCT01098253|2663046|P2|COMPLETED|Overall Study||88
1100146|NCT01098253|2663047|P1|COMPLETED|Overall Study||92
1100147|NCT01098253|2663046|P2|STARTED|Overall Study||88
1100148|NCT01098253|2663047|P1|STARTED|Overall Study||94
1100149|NCT01098305|2663057|P2|NOT COMPLETED|Overall Study||33
1100150|NCT01098305|2663058|P1|NOT COMPLETED|Overall Study||31
1100151|NCT01098305|2663057|P2|COMPLETED|Overall Study||85
1100152|NCT01098305|2663058|P1|COMPLETED|Overall Study||88
1100153|NCT01098305|2663057|P2|STARTED|Overall Study||118
1100154|NCT01098305|2663058|P1|STARTED|Overall Study||119
1100155|NCT01098318|2663069|P3|NOT COMPLETED|Overall Study||3
1100156|NCT01098318|2663070|P2|NOT COMPLETED|Overall Study||7
1100157|NCT01098318|2663071|P1|NOT COMPLETED|Overall Study||3
1100158|NCT01098318|2663069|P3|COMPLETED|Overall Study||15
1100159|NCT01098318|2663070|P2|COMPLETED|Overall Study||12
1100160|NCT01098318|2663071|P1|COMPLETED|Overall Study||17
1100161|NCT01098318|2663069|P3|STARTED|Overall Study||18
1100162|NCT01098318|2663070|P2|STARTED|Overall Study||19
1100163|NCT01098318|2663071|P1|STARTED|Overall Study||20
1100164|NCT01098461|2663083|P4|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
1100165|NCT01098461|2663084|P3|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||1
1100166|NCT01098461|2663085|P2|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||3
1100167|NCT01098461|2663086|P1|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
1100168|NCT01098461|2663083|P4|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
1100169|NCT01098461|2663084|P3|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
1100170|NCT01098461|2663085|P2|COMPLETED|Follow-up (FU) Period (8 Weeks)||49
1100171|NCT01098461|2663086|P1|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
1100172|NCT01098461|2663083|P4|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
1100173|NCT01098461|2663084|P3|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|53
1100174|NCT01098461|2663085|P2|STARTED|Follow-up (FU) Period (8 Weeks)||52
1100175|NCT01098461|2663086|P1|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
1100176|NCT01098461|2663083|P4|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||3
1100177|NCT01098461|2663084|P3|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||1
1100178|NCT01098461|2663085|P2|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||7
1100179|NCT01098461|2663086|P1|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||12
1100180|NCT01098461|2663083|P4|COMPLETED|Treatment Period (TP) (16 Weeks)||50
1100181|NCT01098461|2663084|P3|COMPLETED|Treatment Period (TP) (16 Weeks)||53
1100182|NCT01098461|2663085|P2|COMPLETED|Treatment Period (TP) (16 Weeks)||45
1100183|NCT01098461|2663086|P1|COMPLETED|Treatment Period (TP) (16 Weeks)||41
1100184|NCT01098461|2663083|P4|STARTED|Treatment Period (TP) (16 Weeks)||53
1100185|NCT01098461|2663084|P3|STARTED|Treatment Period (TP) (16 Weeks)||54
1100186|NCT01098461|2663085|P2|STARTED|Treatment Period (TP) (16 Weeks)||52
1100187|NCT01098461|2663086|P1|STARTED|Treatment Period (TP) (16 Weeks)||53
1100188|NCT01098487|2663116|P1|NOT COMPLETED|Overall Study||44
1100189|NCT01098487|2663116|P1|COMPLETED|Overall Study||118
1100190|NCT01098487|2663116|P1|STARTED|Overall Study||162
1100191|NCT01098500|2663128|P1|NOT COMPLETED|Overall Study||0
1100192|NCT01098500|2663128|P1|COMPLETED|Overall Study||3800
1100193|NCT01098500|2663128|P1|STARTED|Overall Study||3800
1100194|NCT01098539|2663145|P2|NOT COMPLETED|Overall Study||68
1100195|NCT01098539|2663146|P1|NOT COMPLETED|Overall Study||51
1100196|NCT01098539|2663145|P2|COMPLETED|Overall Study||178
1100197|NCT01098539|2663146|P1|COMPLETED|Overall Study||198
1100198|NCT01098539|2663145|P2|STARTED|Overall Study||246
1100199|NCT01098539|2663146|P1|STARTED|Overall Study||249
1100200|NCT01098578|2663182|P1|NOT COMPLETED|Overall Study||0
1100201|NCT01098578|2663182|P1|COMPLETED|Overall Study||20
1100202|NCT01098578|2663182|P1|STARTED|Overall Study||20
1100203|NCT01098747|2663193|P4|NOT COMPLETED|Overall Study||0
1100204|NCT01098747|2663194|P3|NOT COMPLETED|Overall Study||0
1100205|NCT01098747|2663195|P2|NOT COMPLETED|Overall Study||0
1100206|NCT01098747|2663196|P1|NOT COMPLETED|Overall Study||0
1100207|NCT01098747|2663193|P4|COMPLETED|Overall Study||87
1100208|NCT01098747|2663194|P3|COMPLETED|Overall Study||86
1100209|NCT01098747|2663195|P2|COMPLETED|Overall Study||95
1100210|NCT01098747|2663196|P1|COMPLETED|Overall Study||48
1100211|NCT01098747|2663193|P4|STARTED|Overall Study||87
1100212|NCT01098747|2663194|P3|STARTED|Overall Study||86
1100213|NCT01098747|2663195|P2|STARTED|Overall Study||95
1100214|NCT01098747|2663196|P1|STARTED|Overall Study||48
1100215|NCT01098812|2663249|P3|NOT COMPLETED|Overall Study||1
1100216|NCT01098812|2663250|P2|NOT COMPLETED|Overall Study||1
1100217|NCT01098812|2663251|P1|NOT COMPLETED|Overall Study||2
1100218|NCT01098812|2663249|P3|COMPLETED|Overall Study||71
1100219|NCT01098812|2663250|P2|COMPLETED|Overall Study||101
1100220|NCT01098812|2663251|P1|COMPLETED|Overall Study||93
1100221|NCT01098812|2663249|P3|STARTED|Overall Study||72
1100222|NCT01098812|2663250|P2|STARTED|Overall Study||102
1100223|NCT01098812|2663251|P1|STARTED|Overall Study||95
1100224|NCT01098851|2663263|P2|NOT COMPLETED|Overall Study||0
1100225|NCT01098851|2663264|P1|NOT COMPLETED|Overall Study||1
1100226|NCT01098851|2663263|P2|COMPLETED|Overall Study||10
1100227|NCT01098851|2663264|P1|COMPLETED|Overall Study||10
1100228|NCT01098851|2663263|P2|STARTED|Overall Study||10
1100229|NCT01098851|2663264|P1|STARTED|Overall Study||11
1100230|NCT01099111|2663277|P5|NOT COMPLETED|Overall Study||0
1100231|NCT01099111|2663278|P4|NOT COMPLETED|Overall Study||0
1100232|NCT01099111|2663279|P3|NOT COMPLETED|Overall Study||0
1100233|NCT01099111|2663280|P2|NOT COMPLETED|Overall Study||0
1100234|NCT01099111|2663281|P1|NOT COMPLETED|Overall Study||0
1100235|NCT01099111|2663277|P5|COMPLETED|Overall Study|6 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
1100236|NCT01099111|2663278|P4|COMPLETED|Overall Study||29
1100237|NCT01099111|2663279|P3|COMPLETED|Overall Study|2 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|46
1100238|NCT01099111|2663280|P2|COMPLETED|Overall Study|3 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
1100239|NCT01099111|2663281|P1|COMPLETED|Overall Study|5 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
1100240|NCT01099111|2663277|P5|STARTED|Overall Study||50
1100241|NCT01099111|2663278|P4|STARTED|Overall Study||29
1100242|NCT01099111|2663279|P3|STARTED|Overall Study||46
1100243|NCT01099111|2663280|P2|STARTED|Overall Study||50
1100244|NCT01099111|2663281|P1|STARTED|Overall Study||50
1100245|NCT01099202|2663295|P2|NOT COMPLETED|Overall Study||0
1100246|NCT01099202|2663296|P1|NOT COMPLETED|Overall Study||0
1100247|NCT01099202|2663295|P2|COMPLETED|Overall Study||54
1100248|NCT01099202|2663296|P1|COMPLETED|Overall Study||55
1100249|NCT01099202|2663295|P2|STARTED|Overall Study||54
1100250|NCT01099202|2663296|P1|STARTED|Overall Study||55
1100251|NCT01099215|2663306|P2|NOT COMPLETED|Overall Study||1
1100252|NCT01099215|2663307|P1|NOT COMPLETED|Overall Study||1
1100253|NCT01099215|2663306|P2|COMPLETED|Overall Study||9
1100254|NCT01099215|2663307|P1|COMPLETED|Overall Study||10
1100255|NCT01099215|2663306|P2|STARTED|Overall Study||10
1100256|NCT01099215|2663307|P1|STARTED|Overall Study||11
1100257|NCT01099267|2663343|P1|NOT COMPLETED|MDS-009 Extension Follow-up||0
1100258|NCT01099267|2663343|P1|COMPLETED|MDS-009 Extension Follow-up||54
1100259|NCT01099267|2663343|P1|Other Source of Follow-up Info Used|MDS-009 Extension Follow-up|Social Security Death Index, public records, verbal reports from health providers and next of kin.|21
1100260|NCT01099267|2663343|P1|Informed Consent Given|MDS-009 Extension Follow-up||33
1100261|NCT01099267|2663343|P1|STARTED|MDS-009 Extension Follow-up|Participants from MDS-003 (including some who did not complete) at sites participating in MDS-009.|54
1100262|NCT01099267|2663343|P1|NOT COMPLETED|MDS-003 Study||124
1100263|NCT01099267|2663343|P1|COMPLETED|MDS-003 Study||24
1100264|NCT01099267|2663343|P1|STARTED|MDS-003 Study|This information duplicates results in NCT00065156.|148
1100265|NCT01099358|2663351|P4|NOT COMPLETED|Overall Study||4
1100266|NCT01099358|2663352|P3|NOT COMPLETED|Overall Study||8
1100267|NCT01099358|2663353|P2|NOT COMPLETED|Overall Study||1
1100268|NCT01099358|2663354|P1|NOT COMPLETED|Overall Study||3
1100269|NCT01099358|2663351|P4|COMPLETED|Overall Study||12
1100270|NCT01099358|2663352|P3|COMPLETED|Overall Study||13
1100271|NCT01099358|2663353|P2|COMPLETED|Overall Study||5
1100272|NCT01099358|2663354|P1|COMPLETED|Overall Study||1
1100273|NCT01099358|2663351|P4|Received at Least One Dose of Study Drug|Overall Study||15
1100274|NCT01099358|2663352|P3|Received at Least One Dose of Study Drug|Overall Study||20
1100275|NCT01099358|2663353|P2|Received at Least One Dose of Study Drug|Overall Study||6
1100276|NCT01099358|2663354|P1|Received at Least One Dose of Study Drug|Overall Study||3
1100277|NCT01099358|2663351|P4|STARTED|Overall Study||16
1100278|NCT01099358|2663352|P3|STARTED|Overall Study||21
1100279|NCT01099358|2663353|P2|STARTED|Overall Study||6
1100280|NCT01099358|2663354|P1|STARTED|Overall Study||4
1100281|NCT01099397|2663373|P1|NOT COMPLETED|Overall Study||13
1100282|NCT01099397|2663373|P1|COMPLETED|Overall Study||26
1100283|NCT01099397|2663373|P1|STARTED|Overall Study||39
1100284|NCT01099475|2663380|P2|NOT COMPLETED|Overall Study||0
1100285|NCT01099475|2663381|P1|NOT COMPLETED|Overall Study||0
1100286|NCT01099475|2663380|P2|COMPLETED|Overall Study||10
1100287|NCT01099475|2663381|P1|COMPLETED|Overall Study||10
1100288|NCT01099475|2663380|P2|STARTED|Overall Study||10
1100289|NCT01099475|2663381|P1|STARTED|Overall Study||10
1100290|NCT01099579|2663396|P3|NOT COMPLETED|Stage 2 (ATV Capsules )||15
1100291|NCT01099579|2663397|P2|NOT COMPLETED|Stage 2 (ATV Capsules )||14
1100292|NCT01099579|2663398|P1|NOT COMPLETED|Stage 2 (ATV Capsules )||16
1100293|NCT01099579|2663396|P3|COMPLETED|Stage 2 (ATV Capsules )||0
1100294|NCT01099579|2663397|P2|COMPLETED|Stage 2 (ATV Capsules )||0
1100295|NCT01099579|2663398|P1|COMPLETED|Stage 2 (ATV Capsules )||0
1100296|NCT01099579|2663396|P3|STARTED|Stage 2 (ATV Capsules )||15
1100297|NCT01099579|2663397|P2|STARTED|Stage 2 (ATV Capsules )||14
1100298|NCT01099579|2663398|P1|STARTED|Stage 2 (ATV Capsules )||16
1100299|NCT01099579|2663396|P3|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||1
1100300|NCT01099579|2663397|P2|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||5
1100301|NCT01099579|2663398|P1|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||4
1100302|NCT01099579|2663396|P3|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|15
1100303|NCT01099579|2663397|P2|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|14
1100304|NCT01099579|2663398|P1|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|17
1100305|NCT01099579|2663396|P3|STARTED|Stage 1 (ATV Powder Formulation)||16
1100306|NCT01099579|2663397|P2|STARTED|Stage 1 (ATV Powder Formulation)||19
1100307|NCT01099579|2663398|P1|STARTED|Stage 1 (ATV Powder Formulation)||21
1100308|NCT01099618|2663455|P3|NOT COMPLETED|Overall Study||0
1100309|NCT01099618|2663456|P2|NOT COMPLETED|Overall Study||0
1100310|NCT01099618|2663457|P1|NOT COMPLETED|Overall Study||0
1100311|NCT01099618|2663455|P3|COMPLETED|Overall Study||15
1100312|NCT01099618|2663456|P2|COMPLETED|Overall Study||16
1100313|NCT01099618|2663457|P1|COMPLETED|Overall Study||17
1100314|NCT01099618|2663455|P3|STARTED|Overall Study||15
1100315|NCT01099618|2663456|P2|STARTED|Overall Study||16
1100316|NCT01099618|2663457|P1|STARTED|Overall Study||17
1100317|NCT01099709|2663465|P2|NOT COMPLETED|Period 2||0
1100318|NCT01099709|2663466|P1|NOT COMPLETED|Period 2||0
1100319|NCT01099709|2663465|P2|COMPLETED|Period 2||41
1100320|NCT01099709|2663466|P1|COMPLETED|Period 2||41
1100321|NCT01099709|2663465|P2|STARTED|Period 2||41
1100322|NCT01099709|2663466|P1|STARTED|Period 2||41
1100323|NCT01099709|2663465|P2|NOT COMPLETED|Period 1||2
1100324|NCT01099709|2663466|P1|NOT COMPLETED|Period 1||1
1100325|NCT01099709|2663465|P2|COMPLETED|Period 1||41
1100326|NCT01099709|2663466|P1|COMPLETED|Period 1||41
1100327|NCT01099709|2663465|P2|STARTED|Period 1||43
1100328|NCT01099709|2663466|P1|STARTED|Period 1||42
1100329|NCT01099761|2663480|P4|NOT COMPLETED|Overall Study||0
1100330|NCT01099761|2663481|P3|NOT COMPLETED|Overall Study||0
1100331|NCT01099761|2663482|P2|NOT COMPLETED|Overall Study||0
1100332|NCT01099761|2663483|P1|NOT COMPLETED|Overall Study||0
1100333|NCT01099761|2663480|P4|COMPLETED|Overall Study||6
1100334|NCT01099761|2663481|P3|COMPLETED|Overall Study||0
1100335|NCT01099761|2663482|P2|COMPLETED|Overall Study||9
1100336|NCT01099761|2663483|P1|COMPLETED|Overall Study||9
1100337|NCT01099761|2663480|P4|STARTED|Overall Study||6
1100338|NCT01099761|2663481|P3|STARTED|Overall Study|Study terminated prior to enrolling cohort 3|0
1100339|NCT01099761|2663482|P2|STARTED|Overall Study||9
1100340|NCT01099761|2663483|P1|STARTED|Overall Study||9
1100341|NCT01099774|2663521|P2|NOT COMPLETED|Overall Study||6
1100342|NCT01099774|2663522|P1|NOT COMPLETED|Overall Study||6
1100343|NCT01099774|2663521|P2|COMPLETED|Overall Study||289
1100344|NCT01099774|2663522|P1|COMPLETED|Overall Study||296
1100345|NCT01099774|2663521|P2|STARTED|Overall Study||295
1100346|NCT01099774|2663522|P1|STARTED|Overall Study||302
1100347|NCT01099917|2663534|P1|NOT COMPLETED|Overall Study||27
1100348|NCT01099917|2663534|P1|COMPLETED|Overall Study||18
1100349|NCT01099917|2663534|P1|STARTED|Overall Study||45
1100350|NCT01100073|2663538|P1|NOT COMPLETED|Overall Study||100
1100351|NCT01100073|2663538|P1|COMPLETED|Overall Study|End of study (Visit 3)|1599
1100352|NCT01100073|2663538|P1|STARTED|Overall Study|Baseline (Visit 1)|1699
1100353|NCT01100086|2663553|P2|NOT COMPLETED|Period 2||0
1100354|NCT01100086|2663554|P1|NOT COMPLETED|Period 2||0
1100355|NCT01100086|2663553|P2|COMPLETED|Period 2||41
1100356|NCT01100086|2663554|P1|COMPLETED|Period 2||42
1100357|NCT01100086|2663553|P2|STARTED|Period 2||41
1100358|NCT01100086|2663554|P1|STARTED|Period 2||42
1100359|NCT01100086|2663553|P2|NOT COMPLETED|Period 1||0
1100360|NCT01100086|2663554|P1|NOT COMPLETED|Period 1||1
1100361|NCT01100086|2663553|P2|COMPLETED|Period 1||41
1100362|NCT01100086|2663554|P1|COMPLETED|Period 1||42
1100363|NCT01100086|2663553|P2|STARTED|Period 1||41
1100364|NCT01100086|2663554|P1|STARTED|Period 1||43
1100365|NCT01100112|2663564|P1|NOT COMPLETED|Overall Study||8
1100366|NCT01100112|2663564|P1|COMPLETED|Overall Study||52
1100367|NCT01100112|2663564|P1|STARTED|Overall Study||60
1100368|NCT01100242|2663571|P1|NOT COMPLETED|Overall Study||0
1100369|NCT01100242|2663571|P1|COMPLETED|Overall Study||17
1100370|NCT01100242|2663571|P1|STARTED|Overall Study||17
1100371|NCT01100255|2663579|P2|NOT COMPLETED|Overall Study||0
1100372|NCT01100255|2663580|P1|NOT COMPLETED|Overall Study||0
1100373|NCT01100255|2663579|P2|COMPLETED|Overall Study||7
1100374|NCT01100255|2663580|P1|COMPLETED|Overall Study||8
1100375|NCT01100255|2663579|P2|STARTED|Overall Study||7
1100376|NCT01100255|2663580|P1|STARTED|Overall Study||8
1100377|NCT01100268|2663586|P1|NOT COMPLETED|Overall Study||0
1100378|NCT01100268|2663586|P1|COMPLETED|Overall Study||4
1100379|NCT01100268|2663586|P1|STARTED|Overall Study||4
1100380|NCT01100307|2663593|P2|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||13
1100381|NCT01100307|2663594|P1|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||6
1100382|NCT01100307|2663593|P2|COMPLETED|Open Phase (Week 24 up to Week 54)||99
1100383|NCT01100307|2663594|P1|COMPLETED|Open Phase (Week 24 up to Week 54)||110
1100384|NCT01100307|2663593|P2|STARTED|Open Phase (Week 24 up to Week 54)|Four participants did not enter to the open phase after completing the double masked phase.|112
1100385|NCT01100307|2663594|P1|STARTED|Open Phase (Week 24 up to Week 54)|One participant discontinued from the study due to adverse event before study drug administration.|116
1100386|NCT01100307|2663593|P2|NOT COMPLETED|Double Masked Phase (Up to Week 24)||4
1100387|NCT01100307|2663594|P1|NOT COMPLETED|Double Masked Phase (Up to Week 24)||6
1100388|NCT01100307|2663593|P2|COMPLETED|Double Masked Phase (Up to Week 24)||116
1100389|NCT01100307|2663594|P1|COMPLETED|Double Masked Phase (Up to Week 24)||117
1100390|NCT01100307|2663593|P2|STARTED|Double Masked Phase (Up to Week 24)||120
1100391|NCT01100307|2663594|P1|STARTED|Double Masked Phase (Up to Week 24)||123
1100392|NCT01100320|2663636|P2|NOT COMPLETED|Period 2||1
1100393|NCT01100320|2663637|P1|NOT COMPLETED|Period 2||1
1100394|NCT01100320|2663636|P2|COMPLETED|Period 2||37
1100395|NCT01100320|2663637|P1|COMPLETED|Period 2||37
1100396|NCT01100320|2663636|P2|STARTED|Period 2||38
1100397|NCT01100320|2663637|P1|STARTED|Period 2||38
1100398|NCT01100320|2663636|P2|NOT COMPLETED|Period 1||7
1100399|NCT01100320|2663637|P1|NOT COMPLETED|Period 1||5
1100400|NCT01100320|2663636|P2|COMPLETED|Period 1||38
1100401|NCT01100320|2663637|P1|COMPLETED|Period 1||38
1100402|NCT01100320|2663636|P2|STARTED|Period 1||45
1100403|NCT01100320|2663637|P1|STARTED|Period 1||43
1100404|NCT01100437|2663647|P3|NOT COMPLETED|Treatment 2||0
1100405|NCT01100437|2663648|P2|NOT COMPLETED|Treatment 2||0
1100406|NCT01100437|2663649|P1|NOT COMPLETED|Treatment 2||0
1100407|NCT01100437|2663647|P3|COMPLETED|Treatment 2||0
1100408|NCT01100437|2663648|P2|COMPLETED|Treatment 2||2
1100409|NCT01100437|2663649|P1|COMPLETED|Treatment 2||4
1100410|NCT01100437|2663647|P3|STARTED|Treatment 2||0
1100411|NCT01100437|2663648|P2|STARTED|Treatment 2||2
1100412|NCT01100437|2663649|P1|STARTED|Treatment 2||4
1100413|NCT01100437|2663647|P3|NOT COMPLETED|Washout (4 Days)||0
1100414|NCT01100437|2663648|P2|NOT COMPLETED|Washout (4 Days)||0
1100415|NCT01100437|2663649|P1|NOT COMPLETED|Washout (4 Days)||0
1100416|NCT01100437|2663647|P3|COMPLETED|Washout (4 Days)||0
1100417|NCT01100437|2663648|P2|COMPLETED|Washout (4 Days)||2
1100418|NCT01100437|2663649|P1|COMPLETED|Washout (4 Days)||4
1100419|NCT01100437|2663647|P3|STARTED|Washout (4 Days)||0
1100420|NCT01100437|2663648|P2|STARTED|Washout (4 Days)||2
1100421|NCT01100437|2663649|P1|STARTED|Washout (4 Days)||4
1100422|NCT01100437|2663647|P3|NOT COMPLETED|Treatment 1||0
1100423|NCT01100437|2663648|P2|NOT COMPLETED|Treatment 1||0
1100424|NCT01100437|2663649|P1|NOT COMPLETED|Treatment 1||0
1100425|NCT01100437|2663647|P3|COMPLETED|Treatment 1||0
1100426|NCT01100437|2663648|P2|COMPLETED|Treatment 1||2
1100427|NCT01100437|2663649|P1|COMPLETED|Treatment 1||4
1100428|NCT01100437|2663647|P3|STARTED|Treatment 1||0
1100429|NCT01100437|2663648|P2|STARTED|Treatment 1||2
1100430|NCT01100437|2663649|P1|STARTED|Treatment 1||4
1100431|NCT01100437|2663647|P3|NOT COMPLETED|Maintenance||2
1100432|NCT01100437|2663648|P2|NOT COMPLETED|Maintenance||0
1100433|NCT01100437|2663649|P1|NOT COMPLETED|Maintenance||0
1100434|NCT01100437|2663647|P3|COMPLETED|Maintenance||0
1100435|NCT01100437|2663648|P2|COMPLETED|Maintenance||2
1100436|NCT01100437|2663649|P1|COMPLETED|Maintenance||4
1100437|NCT01100437|2663647|P3|STARTED|Maintenance||2
1100438|NCT01100437|2663648|P2|STARTED|Maintenance||2
1100439|NCT01100437|2663649|P1|STARTED|Maintenance||4
1100440|NCT01100437|2663647|P3|NOT COMPLETED|Titration/Stabilization||6
1100441|NCT01100437|2663648|P2|NOT COMPLETED|Titration/Stabilization||0
1100442|NCT01100437|2663649|P1|NOT COMPLETED|Titration/Stabilization||0
1100443|NCT01100437|2663647|P3|COMPLETED|Titration/Stabilization||2
1100444|NCT01100437|2663648|P2|COMPLETED|Titration/Stabilization||2
1100445|NCT01100437|2663649|P1|COMPLETED|Titration/Stabilization||4
1100446|NCT01100437|2663647|P3|STARTED|Titration/Stabilization||8
1100447|NCT01100437|2663648|P2|STARTED|Titration/Stabilization||2
1100448|NCT01100437|2663649|P1|STARTED|Titration/Stabilization||4
1100449|NCT01100437|2663647|P3|NOT COMPLETED|Screening||0
1100450|NCT01100437|2663648|P2|NOT COMPLETED|Screening||0
1100451|NCT01100437|2663649|P1|NOT COMPLETED|Screening||0
1100452|NCT01100437|2663647|P3|COMPLETED|Screening||8
1100453|NCT01100437|2663648|P2|COMPLETED|Screening||2
1100454|NCT01100437|2663649|P1|COMPLETED|Screening||4
1100455|NCT01100437|2663647|P3|STARTED|Screening||8
1100456|NCT01100437|2663648|P2|STARTED|Screening||2
1100457|NCT01100437|2663649|P1|STARTED|Screening||4
1100458|NCT01092728|2663688|P2|NOT COMPLETED|Overall Study||14
1100459|NCT01092728|2663689|P1|NOT COMPLETED|Overall Study||4
1100460|NCT01092728|2663688|P2|COMPLETED|Overall Study||0
1100461|NCT01092728|2663689|P1|COMPLETED|Overall Study||0
1100462|NCT01092728|2663688|P2|STARTED|Overall Study||14
1100463|NCT01092728|2663689|P1|STARTED|Overall Study||4
1100464|NCT01092767|2663697|P1|NOT COMPLETED|Overall Study||5
1100465|NCT01092767|2663697|P1|COMPLETED|Overall Study||45
1100466|NCT01092767|2663697|P1|STARTED|Overall Study||50
1100467|NCT01092780|2663701|P4|NOT COMPLETED|Treatment Period 4||0
1100468|NCT01092780|2663702|P3|NOT COMPLETED|Treatment Period 4||0
1100469|NCT01092780|2663703|P2|NOT COMPLETED|Treatment Period 4||0
1100470|NCT01092780|2663704|P1|NOT COMPLETED|Treatment Period 4||0
1100471|NCT01092780|2663701|P4|COMPLETED|Treatment Period 4||13
1100472|NCT01092780|2663702|P3|COMPLETED|Treatment Period 4||13
1100473|NCT01092780|2663703|P2|COMPLETED|Treatment Period 4||13
1100474|NCT01092780|2663704|P1|COMPLETED|Treatment Period 4||13
1100475|NCT01092780|2663701|P4|STARTED|Treatment Period 4||13
1100476|NCT01092780|2663702|P3|STARTED|Treatment Period 4||13
1100477|NCT01092780|2663703|P2|STARTED|Treatment Period 4||13
1100478|NCT01092780|2663704|P1|STARTED|Treatment Period 4||13
1100479|NCT01092780|2663701|P4|NOT COMPLETED|Washout Period 3||0
1100480|NCT01092780|2663702|P3|NOT COMPLETED|Washout Period 3||0
1100481|NCT01092780|2663703|P2|NOT COMPLETED|Washout Period 3||0
1100482|NCT01092780|2663704|P1|NOT COMPLETED|Washout Period 3||0
1100483|NCT01092780|2663701|P4|COMPLETED|Washout Period 3||13
1100484|NCT01092780|2663702|P3|COMPLETED|Washout Period 3||13
1100485|NCT01092780|2663703|P2|COMPLETED|Washout Period 3||13
1100486|NCT01092780|2663704|P1|COMPLETED|Washout Period 3||13
1100487|NCT01092780|2663701|P4|STARTED|Washout Period 3||13
1100488|NCT01092780|2663702|P3|STARTED|Washout Period 3||13
1100489|NCT01092780|2663703|P2|STARTED|Washout Period 3||13
1100490|NCT01092780|2663704|P1|STARTED|Washout Period 3||13
1100491|NCT01092780|2663701|P4|NOT COMPLETED|Treatment Period 3||0
1100492|NCT01092780|2663702|P3|NOT COMPLETED|Treatment Period 3||0
1100493|NCT01092780|2663703|P2|NOT COMPLETED|Treatment Period 3||0
1100494|NCT01092780|2663704|P1|NOT COMPLETED|Treatment Period 3||0
1100495|NCT01092780|2663701|P4|COMPLETED|Treatment Period 3||13
1100496|NCT01092780|2663702|P3|COMPLETED|Treatment Period 3||13
1100497|NCT01092780|2663703|P2|COMPLETED|Treatment Period 3||13
1100498|NCT01092780|2663704|P1|COMPLETED|Treatment Period 3||13
1100499|NCT01092780|2663701|P4|STARTED|Treatment Period 3||13
1100500|NCT01092780|2663702|P3|STARTED|Treatment Period 3||13
1100501|NCT01092780|2663703|P2|STARTED|Treatment Period 3||13
1100502|NCT01092780|2663704|P1|STARTED|Treatment Period 3||13
1100503|NCT01092780|2663701|P4|NOT COMPLETED|Washout Period 2||0
1100504|NCT01092780|2663702|P3|NOT COMPLETED|Washout Period 2||1
1100505|NCT01092780|2663703|P2|NOT COMPLETED|Washout Period 2||1
1100506|NCT01092780|2663704|P1|NOT COMPLETED|Washout Period 2||0
1100507|NCT01092780|2663701|P4|COMPLETED|Washout Period 2||13
1100508|NCT01092780|2663702|P3|COMPLETED|Washout Period 2||13
1100509|NCT01092780|2663703|P2|COMPLETED|Washout Period 2||13
1100510|NCT01092780|2663704|P1|COMPLETED|Washout Period 2||13
1100511|NCT01092780|2663701|P4|STARTED|Washout Period 2||13
1100512|NCT01092780|2663702|P3|STARTED|Washout Period 2||14
1100513|NCT01092780|2663703|P2|STARTED|Washout Period 2||14
1100514|NCT01092780|2663704|P1|STARTED|Washout Period 2||13
1100515|NCT01092780|2663701|P4|NOT COMPLETED|Treatment Period 2||0
1100516|NCT01092780|2663702|P3|NOT COMPLETED|Treatment Period 2||0
1100517|NCT01092780|2663703|P2|NOT COMPLETED|Treatment Period 2||0
1100518|NCT01092780|2663704|P1|NOT COMPLETED|Treatment Period 2||0
1100519|NCT01092780|2663701|P4|COMPLETED|Treatment Period 2||13
1100520|NCT01092780|2663702|P3|COMPLETED|Treatment Period 2||14
1100521|NCT01092780|2663703|P2|COMPLETED|Treatment Period 2||14
1100522|NCT01092780|2663704|P1|COMPLETED|Treatment Period 2||13
1100523|NCT01092780|2663701|P4|STARTED|Treatment Period 2||13
1100524|NCT01092780|2663702|P3|STARTED|Treatment Period 2||14
1100525|NCT01092780|2663703|P2|STARTED|Treatment Period 2||14
1100526|NCT01092780|2663704|P1|STARTED|Treatment Period 2||13
1100527|NCT01092780|2663701|P4|NOT COMPLETED|Washout Period 1||0
1100528|NCT01092780|2663702|P3|NOT COMPLETED|Washout Period 1||0
1100529|NCT01092780|2663703|P2|NOT COMPLETED|Washout Period 1||1
1100530|NCT01092780|2663704|P1|NOT COMPLETED|Washout Period 1||1
1100531|NCT01092780|2663701|P4|COMPLETED|Washout Period 1||13
1100532|NCT01092780|2663702|P3|COMPLETED|Washout Period 1||14
1100533|NCT01092780|2663703|P2|COMPLETED|Washout Period 1||14
1100534|NCT01092780|2663704|P1|COMPLETED|Washout Period 1||13
1100535|NCT01092780|2663701|P4|STARTED|Washout Period 1||13
1100536|NCT01092780|2663702|P3|STARTED|Washout Period 1||14
1100537|NCT01092780|2663703|P2|STARTED|Washout Period 1||15
1100538|NCT01092780|2663704|P1|STARTED|Washout Period 1||14
1100539|NCT01092780|2663701|P4|NOT COMPLETED|Treatment Period 1||0
1100540|NCT01092780|2663702|P3|NOT COMPLETED|Treatment Period 1||0
1100541|NCT01092780|2663703|P2|NOT COMPLETED|Treatment Period 1||0
1100542|NCT01092780|2663704|P1|NOT COMPLETED|Treatment Period 1||0
1100543|NCT01092780|2663701|P4|COMPLETED|Treatment Period 1||13
1100544|NCT01092780|2663702|P3|COMPLETED|Treatment Period 1||14
1100545|NCT01092780|2663703|P2|COMPLETED|Treatment Period 1||15
1100546|NCT01092780|2663704|P1|COMPLETED|Treatment Period 1||14
1100547|NCT01092780|2663701|P4|STARTED|Treatment Period 1||13
1100548|NCT01092780|2663702|P3|STARTED|Treatment Period 1||14
1100549|NCT01092780|2663703|P2|STARTED|Treatment Period 1||15
1100550|NCT01092780|2663704|P1|STARTED|Treatment Period 1||14
1100551|NCT01092832|2663736|P2|NOT COMPLETED|Overall Study||0
1100552|NCT01092832|2663737|P1|NOT COMPLETED|Overall Study||1
1100553|NCT01092832|2663736|P2|COMPLETED|Overall Study||8
1100554|NCT01092832|2663737|P1|COMPLETED|Overall Study||13
1100555|NCT01092832|2663736|P2|STARTED|Overall Study||8
1100556|NCT01092832|2663737|P1|STARTED|Overall Study||14
1100557|NCT01092910|2663749|P1|NOT COMPLETED|Overall Study||5
1100558|NCT01092910|2663749|P1|COMPLETED|Overall Study||52
1100559|NCT01092910|2663749|P1|10 Month Follow-up|Overall Study||52
1100560|NCT01092910|2663749|P1|4 Month Follow-up|Overall Study||54
1100561|NCT01092910|2663749|P1|STARTED|Overall Study||57
1100562|NCT01092923|2663761|P2|NOT COMPLETED|Overall Study||0
1100563|NCT01092923|2663762|P1|NOT COMPLETED|Overall Study||0
1100564|NCT01092923|2663761|P2|COMPLETED|Overall Study||10
1100565|NCT01092923|2663762|P1|COMPLETED|Overall Study||10
1100566|NCT01092923|2663761|P2|STARTED|Overall Study||10
1100567|NCT01092923|2663762|P1|STARTED|Overall Study||10
1100568|NCT01093014|2663774|P3|NOT COMPLETED|Overall Study||0
1100569|NCT01093014|2663775|P2|NOT COMPLETED|Overall Study||0
1100570|NCT01093014|2663776|P1|NOT COMPLETED|Overall Study||0
1100571|NCT01093014|2663774|P3|COMPLETED|Overall Study||12
1100572|NCT01093014|2663775|P2|COMPLETED|Overall Study||9
1100573|NCT01093014|2663776|P1|COMPLETED|Overall Study||12
1100574|NCT01093014|2663774|P3|STARTED|Overall Study||12
1100575|NCT01093014|2663775|P2|STARTED|Overall Study||9
1100576|NCT01093014|2663776|P1|STARTED|Overall Study||12
1100577|NCT01093027|2663795|P2|NOT COMPLETED|Visit 2||0
1100578|NCT01093027|2663796|P1|NOT COMPLETED|Visit 2||0
1100579|NCT01093027|2663795|P2|COMPLETED|Visit 2||10
1100580|NCT01093027|2663796|P1|COMPLETED|Visit 2||10
1100581|NCT01093027|2663795|P2|STARTED|Visit 2||10
1100582|NCT01093027|2663796|P1|STARTED|Visit 2||10
1100583|NCT01093027|2663795|P2|NOT COMPLETED|Visit 1||0
1100584|NCT01093027|2663796|P1|NOT COMPLETED|Visit 1||0
1100585|NCT01093027|2663795|P2|COMPLETED|Visit 1||10
1100586|NCT01093027|2663796|P1|COMPLETED|Visit 1||10
1100587|NCT01093027|2663795|P2|STARTED|Visit 1||10
1100588|NCT01093027|2663796|P1|STARTED|Visit 1||10
1100589|NCT01093222|2663804|P1|NOT COMPLETED|Overall Study||40
1100590|NCT01093222|2663804|P1|COMPLETED|Overall Study||0
1100591|NCT01093222|2663804|P1|Eligible and Began Protocol Therapy|Overall Study||34
1100592|NCT01093222|2663804|P1|STARTED|Overall Study||40
1100593|NCT01093417|2663813|P2|NOT COMPLETED|Overall Study||1
1100594|NCT01093417|2663814|P1|NOT COMPLETED|Overall Study||0
1100595|NCT01093417|2663813|P2|COMPLETED|Overall Study||29
1100596|NCT01093417|2663814|P1|COMPLETED|Overall Study||15
1100597|NCT01093417|2663813|P2|STARTED|Overall Study||30
1100598|NCT01093417|2663814|P1|STARTED|Overall Study||15
1100599|NCT01093469|2663825|P3|NOT COMPLETED|Overall Study||1
1100600|NCT01093469|2663826|P2|NOT COMPLETED|Overall Study||0
1100601|NCT01093469|2663827|P1|NOT COMPLETED|Overall Study||0
1100602|NCT01093469|2663825|P3|COMPLETED|Overall Study||12
1100603|NCT01093469|2663826|P2|COMPLETED|Overall Study||13
1100604|NCT01093469|2663827|P1|COMPLETED|Overall Study||13
1100605|NCT01093469|2663825|P3|STARTED|Overall Study||13
1100606|NCT01093469|2663826|P2|STARTED|Overall Study||13
1100607|NCT01093469|2663827|P1|STARTED|Overall Study||13
1100608|NCT01093521|2663835|P1|NOT COMPLETED|Overall Study||0
1100609|NCT01093521|2663835|P1|COMPLETED|Overall Study||20
1100610|NCT01093521|2663835|P1|STARTED|Overall Study||20
1100623|NCT01093599|2663962|P2|NOT COMPLETED|Overall Study||46
1100624|NCT01093599|2663963|P1|NOT COMPLETED|Overall Study||32
1100625|NCT01093599|2663962|P2|COMPLETED|Overall Study||59
1100626|NCT01093599|2663963|P1|COMPLETED|Overall Study||59
1100627|NCT01093599|2663962|P2|STARTED|Overall Study||105
1100628|NCT01093599|2663963|P1|STARTED|Overall Study||91
1100629|NCT01093625|2663971|P2|NOT COMPLETED|1-Year Visit||3
1100630|NCT01093625|2663972|P1|NOT COMPLETED|1-Year Visit||5
1100631|NCT01093625|2663971|P2|COMPLETED|1-Year Visit||37
1100632|NCT01093625|2663972|P1|COMPLETED|1-Year Visit||29
1100633|NCT01093625|2663971|P2|STARTED|1-Year Visit||40
1100634|NCT01093625|2663972|P1|STARTED|1-Year Visit||34
1100635|NCT01093625|2663971|P2|NOT COMPLETED|6-Month Visit||9
1100636|NCT01093625|2663972|P1|NOT COMPLETED|6-Month Visit||8
1100637|NCT01093625|2663971|P2|COMPLETED|6-Month Visit||40
1100638|NCT01093625|2663972|P1|COMPLETED|6-Month Visit||34
1100639|NCT01093625|2663971|P2|STARTED|6-Month Visit||49
1100640|NCT01093625|2663972|P1|STARTED|6-Month Visit||42
1100641|NCT01093625|2663971|P2|NOT COMPLETED|3-Month Visit||0
1100642|NCT01093625|2663972|P1|NOT COMPLETED|3-Month Visit||2
1100643|NCT01093625|2663971|P2|COMPLETED|3-Month Visit||49
1100644|NCT01093625|2663972|P1|COMPLETED|3-Month Visit||42
1100645|NCT01093625|2663971|P2|STARTED|3-Month Visit||49
1100646|NCT01093625|2663972|P1|STARTED|3-Month Visit||44
1100647|NCT01093625|2663971|P2|NOT COMPLETED|1-Month Visit||0
1100648|NCT01093625|2663972|P1|NOT COMPLETED|1-Month Visit||2
1100649|NCT01093625|2663971|P2|COMPLETED|1-Month Visit||49
1100650|NCT01093625|2663972|P1|COMPLETED|1-Month Visit||44
1100651|NCT01093625|2663971|P2|STARTED|1-Month Visit||49
1100652|NCT01093625|2663972|P1|STARTED|1-Month Visit||46
1100653|NCT01093625|2663971|P2|NOT COMPLETED|2-Week Visit||0
1100654|NCT01093625|2663972|P1|NOT COMPLETED|2-Week Visit||1
1100655|NCT01093625|2663971|P2|COMPLETED|2-Week Visit||49
1100656|NCT01093625|2663972|P1|COMPLETED|2-Week Visit||46
1100657|NCT01093625|2663971|P2|STARTED|2-Week Visit||49
1100658|NCT01093625|2663972|P1|STARTED|2-Week Visit||47
1100659|NCT01093625|2663971|P2|NOT COMPLETED|Baseline and Dispensed||0
1100660|NCT01093625|2663972|P1|NOT COMPLETED|Baseline and Dispensed||2
1100661|NCT01093625|2663971|P2|COMPLETED|Baseline and Dispensed||49
1100662|NCT01093625|2663972|P1|COMPLETED|Baseline and Dispensed||47
1100663|NCT01093625|2663971|P2|STARTED|Baseline and Dispensed||49
1100664|NCT01093625|2663972|P1|STARTED|Baseline and Dispensed||49
1100665|NCT01093651|2663992|P2|NOT COMPLETED|Overall Study||0
1100666|NCT01093651|2663993|P1|NOT COMPLETED|Overall Study||0
1100667|NCT01093651|2663992|P2|COMPLETED|Overall Study||10
1100668|NCT01093651|2663993|P1|COMPLETED|Overall Study||10
1100669|NCT01093651|2663992|P2|STARTED|Overall Study||10
1100670|NCT01093651|2663993|P1|STARTED|Overall Study||10
1100671|NCT01093690|2664013|P2|NOT COMPLETED|Overall Study||0
1100672|NCT01093690|2664014|P1|NOT COMPLETED|Overall Study||0
1100673|NCT01093690|2664013|P2|COMPLETED|Overall Study||79
1100674|NCT01093690|2664014|P1|COMPLETED|Overall Study||83
1100675|NCT01093690|2664013|P2|STARTED|Overall Study||79
1100676|NCT01093690|2664014|P1|STARTED|Overall Study||83
1100677|NCT01093755|2664022|P2|NOT COMPLETED|Overall Study||4
1100678|NCT01093755|2664023|P1|NOT COMPLETED|Overall Study||3
1100679|NCT01093755|2664022|P2|COMPLETED|Overall Study||10
1100680|NCT01093755|2664023|P1|COMPLETED|Overall Study||13
1100681|NCT01093755|2664022|P2|STARTED|Overall Study||14
1100682|NCT01093755|2664023|P1|STARTED|Overall Study||16
1100683|NCT01093794|2664031|P4|NOT COMPLETED|Treatment Period 4||0
1100684|NCT01093794|2664032|P3|NOT COMPLETED|Treatment Period 4||0
1100685|NCT01093794|2664033|P2|NOT COMPLETED|Treatment Period 4||0
1100686|NCT01093794|2664034|P1|NOT COMPLETED|Treatment Period 4||0
1100687|NCT01093794|2664031|P4|COMPLETED|Treatment Period 4||7
1100688|NCT01093794|2664032|P3|COMPLETED|Treatment Period 4||6
1100689|NCT01093794|2664033|P2|COMPLETED|Treatment Period 4||7
1100690|NCT01093794|2664034|P1|COMPLETED|Treatment Period 4||7
1100691|NCT01093794|2664031|P4|STARTED|Treatment Period 4||7
1100692|NCT01093794|2664032|P3|STARTED|Treatment Period 4||6
1100693|NCT01093794|2664033|P2|STARTED|Treatment Period 4||7
1100694|NCT01093794|2664034|P1|STARTED|Treatment Period 4||7
1100695|NCT01093794|2664031|P4|NOT COMPLETED|Treatment Period 3||0
1100696|NCT01093794|2664032|P3|NOT COMPLETED|Treatment Period 3||0
1100697|NCT01093794|2664033|P2|NOT COMPLETED|Treatment Period 3||0
1100698|NCT01093794|2664034|P1|NOT COMPLETED|Treatment Period 3||0
1100699|NCT01093794|2664031|P4|COMPLETED|Treatment Period 3||7
1100700|NCT01093794|2664032|P3|COMPLETED|Treatment Period 3||6
1100701|NCT01093794|2664033|P2|COMPLETED|Treatment Period 3||7
1100702|NCT01093794|2664034|P1|COMPLETED|Treatment Period 3||7
1100703|NCT01093794|2664031|P4|STARTED|Treatment Period 3||7
1100704|NCT01093794|2664032|P3|STARTED|Treatment Period 3||6
1100705|NCT01093794|2664033|P2|STARTED|Treatment Period 3||7
1100706|NCT01093794|2664034|P1|STARTED|Treatment Period 3||7
1100707|NCT01093794|2664031|P4|NOT COMPLETED|Treatment Period 2||0
1100708|NCT01093794|2664032|P3|NOT COMPLETED|Treatment Period 2||0
1100709|NCT01093794|2664033|P2|NOT COMPLETED|Treatment Period 2||0
1100710|NCT01093794|2664034|P1|NOT COMPLETED|Treatment Period 2||0
1100711|NCT01093794|2664031|P4|COMPLETED|Treatment Period 2||7
1100712|NCT01093794|2664032|P3|COMPLETED|Treatment Period 2||6
1100713|NCT01093794|2664033|P2|COMPLETED|Treatment Period 2||7
1100714|NCT01093794|2664034|P1|COMPLETED|Treatment Period 2||7
1100715|NCT01093794|2664031|P4|STARTED|Treatment Period 2||7
1100716|NCT01093794|2664032|P3|STARTED|Treatment Period 2|After period 1, one participant was discontinued by the investigator due to a protocol deviation.|6
1100717|NCT01093794|2664033|P2|STARTED|Treatment Period 2||7
1100718|NCT01093794|2664034|P1|STARTED|Treatment Period 2||7
1100719|NCT01093794|2664031|P4|NOT COMPLETED|Treatment Period 1||0
1100720|NCT01093794|2664032|P3|NOT COMPLETED|Treatment Period 1||0
1100721|NCT01093794|2664033|P2|NOT COMPLETED|Treatment Period 1||0
1100722|NCT01093794|2664034|P1|NOT COMPLETED|Treatment Period 1||0
1100723|NCT01093794|2664031|P4|COMPLETED|Treatment Period 1||7
1100724|NCT01093794|2664032|P3|COMPLETED|Treatment Period 1||7
1100725|NCT01093794|2664033|P2|COMPLETED|Treatment Period 1||7
1100726|NCT01093794|2664034|P1|COMPLETED|Treatment Period 1||7
1100727|NCT01093794|2664031|P4|STARTED|Treatment Period 1||7
1100728|NCT01093794|2664032|P3|STARTED|Treatment Period 1||7
1100729|NCT01093794|2664033|P2|STARTED|Treatment Period 1||7
1100730|NCT01093794|2664034|P1|STARTED|Treatment Period 1||7
1100731|NCT01093846|2664051|P3|NOT COMPLETED|Overall Study||21
1100732|NCT01093846|2664052|P2|NOT COMPLETED|Overall Study||18
1100733|NCT01093846|2664053|P1|NOT COMPLETED|Overall Study||19
1100734|NCT01093846|2664051|P3|COMPLETED|Overall Study||1
1100735|NCT01093846|2664052|P2|COMPLETED|Overall Study||0
1100736|NCT01093846|2664053|P1|COMPLETED|Overall Study||0
1100737|NCT01093846|2664051|P3|STARTED|Overall Study||22
1100738|NCT01093846|2664052|P2|STARTED|Overall Study||18
1100739|NCT01093846|2664053|P1|STARTED|Overall Study||19
1100740|NCT01093976|2664059|P1|NOT COMPLETED|Overall Study||0
1100741|NCT01093976|2664059|P1|COMPLETED|Overall Study||14
1100742|NCT01093976|2664059|P1|STARTED|Overall Study||14
1100743|NCT01094119|2664065|P2|NOT COMPLETED|Overall Study||4
1100744|NCT01094119|2664066|P1|NOT COMPLETED|Overall Study||2
1100745|NCT01094119|2664065|P2|COMPLETED|Overall Study||32
1100746|NCT01094119|2664066|P1|COMPLETED|Overall Study||32
1100747|NCT01094119|2664065|P2|STARTED|Overall Study||36
1100748|NCT01094119|2664066|P1|STARTED|Overall Study||34
1100749|NCT01094171|2664074|P1|NOT COMPLETED|Overall Study||10
1100750|NCT01094171|2664074|P1|COMPLETED|Overall Study||390
1100751|NCT01094171|2664074|P1|STARTED|Overall Study||400
1100752|NCT01094522|2664083|P2|NOT COMPLETED|Overall Study||0
1100753|NCT01094522|2664084|P1|NOT COMPLETED|Overall Study||0
1100754|NCT01094522|2664083|P2|COMPLETED|Overall Study||20
1100755|NCT01094522|2664084|P1|COMPLETED|Overall Study||20
1100756|NCT01094522|2664083|P2|STARTED|Overall Study||20
1100757|NCT01094522|2664084|P1|STARTED|Overall Study||20
1100758|NCT01094548|2664096|P2|NOT COMPLETED|Overall Study||0
1100759|NCT01094548|2664097|P1|NOT COMPLETED|Overall Study||0
1100760|NCT01094548|2664096|P2|COMPLETED|Overall Study||17
1100761|NCT01094548|2664097|P1|COMPLETED|Overall Study||17
1100762|NCT01094548|2664096|P2|STARTED|Overall Study||17
1100763|NCT01094548|2664097|P1|STARTED|Overall Study||17
1100764|NCT01094561|2664115|P1|NOT COMPLETED|Overall Study||6
1100765|NCT01094561|2664115|P1|COMPLETED|Overall Study||17
1100766|NCT01094561|2664115|P1|STARTED|Overall Study||23
1100767|NCT01094574|2664126|P6|NOT COMPLETED|Overall Study||0
1100768|NCT01094574|2664127|P5|NOT COMPLETED|Overall Study||0
1100769|NCT01094574|2664128|P4|NOT COMPLETED|Overall Study||0
1100770|NCT01094574|2664129|P3|NOT COMPLETED|Overall Study||0
1100771|NCT01094574|2664130|P2|NOT COMPLETED|Overall Study||0
1100772|NCT01094574|2664131|P1|NOT COMPLETED|Overall Study||0
1100773|NCT01094574|2664126|P6|COMPLETED|Overall Study||2
1100774|NCT01094574|2664127|P5|COMPLETED|Overall Study||2
1100775|NCT01094574|2664128|P4|COMPLETED|Overall Study||2
1100776|NCT01094574|2664129|P3|COMPLETED|Overall Study||2
1100777|NCT01094574|2664130|P2|COMPLETED|Overall Study||1
1100778|NCT01094574|2664131|P1|COMPLETED|Overall Study||1
1100779|NCT01094574|2664126|P6|STARTED|Overall Study||2
1100780|NCT01094574|2664127|P5|STARTED|Overall Study||2
1100781|NCT01094574|2664128|P4|STARTED|Overall Study||2
1100782|NCT01094574|2664129|P3|STARTED|Overall Study||2
1100783|NCT01094574|2664130|P2|STARTED|Overall Study||1
1100784|NCT01094574|2664131|P1|STARTED|Overall Study||1
1100785|NCT01094704|2664180|P2|NOT COMPLETED|Overall Study||0
1100786|NCT01094704|2664181|P1|NOT COMPLETED|Overall Study||0
1100787|NCT01094704|2664180|P2|COMPLETED|Overall Study||8
1100788|NCT01094704|2664181|P1|COMPLETED|Overall Study||8
1100789|NCT01094704|2664180|P2|STARTED|Overall Study||8
1100790|NCT01094704|2664181|P1|STARTED|Overall Study||8
1100791|NCT01094730|2664187|P2|NOT COMPLETED|Period 2 (14 Days)||2
1100792|NCT01094730|2664188|P1|NOT COMPLETED|Period 2 (14 Days)||3
1100793|NCT01094730|2664187|P2|COMPLETED|Period 2 (14 Days)||84
1100794|NCT01094730|2664188|P1|COMPLETED|Period 2 (14 Days)||87
1100795|NCT01094730|2664187|P2|STARTED|Period 2 (14 Days)||86
1100796|NCT01094730|2664188|P1|STARTED|Period 2 (14 Days)||90
1100797|NCT01094730|2664187|P2|NOT COMPLETED|Period 1 (14 Days)||2
1100798|NCT01094730|2664188|P1|NOT COMPLETED|Period 1 (14 Days)||2
1100799|NCT01094730|2664187|P2|COMPLETED|Period 1 (14 Days)||86
1100800|NCT01094730|2664188|P1|COMPLETED|Period 1 (14 Days)||90
1100801|NCT01094730|2664187|P2|STARTED|Period 1 (14 Days)||88
1100802|NCT01094730|2664188|P1|STARTED|Period 1 (14 Days)||92
1100809|NCT01094808|2664219|P3|NOT COMPLETED|Overall Study||0
1100810|NCT01094808|2664220|P2|NOT COMPLETED|Overall Study||1
1100811|NCT01094808|2664221|P1|NOT COMPLETED|Overall Study||1
1100812|NCT01094808|2664219|P3|COMPLETED|Overall Study||21
1100813|NCT01094808|2664220|P2|COMPLETED|Overall Study||19
1100814|NCT01094808|2664221|P1|COMPLETED|Overall Study||20
1100815|NCT01094808|2664219|P3|STARTED|Overall Study||21
1100816|NCT01094808|2664220|P2|STARTED|Overall Study||20
1100817|NCT01094808|2664221|P1|STARTED|Overall Study||21
1100818|NCT01094886|2664256|P1|NOT COMPLETED|Overall Study||7
1100819|NCT01094886|2664256|P1|COMPLETED|Overall Study||46
1100820|NCT01094886|2664256|P1|STARTED|Overall Study||53
1100821|NCT01100502|2664265|P2|NOT COMPLETED|Long-Term Follow-up||139
1100822|NCT01100502|2664266|P1|NOT COMPLETED|Long-Term Follow-up||137
1100823|NCT01100502|2664265|P2|COMPLETED|Long-Term Follow-up|Completed follow-up due to death|25
1100824|NCT01100502|2664266|P1|COMPLETED|Long-Term Follow-up|Completed follow-up due to death|28
1100825|NCT01100502|2664265|P2|STARTED|Long-Term Follow-up|All participants were to be followed after treatment|164
1100826|NCT01100502|2664266|P1|STARTED|Long-Term Follow-up|All participants were to be followed after treatment|165
1100827|NCT01100502|2664265|P2|NOT COMPLETED|Treatment Period||83
1100828|NCT01100502|2664266|P1|NOT COMPLETED|Treatment Period||87
1100829|NCT01100502|2664265|P2|COMPLETED|Treatment Period||81
1100830|NCT01100502|2664266|P1|COMPLETED|Treatment Period||78
1100831|NCT01100502|2664265|P2|STARTED|Treatment Period||164
1100832|NCT01100502|2664266|P1|STARTED|Treatment Period||165
1100833|NCT01100567|2664278|P2|NOT COMPLETED|Overall Study||16
1100834|NCT01100567|2664279|P1|NOT COMPLETED|Overall Study||12
1100835|NCT01100567|2664278|P2|COMPLETED|Overall Study||35
1100836|NCT01100567|2664279|P1|COMPLETED|Overall Study||38
1100837|NCT01100567|2664278|P2|STARTED|Overall Study||51
1100838|NCT01100567|2664279|P1|STARTED|Overall Study||50
1100839|NCT01100606|2664287|P2|NOT COMPLETED|Second Treatment Period||0
1100840|NCT01100606|2664288|P1|NOT COMPLETED|Second Treatment Period||0
1100841|NCT01100606|2664287|P2|COMPLETED|Second Treatment Period|Due to difficulty with syringe nurser, 1 participant completed study using apple sauce|7
1100842|NCT01100606|2664288|P1|COMPLETED|Second Treatment Period|Due to intolerance to apple sauce & apple juice,1 participant completed study with banana-based food|8
1100843|NCT01100606|2664287|P2|STARTED|Second Treatment Period||7
1100844|NCT01100606|2664288|P1|STARTED|Second Treatment Period||8
1100845|NCT01100606|2664287|P2|NOT COMPLETED|First Treatment Period||0
1100846|NCT01100606|2664288|P1|NOT COMPLETED|First Treatment Period||0
1100847|NCT01100606|2664287|P2|COMPLETED|First Treatment Period||7
1100848|NCT01100606|2664288|P1|COMPLETED|First Treatment Period|Due to difficulty with syringe nurser,1 participant completed study with apple sauce,not apple juice|8
1100849|NCT01100606|2664287|P2|STARTED|First Treatment Period||7
1100850|NCT01100606|2664288|P1|STARTED|First Treatment Period||8
1100851|NCT01100658|2664312|P1|NOT COMPLETED|Overall Study||1
1100852|NCT01100658|2664312|P1|COMPLETED|Overall Study||0
1100853|NCT01100658|2664312|P1|STARTED|Overall Study||1
1100854|NCT01100723|2664317|P1|NOT COMPLETED|Overall Study||14
1100855|NCT01100723|2664317|P1|COMPLETED|Overall Study|78 subjects had laboratory data at the 12 month analysis and were compared to their baseline data.|78
1100856|NCT01100723|2664317|P1|6 Month Analysis|Overall Study|85 subjects had laboratory data at the 6 month analysis and were compared to their baseline data.|85
1100857|NCT01100723|2664317|P1|STARTED|Overall Study||92
1100858|NCT01100762|2664326|P1|NOT COMPLETED|Overall Study||0
1100859|NCT01100762|2664326|P1|COMPLETED|Overall Study||10
1100860|NCT01100762|2664326|P1|STARTED|Overall Study||10
1100861|NCT01101165|2664347|P2|NOT COMPLETED|Period 2||1
1100862|NCT01101165|2664348|P1|NOT COMPLETED|Period 2||4
1100863|NCT01101165|2664347|P2|COMPLETED|Period 2||39
1100864|NCT01101165|2664348|P1|COMPLETED|Period 2||41
1100865|NCT01101165|2664347|P2|STARTED|Period 2||40
1100866|NCT01101165|2664348|P1|STARTED|Period 2||45
1100867|NCT01101165|2664347|P2|NOT COMPLETED|Period 1||5
1100868|NCT01101165|2664348|P1|NOT COMPLETED|Period 1||2
1100869|NCT01101165|2664347|P2|COMPLETED|Period 1||40
1100870|NCT01101165|2664348|P1|COMPLETED|Period 1||45
1100871|NCT01101165|2664347|P2|STARTED|Period 1||45
1100872|NCT01101165|2664348|P1|STARTED|Period 1||47
1100873|NCT01101178|2664358|P2|NOT COMPLETED|Period 2||1
1100874|NCT01101178|2664359|P1|NOT COMPLETED|Period 2||0
1100875|NCT01101178|2664358|P2|COMPLETED|Period 2||34
1100876|NCT01101178|2664359|P1|COMPLETED|Period 2||36
1100877|NCT01101178|2664358|P2|STARTED|Period 2||35
1100878|NCT01101178|2664359|P1|STARTED|Period 2||36
1100879|NCT01101178|2664358|P2|NOT COMPLETED|Period 1||4
1100880|NCT01101178|2664359|P1|NOT COMPLETED|Period 1||4
1100881|NCT01101178|2664358|P2|COMPLETED|Period 1||35
1100882|NCT01101178|2664359|P1|COMPLETED|Period 1||36
1100883|NCT01101178|2664358|P2|STARTED|Period 1||39
1100884|NCT01101178|2664359|P1|STARTED|Period 1||40
1100885|NCT01101191|2664370|P2|NOT COMPLETED|Period 2||0
1100886|NCT01101191|2664371|P1|NOT COMPLETED|Period 2||0
1100887|NCT01101191|2664370|P2|COMPLETED|Period 2||40
1100888|NCT01101191|2664371|P1|COMPLETED|Period 2||40
1100889|NCT01101191|2664370|P2|STARTED|Period 2||40
1100890|NCT01101191|2664371|P1|STARTED|Period 2||40
1100891|NCT01101191|2664370|P2|NOT COMPLETED|Period 1||2
1100892|NCT01101191|2664371|P1|NOT COMPLETED|Period 1||2
1100893|NCT01101191|2664370|P2|COMPLETED|Period 1||40
1100894|NCT01101191|2664371|P1|COMPLETED|Period 1||40
1100895|NCT01101191|2664370|P2|STARTED|Period 1||42
1100896|NCT01101191|2664371|P1|STARTED|Period 1||42
1100897|NCT01101308|2664382|P2|NOT COMPLETED|Period 2||0
1100898|NCT01101308|2664383|P1|NOT COMPLETED|Period 2||0
1100899|NCT01101308|2664382|P2|COMPLETED|Period 2||27
1100900|NCT01101308|2664383|P1|COMPLETED|Period 2||24
1100901|NCT01101308|2664382|P2|STARTED|Period 2||27
1100902|NCT01101308|2664383|P1|STARTED|Period 2||24
1100903|NCT01101308|2664382|P2|NOT COMPLETED|Period 1||1
1100904|NCT01101308|2664383|P1|NOT COMPLETED|Period 1||3
1100905|NCT01101308|2664382|P2|COMPLETED|Period 1||27
1100906|NCT01101308|2664383|P1|COMPLETED|Period 1||24
1100907|NCT01101308|2664382|P2|STARTED|Period 1||28
1100908|NCT01101308|2664383|P1|STARTED|Period 1||27
1100909|NCT01101321|2664394|P2|NOT COMPLETED|Period 2||0
1100910|NCT01101321|2664395|P1|NOT COMPLETED|Period 2||0
1100911|NCT01101321|2664394|P2|COMPLETED|Period 2||24
1100912|NCT01101321|2664395|P1|COMPLETED|Period 2||26
1100913|NCT01101321|2664394|P2|STARTED|Period 2||24
1100914|NCT01101321|2664395|P1|STARTED|Period 2||26
1100915|NCT01101321|2664394|P2|NOT COMPLETED|Period 1||4
1100916|NCT01101321|2664395|P1|NOT COMPLETED|Period 1||4
1100917|NCT01101321|2664394|P2|COMPLETED|Period 1||24
1100918|NCT01101321|2664395|P1|COMPLETED|Period 1||26
1100919|NCT01101321|2664394|P2|STARTED|Period 1||28
1100920|NCT01101321|2664395|P1|STARTED|Period 1||30
1100921|NCT01101464|2664407|P2|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
1100922|NCT01101464|2664408|P1|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
1100923|NCT01101464|2664407|P2|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
1100924|NCT01101464|2664408|P1|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
1100925|NCT01101464|2664407|P2|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
1100926|NCT01101464|2664408|P1|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
1100927|NCT01101464|2664407|P2|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
1100928|NCT01101464|2664408|P1|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
1100929|NCT01101464|2664407|P2|COMPLETED|Day 1 Through AM Dose of Day 5||4
1100930|NCT01101464|2664408|P1|COMPLETED|Day 1 Through AM Dose of Day 5||4
1100931|NCT01101464|2664407|P2|STARTED|Day 1 Through AM Dose of Day 5||4
1100932|NCT01101464|2664408|P1|STARTED|Day 1 Through AM Dose of Day 5||4
1100933|NCT01101477|2664421|P3|NOT COMPLETED|Overall Study||1
1100934|NCT01101477|2664422|P2|NOT COMPLETED|Overall Study||3
1100935|NCT01101477|2664423|P1|NOT COMPLETED|Overall Study||5
1100936|NCT01101477|2664421|P3|COMPLETED|Overall Study||45
1100937|NCT01101477|2664422|P2|COMPLETED|Overall Study||46
1100938|NCT01101477|2664423|P1|COMPLETED|Overall Study||44
1100939|NCT01101477|2664421|P3|STARTED|Overall Study||46
1100940|NCT01101477|2664422|P2|STARTED|Overall Study||49
1100941|NCT01101477|2664423|P1|STARTED|Overall Study||49
1100942|NCT01101542|2664431|P1|NOT COMPLETED|Year 6 Surveillance Period||991
1100943|NCT01101542|2664431|P1|COMPLETED|Year 6 Surveillance Period||2100
1100944|NCT01101542|2664431|P1|STARTED|Year 6 Surveillance Period||3091
1100945|NCT01101542|2664431|P1|NOT COMPLETED|Year 5 Surveillance Period||141
1100946|NCT01101542|2664431|P1|COMPLETED|Year 5 Surveillance Period||668
1100947|NCT01101542|2664431|P1|STARTED|Year 5 Surveillance Period||809
1100948|NCT01101542|2664431|P1|NOT COMPLETED|Year 4 Surveillance Period||287
1100949|NCT01101542|2664431|P1|COMPLETED|Year 4 Surveillance Period||282
1100950|NCT01101542|2664431|P1|STARTED|Year 4 Surveillance Period||569
1100951|NCT01101542|2664431|P1|NOT COMPLETED|Year 3 Surveillance Period||11
1100952|NCT01101542|2664431|P1|COMPLETED|Year 3 Surveillance Period||94
1100953|NCT01101542|2664431|P1|STARTED|Year 3 Surveillance Period||105
1100954|NCT01101841|2664449|P2|NOT COMPLETED|Overall Study||67
1100955|NCT01101841|2664450|P1|NOT COMPLETED|Overall Study||50
1100956|NCT01101841|2664449|P2|COMPLETED|Overall Study||218
1100957|NCT01101841|2664450|P1|COMPLETED|Overall Study||235
1100958|NCT01101841|2664449|P2|STARTED|Overall Study||285
1100959|NCT01101841|2664450|P1|STARTED|Overall Study||285
1100966|NCT01101958|2664503|P2|NOT COMPLETED|Overall Study||5
1100967|NCT01101958|2664504|P1|NOT COMPLETED|Overall Study||11
1100968|NCT01101958|2664503|P2|COMPLETED|Overall Study||29
1100969|NCT01101958|2664504|P1|COMPLETED|Overall Study||51
1100970|NCT01101958|2664503|P2|STARTED|Overall Study||34
1100971|NCT01101958|2664504|P1|STARTED|Overall Study||62
1100972|NCT01101971|2664510|P1|NOT COMPLETED|Overall Study||0
1100973|NCT01101971|2664510|P1|COMPLETED|Overall Study||45
1100974|NCT01101971|2664510|P1|STARTED|Overall Study||45
1100975|NCT01102140|2664516|P2|NOT COMPLETED|Overall Study||2
1100976|NCT01102140|2664517|P1|NOT COMPLETED|Overall Study||3
1100977|NCT01102140|2664516|P2|COMPLETED|Overall Study||5
1100978|NCT01102140|2664517|P1|COMPLETED|Overall Study||10
1100979|NCT01102140|2664516|P2|STARTED|Overall Study||7
1100980|NCT01102140|2664517|P1|STARTED|Overall Study||13
1100981|NCT01102218|2664531|P2|NOT COMPLETED|Overall Study||10
1100982|NCT01102218|2664532|P1|NOT COMPLETED|Overall Study||11
1100983|NCT01102218|2664531|P2|COMPLETED|Overall Study||14
1100984|NCT01102218|2664532|P1|COMPLETED|Overall Study||13
1100985|NCT01102218|2664531|P2|STARTED|Overall Study||24
1100986|NCT01102218|2664532|P1|STARTED|Overall Study||24
1100987|NCT01102257|2664540|P2|NOT COMPLETED|Overall Study||0
1100988|NCT01102257|2664541|P1|NOT COMPLETED|Overall Study||2
1100989|NCT01102257|2664540|P2|COMPLETED|Overall Study||9
1100990|NCT01102257|2664541|P1|COMPLETED|Overall Study|2 withdrew from the study d/t adverse events. 1 had shortness of breath and the other had chest pain|7
1100991|NCT01102257|2664540|P2|STARTED|Overall Study||9
1100992|NCT01102257|2664541|P1|STARTED|Overall Study||9
1100993|NCT01102270|2664547|P2|NOT COMPLETED|Overall Study||0
1100994|NCT01102270|2664548|P1|NOT COMPLETED|Overall Study||0
1100995|NCT01102270|2664547|P2|COMPLETED|Overall Study||9
1100996|NCT01102270|2664548|P1|COMPLETED|Overall Study||8
1100997|NCT01102270|2664547|P2|STARTED|Overall Study||9
1100998|NCT01102270|2664548|P1|STARTED|Overall Study||8
1100999|NCT01102374|2664562|P2|NOT COMPLETED|Overall Study||19
1101000|NCT01102374|2664563|P1|NOT COMPLETED|Overall Study||16
1101001|NCT01102374|2664562|P2|COMPLETED|Overall Study||33
1101002|NCT01102374|2664563|P1|COMPLETED|Overall Study||39
1101003|NCT01102374|2664562|P2|STARTED|Overall Study||52
1101004|NCT01102374|2664563|P1|STARTED|Overall Study||55
1101005|NCT01102413|2664599|P2|NOT COMPLETED|Overall Study||12
1101006|NCT01102413|2664600|P1|NOT COMPLETED|Overall Study||25
1101007|NCT01102413|2664599|P2|COMPLETED|Overall Study||106
1101008|NCT01102413|2664600|P1|COMPLETED|Overall Study||208
1101009|NCT01102413|2664599|P2|STARTED|Overall Study||118
1101010|NCT01102413|2664600|P1|STARTED|Overall Study||233
1101011|NCT01102491|2664610|P2|NOT COMPLETED|Overall Study||12
1101012|NCT01102491|2664611|P1|NOT COMPLETED|Overall Study||11
1101013|NCT01102491|2664610|P2|COMPLETED|Overall Study|12 patients were excluded|59
1101014|NCT01102491|2664611|P1|COMPLETED|Overall Study|11 patient excluded|60
1101015|NCT01102491|2664610|P2|STARTED|Overall Study||71
1101016|NCT01102491|2664611|P1|STARTED|Overall Study||71
1101017|NCT01102764|2664619|P2|NOT COMPLETED|Overall Study||13
1101018|NCT01102764|2664620|P1|NOT COMPLETED|Overall Study||21
1101019|NCT01102764|2664619|P2|COMPLETED|Overall Study||55
1101020|NCT01102764|2664620|P1|COMPLETED|Overall Study||43
1101021|NCT01102764|2664619|P2|STARTED|Overall Study||68
1101022|NCT01102764|2664620|P1|STARTED|Overall Study||64
1101023|NCT01102777|2664632|P2|NOT COMPLETED|Overall Study||16
1101024|NCT01102777|2664633|P1|NOT COMPLETED|Overall Study||9
1101025|NCT01102777|2664632|P2|COMPLETED|Overall Study||139
1101026|NCT01102777|2664633|P1|COMPLETED|Overall Study||75
1101027|NCT01102777|2664632|P2|STARTED|Overall Study||155
1101028|NCT01102777|2664633|P1|STARTED|Overall Study||84
1101029|NCT01102803|2664659|P2|NOT COMPLETED|Post to Follow-Up||3
1101030|NCT01102803|2664660|P1|NOT COMPLETED|Post to Follow-Up||1
1101031|NCT01102803|2664659|P2|COMPLETED|Post to Follow-Up||12
1101032|NCT01102803|2664660|P1|COMPLETED|Post to Follow-Up||10
1101033|NCT01102803|2664659|P2|STARTED|Post to Follow-Up||15
1101034|NCT01102803|2664660|P1|STARTED|Post to Follow-Up||11
1101035|NCT01102803|2664659|P2|NOT COMPLETED|Baseline to Post-Treatment||0
1101036|NCT01102803|2664660|P1|NOT COMPLETED|Baseline to Post-Treatment||3
1101037|NCT01102803|2664659|P2|COMPLETED|Baseline to Post-Treatment||15
1101038|NCT01102803|2664660|P1|COMPLETED|Baseline to Post-Treatment||11
1101039|NCT01102803|2664659|P2|STARTED|Baseline to Post-Treatment||15
1101040|NCT01102803|2664660|P1|STARTED|Baseline to Post-Treatment||14
1101041|NCT01102894|2664672|P1|NOT COMPLETED|Overall Study||0
1101042|NCT01102894|2664672|P1|COMPLETED|Overall Study||10
1101043|NCT01102894|2664672|P1|STARTED|Overall Study||10
1101044|NCT01102972|2664684|P2|NOT COMPLETED|Overall Study||14
1101045|NCT01102972|2664685|P1|NOT COMPLETED|Overall Study||29
1101046|NCT01102972|2664684|P2|COMPLETED|Overall Study|These participants completed Study Week 48.|83
1101047|NCT01102972|2664685|P1|COMPLETED|Overall Study|These participants completed Study Week 48.|170
1101048|NCT01102972|2664684|P2|Completed Week 24|Overall Study||88
1101049|NCT01102972|2664685|P1|Completed Week 24|Overall Study||180
1101050|NCT01102972|2664684|P2|STARTED|Overall Study|297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn’t “start” the study.|97
1101051|NCT01102972|2664685|P1|STARTED|Overall Study|297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn’t “start” the study.|199
1101052|NCT01103063|2664739|P2|NOT COMPLETED|Overall Study||421
1101053|NCT01103063|2664740|P1|NOT COMPLETED|Overall Study||477
1101054|NCT01103063|2664739|P2|COMPLETED|Overall Study||1024
1101055|NCT01103063|2664740|P1|COMPLETED|Overall Study||969
1101056|NCT01103063|2664739|P2|STARTED|Overall Study||1445
1101057|NCT01103063|2664740|P1|STARTED|Overall Study||1446
1101058|NCT01103141|2664808|P2|NOT COMPLETED|Overall Study||2
1101059|NCT01103141|2664809|P1|NOT COMPLETED|Overall Study||2
1101060|NCT01103141|2664808|P2|COMPLETED|Overall Study||74
1101061|NCT01103141|2664809|P1|COMPLETED|Overall Study||65
1101062|NCT01103141|2664808|P2|STARTED|Overall Study||76
1101063|NCT01103141|2664809|P1|STARTED|Overall Study||67
1101064|NCT01103232|2664817|P2|NOT COMPLETED|Overall Study||2
1101065|NCT01103232|2664818|P1|NOT COMPLETED|Overall Study||1
1101066|NCT01103232|2664817|P2|COMPLETED|Overall Study||11
1101067|NCT01103232|2664818|P1|COMPLETED|Overall Study||12
1101068|NCT01103232|2664817|P2|STARTED|Overall Study||13
1101069|NCT01103232|2664818|P1|STARTED|Overall Study||13
1101070|NCT01103271|2664826|P2|NOT COMPLETED|Overall Study||4
1101071|NCT01103271|2664827|P1|NOT COMPLETED|Overall Study||1
1101072|NCT01103271|2664826|P2|COMPLETED|Overall Study||5
1101073|NCT01103271|2664827|P1|COMPLETED|Overall Study||10
1101074|NCT01103271|2664826|P2|STARTED|Overall Study||9
1101075|NCT01103271|2664827|P1|STARTED|Overall Study||11
1101076|NCT01103284|2664836|P2|NOT COMPLETED|Overall Study||44
1101077|NCT01103284|2664837|P1|NOT COMPLETED|Overall Study||42
1101078|NCT01103284|2664836|P2|COMPLETED|Overall Study||195
1101079|NCT01103284|2664837|P1|COMPLETED|Overall Study||194
1101080|NCT01103284|2664836|P2|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS)|235
1101081|NCT01103284|2664837|P1|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS) population|233
1101082|NCT01103284|2664836|P2|Treated|Overall Study||238
1101083|NCT01103284|2664837|P1|Treated|Overall Study||236
1101084|NCT01103284|2664836|P2|STARTED|Overall Study||239
1101085|NCT01103284|2664837|P1|STARTED|Overall Study||236
1101086|NCT01103323|2664853|P2|NOT COMPLETED|Switched From Placebo to Regorafenib||1
1101087|NCT01103323|2664854|P1|NOT COMPLETED|Switched From Placebo to Regorafenib||0
1101088|NCT01103323|2664853|P2|COMPLETED|Switched From Placebo to Regorafenib||3
1101089|NCT01103323|2664854|P1|COMPLETED|Switched From Placebo to Regorafenib||0
1101090|NCT01103323|2664853|P2|STARTED|Switched From Placebo to Regorafenib|Participants in the placebo+BSC group switched to Regorafenib treatment after unblinding.|4
1101091|NCT01103323|2664854|P1|STARTED|Switched From Placebo to Regorafenib||0
1101092|NCT01103323|2664853|P2|NOT COMPLETED|Without/Before Drug Switch||18
1101093|NCT01103323|2664854|P1|NOT COMPLETED|Without/Before Drug Switch||76
1101094|NCT01103323|2664853|P2|COMPLETED|Without/Before Drug Switch||237
1101095|NCT01103323|2664854|P1|COMPLETED|Without/Before Drug Switch||429
1101096|NCT01103323|2664853|P2|Participants Received Treatment|Without/Before Drug Switch||253
1101097|NCT01103323|2664854|P1|Participants Received Treatment|Without/Before Drug Switch||500
1101098|NCT01103323|2664853|P2|STARTED|Without/Before Drug Switch||255
1101099|NCT01103323|2664854|P1|STARTED|Without/Before Drug Switch||505
1101100|NCT01103362|2664869|P1|NOT COMPLETED|Overall Study||596
1101101|NCT01103362|2664869|P1|COMPLETED|Overall Study||0
1101102|NCT01103362|2664869|P1|STARTED|Overall Study||596
1101103|NCT01103414|2664878|P5|NOT COMPLETED|Overall Study||15
1101104|NCT01103414|2664879|P4|NOT COMPLETED|Overall Study||7
1101105|NCT01103414|2664880|P3|NOT COMPLETED|Overall Study||15
1101106|NCT01103414|2664881|P2|NOT COMPLETED|Overall Study||9
1101107|NCT01103414|2664882|P1|NOT COMPLETED|Overall Study||13
1101108|NCT01103414|2664878|P5|COMPLETED|Overall Study||56
1101109|NCT01103414|2664879|P4|COMPLETED|Overall Study||64
1101110|NCT01103414|2664880|P3|COMPLETED|Overall Study||56
1101111|NCT01103414|2664881|P2|COMPLETED|Overall Study||62
1101112|NCT01103414|2664882|P1|COMPLETED|Overall Study||59
1101113|NCT01103414|2664878|P5|STARTED|Overall Study||71
1101114|NCT01103414|2664879|P4|STARTED|Overall Study||71
1101115|NCT01103414|2664880|P3|STARTED|Overall Study||71
1101116|NCT01103414|2664881|P2|STARTED|Overall Study||71
1101117|NCT01103414|2664882|P1|STARTED|Overall Study||72
1101118|NCT01103466|2664944|P3|NOT COMPLETED|Third Period (14 +/- 3 Days)||1
1101119|NCT01103466|2664945|P2|NOT COMPLETED|Third Period (14 +/- 3 Days)||0
1101120|NCT01103466|2664946|P1|NOT COMPLETED|Third Period (14 +/- 3 Days)||2
1101121|NCT01103466|2664944|P3|COMPLETED|Third Period (14 +/- 3 Days)||13
1101122|NCT01103466|2664945|P2|COMPLETED|Third Period (14 +/- 3 Days)||8
1101123|NCT01103466|2664946|P1|COMPLETED|Third Period (14 +/- 3 Days)||6
1101124|NCT01103466|2664944|P3|STARTED|Third Period (14 +/- 3 Days)||14
1101125|NCT01103466|2664945|P2|STARTED|Third Period (14 +/- 3 Days)||8
1101126|NCT01103466|2664946|P1|STARTED|Third Period (14 +/- 3 Days)||8
1101127|NCT01103466|2664944|P3|NOT COMPLETED|Second Period (14 +/- 3 Days)||1
1101128|NCT01103466|2664945|P2|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
1101129|NCT01103466|2664946|P1|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
1101130|NCT01103466|2664944|P3|COMPLETED|Second Period (14 +/- 3 Days)||6
1101131|NCT01103466|2664945|P2|COMPLETED|Second Period (14 +/- 3 Days)||11
1101132|NCT01103466|2664946|P1|COMPLETED|Second Period (14 +/- 3 Days)||13
1101133|NCT01103466|2664944|P3|STARTED|Second Period (14 +/- 3 Days)||7
1101134|NCT01103466|2664945|P2|STARTED|Second Period (14 +/- 3 Days)||13
1101135|NCT01103466|2664946|P1|STARTED|Second Period (14 +/- 3 Days)||15
1101136|NCT01103466|2664944|P3|NOT COMPLETED|First Period (14 +/- 3 Days)||0
1101137|NCT01103466|2664945|P2|NOT COMPLETED|First Period (14 +/- 3 Days)||0
1101138|NCT01103466|2664946|P1|NOT COMPLETED|First Period (14 +/- 3 Days)||2
1101139|NCT01103466|2664944|P3|COMPLETED|First Period (14 +/- 3 Days)||13
1101140|NCT01103466|2664945|P2|COMPLETED|First Period (14 +/- 3 Days)||12
1101141|NCT01103466|2664946|P1|COMPLETED|First Period (14 +/- 3 Days)||10
1101142|NCT01103466|2664944|P3|STARTED|First Period (14 +/- 3 Days)||13
1101143|NCT01103466|2664945|P2|STARTED|First Period (14 +/- 3 Days)||12
1101144|NCT01103466|2664946|P1|STARTED|First Period (14 +/- 3 Days)||12
1101145|NCT01103479|2664957|P3|NOT COMPLETED|Overall Study||14
1101146|NCT01103479|2664958|P2|NOT COMPLETED|Overall Study||9
1101147|NCT01103479|2664959|P1|NOT COMPLETED|Overall Study||5
1101148|NCT01103479|2664957|P3|COMPLETED|Overall Study||174
1101149|NCT01103479|2664958|P2|COMPLETED|Overall Study||201
1101150|NCT01103479|2664959|P1|COMPLETED|Overall Study||163
1101151|NCT01103479|2664957|P3|STARTED|Overall Study||188
1101152|NCT01103479|2664958|P2|STARTED|Overall Study||210
1101153|NCT01103479|2664959|P1|STARTED|Overall Study||168
1101154|NCT01103492|2664972|P1|NOT COMPLETED|Overall Study||0
1101155|NCT01103492|2664972|P1|COMPLETED|Overall Study||1
1101156|NCT01103492|2664972|P1|STARTED|Overall Study||1
1101157|NCT01097915|2664979|P3|NOT COMPLETED|Overall Study||30
1101158|NCT01097915|2664980|P2|NOT COMPLETED|Overall Study||42
1101159|NCT01097915|2664981|P1|NOT COMPLETED|Overall Study||23
1101160|NCT01097915|2664979|P3|COMPLETED|Overall Study||20
1101161|NCT01097915|2664980|P2|COMPLETED|Overall Study||28
1101162|NCT01097915|2664981|P1|COMPLETED|Overall Study||27
1101163|NCT01097915|2664979|P3|STARTED|Overall Study||50
1101164|NCT01097915|2664980|P2|STARTED|Overall Study||70
1101165|NCT01097915|2664981|P1|STARTED|Overall Study||50
1101166|NCT01103713|2664995|P1|NOT COMPLETED|Overall Study||13
1101167|NCT01103713|2664995|P1|COMPLETED|Overall Study||155
1101168|NCT01103713|2664995|P1|STARTED|Overall Study||168
1101169|NCT01104701|2665025|P4|NOT COMPLETED|Overall Study||2
1101170|NCT01104701|2665026|P3|NOT COMPLETED|Overall Study||2
1101171|NCT01104701|2665027|P2|NOT COMPLETED|Overall Study||3
1101172|NCT01104701|2665028|P1|NOT COMPLETED|Overall Study||0
1101173|NCT01104701|2665025|P4|COMPLETED|Overall Study||28
1101174|NCT01104701|2665026|P3|COMPLETED|Overall Study||29
1101175|NCT01104701|2665027|P2|COMPLETED|Overall Study||27
1101176|NCT01104701|2665028|P1|COMPLETED|Overall Study||30
1101177|NCT01104701|2665025|P4|STARTED|Overall Study||30
1101178|NCT01104701|2665026|P3|STARTED|Overall Study||31
1101179|NCT01104701|2665027|P2|STARTED|Overall Study||30
1101180|NCT01104701|2665028|P1|STARTED|Overall Study||30
1101181|NCT01104870|2665085|P3|NOT COMPLETED|Overall Study||2
1101182|NCT01104870|2665086|P2|NOT COMPLETED|Overall Study||1
1101183|NCT01104870|2665087|P1|NOT COMPLETED|Overall Study||1
1101184|NCT01104870|2665085|P3|COMPLETED|Overall Study||18
1101185|NCT01104870|2665086|P2|COMPLETED|Overall Study||18
1101186|NCT01104870|2665087|P1|COMPLETED|Overall Study||10
1101187|NCT01104870|2665085|P3|STARTED|Overall Study||20
1101188|NCT01104870|2665086|P2|STARTED|Overall Study||19
1101189|NCT01104870|2665087|P1|STARTED|Overall Study||11
1101190|NCT01105065|2665116|P1|NOT COMPLETED|Overall Study||6
1101191|NCT01105065|2665116|P1|COMPLETED|Overall Study||17
1101192|NCT01105065|2665116|P1|STARTED|Overall Study||23
1101193|NCT01105091|2665124|P2|NOT COMPLETED|Overall Study||0
1101194|NCT01105091|2665125|P1|NOT COMPLETED|Overall Study||2
1101195|NCT01105091|2665124|P2|COMPLETED|Overall Study||10
1101196|NCT01105091|2665125|P1|COMPLETED|Overall Study||18
1101197|NCT01105091|2665124|P2|STARTED|Overall Study||10
1101198|NCT01105091|2665125|P1|STARTED|Overall Study||20
1101199|NCT01105117|2665151|P2|NOT COMPLETED|Overall Study||0
1101200|NCT01105117|2665152|P1|NOT COMPLETED|Overall Study||0
1101201|NCT01105117|2665151|P2|COMPLETED|Overall Study||1
1101202|NCT01105117|2665152|P1|COMPLETED|Overall Study||1
1101203|NCT01105117|2665151|P2|STARTED|Overall Study||1
1101204|NCT01105117|2665152|P1|STARTED|Overall Study||1
1101205|NCT01105130|2665163|P3|NOT COMPLETED|Overall Study||10
1101206|NCT01105130|2665164|P2|NOT COMPLETED|Overall Study||11
1101207|NCT01105130|2665165|P1|NOT COMPLETED|Overall Study||10
1101208|NCT01105130|2665163|P3|COMPLETED|Overall Study||37
1101209|NCT01105130|2665164|P2|COMPLETED|Overall Study||34
1101210|NCT01105130|2665165|P1|COMPLETED|Overall Study||38
1101211|NCT01105130|2665163|P3|STARTED|Overall Study||47
1101212|NCT01105130|2665164|P2|STARTED|Overall Study||45
1101213|NCT01105130|2665165|P1|STARTED|Overall Study||48
1101214|NCT01105247|2665184|P2|NOT COMPLETED|Overall Study||0
1101215|NCT01105247|2665185|P1|NOT COMPLETED|Overall Study||37
1101216|NCT01105247|2665184|P2|COMPLETED|Overall Study||16
1101217|NCT01105247|2665185|P1|COMPLETED|Overall Study||79
1101218|NCT01105247|2665184|P2|STARTED|Overall Study||16
1101219|NCT01105247|2665185|P1|STARTED|Overall Study||116
1101220|NCT01105312|2665201|P3|NOT COMPLETED|Overall Study||0
1101221|NCT01105312|2665202|P2|NOT COMPLETED|Overall Study||0
1101222|NCT01105312|2665203|P1|NOT COMPLETED|Overall Study||3
1101223|NCT01105312|2665201|P3|COMPLETED|Overall Study||6
1101224|NCT01105312|2665202|P2|COMPLETED|Overall Study||6
1101225|NCT01105312|2665203|P1|COMPLETED|Overall Study||13
1101226|NCT01105312|2665201|P3|STARTED|Overall Study||6
1101227|NCT01105312|2665202|P2|STARTED|Overall Study||6
1101228|NCT01105312|2665203|P1|STARTED|Overall Study||16
1101229|NCT01105377|2665221|P2|NOT COMPLETED|Overall Study||1
1101230|NCT01105377|2665222|P1|NOT COMPLETED|Overall Study||0
1101231|NCT01105377|2665221|P2|COMPLETED|Overall Study||22
1101232|NCT01105377|2665222|P1|COMPLETED|Overall Study||24
1101233|NCT01105377|2665221|P2|STARTED|Overall Study||23
1101234|NCT01105377|2665222|P1|STARTED|Overall Study||24
1101235|NCT01105533|2665230|P9|NOT COMPLETED|Overall Study||12
1101236|NCT01105533|2665231|P8|NOT COMPLETED|Overall Study||4
1101237|NCT01105533|2665232|P7|NOT COMPLETED|Overall Study||8
1101238|NCT01105533|2665233|P6|NOT COMPLETED|Overall Study||7
1101239|NCT01105533|2665234|P5|NOT COMPLETED|Overall Study||7
1101240|NCT01105533|2665235|P4|NOT COMPLETED|Overall Study||3
1101241|NCT01105533|2665236|P3|NOT COMPLETED|Overall Study||3
1101242|NCT01105533|2665237|P2|NOT COMPLETED|Overall Study||1
1101243|NCT01105533|2665238|P1|NOT COMPLETED|Overall Study||1
1101244|NCT01105533|2665230|P9|COMPLETED|Overall Study||0
1101245|NCT01105533|2665231|P8|COMPLETED|Overall Study||0
1101246|NCT01105533|2665232|P7|COMPLETED|Overall Study||0
1101247|NCT01105533|2665233|P6|COMPLETED|Overall Study||0
1101248|NCT01105533|2665234|P5|COMPLETED|Overall Study||0
1101249|NCT01105533|2665235|P4|COMPLETED|Overall Study||0
1101250|NCT01105533|2665236|P3|COMPLETED|Overall Study||0
1101251|NCT01105533|2665237|P2|COMPLETED|Overall Study||0
1101252|NCT01105533|2665238|P1|COMPLETED|Overall Study||0
1101253|NCT01105533|2665230|P9|STARTED|Overall Study||12
1101254|NCT01105533|2665231|P8|STARTED|Overall Study||4
1101255|NCT01105533|2665232|P7|STARTED|Overall Study||8
1101256|NCT01105533|2665233|P6|STARTED|Overall Study||7
1101257|NCT01105533|2665234|P5|STARTED|Overall Study||7
1101258|NCT01105533|2665235|P4|STARTED|Overall Study||3
1101259|NCT01105533|2665236|P3|STARTED|Overall Study||3
1101260|NCT01105533|2665237|P2|STARTED|Overall Study||1
1101261|NCT01105533|2665238|P1|STARTED|Overall Study||1
1101262|NCT01105650|2665329|P4|NOT COMPLETED|Overall Study||0
1101263|NCT01105650|2665330|P3|NOT COMPLETED|Overall Study||0
1101264|NCT01105650|2665331|P2|NOT COMPLETED|Overall Study||0
1101265|NCT01105650|2665332|P1|NOT COMPLETED|Overall Study||0
1101266|NCT01105650|2665329|P4|COMPLETED|Overall Study||0
1101267|NCT01105650|2665330|P3|COMPLETED|Overall Study||7
1101268|NCT01105650|2665331|P2|COMPLETED|Overall Study||3
1101269|NCT01105650|2665332|P1|COMPLETED|Overall Study||3
1101270|NCT01105650|2665329|P4|STARTED|Overall Study|Arm 3 was determined to be successful, thus eliminating the need to test Arm 4.|0
1101271|NCT01105650|2665330|P3|STARTED|Overall Study||7
1101272|NCT01105650|2665331|P2|STARTED|Overall Study||3
1101273|NCT01105650|2665332|P1|STARTED|Overall Study||3
1101274|NCT01105702|2665349|P1|NOT COMPLETED|Overall Study||18
1101275|NCT01105702|2665349|P1|COMPLETED|Overall Study||10
1101276|NCT01105702|2665349|P1|STARTED|Overall Study||28
1101277|NCT01105754|2665358|P2|NOT COMPLETED|Overall Study||12
1101278|NCT01105754|2665359|P1|NOT COMPLETED|Overall Study||15
1101279|NCT01105754|2665358|P2|COMPLETED|Overall Study||307
1101280|NCT01105754|2665359|P1|COMPLETED|Overall Study||304
1101281|NCT01105754|2665358|P2|STARTED|Overall Study||319
1101282|NCT01105754|2665359|P1|STARTED|Overall Study||319
1101283|NCT01105767|2665370|P3|NOT COMPLETED|Overall Study||1184
1101284|NCT01105767|2665371|P2|NOT COMPLETED|Overall Study||1614
1101285|NCT01105767|2665372|P1|NOT COMPLETED|Overall Study||1160
1101286|NCT01105767|2665370|P3|COMPLETED|Overall Study||8846
1101287|NCT01105767|2665371|P2|COMPLETED|Overall Study||9250
1101288|NCT01105767|2665372|P1|COMPLETED|Overall Study||8155
1101289|NCT01105767|2665370|P3|STARTED|Overall Study||10030
1101290|NCT01105767|2665371|P2|STARTED|Overall Study||10864
1101291|NCT01105767|2665372|P1|STARTED|Overall Study||9315
1101292|NCT01105936|2665383|P4|NOT COMPLETED|Period 3||0
1101293|NCT01105936|2665384|P3|NOT COMPLETED|Period 3||0
1101294|NCT01105936|2665385|P2|NOT COMPLETED|Period 3||2
1101295|NCT01105936|2665386|P1|NOT COMPLETED|Period 3||0
1101296|NCT01105936|2665383|P4|COMPLETED|Period 3||7
1101297|NCT01105936|2665384|P3|COMPLETED|Period 3||7
1101298|NCT01105936|2665385|P2|COMPLETED|Period 3||6
1101299|NCT01105936|2665386|P1|COMPLETED|Period 3||7
1101300|NCT01105936|2665383|P4|STARTED|Period 3||7
1101301|NCT01105936|2665384|P3|STARTED|Period 3||7
1101302|NCT01105936|2665385|P2|STARTED|Period 3||8
1101303|NCT01105936|2665386|P1|STARTED|Period 3||7
1101304|NCT01105936|2665383|P4|NOT COMPLETED|Wash-out Period 2||0
1101305|NCT01105936|2665384|P3|NOT COMPLETED|Wash-out Period 2||0
1101306|NCT01105936|2665385|P2|NOT COMPLETED|Wash-out Period 2||0
1101307|NCT01105936|2665386|P1|NOT COMPLETED|Wash-out Period 2||0
1101308|NCT01105936|2665383|P4|COMPLETED|Wash-out Period 2||7
1101309|NCT01105936|2665384|P3|COMPLETED|Wash-out Period 2||7
1101310|NCT01105936|2665385|P2|COMPLETED|Wash-out Period 2||8
1101311|NCT01105936|2665386|P1|COMPLETED|Wash-out Period 2||7
1101312|NCT01105936|2665383|P4|STARTED|Wash-out Period 2||7
1101313|NCT01105936|2665384|P3|STARTED|Wash-out Period 2||7
1101314|NCT01105936|2665385|P2|STARTED|Wash-out Period 2||8
1101315|NCT01105936|2665386|P1|STARTED|Wash-out Period 2||7
1101316|NCT01105936|2665383|P4|NOT COMPLETED|Period 2||0
1101317|NCT01105936|2665384|P3|NOT COMPLETED|Period 2||0
1101318|NCT01105936|2665385|P2|NOT COMPLETED|Period 2||0
1101319|NCT01105936|2665386|P1|NOT COMPLETED|Period 2||1
1101320|NCT01105936|2665383|P4|COMPLETED|Period 2||7
1101321|NCT01105936|2665384|P3|COMPLETED|Period 2||7
1101322|NCT01105936|2665385|P2|COMPLETED|Period 2||8
1101323|NCT01105936|2665386|P1|COMPLETED|Period 2||7
1101324|NCT01105936|2665383|P4|STARTED|Period 2||7
1101325|NCT01105936|2665384|P3|STARTED|Period 2||7
1101326|NCT01105936|2665385|P2|STARTED|Period 2||8
1101327|NCT01105936|2665386|P1|STARTED|Period 2||8
1101328|NCT01105936|2665383|P4|NOT COMPLETED|Wash-out Period 1||0
1101329|NCT01105936|2665384|P3|NOT COMPLETED|Wash-out Period 1||0
1101330|NCT01105936|2665385|P2|NOT COMPLETED|Wash-out Period 1||0
1101331|NCT01105936|2665386|P1|NOT COMPLETED|Wash-out Period 1||0
1101332|NCT01105936|2665383|P4|COMPLETED|Wash-out Period 1||7
1101333|NCT01105936|2665384|P3|COMPLETED|Wash-out Period 1||7
1101334|NCT01105936|2665385|P2|COMPLETED|Wash-out Period 1||8
1101335|NCT01105936|2665386|P1|COMPLETED|Wash-out Period 1||8
1101336|NCT01105936|2665383|P4|STARTED|Wash-out Period 1||7
1101337|NCT01105936|2665384|P3|STARTED|Wash-out Period 1||7
1101338|NCT01105936|2665385|P2|STARTED|Wash-out Period 1||8
1101339|NCT01105936|2665386|P1|STARTED|Wash-out Period 1||8
1101340|NCT01105936|2665383|P4|NOT COMPLETED|Period 1||1
1101341|NCT01105936|2665384|P3|NOT COMPLETED|Period 1||0
1101342|NCT01105936|2665385|P2|NOT COMPLETED|Period 1||0
1101343|NCT01105936|2665386|P1|NOT COMPLETED|Period 1||0
1101344|NCT01105936|2665383|P4|COMPLETED|Period 1||7
1101345|NCT01105936|2665384|P3|COMPLETED|Period 1||7
1101346|NCT01105936|2665385|P2|COMPLETED|Period 1||8
1101347|NCT01105936|2665386|P1|COMPLETED|Period 1||8
1101348|NCT01105936|2665383|P4|STARTED|Period 1||8
1101349|NCT01105936|2665384|P3|STARTED|Period 1||7
1101350|NCT01105936|2665385|P2|STARTED|Period 1||8
1101351|NCT01105936|2665386|P1|STARTED|Period 1||8
1101352|NCT01106014|2665414|P2|NOT COMPLETED|Overall Study||330
1101353|NCT01106014|2665415|P1|NOT COMPLETED|Overall Study||285
1101354|NCT01106014|2665414|P2|COMPLETED|Overall Study||252
1101355|NCT01106014|2665415|P1|COMPLETED|Overall Study||289
1101356|NCT01106014|2665414|P2|STARTED|Overall Study||582
1101357|NCT01106014|2665415|P1|STARTED|Overall Study||574
1101358|NCT01106040|2665425|P1|NOT COMPLETED|Overall Study||11
1101359|NCT01106040|2665425|P1|COMPLETED|Overall Study||152
1101360|NCT01106040|2665425|P1|STARTED|Overall Study||163
1101361|NCT01106092|2665434|P4|NOT COMPLETED|Overall Study||1
1101362|NCT01106092|2665435|P3|NOT COMPLETED|Overall Study||0
1101363|NCT01106092|2665436|P2|NOT COMPLETED|Overall Study||0
1101364|NCT01106092|2665437|P1|NOT COMPLETED|Overall Study||0
1101365|NCT01106092|2665434|P4|COMPLETED|Overall Study||77
1101366|NCT01106092|2665435|P3|COMPLETED|Overall Study||78
1101367|NCT01106092|2665436|P2|COMPLETED|Overall Study||78
1101368|NCT01106092|2665437|P1|COMPLETED|Overall Study||78
1101369|NCT01106092|2665434|P4|STARTED|Overall Study||78
1101370|NCT01106092|2665435|P3|STARTED|Overall Study||78
1101371|NCT01106092|2665436|P2|STARTED|Overall Study||78
1101372|NCT01106092|2665437|P1|STARTED|Overall Study||78
1101373|NCT01106157|2665517|P2|NOT COMPLETED|Overall Study||0
1101374|NCT01106157|2665518|P1|NOT COMPLETED|Overall Study||1
1101375|NCT01106157|2665517|P2|COMPLETED|Overall Study||8
1101376|NCT01106157|2665518|P1|COMPLETED|Overall Study||16
1101377|NCT01106157|2665517|P2|STARTED|Overall Study||8
1101378|NCT01106157|2665518|P1|STARTED|Overall Study||17
1101379|NCT01106248|2665542|P1|NOT COMPLETED|Overall Study||3
1101380|NCT01106248|2665542|P1|COMPLETED|Overall Study||23
1101381|NCT01106248|2665542|P1|STARTED|Overall Study||26
1101382|NCT01106287|2665552|P4|NOT COMPLETED|Overall Study||0
1101383|NCT01106287|2665553|P3|NOT COMPLETED|Overall Study||0
1101384|NCT01106287|2665554|P2|NOT COMPLETED|Overall Study||0
1101385|NCT01106287|2665555|P1|NOT COMPLETED|Overall Study||1
1101386|NCT01106287|2665552|P4|COMPLETED|Overall Study||3
1101387|NCT01106287|2665553|P3|COMPLETED|Overall Study||3
1101388|NCT01106287|2665554|P2|COMPLETED|Overall Study||3
1101389|NCT01106287|2665555|P1|COMPLETED|Overall Study||3
1101390|NCT01106287|2665552|P4|STARTED|Overall Study||3
1101391|NCT01106287|2665553|P3|STARTED|Overall Study||3
1101392|NCT01106287|2665554|P2|STARTED|Overall Study||3
1101393|NCT01106287|2665555|P1|STARTED|Overall Study|One participant that discontinued the study due to a pre-treatment adverse event was replaced.|4
1101394|NCT01106326|2665575|P1|NOT COMPLETED|Overall Study||2
1101395|NCT01106326|2665575|P1|COMPLETED|Overall Study||28
1101396|NCT01106326|2665575|P1|STARTED|Overall Study||30
1101397|NCT01106352|2665586|P5|NOT COMPLETED|Overall Study||8
1101398|NCT01106352|2665587|P4|NOT COMPLETED|Overall Study||13
1101399|NCT01106352|2665588|P3|NOT COMPLETED|Overall Study||2
1101400|NCT01106352|2665589|P2|NOT COMPLETED|Overall Study||0
1101401|NCT01106352|2665590|P1|NOT COMPLETED|Overall Study||1
1101402|NCT01106352|2665586|P5|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|9
1101403|NCT01106352|2665587|P4|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|23
1101404|NCT01106352|2665588|P3|COMPLETED|Overall Study||5
1101405|NCT01106352|2665589|P2|COMPLETED|Overall Study||3
1101406|NCT01106352|2665590|P1|COMPLETED|Overall Study||6
1101407|NCT01106352|2665586|P5|Completed Safety Cohort|Overall Study||9
1101408|NCT01106352|2665587|P4|Completed Safety Cohort|Overall Study||23
1101409|NCT01106352|2665588|P3|Completed Safety Cohort|Overall Study||0
1101410|NCT01106352|2665589|P2|Completed Safety Cohort|Overall Study||0
1101411|NCT01106352|2665590|P1|Completed Safety Cohort|Overall Study||0
1101412|NCT01106352|2665586|P5|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|13
1101413|NCT01106352|2665587|P4|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|33
1101414|NCT01106352|2665588|P3|Treated Safety Cohort|Overall Study||0
1101415|NCT01106352|2665589|P2|Treated Safety Cohort|Overall Study||0
1101416|NCT01106352|2665590|P1|Treated Safety Cohort|Overall Study||0
1101417|NCT01106352|2665586|P5|Started Safety Cohort|Overall Study||17
1101418|NCT01106352|2665587|P4|Started Safety Cohort|Overall Study||36
1101419|NCT01106352|2665588|P3|Started Safety Cohort|Overall Study||0
1101420|NCT01106352|2665589|P2|Started Safety Cohort|Overall Study||0
1101421|NCT01106352|2665590|P1|Started Safety Cohort|Overall Study||0
1101422|NCT01106352|2665586|P5|Completed Dose Escalation|Overall Study||0
1101423|NCT01106352|2665587|P4|Completed Dose Escalation|Overall Study||0
1101424|NCT01106352|2665588|P3|Completed Dose Escalation|Overall Study||5
1101425|NCT01106352|2665589|P2|Completed Dose Escalation|Overall Study||3
1101426|NCT01106352|2665590|P1|Completed Dose Escalation|Overall Study||6
1101427|NCT01106352|2665586|P5|Started Dose Escalation|Overall Study||0
1101428|NCT01106352|2665587|P4|Started Dose Escalation|Overall Study||0
1101429|NCT01106352|2665588|P3|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
1101430|NCT01106352|2665589|P2|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|3
1101431|NCT01106352|2665590|P1|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
1101432|NCT01106352|2665586|P5|STARTED|Overall Study||17
1101433|NCT01106352|2665587|P4|STARTED|Overall Study||36
1101434|NCT01106352|2665588|P3|STARTED|Overall Study||7
1101435|NCT01106352|2665589|P2|STARTED|Overall Study||3
1101436|NCT01106352|2665590|P1|STARTED|Overall Study||7
1101437|NCT01106391|2665676|P1|NOT COMPLETED|Overall Study||0
1101438|NCT01106391|2665676|P1|COMPLETED|Overall Study||60
1101439|NCT01106391|2665676|P1|STARTED|Overall Study||60
1101440|NCT01106404|2665683|P2|NOT COMPLETED|Period II (Second 6 Weeks)||0
1101441|NCT01106404|2665684|P1|NOT COMPLETED|Period II (Second 6 Weeks)||0
1101442|NCT01106404|2665683|P2|COMPLETED|Period II (Second 6 Weeks)||38
1101443|NCT01106404|2665684|P1|COMPLETED|Period II (Second 6 Weeks)||33
1101444|NCT01106404|2665683|P2|STARTED|Period II (Second 6 Weeks)||38
1101445|NCT01106404|2665684|P1|STARTED|Period II (Second 6 Weeks)||33
1101446|NCT01106404|2665683|P2|NOT COMPLETED|Period I (First 6 Weeks)||2
1101447|NCT01106404|2665684|P1|NOT COMPLETED|Period I (First 6 Weeks)||3
1101448|NCT01106404|2665683|P2|COMPLETED|Period I (First 6 Weeks)||38
1101449|NCT01106404|2665684|P1|COMPLETED|Period I (First 6 Weeks)||33
1101450|NCT01106404|2665683|P2|STARTED|Period I (First 6 Weeks)||40
1101451|NCT01106404|2665684|P1|STARTED|Period I (First 6 Weeks)||36
1101452|NCT01106430|2665699|P2|NOT COMPLETED|Overall Study||33
1101453|NCT01106430|2665700|P1|NOT COMPLETED|Overall Study||33
1101454|NCT01106430|2665699|P2|COMPLETED|Overall Study||101
1101455|NCT01106430|2665700|P1|COMPLETED|Overall Study||100
1101456|NCT01106430|2665699|P2|STARTED|Overall Study||134
1101457|NCT01106430|2665700|P1|STARTED|Overall Study||133
1101458|NCT01106456|2665722|P2|NOT COMPLETED|Overall Study||124
1101459|NCT01106456|2665723|P1|NOT COMPLETED|Overall Study||103
1101460|NCT01106456|2665722|P2|COMPLETED|Overall Study||96
1101461|NCT01106456|2665723|P1|COMPLETED|Overall Study||140
1101462|NCT01106456|2665722|P2|STARTED|Overall Study||220
1101463|NCT01106456|2665723|P1|STARTED|Overall Study||243
1101467|NCT01106586|2665752|P2|NOT COMPLETED|Overall Study||285
1101468|NCT01106586|2665753|P1|NOT COMPLETED|Overall Study||285
1101469|NCT01106586|2665752|P2|COMPLETED|Overall Study||70
1101470|NCT01106586|2665753|P1|COMPLETED|Overall Study||68
1101471|NCT01106586|2665752|P2|STARTED|Overall Study||355
1101472|NCT01106586|2665753|P1|STARTED|Overall Study||353
1101473|NCT01106625|2665774|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||17
1101474|NCT01106625|2665775|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
1101475|NCT01106625|2665776|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||29
1101476|NCT01106625|2665774|P3|COMPLETED|Extension Period: Week 26 to Week 52||111
1101477|NCT01106625|2665775|P2|COMPLETED|Extension Period: Week 26 to Week 52||109
1101478|NCT01106625|2665776|P1|COMPLETED|Extension Period: Week 26 to Week 52||90
1101479|NCT01106625|2665774|P3|STARTED|Extension Period: Week 26 to Week 52|1 pt discontinued last day of core: withdrawal by subject (1).|128
1101480|NCT01106625|2665775|P2|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued last day of core: adverse event (1), not specified (1).|127
1101481|NCT01106625|2665776|P1|STARTED|Extension Period: Week 26 to Week 52|4 pts discontinued last day of core: physician decision (1), noncompliance (1), not specified (2).|119
1101482|NCT01106625|2665774|P3|NOT COMPLETED|Core Period: Baseline to Week 26||27
1101483|NCT01106625|2665775|P2|NOT COMPLETED|Core Period: Baseline to Week 26||28
1101484|NCT01106625|2665776|P1|NOT COMPLETED|Core Period: Baseline to Week 26||33
1101485|NCT01106625|2665774|P3|COMPLETED|Core Period: Baseline to Week 26||129
1101486|NCT01106625|2665775|P2|COMPLETED|Core Period: Baseline to Week 26||129
1101487|NCT01106625|2665776|P1|COMPLETED|Core Period: Baseline to Week 26||123
1101488|NCT01106625|2665774|P3|STARTED|Core Period: Baseline to Week 26||156
1101489|NCT01106625|2665775|P2|STARTED|Core Period: Baseline to Week 26||157
1101490|NCT01106625|2665776|P1|STARTED|Core Period: Baseline to Week 26||156
1101491|NCT01106651|2665808|P3|NOT COMPLETED|Overall Study||58
1101492|NCT01106651|2665809|P2|NOT COMPLETED|Overall Study||57
1101493|NCT01106651|2665810|P1|NOT COMPLETED|Overall Study||79
1101494|NCT01106651|2665808|P3|COMPLETED|Overall Study||178
1101495|NCT01106651|2665809|P2|COMPLETED|Overall Study||184
1101496|NCT01106651|2665810|P1|COMPLETED|Overall Study||158
1101497|NCT01106651|2665808|P3|STARTED|Overall Study||236
1101498|NCT01106651|2665809|P2|STARTED|Overall Study||241
1101499|NCT01106651|2665810|P1|STARTED|Overall Study||237
1101500|NCT01106677|2665864|P4|NOT COMPLETED|Extension Period: Week 26 to Week 52||28
1101501|NCT01106677|2665865|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||22
1101502|NCT01106677|2665866|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
1101503|NCT01106677|2665867|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||15
1101504|NCT01106677|2665864|P4|COMPLETED|Extension Period: Week 26 to Week 52||285
1101505|NCT01106677|2665865|P3|COMPLETED|Extension Period: Week 26 to Week 52||299
1101506|NCT01106677|2665866|P2|COMPLETED|Extension Period: Week 26 to Week 52||298
1101507|NCT01106677|2665867|P1|COMPLETED|Extension Period: Week 26 to Week 52||138
1101508|NCT01106677|2665864|P4|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(3), physician decision(2), lost to f/u(1).|313
1101509|NCT01106677|2665865|P3|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: not specified(1), withdrawal by subject(1).|321
1101510|NCT01106677|2665866|P2|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(5), withdrawal by subject(1).|316
1101511|NCT01106677|2665867|P1|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: protcol violation(1), lost to f/u(1).|153
1101512|NCT01106677|2665864|P4|NOT COMPLETED|Core Period: Baseline to Week 26||47
1101513|NCT01106677|2665865|P3|NOT COMPLETED|Core Period: Baseline to Week 26||44
1101514|NCT01106677|2665866|P2|NOT COMPLETED|Core Period: Baseline to Week 26||46
1101515|NCT01106677|2665867|P1|NOT COMPLETED|Core Period: Baseline to Week 26||28
1101516|NCT01106677|2665864|P4|COMPLETED|Core Period: Baseline to Week 26||319
1101517|NCT01106677|2665865|P3|COMPLETED|Core Period: Baseline to Week 26||323
1101518|NCT01106677|2665866|P2|COMPLETED|Core Period: Baseline to Week 26||322
1101519|NCT01106677|2665867|P1|COMPLETED|Core Period: Baseline to Week 26||155
1101520|NCT01106677|2665864|P4|STARTED|Core Period: Baseline to Week 26||366
1101521|NCT01106677|2665865|P3|STARTED|Core Period: Baseline to Week 26||367
1101522|NCT01106677|2665866|P2|STARTED|Core Period: Baseline to Week 26||368
1101523|NCT01106677|2665867|P1|STARTED|Core Period: Baseline to Week 26||183
1101524|NCT01106690|2665930|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
1101525|NCT01106690|2665931|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
1101526|NCT01106690|2665932|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
1101527|NCT01106690|2665930|P3|COMPLETED|Extension Period: Week 26 to Week 52||89
1101528|NCT01106690|2665931|P2|COMPLETED|Extension Period: Week 26 to Week 52||96
1101529|NCT01106690|2665932|P1|COMPLETED|Extension Period: Week 26 to Week 52||78
1101530|NCT01106690|2665930|P3|STARTED|Extension Period: Week 26 to Week 52|5 pts completed core but did not exter ext: lost to f/u(1), not spec(2), AE(1), eGFR criteria(1).|96
1101531|NCT01106690|2665931|P2|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|103
1101532|NCT01106690|2665932|P1|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|90
1101533|NCT01106690|2665930|P3|NOT COMPLETED|Core Period: Baseline to Week 26||13
1101534|NCT01106690|2665931|P2|NOT COMPLETED|Core Period: Baseline to Week 26||9
1101535|NCT01106690|2665932|P1|NOT COMPLETED|Core Period: Baseline to Week 26||24
1101536|NCT01106690|2665930|P3|COMPLETED|Core Period: Baseline to Week 26||101
1101537|NCT01106690|2665931|P2|COMPLETED|Core Period: Baseline to Week 26||104
1101538|NCT01106690|2665932|P1|COMPLETED|Core Period: Baseline to Week 26||91
1101539|NCT01106690|2665930|P3|STARTED|Core Period: Baseline to Week 26||114
1101540|NCT01106690|2665931|P2|STARTED|Core Period: Baseline to Week 26||113
1101541|NCT01106690|2665932|P1|STARTED|Core Period: Baseline to Week 26||115
1101542|NCT01106846|2665966|P2|NOT COMPLETED|Overall Study||1
1101543|NCT01106846|2665967|P1|NOT COMPLETED|Overall Study||0
1101544|NCT01106846|2665966|P2|COMPLETED|Overall Study||9
1101545|NCT01106846|2665967|P1|COMPLETED|Overall Study||12
1101546|NCT01106846|2665966|P2|STARTED|Overall Study||10
1101547|NCT01106846|2665967|P1|STARTED|Overall Study||12
1101548|NCT01106859|2665973|P1|NOT COMPLETED|Overall Study||0
1101549|NCT01106859|2665973|P1|COMPLETED|Overall Study||40
1101550|NCT01106859|2665973|P1|STARTED|Overall Study|Intent to treat population and safety population are the same (40 participants)|40
1101551|NCT01106911|2666012|P1|NOT COMPLETED|Overall Study||5
1101552|NCT01106911|2666012|P1|COMPLETED|Overall Study||1080
1101553|NCT01106911|2666012|P1|STARTED|Overall Study||1085
1101554|NCT01106950|2666016|P1|NOT COMPLETED|Overall Study||0
1101555|NCT01106950|2666016|P1|COMPLETED|Overall Study||15
1101556|NCT01106950|2666016|P1|STARTED|Overall Study||15
1101557|NCT01106976|2666026|P1|NOT COMPLETED|Overall Study||8
1101558|NCT01106976|2666026|P1|COMPLETED|Overall Study||59
1101559|NCT01106976|2666026|P1|STARTED|Overall Study||67
1101560|NCT01100853|2666032|P2|NOT COMPLETED|Overall Study||23
1101561|NCT01100853|2666033|P1|NOT COMPLETED|Overall Study||27
1101562|NCT01100853|2666032|P2|COMPLETED|Overall Study||26
1101563|NCT01100853|2666033|P1|COMPLETED|Overall Study||24
1101564|NCT01100853|2666032|P2|STARTED|Overall Study||49
1101565|NCT01100853|2666033|P1|STARTED|Overall Study||51
1101566|NCT01100931|2666051|P2|NOT COMPLETED|Phase II||0
1101567|NCT01100931|2666052|P1|NOT COMPLETED|Phase II||0
1101568|NCT01100931|2666051|P2|COMPLETED|Phase II||19
1101569|NCT01100931|2666052|P1|COMPLETED|Phase II||0
1101570|NCT01100931|2666051|P2|STARTED|Phase II||19
1101571|NCT01100931|2666052|P1|STARTED|Phase II||0
1101572|NCT01100931|2666051|P2|NOT COMPLETED|Phase I||0
1101573|NCT01100931|2666052|P1|NOT COMPLETED|Phase I||0
1101574|NCT01100931|2666051|P2|COMPLETED|Phase I||0
1101575|NCT01100931|2666052|P1|COMPLETED|Phase I||22
1101576|NCT01100931|2666051|P2|STARTED|Phase I||0
1101577|NCT01100931|2666052|P1|STARTED|Phase I||22
1101578|NCT01100944|2666060|P3|NOT COMPLETED|Expansion Phase - Phase 2||0
1101579|NCT01100944|2666061|P2|NOT COMPLETED|Expansion Phase - Phase 2||0
1101580|NCT01100944|2666062|P1|NOT COMPLETED|Expansion Phase - Phase 2||0
1101581|NCT01100944|2666060|P3|COMPLETED|Expansion Phase - Phase 2||18
1101582|NCT01100944|2666061|P2|COMPLETED|Expansion Phase - Phase 2||0
1101583|NCT01100944|2666062|P1|COMPLETED|Expansion Phase - Phase 2||0
1101584|NCT01100944|2666060|P3|STARTED|Expansion Phase - Phase 2||18
1101585|NCT01100944|2666061|P2|STARTED|Expansion Phase - Phase 2||0
1101586|NCT01100944|2666062|P1|STARTED|Expansion Phase - Phase 2||0
1101587|NCT01100944|2666060|P3|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
1101588|NCT01100944|2666061|P2|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||2
1101589|NCT01100944|2666062|P1|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
1101590|NCT01100944|2666060|P3|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
1101591|NCT01100944|2666061|P2|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
1101592|NCT01100944|2666062|P1|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
1101593|NCT01100944|2666060|P3|STARTED|Dose Escalation Phase 1 Dose Level 2||0
1101594|NCT01100944|2666061|P2|STARTED|Dose Escalation Phase 1 Dose Level 2||2
1101595|NCT01100944|2666062|P1|STARTED|Dose Escalation Phase 1 Dose Level 2||0
1101596|NCT01100944|2666060|P3|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
1101597|NCT01100944|2666061|P2|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
1101598|NCT01100944|2666062|P1|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||4
1101599|NCT01100944|2666060|P3|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
1101600|NCT01100944|2666061|P2|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
1101601|NCT01100944|2666062|P1|COMPLETED|Dose Escalation Phase 1 Dose Level 1||2
1101602|NCT01100944|2666060|P3|STARTED|Dose Escalation Phase 1 Dose Level 1||0
1101603|NCT01100944|2666061|P2|STARTED|Dose Escalation Phase 1 Dose Level 1||0
1101604|NCT01100944|2666062|P1|STARTED|Dose Escalation Phase 1 Dose Level 1||6
1101605|NCT01101022|2666109|P2|NOT COMPLETED|Overall Study||27
1101606|NCT01101022|2666110|P1|NOT COMPLETED|Overall Study||17
1101607|NCT01101022|2666109|P2|COMPLETED|Overall Study||53
1101608|NCT01101022|2666110|P1|COMPLETED|Overall Study||62
1101609|NCT01101022|2666109|P2|STARTED|Overall Study||80
1101610|NCT01101022|2666110|P1|STARTED|Overall Study||79
1101611|NCT01107197|2666146|P2|NOT COMPLETED|Overall Study||23
1101612|NCT01107197|2666147|P1|NOT COMPLETED|Overall Study||20
1101613|NCT01107197|2666146|P2|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 64 patients )|78
1101614|NCT01107197|2666147|P1|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 67 patients )|79
1101615|NCT01107197|2666146|P2|STARTED|Overall Study||101
1101616|NCT01107197|2666147|P1|STARTED|Overall Study||99
1101617|NCT01107353|2666167|P2|NOT COMPLETED|Overall Study||0
1101618|NCT01107353|2666168|P1|NOT COMPLETED|Overall Study||1
1101619|NCT01107353|2666167|P2|COMPLETED|Overall Study||20
1101620|NCT01107353|2666168|P1|COMPLETED|Overall Study||19
1101621|NCT01107353|2666167|P2|STARTED|Overall Study||20
1101622|NCT01107353|2666168|P1|STARTED|Overall Study||20
1101623|NCT01107379|2666174|P1|NOT COMPLETED|Overall Study||21
1101624|NCT01107379|2666174|P1|COMPLETED|Overall Study||182
1101625|NCT01107379|2666174|P1|STARTED|Overall Study||203
1101626|NCT01107392|2666185|P2|NOT COMPLETED|Overall Study||3
1101627|NCT01107392|2666186|P1|NOT COMPLETED|Overall Study||5
1101628|NCT01107392|2666185|P2|COMPLETED|Overall Study||154
1101629|NCT01107392|2666186|P1|COMPLETED|Overall Study||153
1101630|NCT01107392|2666185|P2|STARTED|Overall Study||157
1101631|NCT01107392|2666186|P1|STARTED|Overall Study||158
1101632|NCT01107405|2666203|P5|NOT COMPLETED|Overall Study||3
1101633|NCT01107405|2666204|P4|NOT COMPLETED|Overall Study||3
1101634|NCT01107405|2666205|P3|NOT COMPLETED|Overall Study||2
1101635|NCT01107405|2666206|P2|NOT COMPLETED|Overall Study||1
1101636|NCT01107405|2666207|P1|NOT COMPLETED|Overall Study||2
1101637|NCT01107405|2666203|P5|COMPLETED|Overall Study||17
1101638|NCT01107405|2666204|P4|COMPLETED|Overall Study||17
1101639|NCT01107405|2666205|P3|COMPLETED|Overall Study||18
1101640|NCT01107405|2666206|P2|COMPLETED|Overall Study||19
1101641|NCT01107405|2666207|P1|COMPLETED|Overall Study||19
1101642|NCT01107405|2666203|P5|STARTED|Overall Study||20
1101643|NCT01107405|2666204|P4|STARTED|Overall Study||20
1101644|NCT01107405|2666205|P3|STARTED|Overall Study||20
1101645|NCT01107405|2666206|P2|STARTED|Overall Study||20
1101646|NCT01107405|2666207|P1|STARTED|Overall Study||21
1101647|NCT01107418|2666248|P1|NOT COMPLETED|Overall Study||52
1101648|NCT01107418|2666248|P1|COMPLETED|Overall Study||0
1101649|NCT01107418|2666248|P1|STARTED|Overall Study||52
1101650|NCT01107457|2666321|P6|NOT COMPLETED|Part B and C||120
1101651|NCT01107457|2666322|P5|NOT COMPLETED|Part B and C||0
1101652|NCT01107457|2666323|P4|NOT COMPLETED|Part B and C||0
1101653|NCT01107457|2666324|P3|NOT COMPLETED|Part B and C||0
1101654|NCT01107457|2666325|P2|NOT COMPLETED|Part B and C||0
1101655|NCT01107457|2666326|P1|NOT COMPLETED|Part B and C||0
1101656|NCT01107457|2666321|P6|COMPLETED|Part B and C|No participants completed the study as Part C was stopped.|0
1101657|NCT01107457|2666322|P5|COMPLETED|Part B and C||0
1101658|NCT01107457|2666323|P4|COMPLETED|Part B and C||0
1101659|NCT01107457|2666324|P3|COMPLETED|Part B and C||0
1101660|NCT01107457|2666325|P2|COMPLETED|Part B and C||0
1101661|NCT01107457|2666326|P1|COMPLETED|Part B and C||0
1101662|NCT01107457|2666321|P6|Post Treatment Safety Visits|Part B and C|Only participants with neutropenia entered the post treatment safety visits.|6
1101663|NCT01107457|2666322|P5|Post Treatment Safety Visits|Part B and C||0
1101664|NCT01107457|2666323|P4|Post Treatment Safety Visits|Part B and C||0
1101665|NCT01107457|2666324|P3|Post Treatment Safety Visits|Part B and C||0
1101666|NCT01107457|2666325|P2|Post Treatment Safety Visits|Part B and C||0
1101667|NCT01107457|2666326|P1|Post Treatment Safety Visits|Part B and C||0
1101668|NCT01107457|2666321|P6|Completed Part C|Part B and C|Part C was stopped once ixekizumab became available through marketing authorization.|0
1101669|NCT01107457|2666322|P5|Completed Part C|Part B and C||0
1101670|NCT01107457|2666323|P4|Completed Part C|Part B and C||0
1101671|NCT01107457|2666324|P3|Completed Part C|Part B and C||0
1101672|NCT01107457|2666325|P2|Completed Part C|Part B and C||0
1101673|NCT01107457|2666326|P1|Completed Part C|Part B and C||0
1101674|NCT01107457|2666321|P6|Completed Part B (Week 240)|Part B and C||74
1101675|NCT01107457|2666322|P5|Completed Part B (Week 240)|Part B and C||0
1101676|NCT01107457|2666323|P4|Completed Part B (Week 240)|Part B and C||0
1101677|NCT01107457|2666324|P3|Completed Part B (Week 240)|Part B and C||0
1101678|NCT01107457|2666325|P2|Completed Part B (Week 240)|Part B and C||0
1101679|NCT01107457|2666326|P1|Completed Part B (Week 240)|Part B and C||0
1101680|NCT01107457|2666321|P6|STARTED|Part B and C|80 and 120 mg ixekizumab were administered during Part B and C.|120
1101681|NCT01107457|2666322|P5|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
1101682|NCT01107457|2666323|P4|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
1101683|NCT01107457|2666324|P3|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
1101684|NCT01107457|2666325|P2|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
1101685|NCT01107457|2666326|P1|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
1101686|NCT01107457|2666321|P6|NOT COMPLETED|Part A||0
1101687|NCT01107457|2666322|P5|NOT COMPLETED|Part A||1
1101688|NCT01107457|2666323|P4|NOT COMPLETED|Part A||3
1101689|NCT01107457|2666324|P3|NOT COMPLETED|Part A||1
1101690|NCT01107457|2666325|P2|NOT COMPLETED|Part A||7
1101691|NCT01107457|2666326|P1|NOT COMPLETED|Part A||5
1101692|NCT01107457|2666321|P6|COMPLETED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
1101693|NCT01107457|2666322|P5|COMPLETED|Part A||27
1101694|NCT01107457|2666323|P4|COMPLETED|Part A||26
1101695|NCT01107457|2666324|P3|COMPLETED|Part A||29
1101696|NCT01107457|2666325|P2|COMPLETED|Part A||21
1101697|NCT01107457|2666326|P1|COMPLETED|Part A||22
1101698|NCT01107457|2666321|P6|Received at Least 1 Dose of Study Drug|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
1101699|NCT01107457|2666322|P5|Received at Least 1 Dose of Study Drug|Part A||28
1101700|NCT01107457|2666323|P4|Received at Least 1 Dose of Study Drug|Part A||29
1101701|NCT01107457|2666324|P3|Received at Least 1 Dose of Study Drug|Part A||30
1101702|NCT01107457|2666325|P2|Received at Least 1 Dose of Study Drug|Part A||28
1101703|NCT01107457|2666326|P1|Received at Least 1 Dose of Study Drug|Part A||27
1101704|NCT01107457|2666321|P6|STARTED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
1101705|NCT01107457|2666322|P5|STARTED|Part A||28
1101706|NCT01107457|2666323|P4|STARTED|Part A||29
1101707|NCT01107457|2666324|P3|STARTED|Part A||30
1101708|NCT01107457|2666325|P2|STARTED|Part A||28
1101709|NCT01107457|2666326|P1|STARTED|Part A||27
1101710|NCT01107730|2666455|P3|NOT COMPLETED|Overall Study||0
1101711|NCT01107730|2666456|P2|NOT COMPLETED|Overall Study||0
1101712|NCT01107730|2666457|P1|NOT COMPLETED|Overall Study||0
1101713|NCT01107730|2666455|P3|COMPLETED|Overall Study||11
1101714|NCT01107730|2666456|P2|COMPLETED|Overall Study||11
1101715|NCT01107730|2666457|P1|COMPLETED|Overall Study||11
1101716|NCT01107730|2666455|P3|STARTED|Overall Study||11
1101717|NCT01107730|2666456|P2|STARTED|Overall Study||11
1101718|NCT01107730|2666457|P1|STARTED|Overall Study||11
1101719|NCT01107743|2666465|P1|NOT COMPLETED|Overall Study||46
1101720|NCT01107743|2666465|P1|COMPLETED|Overall Study||1245
1101721|NCT01107743|2666465|P1|STARTED|Overall Study||1291
1101722|NCT01107834|2666553|P2|NOT COMPLETED|Overall Study||0
1101723|NCT01107834|2666554|P1|NOT COMPLETED|Overall Study||0
1101724|NCT01107834|2666553|P2|COMPLETED|Overall Study||30
1101725|NCT01107834|2666554|P1|COMPLETED|Overall Study||30
1101726|NCT01107834|2666553|P2|STARTED|Overall Study||30
1101727|NCT01107834|2666554|P1|STARTED|Overall Study||30
1101728|NCT01107886|2666572|P2|NOT COMPLETED|Overall Study||214
1101729|NCT01107886|2666573|P1|NOT COMPLETED|Overall Study||202
1101730|NCT01107886|2666572|P2|COMPLETED|Overall Study|Completed subjects|7998
1101731|NCT01107886|2666573|P1|COMPLETED|Overall Study|Completed subjects|8078
1101732|NCT01107886|2666572|P2|STARTED|Overall Study|Randomized subjects|8212
1101733|NCT01107886|2666573|P1|STARTED|Overall Study|Randomized subjects|8280
1101734|NCT01107899|2666586|P3|NOT COMPLETED|Overall Study||4
1101735|NCT01107899|2666587|P2|NOT COMPLETED|Overall Study||0
1101736|NCT01107899|2666588|P1|NOT COMPLETED|Overall Study||5
1101737|NCT01107899|2666586|P3|COMPLETED|Overall Study||5
1101738|NCT01107899|2666587|P2|COMPLETED|Overall Study||10
1101739|NCT01107899|2666588|P1|COMPLETED|Overall Study||5
1101740|NCT01107899|2666586|P3|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|4
1101741|NCT01107899|2666587|P2|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|10
1101742|NCT01107899|2666588|P1|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|5
1101743|NCT01107899|2666586|P3|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|6
1101744|NCT01107899|2666587|P2|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|10
1101745|NCT01107899|2666588|P1|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|5
1101746|NCT01107899|2666586|P3|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|6
1101747|NCT01107899|2666587|P2|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|10
1101748|NCT01107899|2666588|P1|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|5
1101749|NCT01107899|2666586|P3|Received at Least One Dose of Study Drug|Overall Study||8
1101750|NCT01107899|2666587|P2|Received at Least One Dose of Study Drug|Overall Study||10
1101751|NCT01107899|2666588|P1|Received at Least One Dose of Study Drug|Overall Study||10
1101752|NCT01107899|2666586|P3|STARTED|Overall Study||9
1101753|NCT01107899|2666587|P2|STARTED|Overall Study||10
1101754|NCT01107899|2666588|P1|STARTED|Overall Study||10
1101755|NCT01107912|2666636|P6|NOT COMPLETED|Period 3||0
1101756|NCT01107912|2666637|P5|NOT COMPLETED|Period 3||0
1101757|NCT01107912|2666638|P4|NOT COMPLETED|Period 3||1
1101758|NCT01107912|2666639|P3|NOT COMPLETED|Period 3||1
1101759|NCT01107912|2666640|P2|NOT COMPLETED|Period 3||1
1101760|NCT01107912|2666641|P1|NOT COMPLETED|Period 3||0
1101761|NCT01107912|2666636|P6|COMPLETED|Period 3||41
1101762|NCT01107912|2666637|P5|COMPLETED|Period 3||0
1101763|NCT01107912|2666638|P4|COMPLETED|Period 3||37
1101764|NCT01107912|2666639|P3|COMPLETED|Period 3||35
1101765|NCT01107912|2666640|P2|COMPLETED|Period 3||34
1101766|NCT01107912|2666641|P1|COMPLETED|Period 3||0
1101767|NCT01107912|2666636|P6|STARTED|Period 3|Participants who received 5 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|41
1101768|NCT01107912|2666637|P5|STARTED|Period 3||0
1101769|NCT01107912|2666638|P4|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 5 mg prasugrel in Period 3|38
1101770|NCT01107912|2666639|P3|STARTED|Period 3|Participants who received 10 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|36
1101771|NCT01107912|2666640|P2|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 10 mg prasugrel in Period 3|35
1101772|NCT01107912|2666641|P1|STARTED|Period 3||0
1101773|NCT01107912|2666636|P6|NOT COMPLETED|Period 2||0
1101774|NCT01107912|2666637|P5|NOT COMPLETED|Period 2||0
1101775|NCT01107912|2666638|P4|NOT COMPLETED|Period 2||0
1101776|NCT01107912|2666639|P3|NOT COMPLETED|Period 2||1
1101777|NCT01107912|2666640|P2|NOT COMPLETED|Period 2||0
1101778|NCT01107912|2666641|P1|NOT COMPLETED|Period 2||0
1101779|NCT01107912|2666636|P6|COMPLETED|Period 2||38
1101780|NCT01107912|2666637|P5|COMPLETED|Period 2||0
1101781|NCT01107912|2666638|P4|COMPLETED|Period 2||41
1101782|NCT01107912|2666639|P3|COMPLETED|Period 2||35
1101783|NCT01107912|2666640|P2|COMPLETED|Period 2||36
1101784|NCT01107912|2666641|P1|COMPLETED|Period 2||0
1101785|NCT01107912|2666636|P6|STARTED|Period 2||38
1101786|NCT01107912|2666637|P5|STARTED|Period 2|Participants switched to either 5 mg prasugrel or 75 mg clopidogrel in Period 2.|0
1101787|NCT01107912|2666638|P4|STARTED|Period 2||41
1101788|NCT01107912|2666639|P3|STARTED|Period 2||36
1101789|NCT01107912|2666640|P2|STARTED|Period 2||36
1101790|NCT01107912|2666641|P1|STARTED|Period 2|Participants switched to either 10 mg prasugrel or 75 mg clopidogrel in Period 2.|0
1101791|NCT01107912|2666636|P6|NOT COMPLETED|Period 1||0
1101792|NCT01107912|2666637|P5|NOT COMPLETED|Period 1||3
1101793|NCT01107912|2666638|P4|NOT COMPLETED|Period 1||0
1101794|NCT01107912|2666639|P3|NOT COMPLETED|Period 1||0
1101795|NCT01107912|2666640|P2|NOT COMPLETED|Period 1||0
1101796|NCT01107912|2666641|P1|NOT COMPLETED|Period 1||1
1101797|NCT01107912|2666636|P6|COMPLETED|Period 1||0
1101798|NCT01107912|2666637|P5|COMPLETED|Period 1||79
1101799|NCT01107912|2666638|P4|COMPLETED|Period 1||0
1101800|NCT01107912|2666639|P3|COMPLETED|Period 1||0
1101801|NCT01107912|2666640|P2|COMPLETED|Period 1||0
1101802|NCT01107912|2666641|P1|COMPLETED|Period 1||72
1101803|NCT01107912|2666636|P6|Received at Least 1 Dose of Study Drug|Period 1||0
1101804|NCT01107912|2666637|P5|Received at Least 1 Dose of Study Drug|Period 1||82
1101805|NCT01107912|2666638|P4|Received at Least 1 Dose of Study Drug|Period 1||0
1101806|NCT01107912|2666639|P3|Received at Least 1 Dose of Study Drug|Period 1||0
1101807|NCT01107912|2666640|P2|Received at Least 1 Dose of Study Drug|Period 1||0
1101808|NCT01107912|2666641|P1|Received at Least 1 Dose of Study Drug|Period 1||73
1101809|NCT01107912|2666636|P6|STARTED|Period 1||0
1101810|NCT01107912|2666637|P5|STARTED|Period 1||82
1101811|NCT01107912|2666638|P4|STARTED|Period 1||0
1101812|NCT01107912|2666639|P3|STARTED|Period 1||0
1101813|NCT01107912|2666640|P2|STARTED|Period 1||0
1101814|NCT01107912|2666641|P1|STARTED|Period 1||73
1101815|NCT01107925|2666679|P6|NOT COMPLETED|Period 3||0
1101816|NCT01107925|2666680|P5|NOT COMPLETED|Period 3||0
1101817|NCT01107925|2666681|P4|NOT COMPLETED|Period 3||0
1101818|NCT01107925|2666682|P3|NOT COMPLETED|Period 3||0
1101819|NCT01107925|2666683|P2|NOT COMPLETED|Period 3||0
1101820|NCT01107925|2666684|P1|NOT COMPLETED|Period 3||0
1101821|NCT01107925|2666679|P6|COMPLETED|Period 3||20
1101822|NCT01107925|2666680|P5|COMPLETED|Period 3||0
1101823|NCT01107925|2666681|P4|COMPLETED|Period 3||16
1101824|NCT01107925|2666682|P3|COMPLETED|Period 3||15
1101825|NCT01107925|2666683|P2|COMPLETED|Period 3||17
1101826|NCT01107925|2666684|P1|COMPLETED|Period 3||0
1101827|NCT01107925|2666679|P6|Took at Least 1 Dose of Study Drug|Period 3||20
1101828|NCT01107925|2666680|P5|Took at Least 1 Dose of Study Drug|Period 3||0
1101829|NCT01107925|2666681|P4|Took at Least 1 Dose of Study Drug|Period 3||16
1101830|NCT01107925|2666682|P3|Took at Least 1 Dose of Study Drug|Period 3||15
1101831|NCT01107925|2666683|P2|Took at Least 1 Dose of Study Drug|Period 3||17
1101832|NCT01107925|2666684|P1|Took at Least 1 Dose of Study Drug|Period 3||0
1101833|NCT01107925|2666679|P6|STARTED|Period 3|5 mg prasugrel (Period 2, HBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|20
1101834|NCT01107925|2666680|P5|STARTED|Period 3||0
1101835|NCT01107925|2666681|P4|STARTED|Period 3|75 mg clopidogrel (Period 2, HBW treatment sequence) crossed over to 5 mg prasugrel (Period 3).|16
1101836|NCT01107925|2666682|P3|STARTED|Period 3|10 mg prasugrel (Period 2, LBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|15
1101837|NCT01107925|2666683|P2|STARTED|Period 3|75 mg clopidogrel (Period 2, LBW treatment sequence) crossed over to 10 mg prasugrel (Period 3).|17
1101838|NCT01107925|2666684|P1|STARTED|Period 3||0
1101839|NCT01107925|2666679|P6|NOT COMPLETED|Period 2||1
1101840|NCT01107925|2666680|P5|NOT COMPLETED|Period 2||0
1101841|NCT01107925|2666681|P4|NOT COMPLETED|Period 2||0
1101842|NCT01107925|2666682|P3|NOT COMPLETED|Period 2||0
1101843|NCT01107925|2666683|P2|NOT COMPLETED|Period 2||1
1101844|NCT01107925|2666684|P1|NOT COMPLETED|Period 2||0
1101845|NCT01107925|2666679|P6|COMPLETED|Period 2||16
1101846|NCT01107925|2666680|P5|COMPLETED|Period 2||0
1101847|NCT01107925|2666681|P4|COMPLETED|Period 2||20
1101848|NCT01107925|2666682|P3|COMPLETED|Period 2||17
1101849|NCT01107925|2666683|P2|COMPLETED|Period 2||15
1101850|NCT01107925|2666684|P1|COMPLETED|Period 2||0
1101851|NCT01107925|2666679|P6|Took at Least 1 Dose of Study Drug|Period 2||17
1101852|NCT01107925|2666680|P5|Took at Least 1 Dose of Study Drug|Period 2||0
1101853|NCT01107925|2666681|P4|Took at Least 1 Dose of Study Drug|Period 2||20
1101854|NCT01107925|2666682|P3|Took at Least 1 Dose of Study Drug|Period 2||17
1101855|NCT01107925|2666683|P2|Took at Least 1 Dose of Study Drug|Period 2||16
1101856|NCT01107925|2666684|P1|Took at Least 1 Dose of Study Drug|Period 2||0
1101857|NCT01107925|2666679|P6|STARTED|Period 2||17
1101858|NCT01107925|2666680|P5|STARTED|Period 2|10 mg prasugrel (Period 1, HBW treatment) switched to 5 mg prasugrel or 75 mg clopidogrel (Period 2)|0
1101859|NCT01107925|2666681|P4|STARTED|Period 2||20
1101860|NCT01107925|2666682|P3|STARTED|Period 2||17
1101861|NCT01107925|2666683|P2|STARTED|Period 2||16
1101862|NCT01107925|2666684|P1|STARTED|Period 2|5 mg prasugrel (Period 1, LBW treatment) switched to 10 mg prasugrel or 75 mg clopidogrel (Period 2)|0
1101863|NCT01107925|2666679|P6|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
1101864|NCT01107925|2666680|P5|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
1101865|NCT01107925|2666681|P4|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
1101866|NCT01107925|2666682|P3|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
1101867|NCT01107925|2666683|P2|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
1101868|NCT01107925|2666684|P1|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
1101869|NCT01107925|2666679|P6|COMPLETED|Period 1-Randomization up Through Day 12||0
1101870|NCT01107925|2666680|P5|COMPLETED|Period 1-Randomization up Through Day 12||37
1101871|NCT01107925|2666681|P4|COMPLETED|Period 1-Randomization up Through Day 12||0
1101872|NCT01107925|2666682|P3|COMPLETED|Period 1-Randomization up Through Day 12||0
1101873|NCT01107925|2666683|P2|COMPLETED|Period 1-Randomization up Through Day 12||0
1101874|NCT01107925|2666684|P1|COMPLETED|Period 1-Randomization up Through Day 12||33
1101875|NCT01107925|2666679|P6|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
1101876|NCT01107925|2666680|P5|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||38
1101877|NCT01107925|2666681|P4|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
1101878|NCT01107925|2666682|P3|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
1101879|NCT01107925|2666683|P2|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
1101880|NCT01107925|2666684|P1|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||34
1101881|NCT01107925|2666679|P6|STARTED|Period 1-Randomization up Through Day 12||0
1101882|NCT01107925|2666680|P5|STARTED|Period 1-Randomization up Through Day 12||38
1101883|NCT01107925|2666681|P4|STARTED|Period 1-Randomization up Through Day 12||0
1101884|NCT01107925|2666682|P3|STARTED|Period 1-Randomization up Through Day 12||0
1101885|NCT01107925|2666683|P2|STARTED|Period 1-Randomization up Through Day 12||0
1101886|NCT01107925|2666684|P1|STARTED|Period 1-Randomization up Through Day 12||34
1101887|NCT01108003|2666720|P2|NOT COMPLETED|Overall Study||0
1101888|NCT01108003|2666721|P1|NOT COMPLETED|Overall Study||0
1101889|NCT01108003|2666720|P2|COMPLETED|Overall Study||3
1101890|NCT01108003|2666721|P1|COMPLETED|Overall Study||4
1101891|NCT01108003|2666720|P2|STARTED|Overall Study||3
1101892|NCT01108003|2666721|P1|STARTED|Overall Study||4
1101893|NCT01108055|2666729|P1|NOT COMPLETED|Overall Study||15
1101894|NCT01108055|2666729|P1|COMPLETED|Overall Study||28
1101895|NCT01108055|2666729|P1|Eligible and Started Treatment|Overall Study||32
1101896|NCT01108055|2666729|P1|STARTED|Overall Study||43
1101897|NCT01108081|2666741|P4|NOT COMPLETED|Overall Study||4
1101898|NCT01108081|2666742|P3|NOT COMPLETED|Overall Study||0
1101899|NCT01108081|2666743|P2|NOT COMPLETED|Overall Study||2
1101900|NCT01108081|2666744|P1|NOT COMPLETED|Overall Study||2
1101901|NCT01108081|2666741|P4|COMPLETED|Overall Study||39
1101902|NCT01108081|2666742|P3|COMPLETED|Overall Study||38
1101903|NCT01108081|2666743|P2|COMPLETED|Overall Study||40
1101904|NCT01108081|2666744|P1|COMPLETED|Overall Study||44
1101905|NCT01108081|2666741|P4|STARTED|Overall Study||43
1101906|NCT01108081|2666742|P3|STARTED|Overall Study||38
1101907|NCT01108081|2666743|P2|STARTED|Overall Study||42
1101908|NCT01108081|2666744|P1|STARTED|Overall Study||46
1101909|NCT01108185|2666758|P1|NOT COMPLETED|Overall Study||27
1101910|NCT01108185|2666758|P1|COMPLETED|Overall Study||3154
1101911|NCT01108185|2666758|P1|Per Protocol Population|Overall Study||3181
1101912|NCT01108185|2666758|P1|STARTED|Overall Study||3181
1101913|NCT01108237|2666773|P2|NOT COMPLETED|Overall Study||17
1101914|NCT01108237|2666774|P1|NOT COMPLETED|Overall Study||9
1101915|NCT01108237|2666773|P2|COMPLETED|Overall Study||84
1101916|NCT01108237|2666774|P1|COMPLETED|Overall Study|66 subjects underwent surgery per the protocol, however, only 64 met the primary end point.|64
1101917|NCT01108237|2666773|P2|STARTED|Overall Study||101
1101918|NCT01108237|2666774|P1|STARTED|Overall Study|78 subjects were consented with intent to treat, however, 73 had surgery.|73
1101919|NCT01108263|2666782|P2|NOT COMPLETED|Overall Study||1
1101920|NCT01108263|2666783|P1|NOT COMPLETED|Overall Study||0
1101921|NCT01108263|2666782|P2|COMPLETED|Overall Study||2
1101922|NCT01108263|2666783|P1|COMPLETED|Overall Study||2
1101923|NCT01108263|2666782|P2|STARTED|Overall Study||3
1101924|NCT01108263|2666783|P1|STARTED|Overall Study||2
1101925|NCT01108341|2666791|P1|NOT COMPLETED|Overall Study||5
1101926|NCT01108341|2666791|P1|COMPLETED|Overall Study||45
1101927|NCT01108341|2666791|P1|Safety Set (Enrolled and Treated)|Overall Study||49
1101928|NCT01108341|2666791|P1|STARTED|Overall Study||50
1101929|NCT01108406|2666796|P1|NOT COMPLETED|Overall Study||0
1101930|NCT01108406|2666796|P1|COMPLETED|Overall Study||22
1101931|NCT01108406|2666796|P1|STARTED|Overall Study||22
1101938|NCT01108458|2666839|P1|NOT COMPLETED|Overall Study||1
1101939|NCT01108458|2666839|P1|COMPLETED|Overall Study||0
1101940|NCT01108458|2666839|P1|STARTED|Overall Study||1
1101941|NCT01108510|2666850|P2|NOT COMPLETED|Overall Study||268
1101942|NCT01108510|2666851|P1|NOT COMPLETED|Overall Study||279
1101943|NCT01108510|2666850|P2|COMPLETED|Overall Study||81
1101944|NCT01108510|2666851|P1|COMPLETED|Overall Study||70
1101945|NCT01108510|2666850|P2|STARTED|Overall Study||349
1101946|NCT01108510|2666851|P1|STARTED|Overall Study||349
1101947|NCT01108523|2666871|P1|NOT COMPLETED|Overall Study||4
1101948|NCT01108523|2666871|P1|COMPLETED|Overall Study||3
1101949|NCT01108523|2666871|P1|STARTED|Overall Study||7
1101950|NCT01108718|2666878|P2|NOT COMPLETED|Received Second Intervention (2 Months)||0
1101951|NCT01108718|2666879|P1|NOT COMPLETED|Received Second Intervention (2 Months)||1
1101952|NCT01108718|2666878|P2|COMPLETED|Received Second Intervention (2 Months)||7
1101953|NCT01108718|2666879|P1|COMPLETED|Received Second Intervention (2 Months)||4
1101954|NCT01108718|2666878|P2|STARTED|Received Second Intervention (2 Months)||7
1101955|NCT01108718|2666879|P1|STARTED|Received Second Intervention (2 Months)|Used control mattress was delivered to participant at crossover causing her to withdraw.|5
1101956|NCT01108718|2666878|P2|NOT COMPLETED|Received First Intervention (2 Months)||0
1101957|NCT01108718|2666879|P1|NOT COMPLETED|Received First Intervention (2 Months)||0
1101958|NCT01108718|2666878|P2|COMPLETED|Received First Intervention (2 Months)||7
1101959|NCT01108718|2666879|P1|COMPLETED|Received First Intervention (2 Months)||5
1101960|NCT01108718|2666878|P2|STARTED|Received First Intervention (2 Months)||7
1101961|NCT01108718|2666879|P1|STARTED|Received First Intervention (2 Months)||5
1101962|NCT01108731|2666886|P2|NOT COMPLETED|Overall Study||4
1101963|NCT01108731|2666887|P1|NOT COMPLETED|Overall Study||4
1101964|NCT01108731|2666886|P2|COMPLETED|Overall Study||13
1101965|NCT01108731|2666887|P1|COMPLETED|Overall Study||13
1101966|NCT01108731|2666886|P2|STARTED|Overall Study||17
1101967|NCT01108731|2666887|P1|STARTED|Overall Study||17
1101968|NCT01108796|2666901|P2|NOT COMPLETED|Overall Study||7
1101969|NCT01108796|2666902|P1|NOT COMPLETED|Overall Study||7
1101970|NCT01108796|2666901|P2|COMPLETED|Overall Study||1060
1101971|NCT01108796|2666902|P1|COMPLETED|Overall Study||767
1101972|NCT01108796|2666901|P2|STARTED|Overall Study||1067
1101973|NCT01108796|2666902|P1|STARTED|Overall Study||774
1101974|NCT01108809|2666934|P1|NOT COMPLETED|Overall Study||4
1101975|NCT01108809|2666934|P1|COMPLETED|Overall Study||291
1101976|NCT01108809|2666934|P1|STARTED|Overall Study||295
1101977|NCT01108835|2666949|P2|NOT COMPLETED|Overall Study||21
1101978|NCT01108835|2666950|P1|NOT COMPLETED|Overall Study||17
1101979|NCT01108835|2666949|P2|COMPLETED|Overall Study||69
1101980|NCT01108835|2666950|P1|COMPLETED|Overall Study||73
1101981|NCT01108835|2666949|P2|STARTED|Overall Study||90
1101982|NCT01108835|2666950|P1|STARTED|Overall Study||90
1101983|NCT01109056|2666966|P2|NOT COMPLETED|Overall Study||5
1101984|NCT01109056|2666967|P1|NOT COMPLETED|Overall Study||7
1101985|NCT01109056|2666966|P2|COMPLETED|Overall Study||53
1101986|NCT01109056|2666967|P1|COMPLETED|Overall Study||50
1101987|NCT01109056|2666966|P2|STARTED|Overall Study||58
1101988|NCT01109056|2666967|P1|STARTED|Overall Study||57
1101989|NCT01109108|2666979|P2|NOT COMPLETED|Overall Study||0
1101990|NCT01109108|2666980|P1|NOT COMPLETED|Overall Study||0
1101991|NCT01109108|2666979|P2|COMPLETED|Overall Study||4755
1101992|NCT01109108|2666980|P1|COMPLETED|Overall Study||4035
1101993|NCT01109108|2666979|P2|STARTED|Overall Study||4755
1101994|NCT01109108|2666980|P1|STARTED|Overall Study||4035
1101995|NCT01109147|2666989|P3|NOT COMPLETED|Overall Study||10
1101996|NCT01109147|2666990|P2|NOT COMPLETED|Overall Study||3
1101997|NCT01109147|2666991|P1|NOT COMPLETED|Overall Study||2
1101998|NCT01109147|2666989|P3|COMPLETED|Overall Study|10 have been excluded of the results|26
1101999|NCT01109147|2666990|P2|COMPLETED|Overall Study|3 have been excluded of the results|11
1102000|NCT01109147|2666991|P1|COMPLETED|Overall Study|2 have been excluded of the results|15
1102001|NCT01109147|2666989|P3|STARTED|Overall Study||36
1102002|NCT01109147|2666990|P2|STARTED|Overall Study||14
1102003|NCT01109147|2666991|P1|STARTED|Overall Study||17
1102004|NCT01109173|2667003|P4|NOT COMPLETED|Overall Study||93
1102005|NCT01109173|2667004|P3|NOT COMPLETED|Overall Study||101
1102006|NCT01109173|2667005|P2|NOT COMPLETED|Overall Study||86
1102007|NCT01109173|2667006|P1|NOT COMPLETED|Overall Study||88
1102008|NCT01109173|2667003|P4|COMPLETED|Overall Study||120
1102009|NCT01109173|2667004|P3|COMPLETED|Overall Study||110
1102010|NCT01109173|2667005|P2|COMPLETED|Overall Study||759
1102011|NCT01109173|2667006|P1|COMPLETED|Overall Study||763
1102012|NCT01109173|2667003|P4|STARTED|Overall Study||213
1102013|NCT01109173|2667004|P3|STARTED|Overall Study||211
1102014|NCT01109173|2667005|P2|STARTED|Overall Study||845
1102015|NCT01109173|2667006|P1|STARTED|Overall Study||851
1102016|NCT01109316|2667026|P3|NOT COMPLETED|Study Period 3||1
1102017|NCT01109316|2667027|P2|NOT COMPLETED|Study Period 3||2
1102018|NCT01109316|2667028|P1|NOT COMPLETED|Study Period 3||0
1102019|NCT01109316|2667026|P3|COMPLETED|Study Period 3||38
1102020|NCT01109316|2667027|P2|COMPLETED|Study Period 3||39
1102021|NCT01109316|2667028|P1|COMPLETED|Study Period 3||39
1102022|NCT01109316|2667026|P3|STARTED|Study Period 3||39
1102023|NCT01109316|2667027|P2|STARTED|Study Period 3||41
1102024|NCT01109316|2667028|P1|STARTED|Study Period 3||39
1102025|NCT01109316|2667026|P3|NOT COMPLETED|Study Period 2||2
1102026|NCT01109316|2667027|P2|NOT COMPLETED|Study Period 2||2
1102027|NCT01109316|2667028|P1|NOT COMPLETED|Study Period 2||1
1102028|NCT01109316|2667026|P3|COMPLETED|Study Period 2||41
1102029|NCT01109316|2667027|P2|COMPLETED|Study Period 2||40
1102030|NCT01109316|2667028|P1|COMPLETED|Study Period 2||38
1102031|NCT01109316|2667026|P3|STARTED|Study Period 2||43
1102032|NCT01109316|2667027|P2|STARTED|Study Period 2||42
1102033|NCT01109316|2667028|P1|STARTED|Study Period 2||39
1102034|NCT01109316|2667026|P3|NOT COMPLETED|Study Period 1||4
1102035|NCT01109316|2667027|P2|NOT COMPLETED|Study Period 1||4
1102036|NCT01109316|2667028|P1|NOT COMPLETED|Study Period 1||0
1102037|NCT01109316|2667026|P3|COMPLETED|Study Period 1||40
1102038|NCT01109316|2667027|P2|COMPLETED|Study Period 1||40
1102039|NCT01109316|2667028|P1|COMPLETED|Study Period 1||44
1102040|NCT01109316|2667026|P3|Received at Least One Dose of Study Drug|Study Period 1||42
1102041|NCT01109316|2667027|P2|Received at Least One Dose of Study Drug|Study Period 1||44
1102042|NCT01109316|2667028|P1|Received at Least One Dose of Study Drug|Study Period 1||44
1102043|NCT01109316|2667026|P3|STARTED|Study Period 1||44
1102044|NCT01109316|2667027|P2|STARTED|Study Period 1||44
1102045|NCT01109316|2667028|P1|STARTED|Study Period 1||44
1102046|NCT01109381|2667072|P1|NOT COMPLETED|Overall Study||2
1102047|NCT01109381|2667072|P1|COMPLETED|Overall Study||31
1102048|NCT01109381|2667072|P1|STARTED|Overall Study||33
1102049|NCT01109524|2667078|P1|NOT COMPLETED|Overall Study||57
1102050|NCT01109524|2667078|P1|COMPLETED|Overall Study||3
1102051|NCT01109524|2667078|P1|STARTED|Overall Study||60
1102052|NCT01109576|2667088|P1|NOT COMPLETED|Overall Study||1
1102053|NCT01109576|2667088|P1|COMPLETED|Overall Study||12
1102054|NCT01109576|2667088|P1|STARTED|Overall Study||13
1102055|NCT01109602|2667095|P3|NOT COMPLETED|Overall Study||1
1102056|NCT01109602|2667096|P2|NOT COMPLETED|Overall Study||2
1102057|NCT01109602|2667097|P1|NOT COMPLETED|Overall Study||1
1102058|NCT01109602|2667095|P3|COMPLETED|Overall Study||9
1102059|NCT01109602|2667096|P2|COMPLETED|Overall Study||21
1102060|NCT01109602|2667097|P1|COMPLETED|Overall Study||13
1102061|NCT01109602|2667095|P3|STARTED|Overall Study||10
1102062|NCT01109602|2667096|P2|STARTED|Overall Study||23
1102063|NCT01109602|2667097|P1|STARTED|Overall Study||14
1102064|NCT01109849|2667110|P5|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
1102065|NCT01109849|2667111|P4|NOT COMPLETED|Adaptive Randomization: Weight Recovery||3
1102066|NCT01109849|2667112|P3|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
1102067|NCT01109849|2667113|P2|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
1102068|NCT01109849|2667114|P1|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
1102069|NCT01109849|2667110|P5|COMPLETED|Adaptive Randomization: Weight Recovery||24
1102070|NCT01109849|2667111|P4|COMPLETED|Adaptive Randomization: Weight Recovery||20
1102071|NCT01109849|2667112|P3|COMPLETED|Adaptive Randomization: Weight Recovery||23
1102072|NCT01109849|2667113|P2|COMPLETED|Adaptive Randomization: Weight Recovery||0
1102073|NCT01109849|2667114|P1|COMPLETED|Adaptive Randomization: Weight Recovery||0
1102074|NCT01109849|2667110|P5|STARTED|Adaptive Randomization: Weight Recovery||25
1102075|NCT01109849|2667111|P4|STARTED|Adaptive Randomization: Weight Recovery||23
1102076|NCT01109849|2667112|P3|STARTED|Adaptive Randomization: Weight Recovery||24
1102077|NCT01109849|2667113|P2|STARTED|Adaptive Randomization: Weight Recovery||0
1102078|NCT01109849|2667114|P1|STARTED|Adaptive Randomization: Weight Recovery||0
1102079|NCT01109849|2667110|P5|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
1102080|NCT01109849|2667111|P4|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
1102081|NCT01109849|2667112|P3|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
1102082|NCT01109849|2667113|P2|NOT COMPLETED|Initial Randomization: ADHD Treatment||49
1102083|NCT01109849|2667114|P1|NOT COMPLETED|Initial Randomization: ADHD Treatment||18
1102084|NCT01109849|2667110|P5|COMPLETED|Initial Randomization: ADHD Treatment||0
1102085|NCT01109849|2667111|P4|COMPLETED|Initial Randomization: ADHD Treatment||0
1102086|NCT01109849|2667112|P3|COMPLETED|Initial Randomization: ADHD Treatment||0
1102087|NCT01109849|2667113|P2|COMPLETED|Initial Randomization: ADHD Treatment||131
1102088|NCT01109849|2667114|P1|COMPLETED|Initial Randomization: ADHD Treatment||32
1102089|NCT01109849|2667110|P5|STARTED|Initial Randomization: ADHD Treatment||0
1102090|NCT01109849|2667111|P4|STARTED|Initial Randomization: ADHD Treatment||0
1102091|NCT01109849|2667112|P3|STARTED|Initial Randomization: ADHD Treatment||0
1102092|NCT01109849|2667113|P2|STARTED|Initial Randomization: ADHD Treatment||180
1102093|NCT01109849|2667114|P1|STARTED|Initial Randomization: ADHD Treatment||50
1102094|NCT01109979|2667165|P2|NOT COMPLETED|Overall Study||1
1102095|NCT01109979|2667166|P1|NOT COMPLETED|Overall Study||2
1102096|NCT01109979|2667165|P2|COMPLETED|Overall Study||11
1102097|NCT01109979|2667166|P1|COMPLETED|Overall Study||10
1102098|NCT01109979|2667165|P2|STARTED|Overall Study||12
1102099|NCT01109979|2667166|P1|STARTED|Overall Study||12
1102100|NCT01110005|2667174|P2|NOT COMPLETED|Overall Study||5
1102101|NCT01110005|2667175|P1|NOT COMPLETED|Overall Study||4
1102102|NCT01110005|2667174|P2|COMPLETED|Overall Study||156
1102103|NCT01110005|2667175|P1|COMPLETED|Overall Study||153
1102104|NCT01110005|2667174|P2|STARTED|Overall Study||161
1102105|NCT01110005|2667175|P1|STARTED|Overall Study||157
1102106|NCT01103934|2667187|P2|NOT COMPLETED|Overall Study||0
1102107|NCT01103934|2667188|P1|NOT COMPLETED|Overall Study||0
1102108|NCT01103934|2667187|P2|COMPLETED|Overall Study||18
1102109|NCT01103934|2667188|P1|COMPLETED|Overall Study||17
1102110|NCT01103934|2667187|P2|STARTED|Overall Study||18
1102111|NCT01103934|2667188|P1|STARTED|Overall Study||17
1102112|NCT01103960|2667198|P2|NOT COMPLETED|Overall Study||2
1102113|NCT01103960|2667199|P1|NOT COMPLETED|Overall Study||5
1102114|NCT01103960|2667198|P2|COMPLETED|Overall Study|Completed study medication.|158
1102115|NCT01103960|2667199|P1|COMPLETED|Overall Study|Completed study medication.|159
1102116|NCT01103960|2667198|P2|STARTED|Overall Study|Randomised and treated.|160
1102117|NCT01103960|2667199|P1|STARTED|Overall Study|Randomised and treated.|164
1102118|NCT01103973|2667225|P2|NOT COMPLETED|Overall Study||0
1102119|NCT01103973|2667226|P1|NOT COMPLETED|Overall Study||0
1102120|NCT01103973|2667225|P2|COMPLETED|Overall Study||46
1102121|NCT01103973|2667226|P1|COMPLETED|Overall Study||51
1102122|NCT01103973|2667225|P2|STARTED|Overall Study||46
1102123|NCT01103973|2667226|P1|STARTED|Overall Study||51
1102124|NCT01104103|2667234|P2|NOT COMPLETED|Overall Study||0
1102125|NCT01104103|2667235|P1|NOT COMPLETED|Overall Study||0
1102126|NCT01104103|2667234|P2|COMPLETED|Overall Study||224
1102127|NCT01104103|2667235|P1|COMPLETED|Overall Study||243
1102128|NCT01104103|2667234|P2|STARTED|Overall Study||224
1102129|NCT01104103|2667235|P1|STARTED|Overall Study||243
1102130|NCT01104116|2667243|P1|NOT COMPLETED|Overall Study||0
1102131|NCT01104116|2667243|P1|COMPLETED|Overall Study||1
1102132|NCT01104116|2667243|P1|STARTED|Overall Study||1
1102133|NCT01104155|2667250|P2|NOT COMPLETED|Overall Study||18
1102134|NCT01104155|2667251|P1|NOT COMPLETED|Overall Study||25
1102135|NCT01104155|2667250|P2|COMPLETED|Overall Study||42
1102136|NCT01104155|2667251|P1|COMPLETED|Overall Study||38
1102137|NCT01104155|2667250|P2|STARTED|Overall Study||60
1102138|NCT01104155|2667251|P1|STARTED|Overall Study||63
1102139|NCT01104207|2667267|P2|NOT COMPLETED|Overall Study||3
1102140|NCT01104207|2667268|P1|NOT COMPLETED|Overall Study||3
1102141|NCT01104207|2667267|P2|COMPLETED|Overall Study||32
1102142|NCT01104207|2667268|P1|COMPLETED|Overall Study||32
1102143|NCT01104207|2667267|P2|STARTED|Overall Study||35
1102144|NCT01104207|2667268|P1|STARTED|Overall Study||35
1102145|NCT01104246|2667274|P1|NOT COMPLETED|Overall Study||5
1102146|NCT01104246|2667274|P1|COMPLETED|Overall Study||35
1102147|NCT01104246|2667274|P1|Baseline Characteristics Measured|Overall Study||35
1102148|NCT01104246|2667274|P1|STARTED|Overall Study||40
1102149|NCT01104285|2667280|P2|NOT COMPLETED|Overall Study||0
1102150|NCT01104285|2667281|P1|NOT COMPLETED|Overall Study||0
1102151|NCT01104285|2667280|P2|COMPLETED|Overall Study||86
1102152|NCT01104285|2667281|P1|COMPLETED|Overall Study||112
1102153|NCT01104285|2667280|P2|STARTED|Overall Study||86
1102154|NCT01104285|2667281|P1|STARTED|Overall Study||112
1102155|NCT01104311|2667289|P2|NOT COMPLETED|Overall Study||12
1102156|NCT01104311|2667290|P1|NOT COMPLETED|Overall Study||10
1102157|NCT01104311|2667289|P2|COMPLETED|Overall Study||54
1102158|NCT01104311|2667290|P1|COMPLETED|Overall Study||56
1102159|NCT01104311|2667289|P2|STARTED|Overall Study||66
1102160|NCT01104311|2667290|P1|STARTED|Overall Study||66
1102161|NCT01104376|2667308|P1|NOT COMPLETED|Overall Study||28
1102162|NCT01104376|2667308|P1|COMPLETED|Overall Study||61
1102163|NCT01104376|2667308|P1|STARTED|Overall Study||89
1102164|NCT01104493|2667314|P2|NOT COMPLETED|Overall Study||2
1102165|NCT01104493|2667315|P1|NOT COMPLETED|Overall Study||0
1102166|NCT01104493|2667314|P2|COMPLETED|Overall Study||58
1102167|NCT01104493|2667315|P1|COMPLETED|Overall Study||240
1102168|NCT01104493|2667314|P2|STARTED|Overall Study||60
1102169|NCT01104493|2667315|P1|STARTED|Overall Study||240
1102170|NCT01104558|2667333|P1|NOT COMPLETED|Overall Study||17
1102171|NCT01104558|2667333|P1|COMPLETED|Overall Study||83
1102172|NCT01104558|2667333|P1|STARTED|Overall Study||100
1102173|NCT01104584|2667374|P1|NOT COMPLETED|Overall Study||23
1102174|NCT01104584|2667374|P1|COMPLETED|Overall Study|study course completed|437
1102175|NCT01104584|2667374|P1|Fulfilled Requirements of FAS Population|Overall Study||397
1102176|NCT01104584|2667374|P1|Received Treatment|Overall Study|treatment started|439
1102177|NCT01104584|2667374|P1|STARTED|Overall Study|screened and enrolled|460
1102178|NCT01104636|2667444|P1|NOT COMPLETED|Overall Study||178
1102179|NCT01104636|2667444|P1|COMPLETED|Overall Study||999
1102180|NCT01104636|2667444|P1|STARTED|Overall Study||1177
1102181|NCT01104662|2667457|P8|NOT COMPLETED|Overall Study||0
1102182|NCT01104662|2667458|P7|NOT COMPLETED|Overall Study||0
1102183|NCT01104662|2667459|P6|NOT COMPLETED|Overall Study||4
1102184|NCT01104662|2667460|P5|NOT COMPLETED|Overall Study||1
1102185|NCT01104662|2667461|P4|NOT COMPLETED|Overall Study||1
1102186|NCT01104662|2667462|P3|NOT COMPLETED|Overall Study||1
1102187|NCT01104662|2667463|P2|NOT COMPLETED|Overall Study||10
1102188|NCT01104662|2667464|P1|NOT COMPLETED|Overall Study||10
1102189|NCT01104662|2667457|P8|COMPLETED|Overall Study||6
1102190|NCT01104662|2667458|P7|COMPLETED|Overall Study||5
1102191|NCT01104662|2667459|P6|COMPLETED|Overall Study||12
1102192|NCT01104662|2667460|P5|COMPLETED|Overall Study||14
1102193|NCT01104662|2667461|P4|COMPLETED|Overall Study||3
1102194|NCT01104662|2667462|P3|COMPLETED|Overall Study||4
1102195|NCT01104662|2667463|P2|COMPLETED|Overall Study||11
1102196|NCT01104662|2667464|P1|COMPLETED|Overall Study||10
1102197|NCT01104662|2667457|P8|Received at Least 1 Dose of Study Drug|Overall Study||6
1102198|NCT01104662|2667458|P7|Received at Least 1 Dose of Study Drug|Overall Study||5
1102199|NCT01104662|2667459|P6|Received at Least 1 Dose of Study Drug|Overall Study||15
1102200|NCT01104662|2667460|P5|Received at Least 1 Dose of Study Drug|Overall Study||15
1102201|NCT01104662|2667461|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
1102202|NCT01104662|2667462|P3|Received at Least 1 Dose of Study Drug|Overall Study||4
1102203|NCT01104662|2667463|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
1102204|NCT01104662|2667464|P1|Received at Least 1 Dose of Study Drug|Overall Study||17
1102205|NCT01104662|2667457|P8|STARTED|Overall Study||6
1102206|NCT01104662|2667458|P7|STARTED|Overall Study||5
1102207|NCT01104662|2667459|P6|STARTED|Overall Study||16
1102208|NCT01104662|2667460|P5|STARTED|Overall Study||15
1102209|NCT01104662|2667461|P4|STARTED|Overall Study||4
1102210|NCT01104662|2667462|P3|STARTED|Overall Study||5
1102211|NCT01104662|2667463|P2|STARTED|Overall Study||21
1102212|NCT01104662|2667464|P1|STARTED|Overall Study||20
1102213|NCT01110135|2667490|P1|NOT COMPLETED|Overall Study||9
1102214|NCT01110135|2667490|P1|COMPLETED|Overall Study||34
1102215|NCT01110135|2667490|P1|STARTED|Overall Study||43
1102216|NCT01110187|2667496|P2|NOT COMPLETED|Overall Study||0
1102217|NCT01110187|2667497|P1|NOT COMPLETED|Overall Study||0
1102218|NCT01110187|2667496|P2|COMPLETED|Overall Study|completed 7 day treatment|4
1102219|NCT01110187|2667497|P1|COMPLETED|Overall Study|completed 7 day treatment|7
1102220|NCT01110187|2667496|P2|STARTED|Overall Study||4
1102221|NCT01110187|2667497|P1|STARTED|Overall Study||7
1102222|NCT01110200|2667507|P2|NOT COMPLETED|Overall Study||121
1102223|NCT01110200|2667508|P1|NOT COMPLETED|Overall Study||106
1102224|NCT01110200|2667507|P2|COMPLETED|Overall Study||204
1102225|NCT01110200|2667508|P1|COMPLETED|Overall Study||208
1102226|NCT01110200|2667507|P2|STARTED|Overall Study||325
1102227|NCT01110200|2667508|P1|STARTED|Overall Study||314
1102228|NCT01110239|2667526|P4|NOT COMPLETED|10 Min Ischemia||0
1102229|NCT01110239|2667527|P3|NOT COMPLETED|10 Min Ischemia||0
1102230|NCT01110239|2667528|P2|NOT COMPLETED|10 Min Ischemia||0
1102231|NCT01110239|2667529|P1|NOT COMPLETED|10 Min Ischemia||0
1102232|NCT01110239|2667526|P4|COMPLETED|10 Min Ischemia||6
1102233|NCT01110239|2667527|P3|COMPLETED|10 Min Ischemia||0
1102234|NCT01110239|2667528|P2|COMPLETED|10 Min Ischemia||0
1102235|NCT01110239|2667529|P1|COMPLETED|10 Min Ischemia||0
1102236|NCT01110239|2667526|P4|STARTED|10 Min Ischemia||6
1102237|NCT01110239|2667527|P3|STARTED|10 Min Ischemia||0
1102238|NCT01110239|2667528|P2|STARTED|10 Min Ischemia||0
1102239|NCT01110239|2667529|P1|STARTED|10 Min Ischemia||0
1102240|NCT01110239|2667526|P4|NOT COMPLETED|7.5 Min Ischemia||0
1102241|NCT01110239|2667527|P3|NOT COMPLETED|7.5 Min Ischemia||1
1102242|NCT01110239|2667528|P2|NOT COMPLETED|7.5 Min Ischemia||0
1102243|NCT01110239|2667529|P1|NOT COMPLETED|7.5 Min Ischemia||0
1102244|NCT01110239|2667526|P4|COMPLETED|7.5 Min Ischemia||0
1102245|NCT01110239|2667527|P3|COMPLETED|7.5 Min Ischemia||6
1102246|NCT01110239|2667528|P2|COMPLETED|7.5 Min Ischemia||0
1102247|NCT01110239|2667529|P1|COMPLETED|7.5 Min Ischemia||0
1102248|NCT01110239|2667526|P4|STARTED|7.5 Min Ischemia||0
1102249|NCT01110239|2667527|P3|STARTED|7.5 Min Ischemia||7
1102250|NCT01110239|2667528|P2|STARTED|7.5 Min Ischemia||0
1102251|NCT01110239|2667529|P1|STARTED|7.5 Min Ischemia||0
1102252|NCT01110239|2667526|P4|NOT COMPLETED|5 Min Ischemia||0
1102253|NCT01110239|2667527|P3|NOT COMPLETED|5 Min Ischemia||0
1102254|NCT01110239|2667528|P2|NOT COMPLETED|5 Min Ischemia||14
1102255|NCT01110239|2667529|P1|NOT COMPLETED|5 Min Ischemia||0
1102256|NCT01110239|2667526|P4|COMPLETED|5 Min Ischemia||0
1102257|NCT01110239|2667527|P3|COMPLETED|5 Min Ischemia||0
1102258|NCT01110239|2667528|P2|COMPLETED|5 Min Ischemia||0
1102259|NCT01110239|2667529|P1|COMPLETED|5 Min Ischemia||0
1102260|NCT01110239|2667526|P4|STARTED|5 Min Ischemia||0
1102261|NCT01110239|2667527|P3|STARTED|5 Min Ischemia||0
1102262|NCT01110239|2667528|P2|STARTED|5 Min Ischemia||14
1102263|NCT01110239|2667529|P1|STARTED|5 Min Ischemia||0
1102264|NCT01110239|2667526|P4|NOT COMPLETED|Sham Preconditioning||0
1102265|NCT01110239|2667527|P3|NOT COMPLETED|Sham Preconditioning||1
1102266|NCT01110239|2667528|P2|NOT COMPLETED|Sham Preconditioning||0
1102267|NCT01110239|2667529|P1|NOT COMPLETED|Sham Preconditioning||0
1102268|NCT01110239|2667526|P4|COMPLETED|Sham Preconditioning||6
1102269|NCT01110239|2667527|P3|COMPLETED|Sham Preconditioning||6
1102270|NCT01110239|2667528|P2|COMPLETED|Sham Preconditioning||14
1102271|NCT01110239|2667529|P1|COMPLETED|Sham Preconditioning||7
1102272|NCT01110239|2667526|P4|STARTED|Sham Preconditioning||6
1102273|NCT01110239|2667527|P3|STARTED|Sham Preconditioning||7
1102274|NCT01110239|2667528|P2|STARTED|Sham Preconditioning||14
1102275|NCT01110239|2667529|P1|STARTED|Sham Preconditioning||7
1102276|NCT01110252|2667543|P1|NOT COMPLETED|Post-procedure (Stem Cells Infusion)||0
1102277|NCT01110252|2667543|P1|COMPLETED|Post-procedure (Stem Cells Infusion)||4
1102278|NCT01110252|2667543|P1|STARTED|Post-procedure (Stem Cells Infusion)||4
1102279|NCT01110252|2667543|P1|NOT COMPLETED|Pre-procedure (Stem Cells Infusion)||0
1102280|NCT01110252|2667543|P1|COMPLETED|Pre-procedure (Stem Cells Infusion)||4
1102281|NCT01110252|2667543|P1|STARTED|Pre-procedure (Stem Cells Infusion)||4
1102282|NCT01110330|2667559|P3|NOT COMPLETED|Overall Study||26
1102283|NCT01110330|2667560|P2|NOT COMPLETED|Overall Study||23
1102284|NCT01110330|2667561|P1|NOT COMPLETED|Overall Study||15
1102285|NCT01110330|2667559|P3|COMPLETED|Overall Study||208
1102286|NCT01110330|2667560|P2|COMPLETED|Overall Study||207
1102287|NCT01110330|2667561|P1|COMPLETED|Overall Study||104
1102288|NCT01110330|2667559|P3|Positive Baseline Culture Set|Overall Study||114
1102289|NCT01110330|2667560|P2|Positive Baseline Culture Set|Overall Study||111
1102290|NCT01110330|2667561|P1|Positive Baseline Culture Set|Overall Study||56
1102291|NCT01110330|2667559|P3|STARTED|Overall Study||234
1102292|NCT01110330|2667560|P2|STARTED|Overall Study||230
1102293|NCT01110330|2667561|P1|STARTED|Overall Study||119
1102294|NCT01110382|2667574|P2|NOT COMPLETED|Overall Study||2
1102295|NCT01110382|2667575|P1|NOT COMPLETED|Overall Study||0
1102296|NCT01110382|2667574|P2|COMPLETED|Overall Study||8
1102297|NCT01110382|2667575|P1|COMPLETED|Overall Study||31
1102298|NCT01110382|2667574|P2|STARTED|Overall Study||10
1102299|NCT01110382|2667575|P1|STARTED|Overall Study||31
1102300|NCT01110408|2667595|P2|NOT COMPLETED|Overall Study||0
1102301|NCT01110408|2667596|P1|NOT COMPLETED|Overall Study||1
1102302|NCT01110408|2667595|P2|COMPLETED|Overall Study||10
1102303|NCT01110408|2667596|P1|COMPLETED|Overall Study||30
1102304|NCT01110408|2667595|P2|STARTED|Overall Study||10
1102305|NCT01110408|2667596|P1|STARTED|Overall Study||31
1102306|NCT01114945|2667618|P4|NOT COMPLETED|Overall Study||0
1102307|NCT01114945|2667619|P3|NOT COMPLETED|Overall Study||0
1102308|NCT01114945|2667620|P2|NOT COMPLETED|Overall Study||0
1102309|NCT01114945|2667621|P1|NOT COMPLETED|Overall Study||0
1102310|NCT01114945|2667618|P4|COMPLETED|Overall Study||31
1102311|NCT01114945|2667619|P3|COMPLETED|Overall Study||30
1102312|NCT01114945|2667620|P2|COMPLETED|Overall Study||30
1102313|NCT01114945|2667621|P1|COMPLETED|Overall Study||30
1102314|NCT01114945|2667618|P4|STARTED|Overall Study||31
1102315|NCT01114945|2667619|P3|STARTED|Overall Study||30
1102316|NCT01114945|2667620|P2|STARTED|Overall Study||30
1102317|NCT01114945|2667621|P1|STARTED|Overall Study||30
1102318|NCT01114997|2667646|P3|NOT COMPLETED|Overall Study||0
1102319|NCT01114997|2667647|P2|NOT COMPLETED|Overall Study||0
1102320|NCT01114997|2667648|P1|NOT COMPLETED|Overall Study||0
1102321|NCT01114997|2667646|P3|COMPLETED|Overall Study||11
1102322|NCT01114997|2667647|P2|COMPLETED|Overall Study||10
1102323|NCT01114997|2667648|P1|COMPLETED|Overall Study||11
1102324|NCT01114997|2667646|P3|STARTED|Overall Study||11
1102325|NCT01114997|2667647|P2|STARTED|Overall Study||10
1102326|NCT01114997|2667648|P1|STARTED|Overall Study||11
1102327|NCT01115101|2667676|P2|NOT COMPLETED|Overall Study||0
1102328|NCT01115101|2667677|P1|NOT COMPLETED|Overall Study||0
1102329|NCT01115101|2667676|P2|COMPLETED|Overall Study||126
1102330|NCT01115101|2667677|P1|COMPLETED|Overall Study||113
1102331|NCT01115101|2667676|P2|STARTED|Overall Study||126
1102332|NCT01115101|2667677|P1|STARTED|Overall Study||113
1102333|NCT01115166|2667683|P1|NOT COMPLETED|Overall Study||0
1102334|NCT01115166|2667683|P1|COMPLETED|Overall Study||10
1102335|NCT01115166|2667683|P1|STARTED|Overall Study||10
1102336|NCT01115452|2667689|P1|NOT COMPLETED|Overall Study||0
1102337|NCT01115452|2667689|P1|COMPLETED|Overall Study||32
1102338|NCT01115452|2667689|P1|STARTED|Overall Study||32
1102339|NCT01115491|2667739|P1|NOT COMPLETED|Overall Study||30
1102340|NCT01115491|2667739|P1|COMPLETED|Overall Study||2
1102341|NCT01115491|2667739|P1|STARTED|Overall Study||32
1102342|NCT01115517|2667750|P2|NOT COMPLETED|Overall Study||5
1102343|NCT01115517|2667751|P1|NOT COMPLETED|Overall Study||4
1102344|NCT01115517|2667750|P2|COMPLETED|Overall Study||16
1102345|NCT01115517|2667751|P1|COMPLETED|Overall Study||14
1102346|NCT01115517|2667750|P2|STARTED|Overall Study||21
1102347|NCT01115517|2667751|P1|STARTED|Overall Study||18
1102348|NCT01115556|2667763|P2|NOT COMPLETED|Overall Study||0
1102349|NCT01115556|2667764|P1|NOT COMPLETED|Overall Study||0
1102350|NCT01115556|2667763|P2|COMPLETED|Overall Study||2
1102351|NCT01115556|2667764|P1|COMPLETED|Overall Study||7
1102352|NCT01115556|2667763|P2|STARTED|Overall Study||2
1102353|NCT01115556|2667764|P1|STARTED|Overall Study||7
1102354|NCT01115569|2667772|P2|NOT COMPLETED|Maintenance Phase||139
1102355|NCT01115569|2667773|P1|NOT COMPLETED|Maintenance Phase||0
1102356|NCT01115569|2667772|P2|COMPLETED|Maintenance Phase||285
1102357|NCT01115569|2667773|P1|COMPLETED|Maintenance Phase||0
1102358|NCT01115569|2667772|P2|STARTED|Maintenance Phase||424
1102359|NCT01115569|2667773|P1|STARTED|Maintenance Phase||0
1102360|NCT01115569|2667772|P2|NOT COMPLETED|Conversion/Titration Phase||0
1102361|NCT01115569|2667773|P1|NOT COMPLETED|Conversion/Titration Phase||214
1102362|NCT01115569|2667772|P2|COMPLETED|Conversion/Titration Phase||0
1102363|NCT01115569|2667773|P1|COMPLETED|Conversion/Titration Phase||424
1102364|NCT01115569|2667772|P2|STARTED|Conversion/Titration Phase||0
1102365|NCT01115569|2667773|P1|STARTED|Conversion/Titration Phase||638
1102366|NCT01115582|2667778|P1|NOT COMPLETED|Overall Study||0
1102367|NCT01115582|2667778|P1|COMPLETED|Overall Study||16
1102368|NCT01115582|2667778|P1|STARTED|Overall Study||16
1102369|NCT01115660|2667789|P2|NOT COMPLETED|Overall Study||0
1102370|NCT01115660|2667790|P1|NOT COMPLETED|Overall Study||1
1102371|NCT01115660|2667789|P2|COMPLETED|Overall Study||10
1102372|NCT01115660|2667790|P1|COMPLETED|Overall Study||19
1102373|NCT01115660|2667789|P2|STARTED|Overall Study||10
1102374|NCT01115660|2667790|P1|STARTED|Overall Study||20
1102375|NCT01115673|2667801|P3|NOT COMPLETED|Overall Study||0
1102376|NCT01115673|2667802|P2|NOT COMPLETED|Overall Study||0
1102377|NCT01115673|2667803|P1|NOT COMPLETED|Overall Study||0
1102378|NCT01115673|2667801|P3|COMPLETED|Overall Study||60
1102379|NCT01115673|2667802|P2|COMPLETED|Overall Study||241
1102380|NCT01115673|2667803|P1|COMPLETED|Overall Study||239
1102381|NCT01115673|2667801|P3|STARTED|Overall Study||60
1102382|NCT01115673|2667802|P2|STARTED|Overall Study||241
1102383|NCT01115673|2667803|P1|STARTED|Overall Study||239
1102384|NCT01115699|2667937|P1|NOT COMPLETED|Overall Study||0
1102385|NCT01115699|2667937|P1|COMPLETED|Overall Study||2
1102386|NCT01115699|2667937|P1|STARTED|Overall Study||2
1102387|NCT01115738|2667945|P3|NOT COMPLETED|Overall Study||27
1102388|NCT01115738|2667946|P2|NOT COMPLETED|Overall Study||21
1102389|NCT01115738|2667947|P1|NOT COMPLETED|Overall Study||25
1102390|NCT01115738|2667945|P3|COMPLETED|Overall Study||62
1102391|NCT01115738|2667946|P2|COMPLETED|Overall Study||62
1102392|NCT01115738|2667947|P1|COMPLETED|Overall Study||85
1102393|NCT01115738|2667945|P3|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|50
1102394|NCT01115738|2667946|P2|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|47
1102395|NCT01115738|2667947|P1|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|52
1102396|NCT01115738|2667945|P3|Received Any Treatment|Overall Study||88
1102397|NCT01115738|2667946|P2|Received Any Treatment|Overall Study||79
1102398|NCT01115738|2667947|P1|Received Any Treatment|Overall Study||109
1102399|NCT01115738|2667945|P3|STARTED|Overall Study||89
1102400|NCT01115738|2667946|P2|STARTED|Overall Study||83
1102401|NCT01115738|2667947|P1|STARTED|Overall Study||110
1102402|NCT01115855|2667983|P2|NOT COMPLETED|Overall Study||36
1102403|NCT01115855|2667984|P1|NOT COMPLETED|Overall Study||36
1102404|NCT01115855|2667983|P2|COMPLETED|Overall Study||74
1102405|NCT01115855|2667984|P1|COMPLETED|Overall Study||75
1102406|NCT01115855|2667983|P2|STARTED|Overall Study||110
1102407|NCT01115855|2667984|P1|STARTED|Overall Study||111
1102408|NCT01115933|2668032|P1|NOT COMPLETED|Overall Study||1
1102409|NCT01115933|2668032|P1|COMPLETED|Overall Study||64
1102410|NCT01115933|2668032|P1|STARTED|Overall Study||65
1102411|NCT01115998|2668129|P2|NOT COMPLETED|Overall Study||6
1102412|NCT01115998|2668130|P1|NOT COMPLETED|Overall Study||6
1102413|NCT01115998|2668129|P2|COMPLETED|Overall Study||11
1102414|NCT01115998|2668130|P1|COMPLETED|Overall Study||11
1102415|NCT01115998|2668129|P2|STARTED|Overall Study||17
1102416|NCT01115998|2668130|P1|STARTED|Overall Study||17
1102417|NCT01116024|2668140|P1|NOT COMPLETED|Overall Study||52
1102418|NCT01116024|2668140|P1|COMPLETED|Overall Study|Patient Enrollment stop date|96
1102419|NCT01116024|2668140|P1|STARTED|Overall Study|Patient Enrollment start date|148
1102420|NCT01116037|2668179|P1|NOT COMPLETED|Overall Study||25
1102421|NCT01116037|2668179|P1|COMPLETED|Overall Study||1
1102422|NCT01116037|2668179|P1|STARTED|Overall Study||26
1102423|NCT01116102|2668192|P8|NOT COMPLETED|Overall Study||0
1102424|NCT01116102|2668193|P7|NOT COMPLETED|Overall Study||0
1102425|NCT01116102|2668194|P6|NOT COMPLETED|Overall Study||0
1102426|NCT01116102|2668195|P5|NOT COMPLETED|Overall Study||0
1102427|NCT01116102|2668196|P4|NOT COMPLETED|Overall Study||0
1102428|NCT01116102|2668197|P3|NOT COMPLETED|Overall Study||0
1102429|NCT01116102|2668198|P2|NOT COMPLETED|Overall Study||0
1102430|NCT01116102|2668199|P1|NOT COMPLETED|Overall Study||0
1102431|NCT01116102|2668192|P8|COMPLETED|Overall Study||3
1102432|NCT01116102|2668193|P7|COMPLETED|Overall Study||2
1102433|NCT01116102|2668194|P6|COMPLETED|Overall Study||2
1102434|NCT01116102|2668195|P5|COMPLETED|Overall Study||2
1102435|NCT01116102|2668196|P4|COMPLETED|Overall Study||3
1102436|NCT01116102|2668197|P3|COMPLETED|Overall Study||3
1102437|NCT01116102|2668198|P2|COMPLETED|Overall Study||3
1102438|NCT01116102|2668199|P1|COMPLETED|Overall Study||2
1102439|NCT01116102|2668192|P8|STARTED|Overall Study||3
1102440|NCT01116102|2668193|P7|STARTED|Overall Study||2
1102441|NCT01116102|2668194|P6|STARTED|Overall Study||2
1102442|NCT01116102|2668195|P5|STARTED|Overall Study||2
1102443|NCT01116102|2668196|P4|STARTED|Overall Study||3
1102444|NCT01116102|2668197|P3|STARTED|Overall Study||3
1102445|NCT01116102|2668198|P2|STARTED|Overall Study||3
1102446|NCT01116102|2668199|P1|STARTED|Overall Study||2
1102447|NCT01116232|2668241|P1|NOT COMPLETED|Overall Study||4
1102448|NCT01116232|2668241|P1|COMPLETED|Overall Study||0
1102449|NCT01116232|2668241|P1|STARTED|Overall Study||4
1102462|NCT01116466|2668285|P1|NOT COMPLETED|Overall Study||0
1102463|NCT01116466|2668285|P1|COMPLETED|Overall Study||5
1102464|NCT01116466|2668285|P1|STARTED|Overall Study||5
1102465|NCT01116687|2668293|P1|NOT COMPLETED|Overall Study||4
1102466|NCT01116687|2668293|P1|COMPLETED|Overall Study||33
1102467|NCT01116687|2668293|P1|STARTED|Overall Study||37
1102468|NCT01116882|2668302|P2|NOT COMPLETED|12-month||99
1102469|NCT01116882|2668303|P1|NOT COMPLETED|12-month||267
1102470|NCT01116882|2668302|P2|COMPLETED|12-month||787
1102471|NCT01116882|2668303|P1|COMPLETED|12-month||2439
1102472|NCT01116882|2668302|P2|STARTED|12-month||886
1102473|NCT01116882|2668303|P1|STARTED|12-month||2706
1102474|NCT01116882|2668302|P2|NOT COMPLETED|30-day||31
1102475|NCT01116882|2668303|P1|NOT COMPLETED|30-day||68
1102476|NCT01116882|2668302|P2|COMPLETED|30-day||886
1102477|NCT01116882|2668303|P1|COMPLETED|30-day||2706
1102478|NCT01116882|2668302|P2|STARTED|30-day||917
1102479|NCT01116882|2668303|P1|STARTED|30-day||2774
1102480|NCT01116921|2668343|P2|NOT COMPLETED|Overall Study||0
1102481|NCT01116921|2668344|P1|NOT COMPLETED|Overall Study||0
1102482|NCT01116921|2668343|P2|COMPLETED|Overall Study||50
1102483|NCT01116921|2668344|P1|COMPLETED|Overall Study||53
1102484|NCT01116921|2668343|P2|STARTED|Overall Study||50
1102485|NCT01116921|2668344|P1|STARTED|Overall Study||53
1102486|NCT01116934|2668362|P2|NOT COMPLETED|Overall Study||0
1102487|NCT01116934|2668363|P1|NOT COMPLETED|Overall Study||0
1102488|NCT01116934|2668362|P2|COMPLETED|Overall Study||9
1102489|NCT01116934|2668363|P1|COMPLETED|Overall Study||8
1102490|NCT01116934|2668362|P2|STARTED|Overall Study||9
1102491|NCT01116934|2668363|P1|STARTED|Overall Study||8
1102492|NCT01116986|2668401|P32|NOT COMPLETED|Overall Study||3
1102493|NCT01116986|2668402|P31|NOT COMPLETED|Overall Study||1
1102494|NCT01116986|2668403|P30|NOT COMPLETED|Overall Study||0
1102495|NCT01116986|2668404|P29|NOT COMPLETED|Overall Study||0
1102496|NCT01116986|2668405|P28|NOT COMPLETED|Overall Study||1
1102497|NCT01116986|2668406|P27|NOT COMPLETED|Overall Study||4
1102498|NCT01116986|2668407|P26|NOT COMPLETED|Overall Study||0
1102499|NCT01116986|2668408|P25|NOT COMPLETED|Overall Study||3
1102500|NCT01116986|2668409|P24|NOT COMPLETED|Overall Study||2
1102501|NCT01116986|2668410|P23|NOT COMPLETED|Overall Study||4
1102502|NCT01116986|2668411|P22|NOT COMPLETED|Overall Study||2
1102503|NCT01116986|2668412|P21|NOT COMPLETED|Overall Study||2
1102504|NCT01116986|2668413|P20|NOT COMPLETED|Overall Study||2
1102505|NCT01116986|2668414|P19|NOT COMPLETED|Overall Study||3
1102506|NCT01116986|2668415|P18|NOT COMPLETED|Overall Study||5
1102507|NCT01116986|2668416|P17|NOT COMPLETED|Overall Study||3
1102508|NCT01116986|2668417|P16|NOT COMPLETED|Overall Study||6
1102509|NCT01116986|2668418|P15|NOT COMPLETED|Overall Study||0
1102510|NCT01116986|2668419|P14|NOT COMPLETED|Overall Study||3
1102511|NCT01116986|2668420|P13|NOT COMPLETED|Overall Study||1
1102512|NCT01116986|2668421|P12|NOT COMPLETED|Overall Study||0
1102513|NCT01116986|2668422|P11|NOT COMPLETED|Overall Study||1
1102514|NCT01116986|2668423|P10|NOT COMPLETED|Overall Study||4
1102515|NCT01116986|2668424|P9|NOT COMPLETED|Overall Study||1
1102516|NCT01116986|2668425|P8|NOT COMPLETED|Overall Study||2
1102517|NCT01116986|2668426|P7|NOT COMPLETED|Overall Study||2
1102518|NCT01116986|2668427|P6|NOT COMPLETED|Overall Study||2
1102519|NCT01116986|2668428|P5|NOT COMPLETED|Overall Study||4
1102520|NCT01116986|2668429|P4|NOT COMPLETED|Overall Study||2
1102521|NCT01116986|2668430|P3|NOT COMPLETED|Overall Study||2
1102522|NCT01116986|2668431|P2|NOT COMPLETED|Overall Study||3
1102523|NCT01116986|2668432|P1|NOT COMPLETED|Overall Study||2
1102524|NCT01116986|2668401|P32|COMPLETED|Overall Study||14
1102525|NCT01116986|2668402|P31|COMPLETED|Overall Study||16
1102526|NCT01116986|2668403|P30|COMPLETED|Overall Study||17
1102527|NCT01116986|2668404|P29|COMPLETED|Overall Study||17
1102528|NCT01116986|2668405|P28|COMPLETED|Overall Study||18
1102529|NCT01116986|2668406|P27|COMPLETED|Overall Study||14
1102530|NCT01116986|2668407|P26|COMPLETED|Overall Study||19
1102531|NCT01116986|2668408|P25|COMPLETED|Overall Study||15
1102532|NCT01116986|2668409|P24|COMPLETED|Overall Study||19
1102533|NCT01116986|2668410|P23|COMPLETED|Overall Study||19
1102534|NCT01116986|2668411|P22|COMPLETED|Overall Study||18
1102535|NCT01116986|2668412|P21|COMPLETED|Overall Study||22
1102536|NCT01116986|2668413|P20|COMPLETED|Overall Study||13
1102537|NCT01116986|2668414|P19|COMPLETED|Overall Study||20
1102538|NCT01116986|2668415|P18|COMPLETED|Overall Study||19
1102539|NCT01116986|2668416|P17|COMPLETED|Overall Study||13
1102540|NCT01116986|2668417|P16|COMPLETED|Overall Study||15
1102541|NCT01116986|2668418|P15|COMPLETED|Overall Study||17
1102542|NCT01116986|2668419|P14|COMPLETED|Overall Study||16
1102543|NCT01116986|2668420|P13|COMPLETED|Overall Study||16
1102544|NCT01116986|2668421|P12|COMPLETED|Overall Study||20
1102545|NCT01116986|2668422|P11|COMPLETED|Overall Study||18
1102546|NCT01116986|2668423|P10|COMPLETED|Overall Study||19
1102547|NCT01116986|2668424|P9|COMPLETED|Overall Study||19
1102548|NCT01116986|2668425|P8|COMPLETED|Overall Study||20
1102549|NCT01116986|2668426|P7|COMPLETED|Overall Study||20
1102550|NCT01116986|2668427|P6|COMPLETED|Overall Study||20
1102551|NCT01116986|2668428|P5|COMPLETED|Overall Study||20
1102552|NCT01116986|2668429|P4|COMPLETED|Overall Study||20
1102553|NCT01116986|2668430|P3|COMPLETED|Overall Study||16
1102554|NCT01116986|2668431|P2|COMPLETED|Overall Study||16
1102555|NCT01116986|2668432|P1|COMPLETED|Overall Study||22
1102556|NCT01116986|2668401|P32|STARTED|Overall Study||17
1102557|NCT01116986|2668402|P31|STARTED|Overall Study||17
1102558|NCT01116986|2668403|P30|STARTED|Overall Study||17
1102559|NCT01116986|2668404|P29|STARTED|Overall Study||17
1102560|NCT01116986|2668405|P28|STARTED|Overall Study||19
1102561|NCT01116986|2668406|P27|STARTED|Overall Study||18
1102562|NCT01116986|2668407|P26|STARTED|Overall Study||19
1102563|NCT01116986|2668408|P25|STARTED|Overall Study||18
1102564|NCT01116986|2668409|P24|STARTED|Overall Study||21
1102565|NCT01116986|2668410|P23|STARTED|Overall Study||23
1102566|NCT01116986|2668411|P22|STARTED|Overall Study||20
1102567|NCT01116986|2668412|P21|STARTED|Overall Study||24
1102568|NCT01116986|2668413|P20|STARTED|Overall Study||15
1102569|NCT01116986|2668414|P19|STARTED|Overall Study||23
1102570|NCT01116986|2668415|P18|STARTED|Overall Study||24
1102571|NCT01116986|2668416|P17|STARTED|Overall Study||16
1102572|NCT01116986|2668417|P16|STARTED|Overall Study||21
1102573|NCT01116986|2668418|P15|STARTED|Overall Study||17
1102574|NCT01116986|2668419|P14|STARTED|Overall Study||19
1102575|NCT01116986|2668420|P13|STARTED|Overall Study||17
1102576|NCT01116986|2668421|P12|STARTED|Overall Study||20
1102577|NCT01116986|2668422|P11|STARTED|Overall Study||19
1102578|NCT01116986|2668423|P10|STARTED|Overall Study||23
1102579|NCT01116986|2668424|P9|STARTED|Overall Study||20
1102580|NCT01116986|2668425|P8|STARTED|Overall Study||22
1102581|NCT01116986|2668426|P7|STARTED|Overall Study||22
1102582|NCT01116986|2668427|P6|STARTED|Overall Study||22
1102583|NCT01116986|2668428|P5|STARTED|Overall Study||24
1102584|NCT01116986|2668429|P4|STARTED|Overall Study||22
1102585|NCT01116986|2668430|P3|STARTED|Overall Study||18
1102586|NCT01116986|2668431|P2|STARTED|Overall Study||19
1102587|NCT01116986|2668432|P1|STARTED|Overall Study||24
1102588|NCT01117012|2668466|P2|NOT COMPLETED|Overall Study||5
1102589|NCT01117012|2668467|P1|NOT COMPLETED|Overall Study||8
1102590|NCT01117012|2668466|P2|COMPLETED|Overall Study||98
1102591|NCT01117012|2668467|P1|COMPLETED|Overall Study||81
1102592|NCT01117012|2668466|P2|STARTED|Overall Study||103
1102593|NCT01117012|2668467|P1|STARTED|Overall Study||89
1102594|NCT01117051|2668485|P2|NOT COMPLETED|Overall Study||11
1102595|NCT01117051|2668486|P1|NOT COMPLETED|Overall Study||13
1102596|NCT01117051|2668485|P2|COMPLETED|Overall Study||77
1102597|NCT01117051|2668486|P1|COMPLETED|Overall Study||73
1102598|NCT01117051|2668485|P2|STARTED|Overall Study||88
1102599|NCT01117051|2668486|P1|STARTED|Overall Study||86
1102600|NCT01117090|2668494|P1|NOT COMPLETED|Overall Study||0
1102601|NCT01117090|2668494|P1|COMPLETED|Overall Study||47
1102602|NCT01117090|2668494|P1|STARTED|Overall Study||47
1102603|NCT01117181|2668507|P2|NOT COMPLETED|Overall Study||2
1102604|NCT01117181|2668508|P1|NOT COMPLETED|Overall Study||1
1102605|NCT01117181|2668507|P2|COMPLETED|Overall Study||29
1102606|NCT01117181|2668508|P1|COMPLETED|Overall Study||28
1102607|NCT01117181|2668507|P2|STARTED|Overall Study||31
1102608|NCT01117181|2668508|P1|STARTED|Overall Study||29
1102609|NCT01117311|2668526|P2|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
1102610|NCT01117311|2668527|P1|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
1102611|NCT01117311|2668526|P2|COMPLETED|Second Intervention - Mixed Meal 3||4
1102612|NCT01117311|2668527|P1|COMPLETED|Second Intervention - Mixed Meal 3||3
1102613|NCT01117311|2668526|P2|STARTED|Second Intervention - Mixed Meal 3||4
1102614|NCT01117311|2668527|P1|STARTED|Second Intervention - Mixed Meal 3||3
1102615|NCT01117311|2668526|P2|NOT COMPLETED|First Intervention - Mixed Meal 2||0
1102616|NCT01117311|2668527|P1|NOT COMPLETED|First Intervention - Mixed Meal 2||0
1102617|NCT01117311|2668526|P2|COMPLETED|First Intervention - Mixed Meal 2||4
1102618|NCT01117311|2668527|P1|COMPLETED|First Intervention - Mixed Meal 2||3
1102619|NCT01117311|2668526|P2|STARTED|First Intervention - Mixed Meal 2||4
1102620|NCT01117311|2668527|P1|STARTED|First Intervention - Mixed Meal 2||3
1102621|NCT01117311|2668526|P2|NOT COMPLETED|Lead-in Mixed Meal 1||0
1102622|NCT01117311|2668527|P1|NOT COMPLETED|Lead-in Mixed Meal 1||0
1102623|NCT01117311|2668526|P2|COMPLETED|Lead-in Mixed Meal 1||4
1102624|NCT01117311|2668527|P1|COMPLETED|Lead-in Mixed Meal 1||3
1102625|NCT01117311|2668526|P2|STARTED|Lead-in Mixed Meal 1||4
1102626|NCT01117311|2668527|P1|STARTED|Lead-in Mixed Meal 1||3
1102627|NCT01117337|2668537|P2|NOT COMPLETED|Overall Study||0
1102628|NCT01117337|2668538|P1|NOT COMPLETED|Overall Study||4
1102629|NCT01117337|2668537|P2|COMPLETED|Overall Study||52
1102630|NCT01117337|2668538|P1|COMPLETED|Overall Study|48 completed one year follow-up. 4 lost to follow-up.|48
1102631|NCT01117337|2668537|P2|Underwent Surgery|Overall Study||52
1102632|NCT01117337|2668538|P1|Underwent Surgery|Overall Study|52 patients underwent surgery|52
1102633|NCT01117337|2668537|P2|STARTED|Overall Study||52
1102634|NCT01117337|2668538|P1|STARTED|Overall Study|52 pateints on inguinal hernia were randomized to mesh fixation group|52
1102635|NCT01117350|2668550|P2|NOT COMPLETED|Extension Period||63
1102636|NCT01117350|2668551|P1|NOT COMPLETED|Extension Period||0
1102637|NCT01117350|2668550|P2|COMPLETED|Extension Period||147
1102638|NCT01117350|2668551|P1|COMPLETED|Extension Period||0
1102639|NCT01117350|2668550|P2|mITT Population (Extension)|Extension Period|mITT (extension): treated patients with at least 1 efficacy value both at entry and during extension|154
1102640|NCT01117350|2668551|P1|mITT Population (Extension)|Extension Period||0
1102641|NCT01117350|2668550|P2|TREATED = Safety Population (Extension)|Extension Period|Safety population (extension): treated with insulin glargine during the extension period|160
1102642|NCT01117350|2668551|P1|TREATED = Safety Population (Extension)|Extension Period||0
1102643|NCT01117350|2668550|P2|STARTED|Extension Period|STARTED: patients having completed the comparative period and eligible for the extension period|210
1102644|NCT01117350|2668551|P1|STARTED|Extension Period||0
1102645|NCT01117350|2668550|P2|NOT COMPLETED|Comparative Period||75
1102646|NCT01117350|2668551|P1|NOT COMPLETED|Comparative Period||42
1102647|NCT01117350|2668550|P2|COMPLETED|Comparative Period||414
1102648|NCT01117350|2668551|P1|COMPLETED|Comparative Period||447
1102649|NCT01117350|2668550|P2|mITT Population|Comparative Period||470
1102650|NCT01117350|2668551|P1|mITT Population|Comparative Period|modified Intent-To-Treat population: treated patients with at least one efficacy post-baseline value|474
1102651|NCT01117350|2668550|P2|TREATED = Safety Population|Comparative Period||481
1102652|NCT01117350|2668551|P1|TREATED = Safety Population|Comparative Period|Safety population: all randomized and treated patients (received at least one dose)|484
1102653|NCT01117350|2668550|P2|STARTED|Comparative Period||489
1102654|NCT01117350|2668551|P1|STARTED|Comparative Period|STARTED: randomized|489
1102655|NCT01117428|2668587|P6|NOT COMPLETED|Overall Study||20
1102656|NCT01117428|2668588|P5|NOT COMPLETED|Overall Study||17
1102657|NCT01117428|2668589|P4|NOT COMPLETED|Overall Study||12
1102658|NCT01117428|2668590|P3|NOT COMPLETED|Overall Study||13
1102659|NCT01117428|2668591|P2|NOT COMPLETED|Overall Study||29
1102660|NCT01117428|2668592|P1|NOT COMPLETED|Overall Study||20
1102661|NCT01117428|2668587|P6|COMPLETED|Overall Study||0
1102662|NCT01117428|2668588|P5|COMPLETED|Overall Study||0
1102663|NCT01117428|2668589|P4|COMPLETED|Overall Study||0
1102664|NCT01117428|2668590|P3|COMPLETED|Overall Study||0
1102665|NCT01117428|2668591|P2|COMPLETED|Overall Study||0
1102666|NCT01117428|2668592|P1|COMPLETED|Overall Study||0
1102667|NCT01117428|2668587|P6|STARTED|Overall Study||20
1102668|NCT01117428|2668588|P5|STARTED|Overall Study||17
1102669|NCT01117428|2668589|P4|STARTED|Overall Study||12
1102670|NCT01117428|2668590|P3|STARTED|Overall Study||13
1102671|NCT01117428|2668591|P2|STARTED|Overall Study||29
1102672|NCT01117428|2668592|P1|STARTED|Overall Study|"0.4 mg/kg=1
0.75 mg/kg=1
1.5 mg/kg=3
3 mg/kg=3
6 mg/kg=3
9 mg/kg=6
12 mg/kg=3"|20
1102673|NCT01107535|2668624|P1|NOT COMPLETED|Overall Study||5
1102674|NCT01107535|2668624|P1|COMPLETED|Overall Study||77
1102675|NCT01107535|2668624|P1|Number of Participants Analyzed|Overall Study||82
1102676|NCT01107535|2668624|P1|STARTED|Overall Study||82
1102677|NCT01117454|2668634|P2|NOT COMPLETED|Overall Study||1
1102678|NCT01117454|2668635|P1|NOT COMPLETED|Overall Study||0
1102679|NCT01117454|2668634|P2|COMPLETED|Overall Study||7
1102680|NCT01117454|2668635|P1|COMPLETED|Overall Study||6
1102681|NCT01117454|2668634|P2|STARTED|Overall Study||8
1102682|NCT01117454|2668635|P1|STARTED|Overall Study||6
1102683|NCT01117480|2668641|P1|NOT COMPLETED|Overall Study||28
1102684|NCT01117480|2668641|P1|COMPLETED|Overall Study||985
1102685|NCT01117480|2668641|P1|STARTED|Overall Study||1013
1102686|NCT01117623|2668655|P8|NOT COMPLETED|Overall Study||26
1102687|NCT01117623|2668656|P7|NOT COMPLETED|Overall Study||6
1102688|NCT01117623|2668657|P6|NOT COMPLETED|Overall Study||16
1102689|NCT01117623|2668658|P5|NOT COMPLETED|Overall Study||10
1102690|NCT01117623|2668659|P4|NOT COMPLETED|Overall Study||6
1102691|NCT01117623|2668660|P3|NOT COMPLETED|Overall Study||11
1102692|NCT01117623|2668661|P2|NOT COMPLETED|Overall Study||8
1102693|NCT01117623|2668662|P1|NOT COMPLETED|Overall Study||3
1102694|NCT01117623|2668655|P8|COMPLETED|Overall Study||0
1102695|NCT01117623|2668656|P7|COMPLETED|Overall Study||0
1102696|NCT01117623|2668657|P6|COMPLETED|Overall Study||0
1102697|NCT01117623|2668658|P5|COMPLETED|Overall Study||0
1102698|NCT01117623|2668659|P4|COMPLETED|Overall Study||0
1102699|NCT01117623|2668660|P3|COMPLETED|Overall Study||0
1102700|NCT01117623|2668661|P2|COMPLETED|Overall Study||0
1102701|NCT01117623|2668662|P1|COMPLETED|Overall Study||0
1102702|NCT01117623|2668655|P8|PK Population|Overall Study||24
1102703|NCT01117623|2668656|P7|PK Population|Overall Study||6
1102704|NCT01117623|2668657|P6|PK Population|Overall Study||14
1102705|NCT01117623|2668658|P5|PK Population|Overall Study||10
1102706|NCT01117623|2668659|P4|PK Population|Overall Study||6
1102707|NCT01117623|2668660|P3|PK Population|Overall Study||10
1102708|NCT01117623|2668661|P2|PK Population|Overall Study||8
1102709|NCT01117623|2668662|P1|PK Population|Overall Study||3
1102710|NCT01117623|2668655|P8|ITT Efficacy Analysis Population|Overall Study||22
1102711|NCT01117623|2668656|P7|ITT Efficacy Analysis Population|Overall Study||6
1102712|NCT01117623|2668657|P6|ITT Efficacy Analysis Population|Overall Study||16
1102713|NCT01117623|2668658|P5|ITT Efficacy Analysis Population|Overall Study||10
1102714|NCT01117623|2668659|P4|ITT Efficacy Analysis Population|Overall Study||5
1102715|NCT01117623|2668660|P3|ITT Efficacy Analysis Population|Overall Study||11
1102716|NCT01117623|2668661|P2|ITT Efficacy Analysis Population|Overall Study||8
1102717|NCT01117623|2668662|P1|ITT Efficacy Analysis Population|Overall Study||3
1102718|NCT01117623|2668655|P8|STARTED|Overall Study||26
1102719|NCT01117623|2668656|P7|STARTED|Overall Study||6
1102720|NCT01117623|2668657|P6|STARTED|Overall Study||16
1102721|NCT01117623|2668658|P5|STARTED|Overall Study||10
1102722|NCT01117623|2668659|P4|STARTED|Overall Study||6
1102723|NCT01117623|2668660|P3|STARTED|Overall Study||11
1102724|NCT01117623|2668661|P2|STARTED|Overall Study||8
1102725|NCT01117623|2668662|P1|STARTED|Overall Study||3
1102726|NCT01117727|2668814|P1|NOT COMPLETED|Overall Study||0
1102727|NCT01117727|2668814|P1|COMPLETED|Overall Study||1
1102728|NCT01117727|2668814|P1|STARTED|Overall Study||1
1102729|NCT01117766|2668819|P2|NOT COMPLETED|Second Intervention||5
1102730|NCT01117766|2668820|P1|NOT COMPLETED|Second Intervention||2
1102731|NCT01117766|2668819|P2|COMPLETED|Second Intervention||9
1102732|NCT01117766|2668820|P1|COMPLETED|Second Intervention||11
1102733|NCT01117766|2668819|P2|STARTED|Second Intervention||14
1102734|NCT01117766|2668820|P1|STARTED|Second Intervention||13
1102735|NCT01117766|2668819|P2|NOT COMPLETED|Washout Period||2
1102736|NCT01117766|2668820|P1|NOT COMPLETED|Washout Period||0
1102737|NCT01117766|2668819|P2|COMPLETED|Washout Period||14
1102738|NCT01117766|2668820|P1|COMPLETED|Washout Period||13
1102739|NCT01117766|2668819|P2|STARTED|Washout Period||16
1102740|NCT01117766|2668820|P1|STARTED|Washout Period||13
1102741|NCT01117766|2668819|P2|NOT COMPLETED|First Intervention||1
1102742|NCT01117766|2668820|P1|NOT COMPLETED|First Intervention||1
1102743|NCT01117766|2668819|P2|COMPLETED|First Intervention||16
1102744|NCT01117766|2668820|P1|COMPLETED|First Intervention||13
1102745|NCT01117766|2668819|P2|Received Treatment|First Intervention||17
1102746|NCT01117766|2668820|P1|Received Treatment|First Intervention||14
1102747|NCT01117766|2668819|P2|STARTED|First Intervention||17
1102748|NCT01117766|2668820|P1|STARTED|First Intervention||14
1102749|NCT01119001|2668844|P1|NOT COMPLETED|Overall Study||2
1102750|NCT01119001|2668844|P1|COMPLETED|Overall Study||11
1102751|NCT01119001|2668844|P1|STARTED|Overall Study||13
1102752|NCT01119040|2668850|P1|NOT COMPLETED|Overall Study||1
1102753|NCT01119040|2668850|P1|COMPLETED|Overall Study||0
1102754|NCT01119040|2668850|P1|STARTED|Overall Study||1
1102755|NCT01119118|2668854|P1|NOT COMPLETED|Overall Study||1
1102756|NCT01119118|2668854|P1|COMPLETED|Overall Study||5
1102757|NCT01119118|2668854|P1|STARTED|Overall Study||6
1102758|NCT01119131|2668865|P3|NOT COMPLETED|Overall Study||6
1102759|NCT01119131|2668866|P2|NOT COMPLETED|Overall Study||1
1102760|NCT01119131|2668867|P1|NOT COMPLETED|Overall Study||2
1102761|NCT01119131|2668865|P3|COMPLETED|Overall Study||24
1102762|NCT01119131|2668866|P2|COMPLETED|Overall Study||27
1102763|NCT01119131|2668867|P1|COMPLETED|Overall Study||8
1102764|NCT01119131|2668865|P3|STARTED|Overall Study||30
1102765|NCT01119131|2668866|P2|STARTED|Overall Study||28
1102766|NCT01119131|2668867|P1|STARTED|Overall Study||10
1102767|NCT01119222|2668896|P4|NOT COMPLETED|Overall Study||0
1102768|NCT01119222|2668897|P3|NOT COMPLETED|Overall Study||0
1102769|NCT01119222|2668898|P2|NOT COMPLETED|Overall Study||0
1102770|NCT01119222|2668899|P1|NOT COMPLETED|Overall Study||0
1102771|NCT01119222|2668896|P4|COMPLETED|Overall Study||4
1102772|NCT01119222|2668897|P3|COMPLETED|Overall Study||5
1102773|NCT01119222|2668898|P2|COMPLETED|Overall Study||5
1102774|NCT01119222|2668899|P1|COMPLETED|Overall Study||5
1102775|NCT01119222|2668896|P4|STARTED|Overall Study||4
1102776|NCT01119222|2668897|P3|STARTED|Overall Study||5
1102777|NCT01119222|2668898|P2|STARTED|Overall Study||5
1102778|NCT01119222|2668899|P1|STARTED|Overall Study||5
1102779|NCT01119287|2668943|P6|NOT COMPLETED|Overall Study||0
1102780|NCT01119287|2668944|P5|NOT COMPLETED|Overall Study||1
1102781|NCT01119287|2668945|P4|NOT COMPLETED|Overall Study||2
1102782|NCT01119287|2668946|P3|NOT COMPLETED|Overall Study||2
1102783|NCT01119287|2668947|P2|NOT COMPLETED|Overall Study||0
1102784|NCT01119287|2668948|P1|NOT COMPLETED|Overall Study||0
1102785|NCT01119287|2668943|P6|COMPLETED|Overall Study||32
1102786|NCT01119287|2668944|P5|COMPLETED|Overall Study||30
1102787|NCT01119287|2668945|P4|COMPLETED|Overall Study||29
1102788|NCT01119287|2668946|P3|COMPLETED|Overall Study||24
1102789|NCT01119287|2668947|P2|COMPLETED|Overall Study||24
1102790|NCT01119287|2668948|P1|COMPLETED|Overall Study||26
1102791|NCT01119287|2668943|P6|STARTED|Overall Study||32
1102792|NCT01119287|2668944|P5|STARTED|Overall Study||31
1102793|NCT01119287|2668945|P4|STARTED|Overall Study||31
1102794|NCT01119287|2668946|P3|STARTED|Overall Study||26
1102795|NCT01119287|2668947|P2|STARTED|Overall Study||24
1102796|NCT01119287|2668948|P1|STARTED|Overall Study||26
1102797|NCT01119443|2668963|P2|NOT COMPLETED|End of Study (All Patients)||0
1102798|NCT01119443|2668964|P1|NOT COMPLETED|End of Study (All Patients)||0
1102799|NCT01119443|2668963|P2|COMPLETED|End of Study (All Patients)||14
1102800|NCT01119443|2668964|P1|COMPLETED|End of Study (All Patients)||14
1102801|NCT01119443|2668963|P2|STARTED|End of Study (All Patients)||14
1102802|NCT01119443|2668964|P1|STARTED|End of Study (All Patients)||14
1102803|NCT01119443|2668963|P2|NOT COMPLETED|Down-titration Period (1 Day)||0
1102804|NCT01119443|2668964|P1|NOT COMPLETED|Down-titration Period (1 Day)||0
1102805|NCT01119443|2668963|P2|COMPLETED|Down-titration Period (1 Day)||13
1102806|NCT01119443|2668964|P1|COMPLETED|Down-titration Period (1 Day)||14
1102807|NCT01119443|2668963|P2|STARTED|Down-titration Period (1 Day)||13
1102808|NCT01119443|2668964|P1|STARTED|Down-titration Period (1 Day)||14
1102809|NCT01119443|2668963|P2|NOT COMPLETED|Crossover Period 4 (5 Days)||0
1102810|NCT01119443|2668964|P1|NOT COMPLETED|Crossover Period 4 (5 Days)||0
1102811|NCT01119443|2668963|P2|COMPLETED|Crossover Period 4 (5 Days)||13
1102812|NCT01119443|2668964|P1|COMPLETED|Crossover Period 4 (5 Days)||14
1102813|NCT01119443|2668963|P2|STARTED|Crossover Period 4 (5 Days)||13
1102814|NCT01119443|2668964|P1|STARTED|Crossover Period 4 (5 Days)||14
1102815|NCT01119443|2668963|P2|NOT COMPLETED|Crossover Period 3 (5 Days)||0
1102816|NCT01119443|2668964|P1|NOT COMPLETED|Crossover Period 3 (5 Days)||0
1102817|NCT01119443|2668963|P2|COMPLETED|Crossover Period 3 (5 Days)||13
1102818|NCT01119443|2668964|P1|COMPLETED|Crossover Period 3 (5 Days)||14
1102819|NCT01119443|2668963|P2|STARTED|Crossover Period 3 (5 Days)||13
1102820|NCT01119443|2668964|P1|STARTED|Crossover Period 3 (5 Days)||14
1102821|NCT01119443|2668963|P2|NOT COMPLETED|Crossover Period 2 (5 Days)||0
1102822|NCT01119443|2668964|P1|NOT COMPLETED|Crossover Period 2 (5 Days)||0
1102823|NCT01119443|2668963|P2|COMPLETED|Crossover Period 2 (5 Days)||13
1102824|NCT01119443|2668964|P1|COMPLETED|Crossover Period 2 (5 Days)||14
1102825|NCT01119443|2668963|P2|STARTED|Crossover Period 2 (5 Days)||13
1102826|NCT01119443|2668964|P1|STARTED|Crossover Period 2 (5 Days)||14
1102827|NCT01119443|2668963|P2|NOT COMPLETED|Crossover Period 1 (5 Days)||1
1102828|NCT01119443|2668964|P1|NOT COMPLETED|Crossover Period 1 (5 Days)||0
1102829|NCT01119443|2668963|P2|COMPLETED|Crossover Period 1 (5 Days)||13
1102830|NCT01119443|2668964|P1|COMPLETED|Crossover Period 1 (5 Days)||14
1102831|NCT01119443|2668963|P2|STARTED|Crossover Period 1 (5 Days)||14
1102832|NCT01119443|2668964|P1|STARTED|Crossover Period 1 (5 Days)||14
1102833|NCT01119443|2668963|P2|NOT COMPLETED|Up-titration Period (10 Days)||0
1102834|NCT01119443|2668964|P1|NOT COMPLETED|Up-titration Period (10 Days)||0
1102835|NCT01119443|2668963|P2|COMPLETED|Up-titration Period (10 Days)||14
1102836|NCT01119443|2668964|P1|COMPLETED|Up-titration Period (10 Days)||14
1102837|NCT01119443|2668963|P2|STARTED|Up-titration Period (10 Days)||14
1102838|NCT01119443|2668964|P1|STARTED|Up-titration Period (10 Days)||14
1102839|NCT01119625|2669003|P2|NOT COMPLETED|Overall Study||4
1102840|NCT01119625|2669004|P1|NOT COMPLETED|Overall Study||3
1102841|NCT01119625|2669003|P2|COMPLETED|Overall Study||116
1102842|NCT01119625|2669004|P1|COMPLETED|Overall Study||115
1102843|NCT01119625|2669003|P2|STARTED|Overall Study||120
1102844|NCT01119625|2669004|P1|STARTED|Overall Study||118
1102845|NCT01119703|2669046|P2|NOT COMPLETED|Overall Study||1
1102846|NCT01119703|2669047|P1|NOT COMPLETED|Overall Study||0
1102847|NCT01119703|2669046|P2|COMPLETED|Overall Study||143
1102848|NCT01119703|2669047|P1|COMPLETED|Overall Study||30
1102849|NCT01119703|2669046|P2|STARTED|Overall Study||144
1102850|NCT01119703|2669047|P1|STARTED|Overall Study||30
1102851|NCT01119716|2669059|P1|NOT COMPLETED|Overall Study||0
1102852|NCT01119716|2669059|P1|COMPLETED|Overall Study||4658
1102853|NCT01119716|2669059|P1|STARTED|Overall Study||4658
1102854|NCT01119755|2669080|P1|NOT COMPLETED|Overall Study||0
1102855|NCT01119755|2669080|P1|COMPLETED|Overall Study||80
1102856|NCT01119755|2669080|P1|STARTED|Overall Study||80
1102857|NCT01119768|2669093|P2|NOT COMPLETED|Follow-up||2
1102858|NCT01119768|2669094|P1|NOT COMPLETED|Follow-up||1
1102859|NCT01119768|2669093|P2|COMPLETED|Follow-up||122
1102860|NCT01119768|2669094|P1|COMPLETED|Follow-up||135
1102861|NCT01119768|2669093|P2|STARTED|Follow-up||124
1102862|NCT01119768|2669094|P1|STARTED|Follow-up||136
1102863|NCT01119768|2669093|P2|NOT COMPLETED|Treatment Period||25
1102864|NCT01119768|2669094|P1|NOT COMPLETED|Treatment Period||18
1102865|NCT01119768|2669093|P2|COMPLETED|Treatment Period||126
1102866|NCT01119768|2669094|P1|COMPLETED|Treatment Period||136
1102867|NCT01119768|2669093|P2|STARTED|Treatment Period||151
1102868|NCT01119768|2669094|P1|STARTED|Treatment Period||154
1102869|NCT01119794|2669116|P1|NOT COMPLETED|Overall Study||0
1102870|NCT01119794|2669116|P1|COMPLETED|Overall Study||10
1102871|NCT01119794|2669116|P1|STARTED|Overall Study||10
1102872|NCT01119859|2669122|P2|NOT COMPLETED|Overall Study||30
1102873|NCT01119859|2669123|P1|NOT COMPLETED|Overall Study||24
1102874|NCT01119859|2669122|P2|COMPLETED|Overall Study||133
1102875|NCT01119859|2669123|P1|COMPLETED|Overall Study||139
1102876|NCT01119859|2669122|P2|STARTED|Overall Study||163
1102877|NCT01119859|2669123|P1|STARTED|Overall Study||163
1102878|NCT01119937|2669141|P2|NOT COMPLETED|Overall Study||7
1102879|NCT01119937|2669142|P1|NOT COMPLETED|Overall Study||19
1102880|NCT01119937|2669141|P2|COMPLETED|Overall Study||33
1102881|NCT01119937|2669142|P1|COMPLETED|Overall Study||104
1102882|NCT01119937|2669141|P2|STARTED|Overall Study||40
1102883|NCT01119937|2669142|P1|STARTED|Overall Study||123
1102884|NCT01119950|2669168|P1|NOT COMPLETED|Overall Study||47
1102885|NCT01119950|2669168|P1|COMPLETED|Overall Study|These participants completed both periods 1 and 2|341
1102886|NCT01119950|2669168|P1|Placebo|Overall Study|3 randomized participants did not receive study drug, 82 completed treatment, 5 discontinued.|94
1102887|NCT01119950|2669168|P1|NVA237 50 ug b.i.d.|Overall Study|6 randomized and 1 misrandomized patients did not receive study drug, 82 completed, 5 discontinued.|94
1102888|NCT01119950|2669168|P1|NVA237 100 ug q.d.|Overall Study|2 randomized participants did not receive study drug, 92 completed treatment, 4 discontinued.|98
1102889|NCT01119950|2669168|P1|NVA237 25 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 7 discontinued.|100
1102890|NCT01119950|2669168|P1|NVA237 50 ug q.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 3 discontinued.|96
1102891|NCT01119950|2669168|P1|NVA237 12.5 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 93 completed treatment, 2 discontinued.|99
1102892|NCT01119950|2669168|P1|NVA237 25 ug q.d.|Overall Study|3 randomized participants did not receive study drug, 91 completed treatment, 5 discontinued.|99
1102893|NCT01119950|2669168|P1|NVA237 12.5 ug q.d.|Overall Study|5 randomized and 2 misrandomized patients did not receive study drug, 80 completed, 9 discontinued.|96
1102894|NCT01119950|2669168|P1|STARTED|Overall Study|These participants were randomized to 2 different treatment sequences during period 1 and 2.|388
1102895|NCT01120067|2669415|P2|NOT COMPLETED|Overall Study||1
1102896|NCT01120067|2669416|P1|NOT COMPLETED|Overall Study||5
1102897|NCT01120067|2669415|P2|COMPLETED|Overall Study||10
1102898|NCT01120067|2669416|P1|COMPLETED|Overall Study||7
1102899|NCT01120067|2669415|P2|STARTED|Overall Study||11
1102900|NCT01120067|2669416|P1|STARTED|Overall Study||12
1102901|NCT01120093|2669422|P5|NOT COMPLETED|Treatment Period 5||0
1102902|NCT01120093|2669423|P4|NOT COMPLETED|Treatment Period 5||1
1102903|NCT01120093|2669424|P3|NOT COMPLETED|Treatment Period 5||0
1102904|NCT01120093|2669425|P2|NOT COMPLETED|Treatment Period 5||1
1102905|NCT01120093|2669426|P1|NOT COMPLETED|Treatment Period 5||0
1102906|NCT01120093|2669422|P5|COMPLETED|Treatment Period 5||13
1102907|NCT01120093|2669423|P4|COMPLETED|Treatment Period 5||11
1102908|NCT01120093|2669424|P3|COMPLETED|Treatment Period 5||15
1102909|NCT01120093|2669425|P2|COMPLETED|Treatment Period 5||12
1102910|NCT01120093|2669426|P1|COMPLETED|Treatment Period 5||17
1102911|NCT01120093|2669422|P5|STARTED|Treatment Period 5||13
1102912|NCT01120093|2669423|P4|STARTED|Treatment Period 5||12
1102913|NCT01120093|2669424|P3|STARTED|Treatment Period 5||15
1102914|NCT01120093|2669425|P2|STARTED|Treatment Period 5||13
1102915|NCT01120093|2669426|P1|STARTED|Treatment Period 5||17
1102916|NCT01120093|2669422|P5|NOT COMPLETED|Treatment Period 4||0
1102917|NCT01120093|2669423|P4|NOT COMPLETED|Treatment Period 4||0
1102918|NCT01120093|2669424|P3|NOT COMPLETED|Treatment Period 4||0
1102919|NCT01120093|2669425|P2|NOT COMPLETED|Treatment Period 4||0
1102920|NCT01120093|2669426|P1|NOT COMPLETED|Treatment Period 4||1
1102921|NCT01120093|2669422|P5|COMPLETED|Treatment Period 4||13
1102922|NCT01120093|2669423|P4|COMPLETED|Treatment Period 4||12
1102923|NCT01120093|2669424|P3|COMPLETED|Treatment Period 4||15
1102924|NCT01120093|2669425|P2|COMPLETED|Treatment Period 4||13
1102925|NCT01120093|2669426|P1|COMPLETED|Treatment Period 4||17
1102926|NCT01120093|2669422|P5|STARTED|Treatment Period 4||13
1102927|NCT01120093|2669423|P4|STARTED|Treatment Period 4||12
1102928|NCT01120093|2669424|P3|STARTED|Treatment Period 4||15
1102929|NCT01120093|2669425|P2|STARTED|Treatment Period 4||13
1102930|NCT01120093|2669426|P1|STARTED|Treatment Period 4||18
1102931|NCT01120093|2669422|P5|NOT COMPLETED|Treatment Period 3||1
1102932|NCT01120093|2669423|P4|NOT COMPLETED|Treatment Period 3||1
1102933|NCT01120093|2669424|P3|NOT COMPLETED|Treatment Period 3||1
1102934|NCT01120093|2669425|P2|NOT COMPLETED|Treatment Period 3||0
1102935|NCT01120093|2669426|P1|NOT COMPLETED|Treatment Period 3||0
1102936|NCT01120093|2669422|P5|COMPLETED|Treatment Period 3||13
1102937|NCT01120093|2669423|P4|COMPLETED|Treatment Period 3||12
1102938|NCT01120093|2669424|P3|COMPLETED|Treatment Period 3||15
1102939|NCT01120093|2669425|P2|COMPLETED|Treatment Period 3||13
1102940|NCT01120093|2669426|P1|COMPLETED|Treatment Period 3||18
1102941|NCT01120093|2669422|P5|STARTED|Treatment Period 3||14
1102942|NCT01120093|2669423|P4|STARTED|Treatment Period 3||13
1102943|NCT01120093|2669424|P3|STARTED|Treatment Period 3||16
1102944|NCT01120093|2669425|P2|STARTED|Treatment Period 3||13
1102945|NCT01120093|2669426|P1|STARTED|Treatment Period 3||18
1102946|NCT01120093|2669422|P5|NOT COMPLETED|Treatment Period 2||1
1102947|NCT01120093|2669423|P4|NOT COMPLETED|Treatment Period 2||1
1102948|NCT01120093|2669424|P3|NOT COMPLETED|Treatment Period 2||0
1102949|NCT01120093|2669425|P2|NOT COMPLETED|Treatment Period 2||0
1102950|NCT01120093|2669426|P1|NOT COMPLETED|Treatment Period 2||0
1102951|NCT01120093|2669422|P5|COMPLETED|Treatment Period 2||14
1102952|NCT01120093|2669423|P4|COMPLETED|Treatment Period 2||13
1102953|NCT01120093|2669424|P3|COMPLETED|Treatment Period 2||16
1102954|NCT01120093|2669425|P2|COMPLETED|Treatment Period 2||13
1102955|NCT01120093|2669426|P1|COMPLETED|Treatment Period 2||18
1102956|NCT01120093|2669422|P5|STARTED|Treatment Period 2||15
1102957|NCT01120093|2669423|P4|STARTED|Treatment Period 2||14
1102958|NCT01120093|2669424|P3|STARTED|Treatment Period 2||16
1102959|NCT01120093|2669425|P2|STARTED|Treatment Period 2||13
1102960|NCT01120093|2669426|P1|STARTED|Treatment Period 2||18
1102961|NCT01120093|2669422|P5|NOT COMPLETED|Treatment Period 1||1
1102962|NCT01120093|2669423|P4|NOT COMPLETED|Treatment Period 1||0
1102963|NCT01120093|2669424|P3|NOT COMPLETED|Treatment Period 1||1
1102964|NCT01120093|2669425|P2|NOT COMPLETED|Treatment Period 1||1
1102965|NCT01120093|2669426|P1|NOT COMPLETED|Treatment Period 1||0
1102966|NCT01120093|2669422|P5|COMPLETED|Treatment Period 1||15
1102967|NCT01120093|2669423|P4|COMPLETED|Treatment Period 1||14
1102968|NCT01120093|2669424|P3|COMPLETED|Treatment Period 1||16
1102969|NCT01120093|2669425|P2|COMPLETED|Treatment Period 1||13
1102970|NCT01120093|2669426|P1|COMPLETED|Treatment Period 1||18
1102971|NCT01120093|2669422|P5|STARTED|Treatment Period 1||16
1102972|NCT01120093|2669423|P4|STARTED|Treatment Period 1||14
1102973|NCT01120093|2669424|P3|STARTED|Treatment Period 1||17
1102974|NCT01120093|2669425|P2|STARTED|Treatment Period 1||14
1102975|NCT01120093|2669426|P1|STARTED|Treatment Period 1||18
1102976|NCT01120184|2669456|P3|NOT COMPLETED|Overall Study||363
1102977|NCT01120184|2669457|P2|NOT COMPLETED|Overall Study||367
1102978|NCT01120184|2669458|P1|NOT COMPLETED|Overall Study||365
1102979|NCT01120184|2669456|P3|COMPLETED|Overall Study||0
1102980|NCT01120184|2669457|P2|COMPLETED|Overall Study||0
1102981|NCT01120184|2669458|P1|COMPLETED|Overall Study||0
1102982|NCT01120184|2669456|P3|Treated|Overall Study||360
1102983|NCT01120184|2669457|P2|Treated|Overall Study||365
1102984|NCT01120184|2669458|P1|Treated|Overall Study||355
1102985|NCT01120184|2669456|P3|STARTED|Overall Study||363
1102986|NCT01120184|2669457|P2|STARTED|Overall Study||367
1102987|NCT01120184|2669458|P1|STARTED|Overall Study||365
1102988|NCT01120197|2669582|P2|NOT COMPLETED|Overall Study||10
1102989|NCT01120197|2669583|P1|NOT COMPLETED|Overall Study||9
1102990|NCT01120197|2669582|P2|COMPLETED|Overall Study||32
1102991|NCT01120197|2669583|P1|COMPLETED|Overall Study||38
1102992|NCT01120197|2669582|P2|STARTED|Overall Study||42
1102993|NCT01120197|2669583|P1|STARTED|Overall Study||47
1102994|NCT01120210|2669599|P2|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
1102995|NCT01120210|2669600|P1|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
1102996|NCT01120210|2669599|P2|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
1102997|NCT01120210|2669600|P1|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
1102998|NCT01120210|2669599|P2|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
1102999|NCT01120210|2669600|P1|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
1103000|NCT01120210|2669599|P2|NOT COMPLETED|MAIN INFUSION||1
1103001|NCT01120210|2669600|P1|NOT COMPLETED|MAIN INFUSION||1
1103002|NCT01120210|2669599|P2|COMPLETED|MAIN INFUSION||45
1103003|NCT01120210|2669600|P1|COMPLETED|MAIN INFUSION||15
1103004|NCT01120210|2669599|P2|STARTED|MAIN INFUSION||46
1103005|NCT01120210|2669600|P1|STARTED|MAIN INFUSION||16
1103006|NCT01120223|2669630|P1|NOT COMPLETED|Overall Study||4
1103007|NCT01120223|2669630|P1|COMPLETED|Overall Study||74
1103008|NCT01120223|2669630|P1|STARTED|Overall Study||78
1103009|NCT01120236|2669660|P2|NOT COMPLETED|Overall Study||0
1103010|NCT01120236|2669661|P1|NOT COMPLETED|Overall Study||0
1103011|NCT01120236|2669660|P2|COMPLETED|Overall Study||106
1103012|NCT01120236|2669661|P1|COMPLETED|Overall Study||105
1103013|NCT01120236|2669660|P2|STARTED|Overall Study||106
1103014|NCT01120236|2669661|P1|STARTED|Overall Study||105
1103015|NCT01120275|2669671|P1|NOT COMPLETED|Overall Study||36
1103016|NCT01120275|2669671|P1|COMPLETED|Overall Study||0
1103017|NCT01120275|2669671|P1|Eligible and Treated|Overall Study||32
1103018|NCT01120275|2669671|P1|STARTED|Overall Study||36
1103019|NCT01120379|2669678|P1|NOT COMPLETED|Four Year Timepoint||368
1103020|NCT01120379|2669678|P1|COMPLETED|Four Year Timepoint||3923
1103021|NCT01120379|2669678|P1|STARTED|Four Year Timepoint||4291
1103022|NCT01120379|2669678|P1|NOT COMPLETED|Three Year Timepoint||214
1103023|NCT01120379|2669678|P1|COMPLETED|Three Year Timepoint||4291
1103024|NCT01120379|2669678|P1|STARTED|Three Year Timepoint||4505
1103025|NCT01120379|2669678|P1|NOT COMPLETED|Two Year Timepoint||237
1103026|NCT01120379|2669678|P1|COMPLETED|Two Year Timepoint||4505
1103027|NCT01120379|2669678|P1|STARTED|Two Year Timepoint||4742
1103028|NCT01120379|2669678|P1|NOT COMPLETED|One Year Timepoint||278
1103029|NCT01120379|2669678|P1|COMPLETED|One Year Timepoint||4742
1103030|NCT01120379|2669678|P1|STARTED|One Year Timepoint||5020
1103031|NCT01120405|2669716|P2|NOT COMPLETED|Overall Study||33
1103032|NCT01120405|2669717|P1|NOT COMPLETED|Overall Study||27
1103033|NCT01120405|2669716|P2|COMPLETED|Overall Study||269
1103034|NCT01120405|2669717|P1|COMPLETED|Overall Study||271
1103035|NCT01120405|2669716|P2|STARTED|Overall Study||302
1103036|NCT01120405|2669717|P1|STARTED|Overall Study||298
1103037|NCT01120626|2669747|P2|NOT COMPLETED|Overall Study||0
1103038|NCT01120626|2669748|P1|NOT COMPLETED|Overall Study||1
1103039|NCT01120626|2669747|P2|COMPLETED|Overall Study||22
1103040|NCT01120626|2669748|P1|COMPLETED|Overall Study||19
1103041|NCT01120626|2669747|P2|STARTED|Overall Study||22
1103042|NCT01120626|2669748|P1|STARTED|Overall Study||20
1103043|NCT01120691|2669759|P3|NOT COMPLETED|Overall Study||183
1103044|NCT01120691|2669760|P2|NOT COMPLETED|Overall Study||203
1103045|NCT01120691|2669761|P1|NOT COMPLETED|Overall Study||171
1103046|NCT01120691|2669759|P3|COMPLETED|Overall Study||559
1103047|NCT01120691|2669760|P2|COMPLETED|Overall Study||538
1103048|NCT01120691|2669761|P1|COMPLETED|Overall Study||570
1103049|NCT01120691|2669759|P3|Modified Full Analysis Set (mFAS)|Overall Study||737
1103050|NCT01120691|2669760|P2|Modified Full Analysis Set (mFAS)|Overall Study||739
1103051|NCT01120691|2669761|P1|Modified Full Analysis Set (mFAS)|Overall Study||729
1103052|NCT01120691|2669759|P3|Modified Safety Set (mSAF)|Overall Study||737
1103053|NCT01120691|2669760|P2|Modified Safety Set (mSAF)|Overall Study||740
1103054|NCT01120691|2669761|P1|Modified Safety Set (mSAF)|Overall Study||729
1103055|NCT01120691|2669759|P3|Safety Set (SAF)|Overall Study||739
1103056|NCT01120691|2669760|P2|Safety Set (SAF)|Overall Study||740
1103057|NCT01120691|2669761|P1|Safety Set (SAF)|Overall Study||736
1103058|NCT01120691|2669759|P3|Full Analysis Set (FAS)|Overall Study||739
1103059|NCT01120691|2669760|P2|Full Analysis Set (FAS)|Overall Study||739
1103060|NCT01120691|2669761|P1|Full Analysis Set (FAS)|Overall Study||736
1103061|NCT01120691|2669759|P3|STARTED|Overall Study||742
1103062|NCT01120691|2669760|P2|STARTED|Overall Study||741
1103063|NCT01120691|2669761|P1|STARTED|Overall Study||741
1103064|NCT01120704|2669835|P32|NOT COMPLETED|Overall Study||1
1103065|NCT01120704|2669836|P31|NOT COMPLETED|Overall Study||2
1103066|NCT01120704|2669837|P30|NOT COMPLETED|Overall Study||3
1103067|NCT01120704|2669838|P29|NOT COMPLETED|Overall Study||5
1103068|NCT01120704|2669839|P28|NOT COMPLETED|Overall Study||2
1103069|NCT01120704|2669840|P27|NOT COMPLETED|Overall Study||3
1103070|NCT01120704|2669841|P26|NOT COMPLETED|Overall Study||0
1103071|NCT01120704|2669842|P25|NOT COMPLETED|Overall Study||2
1103072|NCT01120704|2669843|P24|NOT COMPLETED|Overall Study||3
1103073|NCT01120704|2669844|P23|NOT COMPLETED|Overall Study||4
1103074|NCT01120704|2669845|P22|NOT COMPLETED|Overall Study||0
1103075|NCT01120704|2669846|P21|NOT COMPLETED|Overall Study||3
1103076|NCT01120704|2669847|P20|NOT COMPLETED|Overall Study||3
1103077|NCT01120704|2669848|P19|NOT COMPLETED|Overall Study||2
1103078|NCT01120704|2669849|P18|NOT COMPLETED|Overall Study||0
1103079|NCT01120704|2669850|P17|NOT COMPLETED|Overall Study||1
1103080|NCT01120704|2669851|P16|NOT COMPLETED|Overall Study||2
1103081|NCT01120704|2669852|P15|NOT COMPLETED|Overall Study||1
1103082|NCT01120704|2669853|P14|NOT COMPLETED|Overall Study||4
1103083|NCT01120704|2669854|P13|NOT COMPLETED|Overall Study||3
1103084|NCT01120704|2669855|P12|NOT COMPLETED|Overall Study||2
1103085|NCT01120704|2669856|P11|NOT COMPLETED|Overall Study||1
1103086|NCT01120704|2669857|P10|NOT COMPLETED|Overall Study||1
1103087|NCT01120704|2669858|P9|NOT COMPLETED|Overall Study||3
1103088|NCT01120704|2669859|P8|NOT COMPLETED|Overall Study||2
1103089|NCT01120704|2669860|P7|NOT COMPLETED|Overall Study||3
1103090|NCT01120704|2669861|P6|NOT COMPLETED|Overall Study||1
1103091|NCT01120704|2669862|P5|NOT COMPLETED|Overall Study||2
1103092|NCT01120704|2669863|P4|NOT COMPLETED|Overall Study||4
1103093|NCT01120704|2669864|P3|NOT COMPLETED|Overall Study||1
1103094|NCT01120704|2669865|P2|NOT COMPLETED|Overall Study||4
1103095|NCT01120704|2669866|P1|NOT COMPLETED|Overall Study||3
1103096|NCT01120704|2669835|P32|COMPLETED|Overall Study||17
1103097|NCT01120704|2669836|P31|COMPLETED|Overall Study||12
1103098|NCT01120704|2669837|P30|COMPLETED|Overall Study||12
1103099|NCT01120704|2669838|P29|COMPLETED|Overall Study||14
1103100|NCT01120704|2669839|P28|COMPLETED|Overall Study||16
1103101|NCT01120704|2669840|P27|COMPLETED|Overall Study||15
1103102|NCT01120704|2669841|P26|COMPLETED|Overall Study||14
1103103|NCT01120704|2669842|P25|COMPLETED|Overall Study||16
1103104|NCT01120704|2669843|P24|COMPLETED|Overall Study||13
1103105|NCT01120704|2669844|P23|COMPLETED|Overall Study||17
1103106|NCT01120704|2669845|P22|COMPLETED|Overall Study||16
1103107|NCT01120704|2669846|P21|COMPLETED|Overall Study||14
1103108|NCT01120704|2669847|P20|COMPLETED|Overall Study||15
1103109|NCT01120704|2669848|P19|COMPLETED|Overall Study||15
1103110|NCT01120704|2669849|P18|COMPLETED|Overall Study||16
1103111|NCT01120704|2669850|P17|COMPLETED|Overall Study||13
1103112|NCT01120704|2669851|P16|COMPLETED|Overall Study||16
1103113|NCT01120704|2669852|P15|COMPLETED|Overall Study||17
1103114|NCT01120704|2669853|P14|COMPLETED|Overall Study||15
1103115|NCT01120704|2669854|P13|COMPLETED|Overall Study||14
1103116|NCT01120704|2669855|P12|COMPLETED|Overall Study||14
1103117|NCT01120704|2669856|P11|COMPLETED|Overall Study||16
1103118|NCT01120704|2669857|P10|COMPLETED|Overall Study||19
1103119|NCT01120704|2669858|P9|COMPLETED|Overall Study||19
1103120|NCT01120704|2669859|P8|COMPLETED|Overall Study||13
1103121|NCT01120704|2669860|P7|COMPLETED|Overall Study||12
1103122|NCT01120704|2669861|P6|COMPLETED|Overall Study||18
1103123|NCT01120704|2669862|P5|COMPLETED|Overall Study||14
1103124|NCT01120704|2669863|P4|COMPLETED|Overall Study||15
1103125|NCT01120704|2669864|P3|COMPLETED|Overall Study||13
1103126|NCT01120704|2669865|P2|COMPLETED|Overall Study||13
1103127|NCT01120704|2669866|P1|COMPLETED|Overall Study||10
1103128|NCT01120704|2669835|P32|STARTED|Overall Study||18
1103129|NCT01120704|2669836|P31|STARTED|Overall Study||14
1103130|NCT01120704|2669837|P30|STARTED|Overall Study||15
1103131|NCT01120704|2669838|P29|STARTED|Overall Study||19
1103132|NCT01120704|2669839|P28|STARTED|Overall Study||18
1103133|NCT01120704|2669840|P27|STARTED|Overall Study||18
1103134|NCT01120704|2669841|P26|STARTED|Overall Study||14
1103135|NCT01120704|2669842|P25|STARTED|Overall Study||18
1103136|NCT01120704|2669843|P24|STARTED|Overall Study||16
1103137|NCT01120704|2669844|P23|STARTED|Overall Study||21
1103138|NCT01120704|2669845|P22|STARTED|Overall Study||16
1103139|NCT01120704|2669846|P21|STARTED|Overall Study||17
1103140|NCT01120704|2669847|P20|STARTED|Overall Study||18
1103141|NCT01120704|2669848|P19|STARTED|Overall Study||17
1103142|NCT01120704|2669849|P18|STARTED|Overall Study||16
1103143|NCT01120704|2669850|P17|STARTED|Overall Study||14
1103144|NCT01120704|2669851|P16|STARTED|Overall Study||18
1103145|NCT01120704|2669852|P15|STARTED|Overall Study||18
1103146|NCT01120704|2669853|P14|STARTED|Overall Study||19
1103147|NCT01120704|2669854|P13|STARTED|Overall Study||17
1103148|NCT01120704|2669855|P12|STARTED|Overall Study||16
1103149|NCT01120704|2669856|P11|STARTED|Overall Study||17
1103150|NCT01120704|2669857|P10|STARTED|Overall Study||20
1103151|NCT01120704|2669858|P9|STARTED|Overall Study||22
1103152|NCT01120704|2669859|P8|STARTED|Overall Study||15
1103153|NCT01120704|2669860|P7|STARTED|Overall Study||15
1103154|NCT01120704|2669861|P6|STARTED|Overall Study||19
1103155|NCT01120704|2669862|P5|STARTED|Overall Study||16
1103156|NCT01120704|2669863|P4|STARTED|Overall Study||19
1103157|NCT01120704|2669864|P3|STARTED|Overall Study||14
1103158|NCT01120704|2669865|P2|STARTED|Overall Study||17
1103159|NCT01120704|2669866|P1|STARTED|Overall Study||13
1103160|NCT01120717|2669892|P2|NOT COMPLETED|Overall Study||24
1103161|NCT01120717|2669893|P1|NOT COMPLETED|Overall Study||32
1103162|NCT01120717|2669892|P2|COMPLETED|Overall Study||89
1103163|NCT01120717|2669893|P1|COMPLETED|Overall Study||194
1103164|NCT01120717|2669892|P2|Safety Population: Received Study Drug|Overall Study||113
1103165|NCT01120717|2669893|P1|Safety Population: Received Study Drug|Overall Study||225
1103166|NCT01120717|2669892|P2|STARTED|Overall Study||113
1103167|NCT01120717|2669893|P1|STARTED|Overall Study||226
1103171|NCT01120808|2669913|P1|NOT COMPLETED|Overall Study||46
1103172|NCT01120808|2669913|P1|COMPLETED|Overall Study||90
1103173|NCT01120808|2669913|P1|STARTED|Overall Study||136
1103174|NCT01120834|2669917|P1|NOT COMPLETED|Overall Study||0
1103175|NCT01120834|2669917|P1|COMPLETED|Overall Study||18
1103176|NCT01120834|2669917|P1|STARTED|Overall Study||18
1103177|NCT01120899|2669921|P1|NOT COMPLETED|Overall Study||3
1103178|NCT01120899|2669921|P1|COMPLETED|Overall Study||3
1103179|NCT01120899|2669921|P1|Month 18|Overall Study||3
1103180|NCT01120899|2669921|P1|Month 12|Overall Study||3
1103181|NCT01120899|2669921|P1|Month 6|Overall Study||5
1103182|NCT01120899|2669921|P1|STARTED|Overall Study||6
1103183|NCT01120990|2669941|P1|NOT COMPLETED|Overall Study||0
1103184|NCT01120990|2669941|P1|COMPLETED|Overall Study||51
1103185|NCT01120990|2669941|P1|STARTED|Overall Study||51
1103186|NCT01121146|2669950|P2|NOT COMPLETED|Overall Study||42
1103187|NCT01121146|2669951|P1|NOT COMPLETED|Overall Study||26
1103188|NCT01121146|2669950|P2|COMPLETED|Overall Study|The 72 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|72
1103189|NCT01121146|2669951|P1|COMPLETED|Overall Study|The 90 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|90
1103190|NCT01121146|2669950|P2|STARTED|Overall Study||114
1103191|NCT01121146|2669951|P1|STARTED|Overall Study||116
1103192|NCT01121172|2669967|P2|NOT COMPLETED|Overall Study||0
1103193|NCT01121172|2669968|P1|NOT COMPLETED|Overall Study||0
1103194|NCT01121172|2669967|P2|COMPLETED|Overall Study||90
1103195|NCT01121172|2669968|P1|COMPLETED|Overall Study||90
1103196|NCT01121172|2669967|P2|STARTED|Overall Study||90
1103197|NCT01121172|2669968|P1|STARTED|Overall Study||90
1103198|NCT01121185|2669977|P2|NOT COMPLETED|Overall Study||1
1103199|NCT01121185|2669978|P1|NOT COMPLETED|Overall Study||1
1103200|NCT01121185|2669977|P2|COMPLETED|Overall Study||5
1103201|NCT01121185|2669978|P1|COMPLETED|Overall Study||6
1103202|NCT01121185|2669977|P2|Transplanted|Overall Study||5
1103203|NCT01121185|2669978|P1|Transplanted|Overall Study|One subject initiated the first study infusion, but transplant surgery was subsequently cancelled.|6
1103204|NCT01121185|2669977|P2|Infused|Overall Study|Excluded medical condition identified in one subject after randomization but before study infusion.|5
1103205|NCT01121185|2669978|P1|Infused|Overall Study||7
1103206|NCT01121185|2669977|P2|STARTED|Overall Study||6
1103207|NCT01121185|2669978|P1|STARTED|Overall Study||7
1103208|NCT01121211|2670002|P2|NOT COMPLETED|Overall Study||12
1103209|NCT01121211|2670003|P1|NOT COMPLETED|Overall Study||11
1103210|NCT01121211|2670002|P2|COMPLETED|Overall Study||35
1103211|NCT01121211|2670003|P1|COMPLETED|Overall Study||32
1103212|NCT01121211|2670002|P2|STARTED|Overall Study||47
1103213|NCT01121211|2670003|P1|STARTED|Overall Study||43
1103214|NCT01121263|2670013|P2|NOT COMPLETED|Overall Study||15
1103215|NCT01121263|2670014|P1|NOT COMPLETED|Overall Study||25
1103216|NCT01121263|2670013|P2|COMPLETED|Overall Study||83
1103217|NCT01121263|2670014|P1|COMPLETED|Overall Study||175
1103218|NCT01121263|2670013|P2|STARTED|Overall Study||98
1103219|NCT01121263|2670014|P1|STARTED|Overall Study||200
1103220|NCT01121393|2670024|P2|NOT COMPLETED|Overall Study||84
1103221|NCT01121393|2670025|P1|NOT COMPLETED|Overall Study||219
1103222|NCT01121393|2670024|P2|COMPLETED|Overall Study|Completed 6 courses of chemotherapy|38
1103223|NCT01121393|2670025|P1|COMPLETED|Overall Study|On-treatment at analysis cut-off date (27 December 2013)|23
1103224|NCT01121393|2670024|P2|STARTED|Overall Study|randomised|122
1103225|NCT01121393|2670025|P1|STARTED|Overall Study|randomised|242
1103226|NCT01121406|2670070|P2|NOT COMPLETED|Overall Study||55
1103227|NCT01121406|2670071|P1|NOT COMPLETED|Overall Study||55
1103228|NCT01121406|2670070|P2|COMPLETED|Overall Study||0
1103229|NCT01121406|2670071|P1|COMPLETED|Overall Study||0
1103230|NCT01121406|2670070|P2|STARTED|Overall Study|24 patients switched to Volasertib (BI 6727) due to disease progression or occurrence of toxicity|55
1103231|NCT01121406|2670071|P1|STARTED|Overall Study||55
1103232|NCT01110421|2670121|P2|NOT COMPLETED|Overall Study||0
1103233|NCT01110421|2670122|P1|NOT COMPLETED|Overall Study||0
1103234|NCT01110421|2670121|P2|COMPLETED|Overall Study||2
1103235|NCT01110421|2670122|P1|COMPLETED|Overall Study|Includes 1 participant who discontinued study drug due to an adverse event of empyema on Days 9-13.|5
1103236|NCT01110421|2670121|P2|STARTED|Overall Study||2
1103237|NCT01110421|2670122|P1|STARTED|Overall Study||5
1103238|NCT01110499|2670148|P8|NOT COMPLETED|Overall Study||0
1103239|NCT01110499|2670149|P7|NOT COMPLETED|Overall Study||0
1103240|NCT01110499|2670150|P6|NOT COMPLETED|Overall Study||0
1103241|NCT01110499|2670151|P5|NOT COMPLETED|Overall Study||0
1103242|NCT01110499|2670152|P4|NOT COMPLETED|Overall Study||0
1103243|NCT01110499|2670153|P3|NOT COMPLETED|Overall Study||0
1103244|NCT01110499|2670154|P2|NOT COMPLETED|Overall Study||0
1103245|NCT01110499|2670155|P1|NOT COMPLETED|Overall Study||0
1103246|NCT01110499|2670148|P8|COMPLETED|Overall Study||40
1103247|NCT01110499|2670149|P7|COMPLETED|Overall Study||39
1103248|NCT01110499|2670150|P6|COMPLETED|Overall Study||14
1103249|NCT01110499|2670151|P5|COMPLETED|Overall Study||14
1103250|NCT01110499|2670152|P4|COMPLETED|Overall Study||14
1103251|NCT01110499|2670153|P3|COMPLETED|Overall Study||14
1103252|NCT01110499|2670154|P2|COMPLETED|Overall Study||14
1103253|NCT01110499|2670155|P1|COMPLETED|Overall Study||14
1103254|NCT01110499|2670148|P8|STARTED|Overall Study||40
1103255|NCT01110499|2670149|P7|STARTED|Overall Study||39
1103256|NCT01110499|2670150|P6|STARTED|Overall Study||14
1103257|NCT01110499|2670151|P5|STARTED|Overall Study||14
1103258|NCT01110499|2670152|P4|STARTED|Overall Study||14
1103259|NCT01110499|2670153|P3|STARTED|Overall Study||14
1103260|NCT01110499|2670154|P2|STARTED|Overall Study||14
1103261|NCT01110499|2670155|P1|STARTED|Overall Study||14
1103262|NCT01110915|2670177|P2|NOT COMPLETED|Overall Study||2
1103263|NCT01110915|2670178|P1|NOT COMPLETED|Overall Study||10
1103264|NCT01110915|2670177|P2|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|84
1103265|NCT01110915|2670178|P1|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|167
1103266|NCT01110915|2670177|P2|STARTED|Overall Study|Subjects being randomized to the Control group.|86
1103267|NCT01110915|2670178|P1|STARTED|Overall Study|Subjects being randomized to the MRI group.|177
1103268|NCT01110967|2670193|P1|NOT COMPLETED|Overall Study||9
1103269|NCT01110967|2670193|P1|COMPLETED|Overall Study||31
1103270|NCT01110967|2670193|P1|12 Months Follow up|Overall Study||31
1103271|NCT01110967|2670193|P1|6 Months Follow up|Overall Study||24
1103272|NCT01110967|2670193|P1|3 Months Follow up|Overall Study||28
1103273|NCT01110967|2670193|P1|1 Month Follow up|Overall Study||26
1103274|NCT01110967|2670193|P1|Surgery|Overall Study||40
1103275|NCT01110967|2670193|P1|STARTED|Overall Study||40
1103276|NCT01111110|2670206|P2|NOT COMPLETED|Overall Study||0
1103277|NCT01111110|2670207|P1|NOT COMPLETED|Overall Study||0
1103278|NCT01111110|2670206|P2|COMPLETED|Overall Study||4
1103279|NCT01111110|2670207|P1|COMPLETED|Overall Study||3
1103280|NCT01111110|2670206|P2|STARTED|Overall Study||4
1103281|NCT01111110|2670207|P1|STARTED|Overall Study||3
1103282|NCT01111123|2670219|P2|NOT COMPLETED|Maintenance Phase||2
1103283|NCT01111123|2670220|P1|NOT COMPLETED|Maintenance Phase||0
1103284|NCT01111123|2670219|P2|COMPLETED|Maintenance Phase||18
1103285|NCT01111123|2670220|P1|COMPLETED|Maintenance Phase||21
1103286|NCT01111123|2670219|P2|STARTED|Maintenance Phase||20
1103287|NCT01111123|2670220|P1|STARTED|Maintenance Phase||21
1103288|NCT01111123|2670219|P2|NOT COMPLETED|Open- Label Phase||0
1103289|NCT01111123|2670220|P1|NOT COMPLETED|Open- Label Phase||14
1103290|NCT01111123|2670219|P2|COMPLETED|Open- Label Phase||0
1103291|NCT01111123|2670220|P1|COMPLETED|Open- Label Phase||41
1103292|NCT01111123|2670219|P2|STARTED|Open- Label Phase||0
1103293|NCT01111123|2670220|P1|STARTED|Open- Label Phase||55
1103294|NCT01111149|2670231|P3|NOT COMPLETED|Overall Study||4
1103295|NCT01111149|2670232|P2|NOT COMPLETED|Overall Study||1
1103296|NCT01111149|2670233|P1|NOT COMPLETED|Overall Study||2
1103297|NCT01111149|2670231|P3|COMPLETED|Overall Study||5
1103298|NCT01111149|2670232|P2|COMPLETED|Overall Study||5
1103299|NCT01111149|2670233|P1|COMPLETED|Overall Study||7
1103300|NCT01111149|2670231|P3|STARTED|Overall Study||9
1103301|NCT01111149|2670232|P2|STARTED|Overall Study||6
1103302|NCT01111149|2670233|P1|STARTED|Overall Study||9
1103303|NCT01111162|2670307|P1|NOT COMPLETED|Overall Study||0
1103304|NCT01111162|2670307|P1|COMPLETED|Overall Study||120
1103305|NCT01111162|2670307|P1|STARTED|Overall Study||120
1103306|NCT01111240|2670312|P1|NOT COMPLETED|Overall Study||1066
1103307|NCT01111240|2670312|P1|COMPLETED|Overall Study||3569
1103308|NCT01111240|2670312|P1|STARTED|Overall Study||4635
1103309|NCT01111292|2670336|P2|NOT COMPLETED|Follow-Up||0
1103310|NCT01111292|2670337|P1|NOT COMPLETED|Follow-Up||0
1103311|NCT01111292|2670336|P2|COMPLETED|Follow-Up||1
1103312|NCT01111292|2670337|P1|COMPLETED|Follow-Up||2
1103313|NCT01111292|2670336|P2|STARTED|Follow-Up||1
1103314|NCT01111292|2670337|P1|STARTED|Follow-Up||2
1103315|NCT01111292|2670336|P2|NOT COMPLETED|Post Treatment Biopsy||0
1103316|NCT01111292|2670337|P1|NOT COMPLETED|Post Treatment Biopsy||0
1103317|NCT01111292|2670336|P2|COMPLETED|Post Treatment Biopsy||1
1103318|NCT01111292|2670337|P1|COMPLETED|Post Treatment Biopsy||2
1103319|NCT01111292|2670336|P2|STARTED|Post Treatment Biopsy||1
1103320|NCT01111292|2670337|P1|STARTED|Post Treatment Biopsy||2
1103321|NCT01111292|2670336|P2|NOT COMPLETED|Treatment||1
1103322|NCT01111292|2670337|P1|NOT COMPLETED|Treatment||1
1103323|NCT01111292|2670336|P2|COMPLETED|Treatment||1
1103324|NCT01111292|2670337|P1|COMPLETED|Treatment||2
1103325|NCT01111292|2670336|P2|STARTED|Treatment||2
1103326|NCT01111292|2670337|P1|STARTED|Treatment||3
1103327|NCT01111292|2670336|P2|NOT COMPLETED|Randomization||0
1103328|NCT01111292|2670337|P1|NOT COMPLETED|Randomization||0
1103329|NCT01111292|2670336|P2|COMPLETED|Randomization||2
1103330|NCT01111292|2670337|P1|COMPLETED|Randomization||3
1103331|NCT01111292|2670336|P2|STARTED|Randomization||2
1103332|NCT01111292|2670337|P1|STARTED|Randomization||3
1103339|NCT01111318|2670360|P4|NOT COMPLETED|Overall Study||0
1103340|NCT01111318|2670361|P3|NOT COMPLETED|Overall Study||0
1103341|NCT01111318|2670362|P2|NOT COMPLETED|Overall Study||0
1103342|NCT01111318|2670363|P1|NOT COMPLETED|Overall Study||0
1103343|NCT01111318|2670360|P4|COMPLETED|Overall Study||8
1103344|NCT01111318|2670361|P3|COMPLETED|Overall Study||8
1103345|NCT01111318|2670362|P2|COMPLETED|Overall Study||8
1103346|NCT01111318|2670363|P1|COMPLETED|Overall Study||12
1103347|NCT01111318|2670360|P4|STARTED|Overall Study||8
1103348|NCT01111318|2670361|P3|STARTED|Overall Study||8
1103349|NCT01111318|2670362|P2|STARTED|Overall Study||8
1103350|NCT01111318|2670363|P1|STARTED|Overall Study||12
1103351|NCT01111331|2670425|P2|NOT COMPLETED|Overall Study||0
1103352|NCT01111331|2670426|P1|NOT COMPLETED|Overall Study||0
1103353|NCT01111331|2670425|P2|COMPLETED|Overall Study||9
1103354|NCT01111331|2670426|P1|COMPLETED|Overall Study||9
1103355|NCT01111331|2670425|P2|STARTED|Overall Study||9
1103356|NCT01111331|2670426|P1|STARTED|Overall Study||9
1103357|NCT01111370|2670504|P1|NOT COMPLETED|Overall Study||2
1103358|NCT01111370|2670504|P1|COMPLETED|Overall Study||58
1103359|NCT01111370|2670504|P1|STARTED|Overall Study||60
1103360|NCT01111461|2670508|P1|NOT COMPLETED|Overall Study||51
1103361|NCT01111461|2670508|P1|COMPLETED|Overall Study|On treatment at data cut-off or on treatment until disease progression|82
1103362|NCT01111461|2670508|P1|STARTED|Overall Study||133
1103363|NCT01111526|2670521|P3|NOT COMPLETED|Overall Study||2
1103364|NCT01111526|2670522|P2|NOT COMPLETED|Overall Study||1
1103365|NCT01111526|2670523|P1|NOT COMPLETED|Overall Study||0
1103366|NCT01111526|2670521|P3|COMPLETED|Overall Study||8
1103367|NCT01111526|2670522|P2|COMPLETED|Overall Study||7
1103368|NCT01111526|2670523|P1|COMPLETED|Overall Study||4
1103369|NCT01111526|2670521|P3|STARTED|Overall Study||10
1103370|NCT01111526|2670522|P2|STARTED|Overall Study||8
1103371|NCT01111526|2670523|P1|STARTED|Overall Study||4
1103372|NCT01111838|2670535|P1|NOT COMPLETED|Overall Study||7
1103373|NCT01111838|2670535|P1|COMPLETED|Overall Study||15
1103374|NCT01111838|2670535|P1|STARTED|Overall Study||22
1103375|NCT01111851|2670541|P2|NOT COMPLETED|Overall Study||0
1103376|NCT01111851|2670542|P1|NOT COMPLETED|Overall Study||2
1103377|NCT01111851|2670541|P2|COMPLETED|Overall Study||8
1103378|NCT01111851|2670542|P1|COMPLETED|Overall Study||6
1103379|NCT01111851|2670541|P2|STARTED|Overall Study||8
1103380|NCT01111851|2670542|P1|STARTED|Overall Study||8
1103381|NCT01112514|2670554|P1|NOT COMPLETED|Overall Study||1
1103382|NCT01112514|2670554|P1|COMPLETED|Overall Study||3
1103383|NCT01112514|2670554|P1|STARTED|Overall Study||4
1103384|NCT01112579|2670560|P2|NOT COMPLETED|Overall Study||3
1103385|NCT01112579|2670561|P1|NOT COMPLETED|Overall Study||1
1103386|NCT01112579|2670560|P2|COMPLETED|Overall Study||21
1103387|NCT01112579|2670561|P1|COMPLETED|Overall Study||41
1103388|NCT01112579|2670560|P2|STARTED|Overall Study||24
1103389|NCT01112579|2670561|P1|STARTED|Overall Study||42
1103390|NCT01112670|2670571|P6|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
1103391|NCT01112670|2670572|P5|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
1103392|NCT01112670|2670573|P4|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
1103393|NCT01112670|2670574|P3|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
1103394|NCT01112670|2670575|P2|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
1103395|NCT01112670|2670576|P1|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
1103396|NCT01112670|2670571|P6|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||5
1103397|NCT01112670|2670572|P5|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
1103398|NCT01112670|2670573|P4|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||4
1103399|NCT01112670|2670574|P3|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
1103400|NCT01112670|2670575|P2|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||3
1103401|NCT01112670|2670576|P1|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
1103402|NCT01112670|2670571|P6|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||5
1103403|NCT01112670|2670572|P5|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
1103404|NCT01112670|2670573|P4|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||4
1103405|NCT01112670|2670574|P3|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
1103406|NCT01112670|2670575|P2|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||3
1103407|NCT01112670|2670576|P1|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
1103408|NCT01112670|2670571|P6|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
1103409|NCT01112670|2670572|P5|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
1103410|NCT01112670|2670573|P4|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
1103411|NCT01112670|2670574|P3|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
1103412|NCT01112670|2670575|P2|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
1103413|NCT01112670|2670576|P1|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
1103414|NCT01112670|2670571|P6|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
1103415|NCT01112670|2670572|P5|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||5
1103416|NCT01112670|2670573|P4|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
1103417|NCT01112670|2670574|P3|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||6
1103418|NCT01112670|2670575|P2|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
1103419|NCT01112670|2670576|P1|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||7
1103420|NCT01112670|2670571|P6|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
1103421|NCT01112670|2670572|P5|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||6
1103422|NCT01112670|2670573|P4|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
1103423|NCT01112670|2670574|P3|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||7
1103424|NCT01112670|2670575|P2|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
1103425|NCT01112670|2670576|P1|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||8
1103426|NCT01112683|2670614|P2|NOT COMPLETED|Overall Study||1
1103427|NCT01112683|2670615|P1|NOT COMPLETED|Overall Study||1
1103428|NCT01112683|2670614|P2|COMPLETED|Overall Study||19
1103429|NCT01112683|2670615|P1|COMPLETED|Overall Study||18
1103430|NCT01112683|2670614|P2|STARTED|Overall Study||20
1103431|NCT01112683|2670615|P1|STARTED|Overall Study||19
1103432|NCT01112696|2670625|P1|NOT COMPLETED|Overall Study||2
1103433|NCT01112696|2670625|P1|COMPLETED|Overall Study||98
1103434|NCT01112696|2670625|P1|STARTED|Overall Study||100
1103435|NCT01112865|2670629|P2|NOT COMPLETED|Second Intervention||0
1103436|NCT01112865|2670630|P1|NOT COMPLETED|Second Intervention||0
1103437|NCT01112865|2670629|P2|COMPLETED|Second Intervention||61
1103438|NCT01112865|2670630|P1|COMPLETED|Second Intervention||59
1103439|NCT01112865|2670629|P2|STARTED|Second Intervention||61
1103440|NCT01112865|2670630|P1|STARTED|Second Intervention||59
1103441|NCT01112865|2670629|P2|NOT COMPLETED|First Intervention||0
1103442|NCT01112865|2670630|P1|NOT COMPLETED|First Intervention||0
1103443|NCT01112865|2670629|P2|COMPLETED|First Intervention||61
1103444|NCT01112865|2670630|P1|COMPLETED|First Intervention||59
1103445|NCT01112865|2670629|P2|STARTED|First Intervention||61
1103446|NCT01112865|2670630|P1|STARTED|First Intervention||59
1103447|NCT01112917|2670640|P2|NOT COMPLETED|Overall Study||15
1103448|NCT01112917|2670641|P1|NOT COMPLETED|Overall Study||7
1103449|NCT01112917|2670640|P2|COMPLETED|Overall Study||38
1103450|NCT01112917|2670641|P1|COMPLETED|Overall Study||89
1103451|NCT01112917|2670640|P2|STARTED|Overall Study||53
1103452|NCT01112917|2670641|P1|STARTED|Overall Study||96
1103453|NCT01113008|2670648|P2|NOT COMPLETED|Overall Study||0
1103454|NCT01113008|2670649|P1|NOT COMPLETED|Overall Study||0
1103455|NCT01113008|2670648|P2|COMPLETED|Overall Study||133
1103456|NCT01113008|2670649|P1|COMPLETED|Overall Study||133
1103457|NCT01113008|2670648|P2|STARTED|Overall Study||133
1103458|NCT01113008|2670649|P1|STARTED|Overall Study||133
1103459|NCT01113385|2670659|P1|NOT COMPLETED|Overall Study||0
1103460|NCT01113385|2670659|P1|COMPLETED|Overall Study||7
1103461|NCT01113385|2670659|P1|STARTED|Overall Study||7
1103462|NCT01113398|2670664|P1|NOT COMPLETED|Overall Study||0
1103463|NCT01113398|2670664|P1|COMPLETED|Overall Study|Completed= Discontinued study drug due to disease progression, death, toxicity or any other reason|36
1103464|NCT01113398|2670664|P1|STARTED|Overall Study||36
1103465|NCT01113463|2670671|P1|NOT COMPLETED|Overall Study||5
1103466|NCT01113463|2670671|P1|COMPLETED|Overall Study||12
1103467|NCT01113463|2670671|P1|STARTED|Overall Study||17
1103468|NCT01113541|2670676|P1|NOT COMPLETED|Overall Study||13
1103469|NCT01113541|2670676|P1|COMPLETED|Overall Study||0
1103470|NCT01113541|2670676|P1|STARTED|Overall Study||13
1103471|NCT01113580|2670711|P2|NOT COMPLETED|Overall Study||0
1103472|NCT01113580|2670712|P1|NOT COMPLETED|Overall Study||1
1103473|NCT01113580|2670711|P2|COMPLETED|Overall Study||60
1103474|NCT01113580|2670712|P1|COMPLETED|Overall Study||59
1103475|NCT01113580|2670711|P2|STARTED|Overall Study||60
1103476|NCT01113580|2670712|P1|STARTED|Overall Study||60
1103477|NCT01113632|2670728|P2|NOT COMPLETED|Overall Study||25
1103478|NCT01113632|2670729|P1|NOT COMPLETED|Overall Study||31
1103479|NCT01113632|2670728|P2|COMPLETED|Overall Study||19
1103480|NCT01113632|2670729|P1|COMPLETED|Overall Study||2
1103481|NCT01113632|2670728|P2|STARTED|Overall Study||44
1103482|NCT01113632|2670729|P1|STARTED|Overall Study||33
1103483|NCT01113710|2670743|P1|NOT COMPLETED|Overall Study||269
1103484|NCT01113710|2670743|P1|COMPLETED|Overall Study|"Discontinued reasons for Other are listed in the Participant Flow."|418
1103485|NCT01113710|2670743|P1|STARTED|Overall Study|See Additional Study Description for further information regarding withdrawal due to Adverse Event.|687
1103486|NCT01113723|2670754|P2|NOT COMPLETED|Overall Study||0
1103487|NCT01113723|2670755|P1|NOT COMPLETED|Overall Study||0
1103488|NCT01113723|2670754|P2|COMPLETED|Overall Study||70
1103489|NCT01113723|2670755|P1|COMPLETED|Overall Study||70
1103490|NCT01113723|2670754|P2|STARTED|Overall Study||70
1103491|NCT01113723|2670755|P1|STARTED|Overall Study||70
1103492|NCT01113749|2670767|P2|NOT COMPLETED|Overall Study||2
1103493|NCT01113749|2670768|P1|NOT COMPLETED|Overall Study||1
1103494|NCT01113749|2670767|P2|COMPLETED|Overall Study||127
1103495|NCT01113749|2670768|P1|COMPLETED|Overall Study||126
1103496|NCT01113749|2670767|P2|STARTED|Overall Study||129
1103497|NCT01113749|2670768|P1|STARTED|Overall Study||127
1103498|NCT01113931|2670780|P2|NOT COMPLETED|Overall Study||17
1103499|NCT01113931|2670781|P1|NOT COMPLETED|Overall Study||19
1103500|NCT01113931|2670780|P2|COMPLETED|Overall Study||231
1103501|NCT01113931|2670781|P1|COMPLETED|Overall Study||228
1103502|NCT01113931|2670780|P2|mITT Population|Overall Study||190
1103503|NCT01113931|2670781|P1|mITT Population|Overall Study||188
1103504|NCT01113931|2670780|P2|Safety Population|Overall Study||248
1103505|NCT01113931|2670781|P1|Safety Population|Overall Study|1 subject did not take any study medication|246
1103506|NCT01113931|2670780|P2|STARTED|Overall Study||248
1103507|NCT01113931|2670781|P1|STARTED|Overall Study||247
1103508|NCT01114334|2670795|P2|NOT COMPLETED|Overall Study||22
1103509|NCT01114334|2670796|P1|NOT COMPLETED|Overall Study||21
1103510|NCT01114334|2670795|P2|COMPLETED|Overall Study||58
1103511|NCT01114334|2670796|P1|COMPLETED|Overall Study||67
1103512|NCT01114334|2670795|P2|STARTED|Overall Study||80
1103513|NCT01114334|2670796|P1|STARTED|Overall Study||88
1103514|NCT01114360|2670806|P2|NOT COMPLETED|Intervention 2 (4 Weeks)||0
1103515|NCT01114360|2670807|P1|NOT COMPLETED|Intervention 2 (4 Weeks)||0
1103516|NCT01114360|2670806|P2|COMPLETED|Intervention 2 (4 Weeks)||18
1103517|NCT01114360|2670807|P1|COMPLETED|Intervention 2 (4 Weeks)||18
1103518|NCT01114360|2670806|P2|STARTED|Intervention 2 (4 Weeks)||18
1103519|NCT01114360|2670807|P1|STARTED|Intervention 2 (4 Weeks)||18
1103520|NCT01114360|2670806|P2|NOT COMPLETED|Intervention 1 (4 Weeks)||1
1103521|NCT01114360|2670807|P1|NOT COMPLETED|Intervention 1 (4 Weeks)||0
1103522|NCT01114360|2670806|P2|COMPLETED|Intervention 1 (4 Weeks)||18
1103523|NCT01114360|2670807|P1|COMPLETED|Intervention 1 (4 Weeks)||18
1103524|NCT01114360|2670806|P2|STARTED|Intervention 1 (4 Weeks)||19
1103525|NCT01114360|2670807|P1|STARTED|Intervention 1 (4 Weeks)||18
1103526|NCT01114373|2670843|P2|NOT COMPLETED|Intervention 2 (4 Weeks)||1
1103527|NCT01114373|2670844|P1|NOT COMPLETED|Intervention 2 (4 Weeks)||0
1103528|NCT01114373|2670843|P2|COMPLETED|Intervention 2 (4 Weeks)||18
1103529|NCT01114373|2670844|P1|COMPLETED|Intervention 2 (4 Weeks)||18
1103530|NCT01114373|2670843|P2|STARTED|Intervention 2 (4 Weeks)||19
1103531|NCT01114373|2670844|P1|STARTED|Intervention 2 (4 Weeks)||18
1103532|NCT01114373|2670843|P2|NOT COMPLETED|Intervention 1 (4 Weeks)||0
1103533|NCT01114373|2670844|P1|NOT COMPLETED|Intervention 1 (4 Weeks)||3
1103534|NCT01114373|2670843|P2|COMPLETED|Intervention 1 (4 Weeks)||19
1103535|NCT01114373|2670844|P1|COMPLETED|Intervention 1 (4 Weeks)||18
1103536|NCT01114373|2670843|P2|STARTED|Intervention 1 (4 Weeks)||19
1103537|NCT01114373|2670844|P1|STARTED|Intervention 1 (4 Weeks)||21
1103538|NCT01114438|2670876|P1|NOT COMPLETED|Overall Study||14
1103539|NCT01114438|2670876|P1|COMPLETED|Overall Study||31
1103540|NCT01114438|2670876|P1|STARTED|Overall Study||45
1103541|NCT01114503|2670886|P1|NOT COMPLETED|Overall Study||0
1103542|NCT01114503|2670886|P1|COMPLETED|Overall Study||2
1103543|NCT01114503|2670886|P1|STARTED|Overall Study||2
1103544|NCT01114516|2670909|P2|NOT COMPLETED|Overall Study||1
1103545|NCT01114516|2670910|P1|NOT COMPLETED|Overall Study||2
1103546|NCT01114516|2670909|P2|COMPLETED|Overall Study||26
1103547|NCT01114516|2670910|P1|COMPLETED|Overall Study||24
1103548|NCT01114516|2670909|P2|STARTED|Overall Study||27
1103549|NCT01114516|2670910|P1|STARTED|Overall Study||26
1103550|NCT01114529|2670927|P3|NOT COMPLETED|Completed Study Phase at Month 24||14
1103551|NCT01114529|2670928|P2|NOT COMPLETED|Completed Study Phase at Month 24||16
1103552|NCT01114529|2670929|P1|NOT COMPLETED|Completed Study Phase at Month 24||40
1103553|NCT01114529|2670927|P3|COMPLETED|Completed Study Phase at Month 24|at month 24|111
1103554|NCT01114529|2670928|P2|COMPLETED|Completed Study Phase at Month 24|at month 24|215
1103555|NCT01114529|2670929|P1|COMPLETED|Completed Study Phase at Month 24|at month 24|313
1103556|NCT01114529|2670927|P3|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|125
1103557|NCT01114529|2670928|P2|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|231
1103558|NCT01114529|2670929|P1|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|353
1103559|NCT01114529|2670927|P3|NOT COMPLETED|Completed Study Medication at Month 24||32
1103560|NCT01114529|2670928|P2|NOT COMPLETED|Completed Study Medication at Month 24||41
1103561|NCT01114529|2670929|P1|NOT COMPLETED|Completed Study Medication at Month 24||124
1103562|NCT01114529|2670927|P3|COMPLETED|Completed Study Medication at Month 24|completed at month 24|93
1103563|NCT01114529|2670928|P2|COMPLETED|Completed Study Medication at Month 24|completed at month 24|190
1103564|NCT01114529|2670929|P1|COMPLETED|Completed Study Medication at Month 24|completed at month 24|229
1103565|NCT01114529|2670927|P3|STARTED|Completed Study Medication at Month 24|Randomized set-125 Full analysis set -125 Safety analysis set -121***|125
1103566|NCT01114529|2670928|P2|STARTED|Completed Study Medication at Month 24|Randomized set -231 Full analysis set -231 Safety analysis set -238**|231
1103567|NCT01114529|2670929|P1|STARTED|Completed Study Medication at Month 24|Randomized set - 360 Full analysis set - 353 Safety analysis set -346*|353
1103568|NCT01114581|2670948|P2|NOT COMPLETED|Overall Study||0
1103569|NCT01114581|2670949|P1|NOT COMPLETED|Overall Study||0
1103570|NCT01114581|2670948|P2|COMPLETED|Overall Study||19
1103571|NCT01114581|2670949|P1|COMPLETED|Overall Study||19
1103572|NCT01114581|2670948|P2|STARTED|Overall Study||19
1103573|NCT01114581|2670949|P1|STARTED|Overall Study||19
1103574|NCT01114672|2670959|P2|NOT COMPLETED|Overall Study||2
1103575|NCT01114672|2670960|P1|NOT COMPLETED|Overall Study||4
1103576|NCT01114672|2670959|P2|COMPLETED|Overall Study||23
1103577|NCT01114672|2670960|P1|COMPLETED|Overall Study||21
1103578|NCT01114672|2670959|P2|STARTED|Overall Study||25
1103579|NCT01114672|2670960|P1|STARTED|Overall Study||25
1103583|NCT01114737|2670986|P2|NOT COMPLETED|Open-Label Treatment Period||2
1103584|NCT01114737|2670987|P1|NOT COMPLETED|Open-Label Treatment Period||5
1103585|NCT01114737|2670986|P2|COMPLETED|Open-Label Treatment Period||95
1103586|NCT01114737|2670987|P1|COMPLETED|Open-Label Treatment Period||100
1103587|NCT01114737|2670986|P2|STARTED|Open-Label Treatment Period|Two subjects did not receive a single dose of the study drug|97
1103588|NCT01114737|2670987|P1|STARTED|Open-Label Treatment Period|One subject did not receive a single dose of the study drug|105
1103589|NCT01114737|2670986|P2|NOT COMPLETED|Randomized Treatment Period||1
1103590|NCT01114737|2670987|P1|NOT COMPLETED|Randomized Treatment Period||3
1103591|NCT01114737|2670986|P2|COMPLETED|Randomized Treatment Period||97
1103592|NCT01114737|2670987|P1|COMPLETED|Randomized Treatment Period||105
1103593|NCT01114737|2670986|P2|STARTED|Randomized Treatment Period||98
1103594|NCT01114737|2670987|P1|STARTED|Randomized Treatment Period||108
1103595|NCT01114828|2671037|P2|NOT COMPLETED|Overall Study||4
1103596|NCT01114828|2671038|P1|NOT COMPLETED|Overall Study||3
1103597|NCT01114828|2671037|P2|COMPLETED|Overall Study||17
1103598|NCT01114828|2671038|P1|COMPLETED|Overall Study||16
1103599|NCT01114828|2671037|P2|STARTED|Overall Study||21
1103600|NCT01114828|2671038|P1|STARTED|Overall Study||19
1103601|NCT01114880|2671048|P2|NOT COMPLETED|Period 2 (Week 12 to Week 24)||2
1103602|NCT01114880|2671049|P1|NOT COMPLETED|Period 2 (Week 12 to Week 24)||3
1103603|NCT01114880|2671048|P2|COMPLETED|Period 2 (Week 12 to Week 24)||111
1103604|NCT01114880|2671049|P1|COMPLETED|Period 2 (Week 12 to Week 24)||221
1103605|NCT01114880|2671048|P2|STARTED|Period 2 (Week 12 to Week 24)||113
1103606|NCT01114880|2671049|P1|STARTED|Period 2 (Week 12 to Week 24)||224
1103607|NCT01114880|2671048|P2|NOT COMPLETED|Period 1 (Week 0 to Week 12)||2
1103608|NCT01114880|2671049|P1|NOT COMPLETED|Period 1 (Week 0 to Week 12)||5
1103609|NCT01114880|2671048|P2|COMPLETED|Period 1 (Week 0 to Week 12)||113
1103610|NCT01114880|2671049|P1|COMPLETED|Period 1 (Week 0 to Week 12)||224
1103611|NCT01114880|2671048|P2|STARTED|Period 1 (Week 0 to Week 12)||115
1103612|NCT01114880|2671049|P1|STARTED|Period 1 (Week 0 to Week 12)||229
1103613|NCT01114893|2671104|P5|NOT COMPLETED|Overall Study||0
1103614|NCT01114893|2671105|P4|NOT COMPLETED|Overall Study||0
1103615|NCT01114893|2671106|P3|NOT COMPLETED|Overall Study||0
1103616|NCT01114893|2671107|P2|NOT COMPLETED|Overall Study||0
1103617|NCT01114893|2671108|P1|NOT COMPLETED|Overall Study||0
1103618|NCT01114893|2671104|P5|COMPLETED|Overall Study||12
1103619|NCT01114893|2671105|P4|COMPLETED|Overall Study||13
1103620|NCT01114893|2671106|P3|COMPLETED|Overall Study||14
1103621|NCT01114893|2671107|P2|COMPLETED|Overall Study||14
1103622|NCT01114893|2671108|P1|COMPLETED|Overall Study||14
1103623|NCT01114893|2671104|P5|STARTED|Overall Study||12
1103624|NCT01114893|2671105|P4|STARTED|Overall Study||13
1103625|NCT01114893|2671106|P3|STARTED|Overall Study||14
1103626|NCT01114893|2671107|P2|STARTED|Overall Study||14
1103627|NCT01114893|2671108|P1|STARTED|Overall Study||14
1103628|NCT01121484|2671127|P2|NOT COMPLETED|Overall Study||43
1103629|NCT01121484|2671128|P1|NOT COMPLETED|Overall Study||33
1103630|NCT01121484|2671127|P2|COMPLETED|Overall Study||178
1103631|NCT01121484|2671128|P1|COMPLETED|Overall Study||185
1103632|NCT01121484|2671127|P2|Treated|Overall Study||217
1103633|NCT01121484|2671128|P1|Treated|Overall Study||217
1103634|NCT01121484|2671127|P2|STARTED|Overall Study||221
1103635|NCT01121484|2671128|P1|STARTED|Overall Study||218
1103636|NCT01121536|2671144|P1|NOT COMPLETED|Overall Study||361
1103637|NCT01121536|2671144|P1|COMPLETED|Overall Study|One participant 'completed' early due to study closeout.|506
1103638|NCT01121536|2671144|P1|Full Analysis Population|Overall Study|Treated participants who had at least 1 post-baseline efficacy assessment.|859
1103639|NCT01121536|2671144|P1|Safety Population|Overall Study|Participants treated|863
1103640|NCT01121536|2671144|P1|STARTED|Overall Study||867
1103641|NCT01121549|2671163|P1|NOT COMPLETED|Overall Study||347
1103642|NCT01121549|2671163|P1|COMPLETED|Overall Study||31
1103643|NCT01121549|2671163|P1|STARTED|Overall Study||378
1103644|NCT01121562|2671174|P1|NOT COMPLETED|Overall Study||12
1103645|NCT01121562|2671174|P1|COMPLETED|Overall Study||0
1103646|NCT01121562|2671174|P1|STARTED|Overall Study||12
1103647|NCT01121575|2671189|P6|NOT COMPLETED|Overall Study||12
1103648|NCT01121575|2671190|P5|NOT COMPLETED|Overall Study||25
1103649|NCT01121575|2671191|P4|NOT COMPLETED|Overall Study||6
1103650|NCT01121575|2671192|P3|NOT COMPLETED|Overall Study||7
1103651|NCT01121575|2671193|P2|NOT COMPLETED|Overall Study||6
1103652|NCT01121575|2671194|P1|NOT COMPLETED|Overall Study||14
1103653|NCT01121575|2671189|P6|COMPLETED|Overall Study||0
1103654|NCT01121575|2671190|P5|COMPLETED|Overall Study||0
1103655|NCT01121575|2671191|P4|COMPLETED|Overall Study||0
1103656|NCT01121575|2671192|P3|COMPLETED|Overall Study||0
1103657|NCT01121575|2671193|P2|COMPLETED|Overall Study||0
1103658|NCT01121575|2671194|P1|COMPLETED|Overall Study||0
1103659|NCT01121575|2671189|P6|Treated|Overall Study||12
1103660|NCT01121575|2671190|P5|Treated|Overall Study||25
1103661|NCT01121575|2671191|P4|Treated|Overall Study||6
1103662|NCT01121575|2671192|P3|Treated|Overall Study||7
1103663|NCT01121575|2671193|P2|Treated|Overall Study||6
1103664|NCT01121575|2671194|P1|Treated|Overall Study||14
1103665|NCT01121575|2671189|P6|STARTED|Overall Study||12
1103666|NCT01121575|2671190|P5|STARTED|Overall Study||25
1103667|NCT01121575|2671191|P4|STARTED|Overall Study||6
1103668|NCT01121575|2671192|P3|STARTED|Overall Study||7
1103669|NCT01121575|2671193|P2|STARTED|Overall Study||6
1103670|NCT01121575|2671194|P1|STARTED|Overall Study||14
1103671|NCT01121666|2671320|P2|NOT COMPLETED|Overall Study||10
1103672|NCT01121666|2671321|P1|NOT COMPLETED|Overall Study||29
1103673|NCT01121666|2671320|P2|COMPLETED|Overall Study||113
1103674|NCT01121666|2671321|P1|COMPLETED|Overall Study||220
1103675|NCT01121666|2671320|P2|STARTED|Overall Study||123
1103676|NCT01121666|2671321|P1|STARTED|Overall Study||249
1103677|NCT01121757|2671373|P2|NOT COMPLETED|Combination||1
1103678|NCT01121757|2671374|P1|NOT COMPLETED|Combination||2
1103679|NCT01121757|2671373|P2|COMPLETED|Combination||0
1103680|NCT01121757|2671374|P1|COMPLETED|Combination||0
1103681|NCT01121757|2671373|P2|STARTED|Combination||1
1103682|NCT01121757|2671374|P1|STARTED|Combination|2 subjects did not start combination drug. 1 elected surgery 1 had a complete response after drug 2.|2
1103683|NCT01121757|2671373|P2|NOT COMPLETED|Second Drug||0
1103684|NCT01121757|2671374|P1|NOT COMPLETED|Second Drug||0
1103685|NCT01121757|2671373|P2|COMPLETED|Second Drug||1
1103686|NCT01121757|2671374|P1|COMPLETED|Second Drug||4
1103687|NCT01121757|2671373|P2|STARTED|Second Drug||1
1103688|NCT01121757|2671374|P1|STARTED|Second Drug|1 subject did not start drug 2 due to disease progression|4
1103689|NCT01121757|2671373|P2|NOT COMPLETED|First Drug||2
1103690|NCT01121757|2671374|P1|NOT COMPLETED|First Drug||1
1103691|NCT01121757|2671373|P2|COMPLETED|First Drug|Completed a minimum of 4 cycles of Lenalidomide|1
1103692|NCT01121757|2671374|P1|COMPLETED|First Drug|Completed a minimum of 4 cycles of Azacitidine.|5
1103693|NCT01121757|2671373|P2|STARTED|First Drug||3
1103694|NCT01121757|2671374|P1|STARTED|First Drug||6
1103695|NCT01123356|2671388|P1|NOT COMPLETED|Overall Study||7
1103696|NCT01123356|2671388|P1|COMPLETED|Overall Study||14
1103697|NCT01123356|2671388|P1|STARTED|Overall Study||21
1103698|NCT01123395|2671396|P2|NOT COMPLETED|Period 2||0
1103699|NCT01123395|2671397|P1|NOT COMPLETED|Period 2||0
1103700|NCT01123395|2671396|P2|COMPLETED|Period 2||7
1103701|NCT01123395|2671397|P1|COMPLETED|Period 2||8
1103702|NCT01123395|2671396|P2|STARTED|Period 2||7
1103703|NCT01123395|2671397|P1|STARTED|Period 2||8
1103704|NCT01123395|2671396|P2|NOT COMPLETED|Washout Period of 14 Days||1
1103705|NCT01123395|2671397|P1|NOT COMPLETED|Washout Period of 14 Days||0
1103706|NCT01123395|2671396|P2|COMPLETED|Washout Period of 14 Days||7
1103707|NCT01123395|2671397|P1|COMPLETED|Washout Period of 14 Days||8
1103708|NCT01123395|2671396|P2|STARTED|Washout Period of 14 Days||8
1103709|NCT01123395|2671397|P1|STARTED|Washout Period of 14 Days||8
1103710|NCT01123395|2671396|P2|NOT COMPLETED|Period 1||0
1103711|NCT01123395|2671397|P1|NOT COMPLETED|Period 1||0
1103712|NCT01123395|2671396|P2|COMPLETED|Period 1||8
1103713|NCT01123395|2671397|P1|COMPLETED|Period 1||8
1103714|NCT01123395|2671396|P2|STARTED|Period 1||8
1103715|NCT01123395|2671397|P1|STARTED|Period 1||8
1103716|NCT01123512|2671409|P2|NOT COMPLETED|Overall Study||21
1103717|NCT01123512|2671410|P1|NOT COMPLETED|Overall Study||26
1103718|NCT01123512|2671409|P2|COMPLETED|Overall Study||126
1103719|NCT01123512|2671410|P1|COMPLETED|Overall Study||127
1103720|NCT01123512|2671409|P2|STARTED|Overall Study||147
1103721|NCT01123512|2671410|P1|STARTED|Overall Study||153
1103722|NCT01123642|2671416|P1|NOT COMPLETED|Overall Study||68
1103723|NCT01123642|2671416|P1|COMPLETED|Overall Study||277
1103724|NCT01123642|2671416|P1|STARTED|Overall Study||345
1103725|NCT01123850|2671420|P1|NOT COMPLETED|Overall Study||45
1103726|NCT01123850|2671420|P1|COMPLETED|Overall Study||0
1103727|NCT01123850|2671420|P1|STARTED|Overall Study||45
1103728|NCT01123889|2671427|P2|NOT COMPLETED|Overall Study||1
1103729|NCT01123889|2671428|P1|NOT COMPLETED|Overall Study||3
1103730|NCT01123889|2671427|P2|COMPLETED|Overall Study||6
1103731|NCT01123889|2671428|P1|COMPLETED|Overall Study||2
1103732|NCT01123889|2671427|P2|STARTED|Overall Study||7
1103733|NCT01123889|2671428|P1|STARTED|Overall Study||5
1103734|NCT01123928|2671440|P2|NOT COMPLETED|Overall Study||0
1103735|NCT01123928|2671441|P1|NOT COMPLETED|Overall Study||0
1103736|NCT01123928|2671440|P2|COMPLETED|Overall Study||222
1103737|NCT01123928|2671441|P1|COMPLETED|Overall Study||212
1103738|NCT01123928|2671440|P2|STARTED|Overall Study||222
1103739|NCT01123928|2671441|P1|STARTED|Overall Study||212
1103740|NCT01123941|2671461|P2|NOT COMPLETED|Overall Study||1
1103741|NCT01123941|2671462|P1|NOT COMPLETED|Overall Study||2
1103742|NCT01123941|2671461|P2|COMPLETED|Overall Study||24
1103743|NCT01123941|2671462|P1|COMPLETED|Overall Study||23
1103744|NCT01123941|2671461|P2|STARTED|Overall Study||25
1103745|NCT01123941|2671462|P1|STARTED|Overall Study||25
1103746|NCT01123980|2671476|P2|NOT COMPLETED|Overall Study||24
1103747|NCT01123980|2671477|P1|NOT COMPLETED|Overall Study||19
1103748|NCT01123980|2671476|P2|COMPLETED|Overall Study||236
1103749|NCT01123980|2671477|P1|COMPLETED|Overall Study||242
1103750|NCT01123980|2671476|P2|STARTED|Overall Study||260
1103751|NCT01123980|2671477|P1|STARTED|Overall Study||261
1103752|NCT01124006|2671498|P3|NOT COMPLETED|Overall Study||2
1103753|NCT01124006|2671499|P2|NOT COMPLETED|Overall Study||2
1103754|NCT01124006|2671500|P1|NOT COMPLETED|Overall Study||3
1103755|NCT01124006|2671498|P3|COMPLETED|Overall Study||2
1103756|NCT01124006|2671499|P2|COMPLETED|Overall Study||8
1103757|NCT01124006|2671500|P1|COMPLETED|Overall Study||7
1103758|NCT01124006|2671498|P3|STARTED|Overall Study||4
1103759|NCT01124006|2671499|P2|STARTED|Overall Study||10
1103760|NCT01124006|2671500|P1|STARTED|Overall Study||10
1103761|NCT01124045|2671528|P2|NOT COMPLETED|Overall Study||3
1103762|NCT01124045|2671529|P1|NOT COMPLETED|Overall Study||0
1103763|NCT01124045|2671528|P2|COMPLETED|Overall Study||37
1103764|NCT01124045|2671529|P1|COMPLETED|Overall Study||39
1103765|NCT01124045|2671528|P2|STARTED|Overall Study||40
1103766|NCT01124045|2671529|P1|STARTED|Overall Study||39
1103767|NCT01124097|2671563|P4|NOT COMPLETED|Overall Study||14
1103768|NCT01124097|2671564|P3|NOT COMPLETED|Overall Study||20
1103769|NCT01124097|2671565|P2|NOT COMPLETED|Overall Study||22
1103770|NCT01124097|2671566|P1|NOT COMPLETED|Overall Study||34
1103771|NCT01124097|2671563|P4|COMPLETED|Overall Study||46
1103772|NCT01124097|2671564|P3|COMPLETED|Overall Study||40
1103773|NCT01124097|2671565|P2|COMPLETED|Overall Study||38
1103774|NCT01124097|2671566|P1|COMPLETED|Overall Study||26
1103775|NCT01124097|2671563|P4|Efficacy Population|Overall Study||51
1103776|NCT01124097|2671564|P3|Efficacy Population|Overall Study||53
1103777|NCT01124097|2671565|P2|Efficacy Population|Overall Study||53
1103778|NCT01124097|2671566|P1|Efficacy Population|Overall Study||52
1103779|NCT01124097|2671563|P4|Safety Population|Overall Study||60
1103780|NCT01124097|2671564|P3|Safety Population|Overall Study||60
1103781|NCT01124097|2671565|P2|Safety Population|Overall Study||60
1103782|NCT01124097|2671566|P1|Safety Population|Overall Study||60
1103783|NCT01124097|2671563|P4|STARTED|Overall Study||60
1103784|NCT01124097|2671564|P3|STARTED|Overall Study||60
1103785|NCT01124097|2671565|P2|STARTED|Overall Study||60
1103786|NCT01124097|2671566|P1|STARTED|Overall Study||60
1103787|NCT01124149|2671576|P1|NOT COMPLETED|Maintenance Phase||96
1103788|NCT01124149|2671576|P1|COMPLETED|Maintenance Phase||373
1103789|NCT01124149|2671576|P1|STARTED|Maintenance Phase||469
1103790|NCT01124149|2671576|P1|NOT COMPLETED|Acute Phase||83
1103791|NCT01124149|2671576|P1|COMPLETED|Acute Phase||639
1103792|NCT01124149|2671576|P1|STARTED|Acute Phase||722
1103793|NCT01124162|2671594|P2|NOT COMPLETED|Second Intervention||0
1103794|NCT01124162|2671595|P1|NOT COMPLETED|Second Intervention||0
1103795|NCT01124162|2671594|P2|COMPLETED|Second Intervention||40
1103796|NCT01124162|2671595|P1|COMPLETED|Second Intervention||37
1103797|NCT01124162|2671594|P2|STARTED|Second Intervention||40
1103798|NCT01124162|2671595|P1|STARTED|Second Intervention||37
1103799|NCT01124162|2671594|P2|NOT COMPLETED|Washout of 7 Days||0
1103800|NCT01124162|2671595|P1|NOT COMPLETED|Washout of 7 Days||1
1103801|NCT01124162|2671594|P2|COMPLETED|Washout of 7 Days||40
1103802|NCT01124162|2671595|P1|COMPLETED|Washout of 7 Days||37
1103803|NCT01124162|2671594|P2|STARTED|Washout of 7 Days||40
1103804|NCT01124162|2671595|P1|STARTED|Washout of 7 Days||38
1103805|NCT01124162|2671594|P2|NOT COMPLETED|First Intervention||0
1103806|NCT01124162|2671595|P1|NOT COMPLETED|First Intervention||2
1103807|NCT01124162|2671594|P2|COMPLETED|First Intervention||40
1103808|NCT01124162|2671595|P1|COMPLETED|First Intervention||38
1103809|NCT01124162|2671594|P2|STARTED|First Intervention||40
1103810|NCT01124162|2671595|P1|STARTED|First Intervention||40
1103811|NCT01124175|2671613|P2|NOT COMPLETED|Second Intervention||0
1103812|NCT01124175|2671614|P1|NOT COMPLETED|Second Intervention||0
1103813|NCT01124175|2671613|P2|COMPLETED|Second Intervention||38
1103814|NCT01124175|2671614|P1|COMPLETED|Second Intervention||40
1103815|NCT01124175|2671613|P2|STARTED|Second Intervention||38
1103816|NCT01124175|2671614|P1|STARTED|Second Intervention||40
1103817|NCT01124175|2671613|P2|NOT COMPLETED|Washout of 7 Days||2
1103818|NCT01124175|2671614|P1|NOT COMPLETED|Washout of 7 Days||0
1103819|NCT01124175|2671613|P2|COMPLETED|Washout of 7 Days||38
1103820|NCT01124175|2671614|P1|COMPLETED|Washout of 7 Days||40
1103821|NCT01124175|2671613|P2|STARTED|Washout of 7 Days||40
1103822|NCT01124175|2671614|P1|STARTED|Washout of 7 Days||40
1103823|NCT01124175|2671613|P2|NOT COMPLETED|First Intervention||0
1103824|NCT01124175|2671614|P1|NOT COMPLETED|First Intervention||0
1103825|NCT01124175|2671613|P2|COMPLETED|First Intervention||40
1103826|NCT01124175|2671614|P1|COMPLETED|First Intervention||40
1103827|NCT01124175|2671613|P2|STARTED|First Intervention||40
1103828|NCT01124175|2671614|P1|STARTED|First Intervention||40
1103829|NCT01124188|2671632|P2|NOT COMPLETED|Overall Study||6
1103830|NCT01124188|2671633|P1|NOT COMPLETED|Overall Study||8
1103831|NCT01124188|2671632|P2|COMPLETED|Overall Study||65
1103832|NCT01124188|2671633|P1|COMPLETED|Overall Study||60
1103833|NCT01124188|2671632|P2|STARTED|Overall Study||71
1103834|NCT01124188|2671633|P1|STARTED|Overall Study||68
1103835|NCT01124292|2671646|P3|NOT COMPLETED|Overall Study||10
1103836|NCT01124292|2671647|P2|NOT COMPLETED|Overall Study||15
1103837|NCT01124292|2671648|P1|NOT COMPLETED|Overall Study||2
1103838|NCT01124292|2671646|P3|COMPLETED|Overall Study||11
1103839|NCT01124292|2671647|P2|COMPLETED|Overall Study||9
1103840|NCT01124292|2671648|P1|COMPLETED|Overall Study||14
1103841|NCT01124292|2671646|P3|STARTED|Overall Study||21
1103842|NCT01124292|2671647|P2|STARTED|Overall Study||24
1103843|NCT01124292|2671648|P1|STARTED|Overall Study||16
1103844|NCT01124305|2671706|P2|NOT COMPLETED|Overall Study||10
1103845|NCT01124305|2671707|P1|NOT COMPLETED|Overall Study||8
1103846|NCT01124305|2671706|P2|COMPLETED|Overall Study||26
1103847|NCT01124305|2671707|P1|COMPLETED|Overall Study||26
1103848|NCT01124305|2671706|P2|STARTED|Overall Study||36
1103849|NCT01124305|2671707|P1|STARTED|Overall Study||34
1103850|NCT01124370|2671719|P1|NOT COMPLETED|Overall Study||20
1103851|NCT01124370|2671719|P1|COMPLETED|Overall Study|Completed 2 year post-implant follow-up|37
1103852|NCT01124370|2671719|P1|3 Month Visit|Overall Study|Defines evaluable population|47
1103853|NCT01124370|2671719|P1|Therapy Initiated|Overall Study||48
1103854|NCT01124370|2671719|P1|Successfully Implanted|Overall Study||50
1103855|NCT01124370|2671719|P1|STARTED|Overall Study|Underwent implant attempt|57
1103856|NCT01124422|2671731|P3|NOT COMPLETED|4-Week Double-blind Treatment Phase||9
1103857|NCT01124422|2671732|P2|NOT COMPLETED|4-Week Double-blind Treatment Phase||11
1103858|NCT01124422|2671733|P1|NOT COMPLETED|4-Week Double-blind Treatment Phase||0
1103859|NCT01124422|2671731|P3|COMPLETED|4-Week Double-blind Treatment Phase||115
1103860|NCT01124422|2671732|P2|COMPLETED|4-Week Double-blind Treatment Phase||120
1103861|NCT01124422|2671733|P1|COMPLETED|4-Week Double-blind Treatment Phase||0
1103862|NCT01124422|2671731|P3|STARTED|4-Week Double-blind Treatment Phase||124
1103863|NCT01124422|2671732|P2|STARTED|4-Week Double-blind Treatment Phase||131
1103864|NCT01124422|2671733|P1|STARTED|4-Week Double-blind Treatment Phase||0
1103865|NCT01124422|2671731|P3|NOT COMPLETED|4-Week Open-label Run-in Phase||0
1103866|NCT01124422|2671732|P2|NOT COMPLETED|4-Week Open-label Run-in Phase||0
1103867|NCT01124422|2671733|P1|NOT COMPLETED|4-Week Open-label Run-in Phase||83
1103868|NCT01124422|2671731|P3|COMPLETED|4-Week Open-label Run-in Phase||0
1103869|NCT01124422|2671732|P2|COMPLETED|4-Week Open-label Run-in Phase||0
1103870|NCT01124422|2671733|P1|COMPLETED|4-Week Open-label Run-in Phase||255
1103871|NCT01124422|2671731|P3|STARTED|4-Week Open-label Run-in Phase||0
1103872|NCT01124422|2671732|P2|STARTED|4-Week Open-label Run-in Phase||0
1103873|NCT01124422|2671733|P1|STARTED|4-Week Open-label Run-in Phase||338
1103874|NCT01124448|2671777|P2|NOT COMPLETED|Overall Study||3
1103875|NCT01124448|2671778|P1|NOT COMPLETED|Overall Study||2
1103876|NCT01124448|2671777|P2|COMPLETED|Overall Study||12
1103877|NCT01124448|2671778|P1|COMPLETED|Overall Study||23
1103878|NCT01124448|2671777|P2|STARTED|Overall Study||15
1103879|NCT01124448|2671778|P1|STARTED|Overall Study||25
1103880|NCT01124604|2671786|P2|NOT COMPLETED|Overall Study||2
1103881|NCT01124604|2671787|P1|NOT COMPLETED|Overall Study||15
1103882|NCT01124604|2671786|P2|COMPLETED|Overall Study||29
1103883|NCT01124604|2671787|P1|COMPLETED|Overall Study||45
1103884|NCT01124604|2671786|P2|STARTED|Overall Study||31
1103885|NCT01124604|2671787|P1|STARTED|Overall Study||60
1103886|NCT01124617|2671826|P2|NOT COMPLETED|Overall Study||6
1103887|NCT01124617|2671827|P1|NOT COMPLETED|Overall Study||19
1103888|NCT01124617|2671826|P2|COMPLETED|Overall Study||25
1103889|NCT01124617|2671827|P1|COMPLETED|Overall Study||41
1103890|NCT01124617|2671826|P2|STARTED|Overall Study||31
1103891|NCT01124617|2671827|P1|STARTED|Overall Study||60
1103892|NCT01124643|2671857|P1|NOT COMPLETED|Overall Study||1
1103893|NCT01124643|2671857|P1|COMPLETED|Overall Study||34
1103894|NCT01124643|2671857|P1|STARTED|Overall Study||35
1103895|NCT01124786|2671871|P2|NOT COMPLETED|Overall Study||5
1103896|NCT01124786|2671872|P1|NOT COMPLETED|Overall Study||4
1103897|NCT01124786|2671871|P2|COMPLETED|Overall Study||180
1103898|NCT01124786|2671872|P1|COMPLETED|Overall Study||178
1103899|NCT01124786|2671871|P2|Tumor Evaluable Population|Overall Study||180
1103900|NCT01124786|2671872|P1|Tumor Evaluable Population|Overall Study|All pts with measurable/evaluable tumor at baseline per RECIST and have received ≥ one dose of drug|178
1103901|NCT01124786|2671871|P2|Safety Population|Overall Study||181
1103902|NCT01124786|2671872|P1|Safety Population|Overall Study|All pts who received at least one dose of study drug|179
1103903|NCT01124786|2671871|P2|Intent-to-Treat (ITT) Population|Overall Study||185
1103904|NCT01124786|2671872|P1|Intent-to-Treat (ITT) Population|Overall Study|All randomized patients (pts)|182
1103905|NCT01124786|2671871|P2|STARTED|Overall Study||185
1103906|NCT01124786|2671872|P1|STARTED|Overall Study||182
1103907|NCT01124838|2671894|P2|NOT COMPLETED|Overall Study||15
1103908|NCT01124838|2671895|P1|NOT COMPLETED|Overall Study||18
1103909|NCT01124838|2671894|P2|COMPLETED|Overall Study||116
1103910|NCT01124838|2671895|P1|COMPLETED|Overall Study||112
1103911|NCT01124838|2671894|P2|Enrolled in Japan Sub-study|Overall Study||16
1103912|NCT01124838|2671895|P1|Enrolled in Japan Sub-study|Overall Study||16
1103913|NCT01124838|2671894|P2|Enrolled in Main Study|Overall Study||115
1103914|NCT01124838|2671895|P1|Enrolled in Main Study|Overall Study||114
1103915|NCT01124838|2671894|P2|STARTED|Overall Study||131
1103916|NCT01124838|2671895|P1|STARTED|Overall Study||130
1103917|NCT01124864|2671945|P6|NOT COMPLETED|Overall Study||3
1103918|NCT01124864|2671946|P5|NOT COMPLETED|Overall Study||30
1103919|NCT01124864|2671947|P4|NOT COMPLETED|Overall Study||21
1103920|NCT01124864|2671948|P3|NOT COMPLETED|Overall Study||34
1103921|NCT01124864|2671949|P2|NOT COMPLETED|Overall Study||35
1103922|NCT01124864|2671950|P1|NOT COMPLETED|Overall Study||28
1103923|NCT01124864|2671945|P6|COMPLETED|Overall Study||0
1103924|NCT01124864|2671946|P5|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
1103925|NCT01124864|2671947|P4|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
1103926|NCT01124864|2671948|P3|COMPLETED|Overall Study||0
1103927|NCT01124864|2671949|P2|COMPLETED|Overall Study||0
1103928|NCT01124864|2671950|P1|COMPLETED|Overall Study||0
1103929|NCT01124864|2671945|P6|STARTED|Overall Study||3
1103930|NCT01124864|2671946|P5|STARTED|Overall Study||31
1103931|NCT01124864|2671947|P4|STARTED|Overall Study||22
1103932|NCT01124864|2671948|P3|STARTED|Overall Study||34
1103933|NCT01124864|2671949|P2|STARTED|Overall Study||35
1103934|NCT01124864|2671950|P1|STARTED|Overall Study||28
1103935|NCT01124916|2671984|P2|NOT COMPLETED|Overall Study||2
1103936|NCT01124916|2671985|P1|NOT COMPLETED|Overall Study||3
1103937|NCT01124916|2671984|P2|COMPLETED|Overall Study||38
1103938|NCT01124916|2671985|P1|COMPLETED|Overall Study||35
1103939|NCT01124916|2671984|P2|STARTED|Overall Study||40
1103940|NCT01124916|2671985|P1|STARTED|Overall Study||38
1103941|NCT01124955|2671995|P2|NOT COMPLETED|Overall Study||0
1103942|NCT01124955|2671996|P1|NOT COMPLETED|Overall Study||0
1103943|NCT01124955|2671995|P2|COMPLETED|Overall Study||40
1103944|NCT01124955|2671996|P1|COMPLETED|Overall Study||40
1103945|NCT01124955|2671995|P2|STARTED|Overall Study||40
1103946|NCT01124955|2671996|P1|STARTED|Overall Study||40
1103947|NCT01125098|2672012|P2|NOT COMPLETED|Overall Study||0
1103948|NCT01125098|2672013|P1|NOT COMPLETED|Overall Study||3
1103949|NCT01125098|2672012|P2|COMPLETED|Overall Study||90
1103950|NCT01125098|2672013|P1|COMPLETED|Overall Study||88
1103951|NCT01125098|2672012|P2|STARTED|Overall Study||90
1103952|NCT01125098|2672013|P1|STARTED|Overall Study||91
1103953|NCT01125189|2672022|P3|NOT COMPLETED|Follow up Period||16
1103954|NCT01125189|2672023|P2|NOT COMPLETED|Follow up Period||15
1103955|NCT01125189|2672024|P1|NOT COMPLETED|Follow up Period||20
1103956|NCT01125189|2672022|P3|COMPLETED|Follow up Period||58
1103957|NCT01125189|2672023|P2|COMPLETED|Follow up Period||138
1103958|NCT01125189|2672024|P1|COMPLETED|Follow up Period||132
1103959|NCT01125189|2672022|P3|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|74
1103960|NCT01125189|2672023|P2|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|153
1103961|NCT01125189|2672024|P1|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|152
1103962|NCT01125189|2672022|P3|NOT COMPLETED|Treatment Period||41
1103963|NCT01125189|2672023|P2|NOT COMPLETED|Treatment Period||35
1103964|NCT01125189|2672024|P1|NOT COMPLETED|Treatment Period||31
1103965|NCT01125189|2672022|P3|COMPLETED|Treatment Period||37
1103966|NCT01125189|2672023|P2|COMPLETED|Treatment Period||123
1103967|NCT01125189|2672024|P1|COMPLETED|Treatment Period||128
1103968|NCT01125189|2672022|P3|STARTED|Treatment Period||78
1103969|NCT01125189|2672023|P2|STARTED|Treatment Period||158
1103970|NCT01125189|2672024|P1|STARTED|Treatment Period||159
1103971|NCT01125202|2672052|P2|NOT COMPLETED|Overall Study||7
1103972|NCT01125202|2672053|P1|NOT COMPLETED|Overall Study||12
1103973|NCT01125202|2672052|P2|COMPLETED|Overall Study||79
1103974|NCT01125202|2672053|P1|COMPLETED|Overall Study||81
1103975|NCT01125202|2672052|P2|STARTED|Overall Study||86
1103976|NCT01125202|2672053|P1|STARTED|Overall Study||93
1103977|NCT01125514|2672075|P1|NOT COMPLETED|Treatment Period2(Day9-Day27) and Day 28||4
1103978|NCT01125514|2672075|P1|COMPLETED|Treatment Period2(Day9-Day27) and Day 28||28
1103979|NCT01125514|2672075|P1|STARTED|Treatment Period2(Day9-Day27) and Day 28||32
1103980|NCT01125514|2672075|P1|NOT COMPLETED|Treatment Period 2 (Day 8 - Day 17)||3
1103981|NCT01125514|2672075|P1|COMPLETED|Treatment Period 2 (Day 8 - Day 17)||32
1103982|NCT01125514|2672075|P1|Pharmacodynamics (PD) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
1103983|NCT01125514|2672075|P1|Pharmacokinetic (PK) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
1103984|NCT01125514|2672075|P1|STARTED|Treatment Period 2 (Day 8 - Day 17)||35
1103985|NCT01125514|2672075|P1|NOT COMPLETED|Treatment Period 1 (Day 1 - Day 7)||2
1103986|NCT01125514|2672075|P1|COMPLETED|Treatment Period 1 (Day 1 - Day 7)||35
1103987|NCT01125514|2672075|P1|STARTED|Treatment Period 1 (Day 1 - Day 7)|Randomized and safety population|37
1103988|NCT01125566|2672149|P3|NOT COMPLETED|Patients Who Switched From AV to TV||24
1103989|NCT01125566|2672150|P2|NOT COMPLETED|Patients Who Switched From AV to TV||0
1103990|NCT01125566|2672151|P1|NOT COMPLETED|Patients Who Switched From AV to TV||0
1103991|NCT01125566|2672149|P3|COMPLETED|Patients Who Switched From AV to TV|On TV treatment at analysis cut-off date (03Sep2013)|49
1103992|NCT01125566|2672150|P2|COMPLETED|Patients Who Switched From AV to TV||0
1103993|NCT01125566|2672151|P1|COMPLETED|Patients Who Switched From AV to TV||0
1103994|NCT01125566|2672149|P3|STARTED|Patients Who Switched From AV to TV|All patients without disease progression who chose to switch from AV to TV by 08Jun2013|73
1103995|NCT01125566|2672150|P2|STARTED|Patients Who Switched From AV to TV||0
1103996|NCT01125566|2672151|P1|STARTED|Patients Who Switched From AV to TV||0
1103997|NCT01125566|2672149|P3|NOT COMPLETED|Patients Before the Switch (26Apr2013)||0
1103998|NCT01125566|2672150|P2|NOT COMPLETED|Patients Before the Switch (26Apr2013)||136
1103999|NCT01125566|2672151|P1|NOT COMPLETED|Patients Before the Switch (26Apr2013)||260
1104000|NCT01125566|2672149|P3|COMPLETED|Patients Before the Switch (26Apr2013)||0
1104001|NCT01125566|2672150|P2|COMPLETED|Patients Before the Switch (26Apr2013)|On treatment at analysis cut-off date (03Sep2013)|33
1104002|NCT01125566|2672151|P1|COMPLETED|Patients Before the Switch (26Apr2013)|All patients without disease progression who were on treatment on 08Jun2013|79
1104003|NCT01125566|2672149|P3|STARTED|Patients Before the Switch (26Apr2013)||0
1104004|NCT01125566|2672150|P2|STARTED|Patients Before the Switch (26Apr2013)|Randomised|169
1104005|NCT01125566|2672151|P1|STARTED|Patients Before the Switch (26Apr2013)|Randomised|339
1104006|NCT01125605|2672164|P1|NOT COMPLETED|Overall Study||0
1104007|NCT01125605|2672164|P1|COMPLETED|Overall Study||325
1104008|NCT01125605|2672164|P1|Safety|Overall Study|1 patient was only analysed for safety|326
1104009|NCT01125605|2672164|P1|STARTED|Overall Study|started = had baseline values|325
1104010|NCT01125722|2672197|P2|NOT COMPLETED|Overall Study||1
1104011|NCT01125722|2672198|P1|NOT COMPLETED|Overall Study||3
1104012|NCT01125722|2672197|P2|COMPLETED|Overall Study||36
1104013|NCT01125722|2672198|P1|COMPLETED|Overall Study||34
1104014|NCT01125722|2672197|P2|STARTED|Overall Study||37
1104015|NCT01125722|2672198|P1|STARTED|Overall Study||37
1104016|NCT01125748|2672214|P2|NOT COMPLETED|Overall Study||14
1104017|NCT01125748|2672215|P1|NOT COMPLETED|Overall Study||10
1104018|NCT01125748|2672214|P2|COMPLETED|Overall Study||74
1104019|NCT01125748|2672215|P1|COMPLETED|Overall Study||78
1104020|NCT01125748|2672214|P2|STARTED|Overall Study||88
1104021|NCT01125748|2672215|P1|STARTED|Overall Study||88
1104022|NCT01125774|2672225|P4|NOT COMPLETED|Overall Study||3
1104023|NCT01125774|2672226|P3|NOT COMPLETED|Overall Study||9
1104024|NCT01125774|2672227|P2|NOT COMPLETED|Overall Study||554
1104025|NCT01125774|2672228|P1|NOT COMPLETED|Overall Study||1125
1104026|NCT01125774|2672225|P4|COMPLETED|Overall Study|Completed study at least once|3
1104027|NCT01125774|2672226|P3|COMPLETED|Overall Study|"Completed study at least once while treated with telcagepant (otherwise counted Not Completed)"|13
1104028|NCT01125774|2672227|P2|COMPLETED|Overall Study||948
1104029|NCT01125774|2672228|P1|COMPLETED|Overall Study||1893
1104030|NCT01125774|2672225|P4|Treated|Overall Study||5
1104031|NCT01125774|2672226|P3|Treated|Overall Study|Received telcagepant|21
1104032|NCT01125774|2672227|P2|Treated|Overall Study|1 mistakenly took telcagepant and is included with telcagepant group for adverse event analysis|1322
1104033|NCT01125774|2672228|P1|Treated|Overall Study||2638
1104034|NCT01125774|2672225|P4|STARTED|Overall Study|Unique participants randomized|6
1104035|NCT01125774|2672226|P3|STARTED|Overall Study|Unique participants randomized|22
1104036|NCT01125774|2672227|P2|STARTED|Overall Study|Randomized|1502
1104037|NCT01125774|2672228|P1|STARTED|Overall Study|Randomized|3018
1104044|NCT01112241|2672265|P1|NOT COMPLETED|Overall Study||0
1104045|NCT01112241|2672265|P1|COMPLETED|Overall Study||17
1104046|NCT01112241|2672265|P1|STARTED|Overall Study||17
1104047|NCT01112267|2672280|P2|NOT COMPLETED|Overall Study||18
1104048|NCT01112267|2672281|P1|NOT COMPLETED|Overall Study||34
1104049|NCT01112267|2672280|P2|COMPLETED|Overall Study||104
1104050|NCT01112267|2672281|P1|COMPLETED|Overall Study||92
1104051|NCT01112267|2672280|P2|Treated|Overall Study||120
1104052|NCT01112267|2672281|P1|Treated|Overall Study||125
1104053|NCT01112267|2672280|P2|STARTED|Overall Study||122
1104054|NCT01112267|2672281|P1|STARTED|Overall Study||126
1104055|NCT01117857|2672299|P1|NOT COMPLETED|Overall Study||9
1104056|NCT01117857|2672299|P1|COMPLETED|Overall Study||13
1104057|NCT01117857|2672299|P1|STARTED|Overall Study||22
1104058|NCT01117870|2672309|P2|NOT COMPLETED|Overall Study||0
1104059|NCT01117870|2672310|P1|NOT COMPLETED|Overall Study||1
1104060|NCT01117870|2672309|P2|COMPLETED|Overall Study||16
1104061|NCT01117870|2672310|P1|COMPLETED|Overall Study|One did not receive the allocated intervention; (degenerate spine/inability to place needle).|14
1104062|NCT01117870|2672309|P2|STARTED|Overall Study||16
1104063|NCT01117870|2672310|P1|STARTED|Overall Study||15
1104064|NCT01117948|2672326|P2|NOT COMPLETED|Open Label||47
1104065|NCT01117948|2672327|P1|NOT COMPLETED|Open Label||52
1104066|NCT01117948|2672326|P2|COMPLETED|Open Label||51
1104067|NCT01117948|2672327|P1|COMPLETED|Open Label||41
1104068|NCT01117948|2672326|P2|STARTED|Open Label||98
1104069|NCT01117948|2672327|P1|STARTED|Open Label||93
1104070|NCT01117948|2672326|P2|NOT COMPLETED|Double Blind||10
1104071|NCT01117948|2672327|P1|NOT COMPLETED|Double Blind||18
1104072|NCT01117948|2672326|P2|COMPLETED|Double Blind||98
1104073|NCT01117948|2672327|P1|COMPLETED|Double Blind||93
1104074|NCT01117948|2672326|P2|STARTED|Double Blind||108
1104075|NCT01117948|2672327|P1|STARTED|Double Blind||111
1104076|NCT01117987|2672335|P2|NOT COMPLETED|Overall Study||74
1104077|NCT01117987|2672336|P1|NOT COMPLETED|Overall Study||61
1104078|NCT01117987|2672335|P2|COMPLETED|Overall Study||4
1104079|NCT01117987|2672336|P1|COMPLETED|Overall Study||5
1104080|NCT01117987|2672335|P2|STARTED|Overall Study||78
1104081|NCT01117987|2672336|P1|STARTED|Overall Study||66
1104082|NCT01118013|2672346|P1|NOT COMPLETED|Overall Study||0
1104083|NCT01118013|2672346|P1|COMPLETED|Overall Study||6
1104084|NCT01118013|2672346|P1|STARTED|Overall Study||6
1104085|NCT01118091|2672356|P2|NOT COMPLETED|Overall Study||0
1104086|NCT01118091|2672357|P1|NOT COMPLETED|Overall Study||0
1104087|NCT01118091|2672356|P2|COMPLETED|Overall Study||5
1104088|NCT01118091|2672357|P1|COMPLETED|Overall Study|Continued from above: These 2 pts are only represented in Arm 1 (and not Arm 2).|7
1104089|NCT01118091|2672356|P2|STARTED|Overall Study||5
1104090|NCT01118091|2672357|P1|STARTED|Overall Study|2pts were randomized to Arm 2, were not able to grow cell product, were treated with Arm 1 regimen.|7
1104091|NCT01118117|2672369|P2|NOT COMPLETED|Overall Study||0
1104092|NCT01118117|2672370|P1|NOT COMPLETED|Overall Study||21
1104093|NCT01118117|2672369|P2|COMPLETED|Overall Study||15
1104094|NCT01118117|2672370|P1|COMPLETED|Overall Study||240
1104095|NCT01118117|2672369|P2|STARTED|Overall Study||15
1104096|NCT01118117|2672370|P1|STARTED|Overall Study||261
1104097|NCT01118143|2672391|P2|NOT COMPLETED|Overall Study||5
1104098|NCT01118143|2672392|P1|NOT COMPLETED|Overall Study||2
1104099|NCT01118143|2672391|P2|COMPLETED|Overall Study||64
1104100|NCT01118143|2672392|P1|COMPLETED|Overall Study||62
1104101|NCT01118143|2672391|P2|STARTED|Overall Study||69
1104102|NCT01118143|2672392|P1|STARTED|Overall Study||64
1104103|NCT01118221|2672402|P2|NOT COMPLETED|Overall Study||1
1104104|NCT01118221|2672403|P1|NOT COMPLETED|Overall Study||3
1104105|NCT01118221|2672402|P2|COMPLETED|Overall Study||10
1104106|NCT01118221|2672403|P1|COMPLETED|Overall Study||11
1104107|NCT01118221|2672402|P2|STARTED|Overall Study||11
1104108|NCT01118221|2672403|P1|STARTED|Overall Study||14
1104109|NCT01118273|2672419|P6|NOT COMPLETED|Overall Study||0
1104110|NCT01118273|2672420|P5|NOT COMPLETED|Overall Study||0
1104111|NCT01118273|2672421|P4|NOT COMPLETED|Overall Study||0
1104112|NCT01118273|2672422|P3|NOT COMPLETED|Overall Study||0
1104113|NCT01118273|2672423|P2|NOT COMPLETED|Overall Study||0
1104114|NCT01118273|2672424|P1|NOT COMPLETED|Overall Study||0
1104115|NCT01118273|2672419|P6|COMPLETED|Overall Study||27
1104116|NCT01118273|2672420|P5|COMPLETED|Overall Study||27
1104117|NCT01118273|2672421|P4|COMPLETED|Overall Study||27
1104118|NCT01118273|2672422|P3|COMPLETED|Overall Study||27
1104119|NCT01118273|2672423|P2|COMPLETED|Overall Study||27
1104120|NCT01118273|2672424|P1|COMPLETED|Overall Study||27
1104121|NCT01118273|2672419|P6|STARTED|Overall Study||27
1104122|NCT01118273|2672420|P5|STARTED|Overall Study||27
1104123|NCT01118273|2672421|P4|STARTED|Overall Study||27
1104124|NCT01118273|2672422|P3|STARTED|Overall Study||27
1104125|NCT01118273|2672423|P2|STARTED|Overall Study||27
1104126|NCT01118273|2672424|P1|STARTED|Overall Study||27
1104127|NCT01118312|2672590|P2|NOT COMPLETED|Overall Study||35
1104128|NCT01118312|2672591|P1|NOT COMPLETED|Overall Study||34
1104129|NCT01118312|2672590|P2|COMPLETED|Overall Study||164
1104130|NCT01118312|2672591|P1|COMPLETED|Overall Study||155
1104131|NCT01118312|2672590|P2|STARTED|Overall Study||199
1104132|NCT01118312|2672591|P1|STARTED|Overall Study||189
1104133|NCT01118325|2672602|P3|NOT COMPLETED|Overall Study||1
1104134|NCT01118325|2672603|P2|NOT COMPLETED|Overall Study||0
1104135|NCT01118325|2672604|P1|NOT COMPLETED|Overall Study||1
1104136|NCT01118325|2672602|P3|COMPLETED|Overall Study||45
1104137|NCT01118325|2672603|P2|COMPLETED|Overall Study||43
1104138|NCT01118325|2672604|P1|COMPLETED|Overall Study||49
1104139|NCT01118325|2672602|P3|STARTED|Overall Study||46
1104140|NCT01118325|2672603|P2|STARTED|Overall Study||43
1104141|NCT01118325|2672604|P1|STARTED|Overall Study||50
1104142|NCT01118377|2672648|P1|NOT COMPLETED|Overall Study||42
1104143|NCT01118377|2672648|P1|COMPLETED|Overall Study||3
1104144|NCT01118377|2672648|P1|STARTED|Overall Study||45
1104145|NCT01118455|2672656|P2|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
1104146|NCT01118455|2672657|P1|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
1104147|NCT01118455|2672656|P2|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||69
1104148|NCT01118455|2672657|P1|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||65
1104149|NCT01118455|2672656|P2|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||69
1104150|NCT01118455|2672657|P1|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||65
1104151|NCT01118455|2672656|P2|NOT COMPLETED|Baseline [Visits 1 & 2]||0
1104152|NCT01118455|2672657|P1|NOT COMPLETED|Baseline [Visits 1 & 2]||1
1104153|NCT01118455|2672656|P2|COMPLETED|Baseline [Visits 1 & 2]||69
1104154|NCT01118455|2672657|P1|COMPLETED|Baseline [Visits 1 & 2]||65
1104155|NCT01118455|2672656|P2|Actual Patients Treated|Baseline [Visits 1 & 2]||69
1104156|NCT01118455|2672657|P1|Actual Patients Treated|Baseline [Visits 1 & 2]||65
1104157|NCT01118455|2672656|P2|STARTED|Baseline [Visits 1 & 2]||69
1104158|NCT01118455|2672657|P1|STARTED|Baseline [Visits 1 & 2]||66
1104159|NCT01118624|2672685|P1|NOT COMPLETED|Overall Study||22
1104160|NCT01118624|2672685|P1|COMPLETED|Overall Study||0
1104161|NCT01118624|2672685|P1|STARTED|Overall Study||22
1104162|NCT01118663|2672694|P2|NOT COMPLETED|Overall Study||2
1104163|NCT01118663|2672695|P1|NOT COMPLETED|Overall Study||2
1104164|NCT01118663|2672694|P2|COMPLETED|Overall Study||8
1104165|NCT01118663|2672695|P1|COMPLETED|Overall Study||5
1104166|NCT01118663|2672694|P2|STARTED|Overall Study||10
1104167|NCT01118663|2672695|P1|STARTED|Overall Study||7
1104168|NCT01118728|2672709|P1|NOT COMPLETED|Overall Study||223
1104169|NCT01118728|2672709|P1|COMPLETED|Overall Study||0
1104170|NCT01118728|2672709|P1|STARTED|Overall Study||223
1104177|NCT01118780|2672725|P2|NOT COMPLETED|Overall Study||35
1104178|NCT01118780|2672726|P1|NOT COMPLETED|Overall Study||36
1104179|NCT01118780|2672725|P2|COMPLETED|Overall Study||105
1104180|NCT01118780|2672726|P1|COMPLETED|Overall Study||115
1104181|NCT01118780|2672725|P2|STARTED|Overall Study||140
1104182|NCT01118780|2672726|P1|STARTED|Overall Study||151
1104183|NCT01118845|2672773|P1|NOT COMPLETED|Overall Study||42
1104184|NCT01118845|2672773|P1|COMPLETED|Overall Study||17
1104185|NCT01118845|2672773|P1|STARTED|Overall Study||59
1104186|NCT01118949|2672792|P1|NOT COMPLETED|Overall Study||9
1104187|NCT01118949|2672792|P1|COMPLETED|Overall Study||40
1104188|NCT01118949|2672792|P1|STARTED|Overall Study||49
1104189|NCT01118962|2672801|P1|NOT COMPLETED|Overall Study||10
1104190|NCT01118962|2672801|P1|COMPLETED|Overall Study||29
1104191|NCT01118962|2672801|P1|STARTED|Overall Study||39
1104192|NCT01118975|2672808|P2|NOT COMPLETED|Overall Study||1
1104193|NCT01118975|2672809|P1|NOT COMPLETED|Overall Study||0
1104194|NCT01118975|2672808|P2|COMPLETED|Overall Study||2
1104195|NCT01118975|2672809|P1|COMPLETED|Overall Study||9
1104196|NCT01118975|2672808|P2|STARTED|Overall Study||3
1104197|NCT01118975|2672809|P1|STARTED|Overall Study||9
1104198|NCT01118988|2672818|P3|NOT COMPLETED|Overall Study||4
1104199|NCT01118988|2672819|P2|NOT COMPLETED|Overall Study||1
1104200|NCT01118988|2672820|P1|NOT COMPLETED|Overall Study||5
1104201|NCT01118988|2672818|P3|COMPLETED|Overall Study||3
1104202|NCT01118988|2672819|P2|COMPLETED|Overall Study||3
1104203|NCT01118988|2672820|P1|COMPLETED|Overall Study||11
1104204|NCT01118988|2672818|P3|STARTED|Overall Study||7
1104205|NCT01118988|2672819|P2|STARTED|Overall Study||4
1104206|NCT01118988|2672820|P1|STARTED|Overall Study||16
1104207|NCT01125800|2672856|P5|NOT COMPLETED|Phase II||11
1104208|NCT01125800|2672857|P4|NOT COMPLETED|Phase II||1
1104209|NCT01125800|2672858|P3|NOT COMPLETED|Phase II||0
1104210|NCT01125800|2672859|P2|NOT COMPLETED|Phase II||0
1104211|NCT01125800|2672860|P1|NOT COMPLETED|Phase II||0
1104212|NCT01125800|2672856|P5|COMPLETED|Phase II||5
1104213|NCT01125800|2672857|P4|COMPLETED|Phase II||0
1104214|NCT01125800|2672858|P3|COMPLETED|Phase II||0
1104215|NCT01125800|2672859|P2|COMPLETED|Phase II||0
1104216|NCT01125800|2672860|P1|COMPLETED|Phase II||0
1104217|NCT01125800|2672856|P5|STARTED|Phase II|Additional participants were enrolled to this treatment in this period.|16
1104218|NCT01125800|2672857|P4|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|1
1104219|NCT01125800|2672858|P3|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
1104220|NCT01125800|2672859|P2|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
1104221|NCT01125800|2672860|P1|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
1104222|NCT01125800|2672856|P5|NOT COMPLETED|Phase I||0
1104223|NCT01125800|2672857|P4|NOT COMPLETED|Phase I||11
1104224|NCT01125800|2672858|P3|NOT COMPLETED|Phase I||4
1104225|NCT01125800|2672859|P2|NOT COMPLETED|Phase I||9
1104226|NCT01125800|2672860|P1|NOT COMPLETED|Phase I||8
1104227|NCT01125800|2672856|P5|COMPLETED|Phase I||0
1104228|NCT01125800|2672857|P4|COMPLETED|Phase I||10
1104229|NCT01125800|2672858|P3|COMPLETED|Phase I||7
1104230|NCT01125800|2672859|P2|COMPLETED|Phase I||7
1104231|NCT01125800|2672860|P1|COMPLETED|Phase I||3
1104232|NCT01125800|2672856|P5|STARTED|Phase I|None of participants were enrolled to this treatment in this period.|0
1104233|NCT01125800|2672857|P4|STARTED|Phase I||21
1104234|NCT01125800|2672858|P3|STARTED|Phase I||11
1104235|NCT01125800|2672859|P2|STARTED|Phase I||16
1104236|NCT01125800|2672860|P1|STARTED|Phase I||11
1104237|NCT01125813|2672897|P1|NOT COMPLETED|Overall Study||6
1104238|NCT01125813|2672897|P1|COMPLETED|Overall Study||30
1104239|NCT01125813|2672897|P1|STARTED|Overall Study||36
1104240|NCT01125917|2672902|P1|NOT COMPLETED|Overall Study||339
1104241|NCT01125917|2672902|P1|COMPLETED|Overall Study||15
1104242|NCT01125917|2672902|P1|STARTED|Overall Study||354
1104243|NCT01125930|2672908|P2|NOT COMPLETED|Overall Study||10
1104244|NCT01125930|2672909|P1|NOT COMPLETED|Overall Study||1
1104245|NCT01125930|2672908|P2|COMPLETED|Overall Study||36
1104246|NCT01125930|2672909|P1|COMPLETED|Overall Study||21
1104247|NCT01125930|2672908|P2|STARTED|Overall Study||46
1104248|NCT01125930|2672909|P1|STARTED|Overall Study||22
1104249|NCT01126060|2673065|P2|NOT COMPLETED|Overall Study||2
1104250|NCT01126060|2673066|P1|NOT COMPLETED|Overall Study||0
1104251|NCT01126060|2673065|P2|COMPLETED|Overall Study||38
1104252|NCT01126060|2673066|P1|COMPLETED|Overall Study||40
1104253|NCT01126060|2673065|P2|STARTED|Overall Study||40
1104254|NCT01126060|2673066|P1|STARTED|Overall Study||40
1104255|NCT01126099|2673074|P2|NOT COMPLETED|Open-label Extension||1
1104256|NCT01126099|2673075|P1|NOT COMPLETED|Open-label Extension||1
1104257|NCT01126099|2673074|P2|COMPLETED|Open-label Extension||6
1104258|NCT01126099|2673075|P1|COMPLETED|Open-label Extension||4
1104259|NCT01126099|2673074|P2|STARTED|Open-label Extension||7
1104260|NCT01126099|2673075|P1|STARTED|Open-label Extension|2 in the Prazosin arm of the Double Blind Phase elected not to enter the Open-Label extension|5
1104261|NCT01126099|2673074|P2|NOT COMPLETED|Double Blind Phase||2
1104262|NCT01126099|2673075|P1|NOT COMPLETED|Double Blind Phase||4
1104263|NCT01126099|2673074|P2|COMPLETED|Double Blind Phase||7
1104264|NCT01126099|2673075|P1|COMPLETED|Double Blind Phase||7
1104265|NCT01126099|2673074|P2|STARTED|Double Blind Phase||9
1104266|NCT01126099|2673075|P1|STARTED|Double Blind Phase||11
1104267|NCT01126359|2673087|P2|NOT COMPLETED|Second Intervention (20-minutes)||0
1104268|NCT01126359|2673088|P1|NOT COMPLETED|Second Intervention (20-minutes)||0
1104269|NCT01126359|2673087|P2|COMPLETED|Second Intervention (20-minutes)||5
1104270|NCT01126359|2673088|P1|COMPLETED|Second Intervention (20-minutes)||5
1104271|NCT01126359|2673087|P2|STARTED|Second Intervention (20-minutes)||5
1104272|NCT01126359|2673088|P1|STARTED|Second Intervention (20-minutes)||5
1104273|NCT01126359|2673087|P2|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
1104274|NCT01126359|2673088|P1|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
1104275|NCT01126359|2673087|P2|COMPLETED|Dressing Replacement/Healing (48-hours)||5
1104276|NCT01126359|2673088|P1|COMPLETED|Dressing Replacement/Healing (48-hours)||5
1104277|NCT01126359|2673087|P2|STARTED|Dressing Replacement/Healing (48-hours)||5
1104278|NCT01126359|2673088|P1|STARTED|Dressing Replacement/Healing (48-hours)||5
1104279|NCT01126359|2673087|P2|NOT COMPLETED|First Intervention (20-minutes)||1
1104280|NCT01126359|2673088|P1|NOT COMPLETED|First Intervention (20-minutes)||0
1104281|NCT01126359|2673087|P2|COMPLETED|First Intervention (20-minutes)||5
1104282|NCT01126359|2673088|P1|COMPLETED|First Intervention (20-minutes)||5
1104283|NCT01126359|2673087|P2|STARTED|First Intervention (20-minutes)||6
1104284|NCT01126359|2673088|P1|STARTED|First Intervention (20-minutes)||5
1104382|NCT01127139|2673424|P1|COMPLETED|Overall Study||3771
1104309|NCT01126437|2673137|P3|NOT COMPLETED|Overall Study||1313
1104310|NCT01126437|2673138|P2|NOT COMPLETED|Overall Study||1330
1104311|NCT01126437|2673139|P1|NOT COMPLETED|Overall Study||1341
1104312|NCT01126437|2673137|P3|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
1104313|NCT01126437|2673138|P2|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4399
1104314|NCT01126437|2673139|P1|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
1104315|NCT01126437|2673137|P3|STARTED|Overall Study||5713
1104316|NCT01126437|2673138|P2|STARTED|Overall Study||5729
1104317|NCT01126437|2673139|P1|STARTED|Overall Study||5741
1104318|NCT01126541|2673174|P3|NOT COMPLETED|Overall Study||26
1104319|NCT01126541|2673175|P2|NOT COMPLETED|Overall Study||12
1104320|NCT01126541|2673176|P1|NOT COMPLETED|Overall Study||10
1104321|NCT01126541|2673174|P3|COMPLETED|Overall Study||55
1104322|NCT01126541|2673175|P2|COMPLETED|Overall Study||61
1104323|NCT01126541|2673176|P1|COMPLETED|Overall Study||60
1104324|NCT01126541|2673174|P3|STARTED|Overall Study||81
1104325|NCT01126541|2673175|P2|STARTED|Overall Study||73
1104326|NCT01126541|2673176|P1|STARTED|Overall Study||70
1104327|NCT01126580|2673260|P3|NOT COMPLETED|Overall Study||55
1104328|NCT01126580|2673261|P2|NOT COMPLETED|Overall Study||52
1104329|NCT01126580|2673262|P1|NOT COMPLETED|Overall Study||49
1104330|NCT01126580|2673260|P3|COMPLETED|Overall Study||213
1104331|NCT01126580|2673261|P2|COMPLETED|Overall Study||218
1104332|NCT01126580|2673262|P1|COMPLETED|Overall Study||220
1104333|NCT01126580|2673260|P3|Completed 26 Weeks|Overall Study||226
1104334|NCT01126580|2673261|P2|Completed 26 Weeks|Overall Study||242
1104335|NCT01126580|2673262|P1|Completed 26 Weeks|Overall Study||233
1104336|NCT01126580|2673260|P3|Received at Least 1 Dose of Study Drug|Overall Study||268
1104337|NCT01126580|2673261|P2|Received at Least 1 Dose of Study Drug|Overall Study||270
1104338|NCT01126580|2673262|P1|Received at Least 1 Dose of Study Drug|Overall Study||269
1104339|NCT01126580|2673260|P3|STARTED|Overall Study||268
1104340|NCT01126580|2673261|P2|STARTED|Overall Study||270
1104341|NCT01126580|2673262|P1|STARTED|Overall Study||269
1104342|NCT01126593|2673357|P3|NOT COMPLETED|Overall Study||2
1104343|NCT01126593|2673358|P2|NOT COMPLETED|Overall Study||2
1104344|NCT01126593|2673359|P1|NOT COMPLETED|Overall Study||4
1104345|NCT01126593|2673357|P3|COMPLETED|Overall Study||32
1104346|NCT01126593|2673358|P2|COMPLETED|Overall Study||27
1104347|NCT01126593|2673359|P1|COMPLETED|Overall Study||29
1104348|NCT01126593|2673357|P3|STARTED|Overall Study||34
1104349|NCT01126593|2673358|P2|STARTED|Overall Study||29
1104350|NCT01126593|2673359|P1|STARTED|Overall Study||33
1104351|NCT01126619|2673367|P1|NOT COMPLETED|Overall Study||17
1104352|NCT01126619|2673367|P1|COMPLETED|Overall Study|The completed population was used for all effectiveness analyses.|86
1104353|NCT01126619|2673367|P1|STARTED|Overall Study||103
1104354|NCT01126671|2673381|P2|NOT COMPLETED|Overall Study||0
1104355|NCT01126671|2673382|P1|NOT COMPLETED|Overall Study||0
1104356|NCT01126671|2673381|P2|COMPLETED|Overall Study||29
1104357|NCT01126671|2673382|P1|COMPLETED|Overall Study||25
1104358|NCT01126671|2673381|P2|STARTED|Overall Study||29
1104359|NCT01126671|2673382|P1|STARTED|Overall Study||25
1104360|NCT01126723|2673392|P2|NOT COMPLETED|Overall Study||3
1104361|NCT01126723|2673393|P1|NOT COMPLETED|Overall Study||6
1104362|NCT01126723|2673392|P2|COMPLETED|Overall Study||28
1104363|NCT01126723|2673393|P1|COMPLETED|Overall Study||29
1104364|NCT01126723|2673392|P2|STARTED|Overall Study||31
1104365|NCT01126723|2673393|P1|STARTED|Overall Study||35
1104372|NCT01126957|2673408|P1|NOT COMPLETED|Overall Study||0
1104373|NCT01126957|2673408|P1|COMPLETED|Overall Study||103
1104374|NCT01126957|2673408|P1|STARTED|Overall Study||103
1104375|NCT01127087|2673415|P2|NOT COMPLETED|Overall Study||0
1104376|NCT01127087|2673416|P1|NOT COMPLETED|Overall Study||0
1104377|NCT01127087|2673415|P2|COMPLETED|Overall Study||2
1104378|NCT01127087|2673416|P1|COMPLETED|Overall Study||8
1104379|NCT01127087|2673415|P2|STARTED|Overall Study||2
1104380|NCT01127087|2673416|P1|STARTED|Overall Study||8
1104381|NCT01127139|2673424|P1|NOT COMPLETED|Overall Study||57
1104383|NCT01127139|2673424|P1|Number of Participants Analyzed|Overall Study||3828
1104384|NCT01127139|2673424|P1|STARTED|Overall Study||3828
1104385|NCT01127165|2673441|P2|NOT COMPLETED|Overall Study||19
1104386|NCT01127165|2673442|P1|NOT COMPLETED|Overall Study||16
1104387|NCT01127165|2673441|P2|COMPLETED|Overall Study||41
1104388|NCT01127165|2673442|P1|COMPLETED|Overall Study||49
1104389|NCT01127165|2673441|P2|STARTED|Overall Study||60
1104390|NCT01127165|2673442|P1|STARTED|Overall Study||65
1104391|NCT01127256|2673456|P2|NOT COMPLETED|Overall Study||39
1104392|NCT01127256|2673457|P1|NOT COMPLETED|Overall Study||39
1104393|NCT01127256|2673456|P2|COMPLETED|Overall Study||65
1104394|NCT01127256|2673457|P1|COMPLETED|Overall Study||57
1104395|NCT01127256|2673456|P2|STARTED|Overall Study||104
1104396|NCT01127256|2673457|P1|STARTED|Overall Study||96
1104397|NCT01127321|2673472|P5|NOT COMPLETED|Overall Study||0
1104398|NCT01127321|2673473|P4|NOT COMPLETED|Overall Study||0
1104399|NCT01127321|2673474|P3|NOT COMPLETED|Overall Study||0
1104400|NCT01127321|2673475|P2|NOT COMPLETED|Overall Study||0
1104401|NCT01127321|2673476|P1|NOT COMPLETED|Overall Study||0
1104402|NCT01127321|2673472|P5|COMPLETED|Overall Study||5
1104403|NCT01127321|2673473|P4|COMPLETED|Overall Study||7
1104404|NCT01127321|2673474|P3|COMPLETED|Overall Study||1
1104405|NCT01127321|2673475|P2|COMPLETED|Overall Study||1
1104406|NCT01127321|2673476|P1|COMPLETED|Overall Study||3
1104407|NCT01127321|2673472|P5|STARTED|Overall Study||5
1104408|NCT01127321|2673473|P4|STARTED|Overall Study||7
1104409|NCT01127321|2673474|P3|STARTED|Overall Study||1
1104410|NCT01127321|2673475|P2|STARTED|Overall Study||1
1104411|NCT01127321|2673476|P1|STARTED|Overall Study||3
1104412|NCT01127438|2673504|P6|NOT COMPLETED|Overall Study||0
1104413|NCT01127438|2673505|P5|NOT COMPLETED|Overall Study||0
1104414|NCT01127438|2673506|P4|NOT COMPLETED|Overall Study||0
1104415|NCT01127438|2673507|P3|NOT COMPLETED|Overall Study||0
1104416|NCT01127438|2673508|P2|NOT COMPLETED|Overall Study||0
1104417|NCT01127438|2673509|P1|NOT COMPLETED|Overall Study||0
1104418|NCT01127438|2673504|P6|COMPLETED|Overall Study||25
1104419|NCT01127438|2673505|P5|COMPLETED|Overall Study||28
1104420|NCT01127438|2673506|P4|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|24
1104421|NCT01127438|2673507|P3|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|26
1104422|NCT01127438|2673508|P2|COMPLETED|Overall Study||25
1104423|NCT01127438|2673509|P1|COMPLETED|Overall Study||25
1104424|NCT01127438|2673504|P6|STARTED|Overall Study||25
1104425|NCT01127438|2673505|P5|STARTED|Overall Study||28
1104426|NCT01127438|2673506|P4|STARTED|Overall Study||24
1104427|NCT01127438|2673507|P3|STARTED|Overall Study||26
1104428|NCT01127438|2673508|P2|STARTED|Overall Study||25
1104429|NCT01127438|2673509|P1|STARTED|Overall Study||25
1104430|NCT01127581|2673533|P2|NOT COMPLETED|Overall Study||0
1104431|NCT01127581|2673534|P1|NOT COMPLETED|Overall Study||0
1104432|NCT01127581|2673533|P2|COMPLETED|Overall Study||680
1104433|NCT01127581|2673534|P1|COMPLETED|Overall Study||678
1104434|NCT01127581|2673533|P2|STARTED|Overall Study||680
1104435|NCT01127581|2673534|P1|STARTED|Overall Study||678
1104436|NCT01127607|2673562|P2|NOT COMPLETED|Phase II (Between Subjects)||2
1104437|NCT01127607|2673563|P1|NOT COMPLETED|Phase II (Between Subjects)||1
1104438|NCT01127607|2673562|P2|COMPLETED|Phase II (Between Subjects)||11
1104439|NCT01127607|2673563|P1|COMPLETED|Phase II (Between Subjects)||13
1104440|NCT01127607|2673562|P2|STARTED|Phase II (Between Subjects)||13
1104441|NCT01127607|2673563|P1|STARTED|Phase II (Between Subjects)||14
1104442|NCT01127607|2673562|P2|NOT COMPLETED|Phase I (Within Subjects)||0
1104443|NCT01127607|2673563|P1|NOT COMPLETED|Phase I (Within Subjects)||0
1104444|NCT01127607|2673562|P2|COMPLETED|Phase I (Within Subjects)||13
1104445|NCT01127607|2673563|P1|COMPLETED|Phase I (Within Subjects)||14
1104446|NCT01127607|2673562|P2|STARTED|Phase I (Within Subjects)||13
1104447|NCT01127607|2673563|P1|STARTED|Phase I (Within Subjects)||14
1104448|NCT01127646|2673636|P2|NOT COMPLETED|Overall Study||1
1104449|NCT01127646|2673637|P1|NOT COMPLETED|Overall Study||1
1104450|NCT01127646|2673636|P2|COMPLETED|Overall Study||7
1104451|NCT01127646|2673637|P1|COMPLETED|Overall Study||14
1104452|NCT01127646|2673636|P2|STARTED|Overall Study||8
1104453|NCT01127646|2673637|P1|STARTED|Overall Study||15
1104454|NCT01127659|2673675|P6|NOT COMPLETED|Overall Study||0
1104455|NCT01127659|2673676|P5|NOT COMPLETED|Overall Study||0
1104456|NCT01127659|2673677|P4|NOT COMPLETED|Overall Study||4
1104457|NCT01127659|2673678|P3|NOT COMPLETED|Overall Study||2
1104458|NCT01127659|2673679|P2|NOT COMPLETED|Overall Study||8
1104459|NCT01127659|2673680|P1|NOT COMPLETED|Overall Study||2
1104460|NCT01127659|2673675|P6|COMPLETED|Overall Study||21
1104461|NCT01127659|2673676|P5|COMPLETED|Overall Study||50
1104462|NCT01127659|2673677|P4|COMPLETED|Overall Study||6
1104463|NCT01127659|2673678|P3|COMPLETED|Overall Study||10
1104464|NCT01127659|2673679|P2|COMPLETED|Overall Study||14
1104465|NCT01127659|2673680|P1|COMPLETED|Overall Study||20
1104466|NCT01127659|2673675|P6|STARTED|Overall Study||21
1104467|NCT01127659|2673676|P5|STARTED|Overall Study||50
1104468|NCT01127659|2673677|P4|STARTED|Overall Study||10
1104469|NCT01127659|2673678|P3|STARTED|Overall Study||12
1104470|NCT01127659|2673679|P2|STARTED|Overall Study||22
1104471|NCT01127659|2673680|P1|STARTED|Overall Study||22
1104472|NCT01127737|2673696|P2|NOT COMPLETED|Overall Study||0
1104473|NCT01127737|2673697|P1|NOT COMPLETED|Overall Study||0
1104474|NCT01127737|2673696|P2|COMPLETED|Overall Study||38
1104475|NCT01127737|2673697|P1|COMPLETED|Overall Study||37
1104476|NCT01127737|2673696|P2|STARTED|Overall Study||38
1104477|NCT01127737|2673697|P1|STARTED|Overall Study||37
1104478|NCT01127763|2673703|P1|NOT COMPLETED|Overall Study||5
1104479|NCT01127763|2673703|P1|COMPLETED|Overall Study|Patients off study due to disease progression were considered to have completed the study.|20
1104480|NCT01127763|2673703|P1|STARTED|Overall Study||25
1104481|NCT01128049|2673715|P3|NOT COMPLETED|Overall Study||0
1104482|NCT01128049|2673716|P2|NOT COMPLETED|Overall Study||0
1104483|NCT01128049|2673717|P1|NOT COMPLETED|Overall Study||0
1104484|NCT01128049|2673715|P3|COMPLETED|Overall Study||5
1104485|NCT01128049|2673716|P2|COMPLETED|Overall Study||5
1104486|NCT01128049|2673717|P1|COMPLETED|Overall Study||5
1104487|NCT01128049|2673715|P3|STARTED|Overall Study||5
1104488|NCT01128049|2673716|P2|STARTED|Overall Study||5
1104489|NCT01128049|2673717|P1|STARTED|Overall Study||5
1104490|NCT01128114|2673725|P1|NOT COMPLETED|Overall Study||8
1104491|NCT01128114|2673725|P1|COMPLETED|Overall Study||24
1104492|NCT01128114|2673725|P1|STARTED|Overall Study||32
1104493|NCT01128153|2673731|P2|NOT COMPLETED|Overall Study||15
1104494|NCT01128153|2673732|P1|NOT COMPLETED|Overall Study||16
1104495|NCT01128153|2673731|P2|COMPLETED|Overall Study|Completed 24 weeks|113
1104496|NCT01128153|2673732|P1|COMPLETED|Overall Study|Completed 24 weeks|113
1104497|NCT01128153|2673731|P2|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|128
1104498|NCT01128153|2673732|P1|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|127
1104499|NCT01128153|2673731|P2|STARTED|Overall Study|Randomised|128
1104500|NCT01128153|2673732|P1|STARTED|Overall Study|Randomised|129
1104501|NCT01128179|2673750|P2|NOT COMPLETED|Overall Study||0
1104502|NCT01128179|2673751|P1|NOT COMPLETED|Overall Study||2
1104503|NCT01128179|2673750|P2|COMPLETED|Overall Study||12
1104504|NCT01128179|2673751|P1|COMPLETED|Overall Study||21
1104505|NCT01128179|2673750|P2|STARTED|Overall Study||12
1104506|NCT01128179|2673751|P1|STARTED|Overall Study||23
1104507|NCT01128192|2673771|P3|NOT COMPLETED|Overall Study||0
1104508|NCT01128192|2673772|P2|NOT COMPLETED|Overall Study||0
1104509|NCT01128192|2673773|P1|NOT COMPLETED|Overall Study||0
1104510|NCT01128192|2673771|P3|COMPLETED|Overall Study||7
1104511|NCT01128192|2673772|P2|COMPLETED|Overall Study||19
1104512|NCT01128192|2673773|P1|COMPLETED|Overall Study||19
1104513|NCT01128192|2673771|P3|STARTED|Overall Study||7
1104514|NCT01128192|2673772|P2|STARTED|Overall Study||19
1104515|NCT01128192|2673773|P1|STARTED|Overall Study||19
1104516|NCT01128244|2673800|P1|NOT COMPLETED|Overall Study||3
1104517|NCT01128244|2673800|P1|COMPLETED|Overall Study||10
1104518|NCT01128244|2673800|P1|STARTED|Overall Study||13
1104519|NCT01128270|2673808|P1|NOT COMPLETED|Therapeutic Chloral Hydrate (2B)||0
1104520|NCT01128270|2673808|P1|COMPLETED|Therapeutic Chloral Hydrate (2B)||8
1104521|NCT01128270|2673808|P1|STARTED|Therapeutic Chloral Hydrate (2B)||8
1104522|NCT01128270|2673808|P1|NOT COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||0
1104523|NCT01128270|2673808|P1|COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||8
1104524|NCT01128270|2673808|P1|STARTED|Therapeutic Chloral Hydrate and DCA (2A)||8
1104525|NCT01128270|2673808|P1|NOT COMPLETED|Environmental Chloral Hydrate (1B)||0
1104526|NCT01128270|2673808|P1|COMPLETED|Environmental Chloral Hydrate (1B)||8
1104527|NCT01128270|2673808|P1|STARTED|Environmental Chloral Hydrate (1B)|Per the suggestion from Heather, periods are not in chronological order, but defined by treatment.|8
1104528|NCT01128270|2673808|P1|NOT COMPLETED|Environment Chloral Hydrate and DCA (1A)||0
1104529|NCT01128270|2673808|P1|COMPLETED|Environment Chloral Hydrate and DCA (1A)||7
1104530|NCT01128270|2673808|P1|STARTED|Environment Chloral Hydrate and DCA (1A)||7
1104531|NCT01128296|2673821|P6|NOT COMPLETED|Overall Study||5
1104532|NCT01128296|2673822|P5|NOT COMPLETED|Overall Study||0
1104533|NCT01128296|2673823|P4|NOT COMPLETED|Overall Study||0
1104534|NCT01128296|2673824|P3|NOT COMPLETED|Overall Study||0
1104535|NCT01128296|2673825|P2|NOT COMPLETED|Overall Study||0
1104536|NCT01128296|2673826|P1|NOT COMPLETED|Overall Study||0
1104537|NCT01128296|2673821|P6|COMPLETED|Overall Study||21
1104538|NCT01128296|2673822|P5|COMPLETED|Overall Study||1
1104539|NCT01128296|2673823|P4|COMPLETED|Overall Study||1
1104540|NCT01128296|2673824|P3|COMPLETED|Overall Study||1
1104541|NCT01128296|2673825|P2|COMPLETED|Overall Study||1
1104542|NCT01128296|2673826|P1|COMPLETED|Overall Study||1
1104543|NCT01128296|2673821|P6|STARTED|Overall Study||26
1104544|NCT01128296|2673822|P5|STARTED|Overall Study||1
1104545|NCT01128296|2673823|P4|STARTED|Overall Study||1
1104546|NCT01128296|2673824|P3|STARTED|Overall Study||1
1104547|NCT01128296|2673825|P2|STARTED|Overall Study||1
1104548|NCT01128296|2673826|P1|STARTED|Overall Study||1
1104549|NCT01128361|2673846|P2|NOT COMPLETED|Overall Study||3
1104550|NCT01128361|2673847|P1|NOT COMPLETED|Overall Study||5
1104551|NCT01128361|2673846|P2|COMPLETED|Overall Study||34
1104552|NCT01128361|2673847|P1|COMPLETED|Overall Study||34
1104553|NCT01128361|2673846|P2|STARTED|Overall Study||37
1104554|NCT01128361|2673847|P1|STARTED|Overall Study||39
1104555|NCT01128400|2673862|P3|NOT COMPLETED|Overall Study||16
1104556|NCT01128400|2673863|P2|NOT COMPLETED|Overall Study||0
1104557|NCT01128400|2673864|P1|NOT COMPLETED|Overall Study||2
1104558|NCT01128400|2673862|P3|COMPLETED|Overall Study||7
1104559|NCT01128400|2673863|P2|COMPLETED|Overall Study||9
1104560|NCT01128400|2673864|P1|COMPLETED|Overall Study||6
1104561|NCT01128400|2673862|P3|STARTED|Overall Study||23
1104562|NCT01128400|2673863|P2|STARTED|Overall Study||9
1104563|NCT01128400|2673864|P1|STARTED|Overall Study||8
1104564|NCT01128413|2673877|P2|NOT COMPLETED|Overall Study||1
1104565|NCT01128413|2673878|P1|NOT COMPLETED|Overall Study||4
1104566|NCT01128413|2673877|P2|COMPLETED|Overall Study||10
1104567|NCT01128413|2673878|P1|COMPLETED|Overall Study||7
1104568|NCT01128413|2673877|P2|STARTED|Overall Study||11
1104569|NCT01128413|2673878|P1|STARTED|Overall Study||11
1104570|NCT01128426|2673884|P1|NOT COMPLETED|Overall Study||0
1104571|NCT01128426|2673884|P1|COMPLETED|Overall Study||53902
1104572|NCT01128426|2673884|P1|STARTED|Overall Study||53902
1104573|NCT01128543|2673902|P1|NOT COMPLETED|Overall Study||4
1104574|NCT01128543|2673902|P1|COMPLETED|Overall Study||25
1104575|NCT01128543|2673902|P1|STARTED|Overall Study||29
1104576|NCT01128569|2673908|P6|NOT COMPLETED|Treatment Period 3||0
1104577|NCT01128569|2673909|P5|NOT COMPLETED|Treatment Period 3||0
1104578|NCT01128569|2673910|P4|NOT COMPLETED|Treatment Period 3||0
1104579|NCT01128569|2673911|P3|NOT COMPLETED|Treatment Period 3||0
1104580|NCT01128569|2673912|P2|NOT COMPLETED|Treatment Period 3||0
1104581|NCT01128569|2673913|P1|NOT COMPLETED|Treatment Period 3||0
1104582|NCT01128569|2673908|P6|COMPLETED|Treatment Period 3||9
1104583|NCT01128569|2673909|P5|COMPLETED|Treatment Period 3||9
1104584|NCT01128569|2673910|P4|COMPLETED|Treatment Period 3||8
1104585|NCT01128569|2673911|P3|COMPLETED|Treatment Period 3||8
1104586|NCT01128569|2673912|P2|COMPLETED|Treatment Period 3||7
1104587|NCT01128569|2673913|P1|COMPLETED|Treatment Period 3||9
1104588|NCT01128569|2673908|P6|STARTED|Treatment Period 3||9
1104589|NCT01128569|2673909|P5|STARTED|Treatment Period 3||9
1104590|NCT01128569|2673910|P4|STARTED|Treatment Period 3||8
1104591|NCT01128569|2673911|P3|STARTED|Treatment Period 3||8
1104592|NCT01128569|2673912|P2|STARTED|Treatment Period 3||7
1104593|NCT01128569|2673913|P1|STARTED|Treatment Period 3||9
1104594|NCT01128569|2673908|P6|NOT COMPLETED|Washout Period 2||0
1104595|NCT01128569|2673909|P5|NOT COMPLETED|Washout Period 2||0
1104596|NCT01128569|2673910|P4|NOT COMPLETED|Washout Period 2||0
1104597|NCT01128569|2673911|P3|NOT COMPLETED|Washout Period 2||0
1104598|NCT01128569|2673912|P2|NOT COMPLETED|Washout Period 2||0
1104599|NCT01128569|2673913|P1|NOT COMPLETED|Washout Period 2||0
1104600|NCT01128569|2673908|P6|COMPLETED|Washout Period 2||9
1104601|NCT01128569|2673909|P5|COMPLETED|Washout Period 2||9
1104602|NCT01128569|2673910|P4|COMPLETED|Washout Period 2||8
1104603|NCT01128569|2673911|P3|COMPLETED|Washout Period 2||8
1104604|NCT01128569|2673912|P2|COMPLETED|Washout Period 2||7
1104605|NCT01128569|2673913|P1|COMPLETED|Washout Period 2||9
1104606|NCT01128569|2673908|P6|STARTED|Washout Period 2||9
1104607|NCT01128569|2673909|P5|STARTED|Washout Period 2||9
1104608|NCT01128569|2673910|P4|STARTED|Washout Period 2||8
1104609|NCT01128569|2673911|P3|STARTED|Washout Period 2||8
1104610|NCT01128569|2673912|P2|STARTED|Washout Period 2||7
1104611|NCT01128569|2673913|P1|STARTED|Washout Period 2||9
1104612|NCT01128569|2673908|P6|NOT COMPLETED|Treatment Period 2||0
1104613|NCT01128569|2673909|P5|NOT COMPLETED|Treatment Period 2||0
1104614|NCT01128569|2673910|P4|NOT COMPLETED|Treatment Period 2||0
1104615|NCT01128569|2673911|P3|NOT COMPLETED|Treatment Period 2||0
1104616|NCT01128569|2673912|P2|NOT COMPLETED|Treatment Period 2||1
1104617|NCT01128569|2673913|P1|NOT COMPLETED|Treatment Period 2||0
1104618|NCT01128569|2673908|P6|COMPLETED|Treatment Period 2||9
1104619|NCT01128569|2673909|P5|COMPLETED|Treatment Period 2||9
1104620|NCT01128569|2673910|P4|COMPLETED|Treatment Period 2||8
1104621|NCT01128569|2673911|P3|COMPLETED|Treatment Period 2||8
1104622|NCT01128569|2673912|P2|COMPLETED|Treatment Period 2||7
1104623|NCT01128569|2673913|P1|COMPLETED|Treatment Period 2||9
1104624|NCT01128569|2673908|P6|STARTED|Treatment Period 2||9
1104625|NCT01128569|2673909|P5|STARTED|Treatment Period 2||9
1104626|NCT01128569|2673910|P4|STARTED|Treatment Period 2||8
1104627|NCT01128569|2673911|P3|STARTED|Treatment Period 2||8
1104628|NCT01128569|2673912|P2|STARTED|Treatment Period 2||8
1104629|NCT01128569|2673913|P1|STARTED|Treatment Period 2||9
1104630|NCT01128569|2673908|P6|NOT COMPLETED|Washout Period 1||0
1104631|NCT01128569|2673909|P5|NOT COMPLETED|Washout Period 1||0
1104632|NCT01128569|2673910|P4|NOT COMPLETED|Washout Period 1||0
1104633|NCT01128569|2673911|P3|NOT COMPLETED|Washout Period 1||1
1104634|NCT01128569|2673912|P2|NOT COMPLETED|Washout Period 1||0
1104635|NCT01128569|2673913|P1|NOT COMPLETED|Washout Period 1||0
1104636|NCT01128569|2673908|P6|COMPLETED|Washout Period 1||9
1104637|NCT01128569|2673909|P5|COMPLETED|Washout Period 1||9
1104638|NCT01128569|2673910|P4|COMPLETED|Washout Period 1||8
1104639|NCT01128569|2673911|P3|COMPLETED|Washout Period 1||8
1104640|NCT01128569|2673912|P2|COMPLETED|Washout Period 1||8
1104641|NCT01128569|2673913|P1|COMPLETED|Washout Period 1||9
1104642|NCT01128569|2673908|P6|STARTED|Washout Period 1||9
1104643|NCT01128569|2673909|P5|STARTED|Washout Period 1||9
1104644|NCT01128569|2673910|P4|STARTED|Washout Period 1||8
1104645|NCT01128569|2673911|P3|STARTED|Washout Period 1||9
1104646|NCT01128569|2673912|P2|STARTED|Washout Period 1||8
1104647|NCT01128569|2673913|P1|STARTED|Washout Period 1||9
1104648|NCT01128569|2673908|P6|NOT COMPLETED|Treatment Period 1||0
1104649|NCT01128569|2673909|P5|NOT COMPLETED|Treatment Period 1||0
1104650|NCT01128569|2673910|P4|NOT COMPLETED|Treatment Period 1||0
1104651|NCT01128569|2673911|P3|NOT COMPLETED|Treatment Period 1||0
1104652|NCT01128569|2673912|P2|NOT COMPLETED|Treatment Period 1||0
1104653|NCT01128569|2673913|P1|NOT COMPLETED|Treatment Period 1||0
1104654|NCT01128569|2673908|P6|COMPLETED|Treatment Period 1||9
1104655|NCT01128569|2673909|P5|COMPLETED|Treatment Period 1||9
1104656|NCT01128569|2673910|P4|COMPLETED|Treatment Period 1||8
1104657|NCT01128569|2673911|P3|COMPLETED|Treatment Period 1||9
1104658|NCT01128569|2673912|P2|COMPLETED|Treatment Period 1||8
1104659|NCT01128569|2673913|P1|COMPLETED|Treatment Period 1||9
1104660|NCT01128569|2673908|P6|STARTED|Treatment Period 1||9
1104661|NCT01128569|2673909|P5|STARTED|Treatment Period 1||9
1104662|NCT01128569|2673910|P4|STARTED|Treatment Period 1||8
1104663|NCT01128569|2673911|P3|STARTED|Treatment Period 1||9
1104664|NCT01128569|2673912|P2|STARTED|Treatment Period 1||8
1104665|NCT01128569|2673913|P1|STARTED|Treatment Period 1||9
1104666|NCT01128595|2673930|P4|NOT COMPLETED|Treatment Period 4||0
1104667|NCT01128595|2673931|P3|NOT COMPLETED|Treatment Period 4||0
1104668|NCT01128595|2673932|P2|NOT COMPLETED|Treatment Period 4||0
1104669|NCT01128595|2673933|P1|NOT COMPLETED|Treatment Period 4||0
1104670|NCT01128595|2673930|P4|COMPLETED|Treatment Period 4||7
1104671|NCT01128595|2673931|P3|COMPLETED|Treatment Period 4||7
1104672|NCT01128595|2673932|P2|COMPLETED|Treatment Period 4||5
1104673|NCT01128595|2673933|P1|COMPLETED|Treatment Period 4||7
1104674|NCT01128595|2673930|P4|STARTED|Treatment Period 4||7
1104675|NCT01128595|2673931|P3|STARTED|Treatment Period 4||7
1104676|NCT01128595|2673932|P2|STARTED|Treatment Period 4||5
1104677|NCT01128595|2673933|P1|STARTED|Treatment Period 4||7
1104678|NCT01128595|2673930|P4|NOT COMPLETED|Washout Period 3||0
1104679|NCT01128595|2673931|P3|NOT COMPLETED|Washout Period 3||0
1104680|NCT01128595|2673932|P2|NOT COMPLETED|Washout Period 3||0
1104681|NCT01128595|2673933|P1|NOT COMPLETED|Washout Period 3||0
1104682|NCT01128595|2673930|P4|COMPLETED|Washout Period 3||7
1104683|NCT01128595|2673931|P3|COMPLETED|Washout Period 3||7
1104684|NCT01128595|2673932|P2|COMPLETED|Washout Period 3||5
1104685|NCT01128595|2673933|P1|COMPLETED|Washout Period 3||7
1104686|NCT01128595|2673930|P4|STARTED|Washout Period 3||7
1104687|NCT01128595|2673931|P3|STARTED|Washout Period 3||7
1104688|NCT01128595|2673932|P2|STARTED|Washout Period 3||5
1104689|NCT01128595|2673933|P1|STARTED|Washout Period 3||7
1104690|NCT01128595|2673930|P4|NOT COMPLETED|Treatment Period 3||0
1104691|NCT01128595|2673931|P3|NOT COMPLETED|Treatment Period 3||0
1104692|NCT01128595|2673932|P2|NOT COMPLETED|Treatment Period 3||1
1104693|NCT01128595|2673933|P1|NOT COMPLETED|Treatment Period 3||0
1104694|NCT01128595|2673930|P4|COMPLETED|Treatment Period 3||7
1104695|NCT01128595|2673931|P3|COMPLETED|Treatment Period 3||7
1104696|NCT01128595|2673932|P2|COMPLETED|Treatment Period 3||5
1104697|NCT01128595|2673933|P1|COMPLETED|Treatment Period 3||7
1104698|NCT01128595|2673930|P4|STARTED|Treatment Period 3||7
1104699|NCT01128595|2673931|P3|STARTED|Treatment Period 3||7
1104700|NCT01128595|2673932|P2|STARTED|Treatment Period 3||6
1104701|NCT01128595|2673933|P1|STARTED|Treatment Period 3||7
1104702|NCT01128595|2673930|P4|NOT COMPLETED|Washout Period 2||0
1104703|NCT01128595|2673931|P3|NOT COMPLETED|Washout Period 2||0
1104704|NCT01128595|2673932|P2|NOT COMPLETED|Washout Period 2||0
1104705|NCT01128595|2673933|P1|NOT COMPLETED|Washout Period 2||0
1104706|NCT01128595|2673930|P4|COMPLETED|Washout Period 2||7
1104707|NCT01128595|2673931|P3|COMPLETED|Washout Period 2||7
1104708|NCT01128595|2673932|P2|COMPLETED|Washout Period 2||6
1104709|NCT01128595|2673933|P1|COMPLETED|Washout Period 2||7
1104710|NCT01128595|2673930|P4|STARTED|Washout Period 2||7
1104711|NCT01128595|2673931|P3|STARTED|Washout Period 2||7
1104712|NCT01128595|2673932|P2|STARTED|Washout Period 2||6
1104713|NCT01128595|2673933|P1|STARTED|Washout Period 2||7
1104714|NCT01128595|2673930|P4|NOT COMPLETED|Treatment Period 2||0
1104715|NCT01128595|2673931|P3|NOT COMPLETED|Treatment Period 2||0
1104716|NCT01128595|2673932|P2|NOT COMPLETED|Treatment Period 2||0
1104717|NCT01128595|2673933|P1|NOT COMPLETED|Treatment Period 2||0
1104718|NCT01128595|2673930|P4|COMPLETED|Treatment Period 2||7
1104719|NCT01128595|2673931|P3|COMPLETED|Treatment Period 2||7
1104720|NCT01128595|2673932|P2|COMPLETED|Treatment Period 2||6
1104721|NCT01128595|2673933|P1|COMPLETED|Treatment Period 2||7
1104722|NCT01128595|2673930|P4|STARTED|Treatment Period 2||7
1104723|NCT01128595|2673931|P3|STARTED|Treatment Period 2||7
1104724|NCT01128595|2673932|P2|STARTED|Treatment Period 2||6
1104725|NCT01128595|2673933|P1|STARTED|Treatment Period 2||7
1104726|NCT01128595|2673930|P4|NOT COMPLETED|Washout Period 1||0
1104727|NCT01128595|2673931|P3|NOT COMPLETED|Washout Period 1||0
1104728|NCT01128595|2673932|P2|NOT COMPLETED|Washout Period 1||0
1104729|NCT01128595|2673933|P1|NOT COMPLETED|Washout Period 1||0
1104730|NCT01128595|2673930|P4|COMPLETED|Washout Period 1||7
1104731|NCT01128595|2673931|P3|COMPLETED|Washout Period 1||7
1104732|NCT01128595|2673932|P2|COMPLETED|Washout Period 1||6
1104733|NCT01128595|2673933|P1|COMPLETED|Washout Period 1||7
1104734|NCT01128595|2673930|P4|STARTED|Washout Period 1||7
1104735|NCT01128595|2673931|P3|STARTED|Washout Period 1||7
1104736|NCT01128595|2673932|P2|STARTED|Washout Period 1||6
1104737|NCT01128595|2673933|P1|STARTED|Washout Period 1||7
1104738|NCT01128595|2673930|P4|NOT COMPLETED|Treatment Period 1||0
1104739|NCT01128595|2673931|P3|NOT COMPLETED|Treatment Period 1||0
1104740|NCT01128595|2673932|P2|NOT COMPLETED|Treatment Period 1||0
1104741|NCT01128595|2673933|P1|NOT COMPLETED|Treatment Period 1||0
1104742|NCT01128595|2673930|P4|COMPLETED|Treatment Period 1||7
1104743|NCT01128595|2673931|P3|COMPLETED|Treatment Period 1||7
1104744|NCT01128595|2673932|P2|COMPLETED|Treatment Period 1||6
1104745|NCT01128595|2673933|P1|COMPLETED|Treatment Period 1||7
1104746|NCT01128595|2673930|P4|STARTED|Treatment Period 1||7
1104747|NCT01128595|2673931|P3|STARTED|Treatment Period 1||7
1104748|NCT01128595|2673932|P2|STARTED|Treatment Period 1||6
1104749|NCT01128595|2673933|P1|STARTED|Treatment Period 1||7
1104750|NCT01128738|2673965|P2|NOT COMPLETED|Second TP||3
1104751|NCT01128738|2673966|P1|NOT COMPLETED|Second TP||0
1104752|NCT01128738|2673965|P2|COMPLETED|Second TP||63
1104753|NCT01128738|2673966|P1|COMPLETED|Second TP||34
1104754|NCT01128738|2673965|P2|STARTED|Second TP|Only participants who received a second treatment entered this phase.|66
1104755|NCT01128738|2673966|P1|STARTED|Second TP|Only participants who received a second treatment entered this phase.|34
1104756|NCT01128738|2673965|P2|NOT COMPLETED|First Treatment Phase (TP)||1
1104757|NCT01128738|2673966|P1|NOT COMPLETED|First Treatment Phase (TP)||4
1104758|NCT01128738|2673965|P2|COMPLETED|First Treatment Phase (TP)||73
1104759|NCT01128738|2673966|P1|COMPLETED|First Treatment Phase (TP)||74
1104760|NCT01128738|2673965|P2|STARTED|First Treatment Phase (TP)||74
1104761|NCT01128738|2673966|P1|STARTED|First Treatment Phase (TP)||78
1104762|NCT01121900|2674089|P2|NOT COMPLETED|Second Intervention Period||0
1104763|NCT01121900|2674090|P1|NOT COMPLETED|Second Intervention Period||0
1104764|NCT01121900|2674089|P2|COMPLETED|Second Intervention Period||11
1104765|NCT01121900|2674090|P1|COMPLETED|Second Intervention Period||12
1104766|NCT01121900|2674089|P2|STARTED|Second Intervention Period||11
1104767|NCT01121900|2674090|P1|STARTED|Second Intervention Period||12
1104768|NCT01121900|2674089|P2|NOT COMPLETED|Washout Period of 7 Days||1
1104769|NCT01121900|2674090|P1|NOT COMPLETED|Washout Period of 7 Days||0
1104770|NCT01121900|2674089|P2|COMPLETED|Washout Period of 7 Days||11
1104771|NCT01121900|2674090|P1|COMPLETED|Washout Period of 7 Days||12
1104772|NCT01121900|2674089|P2|STARTED|Washout Period of 7 Days||12
1104773|NCT01121900|2674090|P1|STARTED|Washout Period of 7 Days||12
1104774|NCT01121900|2674089|P2|NOT COMPLETED|First Intervention Period||1
1104775|NCT01121900|2674090|P1|NOT COMPLETED|First Intervention Period||1
1104776|NCT01121900|2674089|P2|COMPLETED|First Intervention Period||12
1104777|NCT01121900|2674090|P1|COMPLETED|First Intervention Period||12
1104778|NCT01121900|2674089|P2|STARTED|First Intervention Period||13
1104779|NCT01121900|2674090|P1|STARTED|First Intervention Period||13
1104780|NCT01121913|2674108|P4|NOT COMPLETED|Fourth Intervention Period||0
1104781|NCT01121913|2674109|P3|NOT COMPLETED|Fourth Intervention Period||0
1104782|NCT01121913|2674110|P2|NOT COMPLETED|Fourth Intervention Period||0
1104783|NCT01121913|2674111|P1|NOT COMPLETED|Fourth Intervention Period||0
1104784|NCT01121913|2674108|P4|COMPLETED|Fourth Intervention Period||6
1104785|NCT01121913|2674109|P3|COMPLETED|Fourth Intervention Period||3
1104786|NCT01121913|2674110|P2|COMPLETED|Fourth Intervention Period||6
1104787|NCT01121913|2674111|P1|COMPLETED|Fourth Intervention Period||4
1104788|NCT01121913|2674108|P4|STARTED|Fourth Intervention Period||6
1104789|NCT01121913|2674109|P3|STARTED|Fourth Intervention Period||3
1104790|NCT01121913|2674110|P2|STARTED|Fourth Intervention Period||6
1104791|NCT01121913|2674111|P1|STARTED|Fourth Intervention Period||4
1104792|NCT01121913|2674108|P4|NOT COMPLETED|Third Washout Period||0
1104793|NCT01121913|2674109|P3|NOT COMPLETED|Third Washout Period||0
1104794|NCT01121913|2674110|P2|NOT COMPLETED|Third Washout Period||0
1104795|NCT01121913|2674111|P1|NOT COMPLETED|Third Washout Period||1
1104796|NCT01121913|2674108|P4|COMPLETED|Third Washout Period||6
1104797|NCT01121913|2674109|P3|COMPLETED|Third Washout Period||3
1104798|NCT01121913|2674110|P2|COMPLETED|Third Washout Period||6
1104799|NCT01121913|2674111|P1|COMPLETED|Third Washout Period||4
1104800|NCT01121913|2674108|P4|STARTED|Third Washout Period||6
1104801|NCT01121913|2674109|P3|STARTED|Third Washout Period||3
1104802|NCT01121913|2674110|P2|STARTED|Third Washout Period||6
1104803|NCT01121913|2674111|P1|STARTED|Third Washout Period||5
1104804|NCT01121913|2674108|P4|NOT COMPLETED|Third Intervention Period||0
1104805|NCT01121913|2674109|P3|NOT COMPLETED|Third Intervention Period||0
1104806|NCT01121913|2674110|P2|NOT COMPLETED|Third Intervention Period||0
1104807|NCT01121913|2674111|P1|NOT COMPLETED|Third Intervention Period||0
1104808|NCT01121913|2674108|P4|COMPLETED|Third Intervention Period||6
1104809|NCT01121913|2674109|P3|COMPLETED|Third Intervention Period||3
1104810|NCT01121913|2674110|P2|COMPLETED|Third Intervention Period||6
1104811|NCT01121913|2674111|P1|COMPLETED|Third Intervention Period||5
1104812|NCT01121913|2674108|P4|STARTED|Third Intervention Period||6
1104813|NCT01121913|2674109|P3|STARTED|Third Intervention Period||3
1104814|NCT01121913|2674110|P2|STARTED|Third Intervention Period||6
1104815|NCT01121913|2674111|P1|STARTED|Third Intervention Period||5
1104816|NCT01121913|2674108|P4|NOT COMPLETED|Second Washout Period||0
1104817|NCT01121913|2674109|P3|NOT COMPLETED|Second Washout Period||1
1104818|NCT01121913|2674110|P2|NOT COMPLETED|Second Washout Period||0
1104819|NCT01121913|2674111|P1|NOT COMPLETED|Second Washout Period||0
1104820|NCT01121913|2674108|P4|COMPLETED|Second Washout Period||6
1104821|NCT01121913|2674109|P3|COMPLETED|Second Washout Period||3
1104822|NCT01121913|2674110|P2|COMPLETED|Second Washout Period||6
1104823|NCT01121913|2674111|P1|COMPLETED|Second Washout Period||5
1104824|NCT01121913|2674108|P4|STARTED|Second Washout Period||6
1104825|NCT01121913|2674109|P3|STARTED|Second Washout Period||4
1104826|NCT01121913|2674110|P2|STARTED|Second Washout Period||6
1104827|NCT01121913|2674111|P1|STARTED|Second Washout Period||5
1104828|NCT01121913|2674108|P4|NOT COMPLETED|Second Intervention Period||0
1104829|NCT01121913|2674109|P3|NOT COMPLETED|Second Intervention Period||1
1104830|NCT01121913|2674110|P2|NOT COMPLETED|Second Intervention Period||0
1104831|NCT01121913|2674111|P1|NOT COMPLETED|Second Intervention Period||0
1104832|NCT01121913|2674108|P4|COMPLETED|Second Intervention Period||6
1104833|NCT01121913|2674109|P3|COMPLETED|Second Intervention Period||4
1104834|NCT01121913|2674110|P2|COMPLETED|Second Intervention Period||6
1104835|NCT01121913|2674111|P1|COMPLETED|Second Intervention Period||5
1104836|NCT01121913|2674108|P4|STARTED|Second Intervention Period||6
1104837|NCT01121913|2674109|P3|STARTED|Second Intervention Period||5
1104838|NCT01121913|2674110|P2|STARTED|Second Intervention Period||6
1104839|NCT01121913|2674111|P1|STARTED|Second Intervention Period||5
1104840|NCT01121913|2674108|P4|NOT COMPLETED|First Washout Period||0
1104841|NCT01121913|2674109|P3|NOT COMPLETED|First Washout Period||0
1104842|NCT01121913|2674110|P2|NOT COMPLETED|First Washout Period||0
1104843|NCT01121913|2674111|P1|NOT COMPLETED|First Washout Period||1
1104844|NCT01121913|2674108|P4|COMPLETED|First Washout Period||6
1104845|NCT01121913|2674109|P3|COMPLETED|First Washout Period||5
1104846|NCT01121913|2674110|P2|COMPLETED|First Washout Period||6
1104847|NCT01121913|2674111|P1|COMPLETED|First Washout Period||5
1104848|NCT01121913|2674108|P4|STARTED|First Washout Period||6
1104849|NCT01121913|2674109|P3|STARTED|First Washout Period||5
1104850|NCT01121913|2674110|P2|STARTED|First Washout Period||6
1104851|NCT01121913|2674111|P1|STARTED|First Washout Period||6
1104852|NCT01121913|2674108|P4|NOT COMPLETED|First Intervention Period||0
1104853|NCT01121913|2674109|P3|NOT COMPLETED|First Intervention Period||1
1104854|NCT01121913|2674110|P2|NOT COMPLETED|First Intervention Period||0
1104855|NCT01121913|2674111|P1|NOT COMPLETED|First Intervention Period||0
1104856|NCT01121913|2674108|P4|COMPLETED|First Intervention Period||6
1104857|NCT01121913|2674109|P3|COMPLETED|First Intervention Period||5
1104858|NCT01121913|2674110|P2|COMPLETED|First Intervention Period||6
1104859|NCT01121913|2674111|P1|COMPLETED|First Intervention Period||6
1104860|NCT01121913|2674108|P4|STARTED|First Intervention Period||6
1104861|NCT01121913|2674109|P3|STARTED|First Intervention Period||6
1104862|NCT01121913|2674110|P2|STARTED|First Intervention Period||6
1104863|NCT01121913|2674111|P1|STARTED|First Intervention Period||6
1104864|NCT01121926|2674141|P2|NOT COMPLETED|Second Intervention Period||0
1104865|NCT01121926|2674142|P1|NOT COMPLETED|Second Intervention Period||0
1104866|NCT01121926|2674141|P2|COMPLETED|Second Intervention Period||13
1104867|NCT01121926|2674142|P1|COMPLETED|Second Intervention Period||14
1104868|NCT01121926|2674141|P2|STARTED|Second Intervention Period||13
1104869|NCT01121926|2674142|P1|STARTED|Second Intervention Period||14
1104870|NCT01121926|2674141|P2|NOT COMPLETED|Washout Period||2
1104871|NCT01121926|2674142|P1|NOT COMPLETED|Washout Period||0
1104872|NCT01121926|2674141|P2|COMPLETED|Washout Period||13
1104873|NCT01121926|2674142|P1|COMPLETED|Washout Period||14
1104874|NCT01121926|2674141|P2|STARTED|Washout Period||15
1104875|NCT01121926|2674142|P1|STARTED|Washout Period||14
1104876|NCT01121926|2674141|P2|NOT COMPLETED|First Intervention Period||0
1104877|NCT01121926|2674142|P1|NOT COMPLETED|First Intervention Period||1
1104878|NCT01121926|2674141|P2|COMPLETED|First Intervention Period||15
1104879|NCT01121926|2674142|P1|COMPLETED|First Intervention Period||14
1104880|NCT01121926|2674141|P2|STARTED|First Intervention Period||15
1104881|NCT01121926|2674142|P1|STARTED|First Intervention Period||15
1104882|NCT01121939|2674160|P1|NOT COMPLETED|Overall Study||43
1104883|NCT01121939|2674160|P1|COMPLETED|Overall Study|Patients remained on-study until disease progression or unacceptable toxicity occurred.|0
1104884|NCT01121939|2674160|P1|STARTED|Overall Study||43
1104885|NCT01121991|2674174|P1|NOT COMPLETED|Overall Study||6
1104886|NCT01121991|2674174|P1|COMPLETED|Overall Study||46
1104887|NCT01121991|2674174|P1|STARTED|Overall Study|Number of participants treated|52
1104888|NCT01122030|2674192|P7|NOT COMPLETED|Overall Study||0
1104889|NCT01122030|2674193|P6|NOT COMPLETED|Overall Study||0
1104890|NCT01122030|2674194|P5|NOT COMPLETED|Overall Study||0
1104891|NCT01122030|2674195|P4|NOT COMPLETED|Overall Study||0
1104892|NCT01122030|2674196|P3|NOT COMPLETED|Overall Study||0
1104893|NCT01122030|2674197|P2|NOT COMPLETED|Overall Study||0
1104894|NCT01122030|2674198|P1|NOT COMPLETED|Overall Study||0
1104895|NCT01122030|2674192|P7|COMPLETED|Overall Study||9
1104896|NCT01122030|2674193|P6|COMPLETED|Overall Study||9
1104897|NCT01122030|2674194|P5|COMPLETED|Overall Study||9
1104898|NCT01122030|2674195|P4|COMPLETED|Overall Study||9
1104899|NCT01122030|2674196|P3|COMPLETED|Overall Study||9
1104900|NCT01122030|2674197|P2|COMPLETED|Overall Study||9
1104901|NCT01122030|2674198|P1|COMPLETED|Overall Study||18
1104902|NCT01122030|2674192|P7|Received Treatment|Overall Study||9
1104903|NCT01122030|2674193|P6|Received Treatment|Overall Study||9
1104904|NCT01122030|2674194|P5|Received Treatment|Overall Study||9
1104905|NCT01122030|2674195|P4|Received Treatment|Overall Study||9
1104906|NCT01122030|2674196|P3|Received Treatment|Overall Study||9
1104907|NCT01122030|2674197|P2|Received Treatment|Overall Study||9
1104908|NCT01122030|2674198|P1|Received Treatment|Overall Study||18
1104909|NCT01122030|2674192|P7|STARTED|Overall Study||9
1104910|NCT01122030|2674193|P6|STARTED|Overall Study||9
1104911|NCT01122030|2674194|P5|STARTED|Overall Study||9
1104912|NCT01122030|2674195|P4|STARTED|Overall Study||9
1104913|NCT01122030|2674196|P3|STARTED|Overall Study||9
1104914|NCT01122030|2674197|P2|STARTED|Overall Study||9
1104915|NCT01122030|2674198|P1|STARTED|Overall Study||18
1104916|NCT01122108|2674384|P2|NOT COMPLETED|Overall Study||0
1104917|NCT01122108|2674385|P1|NOT COMPLETED|Overall Study||0
1104918|NCT01122108|2674384|P2|COMPLETED|Overall Study||21
1104919|NCT01122108|2674385|P1|COMPLETED|Overall Study||21
1104920|NCT01122108|2674384|P2|STARTED|Overall Study||21
1104921|NCT01122108|2674385|P1|STARTED|Overall Study||21
1104922|NCT01122160|2674394|P2|NOT COMPLETED|Second Intervention (7 Days)||0
1104923|NCT01122160|2674395|P1|NOT COMPLETED|Second Intervention (7 Days)||0
1104924|NCT01122160|2674394|P2|COMPLETED|Second Intervention (7 Days)||5
1104925|NCT01122160|2674395|P1|COMPLETED|Second Intervention (7 Days)||6
1104926|NCT01122160|2674394|P2|STARTED|Second Intervention (7 Days)||5
1104927|NCT01122160|2674395|P1|STARTED|Second Intervention (7 Days)||6
1104928|NCT01122160|2674394|P2|NOT COMPLETED|Washout (7-14 Days)||0
1104929|NCT01122160|2674395|P1|NOT COMPLETED|Washout (7-14 Days)||0
1104930|NCT01122160|2674394|P2|COMPLETED|Washout (7-14 Days)||5
1104931|NCT01122160|2674395|P1|COMPLETED|Washout (7-14 Days)||6
1104932|NCT01122160|2674394|P2|STARTED|Washout (7-14 Days)||5
1104933|NCT01122160|2674395|P1|STARTED|Washout (7-14 Days)||6
1104934|NCT01122160|2674394|P2|NOT COMPLETED|First Intervention (7 Days)||0
1104935|NCT01122160|2674395|P1|NOT COMPLETED|First Intervention (7 Days)||0
1104936|NCT01122160|2674394|P2|COMPLETED|First Intervention (7 Days)||5
1104937|NCT01122160|2674395|P1|COMPLETED|First Intervention (7 Days)||6
1104938|NCT01122160|2674394|P2|STARTED|First Intervention (7 Days)||5
1104939|NCT01122160|2674395|P1|STARTED|First Intervention (7 Days)||6
1104940|NCT01122238|2674417|P16|NOT COMPLETED|Overall Study||0
1104941|NCT01122238|2674418|P15|NOT COMPLETED|Overall Study||0
1104942|NCT01122238|2674419|P14|NOT COMPLETED|Overall Study||1
1104943|NCT01122238|2674420|P13|NOT COMPLETED|Overall Study||2
1104944|NCT01122238|2674421|P12|NOT COMPLETED|Overall Study||2
1104945|NCT01122238|2674422|P11|NOT COMPLETED|Overall Study||0
1104946|NCT01122238|2674423|P10|NOT COMPLETED|Overall Study||1
1104947|NCT01122238|2674424|P9|NOT COMPLETED|Overall Study||1
1104948|NCT01122238|2674425|P8|NOT COMPLETED|Overall Study||0
1104949|NCT01122238|2674426|P7|NOT COMPLETED|Overall Study||1
1104950|NCT01122238|2674427|P6|NOT COMPLETED|Overall Study||1
1104951|NCT01122238|2674428|P5|NOT COMPLETED|Overall Study||0
1104952|NCT01122238|2674429|P4|NOT COMPLETED|Overall Study||0
1104953|NCT01122238|2674430|P3|NOT COMPLETED|Overall Study||5
1104954|NCT01122238|2674431|P2|NOT COMPLETED|Overall Study||1
1104955|NCT01122238|2674432|P1|NOT COMPLETED|Overall Study||2
1104956|NCT01122238|2674417|P16|COMPLETED|Overall Study||31
1104957|NCT01122238|2674418|P15|COMPLETED|Overall Study||28
1104958|NCT01122238|2674419|P14|COMPLETED|Overall Study||31
1104959|NCT01122238|2674420|P13|COMPLETED|Overall Study||28
1104960|NCT01122238|2674421|P12|COMPLETED|Overall Study||31
1104961|NCT01122238|2674422|P11|COMPLETED|Overall Study||32
1104962|NCT01122238|2674423|P10|COMPLETED|Overall Study||33
1104963|NCT01122238|2674424|P9|COMPLETED|Overall Study||31
1104964|NCT01122238|2674425|P8|COMPLETED|Overall Study||32
1104965|NCT01122238|2674426|P7|COMPLETED|Overall Study||34
1104966|NCT01122238|2674427|P6|COMPLETED|Overall Study||31
1104967|NCT01122238|2674428|P5|COMPLETED|Overall Study||33
1104968|NCT01122238|2674429|P4|COMPLETED|Overall Study||33
1104969|NCT01122238|2674430|P3|COMPLETED|Overall Study||28
1104970|NCT01122238|2674431|P2|COMPLETED|Overall Study||36
1104971|NCT01122238|2674432|P1|COMPLETED|Overall Study||28
1104972|NCT01122238|2674417|P16|STARTED|Overall Study||31
1104973|NCT01122238|2674418|P15|STARTED|Overall Study||28
1104974|NCT01122238|2674419|P14|STARTED|Overall Study||32
1104975|NCT01122238|2674420|P13|STARTED|Overall Study||30
1104976|NCT01122238|2674421|P12|STARTED|Overall Study||33
1104977|NCT01122238|2674422|P11|STARTED|Overall Study||32
1104978|NCT01122238|2674423|P10|STARTED|Overall Study||34
1104979|NCT01122238|2674424|P9|STARTED|Overall Study||32
1104980|NCT01122238|2674425|P8|STARTED|Overall Study||32
1104981|NCT01122238|2674426|P7|STARTED|Overall Study||35
1104982|NCT01122238|2674427|P6|STARTED|Overall Study||32
1104983|NCT01122238|2674428|P5|STARTED|Overall Study||33
1104984|NCT01122238|2674429|P4|STARTED|Overall Study||33
1104985|NCT01122238|2674430|P3|STARTED|Overall Study||33
1104986|NCT01122238|2674431|P2|STARTED|Overall Study||37
1104987|NCT01122238|2674432|P1|STARTED|Overall Study||30
1104988|NCT01122264|2674457|P3|NOT COMPLETED|Overall Study||47
1104989|NCT01122264|2674458|P2|NOT COMPLETED|Overall Study||29
1104990|NCT01122264|2674459|P1|NOT COMPLETED|Overall Study||32
1104991|NCT01122264|2674457|P3|COMPLETED|Overall Study||214
1104992|NCT01122264|2674458|P2|COMPLETED|Overall Study||228
1104993|NCT01122264|2674459|P1|COMPLETED|Overall Study||220
1104994|NCT01122264|2674457|P3|Received at Least 1 Dose of Study Drug|Overall Study||260
1104995|NCT01122264|2674458|P2|Received at Least 1 Dose of Study Drug|Overall Study||257
1104996|NCT01122264|2674459|P1|Received at Least 1 Dose of Study Drug|Overall Study||250
1104997|NCT01122264|2674457|P3|STARTED|Overall Study||261
1104998|NCT01122264|2674458|P2|STARTED|Overall Study||257
1104999|NCT01122264|2674459|P1|STARTED|Overall Study||252
1105000|NCT01122381|2674518|P2|NOT COMPLETED|Overall Study||1
1105001|NCT01122381|2674519|P1|NOT COMPLETED|Overall Study||0
1105002|NCT01122381|2674518|P2|COMPLETED|Overall Study||0
1105003|NCT01122381|2674519|P1|COMPLETED|Overall Study|Subject never took the drug per review of ESX levels after unblinding|1
1105004|NCT01122381|2674518|P2|STARTED|Overall Study||1
1105005|NCT01122381|2674519|P1|STARTED|Overall Study||1
1105006|NCT01122394|2674527|P2|NOT COMPLETED|Overall Study||4
1105007|NCT01122394|2674528|P1|NOT COMPLETED|Overall Study||3
1105008|NCT01122394|2674527|P2|COMPLETED|Overall Study||70
1105009|NCT01122394|2674528|P1|COMPLETED|Overall Study||63
1105010|NCT01122394|2674527|P2|STARTED|Overall Study||74
1105011|NCT01122394|2674528|P1|STARTED|Overall Study||66
1105012|NCT01122511|2674544|P2|NOT COMPLETED|Overall Study||2
1105013|NCT01122511|2674545|P1|NOT COMPLETED|Overall Study||2
1105014|NCT01122511|2674544|P2|COMPLETED|Overall Study||0
1105015|NCT01122511|2674545|P1|COMPLETED|Overall Study||0
1105016|NCT01122511|2674544|P2|STARTED|Overall Study||2
1105017|NCT01122511|2674545|P1|STARTED|Overall Study||2
1105018|NCT01122576|2674560|P3|NOT COMPLETED|Post-Cataract Surgery||2
1105019|NCT01122576|2674561|P2|NOT COMPLETED|Post-Cataract Surgery||0
1105020|NCT01122576|2674562|P1|NOT COMPLETED|Post-Cataract Surgery||0
1105021|NCT01122576|2674560|P3|COMPLETED|Post-Cataract Surgery||22
1105022|NCT01122576|2674561|P2|COMPLETED|Post-Cataract Surgery||25
1105023|NCT01122576|2674562|P1|COMPLETED|Post-Cataract Surgery||26
1105024|NCT01122576|2674560|P3|STARTED|Post-Cataract Surgery||24
1105025|NCT01122576|2674561|P2|STARTED|Post-Cataract Surgery||25
1105026|NCT01122576|2674562|P1|STARTED|Post-Cataract Surgery||26
1105027|NCT01122576|2674560|P3|NOT COMPLETED|Pre-Cataract Surgery||2
1105028|NCT01122576|2674561|P2|NOT COMPLETED|Pre-Cataract Surgery||1
1105029|NCT01122576|2674562|P1|NOT COMPLETED|Pre-Cataract Surgery||0
1105030|NCT01122576|2674560|P3|COMPLETED|Pre-Cataract Surgery||24
1105031|NCT01122576|2674561|P2|COMPLETED|Pre-Cataract Surgery||25
1105032|NCT01122576|2674562|P1|COMPLETED|Pre-Cataract Surgery||26
1105033|NCT01122576|2674560|P3|STARTED|Pre-Cataract Surgery||26
1105034|NCT01122576|2674561|P2|STARTED|Pre-Cataract Surgery||26
1105035|NCT01122576|2674562|P1|STARTED|Pre-Cataract Surgery||26
1105036|NCT01122680|2674699|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
1105037|NCT01122680|2674700|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
1105038|NCT01122680|2674701|P2|NOT COMPLETED|Period 3 (4 Weeks)||1
1105039|NCT01122680|2674702|P1|NOT COMPLETED|Period 3 (4 Weeks)||1
1105040|NCT01122680|2674699|P4|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|23
1105041|NCT01122680|2674700|P3|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|26
1105042|NCT01122680|2674701|P2|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
1105043|NCT01122680|2674702|P1|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
1105044|NCT01122680|2674699|P4|STARTED|Period 3 (4 Weeks)|Entered this study period.|23
1105045|NCT01122680|2674700|P3|STARTED|Period 3 (4 Weeks)|Entered this study period.|26
1105046|NCT01122680|2674701|P2|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
1105047|NCT01122680|2674702|P1|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
1105048|NCT01122680|2674699|P4|NOT COMPLETED|Period 2 (4 Weeks)||1
1105049|NCT01122680|2674700|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
1105050|NCT01122680|2674701|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
1105051|NCT01122680|2674702|P1|NOT COMPLETED|Period 2 (4 Weeks)||1
1105052|NCT01122680|2674699|P4|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|23
1105053|NCT01122680|2674700|P3|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|26
1105054|NCT01122680|2674701|P2|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
1105055|NCT01122680|2674702|P1|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
1105056|NCT01122680|2674699|P4|STARTED|Period 2 (4 Weeks)|Entered this study period.|24
1105057|NCT01122680|2674700|P3|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
1105058|NCT01122680|2674701|P2|STARTED|Period 2 (4 Weeks)|Entered this study period.|25
1105059|NCT01122680|2674702|P1|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
1105060|NCT01122680|2674699|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
1105061|NCT01122680|2674700|P3|NOT COMPLETED|Period 1 (4 Weeks)||0
1105062|NCT01122680|2674701|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
1105063|NCT01122680|2674702|P1|NOT COMPLETED|Period 1 (4 Weeks)||3
1105064|NCT01122680|2674699|P4|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|24
1105065|NCT01122680|2674700|P3|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
1105066|NCT01122680|2674701|P2|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|25
1105067|NCT01122680|2674702|P1|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
1105068|NCT01122680|2674699|P4|STARTED|Period 1 (4 Weeks)|Entered this study period.|24
1105069|NCT01122680|2674700|P3|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
1105070|NCT01122680|2674701|P2|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
1105071|NCT01122680|2674702|P1|STARTED|Period 1 (4 Weeks)|Entered this study period.|29
1105072|NCT01122862|2674764|P3|NOT COMPLETED|Period 3||0
1105073|NCT01122862|2674765|P2|NOT COMPLETED|Period 3||0
1105074|NCT01122862|2674766|P1|NOT COMPLETED|Period 3||0
1105075|NCT01122862|2674764|P3|COMPLETED|Period 3||8
1105076|NCT01122862|2674765|P2|COMPLETED|Period 3||7
1105077|NCT01122862|2674766|P1|COMPLETED|Period 3||6
1105078|NCT01122862|2674764|P3|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|8
1105079|NCT01122862|2674765|P2|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|7
1105080|NCT01122862|2674766|P1|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|6
1105081|NCT01122862|2674764|P3|NOT COMPLETED|Period 2||1
1105082|NCT01122862|2674765|P2|NOT COMPLETED|Period 2||0
1105083|NCT01122862|2674766|P1|NOT COMPLETED|Period 2||0
1105084|NCT01122862|2674764|P3|COMPLETED|Period 2||6
1105085|NCT01122862|2674765|P2|COMPLETED|Period 2||7
1105086|NCT01122862|2674766|P1|COMPLETED|Period 2||8
1105087|NCT01122862|2674764|P3|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
1105088|NCT01122862|2674765|P2|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
1105089|NCT01122862|2674766|P1|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|8
1105090|NCT01122862|2674764|P3|NOT COMPLETED|Period 1||0
1105091|NCT01122862|2674765|P2|NOT COMPLETED|Period 1||1
1105092|NCT01122862|2674766|P1|NOT COMPLETED|Period 1||0
1105093|NCT01122862|2674764|P3|COMPLETED|Period 1||7
1105094|NCT01122862|2674765|P2|COMPLETED|Period 1||7
1105095|NCT01122862|2674766|P1|COMPLETED|Period 1||8
1105096|NCT01122862|2674764|P3|STARTED|Period 1||7
1105097|NCT01122862|2674765|P2|STARTED|Period 1||8
1105098|NCT01122862|2674766|P1|STARTED|Period 1||8
1105099|NCT01122901|2674786|P2|NOT COMPLETED|Overall Study||0
1105100|NCT01122901|2674787|P1|NOT COMPLETED|Overall Study||0
1105101|NCT01122901|2674786|P2|COMPLETED|Overall Study||7
1105102|NCT01122901|2674787|P1|COMPLETED|Overall Study||40
1105103|NCT01122901|2674786|P2|STARTED|Overall Study||7
1105104|NCT01122901|2674787|P1|STARTED|Overall Study||40
1105105|NCT01122927|2674805|P2|NOT COMPLETED|Period 2- Open-label Treatment Phase||312
1105106|NCT01122927|2674806|P1|NOT COMPLETED|Period 2- Open-label Treatment Phase||0
1105107|NCT01122927|2674805|P2|COMPLETED|Period 2- Open-label Treatment Phase|De novo participants who completed Month 24 visit or rolled over from study NCT01149655.|198
1105108|NCT01122927|2674806|P1|COMPLETED|Period 2- Open-label Treatment Phase||0
1105109|NCT01122927|2674805|P2|STARTED|Period 2- Open-label Treatment Phase|362 were de novo participants and 148 had rolled over from study NCT01149655.|510
1105110|NCT01122927|2674806|P1|STARTED|Period 2- Open-label Treatment Phase||0
1105111|NCT01122927|2674805|P2|NOT COMPLETED|Period 1 - Conversion Phase||0
1105112|NCT01122927|2674806|P1|NOT COMPLETED|Period 1 - Conversion Phase||14
1105113|NCT01122927|2674805|P2|COMPLETED|Period 1 - Conversion Phase||0
1105114|NCT01122927|2674806|P1|COMPLETED|Period 1 - Conversion Phase||283
1105115|NCT01122927|2674805|P2|STARTED|Period 1 - Conversion Phase||0
1105116|NCT01122927|2674806|P1|STARTED|Period 1 - Conversion Phase||297
1105117|NCT01123083|2674839|P2|NOT COMPLETED|Overall Study||15
1105118|NCT01123083|2674840|P1|NOT COMPLETED|Overall Study||11
1105119|NCT01123083|2674839|P2|COMPLETED|Overall Study||103
1105120|NCT01123083|2674840|P1|COMPLETED|Overall Study||50
1105121|NCT01123083|2674839|P2|STARTED|Overall Study||118
1105122|NCT01123083|2674840|P1|STARTED|Overall Study||61
1105123|NCT01123148|2674864|P1|NOT COMPLETED|Overall Study||2
1105124|NCT01123148|2674864|P1|COMPLETED|Overall Study||12
1105125|NCT01123148|2674864|P1|BCI Calibration >50% Accuracy|Overall Study||13
1105126|NCT01123148|2674864|P1|STARTED|Overall Study||14
1105127|NCT01123161|2674870|P2|NOT COMPLETED|Overall Study||0
1105128|NCT01123161|2674871|P1|NOT COMPLETED|Overall Study||2
1105129|NCT01123161|2674870|P2|COMPLETED|Overall Study||63
1105130|NCT01123161|2674871|P1|COMPLETED|Overall Study||55
1105131|NCT01123161|2674870|P2|STARTED|Overall Study||63
1105132|NCT01123161|2674871|P1|STARTED|Overall Study||57
1105133|NCT01123200|2674889|P1|NOT COMPLETED|Overall Study||1
1105134|NCT01123200|2674889|P1|COMPLETED|Overall Study||0
1105135|NCT01123200|2674889|P1|STARTED|Overall Study||1
1105136|NCT01128829|2674894|P2|NOT COMPLETED|Overall Study||0
1105137|NCT01128829|2674895|P1|NOT COMPLETED|Overall Study||0
1105138|NCT01128829|2674894|P2|COMPLETED|Overall Study||11
1105139|NCT01128829|2674895|P1|COMPLETED|Overall Study||6
1105140|NCT01128829|2674894|P2|STARTED|Overall Study||11
1105141|NCT01128829|2674895|P1|STARTED|Overall Study||6
1105142|NCT01128894|2674901|P2|NOT COMPLETED|Overall Study||68
1105143|NCT01128894|2674902|P1|NOT COMPLETED|Overall Study||58
1105144|NCT01128894|2674901|P2|COMPLETED|Overall Study||340
1105145|NCT01128894|2674902|P1|COMPLETED|Overall Study||346
1105146|NCT01128894|2674901|P2|STARTED|Overall Study||408
1105147|NCT01128894|2674902|P1|STARTED|Overall Study||404
1105148|NCT01128946|2674920|P4|NOT COMPLETED|Period IV||0
1105149|NCT01128946|2674921|P3|NOT COMPLETED|Period IV||0
1105150|NCT01128946|2674922|P2|NOT COMPLETED|Period IV||0
1105151|NCT01128946|2674923|P1|NOT COMPLETED|Period IV||0
1105152|NCT01128946|2674920|P4|COMPLETED|Period IV||19
1105153|NCT01128946|2674921|P3|COMPLETED|Period IV||19
1105154|NCT01128946|2674922|P2|COMPLETED|Period IV||20
1105155|NCT01128946|2674923|P1|COMPLETED|Period IV||19
1105156|NCT01128946|2674920|P4|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
1105157|NCT01128946|2674921|P3|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
1105158|NCT01128946|2674922|P2|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|20
1105159|NCT01128946|2674923|P1|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
1105160|NCT01128946|2674920|P4|NOT COMPLETED|Period III||0
1105161|NCT01128946|2674921|P3|NOT COMPLETED|Period III||0
1105162|NCT01128946|2674922|P2|NOT COMPLETED|Period III||0
1105163|NCT01128946|2674923|P1|NOT COMPLETED|Period III||1
1105164|NCT01128946|2674920|P4|COMPLETED|Period III||19
1105165|NCT01128946|2674921|P3|COMPLETED|Period III||20
1105166|NCT01128946|2674922|P2|COMPLETED|Period III||19
1105167|NCT01128946|2674923|P1|COMPLETED|Period III||19
1105168|NCT01128946|2674920|P4|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
1105169|NCT01128946|2674921|P3|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
1105170|NCT01128946|2674922|P2|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
1105171|NCT01128946|2674923|P1|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
1105172|NCT01128946|2674920|P4|NOT COMPLETED|Period II||1
1105173|NCT01128946|2674921|P3|NOT COMPLETED|Period II||0
1105174|NCT01128946|2674922|P2|NOT COMPLETED|Period II||1
1105175|NCT01128946|2674923|P1|NOT COMPLETED|Period II||0
1105176|NCT01128946|2674920|P4|COMPLETED|Period II||19
1105177|NCT01128946|2674921|P3|COMPLETED|Period II||20
1105178|NCT01128946|2674922|P2|COMPLETED|Period II||19
1105179|NCT01128946|2674923|P1|COMPLETED|Period II||20
1105180|NCT01128946|2674920|P4|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
1105181|NCT01128946|2674921|P3|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
1105182|NCT01128946|2674922|P2|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
1105183|NCT01128946|2674923|P1|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
1105184|NCT01128946|2674920|P4|NOT COMPLETED|Period I||1
1105185|NCT01128946|2674921|P3|NOT COMPLETED|Period I||1
1105186|NCT01128946|2674922|P2|NOT COMPLETED|Period I||1
1105187|NCT01128946|2674923|P1|NOT COMPLETED|Period I||0
1105188|NCT01128946|2674920|P4|COMPLETED|Period I||20
1105189|NCT01128946|2674921|P3|COMPLETED|Period I||20
1105190|NCT01128946|2674922|P2|COMPLETED|Period I||20
1105191|NCT01128946|2674923|P1|COMPLETED|Period I||20
1105192|NCT01128946|2674920|P4|STARTED|Period I||21
1105193|NCT01128946|2674921|P3|STARTED|Period I||21
1105194|NCT01128946|2674922|P2|STARTED|Period I||21
1105195|NCT01128946|2674923|P1|STARTED|Period I||20
1105196|NCT01128959|2674939|P1|NOT COMPLETED|Treatment Period||4
1105197|NCT01128959|2674939|P1|COMPLETED|Treatment Period||101
1105198|NCT01128959|2674939|P1|STARTED|Treatment Period||105
1105199|NCT01128959|2674939|P1|NOT COMPLETED|Lead in Period||3
1105200|NCT01128959|2674939|P1|COMPLETED|Lead in Period||105
1105201|NCT01128959|2674939|P1|STARTED|Lead in Period||108
1105202|NCT01128972|2674945|P5|NOT COMPLETED|Period V||0
1105203|NCT01128972|2674946|P4|NOT COMPLETED|Period V||0
1105204|NCT01128972|2674947|P3|NOT COMPLETED|Period V||0
1105205|NCT01128972|2674948|P2|NOT COMPLETED|Period V||0
1105206|NCT01128972|2674949|P1|NOT COMPLETED|Period V||0
1105207|NCT01128972|2674945|P5|COMPLETED|Period V||7
1105208|NCT01128972|2674946|P4|COMPLETED|Period V||7
1105209|NCT01128972|2674947|P3|COMPLETED|Period V||7
1105210|NCT01128972|2674948|P2|COMPLETED|Period V||7
1105211|NCT01128972|2674949|P1|COMPLETED|Period V||8
1105212|NCT01128972|2674945|P5|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
1105213|NCT01128972|2674946|P4|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
1105214|NCT01128972|2674947|P3|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
1105215|NCT01128972|2674948|P2|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
1105216|NCT01128972|2674949|P1|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|8
1105217|NCT01128972|2674945|P5|NOT COMPLETED|Period IV||0
1105218|NCT01128972|2674946|P4|NOT COMPLETED|Period IV||0
1105219|NCT01128972|2674947|P3|NOT COMPLETED|Period IV||0
1105220|NCT01128972|2674948|P2|NOT COMPLETED|Period IV||0
1105221|NCT01128972|2674949|P1|NOT COMPLETED|Period IV||0
1105222|NCT01128972|2674945|P5|COMPLETED|Period IV||7
1105223|NCT01128972|2674946|P4|COMPLETED|Period IV||7
1105224|NCT01128972|2674947|P3|COMPLETED|Period IV||7
1105225|NCT01128972|2674948|P2|COMPLETED|Period IV||8
1105226|NCT01128972|2674949|P1|COMPLETED|Period IV||7
1105227|NCT01128972|2674945|P5|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
1105228|NCT01128972|2674946|P4|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
1105229|NCT01128972|2674947|P3|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
1105230|NCT01128972|2674948|P2|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|8
1105231|NCT01128972|2674949|P1|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
1105232|NCT01128972|2674945|P5|NOT COMPLETED|Period III||0
1105233|NCT01128972|2674946|P4|NOT COMPLETED|Period III||0
1105234|NCT01128972|2674947|P3|NOT COMPLETED|Period III||0
1105235|NCT01128972|2674948|P2|NOT COMPLETED|Period III||0
1105236|NCT01128972|2674949|P1|NOT COMPLETED|Period III||0
1105237|NCT01128972|2674945|P5|COMPLETED|Period III||7
1105238|NCT01128972|2674946|P4|COMPLETED|Period III||7
1105239|NCT01128972|2674947|P3|COMPLETED|Period III||8
1105240|NCT01128972|2674948|P2|COMPLETED|Period III||7
1105241|NCT01128972|2674949|P1|COMPLETED|Period III||7
1105242|NCT01128972|2674945|P5|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
1105243|NCT01128972|2674946|P4|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
1105244|NCT01128972|2674947|P3|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|8
1105245|NCT01128972|2674948|P2|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
1105246|NCT01128972|2674949|P1|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
1105247|NCT01128972|2674945|P5|NOT COMPLETED|Period II||0
1105248|NCT01128972|2674946|P4|NOT COMPLETED|Period II||0
1105249|NCT01128972|2674947|P3|NOT COMPLETED|Period II||0
1105250|NCT01128972|2674948|P2|NOT COMPLETED|Period II||0
1105251|NCT01128972|2674949|P1|NOT COMPLETED|Period II||0
1105252|NCT01128972|2674945|P5|COMPLETED|Period II||7
1105253|NCT01128972|2674946|P4|COMPLETED|Period II||8
1105254|NCT01128972|2674947|P3|COMPLETED|Period II||7
1105255|NCT01128972|2674948|P2|COMPLETED|Period II||7
1105256|NCT01128972|2674949|P1|COMPLETED|Period II||7
1105257|NCT01128972|2674945|P5|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
1105258|NCT01128972|2674946|P4|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|8
1105259|NCT01128972|2674947|P3|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
1105260|NCT01128972|2674948|P2|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
1105261|NCT01128972|2674949|P1|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
1105262|NCT01128972|2674945|P5|NOT COMPLETED|Period I||0
1105263|NCT01128972|2674946|P4|NOT COMPLETED|Period I||0
1105264|NCT01128972|2674947|P3|NOT COMPLETED|Period I||0
1105265|NCT01128972|2674948|P2|NOT COMPLETED|Period I||0
1105266|NCT01128972|2674949|P1|NOT COMPLETED|Period I||0
1105267|NCT01128972|2674945|P5|COMPLETED|Period I||8
1105268|NCT01128972|2674946|P4|COMPLETED|Period I||7
1105269|NCT01128972|2674947|P3|COMPLETED|Period I||7
1105270|NCT01128972|2674948|P2|COMPLETED|Period I||7
1105271|NCT01128972|2674949|P1|COMPLETED|Period I||7
1105272|NCT01128972|2674945|P5|STARTED|Period I||8
1105273|NCT01128972|2674946|P4|STARTED|Period I||7
1105274|NCT01128972|2674947|P3|STARTED|Period I||7
1105275|NCT01128972|2674948|P2|STARTED|Period I||7
1105276|NCT01128972|2674949|P1|STARTED|Period I||7
1105277|NCT01129011|2674980|P2|NOT COMPLETED|Overall Study||57
1105278|NCT01129011|2674981|P1|NOT COMPLETED|Overall Study||59
1105279|NCT01129011|2674980|P2|COMPLETED|Overall Study||153
1105280|NCT01129011|2674981|P1|COMPLETED|Overall Study||151
1105281|NCT01129011|2674980|P2|STARTED|Overall Study|Safety, Intent-to-Treat population|210
1105282|NCT01129011|2674981|P1|STARTED|Overall Study|Safety, Intent-to-Treat population|210
1105283|NCT01129102|2675006|P3|NOT COMPLETED|Overall Study||7
1105284|NCT01129102|2675007|P2|NOT COMPLETED|Overall Study||6
1105285|NCT01129102|2675008|P1|NOT COMPLETED|Overall Study||8
1105286|NCT01129102|2675006|P3|COMPLETED|Overall Study||48
1105287|NCT01129102|2675007|P2|COMPLETED|Overall Study||44
1105288|NCT01129102|2675008|P1|COMPLETED|Overall Study||102
1105289|NCT01129102|2675006|P3|STARTED|Overall Study||55
1105290|NCT01129102|2675007|P2|STARTED|Overall Study||50
1105291|NCT01129102|2675008|P1|STARTED|Overall Study||110
1105292|NCT01129115|2675021|P4|NOT COMPLETED|Overall Study||9
1105293|NCT01129115|2675022|P3|NOT COMPLETED|Overall Study||6
1105294|NCT01129115|2675023|P2|NOT COMPLETED|Overall Study||7
1105295|NCT01129115|2675024|P1|NOT COMPLETED|Overall Study||2
1105296|NCT01129115|2675021|P4|COMPLETED|Overall Study||15
1105297|NCT01129115|2675022|P3|COMPLETED|Overall Study||21
1105298|NCT01129115|2675023|P2|COMPLETED|Overall Study||18
1105299|NCT01129115|2675024|P1|COMPLETED|Overall Study||23
1105300|NCT01129115|2675021|P4|STARTED|Overall Study||24
1105301|NCT01129115|2675022|P3|STARTED|Overall Study||27
1105302|NCT01129115|2675023|P2|STARTED|Overall Study||25
1105303|NCT01129115|2675024|P1|STARTED|Overall Study||25
1105304|NCT01129128|2675061|P3|NOT COMPLETED|Overall Study||4
1105305|NCT01129128|2675062|P2|NOT COMPLETED|Overall Study||4
1105306|NCT01129128|2675063|P1|NOT COMPLETED|Overall Study||3
1105307|NCT01129128|2675061|P3|COMPLETED|Overall Study||19
1105308|NCT01129128|2675062|P2|COMPLETED|Overall Study||18
1105309|NCT01129128|2675063|P1|COMPLETED|Overall Study||19
1105310|NCT01129128|2675061|P3|STARTED|Overall Study||23
1105311|NCT01129128|2675062|P2|STARTED|Overall Study||22
1105312|NCT01129128|2675063|P1|STARTED|Overall Study||22
1105313|NCT01129141|2675085|P2|NOT COMPLETED|Overall Study||13
1105314|NCT01129141|2675086|P1|NOT COMPLETED|Overall Study||15
1105315|NCT01129141|2675085|P2|COMPLETED|Overall Study||91
1105316|NCT01129141|2675086|P1|COMPLETED|Overall Study||86
1105317|NCT01129141|2675085|P2|STARTED|Overall Study||104
1105318|NCT01129141|2675086|P1|STARTED|Overall Study||101
1105319|NCT01131884|2675094|P2|NOT COMPLETED|Overall Study||0
1105320|NCT01131884|2675095|P1|NOT COMPLETED|Overall Study||0
1105321|NCT01131884|2675094|P2|COMPLETED|Overall Study||0
1105322|NCT01131884|2675095|P1|COMPLETED|Overall Study||1
1105323|NCT01131884|2675094|P2|STARTED|Overall Study||0
1105324|NCT01131884|2675095|P1|STARTED|Overall Study||1
1105325|NCT01132118|2675103|P2|NOT COMPLETED|Second Intervention (8 Weeks)||1
1105326|NCT01132118|2675104|P1|NOT COMPLETED|Second Intervention (8 Weeks)||0
1105327|NCT01132118|2675103|P2|COMPLETED|Second Intervention (8 Weeks)||11
1105328|NCT01132118|2675104|P1|COMPLETED|Second Intervention (8 Weeks)||12
1105329|NCT01132118|2675103|P2|STARTED|Second Intervention (8 Weeks)||12
1105330|NCT01132118|2675104|P1|STARTED|Second Intervention (8 Weeks)||12
1105331|NCT01132118|2675103|P2|NOT COMPLETED|First Intervention (8 Weeks)||3
1105332|NCT01132118|2675104|P1|NOT COMPLETED|First Intervention (8 Weeks)||3
1105333|NCT01132118|2675103|P2|COMPLETED|First Intervention (8 Weeks)||12
1105334|NCT01132118|2675104|P1|COMPLETED|First Intervention (8 Weeks)||12
1105335|NCT01132118|2675103|P2|STARTED|First Intervention (8 Weeks)||15
1105336|NCT01132118|2675104|P1|STARTED|First Intervention (8 Weeks)||15
1105337|NCT01132144|2675124|P2|NOT COMPLETED|Overall Study||0
1105338|NCT01132144|2675125|P1|NOT COMPLETED|Overall Study||0
1105339|NCT01132144|2675124|P2|COMPLETED|Overall Study||79
1105340|NCT01132144|2675125|P1|COMPLETED|Overall Study||79
1105341|NCT01132144|2675124|P2|STARTED|Overall Study||79
1105342|NCT01132144|2675125|P1|STARTED|Overall Study||79
1105343|NCT01132313|2675157|P12|NOT COMPLETED|Overall Study||0
1105344|NCT01132313|2675158|P11|NOT COMPLETED|Overall Study||1
1105345|NCT01132313|2675159|P10|NOT COMPLETED|Overall Study||20
1105346|NCT01132313|2675160|P9|NOT COMPLETED|Overall Study||21
1105347|NCT01132313|2675161|P8|NOT COMPLETED|Overall Study||8
1105348|NCT01132313|2675162|P7|NOT COMPLETED|Overall Study||30
1105349|NCT01132313|2675163|P6|NOT COMPLETED|Overall Study||25
1105350|NCT01132313|2675164|P5|NOT COMPLETED|Overall Study||45
1105351|NCT01132313|2675165|P4|NOT COMPLETED|Overall Study||32
1105352|NCT01132313|2675166|P3|NOT COMPLETED|Overall Study||20
1105353|NCT01132313|2675167|P2|NOT COMPLETED|Overall Study||0
1105354|NCT01132313|2675168|P1|NOT COMPLETED|Overall Study||3
1105355|NCT01132313|2675157|P12|COMPLETED|Overall Study||2
1105356|NCT01132313|2675158|P11|COMPLETED|Overall Study||0
1105357|NCT01132313|2675159|P10|COMPLETED|Overall Study||5
1105358|NCT01132313|2675160|P9|COMPLETED|Overall Study||5
1105359|NCT01132313|2675161|P8|COMPLETED|Overall Study||24
1105360|NCT01132313|2675162|P7|COMPLETED|Overall Study||19
1105361|NCT01132313|2675163|P6|COMPLETED|Overall Study||54
1105362|NCT01132313|2675164|P5|COMPLETED|Overall Study||34
1105363|NCT01132313|2675165|P4|COMPLETED|Overall Study||48
1105364|NCT01132313|2675166|P3|COMPLETED|Overall Study||61
1105365|NCT01132313|2675167|P2|COMPLETED|Overall Study||17
1105366|NCT01132313|2675168|P1|COMPLETED|Overall Study||14
1105367|NCT01132313|2675157|P12|STARTED|Overall Study||2
1105368|NCT01132313|2675158|P11|STARTED|Overall Study||1
1105369|NCT01132313|2675159|P10|STARTED|Overall Study||25
1105370|NCT01132313|2675160|P9|STARTED|Overall Study||26
1105371|NCT01132313|2675161|P8|STARTED|Overall Study||32
1105372|NCT01132313|2675162|P7|STARTED|Overall Study||49
1105373|NCT01132313|2675163|P6|STARTED|Overall Study||79
1105374|NCT01132313|2675164|P5|STARTED|Overall Study||79
1105375|NCT01132313|2675165|P4|STARTED|Overall Study||80
1105376|NCT01132313|2675166|P3|STARTED|Overall Study||81
1105377|NCT01132313|2675167|P2|STARTED|Overall Study||17
1105378|NCT01132313|2675168|P1|STARTED|Overall Study||17
1105379|NCT01132326|2675223|P1|NOT COMPLETED|Overall Study||218
1105380|NCT01132326|2675223|P1|COMPLETED|Overall Study||132
1105381|NCT01132326|2675223|P1|STARTED|Overall Study||350
1105382|NCT01132378|2675227|P1|NOT COMPLETED|Overall Study||0
1105383|NCT01132378|2675227|P1|COMPLETED|Overall Study||40
1105384|NCT01132378|2675227|P1|STARTED|Overall Study||40
1105385|NCT01132495|2675236|P4|NOT COMPLETED|Overall Study||12
1105386|NCT01132495|2675237|P3|NOT COMPLETED|Overall Study||20
1105387|NCT01132495|2675238|P2|NOT COMPLETED|Overall Study||38
1105388|NCT01132495|2675239|P1|NOT COMPLETED|Overall Study||40
1105389|NCT01132495|2675236|P4|COMPLETED|Overall Study||104
1105390|NCT01132495|2675237|P3|COMPLETED|Overall Study||146
1105391|NCT01132495|2675238|P2|COMPLETED|Overall Study||403
1105392|NCT01132495|2675239|P1|COMPLETED|Overall Study||407
1105393|NCT01132495|2675236|P4|STARTED|Overall Study||116
1105394|NCT01132495|2675237|P3|STARTED|Overall Study||166
1105395|NCT01132495|2675238|P2|STARTED|Overall Study||441
1105396|NCT01132495|2675239|P1|STARTED|Overall Study||447
1105397|NCT01132508|2675247|P1|NOT COMPLETED|Overall Study||9
1105398|NCT01132508|2675247|P1|COMPLETED|Overall Study||24
1105399|NCT01132508|2675247|P1|104 Weeks|Overall Study||27
1105400|NCT01132508|2675247|P1|78 Weeks|Overall Study||28
1105401|NCT01132508|2675247|P1|52 Weeks|Overall Study||30
1105402|NCT01132508|2675247|P1|26 Weeks|Overall Study||33
1105403|NCT01132508|2675247|P1|12 Weeks|Overall Study||33
1105404|NCT01132508|2675247|P1|6 Weeks|Overall Study||33
1105405|NCT01132508|2675247|P1|Treated at Baseline|Overall Study||33
1105406|NCT01132508|2675247|P1|STARTED|Overall Study||33
1105407|NCT01132547|2675305|P2|NOT COMPLETED|Overall Study||1
1105408|NCT01132547|2675306|P1|NOT COMPLETED|Overall Study||4
1105409|NCT01132547|2675305|P2|COMPLETED|Overall Study||12
1105410|NCT01132547|2675306|P1|COMPLETED|Overall Study||5
1105411|NCT01132547|2675305|P2|STARTED|Overall Study||13
1105412|NCT01132547|2675306|P1|STARTED|Overall Study||9
1105413|NCT01132651|2675318|P2|NOT COMPLETED|Overall Study||1
1105414|NCT01132651|2675319|P1|NOT COMPLETED|Overall Study||1
1105415|NCT01132651|2675318|P2|COMPLETED|Overall Study||4
1105416|NCT01132651|2675319|P1|COMPLETED|Overall Study||3
1105417|NCT01132651|2675318|P2|STARTED|Overall Study||5
1105418|NCT01132651|2675319|P1|STARTED|Overall Study||4
1105419|NCT01132664|2675332|P5|NOT COMPLETED|BM Cohort||6
1105420|NCT01132664|2675333|P4|NOT COMPLETED|BM Cohort||3
1105421|NCT01132664|2675334|P3|NOT COMPLETED|BM Cohort||0
1105422|NCT01132664|2675335|P2|NOT COMPLETED|BM Cohort||0
1105423|NCT01132664|2675336|P1|NOT COMPLETED|BM Cohort||0
1105424|NCT01132664|2675332|P5|COMPLETED|BM Cohort||0
1105425|NCT01132664|2675333|P4|COMPLETED|BM Cohort||0
1105426|NCT01132664|2675334|P3|COMPLETED|BM Cohort||0
1105427|NCT01132664|2675335|P2|COMPLETED|BM Cohort||0
1105428|NCT01132664|2675336|P1|COMPLETED|BM Cohort||0
1105429|NCT01132664|2675332|P5|STARTED|BM Cohort||6
1105430|NCT01132664|2675333|P4|STARTED|BM Cohort||3
1105431|NCT01132664|2675334|P3|STARTED|BM Cohort||0
1105432|NCT01132664|2675335|P2|STARTED|BM Cohort||0
1105433|NCT01132664|2675336|P1|STARTED|BM Cohort||0
1105434|NCT01132664|2675332|P5|NOT COMPLETED|Phase ll||0
1105435|NCT01132664|2675333|P4|NOT COMPLETED|Phase ll||0
1105436|NCT01132664|2675334|P3|NOT COMPLETED|Phase ll||50
1105437|NCT01132664|2675335|P2|NOT COMPLETED|Phase ll||0
1105438|NCT01132664|2675336|P1|NOT COMPLETED|Phase ll||0
1105439|NCT01132664|2675332|P5|COMPLETED|Phase ll||0
1105440|NCT01132664|2675333|P4|COMPLETED|Phase ll||0
1105441|NCT01132664|2675334|P3|COMPLETED|Phase ll||0
1105442|NCT01132664|2675335|P2|COMPLETED|Phase ll||0
1105443|NCT01132664|2675336|P1|COMPLETED|Phase ll||0
1105444|NCT01132664|2675332|P5|STARTED|Phase ll||0
1105445|NCT01132664|2675333|P4|STARTED|Phase ll||0
1105446|NCT01132664|2675334|P3|STARTED|Phase ll|Of the 50 patients, 8 were from phase lb & were eligible for inclusion in Phase II|50
1105447|NCT01132664|2675335|P2|STARTED|Phase ll||0
1105448|NCT01132664|2675336|P1|STARTED|Phase ll||0
1105449|NCT01132664|2675332|P5|NOT COMPLETED|Phase lb||0
1105450|NCT01132664|2675333|P4|NOT COMPLETED|Phase lb||0
1105451|NCT01132664|2675334|P3|NOT COMPLETED|Phase lb||0
1105452|NCT01132664|2675335|P2|NOT COMPLETED|Phase lb||12
1105453|NCT01132664|2675336|P1|NOT COMPLETED|Phase lb||5
1105454|NCT01132664|2675332|P5|COMPLETED|Phase lb||0
1105455|NCT01132664|2675333|P4|COMPLETED|Phase lb||0
1105456|NCT01132664|2675334|P3|COMPLETED|Phase lb||0
1105457|NCT01132664|2675335|P2|COMPLETED|Phase lb||0
1105458|NCT01132664|2675336|P1|COMPLETED|Phase lb||0
1105459|NCT01132664|2675332|P5|STARTED|Phase lb||0
1105460|NCT01132664|2675333|P4|STARTED|Phase lb||0
1105461|NCT01132664|2675334|P3|STARTED|Phase lb||0
1105462|NCT01132664|2675335|P2|STARTED|Phase lb||12
1105463|NCT01132664|2675336|P1|STARTED|Phase lb||5
1105464|NCT01132690|2675370|P2|NOT COMPLETED|Overall Study||0
1105465|NCT01132690|2675371|P1|NOT COMPLETED|Overall Study||0
1105466|NCT01132690|2675370|P2|COMPLETED|Overall Study||5
1105467|NCT01132690|2675371|P1|COMPLETED|Overall Study||6
1105468|NCT01132690|2675370|P2|STARTED|Overall Study||5
1105469|NCT01132690|2675371|P1|STARTED|Overall Study||6
1105470|NCT01132820|2675387|P1|NOT COMPLETED|Overall Study||5
1105471|NCT01132820|2675387|P1|COMPLETED|Overall Study||48
1105472|NCT01132820|2675387|P1|STARTED|Overall Study||53
1105473|NCT01132846|2675399|P3|NOT COMPLETED|Overall Study||11
1105474|NCT01132846|2675400|P2|NOT COMPLETED|Overall Study||18
1105475|NCT01132846|2675401|P1|NOT COMPLETED|Overall Study||16
1105476|NCT01132846|2675399|P3|COMPLETED|Overall Study||108
1105477|NCT01132846|2675400|P2|COMPLETED|Overall Study||101
1105478|NCT01132846|2675401|P1|COMPLETED|Overall Study||106
1105479|NCT01132846|2675399|P3|STARTED|Overall Study||119
1105480|NCT01132846|2675400|P2|STARTED|Overall Study||119
1105481|NCT01132846|2675401|P1|STARTED|Overall Study||122
1105482|NCT01133171|2675454|P3|NOT COMPLETED|Overall Study||0
1105483|NCT01133171|2675455|P2|NOT COMPLETED|Overall Study||2
1105484|NCT01133171|2675456|P1|NOT COMPLETED|Overall Study||1
1105485|NCT01133171|2675454|P3|COMPLETED|Overall Study||25
1105486|NCT01133171|2675455|P2|COMPLETED|Overall Study||25
1105487|NCT01133171|2675456|P1|COMPLETED|Overall Study||24
1105488|NCT01133171|2675454|P3|STARTED|Overall Study||25
1105489|NCT01133171|2675455|P2|STARTED|Overall Study||27
1105490|NCT01133171|2675456|P1|STARTED|Overall Study||25
1105491|NCT01133275|2675466|P1|NOT COMPLETED|Overall Study||2
1105492|NCT01133275|2675466|P1|COMPLETED|Overall Study||26
1105493|NCT01133275|2675466|P1|STARTED|Overall Study||28
1105494|NCT01133288|2675471|P1|NOT COMPLETED|Intervention Allocation||2
1105495|NCT01133288|2675471|P1|COMPLETED|Intervention Allocation||0
1105496|NCT01133288|2675471|P1|STARTED|Intervention Allocation||2
1105497|NCT01133288|2675471|P1|NOT COMPLETED|Eligibility Assessment||5
1105498|NCT01133288|2675471|P1|COMPLETED|Eligibility Assessment||2
1105499|NCT01133288|2675471|P1|STARTED|Eligibility Assessment||7
1105500|NCT01133379|2675479|P3|NOT COMPLETED|Overall Study||2
1105501|NCT01133379|2675480|P2|NOT COMPLETED|Overall Study||2
1105502|NCT01133379|2675481|P1|NOT COMPLETED|Overall Study||1
1105503|NCT01133379|2675479|P3|COMPLETED|Overall Study||56
1105504|NCT01133379|2675480|P2|COMPLETED|Overall Study||56
1105505|NCT01133379|2675481|P1|COMPLETED|Overall Study||57
1105506|NCT01133379|2675479|P3|STARTED|Overall Study||58
1105507|NCT01133379|2675480|P2|STARTED|Overall Study||58
1105508|NCT01133379|2675481|P1|STARTED|Overall Study||58
1105509|NCT01133392|2675536|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
1105510|NCT01133392|2675537|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
1105511|NCT01133392|2675536|P2|COMPLETED|Fourth Intervention (1 Day)||16
1105512|NCT01133392|2675537|P1|COMPLETED|Fourth Intervention (1 Day)||20
1105513|NCT01133392|2675536|P2|STARTED|Fourth Intervention (1 Day)||16
1105514|NCT01133392|2675537|P1|STARTED|Fourth Intervention (1 Day)||20
1105515|NCT01133392|2675536|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
1105516|NCT01133392|2675537|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
1105517|NCT01133392|2675536|P2|COMPLETED|Interval Between Dosing (4-7 Days)||16
1105518|NCT01133392|2675537|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
1105519|NCT01133392|2675536|P2|STARTED|Interval Between Dosing (4-7 Days)||17
1105520|NCT01133392|2675537|P1|STARTED|Interval Between Dosing (4-7 Days)||20
1105521|NCT01133392|2675536|P2|NOT COMPLETED|Third Intervention (1 Day)||0
1105522|NCT01133392|2675537|P1|NOT COMPLETED|Third Intervention (1 Day)||0
1105523|NCT01133392|2675536|P2|COMPLETED|Third Intervention (1 Day)||17
1105524|NCT01133392|2675537|P1|COMPLETED|Third Intervention (1 Day)||20
1105525|NCT01133392|2675536|P2|STARTED|Third Intervention (1 Day)||17
1105526|NCT01133392|2675537|P1|STARTED|Third Intervention (1 Day)||20
1105527|NCT01133392|2675536|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
1105528|NCT01133392|2675537|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
1105529|NCT01133392|2675536|P2|COMPLETED|Interval Between Dosing (4-7 Days)||17
1105530|NCT01133392|2675537|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
1105531|NCT01133392|2675536|P2|STARTED|Interval Between Dosing (4-7 Days)||17
1105532|NCT01133392|2675537|P1|STARTED|Interval Between Dosing (4-7 Days)||20
1105533|NCT01133392|2675536|P2|NOT COMPLETED|Second Intervention (1 Day)||0
1105534|NCT01133392|2675537|P1|NOT COMPLETED|Second Intervention (1 Day)||0
1105535|NCT01133392|2675536|P2|COMPLETED|Second Intervention (1 Day)||17
1105536|NCT01133392|2675537|P1|COMPLETED|Second Intervention (1 Day)||20
1105537|NCT01133392|2675536|P2|STARTED|Second Intervention (1 Day)||17
1105538|NCT01133392|2675537|P1|STARTED|Second Intervention (1 Day)||20
1105539|NCT01133392|2675536|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
1105540|NCT01133392|2675537|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
1105541|NCT01133392|2675536|P2|COMPLETED|Interval Between Dosing (4-7 Days)||17
1105542|NCT01133392|2675537|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
1105543|NCT01133392|2675536|P2|STARTED|Interval Between Dosing (4-7 Days)||18
1105544|NCT01133392|2675537|P1|STARTED|Interval Between Dosing (4-7 Days)||20
1105545|NCT01133392|2675536|P2|NOT COMPLETED|First Intervention (1 Day )||0
1105546|NCT01133392|2675537|P1|NOT COMPLETED|First Intervention (1 Day )||0
1105547|NCT01133392|2675536|P2|COMPLETED|First Intervention (1 Day )||18
1105548|NCT01133392|2675537|P1|COMPLETED|First Intervention (1 Day )||20
1105549|NCT01133392|2675536|P2|STARTED|First Intervention (1 Day )||18
1105550|NCT01133392|2675537|P1|STARTED|First Intervention (1 Day )||20
1105551|NCT01133418|2675553|P2|NOT COMPLETED|Overall Study||6
1105552|NCT01133418|2675554|P1|NOT COMPLETED|Overall Study||5
1105553|NCT01133418|2675553|P2|COMPLETED|Overall Study||32
1105554|NCT01133418|2675554|P1|COMPLETED|Overall Study||29
1105555|NCT01133418|2675553|P2|STARTED|Overall Study||38
1105556|NCT01133418|2675554|P1|STARTED|Overall Study||34
1105557|NCT01133522|2675576|P10|NOT COMPLETED|Overall Study||0
1105558|NCT01133522|2675577|P9|NOT COMPLETED|Overall Study||0
1105559|NCT01133522|2675578|P8|NOT COMPLETED|Overall Study||0
1105560|NCT01133522|2675579|P7|NOT COMPLETED|Overall Study||0
1105561|NCT01133522|2675580|P6|NOT COMPLETED|Overall Study||0
1105562|NCT01133522|2675581|P5|NOT COMPLETED|Overall Study||1
1105563|NCT01133522|2675582|P4|NOT COMPLETED|Overall Study||1
1105564|NCT01133522|2675583|P3|NOT COMPLETED|Overall Study||0
1105565|NCT01133522|2675584|P2|NOT COMPLETED|Overall Study||1
1105566|NCT01133522|2675585|P1|NOT COMPLETED|Overall Study||0
1105567|NCT01133522|2675576|P10|COMPLETED|Overall Study||4
1105568|NCT01133522|2675577|P9|COMPLETED|Overall Study||2
1105569|NCT01133522|2675578|P8|COMPLETED|Overall Study||9
1105570|NCT01133522|2675579|P7|COMPLETED|Overall Study||2
1105571|NCT01133522|2675580|P6|COMPLETED|Overall Study||6
1105572|NCT01133522|2675581|P5|COMPLETED|Overall Study||6
1105573|NCT01133522|2675582|P4|COMPLETED|Overall Study||6
1105574|NCT01133522|2675583|P3|COMPLETED|Overall Study||6
1105575|NCT01133522|2675584|P2|COMPLETED|Overall Study||6
1105576|NCT01133522|2675585|P1|COMPLETED|Overall Study||10
1105577|NCT01133522|2675576|P10|Received Treatment|Overall Study||4
1105578|NCT01133522|2675577|P9|Received Treatment|Overall Study||2
1105579|NCT01133522|2675578|P8|Received Treatment|Overall Study||9
1105580|NCT01133522|2675579|P7|Received Treatment|Overall Study||2
1105581|NCT01133522|2675580|P6|Received Treatment|Overall Study||6
1105582|NCT01133522|2675581|P5|Received Treatment|Overall Study||6
1105583|NCT01133522|2675582|P4|Received Treatment|Overall Study||6
1105584|NCT01133522|2675583|P3|Received Treatment|Overall Study||6
1105585|NCT01133522|2675584|P2|Received Treatment|Overall Study||6
1105586|NCT01133522|2675585|P1|Received Treatment|Overall Study||10
1105587|NCT01133522|2675576|P10|STARTED|Overall Study||4
1105588|NCT01133522|2675577|P9|STARTED|Overall Study||2
1105589|NCT01133522|2675578|P8|STARTED|Overall Study||9
1105590|NCT01133522|2675579|P7|STARTED|Overall Study||2
1105591|NCT01133522|2675580|P6|STARTED|Overall Study||6
1105592|NCT01133522|2675581|P5|STARTED|Overall Study||7
1105593|NCT01133522|2675582|P4|STARTED|Overall Study||7
1105594|NCT01133522|2675583|P3|STARTED|Overall Study||6
1105595|NCT01133522|2675584|P2|STARTED|Overall Study||7
1105596|NCT01133522|2675585|P1|STARTED|Overall Study||10
1105597|NCT01133626|2675654|P3|NOT COMPLETED|Overall Study||2
1105598|NCT01133626|2675655|P2|NOT COMPLETED|Overall Study||5
1105599|NCT01133626|2675656|P1|NOT COMPLETED|Overall Study||1
1105600|NCT01133626|2675654|P3|COMPLETED|Overall Study||9
1105601|NCT01133626|2675655|P2|COMPLETED|Overall Study||41
1105602|NCT01133626|2675656|P1|COMPLETED|Overall Study||49
1105603|NCT01133626|2675654|P3|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|9
1105604|NCT01133626|2675655|P2|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|41
1105605|NCT01133626|2675656|P1|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|48
1105606|NCT01133626|2675654|P3|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|11
1105607|NCT01133626|2675655|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|46
1105608|NCT01133626|2675656|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|50
1105609|NCT01133626|2675654|P3|STARTED|Overall Study||11
1105610|NCT01133626|2675655|P2|STARTED|Overall Study||46
1105611|NCT01133626|2675656|P1|STARTED|Overall Study||50
1105612|NCT01133665|2675664|P1|NOT COMPLETED|Overall Study||2
1105613|NCT01133665|2675664|P1|COMPLETED|Overall Study||40
1105614|NCT01133665|2675664|P1|STARTED|Overall Study||42
1105615|NCT01133704|2675707|P2|NOT COMPLETED|Overall Study||26
1105616|NCT01133704|2675708|P1|NOT COMPLETED|Overall Study||49
1105617|NCT01133704|2675707|P2|COMPLETED|Overall Study|(including 3 year follow-up)|7
1105618|NCT01133704|2675708|P1|COMPLETED|Overall Study|(including 3 year follow-up)|16
1105619|NCT01133704|2675707|P2|STARTED|Overall Study||33
1105620|NCT01133704|2675708|P1|STARTED|Overall Study||65
1105621|NCT01133756|2675719|P3|NOT COMPLETED|Overall Study||2
1105622|NCT01133756|2675720|P2|NOT COMPLETED|Overall Study||3
1105623|NCT01133756|2675721|P1|NOT COMPLETED|Overall Study||2
1105624|NCT01133756|2675719|P3|COMPLETED|Overall Study||0
1105625|NCT01133756|2675720|P2|COMPLETED|Overall Study||0
1105626|NCT01133756|2675721|P1|COMPLETED|Overall Study||0
1105627|NCT01133756|2675719|P3|Completed 6 Cycles|Overall Study||0
1105628|NCT01133756|2675720|P2|Completed 6 Cycles|Overall Study||0
1105629|NCT01133756|2675721|P1|Completed 6 Cycles|Overall Study|One participant completed 6 cycles and remained in the study until 18 Sep 2012.|1
1105630|NCT01133756|2675719|P3|STARTED|Overall Study||2
1105631|NCT01133756|2675720|P2|STARTED|Overall Study||3
1105632|NCT01133756|2675721|P1|STARTED|Overall Study||2
1105633|NCT01133821|2675737|P2|NOT COMPLETED|Overall Study||19
1105634|NCT01133821|2675738|P1|NOT COMPLETED|Overall Study||18
1105635|NCT01133821|2675737|P2|COMPLETED|Overall Study||28
1105636|NCT01133821|2675738|P1|COMPLETED|Overall Study||27
1105637|NCT01133821|2675737|P2|STARTED|Overall Study||47
1105638|NCT01133821|2675738|P1|STARTED|Overall Study||45
1105639|NCT01133847|2675747|P3|NOT COMPLETED|Follow-Up Phase||7
1105640|NCT01133847|2675748|P2|NOT COMPLETED|Follow-Up Phase||3
1105641|NCT01133847|2675749|P1|NOT COMPLETED|Follow-Up Phase||1
1105642|NCT01133847|2675747|P3|COMPLETED|Follow-Up Phase||60
1105643|NCT01133847|2675748|P2|COMPLETED|Follow-Up Phase||70
1105644|NCT01133847|2675749|P1|COMPLETED|Follow-Up Phase||72
1105645|NCT01133847|2675747|P3|STARTED|Follow-Up Phase||67
1105646|NCT01133847|2675748|P2|STARTED|Follow-Up Phase||73
1105647|NCT01133847|2675749|P1|STARTED|Follow-Up Phase||73
1105648|NCT01133847|2675747|P3|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||3
1105649|NCT01133847|2675748|P2|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||1
1105650|NCT01133847|2675749|P1|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||5
1105651|NCT01133847|2675747|P3|COMPLETED|Active Treatment Phase (Weeks 1-16)||67
1105652|NCT01133847|2675748|P2|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
1105653|NCT01133847|2675749|P1|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
1105654|NCT01133847|2675747|P3|STARTED|Active Treatment Phase (Weeks 1-16)||70
1105655|NCT01133847|2675748|P2|STARTED|Active Treatment Phase (Weeks 1-16)||74
1105656|NCT01133847|2675749|P1|STARTED|Active Treatment Phase (Weeks 1-16)||78
1105657|NCT01133860|2675787|P1|NOT COMPLETED|Overall Study||0
1105658|NCT01133860|2675787|P1|COMPLETED|Overall Study||12
1105659|NCT01133860|2675787|P1|STARTED|Overall Study||12
1105660|NCT01133977|2675799|P5|NOT COMPLETED|Overall Study||38
1105661|NCT01133977|2675800|P4|NOT COMPLETED|Overall Study||39
1105662|NCT01133977|2675801|P3|NOT COMPLETED|Overall Study||6
1105663|NCT01133977|2675802|P2|NOT COMPLETED|Overall Study||7
1105664|NCT01133977|2675803|P1|NOT COMPLETED|Overall Study||3
1105665|NCT01133977|2675799|P5|COMPLETED|Overall Study||1
1105666|NCT01133977|2675800|P4|COMPLETED|Overall Study||3
1105667|NCT01133977|2675801|P3|COMPLETED|Overall Study||0
1105668|NCT01133977|2675802|P2|COMPLETED|Overall Study||0
1105669|NCT01133977|2675803|P1|COMPLETED|Overall Study||0
1105670|NCT01133977|2675799|P5|STARTED|Overall Study|Treated|39
1105671|NCT01133977|2675800|P4|STARTED|Overall Study|Treated|42
1105672|NCT01133977|2675801|P3|STARTED|Overall Study|Treated|6
1105673|NCT01133977|2675802|P2|STARTED|Overall Study|Treated|7
1105674|NCT01133977|2675803|P1|STARTED|Overall Study|Treated|3
1105675|NCT01134016|2675820|P1|NOT COMPLETED|Overall Study||3
1105676|NCT01134016|2675820|P1|COMPLETED|Overall Study||10
1105677|NCT01134016|2675820|P1|STARTED|Overall Study||13
1105678|NCT01134042|2675856|P3|NOT COMPLETED|Overall Study||34
1105679|NCT01134042|2675857|P2|NOT COMPLETED|Overall Study||28
1105680|NCT01134042|2675858|P1|NOT COMPLETED|Overall Study||48
1105681|NCT01134042|2675856|P3|COMPLETED|Overall Study||161
1105682|NCT01134042|2675857|P2|COMPLETED|Overall Study||169
1105683|NCT01134042|2675858|P1|COMPLETED|Overall Study||146
1105684|NCT01134042|2675856|P3|STARTED|Overall Study||195
1105685|NCT01134042|2675857|P2|STARTED|Overall Study||197
1105686|NCT01134042|2675858|P1|STARTED|Overall Study||194
1105687|NCT01134081|2675896|P1|NOT COMPLETED|Overall Study||0
1105688|NCT01134081|2675896|P1|COMPLETED|Overall Study||44
1105689|NCT01134081|2675896|P1|STARTED|Overall Study||44
1105690|NCT01134107|2675906|P2|NOT COMPLETED|Period 2-Second Treatment Intervention||0
1105691|NCT01134107|2675907|P1|NOT COMPLETED|Period 2-Second Treatment Intervention||4
1105692|NCT01134107|2675906|P2|COMPLETED|Period 2-Second Treatment Intervention||61
1105693|NCT01134107|2675907|P1|COMPLETED|Period 2-Second Treatment Intervention||57
1105694|NCT01134107|2675906|P2|STARTED|Period 2-Second Treatment Intervention||61
1105695|NCT01134107|2675907|P1|STARTED|Period 2-Second Treatment Intervention||61
1105696|NCT01134107|2675906|P2|NOT COMPLETED|Period 1-First Treatment Intervention||5
1105697|NCT01134107|2675907|P1|NOT COMPLETED|Period 1-First Treatment Intervention||6
1105698|NCT01134107|2675906|P2|COMPLETED|Period 1-First Treatment Intervention||61
1105699|NCT01134107|2675907|P1|COMPLETED|Period 1-First Treatment Intervention||61
1105700|NCT01134107|2675906|P2|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
1105701|NCT01134107|2675907|P1|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
1105702|NCT01134107|2675906|P2|STARTED|Period 1-First Treatment Intervention||66
1105703|NCT01134107|2675907|P1|STARTED|Period 1-First Treatment Intervention||67
1105704|NCT01126268|2675939|P1|NOT COMPLETED|Overall Study||1
1105705|NCT01126268|2675939|P1|COMPLETED|Overall Study||37
1105706|NCT01126268|2675939|P1|STARTED|Overall Study||38
1105707|NCT01134276|2675963|P2|NOT COMPLETED|Overall Study||0
1105708|NCT01134276|2675964|P1|NOT COMPLETED|Overall Study||0
1105709|NCT01134276|2675963|P2|COMPLETED|Overall Study||107
1105710|NCT01134276|2675964|P1|COMPLETED|Overall Study||104
1105711|NCT01134276|2675963|P2|STARTED|Overall Study||107
1105712|NCT01134276|2675964|P1|STARTED|Overall Study||104
1105713|NCT01134315|2675976|P2|NOT COMPLETED|Overall Study||19
1105714|NCT01134315|2675977|P1|NOT COMPLETED|Overall Study||9
1105715|NCT01134315|2675976|P2|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|21
1105716|NCT01134315|2675977|P1|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|12
1105717|NCT01134315|2675976|P2|STARTED|Overall Study||40
1105718|NCT01134315|2675977|P1|STARTED|Overall Study||21
1105719|NCT01134328|2676001|P4|NOT COMPLETED|Overall Study||4
1105720|NCT01134328|2676002|P3|NOT COMPLETED|Overall Study||3
1105721|NCT01134328|2676003|P2|NOT COMPLETED|Overall Study||3
1105722|NCT01134328|2676004|P1|NOT COMPLETED|Overall Study||2
1105723|NCT01134328|2676001|P4|COMPLETED|Overall Study||17
1105724|NCT01134328|2676002|P3|COMPLETED|Overall Study||17
1105725|NCT01134328|2676003|P2|COMPLETED|Overall Study||18
1105726|NCT01134328|2676004|P1|COMPLETED|Overall Study||19
1105727|NCT01134328|2676001|P4|STARTED|Overall Study||21
1105728|NCT01134328|2676002|P3|STARTED|Overall Study||20
1105729|NCT01134328|2676003|P2|STARTED|Overall Study||21
1105730|NCT01134328|2676004|P1|STARTED|Overall Study||21
1105731|NCT01134393|2676102|P1|NOT COMPLETED|Overall Study||52
1105732|NCT01134393|2676102|P1|COMPLETED|Overall Study|Completed trial medication.|449
1105733|NCT01134393|2676102|P1|STARTED|Overall Study|Entered and treated.|501
1105734|NCT01134510|2676118|P2|NOT COMPLETED|Overall Study||1
1105735|NCT01134510|2676119|P1|NOT COMPLETED|Overall Study||0
1105736|NCT01134510|2676118|P2|COMPLETED|Overall Study||9
1105737|NCT01134510|2676119|P1|COMPLETED|Overall Study||10
1105738|NCT01134510|2676118|P2|Month 3|Overall Study||9
1105739|NCT01134510|2676119|P1|Month 3|Overall Study||10
1105740|NCT01134510|2676118|P2|Month 1|Overall Study||10
1105741|NCT01134510|2676119|P1|Month 1|Overall Study||10
1105742|NCT01134510|2676118|P2|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
1105743|NCT01134510|2676119|P1|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
1105744|NCT01134510|2676118|P2|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
1105745|NCT01134510|2676119|P1|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
1105746|NCT01134510|2676118|P2|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
1105747|NCT01134510|2676119|P1|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
1105748|NCT01134510|2676118|P2|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
1105749|NCT01134510|2676119|P1|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
1105750|NCT01134510|2676118|P2|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
1105751|NCT01134510|2676119|P1|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
1105752|NCT01134510|2676118|P2|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
1105753|NCT01134510|2676119|P1|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
1105754|NCT01134510|2676118|P2|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
1105755|NCT01134510|2676119|P1|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
1105756|NCT01134510|2676118|P2|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
1105757|NCT01134510|2676119|P1|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
1105758|NCT01135992|2676131|P1|NOT COMPLETED|Overall Study||21
1105759|NCT01135992|2676131|P1|COMPLETED|Overall Study||122
1105760|NCT01135992|2676131|P1|Full Analysis Set|Overall Study||129
1105761|NCT01135992|2676131|P1|Exposed|Overall Study|One subject was withdrawn before being exposed.|142
1105762|NCT01135992|2676131|P1|STARTED|Overall Study||143
1105763|NCT01136174|2676144|P4|NOT COMPLETED|Overall Study||4
1105764|NCT01136174|2676145|P3|NOT COMPLETED|Overall Study||0
1105765|NCT01136174|2676146|P2|NOT COMPLETED|Overall Study||0
1105766|NCT01136174|2676147|P1|NOT COMPLETED|Overall Study||0
1105767|NCT01136174|2676144|P4|COMPLETED|Overall Study||20
1105768|NCT01136174|2676145|P3|COMPLETED|Overall Study||8
1105769|NCT01136174|2676146|P2|COMPLETED|Overall Study||6
1105770|NCT01136174|2676147|P1|COMPLETED|Overall Study||12
1105771|NCT01136174|2676144|P4|STARTED|Overall Study||24
1105772|NCT01136174|2676145|P3|STARTED|Overall Study||8
1105773|NCT01136174|2676146|P2|STARTED|Overall Study||6
1105774|NCT01136174|2676147|P1|STARTED|Overall Study||12
1105775|NCT01136226|2676227|P1|NOT COMPLETED|Overall Study||13
1105776|NCT01136226|2676227|P1|COMPLETED|Overall Study||29
1105777|NCT01136226|2676227|P1|STARTED|Overall Study||42
1105778|NCT01136291|2676233|P2|NOT COMPLETED|Overall Study||1
1105779|NCT01136291|2676234|P1|NOT COMPLETED|Overall Study||1
1105780|NCT01136291|2676233|P2|COMPLETED|Overall Study||41
1105781|NCT01136291|2676234|P1|COMPLETED|Overall Study||39
1105782|NCT01136291|2676233|P2|Follow|Overall Study||42
1105783|NCT01136291|2676234|P1|Follow|Overall Study||40
1105784|NCT01136291|2676233|P2|STARTED|Overall Study||42
1105785|NCT01136291|2676234|P1|STARTED|Overall Study||40
1105786|NCT01136356|2676244|P2|NOT COMPLETED|Second 18-day Withdrawal||1
1105787|NCT01136356|2676245|P1|NOT COMPLETED|Second 18-day Withdrawal||0
1105788|NCT01136356|2676244|P2|COMPLETED|Second 18-day Withdrawal||5
1105789|NCT01136356|2676245|P1|COMPLETED|Second 18-day Withdrawal||2
1105790|NCT01136356|2676244|P2|STARTED|Second 18-day Withdrawal||6
1105791|NCT01136356|2676245|P1|STARTED|Second 18-day Withdrawal||2
1105792|NCT01136356|2676244|P2|NOT COMPLETED|Second Intervention||0
1105793|NCT01136356|2676245|P1|NOT COMPLETED|Second Intervention||0
1105794|NCT01136356|2676244|P2|COMPLETED|Second Intervention||6
1105795|NCT01136356|2676245|P1|COMPLETED|Second Intervention||2
1105796|NCT01136356|2676244|P2|STARTED|Second Intervention||6
1105797|NCT01136356|2676245|P1|STARTED|Second Intervention||2
1105798|NCT01136356|2676244|P2|NOT COMPLETED|First 18-day Withdrawal||0
1105799|NCT01136356|2676245|P1|NOT COMPLETED|First 18-day Withdrawal||4
1105800|NCT01136356|2676244|P2|COMPLETED|First 18-day Withdrawal||6
1105801|NCT01136356|2676245|P1|COMPLETED|First 18-day Withdrawal||2
1105802|NCT01136356|2676244|P2|STARTED|First 18-day Withdrawal||6
1105803|NCT01136356|2676245|P1|STARTED|First 18-day Withdrawal||6
1105804|NCT01136356|2676244|P2|NOT COMPLETED|First Intervention||0
1105805|NCT01136356|2676245|P1|NOT COMPLETED|First Intervention||0
1105806|NCT01136356|2676244|P2|COMPLETED|First Intervention||6
1105807|NCT01136356|2676245|P1|COMPLETED|First Intervention||6
1105808|NCT01136356|2676244|P2|STARTED|First Intervention||6
1105809|NCT01136356|2676245|P1|STARTED|First Intervention||6
1105810|NCT01136382|2676256|P2|NOT COMPLETED|Overall Study||31
1105811|NCT01136382|2676257|P1|NOT COMPLETED|Overall Study||60
1105812|NCT01136382|2676256|P2|COMPLETED|Overall Study||121
1105813|NCT01136382|2676257|P1|COMPLETED|Overall Study||92
1105814|NCT01136382|2676256|P2|STARTED|Overall Study||152
1105815|NCT01136382|2676257|P1|STARTED|Overall Study||152
1105816|NCT01136408|2676286|P3|NOT COMPLETED|Overall Study||5
1105817|NCT01136408|2676287|P2|NOT COMPLETED|Overall Study||9
1105818|NCT01136408|2676288|P1|NOT COMPLETED|Overall Study||5
1105819|NCT01136408|2676286|P3|COMPLETED|Overall Study||57
1105820|NCT01136408|2676287|P2|COMPLETED|Overall Study||49
1105821|NCT01136408|2676288|P1|COMPLETED|Overall Study||41
1105822|NCT01136408|2676286|P3|STARTED|Overall Study||62
1105823|NCT01136408|2676287|P2|STARTED|Overall Study||58
1105824|NCT01136408|2676288|P1|STARTED|Overall Study||46
1105825|NCT01136486|2676343|P1|NOT COMPLETED|Overall Study||0
1105826|NCT01136486|2676343|P1|COMPLETED|Overall Study||56
1105827|NCT01136486|2676343|P1|STARTED|Overall Study||56
1105828|NCT01136655|2676347|P1|NOT COMPLETED|Washout After BUD 160/ Foradil (7 Days)||0
1105829|NCT01136655|2676347|P1|COMPLETED|Washout After BUD 160/ Foradil (7 Days)||50
1105830|NCT01136655|2676347|P1|STARTED|Washout After BUD 160/ Foradil (7 Days)||50
1105831|NCT01136655|2676347|P1|NOT COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||0
1105832|NCT01136655|2676347|P1|COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||50
1105833|NCT01136655|2676347|P1|STARTED|BUD 160/ Foradil 12.0 (1 Dose)||50
1105834|NCT01136655|2676347|P1|NOT COMPLETED|Washout After BUD 160 (7 Days)||0
1105835|NCT01136655|2676347|P1|COMPLETED|Washout After BUD 160 (7 Days)||51
1105836|NCT01136655|2676347|P1|STARTED|Washout After BUD 160 (7 Days)||51
1105837|NCT01136655|2676347|P1|NOT COMPLETED|BUD 160 (1 Dose)||0
1105838|NCT01136655|2676347|P1|COMPLETED|BUD 160 (1 Dose)||51
1105839|NCT01136655|2676347|P1|STARTED|BUD 160 (1 Dose)||51
1105840|NCT01136655|2676347|P1|NOT COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||2
1105841|NCT01136655|2676347|P1|COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||51
1105842|NCT01136655|2676347|P1|STARTED|Washout After BUD 160/FM 9.0 (7 Days)||53
1105843|NCT01136655|2676347|P1|NOT COMPLETED|BUD 160/FM 9.0 (1 Dose)||0
1105844|NCT01136655|2676347|P1|COMPLETED|BUD 160/FM 9.0 (1 Dose)||53
1105845|NCT01136655|2676347|P1|STARTED|BUD 160/FM 9.0 (1 Dose)||53
1105846|NCT01136655|2676347|P1|NOT COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||1
1105847|NCT01136655|2676347|P1|COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||52
1105848|NCT01136655|2676347|P1|STARTED|Washout After BUD 160/FM 4.5 (7 Days)||53
1105849|NCT01136655|2676347|P1|NOT COMPLETED|BUD 160/FM 4.5 (1 Dose)||0
1105850|NCT01136655|2676347|P1|COMPLETED|BUD 160/FM 4.5 (1 Dose)||53
1105851|NCT01136655|2676347|P1|STARTED|BUD 160/FM 4.5 (1 Dose)||53
1105852|NCT01136655|2676347|P1|NOT COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||1
1105853|NCT01136655|2676347|P1|COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||53
1105854|NCT01136655|2676347|P1|STARTED|Washout After BUD 160/FM 2.25 (7 Days)||54
1105855|NCT01136655|2676347|P1|NOT COMPLETED|BUD 160/FM 2.25 (1 Dose)||0
1105856|NCT01136655|2676347|P1|COMPLETED|BUD 160/FM 2.25 (1 Dose)||54
1105857|NCT01136655|2676347|P1|STARTED|BUD 160/FM 2.25 (1 Dose)||54
1105858|NCT01136746|2676375|P2|NOT COMPLETED|Overall Study||3
1105859|NCT01136746|2676376|P1|NOT COMPLETED|Overall Study||3
1105860|NCT01136746|2676375|P2|COMPLETED|Overall Study||4
1105861|NCT01136746|2676376|P1|COMPLETED|Overall Study||6
1105862|NCT01136746|2676375|P2|STARTED|Overall Study||7
1105863|NCT01136746|2676376|P1|STARTED|Overall Study||9
1105864|NCT01136772|2676438|P2|NOT COMPLETED|Overall Study||110
1105865|NCT01136772|2676439|P1|NOT COMPLETED|Overall Study||116
1105866|NCT01136772|2676438|P2|COMPLETED|Overall Study||44
1105867|NCT01136772|2676439|P1|COMPLETED|Overall Study||41
1105868|NCT01136772|2676438|P2|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
1105869|NCT01136772|2676439|P1|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
1105870|NCT01136772|2676438|P2|STARTED|Overall Study||154
1105871|NCT01136772|2676439|P1|STARTED|Overall Study||157
1105872|NCT01136785|2676449|P2|NOT COMPLETED|Overall Study||1
1105873|NCT01136785|2676450|P1|NOT COMPLETED|Overall Study||2
1105874|NCT01136785|2676449|P2|COMPLETED|Overall Study||6
1105875|NCT01136785|2676450|P1|COMPLETED|Overall Study||13
1105876|NCT01136785|2676449|P2|STARTED|Overall Study||7
1105877|NCT01136785|2676450|P1|STARTED|Overall Study||15
1105878|NCT01136876|2676465|P2|NOT COMPLETED|Overall Study||6
1105879|NCT01136876|2676466|P1|NOT COMPLETED|Overall Study||3
1105880|NCT01136876|2676465|P2|COMPLETED|Overall Study||23
1105881|NCT01136876|2676466|P1|COMPLETED|Overall Study||25
1105882|NCT01136876|2676465|P2|STARTED|Overall Study||29
1105883|NCT01136876|2676466|P1|STARTED|Overall Study||28
1105884|NCT01136915|2676476|P2|NOT COMPLETED|Overall Study||1
1105885|NCT01136915|2676477|P1|NOT COMPLETED|Overall Study||2
1105886|NCT01136915|2676476|P2|COMPLETED|Overall Study||6
1105887|NCT01136915|2676477|P1|COMPLETED|Overall Study||6
1105888|NCT01136915|2676476|P2|STARTED|Overall Study||7
1105889|NCT01136915|2676477|P1|STARTED|Overall Study||8
1105890|NCT01136954|2676487|P2|NOT COMPLETED|Overall Study||21
1105891|NCT01136954|2676488|P1|NOT COMPLETED|Overall Study||24
1105892|NCT01136954|2676487|P2|COMPLETED|Overall Study||51
1105893|NCT01136954|2676488|P1|COMPLETED|Overall Study||48
1105894|NCT01136954|2676487|P2|STARTED|Overall Study||72
1105895|NCT01136954|2676488|P1|STARTED|Overall Study||72
1105896|NCT01136967|2676502|P2|NOT COMPLETED|Overall Study||27
1105897|NCT01136967|2676503|P1|NOT COMPLETED|Overall Study||24
1105898|NCT01136967|2676502|P2|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (15 April 2013)|62
1105899|NCT01136967|2676503|P1|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (18 January 2012)|69
1105900|NCT01136967|2676502|P2|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (15 April 2013)|6
1105901|NCT01136967|2676503|P1|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (18 January 2012)|14
1105902|NCT01136967|2676502|P2|Disease Progression|Overall Study||56
1105903|NCT01136967|2676503|P1|Disease Progression|Overall Study||55
1105904|NCT01136967|2676502|P2|STARTED|Overall Study||89
1105905|NCT01136967|2676503|P1|STARTED|Overall Study||93
1105906|NCT01137032|2676519|P1|NOT COMPLETED|Overall Study||0
1105907|NCT01137032|2676519|P1|COMPLETED|Overall Study||19
1105908|NCT01137032|2676519|P1|STARTED|Overall Study||19
1105909|NCT01137071|2676525|P1|NOT COMPLETED|Overall Study||14
1105910|NCT01137071|2676525|P1|COMPLETED|Overall Study|Of the eligible patients|15
1105911|NCT01137071|2676525|P1|STARTED|Overall Study|all patients considered eligible were included on the study|29
1105912|NCT01137292|2676586|P1|NOT COMPLETED|Overall Study||54
1105913|NCT01137292|2676586|P1|COMPLETED|Overall Study||123
1105914|NCT01137292|2676586|P1|STARTED|Overall Study||177
1105915|NCT01137370|2676595|P2|NOT COMPLETED|Overall Study||0
1105916|NCT01137370|2676596|P1|NOT COMPLETED|Overall Study||0
1105917|NCT01137370|2676595|P2|COMPLETED|Overall Study||87
1105918|NCT01137370|2676596|P1|COMPLETED|Overall Study||116
1105919|NCT01137370|2676595|P2|STARTED|Overall Study||87
1105920|NCT01137370|2676596|P1|STARTED|Overall Study||116
1105921|NCT01137396|2676604|P2|NOT COMPLETED|Overall Study||2
1105922|NCT01137396|2676605|P1|NOT COMPLETED|Overall Study||8
1105923|NCT01137396|2676604|P2|COMPLETED|Overall Study||25
1105924|NCT01137396|2676605|P1|COMPLETED|Overall Study||22
1105925|NCT01137396|2676604|P2|STARTED|Overall Study||27
1105926|NCT01137396|2676605|P1|STARTED|Overall Study||30
1105927|NCT01137435|2676613|P1|NOT COMPLETED|Overall Study||28
1105928|NCT01137435|2676613|P1|COMPLETED|Overall Study||659
1105929|NCT01137435|2676613|P1|STARTED|Overall Study||687
1105930|NCT01137474|2676624|P4|NOT COMPLETED|Overall Study||21
1105931|NCT01137474|2676625|P3|NOT COMPLETED|Overall Study||7
1105932|NCT01137474|2676626|P2|NOT COMPLETED|Overall Study||12
1105933|NCT01137474|2676627|P1|NOT COMPLETED|Overall Study||24
1105934|NCT01137474|2676624|P4|COMPLETED|Overall Study||281
1105935|NCT01137474|2676625|P3|COMPLETED|Overall Study||158
1105936|NCT01137474|2676626|P2|COMPLETED|Overall Study||154
1105937|NCT01137474|2676627|P1|COMPLETED|Overall Study||287
1105938|NCT01137474|2676624|P4|Received Treatment|Overall Study||302
1105939|NCT01137474|2676625|P3|Received Treatment|Overall Study||165
1105940|NCT01137474|2676626|P2|Received Treatment|Overall Study||166
1105941|NCT01137474|2676627|P1|Received Treatment|Overall Study||311
1105942|NCT01137474|2676624|P4|STARTED|Overall Study||302
1105943|NCT01137474|2676625|P3|STARTED|Overall Study||165
1105944|NCT01137474|2676626|P2|STARTED|Overall Study||166
1105945|NCT01137474|2676627|P1|STARTED|Overall Study||311
1105946|NCT01137539|2676645|P1|NOT COMPLETED|Overall Study||0
1105947|NCT01137539|2676645|P1|COMPLETED|Overall Study||50
1105948|NCT01137539|2676645|P1|STARTED|Overall Study||50
1105949|NCT01137578|2676650|P3|NOT COMPLETED|Overall Study||6
1105950|NCT01137578|2676651|P2|NOT COMPLETED|Overall Study||2
1105951|NCT01137578|2676652|P1|NOT COMPLETED|Overall Study||16
1105952|NCT01137578|2676650|P3|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|37
1105953|NCT01137578|2676651|P2|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|12
1105954|NCT01137578|2676652|P1|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|61
1105955|NCT01137578|2676650|P3|STARTED|Overall Study||43
1105956|NCT01137578|2676651|P2|STARTED|Overall Study||14
1105957|NCT01137578|2676652|P1|STARTED|Overall Study||77
1105958|NCT01137604|2676696|P4|NOT COMPLETED|Overall Study||11
1105959|NCT01137604|2676697|P3|NOT COMPLETED|Overall Study||13
1105960|NCT01137604|2676698|P2|NOT COMPLETED|Overall Study||10
1105961|NCT01137604|2676699|P1|NOT COMPLETED|Overall Study||2
1105962|NCT01137604|2676696|P4|COMPLETED|Overall Study||21
1105963|NCT01137604|2676697|P3|COMPLETED|Overall Study||26
1105964|NCT01137604|2676698|P2|COMPLETED|Overall Study||32
1105965|NCT01137604|2676699|P1|COMPLETED|Overall Study|Participants with disease progression and treatment ongoing at data cutoff (19 Mar 2013)|36
1105966|NCT01137604|2676696|P4|Treatment Ongoing at Data Cutoff|Overall Study||0
1105967|NCT01137604|2676697|P3|Treatment Ongoing at Data Cutoff|Overall Study||1
1105968|NCT01137604|2676698|P2|Treatment Ongoing at Data Cutoff|Overall Study||3
1105969|NCT01137604|2676699|P1|Treatment Ongoing at Data Cutoff|Overall Study||2
1105970|NCT01137604|2676696|P4|Disease Progression|Overall Study||21
1105971|NCT01137604|2676697|P3|Disease Progression|Overall Study||25
1105972|NCT01137604|2676698|P2|Disease Progression|Overall Study||29
1105973|NCT01137604|2676699|P1|Disease Progression|Overall Study||34
1105974|NCT01137604|2676696|P4|STARTED|Overall Study||32
1105975|NCT01137604|2676697|P3|STARTED|Overall Study||39
1105976|NCT01137604|2676698|P2|STARTED|Overall Study||42
1105977|NCT01137604|2676699|P1|STARTED|Overall Study|39 participants were randomized but 1 participant died prior to receiving treatment.|38
1105978|NCT01137682|2676736|P3|NOT COMPLETED|Overall Study||3
1105979|NCT01137682|2676737|P2|NOT COMPLETED|Overall Study||8
1105980|NCT01137682|2676738|P1|NOT COMPLETED|Overall Study||6
1105981|NCT01137682|2676736|P3|COMPLETED|Overall Study||65
1105982|NCT01137682|2676737|P2|COMPLETED|Overall Study||57
1105983|NCT01137682|2676738|P1|COMPLETED|Overall Study||59
1105984|NCT01137682|2676736|P3|Safety Set|Overall Study|2 patients never received drug.|66
1105985|NCT01137682|2676737|P2|Safety Set|Overall Study|2 patients never received drug. 1 patient had no post baseline safety assement.|62
1105986|NCT01137682|2676738|P1|Safety Set|Overall Study|2 patients never received drug.|63
1105987|NCT01137682|2676736|P3|Continuing Into Extension|Overall Study||62
1105988|NCT01137682|2676737|P2|Continuing Into Extension|Overall Study||53
1105989|NCT01137682|2676738|P1|Continuing Into Extension|Overall Study||56
1105990|NCT01137682|2676736|P3|Not Continuing Into Extension|Overall Study||3
1105991|NCT01137682|2676737|P2|Not Continuing Into Extension|Overall Study||4
1105992|NCT01137682|2676738|P1|Not Continuing Into Extension|Overall Study||3
1105993|NCT01137682|2676736|P3|Completed 24-Week Core Phase|Overall Study||65
1105994|NCT01137682|2676737|P2|Completed 24-Week Core Phase|Overall Study||57
1105995|NCT01137682|2676738|P1|Completed 24-Week Core Phase|Overall Study||59
1105996|NCT01137682|2676736|P3|Treated|Overall Study||67
1105997|NCT01137682|2676737|P2|Treated|Overall Study||64
1105998|NCT01137682|2676738|P1|Treated|Overall Study||63
1105999|NCT01137682|2676736|P3|Not Treated|Overall Study||1
1106000|NCT01137682|2676737|P2|Not Treated|Overall Study||1
1106001|NCT01137682|2676738|P1|Not Treated|Overall Study||2
1106002|NCT01137682|2676736|P3|STARTED|Overall Study||68
1106003|NCT01137682|2676737|P2|STARTED|Overall Study||65
1106004|NCT01137682|2676738|P1|STARTED|Overall Study||65
1106005|NCT01137773|2676751|P2|NOT COMPLETED|Overall Study||3
1106006|NCT01137773|2676752|P1|NOT COMPLETED|Overall Study||9
1106007|NCT01137773|2676751|P2|COMPLETED|Overall Study||20
1106008|NCT01137773|2676752|P1|COMPLETED|Overall Study||24
1106009|NCT01137773|2676751|P2|STARTED|Overall Study||23
1106010|NCT01137773|2676752|P1|STARTED|Overall Study||33
1106011|NCT01137786|2676762|P2|NOT COMPLETED|Overall Study||3
1106012|NCT01137786|2676763|P1|NOT COMPLETED|Overall Study||1
1106013|NCT01137786|2676762|P2|COMPLETED|Overall Study||21
1106014|NCT01137786|2676763|P1|COMPLETED|Overall Study||24
1106015|NCT01137786|2676762|P2|STARTED|Overall Study||24
1106016|NCT01137786|2676763|P1|STARTED|Overall Study||25
1106017|NCT01137812|2676773|P2|NOT COMPLETED|Overall Study||168
1106018|NCT01137812|2676774|P1|NOT COMPLETED|Overall Study||123
1106019|NCT01137812|2676773|P2|COMPLETED|Overall Study||210
1106020|NCT01137812|2676774|P1|COMPLETED|Overall Study||254
1106021|NCT01137812|2676773|P2|STARTED|Overall Study||378
1106022|NCT01137812|2676774|P1|STARTED|Overall Study||377
1106023|NCT01137890|2676794|P2|NOT COMPLETED|Overall Study||3
1106024|NCT01137890|2676795|P1|NOT COMPLETED|Overall Study||6
1106025|NCT01137890|2676794|P2|COMPLETED|Overall Study||2
1106026|NCT01137890|2676795|P1|COMPLETED|Overall Study||8
1106027|NCT01137890|2676794|P2|STARTED|Overall Study||5
1106028|NCT01137890|2676795|P1|STARTED|Overall Study||14
1106029|NCT01138007|2676868|P3|NOT COMPLETED|Overall Study||48
1106030|NCT01138007|2676869|P2|NOT COMPLETED|Overall Study||30
1106031|NCT01138007|2676870|P1|NOT COMPLETED|Overall Study||22
1106032|NCT01138007|2676868|P3|COMPLETED|Overall Study||144
1106033|NCT01138007|2676869|P2|COMPLETED|Overall Study||160
1106034|NCT01138007|2676870|P1|COMPLETED|Overall Study||165
1106035|NCT01138007|2676868|P3|STARTED|Overall Study||192
1106036|NCT01138007|2676869|P2|STARTED|Overall Study||190
1106037|NCT01138007|2676870|P1|STARTED|Overall Study||187
1106038|NCT01138046|2676902|P1|NOT COMPLETED|Overall Study||6
1106039|NCT01138046|2676902|P1|COMPLETED|Overall Study||6
1106040|NCT01138046|2676902|P1|STARTED|Overall Study||12
1106041|NCT01138098|2676921|P2|NOT COMPLETED|Overall Study||0
1106042|NCT01138098|2676922|P1|NOT COMPLETED|Overall Study||0
1106043|NCT01138098|2676921|P2|COMPLETED|Overall Study||90
1106044|NCT01138098|2676922|P1|COMPLETED|Overall Study||95
1106045|NCT01138098|2676921|P2|STARTED|Overall Study||90
1106046|NCT01138098|2676922|P1|STARTED|Overall Study||95
1106047|NCT01138111|2676944|P1|NOT COMPLETED|Overall Study||9
1106048|NCT01138111|2676944|P1|COMPLETED|Overall Study||36
1106049|NCT01138111|2676944|P1|STARTED|Overall Study||45
1106050|NCT01138124|2676977|P4|NOT COMPLETED|Overall Study||0
1106051|NCT01138124|2676978|P3|NOT COMPLETED|Overall Study||0
1106052|NCT01138124|2676979|P2|NOT COMPLETED|Overall Study||0
1106053|NCT01138124|2676980|P1|NOT COMPLETED|Overall Study||0
1106054|NCT01138124|2676977|P4|COMPLETED|Overall Study||19046
1106055|NCT01138124|2676978|P3|COMPLETED|Overall Study||1981
1106056|NCT01138124|2676979|P2|COMPLETED|Overall Study||30026
1106057|NCT01138124|2676980|P1|COMPLETED|Overall Study||3149
1106058|NCT01138124|2676977|P4|STARTED|Overall Study||19046
1106059|NCT01138124|2676978|P3|STARTED|Overall Study||1981
1106060|NCT01138124|2676979|P2|STARTED|Overall Study||30026
1106061|NCT01138124|2676980|P1|STARTED|Overall Study||3149
1106062|NCT01138150|2677004|P2|NOT COMPLETED|Overall Study||1
1106063|NCT01138150|2677005|P1|NOT COMPLETED|Overall Study||1
1106064|NCT01138150|2677004|P2|COMPLETED|Overall Study||17
1106065|NCT01138150|2677005|P1|COMPLETED|Overall Study||17
1106066|NCT01138150|2677004|P2|STARTED|Overall Study||18
1106067|NCT01138150|2677005|P1|STARTED|Overall Study||18
1106068|NCT01129206|2677057|P1|NOT COMPLETED|Overall Study||0
1106069|NCT01129206|2677057|P1|COMPLETED|Overall Study||6
1106070|NCT01129206|2677057|P1|STARTED|Overall Study||6
1106077|NCT01129284|2677077|P3|NOT COMPLETED|Overall Study||1
1106078|NCT01129284|2677078|P2|NOT COMPLETED|Overall Study||0
1106079|NCT01129284|2677079|P1|NOT COMPLETED|Overall Study||2
1106080|NCT01129284|2677077|P3|COMPLETED|Overall Study||4
1106081|NCT01129284|2677078|P2|COMPLETED|Overall Study||5
1106082|NCT01129284|2677079|P1|COMPLETED|Overall Study||3
1106083|NCT01129284|2677077|P3|STARTED|Overall Study||5
1106084|NCT01129284|2677078|P2|STARTED|Overall Study||5
1106085|NCT01129284|2677079|P1|STARTED|Overall Study||5
1106086|NCT01129336|2677092|P2|NOT COMPLETED|Overall Study||16
1106087|NCT01129336|2677093|P1|NOT COMPLETED|Overall Study||12
1106088|NCT01129336|2677092|P2|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|13
1106089|NCT01129336|2677093|P1|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|3
1106090|NCT01129336|2677092|P2|Completed Treatment|Overall Study||3
1106091|NCT01129336|2677093|P1|Completed Treatment|Overall Study||1
1106092|NCT01129336|2677092|P2|STARTED|Overall Study||29
1106093|NCT01129336|2677093|P1|STARTED|Overall Study||15
1106094|NCT01129531|2677108|P3|NOT COMPLETED|Treatment Cycle 2||5
1106095|NCT01129531|2677109|P2|NOT COMPLETED|Treatment Cycle 2||3
1106096|NCT01129531|2677110|P1|NOT COMPLETED|Treatment Cycle 2||6
1106097|NCT01129531|2677108|P3|COMPLETED|Treatment Cycle 2||74
1106098|NCT01129531|2677109|P2|COMPLETED|Treatment Cycle 2||92
1106099|NCT01129531|2677110|P1|COMPLETED|Treatment Cycle 2||88
1106100|NCT01129531|2677108|P3|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|79
1106101|NCT01129531|2677109|P2|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|95
1106102|NCT01129531|2677110|P1|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|94
1106103|NCT01129531|2677108|P3|NOT COMPLETED|Treatment Cycle 1||16
1106104|NCT01129531|2677109|P2|NOT COMPLETED|Treatment Cycle 1||6
1106105|NCT01129531|2677110|P1|NOT COMPLETED|Treatment Cycle 1||4
1106106|NCT01129531|2677108|P3|COMPLETED|Treatment Cycle 1||110
1106107|NCT01129531|2677109|P2|COMPLETED|Treatment Cycle 1||78
1106108|NCT01129531|2677110|P1|COMPLETED|Treatment Cycle 1||80
1106109|NCT01129531|2677108|P3|STARTED|Treatment Cycle 1||126
1106110|NCT01129531|2677109|P2|STARTED|Treatment Cycle 1||84
1106111|NCT01129531|2677110|P1|STARTED|Treatment Cycle 1||84
1106112|NCT01129557|2677133|P3|NOT COMPLETED|Overall Study||4
1106113|NCT01129557|2677134|P2|NOT COMPLETED|Overall Study||5
1106114|NCT01129557|2677135|P1|NOT COMPLETED|Overall Study||4
1106115|NCT01129557|2677133|P3|COMPLETED|Overall Study||10
1106116|NCT01129557|2677134|P2|COMPLETED|Overall Study||12
1106117|NCT01129557|2677135|P1|COMPLETED|Overall Study||11
1106118|NCT01129557|2677133|P3|STARTED|Overall Study||14
1106119|NCT01129557|2677134|P2|STARTED|Overall Study||17
1106120|NCT01129557|2677135|P1|STARTED|Overall Study||15
1106121|NCT01129583|2677205|P2|NOT COMPLETED|Overall Study||2
1106122|NCT01129583|2677206|P1|NOT COMPLETED|Overall Study||3
1106123|NCT01129583|2677205|P2|COMPLETED|Overall Study||7
1106124|NCT01129583|2677206|P1|COMPLETED|Overall Study||6
1106125|NCT01129583|2677205|P2|STARTED|Overall Study||9
1106126|NCT01129583|2677206|P1|STARTED|Overall Study||9
1106127|NCT01129622|2677216|P1|NOT COMPLETED|Overall Study||2
1106128|NCT01129622|2677216|P1|COMPLETED|Overall Study||14
1106129|NCT01129622|2677216|P1|STARTED|Overall Study||16
1106130|NCT01129765|2677221|P1|NOT COMPLETED|Overall Study||0
1106131|NCT01129765|2677221|P1|COMPLETED|Overall Study||30
1106132|NCT01129765|2677221|P1|STARTED|Overall Study||30
1106133|NCT01129778|2677230|P1|NOT COMPLETED|Overall Study||7
1106134|NCT01129778|2677230|P1|COMPLETED|Overall Study||15
1106135|NCT01129778|2677230|P1|STARTED|Overall Study||22
1106136|NCT01129921|2677237|P2|NOT COMPLETED|After Sham Cross-over to Mild, One Year||7
1106137|NCT01129921|2677238|P1|NOT COMPLETED|After Sham Cross-over to Mild, One Year||2
1106138|NCT01129921|2677237|P2|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis prior to x-over. After x-over 13 reported Year 1.|13
1106139|NCT01129921|2677238|P1|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis. Eighteen reported Year 1 outcomes.|18
1106140|NCT01129921|2677237|P2|STARTED|After Sham Cross-over to Mild, One Year||20
1106141|NCT01129921|2677238|P1|STARTED|After Sham Cross-over to Mild, One Year||20
1106142|NCT01129921|2677237|P2|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
1106143|NCT01129921|2677238|P1|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
1106144|NCT01129921|2677237|P2|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
1106145|NCT01129921|2677238|P1|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
1106146|NCT01129921|2677237|P2|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
1106147|NCT01129921|2677238|P1|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
1106148|NCT01129960|2677252|P4|NOT COMPLETED|Overall Study||13
1106149|NCT01129960|2677253|P3|NOT COMPLETED|Overall Study||26
1106150|NCT01129960|2677254|P2|NOT COMPLETED|Overall Study||22
1106151|NCT01129960|2677255|P1|NOT COMPLETED|Overall Study||30
1106152|NCT01129960|2677252|P4|COMPLETED|Overall Study||70
1106153|NCT01129960|2677253|P3|COMPLETED|Overall Study||56
1106154|NCT01129960|2677254|P2|COMPLETED|Overall Study||61
1106155|NCT01129960|2677255|P1|COMPLETED|Overall Study||54
1106156|NCT01129960|2677252|P4|Full Analysis Set (FAS|Overall Study||71
1106157|NCT01129960|2677253|P3|Full Analysis Set (FAS|Overall Study||68
1106158|NCT01129960|2677254|P2|Full Analysis Set (FAS|Overall Study||67
1106159|NCT01129960|2677255|P1|Full Analysis Set (FAS|Overall Study||71
1106160|NCT01129960|2677252|P4|Per-Protocol|Overall Study||55
1106161|NCT01129960|2677253|P3|Per-Protocol|Overall Study||49
1106162|NCT01129960|2677254|P2|Per-Protocol|Overall Study||52
1106163|NCT01129960|2677255|P1|Per-Protocol|Overall Study||34
1106164|NCT01129960|2677252|P4|Intent-to-Treat|Overall Study||83
1106165|NCT01129960|2677253|P3|Intent-to-Treat|Overall Study||82
1106166|NCT01129960|2677254|P2|Intent-to-Treat|Overall Study||83
1106167|NCT01129960|2677255|P1|Intent-to-Treat|Overall Study||84
1106168|NCT01129960|2677252|P4|Safety|Overall Study||82
1106169|NCT01129960|2677253|P3|Safety|Overall Study|One subject was randomized to placebo, but was dispensed in error with an ESL 800 mg kit at DB Visit|83
1106170|NCT01129960|2677254|P2|Safety|Overall Study||83
1106171|NCT01129960|2677255|P1|Safety|Overall Study||84
1106172|NCT01129960|2677252|P4|STARTED|Overall Study||83
1106173|NCT01129960|2677253|P3|STARTED|Overall Study||82
1106174|NCT01129960|2677254|P2|STARTED|Overall Study||83
1106175|NCT01129960|2677255|P1|STARTED|Overall Study||84
1106176|NCT01130051|2677265|P2|NOT COMPLETED|Period 2||0
1106177|NCT01130051|2677266|P1|NOT COMPLETED|Period 2||0
1106178|NCT01130051|2677265|P2|COMPLETED|Period 2||6
1106179|NCT01130051|2677266|P1|COMPLETED|Period 2||7
1106180|NCT01130051|2677265|P2|STARTED|Period 2||6
1106181|NCT01130051|2677266|P1|STARTED|Period 2||7
1106182|NCT01130051|2677265|P2|NOT COMPLETED|Washout Period of 14 Days||2
1106183|NCT01130051|2677266|P1|NOT COMPLETED|Washout Period of 14 Days||1
1106184|NCT01130051|2677265|P2|COMPLETED|Washout Period of 14 Days||6
1106185|NCT01130051|2677266|P1|COMPLETED|Washout Period of 14 Days||7
1106186|NCT01130051|2677265|P2|STARTED|Washout Period of 14 Days||8
1106187|NCT01130051|2677266|P1|STARTED|Washout Period of 14 Days||8
1106188|NCT01130051|2677265|P2|NOT COMPLETED|Period 1||0
1106189|NCT01130051|2677266|P1|NOT COMPLETED|Period 1||0
1106190|NCT01130051|2677265|P2|COMPLETED|Period 1||8
1106191|NCT01130051|2677266|P1|COMPLETED|Period 1||8
1106192|NCT01130051|2677265|P2|STARTED|Period 1||8
1106193|NCT01130051|2677266|P1|STARTED|Period 1||8
1106194|NCT01130103|2677278|P2|NOT COMPLETED|Maintenance Treatment||2
1106195|NCT01130103|2677279|P1|NOT COMPLETED|Maintenance Treatment||2
1106196|NCT01130103|2677278|P2|COMPLETED|Maintenance Treatment||11
1106197|NCT01130103|2677279|P1|COMPLETED|Maintenance Treatment||11
1106198|NCT01130103|2677278|P2|STARTED|Maintenance Treatment||13
1106199|NCT01130103|2677279|P1|STARTED|Maintenance Treatment||13
1106200|NCT01130103|2677278|P2|NOT COMPLETED|Randomized Treatment||5
1106201|NCT01130103|2677279|P1|NOT COMPLETED|Randomized Treatment||6
1106202|NCT01130103|2677278|P2|COMPLETED|Randomized Treatment||13
1106203|NCT01130103|2677279|P1|COMPLETED|Randomized Treatment||13
1106204|NCT01130103|2677278|P2|STARTED|Randomized Treatment||18
1106205|NCT01130103|2677279|P1|STARTED|Randomized Treatment||19
1106206|NCT01130168|2677293|P6|NOT COMPLETED|Period 3||0
1106207|NCT01130168|2677294|P5|NOT COMPLETED|Period 3||0
1106208|NCT01130168|2677295|P4|NOT COMPLETED|Period 3||0
1106209|NCT01130168|2677296|P3|NOT COMPLETED|Period 3||0
1106210|NCT01130168|2677297|P2|NOT COMPLETED|Period 3||0
1106211|NCT01130168|2677298|P1|NOT COMPLETED|Period 3||0
1106212|NCT01130168|2677293|P6|COMPLETED|Period 3||6
1106213|NCT01130168|2677294|P5|COMPLETED|Period 3||5
1106214|NCT01130168|2677295|P4|COMPLETED|Period 3||5
1106215|NCT01130168|2677296|P3|COMPLETED|Period 3||5
1106216|NCT01130168|2677297|P2|COMPLETED|Period 3||6
1106217|NCT01130168|2677298|P1|COMPLETED|Period 3||6
1106218|NCT01130168|2677293|P6|STARTED|Period 3||6
1106219|NCT01130168|2677294|P5|STARTED|Period 3||5
1106220|NCT01130168|2677295|P4|STARTED|Period 3||5
1106221|NCT01130168|2677296|P3|STARTED|Period 3||5
1106222|NCT01130168|2677297|P2|STARTED|Period 3||6
1106223|NCT01130168|2677298|P1|STARTED|Period 3||6
1106224|NCT01130168|2677293|P6|NOT COMPLETED|Period 2||0
1106225|NCT01130168|2677294|P5|NOT COMPLETED|Period 2||0
1106226|NCT01130168|2677295|P4|NOT COMPLETED|Period 2||0
1106227|NCT01130168|2677296|P3|NOT COMPLETED|Period 2||0
1106228|NCT01130168|2677297|P2|NOT COMPLETED|Period 2||0
1106229|NCT01130168|2677298|P1|NOT COMPLETED|Period 2||0
1106230|NCT01130168|2677293|P6|COMPLETED|Period 2||6
1106231|NCT01130168|2677294|P5|COMPLETED|Period 2||5
1106232|NCT01130168|2677295|P4|COMPLETED|Period 2||5
1106233|NCT01130168|2677296|P3|COMPLETED|Period 2||5
1106234|NCT01130168|2677297|P2|COMPLETED|Period 2||6
1106235|NCT01130168|2677298|P1|COMPLETED|Period 2||6
1106236|NCT01130168|2677293|P6|STARTED|Period 2||6
1106237|NCT01130168|2677294|P5|STARTED|Period 2||5
1106238|NCT01130168|2677295|P4|STARTED|Period 2||5
1106239|NCT01130168|2677296|P3|STARTED|Period 2||5
1106240|NCT01130168|2677297|P2|STARTED|Period 2||6
1106241|NCT01130168|2677298|P1|STARTED|Period 2||6
1106242|NCT01130168|2677293|P6|NOT COMPLETED|Period 1||0
1106243|NCT01130168|2677294|P5|NOT COMPLETED|Period 1||0
1106244|NCT01130168|2677295|P4|NOT COMPLETED|Period 1||3
1106245|NCT01130168|2677296|P3|NOT COMPLETED|Period 1||1
1106246|NCT01130168|2677297|P2|NOT COMPLETED|Period 1||1
1106247|NCT01130168|2677298|P1|NOT COMPLETED|Period 1||0
1106248|NCT01130168|2677293|P6|COMPLETED|Period 1||6
1106249|NCT01130168|2677294|P5|COMPLETED|Period 1||5
1106250|NCT01130168|2677295|P4|COMPLETED|Period 1||5
1106251|NCT01130168|2677296|P3|COMPLETED|Period 1||5
1106252|NCT01130168|2677297|P2|COMPLETED|Period 1||6
1106253|NCT01130168|2677298|P1|COMPLETED|Period 1||6
1106254|NCT01130168|2677293|P6|STARTED|Period 1||6
1106255|NCT01130168|2677294|P5|STARTED|Period 1||5
1106256|NCT01130168|2677295|P4|STARTED|Period 1||8
1106257|NCT01130168|2677296|P3|STARTED|Period 1||6
1106258|NCT01130168|2677297|P2|STARTED|Period 1||7
1106259|NCT01130168|2677298|P1|STARTED|Period 1||6
1106260|NCT01130337|2677333|P1|NOT COMPLETED|Overall Study||14
1106261|NCT01130337|2677333|P1|COMPLETED|Overall Study||22
1106262|NCT01130337|2677333|P1|STARTED|Overall Study||36
1106293|NCT01130532|2677361|P4|NOT COMPLETED|Period IV (Weeks 13-16)||10
1106294|NCT01130532|2677362|P3|NOT COMPLETED|Period IV (Weeks 13-16)||0
1106295|NCT01130532|2677363|P2|NOT COMPLETED|Period IV (Weeks 13-16)||0
1106296|NCT01130532|2677364|P1|NOT COMPLETED|Period IV (Weeks 13-16)||0
1106297|NCT01130532|2677361|P4|COMPLETED|Period IV (Weeks 13-16)||552
1106298|NCT01130532|2677362|P3|COMPLETED|Period IV (Weeks 13-16)||0
1106299|NCT01130532|2677363|P2|COMPLETED|Period IV (Weeks 13-16)||0
1106300|NCT01130532|2677364|P1|COMPLETED|Period IV (Weeks 13-16)||0
1106301|NCT01130532|2677361|P4|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||546
1106302|NCT01130532|2677362|P3|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
1106303|NCT01130532|2677363|P2|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
1106304|NCT01130532|2677364|P1|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
1106305|NCT01130532|2677361|P4|STARTED|Period IV (Weeks 13-16)|Three participants who completed Period III chose not to continue into Period IV.|562
1106306|NCT01130532|2677362|P3|STARTED|Period IV (Weeks 13-16)||0
1106307|NCT01130532|2677363|P2|STARTED|Period IV (Weeks 13-16)||0
1106308|NCT01130532|2677364|P1|STARTED|Period IV (Weeks 13-16)||0
1106309|NCT01130532|2677361|P4|NOT COMPLETED|Period III (Weeks 0-12)||0
1106310|NCT01130532|2677362|P3|NOT COMPLETED|Period III (Weeks 0-12)||19
1106311|NCT01130532|2677363|P2|NOT COMPLETED|Period III (Weeks 0-12)||18
1106312|NCT01130532|2677364|P1|NOT COMPLETED|Period III (Weeks 0-12)||21
1106313|NCT01130532|2677361|P4|COMPLETED|Period III (Weeks 0-12)||0
1106314|NCT01130532|2677362|P3|COMPLETED|Period III (Weeks 0-12)||190
1106315|NCT01130532|2677363|P2|COMPLETED|Period III (Weeks 0-12)||189
1106316|NCT01130532|2677364|P1|COMPLETED|Period III (Weeks 0-12)||186
1106317|NCT01130532|2677361|P4|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||0
1106318|NCT01130532|2677362|P3|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||207
1106319|NCT01130532|2677363|P2|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
1106320|NCT01130532|2677364|P1|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
1106321|NCT01130532|2677361|P4|STARTED|Period III (Weeks 0-12)||0
1106322|NCT01130532|2677362|P3|STARTED|Period III (Weeks 0-12)||209
1106323|NCT01130532|2677363|P2|STARTED|Period III (Weeks 0-12)||207
1106324|NCT01130532|2677364|P1|STARTED|Period III (Weeks 0-12)||207
1106325|NCT01130597|2677409|P1|NOT COMPLETED|Overall Study||7
1106326|NCT01130597|2677409|P1|COMPLETED|Overall Study||56
1106327|NCT01130597|2677409|P1|STARTED|Overall Study||63
1106328|NCT01130740|2677433|P2|NOT COMPLETED|Overall Study||15
1106329|NCT01130740|2677434|P1|NOT COMPLETED|Overall Study||12
1106330|NCT01130740|2677433|P2|COMPLETED|Overall Study||136
1106331|NCT01130740|2677434|P1|COMPLETED|Overall Study||137
1106332|NCT01130740|2677433|P2|STARTED|Overall Study||151
1106333|NCT01130740|2677434|P1|STARTED|Overall Study||149
1106334|NCT01130831|2677444|P1|NOT COMPLETED|Overall Study||14
1106335|NCT01130831|2677444|P1|COMPLETED|Overall Study||52
1106336|NCT01130831|2677444|P1|STARTED|Overall Study||66
1106337|NCT01130844|2677473|P3|NOT COMPLETED|Overall Study||0
1106338|NCT01130844|2677474|P2|NOT COMPLETED|Overall Study||0
1106339|NCT01130844|2677475|P1|NOT COMPLETED|Overall Study||0
1106340|NCT01130844|2677473|P3|COMPLETED|Overall Study||9
1106341|NCT01130844|2677474|P2|COMPLETED|Overall Study||22
1106342|NCT01130844|2677475|P1|COMPLETED|Overall Study||21
1106343|NCT01130844|2677473|P3|STARTED|Overall Study||9
1106344|NCT01130844|2677474|P2|STARTED|Overall Study||22
1106345|NCT01130844|2677475|P1|STARTED|Overall Study||21
1106346|NCT01130883|2677513|P1|NOT COMPLETED|Overall Study||10
1106347|NCT01130883|2677513|P1|COMPLETED|Overall Study||3120
1106348|NCT01130883|2677513|P1|Participants Analyzed|Overall Study||3128
1106349|NCT01130883|2677513|P1|STARTED|Overall Study||3130
1106350|NCT01130974|2677529|P2|NOT COMPLETED|Overall Study||13
1106351|NCT01130974|2677530|P1|NOT COMPLETED|Overall Study||15
1106352|NCT01130974|2677529|P2|COMPLETED|Overall Study||87
1106353|NCT01130974|2677530|P1|COMPLETED|Overall Study||85
1106354|NCT01130974|2677529|P2|STARTED|Overall Study||100
1106355|NCT01130974|2677530|P1|STARTED|Overall Study||100
1106356|NCT01131052|2677552|P2|NOT COMPLETED|Overall Study||0
1106357|NCT01131052|2677553|P1|NOT COMPLETED|Overall Study||0
1106358|NCT01131052|2677552|P2|COMPLETED|Overall Study||75
1106359|NCT01131052|2677553|P1|COMPLETED|Overall Study||75
1106360|NCT01131052|2677552|P2|STARTED|Overall Study||75
1106361|NCT01131052|2677553|P1|STARTED|Overall Study||75
1106362|NCT01131065|2677573|P1|NOT COMPLETED|Overall Study||0
1106363|NCT01131065|2677573|P1|COMPLETED|Overall Study||15
1106364|NCT01131065|2677573|P1|STARTED|Overall Study||15
1106365|NCT01131078|2677582|P3|NOT COMPLETED|Overall Study||102
1106366|NCT01131078|2677583|P2|NOT COMPLETED|Overall Study||101
1106367|NCT01131078|2677584|P1|NOT COMPLETED|Overall Study||101
1106368|NCT01131078|2677582|P3|COMPLETED|Overall Study||1
1106369|NCT01131078|2677583|P2|COMPLETED|Overall Study||1
1106370|NCT01131078|2677584|P1|COMPLETED|Overall Study||0
1106371|NCT01131078|2677582|P3|STARTED|Overall Study||103
1106372|NCT01131078|2677583|P2|STARTED|Overall Study||102
1106373|NCT01131078|2677584|P1|STARTED|Overall Study||101
1106374|NCT01131130|2677640|P1|NOT COMPLETED|Period 3- Crossover||1
1106375|NCT01131130|2677640|P1|COMPLETED|Period 3- Crossover||116
1106376|NCT01131130|2677640|P1|STARTED|Period 3- Crossover||117
1106377|NCT01131130|2677640|P1|NOT COMPLETED|Period 2 - Crossover||0
1106378|NCT01131130|2677640|P1|COMPLETED|Period 2 - Crossover||117
1106379|NCT01131130|2677640|P1|STARTED|Period 2 - Crossover||117
1106380|NCT01131130|2677640|P1|NOT COMPLETED|Period 1 - Baseline||1
1106381|NCT01131130|2677640|P1|COMPLETED|Period 1 - Baseline|Participant was discontinued 1 day following dispensing and not reported in result tables|117
1106382|NCT01131130|2677640|P1|STARTED|Period 1 - Baseline||118
1106389|NCT01131299|2677664|P2|NOT COMPLETED|Overall Study||7
1106390|NCT01131299|2677665|P1|NOT COMPLETED|Overall Study||4
1106391|NCT01131299|2677664|P2|COMPLETED|Overall Study||37
1106392|NCT01131299|2677665|P1|COMPLETED|Overall Study||38
1106393|NCT01131299|2677664|P2|STARTED|Overall Study||44
1106394|NCT01131299|2677665|P1|STARTED|Overall Study||42
1106395|NCT01131455|2677679|P3|NOT COMPLETED|Overall Study||0
1106396|NCT01131455|2677680|P2|NOT COMPLETED|Overall Study||4
1106397|NCT01131455|2677681|P1|NOT COMPLETED|Overall Study||6
1106398|NCT01131455|2677679|P3|COMPLETED|Overall Study||0
1106399|NCT01131455|2677680|P2|COMPLETED|Overall Study||0
1106400|NCT01131455|2677681|P1|COMPLETED|Overall Study||0
1106401|NCT01131455|2677679|P3|STARTED|Overall Study||0
1106402|NCT01131455|2677680|P2|STARTED|Overall Study||4
1106403|NCT01131455|2677681|P1|STARTED|Overall Study||6
1106404|NCT01131494|2677689|P1|NOT COMPLETED|Overall Study||2
1106405|NCT01131494|2677689|P1|COMPLETED|Overall Study||15
1106406|NCT01131494|2677689|P1|STARTED|Overall Study||17
1106407|NCT01131507|2677696|P1|NOT COMPLETED|Overall Study||3
1106408|NCT01131507|2677696|P1|COMPLETED|Overall Study||12
1106409|NCT01131507|2677696|P1|STARTED|Overall Study||15
1106410|NCT01131520|2677703|P2|NOT COMPLETED|Overall Study||4
1106411|NCT01131520|2677704|P1|NOT COMPLETED|Overall Study||1
1106412|NCT01131520|2677703|P2|COMPLETED|Overall Study||176
1106413|NCT01131520|2677704|P1|COMPLETED|Overall Study||179
1106414|NCT01131520|2677703|P2|STARTED|Overall Study||180
1106415|NCT01131520|2677704|P1|STARTED|Overall Study||180
1106416|NCT01131585|2677728|P2|NOT COMPLETED|Overall Study||43
1106417|NCT01131585|2677729|P1|NOT COMPLETED|Overall Study||85
1106418|NCT01131585|2677728|P2|COMPLETED|Overall Study||0
1106419|NCT01131585|2677729|P1|COMPLETED|Overall Study||0
1106420|NCT01131585|2677728|P2|STARTED|Overall Study||43
1106421|NCT01131585|2677729|P1|STARTED|Overall Study||85
1106422|NCT01131676|2677738|P3|NOT COMPLETED|Discontinuation From Study (Treated Set)||63
1106423|NCT01131676|2677739|P2|NOT COMPLETED|Discontinuation From Study (Treated Set)||81
1106424|NCT01131676|2677740|P1|NOT COMPLETED|Discontinuation From Study (Treated Set)||67
1106425|NCT01131676|2677738|P3|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2279
1106426|NCT01131676|2677739|P2|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2264
1106427|NCT01131676|2677740|P1|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2266
1106428|NCT01131676|2677738|P3|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2327
1106429|NCT01131676|2677739|P2|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2324
1106430|NCT01131676|2677740|P1|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2316
1106431|NCT01131676|2677738|P3|STARTED|Discontinuation From Study (Treated Set)||2342
1106432|NCT01131676|2677739|P2|STARTED|Discontinuation From Study (Treated Set)||2345
1106433|NCT01131676|2677740|P1|STARTED|Discontinuation From Study (Treated Set)||2333
1106434|NCT01131676|2677738|P3|NOT COMPLETED|Discontinuation From Treatment||544
1106435|NCT01131676|2677739|P2|NOT COMPLETED|Discontinuation From Treatment||557
1106436|NCT01131676|2677740|P1|NOT COMPLETED|Discontinuation From Treatment||687
1106437|NCT01131676|2677738|P3|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1800
1106438|NCT01131676|2677739|P2|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1790
1106439|NCT01131676|2677740|P1|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1650
1106440|NCT01131676|2677738|P3|STARTED|Discontinuation From Treatment|Randomised|2344
1106441|NCT01131676|2677739|P2|STARTED|Discontinuation From Treatment|Randomised|2347
1106442|NCT01131676|2677740|P1|STARTED|Discontinuation From Treatment|Randomised|2337
1106443|NCT01138475|2677776|P3|NOT COMPLETED|Overall Study||0
1106444|NCT01138475|2677777|P2|NOT COMPLETED|Overall Study||0
1106445|NCT01138475|2677778|P1|NOT COMPLETED|Overall Study||0
1106446|NCT01138475|2677776|P3|COMPLETED|Overall Study||17
1106447|NCT01138475|2677777|P2|COMPLETED|Overall Study||16
1106448|NCT01138475|2677778|P1|COMPLETED|Overall Study||16
1106449|NCT01138475|2677776|P3|STARTED|Overall Study||17
1106450|NCT01138475|2677777|P2|STARTED|Overall Study||16
1106451|NCT01138475|2677778|P1|STARTED|Overall Study||16
1106452|NCT01138501|2677810|P1|NOT COMPLETED|Overall Study||5
1106453|NCT01138501|2677810|P1|COMPLETED|Overall Study||60
1106454|NCT01138501|2677810|P1|Exposed|Overall Study||63
1106455|NCT01138501|2677810|P1|STARTED|Overall Study|Two subjects withdrew consent after being enrolled but before receiving any trial product.|65
1106456|NCT01138514|2677818|P3|NOT COMPLETED|Overall Study||93
1106457|NCT01138514|2677819|P2|NOT COMPLETED|Overall Study||53
1106458|NCT01138514|2677820|P1|NOT COMPLETED|Overall Study||48
1106459|NCT01138514|2677818|P3|COMPLETED|Overall Study||424
1106460|NCT01138514|2677819|P2|COMPLETED|Overall Study||463
1106461|NCT01138514|2677820|P1|COMPLETED|Overall Study||474
1106462|NCT01138514|2677818|P3|STARTED|Overall Study||517
1106463|NCT01138514|2677819|P2|STARTED|Overall Study||516
1106464|NCT01138514|2677820|P1|STARTED|Overall Study||522
1106465|NCT01138657|2677836|P2|NOT COMPLETED|Overall Study||18
1106466|NCT01138657|2677837|P1|NOT COMPLETED|Overall Study||8
1106467|NCT01138657|2677836|P2|COMPLETED|Overall Study||101
1106468|NCT01138657|2677837|P1|COMPLETED|Overall Study||112
1106469|NCT01138657|2677836|P2|Enrolled in Japan Sub-study|Overall Study||8
1106470|NCT01138657|2677837|P1|Enrolled in Japan Sub-study|Overall Study||8
1106471|NCT01138657|2677836|P2|Enrolled in Main Study|Overall Study||111
1106472|NCT01138657|2677837|P1|Enrolled in Main Study|Overall Study||112
1106473|NCT01138657|2677836|P2|STARTED|Overall Study||119
1106474|NCT01138657|2677837|P1|STARTED|Overall Study||120
1106475|NCT01138735|2677883|P2|NOT COMPLETED|Overall Study||17
1106476|NCT01138735|2677884|P1|NOT COMPLETED|Overall Study||8
1106477|NCT01138735|2677883|P2|COMPLETED|Overall Study||126
1106478|NCT01138735|2677884|P1|COMPLETED|Overall Study||134
1106479|NCT01138735|2677883|P2|STARTED|Overall Study||143
1106480|NCT01138735|2677884|P1|STARTED|Overall Study||142
1106481|NCT01138826|2677896|P6|NOT COMPLETED|Third Intervention Period||0
1106482|NCT01138826|2677897|P5|NOT COMPLETED|Third Intervention Period||0
1106483|NCT01138826|2677898|P4|NOT COMPLETED|Third Intervention Period||0
1106484|NCT01138826|2677899|P3|NOT COMPLETED|Third Intervention Period||0
1106485|NCT01138826|2677900|P2|NOT COMPLETED|Third Intervention Period||0
1106486|NCT01138826|2677901|P1|NOT COMPLETED|Third Intervention Period||0
1106487|NCT01138826|2677896|P6|COMPLETED|Third Intervention Period||3
1106488|NCT01138826|2677897|P5|COMPLETED|Third Intervention Period||2
1106489|NCT01138826|2677898|P4|COMPLETED|Third Intervention Period||3
1106490|NCT01138826|2677899|P3|COMPLETED|Third Intervention Period||3
1106491|NCT01138826|2677900|P2|COMPLETED|Third Intervention Period||2
1106492|NCT01138826|2677901|P1|COMPLETED|Third Intervention Period||2
1106493|NCT01138826|2677896|P6|STARTED|Third Intervention Period||3
1106494|NCT01138826|2677897|P5|STARTED|Third Intervention Period||2
1106495|NCT01138826|2677898|P4|STARTED|Third Intervention Period||3
1106496|NCT01138826|2677899|P3|STARTED|Third Intervention Period||3
1106497|NCT01138826|2677900|P2|STARTED|Third Intervention Period||2
1106498|NCT01138826|2677901|P1|STARTED|Third Intervention Period||2
1106499|NCT01138826|2677896|P6|NOT COMPLETED|Washout Period II (of 16 Days)||0
1106500|NCT01138826|2677897|P5|NOT COMPLETED|Washout Period II (of 16 Days)||0
1106501|NCT01138826|2677898|P4|NOT COMPLETED|Washout Period II (of 16 Days)||0
1106502|NCT01138826|2677899|P3|NOT COMPLETED|Washout Period II (of 16 Days)||0
1106503|NCT01138826|2677900|P2|NOT COMPLETED|Washout Period II (of 16 Days)||0
1106504|NCT01138826|2677901|P1|NOT COMPLETED|Washout Period II (of 16 Days)||0
1106505|NCT01138826|2677896|P6|COMPLETED|Washout Period II (of 16 Days)||3
1106506|NCT01138826|2677897|P5|COMPLETED|Washout Period II (of 16 Days)||2
1106507|NCT01138826|2677898|P4|COMPLETED|Washout Period II (of 16 Days)||3
1106508|NCT01138826|2677899|P3|COMPLETED|Washout Period II (of 16 Days)||3
1106509|NCT01138826|2677900|P2|COMPLETED|Washout Period II (of 16 Days)||2
1106510|NCT01138826|2677901|P1|COMPLETED|Washout Period II (of 16 Days)||2
1106511|NCT01138826|2677896|P6|STARTED|Washout Period II (of 16 Days)||3
1106512|NCT01138826|2677897|P5|STARTED|Washout Period II (of 16 Days)||2
1106513|NCT01138826|2677898|P4|STARTED|Washout Period II (of 16 Days)||3
1106514|NCT01138826|2677899|P3|STARTED|Washout Period II (of 16 Days)||3
1106515|NCT01138826|2677900|P2|STARTED|Washout Period II (of 16 Days)||2
1106516|NCT01138826|2677901|P1|STARTED|Washout Period II (of 16 Days)||2
1106517|NCT01138826|2677896|P6|NOT COMPLETED|Second Intervention Period||0
1106518|NCT01138826|2677897|P5|NOT COMPLETED|Second Intervention Period||0
1106519|NCT01138826|2677898|P4|NOT COMPLETED|Second Intervention Period||0
1106520|NCT01138826|2677899|P3|NOT COMPLETED|Second Intervention Period||0
1106521|NCT01138826|2677900|P2|NOT COMPLETED|Second Intervention Period||0
1106522|NCT01138826|2677901|P1|NOT COMPLETED|Second Intervention Period||0
1106523|NCT01138826|2677896|P6|COMPLETED|Second Intervention Period||3
1106524|NCT01138826|2677897|P5|COMPLETED|Second Intervention Period||2
1106525|NCT01138826|2677898|P4|COMPLETED|Second Intervention Period||3
1106526|NCT01138826|2677899|P3|COMPLETED|Second Intervention Period||3
1106527|NCT01138826|2677900|P2|COMPLETED|Second Intervention Period||2
1106528|NCT01138826|2677901|P1|COMPLETED|Second Intervention Period||2
1106529|NCT01138826|2677896|P6|STARTED|Second Intervention Period||3
1106530|NCT01138826|2677897|P5|STARTED|Second Intervention Period||2
1106531|NCT01138826|2677898|P4|STARTED|Second Intervention Period||3
1106532|NCT01138826|2677899|P3|STARTED|Second Intervention Period||3
1106533|NCT01138826|2677900|P2|STARTED|Second Intervention Period||2
1106534|NCT01138826|2677901|P1|STARTED|Second Intervention Period||2
1106535|NCT01138826|2677896|P6|NOT COMPLETED|Washout Period I (of 16 Days)||0
1106536|NCT01138826|2677897|P5|NOT COMPLETED|Washout Period I (of 16 Days)||1
1106537|NCT01138826|2677898|P4|NOT COMPLETED|Washout Period I (of 16 Days)||0
1106538|NCT01138826|2677899|P3|NOT COMPLETED|Washout Period I (of 16 Days)||0
1106539|NCT01138826|2677900|P2|NOT COMPLETED|Washout Period I (of 16 Days)||1
1106540|NCT01138826|2677901|P1|NOT COMPLETED|Washout Period I (of 16 Days)||1
1106541|NCT01138826|2677896|P6|COMPLETED|Washout Period I (of 16 Days)||3
1106542|NCT01138826|2677897|P5|COMPLETED|Washout Period I (of 16 Days)||2
1106543|NCT01138826|2677898|P4|COMPLETED|Washout Period I (of 16 Days)||3
1106544|NCT01138826|2677899|P3|COMPLETED|Washout Period I (of 16 Days)||3
1106545|NCT01138826|2677900|P2|COMPLETED|Washout Period I (of 16 Days)||2
1106546|NCT01138826|2677901|P1|COMPLETED|Washout Period I (of 16 Days)||2
1106547|NCT01138826|2677896|P6|STARTED|Washout Period I (of 16 Days)||3
1106548|NCT01138826|2677897|P5|STARTED|Washout Period I (of 16 Days)||3
1106549|NCT01138826|2677898|P4|STARTED|Washout Period I (of 16 Days)||3
1106550|NCT01138826|2677899|P3|STARTED|Washout Period I (of 16 Days)||3
1106551|NCT01138826|2677900|P2|STARTED|Washout Period I (of 16 Days)||3
1106552|NCT01138826|2677901|P1|STARTED|Washout Period I (of 16 Days)||3
1106553|NCT01138826|2677896|P6|NOT COMPLETED|First Intervention Period||0
1106554|NCT01138826|2677897|P5|NOT COMPLETED|First Intervention Period||0
1106555|NCT01138826|2677898|P4|NOT COMPLETED|First Intervention Period||0
1106556|NCT01138826|2677899|P3|NOT COMPLETED|First Intervention Period||0
1106557|NCT01138826|2677900|P2|NOT COMPLETED|First Intervention Period||0
1106558|NCT01138826|2677901|P1|NOT COMPLETED|First Intervention Period||0
1106559|NCT01138826|2677896|P6|COMPLETED|First Intervention Period||3
1106560|NCT01138826|2677897|P5|COMPLETED|First Intervention Period||3
1106561|NCT01138826|2677898|P4|COMPLETED|First Intervention Period||3
1106562|NCT01138826|2677899|P3|COMPLETED|First Intervention Period||3
1106563|NCT01138826|2677900|P2|COMPLETED|First Intervention Period||3
1106564|NCT01138826|2677901|P1|COMPLETED|First Intervention Period||3
1106565|NCT01138826|2677896|P6|STARTED|First Intervention Period||3
1106566|NCT01138826|2677897|P5|STARTED|First Intervention Period||3
1106567|NCT01138826|2677898|P4|STARTED|First Intervention Period||3
1106568|NCT01138826|2677899|P3|STARTED|First Intervention Period||3
1106569|NCT01138826|2677900|P2|STARTED|First Intervention Period||3
1106570|NCT01138826|2677901|P1|STARTED|First Intervention Period||3
1106571|NCT01138969|2677923|P2|NOT COMPLETED|Overall Study||0
1106572|NCT01138969|2677924|P1|NOT COMPLETED|Overall Study||0
1106573|NCT01138969|2677923|P2|COMPLETED|Overall Study||82
1106574|NCT01138969|2677924|P1|COMPLETED|Overall Study||83
1106575|NCT01138969|2677923|P2|STARTED|Overall Study||82
1106576|NCT01138969|2677924|P1|STARTED|Overall Study||83
1106577|NCT01138995|2677934|P2|NOT COMPLETED|Overall Study||25
1106578|NCT01138995|2677935|P1|NOT COMPLETED|Overall Study||10
1106579|NCT01138995|2677934|P2|COMPLETED|Overall Study||74
1106580|NCT01138995|2677935|P1|COMPLETED|Overall Study||88
1106581|NCT01138995|2677934|P2|STARTED|Overall Study||99
1106582|NCT01138995|2677935|P1|STARTED|Overall Study||98
1106583|NCT01139008|2677945|P1|NOT COMPLETED|Overall Study||6
1106584|NCT01139008|2677945|P1|COMPLETED|Overall Study||74
1106585|NCT01139008|2677945|P1|STARTED|Overall Study||80
1106586|NCT01139021|2677960|P6|NOT COMPLETED|Overall Study||0
1106587|NCT01139021|2677961|P5|NOT COMPLETED|Overall Study||9
1106588|NCT01139021|2677962|P4|NOT COMPLETED|Overall Study||1
1106589|NCT01139021|2677963|P3|NOT COMPLETED|Overall Study||0
1106590|NCT01139021|2677964|P2|NOT COMPLETED|Overall Study||0
1106591|NCT01139021|2677965|P1|NOT COMPLETED|Overall Study||1
1106592|NCT01139021|2677960|P6|COMPLETED|Overall Study||1
1106593|NCT01139021|2677961|P5|COMPLETED|Overall Study||107
1106594|NCT01139021|2677962|P4|COMPLETED|Overall Study||18
1106595|NCT01139021|2677963|P3|COMPLETED|Overall Study||67
1106596|NCT01139021|2677964|P2|COMPLETED|Overall Study||153
1106597|NCT01139021|2677965|P1|COMPLETED|Overall Study||151
1106598|NCT01139021|2677960|P6|STARTED|Overall Study||1
1106599|NCT01139021|2677961|P5|STARTED|Overall Study||116
1106600|NCT01139021|2677962|P4|STARTED|Overall Study||19
1106601|NCT01139021|2677963|P3|STARTED|Overall Study||67
1106602|NCT01139021|2677964|P2|STARTED|Overall Study||153
1106603|NCT01139021|2677965|P1|STARTED|Overall Study||152
1106604|NCT01139047|2678001|P1|NOT COMPLETED|Overall Study||1
1106605|NCT01139047|2678001|P1|COMPLETED|Overall Study||76
1106606|NCT01139047|2678001|P1|STARTED|Overall Study||77
1106607|NCT01139125|2678010|P1|NOT COMPLETED|Overall Study||1
1106608|NCT01139125|2678010|P1|COMPLETED|Overall Study||2
1106609|NCT01139125|2678010|P1|STARTED|Overall Study||3
1106610|NCT01139164|2678017|P3|NOT COMPLETED|Overall Study||0
1106611|NCT01139164|2678018|P2|NOT COMPLETED|Overall Study||2
1106612|NCT01139164|2678019|P1|NOT COMPLETED|Overall Study||0
1106613|NCT01139164|2678017|P3|COMPLETED|Overall Study||7
1106614|NCT01139164|2678018|P2|COMPLETED|Overall Study||65
1106615|NCT01139164|2678019|P1|COMPLETED|Overall Study||4
1106616|NCT01139164|2678017|P3|STARTED|Overall Study||7
1106617|NCT01139164|2678018|P2|STARTED|Overall Study||67
1106618|NCT01139164|2678019|P1|STARTED|Overall Study||4
1106619|NCT01139190|2678035|P2|NOT COMPLETED|Overall Study||1
1106620|NCT01139190|2678036|P1|NOT COMPLETED|Overall Study||0
1106621|NCT01139190|2678035|P2|COMPLETED|Overall Study||38
1106622|NCT01139190|2678036|P1|COMPLETED|Overall Study||38
1106623|NCT01139190|2678035|P2|STARTED|Overall Study||39
1106624|NCT01139190|2678036|P1|STARTED|Overall Study||38
1106625|NCT01139294|2678044|P2|NOT COMPLETED|Overall Study||0
1106626|NCT01139294|2678045|P1|NOT COMPLETED|Overall Study||0
1106627|NCT01139294|2678044|P2|COMPLETED|Overall Study||0
1106628|NCT01139294|2678045|P1|COMPLETED|Overall Study||0
1106629|NCT01139294|2678044|P2|STARTED|Overall Study||0
1106630|NCT01139294|2678045|P1|STARTED|Overall Study||0
1106631|NCT01139411|2678055|P2|NOT COMPLETED|Overall Study||4
1106632|NCT01139411|2678056|P1|NOT COMPLETED|Overall Study||2
1106633|NCT01139411|2678055|P2|COMPLETED|Overall Study||19
1106634|NCT01139411|2678056|P1|COMPLETED|Overall Study||24
1106635|NCT01139411|2678055|P2|STARTED|Overall Study||23
1106636|NCT01139411|2678056|P1|STARTED|Overall Study||26
1106637|NCT01139450|2678077|P3|NOT COMPLETED|Overall Study||38
1106638|NCT01139450|2678078|P2|NOT COMPLETED|Overall Study||25
1106639|NCT01139450|2678079|P1|NOT COMPLETED|Overall Study||27
1106640|NCT01139450|2678077|P3|COMPLETED|Overall Study||262
1106641|NCT01139450|2678078|P2|COMPLETED|Overall Study||272
1106642|NCT01139450|2678079|P1|COMPLETED|Overall Study||275
1106643|NCT01139450|2678077|P3|STARTED|Overall Study||300
1106644|NCT01139450|2678078|P2|STARTED|Overall Study||297
1106645|NCT01139450|2678079|P1|STARTED|Overall Study||302
1106646|NCT01139515|2678087|P4|NOT COMPLETED|Fourth Intervention Period||0
1106647|NCT01139515|2678088|P3|NOT COMPLETED|Fourth Intervention Period||0
1106648|NCT01139515|2678089|P2|NOT COMPLETED|Fourth Intervention Period||0
1106649|NCT01139515|2678090|P1|NOT COMPLETED|Fourth Intervention Period||0
1106650|NCT01139515|2678087|P4|COMPLETED|Fourth Intervention Period||4
1106651|NCT01139515|2678088|P3|COMPLETED|Fourth Intervention Period||4
1106652|NCT01139515|2678089|P2|COMPLETED|Fourth Intervention Period||4
1106653|NCT01139515|2678090|P1|COMPLETED|Fourth Intervention Period||4
1106654|NCT01139515|2678087|P4|STARTED|Fourth Intervention Period||4
1106655|NCT01139515|2678088|P3|STARTED|Fourth Intervention Period||4
1106656|NCT01139515|2678089|P2|STARTED|Fourth Intervention Period||4
1106657|NCT01139515|2678090|P1|STARTED|Fourth Intervention Period||4
1106658|NCT01139515|2678087|P4|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
1106659|NCT01139515|2678088|P3|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
1106660|NCT01139515|2678089|P2|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
1106661|NCT01139515|2678090|P1|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
1106662|NCT01139515|2678087|P4|COMPLETED|Washout Period 3 (46 Hrs)||4
1106663|NCT01139515|2678088|P3|COMPLETED|Washout Period 3 (46 Hrs)||4
1106664|NCT01139515|2678089|P2|COMPLETED|Washout Period 3 (46 Hrs)||4
1106665|NCT01139515|2678090|P1|COMPLETED|Washout Period 3 (46 Hrs)||4
1106666|NCT01139515|2678087|P4|STARTED|Washout Period 3 (46 Hrs)||4
1106667|NCT01139515|2678088|P3|STARTED|Washout Period 3 (46 Hrs)||4
1106668|NCT01139515|2678089|P2|STARTED|Washout Period 3 (46 Hrs)||4
1106669|NCT01139515|2678090|P1|STARTED|Washout Period 3 (46 Hrs)||4
1106670|NCT01139515|2678087|P4|NOT COMPLETED|Third Intervention Period||0
1106671|NCT01139515|2678088|P3|NOT COMPLETED|Third Intervention Period||0
1106672|NCT01139515|2678089|P2|NOT COMPLETED|Third Intervention Period||0
1106673|NCT01139515|2678090|P1|NOT COMPLETED|Third Intervention Period||0
1106674|NCT01139515|2678087|P4|COMPLETED|Third Intervention Period||4
1106675|NCT01139515|2678088|P3|COMPLETED|Third Intervention Period||4
1106676|NCT01139515|2678089|P2|COMPLETED|Third Intervention Period||4
1106677|NCT01139515|2678090|P1|COMPLETED|Third Intervention Period||4
1106678|NCT01139515|2678087|P4|STARTED|Third Intervention Period||4
1106679|NCT01139515|2678088|P3|STARTED|Third Intervention Period||4
1106680|NCT01139515|2678089|P2|STARTED|Third Intervention Period||4
1106681|NCT01139515|2678090|P1|STARTED|Third Intervention Period||4
1106682|NCT01139515|2678087|P4|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
1106683|NCT01139515|2678088|P3|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
1106684|NCT01139515|2678089|P2|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
1106685|NCT01139515|2678090|P1|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
1106686|NCT01139515|2678087|P4|COMPLETED|Washout Period 2 (46 Hrs)||4
1106687|NCT01139515|2678088|P3|COMPLETED|Washout Period 2 (46 Hrs)||4
1106688|NCT01139515|2678089|P2|COMPLETED|Washout Period 2 (46 Hrs)||4
1106689|NCT01139515|2678090|P1|COMPLETED|Washout Period 2 (46 Hrs)||4
1106690|NCT01139515|2678087|P4|STARTED|Washout Period 2 (46 Hrs)||4
1106691|NCT01139515|2678088|P3|STARTED|Washout Period 2 (46 Hrs)||4
1106692|NCT01139515|2678089|P2|STARTED|Washout Period 2 (46 Hrs)||4
1106693|NCT01139515|2678090|P1|STARTED|Washout Period 2 (46 Hrs)||4
1106694|NCT01139515|2678087|P4|NOT COMPLETED|Second Intervention Period||0
1106695|NCT01139515|2678088|P3|NOT COMPLETED|Second Intervention Period||0
1106696|NCT01139515|2678089|P2|NOT COMPLETED|Second Intervention Period||0
1106697|NCT01139515|2678090|P1|NOT COMPLETED|Second Intervention Period||0
1106698|NCT01139515|2678087|P4|COMPLETED|Second Intervention Period||4
1106699|NCT01139515|2678088|P3|COMPLETED|Second Intervention Period||4
1106700|NCT01139515|2678089|P2|COMPLETED|Second Intervention Period||4
1106701|NCT01139515|2678090|P1|COMPLETED|Second Intervention Period||4
1106702|NCT01139515|2678087|P4|STARTED|Second Intervention Period||4
1106703|NCT01139515|2678088|P3|STARTED|Second Intervention Period||4
1106704|NCT01139515|2678089|P2|STARTED|Second Intervention Period||4
1106705|NCT01139515|2678090|P1|STARTED|Second Intervention Period||4
1106706|NCT01139515|2678087|P4|NOT COMPLETED|Washout Period I (46hrs)||0
1106707|NCT01139515|2678088|P3|NOT COMPLETED|Washout Period I (46hrs)||0
1106708|NCT01139515|2678089|P2|NOT COMPLETED|Washout Period I (46hrs)||0
1106709|NCT01139515|2678090|P1|NOT COMPLETED|Washout Period I (46hrs)||0
1106710|NCT01139515|2678087|P4|COMPLETED|Washout Period I (46hrs)||4
1106711|NCT01139515|2678088|P3|COMPLETED|Washout Period I (46hrs)||4
1106712|NCT01139515|2678089|P2|COMPLETED|Washout Period I (46hrs)||4
1106713|NCT01139515|2678090|P1|COMPLETED|Washout Period I (46hrs)||4
1106714|NCT01139515|2678087|P4|STARTED|Washout Period I (46hrs)||4
1106715|NCT01139515|2678088|P3|STARTED|Washout Period I (46hrs)||4
1106716|NCT01139515|2678089|P2|STARTED|Washout Period I (46hrs)||4
1106717|NCT01139515|2678090|P1|STARTED|Washout Period I (46hrs)||4
1106718|NCT01139515|2678087|P4|NOT COMPLETED|First Intervention Period||0
1106719|NCT01139515|2678088|P3|NOT COMPLETED|First Intervention Period||0
1106720|NCT01139515|2678089|P2|NOT COMPLETED|First Intervention Period||0
1106721|NCT01139515|2678090|P1|NOT COMPLETED|First Intervention Period||0
1106722|NCT01139515|2678087|P4|COMPLETED|First Intervention Period||4
1106723|NCT01139515|2678088|P3|COMPLETED|First Intervention Period||4
1106724|NCT01139515|2678089|P2|COMPLETED|First Intervention Period||4
1106725|NCT01139515|2678090|P1|COMPLETED|First Intervention Period||4
1106726|NCT01139515|2678087|P4|STARTED|First Intervention Period||4
1106727|NCT01139515|2678088|P3|STARTED|First Intervention Period||4
1106728|NCT01139515|2678089|P2|STARTED|First Intervention Period||4
1106729|NCT01139515|2678090|P1|STARTED|First Intervention Period||4
1106730|NCT01139580|2678118|P2|NOT COMPLETED|Overall Study||18
1106731|NCT01139580|2678119|P1|NOT COMPLETED|Overall Study||23
1106732|NCT01139580|2678118|P2|COMPLETED|Overall Study||164
1106733|NCT01139580|2678119|P1|COMPLETED|Overall Study||158
1106734|NCT01139580|2678118|P2|STARTED|Overall Study||182
1106735|NCT01139580|2678119|P1|STARTED|Overall Study||181
1106736|NCT01139658|2678137|P2|NOT COMPLETED|Overall Study||113
1106737|NCT01139658|2678138|P1|NOT COMPLETED|Overall Study||56
1106738|NCT01139658|2678137|P2|COMPLETED|Overall Study||816
1106739|NCT01139658|2678138|P1|COMPLETED|Overall Study||691
1106740|NCT01139658|2678137|P2|STARTED|Overall Study||929
1106741|NCT01139658|2678138|P1|STARTED|Overall Study||747
1106742|NCT01139762|2678176|P3|NOT COMPLETED|Double-Blind Randomized Active Treatment||64
1106743|NCT01139762|2678177|P2|NOT COMPLETED|Double-Blind Randomized Active Treatment||40
1106744|NCT01139762|2678178|P1|NOT COMPLETED|Double-Blind Randomized Active Treatment||0
1106745|NCT01139762|2678176|P3|COMPLETED|Double-Blind Randomized Active Treatment||286
1106746|NCT01139762|2678177|P2|COMPLETED|Double-Blind Randomized Active Treatment||306
1106747|NCT01139762|2678178|P1|COMPLETED|Double-Blind Randomized Active Treatment||0
1106748|NCT01139762|2678176|P3|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||350
1106749|NCT01139762|2678177|P2|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||345
1106750|NCT01139762|2678178|P1|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||0
1106751|NCT01139762|2678176|P3|STARTED|Double-Blind Randomized Active Treatment||350
1106752|NCT01139762|2678177|P2|STARTED|Double-Blind Randomized Active Treatment||346
1106753|NCT01139762|2678178|P1|STARTED|Double-Blind Randomized Active Treatment||0
1106754|NCT01139762|2678176|P3|NOT COMPLETED|Washout and Placebo Lead-In Period||0
1106755|NCT01139762|2678177|P2|NOT COMPLETED|Washout and Placebo Lead-In Period||0
1106756|NCT01139762|2678178|P1|NOT COMPLETED|Washout and Placebo Lead-In Period||374
1106757|NCT01139762|2678176|P3|COMPLETED|Washout and Placebo Lead-In Period||0
1106758|NCT01139762|2678177|P2|COMPLETED|Washout and Placebo Lead-In Period||0
1106759|NCT01139762|2678178|P1|COMPLETED|Washout and Placebo Lead-In Period||696
1106760|NCT01139762|2678176|P3|STARTED|Washout and Placebo Lead-In Period||0
1106761|NCT01139762|2678177|P2|STARTED|Washout and Placebo Lead-In Period||0
1106762|NCT01139762|2678178|P1|STARTED|Washout and Placebo Lead-In Period||1070
1106763|NCT01139814|2678211|P1|NOT COMPLETED|Overall Study||0
1106764|NCT01139814|2678211|P1|COMPLETED|Overall Study||181
1106765|NCT01139814|2678211|P1|STARTED|Overall Study||181
1106766|NCT01139879|2678216|P1|NOT COMPLETED|Overall Study||0
1106767|NCT01139879|2678216|P1|COMPLETED|Overall Study||10
1106768|NCT01139879|2678216|P1|STARTED|Overall Study||10
1106769|NCT01139996|2678224|P2|NOT COMPLETED|Overall Study||0
1106770|NCT01139996|2678225|P1|NOT COMPLETED|Overall Study||0
1106771|NCT01139996|2678224|P2|COMPLETED|Overall Study||11
1106772|NCT01139996|2678225|P1|COMPLETED|Overall Study||11
1106773|NCT01139996|2678224|P2|STARTED|Overall Study||11
1106774|NCT01139996|2678225|P1|STARTED|Overall Study||11
1106775|NCT01140048|2678231|P1|NOT COMPLETED|Overall Study||45
1106776|NCT01140048|2678231|P1|COMPLETED|Overall Study||298
1106777|NCT01140048|2678231|P1|STARTED|Overall Study||343
1106778|NCT01140061|2678247|P10|NOT COMPLETED|Extension||1
1106779|NCT01140061|2678248|P9|NOT COMPLETED|Extension||0
1106780|NCT01140061|2678249|P8|NOT COMPLETED|Extension||0
1106781|NCT01140061|2678250|P7|NOT COMPLETED|Extension||0
1106782|NCT01140061|2678251|P6|NOT COMPLETED|Extension||0
1106783|NCT01140061|2678252|P5|NOT COMPLETED|Extension||0
1106784|NCT01140061|2678253|P4|NOT COMPLETED|Extension||0
1106785|NCT01140061|2678254|P3|NOT COMPLETED|Extension||0
1106786|NCT01140061|2678255|P2|NOT COMPLETED|Extension||0
1106787|NCT01140061|2678256|P1|NOT COMPLETED|Extension||0
1106788|NCT01140061|2678247|P10|COMPLETED|Extension||1
1106789|NCT01140061|2678248|P9|COMPLETED|Extension||7
1106790|NCT01140061|2678249|P8|COMPLETED|Extension||0
1106791|NCT01140061|2678250|P7|COMPLETED|Extension||0
1106792|NCT01140061|2678251|P6|COMPLETED|Extension||0
1106793|NCT01140061|2678252|P5|COMPLETED|Extension||0
1106794|NCT01140061|2678253|P4|COMPLETED|Extension||0
1106795|NCT01140061|2678254|P3|COMPLETED|Extension||0
1106796|NCT01140061|2678255|P2|COMPLETED|Extension||0
1106797|NCT01140061|2678256|P1|COMPLETED|Extension||0
1106798|NCT01140061|2678247|P10|STARTED|Extension||2
1106799|NCT01140061|2678248|P9|STARTED|Extension||7
1106800|NCT01140061|2678249|P8|STARTED|Extension||0
1106801|NCT01140061|2678250|P7|STARTED|Extension||0
1106802|NCT01140061|2678251|P6|STARTED|Extension||0
1106803|NCT01140061|2678252|P5|STARTED|Extension||0
1106804|NCT01140061|2678253|P4|STARTED|Extension||0
1106805|NCT01140061|2678254|P3|STARTED|Extension||0
1106806|NCT01140061|2678255|P2|STARTED|Extension||0
1106807|NCT01140061|2678256|P1|STARTED|Extension||0
1106808|NCT01140061|2678247|P10|NOT COMPLETED|Part III||0
1106809|NCT01140061|2678248|P9|NOT COMPLETED|Part III||0
1106810|NCT01140061|2678249|P8|NOT COMPLETED|Part III||0
1106811|NCT01140061|2678250|P7|NOT COMPLETED|Part III||0
1106812|NCT01140061|2678251|P6|NOT COMPLETED|Part III||0
1106813|NCT01140061|2678252|P5|NOT COMPLETED|Part III||0
1106814|NCT01140061|2678253|P4|NOT COMPLETED|Part III||0
1106815|NCT01140061|2678254|P3|NOT COMPLETED|Part III||0
1106816|NCT01140061|2678255|P2|NOT COMPLETED|Part III||0
1106817|NCT01140061|2678256|P1|NOT COMPLETED|Part III||0
1106818|NCT01140061|2678247|P10|COMPLETED|Part III||2
1106819|NCT01140061|2678248|P9|COMPLETED|Part III||7
1106820|NCT01140061|2678249|P8|COMPLETED|Part III||0
1106821|NCT01140061|2678250|P7|COMPLETED|Part III||0
1106822|NCT01140061|2678251|P6|COMPLETED|Part III||0
1106823|NCT01140061|2678252|P5|COMPLETED|Part III||0
1106824|NCT01140061|2678253|P4|COMPLETED|Part III||0
1106825|NCT01140061|2678254|P3|COMPLETED|Part III||0
1106826|NCT01140061|2678255|P2|COMPLETED|Part III||0
1106827|NCT01140061|2678256|P1|COMPLETED|Part III||0
1106828|NCT01140061|2678247|P10|STARTED|Part III|Includes 1 replacement participant|2
1106829|NCT01140061|2678248|P9|STARTED|Part III||7
1106830|NCT01140061|2678249|P8|STARTED|Part III||0
1106831|NCT01140061|2678250|P7|STARTED|Part III||0
1106832|NCT01140061|2678251|P6|STARTED|Part III||0
1106833|NCT01140061|2678252|P5|STARTED|Part III||0
1106834|NCT01140061|2678253|P4|STARTED|Part III||0
1106835|NCT01140061|2678254|P3|STARTED|Part III||0
1106836|NCT01140061|2678255|P2|STARTED|Part III||0
1106837|NCT01140061|2678256|P1|STARTED|Part III||0
1106838|NCT01140061|2678247|P10|NOT COMPLETED|Part II||0
1106839|NCT01140061|2678248|P9|NOT COMPLETED|Part II||0
1106840|NCT01140061|2678249|P8|NOT COMPLETED|Part II||0
1106841|NCT01140061|2678250|P7|NOT COMPLETED|Part II||0
1106842|NCT01140061|2678251|P6|NOT COMPLETED|Part II||0
1106843|NCT01140061|2678252|P5|NOT COMPLETED|Part II||0
1106844|NCT01140061|2678253|P4|NOT COMPLETED|Part II||0
1106845|NCT01140061|2678254|P3|NOT COMPLETED|Part II||0
1106846|NCT01140061|2678255|P2|NOT COMPLETED|Part II||0
1106847|NCT01140061|2678256|P1|NOT COMPLETED|Part II||0
1106848|NCT01140061|2678247|P10|COMPLETED|Part II||0
1106849|NCT01140061|2678248|P9|COMPLETED|Part II||0
1106850|NCT01140061|2678249|P8|COMPLETED|Part II||2
1106851|NCT01140061|2678250|P7|COMPLETED|Part II||6
1106852|NCT01140061|2678251|P6|COMPLETED|Part II||2
1106853|NCT01140061|2678252|P5|COMPLETED|Part II||6
1106854|NCT01140061|2678253|P4|COMPLETED|Part II||2
1106855|NCT01140061|2678254|P3|COMPLETED|Part II||6
1106856|NCT01140061|2678255|P2|COMPLETED|Part II||0
1106857|NCT01140061|2678256|P1|COMPLETED|Part II||0
1106858|NCT01140061|2678247|P10|STARTED|Part II||0
1106859|NCT01140061|2678248|P9|STARTED|Part II||0
1106860|NCT01140061|2678249|P8|STARTED|Part II||2
1106861|NCT01140061|2678250|P7|STARTED|Part II||6
1106862|NCT01140061|2678251|P6|STARTED|Part II||2
1106863|NCT01140061|2678252|P5|STARTED|Part II||6
1106864|NCT01140061|2678253|P4|STARTED|Part II||2
1106865|NCT01140061|2678254|P3|STARTED|Part II||6
1106866|NCT01140061|2678255|P2|STARTED|Part II||0
1106867|NCT01140061|2678256|P1|STARTED|Part II||0
1106868|NCT01140061|2678247|P10|NOT COMPLETED|Part I||0
1106869|NCT01140061|2678248|P9|NOT COMPLETED|Part I||0
1106870|NCT01140061|2678249|P8|NOT COMPLETED|Part I||0
1106871|NCT01140061|2678250|P7|NOT COMPLETED|Part I||0
1106872|NCT01140061|2678251|P6|NOT COMPLETED|Part I||0
1106873|NCT01140061|2678252|P5|NOT COMPLETED|Part I||0
1106874|NCT01140061|2678253|P4|NOT COMPLETED|Part I||0
1106875|NCT01140061|2678254|P3|NOT COMPLETED|Part I||0
1106876|NCT01140061|2678255|P2|NOT COMPLETED|Part I||0
1106877|NCT01140061|2678256|P1|NOT COMPLETED|Part I||1
1106878|NCT01140061|2678247|P10|COMPLETED|Part I||0
1106879|NCT01140061|2678248|P9|COMPLETED|Part I||0
1106880|NCT01140061|2678249|P8|COMPLETED|Part I||0
1106881|NCT01140061|2678250|P7|COMPLETED|Part I||0
1106882|NCT01140061|2678251|P6|COMPLETED|Part I||0
1106883|NCT01140061|2678252|P5|COMPLETED|Part I||0
1106884|NCT01140061|2678253|P4|COMPLETED|Part I||0
1106885|NCT01140061|2678254|P3|COMPLETED|Part I||0
1106886|NCT01140061|2678255|P2|COMPLETED|Part I||2
1106887|NCT01140061|2678256|P1|COMPLETED|Part I||6
1106888|NCT01140061|2678247|P10|STARTED|Part I||0
1106889|NCT01140061|2678248|P9|STARTED|Part I||0
1106890|NCT01140061|2678249|P8|STARTED|Part I||0
1106891|NCT01140061|2678250|P7|STARTED|Part I||0
1106892|NCT01140061|2678251|P6|STARTED|Part I||0
1106893|NCT01140061|2678252|P5|STARTED|Part I||0
1106894|NCT01140061|2678253|P4|STARTED|Part I||0
1106895|NCT01140061|2678254|P3|STARTED|Part I||0
1106896|NCT01140061|2678255|P2|STARTED|Part I||2
1106897|NCT01140061|2678256|P1|STARTED|Part I|Includes 1 replacement participant|7
1106898|NCT01140191|2678283|P1|NOT COMPLETED|Overall Study||0
1106899|NCT01140191|2678283|P1|COMPLETED|Overall Study||1
1106900|NCT01140191|2678283|P1|STARTED|Overall Study||1
1106901|NCT01140295|2678294|P2|NOT COMPLETED|Overall Study||2
1106902|NCT01140295|2678295|P1|NOT COMPLETED|Overall Study||1
1106903|NCT01140295|2678294|P2|COMPLETED|Overall Study||14
1106904|NCT01140295|2678295|P1|COMPLETED|Overall Study||16
1106905|NCT01140295|2678294|P2|STARTED|Overall Study||16
1106906|NCT01140295|2678295|P1|STARTED|Overall Study||17
1106907|NCT01140347|2678305|P2|NOT COMPLETED|Overall Study||14
1106908|NCT01140347|2678306|P1|NOT COMPLETED|Overall Study||18
1106909|NCT01140347|2678305|P2|COMPLETED|Overall Study||268
1106910|NCT01140347|2678306|P1|COMPLETED|Overall Study||265
1106911|NCT01140347|2678305|P2|Received at Least 1 Dose of Study Drug|Overall Study||276
1106912|NCT01140347|2678306|P1|Received at Least 1 Dose of Study Drug|Overall Study||277
1106913|NCT01140347|2678305|P2|STARTED|Overall Study||282
1106914|NCT01140347|2678306|P1|STARTED|Overall Study||283
1106915|NCT01140360|2678329|P1|NOT COMPLETED|Overall Study||6
1106916|NCT01140360|2678329|P1|COMPLETED|Overall Study||15
1106917|NCT01140360|2678329|P1|STARTED|Overall Study||21
1106918|NCT01140477|2678335|P2|NOT COMPLETED|Overall Study||6
1106919|NCT01140477|2678336|P1|NOT COMPLETED|Overall Study||8
1106920|NCT01140477|2678335|P2|COMPLETED|Overall Study||70
1106921|NCT01140477|2678336|P1|COMPLETED|Overall Study||145
1106922|NCT01140477|2678335|P2|STARTED|Overall Study||76
1106923|NCT01140477|2678336|P1|STARTED|Overall Study||153
1106924|NCT01140503|2678345|P1|NOT COMPLETED|Overall Study||1
1106925|NCT01140503|2678345|P1|COMPLETED|Overall Study||4
1106926|NCT01140503|2678345|P1|STARTED|Overall Study||5
1106927|NCT01140646|2678351|P1|NOT COMPLETED|Overall Study||9
1106928|NCT01140646|2678351|P1|COMPLETED|Overall Study||34
1106929|NCT01140646|2678351|P1|STARTED|Overall Study||43
1106930|NCT01140815|2678357|P2|NOT COMPLETED|Overall Study||0
1106931|NCT01140815|2678358|P1|NOT COMPLETED|Overall Study||0
1106932|NCT01140815|2678357|P2|COMPLETED|Overall Study||25
1106933|NCT01140815|2678358|P1|COMPLETED|Overall Study||25
1106934|NCT01140815|2678357|P2|STARTED|Overall Study||25
1106935|NCT01140815|2678358|P1|STARTED|Overall Study||25
1106936|NCT01140867|2678388|P1|NOT COMPLETED|Overall Study||33
1106937|NCT01140867|2678388|P1|COMPLETED|Overall Study||88
1106938|NCT01140867|2678388|P1|STARTED|Overall Study||121
1106939|NCT01140880|2678397|P2|NOT COMPLETED|Overall Study||44
1106940|NCT01140880|2678398|P1|NOT COMPLETED|Overall Study||14
1106941|NCT01140880|2678397|P2|COMPLETED|Overall Study||56
1106942|NCT01140880|2678398|P1|COMPLETED|Overall Study||56
1106943|NCT01140880|2678397|P2|STARTED|Overall Study||100
1106944|NCT01140880|2678398|P1|STARTED|Overall Study||70
1106945|NCT01140906|2678414|P4|NOT COMPLETED|Overall Study||16
1106946|NCT01140906|2678415|P3|NOT COMPLETED|Overall Study||26
1106947|NCT01140906|2678416|P2|NOT COMPLETED|Overall Study||34
1106948|NCT01140906|2678417|P1|NOT COMPLETED|Overall Study||25
1106949|NCT01140906|2678414|P4|COMPLETED|Overall Study||131
1106950|NCT01140906|2678415|P3|COMPLETED|Overall Study||125
1106951|NCT01140906|2678416|P2|COMPLETED|Overall Study||117
1106952|NCT01140906|2678417|P1|COMPLETED|Overall Study||133
1106953|NCT01140906|2678414|P4|STARTED|Overall Study||147
1106954|NCT01140906|2678415|P3|STARTED|Overall Study||151
1106955|NCT01140906|2678416|P2|STARTED|Overall Study||151
1106956|NCT01140906|2678417|P1|STARTED|Overall Study||158
1106957|NCT01141205|2678457|P2|NOT COMPLETED|Overall Study||2
1106958|NCT01141205|2678458|P1|NOT COMPLETED|Overall Study||3
1106959|NCT01141205|2678457|P2|COMPLETED|Overall Study||3
1106960|NCT01141205|2678458|P1|COMPLETED|Overall Study||15
1106961|NCT01141205|2678457|P2|STARTED|Overall Study||5
1106962|NCT01141205|2678458|P1|STARTED|Overall Study||18
1106963|NCT01141283|2678470|P1|NOT COMPLETED|Overall Study||88
1106964|NCT01141283|2678470|P1|COMPLETED|Overall Study||202
1106965|NCT01141283|2678470|P1|STARTED|Overall Study||290
1106966|NCT01134549|2678479|P5|NOT COMPLETED|Overall Study||0
1106967|NCT01134549|2678480|P4|NOT COMPLETED|Overall Study||0
1106968|NCT01134549|2678481|P3|NOT COMPLETED|Overall Study||0
1106969|NCT01134549|2678482|P2|NOT COMPLETED|Overall Study||0
1106970|NCT01134549|2678483|P1|NOT COMPLETED|Overall Study||0
1106971|NCT01134549|2678479|P5|COMPLETED|Overall Study||6
1106972|NCT01134549|2678480|P4|COMPLETED|Overall Study||6
1106973|NCT01134549|2678481|P3|COMPLETED|Overall Study||6
1106974|NCT01134549|2678482|P2|COMPLETED|Overall Study||6
1106975|NCT01134549|2678483|P1|COMPLETED|Overall Study||8
1106976|NCT01134549|2678479|P5|STARTED|Overall Study||6
1106977|NCT01134549|2678480|P4|STARTED|Overall Study||6
1106978|NCT01134549|2678481|P3|STARTED|Overall Study||6
1106979|NCT01134549|2678482|P2|STARTED|Overall Study||6
1106980|NCT01134549|2678483|P1|STARTED|Overall Study||8
1106981|NCT01134614|2678569|P2|NOT COMPLETED|Overall Study||122
1106982|NCT01134614|2678570|P1|NOT COMPLETED|Overall Study||123
1106983|NCT01134614|2678569|P2|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicities|0
1106984|NCT01134614|2678570|P1|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicity.|0
1106985|NCT01134614|2678569|P2|Treated and Toxicity Assessed|Overall Study||120
1106986|NCT01134614|2678570|P1|Treated and Toxicity Assessed|Overall Study||118
1106987|NCT01134614|2678569|P2|Treated|Overall Study||121
1106988|NCT01134614|2678570|P1|Treated|Overall Study||119
1106989|NCT01134614|2678569|P2|STARTED|Overall Study||122
1106990|NCT01134614|2678570|P1|STARTED|Overall Study||123
1106991|NCT01134627|2678582|P2|NOT COMPLETED|Overall Study||67
1106992|NCT01134627|2678583|P1|NOT COMPLETED|Overall Study||69
1106993|NCT01134627|2678582|P2|COMPLETED|Overall Study||88
1106994|NCT01134627|2678583|P1|COMPLETED|Overall Study||80
1106995|NCT01134627|2678582|P2|STARTED|Overall Study|Number of participants treated.|155
1106996|NCT01134627|2678583|P1|STARTED|Overall Study|Number of participants treated.|149
1106997|NCT01134705|2678613|P2|NOT COMPLETED|Overall Study||22
1106998|NCT01134705|2678614|P1|NOT COMPLETED|Overall Study||15
1106999|NCT01134705|2678613|P2|COMPLETED|Overall Study||216
1107000|NCT01134705|2678614|P1|COMPLETED|Overall Study||221
1107001|NCT01134705|2678613|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|234
1107002|NCT01134705|2678614|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|232
1107003|NCT01134705|2678613|P2|STARTED|Overall Study||238
1107004|NCT01134705|2678614|P1|STARTED|Overall Study||236
1107005|NCT01134731|2678627|P3|NOT COMPLETED|Overall Study||8
1107006|NCT01134731|2678628|P2|NOT COMPLETED|Overall Study||11
1107007|NCT01134731|2678629|P1|NOT COMPLETED|Overall Study||13
1107008|NCT01134731|2678627|P3|COMPLETED|Overall Study||2
1107009|NCT01134731|2678628|P2|COMPLETED|Overall Study||10
1107010|NCT01134731|2678629|P1|COMPLETED|Overall Study||10
1107011|NCT01134731|2678627|P3|STARTED|Overall Study||10
1107012|NCT01134731|2678628|P2|STARTED|Overall Study||21
1107013|NCT01134731|2678629|P1|STARTED|Overall Study||23
1107014|NCT01134783|2678642|P2|NOT COMPLETED|Overall Study||37
1107015|NCT01134783|2678643|P1|NOT COMPLETED|Overall Study||36
1107016|NCT01134783|2678642|P2|COMPLETED|Overall Study||180
1107017|NCT01134783|2678643|P1|COMPLETED|Overall Study||188
1107018|NCT01134783|2678642|P2|STARTED|Overall Study||217
1107019|NCT01134783|2678643|P1|STARTED|Overall Study||224
1107020|NCT01134887|2678663|P4|NOT COMPLETED|Overall Study||0
1107021|NCT01134887|2678664|P3|NOT COMPLETED|Overall Study||0
1107022|NCT01134887|2678665|P2|NOT COMPLETED|Overall Study||4
1107023|NCT01134887|2678666|P1|NOT COMPLETED|Overall Study||0
1107024|NCT01134887|2678663|P4|COMPLETED|Overall Study||5
1107025|NCT01134887|2678664|P3|COMPLETED|Overall Study||5
1107026|NCT01134887|2678665|P2|COMPLETED|Overall Study|Four patients in the Veteran-Control arm did not have two clinic visits videotaped and left study.|7
1107027|NCT01134887|2678666|P1|COMPLETED|Overall Study||9
1107028|NCT01134887|2678663|P4|STARTED|Overall Study||5
1107029|NCT01134887|2678664|P3|STARTED|Overall Study||5
1107030|NCT01134887|2678665|P2|STARTED|Overall Study||11
1107031|NCT01134887|2678666|P1|STARTED|Overall Study||9
1107032|NCT01134900|2678676|P2|NOT COMPLETED|Overall Study||0
1107033|NCT01134900|2678677|P1|NOT COMPLETED|Overall Study||0
1107034|NCT01134900|2678676|P2|COMPLETED|Overall Study||196
1107035|NCT01134900|2678677|P1|COMPLETED|Overall Study||200
1107036|NCT01134900|2678676|P2|STARTED|Overall Study||196
1107037|NCT01134900|2678677|P1|STARTED|Overall Study||200
1107038|NCT01134939|2678693|P8|NOT COMPLETED|Overall Study||0
1107039|NCT01134939|2678694|P7|NOT COMPLETED|Overall Study||9
1107040|NCT01134939|2678695|P6|NOT COMPLETED|Overall Study||9
1107041|NCT01134939|2678696|P5|NOT COMPLETED|Overall Study||10
1107042|NCT01134939|2678697|P4|NOT COMPLETED|Overall Study||14
1107043|NCT01134939|2678698|P3|NOT COMPLETED|Overall Study||10
1107044|NCT01134939|2678699|P2|NOT COMPLETED|Overall Study||18
1107045|NCT01134939|2678700|P1|NOT COMPLETED|Overall Study||17
1107046|NCT01134939|2678693|P8|COMPLETED|Overall Study||1
1107047|NCT01134939|2678694|P7|COMPLETED|Overall Study||10
1107048|NCT01134939|2678695|P6|COMPLETED|Overall Study||5
1107049|NCT01134939|2678696|P5|COMPLETED|Overall Study||23
1107050|NCT01134939|2678697|P4|COMPLETED|Overall Study||32
1107051|NCT01134939|2678698|P3|COMPLETED|Overall Study||41
1107052|NCT01134939|2678699|P2|COMPLETED|Overall Study||24
1107053|NCT01134939|2678700|P1|COMPLETED|Overall Study||42
1107054|NCT01134939|2678693|P8|STARTED|Overall Study||1
1107055|NCT01134939|2678694|P7|STARTED|Overall Study||19
1107056|NCT01134939|2678695|P6|STARTED|Overall Study||14
1107057|NCT01134939|2678696|P5|STARTED|Overall Study||33
1107058|NCT01134939|2678697|P4|STARTED|Overall Study||46
1107059|NCT01134939|2678698|P3|STARTED|Overall Study||51
1107060|NCT01134939|2678699|P2|STARTED|Overall Study||42
1107061|NCT01134939|2678700|P1|STARTED|Overall Study||59
1107062|NCT01134952|2678810|P1|NOT COMPLETED|Overall Study||0
1107063|NCT01134952|2678810|P1|COMPLETED|Overall Study||11
1107064|NCT01134952|2678810|P1|STARTED|Overall Study||11
1107065|NCT01135017|2678826|P2|NOT COMPLETED|Overall Study||12
1107066|NCT01135017|2678827|P1|NOT COMPLETED|Overall Study||6
1107067|NCT01135017|2678826|P2|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|45
1107068|NCT01135017|2678827|P1|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|49
1107069|NCT01135017|2678826|P2|Evaluable for Efficacy|Overall Study|Two participants did not have interrogation of the pacemaker after randomization|55
1107070|NCT01135017|2678827|P1|Evaluable for Efficacy|Overall Study||55
1107071|NCT01135017|2678826|P2|Treated|Overall Study||57
1107072|NCT01135017|2678827|P1|Treated|Overall Study||55
1107073|NCT01135017|2678826|P2|STARTED|Overall Study||57
1107074|NCT01135017|2678827|P1|STARTED|Overall Study||55
1107075|NCT01135069|2678846|P3|NOT COMPLETED|Overall Study||10
1107076|NCT01135069|2678847|P2|NOT COMPLETED|Overall Study||32
1107077|NCT01135069|2678848|P1|NOT COMPLETED|Overall Study||36
1107078|NCT01135069|2678846|P3|COMPLETED|Overall Study||56
1107079|NCT01135069|2678847|P2|COMPLETED|Overall Study||177
1107080|NCT01135069|2678848|P1|COMPLETED|Overall Study||169
1107081|NCT01135069|2678846|P3|STARTED|Overall Study||66
1107082|NCT01135069|2678847|P2|STARTED|Overall Study||209
1107083|NCT01135069|2678848|P1|STARTED|Overall Study||205
1107084|NCT01135134|2678858|P2|NOT COMPLETED|Overall Study||1
1107085|NCT01135134|2678859|P1|NOT COMPLETED|Overall Study||2
1107086|NCT01135134|2678858|P2|COMPLETED|Overall Study||112
1107087|NCT01135134|2678859|P1|COMPLETED|Overall Study||218
1107088|NCT01135134|2678858|P2|STARTED|Overall Study||113
1107089|NCT01135134|2678859|P1|STARTED|Overall Study||220
1107090|NCT01135186|2678867|P1|NOT COMPLETED|Overall Study||0
1107091|NCT01135186|2678867|P1|COMPLETED|Overall Study||9
1107092|NCT01135186|2678867|P1|STARTED|Overall Study||9
1107093|NCT01135368|2678874|P1|NOT COMPLETED|Overall Study||251
1107094|NCT01135368|2678874|P1|COMPLETED|Overall Study||255
1107095|NCT01135368|2678874|P1|STARTED|Overall Study||506
1107096|NCT01135381|2678994|P4|NOT COMPLETED|Overall Study||1
1107097|NCT01135381|2678995|P3|NOT COMPLETED|Overall Study||4
1107098|NCT01135381|2678996|P2|NOT COMPLETED|Overall Study||7
1107099|NCT01135381|2678997|P1|NOT COMPLETED|Overall Study||21
1107100|NCT01135381|2678994|P4|COMPLETED|Overall Study||67
1107101|NCT01135381|2678995|P3|COMPLETED|Overall Study||65
1107102|NCT01135381|2678996|P2|COMPLETED|Overall Study||178
1107103|NCT01135381|2678997|P1|COMPLETED|Overall Study||168
1107104|NCT01135381|2678994|P4|STARTED|Overall Study||68
1107105|NCT01135381|2678995|P3|STARTED|Overall Study||69
1107106|NCT01135381|2678996|P2|STARTED|Overall Study||185
1107107|NCT01135381|2678997|P1|STARTED|Overall Study||189
1107108|NCT01135420|2679017|P2|NOT COMPLETED|Overall Study||32
1107109|NCT01135420|2679018|P1|NOT COMPLETED|Overall Study||44
1107110|NCT01135420|2679017|P2|COMPLETED|Overall Study||175
1107111|NCT01135420|2679018|P1|COMPLETED|Overall Study||155
1107112|NCT01135420|2679017|P2|STARTED|Overall Study||207
1107113|NCT01135420|2679018|P1|STARTED|Overall Study||199
1107114|NCT01135498|2679024|P1|NOT COMPLETED|Overall Study||90
1107115|NCT01135498|2679024|P1|COMPLETED|Overall Study||0
1107116|NCT01135498|2679024|P1|STARTED|Overall Study||90
1107117|NCT01135511|2679042|P9|NOT COMPLETED|Overall Study||1
1107118|NCT01135511|2679043|P8|NOT COMPLETED|Overall Study||1
1107119|NCT01135511|2679044|P7|NOT COMPLETED|Overall Study||1
1107120|NCT01135511|2679045|P6|NOT COMPLETED|Overall Study||1
1107121|NCT01135511|2679046|P5|NOT COMPLETED|Overall Study||1
1107122|NCT01135511|2679047|P4|NOT COMPLETED|Overall Study||3
1107123|NCT01135511|2679048|P3|NOT COMPLETED|Overall Study||8
1107124|NCT01135511|2679049|P2|NOT COMPLETED|Overall Study||3
1107125|NCT01135511|2679050|P1|NOT COMPLETED|Overall Study||0
1107126|NCT01135511|2679042|P9|COMPLETED|Overall Study||20
1107127|NCT01135511|2679043|P8|COMPLETED|Overall Study||20
1107128|NCT01135511|2679044|P7|COMPLETED|Overall Study||18
1107129|NCT01135511|2679045|P6|COMPLETED|Overall Study||20
1107130|NCT01135511|2679046|P5|COMPLETED|Overall Study||38
1107131|NCT01135511|2679047|P4|COMPLETED|Overall Study||37
1107132|NCT01135511|2679048|P3|COMPLETED|Overall Study||33
1107133|NCT01135511|2679049|P2|COMPLETED|Overall Study||39
1107134|NCT01135511|2679050|P1|COMPLETED|Overall Study||41
1107135|NCT01135511|2679042|P9|STARTED|Overall Study||21
1107136|NCT01135511|2679043|P8|STARTED|Overall Study||21
1107137|NCT01135511|2679044|P7|STARTED|Overall Study||19
1107138|NCT01135511|2679045|P6|STARTED|Overall Study||21
1107139|NCT01135511|2679046|P5|STARTED|Overall Study||39
1107140|NCT01135511|2679047|P4|STARTED|Overall Study||40
1107141|NCT01135511|2679048|P3|STARTED|Overall Study||41
1107142|NCT01135511|2679049|P2|STARTED|Overall Study||42
1107143|NCT01135511|2679050|P1|STARTED|Overall Study||41
1107144|NCT01135524|2679332|P1|NOT COMPLETED|Overall Study||196
1107145|NCT01135524|2679332|P1|COMPLETED|Overall Study||0
1107146|NCT01135524|2679332|P1|STARTED|Overall Study||196
1107147|NCT01135914|2679339|P3|NOT COMPLETED|Overall Study||22
1107148|NCT01135914|2679340|P2|NOT COMPLETED|Overall Study||5
1107149|NCT01135914|2679341|P1|NOT COMPLETED|Overall Study||4
1107150|NCT01135914|2679339|P3|COMPLETED|Overall Study||59
1107151|NCT01135914|2679340|P2|COMPLETED|Overall Study||75
1107152|NCT01135914|2679341|P1|COMPLETED|Overall Study||74
1107153|NCT01135914|2679339|P3|Safety Population|Overall Study||74
1107154|NCT01135914|2679340|P2|Safety Population|Overall Study||75
1107155|NCT01135914|2679341|P1|Safety Population|Overall Study||73
1107156|NCT01135914|2679339|P3|Intent to Treat (ITT) Population|Overall Study||72
1107157|NCT01135914|2679340|P2|Intent to Treat (ITT) Population|Overall Study||75
1107158|NCT01135914|2679341|P1|Intent to Treat (ITT) Population|Overall Study||73
1107159|NCT01135914|2679339|P3|STARTED|Overall Study||81
1107160|NCT01135914|2679340|P2|STARTED|Overall Study||80
1107161|NCT01135914|2679341|P1|STARTED|Overall Study||78
1107162|NCT01141374|2679373|P3|NOT COMPLETED|Overall Study||0
1107163|NCT01141374|2679374|P2|NOT COMPLETED|Overall Study||0
1107164|NCT01141374|2679375|P1|NOT COMPLETED|Overall Study||0
1107165|NCT01141374|2679373|P3|COMPLETED|Overall Study||22
1107166|NCT01141374|2679374|P2|COMPLETED|Overall Study||27
1107167|NCT01141374|2679375|P1|COMPLETED|Overall Study||26
1107168|NCT01141374|2679373|P3|STARTED|Overall Study||22
1107169|NCT01141374|2679374|P2|STARTED|Overall Study||27
1107170|NCT01141374|2679375|P1|STARTED|Overall Study||26
1107171|NCT01141491|2679388|P2|NOT COMPLETED|Overall Study||47
1107172|NCT01141491|2679389|P1|NOT COMPLETED|Overall Study||48
1107173|NCT01141491|2679388|P2|COMPLETED|Overall Study||21
1107174|NCT01141491|2679389|P1|COMPLETED|Overall Study||20
1107175|NCT01141491|2679388|P2|STARTED|Overall Study||68
1107176|NCT01141491|2679389|P1|STARTED|Overall Study||68
1107177|NCT01141569|2679395|P1|NOT COMPLETED|Overall Study||0
1107178|NCT01141569|2679395|P1|COMPLETED|Overall Study||12
1107179|NCT01141569|2679395|P1|STARTED|Overall Study||12
1107180|NCT01141595|2679404|P1|NOT COMPLETED|Overall Study||2
1107181|NCT01141595|2679404|P1|COMPLETED|Overall Study||8
1107182|NCT01141595|2679404|P1|STARTED|Overall Study||10
1107183|NCT01141647|2679408|P1|NOT COMPLETED|Overall Study||46
1107184|NCT01141647|2679408|P1|COMPLETED|Overall Study||167
1107185|NCT01141647|2679408|P1|STARTED|Overall Study||213
1107186|NCT01142193|2679423|P2|NOT COMPLETED|Overall Study||11
1107187|NCT01142193|2679424|P1|NOT COMPLETED|Overall Study||21
1107188|NCT01142193|2679423|P2|COMPLETED|Overall Study||114
1107189|NCT01142193|2679424|P1|COMPLETED|Overall Study||103
1107190|NCT01142193|2679423|P2|STARTED|Overall Study||125
1107191|NCT01142193|2679424|P1|STARTED|Overall Study||124
1107195|NCT01142323|2679454|P1|NOT COMPLETED|Overall Study||0
1107196|NCT01142323|2679454|P1|COMPLETED|Overall Study||8
1107197|NCT01142323|2679454|P1|STARTED|Overall Study||8
1107198|NCT01142336|2679461|P2|NOT COMPLETED|Overall Study||2
1107199|NCT01142336|2679462|P1|NOT COMPLETED|Overall Study||1
1107200|NCT01142336|2679461|P2|COMPLETED|Overall Study||21
1107201|NCT01142336|2679462|P1|COMPLETED|Overall Study||25
1107202|NCT01142336|2679461|P2|STARTED|Overall Study||23
1107203|NCT01142336|2679462|P1|STARTED|Overall Study||26
1107204|NCT01142388|2679474|P2|NOT COMPLETED|Overall Study||47
1107205|NCT01142388|2679475|P1|NOT COMPLETED|Overall Study||47
1107206|NCT01142388|2679474|P2|COMPLETED|Overall Study||0
1107207|NCT01142388|2679475|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|0
1107208|NCT01142388|2679474|P2|Treated|Overall Study||44
1107209|NCT01142388|2679475|P1|Treated|Overall Study||40
1107210|NCT01142388|2679474|P2|Eligible|Overall Study||44
1107211|NCT01142388|2679475|P1|Eligible|Overall Study||43
1107212|NCT01142388|2679474|P2|STARTED|Overall Study||47
1107213|NCT01142388|2679475|P1|STARTED|Overall Study||47
1107214|NCT01142466|2679487|P2|NOT COMPLETED|Overall Study||2
1107215|NCT01142466|2679488|P1|NOT COMPLETED|Overall Study||3
1107216|NCT01142466|2679487|P2|COMPLETED|Overall Study||13
1107217|NCT01142466|2679488|P1|COMPLETED|Overall Study||12
1107218|NCT01142466|2679487|P2|STARTED|Overall Study||15
1107219|NCT01142466|2679488|P1|STARTED|Overall Study||15
1107220|NCT01142596|2679508|P2|NOT COMPLETED|Overall Study||86
1107221|NCT01142596|2679509|P1|NOT COMPLETED|Overall Study||29
1107222|NCT01142596|2679508|P2|COMPLETED|Overall Study||71
1107223|NCT01142596|2679509|P1|COMPLETED|Overall Study||15
1107224|NCT01142596|2679508|P2|STARTED|Overall Study||157
1107225|NCT01142596|2679509|P1|STARTED|Overall Study||44
1107226|NCT01142661|2679559|P1|NOT COMPLETED|Overall Study||4
1107227|NCT01142661|2679559|P1|COMPLETED|Overall Study||5
1107228|NCT01142661|2679559|P1|STARTED|Overall Study||9
1107229|NCT01142726|2679567|P3|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||3
1107230|NCT01142726|2679568|P2|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||2
1107231|NCT01142726|2679569|P1|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||1
1107232|NCT01142726|2679567|P3|COMPLETED|Re-Exposure Phase: Months 24 up to 30||40
1107233|NCT01142726|2679568|P2|COMPLETED|Re-Exposure Phase: Months 24 up to 30||46
1107234|NCT01142726|2679569|P1|COMPLETED|Re-Exposure Phase: Months 24 up to 30||54
1107235|NCT01142726|2679567|P3|STARTED|Re-Exposure Phase: Months 24 up to 30||43
1107236|NCT01142726|2679568|P2|STARTED|Re-Exposure Phase: Months 24 up to 30||48
1107237|NCT01142726|2679569|P1|STARTED|Re-Exposure Phase: Months 24 up to 30||55
1107238|NCT01142726|2679567|P3|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||58
1107239|NCT01142726|2679568|P2|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||56
1107240|NCT01142726|2679569|P1|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||70
1107241|NCT01142726|2679567|P3|COMPLETED|Withdrawal Phase: Months 12 up to 24||17
1107242|NCT01142726|2679568|P2|COMPLETED|Withdrawal Phase: Months 12 up to 24||10
1107243|NCT01142726|2679569|P1|COMPLETED|Withdrawal Phase: Months 12 up to 24||14
1107244|NCT01142726|2679567|P3|STARTED|Withdrawal Phase: Months 12 up to 24||75
1107245|NCT01142726|2679568|P2|STARTED|Withdrawal Phase: Months 12 up to 24||66
1107246|NCT01142726|2679569|P1|STARTED|Withdrawal Phase: Months 12 up to 24||84
1107247|NCT01142726|2679567|P3|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||20
1107248|NCT01142726|2679568|P2|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||25
1107249|NCT01142726|2679569|P1|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||16
1107250|NCT01142726|2679567|P3|COMPLETED|Treatment Phase: Day 1 Through Month 12||96
1107251|NCT01142726|2679568|P2|COMPLETED|Treatment Phase: Day 1 Through Month 12||91
1107252|NCT01142726|2679569|P1|COMPLETED|Treatment Phase: Day 1 Through Month 12||103
1107253|NCT01142726|2679567|P3|STARTED|Treatment Phase: Day 1 Through Month 12||116
1107254|NCT01142726|2679568|P2|STARTED|Treatment Phase: Day 1 Through Month 12||116
1107255|NCT01142726|2679569|P1|STARTED|Treatment Phase: Day 1 Through Month 12||119
1107256|NCT01142908|2679634|P2|NOT COMPLETED|Overall Study||22
1107257|NCT01142908|2679635|P1|NOT COMPLETED|Overall Study||32
1107258|NCT01142908|2679634|P2|COMPLETED|Overall Study||191
1107259|NCT01142908|2679635|P1|COMPLETED|Overall Study||183
1107260|NCT01142908|2679634|P2|6 Month f/u|Overall Study||196
1107261|NCT01142908|2679635|P1|6 Month f/u|Overall Study||188
1107262|NCT01142908|2679634|P2|STARTED|Overall Study||213
1107263|NCT01142908|2679635|P1|STARTED|Overall Study||215
1107264|NCT01143038|2679681|P1|NOT COMPLETED|Overall Study||16
1107265|NCT01143038|2679681|P1|COMPLETED|Overall Study|Defined as completion of romiplostim treatment|59
1107266|NCT01143038|2679681|P1|STARTED|Overall Study||75
1107267|NCT01143051|2679695|P6|NOT COMPLETED|Visit 3||0
1107268|NCT01143051|2679696|P5|NOT COMPLETED|Visit 3||0
1107269|NCT01143051|2679697|P4|NOT COMPLETED|Visit 3||0
1107270|NCT01143051|2679698|P3|NOT COMPLETED|Visit 3||0
1107271|NCT01143051|2679699|P2|NOT COMPLETED|Visit 3||0
1107272|NCT01143051|2679700|P1|NOT COMPLETED|Visit 3||0
1107273|NCT01143051|2679695|P6|COMPLETED|Visit 3||3
1107274|NCT01143051|2679696|P5|COMPLETED|Visit 3||4
1107275|NCT01143051|2679697|P4|COMPLETED|Visit 3||4
1107276|NCT01143051|2679698|P3|COMPLETED|Visit 3||3
1107277|NCT01143051|2679699|P2|COMPLETED|Visit 3||4
1107278|NCT01143051|2679700|P1|COMPLETED|Visit 3||4
1107279|NCT01143051|2679695|P6|STARTED|Visit 3||3
1107280|NCT01143051|2679696|P5|STARTED|Visit 3||4
1107281|NCT01143051|2679697|P4|STARTED|Visit 3||4
1107282|NCT01143051|2679698|P3|STARTED|Visit 3||3
1107283|NCT01143051|2679699|P2|STARTED|Visit 3||4
1107284|NCT01143051|2679700|P1|STARTED|Visit 3||4
1107285|NCT01143051|2679695|P6|NOT COMPLETED|3-14 Day Washout||1
1107286|NCT01143051|2679696|P5|NOT COMPLETED|3-14 Day Washout||0
1107287|NCT01143051|2679697|P4|NOT COMPLETED|3-14 Day Washout||0
1107288|NCT01143051|2679698|P3|NOT COMPLETED|3-14 Day Washout||0
1107289|NCT01143051|2679699|P2|NOT COMPLETED|3-14 Day Washout||0
1107290|NCT01143051|2679700|P1|NOT COMPLETED|3-14 Day Washout||0
1107291|NCT01143051|2679695|P6|COMPLETED|3-14 Day Washout||3
1107292|NCT01143051|2679696|P5|COMPLETED|3-14 Day Washout||4
1107293|NCT01143051|2679697|P4|COMPLETED|3-14 Day Washout||4
1107294|NCT01143051|2679698|P3|COMPLETED|3-14 Day Washout||3
1107295|NCT01143051|2679699|P2|COMPLETED|3-14 Day Washout||4
1107296|NCT01143051|2679700|P1|COMPLETED|3-14 Day Washout||4
1107297|NCT01143051|2679695|P6|STARTED|3-14 Day Washout||4
1107298|NCT01143051|2679696|P5|STARTED|3-14 Day Washout||4
1107299|NCT01143051|2679697|P4|STARTED|3-14 Day Washout||4
1107300|NCT01143051|2679698|P3|STARTED|3-14 Day Washout||3
1107301|NCT01143051|2679699|P2|STARTED|3-14 Day Washout||4
1107302|NCT01143051|2679700|P1|STARTED|3-14 Day Washout||4
1107303|NCT01143051|2679695|P6|NOT COMPLETED|Visit 2||0
1107304|NCT01143051|2679696|P5|NOT COMPLETED|Visit 2||0
1107305|NCT01143051|2679697|P4|NOT COMPLETED|Visit 2||0
1107306|NCT01143051|2679698|P3|NOT COMPLETED|Visit 2||0
1107307|NCT01143051|2679699|P2|NOT COMPLETED|Visit 2||0
1107308|NCT01143051|2679700|P1|NOT COMPLETED|Visit 2||0
1107309|NCT01143051|2679695|P6|COMPLETED|Visit 2||4
1107310|NCT01143051|2679696|P5|COMPLETED|Visit 2||4
1107311|NCT01143051|2679697|P4|COMPLETED|Visit 2||4
1107312|NCT01143051|2679698|P3|COMPLETED|Visit 2||3
1107313|NCT01143051|2679699|P2|COMPLETED|Visit 2||4
1107314|NCT01143051|2679700|P1|COMPLETED|Visit 2||4
1107315|NCT01143051|2679695|P6|STARTED|Visit 2||4
1107316|NCT01143051|2679696|P5|STARTED|Visit 2||4
1107317|NCT01143051|2679697|P4|STARTED|Visit 2||4
1107318|NCT01143051|2679698|P3|STARTED|Visit 2||3
1107319|NCT01143051|2679699|P2|STARTED|Visit 2||4
1107320|NCT01143051|2679700|P1|STARTED|Visit 2||4
1107321|NCT01143051|2679695|P6|NOT COMPLETED|3-14 Day Washout||0
1107322|NCT01143051|2679696|P5|NOT COMPLETED|3-14 Day Washout||0
1107323|NCT01143051|2679697|P4|NOT COMPLETED|3-14 Day Washout||0
1107324|NCT01143051|2679698|P3|NOT COMPLETED|3-14 Day Washout||1
1107325|NCT01143051|2679699|P2|NOT COMPLETED|3-14 Day Washout||0
1107326|NCT01143051|2679700|P1|NOT COMPLETED|3-14 Day Washout||0
1107327|NCT01143051|2679695|P6|COMPLETED|3-14 Day Washout||4
1107328|NCT01143051|2679696|P5|COMPLETED|3-14 Day Washout||4
1107329|NCT01143051|2679697|P4|COMPLETED|3-14 Day Washout||4
1107330|NCT01143051|2679698|P3|COMPLETED|3-14 Day Washout||3
1107331|NCT01143051|2679699|P2|COMPLETED|3-14 Day Washout||4
1107332|NCT01143051|2679700|P1|COMPLETED|3-14 Day Washout||4
1107333|NCT01143051|2679695|P6|STARTED|3-14 Day Washout||4
1107334|NCT01143051|2679696|P5|STARTED|3-14 Day Washout||4
1107335|NCT01143051|2679697|P4|STARTED|3-14 Day Washout||4
1107336|NCT01143051|2679698|P3|STARTED|3-14 Day Washout||4
1107337|NCT01143051|2679699|P2|STARTED|3-14 Day Washout||4
1107338|NCT01143051|2679700|P1|STARTED|3-14 Day Washout||4
1107339|NCT01143051|2679695|P6|NOT COMPLETED|Visit 1||0
1107340|NCT01143051|2679696|P5|NOT COMPLETED|Visit 1||0
1107341|NCT01143051|2679697|P4|NOT COMPLETED|Visit 1||0
1107342|NCT01143051|2679698|P3|NOT COMPLETED|Visit 1||0
1107343|NCT01143051|2679699|P2|NOT COMPLETED|Visit 1||0
1107344|NCT01143051|2679700|P1|NOT COMPLETED|Visit 1||0
1107345|NCT01143051|2679695|P6|COMPLETED|Visit 1||4
1107346|NCT01143051|2679696|P5|COMPLETED|Visit 1||4
1107347|NCT01143051|2679697|P4|COMPLETED|Visit 1||4
1107348|NCT01143051|2679698|P3|COMPLETED|Visit 1||4
1107349|NCT01143051|2679699|P2|COMPLETED|Visit 1||4
1107350|NCT01143051|2679700|P1|COMPLETED|Visit 1||4
1107351|NCT01143051|2679695|P6|STARTED|Visit 1||4
1107352|NCT01143051|2679696|P5|STARTED|Visit 1||4
1107353|NCT01143051|2679697|P4|STARTED|Visit 1||4
1107354|NCT01143051|2679698|P3|STARTED|Visit 1||4
1107355|NCT01143051|2679699|P2|STARTED|Visit 1||4
1107356|NCT01143051|2679700|P1|STARTED|Visit 1||4
1107357|NCT01143077|2679726|P3|NOT COMPLETED|Overall Study||15
1107358|NCT01143077|2679727|P2|NOT COMPLETED|Overall Study||15
1107359|NCT01143077|2679728|P1|NOT COMPLETED|Overall Study||16
1107360|NCT01143077|2679726|P3|COMPLETED|Overall Study||67
1107361|NCT01143077|2679727|P2|COMPLETED|Overall Study||73
1107362|NCT01143077|2679728|P1|COMPLETED|Overall Study||58
1107363|NCT01143077|2679726|P3|STARTED|Overall Study||82
1107364|NCT01143077|2679727|P2|STARTED|Overall Study||88
1107365|NCT01143077|2679728|P1|STARTED|Overall Study||74
1107366|NCT01143090|2679739|P1|NOT COMPLETED|Overall Study||51
1107367|NCT01143090|2679739|P1|COMPLETED|Overall Study||98
1107368|NCT01143090|2679739|P1|STARTED|Overall Study||149
1107369|NCT01143142|2679745|P2|NOT COMPLETED|Overall Study||0
1107370|NCT01143142|2679746|P1|NOT COMPLETED|Overall Study||0
1107371|NCT01143142|2679745|P2|COMPLETED|Overall Study||34
1107372|NCT01143142|2679746|P1|COMPLETED|Overall Study||36
1107373|NCT01143142|2679745|P2|STARTED|Overall Study||34
1107374|NCT01143142|2679746|P1|STARTED|Overall Study||36
1107375|NCT01143207|2679754|P1|NOT COMPLETED|Overall Study||2
1107376|NCT01143207|2679754|P1|COMPLETED|Overall Study||24
1107377|NCT01143207|2679754|P1|STARTED|Overall Study||26
1107378|NCT01143259|2679765|P2|NOT COMPLETED|Overall Study||20
1107379|NCT01143259|2679766|P1|NOT COMPLETED|Overall Study||23
1107380|NCT01143259|2679765|P2|COMPLETED|Overall Study||118
1107381|NCT01143259|2679766|P1|COMPLETED|Overall Study||113
1107382|NCT01143259|2679765|P2|STARTED|Overall Study||138
1107383|NCT01143259|2679766|P1|STARTED|Overall Study||136
1107384|NCT01143272|2679776|P2|NOT COMPLETED|Overall Study||0
1107385|NCT01143272|2679777|P1|NOT COMPLETED|Overall Study||0
1107386|NCT01143272|2679776|P2|COMPLETED|Overall Study||231
1107387|NCT01143272|2679777|P1|COMPLETED|Overall Study||246
1107388|NCT01143272|2679776|P2|STARTED|Overall Study||231
1107389|NCT01143272|2679777|P1|STARTED|Overall Study||246
1107390|NCT01143324|2679795|P1|NOT COMPLETED|Overall Study||19
1107391|NCT01143324|2679795|P1|COMPLETED|Overall Study||233
1107392|NCT01143324|2679795|P1|STARTED|Overall Study||252
1107393|NCT01143337|2679813|P3|NOT COMPLETED|Overall Study||12
1107394|NCT01143337|2679814|P2|NOT COMPLETED|Overall Study||11
1107395|NCT01143337|2679815|P1|NOT COMPLETED|Overall Study||10
1107396|NCT01143337|2679813|P3|COMPLETED|Overall Study|Frequency of this arm AE was higher than assumption before study initiation.|1
1107397|NCT01143337|2679814|P2|COMPLETED|Overall Study||39
1107398|NCT01143337|2679815|P1|COMPLETED|Overall Study||39
1107399|NCT01143337|2679813|P3|STARTED|Overall Study||13
1107400|NCT01143337|2679814|P2|STARTED|Overall Study||50
1107401|NCT01143337|2679815|P1|STARTED|Overall Study||49
1107402|NCT01143402|2679832|P3|NOT COMPLETED|Overall Study||1
1107403|NCT01143402|2679833|P2|NOT COMPLETED|Overall Study||1
1107404|NCT01143402|2679834|P1|NOT COMPLETED|Overall Study||1
1107405|NCT01143402|2679832|P3|COMPLETED|Overall Study||18
1107406|NCT01143402|2679833|P2|COMPLETED|Overall Study||49
1107407|NCT01143402|2679834|P1|COMPLETED|Overall Study||50
1107408|NCT01143402|2679832|P3|STARTED|Overall Study||19
1107409|NCT01143402|2679833|P2|STARTED|Overall Study||50
1107410|NCT01143402|2679834|P1|STARTED|Overall Study||51
1107411|NCT01143610|2679845|P2|NOT COMPLETED|Overall Study||0
1107412|NCT01143610|2679846|P1|NOT COMPLETED|Overall Study||0
1107413|NCT01143610|2679845|P2|COMPLETED|Overall Study||8
1107414|NCT01143610|2679846|P1|COMPLETED|Overall Study||7
1107415|NCT01143610|2679845|P2|STARTED|Overall Study||8
1107416|NCT01143610|2679846|P1|STARTED|Overall Study||7
1107417|NCT01143636|2679857|P4|NOT COMPLETED|Overall Study||0
1107418|NCT01143636|2679858|P3|NOT COMPLETED|Overall Study||0
1107419|NCT01143636|2679859|P2|NOT COMPLETED|Overall Study||1
1107420|NCT01143636|2679860|P1|NOT COMPLETED|Overall Study||1
1107421|NCT01143636|2679857|P4|COMPLETED|Overall Study||7
1107422|NCT01143636|2679858|P3|COMPLETED|Overall Study||8
1107423|NCT01143636|2679859|P2|COMPLETED|Overall Study||4
1107424|NCT01143636|2679860|P1|COMPLETED|Overall Study||5
1107425|NCT01143636|2679857|P4|STARTED|Overall Study||7
1107426|NCT01143636|2679858|P3|STARTED|Overall Study||8
1107427|NCT01143636|2679859|P2|STARTED|Overall Study||5
1107428|NCT01143636|2679860|P1|STARTED|Overall Study||6
1107429|NCT01143649|2679893|P6|NOT COMPLETED|Overall Study||2
1107430|NCT01143649|2679894|P5|NOT COMPLETED|Overall Study||1
1107431|NCT01143649|2679895|P4|NOT COMPLETED|Overall Study||0
1107432|NCT01143649|2679896|P3|NOT COMPLETED|Overall Study||0
1107433|NCT01143649|2679897|P2|NOT COMPLETED|Overall Study||0
1107434|NCT01143649|2679898|P1|NOT COMPLETED|Overall Study||0
1107435|NCT01143649|2679893|P6|COMPLETED|Overall Study||3
1107436|NCT01143649|2679894|P5|COMPLETED|Overall Study||4
1107437|NCT01143649|2679895|P4|COMPLETED|Overall Study||10
1107438|NCT01143649|2679896|P3|COMPLETED|Overall Study||10
1107439|NCT01143649|2679897|P2|COMPLETED|Overall Study||7
1107440|NCT01143649|2679898|P1|COMPLETED|Overall Study||7
1107441|NCT01143649|2679893|P6|STARTED|Overall Study||5
1107442|NCT01143649|2679894|P5|STARTED|Overall Study||5
1107443|NCT01143649|2679895|P4|STARTED|Overall Study||10
1107444|NCT01143649|2679896|P3|STARTED|Overall Study||10
1107445|NCT01143649|2679897|P2|STARTED|Overall Study||7
1107446|NCT01143649|2679898|P1|STARTED|Overall Study||7
1107447|NCT01143688|2679912|P1|NOT COMPLETED|Overall Study||0
1107448|NCT01143688|2679912|P1|COMPLETED|Overall Study||39
1107449|NCT01143688|2679912|P1|STARTED|Overall Study||39
1107450|NCT01143701|2679928|P2|NOT COMPLETED|Overall Study||32
1107451|NCT01143701|2679929|P1|NOT COMPLETED|Overall Study||23
1107452|NCT01143701|2679928|P2|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|287
1107453|NCT01143701|2679929|P1|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|235
1107454|NCT01143701|2679928|P2|STARTED|Overall Study||319
1107455|NCT01143701|2679929|P1|STARTED|Overall Study||258
1107456|NCT01143714|2679939|P2|NOT COMPLETED|Overall Study||3
1107457|NCT01143714|2679940|P1|NOT COMPLETED|Overall Study||7
1107458|NCT01143714|2679939|P2|COMPLETED|Overall Study||25
1107459|NCT01143714|2679940|P1|COMPLETED|Overall Study||22
1107460|NCT01143714|2679939|P2|STARTED|Overall Study||28
1107461|NCT01143714|2679940|P1|STARTED|Overall Study||29
1107462|NCT01143727|2679950|P2|NOT COMPLETED|Overall Study||0
1107463|NCT01143727|2679951|P1|NOT COMPLETED|Overall Study||0
1107464|NCT01143727|2679950|P2|COMPLETED|Overall Study||8
1107465|NCT01143727|2679951|P1|COMPLETED|Overall Study||9
1107466|NCT01143727|2679950|P2|STARTED|Overall Study||8
1107467|NCT01143727|2679951|P1|STARTED|Overall Study||9
1107468|NCT01143766|2679961|P2|NOT COMPLETED|Overall Study||0
1107469|NCT01143766|2679962|P1|NOT COMPLETED|Overall Study||0
1107470|NCT01143766|2679961|P2|COMPLETED|Overall Study||31
1107471|NCT01143766|2679962|P1|COMPLETED|Overall Study||25
1107472|NCT01143766|2679961|P2|STARTED|Overall Study||31
1107473|NCT01143766|2679962|P1|STARTED|Overall Study||25
1107474|NCT01143792|2679971|P3|NOT COMPLETED|Overall Study||0
1107475|NCT01143792|2679972|P2|NOT COMPLETED|Overall Study||0
1107476|NCT01143792|2679973|P1|NOT COMPLETED|Overall Study||0
1107477|NCT01143792|2679971|P3|COMPLETED|Overall Study||91
1107478|NCT01143792|2679972|P2|COMPLETED|Overall Study||86
1107479|NCT01143792|2679973|P1|COMPLETED|Overall Study||93
1107480|NCT01143792|2679971|P3|STARTED|Overall Study||91
1107481|NCT01143792|2679972|P2|STARTED|Overall Study||86
1107482|NCT01143792|2679973|P1|STARTED|Overall Study||93
1107483|NCT01143818|2680005|P1|NOT COMPLETED|Overall Study||250
1107484|NCT01143818|2680005|P1|COMPLETED|Overall Study||799
1107485|NCT01143818|2680005|P1|STARTED|Overall Study|A total of 1053 participants were enrolled but only 1049 received study drug.|1049
1107486|NCT01143883|2680014|P2|NOT COMPLETED|Overall Study||0
1107487|NCT01143883|2680015|P1|NOT COMPLETED|Overall Study||0
1107488|NCT01143883|2680014|P2|COMPLETED|Overall Study||55
1107489|NCT01143883|2680015|P1|COMPLETED|Overall Study||55
1107490|NCT01143883|2680014|P2|STARTED|Overall Study||55
1107491|NCT01143883|2680015|P1|STARTED|Overall Study||55
1107492|NCT01143896|2680023|P2|NOT COMPLETED|Overall Study||25
1107493|NCT01143896|2680024|P1|NOT COMPLETED|Overall Study||42
1107494|NCT01143896|2680023|P2|COMPLETED|Overall Study||128
1107495|NCT01143896|2680024|P1|COMPLETED|Overall Study||114
1107496|NCT01143896|2680023|P2|STARTED|Overall Study||153
1107497|NCT01143896|2680024|P1|STARTED|Overall Study||156
1107498|NCT01144026|2680042|P2|NOT COMPLETED|Overall Study||0
1107499|NCT01144026|2680043|P1|NOT COMPLETED|Overall Study||0
1107500|NCT01144026|2680042|P2|COMPLETED|Overall Study||5
1107501|NCT01144026|2680043|P1|COMPLETED|Overall Study||10
1107502|NCT01144026|2680042|P2|STARTED|Overall Study||5
1107503|NCT01144026|2680043|P1|STARTED|Overall Study||10
1107504|NCT01144052|2680051|P2|NOT COMPLETED|Overall Study||1
1107505|NCT01144052|2680052|P1|NOT COMPLETED|Overall Study||1
1107506|NCT01144052|2680051|P2|COMPLETED|Overall Study||8
1107507|NCT01144052|2680052|P1|COMPLETED|Overall Study||9
1107508|NCT01144052|2680051|P2|STARTED|Overall Study||9
1107509|NCT01144052|2680052|P1|STARTED|Overall Study||10
1107510|NCT01144182|2680074|P2|NOT COMPLETED|Overall Study||21
1107511|NCT01144182|2680075|P1|NOT COMPLETED|Overall Study||17
1107512|NCT01144182|2680074|P2|COMPLETED|Overall Study||47
1107513|NCT01144182|2680075|P1|COMPLETED|Overall Study||51
1107514|NCT01144182|2680074|P2|STARTED|Overall Study||68
1107515|NCT01144182|2680075|P1|STARTED|Overall Study||68
1107516|NCT01144286|2680109|P4|NOT COMPLETED|Overall Study||0
1107517|NCT01144286|2680110|P3|NOT COMPLETED|Overall Study||0
1107518|NCT01144286|2680111|P2|NOT COMPLETED|Overall Study||0
1107519|NCT01144286|2680112|P1|NOT COMPLETED|Overall Study||0
1107520|NCT01144286|2680109|P4|COMPLETED|Overall Study||56
1107521|NCT01144286|2680110|P3|COMPLETED|Overall Study||58
1107522|NCT01144286|2680111|P2|COMPLETED|Overall Study||58
1107523|NCT01144286|2680112|P1|COMPLETED|Overall Study||57
1107524|NCT01144286|2680109|P4|STARTED|Overall Study||56
1107525|NCT01144286|2680110|P3|STARTED|Overall Study||58
1107526|NCT01144286|2680111|P2|STARTED|Overall Study||58
1107527|NCT01144286|2680112|P1|STARTED|Overall Study||57
1107528|NCT01144299|2680128|P2|NOT COMPLETED|Overall Study||0
1107529|NCT01144299|2680129|P1|NOT COMPLETED|Overall Study||2
1107530|NCT01144299|2680128|P2|COMPLETED|Overall Study||54
1107531|NCT01144299|2680129|P1|COMPLETED|Overall Study||58
1107532|NCT01144299|2680128|P2|STARTED|Overall Study||54
1107533|NCT01144299|2680129|P1|STARTED|Overall Study||60
1107534|NCT01144364|2680153|P3|NOT COMPLETED|Follow-Up/Maintenance Phase||41
1107535|NCT01144364|2680154|P2|NOT COMPLETED|Follow-Up/Maintenance Phase||35
1107536|NCT01144364|2680155|P1|NOT COMPLETED|Follow-Up/Maintenance Phase||0
1107537|NCT01144364|2680153|P3|COMPLETED|Follow-Up/Maintenance Phase||60
1107538|NCT01144364|2680154|P2|COMPLETED|Follow-Up/Maintenance Phase||66
1107539|NCT01144364|2680155|P1|COMPLETED|Follow-Up/Maintenance Phase||0
1107540|NCT01144364|2680153|P3|STARTED|Follow-Up/Maintenance Phase||101
1107541|NCT01144364|2680154|P2|STARTED|Follow-Up/Maintenance Phase||101
1107542|NCT01144364|2680155|P1|STARTED|Follow-Up/Maintenance Phase||0
1107543|NCT01144364|2680153|P3|NOT COMPLETED|Induction Phase||0
1107544|NCT01144364|2680154|P2|NOT COMPLETED|Induction Phase||0
1107545|NCT01144364|2680155|P1|NOT COMPLETED|Induction Phase||32
1107546|NCT01144364|2680153|P3|COMPLETED|Induction Phase||0
1107547|NCT01144364|2680154|P2|COMPLETED|Induction Phase||0
1107548|NCT01144364|2680155|P1|COMPLETED|Induction Phase||202
1107549|NCT01144364|2680153|P3|STARTED|Induction Phase||0
1107550|NCT01144364|2680154|P2|STARTED|Induction Phase||0
1107551|NCT01144364|2680155|P1|STARTED|Induction Phase||234
1107552|NCT01144403|2680179|P1|NOT COMPLETED|Overall Study||5
1107553|NCT01144403|2680179|P1|COMPLETED|Overall Study||3
1107554|NCT01144403|2680179|P1|STARTED|Overall Study||8
1107567|NCT01144442|2680205|P1|NOT COMPLETED|Overall Study||0
1107568|NCT01144442|2680205|P1|COMPLETED|Overall Study||10
1107569|NCT01144442|2680205|P1|STARTED|Overall Study||10
1107570|NCT01144598|2680210|P1|NOT COMPLETED|Overall Study||0
1107571|NCT01144598|2680210|P1|COMPLETED|Overall Study||356
1107572|NCT01144598|2680210|P1|Analysis Population|Overall Study||356
1107573|NCT01144598|2680210|P1|STARTED|Overall Study||356
1107574|NCT01144624|2680231|P3|NOT COMPLETED|Overall Study||0
1107575|NCT01144624|2680232|P2|NOT COMPLETED|Overall Study||0
1107576|NCT01144624|2680233|P1|NOT COMPLETED|Overall Study||0
1107577|NCT01144624|2680231|P3|COMPLETED|Overall Study|Two patients died during the study. Death was not a reason for treatment or study discontinuation.|6
1107578|NCT01144624|2680232|P2|COMPLETED|Overall Study||7
1107579|NCT01144624|2680233|P1|COMPLETED|Overall Study|One patient died during the study. Death was not a reason for treatment or study discontinuation.|7
1107580|NCT01144624|2680231|P3|Completed Treatment|Overall Study|Two patients died during the dosing period. Death was not a reason for treatment discontinuation.|6
1107581|NCT01144624|2680232|P2|Completed Treatment|Overall Study||7
1107582|NCT01144624|2680233|P1|Completed Treatment|Overall Study|One patient died after completing the full course of study treatment.|7
1107583|NCT01144624|2680231|P3|Received Treatment|Overall Study||6
1107584|NCT01144624|2680232|P2|Received Treatment|Overall Study||7
1107585|NCT01144624|2680233|P1|Received Treatment|Overall Study||7
1107586|NCT01144624|2680231|P3|STARTED|Overall Study||6
1107587|NCT01144624|2680232|P2|STARTED|Overall Study||7
1107588|NCT01144624|2680233|P1|STARTED|Overall Study||7
1107589|NCT01144715|2680249|P2|NOT COMPLETED|Overall Study||3
1107590|NCT01144715|2680250|P1|NOT COMPLETED|Overall Study||4
1107591|NCT01144715|2680249|P2|COMPLETED|Overall Study||45
1107592|NCT01144715|2680250|P1|COMPLETED|Overall Study||47
1107593|NCT01144715|2680249|P2|STARTED|Overall Study||48
1107594|NCT01144715|2680250|P1|STARTED|Overall Study||51
1107595|NCT01144949|2680264|P2|NOT COMPLETED|Overall Study||14
1107596|NCT01144949|2680265|P1|NOT COMPLETED|Overall Study||11
1107597|NCT01144949|2680264|P2|COMPLETED|Overall Study||106
1107598|NCT01144949|2680265|P1|COMPLETED|Overall Study||108
1107599|NCT01144949|2680264|P2|STARTED|Overall Study||120
1107600|NCT01144949|2680265|P1|STARTED|Overall Study||119
1107601|NCT01145352|2680281|P1|NOT COMPLETED|Overall Study||11
1107602|NCT01145352|2680281|P1|COMPLETED|Overall Study||102
1107603|NCT01145352|2680281|P1|STARTED|Overall Study||113
1107604|NCT01145391|2680291|P2|NOT COMPLETED|Overall Study||0
1107605|NCT01145391|2680292|P1|NOT COMPLETED|Overall Study||0
1107606|NCT01145391|2680291|P2|COMPLETED|Overall Study||298
1107607|NCT01145391|2680292|P1|COMPLETED|Overall Study||293
1107608|NCT01145391|2680291|P2|9 Months Post-randomization|Overall Study||298
1107609|NCT01145391|2680292|P1|9 Months Post-randomization|Overall Study||293
1107610|NCT01145391|2680291|P2|STARTED|Overall Study||298
1107611|NCT01145391|2680292|P1|STARTED|Overall Study||293
1107612|NCT01145417|2680302|P2|NOT COMPLETED|Overall Study||47
1107613|NCT01145417|2680303|P1|NOT COMPLETED|Overall Study||41
1107614|NCT01145417|2680302|P2|COMPLETED|Overall Study||62
1107615|NCT01145417|2680303|P1|COMPLETED|Overall Study||67
1107616|NCT01145417|2680302|P2|STARTED|Overall Study||109
1107617|NCT01145417|2680303|P1|STARTED|Overall Study||108
1107618|NCT01145482|2680327|P2|NOT COMPLETED|Second Intervention (1 Day)||0
1107619|NCT01145482|2680328|P1|NOT COMPLETED|Second Intervention (1 Day)||0
1107620|NCT01145482|2680327|P2|COMPLETED|Second Intervention (1 Day)||6
1107621|NCT01145482|2680328|P1|COMPLETED|Second Intervention (1 Day)||5
1107622|NCT01145482|2680327|P2|STARTED|Second Intervention (1 Day)||6
1107623|NCT01145482|2680328|P1|STARTED|Second Intervention (1 Day)||5
1107624|NCT01145482|2680327|P2|NOT COMPLETED|First Intervention (1 Day)||1
1107625|NCT01145482|2680328|P1|NOT COMPLETED|First Intervention (1 Day)||0
1107626|NCT01145482|2680327|P2|COMPLETED|First Intervention (1 Day)||5
1107627|NCT01145482|2680328|P1|COMPLETED|First Intervention (1 Day)||6
1107628|NCT01145482|2680327|P2|STARTED|First Intervention (1 Day)||6
1107629|NCT01145482|2680328|P1|STARTED|First Intervention (1 Day)||6
1107630|NCT01145495|2680336|P1|NOT COMPLETED|Overall Study||12
1107631|NCT01145495|2680336|P1|COMPLETED|Overall Study||51
1107632|NCT01145495|2680336|P1|STARTED|Overall Study||63
1107633|NCT01145508|2680342|P2|NOT COMPLETED|Overall Study||2
1107634|NCT01145508|2680343|P1|NOT COMPLETED|Overall Study||5
1107635|NCT01145508|2680342|P2|COMPLETED|Overall Study||1
1107636|NCT01145508|2680343|P1|COMPLETED|Overall Study||2
1107637|NCT01145508|2680342|P2|Treated|Overall Study||2
1107638|NCT01145508|2680343|P1|Treated|Overall Study||6
1107639|NCT01145508|2680342|P2|STARTED|Overall Study||3
1107640|NCT01145508|2680343|P1|STARTED|Overall Study||7
1107641|NCT01145547|2680349|P2|NOT COMPLETED|Overall Study||0
1107642|NCT01145547|2680350|P1|NOT COMPLETED|Overall Study||0
1107643|NCT01145547|2680349|P2|COMPLETED|Overall Study||3
1107644|NCT01145547|2680350|P1|COMPLETED|Overall Study||4
1107645|NCT01145547|2680349|P2|STARTED|Overall Study||3
1107646|NCT01145547|2680350|P1|STARTED|Overall Study||4
1107647|NCT01145560|2680359|P3|NOT COMPLETED|Overall Study||2
1107648|NCT01145560|2680360|P2|NOT COMPLETED|Overall Study||4
1107649|NCT01145560|2680361|P1|NOT COMPLETED|Overall Study||4
1107650|NCT01145560|2680359|P3|COMPLETED|Overall Study|27 patients died during the study. Death was not a reason for treatment or study discontinuation.|98
1107651|NCT01145560|2680360|P2|COMPLETED|Overall Study|33 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
1107652|NCT01145560|2680361|P1|COMPLETED|Overall Study|20 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
1107653|NCT01145560|2680359|P3|Completed Treatment|Overall Study|7 patients died during the treatment period without completing the full course of treatment.|78
1107654|NCT01145560|2680360|P2|Completed Treatment|Overall Study|8 patients died during the treatment period without completing the full course of treatment.|85
1107655|NCT01145560|2680361|P1|Completed Treatment|Overall Study|9 patients died during the treatment period without completing the full course of treatment.|69
1107656|NCT01145560|2680359|P3|Received Treatment|Overall Study||99
1107657|NCT01145560|2680360|P2|Received Treatment|Overall Study||98
1107658|NCT01145560|2680361|P1|Received Treatment|Overall Study||99
1107659|NCT01145560|2680359|P3|STARTED|Overall Study||100
1107660|NCT01145560|2680360|P2|STARTED|Overall Study||100
1107661|NCT01145560|2680361|P1|STARTED|Overall Study||100
1107662|NCT01145625|2680380|P2|NOT COMPLETED|Overall Study||31
1107663|NCT01145625|2680381|P1|NOT COMPLETED|Overall Study||24
1107664|NCT01145625|2680380|P2|COMPLETED|Overall Study||130
1107665|NCT01145625|2680381|P1|COMPLETED|Overall Study||137
1107666|NCT01145625|2680380|P2|STARTED|Overall Study||161
1107667|NCT01145625|2680381|P1|STARTED|Overall Study||161
1107668|NCT01145638|2680393|P2|NOT COMPLETED|Overall Study||57
1107669|NCT01145638|2680394|P1|NOT COMPLETED|Overall Study||90
1107670|NCT01145638|2680393|P2|COMPLETED|Overall Study||62
1107671|NCT01145638|2680394|P1|COMPLETED|Overall Study||141
1107672|NCT01145638|2680393|P2|STARTED|Overall Study||119
1107673|NCT01145638|2680394|P1|STARTED|Overall Study||231
1107674|NCT01145755|2680405|P3|NOT COMPLETED|Overall Study||25
1107675|NCT01145755|2680406|P2|NOT COMPLETED|Overall Study||28
1107676|NCT01145755|2680407|P1|NOT COMPLETED|Overall Study||20
1107677|NCT01145755|2680405|P3|COMPLETED|Overall Study||19
1107678|NCT01145755|2680406|P2|COMPLETED|Overall Study||19
1107679|NCT01145755|2680407|P1|COMPLETED|Overall Study||20
1107680|NCT01145755|2680405|P3|STARTED|Overall Study||44
1107681|NCT01145755|2680406|P2|STARTED|Overall Study||47
1107682|NCT01145755|2680407|P1|STARTED|Overall Study||40
1107683|NCT01145898|2680423|P2|NOT COMPLETED|3-year Treatment||16
1107684|NCT01145898|2680424|P1|NOT COMPLETED|3-year Treatment||3
1107685|NCT01145898|2680423|P2|COMPLETED|3-year Treatment||28
1107686|NCT01145898|2680424|P1|COMPLETED|3-year Treatment||9
1107687|NCT01145898|2680423|P2|STARTED|3-year Treatment||44
1107688|NCT01145898|2680424|P1|STARTED|3-year Treatment||12
1107689|NCT01145898|2680423|P2|NOT COMPLETED|6-month Treatment||0
1107690|NCT01145898|2680424|P1|NOT COMPLETED|6-month Treatment||0
1107691|NCT01145898|2680423|P2|COMPLETED|6-month Treatment||44
1107692|NCT01145898|2680424|P1|COMPLETED|6-month Treatment||12
1107693|NCT01145898|2680423|P2|STARTED|6-month Treatment||44
1107694|NCT01145898|2680424|P1|STARTED|6-month Treatment||12
1107695|NCT01146054|2680455|P1|NOT COMPLETED|Overall Study||10
1107696|NCT01146054|2680455|P1|COMPLETED|Overall Study||49
1107697|NCT01146054|2680455|P1|STARTED|Overall Study||59
1107698|NCT01146275|2680463|P1|NOT COMPLETED|Overall Study||0
1107699|NCT01146275|2680463|P1|COMPLETED|Overall Study||6
1107700|NCT01146275|2680463|P1|STARTED|Overall Study||6
1107701|NCT01146288|2680470|P2|NOT COMPLETED|Second Intervention (1 Day)||0
1107702|NCT01146288|2680471|P1|NOT COMPLETED|Second Intervention (1 Day)||0
1107703|NCT01146288|2680470|P2|COMPLETED|Second Intervention (1 Day)||5
1107704|NCT01146288|2680471|P1|COMPLETED|Second Intervention (1 Day)||7
1107705|NCT01146288|2680470|P2|STARTED|Second Intervention (1 Day)||5
1107706|NCT01146288|2680471|P1|STARTED|Second Intervention (1 Day)||7
1107707|NCT01146288|2680470|P2|NOT COMPLETED|First Intervention(1 Day)||1
1107708|NCT01146288|2680471|P1|NOT COMPLETED|First Intervention(1 Day)||0
1107709|NCT01146288|2680470|P2|COMPLETED|First Intervention(1 Day)||5
1107710|NCT01146288|2680471|P1|COMPLETED|First Intervention(1 Day)||7
1107711|NCT01146288|2680470|P2|STARTED|First Intervention(1 Day)||6
1107712|NCT01146288|2680471|P1|STARTED|First Intervention(1 Day)||7
1107713|NCT01146379|2680484|P4|NOT COMPLETED|Overall Study||1
1107714|NCT01146379|2680485|P3|NOT COMPLETED|Overall Study||0
1107715|NCT01146379|2680486|P2|NOT COMPLETED|Overall Study||1
1107716|NCT01146379|2680487|P1|NOT COMPLETED|Overall Study||1
1107717|NCT01146379|2680484|P4|COMPLETED|Overall Study||20
1107718|NCT01146379|2680485|P3|COMPLETED|Overall Study||21
1107719|NCT01146379|2680486|P2|COMPLETED|Overall Study||21
1107720|NCT01146379|2680487|P1|COMPLETED|Overall Study||20
1107721|NCT01146379|2680484|P4|STARTED|Overall Study||21
1107722|NCT01146379|2680485|P3|STARTED|Overall Study||21
1107723|NCT01146379|2680486|P2|STARTED|Overall Study||22
1107724|NCT01146379|2680487|P1|STARTED|Overall Study||21
1107725|NCT01146418|2680499|P4|NOT COMPLETED|Live-Born Infant Follow Up||5
1107726|NCT01146418|2680500|P3|NOT COMPLETED|Live-Born Infant Follow Up||6
1107727|NCT01146418|2680501|P2|NOT COMPLETED|Live-Born Infant Follow Up||0
1107728|NCT01146418|2680502|P1|NOT COMPLETED|Live-Born Infant Follow Up||0
1107729|NCT01146418|2680499|P4|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|51
1107730|NCT01146418|2680500|P3|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|55
1107731|NCT01146418|2680501|P2|COMPLETED|Live-Born Infant Follow Up||0
1107732|NCT01146418|2680502|P1|COMPLETED|Live-Born Infant Follow Up||0
1107733|NCT01146418|2680499|P4|STARTED|Live-Born Infant Follow Up||56
1107734|NCT01146418|2680500|P3|STARTED|Live-Born Infant Follow Up||61
1107735|NCT01146418|2680501|P2|STARTED|Live-Born Infant Follow Up||0
1107736|NCT01146418|2680502|P1|STARTED|Live-Born Infant Follow Up||0
1107737|NCT01146418|2680499|P4|NOT COMPLETED|Women/Expectant Mother Follow Up||0
1107738|NCT01146418|2680500|P3|NOT COMPLETED|Women/Expectant Mother Follow Up||0
1107739|NCT01146418|2680501|P2|NOT COMPLETED|Women/Expectant Mother Follow Up||40
1107740|NCT01146418|2680502|P1|NOT COMPLETED|Women/Expectant Mother Follow Up||44
1107741|NCT01146418|2680499|P4|COMPLETED|Women/Expectant Mother Follow Up||0
1107742|NCT01146418|2680500|P3|COMPLETED|Women/Expectant Mother Follow Up||0
1107743|NCT01146418|2680501|P2|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|110
1107744|NCT01146418|2680502|P1|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|113
1107745|NCT01146418|2680499|P4|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
1107746|NCT01146418|2680500|P3|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
1107747|NCT01146418|2680501|P2|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|50
1107748|NCT01146418|2680502|P1|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|52
1107749|NCT01146418|2680499|P4|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
1107750|NCT01146418|2680500|P3|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
1107751|NCT01146418|2680501|P2|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||147
1107752|NCT01146418|2680502|P1|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||151
1107753|NCT01146418|2680499|P4|STARTED|Women/Expectant Mother Follow Up||0
1107754|NCT01146418|2680500|P3|STARTED|Women/Expectant Mother Follow Up||0
1107755|NCT01146418|2680501|P2|STARTED|Women/Expectant Mother Follow Up|Participants from base study P06029 with at least one embryo thawed for use in FTET cycle.|150
1107756|NCT01146418|2680502|P1|STARTED|Women/Expectant Mother Follow Up|Participants from Base Study P06029 with at least one embryo thawed for use in FTET cycle.|157
1107757|NCT01146418|2680499|P4|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
1107758|NCT01146418|2680500|P3|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
1107759|NCT01146418|2680501|P2|NOT COMPLETED|Base Study P06029 (NCT01144416)||49
1107760|NCT01146418|2680502|P1|NOT COMPLETED|Base Study P06029 (NCT01144416)||62
1107761|NCT01146418|2680499|P4|COMPLETED|Base Study P06029 (NCT01144416)||0
1107762|NCT01146418|2680500|P3|COMPLETED|Base Study P06029 (NCT01144416)||0
1107763|NCT01146418|2680501|P2|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|647
1107764|NCT01146418|2680502|P1|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|632
1107765|NCT01146418|2680499|P4|STARTED|Base Study P06029 (NCT01144416)||0
1107766|NCT01146418|2680500|P3|STARTED|Base Study P06029 (NCT01144416)||0
1107767|NCT01146418|2680501|P2|STARTED|Base Study P06029 (NCT01144416)||696
1107768|NCT01146418|2680502|P1|STARTED|Base Study P06029 (NCT01144416)||694
1107769|NCT01146457|2680519|P5|NOT COMPLETED|Overall Study||0
1107770|NCT01146457|2680520|P4|NOT COMPLETED|Overall Study||0
1107771|NCT01146457|2680521|P3|NOT COMPLETED|Overall Study||1
1107772|NCT01146457|2680522|P2|NOT COMPLETED|Overall Study||0
1107773|NCT01146457|2680523|P1|NOT COMPLETED|Overall Study||0
1107774|NCT01146457|2680519|P5|COMPLETED|Overall Study||13
1107775|NCT01146457|2680520|P4|COMPLETED|Overall Study||13
1107776|NCT01146457|2680521|P3|COMPLETED|Overall Study||20
1107777|NCT01146457|2680522|P2|COMPLETED|Overall Study||17
1107778|NCT01146457|2680523|P1|COMPLETED|Overall Study||19
1107779|NCT01146457|2680519|P5|STARTED|Overall Study||13
1107780|NCT01146457|2680520|P4|STARTED|Overall Study||13
1107781|NCT01146457|2680521|P3|STARTED|Overall Study||21
1107782|NCT01146457|2680522|P2|STARTED|Overall Study||17
1107783|NCT01146457|2680523|P1|STARTED|Overall Study||19
1107784|NCT01146600|2680537|P2|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
1107785|NCT01146600|2680538|P1|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
1107786|NCT01146600|2680537|P2|COMPLETED|Period 2 (Weeks 4 & 5)||10
1107787|NCT01146600|2680538|P1|COMPLETED|Period 2 (Weeks 4 & 5)||10
1107788|NCT01146600|2680537|P2|STARTED|Period 2 (Weeks 4 & 5)||10
1107789|NCT01146600|2680538|P1|STARTED|Period 2 (Weeks 4 & 5)||10
1107790|NCT01146600|2680537|P2|NOT COMPLETED|Washout (Week 3)||0
1107791|NCT01146600|2680538|P1|NOT COMPLETED|Washout (Week 3)||0
1107792|NCT01146600|2680537|P2|COMPLETED|Washout (Week 3)||10
1107793|NCT01146600|2680538|P1|COMPLETED|Washout (Week 3)||10
1107794|NCT01146600|2680537|P2|STARTED|Washout (Week 3)||10
1107795|NCT01146600|2680538|P1|STARTED|Washout (Week 3)||10
1107796|NCT01146600|2680537|P2|NOT COMPLETED|Period 1 (Weeks 1 & 2)||0
1107797|NCT01146600|2680538|P1|NOT COMPLETED|Period 1 (Weeks 1 & 2)||3
1107798|NCT01146600|2680537|P2|COMPLETED|Period 1 (Weeks 1 & 2)||10
1107799|NCT01146600|2680538|P1|COMPLETED|Period 1 (Weeks 1 & 2)||10
1107800|NCT01146600|2680537|P2|STARTED|Period 1 (Weeks 1 & 2)||10
1107801|NCT01146600|2680538|P1|STARTED|Period 1 (Weeks 1 & 2)||13
1107802|NCT01146613|2680565|P2|NOT COMPLETED|Overall Study||12
1107803|NCT01146613|2680566|P1|NOT COMPLETED|Overall Study||7
1107804|NCT01146613|2680565|P2|COMPLETED|Overall Study||89
1107805|NCT01146613|2680566|P1|COMPLETED|Overall Study||92
1107806|NCT01146613|2680565|P2|STARTED|Overall Study||101
1107807|NCT01146613|2680566|P1|STARTED|Overall Study||99
1107808|NCT01146782|2680572|P1|NOT COMPLETED|Primary Endpoint Cohort||6
1107809|NCT01146782|2680572|P1|COMPLETED|Primary Endpoint Cohort|57 Subjects in the Primary Endpoint Cohort completed the 28 day study|57
1107810|NCT01146782|2680572|P1|STARTED|Primary Endpoint Cohort|63 Subjects in the Primary Endpoint Cohort|63
1107811|NCT01146782|2680572|P1|NOT COMPLETED|Safety Cohort||83
1107812|NCT01146782|2680572|P1|COMPLETED|Safety Cohort||63
1107813|NCT01146782|2680572|P1|STARTED|Safety Cohort||146
1107814|NCT01146782|2680572|P1|NOT COMPLETED|Screening Cohort||221
1107815|NCT01146782|2680572|P1|COMPLETED|Screening Cohort||146
1107816|NCT01146782|2680572|P1|STARTED|Screening Cohort||367
1107817|NCT01146808|2680579|P1|NOT COMPLETED|Overall Study||0
1107818|NCT01146808|2680579|P1|COMPLETED|Overall Study||16
1107819|NCT01146808|2680579|P1|STARTED|Overall Study||16
1107820|NCT01146860|2680587|P2|NOT COMPLETED|Overall Study||1
1107821|NCT01146860|2680588|P1|NOT COMPLETED|Overall Study||0
1107822|NCT01146860|2680587|P2|COMPLETED|Overall Study||191
1107823|NCT01146860|2680588|P1|COMPLETED|Overall Study||194
1107824|NCT01146860|2680587|P2|STARTED|Overall Study||192
1107825|NCT01146860|2680588|P1|STARTED|Overall Study||194
1107826|NCT01146873|2680604|P2|NOT COMPLETED|Overall Study||6
1107827|NCT01146873|2680605|P1|NOT COMPLETED|Overall Study||0
1107828|NCT01146873|2680604|P2|COMPLETED|Overall Study||144
1107829|NCT01146873|2680605|P1|COMPLETED|Overall Study||148
1107830|NCT01146873|2680604|P2|STARTED|Overall Study||150
1107831|NCT01146873|2680605|P1|STARTED|Overall Study||148
1107832|NCT01146912|2680626|P8|NOT COMPLETED|Overall Study||0
1107833|NCT01146912|2680627|P7|NOT COMPLETED|Overall Study||56
1107834|NCT01146912|2680628|P6|NOT COMPLETED|Overall Study||61
1107835|NCT01146912|2680629|P5|NOT COMPLETED|Overall Study||41
1107836|NCT01146912|2680630|P4|NOT COMPLETED|Overall Study||17
1107837|NCT01146912|2680631|P3|NOT COMPLETED|Overall Study||17
1107838|NCT01146912|2680632|P2|NOT COMPLETED|Overall Study||822
1107839|NCT01146912|2680633|P1|NOT COMPLETED|Overall Study||817
1107840|NCT01146912|2680626|P8|COMPLETED|Overall Study|Parents are considered subjects but outcomes are on child level|14675
1107841|NCT01146912|2680627|P7|COMPLETED|Overall Study||1764
1107842|NCT01146912|2680628|P6|COMPLETED|Overall Study||1760
1107843|NCT01146912|2680629|P5|COMPLETED|Overall Study||1780
1107844|NCT01146912|2680630|P4|COMPLETED|Overall Study||577
1107845|NCT01146912|2680631|P3|COMPLETED|Overall Study||576
1107846|NCT01146912|2680632|P2|COMPLETED|Overall Study||3784
1107847|NCT01146912|2680633|P1|COMPLETED|Overall Study||3790
1107848|NCT01146912|2680626|P8|STARTED|Overall Study||14675
1107849|NCT01146912|2680627|P7|STARTED|Overall Study||1820
1107850|NCT01146912|2680628|P6|STARTED|Overall Study||1821
1107851|NCT01146912|2680629|P5|STARTED|Overall Study||1821
1107852|NCT01146912|2680630|P4|STARTED|Overall Study||594
1107853|NCT01146912|2680631|P3|STARTED|Overall Study||593
1107854|NCT01146912|2680632|P2|STARTED|Overall Study||4606
1107855|NCT01146912|2680633|P1|STARTED|Overall Study||4607
1107856|NCT01146951|2680655|P2|NOT COMPLETED|Overall Study||1
1107857|NCT01146951|2680656|P1|NOT COMPLETED|Overall Study||4
1107858|NCT01146951|2680655|P2|COMPLETED|Overall Study||29
1107859|NCT01146951|2680656|P1|COMPLETED|Overall Study||25
1107860|NCT01146951|2680655|P2|STARTED|Overall Study||30
1107861|NCT01146951|2680656|P1|STARTED|Overall Study||29
1107862|NCT01147042|2680672|P2|NOT COMPLETED|Overall Study||0
1107863|NCT01147042|2680673|P1|NOT COMPLETED|Overall Study||0
1107864|NCT01147042|2680672|P2|COMPLETED|Overall Study||0
1107865|NCT01147042|2680673|P1|COMPLETED|Overall Study||2
1107866|NCT01147042|2680672|P2|STARTED|Overall Study||0
1107867|NCT01147042|2680673|P1|STARTED|Overall Study||2
1107868|NCT01147055|2680678|P2|NOT COMPLETED|Second Intervention Period||0
1107869|NCT01147055|2680679|P1|NOT COMPLETED|Second Intervention Period||0
1107870|NCT01147055|2680678|P2|COMPLETED|Second Intervention Period||14
1107871|NCT01147055|2680679|P1|COMPLETED|Second Intervention Period||0
1107872|NCT01147055|2680678|P2|STARTED|Second Intervention Period||14
1107873|NCT01147055|2680679|P1|STARTED|Second Intervention Period||0
1107874|NCT01147055|2680678|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1107875|NCT01147055|2680679|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1107876|NCT01147055|2680678|P2|COMPLETED|Washout Period (at Least 14 Days)||0
1107877|NCT01147055|2680679|P1|COMPLETED|Washout Period (at Least 14 Days)||14
1107878|NCT01147055|2680678|P2|STARTED|Washout Period (at Least 14 Days)||0
1107879|NCT01147055|2680679|P1|STARTED|Washout Period (at Least 14 Days)||14
1107880|NCT01147055|2680678|P2|NOT COMPLETED|First Intervention Period||0
1107881|NCT01147055|2680679|P1|NOT COMPLETED|First Intervention Period||1
1107882|NCT01147055|2680678|P2|COMPLETED|First Intervention Period||0
1107883|NCT01147055|2680679|P1|COMPLETED|First Intervention Period||14
1107884|NCT01147055|2680678|P2|STARTED|First Intervention Period||0
1107885|NCT01147055|2680679|P1|STARTED|First Intervention Period||15
1107886|NCT01147068|2680718|P7|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
1107887|NCT01147068|2680719|P6|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
1107888|NCT01147068|2680720|P5|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
1107889|NCT01147068|2680721|P4|NOT COMPLETED|Subjects That Completed Safety Follow-up||2
1107890|NCT01147068|2680722|P3|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
1107891|NCT01147068|2680723|P2|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
1107892|NCT01147068|2680724|P1|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
1107893|NCT01147068|2680718|P7|COMPLETED|Subjects That Completed Safety Follow-up||54
1107894|NCT01147068|2680719|P6|COMPLETED|Subjects That Completed Safety Follow-up||52
1107895|NCT01147068|2680720|P5|COMPLETED|Subjects That Completed Safety Follow-up||56
1107896|NCT01147068|2680721|P4|COMPLETED|Subjects That Completed Safety Follow-up||54
1107897|NCT01147068|2680722|P3|COMPLETED|Subjects That Completed Safety Follow-up||55
1107898|NCT01147068|2680723|P2|COMPLETED|Subjects That Completed Safety Follow-up||56
1107899|NCT01147068|2680724|P1|COMPLETED|Subjects That Completed Safety Follow-up||59
1107900|NCT01147068|2680718|P7|STARTED|Subjects That Completed Safety Follow-up||55
1107901|NCT01147068|2680719|P6|STARTED|Subjects That Completed Safety Follow-up|One subject was lost to follow up and one subject did not complete the study.|53
1107902|NCT01147068|2680720|P5|STARTED|Subjects That Completed Safety Follow-up|Data for one subject is unknown.|56
1107903|NCT01147068|2680721|P4|STARTED|Subjects That Completed Safety Follow-up||56
1107904|NCT01147068|2680722|P3|STARTED|Subjects That Completed Safety Follow-up|Data on three subjects is unknown.|55
1107905|NCT01147068|2680723|P2|STARTED|Subjects That Completed Safety Follow-up|One subject was ineligible, one subject did not complete the study, and the other data is unknown.|57
1107906|NCT01147068|2680724|P1|STARTED|Subjects That Completed Safety Follow-up|Participants were eligible for follow-up regardless of number of doses received.|60
1107907|NCT01147068|2680718|P7|NOT COMPLETED|Subjects That Received 2nd Dose||0
1107908|NCT01147068|2680719|P6|NOT COMPLETED|Subjects That Received 2nd Dose||2
1107909|NCT01147068|2680720|P5|NOT COMPLETED|Subjects That Received 2nd Dose||1
1107910|NCT01147068|2680721|P4|NOT COMPLETED|Subjects That Received 2nd Dose||0
1107911|NCT01147068|2680722|P3|NOT COMPLETED|Subjects That Received 2nd Dose||3
1107912|NCT01147068|2680723|P2|NOT COMPLETED|Subjects That Received 2nd Dose||5
1107913|NCT01147068|2680724|P1|NOT COMPLETED|Subjects That Received 2nd Dose||1
1107914|NCT01147068|2680718|P7|COMPLETED|Subjects That Received 2nd Dose||55
1107915|NCT01147068|2680719|P6|COMPLETED|Subjects That Received 2nd Dose||51
1107916|NCT01147068|2680720|P5|COMPLETED|Subjects That Received 2nd Dose||55
1107917|NCT01147068|2680721|P4|COMPLETED|Subjects That Received 2nd Dose||56
1107918|NCT01147068|2680722|P3|COMPLETED|Subjects That Received 2nd Dose||52
1107919|NCT01147068|2680723|P2|COMPLETED|Subjects That Received 2nd Dose||52
1107920|NCT01147068|2680724|P1|COMPLETED|Subjects That Received 2nd Dose||59
1107921|NCT01147068|2680718|P7|STARTED|Subjects That Received 2nd Dose||55
1107922|NCT01147068|2680719|P6|STARTED|Subjects That Received 2nd Dose||53
1107923|NCT01147068|2680720|P5|STARTED|Subjects That Received 2nd Dose||56
1107924|NCT01147068|2680721|P4|STARTED|Subjects That Received 2nd Dose||56
1107925|NCT01147068|2680722|P3|STARTED|Subjects That Received 2nd Dose||55
1107926|NCT01147068|2680723|P2|STARTED|Subjects That Received 2nd Dose||57
1107927|NCT01147068|2680724|P1|STARTED|Subjects That Received 2nd Dose||60
1107928|NCT01147068|2680718|P7|NOT COMPLETED|Subjects That Received 1st Dose||0
1107929|NCT01147068|2680719|P6|NOT COMPLETED|Subjects That Received 1st Dose||0
1107930|NCT01147068|2680720|P5|NOT COMPLETED|Subjects That Received 1st Dose||0
1107931|NCT01147068|2680721|P4|NOT COMPLETED|Subjects That Received 1st Dose||0
1107932|NCT01147068|2680722|P3|NOT COMPLETED|Subjects That Received 1st Dose||0
1107933|NCT01147068|2680723|P2|NOT COMPLETED|Subjects That Received 1st Dose||0
1107934|NCT01147068|2680724|P1|NOT COMPLETED|Subjects That Received 1st Dose||0
1107935|NCT01147068|2680718|P7|COMPLETED|Subjects That Received 1st Dose||55
1107936|NCT01147068|2680719|P6|COMPLETED|Subjects That Received 1st Dose||53
1107937|NCT01147068|2680720|P5|COMPLETED|Subjects That Received 1st Dose||56
1107938|NCT01147068|2680721|P4|COMPLETED|Subjects That Received 1st Dose||56
1107939|NCT01147068|2680722|P3|COMPLETED|Subjects That Received 1st Dose||55
1107940|NCT01147068|2680723|P2|COMPLETED|Subjects That Received 1st Dose||57
1107941|NCT01147068|2680724|P1|COMPLETED|Subjects That Received 1st Dose||60
1107942|NCT01147068|2680718|P7|STARTED|Subjects That Received 1st Dose||55
1107943|NCT01147068|2680719|P6|STARTED|Subjects That Received 1st Dose||53
1107944|NCT01147068|2680720|P5|STARTED|Subjects That Received 1st Dose||56
1107945|NCT01147068|2680721|P4|STARTED|Subjects That Received 1st Dose||56
1107946|NCT01147068|2680722|P3|STARTED|Subjects That Received 1st Dose||55
1107947|NCT01147068|2680723|P2|STARTED|Subjects That Received 1st Dose||57
1107948|NCT01147068|2680724|P1|STARTED|Subjects That Received 1st Dose||60
1107952|NCT01147250|2680767|P2|NOT COMPLETED|Overall Study||105
1107953|NCT01147250|2680768|P1|NOT COMPLETED|Overall Study||110
1107954|NCT01147250|2680767|P2|COMPLETED|Overall Study||2929
1107955|NCT01147250|2680768|P1|COMPLETED|Overall Study||2924
1107956|NCT01147250|2680767|P2|Treated|Overall Study||3031
1107957|NCT01147250|2680768|P1|Treated|Overall Study||3032
1107958|NCT01147250|2680767|P2|STARTED|Overall Study||3034
1107959|NCT01147250|2680768|P1|STARTED|Overall Study||3034
1107960|NCT01147302|2680782|P2|NOT COMPLETED|Overall Study||0
1107961|NCT01147302|2680783|P1|NOT COMPLETED|Overall Study||0
1107962|NCT01147302|2680782|P2|COMPLETED|Overall Study||9
1107963|NCT01147302|2680783|P1|COMPLETED|Overall Study||9
1107964|NCT01147302|2680782|P2|STARTED|Overall Study||9
1107965|NCT01147302|2680783|P1|STARTED|Overall Study||9
1107966|NCT01147341|2680815|P2|NOT COMPLETED|Open Label Period||0
1107967|NCT01147341|2680816|P1|NOT COMPLETED|Open Label Period||4
1107968|NCT01147341|2680815|P2|COMPLETED|Open Label Period||8
1107969|NCT01147341|2680816|P1|COMPLETED|Open Label Period||22
1107970|NCT01147341|2680815|P2|STARTED|Open Label Period||8
1107971|NCT01147341|2680816|P1|STARTED|Open Label Period||26
1107972|NCT01147341|2680815|P2|NOT COMPLETED|Double Blind Period||2
1107973|NCT01147341|2680816|P1|NOT COMPLETED|Double Blind Period||1
1107974|NCT01147341|2680815|P2|COMPLETED|Double Blind Period||8
1107975|NCT01147341|2680816|P1|COMPLETED|Double Blind Period||26
1107976|NCT01147341|2680815|P2|STARTED|Double Blind Period||10
1107977|NCT01147341|2680816|P1|STARTED|Double Blind Period||27
1107978|NCT01147380|2680846|P2|NOT COMPLETED|Overall Study||0
1107979|NCT01147380|2680847|P1|NOT COMPLETED|Overall Study||0
1107980|NCT01147380|2680846|P2|COMPLETED|Overall Study||12
1107981|NCT01147380|2680847|P1|COMPLETED|Overall Study||6
1107982|NCT01147380|2680846|P2|STARTED|Overall Study||12
1107983|NCT01147380|2680847|P1|STARTED|Overall Study||6
1107984|NCT01147393|2680855|P1|NOT COMPLETED|Dose Level -1||1
1107985|NCT01147393|2680855|P1|COMPLETED|Dose Level -1||0
1107986|NCT01147393|2680855|P1|STARTED|Dose Level -1||1
1107987|NCT01147393|2680855|P1|NOT COMPLETED|Dose Level 1||2
1107988|NCT01147393|2680855|P1|COMPLETED|Dose Level 1||1
1107989|NCT01147393|2680855|P1|STARTED|Dose Level 1||3
1107990|NCT01147406|2680869|P6|NOT COMPLETED|Overall Study||0
1107991|NCT01147406|2680870|P5|NOT COMPLETED|Overall Study||0
1107992|NCT01147406|2680871|P4|NOT COMPLETED|Overall Study||0
1107993|NCT01147406|2680872|P3|NOT COMPLETED|Overall Study||0
1107994|NCT01147406|2680873|P2|NOT COMPLETED|Overall Study||0
1107995|NCT01147406|2680874|P1|NOT COMPLETED|Overall Study||0
1107996|NCT01147406|2680869|P6|COMPLETED|Overall Study||10
1107997|NCT01147406|2680870|P5|COMPLETED|Overall Study||6
1107998|NCT01147406|2680871|P4|COMPLETED|Overall Study||6
1107999|NCT01147406|2680872|P3|COMPLETED|Overall Study||1
1108000|NCT01147406|2680873|P2|COMPLETED|Overall Study||12
1108001|NCT01147406|2680874|P1|COMPLETED|Overall Study||6
1108002|NCT01147406|2680869|P6|STARTED|Overall Study||10
1108003|NCT01147406|2680870|P5|STARTED|Overall Study||6
1108004|NCT01147406|2680871|P4|STARTED|Overall Study||6
1108005|NCT01147406|2680872|P3|STARTED|Overall Study||1
1108006|NCT01147406|2680873|P2|STARTED|Overall Study||12
1108007|NCT01147406|2680874|P1|STARTED|Overall Study||6
1108008|NCT01147458|2680894|P4|NOT COMPLETED|Second Intervention||4
1108009|NCT01147458|2680895|P3|NOT COMPLETED|Second Intervention||8
1108010|NCT01147458|2680896|P2|NOT COMPLETED|Second Intervention||7
1108011|NCT01147458|2680897|P1|NOT COMPLETED|Second Intervention||9
1108012|NCT01147458|2680894|P4|COMPLETED|Second Intervention||30
1108013|NCT01147458|2680895|P3|COMPLETED|Second Intervention||27
1108014|NCT01147458|2680896|P2|COMPLETED|Second Intervention||24
1108015|NCT01147458|2680897|P1|COMPLETED|Second Intervention||25
1108016|NCT01147458|2680894|P4|STARTED|Second Intervention||34
1108017|NCT01147458|2680895|P3|STARTED|Second Intervention||35
1108018|NCT01147458|2680896|P2|STARTED|Second Intervention||31
1108019|NCT01147458|2680897|P1|STARTED|Second Intervention||34
1108020|NCT01147458|2680894|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
1108021|NCT01147458|2680895|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
1108022|NCT01147458|2680896|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
1108023|NCT01147458|2680897|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
1108024|NCT01147458|2680894|P4|COMPLETED|Washout Period of 2 Weeks||34
1108025|NCT01147458|2680895|P3|COMPLETED|Washout Period of 2 Weeks||35
1108026|NCT01147458|2680896|P2|COMPLETED|Washout Period of 2 Weeks||31
1108027|NCT01147458|2680897|P1|COMPLETED|Washout Period of 2 Weeks||34
1108028|NCT01147458|2680894|P4|STARTED|Washout Period of 2 Weeks||34
1108029|NCT01147458|2680895|P3|STARTED|Washout Period of 2 Weeks||35
1108030|NCT01147458|2680896|P2|STARTED|Washout Period of 2 Weeks||31
1108031|NCT01147458|2680897|P1|STARTED|Washout Period of 2 Weeks||34
1108032|NCT01147458|2680894|P4|NOT COMPLETED|First Intervention||14
1108033|NCT01147458|2680895|P3|NOT COMPLETED|First Intervention||12
1108034|NCT01147458|2680896|P2|NOT COMPLETED|First Intervention||16
1108035|NCT01147458|2680897|P1|NOT COMPLETED|First Intervention||14
1108036|NCT01147458|2680894|P4|COMPLETED|First Intervention||34
1108037|NCT01147458|2680895|P3|COMPLETED|First Intervention||35
1108038|NCT01147458|2680896|P2|COMPLETED|First Intervention||31
1108039|NCT01147458|2680897|P1|COMPLETED|First Intervention||34
1108040|NCT01147458|2680894|P4|STARTED|First Intervention||48
1108041|NCT01147458|2680895|P3|STARTED|First Intervention||47
1108042|NCT01147458|2680896|P2|STARTED|First Intervention||47
1108043|NCT01147458|2680897|P1|STARTED|First Intervention||48
1108044|NCT01147471|2680947|P2|NOT COMPLETED|6 Month Follow Up||2
1108045|NCT01147471|2680948|P1|NOT COMPLETED|6 Month Follow Up||4
1108046|NCT01147471|2680947|P2|COMPLETED|6 Month Follow Up||4
1108047|NCT01147471|2680948|P1|COMPLETED|6 Month Follow Up||8
1108048|NCT01147471|2680947|P2|STARTED|6 Month Follow Up||6
1108049|NCT01147471|2680948|P1|STARTED|6 Month Follow Up||12
1108050|NCT01147471|2680947|P2|NOT COMPLETED|3 Month Follow Up||2
1108051|NCT01147471|2680948|P1|NOT COMPLETED|3 Month Follow Up||1
1108052|NCT01147471|2680947|P2|COMPLETED|3 Month Follow Up||6
1108053|NCT01147471|2680948|P1|COMPLETED|3 Month Follow Up||12
1108054|NCT01147471|2680947|P2|STARTED|3 Month Follow Up||8
1108055|NCT01147471|2680948|P1|STARTED|3 Month Follow Up||13
1108056|NCT01147471|2680947|P2|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||3
1108057|NCT01147471|2680948|P1|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||0
1108058|NCT01147471|2680947|P2|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||8
1108059|NCT01147471|2680948|P1|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||13
1108060|NCT01147471|2680947|P2|STARTED|Post-discharge Follow Up (Approx 2 Wks)||11
1108061|NCT01147471|2680948|P1|STARTED|Post-discharge Follow Up (Approx 2 Wks)||13
1108062|NCT01147471|2680947|P2|NOT COMPLETED|Through Initial Hospital Discharge||0
1108063|NCT01147471|2680948|P1|NOT COMPLETED|Through Initial Hospital Discharge||0
1108064|NCT01147471|2680947|P2|COMPLETED|Through Initial Hospital Discharge||11
1108065|NCT01147471|2680948|P1|COMPLETED|Through Initial Hospital Discharge||13
1108066|NCT01147471|2680947|P2|STARTED|Through Initial Hospital Discharge||11
1108067|NCT01147471|2680948|P1|STARTED|Through Initial Hospital Discharge||13
1108068|NCT01147497|2680964|P2|NOT COMPLETED|Overall Study||0
1108069|NCT01147497|2680965|P1|NOT COMPLETED|Overall Study||2
1108070|NCT01147497|2680964|P2|COMPLETED|Overall Study||36
1108071|NCT01147497|2680965|P1|COMPLETED|Overall Study||35
1108072|NCT01147497|2680964|P2|STARTED|Overall Study||36
1108073|NCT01147497|2680965|P1|STARTED|Overall Study||37
1108074|NCT01141660|2680977|P2|NOT COMPLETED|Overall Study||12
1108075|NCT01141660|2680978|P1|NOT COMPLETED|Overall Study||0
1108076|NCT01141660|2680977|P2|COMPLETED|Overall Study||48
1108077|NCT01141660|2680978|P1|COMPLETED|Overall Study||71
1108078|NCT01141660|2680977|P2|STARTED|Overall Study||60
1108079|NCT01141660|2680978|P1|STARTED|Overall Study||71
1108083|NCT01141725|2681003|P3|NOT COMPLETED|Overall Study||0
1108084|NCT01141725|2681004|P2|NOT COMPLETED|Overall Study||0
1108085|NCT01141725|2681005|P1|NOT COMPLETED|Overall Study||0
1108086|NCT01141725|2681003|P3|COMPLETED|Overall Study||3
1108087|NCT01141725|2681004|P2|COMPLETED|Overall Study||33
1108088|NCT01141725|2681005|P1|COMPLETED|Overall Study||3
1108089|NCT01141725|2681003|P3|STARTED|Overall Study||3
1108090|NCT01141725|2681004|P2|STARTED|Overall Study||33
1108091|NCT01141725|2681005|P1|STARTED|Overall Study||3
1108092|NCT01142115|2681017|P2|NOT COMPLETED|Second Intervention||0
1108093|NCT01142115|2681018|P1|NOT COMPLETED|Second Intervention||0
1108094|NCT01142115|2681017|P2|COMPLETED|Second Intervention||19
1108095|NCT01142115|2681018|P1|COMPLETED|Second Intervention||19
1108096|NCT01142115|2681017|P2|STARTED|Second Intervention||19
1108097|NCT01142115|2681018|P1|STARTED|Second Intervention||19
1108098|NCT01142115|2681017|P2|NOT COMPLETED|First Intervention||1
1108099|NCT01142115|2681018|P1|NOT COMPLETED|First Intervention||2
1108100|NCT01142115|2681017|P2|COMPLETED|First Intervention||19
1108101|NCT01142115|2681018|P1|COMPLETED|First Intervention||19
1108102|NCT01142115|2681017|P2|STARTED|First Intervention||20
1108103|NCT01142115|2681018|P1|STARTED|First Intervention||21
1108104|NCT01142128|2681037|P1|NOT COMPLETED|Overall Study||4
1108105|NCT01142128|2681037|P1|COMPLETED|Overall Study||4
1108106|NCT01142128|2681037|P1|Viokase 16 Plus Placebo to Nexium|Overall Study||0
1108107|NCT01142128|2681037|P1|Viokase 16 Plus Nexium|Overall Study||2
1108108|NCT01142128|2681037|P1|Placebo to Nexium, Alone|Overall Study||3
1108109|NCT01142128|2681037|P1|Nexium Alone|Overall Study||3
1108110|NCT01142128|2681037|P1|STARTED|Overall Study||8
1108111|NCT01147601|2681049|P2|NOT COMPLETED|Overall Study||0
1108112|NCT01147601|2681050|P1|NOT COMPLETED|Overall Study||3
1108113|NCT01147601|2681049|P2|COMPLETED|Overall Study||1
1108114|NCT01147601|2681050|P1|COMPLETED|Overall Study||2
1108115|NCT01147601|2681049|P2|STARTED|Overall Study||1
1108116|NCT01147601|2681050|P1|STARTED|Overall Study||5
1108117|NCT01147627|2681059|P3|NOT COMPLETED|Overall Study||18
1108118|NCT01147627|2681060|P2|NOT COMPLETED|Overall Study||24
1108119|NCT01147627|2681061|P1|NOT COMPLETED|Overall Study||32
1108120|NCT01147627|2681059|P3|COMPLETED|Overall Study||118
1108121|NCT01147627|2681060|P2|COMPLETED|Overall Study||114
1108122|NCT01147627|2681061|P1|COMPLETED|Overall Study||110
1108123|NCT01147627|2681059|P3|STARTED|Overall Study||136
1108124|NCT01147627|2681060|P2|STARTED|Overall Study||138
1108125|NCT01147627|2681061|P1|STARTED|Overall Study||142
1108126|NCT01147640|2681071|P2|NOT COMPLETED|Overall Study||1
1108127|NCT01147640|2681072|P1|NOT COMPLETED|Overall Study||5
1108128|NCT01147640|2681071|P2|COMPLETED|Overall Study||38
1108129|NCT01147640|2681072|P1|COMPLETED|Overall Study||78
1108130|NCT01147640|2681071|P2|STARTED|Overall Study||39
1108131|NCT01147640|2681072|P1|STARTED|Overall Study||83
1108144|NCT01147744|2681149|P7|NOT COMPLETED|Overall Study||19
1108145|NCT01147744|2681150|P6|NOT COMPLETED|Overall Study||20
1108146|NCT01147744|2681151|P5|NOT COMPLETED|Overall Study||25
1108147|NCT01147744|2681152|P4|NOT COMPLETED|Overall Study||18
1108148|NCT01147744|2681153|P3|NOT COMPLETED|Overall Study||18
1108149|NCT01147744|2681154|P2|NOT COMPLETED|Overall Study||23
1108150|NCT01147744|2681155|P1|NOT COMPLETED|Overall Study||29
1108151|NCT01147744|2681149|P7|COMPLETED|Overall Study||78
1108152|NCT01147744|2681150|P6|COMPLETED|Overall Study||83
1108153|NCT01147744|2681151|P5|COMPLETED|Overall Study||76
1108154|NCT01147744|2681152|P4|COMPLETED|Overall Study||82
1108155|NCT01147744|2681153|P3|COMPLETED|Overall Study||82
1108156|NCT01147744|2681154|P2|COMPLETED|Overall Study||76
1108157|NCT01147744|2681155|P1|COMPLETED|Overall Study||71
1108158|NCT01147744|2681149|P7|STARTED|Overall Study||97
1108159|NCT01147744|2681150|P6|STARTED|Overall Study||103
1108160|NCT01147744|2681151|P5|STARTED|Overall Study||101
1108161|NCT01147744|2681152|P4|STARTED|Overall Study||100
1108162|NCT01147744|2681153|P3|STARTED|Overall Study||100
1108163|NCT01147744|2681154|P2|STARTED|Overall Study||99
1108164|NCT01147744|2681155|P1|STARTED|Overall Study||100
1108165|NCT01147809|2681254|P6|NOT COMPLETED|Phase II (168 Days)||33
1108166|NCT01147809|2681255|P5|NOT COMPLETED|Phase II (168 Days)||16
1108167|NCT01147809|2681256|P4|NOT COMPLETED|Phase II (168 Days)||0
1108168|NCT01147809|2681257|P3|NOT COMPLETED|Phase II (168 Days)||0
1108169|NCT01147809|2681258|P2|NOT COMPLETED|Phase II (168 Days)||0
1108170|NCT01147809|2681259|P1|NOT COMPLETED|Phase II (168 Days)||0
1108171|NCT01147809|2681254|P6|COMPLETED|Phase II (168 Days)||19
1108172|NCT01147809|2681255|P5|COMPLETED|Phase II (168 Days)||7
1108173|NCT01147809|2681256|P4|COMPLETED|Phase II (168 Days)||0
1108174|NCT01147809|2681257|P3|COMPLETED|Phase II (168 Days)||0
1108175|NCT01147809|2681258|P2|COMPLETED|Phase II (168 Days)||0
1108176|NCT01147809|2681259|P1|COMPLETED|Phase II (168 Days)||0
1108177|NCT01147809|2681254|P6|Ongoing|Phase II (168 Days)||0
1108178|NCT01147809|2681255|P5|Ongoing|Phase II (168 Days)||1
1108179|NCT01147809|2681256|P4|Ongoing|Phase II (168 Days)||0
1108180|NCT01147809|2681257|P3|Ongoing|Phase II (168 Days)||0
1108181|NCT01147809|2681258|P2|Ongoing|Phase II (168 Days)||0
1108182|NCT01147809|2681259|P1|Ongoing|Phase II (168 Days)||0
1108183|NCT01147809|2681254|P6|STARTED|Phase II (168 Days)||52
1108184|NCT01147809|2681255|P5|STARTED|Phase II (168 Days)||23
1108185|NCT01147809|2681256|P4|STARTED|Phase II (168 Days)||0
1108186|NCT01147809|2681257|P3|STARTED|Phase II (168 Days)||0
1108187|NCT01147809|2681258|P2|STARTED|Phase II (168 Days)||0
1108188|NCT01147809|2681259|P1|STARTED|Phase II (168 Days)||0
1108189|NCT01147809|2681254|P6|NOT COMPLETED|Phase I (168 Days)||0
1108190|NCT01147809|2681255|P5|NOT COMPLETED|Phase I (168 Days)||0
1108191|NCT01147809|2681256|P4|NOT COMPLETED|Phase I (168 Days)||5
1108192|NCT01147809|2681257|P3|NOT COMPLETED|Phase I (168 Days)||2
1108193|NCT01147809|2681258|P2|NOT COMPLETED|Phase I (168 Days)||1
1108194|NCT01147809|2681259|P1|NOT COMPLETED|Phase I (168 Days)||1
1108195|NCT01147809|2681254|P6|COMPLETED|Phase I (168 Days)||0
1108196|NCT01147809|2681255|P5|COMPLETED|Phase I (168 Days)||0
1108197|NCT01147809|2681256|P4|COMPLETED|Phase I (168 Days)||5
1108198|NCT01147809|2681257|P3|COMPLETED|Phase I (168 Days)||2
1108199|NCT01147809|2681258|P2|COMPLETED|Phase I (168 Days)||8
1108200|NCT01147809|2681259|P1|COMPLETED|Phase I (168 Days)||2
1108201|NCT01147809|2681254|P6|STARTED|Phase I (168 Days)||0
1108202|NCT01147809|2681255|P5|STARTED|Phase I (168 Days)||0
1108203|NCT01147809|2681256|P4|STARTED|Phase I (168 Days)||10
1108204|NCT01147809|2681257|P3|STARTED|Phase I (168 Days)||4
1108205|NCT01147809|2681258|P2|STARTED|Phase I (168 Days)||9
1108206|NCT01147809|2681259|P1|STARTED|Phase I (168 Days)||3
1108207|NCT01147822|2681375|P2|NOT COMPLETED|Overall Study||179
1108208|NCT01147822|2681376|P1|NOT COMPLETED|Overall Study||188
1108209|NCT01147822|2681375|P2|COMPLETED|Overall Study||0
1108210|NCT01147822|2681376|P1|COMPLETED|Overall Study||0
1108211|NCT01147822|2681375|P2|Not Completed/Ongoing|Overall Study||102
1108212|NCT01147822|2681376|P1|Not Completed/Ongoing|Overall Study||111
1108213|NCT01147822|2681375|P2|STARTED|Overall Study||179
1108214|NCT01147822|2681376|P1|STARTED|Overall Study||188
1108215|NCT01147848|2681392|P3|NOT COMPLETED|Randomized Phase||46
1108216|NCT01147848|2681393|P2|NOT COMPLETED|Randomized Phase||45
1108217|NCT01147848|2681394|P1|NOT COMPLETED|Randomized Phase||0
1108218|NCT01147848|2681392|P3|COMPLETED|Randomized Phase||357
1108219|NCT01147848|2681393|P2|COMPLETED|Randomized Phase||358
1108220|NCT01147848|2681394|P1|COMPLETED|Randomized Phase||0
1108221|NCT01147848|2681392|P3|STARTED|Randomized Phase||403
1108222|NCT01147848|2681393|P2|STARTED|Randomized Phase||403
1108223|NCT01147848|2681394|P1|STARTED|Randomized Phase||0
1108224|NCT01147848|2681392|P3|NOT COMPLETED|Run-in Period||0
1108225|NCT01147848|2681393|P2|NOT COMPLETED|Run-in Period||0
1108226|NCT01147848|2681394|P1|NOT COMPLETED|Run-in Period||758
1108227|NCT01147848|2681392|P3|COMPLETED|Run-in Period||0
1108228|NCT01147848|2681393|P2|COMPLETED|Run-in Period||0
1108229|NCT01147848|2681394|P1|COMPLETED|Run-in Period||806
1108230|NCT01147848|2681392|P3|STARTED|Run-in Period||0
1108231|NCT01147848|2681393|P2|STARTED|Run-in Period||0
1108232|NCT01147848|2681394|P1|STARTED|Run-in Period||1564
1108233|NCT01147874|2681424|P1|NOT COMPLETED|Overall Study||67
1108234|NCT01147874|2681424|P1|COMPLETED|Overall Study||946
1108235|NCT01147874|2681424|P1|STARTED|Overall Study||1013
1108236|NCT01147900|2681433|P3|NOT COMPLETED|At Year 10||0
1108237|NCT01147900|2681434|P2|NOT COMPLETED|At Year 10||1
1108238|NCT01147900|2681435|P1|NOT COMPLETED|At Year 10||0
1108239|NCT01147900|2681433|P3|COMPLETED|At Year 10||62
1108240|NCT01147900|2681434|P2|COMPLETED|At Year 10||59
1108241|NCT01147900|2681435|P1|COMPLETED|At Year 10||55
1108242|NCT01147900|2681433|P3|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled.|62
1108243|NCT01147900|2681434|P2|STARTED|At Year 10||60
1108244|NCT01147900|2681435|P1|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled|55
1108245|NCT01147900|2681433|P3|NOT COMPLETED|At Year 8.5||0
1108246|NCT01147900|2681434|P2|NOT COMPLETED|At Year 8.5||0
1108247|NCT01147900|2681435|P1|NOT COMPLETED|At Year 8.5||0
1108248|NCT01147900|2681433|P3|COMPLETED|At Year 8.5||66
1108249|NCT01147900|2681434|P2|COMPLETED|At Year 8.5||60
1108250|NCT01147900|2681435|P1|COMPLETED|At Year 8.5||54
1108251|NCT01147900|2681433|P3|STARTED|At Year 8.5||66
1108252|NCT01147900|2681434|P2|STARTED|At Year 8.5||60
1108253|NCT01147900|2681435|P1|STARTED|At Year 8.5||54
1108254|NCT01147926|2681496|P2|NOT COMPLETED|Overall Study||29
1108255|NCT01147926|2681497|P1|NOT COMPLETED|Overall Study||27
1108256|NCT01147926|2681496|P2|COMPLETED|Overall Study||158
1108257|NCT01147926|2681497|P1|COMPLETED|Overall Study||160
1108258|NCT01147926|2681496|P2|STARTED|Overall Study||187
1108259|NCT01147926|2681497|P1|STARTED|Overall Study||187
1108260|NCT01149057|2681529|P1|NOT COMPLETED|Overall Study||57
1108261|NCT01149057|2681529|P1|COMPLETED|Overall Study||88
1108262|NCT01149057|2681529|P1|STARTED|Overall Study||145
1108263|NCT01149148|2681556|P2|NOT COMPLETED|Overall Study||2
1108264|NCT01149148|2681557|P1|NOT COMPLETED|Overall Study||2
1108265|NCT01149148|2681556|P2|COMPLETED|Overall Study||11
1108266|NCT01149148|2681557|P1|COMPLETED|Overall Study||10
1108267|NCT01149148|2681556|P2|STARTED|Overall Study||13
1108268|NCT01149148|2681557|P1|STARTED|Overall Study||12
1108269|NCT01149421|2681568|P3|NOT COMPLETED|Overall Study||44
1108270|NCT01149421|2681569|P2|NOT COMPLETED|Overall Study||29
1108271|NCT01149421|2681570|P1|NOT COMPLETED|Overall Study||52
1108272|NCT01149421|2681568|P3|COMPLETED|Overall Study||206
1108273|NCT01149421|2681569|P2|COMPLETED|Overall Study||225
1108274|NCT01149421|2681570|P1|COMPLETED|Overall Study||199
1108275|NCT01149421|2681568|P3|Received at Least One Dose of Study Drug|Overall Study||250
1108276|NCT01149421|2681569|P2|Received at Least One Dose of Study Drug|Overall Study||254
1108277|NCT01149421|2681570|P1|Received at Least One Dose of Study Drug|Overall Study||251
1108278|NCT01149421|2681568|P3|STARTED|Overall Study||250
1108279|NCT01149421|2681569|P2|STARTED|Overall Study||254
1108280|NCT01149421|2681570|P1|STARTED|Overall Study||251
1108281|NCT01149434|2681651|P2|NOT COMPLETED|Overall Study||5
1108282|NCT01149434|2681652|P1|NOT COMPLETED|Overall Study||0
1108283|NCT01149434|2681651|P2|COMPLETED|Overall Study||10
1108284|NCT01149434|2681652|P1|COMPLETED|Overall Study||4
1108285|NCT01149434|2681651|P2|STARTED|Overall Study||15
1108286|NCT01149434|2681652|P1|STARTED|Overall Study||4
1108287|NCT01149460|2681665|P2|NOT COMPLETED|Overall Study||2
1108288|NCT01149460|2681666|P1|NOT COMPLETED|Overall Study||0
1108289|NCT01149460|2681665|P2|COMPLETED|Overall Study||16
1108290|NCT01149460|2681666|P1|COMPLETED|Overall Study||18
1108291|NCT01149460|2681665|P2|STARTED|Overall Study||18
1108292|NCT01149460|2681666|P1|STARTED|Overall Study||18
1108293|NCT01149473|2681684|P2|NOT COMPLETED|Second Intervention||0
1108294|NCT01149473|2681685|P1|NOT COMPLETED|Second Intervention||0
1108295|NCT01149473|2681684|P2|COMPLETED|Second Intervention||38
1108296|NCT01149473|2681685|P1|COMPLETED|Second Intervention||38
1108297|NCT01149473|2681684|P2|STARTED|Second Intervention||38
1108298|NCT01149473|2681685|P1|STARTED|Second Intervention||38
1108299|NCT01149473|2681684|P2|NOT COMPLETED|Washout of 7 Days||1
1108300|NCT01149473|2681685|P1|NOT COMPLETED|Washout of 7 Days||1
1108301|NCT01149473|2681684|P2|COMPLETED|Washout of 7 Days||38
1108302|NCT01149473|2681685|P1|COMPLETED|Washout of 7 Days||38
1108303|NCT01149473|2681684|P2|STARTED|Washout of 7 Days||39
1108304|NCT01149473|2681685|P1|STARTED|Washout of 7 Days||39
1108305|NCT01149473|2681684|P2|NOT COMPLETED|First Intervention||1
1108306|NCT01149473|2681685|P1|NOT COMPLETED|First Intervention||1
1108307|NCT01149473|2681684|P2|COMPLETED|First Intervention||39
1108308|NCT01149473|2681685|P1|COMPLETED|First Intervention||39
1108309|NCT01149473|2681684|P2|STARTED|First Intervention||40
1108310|NCT01149473|2681685|P1|STARTED|First Intervention||40
1108311|NCT01149486|2681703|P2|NOT COMPLETED|Second Intervention||0
1108312|NCT01149486|2681704|P1|NOT COMPLETED|Second Intervention||0
1108313|NCT01149486|2681703|P2|COMPLETED|Second Intervention||9
1108314|NCT01149486|2681704|P1|COMPLETED|Second Intervention||10
1108315|NCT01149486|2681703|P2|STARTED|Second Intervention||9
1108316|NCT01149486|2681704|P1|STARTED|Second Intervention||10
1108317|NCT01149486|2681703|P2|NOT COMPLETED|Washout of 7 Days||0
1108318|NCT01149486|2681704|P1|NOT COMPLETED|Washout of 7 Days||0
1108319|NCT01149486|2681703|P2|COMPLETED|Washout of 7 Days||9
1108320|NCT01149486|2681704|P1|COMPLETED|Washout of 7 Days||10
1108321|NCT01149486|2681703|P2|STARTED|Washout of 7 Days||9
1108322|NCT01149486|2681704|P1|STARTED|Washout of 7 Days||10
1108323|NCT01149486|2681703|P2|NOT COMPLETED|First Intervention||1
1108324|NCT01149486|2681704|P1|NOT COMPLETED|First Intervention||0
1108325|NCT01149486|2681703|P2|COMPLETED|First Intervention||9
1108326|NCT01149486|2681704|P1|COMPLETED|First Intervention||10
1108327|NCT01149486|2681703|P2|STARTED|First Intervention||10
1108328|NCT01149486|2681704|P1|STARTED|First Intervention||10
1108329|NCT01149512|2681726|P1|NOT COMPLETED|Overall Study||0
1108330|NCT01149512|2681726|P1|COMPLETED|Overall Study||178
1108331|NCT01149512|2681726|P1|STARTED|Overall Study||178
1108332|NCT01149538|2681733|P2|NOT COMPLETED|Overall Study||4
1108333|NCT01149538|2681734|P1|NOT COMPLETED|Overall Study||5
1108334|NCT01149538|2681733|P2|COMPLETED|Overall Study||25
1108335|NCT01149538|2681734|P1|COMPLETED|Overall Study||26
1108336|NCT01149538|2681733|P2|STARTED|Overall Study||29
1108337|NCT01149538|2681734|P1|STARTED|Overall Study||31
1108338|NCT01149616|2681750|P2|NOT COMPLETED|Overall Study||0
1108339|NCT01149616|2681751|P1|NOT COMPLETED|Overall Study||0
1108340|NCT01149616|2681750|P2|COMPLETED|Overall Study||41
1108341|NCT01149616|2681751|P1|COMPLETED|Overall Study||41
1108342|NCT01149616|2681750|P2|STARTED|Overall Study||41
1108343|NCT01149616|2681751|P1|STARTED|Overall Study||41
1108344|NCT01149655|2681763|P4|NOT COMPLETED|Period 3-DB Maintenance Phase||42
1108345|NCT01149655|2681764|P3|NOT COMPLETED|Period 3-DB Maintenance Phase||83
1108346|NCT01149655|2681765|P2|NOT COMPLETED|Period 3-DB Maintenance Phase||0
1108347|NCT01149655|2681766|P1|NOT COMPLETED|Period 3-DB Maintenance Phase||0
1108348|NCT01149655|2681763|P4|COMPLETED|Period 3-DB Maintenance Phase||6
1108349|NCT01149655|2681764|P3|COMPLETED|Period 3-DB Maintenance Phase||15
1108350|NCT01149655|2681765|P2|COMPLETED|Period 3-DB Maintenance Phase||0
1108351|NCT01149655|2681766|P1|COMPLETED|Period 3-DB Maintenance Phase||0
1108352|NCT01149655|2681763|P4|STARTED|Period 3-DB Maintenance Phase||48
1108353|NCT01149655|2681764|P3|STARTED|Period 3-DB Maintenance Phase||98
1108354|NCT01149655|2681765|P2|STARTED|Period 3-DB Maintenance Phase||0
1108355|NCT01149655|2681766|P1|STARTED|Period 3-DB Maintenance Phase||0
1108356|NCT01149655|2681763|P4|NOT COMPLETED|Period 2-Stabilization Phase||0
1108357|NCT01149655|2681764|P3|NOT COMPLETED|Period 2-Stabilization Phase||0
1108358|NCT01149655|2681765|P2|NOT COMPLETED|Period 2-Stabilization Phase||37
1108359|NCT01149655|2681766|P1|NOT COMPLETED|Period 2-Stabilization Phase||0
1108360|NCT01149655|2681763|P4|COMPLETED|Period 2-Stabilization Phase||0
1108361|NCT01149655|2681764|P3|COMPLETED|Period 2-Stabilization Phase||0
1108362|NCT01149655|2681765|P2|COMPLETED|Period 2-Stabilization Phase||146
1108363|NCT01149655|2681766|P1|COMPLETED|Period 2-Stabilization Phase||0
1108364|NCT01149655|2681763|P4|STARTED|Period 2-Stabilization Phase||0
1108365|NCT01149655|2681764|P3|STARTED|Period 2-Stabilization Phase||0
1108366|NCT01149655|2681765|P2|STARTED|Period 2-Stabilization Phase||183
1108367|NCT01149655|2681766|P1|STARTED|Period 2-Stabilization Phase||0
1108368|NCT01149655|2681763|P4|NOT COMPLETED|Period 1 - Conversion Phase||0
1108369|NCT01149655|2681764|P3|NOT COMPLETED|Period 1 - Conversion Phase||0
1108370|NCT01149655|2681765|P2|NOT COMPLETED|Period 1 - Conversion Phase||0
1108371|NCT01149655|2681766|P1|NOT COMPLETED|Period 1 - Conversion Phase||18
1108372|NCT01149655|2681763|P4|COMPLETED|Period 1 - Conversion Phase||0
1108373|NCT01149655|2681764|P3|COMPLETED|Period 1 - Conversion Phase||0
1108374|NCT01149655|2681765|P2|COMPLETED|Period 1 - Conversion Phase||0
1108375|NCT01149655|2681766|P1|COMPLETED|Period 1 - Conversion Phase||168
1108376|NCT01149655|2681763|P4|STARTED|Period 1 - Conversion Phase||0
1108377|NCT01149655|2681764|P3|STARTED|Period 1 - Conversion Phase||0
1108378|NCT01149655|2681765|P2|STARTED|Period 1 - Conversion Phase||0
1108379|NCT01149655|2681766|P1|STARTED|Period 1 - Conversion Phase||186
1108380|NCT01149733|2681796|P2|NOT COMPLETED|Overall Study||0
1108381|NCT01149733|2681797|P1|NOT COMPLETED|Overall Study||0
1108382|NCT01149733|2681796|P2|COMPLETED|Overall Study||16
1108383|NCT01149733|2681797|P1|COMPLETED|Overall Study||16
1108384|NCT01149733|2681796|P2|STARTED|Overall Study||16
1108385|NCT01149733|2681797|P1|STARTED|Overall Study||16
1108386|NCT01149759|2681807|P1|NOT COMPLETED|Overall Study||0
1108387|NCT01149759|2681807|P1|COMPLETED|Overall Study||9
1108388|NCT01149759|2681807|P1|STARTED|Overall Study||9
1108389|NCT01149772|2681814|P2|NOT COMPLETED|Overall Study||21
1108390|NCT01149772|2681815|P1|NOT COMPLETED|Overall Study||48
1108391|NCT01149772|2681814|P2|COMPLETED|Overall Study||101
1108392|NCT01149772|2681815|P1|COMPLETED|Overall Study||132
1108393|NCT01149772|2681814|P2|STARTED|Overall Study||122
1108394|NCT01149772|2681815|P1|STARTED|Overall Study||180
1108395|NCT01149785|2681831|P2|NOT COMPLETED|Second Intervention||0
1108396|NCT01149785|2681832|P1|NOT COMPLETED|Second Intervention||0
1108397|NCT01149785|2681831|P2|COMPLETED|Second Intervention||15
1108398|NCT01149785|2681832|P1|COMPLETED|Second Intervention||0
1108399|NCT01149785|2681831|P2|STARTED|Second Intervention||15
1108400|NCT01149785|2681832|P1|STARTED|Second Intervention||0
1108401|NCT01149785|2681831|P2|NOT COMPLETED|Washout Period of at Least 14 Days||0
1108402|NCT01149785|2681832|P1|NOT COMPLETED|Washout Period of at Least 14 Days||0
1108403|NCT01149785|2681831|P2|COMPLETED|Washout Period of at Least 14 Days||0
1108404|NCT01149785|2681832|P1|COMPLETED|Washout Period of at Least 14 Days||15
1108405|NCT01149785|2681831|P2|STARTED|Washout Period of at Least 14 Days||0
1108406|NCT01149785|2681832|P1|STARTED|Washout Period of at Least 14 Days||15
1108407|NCT01149785|2681831|P2|NOT COMPLETED|First Intervention||0
1108408|NCT01149785|2681832|P1|NOT COMPLETED|First Intervention||0
1108409|NCT01149785|2681831|P2|COMPLETED|First Intervention||0
1108410|NCT01149785|2681832|P1|COMPLETED|First Intervention||15
1108411|NCT01149785|2681831|P2|STARTED|First Intervention||0
1108412|NCT01149785|2681832|P1|STARTED|First Intervention||15
1108413|NCT01149863|2681864|P1|NOT COMPLETED|Overall Study||3
1108414|NCT01149863|2681864|P1|COMPLETED|Overall Study||31
1108415|NCT01149863|2681864|P1|STARTED|Overall Study||34
1108416|NCT01149876|2681873|P4|NOT COMPLETED|Overall Study||0
1108417|NCT01149876|2681874|P3|NOT COMPLETED|Overall Study||1
1108418|NCT01149876|2681875|P2|NOT COMPLETED|Overall Study||0
1108419|NCT01149876|2681876|P1|NOT COMPLETED|Overall Study||1
1108420|NCT01149876|2681873|P4|COMPLETED|Overall Study||18
1108421|NCT01149876|2681874|P3|COMPLETED|Overall Study||20
1108422|NCT01149876|2681875|P2|COMPLETED|Overall Study||20
1108423|NCT01149876|2681876|P1|COMPLETED|Overall Study||20
1108424|NCT01149876|2681873|P4|STARTED|Overall Study||18
1108425|NCT01149876|2681874|P3|STARTED|Overall Study||21
1108426|NCT01149876|2681875|P2|STARTED|Overall Study||20
1108427|NCT01149876|2681876|P1|STARTED|Overall Study||21
1108428|NCT01150097|2681893|P3|NOT COMPLETED|Months 24 to 48 Post-transplantation||0
1108429|NCT01150097|2681894|P2|NOT COMPLETED|Months 24 to 48 Post-transplantation||4
1108430|NCT01150097|2681895|P1|NOT COMPLETED|Months 24 to 48 Post-transplantation||11
1108431|NCT01150097|2681893|P3|COMPLETED|Months 24 to 48 Post-transplantation||0
1108432|NCT01150097|2681894|P2|COMPLETED|Months 24 to 48 Post-transplantation||47
1108433|NCT01150097|2681895|P1|COMPLETED|Months 24 to 48 Post-transplantation||95
1108434|NCT01150097|2681893|P3|STARTED|Months 24 to 48 Post-transplantation||0
1108435|NCT01150097|2681894|P2|STARTED|Months 24 to 48 Post-transplantation||51
1108436|NCT01150097|2681895|P1|STARTED|Months 24 to 48 Post-transplantation||106
1108437|NCT01150097|2681893|P3|NOT COMPLETED|Months 24 to 36 Post-transplantation||8
1108438|NCT01150097|2681894|P2|NOT COMPLETED|Months 24 to 36 Post-transplantation||2
1108439|NCT01150097|2681895|P1|NOT COMPLETED|Months 24 to 36 Post-transplantation||10
1108440|NCT01150097|2681893|P3|COMPLETED|Months 24 to 36 Post-transplantation||117
1108441|NCT01150097|2681894|P2|COMPLETED|Months 24 to 36 Post-transplantation||49
1108442|NCT01150097|2681895|P1|COMPLETED|Months 24 to 36 Post-transplantation||96
1108443|NCT01150097|2681893|P3|STARTED|Months 24 to 36 Post-transplantation||125
1108444|NCT01150097|2681894|P2|STARTED|Months 24 to 36 Post-transplantation||51
1108445|NCT01150097|2681895|P1|STARTED|Months 24 to 36 Post-transplantation||106
1108446|NCT01150123|2681936|P18|NOT COMPLETED|Overall Study||1
1108447|NCT01150123|2681937|P17|NOT COMPLETED|Overall Study||0
1108448|NCT01150123|2681938|P16|NOT COMPLETED|Overall Study||1
1108449|NCT01150123|2681939|P15|NOT COMPLETED|Overall Study||0
1108450|NCT01150123|2681940|P14|NOT COMPLETED|Overall Study||0
1108451|NCT01150123|2681941|P13|NOT COMPLETED|Overall Study||3
1108452|NCT01150123|2681942|P12|NOT COMPLETED|Overall Study||1
1108453|NCT01150123|2681943|P11|NOT COMPLETED|Overall Study||2
1108454|NCT01150123|2681944|P10|NOT COMPLETED|Overall Study||1
1108455|NCT01150123|2681945|P9|NOT COMPLETED|Overall Study||5
1108456|NCT01150123|2681946|P8|NOT COMPLETED|Overall Study||3
1108457|NCT01150123|2681947|P7|NOT COMPLETED|Overall Study||0
1108458|NCT01150123|2681948|P6|NOT COMPLETED|Overall Study||6
1108459|NCT01150123|2681949|P5|NOT COMPLETED|Overall Study||3
1108460|NCT01150123|2681950|P4|NOT COMPLETED|Overall Study||3
1108461|NCT01150123|2681951|P3|NOT COMPLETED|Overall Study||4
1108462|NCT01150123|2681952|P2|NOT COMPLETED|Overall Study||2
1108463|NCT01150123|2681953|P1|NOT COMPLETED|Overall Study||3
1108464|NCT01150123|2681936|P18|COMPLETED|Overall Study||19
1108465|NCT01150123|2681937|P17|COMPLETED|Overall Study||40
1108466|NCT01150123|2681938|P16|COMPLETED|Overall Study||39
1108467|NCT01150123|2681939|P15|COMPLETED|Overall Study||40
1108468|NCT01150123|2681940|P14|COMPLETED|Overall Study||40
1108469|NCT01150123|2681941|P13|COMPLETED|Overall Study||37
1108470|NCT01150123|2681942|P12|COMPLETED|Overall Study||39
1108471|NCT01150123|2681943|P11|COMPLETED|Overall Study||38
1108472|NCT01150123|2681944|P10|COMPLETED|Overall Study||39
1108473|NCT01150123|2681945|P9|COMPLETED|Overall Study||15
1108474|NCT01150123|2681946|P8|COMPLETED|Overall Study||37
1108475|NCT01150123|2681947|P7|COMPLETED|Overall Study||39
1108476|NCT01150123|2681948|P6|COMPLETED|Overall Study||34
1108477|NCT01150123|2681949|P5|COMPLETED|Overall Study||37
1108478|NCT01150123|2681950|P4|COMPLETED|Overall Study||37
1108479|NCT01150123|2681951|P3|COMPLETED|Overall Study||35
1108480|NCT01150123|2681952|P2|COMPLETED|Overall Study||38
1108481|NCT01150123|2681953|P1|COMPLETED|Overall Study||37
1108482|NCT01150123|2681936|P18|STARTED|Overall Study||20
1108483|NCT01150123|2681937|P17|STARTED|Overall Study||40
1108484|NCT01150123|2681938|P16|STARTED|Overall Study||40
1108485|NCT01150123|2681939|P15|STARTED|Overall Study||40
1108486|NCT01150123|2681940|P14|STARTED|Overall Study||40
1108487|NCT01150123|2681941|P13|STARTED|Overall Study||40
1108488|NCT01150123|2681942|P12|STARTED|Overall Study||40
1108489|NCT01150123|2681943|P11|STARTED|Overall Study||40
1108490|NCT01150123|2681944|P10|STARTED|Overall Study||40
1108491|NCT01150123|2681945|P9|STARTED|Overall Study||20
1108492|NCT01150123|2681946|P8|STARTED|Overall Study||40
1108493|NCT01150123|2681947|P7|STARTED|Overall Study||39
1108494|NCT01150123|2681948|P6|STARTED|Overall Study||40
1108495|NCT01150123|2681949|P5|STARTED|Overall Study||40
1108496|NCT01150123|2681950|P4|STARTED|Overall Study||40
1108497|NCT01150123|2681951|P3|STARTED|Overall Study||39
1108498|NCT01150123|2681952|P2|STARTED|Overall Study||40
1108499|NCT01150123|2681953|P1|STARTED|Overall Study||40
1108500|NCT01150357|2682129|P3|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||2
1108501|NCT01150357|2682130|P2|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||0
1108502|NCT01150357|2682131|P1|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||3
1108503|NCT01150357|2682129|P3|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||100
1108504|NCT01150357|2682130|P2|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||51
1108505|NCT01150357|2682131|P1|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||104
1108506|NCT01150357|2682129|P3|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||51
1108507|NCT01150357|2682130|P2|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||21
1108508|NCT01150357|2682131|P1|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||54
1108509|NCT01150357|2682129|P3|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||52
1108510|NCT01150357|2682130|P2|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||21
1108511|NCT01150357|2682131|P1|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||57
1108512|NCT01150357|2682129|P3|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||49
1108513|NCT01150357|2682130|P2|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
1108514|NCT01150357|2682131|P1|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
1108515|NCT01150357|2682129|P3|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
1108516|NCT01150357|2682130|P2|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
1108517|NCT01150357|2682131|P1|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
1108518|NCT01150357|2682129|P3|STARTED|Placebo-controlled Withdrawal (Phase 2)||102
1108519|NCT01150357|2682130|P2|STARTED|Placebo-controlled Withdrawal (Phase 2)||51
1108520|NCT01150357|2682131|P1|STARTED|Placebo-controlled Withdrawal (Phase 2)||107
1108521|NCT01150357|2682129|P3|NOT COMPLETED|Dose Response Phase (Phase 1)||3
1108522|NCT01150357|2682130|P2|NOT COMPLETED|Dose Response Phase (Phase 1)||3
1108523|NCT01150357|2682131|P1|NOT COMPLETED|Dose Response Phase (Phase 1)||1
1108524|NCT01150357|2682129|P3|COMPLETED|Dose Response Phase (Phase 1)||102
1108525|NCT01150357|2682130|P2|COMPLETED|Dose Response Phase (Phase 1)||51
1108526|NCT01150357|2682131|P1|COMPLETED|Dose Response Phase (Phase 1)||107
1108527|NCT01150357|2682129|P3|STARTED|Dose Response Phase (Phase 1)||105
1108528|NCT01150357|2682130|P2|STARTED|Dose Response Phase (Phase 1)||54
1108529|NCT01150357|2682131|P1|STARTED|Dose Response Phase (Phase 1)||108
1108530|NCT01150409|2682195|P2|NOT COMPLETED|Overall Study||0
1108531|NCT01150409|2682196|P1|NOT COMPLETED|Overall Study||0
1108532|NCT01150409|2682195|P2|COMPLETED|Overall Study||0
1108533|NCT01150409|2682196|P1|COMPLETED|Overall Study||11
1108534|NCT01150409|2682195|P2|STARTED|Overall Study||0
1108535|NCT01150409|2682196|P1|STARTED|Overall Study||11
1108536|NCT01150461|2682204|P2|NOT COMPLETED|Overall Study||0
1108537|NCT01150461|2682205|P1|NOT COMPLETED|Overall Study||0
1108538|NCT01150461|2682204|P2|COMPLETED|Overall Study||9
1108539|NCT01150461|2682205|P1|COMPLETED|Overall Study||11
1108540|NCT01150461|2682204|P2|STARTED|Overall Study||9
1108541|NCT01150461|2682205|P1|STARTED|Overall Study||11
1108542|NCT01150474|2682215|P2|NOT COMPLETED|Overall Study||3
1108543|NCT01150474|2682216|P1|NOT COMPLETED|Overall Study||10
1108544|NCT01150474|2682215|P2|COMPLETED|Overall Study||49
1108545|NCT01150474|2682216|P1|COMPLETED|Overall Study||41
1108546|NCT01150474|2682215|P2|STARTED|Overall Study||52
1108547|NCT01150474|2682216|P1|STARTED|Overall Study||51
1108548|NCT01150500|2682238|P1|NOT COMPLETED|Overall Study||65
1108549|NCT01150500|2682238|P1|COMPLETED|Overall Study||0
1108550|NCT01150500|2682238|P1|STARTED|Overall Study||65
1108551|NCT01150760|2682249|P2|NOT COMPLETED|Overall Study||0
1108552|NCT01150760|2682250|P1|NOT COMPLETED|Overall Study||0
1108553|NCT01150760|2682249|P2|COMPLETED|Overall Study||3525
1108554|NCT01150760|2682250|P1|COMPLETED|Overall Study||3525
1108555|NCT01150760|2682249|P2|STARTED|Overall Study||3525
1108556|NCT01150760|2682250|P1|STARTED|Overall Study||3525
1108557|NCT01150903|2682284|P2|NOT COMPLETED|Overall Study||0
1108558|NCT01150903|2682285|P1|NOT COMPLETED|Overall Study||0
1108559|NCT01150903|2682284|P2|COMPLETED|Overall Study||74124
1108560|NCT01150903|2682285|P1|COMPLETED|Overall Study||24708
1108561|NCT01150903|2682284|P2|STARTED|Overall Study||74124
1108562|NCT01150903|2682285|P1|STARTED|Overall Study||24708
1108563|NCT01150981|2682301|P2|NOT COMPLETED|Overall Study||2
1108564|NCT01150981|2682302|P1|NOT COMPLETED|Overall Study||4
1108565|NCT01150981|2682301|P2|COMPLETED|Overall Study||13
1108566|NCT01150981|2682302|P1|COMPLETED|Overall Study||16
1108567|NCT01150981|2682301|P2|STARTED|Overall Study||15
1108568|NCT01150981|2682302|P1|STARTED|Overall Study||20
1108569|NCT01151020|2682310|P1|NOT COMPLETED|Overall Study||110
1108570|NCT01151020|2682310|P1|COMPLETED|Overall Study||0
1108571|NCT01151020|2682310|P1|12-month|Overall Study||99
1108572|NCT01151020|2682310|P1|30-day|Overall Study||110
1108573|NCT01151020|2682310|P1|STARTED|Overall Study||110
1108574|NCT01151046|2682317|P2|NOT COMPLETED|Overall Study||0
1108575|NCT01151046|2682318|P1|NOT COMPLETED|Overall Study||3
1108576|NCT01151046|2682317|P2|COMPLETED|Overall Study||59
1108577|NCT01151046|2682318|P1|COMPLETED|Overall Study||56
1108578|NCT01151046|2682317|P2|STARTED|Overall Study||59
1108579|NCT01151046|2682318|P1|STARTED|Overall Study||59
1108580|NCT01151085|2682330|P1|NOT COMPLETED|Overall Study||56
1108581|NCT01151085|2682330|P1|COMPLETED|Overall Study||946
1108582|NCT01151085|2682330|P1|STARTED|Overall Study||1002
1108583|NCT01151098|2682346|P1|NOT COMPLETED|Overall Study||117
1108584|NCT01151098|2682346|P1|COMPLETED|Overall Study||72
1108585|NCT01151098|2682346|P1|STARTED|Overall Study|Extension Safety Population|189
1108586|NCT01151137|2682352|P2|NOT COMPLETED|Overall Study||28
1108587|NCT01151137|2682353|P1|NOT COMPLETED|Overall Study||16
1108588|NCT01151137|2682352|P2|COMPLETED|Overall Study||1591
1108589|NCT01151137|2682353|P1|COMPLETED|Overall Study||1601
1108590|NCT01151137|2682352|P2|Discontinued Treatment|Overall Study||342
1108591|NCT01151137|2682353|P1|Discontinued Treatment|Overall Study||171
1108592|NCT01151137|2682352|P2|Treated|Overall Study||1613
1108593|NCT01151137|2682353|P1|Treated|Overall Study|One participant randomized to the placebo group received Dronedarone for 7 days by mistake|1610
1108594|NCT01151137|2682352|P2|STARTED|Overall Study||1619
1108595|NCT01151137|2682353|P1|STARTED|Overall Study||1617
1108596|NCT01151189|2682373|P2|NOT COMPLETED|Overall Study||10
1108597|NCT01151189|2682374|P1|NOT COMPLETED|Overall Study||15
1108598|NCT01151189|2682373|P2|COMPLETED|Overall Study||314
1108599|NCT01151189|2682374|P1|COMPLETED|Overall Study||311
1108600|NCT01151189|2682373|P2|Received Vaccine|Overall Study||324
1108601|NCT01151189|2682374|P1|Received Vaccine|Overall Study||325
1108602|NCT01151189|2682373|P2|STARTED|Overall Study||324
1108603|NCT01151189|2682374|P1|STARTED|Overall Study||326
1108604|NCT01151215|2682399|P3|NOT COMPLETED|Overall Study||19
1108605|NCT01151215|2682400|P2|NOT COMPLETED|Overall Study||23
1108606|NCT01151215|2682401|P1|NOT COMPLETED|Overall Study||20
1108607|NCT01151215|2682399|P3|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|102
1108608|NCT01151215|2682400|P2|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|95
1108609|NCT01151215|2682401|P1|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|100
1108610|NCT01151215|2682399|P3|STARTED|Overall Study||121
1108611|NCT01151215|2682400|P2|STARTED|Overall Study||118
1108612|NCT01151215|2682401|P1|STARTED|Overall Study||120
1108613|NCT01151280|2682412|P1|NOT COMPLETED|Overall Study||4
1108614|NCT01151280|2682412|P1|COMPLETED|Overall Study||6
1108615|NCT01151280|2682412|P1|STARTED|Overall Study||10
1108616|NCT01151345|2682422|P2|NOT COMPLETED|Second Intervention Period||0
1108617|NCT01151345|2682423|P1|NOT COMPLETED|Second Intervention Period||0
1108618|NCT01151345|2682422|P2|COMPLETED|Second Intervention Period||12
1108619|NCT01151345|2682423|P1|COMPLETED|Second Intervention Period||13
1108620|NCT01151345|2682422|P2|STARTED|Second Intervention Period||12
1108621|NCT01151345|2682423|P1|STARTED|Second Intervention Period||13
1108622|NCT01151345|2682422|P2|NOT COMPLETED|Wash-out Period (7 Days)||0
1108623|NCT01151345|2682423|P1|NOT COMPLETED|Wash-out Period (7 Days)||0
1108624|NCT01151345|2682422|P2|COMPLETED|Wash-out Period (7 Days)||12
1108625|NCT01151345|2682423|P1|COMPLETED|Wash-out Period (7 Days)||13
1108626|NCT01151345|2682422|P2|STARTED|Wash-out Period (7 Days)||12
1108627|NCT01151345|2682423|P1|STARTED|Wash-out Period (7 Days)||13
1108628|NCT01151345|2682422|P2|NOT COMPLETED|First Intervention Period||1
1108629|NCT01151345|2682423|P1|NOT COMPLETED|First Intervention Period||0
1108630|NCT01151345|2682422|P2|COMPLETED|First Intervention Period||12
1108631|NCT01151345|2682423|P1|COMPLETED|First Intervention Period||13
1108632|NCT01151345|2682422|P2|Treated|First Intervention Period||12
1108633|NCT01151345|2682423|P1|Treated|First Intervention Period||13
1108634|NCT01151345|2682422|P2|STARTED|First Intervention Period||13
1108635|NCT01151345|2682423|P1|STARTED|First Intervention Period||13
1108636|NCT01151371|2682440|P3|NOT COMPLETED|Overall Study||7
1108637|NCT01151371|2682441|P2|NOT COMPLETED|Overall Study||1
1108638|NCT01151371|2682442|P1|NOT COMPLETED|Overall Study||5
1108639|NCT01151371|2682440|P3|COMPLETED|Overall Study||146
1108640|NCT01151371|2682441|P2|COMPLETED|Overall Study||149
1108641|NCT01151371|2682442|P1|COMPLETED|Overall Study||144
1108642|NCT01151371|2682440|P3|STARTED|Overall Study||153
1108643|NCT01151371|2682441|P2|STARTED|Overall Study||150
1108644|NCT01151371|2682442|P1|STARTED|Overall Study||149
1108645|NCT01151410|2682473|P2|NOT COMPLETED|Overall Study||15
1108646|NCT01151410|2682474|P1|NOT COMPLETED|Overall Study||11
1108647|NCT01151410|2682473|P2|COMPLETED|Overall Study||89
1108648|NCT01151410|2682474|P1|COMPLETED|Overall Study||93
1108649|NCT01151410|2682473|P2|Safety Set (SAF)|Overall Study|Number of patients in SAF differed due to kit dispensing error in 1 patient at Visit 12|103
1108650|NCT01151410|2682474|P1|Safety Set (SAF)|Overall Study||105
1108651|NCT01151410|2682473|P2|STARTED|Overall Study||104
1108652|NCT01151410|2682474|P1|STARTED|Overall Study||104
1108653|NCT01151436|2682484|P1|NOT COMPLETED|Overall Study||1
1108654|NCT01151436|2682484|P1|COMPLETED|Overall Study||76
1108655|NCT01151436|2682484|P1|STARTED|Overall Study||77
1108656|NCT01151449|2682514|P1|NOT COMPLETED|Overall Study||0
1108657|NCT01151449|2682514|P1|COMPLETED|Overall Study||6
1108658|NCT01151449|2682514|P1|STARTED|Overall Study||6
1108659|NCT01151553|2682522|P1|NOT COMPLETED|Overall Study||0
1108660|NCT01151553|2682522|P1|COMPLETED|Overall Study||5
1108661|NCT01151553|2682522|P1|STARTED|Overall Study||5
1108662|NCT01145001|2682530|P4|NOT COMPLETED|Overall Study||6
1108663|NCT01145001|2682531|P3|NOT COMPLETED|Overall Study||5
1108664|NCT01145001|2682532|P2|NOT COMPLETED|Overall Study||6
1108665|NCT01145001|2682533|P1|NOT COMPLETED|Overall Study||8
1108666|NCT01145001|2682530|P4|COMPLETED|Overall Study||31
1108667|NCT01145001|2682531|P3|COMPLETED|Overall Study||39
1108668|NCT01145001|2682532|P2|COMPLETED|Overall Study||31
1108669|NCT01145001|2682533|P1|COMPLETED|Overall Study||28
1108670|NCT01145001|2682530|P4|STARTED|Overall Study||37
1108671|NCT01145001|2682531|P3|STARTED|Overall Study||44
1108672|NCT01145001|2682532|P2|STARTED|Overall Study||37
1108673|NCT01145001|2682533|P1|STARTED|Overall Study||36
1108674|NCT01145053|2682547|P1|NOT COMPLETED|Overall Study||93
1108675|NCT01145053|2682547|P1|COMPLETED|Overall Study||248
1108676|NCT01145053|2682547|P1|STARTED|Overall Study||341
1108677|NCT01151579|2682559|P2|NOT COMPLETED|Overall Study||7
1108678|NCT01151579|2682560|P1|NOT COMPLETED|Overall Study||12
1108679|NCT01151579|2682559|P2|COMPLETED|Overall Study||24
1108680|NCT01151579|2682560|P1|COMPLETED|Overall Study||46
1108681|NCT01151579|2682559|P2|STARTED|Overall Study||31
1108682|NCT01151579|2682560|P1|STARTED|Overall Study||58
1108683|NCT01151761|2682570|P1|NOT COMPLETED|Overall Study||0
1108684|NCT01151761|2682570|P1|COMPLETED|Overall Study||2
1108685|NCT01151761|2682570|P1|STARTED|Overall Study||2
1108686|NCT01151852|2682583|P2|NOT COMPLETED|Overall Study||0
1108687|NCT01151852|2682584|P1|NOT COMPLETED|Overall Study||0
1108688|NCT01151852|2682583|P2|COMPLETED|Overall Study||40
1108689|NCT01151852|2682584|P1|COMPLETED|Overall Study||41
1108690|NCT01151852|2682583|P2|STARTED|Overall Study||40
1108691|NCT01151852|2682584|P1|STARTED|Overall Study||41
1108692|NCT01152697|2682600|P1|NOT COMPLETED|Overall Study||19
1108693|NCT01152697|2682600|P1|COMPLETED|Overall Study||11
1108694|NCT01152697|2682600|P1|STARTED|Overall Study||30
1108695|NCT01152788|2682625|P2|NOT COMPLETED|Overall Study||4
1108696|NCT01152788|2682626|P1|NOT COMPLETED|Overall Study||0
1108697|NCT01152788|2682625|P2|COMPLETED|Overall Study||28
1108698|NCT01152788|2682626|P1|COMPLETED|Overall Study||32
1108699|NCT01152788|2682625|P2|STARTED|Overall Study||32
1108700|NCT01152788|2682626|P1|STARTED|Overall Study||32
1108701|NCT01152814|2682638|P1|NOT COMPLETED|Overall Study||2
1108702|NCT01152814|2682638|P1|COMPLETED|Overall Study||62
1108703|NCT01152814|2682638|P1|STARTED|Overall Study||64
1108708|NCT01153009|2682662|P4|NOT COMPLETED|Overall Study||37
1108709|NCT01153009|2682663|P3|NOT COMPLETED|Overall Study||41
1108710|NCT01153009|2682664|P2|NOT COMPLETED|Overall Study||34
1108711|NCT01153009|2682665|P1|NOT COMPLETED|Overall Study||32
1108712|NCT01153009|2682662|P4|COMPLETED|Overall Study||115
1108713|NCT01153009|2682663|P3|COMPLETED|Overall Study||113
1108714|NCT01153009|2682664|P2|COMPLETED|Overall Study||113
1108715|NCT01153009|2682665|P1|COMPLETED|Overall Study||129
1108716|NCT01153009|2682662|P4|Treated|Overall Study||150
1108717|NCT01153009|2682663|P3|Treated|Overall Study||154
1108718|NCT01153009|2682664|P2|Treated|Overall Study||147
1108719|NCT01153009|2682665|P1|Treated|Overall Study||159
1108720|NCT01153009|2682662|P4|STARTED|Overall Study||152
1108721|NCT01153009|2682663|P3|STARTED|Overall Study||154
1108722|NCT01153009|2682664|P2|STARTED|Overall Study||147
1108723|NCT01153009|2682665|P1|STARTED|Overall Study||161
1108724|NCT01153269|2682695|P1|NOT COMPLETED|Overall Study||2
1108725|NCT01153269|2682695|P1|COMPLETED|Overall Study||31
1108726|NCT01153269|2682695|P1|Participants Analyzed|Overall Study||33
1108727|NCT01153269|2682695|P1|STARTED|Overall Study||33
1108728|NCT01153321|2682756|P2|NOT COMPLETED|Overall Study||3
1108729|NCT01153321|2682757|P1|NOT COMPLETED|Overall Study||1
1108730|NCT01153321|2682756|P2|COMPLETED|Overall Study||19
1108731|NCT01153321|2682757|P1|COMPLETED|Overall Study||21
1108732|NCT01153321|2682756|P2|STARTED|Overall Study||22
1108733|NCT01153321|2682757|P1|STARTED|Overall Study||22
1108734|NCT01153347|2682873|P4|NOT COMPLETED|Overall Study||32
1108735|NCT01153347|2682874|P3|NOT COMPLETED|Overall Study||50
1108736|NCT01153347|2682875|P2|NOT COMPLETED|Overall Study||44
1108737|NCT01153347|2682876|P1|NOT COMPLETED|Overall Study||33
1108738|NCT01153347|2682873|P4|COMPLETED|Overall Study||129
1108739|NCT01153347|2682874|P3|COMPLETED|Overall Study||110
1108740|NCT01153347|2682875|P2|COMPLETED|Overall Study||116
1108741|NCT01153347|2682876|P1|COMPLETED|Overall Study||127
1108742|NCT01153347|2682873|P4|Received Treatment|Overall Study||160
1108743|NCT01153347|2682874|P3|Received Treatment|Overall Study||158
1108744|NCT01153347|2682875|P2|Received Treatment|Overall Study||158
1108745|NCT01153347|2682876|P1|Received Treatment|Overall Study||160
1108746|NCT01153347|2682873|P4|STARTED|Overall Study||161
1108747|NCT01153347|2682874|P3|STARTED|Overall Study||160
1108748|NCT01153347|2682875|P2|STARTED|Overall Study||160
1108749|NCT01153347|2682876|P1|STARTED|Overall Study||160
1108750|NCT01153425|2682976|P2|NOT COMPLETED|Overall Study||3
1108751|NCT01153425|2682977|P1|NOT COMPLETED|Overall Study||3
1108752|NCT01153425|2682976|P2|COMPLETED|Overall Study||14
1108753|NCT01153425|2682977|P1|COMPLETED|Overall Study||13
1108754|NCT01153425|2682976|P2|STARTED|Overall Study||17
1108755|NCT01153425|2682977|P1|STARTED|Overall Study||16
1108756|NCT01153503|2682988|P3|NOT COMPLETED|Overall Study||0
1108757|NCT01153503|2682989|P2|NOT COMPLETED|Overall Study||1
1108758|NCT01153503|2682990|P1|NOT COMPLETED|Overall Study||0
1108759|NCT01153503|2682988|P3|COMPLETED|Overall Study||25
1108760|NCT01153503|2682989|P2|COMPLETED|Overall Study||24
1108761|NCT01153503|2682990|P1|COMPLETED|Overall Study||25
1108762|NCT01153503|2682988|P3|STARTED|Overall Study||25
1108763|NCT01153503|2682989|P2|STARTED|Overall Study||25
1108764|NCT01153503|2682990|P1|STARTED|Overall Study||25
1108765|NCT01153581|2682998|P1|NOT COMPLETED|Overall Study||0
1108766|NCT01153581|2682998|P1|COMPLETED|Overall Study||109
1108767|NCT01153581|2682998|P1|STARTED|Overall Study||109
1108768|NCT01153620|2683010|P2|NOT COMPLETED|Overall Study||0
1108769|NCT01153620|2683011|P1|NOT COMPLETED|Overall Study||0
1108770|NCT01153620|2683010|P2|COMPLETED|Overall Study|30 patients (31 wounds)|30
1108771|NCT01153620|2683011|P1|COMPLETED|Overall Study||30
1108772|NCT01153620|2683010|P2|STARTED|Overall Study|30 patients (31 wounds)|30
1108773|NCT01153620|2683011|P1|STARTED|Overall Study||30
1108774|NCT01153633|2683019|P2|NOT COMPLETED|Overall Study||4
1108775|NCT01153633|2683020|P1|NOT COMPLETED|Overall Study||4
1108776|NCT01153633|2683019|P2|COMPLETED|Overall Study||13
1108777|NCT01153633|2683020|P1|COMPLETED|Overall Study||13
1108778|NCT01153633|2683019|P2|STARTED|Overall Study||17
1108779|NCT01153633|2683020|P1|STARTED|Overall Study||17
1108780|NCT01153672|2683036|P1|NOT COMPLETED|Overall Study||2
1108781|NCT01153672|2683036|P1|COMPLETED|Overall Study||6
1108782|NCT01153672|2683036|P1|STARTED|Overall Study||8
1108783|NCT01153685|2683044|P2|NOT COMPLETED|Overall Study||0
1108784|NCT01153685|2683045|P1|NOT COMPLETED|Overall Study||0
1108785|NCT01153685|2683044|P2|COMPLETED|Overall Study||70
1108786|NCT01153685|2683045|P1|COMPLETED|Overall Study||50
1108787|NCT01153685|2683044|P2|STARTED|Overall Study||70
1108788|NCT01153685|2683045|P1|STARTED|Overall Study||50
1108789|NCT01153698|2683069|P1|NOT COMPLETED|Overall Study||29
1108790|NCT01153698|2683069|P1|COMPLETED|Overall Study|Completed Pradaxa treatment.|139
1108791|NCT01153698|2683069|P1|STARTED|Overall Study|Entered and treated.|168
1108792|NCT01153711|2683083|P1|NOT COMPLETED|Overall Study||0
1108793|NCT01153711|2683083|P1|COMPLETED|Overall Study||32
1108794|NCT01153711|2683083|P1|STARTED|Overall Study||32
1108795|NCT01153724|2683103|P1|NOT COMPLETED|Treatment Period 2||2
1108796|NCT01153724|2683103|P1|COMPLETED|Treatment Period 2||32
1108797|NCT01153724|2683103|P1|STARTED|Treatment Period 2||34
1108798|NCT01153724|2683103|P1|NOT COMPLETED|Treatment Period 1||1
1108799|NCT01153724|2683103|P1|COMPLETED|Treatment Period 1||34
1108800|NCT01153724|2683103|P1|STARTED|Treatment Period 1||35
1108801|NCT01153763|2683123|P1|NOT COMPLETED|Overall Study||21
1108802|NCT01153763|2683123|P1|COMPLETED|Overall Study||71
1108803|NCT01153763|2683123|P1|STARTED|Overall Study||92
1108804|NCT01153815|2683141|P2|NOT COMPLETED|Overall Study||5
1108805|NCT01153815|2683142|P1|NOT COMPLETED|Overall Study||9
1108806|NCT01153815|2683141|P2|COMPLETED|Overall Study||82
1108807|NCT01153815|2683142|P1|COMPLETED|Overall Study||74
1108808|NCT01153815|2683141|P2|STARTED|Overall Study||87
1108809|NCT01153815|2683142|P1|STARTED|Overall Study||83
1108810|NCT01153841|2683166|P2|NOT COMPLETED|Overall Study||0
1108811|NCT01153841|2683167|P1|NOT COMPLETED|Overall Study||6
1108812|NCT01153841|2683166|P2|COMPLETED|Overall Study||99
1108813|NCT01153841|2683167|P1|COMPLETED|Overall Study||193
1108814|NCT01153841|2683166|P2|STARTED|Overall Study||99
1108815|NCT01153841|2683167|P1|STARTED|Overall Study||199
1108816|NCT01153893|2683183|P2|NOT COMPLETED|Overall Study||0
1108817|NCT01153893|2683184|P1|NOT COMPLETED|Overall Study||1
1108818|NCT01153893|2683183|P2|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 3.|36
1108819|NCT01153893|2683184|P1|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 1.|67
1108820|NCT01153893|2683183|P2|STARTED|Overall Study||36
1108821|NCT01153893|2683184|P1|STARTED|Overall Study|Issues with the informed consent obtained from one child led to related data not used in this report|68
1108822|NCT01153958|2683210|P2|NOT COMPLETED|Overall Study||32
1108823|NCT01153958|2683211|P1|NOT COMPLETED|Overall Study||36
1108824|NCT01153958|2683210|P2|COMPLETED|Overall Study||35
1108825|NCT01153958|2683211|P1|COMPLETED|Overall Study||30
1108826|NCT01153958|2683210|P2|STARTED|Overall Study||67
1108827|NCT01153958|2683211|P1|STARTED|Overall Study||66
1108828|NCT01153971|2683227|P1|NOT COMPLETED|Follow-up (Months 17-40 of Study)||4
1108829|NCT01153971|2683227|P1|COMPLETED|Follow-up (Months 17-40 of Study)||37
1108830|NCT01153971|2683227|P1|STARTED|Follow-up (Months 17-40 of Study)||41
1108831|NCT01153971|2683227|P1|NOT COMPLETED|Maintenance Phase (Months 8-16 of Study)||3
1108832|NCT01153971|2683227|P1|COMPLETED|Maintenance Phase (Months 8-16 of Study)||41
1108833|NCT01153971|2683227|P1|STARTED|Maintenance Phase (Months 8-16 of Study)||44
1108834|NCT01153971|2683227|P1|NOT COMPLETED|Induction Phase (Months 1 to 7 of Study)||3
1108835|NCT01153971|2683227|P1|COMPLETED|Induction Phase (Months 1 to 7 of Study)||44
1108836|NCT01153971|2683227|P1|STARTED|Induction Phase (Months 1 to 7 of Study)||47
1108837|NCT01153984|2683248|P1|NOT COMPLETED|Overall Study||2
1108838|NCT01153984|2683248|P1|COMPLETED|Overall Study||21
1108839|NCT01153984|2683248|P1|STARTED|Overall Study||23
1108840|NCT01154010|2683261|P2|NOT COMPLETED|Overall Study||1
1108841|NCT01154010|2683262|P1|NOT COMPLETED|Overall Study||0
1108842|NCT01154010|2683261|P2|COMPLETED|Overall Study||8
1108843|NCT01154010|2683262|P1|COMPLETED|Overall Study||9
1108844|NCT01154010|2683261|P2|STARTED|Overall Study||9
1108845|NCT01154010|2683262|P1|STARTED|Overall Study||9
1108846|NCT01154036|2683271|P8|NOT COMPLETED|Phase II||6
1108847|NCT01154036|2683272|P7|NOT COMPLETED|Phase II||9
1108848|NCT01154036|2683273|P6|NOT COMPLETED|Phase II||5
1108849|NCT01154036|2683274|P5|NOT COMPLETED|Phase II||8
1108850|NCT01154036|2683275|P4|NOT COMPLETED|Phase II||1
1108851|NCT01154036|2683276|P3|NOT COMPLETED|Phase II||0
1108852|NCT01154036|2683277|P2|NOT COMPLETED|Phase II||0
1108853|NCT01154036|2683278|P1|NOT COMPLETED|Phase II||0
1108854|NCT01154036|2683271|P8|COMPLETED|Phase II||200
1108855|NCT01154036|2683272|P7|COMPLETED|Phase II||225
1108856|NCT01154036|2683273|P6|COMPLETED|Phase II||121
1108857|NCT01154036|2683274|P5|COMPLETED|Phase II||116
1108858|NCT01154036|2683275|P4|COMPLETED|Phase II||27
1108859|NCT01154036|2683276|P3|COMPLETED|Phase II||0
1108860|NCT01154036|2683277|P2|COMPLETED|Phase II||0
1108861|NCT01154036|2683278|P1|COMPLETED|Phase II||0
1108862|NCT01154036|2683271|P8|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|206
1108863|NCT01154036|2683272|P7|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|234
1108864|NCT01154036|2683273|P6|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|126
1108865|NCT01154036|2683274|P5|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|124
1108866|NCT01154036|2683275|P4|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|28
1108867|NCT01154036|2683276|P3|STARTED|Phase II||0
1108868|NCT01154036|2683277|P2|STARTED|Phase II||0
1108869|NCT01154036|2683278|P1|STARTED|Phase II||0
1108870|NCT01154036|2683271|P8|NOT COMPLETED|Phase I||0
1108871|NCT01154036|2683272|P7|NOT COMPLETED|Phase I||0
1108872|NCT01154036|2683273|P6|NOT COMPLETED|Phase I||0
1108873|NCT01154036|2683274|P5|NOT COMPLETED|Phase I||0
1108874|NCT01154036|2683275|P4|NOT COMPLETED|Phase I||0
1108875|NCT01154036|2683276|P3|NOT COMPLETED|Phase I||56
1108876|NCT01154036|2683277|P2|NOT COMPLETED|Phase I||28
1108877|NCT01154036|2683278|P1|NOT COMPLETED|Phase I||3
1108878|NCT01154036|2683271|P8|COMPLETED|Phase I||0
1108879|NCT01154036|2683272|P7|COMPLETED|Phase I||0
1108880|NCT01154036|2683273|P6|COMPLETED|Phase I||0
1108881|NCT01154036|2683274|P5|COMPLETED|Phase I||0
1108882|NCT01154036|2683275|P4|COMPLETED|Phase I||0
1108883|NCT01154036|2683276|P3|COMPLETED|Phase I|Not all completers were eligible for Phase II|888
1108884|NCT01154036|2683277|P2|COMPLETED|Phase I|Not all completers were eligible for Phase II|455
1108885|NCT01154036|2683278|P1|COMPLETED|Phase I|Not all completers were eligible for Phase II|117
1108886|NCT01154036|2683271|P8|STARTED|Phase I||0
1108887|NCT01154036|2683272|P7|STARTED|Phase I||0
1108888|NCT01154036|2683273|P6|STARTED|Phase I||0
1108889|NCT01154036|2683274|P5|STARTED|Phase I||0
1108890|NCT01154036|2683275|P4|STARTED|Phase I||0
1108891|NCT01154036|2683276|P3|STARTED|Phase I||944
1108892|NCT01154036|2683277|P2|STARTED|Phase I||483
1108893|NCT01154036|2683278|P1|STARTED|Phase I||120
1108894|NCT01154127|2683402|P2|NOT COMPLETED|Period 2 (21 Days)||1
1108895|NCT01154127|2683403|P1|NOT COMPLETED|Period 2 (21 Days)||0
1108896|NCT01154127|2683402|P2|COMPLETED|Period 2 (21 Days)||46
1108897|NCT01154127|2683403|P1|COMPLETED|Period 2 (21 Days)||49
1108898|NCT01154127|2683402|P2|STARTED|Period 2 (21 Days)||47
1108899|NCT01154127|2683403|P1|STARTED|Period 2 (21 Days)||49
1108900|NCT01154127|2683402|P2|NOT COMPLETED|Washout (14 - 28 Days)||0
1108901|NCT01154127|2683403|P1|NOT COMPLETED|Washout (14 - 28 Days)||3
1108902|NCT01154127|2683402|P2|COMPLETED|Washout (14 - 28 Days)||47
1108903|NCT01154127|2683403|P1|COMPLETED|Washout (14 - 28 Days)||49
1108904|NCT01154127|2683402|P2|STARTED|Washout (14 - 28 Days)||47
1108905|NCT01154127|2683403|P1|STARTED|Washout (14 - 28 Days)||52
1108906|NCT01154127|2683402|P2|NOT COMPLETED|Period 1 (21 Days)||6
1108907|NCT01154127|2683403|P1|NOT COMPLETED|Period 1 (21 Days)||3
1108908|NCT01154127|2683402|P2|COMPLETED|Period 1 (21 Days)||47
1108909|NCT01154127|2683403|P1|COMPLETED|Period 1 (21 Days)||52
1108910|NCT01154127|2683402|P2|STARTED|Period 1 (21 Days)||53
1108911|NCT01154127|2683403|P1|STARTED|Period 1 (21 Days)||55
1108912|NCT01154140|2683427|P2|NOT COMPLETED|Overall Study||171
1108913|NCT01154140|2683428|P1|NOT COMPLETED|Overall Study||172
1108914|NCT01154140|2683427|P2|COMPLETED|Overall Study||0
1108915|NCT01154140|2683428|P1|COMPLETED|Overall Study||0
1108916|NCT01154140|2683427|P2|Treated|Overall Study||169
1108917|NCT01154140|2683428|P1|Treated|Overall Study||171
1108918|NCT01154140|2683427|P2|STARTED|Overall Study||171
1108919|NCT01154140|2683428|P1|STARTED|Overall Study||172
1108920|NCT01154153|2683477|P2|NOT COMPLETED|Overall Study||3
1108921|NCT01154153|2683478|P1|NOT COMPLETED|Overall Study||5
1108922|NCT01154153|2683477|P2|COMPLETED|Overall Study||66
1108923|NCT01154153|2683478|P1|COMPLETED|Overall Study||66
1108924|NCT01154153|2683477|P2|STARTED|Overall Study||69
1108925|NCT01154153|2683478|P1|STARTED|Overall Study||71
1108926|NCT01154166|2683496|P2|NOT COMPLETED|Overall Study||12
1108927|NCT01154166|2683497|P1|NOT COMPLETED|Overall Study||34
1108928|NCT01154166|2683496|P2|COMPLETED|Overall Study||163
1108929|NCT01154166|2683497|P1|COMPLETED|Overall Study||135
1108930|NCT01154166|2683496|P2|STARTED|Overall Study||175
1108931|NCT01154166|2683497|P1|STARTED|Overall Study||169
1108932|NCT01154218|2683527|P4|NOT COMPLETED|Fourth Intervention Period||0
1108933|NCT01154218|2683528|P3|NOT COMPLETED|Fourth Intervention Period||0
1108934|NCT01154218|2683529|P2|NOT COMPLETED|Fourth Intervention Period||0
1108935|NCT01154218|2683530|P1|NOT COMPLETED|Fourth Intervention Period||1
1108936|NCT01154218|2683527|P4|COMPLETED|Fourth Intervention Period||8
1108937|NCT01154218|2683528|P3|COMPLETED|Fourth Intervention Period||9
1108938|NCT01154218|2683529|P2|COMPLETED|Fourth Intervention Period||8
1108939|NCT01154218|2683530|P1|COMPLETED|Fourth Intervention Period||8
1108940|NCT01154218|2683527|P4|STARTED|Fourth Intervention Period||8
1108941|NCT01154218|2683528|P3|STARTED|Fourth Intervention Period||9
1108942|NCT01154218|2683529|P2|STARTED|Fourth Intervention Period||8
1108943|NCT01154218|2683530|P1|STARTED|Fourth Intervention Period||9
1108944|NCT01154218|2683527|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||1
1108945|NCT01154218|2683528|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1108946|NCT01154218|2683529|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1108947|NCT01154218|2683530|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1108948|NCT01154218|2683527|P4|COMPLETED|Washout Period (at Least 14 Days)||8
1108949|NCT01154218|2683528|P3|COMPLETED|Washout Period (at Least 14 Days)||9
1108950|NCT01154218|2683529|P2|COMPLETED|Washout Period (at Least 14 Days)||8
1108951|NCT01154218|2683530|P1|COMPLETED|Washout Period (at Least 14 Days)||9
1108952|NCT01154218|2683527|P4|STARTED|Washout Period (at Least 14 Days)||9
1108953|NCT01154218|2683528|P3|STARTED|Washout Period (at Least 14 Days)||9
1108954|NCT01154218|2683529|P2|STARTED|Washout Period (at Least 14 Days)||8
1108955|NCT01154218|2683530|P1|STARTED|Washout Period (at Least 14 Days)||9
1108956|NCT01154218|2683527|P4|NOT COMPLETED|Third Intervention Period||0
1108957|NCT01154218|2683528|P3|NOT COMPLETED|Third Intervention Period||0
1108958|NCT01154218|2683529|P2|NOT COMPLETED|Third Intervention Period||1
1108959|NCT01154218|2683530|P1|NOT COMPLETED|Third Intervention Period||0
1108960|NCT01154218|2683527|P4|COMPLETED|Third Intervention Period||9
1108961|NCT01154218|2683528|P3|COMPLETED|Third Intervention Period||9
1108962|NCT01154218|2683529|P2|COMPLETED|Third Intervention Period||8
1108963|NCT01154218|2683530|P1|COMPLETED|Third Intervention Period||9
1108964|NCT01154218|2683527|P4|STARTED|Third Intervention Period||9
1108965|NCT01154218|2683528|P3|STARTED|Third Intervention Period||9
1108966|NCT01154218|2683529|P2|STARTED|Third Intervention Period||9
1108967|NCT01154218|2683530|P1|STARTED|Third Intervention Period||9
1108968|NCT01154218|2683527|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1108969|NCT01154218|2683528|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1108970|NCT01154218|2683529|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1108971|NCT01154218|2683530|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1108972|NCT01154218|2683527|P4|COMPLETED|Washout Period (at Least 14 Days)||9
1108973|NCT01154218|2683528|P3|COMPLETED|Washout Period (at Least 14 Days)||9
1108974|NCT01154218|2683529|P2|COMPLETED|Washout Period (at Least 14 Days)||9
1108975|NCT01154218|2683530|P1|COMPLETED|Washout Period (at Least 14 Days)||9
1108976|NCT01154218|2683527|P4|STARTED|Washout Period (at Least 14 Days)||9
1108977|NCT01154218|2683528|P3|STARTED|Washout Period (at Least 14 Days)||9
1108978|NCT01154218|2683529|P2|STARTED|Washout Period (at Least 14 Days)||9
1108979|NCT01154218|2683530|P1|STARTED|Washout Period (at Least 14 Days)||9
1108980|NCT01154218|2683527|P4|NOT COMPLETED|Second Intervention Period||0
1108981|NCT01154218|2683528|P3|NOT COMPLETED|Second Intervention Period||0
1108982|NCT01154218|2683529|P2|NOT COMPLETED|Second Intervention Period||0
1108983|NCT01154218|2683530|P1|NOT COMPLETED|Second Intervention Period||0
1108984|NCT01154218|2683527|P4|COMPLETED|Second Intervention Period||9
1108985|NCT01154218|2683528|P3|COMPLETED|Second Intervention Period||9
1108986|NCT01154218|2683529|P2|COMPLETED|Second Intervention Period||9
1108987|NCT01154218|2683530|P1|COMPLETED|Second Intervention Period||9
1108988|NCT01154218|2683527|P4|STARTED|Second Intervention Period||9
1108989|NCT01154218|2683528|P3|STARTED|Second Intervention Period||9
1108990|NCT01154218|2683529|P2|STARTED|Second Intervention Period||9
1108991|NCT01154218|2683530|P1|STARTED|Second Intervention Period||9
1108992|NCT01154218|2683527|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1108993|NCT01154218|2683528|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1108994|NCT01154218|2683529|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1108995|NCT01154218|2683530|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1108996|NCT01154218|2683527|P4|COMPLETED|Washout Period (at Least 14 Days)||9
1108997|NCT01154218|2683528|P3|COMPLETED|Washout Period (at Least 14 Days)||9
1108998|NCT01154218|2683529|P2|COMPLETED|Washout Period (at Least 14 Days)||9
1108999|NCT01154218|2683530|P1|COMPLETED|Washout Period (at Least 14 Days)||9
1109000|NCT01154218|2683527|P4|STARTED|Washout Period (at Least 14 Days)||9
1109001|NCT01154218|2683528|P3|STARTED|Washout Period (at Least 14 Days)||9
1109002|NCT01154218|2683529|P2|STARTED|Washout Period (at Least 14 Days)||9
1109003|NCT01154218|2683530|P1|STARTED|Washout Period (at Least 14 Days)||9
1109004|NCT01154218|2683527|P4|NOT COMPLETED|First Intervention Period||0
1109005|NCT01154218|2683528|P3|NOT COMPLETED|First Intervention Period||0
1109006|NCT01154218|2683529|P2|NOT COMPLETED|First Intervention Period||0
1109007|NCT01154218|2683530|P1|NOT COMPLETED|First Intervention Period||0
1109008|NCT01154218|2683527|P4|COMPLETED|First Intervention Period||9
1109009|NCT01154218|2683528|P3|COMPLETED|First Intervention Period||9
1109010|NCT01154218|2683529|P2|COMPLETED|First Intervention Period||9
1109011|NCT01154218|2683530|P1|COMPLETED|First Intervention Period||9
1109012|NCT01154218|2683527|P4|STARTED|First Intervention Period||9
1109013|NCT01154218|2683528|P3|STARTED|First Intervention Period||9
1109014|NCT01154218|2683529|P2|STARTED|First Intervention Period||9
1109015|NCT01154218|2683530|P1|STARTED|First Intervention Period||9
1109016|NCT01154231|2683580|P1|NOT COMPLETED|Overall Study||2
1109017|NCT01154231|2683580|P1|COMPLETED|Overall Study||312
1109018|NCT01154231|2683580|P1|STARTED|Overall Study||314
1109019|NCT01154283|2683588|P2|NOT COMPLETED|7-12 Weeks||1
1109020|NCT01154283|2683589|P1|NOT COMPLETED|7-12 Weeks||1
1109021|NCT01154283|2683588|P2|COMPLETED|7-12 Weeks||10
1109022|NCT01154283|2683589|P1|COMPLETED|7-12 Weeks||6
1109023|NCT01154283|2683588|P2|STARTED|7-12 Weeks||11
1109024|NCT01154283|2683589|P1|STARTED|7-12 Weeks||7
1109025|NCT01154283|2683588|P2|NOT COMPLETED|0-6 Weeks||3
1109026|NCT01154283|2683589|P1|NOT COMPLETED|0-6 Weeks||7
1109027|NCT01154283|2683588|P2|COMPLETED|0-6 Weeks||11
1109028|NCT01154283|2683589|P1|COMPLETED|0-6 Weeks||7
1109029|NCT01154283|2683588|P2|STARTED|0-6 Weeks||14
1109030|NCT01154283|2683589|P1|STARTED|0-6 Weeks||14
1109031|NCT01154296|2683603|P2|NOT COMPLETED|6-month Follow-up||328
1109032|NCT01154296|2683604|P1|NOT COMPLETED|6-month Follow-up||328
1109033|NCT01154296|2683603|P2|COMPLETED|6-month Follow-up||2179
1109034|NCT01154296|2683604|P1|COMPLETED|6-month Follow-up||2177
1109035|NCT01154296|2683603|P2|STARTED|6-month Follow-up||2507
1109036|NCT01154296|2683604|P1|STARTED|6-month Follow-up||2505
1109037|NCT01154296|2683603|P2|NOT COMPLETED|Randomization and Intervention||2
1109038|NCT01154296|2683604|P1|NOT COMPLETED|Randomization and Intervention||5
1109039|NCT01154296|2683603|P2|COMPLETED|Randomization and Intervention||2505
1109040|NCT01154296|2683604|P1|COMPLETED|Randomization and Intervention||2500
1109041|NCT01154296|2683603|P2|STARTED|Randomization and Intervention||2507
1109042|NCT01154296|2683604|P1|STARTED|Randomization and Intervention||2505
1109043|NCT01154322|2683620|P1|NOT COMPLETED|Overall Study||2
1109044|NCT01154322|2683620|P1|COMPLETED|Overall Study||14
1109045|NCT01154322|2683620|P1|STARTED|Overall Study||16
1109046|NCT01154335|2683628|P3|NOT COMPLETED|Overall Study||5
1109047|NCT01154335|2683629|P2|NOT COMPLETED|Overall Study||6
1109048|NCT01154335|2683630|P1|NOT COMPLETED|Overall Study||7
1109049|NCT01154335|2683628|P3|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
1109050|NCT01154335|2683629|P2|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
1109051|NCT01154335|2683630|P1|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
1109052|NCT01154335|2683628|P3|STARTED|Overall Study||5
1109053|NCT01154335|2683629|P2|STARTED|Overall Study||6
1109054|NCT01154335|2683630|P1|STARTED|Overall Study||7
1109055|NCT01154452|2683641|P4|NOT COMPLETED|Phase II||6
1109056|NCT01154452|2683642|P3|NOT COMPLETED|Phase II||5
1109057|NCT01154452|2683643|P2|NOT COMPLETED|Phase II||0
1109058|NCT01154452|2683644|P1|NOT COMPLETED|Phase II||0
1109059|NCT01154452|2683641|P4|COMPLETED|Phase II||27
1109060|NCT01154452|2683642|P3|COMPLETED|Phase II||30
1109061|NCT01154452|2683643|P2|COMPLETED|Phase II||0
1109062|NCT01154452|2683644|P1|COMPLETED|Phase II||0
1109063|NCT01154452|2683641|P4|STARTED|Phase II||33
1109064|NCT01154452|2683642|P3|STARTED|Phase II||35
1109065|NCT01154452|2683643|P2|STARTED|Phase II||0
1109066|NCT01154452|2683644|P1|STARTED|Phase II||0
1109067|NCT01154452|2683641|P4|NOT COMPLETED|Phase Ib||0
1109068|NCT01154452|2683642|P3|NOT COMPLETED|Phase Ib||0
1109069|NCT01154452|2683643|P2|NOT COMPLETED|Phase Ib||1
1109070|NCT01154452|2683644|P1|NOT COMPLETED|Phase Ib||3
1109071|NCT01154452|2683641|P4|COMPLETED|Phase Ib||0
1109072|NCT01154452|2683642|P3|COMPLETED|Phase Ib||0
1109073|NCT01154452|2683643|P2|COMPLETED|Phase Ib||3
1109074|NCT01154452|2683644|P1|COMPLETED|Phase Ib||3
1109075|NCT01154452|2683641|P4|STARTED|Phase Ib||0
1109076|NCT01154452|2683642|P3|STARTED|Phase Ib||0
1109077|NCT01154452|2683643|P2|STARTED|Phase Ib||4
1109078|NCT01154452|2683644|P1|STARTED|Phase Ib||6
1109079|NCT01154634|2683659|P4|NOT COMPLETED|Period 7 - Fourth Intervention||0
1109080|NCT01154634|2683660|P3|NOT COMPLETED|Period 7 - Fourth Intervention||0
1109081|NCT01154634|2683661|P2|NOT COMPLETED|Period 7 - Fourth Intervention||0
1109082|NCT01154634|2683662|P1|NOT COMPLETED|Period 7 - Fourth Intervention||0
1109083|NCT01154634|2683659|P4|COMPLETED|Period 7 - Fourth Intervention||5
1109084|NCT01154634|2683660|P3|COMPLETED|Period 7 - Fourth Intervention||4
1109085|NCT01154634|2683661|P2|COMPLETED|Period 7 - Fourth Intervention||7
1109086|NCT01154634|2683662|P1|COMPLETED|Period 7 - Fourth Intervention||4
1109087|NCT01154634|2683659|P4|STARTED|Period 7 - Fourth Intervention||5
1109088|NCT01154634|2683660|P3|STARTED|Period 7 - Fourth Intervention||4
1109089|NCT01154634|2683661|P2|STARTED|Period 7 - Fourth Intervention||7
1109090|NCT01154634|2683662|P1|STARTED|Period 7 - Fourth Intervention||4
1109091|NCT01154634|2683659|P4|NOT COMPLETED|Period 6 - Washout||0
1109092|NCT01154634|2683660|P3|NOT COMPLETED|Period 6 - Washout||0
1109093|NCT01154634|2683661|P2|NOT COMPLETED|Period 6 - Washout||0
1109094|NCT01154634|2683662|P1|NOT COMPLETED|Period 6 - Washout||0
1109095|NCT01154634|2683659|P4|COMPLETED|Period 6 - Washout||5
1109096|NCT01154634|2683660|P3|COMPLETED|Period 6 - Washout||4
1109097|NCT01154634|2683661|P2|COMPLETED|Period 6 - Washout||7
1109098|NCT01154634|2683662|P1|COMPLETED|Period 6 - Washout||4
1109099|NCT01154634|2683659|P4|STARTED|Period 6 - Washout||5
1109100|NCT01154634|2683660|P3|STARTED|Period 6 - Washout||4
1109101|NCT01154634|2683661|P2|STARTED|Period 6 - Washout||7
1109102|NCT01154634|2683662|P1|STARTED|Period 6 - Washout||4
1109103|NCT01154634|2683659|P4|NOT COMPLETED|Period 5 - Third Intervention||0
1109104|NCT01154634|2683660|P3|NOT COMPLETED|Period 5 - Third Intervention||0
1109105|NCT01154634|2683661|P2|NOT COMPLETED|Period 5 - Third Intervention||0
1109106|NCT01154634|2683662|P1|NOT COMPLETED|Period 5 - Third Intervention||0
1109107|NCT01154634|2683659|P4|COMPLETED|Period 5 - Third Intervention||5
1109108|NCT01154634|2683660|P3|COMPLETED|Period 5 - Third Intervention||4
1109109|NCT01154634|2683661|P2|COMPLETED|Period 5 - Third Intervention||7
1109110|NCT01154634|2683662|P1|COMPLETED|Period 5 - Third Intervention||4
1109111|NCT01154634|2683659|P4|STARTED|Period 5 - Third Intervention||5
1109112|NCT01154634|2683660|P3|STARTED|Period 5 - Third Intervention||4
1109113|NCT01154634|2683661|P2|STARTED|Period 5 - Third Intervention||7
1109114|NCT01154634|2683662|P1|STARTED|Period 5 - Third Intervention||4
1109115|NCT01154634|2683659|P4|NOT COMPLETED|Period 4 - Washout||0
1109116|NCT01154634|2683660|P3|NOT COMPLETED|Period 4 - Washout||0
1109117|NCT01154634|2683661|P2|NOT COMPLETED|Period 4 - Washout||0
1109118|NCT01154634|2683662|P1|NOT COMPLETED|Period 4 - Washout||0
1109119|NCT01154634|2683659|P4|COMPLETED|Period 4 - Washout||5
1109120|NCT01154634|2683660|P3|COMPLETED|Period 4 - Washout||4
1109121|NCT01154634|2683661|P2|COMPLETED|Period 4 - Washout||7
1109122|NCT01154634|2683662|P1|COMPLETED|Period 4 - Washout||4
1109123|NCT01154634|2683659|P4|STARTED|Period 4 - Washout||5
1109124|NCT01154634|2683660|P3|STARTED|Period 4 - Washout||4
1109125|NCT01154634|2683661|P2|STARTED|Period 4 - Washout||7
1109126|NCT01154634|2683662|P1|STARTED|Period 4 - Washout||4
1109127|NCT01154634|2683659|P4|NOT COMPLETED|Period 3- Second Intervention||0
1109128|NCT01154634|2683660|P3|NOT COMPLETED|Period 3- Second Intervention||0
1109129|NCT01154634|2683661|P2|NOT COMPLETED|Period 3- Second Intervention||0
1109130|NCT01154634|2683662|P1|NOT COMPLETED|Period 3- Second Intervention||0
1109131|NCT01154634|2683659|P4|COMPLETED|Period 3- Second Intervention||5
1109132|NCT01154634|2683660|P3|COMPLETED|Period 3- Second Intervention||4
1109133|NCT01154634|2683661|P2|COMPLETED|Period 3- Second Intervention||7
1109134|NCT01154634|2683662|P1|COMPLETED|Period 3- Second Intervention||4
1109135|NCT01154634|2683659|P4|STARTED|Period 3- Second Intervention||5
1109136|NCT01154634|2683660|P3|STARTED|Period 3- Second Intervention||4
1109137|NCT01154634|2683661|P2|STARTED|Period 3- Second Intervention||7
1109138|NCT01154634|2683662|P1|STARTED|Period 3- Second Intervention||4
1109139|NCT01154634|2683659|P4|NOT COMPLETED|Period 2 - Washout||0
1109140|NCT01154634|2683660|P3|NOT COMPLETED|Period 2 - Washout||0
1109141|NCT01154634|2683661|P2|NOT COMPLETED|Period 2 - Washout||0
1109142|NCT01154634|2683662|P1|NOT COMPLETED|Period 2 - Washout||0
1109143|NCT01154634|2683659|P4|COMPLETED|Period 2 - Washout||5
1109144|NCT01154634|2683660|P3|COMPLETED|Period 2 - Washout||4
1109145|NCT01154634|2683661|P2|COMPLETED|Period 2 - Washout||7
1109146|NCT01154634|2683662|P1|COMPLETED|Period 2 - Washout||4
1109147|NCT01154634|2683659|P4|STARTED|Period 2 - Washout||5
1109148|NCT01154634|2683660|P3|STARTED|Period 2 - Washout||4
1109149|NCT01154634|2683661|P2|STARTED|Period 2 - Washout||7
1109150|NCT01154634|2683662|P1|STARTED|Period 2 - Washout||4
1109151|NCT01154634|2683659|P4|NOT COMPLETED|Period 1 - First Intervention||0
1109152|NCT01154634|2683660|P3|NOT COMPLETED|Period 1 - First Intervention||0
1109153|NCT01154634|2683661|P2|NOT COMPLETED|Period 1 - First Intervention||0
1109154|NCT01154634|2683662|P1|NOT COMPLETED|Period 1 - First Intervention||0
1109155|NCT01154634|2683659|P4|COMPLETED|Period 1 - First Intervention||5
1109156|NCT01154634|2683660|P3|COMPLETED|Period 1 - First Intervention||4
1109157|NCT01154634|2683661|P2|COMPLETED|Period 1 - First Intervention||7
1109158|NCT01154634|2683662|P1|COMPLETED|Period 1 - First Intervention||4
1109159|NCT01154634|2683659|P4|STARTED|Period 1 - First Intervention||5
1109160|NCT01154634|2683660|P3|STARTED|Period 1 - First Intervention||4
1109161|NCT01154634|2683661|P2|STARTED|Period 1 - First Intervention||7
1109162|NCT01154634|2683662|P1|STARTED|Period 1 - First Intervention||4
1109163|NCT01154673|2683702|P2|NOT COMPLETED|Overall Study||0
1109164|NCT01154673|2683703|P1|NOT COMPLETED|Overall Study||2
1109165|NCT01154673|2683702|P2|COMPLETED|Overall Study||16
1109166|NCT01154673|2683703|P1|COMPLETED|Overall Study||14
1109167|NCT01154673|2683702|P2|STARTED|Overall Study||16
1109168|NCT01154673|2683703|P1|STARTED|Overall Study||16
1109169|NCT01154699|2683711|P2|NOT COMPLETED|Second Intervention||0
1109170|NCT01154699|2683712|P1|NOT COMPLETED|Second Intervention||0
1109171|NCT01154699|2683711|P2|COMPLETED|Second Intervention||8
1109172|NCT01154699|2683712|P1|COMPLETED|Second Intervention||13
1109173|NCT01154699|2683711|P2|Subjects With Asthma + OSA|Second Intervention||2
1109174|NCT01154699|2683712|P1|Subjects With Asthma + OSA|Second Intervention||6
1109175|NCT01154699|2683711|P2|Subjects With Asthma Only|Second Intervention||6
1109176|NCT01154699|2683712|P1|Subjects With Asthma Only|Second Intervention||7
1109177|NCT01154699|2683711|P2|STARTED|Second Intervention||8
1109178|NCT01154699|2683712|P1|STARTED|Second Intervention||13
1109179|NCT01154699|2683711|P2|NOT COMPLETED|Washout Period (4 Weeks)||0
1109180|NCT01154699|2683712|P1|NOT COMPLETED|Washout Period (4 Weeks)||0
1109181|NCT01154699|2683711|P2|COMPLETED|Washout Period (4 Weeks)||8
1109182|NCT01154699|2683712|P1|COMPLETED|Washout Period (4 Weeks)||13
1109183|NCT01154699|2683711|P2|Subjects With Asthma + OSA|Washout Period (4 Weeks)||2
1109184|NCT01154699|2683712|P1|Subjects With Asthma + OSA|Washout Period (4 Weeks)||6
1109185|NCT01154699|2683711|P2|Subjects With Asthma Only|Washout Period (4 Weeks)||6
1109186|NCT01154699|2683712|P1|Subjects With Asthma Only|Washout Period (4 Weeks)||7
1109187|NCT01154699|2683711|P2|STARTED|Washout Period (4 Weeks)||8
1109188|NCT01154699|2683712|P1|STARTED|Washout Period (4 Weeks)||13
1109189|NCT01154699|2683711|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
1109190|NCT01154699|2683712|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
1109191|NCT01154699|2683711|P2|COMPLETED|First Intervention (4 Weeks)||8
1109192|NCT01154699|2683712|P1|COMPLETED|First Intervention (4 Weeks)||13
1109193|NCT01154699|2683711|P2|Subjects With Asthma + OSA|First Intervention (4 Weeks)||2
1109194|NCT01154699|2683712|P1|Subjects With Asthma + OSA|First Intervention (4 Weeks)||6
1109195|NCT01154699|2683711|P2|Subjects With Asthma Only|First Intervention (4 Weeks)||6
1109196|NCT01154699|2683712|P1|Subjects With Asthma Only|First Intervention (4 Weeks)||7
1109197|NCT01154699|2683711|P2|STARTED|First Intervention (4 Weeks)||8
1109198|NCT01154699|2683712|P1|STARTED|First Intervention (4 Weeks)||13
1109199|NCT01154751|2683728|P1|NOT COMPLETED|3-year Follow-up||49
1109200|NCT01154751|2683728|P1|COMPLETED|3-year Follow-up||34
1109201|NCT01154751|2683728|P1|STARTED|3-year Follow-up||83
1109202|NCT01154751|2683728|P1|NOT COMPLETED|2-year Follow-up||10
1109203|NCT01154751|2683728|P1|COMPLETED|2-year Follow-up||83
1109204|NCT01154751|2683728|P1|STARTED|2-year Follow-up||93
1109205|NCT01154751|2683728|P1|NOT COMPLETED|1-year Follow-up||5
1109206|NCT01154751|2683728|P1|COMPLETED|1-year Follow-up||93
1109207|NCT01154751|2683728|P1|STARTED|1-year Follow-up||98
1109208|NCT01154751|2683728|P1|NOT COMPLETED|6-month Follow-up||11
1109209|NCT01154751|2683728|P1|COMPLETED|6-month Follow-up||98
1109210|NCT01154751|2683728|P1|STARTED|6-month Follow-up||109
1109247|NCT01154985|2683810|P3|NOT COMPLETED|Overall Study||18
1109248|NCT01154985|2683811|P2|NOT COMPLETED|Overall Study||27
1109249|NCT01154985|2683812|P1|NOT COMPLETED|Overall Study||17
1109250|NCT01154985|2683810|P3|COMPLETED|Overall Study||68
1109251|NCT01154985|2683811|P2|COMPLETED|Overall Study||55
1109252|NCT01154985|2683812|P1|COMPLETED|Overall Study||58
1109253|NCT01154985|2683810|P3|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|64
1109254|NCT01154985|2683811|P2|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
1109255|NCT01154985|2683812|P1|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
1109256|NCT01154985|2683810|P3|Valid Biopsy -Baseline and Month 12.5|Overall Study||68
1109257|NCT01154985|2683811|P2|Valid Biopsy -Baseline and Month 12.5|Overall Study||62
1109258|NCT01154985|2683812|P1|Valid Biopsy -Baseline and Month 12.5|Overall Study||60
1109259|NCT01154985|2683810|P3|Full Analysis Set|Overall Study|Received at least one dose of study medication|86
1109260|NCT01154985|2683811|P2|Full Analysis Set|Overall Study|Received at least one dose of study medication|82
1109261|NCT01154985|2683812|P1|Full Analysis Set|Overall Study|Received at least one dose of study medication|75
1109262|NCT01154985|2683810|P3|STARTED|Overall Study|Randomized|86
1109263|NCT01154985|2683811|P2|STARTED|Overall Study|Randomized|82
1109264|NCT01154985|2683812|P1|STARTED|Overall Study|Randomized|75
1109265|NCT01155011|2683828|P2|NOT COMPLETED|6 to 12 Months||10
1109266|NCT01155011|2683829|P1|NOT COMPLETED|6 to 12 Months||9
1109267|NCT01155011|2683828|P2|COMPLETED|6 to 12 Months||121
1109268|NCT01155011|2683829|P1|COMPLETED|6 to 12 Months||120
1109269|NCT01155011|2683828|P2|STARTED|6 to 12 Months||131
1109270|NCT01155011|2683829|P1|STARTED|6 to 12 Months||129
1109271|NCT01155011|2683828|P2|NOT COMPLETED|Baseline to 6 Months||25
1109272|NCT01155011|2683829|P1|NOT COMPLETED|Baseline to 6 Months||22
1109273|NCT01155011|2683828|P2|COMPLETED|Baseline to 6 Months||131
1109274|NCT01155011|2683829|P1|COMPLETED|Baseline to 6 Months||129
1109275|NCT01155011|2683828|P2|STARTED|Baseline to 6 Months||156
1109276|NCT01155011|2683829|P1|STARTED|Baseline to 6 Months||151
1109277|NCT01155024|2683839|P2|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||6
1109278|NCT01155024|2683840|P1|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||0
1109279|NCT01155024|2683839|P2|COMPLETED|Direct Manufactured Socket 3 Month Trial||4
1109280|NCT01155024|2683840|P1|COMPLETED|Direct Manufactured Socket 3 Month Trial||0
1109281|NCT01155024|2683839|P2|STARTED|Direct Manufactured Socket 3 Month Trial||10
1109282|NCT01155024|2683840|P1|STARTED|Direct Manufactured Socket 3 Month Trial||0
1109283|NCT01155024|2683839|P2|NOT COMPLETED|Second Socket Intervention Fitting||0
1109284|NCT01155024|2683840|P1|NOT COMPLETED|Second Socket Intervention Fitting||0
1109285|NCT01155024|2683839|P2|COMPLETED|Second Socket Intervention Fitting||5
1109286|NCT01155024|2683840|P1|COMPLETED|Second Socket Intervention Fitting||5
1109287|NCT01155024|2683839|P2|STARTED|Second Socket Intervention Fitting||5
1109288|NCT01155024|2683840|P1|STARTED|Second Socket Intervention Fitting||5
1109289|NCT01155024|2683839|P2|NOT COMPLETED|First Socket Intervention Fitting||0
1109290|NCT01155024|2683840|P1|NOT COMPLETED|First Socket Intervention Fitting||0
1109291|NCT01155024|2683839|P2|COMPLETED|First Socket Intervention Fitting||5
1109292|NCT01155024|2683840|P1|COMPLETED|First Socket Intervention Fitting||5
1109293|NCT01155024|2683839|P2|STARTED|First Socket Intervention Fitting||5
1109294|NCT01155024|2683840|P1|STARTED|First Socket Intervention Fitting||5
1109295|NCT01155063|2683848|P1|NOT COMPLETED|Overall Study||89
1109296|NCT01155063|2683848|P1|COMPLETED|Overall Study||0
1109297|NCT01155063|2683848|P1|STARTED|Overall Study||89
1109298|NCT01148017|2683862|P4|NOT COMPLETED|Overall Study||0
1109299|NCT01148017|2683863|P3|NOT COMPLETED|Overall Study||0
1109300|NCT01148017|2683864|P2|NOT COMPLETED|Overall Study||34
1109301|NCT01148017|2683865|P1|NOT COMPLETED|Overall Study||80
1109302|NCT01148017|2683862|P4|COMPLETED|Overall Study||45
1109303|NCT01148017|2683863|P3|COMPLETED|Overall Study||53
1109304|NCT01148017|2683864|P2|COMPLETED|Overall Study||87
1109305|NCT01148017|2683865|P1|COMPLETED|Overall Study||134
1109306|NCT01148017|2683862|P4|STARTED|Overall Study||45
1109307|NCT01148017|2683863|P3|STARTED|Overall Study||53
1109308|NCT01148017|2683864|P2|STARTED|Overall Study||121
1109309|NCT01148017|2683865|P1|STARTED|Overall Study||214
1109310|NCT01148056|2683902|P1|NOT COMPLETED|Overall Study||0
1109311|NCT01148056|2683902|P1|COMPLETED|Overall Study||2
1109312|NCT01148056|2683902|P1|STARTED|Overall Study||2
1109313|NCT01148420|2683911|P1|NOT COMPLETED|Overall Study||0
1109314|NCT01148420|2683911|P1|COMPLETED|Overall Study||48
1109315|NCT01148420|2683911|P1|STARTED|Overall Study||48
1109316|NCT01148511|2683919|P3|NOT COMPLETED|Randomized||6
1109317|NCT01148511|2683920|P2|NOT COMPLETED|Randomized||10
1109318|NCT01148511|2683921|P1|NOT COMPLETED|Randomized||0
1109319|NCT01148511|2683919|P3|COMPLETED|Randomized||39
1109320|NCT01148511|2683920|P2|COMPLETED|Randomized||38
1109321|NCT01148511|2683921|P1|COMPLETED|Randomized||0
1109322|NCT01148511|2683919|P3|STARTED|Randomized||45
1109323|NCT01148511|2683920|P2|STARTED|Randomized||48
1109324|NCT01148511|2683921|P1|STARTED|Randomized|All patients were randomized into the Treat and Extend and the Treat and Observe treatment groups.|0
1109325|NCT01148511|2683919|P3|NOT COMPLETED|Exposed to Study Drug||0
1109326|NCT01148511|2683920|P2|NOT COMPLETED|Exposed to Study Drug||0
1109327|NCT01148511|2683921|P1|NOT COMPLETED|Exposed to Study Drug||6
1109328|NCT01148511|2683919|P3|COMPLETED|Exposed to Study Drug||0
1109329|NCT01148511|2683920|P2|COMPLETED|Exposed to Study Drug||0
1109330|NCT01148511|2683921|P1|COMPLETED|Exposed to Study Drug||93
1109331|NCT01148511|2683919|P3|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
1109332|NCT01148511|2683920|P2|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
1109333|NCT01148511|2683921|P1|STARTED|Exposed to Study Drug||99
1109334|NCT01148524|2683949|P9|NOT COMPLETED|Overall Study||0
1109335|NCT01148524|2683950|P8|NOT COMPLETED|Overall Study||0
1109336|NCT01148524|2683951|P7|NOT COMPLETED|Overall Study||0
1109337|NCT01148524|2683952|P6|NOT COMPLETED|Overall Study||0
1109338|NCT01148524|2683953|P5|NOT COMPLETED|Overall Study||0
1109339|NCT01148524|2683954|P4|NOT COMPLETED|Overall Study||0
1109340|NCT01148524|2683955|P3|NOT COMPLETED|Overall Study||0
1109341|NCT01148524|2683956|P2|NOT COMPLETED|Overall Study||0
1109342|NCT01148524|2683957|P1|NOT COMPLETED|Overall Study||0
1109343|NCT01148524|2683949|P9|COMPLETED|Overall Study||151
1109344|NCT01148524|2683950|P8|COMPLETED|Overall Study||51
1109345|NCT01148524|2683951|P7|COMPLETED|Overall Study||153
1109346|NCT01148524|2683952|P6|COMPLETED|Overall Study||106
1109347|NCT01148524|2683953|P5|COMPLETED|Overall Study||57
1109348|NCT01148524|2683954|P4|COMPLETED|Overall Study||102
1109349|NCT01148524|2683955|P3|COMPLETED|Overall Study||53
1109350|NCT01148524|2683956|P2|COMPLETED|Overall Study||95
1109351|NCT01148524|2683957|P1|COMPLETED|Overall Study||49
1109352|NCT01148524|2683949|P9|STARTED|Overall Study||151
1109353|NCT01148524|2683950|P8|STARTED|Overall Study||51
1109354|NCT01148524|2683951|P7|STARTED|Overall Study||153
1109355|NCT01148524|2683952|P6|STARTED|Overall Study||106
1109356|NCT01148524|2683953|P5|STARTED|Overall Study||57
1109357|NCT01148524|2683954|P4|STARTED|Overall Study||102
1109358|NCT01148524|2683955|P3|STARTED|Overall Study||53
1109359|NCT01148524|2683956|P2|STARTED|Overall Study||95
1109360|NCT01148524|2683957|P1|STARTED|Overall Study||49
1109361|NCT01148537|2684006|P3|NOT COMPLETED|Overall Study||3
1109362|NCT01148537|2684007|P2|NOT COMPLETED|Overall Study||0
1109363|NCT01148537|2684008|P1|NOT COMPLETED|Overall Study||3
1109364|NCT01148537|2684006|P3|COMPLETED|Overall Study||41
1109365|NCT01148537|2684007|P2|COMPLETED|Overall Study||44
1109366|NCT01148537|2684008|P1|COMPLETED|Overall Study||41
1109367|NCT01148537|2684006|P3|STARTED|Overall Study||44
1109368|NCT01148537|2684007|P2|STARTED|Overall Study||44
1109369|NCT01148537|2684008|P1|STARTED|Overall Study||44
1109370|NCT01148693|2684031|P2|NOT COMPLETED|Overall Study||10
1109371|NCT01148693|2684032|P1|NOT COMPLETED|Overall Study||13
1109372|NCT01148693|2684031|P2|COMPLETED|Overall Study||57
1109373|NCT01148693|2684032|P1|COMPLETED|Overall Study||57
1109374|NCT01148693|2684031|P2|STARTED|Overall Study||67
1109375|NCT01148693|2684032|P1|STARTED|Overall Study||70
1109376|NCT01148745|2684038|P1|NOT COMPLETED|Overall Study||0
1109377|NCT01148745|2684038|P1|COMPLETED|Overall Study||15
1109378|NCT01148745|2684038|P1|STARTED|Overall Study||15
1109379|NCT01148771|2684046|P2|NOT COMPLETED|Second Intervention||0
1109380|NCT01148771|2684047|P1|NOT COMPLETED|Second Intervention||0
1109381|NCT01148771|2684046|P2|COMPLETED|Second Intervention||5
1109382|NCT01148771|2684047|P1|COMPLETED|Second Intervention||6
1109383|NCT01148771|2684046|P2|STARTED|Second Intervention||5
1109384|NCT01148771|2684047|P1|STARTED|Second Intervention||6
1109385|NCT01148771|2684046|P2|NOT COMPLETED|Washout Period||1
1109386|NCT01148771|2684047|P1|NOT COMPLETED|Washout Period||0
1109387|NCT01148771|2684046|P2|COMPLETED|Washout Period||5
1109388|NCT01148771|2684047|P1|COMPLETED|Washout Period||6
1109389|NCT01148771|2684046|P2|STARTED|Washout Period||6
1109390|NCT01148771|2684047|P1|STARTED|Washout Period||6
1109391|NCT01148771|2684046|P2|NOT COMPLETED|First Intervention||0
1109392|NCT01148771|2684047|P1|NOT COMPLETED|First Intervention||0
1109393|NCT01148771|2684046|P2|COMPLETED|First Intervention||6
1109394|NCT01148771|2684047|P1|COMPLETED|First Intervention||6
1109395|NCT01148771|2684046|P2|STARTED|First Intervention||6
1109396|NCT01148771|2684047|P1|STARTED|First Intervention||6
1109397|NCT01148836|2684061|P2|NOT COMPLETED|Overall Study||2
1109398|NCT01148836|2684062|P1|NOT COMPLETED|Overall Study||1
1109399|NCT01148836|2684061|P2|COMPLETED|Overall Study||8
1109400|NCT01148836|2684062|P1|COMPLETED|Overall Study|Enrollment completed|7
1109401|NCT01148836|2684061|P2|STARTED|Overall Study||10
1109402|NCT01148836|2684062|P1|STARTED|Overall Study|Enrollment completed|8
1109403|NCT01148862|2684081|P2|NOT COMPLETED|Second Intervention||2
1109404|NCT01148862|2684082|P1|NOT COMPLETED|Second Intervention||0
1109405|NCT01148862|2684081|P2|COMPLETED|Second Intervention||23
1109406|NCT01148862|2684082|P1|COMPLETED|Second Intervention||25
1109407|NCT01148862|2684081|P2|STARTED|Second Intervention||25
1109408|NCT01148862|2684082|P1|STARTED|Second Intervention||25
1109409|NCT01148862|2684081|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
1109410|NCT01148862|2684082|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
1109411|NCT01148862|2684081|P2|COMPLETED|Washout Period of 2 Weeks||25
1109412|NCT01148862|2684082|P1|COMPLETED|Washout Period of 2 Weeks||25
1109413|NCT01148862|2684081|P2|STARTED|Washout Period of 2 Weeks||25
1109414|NCT01148862|2684082|P1|STARTED|Washout Period of 2 Weeks||25
1109415|NCT01148862|2684081|P2|NOT COMPLETED|First Intervention||0
1109416|NCT01148862|2684082|P1|NOT COMPLETED|First Intervention||0
1109417|NCT01148862|2684081|P2|COMPLETED|First Intervention||25
1109418|NCT01148862|2684082|P1|COMPLETED|First Intervention||25
1109419|NCT01148862|2684081|P2|STARTED|First Intervention||25
1109420|NCT01148862|2684082|P1|STARTED|First Intervention||25
1109421|NCT01148979|2684092|P2|NOT COMPLETED|Overall Study||1
1109422|NCT01148979|2684093|P1|NOT COMPLETED|Overall Study||0
1109423|NCT01148979|2684092|P2|COMPLETED|Overall Study||15
1109424|NCT01148979|2684093|P1|COMPLETED|Overall Study||13
1109425|NCT01148979|2684092|P2|STARTED|Overall Study||16
1109426|NCT01148979|2684093|P1|STARTED|Overall Study||13
1109427|NCT01155141|2684099|P1|NOT COMPLETED|Overall Study||2
1109428|NCT01155141|2684099|P1|COMPLETED|Overall Study||14
1109429|NCT01155141|2684099|P1|STARTED|Overall Study||16
1109430|NCT01155154|2684114|P3|NOT COMPLETED|Overall Study||0
1109431|NCT01155154|2684115|P2|NOT COMPLETED|Overall Study||0
1109432|NCT01155154|2684116|P1|NOT COMPLETED|Overall Study||0
1109433|NCT01155154|2684114|P3|COMPLETED|Overall Study||24
1109434|NCT01155154|2684115|P2|COMPLETED|Overall Study||24
1109435|NCT01155154|2684116|P1|COMPLETED|Overall Study||25
1109436|NCT01155154|2684114|P3|STARTED|Overall Study||24
1109437|NCT01155154|2684115|P2|STARTED|Overall Study||24
1109438|NCT01155154|2684116|P1|STARTED|Overall Study||25
1109439|NCT01155167|2684126|P2|NOT COMPLETED|Overall Study||0
1109440|NCT01155167|2684127|P1|NOT COMPLETED|Overall Study||3
1109441|NCT01155167|2684126|P2|COMPLETED|Overall Study||43
1109442|NCT01155167|2684127|P1|COMPLETED|Overall Study||40
1109443|NCT01155167|2684126|P2|STARTED|Overall Study||43
1109444|NCT01155167|2684127|P1|STARTED|Overall Study||43
1109445|NCT01155180|2684139|P2|NOT COMPLETED|Overall Study||0
1109446|NCT01155180|2684140|P1|NOT COMPLETED|Overall Study||0
1109447|NCT01155180|2684139|P2|COMPLETED|Overall Study||6
1109448|NCT01155180|2684140|P1|COMPLETED|Overall Study||18
1109449|NCT01155180|2684139|P2|STARTED|Overall Study||6
1109450|NCT01155180|2684140|P1|STARTED|Overall Study||18
1109451|NCT01155219|2684148|P2|NOT COMPLETED|Overall Study||3
1109452|NCT01155219|2684149|P1|NOT COMPLETED|Overall Study||4
1109453|NCT01155219|2684148|P2|COMPLETED|Overall Study||70
1109454|NCT01155219|2684149|P1|COMPLETED|Overall Study||73
1109455|NCT01155219|2684148|P2|STARTED|Overall Study||73
1109456|NCT01155219|2684149|P1|STARTED|Overall Study||77
1109457|NCT01155284|2684157|P2|NOT COMPLETED|Overall Study||5
1109458|NCT01155284|2684158|P1|NOT COMPLETED|Overall Study||7
1109459|NCT01155284|2684157|P2|COMPLETED|Overall Study||18
1109460|NCT01155284|2684158|P1|COMPLETED|Overall Study||40
1109461|NCT01155284|2684157|P2|STARTED|Overall Study||23
1109462|NCT01155284|2684158|P1|STARTED|Overall Study||47
1109463|NCT01155323|2684166|P2|NOT COMPLETED|Second Intervention||1
1109464|NCT01155323|2684167|P1|NOT COMPLETED|Second Intervention||1
1109465|NCT01155323|2684166|P2|COMPLETED|Second Intervention||56
1109466|NCT01155323|2684167|P1|COMPLETED|Second Intervention||58
1109467|NCT01155323|2684166|P2|STARTED|Second Intervention||57
1109468|NCT01155323|2684167|P1|STARTED|Second Intervention||59
1109469|NCT01155323|2684166|P2|NOT COMPLETED|First Intervention||1
1109470|NCT01155323|2684167|P1|NOT COMPLETED|First Intervention||1
1109471|NCT01155323|2684166|P2|COMPLETED|First Intervention||57
1109472|NCT01155323|2684167|P1|COMPLETED|First Intervention||59
1109473|NCT01155323|2684166|P2|STARTED|First Intervention||58
1109474|NCT01155323|2684167|P1|STARTED|First Intervention||60
1109475|NCT01155336|2684185|P2|NOT COMPLETED|Overall Study||0
1109476|NCT01155336|2684186|P1|NOT COMPLETED|Overall Study||0
1109477|NCT01155336|2684185|P2|COMPLETED|Overall Study|We did not complete the study.|4
1109478|NCT01155336|2684186|P1|COMPLETED|Overall Study|We did not complete the study.|0
1109479|NCT01155336|2684185|P2|STARTED|Overall Study|We did not complete the study.|4
1109480|NCT01155336|2684186|P1|STARTED|Overall Study|We did not complete the study.|0
1109481|NCT01155726|2684192|P4|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
1109482|NCT01155726|2684193|P3|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
1109483|NCT01155726|2684194|P2|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
1109484|NCT01155726|2684195|P1|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
1109485|NCT01155726|2684192|P4|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||25
1109486|NCT01155726|2684193|P3|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||28
1109487|NCT01155726|2684194|P2|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||20
1109488|NCT01155726|2684195|P1|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||23
1109489|NCT01155726|2684192|P4|STARTED|Period 2, 3 Days (Unmask) or (Partial)||25
1109490|NCT01155726|2684193|P3|STARTED|Period 2, 3 Days (Unmask) or (Partial)||28
1109491|NCT01155726|2684194|P2|STARTED|Period 2, 3 Days (Unmask) or (Partial)||20
1109492|NCT01155726|2684195|P1|STARTED|Period 2, 3 Days (Unmask) or (Partial)||23
1109493|NCT01155726|2684192|P4|NOT COMPLETED|Period 1, 3 Days (Masked)||0
1109494|NCT01155726|2684193|P3|NOT COMPLETED|Period 1, 3 Days (Masked)||2
1109495|NCT01155726|2684194|P2|NOT COMPLETED|Period 1, 3 Days (Masked)||0
1109496|NCT01155726|2684195|P1|NOT COMPLETED|Period 1, 3 Days (Masked)||1
1109497|NCT01155726|2684192|P4|COMPLETED|Period 1, 3 Days (Masked)||25
1109498|NCT01155726|2684193|P3|COMPLETED|Period 1, 3 Days (Masked)||28
1109499|NCT01155726|2684194|P2|COMPLETED|Period 1, 3 Days (Masked)||20
1109500|NCT01155726|2684195|P1|COMPLETED|Period 1, 3 Days (Masked)||23
1109501|NCT01155726|2684192|P4|STARTED|Period 1, 3 Days (Masked)||25
1109502|NCT01155726|2684193|P3|STARTED|Period 1, 3 Days (Masked)||30
1109503|NCT01155726|2684194|P2|STARTED|Period 1, 3 Days (Masked)||20
1109504|NCT01155726|2684195|P1|STARTED|Period 1, 3 Days (Masked)||24
1109505|NCT01155830|2684220|P3|NOT COMPLETED|Overall Study||0
1109506|NCT01155830|2684221|P2|NOT COMPLETED|Overall Study||0
1109507|NCT01155830|2684222|P1|NOT COMPLETED|Overall Study||0
1109508|NCT01155830|2684220|P3|COMPLETED|Overall Study||21
1109509|NCT01155830|2684221|P2|COMPLETED|Overall Study||0
1109510|NCT01155830|2684222|P1|COMPLETED|Overall Study||0
1109511|NCT01155830|2684220|P3|STARTED|Overall Study||21
1109512|NCT01155830|2684221|P2|STARTED|Overall Study||0
1109513|NCT01155830|2684222|P1|STARTED|Overall Study||0
1109514|NCT01155869|2684235|P2|NOT COMPLETED|Overall Study||1
1109515|NCT01155869|2684236|P1|NOT COMPLETED|Overall Study||3
1109516|NCT01155869|2684235|P2|COMPLETED|Overall Study||3
1109517|NCT01155869|2684236|P1|COMPLETED|Overall Study||0
1109518|NCT01155869|2684235|P2|STARTED|Overall Study||4
1109519|NCT01155869|2684236|P1|STARTED|Overall Study||3
1109520|NCT01155999|2684246|P2|NOT COMPLETED|Overall Study||4
1109521|NCT01155999|2684247|P1|NOT COMPLETED|Overall Study||7
1109522|NCT01155999|2684246|P2|COMPLETED|Overall Study||136
1109523|NCT01155999|2684247|P1|COMPLETED|Overall Study||139
1109524|NCT01155999|2684246|P2|STARTED|Overall Study||140
1109525|NCT01155999|2684247|P1|STARTED|Overall Study||146
1109526|NCT01156012|2684255|P2|NOT COMPLETED|Overall Study||3
1109527|NCT01156012|2684256|P1|NOT COMPLETED|Overall Study||7
1109528|NCT01156012|2684255|P2|COMPLETED|Overall Study||186
1109529|NCT01156012|2684256|P1|COMPLETED|Overall Study||206
1109530|NCT01156012|2684255|P2|STARTED|Overall Study||189
1109531|NCT01156012|2684256|P1|STARTED|Overall Study||213
1109532|NCT01156051|2684264|P2|NOT COMPLETED|Overall Study||1
1109533|NCT01156051|2684265|P1|NOT COMPLETED|Overall Study||1
1109534|NCT01156051|2684264|P2|COMPLETED|Overall Study||16
1109535|NCT01156051|2684265|P1|COMPLETED|Overall Study||11
1109536|NCT01156051|2684264|P2|STARTED|Overall Study||17
1109537|NCT01156051|2684265|P1|STARTED|Overall Study||12
1109538|NCT01156116|2684279|P2|NOT COMPLETED|Overall Study||1
1109539|NCT01156116|2684280|P1|NOT COMPLETED|Overall Study||5
1109540|NCT01156116|2684279|P2|COMPLETED|Overall Study||12
1109541|NCT01156116|2684280|P1|COMPLETED|Overall Study||21
1109542|NCT01156116|2684279|P2|STARTED|Overall Study||13
1109543|NCT01156116|2684280|P1|STARTED|Overall Study||26
1109544|NCT01156142|2684294|P2|NOT COMPLETED|Overall Study||7
1109545|NCT01156142|2684295|P1|NOT COMPLETED|Overall Study||8
1109546|NCT01156142|2684294|P2|COMPLETED|Overall Study||71
1109547|NCT01156142|2684295|P1|COMPLETED|Overall Study||69
1109548|NCT01156142|2684294|P2|STARTED|Overall Study||78
1109549|NCT01156142|2684295|P1|STARTED|Overall Study||77
1109550|NCT01156311|2684313|P4|NOT COMPLETED|6-month Add-on Therapy Period||10
1109551|NCT01156311|2684314|P3|NOT COMPLETED|6-month Add-on Therapy Period||12
1109552|NCT01156311|2684315|P2|NOT COMPLETED|6-month Add-on Therapy Period||0
1109553|NCT01156311|2684316|P1|NOT COMPLETED|6-month Add-on Therapy Period||0
1109554|NCT01156311|2684313|P4|COMPLETED|6-month Add-on Therapy Period||37
1109555|NCT01156311|2684314|P3|COMPLETED|6-month Add-on Therapy Period||45
1109556|NCT01156311|2684315|P2|COMPLETED|6-month Add-on Therapy Period||0
1109557|NCT01156311|2684316|P1|COMPLETED|6-month Add-on Therapy Period||0
1109558|NCT01156311|2684313|P4|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||38
1109559|NCT01156311|2684314|P3|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||45
1109560|NCT01156311|2684315|P2|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
1109561|NCT01156311|2684316|P1|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
1109562|NCT01156311|2684313|P4|STARTED|6-month Add-on Therapy Period||47
1109563|NCT01156311|2684314|P3|STARTED|6-month Add-on Therapy Period||57
1109564|NCT01156311|2684315|P2|STARTED|6-month Add-on Therapy Period||0
1109565|NCT01156311|2684316|P1|STARTED|6-month Add-on Therapy Period||0
1109566|NCT01156311|2684313|P4|NOT COMPLETED|2-Month Monotherapy Period||0
1109567|NCT01156311|2684314|P3|NOT COMPLETED|2-Month Monotherapy Period||0
1109568|NCT01156311|2684315|P2|NOT COMPLETED|2-Month Monotherapy Period||2
1109569|NCT01156311|2684316|P1|NOT COMPLETED|2-Month Monotherapy Period||2
1109570|NCT01156311|2684313|P4|COMPLETED|2-Month Monotherapy Period||0
1109571|NCT01156311|2684314|P3|COMPLETED|2-Month Monotherapy Period||0
1109572|NCT01156311|2684315|P2|COMPLETED|2-Month Monotherapy Period||47
1109573|NCT01156311|2684316|P1|COMPLETED|2-Month Monotherapy Period||57
1109574|NCT01156311|2684313|P4|STARTED|2-Month Monotherapy Period||0
1109575|NCT01156311|2684314|P3|STARTED|2-Month Monotherapy Period||0
1109576|NCT01156311|2684315|P2|STARTED|2-Month Monotherapy Period||49
1109577|NCT01156311|2684316|P1|STARTED|2-Month Monotherapy Period||59
1109578|NCT01156363|2684338|P1|NOT COMPLETED|Overall Study||22
1109579|NCT01156363|2684338|P1|COMPLETED|Overall Study||64
1109580|NCT01156363|2684338|P1|STARTED|Overall Study||86
1109581|NCT01156376|2684361|P3|NOT COMPLETED|Overall Study||4
1109582|NCT01156376|2684362|P2|NOT COMPLETED|Overall Study||0
1109583|NCT01156376|2684363|P1|NOT COMPLETED|Overall Study||1
1109584|NCT01156376|2684361|P3|COMPLETED|Overall Study||23
1109585|NCT01156376|2684362|P2|COMPLETED|Overall Study||26
1109586|NCT01156376|2684363|P1|COMPLETED|Overall Study||26
1109587|NCT01156376|2684361|P3|STARTED|Overall Study||27
1109588|NCT01156376|2684362|P2|STARTED|Overall Study||26
1109589|NCT01156376|2684363|P1|STARTED|Overall Study||27
1109590|NCT01156480|2684586|P2|NOT COMPLETED|Overall Study||1
1109591|NCT01156480|2684587|P1|NOT COMPLETED|Overall Study||0
1109592|NCT01156480|2684586|P2|COMPLETED|Overall Study||1
1109593|NCT01156480|2684587|P1|COMPLETED|Overall Study||0
1109594|NCT01156480|2684586|P2|STARTED|Overall Study||2
1109595|NCT01156480|2684587|P1|STARTED|Overall Study||0
1109596|NCT01156532|2684595|P1|NOT COMPLETED|Overall Study||2
1109597|NCT01156532|2684595|P1|COMPLETED|Overall Study||28
1109598|NCT01156532|2684595|P1|STARTED|Overall Study||30
1109599|NCT01156571|2684607|P2|NOT COMPLETED|Overall Study||19
1109600|NCT01156571|2684608|P1|NOT COMPLETED|Overall Study||17
1109601|NCT01156571|2684607|P2|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5545
1109602|NCT01156571|2684608|P1|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5564
1109603|NCT01156571|2684607|P2|STARTED|Overall Study|ITT: defined as all patients randomized.|5564
1109604|NCT01156571|2684608|P1|STARTED|Overall Study|ITT: defined as all patients randomized.|5581
1109605|NCT01156597|2684620|P2|NOT COMPLETED|Overall Study||1
1109606|NCT01156597|2684621|P1|NOT COMPLETED|Overall Study||3
1109607|NCT01156597|2684620|P2|COMPLETED|Overall Study||13
1109608|NCT01156597|2684621|P1|COMPLETED|Overall Study||13
1109609|NCT01156597|2684620|P2|STARTED|Overall Study||14
1109610|NCT01156597|2684621|P1|STARTED|Overall Study||16
1109611|NCT01156701|2684631|P4|NOT COMPLETED|Overall Study||0
1109612|NCT01156701|2684632|P3|NOT COMPLETED|Overall Study||0
1109613|NCT01156701|2684633|P2|NOT COMPLETED|Overall Study||0
1109614|NCT01156701|2684634|P1|NOT COMPLETED|Overall Study||0
1109615|NCT01156701|2684631|P4|COMPLETED|Overall Study||6725
1109616|NCT01156701|2684632|P3|COMPLETED|Overall Study||163716
1109617|NCT01156701|2684633|P2|COMPLETED|Overall Study||1007
1109618|NCT01156701|2684634|P1|COMPLETED|Overall Study||257
1109619|NCT01156701|2684631|P4|STARTED|Overall Study||6725
1109620|NCT01156701|2684632|P3|STARTED|Overall Study||163716
1109621|NCT01156701|2684633|P2|STARTED|Overall Study||1007
1109622|NCT01156701|2684634|P1|STARTED|Overall Study||257
1109623|NCT01156792|2684668|P1|NOT COMPLETED|Overall Study||69
1109624|NCT01156792|2684668|P1|COMPLETED|Overall Study||93
1109625|NCT01156792|2684668|P1|STARTED|Overall Study||162
1109626|NCT01156844|2684737|P4|NOT COMPLETED|Overall Study||6
1109627|NCT01156844|2684738|P3|NOT COMPLETED|Overall Study||6
1109628|NCT01156844|2684739|P2|NOT COMPLETED|Overall Study||2
1109629|NCT01156844|2684740|P1|NOT COMPLETED|Overall Study||2
1109630|NCT01156844|2684737|P4|COMPLETED|Overall Study||41
1109631|NCT01156844|2684738|P3|COMPLETED|Overall Study||42
1109632|NCT01156844|2684739|P2|COMPLETED|Overall Study||46
1109633|NCT01156844|2684740|P1|COMPLETED|Overall Study||46
1109634|NCT01156844|2684737|P4|PD & Safety Sets: Received Study Drug|Overall Study||46
1109635|NCT01156844|2684738|P3|PD & Safety Sets: Received Study Drug|Overall Study||48
1109636|NCT01156844|2684739|P2|PD & Safety Sets: Received Study Drug|Overall Study||47
1109637|NCT01156844|2684740|P1|PD & Safety Sets: Received Study Drug|Overall Study|PD=Pharmacodynamic|48
1109638|NCT01156844|2684737|P4|STARTED|Overall Study||47
1109639|NCT01156844|2684738|P3|STARTED|Overall Study||48
1109640|NCT01156844|2684739|P2|STARTED|Overall Study||48
1109641|NCT01156844|2684740|P1|STARTED|Overall Study|Randomized participants.|48
1109642|NCT01156987|2684761|P2|NOT COMPLETED|Overall Study||11
1109643|NCT01156987|2684762|P1|NOT COMPLETED|Overall Study||0
1109644|NCT01156987|2684761|P2|COMPLETED|Overall Study||12
1109645|NCT01156987|2684762|P1|COMPLETED|Overall Study||8
1109646|NCT01156987|2684761|P2|STARTED|Overall Study||23
1109647|NCT01156987|2684762|P1|STARTED|Overall Study||8
1109648|NCT01157065|2684770|P2|NOT COMPLETED|Overall Study||1
1109649|NCT01157065|2684771|P1|NOT COMPLETED|Overall Study||0
1109650|NCT01157065|2684770|P2|COMPLETED|Overall Study||10
1109651|NCT01157065|2684771|P1|COMPLETED|Overall Study||38
1109652|NCT01157065|2684770|P2|STARTED|Overall Study||11
1109653|NCT01157065|2684771|P1|STARTED|Overall Study||38
1109654|NCT01157078|2684781|P2|NOT COMPLETED|Overall Study||36
1109655|NCT01157078|2684782|P1|NOT COMPLETED|Overall Study||35
1109656|NCT01157078|2684781|P2|COMPLETED|Overall Study||124
1109657|NCT01157078|2684782|P1|COMPLETED|Overall Study||124
1109658|NCT01157078|2684781|P2|Received Treatment|Overall Study||159
1109659|NCT01157078|2684782|P1|Received Treatment|Overall Study||157
1109660|NCT01157078|2684781|P2|STARTED|Overall Study||160
1109661|NCT01157078|2684782|P1|STARTED|Overall Study||159
1109662|NCT01157117|2684833|P3|NOT COMPLETED|Overall Study||15
1109663|NCT01157117|2684834|P2|NOT COMPLETED|Overall Study||11
1109664|NCT01157117|2684835|P1|NOT COMPLETED|Overall Study||9
1109665|NCT01157117|2684833|P3|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|5
1109666|NCT01157117|2684834|P2|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|18
1109667|NCT01157117|2684835|P1|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|19
1109668|NCT01157117|2684833|P3|Completed Final Month 38 Study Visit|Overall Study||3
1109669|NCT01157117|2684834|P2|Completed Final Month 38 Study Visit|Overall Study||18
1109670|NCT01157117|2684835|P1|Completed Final Month 38 Study Visit|Overall Study||19
1109671|NCT01157117|2684833|P3|Completed Month 32 Tolerance OFC|Overall Study||0
1109672|NCT01157117|2684834|P2|Completed Month 32 Tolerance OFC|Overall Study||20
1109673|NCT01157117|2684835|P1|Completed Month 32 Tolerance OFC|Overall Study||24
1109674|NCT01157117|2684833|P3|Discontinued Milk OIT at Month 30|Overall Study||0
1109675|NCT01157117|2684834|P2|Discontinued Milk OIT at Month 30|Overall Study||20
1109676|NCT01157117|2684835|P1|Discontinued Milk OIT at Month 30|Overall Study||24
1109677|NCT01157117|2684833|P3|Completed Month 28 Desensitization OFC|Overall Study||0
1109678|NCT01157117|2684834|P2|Completed Month 28 Desensitization OFC|Overall Study||24
1109679|NCT01157117|2684835|P1|Completed Month 28 Desensitization OFC|Overall Study||26
1109680|NCT01157117|2684833|P3|Unblinded at Month 16|Overall Study||0
1109681|NCT01157117|2684834|P2|Unblinded at Month 16|Overall Study||26
1109682|NCT01157117|2684835|P1|Unblinded at Month 16|Overall Study||26
1109683|NCT01157117|2684833|P3|Reached Milk OIT Maintenance Dosing|Overall Study||0
1109684|NCT01157117|2684834|P2|Reached Milk OIT Maintenance Dosing|Overall Study||26
1109685|NCT01157117|2684835|P1|Reached Milk OIT Maintenance Dosing|Overall Study||26
1109686|NCT01157117|2684833|P3|Began Milk OIT Dosing at Month 4|Overall Study||0
1109687|NCT01157117|2684834|P2|Began Milk OIT Dosing at Month 4|Overall Study||28
1109688|NCT01157117|2684835|P1|Began Milk OIT Dosing at Month 4|Overall Study||27
1109689|NCT01157117|2684833|P3|Began Omalizumab or Placebo Dosing|Overall Study||0
1109690|NCT01157117|2684834|P2|Began Omalizumab or Placebo Dosing|Overall Study||28
1109691|NCT01157117|2684835|P1|Began Omalizumab or Placebo Dosing|Overall Study||27
1109692|NCT01157117|2684833|P3|STARTED|Overall Study||20
1109693|NCT01157117|2684834|P2|STARTED|Overall Study||29
1109694|NCT01157117|2684835|P1|STARTED|Overall Study||28
1109695|NCT01157169|2684876|P2|NOT COMPLETED|Second Intervention||1
1109696|NCT01157169|2684877|P1|NOT COMPLETED|Second Intervention||0
1109697|NCT01157169|2684876|P2|COMPLETED|Second Intervention||17
1109698|NCT01157169|2684877|P1|COMPLETED|Second Intervention||16
1109699|NCT01157169|2684876|P2|STARTED|Second Intervention||18
1109700|NCT01157169|2684877|P1|STARTED|Second Intervention||16
1109701|NCT01157169|2684876|P2|NOT COMPLETED|Washout of 10 Days||0
1109702|NCT01157169|2684877|P1|NOT COMPLETED|Washout of 10 Days||0
1109703|NCT01157169|2684876|P2|COMPLETED|Washout of 10 Days||18
1109704|NCT01157169|2684877|P1|COMPLETED|Washout of 10 Days||16
1109705|NCT01157169|2684876|P2|STARTED|Washout of 10 Days||18
1109706|NCT01157169|2684877|P1|STARTED|Washout of 10 Days||16
1109707|NCT01157169|2684876|P2|NOT COMPLETED|First Intervention||2
1109708|NCT01157169|2684877|P1|NOT COMPLETED|First Intervention||4
1109709|NCT01157169|2684876|P2|COMPLETED|First Intervention||18
1109710|NCT01157169|2684877|P1|COMPLETED|First Intervention||16
1109711|NCT01157169|2684876|P2|STARTED|First Intervention||20
1109712|NCT01157169|2684877|P1|STARTED|First Intervention||20
1109713|NCT01157182|2684895|P2|NOT COMPLETED|Second Intervention||0
1109714|NCT01157182|2684896|P1|NOT COMPLETED|Second Intervention||0
1109715|NCT01157182|2684895|P2|COMPLETED|Second Intervention||18
1109716|NCT01157182|2684896|P1|COMPLETED|Second Intervention||16
1109717|NCT01157182|2684895|P2|STARTED|Second Intervention||18
1109718|NCT01157182|2684896|P1|STARTED|Second Intervention||16
1109719|NCT01157182|2684895|P2|NOT COMPLETED|Washout of 28 Days||0
1109720|NCT01157182|2684896|P1|NOT COMPLETED|Washout of 28 Days||2
1109721|NCT01157182|2684895|P2|COMPLETED|Washout of 28 Days||18
1109722|NCT01157182|2684896|P1|COMPLETED|Washout of 28 Days||16
1109723|NCT01157182|2684895|P2|STARTED|Washout of 28 Days||18
1109724|NCT01157182|2684896|P1|STARTED|Washout of 28 Days||18
1109725|NCT01157182|2684895|P2|NOT COMPLETED|First Intervention||0
1109726|NCT01157182|2684896|P1|NOT COMPLETED|First Intervention||0
1109727|NCT01157182|2684895|P2|COMPLETED|First Intervention||18
1109728|NCT01157182|2684896|P1|COMPLETED|First Intervention||18
1109729|NCT01157182|2684895|P2|STARTED|First Intervention||18
1109730|NCT01157182|2684896|P1|STARTED|First Intervention||18
1109731|NCT01157234|2684944|P2|NOT COMPLETED|Overall Study||0
1109732|NCT01157234|2684945|P1|NOT COMPLETED|Overall Study||1
1109733|NCT01157234|2684944|P2|COMPLETED|Overall Study||15
1109734|NCT01157234|2684945|P1|COMPLETED|Overall Study||14
1109735|NCT01157234|2684944|P2|STARTED|Overall Study||15
1109736|NCT01157234|2684945|P1|STARTED|Overall Study||15
1109737|NCT01157351|2684977|P2|NOT COMPLETED|Overall Study||132
1109738|NCT01157351|2684978|P1|NOT COMPLETED|Overall Study||137
1109739|NCT01157351|2684977|P2|COMPLETED|Overall Study||88
1109740|NCT01157351|2684978|P1|COMPLETED|Overall Study||93
1109741|NCT01157351|2684977|P2|Treated|Overall Study||218
1109742|NCT01157351|2684978|P1|Treated|Overall Study||226
1109743|NCT01157351|2684977|P2|STARTED|Overall Study||220
1109744|NCT01157351|2684978|P1|STARTED|Overall Study||230
1109745|NCT01157377|2685001|P7|NOT COMPLETED|Overall Study||2
1109746|NCT01157377|2685002|P6|NOT COMPLETED|Overall Study||3
1109747|NCT01157377|2685003|P5|NOT COMPLETED|Overall Study||2
1109748|NCT01157377|2685004|P4|NOT COMPLETED|Overall Study||1
1109749|NCT01157377|2685005|P3|NOT COMPLETED|Overall Study||1
1109750|NCT01157377|2685006|P2|NOT COMPLETED|Overall Study||3
1109751|NCT01157377|2685007|P1|NOT COMPLETED|Overall Study||2
1109752|NCT01157377|2685001|P7|COMPLETED|Overall Study||27
1109753|NCT01157377|2685002|P6|COMPLETED|Overall Study||16
1109754|NCT01157377|2685003|P5|COMPLETED|Overall Study||18
1109755|NCT01157377|2685004|P4|COMPLETED|Overall Study||14
1109756|NCT01157377|2685005|P3|COMPLETED|Overall Study||26
1109757|NCT01157377|2685006|P2|COMPLETED|Overall Study||20
1109758|NCT01157377|2685007|P1|COMPLETED|Overall Study||21
1109759|NCT01157377|2685001|P7|STARTED|Overall Study||29
1109760|NCT01157377|2685002|P6|STARTED|Overall Study||19
1109761|NCT01157377|2685003|P5|STARTED|Overall Study||20
1109762|NCT01157377|2685004|P4|STARTED|Overall Study||15
1109763|NCT01157377|2685005|P3|STARTED|Overall Study||27
1109764|NCT01157377|2685006|P2|STARTED|Overall Study||23
1109765|NCT01157377|2685007|P1|STARTED|Overall Study||23
1109766|NCT01157416|2685025|P2|NOT COMPLETED|Overall Study||0
1109767|NCT01157416|2685026|P1|NOT COMPLETED|Overall Study||2
1109768|NCT01157416|2685025|P2|COMPLETED|Overall Study||16
1109769|NCT01157416|2685026|P1|COMPLETED|Overall Study||15
1109770|NCT01157416|2685025|P2|STARTED|Overall Study||16
1109771|NCT01157416|2685026|P1|STARTED|Overall Study||17
1109772|NCT01157429|2685034|P2|NOT COMPLETED|Overall Study||4
1109773|NCT01157429|2685035|P1|NOT COMPLETED|Overall Study||4
1109774|NCT01157429|2685034|P2|COMPLETED|Overall Study||8
1109775|NCT01157429|2685035|P1|COMPLETED|Overall Study||8
1109776|NCT01157429|2685034|P2|STARTED|Overall Study||12
1109777|NCT01157429|2685035|P1|STARTED|Overall Study||12
1109778|NCT01157533|2685041|P1|NOT COMPLETED|Overall Study||0
1109779|NCT01157533|2685041|P1|COMPLETED|Overall Study||1
1109780|NCT01157533|2685041|P1|STARTED|Overall Study||1
1109781|NCT01157845|2685045|P1|NOT COMPLETED|Overall Study||35
1109782|NCT01157845|2685045|P1|COMPLETED|Overall Study||130
1109783|NCT01157845|2685045|P1|STARTED|Overall Study||165
1109784|NCT01151904|2685050|P1|NOT COMPLETED|Overall Study||0
1109785|NCT01151904|2685050|P1|COMPLETED|Overall Study||17
1109786|NCT01151904|2685050|P1|STARTED|Overall Study||17
1109787|NCT01152112|2685058|P2|NOT COMPLETED|Overall Study||0
1109788|NCT01152112|2685059|P1|NOT COMPLETED|Overall Study||0
1109789|NCT01152112|2685058|P2|COMPLETED|Overall Study||32
1109790|NCT01152112|2685059|P1|COMPLETED|Overall Study||42
1109791|NCT01152112|2685058|P2|STARTED|Overall Study||32
1109792|NCT01152112|2685059|P1|STARTED|Overall Study||42
1109793|NCT01152190|2685067|P2|NOT COMPLETED|Overall Study||8
1109794|NCT01152190|2685068|P1|NOT COMPLETED|Overall Study||5
1109795|NCT01152190|2685067|P2|COMPLETED|Overall Study||39
1109796|NCT01152190|2685068|P1|COMPLETED|Overall Study||45
1109797|NCT01152190|2685067|P2|Received at Least 1 Dose of Study Drug|Overall Study||47
1109798|NCT01152190|2685068|P1|Received at Least 1 Dose of Study Drug|Overall Study||50
1109799|NCT01152190|2685067|P2|STARTED|Overall Study||47
1109800|NCT01152190|2685068|P1|STARTED|Overall Study||50
1109801|NCT01152294|2685082|P2|NOT COMPLETED|Overall Study||0
1109802|NCT01152294|2685083|P1|NOT COMPLETED|Overall Study||0
1109803|NCT01152294|2685082|P2|COMPLETED|Overall Study||188
1109804|NCT01152294|2685083|P1|COMPLETED|Overall Study||213
1109805|NCT01152294|2685082|P2|STARTED|Overall Study||188
1109806|NCT01152294|2685083|P1|STARTED|Overall Study||213
1109807|NCT01152307|2685091|P2|NOT COMPLETED|Overall Study||0
1109808|NCT01152307|2685092|P1|NOT COMPLETED|Overall Study||0
1109809|NCT01152307|2685091|P2|COMPLETED|Overall Study||214
1109810|NCT01152307|2685092|P1|COMPLETED|Overall Study||191
1109811|NCT01152307|2685091|P2|STARTED|Overall Study||214
1109812|NCT01152307|2685092|P1|STARTED|Overall Study||191
1109813|NCT01152359|2685100|P2|NOT COMPLETED|Overall Study||22
1109814|NCT01152359|2685101|P1|NOT COMPLETED|Overall Study||24
1109815|NCT01152359|2685100|P2|COMPLETED|Overall Study||80
1109816|NCT01152359|2685101|P1|COMPLETED|Overall Study||81
1109817|NCT01152359|2685100|P2|STARTED|Overall Study||102
1109818|NCT01152359|2685101|P1|STARTED|Overall Study||105
1109819|NCT01152385|2685111|P4|NOT COMPLETED|Overall Study||5
1109820|NCT01152385|2685112|P3|NOT COMPLETED|Overall Study||5
1109821|NCT01152385|2685113|P2|NOT COMPLETED|Overall Study||6
1109822|NCT01152385|2685114|P1|NOT COMPLETED|Overall Study||9
1109823|NCT01152385|2685111|P4|COMPLETED|Overall Study||50
1109824|NCT01152385|2685112|P3|COMPLETED|Overall Study||51
1109825|NCT01152385|2685113|P2|COMPLETED|Overall Study||52
1109826|NCT01152385|2685114|P1|COMPLETED|Overall Study||46
1109827|NCT01152385|2685111|P4|STARTED|Overall Study||55
1109828|NCT01152385|2685112|P3|STARTED|Overall Study||56
1109829|NCT01152385|2685113|P2|STARTED|Overall Study||58
1109830|NCT01152385|2685114|P1|STARTED|Overall Study||55
1109831|NCT01152437|2685155|P3|NOT COMPLETED|Overall Study||43
1109832|NCT01152437|2685156|P2|NOT COMPLETED|Overall Study||15
1109833|NCT01152437|2685157|P1|NOT COMPLETED|Overall Study||36
1109834|NCT01152437|2685155|P3|COMPLETED|Overall Study||0
1109835|NCT01152437|2685156|P2|COMPLETED|Overall Study||0
1109836|NCT01152437|2685157|P1|COMPLETED|Overall Study||0
1109837|NCT01152437|2685155|P3|STARTED|Overall Study|entered|43
1109838|NCT01152437|2685156|P2|STARTED|Overall Study|randomised|15
1109839|NCT01152437|2685157|P1|STARTED|Overall Study|randomised|36
1109840|NCT01152450|2685173|P6|NOT COMPLETED|Period 3 (4 Weeks)||0
1109841|NCT01152450|2685174|P5|NOT COMPLETED|Period 3 (4 Weeks)||0
1109842|NCT01152450|2685175|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
1109843|NCT01152450|2685176|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
1109844|NCT01152450|2685177|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
1109845|NCT01152450|2685178|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
1109846|NCT01152450|2685173|P6|COMPLETED|Period 3 (4 Weeks)||12
1109847|NCT01152450|2685174|P5|COMPLETED|Period 3 (4 Weeks)||16
1109848|NCT01152450|2685175|P4|COMPLETED|Period 3 (4 Weeks)||15
1109849|NCT01152450|2685176|P3|COMPLETED|Period 3 (4 Weeks)||16
1109850|NCT01152450|2685177|P2|COMPLETED|Period 3 (4 Weeks)||15
1109851|NCT01152450|2685178|P1|COMPLETED|Period 3 (4 Weeks)||15
1109852|NCT01152450|2685173|P6|STARTED|Period 3 (4 Weeks)||12
1109853|NCT01152450|2685174|P5|STARTED|Period 3 (4 Weeks)||16
1109854|NCT01152450|2685175|P4|STARTED|Period 3 (4 Weeks)||15
1109855|NCT01152450|2685176|P3|STARTED|Period 3 (4 Weeks)||16
1109856|NCT01152450|2685177|P2|STARTED|Period 3 (4 Weeks)||15
1109857|NCT01152450|2685178|P1|STARTED|Period 3 (4 Weeks)||15
1109858|NCT01152450|2685173|P6|NOT COMPLETED|Period 2 (4 Weeks)||0
1109859|NCT01152450|2685174|P5|NOT COMPLETED|Period 2 (4 Weeks)||0
1109860|NCT01152450|2685175|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
1109861|NCT01152450|2685176|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
1109862|NCT01152450|2685177|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
1109863|NCT01152450|2685178|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
1109864|NCT01152450|2685173|P6|COMPLETED|Period 2 (4 Weeks)||12
1109865|NCT01152450|2685174|P5|COMPLETED|Period 2 (4 Weeks)||16
1109866|NCT01152450|2685175|P4|COMPLETED|Period 2 (4 Weeks)||15
1109867|NCT01152450|2685176|P3|COMPLETED|Period 2 (4 Weeks)||16
1109868|NCT01152450|2685177|P2|COMPLETED|Period 2 (4 Weeks)||15
1109869|NCT01152450|2685178|P1|COMPLETED|Period 2 (4 Weeks)||15
1109870|NCT01152450|2685173|P6|STARTED|Period 2 (4 Weeks)||12
1109871|NCT01152450|2685174|P5|STARTED|Period 2 (4 Weeks)||16
1109872|NCT01152450|2685175|P4|STARTED|Period 2 (4 Weeks)||15
1109873|NCT01152450|2685176|P3|STARTED|Period 2 (4 Weeks)||16
1109874|NCT01152450|2685177|P2|STARTED|Period 2 (4 Weeks)||15
1109875|NCT01152450|2685178|P1|STARTED|Period 2 (4 Weeks)||15
1109876|NCT01152450|2685173|P6|NOT COMPLETED|Period 1 (4 Weeks)||1
1109877|NCT01152450|2685174|P5|NOT COMPLETED|Period 1 (4 Weeks)||2
1109878|NCT01152450|2685175|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
1109879|NCT01152450|2685176|P3|NOT COMPLETED|Period 1 (4 Weeks)||1
1109880|NCT01152450|2685177|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
1109881|NCT01152450|2685178|P1|NOT COMPLETED|Period 1 (4 Weeks)||0
1109882|NCT01152450|2685173|P6|COMPLETED|Period 1 (4 Weeks)||12
1109883|NCT01152450|2685174|P5|COMPLETED|Period 1 (4 Weeks)||16
1109884|NCT01152450|2685175|P4|COMPLETED|Period 1 (4 Weeks)||15
1109885|NCT01152450|2685176|P3|COMPLETED|Period 1 (4 Weeks)||16
1109886|NCT01152450|2685177|P2|COMPLETED|Period 1 (4 Weeks)||15
1109887|NCT01152450|2685178|P1|COMPLETED|Period 1 (4 Weeks)||15
1109888|NCT01152450|2685173|P6|STARTED|Period 1 (4 Weeks)||13
1109889|NCT01152450|2685174|P5|STARTED|Period 1 (4 Weeks)||18
1109890|NCT01152450|2685175|P4|STARTED|Period 1 (4 Weeks)||15
1109891|NCT01152450|2685176|P3|STARTED|Period 1 (4 Weeks)||17
1109892|NCT01152450|2685177|P2|STARTED|Period 1 (4 Weeks)||16
1109893|NCT01152450|2685178|P1|STARTED|Period 1 (4 Weeks)||15
1109894|NCT01152554|2685248|P2|NOT COMPLETED|Overall Study||111
1109895|NCT01152554|2685249|P1|NOT COMPLETED|Overall Study||334
1109896|NCT01152554|2685248|P2|COMPLETED|Overall Study||92
1109897|NCT01152554|2685249|P1|COMPLETED|Overall Study||276
1109898|NCT01152554|2685248|P2|Received Treatment|Overall Study||201
1109899|NCT01152554|2685249|P1|Received Treatment|Overall Study||607
1109900|NCT01152554|2685248|P2|STARTED|Overall Study||203
1109901|NCT01152554|2685249|P1|STARTED|Overall Study||610
1109902|NCT01152580|2685273|P2|NOT COMPLETED|Overall Study||1
1109903|NCT01152580|2685274|P1|NOT COMPLETED|Overall Study||0
1109904|NCT01152580|2685273|P2|COMPLETED|Overall Study||13
1109905|NCT01152580|2685274|P1|COMPLETED|Overall Study||5
1109906|NCT01152580|2685273|P2|STARTED|Overall Study||14
1109907|NCT01152580|2685274|P1|STARTED|Overall Study||5
1109908|NCT01158118|2685296|P2|NOT COMPLETED|Overall Study||3
1109909|NCT01158118|2685297|P1|NOT COMPLETED|Overall Study||1
1109910|NCT01158118|2685296|P2|COMPLETED|Overall Study||21
1109911|NCT01158118|2685297|P1|COMPLETED|Overall Study||23
1109912|NCT01158118|2685296|P2|STARTED|Overall Study||24
1109913|NCT01158118|2685297|P1|STARTED|Overall Study||24
1109914|NCT01158261|2685313|P1|NOT COMPLETED|Overall Study||17
1109915|NCT01158261|2685313|P1|COMPLETED|Overall Study||283
1109916|NCT01158261|2685313|P1|STARTED|Overall Study||300
1109917|NCT01158378|2685319|P2|NOT COMPLETED|Overall Study||9
1109918|NCT01158378|2685320|P1|NOT COMPLETED|Overall Study||10
1109919|NCT01158378|2685319|P2|COMPLETED|Overall Study||117
1109920|NCT01158378|2685320|P1|COMPLETED|Overall Study||114
1109921|NCT01158378|2685319|P2|STARTED|Overall Study||126
1109922|NCT01158378|2685320|P1|STARTED|Overall Study||124
1109923|NCT01160380|2685334|P2|NOT COMPLETED|Overall Study||5
1109924|NCT01160380|2685335|P1|NOT COMPLETED|Overall Study||8
1109925|NCT01160380|2685334|P2|COMPLETED|Overall Study||20
1109926|NCT01160380|2685335|P1|COMPLETED|Overall Study||17
1109927|NCT01160380|2685334|P2|STARTED|Overall Study||25
1109928|NCT01160380|2685335|P1|STARTED|Overall Study||25
1109929|NCT01160445|2685355|P2|NOT COMPLETED|Overall Study||0
1109930|NCT01160445|2685356|P1|NOT COMPLETED|Overall Study||0
1109931|NCT01160445|2685355|P2|COMPLETED|Overall Study||2
1109932|NCT01160445|2685356|P1|COMPLETED|Overall Study||7
1109933|NCT01160445|2685355|P2|STARTED|Overall Study||2
1109934|NCT01160445|2685356|P1|STARTED|Overall Study||7
1109935|NCT01160458|2685364|P1|NOT COMPLETED|Overall Study||0
1109936|NCT01160458|2685364|P1|COMPLETED|Overall Study||20
1109937|NCT01160458|2685364|P1|STARTED|Overall Study||20
1109938|NCT01160484|2685372|P1|NOT COMPLETED|Overall Study||18
1109939|NCT01160484|2685372|P1|COMPLETED|Overall Study||22
1109940|NCT01160484|2685372|P1|STARTED|Overall Study||40
1109941|NCT01160614|2685384|P2|NOT COMPLETED|Overall Study||2
1109942|NCT01160614|2685385|P1|NOT COMPLETED|Overall Study||0
1109943|NCT01160614|2685384|P2|COMPLETED|Overall Study||23
1109944|NCT01160614|2685385|P1|COMPLETED|Overall Study||5
1109945|NCT01160614|2685384|P2|STARTED|Overall Study||25
1109946|NCT01160614|2685385|P1|STARTED|Overall Study||5
1109947|NCT01160640|2685435|P2|NOT COMPLETED|Overall Study||6
1109948|NCT01160640|2685436|P1|NOT COMPLETED|Overall Study||4
1109949|NCT01160640|2685435|P2|COMPLETED|Overall Study||110
1109950|NCT01160640|2685436|P1|COMPLETED|Overall Study||113
1109951|NCT01160640|2685435|P2|STARTED|Overall Study||116
1109952|NCT01160640|2685436|P1|STARTED|Overall Study||117
1109953|NCT01160744|2685454|P4|NOT COMPLETED|Overall Study||22
1109954|NCT01160744|2685455|P3|NOT COMPLETED|Overall Study||20
1109955|NCT01160744|2685456|P2|NOT COMPLETED|Overall Study||25
1109956|NCT01160744|2685457|P1|NOT COMPLETED|Overall Study||20
1109957|NCT01160744|2685454|P4|COMPLETED|Overall Study||49
1109958|NCT01160744|2685455|P3|COMPLETED|Overall Study||49
1109959|NCT01160744|2685456|P2|COMPLETED|Overall Study||44
1109960|NCT01160744|2685457|P1|COMPLETED|Overall Study||51
1109961|NCT01160744|2685454|P4|Received Study Drug|Overall Study||71
1109962|NCT01160744|2685455|P3|Received Study Drug|Overall Study||63
1109963|NCT01160744|2685456|P2|Received Study Drug|Overall Study||67
1109964|NCT01160744|2685457|P1|Received Study Drug|Overall Study||69
1109965|NCT01160744|2685454|P4|STARTED|Overall Study||71
1109966|NCT01160744|2685455|P3|STARTED|Overall Study||69
1109967|NCT01160744|2685456|P2|STARTED|Overall Study||69
1109968|NCT01160744|2685457|P1|STARTED|Overall Study||71
1109969|NCT01160770|2685491|P1|NOT COMPLETED|Overall Study||79
1109970|NCT01160770|2685491|P1|COMPLETED|Overall Study||188
1109971|NCT01160770|2685491|P1|STARTED|Overall Study||267
1109972|NCT01160822|2685507|P7|NOT COMPLETED|Overall Study||9
1109973|NCT01160822|2685508|P6|NOT COMPLETED|Overall Study||7
1109974|NCT01160822|2685509|P5|NOT COMPLETED|Overall Study||9
1109975|NCT01160822|2685510|P4|NOT COMPLETED|Overall Study||0
1109976|NCT01160822|2685511|P3|NOT COMPLETED|Overall Study||0
1109977|NCT01160822|2685512|P2|NOT COMPLETED|Overall Study||0
1109978|NCT01160822|2685513|P1|NOT COMPLETED|Overall Study||0
1109979|NCT01160822|2685507|P7|COMPLETED|Overall Study||44
1109980|NCT01160822|2685508|P6|COMPLETED|Overall Study||40
1109981|NCT01160822|2685509|P5|COMPLETED|Overall Study||36
1109982|NCT01160822|2685510|P4|COMPLETED|Overall Study||5
1109983|NCT01160822|2685511|P3|COMPLETED|Overall Study||6
1109984|NCT01160822|2685512|P2|COMPLETED|Overall Study||7
1109985|NCT01160822|2685513|P1|COMPLETED|Overall Study||6
1109986|NCT01160822|2685507|P7|STARTED|Overall Study||53
1109987|NCT01160822|2685508|P6|STARTED|Overall Study||47
1109988|NCT01160822|2685509|P5|STARTED|Overall Study||45
1109989|NCT01160822|2685510|P4|STARTED|Overall Study||5
1109990|NCT01160822|2685511|P3|STARTED|Overall Study||6
1109991|NCT01160822|2685512|P2|STARTED|Overall Study||7
1109992|NCT01160822|2685513|P1|STARTED|Overall Study||6
1109993|NCT01160848|2685604|P2|NOT COMPLETED|Overall Study||0
1109994|NCT01160848|2685605|P1|NOT COMPLETED|Overall Study||0
1109995|NCT01160848|2685604|P2|COMPLETED|Overall Study||8
1109996|NCT01160848|2685605|P1|COMPLETED|Overall Study||12
1109997|NCT01160848|2685604|P2|STARTED|Overall Study||8
1109998|NCT01160848|2685605|P1|STARTED|Overall Study||12
1109999|NCT01161121|2685627|P1|NOT COMPLETED|Overall Study||0
1110000|NCT01161121|2685627|P1|COMPLETED|Overall Study||46
1110001|NCT01161121|2685627|P1|STARTED|Overall Study||46
1110002|NCT01161160|2685640|P3|NOT COMPLETED|Overall Study||0
1110003|NCT01161160|2685641|P2|NOT COMPLETED|Overall Study||0
1110004|NCT01161160|2685642|P1|NOT COMPLETED|Overall Study||0
1110005|NCT01161160|2685640|P3|COMPLETED|Overall Study||58
1110006|NCT01161160|2685641|P2|COMPLETED|Overall Study||75
1110007|NCT01161160|2685642|P1|COMPLETED|Overall Study||76
1110008|NCT01161160|2685640|P3|STARTED|Overall Study||58
1110009|NCT01161160|2685641|P2|STARTED|Overall Study||75
1110010|NCT01161160|2685642|P1|STARTED|Overall Study||76
1110011|NCT01161173|2685713|P1|NOT COMPLETED|Overall Study||347
1110012|NCT01161173|2685713|P1|COMPLETED|Overall Study||0
1110013|NCT01161173|2685713|P1|STARTED|Overall Study||347
1110014|NCT01161225|2685725|P3|NOT COMPLETED|Overall Study||2
1110015|NCT01161225|2685726|P2|NOT COMPLETED|Overall Study||9
1110016|NCT01161225|2685727|P1|NOT COMPLETED|Overall Study||14
1110017|NCT01161225|2685725|P3|COMPLETED|Overall Study||12
1110018|NCT01161225|2685726|P2|COMPLETED|Overall Study||44
1110019|NCT01161225|2685727|P1|COMPLETED|Overall Study||45
1110020|NCT01161225|2685725|P3|STARTED|Overall Study||14
1110021|NCT01161225|2685726|P2|STARTED|Overall Study||53
1110022|NCT01161225|2685727|P1|STARTED|Overall Study||59
1110023|NCT01161329|2685758|P2|NOT COMPLETED|Overall Study||10
1110024|NCT01161329|2685759|P1|NOT COMPLETED|Overall Study||4
1110025|NCT01161329|2685758|P2|COMPLETED|Overall Study||24
1110026|NCT01161329|2685759|P1|COMPLETED|Overall Study||29
1110027|NCT01161329|2685758|P2|STARTED|Overall Study||34
1110028|NCT01161329|2685759|P1|STARTED|Overall Study||33
1110029|NCT01161407|2685769|P2|NOT COMPLETED|Overall Study||1
1110030|NCT01161407|2685770|P1|NOT COMPLETED|Overall Study||3
1110031|NCT01161407|2685769|P2|COMPLETED|Overall Study||5
1110032|NCT01161407|2685770|P1|COMPLETED|Overall Study||3
1110033|NCT01161407|2685769|P2|STARTED|Overall Study||6
1110034|NCT01161407|2685770|P1|STARTED|Overall Study||6
1110035|NCT01161420|2685780|P1|NOT COMPLETED|Withdrawal Study - Withdrawal||0
1110036|NCT01161420|2685780|P1|COMPLETED|Withdrawal Study - Withdrawal||23
1110037|NCT01161420|2685780|P1|STARTED|Withdrawal Study - Withdrawal||23
1110038|NCT01161420|2685780|P1|NOT COMPLETED|Withdrawal Study - Maintenance||0
1110039|NCT01161420|2685780|P1|COMPLETED|Withdrawal Study - Maintenance||23
1110040|NCT01161420|2685780|P1|STARTED|Withdrawal Study - Maintenance||23
1110041|NCT01161420|2685780|P1|NOT COMPLETED|Inspire Therapy||2
1110042|NCT01161420|2685780|P1|COMPLETED|Inspire Therapy||124
1110043|NCT01161420|2685780|P1|STARTED|Inspire Therapy||126
1110044|NCT01161446|2685794|P2|NOT COMPLETED|Overall Study||15
1110045|NCT01161446|2685795|P1|NOT COMPLETED|Overall Study||18
1110046|NCT01161446|2685794|P2|COMPLETED|Overall Study||99
1110047|NCT01161446|2685795|P1|COMPLETED|Overall Study||98
1110048|NCT01161446|2685794|P2|STARTED|Overall Study||114
1110049|NCT01161446|2685795|P1|STARTED|Overall Study||116
1110050|NCT01161472|2685807|P4|NOT COMPLETED|Fourth Intervention Period||0
1110051|NCT01161472|2685808|P3|NOT COMPLETED|Fourth Intervention Period||0
1110052|NCT01161472|2685809|P2|NOT COMPLETED|Fourth Intervention Period||0
1110053|NCT01161472|2685810|P1|NOT COMPLETED|Fourth Intervention Period||0
1110054|NCT01161472|2685807|P4|COMPLETED|Fourth Intervention Period||5
1110055|NCT01161472|2685808|P3|COMPLETED|Fourth Intervention Period||5
1110056|NCT01161472|2685809|P2|COMPLETED|Fourth Intervention Period||5
1110057|NCT01161472|2685810|P1|COMPLETED|Fourth Intervention Period||4
1110058|NCT01161472|2685807|P4|STARTED|Fourth Intervention Period||5
1110059|NCT01161472|2685808|P3|STARTED|Fourth Intervention Period||5
1110060|NCT01161472|2685809|P2|STARTED|Fourth Intervention Period||5
1110061|NCT01161472|2685810|P1|STARTED|Fourth Intervention Period||4
1110062|NCT01161472|2685807|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
1110063|NCT01161472|2685808|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
1110064|NCT01161472|2685809|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
1110065|NCT01161472|2685810|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
1110066|NCT01161472|2685807|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
1110067|NCT01161472|2685808|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
1110068|NCT01161472|2685809|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
1110069|NCT01161472|2685810|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
1110070|NCT01161472|2685807|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
1110071|NCT01161472|2685808|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
1110072|NCT01161472|2685809|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
1110073|NCT01161472|2685810|P1|STARTED|Washout Period (At Least 3 to 6 Days)||4
1110074|NCT01161472|2685807|P4|NOT COMPLETED|Third Intervention Period||0
1110075|NCT01161472|2685808|P3|NOT COMPLETED|Third Intervention Period||0
1110076|NCT01161472|2685809|P2|NOT COMPLETED|Third Intervention Period||0
1110077|NCT01161472|2685810|P1|NOT COMPLETED|Third Intervention Period||0
1110078|NCT01161472|2685807|P4|COMPLETED|Third Intervention Period||5
1110079|NCT01161472|2685808|P3|COMPLETED|Third Intervention Period||5
1110080|NCT01161472|2685809|P2|COMPLETED|Third Intervention Period||5
1110081|NCT01161472|2685810|P1|COMPLETED|Third Intervention Period||4
1110082|NCT01161472|2685807|P4|STARTED|Third Intervention Period||5
1110083|NCT01161472|2685808|P3|STARTED|Third Intervention Period||5
1110084|NCT01161472|2685809|P2|STARTED|Third Intervention Period||5
1110085|NCT01161472|2685810|P1|STARTED|Third Intervention Period||4
1110086|NCT01161472|2685807|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
1110087|NCT01161472|2685808|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
1110088|NCT01161472|2685809|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
1110089|NCT01161472|2685810|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||1
1110090|NCT01161472|2685807|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
1110091|NCT01161472|2685808|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
1110092|NCT01161472|2685809|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
1110093|NCT01161472|2685810|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
1110094|NCT01161472|2685807|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
1110095|NCT01161472|2685808|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
1110096|NCT01161472|2685809|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
1110097|NCT01161472|2685810|P1|STARTED|Washout Period (At Least 3 to 6 Days)||5
1110098|NCT01161472|2685807|P4|NOT COMPLETED|Second Intervention Period||0
1110099|NCT01161472|2685808|P3|NOT COMPLETED|Second Intervention Period||0
1110100|NCT01161472|2685809|P2|NOT COMPLETED|Second Intervention Period||0
1110101|NCT01161472|2685810|P1|NOT COMPLETED|Second Intervention Period||0
1110102|NCT01161472|2685807|P4|COMPLETED|Second Intervention Period||5
1110103|NCT01161472|2685808|P3|COMPLETED|Second Intervention Period||5
1110104|NCT01161472|2685809|P2|COMPLETED|Second Intervention Period||5
1110105|NCT01161472|2685810|P1|COMPLETED|Second Intervention Period||5
1110106|NCT01161472|2685807|P4|STARTED|Second Intervention Period||5
1110107|NCT01161472|2685808|P3|STARTED|Second Intervention Period||5
1110108|NCT01161472|2685809|P2|STARTED|Second Intervention Period||5
1110109|NCT01161472|2685810|P1|STARTED|Second Intervention Period||5
1110110|NCT01161472|2685807|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
1110111|NCT01161472|2685808|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
1110112|NCT01161472|2685809|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
1110113|NCT01161472|2685810|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
1110114|NCT01161472|2685807|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
1110115|NCT01161472|2685808|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
1110116|NCT01161472|2685809|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
1110117|NCT01161472|2685810|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
1110118|NCT01161472|2685807|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
1110119|NCT01161472|2685808|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
1110120|NCT01161472|2685809|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
1110121|NCT01161472|2685810|P1|STARTED|Washout Period (At Least 3 to 6 Days)||5
1110122|NCT01161472|2685807|P4|NOT COMPLETED|First Intervention Period||0
1110123|NCT01161472|2685808|P3|NOT COMPLETED|First Intervention Period||0
1110124|NCT01161472|2685809|P2|NOT COMPLETED|First Intervention Period||0
1110125|NCT01161472|2685810|P1|NOT COMPLETED|First Intervention Period||0
1110126|NCT01161472|2685807|P4|COMPLETED|First Intervention Period||5
1110127|NCT01161472|2685808|P3|COMPLETED|First Intervention Period||5
1110128|NCT01161472|2685809|P2|COMPLETED|First Intervention Period||5
1110129|NCT01161472|2685810|P1|COMPLETED|First Intervention Period||5
1110130|NCT01161472|2685807|P4|Treated|First Intervention Period||5
1110131|NCT01161472|2685808|P3|Treated|First Intervention Period||5
1110132|NCT01161472|2685809|P2|Treated|First Intervention Period||5
1110133|NCT01161472|2685810|P1|Treated|First Intervention Period||5
1110134|NCT01161472|2685807|P4|STARTED|First Intervention Period||5
1110135|NCT01161472|2685808|P3|STARTED|First Intervention Period||5
1110136|NCT01161472|2685809|P2|STARTED|First Intervention Period||5
1110137|NCT01161472|2685810|P1|STARTED|First Intervention Period||5
1110138|NCT01161498|2685866|P2|NOT COMPLETED|Overall Study||1
1110139|NCT01161498|2685867|P1|NOT COMPLETED|Overall Study||0
1110140|NCT01161498|2685866|P2|COMPLETED|Overall Study||1
1110141|NCT01161498|2685867|P1|COMPLETED|Overall Study||3
1110142|NCT01161498|2685866|P2|STARTED|Overall Study||2
1110143|NCT01161498|2685867|P1|STARTED|Overall Study||3
1110144|NCT01161537|2685891|P1|NOT COMPLETED|Part B||2
1110145|NCT01161537|2685891|P1|COMPLETED|Part B||7
1110146|NCT01161537|2685891|P1|STARTED|Part B|4 subjects from Part A continued in Part B of the study.|9
1110147|NCT01161537|2685891|P1|NOT COMPLETED|Part A||0
1110148|NCT01161537|2685891|P1|COMPLETED|Part A||8
1110149|NCT01161537|2685891|P1|STARTED|Part A||8
1110150|NCT01161563|2685909|P2|NOT COMPLETED|Overall Study||6
1110151|NCT01161563|2685910|P1|NOT COMPLETED|Overall Study||5
1110152|NCT01161563|2685909|P2|COMPLETED|Overall Study||49
1110153|NCT01161563|2685910|P1|COMPLETED|Overall Study||58
1110154|NCT01161563|2685909|P2|STARTED|Overall Study||55
1110155|NCT01161563|2685910|P1|STARTED|Overall Study||63
1110156|NCT01161628|2685918|P1|NOT COMPLETED|Overall Study||8
1110157|NCT01161628|2685918|P1|COMPLETED|Overall Study||17
1110158|NCT01161628|2685918|P1|STARTED|Overall Study||25
1110159|NCT01161771|2685930|P1|NOT COMPLETED|Overall Study||0
1110160|NCT01161771|2685930|P1|COMPLETED|Overall Study||32
1110161|NCT01161771|2685930|P1|STARTED|Overall Study||32
1110162|NCT01162096|2685939|P1|NOT COMPLETED|Overall Study||0
1110163|NCT01162096|2685939|P1|COMPLETED|Overall Study||34
1110164|NCT01162096|2685939|P1|STARTED|Overall Study||34
1110165|NCT01162122|2685945|P2|NOT COMPLETED|Overall Study||196
1110166|NCT01162122|2685946|P1|NOT COMPLETED|Overall Study||191
1110167|NCT01162122|2685945|P2|COMPLETED|Overall Study||3356
1110168|NCT01162122|2685946|P1|COMPLETED|Overall Study||3361
1110169|NCT01162122|2685945|P2|Vaccinated|Overall Study||3541
1110170|NCT01162122|2685946|P1|Vaccinated|Overall Study||3541
1110171|NCT01162122|2685945|P2|STARTED|Overall Study||3552
1110172|NCT01162122|2685946|P1|STARTED|Overall Study||3552
1110173|NCT01162135|2686003|P1|NOT COMPLETED|Overall Study||3
1110174|NCT01162135|2686003|P1|COMPLETED|Overall Study||13
1110175|NCT01162135|2686003|P1|STARTED|Overall Study||16
1110176|NCT01162304|2686007|P1|NOT COMPLETED|Overall Study||11
1110177|NCT01162304|2686007|P1|COMPLETED|Overall Study||7
1110178|NCT01162304|2686007|P1|STARTED|Overall Study||18
1110179|NCT01162317|2686023|P2|NOT COMPLETED|Overall Study||2
1110180|NCT01162317|2686024|P1|NOT COMPLETED|Overall Study||3
1110181|NCT01162317|2686023|P2|COMPLETED|Overall Study||28
1110182|NCT01162317|2686024|P1|COMPLETED|Overall Study||27
1110183|NCT01162317|2686023|P2|STARTED|Overall Study||30
1110184|NCT01162317|2686024|P1|STARTED|Overall Study||30
1110185|NCT01162421|2686034|P2|NOT COMPLETED|Overall Study||13
1110186|NCT01162421|2686035|P1|NOT COMPLETED|Overall Study||8
1110187|NCT01162421|2686034|P2|COMPLETED|Overall Study||27
1110188|NCT01162421|2686035|P1|COMPLETED|Overall Study||29
1110189|NCT01162421|2686034|P2|STARTED|Overall Study||40
1110190|NCT01162421|2686035|P1|STARTED|Overall Study||37
1110191|NCT01162473|2686115|P2|NOT COMPLETED|Overall Study||5
1110192|NCT01162473|2686116|P1|NOT COMPLETED|Overall Study||2
1110193|NCT01162473|2686115|P2|COMPLETED|Overall Study||12
1110194|NCT01162473|2686116|P1|COMPLETED|Overall Study||6
1110195|NCT01162473|2686115|P2|STARTED|Overall Study||17
1110196|NCT01162473|2686116|P1|STARTED|Overall Study||8
1110211|NCT01162733|2686145|P2|NOT COMPLETED|Overall Study||25
1110212|NCT01162733|2686146|P1|NOT COMPLETED|Overall Study||27
1110213|NCT01162733|2686145|P2|COMPLETED|Overall Study||25
1110214|NCT01162733|2686146|P1|COMPLETED|Overall Study||22
1110215|NCT01162733|2686145|P2|STARTED|Overall Study||50
1110216|NCT01162733|2686146|P1|STARTED|Overall Study||49
1110217|NCT01155466|2686159|P5|NOT COMPLETED|Overall Study||27
1110218|NCT01155466|2686160|P4|NOT COMPLETED|Overall Study||21
1110219|NCT01155466|2686161|P3|NOT COMPLETED|Overall Study||20
1110220|NCT01155466|2686162|P2|NOT COMPLETED|Overall Study||25
1110221|NCT01155466|2686163|P1|NOT COMPLETED|Overall Study||22
1110222|NCT01155466|2686159|P5|COMPLETED|Overall Study|Completed treatment phase|129
1110223|NCT01155466|2686160|P4|COMPLETED|Overall Study|Completed treatment phase|134
1110224|NCT01155466|2686161|P3|COMPLETED|Overall Study|Completed treatment phase|136
1110225|NCT01155466|2686162|P2|COMPLETED|Overall Study|Completed treatment phase|130
1110226|NCT01155466|2686163|P1|COMPLETED|Overall Study|Completed treatment phase|134
1110227|NCT01155466|2686159|P5|Treated|Overall Study||154
1110228|NCT01155466|2686160|P4|Treated|Overall Study||155
1110229|NCT01155466|2686161|P3|Treated|Overall Study||153
1110230|NCT01155466|2686162|P2|Treated|Overall Study||153
1110231|NCT01155466|2686163|P1|Treated|Overall Study||154
1110232|NCT01155466|2686159|P5|STARTED|Overall Study||156
1110233|NCT01155466|2686160|P4|STARTED|Overall Study||155
1110234|NCT01155466|2686161|P3|STARTED|Overall Study||156
1110235|NCT01155466|2686162|P2|STARTED|Overall Study||155
1110236|NCT01155466|2686163|P1|STARTED|Overall Study||156
1110237|NCT01155479|2686220|P5|NOT COMPLETED|Part II||55
1110238|NCT01155479|2686221|P4|NOT COMPLETED|Part II||50
1110239|NCT01155479|2686222|P3|NOT COMPLETED|Part II||58
1110240|NCT01155479|2686223|P2|NOT COMPLETED|Part II||61
1110241|NCT01155479|2686224|P1|NOT COMPLETED|Part II||59
1110242|NCT01155479|2686220|P5|COMPLETED|Part II||126
1110243|NCT01155479|2686221|P4|COMPLETED|Part II||127
1110244|NCT01155479|2686222|P3|COMPLETED|Part II||109
1110245|NCT01155479|2686223|P2|COMPLETED|Part II||116
1110246|NCT01155479|2686224|P1|COMPLETED|Part II||107
1110247|NCT01155479|2686220|P5|STARTED|Part II||181
1110248|NCT01155479|2686221|P4|STARTED|Part II||177
1110249|NCT01155479|2686222|P3|STARTED|Part II||167
1110250|NCT01155479|2686223|P2|STARTED|Part II||177
1110251|NCT01155479|2686224|P1|STARTED|Part II||166
1110252|NCT01155479|2686220|P5|NOT COMPLETED|Part I||23
1110253|NCT01155479|2686221|P4|NOT COMPLETED|Part I||27
1110254|NCT01155479|2686222|P3|NOT COMPLETED|Part I||39
1110255|NCT01155479|2686223|P2|NOT COMPLETED|Part I||27
1110256|NCT01155479|2686224|P1|NOT COMPLETED|Part I||38
1110257|NCT01155479|2686220|P5|COMPLETED|Part I||181
1110258|NCT01155479|2686221|P4|COMPLETED|Part I||177
1110259|NCT01155479|2686222|P3|COMPLETED|Part I||167
1110260|NCT01155479|2686223|P2|COMPLETED|Part I||177
1110261|NCT01155479|2686224|P1|COMPLETED|Part I||166
1110262|NCT01155479|2686220|P5|Treated|Part I||203
1110263|NCT01155479|2686221|P4|Treated|Part I||198
1110264|NCT01155479|2686222|P3|Treated|Part I||204
1110265|NCT01155479|2686223|P2|Treated|Part I||202
1110266|NCT01155479|2686224|P1|Treated|Part I||200
1110267|NCT01155479|2686220|P5|STARTED|Part I||204
1110268|NCT01155479|2686221|P4|STARTED|Part I||204
1110269|NCT01155479|2686222|P3|STARTED|Part I||206
1110270|NCT01155479|2686223|P2|STARTED|Part I||204
1110271|NCT01155479|2686224|P1|STARTED|Part I||204
1110272|NCT01155531|2686275|P4|NOT COMPLETED|Overall Study||1
1110273|NCT01155531|2686276|P3|NOT COMPLETED|Overall Study||2
1110274|NCT01155531|2686277|P2|NOT COMPLETED|Overall Study||0
1110275|NCT01155531|2686278|P1|NOT COMPLETED|Overall Study||1
1110276|NCT01155531|2686275|P4|COMPLETED|Overall Study||9
1110277|NCT01155531|2686276|P3|COMPLETED|Overall Study||8
1110278|NCT01155531|2686277|P2|COMPLETED|Overall Study||10
1110279|NCT01155531|2686278|P1|COMPLETED|Overall Study||9
1110280|NCT01155531|2686275|P4|STARTED|Overall Study||10
1110281|NCT01155531|2686276|P3|STARTED|Overall Study||10
1110282|NCT01155531|2686277|P2|STARTED|Overall Study||10
1110283|NCT01155531|2686278|P1|STARTED|Overall Study||10
1110284|NCT01155570|2686296|P1|NOT COMPLETED|Overall Study||142
1110285|NCT01155570|2686296|P1|COMPLETED|Overall Study||592
1110286|NCT01155570|2686296|P1|Efficacy Analysis Population|Overall Study|5 received Humira off-label, 21 did not receive Humira after the first administration|708
1110287|NCT01155570|2686296|P1|STARTED|Overall Study|Safety Analysis Population|734
1110288|NCT01162863|2686329|P3|NOT COMPLETED|Overall Study||0
1110289|NCT01162863|2686330|P2|NOT COMPLETED|Overall Study||1
1110290|NCT01162863|2686331|P1|NOT COMPLETED|Overall Study||1
1110291|NCT01162863|2686329|P3|COMPLETED|Overall Study||17
1110292|NCT01162863|2686330|P2|COMPLETED|Overall Study||16
1110293|NCT01162863|2686331|P1|COMPLETED|Overall Study||17
1110294|NCT01162863|2686329|P3|STARTED|Overall Study||17
1110295|NCT01162863|2686330|P2|STARTED|Overall Study||17
1110296|NCT01162863|2686331|P1|STARTED|Overall Study||18
1110297|NCT01163032|2686348|P3|NOT COMPLETED|Open Label Extension Phase||16
1110298|NCT01163032|2686349|P2|NOT COMPLETED|Open Label Extension Phase||0
1110299|NCT01163032|2686350|P1|NOT COMPLETED|Open Label Extension Phase||0
1110300|NCT01163032|2686348|P3|COMPLETED|Open Label Extension Phase||39
1110301|NCT01163032|2686349|P2|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
1110302|NCT01163032|2686350|P1|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
1110303|NCT01163032|2686348|P3|STARTED|Open Label Extension Phase|3 randomized patients rolled into extension (2 randomized to tasimelteon and one to placebo)|55
1110304|NCT01163032|2686349|P2|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
1110305|NCT01163032|2686350|P1|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
1110306|NCT01163032|2686348|P3|NOT COMPLETED|Randomization Phase||0
1110307|NCT01163032|2686349|P2|NOT COMPLETED|Randomization Phase||12
1110308|NCT01163032|2686350|P1|NOT COMPLETED|Randomization Phase||10
1110309|NCT01163032|2686348|P3|COMPLETED|Randomization Phase|Not applicable for Randomized Phase|0
1110310|NCT01163032|2686349|P2|COMPLETED|Randomization Phase||30
1110311|NCT01163032|2686350|P1|COMPLETED|Randomization Phase||32
1110312|NCT01163032|2686348|P3|STARTED|Randomization Phase|Not applicable for Randomized Phase|0
1110313|NCT01163032|2686349|P2|STARTED|Randomization Phase||42
1110314|NCT01163032|2686350|P1|STARTED|Randomization Phase||42
1110315|NCT01163097|2686383|P3|NOT COMPLETED|Overall Study||0
1110316|NCT01163097|2686384|P2|NOT COMPLETED|Overall Study||0
1110317|NCT01163097|2686385|P1|NOT COMPLETED|Overall Study||6
1110318|NCT01163097|2686383|P3|COMPLETED|Overall Study||8
1110319|NCT01163097|2686384|P2|COMPLETED|Overall Study||16
1110320|NCT01163097|2686385|P1|COMPLETED|Overall Study||14
1110321|NCT01163097|2686383|P3|STARTED|Overall Study||8
1110322|NCT01163097|2686384|P2|STARTED|Overall Study||16
1110323|NCT01163097|2686385|P1|STARTED|Overall Study|15 subjects were successfully titrated and entered the palifermin treatment|20
1110324|NCT01163253|2686437|P2|NOT COMPLETED|Overall Study||586
1110325|NCT01163253|2686438|P1|NOT COMPLETED|Overall Study||2281
1110326|NCT01163253|2686437|P2|COMPLETED|Overall Study||0
1110327|NCT01163253|2686438|P1|COMPLETED|Overall Study||0
1110328|NCT01163253|2686437|P2|STARTED|Overall Study||586
1110329|NCT01163253|2686438|P1|STARTED|Overall Study||2281
1110330|NCT01163266|2686601|P3|NOT COMPLETED|Overall Study||28
1110331|NCT01163266|2686602|P2|NOT COMPLETED|Overall Study||31
1110332|NCT01163266|2686603|P1|NOT COMPLETED|Overall Study||18
1110333|NCT01163266|2686601|P3|COMPLETED|Overall Study||122
1110334|NCT01163266|2686602|P2|COMPLETED|Overall Study||124
1110335|NCT01163266|2686603|P1|COMPLETED|Overall Study||139
1110336|NCT01163266|2686601|P3|Treated|Overall Study||150
1110337|NCT01163266|2686602|P2|Treated|Overall Study||155
1110338|NCT01163266|2686603|P1|Treated|Overall Study||157
1110339|NCT01163266|2686601|P3|STARTED|Overall Study||150
1110340|NCT01163266|2686602|P2|STARTED|Overall Study||155
1110341|NCT01163266|2686603|P1|STARTED|Overall Study||157
1110342|NCT01163279|2686628|P2|NOT COMPLETED|Overall Study||0
1110343|NCT01163279|2686629|P1|NOT COMPLETED|Overall Study||2
1110344|NCT01163279|2686628|P2|COMPLETED|Overall Study||9
1110345|NCT01163279|2686629|P1|COMPLETED|Overall Study||8
1110346|NCT01163279|2686628|P2|STARTED|Overall Study||9
1110347|NCT01163279|2686629|P1|STARTED|Overall Study||10
1110348|NCT01163292|2686657|P2|NOT COMPLETED|Overall Study||22
1110349|NCT01163292|2686658|P1|NOT COMPLETED|Overall Study||41
1110350|NCT01163292|2686657|P2|COMPLETED|Overall Study||92
1110351|NCT01163292|2686658|P1|COMPLETED|Overall Study||65
1110352|NCT01163292|2686657|P2|STARTED|Overall Study||114
1110353|NCT01163292|2686658|P1|STARTED|Overall Study||106
1110354|NCT01163318|2686672|P1|NOT COMPLETED|Overall Study||268
1110355|NCT01163318|2686672|P1|COMPLETED|Overall Study||284
1110356|NCT01163318|2686672|P1|STARTED|Overall Study||552
1110357|NCT01163461|2686679|P2|NOT COMPLETED|Overall Study||0
1110358|NCT01163461|2686680|P1|NOT COMPLETED|Overall Study||0
1110359|NCT01163461|2686679|P2|COMPLETED|Overall Study||14
1110360|NCT01163461|2686680|P1|COMPLETED|Overall Study||14
1110361|NCT01163461|2686679|P2|STARTED|Overall Study||14
1110362|NCT01163461|2686680|P1|STARTED|Overall Study||14
1110363|NCT01163474|2686684|P1|NOT COMPLETED|Overall Study||16
1110364|NCT01163474|2686684|P1|COMPLETED|Overall Study||24
1110365|NCT01163474|2686684|P1|STARTED|Overall Study||40
1110366|NCT01163604|2686692|P2|NOT COMPLETED|Overall Study||0
1110367|NCT01163604|2686693|P1|NOT COMPLETED|Overall Study||0
1110368|NCT01163604|2686692|P2|COMPLETED|Overall Study|August 2011|56
1110369|NCT01163604|2686693|P1|COMPLETED|Overall Study|August 2011|58
1110370|NCT01163604|2686692|P2|STARTED|Overall Study|August 2010|56
1110371|NCT01163604|2686693|P1|STARTED|Overall Study|August 2010|58
1110372|NCT01163617|2686699|P8|NOT COMPLETED|Phase B (Injection Time), Week 4||0
1110373|NCT01163617|2686700|P7|NOT COMPLETED|Phase B (Injection Time), Week 4||0
1110374|NCT01163617|2686701|P6|NOT COMPLETED|Phase B (Injection Time), Week 4||0
1110375|NCT01163617|2686702|P5|NOT COMPLETED|Phase B (Injection Time), Week 4||0
1110376|NCT01163617|2686703|P4|NOT COMPLETED|Phase B (Injection Time), Week 4||0
1110377|NCT01163617|2686704|P3|NOT COMPLETED|Phase B (Injection Time), Week 4||0
1110378|NCT01163617|2686705|P2|NOT COMPLETED|Phase B (Injection Time), Week 4||0
1110379|NCT01163617|2686706|P1|NOT COMPLETED|Phase B (Injection Time), Week 4||0
1110380|NCT01163617|2686699|P8|COMPLETED|Phase B (Injection Time), Week 4||20
1110381|NCT01163617|2686700|P7|COMPLETED|Phase B (Injection Time), Week 4||16
1110382|NCT01163617|2686701|P6|COMPLETED|Phase B (Injection Time), Week 4||27
1110383|NCT01163617|2686702|P5|COMPLETED|Phase B (Injection Time), Week 4||18
1110384|NCT01163617|2686703|P4|COMPLETED|Phase B (Injection Time), Week 4||0
1110385|NCT01163617|2686704|P3|COMPLETED|Phase B (Injection Time), Week 4||0
1110386|NCT01163617|2686705|P2|COMPLETED|Phase B (Injection Time), Week 4||0
1110387|NCT01163617|2686706|P1|COMPLETED|Phase B (Injection Time), Week 4||0
1110388|NCT01163617|2686699|P8|STARTED|Phase B (Injection Time), Week 4||20
1110389|NCT01163617|2686700|P7|STARTED|Phase B (Injection Time), Week 4||16
1110390|NCT01163617|2686701|P6|STARTED|Phase B (Injection Time), Week 4||27
1110391|NCT01163617|2686702|P5|STARTED|Phase B (Injection Time), Week 4||18
1110392|NCT01163617|2686703|P4|STARTED|Phase B (Injection Time), Week 4||0
1110393|NCT01163617|2686704|P3|STARTED|Phase B (Injection Time), Week 4||0
1110394|NCT01163617|2686705|P2|STARTED|Phase B (Injection Time), Week 4||0
1110395|NCT01163617|2686706|P1|STARTED|Phase B (Injection Time), Week 4||0
1110396|NCT01163617|2686699|P8|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
1110397|NCT01163617|2686700|P7|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
1110398|NCT01163617|2686701|P6|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
1110399|NCT01163617|2686702|P5|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
1110400|NCT01163617|2686703|P4|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
1110401|NCT01163617|2686704|P3|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||1
1110402|NCT01163617|2686705|P2|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||2
1110403|NCT01163617|2686706|P1|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
1110404|NCT01163617|2686699|P8|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
1110405|NCT01163617|2686700|P7|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
1110406|NCT01163617|2686701|P6|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
1110407|NCT01163617|2686702|P5|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
1110408|NCT01163617|2686703|P4|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
1110409|NCT01163617|2686704|P3|COMPLETED|Phase A (User Experience), Weeks 0 and 2||20
1110410|NCT01163617|2686705|P2|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
1110411|NCT01163617|2686706|P1|COMPLETED|Phase A (User Experience), Weeks 0 and 2||19
1110412|NCT01163617|2686699|P8|STARTED|Phase A (User Experience), Weeks 0 and 2||0
1110413|NCT01163617|2686700|P7|STARTED|Phase A (User Experience), Weeks 0 and 2||0
1110414|NCT01163617|2686701|P6|STARTED|Phase A (User Experience), Weeks 0 and 2||0
1110415|NCT01163617|2686702|P5|STARTED|Phase A (User Experience), Weeks 0 and 2||0
1110416|NCT01163617|2686703|P4|STARTED|Phase A (User Experience), Weeks 0 and 2||21
1110417|NCT01163617|2686704|P3|STARTED|Phase A (User Experience), Weeks 0 and 2||21
1110418|NCT01163617|2686705|P2|STARTED|Phase A (User Experience), Weeks 0 and 2||23
1110419|NCT01163617|2686706|P1|STARTED|Phase A (User Experience), Weeks 0 and 2||19
1110420|NCT01163656|2686728|P2|NOT COMPLETED|Overall Study||3
1110421|NCT01163656|2686729|P1|NOT COMPLETED|Overall Study||3
1110422|NCT01163656|2686728|P2|COMPLETED|Overall Study||30
1110423|NCT01163656|2686729|P1|COMPLETED|Overall Study||30
1110424|NCT01163656|2686728|P2|STARTED|Overall Study||33
1110425|NCT01163656|2686729|P1|STARTED|Overall Study||33
1110426|NCT01163721|2686737|P2|NOT COMPLETED|Overall Study||12
1110427|NCT01163721|2686738|P1|NOT COMPLETED|Overall Study||8
1110428|NCT01163721|2686737|P2|COMPLETED|Overall Study||29
1110429|NCT01163721|2686738|P1|COMPLETED|Overall Study||31
1110430|NCT01163721|2686737|P2|STARTED|Overall Study||41
1110431|NCT01163721|2686738|P1|STARTED|Overall Study||39
1110432|NCT01163747|2686750|P2|NOT COMPLETED|Overall Study||11
1110433|NCT01163747|2686751|P1|NOT COMPLETED|Overall Study||6
1110434|NCT01163747|2686750|P2|COMPLETED|Overall Study||49
1110435|NCT01163747|2686751|P1|COMPLETED|Overall Study||25
1110524|NCT01164475|2686944|P2|NOT COMPLETED|Overall Study||2
1110436|NCT01163747|2686750|P2|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|54
1110437|NCT01163747|2686751|P1|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|27
1110438|NCT01163747|2686750|P2|STARTED|Overall Study||60
1110439|NCT01163747|2686751|P1|STARTED|Overall Study||31
1110440|NCT01163760|2686769|P4|NOT COMPLETED|Period 4 (Follow-up)||0
1110441|NCT01163760|2686770|P3|NOT COMPLETED|Period 4 (Follow-up)||0
1110442|NCT01163760|2686771|P2|NOT COMPLETED|Period 4 (Follow-up)||0
1110443|NCT01163760|2686772|P1|NOT COMPLETED|Period 4 (Follow-up)||0
1110444|NCT01163760|2686769|P4|COMPLETED|Period 4 (Follow-up)||12
1110445|NCT01163760|2686770|P3|COMPLETED|Period 4 (Follow-up)||13
1110446|NCT01163760|2686771|P2|COMPLETED|Period 4 (Follow-up)||13
1110447|NCT01163760|2686772|P1|COMPLETED|Period 4 (Follow-up)||12
1110448|NCT01163760|2686769|P4|STARTED|Period 4 (Follow-up)||12
1110449|NCT01163760|2686770|P3|STARTED|Period 4 (Follow-up)||13
1110450|NCT01163760|2686771|P2|STARTED|Period 4 (Follow-up)||13
1110451|NCT01163760|2686772|P1|STARTED|Period 4 (Follow-up)||12
1110452|NCT01163760|2686769|P4|NOT COMPLETED|Period 3 (Fit)||0
1110453|NCT01163760|2686770|P3|NOT COMPLETED|Period 3 (Fit)||0
1110454|NCT01163760|2686771|P2|NOT COMPLETED|Period 3 (Fit)||0
1110455|NCT01163760|2686772|P1|NOT COMPLETED|Period 3 (Fit)||0
1110456|NCT01163760|2686769|P4|COMPLETED|Period 3 (Fit)||12
1110457|NCT01163760|2686770|P3|COMPLETED|Period 3 (Fit)||13
1110458|NCT01163760|2686771|P2|COMPLETED|Period 3 (Fit)||13
1110459|NCT01163760|2686772|P1|COMPLETED|Period 3 (Fit)||12
1110460|NCT01163760|2686769|P4|STARTED|Period 3 (Fit)||12
1110461|NCT01163760|2686770|P3|STARTED|Period 3 (Fit)||13
1110462|NCT01163760|2686771|P2|STARTED|Period 3 (Fit)||13
1110463|NCT01163760|2686772|P1|STARTED|Period 3 (Fit)||12
1110464|NCT01163760|2686769|P4|NOT COMPLETED|Period 2 (Follow-up)||0
1110465|NCT01163760|2686770|P3|NOT COMPLETED|Period 2 (Follow-up)||0
1110466|NCT01163760|2686771|P2|NOT COMPLETED|Period 2 (Follow-up)||0
1110467|NCT01163760|2686772|P1|NOT COMPLETED|Period 2 (Follow-up)||0
1110468|NCT01163760|2686769|P4|COMPLETED|Period 2 (Follow-up)||12
1110469|NCT01163760|2686770|P3|COMPLETED|Period 2 (Follow-up)||13
1110470|NCT01163760|2686771|P2|COMPLETED|Period 2 (Follow-up)||13
1110471|NCT01163760|2686772|P1|COMPLETED|Period 2 (Follow-up)||12
1110472|NCT01163760|2686769|P4|STARTED|Period 2 (Follow-up)||12
1110473|NCT01163760|2686770|P3|STARTED|Period 2 (Follow-up)||13
1110474|NCT01163760|2686771|P2|STARTED|Period 2 (Follow-up)||13
1110475|NCT01163760|2686772|P1|STARTED|Period 2 (Follow-up)||12
1110476|NCT01163760|2686769|P4|NOT COMPLETED|Period 1 (Fit)||0
1110477|NCT01163760|2686770|P3|NOT COMPLETED|Period 1 (Fit)||0
1110478|NCT01163760|2686771|P2|NOT COMPLETED|Period 1 (Fit)||0
1110479|NCT01163760|2686772|P1|NOT COMPLETED|Period 1 (Fit)||0
1110480|NCT01163760|2686769|P4|COMPLETED|Period 1 (Fit)||12
1110481|NCT01163760|2686770|P3|COMPLETED|Period 1 (Fit)||13
1110482|NCT01163760|2686771|P2|COMPLETED|Period 1 (Fit)||13
1110483|NCT01163760|2686772|P1|COMPLETED|Period 1 (Fit)||12
1110484|NCT01163760|2686769|P4|STARTED|Period 1 (Fit)||12
1110485|NCT01163760|2686770|P3|STARTED|Period 1 (Fit)||13
1110486|NCT01163760|2686771|P2|STARTED|Period 1 (Fit)||13
1110487|NCT01163760|2686772|P1|STARTED|Period 1 (Fit)||12
1110488|NCT01163851|2686786|P2|NOT COMPLETED|Overall Study||1
1110489|NCT01163851|2686787|P1|NOT COMPLETED|Overall Study||1
1110490|NCT01163851|2686786|P2|COMPLETED|Overall Study||11
1110491|NCT01163851|2686787|P1|COMPLETED|Overall Study||12
1110492|NCT01163851|2686786|P2|TREATED|Overall Study||12
1110493|NCT01163851|2686787|P1|TREATED|Overall Study||12
1110494|NCT01163851|2686786|P2|STARTED|Overall Study||12
1110495|NCT01163851|2686787|P1|STARTED|Overall Study||13
1110496|NCT01163916|2686864|P3|NOT COMPLETED|Overall Study||20
1110497|NCT01163916|2686865|P2|NOT COMPLETED|Overall Study||4
1110498|NCT01163916|2686866|P1|NOT COMPLETED|Overall Study||30
1110499|NCT01163916|2686864|P3|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|71
1110500|NCT01163916|2686865|P2|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|31
1110501|NCT01163916|2686866|P1|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|96
1110502|NCT01163916|2686864|P3|Safety Population|Overall Study||91
1110503|NCT01163916|2686865|P2|Safety Population|Overall Study||35
1110504|NCT01163916|2686866|P1|Safety Population|Overall Study|One patient discontinued prior to receiving treatment with adalimumab due to absence of medication.|125
1110505|NCT01163916|2686864|P3|STARTED|Overall Study||91
1110506|NCT01163916|2686865|P2|STARTED|Overall Study||35
1110507|NCT01163916|2686866|P1|STARTED|Overall Study||126
1110508|NCT01163955|2686904|P2|NOT COMPLETED|Overall Study||4
1110509|NCT01163955|2686905|P1|NOT COMPLETED|Overall Study||0
1110510|NCT01163955|2686904|P2|COMPLETED|Overall Study||26
1110511|NCT01163955|2686905|P1|COMPLETED|Overall Study||26
1110512|NCT01163955|2686904|P2|STARTED|Overall Study||30
1110513|NCT01163955|2686905|P1|STARTED|Overall Study||26
1110514|NCT01164007|2686911|P1|NOT COMPLETED|Overall Study||40
1110515|NCT01164007|2686911|P1|COMPLETED|Overall Study||0
1110516|NCT01164007|2686911|P1|Treated|Overall Study||37
1110517|NCT01164007|2686911|P1|STARTED|Overall Study||40
1110518|NCT01164137|2686927|P2|NOT COMPLETED|Overall Study||0
1110519|NCT01164137|2686928|P1|NOT COMPLETED|Overall Study||3
1110520|NCT01164137|2686927|P2|COMPLETED|Overall Study||76
1110521|NCT01164137|2686928|P1|COMPLETED|Overall Study||77
1110522|NCT01164137|2686927|P2|STARTED|Overall Study||76
1110523|NCT01164137|2686928|P1|STARTED|Overall Study||80
1110525|NCT01164475|2686945|P1|NOT COMPLETED|Overall Study||2
1110526|NCT01164475|2686944|P2|COMPLETED|Overall Study||29
1110527|NCT01164475|2686945|P1|COMPLETED|Overall Study||28
1110528|NCT01164475|2686944|P2|STARTED|Overall Study||31
1110529|NCT01164475|2686945|P1|STARTED|Overall Study||30
1110530|NCT01164501|2686972|P3|NOT COMPLETED|Overall Study||42
1110531|NCT01164501|2686973|P2|NOT COMPLETED|Overall Study||10
1110532|NCT01164501|2686974|P1|NOT COMPLETED|Overall Study||43
1110533|NCT01164501|2686972|P3|COMPLETED|Overall Study||280
1110534|NCT01164501|2686973|P2|COMPLETED|Overall Study||88
1110535|NCT01164501|2686974|P1|COMPLETED|Overall Study||278
1110536|NCT01164501|2686972|P3|STARTED|Overall Study||322
1110537|NCT01164501|2686973|P2|STARTED|Overall Study||98
1110538|NCT01164501|2686974|P1|STARTED|Overall Study||321
1110539|NCT01164579|2686992|P3|NOT COMPLETED|Overall Study||16
1110540|NCT01164579|2686993|P2|NOT COMPLETED|Overall Study||9
1110541|NCT01164579|2686994|P1|NOT COMPLETED|Overall Study||8
1110542|NCT01164579|2686992|P3|COMPLETED|Overall Study||21
1110543|NCT01164579|2686993|P2|COMPLETED|Overall Study||27
1110544|NCT01164579|2686994|P1|COMPLETED|Overall Study||28
1110545|NCT01164579|2686992|P3|STARTED|Overall Study||37
1110546|NCT01164579|2686993|P2|STARTED|Overall Study||36
1110547|NCT01164579|2686994|P1|STARTED|Overall Study||36
1110548|NCT01164644|2687073|P2|NOT COMPLETED|Overall Study||1
1110549|NCT01164644|2687074|P1|NOT COMPLETED|Overall Study||3
1110550|NCT01164644|2687073|P2|COMPLETED|Overall Study||13
1110551|NCT01164644|2687074|P1|COMPLETED|Overall Study||9
1110552|NCT01164644|2687073|P2|STARTED|Overall Study||14
1110553|NCT01164644|2687074|P1|STARTED|Overall Study||12
1110554|NCT01164722|2687086|P2|NOT COMPLETED|Overall Study||15
1110555|NCT01164722|2687087|P1|NOT COMPLETED|Overall Study||18
1110556|NCT01164722|2687086|P2|COMPLETED|Overall Study||45
1110557|NCT01164722|2687087|P1|COMPLETED|Overall Study||42
1110558|NCT01164722|2687086|P2|STARTED|Overall Study||60
1110559|NCT01164722|2687087|P1|STARTED|Overall Study||60
1110560|NCT01164865|2687103|P2|NOT COMPLETED|Overall Study||1
1110561|NCT01164865|2687104|P1|NOT COMPLETED|Overall Study||2
1110562|NCT01164865|2687103|P2|COMPLETED|Overall Study||38
1110563|NCT01164865|2687104|P1|COMPLETED|Overall Study||37
1110564|NCT01164865|2687103|P2|STARTED|Overall Study||39
1110565|NCT01164865|2687104|P1|STARTED|Overall Study||39
1110566|NCT01164891|2687112|P1|NOT COMPLETED|Overall Study||6
1110567|NCT01164891|2687112|P1|COMPLETED|Overall Study||1
1110568|NCT01164891|2687112|P1|STARTED|Overall Study||7
1110569|NCT01165021|2687130|P1|NOT COMPLETED|Overall Study||1
1110570|NCT01165021|2687130|P1|COMPLETED|Overall Study||18
1110571|NCT01165021|2687130|P1|3 Cycles of Chemo, Then Surgery|Overall Study||15
1110572|NCT01165021|2687130|P1|≥1 Dose Chemo, Baseline, Cy 3 Assessment|Overall Study||17
1110573|NCT01165021|2687130|P1|≥1 Dose Chemo|Overall Study||19
1110574|NCT01165021|2687130|P1|STARTED|Overall Study||19
1110575|NCT01165047|2687138|P1|NOT COMPLETED|Overall Study||0
1110576|NCT01165047|2687138|P1|COMPLETED|Overall Study||10
1110577|NCT01165047|2687138|P1|STARTED|Overall Study||10
1110578|NCT01165112|2687142|P1|NOT COMPLETED|Overall Study||0
1110579|NCT01165112|2687142|P1|COMPLETED|Overall Study||48
1110580|NCT01165112|2687142|P1|STARTED|Overall Study||48
1110581|NCT01165138|2687152|P4|NOT COMPLETED|Overall Study||22
1110582|NCT01165138|2687153|P3|NOT COMPLETED|Overall Study||20
1110583|NCT01165138|2687154|P2|NOT COMPLETED|Overall Study||52
1110584|NCT01165138|2687155|P1|NOT COMPLETED|Overall Study||0
1110585|NCT01165138|2687152|P4|COMPLETED|Overall Study||179
1110586|NCT01165138|2687153|P3|COMPLETED|Overall Study||185
1110587|NCT01165138|2687154|P2|COMPLETED|Overall Study||151
1110588|NCT01165138|2687155|P1|COMPLETED|Overall Study||0
1110589|NCT01165138|2687152|P4|STARTED|Overall Study||201
1110590|NCT01165138|2687153|P3|STARTED|Overall Study||205
1110591|NCT01165138|2687154|P2|STARTED|Overall Study||203
1110592|NCT01165138|2687155|P1|STARTED|Overall Study||0
1110593|NCT01165177|2687216|P2|NOT COMPLETED|Overall Study||902
1110594|NCT01165177|2687217|P1|NOT COMPLETED|Overall Study||922
1110595|NCT01165177|2687216|P2|COMPLETED|Overall Study||6808
1110596|NCT01165177|2687217|P1|COMPLETED|Overall Study||6773
1110597|NCT01165177|2687216|P2|STARTED|Overall Study||7710
1110598|NCT01165177|2687217|P1|STARTED|Overall Study||7695
1110599|NCT01165203|2687341|P2|NOT COMPLETED|Extended Safety Follow-up Phase||4
1110600|NCT01165203|2687342|P1|NOT COMPLETED|Extended Safety Follow-up Phase||7
1110601|NCT01165203|2687341|P2|COMPLETED|Extended Safety Follow-up Phase||45
1110602|NCT01165203|2687342|P1|COMPLETED|Extended Safety Follow-up Phase||67
1110603|NCT01165203|2687341|P2|STARTED|Extended Safety Follow-up Phase||49
1110604|NCT01165203|2687342|P1|STARTED|Extended Safety Follow-up Phase||74
1110605|NCT01165203|2687341|P2|NOT COMPLETED|Active Phase||2
1110606|NCT01165203|2687342|P1|NOT COMPLETED|Active Phase||5
1110607|NCT01165203|2687341|P2|COMPLETED|Active Phase||47
1110608|NCT01165203|2687342|P1|COMPLETED|Active Phase||69
1110609|NCT01165203|2687341|P2|STARTED|Active Phase||49
1110610|NCT01165203|2687342|P1|STARTED|Active Phase||74
1110611|NCT01165216|2687432|P2|NOT COMPLETED|Overall Study||7
1110612|NCT01165216|2687433|P1|NOT COMPLETED|Overall Study||8
1110613|NCT01165216|2687432|P2|COMPLETED|Overall Study|Completed=still on study drug|0
1110614|NCT01165216|2687433|P1|COMPLETED|Overall Study|Completed=still on study drug|0
1110615|NCT01165216|2687432|P2|Received at Least 1 Dose of Ipilimumab|Overall Study||6
1110616|NCT01165216|2687433|P1|Received at Least 1 Dose of Ipilimumab|Overall Study||6
1110617|NCT01165216|2687432|P2|STARTED|Overall Study|Participants who received any study drug|7
1110618|NCT01165216|2687433|P1|STARTED|Overall Study|Participants who received any study drug|8
1110619|NCT01165242|2687456|P3|NOT COMPLETED|Overall Study||14
1110620|NCT01165242|2687457|P2|NOT COMPLETED|Overall Study||10
1110621|NCT01165242|2687458|P1|NOT COMPLETED|Overall Study||10
1110622|NCT01165242|2687456|P3|COMPLETED|Overall Study||324
1110623|NCT01165242|2687457|P2|COMPLETED|Overall Study||326
1110624|NCT01165242|2687458|P1|COMPLETED|Overall Study||327
1110625|NCT01165242|2687456|P3|STARTED|Overall Study||338
1110626|NCT01165242|2687457|P2|STARTED|Overall Study||336
1110627|NCT01165242|2687458|P1|STARTED|Overall Study||337
1110628|NCT01165281|2687492|P2|NOT COMPLETED|Overall Study||51
1110629|NCT01165281|2687493|P1|NOT COMPLETED|Overall Study||58
1110630|NCT01165281|2687492|P2|COMPLETED|Overall Study||121
1110631|NCT01165281|2687493|P1|COMPLETED|Overall Study||110
1110632|NCT01165281|2687492|P2|STARTED|Overall Study||172
1110633|NCT01165281|2687493|P1|STARTED|Overall Study||168
1110634|NCT01165307|2687513|P2|NOT COMPLETED|Overall Study||3
1110635|NCT01165307|2687514|P1|NOT COMPLETED|Overall Study||14
1110636|NCT01165307|2687513|P2|COMPLETED|Overall Study||31
1110637|NCT01165307|2687514|P1|COMPLETED|Overall Study||19
1110638|NCT01165307|2687513|P2|STARTED|Overall Study||34
1110639|NCT01165307|2687514|P1|STARTED|Overall Study||33
1110640|NCT01165320|2687544|P3|NOT COMPLETED|Overall Study||0
1110641|NCT01165320|2687545|P2|NOT COMPLETED|Overall Study||4
1110642|NCT01165320|2687546|P1|NOT COMPLETED|Overall Study||3
1110643|NCT01165320|2687544|P3|COMPLETED|Overall Study||0
1110644|NCT01165320|2687545|P2|COMPLETED|Overall Study||4
1110645|NCT01165320|2687546|P1|COMPLETED|Overall Study||9
1110646|NCT01165320|2687544|P3|STARTED|Overall Study|No participants with esophageal candidiasis were identified for inclusion in the study|0
1110647|NCT01165320|2687545|P2|STARTED|Overall Study||8
1110648|NCT01165320|2687546|P1|STARTED|Overall Study||12
1110649|NCT01165424|2687554|P1|NOT COMPLETED|Overall Study||4
1110650|NCT01165424|2687554|P1|COMPLETED|Overall Study||76
1110651|NCT01165424|2687554|P1|STARTED|Overall Study||80
1110652|NCT01165450|2687559|P1|NOT COMPLETED|Overall Study||0
1110653|NCT01165450|2687559|P1|COMPLETED|Overall Study||2
1110654|NCT01165450|2687559|P1|STARTED|Overall Study||2
1110655|NCT01165541|2687569|P1|NOT COMPLETED|Quetiapine XR and Mirtazepine||5
1110656|NCT01165541|2687569|P1|COMPLETED|Quetiapine XR and Mirtazepine||11
1110657|NCT01165541|2687569|P1|STARTED|Quetiapine XR and Mirtazepine||16
1110658|NCT01165541|2687569|P1|NOT COMPLETED|Quetiapine XR Monotherapy||4
1110659|NCT01165541|2687569|P1|COMPLETED|Quetiapine XR Monotherapy||16
1110660|NCT01165541|2687569|P1|STARTED|Quetiapine XR Monotherapy||20
1110661|NCT01165554|2687575|P1|NOT COMPLETED|Overall Study||23
1110662|NCT01165554|2687575|P1|COMPLETED|Overall Study||180
1110663|NCT01165554|2687575|P1|STARTED|Overall Study|This was the number of subjects that started the study.|203
1110664|NCT01165684|2687584|P2|NOT COMPLETED|Overall Study||52
1110665|NCT01165684|2687585|P1|NOT COMPLETED|Overall Study||28
1110666|NCT01165684|2687584|P2|COMPLETED|Overall Study||148
1110667|NCT01165684|2687585|P1|COMPLETED|Overall Study||173
1110668|NCT01165684|2687584|P2|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|199
1110669|NCT01165684|2687585|P1|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|198
1110670|NCT01165684|2687584|P2|STARTED|Overall Study||200
1110671|NCT01165684|2687585|P1|STARTED|Overall Study||201
1110672|NCT01158534|2687619|P1|NOT COMPLETED|Overall Study||3
1110673|NCT01158534|2687619|P1|COMPLETED|Overall Study|All three pts that did not complete study had some treatment|14
1110674|NCT01158534|2687619|P1|STARTED|Overall Study||17
1110675|NCT01158703|2687629|P2|NOT COMPLETED|Overall Study||0
1110676|NCT01158703|2687630|P1|NOT COMPLETED|Overall Study||0
1110677|NCT01158703|2687629|P2|COMPLETED|Overall Study||8
1110678|NCT01158703|2687630|P1|COMPLETED|Overall Study||12
1110679|NCT01158703|2687629|P2|STARTED|Overall Study||8
1110680|NCT01158703|2687630|P1|STARTED|Overall Study||12
1110681|NCT01158716|2687648|P2|NOT COMPLETED|Overall Study||1
1110682|NCT01158716|2687649|P1|NOT COMPLETED|Overall Study||1
1110683|NCT01158716|2687648|P2|COMPLETED|Overall Study||47
1110684|NCT01158716|2687649|P1|COMPLETED|Overall Study||47
1110685|NCT01158716|2687648|P2|STARTED|Overall Study||48
1110686|NCT01158716|2687649|P1|STARTED|Overall Study||48
1110687|NCT01158924|2687657|P2|NOT COMPLETED|Overall Study||3
1110688|NCT01158924|2687658|P1|NOT COMPLETED|Overall Study||1
1110689|NCT01158924|2687657|P2|COMPLETED|Overall Study||23
1110690|NCT01158924|2687658|P1|COMPLETED|Overall Study||13
1110691|NCT01158924|2687657|P2|STARTED|Overall Study||26
1110692|NCT01158924|2687658|P1|STARTED|Overall Study||14
1110693|NCT01159054|2687672|P1|NOT COMPLETED|Overall Study||20
1110694|NCT01159054|2687672|P1|COMPLETED|Overall Study||2
1110695|NCT01159054|2687672|P1|STARTED|Overall Study||22
1110696|NCT01159171|2687684|P1|NOT COMPLETED|Overall Study||50
1110697|NCT01159171|2687684|P1|COMPLETED|Overall Study||0
1110698|NCT01159171|2687684|P1|STARTED|Overall Study||50
1110699|NCT01159262|2687702|P3|NOT COMPLETED|Overall Study||0
1110700|NCT01159262|2687703|P2|NOT COMPLETED|Overall Study||0
1110701|NCT01159262|2687704|P1|NOT COMPLETED|Overall Study||0
1110702|NCT01159262|2687702|P3|COMPLETED|Overall Study||8
1110703|NCT01159262|2687703|P2|COMPLETED|Overall Study||14
1110704|NCT01159262|2687704|P1|COMPLETED|Overall Study||14
1110705|NCT01159262|2687702|P3|STARTED|Overall Study||8
1110706|NCT01159262|2687703|P2|STARTED|Overall Study||14
1110707|NCT01159262|2687704|P1|STARTED|Overall Study||14
1110708|NCT01159431|2687738|P2|NOT COMPLETED|Overall Study||6
1110709|NCT01159431|2687739|P1|NOT COMPLETED|Overall Study||2
1110710|NCT01159431|2687738|P2|COMPLETED|Overall Study||19
1110711|NCT01159431|2687739|P1|COMPLETED|Overall Study||23
1110712|NCT01159431|2687738|P2|STARTED|Overall Study||25
1110713|NCT01159431|2687739|P1|STARTED|Overall Study||25
1110714|NCT01159535|2687758|P3|NOT COMPLETED|Overall Study||31
1110715|NCT01159535|2687759|P2|NOT COMPLETED|Overall Study||24
1110716|NCT01159535|2687760|P1|NOT COMPLETED|Overall Study||24
1110717|NCT01159535|2687758|P3|COMPLETED|Overall Study||64
1110718|NCT01159535|2687759|P2|COMPLETED|Overall Study||64
1110719|NCT01159535|2687760|P1|COMPLETED|Overall Study||79
1110720|NCT01159535|2687758|P3|STARTED|Overall Study||95
1110721|NCT01159535|2687759|P2|STARTED|Overall Study||88
1110722|NCT01159535|2687760|P1|STARTED|Overall Study||103
1110723|NCT01159574|2687768|P1|NOT COMPLETED|Follow Up Phase||20
1110724|NCT01159574|2687768|P1|COMPLETED|Follow Up Phase|Completion defined as those that are no longer in long term follow up due to death.|92
1110725|NCT01159574|2687768|P1|STARTED|Follow Up Phase||112
1110726|NCT01159574|2687768|P1|NOT COMPLETED|Treatment Phase||21
1110727|NCT01159574|2687768|P1|COMPLETED|Treatment Phase||100
1110728|NCT01159574|2687768|P1|STARTED|Treatment Phase||121
1110729|NCT01159600|2687782|P8|NOT COMPLETED|Overall Study||18
1110730|NCT01159600|2687783|P7|NOT COMPLETED|Overall Study||19
1110731|NCT01159600|2687784|P6|NOT COMPLETED|Overall Study||18
1110732|NCT01159600|2687785|P5|NOT COMPLETED|Overall Study||24
1110733|NCT01159600|2687786|P4|NOT COMPLETED|Overall Study||11
1110734|NCT01159600|2687787|P3|NOT COMPLETED|Overall Study||18
1110735|NCT01159600|2687788|P2|NOT COMPLETED|Overall Study||8
1110736|NCT01159600|2687789|P1|NOT COMPLETED|Overall Study||21
1110737|NCT01159600|2687782|P8|COMPLETED|Overall Study||85
1110738|NCT01159600|2687783|P7|COMPLETED|Overall Study||199
1110739|NCT01159600|2687784|P6|COMPLETED|Overall Study||208
1110740|NCT01159600|2687785|P5|COMPLETED|Overall Study||201
1110741|NCT01159600|2687786|P4|COMPLETED|Overall Study||58
1110742|NCT01159600|2687787|P3|COMPLETED|Overall Study||196
1110743|NCT01159600|2687788|P2|COMPLETED|Overall Study||209
1110744|NCT01159600|2687789|P1|COMPLETED|Overall Study||186
1110745|NCT01159600|2687782|P8|STARTED|Overall Study||103
1110746|NCT01159600|2687783|P7|STARTED|Overall Study||218
1110747|NCT01159600|2687784|P6|STARTED|Overall Study||226
1110748|NCT01159600|2687785|P5|STARTED|Overall Study||225
1110749|NCT01159600|2687786|P4|STARTED|Overall Study||69
1110750|NCT01159600|2687787|P3|STARTED|Overall Study||214
1110751|NCT01159600|2687788|P2|STARTED|Overall Study||217
1110752|NCT01159600|2687789|P1|STARTED|Overall Study||207
1110753|NCT01159665|2687837|P6|NOT COMPLETED|Overall Study||0
1110754|NCT01159665|2687838|P5|NOT COMPLETED|Overall Study||0
1110755|NCT01159665|2687839|P4|NOT COMPLETED|Overall Study||0
1110756|NCT01159665|2687840|P3|NOT COMPLETED|Overall Study||0
1110757|NCT01159665|2687841|P2|NOT COMPLETED|Overall Study||1
1110758|NCT01159665|2687842|P1|NOT COMPLETED|Overall Study||0
1110759|NCT01159665|2687837|P6|COMPLETED|Overall Study||4
1110760|NCT01159665|2687838|P5|COMPLETED|Overall Study||4
1110761|NCT01159665|2687839|P4|COMPLETED|Overall Study||4
1110762|NCT01159665|2687840|P3|COMPLETED|Overall Study||8
1110763|NCT01159665|2687841|P2|COMPLETED|Overall Study||8
1110764|NCT01159665|2687842|P1|COMPLETED|Overall Study||9
1110765|NCT01159665|2687837|P6|STARTED|Overall Study||4
1110766|NCT01159665|2687838|P5|STARTED|Overall Study||4
1110767|NCT01159665|2687839|P4|STARTED|Overall Study||4
1110768|NCT01159665|2687840|P3|STARTED|Overall Study||8
1110769|NCT01159665|2687841|P2|STARTED|Overall Study||9
1110770|NCT01159665|2687842|P1|STARTED|Overall Study||9
1110771|NCT01159691|2687862|P1|NOT COMPLETED|Overall Study||22
1110772|NCT01159691|2687862|P1|COMPLETED|Overall Study|Multiple discontinuation reasons were possible.|54
1110773|NCT01159691|2687862|P1|STARTED|Overall Study||76
1110774|NCT01159743|2687871|P2|NOT COMPLETED|Overall Study||0
1110775|NCT01159743|2687872|P1|NOT COMPLETED|Overall Study||0
1110776|NCT01159743|2687871|P2|COMPLETED|Overall Study||109
1110777|NCT01159743|2687872|P1|COMPLETED|Overall Study||237
1110778|NCT01159743|2687871|P2|STARTED|Overall Study||109
1110779|NCT01159743|2687872|P1|STARTED|Overall Study||237
1110780|NCT01159769|2687884|P1|NOT COMPLETED|Overall Study||1
1110781|NCT01159769|2687884|P1|COMPLETED|Overall Study||214
1110782|NCT01159769|2687884|P1|STARTED|Overall Study||215
1110783|NCT01159912|2687892|P3|NOT COMPLETED|Overall Study||26
1110784|NCT01159912|2687893|P2|NOT COMPLETED|Overall Study||22
1110785|NCT01159912|2687894|P1|NOT COMPLETED|Overall Study||40
1110786|NCT01159912|2687892|P3|COMPLETED|Overall Study||88
1110787|NCT01159912|2687893|P2|COMPLETED|Overall Study||92
1110788|NCT01159912|2687894|P1|COMPLETED|Overall Study||75
1110789|NCT01159912|2687892|P3|STARTED|Overall Study||114
1110790|NCT01159912|2687893|P2|STARTED|Overall Study||114
1110791|NCT01159912|2687894|P1|STARTED|Overall Study||115
1110792|NCT01159938|2687920|P5|NOT COMPLETED|Second Study Period||0
1110793|NCT01159938|2687921|P4|NOT COMPLETED|Second Study Period||0
1110794|NCT01159938|2687922|P3|NOT COMPLETED|Second Study Period||0
1110795|NCT01159938|2687923|P2|NOT COMPLETED|Second Study Period||0
1110796|NCT01159938|2687924|P1|NOT COMPLETED|Second Study Period||0
1110797|NCT01159938|2687920|P5|COMPLETED|Second Study Period||12
1110798|NCT01159938|2687921|P4|COMPLETED|Second Study Period||12
1110799|NCT01159938|2687922|P3|COMPLETED|Second Study Period||10
1110800|NCT01159938|2687923|P2|COMPLETED|Second Study Period||11
1110801|NCT01159938|2687924|P1|COMPLETED|Second Study Period||0
1110802|NCT01159938|2687920|P5|STARTED|Second Study Period||12
1110803|NCT01159938|2687921|P4|STARTED|Second Study Period||12
1110804|NCT01159938|2687922|P3|STARTED|Second Study Period||10
1110805|NCT01159938|2687923|P2|STARTED|Second Study Period||11
1110806|NCT01159938|2687924|P1|STARTED|Second Study Period||0
1110807|NCT01159938|2687920|P5|NOT COMPLETED|First Study Period||0
1110808|NCT01159938|2687921|P4|NOT COMPLETED|First Study Period||0
1110809|NCT01159938|2687922|P3|NOT COMPLETED|First Study Period||1
1110810|NCT01159938|2687923|P2|NOT COMPLETED|First Study Period||0
1110811|NCT01159938|2687924|P1|NOT COMPLETED|First Study Period||0
1110812|NCT01159938|2687920|P5|COMPLETED|First Study Period||12
1110813|NCT01159938|2687921|P4|COMPLETED|First Study Period||12
1110814|NCT01159938|2687922|P3|COMPLETED|First Study Period||10
1110815|NCT01159938|2687923|P2|COMPLETED|First Study Period||11
1110816|NCT01159938|2687924|P1|COMPLETED|First Study Period||26
1110817|NCT01159938|2687920|P5|Safety and Efficacy Analysis Population|First Study Period||12
1110818|NCT01159938|2687921|P4|Safety and Efficacy Analysis Population|First Study Period||12
1110819|NCT01159938|2687922|P3|Safety and Efficacy Analysis Population|First Study Period|Microalbuminuria relaxed with protocol amendment. T2DM albuminuria participant included in analyses.|11
1110820|NCT01159938|2687923|P2|Safety and Efficacy Analysis Population|First Study Period||11
1110821|NCT01159938|2687924|P1|Safety and Efficacy Analysis Population|First Study Period|One healthy participant completed study but was excluded from analyses (major protocol violation).|25
1110822|NCT01159938|2687920|P5|Received at Least 1 Dose of Study Drug|First Study Period||12
1110823|NCT01159938|2687921|P4|Received at Least 1 Dose of Study Drug|First Study Period||12
1110824|NCT01159938|2687922|P3|Received at Least 1 Dose of Study Drug|First Study Period||11
1110825|NCT01159938|2687923|P2|Received at Least 1 Dose of Study Drug|First Study Period||11
1110826|NCT01159938|2687924|P1|Received at Least 1 Dose of Study Drug|First Study Period||0
1110827|NCT01159938|2687920|P5|STARTED|First Study Period||12
1110828|NCT01159938|2687921|P4|STARTED|First Study Period||12
1110829|NCT01159938|2687922|P3|STARTED|First Study Period||11
1110830|NCT01159938|2687923|P2|STARTED|First Study Period||11
1110831|NCT01159938|2687924|P1|STARTED|First Study Period||26
1110832|NCT01160237|2687987|P3|NOT COMPLETED|Overall Study||0
1110833|NCT01160237|2687988|P2|NOT COMPLETED|Overall Study||0
1110834|NCT01160237|2687989|P1|NOT COMPLETED|Overall Study||0
1110835|NCT01160237|2687987|P3|COMPLETED|Overall Study||0
1110836|NCT01160237|2687988|P2|COMPLETED|Overall Study||3
1110837|NCT01160237|2687989|P1|COMPLETED|Overall Study||4
1110838|NCT01160237|2687987|P3|STARTED|Overall Study||0
1110839|NCT01160237|2687988|P2|STARTED|Overall Study||3
1110840|NCT01160237|2687989|P1|STARTED|Overall Study||4
1110841|NCT01165775|2688012|P1|NOT COMPLETED|Overall Study||2
1110842|NCT01165775|2688012|P1|COMPLETED|Overall Study||15
1110843|NCT01165775|2688012|P1|STARTED|Overall Study||17
1110847|NCT01165983|2688026|P2|NOT COMPLETED|Overall Study||7
1110848|NCT01165983|2688027|P1|NOT COMPLETED|Overall Study||5
1110849|NCT01165983|2688026|P2|COMPLETED|Overall Study||42
1110850|NCT01165983|2688027|P1|COMPLETED|Overall Study||46
1110851|NCT01165983|2688026|P2|STARTED|Overall Study||49
1110852|NCT01165983|2688027|P1|STARTED|Overall Study||51
1110853|NCT01165996|2688071|P1|NOT COMPLETED|Overall Study||2
1110854|NCT01165996|2688071|P1|COMPLETED|Overall Study||23
1110855|NCT01165996|2688071|P1|Maintenance Phase|Overall Study||23
1110856|NCT01165996|2688071|P1|Induction Phase|Overall Study||25
1110857|NCT01165996|2688071|P1|STARTED|Overall Study||25
1110858|NCT01166139|2688077|P1|NOT COMPLETED|Overall Study||3
1110859|NCT01166139|2688077|P1|COMPLETED|Overall Study||7
1110860|NCT01166139|2688077|P1|STARTED|Overall Study||10
1110861|NCT01166178|2688085|P2|NOT COMPLETED|Overall Study||8
1110862|NCT01166178|2688086|P1|NOT COMPLETED|Overall Study||21
1110863|NCT01166178|2688085|P2|COMPLETED|Overall Study||0
1110864|NCT01166178|2688086|P1|COMPLETED|Overall Study||0
1110865|NCT01166178|2688085|P2|STARTED|Overall Study||8
1110866|NCT01166178|2688086|P1|STARTED|Overall Study||21
1110867|NCT01166230|2688114|P2|NOT COMPLETED|Overall Study||16
1110868|NCT01166230|2688115|P1|NOT COMPLETED|Overall Study||19
1110869|NCT01166230|2688114|P2|COMPLETED|Overall Study||255
1110870|NCT01166230|2688115|P1|COMPLETED|Overall Study||261
1110871|NCT01166230|2688114|P2|STARTED|Overall Study||271
1110872|NCT01166230|2688115|P1|STARTED|Overall Study||280
1110873|NCT01166282|2688129|P3|NOT COMPLETED|Open-label Period||17
1110874|NCT01166282|2688130|P2|NOT COMPLETED|Open-label Period||0
1110875|NCT01166282|2688131|P1|NOT COMPLETED|Open-label Period||0
1110876|NCT01166282|2688129|P3|COMPLETED|Open-label Period||29
1110877|NCT01166282|2688130|P2|COMPLETED|Open-label Period||0
1110878|NCT01166282|2688131|P1|COMPLETED|Open-label Period||0
1110879|NCT01166282|2688129|P3|STARTED|Open-label Period||46
1110880|NCT01166282|2688130|P2|STARTED|Open-label Period||0
1110881|NCT01166282|2688131|P1|STARTED|Open-label Period||0
1110882|NCT01166282|2688129|P3|NOT COMPLETED|Double-blind Period||0
1110883|NCT01166282|2688130|P2|NOT COMPLETED|Double-blind Period||0
1110884|NCT01166282|2688131|P1|NOT COMPLETED|Double-blind Period||0
1110885|NCT01166282|2688129|P3|COMPLETED|Double-blind Period||0
1110886|NCT01166282|2688130|P2|COMPLETED|Double-blind Period||31
1110887|NCT01166282|2688131|P1|COMPLETED|Double-blind Period||15
1110888|NCT01166282|2688129|P3|STARTED|Double-blind Period||0
1110889|NCT01166282|2688130|P2|STARTED|Double-blind Period||31
1110890|NCT01166282|2688131|P1|STARTED|Double-blind Period||15
1110891|NCT01166646|2688155|P2|NOT COMPLETED|Overall Study||1
1110892|NCT01166646|2688156|P1|NOT COMPLETED|Overall Study||1
1110893|NCT01166646|2688155|P2|COMPLETED|Overall Study||21
1110894|NCT01166646|2688156|P1|COMPLETED|Overall Study||20
1110895|NCT01166646|2688155|P2|STARTED|Overall Study||22
1110896|NCT01166646|2688156|P1|STARTED|Overall Study||21
1110897|NCT01166659|2688172|P1|NOT COMPLETED|Overall Study||13
1110898|NCT01166659|2688172|P1|COMPLETED|Overall Study||35
1110899|NCT01166659|2688172|P1|STARTED|Overall Study||48
1110900|NCT01166724|2688181|P2|NOT COMPLETED|Overall Study||5
1110901|NCT01166724|2688182|P1|NOT COMPLETED|Overall Study||7
1110902|NCT01166724|2688181|P2|COMPLETED|Overall Study||0
1110903|NCT01166724|2688182|P1|COMPLETED|Overall Study||0
1110904|NCT01166724|2688181|P2|STARTED|Overall Study||5
1110905|NCT01166724|2688182|P1|STARTED|Overall Study||7
1110906|NCT01166750|2688192|P2|NOT COMPLETED|Overall Study||0
1110907|NCT01166750|2688193|P1|NOT COMPLETED|Overall Study||1
1110908|NCT01166750|2688192|P2|COMPLETED|Overall Study||13
1110909|NCT01166750|2688193|P1|COMPLETED|Overall Study||9
1110910|NCT01166750|2688192|P2|STARTED|Overall Study||13
1110911|NCT01166750|2688193|P1|STARTED|Overall Study||10
1110912|NCT01166763|2688199|P1|NOT COMPLETED|Overall Study||3
1110913|NCT01166763|2688199|P1|COMPLETED|Overall Study||27
1110914|NCT01166763|2688199|P1|STARTED|Overall Study||30
1110915|NCT01166958|2688207|P2|NOT COMPLETED|Overall Study||0
1110916|NCT01166958|2688208|P1|NOT COMPLETED|Overall Study||1
1110917|NCT01166958|2688207|P2|COMPLETED|Overall Study||13
1110918|NCT01166958|2688208|P1|COMPLETED|Overall Study||12
1110919|NCT01166958|2688207|P2|STARTED|Overall Study||13
1110920|NCT01166958|2688208|P1|STARTED|Overall Study||13
1110921|NCT01166971|2688224|P2|NOT COMPLETED|Overall Study||1
1110922|NCT01166971|2688225|P1|NOT COMPLETED|Overall Study||1
1110923|NCT01166971|2688224|P2|COMPLETED|Overall Study||30
1110924|NCT01166971|2688225|P1|COMPLETED|Overall Study||32
1110925|NCT01166971|2688224|P2|STARTED|Overall Study||31
1110926|NCT01166971|2688225|P1|STARTED|Overall Study||33
1110927|NCT01166997|2688233|P2|NOT COMPLETED|Overall Study||0
1110928|NCT01166997|2688234|P1|NOT COMPLETED|Overall Study||2
1110929|NCT01166997|2688233|P2|COMPLETED|Overall Study||30
1110930|NCT01166997|2688234|P1|COMPLETED|Overall Study||27
1110931|NCT01166997|2688233|P2|STARTED|Overall Study||30
1110932|NCT01166997|2688234|P1|STARTED|Overall Study||29
1110933|NCT01167023|2688244|P3|NOT COMPLETED|Overall Study||2
1110934|NCT01167023|2688245|P2|NOT COMPLETED|Overall Study||3
1110935|NCT01167023|2688246|P1|NOT COMPLETED|Overall Study||0
1110936|NCT01167023|2688244|P3|COMPLETED|Overall Study||39
1110937|NCT01167023|2688245|P2|COMPLETED|Overall Study||18
1110938|NCT01167023|2688246|P1|COMPLETED|Overall Study||0
1110939|NCT01167023|2688244|P3|Received at Least 1 Dose of Study Drug|Overall Study||41
1110940|NCT01167023|2688245|P2|Received at Least 1 Dose of Study Drug|Overall Study||19
1110941|NCT01167023|2688246|P1|Received at Least 1 Dose of Study Drug|Overall Study||0
1110942|NCT01167023|2688244|P3|STARTED|Overall Study||41
1110943|NCT01167023|2688245|P2|STARTED|Overall Study||21
1110944|NCT01167023|2688246|P1|STARTED|Overall Study||0
1110945|NCT01167140|2688264|P1|NOT COMPLETED|Overall Study||1
1110946|NCT01167140|2688264|P1|COMPLETED|Overall Study||41
1110947|NCT01167140|2688264|P1|STARTED|Overall Study||42
1110948|NCT01167153|2688272|P2|NOT COMPLETED|Overall Study||33
1110949|NCT01167153|2688273|P1|NOT COMPLETED|Overall Study||18
1110950|NCT01167153|2688272|P2|COMPLETED|Overall Study||249
1110951|NCT01167153|2688273|P1|COMPLETED|Overall Study||264
1110952|NCT01167153|2688272|P2|Intention to Treat (ITT)|Overall Study||268
1110953|NCT01167153|2688273|P1|Intention to Treat (ITT)|Overall Study||272
1110954|NCT01167153|2688272|P2|STARTED|Overall Study||282
1110955|NCT01167153|2688273|P1|STARTED|Overall Study||282
1110956|NCT01167192|2688291|P1|NOT COMPLETED|Overall Study||4
1110957|NCT01167192|2688291|P1|COMPLETED|Overall Study||6
1110958|NCT01167192|2688291|P1|STARTED|Overall Study||10
1110959|NCT01167257|2688308|P2|NOT COMPLETED|Overall Study||3
1110960|NCT01167257|2688309|P1|NOT COMPLETED|Overall Study||3
1110961|NCT01167257|2688308|P2|COMPLETED|Overall Study||28
1110962|NCT01167257|2688309|P1|COMPLETED|Overall Study||28
1110963|NCT01167257|2688308|P2|STARTED|Overall Study||31
1110964|NCT01167257|2688309|P1|STARTED|Overall Study||31
1110965|NCT01167426|2688331|P1|NOT COMPLETED|Overall Study||10
1110966|NCT01167426|2688331|P1|COMPLETED|Overall Study||138
1110967|NCT01167426|2688331|P1|STARTED|Overall Study||148
1110971|NCT01167504|2688342|P1|NOT COMPLETED|Overall Study||3
1110972|NCT01167504|2688342|P1|COMPLETED|Overall Study||12
1110973|NCT01167504|2688342|P1|STARTED|Overall Study||15
1110974|NCT01167582|2688349|P2|NOT COMPLETED|Overall Study||1
1110975|NCT01167582|2688350|P1|NOT COMPLETED|Overall Study||0
1110976|NCT01167582|2688349|P2|COMPLETED|Overall Study||54
1110977|NCT01167582|2688350|P1|COMPLETED|Overall Study||55
1110978|NCT01167582|2688349|P2|STARTED|Overall Study||55
1110979|NCT01167582|2688350|P1|STARTED|Overall Study||55
1110980|NCT01167608|2688362|P1|NOT COMPLETED|Overall Study||114
1110981|NCT01167608|2688362|P1|COMPLETED|Overall Study||769
1110982|NCT01167608|2688362|P1|STARTED|Overall Study||883
1110983|NCT01167634|2688375|P4|NOT COMPLETED|Overall Study||4
1110984|NCT01167634|2688376|P3|NOT COMPLETED|Overall Study||3
1110985|NCT01167634|2688377|P2|NOT COMPLETED|Overall Study||4
1110986|NCT01167634|2688378|P1|NOT COMPLETED|Overall Study||2
1110987|NCT01167634|2688375|P4|COMPLETED|Overall Study||29
1110988|NCT01167634|2688376|P3|COMPLETED|Overall Study||30
1110989|NCT01167634|2688377|P2|COMPLETED|Overall Study||29
1110990|NCT01167634|2688378|P1|COMPLETED|Overall Study||31
1110991|NCT01167634|2688375|P4|STARTED|Overall Study||33
1110992|NCT01167634|2688376|P3|STARTED|Overall Study||33
1110993|NCT01167634|2688377|P2|STARTED|Overall Study||33
1110994|NCT01167634|2688378|P1|STARTED|Overall Study||33
1110995|NCT01167829|2688388|P1|NOT COMPLETED|Overall Study||0
1110996|NCT01167829|2688388|P1|COMPLETED|Overall Study||12
1110997|NCT01167829|2688388|P1|STARTED|Overall Study||12
1110998|NCT01167881|2688403|P2|NOT COMPLETED|Overall Study||191
1110999|NCT01167881|2688404|P1|NOT COMPLETED|Overall Study||159
1111000|NCT01167881|2688403|P2|COMPLETED|Overall Study||589
1111001|NCT01167881|2688404|P1|COMPLETED|Overall Study||610
1111002|NCT01167881|2688403|P2|Completed After 4 Years Treatment|Overall Study||462
1111003|NCT01167881|2688404|P1|Completed After 4 Years Treatment|Overall Study||515
1111004|NCT01167881|2688403|P2|Completed After 2 Years Treatment|Overall Study||127
1111005|NCT01167881|2688404|P1|Completed After 2 Years Treatment|Overall Study||95
1111006|NCT01167881|2688403|P2|STARTED|Overall Study||780
1111007|NCT01167881|2688404|P1|STARTED|Overall Study||769
1111008|NCT01168024|2688430|P2|NOT COMPLETED|Overall Study||0
1111009|NCT01168024|2688431|P1|NOT COMPLETED|Overall Study||0
1111010|NCT01168024|2688430|P2|COMPLETED|Overall Study||3
1111011|NCT01168024|2688431|P1|COMPLETED|Overall Study||13
1111012|NCT01168024|2688430|P2|STARTED|Overall Study||3
1111013|NCT01168024|2688431|P1|STARTED|Overall Study|13 tx/3 controls. Roll-ins occurred for product training, several more treatment cases than control.|13
1111014|NCT01168232|2688443|P1|NOT COMPLETED|Overall Study||8
1111015|NCT01168232|2688443|P1|COMPLETED|Overall Study|Eligible and treated patients|34
1111016|NCT01168232|2688443|P1|STARTED|Overall Study||42
1111017|NCT01168349|2688450|P1|NOT COMPLETED|Overall Study||301
1111018|NCT01168349|2688450|P1|COMPLETED|Overall Study||754
1111019|NCT01168349|2688450|P1|STARTED|Overall Study||1055
1111020|NCT01168427|2688556|P1|NOT COMPLETED|Overall Study||1
1111021|NCT01168427|2688556|P1|COMPLETED|Overall Study||65
1111022|NCT01168427|2688556|P1|STARTED|Overall Study||66
1111023|NCT01168596|2688563|P2|NOT COMPLETED|Overall Study||1
1111024|NCT01168596|2688564|P1|NOT COMPLETED|Overall Study||3
1111025|NCT01168596|2688563|P2|COMPLETED|Overall Study||13
1111026|NCT01168596|2688564|P1|COMPLETED|Overall Study||13
1111027|NCT01168596|2688563|P2|STARTED|Overall Study||14
1111028|NCT01168596|2688564|P1|STARTED|Overall Study||16
1111029|NCT01163149|2688611|P3|NOT COMPLETED|Extension Treatment Period||2
1111030|NCT01163149|2688612|P2|NOT COMPLETED|Extension Treatment Period||1
1111031|NCT01163149|2688613|P1|NOT COMPLETED|Extension Treatment Period||2
1111032|NCT01163149|2688611|P3|COMPLETED|Extension Treatment Period||4
1111033|NCT01163149|2688612|P2|COMPLETED|Extension Treatment Period||5
1111034|NCT01163149|2688613|P1|COMPLETED|Extension Treatment Period||5
1111035|NCT01163149|2688611|P3|STARTED|Extension Treatment Period||6
1111036|NCT01163149|2688612|P2|STARTED|Extension Treatment Period||6
1111037|NCT01163149|2688613|P1|STARTED|Extension Treatment Period||7
1111038|NCT01163149|2688611|P3|NOT COMPLETED|Primary Treatment Period||0
1111039|NCT01163149|2688612|P2|NOT COMPLETED|Primary Treatment Period||0
1111040|NCT01163149|2688613|P1|NOT COMPLETED|Primary Treatment Period||0
1111041|NCT01163149|2688611|P3|COMPLETED|Primary Treatment Period||6
1111042|NCT01163149|2688612|P2|COMPLETED|Primary Treatment Period||6
1111043|NCT01163149|2688613|P1|COMPLETED|Primary Treatment Period||7
1111044|NCT01163149|2688611|P3|STARTED|Primary Treatment Period||6
1111045|NCT01163149|2688612|P2|STARTED|Primary Treatment Period||6
1111046|NCT01163149|2688613|P1|STARTED|Primary Treatment Period||7
1111047|NCT01163162|2688655|P1|NOT COMPLETED|Overall Study||0
1111048|NCT01163162|2688655|P1|COMPLETED|Overall Study||16
1111049|NCT01163162|2688655|P1|STARTED|Overall Study||16
1111050|NCT01163214|2688663|P2|NOT COMPLETED|Overall Study||0
1111051|NCT01163214|2688664|P1|NOT COMPLETED|Overall Study||0
1111052|NCT01163214|2688663|P2|COMPLETED|Overall Study||81
1111053|NCT01163214|2688664|P1|COMPLETED|Overall Study||79
1111054|NCT01163214|2688663|P2|STARTED|Overall Study||81
1111055|NCT01163214|2688664|P1|STARTED|Overall Study||79
1111056|NCT01168674|2688680|P2|NOT COMPLETED|Overall Study||0
1111057|NCT01168674|2688681|P1|NOT COMPLETED|Overall Study||0
1111058|NCT01168674|2688680|P2|COMPLETED|Overall Study||24
1111059|NCT01168674|2688681|P1|COMPLETED|Overall Study||25
1111060|NCT01168674|2688680|P2|STARTED|Overall Study||24
1111061|NCT01168674|2688681|P1|STARTED|Overall Study||25
1111062|NCT01168687|2688690|P2|NOT COMPLETED|Overall Study||0
1111063|NCT01168687|2688691|P1|NOT COMPLETED|Overall Study||0
1111064|NCT01168687|2688690|P2|COMPLETED|Overall Study||23
1111065|NCT01168687|2688691|P1|COMPLETED|Overall Study||23
1111066|NCT01168687|2688690|P2|STARTED|Overall Study||23
1111067|NCT01168687|2688691|P1|STARTED|Overall Study||23
1111068|NCT01168726|2688700|P3|NOT COMPLETED|Overall Study||5
1111069|NCT01168726|2688701|P2|NOT COMPLETED|Overall Study||9
1111070|NCT01168726|2688702|P1|NOT COMPLETED|Overall Study||8
1111071|NCT01168726|2688700|P3|COMPLETED|Overall Study||128
1111072|NCT01168726|2688701|P2|COMPLETED|Overall Study||112
1111073|NCT01168726|2688702|P1|COMPLETED|Overall Study||103
1111074|NCT01168726|2688700|P3|STARTED|Overall Study||133
1111075|NCT01168726|2688701|P2|STARTED|Overall Study||121
1111076|NCT01168726|2688702|P1|STARTED|Overall Study||111
1111077|NCT01168856|2688721|P2|NOT COMPLETED|Overall Study||343
1111078|NCT01168856|2688722|P1|NOT COMPLETED|Overall Study||18
1111079|NCT01168856|2688721|P2|COMPLETED|Overall Study||215
1111080|NCT01168856|2688722|P1|COMPLETED|Overall Study||158
1111081|NCT01168856|2688721|P2|STARTED|Overall Study||558
1111082|NCT01168856|2688722|P1|STARTED|Overall Study||176
1111083|NCT01168934|2688779|P2|NOT COMPLETED|Second Intervention Period||0
1111084|NCT01168934|2688780|P1|NOT COMPLETED|Second Intervention Period||0
1111085|NCT01168934|2688779|P2|COMPLETED|Second Intervention Period||7
1111086|NCT01168934|2688780|P1|COMPLETED|Second Intervention Period||7
1111087|NCT01168934|2688779|P2|STARTED|Second Intervention Period||7
1111088|NCT01168934|2688780|P1|STARTED|Second Intervention Period||7
1111089|NCT01168934|2688779|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1111090|NCT01168934|2688780|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
1111091|NCT01168934|2688779|P2|COMPLETED|Washout Period (at Least 14 Days)||7
1111092|NCT01168934|2688780|P1|COMPLETED|Washout Period (at Least 14 Days)||7
1111093|NCT01168934|2688779|P2|STARTED|Washout Period (at Least 14 Days)||7
1111094|NCT01168934|2688780|P1|STARTED|Washout Period (at Least 14 Days)||7
1111095|NCT01168934|2688779|P2|NOT COMPLETED|First Intervention Period||0
1111096|NCT01168934|2688780|P1|NOT COMPLETED|First Intervention Period||0
1111097|NCT01168934|2688779|P2|COMPLETED|First Intervention Period||7
1111098|NCT01168934|2688780|P1|COMPLETED|First Intervention Period||7
1111099|NCT01168934|2688779|P2|STARTED|First Intervention Period||7
1111100|NCT01168934|2688780|P1|STARTED|First Intervention Period||7
1111101|NCT01170364|2688814|P2|NOT COMPLETED|Overall Study||1
1111102|NCT01170364|2688815|P1|NOT COMPLETED|Overall Study||4
1111103|NCT01170364|2688814|P2|COMPLETED|Overall Study|One participant was unable to begin the second testing period due to scheduling conflicts.|5
1111104|NCT01170364|2688815|P1|COMPLETED|Overall Study||4
1111105|NCT01170364|2688814|P2|STARTED|Overall Study||6
1111106|NCT01170364|2688815|P1|STARTED|Overall Study||8
1111107|NCT01170390|2688823|P3|NOT COMPLETED|Randomized Treatment||0
1111108|NCT01170390|2688824|P2|NOT COMPLETED|Randomized Treatment||1
1111109|NCT01170390|2688825|P1|NOT COMPLETED|Randomized Treatment||0
1111110|NCT01170390|2688823|P3|COMPLETED|Randomized Treatment||15
1111111|NCT01170390|2688824|P2|COMPLETED|Randomized Treatment||16
1111112|NCT01170390|2688825|P1|COMPLETED|Randomized Treatment||0
1111113|NCT01170390|2688823|P3|STARTED|Randomized Treatment||15
1111114|NCT01170390|2688824|P2|STARTED|Randomized Treatment||17
1111115|NCT01170390|2688825|P1|STARTED|Randomized Treatment||0
1111116|NCT01170390|2688823|P3|NOT COMPLETED|Oral Contraceptives||0
1111117|NCT01170390|2688824|P2|NOT COMPLETED|Oral Contraceptives||0
1111118|NCT01170390|2688825|P1|NOT COMPLETED|Oral Contraceptives||1
1111119|NCT01170390|2688823|P3|COMPLETED|Oral Contraceptives||0
1111120|NCT01170390|2688824|P2|COMPLETED|Oral Contraceptives||0
1111121|NCT01170390|2688825|P1|COMPLETED|Oral Contraceptives||31
1111122|NCT01170390|2688823|P3|STARTED|Oral Contraceptives||0
1111123|NCT01170390|2688824|P2|STARTED|Oral Contraceptives||0
1111124|NCT01170390|2688825|P1|STARTED|Oral Contraceptives||32
1111125|NCT01170533|2688839|P2|NOT COMPLETED|Pantoprazole Cross-over||0
1111126|NCT01170533|2688840|P1|NOT COMPLETED|Pantoprazole Cross-over||0
1111127|NCT01170533|2688839|P2|COMPLETED|Pantoprazole Cross-over||20
1111128|NCT01170533|2688840|P1|COMPLETED|Pantoprazole Cross-over||0
1111129|NCT01170533|2688839|P2|STARTED|Pantoprazole Cross-over|15 participants continued from omeprazole cross-over; the remaining 5 were new participants|20
1111130|NCT01170533|2688840|P1|STARTED|Pantoprazole Cross-over||0
1111131|NCT01170533|2688839|P2|NOT COMPLETED|Omeprazole Cross-over||0
1111132|NCT01170533|2688840|P1|NOT COMPLETED|Omeprazole Cross-over||0
1111133|NCT01170533|2688839|P2|COMPLETED|Omeprazole Cross-over||0
1111134|NCT01170533|2688840|P1|COMPLETED|Omeprazole Cross-over||20
1111135|NCT01170533|2688839|P2|STARTED|Omeprazole Cross-over||0
1111136|NCT01170533|2688840|P1|STARTED|Omeprazole Cross-over||20
1111137|NCT01170546|2688854|P4|NOT COMPLETED|Overall Study||0
1111138|NCT01170546|2688855|P3|NOT COMPLETED|Overall Study||0
1111139|NCT01170546|2688856|P2|NOT COMPLETED|Overall Study||0
1111140|NCT01170546|2688857|P1|NOT COMPLETED|Overall Study||0
1111141|NCT01170546|2688854|P4|COMPLETED|Overall Study||8
1111142|NCT01170546|2688855|P3|COMPLETED|Overall Study||6
1111143|NCT01170546|2688856|P2|COMPLETED|Overall Study||7
1111144|NCT01170546|2688857|P1|COMPLETED|Overall Study||7
1111145|NCT01170546|2688854|P4|STARTED|Overall Study||8
1111146|NCT01170546|2688855|P3|STARTED|Overall Study||6
1111147|NCT01170546|2688856|P2|STARTED|Overall Study||7
1111148|NCT01170546|2688857|P1|STARTED|Overall Study||7
1111149|NCT01170598|2688867|P1|NOT COMPLETED|Overall Study||6
1111150|NCT01170598|2688867|P1|COMPLETED|Overall Study||29
1111151|NCT01170598|2688867|P1|STARTED|Overall Study||35
1111152|NCT01170663|2688884|P2|NOT COMPLETED|Overall Study||27
1111153|NCT01170663|2688885|P1|NOT COMPLETED|Overall Study||24
1111154|NCT01170663|2688884|P2|COMPLETED|Overall Study|Participants who died due to any cause or alive at study end but off study drug considered complete.|308
1111155|NCT01170663|2688885|P1|COMPLETED|Overall Study|Participants who died due to any cause or alive at study end but off study drug considered complete.|306
1111156|NCT01170663|2688884|P2|Received Any Treatment (Safety Pop)|Overall Study||329
1111157|NCT01170663|2688885|P1|Received Any Treatment (Safety Pop)|Overall Study||327
1111158|NCT01170663|2688884|P2|STARTED|Overall Study||335
1111159|NCT01170663|2688885|P1|STARTED|Overall Study||330
1111160|NCT01170754|2688915|P2|NOT COMPLETED|Overall Study||0
1111161|NCT01170754|2688916|P1|NOT COMPLETED|Overall Study||0
1111162|NCT01170754|2688915|P2|COMPLETED|Overall Study||70
1111163|NCT01170754|2688916|P1|COMPLETED|Overall Study||66
1111164|NCT01170754|2688915|P2|STARTED|Overall Study||70
1111165|NCT01170754|2688916|P1|STARTED|Overall Study||66
1111166|NCT01170884|2688946|P2|NOT COMPLETED|Overall Study||2
1111167|NCT01170884|2688947|P1|NOT COMPLETED|Overall Study||5
1111168|NCT01170884|2688946|P2|COMPLETED|Overall Study||60
1111169|NCT01170884|2688947|P1|COMPLETED|Overall Study||54
1111170|NCT01170884|2688946|P2|STARTED|Overall Study||62
1111171|NCT01170884|2688947|P1|STARTED|Overall Study||59
1111172|NCT01170949|2688955|P2|NOT COMPLETED|Overall Study||4
1111173|NCT01170949|2688956|P1|NOT COMPLETED|Overall Study||7
1111174|NCT01170949|2688955|P2|COMPLETED|Overall Study||22
1111175|NCT01170949|2688956|P1|COMPLETED|Overall Study||43
1111176|NCT01170949|2688955|P2|STARTED|Overall Study||26
1111177|NCT01170949|2688956|P1|STARTED|Overall Study||50
1111178|NCT01170962|2688965|P3|NOT COMPLETED|Follow up Period||6
1111179|NCT01170962|2688966|P2|NOT COMPLETED|Follow up Period||27
1111180|NCT01170962|2688967|P1|NOT COMPLETED|Follow up Period||39
1111181|NCT01170962|2688965|P3|COMPLETED|Follow up Period||9
1111182|NCT01170962|2688966|P2|COMPLETED|Follow up Period||165
1111183|NCT01170962|2688967|P1|COMPLETED|Follow up Period||159
1111184|NCT01170962|2688965|P3|STARTED|Follow up Period|Out of 17 participants who entered the treatment period, 15 continued in the follow-up period.|15
1111185|NCT01170962|2688966|P2|STARTED|Follow up Period|Out of 199 participants who entered the treatment period, 192 continued in the follow-up period.|192
1111186|NCT01170962|2688967|P1|STARTED|Follow up Period|Out of 203 participants who entered the treatment period, 198 continued in the follow-up period.|198
1111187|NCT01170962|2688965|P3|NOT COMPLETED|Treatment Period||12
1111188|NCT01170962|2688966|P2|NOT COMPLETED|Treatment Period||111
1111189|NCT01170962|2688967|P1|NOT COMPLETED|Treatment Period||127
1111190|NCT01170962|2688965|P3|COMPLETED|Treatment Period||5
1111191|NCT01170962|2688966|P2|COMPLETED|Treatment Period||88
1111192|NCT01170962|2688967|P1|COMPLETED|Treatment Period||76
1111193|NCT01170962|2688965|P3|PDR ­Randomized to 48 Weeks Follow­-up|Treatment Period||0
1111194|NCT01170962|2688966|P2|PDR ­Randomized to 48 Weeks Follow­-up|Treatment Period||36
1111195|NCT01170962|2688967|P1|PDR ­Randomized to 48 Weeks Follow­-up|Treatment Period||28
1111196|NCT01170962|2688965|P3|PDR ­Randomized to 24 Weeks pegIFNα­-2a|Treatment Period||0
1111197|NCT01170962|2688966|P2|PDR ­Randomized to 24 Weeks pegIFNα­-2a|Treatment Period||36
1111198|NCT01170962|2688967|P1|PDR ­Randomized to 24 Weeks pegIFNα­-2a|Treatment Period||30
1111199|NCT01170962|2688965|P3|No PDR|Treatment Period||17
1111200|NCT01170962|2688966|P2|No PDR|Treatment Period||127
1111201|NCT01170962|2688967|P1|No PDR|Treatment Period||145
1111202|NCT01170962|2688965|P3|STARTED|Treatment Period||17
1111203|NCT01170962|2688966|P2|STARTED|Treatment Period||199
1111204|NCT01170962|2688967|P1|STARTED|Treatment Period||203
1111205|NCT01171118|2689011|P1|NOT COMPLETED|Overall Study||0
1111206|NCT01171118|2689011|P1|COMPLETED|Overall Study||10
1111207|NCT01171118|2689011|P1|STARTED|Overall Study||10
1111208|NCT01171183|2689023|P2|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||5
1111209|NCT01171183|2689024|P1|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||10
1111210|NCT01171183|2689023|P2|COMPLETED|Outpatient Participation (Weeks 3-10)||4
1111211|NCT01171183|2689024|P1|COMPLETED|Outpatient Participation (Weeks 3-10)||2
1111212|NCT01171183|2689023|P2|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but was discharged due to protocol noncompliance.|9
1111213|NCT01171183|2689024|P1|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but withdrew prior to starting the outpatient phase.|12
1111214|NCT01171183|2689023|P2|NOT COMPLETED|Residential Facility (Weeks 1-2)||6
1111215|NCT01171183|2689024|P1|NOT COMPLETED|Residential Facility (Weeks 1-2)||2
1111216|NCT01171183|2689023|P2|COMPLETED|Residential Facility (Weeks 1-2)||10
1111217|NCT01171183|2689024|P1|COMPLETED|Residential Facility (Weeks 1-2)||13
1111218|NCT01171183|2689023|P2|STARTED|Residential Facility (Weeks 1-2)|Subjects receiving at least one dose of study med. One did not due to BP outside study parameters.|16
1111219|NCT01171183|2689024|P1|STARTED|Residential Facility (Weeks 1-2)|Those who were admitted to the residential facility and received at least one dose of study med.|15
1111220|NCT01171521|2689032|P1|NOT COMPLETED|Overall Study||6
1111221|NCT01171521|2689032|P1|COMPLETED|Overall Study||0
1111222|NCT01171521|2689032|P1|STARTED|Overall Study||6
1111223|NCT01171534|2689039|P2|NOT COMPLETED|Overall Study||3
1111224|NCT01171534|2689040|P1|NOT COMPLETED|Overall Study||0
1111225|NCT01171534|2689039|P2|COMPLETED|Overall Study||4
1111226|NCT01171534|2689040|P1|COMPLETED|Overall Study||0
1111227|NCT01171534|2689039|P2|STARTED|Overall Study||7
1111228|NCT01171534|2689040|P1|STARTED|Overall Study|retrospective arm never performed on study|0
1111229|NCT01171612|2689048|P1|NOT COMPLETED|Overall Study||51
1111230|NCT01171612|2689048|P1|COMPLETED|Overall Study||432
1111231|NCT01171612|2689048|P1|STARTED|Overall Study||483
1111232|NCT01171677|2689058|P2|NOT COMPLETED|Overall Study||3
1111233|NCT01171677|2689059|P1|NOT COMPLETED|Overall Study||6
1111234|NCT01171677|2689058|P2|COMPLETED|Overall Study||12
1111235|NCT01171677|2689059|P1|COMPLETED|Overall Study||11
1111236|NCT01171677|2689058|P2|STARTED|Overall Study||15
1111237|NCT01171677|2689059|P1|STARTED|Overall Study||17
1111238|NCT01171690|2689093|P2|NOT COMPLETED|Overall Study||0
1111239|NCT01171690|2689094|P1|NOT COMPLETED|Overall Study||0
1111240|NCT01171690|2689093|P2|COMPLETED|Overall Study||5
1111241|NCT01171690|2689094|P1|COMPLETED|Overall Study||5
1111242|NCT01171690|2689093|P2|STARTED|Overall Study||5
1111243|NCT01171690|2689094|P1|STARTED|Overall Study||5
1111244|NCT01171794|2689104|P2|NOT COMPLETED|Overall Study||0
1111245|NCT01171794|2689105|P1|NOT COMPLETED|Overall Study||3
1111246|NCT01171794|2689104|P2|COMPLETED|Overall Study||42
1111247|NCT01171794|2689105|P1|COMPLETED|Overall Study||44
1111248|NCT01171794|2689104|P2|STARTED|Overall Study||42
1111249|NCT01171794|2689105|P1|STARTED|Overall Study||47
1111250|NCT01171820|2689115|P2|NOT COMPLETED|Overall Study||6
1111251|NCT01171820|2689116|P1|NOT COMPLETED|Overall Study||6
1111252|NCT01171820|2689115|P2|COMPLETED|Overall Study||212
1111253|NCT01171820|2689116|P1|COMPLETED|Overall Study||100
1111254|NCT01171820|2689115|P2|STARTED|Overall Study||218
1111255|NCT01171820|2689116|P1|STARTED|Overall Study||106
1111256|NCT01171924|2689172|P2|NOT COMPLETED|Overall Study||23
1111257|NCT01171924|2689173|P1|NOT COMPLETED|Overall Study||23
1111258|NCT01171924|2689172|P2|COMPLETED|Overall Study||0
1111259|NCT01171924|2689173|P1|COMPLETED|Overall Study||0
1111260|NCT01171924|2689172|P2|STARTED|Overall Study||23
1111261|NCT01171924|2689173|P1|STARTED|Overall Study||23
1111262|NCT01171963|2689181|P2|NOT COMPLETED|Overall Study||168
1111263|NCT01171963|2689182|P1|NOT COMPLETED|Overall Study||148
1111264|NCT01171963|2689181|P2|COMPLETED|Overall Study||1499
1111265|NCT01171963|2689182|P1|COMPLETED|Overall Study||1518
1111266|NCT01171963|2689181|P2|STARTED|Overall Study||1667
1111267|NCT01171963|2689182|P1|STARTED|Overall Study||1666
1111268|NCT01171976|2689241|P3|NOT COMPLETED|Overall Study||15
1111269|NCT01171976|2689242|P2|NOT COMPLETED|Overall Study||11
1111270|NCT01171976|2689243|P1|NOT COMPLETED|Overall Study||14
1111271|NCT01171976|2689241|P3|COMPLETED|Overall Study||108
1111272|NCT01171976|2689242|P2|COMPLETED|Overall Study||117
1111273|NCT01171976|2689243|P1|COMPLETED|Overall Study||107
1111274|NCT01171976|2689241|P3|Safety Set|Overall Study|Exclude 1 who did not get drug and 4 got laser treatment|118
1111275|NCT01171976|2689242|P2|Safety Set|Overall Study|Exclude 1 who did not get drug and 3 got laser treatment, include 2 from 1st arm with no laser|126
1111276|NCT01171976|2689243|P1|Safety Set|Overall Study|Include 4 from PRN and 3 from TE alone who got laser treatment, exclude 2 with no laser treatment.|126
1111277|NCT01171976|2689241|P3|STARTED|Overall Study||123
1111278|NCT01171976|2689242|P2|STARTED|Overall Study||128
1111279|NCT01171976|2689243|P1|STARTED|Overall Study||121
1111280|NCT01171989|2689281|P3|NOT COMPLETED|Overall Study||1
1111281|NCT01171989|2689282|P2|NOT COMPLETED|Overall Study||0
1111282|NCT01171989|2689283|P1|NOT COMPLETED|Overall Study||0
1111283|NCT01171989|2689281|P3|COMPLETED|Overall Study||120
1111284|NCT01171989|2689282|P2|COMPLETED|Overall Study||133
1111285|NCT01171989|2689283|P1|COMPLETED|Overall Study||137
1111286|NCT01171989|2689281|P3|STARTED|Overall Study||121
1111287|NCT01171989|2689282|P2|STARTED|Overall Study||133
1111288|NCT01171989|2689283|P1|STARTED|Overall Study||137
1111289|NCT01172145|2689356|P2|NOT COMPLETED|Overall Study||0
1111290|NCT01172145|2689357|P1|NOT COMPLETED|Overall Study||0
1111291|NCT01172145|2689356|P2|COMPLETED|Overall Study||11
1111292|NCT01172145|2689357|P1|COMPLETED|Overall Study||11
1111293|NCT01172145|2689356|P2|STARTED|Overall Study||11
1111294|NCT01172145|2689357|P1|STARTED|Overall Study||11
1111295|NCT01172184|2689377|P1|NOT COMPLETED|Overall Study||0
1111296|NCT01172184|2689377|P1|COMPLETED|Overall Study||111
1111297|NCT01172184|2689377|P1|STARTED|Overall Study||111
1111298|NCT01172288|2689385|P2|NOT COMPLETED|Overall Study||1
1111299|NCT01172288|2689386|P1|NOT COMPLETED|Overall Study||1
1111300|NCT01172288|2689385|P2|COMPLETED|Overall Study||13
1111301|NCT01172288|2689386|P1|COMPLETED|Overall Study||16
1111302|NCT01172288|2689385|P2|STARTED|Overall Study||14
1111303|NCT01172288|2689386|P1|STARTED|Overall Study||17
1111304|NCT01172353|2689402|P2|NOT COMPLETED|Overall Study||0
1111305|NCT01172353|2689403|P1|NOT COMPLETED|Overall Study||0
1111306|NCT01172353|2689402|P2|COMPLETED|Overall Study||151
1111307|NCT01172353|2689403|P1|COMPLETED|Overall Study||150
1111308|NCT01172353|2689402|P2|STARTED|Overall Study||151
1111309|NCT01172353|2689403|P1|STARTED|Overall Study||150
1111310|NCT01172418|2689413|P2|NOT COMPLETED|Overall Study||0
1111311|NCT01172418|2689414|P1|NOT COMPLETED|Overall Study||0
1111312|NCT01172418|2689413|P2|COMPLETED|Overall Study||100
1111313|NCT01172418|2689414|P1|COMPLETED|Overall Study||100
1111314|NCT01172418|2689413|P2|STARTED|Overall Study||100
1111315|NCT01172418|2689414|P1|STARTED|Overall Study||100
1111316|NCT01172522|2689422|P2|NOT COMPLETED|Overall Study||0
1111317|NCT01172522|2689423|P1|NOT COMPLETED|Overall Study||0
1111318|NCT01172522|2689422|P2|COMPLETED|Overall Study||15
1111319|NCT01172522|2689423|P1|COMPLETED|Overall Study||15
1111320|NCT01172522|2689422|P2|STARTED|Overall Study||15
1111321|NCT01172522|2689423|P1|STARTED|Overall Study||15
1111322|NCT01172535|2689428|P1|NOT COMPLETED|Overall Study||8
1111323|NCT01172535|2689428|P1|COMPLETED|Overall Study||89
1111324|NCT01172535|2689428|P1|STARTED|Overall Study||97
1111325|NCT01172600|2689445|P2|NOT COMPLETED|Overall Study||0
1111326|NCT01172600|2689446|P1|NOT COMPLETED|Overall Study||0
1111327|NCT01172600|2689445|P2|COMPLETED|Overall Study||39
1111328|NCT01172600|2689446|P1|COMPLETED|Overall Study||39
1111329|NCT01172600|2689445|P2|STARTED|Overall Study||39
1111330|NCT01172600|2689446|P1|STARTED|Overall Study||39
1111331|NCT01172808|2689480|P4|NOT COMPLETED|Overall Study||15
1111332|NCT01172808|2689481|P3|NOT COMPLETED|Overall Study||23
1111333|NCT01172808|2689482|P2|NOT COMPLETED|Overall Study||13
1111334|NCT01172808|2689483|P1|NOT COMPLETED|Overall Study||21
1111335|NCT01172808|2689480|P4|COMPLETED|Overall Study||260
1111336|NCT01172808|2689481|P3|COMPLETED|Overall Study||241
1111337|NCT01172808|2689482|P2|COMPLETED|Overall Study||249
1111338|NCT01172808|2689483|P1|COMPLETED|Overall Study||248
1111339|NCT01172808|2689480|P4|STARTED|Overall Study|Entered and Treated|275
1111340|NCT01172808|2689481|P3|STARTED|Overall Study|Entered and Treated|264
1111341|NCT01172808|2689482|P2|STARTED|Overall Study|Entered and Treated|262
1111342|NCT01172808|2689483|P1|STARTED|Overall Study|Entered and Treated|269
1111343|NCT01172821|2689573|P4|NOT COMPLETED|Overall Study||17
1111344|NCT01172821|2689574|P3|NOT COMPLETED|Overall Study||13
1111345|NCT01172821|2689575|P2|NOT COMPLETED|Overall Study||12
1111346|NCT01172821|2689576|P1|NOT COMPLETED|Overall Study||14
1111347|NCT01172821|2689573|P4|COMPLETED|Overall Study||249
1111348|NCT01172821|2689574|P3|COMPLETED|Overall Study||240
1111349|NCT01172821|2689575|P2|COMPLETED|Overall Study||245
1111350|NCT01172821|2689576|P1|COMPLETED|Overall Study||240
1111351|NCT01172821|2689573|P4|STARTED|Overall Study|Entered and Treated|266
1111352|NCT01172821|2689574|P3|STARTED|Overall Study|Entered and Treated|253
1111353|NCT01172821|2689575|P2|STARTED|Overall Study|Entered and Treated|257
1111354|NCT01172821|2689576|P1|STARTED|Overall Study|Entered and Treated|254
1111355|NCT01172847|2689662|P1|NOT COMPLETED|Overall Study||3
1111356|NCT01172847|2689662|P1|COMPLETED|Overall Study||21
1111357|NCT01172847|2689662|P1|Oseltamivir + Rimantadine|Overall Study||21
1111358|NCT01172847|2689662|P1|Rimantadine|Overall Study||22
1111359|NCT01172847|2689662|P1|Oseltamivir|Overall Study||24
1111360|NCT01172847|2689662|P1|STARTED|Overall Study||24
1111361|NCT01166126|2689687|P1|NOT COMPLETED|Overall Study||0
1111362|NCT01166126|2689687|P1|COMPLETED|Overall Study||4
1111363|NCT01166126|2689687|P1|STARTED|Overall Study||4
1111364|NCT01172873|2689696|P2|NOT COMPLETED|Overall Study||2
1111365|NCT01172873|2689697|P1|NOT COMPLETED|Overall Study||3
1111366|NCT01172873|2689696|P2|COMPLETED|Overall Study||3
1111367|NCT01172873|2689697|P1|COMPLETED|Overall Study||8
1111368|NCT01172873|2689696|P2|STARTED|Overall Study||5
1111369|NCT01172873|2689697|P1|STARTED|Overall Study||11
1111370|NCT01172938|2689710|P7|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
1111371|NCT01172938|2689711|P6|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||15
1111372|NCT01172938|2689712|P5|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||4
1111373|NCT01172938|2689713|P4|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||7
1111374|NCT01172938|2689714|P3|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||15
1111375|NCT01172938|2689715|P2|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||12
1111376|NCT01172938|2689716|P1|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
1111377|NCT01172938|2689710|P7|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||22
1111378|NCT01172938|2689711|P6|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||34
1111379|NCT01172938|2689712|P5|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||19
1111380|NCT01172938|2689713|P4|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||44
1111381|NCT01172938|2689714|P3|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||130
1111382|NCT01172938|2689715|P2|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||124
1111383|NCT01172938|2689716|P1|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
1111384|NCT01172938|2689710|P7|STARTED|Active Treatment Phase (Weeks 25 - 52)||24
1111385|NCT01172938|2689711|P6|STARTED|Active Treatment Phase (Weeks 25 - 52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|49
1111386|NCT01172938|2689712|P5|STARTED|Active Treatment Phase (Weeks 25 - 52)||23
1111387|NCT01172938|2689713|P4|STARTED|Active Treatment Phase (Weeks 25 - 52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|51
1111388|NCT01172938|2689714|P3|STARTED|Active Treatment Phase (Weeks 25 - 52)|Three participants who completed Week 24 did not enter the active treatment phase|145
1111389|NCT01172938|2689715|P2|STARTED|Active Treatment Phase (Weeks 25 - 52)|Ten participants who completed Week 24 did not enter the active treatment phase|136
1111390|NCT01172938|2689716|P1|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
1111391|NCT01172938|2689710|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1111392|NCT01172938|2689711|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1111393|NCT01172938|2689712|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1111394|NCT01172938|2689713|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1111395|NCT01172938|2689714|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
1111396|NCT01172938|2689715|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
1111397|NCT01172938|2689716|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||18
1111398|NCT01172938|2689710|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1111399|NCT01172938|2689711|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1111400|NCT01172938|2689712|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1111401|NCT01172938|2689713|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1111402|NCT01172938|2689714|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||148
1111403|NCT01172938|2689715|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||146
1111404|NCT01172938|2689716|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|One participant who completed Week 24 did not enter the active treatment phase|150
1111405|NCT01172938|2689710|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1111406|NCT01172938|2689711|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1111407|NCT01172938|2689712|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1111408|NCT01172938|2689713|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1111409|NCT01172938|2689714|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||58
1111410|NCT01172938|2689715|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Six participants who escaped early did not complete Week 24|78
1111411|NCT01172938|2689716|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Five participants who escaped early did not complete Week 24|107
1111412|NCT01172938|2689710|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1111498|NCT01175369|2690044|P2|NOT COMPLETED|Overall Study||5
1111413|NCT01172938|2689711|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1111414|NCT01172938|2689712|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1111415|NCT01172938|2689713|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1111416|NCT01172938|2689714|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||154
1111417|NCT01172938|2689715|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||158
1111418|NCT01172938|2689716|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||158
1111419|NCT01172938|2689710|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1111420|NCT01172938|2689711|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1111421|NCT01172938|2689712|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1111422|NCT01172938|2689713|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1111423|NCT01172938|2689714|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||168
1111424|NCT01172938|2689715|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||168
1111425|NCT01172938|2689716|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||168
1111426|NCT01172938|2689710|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1111427|NCT01172938|2689711|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1111428|NCT01172938|2689712|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1111429|NCT01172938|2689713|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1111430|NCT01172938|2689714|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||168
1111431|NCT01172938|2689715|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||168
1111432|NCT01172938|2689716|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||168
1111433|NCT01173029|2689895|P2|NOT COMPLETED|Overall Study||0
1111434|NCT01173029|2689896|P1|NOT COMPLETED|Overall Study||0
1111435|NCT01173029|2689895|P2|COMPLETED|Overall Study||31
1111436|NCT01173029|2689896|P1|COMPLETED|Overall Study||61
1111437|NCT01173029|2689895|P2|STARTED|Overall Study||31
1111438|NCT01173029|2689896|P1|STARTED|Overall Study||61
1111439|NCT01173055|2689915|P2|NOT COMPLETED|Period 2 - Day 64 to 112||1
1111440|NCT01173055|2689916|P1|NOT COMPLETED|Period 2 - Day 64 to 112||0
1111441|NCT01173055|2689915|P2|COMPLETED|Period 2 - Day 64 to 112||9
1111442|NCT01173055|2689916|P1|COMPLETED|Period 2 - Day 64 to 112||8
1111443|NCT01173055|2689915|P2|STARTED|Period 2 - Day 64 to 112||10
1111444|NCT01173055|2689916|P1|STARTED|Period 2 - Day 64 to 112||8
1111445|NCT01173055|2689915|P2|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
1111446|NCT01173055|2689916|P1|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
1111447|NCT01173055|2689915|P2|COMPLETED|Placebo Washout Period - Day 50 to 63||10
1111448|NCT01173055|2689916|P1|COMPLETED|Placebo Washout Period - Day 50 to 63||8
1111449|NCT01173055|2689915|P2|STARTED|Placebo Washout Period - Day 50 to 63||10
1111450|NCT01173055|2689916|P1|STARTED|Placebo Washout Period - Day 50 to 63||8
1111451|NCT01173055|2689915|P2|NOT COMPLETED|Period 1 - Day 1 to 49||2
1111452|NCT01173055|2689916|P1|NOT COMPLETED|Period 1 - Day 1 to 49||2
1111453|NCT01173055|2689915|P2|COMPLETED|Period 1 - Day 1 to 49||10
1111454|NCT01173055|2689916|P1|COMPLETED|Period 1 - Day 1 to 49||8
1111455|NCT01173055|2689915|P2|STARTED|Period 1 - Day 1 to 49||12
1111456|NCT01173055|2689916|P1|STARTED|Period 1 - Day 1 to 49||10
1111457|NCT01173120|2689932|P1|NOT COMPLETED|Overall Study||62
1111458|NCT01173120|2689932|P1|COMPLETED|Overall Study||0
1111459|NCT01173120|2689932|P1|Discontinued ACP Substudy and Main Study|Overall Study||5
1111460|NCT01173120|2689932|P1|Switched Back to Main Study|Overall Study||57
1111461|NCT01173120|2689932|P1|STARTED|Overall Study||62
1111462|NCT01175148|2689950|P2|NOT COMPLETED|Overall Study||0
1111463|NCT01175148|2689951|P1|NOT COMPLETED|Overall Study||0
1111464|NCT01175148|2689950|P2|COMPLETED|Overall Study||30
1111465|NCT01175148|2689951|P1|COMPLETED|Overall Study||30
1111466|NCT01175148|2689950|P2|STARTED|Overall Study||30
1111467|NCT01175148|2689951|P1|STARTED|Overall Study||30
1111480|NCT01175226|2690008|P2|NOT COMPLETED|Overall Study||5
1111481|NCT01175226|2690009|P1|NOT COMPLETED|Overall Study||11
1111482|NCT01175226|2690008|P2|COMPLETED|Overall Study||140
1111483|NCT01175226|2690009|P1|COMPLETED|Overall Study||144
1111484|NCT01175226|2690008|P2|STARTED|Overall Study||145
1111485|NCT01175226|2690009|P1|STARTED|Overall Study||155
1111486|NCT01175317|2690017|P2|NOT COMPLETED|Overall Study||0
1111487|NCT01175317|2690018|P1|NOT COMPLETED|Overall Study||0
1111488|NCT01175317|2690017|P2|COMPLETED|Overall Study||31
1111489|NCT01175317|2690018|P1|COMPLETED|Overall Study||27
1111490|NCT01175317|2690017|P2|STARTED|Overall Study||31
1111491|NCT01175317|2690018|P1|STARTED|Overall Study||27
1111492|NCT01175343|2690026|P1|NOT COMPLETED|Overall Study||0
1111493|NCT01175343|2690026|P1|COMPLETED|Overall Study||44
1111494|NCT01175343|2690026|P1|STARTED|Overall Study||44
1111495|NCT01175356|2690036|P1|NOT COMPLETED|Overall Study||81
1111496|NCT01175356|2690036|P1|COMPLETED|Overall Study||18
1111497|NCT01175356|2690036|P1|STARTED|Overall Study||99
1111499|NCT01175369|2690045|P1|NOT COMPLETED|Overall Study||2
1111500|NCT01175369|2690044|P2|COMPLETED|Overall Study||260
1111501|NCT01175369|2690045|P1|COMPLETED|Overall Study||263
1111502|NCT01175369|2690044|P2|STARTED|Overall Study||265
1111503|NCT01175369|2690045|P1|STARTED|Overall Study||265
1111504|NCT01175382|2690054|P3|NOT COMPLETED|Overall Study||6
1111505|NCT01175382|2690055|P2|NOT COMPLETED|Overall Study||7
1111506|NCT01175382|2690056|P1|NOT COMPLETED|Overall Study||8
1111507|NCT01175382|2690054|P3|COMPLETED|Overall Study||59
1111508|NCT01175382|2690055|P2|COMPLETED|Overall Study||61
1111509|NCT01175382|2690056|P1|COMPLETED|Overall Study||63
1111510|NCT01175382|2690054|P3|STARTED|Overall Study||65
1111511|NCT01175382|2690055|P2|STARTED|Overall Study||68
1111512|NCT01175382|2690056|P1|STARTED|Overall Study||71
1111513|NCT01175395|2690133|P1|NOT COMPLETED|Overall Study||0
1111514|NCT01175395|2690133|P1|COMPLETED|Overall Study||10
1111515|NCT01175395|2690133|P1|STARTED|Overall Study||10
1111516|NCT01175434|2690140|P2|NOT COMPLETED|Overall Study||0
1111517|NCT01175434|2690141|P1|NOT COMPLETED|Overall Study||0
1111518|NCT01175434|2690140|P2|COMPLETED|Overall Study||51
1111519|NCT01175434|2690141|P1|COMPLETED|Overall Study||48
1111520|NCT01175434|2690140|P2|STARTED|Overall Study||51
1111521|NCT01175434|2690141|P1|STARTED|Overall Study||48
1111522|NCT01175473|2690149|P2|NOT COMPLETED|Overall Study||2
1111523|NCT01175473|2690150|P1|NOT COMPLETED|Overall Study||2
1111524|NCT01175473|2690149|P2|COMPLETED|Overall Study||69
1111525|NCT01175473|2690150|P1|COMPLETED|Overall Study||75
1111526|NCT01175473|2690149|P2|Pharmacodynamic (PD) Population|Overall Study||68
1111527|NCT01175473|2690150|P1|Pharmacodynamic (PD) Population|Overall Study|All patients who received at least 1 dose; had baseline and at least 1 post-baseline PD assessment.|75
1111528|NCT01175473|2690149|P2|Safety Population|Overall Study||71
1111529|NCT01175473|2690150|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|77
1111530|NCT01175473|2690149|P2|STARTED|Overall Study||71
1111531|NCT01175473|2690150|P1|STARTED|Overall Study|Randomized and treated.|77
1111532|NCT01175590|2690176|P2|NOT COMPLETED|Overall Study||10
1111533|NCT01175590|2690177|P1|NOT COMPLETED|Overall Study||12
1111534|NCT01175590|2690176|P2|COMPLETED|Overall Study||161
1111535|NCT01175590|2690177|P1|COMPLETED|Overall Study||335
1111536|NCT01175590|2690176|P2|Safety Population|Overall Study||170
1111537|NCT01175590|2690177|P1|Safety Population|Overall Study||344
1111538|NCT01175590|2690176|P2|Modified Intent to Treat Population|Overall Study||87
1111539|NCT01175590|2690177|P1|Modified Intent to Treat Population|Overall Study||212
1111540|NCT01175590|2690176|P2|STARTED|Overall Study||171
1111541|NCT01175590|2690177|P1|STARTED|Overall Study||347
1111542|NCT01175668|2690211|P2|NOT COMPLETED|Overall Study||0
1111543|NCT01175668|2690212|P1|NOT COMPLETED|Overall Study||2
1111544|NCT01175668|2690211|P2|COMPLETED|Overall Study||34
1111545|NCT01175668|2690212|P1|COMPLETED|Overall Study||32
1111546|NCT01175668|2690211|P2|STARTED|Overall Study||34
1111547|NCT01175668|2690212|P1|STARTED|Overall Study||34
1111548|NCT01175707|2690222|P2|NOT COMPLETED|Overall Study||6
1111549|NCT01175707|2690223|P1|NOT COMPLETED|Overall Study||4
1111550|NCT01175707|2690222|P2|COMPLETED|Overall Study||34
1111551|NCT01175707|2690223|P1|COMPLETED|Overall Study||36
1111552|NCT01175707|2690222|P2|STARTED|Overall Study||40
1111553|NCT01175707|2690223|P1|STARTED|Overall Study||40
1111554|NCT01175798|2690259|P2|NOT COMPLETED|Overall Study||21
1111555|NCT01175798|2690260|P1|NOT COMPLETED|Overall Study||7
1111556|NCT01175798|2690259|P2|COMPLETED|Overall Study||41
1111557|NCT01175798|2690260|P1|COMPLETED|Overall Study||27
1111558|NCT01175798|2690259|P2|STARTED|Overall Study||62
1111559|NCT01175798|2690260|P1|STARTED|Overall Study||34
1111560|NCT01175811|2690268|P2|NOT COMPLETED|Overall Study||14
1111561|NCT01175811|2690269|P1|NOT COMPLETED|Overall Study||16
1111562|NCT01175811|2690268|P2|COMPLETED|Overall Study||189
1111563|NCT01175811|2690269|P1|COMPLETED|Overall Study||183
1111564|NCT01175811|2690268|P2|Received at Least 1 Dose of Study Drug|Overall Study||202
1111565|NCT01175811|2690269|P1|Received at Least 1 Dose of Study Drug|Overall Study||197
1111566|NCT01175811|2690268|P2|STARTED|Overall Study||203
1111567|NCT01175811|2690269|P1|STARTED|Overall Study||199
1111568|NCT01175824|2690295|P2|NOT COMPLETED|Overall Study||22
1111569|NCT01175824|2690296|P1|NOT COMPLETED|Overall Study||16
1111570|NCT01175824|2690295|P2|COMPLETED|Overall Study||220
1111571|NCT01175824|2690296|P1|COMPLETED|Overall Study||220
1111572|NCT01175824|2690295|P2|Received at Least 1 Dose of Study Drug|Overall Study||240
1111573|NCT01175824|2690296|P1|Received at Least 1 Dose of Study Drug|Overall Study||236
1111574|NCT01175824|2690295|P2|STARTED|Overall Study||242
1111575|NCT01175824|2690296|P1|STARTED|Overall Study||236
1111576|NCT01175850|2690330|P2|NOT COMPLETED|IN.PACT SFA II Phase||5
1111577|NCT01175850|2690331|P1|NOT COMPLETED|IN.PACT SFA II Phase||12
1111578|NCT01175850|2690330|P2|COMPLETED|IN.PACT SFA II Phase||55
1111579|NCT01175850|2690331|P1|COMPLETED|IN.PACT SFA II Phase||109
1111580|NCT01175850|2690330|P2|STARTED|IN.PACT SFA II Phase||60
1111581|NCT01175850|2690331|P1|STARTED|IN.PACT SFA II Phase||121
1111582|NCT01175850|2690330|P2|NOT COMPLETED|IN.PACT SFA I Phase||2
1111583|NCT01175850|2690331|P1|NOT COMPLETED|IN.PACT SFA I Phase||11
1111584|NCT01175850|2690330|P2|COMPLETED|IN.PACT SFA I Phase||49
1111585|NCT01175850|2690331|P1|COMPLETED|IN.PACT SFA I Phase||88
1111586|NCT01175850|2690330|P2|STARTED|IN.PACT SFA I Phase||51
1111587|NCT01175850|2690331|P1|STARTED|IN.PACT SFA I Phase||99
1111588|NCT01175902|2690375|P2|NOT COMPLETED|Overall Study||0
1111589|NCT01175902|2690376|P1|NOT COMPLETED|Overall Study||0
1111590|NCT01175902|2690375|P2|COMPLETED|Overall Study||22
1111591|NCT01175902|2690376|P1|COMPLETED|Overall Study||22
1111592|NCT01175902|2690375|P2|STARTED|Overall Study||22
1111593|NCT01175902|2690376|P1|STARTED|Overall Study||22
1111594|NCT01176032|2690394|P2|NOT COMPLETED|Overall Study||1
1111595|NCT01176032|2690395|P1|NOT COMPLETED|Overall Study||6
1111596|NCT01176032|2690394|P2|COMPLETED|Overall Study||36
1111597|NCT01176032|2690395|P1|COMPLETED|Overall Study||31
1111598|NCT01176032|2690394|P2|Intention-to-treat (ITT) Population|Overall Study||37
1111599|NCT01176032|2690395|P1|Intention-to-treat (ITT) Population|Overall Study||32
1111600|NCT01176032|2690394|P2|STARTED|Overall Study||37
1111601|NCT01176032|2690395|P1|STARTED|Overall Study|"Started indicates randomized and safety population"|37
1111602|NCT01176058|2690455|P2|NOT COMPLETED|Overall Study||3
1111603|NCT01176058|2690456|P1|NOT COMPLETED|Overall Study||4
1111604|NCT01176058|2690455|P2|COMPLETED|Overall Study||5
1111605|NCT01176058|2690456|P1|COMPLETED|Overall Study||5
1111606|NCT01176058|2690455|P2|STARTED|Overall Study||8
1111607|NCT01176058|2690456|P1|STARTED|Overall Study||9
1111608|NCT01176240|2690482|P2|NOT COMPLETED|Study 306B||17
1111609|NCT01176240|2690483|P1|NOT COMPLETED|Study 306B||26
1111610|NCT01176240|2690482|P2|COMPLETED|Study 306B||68
1111611|NCT01176240|2690483|P1|COMPLETED|Study 306B||63
1111612|NCT01176240|2690482|P2|4 wk of Stable Dosing and Visit 6|Study 306B||73
1111613|NCT01176240|2690483|P1|4 wk of Stable Dosing and Visit 6|Study 306B||67
1111614|NCT01176240|2690482|P2|2 wk of Stable Dosing and Visit 5|Study 306B||75
1111615|NCT01176240|2690483|P1|2 wk of Stable Dosing and Visit 5|Study 306B||68
1111616|NCT01176240|2690482|P2|1 wk of Stable Dosing and Visit 4|Study 306B||78
1111617|NCT01176240|2690483|P1|1 wk of Stable Dosing and Visit 4|Study 306B||69
1111618|NCT01176240|2690482|P2|Took at Least 1 Dose of Study Drug|Study 306B|One randomized patient discontinued before receiving study drug.|84
1111619|NCT01176240|2690483|P1|Took at Least 1 Dose of Study Drug|Study 306B|Two randomized patients discontinued before receiving study drug.|87
1111620|NCT01176240|2690482|P2|STARTED|Study 306B||85
1111621|NCT01176240|2690483|P1|STARTED|Study 306B||89
1111622|NCT01176240|2690482|P2|NOT COMPLETED|Study 306A||3
1111623|NCT01176240|2690483|P1|NOT COMPLETED|Study 306A||3
1111624|NCT01176240|2690482|P2|COMPLETED|Study 306A||24
1111625|NCT01176240|2690483|P1|COMPLETED|Study 306A||21
1111626|NCT01176240|2690482|P2|STARTED|Study 306A||27
1111627|NCT01176240|2690483|P1|STARTED|Study 306A||24
1111628|NCT01176292|2690509|P2|NOT COMPLETED|Overall Study||9
1111629|NCT01176292|2690510|P1|NOT COMPLETED|Overall Study||5
1111630|NCT01176292|2690509|P2|COMPLETED|Overall Study||62
1111631|NCT01176292|2690510|P1|COMPLETED|Overall Study||66
1111632|NCT01176292|2690509|P2|STARTED|Overall Study||71
1111633|NCT01176292|2690510|P1|STARTED|Overall Study||71
1111634|NCT01176448|2690528|P1|NOT COMPLETED|Overall Study||0
1111635|NCT01176448|2690528|P1|COMPLETED|Overall Study||6
1111636|NCT01176448|2690528|P1|STARTED|Overall Study||6
1111637|NCT01176513|2690536|P1|NOT COMPLETED|Overall Study||3
1111638|NCT01176513|2690536|P1|COMPLETED|Overall Study||22
1111639|NCT01176513|2690536|P1|STARTED|Overall Study||25
1111640|NCT01176565|2690543|P2|NOT COMPLETED|Overall Study||19
1111641|NCT01176565|2690544|P1|NOT COMPLETED|Overall Study||20
1111642|NCT01176565|2690543|P2|COMPLETED|Overall Study||481
1111643|NCT01176565|2690544|P1|COMPLETED|Overall Study||480
1111644|NCT01176565|2690543|P2|STARTED|Overall Study||500
1111645|NCT01176565|2690544|P1|STARTED|Overall Study||500
1111646|NCT01176773|2690562|P1|NOT COMPLETED|Overall Study||3
1111647|NCT01176773|2690562|P1|COMPLETED|Overall Study||59
1111648|NCT01176773|2690562|P1|STARTED|Overall Study||62
1111649|NCT01176877|2690571|P1|NOT COMPLETED|Overall Study||9
1111650|NCT01176877|2690571|P1|COMPLETED|Overall Study||31
1111651|NCT01176877|2690571|P1|STARTED|Overall Study||40
1111652|NCT01176955|2690578|P2|NOT COMPLETED|Overall Study||2
1111653|NCT01176955|2690579|P1|NOT COMPLETED|Overall Study||3
1111654|NCT01176955|2690578|P2|COMPLETED|Overall Study||8
1111655|NCT01176955|2690579|P1|COMPLETED|Overall Study||7
1111656|NCT01176955|2690578|P2|STARTED|Overall Study||10
1111657|NCT01176955|2690579|P1|STARTED|Overall Study||10
1111658|NCT01176968|2690591|P2|NOT COMPLETED|Overall Study||82
1111659|NCT01176968|2690592|P1|NOT COMPLETED|Overall Study||84
1111660|NCT01176968|2690591|P2|COMPLETED|Overall Study||424
1111661|NCT01176968|2690592|P1|COMPLETED|Overall Study||422
1111662|NCT01176968|2690591|P2|Treated|Overall Study||505
1111663|NCT01176968|2690592|P1|Treated|Overall Study||505
1111664|NCT01176968|2690591|P2|STARTED|Overall Study||506
1111665|NCT01176968|2690592|P1|STARTED|Overall Study||506
1111666|NCT01177007|2690624|P1|NOT COMPLETED|Overall Study||38
1111667|NCT01177007|2690624|P1|COMPLETED|Overall Study||12
1111668|NCT01177007|2690624|P1|Completed First Clinical and Imaging|Overall Study||43
1111669|NCT01177007|2690624|P1|Completed First Y90 Treatment|Overall Study||50
1111670|NCT01177007|2690624|P1|STARTED|Overall Study||50
1111671|NCT01177098|2690638|P2|NOT COMPLETED|Overall Study||12
1111672|NCT01177098|2690639|P1|NOT COMPLETED|Overall Study||9
1111673|NCT01177098|2690638|P2|COMPLETED|Overall Study||271
1111674|NCT01177098|2690639|P1|COMPLETED|Overall Study||269
1111675|NCT01177098|2690638|P2|STARTED|Overall Study||283
1111676|NCT01177098|2690639|P1|STARTED|Overall Study||278
1111677|NCT01177228|2690659|P4|NOT COMPLETED|Overall Study||0
1111678|NCT01177228|2690660|P3|NOT COMPLETED|Overall Study||0
1111679|NCT01177228|2690661|P2|NOT COMPLETED|Overall Study||2
1111680|NCT01177228|2690662|P1|NOT COMPLETED|Overall Study||1
1111681|NCT01177228|2690659|P4|COMPLETED|Overall Study||11
1111682|NCT01177228|2690660|P3|COMPLETED|Overall Study||14
1111683|NCT01177228|2690661|P2|COMPLETED|Overall Study||11
1111684|NCT01177228|2690662|P1|COMPLETED|Overall Study||8
1111685|NCT01177228|2690659|P4|Received Treatment|Overall Study||11
1111686|NCT01177228|2690660|P3|Received Treatment|Overall Study||14
1111687|NCT01177228|2690661|P2|Received Treatment|Overall Study||12
1111688|NCT01177228|2690662|P1|Received Treatment|Overall Study||9
1111689|NCT01177228|2690659|P4|STARTED|Overall Study||11
1111690|NCT01177228|2690660|P3|STARTED|Overall Study||14
1111691|NCT01177228|2690661|P2|STARTED|Overall Study||13
1111692|NCT01177228|2690662|P1|STARTED|Overall Study||9
1111693|NCT01177293|2690700|P2|NOT COMPLETED|Second Intervention Period||0
1111694|NCT01177293|2690701|P1|NOT COMPLETED|Second Intervention Period||0
1111695|NCT01177293|2690700|P2|COMPLETED|Second Intervention Period||6
1111696|NCT01177293|2690701|P1|COMPLETED|Second Intervention Period||7
1111697|NCT01177293|2690700|P2|STARTED|Second Intervention Period||6
1111698|NCT01177293|2690701|P1|STARTED|Second Intervention Period||7
1111699|NCT01177293|2690700|P2|NOT COMPLETED|Washout Period (of 14 Days)||1
1111700|NCT01177293|2690701|P1|NOT COMPLETED|Washout Period (of 14 Days)||0
1111701|NCT01177293|2690700|P2|COMPLETED|Washout Period (of 14 Days)||6
1111702|NCT01177293|2690701|P1|COMPLETED|Washout Period (of 14 Days)||7
1111703|NCT01177293|2690700|P2|STARTED|Washout Period (of 14 Days)||7
1111704|NCT01177293|2690701|P1|STARTED|Washout Period (of 14 Days)||7
1111705|NCT01177293|2690700|P2|NOT COMPLETED|First Intervention Period||0
1111706|NCT01177293|2690701|P1|NOT COMPLETED|First Intervention Period||0
1111707|NCT01177293|2690700|P2|COMPLETED|First Intervention Period||7
1111708|NCT01177293|2690701|P1|COMPLETED|First Intervention Period||7
1111709|NCT01177293|2690700|P2|STARTED|First Intervention Period||7
1111710|NCT01177293|2690701|P1|STARTED|First Intervention Period||7
1111711|NCT01177384|2690717|P2|NOT COMPLETED|Overall Study||26
1111712|NCT01177384|2690718|P1|NOT COMPLETED|Overall Study||14
1111713|NCT01177384|2690717|P2|COMPLETED|Overall Study||164
1111714|NCT01177384|2690718|P1|COMPLETED|Overall Study||177
1111715|NCT01177384|2690717|P2|STARTED|Overall Study|Includes the second randomization of a participant|190
1111716|NCT01177384|2690718|P1|STARTED|Overall Study||191
1111717|NCT01177410|2690733|P3|NOT COMPLETED|Overall Study||5
1111718|NCT01177410|2690734|P2|NOT COMPLETED|Overall Study||7
1111719|NCT01177410|2690735|P1|NOT COMPLETED|Overall Study||1
1111720|NCT01177410|2690733|P3|COMPLETED|Overall Study||45
1111721|NCT01177410|2690734|P2|COMPLETED|Overall Study||40
1111722|NCT01177410|2690735|P1|COMPLETED|Overall Study||50
1111723|NCT01177410|2690733|P3|STARTED|Overall Study||50
1111724|NCT01177410|2690734|P2|STARTED|Overall Study||47
1111725|NCT01177410|2690735|P1|STARTED|Overall Study||51
1111726|NCT01168973|2690748|P2|NOT COMPLETED|Overall Study||611
1111727|NCT01168973|2690749|P1|NOT COMPLETED|Overall Study||613
1111728|NCT01168973|2690748|P2|COMPLETED|Overall Study||14
1111729|NCT01168973|2690749|P1|COMPLETED|Overall Study||15
1111730|NCT01168973|2690748|P2|Received Any Quantity of Any Study Drug|Overall Study|Three participants randomized to placebo and docetaxel received 1 dose of ramucirumab in error.|621
1111731|NCT01168973|2690749|P1|Received Any Quantity of Any Study Drug|Overall Study||624
1111732|NCT01168973|2690748|P2|STARTED|Overall Study||625
1111733|NCT01168973|2690749|P1|STARTED|Overall Study||628
1111734|NCT01168986|2690773|P3|NOT COMPLETED|Overall Study||0
1111735|NCT01168986|2690774|P2|NOT COMPLETED|Overall Study||1
1111736|NCT01168986|2690775|P1|NOT COMPLETED|Overall Study||2
1111737|NCT01168986|2690773|P3|COMPLETED|Overall Study||21
1111738|NCT01168986|2690774|P2|COMPLETED|Overall Study||20
1111739|NCT01168986|2690775|P1|COMPLETED|Overall Study||18
1111740|NCT01168986|2690773|P3|STARTED|Overall Study||21
1111741|NCT01168986|2690774|P2|STARTED|Overall Study||21
1111742|NCT01168986|2690775|P1|STARTED|Overall Study||20
1111743|NCT01168999|2690796|P4|NOT COMPLETED|Overall Study||0
1111744|NCT01168999|2690797|P3|NOT COMPLETED|Overall Study||0
1111745|NCT01168999|2690798|P2|NOT COMPLETED|Overall Study||1
1111746|NCT01168999|2690799|P1|NOT COMPLETED|Overall Study||2
1111747|NCT01168999|2690796|P4|COMPLETED|Overall Study||28
1111748|NCT01168999|2690797|P3|COMPLETED|Overall Study||27
1111749|NCT01168999|2690798|P2|COMPLETED|Overall Study||26
1111750|NCT01168999|2690799|P1|COMPLETED|Overall Study||26
1111751|NCT01168999|2690796|P4|STARTED|Overall Study||28
1111752|NCT01168999|2690797|P3|STARTED|Overall Study||27
1111753|NCT01168999|2690798|P2|STARTED|Overall Study||27
1111754|NCT01168999|2690799|P1|STARTED|Overall Study||28
1111755|NCT01169038|2690841|P1|NOT COMPLETED|Overall Study||7
1111756|NCT01169038|2690841|P1|COMPLETED|Overall Study||8
1111757|NCT01169038|2690841|P1|STARTED|Overall Study||15
1111758|NCT01169064|2690847|P2|NOT COMPLETED|Overall Study||0
1111759|NCT01169064|2690848|P1|NOT COMPLETED|Overall Study||0
1111760|NCT01169064|2690847|P2|COMPLETED|Overall Study||236
1111761|NCT01169064|2690848|P1|COMPLETED|Overall Study||239
1111762|NCT01169064|2690847|P2|STARTED|Overall Study||236
1111763|NCT01169064|2690848|P1|STARTED|Overall Study||239
1111764|NCT01169103|2690860|P2|NOT COMPLETED|Overall Study||4
1111765|NCT01169103|2690861|P1|NOT COMPLETED|Overall Study||6
1111766|NCT01169103|2690860|P2|COMPLETED|Overall Study||7
1111767|NCT01169103|2690861|P1|COMPLETED|Overall Study||5
1111768|NCT01169103|2690860|P2|STARTED|Overall Study||11
1111769|NCT01169103|2690861|P1|STARTED|Overall Study||11
1111770|NCT01169311|2690875|P1|NOT COMPLETED|Overall Study||0
1111771|NCT01169311|2690875|P1|COMPLETED|Overall Study||27
1111772|NCT01169311|2690875|P1|STARTED|Overall Study||27
1111773|NCT01169467|2690889|P2|NOT COMPLETED|Overall Study||4
1111774|NCT01169467|2690890|P1|NOT COMPLETED|Overall Study||7
1111775|NCT01169467|2690889|P2|COMPLETED|Overall Study||36
1111776|NCT01169467|2690890|P1|COMPLETED|Overall Study||37
1111777|NCT01169467|2690889|P2|STARTED|Overall Study||40
1111778|NCT01169467|2690890|P1|STARTED|Overall Study||44
1111779|NCT01169493|2690910|P6|NOT COMPLETED|Period 3 (6 Months)||0
1111780|NCT01169493|2690911|P5|NOT COMPLETED|Period 3 (6 Months)||0
1111781|NCT01169493|2690912|P4|NOT COMPLETED|Period 3 (6 Months)||0
1111782|NCT01169493|2690913|P3|NOT COMPLETED|Period 3 (6 Months)||1
1111783|NCT01169493|2690914|P2|NOT COMPLETED|Period 3 (6 Months)||2
1111784|NCT01169493|2690915|P1|NOT COMPLETED|Period 3 (6 Months)||0
1111785|NCT01169493|2690910|P6|COMPLETED|Period 3 (6 Months)||2
1111786|NCT01169493|2690911|P5|COMPLETED|Period 3 (6 Months)||0
1111787|NCT01169493|2690912|P4|COMPLETED|Period 3 (6 Months)||0
1111788|NCT01169493|2690913|P3|COMPLETED|Period 3 (6 Months)||2
1111789|NCT01169493|2690914|P2|COMPLETED|Period 3 (6 Months)||1
1111790|NCT01169493|2690915|P1|COMPLETED|Period 3 (6 Months)||2
1111791|NCT01169493|2690910|P6|STARTED|Period 3 (6 Months)||2
1111792|NCT01169493|2690911|P5|STARTED|Period 3 (6 Months)||0
1111793|NCT01169493|2690912|P4|STARTED|Period 3 (6 Months)||0
1111794|NCT01169493|2690913|P3|STARTED|Period 3 (6 Months)||3
1111795|NCT01169493|2690914|P2|STARTED|Period 3 (6 Months)||3
1111796|NCT01169493|2690915|P1|STARTED|Period 3 (6 Months)||2
1111797|NCT01169493|2690910|P6|NOT COMPLETED|Period 2 (6 Months)||0
1111798|NCT01169493|2690911|P5|NOT COMPLETED|Period 2 (6 Months)||0
1111799|NCT01169493|2690912|P4|NOT COMPLETED|Period 2 (6 Months)||0
1111800|NCT01169493|2690913|P3|NOT COMPLETED|Period 2 (6 Months)||0
1111801|NCT01169493|2690914|P2|NOT COMPLETED|Period 2 (6 Months)||0
1111802|NCT01169493|2690915|P1|NOT COMPLETED|Period 2 (6 Months)||0
1111803|NCT01169493|2690910|P6|COMPLETED|Period 2 (6 Months)||2
1111804|NCT01169493|2690911|P5|COMPLETED|Period 2 (6 Months)||0
1111805|NCT01169493|2690912|P4|COMPLETED|Period 2 (6 Months)||0
1111806|NCT01169493|2690913|P3|COMPLETED|Period 2 (6 Months)||3
1111807|NCT01169493|2690914|P2|COMPLETED|Period 2 (6 Months)||3
1111808|NCT01169493|2690915|P1|COMPLETED|Period 2 (6 Months)||2
1111809|NCT01169493|2690910|P6|STARTED|Period 2 (6 Months)||2
1111810|NCT01169493|2690911|P5|STARTED|Period 2 (6 Months)||0
1111811|NCT01169493|2690912|P4|STARTED|Period 2 (6 Months)||0
1111812|NCT01169493|2690913|P3|STARTED|Period 2 (6 Months)||3
1111813|NCT01169493|2690914|P2|STARTED|Period 2 (6 Months)||3
1111814|NCT01169493|2690915|P1|STARTED|Period 2 (6 Months)||2
1111815|NCT01169493|2690910|P6|NOT COMPLETED|Period 1 (6 Months)||3
1111816|NCT01169493|2690911|P5|NOT COMPLETED|Period 1 (6 Months)||0
1111817|NCT01169493|2690912|P4|NOT COMPLETED|Period 1 (6 Months)||0
1111818|NCT01169493|2690913|P3|NOT COMPLETED|Period 1 (6 Months)||2
1111819|NCT01169493|2690914|P2|NOT COMPLETED|Period 1 (6 Months)||1
1111820|NCT01169493|2690915|P1|NOT COMPLETED|Period 1 (6 Months)||0
1111821|NCT01169493|2690910|P6|COMPLETED|Period 1 (6 Months)||2
1111822|NCT01169493|2690911|P5|COMPLETED|Period 1 (6 Months)||0
1111823|NCT01169493|2690912|P4|COMPLETED|Period 1 (6 Months)||0
1111824|NCT01169493|2690913|P3|COMPLETED|Period 1 (6 Months)||3
1111825|NCT01169493|2690914|P2|COMPLETED|Period 1 (6 Months)||3
1111826|NCT01169493|2690915|P1|COMPLETED|Period 1 (6 Months)||2
1111827|NCT01169493|2690910|P6|STARTED|Period 1 (6 Months)||5
1111828|NCT01169493|2690911|P5|STARTED|Period 1 (6 Months)||0
1111829|NCT01169493|2690912|P4|STARTED|Period 1 (6 Months)||0
1111830|NCT01169493|2690913|P3|STARTED|Period 1 (6 Months)||5
1111831|NCT01169493|2690914|P2|STARTED|Period 1 (6 Months)||4
1111832|NCT01169493|2690915|P1|STARTED|Period 1 (6 Months)||2
1111833|NCT01169519|2690944|P1|NOT COMPLETED|Overall Study||0
1111834|NCT01169519|2690944|P1|COMPLETED|Overall Study||21
1111835|NCT01169519|2690944|P1|STARTED|Overall Study|This was a pre-post study, All patients receiving a baseline assessment, also received sildenafil.|21
1111836|NCT01169558|2690956|P1|NOT COMPLETED|Overall Study||156
1111837|NCT01169558|2690956|P1|COMPLETED|Overall Study||6
1111838|NCT01169558|2690956|P1|STARTED|Overall Study||162
1111839|NCT01169610|2690963|P1|NOT COMPLETED|Overall Study||0
1111840|NCT01169610|2690963|P1|COMPLETED|Overall Study||1
1111841|NCT01169610|2690963|P1|STARTED|Overall Study||1
1111842|NCT01169649|2690971|P1|NOT COMPLETED|Overall Study||3
1111843|NCT01169649|2690971|P1|COMPLETED|Overall Study||8
1111844|NCT01169649|2690971|P1|STARTED|Overall Study||11
1111845|NCT01169675|2690980|P5|NOT COMPLETED|Overall Study||6
1111846|NCT01169675|2690981|P4|NOT COMPLETED|Overall Study||17
1111847|NCT01169675|2690982|P3|NOT COMPLETED|Overall Study||7
1111848|NCT01169675|2690983|P2|NOT COMPLETED|Overall Study||3
1111849|NCT01169675|2690984|P1|NOT COMPLETED|Overall Study||20
1111850|NCT01169675|2690980|P5|COMPLETED|Overall Study||0
1111851|NCT01169675|2690981|P4|COMPLETED|Overall Study||0
1111852|NCT01169675|2690982|P3|COMPLETED|Overall Study||0
1111853|NCT01169675|2690983|P2|COMPLETED|Overall Study||0
1111854|NCT01169675|2690984|P1|COMPLETED|Overall Study||0
1111855|NCT01169675|2690980|P5|STARTED|Overall Study||6
1111856|NCT01169675|2690981|P4|STARTED|Overall Study||17
1111857|NCT01169675|2690982|P3|STARTED|Overall Study||7
1111858|NCT01169675|2690983|P2|STARTED|Overall Study||3
1111859|NCT01169675|2690984|P1|STARTED|Overall Study||20
1111860|NCT01169701|2691023|P2|NOT COMPLETED|Overall Study||10
1111861|NCT01169701|2691024|P1|NOT COMPLETED|Overall Study||5
1111862|NCT01169701|2691023|P2|COMPLETED|Overall Study||25
1111863|NCT01169701|2691024|P1|COMPLETED|Overall Study||31
1111864|NCT01169701|2691023|P2|Intent to Treat (ITT) Set|Overall Study||28
1111865|NCT01169701|2691024|P1|Intent to Treat (ITT) Set|Overall Study||32
1111866|NCT01169701|2691023|P2|Safety Set|Overall Study||35
1111867|NCT01169701|2691024|P1|Safety Set|Overall Study||36
1111868|NCT01169701|2691023|P2|STARTED|Overall Study||35
1111869|NCT01169701|2691024|P1|STARTED|Overall Study||36
1111870|NCT01169753|2691058|P2|NOT COMPLETED|Overall Study||1
1111871|NCT01169753|2691059|P1|NOT COMPLETED|Overall Study||0
1111872|NCT01169753|2691058|P2|COMPLETED|Overall Study||0
1111873|NCT01169753|2691059|P1|COMPLETED|Overall Study||0
1111874|NCT01169753|2691058|P2|STARTED|Overall Study||1
1111875|NCT01169753|2691059|P1|STARTED|Overall Study||0
1111876|NCT01169779|2691067|P2|NOT COMPLETED|Overall Study||17
1111877|NCT01169779|2691068|P1|NOT COMPLETED|Overall Study||11
1111878|NCT01169779|2691067|P2|COMPLETED|Overall Study||179
1111879|NCT01169779|2691068|P1|COMPLETED|Overall Study||184
1111880|NCT01169779|2691067|P2|Subgroup for Standardized Meal Test|Overall Study||121
1111881|NCT01169779|2691068|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|130
1111882|NCT01169779|2691067|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||195
1111883|NCT01169779|2691068|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|193
1111884|NCT01169779|2691067|P2|Treated/Safety Population|Overall Study||196
1111885|NCT01169779|2691068|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|194
1111886|NCT01169779|2691067|P2|STARTED|Overall Study||196
1111887|NCT01169779|2691068|P1|STARTED|Overall Study|Randomized.|195
1111888|NCT01169987|2691092|P1|NOT COMPLETED|Overall Study||31
1111889|NCT01169987|2691092|P1|COMPLETED|Overall Study||160
1111890|NCT01169987|2691092|P1|STARTED|Overall Study||191
1111891|NCT01170039|2691158|P2|NOT COMPLETED|Overall Study||6
1111892|NCT01170039|2691159|P1|NOT COMPLETED|Overall Study||8
1111893|NCT01170039|2691158|P2|COMPLETED|Overall Study||33
1111894|NCT01170039|2691159|P1|COMPLETED|Overall Study||29
1111895|NCT01170039|2691158|P2|STARTED|Overall Study||39
1111896|NCT01170039|2691159|P1|STARTED|Overall Study||37
1111897|NCT01170091|2691171|P1|NOT COMPLETED|Overall Study||24
1111898|NCT01170091|2691171|P1|COMPLETED|Overall Study||627
1111899|NCT01170091|2691171|P1|STARTED|Overall Study||651
1111900|NCT01170117|2691180|P2|NOT COMPLETED|Overall Study||20
1111901|NCT01170117|2691181|P1|NOT COMPLETED|Overall Study||30
1111902|NCT01170117|2691180|P2|COMPLETED|Overall Study||55
1111903|NCT01170117|2691181|P1|COMPLETED|Overall Study||47
1111904|NCT01170117|2691180|P2|STARTED|Overall Study||75
1111905|NCT01170117|2691181|P1|STARTED|Overall Study||77
1111906|NCT01170208|2691192|P3|NOT COMPLETED|Overall Study||2
1111907|NCT01170208|2691193|P2|NOT COMPLETED|Overall Study||0
1111908|NCT01170208|2691194|P1|NOT COMPLETED|Overall Study||6
1111909|NCT01170208|2691192|P3|COMPLETED|Overall Study||4
1111910|NCT01170208|2691193|P2|COMPLETED|Overall Study||20
1111911|NCT01170208|2691194|P1|COMPLETED|Overall Study||14
1111912|NCT01170208|2691192|P3|STARTED|Overall Study||6
1111913|NCT01170208|2691193|P2|STARTED|Overall Study||20
1111914|NCT01170208|2691194|P1|STARTED|Overall Study||20
1111915|NCT01170221|2691204|P2|NOT COMPLETED|Overall Study||28
1111916|NCT01170221|2691205|P1|NOT COMPLETED|Overall Study||33
1111917|NCT01170221|2691204|P2|COMPLETED|Overall Study||307
1111918|NCT01170221|2691205|P1|COMPLETED|Overall Study||299
1111919|NCT01170221|2691204|P2|STARTED|Overall Study||335
1111920|NCT01170221|2691205|P1|STARTED|Overall Study||332
1111921|NCT01170247|2691227|P2|NOT COMPLETED|Overall Study||0
1111922|NCT01170247|2691228|P1|NOT COMPLETED|Overall Study||0
1111923|NCT01170247|2691227|P2|COMPLETED|Overall Study||1
1111924|NCT01170247|2691228|P1|COMPLETED|Overall Study||2
1111925|NCT01170247|2691227|P2|STARTED|Overall Study||1
1111926|NCT01170247|2691228|P1|STARTED|Overall Study||2
1111927|NCT01170273|2691236|P2|NOT COMPLETED|Overall Study||9
1111928|NCT01170273|2691237|P1|NOT COMPLETED|Overall Study||8
1111929|NCT01170273|2691236|P2|COMPLETED|Overall Study||57
1111930|NCT01170273|2691237|P1|COMPLETED|Overall Study||56
1111931|NCT01170273|2691236|P2|STARTED|Overall Study||66
1111932|NCT01170273|2691237|P1|STARTED|Overall Study||64
1111933|NCT01177553|2691245|P2|NOT COMPLETED|Overall Study||0
1111934|NCT01177553|2691246|P1|NOT COMPLETED|Overall Study||1
1111935|NCT01177553|2691245|P2|COMPLETED|Overall Study|data as of March 2009|2
1111936|NCT01177553|2691246|P1|COMPLETED|Overall Study|data as of March 2009|2
1111937|NCT01177553|2691245|P2|STARTED|Overall Study||2
1111938|NCT01177553|2691246|P1|STARTED|Overall Study||3
1111939|NCT01177670|2691252|P1|NOT COMPLETED|Overall Study||169
1111940|NCT01177670|2691252|P1|COMPLETED|Overall Study||0
1111941|NCT01177670|2691252|P1|STARTED|Overall Study||169
1111942|NCT01177709|2691257|P1|NOT COMPLETED|Overall Study||0
1111943|NCT01177709|2691257|P1|COMPLETED|Overall Study||12
1111944|NCT01177709|2691257|P1|STARTED|Overall Study||12
1111945|NCT01177722|2691267|P4|NOT COMPLETED|Overall Study||7
1111946|NCT01177722|2691268|P3|NOT COMPLETED|Overall Study||9
1111947|NCT01177722|2691269|P2|NOT COMPLETED|Overall Study||10
1111948|NCT01177722|2691270|P1|NOT COMPLETED|Overall Study||13
1111949|NCT01177722|2691267|P4|COMPLETED|Overall Study||338
1111950|NCT01177722|2691268|P3|COMPLETED|Overall Study||333
1111951|NCT01177722|2691269|P2|COMPLETED|Overall Study||334
1111952|NCT01177722|2691270|P1|COMPLETED|Overall Study||331
1111953|NCT01177722|2691267|P4|STARTED|Overall Study||345
1111954|NCT01177722|2691268|P3|STARTED|Overall Study||342
1111955|NCT01177722|2691269|P2|STARTED|Overall Study|A randomized participant got Batch A vaccine, analyses was according to actual vaccine administered.|344
1111956|NCT01177722|2691270|P1|STARTED|Overall Study|A Batch B participant got Batch A vaccine data analyses was according to actual vaccine administered|344
1111960|NCT01177800|2691302|P2|NOT COMPLETED|Overall Study||5
1111961|NCT01177800|2691303|P1|NOT COMPLETED|Overall Study||10
1111962|NCT01177800|2691302|P2|COMPLETED|Overall Study||40
1111963|NCT01177800|2691303|P1|COMPLETED|Overall Study||74
1111964|NCT01177800|2691302|P2|STARTED|Overall Study||45
1111965|NCT01177800|2691303|P1|STARTED|Overall Study||84
1111966|NCT01177813|2691322|P5|NOT COMPLETED|Overall Study||9
1111967|NCT01177813|2691323|P4|NOT COMPLETED|Overall Study||17
1111968|NCT01177813|2691324|P3|NOT COMPLETED|Overall Study||20
1111969|NCT01177813|2691325|P2|NOT COMPLETED|Overall Study||18
1111970|NCT01177813|2691326|P1|NOT COMPLETED|Overall Study||41
1111971|NCT01177813|2691322|P5|COMPLETED|Overall Study||78
1111972|NCT01177813|2691323|P4|COMPLETED|Overall Study||206
1111973|NCT01177813|2691324|P3|COMPLETED|Overall Study||204
1111974|NCT01177813|2691325|P2|COMPLETED|Overall Study||206
1111975|NCT01177813|2691326|P1|COMPLETED|Overall Study||187
1111976|NCT01177813|2691322|P5|STARTED|Overall Study||87
1111977|NCT01177813|2691323|P4|STARTED|Overall Study||223
1111978|NCT01177813|2691324|P3|STARTED|Overall Study||224
1111979|NCT01177813|2691325|P2|STARTED|Overall Study||224
1111980|NCT01177813|2691326|P1|STARTED|Overall Study||228
1111981|NCT01179048|2691355|P2|NOT COMPLETED|Overall Study||159
1111982|NCT01179048|2691356|P1|NOT COMPLETED|Overall Study||139
1111983|NCT01179048|2691355|P2|COMPLETED|Overall Study||4513
1111984|NCT01179048|2691356|P1|COMPLETED|Overall Study||4529
1111985|NCT01179048|2691355|P2|STARTED|Overall Study||4672
1111986|NCT01179048|2691356|P1|STARTED|Overall Study||4668
1111987|NCT01179113|2691374|P2|NOT COMPLETED|Overall Study||0
1111988|NCT01179113|2691375|P1|NOT COMPLETED|Overall Study||0
1111989|NCT01179113|2691374|P2|COMPLETED|Overall Study||16
1111990|NCT01179113|2691375|P1|COMPLETED|Overall Study||17
1111991|NCT01179113|2691374|P2|STARTED|Overall Study||16
1111992|NCT01179113|2691375|P1|STARTED|Overall Study||17
1111999|NCT01179217|2691404|P2|NOT COMPLETED|Overall Study||19
1112000|NCT01179217|2691405|P1|NOT COMPLETED|Overall Study||55
1112001|NCT01179217|2691404|P2|COMPLETED|Overall Study||59
1112002|NCT01179217|2691405|P1|COMPLETED|Overall Study||97
1112003|NCT01179217|2691404|P2|STARTED|Overall Study||78
1112004|NCT01179217|2691405|P1|STARTED|Overall Study||152
1112005|NCT01179334|2691431|P2|NOT COMPLETED|Long-term Extension (LTE) Period||6
1112006|NCT01179334|2691432|P1|NOT COMPLETED|Long-term Extension (LTE) Period||11
1112007|NCT01179334|2691431|P2|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
1112008|NCT01179334|2691432|P1|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
1112009|NCT01179334|2691431|P2|STARTED|Long-term Extension (LTE) Period||6
1112010|NCT01179334|2691432|P1|STARTED|Long-term Extension (LTE) Period||11
1112011|NCT01179334|2691431|P2|NOT COMPLETED|Treatment Period||0
1112012|NCT01179334|2691432|P1|NOT COMPLETED|Treatment Period||1
1112013|NCT01179334|2691431|P2|COMPLETED|Treatment Period||6
1112014|NCT01179334|2691432|P1|COMPLETED|Treatment Period||11
1112015|NCT01179334|2691431|P2|Participants Received Treatment|Treatment Period||6
1112016|NCT01179334|2691432|P1|Participants Received Treatment|Treatment Period||12
1112017|NCT01179334|2691431|P2|STARTED|Treatment Period||6
1112018|NCT01179334|2691432|P1|STARTED|Treatment Period||12
1112019|NCT01179347|2691462|P2|NOT COMPLETED|Open-label Period (12 Weeks)||16
1112020|NCT01179347|2691463|P1|NOT COMPLETED|Open-label Period (12 Weeks)||15
1112021|NCT01179347|2691462|P2|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|278
1112022|NCT01179347|2691463|P1|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|132
1112023|NCT01179347|2691462|P2|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|294
1112024|NCT01179347|2691463|P1|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|147
1112025|NCT01179347|2691462|P2|NOT COMPLETED|Double-blind Period (12 Weeks)||14
1112026|NCT01179347|2691463|P1|NOT COMPLETED|Double-blind Period (12 Weeks)||8
1112027|NCT01179347|2691462|P2|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|294
1112028|NCT01179347|2691463|P1|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|147
1112029|NCT01179347|2691462|P2|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|308
1112030|NCT01179347|2691463|P1|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|155
1112031|NCT01179399|2691483|P1|NOT COMPLETED|Overall Study||32
1112032|NCT01179399|2691483|P1|COMPLETED|Overall Study||0
1112033|NCT01179399|2691483|P1|STARTED|Overall Study||32
1112034|NCT01179490|2691487|P1|NOT COMPLETED|Overall Study||0
1112035|NCT01179490|2691487|P1|COMPLETED|Overall Study||5
1112036|NCT01179490|2691487|P1|STARTED|Overall Study||5
1112037|NCT01179516|2691511|P3|NOT COMPLETED|Overall Study||31
1112038|NCT01179516|2691512|P2|NOT COMPLETED|Overall Study||26
1112039|NCT01179516|2691513|P1|NOT COMPLETED|Overall Study||27
1112040|NCT01179516|2691511|P3|COMPLETED|Overall Study||121
1112041|NCT01179516|2691512|P2|COMPLETED|Overall Study||131
1112042|NCT01179516|2691513|P1|COMPLETED|Overall Study||133
1112043|NCT01179516|2691511|P3|Treated|Overall Study||151
1112044|NCT01179516|2691512|P2|Treated|Overall Study||154
1112045|NCT01179516|2691513|P1|Treated|Overall Study||160
1112046|NCT01179516|2691511|P3|STARTED|Overall Study||152
1112047|NCT01179516|2691512|P2|STARTED|Overall Study||157
1112048|NCT01179516|2691513|P1|STARTED|Overall Study||160
1112049|NCT01179568|2691540|P4|NOT COMPLETED|Overall Study||20
1112050|NCT01179568|2691541|P3|NOT COMPLETED|Overall Study||23
1112051|NCT01179568|2691542|P2|NOT COMPLETED|Overall Study||38
1112052|NCT01179568|2691543|P1|NOT COMPLETED|Overall Study||28
1112053|NCT01179568|2691540|P4|COMPLETED|Overall Study||76
1112054|NCT01179568|2691541|P3|COMPLETED|Overall Study||76
1112055|NCT01179568|2691542|P2|COMPLETED|Overall Study||61
1112056|NCT01179568|2691543|P1|COMPLETED|Overall Study||73
1112057|NCT01179568|2691540|P4|Completed Week 12 Assessment|Overall Study||75
1112058|NCT01179568|2691541|P3|Completed Week 12 Assessment|Overall Study||76
1112059|NCT01179568|2691542|P2|Completed Week 12 Assessment|Overall Study||69
1112060|NCT01179568|2691543|P1|Completed Week 12 Assessment|Overall Study||69
1112061|NCT01179568|2691540|P4|STARTED|Overall Study||96
1112062|NCT01179568|2691541|P3|STARTED|Overall Study||99
1112063|NCT01179568|2691542|P2|STARTED|Overall Study||99
1112064|NCT01179568|2691543|P1|STARTED|Overall Study||101
1112065|NCT01179672|2691565|P2|NOT COMPLETED|Overall Study||26
1112066|NCT01179672|2691566|P1|NOT COMPLETED|Overall Study||30
1112067|NCT01179672|2691565|P2|COMPLETED|Overall Study||176
1112068|NCT01179672|2691566|P1|COMPLETED|Overall Study||173
1112069|NCT01179672|2691565|P2|Entered Taper|Overall Study||177
1112070|NCT01179672|2691566|P1|Entered Taper|Overall Study||181
1112071|NCT01179672|2691565|P2|Received at Least 1 Dose of Study Drug|Overall Study||202
1112072|NCT01179672|2691566|P1|Received at Least 1 Dose of Study Drug|Overall Study||202
1112073|NCT01179672|2691565|P2|STARTED|Overall Study||202
1112074|NCT01179672|2691566|P1|STARTED|Overall Study||203
1112075|NCT01179737|2691596|P4|NOT COMPLETED|Extension||0
1112076|NCT01179737|2691597|P3|NOT COMPLETED|Extension||0
1112077|NCT01179737|2691598|P2|NOT COMPLETED|Extension||0
1112078|NCT01179737|2691599|P1|NOT COMPLETED|Extension||3
1112079|NCT01179737|2691596|P4|COMPLETED|Extension||0
1112080|NCT01179737|2691597|P3|COMPLETED|Extension||0
1112081|NCT01179737|2691598|P2|COMPLETED|Extension||0
1112082|NCT01179737|2691599|P1|COMPLETED|Extension||0
1112083|NCT01179737|2691596|P4|STARTED|Extension||0
1112084|NCT01179737|2691597|P3|STARTED|Extension||0
1112085|NCT01179737|2691598|P2|STARTED|Extension|One patient did not enrol in the extension|0
1112086|NCT01179737|2691599|P1|STARTED|Extension|Two patients did not enrol in the extension|3
1112087|NCT01179737|2691596|P4|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
1112088|NCT01179737|2691597|P3|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
1112089|NCT01179737|2691598|P2|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
1112090|NCT01179737|2691599|P1|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||1
1112091|NCT01179737|2691596|P4|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
1112092|NCT01179737|2691597|P3|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
1112093|NCT01179737|2691598|P2|COMPLETED|Cohort 1 & Cohort 2 Expansion||1
1112094|NCT01179737|2691599|P1|COMPLETED|Cohort 1 & Cohort 2 Expansion||4
1112095|NCT01179737|2691596|P4|STARTED|Cohort 1 & Cohort 2 Expansion||0
1112096|NCT01179737|2691597|P3|STARTED|Cohort 1 & Cohort 2 Expansion||0
1112097|NCT01179737|2691598|P2|STARTED|Cohort 1 & Cohort 2 Expansion||1
1112098|NCT01179737|2691599|P1|STARTED|Cohort 1 & Cohort 2 Expansion|2 participants did not enroll in extension|5
1112099|NCT01179737|2691596|P4|NOT COMPLETED|Cohort 1 & Cohort 2||4
1112100|NCT01179737|2691597|P3|NOT COMPLETED|Cohort 1 & Cohort 2||4
1112101|NCT01179737|2691598|P2|NOT COMPLETED|Cohort 1 & Cohort 2||2
1112102|NCT01179737|2691599|P1|NOT COMPLETED|Cohort 1 & Cohort 2||5
1112103|NCT01179737|2691596|P4|COMPLETED|Cohort 1 & Cohort 2||0
1112104|NCT01179737|2691597|P3|COMPLETED|Cohort 1 & Cohort 2||0
1112105|NCT01179737|2691598|P2|COMPLETED|Cohort 1 & Cohort 2||1
1112106|NCT01179737|2691599|P1|COMPLETED|Cohort 1 & Cohort 2||7
1112107|NCT01179737|2691596|P4|STARTED|Cohort 1 & Cohort 2||4
1112108|NCT01179737|2691597|P3|STARTED|Cohort 1 & Cohort 2||4
1112109|NCT01179737|2691598|P2|STARTED|Cohort 1 & Cohort 2|One patient was missing the end of study evaluation|3
1112110|NCT01179737|2691599|P1|STARTED|Cohort 1 & Cohort 2||12
1112111|NCT01179919|2691608|P1|NOT COMPLETED|Overall Study||2
1112112|NCT01179919|2691608|P1|COMPLETED|Overall Study||19
1112113|NCT01179919|2691608|P1|STARTED|Overall Study||21
1112114|NCT01179984|2691613|P1|NOT COMPLETED|Overall Study||18
1112115|NCT01179984|2691613|P1|COMPLETED|Overall Study||58
1112116|NCT01179984|2691613|P1|STARTED|Overall Study||76
1112125|NCT01180127|2691646|P4|NOT COMPLETED|Overall Study||1
1112126|NCT01180127|2691647|P3|NOT COMPLETED|Overall Study||1
1112127|NCT01180127|2691648|P2|NOT COMPLETED|Overall Study||0
1112128|NCT01180127|2691649|P1|NOT COMPLETED|Overall Study||2
1112129|NCT01180127|2691646|P4|COMPLETED|Overall Study||9
1112130|NCT01180127|2691647|P3|COMPLETED|Overall Study||9
1112131|NCT01180127|2691648|P2|COMPLETED|Overall Study||11
1112132|NCT01180127|2691649|P1|COMPLETED|Overall Study||8
1112133|NCT01180127|2691646|P4|STARTED|Overall Study||10
1112134|NCT01180127|2691647|P3|STARTED|Overall Study||10
1112135|NCT01180127|2691648|P2|STARTED|Overall Study||11
1112136|NCT01180127|2691649|P1|STARTED|Overall Study||10
1112137|NCT01180244|2691673|P2|NOT COMPLETED|Overall Study||8
1112138|NCT01180244|2691674|P1|NOT COMPLETED|Overall Study||6
1112139|NCT01180244|2691673|P2|COMPLETED|Overall Study|Number of placebo group patients who completed all study visits and are evaluable|38
1112140|NCT01180244|2691674|P1|COMPLETED|Overall Study|Number of active treatment patients who completed all study visits and are evaluable|39
1112141|NCT01180244|2691673|P2|Received Treatment|Overall Study|Number of patients in the placebo group that received at least one sham treatment|45
1112142|NCT01180244|2691674|P1|Received Treatment|Overall Study|Number of patients in the active treatment group that received at least one study treatment|40
1112143|NCT01180244|2691673|P2|STARTED|Overall Study|Number of enrolled patients initially randomized to placebo group|46
1112144|NCT01180244|2691674|P1|STARTED|Overall Study|Number of enrolled patients initially randomized to active treatment group|45
1112145|NCT01180296|2691690|P2|NOT COMPLETED|Overall Study||2
1112146|NCT01180296|2691691|P1|NOT COMPLETED|Overall Study||1
1112147|NCT01180296|2691690|P2|COMPLETED|Overall Study||14
1112148|NCT01180296|2691691|P1|COMPLETED|Overall Study||19
1112149|NCT01180296|2691690|P2|STARTED|Overall Study||16
1112150|NCT01180296|2691691|P1|STARTED|Overall Study||20
1112151|NCT01180400|2691699|P2|NOT COMPLETED|Overall Study||27
1112152|NCT01180400|2691700|P1|NOT COMPLETED|Overall Study||25
1112153|NCT01180400|2691699|P2|COMPLETED|Overall Study||121
1112154|NCT01180400|2691700|P1|COMPLETED|Overall Study||122
1112155|NCT01180400|2691699|P2|Received Treatment|Overall Study||146
1112156|NCT01180400|2691700|P1|Received Treatment|Overall Study||147
1112157|NCT01180400|2691699|P2|STARTED|Overall Study||148
1112158|NCT01180400|2691700|P1|STARTED|Overall Study||147
1112159|NCT01180647|2691748|P2|NOT COMPLETED|Overall Study||6
1112160|NCT01180647|2691749|P1|NOT COMPLETED|Overall Study||5
1112161|NCT01180647|2691748|P2|COMPLETED|Overall Study||11
1112162|NCT01180647|2691749|P1|COMPLETED|Overall Study||12
1112163|NCT01180647|2691748|P2|STARTED|Overall Study||17
1112164|NCT01180647|2691749|P1|STARTED|Overall Study||17
1112165|NCT01180660|2691767|P2|NOT COMPLETED|Overall Study||0
1112166|NCT01180660|2691768|P1|NOT COMPLETED|Overall Study||1
1112167|NCT01180660|2691767|P2|COMPLETED|Overall Study||26
1112168|NCT01180660|2691768|P1|COMPLETED|Overall Study||24
1112169|NCT01180660|2691767|P2|STARTED|Overall Study||26
1112170|NCT01180660|2691768|P1|STARTED|Overall Study||25
1112171|NCT01180777|2691776|P1|NOT COMPLETED|Overall Study||12
1112172|NCT01180777|2691776|P1|COMPLETED|Overall Study||80
1112173|NCT01180777|2691776|P1|STARTED|Overall Study||92
1112174|NCT01180790|2691795|P7|NOT COMPLETED|Overall Study||1
1112175|NCT01180790|2691796|P6|NOT COMPLETED|Overall Study||7
1112176|NCT01180790|2691797|P5|NOT COMPLETED|Overall Study||5
1112177|NCT01180790|2691798|P4|NOT COMPLETED|Overall Study||9
1112178|NCT01180790|2691799|P3|NOT COMPLETED|Overall Study||13
1112179|NCT01180790|2691800|P2|NOT COMPLETED|Overall Study||5
1112180|NCT01180790|2691801|P1|NOT COMPLETED|Overall Study||9
1112181|NCT01180790|2691795|P7|COMPLETED|Overall Study||18
1112182|NCT01180790|2691796|P6|COMPLETED|Overall Study||13
1112183|NCT01180790|2691797|P5|COMPLETED|Overall Study||14
1112184|NCT01180790|2691798|P4|COMPLETED|Overall Study||6
1112185|NCT01180790|2691799|P3|COMPLETED|Overall Study||4
1112186|NCT01180790|2691800|P2|COMPLETED|Overall Study||11
1112187|NCT01180790|2691801|P1|COMPLETED|Overall Study||7
1112188|NCT01180790|2691795|P7|STARTED|Overall Study||19
1112189|NCT01180790|2691796|P6|STARTED|Overall Study||20
1112190|NCT01180790|2691797|P5|STARTED|Overall Study||19
1112191|NCT01180790|2691798|P4|STARTED|Overall Study||15
1112192|NCT01180790|2691799|P3|STARTED|Overall Study||17
1112193|NCT01180790|2691800|P2|STARTED|Overall Study||16
1112194|NCT01180790|2691801|P1|STARTED|Overall Study||16
1112195|NCT01180894|2691868|P2|NOT COMPLETED|Overall Study||0
1112196|NCT01180894|2691869|P1|NOT COMPLETED|Overall Study||0
1112197|NCT01180894|2691868|P2|COMPLETED|Overall Study||75
1112198|NCT01180894|2691869|P1|COMPLETED|Overall Study||75
1112199|NCT01180894|2691868|P2|STARTED|Overall Study||75
1112200|NCT01180894|2691869|P1|STARTED|Overall Study||75
1112201|NCT01180985|2691881|P2|NOT COMPLETED|Period 2 (7 +/- 1 Days)||0
1112202|NCT01180985|2691882|P1|NOT COMPLETED|Period 2 (7 +/- 1 Days)||1
1112203|NCT01180985|2691881|P2|COMPLETED|Period 2 (7 +/- 1 Days)||26
1112204|NCT01180985|2691882|P1|COMPLETED|Period 2 (7 +/- 1 Days)||26
1112205|NCT01180985|2691881|P2|STARTED|Period 2 (7 +/- 1 Days)||26
1112206|NCT01180985|2691882|P1|STARTED|Period 2 (7 +/- 1 Days)||27
1112207|NCT01180985|2691881|P2|NOT COMPLETED|Period 1 (7 +/- Days)||0
1112208|NCT01180985|2691882|P1|NOT COMPLETED|Period 1 (7 +/- Days)||0
1112209|NCT01180985|2691881|P2|COMPLETED|Period 1 (7 +/- Days)||26
1112210|NCT01180985|2691882|P1|COMPLETED|Period 1 (7 +/- Days)||27
1112211|NCT01180985|2691881|P2|STARTED|Period 1 (7 +/- Days)||26
1112212|NCT01180985|2691882|P1|STARTED|Period 1 (7 +/- Days)||27
1112213|NCT01180998|2691902|P3|NOT COMPLETED|Overall Study||10
1112214|NCT01180998|2691903|P2|NOT COMPLETED|Overall Study||4
1112215|NCT01180998|2691904|P1|NOT COMPLETED|Overall Study||4
1112216|NCT01180998|2691902|P3|COMPLETED|Overall Study||51
1112217|NCT01180998|2691903|P2|COMPLETED|Overall Study||68
1112218|NCT01180998|2691904|P1|COMPLETED|Overall Study||63
1112219|NCT01180998|2691902|P3|STARTED|Overall Study||61
1112220|NCT01180998|2691903|P2|STARTED|Overall Study||72
1112221|NCT01180998|2691904|P1|STARTED|Overall Study||67
1112222|NCT01181011|2691918|P1|NOT COMPLETED|Overall Study||3
1112223|NCT01181011|2691918|P1|COMPLETED|Overall Study||25
1112224|NCT01181011|2691918|P1|Received Amlodipine 5mg|Overall Study||26
1112225|NCT01181011|2691918|P1|Received Telmisartan 80mg,Amlodipine 5mg|Overall Study||27
1112226|NCT01181011|2691918|P1|Received Telmisartan 80mg|Overall Study||27
1112227|NCT01181011|2691918|P1|STARTED|Overall Study||28
1112228|NCT01181050|2691967|P2|NOT COMPLETED|Overall Study||0
1112229|NCT01181050|2691968|P1|NOT COMPLETED|Overall Study||0
1112230|NCT01181050|2691967|P2|COMPLETED|Overall Study||22
1112231|NCT01181050|2691968|P1|COMPLETED|Overall Study||41
1112232|NCT01181050|2691967|P2|STARTED|Overall Study||22
1112233|NCT01181050|2691968|P1|STARTED|Overall Study||41
1112234|NCT01181102|2691980|P2|NOT COMPLETED|Overall Study||46
1112235|NCT01181102|2691981|P1|NOT COMPLETED|Overall Study||51
1112236|NCT01181102|2691980|P2|COMPLETED|Overall Study||310
1112237|NCT01181102|2691981|P1|COMPLETED|Overall Study||309
1112238|NCT01181102|2691980|P2|Efficacy Analysis Population|Overall Study||295
1112239|NCT01181102|2691981|P1|Efficacy Analysis Population|Overall Study||299
1112240|NCT01181102|2691980|P2|Safety Analysis Set|Overall Study||349
1112241|NCT01181102|2691981|P1|Safety Analysis Set|Overall Study||354
1112242|NCT01181102|2691980|P2|STARTED|Overall Study||356
1112243|NCT01181102|2691981|P1|STARTED|Overall Study||360
1112244|NCT01181128|2691992|P3|NOT COMPLETED|Overall Study||1
1112245|NCT01181128|2691993|P2|NOT COMPLETED|Overall Study||5
1112246|NCT01181128|2691994|P1|NOT COMPLETED|Overall Study||6
1112247|NCT01181128|2691992|P3|COMPLETED|Overall Study||22
1112248|NCT01181128|2691993|P2|COMPLETED|Overall Study||19
1112249|NCT01181128|2691994|P1|COMPLETED|Overall Study||112
1112250|NCT01181128|2691992|P3|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|0
1112251|NCT01181128|2691993|P2|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|1
1112252|NCT01181128|2691994|P1|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|8
1112253|NCT01181128|2691992|P3|Pharmacokinetic (PK) Subgroup|Overall Study||0
1112254|NCT01181128|2691993|P2|Pharmacokinetic (PK) Subgroup|Overall Study||0
1112255|NCT01181128|2691994|P1|Pharmacokinetic (PK) Subgroup|Overall Study||30
1112256|NCT01181128|2691992|P3|STARTED|Overall Study||23
1112257|NCT01181128|2691993|P2|STARTED|Overall Study||24
1112258|NCT01181128|2691994|P1|STARTED|Overall Study||118
1112259|NCT01181141|2692082|P2|NOT COMPLETED|Overall Study||4
1112260|NCT01181141|2692083|P1|NOT COMPLETED|Overall Study||12
1112261|NCT01181141|2692082|P2|COMPLETED|Overall Study||26
1112262|NCT01181141|2692083|P1|COMPLETED|Overall Study||50
1112263|NCT01181141|2692082|P2|Safety Analysis Population|Overall Study||29
1112264|NCT01181141|2692083|P1|Safety Analysis Population|Overall Study||59
1112265|NCT01181141|2692082|P2|STARTED|Overall Study||30
1112266|NCT01181141|2692083|P1|STARTED|Overall Study||62
1112267|NCT01181167|2692091|P2|NOT COMPLETED|Overall Study||32
1112268|NCT01181167|2692092|P1|NOT COMPLETED|Overall Study||23
1112269|NCT01181167|2692091|P2|COMPLETED|Overall Study||271
1112270|NCT01181167|2692092|P1|COMPLETED|Overall Study||284
1112271|NCT01181167|2692091|P2|Efficacy Analysis Population|Overall Study||248
1112272|NCT01181167|2692092|P1|Efficacy Analysis Population|Overall Study||255
1112273|NCT01181167|2692091|P2|STARTED|Overall Study||303
1112274|NCT01181167|2692092|P1|STARTED|Overall Study||307
1112275|NCT01181258|2692100|P1|NOT COMPLETED|Overall Study||0
1112276|NCT01181258|2692100|P1|COMPLETED|Overall Study||16
1112277|NCT01181258|2692100|P1|STARTED|Overall Study||16
1112278|NCT01181271|2692107|P1|NOT COMPLETED|Allogeneic Transplant||0
1112279|NCT01181271|2692107|P1|COMPLETED|Allogeneic Transplant||29
1112280|NCT01181271|2692107|P1|STARTED|Allogeneic Transplant||29
1112281|NCT01181271|2692107|P1|NOT COMPLETED|Evaluation for Allogeneic Transplant||13
1112282|NCT01181271|2692107|P1|COMPLETED|Evaluation for Allogeneic Transplant||29
1112283|NCT01181271|2692107|P1|STARTED|Evaluation for Allogeneic Transplant||42
1112284|NCT01181271|2692107|P1|NOT COMPLETED|Autologous Transplant||0
1112285|NCT01181271|2692107|P1|COMPLETED|Autologous Transplant||42
1112286|NCT01181271|2692107|P1|STARTED|Autologous Transplant||42
1112287|NCT01181323|2692126|P4|NOT COMPLETED|Overall Study||3
1112288|NCT01181323|2692127|P3|NOT COMPLETED|Overall Study||1
1112289|NCT01181323|2692128|P2|NOT COMPLETED|Overall Study||3
1112290|NCT01181323|2692129|P1|NOT COMPLETED|Overall Study||1
1112291|NCT01181323|2692126|P4|COMPLETED|Overall Study||122
1112292|NCT01181323|2692127|P3|COMPLETED|Overall Study||123
1112293|NCT01181323|2692128|P2|COMPLETED|Overall Study||121
1112294|NCT01181323|2692129|P1|COMPLETED|Overall Study||123
1112295|NCT01181323|2692126|P4|STARTED|Overall Study||125
1112296|NCT01181323|2692127|P3|STARTED|Overall Study||124
1112297|NCT01181323|2692128|P2|STARTED|Overall Study||124
1112298|NCT01181323|2692129|P1|STARTED|Overall Study||124
1112299|NCT01181349|2692204|P1|NOT COMPLETED|Overall Study||0
1112300|NCT01181349|2692204|P1|COMPLETED|Overall Study||350
1112301|NCT01181349|2692204|P1|STARTED|Overall Study||350
1112302|NCT01173211|2692222|P6|NOT COMPLETED|Overall Study||0
1112303|NCT01173211|2692223|P5|NOT COMPLETED|Overall Study||0
1112304|NCT01173211|2692224|P4|NOT COMPLETED|Overall Study||0
1112305|NCT01173211|2692225|P3|NOT COMPLETED|Overall Study||2
1112306|NCT01173211|2692226|P2|NOT COMPLETED|Overall Study||1
1112307|NCT01173211|2692227|P1|NOT COMPLETED|Overall Study||2
1112308|NCT01173211|2692222|P6|COMPLETED|Overall Study||13
1112309|NCT01173211|2692223|P5|COMPLETED|Overall Study||16
1112310|NCT01173211|2692224|P4|COMPLETED|Overall Study||15
1112311|NCT01173211|2692225|P3|COMPLETED|Overall Study||44
1112312|NCT01173211|2692226|P2|COMPLETED|Overall Study||44
1112313|NCT01173211|2692227|P1|COMPLETED|Overall Study||46
1112314|NCT01173211|2692222|P6|STARTED|Overall Study||13
1112315|NCT01173211|2692223|P5|STARTED|Overall Study||16
1112316|NCT01173211|2692224|P4|STARTED|Overall Study||15
1112317|NCT01173211|2692225|P3|STARTED|Overall Study||46
1112318|NCT01173211|2692226|P2|STARTED|Overall Study||45
1112319|NCT01173211|2692227|P1|STARTED|Overall Study||48
1112320|NCT01173471|2692332|P4|NOT COMPLETED|Overall Study||1
1112321|NCT01173471|2692333|P3|NOT COMPLETED|Overall Study||3
1112322|NCT01173471|2692334|P2|NOT COMPLETED|Overall Study||0
1112323|NCT01173471|2692335|P1|NOT COMPLETED|Overall Study||2
1112324|NCT01173471|2692332|P4|COMPLETED|Overall Study|Completed study|18
1112325|NCT01173471|2692333|P3|COMPLETED|Overall Study|Completed study|15
1112326|NCT01173471|2692334|P2|COMPLETED|Overall Study|Completed study|7
1112327|NCT01173471|2692335|P1|COMPLETED|Overall Study|Completed study|4
1112328|NCT01173471|2692332|P4|Completed Treatment|Overall Study||18
1112329|NCT01173471|2692333|P3|Completed Treatment|Overall Study||15
1112330|NCT01173471|2692334|P2|Completed Treatment|Overall Study||7
1112331|NCT01173471|2692335|P1|Completed Treatment|Overall Study||4
1112332|NCT01173471|2692332|P4|Received Treatment|Overall Study||19
1112333|NCT01173471|2692333|P3|Received Treatment|Overall Study||18
1112334|NCT01173471|2692334|P2|Received Treatment|Overall Study||7
1112335|NCT01173471|2692335|P1|Received Treatment|Overall Study||6
1112336|NCT01173471|2692332|P4|STARTED|Overall Study|Randomized|19
1112337|NCT01173471|2692333|P3|STARTED|Overall Study|Randomized|18
1112338|NCT01173471|2692334|P2|STARTED|Overall Study|Randomized|7
1112339|NCT01173471|2692335|P1|STARTED|Overall Study|Randomized|6
1112340|NCT01173523|2692355|P2|NOT COMPLETED|Overall Study||12
1112341|NCT01173523|2692356|P1|NOT COMPLETED|Overall Study||13
1112342|NCT01173523|2692355|P2|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
1112343|NCT01173523|2692356|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
1112344|NCT01173523|2692355|P2|STARTED|Overall Study||12
1112345|NCT01173523|2692356|P1|STARTED|Overall Study||13
1112346|NCT01173653|2692370|P2|NOT COMPLETED|Overall Study||41
1112347|NCT01173653|2692371|P1|NOT COMPLETED|Overall Study||53
1112348|NCT01173653|2692370|P2|COMPLETED|Overall Study||49
1112349|NCT01173653|2692371|P1|COMPLETED|Overall Study||56
1112350|NCT01173653|2692370|P2|STARTED|Overall Study||90
1112351|NCT01173653|2692371|P1|STARTED|Overall Study||109
1112352|NCT01173679|2692377|P1|NOT COMPLETED|Overall Study||1
1112353|NCT01173679|2692377|P1|COMPLETED|Overall Study||9
1112354|NCT01173679|2692377|P1|STARTED|Overall Study||10
1112355|NCT01173718|2692383|P1|NOT COMPLETED|Overall Study||44
1112356|NCT01173718|2692383|P1|COMPLETED|Overall Study||94
1112357|NCT01173718|2692383|P1|STARTED|Overall Study||138
1112358|NCT01173848|2692394|P2|NOT COMPLETED|Overall Study||8
1112359|NCT01173848|2692395|P1|NOT COMPLETED|Overall Study||4
1112360|NCT01173848|2692394|P2|COMPLETED|Overall Study||3
1112361|NCT01173848|2692395|P1|COMPLETED|Overall Study||4
1112362|NCT01173848|2692394|P2|STARTED|Overall Study||11
1112363|NCT01173848|2692395|P1|STARTED|Overall Study||8
1112364|NCT01173874|2692402|P2|NOT COMPLETED|Overall Study||23
1112365|NCT01173874|2692403|P1|NOT COMPLETED|Overall Study||23
1112366|NCT01173874|2692402|P2|COMPLETED|Overall Study||41
1112367|NCT01173874|2692403|P1|COMPLETED|Overall Study||33
1112368|NCT01173874|2692402|P2|STARTED|Overall Study||64
1112369|NCT01173874|2692403|P1|STARTED|Overall Study||56
1112370|NCT01174004|2692417|P2|NOT COMPLETED|Overall Study||16
1112371|NCT01174004|2692418|P1|NOT COMPLETED|Overall Study||7
1112372|NCT01174004|2692417|P2|COMPLETED|Overall Study||89
1112373|NCT01174004|2692418|P1|COMPLETED|Overall Study||87
1112374|NCT01174004|2692417|P2|STARTED|Overall Study||105
1112375|NCT01174004|2692418|P1|STARTED|Overall Study||94
1112376|NCT01174030|2692431|P5|NOT COMPLETED|Overall Study||1
1112377|NCT01174030|2692432|P4|NOT COMPLETED|Overall Study||2
1112378|NCT01174030|2692433|P3|NOT COMPLETED|Overall Study||2
1112379|NCT01174030|2692434|P2|NOT COMPLETED|Overall Study||2
1112380|NCT01174030|2692435|P1|NOT COMPLETED|Overall Study||2
1112381|NCT01174030|2692431|P5|COMPLETED|Overall Study||52
1112382|NCT01174030|2692432|P4|COMPLETED|Overall Study||53
1112383|NCT01174030|2692433|P3|COMPLETED|Overall Study||52
1112384|NCT01174030|2692434|P2|COMPLETED|Overall Study||52
1112385|NCT01174030|2692435|P1|COMPLETED|Overall Study||51
1112386|NCT01174030|2692431|P5|STARTED|Overall Study||53
1112387|NCT01174030|2692432|P4|STARTED|Overall Study||55
1112388|NCT01174030|2692433|P3|STARTED|Overall Study||54
1112389|NCT01174030|2692434|P2|STARTED|Overall Study||54
1112390|NCT01174030|2692435|P1|STARTED|Overall Study||53
1112391|NCT01174043|2692457|P1|NOT COMPLETED|Overall Study||11
1112392|NCT01174043|2692457|P1|COMPLETED|Overall Study||0
1112393|NCT01174043|2692457|P1|STARTED|Overall Study||11
1112394|NCT01174160|2692465|P2|NOT COMPLETED|Overall Study||6
1112395|NCT01174160|2692466|P1|NOT COMPLETED|Overall Study||8
1112396|NCT01174160|2692465|P2|COMPLETED|Overall Study||56
1112397|NCT01174160|2692466|P1|COMPLETED|Overall Study||53
1112398|NCT01174160|2692465|P2|Discontinued Post Dose|Overall Study||0
1112399|NCT01174160|2692466|P1|Discontinued Post Dose|Overall Study||2
1112400|NCT01174160|2692465|P2|Dosed|Overall Study||56
1112401|NCT01174160|2692466|P1|Dosed|Overall Study||55
1112402|NCT01174160|2692465|P2|Discontinued Pre Dose|Overall Study||6
1112403|NCT01174160|2692466|P1|Discontinued Pre Dose|Overall Study||6
1112404|NCT01174160|2692465|P2|STARTED|Overall Study||62
1112405|NCT01174160|2692466|P1|STARTED|Overall Study||61
1112406|NCT01174173|2692472|P1|NOT COMPLETED|Overall Study||1
1112407|NCT01174173|2692472|P1|COMPLETED|Overall Study||10
1112408|NCT01174173|2692472|P1|STARTED|Overall Study||11
1112409|NCT01174186|2692482|P2|NOT COMPLETED|Overall Study||3
1112410|NCT01174186|2692483|P1|NOT COMPLETED|Overall Study||0
1112411|NCT01174186|2692482|P2|COMPLETED|Overall Study||12
1112412|NCT01174186|2692483|P1|COMPLETED|Overall Study||15
1112413|NCT01174186|2692482|P2|STARTED|Overall Study||15
1112414|NCT01174186|2692483|P1|STARTED|Overall Study|Patients were included over three years|15
1112415|NCT01174264|2692493|P3|NOT COMPLETED|Steady-state Pharmacokinetics||2
1112416|NCT01174264|2692494|P2|NOT COMPLETED|Steady-state Pharmacokinetics||0
1112417|NCT01174264|2692495|P1|NOT COMPLETED|Steady-state Pharmacokinetics||6
1112418|NCT01174264|2692493|P3|COMPLETED|Steady-state Pharmacokinetics||27
1112419|NCT01174264|2692494|P2|COMPLETED|Steady-state Pharmacokinetics||0
1112420|NCT01174264|2692495|P1|COMPLETED|Steady-state Pharmacokinetics||25
1112421|NCT01174264|2692493|P3|STARTED|Steady-state Pharmacokinetics|Includes 11 patients from period 1 high-fat arm and 18 patients from period 1 low-fat arm|29
1112422|NCT01174264|2692494|P2|STARTED|Steady-state Pharmacokinetics|Patients in period 2 were randomized to fasting vs. fed state only.|0
1112423|NCT01174264|2692495|P1|STARTED|Steady-state Pharmacokinetics|Includes 22 patients from period 1 fasting arm and 9 patients from period 1 high-fat arm|31
1112424|NCT01174264|2692493|P3|NOT COMPLETED|Single Dose Pharmacokinetics||2
1112425|NCT01174264|2692494|P2|NOT COMPLETED|Single Dose Pharmacokinetics||0
1112426|NCT01174264|2692495|P1|NOT COMPLETED|Single Dose Pharmacokinetics||1
1112427|NCT01174264|2692493|P3|COMPLETED|Single Dose Pharmacokinetics||18
1112428|NCT01174264|2692494|P2|COMPLETED|Single Dose Pharmacokinetics||20
1112429|NCT01174264|2692495|P1|COMPLETED|Single Dose Pharmacokinetics||22
1112430|NCT01174264|2692493|P3|STARTED|Single Dose Pharmacokinetics||20
1112431|NCT01174264|2692494|P2|STARTED|Single Dose Pharmacokinetics||20
1112432|NCT01174264|2692495|P1|STARTED|Single Dose Pharmacokinetics||23
1112433|NCT01174342|2692527|P1|NOT COMPLETED|Overall Study||4
1112434|NCT01174342|2692527|P1|COMPLETED|Overall Study||26
1112435|NCT01174342|2692527|P1|STARTED|Overall Study||30
1112436|NCT01174446|2692531|P4|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
1112437|NCT01174446|2692532|P3|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
1112438|NCT01174446|2692533|P2|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
1112439|NCT01174446|2692534|P1|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
1112440|NCT01174446|2692531|P4|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
1112441|NCT01174446|2692532|P3|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
1112442|NCT01174446|2692533|P2|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
1112443|NCT01174446|2692534|P1|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
1112444|NCT01174446|2692531|P4|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
1112445|NCT01174446|2692532|P3|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
1112446|NCT01174446|2692533|P2|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
1112447|NCT01174446|2692534|P1|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
1112448|NCT01174446|2692531|P4|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
1112449|NCT01174446|2692532|P3|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||2
1112450|NCT01174446|2692533|P2|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
1112451|NCT01174446|2692534|P1|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
1112452|NCT01174446|2692531|P4|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
1112453|NCT01174446|2692532|P3|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||29
1112454|NCT01174446|2692533|P2|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
1112455|NCT01174446|2692534|P1|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
1112456|NCT01174446|2692531|P4|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|14
1112457|NCT01174446|2692532|P3|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|31
1112458|NCT01174446|2692533|P2|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
1112459|NCT01174446|2692534|P1|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
1112460|NCT01174446|2692531|P4|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
1112461|NCT01174446|2692532|P3|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
1112462|NCT01174446|2692533|P2|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
1112463|NCT01174446|2692534|P1|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
1112464|NCT01174446|2692531|P4|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
1112465|NCT01174446|2692532|P3|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
1112466|NCT01174446|2692533|P2|COMPLETED|Part 1 -Pharmacokinetic Crossover||14
1112467|NCT01174446|2692534|P1|COMPLETED|Part 1 -Pharmacokinetic Crossover|BAX326 was mistakenly infused for second PK infusion (ie should have been BeneFIX) for 1 participant|14
1112468|NCT01174446|2692531|P4|STARTED|Part 1 -Pharmacokinetic Crossover||0
1112469|NCT01174446|2692532|P3|STARTED|Part 1 -Pharmacokinetic Crossover||0
1112470|NCT01174446|2692533|P2|STARTED|Part 1 -Pharmacokinetic Crossover||14
1112471|NCT01174446|2692534|P1|STARTED|Part 1 -Pharmacokinetic Crossover||14
1112472|NCT01174459|2692721|P1|NOT COMPLETED|Overall Study||5
1112473|NCT01174459|2692721|P1|COMPLETED|Overall Study|Case report form (CRF) collected|566
1112474|NCT01174459|2692721|P1|STARTED|Overall Study|Registered patients|571
1112475|NCT01174550|2692728|P2|NOT COMPLETED|Overall Study||873
1112476|NCT01174550|2692729|P1|NOT COMPLETED|Overall Study||1270
1112477|NCT01174550|2692728|P2|COMPLETED|Overall Study||4123
1112478|NCT01174550|2692729|P1|COMPLETED|Overall Study||3737
1112479|NCT01174550|2692728|P2|STARTED|Overall Study||4996
1112480|NCT01174550|2692729|P1|STARTED|Overall Study||5007
1112481|NCT01174576|2692757|P1|NOT COMPLETED|Overall Study||0
1112482|NCT01174576|2692757|P1|COMPLETED|Overall Study||16
1112483|NCT01174576|2692757|P1|STARTED|Overall Study|All participants received all interventions without exception.|16
1112484|NCT01174784|2692798|P1|NOT COMPLETED|Overall Study||0
1112485|NCT01174784|2692798|P1|COMPLETED|Overall Study||88
1112486|NCT01174784|2692798|P1|STARTED|Overall Study||88
1112487|NCT01175005|2692803|P1|NOT COMPLETED|Overall Study||0
1112488|NCT01175005|2692803|P1|COMPLETED|Overall Study||62
1112489|NCT01175005|2692803|P1|STARTED|Overall Study||62
1112490|NCT01175018|2692810|P2|NOT COMPLETED|Overall Study||1
1112491|NCT01175018|2692811|P1|NOT COMPLETED|Overall Study||3
1112492|NCT01175018|2692810|P2|COMPLETED|Overall Study||14
1112493|NCT01175018|2692811|P1|COMPLETED|Overall Study||12
1112494|NCT01175018|2692810|P2|STARTED|Overall Study||15
1112495|NCT01175018|2692811|P1|STARTED|Overall Study||15
1112496|NCT01175031|2692847|P1|NOT COMPLETED|Overall Study||0
1112497|NCT01175031|2692847|P1|COMPLETED|Overall Study||45
1112498|NCT01175031|2692847|P1|STARTED|Overall Study||45
1112499|NCT01181492|2692858|P3|NOT COMPLETED|Overall Study||0
1112500|NCT01181492|2692859|P2|NOT COMPLETED|Overall Study||0
1112501|NCT01181492|2692860|P1|NOT COMPLETED|Overall Study||0
1112502|NCT01181492|2692858|P3|COMPLETED|Overall Study||7
1112503|NCT01181492|2692859|P2|COMPLETED|Overall Study||66
1112504|NCT01181492|2692860|P1|COMPLETED|Overall Study||103
1112505|NCT01181492|2692858|P3|STARTED|Overall Study||7
1112506|NCT01181492|2692859|P2|STARTED|Overall Study||66
1112507|NCT01181492|2692860|P1|STARTED|Overall Study||103
1112508|NCT01181531|2692876|P2|NOT COMPLETED|Overall Study||53
1112509|NCT01181531|2692877|P1|NOT COMPLETED|Overall Study||61
1112510|NCT01181531|2692876|P2|COMPLETED|Overall Study||102
1112511|NCT01181531|2692877|P1|COMPLETED|Overall Study||96
1112512|NCT01181531|2692876|P2|Received Investigational Product|Overall Study||153
1112513|NCT01181531|2692877|P1|Received Investigational Product|Overall Study||155
1112514|NCT01181531|2692876|P2|STARTED|Overall Study|Subjects are randomized after washout.|155
1112515|NCT01181531|2692877|P1|STARTED|Overall Study|Subjects are randomized after washout.|157
1112516|NCT01181609|2692887|P1|NOT COMPLETED|Overall Study||53
1112517|NCT01181609|2692887|P1|COMPLETED|Overall Study||1
1112518|NCT01181609|2692887|P1|STARTED|Overall Study||54
1112519|NCT01182194|2692900|P2|NOT COMPLETED|Second Intervention||0
1112520|NCT01182194|2692901|P1|NOT COMPLETED|Second Intervention||0
1112521|NCT01182194|2692900|P2|COMPLETED|Second Intervention||16
1112522|NCT01182194|2692901|P1|COMPLETED|Second Intervention||15
1112523|NCT01182194|2692900|P2|STARTED|Second Intervention||16
1112524|NCT01182194|2692901|P1|STARTED|Second Intervention||15
1112525|NCT01182194|2692900|P2|NOT COMPLETED|Washout of 28 Days||0
1112526|NCT01182194|2692901|P1|NOT COMPLETED|Washout of 28 Days||1
1112527|NCT01182194|2692900|P2|COMPLETED|Washout of 28 Days||16
1112528|NCT01182194|2692901|P1|COMPLETED|Washout of 28 Days||15
1112529|NCT01182194|2692900|P2|STARTED|Washout of 28 Days||16
1112530|NCT01182194|2692901|P1|STARTED|Washout of 28 Days||16
1112531|NCT01182194|2692900|P2|NOT COMPLETED|First Intervention||0
1112532|NCT01182194|2692901|P1|NOT COMPLETED|First Intervention||0
1112533|NCT01182194|2692900|P2|COMPLETED|First Intervention||16
1112534|NCT01182194|2692901|P1|COMPLETED|First Intervention||16
1112535|NCT01182194|2692900|P2|STARTED|First Intervention||16
1112536|NCT01182194|2692901|P1|STARTED|First Intervention||16
1112537|NCT01182207|2692919|P2|NOT COMPLETED|Second Intervention||0
1112538|NCT01182207|2692920|P1|NOT COMPLETED|Second Intervention||1
1112539|NCT01182207|2692919|P2|COMPLETED|Second Intervention||14
1112540|NCT01182207|2692920|P1|COMPLETED|Second Intervention||17
1112541|NCT01182207|2692919|P2|STARTED|Second Intervention||14
1112542|NCT01182207|2692920|P1|STARTED|Second Intervention||18
1112543|NCT01182207|2692919|P2|NOT COMPLETED|Washout of 28 Days||0
1112544|NCT01182207|2692920|P1|NOT COMPLETED|Washout of 28 Days||0
1112545|NCT01182207|2692919|P2|COMPLETED|Washout of 28 Days||14
1112546|NCT01182207|2692920|P1|COMPLETED|Washout of 28 Days||18
1112547|NCT01182207|2692919|P2|STARTED|Washout of 28 Days||14
1112548|NCT01182207|2692920|P1|STARTED|Washout of 28 Days||18
1112549|NCT01182207|2692919|P2|NOT COMPLETED|First Intervention||1
1112550|NCT01182207|2692920|P1|NOT COMPLETED|First Intervention||0
1112551|NCT01182207|2692919|P2|COMPLETED|First Intervention||14
1112552|NCT01182207|2692920|P1|COMPLETED|First Intervention||18
1112553|NCT01182207|2692919|P2|STARTED|First Intervention||15
1112554|NCT01182207|2692920|P1|STARTED|First Intervention||18
1112555|NCT01182285|2692936|P3|NOT COMPLETED|Third Intervention Week 11-52||8
1112556|NCT01182285|2692937|P2|NOT COMPLETED|Third Intervention Week 11-52||0
1112557|NCT01182285|2692938|P1|NOT COMPLETED|Third Intervention Week 11-52||0
1112558|NCT01182285|2692936|P3|COMPLETED|Third Intervention Week 11-52||0
1112559|NCT01182285|2692937|P2|COMPLETED|Third Intervention Week 11-52||0
1112560|NCT01182285|2692938|P1|COMPLETED|Third Intervention Week 11-52||0
1112561|NCT01182285|2692936|P3|STARTED|Third Intervention Week 11-52|2 subj. taken off study after completing ph 1: 1 due to a negative uptake scan & one off due to PD.|8
1112562|NCT01182285|2692937|P2|STARTED|Third Intervention Week 11-52||0
1112563|NCT01182285|2692938|P1|STARTED|Third Intervention Week 11-52||0
1112564|NCT01182285|2692936|P3|NOT COMPLETED|Second Intervention Week 11-17||0
1112565|NCT01182285|2692937|P2|NOT COMPLETED|Second Intervention Week 11-17||0
1112566|NCT01182285|2692938|P1|NOT COMPLETED|Second Intervention Week 11-17||0
1112567|NCT01182285|2692936|P3|COMPLETED|Second Intervention Week 11-17||0
1112568|NCT01182285|2692937|P2|COMPLETED|Second Intervention Week 11-17||0
1112569|NCT01182285|2692938|P1|COMPLETED|Second Intervention Week 11-17||0
1112570|NCT01182285|2692936|P3|STARTED|Second Intervention Week 11-17||0
1112571|NCT01182285|2692937|P2|STARTED|Second Intervention Week 11-17||0
1112572|NCT01182285|2692938|P1|STARTED|Second Intervention Week 11-17||0
1112573|NCT01182285|2692936|P3|NOT COMPLETED|First Intervention Week 1-10||0
1112574|NCT01182285|2692937|P2|NOT COMPLETED|First Intervention Week 1-10||0
1112575|NCT01182285|2692938|P1|NOT COMPLETED|First Intervention Week 1-10||3
1112576|NCT01182285|2692936|P3|COMPLETED|First Intervention Week 1-10||0
1112577|NCT01182285|2692937|P2|COMPLETED|First Intervention Week 1-10||0
1112578|NCT01182285|2692938|P1|COMPLETED|First Intervention Week 1-10||10
1112579|NCT01182285|2692936|P3|STARTED|First Intervention Week 1-10||0
1112580|NCT01182285|2692937|P2|STARTED|First Intervention Week 1-10||0
1112581|NCT01182285|2692938|P1|STARTED|First Intervention Week 1-10||13
1112582|NCT01182298|2692946|P1|NOT COMPLETED|Overall Study||6
1112583|NCT01182298|2692946|P1|COMPLETED|Overall Study||4
1112584|NCT01182298|2692946|P1|STARTED|Overall Study||10
1112585|NCT01182337|2692952|P2|NOT COMPLETED|Overall Study||2
1112586|NCT01182337|2692953|P1|NOT COMPLETED|Overall Study||3
1112587|NCT01182337|2692952|P2|COMPLETED|Overall Study||7
1112588|NCT01182337|2692953|P1|COMPLETED|Overall Study||19
1112589|NCT01182337|2692952|P2|STARTED|Overall Study||9
1112590|NCT01182337|2692953|P1|STARTED|Overall Study||22
1112591|NCT01182376|2692973|P2|NOT COMPLETED|Overall Study||5
1112592|NCT01182376|2692974|P1|NOT COMPLETED|Overall Study||11
1112593|NCT01182376|2692973|P2|COMPLETED|Overall Study||13
1112594|NCT01182376|2692974|P1|COMPLETED|Overall Study||4
1112595|NCT01182376|2692973|P2|STARTED|Overall Study||18
1112596|NCT01182376|2692974|P1|STARTED|Overall Study||15
1112597|NCT01182428|2692982|P2|NOT COMPLETED|Overall Study||1
1112598|NCT01182428|2692983|P1|NOT COMPLETED|Overall Study||11
1112599|NCT01182428|2692982|P2|COMPLETED|Overall Study||150
1112600|NCT01182428|2692983|P1|COMPLETED|Overall Study||293
1112601|NCT01182428|2692982|P2|STARTED|Overall Study||151
1112602|NCT01182428|2692983|P1|STARTED|Overall Study||304
1112603|NCT01182480|2693047|P1|NOT COMPLETED|Overall Study||0
1112604|NCT01182480|2693047|P1|COMPLETED|Overall Study||47
1112605|NCT01182480|2693047|P1|STARTED|Overall Study||47
1112606|NCT01182493|2693053|P2|NOT COMPLETED|Overall Study||7
1112607|NCT01182493|2693054|P1|NOT COMPLETED|Overall Study||16
1112608|NCT01182493|2693053|P2|COMPLETED|Overall Study||156
1112609|NCT01182493|2693054|P1|COMPLETED|Overall Study||152
1112610|NCT01182493|2693053|P2|STARTED|Overall Study||163
1112611|NCT01182493|2693054|P1|STARTED|Overall Study||168
1112612|NCT01182610|2693060|P1|NOT COMPLETED|Overall Study||0
1112613|NCT01182610|2693060|P1|COMPLETED|Overall Study||1
1112614|NCT01182610|2693060|P1|STARTED|Overall Study||1
1112615|NCT01182675|2693070|P2|NOT COMPLETED|Overall Study||0
1112616|NCT01182675|2693071|P1|NOT COMPLETED|Overall Study||0
1112617|NCT01182675|2693070|P2|COMPLETED|Overall Study||0
1112618|NCT01182675|2693071|P1|COMPLETED|Overall Study||7
1112619|NCT01182675|2693070|P2|STARTED|Overall Study||0
1112620|NCT01182675|2693071|P1|STARTED|Overall Study||7
1112621|NCT01182727|2693077|P1|NOT COMPLETED|Overall Study||0
1112622|NCT01182727|2693077|P1|COMPLETED|Overall Study||10
1112623|NCT01182727|2693077|P1|STARTED|Overall Study||10
1112624|NCT01182805|2693081|P1|NOT COMPLETED|Overall Study||0
1112625|NCT01182805|2693081|P1|COMPLETED|Overall Study||50
1112626|NCT01182805|2693081|P1|STARTED|Overall Study||50
1112627|NCT01183013|2693097|P7|NOT COMPLETED|Overall Study||37
1112628|NCT01183013|2693098|P6|NOT COMPLETED|Overall Study||45
1112629|NCT01183013|2693099|P5|NOT COMPLETED|Overall Study||36
1112630|NCT01183013|2693100|P4|NOT COMPLETED|Overall Study||30
1112631|NCT01183013|2693101|P3|NOT COMPLETED|Overall Study||41
1112632|NCT01183013|2693102|P2|NOT COMPLETED|Overall Study||39
1112633|NCT01183013|2693103|P1|NOT COMPLETED|Overall Study||45
1112634|NCT01183013|2693097|P7|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|96
1112635|NCT01183013|2693098|P6|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|88
1112636|NCT01183013|2693099|P5|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|90
1112637|NCT01183013|2693100|P4|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|105
1112638|NCT01183013|2693101|P3|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|97
1112639|NCT01183013|2693102|P2|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|101
1112640|NCT01183013|2693103|P1|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|86
1112641|NCT01183013|2693097|P7|STARTED|Overall Study||133
1112642|NCT01183013|2693098|P6|STARTED|Overall Study||133
1112643|NCT01183013|2693099|P5|STARTED|Overall Study||126
1112644|NCT01183013|2693100|P4|STARTED|Overall Study||135
1112645|NCT01183013|2693101|P3|STARTED|Overall Study||138
1112646|NCT01183013|2693102|P2|STARTED|Overall Study||140
1112647|NCT01183013|2693103|P1|STARTED|Overall Study||131
1112648|NCT01183065|2693182|P1|NOT COMPLETED|Overall Study||1
1112649|NCT01183065|2693182|P1|COMPLETED|Overall Study||12
1112650|NCT01183065|2693182|P1|STARTED|Overall Study||13
1112651|NCT01183104|2693188|P2|NOT COMPLETED|Overall Study||92
1112652|NCT01183104|2693189|P1|NOT COMPLETED|Overall Study||77
1112653|NCT01183104|2693188|P2|COMPLETED|Overall Study||60
1112654|NCT01183104|2693189|P1|COMPLETED|Overall Study||76
1112655|NCT01183104|2693188|P2|Enrolled in Extension Study|Overall Study||61
1112656|NCT01183104|2693189|P1|Enrolled in Extension Study|Overall Study||80
1112657|NCT01183104|2693188|P2|Completed 52-week Treatment|Overall Study||111
1112658|NCT01183104|2693189|P1|Completed 52-week Treatment|Overall Study||119
1112659|NCT01183104|2693188|P2|Continued Treatment for 12 Weeks|Overall Study||129
1112660|NCT01183104|2693189|P1|Continued Treatment for 12 Weeks|Overall Study||143
1112661|NCT01183104|2693188|P2|Received Study Drug|Overall Study||143
1112662|NCT01183104|2693189|P1|Received Study Drug|Overall Study||148
1112663|NCT01183104|2693188|P2|STARTED|Overall Study||152
1112664|NCT01183104|2693189|P1|STARTED|Overall Study||153
1112665|NCT01183169|2693209|P7|NOT COMPLETED|Post-switch Phase||9
1112666|NCT01183169|2693210|P6|NOT COMPLETED|Post-switch Phase||14
1112667|NCT01183169|2693211|P5|NOT COMPLETED|Post-switch Phase||0
1112668|NCT01183169|2693212|P4|NOT COMPLETED|Post-switch Phase||0
1112669|NCT01183169|2693213|P3|NOT COMPLETED|Post-switch Phase||0
1112670|NCT01183169|2693214|P2|NOT COMPLETED|Post-switch Phase||0
1112671|NCT01183169|2693215|P1|NOT COMPLETED|Post-switch Phase||0
1112672|NCT01183169|2693209|P7|COMPLETED|Post-switch Phase||21
1112673|NCT01183169|2693210|P6|COMPLETED|Post-switch Phase||21
1112674|NCT01183169|2693211|P5|COMPLETED|Post-switch Phase||0
1112675|NCT01183169|2693212|P4|COMPLETED|Post-switch Phase||0
1112676|NCT01183169|2693213|P3|COMPLETED|Post-switch Phase||0
1112677|NCT01183169|2693214|P2|COMPLETED|Post-switch Phase||0
1112678|NCT01183169|2693215|P1|COMPLETED|Post-switch Phase||0
1112679|NCT01183169|2693209|P7|Completed Treatment|Post-switch Phase||13
1112680|NCT01183169|2693210|P6|Completed Treatment|Post-switch Phase||12
1112681|NCT01183169|2693211|P5|Completed Treatment|Post-switch Phase||0
1112682|NCT01183169|2693212|P4|Completed Treatment|Post-switch Phase||0
1112683|NCT01183169|2693213|P3|Completed Treatment|Post-switch Phase||0
1112684|NCT01183169|2693214|P2|Completed Treatment|Post-switch Phase||0
1112685|NCT01183169|2693215|P1|Completed Treatment|Post-switch Phase||0
1112686|NCT01183169|2693209|P7|STARTED|Post-switch Phase|Participants in Treatment C2 who switched to active ALV|30
1112687|NCT01183169|2693210|P6|STARTED|Post-switch Phase|Participants in Treatment C1 who switched to active ALV|35
1112688|NCT01183169|2693211|P5|STARTED|Post-switch Phase|Not a post-switch group|0
1112689|NCT01183169|2693212|P4|STARTED|Post-switch Phase|Not a post-switch group|0
1112690|NCT01183169|2693213|P3|STARTED|Post-switch Phase|Not a post-switch group|0
1112691|NCT01183169|2693214|P2|STARTED|Post-switch Phase|Not a post-switch group|0
1112692|NCT01183169|2693215|P1|STARTED|Post-switch Phase|Not a post-switch group|0
1112693|NCT01183169|2693209|P7|NOT COMPLETED|Main Phase||0
1112694|NCT01183169|2693210|P6|NOT COMPLETED|Main Phase||0
1112695|NCT01183169|2693211|P5|NOT COMPLETED|Main Phase||26
1112696|NCT01183169|2693212|P4|NOT COMPLETED|Main Phase||37
1112697|NCT01183169|2693213|P3|NOT COMPLETED|Main Phase||41
1112698|NCT01183169|2693214|P2|NOT COMPLETED|Main Phase||22
1112699|NCT01183169|2693215|P1|NOT COMPLETED|Main Phase||27
1112700|NCT01183169|2693209|P7|COMPLETED|Main Phase||0
1112701|NCT01183169|2693210|P6|COMPLETED|Main Phase||0
1112702|NCT01183169|2693211|P5|COMPLETED|Main Phase||83
1112703|NCT01183169|2693212|P4|COMPLETED|Main Phase||18
1112704|NCT01183169|2693213|P3|COMPLETED|Main Phase||18
1112705|NCT01183169|2693214|P2|COMPLETED|Main Phase||93
1112706|NCT01183169|2693215|P1|COMPLETED|Main Phase||94
1112707|NCT01183169|2693209|P7|Switched to ALV|Main Phase||0
1112708|NCT01183169|2693210|P6|Switched to ALV|Main Phase||0
1112709|NCT01183169|2693211|P5|Switched to ALV|Main Phase||0
1112710|NCT01183169|2693212|P4|Switched to ALV|Main Phase||30
1112711|NCT01183169|2693213|P3|Switched to ALV|Main Phase||35
1112712|NCT01183169|2693214|P2|Switched to ALV|Main Phase||0
1112713|NCT01183169|2693215|P1|Switched to ALV|Main Phase||0
1112714|NCT01183169|2693209|P7|Completed Treatment|Main Phase||0
1112715|NCT01183169|2693210|P6|Completed Treatment|Main Phase||0
1112716|NCT01183169|2693211|P5|Completed Treatment|Main Phase||77
1112717|NCT01183169|2693212|P4|Completed Treatment|Main Phase||17
1112718|NCT01183169|2693213|P3|Completed Treatment|Main Phase||17
1112719|NCT01183169|2693214|P2|Completed Treatment|Main Phase||78
1112720|NCT01183169|2693215|P1|Completed Treatment|Main Phase||72
1112721|NCT01183169|2693209|P7|STARTED|Main Phase||0
1112722|NCT01183169|2693210|P6|STARTED|Main Phase||0
1112723|NCT01183169|2693211|P5|STARTED|Main Phase||109
1112724|NCT01183169|2693212|P4|STARTED|Main Phase||55
1112725|NCT01183169|2693213|P3|STARTED|Main Phase||59
1112726|NCT01183169|2693214|P2|STARTED|Main Phase||115
1112727|NCT01183169|2693215|P1|STARTED|Main Phase||121
1112728|NCT01183234|2693289|P2|NOT COMPLETED|Second Intervention||0
1112729|NCT01183234|2693290|P1|NOT COMPLETED|Second Intervention||0
1112730|NCT01183234|2693289|P2|COMPLETED|Second Intervention||14
1112731|NCT01183234|2693290|P1|COMPLETED|Second Intervention||13
1112732|NCT01183234|2693289|P2|STARTED|Second Intervention||14
1112733|NCT01183234|2693290|P1|STARTED|Second Intervention||13
1112734|NCT01183234|2693289|P2|NOT COMPLETED|Washout||0
1112735|NCT01183234|2693290|P1|NOT COMPLETED|Washout||0
1112736|NCT01183234|2693289|P2|COMPLETED|Washout||14
1112737|NCT01183234|2693290|P1|COMPLETED|Washout||13
1112738|NCT01183234|2693289|P2|STARTED|Washout||14
1112739|NCT01183234|2693290|P1|STARTED|Washout||13
1112740|NCT01183234|2693289|P2|NOT COMPLETED|First Intervention||0
1112741|NCT01183234|2693290|P1|NOT COMPLETED|First Intervention||1
1112742|NCT01183234|2693289|P2|COMPLETED|First Intervention||14
1112743|NCT01183234|2693290|P1|COMPLETED|First Intervention||13
1112744|NCT01183234|2693289|P2|STARTED|First Intervention||14
1112745|NCT01183234|2693290|P1|STARTED|First Intervention||14
1112746|NCT01183312|2693302|P2|NOT COMPLETED|Second Intervention Day||0
1112747|NCT01183312|2693303|P1|NOT COMPLETED|Second Intervention Day||0
1112748|NCT01183312|2693302|P2|COMPLETED|Second Intervention Day||5
1112749|NCT01183312|2693303|P1|COMPLETED|Second Intervention Day||5
1112750|NCT01183312|2693302|P2|STARTED|Second Intervention Day||5
1112751|NCT01183312|2693303|P1|STARTED|Second Intervention Day||5
1112752|NCT01183312|2693302|P2|NOT COMPLETED|Washout Period of at Least 1 Week||0
1112753|NCT01183312|2693303|P1|NOT COMPLETED|Washout Period of at Least 1 Week||0
1112754|NCT01183312|2693302|P2|COMPLETED|Washout Period of at Least 1 Week||5
1112755|NCT01183312|2693303|P1|COMPLETED|Washout Period of at Least 1 Week||5
1112756|NCT01183312|2693302|P2|STARTED|Washout Period of at Least 1 Week||5
1112757|NCT01183312|2693303|P1|STARTED|Washout Period of at Least 1 Week||5
1112758|NCT01183312|2693302|P2|NOT COMPLETED|First Intervention Day||0
1112759|NCT01183312|2693303|P1|NOT COMPLETED|First Intervention Day||0
1112760|NCT01183312|2693302|P2|COMPLETED|First Intervention Day||5
1112761|NCT01183312|2693303|P1|COMPLETED|First Intervention Day||5
1112762|NCT01183312|2693302|P2|STARTED|First Intervention Day||5
1112763|NCT01183312|2693303|P1|STARTED|First Intervention Day||5
1112764|NCT01183390|2693323|P2|NOT COMPLETED|Second Intervention||0
1112765|NCT01183390|2693324|P1|NOT COMPLETED|Second Intervention||0
1112766|NCT01183390|2693323|P2|COMPLETED|Second Intervention||10
1112767|NCT01183390|2693324|P1|COMPLETED|Second Intervention||11
1112768|NCT01183390|2693323|P2|STARTED|Second Intervention||10
1112769|NCT01183390|2693324|P1|STARTED|Second Intervention||11
1112770|NCT01183390|2693323|P2|NOT COMPLETED|Washout of 21 Days||0
1112771|NCT01183390|2693324|P1|NOT COMPLETED|Washout of 21 Days||0
1112772|NCT01183390|2693323|P2|COMPLETED|Washout of 21 Days||10
1112773|NCT01183390|2693324|P1|COMPLETED|Washout of 21 Days||11
1112774|NCT01183390|2693323|P2|STARTED|Washout of 21 Days||10
1112775|NCT01183390|2693324|P1|STARTED|Washout of 21 Days||11
1112776|NCT01183390|2693323|P2|NOT COMPLETED|First Intervention||1
1112777|NCT01183390|2693324|P1|NOT COMPLETED|First Intervention||0
1112778|NCT01183390|2693323|P2|COMPLETED|First Intervention||10
1112779|NCT01183390|2693324|P1|COMPLETED|First Intervention||11
1112780|NCT01183390|2693323|P2|STARTED|First Intervention||11
1112781|NCT01183390|2693324|P1|STARTED|First Intervention||11
1112782|NCT01183468|2693336|P4|NOT COMPLETED|Overall Study||0
1112783|NCT01183468|2693337|P3|NOT COMPLETED|Overall Study||0
1112784|NCT01183468|2693338|P2|NOT COMPLETED|Overall Study||2
1112785|NCT01183468|2693339|P1|NOT COMPLETED|Overall Study||3
1112786|NCT01183468|2693336|P4|COMPLETED|Overall Study||0
1112787|NCT01183468|2693337|P3|COMPLETED|Overall Study||0
1112788|NCT01183468|2693338|P2|COMPLETED|Overall Study||7
1112789|NCT01183468|2693339|P1|COMPLETED|Overall Study||5
1112790|NCT01183468|2693336|P4|STARTED|Overall Study||0
1112791|NCT01183468|2693337|P3|STARTED|Overall Study||0
1112792|NCT01183468|2693338|P2|STARTED|Overall Study||9
1112793|NCT01183468|2693339|P1|STARTED|Overall Study||8
1112794|NCT01183481|2693347|P1|NOT COMPLETED|Overall Study||0
1112795|NCT01183481|2693347|P1|COMPLETED|Overall Study||19
1112796|NCT01183481|2693347|P1|STARTED|Overall Study||19
1112797|NCT01183533|2693355|P1|NOT COMPLETED|Overall Study||0
1112798|NCT01183533|2693355|P1|COMPLETED|Overall Study|- all pre-planned 40 patients received the study medication.|40
1112799|NCT01183533|2693355|P1|STARTED|Overall Study|Between Oct 2010 and Oct 2013.|40
1112800|NCT01183546|2693361|P1|NOT COMPLETED|Overall Study||0
1112801|NCT01183546|2693361|P1|COMPLETED|Overall Study||53
1112802|NCT01183546|2693361|P1|STARTED|Overall Study||53
1112803|NCT01183650|2693370|P2|NOT COMPLETED|Overall Study||0
1112804|NCT01183650|2693371|P1|NOT COMPLETED|Overall Study||0
1112805|NCT01183650|2693370|P2|COMPLETED|Overall Study||12
1112806|NCT01183650|2693371|P1|COMPLETED|Overall Study||12
1112807|NCT01183650|2693370|P2|STARTED|Overall Study||12
1112808|NCT01183650|2693371|P1|STARTED|Overall Study||12
1112809|NCT01183728|2693381|P1|NOT COMPLETED|Overall Study||0
1112810|NCT01183728|2693381|P1|COMPLETED|Overall Study||12
1112811|NCT01183728|2693381|P1|STARTED|Overall Study||12
1112812|NCT01183780|2693388|P2|NOT COMPLETED|Overall Study||25
1112813|NCT01183780|2693389|P1|NOT COMPLETED|Overall Study||31
1112814|NCT01183780|2693388|P2|COMPLETED|Overall Study||511
1112815|NCT01183780|2693389|P1|COMPLETED|Overall Study||505
1112816|NCT01183780|2693388|P2|Received at Least 1 Dose of Study Drug|Overall Study||529
1112817|NCT01183780|2693389|P1|Received at Least 1 Dose of Study Drug|Overall Study||528
1112818|NCT01183780|2693388|P2|STARTED|Overall Study||536
1112819|NCT01183780|2693389|P1|STARTED|Overall Study||536
1112820|NCT01183858|2693408|P2|NOT COMPLETED|Overall Study||156
1112821|NCT01183858|2693409|P1|NOT COMPLETED|Overall Study||153
1112822|NCT01183858|2693408|P2|COMPLETED|Overall Study||3
1112823|NCT01183858|2693409|P1|COMPLETED|Overall Study||1
1112824|NCT01183858|2693408|P2|Safety Population|Overall Study||158
1112825|NCT01183858|2693409|P1|Safety Population|Overall Study||154
1112826|NCT01183858|2693408|P2|STARTED|Overall Study||159
1112827|NCT01183858|2693409|P1|STARTED|Overall Study||154
1112828|NCT01183975|2693429|P1|NOT COMPLETED|Overall Study||73
1112829|NCT01183975|2693429|P1|COMPLETED|Overall Study||444
1112830|NCT01183975|2693429|P1|STARTED|Overall Study||517
1112831|NCT01184014|2693436|P2|NOT COMPLETED|Overall Study||6
1112832|NCT01184014|2693437|P1|NOT COMPLETED|Overall Study||5
1112833|NCT01184014|2693436|P2|COMPLETED|Overall Study||31
1112834|NCT01184014|2693437|P1|COMPLETED|Overall Study||30
1112835|NCT01184014|2693436|P2|STARTED|Overall Study||37
1112836|NCT01184014|2693437|P1|STARTED|Overall Study||35
1112837|NCT01184053|2693443|P1|NOT COMPLETED|Overall Study||3
1112838|NCT01184053|2693443|P1|COMPLETED|Overall Study||0
1112839|NCT01184053|2693443|P1|STARTED|Overall Study||3
1112840|NCT01184079|2693452|P2|NOT COMPLETED|Overall Study||2
1112841|NCT01184079|2693453|P1|NOT COMPLETED|Overall Study||14
1112842|NCT01184079|2693452|P2|COMPLETED|Overall Study||107
1112843|NCT01184079|2693453|P1|COMPLETED|Overall Study||97
1112844|NCT01184079|2693452|P2|Final Blood Draw|Overall Study||107
1112845|NCT01184079|2693453|P1|Final Blood Draw|Overall Study||97
1112846|NCT01184079|2693452|P2|Dose 3|Overall Study||107
1112847|NCT01184079|2693453|P1|Dose 3|Overall Study||101
1112848|NCT01184079|2693452|P2|Dose 2|Overall Study||108
1112849|NCT01184079|2693453|P1|Dose 2|Overall Study||110
1112850|NCT01184079|2693452|P2|STARTED|Overall Study||109
1112851|NCT01184079|2693453|P1|STARTED|Overall Study||111
1112852|NCT01184118|2693463|P1|NOT COMPLETED|Overall Study||18
1112853|NCT01184118|2693463|P1|COMPLETED|Overall Study||18
1112854|NCT01184118|2693463|P1|FP MDI as Indicated (2 Weeks)|Overall Study||18
1112855|NCT01184118|2693463|P1|FP MDI 880 mcg/Day (2 Weeks)|Overall Study||18
1112856|NCT01184118|2693463|P1|FP MDI 1,760 mcg/Day (16 Weeks)|Overall Study||18
1112857|NCT01184118|2693463|P1|STARTED|Overall Study||36
1112858|NCT01184417|2693471|P2|NOT COMPLETED|Overall Study||0
1112859|NCT01184417|2693472|P1|NOT COMPLETED|Overall Study||0
1112860|NCT01184417|2693471|P2|COMPLETED|Overall Study||51
1112861|NCT01184417|2693472|P1|COMPLETED|Overall Study||51
1112862|NCT01184417|2693471|P2|STARTED|Overall Study||51
1112863|NCT01184417|2693472|P1|STARTED|Overall Study||51
1112864|NCT01177943|2693494|P2|NOT COMPLETED|Second Intervention||0
1112865|NCT01177943|2693495|P1|NOT COMPLETED|Second Intervention||0
1112866|NCT01177943|2693494|P2|COMPLETED|Second Intervention||21
1112867|NCT01177943|2693495|P1|COMPLETED|Second Intervention||19
1112868|NCT01177943|2693494|P2|STARTED|Second Intervention||21
1112869|NCT01177943|2693495|P1|STARTED|Second Intervention||19
1112870|NCT01177943|2693494|P2|NOT COMPLETED|First Intervention||0
1112871|NCT01177943|2693495|P1|NOT COMPLETED|First Intervention||2
1112872|NCT01177943|2693494|P2|COMPLETED|First Intervention||21
1112873|NCT01177943|2693495|P1|COMPLETED|First Intervention||19
1112874|NCT01177943|2693494|P2|STARTED|First Intervention||21
1112875|NCT01177943|2693495|P1|STARTED|First Intervention||21
1112876|NCT01177956|2693503|P1|NOT COMPLETED|Overall Study||0
1112877|NCT01177956|2693503|P1|COMPLETED|Overall Study||68
1112878|NCT01177956|2693503|P1|STARTED|Overall Study||68
1112879|NCT01177969|2693518|P2|NOT COMPLETED|Overall Study||3
1112880|NCT01177969|2693519|P1|NOT COMPLETED|Overall Study||3
1112881|NCT01177969|2693518|P2|COMPLETED|Overall Study||11
1112882|NCT01177969|2693519|P1|COMPLETED|Overall Study||16
1112883|NCT01177969|2693518|P2|STARTED|Overall Study||14
1112884|NCT01177969|2693519|P1|STARTED|Overall Study||19
1112885|NCT01178073|2693530|P3|NOT COMPLETED|Overall Study||46
1112886|NCT01178073|2693531|P2|NOT COMPLETED|Overall Study||44
1112887|NCT01178073|2693532|P1|NOT COMPLETED|Overall Study||62
1112888|NCT01178073|2693530|P3|COMPLETED|Overall Study||105
1112889|NCT01178073|2693531|P2|COMPLETED|Overall Study||108
1112890|NCT01178073|2693532|P1|COMPLETED|Overall Study||240
1112891|NCT01178073|2693530|P3|STARTED|Overall Study||151
1112892|NCT01178073|2693531|P2|STARTED|Overall Study||152
1112893|NCT01178073|2693532|P1|STARTED|Overall Study||302
1112894|NCT01178099|2693565|P2|NOT COMPLETED|Overall Study||1
1112895|NCT01178099|2693566|P1|NOT COMPLETED|Overall Study||0
1112896|NCT01178099|2693565|P2|COMPLETED|Overall Study||12
1112897|NCT01178099|2693566|P1|COMPLETED|Overall Study||13
1112898|NCT01178099|2693565|P2|STARTED|Overall Study||13
1112899|NCT01178099|2693566|P1|STARTED|Overall Study||13
1112900|NCT01178125|2693604|P1|NOT COMPLETED|Overall Study||1178
1112901|NCT01178125|2693604|P1|COMPLETED|Overall Study||1680
1112902|NCT01178125|2693604|P1|Pregnancy ITT (PITT) Population|Overall Study|Participants in the ITT population between the ages of 18 and 35, inclusive.|2401
1112903|NCT01178125|2693604|P1|Intent to Treat (ITT) Population|Overall Study|Completed at least one 28-day cycle of investigational product.|2607
1112904|NCT01178125|2693604|P1|Safety Population|Overall Study|Received at least 1 dose of DR-102.|2765
1112905|NCT01178125|2693604|P1|STARTED|Overall Study|Number enrolled.|2858
1112906|NCT01178138|2693631|P1|NOT COMPLETED|Overall Study||23
1112907|NCT01178138|2693631|P1|COMPLETED|Overall Study||1
1112908|NCT01178138|2693631|P1|Completed 3 Sessions|Overall Study||1
1112909|NCT01178138|2693631|P1|Completed 5 Sessions|Overall Study||1
1112910|NCT01178138|2693631|P1|Completed 6 Sessions|Overall Study||1
1112911|NCT01178138|2693631|P1|STARTED|Overall Study||24
1112912|NCT01178268|2693654|P2|NOT COMPLETED|Overall Study||1
1112913|NCT01178268|2693655|P1|NOT COMPLETED|Overall Study||7
1112914|NCT01178268|2693654|P2|COMPLETED|Overall Study||120
1112915|NCT01178268|2693655|P1|COMPLETED|Overall Study||360
1112916|NCT01178268|2693654|P2|STARTED|Overall Study||121
1112917|NCT01178268|2693655|P1|STARTED|Overall Study||367
1112918|NCT01178281|2693874|P2|NOT COMPLETED|Overall Study||77
1112919|NCT01178281|2693875|P1|NOT COMPLETED|Overall Study||149
1112920|NCT01178281|2693874|P2|COMPLETED|Overall Study|Participants remain on treatment|7
1112921|NCT01178281|2693875|P1|COMPLETED|Overall Study|Participants remain on treatment|19
1112922|NCT01178281|2693874|P2|STARTED|Overall Study|Intent to Treat Population (ITT)|84
1112923|NCT01178281|2693875|P1|STARTED|Overall Study|Intent to Treat Population (ITT)|168
1112927|NCT01178333|2693905|P3|NOT COMPLETED|Overall Study||0
1112928|NCT01178333|2693906|P2|NOT COMPLETED|Overall Study||0
1112929|NCT01178333|2693907|P1|NOT COMPLETED|Overall Study||0
1112930|NCT01178333|2693905|P3|COMPLETED|Overall Study||87
1112931|NCT01178333|2693906|P2|COMPLETED|Overall Study||284
1112932|NCT01178333|2693907|P1|COMPLETED|Overall Study||71
1112933|NCT01178333|2693905|P3|STARTED|Overall Study||87
1112934|NCT01178333|2693906|P2|STARTED|Overall Study||284
1112935|NCT01178333|2693907|P1|STARTED|Overall Study||71
1112936|NCT01178385|2693963|P2|NOT COMPLETED|Overall Study||0
1112937|NCT01178385|2693964|P1|NOT COMPLETED|Overall Study||2
1112938|NCT01178385|2693963|P2|COMPLETED|Overall Study||21
1112939|NCT01178385|2693964|P1|COMPLETED|Overall Study||22
1112940|NCT01178385|2693963|P2|STARTED|Overall Study||21
1112941|NCT01178385|2693964|P1|STARTED|Overall Study||24
1112942|NCT01178528|2693977|P3|NOT COMPLETED|Overall Study||0
1112943|NCT01178528|2693978|P2|NOT COMPLETED|Overall Study||0
1112944|NCT01178528|2693979|P1|NOT COMPLETED|Overall Study||0
1112945|NCT01178528|2693977|P3|COMPLETED|Overall Study||42
1112946|NCT01178528|2693978|P2|COMPLETED|Overall Study||38
1112947|NCT01178528|2693979|P1|COMPLETED|Overall Study||41
1112948|NCT01178528|2693977|P3|STARTED|Overall Study||42
1112949|NCT01178528|2693978|P2|STARTED|Overall Study||38
1112950|NCT01178528|2693979|P1|STARTED|Overall Study||41
1112951|NCT01178671|2693998|P2|NOT COMPLETED|Overall Study||15
1112952|NCT01178671|2693999|P1|NOT COMPLETED|Overall Study||12
1112953|NCT01178671|2693998|P2|COMPLETED|Overall Study||3
1112954|NCT01178671|2693999|P1|COMPLETED|Overall Study||6
1112955|NCT01178671|2693998|P2|STARTED|Overall Study||18
1112956|NCT01178671|2693999|P1|STARTED|Overall Study||18
1112957|NCT01178762|2694023|P1|NOT COMPLETED|Overall Study||15
1112958|NCT01178762|2694023|P1|COMPLETED|Overall Study||27
1112959|NCT01178762|2694023|P1|STARTED|Overall Study||42
1112960|NCT01178827|2694030|P3|NOT COMPLETED|Overall Study||0
1112961|NCT01178827|2694031|P2|NOT COMPLETED|Overall Study||0
1112962|NCT01178827|2694032|P1|NOT COMPLETED|Overall Study||0
1112963|NCT01178827|2694030|P3|COMPLETED|Overall Study||4
1112964|NCT01178827|2694031|P2|COMPLETED|Overall Study||10
1112965|NCT01178827|2694032|P1|COMPLETED|Overall Study||6
1112966|NCT01178827|2694030|P3|STARTED|Overall Study||4
1112967|NCT01178827|2694031|P2|STARTED|Overall Study||10
1112968|NCT01178827|2694032|P1|STARTED|Overall Study||6
1112969|NCT01178853|2694063|P2|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||3
1112970|NCT01178853|2694064|P1|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||0
1112971|NCT01178853|2694063|P2|COMPLETED|Period 4 (Warfarin + Study Drug)||19
1112972|NCT01178853|2694064|P1|COMPLETED|Period 4 (Warfarin + Study Drug)||21
1112973|NCT01178853|2694063|P2|STARTED|Period 4 (Warfarin + Study Drug)||22
1112974|NCT01178853|2694064|P1|STARTED|Period 4 (Warfarin + Study Drug)||21
1112975|NCT01178853|2694063|P2|NOT COMPLETED|Period 3 (Warfarin Titration)||0
1112976|NCT01178853|2694064|P1|NOT COMPLETED|Period 3 (Warfarin Titration)||1
1112977|NCT01178853|2694063|P2|COMPLETED|Period 3 (Warfarin Titration)||22
1112978|NCT01178853|2694064|P1|COMPLETED|Period 3 (Warfarin Titration)||21
1112979|NCT01178853|2694063|P2|STARTED|Period 3 (Warfarin Titration)||22
1112980|NCT01178853|2694064|P1|STARTED|Period 3 (Warfarin Titration)||22
1112981|NCT01178853|2694063|P2|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||0
1112982|NCT01178853|2694064|P1|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||1
1112983|NCT01178853|2694063|P2|COMPLETED|Period 2 (Warfarin + Study Drug)||22
1112984|NCT01178853|2694064|P1|COMPLETED|Period 2 (Warfarin + Study Drug)||22
1112985|NCT01178853|2694063|P2|STARTED|Period 2 (Warfarin + Study Drug)||22
1112986|NCT01178853|2694064|P1|STARTED|Period 2 (Warfarin + Study Drug)||23
1112987|NCT01178853|2694063|P2|NOT COMPLETED|Period 1 (Warfarin Titration)||2
1112988|NCT01178853|2694064|P1|NOT COMPLETED|Period 1 (Warfarin Titration)||1
1112989|NCT01178853|2694063|P2|COMPLETED|Period 1 (Warfarin Titration)||22
1112990|NCT01178853|2694064|P1|COMPLETED|Period 1 (Warfarin Titration)||23
1112991|NCT01178853|2694063|P2|STARTED|Period 1 (Warfarin Titration)||24
1112992|NCT01178853|2694064|P1|STARTED|Period 1 (Warfarin Titration)||24
1112993|NCT01184755|2694073|P3|NOT COMPLETED|Overall Study||6
1112994|NCT01184755|2694074|P2|NOT COMPLETED|Overall Study||11
1112995|NCT01184755|2694075|P1|NOT COMPLETED|Overall Study||25
1112996|NCT01184755|2694073|P3|COMPLETED|Overall Study||56
1112997|NCT01184755|2694074|P2|COMPLETED|Overall Study||54
1112998|NCT01184755|2694075|P1|COMPLETED|Overall Study||101
1112999|NCT01184755|2694073|P3|STARTED|Overall Study||62
1113000|NCT01184755|2694074|P2|STARTED|Overall Study||65
1113001|NCT01184755|2694075|P1|STARTED|Overall Study||126
1113002|NCT01184846|2694083|P1|NOT COMPLETED|Overall Study||3
1113003|NCT01184846|2694083|P1|COMPLETED|Overall Study||25
1113004|NCT01184846|2694083|P1|STARTED|Overall Study||28
1113005|NCT01184859|2694106|P5|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
1113006|NCT01184859|2694107|P4|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
1113007|NCT01184859|2694108|P3|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
1113008|NCT01184859|2694109|P2|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
1113009|NCT01184859|2694110|P1|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
1113010|NCT01184859|2694106|P5|COMPLETED|Period 2: Daily Dose for 28 Days||22
1113011|NCT01184859|2694107|P4|COMPLETED|Period 2: Daily Dose for 28 Days||22
1113012|NCT01184859|2694108|P3|COMPLETED|Period 2: Daily Dose for 28 Days||22
1113013|NCT01184859|2694109|P2|COMPLETED|Period 2: Daily Dose for 28 Days||23
1113014|NCT01184859|2694110|P1|COMPLETED|Period 2: Daily Dose for 28 Days||22
1113015|NCT01184859|2694106|P5|STARTED|Period 2: Daily Dose for 28 Days||23
1113016|NCT01184859|2694107|P4|STARTED|Period 2: Daily Dose for 28 Days||22
1113017|NCT01184859|2694108|P3|STARTED|Period 2: Daily Dose for 28 Days||22
1113018|NCT01184859|2694109|P2|STARTED|Period 2: Daily Dose for 28 Days||23
1113019|NCT01184859|2694110|P1|STARTED|Period 2: Daily Dose for 28 Days||23
1113020|NCT01184859|2694106|P5|NOT COMPLETED|Washout Period||0
1113021|NCT01184859|2694107|P4|NOT COMPLETED|Washout Period||0
1113022|NCT01184859|2694108|P3|NOT COMPLETED|Washout Period||0
1113023|NCT01184859|2694109|P2|NOT COMPLETED|Washout Period||0
1113024|NCT01184859|2694110|P1|NOT COMPLETED|Washout Period||0
1113025|NCT01184859|2694106|P5|COMPLETED|Washout Period||23
1113026|NCT01184859|2694107|P4|COMPLETED|Washout Period||22
1113027|NCT01184859|2694108|P3|COMPLETED|Washout Period||22
1113028|NCT01184859|2694109|P2|COMPLETED|Washout Period||23
1113029|NCT01184859|2694110|P1|COMPLETED|Washout Period||23
1113030|NCT01184859|2694106|P5|STARTED|Washout Period||23
1113031|NCT01184859|2694107|P4|STARTED|Washout Period||22
1113032|NCT01184859|2694108|P3|STARTED|Washout Period||22
1113033|NCT01184859|2694109|P2|STARTED|Washout Period||23
1113034|NCT01184859|2694110|P1|STARTED|Washout Period||23
1113035|NCT01184859|2694106|P5|NOT COMPLETED|Period 1: Single Dose||1
1113036|NCT01184859|2694107|P4|NOT COMPLETED|Period 1: Single Dose||0
1113037|NCT01184859|2694108|P3|NOT COMPLETED|Period 1: Single Dose||0
1113038|NCT01184859|2694109|P2|NOT COMPLETED|Period 1: Single Dose||2
1113039|NCT01184859|2694110|P1|NOT COMPLETED|Period 1: Single Dose||0
1113040|NCT01184859|2694106|P5|COMPLETED|Period 1: Single Dose||23
1113041|NCT01184859|2694107|P4|COMPLETED|Period 1: Single Dose||22
1113042|NCT01184859|2694108|P3|COMPLETED|Period 1: Single Dose||22
1113043|NCT01184859|2694109|P2|COMPLETED|Period 1: Single Dose||23
1113044|NCT01184859|2694110|P1|COMPLETED|Period 1: Single Dose||23
1113045|NCT01184859|2694106|P5|Per Protocol (PP)|Period 1: Single Dose|1 additional participant disqualified due to 'other'.|23
1113046|NCT01184859|2694107|P4|Per Protocol (PP)|Period 1: Single Dose||21
1113047|NCT01184859|2694108|P3|Per Protocol (PP)|Period 1: Single Dose||22
1113048|NCT01184859|2694109|P2|Per Protocol (PP)|Period 1: Single Dose||23
1113049|NCT01184859|2694110|P1|Per Protocol (PP)|Period 1: Single Dose||23
1113050|NCT01184859|2694106|P5|Full Analysis Set (FAS)|Period 1: Single Dose||24
1113051|NCT01184859|2694107|P4|Full Analysis Set (FAS)|Period 1: Single Dose|1 participant disqualified due to major entry criteria violation|21
1113052|NCT01184859|2694108|P3|Full Analysis Set (FAS)|Period 1: Single Dose||22
1113053|NCT01184859|2694109|P2|Full Analysis Set (FAS)|Period 1: Single Dose|2 participants disqualified due to no post-baseline primary efficacy data, and/or 'other'.|23
1113054|NCT01184859|2694110|P1|Full Analysis Set (FAS)|Period 1: Single Dose||23
1113055|NCT01184859|2694106|P5|STARTED|Period 1: Single Dose||24
1113056|NCT01184859|2694107|P4|STARTED|Period 1: Single Dose||22
1113057|NCT01184859|2694108|P3|STARTED|Period 1: Single Dose||22
1113058|NCT01184859|2694109|P2|STARTED|Period 1: Single Dose||25
1113059|NCT01184859|2694110|P1|STARTED|Period 1: Single Dose||23
1113060|NCT01184872|2694204|P2|NOT COMPLETED|Overall Study||8
1113061|NCT01184872|2694205|P1|NOT COMPLETED|Overall Study||10
1113062|NCT01184872|2694204|P2|COMPLETED|Overall Study||31
1113063|NCT01184872|2694205|P1|COMPLETED|Overall Study||71
1113064|NCT01184872|2694204|P2|Microbiologically Evaluable Set (MES)|Overall Study||27
1113065|NCT01184872|2694205|P1|Microbiologically Evaluable Set (MES)|Overall Study||65
1113066|NCT01184872|2694204|P2|Clinical Evaluable Set (CES)|Overall Study||30
1113067|NCT01184872|2694205|P1|Clinical Evaluable Set (CES)|Overall Study||73
1113068|NCT01184872|2694204|P2|Safety Set|Overall Study||40
1113069|NCT01184872|2694205|P1|Safety Set|Overall Study|One patient randomized to Daptomycin received Vancomycin.|80
1113070|NCT01184872|2694204|P2|STARTED|Overall Study||39
1113071|NCT01184872|2694205|P1|STARTED|Overall Study|"Started indicates randomized and full analysis set."|81
1113072|NCT01184885|2694219|P1|NOT COMPLETED|Overall Study||0
1113073|NCT01184885|2694219|P1|COMPLETED|Overall Study||7
1113074|NCT01184885|2694219|P1|STARTED|Overall Study||7
1113075|NCT01184898|2694224|P1|NOT COMPLETED|Overall Study||0
1113076|NCT01184898|2694224|P1|COMPLETED|Overall Study||36
1113077|NCT01184898|2694224|P1|STARTED|Overall Study||36
1113078|NCT01184989|2694231|P1|NOT COMPLETED|Overall Study||12
1113079|NCT01184989|2694231|P1|COMPLETED|Overall Study||100
1113080|NCT01184989|2694231|P1|STARTED|Overall Study|Treated Patients|112
1113081|NCT01185834|2694237|P1|NOT COMPLETED|Overall Study||14
1113082|NCT01185834|2694237|P1|COMPLETED|Overall Study||104
1113083|NCT01185834|2694237|P1|STARTED|Overall Study||118
1113084|NCT01185964|2694245|P4|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||5
1113085|NCT01185964|2694246|P3|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
1113086|NCT01185964|2694247|P2|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
1113087|NCT01185964|2694248|P1|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
1113088|NCT01185964|2694245|P4|COMPLETED|Optional Olaratumab Monotherapy on Dox||25
1113089|NCT01185964|2694246|P3|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
1113090|NCT01185964|2694247|P2|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
1113091|NCT01185964|2694248|P1|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
1113092|NCT01185964|2694245|P4|STARTED|Optional Olaratumab Monotherapy on Dox|Participants with disease progression after treatment received olaratumab.|30
1113093|NCT01185964|2694246|P3|STARTED|Optional Olaratumab Monotherapy on Dox||0
1113094|NCT01185964|2694247|P2|STARTED|Optional Olaratumab Monotherapy on Dox||0
1113095|NCT01185964|2694248|P1|STARTED|Optional Olaratumab Monotherapy on Dox||0
1113096|NCT01185964|2694245|P4|NOT COMPLETED|Phase 1b and Phase 2||0
1113097|NCT01185964|2694246|P3|NOT COMPLETED|Phase 1b and Phase 2||9
1113098|NCT01185964|2694247|P2|NOT COMPLETED|Phase 1b and Phase 2||10
1113099|NCT01185964|2694248|P1|NOT COMPLETED|Phase 1b and Phase 2||2
1113100|NCT01185964|2694245|P4|COMPLETED|Phase 1b and Phase 2||0
1113101|NCT01185964|2694246|P3|COMPLETED|Phase 1b and Phase 2||58
1113102|NCT01185964|2694247|P2|COMPLETED|Phase 1b and Phase 2||56
1113103|NCT01185964|2694248|P1|COMPLETED|Phase 1b and Phase 2||13
1113104|NCT01185964|2694245|P4|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||0
1113105|NCT01185964|2694246|P3|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||65
1113106|NCT01185964|2694247|P2|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||64
1113107|NCT01185964|2694248|P1|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||15
1113108|NCT01185964|2694245|P4|STARTED|Phase 1b and Phase 2||0
1113109|NCT01185964|2694246|P3|STARTED|Phase 1b and Phase 2||67
1113110|NCT01185964|2694247|P2|STARTED|Phase 1b and Phase 2||66
1113111|NCT01185964|2694248|P1|STARTED|Phase 1b and Phase 2||15
1113112|NCT01186250|2694276|P2|NOT COMPLETED|Overall Study||0
1113113|NCT01186250|2694277|P1|NOT COMPLETED|Overall Study||1
1113114|NCT01186250|2694276|P2|COMPLETED|Overall Study||9
1113115|NCT01186250|2694277|P1|COMPLETED|Overall Study||8
1113116|NCT01186250|2694276|P2|STARTED|Overall Study||9
1113117|NCT01186250|2694277|P1|STARTED|Overall Study||9
1113118|NCT01186406|2694295|P1|NOT COMPLETED|Overall Study||0
1113119|NCT01186406|2694295|P1|COMPLETED|Overall Study||41
1113120|NCT01186406|2694295|P1|STARTED|Overall Study||41
1113121|NCT01186419|2694304|P2|NOT COMPLETED|Overall Study||9
1113122|NCT01186419|2694305|P1|NOT COMPLETED|Overall Study||7
1113123|NCT01186419|2694304|P2|COMPLETED|Overall Study||18
1113124|NCT01186419|2694305|P1|COMPLETED|Overall Study||17
1113125|NCT01186419|2694304|P2|STARTED|Overall Study||27
1113126|NCT01186419|2694305|P1|STARTED|Overall Study||24
1113127|NCT01186458|2694312|P1|NOT COMPLETED|Overall Study||1
1113128|NCT01186458|2694312|P1|COMPLETED|Overall Study||3
1113129|NCT01186458|2694312|P1|STARTED|Overall Study||4
1113130|NCT01186562|2694321|P2|NOT COMPLETED|Overall Study||2
1113131|NCT01186562|2694322|P1|NOT COMPLETED|Overall Study||4
1113132|NCT01186562|2694321|P2|COMPLETED|Overall Study||27
1113133|NCT01186562|2694322|P1|COMPLETED|Overall Study||50
1113134|NCT01186562|2694321|P2|STARTED|Overall Study||29
1113135|NCT01186562|2694322|P1|STARTED|Overall Study||54
1113139|NCT01186705|2694346|P1|NOT COMPLETED|Overall Study||0
1113140|NCT01186705|2694346|P1|COMPLETED|Overall Study||1
1113141|NCT01186705|2694346|P1|STARTED|Overall Study||1
1113142|NCT01186744|2694356|P6|NOT COMPLETED|Overall Study||26
1113143|NCT01186744|2694357|P5|NOT COMPLETED|Overall Study||6
1113144|NCT01186744|2694358|P4|NOT COMPLETED|Overall Study||12
1113145|NCT01186744|2694359|P3|NOT COMPLETED|Overall Study||6
1113146|NCT01186744|2694360|P2|NOT COMPLETED|Overall Study||152
1113147|NCT01186744|2694361|P1|NOT COMPLETED|Overall Study||208
1113148|NCT01186744|2694356|P6|COMPLETED|Overall Study||107
1113149|NCT01186744|2694357|P5|COMPLETED|Overall Study||39
1113150|NCT01186744|2694358|P4|COMPLETED|Overall Study||70
1113151|NCT01186744|2694359|P3|COMPLETED|Overall Study||25
1113152|NCT01186744|2694360|P2|COMPLETED|Overall Study||5
1113153|NCT01186744|2694361|P1|COMPLETED|Overall Study||10
1113154|NCT01186744|2694356|P6|STARTED|Overall Study||133
1113155|NCT01186744|2694357|P5|STARTED|Overall Study||45
1113156|NCT01186744|2694358|P4|STARTED|Overall Study||82
1113157|NCT01186744|2694359|P3|STARTED|Overall Study||31
1113158|NCT01186744|2694360|P2|STARTED|Overall Study||157
1113159|NCT01186744|2694361|P1|STARTED|Overall Study||218
1113160|NCT01186796|2694779|P2|NOT COMPLETED|Overall Study||2
1113161|NCT01186796|2694780|P1|NOT COMPLETED|Overall Study||4
1113162|NCT01186796|2694779|P2|COMPLETED|Overall Study||14
1113163|NCT01186796|2694780|P1|COMPLETED|Overall Study||10
1113164|NCT01186796|2694779|P2|STARTED|Overall Study|1 subject was randomized but withdrew before study interventions.|16
1113165|NCT01186796|2694780|P1|STARTED|Overall Study||14
1113166|NCT01186848|2694794|P1|NOT COMPLETED|Overall Study||8
1113167|NCT01186848|2694794|P1|COMPLETED|Overall Study||22
1113168|NCT01186848|2694794|P1|STARTED|Overall Study||30
1113169|NCT01186939|2694800|P1|NOT COMPLETED|Overall Study||40
1113170|NCT01186939|2694800|P1|COMPLETED|Overall Study||0
1113171|NCT01186939|2694800|P1|STARTED|Overall Study||40
1113172|NCT01187004|2694806|P2|NOT COMPLETED|Overall Study||0
1113173|NCT01187004|2694807|P1|NOT COMPLETED|Overall Study||0
1113174|NCT01187004|2694806|P2|COMPLETED|Overall Study||144
1113175|NCT01187004|2694807|P1|COMPLETED|Overall Study||20
1113176|NCT01187004|2694806|P2|STARTED|Overall Study||144
1113177|NCT01187004|2694807|P1|STARTED|Overall Study||20
1113178|NCT01187017|2694814|P1|NOT COMPLETED|Overall Study||0
1113179|NCT01187017|2694814|P1|COMPLETED|Overall Study||1
1113180|NCT01187017|2694814|P1|STARTED|Overall Study||1
1113181|NCT01187043|2694823|P5|NOT COMPLETED|Overall Study||2
1113182|NCT01187043|2694824|P4|NOT COMPLETED|Overall Study||0
1113183|NCT01187043|2694825|P3|NOT COMPLETED|Overall Study||4
1113184|NCT01187043|2694826|P2|NOT COMPLETED|Overall Study||0
1113185|NCT01187043|2694827|P1|NOT COMPLETED|Overall Study||1
1113186|NCT01187043|2694823|P5|COMPLETED|Overall Study||10
1113187|NCT01187043|2694824|P4|COMPLETED|Overall Study||12
1113188|NCT01187043|2694825|P3|COMPLETED|Overall Study||8
1113189|NCT01187043|2694826|P2|COMPLETED|Overall Study||10
1113190|NCT01187043|2694827|P1|COMPLETED|Overall Study||11
1113191|NCT01187043|2694823|P5|STARTED|Overall Study||12
1113192|NCT01187043|2694824|P4|STARTED|Overall Study||12
1113193|NCT01187043|2694825|P3|STARTED|Overall Study||12
1113194|NCT01187043|2694826|P2|STARTED|Overall Study||10
1113195|NCT01187043|2694827|P1|STARTED|Overall Study||12
1113196|NCT01187355|2694841|P2|NOT COMPLETED|Overall Study||20
1113197|NCT01187355|2694842|P1|NOT COMPLETED|Overall Study||18
1113198|NCT01187355|2694841|P2|COMPLETED|Overall Study||277
1113199|NCT01187355|2694842|P1|COMPLETED|Overall Study||276
1113200|NCT01187355|2694841|P2|STARTED|Overall Study||297
1113201|NCT01187355|2694842|P1|STARTED|Overall Study||294
1113202|NCT01187433|2694854|P2|NOT COMPLETED|Overall Study||4
1113203|NCT01187433|2694855|P1|NOT COMPLETED|Overall Study||11
1113204|NCT01187433|2694854|P2|COMPLETED|Overall Study||46
1113205|NCT01187433|2694855|P1|COMPLETED|Overall Study||89
1113206|NCT01187433|2694854|P2|STARTED|Overall Study||50
1113207|NCT01187433|2694855|P1|STARTED|Overall Study||100
1113208|NCT01187498|2694883|P2|NOT COMPLETED|Overall Study||10
1113209|NCT01187498|2694884|P1|NOT COMPLETED|Overall Study||9
1113210|NCT01187498|2694883|P2|COMPLETED|Overall Study||60
1113211|NCT01187498|2694884|P1|COMPLETED|Overall Study||64
1113212|NCT01187498|2694883|P2|STARTED|Overall Study||70
1113213|NCT01187498|2694884|P1|STARTED|Overall Study||73
1113214|NCT01187511|2694912|P2|NOT COMPLETED|Overall Study||1
1113215|NCT01187511|2694913|P1|NOT COMPLETED|Overall Study||8
1113216|NCT01187511|2694912|P2|COMPLETED|Overall Study||21
1113217|NCT01187511|2694913|P1|COMPLETED|Overall Study||14
1113218|NCT01187511|2694912|P2|STARTED|Overall Study||22
1113219|NCT01187511|2694913|P1|STARTED|Overall Study||22
1113220|NCT01187550|2695021|P2|NOT COMPLETED|Overall Study||1
1113221|NCT01187550|2695022|P1|NOT COMPLETED|Overall Study||14
1113222|NCT01187550|2695021|P2|COMPLETED|Overall Study||29
1113223|NCT01187550|2695022|P1|COMPLETED|Overall Study||169
1113224|NCT01187550|2695021|P2|Treated|Overall Study||30
1113225|NCT01187550|2695022|P1|Treated|Overall Study||175
1113226|NCT01187550|2695021|P2|STARTED|Overall Study||30
1113227|NCT01187550|2695022|P1|STARTED|Overall Study||183
1113228|NCT01187771|2695040|P2|NOT COMPLETED|Overall Study||3
1113229|NCT01187771|2695041|P1|NOT COMPLETED|Overall Study||3
1113230|NCT01187771|2695040|P2|COMPLETED|Overall Study||18
1113231|NCT01187771|2695041|P1|COMPLETED|Overall Study||25
1113232|NCT01187771|2695040|P2|STARTED|Overall Study||21
1113233|NCT01187771|2695041|P1|STARTED|Overall Study||28
1113234|NCT01187901|2695063|P2|NOT COMPLETED|Overall Study||10
1113235|NCT01187901|2695064|P1|NOT COMPLETED|Overall Study||9
1113236|NCT01187901|2695063|P2|COMPLETED|Overall Study||36
1113237|NCT01187901|2695064|P1|COMPLETED|Overall Study||37
1113238|NCT01187901|2695063|P2|STARTED|Overall Study||46
1113239|NCT01187901|2695064|P1|STARTED|Overall Study||46
1113240|NCT01187914|2695080|P1|NOT COMPLETED|Overall Study||0
1113241|NCT01187914|2695080|P1|COMPLETED|Overall Study||40
1113242|NCT01187914|2695080|P1|STARTED|Overall Study||40
1113243|NCT01187953|2695086|P2|NOT COMPLETED|Overall Study||21
1113244|NCT01187953|2695087|P1|NOT COMPLETED|Overall Study||15
1113245|NCT01187953|2695086|P2|COMPLETED|Overall Study||254
1113246|NCT01187953|2695087|P1|COMPLETED|Overall Study||253
1113247|NCT01187953|2695086|P2|Dosed|Overall Study||271
1113248|NCT01187953|2695087|P1|Dosed|Overall Study||266
1113249|NCT01187953|2695086|P2|STARTED|Overall Study||275
1113250|NCT01187953|2695087|P1|STARTED|Overall Study||268
1113251|NCT01188109|2695095|P1|NOT COMPLETED|Overall Study||0
1113252|NCT01188109|2695095|P1|COMPLETED|Overall Study||22
1113253|NCT01188109|2695095|P1|STARTED|Overall Study||22
1113254|NCT01188226|2695100|P1|NOT COMPLETED|Overall Study||4
1113255|NCT01188226|2695100|P1|COMPLETED|Overall Study||6
1113256|NCT01188226|2695100|P1|STARTED|Overall Study||10
1113257|NCT01181726|2695141|P2|NOT COMPLETED|Second Intervention||0
1113258|NCT01181726|2695142|P1|NOT COMPLETED|Second Intervention||0
1113259|NCT01181726|2695141|P2|COMPLETED|Second Intervention||20
1113260|NCT01181726|2695142|P1|COMPLETED|Second Intervention||19
1113261|NCT01181726|2695141|P2|STARTED|Second Intervention||20
1113262|NCT01181726|2695142|P1|STARTED|Second Intervention||19
1113263|NCT01181726|2695141|P2|NOT COMPLETED|Washout of 28 Days||0
1113264|NCT01181726|2695142|P1|NOT COMPLETED|Washout of 28 Days||0
1113265|NCT01181726|2695141|P2|COMPLETED|Washout of 28 Days||20
1113266|NCT01181726|2695142|P1|COMPLETED|Washout of 28 Days||19
1113267|NCT01181726|2695141|P2|STARTED|Washout of 28 Days||20
1113268|NCT01181726|2695142|P1|STARTED|Washout of 28 Days||19
1113269|NCT01181726|2695141|P2|NOT COMPLETED|First Intervention||0
1113270|NCT01181726|2695142|P1|NOT COMPLETED|First Intervention||1
1113271|NCT01181726|2695141|P2|COMPLETED|First Intervention||20
1113272|NCT01181726|2695142|P1|COMPLETED|First Intervention||19
1113273|NCT01181726|2695141|P2|STARTED|First Intervention||20
1113274|NCT01181726|2695142|P1|STARTED|First Intervention||20
1113275|NCT01181778|2695188|P1|NOT COMPLETED|Overall Study||48
1113276|NCT01181778|2695188|P1|COMPLETED|Overall Study||1871
1113277|NCT01181778|2695188|P1|STARTED|Overall Study||1919
1113278|NCT01181804|2695198|P4|NOT COMPLETED|Period 4, Fasted (Part 2)||0
1113279|NCT01181804|2695199|P3|NOT COMPLETED|Period 4, Fasted (Part 2)||1
1113280|NCT01181804|2695200|P2|NOT COMPLETED|Period 4, Fasted (Part 2)||0
1113281|NCT01181804|2695201|P1|NOT COMPLETED|Period 4, Fasted (Part 2)||0
1113282|NCT01181804|2695198|P4|COMPLETED|Period 4, Fasted (Part 2)||58
1113283|NCT01181804|2695199|P3|COMPLETED|Period 4, Fasted (Part 2)||58
1113284|NCT01181804|2695200|P2|COMPLETED|Period 4, Fasted (Part 2)||0
1113285|NCT01181804|2695201|P1|COMPLETED|Period 4, Fasted (Part 2)||0
1113286|NCT01181804|2695198|P4|STARTED|Period 4, Fasted (Part 2)||58
1113287|NCT01181804|2695199|P3|STARTED|Period 4, Fasted (Part 2)||59
1113288|NCT01181804|2695200|P2|STARTED|Period 4, Fasted (Part 2)||0
1113289|NCT01181804|2695201|P1|STARTED|Period 4, Fasted (Part 2)||0
1113290|NCT01181804|2695198|P4|NOT COMPLETED|Period 3, Fasted (Part 2)||0
1113291|NCT01181804|2695199|P3|NOT COMPLETED|Period 3, Fasted (Part 2)||0
1113292|NCT01181804|2695200|P2|NOT COMPLETED|Period 3, Fasted (Part 2)||0
1113293|NCT01181804|2695201|P1|NOT COMPLETED|Period 3, Fasted (Part 2)||0
1113294|NCT01181804|2695198|P4|COMPLETED|Period 3, Fasted (Part 2)||58
1113295|NCT01181804|2695199|P3|COMPLETED|Period 3, Fasted (Part 2)||59
1113296|NCT01181804|2695200|P2|COMPLETED|Period 3, Fasted (Part 2)||0
1113297|NCT01181804|2695201|P1|COMPLETED|Period 3, Fasted (Part 2)||0
1113298|NCT01181804|2695198|P4|STARTED|Period 3, Fasted (Part 2)||58
1113299|NCT01181804|2695199|P3|STARTED|Period 3, Fasted (Part 2)||59
1113300|NCT01181804|2695200|P2|STARTED|Period 3, Fasted (Part 2)||0
1113301|NCT01181804|2695201|P1|STARTED|Period 3, Fasted (Part 2)||0
1113302|NCT01181804|2695198|P4|NOT COMPLETED|Period 2, Fed (Part 1)||0
1113303|NCT01181804|2695199|P3|NOT COMPLETED|Period 2, Fed (Part 1)||0
1113304|NCT01181804|2695200|P2|NOT COMPLETED|Period 2, Fed (Part 1)||0
1113305|NCT01181804|2695201|P1|NOT COMPLETED|Period 2, Fed (Part 1)||0
1113306|NCT01181804|2695198|P4|COMPLETED|Period 2, Fed (Part 1)||0
1113307|NCT01181804|2695199|P3|COMPLETED|Period 2, Fed (Part 1)||0
1113308|NCT01181804|2695200|P2|COMPLETED|Period 2, Fed (Part 1)||30
1113309|NCT01181804|2695201|P1|COMPLETED|Period 2, Fed (Part 1)||30
1113310|NCT01181804|2695198|P4|STARTED|Period 2, Fed (Part 1)||0
1113311|NCT01181804|2695199|P3|STARTED|Period 2, Fed (Part 1)||0
1113312|NCT01181804|2695200|P2|STARTED|Period 2, Fed (Part 1)||30
1113313|NCT01181804|2695201|P1|STARTED|Period 2, Fed (Part 1)||30
1113314|NCT01181804|2695198|P4|NOT COMPLETED|Period 1, Fed (Part 1)||0
1113315|NCT01181804|2695199|P3|NOT COMPLETED|Period 1, Fed (Part 1)||0
1113316|NCT01181804|2695200|P2|NOT COMPLETED|Period 1, Fed (Part 1)||0
1113317|NCT01181804|2695201|P1|NOT COMPLETED|Period 1, Fed (Part 1)||0
1113318|NCT01181804|2695198|P4|COMPLETED|Period 1, Fed (Part 1)||0
1113319|NCT01181804|2695199|P3|COMPLETED|Period 1, Fed (Part 1)||0
1113320|NCT01181804|2695200|P2|COMPLETED|Period 1, Fed (Part 1)||30
1113321|NCT01181804|2695201|P1|COMPLETED|Period 1, Fed (Part 1)||30
1113322|NCT01181804|2695198|P4|STARTED|Period 1, Fed (Part 1)||0
1113323|NCT01181804|2695199|P3|STARTED|Period 1, Fed (Part 1)||0
1113324|NCT01181804|2695200|P2|STARTED|Period 1, Fed (Part 1)||30
1113325|NCT01181804|2695201|P1|STARTED|Period 1, Fed (Part 1)||30
1113326|NCT01181895|2695226|P3|NOT COMPLETED|Overall Study||18
1113327|NCT01181895|2695227|P2|NOT COMPLETED|Overall Study||14
1113328|NCT01181895|2695228|P1|NOT COMPLETED|Overall Study||17
1113329|NCT01181895|2695226|P3|COMPLETED|Overall Study||98
1113330|NCT01181895|2695227|P2|COMPLETED|Overall Study||101
1113331|NCT01181895|2695228|P1|COMPLETED|Overall Study||99
1113332|NCT01181895|2695226|P3|STARTED|Overall Study||116
1113333|NCT01181895|2695227|P2|STARTED|Overall Study||115
1113334|NCT01181895|2695228|P1|STARTED|Overall Study||116
1113335|NCT01181921|2695257|P1|NOT COMPLETED|Overall Study||1
1113336|NCT01181921|2695257|P1|COMPLETED|Overall Study||0
1113337|NCT01181921|2695257|P1|STARTED|Overall Study||1
1113338|NCT01181947|2695261|P1|NOT COMPLETED|Overall Study||0
1113339|NCT01181947|2695261|P1|COMPLETED|Overall Study||100
1113340|NCT01181947|2695261|P1|STARTED|Overall Study||100
1113341|NCT01181986|2695268|P3|NOT COMPLETED|Phase 2||0
1113342|NCT01181986|2695269|P2|NOT COMPLETED|Phase 2||4
1113343|NCT01181986|2695270|P1|NOT COMPLETED|Phase 2||0
1113344|NCT01181986|2695268|P3|COMPLETED|Phase 2||0
1113345|NCT01181986|2695269|P2|COMPLETED|Phase 2||18
1113346|NCT01181986|2695270|P1|COMPLETED|Phase 2||18
1113347|NCT01181986|2695268|P3|STARTED|Phase 2|N/A for Sub-study 2|0
1113348|NCT01181986|2695269|P2|STARTED|Phase 2||22
1113349|NCT01181986|2695270|P1|STARTED|Phase 2||18
1113350|NCT01181986|2695268|P3|NOT COMPLETED|Phase 1||2
1113351|NCT01181986|2695269|P2|NOT COMPLETED|Phase 1||1
1113352|NCT01181986|2695270|P1|NOT COMPLETED|Phase 1||1
1113353|NCT01181986|2695268|P3|COMPLETED|Phase 1||32
1113354|NCT01181986|2695269|P2|COMPLETED|Phase 1||22
1113355|NCT01181986|2695270|P1|COMPLETED|Phase 1||18
1113356|NCT01181986|2695268|P3|Exendin-9+Exenatide|Phase 1||33
1113357|NCT01181986|2695269|P2|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
1113358|NCT01181986|2695270|P1|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
1113359|NCT01181986|2695268|P3|Saline+Placebo|Phase 1||33
1113360|NCT01181986|2695269|P2|Saline+Placebo|Phase 1|N/A for this arm|0
1113361|NCT01181986|2695270|P1|Saline+Placebo|Phase 1|N/A for this arm|0
1113362|NCT01181986|2695268|P3|Saline+Exenatide|Phase 1||32
1113363|NCT01181986|2695269|P2|Saline+Exenatide|Phase 1|N/A for this arm|0
1113364|NCT01181986|2695270|P1|Saline+Exenatide|Phase 1|N/A for this arm|0
1113365|NCT01181986|2695268|P3|STARTED|Phase 1||34
1113366|NCT01181986|2695269|P2|STARTED|Phase 1||23
1113367|NCT01181986|2695270|P1|STARTED|Phase 1||19
1113368|NCT01182103|2695288|P2|NOT COMPLETED|Overall Study||0
1113369|NCT01182103|2695289|P1|NOT COMPLETED|Overall Study||0
1113370|NCT01182103|2695288|P2|COMPLETED|Overall Study||62
1113371|NCT01182103|2695289|P1|COMPLETED|Overall Study||48
1113372|NCT01182103|2695288|P2|STARTED|Overall Study||62
1113373|NCT01182103|2695289|P1|STARTED|Overall Study||48
1113374|NCT01182181|2695303|P2|NOT COMPLETED|Second Intervention||0
1113375|NCT01182181|2695304|P1|NOT COMPLETED|Second Intervention||0
1113376|NCT01182181|2695303|P2|COMPLETED|Second Intervention||10
1113377|NCT01182181|2695304|P1|COMPLETED|Second Intervention||10
1113378|NCT01182181|2695303|P2|STARTED|Second Intervention||10
1113379|NCT01182181|2695304|P1|STARTED|Second Intervention||10
1113380|NCT01182181|2695303|P2|NOT COMPLETED|Washout of 21 Days||1
1113381|NCT01182181|2695304|P1|NOT COMPLETED|Washout of 21 Days||0
1113382|NCT01182181|2695303|P2|COMPLETED|Washout of 21 Days||10
1113383|NCT01182181|2695304|P1|COMPLETED|Washout of 21 Days||10
1113384|NCT01182181|2695303|P2|STARTED|Washout of 21 Days||11
1113385|NCT01182181|2695304|P1|STARTED|Washout of 21 Days||10
1113386|NCT01182181|2695303|P2|NOT COMPLETED|First Intervention||0
1113387|NCT01182181|2695304|P1|NOT COMPLETED|First Intervention||1
1113388|NCT01182181|2695303|P2|COMPLETED|First Intervention||11
1113389|NCT01182181|2695304|P1|COMPLETED|First Intervention||10
1113390|NCT01182181|2695303|P2|STARTED|First Intervention||11
1113391|NCT01182181|2695304|P1|STARTED|First Intervention||11
1113392|NCT01188343|2695315|P3|NOT COMPLETED|Overall Study||1
1113393|NCT01188343|2695316|P2|NOT COMPLETED|Overall Study||26
1113394|NCT01188343|2695317|P1|NOT COMPLETED|Overall Study||1
1113395|NCT01188343|2695315|P3|COMPLETED|Overall Study||220
1113396|NCT01188343|2695316|P2|COMPLETED|Overall Study||193
1113397|NCT01188343|2695317|P1|COMPLETED|Overall Study||101
1113398|NCT01188343|2695315|P3|STARTED|Overall Study||221
1113399|NCT01188343|2695316|P2|STARTED|Overall Study||219
1113400|NCT01188343|2695317|P1|STARTED|Overall Study||102
1113401|NCT01188421|2695346|P3|NOT COMPLETED|Overall Study||14
1113402|NCT01188421|2695347|P2|NOT COMPLETED|Overall Study||10
1113403|NCT01188421|2695348|P1|NOT COMPLETED|Overall Study||3
1113404|NCT01188421|2695346|P3|COMPLETED|Overall Study||22
1113405|NCT01188421|2695347|P2|COMPLETED|Overall Study||26
1113406|NCT01188421|2695348|P1|COMPLETED|Overall Study||28
1113407|NCT01188421|2695346|P3|STARTED|Overall Study||36
1113408|NCT01188421|2695347|P2|STARTED|Overall Study||36
1113409|NCT01188421|2695348|P1|STARTED|Overall Study||31
1113410|NCT01188447|2695356|P1|NOT COMPLETED|Overall Study||0
1113411|NCT01188447|2695356|P1|COMPLETED|Overall Study||4034
1113412|NCT01188447|2695356|P1|STARTED|Overall Study||4034
1113413|NCT01188499|2695369|P5|NOT COMPLETED|Overall Study||0
1113414|NCT01188499|2695370|P4|NOT COMPLETED|Overall Study||0
1113415|NCT01188499|2695371|P3|NOT COMPLETED|Overall Study||0
1113416|NCT01188499|2695372|P2|NOT COMPLETED|Overall Study||0
1113417|NCT01188499|2695373|P1|NOT COMPLETED|Overall Study||0
1113418|NCT01188499|2695369|P5|COMPLETED|Overall Study||18
1113419|NCT01188499|2695370|P4|COMPLETED|Overall Study||18
1113420|NCT01188499|2695371|P3|COMPLETED|Overall Study||33
1113421|NCT01188499|2695372|P2|COMPLETED|Overall Study||83
1113422|NCT01188499|2695373|P1|COMPLETED|Overall Study||24
1113423|NCT01188499|2695369|P5|STARTED|Overall Study||18
1113424|NCT01188499|2695370|P4|STARTED|Overall Study||18
1113425|NCT01188499|2695371|P3|STARTED|Overall Study||33
1113426|NCT01188499|2695372|P2|STARTED|Overall Study||83
1113427|NCT01188499|2695373|P1|STARTED|Overall Study||24
1113428|NCT01188538|2695392|P2|NOT COMPLETED|Overall Study||1
1113429|NCT01188538|2695393|P1|NOT COMPLETED|Overall Study||0
1113430|NCT01188538|2695392|P2|COMPLETED|Overall Study||19
1113431|NCT01188538|2695393|P1|COMPLETED|Overall Study||20
1113432|NCT01188538|2695392|P2|STARTED|Overall Study||20
1113433|NCT01188538|2695393|P1|STARTED|Overall Study||20
1113434|NCT01188551|2695405|P4|NOT COMPLETED|Overall Study||0
1113435|NCT01188551|2695406|P3|NOT COMPLETED|Overall Study||0
1113436|NCT01188551|2695407|P2|NOT COMPLETED|Overall Study||0
1113437|NCT01188551|2695408|P1|NOT COMPLETED|Overall Study||1
1113438|NCT01188551|2695405|P4|COMPLETED|Overall Study||25
1113439|NCT01188551|2695406|P3|COMPLETED|Overall Study||25
1113440|NCT01188551|2695407|P2|COMPLETED|Overall Study||25
1113441|NCT01188551|2695408|P1|COMPLETED|Overall Study||24
1113442|NCT01188551|2695405|P4|STARTED|Overall Study||25
1113443|NCT01188551|2695406|P3|STARTED|Overall Study||25
1113444|NCT01188551|2695407|P2|STARTED|Overall Study||25
1113445|NCT01188551|2695408|P1|STARTED|Overall Study||25
1113446|NCT01188564|2695424|P2|NOT COMPLETED|Open Label Phase||0
1113447|NCT01188564|2695425|P1|NOT COMPLETED|Open Label Phase||0
1113448|NCT01188564|2695424|P2|COMPLETED|Open Label Phase||20
1113449|NCT01188564|2695425|P1|COMPLETED|Open Label Phase||24
1113450|NCT01188564|2695424|P2|STARTED|Open Label Phase|Not all Double Blind Phase participants went on to Open Label Phase|20
1113451|NCT01188564|2695425|P1|STARTED|Open Label Phase|Not all Double-Blind Phase participants went on to Open Label Phase|24
1113452|NCT01188564|2695424|P2|NOT COMPLETED|Double-blind Phase||0
1113453|NCT01188564|2695425|P1|NOT COMPLETED|Double-blind Phase||1
1113454|NCT01188564|2695424|P2|COMPLETED|Double-blind Phase||31
1113455|NCT01188564|2695425|P1|COMPLETED|Double-blind Phase||43
1113456|NCT01188564|2695424|P2|STARTED|Double-blind Phase||31
1113457|NCT01188564|2695425|P1|STARTED|Double-blind Phase||44
1113458|NCT01188577|2695435|P2|NOT COMPLETED|Visit 2||0
1113459|NCT01188577|2695436|P1|NOT COMPLETED|Visit 2||0
1113460|NCT01188577|2695435|P2|COMPLETED|Visit 2||12
1113461|NCT01188577|2695436|P1|COMPLETED|Visit 2||11
1113462|NCT01188577|2695435|P2|STARTED|Visit 2||12
1113463|NCT01188577|2695436|P1|STARTED|Visit 2||11
1113464|NCT01188577|2695435|P2|NOT COMPLETED|3-14 Day Washout||0
1113465|NCT01188577|2695436|P1|NOT COMPLETED|3-14 Day Washout||0
1113466|NCT01188577|2695435|P2|COMPLETED|3-14 Day Washout||12
1113467|NCT01188577|2695436|P1|COMPLETED|3-14 Day Washout||11
1113468|NCT01188577|2695435|P2|STARTED|3-14 Day Washout||12
1113469|NCT01188577|2695436|P1|STARTED|3-14 Day Washout||11
1113470|NCT01188577|2695435|P2|NOT COMPLETED|Visit 1||0
1113471|NCT01188577|2695436|P1|NOT COMPLETED|Visit 1||0
1113472|NCT01188577|2695435|P2|COMPLETED|Visit 1||12
1113473|NCT01188577|2695436|P1|COMPLETED|Visit 1||11
1113474|NCT01188577|2695435|P2|STARTED|Visit 1||12
1113475|NCT01188577|2695436|P1|STARTED|Visit 1||11
1113476|NCT01190254|2695455|P3|NOT COMPLETED|Overall Study||22
1113477|NCT01190254|2695456|P2|NOT COMPLETED|Overall Study||17
1113478|NCT01190254|2695457|P1|NOT COMPLETED|Overall Study||21
1113479|NCT01190254|2695455|P3|COMPLETED|Overall Study||84
1113480|NCT01190254|2695456|P2|COMPLETED|Overall Study||81
1113481|NCT01190254|2695457|P1|COMPLETED|Overall Study||81
1113482|NCT01190254|2695455|P3|Treated|Overall Study||106
1113483|NCT01190254|2695456|P2|Treated|Overall Study||98
1113484|NCT01190254|2695457|P1|Treated|Overall Study||102
1113485|NCT01190254|2695455|P3|STARTED|Overall Study||106
1113486|NCT01190254|2695456|P2|STARTED|Overall Study||98
1113487|NCT01190254|2695457|P1|STARTED|Overall Study||102
1113488|NCT01190267|2695521|P2|NOT COMPLETED|Overall Study||4
1113489|NCT01190267|2695522|P1|NOT COMPLETED|Overall Study||41
1113490|NCT01190267|2695521|P2|COMPLETED|Overall Study||4
1113491|NCT01190267|2695522|P1|COMPLETED|Overall Study||155
1113492|NCT01190267|2695521|P2|STARTED|Overall Study||8
1113493|NCT01190267|2695522|P1|STARTED|Overall Study||196
1113494|NCT01190306|2695532|P2|NOT COMPLETED|Overall Study||0
1113495|NCT01190306|2695533|P1|NOT COMPLETED|Overall Study||0
1113496|NCT01190306|2695532|P2|COMPLETED|Overall Study||66
1113497|NCT01190306|2695533|P1|COMPLETED|Overall Study||61
1113498|NCT01190306|2695532|P2|STARTED|Overall Study||66
1113499|NCT01190306|2695533|P1|STARTED|Overall Study||61
1113500|NCT01190436|2695539|P1|NOT COMPLETED|Overall Study||39
1113501|NCT01190436|2695539|P1|COMPLETED|Overall Study||86
1113502|NCT01190436|2695539|P1|STARTED|Overall Study||125
1113503|NCT01190514|2695553|P4|NOT COMPLETED|Fourth Intervention (Period 4)||0
1113504|NCT01190514|2695554|P3|NOT COMPLETED|Fourth Intervention (Period 4)||0
1113505|NCT01190514|2695555|P2|NOT COMPLETED|Fourth Intervention (Period 4)||0
1113506|NCT01190514|2695556|P1|NOT COMPLETED|Fourth Intervention (Period 4)||0
1113507|NCT01190514|2695553|P4|COMPLETED|Fourth Intervention (Period 4)||10
1113508|NCT01190514|2695554|P3|COMPLETED|Fourth Intervention (Period 4)||10
1113509|NCT01190514|2695555|P2|COMPLETED|Fourth Intervention (Period 4)||10
1113510|NCT01190514|2695556|P1|COMPLETED|Fourth Intervention (Period 4)||9
1113511|NCT01190514|2695553|P4|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment A|10
1113512|NCT01190514|2695554|P3|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment B|10
1113513|NCT01190514|2695555|P2|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment C|10
1113514|NCT01190514|2695556|P1|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment D|9
1113515|NCT01190514|2695553|P4|NOT COMPLETED|Third Intervention (Period 3)||0
1113516|NCT01190514|2695554|P3|NOT COMPLETED|Third Intervention (Period 3)||0
1113517|NCT01190514|2695555|P2|NOT COMPLETED|Third Intervention (Period 3)||0
1113518|NCT01190514|2695556|P1|NOT COMPLETED|Third Intervention (Period 3)||1
1113519|NCT01190514|2695553|P4|COMPLETED|Third Intervention (Period 3)||10
1113520|NCT01190514|2695554|P3|COMPLETED|Third Intervention (Period 3)||10
1113521|NCT01190514|2695555|P2|COMPLETED|Third Intervention (Period 3)||10
1113522|NCT01190514|2695556|P1|COMPLETED|Third Intervention (Period 3)|Discontinued participant received treatments ABC of sequence ABCD.|9
1113523|NCT01190514|2695553|P4|STARTED|Third Intervention (Period 3)|Period 3 received treatment B|10
1113524|NCT01190514|2695554|P3|STARTED|Third Intervention (Period 3)|Period 3 received treatment A|10
1113525|NCT01190514|2695555|P2|STARTED|Third Intervention (Period 3)|Period 3 received treatment D|10
1113526|NCT01190514|2695556|P1|STARTED|Third Intervention (Period 3)|Period 3 received treatment C|10
1113527|NCT01190514|2695553|P4|NOT COMPLETED|Second Intervention (Period 2)||0
1113528|NCT01190514|2695554|P3|NOT COMPLETED|Second Intervention (Period 2)||0
1113529|NCT01190514|2695555|P2|NOT COMPLETED|Second Intervention (Period 2)||0
1113530|NCT01190514|2695556|P1|NOT COMPLETED|Second Intervention (Period 2)||0
1113531|NCT01190514|2695553|P4|COMPLETED|Second Intervention (Period 2)||10
1113532|NCT01190514|2695554|P3|COMPLETED|Second Intervention (Period 2)||10
1113533|NCT01190514|2695555|P2|COMPLETED|Second Intervention (Period 2)||10
1113534|NCT01190514|2695556|P1|COMPLETED|Second Intervention (Period 2)||10
1113535|NCT01190514|2695553|P4|STARTED|Second Intervention (Period 2)|Period 2 received treatment C|10
1113536|NCT01190514|2695554|P3|STARTED|Second Intervention (Period 2)|Period 2 received treatment D|10
1113537|NCT01190514|2695555|P2|STARTED|Second Intervention (Period 2)|Period 2 received treatment A|10
1113538|NCT01190514|2695556|P1|STARTED|Second Intervention (Period 2)|Period 2 received treatment B|10
1113539|NCT01190514|2695553|P4|NOT COMPLETED|First Intervention (Period 1)||0
1113540|NCT01190514|2695554|P3|NOT COMPLETED|First Intervention (Period 1)||0
1113541|NCT01190514|2695555|P2|NOT COMPLETED|First Intervention (Period 1)||0
1113542|NCT01190514|2695556|P1|NOT COMPLETED|First Intervention (Period 1)||1
1113543|NCT01190514|2695553|P4|COMPLETED|First Intervention (Period 1)||10
1113544|NCT01190514|2695554|P3|COMPLETED|First Intervention (Period 1)||10
1113545|NCT01190514|2695555|P2|COMPLETED|First Intervention (Period 1)||10
1113546|NCT01190514|2695556|P1|COMPLETED|First Intervention (Period 1)|Discontinued participant received treatment A of sequence ABCD.|10
1113547|NCT01190514|2695553|P4|STARTED|First Intervention (Period 1)||10
1113548|NCT01190514|2695554|P3|STARTED|First Intervention (Period 1)||10
1113549|NCT01190514|2695555|P2|STARTED|First Intervention (Period 1)||10
1113550|NCT01190514|2695556|P1|STARTED|First Intervention (Period 1)||11
1113551|NCT01190527|2695586|P1|NOT COMPLETED|Overall Study||0
1113552|NCT01190527|2695586|P1|COMPLETED|Overall Study||42
1113553|NCT01190527|2695586|P1|STARTED|Overall Study||42
1113554|NCT01190566|2695595|P2|NOT COMPLETED|Overall Study||0
1113555|NCT01190566|2695596|P1|NOT COMPLETED|Overall Study||0
1113556|NCT01190566|2695595|P2|COMPLETED|Overall Study||42
1113557|NCT01190566|2695596|P1|COMPLETED|Overall Study||6
1113558|NCT01190566|2695595|P2|STARTED|Overall Study||42
1113559|NCT01190566|2695596|P1|STARTED|Overall Study||6
1113560|NCT01190813|2695619|P2|NOT COMPLETED|Overall Study||4
1113561|NCT01190813|2695620|P1|NOT COMPLETED|Overall Study||4
1113562|NCT01190813|2695619|P2|COMPLETED|Overall Study||45
1113563|NCT01190813|2695620|P1|COMPLETED|Overall Study||86
1113564|NCT01190813|2695619|P2|26-week Visit|Overall Study|0 missed, 0 dropped|45
1113565|NCT01190813|2695620|P1|26-week Visit|Overall Study|0 missed, 0 dropped|86
1113566|NCT01190813|2695619|P2|23-week Phone Call|Overall Study|4 missed, 0 dropped|41
1113567|NCT01190813|2695620|P1|23-week Phone Call|Overall Study|4 missed, 1 dropped|82
1113568|NCT01190813|2695619|P2|18-week Visit (Masked Primary)|Overall Study|1 dropped|45
1113569|NCT01190813|2695620|P1|18-week Visit (Masked Primary)|Overall Study|0 dropped|87
1113570|NCT01190813|2695619|P2|16-week Visit|Overall Study|2 dropped|46
1113571|NCT01190813|2695620|P1|16-week Visit|Overall Study|1 dropped|87
1113572|NCT01190813|2695619|P2|13-week Phone Call|Overall Study|0 dropped, 0 missed|48
1113573|NCT01190813|2695620|P1|13-week Phone Call|Overall Study|6 missed, 0 dropped|82
1113574|NCT01190813|2695619|P2|10-week Visit|Overall Study|0 dropped, 0 missed|48
1113575|NCT01190813|2695620|P1|10-week Visit|Overall Study|0 missed, 0 dropped|88
1113576|NCT01190813|2695619|P2|7-week Phone Call|Overall Study|2 missed, 0 dropped|46
1113577|NCT01190813|2695620|P1|7-week Phone Call|Overall Study|3 missed, 0 dropped|85
1113578|NCT01190813|2695619|P2|4-week Visit|Overall Study|1 missed, 1 dropped|47
1113579|NCT01190813|2695620|P1|4-week Visit|Overall Study|0 missed, 1 dropped|88
1113580|NCT01190813|2695619|P2|2-week Phone Call|Overall Study|1 missed, 0 dropped|48
1113581|NCT01190813|2695620|P1|2-week Phone Call|Overall Study|2 missed, 1 dropped|87
1113582|NCT01190813|2695619|P2|STARTED|Overall Study||49
1113583|NCT01190813|2695620|P1|STARTED|Overall Study||90
1113584|NCT01190839|2695712|P2|NOT COMPLETED|Overall Study||147
1113585|NCT01190839|2695713|P1|NOT COMPLETED|Overall Study||150
1113586|NCT01190839|2695712|P2|COMPLETED|Overall Study||0
1113587|NCT01190839|2695713|P1|COMPLETED|Overall Study||0
1113588|NCT01190839|2695712|P2|Treated|Overall Study||143
1113589|NCT01190839|2695713|P1|Treated|Overall Study||148
1113590|NCT01190839|2695712|P2|STARTED|Overall Study||147
1113591|NCT01190839|2695713|P1|STARTED|Overall Study||150
1113592|NCT01190865|2695725|P1|NOT COMPLETED|Overall Study||3
1113593|NCT01190865|2695725|P1|COMPLETED|Overall Study||25
1113594|NCT01190865|2695725|P1|STARTED|Overall Study||28
1113595|NCT01190878|2695734|P4|NOT COMPLETED|Overall Study||20
1113596|NCT01190878|2695735|P3|NOT COMPLETED|Overall Study||5
1113597|NCT01190878|2695736|P2|NOT COMPLETED|Overall Study||3
1113598|NCT01190878|2695737|P1|NOT COMPLETED|Overall Study||3
1113599|NCT01190878|2695734|P4|COMPLETED|Overall Study||22
1113600|NCT01190878|2695735|P3|COMPLETED|Overall Study||37
1113601|NCT01190878|2695736|P2|COMPLETED|Overall Study||42
1113602|NCT01190878|2695737|P1|COMPLETED|Overall Study||37
1113603|NCT01190878|2695734|P4|STARTED|Overall Study||42
1113604|NCT01190878|2695735|P3|STARTED|Overall Study||42
1113605|NCT01190878|2695736|P2|STARTED|Overall Study||45
1113606|NCT01190878|2695737|P1|STARTED|Overall Study||40
1113607|NCT01190891|2695749|P2|NOT COMPLETED|Overall Study||0
1113608|NCT01190891|2695750|P1|NOT COMPLETED|Overall Study||6
1113609|NCT01190891|2695749|P2|COMPLETED|Overall Study||52
1113610|NCT01190891|2695750|P1|COMPLETED|Overall Study||46
1113611|NCT01190891|2695749|P2|STARTED|Overall Study||52
1113612|NCT01190891|2695750|P1|STARTED|Overall Study||52
1113613|NCT01191008|2695758|P1|NOT COMPLETED|Overall Study||15
1113614|NCT01191008|2695758|P1|COMPLETED|Overall Study||618
1113615|NCT01191008|2695758|P1|STARTED|Overall Study||633
1113616|NCT01191086|2695764|P1|NOT COMPLETED|Overall Study||62
1113617|NCT01191086|2695764|P1|COMPLETED|Overall Study||148
1113618|NCT01191086|2695764|P1|STARTED|Overall Study||210
1113619|NCT01191190|2695768|P1|NOT COMPLETED|Overall Study||1
1113620|NCT01191190|2695768|P1|COMPLETED|Overall Study||20
1113621|NCT01191190|2695768|P1|STARTED|Overall Study||21
1113622|NCT01191242|2695781|P1|NOT COMPLETED|Overall Study||0
1113623|NCT01191242|2695781|P1|COMPLETED|Overall Study||31
1113624|NCT01191242|2695781|P1|STARTED|Overall Study||31
1113625|NCT01191255|2695800|P4|NOT COMPLETED|Efficacy Assessment Period||6
1113626|NCT01191255|2695801|P3|NOT COMPLETED|Efficacy Assessment Period||26
1113627|NCT01191255|2695802|P2|NOT COMPLETED|Efficacy Assessment Period||0
1113628|NCT01191255|2695803|P1|NOT COMPLETED|Efficacy Assessment Period||0
1113629|NCT01191255|2695800|P4|COMPLETED|Efficacy Assessment Period||90
1113630|NCT01191255|2695801|P3|COMPLETED|Efficacy Assessment Period||70
1113631|NCT01191255|2695802|P2|COMPLETED|Efficacy Assessment Period||0
1113632|NCT01191255|2695803|P1|COMPLETED|Efficacy Assessment Period||0
1113633|NCT01191255|2695800|P4|STARTED|Efficacy Assessment Period||96
1113634|NCT01191255|2695801|P3|STARTED|Efficacy Assessment Period||96
1113635|NCT01191255|2695802|P2|STARTED|Efficacy Assessment Period||0
1113636|NCT01191255|2695803|P1|STARTED|Efficacy Assessment Period||0
1113637|NCT01191255|2695800|P4|NOT COMPLETED|Safety Assessment Period||0
1113638|NCT01191255|2695801|P3|NOT COMPLETED|Safety Assessment Period||0
1113639|NCT01191255|2695802|P2|NOT COMPLETED|Safety Assessment Period||99
1113640|NCT01191255|2695803|P1|NOT COMPLETED|Safety Assessment Period||38
1113641|NCT01191255|2695800|P4|COMPLETED|Safety Assessment Period||0
1113642|NCT01191255|2695801|P3|COMPLETED|Safety Assessment Period||0
1113643|NCT01191255|2695802|P2|COMPLETED|Safety Assessment Period||193
1113644|NCT01191255|2695803|P1|COMPLETED|Safety Assessment Period||111
1113645|NCT01191255|2695800|P4|Safety Population|Safety Assessment Period||0
1113646|NCT01191255|2695801|P3|Safety Population|Safety Assessment Period||0
1113647|NCT01191255|2695802|P2|Safety Population|Safety Assessment Period||289
1113648|NCT01191255|2695803|P1|Safety Population|Safety Assessment Period||149
1113649|NCT01191255|2695800|P4|STARTED|Safety Assessment Period||0
1113650|NCT01191255|2695801|P3|STARTED|Safety Assessment Period||0
1113651|NCT01191255|2695802|P2|STARTED|Safety Assessment Period||292
1113652|NCT01191255|2695803|P1|STARTED|Safety Assessment Period|3 subjects were assigned to receive KRX-0502 but didn't receive a single dose|149
1113653|NCT01191268|2695832|P3|NOT COMPLETED|Overall Study||52
1113654|NCT01191268|2695833|P2|NOT COMPLETED|Overall Study||55
1113655|NCT01191268|2695834|P1|NOT COMPLETED|Overall Study||58
1113656|NCT01191268|2695832|P3|COMPLETED|Overall Study||244
1113657|NCT01191268|2695833|P2|COMPLETED|Overall Study||238
1113658|NCT01191268|2695834|P1|COMPLETED|Overall Study||237
1113659|NCT01191268|2695832|P3|Received at Least One Dose of Study Drug|Overall Study||296
1113660|NCT01191268|2695833|P2|Received at Least One Dose of Study Drug|Overall Study||293
1113661|NCT01191268|2695834|P1|Received at Least One Dose of Study Drug|Overall Study||295
1113662|NCT01191268|2695832|P3|STARTED|Overall Study||296
1113663|NCT01191268|2695833|P2|STARTED|Overall Study||293
1113664|NCT01191268|2695834|P1|STARTED|Overall Study||295
1113665|NCT01191320|2695930|P3|NOT COMPLETED|Overall Study||7
1113666|NCT01191320|2695931|P2|NOT COMPLETED|Overall Study||6
1113667|NCT01191320|2695932|P1|NOT COMPLETED|Overall Study||7
1113668|NCT01191320|2695930|P3|COMPLETED|Overall Study||31
1113669|NCT01191320|2695931|P2|COMPLETED|Overall Study||32
1113670|NCT01191320|2695932|P1|COMPLETED|Overall Study||36
1113671|NCT01191320|2695930|P3|STARTED|Overall Study||38
1113672|NCT01191320|2695931|P2|STARTED|Overall Study||38
1113673|NCT01191320|2695932|P1|STARTED|Overall Study||43
1113674|NCT01191398|2695943|P3|NOT COMPLETED|Overall Study||0
1113675|NCT01191398|2695944|P2|NOT COMPLETED|Overall Study||0
1113676|NCT01191398|2695945|P1|NOT COMPLETED|Overall Study||0
1113677|NCT01191398|2695943|P3|COMPLETED|Overall Study||18
1113678|NCT01191398|2695944|P2|COMPLETED|Overall Study||17
1113679|NCT01191398|2695945|P1|COMPLETED|Overall Study||17
1113680|NCT01191398|2695943|P3|STARTED|Overall Study||18
1113681|NCT01191398|2695944|P2|STARTED|Overall Study||17
1113682|NCT01191398|2695945|P1|STARTED|Overall Study||17
1113683|NCT01191411|2695959|P3|NOT COMPLETED|Overall Study||3427
1113684|NCT01191411|2695960|P2|NOT COMPLETED|Overall Study||361
1113685|NCT01191411|2695961|P1|NOT COMPLETED|Overall Study||945
1113686|NCT01191411|2695959|P3|COMPLETED|Overall Study||471
1113687|NCT01191411|2695960|P2|COMPLETED|Overall Study||118
1113688|NCT01191411|2695961|P1|COMPLETED|Overall Study||648
1113689|NCT01191411|2695959|P3|STARTED|Overall Study||3898
1113690|NCT01191411|2695960|P2|STARTED|Overall Study||479
1113691|NCT01191411|2695961|P1|STARTED|Overall Study||1593
1113692|NCT01191476|2695972|P3|NOT COMPLETED|Overall Study||0
1113693|NCT01191476|2695973|P2|NOT COMPLETED|Overall Study||4
1113694|NCT01191476|2695974|P1|NOT COMPLETED|Overall Study||3
1113695|NCT01191476|2695972|P3|COMPLETED|Overall Study||111
1113696|NCT01191476|2695973|P2|COMPLETED|Overall Study||107
1113697|NCT01191476|2695974|P1|COMPLETED|Overall Study||109
1113698|NCT01191476|2695972|P3|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
1113699|NCT01191476|2695973|P2|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
1113700|NCT01191476|2695974|P1|STARTED|Overall Study||112
1113701|NCT01191723|2695994|P6|NOT COMPLETED|Overall Study||0
1113702|NCT01191723|2695995|P5|NOT COMPLETED|Overall Study||0
1113703|NCT01191723|2695996|P4|NOT COMPLETED|Overall Study||0
1113704|NCT01191723|2695997|P3|NOT COMPLETED|Overall Study||0
1113705|NCT01191723|2695998|P2|NOT COMPLETED|Overall Study||0
1113706|NCT01191723|2695999|P1|NOT COMPLETED|Overall Study||0
1113707|NCT01191723|2695994|P6|COMPLETED|Overall Study||9
1113708|NCT01191723|2695995|P5|COMPLETED|Overall Study||9
1113709|NCT01191723|2695996|P4|COMPLETED|Overall Study||9
1113710|NCT01191723|2695997|P3|COMPLETED|Overall Study||9
1113711|NCT01191723|2695998|P2|COMPLETED|Overall Study||9
1113712|NCT01191723|2695999|P1|COMPLETED|Overall Study||9
1113713|NCT01191723|2695994|P6|STARTED|Overall Study||9
1113714|NCT01191723|2695995|P5|STARTED|Overall Study||9
1113715|NCT01191723|2695996|P4|STARTED|Overall Study||9
1113716|NCT01191723|2695997|P3|STARTED|Overall Study||9
1113717|NCT01191723|2695998|P2|STARTED|Overall Study||9
1113718|NCT01191723|2695999|P1|STARTED|Overall Study||9
1113719|NCT01191736|2696024|P7|NOT COMPLETED|Overall Study||0
1113720|NCT01191736|2696025|P6|NOT COMPLETED|Overall Study||0
1113721|NCT01191736|2696026|P5|NOT COMPLETED|Overall Study||0
1113722|NCT01191736|2696027|P4|NOT COMPLETED|Overall Study||0
1113723|NCT01191736|2696028|P3|NOT COMPLETED|Overall Study||0
1113724|NCT01191736|2696029|P2|NOT COMPLETED|Overall Study||0
1113725|NCT01191736|2696030|P1|NOT COMPLETED|Overall Study||0
1113726|NCT01191736|2696024|P7|COMPLETED|Overall Study||45
1113727|NCT01191736|2696025|P6|COMPLETED|Overall Study||50
1113728|NCT01191736|2696026|P5|COMPLETED|Overall Study||48
1113729|NCT01191736|2696027|P4|COMPLETED|Overall Study||46
1113730|NCT01191736|2696028|P3|COMPLETED|Overall Study||49
1113731|NCT01191736|2696029|P2|COMPLETED|Overall Study||47
1113732|NCT01191736|2696030|P1|COMPLETED|Overall Study||51
1113733|NCT01191736|2696024|P7|STARTED|Overall Study||45
1113734|NCT01191736|2696025|P6|STARTED|Overall Study||50
1113735|NCT01191736|2696026|P5|STARTED|Overall Study||48
1113736|NCT01191736|2696027|P4|STARTED|Overall Study||46
1113737|NCT01191736|2696028|P3|STARTED|Overall Study||49
1113738|NCT01191736|2696029|P2|STARTED|Overall Study||47
1113739|NCT01191736|2696030|P1|STARTED|Overall Study||51
1113740|NCT01191749|2696053|P1|NOT COMPLETED|Overall Study||0
1113741|NCT01191749|2696053|P1|COMPLETED|Overall Study||7
1113742|NCT01191749|2696053|P1|STARTED|Overall Study||7
1113743|NCT01191762|2696059|P2|NOT COMPLETED|Overall Study||0
1113744|NCT01191762|2696060|P1|NOT COMPLETED|Overall Study||1
1113745|NCT01191762|2696059|P2|COMPLETED|Overall Study||15
1113746|NCT01191762|2696060|P1|COMPLETED|Overall Study|One subject dropped out on the 3rd treatment day because of gastrointestinal complaints.|14
1113747|NCT01191762|2696059|P2|STARTED|Overall Study||15
1113748|NCT01191762|2696060|P1|STARTED|Overall Study||15
1113749|NCT01191788|2696068|P2|NOT COMPLETED|Overall Study||22
1113750|NCT01191788|2696069|P1|NOT COMPLETED|Overall Study||21
1113751|NCT01191788|2696068|P2|COMPLETED|Overall Study|Completed 3-month followup|137
1113752|NCT01191788|2696069|P1|COMPLETED|Overall Study|Completed 3-month followup|119
1113753|NCT01191788|2696068|P2|STARTED|Overall Study||159
1113754|NCT01191788|2696069|P1|STARTED|Overall Study||140
1113755|NCT01191801|2696079|P2|NOT COMPLETED|Overall Study||337
1113756|NCT01191801|2696080|P1|NOT COMPLETED|Overall Study||316
1113757|NCT01191801|2696079|P2|COMPLETED|Overall Study||18
1113758|NCT01191801|2696080|P1|COMPLETED|Overall Study||40
1113759|NCT01191801|2696079|P2|STARTED|Overall Study||355
1113760|NCT01191801|2696080|P1|STARTED|Overall Study||356
1113761|NCT01191827|2696100|P2|NOT COMPLETED|Overall Study||0
1113762|NCT01191827|2696101|P1|NOT COMPLETED|Overall Study||0
1113763|NCT01191827|2696100|P2|COMPLETED|Overall Study||20
1113764|NCT01191827|2696101|P1|COMPLETED|Overall Study||20
1113765|NCT01191827|2696100|P2|STARTED|Overall Study||20
1113766|NCT01191827|2696101|P1|STARTED|Overall Study||20
1113767|NCT01191944|2696109|P2|NOT COMPLETED|Overall Study||19
1113768|NCT01191944|2696110|P1|NOT COMPLETED|Overall Study||17
1113769|NCT01191944|2696109|P2|COMPLETED|Overall Study|Completed titration/maintenance|220
1113770|NCT01191944|2696110|P1|COMPLETED|Overall Study|Completed titration/maintenance|217
1113771|NCT01191944|2696109|P2|STARTED|Overall Study|Treated titration/maintenance|239
1113772|NCT01191944|2696110|P1|STARTED|Overall Study|Treated titration/maintenance|234
1113773|NCT01192022|2696158|P5|NOT COMPLETED|Overall Study||1
1113774|NCT01192022|2696159|P4|NOT COMPLETED|Overall Study||2
1113775|NCT01192022|2696160|P3|NOT COMPLETED|Overall Study||1
1113776|NCT01192022|2696161|P2|NOT COMPLETED|Overall Study||11
1113777|NCT01192022|2696162|P1|NOT COMPLETED|Overall Study||13
1113778|NCT01192022|2696158|P5|COMPLETED|Overall Study||11
1113779|NCT01192022|2696159|P4|COMPLETED|Overall Study||7
1113780|NCT01192022|2696160|P3|COMPLETED|Overall Study||7
1113781|NCT01192022|2696161|P2|COMPLETED|Overall Study||99
1113782|NCT01192022|2696162|P1|COMPLETED|Overall Study||101
1113783|NCT01192022|2696158|P5|Safety Population-Received Treatment|Overall Study||12
1113784|NCT01192022|2696159|P4|Safety Population-Received Treatment|Overall Study||9
1113785|NCT01192022|2696160|P3|Safety Population-Received Treatment|Overall Study||8
1113786|NCT01192022|2696161|P2|Safety Population-Received Treatment|Overall Study||109
1113787|NCT01192022|2696162|P1|Safety Population-Received Treatment|Overall Study||114
1113788|NCT01192022|2696158|P5|STARTED|Overall Study||12
1113789|NCT01192022|2696159|P4|STARTED|Overall Study||9
1113790|NCT01192022|2696160|P3|STARTED|Overall Study||8
1113791|NCT01192022|2696161|P2|STARTED|Overall Study||110
1113792|NCT01192022|2696162|P1|STARTED|Overall Study||114
1113793|NCT01192126|2696183|P2|NOT COMPLETED|Second Intervention (1 Week)||0
1113794|NCT01192126|2696184|P1|NOT COMPLETED|Second Intervention (1 Week)||0
1113795|NCT01192126|2696183|P2|COMPLETED|Second Intervention (1 Week)||50
1113796|NCT01192126|2696184|P1|COMPLETED|Second Intervention (1 Week)||49
1113797|NCT01192126|2696183|P2|STARTED|Second Intervention (1 Week)||50
1113798|NCT01192126|2696184|P1|STARTED|Second Intervention (1 Week)||49
1113799|NCT01192126|2696183|P2|NOT COMPLETED|First Intervention (1 Week)||1
1113800|NCT01192126|2696184|P1|NOT COMPLETED|First Intervention (1 Week)||2
1113801|NCT01192126|2696183|P2|COMPLETED|First Intervention (1 Week)||50
1113802|NCT01192126|2696184|P1|COMPLETED|First Intervention (1 Week)||49
1113803|NCT01192126|2696183|P2|STARTED|First Intervention (1 Week)||51
1113804|NCT01192126|2696184|P1|STARTED|First Intervention (1 Week)||51
1113805|NCT01192139|2696192|P6|NOT COMPLETED|Period 3||0
1113806|NCT01192139|2696193|P5|NOT COMPLETED|Period 3||0
1113807|NCT01192139|2696194|P4|NOT COMPLETED|Period 3||0
1113808|NCT01192139|2696195|P3|NOT COMPLETED|Period 3||0
1113809|NCT01192139|2696196|P2|NOT COMPLETED|Period 3||0
1113810|NCT01192139|2696197|P1|NOT COMPLETED|Period 3||0
1113811|NCT01192139|2696192|P6|COMPLETED|Period 3||5
1113812|NCT01192139|2696193|P5|COMPLETED|Period 3||5
1113813|NCT01192139|2696194|P4|COMPLETED|Period 3||5
1113814|NCT01192139|2696195|P3|COMPLETED|Period 3||5
1113815|NCT01192139|2696196|P2|COMPLETED|Period 3||5
1113816|NCT01192139|2696197|P1|COMPLETED|Period 3||5
1113817|NCT01192139|2696192|P6|STARTED|Period 3||5
1113818|NCT01192139|2696193|P5|STARTED|Period 3||5
1113819|NCT01192139|2696194|P4|STARTED|Period 3||5
1113820|NCT01192139|2696195|P3|STARTED|Period 3||5
1113821|NCT01192139|2696196|P2|STARTED|Period 3||5
1113822|NCT01192139|2696197|P1|STARTED|Period 3||5
1113823|NCT01192139|2696192|P6|NOT COMPLETED|Period 2||0
1113824|NCT01192139|2696193|P5|NOT COMPLETED|Period 2||0
1113825|NCT01192139|2696194|P4|NOT COMPLETED|Period 2||0
1113826|NCT01192139|2696195|P3|NOT COMPLETED|Period 2||0
1113827|NCT01192139|2696196|P2|NOT COMPLETED|Period 2||0
1113828|NCT01192139|2696197|P1|NOT COMPLETED|Period 2||0
1113829|NCT01192139|2696192|P6|COMPLETED|Period 2||5
1113830|NCT01192139|2696193|P5|COMPLETED|Period 2||5
1113831|NCT01192139|2696194|P4|COMPLETED|Period 2||5
1113832|NCT01192139|2696195|P3|COMPLETED|Period 2||5
1113833|NCT01192139|2696196|P2|COMPLETED|Period 2||5
1113834|NCT01192139|2696197|P1|COMPLETED|Period 2||5
1113835|NCT01192139|2696192|P6|STARTED|Period 2||5
1113836|NCT01192139|2696193|P5|STARTED|Period 2||5
1113837|NCT01192139|2696194|P4|STARTED|Period 2||5
1113838|NCT01192139|2696195|P3|STARTED|Period 2||5
1113839|NCT01192139|2696196|P2|STARTED|Period 2||5
1113840|NCT01192139|2696197|P1|STARTED|Period 2||5
1113841|NCT01192139|2696192|P6|NOT COMPLETED|Period 1||0
1113842|NCT01192139|2696193|P5|NOT COMPLETED|Period 1||0
1113843|NCT01192139|2696194|P4|NOT COMPLETED|Period 1||0
1113844|NCT01192139|2696195|P3|NOT COMPLETED|Period 1||0
1113845|NCT01192139|2696196|P2|NOT COMPLETED|Period 1||0
1113846|NCT01192139|2696197|P1|NOT COMPLETED|Period 1||0
1113847|NCT01192139|2696192|P6|COMPLETED|Period 1||5
1113848|NCT01192139|2696193|P5|COMPLETED|Period 1||5
1113849|NCT01192139|2696194|P4|COMPLETED|Period 1||5
1113850|NCT01192139|2696195|P3|COMPLETED|Period 1||5
1113851|NCT01192139|2696196|P2|COMPLETED|Period 1||5
1113852|NCT01192139|2696197|P1|COMPLETED|Period 1||5
1113853|NCT01192139|2696192|P6|STARTED|Period 1||5
1113854|NCT01192139|2696193|P5|STARTED|Period 1||5
1113855|NCT01192139|2696194|P4|STARTED|Period 1||5
1113856|NCT01192139|2696195|P3|STARTED|Period 1||5
1113857|NCT01192139|2696196|P2|STARTED|Period 1||5
1113858|NCT01192139|2696197|P1|STARTED|Period 1||5
1113859|NCT01192152|2696262|P2|NOT COMPLETED|Period 3||0
1113860|NCT01192152|2696263|P1|NOT COMPLETED|Period 3||1
1113861|NCT01192152|2696262|P2|COMPLETED|Period 3||0
1113862|NCT01192152|2696263|P1|COMPLETED|Period 3||14
1113863|NCT01192152|2696262|P2|STARTED|Period 3||0
1113864|NCT01192152|2696263|P1|STARTED|Period 3||15
1113865|NCT01192152|2696262|P2|NOT COMPLETED|Period 2||0
1113866|NCT01192152|2696263|P1|NOT COMPLETED|Period 2||0
1113867|NCT01192152|2696262|P2|COMPLETED|Period 2||14
1113868|NCT01192152|2696263|P1|COMPLETED|Period 2||15
1113869|NCT01192152|2696262|P2|STARTED|Period 2||14
1113870|NCT01192152|2696263|P1|STARTED|Period 2||15
1113871|NCT01192152|2696262|P2|NOT COMPLETED|Period 1||1
1113872|NCT01192152|2696263|P1|NOT COMPLETED|Period 1||0
1113873|NCT01192152|2696262|P2|COMPLETED|Period 1||14
1113874|NCT01192152|2696263|P1|COMPLETED|Period 1||15
1113875|NCT01192152|2696262|P2|STARTED|Period 1||15
1113876|NCT01192152|2696263|P1|STARTED|Period 1||15
1113877|NCT01192178|2696366|P2|NOT COMPLETED|Overall Study||23
1113878|NCT01192178|2696367|P1|NOT COMPLETED|Overall Study||24
1113879|NCT01192178|2696366|P2|COMPLETED|Overall Study||145
1113880|NCT01192178|2696367|P1|COMPLETED|Overall Study||147
1113881|NCT01192178|2696366|P2|STARTED|Overall Study||168
1113882|NCT01192178|2696367|P1|STARTED|Overall Study||171
1113883|NCT01192191|2696389|P2|NOT COMPLETED|Overall Study||21
1113884|NCT01192191|2696390|P1|NOT COMPLETED|Overall Study||11
1113885|NCT01192191|2696389|P2|COMPLETED|Overall Study||106
1113886|NCT01192191|2696390|P1|COMPLETED|Overall Study||49
1113887|NCT01192191|2696389|P2|STARTED|Overall Study||127
1113888|NCT01192191|2696390|P1|STARTED|Overall Study||60
1113889|NCT01192204|2696416|P2|NOT COMPLETED|Overall Study||0
1113890|NCT01192204|2696417|P1|NOT COMPLETED|Overall Study||1
1113891|NCT01192204|2696416|P2|COMPLETED|Overall Study||18
1113892|NCT01192204|2696417|P1|COMPLETED|Overall Study||22
1113893|NCT01192204|2696416|P2|STARTED|Overall Study||18
1113894|NCT01192204|2696417|P1|STARTED|Overall Study||23
1113895|NCT01192282|2696430|P1|NOT COMPLETED|Overall Study||0
1113896|NCT01192282|2696430|P1|COMPLETED|Overall Study||156
1113897|NCT01192282|2696430|P1|STARTED|Overall Study||156
1113904|NCT01192347|2696462|P1|NOT COMPLETED|Overall Study||12
1113905|NCT01192347|2696462|P1|COMPLETED|Overall Study||163
1113906|NCT01192347|2696462|P1|STARTED|Overall Study||175
1113907|NCT01192412|2696485|P2|NOT COMPLETED|Overall Study||2
1113908|NCT01192412|2696486|P1|NOT COMPLETED|Overall Study||4
1113909|NCT01192412|2696485|P2|COMPLETED|Overall Study||488
1113910|NCT01192412|2696486|P1|COMPLETED|Overall Study||493
1113911|NCT01192412|2696485|P2|STARTED|Overall Study||490
1113912|NCT01192412|2696486|P1|STARTED|Overall Study||497
1113913|NCT01192516|2696497|P3|NOT COMPLETED|Overall Study||8
1113914|NCT01192516|2696498|P2|NOT COMPLETED|Overall Study||17
1113915|NCT01192516|2696499|P1|NOT COMPLETED|Overall Study||20
1113916|NCT01192516|2696497|P3|COMPLETED|Overall Study||55
1113917|NCT01192516|2696498|P2|COMPLETED|Overall Study||49
1113918|NCT01192516|2696499|P1|COMPLETED|Overall Study||46
1113919|NCT01192516|2696497|P3|STARTED|Overall Study|Indicates number of people initially randomized to group|63
1113920|NCT01192516|2696498|P2|STARTED|Overall Study|Indicates number of people initially randomized to group|66
1113921|NCT01192516|2696499|P1|STARTED|Overall Study|Indicates number of people initially randomized to group|66
1113922|NCT01192542|2696531|P2|NOT COMPLETED|Period 2||0
1113923|NCT01192542|2696532|P1|NOT COMPLETED|Period 2||0
1113924|NCT01192542|2696531|P2|COMPLETED|Period 2||20
1113925|NCT01192542|2696532|P1|COMPLETED|Period 2||18
1113926|NCT01192542|2696531|P2|STARTED|Period 2||20
1113927|NCT01192542|2696532|P1|STARTED|Period 2||18
1113928|NCT01192542|2696531|P2|NOT COMPLETED|Period 1||0
1113929|NCT01192542|2696532|P1|NOT COMPLETED|Period 1||0
1113930|NCT01192542|2696531|P2|COMPLETED|Period 1||20
1113931|NCT01192542|2696532|P1|COMPLETED|Period 1||18
1113932|NCT01192542|2696531|P2|STARTED|Period 1||20
1113933|NCT01192542|2696532|P1|STARTED|Period 1||18
1113934|NCT01192698|2696545|P2|NOT COMPLETED|Overall Study||0
1113935|NCT01192698|2696546|P1|NOT COMPLETED|Overall Study||0
1113936|NCT01192698|2696545|P2|COMPLETED|Overall Study||5
1113937|NCT01192698|2696546|P1|COMPLETED|Overall Study||10
1113938|NCT01192698|2696545|P2|STARTED|Overall Study||5
1113939|NCT01192698|2696546|P1|STARTED|Overall Study||10
1113940|NCT01185028|2696552|P1|NOT COMPLETED|Overall Study||4
1113941|NCT01185028|2696552|P1|COMPLETED|Overall Study||4
1113942|NCT01185028|2696552|P1|STARTED|Overall Study||8
1113943|NCT01185080|2696560|P3|NOT COMPLETED|Overall Study||1
1113944|NCT01185080|2696561|P2|NOT COMPLETED|Overall Study||1
1113945|NCT01185080|2696562|P1|NOT COMPLETED|Overall Study||1
1113946|NCT01185080|2696560|P3|COMPLETED|Overall Study||16
1113947|NCT01185080|2696561|P2|COMPLETED|Overall Study||15
1113948|NCT01185080|2696562|P1|COMPLETED|Overall Study||49
1113949|NCT01185080|2696560|P3|STARTED|Overall Study||17
1113950|NCT01185080|2696561|P2|STARTED|Overall Study||16
1113951|NCT01185080|2696562|P1|STARTED|Overall Study||50
1113952|NCT01185249|2696609|P1|NOT COMPLETED|Overall Study||42
1113953|NCT01185249|2696609|P1|COMPLETED|Overall Study|Data was analyzed for patients with three consecutive days of data.|24
1113954|NCT01185249|2696609|P1|STARTED|Overall Study|Total number of patients consented to participate.|66
1113955|NCT01185288|2696616|P2|NOT COMPLETED|Overall Study||16
1113956|NCT01185288|2696617|P1|NOT COMPLETED|Overall Study||19
1113957|NCT01185288|2696616|P2|COMPLETED|Overall Study||139
1113958|NCT01185288|2696617|P1|COMPLETED|Overall Study||135
1113959|NCT01185288|2696616|P2|STARTED|Overall Study||155
1113960|NCT01185288|2696617|P1|STARTED|Overall Study||154
1113961|NCT01185301|2696639|P4|NOT COMPLETED|Overall Study||9
1113962|NCT01185301|2696640|P3|NOT COMPLETED|Overall Study||6
1113963|NCT01185301|2696641|P2|NOT COMPLETED|Overall Study||7
1113964|NCT01185301|2696642|P1|NOT COMPLETED|Overall Study||15
1113965|NCT01185301|2696639|P4|COMPLETED|Overall Study||89
1113966|NCT01185301|2696640|P3|COMPLETED|Overall Study||93
1113967|NCT01185301|2696641|P2|COMPLETED|Overall Study||93
1113968|NCT01185301|2696642|P1|COMPLETED|Overall Study||83
1113969|NCT01185301|2696639|P4|STARTED|Overall Study||98
1113970|NCT01185301|2696640|P3|STARTED|Overall Study||99
1113971|NCT01185301|2696641|P2|STARTED|Overall Study||100
1113972|NCT01185301|2696642|P1|STARTED|Overall Study||98
1113973|NCT01185353|2696705|P10|NOT COMPLETED|Part D (Weeks 76 Through 128)||1
1113974|NCT01185353|2696706|P9|NOT COMPLETED|Part D (Weeks 76 Through 128)||7
1113975|NCT01185353|2696707|P8|NOT COMPLETED|Part D (Weeks 76 Through 128)||3
1113976|NCT01185353|2696708|P7|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
1113977|NCT01185353|2696709|P6|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
1113978|NCT01185353|2696710|P5|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
1113979|NCT01185353|2696711|P4|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
1113980|NCT01185353|2696712|P3|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
1113981|NCT01185353|2696713|P2|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
1113982|NCT01185353|2696714|P1|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
1113983|NCT01185353|2696705|P10|COMPLETED|Part D (Weeks 76 Through 128)||17
1113984|NCT01185353|2696706|P9|COMPLETED|Part D (Weeks 76 Through 128)||40
1113985|NCT01185353|2696707|P8|COMPLETED|Part D (Weeks 76 Through 128)||76
1113986|NCT01185353|2696708|P7|COMPLETED|Part D (Weeks 76 Through 128)||0
1113987|NCT01185353|2696709|P6|COMPLETED|Part D (Weeks 76 Through 128)||0
1113988|NCT01185353|2696710|P5|COMPLETED|Part D (Weeks 76 Through 128)||0
1113989|NCT01185353|2696711|P4|COMPLETED|Part D (Weeks 76 Through 128)||0
1113990|NCT01185353|2696712|P3|COMPLETED|Part D (Weeks 76 Through 128)||0
1113991|NCT01185353|2696713|P2|COMPLETED|Part D (Weeks 76 Through 128)||0
1113992|NCT01185353|2696714|P1|COMPLETED|Part D (Weeks 76 Through 128)||0
1113993|NCT01185353|2696705|P10|STARTED|Part D (Weeks 76 Through 128)||18
1113994|NCT01185353|2696706|P9|STARTED|Part D (Weeks 76 Through 128)||47
1113995|NCT01185353|2696707|P8|STARTED|Part D (Weeks 76 Through 128)||79
1113996|NCT01185353|2696708|P7|STARTED|Part D (Weeks 76 Through 128)||0
1113997|NCT01185353|2696709|P6|STARTED|Part D (Weeks 76 Through 128)||0
1113998|NCT01185353|2696710|P5|STARTED|Part D (Weeks 76 Through 128)||0
1113999|NCT01185353|2696711|P4|STARTED|Part D (Weeks 76 Through 128)||0
1114000|NCT01185353|2696712|P3|STARTED|Part D (Weeks 76 Through 128)||0
1114001|NCT01185353|2696713|P2|STARTED|Part D (Weeks 76 Through 128)||0
1114002|NCT01185353|2696714|P1|STARTED|Part D (Weeks 76 Through 128)||0
1114003|NCT01185353|2696705|P10|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
1114004|NCT01185353|2696706|P9|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
1114005|NCT01185353|2696707|P8|NOT COMPLETED|Part C (Weeks 24 Through 76)||16
1114006|NCT01185353|2696708|P7|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
1114007|NCT01185353|2696709|P6|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
1114008|NCT01185353|2696710|P5|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
1114009|NCT01185353|2696711|P4|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
1114010|NCT01185353|2696712|P3|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
1114011|NCT01185353|2696713|P2|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
1114012|NCT01185353|2696714|P1|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
1114013|NCT01185353|2696705|P10|COMPLETED|Part C (Weeks 24 Through 76)||24
1114014|NCT01185353|2696706|P9|COMPLETED|Part C (Weeks 24 Through 76)||53
1114015|NCT01185353|2696707|P8|COMPLETED|Part C (Weeks 24 Through 76)||92
1114016|NCT01185353|2696708|P7|COMPLETED|Part C (Weeks 24 Through 76)||0
1114017|NCT01185353|2696709|P6|COMPLETED|Part C (Weeks 24 Through 76)||0
1114018|NCT01185353|2696710|P5|COMPLETED|Part C (Weeks 24 Through 76)||0
1114019|NCT01185353|2696711|P4|COMPLETED|Part C (Weeks 24 Through 76)||0
1114020|NCT01185353|2696712|P3|COMPLETED|Part C (Weeks 24 Through 76)||0
1114021|NCT01185353|2696713|P2|COMPLETED|Part C (Weeks 24 Through 76)||0
1114022|NCT01185353|2696714|P1|COMPLETED|Part C (Weeks 24 Through 76)||0
1114023|NCT01185353|2696705|P10|STARTED|Part C (Weeks 24 Through 76)||32
1114024|NCT01185353|2696706|P9|STARTED|Part C (Weeks 24 Through 76)||61
1114025|NCT01185353|2696707|P8|STARTED|Part C (Weeks 24 Through 76)||108
1114026|NCT01185353|2696708|P7|STARTED|Part C (Weeks 24 Through 76)||0
1114027|NCT01185353|2696709|P6|STARTED|Part C (Weeks 24 Through 76)||0
1114028|NCT01185353|2696710|P5|STARTED|Part C (Weeks 24 Through 76)||0
1114029|NCT01185353|2696711|P4|STARTED|Part C (Weeks 24 Through 76)||0
1114030|NCT01185353|2696712|P3|STARTED|Part C (Weeks 24 Through 76)||0
1114031|NCT01185353|2696713|P2|STARTED|Part C (Weeks 24 Through 76)||0
1114032|NCT01185353|2696714|P1|STARTED|Part C (Weeks 24 Through 76)||0
1114033|NCT01185353|2696705|P10|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
1114034|NCT01185353|2696706|P9|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
1114035|NCT01185353|2696707|P8|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
1114036|NCT01185353|2696708|P7|NOT COMPLETED|Part B (Weeks 12 Through 24)||6
1114037|NCT01185353|2696709|P6|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
1114038|NCT01185353|2696710|P5|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
1114039|NCT01185353|2696711|P4|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
1114040|NCT01185353|2696712|P3|NOT COMPLETED|Part B (Weeks 12 Through 24)||2
1114041|NCT01185353|2696713|P2|NOT COMPLETED|Part B (Weeks 12 Through 24)||1
1114042|NCT01185353|2696714|P1|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
1114043|NCT01185353|2696705|P10|COMPLETED|Part B (Weeks 12 Through 24)||0
1114044|NCT01185353|2696706|P9|COMPLETED|Part B (Weeks 12 Through 24)||0
1114045|NCT01185353|2696707|P8|COMPLETED|Part B (Weeks 12 Through 24)||0
1114046|NCT01185353|2696708|P7|COMPLETED|Part B (Weeks 12 Through 24)||57
1114047|NCT01185353|2696709|P6|COMPLETED|Part B (Weeks 12 Through 24)||59
1114048|NCT01185353|2696710|P5|COMPLETED|Part B (Weeks 12 Through 24)||0
1114049|NCT01185353|2696711|P4|COMPLETED|Part B (Weeks 12 Through 24)||45
1114050|NCT01185353|2696712|P3|COMPLETED|Part B (Weeks 12 Through 24)||48
1114051|NCT01185353|2696713|P2|COMPLETED|Part B (Weeks 12 Through 24)||50
1114052|NCT01185353|2696714|P1|COMPLETED|Part B (Weeks 12 Through 24)||0
1114053|NCT01185353|2696705|P10|STARTED|Part B (Weeks 12 Through 24)||0
1114054|NCT01185353|2696706|P9|STARTED|Part B (Weeks 12 Through 24)||0
1114055|NCT01185353|2696707|P8|STARTED|Part B (Weeks 12 Through 24)||0
1114056|NCT01185353|2696708|P7|STARTED|Part B (Weeks 12 Through 24)||63
1114057|NCT01185353|2696709|P6|STARTED|Part B (Weeks 12 Through 24)||63
1114058|NCT01185353|2696710|P5|STARTED|Part B (Weeks 12 Through 24)||0
1114059|NCT01185353|2696711|P4|STARTED|Part B (Weeks 12 Through 24)||49
1114060|NCT01185353|2696712|P3|STARTED|Part B (Weeks 12 Through 24)||50
1114061|NCT01185353|2696713|P2|STARTED|Part B (Weeks 12 Through 24)||51
1114062|NCT01185353|2696714|P1|STARTED|Part B (Weeks 12 Through 24)||0
1114063|NCT01185353|2696705|P10|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
1114064|NCT01185353|2696706|P9|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
1114065|NCT01185353|2696707|P8|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
1114066|NCT01185353|2696708|P7|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
1114067|NCT01185353|2696709|P6|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
1114068|NCT01185353|2696710|P5|NOT COMPLETED|Part A (Weeks 0 Through 12)||16
1114069|NCT01185353|2696711|P4|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
1114070|NCT01185353|2696712|P3|NOT COMPLETED|Part A (Weeks 0 Through 12)||2
1114071|NCT01185353|2696713|P2|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
1114072|NCT01185353|2696714|P1|NOT COMPLETED|Part A (Weeks 0 Through 12)||5
1114073|NCT01185353|2696705|P10|COMPLETED|Part A (Weeks 0 Through 12)||0
1114074|NCT01185353|2696706|P9|COMPLETED|Part A (Weeks 0 Through 12)||0
1114075|NCT01185353|2696707|P8|COMPLETED|Part A (Weeks 0 Through 12)||0
1114076|NCT01185353|2696708|P7|COMPLETED|Part A (Weeks 0 Through 12)||0
1114077|NCT01185353|2696709|P6|COMPLETED|Part A (Weeks 0 Through 12)||0
1114078|NCT01185353|2696710|P5|COMPLETED|Part A (Weeks 0 Through 12)||82
1114079|NCT01185353|2696711|P4|COMPLETED|Part A (Weeks 0 Through 12)||49
1114080|NCT01185353|2696712|P3|COMPLETED|Part A (Weeks 0 Through 12)||50
1114081|NCT01185353|2696713|P2|COMPLETED|Part A (Weeks 0 Through 12)||51
1114082|NCT01185353|2696714|P1|COMPLETED|Part A (Weeks 0 Through 12)||44
1114083|NCT01185353|2696705|P10|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
1114084|NCT01185353|2696706|P9|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
1114085|NCT01185353|2696707|P8|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
1114086|NCT01185353|2696708|P7|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
1114087|NCT01185353|2696709|P6|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
1114088|NCT01185353|2696710|P5|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||98
1114089|NCT01185353|2696711|P4|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||50
1114090|NCT01185353|2696712|P3|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
1114091|NCT01185353|2696713|P2|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
1114092|NCT01185353|2696714|P1|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||49
1114093|NCT01185353|2696705|P10|STARTED|Part A (Weeks 0 Through 12)||0
1114094|NCT01185353|2696706|P9|STARTED|Part A (Weeks 0 Through 12)||0
1114095|NCT01185353|2696707|P8|STARTED|Part A (Weeks 0 Through 12)||0
1114096|NCT01185353|2696708|P7|STARTED|Part A (Weeks 0 Through 12)||0
1114097|NCT01185353|2696709|P6|STARTED|Part A (Weeks 0 Through 12)||0
1114098|NCT01185353|2696710|P5|STARTED|Part A (Weeks 0 Through 12)||98
1114099|NCT01185353|2696711|P4|STARTED|Part A (Weeks 0 Through 12)||50
1114100|NCT01185353|2696712|P3|STARTED|Part A (Weeks 0 Through 12)||52
1114101|NCT01185353|2696713|P2|STARTED|Part A (Weeks 0 Through 12)||52
1114102|NCT01185353|2696714|P1|STARTED|Part A (Weeks 0 Through 12)||49
1114103|NCT01185509|2696874|P2|NOT COMPLETED|Overall Study||20
1114104|NCT01185509|2696875|P1|NOT COMPLETED|Overall Study||11
1114105|NCT01185509|2696874|P2|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
1114106|NCT01185509|2696875|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
1114107|NCT01185509|2696874|P2|STARTED|Overall Study||20
1114108|NCT01185509|2696875|P1|STARTED|Overall Study||11
1114109|NCT01185522|2696885|P1|NOT COMPLETED|Overall Study||108
1114110|NCT01185522|2696885|P1|COMPLETED|Overall Study||585
1114111|NCT01185522|2696885|P1|STARTED|Overall Study||693
1114112|NCT01185561|2696911|P2|NOT COMPLETED|Overall Study||12
1114113|NCT01185561|2696912|P1|NOT COMPLETED|Overall Study||2
1114114|NCT01185561|2696911|P2|COMPLETED|Overall Study||26
1114115|NCT01185561|2696912|P1|COMPLETED|Overall Study||34
1114116|NCT01185561|2696911|P2|STARTED|Overall Study||38
1114117|NCT01185561|2696912|P1|STARTED|Overall Study||36
1114118|NCT01185600|2696926|P2|NOT COMPLETED|Overall Study||45
1114119|NCT01185600|2696927|P1|NOT COMPLETED|Overall Study||32
1114120|NCT01185600|2696926|P2|COMPLETED|Overall Study||59
1114121|NCT01185600|2696927|P1|COMPLETED|Overall Study||41
1114122|NCT01185600|2696926|P2|STARTED|Overall Study||104
1114123|NCT01185600|2696927|P1|STARTED|Overall Study||73
1114124|NCT01185704|2696949|P2|NOT COMPLETED|Overall Study||8
1114125|NCT01185704|2696950|P1|NOT COMPLETED|Overall Study||13
1114126|NCT01185704|2696949|P2|COMPLETED|Overall Study||60
1114127|NCT01185704|2696950|P1|COMPLETED|Overall Study||55
1114128|NCT01185704|2696949|P2|Treated|Overall Study||65
1114129|NCT01185704|2696950|P1|Treated|Overall Study||65
1114130|NCT01185704|2696949|P2|STARTED|Overall Study||68
1114131|NCT01185704|2696950|P1|STARTED|Overall Study||68
1114132|NCT01185782|2696986|P2|NOT COMPLETED|Overall Study||11
1114133|NCT01185782|2696987|P1|NOT COMPLETED|Overall Study||6
1114134|NCT01185782|2696986|P2|COMPLETED|Overall Study||125
1114135|NCT01185782|2696987|P1|COMPLETED|Overall Study||123
1114136|NCT01185782|2696986|P2|Treated|Overall Study||132
1114137|NCT01185782|2696987|P1|Treated|Overall Study||129
1114138|NCT01185782|2696986|P2|STARTED|Overall Study||136
1114139|NCT01185782|2696987|P1|STARTED|Overall Study||129
1114140|NCT01192776|2697017|P4|NOT COMPLETED|Overall Study||20
1114141|NCT01192776|2697018|P3|NOT COMPLETED|Overall Study||21
1114142|NCT01192776|2697019|P2|NOT COMPLETED|Overall Study||21
1114143|NCT01192776|2697020|P1|NOT COMPLETED|Overall Study||11
1114144|NCT01192776|2697017|P4|COMPLETED|Overall Study||63
1114145|NCT01192776|2697018|P3|COMPLETED|Overall Study||75
1114146|NCT01192776|2697019|P2|COMPLETED|Overall Study||69
1114147|NCT01192776|2697020|P1|COMPLETED|Overall Study||84
1114148|NCT01192776|2697017|P4|Died After Discharge|Overall Study||1
1114149|NCT01192776|2697018|P3|Died After Discharge|Overall Study||3
1114150|NCT01192776|2697019|P2|Died After Discharge|Overall Study||2
1114151|NCT01192776|2697020|P1|Died After Discharge|Overall Study||1
1114152|NCT01192776|2697017|P4|Died Prior to Discharge|Overall Study||14
1114153|NCT01192776|2697018|P3|Died Prior to Discharge|Overall Study||15
1114154|NCT01192776|2697019|P2|Died Prior to Discharge|Overall Study||13
1114155|NCT01192776|2697020|P1|Died Prior to Discharge|Overall Study||7
1114156|NCT01192776|2697017|P4|STARTED|Overall Study||83
1114157|NCT01192776|2697018|P3|STARTED|Overall Study||96
1114158|NCT01192776|2697019|P2|STARTED|Overall Study||90
1114159|NCT01192776|2697020|P1|STARTED|Overall Study||95
1114160|NCT01193049|2697070|P2|NOT COMPLETED|Period 3 : Double Blind Crossover||0
1114161|NCT01193049|2697071|P1|NOT COMPLETED|Period 3 : Double Blind Crossover||0
1114162|NCT01193049|2697070|P2|COMPLETED|Period 3 : Double Blind Crossover||6
1114163|NCT01193049|2697071|P1|COMPLETED|Period 3 : Double Blind Crossover||5
1114164|NCT01193049|2697070|P2|STARTED|Period 3 : Double Blind Crossover||6
1114165|NCT01193049|2697071|P1|STARTED|Period 3 : Double Blind Crossover||5
1114166|NCT01193049|2697070|P2|NOT COMPLETED|Washout 2 : 21 Day Washout||0
1114167|NCT01193049|2697071|P1|NOT COMPLETED|Washout 2 : 21 Day Washout||0
1114168|NCT01193049|2697070|P2|COMPLETED|Washout 2 : 21 Day Washout||6
1114169|NCT01193049|2697071|P1|COMPLETED|Washout 2 : 21 Day Washout||5
1114170|NCT01193049|2697070|P2|STARTED|Washout 2 : 21 Day Washout||6
1114171|NCT01193049|2697071|P1|STARTED|Washout 2 : 21 Day Washout||5
1114172|NCT01193049|2697070|P2|NOT COMPLETED|Period 2 : Double Blind Crossover||0
1114173|NCT01193049|2697071|P1|NOT COMPLETED|Period 2 : Double Blind Crossover||0
1114174|NCT01193049|2697070|P2|COMPLETED|Period 2 : Double Blind Crossover||6
1114175|NCT01193049|2697071|P1|COMPLETED|Period 2 : Double Blind Crossover||5
1114176|NCT01193049|2697070|P2|STARTED|Period 2 : Double Blind Crossover||6
1114177|NCT01193049|2697071|P1|STARTED|Period 2 : Double Blind Crossover||5
1114178|NCT01193049|2697070|P2|NOT COMPLETED|Washout 1 : 21 Day Washout||0
1114179|NCT01193049|2697071|P1|NOT COMPLETED|Washout 1 : 21 Day Washout||0
1114180|NCT01193049|2697070|P2|COMPLETED|Washout 1 : 21 Day Washout||6
1114181|NCT01193049|2697071|P1|COMPLETED|Washout 1 : 21 Day Washout||5
1114182|NCT01193049|2697070|P2|STARTED|Washout 1 : 21 Day Washout||6
1114183|NCT01193049|2697071|P1|STARTED|Washout 1 : 21 Day Washout||5
1114184|NCT01193049|2697070|P2|NOT COMPLETED|Period 1: Placebo Run-In||0
1114185|NCT01193049|2697071|P1|NOT COMPLETED|Period 1: Placebo Run-In||0
1114186|NCT01193049|2697070|P2|COMPLETED|Period 1: Placebo Run-In||6
1114187|NCT01193049|2697071|P1|COMPLETED|Period 1: Placebo Run-In||5
1114188|NCT01193049|2697070|P2|STARTED|Period 1: Placebo Run-In||6
1114189|NCT01193049|2697071|P1|STARTED|Period 1: Placebo Run-In||5
1114190|NCT01194219|2697103|P8|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||45
1114191|NCT01194219|2697104|P7|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||61
1114192|NCT01194219|2697105|P6|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||4
1114193|NCT01194219|2697106|P5|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||4
1114194|NCT01194219|2697107|P4|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1114195|NCT01194219|2697108|P3|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1114196|NCT01194219|2697109|P2|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1114197|NCT01194219|2697110|P1|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1114198|NCT01194219|2697103|P8|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)|10 participants discontinued after Week 52 but prior to entry into the long term extension study|163
1114199|NCT01194219|2697104|P7|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)|18 participants discontinued after Week 52 but prior to entry into the long term extension study|184
1114200|NCT01194219|2697105|P6|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)|5 participants discontinued after Week 52 but prior to entry into the long term extension study|73
1114201|NCT01194219|2697106|P5|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)|1 participant discontinued after Week 52 but prior to entry into the long term extension study|73
1114202|NCT01194219|2697107|P4|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1114203|NCT01194219|2697108|P3|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1114204|NCT01194219|2697109|P2|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1114205|NCT01194219|2697110|P1|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1114206|NCT01194219|2697103|P8|Received Topical + Light Therapy|Randomized Withdrawal Phase(Weeks 32-52)||91
1114207|NCT01194219|2697104|P7|Received Topical + Light Therapy|Randomized Withdrawal Phase(Weeks 32-52)||126
1114208|NCT01194219|2697105|P6|Received Topical + Light Therapy|Randomized Withdrawal Phase(Weeks 32-52)||0
1114209|NCT01194219|2697106|P5|Received Topical + Light Therapy|Randomized Withdrawal Phase(Weeks 32-52)||0
1114210|NCT01194219|2697107|P4|Received Topical + Light Therapy|Randomized Withdrawal Phase(Weeks 32-52)||0
1114211|NCT01194219|2697108|P3|Received Topical + Light Therapy|Randomized Withdrawal Phase(Weeks 32-52)||0
1114212|NCT01194219|2697109|P2|Received Topical + Light Therapy|Randomized Withdrawal Phase(Weeks 32-52)||0
1114213|NCT01194219|2697110|P1|Received Topical + Light Therapy|Randomized Withdrawal Phase(Weeks 32-52)||0
1114214|NCT01194219|2697103|P8|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||208
1114215|NCT01194219|2697104|P7|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||245
1114216|NCT01194219|2697105|P6|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|25 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
1114217|NCT01194219|2697106|P5|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|7 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
1114218|NCT01194219|2697107|P4|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
1114219|NCT01194219|2697108|P3|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
1114220|NCT01194219|2697109|P2|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
1114221|NCT01194219|2697110|P1|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
1114222|NCT01194219|2697103|P8|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
1114223|NCT01194219|2697104|P7|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
1114224|NCT01194219|2697105|P6|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
1114225|NCT01194219|2697106|P5|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
1114226|NCT01194219|2697107|P4|NOT COMPLETED|Maintenance Phase (Weeks16-32)||30
1114227|NCT01194219|2697108|P3|NOT COMPLETED|Maintenance Phase (Weeks16-32)||70
1114228|NCT01194219|2697109|P2|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
1114229|NCT01194219|2697110|P1|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
1114230|NCT01194219|2697103|P8|COMPLETED|Maintenance Phase (Weeks16-32)||0
1114231|NCT01194219|2697104|P7|COMPLETED|Maintenance Phase (Weeks16-32)||0
1114232|NCT01194219|2697105|P6|COMPLETED|Maintenance Phase (Weeks16-32)||0
1114233|NCT01194219|2697106|P5|COMPLETED|Maintenance Phase (Weeks16-32)||0
1114234|NCT01194219|2697107|P4|COMPLETED|Maintenance Phase (Weeks16-32)||215
1114235|NCT01194219|2697108|P3|COMPLETED|Maintenance Phase (Weeks16-32)||424
1114236|NCT01194219|2697109|P2|COMPLETED|Maintenance Phase (Weeks16-32)||0
1114237|NCT01194219|2697110|P1|COMPLETED|Maintenance Phase (Weeks16-32)||0
1114238|NCT01194219|2697103|P8|Received Apremilast|Maintenance Phase (Weeks16-32)||0
1114239|NCT01194219|2697104|P7|Received Apremilast|Maintenance Phase (Weeks16-32)||0
1114240|NCT01194219|2697105|P6|Received Apremilast|Maintenance Phase (Weeks16-32)||0
1114241|NCT01194219|2697106|P5|Received Apremilast|Maintenance Phase (Weeks16-32)||0
1114242|NCT01194219|2697107|P4|Received Apremilast|Maintenance Phase (Weeks16-32)|1 participant elected not to participate at the time the first dose was dispensed.|244
1114243|NCT01194219|2697108|P3|Received Apremilast|Maintenance Phase (Weeks16-32)|1 participant elected not to participate at the time the first dose was dispensed.|493
1114244|NCT01194219|2697109|P2|Received Apremilast|Maintenance Phase (Weeks16-32)||0
1114245|NCT01194219|2697110|P1|Received Apremilast|Maintenance Phase (Weeks16-32)||0
1114246|NCT01194219|2697103|P8|STARTED|Maintenance Phase (Weeks16-32)||0
1114247|NCT01194219|2697104|P7|STARTED|Maintenance Phase (Weeks16-32)||0
1114248|NCT01194219|2697105|P6|STARTED|Maintenance Phase (Weeks16-32)||0
1114249|NCT01194219|2697106|P5|STARTED|Maintenance Phase (Weeks16-32)||0
1114250|NCT01194219|2697107|P4|STARTED|Maintenance Phase (Weeks16-32)|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|245
1114251|NCT01194219|2697108|P3|STARTED|Maintenance Phase (Weeks16-32)|9 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|494
1114252|NCT01194219|2697109|P2|STARTED|Maintenance Phase (Weeks16-32)||0
1114253|NCT01194219|2697110|P1|STARTED|Maintenance Phase (Weeks16-32)||0
1114254|NCT01194219|2697103|P8|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1114255|NCT01194219|2697104|P7|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1114256|NCT01194219|2697105|P6|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1114257|NCT01194219|2697106|P5|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1114258|NCT01194219|2697107|P4|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1114259|NCT01194219|2697108|P3|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1114260|NCT01194219|2697109|P2|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||33
1114261|NCT01194219|2697110|P1|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||59
1114262|NCT01194219|2697103|P8|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1114263|NCT01194219|2697104|P7|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1114264|NCT01194219|2697105|P6|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1114265|NCT01194219|2697106|P5|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1114266|NCT01194219|2697107|P4|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1114267|NCT01194219|2697108|P3|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1114268|NCT01194219|2697109|P2|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||249
1114269|NCT01194219|2697110|P1|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||503
1114270|NCT01194219|2697103|P8|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
1114271|NCT01194219|2697104|P7|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
1114272|NCT01194219|2697105|P6|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
1114273|NCT01194219|2697106|P5|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
1114274|NCT01194219|2697107|P4|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
1114275|NCT01194219|2697108|P3|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
1114276|NCT01194219|2697109|P2|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||282
1114277|NCT01194219|2697110|P1|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||560
1114278|NCT01194219|2697103|P8|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
1114279|NCT01194219|2697104|P7|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
1114280|NCT01194219|2697105|P6|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
1114281|NCT01194219|2697106|P5|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
1114282|NCT01194219|2697107|P4|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
1114283|NCT01194219|2697108|P3|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
1114284|NCT01194219|2697109|P2|STARTED|Placebo Controlled Phase (Weeks 0-16)||282
1114285|NCT01194219|2697110|P1|STARTED|Placebo Controlled Phase (Weeks 0-16)||562
1114286|NCT01194245|2697145|P5|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
1114287|NCT01194245|2697146|P4|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
1114288|NCT01194245|2697147|P3|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
1114289|NCT01194245|2697148|P2|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
1114290|NCT01194245|2697149|P1|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
1114291|NCT01194245|2697145|P5|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||28
1114292|NCT01194245|2697146|P4|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
1114293|NCT01194245|2697147|P3|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||27
1114294|NCT01194245|2697148|P2|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
1114295|NCT01194245|2697149|P1|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
1114296|NCT01194245|2697145|P5|STARTED|Treatment Period 2 (Weeks 12 to 24)||28
1114297|NCT01194245|2697146|P4|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
1114298|NCT01194245|2697147|P3|STARTED|Treatment Period 2 (Weeks 12 to 24)||27
1114299|NCT01194245|2697148|P2|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
1114300|NCT01194245|2697149|P1|STARTED|Treatment Period 2 (Weeks 12 to 24)||0
1114301|NCT01194245|2697145|P5|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||2
1114302|NCT01194245|2697146|P4|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
1114303|NCT01194245|2697147|P3|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
1114304|NCT01194245|2697148|P2|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
1114305|NCT01194245|2697149|P1|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
1114306|NCT01194245|2697145|P5|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||28
1114307|NCT01194245|2697146|P4|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
1114308|NCT01194245|2697147|P3|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||27
1114309|NCT01194245|2697148|P2|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
1114310|NCT01194245|2697149|P1|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
1114311|NCT01194245|2697145|P5|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
1114312|NCT01194245|2697146|P4|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
1114313|NCT01194245|2697147|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||28
1114314|NCT01194245|2697148|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||29
1114315|NCT01194245|2697149|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||0
1114316|NCT01194245|2697145|P5|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
1114317|NCT01194245|2697146|P4|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
1114318|NCT01194245|2697147|P3|STARTED|Treatment Period 1 (Weeks 0 to 12)||28
1114319|NCT01194245|2697148|P2|STARTED|Treatment Period 1 (Weeks 0 to 12)||29
1114320|NCT01194245|2697149|P1|STARTED|Treatment Period 1 (Weeks 0 to 12)||0
1114321|NCT01194245|2697145|P5|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
1114322|NCT01194245|2697146|P4|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
1114323|NCT01194245|2697147|P3|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
1114324|NCT01194245|2697148|P2|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
1114325|NCT01194245|2697149|P1|NOT COMPLETED|Titration Period (4 to 6 Weeks)||18
1114326|NCT01194245|2697145|P5|COMPLETED|Titration Period (4 to 6 Weeks)||0
1114327|NCT01194245|2697146|P4|COMPLETED|Titration Period (4 to 6 Weeks)||0
1114328|NCT01194245|2697147|P3|COMPLETED|Titration Period (4 to 6 Weeks)||0
1114329|NCT01194245|2697148|P2|COMPLETED|Titration Period (4 to 6 Weeks)||0
1114330|NCT01194245|2697149|P1|COMPLETED|Titration Period (4 to 6 Weeks)|Participants that completed the Titration Period were randomized to Treatment Period 1.|117
1114331|NCT01194245|2697145|P5|STARTED|Titration Period (4 to 6 Weeks)||0
1114332|NCT01194245|2697146|P4|STARTED|Titration Period (4 to 6 Weeks)||0
1114333|NCT01194245|2697147|P3|STARTED|Titration Period (4 to 6 Weeks)||0
1114334|NCT01194245|2697148|P2|STARTED|Titration Period (4 to 6 Weeks)||0
1114335|NCT01194245|2697149|P1|STARTED|Titration Period (4 to 6 Weeks)||135
1114336|NCT01194258|2697168|P5|NOT COMPLETED|Period 2 (12 Weeks)||2
1114337|NCT01194258|2697169|P4|NOT COMPLETED|Period 2 (12 Weeks)||0
1114338|NCT01194258|2697170|P3|NOT COMPLETED|Period 2 (12 Weeks)||1
1114339|NCT01194258|2697171|P2|NOT COMPLETED|Period 2 (12 Weeks)||2
1114340|NCT01194258|2697172|P1|NOT COMPLETED|Period 2 (12 Weeks)||0
1114341|NCT01194258|2697168|P5|COMPLETED|Period 2 (12 Weeks)||30
1114342|NCT01194258|2697169|P4|COMPLETED|Period 2 (12 Weeks)||29
1114343|NCT01194258|2697170|P3|COMPLETED|Period 2 (12 Weeks)||29
1114344|NCT01194258|2697171|P2|COMPLETED|Period 2 (12 Weeks)||27
1114345|NCT01194258|2697172|P1|COMPLETED|Period 2 (12 Weeks)||0
1114346|NCT01194258|2697168|P5|STARTED|Period 2 (12 Weeks)||32
1114347|NCT01194258|2697169|P4|STARTED|Period 2 (12 Weeks)||29
1114348|NCT01194258|2697170|P3|STARTED|Period 2 (12 Weeks)||30
1114349|NCT01194258|2697171|P2|STARTED|Period 2 (12 Weeks)||29
1114350|NCT01194258|2697172|P1|STARTED|Period 2 (12 Weeks)||0
1114351|NCT01194258|2697168|P5|NOT COMPLETED|Period 1 (12 Weeks)||1
1114352|NCT01194258|2697169|P4|NOT COMPLETED|Period 1 (12 Weeks)||0
1114353|NCT01194258|2697170|P3|NOT COMPLETED|Period 1 (12 Weeks)||0
1114354|NCT01194258|2697171|P2|NOT COMPLETED|Period 1 (12 Weeks)||0
1114355|NCT01194258|2697172|P1|NOT COMPLETED|Period 1 (12 Weeks)||0
1114356|NCT01194258|2697168|P5|COMPLETED|Period 1 (12 Weeks)||32
1114357|NCT01194258|2697169|P4|COMPLETED|Period 1 (12 Weeks)||29
1114358|NCT01194258|2697170|P3|COMPLETED|Period 1 (12 Weeks)||30
1114359|NCT01194258|2697171|P2|COMPLETED|Period 1 (12 Weeks)||29
1114360|NCT01194258|2697172|P1|COMPLETED|Period 1 (12 Weeks)||0
1114361|NCT01194258|2697168|P5|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||33
1114362|NCT01194258|2697169|P4|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
1114363|NCT01194258|2697170|P3|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||30
1114364|NCT01194258|2697171|P2|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
1114365|NCT01194258|2697172|P1|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||0
1114366|NCT01194258|2697168|P5|STARTED|Period 1 (12 Weeks)|After the titration phase, 33 participants were randomized to the Aspart-PH20/Insulin lispro group.|33
1114367|NCT01194258|2697169|P4|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Aspart-PH20 group.|29
1114368|NCT01194258|2697170|P3|STARTED|Period 1 (12 Weeks)|After the titration phase, 30 participants were randomized to the Lispro-PH20/Insulin lispro group.|30
1114369|NCT01194258|2697171|P2|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Lispro-PH20 group.|29
1114370|NCT01194258|2697172|P1|STARTED|Period 1 (12 Weeks)|Participants were randomized to the Insulin lispro or an Analog-PH20 group after titration.|0
1114371|NCT01194258|2697168|P5|NOT COMPLETED|Titration Period||0
1114372|NCT01194258|2697169|P4|NOT COMPLETED|Titration Period||0
1114373|NCT01194258|2697170|P3|NOT COMPLETED|Titration Period||0
1114374|NCT01194258|2697171|P2|NOT COMPLETED|Titration Period||0
1114375|NCT01194258|2697172|P1|NOT COMPLETED|Titration Period||11
1114376|NCT01194258|2697168|P5|COMPLETED|Titration Period||0
1114377|NCT01194258|2697169|P4|COMPLETED|Titration Period||0
1114378|NCT01194258|2697170|P3|COMPLETED|Titration Period||0
1114379|NCT01194258|2697171|P2|COMPLETED|Titration Period||0
1114380|NCT01194258|2697172|P1|COMPLETED|Titration Period||121
1114381|NCT01194258|2697168|P5|STARTED|Titration Period||0
1114382|NCT01194258|2697169|P4|STARTED|Titration Period||0
1114383|NCT01194258|2697170|P3|STARTED|Titration Period||0
1114384|NCT01194258|2697171|P2|STARTED|Titration Period||0
1114385|NCT01194258|2697172|P1|STARTED|Titration Period||132
1114386|NCT01194297|2697193|P2|NOT COMPLETED|Overall Study||0
1114387|NCT01194297|2697194|P1|NOT COMPLETED|Overall Study||0
1114388|NCT01194297|2697193|P2|COMPLETED|Overall Study||1
1114389|NCT01194297|2697194|P1|COMPLETED|Overall Study||2
1114390|NCT01194297|2697193|P2|STARTED|Overall Study||1
1114391|NCT01194297|2697194|P1|STARTED|Overall Study||2
1114392|NCT01194414|2697204|P4|NOT COMPLETED|72 Weeks Open Label Extension||26
1114393|NCT01194414|2697205|P3|NOT COMPLETED|72 Weeks Open Label Extension||8
1114394|NCT01194414|2697206|P2|NOT COMPLETED|72 Weeks Open Label Extension||66
1114395|NCT01194414|2697207|P1|NOT COMPLETED|72 Weeks Open Label Extension||79
1114396|NCT01194414|2697204|P4|COMPLETED|72 Weeks Open Label Extension||160
1114397|NCT01194414|2697205|P3|COMPLETED|72 Weeks Open Label Extension||40
1114398|NCT01194414|2697206|P2|COMPLETED|72 Weeks Open Label Extension||311
1114399|NCT01194414|2697207|P1|COMPLETED|72 Weeks Open Label Extension||445
1114400|NCT01194414|2697204|P4|STARTED|72 Weeks Open Label Extension||186
1114401|NCT01194414|2697205|P3|STARTED|72 Weeks Open Label Extension||48
1114402|NCT01194414|2697206|P2|STARTED|72 Weeks Open Label Extension||377
1114403|NCT01194414|2697207|P1|STARTED|72 Weeks Open Label Extension||524
1114404|NCT01194414|2697204|P4|NOT COMPLETED|24 Weeks Double Blind Period||0
1114405|NCT01194414|2697205|P3|NOT COMPLETED|24 Weeks Double Blind Period||0
1114406|NCT01194414|2697206|P2|NOT COMPLETED|24 Weeks Double Blind Period||67
1114407|NCT01194414|2697207|P1|NOT COMPLETED|24 Weeks Double Blind Period||59
1114408|NCT01194414|2697204|P4|COMPLETED|24 Weeks Double Blind Period||0
1114409|NCT01194414|2697205|P3|COMPLETED|24 Weeks Double Blind Period||0
1114410|NCT01194414|2697206|P2|COMPLETED|24 Weeks Double Blind Period||564
1114411|NCT01194414|2697207|P1|COMPLETED|24 Weeks Double Blind Period||572
1114412|NCT01194414|2697204|P4|Per Protocol Population|24 Weeks Double Blind Period||0
1114413|NCT01194414|2697205|P3|Per Protocol Population|24 Weeks Double Blind Period||0
1114414|NCT01194414|2697206|P2|Per Protocol Population|24 Weeks Double Blind Period||537
1114415|NCT01194414|2697207|P1|Per Protocol Population|24 Weeks Double Blind Period||558
1114416|NCT01194414|2697204|P4|STARTED|24 Weeks Double Blind Period||0
1114417|NCT01194414|2697205|P3|STARTED|24 Weeks Double Blind Period||0
1114418|NCT01194414|2697206|P2|STARTED|24 Weeks Double Blind Period||631
1114419|NCT01194414|2697207|P1|STARTED|24 Weeks Double Blind Period||631
1114420|NCT01194427|2697267|P1|NOT COMPLETED|Overall Study||0
1114421|NCT01194427|2697267|P1|COMPLETED|Overall Study||2
1114422|NCT01194427|2697267|P1|STARTED|Overall Study||2
1114423|NCT01194440|2697271|P1|NOT COMPLETED|Overall Study||12
1114424|NCT01194440|2697271|P1|COMPLETED|Overall Study||47
1114425|NCT01194440|2697271|P1|STARTED|Overall Study||59
1114426|NCT01194453|2697277|P2|NOT COMPLETED|Overall Study||17
1114427|NCT01194453|2697278|P1|NOT COMPLETED|Overall Study||17
1114428|NCT01194453|2697277|P2|COMPLETED|Overall Study||127
1114429|NCT01194453|2697278|P1|COMPLETED|Overall Study||127
1114430|NCT01194453|2697277|P2|STARTED|Overall Study||144
1114431|NCT01194453|2697278|P1|STARTED|Overall Study||144
1114432|NCT01194479|2697288|P4|NOT COMPLETED|Overall Study||0
1114433|NCT01194479|2697289|P3|NOT COMPLETED|Overall Study||0
1114434|NCT01194479|2697290|P2|NOT COMPLETED|Overall Study||0
1114435|NCT01194479|2697291|P1|NOT COMPLETED|Overall Study||0
1114436|NCT01194479|2697288|P4|COMPLETED|Overall Study||5
1114437|NCT01194479|2697289|P3|COMPLETED|Overall Study||2
1114438|NCT01194479|2697290|P2|COMPLETED|Overall Study||4
1114439|NCT01194479|2697291|P1|COMPLETED|Overall Study||3
1114440|NCT01194479|2697288|P4|Cross-over at Second Visit|Overall Study||5
1114441|NCT01194479|2697289|P3|Cross-over at Second Visit|Overall Study||2
1114442|NCT01194479|2697290|P2|Cross-over at Second Visit|Overall Study||4
1114443|NCT01194479|2697291|P1|Cross-over at Second Visit|Overall Study||3
1114444|NCT01194479|2697288|P4|STARTED|Overall Study||5
1114445|NCT01194479|2697289|P3|STARTED|Overall Study||2
1114446|NCT01194479|2697290|P2|STARTED|Overall Study||4
1114447|NCT01194479|2697291|P1|STARTED|Overall Study||3
1114448|NCT01194531|2697315|P2|NOT COMPLETED|Overall Study||3
1114449|NCT01194531|2697316|P1|NOT COMPLETED|Overall Study||5
1114450|NCT01194531|2697315|P2|COMPLETED|Overall Study||27
1114451|NCT01194531|2697316|P1|COMPLETED|Overall Study||24
1114452|NCT01194531|2697315|P2|STARTED|Overall Study||30
1114453|NCT01194531|2697316|P1|STARTED|Overall Study||29
1114454|NCT01194674|2697322|P1|NOT COMPLETED|Overall Study||0
1114455|NCT01194674|2697322|P1|COMPLETED|Overall Study||2
1114456|NCT01194674|2697322|P1|STARTED|Overall Study||2
1114457|NCT01194830|2697331|P2|NOT COMPLETED|Overall Study||27
1114458|NCT01194830|2697332|P1|NOT COMPLETED|Overall Study||36
1114459|NCT01194830|2697331|P2|COMPLETED|Overall Study||83
1114460|NCT01194830|2697332|P1|COMPLETED|Overall Study||88
1114461|NCT01194830|2697331|P2|STARTED|Overall Study||110
1114462|NCT01194830|2697332|P1|STARTED|Overall Study||124
1114463|NCT01194856|2697356|P2|NOT COMPLETED|Overall Study||0
1114464|NCT01194856|2697357|P1|NOT COMPLETED|Overall Study||1
1114465|NCT01194856|2697356|P2|COMPLETED|Overall Study||0
1114466|NCT01194856|2697357|P1|COMPLETED|Overall Study||0
1114467|NCT01194856|2697356|P2|STARTED|Overall Study||0
1114468|NCT01194856|2697357|P1|STARTED|Overall Study||1
1114469|NCT01194869|2697377|P1|NOT COMPLETED|Overall Study||4
1114470|NCT01194869|2697377|P1|COMPLETED|Overall Study||21
1114471|NCT01194869|2697377|P1|STARTED|Overall Study||25
1114472|NCT01194908|2697383|P1|NOT COMPLETED|Overall Study||0
1114473|NCT01194908|2697383|P1|COMPLETED|Overall Study||5
1114474|NCT01194908|2697383|P1|STARTED|Overall Study||5
1114475|NCT01194973|2697388|P1|NOT COMPLETED|26 Week Treatment Period||3
1114476|NCT01194973|2697388|P1|COMPLETED|26 Week Treatment Period||38
1114477|NCT01194973|2697388|P1|STARTED|26 Week Treatment Period||41
1114478|NCT01194973|2697388|P1|NOT COMPLETED|Screening Period||3
1114479|NCT01194973|2697388|P1|COMPLETED|Screening Period||41
1114480|NCT01194973|2697388|P1|STARTED|Screening Period||44
1114481|NCT01194999|2697403|P1|NOT COMPLETED|Overall Study||17
1114482|NCT01194999|2697403|P1|COMPLETED|Overall Study||115
1114483|NCT01194999|2697403|P1|STARTED|Overall Study||132
1114484|NCT01195025|2697407|P5|NOT COMPLETED|Third Intervention C||0
1114485|NCT01195025|2697408|P4|NOT COMPLETED|Third Intervention C||0
1114486|NCT01195025|2697409|P3|NOT COMPLETED|Third Intervention C||0
1114487|NCT01195025|2697410|P2|NOT COMPLETED|Third Intervention C||0
1114488|NCT01195025|2697411|P1|NOT COMPLETED|Third Intervention C||0
1114489|NCT01195025|2697407|P5|COMPLETED|Third Intervention C||1
1114490|NCT01195025|2697408|P4|COMPLETED|Third Intervention C||2
1114491|NCT01195025|2697409|P3|COMPLETED|Third Intervention C||2
1114492|NCT01195025|2697410|P2|COMPLETED|Third Intervention C||3
1114493|NCT01195025|2697411|P1|COMPLETED|Third Intervention C||2
1114494|NCT01195025|2697407|P5|STARTED|Third Intervention C||1
1114495|NCT01195025|2697408|P4|STARTED|Third Intervention C||2
1114496|NCT01195025|2697409|P3|STARTED|Third Intervention C||2
1114497|NCT01195025|2697410|P2|STARTED|Third Intervention C||3
1114498|NCT01195025|2697411|P1|STARTED|Third Intervention C||2
1114499|NCT01195025|2697407|P5|NOT COMPLETED|Second Intervention B||0
1114500|NCT01195025|2697408|P4|NOT COMPLETED|Second Intervention B||0
1114501|NCT01195025|2697409|P3|NOT COMPLETED|Second Intervention B||0
1114502|NCT01195025|2697410|P2|NOT COMPLETED|Second Intervention B||0
1114503|NCT01195025|2697411|P1|NOT COMPLETED|Second Intervention B||0
1114504|NCT01195025|2697407|P5|COMPLETED|Second Intervention B||1
1114505|NCT01195025|2697408|P4|COMPLETED|Second Intervention B||2
1114506|NCT01195025|2697409|P3|COMPLETED|Second Intervention B||2
1114507|NCT01195025|2697410|P2|COMPLETED|Second Intervention B||3
1114508|NCT01195025|2697411|P1|COMPLETED|Second Intervention B||2
1114509|NCT01195025|2697407|P5|STARTED|Second Intervention B||1
1114510|NCT01195025|2697408|P4|STARTED|Second Intervention B||2
1114511|NCT01195025|2697409|P3|STARTED|Second Intervention B||2
1114512|NCT01195025|2697410|P2|STARTED|Second Intervention B||3
1114513|NCT01195025|2697411|P1|STARTED|Second Intervention B||2
1114514|NCT01195025|2697407|P5|NOT COMPLETED|First Intervention A||0
1114515|NCT01195025|2697408|P4|NOT COMPLETED|First Intervention A||0
1114516|NCT01195025|2697409|P3|NOT COMPLETED|First Intervention A||0
1114517|NCT01195025|2697410|P2|NOT COMPLETED|First Intervention A||0
1114518|NCT01195025|2697411|P1|NOT COMPLETED|First Intervention A||0
1114519|NCT01195025|2697407|P5|COMPLETED|First Intervention A||1
1114520|NCT01195025|2697408|P4|COMPLETED|First Intervention A||2
1114521|NCT01195025|2697409|P3|COMPLETED|First Intervention A||2
1114522|NCT01195025|2697410|P2|COMPLETED|First Intervention A||3
1114523|NCT01195025|2697411|P1|COMPLETED|First Intervention A||2
1114524|NCT01195025|2697407|P5|STARTED|First Intervention A||1
1114525|NCT01195025|2697408|P4|STARTED|First Intervention A||2
1114526|NCT01195025|2697409|P3|STARTED|First Intervention A||2
1114527|NCT01195025|2697410|P2|STARTED|First Intervention A||3
1114528|NCT01195025|2697411|P1|STARTED|First Intervention A||2
1114529|NCT01195090|2697420|P2|NOT COMPLETED|Overall Study||8
1114530|NCT01195090|2697421|P1|NOT COMPLETED|Overall Study||6
1114531|NCT01195090|2697420|P2|COMPLETED|Overall Study||52
1114532|NCT01195090|2697421|P1|COMPLETED|Overall Study||54
1114533|NCT01195090|2697420|P2|STARTED|Overall Study||60
1114534|NCT01195090|2697421|P1|STARTED|Overall Study||60
1114535|NCT01195103|2697482|P3|NOT COMPLETED|Overall Study||0
1114536|NCT01195103|2697483|P2|NOT COMPLETED|Overall Study||0
1114537|NCT01195103|2697484|P1|NOT COMPLETED|Overall Study||1
1114538|NCT01195103|2697482|P3|COMPLETED|Overall Study||5
1114539|NCT01195103|2697483|P2|COMPLETED|Overall Study||2
1114540|NCT01195103|2697484|P1|COMPLETED|Overall Study|One patient withdrew after randomization but before received study drug.|5
1114541|NCT01195103|2697482|P3|STARTED|Overall Study||5
1114542|NCT01195103|2697483|P2|STARTED|Overall Study||2
1114543|NCT01195103|2697484|P1|STARTED|Overall Study||6
1114544|NCT01195116|2697494|P2|NOT COMPLETED|Overall Study||0
1114545|NCT01195116|2697495|P1|NOT COMPLETED|Overall Study||0
1114546|NCT01195116|2697494|P2|COMPLETED|Overall Study||20
1114547|NCT01195116|2697495|P1|COMPLETED|Overall Study||21
1114548|NCT01195116|2697494|P2|STARTED|Overall Study||20
1114549|NCT01195116|2697495|P1|STARTED|Overall Study||21
1114550|NCT01195272|2697501|P1|NOT COMPLETED|Overall Study||4
1114551|NCT01195272|2697501|P1|COMPLETED|Overall Study||17
1114552|NCT01195272|2697501|P1|STARTED|Overall Study||21
1114553|NCT01195363|2697520|P2|NOT COMPLETED|Overall Study||9
1114554|NCT01195363|2697521|P1|NOT COMPLETED|Overall Study||11
1114555|NCT01195363|2697520|P2|COMPLETED|Overall Study||4
1114556|NCT01195363|2697521|P1|COMPLETED|Overall Study||4
1114557|NCT01195363|2697520|P2|STARTED|Overall Study||13
1114558|NCT01195363|2697521|P1|STARTED|Overall Study||15
1114559|NCT01195415|2697527|P1|NOT COMPLETED|Overall Study||2
1114560|NCT01195415|2697527|P1|COMPLETED|Overall Study||23
1114561|NCT01195415|2697527|P1|STARTED|Overall Study||25
1114562|NCT01195467|2697534|P1|NOT COMPLETED|Overall Study||10
1114563|NCT01195467|2697534|P1|COMPLETED|Overall Study||30
1114564|NCT01195467|2697534|P1|STARTED|Overall Study||40
1114565|NCT01195584|2697542|P3|NOT COMPLETED|Overall Study||0
1114566|NCT01195584|2697543|P2|NOT COMPLETED|Overall Study||0
1114567|NCT01195584|2697544|P1|NOT COMPLETED|Overall Study||0
1114568|NCT01195584|2697542|P3|COMPLETED|Overall Study||27
1114569|NCT01195584|2697543|P2|COMPLETED|Overall Study||25
1114570|NCT01195584|2697544|P1|COMPLETED|Overall Study||20
1114571|NCT01195584|2697542|P3|STARTED|Overall Study||27
1114572|NCT01195584|2697543|P2|STARTED|Overall Study||25
1114573|NCT01195584|2697544|P1|STARTED|Overall Study||20
1114574|NCT01195597|2697555|P1|NOT COMPLETED|Overall Study||13
1114575|NCT01195597|2697555|P1|COMPLETED|Overall Study||27
1114576|NCT01195597|2697555|P1|STARTED|Overall Study||40
1114577|NCT01195623|2697562|P2|NOT COMPLETED|Overall Study||37
1114578|NCT01195623|2697563|P1|NOT COMPLETED|Overall Study||35
1114579|NCT01195623|2697562|P2|COMPLETED|Overall Study|129 legs|108
1114580|NCT01195623|2697563|P1|COMPLETED|Overall Study|127 legs|113
1114581|NCT01195623|2697562|P2|STARTED|Overall Study|177 legs total operated|145
1114582|NCT01195623|2697563|P1|STARTED|Overall Study|166 legs total operated|148
1114583|NCT01195636|2697573|P2|NOT COMPLETED|Second Intervention (3 Weeks)||2
1114584|NCT01195636|2697574|P1|NOT COMPLETED|Second Intervention (3 Weeks)||1
1114585|NCT01195636|2697573|P2|COMPLETED|Second Intervention (3 Weeks)||27
1114586|NCT01195636|2697574|P1|COMPLETED|Second Intervention (3 Weeks)||27
1114587|NCT01195636|2697573|P2|STARTED|Second Intervention (3 Weeks)||29
1114588|NCT01195636|2697574|P1|STARTED|Second Intervention (3 Weeks)||28
1114589|NCT01195636|2697573|P2|NOT COMPLETED|Washout Period (2 Weeks)||3
1114590|NCT01195636|2697574|P1|NOT COMPLETED|Washout Period (2 Weeks)||2
1114591|NCT01195636|2697573|P2|COMPLETED|Washout Period (2 Weeks)||29
1114592|NCT01195636|2697574|P1|COMPLETED|Washout Period (2 Weeks)||28
1114593|NCT01195636|2697573|P2|STARTED|Washout Period (2 Weeks)||32
1114594|NCT01195636|2697574|P1|STARTED|Washout Period (2 Weeks)||30
1114595|NCT01195636|2697573|P2|NOT COMPLETED|First Intervention (3 Weeks)||3
1114596|NCT01195636|2697574|P1|NOT COMPLETED|First Intervention (3 Weeks)||5
1114597|NCT01195636|2697573|P2|COMPLETED|First Intervention (3 Weeks)||32
1114598|NCT01195636|2697574|P1|COMPLETED|First Intervention (3 Weeks)||30
1114599|NCT01195636|2697573|P2|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||35
1114600|NCT01195636|2697574|P1|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||33
1114601|NCT01195636|2697573|P2|STARTED|First Intervention (3 Weeks)||35
1114602|NCT01195636|2697574|P1|STARTED|First Intervention (3 Weeks)||35
1114603|NCT01195662|2697601|P3|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||1
1114604|NCT01195662|2697602|P2|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||0
1114605|NCT01195662|2697603|P1|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||3
1114606|NCT01195662|2697601|P3|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||119
1114607|NCT01195662|2697602|P2|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||209
1114608|NCT01195662|2697603|P1|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||200
1114609|NCT01195662|2697601|P3|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in the study and entered the follow up period.|120
1114610|NCT01195662|2697602|P2|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|2 participants completed treatment period but chose not to enter follow up period.|209
1114611|NCT01195662|2697603|P1|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in study and entered Follow-Up.|203
1114612|NCT01195662|2697601|P3|NOT COMPLETED|Double Blind Treatment Period||14
1114613|NCT01195662|2697602|P2|NOT COMPLETED|Double Blind Treatment Period||14
1114614|NCT01195662|2697603|P1|NOT COMPLETED|Double Blind Treatment Period||22
1114615|NCT01195662|2697601|P3|COMPLETED|Double Blind Treatment Period||119
1114616|NCT01195662|2697602|P2|COMPLETED|Double Blind Treatment Period||211
1114617|NCT01195662|2697603|P1|COMPLETED|Double Blind Treatment Period||202
1114618|NCT01195662|2697601|P3|STARTED|Double Blind Treatment Period||133
1114619|NCT01195662|2697602|P2|STARTED|Double Blind Treatment Period||225
1114620|NCT01195662|2697603|P1|STARTED|Double Blind Treatment Period||224
1114621|NCT01195675|2697631|P1|NOT COMPLETED|Overall Study||3
1114622|NCT01195675|2697631|P1|COMPLETED|Overall Study||27
1114623|NCT01195675|2697631|P1|Received Placebo 2|Overall Study||28
1114624|NCT01195675|2697631|P1|Received Placebo 1|Overall Study||29
1114625|NCT01195675|2697631|P1|Received Moxifloxacin|Overall Study||29
1114626|NCT01195675|2697631|P1|Received Empa 200mg|Overall Study||30
1114627|NCT01195675|2697631|P1|Received Empa 25mg|Overall Study||28
1114628|NCT01195675|2697631|P1|STARTED|Overall Study||30
1114629|NCT01195701|2697663|P2|NOT COMPLETED|Overall Study||5
1114630|NCT01195701|2697664|P1|NOT COMPLETED|Overall Study||0
1114631|NCT01195701|2697663|P2|COMPLETED|Overall Study||20
1114632|NCT01195701|2697664|P1|COMPLETED|Overall Study||10
1114633|NCT01195701|2697663|P2|STARTED|Overall Study||25
1114634|NCT01195701|2697664|P1|STARTED|Overall Study||10
1114635|NCT01195779|2697704|P14|NOT COMPLETED|Overall Study||0
1114636|NCT01195779|2697705|P13|NOT COMPLETED|Overall Study||0
1114637|NCT01195779|2697706|P12|NOT COMPLETED|Overall Study||0
1114638|NCT01195779|2697707|P11|NOT COMPLETED|Overall Study||0
1114639|NCT01195779|2697708|P10|NOT COMPLETED|Overall Study||0
1114640|NCT01195779|2697709|P9|NOT COMPLETED|Overall Study||0
1114641|NCT01195779|2697710|P8|NOT COMPLETED|Overall Study||0
1114642|NCT01195779|2697711|P7|NOT COMPLETED|Overall Study||0
1114643|NCT01195779|2697712|P6|NOT COMPLETED|Overall Study||0
1114644|NCT01195779|2697713|P5|NOT COMPLETED|Overall Study||0
1114645|NCT01195779|2697714|P4|NOT COMPLETED|Overall Study||0
1114646|NCT01195779|2697715|P3|NOT COMPLETED|Overall Study||0
1114647|NCT01195779|2697716|P2|NOT COMPLETED|Overall Study||0
1114648|NCT01195779|2697717|P1|NOT COMPLETED|Overall Study||0
1114649|NCT01195779|2697704|P14|COMPLETED|Overall Study||1
1114650|NCT01195779|2697705|P13|COMPLETED|Overall Study||0
1114651|NCT01195779|2697706|P12|COMPLETED|Overall Study||1
1114652|NCT01195779|2697707|P11|COMPLETED|Overall Study||0
1114653|NCT01195779|2697708|P10|COMPLETED|Overall Study||0
1114654|NCT01195779|2697709|P9|COMPLETED|Overall Study||0
1114655|NCT01195779|2697710|P8|COMPLETED|Overall Study||1
1114656|NCT01195779|2697711|P7|COMPLETED|Overall Study||0
1114657|NCT01195779|2697712|P6|COMPLETED|Overall Study||0
1114658|NCT01195779|2697713|P5|COMPLETED|Overall Study||1
1114659|NCT01195779|2697714|P4|COMPLETED|Overall Study||0
1114660|NCT01195779|2697715|P3|COMPLETED|Overall Study||0
1114661|NCT01195779|2697716|P2|COMPLETED|Overall Study||0
1114662|NCT01195779|2697717|P1|COMPLETED|Overall Study||0
1114663|NCT01195779|2697704|P14|STARTED|Overall Study||1
1114664|NCT01195779|2697705|P13|STARTED|Overall Study||0
1114665|NCT01195779|2697706|P12|STARTED|Overall Study||1
1114666|NCT01195779|2697707|P11|STARTED|Overall Study||0
1114667|NCT01195779|2697708|P10|STARTED|Overall Study||0
1114668|NCT01195779|2697709|P9|STARTED|Overall Study||0
1114669|NCT01195779|2697710|P8|STARTED|Overall Study||1
1114670|NCT01195779|2697711|P7|STARTED|Overall Study||0
1114671|NCT01195779|2697712|P6|STARTED|Overall Study||0
1114672|NCT01195779|2697713|P5|STARTED|Overall Study||1
1114673|NCT01195779|2697714|P4|STARTED|Overall Study||0
1114674|NCT01195779|2697715|P3|STARTED|Overall Study||0
1114675|NCT01195779|2697716|P2|STARTED|Overall Study||0
1114676|NCT01195779|2697717|P1|STARTED|Overall Study||0
1114677|NCT01195831|2697889|P2|NOT COMPLETED|Overall Study||10
1114678|NCT01195831|2697890|P1|NOT COMPLETED|Overall Study||8
1114679|NCT01195831|2697889|P2|COMPLETED|Overall Study||114
1114680|NCT01195831|2697890|P1|COMPLETED|Overall Study||112
1114681|NCT01195831|2697889|P2|STARTED|Overall Study||124
1114682|NCT01195831|2697890|P1|STARTED|Overall Study||120
1114683|NCT01195844|2697904|P1|NOT COMPLETED|Overall Study||40
1114684|NCT01195844|2697904|P1|COMPLETED|Overall Study||190
1114685|NCT01195844|2697904|P1|STARTED|Overall Study||230
1114686|NCT01195922|2697919|P1|NOT COMPLETED|Overall Study||0
1114687|NCT01195922|2697919|P1|COMPLETED|Overall Study||16
1114688|NCT01195922|2697919|P1|STARTED|Overall Study||16
1114689|NCT01195948|2697928|P3|NOT COMPLETED|Overall Study||2
1114690|NCT01195948|2697929|P2|NOT COMPLETED|Overall Study||1
1114691|NCT01195948|2697930|P1|NOT COMPLETED|Overall Study||0
1114692|NCT01195948|2697928|P3|COMPLETED|Overall Study||9
1114693|NCT01195948|2697929|P2|COMPLETED|Overall Study||9
1114694|NCT01195948|2697930|P1|COMPLETED|Overall Study||10
1114695|NCT01195948|2697928|P3|Week 24|Overall Study||10
1114696|NCT01195948|2697929|P2|Week 24|Overall Study||10
1114697|NCT01195948|2697930|P1|Week 24|Overall Study||10
1114698|NCT01195948|2697928|P3|STARTED|Overall Study||11
1114699|NCT01195948|2697929|P2|STARTED|Overall Study||10
1114700|NCT01195948|2697930|P1|STARTED|Overall Study||10
1114701|NCT01196026|2697962|P6|NOT COMPLETED|Overall Study||0
1114702|NCT01196026|2697963|P5|NOT COMPLETED|Overall Study||1
1114703|NCT01196026|2697964|P4|NOT COMPLETED|Overall Study||0
1114704|NCT01196026|2697965|P3|NOT COMPLETED|Overall Study||0
1114705|NCT01196026|2697966|P2|NOT COMPLETED|Overall Study||8
1114706|NCT01196026|2697967|P1|NOT COMPLETED|Overall Study||1
1114707|NCT01196026|2697962|P6|COMPLETED|Overall Study||24
1114708|NCT01196026|2697963|P5|COMPLETED|Overall Study||42
1114709|NCT01196026|2697964|P4|COMPLETED|Overall Study||10
1114710|NCT01196026|2697965|P3|COMPLETED|Overall Study||23
1114711|NCT01196026|2697966|P2|COMPLETED|Overall Study||36
1114712|NCT01196026|2697967|P1|COMPLETED|Overall Study||9
1114713|NCT01196026|2697962|P6|Completed at Day 28|Overall Study||24
1114714|NCT01196026|2697963|P5|Completed at Day 28|Overall Study||42
1114715|NCT01196026|2697964|P4|Completed at Day 28|Overall Study||10
1114716|NCT01196026|2697965|P3|Completed at Day 28|Overall Study||23
1114717|NCT01196026|2697966|P2|Completed at Day 28|Overall Study||41
1114718|NCT01196026|2697967|P1|Completed at Day 28|Overall Study||9
1114719|NCT01196026|2697962|P6|STARTED|Overall Study||24
1114720|NCT01196026|2697963|P5|STARTED|Overall Study||43
1114721|NCT01196026|2697964|P4|STARTED|Overall Study||10
1114722|NCT01196026|2697965|P3|STARTED|Overall Study||23
1114723|NCT01196026|2697966|P2|STARTED|Overall Study||44
1114724|NCT01196026|2697967|P1|STARTED|Overall Study||10
1114725|NCT01196052|2698200|P1|NOT COMPLETED|Overall Study||23
1114726|NCT01196052|2698200|P1|COMPLETED|Overall Study||130
1114727|NCT01196052|2698200|P1|Received Trastuzumab Emtansine|Overall Study||148
1114728|NCT01196052|2698200|P1|STARTED|Overall Study||153
1114729|NCT01196078|2698213|P2|NOT COMPLETED|Overall Study||37
1114730|NCT01196078|2698214|P1|NOT COMPLETED|Overall Study||33
1114731|NCT01196078|2698213|P2|COMPLETED|Overall Study||20
1114732|NCT01196078|2698214|P1|COMPLETED|Overall Study||24
1114733|NCT01196078|2698213|P2|STARTED|Overall Study||57
1114734|NCT01196078|2698214|P1|STARTED|Overall Study||57
1114735|NCT01196104|2698244|P2|NOT COMPLETED|Overall Study||5
1114736|NCT01196104|2698245|P1|NOT COMPLETED|Overall Study||4
1114737|NCT01196104|2698244|P2|COMPLETED|Overall Study||15
1114738|NCT01196104|2698245|P1|COMPLETED|Overall Study||15
1114739|NCT01196104|2698244|P2|STARTED|Overall Study||20
1114740|NCT01196104|2698245|P1|STARTED|Overall Study||19
1114741|NCT01196377|2698289|P4|NOT COMPLETED|Overall Study||0
1114742|NCT01196377|2698290|P3|NOT COMPLETED|Overall Study||0
1114743|NCT01196377|2698291|P2|NOT COMPLETED|Overall Study||0
1114744|NCT01196377|2698292|P1|NOT COMPLETED|Overall Study||0
1114745|NCT01196377|2698289|P4|COMPLETED|Overall Study||4
1114746|NCT01196377|2698290|P3|COMPLETED|Overall Study||4
1114747|NCT01196377|2698291|P2|COMPLETED|Overall Study||4
1114748|NCT01196377|2698292|P1|COMPLETED|Overall Study||4
1114749|NCT01196377|2698289|P4|STARTED|Overall Study||4
1114750|NCT01196377|2698290|P3|STARTED|Overall Study||4
1114751|NCT01196377|2698291|P2|STARTED|Overall Study||4
1114752|NCT01196377|2698292|P1|STARTED|Overall Study||4
1114753|NCT01196429|2698304|P2|NOT COMPLETED|Overall Study||0
1114754|NCT01196429|2698305|P1|NOT COMPLETED|Overall Study||3
1114755|NCT01196429|2698304|P2|COMPLETED|Overall Study||45
1114756|NCT01196429|2698305|P1|COMPLETED|Overall Study||42
1114757|NCT01196429|2698304|P2|STARTED|Overall Study||45
1114758|NCT01196429|2698305|P1|STARTED|Overall Study||45
1114759|NCT01196442|2698321|P1|NOT COMPLETED|Overall Study||0
1114760|NCT01196442|2698321|P1|COMPLETED|Overall Study||39
1114761|NCT01196442|2698321|P1|STARTED|Overall Study||39
1114762|NCT01188603|2698331|P1|NOT COMPLETED|Overall Study||0
1114763|NCT01188603|2698331|P1|COMPLETED|Overall Study||24
1114764|NCT01188603|2698331|P1|STARTED|Overall Study||24
1114765|NCT01188655|2698339|P1|NOT COMPLETED|Overall Study||13
1114766|NCT01188655|2698339|P1|COMPLETED|Overall Study||76
1114767|NCT01188655|2698339|P1|STARTED|Overall Study||89
1114768|NCT01188668|2698354|P1|NOT COMPLETED|Period 2: Coadministration ARIP + DVS SR||3
1114769|NCT01188668|2698354|P1|COMPLETED|Period 2: Coadministration ARIP + DVS SR||33
1114770|NCT01188668|2698354|P1|STARTED|Period 2: Coadministration ARIP + DVS SR||36
1114771|NCT01188668|2698354|P1|NOT COMPLETED|Period 1: ARIP Alone||2
1114772|NCT01188668|2698354|P1|COMPLETED|Period 1: ARIP Alone||36
1114773|NCT01188668|2698354|P1|STARTED|Period 1: ARIP Alone||38
1114774|NCT01188681|2698391|P4|NOT COMPLETED|Overall Study||1
1114775|NCT01188681|2698392|P3|NOT COMPLETED|Overall Study||1
1114776|NCT01188681|2698393|P2|NOT COMPLETED|Overall Study||0
1114777|NCT01188681|2698394|P1|NOT COMPLETED|Overall Study||0
1114778|NCT01188681|2698391|P4|COMPLETED|Overall Study||33
1114779|NCT01188681|2698392|P3|COMPLETED|Overall Study||32
1114780|NCT01188681|2698393|P2|COMPLETED|Overall Study||6
1114781|NCT01188681|2698394|P1|COMPLETED|Overall Study||6
1114782|NCT01188681|2698391|P4|STARTED|Overall Study|34 patients enrolled, 33 patients treated. One patient withdrew consent and was not treated.|34
1114783|NCT01188681|2698392|P3|STARTED|Overall Study|33 patients enrolled, 32 patients treated. One patient had bladder cancer and was not treated.|33
1114784|NCT01188681|2698393|P2|STARTED|Overall Study||6
1114785|NCT01188681|2698394|P1|STARTED|Overall Study||6
1114786|NCT01188694|2698411|P3|NOT COMPLETED|Overall Study||1
1114787|NCT01188694|2698412|P2|NOT COMPLETED|Overall Study||1
1114788|NCT01188694|2698413|P1|NOT COMPLETED|Overall Study||5
1114789|NCT01188694|2698411|P3|COMPLETED|Overall Study||10
1114790|NCT01188694|2698412|P2|COMPLETED|Overall Study||15
1114791|NCT01188694|2698413|P1|COMPLETED|Overall Study||10
1114792|NCT01188694|2698411|P3|STARTED|Overall Study||11
1114793|NCT01188694|2698412|P2|STARTED|Overall Study||16
1114794|NCT01188694|2698413|P1|STARTED|Overall Study||15
1114795|NCT01188772|2698425|P4|NOT COMPLETED|Overall Study||1
1114796|NCT01188772|2698426|P3|NOT COMPLETED|Overall Study||11
1114797|NCT01188772|2698427|P2|NOT COMPLETED|Overall Study||3
1114798|NCT01188772|2698428|P1|NOT COMPLETED|Overall Study||5
1114799|NCT01188772|2698425|P4|COMPLETED|Overall Study||24
1114800|NCT01188772|2698426|P3|COMPLETED|Overall Study||15
1114801|NCT01188772|2698427|P2|COMPLETED|Overall Study||45
1114802|NCT01188772|2698428|P1|COMPLETED|Overall Study||43
1114803|NCT01188772|2698425|P4|Randomized and Treated|Overall Study||25
1114804|NCT01188772|2698426|P3|Randomized and Treated|Overall Study||26
1114805|NCT01188772|2698427|P2|Randomized and Treated|Overall Study||47
1114806|NCT01188772|2698428|P1|Randomized and Treated|Overall Study||48
1114807|NCT01188772|2698425|P4|STARTED|Overall Study||25
1114808|NCT01188772|2698426|P3|STARTED|Overall Study||26
1114809|NCT01188772|2698427|P2|STARTED|Overall Study||48
1114810|NCT01188772|2698428|P1|STARTED|Overall Study||48
1114811|NCT01188798|2698485|P2|NOT COMPLETED|Overall Study||3
1114812|NCT01188798|2698486|P1|NOT COMPLETED|Overall Study||2
1114813|NCT01188798|2698485|P2|COMPLETED|Overall Study||1
1114814|NCT01188798|2698486|P1|COMPLETED|Overall Study||0
1114815|NCT01188798|2698485|P2|STARTED|Overall Study||4
1114816|NCT01188798|2698486|P1|STARTED|Overall Study||2
1114817|NCT01188811|2698496|P2|NOT COMPLETED|Overall Study||2
1114818|NCT01188811|2698497|P1|NOT COMPLETED|Overall Study||6
1114819|NCT01188811|2698496|P2|COMPLETED|Overall Study||24
1114820|NCT01188811|2698497|P1|COMPLETED|Overall Study||22
1114821|NCT01188811|2698496|P2|STARTED|Overall Study||26
1114822|NCT01188811|2698497|P1|STARTED|Overall Study||28
1114823|NCT01188928|2698511|P4|NOT COMPLETED|Overall Study||18
1114824|NCT01188928|2698512|P3|NOT COMPLETED|Overall Study||14
1114825|NCT01188928|2698513|P2|NOT COMPLETED|Overall Study||62
1114826|NCT01188928|2698514|P1|NOT COMPLETED|Overall Study||38
1114827|NCT01188928|2698511|P4|COMPLETED|Overall Study||77
1114828|NCT01188928|2698512|P3|COMPLETED|Overall Study||82
1114829|NCT01188928|2698513|P2|COMPLETED|Overall Study||417
1114830|NCT01188928|2698514|P1|COMPLETED|Overall Study||444
1114831|NCT01188928|2698511|P4|STARTED|Overall Study||95
1114832|NCT01188928|2698512|P3|STARTED|Overall Study||96
1114833|NCT01188928|2698513|P2|STARTED|Overall Study||479
1114834|NCT01188928|2698514|P1|STARTED|Overall Study||482
1114835|NCT01188967|2698538|P2|NOT COMPLETED|Overall Study||4
1114836|NCT01188967|2698539|P1|NOT COMPLETED|Overall Study||5
1114837|NCT01188967|2698538|P2|COMPLETED|Overall Study||4
1114838|NCT01188967|2698539|P1|COMPLETED|Overall Study||5
1114839|NCT01188967|2698538|P2|STARTED|Overall Study||8
1114840|NCT01188967|2698539|P1|STARTED|Overall Study||10
1114841|NCT01189032|2698554|P3|NOT COMPLETED|Overall Study||6
1114842|NCT01189032|2698555|P2|NOT COMPLETED|Overall Study||7
1114843|NCT01189032|2698556|P1|NOT COMPLETED|Overall Study||5
1114844|NCT01189032|2698554|P3|COMPLETED|Overall Study||90
1114845|NCT01189032|2698555|P2|COMPLETED|Overall Study||89
1114846|NCT01189032|2698556|P1|COMPLETED|Overall Study||89
1114847|NCT01189032|2698554|P3|STARTED|Overall Study||96
1114848|NCT01189032|2698555|P2|STARTED|Overall Study||96
1114849|NCT01189032|2698556|P1|STARTED|Overall Study||94
1114850|NCT01189071|2698566|P2|NOT COMPLETED|Overall Study||0
1114851|NCT01189071|2698567|P1|NOT COMPLETED|Overall Study||0
1114852|NCT01189071|2698566|P2|COMPLETED|Overall Study||0
1114853|NCT01189071|2698567|P1|COMPLETED|Overall Study||0
1114854|NCT01189071|2698566|P2|STARTED|Overall Study||0
1114855|NCT01189071|2698567|P1|STARTED|Overall Study||0
1114856|NCT01189110|2698577|P2|NOT COMPLETED|Overall Study||0
1114857|NCT01189110|2698578|P1|NOT COMPLETED|Overall Study||0
1114858|NCT01189110|2698577|P2|COMPLETED|Overall Study||61
1114859|NCT01189110|2698578|P1|COMPLETED|Overall Study|February, 2011|64
1114860|NCT01189110|2698577|P2|STARTED|Overall Study||61
1114861|NCT01189110|2698578|P1|STARTED|Overall Study|September, 2010|64
1114862|NCT01189123|2698586|P2|NOT COMPLETED|Overall Study||6
1114863|NCT01189123|2698587|P1|NOT COMPLETED|Overall Study||2
1114864|NCT01189123|2698586|P2|COMPLETED|Overall Study||47
1114865|NCT01189123|2698587|P1|COMPLETED|Overall Study||50
1114866|NCT01189123|2698586|P2|STARTED|Overall Study||53
1114867|NCT01189123|2698587|P1|STARTED|Overall Study||52
1114868|NCT01189136|2698597|P2|NOT COMPLETED|Overall Study||0
1114869|NCT01189136|2698598|P1|NOT COMPLETED|Overall Study||0
1114870|NCT01189136|2698597|P2|COMPLETED|Overall Study||42
1114871|NCT01189136|2698598|P1|COMPLETED|Overall Study||42
1114872|NCT01189136|2698597|P2|STARTED|Overall Study||42
1114873|NCT01189136|2698598|P1|STARTED|Overall Study||42
1114874|NCT01189201|2698610|P1|NOT COMPLETED|Overall Study||1
1114875|NCT01189201|2698610|P1|COMPLETED|Overall Study||41
1114876|NCT01189201|2698610|P1|Received Empa/Linagliptin FDC A3(Fasted)|Overall Study||24
1114877|NCT01189201|2698610|P1|Received Empa/Linagliptin FDC A1 (Fed)|Overall Study||18
1114878|NCT01189201|2698610|P1|Rec. Empa/Linagliptin Ind.Tablet(Fasted)|Overall Study||41
1114879|NCT01189201|2698610|P1|Received Empa/Linagliptin FDC A1(Fasted)|Overall Study||42
1114880|NCT01189201|2698610|P1|STARTED|Overall Study||42
1114881|NCT01189227|2698666|P2|NOT COMPLETED|Overall Study||3
1114882|NCT01189227|2698667|P1|NOT COMPLETED|Overall Study||6
1114883|NCT01189227|2698666|P2|COMPLETED|Overall Study||0
1114884|NCT01189227|2698667|P1|COMPLETED|Overall Study||0
1114885|NCT01189227|2698666|P2|STARTED|Overall Study||3
1114886|NCT01189227|2698667|P1|STARTED|Overall Study||6
1114887|NCT01189240|2698673|P3|NOT COMPLETED|Overall Study||0
1114888|NCT01189240|2698674|P2|NOT COMPLETED|Overall Study||0
1114889|NCT01189240|2698675|P1|NOT COMPLETED|Overall Study||0
1114890|NCT01189240|2698673|P3|COMPLETED|Overall Study||3
1114891|NCT01189240|2698674|P2|COMPLETED|Overall Study||6
1114892|NCT01189240|2698675|P1|COMPLETED|Overall Study||4
1114893|NCT01189240|2698673|P3|STARTED|Overall Study||3
1114894|NCT01189240|2698674|P2|STARTED|Overall Study||6
1114895|NCT01189240|2698675|P1|STARTED|Overall Study||4
1114896|NCT01189279|2698697|P3|NOT COMPLETED|Overall Study||1
1114897|NCT01189279|2698698|P2|NOT COMPLETED|Overall Study||0
1114898|NCT01189279|2698699|P1|NOT COMPLETED|Overall Study||1
1114899|NCT01189279|2698697|P3|COMPLETED|Overall Study||13
1114900|NCT01189279|2698698|P2|COMPLETED|Overall Study||14
1114901|NCT01189279|2698699|P1|COMPLETED|Overall Study||13
1114902|NCT01189279|2698697|P3|STARTED|Overall Study||14
1114903|NCT01189279|2698698|P2|STARTED|Overall Study||14
1114904|NCT01189279|2698699|P1|STARTED|Overall Study||14
1114905|NCT01189292|2698721|P2|NOT COMPLETED|Per Protocol Analysis||16
1114906|NCT01189292|2698722|P1|NOT COMPLETED|Per Protocol Analysis||11
1114907|NCT01189292|2698721|P2|COMPLETED|Per Protocol Analysis||60
1114908|NCT01189292|2698722|P1|COMPLETED|Per Protocol Analysis||65
1114909|NCT01189292|2698721|P2|STARTED|Per Protocol Analysis||76
1114910|NCT01189292|2698722|P1|STARTED|Per Protocol Analysis||76
1114911|NCT01189292|2698721|P2|NOT COMPLETED|Intention to Treat Analysis||0
1114912|NCT01189292|2698722|P1|NOT COMPLETED|Intention to Treat Analysis||0
1114913|NCT01189292|2698721|P2|COMPLETED|Intention to Treat Analysis||76
1114914|NCT01189292|2698722|P1|COMPLETED|Intention to Treat Analysis||76
1114915|NCT01189292|2698721|P2|STARTED|Intention to Treat Analysis||76
1114916|NCT01189292|2698722|P1|STARTED|Intention to Treat Analysis||76
1114917|NCT01189370|2698740|P3|NOT COMPLETED|Dose Level 3||6
1114918|NCT01189370|2698741|P2|NOT COMPLETED|Dose Level 3||0
1114919|NCT01189370|2698742|P1|NOT COMPLETED|Dose Level 3||0
1114920|NCT01189370|2698740|P3|COMPLETED|Dose Level 3||6
1114921|NCT01189370|2698741|P2|COMPLETED|Dose Level 3||0
1114922|NCT01189370|2698742|P1|COMPLETED|Dose Level 3||0
1114923|NCT01189370|2698740|P3|STARTED|Dose Level 3||12
1114924|NCT01189370|2698741|P2|STARTED|Dose Level 3||0
1114925|NCT01189370|2698742|P1|STARTED|Dose Level 3||0
1114926|NCT01189370|2698740|P3|NOT COMPLETED|Dose Level 2||0
1114927|NCT01189370|2698741|P2|NOT COMPLETED|Dose Level 2||4
1114928|NCT01189370|2698742|P1|NOT COMPLETED|Dose Level 2||0
1114929|NCT01189370|2698740|P3|COMPLETED|Dose Level 2||0
1114930|NCT01189370|2698741|P2|COMPLETED|Dose Level 2||12
1114931|NCT01189370|2698742|P1|COMPLETED|Dose Level 2||0
1114932|NCT01189370|2698740|P3|STARTED|Dose Level 2||0
1114933|NCT01189370|2698741|P2|STARTED|Dose Level 2||16
1114934|NCT01189370|2698742|P1|STARTED|Dose Level 2||0
1114935|NCT01189370|2698740|P3|NOT COMPLETED|Dose Level 1||0
1114936|NCT01189370|2698741|P2|NOT COMPLETED|Dose Level 1||0
1114937|NCT01189370|2698742|P1|NOT COMPLETED|Dose Level 1||9
1114938|NCT01189370|2698740|P3|COMPLETED|Dose Level 1||0
1114939|NCT01189370|2698741|P2|COMPLETED|Dose Level 1||0
1114940|NCT01189370|2698742|P1|COMPLETED|Dose Level 1||16
1114941|NCT01189370|2698740|P3|STARTED|Dose Level 1||0
1114942|NCT01189370|2698741|P2|STARTED|Dose Level 1||0
1114943|NCT01189370|2698742|P1|STARTED|Dose Level 1||25
1114944|NCT01189435|2698749|P1|NOT COMPLETED|Overall Study||2
1114945|NCT01189435|2698749|P1|COMPLETED|Overall Study||0
1114946|NCT01189435|2698749|P1|STARTED|Overall Study||2
1114947|NCT01189461|2698753|P1|NOT COMPLETED|Overall Study||34
1114948|NCT01189461|2698753|P1|COMPLETED|Overall Study||12
1114949|NCT01189461|2698753|P1|STARTED|Overall Study||46
1114950|NCT01189487|2698760|P1|NOT COMPLETED|Overall Study||3
1114951|NCT01189487|2698760|P1|COMPLETED|Overall Study||44
1114952|NCT01189487|2698760|P1|STARTED|Overall Study|Treated participants|47
1114953|NCT01189500|2698768|P1|NOT COMPLETED|Period 2: Coadministration TAMOX+DVS SR||1
1114954|NCT01189500|2698768|P1|COMPLETED|Period 2: Coadministration TAMOX+DVS SR||28
1114955|NCT01189500|2698768|P1|STARTED|Period 2: Coadministration TAMOX+DVS SR||29
1114956|NCT01189500|2698768|P1|NOT COMPLETED|Period 1: TAMOX Alone||1
1114957|NCT01189500|2698768|P1|COMPLETED|Period 1: TAMOX Alone||29
1114958|NCT01189500|2698768|P1|STARTED|Period 1: TAMOX Alone||30
1114959|NCT01189604|2698836|P7|NOT COMPLETED|Overall Study||1
1114960|NCT01189604|2698837|P6|NOT COMPLETED|Overall Study||1
1114961|NCT01189604|2698838|P5|NOT COMPLETED|Overall Study||2
1114962|NCT01189604|2698839|P4|NOT COMPLETED|Overall Study||0
1114963|NCT01189604|2698840|P3|NOT COMPLETED|Overall Study||0
1114964|NCT01189604|2698841|P2|NOT COMPLETED|Overall Study||1
1114965|NCT01189604|2698842|P1|NOT COMPLETED|Overall Study||1
1114966|NCT01189604|2698836|P7|COMPLETED|Overall Study||9
1114967|NCT01189604|2698837|P6|COMPLETED|Overall Study||10
1114968|NCT01189604|2698838|P5|COMPLETED|Overall Study||18
1114969|NCT01189604|2698839|P4|COMPLETED|Overall Study||20
1114970|NCT01189604|2698840|P3|COMPLETED|Overall Study||20
1114971|NCT01189604|2698841|P2|COMPLETED|Overall Study||20
1114972|NCT01189604|2698842|P1|COMPLETED|Overall Study||20
1114973|NCT01189604|2698836|P7|Administered Study Drug|Overall Study||10
1114974|NCT01189604|2698837|P6|Administered Study Drug|Overall Study||10
1114975|NCT01189604|2698838|P5|Administered Study Drug|Overall Study||20
1114976|NCT01189604|2698839|P4|Administered Study Drug|Overall Study||20
1114977|NCT01189604|2698840|P3|Administered Study Drug|Overall Study||20
1114978|NCT01189604|2698841|P2|Administered Study Drug|Overall Study||20
1114979|NCT01189604|2698842|P1|Administered Study Drug|Overall Study||20
1114980|NCT01189604|2698836|P7|STARTED|Overall Study||10
1114981|NCT01189604|2698837|P6|STARTED|Overall Study||11
1114982|NCT01189604|2698838|P5|STARTED|Overall Study||20
1114983|NCT01189604|2698839|P4|STARTED|Overall Study||20
1114984|NCT01189604|2698840|P3|STARTED|Overall Study||20
1114985|NCT01189604|2698841|P2|STARTED|Overall Study||21
1114986|NCT01189604|2698842|P1|STARTED|Overall Study||21
1114987|NCT01189617|2698888|P2|NOT COMPLETED|Overall Study||0
1114988|NCT01189617|2698889|P1|NOT COMPLETED|Overall Study||0
1114989|NCT01189617|2698888|P2|COMPLETED|Overall Study||35
1114990|NCT01189617|2698889|P1|COMPLETED|Overall Study||35
1114991|NCT01189617|2698888|P2|STARTED|Overall Study||35
1114992|NCT01189617|2698889|P1|STARTED|Overall Study||35
1114993|NCT01189747|2698897|P2|NOT COMPLETED|Overall Study||18
1114994|NCT01189747|2698898|P1|NOT COMPLETED|Overall Study||12
1114995|NCT01189747|2698897|P2|COMPLETED|Overall Study||206
1114996|NCT01189747|2698898|P1|COMPLETED|Overall Study||210
1114997|NCT01189747|2698897|P2|STARTED|Overall Study||224
1114998|NCT01189747|2698898|P1|STARTED|Overall Study||222
1114999|NCT01189760|2698923|P3|NOT COMPLETED|Overall Study||51
1115000|NCT01189760|2698924|P2|NOT COMPLETED|Overall Study||23
1115001|NCT01189760|2698925|P1|NOT COMPLETED|Overall Study||14
1115002|NCT01189760|2698923|P3|COMPLETED|Overall Study||255
1115003|NCT01189760|2698924|P2|COMPLETED|Overall Study||283
1115004|NCT01189760|2698925|P1|COMPLETED|Overall Study||291
1115005|NCT01189760|2698923|P3|STARTED|Overall Study||306
1115006|NCT01189760|2698924|P2|STARTED|Overall Study||306
1115007|NCT01189760|2698925|P1|STARTED|Overall Study||305
1115008|NCT01189812|2698959|P2|NOT COMPLETED|Overall Study||8
1115009|NCT01189812|2698960|P1|NOT COMPLETED|Overall Study||8
1115010|NCT01189812|2698959|P2|COMPLETED|Overall Study||32
1115011|NCT01189812|2698960|P1|COMPLETED|Overall Study||32
1115012|NCT01189812|2698959|P2|STARTED|Overall Study||40
1115013|NCT01189812|2698960|P1|STARTED|Overall Study||40
1115014|NCT01189890|2698968|P2|NOT COMPLETED|Overall Study||39
1115015|NCT01189890|2698969|P1|NOT COMPLETED|Overall Study||37
1115016|NCT01189890|2698968|P2|COMPLETED|Overall Study||200
1115017|NCT01189890|2698969|P1|COMPLETED|Overall Study||204
1115018|NCT01189890|2698968|P2|STARTED|Overall Study|3 randomized glimepiride participants did not receive study drug.|239
1115019|NCT01189890|2698969|P1|STARTED|Overall Study||241
1115020|NCT01190007|2698989|P1|NOT COMPLETED|Overall Study||14
1115021|NCT01190007|2698989|P1|COMPLETED|Overall Study||145
1115022|NCT01190007|2698989|P1|STARTED|Overall Study|Treated|159
1115023|NCT01190085|2699007|P3|NOT COMPLETED|Overall Study||0
1115024|NCT01190085|2699008|P2|NOT COMPLETED|Overall Study||0
1115025|NCT01190085|2699009|P1|NOT COMPLETED|Overall Study||0
1115026|NCT01190085|2699007|P3|COMPLETED|Overall Study||18
1115027|NCT01190085|2699008|P2|COMPLETED|Overall Study||14
1115028|NCT01190085|2699009|P1|COMPLETED|Overall Study||13
1115029|NCT01190085|2699007|P3|STARTED|Overall Study||18
1115030|NCT01190085|2699008|P2|STARTED|Overall Study||14
1115031|NCT01190085|2699009|P1|STARTED|Overall Study||13
1115032|NCT01190098|2699025|P2|NOT COMPLETED|Overall Study||2
1115033|NCT01190098|2699026|P1|NOT COMPLETED|Overall Study||3
1115034|NCT01190098|2699025|P2|COMPLETED|Overall Study||8
1115035|NCT01190098|2699026|P1|COMPLETED|Overall Study||39
1115036|NCT01190098|2699025|P2|STARTED|Overall Study||10
1115037|NCT01190098|2699026|P1|STARTED|Overall Study||42
1115038|NCT01190124|2699049|P3|NOT COMPLETED|Overall Study||1
1115039|NCT01190124|2699050|P2|NOT COMPLETED|Overall Study||0
1115040|NCT01190124|2699051|P1|NOT COMPLETED|Overall Study||17
1115041|NCT01190124|2699049|P3|COMPLETED|Overall Study||19
1115042|NCT01190124|2699050|P2|COMPLETED|Overall Study||24
1115043|NCT01190124|2699051|P1|COMPLETED|Overall Study||90
1115044|NCT01190124|2699049|P3|STARTED|Overall Study||20
1115045|NCT01190124|2699050|P2|STARTED|Overall Study||24
1115046|NCT01190124|2699051|P1|STARTED|Overall Study||107
1115047|NCT01190150|2699089|P2|NOT COMPLETED|Second Treatment||0
1115048|NCT01190150|2699090|P1|NOT COMPLETED|Second Treatment||0
1115049|NCT01190150|2699089|P2|COMPLETED|Second Treatment||7
1115050|NCT01190150|2699090|P1|COMPLETED|Second Treatment||10
1115051|NCT01190150|2699089|P2|STARTED|Second Treatment||7
1115052|NCT01190150|2699090|P1|STARTED|Second Treatment||10
1115053|NCT01190150|2699089|P2|NOT COMPLETED|Washout||2
1115054|NCT01190150|2699090|P1|NOT COMPLETED|Washout||0
1115055|NCT01190150|2699089|P2|COMPLETED|Washout||7
1115056|NCT01190150|2699090|P1|COMPLETED|Washout||10
1115057|NCT01190150|2699089|P2|STARTED|Washout||9
1115058|NCT01190150|2699090|P1|STARTED|Washout||10
1115059|NCT01190150|2699089|P2|NOT COMPLETED|First Treatment||0
1115060|NCT01190150|2699090|P1|NOT COMPLETED|First Treatment||1
1115061|NCT01190150|2699089|P2|COMPLETED|First Treatment||9
1115062|NCT01190150|2699090|P1|COMPLETED|First Treatment||10
1115063|NCT01190150|2699089|P2|STARTED|First Treatment|Randomized, as well as Safety and PK populations|9
1115064|NCT01190150|2699090|P1|STARTED|First Treatment|Randomized, as well as Safety and PK populations|11
1115065|NCT01190215|2699116|P2|NOT COMPLETED|Up to Month 6||0
1115066|NCT01190215|2699117|P1|NOT COMPLETED|Up to Month 6||2
1115067|NCT01190215|2699116|P2|COMPLETED|Up to Month 6||39
1115068|NCT01190215|2699117|P1|COMPLETED|Up to Month 6||36
1115069|NCT01190215|2699116|P2|STARTED|Up to Month 6||39
1115070|NCT01190215|2699117|P1|STARTED|Up to Month 6||38
1115071|NCT01190215|2699116|P2|NOT COMPLETED|Up to Day 28||0
1115072|NCT01190215|2699117|P1|NOT COMPLETED|Up to Day 28||0
1115073|NCT01190215|2699116|P2|COMPLETED|Up to Day 28||39
1115074|NCT01190215|2699117|P1|COMPLETED|Up to Day 28||38
1115075|NCT01190215|2699116|P2|STARTED|Up to Day 28||39
1115076|NCT01190215|2699117|P1|STARTED|Up to Day 28||38
1115077|NCT01196741|2699187|P2|NOT COMPLETED|Overall Study||28
1115078|NCT01196741|2699188|P1|NOT COMPLETED|Overall Study||60
1115079|NCT01196741|2699187|P2|COMPLETED|Overall Study||8
1115080|NCT01196741|2699188|P1|COMPLETED|Overall Study||11
1115081|NCT01196741|2699187|P2|STARTED|Overall Study||36
1115082|NCT01196741|2699188|P1|STARTED|Overall Study||71
1115083|NCT01196923|2699202|P1|NOT COMPLETED|Overall Study||0
1115084|NCT01196923|2699202|P1|COMPLETED|Overall Study||20
1115085|NCT01196923|2699202|P1|STARTED|Overall Study||20
1115086|NCT01196975|2699211|P5|NOT COMPLETED|Overall Study||13
1115087|NCT01196975|2699212|P4|NOT COMPLETED|Overall Study||6
1115088|NCT01196975|2699213|P3|NOT COMPLETED|Overall Study||5
1115089|NCT01196975|2699214|P2|NOT COMPLETED|Overall Study||9
1115090|NCT01196975|2699215|P1|NOT COMPLETED|Overall Study||15
1115091|NCT01196975|2699211|P5|COMPLETED|Overall Study||205
1115092|NCT01196975|2699212|P4|COMPLETED|Overall Study||207
1115093|NCT01196975|2699213|P3|COMPLETED|Overall Study||420
1115094|NCT01196975|2699214|P2|COMPLETED|Overall Study||415
1115095|NCT01196975|2699215|P1|COMPLETED|Overall Study||408
1115096|NCT01196975|2699211|P5|STARTED|Overall Study||218
1115097|NCT01196975|2699212|P4|STARTED|Overall Study||213
1115098|NCT01196975|2699213|P3|STARTED|Overall Study||425
1115099|NCT01196975|2699214|P2|STARTED|Overall Study||424
1115100|NCT01196975|2699215|P1|STARTED|Overall Study||423
1115101|NCT01196988|2699351|P4|NOT COMPLETED|Overall Study||1
1115102|NCT01196988|2699352|P3|NOT COMPLETED|Overall Study||25
1115103|NCT01196988|2699353|P2|NOT COMPLETED|Overall Study||32
1115104|NCT01196988|2699354|P1|NOT COMPLETED|Overall Study||24
1115105|NCT01196988|2699351|P4|COMPLETED|Overall Study||276
1115106|NCT01196988|2699352|P3|COMPLETED|Overall Study||886
1115107|NCT01196988|2699353|P2|COMPLETED|Overall Study||880
1115108|NCT01196988|2699354|P1|COMPLETED|Overall Study||891
1115109|NCT01196988|2699351|P4|STARTED|Overall Study||277
1115110|NCT01196988|2699352|P3|STARTED|Overall Study||911
1115111|NCT01196988|2699353|P2|STARTED|Overall Study||912
1115112|NCT01196988|2699354|P1|STARTED|Overall Study||915
1115113|NCT01197898|2699445|P2|NOT COMPLETED|Overall Study||0
1115114|NCT01197898|2699446|P1|NOT COMPLETED|Overall Study||0
1115115|NCT01197898|2699445|P2|COMPLETED|Overall Study||5
1115116|NCT01197898|2699446|P1|COMPLETED|Overall Study||5
1115117|NCT01197898|2699445|P2|STARTED|Overall Study||5
1115118|NCT01197898|2699446|P1|STARTED|Overall Study||5
1115119|NCT01197911|2699455|P3|NOT COMPLETED|Overall Study||1
1115120|NCT01197911|2699456|P2|NOT COMPLETED|Overall Study||0
1115121|NCT01197911|2699457|P1|NOT COMPLETED|Overall Study||0
1115122|NCT01197911|2699455|P3|COMPLETED|Overall Study||9
1115123|NCT01197911|2699456|P2|COMPLETED|Overall Study||10
1115124|NCT01197911|2699457|P1|COMPLETED|Overall Study||18
1115125|NCT01197911|2699455|P3|STARTED|Overall Study||10
1115126|NCT01197911|2699456|P2|STARTED|Overall Study||10
1115127|NCT01197911|2699457|P1|STARTED|Overall Study||18
1115128|NCT01198145|2699542|P2|NOT COMPLETED|Overall Study||1
1115129|NCT01198145|2699543|P1|NOT COMPLETED|Overall Study||1
1115130|NCT01198145|2699542|P2|COMPLETED|Overall Study||42
1115131|NCT01198145|2699543|P1|COMPLETED|Overall Study||43
1115132|NCT01198145|2699542|P2|STARTED|Overall Study||43
1115133|NCT01198145|2699543|P1|STARTED|Overall Study||44
1115134|NCT01198275|2699565|P2|NOT COMPLETED|Overall Study||5
1115135|NCT01198275|2699566|P1|NOT COMPLETED|Overall Study||6
1115136|NCT01198275|2699565|P2|COMPLETED|Overall Study||94
1115137|NCT01198275|2699566|P1|COMPLETED|Overall Study||94
1115138|NCT01198275|2699565|P2|STARTED|Overall Study||99
1115139|NCT01198275|2699566|P1|STARTED|Overall Study||100
1115140|NCT01198327|2699572|P1|NOT COMPLETED|Overall Study||10
1115141|NCT01198327|2699572|P1|COMPLETED|Overall Study||56
1115142|NCT01198327|2699572|P1|STARTED|Overall Study||66
1115143|NCT01198366|2699586|P6|NOT COMPLETED|Overall Study||13
1115144|NCT01198366|2699587|P5|NOT COMPLETED|Overall Study||15
1115145|NCT01198366|2699588|P4|NOT COMPLETED|Overall Study||5
1115146|NCT01198366|2699589|P3|NOT COMPLETED|Overall Study||8
1115147|NCT01198366|2699590|P2|NOT COMPLETED|Overall Study||7
1115148|NCT01198366|2699591|P1|NOT COMPLETED|Overall Study||12
1115149|NCT01198366|2699586|P6|COMPLETED|Overall Study||128
1115150|NCT01198366|2699587|P5|COMPLETED|Overall Study||125
1115151|NCT01198366|2699588|P4|COMPLETED|Overall Study||47
1115152|NCT01198366|2699589|P3|COMPLETED|Overall Study||43
1115153|NCT01198366|2699590|P2|COMPLETED|Overall Study||44
1115154|NCT01198366|2699591|P1|COMPLETED|Overall Study||40
1115155|NCT01198366|2699586|P6|STARTED|Overall Study||141
1115156|NCT01198366|2699587|P5|STARTED|Overall Study||140
1115157|NCT01198366|2699588|P4|STARTED|Overall Study||52
1115158|NCT01198366|2699589|P3|STARTED|Overall Study||51
1115159|NCT01198366|2699590|P2|STARTED|Overall Study||51
1115160|NCT01198366|2699591|P1|STARTED|Overall Study||52
1115161|NCT01198509|2699635|P6|NOT COMPLETED|Overall Study||0
1115162|NCT01198509|2699636|P5|NOT COMPLETED|Overall Study||0
1115163|NCT01198509|2699637|P4|NOT COMPLETED|Overall Study||0
1115164|NCT01198509|2699638|P3|NOT COMPLETED|Overall Study||0
1115165|NCT01198509|2699639|P2|NOT COMPLETED|Overall Study||0
1115166|NCT01198509|2699640|P1|NOT COMPLETED|Overall Study||1
1115167|NCT01198509|2699635|P6|COMPLETED|Overall Study||58
1115168|NCT01198509|2699636|P5|COMPLETED|Overall Study||20
1115169|NCT01198509|2699637|P4|COMPLETED|Overall Study||66
1115170|NCT01198509|2699638|P3|COMPLETED|Overall Study||19
1115171|NCT01198509|2699639|P2|COMPLETED|Overall Study||10
1115172|NCT01198509|2699640|P1|COMPLETED|Overall Study|Patient declined further participation after enrollment and allocation to treatment group|4
1115173|NCT01198509|2699635|P6|STARTED|Overall Study||58
1115174|NCT01198509|2699636|P5|STARTED|Overall Study||20
1115175|NCT01198509|2699637|P4|STARTED|Overall Study||66
1115176|NCT01198509|2699638|P3|STARTED|Overall Study||19
1115177|NCT01198509|2699639|P2|STARTED|Overall Study||10
1115178|NCT01198509|2699640|P1|STARTED|Overall Study||5
1115179|NCT01198548|2699657|P1|NOT COMPLETED|Overall Study||10
1115180|NCT01198548|2699657|P1|COMPLETED|Overall Study||0
1115181|NCT01198548|2699657|P1|STARTED|Overall Study||10
1115182|NCT01198574|2699670|P4|NOT COMPLETED|Overall Study||4
1115183|NCT01198574|2699671|P3|NOT COMPLETED|Overall Study||1
1115184|NCT01198574|2699672|P2|NOT COMPLETED|Overall Study||1
1115185|NCT01198574|2699673|P1|NOT COMPLETED|Overall Study||4
1115186|NCT01198574|2699670|P4|COMPLETED|Overall Study||98
1115187|NCT01198574|2699671|P3|COMPLETED|Overall Study||99
1115188|NCT01198574|2699672|P2|COMPLETED|Overall Study||101
1115189|NCT01198574|2699673|P1|COMPLETED|Overall Study||94
1115190|NCT01198574|2699670|P4|STARTED|Overall Study||102
1115191|NCT01198574|2699671|P3|STARTED|Overall Study||100
1115192|NCT01198574|2699672|P2|STARTED|Overall Study||102
1115193|NCT01198574|2699673|P1|STARTED|Overall Study||98
1115194|NCT01198600|2699691|P4|NOT COMPLETED|Phase 3: 43 Days of Wear||0
1115195|NCT01198600|2699692|P3|NOT COMPLETED|Phase 3: 43 Days of Wear||0
1115196|NCT01198600|2699693|P2|NOT COMPLETED|Phase 3: 43 Days of Wear||0
1115197|NCT01198600|2699694|P1|NOT COMPLETED|Phase 3: 43 Days of Wear||0
1115198|NCT01198600|2699691|P4|COMPLETED|Phase 3: 43 Days of Wear||38
1115199|NCT01198600|2699692|P3|COMPLETED|Phase 3: 43 Days of Wear||0
1115200|NCT01198600|2699693|P2|COMPLETED|Phase 3: 43 Days of Wear||0
1115201|NCT01198600|2699694|P1|COMPLETED|Phase 3: 43 Days of Wear||0
1115202|NCT01198600|2699691|P4|STARTED|Phase 3: 43 Days of Wear||38
1115203|NCT01198600|2699692|P3|STARTED|Phase 3: 43 Days of Wear||0
1115204|NCT01198600|2699693|P2|STARTED|Phase 3: 43 Days of Wear||0
1115205|NCT01198600|2699694|P1|STARTED|Phase 3: 43 Days of Wear||0
1115206|NCT01198600|2699691|P4|NOT COMPLETED|Phase 2: 56 Days of Wear||0
1115207|NCT01198600|2699692|P3|NOT COMPLETED|Phase 2: 56 Days of Wear||5
1115208|NCT01198600|2699693|P2|NOT COMPLETED|Phase 2: 56 Days of Wear||0
1115209|NCT01198600|2699694|P1|NOT COMPLETED|Phase 2: 56 Days of Wear||0
1115210|NCT01198600|2699691|P4|COMPLETED|Phase 2: 56 Days of Wear||0
1115211|NCT01198600|2699692|P3|COMPLETED|Phase 2: 56 Days of Wear||62
1115212|NCT01198600|2699693|P2|COMPLETED|Phase 2: 56 Days of Wear||0
1115213|NCT01198600|2699694|P1|COMPLETED|Phase 2: 56 Days of Wear||0
1115214|NCT01198600|2699691|P4|STARTED|Phase 2: 56 Days of Wear||0
1115215|NCT01198600|2699692|P3|STARTED|Phase 2: 56 Days of Wear||67
1115216|NCT01198600|2699693|P2|STARTED|Phase 2: 56 Days of Wear||0
1115217|NCT01198600|2699694|P1|STARTED|Phase 2: 56 Days of Wear||0
1115218|NCT01198600|2699691|P4|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
1115219|NCT01198600|2699692|P3|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
1115220|NCT01198600|2699693|P2|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||1
1115221|NCT01198600|2699694|P1|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
1115222|NCT01198600|2699691|P4|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
1115223|NCT01198600|2699692|P3|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
1115224|NCT01198600|2699693|P2|COMPLETED|Phase 1: Period Two, 30 Days of Wear||35
1115225|NCT01198600|2699694|P1|COMPLETED|Phase 1: Period Two, 30 Days of Wear||32
1115226|NCT01198600|2699691|P4|STARTED|Phase 1: Period Two, 30 Days of Wear||0
1115227|NCT01198600|2699692|P3|STARTED|Phase 1: Period Two, 30 Days of Wear||0
1115228|NCT01198600|2699693|P2|STARTED|Phase 1: Period Two, 30 Days of Wear||36
1115229|NCT01198600|2699694|P1|STARTED|Phase 1: Period Two, 30 Days of Wear|One participant discontinued between Period One and Period Two due to unconvenience.|32
1115230|NCT01198600|2699691|P4|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
1115231|NCT01198600|2699692|P3|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
1115232|NCT01198600|2699693|P2|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||1
1115233|NCT01198600|2699694|P1|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||2
1115234|NCT01198600|2699691|P4|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
1115235|NCT01198600|2699692|P3|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
1115236|NCT01198600|2699693|P2|COMPLETED|Phase 1: Period One, 30 Days of Wear||36
1115237|NCT01198600|2699694|P1|COMPLETED|Phase 1: Period One, 30 Days of Wear||33
1115238|NCT01198600|2699691|P4|STARTED|Phase 1: Period One, 30 Days of Wear||0
1115239|NCT01198600|2699692|P3|STARTED|Phase 1: Period One, 30 Days of Wear||0
1115240|NCT01198600|2699693|P2|STARTED|Phase 1: Period One, 30 Days of Wear||37
1115241|NCT01198600|2699694|P1|STARTED|Phase 1: Period One, 30 Days of Wear||35
1115242|NCT01198691|2699718|P2|NOT COMPLETED|6 Week Post-partum Survey||24
1115243|NCT01198691|2699719|P1|NOT COMPLETED|6 Week Post-partum Survey||29
1115244|NCT01198691|2699718|P2|COMPLETED|6 Week Post-partum Survey||26
1115245|NCT01198691|2699719|P1|COMPLETED|6 Week Post-partum Survey||21
1115246|NCT01198691|2699718|P2|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
1115247|NCT01198691|2699719|P1|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
1115248|NCT01198691|2699718|P2|NOT COMPLETED|Survey Prior to Discharge||33
1115249|NCT01198691|2699719|P1|NOT COMPLETED|Survey Prior to Discharge||32
1115250|NCT01198691|2699718|P2|COMPLETED|Survey Prior to Discharge||17
1115251|NCT01198691|2699719|P1|COMPLETED|Survey Prior to Discharge||18
1115252|NCT01198691|2699718|P2|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
1115253|NCT01198691|2699719|P1|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
1115254|NCT01198691|2699718|P2|NOT COMPLETED|Completed VAS Score at Discharge||6
1115255|NCT01198691|2699719|P1|NOT COMPLETED|Completed VAS Score at Discharge||5
1115256|NCT01198691|2699718|P2|COMPLETED|Completed VAS Score at Discharge||44
1115257|NCT01198691|2699719|P1|COMPLETED|Completed VAS Score at Discharge||45
1115258|NCT01198691|2699718|P2|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
1115259|NCT01198691|2699719|P1|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
1115260|NCT01198691|2699718|P2|NOT COMPLETED|Completed VAS Score Postop Day 1||4
1115261|NCT01198691|2699719|P1|NOT COMPLETED|Completed VAS Score Postop Day 1||3
1115262|NCT01198691|2699718|P2|COMPLETED|Completed VAS Score Postop Day 1||46
1115263|NCT01198691|2699719|P1|COMPLETED|Completed VAS Score Postop Day 1||47
1115264|NCT01198691|2699718|P2|STARTED|Completed VAS Score Postop Day 1||50
1115265|NCT01198691|2699719|P1|STARTED|Completed VAS Score Postop Day 1||50
1115266|NCT01198691|2699718|P2|NOT COMPLETED|Completed Surgery -Received Intervention||0
1115267|NCT01198691|2699719|P1|NOT COMPLETED|Completed Surgery -Received Intervention||0
1115268|NCT01198691|2699718|P2|COMPLETED|Completed Surgery -Received Intervention||50
1115269|NCT01198691|2699719|P1|COMPLETED|Completed Surgery -Received Intervention||50
1115270|NCT01198691|2699718|P2|STARTED|Completed Surgery -Received Intervention||50
1115271|NCT01198691|2699719|P1|STARTED|Completed Surgery -Received Intervention||50
1115272|NCT01198756|2699735|P4|NOT COMPLETED|Overall Study||26
1115273|NCT01198756|2699736|P3|NOT COMPLETED|Overall Study||30
1115274|NCT01198756|2699737|P2|NOT COMPLETED|Overall Study||40
1115275|NCT01198756|2699738|P1|NOT COMPLETED|Overall Study||38
1115276|NCT01198756|2699735|P4|COMPLETED|Overall Study||275
1115277|NCT01198756|2699736|P3|COMPLETED|Overall Study||902
1115278|NCT01198756|2699737|P2|COMPLETED|Overall Study||889
1115279|NCT01198756|2699738|P1|COMPLETED|Overall Study||894
1115280|NCT01198756|2699735|P4|STARTED|Overall Study||301
1115281|NCT01198756|2699736|P3|STARTED|Overall Study||932
1115282|NCT01198756|2699737|P2|STARTED|Overall Study||929
1115283|NCT01198756|2699738|P1|STARTED|Overall Study||932
1115284|NCT01198769|2699834|P1|NOT COMPLETED|Overall Study||0
1115285|NCT01198769|2699834|P1|COMPLETED|Overall Study||15
1115286|NCT01198769|2699834|P1|STARTED|Overall Study||15
1115287|NCT01198795|2699843|P1|NOT COMPLETED|Overall Study||82
1115288|NCT01198795|2699843|P1|COMPLETED|Overall Study||80
1115289|NCT01198795|2699843|P1|STARTED|Overall Study||162
1115290|NCT01198873|2699849|P2|NOT COMPLETED|Overall Study||32
1115291|NCT01198873|2699850|P1|NOT COMPLETED|Overall Study||37
1115292|NCT01198873|2699849|P2|COMPLETED|Overall Study||3
1115293|NCT01198873|2699850|P1|COMPLETED|Overall Study||4
1115294|NCT01198873|2699849|P2|Evaluable for Efficacy|Overall Study|9 participants discontinued before completing 3-month treatment and were not assessed post-baseline|26
1115295|NCT01198873|2699850|P1|Evaluable for Efficacy|Overall Study|8 participants discontinued before completing 3-month treatment and were not assessed post-baseline|33
1115296|NCT01198873|2699849|P2|Treated|Overall Study||35
1115297|NCT01198873|2699850|P1|Treated|Overall Study||41
1115298|NCT01198873|2699849|P2|STARTED|Overall Study||35
1115299|NCT01198873|2699850|P1|STARTED|Overall Study||41
1115300|NCT01198977|2699866|P2|NOT COMPLETED|Overall Study||0
1115301|NCT01198977|2699867|P1|NOT COMPLETED|Overall Study||1
1115302|NCT01198977|2699866|P2|COMPLETED|Overall Study||33
1115303|NCT01198977|2699867|P1|COMPLETED|Overall Study||30
1115304|NCT01198977|2699866|P2|STARTED|Overall Study||33
1115305|NCT01198977|2699867|P1|STARTED|Overall Study||31
1115306|NCT01199016|2699877|P1|NOT COMPLETED|Overall Study||77
1115307|NCT01199016|2699877|P1|COMPLETED|Overall Study||162
1115308|NCT01199016|2699877|P1|Treated|Overall Study||236
1115309|NCT01199016|2699877|P1|STARTED|Overall Study||239
1115310|NCT01199042|2699884|P1|NOT COMPLETED|At Home (3 Months)||1
1115311|NCT01199042|2699884|P1|COMPLETED|At Home (3 Months)||26
1115312|NCT01199042|2699884|P1|STARTED|At Home (3 Months)||27
1115313|NCT01199042|2699884|P1|NOT COMPLETED|Sleep Laboratory (3 Nights)||2
1115314|NCT01199042|2699884|P1|COMPLETED|Sleep Laboratory (3 Nights)||27
1115315|NCT01199042|2699884|P1|STARTED|Sleep Laboratory (3 Nights)||29
1115316|NCT01199237|2699895|P2|NOT COMPLETED|Overall Study||0
1115317|NCT01199237|2699896|P1|NOT COMPLETED|Overall Study||0
1115318|NCT01199237|2699895|P2|COMPLETED|Overall Study||40
1115319|NCT01199237|2699896|P1|COMPLETED|Overall Study||41
1115320|NCT01199237|2699895|P2|STARTED|Overall Study||40
1115321|NCT01199237|2699896|P1|STARTED|Overall Study||41
1115322|NCT01199471|2699910|P1|NOT COMPLETED|Overall Study||6
1115323|NCT01199471|2699910|P1|COMPLETED|Overall Study||3994
1115324|NCT01199471|2699910|P1|STARTED|Overall Study|3 patients who did not meet ASA Physical Status Class 1 - 3 were excluded from all analyses.|4000
1115325|NCT01199601|2699921|P2|NOT COMPLETED|Overall Study||78
1115326|NCT01199601|2699922|P1|NOT COMPLETED|Overall Study||69
1115327|NCT01199601|2699921|P2|COMPLETED|Overall Study||344
1115328|NCT01199601|2699922|P1|COMPLETED|Overall Study||353
1115329|NCT01199601|2699921|P2|STARTED|Overall Study|Intervention Group|422
1115330|NCT01199601|2699922|P1|STARTED|Overall Study|Control Group|422
1115331|NCT01199705|2699932|P1|NOT COMPLETED|SCIG Treatment (Efficacy)||0
1115332|NCT01199705|2699932|P1|COMPLETED|SCIG Treatment (Efficacy)||24
1115333|NCT01199705|2699932|P1|STARTED|SCIG Treatment (Efficacy)||24
1115334|NCT01199705|2699932|P1|NOT COMPLETED|SCIG Treatment (Wash-in/Wash-out)||1
1115335|NCT01199705|2699932|P1|COMPLETED|SCIG Treatment (Wash-in/Wash-out)||24
1115336|NCT01199705|2699932|P1|STARTED|SCIG Treatment (Wash-in/Wash-out)||25
1115337|NCT01199705|2699932|P1|NOT COMPLETED|IVIG Treatment||0
1115338|NCT01199705|2699932|P1|COMPLETED|IVIG Treatment||25
1115339|NCT01199705|2699932|P1|STARTED|IVIG Treatment||25
1115340|NCT01199744|2699962|P1|NOT COMPLETED|Overall Study||0
1115341|NCT01199744|2699962|P1|COMPLETED|Overall Study||1575
1115342|NCT01199744|2699962|P1|STARTED|Overall Study||1575
1115343|NCT01199822|2699978|P3|NOT COMPLETED|Overall Study||0
1115344|NCT01199822|2699979|P2|NOT COMPLETED|Overall Study||1
1115345|NCT01199822|2699980|P1|NOT COMPLETED|Overall Study||0
1115346|NCT01199822|2699978|P3|COMPLETED|Overall Study||6
1115347|NCT01199822|2699979|P2|COMPLETED|Overall Study||6
1115348|NCT01199822|2699980|P1|COMPLETED|Overall Study||3
1115349|NCT01199822|2699978|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
1115350|NCT01199822|2699979|P2|Received at Least 1 Dose of Study Drug|Overall Study||7
1115351|NCT01199822|2699980|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
1115352|NCT01199822|2699978|P3|STARTED|Overall Study||6
1115353|NCT01199822|2699979|P2|STARTED|Overall Study||7
1115354|NCT01199822|2699980|P1|STARTED|Overall Study||3
1115355|NCT01199861|2700015|P2|NOT COMPLETED|Overall Study||0
1115356|NCT01199861|2700016|P1|NOT COMPLETED|Overall Study||2
1115357|NCT01199861|2700015|P2|COMPLETED|Overall Study||43
1115358|NCT01199861|2700016|P1|COMPLETED|Overall Study||93
1115359|NCT01199861|2700015|P2|STARTED|Overall Study||43
1115360|NCT01199861|2700016|P1|STARTED|Overall Study||95
1115361|NCT01199926|2700036|P2|NOT COMPLETED|Overall Study||4
1115362|NCT01199926|2700037|P1|NOT COMPLETED|Overall Study||7
1115363|NCT01199926|2700036|P2|COMPLETED|Overall Study||13
1115364|NCT01199926|2700037|P1|COMPLETED|Overall Study||10
1115365|NCT01199926|2700036|P2|STARTED|Overall Study||17
1115366|NCT01199926|2700037|P1|STARTED|Overall Study||17
1115367|NCT01199939|2700047|P1|NOT COMPLETED|Overall Study||13
1115368|NCT01199939|2700047|P1|COMPLETED|Overall Study||41
1115369|NCT01199939|2700047|P1|STARTED|Overall Study|Number of enrolled participants|54
1115370|NCT01199965|2700066|P2|NOT COMPLETED|Overall Study||0
1115371|NCT01199965|2700067|P1|NOT COMPLETED|Overall Study||1
1115372|NCT01199965|2700066|P2|COMPLETED|Overall Study||24
1115373|NCT01199965|2700067|P1|COMPLETED|Overall Study||22
1115374|NCT01199965|2700066|P2|STARTED|Overall Study||24
1115375|NCT01199965|2700067|P1|STARTED|Overall Study||23
1115376|NCT01200069|2700083|P2|NOT COMPLETED|Overall Study||1
1115377|NCT01200069|2700084|P1|NOT COMPLETED|Overall Study||0
1115378|NCT01200069|2700083|P2|COMPLETED|Overall Study||5
1115379|NCT01200069|2700084|P1|COMPLETED|Overall Study||8
1115380|NCT01200069|2700083|P2|STARTED|Overall Study||6
1115381|NCT01200069|2700084|P1|STARTED|Overall Study||8
1115382|NCT01200160|2700136|P1|NOT COMPLETED|Overall Study||62
1115383|NCT01200160|2700136|P1|COMPLETED|Overall Study||66
1115384|NCT01200160|2700136|P1|STARTED|Overall Study||128
1115385|NCT01200342|2700140|P1|NOT COMPLETED|Overall Study||1
1115386|NCT01200342|2700140|P1|COMPLETED|Overall Study||6
1115387|NCT01200342|2700140|P1|STARTED|Overall Study||7
1115394|NCT01200368|2700165|P3|NOT COMPLETED|Toddler Dose||1
1115395|NCT01200368|2700166|P2|NOT COMPLETED|Toddler Dose||3
1115396|NCT01200368|2700167|P1|NOT COMPLETED|Toddler Dose||0
1115397|NCT01200368|2700165|P3|COMPLETED|Toddler Dose||168
1115398|NCT01200368|2700166|P2|COMPLETED|Toddler Dose||159
1115399|NCT01200368|2700167|P1|COMPLETED|Toddler Dose||162
1115400|NCT01200368|2700165|P3|STARTED|Toddler Dose||169
1115401|NCT01200368|2700166|P2|STARTED|Toddler Dose||162
1115402|NCT01200368|2700167|P1|STARTED|Toddler Dose||162
1115403|NCT01200368|2700165|P3|NOT COMPLETED|After Infant Series||9
1115404|NCT01200368|2700166|P2|NOT COMPLETED|After Infant Series||16
1115405|NCT01200368|2700167|P1|NOT COMPLETED|After Infant Series||18
1115406|NCT01200368|2700165|P3|COMPLETED|After Infant Series||169
1115407|NCT01200368|2700166|P2|COMPLETED|After Infant Series||162
1115408|NCT01200368|2700167|P1|COMPLETED|After Infant Series||162
1115409|NCT01200368|2700165|P3|STARTED|After Infant Series||178
1115410|NCT01200368|2700166|P2|STARTED|After Infant Series||178
1115411|NCT01200368|2700167|P1|STARTED|After Infant Series||180
1115412|NCT01200368|2700165|P3|NOT COMPLETED|Infant Series||6
1115413|NCT01200368|2700166|P2|NOT COMPLETED|Infant Series||6
1115414|NCT01200368|2700167|P1|NOT COMPLETED|Infant Series||3
1115415|NCT01200368|2700165|P3|COMPLETED|Infant Series||178
1115416|NCT01200368|2700166|P2|COMPLETED|Infant Series||178
1115417|NCT01200368|2700167|P1|COMPLETED|Infant Series||180
1115418|NCT01200368|2700165|P3|Vaccinated Dose 3|Infant Series||182
1115419|NCT01200368|2700166|P2|Vaccinated Dose 3|Infant Series||178
1115420|NCT01200368|2700167|P1|Vaccinated Dose 3|Infant Series||181
1115421|NCT01200368|2700165|P3|Vaccinated Dose 2|Infant Series||183
1115422|NCT01200368|2700166|P2|Vaccinated Dose 2|Infant Series||182
1115423|NCT01200368|2700167|P1|Vaccinated Dose 2|Infant Series||183
1115424|NCT01200368|2700165|P3|Vaccinated Dose 1|Infant Series||183
1115425|NCT01200368|2700166|P2|Vaccinated Dose 1|Infant Series||183
1115426|NCT01200368|2700167|P1|Vaccinated Dose 1|Infant Series||183
1115427|NCT01200368|2700165|P3|STARTED|Infant Series||184
1115428|NCT01200368|2700166|P2|STARTED|Infant Series||184
1115429|NCT01200368|2700167|P1|STARTED|Infant Series||183
1115430|NCT01193101|2700235|P4|NOT COMPLETED|Overall Study||12
1115431|NCT01193101|2700236|P3|NOT COMPLETED|Overall Study||3
1115432|NCT01193101|2700237|P2|NOT COMPLETED|Overall Study||7
1115433|NCT01193101|2700238|P1|NOT COMPLETED|Overall Study||5
1115434|NCT01193101|2700235|P4|COMPLETED|Overall Study||80
1115435|NCT01193101|2700236|P3|COMPLETED|Overall Study||93
1115436|NCT01193101|2700237|P2|COMPLETED|Overall Study||94
1115437|NCT01193101|2700238|P1|COMPLETED|Overall Study||95
1115438|NCT01193101|2700235|P4|Placebo Withdrawal Set|Overall Study||80
1115439|NCT01193101|2700236|P3|Placebo Withdrawal Set|Overall Study||93
1115440|NCT01193101|2700237|P2|Placebo Withdrawal Set|Overall Study||94
1115441|NCT01193101|2700238|P1|Placebo Withdrawal Set|Overall Study||95
1115442|NCT01193101|2700235|P4|Full Analysis Set|Overall Study||92
1115443|NCT01193101|2700236|P3|Full Analysis Set|Overall Study||96
1115444|NCT01193101|2700237|P2|Full Analysis Set|Overall Study||101
1115445|NCT01193101|2700238|P1|Full Analysis Set|Overall Study||100
1115446|NCT01193101|2700235|P4|STARTED|Overall Study||92
1115447|NCT01193101|2700236|P3|STARTED|Overall Study||96
1115448|NCT01193101|2700237|P2|STARTED|Overall Study||101
1115449|NCT01193101|2700238|P1|STARTED|Overall Study||100
1115450|NCT01193114|2700296|P2|NOT COMPLETED|Overall Study||0
1115451|NCT01193114|2700297|P1|NOT COMPLETED|Overall Study||0
1115452|NCT01193114|2700296|P2|COMPLETED|Overall Study||30
1115453|NCT01193114|2700297|P1|COMPLETED|Overall Study||30
1115454|NCT01193114|2700296|P2|STARTED|Overall Study||30
1115455|NCT01193114|2700297|P1|STARTED|Overall Study||30
1115456|NCT01193127|2700317|P4|NOT COMPLETED|Treated||1
1115457|NCT01193127|2700318|P3|NOT COMPLETED|Treated||0
1115458|NCT01193127|2700319|P2|NOT COMPLETED|Treated||0
1115459|NCT01193127|2700320|P1|NOT COMPLETED|Treated||0
1115460|NCT01193127|2700317|P4|COMPLETED|Treated||55
1115461|NCT01193127|2700318|P3|COMPLETED|Treated||55
1115462|NCT01193127|2700319|P2|COMPLETED|Treated||54
1115463|NCT01193127|2700320|P1|COMPLETED|Treated||57
1115464|NCT01193127|2700317|P4|STARTED|Treated||56
1115465|NCT01193127|2700318|P3|STARTED|Treated||55
1115466|NCT01193127|2700319|P2|STARTED|Treated||54
1115467|NCT01193127|2700320|P1|STARTED|Treated||57
1115468|NCT01193127|2700317|P4|NOT COMPLETED|Randomized||1
1115469|NCT01193127|2700318|P3|NOT COMPLETED|Randomized||0
1115470|NCT01193127|2700319|P2|NOT COMPLETED|Randomized||0
1115471|NCT01193127|2700320|P1|NOT COMPLETED|Randomized||0
1115472|NCT01193127|2700317|P4|COMPLETED|Randomized||56
1115473|NCT01193127|2700318|P3|COMPLETED|Randomized||55
1115474|NCT01193127|2700319|P2|COMPLETED|Randomized||54
1115475|NCT01193127|2700320|P1|COMPLETED|Randomized||57
1115476|NCT01193127|2700317|P4|STARTED|Randomized||57
1115477|NCT01193127|2700318|P3|STARTED|Randomized||55
1115478|NCT01193127|2700319|P2|STARTED|Randomized||54
1115479|NCT01193127|2700320|P1|STARTED|Randomized||57
1115480|NCT01193153|2700622|P2|NOT COMPLETED|Double Blind Relapse Prevention Period||105
1115481|NCT01193153|2700623|P1|NOT COMPLETED|Double Blind Relapse Prevention Period||64
1115482|NCT01193153|2700622|P2|COMPLETED|Double Blind Relapse Prevention Period||65
1115483|NCT01193153|2700623|P1|COMPLETED|Double Blind Relapse Prevention Period||100
1115484|NCT01193153|2700622|P2|STARTED|Double Blind Relapse Prevention Period||170
1115485|NCT01193153|2700623|P1|STARTED|Double Blind Relapse Prevention Period||164
1115486|NCT01193153|2700622|P2|NOT COMPLETED|Open-label Stabilization Period||0
1115487|NCT01193153|2700623|P1|NOT COMPLETED|Open-label Stabilization Period||98
1115488|NCT01193153|2700622|P2|COMPLETED|Open-label Stabilization Period||0
1115489|NCT01193153|2700623|P1|COMPLETED|Open-label Stabilization Period||334
1115490|NCT01193153|2700622|P2|STARTED|Open-label Stabilization Period||0
1115491|NCT01193153|2700623|P1|STARTED|Open-label Stabilization Period||432
1115492|NCT01193153|2700622|P2|NOT COMPLETED|Open-label Lead in Period||0
1115493|NCT01193153|2700623|P1|NOT COMPLETED|Open-label Lead in Period||235
1115494|NCT01193153|2700622|P2|COMPLETED|Open-label Lead in Period||0
1115495|NCT01193153|2700623|P1|COMPLETED|Open-label Lead in Period||432
1115496|NCT01193153|2700622|P2|STARTED|Open-label Lead in Period||0
1115497|NCT01193153|2700623|P1|STARTED|Open-label Lead in Period||667
1115498|NCT01193218|2700659|P8|NOT COMPLETED|12-52 Weeks||4
1115499|NCT01193218|2700660|P7|NOT COMPLETED|12-52 Weeks||3
1115500|NCT01193218|2700661|P6|NOT COMPLETED|12-52 Weeks||5
1115501|NCT01193218|2700662|P5|NOT COMPLETED|12-52 Weeks||4
1115502|NCT01193218|2700663|P4|NOT COMPLETED|12-52 Weeks||3
1115503|NCT01193218|2700664|P3|NOT COMPLETED|12-52 Weeks||4
1115504|NCT01193218|2700665|P2|NOT COMPLETED|12-52 Weeks||0
1115505|NCT01193218|2700666|P1|NOT COMPLETED|12-52 Weeks||5
1115506|NCT01193218|2700659|P8|COMPLETED|12-52 Weeks||49
1115507|NCT01193218|2700660|P7|COMPLETED|12-52 Weeks||51
1115508|NCT01193218|2700661|P6|COMPLETED|12-52 Weeks||101
1115509|NCT01193218|2700662|P5|COMPLETED|12-52 Weeks||104
1115510|NCT01193218|2700663|P4|COMPLETED|12-52 Weeks||50
1115511|NCT01193218|2700664|P3|COMPLETED|12-52 Weeks||50
1115512|NCT01193218|2700665|P2|COMPLETED|12-52 Weeks||50
1115513|NCT01193218|2700666|P1|COMPLETED|12-52 Weeks||45
1115514|NCT01193218|2700659|P8|STARTED|12-52 Weeks||53
1115515|NCT01193218|2700660|P7|STARTED|12-52 Weeks||54
1115516|NCT01193218|2700661|P6|STARTED|12-52 Weeks||106
1115517|NCT01193218|2700662|P5|STARTED|12-52 Weeks||108
1115518|NCT01193218|2700663|P4|STARTED|12-52 Weeks||53
1115519|NCT01193218|2700664|P3|STARTED|12-52 Weeks||54
1115520|NCT01193218|2700665|P2|STARTED|12-52 Weeks||50
1115521|NCT01193218|2700666|P1|STARTED|12-52 Weeks||50
1115522|NCT01193218|2700659|P8|NOT COMPLETED|0-12 Weeks||0
1115523|NCT01193218|2700660|P7|NOT COMPLETED|0-12 Weeks||3
1115524|NCT01193218|2700661|P6|NOT COMPLETED|0-12 Weeks||3
1115525|NCT01193218|2700662|P5|NOT COMPLETED|0-12 Weeks||1
1115526|NCT01193218|2700663|P4|NOT COMPLETED|0-12 Weeks||0
1115527|NCT01193218|2700664|P3|NOT COMPLETED|0-12 Weeks||3
1115528|NCT01193218|2700665|P2|NOT COMPLETED|0-12 Weeks||0
1115529|NCT01193218|2700666|P1|NOT COMPLETED|0-12 Weeks||9
1115530|NCT01193218|2700659|P8|COMPLETED|0-12 Weeks||0
1115531|NCT01193218|2700660|P7|COMPLETED|0-12 Weeks||107
1115532|NCT01193218|2700661|P6|COMPLETED|0-12 Weeks||106
1115533|NCT01193218|2700662|P5|COMPLETED|0-12 Weeks||108
1115534|NCT01193218|2700663|P4|COMPLETED|0-12 Weeks||0
1115535|NCT01193218|2700664|P3|COMPLETED|0-12 Weeks||107
1115536|NCT01193218|2700665|P2|COMPLETED|0-12 Weeks||0
1115537|NCT01193218|2700666|P1|COMPLETED|0-12 Weeks||100
1115538|NCT01193218|2700659|P8|STARTED|0-12 Weeks|It is actually N/A|0
1115539|NCT01193218|2700660|P7|STARTED|0-12 Weeks|It is actually empa 50mg group|110
1115540|NCT01193218|2700661|P6|STARTED|0-12 Weeks||109
1115541|NCT01193218|2700662|P5|STARTED|0-12 Weeks||109
1115542|NCT01193218|2700663|P4|STARTED|0-12 Weeks|It is actually N/A|0
1115543|NCT01193218|2700664|P3|STARTED|0-12 Weeks|It is actually empa 5mg group|110
1115544|NCT01193218|2700665|P2|STARTED|0-12 Weeks|It is actually N/A|0
1115545|NCT01193218|2700666|P1|STARTED|0-12 Weeks|It is actually placebo group|109
1115546|NCT01193244|2700699|P2|NOT COMPLETED|Overall Study||390
1115547|NCT01193244|2700700|P1|NOT COMPLETED|Overall Study||388
1115548|NCT01193244|2700699|P2|COMPLETED|Overall Study||391
1115549|NCT01193244|2700700|P1|COMPLETED|Overall Study||391
1115550|NCT01193244|2700699|P2|Treated|Overall Study|Participants randomized to receive Placebo but crossed-over to receive Orteronel after unblinding.|784
1115551|NCT01193244|2700700|P1|Treated|Overall Study|Participants who continued to receive Placebo after unblinding.|770
1115552|NCT01193244|2700699|P2|STARTED|Overall Study||781
1115553|NCT01193244|2700700|P1|STARTED|Overall Study||779
1115554|NCT01193283|2700750|P1|NOT COMPLETED|Overall Study||1
1115555|NCT01193283|2700750|P1|COMPLETED|Overall Study||21
1115556|NCT01193283|2700750|P1|STARTED|Overall Study||22
1115557|NCT01193335|2700756|P2|NOT COMPLETED|2-Year Follow-up||8
1115558|NCT01193335|2700757|P1|NOT COMPLETED|2-Year Follow-up||7
1115559|NCT01193335|2700756|P2|COMPLETED|2-Year Follow-up||80
1115560|NCT01193335|2700757|P1|COMPLETED|2-Year Follow-up||81
1115561|NCT01193335|2700756|P2|STARTED|2-Year Follow-up||88
1115562|NCT01193335|2700757|P1|STARTED|2-Year Follow-up||88
1115563|NCT01193335|2700756|P2|NOT COMPLETED|1-Year Follow-up||9
1115564|NCT01193335|2700757|P1|NOT COMPLETED|1-Year Follow-up||11
1115565|NCT01193335|2700756|P2|COMPLETED|1-Year Follow-up||88
1115566|NCT01193335|2700757|P1|COMPLETED|1-Year Follow-up||88
1115567|NCT01193335|2700756|P2|STARTED|1-Year Follow-up||97
1115568|NCT01193335|2700757|P1|STARTED|1-Year Follow-up||99
1115569|NCT01193335|2700756|P2|NOT COMPLETED|Toddler Dose||0
1115570|NCT01193335|2700757|P1|NOT COMPLETED|Toddler Dose||0
1115571|NCT01193335|2700756|P2|COMPLETED|Toddler Dose||97
1115572|NCT01193335|2700757|P1|COMPLETED|Toddler Dose||99
1115573|NCT01193335|2700756|P2|STARTED|Toddler Dose||97
1115574|NCT01193335|2700757|P1|STARTED|Toddler Dose||99
1115575|NCT01193335|2700756|P2|NOT COMPLETED|After Infant Series||3
1115576|NCT01193335|2700757|P1|NOT COMPLETED|After Infant Series||1
1115577|NCT01193335|2700756|P2|COMPLETED|After Infant Series||97
1115578|NCT01193335|2700757|P1|COMPLETED|After Infant Series||99
1115579|NCT01193335|2700756|P2|STARTED|After Infant Series||100
1115580|NCT01193335|2700757|P1|STARTED|After Infant Series||100
1115581|NCT01193335|2700756|P2|NOT COMPLETED|Infant Series||0
1115582|NCT01193335|2700757|P1|NOT COMPLETED|Infant Series||0
1115583|NCT01193335|2700756|P2|COMPLETED|Infant Series||100
1115584|NCT01193335|2700757|P1|COMPLETED|Infant Series||100
1115585|NCT01193335|2700756|P2|STARTED|Infant Series||100
1115586|NCT01193335|2700757|P1|STARTED|Infant Series||100
1115587|NCT01193348|2700852|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||2
1115588|NCT01193348|2700852|P1|COMPLETED|Post Treatment Period (Patients Who Disc||8
1115589|NCT01193348|2700852|P1|STARTED|Post Treatment Period (Patients Who Disc||10
1115590|NCT01193348|2700852|P1|NOT COMPLETED|Extension Treatment Period||1
1115591|NCT01193348|2700852|P1|COMPLETED|Extension Treatment Period||16
1115592|NCT01193348|2700852|P1|STARTED|Extension Treatment Period||17
1115593|NCT01193348|2700852|P1|NOT COMPLETED|Treatment Period (26 Weeks)||3
1115594|NCT01193348|2700852|P1|COMPLETED|Treatment Period (26 Weeks)||19
1115595|NCT01193348|2700852|P1|STARTED|Treatment Period (26 Weeks)||22
1115596|NCT01193348|2700852|P1|NOT COMPLETED|Screening Period||5
1115597|NCT01193348|2700852|P1|COMPLETED|Screening Period||22
1115598|NCT01193348|2700852|P1|STARTED|Screening Period||27
1115599|NCT01193556|2700872|P2|NOT COMPLETED|Overall Study||25
1115600|NCT01193556|2700873|P1|NOT COMPLETED|Overall Study||26
1115601|NCT01193556|2700872|P2|COMPLETED|Overall Study||0
1115602|NCT01193556|2700873|P1|COMPLETED|Overall Study||0
1115603|NCT01193556|2700872|P2|STARTED|Overall Study||25
1115604|NCT01193556|2700873|P1|STARTED|Overall Study||26
1115605|NCT01193582|2700885|P4|NOT COMPLETED|12 Month Follow-up||11
1115606|NCT01193582|2700886|P3|NOT COMPLETED|12 Month Follow-up||4
1115607|NCT01193582|2700887|P2|NOT COMPLETED|12 Month Follow-up||0
1115608|NCT01193582|2700888|P1|NOT COMPLETED|12 Month Follow-up||6
1115609|NCT01193582|2700885|P4|COMPLETED|12 Month Follow-up||166
1115610|NCT01193582|2700886|P3|COMPLETED|12 Month Follow-up||113
1115611|NCT01193582|2700887|P2|COMPLETED|12 Month Follow-up||88
1115612|NCT01193582|2700888|P1|COMPLETED|12 Month Follow-up||83
1115613|NCT01193582|2700885|P4|STARTED|12 Month Follow-up||177
1115614|NCT01193582|2700886|P3|STARTED|12 Month Follow-up||117
1115615|NCT01193582|2700887|P2|STARTED|12 Month Follow-up||88
1115616|NCT01193582|2700888|P1|STARTED|12 Month Follow-up||89
1115617|NCT01193582|2700885|P4|NOT COMPLETED|Vaccination Series||3
1115618|NCT01193582|2700886|P3|NOT COMPLETED|Vaccination Series||8
1115619|NCT01193582|2700887|P2|NOT COMPLETED|Vaccination Series||13
1115620|NCT01193582|2700888|P1|NOT COMPLETED|Vaccination Series||11
1115621|NCT01193582|2700885|P4|COMPLETED|Vaccination Series||177
1115622|NCT01193582|2700886|P3|COMPLETED|Vaccination Series||117
1115623|NCT01193582|2700887|P2|COMPLETED|Vaccination Series||88
1115624|NCT01193582|2700888|P1|COMPLETED|Vaccination Series||89
1115625|NCT01193582|2700885|P4|Vaccinated Dose 4|Vaccination Series||0
1115626|NCT01193582|2700886|P3|Vaccinated Dose 4|Vaccination Series||0
1115627|NCT01193582|2700887|P2|Vaccinated Dose 4|Vaccination Series||0
1115628|NCT01193582|2700888|P1|Vaccinated Dose 4|Vaccination Series||90
1115629|NCT01193582|2700885|P4|Vaccinated Dose 3|Vaccination Series||0
1115630|NCT01193582|2700886|P3|Vaccinated Dose 3|Vaccination Series||0
1115631|NCT01193582|2700887|P2|Vaccinated Dose 3|Vaccination Series||89
1115632|NCT01193582|2700888|P1|Vaccinated Dose 3|Vaccination Series||90
1115633|NCT01193582|2700885|P4|Vaccinated Dose 2|Vaccination Series||0
1115634|NCT01193582|2700886|P3|Vaccinated Dose 2|Vaccination Series||118
1115635|NCT01193582|2700887|P2|Vaccinated Dose 2|Vaccination Series||91
1115636|NCT01193582|2700888|P1|Vaccinated Dose 2|Vaccination Series||92
1115637|NCT01193582|2700885|P4|Vaccinated Dose 1|Vaccination Series||180
1115638|NCT01193582|2700886|P3|Vaccinated Dose 1|Vaccination Series||125
1115639|NCT01193582|2700887|P2|Vaccinated Dose 1|Vaccination Series||100
1115640|NCT01193582|2700888|P1|Vaccinated Dose 1|Vaccination Series||100
1115641|NCT01193582|2700885|P4|STARTED|Vaccination Series||180
1115642|NCT01193582|2700886|P3|STARTED|Vaccination Series||125
1115643|NCT01193582|2700887|P2|STARTED|Vaccination Series||101
1115644|NCT01193582|2700888|P1|STARTED|Vaccination Series||100
1115645|NCT01193608|2700922|P6|NOT COMPLETED|Overall Study||2
1115646|NCT01193608|2700923|P5|NOT COMPLETED|Overall Study||5
1115647|NCT01193608|2700924|P4|NOT COMPLETED|Overall Study||3
1115648|NCT01193608|2700925|P3|NOT COMPLETED|Overall Study||2
1115649|NCT01193608|2700926|P2|NOT COMPLETED|Overall Study||2
1115650|NCT01193608|2700927|P1|NOT COMPLETED|Overall Study||0
1115651|NCT01193608|2700922|P6|COMPLETED|Overall Study||17
1115652|NCT01193608|2700923|P5|COMPLETED|Overall Study||19
1115653|NCT01193608|2700924|P4|COMPLETED|Overall Study||14
1115654|NCT01193608|2700925|P3|COMPLETED|Overall Study||14
1115655|NCT01193608|2700926|P2|COMPLETED|Overall Study||4
1115656|NCT01193608|2700927|P1|COMPLETED|Overall Study||6
1115657|NCT01193608|2700922|P6|STARTED|Overall Study||19
1115658|NCT01193608|2700923|P5|STARTED|Overall Study||24
1115659|NCT01193608|2700924|P4|STARTED|Overall Study||17
1115660|NCT01193608|2700925|P3|STARTED|Overall Study||16
1115661|NCT01193608|2700926|P2|STARTED|Overall Study||6
1115662|NCT01193608|2700927|P1|STARTED|Overall Study||6
1115663|NCT01193660|2701163|P3|NOT COMPLETED|Overall Study||2
1115664|NCT01193660|2701164|P2|NOT COMPLETED|Overall Study||3
1115665|NCT01193660|2701165|P1|NOT COMPLETED|Overall Study||4
1115666|NCT01193660|2701163|P3|COMPLETED|Overall Study||32
1115667|NCT01193660|2701164|P2|COMPLETED|Overall Study||33
1115668|NCT01193660|2701165|P1|COMPLETED|Overall Study||31
1115669|NCT01193660|2701163|P3|STARTED|Overall Study||34
1115670|NCT01193660|2701164|P2|STARTED|Overall Study||36
1115671|NCT01193660|2701165|P1|STARTED|Overall Study||35
1115672|NCT01193686|2701205|P2|NOT COMPLETED|Overall Study||1
1115673|NCT01193686|2701206|P1|NOT COMPLETED|Overall Study||7
1115674|NCT01193686|2701205|P2|COMPLETED|Overall Study||8
1115675|NCT01193686|2701206|P1|COMPLETED|Overall Study||8
1115676|NCT01193686|2701205|P2|Completed Visits and Final Assessment|Overall Study||8
1115677|NCT01193686|2701206|P1|Completed Visits and Final Assessment|Overall Study||8
1115678|NCT01193686|2701205|P2|Completed Mentor Training|Overall Study|Not applicable. Recipients were not required to complete training.|0
1115679|NCT01193686|2701206|P1|Completed Mentor Training|Overall Study||9
1115680|NCT01193686|2701205|P2|Completed Baseline Assessment|Overall Study||9
1115681|NCT01193686|2701206|P1|Completed Baseline Assessment|Overall Study||15
1115682|NCT01193686|2701205|P2|STARTED|Overall Study||9
1115683|NCT01193686|2701206|P1|STARTED|Overall Study||15
1115684|NCT01193868|2701220|P1|NOT COMPLETED|Overall Study||0
1115685|NCT01193868|2701220|P1|COMPLETED|Overall Study||6
1115686|NCT01193868|2701220|P1|STARTED|Overall Study||6
1115687|NCT01193907|2701236|P4|NOT COMPLETED|Overall Study||1
1115688|NCT01193907|2701237|P3|NOT COMPLETED|Overall Study||0
1115689|NCT01193907|2701238|P2|NOT COMPLETED|Overall Study||0
1115690|NCT01193907|2701239|P1|NOT COMPLETED|Overall Study||1
1115691|NCT01193907|2701236|P4|COMPLETED|Overall Study||21
1115692|NCT01193907|2701237|P3|COMPLETED|Overall Study||22
1115693|NCT01193907|2701238|P2|COMPLETED|Overall Study||22
1115694|NCT01193907|2701239|P1|COMPLETED|Overall Study||21
1115695|NCT01193907|2701236|P4|STARTED|Overall Study||22
1115696|NCT01193907|2701237|P3|STARTED|Overall Study||22
1115697|NCT01193907|2701238|P2|STARTED|Overall Study||22
1115698|NCT01193907|2701239|P1|STARTED|Overall Study||22
1115699|NCT01193920|2701271|P10|NOT COMPLETED|Overall Study||7
1115700|NCT01193920|2701272|P9|NOT COMPLETED|Overall Study||5
1115701|NCT01193920|2701273|P8|NOT COMPLETED|Overall Study||4
1115702|NCT01193920|2701274|P7|NOT COMPLETED|Overall Study||6
1115703|NCT01193920|2701275|P6|NOT COMPLETED|Overall Study||4
1115704|NCT01193920|2701276|P5|NOT COMPLETED|Overall Study||6
1115705|NCT01193920|2701277|P4|NOT COMPLETED|Overall Study||4
1115706|NCT01193920|2701278|P3|NOT COMPLETED|Overall Study||6
1115707|NCT01193920|2701279|P2|NOT COMPLETED|Overall Study||0
1115708|NCT01193920|2701280|P1|NOT COMPLETED|Overall Study||3
1115709|NCT01193920|2701271|P10|COMPLETED|Overall Study||74
1115710|NCT01193920|2701272|P9|COMPLETED|Overall Study||71
1115711|NCT01193920|2701273|P8|COMPLETED|Overall Study||76
1115712|NCT01193920|2701274|P7|COMPLETED|Overall Study||74
1115713|NCT01193920|2701275|P6|COMPLETED|Overall Study||76
1115714|NCT01193920|2701276|P5|COMPLETED|Overall Study||74
1115715|NCT01193920|2701277|P4|COMPLETED|Overall Study||76
1115716|NCT01193920|2701278|P3|COMPLETED|Overall Study||74
1115717|NCT01193920|2701279|P2|COMPLETED|Overall Study||20
1115718|NCT01193920|2701280|P1|COMPLETED|Overall Study||37
1115719|NCT01193920|2701271|P10|STARTED|Overall Study||81
1115720|NCT01193920|2701272|P9|STARTED|Overall Study||76
1115721|NCT01193920|2701273|P8|STARTED|Overall Study||80
1115722|NCT01193920|2701274|P7|STARTED|Overall Study||80
1115723|NCT01193920|2701275|P6|STARTED|Overall Study||80
1115724|NCT01193920|2701276|P5|STARTED|Overall Study||80
1115725|NCT01193920|2701277|P4|STARTED|Overall Study||80
1115726|NCT01193920|2701278|P3|STARTED|Overall Study||80
1115727|NCT01193920|2701279|P2|STARTED|Overall Study||20
1115728|NCT01193920|2701280|P1|STARTED|Overall Study||40
1115729|NCT01194089|2701332|P2|NOT COMPLETED|Overall Study||0
1115730|NCT01194089|2701333|P1|NOT COMPLETED|Overall Study||0
1115731|NCT01194089|2701332|P2|COMPLETED|Overall Study||47
1115732|NCT01194089|2701333|P1|COMPLETED|Overall Study||42
1115733|NCT01194089|2701332|P2|STARTED|Overall Study||47
1115734|NCT01194089|2701333|P1|STARTED|Overall Study||42
1115735|NCT01194154|2701345|P2|NOT COMPLETED|Overall Study||33
1115736|NCT01194154|2701346|P1|NOT COMPLETED|Overall Study||49
1115737|NCT01194154|2701345|P2|COMPLETED|Overall Study||91
1115738|NCT01194154|2701346|P1|COMPLETED|Overall Study||68
1115739|NCT01194154|2701345|P2|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|117
1115740|NCT01194154|2701346|P1|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|118
1115741|NCT01194154|2701345|P2|Full Analysis Set|Overall Study||120
1115742|NCT01194154|2701346|P1|Full Analysis Set|Overall Study||115
1115743|NCT01194154|2701345|P2|STARTED|Overall Study||124
1115744|NCT01194154|2701346|P1|STARTED|Overall Study||117
1115745|NCT01200433|2701366|P2|NOT COMPLETED|Overall Study||0
1115746|NCT01200433|2701367|P1|NOT COMPLETED|Overall Study||0
1115747|NCT01200433|2701366|P2|COMPLETED|Overall Study||23
1115748|NCT01200433|2701367|P1|COMPLETED|Overall Study||21
1115749|NCT01200433|2701366|P2|STARTED|Overall Study||23
1115750|NCT01200433|2701367|P1|STARTED|Overall Study||21
1115751|NCT01200498|2701387|P1|NOT COMPLETED|Overall Study||0
1115752|NCT01200498|2701387|P1|COMPLETED|Overall Study||22
1115753|NCT01200498|2701387|P1|STARTED|Overall Study||22
1115754|NCT01200511|2701391|P1|NOT COMPLETED|Overall Study||5
1115755|NCT01200511|2701391|P1|COMPLETED|Overall Study||44
1115756|NCT01200511|2701391|P1|STARTED|Overall Study||49
1115757|NCT01200524|2701402|P3|NOT COMPLETED|Overall Study||4
1115758|NCT01200524|2701403|P2|NOT COMPLETED|Overall Study||1
1115759|NCT01200524|2701404|P1|NOT COMPLETED|Overall Study||2
1115760|NCT01200524|2701402|P3|COMPLETED|Overall Study||40
1115761|NCT01200524|2701403|P2|COMPLETED|Overall Study||47
1115762|NCT01200524|2701404|P1|COMPLETED|Overall Study||39
1115763|NCT01200524|2701402|P3|STARTED|Overall Study||44
1115764|NCT01200524|2701403|P2|STARTED|Overall Study||48
1115765|NCT01200524|2701404|P1|STARTED|Overall Study||41
1115766|NCT01200602|2701426|P2|NOT COMPLETED|Overall Study||0
1115767|NCT01200602|2701427|P1|NOT COMPLETED|Overall Study||0
1115768|NCT01200602|2701426|P2|COMPLETED|Overall Study||0
1115769|NCT01200602|2701427|P1|COMPLETED|Overall Study||0
1115770|NCT01200602|2701426|P2|STARTED|Overall Study||0
1115771|NCT01200602|2701427|P1|STARTED|Overall Study||0
1115772|NCT01201486|2701441|P1|NOT COMPLETED|Overall Study||0
1115773|NCT01201486|2701441|P1|COMPLETED|Overall Study||6781
1115774|NCT01201486|2701441|P1|STARTED|Overall Study||6781
1115775|NCT01201629|2701447|P2|NOT COMPLETED|Overall Study||0
1115776|NCT01201629|2701448|P1|NOT COMPLETED|Overall Study||0
1115777|NCT01201629|2701447|P2|COMPLETED|Overall Study||8
1115778|NCT01201629|2701448|P1|COMPLETED|Overall Study||8
1115779|NCT01201629|2701447|P2|STARTED|Overall Study||8
1115780|NCT01201629|2701448|P1|STARTED|Overall Study||8
1115781|NCT01201759|2701460|P2|NOT COMPLETED|Visit 5||0
1115782|NCT01201759|2701461|P1|NOT COMPLETED|Visit 5||0
1115783|NCT01201759|2701460|P2|COMPLETED|Visit 5||3
1115784|NCT01201759|2701461|P1|COMPLETED|Visit 5||7
1115785|NCT01201759|2701460|P2|STARTED|Visit 5||3
1115786|NCT01201759|2701461|P1|STARTED|Visit 5||7
1115787|NCT01201759|2701460|P2|NOT COMPLETED|Visit 4 Crossover||1
1115788|NCT01201759|2701461|P1|NOT COMPLETED|Visit 4 Crossover||0
1115789|NCT01201759|2701460|P2|COMPLETED|Visit 4 Crossover||3
1115790|NCT01201759|2701461|P1|COMPLETED|Visit 4 Crossover||7
1115791|NCT01201759|2701460|P2|STARTED|Visit 4 Crossover||4
1115792|NCT01201759|2701461|P1|STARTED|Visit 4 Crossover||7
1115793|NCT01201759|2701460|P2|NOT COMPLETED|Visit 3 - Washout||3
1115794|NCT01201759|2701461|P1|NOT COMPLETED|Visit 3 - Washout||1
1115795|NCT01201759|2701460|P2|COMPLETED|Visit 3 - Washout||4
1115796|NCT01201759|2701461|P1|COMPLETED|Visit 3 - Washout||7
1115797|NCT01201759|2701460|P2|STARTED|Visit 3 - Washout||7
1115798|NCT01201759|2701461|P1|STARTED|Visit 3 - Washout||8
1115799|NCT01201759|2701460|P2|NOT COMPLETED|Visit 2||0
1115800|NCT01201759|2701461|P1|NOT COMPLETED|Visit 2||0
1115801|NCT01201759|2701460|P2|COMPLETED|Visit 2||7
1115802|NCT01201759|2701461|P1|COMPLETED|Visit 2||8
1115803|NCT01201759|2701460|P2|STARTED|Visit 2||7
1115804|NCT01201759|2701461|P1|STARTED|Visit 2||8
1115805|NCT01201759|2701460|P2|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||1
1115806|NCT01201759|2701461|P1|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||2
1115807|NCT01201759|2701460|P2|COMPLETED|Visit 1 Wash-in ( Untreated)||7
1115808|NCT01201759|2701461|P1|COMPLETED|Visit 1 Wash-in ( Untreated)||8
1115809|NCT01201759|2701460|P2|STARTED|Visit 1 Wash-in ( Untreated)||8
1115810|NCT01201759|2701461|P1|STARTED|Visit 1 Wash-in ( Untreated)||10
1115811|NCT01201772|2701476|P3|NOT COMPLETED|Overall Study||0
1115812|NCT01201772|2701477|P2|NOT COMPLETED|Overall Study||0
1115813|NCT01201772|2701478|P1|NOT COMPLETED|Overall Study||1
1115814|NCT01201772|2701476|P3|COMPLETED|Overall Study||21
1115815|NCT01201772|2701477|P2|COMPLETED|Overall Study||21
1115816|NCT01201772|2701478|P1|COMPLETED|Overall Study||22
1115817|NCT01201772|2701476|P3|STARTED|Overall Study||21
1115818|NCT01201772|2701477|P2|STARTED|Overall Study||21
1115819|NCT01201772|2701478|P1|STARTED|Overall Study||23
1115820|NCT01201785|2701484|P1|NOT COMPLETED|Overall Study||16
1115821|NCT01201785|2701484|P1|COMPLETED|Overall Study||20
1115822|NCT01201785|2701484|P1|STARTED|Overall Study||36
1115823|NCT01201798|2701490|P2|NOT COMPLETED|Overall Study||15
1115824|NCT01201798|2701491|P1|NOT COMPLETED|Overall Study||9
1115825|NCT01201798|2701490|P2|COMPLETED|Overall Study||39
1115826|NCT01201798|2701491|P1|COMPLETED|Overall Study||47
1115827|NCT01201798|2701490|P2|STARTED|Overall Study||54
1115828|NCT01201798|2701491|P1|STARTED|Overall Study||56
1115829|NCT01201811|2701515|P1|NOT COMPLETED|Overall Study||19
1115830|NCT01201811|2701515|P1|COMPLETED|Overall Study||25
1115831|NCT01201811|2701515|P1|STARTED|Overall Study||44
1115832|NCT01201915|2701538|P3|NOT COMPLETED|Overall Study||6
1115833|NCT01201915|2701539|P2|NOT COMPLETED|Overall Study||11
1115834|NCT01201915|2701540|P1|NOT COMPLETED|Overall Study||8
1115835|NCT01201915|2701538|P3|COMPLETED|Overall Study||19
1115836|NCT01201915|2701539|P2|COMPLETED|Overall Study||14
1115837|NCT01201915|2701540|P1|COMPLETED|Overall Study||16
1115838|NCT01201915|2701538|P3|STARTED|Overall Study||25
1115839|NCT01201915|2701539|P2|STARTED|Overall Study||25
1115840|NCT01201915|2701540|P1|STARTED|Overall Study||24
1115841|NCT01201967|2701553|P2|NOT COMPLETED|Overall Study||5
1115842|NCT01201967|2701554|P1|NOT COMPLETED|Overall Study||6
1115843|NCT01201967|2701553|P2|COMPLETED|Overall Study||86
1115844|NCT01201967|2701554|P1|COMPLETED|Overall Study||86
1115845|NCT01201967|2701553|P2|STARTED|Overall Study||91
1115846|NCT01201967|2701554|P1|STARTED|Overall Study||92
1115847|NCT01202071|2701576|P4|NOT COMPLETED|Overall Study||0
1115848|NCT01202071|2701577|P3|NOT COMPLETED|Overall Study||0
1115849|NCT01202071|2701578|P2|NOT COMPLETED|Overall Study||0
1115850|NCT01202071|2701579|P1|NOT COMPLETED|Overall Study||0
1115851|NCT01202071|2701576|P4|COMPLETED|Overall Study||6
1115852|NCT01202071|2701577|P3|COMPLETED|Overall Study||6
1115853|NCT01202071|2701578|P2|COMPLETED|Overall Study||6
1115854|NCT01202071|2701579|P1|COMPLETED|Overall Study||6
1115855|NCT01202071|2701576|P4|STARTED|Overall Study||6
1115856|NCT01202071|2701577|P3|STARTED|Overall Study||6
1115857|NCT01202071|2701578|P2|STARTED|Overall Study||6
1115858|NCT01202071|2701579|P1|STARTED|Overall Study||6
1115859|NCT01202110|2701597|P2|NOT COMPLETED|Overall Study||0
1115860|NCT01202110|2701598|P1|NOT COMPLETED|Overall Study||0
1115861|NCT01202110|2701597|P2|COMPLETED|Overall Study||0
1115862|NCT01202110|2701598|P1|COMPLETED|Overall Study||10
1115863|NCT01202110|2701597|P2|STARTED|Overall Study||0
1115864|NCT01202110|2701598|P1|STARTED|Overall Study||10
1115865|NCT01202162|2701604|P2|NOT COMPLETED|Overall Study||2
1115866|NCT01202162|2701605|P1|NOT COMPLETED|Overall Study||3
1115867|NCT01202162|2701604|P2|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
1115868|NCT01202162|2701605|P1|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
1115869|NCT01202162|2701604|P2|STARTED|Overall Study||42
1115870|NCT01202162|2701605|P1|STARTED|Overall Study||43
1115871|NCT01202188|2701620|P5|NOT COMPLETED|Overall Study||45
1115872|NCT01202188|2701621|P4|NOT COMPLETED|Overall Study||42
1115873|NCT01202188|2701622|P3|NOT COMPLETED|Overall Study||53
1115874|NCT01202188|2701623|P2|NOT COMPLETED|Overall Study||56
1115875|NCT01202188|2701624|P1|NOT COMPLETED|Overall Study||38
1115876|NCT01202188|2701620|P5|COMPLETED|Overall Study||189
1115877|NCT01202188|2701621|P4|COMPLETED|Overall Study||441
1115878|NCT01202188|2701622|P3|COMPLETED|Overall Study||422
1115879|NCT01202188|2701623|P2|COMPLETED|Overall Study||421
1115880|NCT01202188|2701624|P1|COMPLETED|Overall Study||437
1115881|NCT01202188|2701620|P5|Safety Set; Received Study Drug|Overall Study||232
1115882|NCT01202188|2701621|P4|Safety Set; Received Study Drug|Overall Study||480
1115883|NCT01202188|2701622|P3|Safety Set; Received Study Drug|Overall Study||473
1115884|NCT01202188|2701623|P2|Safety Set; Received Study Drug|Overall Study||476
1115885|NCT01202188|2701624|P1|Safety Set; Received Study Drug|Overall Study||474
1115886|NCT01202188|2701620|P5|STARTED|Overall Study||234
1115887|NCT01202188|2701621|P4|STARTED|Overall Study||483
1115888|NCT01202188|2701622|P3|STARTED|Overall Study||475
1115889|NCT01202188|2701623|P2|STARTED|Overall Study||477
1115890|NCT01202188|2701624|P1|STARTED|Overall Study||475
1115891|NCT01202227|2701730|P1|NOT COMPLETED|Overall Study||19
1115892|NCT01202227|2701730|P1|COMPLETED|Overall Study||84
1115893|NCT01202227|2701730|P1|STARTED|Overall Study|Treated|103
1115894|NCT01202253|2701749|P1|NOT COMPLETED|Overall Study||0
1115895|NCT01202253|2701749|P1|COMPLETED|Overall Study||50
1115896|NCT01202253|2701749|P1|STARTED|Overall Study||50
1115897|NCT01202279|2701795|P2|NOT COMPLETED|Overall Study||27
1115898|NCT01202279|2701796|P1|NOT COMPLETED|Overall Study||37
1115899|NCT01202279|2701795|P2|COMPLETED|Overall Study||561
1115900|NCT01202279|2701796|P1|COMPLETED|Overall Study||554
1115901|NCT01202279|2701795|P2|STARTED|Overall Study||588
1115902|NCT01202279|2701796|P1|STARTED|Overall Study||591
1115903|NCT01202565|2701804|P1|NOT COMPLETED|Overall Study||67
1115904|NCT01202565|2701804|P1|COMPLETED|Overall Study|Indicates participants who completed the Month 12 visit|439
1115905|NCT01202565|2701804|P1|Full Analysis Set|Overall Study|Participants with a signed informed consent and any available data regarding adalimumab treatment.|501
1115906|NCT01202565|2701804|P1|STARTED|Overall Study||506
1115907|NCT01202578|2701827|P1|NOT COMPLETED|Overall Study||0
1115908|NCT01202578|2701827|P1|COMPLETED|Overall Study||53
1115909|NCT01202578|2701827|P1|STARTED|Overall Study||53
1115910|NCT01202591|2701840|P6|NOT COMPLETED|Overall Study||4
1115911|NCT01202591|2701841|P5|NOT COMPLETED|Overall Study||5
1115912|NCT01202591|2701842|P4|NOT COMPLETED|Overall Study||7
1115913|NCT01202591|2701843|P3|NOT COMPLETED|Overall Study||11
1115914|NCT01202591|2701844|P2|NOT COMPLETED|Overall Study||5
1115915|NCT01202591|2701845|P1|NOT COMPLETED|Overall Study||5
1115916|NCT01202591|2701840|P6|COMPLETED|Overall Study||0
1115917|NCT01202591|2701841|P5|COMPLETED|Overall Study||0
1115918|NCT01202591|2701842|P4|COMPLETED|Overall Study||2
1115919|NCT01202591|2701843|P3|COMPLETED|Overall Study||1
1115920|NCT01202591|2701844|P2|COMPLETED|Overall Study||0
1115921|NCT01202591|2701845|P1|COMPLETED|Overall Study||0
1115922|NCT01202591|2701840|P6|STARTED|Overall Study||4
1115923|NCT01202591|2701841|P5|STARTED|Overall Study||5
1115924|NCT01202591|2701842|P4|STARTED|Overall Study||9
1115925|NCT01202591|2701843|P3|STARTED|Overall Study||12
1115926|NCT01202591|2701844|P2|STARTED|Overall Study||5
1115927|NCT01202591|2701845|P1|STARTED|Overall Study||5
1115928|NCT01202643|2701861|P2|NOT COMPLETED|Crossover Cycle||0
1115929|NCT01202643|2701862|P1|NOT COMPLETED|Crossover Cycle||0
1115930|NCT01202643|2701861|P2|COMPLETED|Crossover Cycle||2
1115931|NCT01202643|2701862|P1|COMPLETED|Crossover Cycle||1
1115932|NCT01202643|2701861|P2|STARTED|Crossover Cycle|Three patients became pregnant after Period 1, 1 patient chose not to cycle again|2
1115933|NCT01202643|2701862|P1|STARTED|Crossover Cycle|On patient became pregnant following Period 1, Only one non-pregnant chose to cycle again|1
1115934|NCT01202643|2701861|P2|NOT COMPLETED|Period 1||0
1115935|NCT01202643|2701862|P1|NOT COMPLETED|Period 1||0
1115936|NCT01202643|2701861|P2|COMPLETED|Period 1||6
1115937|NCT01202643|2701862|P1|COMPLETED|Period 1||6
1115938|NCT01202643|2701861|P2|STARTED|Period 1||6
1115939|NCT01202643|2701862|P1|STARTED|Period 1||6
1115940|NCT01202656|2701872|P2|NOT COMPLETED|CrossoverCycle||0
1115941|NCT01202656|2701873|P1|NOT COMPLETED|CrossoverCycle||0
1115942|NCT01202656|2701872|P2|COMPLETED|CrossoverCycle||14
1115943|NCT01202656|2701873|P1|COMPLETED|CrossoverCycle||18
1115944|NCT01202656|2701872|P2|STARTED|CrossoverCycle|14 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|14
1115945|NCT01202656|2701873|P1|STARTED|CrossoverCycle|16 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|18
1115946|NCT01202656|2701872|P2|NOT COMPLETED|Cycle 1||0
1115947|NCT01202656|2701873|P1|NOT COMPLETED|Cycle 1||0
1115948|NCT01202656|2701872|P2|COMPLETED|Cycle 1||62
1115949|NCT01202656|2701873|P1|COMPLETED|Cycle 1||67
1115950|NCT01202656|2701872|P2|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|62
1115951|NCT01202656|2701873|P1|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|67
1115952|NCT01202747|2701881|P1|NOT COMPLETED|Overall Study||1
1115953|NCT01202747|2701881|P1|COMPLETED|Overall Study|One subject did not return for the 4 Week visit due to inconvenience.|49
1115954|NCT01202747|2701881|P1|STARTED|Overall Study||50
1115955|NCT01202877|2701888|P3|NOT COMPLETED|Overall Study||6
1115956|NCT01202877|2701889|P2|NOT COMPLETED|Overall Study||1
1115957|NCT01202877|2701890|P1|NOT COMPLETED|Overall Study||0
1115958|NCT01202877|2701888|P3|COMPLETED|Overall Study||34
1115959|NCT01202877|2701889|P2|COMPLETED|Overall Study||7
1115960|NCT01202877|2701890|P1|COMPLETED|Overall Study||6
1115961|NCT01202877|2701888|P3|STARTED|Overall Study||40
1115962|NCT01202877|2701889|P2|STARTED|Overall Study||8
1115963|NCT01202877|2701890|P1|STARTED|Overall Study||6
1115964|NCT01202903|2701901|P2|NOT COMPLETED|Overall Study||16
1115965|NCT01202903|2701902|P1|NOT COMPLETED|Overall Study||11
1115966|NCT01202903|2701901|P2|COMPLETED|Overall Study||292
1115967|NCT01202903|2701902|P1|COMPLETED|Overall Study||297
1115968|NCT01202903|2701901|P2|Safety Set*|Overall Study||299
1115969|NCT01202903|2701902|P1|Safety Set*|Overall Study||310
1115970|NCT01202903|2701901|P2|Full Analysis Set|Overall Study||302
1115971|NCT01202903|2701902|P1|Full Analysis Set|Overall Study||306
1115972|NCT01202903|2701901|P2|STARTED|Overall Study||308
1115973|NCT01202903|2701902|P1|STARTED|Overall Study||308
1115974|NCT01202955|2701928|P2|NOT COMPLETED|Period 3: 10 Days||0
1115975|NCT01202955|2701929|P1|NOT COMPLETED|Period 3: 10 Days||0
1115976|NCT01202955|2701928|P2|COMPLETED|Period 3: 10 Days||8
1115977|NCT01202955|2701929|P1|COMPLETED|Period 3: 10 Days||9
1115978|NCT01202955|2701928|P2|STARTED|Period 3: 10 Days||8
1115979|NCT01202955|2701929|P1|STARTED|Period 3: 10 Days||9
1115980|NCT01202955|2701928|P2|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
1115981|NCT01202955|2701929|P1|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
1115982|NCT01202955|2701928|P2|COMPLETED|Period 2: 7 Days (Wash-Out)||8
1115983|NCT01202955|2701929|P1|COMPLETED|Period 2: 7 Days (Wash-Out)||9
1115984|NCT01202955|2701928|P2|STARTED|Period 2: 7 Days (Wash-Out)||8
1115985|NCT01202955|2701929|P1|STARTED|Period 2: 7 Days (Wash-Out)||9
1115986|NCT01202955|2701928|P2|NOT COMPLETED|Period 1: 10 Days||2
1115987|NCT01202955|2701929|P1|NOT COMPLETED|Period 1: 10 Days||0
1115988|NCT01202955|2701928|P2|COMPLETED|Period 1: 10 Days||8
1115989|NCT01202955|2701929|P1|COMPLETED|Period 1: 10 Days||9
1115990|NCT01202955|2701928|P2|STARTED|Period 1: 10 Days||10
1115991|NCT01202955|2701929|P1|STARTED|Period 1: 10 Days||9
1115992|NCT01203046|2701941|P2|NOT COMPLETED|Overall Study||0
1115993|NCT01203046|2701942|P1|NOT COMPLETED|Overall Study||0
1115994|NCT01203046|2701941|P2|COMPLETED|Overall Study||28
1115995|NCT01203046|2701942|P1|COMPLETED|Overall Study||28
1115996|NCT01203046|2701941|P2|STARTED|Overall Study||28
1115997|NCT01203046|2701942|P1|STARTED|Overall Study||28
1115998|NCT01203072|2701955|P5|NOT COMPLETED|Overall Study||6
1115999|NCT01203072|2701956|P4|NOT COMPLETED|Overall Study||6
1116000|NCT01203072|2701957|P3|NOT COMPLETED|Overall Study||3
1116001|NCT01203072|2701958|P2|NOT COMPLETED|Overall Study||6
1116002|NCT01203072|2701959|P1|NOT COMPLETED|Overall Study||10
1116003|NCT01203072|2701955|P5|COMPLETED|Overall Study||96
1116004|NCT01203072|2701956|P4|COMPLETED|Overall Study||100
1116005|NCT01203072|2701957|P3|COMPLETED|Overall Study||101
1116006|NCT01203072|2701958|P2|COMPLETED|Overall Study||100
1116007|NCT01203072|2701959|P1|COMPLETED|Overall Study||95
1116008|NCT01203072|2701955|P5|STARTED|Overall Study||102
1116009|NCT01203072|2701956|P4|STARTED|Overall Study||106
1116010|NCT01203072|2701957|P3|STARTED|Overall Study||104
1116011|NCT01203072|2701958|P2|STARTED|Overall Study||106
1116012|NCT01203072|2701959|P1|STARTED|Overall Study||105
1116013|NCT01203098|2701979|P3|NOT COMPLETED|Overall Study||11
1116014|NCT01203098|2701980|P2|NOT COMPLETED|Overall Study||4
1116015|NCT01203098|2701981|P1|NOT COMPLETED|Overall Study||6
1116016|NCT01203098|2701979|P3|COMPLETED|Overall Study||78
1116017|NCT01203098|2701980|P2|COMPLETED|Overall Study||82
1116018|NCT01203098|2701981|P1|COMPLETED|Overall Study||83
1116019|NCT01203098|2701979|P3|Safety Analysis Dataset|Overall Study||87
1116020|NCT01203098|2701980|P2|Safety Analysis Dataset|Overall Study||85
1116021|NCT01203098|2701981|P1|Safety Analysis Dataset|Overall Study||89
1116022|NCT01203098|2701979|P3|STARTED|Overall Study||89
1116023|NCT01203098|2701980|P2|STARTED|Overall Study||86
1116024|NCT01203098|2701981|P1|STARTED|Overall Study||89
1116025|NCT01203319|2701995|P3|NOT COMPLETED|Overall Study||5
1116026|NCT01203319|2701996|P2|NOT COMPLETED|Overall Study||9
1116027|NCT01203319|2701997|P1|NOT COMPLETED|Overall Study||6
1116028|NCT01203319|2701995|P3|COMPLETED|Overall Study||217
1116029|NCT01203319|2701996|P2|COMPLETED|Overall Study||426
1116030|NCT01203319|2701997|P1|COMPLETED|Overall Study||428
1116031|NCT01203319|2701995|P3|STARTED|Overall Study||222
1116032|NCT01203319|2701996|P2|STARTED|Overall Study||435
1116033|NCT01203319|2701997|P1|STARTED|Overall Study||434
1116034|NCT01203644|2702013|P2|NOT COMPLETED|Overall Study||0
1116035|NCT01203644|2702014|P1|NOT COMPLETED|Overall Study||0
1116036|NCT01203644|2702013|P2|COMPLETED|Overall Study||50
1116037|NCT01203644|2702014|P1|COMPLETED|Overall Study||26
1116038|NCT01203644|2702013|P2|STARTED|Overall Study||50
1116039|NCT01203644|2702014|P1|STARTED|Overall Study||26
1116040|NCT01203787|2702025|P2|NOT COMPLETED|Overall Study||27
1116041|NCT01203787|2702026|P1|NOT COMPLETED|Overall Study||31
1116042|NCT01203787|2702025|P2|COMPLETED|Overall Study||30
1116043|NCT01203787|2702026|P1|COMPLETED|Overall Study||32
1116044|NCT01203787|2702025|P2|STARTED|Overall Study||57
1116045|NCT01203787|2702026|P1|STARTED|Overall Study||63
1116046|NCT01203826|2702046|P2|NOT COMPLETED|Overall Study||0
1116047|NCT01203826|2702047|P1|NOT COMPLETED|Overall Study||0
1116048|NCT01203826|2702046|P2|COMPLETED|Overall Study||6
1116049|NCT01203826|2702047|P1|COMPLETED|Overall Study||6
1116050|NCT01203826|2702046|P2|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
1116051|NCT01203826|2702047|P1|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
1116052|NCT01203852|2702053|P1|NOT COMPLETED|Chlorthalidone 8 Weeks||0
1116053|NCT01203852|2702053|P1|COMPLETED|Chlorthalidone 8 Weeks||328
1116054|NCT01203852|2702053|P1|Continued From Metoprolol|Chlorthalidone 8 Weeks||282
1116055|NCT01203852|2702053|P1|STARTED|Chlorthalidone 8 Weeks|Subjects were allowed to enter the study at Chlorthalidone without completing Metoprolol.|328
1116056|NCT01203852|2702053|P1|NOT COMPLETED|Washout 2 Weeks||46
1116057|NCT01203852|2702053|P1|COMPLETED|Washout 2 Weeks||282
1116058|NCT01203852|2702053|P1|STARTED|Washout 2 Weeks|Some study subjects did not proceed to the washout phase after the first intervention.|328
1116059|NCT01203852|2702053|P1|NOT COMPLETED|Metoprolol 8 Weeks||470
1116060|NCT01203852|2702053|P1|COMPLETED|Metoprolol 8 Weeks||369
1116061|NCT01203852|2702053|P1|STARTED|Metoprolol 8 Weeks|This is the total number of subjects for both groups.|839
1116062|NCT01203878|2702063|P3|NOT COMPLETED|Overall Study||3
1116063|NCT01203878|2702064|P2|NOT COMPLETED|Overall Study||0
1116064|NCT01203878|2702065|P1|NOT COMPLETED|Overall Study||0
1116065|NCT01203878|2702063|P3|COMPLETED|Overall Study||0
1116066|NCT01203878|2702064|P2|COMPLETED|Overall Study||9
1116067|NCT01203878|2702065|P1|COMPLETED|Overall Study||9
1116068|NCT01203878|2702063|P3|STARTED|Overall Study||3
1116069|NCT01203878|2702064|P2|STARTED|Overall Study||9
1116070|NCT01203878|2702065|P1|STARTED|Overall Study||9
1116071|NCT01203917|2702076|P1|NOT COMPLETED|Overall Study||36
1116072|NCT01203917|2702076|P1|COMPLETED|Overall Study|Patients on-going study at data cut-off(of which 49 were still on study treatment).|71
1116073|NCT01203917|2702076|P1|STARTED|Overall Study|106 patients were EGFR M+ patients and 1 patient was EGFR M+I|107
1116074|NCT01203930|2702088|P2|NOT COMPLETED|Overall Study||41
1116075|NCT01203930|2702089|P1|NOT COMPLETED|Overall Study||21
1116076|NCT01203930|2702088|P2|COMPLETED|Overall Study||0
1116077|NCT01203930|2702089|P1|COMPLETED|Overall Study|43 participants completed 12 cycles and were then eligible to enroll in the extension study (101-99)|43
1116078|NCT01203930|2702088|P2|STARTED|Overall Study||41
1116079|NCT01203930|2702089|P1|STARTED|Overall Study||64
1116080|NCT01197326|2702113|P2|NOT COMPLETED|Overall Study||0
1116081|NCT01197326|2702114|P1|NOT COMPLETED|Overall Study||0
1116082|NCT01197326|2702113|P2|COMPLETED|Overall Study||209
1116083|NCT01197326|2702114|P1|COMPLETED|Overall Study||205
1116084|NCT01197326|2702113|P2|STARTED|Overall Study||209
1116085|NCT01197326|2702114|P1|STARTED|Overall Study||205
1116086|NCT01197417|2702124|P2|NOT COMPLETED|Overall Study||18
1116087|NCT01197417|2702125|P1|NOT COMPLETED|Overall Study||8
1116088|NCT01197417|2702124|P2|COMPLETED|Overall Study||86
1116089|NCT01197417|2702125|P1|COMPLETED|Overall Study||96
1116090|NCT01197417|2702124|P2|Received Study Drug|Overall Study||103
1116091|NCT01197417|2702125|P1|Received Study Drug|Overall Study||101
1116092|NCT01197417|2702124|P2|STARTED|Overall Study||104
1116093|NCT01197417|2702125|P1|STARTED|Overall Study||104
1116094|NCT01197495|2702145|P2|NOT COMPLETED|Overall Study||7
1116095|NCT01197495|2702146|P1|NOT COMPLETED|Overall Study||13
1116096|NCT01197495|2702145|P2|COMPLETED|Overall Study||49
1116097|NCT01197495|2702146|P1|COMPLETED|Overall Study||144
1116098|NCT01197495|2702145|P2|STARTED|Overall Study||56
1116099|NCT01197495|2702146|P1|STARTED|Overall Study||157
1116100|NCT01197508|2702161|P4|NOT COMPLETED|Overall Study||16
1116101|NCT01197508|2702162|P3|NOT COMPLETED|Overall Study||49
1116102|NCT01197508|2702163|P2|NOT COMPLETED|Overall Study||30
1116103|NCT01197508|2702164|P1|NOT COMPLETED|Overall Study||23
1116104|NCT01197508|2702161|P4|COMPLETED|Overall Study||158
1116105|NCT01197508|2702162|P3|COMPLETED|Overall Study||125
1116106|NCT01197508|2702163|P2|COMPLETED|Overall Study||144
1116107|NCT01197508|2702164|P1|COMPLETED|Overall Study||151
1116108|NCT01197508|2702161|P4|Received Treatment|Overall Study||174
1116109|NCT01197508|2702162|P3|Received Treatment|Overall Study||171
1116110|NCT01197508|2702163|P2|Received Treatment|Overall Study||174
1116111|NCT01197508|2702164|P1|Received Treatment|Overall Study||174
1116112|NCT01197508|2702161|P4|STARTED|Overall Study||174
1116113|NCT01197508|2702162|P3|STARTED|Overall Study||174
1116114|NCT01197508|2702163|P2|STARTED|Overall Study||174
1116115|NCT01197508|2702164|P1|STARTED|Overall Study||174
1116116|NCT01197521|2702261|P3|NOT COMPLETED|Overall Study||143
1116117|NCT01197521|2702262|P2|NOT COMPLETED|Overall Study||113
1116118|NCT01197521|2702263|P1|NOT COMPLETED|Overall Study||103
1116188|NCT01197833|2702523|P3|NOT COMPLETED|Overall Study||0
1116119|NCT01197521|2702261|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|161
1116120|NCT01197521|2702262|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|191
1116121|NCT01197521|2702263|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|207
1116122|NCT01197521|2702261|P3|Randomised But Did Not Receive Treatment|Overall Study|Adverse event/eligibility criteria not fulfilled|2
1116123|NCT01197521|2702262|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/other|2
1116124|NCT01197521|2702263|P1|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
1116125|NCT01197521|2702261|P3|STARTED|Overall Study|Patients who received treatment|304
1116126|NCT01197521|2702262|P2|STARTED|Overall Study|Patients who received treatment|304
1116127|NCT01197521|2702263|P1|STARTED|Overall Study|Patients who received treatment|310
1116128|NCT01197534|2702307|P3|NOT COMPLETED|Overall Study||173
1116129|NCT01197534|2702308|P2|NOT COMPLETED|Overall Study||130
1116130|NCT01197534|2702309|P1|NOT COMPLETED|Overall Study||134
1116131|NCT01197534|2702307|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|129
1116132|NCT01197534|2702308|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|168
1116133|NCT01197534|2702309|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|174
1116134|NCT01197534|2702307|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled / Severe non-compliance to protocol|3
1116135|NCT01197534|2702308|P2|Randomised But Did Not Receive Treatment|Overall Study|Adverse event / Other|2
1116136|NCT01197534|2702309|P1|Randomised But Did Not Receive Treatment|Overall Study||0
1116137|NCT01197534|2702307|P3|STARTED|Overall Study|Patients who received treatment|302
1116138|NCT01197534|2702308|P2|STARTED|Overall Study|Patients who received treatment|298
1116139|NCT01197534|2702309|P1|STARTED|Overall Study|Patients who received treatment|308
1116140|NCT01197547|2702350|P1|NOT COMPLETED|Overall Study||22
1116141|NCT01197547|2702350|P1|COMPLETED|Overall Study|992 Intent-To-Treat (ITT) 931 evaluable subjects|992
1116142|NCT01197547|2702350|P1|STARTED|Overall Study||1014
1116143|NCT01197560|2702358|P2|NOT COMPLETED|Overall Study||53
1116144|NCT01197560|2702359|P1|NOT COMPLETED|Overall Study||46
1116145|NCT01197560|2702358|P2|COMPLETED|Overall Study|Completed = those completed and ongoing on treatment at the time of the data cut-off of 04 July 2013|4
1116146|NCT01197560|2702359|P1|COMPLETED|Overall Study|Completed equals participants ongoing on treatment at the time of the data cut-off of 04 July 2013|8
1116147|NCT01197560|2702358|P2|Discontinued Treatment After ≥ 6 Cycles|Overall Study||3
1116148|NCT01197560|2702359|P1|Discontinued Treatment After ≥ 6 Cycles|Overall Study||7
1116149|NCT01197560|2702358|P2|Lenalidomide Crossover|Overall Study||29
1116150|NCT01197560|2702359|P1|Lenalidomide Crossover|Overall Study||0
1116151|NCT01197560|2702358|P2|Received ≥ One Dose Study Drug|Overall Study||55
1116152|NCT01197560|2702359|P1|Received ≥ One Dose Study Drug|Overall Study||54
1116153|NCT01197560|2702358|P2|STARTED|Overall Study|This is the intent to treat population|57
1116154|NCT01197560|2702359|P1|STARTED|Overall Study|This is the intent to treat population|54
1116155|NCT01197755|2702386|P3|NOT COMPLETED|Overall Study||54
1116156|NCT01197755|2702387|P2|NOT COMPLETED|Overall Study||43
1116157|NCT01197755|2702388|P1|NOT COMPLETED|Overall Study||38
1116158|NCT01197755|2702386|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|55
1116159|NCT01197755|2702387|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|65
1116160|NCT01197755|2702388|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|67
1116161|NCT01197755|2702386|P3|Randomised But Did Not Receive Treatment|Overall Study|Severe non-compliance to the protocol|1
1116162|NCT01197755|2702387|P2|Randomised But Did Not Receive Treatment|Overall Study||0
1116163|NCT01197755|2702388|P1|Randomised But Did Not Receive Treatment|Overall Study||0
1116164|NCT01197755|2702386|P3|STARTED|Overall Study|Patients who received treatment|109
1116165|NCT01197755|2702387|P2|STARTED|Overall Study|Patients who received treatment|108
1116166|NCT01197755|2702388|P1|STARTED|Overall Study|Patients who received treatment|105
1116167|NCT01197794|2702435|P7|NOT COMPLETED|Overall Study||21
1116168|NCT01197794|2702436|P6|NOT COMPLETED|Overall Study||19
1116169|NCT01197794|2702437|P5|NOT COMPLETED|Overall Study||14
1116170|NCT01197794|2702438|P4|NOT COMPLETED|Overall Study||12
1116171|NCT01197794|2702439|P3|NOT COMPLETED|Overall Study||13
1116172|NCT01197794|2702440|P2|NOT COMPLETED|Overall Study||15
1116173|NCT01197794|2702441|P1|NOT COMPLETED|Overall Study||16
1116174|NCT01197794|2702435|P7|COMPLETED|Overall Study||142
1116175|NCT01197794|2702436|P6|COMPLETED|Overall Study||144
1116176|NCT01197794|2702437|P5|COMPLETED|Overall Study||149
1116177|NCT01197794|2702438|P4|COMPLETED|Overall Study||152
1116178|NCT01197794|2702439|P3|COMPLETED|Overall Study||153
1116179|NCT01197794|2702440|P2|COMPLETED|Overall Study||146
1116180|NCT01197794|2702441|P1|COMPLETED|Overall Study||148
1116181|NCT01197794|2702435|P7|STARTED|Overall Study|Two participants excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
1116182|NCT01197794|2702436|P6|STARTED|Overall Study||163
1116183|NCT01197794|2702437|P5|STARTED|Overall Study|One participant excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
1116184|NCT01197794|2702438|P4|STARTED|Overall Study||164
1116185|NCT01197794|2702439|P3|STARTED|Overall Study|Two participants did not receive study treatment|166
1116186|NCT01197794|2702440|P2|STARTED|Overall Study|Two participants did not receive study treatment|161
1116187|NCT01197794|2702441|P1|STARTED|Overall Study||164
1116189|NCT01197833|2702524|P2|NOT COMPLETED|Overall Study||0
1116190|NCT01197833|2702525|P1|NOT COMPLETED|Overall Study||0
1116191|NCT01197833|2702523|P3|COMPLETED|Overall Study||40
1116192|NCT01197833|2702524|P2|COMPLETED|Overall Study||39
1116193|NCT01197833|2702525|P1|COMPLETED|Overall Study||38
1116194|NCT01197833|2702523|P3|STARTED|Overall Study||40
1116195|NCT01197833|2702524|P2|STARTED|Overall Study||39
1116196|NCT01197833|2702525|P1|STARTED|Overall Study||38
1116197|NCT01203956|2702536|P2|NOT COMPLETED|Second Two-week Period||6
1116198|NCT01203956|2702537|P1|NOT COMPLETED|Second Two-week Period||5
1116199|NCT01203956|2702536|P2|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|7
1116200|NCT01203956|2702537|P1|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|10
1116201|NCT01203956|2702536|P2|Attended Sleep Studies for 14 Nights|Second Two-week Period||13
1116202|NCT01203956|2702537|P1|Attended Sleep Studies for 14 Nights|Second Two-week Period||15
1116203|NCT01203956|2702536|P2|STARTED|Second Two-week Period||13
1116204|NCT01203956|2702537|P1|STARTED|Second Two-week Period||15
1116205|NCT01203956|2702536|P2|NOT COMPLETED|First Two-week Period||0
1116206|NCT01203956|2702537|P1|NOT COMPLETED|First Two-week Period||0
1116207|NCT01203956|2702536|P2|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|13
1116208|NCT01203956|2702537|P1|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|15
1116209|NCT01203956|2702536|P2|STARTED|First Two-week Period||13
1116210|NCT01203956|2702537|P1|STARTED|First Two-week Period||15
1116211|NCT01204203|2702544|P1|NOT COMPLETED|Overall Study||0
1116212|NCT01204203|2702544|P1|COMPLETED|Overall Study||8
1116213|NCT01204203|2702544|P1|STARTED|Overall Study||8
1116217|NCT01205828|2702554|P1|NOT COMPLETED|Overall Study||0
1116218|NCT01205828|2702554|P1|COMPLETED|Overall Study|Completed the first stage of the study, terminated as pre-planned due to lack of efficacy|16
1116219|NCT01205828|2702554|P1|STARTED|Overall Study||16
1116220|NCT01206101|2702564|P2|NOT COMPLETED|Overall Study||1
1116221|NCT01206101|2702565|P1|NOT COMPLETED|Overall Study||2
1116222|NCT01206101|2702564|P2|COMPLETED|Overall Study||0
1116223|NCT01206101|2702565|P1|COMPLETED|Overall Study||0
1116224|NCT01206101|2702564|P2|STARTED|Overall Study||1
1116225|NCT01206101|2702565|P1|STARTED|Overall Study||2
1116226|NCT01206140|2702583|P2|NOT COMPLETED|Overall Study||0
1116227|NCT01206140|2702584|P1|NOT COMPLETED|Overall Study||1
1116228|NCT01206140|2702583|P2|COMPLETED|Overall Study||35
1116229|NCT01206140|2702584|P1|COMPLETED|Overall Study||34
1116230|NCT01206140|2702583|P2|STARTED|Overall Study||35
1116231|NCT01206140|2702584|P1|STARTED|Overall Study||35
1116232|NCT01206322|2702596|P4|NOT COMPLETED|Overall Study||1
1116233|NCT01206322|2702597|P3|NOT COMPLETED|Overall Study||0
1116234|NCT01206322|2702598|P2|NOT COMPLETED|Overall Study||0
1116235|NCT01206322|2702599|P1|NOT COMPLETED|Overall Study||0
1116236|NCT01206322|2702596|P4|COMPLETED|Overall Study||5
1116237|NCT01206322|2702597|P3|COMPLETED|Overall Study||9
1116238|NCT01206322|2702598|P2|COMPLETED|Overall Study||11
1116239|NCT01206322|2702599|P1|COMPLETED|Overall Study||4
1116240|NCT01206322|2702596|P4|STARTED|Overall Study||6
1116241|NCT01206322|2702597|P3|STARTED|Overall Study||9
1116242|NCT01206322|2702598|P2|STARTED|Overall Study||11
1116243|NCT01206322|2702599|P1|STARTED|Overall Study||4
1116244|NCT01206387|2702615|P2|NOT COMPLETED|Overall Study||0
1116245|NCT01206387|2702616|P1|NOT COMPLETED|Overall Study||1
1116246|NCT01206387|2702615|P2|COMPLETED|Overall Study||60
1116247|NCT01206387|2702616|P1|COMPLETED|Overall Study||59
1116248|NCT01206387|2702615|P2|STARTED|Overall Study||60
1116249|NCT01206387|2702616|P1|STARTED|Overall Study||60
1116250|NCT01206439|2702630|P1|NOT COMPLETED|Overall Study||1
1116251|NCT01206439|2702630|P1|COMPLETED|Overall Study||1
1116252|NCT01206439|2702630|P1|STARTED|Overall Study||2
1116253|NCT01206452|2702636|P2|NOT COMPLETED|Overall Study||0
1116254|NCT01206452|2702637|P1|NOT COMPLETED|Overall Study||0
1116255|NCT01206452|2702636|P2|COMPLETED|Overall Study||30
1116256|NCT01206452|2702637|P1|COMPLETED|Overall Study||30
1116257|NCT01206452|2702636|P2|STARTED|Overall Study||30
1116258|NCT01206452|2702637|P1|STARTED|Overall Study||30
1116259|NCT01206478|2702653|P2|NOT COMPLETED|Overall Study||5
1116260|NCT01206478|2702654|P1|NOT COMPLETED|Overall Study||2
1116261|NCT01206478|2702653|P2|COMPLETED|Overall Study||7
1116262|NCT01206478|2702654|P1|COMPLETED|Overall Study||7
1116263|NCT01206478|2702653|P2|STARTED|Overall Study||12
1116264|NCT01206478|2702654|P1|STARTED|Overall Study||9
1116265|NCT01206517|2702668|P6|NOT COMPLETED|Overall Study||0
1116266|NCT01206517|2702669|P5|NOT COMPLETED|Overall Study||1
1116267|NCT01206517|2702670|P4|NOT COMPLETED|Overall Study||0
1116268|NCT01206517|2702671|P3|NOT COMPLETED|Overall Study||2
1116269|NCT01206517|2702672|P2|NOT COMPLETED|Overall Study||0
1116270|NCT01206517|2702673|P1|NOT COMPLETED|Overall Study||0
1116271|NCT01206517|2702668|P6|COMPLETED|Overall Study||4
1116272|NCT01206517|2702669|P5|COMPLETED|Overall Study||3
1116273|NCT01206517|2702670|P4|COMPLETED|Overall Study||4
1116274|NCT01206517|2702671|P3|COMPLETED|Overall Study||4
1116275|NCT01206517|2702672|P2|COMPLETED|Overall Study||6
1116276|NCT01206517|2702673|P1|COMPLETED|Overall Study||6
1116277|NCT01206517|2702668|P6|STARTED|Overall Study||4
1116278|NCT01206517|2702669|P5|STARTED|Overall Study||4
1116279|NCT01206517|2702670|P4|STARTED|Overall Study||4
1116280|NCT01206517|2702671|P3|STARTED|Overall Study||6
1116281|NCT01206517|2702672|P2|STARTED|Overall Study||6
1116282|NCT01206517|2702673|P1|STARTED|Overall Study||6
1116283|NCT01206582|2702704|P2|NOT COMPLETED|Overall Study||2
1116284|NCT01206582|2702705|P1|NOT COMPLETED|Overall Study||2
1116285|NCT01206582|2702704|P2|COMPLETED|Overall Study||7
1116286|NCT01206582|2702705|P1|COMPLETED|Overall Study||9
1116287|NCT01206582|2702704|P2|STARTED|Overall Study||9
1116288|NCT01206582|2702705|P1|STARTED|Overall Study||11
1116289|NCT01206595|2702733|P2|NOT COMPLETED|Overall Study||0
1116290|NCT01206595|2702734|P1|NOT COMPLETED|Overall Study||0
1116291|NCT01206595|2702733|P2|COMPLETED|Overall Study||20
1116292|NCT01206595|2702734|P1|COMPLETED|Overall Study||38
1116293|NCT01206595|2702733|P2|STARTED|Overall Study||20
1116294|NCT01206595|2702734|P1|STARTED|Overall Study||38
1116295|NCT01206608|2702744|P2|NOT COMPLETED|Overall Study||0
1116296|NCT01206608|2702745|P1|NOT COMPLETED|Overall Study||0
1116297|NCT01206608|2702744|P2|COMPLETED|Overall Study||20
1116298|NCT01206608|2702745|P1|COMPLETED|Overall Study||20
1116299|NCT01206608|2702744|P2|STARTED|Overall Study||20
1116300|NCT01206608|2702745|P1|STARTED|Overall Study||20
1116301|NCT01206660|2702753|P2|NOT COMPLETED|Overall Study||0
1116302|NCT01206660|2702754|P1|NOT COMPLETED|Overall Study||0
1116303|NCT01206660|2702753|P2|COMPLETED|Overall Study||60
1116304|NCT01206660|2702754|P1|COMPLETED|Overall Study||60
1116305|NCT01206660|2702753|P2|STARTED|Overall Study||60
1116306|NCT01206660|2702754|P1|STARTED|Overall Study||60
1116307|NCT01206738|2702767|P3|NOT COMPLETED|Overall Study||19
1116308|NCT01206738|2702768|P2|NOT COMPLETED|Overall Study||25
1116309|NCT01206738|2702769|P1|NOT COMPLETED|Overall Study||23
1116310|NCT01206738|2702767|P3|COMPLETED|Overall Study||42
1116311|NCT01206738|2702768|P2|COMPLETED|Overall Study||49
1116312|NCT01206738|2702769|P1|COMPLETED|Overall Study||40
1116313|NCT01206738|2702767|P3|STARTED|Overall Study||61
1116314|NCT01206738|2702768|P2|STARTED|Overall Study||74
1116315|NCT01206738|2702769|P1|STARTED|Overall Study||63
1116316|NCT01206777|2702779|P1|NOT COMPLETED|Overall Study||2
1116317|NCT01206777|2702779|P1|COMPLETED|Overall Study||50
1116318|NCT01206777|2702779|P1|Discontinued Trial and Deemed Ineligible|Overall Study||2
1116319|NCT01206777|2702779|P1|STARTED|Overall Study||52
1116320|NCT01207102|2702785|P1|NOT COMPLETED|Overall Study||10
1116321|NCT01207102|2702785|P1|COMPLETED|Overall Study||0
1116322|NCT01207102|2702785|P1|STARTED|Overall Study||10
1116323|NCT01207219|2702793|P3|NOT COMPLETED|Overall Study||7
1116324|NCT01207219|2702794|P2|NOT COMPLETED|Overall Study||11
1116325|NCT01207219|2702795|P1|NOT COMPLETED|Overall Study||11
1116326|NCT01207219|2702793|P3|COMPLETED|Overall Study||32
1116327|NCT01207219|2702794|P2|COMPLETED|Overall Study||29
1116328|NCT01207219|2702795|P1|COMPLETED|Overall Study||34
1116329|NCT01207219|2702793|P3|Included in ITT Analysis|Overall Study||38
1116330|NCT01207219|2702794|P2|Included in ITT Analysis|Overall Study||37
1116331|NCT01207219|2702795|P1|Included in ITT Analysis|Overall Study||40
1116332|NCT01207219|2702793|P3|STARTED|Overall Study||39
1116333|NCT01207219|2702794|P2|STARTED|Overall Study||40
1116334|NCT01207219|2702795|P1|STARTED|Overall Study||45
1116335|NCT01207388|2702815|P1|NOT COMPLETED|Overall Study||33
1116336|NCT01207388|2702815|P1|COMPLETED|Overall Study|Completed the core study|83
1116337|NCT01207388|2702815|P1|STARTED|Overall Study||116
1116338|NCT01207401|2702837|P2|NOT COMPLETED|Overall Study||0
1116339|NCT01207401|2702838|P1|NOT COMPLETED|Overall Study||0
1116340|NCT01207401|2702837|P2|COMPLETED|Overall Study||24
1116341|NCT01207401|2702838|P1|COMPLETED|Overall Study||26
1116342|NCT01207401|2702837|P2|STARTED|Overall Study||24
1116343|NCT01207401|2702838|P1|STARTED|Overall Study||26
1116344|NCT01207414|2702846|P2|NOT COMPLETED|Overall Study||82
1116345|NCT01207414|2702847|P1|NOT COMPLETED|Overall Study||73
1116346|NCT01207414|2702846|P2|COMPLETED|Overall Study||178
1116347|NCT01207414|2702847|P1|COMPLETED|Overall Study||168
1116348|NCT01207414|2702846|P2|Safety Population: Received Study Drug|Overall Study||260
1116349|NCT01207414|2702847|P1|Safety Population: Received Study Drug|Overall Study||240
1116350|NCT01207414|2702846|P2|STARTED|Overall Study||260
1116351|NCT01207414|2702847|P1|STARTED|Overall Study|Includes 1 patient randomized in error.|241
1116352|NCT01207427|2702866|P3|NOT COMPLETED|Run-out Placebo Period||0
1116353|NCT01207427|2702867|P2|NOT COMPLETED|Run-out Placebo Period||0
1116354|NCT01207427|2702868|P1|NOT COMPLETED|Run-out Placebo Period||0
1116355|NCT01207427|2702866|P3|COMPLETED|Run-out Placebo Period||41
1116356|NCT01207427|2702867|P2|COMPLETED|Run-out Placebo Period||43
1116357|NCT01207427|2702868|P1|COMPLETED|Run-out Placebo Period||40
1116358|NCT01207427|2702866|P3|STARTED|Run-out Placebo Period||41
1116359|NCT01207427|2702867|P2|STARTED|Run-out Placebo Period||43
1116360|NCT01207427|2702868|P1|STARTED|Run-out Placebo Period||40
1116361|NCT01207427|2702866|P3|NOT COMPLETED|Double-blind Treatment Period||2
1116362|NCT01207427|2702867|P2|NOT COMPLETED|Double-blind Treatment Period||2
1116363|NCT01207427|2702868|P1|NOT COMPLETED|Double-blind Treatment Period||3
1116364|NCT01207427|2702866|P3|COMPLETED|Double-blind Treatment Period||41
1116365|NCT01207427|2702867|P2|COMPLETED|Double-blind Treatment Period||43
1116366|NCT01207427|2702868|P1|COMPLETED|Double-blind Treatment Period||40
1116367|NCT01207427|2702866|P3|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
1116368|NCT01207427|2702867|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||45
1116369|NCT01207427|2702868|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
1116370|NCT01207427|2702866|P3|STARTED|Double-blind Treatment Period||43
1116371|NCT01207427|2702867|P2|STARTED|Double-blind Treatment Period||45
1116372|NCT01207427|2702868|P1|STARTED|Double-blind Treatment Period||43
1116373|NCT01207427|2702866|P3|NOT COMPLETED|Run-in Placebo Period||0
1116374|NCT01207427|2702867|P2|NOT COMPLETED|Run-in Placebo Period||0
1116375|NCT01207427|2702868|P1|NOT COMPLETED|Run-in Placebo Period||0
1116376|NCT01207427|2702866|P3|COMPLETED|Run-in Placebo Period||43
1116377|NCT01207427|2702867|P2|COMPLETED|Run-in Placebo Period||45
1116378|NCT01207427|2702868|P1|COMPLETED|Run-in Placebo Period||43
1116379|NCT01207427|2702866|P3|STARTED|Run-in Placebo Period||43
1116380|NCT01207427|2702867|P2|STARTED|Run-in Placebo Period||45
1116381|NCT01207427|2702868|P1|STARTED|Run-in Placebo Period||43
1116382|NCT01207453|2702878|P2|NOT COMPLETED|2nd Intervention||2
1116383|NCT01207453|2702879|P1|NOT COMPLETED|2nd Intervention||2
1116384|NCT01207453|2702878|P2|COMPLETED|2nd Intervention||15
1116385|NCT01207453|2702879|P1|COMPLETED|2nd Intervention||17
1116386|NCT01207453|2702878|P2|STARTED|2nd Intervention||17
1116387|NCT01207453|2702879|P1|STARTED|2nd Intervention||19
1116388|NCT01207453|2702878|P2|NOT COMPLETED|Washout||0
1116389|NCT01207453|2702879|P1|NOT COMPLETED|Washout||2
1116390|NCT01207453|2702878|P2|COMPLETED|Washout||17
1116391|NCT01207453|2702879|P1|COMPLETED|Washout||19
1116392|NCT01207453|2702878|P2|STARTED|Washout||17
1116393|NCT01207453|2702879|P1|STARTED|Washout||21
1116394|NCT01207453|2702878|P2|NOT COMPLETED|First Intervention||1
1116395|NCT01207453|2702879|P1|NOT COMPLETED|First Intervention||2
1116396|NCT01207453|2702878|P2|COMPLETED|First Intervention||17
1116397|NCT01207453|2702879|P1|COMPLETED|First Intervention||21
1116398|NCT01207453|2702878|P2|STARTED|First Intervention||18
1116399|NCT01207453|2702879|P1|STARTED|First Intervention||23
1116400|NCT01207466|2702898|P2|NOT COMPLETED|Period 2, One Week of Wear||0
1116401|NCT01207466|2702899|P1|NOT COMPLETED|Period 2, One Week of Wear||0
1116402|NCT01207466|2702898|P2|COMPLETED|Period 2, One Week of Wear||48
1116403|NCT01207466|2702899|P1|COMPLETED|Period 2, One Week of Wear||45
1116404|NCT01207466|2702898|P2|STARTED|Period 2, One Week of Wear||48
1116405|NCT01207466|2702899|P1|STARTED|Period 2, One Week of Wear||45
1116406|NCT01207466|2702898|P2|NOT COMPLETED|Period 1, One Week of Wear||0
1116407|NCT01207466|2702899|P1|NOT COMPLETED|Period 1, One Week of Wear||0
1116408|NCT01207466|2702898|P2|COMPLETED|Period 1, One Week of Wear||48
1116409|NCT01207466|2702899|P1|COMPLETED|Period 1, One Week of Wear|One participant discontinued between Period 1 and Period 2 due to inclusion/exclusion criteria.|46
1116410|NCT01207466|2702898|P2|STARTED|Period 1, One Week of Wear||48
1116411|NCT01207466|2702899|P1|STARTED|Period 1, One Week of Wear||46
1116412|NCT01207492|2702905|P1|NOT COMPLETED|Overall Study||15
1116413|NCT01207492|2702905|P1|COMPLETED|Overall Study||2
1116414|NCT01207492|2702905|P1|STARTED|Overall Study||17
1116415|NCT01207570|2702913|P2|NOT COMPLETED|The Second Stage (After Crossover)||0
1116416|NCT01207570|2702914|P1|NOT COMPLETED|The Second Stage (After Crossover)||0
1116417|NCT01207570|2702913|P2|COMPLETED|The Second Stage (After Crossover)||23
1116418|NCT01207570|2702914|P1|COMPLETED|The Second Stage (After Crossover)||31
1116419|NCT01207570|2702913|P2|STARTED|The Second Stage (After Crossover)||23
1116420|NCT01207570|2702914|P1|STARTED|The Second Stage (After Crossover)||31
1116421|NCT01207570|2702913|P2|NOT COMPLETED|The First Stage (Before Crossover)||0
1116422|NCT01207570|2702914|P1|NOT COMPLETED|The First Stage (Before Crossover)||0
1116423|NCT01207570|2702913|P2|COMPLETED|The First Stage (Before Crossover)||31
1116424|NCT01207570|2702914|P1|COMPLETED|The First Stage (Before Crossover)||23
1116425|NCT01207570|2702913|P2|STARTED|The First Stage (Before Crossover)||31
1116426|NCT01207570|2702914|P1|STARTED|The First Stage (Before Crossover)||23
1116427|NCT01207583|2702929|P3|NOT COMPLETED|Overall Study||1
1116428|NCT01207583|2702930|P2|NOT COMPLETED|Overall Study||5
1116429|NCT01207583|2702931|P1|NOT COMPLETED|Overall Study||1
1116430|NCT01207583|2702929|P3|COMPLETED|Overall Study||54
1116431|NCT01207583|2702930|P2|COMPLETED|Overall Study||26
1116432|NCT01207583|2702931|P1|COMPLETED|Overall Study||13
1116433|NCT01207583|2702929|P3|Dose 4|Overall Study||0
1116434|NCT01207583|2702930|P2|Dose 4|Overall Study||0
1116435|NCT01207583|2702931|P1|Dose 4|Overall Study||7
1116436|NCT01207583|2702929|P3|Dose 3|Overall Study||0
1116437|NCT01207583|2702930|P2|Dose 3|Overall Study||27
1116438|NCT01207583|2702931|P1|Dose 3|Overall Study||13
1116439|NCT01207583|2702929|P3|Dose 2|Overall Study||54
1116440|NCT01207583|2702930|P2|Dose 2|Overall Study||29
1116441|NCT01207583|2702931|P1|Dose 2|Overall Study||13
1116442|NCT01207583|2702929|P3|Dose 1|Overall Study||55
1116443|NCT01207583|2702930|P2|Dose 1|Overall Study||31
1116444|NCT01207583|2702931|P1|Dose 1|Overall Study||14
1116445|NCT01207583|2702929|P3|STARTED|Overall Study||55
1116446|NCT01207583|2702930|P2|STARTED|Overall Study||31
1116447|NCT01207583|2702931|P1|STARTED|Overall Study||14
1116448|NCT01207596|2702969|P1|NOT COMPLETED|Overall Study||9
1116449|NCT01207596|2702969|P1|COMPLETED|Overall Study||21
1116450|NCT01207596|2702969|P1|STARTED|Overall Study||30
1116451|NCT01207648|2702979|P1|NOT COMPLETED|Overall Study||0
1116452|NCT01207648|2702979|P1|COMPLETED|Overall Study||307
1116453|NCT01207648|2702979|P1|STARTED|Overall Study||307
1116454|NCT01207687|2702987|P1|NOT COMPLETED|Overall Study||2
1116455|NCT01207687|2702987|P1|COMPLETED|Overall Study||12
1116456|NCT01207687|2702987|P1|STARTED|Overall Study||14
1116457|NCT01207765|2702999|P1|NOT COMPLETED|Overall Study||0
1116458|NCT01207765|2702999|P1|COMPLETED|Overall Study||8
1116459|NCT01207765|2702999|P1|STARTED|Overall Study||8
1116460|NCT01207934|2703008|P3|NOT COMPLETED|Overall Study||0
1116461|NCT01207934|2703009|P2|NOT COMPLETED|Overall Study||0
1116462|NCT01207934|2703010|P1|NOT COMPLETED|Overall Study||0
1116463|NCT01207934|2703008|P3|COMPLETED|Overall Study||6
1116464|NCT01207934|2703009|P2|COMPLETED|Overall Study||6
1116465|NCT01207934|2703010|P1|COMPLETED|Overall Study||6
1116466|NCT01207934|2703008|P3|STARTED|Overall Study||6
1116467|NCT01207934|2703009|P2|STARTED|Overall Study||6
1116468|NCT01207934|2703010|P1|STARTED|Overall Study||6
1116469|NCT01208181|2703030|P5|NOT COMPLETED|Part 2||0
1116470|NCT01208181|2703031|P4|NOT COMPLETED|Part 2||20
1116471|NCT01208181|2703032|P3|NOT COMPLETED|Part 2||16
1116472|NCT01208181|2703033|P2|NOT COMPLETED|Part 2||0
1116473|NCT01208181|2703034|P1|NOT COMPLETED|Part 2||0
1116474|NCT01208181|2703030|P5|COMPLETED|Part 2||0
1116475|NCT01208181|2703031|P4|COMPLETED|Part 2||343
1116476|NCT01208181|2703032|P3|COMPLETED|Part 2||334
1116477|NCT01208181|2703033|P2|COMPLETED|Part 2||0
1116478|NCT01208181|2703034|P1|COMPLETED|Part 2||0
1116479|NCT01208181|2703030|P5|STARTED|Part 2|Per protocol, participants did not receive placebo during Part II of the study|0
1116480|NCT01208181|2703031|P4|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 90 mg in Part II of the study|363
1116481|NCT01208181|2703032|P3|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 60 mg in Part II of the study|350
1116482|NCT01208181|2703033|P2|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
1116483|NCT01208181|2703034|P1|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
1116484|NCT01208181|2703030|P5|NOT COMPLETED|Part 1||22
1116485|NCT01208181|2703031|P4|NOT COMPLETED|Part 1||0
1116486|NCT01208181|2703032|P3|NOT COMPLETED|Part 1||0
1116487|NCT01208181|2703033|P2|NOT COMPLETED|Part 1||55
1116488|NCT01208181|2703034|P1|NOT COMPLETED|Part 1||99
1116489|NCT01208181|2703030|P5|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|96
1116490|NCT01208181|2703031|P4|COMPLETED|Part 1||0
1116491|NCT01208181|2703032|P3|COMPLETED|Part 1||0
1116492|NCT01208181|2703033|P2|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|413
1116493|NCT01208181|2703034|P1|COMPLETED|Part 1|Six participants from this arm did not continue into Part II of the study|719
1116494|NCT01208181|2703030|P5|STARTED|Part 1||118
1116495|NCT01208181|2703031|P4|STARTED|Part 1||0
1116496|NCT01208181|2703032|P3|STARTED|Part 1||0
1116497|NCT01208181|2703033|P2|STARTED|Part 1||468
1116498|NCT01208181|2703034|P1|STARTED|Part 1||818
1116499|NCT01208207|2703066|P7|NOT COMPLETED|Part II||11
1116500|NCT01208207|2703067|P6|NOT COMPLETED|Part II||16
1116501|NCT01208207|2703068|P5|NOT COMPLETED|Part II||23
1116502|NCT01208207|2703069|P4|NOT COMPLETED|Part II||32
1116503|NCT01208207|2703070|P3|NOT COMPLETED|Part II||0
1116504|NCT01208207|2703071|P2|NOT COMPLETED|Part II||0
1116505|NCT01208207|2703072|P1|NOT COMPLETED|Part II||0
1116506|NCT01208207|2703066|P7|COMPLETED|Part II||131
1116507|NCT01208207|2703067|P6|COMPLETED|Part II||129
1116508|NCT01208207|2703068|P5|COMPLETED|Part II||295
1116509|NCT01208207|2703069|P4|COMPLETED|Part II||282
1116510|NCT01208207|2703070|P3|COMPLETED|Part II||0
1116511|NCT01208207|2703071|P2|COMPLETED|Part II||0
1116512|NCT01208207|2703072|P1|COMPLETED|Part II||0
1116513|NCT01208207|2703066|P7|STARTED|Part II||142
1116514|NCT01208207|2703067|P6|STARTED|Part II||145
1116515|NCT01208207|2703068|P5|STARTED|Part II||318
1116516|NCT01208207|2703069|P4|STARTED|Part II||314
1116517|NCT01208207|2703070|P3|STARTED|Part II||0
1116518|NCT01208207|2703071|P2|STARTED|Part II||0
1116519|NCT01208207|2703072|P1|STARTED|Part II||0
1116520|NCT01208207|2703066|P7|NOT COMPLETED|Part I||0
1116521|NCT01208207|2703067|P6|NOT COMPLETED|Part I||0
1116522|NCT01208207|2703068|P5|NOT COMPLETED|Part I||0
1116523|NCT01208207|2703069|P4|NOT COMPLETED|Part I||0
1116524|NCT01208207|2703070|P3|NOT COMPLETED|Part I||15
1116525|NCT01208207|2703071|P2|NOT COMPLETED|Part I||11
1116526|NCT01208207|2703072|P1|NOT COMPLETED|Part I||70
1116527|NCT01208207|2703066|P7|COMPLETED|Part I||0
1116528|NCT01208207|2703067|P6|COMPLETED|Part I||0
1116529|NCT01208207|2703068|P5|COMPLETED|Part I||0
1116530|NCT01208207|2703069|P4|COMPLETED|Part I||0
1116531|NCT01208207|2703070|P3|COMPLETED|Part I||142
1116532|NCT01208207|2703071|P2|COMPLETED|Part I||145
1116533|NCT01208207|2703072|P1|COMPLETED|Part I||632
1116534|NCT01208207|2703066|P7|STARTED|Part I||0
1116535|NCT01208207|2703067|P6|STARTED|Part I||0
1116536|NCT01208207|2703068|P5|STARTED|Part I||0
1116537|NCT01208207|2703069|P4|STARTED|Part I||0
1116538|NCT01208207|2703070|P3|STARTED|Part I||157
1116539|NCT01208207|2703071|P2|STARTED|Part I||156
1116540|NCT01208207|2703072|P1|STARTED|Part I||702
1116541|NCT01208220|2703098|P2|NOT COMPLETED|Overall Study||0
1116542|NCT01208220|2703099|P1|NOT COMPLETED|Overall Study||0
1116543|NCT01208220|2703098|P2|COMPLETED|Overall Study||1
1116544|NCT01208220|2703099|P1|COMPLETED|Overall Study||1
1116545|NCT01208220|2703098|P2|STARTED|Overall Study||1
1116546|NCT01208220|2703099|P1|STARTED|Overall Study||1
1116547|NCT01208233|2703113|P6|NOT COMPLETED|Overall Study||21
1116548|NCT01208233|2703114|P5|NOT COMPLETED|Overall Study||24
1116549|NCT01208233|2703115|P4|NOT COMPLETED|Overall Study||1
1116550|NCT01208233|2703116|P3|NOT COMPLETED|Overall Study||4
1116551|NCT01208233|2703117|P2|NOT COMPLETED|Overall Study||3
1116552|NCT01208233|2703118|P1|NOT COMPLETED|Overall Study||5
1116553|NCT01208233|2703113|P6|COMPLETED|Overall Study||46
1116554|NCT01208233|2703114|P5|COMPLETED|Overall Study||46
1116555|NCT01208233|2703115|P4|COMPLETED|Overall Study||9
1116556|NCT01208233|2703116|P3|COMPLETED|Overall Study||7
1116557|NCT01208233|2703117|P2|COMPLETED|Overall Study||6
1116558|NCT01208233|2703118|P1|COMPLETED|Overall Study||6
1116559|NCT01208233|2703113|P6|STARTED|Overall Study||67
1116560|NCT01208233|2703114|P5|STARTED|Overall Study||70
1116561|NCT01208233|2703115|P4|STARTED|Overall Study||10
1116562|NCT01208233|2703116|P3|STARTED|Overall Study||11
1116563|NCT01208233|2703117|P2|STARTED|Overall Study||9
1116564|NCT01208233|2703118|P1|STARTED|Overall Study||11
1116565|NCT01200758|2703231|P4|NOT COMPLETED|Stage 2||50
1116566|NCT01200758|2703232|P3|NOT COMPLETED|Stage 2||41
1116567|NCT01200758|2703233|P2|NOT COMPLETED|Stage 2||0
1116568|NCT01200758|2703234|P1|NOT COMPLETED|Stage 2||0
1116569|NCT01200758|2703231|P4|COMPLETED|Stage 2|Participants completed treatment period.|92
1116570|NCT01200758|2703232|P3|COMPLETED|Stage 2|Participants completed treatment period.|100
1116571|NCT01200758|2703233|P2|COMPLETED|Stage 2||0
1116572|NCT01200758|2703234|P1|COMPLETED|Stage 2||0
1116573|NCT01200758|2703231|P4|STARTED|Stage 2||142
1116574|NCT01200758|2703232|P3|STARTED|Stage 2||141
1116575|NCT01200758|2703233|P2|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
1116576|NCT01200758|2703234|P1|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
1116577|NCT01200758|2703231|P4|NOT COMPLETED|Stage I||0
1116578|NCT01200758|2703232|P3|NOT COMPLETED|Stage I||0
1116579|NCT01200758|2703233|P2|NOT COMPLETED|Stage I||17
1116580|NCT01200758|2703234|P1|NOT COMPLETED|Stage I||18
1116581|NCT01200758|2703231|P4|COMPLETED|Stage I||0
1116582|NCT01200758|2703232|P3|COMPLETED|Stage I||0
1116583|NCT01200758|2703233|P2|COMPLETED|Stage I|Participants completed treatment period.|46
1116584|NCT01200758|2703234|P1|COMPLETED|Stage I|Participants completed treatment period.|46
1116585|NCT01200758|2703231|P4|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
1116586|NCT01200758|2703232|P3|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
1116587|NCT01200758|2703233|P2|STARTED|Stage I||63
1116588|NCT01200758|2703234|P1|STARTED|Stage I||64
1116589|NCT01200797|2703288|P1|NOT COMPLETED|Overall Study||19
1116590|NCT01200797|2703288|P1|COMPLETED|Overall Study||0
1116591|NCT01200797|2703288|P1|STARTED|Overall Study||19
1116592|NCT01200810|2703298|P2|NOT COMPLETED|Overall Study||5
1116593|NCT01200810|2703299|P1|NOT COMPLETED|Overall Study||5
1116594|NCT01200810|2703298|P2|COMPLETED|Overall Study||0
1116595|NCT01200810|2703299|P1|COMPLETED|Overall Study||0
1116596|NCT01200810|2703298|P2|STARTED|Overall Study||5
1116597|NCT01200810|2703299|P1|STARTED|Overall Study||5
1116598|NCT01200875|2703317|P1|NOT COMPLETED|Overall Study||0
1116599|NCT01200875|2703317|P1|COMPLETED|Overall Study||25
1116600|NCT01200875|2703317|P1|STARTED|Overall Study||25
1116601|NCT01200992|2703323|P2|NOT COMPLETED|Overall Study||41
1116602|NCT01200992|2703324|P1|NOT COMPLETED|Overall Study||37
1116603|NCT01200992|2703323|P2|COMPLETED|Overall Study||4
1116604|NCT01200992|2703324|P1|COMPLETED|Overall Study||2
1116605|NCT01200992|2703323|P2|STARTED|Overall Study||45
1116606|NCT01200992|2703324|P1|STARTED|Overall Study||39
1116607|NCT01201265|2703332|P1|NOT COMPLETED|Overall Study||38
1116608|NCT01201265|2703332|P1|COMPLETED|Overall Study||2
1116609|NCT01201265|2703332|P1|STARTED|Overall Study||40
1116610|NCT01201317|2703347|P3|NOT COMPLETED|Overall Study||8
1116611|NCT01201317|2703348|P2|NOT COMPLETED|Overall Study||7
1116612|NCT01201317|2703349|P1|NOT COMPLETED|Overall Study||9
1116613|NCT01201317|2703347|P3|COMPLETED|Overall Study||33
1116614|NCT01201317|2703348|P2|COMPLETED|Overall Study||38
1116615|NCT01201317|2703349|P1|COMPLETED|Overall Study||39
1116616|NCT01201317|2703347|P3|STARTED|Overall Study||41
1116617|NCT01201317|2703348|P2|STARTED|Overall Study||45
1116618|NCT01201317|2703349|P1|STARTED|Overall Study||48
1116619|NCT01201343|2703369|P1|NOT COMPLETED|Overall Study||19
1116620|NCT01201343|2703369|P1|COMPLETED|Overall Study||60
1116621|NCT01201343|2703369|P1|Treated|Overall Study||76
1116622|NCT01201343|2703369|P1|STARTED|Overall Study||79
1116623|NCT01208337|2703380|P1|NOT COMPLETED|Overall Study||3
1116624|NCT01208337|2703380|P1|COMPLETED|Overall Study||20
1116625|NCT01208337|2703380|P1|Five-year Follow-up|Overall Study||20
1116626|NCT01208337|2703380|P1|One-year Follow-up|Overall Study||23
1116627|NCT01208337|2703380|P1|STARTED|Overall Study||23
1116628|NCT01208402|2703390|P2|NOT COMPLETED|Overall Study||0
1116629|NCT01208402|2703391|P1|NOT COMPLETED|Overall Study||1
1116630|NCT01208402|2703390|P2|COMPLETED|Overall Study||28
1116631|NCT01208402|2703391|P1|COMPLETED|Overall Study||30
1116632|NCT01208402|2703390|P2|STARTED|Overall Study||28
1116633|NCT01208402|2703391|P1|STARTED|Overall Study||31
1116634|NCT01208415|2703407|P1|NOT COMPLETED|Overall Study||40
1116635|NCT01208415|2703407|P1|COMPLETED|Overall Study||0
1116636|NCT01208415|2703407|P1|6 Months|Overall Study||37
1116637|NCT01208415|2703407|P1|STARTED|Overall Study||40
1116638|NCT01208870|2703413|P2|NOT COMPLETED|Overall Study||8
1116639|NCT01208870|2703414|P1|NOT COMPLETED|Overall Study||2
1116640|NCT01208870|2703413|P2|COMPLETED|Overall Study||36
1116641|NCT01208870|2703414|P1|COMPLETED|Overall Study||44
1116642|NCT01208870|2703413|P2|Pilot 2|Overall Study||22
1116643|NCT01208870|2703414|P1|Pilot 2|Overall Study||26
1116644|NCT01208870|2703413|P2|Pilot 1|Overall Study||22
1116645|NCT01208870|2703414|P1|Pilot 1|Overall Study||20
1116646|NCT01208870|2703413|P2|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013.|44
1116647|NCT01208870|2703414|P1|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013|46
1116648|NCT01208961|2703430|P2|NOT COMPLETED|High-Fat Period IV||0
1116649|NCT01208961|2703431|P1|NOT COMPLETED|High-Fat Period IV||0
1116650|NCT01208961|2703430|P2|COMPLETED|High-Fat Period IV||26
1116651|NCT01208961|2703431|P1|COMPLETED|High-Fat Period IV||25
1116652|NCT01208961|2703430|P2|STARTED|High-Fat Period IV||26
1116653|NCT01208961|2703431|P1|STARTED|High-Fat Period IV||25
1116654|NCT01208961|2703430|P2|NOT COMPLETED|High-Fat Period III||0
1116655|NCT01208961|2703431|P1|NOT COMPLETED|High-Fat Period III||1
1116656|NCT01208961|2703430|P2|COMPLETED|High-Fat Period III||26
1116657|NCT01208961|2703431|P1|COMPLETED|High-Fat Period III||25
1116658|NCT01208961|2703430|P2|STARTED|High-Fat Period III||26
1116659|NCT01208961|2703431|P1|STARTED|High-Fat Period III||26
1116660|NCT01208961|2703430|P2|NOT COMPLETED|Low-Fat Period II||0
1116661|NCT01208961|2703431|P1|NOT COMPLETED|Low-Fat Period II||0
1116662|NCT01208961|2703430|P2|COMPLETED|Low-Fat Period II||27
1116663|NCT01208961|2703431|P1|COMPLETED|Low-Fat Period II||26
1116664|NCT01208961|2703430|P2|STARTED|Low-Fat Period II||27
1116665|NCT01208961|2703431|P1|STARTED|Low-Fat Period II||26
1116666|NCT01208961|2703430|P2|NOT COMPLETED|Low-Fat Period I||0
1116667|NCT01208961|2703431|P1|NOT COMPLETED|Low-Fat Period I||0
1116668|NCT01208961|2703430|P2|COMPLETED|Low-Fat Period I||27
1116669|NCT01208961|2703431|P1|COMPLETED|Low-Fat Period I||27
1116670|NCT01208961|2703430|P2|STARTED|Low-Fat Period I||27
1116671|NCT01208961|2703431|P1|STARTED|Low-Fat Period I||27
1116672|NCT01209143|2703442|P2|NOT COMPLETED|Overall Study||20
1116673|NCT01209143|2703443|P1|NOT COMPLETED|Overall Study||19
1116674|NCT01209143|2703442|P2|COMPLETED|Overall Study||8
1116675|NCT01209143|2703443|P1|COMPLETED|Overall Study||5
1116676|NCT01209143|2703442|P2|STARTED|Overall Study||28
1116677|NCT01209143|2703443|P1|STARTED|Overall Study||24
1116678|NCT01209195|2703453|P6|NOT COMPLETED|Overall Study||0
1116679|NCT01209195|2703454|P5|NOT COMPLETED|Overall Study||0
1116680|NCT01209195|2703455|P4|NOT COMPLETED|Overall Study||0
1116681|NCT01209195|2703456|P3|NOT COMPLETED|Overall Study||0
1116682|NCT01209195|2703457|P2|NOT COMPLETED|Overall Study||0
1116683|NCT01209195|2703458|P1|NOT COMPLETED|Overall Study||0
1116684|NCT01209195|2703453|P6|COMPLETED|Overall Study||13
1116685|NCT01209195|2703454|P5|COMPLETED|Overall Study||6
1116686|NCT01209195|2703455|P4|COMPLETED|Overall Study||6
1116687|NCT01209195|2703456|P3|COMPLETED|Overall Study||6
1116688|NCT01209195|2703457|P2|COMPLETED|Overall Study||3
1116689|NCT01209195|2703458|P1|COMPLETED|Overall Study||7
1116690|NCT01209195|2703453|P6|STARTED|Overall Study||13
1116691|NCT01209195|2703454|P5|STARTED|Overall Study||6
1116692|NCT01209195|2703455|P4|STARTED|Overall Study||6
1116693|NCT01209195|2703456|P3|STARTED|Overall Study||6
1116694|NCT01209195|2703457|P2|STARTED|Overall Study||3
1116695|NCT01209195|2703458|P1|STARTED|Overall Study||7
1116696|NCT01209260|2703494|P2|NOT COMPLETED|Overall Study||0
1116697|NCT01209260|2703495|P1|NOT COMPLETED|Overall Study||0
1116698|NCT01209260|2703494|P2|COMPLETED|Overall Study||36
1116699|NCT01209260|2703495|P1|COMPLETED|Overall Study||36
1116700|NCT01209260|2703494|P2|STARTED|Overall Study||36
1116701|NCT01209260|2703495|P1|STARTED|Overall Study||36
1116702|NCT01209286|2703510|P3|NOT COMPLETED|Overall Study||3
1116703|NCT01209286|2703511|P2|NOT COMPLETED|Overall Study||10
1116704|NCT01209286|2703512|P1|NOT COMPLETED|Overall Study||5
1116705|NCT01209286|2703510|P3|COMPLETED|Overall Study||3
1116706|NCT01209286|2703511|P2|COMPLETED|Overall Study||13
1116707|NCT01209286|2703512|P1|COMPLETED|Overall Study||2
1116708|NCT01209286|2703510|P3|STARTED|Overall Study||6
1116709|NCT01209286|2703511|P2|STARTED|Overall Study||23
1116710|NCT01209286|2703512|P1|STARTED|Overall Study||7
1116711|NCT01209520|2703563|P1|NOT COMPLETED|Overall Study||3
1116712|NCT01209520|2703563|P1|COMPLETED|Overall Study||3
1116713|NCT01209520|2703563|P1|STARTED|Overall Study||6
1116714|NCT01209624|2703568|P1|NOT COMPLETED|Overall Study||326
1116715|NCT01209624|2703568|P1|COMPLETED|Overall Study||576
1116716|NCT01209624|2703568|P1|Per Protocol Population|Overall Study||469
1116717|NCT01209624|2703568|P1|STARTED|Overall Study||902
1116718|NCT01209689|2703601|P2|NOT COMPLETED|Overall Study||22
1116719|NCT01209689|2703602|P1|NOT COMPLETED|Overall Study||91
1116720|NCT01209689|2703601|P2|COMPLETED|Overall Study||0
1116721|NCT01209689|2703602|P1|COMPLETED|Overall Study||0
1116722|NCT01209689|2703601|P2|STARTED|Overall Study||22
1116723|NCT01209689|2703602|P1|STARTED|Overall Study||91
1116724|NCT01209702|2703610|P4|NOT COMPLETED|Overall Study||153
1116725|NCT01209702|2703611|P3|NOT COMPLETED|Overall Study||51
1116726|NCT01209702|2703612|P2|NOT COMPLETED|Overall Study||51
1116727|NCT01209702|2703613|P1|NOT COMPLETED|Overall Study||51
1116728|NCT01209702|2703610|P4|COMPLETED|Overall Study||0
1116729|NCT01209702|2703611|P3|COMPLETED|Overall Study||0
1116730|NCT01209702|2703612|P2|COMPLETED|Overall Study||0
1116731|NCT01209702|2703613|P1|COMPLETED|Overall Study||0
1116732|NCT01209702|2703610|P4|Completed 24 Weeks Treatment|Overall Study||10
1116733|NCT01209702|2703611|P3|Completed 24 Weeks Treatment|Overall Study||3
1116734|NCT01209702|2703612|P2|Completed 24 Weeks Treatment|Overall Study||28
1116735|NCT01209702|2703613|P1|Completed 24 Weeks Treatment|Overall Study||19
1116736|NCT01209702|2703610|P4|Completed 12 Weeks Treatment|Overall Study||59
1116737|NCT01209702|2703611|P3|Completed 12 Weeks Treatment|Overall Study||12
1116738|NCT01209702|2703612|P2|Completed 12 Weeks Treatment|Overall Study||48
1116739|NCT01209702|2703613|P1|Completed 12 Weeks Treatment|Overall Study||50
1116740|NCT01209702|2703610|P4|Escape or Switched to Tocilizumab|Overall Study||0
1116741|NCT01209702|2703611|P3|Escape or Switched to Tocilizumab|Overall Study||6
1116742|NCT01209702|2703612|P2|Escape or Switched to Tocilizumab|Overall Study||0
1116743|NCT01209702|2703613|P1|Escape or Switched to Tocilizumab|Overall Study||51
1116744|NCT01209702|2703610|P4|Treated|Overall Study||152
1116745|NCT01209702|2703611|P3|Treated|Overall Study||51
1116746|NCT01209702|2703612|P2|Treated|Overall Study||51
1116747|NCT01209702|2703613|P1|Treated|Overall Study||51
1116748|NCT01209702|2703610|P4|STARTED|Overall Study||153
1116749|NCT01209702|2703611|P3|STARTED|Overall Study||51
1116750|NCT01209702|2703612|P2|STARTED|Overall Study||51
1116751|NCT01209702|2703613|P1|STARTED|Overall Study||51
1116752|NCT01209767|2703667|P1|NOT COMPLETED|Overall Study||4
1116753|NCT01209767|2703667|P1|COMPLETED|Overall Study||18
1116754|NCT01209767|2703667|P1|STARTED|Overall Study||22
1116755|NCT01209780|2703679|P5|NOT COMPLETED|Overall Study||5
1116756|NCT01209780|2703680|P4|NOT COMPLETED|Overall Study||10
1116757|NCT01209780|2703681|P3|NOT COMPLETED|Overall Study||4
1116758|NCT01209780|2703682|P2|NOT COMPLETED|Overall Study||18
1116759|NCT01209780|2703683|P1|NOT COMPLETED|Overall Study||26
1116760|NCT01209780|2703679|P5|COMPLETED|Overall Study||407
1116761|NCT01209780|2703680|P4|COMPLETED|Overall Study||807
1116762|NCT01209780|2703681|P3|COMPLETED|Overall Study||44
1116763|NCT01209780|2703682|P2|COMPLETED|Overall Study||467
1116764|NCT01209780|2703683|P1|COMPLETED|Overall Study||1016
1116765|NCT01209780|2703679|P5|STARTED|Overall Study||412
1116766|NCT01209780|2703680|P4|STARTED|Overall Study||817
1116767|NCT01209780|2703681|P3|STARTED|Overall Study||48
1116768|NCT01209780|2703682|P2|STARTED|Overall Study||485
1116769|NCT01209780|2703683|P1|STARTED|Overall Study||1042
1116770|NCT01209949|2703709|P1|NOT COMPLETED|Overall Study||3
1116771|NCT01209949|2703709|P1|COMPLETED|Overall Study||27
1116772|NCT01209949|2703709|P1|STARTED|Overall Study||30
1116773|NCT01210001|2703718|P3|NOT COMPLETED|Overall Study||12
1116774|NCT01210001|2703719|P2|NOT COMPLETED|Overall Study||11
1116775|NCT01210001|2703720|P1|NOT COMPLETED|Overall Study||19
1116776|NCT01210001|2703718|P3|COMPLETED|Overall Study||156
1116777|NCT01210001|2703719|P2|COMPLETED|Overall Study||154
1116778|NCT01210001|2703720|P1|COMPLETED|Overall Study||147
1116779|NCT01210001|2703718|P3|STARTED|Overall Study||168
1116780|NCT01210001|2703719|P2|STARTED|Overall Study||165
1116781|NCT01210001|2703720|P1|STARTED|Overall Study||166
1116782|NCT01210079|2703742|P2|NOT COMPLETED|Overall Study||0
1116783|NCT01210079|2703743|P1|NOT COMPLETED|Overall Study||0
1116784|NCT01210079|2703742|P2|COMPLETED|Overall Study||16
1116785|NCT01210079|2703743|P1|COMPLETED|Overall Study||10
1116786|NCT01210079|2703742|P2|STARTED|Overall Study||16
1116787|NCT01210079|2703743|P1|STARTED|Overall Study||10
1116788|NCT01210118|2703751|P2|NOT COMPLETED|Overall Study||5
1116789|NCT01210118|2703752|P1|NOT COMPLETED|Overall Study||3
1116790|NCT01210118|2703751|P2|COMPLETED|Overall Study||42
1116791|NCT01210118|2703752|P1|COMPLETED|Overall Study||42
1116792|NCT01210118|2703751|P2|STARTED|Overall Study||47
1116793|NCT01210118|2703752|P1|STARTED|Overall Study||45
1116794|NCT01210144|2703766|P2|NOT COMPLETED|Overall Study||0
1116795|NCT01210144|2703767|P1|NOT COMPLETED|Overall Study||3
1116796|NCT01210144|2703766|P2|COMPLETED|Overall Study||11
1116797|NCT01210144|2703767|P1|COMPLETED|Overall Study||10
1116798|NCT01210144|2703766|P2|STARTED|Overall Study||11
1116799|NCT01210144|2703767|P1|STARTED|Overall Study||13
1116800|NCT01210170|2703787|P1|NOT COMPLETED|Overall Study||7
1116801|NCT01210170|2703787|P1|COMPLETED|Overall Study||15
1116802|NCT01210170|2703787|P1|STARTED|Overall Study||22
1116803|NCT01210443|2703801|P1|NOT COMPLETED|Overall Study||2
1116804|NCT01210443|2703801|P1|COMPLETED|Overall Study||0
1116805|NCT01210443|2703801|P1|STARTED|Overall Study||2
1116806|NCT01210495|2703813|P4|NOT COMPLETED|Overall Study||68
1116807|NCT01210495|2703814|P3|NOT COMPLETED|Overall Study||134
1116808|NCT01210495|2703815|P2|NOT COMPLETED|Overall Study||7
1116809|NCT01210495|2703816|P1|NOT COMPLETED|Overall Study||15
1116810|NCT01210495|2703813|P4|COMPLETED|Overall Study||0
1116811|NCT01210495|2703814|P3|COMPLETED|Overall Study||0
1116812|NCT01210495|2703815|P2|COMPLETED|Overall Study||0
1116813|NCT01210495|2703816|P1|COMPLETED|Overall Study||0
1116814|NCT01210495|2703813|P4|STARTED|Overall Study||68
1116815|NCT01210495|2703814|P3|STARTED|Overall Study||134
1116816|NCT01210495|2703815|P2|STARTED|Overall Study||7
1116817|NCT01210495|2703816|P1|STARTED|Overall Study||15
1116818|NCT01210651|2703880|P2|NOT COMPLETED|Overall Study||8
1116819|NCT01210651|2703881|P1|NOT COMPLETED|Overall Study||5
1116820|NCT01210651|2703880|P2|COMPLETED|Overall Study||10
1116821|NCT01210651|2703881|P1|COMPLETED|Overall Study||15
1116822|NCT01210651|2703880|P2|Number Attending 1st Assigned Session|Overall Study||12
1116823|NCT01210651|2703881|P1|Number Attending 1st Assigned Session|Overall Study||18
1116824|NCT01210651|2703880|P2|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|18
1116825|NCT01210651|2703881|P1|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|20
1116826|NCT01210690|2703895|P1|NOT COMPLETED|Overall Study||26
1116827|NCT01210690|2703895|P1|COMPLETED|Overall Study||75
1116828|NCT01210690|2703895|P1|STARTED|Overall Study||101
1116829|NCT01210716|2703908|P2|NOT COMPLETED|Second TPE Procedure||0
1116830|NCT01210716|2703909|P1|NOT COMPLETED|Second TPE Procedure||3
1116831|NCT01210716|2703908|P2|COMPLETED|Second TPE Procedure||15
1116832|NCT01210716|2703909|P1|COMPLETED|Second TPE Procedure||15
1116833|NCT01210716|2703908|P2|STARTED|Second TPE Procedure||15
1116834|NCT01210716|2703909|P1|STARTED|Second TPE Procedure||18
1116835|NCT01210716|2703908|P2|NOT COMPLETED|First TPE Procedure||2
1116836|NCT01210716|2703909|P1|NOT COMPLETED|First TPE Procedure||2
1116837|NCT01210716|2703908|P2|COMPLETED|First TPE Procedure||15
1116838|NCT01210716|2703909|P1|COMPLETED|First TPE Procedure||18
1116839|NCT01210716|2703908|P2|STARTED|First TPE Procedure||17
1116840|NCT01210716|2703909|P1|STARTED|First TPE Procedure||20
1116841|NCT01210807|2703917|P2|NOT COMPLETED|Overall Study||3
1116842|NCT01210807|2703918|P1|NOT COMPLETED|Overall Study||3
1116843|NCT01210807|2703917|P2|COMPLETED|Overall Study||31
1116844|NCT01210807|2703918|P1|COMPLETED|Overall Study||33
1116845|NCT01210807|2703917|P2|STARTED|Overall Study||34
1116846|NCT01210807|2703918|P1|STARTED|Overall Study||36
1116847|NCT01210820|2703928|P2|NOT COMPLETED|Overall Study||0
1116848|NCT01210820|2703929|P1|NOT COMPLETED|Overall Study||0
1116849|NCT01210820|2703928|P2|COMPLETED|Overall Study||4
1116850|NCT01210820|2703929|P1|COMPLETED|Overall Study||17
1116851|NCT01210820|2703928|P2|STARTED|Overall Study||4
1116852|NCT01210820|2703929|P1|STARTED|Overall Study||17
1116853|NCT01211106|2703939|P2|NOT COMPLETED|Overall Study||11
1116854|NCT01211106|2703940|P1|NOT COMPLETED|Overall Study||13
1116855|NCT01211106|2703939|P2|COMPLETED|Overall Study||77
1116856|NCT01211106|2703940|P1|COMPLETED|Overall Study||82
1116857|NCT01211106|2703939|P2|STARTED|Overall Study||88
1116858|NCT01211106|2703940|P1|STARTED|Overall Study||95
1116859|NCT01204294|2703955|P7|NOT COMPLETED|Overall Study||2
1116860|NCT01204294|2703956|P6|NOT COMPLETED|Overall Study||5
1116861|NCT01204294|2703957|P5|NOT COMPLETED|Overall Study||2
1116862|NCT01204294|2703958|P4|NOT COMPLETED|Overall Study||11
1116863|NCT01204294|2703959|P3|NOT COMPLETED|Overall Study||5
1116864|NCT01204294|2703960|P2|NOT COMPLETED|Overall Study||8
1116865|NCT01204294|2703961|P1|NOT COMPLETED|Overall Study||3
1116866|NCT01204294|2703955|P7|COMPLETED|Overall Study||59
1116867|NCT01204294|2703956|P6|COMPLETED|Overall Study||58
1116868|NCT01204294|2703957|P5|COMPLETED|Overall Study||83
1116869|NCT01204294|2703958|P4|COMPLETED|Overall Study||132
1116870|NCT01204294|2703959|P3|COMPLETED|Overall Study||69
1116871|NCT01204294|2703960|P2|COMPLETED|Overall Study||58
1116872|NCT01204294|2703961|P1|COMPLETED|Overall Study||79
1116873|NCT01204294|2703955|P7|STARTED|Overall Study||61
1116874|NCT01204294|2703956|P6|STARTED|Overall Study||63
1116875|NCT01204294|2703957|P5|STARTED|Overall Study||85
1116876|NCT01204294|2703958|P4|STARTED|Overall Study||143
1116877|NCT01204294|2703959|P3|STARTED|Overall Study||74
1116878|NCT01204294|2703960|P2|STARTED|Overall Study||66
1116879|NCT01204294|2703961|P1|STARTED|Overall Study||82
1116880|NCT01204398|2703984|P1|NOT COMPLETED|Overall Study||1
1116881|NCT01204398|2703984|P1|COMPLETED|Overall Study|Completed trial medication.|26
1116882|NCT01204398|2703984|P1|STARTED|Overall Study|Entered and treated.|27
1116883|NCT01204658|2703998|P4|NOT COMPLETED|Booster Phase||0
1116884|NCT01204658|2703999|P3|NOT COMPLETED|Booster Phase||0
1116885|NCT01204658|2704000|P2|NOT COMPLETED|Booster Phase||0
1116886|NCT01204658|2704001|P1|NOT COMPLETED|Booster Phase||0
1116887|NCT01204658|2703998|P4|COMPLETED|Booster Phase||140
1116888|NCT01204658|2703999|P3|COMPLETED|Booster Phase||140
1116889|NCT01204658|2704000|P2|COMPLETED|Booster Phase||140
1116890|NCT01204658|2704001|P1|COMPLETED|Booster Phase||144
1116891|NCT01204658|2703998|P4|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
1116892|NCT01204658|2703999|P3|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
1116893|NCT01204658|2704000|P2|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
1116894|NCT01204658|2704001|P1|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|144
1116895|NCT01204658|2703998|P4|NOT COMPLETED|Primary Phase||0
1116896|NCT01204658|2703999|P3|NOT COMPLETED|Primary Phase||1
1116897|NCT01204658|2704000|P2|NOT COMPLETED|Primary Phase||0
1116898|NCT01204658|2704001|P1|NOT COMPLETED|Primary Phase||0
1116899|NCT01204658|2703998|P4|COMPLETED|Primary Phase||142
1116900|NCT01204658|2703999|P3|COMPLETED|Primary Phase||144
1116901|NCT01204658|2704000|P2|COMPLETED|Primary Phase||142
1116902|NCT01204658|2704001|P1|COMPLETED|Primary Phase||146
1116903|NCT01204658|2703998|P4|STARTED|Primary Phase||142
1116904|NCT01204658|2703999|P3|STARTED|Primary Phase||145
1116905|NCT01204658|2704000|P2|STARTED|Primary Phase||142
1116906|NCT01204658|2704001|P1|STARTED|Primary Phase||146
1116907|NCT01204671|2704116|P5|NOT COMPLETED|Overall Study||4
1116908|NCT01204671|2704117|P4|NOT COMPLETED|Overall Study||13
1116909|NCT01204671|2704118|P3|NOT COMPLETED|Overall Study||13
1116910|NCT01204671|2704119|P2|NOT COMPLETED|Overall Study||15
1116911|NCT01204671|2704120|P1|NOT COMPLETED|Overall Study||14
1116912|NCT01204671|2704116|P5|COMPLETED|Overall Study||606
1116913|NCT01204671|2704117|P4|COMPLETED|Overall Study||997
1116914|NCT01204671|2704118|P3|COMPLETED|Overall Study||998
1116915|NCT01204671|2704119|P2|COMPLETED|Overall Study||998
1116916|NCT01204671|2704120|P1|COMPLETED|Overall Study||998
1116917|NCT01204671|2704116|P5|STARTED|Overall Study||610
1116918|NCT01204671|2704117|P4|STARTED|Overall Study||1010
1116919|NCT01204671|2704118|P3|STARTED|Overall Study||1011
1116920|NCT01204671|2704119|P2|STARTED|Overall Study||1013
1116921|NCT01204671|2704120|P1|STARTED|Overall Study||1012
1116922|NCT01204697|2704180|P2|NOT COMPLETED|Overall Study||36
1116923|NCT01204697|2704181|P1|NOT COMPLETED|Overall Study||31
1116924|NCT01204697|2704180|P2|COMPLETED|Overall Study||2
1116925|NCT01204697|2704181|P1|COMPLETED|Overall Study||5
1116926|NCT01204697|2704180|P2|Treated|Overall Study||37
1116927|NCT01204697|2704181|P1|Treated|Overall Study||36
1116928|NCT01204697|2704180|P2|STARTED|Overall Study||38
1116929|NCT01204697|2704181|P1|STARTED|Overall Study||36
1116930|NCT01204736|2704201|P4|NOT COMPLETED|Overall Study||0
1116931|NCT01204736|2704202|P3|NOT COMPLETED|Overall Study||0
1116932|NCT01204736|2704203|P2|NOT COMPLETED|Overall Study||0
1116933|NCT01204736|2704204|P1|NOT COMPLETED|Overall Study||0
1116934|NCT01204736|2704201|P4|COMPLETED|Overall Study||2
1116935|NCT01204736|2704202|P3|COMPLETED|Overall Study||3
1116936|NCT01204736|2704203|P2|COMPLETED|Overall Study||5
1116937|NCT01204736|2704204|P1|COMPLETED|Overall Study||4
1116938|NCT01204736|2704201|P4|STARTED|Overall Study||2
1116939|NCT01204736|2704202|P3|STARTED|Overall Study||3
1116940|NCT01204736|2704203|P2|STARTED|Overall Study||5
1116941|NCT01204736|2704204|P1|STARTED|Overall Study||4
1116942|NCT01204775|2704216|P2|NOT COMPLETED|Overall Study||1
1116943|NCT01204775|2704217|P1|NOT COMPLETED|Overall Study||1
1116944|NCT01204775|2704216|P2|COMPLETED|Overall Study||3
1116945|NCT01204775|2704217|P1|COMPLETED|Overall Study||3
1116946|NCT01204775|2704216|P2|Double-blind Treatment Period|Overall Study||4
1116947|NCT01204775|2704217|P1|Double-blind Treatment Period|Overall Study||4
1116948|NCT01204775|2704216|P2|STARTED|Overall Study||4
1116949|NCT01204775|2704217|P1|STARTED|Overall Study||4
1116950|NCT01204788|2704225|P2|NOT COMPLETED|Overall Study||3
1116951|NCT01204788|2704226|P1|NOT COMPLETED|Overall Study||1
1116952|NCT01204788|2704225|P2|COMPLETED|Overall Study||0
1116953|NCT01204788|2704226|P1|COMPLETED|Overall Study||0
1116954|NCT01204788|2704225|P2|STARTED|Overall Study||3
1116955|NCT01204788|2704226|P1|STARTED|Overall Study||1
1116956|NCT01204853|2704232|P1|NOT COMPLETED|Overall Study||0
1116957|NCT01204853|2704232|P1|COMPLETED|Overall Study||2
1116958|NCT01204853|2704232|P1|STARTED|Overall Study||2
1116959|NCT01205035|2704244|P2|NOT COMPLETED|Overall Study||0
1116960|NCT01205035|2704245|P1|NOT COMPLETED|Overall Study||2
1116961|NCT01205035|2704244|P2|COMPLETED|Overall Study||3
1116962|NCT01205035|2704245|P1|COMPLETED|Overall Study||1
1116963|NCT01205035|2704244|P2|STARTED|Overall Study||3
1116964|NCT01205035|2704245|P1|STARTED|Overall Study||3
1116965|NCT01205126|2704261|P2|NOT COMPLETED|Maintenance Phase||40
1116966|NCT01205126|2704262|P1|NOT COMPLETED|Maintenance Phase||37
1116967|NCT01205126|2704261|P2|COMPLETED|Maintenance Phase||67
1116968|NCT01205126|2704262|P1|COMPLETED|Maintenance Phase||70
1116969|NCT01205126|2704261|P2|STARTED|Maintenance Phase||107
1116970|NCT01205126|2704262|P1|STARTED|Maintenance Phase||107
1116971|NCT01205126|2704261|P2|NOT COMPLETED|Between Titration & Maintenance Phase||4
1116972|NCT01205126|2704262|P1|NOT COMPLETED|Between Titration & Maintenance Phase||0
1116973|NCT01205126|2704261|P2|COMPLETED|Between Titration & Maintenance Phase||107
1116974|NCT01205126|2704262|P1|COMPLETED|Between Titration & Maintenance Phase||107
1116975|NCT01205126|2704261|P2|STARTED|Between Titration & Maintenance Phase||111
1116976|NCT01205126|2704262|P1|STARTED|Between Titration & Maintenance Phase||107
1116977|NCT01205126|2704261|P2|NOT COMPLETED|Titration Phase||19
1116978|NCT01205126|2704262|P1|NOT COMPLETED|Titration Phase||23
1116979|NCT01205126|2704261|P2|COMPLETED|Titration Phase||111
1116980|NCT01205126|2704262|P1|COMPLETED|Titration Phase||107
1116981|NCT01205126|2704261|P2|STARTED|Titration Phase||130
1116982|NCT01205126|2704262|P1|STARTED|Titration Phase||130
1116983|NCT01205230|2704280|P2|NOT COMPLETED|Overall Study||0
1116984|NCT01205230|2704281|P1|NOT COMPLETED|Overall Study||5
1116985|NCT01205230|2704280|P2|COMPLETED|Overall Study||13
1116986|NCT01205230|2704281|P1|COMPLETED|Overall Study||16
1116987|NCT01205230|2704280|P2|Combination Therapy|Overall Study||13
1116988|NCT01205230|2704281|P1|Combination Therapy|Overall Study||21
1116989|NCT01205230|2704280|P2|STARTED|Overall Study||13
1116990|NCT01205230|2704281|P1|STARTED|Overall Study||21
1116991|NCT01205269|2704324|P6|NOT COMPLETED|Period 5 - Third Intervention||0
1116992|NCT01205269|2704325|P5|NOT COMPLETED|Period 5 - Third Intervention||0
1116993|NCT01205269|2704326|P4|NOT COMPLETED|Period 5 - Third Intervention||0
1116994|NCT01205269|2704327|P3|NOT COMPLETED|Period 5 - Third Intervention||0
1116995|NCT01205269|2704328|P2|NOT COMPLETED|Period 5 - Third Intervention||0
1116996|NCT01205269|2704329|P1|NOT COMPLETED|Period 5 - Third Intervention||0
1116997|NCT01205269|2704324|P6|COMPLETED|Period 5 - Third Intervention||5
1116998|NCT01205269|2704325|P5|COMPLETED|Period 5 - Third Intervention||5
1116999|NCT01205269|2704326|P4|COMPLETED|Period 5 - Third Intervention||5
1117000|NCT01205269|2704327|P3|COMPLETED|Period 5 - Third Intervention||4
1117001|NCT01205269|2704328|P2|COMPLETED|Period 5 - Third Intervention||4
1117002|NCT01205269|2704329|P1|COMPLETED|Period 5 - Third Intervention||4
1117003|NCT01205269|2704324|P6|STARTED|Period 5 - Third Intervention||5
1117004|NCT01205269|2704325|P5|STARTED|Period 5 - Third Intervention||5
1117005|NCT01205269|2704326|P4|STARTED|Period 5 - Third Intervention||5
1117006|NCT01205269|2704327|P3|STARTED|Period 5 - Third Intervention||4
1117007|NCT01205269|2704328|P2|STARTED|Period 5 - Third Intervention||4
1117008|NCT01205269|2704329|P1|STARTED|Period 5 - Third Intervention||4
1117009|NCT01205269|2704324|P6|NOT COMPLETED|Period 4 - Washout||0
1117010|NCT01205269|2704325|P5|NOT COMPLETED|Period 4 - Washout||0
1117011|NCT01205269|2704326|P4|NOT COMPLETED|Period 4 - Washout||1
1117012|NCT01205269|2704327|P3|NOT COMPLETED|Period 4 - Washout||0
1117013|NCT01205269|2704328|P2|NOT COMPLETED|Period 4 - Washout||0
1117014|NCT01205269|2704329|P1|NOT COMPLETED|Period 4 - Washout||0
1117015|NCT01205269|2704324|P6|COMPLETED|Period 4 - Washout||5
1117016|NCT01205269|2704325|P5|COMPLETED|Period 4 - Washout||5
1117017|NCT01205269|2704326|P4|COMPLETED|Period 4 - Washout||5
1117018|NCT01205269|2704327|P3|COMPLETED|Period 4 - Washout||4
1117019|NCT01205269|2704328|P2|COMPLETED|Period 4 - Washout||4
1117020|NCT01205269|2704329|P1|COMPLETED|Period 4 - Washout||4
1117021|NCT01205269|2704324|P6|STARTED|Period 4 - Washout||5
1117022|NCT01205269|2704325|P5|STARTED|Period 4 - Washout||5
1117023|NCT01205269|2704326|P4|STARTED|Period 4 - Washout||6
1117024|NCT01205269|2704327|P3|STARTED|Period 4 - Washout||4
1117025|NCT01205269|2704328|P2|STARTED|Period 4 - Washout||4
1117026|NCT01205269|2704329|P1|STARTED|Period 4 - Washout||4
1117027|NCT01205269|2704324|P6|NOT COMPLETED|Period 3 - Second Intervention||0
1117028|NCT01205269|2704325|P5|NOT COMPLETED|Period 3 - Second Intervention||0
1117029|NCT01205269|2704326|P4|NOT COMPLETED|Period 3 - Second Intervention||0
1117030|NCT01205269|2704327|P3|NOT COMPLETED|Period 3 - Second Intervention||0
1117031|NCT01205269|2704328|P2|NOT COMPLETED|Period 3 - Second Intervention||0
1117032|NCT01205269|2704329|P1|NOT COMPLETED|Period 3 - Second Intervention||0
1117033|NCT01205269|2704324|P6|COMPLETED|Period 3 - Second Intervention||5
1117034|NCT01205269|2704325|P5|COMPLETED|Period 3 - Second Intervention||5
1117035|NCT01205269|2704326|P4|COMPLETED|Period 3 - Second Intervention||6
1117036|NCT01205269|2704327|P3|COMPLETED|Period 3 - Second Intervention||4
1117037|NCT01205269|2704328|P2|COMPLETED|Period 3 - Second Intervention||4
1117038|NCT01205269|2704329|P1|COMPLETED|Period 3 - Second Intervention||4
1117039|NCT01205269|2704324|P6|STARTED|Period 3 - Second Intervention||5
1117040|NCT01205269|2704325|P5|STARTED|Period 3 - Second Intervention||5
1117041|NCT01205269|2704326|P4|STARTED|Period 3 - Second Intervention||6
1117042|NCT01205269|2704327|P3|STARTED|Period 3 - Second Intervention||4
1117043|NCT01205269|2704328|P2|STARTED|Period 3 - Second Intervention||4
1117044|NCT01205269|2704329|P1|STARTED|Period 3 - Second Intervention||4
1117045|NCT01205269|2704324|P6|NOT COMPLETED|Period 2 - Washout||0
1117046|NCT01205269|2704325|P5|NOT COMPLETED|Period 2 - Washout||0
1117047|NCT01205269|2704326|P4|NOT COMPLETED|Period 2 - Washout||0
1117048|NCT01205269|2704327|P3|NOT COMPLETED|Period 2 - Washout||0
1117049|NCT01205269|2704328|P2|NOT COMPLETED|Period 2 - Washout||0
1117050|NCT01205269|2704329|P1|NOT COMPLETED|Period 2 - Washout||0
1117051|NCT01205269|2704324|P6|COMPLETED|Period 2 - Washout||5
1117052|NCT01205269|2704325|P5|COMPLETED|Period 2 - Washout||5
1117053|NCT01205269|2704326|P4|COMPLETED|Period 2 - Washout||6
1117054|NCT01205269|2704327|P3|COMPLETED|Period 2 - Washout||4
1117055|NCT01205269|2704328|P2|COMPLETED|Period 2 - Washout||4
1117056|NCT01205269|2704329|P1|COMPLETED|Period 2 - Washout||4
1117057|NCT01205269|2704324|P6|STARTED|Period 2 - Washout||5
1117058|NCT01205269|2704325|P5|STARTED|Period 2 - Washout||5
1117059|NCT01205269|2704326|P4|STARTED|Period 2 - Washout||6
1117060|NCT01205269|2704327|P3|STARTED|Period 2 - Washout||4
1117061|NCT01205269|2704328|P2|STARTED|Period 2 - Washout||4
1117062|NCT01205269|2704329|P1|STARTED|Period 2 - Washout||4
1117063|NCT01205269|2704324|P6|NOT COMPLETED|Period 1 - First Intervention||0
1117064|NCT01205269|2704325|P5|NOT COMPLETED|Period 1 - First Intervention||0
1117065|NCT01205269|2704326|P4|NOT COMPLETED|Period 1 - First Intervention||0
1117066|NCT01205269|2704327|P3|NOT COMPLETED|Period 1 - First Intervention||0
1117067|NCT01205269|2704328|P2|NOT COMPLETED|Period 1 - First Intervention||0
1117068|NCT01205269|2704329|P1|NOT COMPLETED|Period 1 - First Intervention||0
1117069|NCT01205269|2704324|P6|COMPLETED|Period 1 - First Intervention||5
1117070|NCT01205269|2704325|P5|COMPLETED|Period 1 - First Intervention||5
1117071|NCT01205269|2704326|P4|COMPLETED|Period 1 - First Intervention||6
1117072|NCT01205269|2704327|P3|COMPLETED|Period 1 - First Intervention||4
1117073|NCT01205269|2704328|P2|COMPLETED|Period 1 - First Intervention||4
1117074|NCT01205269|2704329|P1|COMPLETED|Period 1 - First Intervention||4
1117075|NCT01205269|2704324|P6|STARTED|Period 1 - First Intervention||5
1117076|NCT01205269|2704325|P5|STARTED|Period 1 - First Intervention||5
1117077|NCT01205269|2704326|P4|STARTED|Period 1 - First Intervention||6
1117078|NCT01205269|2704327|P3|STARTED|Period 1 - First Intervention||4
1117079|NCT01205269|2704328|P2|STARTED|Period 1 - First Intervention||4
1117080|NCT01205269|2704329|P1|STARTED|Period 1 - First Intervention||4
1117081|NCT01205399|2704367|P1|NOT COMPLETED|Overall Study||0
1117082|NCT01205399|2704367|P1|COMPLETED|Overall Study||78
1117083|NCT01205399|2704367|P1|STARTED|Overall Study||78
1117084|NCT01205451|2704375|P2|NOT COMPLETED|Overall Study||10
1117085|NCT01205451|2704376|P1|NOT COMPLETED|Overall Study||6
1117086|NCT01205451|2704375|P2|COMPLETED|Overall Study||46
1117087|NCT01205451|2704376|P1|COMPLETED|Overall Study||47
1117088|NCT01205451|2704375|P2|STARTED|Overall Study||56
1117089|NCT01205451|2704376|P1|STARTED|Overall Study||53
1117090|NCT01205503|2704420|P2|NOT COMPLETED|Second Intervention (2nd Cycle)||0
1117091|NCT01205503|2704421|P1|NOT COMPLETED|Second Intervention (2nd Cycle)||0
1117092|NCT01205503|2704420|P2|COMPLETED|Second Intervention (2nd Cycle)||16
1117093|NCT01205503|2704421|P1|COMPLETED|Second Intervention (2nd Cycle)||16
1117094|NCT01205503|2704420|P2|STARTED|Second Intervention (2nd Cycle)||16
1117095|NCT01205503|2704421|P1|STARTED|Second Intervention (2nd Cycle)||16
1117096|NCT01205503|2704420|P2|NOT COMPLETED|First Intervention (1st Cycle)||0
1117097|NCT01205503|2704421|P1|NOT COMPLETED|First Intervention (1st Cycle)||0
1117098|NCT01205503|2704420|P2|COMPLETED|First Intervention (1st Cycle)||16
1117099|NCT01205503|2704421|P1|COMPLETED|First Intervention (1st Cycle)||16
1117100|NCT01205503|2704420|P2|STARTED|First Intervention (1st Cycle)||16
1117101|NCT01205503|2704421|P1|STARTED|First Intervention (1st Cycle)||16
1117102|NCT01205581|2704441|P6|NOT COMPLETED|Overall Study||0
1117103|NCT01205581|2704442|P5|NOT COMPLETED|Overall Study||0
1117104|NCT01205581|2704443|P4|NOT COMPLETED|Overall Study||0
1117105|NCT01205581|2704444|P3|NOT COMPLETED|Overall Study||0
1117106|NCT01205581|2704445|P2|NOT COMPLETED|Overall Study||0
1117107|NCT01205581|2704446|P1|NOT COMPLETED|Overall Study||1
1117108|NCT01205581|2704441|P6|COMPLETED|Overall Study||20
1117109|NCT01205581|2704442|P5|COMPLETED|Overall Study||20
1117110|NCT01205581|2704443|P4|COMPLETED|Overall Study||9
1117111|NCT01205581|2704444|P3|COMPLETED|Overall Study||8
1117112|NCT01205581|2704445|P2|COMPLETED|Overall Study||13
1117113|NCT01205581|2704446|P1|COMPLETED|Overall Study||13
1117114|NCT01205581|2704441|P6|STARTED|Overall Study||20
1117115|NCT01205581|2704442|P5|STARTED|Overall Study||20
1117116|NCT01205581|2704443|P4|STARTED|Overall Study||9
1117117|NCT01205581|2704444|P3|STARTED|Overall Study||8
1117118|NCT01205581|2704445|P2|STARTED|Overall Study||13
1117119|NCT01205581|2704446|P1|STARTED|Overall Study||14
1117120|NCT01205646|2704510|P1|NOT COMPLETED|Overall Study||0
1117121|NCT01205646|2704510|P1|COMPLETED|Overall Study||11
1117122|NCT01205646|2704510|P1|STARTED|Overall Study||11
1117123|NCT01205685|2704514|P1|NOT COMPLETED|Overall Study||11
1117124|NCT01205685|2704514|P1|COMPLETED|Overall Study||0
1117125|NCT01205685|2704514|P1|STARTED|Overall Study||11
1117126|NCT01211145|2704525|P4|NOT COMPLETED|Overall Study||20
1117127|NCT01211145|2704526|P3|NOT COMPLETED|Overall Study||13
1117128|NCT01211145|2704527|P2|NOT COMPLETED|Overall Study||17
1117129|NCT01211145|2704528|P1|NOT COMPLETED|Overall Study||26
1117130|NCT01211145|2704525|P4|COMPLETED|Overall Study||268
1117131|NCT01211145|2704526|P3|COMPLETED|Overall Study||86
1117132|NCT01211145|2704527|P2|COMPLETED|Overall Study||98
1117133|NCT01211145|2704528|P1|COMPLETED|Overall Study|1 patient was not counted as completed or discontinued due to incomplete information (N=270-1=269).|270
1117134|NCT01211145|2704525|P4|STARTED|Overall Study||288
1117135|NCT01211145|2704526|P3|STARTED|Overall Study||99
1117136|NCT01211145|2704527|P2|STARTED|Overall Study||115
1117137|NCT01211145|2704528|P1|STARTED|Overall Study||296
1117138|NCT01211184|2704561|P3|NOT COMPLETED|Overall Study||1
1117139|NCT01211184|2704562|P2|NOT COMPLETED|Overall Study||2
1117140|NCT01211184|2704563|P1|NOT COMPLETED|Overall Study||0
1117141|NCT01211184|2704561|P3|COMPLETED|Overall Study||19
1117142|NCT01211184|2704562|P2|COMPLETED|Overall Study||18
1117143|NCT01211184|2704563|P1|COMPLETED|Overall Study||20
1117144|NCT01211184|2704561|P3|STARTED|Overall Study||20
1117145|NCT01211184|2704562|P2|STARTED|Overall Study||20
1117146|NCT01211184|2704563|P1|STARTED|Overall Study||20
1117147|NCT01211197|2704574|P6|NOT COMPLETED|Treatment Period 3 (1 Day)||0
1117148|NCT01211197|2704575|P5|NOT COMPLETED|Treatment Period 3 (1 Day)||0
1117149|NCT01211197|2704576|P4|NOT COMPLETED|Treatment Period 3 (1 Day)||0
1117150|NCT01211197|2704577|P3|NOT COMPLETED|Treatment Period 3 (1 Day)||0
1117151|NCT01211197|2704578|P2|NOT COMPLETED|Treatment Period 3 (1 Day)||0
1117152|NCT01211197|2704579|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
1117153|NCT01211197|2704574|P6|COMPLETED|Treatment Period 3 (1 Day)||2
1117154|NCT01211197|2704575|P5|COMPLETED|Treatment Period 3 (1 Day)||2
1117155|NCT01211197|2704576|P4|COMPLETED|Treatment Period 3 (1 Day)||3
1117156|NCT01211197|2704577|P3|COMPLETED|Treatment Period 3 (1 Day)||2
1117157|NCT01211197|2704578|P2|COMPLETED|Treatment Period 3 (1 Day)||3
1117158|NCT01211197|2704579|P1|COMPLETED|Treatment Period 3 (1 Day)||2
1117159|NCT01211197|2704574|P6|STARTED|Treatment Period 3 (1 Day)||2
1117160|NCT01211197|2704575|P5|STARTED|Treatment Period 3 (1 Day)||2
1117161|NCT01211197|2704576|P4|STARTED|Treatment Period 3 (1 Day)||3
1117162|NCT01211197|2704577|P3|STARTED|Treatment Period 3 (1 Day)||2
1117163|NCT01211197|2704578|P2|STARTED|Treatment Period 3 (1 Day)||3
1117164|NCT01211197|2704579|P1|STARTED|Treatment Period 3 (1 Day)||2
1117165|NCT01211197|2704574|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
1117166|NCT01211197|2704575|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
1117167|NCT01211197|2704576|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
1117168|NCT01211197|2704577|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
1117169|NCT01211197|2704578|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
1117170|NCT01211197|2704579|P1|NOT COMPLETED|Washout Period 2 (7 Days)||1
1117171|NCT01211197|2704574|P6|COMPLETED|Washout Period 2 (7 Days)||2
1117172|NCT01211197|2704575|P5|COMPLETED|Washout Period 2 (7 Days)||2
1117173|NCT01211197|2704576|P4|COMPLETED|Washout Period 2 (7 Days)||3
1117174|NCT01211197|2704577|P3|COMPLETED|Washout Period 2 (7 Days)||2
1117175|NCT01211197|2704578|P2|COMPLETED|Washout Period 2 (7 Days)||3
1117176|NCT01211197|2704579|P1|COMPLETED|Washout Period 2 (7 Days)||2
1117177|NCT01211197|2704574|P6|STARTED|Washout Period 2 (7 Days)||2
1117178|NCT01211197|2704575|P5|STARTED|Washout Period 2 (7 Days)||2
1117179|NCT01211197|2704576|P4|STARTED|Washout Period 2 (7 Days)||3
1117180|NCT01211197|2704577|P3|STARTED|Washout Period 2 (7 Days)||2
1117181|NCT01211197|2704578|P2|STARTED|Washout Period 2 (7 Days)||3
1117182|NCT01211197|2704579|P1|STARTED|Washout Period 2 (7 Days)||3
1117183|NCT01211197|2704574|P6|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1117184|NCT01211197|2704575|P5|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1117185|NCT01211197|2704576|P4|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1117186|NCT01211197|2704577|P3|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1117187|NCT01211197|2704578|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1117188|NCT01211197|2704579|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
1117189|NCT01211197|2704574|P6|COMPLETED|Treatment Period 2 (1 Day)||2
1117190|NCT01211197|2704575|P5|COMPLETED|Treatment Period 2 (1 Day)||2
1117191|NCT01211197|2704576|P4|COMPLETED|Treatment Period 2 (1 Day)||3
1117192|NCT01211197|2704577|P3|COMPLETED|Treatment Period 2 (1 Day)||2
1117193|NCT01211197|2704578|P2|COMPLETED|Treatment Period 2 (1 Day)||3
1117194|NCT01211197|2704579|P1|COMPLETED|Treatment Period 2 (1 Day)||3
1117195|NCT01211197|2704574|P6|STARTED|Treatment Period 2 (1 Day)||2
1117196|NCT01211197|2704575|P5|STARTED|Treatment Period 2 (1 Day)||2
1117197|NCT01211197|2704576|P4|STARTED|Treatment Period 2 (1 Day)||3
1117198|NCT01211197|2704577|P3|STARTED|Treatment Period 2 (1 Day)||2
1117199|NCT01211197|2704578|P2|STARTED|Treatment Period 2 (1 Day)||3
1117200|NCT01211197|2704579|P1|STARTED|Treatment Period 2 (1 Day)||3
1117201|NCT01211197|2704574|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
1117202|NCT01211197|2704575|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
1117203|NCT01211197|2704576|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
1117204|NCT01211197|2704577|P3|NOT COMPLETED|Washout Period 1 (7 Days)||1
1117205|NCT01211197|2704578|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
1117206|NCT01211197|2704579|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
1117207|NCT01211197|2704574|P6|COMPLETED|Washout Period 1 (7 Days)||2
1117208|NCT01211197|2704575|P5|COMPLETED|Washout Period 1 (7 Days)||2
1117209|NCT01211197|2704576|P4|COMPLETED|Washout Period 1 (7 Days)||3
1117210|NCT01211197|2704577|P3|COMPLETED|Washout Period 1 (7 Days)||2
1117211|NCT01211197|2704578|P2|COMPLETED|Washout Period 1 (7 Days)||3
1117212|NCT01211197|2704579|P1|COMPLETED|Washout Period 1 (7 Days)||3
1117213|NCT01211197|2704574|P6|STARTED|Washout Period 1 (7 Days)||2
1117214|NCT01211197|2704575|P5|STARTED|Washout Period 1 (7 Days)||2
1117215|NCT01211197|2704576|P4|STARTED|Washout Period 1 (7 Days)||3
1117216|NCT01211197|2704577|P3|STARTED|Washout Period 1 (7 Days)||3
1117217|NCT01211197|2704578|P2|STARTED|Washout Period 1 (7 Days)||3
1117218|NCT01211197|2704579|P1|STARTED|Washout Period 1 (7 Days)||3
1117219|NCT01211197|2704574|P6|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1117220|NCT01211197|2704575|P5|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1117221|NCT01211197|2704576|P4|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1117222|NCT01211197|2704577|P3|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1117223|NCT01211197|2704578|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1117224|NCT01211197|2704579|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
1117225|NCT01211197|2704574|P6|COMPLETED|Treatment Period 1 (1 Day)||2
1117226|NCT01211197|2704575|P5|COMPLETED|Treatment Period 1 (1 Day)||2
1117227|NCT01211197|2704576|P4|COMPLETED|Treatment Period 1 (1 Day)||3
1117228|NCT01211197|2704577|P3|COMPLETED|Treatment Period 1 (1 Day)||3
1117229|NCT01211197|2704578|P2|COMPLETED|Treatment Period 1 (1 Day)||3
1117230|NCT01211197|2704579|P1|COMPLETED|Treatment Period 1 (1 Day)||3
1117231|NCT01211197|2704574|P6|STARTED|Treatment Period 1 (1 Day)||2
1117232|NCT01211197|2704575|P5|STARTED|Treatment Period 1 (1 Day)||2
1117233|NCT01211197|2704576|P4|STARTED|Treatment Period 1 (1 Day)||3
1117234|NCT01211197|2704577|P3|STARTED|Treatment Period 1 (1 Day)||3
1117235|NCT01211197|2704578|P2|STARTED|Treatment Period 1 (1 Day)||3
1117236|NCT01211197|2704579|P1|STARTED|Treatment Period 1 (1 Day)||3
1117237|NCT01211340|2704625|P2|NOT COMPLETED|Overall Study||0
1117238|NCT01211340|2704626|P1|NOT COMPLETED|Overall Study||0
1117239|NCT01211340|2704625|P2|COMPLETED|Overall Study||223
1117240|NCT01211340|2704626|P1|COMPLETED|Overall Study||223
1117241|NCT01211340|2704625|P2|STARTED|Overall Study||223
1117242|NCT01211340|2704626|P1|STARTED|Overall Study||223
1117243|NCT01213576|2704640|P4|NOT COMPLETED|Overall Study||4
1117244|NCT01213576|2704641|P3|NOT COMPLETED|Overall Study||5
1117245|NCT01213576|2704642|P2|NOT COMPLETED|Overall Study||4
1117246|NCT01213576|2704643|P1|NOT COMPLETED|Overall Study||3
1117247|NCT01213576|2704640|P4|COMPLETED|Overall Study||13
1117248|NCT01213576|2704641|P3|COMPLETED|Overall Study||13
1117249|NCT01213576|2704642|P2|COMPLETED|Overall Study||13
1117250|NCT01213576|2704643|P1|COMPLETED|Overall Study||15
1117251|NCT01213576|2704640|P4|STARTED|Overall Study||17
1117252|NCT01213576|2704641|P3|STARTED|Overall Study||18
1117253|NCT01213576|2704642|P2|STARTED|Overall Study||17
1117254|NCT01213576|2704643|P1|STARTED|Overall Study||18
1117255|NCT01213589|2704660|P3|NOT COMPLETED|Overall Study||8
1117256|NCT01213589|2704661|P2|NOT COMPLETED|Overall Study||5
1117257|NCT01213589|2704662|P1|NOT COMPLETED|Overall Study||13
1117258|NCT01213589|2704660|P3|COMPLETED|Overall Study||18
1117259|NCT01213589|2704661|P2|COMPLETED|Overall Study||19
1117260|NCT01213589|2704662|P1|COMPLETED|Overall Study||37
1117261|NCT01213589|2704660|P3|STARTED|Overall Study||26
1117262|NCT01213589|2704661|P2|STARTED|Overall Study||24
1117263|NCT01213589|2704662|P1|STARTED|Overall Study||50
1117264|NCT01213706|2704688|P1|NOT COMPLETED|WBPA||0
1117265|NCT01213706|2704688|P1|COMPLETED|WBPA||45
1117266|NCT01213706|2704688|P1|STARTED|WBPA||45
1117267|NCT01213706|2704688|P1|NOT COMPLETED|Washout (1 Hour)||0
1117268|NCT01213706|2704688|P1|COMPLETED|Washout (1 Hour)||45
1117269|NCT01213706|2704688|P1|STARTED|Washout (1 Hour)||45
1117270|NCT01213706|2704688|P1|NOT COMPLETED|Sham WBPA||0
1117271|NCT01213706|2704688|P1|COMPLETED|Sham WBPA||45
1117272|NCT01213706|2704688|P1|STARTED|Sham WBPA||45
1117273|NCT01213823|2704696|P2|NOT COMPLETED|Overall Study||0
1117274|NCT01213823|2704697|P1|NOT COMPLETED|Overall Study||0
1117275|NCT01213823|2704696|P2|COMPLETED|Overall Study||467
1117276|NCT01213823|2704697|P1|COMPLETED|Overall Study||69
1117277|NCT01213823|2704696|P2|STARTED|Overall Study||467
1117278|NCT01213823|2704697|P1|STARTED|Overall Study||69
1117279|NCT01213836|2704705|P2|NOT COMPLETED|Period 2, Second Intervention||0
1117280|NCT01213836|2704706|P1|NOT COMPLETED|Period 2, Second Intervention||0
1117281|NCT01213836|2704705|P2|COMPLETED|Period 2, Second Intervention||29
1117282|NCT01213836|2704706|P1|COMPLETED|Period 2, Second Intervention||31
1117283|NCT01213836|2704705|P2|STARTED|Period 2, Second Intervention||29
1117284|NCT01213836|2704706|P1|STARTED|Period 2, Second Intervention||31
1117285|NCT01213836|2704705|P2|NOT COMPLETED|Period 1, First Intervention||3
1117286|NCT01213836|2704706|P1|NOT COMPLETED|Period 1, First Intervention||3
1117287|NCT01213836|2704705|P2|COMPLETED|Period 1, First Intervention||29
1117288|NCT01213836|2704706|P1|COMPLETED|Period 1, First Intervention||31
1117289|NCT01213836|2704705|P2|STARTED|Period 1, First Intervention||32
1117290|NCT01213836|2704706|P1|STARTED|Period 1, First Intervention||34
1117291|NCT01213966|2704728|P4|NOT COMPLETED|Overall Study||1
1117292|NCT01213966|2704729|P3|NOT COMPLETED|Overall Study||3
1117293|NCT01213966|2704730|P2|NOT COMPLETED|Overall Study||0
1117294|NCT01213966|2704731|P1|NOT COMPLETED|Overall Study||1
1117295|NCT01213966|2704728|P4|COMPLETED|Overall Study||20
1117296|NCT01213966|2704729|P3|COMPLETED|Overall Study||17
1117297|NCT01213966|2704730|P2|COMPLETED|Overall Study||20
1117298|NCT01213966|2704731|P1|COMPLETED|Overall Study||19
1117299|NCT01213966|2704728|P4|STARTED|Overall Study||21
1117300|NCT01213966|2704729|P3|STARTED|Overall Study||20
1117301|NCT01213966|2704730|P2|STARTED|Overall Study||20
1117302|NCT01213966|2704731|P1|STARTED|Overall Study||20
1117303|NCT01214083|2704744|P3|NOT COMPLETED|Overall Study||10
1117304|NCT01214083|2704745|P2|NOT COMPLETED|Overall Study||10
1117305|NCT01214083|2704746|P1|NOT COMPLETED|Overall Study||12
1117306|NCT01214083|2704744|P3|COMPLETED|Overall Study||21
1117307|NCT01214083|2704745|P2|COMPLETED|Overall Study||23
1117308|NCT01214083|2704746|P1|COMPLETED|Overall Study||19
1117309|NCT01214083|2704744|P3|STARTED|Overall Study||31
1117310|NCT01214083|2704745|P2|STARTED|Overall Study||33
1117311|NCT01214083|2704746|P1|STARTED|Overall Study||31
1117312|NCT01214109|2704778|P4|NOT COMPLETED|Overall Study||0
1117313|NCT01214109|2704779|P3|NOT COMPLETED|Overall Study||0
1117314|NCT01214109|2704780|P2|NOT COMPLETED|Overall Study||0
1117315|NCT01214109|2704781|P1|NOT COMPLETED|Overall Study||0
1117316|NCT01214109|2704778|P4|COMPLETED|Overall Study||24
1117317|NCT01214109|2704779|P3|COMPLETED|Overall Study||24
1117318|NCT01214109|2704780|P2|COMPLETED|Overall Study||24
1117319|NCT01214109|2704781|P1|COMPLETED|Overall Study||24
1117320|NCT01214109|2704778|P4|STARTED|Overall Study||24
1117321|NCT01214109|2704779|P3|STARTED|Overall Study||24
1117322|NCT01214109|2704780|P2|STARTED|Overall Study||24
1117323|NCT01214109|2704781|P1|STARTED|Overall Study||24
1117324|NCT01214161|2704872|P2|NOT COMPLETED|Overall Study||0
1117325|NCT01214161|2704873|P1|NOT COMPLETED|Overall Study||0
1117326|NCT01214161|2704872|P2|COMPLETED|Overall Study||100
1117327|NCT01214161|2704873|P1|COMPLETED|Overall Study||100
1117328|NCT01214161|2704872|P2|STARTED|Overall Study||100
1117329|NCT01214161|2704873|P1|STARTED|Overall Study||100
1117330|NCT01214174|2704886|P3|NOT COMPLETED|Overall Study||1
1117331|NCT01214174|2704887|P2|NOT COMPLETED|Overall Study||0
1117332|NCT01214174|2704888|P1|NOT COMPLETED|Overall Study||0
1117333|NCT01214174|2704886|P3|COMPLETED|Overall Study||13
1117334|NCT01214174|2704887|P2|COMPLETED|Overall Study||16
1117335|NCT01214174|2704888|P1|COMPLETED|Overall Study||13
1117336|NCT01214174|2704886|P3|STARTED|Overall Study||14
1117337|NCT01214174|2704887|P2|STARTED|Overall Study||16
1117338|NCT01214174|2704888|P1|STARTED|Overall Study||13
1117339|NCT01214187|2704898|P2|NOT COMPLETED|Overall Study||6
1117340|NCT01214187|2704899|P1|NOT COMPLETED|Overall Study||7
1117341|NCT01214187|2704898|P2|COMPLETED|Overall Study||23
1117342|NCT01214187|2704899|P1|COMPLETED|Overall Study||22
1117343|NCT01214187|2704898|P2|STARTED|Overall Study||29
1117344|NCT01214187|2704899|P1|STARTED|Overall Study||29
1117345|NCT01214239|2704915|P2|NOT COMPLETED|Overall Study||18
1117346|NCT01214239|2704916|P1|NOT COMPLETED|Overall Study||12
1117347|NCT01214239|2704915|P2|COMPLETED|Overall Study||182
1117348|NCT01214239|2704916|P1|COMPLETED|Overall Study||87
1117349|NCT01214239|2704915|P2|STARTED|Overall Study|patients who were randomised and treated with placebo. 1 patient was not treated then not included|200
1117350|NCT01214239|2704916|P1|STARTED|Overall Study|patients who were randomised and treated with placebo|99
1117351|NCT01214252|2704948|P1|NOT COMPLETED|Overall Study||82
1117352|NCT01214252|2704948|P1|COMPLETED|Overall Study||343
1117353|NCT01214252|2704948|P1|STARTED|Overall Study||425
1117354|NCT01214330|2704954|P1|NOT COMPLETED|Overall Study||48
1117355|NCT01214330|2704954|P1|COMPLETED|Overall Study||102
1117356|NCT01214330|2704954|P1|STARTED|Overall Study||150
1117357|NCT01214395|2704958|P1|NOT COMPLETED|Overall Study||5
1117358|NCT01214395|2704958|P1|COMPLETED|Overall Study||0
1117359|NCT01214395|2704958|P1|STARTED|Overall Study||5
1117360|NCT01214434|2704965|P2|NOT COMPLETED|Overall Study||2
1117361|NCT01214434|2704966|P1|NOT COMPLETED|Overall Study||4
1117362|NCT01214434|2704965|P2|COMPLETED|Overall Study||25
1117363|NCT01214434|2704966|P1|COMPLETED|Overall Study||11
1117364|NCT01214434|2704965|P2|STARTED|Overall Study||27
1117365|NCT01214434|2704966|P1|STARTED|Overall Study||15
1117366|NCT01214616|2704986|P4|NOT COMPLETED|Overall Study||6
1117367|NCT01214616|2704987|P3|NOT COMPLETED|Overall Study||3
1117368|NCT01214616|2704988|P2|NOT COMPLETED|Overall Study||5
1117369|NCT01214616|2704989|P1|NOT COMPLETED|Overall Study||3
1117370|NCT01214616|2704986|P4|COMPLETED|Overall Study||0
1117371|NCT01214616|2704987|P3|COMPLETED|Overall Study||0
1117372|NCT01214616|2704988|P2|COMPLETED|Overall Study||0
1117373|NCT01214616|2704989|P1|COMPLETED|Overall Study||0
1117374|NCT01214616|2704986|P4|STARTED|Overall Study|Cohort 3 with afatinib/vinorelbine modification. Skipping vinorelbine allowed and not considered DLT|6
1117375|NCT01214616|2704987|P3|STARTED|Overall Study||3
1117376|NCT01214616|2704988|P2|STARTED|Overall Study||5
1117377|NCT01214616|2704989|P1|STARTED|Overall Study||3
1117378|NCT01214720|2705025|P2|NOT COMPLETED|Overall Study||68
1117379|NCT01214720|2705026|P1|NOT COMPLETED|Overall Study||85
1117380|NCT01214720|2705025|P2|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|233
1117381|NCT01214720|2705026|P1|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|221
1117382|NCT01214720|2705025|P2|STARTED|Overall Study||301
1117383|NCT01214720|2705026|P1|STARTED|Overall Study||306
1117384|NCT01214759|2705043|P1|NOT COMPLETED|Overall Study||48
1117385|NCT01214759|2705043|P1|COMPLETED|Overall Study||55
1117386|NCT01214759|2705043|P1|28 Days nPEP Completion|Overall Study||85
1117387|NCT01214759|2705043|P1|STARTED|Overall Study||103
1117388|NCT01214811|2705049|P1|NOT COMPLETED|Overall Study||3
1117389|NCT01214811|2705049|P1|COMPLETED|Overall Study||24
1117390|NCT01214811|2705049|P1|STARTED|Overall Study||27
1117391|NCT01214824|2705053|P1|NOT COMPLETED|Overall Study||3
1117392|NCT01214824|2705053|P1|COMPLETED|Overall Study||29
1117393|NCT01214824|2705053|P1|STARTED|Overall Study||32
1117412|NCT01214915|2705188|P1|NOT COMPLETED|Overall Study||11
1117413|NCT01214915|2705188|P1|COMPLETED|Overall Study||42
1117414|NCT01214915|2705188|P1|STARTED|Overall Study||53
1117415|NCT01214980|2705198|P2|NOT COMPLETED|Overall Study||2
1117416|NCT01214980|2705199|P1|NOT COMPLETED|Overall Study||3
1117417|NCT01214980|2705198|P2|COMPLETED|Overall Study||14
1117418|NCT01214980|2705199|P1|COMPLETED|Overall Study||13
1117419|NCT01214980|2705198|P2|STARTED|Overall Study||16
1117420|NCT01214980|2705199|P1|STARTED|Overall Study||16
1117421|NCT01215032|2705213|P1|NOT COMPLETED|Overall Study||20
1117422|NCT01215032|2705213|P1|COMPLETED|Overall Study||1
1117423|NCT01215032|2705213|P1|STARTED|Overall Study||21
1117424|NCT01215097|2705223|P2|NOT COMPLETED|Overall Study||14
1117425|NCT01215097|2705224|P1|NOT COMPLETED|Overall Study||12
1117426|NCT01215097|2705223|P2|COMPLETED|Overall Study||191
1117427|NCT01215097|2705224|P1|COMPLETED|Overall Study||88
1117428|NCT01215097|2705223|P2|STARTED|Overall Study|Patients who are randomised and treated with linagliptin.|205
1117429|NCT01215097|2705224|P1|STARTED|Overall Study|Patients who are randomised and treated with placebo. 1 patient was not treated then not included.|100
1117430|NCT01215110|2705261|P5|NOT COMPLETED|Overall Study||0
1117431|NCT01215110|2705262|P4|NOT COMPLETED|Overall Study||1
1117432|NCT01215110|2705263|P3|NOT COMPLETED|Overall Study||2
1117433|NCT01215110|2705264|P2|NOT COMPLETED|Overall Study||0
1117434|NCT01215110|2705265|P1|NOT COMPLETED|Overall Study||0
1117435|NCT01215110|2705261|P5|COMPLETED|Overall Study||8
1117436|NCT01215110|2705262|P4|COMPLETED|Overall Study||14
1117437|NCT01215110|2705263|P3|COMPLETED|Overall Study||13
1117438|NCT01215110|2705264|P2|COMPLETED|Overall Study||15
1117439|NCT01215110|2705265|P1|COMPLETED|Overall Study||15
1117440|NCT01215110|2705261|P5|STARTED|Overall Study||8
1117441|NCT01215110|2705262|P4|STARTED|Overall Study||15
1117442|NCT01215110|2705263|P3|STARTED|Overall Study||15
1117443|NCT01215110|2705264|P2|STARTED|Overall Study||15
1117444|NCT01215110|2705265|P1|STARTED|Overall Study||15
1117445|NCT01215123|2705324|P1|NOT COMPLETED|Overall Study||0
1117446|NCT01215123|2705324|P1|COMPLETED|Overall Study||28
1117447|NCT01215123|2705324|P1|STARTED|Overall Study||28
1117448|NCT01215227|2705335|P6|NOT COMPLETED|Overall Study||58
1117449|NCT01215227|2705336|P5|NOT COMPLETED|Overall Study||48
1117450|NCT01215227|2705337|P4|NOT COMPLETED|Overall Study||49
1117451|NCT01215227|2705338|P3|NOT COMPLETED|Overall Study||57
1117452|NCT01215227|2705339|P2|NOT COMPLETED|Overall Study||119
1117453|NCT01215227|2705340|P1|NOT COMPLETED|Overall Study||121
1117454|NCT01215227|2705335|P6|COMPLETED|Overall Study||51
1117455|NCT01215227|2705336|P5|COMPLETED|Overall Study||45
1117456|NCT01215227|2705337|P4|COMPLETED|Overall Study||48
1117457|NCT01215227|2705338|P3|COMPLETED|Overall Study||50
1117458|NCT01215227|2705339|P2|COMPLETED|Overall Study||96
1117459|NCT01215227|2705340|P1|COMPLETED|Overall Study||97
1117460|NCT01215227|2705335|P6|Treated|Overall Study||108
1117461|NCT01215227|2705336|P5|Treated|Overall Study||93
1117462|NCT01215227|2705337|P4|Treated|Overall Study||96
1117463|NCT01215227|2705338|P3|Treated|Overall Study||106
1117464|NCT01215227|2705339|P2|Treated|Overall Study||215
1117465|NCT01215227|2705340|P1|Treated|Overall Study||218
1117466|NCT01215227|2705335|P6|STARTED|Overall Study||109
1117467|NCT01215227|2705336|P5|STARTED|Overall Study||93
1117468|NCT01215227|2705337|P4|STARTED|Overall Study||97
1117469|NCT01215227|2705338|P3|STARTED|Overall Study||107
1117470|NCT01215227|2705339|P2|STARTED|Overall Study||215
1117471|NCT01215227|2705340|P1|STARTED|Overall Study||218
1117472|NCT01215279|2705386|P2|NOT COMPLETED|Overall Study||0
1117473|NCT01215279|2705387|P1|NOT COMPLETED|Overall Study||0
1117474|NCT01215279|2705386|P2|COMPLETED|Overall Study||32
1117475|NCT01215279|2705387|P1|COMPLETED|Overall Study||31
1117476|NCT01215279|2705386|P2|STARTED|Overall Study||32
1117477|NCT01215279|2705387|P1|STARTED|Overall Study||31
1117478|NCT01215292|2705456|P5|NOT COMPLETED|Overall Study||0
1117479|NCT01215292|2705457|P4|NOT COMPLETED|Overall Study||0
1117480|NCT01215292|2705458|P3|NOT COMPLETED|Overall Study||0
1117481|NCT01215292|2705459|P2|NOT COMPLETED|Overall Study||0
1117482|NCT01215292|2705460|P1|NOT COMPLETED|Overall Study||0
1117483|NCT01215292|2705456|P5|COMPLETED|Overall Study||8
1117484|NCT01215292|2705457|P4|COMPLETED|Overall Study||8
1117485|NCT01215292|2705458|P3|COMPLETED|Overall Study||8
1117486|NCT01215292|2705459|P2|COMPLETED|Overall Study||8
1117487|NCT01215292|2705460|P1|COMPLETED|Overall Study||8
1117488|NCT01215292|2705456|P5|STARTED|Overall Study||8
1117489|NCT01215292|2705457|P4|STARTED|Overall Study||8
1117490|NCT01215292|2705458|P3|STARTED|Overall Study||8
1117491|NCT01215292|2705459|P2|STARTED|Overall Study||8
1117492|NCT01215292|2705460|P1|STARTED|Overall Study||8
1117493|NCT01215344|2705484|P2|NOT COMPLETED|Overall Study||0
1117494|NCT01215344|2705485|P1|NOT COMPLETED|Overall Study||10
1117495|NCT01215344|2705484|P2|COMPLETED|Overall Study||3
1117496|NCT01215344|2705485|P1|COMPLETED|Overall Study||23
1117497|NCT01215344|2705484|P2|STARTED|Overall Study||3
1117498|NCT01215344|2705485|P1|STARTED|Overall Study||33
1117499|NCT01215357|2705493|P1|NOT COMPLETED|Overall Study||12
1117500|NCT01215357|2705493|P1|COMPLETED|Overall Study||22
1117501|NCT01215357|2705493|P1|STARTED|Overall Study||34
1117502|NCT01215422|2705501|P4|NOT COMPLETED|Overall Study||8
1117503|NCT01215422|2705502|P3|NOT COMPLETED|Overall Study||3
1117504|NCT01215422|2705503|P2|NOT COMPLETED|Overall Study||0
1117505|NCT01215422|2705504|P1|NOT COMPLETED|Overall Study||8
1117506|NCT01215422|2705501|P4|COMPLETED|Overall Study||193
1117507|NCT01215422|2705502|P3|COMPLETED|Overall Study||193
1117508|NCT01215422|2705503|P2|COMPLETED|Overall Study||249
1117509|NCT01215422|2705504|P1|COMPLETED|Overall Study||6
1117510|NCT01215422|2705501|P4|STARTED|Overall Study||201
1117511|NCT01215422|2705502|P3|STARTED|Overall Study||196
1117512|NCT01215422|2705503|P2|STARTED|Overall Study||249
1117513|NCT01215422|2705504|P1|STARTED|Overall Study||14
1117514|NCT01215435|2705528|P2|NOT COMPLETED|Overall Study||16
1117515|NCT01215435|2705529|P1|NOT COMPLETED|Overall Study||19
1117516|NCT01215435|2705528|P2|COMPLETED|Overall Study||107
1117517|NCT01215435|2705529|P1|COMPLETED|Overall Study||103
1117518|NCT01215435|2705528|P2|STARTED|Overall Study||123
1117519|NCT01215435|2705529|P1|STARTED|Overall Study||122
1117520|NCT01215513|2705539|P1|NOT COMPLETED|Overall Study||45
1117521|NCT01215513|2705539|P1|COMPLETED|Overall Study||112
1117522|NCT01215513|2705539|P1|CS42A Safety Analysis Set|Overall Study|127 participants were enrolled in the extension study CS42A|127
1117523|NCT01215513|2705539|P1|CS42 and CS42A Full Analysis Set|Overall Study|155 participants received at least 1 dose of degarelix and had at least 1 efficacy assessment|155
1117524|NCT01215513|2705539|P1|CS42 and CS42A Safety Analysis Set|Overall Study|156 participants received at least 1 dose of degarelix|156
1117525|NCT01215513|2705539|P1|STARTED|Overall Study|157 participants were allocated to treatment in CS42 main study (Intent-to-treat analysis set)|157
1117526|NCT01215643|2705551|P5|NOT COMPLETED|Overall Study||11
1117527|NCT01215643|2705552|P4|NOT COMPLETED|Overall Study||4
1117528|NCT01215643|2705553|P3|NOT COMPLETED|Overall Study||12
1117529|NCT01215643|2705554|P2|NOT COMPLETED|Overall Study||4
1117530|NCT01215643|2705555|P1|NOT COMPLETED|Overall Study||9
1117531|NCT01215643|2705551|P5|COMPLETED|Overall Study||29
1117532|NCT01215643|2705552|P4|COMPLETED|Overall Study||35
1117533|NCT01215643|2705553|P3|COMPLETED|Overall Study||82
1117534|NCT01215643|2705554|P2|COMPLETED|Overall Study||80
1117535|NCT01215643|2705555|P1|COMPLETED|Overall Study||74
1117536|NCT01215643|2705551|P5|STARTED|Overall Study||40
1117537|NCT01215643|2705552|P4|STARTED|Overall Study||39
1117538|NCT01215643|2705553|P3|STARTED|Overall Study||94
1117539|NCT01215643|2705554|P2|STARTED|Overall Study||84
1117540|NCT01215643|2705555|P1|STARTED|Overall Study||83
1117541|NCT01215695|2705659|P2|NOT COMPLETED|Overall Study||0
1117542|NCT01215695|2705660|P1|NOT COMPLETED|Overall Study||0
1117543|NCT01215695|2705659|P2|COMPLETED|Overall Study||70
1117544|NCT01215695|2705660|P1|COMPLETED|Overall Study||70
1117545|NCT01215695|2705659|P2|STARTED|Overall Study||70
1117546|NCT01215695|2705660|P1|STARTED|Overall Study||70
1117547|NCT01215721|2705674|P1|NOT COMPLETED|Overall Study||2
1117548|NCT01215721|2705674|P1|COMPLETED|Overall Study||38
1117549|NCT01215721|2705674|P1|STARTED|Overall Study||40
1117550|NCT01215734|2705680|P2|NOT COMPLETED|Overall Study||1
1117551|NCT01215734|2705681|P1|NOT COMPLETED|Overall Study||0
1117552|NCT01215734|2705680|P2|COMPLETED|Overall Study||14
1117553|NCT01215734|2705681|P1|COMPLETED|Overall Study||29
1117554|NCT01215734|2705680|P2|STARTED|Overall Study||15
1117555|NCT01215734|2705681|P1|STARTED|Overall Study||29
1117556|NCT01215786|2705692|P3|NOT COMPLETED|Overall Study||0
1117557|NCT01215786|2705693|P2|NOT COMPLETED|Overall Study||0
1117558|NCT01215786|2705694|P1|NOT COMPLETED|Overall Study||0
1117559|NCT01215786|2705692|P3|COMPLETED|Overall Study||10
1117560|NCT01215786|2705693|P2|COMPLETED|Overall Study||19
1117561|NCT01215786|2705694|P1|COMPLETED|Overall Study||21
1117562|NCT01215786|2705692|P3|STARTED|Overall Study||10
1117563|NCT01215786|2705693|P2|STARTED|Overall Study||19
1117564|NCT01215786|2705694|P1|STARTED|Overall Study||21
1117565|NCT01215851|2705714|P6|NOT COMPLETED|Follow up Period||1
1117566|NCT01215851|2705715|P5|NOT COMPLETED|Follow up Period||0
1117567|NCT01215851|2705716|P4|NOT COMPLETED|Follow up Period||0
1117568|NCT01215851|2705717|P3|NOT COMPLETED|Follow up Period||0
1117569|NCT01215851|2705718|P2|NOT COMPLETED|Follow up Period||0
1117570|NCT01215851|2705719|P1|NOT COMPLETED|Follow up Period||0
1117571|NCT01215851|2705714|P6|COMPLETED|Follow up Period||13
1117572|NCT01215851|2705715|P5|COMPLETED|Follow up Period||10
1117573|NCT01215851|2705716|P4|COMPLETED|Follow up Period||12
1117574|NCT01215851|2705717|P3|COMPLETED|Follow up Period||14
1117575|NCT01215851|2705718|P2|COMPLETED|Follow up Period||14
1117576|NCT01215851|2705719|P1|COMPLETED|Follow up Period||14
1117577|NCT01215851|2705714|P6|STARTED|Follow up Period||14
1117578|NCT01215851|2705715|P5|STARTED|Follow up Period||10
1117579|NCT01215851|2705716|P4|STARTED|Follow up Period||12
1117580|NCT01215851|2705717|P3|STARTED|Follow up Period||14
1117581|NCT01215851|2705718|P2|STARTED|Follow up Period||14
1117582|NCT01215851|2705719|P1|STARTED|Follow up Period||14
1117583|NCT01215851|2705714|P6|NOT COMPLETED|Treatment Period||1
1117584|NCT01215851|2705715|P5|NOT COMPLETED|Treatment Period||0
1117585|NCT01215851|2705716|P4|NOT COMPLETED|Treatment Period||3
1117586|NCT01215851|2705717|P3|NOT COMPLETED|Treatment Period||1
1117587|NCT01215851|2705718|P2|NOT COMPLETED|Treatment Period||1
1117588|NCT01215851|2705719|P1|NOT COMPLETED|Treatment Period||1
1117589|NCT01215851|2705714|P6|COMPLETED|Treatment Period||14
1117590|NCT01215851|2705715|P5|COMPLETED|Treatment Period||10
1117591|NCT01215851|2705716|P4|COMPLETED|Treatment Period||12
1117592|NCT01215851|2705717|P3|COMPLETED|Treatment Period||14
1117593|NCT01215851|2705718|P2|COMPLETED|Treatment Period||14
1117594|NCT01215851|2705719|P1|COMPLETED|Treatment Period||14
1117595|NCT01215851|2705714|P6|STARTED|Treatment Period||15
1117596|NCT01215851|2705715|P5|STARTED|Treatment Period||10
1117597|NCT01215851|2705716|P4|STARTED|Treatment Period||15
1117598|NCT01215851|2705717|P3|STARTED|Treatment Period||15
1117599|NCT01215851|2705718|P2|STARTED|Treatment Period||15
1117600|NCT01215851|2705719|P1|STARTED|Treatment Period||15
1117601|NCT01215929|2705759|P2|NOT COMPLETED|Overall Study||5
1117602|NCT01215929|2705760|P1|NOT COMPLETED|Overall Study||6
1117603|NCT01215929|2705759|P2|COMPLETED|Overall Study||12
1117604|NCT01215929|2705760|P1|COMPLETED|Overall Study||12
1117605|NCT01215929|2705759|P2|STARTED|Overall Study||17
1117606|NCT01215929|2705760|P1|STARTED|Overall Study||18
1117607|NCT01215955|2705770|P4|NOT COMPLETED|Overall Study||53
1117608|NCT01215955|2705771|P3|NOT COMPLETED|Overall Study||48
1117609|NCT01215955|2705772|P2|NOT COMPLETED|Overall Study||53
1117610|NCT01215955|2705773|P1|NOT COMPLETED|Overall Study||45
1117611|NCT01215955|2705770|P4|COMPLETED|Overall Study||241
1117612|NCT01215955|2705771|P3|COMPLETED|Overall Study||244
1117613|NCT01215955|2705772|P2|COMPLETED|Overall Study||210
1117614|NCT01215955|2705773|P1|COMPLETED|Overall Study||223
1117615|NCT01215955|2705770|P4|Received at Least 1 Dose of Study Drug|Overall Study||290
1117616|NCT01215955|2705771|P3|Received at Least 1 Dose of Study Drug|Overall Study||288
1117617|NCT01215955|2705772|P2|Received at Least 1 Dose of Study Drug|Overall Study||261
1117618|NCT01215955|2705773|P1|Received at Least 1 Dose of Study Drug|Overall Study||267
1117619|NCT01215955|2705770|P4|STARTED|Overall Study|Two (2) participants from 1 site were excluded due to quality issues and validity of the data.|294
1117620|NCT01215955|2705771|P3|STARTED|Overall Study|Three (3) participants from 1 site were excluded due to quality issues and validity of data.|292
1117621|NCT01215955|2705772|P2|STARTED|Overall Study||263
1117622|NCT01215955|2705773|P1|STARTED|Overall Study||268
1117623|NCT01215968|2705841|P2|NOT COMPLETED|Overall Study||7
1117624|NCT01215968|2705842|P1|NOT COMPLETED|Overall Study||2
1117625|NCT01215968|2705841|P2|COMPLETED|Overall Study||18
1117626|NCT01215968|2705842|P1|COMPLETED|Overall Study||11
1117627|NCT01215968|2705841|P2|Received at Least 1 Dose of Study Drug|Overall Study|25 participants received placebo during Week 1.|24
1117628|NCT01215968|2705842|P1|Received at Least 1 Dose of Study Drug|Overall Study||13
1117629|NCT01215968|2705841|P2|STARTED|Overall Study||25
1117630|NCT01215968|2705842|P1|STARTED|Overall Study||13
1117631|NCT01215981|2705860|P2|NOT COMPLETED|Overall Study||1
1117632|NCT01215981|2705861|P1|NOT COMPLETED|Overall Study||2
1117633|NCT01215981|2705860|P2|COMPLETED|Overall Study||32
1117634|NCT01215981|2705861|P1|COMPLETED|Overall Study||33
1117635|NCT01215981|2705860|P2|STARTED|Overall Study||33
1117636|NCT01215981|2705861|P1|STARTED|Overall Study||35
1117637|NCT01216072|2705871|P2|NOT COMPLETED|Open-Label Extension Period (3 Months)||14
1117638|NCT01216072|2705872|P1|NOT COMPLETED|Open-Label Extension Period (3 Months)||0
1117639|NCT01216072|2705871|P2|COMPLETED|Open-Label Extension Period (3 Months)||181
1117640|NCT01216072|2705872|P1|COMPLETED|Open-Label Extension Period (3 Months)||0
1117641|NCT01216072|2705871|P2|Safety Set|Open-Label Extension Period (3 Months)||193
1117642|NCT01216072|2705872|P1|Safety Set|Open-Label Extension Period (3 Months)||0
1117643|NCT01216072|2705871|P2|STARTED|Open-Label Extension Period (3 Months)|Only DMT patients, who completed the core study, were eligible for fingolimod.|195
1117644|NCT01216072|2705872|P1|STARTED|Open-Label Extension Period (3 Months)||0
1117645|NCT01216072|2705871|P2|NOT COMPLETED|Open-Label Core Period ( 6 Months)||34
1117646|NCT01216072|2705872|P1|NOT COMPLETED|Open-Label Core Period ( 6 Months)||76
1117647|NCT01216072|2705871|P2|COMPLETED|Open-Label Core Period ( 6 Months)||229
1117648|NCT01216072|2705872|P1|COMPLETED|Open-Label Core Period ( 6 Months)||714
1117649|NCT01216072|2705871|P2|Safety Set|Open-Label Core Period ( 6 Months)||245
1117650|NCT01216072|2705872|P1|Safety Set|Open-Label Core Period ( 6 Months)||783
1117651|NCT01216072|2705871|P2|Full Analysis Set|Open-Label Core Period ( 6 Months)||263
1117652|NCT01216072|2705872|P1|Full Analysis Set|Open-Label Core Period ( 6 Months)|One patient was randomized in error and was not included in FAS.|789
1117653|NCT01216072|2705871|P2|STARTED|Open-Label Core Period ( 6 Months)||263
1117654|NCT01216072|2705872|P1|STARTED|Open-Label Core Period ( 6 Months)||790
1117655|NCT01216943|2705898|P1|NOT COMPLETED|Overall Study||13
1117656|NCT01216943|2705898|P1|COMPLETED|Overall Study||113
1117657|NCT01216943|2705898|P1|STARTED|Overall Study||126
1117658|NCT01217073|2705908|P8|NOT COMPLETED|Extension Period||20
1117659|NCT01217073|2705909|P7|NOT COMPLETED|Extension Period||91
1117660|NCT01217073|2705910|P6|NOT COMPLETED|Extension Period||0
1117661|NCT01217073|2705911|P5|NOT COMPLETED|Extension Period||0
1117662|NCT01217073|2705912|P4|NOT COMPLETED|Extension Period||0
1117663|NCT01217073|2705913|P3|NOT COMPLETED|Extension Period||0
1117664|NCT01217073|2705914|P2|NOT COMPLETED|Extension Period||0
1117665|NCT01217073|2705915|P1|NOT COMPLETED|Extension Period||0
1117666|NCT01217073|2705908|P8|COMPLETED|Extension Period||60
1117667|NCT01217073|2705909|P7|COMPLETED|Extension Period||314
1117668|NCT01217073|2705910|P6|COMPLETED|Extension Period||0
1117669|NCT01217073|2705911|P5|COMPLETED|Extension Period||0
1117670|NCT01217073|2705912|P4|COMPLETED|Extension Period||0
1117671|NCT01217073|2705913|P3|COMPLETED|Extension Period||0
1117672|NCT01217073|2705914|P2|COMPLETED|Extension Period||0
1117673|NCT01217073|2705915|P1|COMPLETED|Extension Period||0
1117674|NCT01217073|2705908|P8|STARTED|Extension Period||80
1117675|NCT01217073|2705909|P7|STARTED|Extension Period||405
1117676|NCT01217073|2705910|P6|STARTED|Extension Period||0
1117677|NCT01217073|2705911|P5|STARTED|Extension Period||0
1117678|NCT01217073|2705912|P4|STARTED|Extension Period||0
1117679|NCT01217073|2705913|P3|STARTED|Extension Period||0
1117680|NCT01217073|2705914|P2|STARTED|Extension Period||0
1117681|NCT01217073|2705915|P1|STARTED|Extension Period||0
1117682|NCT01217073|2705908|P8|NOT COMPLETED|Base Period||0
1117683|NCT01217073|2705909|P7|NOT COMPLETED|Base Period||0
1117684|NCT01217073|2705910|P6|NOT COMPLETED|Base Period||9
1117685|NCT01217073|2705911|P5|NOT COMPLETED|Base Period||15
1117686|NCT01217073|2705912|P4|NOT COMPLETED|Base Period||2
1117687|NCT01217073|2705913|P3|NOT COMPLETED|Base Period||7
1117688|NCT01217073|2705914|P2|NOT COMPLETED|Base Period||5
1117689|NCT01217073|2705915|P1|NOT COMPLETED|Base Period||7
1117690|NCT01217073|2705908|P8|COMPLETED|Base Period||0
1117691|NCT01217073|2705909|P7|COMPLETED|Base Period||0
1117692|NCT01217073|2705910|P6|COMPLETED|Base Period||105
1117693|NCT01217073|2705911|P5|COMPLETED|Base Period||99
1117694|NCT01217073|2705912|P4|COMPLETED|Base Period||113
1117695|NCT01217073|2705913|P3|COMPLETED|Base Period||107
1117696|NCT01217073|2705914|P2|COMPLETED|Base Period||110
1117697|NCT01217073|2705915|P1|COMPLETED|Base Period||106
1117698|NCT01217073|2705908|P8|STARTED|Base Period||0
1117699|NCT01217073|2705909|P7|STARTED|Base Period||0
1117700|NCT01217073|2705910|P6|STARTED|Base Period||114
1117701|NCT01217073|2705911|P5|STARTED|Base Period||114
1117702|NCT01217073|2705912|P4|STARTED|Base Period||115
1117703|NCT01217073|2705913|P3|STARTED|Base Period||114
1117704|NCT01217073|2705914|P2|STARTED|Base Period||115
1117705|NCT01217073|2705915|P1|STARTED|Base Period||113
1117706|NCT01217112|2705988|P5|NOT COMPLETED|Overall Study||1
1117707|NCT01217112|2705989|P4|NOT COMPLETED|Overall Study||2
1117708|NCT01217112|2705990|P3|NOT COMPLETED|Overall Study||1
1117709|NCT01217112|2705991|P2|NOT COMPLETED|Overall Study||2
1117710|NCT01217112|2705992|P1|NOT COMPLETED|Overall Study||0
1117711|NCT01217112|2705988|P5|COMPLETED|Overall Study||13
1117712|NCT01217112|2705989|P4|COMPLETED|Overall Study||10
1117713|NCT01217112|2705990|P3|COMPLETED|Overall Study||12
1117714|NCT01217112|2705991|P2|COMPLETED|Overall Study||10
1117715|NCT01217112|2705992|P1|COMPLETED|Overall Study||11
1117716|NCT01217112|2705988|P5|STARTED|Overall Study||14
1117717|NCT01217112|2705989|P4|STARTED|Overall Study||12
1117718|NCT01217112|2705990|P3|STARTED|Overall Study||13
1117719|NCT01217112|2705991|P2|STARTED|Overall Study||12
1117720|NCT01217112|2705992|P1|STARTED|Overall Study||11
1117721|NCT01217229|2706219|P1|NOT COMPLETED|Overall Study||0
1117722|NCT01217229|2706219|P1|COMPLETED|Overall Study||20
1117723|NCT01217229|2706219|P1|STARTED|Overall Study||20
1117724|NCT01217411|2706226|P3|NOT COMPLETED|Overall Study||0
1117725|NCT01217411|2706227|P2|NOT COMPLETED|Overall Study||0
1117726|NCT01217411|2706228|P1|NOT COMPLETED|Overall Study||0
1117727|NCT01217411|2706226|P3|COMPLETED|Overall Study||0
1117728|NCT01217411|2706227|P2|COMPLETED|Overall Study||0
1117729|NCT01217411|2706228|P1|COMPLETED|Overall Study||5
1117730|NCT01217411|2706226|P3|STARTED|Overall Study||0
1117731|NCT01217411|2706227|P2|STARTED|Overall Study||0
1117732|NCT01217411|2706228|P1|STARTED|Overall Study||5
1117733|NCT01217463|2706235|P2|NOT COMPLETED|Overall Study||8
1117734|NCT01217463|2706236|P1|NOT COMPLETED|Overall Study||13
1117735|NCT01217463|2706235|P2|COMPLETED|Overall Study||94
1117736|NCT01217463|2706236|P1|COMPLETED|Overall Study||86
1117737|NCT01217463|2706235|P2|STARTED|Overall Study||102
1117738|NCT01217463|2706236|P1|STARTED|Overall Study||99
1117739|NCT01217476|2706246|P2|NOT COMPLETED|Overall Study||7
1117740|NCT01217476|2706247|P1|NOT COMPLETED|Overall Study||12
1117741|NCT01217476|2706246|P2|COMPLETED|Overall Study||95
1117742|NCT01217476|2706247|P1|COMPLETED|Overall Study||93
1117743|NCT01217476|2706246|P2|STARTED|Overall Study||102
1117744|NCT01217476|2706247|P1|STARTED|Overall Study||105
1117745|NCT01217515|2706258|P3|NOT COMPLETED|Overall Study||10
1117746|NCT01217515|2706259|P2|NOT COMPLETED|Overall Study||8
1117747|NCT01217515|2706260|P1|NOT COMPLETED|Overall Study||7
1117748|NCT01217515|2706258|P3|COMPLETED|Overall Study||145
1117749|NCT01217515|2706259|P2|COMPLETED|Overall Study||148
1117750|NCT01217515|2706260|P1|COMPLETED|Overall Study||147
1117751|NCT01217515|2706258|P3|STARTED|Overall Study||155
1117752|NCT01217515|2706259|P2|STARTED|Overall Study||156
1117753|NCT01217515|2706260|P1|STARTED|Overall Study||154
1117754|NCT01217606|2706276|P2|NOT COMPLETED|9-Month Masked Extension||11
1117755|NCT01217606|2706277|P1|NOT COMPLETED|9-Month Masked Extension||13
1117756|NCT01217606|2706276|P2|COMPLETED|9-Month Masked Extension||62
1117757|NCT01217606|2706277|P1|COMPLETED|9-Month Masked Extension||54
1117758|NCT01217606|2706276|P2|Not Enrolled in Masked Extension|9-Month Masked Extension||10
1117759|NCT01217606|2706277|P1|Not Enrolled in Masked Extension|9-Month Masked Extension||9
1117760|NCT01217606|2706276|P2|STARTED|9-Month Masked Extension||73
1117761|NCT01217606|2706277|P1|STARTED|9-Month Masked Extension||67
1117762|NCT01217606|2706276|P2|NOT COMPLETED|Initial Treatment Phase||12
1117763|NCT01217606|2706277|P1|NOT COMPLETED|Initial Treatment Phase||14
1117764|NCT01217606|2706276|P2|COMPLETED|Initial Treatment Phase||83
1117765|NCT01217606|2706277|P1|COMPLETED|Initial Treatment Phase||76
1117766|NCT01217606|2706276|P2|STARTED|Initial Treatment Phase||95
1117767|NCT01217606|2706277|P1|STARTED|Initial Treatment Phase||90
1117768|NCT01217749|2706290|P3|NOT COMPLETED|Overall Study||2
1117769|NCT01217749|2706291|P2|NOT COMPLETED|Overall Study||3
1117770|NCT01217749|2706292|P1|NOT COMPLETED|Overall Study||3
1117771|NCT01217749|2706290|P3|COMPLETED|Overall Study||22
1117772|NCT01217749|2706291|P2|COMPLETED|Overall Study||17
1117773|NCT01217749|2706292|P1|COMPLETED|Overall Study||24
1117774|NCT01217749|2706290|P3|STARTED|Overall Study||24
1117775|NCT01217749|2706291|P2|STARTED|Overall Study||20
1117776|NCT01217749|2706292|P1|STARTED|Overall Study||27
1117777|NCT01217801|2706310|P2|NOT COMPLETED|Period 2||0
1117778|NCT01217801|2706311|P1|NOT COMPLETED|Period 2||0
1117779|NCT01217801|2706310|P2|COMPLETED|Period 2||22
1117780|NCT01217801|2706311|P1|COMPLETED|Period 2||23
1117781|NCT01217801|2706310|P2|STARTED|Period 2||22
1117782|NCT01217801|2706311|P1|STARTED|Period 2||23
1117783|NCT01217801|2706310|P2|NOT COMPLETED|Period 1||2
1117784|NCT01217801|2706311|P1|NOT COMPLETED|Period 1||1
1117785|NCT01217801|2706310|P2|COMPLETED|Period 1||22
1117786|NCT01217801|2706311|P1|COMPLETED|Period 1||23
1117787|NCT01217801|2706310|P2|STARTED|Period 1||24
1117788|NCT01217801|2706311|P1|STARTED|Period 1||24
1117789|NCT01217814|2706320|P3|NOT COMPLETED|Overall Study||1
1117790|NCT01217814|2706321|P2|NOT COMPLETED|Overall Study||1
1117791|NCT01217814|2706322|P1|NOT COMPLETED|Overall Study||1
1117792|NCT01217814|2706320|P3|COMPLETED|Overall Study||6
1117793|NCT01217814|2706321|P2|COMPLETED|Overall Study||4
1117794|NCT01217814|2706322|P1|COMPLETED|Overall Study||3
1117795|NCT01217814|2706320|P3|STARTED|Overall Study||7
1117796|NCT01217814|2706321|P2|STARTED|Overall Study||5
1117797|NCT01217814|2706322|P1|STARTED|Overall Study||4
1117798|NCT01217827|2706348|P2|NOT COMPLETED|Overall Study||0
1117799|NCT01217827|2706349|P1|NOT COMPLETED|Overall Study||0
1117800|NCT01217827|2706348|P2|COMPLETED|Overall Study||43
1117801|NCT01217827|2706349|P1|COMPLETED|Overall Study||46
1117802|NCT01217827|2706348|P2|STARTED|Overall Study||43
1117803|NCT01217827|2706349|P1|STARTED|Overall Study||46
1117804|NCT01217840|2706357|P2|NOT COMPLETED|Overall Study||3
1117805|NCT01217840|2706358|P1|NOT COMPLETED|Overall Study||6
1117806|NCT01217840|2706357|P2|COMPLETED|Overall Study||17
1117807|NCT01217840|2706358|P1|COMPLETED|Overall Study||14
1117808|NCT01217840|2706357|P2|STARTED|Overall Study||20
1117809|NCT01217840|2706358|P1|STARTED|Overall Study||20
1117810|NCT01217892|2706368|P4|NOT COMPLETED|Overall Study||8
1117811|NCT01217892|2706369|P3|NOT COMPLETED|Overall Study||9
1117812|NCT01217892|2706370|P2|NOT COMPLETED|Overall Study||6
1117813|NCT01217892|2706371|P1|NOT COMPLETED|Overall Study||7
1117814|NCT01217892|2706368|P4|COMPLETED|Overall Study||93
1117815|NCT01217892|2706369|P3|COMPLETED|Overall Study||90
1117816|NCT01217892|2706370|P2|COMPLETED|Overall Study||94
1117817|NCT01217892|2706371|P1|COMPLETED|Overall Study||93
1117818|NCT01217892|2706368|P4|STARTED|Overall Study||101
1117819|NCT01217892|2706369|P3|STARTED|Overall Study||99
1117820|NCT01217892|2706370|P2|STARTED|Overall Study||100
1117821|NCT01217892|2706371|P1|STARTED|Overall Study||100
1117822|NCT01217944|2706400|P3|NOT COMPLETED|Overall Study||0
1117823|NCT01217944|2706401|P2|NOT COMPLETED|Overall Study||4
1117824|NCT01217944|2706402|P1|NOT COMPLETED|Overall Study||6
1117825|NCT01217944|2706400|P3|COMPLETED|Overall Study||55
1117826|NCT01217944|2706401|P2|COMPLETED|Overall Study||112
1117827|NCT01217944|2706402|P1|COMPLETED|Overall Study||100
1117828|NCT01217944|2706400|P3|Completed 6 Months|Overall Study||55
1117829|NCT01217944|2706401|P2|Completed 6 Months|Overall Study||116
1117830|NCT01217944|2706402|P1|Completed 6 Months|Overall Study||103
1117831|NCT01217944|2706400|P3|Completed 3 Months|Overall Study||55
1117832|NCT01217944|2706401|P2|Completed 3 Months|Overall Study||116
1117833|NCT01217944|2706402|P1|Completed 3 Months|Overall Study||105
1117834|NCT01217944|2706400|P3|STARTED|Overall Study||55
1117835|NCT01217944|2706401|P2|STARTED|Overall Study||116
1117836|NCT01217944|2706402|P1|STARTED|Overall Study||106
1117837|NCT01217957|2706446|P5|NOT COMPLETED|Phase 2||1
1117838|NCT01217957|2706447|P4|NOT COMPLETED|Phase 2||0
1117839|NCT01217957|2706448|P3|NOT COMPLETED|Phase 2||0
1117840|NCT01217957|2706449|P2|NOT COMPLETED|Phase 2||0
1117841|NCT01217957|2706450|P1|NOT COMPLETED|Phase 2||0
1117842|NCT01217957|2706446|P5|COMPLETED|Phase 2|Completed=Participants who are ongoing or who have died on study.|49
1117843|NCT01217957|2706447|P4|COMPLETED|Phase 2||0
1117844|NCT01217957|2706448|P3|COMPLETED|Phase 2||0
1117845|NCT01217957|2706449|P2|COMPLETED|Phase 2||0
1117846|NCT01217957|2706450|P1|COMPLETED|Phase 2||0
1117847|NCT01217957|2706446|P5|STARTED|Phase 2||50
1117848|NCT01217957|2706447|P4|STARTED|Phase 2||0
1117849|NCT01217957|2706448|P3|STARTED|Phase 2||0
1117850|NCT01217957|2706449|P2|STARTED|Phase 2||0
1117851|NCT01217957|2706450|P1|STARTED|Phase 2||0
1117852|NCT01217957|2706446|P5|NOT COMPLETED|Phase 1||0
1117853|NCT01217957|2706447|P4|NOT COMPLETED|Phase 1||1
1117854|NCT01217957|2706448|P3|NOT COMPLETED|Phase 1||1
1117855|NCT01217957|2706449|P2|NOT COMPLETED|Phase 1||0
1117856|NCT01217957|2706450|P1|NOT COMPLETED|Phase 1||1
1117857|NCT01217957|2706446|P5|COMPLETED|Phase 1||0
1117858|NCT01217957|2706447|P4|COMPLETED|Phase 1||2
1117859|NCT01217957|2706448|P3|COMPLETED|Phase 1||5
1117860|NCT01217957|2706449|P2|COMPLETED|Phase 1||3
1117861|NCT01217957|2706450|P1|COMPLETED|Phase 1||2
1117862|NCT01217957|2706446|P5|STARTED|Phase 1||0
1117863|NCT01217957|2706447|P4|STARTED|Phase 1||3
1117864|NCT01217957|2706448|P3|STARTED|Phase 1||6
1117865|NCT01217957|2706449|P2|STARTED|Phase 1||3
1117866|NCT01217957|2706450|P1|STARTED|Phase 1||3
1117867|NCT01218009|2706508|P2|NOT COMPLETED|Overall Study||165
1117868|NCT01218009|2706509|P1|NOT COMPLETED|Overall Study||166
1117869|NCT01218009|2706508|P2|COMPLETED|Overall Study||0
1117870|NCT01218009|2706509|P1|COMPLETED|Overall Study||0
1117871|NCT01218009|2706508|P2|STARTED|Overall Study||165
1117872|NCT01218009|2706509|P1|STARTED|Overall Study||166
1117873|NCT01218087|2706529|P2|NOT COMPLETED|Overall Study||6
1117874|NCT01218087|2706530|P1|NOT COMPLETED|Overall Study||15
1117875|NCT01218087|2706529|P2|COMPLETED|Overall Study||35
1117876|NCT01218087|2706530|P1|COMPLETED|Overall Study||27
1117877|NCT01218087|2706529|P2|STARTED|Overall Study||41
1117878|NCT01218087|2706530|P1|STARTED|Overall Study||42
1117879|NCT01218100|2706542|P4|NOT COMPLETED|Overall Study||34
1117880|NCT01218100|2706543|P3|NOT COMPLETED|Overall Study||27
1117881|NCT01218100|2706544|P2|NOT COMPLETED|Overall Study||25
1117882|NCT01218100|2706545|P1|NOT COMPLETED|Overall Study||24
1117883|NCT01218100|2706542|P4|COMPLETED|Overall Study||156
1117884|NCT01218100|2706543|P3|COMPLETED|Overall Study||162
1117885|NCT01218100|2706544|P2|COMPLETED|Overall Study||165
1117886|NCT01218100|2706545|P1|COMPLETED|Overall Study||71
1117887|NCT01218100|2706542|P4|STARTED|Overall Study||190
1117888|NCT01218100|2706543|P3|STARTED|Overall Study||189
1117889|NCT01218100|2706544|P2|STARTED|Overall Study||190
1117890|NCT01218100|2706545|P1|STARTED|Overall Study||95
1117891|NCT01218243|2706561|P2|NOT COMPLETED|Overall Study||14
1117892|NCT01218243|2706562|P1|NOT COMPLETED|Overall Study||9
1117893|NCT01218243|2706561|P2|COMPLETED|Overall Study||36
1117894|NCT01218243|2706562|P1|COMPLETED|Overall Study||41
1117895|NCT01218243|2706561|P2|Treatment Completed|Overall Study||42
1117896|NCT01218243|2706562|P1|Treatment Completed|Overall Study||45
1117897|NCT01218243|2706561|P2|STARTED|Overall Study||50
1117898|NCT01218243|2706562|P1|STARTED|Overall Study||50
1117899|NCT01218308|2706578|P2|NOT COMPLETED|Overall Study||120
1117900|NCT01218308|2706579|P1|NOT COMPLETED|Overall Study||103
1117901|NCT01218308|2706578|P2|COMPLETED|Overall Study||2464
1117902|NCT01218308|2706579|P1|COMPLETED|Overall Study||2481
1117903|NCT01218308|2706578|P2|STARTED|Overall Study||2584
1117904|NCT01218308|2706579|P1|STARTED|Overall Study||2584
1117905|NCT01218399|2706623|P2|NOT COMPLETED|Overall Study||0
1117906|NCT01218399|2706624|P1|NOT COMPLETED|Overall Study||0
1117907|NCT01218399|2706623|P2|COMPLETED|Overall Study||5
1117908|NCT01218399|2706624|P1|COMPLETED|Overall Study||5
1117909|NCT01218399|2706623|P2|STARTED|Overall Study||5
1117910|NCT01218399|2706624|P1|STARTED|Overall Study||5
1117923|NCT01218477|2706789|P4|NOT COMPLETED|Overall Study||2
1117924|NCT01218477|2706790|P3|NOT COMPLETED|Overall Study||14
1117925|NCT01218477|2706791|P2|NOT COMPLETED|Overall Study||8
1117926|NCT01218477|2706792|P1|NOT COMPLETED|Overall Study||3
1117927|NCT01218477|2706789|P4|COMPLETED|Overall Study|Still receiving study drug|0
1117928|NCT01218477|2706790|P3|COMPLETED|Overall Study|Still receiving study drug|0
1117929|NCT01218477|2706791|P2|COMPLETED|Overall Study|Still receiving study drug|0
1117930|NCT01218477|2706792|P1|COMPLETED|Overall Study|Still receiving study drug|0
1117931|NCT01218477|2706789|P4|STARTED|Overall Study|Participants who received treatment|2
1117932|NCT01218477|2706790|P3|STARTED|Overall Study|Participants who received treatment|14
1117933|NCT01218477|2706791|P2|STARTED|Overall Study|Participants who received treatment|8
1117934|NCT01218477|2706792|P1|STARTED|Overall Study|Participants who received treatment|3
1117935|NCT01218594|2706809|P1|NOT COMPLETED|Overall Study||12
1117936|NCT01218594|2706809|P1|COMPLETED|Overall Study||36
1117937|NCT01218594|2706809|P1|STARTED|Overall Study||48
1117938|NCT01218646|2706817|P4|NOT COMPLETED|Overall Study||1
1117939|NCT01218646|2706818|P3|NOT COMPLETED|Overall Study||2
1117940|NCT01218646|2706819|P2|NOT COMPLETED|Overall Study||0
1117941|NCT01218646|2706820|P1|NOT COMPLETED|Overall Study||1
1117942|NCT01218646|2706817|P4|COMPLETED|Overall Study||63
1117943|NCT01218646|2706818|P3|COMPLETED|Overall Study||223
1117944|NCT01218646|2706819|P2|COMPLETED|Overall Study||225
1117945|NCT01218646|2706820|P1|COMPLETED|Overall Study||224
1117946|NCT01218646|2706817|P4|STARTED|Overall Study||64
1117947|NCT01218646|2706818|P3|STARTED|Overall Study||225
1117948|NCT01218646|2706819|P2|STARTED|Overall Study||225
1117949|NCT01218646|2706820|P1|STARTED|Overall Study||225
1117950|NCT01218802|2706860|P2|NOT COMPLETED|Overall Study||18
1117951|NCT01218802|2706861|P1|NOT COMPLETED|Overall Study||10
1117952|NCT01218802|2706860|P2|COMPLETED|Overall Study||57
1117953|NCT01218802|2706861|P1|COMPLETED|Overall Study||62
1117954|NCT01218802|2706860|P2|STARTED|Overall Study||75
1117955|NCT01218802|2706861|P1|STARTED|Overall Study||72
1117956|NCT01218867|2706880|P11|NOT COMPLETED|Overall Study||0
1117957|NCT01218867|2706881|P10|NOT COMPLETED|Overall Study||0
1117958|NCT01218867|2706882|P9|NOT COMPLETED|Overall Study||0
1117959|NCT01218867|2706883|P8|NOT COMPLETED|Overall Study||0
1117960|NCT01218867|2706884|P7|NOT COMPLETED|Overall Study||1
1117961|NCT01218867|2706885|P6|NOT COMPLETED|Overall Study||0
1117962|NCT01218867|2706886|P5|NOT COMPLETED|Overall Study||0
1117963|NCT01218867|2706887|P4|NOT COMPLETED|Overall Study||0
1117964|NCT01218867|2706888|P3|NOT COMPLETED|Overall Study||0
1117965|NCT01218867|2706889|P2|NOT COMPLETED|Overall Study||0
1117966|NCT01218867|2706890|P1|NOT COMPLETED|Overall Study||0
1117967|NCT01218867|2706880|P11|COMPLETED|Overall Study||2
1117968|NCT01218867|2706881|P10|COMPLETED|Overall Study||4
1117969|NCT01218867|2706882|P9|COMPLETED|Overall Study||3
1117970|NCT01218867|2706883|P8|COMPLETED|Overall Study||3
1117971|NCT01218867|2706884|P7|COMPLETED|Overall Study||3
1117972|NCT01218867|2706885|P6|COMPLETED|Overall Study||1
1117973|NCT01218867|2706886|P5|COMPLETED|Overall Study||1
1117974|NCT01218867|2706887|P4|COMPLETED|Overall Study||1
1117975|NCT01218867|2706888|P3|COMPLETED|Overall Study||3
1117976|NCT01218867|2706889|P2|COMPLETED|Overall Study||1
1117977|NCT01218867|2706890|P1|COMPLETED|Overall Study||1
1117978|NCT01218867|2706880|P11|STARTED|Overall Study||2
1117979|NCT01218867|2706881|P10|STARTED|Overall Study||4
1117980|NCT01218867|2706882|P9|STARTED|Overall Study||3
1117981|NCT01218867|2706883|P8|STARTED|Overall Study||3
1117982|NCT01218867|2706884|P7|STARTED|Overall Study||4
1117983|NCT01218867|2706885|P6|STARTED|Overall Study||1
1117984|NCT01218867|2706886|P5|STARTED|Overall Study||1
1117985|NCT01218867|2706887|P4|STARTED|Overall Study||1
1117986|NCT01218867|2706888|P3|STARTED|Overall Study||3
1117987|NCT01218867|2706889|P2|STARTED|Overall Study||1
1117988|NCT01218867|2706890|P1|STARTED|Overall Study||1
1117989|NCT01218958|2706939|P3|NOT COMPLETED|Overall Study||81
1117990|NCT01218958|2706940|P2|NOT COMPLETED|Overall Study||81
1117991|NCT01218958|2706941|P1|NOT COMPLETED|Overall Study||84
1117992|NCT01218958|2706939|P3|COMPLETED|Overall Study||128
1117993|NCT01218958|2706940|P2|COMPLETED|Overall Study||124
1117994|NCT01218958|2706941|P1|COMPLETED|Overall Study||126
1117995|NCT01218958|2706939|P3|STARTED|Overall Study||209
1117996|NCT01218958|2706940|P2|STARTED|Overall Study||205
1117997|NCT01218958|2706941|P1|STARTED|Overall Study||210
1117998|NCT01218971|2706954|P2|NOT COMPLETED|Overall Study||80
1117999|NCT01218971|2706955|P1|NOT COMPLETED|Overall Study||104
1118000|NCT01218971|2706954|P2|COMPLETED|Overall Study||77
1118001|NCT01218971|2706955|P1|COMPLETED|Overall Study||71
1118002|NCT01218971|2706954|P2|STARTED|Overall Study||157
1118003|NCT01218971|2706955|P1|STARTED|Overall Study||175
1118004|NCT01218984|2706968|P3|NOT COMPLETED|Overall Study||3
1118005|NCT01218984|2706969|P2|NOT COMPLETED|Overall Study||2
1118006|NCT01218984|2706970|P1|NOT COMPLETED|Overall Study||1
1118007|NCT01218984|2706968|P3|COMPLETED|Overall Study||7
1118008|NCT01218984|2706969|P2|COMPLETED|Overall Study||6
1118009|NCT01218984|2706970|P1|COMPLETED|Overall Study||8
1118010|NCT01218984|2706968|P3|STARTED|Overall Study||10
1118011|NCT01218984|2706969|P2|STARTED|Overall Study||8
1118012|NCT01218984|2706970|P1|STARTED|Overall Study||9
1118013|NCT01218997|2706980|P2|NOT COMPLETED|Overall Study||41
1118014|NCT01218997|2706981|P1|NOT COMPLETED|Overall Study||245
1118015|NCT01218997|2706980|P2|COMPLETED|Overall Study||24
1118016|NCT01218997|2706981|P1|COMPLETED|Overall Study||126
1118017|NCT01218997|2706980|P2|STARTED|Overall Study||65
1118018|NCT01218997|2706981|P1|STARTED|Overall Study||371
1118019|NCT01211535|2706989|P2|NOT COMPLETED|Overall Study||1
1118020|NCT01211535|2706990|P1|NOT COMPLETED|Overall Study||0
1118021|NCT01211535|2706989|P2|COMPLETED|Overall Study||51
1118022|NCT01211535|2706990|P1|COMPLETED|Overall Study||52
1118023|NCT01211535|2706989|P2|STARTED|Overall Study||52
1118024|NCT01211535|2706990|P1|STARTED|Overall Study||52
1118025|NCT01211613|2706999|P3|NOT COMPLETED|Overall Study||2
1118026|NCT01211613|2707000|P2|NOT COMPLETED|Overall Study||2
1118027|NCT01211613|2707001|P1|NOT COMPLETED|Overall Study||3
1118028|NCT01211613|2706999|P3|COMPLETED|Overall Study||33
1118029|NCT01211613|2707000|P2|COMPLETED|Overall Study||33
1118030|NCT01211613|2707001|P1|COMPLETED|Overall Study||34
1118031|NCT01211613|2706999|P3|STARTED|Overall Study||35
1118032|NCT01211613|2707000|P2|STARTED|Overall Study||35
1118033|NCT01211613|2707001|P1|STARTED|Overall Study||37
1118034|NCT01211665|2707014|P2|NOT COMPLETED|Overall Study||0
1118035|NCT01211665|2707015|P1|NOT COMPLETED|Overall Study||2
1118036|NCT01211665|2707014|P2|COMPLETED|Overall Study|completed treatment with study drug|1
1118037|NCT01211665|2707015|P1|COMPLETED|Overall Study||0
1118038|NCT01211665|2707014|P2|STARTED|Overall Study||1
1118039|NCT01211665|2707015|P1|STARTED|Overall Study||2
1118040|NCT01211730|2707041|P2|NOT COMPLETED|Overall Study||0
1118041|NCT01211730|2707042|P1|NOT COMPLETED|Overall Study||0
1118042|NCT01211730|2707041|P2|COMPLETED|Overall Study||82
1118043|NCT01211730|2707042|P1|COMPLETED|Overall Study||82
1118044|NCT01211730|2707041|P2|STARTED|Overall Study||82
1118045|NCT01211730|2707042|P1|STARTED|Overall Study||82
1118046|NCT01211769|2707062|P4|NOT COMPLETED|Overall Study||11
1118047|NCT01211769|2707063|P3|NOT COMPLETED|Overall Study||8
1118048|NCT01211769|2707064|P2|NOT COMPLETED|Overall Study||10
1118049|NCT01211769|2707065|P1|NOT COMPLETED|Overall Study||9
1118050|NCT01211769|2707062|P4|COMPLETED|Overall Study||9
1118051|NCT01211769|2707063|P3|COMPLETED|Overall Study||12
1118052|NCT01211769|2707064|P2|COMPLETED|Overall Study||10
1118053|NCT01211769|2707065|P1|COMPLETED|Overall Study||11
1118054|NCT01211769|2707062|P4|Participants/Group|Overall Study||20
1118055|NCT01211769|2707063|P3|Participants/Group|Overall Study||20
1118056|NCT01211769|2707064|P2|Participants/Group|Overall Study||20
1118057|NCT01211769|2707065|P1|Participants/Group|Overall Study||20
1118058|NCT01211769|2707062|P4|STARTED|Overall Study||20
1118059|NCT01211769|2707063|P3|STARTED|Overall Study||20
1118060|NCT01211769|2707064|P2|STARTED|Overall Study||20
1118061|NCT01211769|2707065|P1|STARTED|Overall Study||20
1118062|NCT01211873|2707086|P3|NOT COMPLETED|Overall Study||2
1118063|NCT01211873|2707087|P2|NOT COMPLETED|Overall Study||2
1118064|NCT01211873|2707088|P1|NOT COMPLETED|Overall Study||5
1118065|NCT01211873|2707086|P3|COMPLETED|Overall Study||36
1118066|NCT01211873|2707087|P2|COMPLETED|Overall Study||117
1118067|NCT01211873|2707088|P1|COMPLETED|Overall Study||240
1118068|NCT01211873|2707086|P3|STARTED|Overall Study||38
1118069|NCT01211873|2707087|P2|STARTED|Overall Study||119
1118070|NCT01211873|2707088|P1|STARTED|Overall Study||245
1118071|NCT01212094|2707098|P3|NOT COMPLETED|Years 2 & 3: Treatment Randomization||11
1118072|NCT01212094|2707099|P2|NOT COMPLETED|Years 2 & 3: Treatment Randomization||4
1118073|NCT01212094|2707100|P1|NOT COMPLETED|Years 2 & 3: Treatment Randomization||0
1118074|NCT01212094|2707098|P3|COMPLETED|Years 2 & 3: Treatment Randomization||7
1118075|NCT01212094|2707099|P2|COMPLETED|Years 2 & 3: Treatment Randomization||5
1118076|NCT01212094|2707100|P1|COMPLETED|Years 2 & 3: Treatment Randomization||0
1118077|NCT01212094|2707098|P3|STARTED|Years 2 & 3: Treatment Randomization||18
1118078|NCT01212094|2707099|P2|STARTED|Years 2 & 3: Treatment Randomization||9
1118079|NCT01212094|2707100|P1|STARTED|Years 2 & 3: Treatment Randomization||0
1118080|NCT01212094|2707098|P3|NOT COMPLETED|Year 1: Baseline Monitoring||0
1118081|NCT01212094|2707099|P2|NOT COMPLETED|Year 1: Baseline Monitoring||0
1118082|NCT01212094|2707100|P1|NOT COMPLETED|Year 1: Baseline Monitoring||16
1118083|NCT01212094|2707098|P3|COMPLETED|Year 1: Baseline Monitoring||0
1118084|NCT01212094|2707099|P2|COMPLETED|Year 1: Baseline Monitoring||0
1118085|NCT01212094|2707100|P1|COMPLETED|Year 1: Baseline Monitoring||27
1118086|NCT01212094|2707098|P3|STARTED|Year 1: Baseline Monitoring||0
1118087|NCT01212094|2707099|P2|STARTED|Year 1: Baseline Monitoring||0
1118088|NCT01212094|2707100|P1|STARTED|Year 1: Baseline Monitoring||43
1118089|NCT01212159|2707133|P2|NOT COMPLETED|Overall Study||12
1118090|NCT01212159|2707134|P1|NOT COMPLETED|Overall Study||12
1118091|NCT01212159|2707133|P2|COMPLETED|Overall Study||32
1118092|NCT01212159|2707134|P1|COMPLETED|Overall Study||14
1118093|NCT01212159|2707133|P2|STARTED|Overall Study||44
1118094|NCT01212159|2707134|P1|STARTED|Overall Study||26
1118095|NCT01212172|2707144|P2|NOT COMPLETED|Overall Study||1
1118096|NCT01212172|2707145|P1|NOT COMPLETED|Overall Study||1
1118097|NCT01212172|2707144|P2|COMPLETED|Overall Study||9
1118098|NCT01212172|2707145|P1|COMPLETED|Overall Study||9
1118099|NCT01212172|2707144|P2|STARTED|Overall Study||10
1118100|NCT01212172|2707145|P1|STARTED|Overall Study||10
1118101|NCT01212185|2707155|P2|NOT COMPLETED|Overall Study||1
1118102|NCT01212185|2707156|P1|NOT COMPLETED|Overall Study||2
1118103|NCT01212185|2707155|P2|COMPLETED|Overall Study||7
1118104|NCT01212185|2707156|P1|COMPLETED|Overall Study||4
1118105|NCT01212185|2707155|P2|STARTED|Overall Study||8
1118106|NCT01212185|2707156|P1|STARTED|Overall Study||6
1118107|NCT01212302|2707164|P1|NOT COMPLETED|Overall Study||0
1118108|NCT01212302|2707164|P1|COMPLETED|Overall Study||504
1118109|NCT01212302|2707164|P1|STARTED|Overall Study||504
1118110|NCT01212445|2707171|P3|NOT COMPLETED|Overall Study||0
1118111|NCT01212445|2707172|P2|NOT COMPLETED|Overall Study||0
1118112|NCT01212445|2707173|P1|NOT COMPLETED|Overall Study||0
1118113|NCT01212445|2707171|P3|COMPLETED|Overall Study||51
1118114|NCT01212445|2707172|P2|COMPLETED|Overall Study||51
1118115|NCT01212445|2707173|P1|COMPLETED|Overall Study||52
1118116|NCT01212445|2707171|P3|STARTED|Overall Study||51
1118117|NCT01212445|2707172|P2|STARTED|Overall Study||51
1118118|NCT01212445|2707173|P1|STARTED|Overall Study||52
1118119|NCT01212484|2707202|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
1118120|NCT01212484|2707203|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
1118121|NCT01212484|2707202|P2|COMPLETED|Second Intervention (4 Weeks)||3
1118122|NCT01212484|2707203|P1|COMPLETED|Second Intervention (4 Weeks)||5
1118123|NCT01212484|2707202|P2|STARTED|Second Intervention (4 Weeks)||4
1118124|NCT01212484|2707203|P1|STARTED|Second Intervention (4 Weeks)||5
1118125|NCT01212484|2707202|P2|NOT COMPLETED|First Intervention (4 Weeks)||2
1118126|NCT01212484|2707203|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
1118127|NCT01212484|2707202|P2|COMPLETED|First Intervention (4 Weeks)||4
1118128|NCT01212484|2707203|P1|COMPLETED|First Intervention (4 Weeks)||5
1118129|NCT01212484|2707202|P2|STARTED|First Intervention (4 Weeks)||6
1118130|NCT01212484|2707203|P1|STARTED|First Intervention (4 Weeks)||5
1118131|NCT01212484|2707202|P2|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||0
1118132|NCT01212484|2707203|P1|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||1
1118133|NCT01212484|2707202|P2|COMPLETED|Carbidopa Titration Period (4 Weeks)||6
1118134|NCT01212484|2707203|P1|COMPLETED|Carbidopa Titration Period (4 Weeks)||5
1118135|NCT01212484|2707202|P2|STARTED|Carbidopa Titration Period (4 Weeks)||6
1118136|NCT01212484|2707203|P1|STARTED|Carbidopa Titration Period (4 Weeks)||6
1118137|NCT01212627|2707213|P1|NOT COMPLETED|Overall Study||0
1118138|NCT01212627|2707213|P1|COMPLETED|Overall Study||12
1118139|NCT01212627|2707213|P1|STARTED|Overall Study||12
1118140|NCT01212757|2707220|P7|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
1118141|NCT01212757|2707221|P6|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||7
1118142|NCT01212757|2707222|P5|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
1118143|NCT01212757|2707223|P4|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||8
1118144|NCT01212757|2707224|P3|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||20
1118145|NCT01212757|2707225|P2|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||12
1118146|NCT01212757|2707226|P1|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
1118147|NCT01212757|2707220|P7|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||28
1118148|NCT01212757|2707221|P6|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||34
1118149|NCT01212757|2707222|P5|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||25
1118150|NCT01212757|2707223|P4|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||35
1118151|NCT01212757|2707224|P3|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||114
1118152|NCT01212757|2707225|P2|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||125
1118153|NCT01212757|2707226|P1|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
1118154|NCT01212757|2707220|P7|STARTED|Active Treatment Phase (Weeks 25 - 52)||28
1118155|NCT01212757|2707221|P6|STARTED|Active Treatment Phase (Weeks 25 - 52)|Two participants who escaped early and completed Week 24 did not enter the active treatment phase|41
1118156|NCT01212757|2707222|P5|STARTED|Active Treatment Phase (Weeks 25 - 52)||27
1118157|NCT01212757|2707223|P4|STARTED|Active Treatment Phase (Weeks 25 - 52)||43
1118158|NCT01212757|2707224|P3|STARTED|Active Treatment Phase (Weeks 25 - 52)|Eight participants who completed Week 24 did not enter the active treatment phase|134
1118159|NCT01212757|2707225|P2|STARTED|Active Treatment Phase (Weeks 25 - 52)|Six participants who completed Week 24 did not enter the active treatment phase|137
1118160|NCT01212757|2707226|P1|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
1118161|NCT01212757|2707220|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1118162|NCT01212757|2707221|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1118163|NCT01212757|2707222|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1118164|NCT01212757|2707223|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1118165|NCT01212757|2707224|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||21
1118166|NCT01212757|2707225|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
1118167|NCT01212757|2707226|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||19
1118168|NCT01212757|2707220|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1118169|NCT01212757|2707221|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1118170|NCT01212757|2707222|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1118171|NCT01212757|2707223|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1118172|NCT01212757|2707224|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||142
1118173|NCT01212757|2707225|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||143
1118174|NCT01212757|2707226|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants who completed Week 24 did not enter the active treatment phase|143
1118175|NCT01212757|2707220|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1118176|NCT01212757|2707221|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1118177|NCT01212757|2707222|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1118178|NCT01212757|2707223|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1118179|NCT01212757|2707224|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||64
1118180|NCT01212757|2707225|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Three participants who escaped early did not complete Week 24|59
1118181|NCT01212757|2707226|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Two participants who escaped early did not complete Week 24|88
1118182|NCT01212757|2707220|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1118183|NCT01212757|2707221|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1118184|NCT01212757|2707222|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1118185|NCT01212757|2707223|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1118186|NCT01212757|2707224|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||149
1118187|NCT01212757|2707225|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||151
1118188|NCT01212757|2707226|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||148
1118189|NCT01212757|2707220|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1118190|NCT01212757|2707221|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1118191|NCT01212757|2707222|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1118192|NCT01212757|2707223|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1118193|NCT01212757|2707224|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||162
1118194|NCT01212757|2707225|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||163
1118195|NCT01212757|2707226|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||159
1118196|NCT01212757|2707220|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1118197|NCT01212757|2707221|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1118198|NCT01212757|2707222|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1118199|NCT01212757|2707223|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1118200|NCT01212757|2707224|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
1118201|NCT01212757|2707225|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
1118202|NCT01212757|2707226|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||162
1118266|NCT01212874|2707601|P2|NOT COMPLETED|Overall Study||23
1118267|NCT01212874|2707602|P1|NOT COMPLETED|Overall Study||22
1118268|NCT01212874|2707601|P2|COMPLETED|Overall Study||12
1118269|NCT01212874|2707602|P1|COMPLETED|Overall Study||13
1118270|NCT01212874|2707601|P2|Received Allocated Intervention|Overall Study||12
1118271|NCT01212874|2707602|P1|Received Allocated Intervention|Overall Study||13
1118272|NCT01212874|2707601|P2|STARTED|Overall Study||35
1118273|NCT01212874|2707602|P1|STARTED|Overall Study||35
1118274|NCT01212991|2707612|P2|NOT COMPLETED|Overall Study||374
1118275|NCT01212991|2707613|P1|NOT COMPLETED|Overall Study||613
1118276|NCT01212991|2707612|P2|COMPLETED|Overall Study|Indicates participants continuing in long-term follow-up as of 16SEP2013.|471
1118277|NCT01212991|2707613|P1|COMPLETED|Overall Study|Indicates participants continuing in long-term follow-up as of 16SEP2013.|259
1118278|NCT01212991|2707612|P2|STARTED|Overall Study||845
1118279|NCT01212991|2707613|P1|STARTED|Overall Study||872
1118280|NCT01213043|2707633|P2|NOT COMPLETED|Follow-up||0
1118281|NCT01213043|2707634|P1|NOT COMPLETED|Follow-up||0
1118282|NCT01213043|2707633|P2|COMPLETED|Follow-up||15
1118283|NCT01213043|2707634|P1|COMPLETED|Follow-up||15
1118284|NCT01213043|2707633|P2|STARTED|Follow-up||15
1118285|NCT01213043|2707634|P1|STARTED|Follow-up||15
1118286|NCT01213043|2707633|P2|NOT COMPLETED|Treatment Period 2||0
1118287|NCT01213043|2707634|P1|NOT COMPLETED|Treatment Period 2||0
1118288|NCT01213043|2707633|P2|COMPLETED|Treatment Period 2||15
1118289|NCT01213043|2707634|P1|COMPLETED|Treatment Period 2||15
1118290|NCT01213043|2707633|P2|STARTED|Treatment Period 2||15
1118291|NCT01213043|2707634|P1|STARTED|Treatment Period 2||15
1118292|NCT01213043|2707633|P2|NOT COMPLETED|Washout Period||0
1118293|NCT01213043|2707634|P1|NOT COMPLETED|Washout Period||0
1118294|NCT01213043|2707633|P2|COMPLETED|Washout Period||15
1118295|NCT01213043|2707634|P1|COMPLETED|Washout Period||15
1118296|NCT01213043|2707633|P2|STARTED|Washout Period||15
1118297|NCT01213043|2707634|P1|STARTED|Washout Period||15
1118298|NCT01213043|2707633|P2|NOT COMPLETED|Treatment Period 1||0
1118299|NCT01213043|2707634|P1|NOT COMPLETED|Treatment Period 1||0
1118300|NCT01213043|2707633|P2|COMPLETED|Treatment Period 1||15
1118301|NCT01213043|2707634|P1|COMPLETED|Treatment Period 1||15
1118302|NCT01213043|2707633|P2|STARTED|Treatment Period 1||15
1118303|NCT01213043|2707634|P1|STARTED|Treatment Period 1||15
1118304|NCT01213173|2707662|P2|NOT COMPLETED|Overall Study||16
1118305|NCT01213173|2707663|P1|NOT COMPLETED|Overall Study||12
1118306|NCT01213173|2707662|P2|COMPLETED|Overall Study|Patients who completed the study|110
1118307|NCT01213173|2707663|P1|COMPLETED|Overall Study|Patients who completed the study|113
1118308|NCT01213173|2707662|P2|Patients Included in PP Population|Overall Study||89
1118309|NCT01213173|2707663|P1|Patients Included in PP Population|Overall Study||102
1118310|NCT01213173|2707662|P2|Patients Included in ITT Population|Overall Study||115
1118311|NCT01213173|2707663|P1|Patients Included in ITT Population|Overall Study||116
1118312|NCT01213173|2707662|P2|Patients Included in Safety Population|Overall Study||112
1118313|NCT01213173|2707663|P1|Patients Included in Safety Population|Overall Study||139
1118314|NCT01213173|2707662|P2|STARTED|Overall Study|Patients who were randomized and received treatment|126
1118315|NCT01213173|2707663|P1|STARTED|Overall Study|Patients who were randomized and received treatment|125
1118316|NCT01213199|2707693|P1|NOT COMPLETED|Overall Study||4
1118317|NCT01213199|2707693|P1|COMPLETED|Overall Study||16
1118318|NCT01213199|2707693|P1|STARTED|Overall Study||20
1118319|NCT01213251|2707700|P3|NOT COMPLETED|Overall Study||11
1118320|NCT01213251|2707701|P2|NOT COMPLETED|Overall Study||4
1118321|NCT01213251|2707702|P1|NOT COMPLETED|Overall Study||6
1118322|NCT01213251|2707700|P3|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
1118323|NCT01213251|2707701|P2|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|37
1118324|NCT01213251|2707702|P1|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
1118325|NCT01213251|2707700|P3|STARTED|Overall Study||45
1118326|NCT01213251|2707701|P2|STARTED|Overall Study||41
1118327|NCT01213251|2707702|P1|STARTED|Overall Study||40
1118328|NCT01213264|2707726|P3|NOT COMPLETED|Overall Study||6
1118329|NCT01213264|2707727|P2|NOT COMPLETED|Overall Study||2
1118330|NCT01213264|2707728|P1|NOT COMPLETED|Overall Study||2
1118331|NCT01213264|2707726|P3|COMPLETED|Overall Study||321
1118332|NCT01213264|2707727|P2|COMPLETED|Overall Study||175
1118333|NCT01213264|2707728|P1|COMPLETED|Overall Study||153
1118334|NCT01213264|2707726|P3|STARTED|Overall Study||327
1118335|NCT01213264|2707727|P2|STARTED|Overall Study||177
1118336|NCT01213264|2707728|P1|STARTED|Overall Study||155
1118337|NCT01213316|2707745|P1|NOT COMPLETED|Overall Study||0
1118338|NCT01213316|2707745|P1|COMPLETED|Overall Study||451
1118339|NCT01213316|2707745|P1|Initial Cohort|Overall Study|Participants >=18 years of age in the initial cohort|272
1118340|NCT01213316|2707745|P1|Discontinued Treatment Before 48 Weeks|Overall Study||67
1118341|NCT01213316|2707745|P1|Amendment Cohort: Newly Enrolled|Overall Study|Participants >=50 years of age newly enrolled|179
1118342|NCT01213316|2707745|P1|Amendment Cohort: Prolonged Participants|Overall Study|Participants >=50 years of age in the initial cohort who accept an additional 48-week observation|48
1118343|NCT01213316|2707745|P1|STARTED|Overall Study|Participants in the initial and amendment cohorts|451
1118356|NCT01221272|2707770|P2|NOT COMPLETED|Period 2||2
1118357|NCT01221272|2707771|P1|NOT COMPLETED|Period 2||0
1118358|NCT01221272|2707770|P2|COMPLETED|Period 2||37
1118359|NCT01221272|2707771|P1|COMPLETED|Period 2||39
1118360|NCT01221272|2707770|P2|STARTED|Period 2|1 participant did not complete Period 1, but started and completed Period 2.|39
1118361|NCT01221272|2707771|P1|STARTED|Period 2||39
1118362|NCT01221272|2707770|P2|NOT COMPLETED|Period 1||2
1118363|NCT01221272|2707771|P1|NOT COMPLETED|Period 1||2
1118364|NCT01221272|2707770|P2|COMPLETED|Period 1||38
1118365|NCT01221272|2707771|P1|COMPLETED|Period 1||39
1118366|NCT01221272|2707770|P2|STARTED|Period 1||40
1118367|NCT01221272|2707771|P1|STARTED|Period 1||41
1118368|NCT01221285|2707786|P1|NOT COMPLETED|Overall Study||1
1118369|NCT01221285|2707786|P1|COMPLETED|Overall Study||10
1118370|NCT01221285|2707786|P1|STARTED|Overall Study||11
1118371|NCT01221298|2707795|P1|NOT COMPLETED|Overall Study||0
1118372|NCT01221298|2707795|P1|COMPLETED|Overall Study|The number of participants who completed study drug|11
1118373|NCT01221298|2707795|P1|STARTED|Overall Study||11
1118374|NCT01221311|2707807|P2|NOT COMPLETED|Overall Study||0
1118375|NCT01221311|2707808|P1|NOT COMPLETED|Overall Study||0
1118376|NCT01221311|2707807|P2|COMPLETED|Overall Study||55
1118377|NCT01221311|2707808|P1|COMPLETED|Overall Study||57
1118378|NCT01221311|2707807|P2|STARTED|Overall Study||55
1118379|NCT01221311|2707808|P1|STARTED|Overall Study||57
1118380|NCT01221350|2707816|P2|NOT COMPLETED|Overall Study||3
1118381|NCT01221350|2707817|P1|NOT COMPLETED|Overall Study||5
1118382|NCT01221350|2707816|P2|COMPLETED|Overall Study||24
1118383|NCT01221350|2707817|P1|COMPLETED|Overall Study||23
1118384|NCT01221350|2707816|P2|Analysis Population|Overall Study||24
1118385|NCT01221350|2707817|P1|Analysis Population|Overall Study||23
1118386|NCT01221350|2707816|P2|Received Intervention|Overall Study||27
1118387|NCT01221350|2707817|P1|Received Intervention|Overall Study||28
1118388|NCT01221350|2707816|P2|STARTED|Overall Study||27
1118389|NCT01221350|2707817|P1|STARTED|Overall Study||28
1118390|NCT01221363|2707859|P2|NOT COMPLETED|Overall Study||5
1118391|NCT01221363|2707860|P1|NOT COMPLETED|Overall Study||12
1118392|NCT01221363|2707859|P2|COMPLETED|Overall Study||68
1118393|NCT01221363|2707860|P1|COMPLETED|Overall Study||81
1118394|NCT01221363|2707859|P2|STARTED|Overall Study||73
1118395|NCT01221363|2707860|P1|STARTED|Overall Study||93
1118396|NCT01221441|2707870|P2|NOT COMPLETED|Overall Study||12
1118397|NCT01221441|2707871|P1|NOT COMPLETED|Overall Study||22
1118398|NCT01221441|2707870|P2|COMPLETED|Overall Study||23
1118399|NCT01221441|2707871|P1|COMPLETED|Overall Study||45
1118400|NCT01221441|2707870|P2|STARTED|Overall Study||35
1118401|NCT01221441|2707871|P1|STARTED|Overall Study||67
1118402|NCT01221597|2707903|P2|NOT COMPLETED|Overall Study||16
1118403|NCT01221597|2707904|P1|NOT COMPLETED|Overall Study||36
1118404|NCT01221597|2707903|P2|COMPLETED|Overall Study||124
1118405|NCT01221597|2707904|P1|COMPLETED|Overall Study||241
1118406|NCT01221597|2707903|P2|STARTED|Overall Study||140
1118407|NCT01221597|2707904|P1|STARTED|Overall Study||277
1118408|NCT01221623|2707928|P2|NOT COMPLETED|Overall Study||14
1118409|NCT01221623|2707929|P1|NOT COMPLETED|Overall Study||38
1118410|NCT01221623|2707928|P2|COMPLETED|Overall Study||127
1118411|NCT01221623|2707929|P1|COMPLETED|Overall Study||236
1118412|NCT01221623|2707928|P2|STARTED|Overall Study||141
1118413|NCT01221623|2707929|P1|STARTED|Overall Study||274
1118414|NCT01221727|2707953|P2|NOT COMPLETED|Overall Study||1
1118415|NCT01221727|2707954|P1|NOT COMPLETED|Overall Study||3
1118416|NCT01221727|2707953|P2|COMPLETED|Overall Study||8
1118417|NCT01221727|2707954|P1|COMPLETED|Overall Study||18
1118418|NCT01221727|2707953|P2|Treated|Overall Study|Number of subjects received investigational product|8
1118419|NCT01221727|2707954|P1|Treated|Overall Study|Number of subjects received investigational product|19
1118420|NCT01221727|2707953|P2|STARTED|Overall Study|Number of subjects randomized into the study|9
1118421|NCT01221727|2707954|P1|STARTED|Overall Study|Number of subjects randomized into the study|21
1118422|NCT01221753|2707973|P1|NOT COMPLETED|Overall Study||1
1118423|NCT01221753|2707973|P1|COMPLETED|Overall Study||6
1118424|NCT01221753|2707973|P1|STARTED|Overall Study||7
1118425|NCT01221948|2707978|P1|NOT COMPLETED|Overall Study||14
1118426|NCT01221948|2707978|P1|COMPLETED|Overall Study||39
1118427|NCT01221948|2707978|P1|STARTED|Overall Study||53
1118428|NCT01222078|2707989|P1|NOT COMPLETED|Overall Study||1
1118429|NCT01222078|2707989|P1|COMPLETED|Overall Study||0
1118430|NCT01222078|2707989|P1|STARTED|Overall Study||1
1118431|NCT01222104|2708023|P1|NOT COMPLETED|Overall Study||47
1118432|NCT01222104|2708023|P1|COMPLETED|Overall Study||587
1118433|NCT01222104|2708023|P1|Completed 30-day Visit-No Angio-Seal|Overall Study||90
1118434|NCT01222104|2708023|P1|Completed 30-day Visit-Angio-Seal|Overall Study||497
1118435|NCT01222104|2708023|P1|Successful Deployment and Hemostasis|Overall Study||524
1118436|NCT01222104|2708023|P1|Successful Deployment|Overall Study||529
1118437|NCT01222104|2708023|P1|Angio-Seal Deployment Attempted|Overall Study||534
1118438|NCT01222104|2708023|P1|STARTED|Overall Study||634
1118439|NCT01222117|2708048|P11|NOT COMPLETED|Overall Study||0
1118440|NCT01222117|2708049|P10|NOT COMPLETED|Overall Study||2
1118441|NCT01222117|2708050|P9|NOT COMPLETED|Overall Study||3
1118442|NCT01222117|2708051|P8|NOT COMPLETED|Overall Study||0
1118443|NCT01222117|2708052|P7|NOT COMPLETED|Overall Study||0
1118444|NCT01222117|2708053|P6|NOT COMPLETED|Overall Study||1
1118445|NCT01222117|2708054|P5|NOT COMPLETED|Overall Study||1
1118446|NCT01222117|2708055|P4|NOT COMPLETED|Overall Study||1
1118447|NCT01222117|2708056|P3|NOT COMPLETED|Overall Study||0
1118448|NCT01222117|2708057|P2|NOT COMPLETED|Overall Study||1
1118449|NCT01222117|2708058|P1|NOT COMPLETED|Overall Study||3
1118450|NCT01222117|2708048|P11|COMPLETED|Overall Study||6
1118451|NCT01222117|2708049|P10|COMPLETED|Overall Study||17
1118452|NCT01222117|2708050|P9|COMPLETED|Overall Study||20
1118453|NCT01222117|2708051|P8|COMPLETED|Overall Study||12
1118454|NCT01222117|2708052|P7|COMPLETED|Overall Study||13
1118455|NCT01222117|2708053|P6|COMPLETED|Overall Study||9
1118456|NCT01222117|2708054|P5|COMPLETED|Overall Study||8
1118457|NCT01222117|2708055|P4|COMPLETED|Overall Study||19
1118458|NCT01222117|2708056|P3|COMPLETED|Overall Study||22
1118459|NCT01222117|2708057|P2|COMPLETED|Overall Study||19
1118460|NCT01222117|2708058|P1|COMPLETED|Overall Study||17
1118461|NCT01222117|2708048|P11|STARTED|Overall Study||6
1118462|NCT01222117|2708049|P10|STARTED|Overall Study||19
1118463|NCT01222117|2708050|P9|STARTED|Overall Study||23
1118464|NCT01222117|2708051|P8|STARTED|Overall Study||12
1118465|NCT01222117|2708052|P7|STARTED|Overall Study||13
1118466|NCT01222117|2708053|P6|STARTED|Overall Study||10
1118467|NCT01222117|2708054|P5|STARTED|Overall Study||9
1118468|NCT01222117|2708055|P4|STARTED|Overall Study||20
1118469|NCT01222117|2708056|P3|STARTED|Overall Study||22
1118470|NCT01222117|2708057|P2|STARTED|Overall Study||20
1118471|NCT01222117|2708058|P1|STARTED|Overall Study||20
1118472|NCT01222195|2708093|P1|NOT COMPLETED|Overall Study||0
1118473|NCT01222195|2708093|P1|COMPLETED|Overall Study||1
1118474|NCT01222195|2708093|P1|STARTED|Overall Study||1
1118475|NCT01222234|2708100|P3|NOT COMPLETED|Overall Study||2
1118476|NCT01222234|2708101|P2|NOT COMPLETED|Overall Study||2
1118477|NCT01222234|2708102|P1|NOT COMPLETED|Overall Study||0
1118478|NCT01222234|2708100|P3|COMPLETED|Overall Study||22
1118479|NCT01222234|2708101|P2|COMPLETED|Overall Study||15
1118480|NCT01222234|2708102|P1|COMPLETED|Overall Study||15
1118481|NCT01222234|2708100|P3|STARTED|Overall Study||24
1118482|NCT01222234|2708101|P2|STARTED|Overall Study||17
1118483|NCT01222234|2708102|P1|STARTED|Overall Study||15
1118484|NCT01222286|2708113|P2|NOT COMPLETED|Overall Study||0
1118485|NCT01222286|2708114|P1|NOT COMPLETED|Overall Study||0
1118486|NCT01222286|2708113|P2|COMPLETED|Overall Study||14
1118487|NCT01222286|2708114|P1|COMPLETED|Overall Study||16
1118488|NCT01222286|2708113|P2|STARTED|Overall Study||14
1118489|NCT01222286|2708114|P1|STARTED|Overall Study||16
1118490|NCT01222390|2708126|P1|NOT COMPLETED|Overall Study||0
1118491|NCT01222390|2708126|P1|COMPLETED|Overall Study||12
1118492|NCT01222390|2708126|P1|STARTED|Overall Study||12
1118493|NCT01222403|2708132|P2|NOT COMPLETED|Overall Study||2
1118494|NCT01222403|2708133|P1|NOT COMPLETED|Overall Study||0
1118495|NCT01222403|2708132|P2|COMPLETED|Overall Study||379
1118496|NCT01222403|2708133|P1|COMPLETED|Overall Study||386
1118497|NCT01222403|2708132|P2|STARTED|Overall Study||381
1118498|NCT01222403|2708133|P1|STARTED|Overall Study||386
1118499|NCT01222416|2708145|P2|NOT COMPLETED|Overall Study||0
1118500|NCT01222416|2708146|P1|NOT COMPLETED|Overall Study||20
1118501|NCT01222416|2708145|P2|COMPLETED|Overall Study||0
1118502|NCT01222416|2708146|P1|COMPLETED|Overall Study||30
1118503|NCT01222416|2708145|P2|STARTED|Overall Study||0
1118504|NCT01222416|2708146|P1|STARTED|Overall Study||50
1118505|NCT01222507|2708154|P1|NOT COMPLETED|Overall Study||2
1118506|NCT01222507|2708154|P1|COMPLETED|Overall Study||60
1118507|NCT01222507|2708154|P1|STARTED|Overall Study||62
1118508|NCT01222520|2708160|P2|NOT COMPLETED|Double-blind Period||2
1118509|NCT01222520|2708161|P1|NOT COMPLETED|Double-blind Period||1
1118510|NCT01222520|2708160|P2|COMPLETED|Double-blind Period||85
1118511|NCT01222520|2708161|P1|COMPLETED|Double-blind Period||86
1118512|NCT01222520|2708160|P2|STARTED|Double-blind Period||87
1118513|NCT01222520|2708161|P1|STARTED|Double-blind Period||87
1118514|NCT01222520|2708160|P2|NOT COMPLETED|Open-label run-in Period||23
1118515|NCT01222520|2708161|P1|NOT COMPLETED|Open-label run-in Period||0
1118516|NCT01222520|2708160|P2|COMPLETED|Open-label run-in Period||174
1118517|NCT01222520|2708161|P1|COMPLETED|Open-label run-in Period||0
1118518|NCT01222520|2708160|P2|STARTED|Open-label run-in Period||197
1118519|NCT01222520|2708161|P1|STARTED|Open-label run-in Period||0
1118520|NCT01222533|2708179|P1|NOT COMPLETED|Overall Study||14
1118521|NCT01222533|2708179|P1|COMPLETED|Overall Study|Completed planned observation time (week 21)|140
1118522|NCT01222533|2708179|P1|Received Tio HH18|Overall Study||146
1118523|NCT01222533|2708179|P1|Received Tio R5|Overall Study||150
1118524|NCT01222533|2708179|P1|Received Tio R2.5|Overall Study||145
1118525|NCT01222533|2708179|P1|Received Tio R1.25|Overall Study||147
1118526|NCT01222533|2708179|P1|Received Placebo|Overall Study||147
1118527|NCT01222533|2708179|P1|STARTED|Overall Study|Entered and treated.|154
1118528|NCT01222572|2708316|P3|NOT COMPLETED|Overall Study||0
1118529|NCT01222572|2708317|P2|NOT COMPLETED|Overall Study||0
1118530|NCT01222572|2708318|P1|NOT COMPLETED|Overall Study||0
1118531|NCT01222572|2708316|P3|COMPLETED|Overall Study||0
1118532|NCT01222572|2708317|P2|COMPLETED|Overall Study||0
1118533|NCT01222572|2708318|P1|COMPLETED|Overall Study||1
1118534|NCT01222572|2708316|P3|STARTED|Overall Study||0
1118535|NCT01222572|2708317|P2|STARTED|Overall Study||0
1118536|NCT01222572|2708318|P1|STARTED|Overall Study||1
1118537|NCT01222585|2708322|P1|NOT COMPLETED|Overall Study||0
1118538|NCT01222585|2708322|P1|COMPLETED|Overall Study||24
1118539|NCT01222585|2708322|P1|STARTED|Overall Study||24
1118540|NCT01222689|2708332|P1|NOT COMPLETED|Overall Study||0
1118541|NCT01222689|2708332|P1|COMPLETED|Overall Study||46
1118542|NCT01222689|2708332|P1|STARTED|Overall Study||46
1118543|NCT01222715|2708347|P2|NOT COMPLETED|Overall Study||27
1118544|NCT01222715|2708348|P1|NOT COMPLETED|Overall Study||36
1118545|NCT01222715|2708347|P2|COMPLETED|Overall Study||16
1118546|NCT01222715|2708348|P1|COMPLETED|Overall Study||8
1118547|NCT01222715|2708347|P2|STARTED|Overall Study||43
1118548|NCT01222715|2708348|P1|STARTED|Overall Study||44
1118549|NCT01222832|2708360|P2|NOT COMPLETED|Overall Study||1
1118550|NCT01222832|2708361|P1|NOT COMPLETED|Overall Study||0
1118551|NCT01222832|2708360|P2|COMPLETED|Overall Study||112
1118552|NCT01222832|2708361|P1|COMPLETED|Overall Study||113
1118553|NCT01222832|2708360|P2|STARTED|Overall Study||113
1118554|NCT01222832|2708361|P1|STARTED|Overall Study||113
1118555|NCT01222884|2708369|P2|NOT COMPLETED|Overall Study||4
1118556|NCT01222884|2708370|P1|NOT COMPLETED|Overall Study||24
1118557|NCT01222884|2708369|P2|COMPLETED|Overall Study||113
1118558|NCT01222884|2708370|P1|COMPLETED|Overall Study||210
1118559|NCT01222884|2708369|P2|STARTED|Overall Study||117
1118560|NCT01222884|2708370|P1|STARTED|Overall Study||234
1118561|NCT01223001|2708380|P2|NOT COMPLETED|Overall Study||4
1118562|NCT01223001|2708381|P1|NOT COMPLETED|Overall Study||4
1118563|NCT01223001|2708380|P2|COMPLETED|Overall Study||0
1118564|NCT01223001|2708381|P1|COMPLETED|Overall Study||0
1118565|NCT01223001|2708380|P2|STARTED|Overall Study||4
1118566|NCT01223001|2708381|P1|STARTED|Overall Study||4
1118567|NCT01223027|2708389|P2|NOT COMPLETED|Overall Study||277
1118568|NCT01223027|2708390|P1|NOT COMPLETED|Overall Study||274
1118569|NCT01223027|2708389|P2|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|9
1118570|NCT01223027|2708390|P1|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|10
1118571|NCT01223027|2708389|P2|STARTED|Overall Study||286
1118572|NCT01223027|2708390|P1|STARTED|Overall Study||284
1118573|NCT01223196|2708413|P2|NOT COMPLETED|Overall Study||0
1118574|NCT01223196|2708414|P1|NOT COMPLETED|Overall Study||4
1118575|NCT01223196|2708413|P2|COMPLETED|Overall Study||11
1118576|NCT01223196|2708414|P1|COMPLETED|Overall Study||9
1118577|NCT01223196|2708413|P2|STARTED|Overall Study||11
1118578|NCT01223196|2708414|P1|STARTED|Overall Study||13
1118585|NCT01223365|2708447|P1|NOT COMPLETED|Open-label Treatment Period||102
1118586|NCT01223365|2708447|P1|COMPLETED|Open-label Treatment Period||189
1118587|NCT01223365|2708447|P1|STARTED|Open-label Treatment Period||291
1118588|NCT01223365|2708447|P1|NOT COMPLETED|Open-label Titration Period||39
1118589|NCT01223365|2708447|P1|COMPLETED|Open-label Titration Period||291
1118590|NCT01223365|2708447|P1|Achieved Stable Pain Relief|Open-label Titration Period||294
1118591|NCT01223365|2708447|P1|Safety Analysis Set|Open-label Titration Period||329
1118592|NCT01223365|2708447|P1|STARTED|Open-label Titration Period||330
1118593|NCT01223469|2708490|P2|NOT COMPLETED|Overall Study||0
1118594|NCT01223469|2708491|P1|NOT COMPLETED|Overall Study||0
1118595|NCT01223469|2708490|P2|COMPLETED|Overall Study||43
1118596|NCT01223469|2708491|P1|COMPLETED|Overall Study||34
1118597|NCT01223469|2708490|P2|STARTED|Overall Study||43
1118598|NCT01223469|2708491|P1|STARTED|Overall Study||34
1118599|NCT01223703|2708499|P2|NOT COMPLETED|Overall Study||0
1118600|NCT01223703|2708500|P1|NOT COMPLETED|Overall Study||0
1118601|NCT01223703|2708499|P2|COMPLETED|Overall Study||66
1118602|NCT01223703|2708500|P1|COMPLETED|Overall Study||67
1118603|NCT01223703|2708499|P2|STARTED|Overall Study||66
1118604|NCT01223703|2708500|P1|STARTED|Overall Study||67
1118605|NCT01216163|2708515|P3|NOT COMPLETED|Overall Study||0
1118606|NCT01216163|2708516|P2|NOT COMPLETED|Overall Study||1
1118607|NCT01216163|2708517|P1|NOT COMPLETED|Overall Study||1
1118608|NCT01216163|2708515|P3|COMPLETED|Overall Study||85
1118609|NCT01216163|2708516|P2|COMPLETED|Overall Study||87
1118610|NCT01216163|2708517|P1|COMPLETED|Overall Study||44
1118611|NCT01216163|2708515|P3|STARTED|Overall Study||85
1118612|NCT01216163|2708516|P2|STARTED|Overall Study||88
1118613|NCT01216163|2708517|P1|STARTED|Overall Study||45
1118614|NCT01216241|2708569|P2|NOT COMPLETED|Overall Study||0
1118615|NCT01216241|2708570|P1|NOT COMPLETED|Overall Study||0
1118616|NCT01216241|2708569|P2|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
1118617|NCT01216241|2708570|P1|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
1118618|NCT01216241|2708569|P2|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
1118619|NCT01216241|2708570|P1|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
1118620|NCT01216319|2708576|P1|NOT COMPLETED|Overall Study||4
1118621|NCT01216319|2708576|P1|COMPLETED|Overall Study||46
1118622|NCT01216319|2708576|P1|STARTED|Overall Study||50
1118623|NCT01216397|2708581|P2|NOT COMPLETED|Period 2||0
1118624|NCT01216397|2708582|P1|NOT COMPLETED|Period 2||0
1118625|NCT01216397|2708581|P2|COMPLETED|Period 2||20
1118626|NCT01216397|2708582|P1|COMPLETED|Period 2||20
1118627|NCT01216397|2708581|P2|STARTED|Period 2||20
1118628|NCT01216397|2708582|P1|STARTED|Period 2||20
1118629|NCT01216397|2708581|P2|NOT COMPLETED|Washout (35 Days)||0
1118630|NCT01216397|2708582|P1|NOT COMPLETED|Washout (35 Days)||0
1118631|NCT01216397|2708581|P2|COMPLETED|Washout (35 Days)||20
1118632|NCT01216397|2708582|P1|COMPLETED|Washout (35 Days)||20
1118633|NCT01216397|2708581|P2|STARTED|Washout (35 Days)||20
1118634|NCT01216397|2708582|P1|STARTED|Washout (35 Days)||20
1118635|NCT01216397|2708581|P2|NOT COMPLETED|Period 1||0
1118636|NCT01216397|2708582|P1|NOT COMPLETED|Period 1||0
1118637|NCT01216397|2708581|P2|COMPLETED|Period 1||20
1118638|NCT01216397|2708582|P1|COMPLETED|Period 1||20
1118639|NCT01216397|2708581|P2|STARTED|Period 1||20
1118640|NCT01216397|2708582|P1|STARTED|Period 1||20
1118641|NCT01216410|2708637|P3|NOT COMPLETED|Overall Study||3
1118642|NCT01216410|2708638|P2|NOT COMPLETED|Overall Study||1
1118643|NCT01216410|2708639|P1|NOT COMPLETED|Overall Study||2
1118644|NCT01216410|2708637|P3|COMPLETED|Overall Study||100
1118645|NCT01216410|2708638|P2|COMPLETED|Overall Study||99
1118646|NCT01216410|2708639|P1|COMPLETED|Overall Study||101
1118647|NCT01216410|2708637|P3|STARTED|Overall Study||103
1118648|NCT01216410|2708638|P2|STARTED|Overall Study||100
1118649|NCT01216410|2708639|P1|STARTED|Overall Study||103
1118650|NCT01216631|2708662|P3|NOT COMPLETED|Overall Study||0
1118651|NCT01216631|2708663|P2|NOT COMPLETED|Overall Study||0
1118652|NCT01216631|2708664|P1|NOT COMPLETED|Overall Study||0
1118653|NCT01216631|2708662|P3|COMPLETED|Overall Study||1
1118654|NCT01216631|2708663|P2|COMPLETED|Overall Study||0
1118655|NCT01216631|2708664|P1|COMPLETED|Overall Study||0
1118656|NCT01216631|2708662|P3|STARTED|Overall Study||1
1118657|NCT01216631|2708663|P2|STARTED|Overall Study||0
1118658|NCT01216631|2708664|P1|STARTED|Overall Study||0
1118659|NCT01216735|2708674|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
1118660|NCT01216735|2708675|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
1118661|NCT01216735|2708674|P2|COMPLETED|Second Intervention (3 Weeks)||7
1118662|NCT01216735|2708675|P1|COMPLETED|Second Intervention (3 Weeks)||8
1118663|NCT01216735|2708674|P2|STARTED|Second Intervention (3 Weeks)||7
1118664|NCT01216735|2708675|P1|STARTED|Second Intervention (3 Weeks)||8
1118665|NCT01216735|2708674|P2|NOT COMPLETED|Washout (3 Weeks)||0
1118666|NCT01216735|2708675|P1|NOT COMPLETED|Washout (3 Weeks)||0
1118667|NCT01216735|2708674|P2|COMPLETED|Washout (3 Weeks)||7
1118668|NCT01216735|2708675|P1|COMPLETED|Washout (3 Weeks)||8
1118669|NCT01216735|2708674|P2|STARTED|Washout (3 Weeks)||7
1118670|NCT01216735|2708675|P1|STARTED|Washout (3 Weeks)||8
1118671|NCT01216735|2708674|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
1118672|NCT01216735|2708675|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
1118673|NCT01216735|2708674|P2|COMPLETED|First Intervention (3 Weeks)||7
1118674|NCT01216735|2708675|P1|COMPLETED|First Intervention (3 Weeks)||8
1118675|NCT01216735|2708674|P2|STARTED|First Intervention (3 Weeks)||7
1118676|NCT01216735|2708675|P1|STARTED|First Intervention (3 Weeks)||8
1118677|NCT01216748|2708683|P1|NOT COMPLETED|Overall Study||0
1118678|NCT01216748|2708683|P1|COMPLETED|Overall Study||10
1118679|NCT01216748|2708683|P1|Eucapnic Hyperventilation|Overall Study||10
1118680|NCT01216748|2708683|P1|Hypercapnic Hyperventilation|Overall Study||10
1118681|NCT01216748|2708683|P1|Hypocapnic Hyperventilation|Overall Study||10
1118682|NCT01216748|2708683|P1|Quiet Breathing|Overall Study||10
1118683|NCT01216748|2708683|P1|STARTED|Overall Study||10
1118684|NCT01216761|2708688|P3|NOT COMPLETED|Overall Study||0
1118685|NCT01216761|2708689|P2|NOT COMPLETED|Overall Study||0
1118686|NCT01216761|2708690|P1|NOT COMPLETED|Overall Study||0
1118687|NCT01216761|2708688|P3|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
1118688|NCT01216761|2708689|P2|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
1118689|NCT01216761|2708690|P1|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
1118690|NCT01216761|2708688|P3|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
1118691|NCT01216761|2708689|P2|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
1118692|NCT01216761|2708690|P1|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
1118693|NCT01223937|2708700|P2|NOT COMPLETED|Overall Study||18
1118694|NCT01223937|2708701|P1|NOT COMPLETED|Overall Study||17
1118695|NCT01223937|2708700|P2|COMPLETED|Overall Study||119
1118696|NCT01223937|2708701|P1|COMPLETED|Overall Study||114
1118697|NCT01223937|2708700|P2|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|135
1118698|NCT01223937|2708701|P1|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|126
1118699|NCT01223937|2708700|P2|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|133
1118700|NCT01223937|2708701|P1|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|128
1118701|NCT01223937|2708700|P2|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|137
1118702|NCT01223937|2708701|P1|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|131
1118703|NCT01224015|2708726|P3|NOT COMPLETED|Overall Study||13
1118704|NCT01224015|2708727|P2|NOT COMPLETED|Overall Study||16
1118705|NCT01224015|2708728|P1|NOT COMPLETED|Overall Study||14
1118706|NCT01224015|2708726|P3|COMPLETED|Overall Study||83
1118707|NCT01224015|2708727|P2|COMPLETED|Overall Study||211
1118708|NCT01224015|2708728|P1|COMPLETED|Overall Study||347
1118709|NCT01224015|2708726|P3|STARTED|Overall Study||96
1118710|NCT01224015|2708727|P2|STARTED|Overall Study||227
1118711|NCT01224015|2708728|P1|STARTED|Overall Study||361
1118712|NCT01224626|2708736|P1|NOT COMPLETED|Overall Study||1
1118713|NCT01224626|2708736|P1|COMPLETED|Overall Study||41
1118714|NCT01224626|2708736|P1|STARTED|Overall Study||42
1118715|NCT01224639|2708750|P8|NOT COMPLETED|Overall Study||2
1118716|NCT01224639|2708751|P7|NOT COMPLETED|Overall Study||1
1118717|NCT01224639|2708752|P6|NOT COMPLETED|Overall Study||0
1118718|NCT01224639|2708753|P5|NOT COMPLETED|Overall Study||2
1118719|NCT01224639|2708754|P4|NOT COMPLETED|Overall Study||0
1118720|NCT01224639|2708755|P3|NOT COMPLETED|Overall Study||0
1118721|NCT01224639|2708756|P2|NOT COMPLETED|Overall Study||0
1118722|NCT01224639|2708757|P1|NOT COMPLETED|Overall Study||0
1118723|NCT01224639|2708750|P8|COMPLETED|Overall Study||3
1118724|NCT01224639|2708751|P7|COMPLETED|Overall Study||17
1118725|NCT01224639|2708752|P6|COMPLETED|Overall Study||4
1118726|NCT01224639|2708753|P5|COMPLETED|Overall Study||19
1118727|NCT01224639|2708754|P4|COMPLETED|Overall Study||3
1118728|NCT01224639|2708755|P3|COMPLETED|Overall Study||21
1118729|NCT01224639|2708756|P2|COMPLETED|Overall Study||5
1118730|NCT01224639|2708757|P1|COMPLETED|Overall Study||19
1118731|NCT01224639|2708750|P8|STARTED|Overall Study||5
1118732|NCT01224639|2708751|P7|STARTED|Overall Study||18
1118733|NCT01224639|2708752|P6|STARTED|Overall Study||4
1118734|NCT01224639|2708753|P5|STARTED|Overall Study||21
1118735|NCT01224639|2708754|P4|STARTED|Overall Study||3
1118736|NCT01224639|2708755|P3|STARTED|Overall Study||21
1118737|NCT01224639|2708756|P2|STARTED|Overall Study||5
1118738|NCT01224639|2708757|P1|STARTED|Overall Study||19
1118739|NCT01224782|2708863|P1|NOT COMPLETED|Overall Study||264
1118740|NCT01224782|2708863|P1|COMPLETED|Overall Study||730
1118741|NCT01224782|2708863|P1|STARTED|Overall Study||994
1118742|NCT01224821|2708872|P1|NOT COMPLETED|Long-Term Follow-Up||11
1118743|NCT01224821|2708872|P1|COMPLETED|Long-Term Follow-Up||0
1118744|NCT01224821|2708872|P1|STARTED|Long-Term Follow-Up|11/47 participants withdrawing from this study enrolled in the LTFU study for continued evaluation.|11
1118745|NCT01224821|2708872|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||46
1118746|NCT01224821|2708872|P1|COMPLETED|Dosimetric and Therapeutic Treatment|This participant completed the study per Protocol Amendment 2.|1
1118747|NCT01224821|2708872|P1|STARTED|Dosimetric and Therapeutic Treatment||47
1118748|NCT01225029|2708893|P2|NOT COMPLETED|Overall Study||0
1118749|NCT01225029|2708894|P1|NOT COMPLETED|Overall Study||0
1118750|NCT01225029|2708893|P2|COMPLETED|Overall Study||32
1118751|NCT01225029|2708894|P1|COMPLETED|Overall Study||32
1118752|NCT01225029|2708893|P2|STARTED|Overall Study||32
1118753|NCT01225029|2708894|P1|STARTED|Overall Study||32
1118754|NCT01225055|2708907|P3|NOT COMPLETED|Overall Study||3
1118755|NCT01225055|2708908|P2|NOT COMPLETED|Overall Study||2
1118756|NCT01225055|2708909|P1|NOT COMPLETED|Overall Study||0
1118757|NCT01225055|2708907|P3|COMPLETED|Overall Study||18
1118758|NCT01225055|2708908|P2|COMPLETED|Overall Study||18
1118759|NCT01225055|2708909|P1|COMPLETED|Overall Study||20
1118760|NCT01225055|2708907|P3|STARTED|Overall Study||21
1118761|NCT01225055|2708908|P2|STARTED|Overall Study||20
1118762|NCT01225055|2708909|P1|STARTED|Overall Study||20
1118763|NCT01225068|2708934|P2|NOT COMPLETED|Overall Study||1
1118764|NCT01225068|2708935|P1|NOT COMPLETED|Overall Study||4
1118765|NCT01225068|2708934|P2|COMPLETED|Overall Study||19
1118766|NCT01225068|2708935|P1|COMPLETED|Overall Study||16
1118767|NCT01225068|2708934|P2|STARTED|Overall Study||20
1118768|NCT01225068|2708935|P1|STARTED|Overall Study||20
1118769|NCT01225146|2708943|P2|NOT COMPLETED|Overall Study||2
1118770|NCT01225146|2708944|P1|NOT COMPLETED|Overall Study||0
1118771|NCT01225146|2708943|P2|COMPLETED|Overall Study||0
1118772|NCT01225146|2708944|P1|COMPLETED|Overall Study||6
1118773|NCT01225146|2708943|P2|STARTED|Overall Study||2
1118774|NCT01225146|2708944|P1|STARTED|Overall Study||6
1118775|NCT01225159|2708962|P2|NOT COMPLETED|Overall Study||0
1118776|NCT01225159|2708963|P1|NOT COMPLETED|Overall Study||1
1118777|NCT01225159|2708962|P2|COMPLETED|Overall Study||100
1118778|NCT01225159|2708963|P1|COMPLETED|Overall Study||99
1118779|NCT01225159|2708962|P2|STARTED|Overall Study||100
1118780|NCT01225159|2708963|P1|STARTED|Overall Study||100
1118781|NCT01225211|2708981|P10|NOT COMPLETED|Overall Study||5
1118782|NCT01225211|2708982|P9|NOT COMPLETED|Overall Study||1
1118783|NCT01225211|2708983|P8|NOT COMPLETED|Overall Study||0
1118784|NCT01225211|2708984|P7|NOT COMPLETED|Overall Study||1
1118785|NCT01225211|2708985|P6|NOT COMPLETED|Overall Study||0
1118786|NCT01225211|2708986|P5|NOT COMPLETED|Overall Study||0
1118787|NCT01225211|2708987|P4|NOT COMPLETED|Overall Study||0
1118788|NCT01225211|2708988|P3|NOT COMPLETED|Overall Study||1
1118789|NCT01225211|2708989|P2|NOT COMPLETED|Overall Study||0
1118790|NCT01225211|2708990|P1|NOT COMPLETED|Overall Study||0
1118791|NCT01225211|2708981|P10|COMPLETED|Overall Study||57
1118792|NCT01225211|2708982|P9|COMPLETED|Overall Study||62
1118793|NCT01225211|2708983|P8|COMPLETED|Overall Study||11
1118794|NCT01225211|2708984|P7|COMPLETED|Overall Study||41
1118795|NCT01225211|2708985|P6|COMPLETED|Overall Study||21
1118796|NCT01225211|2708986|P5|COMPLETED|Overall Study||23
1118797|NCT01225211|2708987|P4|COMPLETED|Overall Study||27
1118798|NCT01225211|2708988|P3|COMPLETED|Overall Study||20
1118799|NCT01225211|2708989|P2|COMPLETED|Overall Study||20
1118800|NCT01225211|2708990|P1|COMPLETED|Overall Study||21
1118801|NCT01225211|2708981|P10|STARTED|Overall Study||62
1118802|NCT01225211|2708982|P9|STARTED|Overall Study||63
1118803|NCT01225211|2708983|P8|STARTED|Overall Study||11
1118804|NCT01225211|2708984|P7|STARTED|Overall Study||42
1118805|NCT01225211|2708985|P6|STARTED|Overall Study||21
1118806|NCT01225211|2708986|P5|STARTED|Overall Study||23
1118807|NCT01225211|2708987|P4|STARTED|Overall Study||27
1118808|NCT01225211|2708988|P3|STARTED|Overall Study||21
1118809|NCT01225211|2708989|P2|STARTED|Overall Study||20
1118810|NCT01225211|2708990|P1|STARTED|Overall Study||21
1118811|NCT01225263|2709093|P2|NOT COMPLETED|Weeks 13 to 24||1
1118812|NCT01225263|2709094|P1|NOT COMPLETED|Weeks 13 to 24||4
1118813|NCT01225263|2709093|P2|COMPLETED|Weeks 13 to 24||28
1118814|NCT01225263|2709094|P1|COMPLETED|Weeks 13 to 24||24
1118815|NCT01225263|2709093|P2|STARTED|Weeks 13 to 24||29
1118816|NCT01225263|2709094|P1|STARTED|Weeks 13 to 24||28
1118817|NCT01225263|2709093|P2|NOT COMPLETED|Weeks 1 to 12||0
1118818|NCT01225263|2709094|P1|NOT COMPLETED|Weeks 1 to 12||0
1118819|NCT01225263|2709093|P2|COMPLETED|Weeks 1 to 12||29
1118820|NCT01225263|2709094|P1|COMPLETED|Weeks 1 to 12||28
1118821|NCT01225263|2709093|P2|STARTED|Weeks 1 to 12||29
1118822|NCT01225263|2709094|P1|STARTED|Weeks 1 to 12||28
1118823|NCT01225289|2709104|P2|NOT COMPLETED|Overall Study||1
1118824|NCT01225289|2709105|P1|NOT COMPLETED|Overall Study||0
1118825|NCT01225289|2709104|P2|COMPLETED|Overall Study||17
1118826|NCT01225289|2709105|P1|COMPLETED|Overall Study||18
1118827|NCT01225289|2709104|P2|STARTED|Overall Study||18
1118828|NCT01225289|2709105|P1|STARTED|Overall Study||18
1118829|NCT01225354|2709117|P1|NOT COMPLETED|Overall Study||1
1118830|NCT01225354|2709117|P1|COMPLETED|Overall Study||19
1118831|NCT01225354|2709117|P1|STARTED|Overall Study||20
1118832|NCT01225549|2709122|P10|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
1118833|NCT01225549|2709123|P9|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
1118834|NCT01225549|2709124|P8|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
1118835|NCT01225549|2709125|P7|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
1118836|NCT01225549|2709126|P6|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
1118837|NCT01225549|2709127|P5|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
1118838|NCT01225549|2709128|P4|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
1118839|NCT01225549|2709129|P3|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
1118840|NCT01225549|2709130|P2|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
1118841|NCT01225549|2709131|P1|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
1118842|NCT01225549|2709122|P10|COMPLETED|Period 7 - Fourth Treatment Period||1
1118843|NCT01225549|2709123|P9|COMPLETED|Period 7 - Fourth Treatment Period||4
1118844|NCT01225549|2709124|P8|COMPLETED|Period 7 - Fourth Treatment Period||1
1118845|NCT01225549|2709125|P7|COMPLETED|Period 7 - Fourth Treatment Period||3
1118846|NCT01225549|2709126|P6|COMPLETED|Period 7 - Fourth Treatment Period||1
1118847|NCT01225549|2709127|P5|COMPLETED|Period 7 - Fourth Treatment Period||1
1118848|NCT01225549|2709128|P4|COMPLETED|Period 7 - Fourth Treatment Period||0
1118849|NCT01225549|2709129|P3|COMPLETED|Period 7 - Fourth Treatment Period||3
1118850|NCT01225549|2709130|P2|COMPLETED|Period 7 - Fourth Treatment Period||3
1118851|NCT01225549|2709131|P1|COMPLETED|Period 7 - Fourth Treatment Period||1
1118852|NCT01225549|2709122|P10|STARTED|Period 7 - Fourth Treatment Period||1
1118853|NCT01225549|2709123|P9|STARTED|Period 7 - Fourth Treatment Period||4
1118854|NCT01225549|2709124|P8|STARTED|Period 7 - Fourth Treatment Period||1
1118855|NCT01225549|2709125|P7|STARTED|Period 7 - Fourth Treatment Period||3
1118856|NCT01225549|2709126|P6|STARTED|Period 7 - Fourth Treatment Period||1
1118857|NCT01225549|2709127|P5|STARTED|Period 7 - Fourth Treatment Period||1
1118858|NCT01225549|2709128|P4|STARTED|Period 7 - Fourth Treatment Period||0
1118859|NCT01225549|2709129|P3|STARTED|Period 7 - Fourth Treatment Period||3
1118860|NCT01225549|2709130|P2|STARTED|Period 7 - Fourth Treatment Period||3
1118861|NCT01225549|2709131|P1|STARTED|Period 7 - Fourth Treatment Period||1
1118862|NCT01225549|2709122|P10|NOT COMPLETED|Period 6 - Washout||0
1118863|NCT01225549|2709123|P9|NOT COMPLETED|Period 6 - Washout||0
1118864|NCT01225549|2709124|P8|NOT COMPLETED|Period 6 - Washout||0
1118865|NCT01225549|2709125|P7|NOT COMPLETED|Period 6 - Washout||0
1118866|NCT01225549|2709126|P6|NOT COMPLETED|Period 6 - Washout||0
1118867|NCT01225549|2709127|P5|NOT COMPLETED|Period 6 - Washout||0
1118868|NCT01225549|2709128|P4|NOT COMPLETED|Period 6 - Washout||1
1118869|NCT01225549|2709129|P3|NOT COMPLETED|Period 6 - Washout||0
1118870|NCT01225549|2709130|P2|NOT COMPLETED|Period 6 - Washout||0
1118871|NCT01225549|2709131|P1|NOT COMPLETED|Period 6 - Washout||0
1118872|NCT01225549|2709122|P10|COMPLETED|Period 6 - Washout||1
1118873|NCT01225549|2709123|P9|COMPLETED|Period 6 - Washout||4
1118874|NCT01225549|2709124|P8|COMPLETED|Period 6 - Washout||1
1118875|NCT01225549|2709125|P7|COMPLETED|Period 6 - Washout||3
1118876|NCT01225549|2709126|P6|COMPLETED|Period 6 - Washout||1
1118877|NCT01225549|2709127|P5|COMPLETED|Period 6 - Washout||1
1118878|NCT01225549|2709128|P4|COMPLETED|Period 6 - Washout||0
1118879|NCT01225549|2709129|P3|COMPLETED|Period 6 - Washout||3
1118880|NCT01225549|2709130|P2|COMPLETED|Period 6 - Washout||3
1118881|NCT01225549|2709131|P1|COMPLETED|Period 6 - Washout||1
1118882|NCT01225549|2709122|P10|STARTED|Period 6 - Washout||1
1118883|NCT01225549|2709123|P9|STARTED|Period 6 - Washout||4
1118884|NCT01225549|2709124|P8|STARTED|Period 6 - Washout||1
1118885|NCT01225549|2709125|P7|STARTED|Period 6 - Washout||3
1118886|NCT01225549|2709126|P6|STARTED|Period 6 - Washout||1
1118887|NCT01225549|2709127|P5|STARTED|Period 6 - Washout||1
1118888|NCT01225549|2709128|P4|STARTED|Period 6 - Washout||1
1118889|NCT01225549|2709129|P3|STARTED|Period 6 - Washout||3
1118890|NCT01225549|2709130|P2|STARTED|Period 6 - Washout||3
1118891|NCT01225549|2709131|P1|STARTED|Period 6 - Washout||1
1118892|NCT01225549|2709122|P10|NOT COMPLETED|Period 5 - Third Treatment Period||0
1118893|NCT01225549|2709123|P9|NOT COMPLETED|Period 5 - Third Treatment Period||0
1118894|NCT01225549|2709124|P8|NOT COMPLETED|Period 5 - Third Treatment Period||0
1118895|NCT01225549|2709125|P7|NOT COMPLETED|Period 5 - Third Treatment Period||0
1118896|NCT01225549|2709126|P6|NOT COMPLETED|Period 5 - Third Treatment Period||0
1118897|NCT01225549|2709127|P5|NOT COMPLETED|Period 5 - Third Treatment Period||0
1118898|NCT01225549|2709128|P4|NOT COMPLETED|Period 5 - Third Treatment Period||0
1118899|NCT01225549|2709129|P3|NOT COMPLETED|Period 5 - Third Treatment Period||0
1118900|NCT01225549|2709130|P2|NOT COMPLETED|Period 5 - Third Treatment Period||0
1118901|NCT01225549|2709131|P1|NOT COMPLETED|Period 5 - Third Treatment Period||0
1118902|NCT01225549|2709122|P10|COMPLETED|Period 5 - Third Treatment Period||1
1118903|NCT01225549|2709123|P9|COMPLETED|Period 5 - Third Treatment Period||4
1118904|NCT01225549|2709124|P8|COMPLETED|Period 5 - Third Treatment Period||1
1118905|NCT01225549|2709125|P7|COMPLETED|Period 5 - Third Treatment Period||3
1118906|NCT01225549|2709126|P6|COMPLETED|Period 5 - Third Treatment Period||1
1118907|NCT01225549|2709127|P5|COMPLETED|Period 5 - Third Treatment Period||1
1118908|NCT01225549|2709128|P4|COMPLETED|Period 5 - Third Treatment Period||1
1118909|NCT01225549|2709129|P3|COMPLETED|Period 5 - Third Treatment Period||3
1118910|NCT01225549|2709130|P2|COMPLETED|Period 5 - Third Treatment Period||3
1118911|NCT01225549|2709131|P1|COMPLETED|Period 5 - Third Treatment Period||1
1118912|NCT01225549|2709122|P10|STARTED|Period 5 - Third Treatment Period||1
1118913|NCT01225549|2709123|P9|STARTED|Period 5 - Third Treatment Period||4
1118914|NCT01225549|2709124|P8|STARTED|Period 5 - Third Treatment Period||1
1118915|NCT01225549|2709125|P7|STARTED|Period 5 - Third Treatment Period||3
1118916|NCT01225549|2709126|P6|STARTED|Period 5 - Third Treatment Period||1
1118917|NCT01225549|2709127|P5|STARTED|Period 5 - Third Treatment Period||1
1118918|NCT01225549|2709128|P4|STARTED|Period 5 - Third Treatment Period||1
1118919|NCT01225549|2709129|P3|STARTED|Period 5 - Third Treatment Period||3
1118920|NCT01225549|2709130|P2|STARTED|Period 5 - Third Treatment Period||3
1118921|NCT01225549|2709131|P1|STARTED|Period 5 - Third Treatment Period||1
1118922|NCT01225549|2709122|P10|NOT COMPLETED|Period 4 - Washout||0
1118923|NCT01225549|2709123|P9|NOT COMPLETED|Period 4 - Washout||0
1118924|NCT01225549|2709124|P8|NOT COMPLETED|Period 4 - Washout||0
1118925|NCT01225549|2709125|P7|NOT COMPLETED|Period 4 - Washout||0
1118926|NCT01225549|2709126|P6|NOT COMPLETED|Period 4 - Washout||0
1118927|NCT01225549|2709127|P5|NOT COMPLETED|Period 4 - Washout||0
1118928|NCT01225549|2709128|P4|NOT COMPLETED|Period 4 - Washout||0
1118929|NCT01225549|2709129|P3|NOT COMPLETED|Period 4 - Washout||0
1118930|NCT01225549|2709130|P2|NOT COMPLETED|Period 4 - Washout||1
1118931|NCT01225549|2709131|P1|NOT COMPLETED|Period 4 - Washout||0
1118932|NCT01225549|2709122|P10|COMPLETED|Period 4 - Washout||1
1118933|NCT01225549|2709123|P9|COMPLETED|Period 4 - Washout||4
1118934|NCT01225549|2709124|P8|COMPLETED|Period 4 - Washout||1
1118935|NCT01225549|2709125|P7|COMPLETED|Period 4 - Washout||3
1118936|NCT01225549|2709126|P6|COMPLETED|Period 4 - Washout||1
1118937|NCT01225549|2709127|P5|COMPLETED|Period 4 - Washout||1
1118938|NCT01225549|2709128|P4|COMPLETED|Period 4 - Washout||1
1118939|NCT01225549|2709129|P3|COMPLETED|Period 4 - Washout||3
1118940|NCT01225549|2709130|P2|COMPLETED|Period 4 - Washout||3
1118941|NCT01225549|2709131|P1|COMPLETED|Period 4 - Washout||1
1118942|NCT01225549|2709122|P10|STARTED|Period 4 - Washout||1
1118943|NCT01225549|2709123|P9|STARTED|Period 4 - Washout||4
1118944|NCT01225549|2709124|P8|STARTED|Period 4 - Washout||1
1118945|NCT01225549|2709125|P7|STARTED|Period 4 - Washout||3
1118946|NCT01225549|2709126|P6|STARTED|Period 4 - Washout||1
1118947|NCT01225549|2709127|P5|STARTED|Period 4 - Washout||1
1118948|NCT01225549|2709128|P4|STARTED|Period 4 - Washout||1
1118949|NCT01225549|2709129|P3|STARTED|Period 4 - Washout||3
1118950|NCT01225549|2709130|P2|STARTED|Period 4 - Washout||4
1118951|NCT01225549|2709131|P1|STARTED|Period 4 - Washout||1
1118952|NCT01225549|2709122|P10|NOT COMPLETED|Period 3 - Second Treatment Period||0
1118953|NCT01225549|2709123|P9|NOT COMPLETED|Period 3 - Second Treatment Period||0
1118954|NCT01225549|2709124|P8|NOT COMPLETED|Period 3 - Second Treatment Period||0
1118955|NCT01225549|2709125|P7|NOT COMPLETED|Period 3 - Second Treatment Period||0
1118956|NCT01225549|2709126|P6|NOT COMPLETED|Period 3 - Second Treatment Period||0
1118957|NCT01225549|2709127|P5|NOT COMPLETED|Period 3 - Second Treatment Period||0
1118958|NCT01225549|2709128|P4|NOT COMPLETED|Period 3 - Second Treatment Period||0
1118959|NCT01225549|2709129|P3|NOT COMPLETED|Period 3 - Second Treatment Period||0
1118960|NCT01225549|2709130|P2|NOT COMPLETED|Period 3 - Second Treatment Period||0
1118961|NCT01225549|2709131|P1|NOT COMPLETED|Period 3 - Second Treatment Period||0
1118962|NCT01225549|2709122|P10|COMPLETED|Period 3 - Second Treatment Period||1
1118963|NCT01225549|2709123|P9|COMPLETED|Period 3 - Second Treatment Period||4
1118964|NCT01225549|2709124|P8|COMPLETED|Period 3 - Second Treatment Period||1
1118965|NCT01225549|2709125|P7|COMPLETED|Period 3 - Second Treatment Period||3
1118966|NCT01225549|2709126|P6|COMPLETED|Period 3 - Second Treatment Period||1
1118967|NCT01225549|2709127|P5|COMPLETED|Period 3 - Second Treatment Period||1
1118968|NCT01225549|2709128|P4|COMPLETED|Period 3 - Second Treatment Period||1
1118969|NCT01225549|2709129|P3|COMPLETED|Period 3 - Second Treatment Period||3
1118970|NCT01225549|2709130|P2|COMPLETED|Period 3 - Second Treatment Period||4
1118971|NCT01225549|2709131|P1|COMPLETED|Period 3 - Second Treatment Period||1
1118972|NCT01225549|2709122|P10|STARTED|Period 3 - Second Treatment Period||1
1118973|NCT01225549|2709123|P9|STARTED|Period 3 - Second Treatment Period||4
1118974|NCT01225549|2709124|P8|STARTED|Period 3 - Second Treatment Period||1
1118975|NCT01225549|2709125|P7|STARTED|Period 3 - Second Treatment Period||3
1118976|NCT01225549|2709126|P6|STARTED|Period 3 - Second Treatment Period||1
1118977|NCT01225549|2709127|P5|STARTED|Period 3 - Second Treatment Period||1
1118978|NCT01225549|2709128|P4|STARTED|Period 3 - Second Treatment Period||1
1118979|NCT01225549|2709129|P3|STARTED|Period 3 - Second Treatment Period||3
1118980|NCT01225549|2709130|P2|STARTED|Period 3 - Second Treatment Period||4
1118981|NCT01225549|2709131|P1|STARTED|Period 3 - Second Treatment Period||1
1118982|NCT01225549|2709122|P10|NOT COMPLETED|Period 2 - Washout||0
1118983|NCT01225549|2709123|P9|NOT COMPLETED|Period 2 - Washout||0
1118984|NCT01225549|2709124|P8|NOT COMPLETED|Period 2 - Washout||0
1118985|NCT01225549|2709125|P7|NOT COMPLETED|Period 2 - Washout||0
1118986|NCT01225549|2709126|P6|NOT COMPLETED|Period 2 - Washout||0
1118987|NCT01225549|2709127|P5|NOT COMPLETED|Period 2 - Washout||0
1118988|NCT01225549|2709128|P4|NOT COMPLETED|Period 2 - Washout||0
1118989|NCT01225549|2709129|P3|NOT COMPLETED|Period 2 - Washout||0
1118990|NCT01225549|2709130|P2|NOT COMPLETED|Period 2 - Washout||0
1118991|NCT01225549|2709131|P1|NOT COMPLETED|Period 2 - Washout||0
1118992|NCT01225549|2709122|P10|COMPLETED|Period 2 - Washout||1
1118993|NCT01225549|2709123|P9|COMPLETED|Period 2 - Washout||4
1118994|NCT01225549|2709124|P8|COMPLETED|Period 2 - Washout||1
1118995|NCT01225549|2709125|P7|COMPLETED|Period 2 - Washout||3
1118996|NCT01225549|2709126|P6|COMPLETED|Period 2 - Washout||1
1118997|NCT01225549|2709127|P5|COMPLETED|Period 2 - Washout||1
1118998|NCT01225549|2709128|P4|COMPLETED|Period 2 - Washout||1
1118999|NCT01225549|2709129|P3|COMPLETED|Period 2 - Washout||3
1119000|NCT01225549|2709130|P2|COMPLETED|Period 2 - Washout||4
1119001|NCT01225549|2709131|P1|COMPLETED|Period 2 - Washout||1
1119002|NCT01225549|2709122|P10|STARTED|Period 2 - Washout||1
1119003|NCT01225549|2709123|P9|STARTED|Period 2 - Washout||4
1119004|NCT01225549|2709124|P8|STARTED|Period 2 - Washout||1
1119005|NCT01225549|2709125|P7|STARTED|Period 2 - Washout||3
1119006|NCT01225549|2709126|P6|STARTED|Period 2 - Washout||1
1119007|NCT01225549|2709127|P5|STARTED|Period 2 - Washout||1
1119008|NCT01225549|2709128|P4|STARTED|Period 2 - Washout||1
1119009|NCT01225549|2709129|P3|STARTED|Period 2 - Washout||3
1119010|NCT01225549|2709130|P2|STARTED|Period 2 - Washout||4
1119011|NCT01225549|2709131|P1|STARTED|Period 2 - Washout||1
1119012|NCT01225549|2709122|P10|NOT COMPLETED|Period 1 - First Treatment Period||0
1119013|NCT01225549|2709123|P9|NOT COMPLETED|Period 1 - First Treatment Period||0
1119014|NCT01225549|2709124|P8|NOT COMPLETED|Period 1 - First Treatment Period||0
1119015|NCT01225549|2709125|P7|NOT COMPLETED|Period 1 - First Treatment Period||0
1119016|NCT01225549|2709126|P6|NOT COMPLETED|Period 1 - First Treatment Period||0
1119017|NCT01225549|2709127|P5|NOT COMPLETED|Period 1 - First Treatment Period||0
1119018|NCT01225549|2709128|P4|NOT COMPLETED|Period 1 - First Treatment Period||0
1119019|NCT01225549|2709129|P3|NOT COMPLETED|Period 1 - First Treatment Period||0
1119020|NCT01225549|2709130|P2|NOT COMPLETED|Period 1 - First Treatment Period||0
1119021|NCT01225549|2709131|P1|NOT COMPLETED|Period 1 - First Treatment Period||0
1119022|NCT01225549|2709122|P10|COMPLETED|Period 1 - First Treatment Period||1
1119023|NCT01225549|2709123|P9|COMPLETED|Period 1 - First Treatment Period||4
1119024|NCT01225549|2709124|P8|COMPLETED|Period 1 - First Treatment Period||1
1119025|NCT01225549|2709125|P7|COMPLETED|Period 1 - First Treatment Period||3
1119026|NCT01225549|2709126|P6|COMPLETED|Period 1 - First Treatment Period||1
1119027|NCT01225549|2709127|P5|COMPLETED|Period 1 - First Treatment Period||1
1119028|NCT01225549|2709128|P4|COMPLETED|Period 1 - First Treatment Period||1
1119029|NCT01225549|2709129|P3|COMPLETED|Period 1 - First Treatment Period||3
1119030|NCT01225549|2709130|P2|COMPLETED|Period 1 - First Treatment Period||4
1119031|NCT01225549|2709131|P1|COMPLETED|Period 1 - First Treatment Period||1
1119032|NCT01225549|2709122|P10|STARTED|Period 1 - First Treatment Period||1
1119033|NCT01225549|2709123|P9|STARTED|Period 1 - First Treatment Period||4
1119034|NCT01225549|2709124|P8|STARTED|Period 1 - First Treatment Period||1
1119035|NCT01225549|2709125|P7|STARTED|Period 1 - First Treatment Period||3
1119036|NCT01225549|2709126|P6|STARTED|Period 1 - First Treatment Period||1
1119037|NCT01225549|2709127|P5|STARTED|Period 1 - First Treatment Period||1
1119038|NCT01225549|2709128|P4|STARTED|Period 1 - First Treatment Period||1
1119039|NCT01225549|2709129|P3|STARTED|Period 1 - First Treatment Period||3
1119040|NCT01225549|2709130|P2|STARTED|Period 1 - First Treatment Period||4
1119041|NCT01225549|2709131|P1|STARTED|Period 1 - First Treatment Period||1
1119042|NCT01225562|2709176|P3|NOT COMPLETED|Overall Study||53
1119043|NCT01225562|2709177|P2|NOT COMPLETED|Overall Study||56
1119044|NCT01225562|2709178|P1|NOT COMPLETED|Overall Study||55
1119045|NCT01225562|2709176|P3|COMPLETED|Overall Study||7014
1119046|NCT01225562|2709177|P2|COMPLETED|Overall Study||6989
1119047|NCT01225562|2709178|P1|COMPLETED|Overall Study||6995
1119048|NCT01225562|2709176|P3|STARTED|Overall Study||7067
1119049|NCT01225562|2709177|P2|STARTED|Overall Study||7045
1119050|NCT01225562|2709178|P1|STARTED|Overall Study||7050
1119051|NCT01225731|2709200|P13|NOT COMPLETED|Part 3||7
1119052|NCT01225731|2709201|P12|NOT COMPLETED|Part 3||10
1119053|NCT01225731|2709202|P11|NOT COMPLETED|Part 3||6
1119054|NCT01225731|2709203|P10|NOT COMPLETED|Part 3||0
1119055|NCT01225731|2709204|P9|NOT COMPLETED|Part 3||0
1119056|NCT01225731|2709205|P8|NOT COMPLETED|Part 3||0
1119057|NCT01225731|2709206|P7|NOT COMPLETED|Part 3||0
1119058|NCT01225731|2709207|P6|NOT COMPLETED|Part 3||0
1119059|NCT01225731|2709208|P5|NOT COMPLETED|Part 3||0
1119060|NCT01225731|2709209|P4|NOT COMPLETED|Part 3||0
1119061|NCT01225731|2709210|P3|NOT COMPLETED|Part 3||0
1119062|NCT01225731|2709211|P2|NOT COMPLETED|Part 3||0
1119063|NCT01225731|2709212|P1|NOT COMPLETED|Part 3||0
1119064|NCT01225731|2709200|P13|COMPLETED|Part 3||60
1119065|NCT01225731|2709201|P12|COMPLETED|Part 3||116
1119066|NCT01225731|2709202|P11|COMPLETED|Part 3||80
1119067|NCT01225731|2709203|P10|COMPLETED|Part 3||10
1119068|NCT01225731|2709204|P9|COMPLETED|Part 3||0
1119069|NCT01225731|2709205|P8|COMPLETED|Part 3||0
1119070|NCT01225731|2709206|P7|COMPLETED|Part 3||0
1119071|NCT01225731|2709207|P6|COMPLETED|Part 3||0
1119072|NCT01225731|2709208|P5|COMPLETED|Part 3||0
1119073|NCT01225731|2709209|P4|COMPLETED|Part 3||0
1119074|NCT01225731|2709210|P3|COMPLETED|Part 3||0
1119075|NCT01225731|2709211|P2|COMPLETED|Part 3||0
1119076|NCT01225731|2709212|P1|COMPLETED|Part 3||0
1119077|NCT01225731|2709200|P13|STARTED|Part 3|Not all participants entered follow-up|67
1119078|NCT01225731|2709201|P12|STARTED|Part 3|Not all participants entered follow-up|126
1119079|NCT01225731|2709202|P11|STARTED|Part 3|Not all participants entered follow-up|86
1119080|NCT01225731|2709203|P10|STARTED|Part 3|Not all participants entered follow-up|10
1119081|NCT01225731|2709204|P9|STARTED|Part 3|Participants could enter the follow-up period|0
1119082|NCT01225731|2709205|P8|STARTED|Part 3|Participants could enter the follow-up period|0
1119083|NCT01225731|2709206|P7|STARTED|Part 3|Participants could enter the follow-up period|0
1119084|NCT01225731|2709207|P6|STARTED|Part 3|Participants could enter the follow-up period|0
1119085|NCT01225731|2709208|P5|STARTED|Part 3||0
1119086|NCT01225731|2709209|P4|STARTED|Part 3||0
1119087|NCT01225731|2709210|P3|STARTED|Part 3||0
1119088|NCT01225731|2709211|P2|STARTED|Part 3||0
1119089|NCT01225731|2709212|P1|STARTED|Part 3||0
1119090|NCT01225731|2709200|P13|NOT COMPLETED|Part 2||0
1119091|NCT01225731|2709201|P12|NOT COMPLETED|Part 2||0
1119092|NCT01225731|2709202|P11|NOT COMPLETED|Part 2||0
1119093|NCT01225731|2709203|P10|NOT COMPLETED|Part 2||0
1119094|NCT01225731|2709204|P9|NOT COMPLETED|Part 2||11
1119095|NCT01225731|2709205|P8|NOT COMPLETED|Part 2||25
1119096|NCT01225731|2709206|P7|NOT COMPLETED|Part 2||8
1119097|NCT01225731|2709207|P6|NOT COMPLETED|Part 2||3
1119098|NCT01225731|2709208|P5|NOT COMPLETED|Part 2||0
1119099|NCT01225731|2709209|P4|NOT COMPLETED|Part 2||0
1119100|NCT01225731|2709210|P3|NOT COMPLETED|Part 2||0
1119101|NCT01225731|2709211|P2|NOT COMPLETED|Part 2||0
1119102|NCT01225731|2709212|P1|NOT COMPLETED|Part 2||0
1119103|NCT01225731|2709200|P13|COMPLETED|Part 2||0
1119104|NCT01225731|2709201|P12|COMPLETED|Part 2||0
1119105|NCT01225731|2709202|P11|COMPLETED|Part 2||0
1119106|NCT01225731|2709203|P10|COMPLETED|Part 2||0
1119107|NCT01225731|2709204|P9|COMPLETED|Part 2||68
1119108|NCT01225731|2709205|P8|COMPLETED|Part 2||128
1119109|NCT01225731|2709206|P7|COMPLETED|Part 2||86
1119110|NCT01225731|2709207|P6|COMPLETED|Part 2||10
1119111|NCT01225731|2709208|P5|COMPLETED|Part 2||0
1119112|NCT01225731|2709209|P4|COMPLETED|Part 2||0
1119113|NCT01225731|2709210|P3|COMPLETED|Part 2||0
1119114|NCT01225731|2709211|P2|COMPLETED|Part 2||0
1119115|NCT01225731|2709212|P1|COMPLETED|Part 2||0
1119116|NCT01225731|2709200|P13|STARTED|Part 2||0
1119117|NCT01225731|2709201|P12|STARTED|Part 2||0
1119118|NCT01225731|2709202|P11|STARTED|Part 2||0
1119119|NCT01225731|2709203|P10|STARTED|Part 2||0
1119120|NCT01225731|2709204|P9|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|79
1119121|NCT01225731|2709205|P8|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|153
1119122|NCT01225731|2709206|P7|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|94
1119123|NCT01225731|2709207|P6|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|13
1119124|NCT01225731|2709208|P5|STARTED|Part 2|Participants could progress into Part 2; no placebo was given in Part 2|0
1119125|NCT01225731|2709209|P4|STARTED|Part 2|Participants could progress into Part 2|0
1119126|NCT01225731|2709210|P3|STARTED|Part 2|Participants could progress into Part 2|0
1119127|NCT01225731|2709211|P2|STARTED|Part 2|Participants could progress into Part 2|0
1119128|NCT01225731|2709212|P1|STARTED|Part 2|Participants could progress into Part 2|0
1119129|NCT01225731|2709200|P13|NOT COMPLETED|Part 1||0
1119130|NCT01225731|2709201|P12|NOT COMPLETED|Part 1||0
1119131|NCT01225731|2709202|P11|NOT COMPLETED|Part 1||0
1119132|NCT01225731|2709203|P10|NOT COMPLETED|Part 1||0
1119133|NCT01225731|2709204|P9|NOT COMPLETED|Part 1||0
1119134|NCT01225731|2709205|P8|NOT COMPLETED|Part 1||0
1119135|NCT01225731|2709206|P7|NOT COMPLETED|Part 1||0
1119136|NCT01225731|2709207|P6|NOT COMPLETED|Part 1||0
1119137|NCT01225731|2709208|P5|NOT COMPLETED|Part 1||6
1119138|NCT01225731|2709209|P4|NOT COMPLETED|Part 1||2
1119139|NCT01225731|2709210|P3|NOT COMPLETED|Part 1||1
1119140|NCT01225731|2709211|P2|NOT COMPLETED|Part 1||5
1119141|NCT01225731|2709212|P1|NOT COMPLETED|Part 1||2
1119142|NCT01225731|2709200|P13|COMPLETED|Part 1||0
1119143|NCT01225731|2709201|P12|COMPLETED|Part 1||0
1119144|NCT01225731|2709202|P11|COMPLETED|Part 1||0
1119145|NCT01225731|2709203|P10|COMPLETED|Part 1||0
1119146|NCT01225731|2709204|P9|COMPLETED|Part 1||0
1119147|NCT01225731|2709205|P8|COMPLETED|Part 1||0
1119148|NCT01225731|2709206|P7|COMPLETED|Part 1||0
1119149|NCT01225731|2709207|P6|COMPLETED|Part 1||0
1119150|NCT01225731|2709208|P5|COMPLETED|Part 1||40
1119151|NCT01225731|2709209|P4|COMPLETED|Part 1||84
1119152|NCT01225731|2709210|P3|COMPLETED|Part 1||88
1119153|NCT01225731|2709211|P2|COMPLETED|Part 1||87
1119154|NCT01225731|2709212|P1|COMPLETED|Part 1||40
1119155|NCT01225731|2709200|P13|STARTED|Part 1||0
1119156|NCT01225731|2709201|P12|STARTED|Part 1||0
1119157|NCT01225731|2709202|P11|STARTED|Part 1||0
1119158|NCT01225731|2709203|P10|STARTED|Part 1||0
1119159|NCT01225731|2709204|P9|STARTED|Part 1||0
1119160|NCT01225731|2709205|P8|STARTED|Part 1||0
1119161|NCT01225731|2709206|P7|STARTED|Part 1||0
1119162|NCT01225731|2709207|P6|STARTED|Part 1||0
1119163|NCT01225731|2709208|P5|STARTED|Part 1||46
1119164|NCT01225731|2709209|P4|STARTED|Part 1||86
1119165|NCT01225731|2709210|P3|STARTED|Part 1||89
1119166|NCT01225731|2709211|P2|STARTED|Part 1||92
1119167|NCT01225731|2709212|P1|STARTED|Part 1||42
1119168|NCT01225822|2709309|P5|NOT COMPLETED|Overall Study||31
1119169|NCT01225822|2709310|P4|NOT COMPLETED|Overall Study||52
1119170|NCT01225822|2709311|P3|NOT COMPLETED|Overall Study||38
1119171|NCT01225822|2709312|P2|NOT COMPLETED|Overall Study||56
1119172|NCT01225822|2709313|P1|NOT COMPLETED|Overall Study||38
1119173|NCT01225822|2709309|P5|COMPLETED|Overall Study||361
1119174|NCT01225822|2709310|P4|COMPLETED|Overall Study||333
1119175|NCT01225822|2709311|P3|COMPLETED|Overall Study||355
1119176|NCT01225822|2709312|P2|COMPLETED|Overall Study||334
1119177|NCT01225822|2709313|P1|COMPLETED|Overall Study||351
1119178|NCT01225822|2709309|P5|STARTED|Overall Study||392
1119179|NCT01225822|2709310|P4|STARTED|Overall Study||385
1119180|NCT01225822|2709311|P3|STARTED|Overall Study||393
1119181|NCT01225822|2709312|P2|STARTED|Overall Study||390
1119182|NCT01225822|2709313|P1|STARTED|Overall Study||389
1119183|NCT01225835|2709377|P2|NOT COMPLETED|Overall Study||3
1119184|NCT01225835|2709378|P1|NOT COMPLETED|Overall Study||7
1119185|NCT01225835|2709377|P2|COMPLETED|Overall Study|hCG criterion met|59
1119186|NCT01225835|2709378|P1|COMPLETED|Overall Study|hCG criterion met|55
1119187|NCT01225835|2709377|P2|Per Protocol Population|Overall Study||58
1119188|NCT01225835|2709378|P1|Per Protocol Population|Overall Study||48
1119189|NCT01225835|2709377|P2|STARTED|Overall Study||62
1119190|NCT01225835|2709378|P1|STARTED|Overall Study||62
1119194|NCT01225926|2709431|P2|NOT COMPLETED|Overall Study||0
1119195|NCT01225926|2709432|P1|NOT COMPLETED|Overall Study||0
1119196|NCT01225926|2709431|P2|COMPLETED|Overall Study||12
1119197|NCT01225926|2709432|P1|COMPLETED|Overall Study||12
1119198|NCT01225926|2709431|P2|STARTED|Overall Study||12
1119199|NCT01225926|2709432|P1|STARTED|Overall Study||12
1119200|NCT01225952|2709441|P3|NOT COMPLETED|Overall Study||6
1119201|NCT01225952|2709442|P2|NOT COMPLETED|Overall Study||4
1119202|NCT01225952|2709443|P1|NOT COMPLETED|Overall Study||6
1119203|NCT01225952|2709441|P3|COMPLETED|Overall Study||25
1119204|NCT01225952|2709442|P2|COMPLETED|Overall Study||27
1119205|NCT01225952|2709443|P1|COMPLETED|Overall Study||25
1119206|NCT01225952|2709441|P3|STARTED|Overall Study||31
1119207|NCT01225952|2709442|P2|STARTED|Overall Study||31
1119208|NCT01225952|2709443|P1|STARTED|Overall Study||31
1119209|NCT01225991|2709526|P1|NOT COMPLETED|Overall Study||6
1119210|NCT01225991|2709526|P1|COMPLETED|Overall Study||12
1119211|NCT01225991|2709526|P1|STARTED|Overall Study||18
1119212|NCT01226043|2709532|P4|NOT COMPLETED|30-week Observational Phase||13
1119213|NCT01226043|2709533|P3|NOT COMPLETED|30-week Observational Phase||6
1119214|NCT01226043|2709534|P2|NOT COMPLETED|30-week Observational Phase||0
1119215|NCT01226043|2709535|P1|NOT COMPLETED|30-week Observational Phase||0
1119216|NCT01226043|2709532|P4|COMPLETED|30-week Observational Phase||140
1119217|NCT01226043|2709533|P3|COMPLETED|30-week Observational Phase||153
1119218|NCT01226043|2709534|P2|COMPLETED|30-week Observational Phase||0
1119219|NCT01226043|2709535|P1|COMPLETED|30-week Observational Phase||0
1119220|NCT01226043|2709532|P4|TREATED|30-week Observational Phase||153
1119221|NCT01226043|2709533|P3|TREATED|30-week Observational Phase||159
1119222|NCT01226043|2709534|P2|TREATED|30-week Observational Phase||0
1119223|NCT01226043|2709535|P1|TREATED|30-week Observational Phase||0
1119224|NCT01226043|2709532|P4|STARTED|30-week Observational Phase||153
1119225|NCT01226043|2709533|P3|STARTED|30-week Observational Phase||159
1119226|NCT01226043|2709534|P2|STARTED|30-week Observational Phase||0
1119227|NCT01226043|2709535|P1|STARTED|30-week Observational Phase||0
1119228|NCT01226043|2709532|P4|NOT COMPLETED|6-week Re-randomization Phase||11
1119229|NCT01226043|2709533|P3|NOT COMPLETED|6-week Re-randomization Phase||7
1119230|NCT01226043|2709534|P2|NOT COMPLETED|6-week Re-randomization Phase||0
1119231|NCT01226043|2709535|P1|NOT COMPLETED|6-week Re-randomization Phase||0
1119232|NCT01226043|2709532|P4|COMPLETED|6-week Re-randomization Phase|3 patients did not enter the observational phase of the study|156
1119233|NCT01226043|2709533|P3|COMPLETED|6-week Re-randomization Phase||159
1119234|NCT01226043|2709534|P2|COMPLETED|6-week Re-randomization Phase||0
1119235|NCT01226043|2709535|P1|COMPLETED|6-week Re-randomization Phase||0
1119236|NCT01226043|2709532|P4|TREATED|6-week Re-randomization Phase||165
1119237|NCT01226043|2709533|P3|TREATED|6-week Re-randomization Phase||165
1119238|NCT01226043|2709534|P2|TREATED|6-week Re-randomization Phase||0
1119239|NCT01226043|2709535|P1|TREATED|6-week Re-randomization Phase||0
1119240|NCT01226043|2709532|P4|STARTED|6-week Re-randomization Phase||167
1119241|NCT01226043|2709533|P3|STARTED|6-week Re-randomization Phase||166
1119242|NCT01226043|2709534|P2|STARTED|6-week Re-randomization Phase||0
1119243|NCT01226043|2709535|P1|STARTED|6-week Re-randomization Phase||0
1119244|NCT01226043|2709532|P4|NOT COMPLETED|4-week Crossover Phase - Period 2||0
1119245|NCT01226043|2709533|P3|NOT COMPLETED|4-week Crossover Phase - Period 2||0
1119246|NCT01226043|2709534|P2|NOT COMPLETED|4-week Crossover Phase - Period 2||6
1119247|NCT01226043|2709535|P1|NOT COMPLETED|4-week Crossover Phase - Period 2||4
1119248|NCT01226043|2709532|P4|COMPLETED|4-week Crossover Phase - Period 2||0
1119249|NCT01226043|2709533|P3|COMPLETED|4-week Crossover Phase - Period 2||0
1119250|NCT01226043|2709534|P2|COMPLETED|4-week Crossover Phase - Period 2|22 patients were not re-randomized to the second phase of the study|188
1119251|NCT01226043|2709535|P1|COMPLETED|4-week Crossover Phase - Period 2|28 patients were not re-randomized to the second phase of the study|195
1119252|NCT01226043|2709532|P4|TREATED|4-week Crossover Phase - Period 2||0
1119253|NCT01226043|2709533|P3|TREATED|4-week Crossover Phase - Period 2||0
1119254|NCT01226043|2709534|P2|TREATED|4-week Crossover Phase - Period 2||194
1119255|NCT01226043|2709535|P1|TREATED|4-week Crossover Phase - Period 2||199
1119256|NCT01226043|2709532|P4|STARTED|4-week Crossover Phase - Period 2||0
1119257|NCT01226043|2709533|P3|STARTED|4-week Crossover Phase - Period 2||0
1119258|NCT01226043|2709534|P2|STARTED|4-week Crossover Phase - Period 2||194
1119259|NCT01226043|2709535|P1|STARTED|4-week Crossover Phase - Period 2||199
1119260|NCT01226043|2709532|P4|NOT COMPLETED|4-week Crossover Phase - Period 1||0
1119261|NCT01226043|2709533|P3|NOT COMPLETED|4-week Crossover Phase - Period 1||0
1119262|NCT01226043|2709534|P2|NOT COMPLETED|4-week Crossover Phase - Period 1||9
1119263|NCT01226043|2709535|P1|NOT COMPLETED|4-week Crossover Phase - Period 1||3
1119264|NCT01226043|2709532|P4|COMPLETED|4-week Crossover Phase - Period 1||0
1119265|NCT01226043|2709533|P3|COMPLETED|4-week Crossover Phase - Period 1||0
1119266|NCT01226043|2709534|P2|COMPLETED|4-week Crossover Phase - Period 1||194
1119267|NCT01226043|2709535|P1|COMPLETED|4-week Crossover Phase - Period 1||199
1119268|NCT01226043|2709532|P4|TREATED|4-week Crossover Phase - Period 1||0
1119269|NCT01226043|2709533|P3|TREATED|4-week Crossover Phase - Period 1||0
1119270|NCT01226043|2709534|P2|TREATED|4-week Crossover Phase - Period 1||200
1119271|NCT01226043|2709535|P1|TREATED|4-week Crossover Phase - Period 1||202
1119272|NCT01226043|2709532|P4|STARTED|4-week Crossover Phase - Period 1||0
1119273|NCT01226043|2709533|P3|STARTED|4-week Crossover Phase - Period 1||0
1119274|NCT01226043|2709534|P2|STARTED|4-week Crossover Phase - Period 1||203
1119275|NCT01226043|2709535|P1|STARTED|4-week Crossover Phase - Period 1||202
1119276|NCT01226095|2709573|P1|NOT COMPLETED|Overall Study||1
1119277|NCT01226095|2709573|P1|COMPLETED|Overall Study||518
1119278|NCT01226095|2709573|P1|STARTED|Overall Study||519
1119279|NCT01226121|2709599|P3|NOT COMPLETED|Overall Study||1
1119280|NCT01226121|2709600|P2|NOT COMPLETED|Overall Study||0
1119281|NCT01226121|2709601|P1|NOT COMPLETED|Overall Study||2
1119282|NCT01226121|2709599|P3|COMPLETED|Overall Study||12
1119283|NCT01226121|2709600|P2|COMPLETED|Overall Study||11
1119284|NCT01226121|2709601|P1|COMPLETED|Overall Study||11
1119285|NCT01226121|2709599|P3|30 Day Evaluation|Overall Study||13
1119286|NCT01226121|2709600|P2|30 Day Evaluation|Overall Study||11
1119287|NCT01226121|2709601|P1|30 Day Evaluation|Overall Study||12
1119288|NCT01226121|2709599|P3|STARTED|Overall Study||13
1119289|NCT01226121|2709600|P2|STARTED|Overall Study||11
1119290|NCT01226121|2709601|P1|STARTED|Overall Study||13
1119291|NCT01226420|2709612|P1|NOT COMPLETED|Overall Study||0
1119292|NCT01226420|2709612|P1|COMPLETED|Overall Study||6
1119293|NCT01226420|2709612|P1|STARTED|Overall Study||6
1119294|NCT01226459|2709619|P2|NOT COMPLETED|Overall Study||32
1119295|NCT01226459|2709620|P1|NOT COMPLETED|Overall Study||21
1119296|NCT01226459|2709619|P2|COMPLETED|Overall Study||171
1119297|NCT01226459|2709620|P1|COMPLETED|Overall Study||180
1119298|NCT01226459|2709619|P2|STARTED|Overall Study||203
1119299|NCT01226459|2709620|P1|STARTED|Overall Study||201
1119300|NCT01226511|2709632|P2|NOT COMPLETED|Taper Period||3
1119301|NCT01226511|2709633|P1|NOT COMPLETED|Taper Period||5
1119302|NCT01226511|2709632|P2|COMPLETED|Taper Period||54
1119303|NCT01226511|2709633|P1|COMPLETED|Taper Period||46
1119304|NCT01226511|2709632|P2|STARTED|Taper Period||57
1119305|NCT01226511|2709633|P1|STARTED|Taper Period||51
1119306|NCT01226511|2709632|P2|NOT COMPLETED|Extension Treatment Period||27
1119307|NCT01226511|2709633|P1|NOT COMPLETED|Extension Treatment Period||27
1119308|NCT01226511|2709632|P2|COMPLETED|Extension Treatment Period|Thirty-five (35) participants who completed extension treatment did not enter the taper period.|83
1119393|NCT01219673|2709921|P1|COMPLETED|Overall Study||0
1119309|NCT01226511|2709633|P1|COMPLETED|Extension Treatment Period|Thirty-nine (39) participants who completed extension treatment did not enter the taper period.|81
1119310|NCT01226511|2709632|P2|STARTED|Extension Treatment Period|Twenty-three (23) participants who discontinued extension treatment did not enter the taper period.|110
1119311|NCT01226511|2709633|P1|STARTED|Extension Treatment Period|Nineteen (19) participants who discontinued extension treatment did not enter the taper period.|108
1119312|NCT01226511|2709632|P2|NOT COMPLETED|Acute Treatment Period||31
1119313|NCT01226511|2709633|P1|NOT COMPLETED|Acute Treatment Period||32
1119314|NCT01226511|2709632|P2|COMPLETED|Acute Treatment Period||110
1119315|NCT01226511|2709633|P1|COMPLETED|Acute Treatment Period||108
1119316|NCT01226511|2709632|P2|STARTED|Acute Treatment Period|Twenty-six (26) participants who discontinued acute treatment did not enter the taper period.|141
1119317|NCT01226511|2709633|P1|STARTED|Acute Treatment Period|Thirty-one (31) participants who discontinued acute treatment did not enter the taper period.|140
1119318|NCT01226706|2709671|P2|NOT COMPLETED|Overall Study||0
1119319|NCT01226706|2709672|P1|NOT COMPLETED|Overall Study||0
1119320|NCT01226706|2709671|P2|COMPLETED|Overall Study||11
1119321|NCT01226706|2709672|P1|COMPLETED|Overall Study||10
1119322|NCT01226706|2709671|P2|STARTED|Overall Study||11
1119323|NCT01226706|2709672|P1|STARTED|Overall Study||10
1119324|NCT01226719|2709754|P1|NOT COMPLETED|Overall Study||13
1119325|NCT01226719|2709754|P1|COMPLETED|Overall Study|Completed = patient is surgical candidate, underwent resection, received treatment to week 24.|2
1119326|NCT01226719|2709754|P1|STARTED|Overall Study||15
1119327|NCT01226732|2709768|P6|NOT COMPLETED|Overall Study||6
1119328|NCT01226732|2709769|P5|NOT COMPLETED|Overall Study||3
1119329|NCT01226732|2709770|P4|NOT COMPLETED|Overall Study||5
1119330|NCT01226732|2709771|P3|NOT COMPLETED|Overall Study||3
1119331|NCT01226732|2709772|P2|NOT COMPLETED|Overall Study||3
1119332|NCT01226732|2709773|P1|NOT COMPLETED|Overall Study||3
1119333|NCT01226732|2709768|P6|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
1119334|NCT01226732|2709769|P5|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
1119335|NCT01226732|2709770|P4|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
1119336|NCT01226732|2709771|P3|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
1119337|NCT01226732|2709772|P2|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
1119338|NCT01226732|2709773|P1|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
1119339|NCT01226732|2709768|P6|STARTED|Overall Study||6
1119340|NCT01226732|2709769|P5|STARTED|Overall Study||3
1119341|NCT01226732|2709770|P4|STARTED|Overall Study||5
1119342|NCT01226732|2709771|P3|STARTED|Overall Study||3
1119343|NCT01226732|2709772|P2|STARTED|Overall Study||3
1119344|NCT01226732|2709773|P1|STARTED|Overall Study||3
1119345|NCT01226745|2709795|P6|NOT COMPLETED|Overall Study||5
1119346|NCT01226745|2709796|P5|NOT COMPLETED|Overall Study||4
1119347|NCT01226745|2709797|P4|NOT COMPLETED|Overall Study||5
1119348|NCT01226745|2709798|P3|NOT COMPLETED|Overall Study||20
1119349|NCT01226745|2709799|P2|NOT COMPLETED|Overall Study||16
1119350|NCT01226745|2709800|P1|NOT COMPLETED|Overall Study||17
1119351|NCT01226745|2709795|P6|COMPLETED|Overall Study||24
1119352|NCT01226745|2709796|P5|COMPLETED|Overall Study||22
1119353|NCT01226745|2709797|P4|COMPLETED|Overall Study||24
1119354|NCT01226745|2709798|P3|COMPLETED|Overall Study||69
1119355|NCT01226745|2709799|P2|COMPLETED|Overall Study||71
1119356|NCT01226745|2709800|P1|COMPLETED|Overall Study||63
1119357|NCT01226745|2709795|P6|STARTED|Overall Study||29
1119358|NCT01226745|2709796|P5|STARTED|Overall Study||26
1119359|NCT01226745|2709797|P4|STARTED|Overall Study||29
1119360|NCT01226745|2709798|P3|STARTED|Overall Study||89
1119361|NCT01226745|2709799|P2|STARTED|Overall Study||87
1119362|NCT01226745|2709800|P1|STARTED|Overall Study||80
1119363|NCT01227005|2709876|P2|NOT COMPLETED|Overall Study||1
1119364|NCT01227005|2709877|P1|NOT COMPLETED|Overall Study||5
1119365|NCT01227005|2709876|P2|COMPLETED|Overall Study||51
1119366|NCT01227005|2709877|P1|COMPLETED|Overall Study||50
1119367|NCT01227005|2709876|P2|STARTED|Overall Study||52
1119368|NCT01227005|2709877|P1|STARTED|Overall Study||55
1119369|NCT01227018|2709887|P1|NOT COMPLETED|Overall Study||15
1119370|NCT01227018|2709887|P1|COMPLETED|Overall Study||0
1119371|NCT01227018|2709887|P1|STARTED|Overall Study||15
1119372|NCT01227057|2709897|P2|NOT COMPLETED|Overall Study||8
1119373|NCT01227057|2709898|P1|NOT COMPLETED|Overall Study||6
1119374|NCT01227057|2709897|P2|COMPLETED|Overall Study||19
1119375|NCT01227057|2709898|P1|COMPLETED|Overall Study||25
1119376|NCT01227057|2709897|P2|STARTED|Overall Study||27
1119377|NCT01227057|2709898|P1|STARTED|Overall Study||31
1119378|NCT01219673|2709914|P8|NOT COMPLETED|Overall Study||0
1119379|NCT01219673|2709915|P7|NOT COMPLETED|Overall Study||0
1119380|NCT01219673|2709916|P6|NOT COMPLETED|Overall Study||0
1119381|NCT01219673|2709917|P5|NOT COMPLETED|Overall Study||0
1119382|NCT01219673|2709918|P4|NOT COMPLETED|Overall Study||0
1119383|NCT01219673|2709919|P3|NOT COMPLETED|Overall Study||0
1119384|NCT01219673|2709920|P2|NOT COMPLETED|Overall Study||0
1119385|NCT01219673|2709921|P1|NOT COMPLETED|Overall Study||0
1119386|NCT01219673|2709914|P8|COMPLETED|Overall Study||0
1119387|NCT01219673|2709915|P7|COMPLETED|Overall Study||0
1119388|NCT01219673|2709916|P6|COMPLETED|Overall Study||0
1119389|NCT01219673|2709917|P5|COMPLETED|Overall Study||0
1119390|NCT01219673|2709918|P4|COMPLETED|Overall Study||0
1119391|NCT01219673|2709919|P3|COMPLETED|Overall Study||1
1119392|NCT01219673|2709920|P2|COMPLETED|Overall Study||0
1119394|NCT01219673|2709914|P8|STARTED|Overall Study||0
1119395|NCT01219673|2709915|P7|STARTED|Overall Study||0
1119396|NCT01219673|2709916|P6|STARTED|Overall Study||0
1119397|NCT01219673|2709917|P5|STARTED|Overall Study||0
1119398|NCT01219673|2709918|P4|STARTED|Overall Study||0
1119399|NCT01219673|2709919|P3|STARTED|Overall Study||1
1119400|NCT01219673|2709920|P2|STARTED|Overall Study||0
1119401|NCT01219673|2709921|P1|STARTED|Overall Study||0
1119402|NCT01219738|2709939|P1|NOT COMPLETED|Overall Study||0
1119403|NCT01219738|2709939|P1|COMPLETED|Overall Study||20
1119404|NCT01219738|2709939|P1|Budesonide 720- 4 Times|Overall Study||20
1119405|NCT01219738|2709939|P1|Budesonide 1440|Overall Study||20
1119406|NCT01219738|2709939|P1|Budesonide 720|Overall Study||20
1119407|NCT01219738|2709939|P1|Budesonide 360|Overall Study||20
1119408|NCT01219738|2709939|P1|STARTED|Overall Study||20
1119409|NCT01219777|2709952|P1|NOT COMPLETED|Overall Study||0
1119410|NCT01219777|2709952|P1|COMPLETED|Overall Study||9
1119411|NCT01219777|2709952|P1|STARTED|Overall Study||9
1119412|NCT01219855|2709962|P5|NOT COMPLETED|Overall Study||1
1119413|NCT01219855|2709963|P4|NOT COMPLETED|Overall Study||1
1119414|NCT01219855|2709964|P3|NOT COMPLETED|Overall Study||1
1119415|NCT01219855|2709965|P2|NOT COMPLETED|Overall Study||5
1119416|NCT01219855|2709966|P1|NOT COMPLETED|Overall Study||1
1119417|NCT01219855|2709962|P5|COMPLETED|Overall Study||13
1119418|NCT01219855|2709963|P4|COMPLETED|Overall Study||12
1119419|NCT01219855|2709964|P3|COMPLETED|Overall Study||16
1119420|NCT01219855|2709965|P2|COMPLETED|Overall Study||12
1119421|NCT01219855|2709966|P1|COMPLETED|Overall Study||16
1119422|NCT01219855|2709962|P5|STARTED|Overall Study||14
1119423|NCT01219855|2709963|P4|STARTED|Overall Study||13
1119424|NCT01219855|2709964|P3|STARTED|Overall Study||17
1119425|NCT01219855|2709965|P2|STARTED|Overall Study||17
1119426|NCT01219855|2709966|P1|STARTED|Overall Study||17
1119427|NCT01219881|2710004|P2|NOT COMPLETED|Overall Study||5
1119428|NCT01219881|2710005|P1|NOT COMPLETED|Overall Study||4
1119429|NCT01219881|2710004|P2|COMPLETED|Overall Study||32
1119430|NCT01219881|2710005|P1|COMPLETED|Overall Study||34
1119431|NCT01219881|2710004|P2|STARTED|Overall Study||37
1119432|NCT01219881|2710005|P1|STARTED|Overall Study||38
1119433|NCT01219933|2710017|P1|NOT COMPLETED|Overall Study||38
1119434|NCT01219933|2710017|P1|COMPLETED|Overall Study||30
1119435|NCT01219933|2710017|P1|STARTED|Overall Study||68
1119436|NCT01219985|2710054|P1|NOT COMPLETED|Overall Study||20
1119437|NCT01219985|2710054|P1|COMPLETED|Overall Study||30
1119438|NCT01219985|2710054|P1|STARTED|Overall Study||50
1119439|NCT01220128|2710067|P7|NOT COMPLETED|Overall Study||5
1119440|NCT01220128|2710068|P6|NOT COMPLETED|Overall Study||0
1119441|NCT01220128|2710069|P5|NOT COMPLETED|Overall Study||0
1119442|NCT01220128|2710070|P4|NOT COMPLETED|Overall Study||0
1119443|NCT01220128|2710071|P3|NOT COMPLETED|Overall Study||3
1119444|NCT01220128|2710072|P2|NOT COMPLETED|Overall Study||1
1119445|NCT01220128|2710073|P1|NOT COMPLETED|Overall Study||4
1119446|NCT01220128|2710067|P7|COMPLETED|Overall Study||3
1119447|NCT01220128|2710068|P6|COMPLETED|Overall Study||4
1119448|NCT01220128|2710069|P5|COMPLETED|Overall Study||11
1119449|NCT01220128|2710070|P4|COMPLETED|Overall Study||6
1119450|NCT01220128|2710071|P3|COMPLETED|Overall Study||6
1119451|NCT01220128|2710072|P2|COMPLETED|Overall Study||6
1119452|NCT01220128|2710073|P1|COMPLETED|Overall Study||11
1119453|NCT01220128|2710067|P7|STARTED|Overall Study||8
1119454|NCT01220128|2710068|P6|STARTED|Overall Study||4
1119455|NCT01220128|2710069|P5|STARTED|Overall Study||11
1119456|NCT01220128|2710070|P4|STARTED|Overall Study||6
1119457|NCT01220128|2710071|P3|STARTED|Overall Study||9
1119458|NCT01220128|2710072|P2|STARTED|Overall Study||7
1119459|NCT01220128|2710073|P1|STARTED|Overall Study||15
1119460|NCT01220180|2710281|P1|NOT COMPLETED|Overall Study||207
1119461|NCT01220180|2710281|P1|COMPLETED|Overall Study||3968
1119462|NCT01220180|2710281|P1|Treated|Overall Study||4174
1119463|NCT01220180|2710281|P1|STARTED|Overall Study||4175
1119464|NCT01220297|2710306|P1|NOT COMPLETED|Overall Study||3
1119465|NCT01220297|2710306|P1|COMPLETED|Overall Study||0
1119466|NCT01220297|2710306|P1|STARTED|Overall Study||3
1119467|NCT01220401|2710320|P1|NOT COMPLETED|Overall Study||3
1119468|NCT01220401|2710320|P1|COMPLETED|Overall Study||18
1119469|NCT01220401|2710320|P1|STARTED|Overall Study||21
1119470|NCT01220466|2710330|P3|NOT COMPLETED|Overall Study||0
1119471|NCT01220466|2710331|P2|NOT COMPLETED|Overall Study||0
1119472|NCT01220466|2710332|P1|NOT COMPLETED|Overall Study||0
1119473|NCT01220466|2710330|P3|COMPLETED|Overall Study|16 eyes|10
1119474|NCT01220466|2710331|P2|COMPLETED|Overall Study|108 eyes|56
1119475|NCT01220466|2710332|P1|COMPLETED|Overall Study|19 eyes|11
1119476|NCT01220466|2710330|P3|STARTED|Overall Study|16 eyes|10
1119477|NCT01220466|2710331|P2|STARTED|Overall Study|108 eyes|56
1119478|NCT01220466|2710332|P1|STARTED|Overall Study|19 eyes|11
1119479|NCT01220557|2710354|P2|NOT COMPLETED|Overall Study||5
1119480|NCT01220557|2710355|P1|NOT COMPLETED|Overall Study||6
1119481|NCT01220557|2710354|P2|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|74
1119482|NCT01220557|2710355|P1|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|75
1119483|NCT01220557|2710354|P2|STARTED|Overall Study||79
1119484|NCT01220557|2710355|P1|STARTED|Overall Study||81
1119485|NCT01220609|2710361|P1|NOT COMPLETED|Overall Study||3
1119486|NCT01220609|2710361|P1|COMPLETED|Overall Study|Eligible and treated patients|23
1119487|NCT01220609|2710361|P1|STARTED|Overall Study||26
1119488|NCT01220739|2710369|P2|NOT COMPLETED|Overall Study||0
1119489|NCT01220739|2710370|P1|NOT COMPLETED|Overall Study||0
1119490|NCT01220739|2710369|P2|COMPLETED|Overall Study||5
1119491|NCT01220739|2710370|P1|COMPLETED|Overall Study||7
1119492|NCT01220739|2710369|P2|STARTED|Overall Study||5
1119493|NCT01220739|2710370|P1|STARTED|Overall Study||7
1119494|NCT01220869|2710378|P1|NOT COMPLETED|Overall Study||6
1119495|NCT01220869|2710378|P1|COMPLETED|Overall Study||104
1119496|NCT01220869|2710378|P1|STARTED|Overall Study||110
1119497|NCT01221090|2710390|P4|NOT COMPLETED|Overall Study||22
1119498|NCT01221090|2710391|P3|NOT COMPLETED|Overall Study||42
1119499|NCT01221090|2710392|P2|NOT COMPLETED|Overall Study||34
1119500|NCT01221090|2710393|P1|NOT COMPLETED|Overall Study||15
1119501|NCT01221090|2710390|P4|COMPLETED|Overall Study||73
1119502|NCT01221090|2710391|P3|COMPLETED|Overall Study||57
1119503|NCT01221090|2710392|P2|COMPLETED|Overall Study||47
1119504|NCT01221090|2710393|P1|COMPLETED|Overall Study||86
1119505|NCT01221090|2710390|P4|STARTED|Overall Study||95
1119506|NCT01221090|2710391|P3|STARTED|Overall Study||99
1119507|NCT01221090|2710392|P2|STARTED|Overall Study||81
1119508|NCT01221090|2710393|P1|STARTED|Overall Study||101
1119509|NCT01227265|2710422|P3|NOT COMPLETED|Overall Study||14
1119510|NCT01227265|2710423|P2|NOT COMPLETED|Overall Study||20
1119511|NCT01227265|2710424|P1|NOT COMPLETED|Overall Study||19
1119512|NCT01227265|2710422|P3|COMPLETED|Overall Study||145
1119513|NCT01227265|2710423|P2|COMPLETED|Overall Study||139
1119514|NCT01227265|2710424|P1|COMPLETED|Overall Study||139
1119515|NCT01227265|2710422|P3|Treated|Overall Study||159
1119516|NCT01227265|2710423|P2|Treated|Overall Study||157
1119517|NCT01227265|2710424|P1|Treated|Overall Study||157
1119518|NCT01227265|2710422|P3|STARTED|Overall Study||159
1119519|NCT01227265|2710423|P2|STARTED|Overall Study||159
1119520|NCT01227265|2710424|P1|STARTED|Overall Study||158
1119521|NCT01227278|2710452|P2|NOT COMPLETED|Overall Study||8
1119522|NCT01227278|2710453|P1|NOT COMPLETED|Overall Study||5
1119523|NCT01227278|2710452|P2|COMPLETED|Overall Study||43
1119524|NCT01227278|2710453|P1|COMPLETED|Overall Study||45
1119525|NCT01227278|2710452|P2|STARTED|Overall Study||51
1119526|NCT01227278|2710453|P1|STARTED|Overall Study||50
1119527|NCT01227382|2710477|P1|NOT COMPLETED|Overall Study||0
1119528|NCT01227382|2710477|P1|COMPLETED|Overall Study||26
1119529|NCT01227382|2710477|P1|STARTED|Overall Study||26
1119530|NCT01227395|2710489|P2|NOT COMPLETED|Overall Study||1
1119531|NCT01227395|2710490|P1|NOT COMPLETED|Overall Study||0
1119532|NCT01227395|2710489|P2|COMPLETED|Overall Study||84
1119533|NCT01227395|2710490|P1|COMPLETED|Overall Study||391
1119534|NCT01227395|2710489|P2|STARTED|Overall Study||85
1119535|NCT01227395|2710490|P1|STARTED|Overall Study||391
1119536|NCT01227421|2710521|P3|NOT COMPLETED|Overall Study||10
1119537|NCT01227421|2710522|P2|NOT COMPLETED|Overall Study||18
1119538|NCT01227421|2710523|P1|NOT COMPLETED|Overall Study||11
1119539|NCT01227421|2710521|P3|COMPLETED|Overall Study||201
1119540|NCT01227421|2710522|P2|COMPLETED|Overall Study||194
1119541|NCT01227421|2710523|P1|COMPLETED|Overall Study||190
1119542|NCT01227421|2710521|P3|STARTED|Overall Study||211
1119543|NCT01227421|2710522|P2|STARTED|Overall Study||212
1119544|NCT01227421|2710523|P1|STARTED|Overall Study||201
1119545|NCT01227434|2710575|P2|NOT COMPLETED|Overall Study||0
1119546|NCT01227434|2710576|P1|NOT COMPLETED|Overall Study||0
1119547|NCT01227434|2710575|P2|COMPLETED|Overall Study||16
1119548|NCT01227434|2710576|P1|COMPLETED|Overall Study||6
1119549|NCT01227434|2710575|P2|STARTED|Overall Study||16
1119550|NCT01227434|2710576|P1|STARTED|Overall Study||6
1119551|NCT01228591|2710584|P2|NOT COMPLETED|Final Visit||0
1119552|NCT01228591|2710585|P1|NOT COMPLETED|Final Visit||0
1119553|NCT01228591|2710584|P2|COMPLETED|Final Visit||16
1119554|NCT01228591|2710585|P1|COMPLETED|Final Visit||17
1119555|NCT01228591|2710584|P2|STARTED|Final Visit||16
1119556|NCT01228591|2710585|P1|STARTED|Final Visit||17
1119557|NCT01228591|2710584|P2|NOT COMPLETED|1-Week Follow-Up||0
1119558|NCT01228591|2710585|P1|NOT COMPLETED|1-Week Follow-Up||0
1119559|NCT01228591|2710584|P2|COMPLETED|1-Week Follow-Up||16
1119560|NCT01228591|2710585|P1|COMPLETED|1-Week Follow-Up||17
1119561|NCT01228591|2710584|P2|STARTED|1-Week Follow-Up||16
1119562|NCT01228591|2710585|P1|STARTED|1-Week Follow-Up||17
1119563|NCT01228591|2710584|P2|NOT COMPLETED|Baseline||2
1119564|NCT01228591|2710585|P1|NOT COMPLETED|Baseline||1
1119565|NCT01228591|2710584|P2|COMPLETED|Baseline||16
1119566|NCT01228591|2710585|P1|COMPLETED|Baseline||17
1119567|NCT01228591|2710584|P2|STARTED|Baseline||18
1119568|NCT01228591|2710585|P1|STARTED|Baseline||18
1119579|NCT01228747|2710620|P2|NOT COMPLETED|Overall Study||45
1119580|NCT01228747|2710621|P1|NOT COMPLETED|Overall Study||65
1119581|NCT01228747|2710620|P2|COMPLETED|Overall Study||81
1119582|NCT01228747|2710621|P1|COMPLETED|Overall Study||60
1119583|NCT01228747|2710620|P2|STARTED|Overall Study||126
1119584|NCT01228747|2710621|P1|STARTED|Overall Study||125
1119585|NCT01228903|2710637|P2|NOT COMPLETED|Overall Study||5
1119586|NCT01228903|2710638|P1|NOT COMPLETED|Overall Study||5
1119587|NCT01228903|2710637|P2|COMPLETED|Overall Study||34
1119588|NCT01228903|2710638|P1|COMPLETED|Overall Study||36
1119589|NCT01228903|2710637|P2|STARTED|Overall Study||39
1119590|NCT01228903|2710638|P1|STARTED|Overall Study||41
1119591|NCT01228929|2710657|P3|NOT COMPLETED|High Temperature Condition||0
1119592|NCT01228929|2710658|P2|NOT COMPLETED|High Temperature Condition||0
1119593|NCT01228929|2710659|P1|NOT COMPLETED|High Temperature Condition||0
1119594|NCT01228929|2710657|P3|COMPLETED|High Temperature Condition||6
1119595|NCT01228929|2710658|P2|COMPLETED|High Temperature Condition||6
1119596|NCT01228929|2710659|P1|COMPLETED|High Temperature Condition||6
1119597|NCT01228929|2710657|P3|STARTED|High Temperature Condition||6
1119598|NCT01228929|2710658|P2|STARTED|High Temperature Condition||6
1119599|NCT01228929|2710659|P1|STARTED|High Temperature Condition||6
1119600|NCT01228929|2710657|P3|NOT COMPLETED|Low Humidity Condition||0
1119601|NCT01228929|2710658|P2|NOT COMPLETED|Low Humidity Condition||0
1119602|NCT01228929|2710659|P1|NOT COMPLETED|Low Humidity Condition||0
1119603|NCT01228929|2710657|P3|COMPLETED|Low Humidity Condition||6
1119604|NCT01228929|2710658|P2|COMPLETED|Low Humidity Condition||6
1119605|NCT01228929|2710659|P1|COMPLETED|Low Humidity Condition||6
1119606|NCT01228929|2710657|P3|STARTED|Low Humidity Condition||6
1119607|NCT01228929|2710658|P2|STARTED|Low Humidity Condition||6
1119608|NCT01228929|2710659|P1|STARTED|Low Humidity Condition||6
1119609|NCT01228929|2710657|P3|NOT COMPLETED|Nominal Condition||0
1119610|NCT01228929|2710658|P2|NOT COMPLETED|Nominal Condition||0
1119611|NCT01228929|2710659|P1|NOT COMPLETED|Nominal Condition||0
1119612|NCT01228929|2710657|P3|COMPLETED|Nominal Condition||6
1119613|NCT01228929|2710658|P2|COMPLETED|Nominal Condition||6
1119614|NCT01228929|2710659|P1|COMPLETED|Nominal Condition||6
1119615|NCT01228929|2710657|P3|STARTED|Nominal Condition||6
1119616|NCT01228929|2710658|P2|STARTED|Nominal Condition||6
1119617|NCT01228929|2710659|P1|STARTED|Nominal Condition||6
1119618|NCT01228968|2710667|P1|NOT COMPLETED|Overall Study||0
1119619|NCT01228968|2710667|P1|COMPLETED|Overall Study||9
1119620|NCT01228968|2710667|P1|STARTED|Overall Study||9
1119621|NCT01229111|2710674|P1|NOT COMPLETED|Overall Study||1
1119622|NCT01229111|2710674|P1|COMPLETED|Overall Study||13
1119623|NCT01229111|2710674|P1|STARTED|Overall Study||14
1119624|NCT01229150|2710686|P4|NOT COMPLETED|Overall Study||0
1119625|NCT01229150|2710687|P3|NOT COMPLETED|Overall Study||0
1119626|NCT01229150|2710688|P2|NOT COMPLETED|Overall Study||2
1119627|NCT01229150|2710689|P1|NOT COMPLETED|Overall Study||2
1119628|NCT01229150|2710686|P4|COMPLETED|Overall Study||19
1119629|NCT01229150|2710687|P3|COMPLETED|Overall Study||19
1119630|NCT01229150|2710688|P2|COMPLETED|Overall Study||9
1119631|NCT01229150|2710689|P1|COMPLETED|Overall Study||28
1119632|NCT01229150|2710686|P4|STARTED|Overall Study||19
1119633|NCT01229150|2710687|P3|STARTED|Overall Study||19
1119634|NCT01229150|2710688|P2|STARTED|Overall Study||11
1119635|NCT01229150|2710689|P1|STARTED|Overall Study||30
1119636|NCT01229176|2710754|P8|NOT COMPLETED|Overall Study||3
1119637|NCT01229176|2710755|P7|NOT COMPLETED|Overall Study||0
1119638|NCT01229176|2710756|P6|NOT COMPLETED|Overall Study||2
1119639|NCT01229176|2710757|P5|NOT COMPLETED|Overall Study||2
1119640|NCT01229176|2710758|P4|NOT COMPLETED|Overall Study||1
1119641|NCT01229176|2710759|P3|NOT COMPLETED|Overall Study||0
1119642|NCT01229176|2710760|P2|NOT COMPLETED|Overall Study||3
1119643|NCT01229176|2710761|P1|NOT COMPLETED|Overall Study||0
1119644|NCT01229176|2710754|P8|COMPLETED|Overall Study||17
1119645|NCT01229176|2710755|P7|COMPLETED|Overall Study||20
1119646|NCT01229176|2710756|P6|COMPLETED|Overall Study||18
1119647|NCT01229176|2710757|P5|COMPLETED|Overall Study||18
1119648|NCT01229176|2710758|P4|COMPLETED|Overall Study||19
1119649|NCT01229176|2710759|P3|COMPLETED|Overall Study||20
1119650|NCT01229176|2710760|P2|COMPLETED|Overall Study||37
1119651|NCT01229176|2710761|P1|COMPLETED|Overall Study||40
1119652|NCT01229176|2710754|P8|STARTED|Overall Study||20
1119653|NCT01229176|2710755|P7|STARTED|Overall Study||20
1119654|NCT01229176|2710756|P6|STARTED|Overall Study||20
1119655|NCT01229176|2710757|P5|STARTED|Overall Study||20
1119656|NCT01229176|2710758|P4|STARTED|Overall Study||20
1119657|NCT01229176|2710759|P3|STARTED|Overall Study||20
1119658|NCT01229176|2710760|P2|STARTED|Overall Study||40
1119659|NCT01229176|2710761|P1|STARTED|Overall Study||40
1119660|NCT01229228|2710816|P5|NOT COMPLETED|Overall Study||1
1119661|NCT01229228|2710817|P4|NOT COMPLETED|Overall Study||0
1119662|NCT01229228|2710818|P3|NOT COMPLETED|Overall Study||1
1119663|NCT01229228|2710819|P2|NOT COMPLETED|Overall Study||0
1119664|NCT01229228|2710820|P1|NOT COMPLETED|Overall Study||1
1119665|NCT01229228|2710816|P5|COMPLETED|Overall Study||50
1119666|NCT01229228|2710817|P4|COMPLETED|Overall Study||51
1119667|NCT01229228|2710818|P3|COMPLETED|Overall Study||49
1119668|NCT01229228|2710819|P2|COMPLETED|Overall Study||51
1119669|NCT01229228|2710820|P1|COMPLETED|Overall Study||50
1119670|NCT01229228|2710816|P5|STARTED|Overall Study||51
1119671|NCT01229228|2710817|P4|STARTED|Overall Study||51
1119672|NCT01229228|2710818|P3|STARTED|Overall Study||50
1119673|NCT01229228|2710819|P2|STARTED|Overall Study||51
1119674|NCT01229228|2710820|P1|STARTED|Overall Study||51
1119675|NCT01229254|2710835|P3|NOT COMPLETED|Overall Study||12
1119676|NCT01229254|2710836|P2|NOT COMPLETED|Overall Study||16
1119677|NCT01229254|2710837|P1|NOT COMPLETED|Overall Study||15
1119678|NCT01229254|2710835|P3|COMPLETED|Overall Study||61
1119679|NCT01229254|2710836|P2|COMPLETED|Overall Study||58
1119680|NCT01229254|2710837|P1|COMPLETED|Overall Study||27
1119681|NCT01229254|2710835|P3|STARTED|Overall Study||73
1119682|NCT01229254|2710836|P2|STARTED|Overall Study||74
1119683|NCT01229254|2710837|P1|STARTED|Overall Study||42
1119684|NCT01229371|2710850|P4|NOT COMPLETED|Overall Study||0
1119685|NCT01229371|2710851|P3|NOT COMPLETED|Overall Study||0
1119686|NCT01229371|2710852|P2|NOT COMPLETED|Overall Study||1
1119687|NCT01229371|2710853|P1|NOT COMPLETED|Overall Study||0
1119688|NCT01229371|2710850|P4|COMPLETED|Overall Study||110
1119689|NCT01229371|2710851|P3|COMPLETED|Overall Study||110
1119690|NCT01229371|2710852|P2|COMPLETED|Overall Study||110
1119691|NCT01229371|2710853|P1|COMPLETED|Overall Study||109
1119692|NCT01229371|2710850|P4|STARTED|Overall Study||110
1119693|NCT01229371|2710851|P3|STARTED|Overall Study||110
1119694|NCT01229371|2710852|P2|STARTED|Overall Study||111
1119695|NCT01229371|2710853|P1|STARTED|Overall Study||109
1119696|NCT01229397|2710877|P2|NOT COMPLETED|Overall Study||9
1119697|NCT01229397|2710878|P1|NOT COMPLETED|Overall Study||11
1119698|NCT01229397|2710877|P2|COMPLETED|Overall Study||93
1119699|NCT01229397|2710878|P1|COMPLETED|Overall Study||92
1119700|NCT01229397|2710877|P2|STARTED|Overall Study||102
1119701|NCT01229397|2710878|P1|STARTED|Overall Study||103
1119702|NCT01229410|2710894|P2|NOT COMPLETED|Overall Study||3
1119703|NCT01229410|2710895|P1|NOT COMPLETED|Overall Study||5
1119704|NCT01229410|2710894|P2|COMPLETED|Overall Study||9
1119705|NCT01229410|2710895|P1|COMPLETED|Overall Study||7
1119706|NCT01229410|2710894|P2|STARTED|Overall Study||12
1119707|NCT01229410|2710895|P1|STARTED|Overall Study||12
1119708|NCT01229423|2710905|P1|NOT COMPLETED|Overall Study||15
1119709|NCT01229423|2710905|P1|COMPLETED|Overall Study||47
1119710|NCT01229423|2710905|P1|STARTED|Overall Study||62
1119711|NCT01229436|2710914|P1|NOT COMPLETED|Overall Study||5
1119712|NCT01229436|2710914|P1|COMPLETED|Overall Study||249
1119713|NCT01229436|2710914|P1|STARTED|Overall Study||254
1119714|NCT01229462|2710954|P2|NOT COMPLETED|Overall Study||9
1119715|NCT01229462|2710955|P1|NOT COMPLETED|Overall Study||5
1119716|NCT01229462|2710954|P2|COMPLETED|Overall Study||109
1119717|NCT01229462|2710955|P1|COMPLETED|Overall Study||115
1119718|NCT01229462|2710954|P2|STARTED|Overall Study||118
1119719|NCT01229462|2710955|P1|STARTED|Overall Study||120
1119720|NCT01229527|2710964|P3|NOT COMPLETED|Overall Study||0
1119721|NCT01229527|2710965|P2|NOT COMPLETED|Overall Study||0
1119722|NCT01229527|2710966|P1|NOT COMPLETED|Overall Study||0
1119723|NCT01229527|2710964|P3|COMPLETED|Overall Study||30
1119724|NCT01229527|2710965|P2|COMPLETED|Overall Study||30
1119725|NCT01229527|2710966|P1|COMPLETED|Overall Study||30
1119726|NCT01229527|2710964|P3|STARTED|Overall Study||30
1119727|NCT01229527|2710965|P2|STARTED|Overall Study||30
1119728|NCT01229527|2710966|P1|STARTED|Overall Study||30
1119729|NCT01229722|2710979|P2|NOT COMPLETED|Overall Study||0
1119730|NCT01229722|2710980|P1|NOT COMPLETED|Overall Study||4
1119731|NCT01229722|2710979|P2|COMPLETED|Overall Study||36
1119732|NCT01229722|2710980|P1|COMPLETED|Overall Study||30
1119733|NCT01229722|2710979|P2|STARTED|Overall Study||36
1119734|NCT01229722|2710980|P1|STARTED|Overall Study||34
1119735|NCT01229735|2710988|P2|NOT COMPLETED|Overall Study||66
1119736|NCT01229735|2710989|P1|NOT COMPLETED|Overall Study||66
1119737|NCT01229735|2710988|P2|COMPLETED|Overall Study||100
1119738|NCT01229735|2710989|P1|COMPLETED|Overall Study||111
1119739|NCT01229735|2710988|P2|STARTED|Overall Study||166
1119740|NCT01229735|2710989|P1|STARTED|Overall Study||177
1119741|NCT01229891|2711006|P3|NOT COMPLETED|Overall Study||0
1119742|NCT01229891|2711007|P2|NOT COMPLETED|Overall Study||0
1119743|NCT01229891|2711008|P1|NOT COMPLETED|Overall Study||0
1119744|NCT01229891|2711006|P3|COMPLETED|Overall Study||30
1119745|NCT01229891|2711007|P2|COMPLETED|Overall Study||30
1119746|NCT01229891|2711008|P1|COMPLETED|Overall Study||30
1119747|NCT01229891|2711006|P3|STARTED|Overall Study||30
1119748|NCT01229891|2711007|P2|STARTED|Overall Study||30
1119749|NCT01229891|2711008|P1|STARTED|Overall Study||30
1119750|NCT01229943|2711039|P2|NOT COMPLETED|Overall Study||17
1119751|NCT01229943|2711040|P1|NOT COMPLETED|Overall Study||18
1119752|NCT01229943|2711039|P2|COMPLETED|Overall Study||58
1119753|NCT01229943|2711040|P1|COMPLETED|Overall Study||57
1119754|NCT01229943|2711039|P2|STARTED|Overall Study||75
1119755|NCT01229943|2711040|P1|STARTED|Overall Study||75
1119756|NCT01230021|2711050|P1|NOT COMPLETED|Overall Study||0
1119757|NCT01230021|2711050|P1|COMPLETED|Overall Study||6
1119758|NCT01230021|2711050|P1|STARTED|Overall Study||6
1119759|NCT01230060|2711070|P1|NOT COMPLETED|Overall Study||1
1119760|NCT01230060|2711070|P1|COMPLETED|Overall Study||121
1119761|NCT01230060|2711070|P1|STARTED|Overall Study||122
1119762|NCT01230177|2711074|P1|NOT COMPLETED|Overall Study||0
1119763|NCT01230177|2711074|P1|COMPLETED|Overall Study||3
1119764|NCT01230177|2711074|P1|STARTED|Overall Study||3
1119765|NCT01230307|2711084|P2|NOT COMPLETED|Overall Study||2
1119766|NCT01230307|2711085|P1|NOT COMPLETED|Overall Study||0
1119767|NCT01230307|2711084|P2|COMPLETED|Overall Study||4
1119768|NCT01230307|2711085|P1|COMPLETED|Overall Study||6
1119769|NCT01230307|2711084|P2|STARTED|Overall Study||6
1119770|NCT01230307|2711085|P1|STARTED|Overall Study||6
1119771|NCT01230424|2711099|P2|NOT COMPLETED|Overall Study||0
1119772|NCT01230424|2711100|P1|NOT COMPLETED|Overall Study||0
1119773|NCT01230424|2711099|P2|COMPLETED|Overall Study||70
1119774|NCT01230424|2711100|P1|COMPLETED|Overall Study||70
1119775|NCT01230424|2711099|P2|STARTED|Overall Study||70
1119776|NCT01230424|2711100|P1|STARTED|Overall Study||70
1119777|NCT01230502|2711129|P3|NOT COMPLETED|Overall Study||0
1119778|NCT01230502|2711130|P2|NOT COMPLETED|Overall Study||0
1119779|NCT01230502|2711131|P1|NOT COMPLETED|Overall Study||0
1119780|NCT01230502|2711129|P3|COMPLETED|Overall Study||0
1119781|NCT01230502|2711130|P2|COMPLETED|Overall Study||0
1119782|NCT01230502|2711131|P1|COMPLETED|Overall Study||9
1119783|NCT01230502|2711129|P3|STARTED|Overall Study||0
1119784|NCT01230502|2711130|P2|STARTED|Overall Study||0
1119785|NCT01230502|2711131|P1|STARTED|Overall Study||9
1119786|NCT01230710|2711142|P1|NOT COMPLETED|Overall Study||49
1119787|NCT01230710|2711142|P1|COMPLETED|Overall Study||2
1119788|NCT01230710|2711142|P1|STARTED|Overall Study||51
1119789|NCT01230749|2711154|P4|NOT COMPLETED|Overall Study||2
1119790|NCT01230749|2711155|P3|NOT COMPLETED|Overall Study||2
1119791|NCT01230749|2711156|P2|NOT COMPLETED|Overall Study||2
1119792|NCT01230749|2711157|P1|NOT COMPLETED|Overall Study||0
1119793|NCT01230749|2711154|P4|COMPLETED|Overall Study||20
1119794|NCT01230749|2711155|P3|COMPLETED|Overall Study||21
1119795|NCT01230749|2711156|P2|COMPLETED|Overall Study||20
1119796|NCT01230749|2711157|P1|COMPLETED|Overall Study||22
1119797|NCT01230749|2711154|P4|STARTED|Overall Study||22
1119798|NCT01230749|2711155|P3|STARTED|Overall Study||23
1119799|NCT01230749|2711156|P2|STARTED|Overall Study||22
1119800|NCT01230749|2711157|P1|STARTED|Overall Study||22
1119801|NCT01230788|2711192|P1|NOT COMPLETED|Overall Study||1
1119802|NCT01230788|2711192|P1|COMPLETED|Overall Study||0
1119803|NCT01230788|2711192|P1|STARTED|Overall Study||1
1119804|NCT01230814|2711202|P2|NOT COMPLETED|Overall Study||4
1119805|NCT01230814|2711203|P1|NOT COMPLETED|Overall Study||13
1119806|NCT01230814|2711202|P2|COMPLETED|Overall Study||112
1119807|NCT01230814|2711203|P1|COMPLETED|Overall Study||105
1119808|NCT01230814|2711202|P2|STARTED|Overall Study||116
1119809|NCT01230814|2711203|P1|STARTED|Overall Study||118
1119810|NCT01230827|2711219|P4|NOT COMPLETED|Overall Study||78
1119811|NCT01230827|2711220|P3|NOT COMPLETED|Overall Study||65
1119812|NCT01230827|2711221|P2|NOT COMPLETED|Overall Study||11
1119813|NCT01230827|2711222|P1|NOT COMPLETED|Overall Study||19
1119814|NCT01230827|2711219|P4|COMPLETED|Overall Study||0
1119815|NCT01230827|2711220|P3|COMPLETED|Overall Study||0
1119816|NCT01230827|2711221|P2|COMPLETED|Overall Study||0
1119817|NCT01230827|2711222|P1|COMPLETED|Overall Study||0
1119818|NCT01230827|2711219|P4|STARTED|Overall Study||78
1119819|NCT01230827|2711220|P3|STARTED|Overall Study||65
1119820|NCT01230827|2711221|P2|STARTED|Overall Study||11
1119821|NCT01230827|2711222|P1|STARTED|Overall Study||19
1119822|NCT01230892|2711238|P2|NOT COMPLETED|Overall Study||1
1119823|NCT01230892|2711239|P1|NOT COMPLETED|Overall Study||3
1119824|NCT01230892|2711238|P2|COMPLETED|Overall Study||13
1119825|NCT01230892|2711239|P1|COMPLETED|Overall Study||12
1119826|NCT01230892|2711238|P2|STARTED|Overall Study||14
1119827|NCT01230892|2711239|P1|STARTED|Overall Study||15
1119828|NCT01224171|2711247|P2|NOT COMPLETED|Overall Study||13
1119829|NCT01224171|2711248|P1|NOT COMPLETED|Overall Study||15
1119830|NCT01224171|2711247|P2|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|196
1119831|NCT01224171|2711248|P1|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|192
1119832|NCT01224171|2711247|P2|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|158
1119833|NCT01224171|2711248|P1|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|157
1119834|NCT01224171|2711247|P2|STARTED|Overall Study||209
1119835|NCT01224171|2711248|P1|STARTED|Overall Study||207
1119836|NCT01224236|2711270|P2|NOT COMPLETED|Overall Study||1
1119837|NCT01224236|2711271|P1|NOT COMPLETED|Overall Study||1
1119838|NCT01224236|2711270|P2|COMPLETED|Overall Study||73
1119839|NCT01224236|2711271|P1|COMPLETED|Overall Study||75
1119840|NCT01224236|2711270|P2|STARTED|Overall Study||74
1119841|NCT01224236|2711271|P1|STARTED|Overall Study||76
1119842|NCT01224431|2711281|P2|NOT COMPLETED|Overall Study||5
1119843|NCT01224431|2711282|P1|NOT COMPLETED|Overall Study||0
1119844|NCT01224431|2711281|P2|COMPLETED|Overall Study||25
1119845|NCT01224431|2711282|P1|COMPLETED|Overall Study||30
1119846|NCT01224431|2711281|P2|STARTED|Overall Study||30
1119847|NCT01224431|2711282|P1|STARTED|Overall Study||30
1119848|NCT01224444|2711288|P1|NOT COMPLETED|Overall Study||0
1119849|NCT01224444|2711288|P1|COMPLETED|Overall Study||269
1119850|NCT01224444|2711288|P1|STARTED|Overall Study||269
1119851|NCT01231230|2711292|P1|NOT COMPLETED|Overall Study||0
1119852|NCT01231230|2711292|P1|COMPLETED|Overall Study||14
1119853|NCT01231230|2711292|P1|Placebo|Overall Study||14
1119854|NCT01231230|2711292|P1|Fluticasone/Salmeterol|Overall Study||14
1119855|NCT01231230|2711292|P1|Salmeterol|Overall Study||14
1119856|NCT01231230|2711292|P1|Fluticasone|Overall Study||14
1119857|NCT01231230|2711292|P1|STARTED|Overall Study||14
1119858|NCT01231321|2711302|P1|NOT COMPLETED|Overall Study||5
1119859|NCT01231321|2711302|P1|COMPLETED|Overall Study||95
1119860|NCT01231321|2711302|P1|STARTED|Overall Study||100
1119861|NCT01231334|2711315|P2|NOT COMPLETED|Overall Study||21
1119862|NCT01231334|2711316|P1|NOT COMPLETED|Overall Study||19
1119863|NCT01231334|2711315|P2|COMPLETED|Overall Study||120
1119864|NCT01231334|2711316|P1|COMPLETED|Overall Study||126
1119865|NCT01231334|2711315|P2|STARTED|Overall Study||141
1119866|NCT01231334|2711316|P1|STARTED|Overall Study||145
1119867|NCT01233232|2711337|P3|NOT COMPLETED|Overall Study||0
1119868|NCT01233232|2711338|P2|NOT COMPLETED|Overall Study||0
1119869|NCT01233232|2711339|P1|NOT COMPLETED|Overall Study||1
1119870|NCT01233232|2711337|P3|COMPLETED|Overall Study||28
1119871|NCT01233232|2711338|P2|COMPLETED|Overall Study||30
1119872|NCT01233232|2711339|P1|COMPLETED|Overall Study||28
1119873|NCT01233232|2711337|P3|STARTED|Overall Study||28
1119874|NCT01233232|2711338|P2|STARTED|Overall Study||30
1119875|NCT01233232|2711339|P1|STARTED|Overall Study||29
1119876|NCT01233258|2711395|P6|NOT COMPLETED|Second Intervention (6 Months)||0
1119877|NCT01233258|2711396|P5|NOT COMPLETED|Second Intervention (6 Months)||0
1119878|NCT01233258|2711397|P4|NOT COMPLETED|Second Intervention (6 Months)||0
1119879|NCT01233258|2711398|P3|NOT COMPLETED|Second Intervention (6 Months)||0
1119880|NCT01233258|2711399|P2|NOT COMPLETED|Second Intervention (6 Months)||0
1119881|NCT01233258|2711400|P1|NOT COMPLETED|Second Intervention (6 Months)||0
1119882|NCT01233258|2711395|P6|COMPLETED|Second Intervention (6 Months)||15
1119883|NCT01233258|2711396|P5|COMPLETED|Second Intervention (6 Months)||16
1119884|NCT01233258|2711397|P4|COMPLETED|Second Intervention (6 Months)||15
1119885|NCT01233258|2711398|P3|COMPLETED|Second Intervention (6 Months)||13
1119886|NCT01233258|2711399|P2|COMPLETED|Second Intervention (6 Months)||10
1119887|NCT01233258|2711400|P1|COMPLETED|Second Intervention (6 Months)||10
1119888|NCT01233258|2711395|P6|STARTED|Second Intervention (6 Months)||15
1119889|NCT01233258|2711396|P5|STARTED|Second Intervention (6 Months)||16
1119890|NCT01233258|2711397|P4|STARTED|Second Intervention (6 Months)||15
1119891|NCT01233258|2711398|P3|STARTED|Second Intervention (6 Months)||13
1119892|NCT01233258|2711399|P2|STARTED|Second Intervention (6 Months)||10
1119893|NCT01233258|2711400|P1|STARTED|Second Intervention (6 Months)||10
1119894|NCT01233258|2711395|P6|NOT COMPLETED|Washout (2-3 Days)||0
1119895|NCT01233258|2711396|P5|NOT COMPLETED|Washout (2-3 Days)||0
1119896|NCT01233258|2711397|P4|NOT COMPLETED|Washout (2-3 Days)||0
1119897|NCT01233258|2711398|P3|NOT COMPLETED|Washout (2-3 Days)||0
1119898|NCT01233258|2711399|P2|NOT COMPLETED|Washout (2-3 Days)||0
1119899|NCT01233258|2711400|P1|NOT COMPLETED|Washout (2-3 Days)||0
1119900|NCT01233258|2711395|P6|COMPLETED|Washout (2-3 Days)||15
1119901|NCT01233258|2711396|P5|COMPLETED|Washout (2-3 Days)||16
1119902|NCT01233258|2711397|P4|COMPLETED|Washout (2-3 Days)||15
1119903|NCT01233258|2711398|P3|COMPLETED|Washout (2-3 Days)||13
1119904|NCT01233258|2711399|P2|COMPLETED|Washout (2-3 Days)||10
1119905|NCT01233258|2711400|P1|COMPLETED|Washout (2-3 Days)||10
1119906|NCT01233258|2711395|P6|STARTED|Washout (2-3 Days)||15
1119907|NCT01233258|2711396|P5|STARTED|Washout (2-3 Days)||16
1119908|NCT01233258|2711397|P4|STARTED|Washout (2-3 Days)||15
1119909|NCT01233258|2711398|P3|STARTED|Washout (2-3 Days)||13
1119910|NCT01233258|2711399|P2|STARTED|Washout (2-3 Days)||10
1119911|NCT01233258|2711400|P1|STARTED|Washout (2-3 Days)||10
1119912|NCT01233258|2711395|P6|NOT COMPLETED|First Intervention (6 Months)||1
1119913|NCT01233258|2711396|P5|NOT COMPLETED|First Intervention (6 Months)||0
1119914|NCT01233258|2711397|P4|NOT COMPLETED|First Intervention (6 Months)||1
1119915|NCT01233258|2711398|P3|NOT COMPLETED|First Intervention (6 Months)||1
1119916|NCT01233258|2711399|P2|NOT COMPLETED|First Intervention (6 Months)||0
1119917|NCT01233258|2711400|P1|NOT COMPLETED|First Intervention (6 Months)||1
1119918|NCT01233258|2711395|P6|COMPLETED|First Intervention (6 Months)||15
1119919|NCT01233258|2711396|P5|COMPLETED|First Intervention (6 Months)||16
1119920|NCT01233258|2711397|P4|COMPLETED|First Intervention (6 Months)||15
1119921|NCT01233258|2711398|P3|COMPLETED|First Intervention (6 Months)||13
1119922|NCT01233258|2711399|P2|COMPLETED|First Intervention (6 Months)||10
1119923|NCT01233258|2711400|P1|COMPLETED|First Intervention (6 Months)||10
1119924|NCT01233258|2711395|P6|Participants Received Treatment|First Intervention (6 Months)||15
1119925|NCT01233258|2711396|P5|Participants Received Treatment|First Intervention (6 Months)||16
1119926|NCT01233258|2711397|P4|Participants Received Treatment|First Intervention (6 Months)||15
1119927|NCT01233258|2711398|P3|Participants Received Treatment|First Intervention (6 Months)||13
1119928|NCT01233258|2711399|P2|Participants Received Treatment|First Intervention (6 Months)||10
1119929|NCT01233258|2711400|P1|Participants Received Treatment|First Intervention (6 Months)||11
1119930|NCT01233258|2711395|P6|STARTED|First Intervention (6 Months)||16
1119931|NCT01233258|2711396|P5|STARTED|First Intervention (6 Months)||16
1119932|NCT01233258|2711397|P4|STARTED|First Intervention (6 Months)||16
1119933|NCT01233258|2711398|P3|STARTED|First Intervention (6 Months)||14
1119934|NCT01233258|2711399|P2|STARTED|First Intervention (6 Months)||10
1119935|NCT01233258|2711400|P1|STARTED|First Intervention (6 Months)||11
1119936|NCT01233284|2711417|P5|NOT COMPLETED|Period 4 (4 Weeks)||0
1119937|NCT01233284|2711418|P4|NOT COMPLETED|Period 4 (4 Weeks)||1
1119938|NCT01233284|2711419|P3|NOT COMPLETED|Period 4 (4 Weeks)||0
1119939|NCT01233284|2711420|P2|NOT COMPLETED|Period 4 (4 Weeks)||1
1119940|NCT01233284|2711421|P1|NOT COMPLETED|Period 4 (4 Weeks)||0
1119941|NCT01233284|2711417|P5|COMPLETED|Period 4 (4 Weeks)||1
1119942|NCT01233284|2711418|P4|COMPLETED|Period 4 (4 Weeks)||33
1119943|NCT01233284|2711419|P3|COMPLETED|Period 4 (4 Weeks)||35
1119944|NCT01233284|2711420|P2|COMPLETED|Period 4 (4 Weeks)||36
1119945|NCT01233284|2711421|P1|COMPLETED|Period 4 (4 Weeks)||36
1119946|NCT01233284|2711417|P5|STARTED|Period 4 (4 Weeks)||1
1119947|NCT01233284|2711418|P4|STARTED|Period 4 (4 Weeks)||34
1119948|NCT01233284|2711419|P3|STARTED|Period 4 (4 Weeks)||35
1119949|NCT01233284|2711420|P2|STARTED|Period 4 (4 Weeks)||37
1119950|NCT01233284|2711421|P1|STARTED|Period 4 (4 Weeks)||36
1119951|NCT01233284|2711417|P5|NOT COMPLETED|Period 3 (4 Weeks)||0
1119952|NCT01233284|2711418|P4|NOT COMPLETED|Period 3 (4 Weeks)||1
1119953|NCT01233284|2711419|P3|NOT COMPLETED|Period 3 (4 Weeks)||1
1119954|NCT01233284|2711420|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
1119955|NCT01233284|2711421|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
1119956|NCT01233284|2711417|P5|COMPLETED|Period 3 (4 Weeks)||1
1119957|NCT01233284|2711418|P4|COMPLETED|Period 3 (4 Weeks)||34
1119958|NCT01233284|2711419|P3|COMPLETED|Period 3 (4 Weeks)||35
1119959|NCT01233284|2711420|P2|COMPLETED|Period 3 (4 Weeks)||37
1119960|NCT01233284|2711421|P1|COMPLETED|Period 3 (4 Weeks)||36
1119961|NCT01233284|2711417|P5|STARTED|Period 3 (4 Weeks)||1
1119962|NCT01233284|2711418|P4|STARTED|Period 3 (4 Weeks)||35
1119963|NCT01233284|2711419|P3|STARTED|Period 3 (4 Weeks)||36
1119964|NCT01233284|2711420|P2|STARTED|Period 3 (4 Weeks)||37
1119965|NCT01233284|2711421|P1|STARTED|Period 3 (4 Weeks)||36
1119966|NCT01233284|2711417|P5|NOT COMPLETED|Period 2 (4 Weeks)||0
1119967|NCT01233284|2711418|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
1119968|NCT01233284|2711419|P3|NOT COMPLETED|Period 2 (4 Weeks)||1
1119969|NCT01233284|2711420|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
1119970|NCT01233284|2711421|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
1119971|NCT01233284|2711417|P5|COMPLETED|Period 2 (4 Weeks)||1
1119972|NCT01233284|2711418|P4|COMPLETED|Period 2 (4 Weeks)||35
1119973|NCT01233284|2711419|P3|COMPLETED|Period 2 (4 Weeks)||36
1119974|NCT01233284|2711420|P2|COMPLETED|Period 2 (4 Weeks)||37
1119975|NCT01233284|2711421|P1|COMPLETED|Period 2 (4 Weeks)||36
1119976|NCT01233284|2711417|P5|STARTED|Period 2 (4 Weeks)||1
1119977|NCT01233284|2711418|P4|STARTED|Period 2 (4 Weeks)||35
1119978|NCT01233284|2711419|P3|STARTED|Period 2 (4 Weeks)||37
1119979|NCT01233284|2711420|P2|STARTED|Period 2 (4 Weeks)||37
1119980|NCT01233284|2711421|P1|STARTED|Period 2 (4 Weeks)||36
1119981|NCT01233284|2711417|P5|NOT COMPLETED|Period 1 (4 Weeks)||0
1119982|NCT01233284|2711418|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
1119983|NCT01233284|2711419|P3|NOT COMPLETED|Period 1 (4 Weeks)||1
1119984|NCT01233284|2711420|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
1119985|NCT01233284|2711421|P1|NOT COMPLETED|Period 1 (4 Weeks)||1
1119986|NCT01233284|2711417|P5|COMPLETED|Period 1 (4 Weeks)||1
1119987|NCT01233284|2711418|P4|COMPLETED|Period 1 (4 Weeks)||35
1119988|NCT01233284|2711419|P3|COMPLETED|Period 1 (4 Weeks)||37
1119989|NCT01233284|2711420|P2|COMPLETED|Period 1 (4 Weeks)||37
1119990|NCT01233284|2711421|P1|COMPLETED|Period 1 (4 Weeks)||36
1119991|NCT01233284|2711417|P5|STARTED|Period 1 (4 Weeks)||1
1119992|NCT01233284|2711418|P4|STARTED|Period 1 (4 Weeks)||35
1119993|NCT01233284|2711419|P3|STARTED|Period 1 (4 Weeks)||38
1119994|NCT01233284|2711420|P2|STARTED|Period 1 (4 Weeks)||38
1119995|NCT01233284|2711421|P1|STARTED|Period 1 (4 Weeks)||37
1119996|NCT01233687|2711499|P1|NOT COMPLETED|Phase II AMG 102 + Erlotinib||4
1119997|NCT01233687|2711499|P1|COMPLETED|Phase II AMG 102 + Erlotinib||45
1119998|NCT01233687|2711499|P1|Response-Evaluable|Phase II AMG 102 + Erlotinib||45
1119999|NCT01233687|2711499|P1|STARTED|Phase II AMG 102 + Erlotinib|Includes 7 participants from Phase 1 part of study.|49
1120000|NCT01233687|2711499|P1|NOT COMPLETED|Phase I RP2D AMG 102 + Erlotinib||0
1120001|NCT01233687|2711499|P1|COMPLETED|Phase I RP2D AMG 102 + Erlotinib||7
1120002|NCT01233687|2711499|P1|STARTED|Phase I RP2D AMG 102 + Erlotinib||7
1120003|NCT01233726|2711510|P3|NOT COMPLETED|Overall Study||1
1120004|NCT01233726|2711511|P2|NOT COMPLETED|Overall Study||0
1120005|NCT01233726|2711512|P1|NOT COMPLETED|Overall Study||1
1120006|NCT01233726|2711510|P3|COMPLETED|Overall Study||52
1120007|NCT01233726|2711511|P2|COMPLETED|Overall Study||53
1120008|NCT01233726|2711512|P1|COMPLETED|Overall Study||52
1120009|NCT01233726|2711510|P3|STARTED|Overall Study||53
1120010|NCT01233726|2711511|P2|STARTED|Overall Study||53
1120011|NCT01233726|2711512|P1|STARTED|Overall Study||53
1120012|NCT01233817|2711550|P1|NOT COMPLETED|Overall Study||3
1120013|NCT01233817|2711550|P1|COMPLETED|Overall Study||9
1120014|NCT01233817|2711550|P1|STARTED|Overall Study||12
1120015|NCT01233869|2711558|P4|NOT COMPLETED|Extended Treatment Period (46 Months)||16
1120016|NCT01233869|2711559|P3|NOT COMPLETED|Extended Treatment Period (46 Months)||5
1120017|NCT01233869|2711560|P2|NOT COMPLETED|Extended Treatment Period (46 Months)||3
1120018|NCT01233869|2711561|P1|NOT COMPLETED|Extended Treatment Period (46 Months)||14
1120019|NCT01233869|2711558|P4|COMPLETED|Extended Treatment Period (46 Months)||18
1120020|NCT01233869|2711559|P3|COMPLETED|Extended Treatment Period (46 Months)||17
1120021|NCT01233869|2711560|P2|COMPLETED|Extended Treatment Period (46 Months)||0
1120022|NCT01233869|2711561|P1|COMPLETED|Extended Treatment Period (46 Months)||20
1120023|NCT01233869|2711558|P4|STARTED|Extended Treatment Period (46 Months)||34
1120024|NCT01233869|2711559|P3|STARTED|Extended Treatment Period (46 Months)||22
1120025|NCT01233869|2711560|P2|STARTED|Extended Treatment Period (46 Months)||3
1120026|NCT01233869|2711561|P1|STARTED|Extended Treatment Period (46 Months)||34
1120027|NCT01233869|2711558|P4|NOT COMPLETED|Washout Period 30 Days||0
1120028|NCT01233869|2711559|P3|NOT COMPLETED|Washout Period 30 Days||0
1120029|NCT01233869|2711560|P2|NOT COMPLETED|Washout Period 30 Days||0
1120030|NCT01233869|2711561|P1|NOT COMPLETED|Washout Period 30 Days||0
1120031|NCT01233869|2711558|P4|COMPLETED|Washout Period 30 Days||34
1120032|NCT01233869|2711559|P3|COMPLETED|Washout Period 30 Days||22
1120033|NCT01233869|2711560|P2|COMPLETED|Washout Period 30 Days||3
1120034|NCT01233869|2711561|P1|COMPLETED|Washout Period 30 Days||34
1120035|NCT01233869|2711558|P4|STARTED|Washout Period 30 Days||34
1120036|NCT01233869|2711559|P3|STARTED|Washout Period 30 Days||22
1120037|NCT01233869|2711560|P2|STARTED|Washout Period 30 Days||3
1120038|NCT01233869|2711561|P1|STARTED|Washout Period 30 Days||34
1120039|NCT01233869|2711558|P4|NOT COMPLETED|Initial Treatment Period (24 Months)||22
1120040|NCT01233869|2711559|P3|NOT COMPLETED|Initial Treatment Period (24 Months)||2
1120041|NCT01233869|2711560|P2|NOT COMPLETED|Initial Treatment Period (24 Months)||28
1120042|NCT01233869|2711561|P1|NOT COMPLETED|Initial Treatment Period (24 Months)||24
1120043|NCT01233869|2711558|P4|COMPLETED|Initial Treatment Period (24 Months)||34
1120044|NCT01233869|2711559|P3|COMPLETED|Initial Treatment Period (24 Months)||22
1120045|NCT01233869|2711560|P2|COMPLETED|Initial Treatment Period (24 Months)||3
1120046|NCT01233869|2711561|P1|COMPLETED|Initial Treatment Period (24 Months)||34
1120047|NCT01233869|2711558|P4|STARTED|Initial Treatment Period (24 Months)||56
1120048|NCT01233869|2711559|P3|STARTED|Initial Treatment Period (24 Months)||24
1120049|NCT01233869|2711560|P2|STARTED|Initial Treatment Period (24 Months)||31
1120050|NCT01233869|2711561|P1|STARTED|Initial Treatment Period (24 Months)||58
1120051|NCT01233921|2711649|P2|NOT COMPLETED|Overall Study||0
1120052|NCT01233921|2711650|P1|NOT COMPLETED|Overall Study||0
1120053|NCT01233921|2711649|P2|COMPLETED|Overall Study||3
1120054|NCT01233921|2711650|P1|COMPLETED|Overall Study||3
1120055|NCT01233921|2711649|P2|STARTED|Overall Study||3
1120056|NCT01233921|2711650|P1|STARTED|Overall Study||3
1120057|NCT01233999|2711658|P1|NOT COMPLETED|Overall Study||2
1120058|NCT01233999|2711658|P1|COMPLETED|Overall Study||8
1120059|NCT01233999|2711658|P1|STARTED|Overall Study||10
1120060|NCT01234103|2711664|P2|NOT COMPLETED|Overall Study||0
1120061|NCT01234103|2711665|P1|NOT COMPLETED|Overall Study||0
1120062|NCT01234103|2711664|P2|COMPLETED|Overall Study||391
1120063|NCT01234103|2711665|P1|COMPLETED|Overall Study||542
1120064|NCT01234103|2711664|P2|STARTED|Overall Study||391
1120065|NCT01234103|2711665|P1|STARTED|Overall Study||542
1120066|NCT01234207|2711673|P2|NOT COMPLETED|Second Intervention||0
1120067|NCT01234207|2711674|P1|NOT COMPLETED|Second Intervention||0
1120068|NCT01234207|2711673|P2|COMPLETED|Second Intervention||48
1120069|NCT01234207|2711674|P1|COMPLETED|Second Intervention||47
1120070|NCT01234207|2711673|P2|STARTED|Second Intervention||48
1120071|NCT01234207|2711674|P1|STARTED|Second Intervention||47
1120072|NCT01234207|2711673|P2|NOT COMPLETED|1-Week Washout Period||0
1120073|NCT01234207|2711674|P1|NOT COMPLETED|1-Week Washout Period||0
1120074|NCT01234207|2711673|P2|COMPLETED|1-Week Washout Period||48
1120075|NCT01234207|2711674|P1|COMPLETED|1-Week Washout Period||47
1120076|NCT01234207|2711673|P2|STARTED|1-Week Washout Period||48
1120077|NCT01234207|2711674|P1|STARTED|1-Week Washout Period||47
1120078|NCT01234207|2711673|P2|NOT COMPLETED|First Intervention||0
1120079|NCT01234207|2711674|P1|NOT COMPLETED|First Intervention||0
1120080|NCT01234207|2711673|P2|COMPLETED|First Intervention||48
1120081|NCT01234207|2711674|P1|COMPLETED|First Intervention||47
1120082|NCT01234207|2711673|P2|STARTED|First Intervention||48
1120083|NCT01234207|2711674|P1|STARTED|First Intervention||47
1120084|NCT01234337|2711696|P2|NOT COMPLETED|Overall Study||64
1120085|NCT01234337|2711697|P1|NOT COMPLETED|Overall Study||97
1120086|NCT01234337|2711696|P2|COMPLETED|Overall Study||207
1120087|NCT01234337|2711697|P1|COMPLETED|Overall Study||169
1120088|NCT01234337|2711696|P2|Participants Received Treatment|Overall Study||267
1120089|NCT01234337|2711697|P1|Participants Received Treatment|Overall Study||260
1120090|NCT01234337|2711696|P2|STARTED|Overall Study||271
1120091|NCT01234337|2711697|P1|STARTED|Overall Study||266
1120092|NCT01234467|2711725|P1|NOT COMPLETED|Overall Study||12
1120093|NCT01234467|2711725|P1|COMPLETED|Overall Study||11
1120094|NCT01234467|2711725|P1|STARTED|Overall Study||23
1120095|NCT01234675|2711734|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
1120096|NCT01234675|2711735|P1|NOT COMPLETED|Second Intervention (6 Weeks)||2
1120097|NCT01234675|2711734|P2|COMPLETED|Second Intervention (6 Weeks)||8
1120098|NCT01234675|2711735|P1|COMPLETED|Second Intervention (6 Weeks)||7
1120099|NCT01234675|2711734|P2|STARTED|Second Intervention (6 Weeks)||8
1120100|NCT01234675|2711735|P1|STARTED|Second Intervention (6 Weeks)||9
1120101|NCT01234675|2711734|P2|NOT COMPLETED|First Intervention (6 Weeks)||1
1120102|NCT01234675|2711735|P1|NOT COMPLETED|First Intervention (6 Weeks)||1
1120103|NCT01234675|2711734|P2|COMPLETED|First Intervention (6 Weeks)||8
1120104|NCT01234675|2711735|P1|COMPLETED|First Intervention (6 Weeks)||9
1120105|NCT01234675|2711734|P2|STARTED|First Intervention (6 Weeks)||9
1120106|NCT01234675|2711735|P1|STARTED|First Intervention (6 Weeks)||10
1120107|NCT01234714|2711749|P1|NOT COMPLETED|Overall Study||0
1120108|NCT01234714|2711749|P1|COMPLETED|Overall Study||84
1120109|NCT01234714|2711749|P1|STARTED|Overall Study||84
1120116|NCT01234870|2711780|P1|NOT COMPLETED|Overall Study||0
1120117|NCT01234870|2711780|P1|COMPLETED|Overall Study||40
1120118|NCT01234870|2711780|P1|STARTED|Overall Study||40
1120119|NCT01234883|2711787|P2|NOT COMPLETED|Overall Study||13
1120120|NCT01234883|2711788|P1|NOT COMPLETED|Overall Study||10
1120121|NCT01234883|2711787|P2|COMPLETED|Overall Study||36
1120122|NCT01234883|2711788|P1|COMPLETED|Overall Study||41
1120123|NCT01234883|2711787|P2|STARTED|Overall Study||49
1120124|NCT01234883|2711788|P1|STARTED|Overall Study||51
1120125|NCT01234922|2711798|P4|NOT COMPLETED|Overall Study||0
1120126|NCT01234922|2711799|P3|NOT COMPLETED|Overall Study||0
1120127|NCT01234922|2711800|P2|NOT COMPLETED|Overall Study||0
1120128|NCT01234922|2711801|P1|NOT COMPLETED|Overall Study||0
1120129|NCT01234922|2711798|P4|COMPLETED|Overall Study||2
1120130|NCT01234922|2711799|P3|COMPLETED|Overall Study||2
1120131|NCT01234922|2711800|P2|COMPLETED|Overall Study||1
1120132|NCT01234922|2711801|P1|COMPLETED|Overall Study||1
1120133|NCT01234922|2711798|P4|STARTED|Overall Study||2
1120134|NCT01234922|2711799|P3|STARTED|Overall Study||2
1120135|NCT01234922|2711800|P2|STARTED|Overall Study||1
1120136|NCT01234922|2711801|P1|STARTED|Overall Study||1
1120137|NCT01235195|2711811|P2|NOT COMPLETED|Second Intervention||0
1120138|NCT01235195|2711812|P1|NOT COMPLETED|Second Intervention||0
1120139|NCT01235195|2711811|P2|COMPLETED|Second Intervention||15
1120140|NCT01235195|2711812|P1|COMPLETED|Second Intervention||15
1120141|NCT01235195|2711811|P2|STARTED|Second Intervention||15
1120142|NCT01235195|2711812|P1|STARTED|Second Intervention||15
1120143|NCT01235195|2711811|P2|NOT COMPLETED|Washout Period of At Least 8 Days||0
1120144|NCT01235195|2711812|P1|NOT COMPLETED|Washout Period of At Least 8 Days||0
1120145|NCT01235195|2711811|P2|COMPLETED|Washout Period of At Least 8 Days||15
1120146|NCT01235195|2711812|P1|COMPLETED|Washout Period of At Least 8 Days||15
1120147|NCT01235195|2711811|P2|STARTED|Washout Period of At Least 8 Days||15
1120148|NCT01235195|2711812|P1|STARTED|Washout Period of At Least 8 Days||15
1120149|NCT01235195|2711811|P2|NOT COMPLETED|First Intervention||0
1120150|NCT01235195|2711812|P1|NOT COMPLETED|First Intervention||0
1120151|NCT01235195|2711811|P2|COMPLETED|First Intervention||15
1120152|NCT01235195|2711812|P1|COMPLETED|First Intervention||15
1120153|NCT01235195|2711811|P2|STARTED|First Intervention||15
1120154|NCT01235195|2711812|P1|STARTED|First Intervention||15
1120155|NCT01235234|2711831|P3|NOT COMPLETED|Overall Study||1
1120156|NCT01235234|2711832|P2|NOT COMPLETED|Overall Study||2
1120157|NCT01235234|2711833|P1|NOT COMPLETED|Overall Study||2
1120158|NCT01235234|2711831|P3|COMPLETED|Overall Study||80
1120159|NCT01235234|2711832|P2|COMPLETED|Overall Study||76
1120160|NCT01235234|2711833|P1|COMPLETED|Overall Study||75
1120161|NCT01235234|2711831|P3|STARTED|Overall Study||81
1120162|NCT01235234|2711832|P2|STARTED|Overall Study||78
1120163|NCT01235234|2711833|P1|STARTED|Overall Study||77
1120164|NCT01235338|2711843|P2|NOT COMPLETED|Overall Study||5
1120165|NCT01235338|2711844|P1|NOT COMPLETED|Overall Study||11
1120166|NCT01235338|2711843|P2|COMPLETED|Overall Study||33
1120167|NCT01235338|2711844|P1|COMPLETED|Overall Study||31
1120168|NCT01235338|2711843|P2|STARTED|Overall Study||38
1120169|NCT01235338|2711844|P1|STARTED|Overall Study||42
1120170|NCT01235377|2711888|P2|NOT COMPLETED|Overall Study||1
1120171|NCT01235377|2711889|P1|NOT COMPLETED|Overall Study||1
1120172|NCT01235377|2711888|P2|COMPLETED|Overall Study||8
1120173|NCT01235377|2711889|P1|COMPLETED|Overall Study||10
1120174|NCT01235377|2711888|P2|STARTED|Overall Study||9
1120175|NCT01235377|2711889|P1|STARTED|Overall Study||11
1120176|NCT01235403|2711895|P1|NOT COMPLETED|Overall Study||26
1120177|NCT01235403|2711895|P1|COMPLETED|Overall Study||74
1120178|NCT01235403|2711895|P1|STARTED|Overall Study||100
1120179|NCT01235442|2711903|P2|NOT COMPLETED|Overall Study||44
1120180|NCT01235442|2711904|P1|NOT COMPLETED|Overall Study||44
1120181|NCT01235442|2711903|P2|COMPLETED|Overall Study||251
1120182|NCT01235442|2711904|P1|COMPLETED|Overall Study||253
1120183|NCT01235442|2711903|P2|STARTED|Overall Study||295
1120184|NCT01235442|2711904|P1|STARTED|Overall Study||297
1120185|NCT01235507|2711922|P1|NOT COMPLETED|Overall Study||2
1120186|NCT01235507|2711922|P1|COMPLETED|Overall Study||69
1120187|NCT01235507|2711922|P1|STARTED|Overall Study||71
1120188|NCT01235546|2711936|P2|NOT COMPLETED|Overall Study||1
1120189|NCT01235546|2711937|P1|NOT COMPLETED|Overall Study||2
1120190|NCT01235546|2711936|P2|COMPLETED|Overall Study||1018
1120191|NCT01235546|2711937|P1|COMPLETED|Overall Study||992
1120192|NCT01235546|2711936|P2|STARTED|Overall Study||1019
1120193|NCT01235546|2711937|P1|STARTED|Overall Study||994
1120194|NCT01235598|2711963|P2|NOT COMPLETED|Overall Study||4
1120195|NCT01235598|2711964|P1|NOT COMPLETED|Overall Study||1
1120196|NCT01235598|2711963|P2|COMPLETED|Overall Study||24
1120197|NCT01235598|2711964|P1|COMPLETED|Overall Study||12
1120198|NCT01235598|2711963|P2|STARTED|Overall Study|One subject was randomized to the CZP Arm but never received an injection (due to pre-treatment AE)|28
1120199|NCT01235598|2711964|P1|STARTED|Overall Study||13
1120200|NCT01227512|2712009|P2|NOT COMPLETED|Overall Study||10
1120201|NCT01227512|2712010|P1|NOT COMPLETED|Overall Study||13
1120202|NCT01227512|2712009|P2|COMPLETED|Overall Study||48
1120203|NCT01227512|2712010|P1|COMPLETED|Overall Study||53
1120204|NCT01227512|2712009|P2|STARTED|Overall Study||58
1120205|NCT01227512|2712010|P1|STARTED|Overall Study||66
1120206|NCT01227551|2712030|P1|NOT COMPLETED|Overall Study||34
1120207|NCT01227551|2712030|P1|COMPLETED|Overall Study||23
1120208|NCT01227551|2712030|P1|STARTED|Overall Study||57
1120209|NCT01227564|2712038|P3|NOT COMPLETED|Overall Study||6
1120210|NCT01227564|2712039|P2|NOT COMPLETED|Overall Study||2
1120211|NCT01227564|2712040|P1|NOT COMPLETED|Overall Study||4
1120212|NCT01227564|2712038|P3|COMPLETED|Overall Study|Completed study|15
1120213|NCT01227564|2712039|P2|COMPLETED|Overall Study|Completed study|18
1120214|NCT01227564|2712040|P1|COMPLETED|Overall Study|Completed study|18
1120215|NCT01227564|2712038|P3|Completed Treatment|Overall Study|1 participant stopped treatment due to lack of efficacy, 3 due to no longer willing to participate.|17
1120216|NCT01227564|2712039|P2|Completed Treatment|Overall Study|2 participants discontinued treatment due to no longer willing to participate in study.|18
1120217|NCT01227564|2712040|P1|Completed Treatment|Overall Study|1 participant discontinued treatment due to an adverse event (AE).|21
1120218|NCT01227564|2712038|P3|Treated|Overall Study||21
1120219|NCT01227564|2712039|P2|Treated|Overall Study||20
1120220|NCT01227564|2712040|P1|Treated|Overall Study||22
1120221|NCT01227564|2712038|P3|STARTED|Overall Study||21
1120222|NCT01227564|2712039|P2|STARTED|Overall Study||20
1120223|NCT01227564|2712040|P1|STARTED|Overall Study||22
1120224|NCT01227577|2712171|P1|NOT COMPLETED|Overall Study||35
1120225|NCT01227577|2712171|P1|COMPLETED|Overall Study||93
1120226|NCT01227577|2712171|P1|STARTED|Overall Study||128
1120227|NCT01227629|2712193|P10|NOT COMPLETED|Overall Study||2
1120228|NCT01227629|2712194|P9|NOT COMPLETED|Overall Study||6
1120229|NCT01227629|2712195|P8|NOT COMPLETED|Overall Study||6
1120230|NCT01227629|2712196|P7|NOT COMPLETED|Overall Study||8
1120231|NCT01227629|2712197|P6|NOT COMPLETED|Overall Study||1
1120232|NCT01227629|2712198|P5|NOT COMPLETED|Overall Study||2
1120233|NCT01227629|2712199|P4|NOT COMPLETED|Overall Study||8
1120234|NCT01227629|2712200|P3|NOT COMPLETED|Overall Study||1
1120235|NCT01227629|2712201|P2|NOT COMPLETED|Overall Study||2
1120236|NCT01227629|2712202|P1|NOT COMPLETED|Overall Study||2
1120237|NCT01227629|2712193|P10|COMPLETED|Overall Study||68
1120238|NCT01227629|2712194|P9|COMPLETED|Overall Study||24
1120239|NCT01227629|2712195|P8|COMPLETED|Overall Study||27
1120240|NCT01227629|2712196|P7|COMPLETED|Overall Study||90
1120241|NCT01227629|2712197|P6|COMPLETED|Overall Study||32
1120242|NCT01227629|2712198|P5|COMPLETED|Overall Study||32
1120243|NCT01227629|2712199|P4|COMPLETED|Overall Study||91
1120244|NCT01227629|2712200|P3|COMPLETED|Overall Study||26
1120245|NCT01227629|2712201|P2|COMPLETED|Overall Study||18
1120246|NCT01227629|2712202|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|56
1120247|NCT01227629|2712193|P10|STARTED|Overall Study||70
1120248|NCT01227629|2712194|P9|STARTED|Overall Study||30
1120249|NCT01227629|2712195|P8|STARTED|Overall Study||33
1120250|NCT01227629|2712196|P7|STARTED|Overall Study||98
1120251|NCT01227629|2712197|P6|STARTED|Overall Study||33
1120252|NCT01227629|2712198|P5|STARTED|Overall Study||34
1120253|NCT01227629|2712199|P4|STARTED|Overall Study||99
1120254|NCT01227629|2712200|P3|STARTED|Overall Study||27
1120255|NCT01227629|2712201|P2|STARTED|Overall Study||20
1120256|NCT01227629|2712202|P1|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|58
1120257|NCT01227655|2712441|P3|NOT COMPLETED|Overall Study||14
1120258|NCT01227655|2712442|P2|NOT COMPLETED|Overall Study||26
1120259|NCT01227655|2712443|P1|NOT COMPLETED|Overall Study||11
1120260|NCT01227655|2712441|P3|COMPLETED|Overall Study||130
1120261|NCT01227655|2712442|P2|COMPLETED|Overall Study||128
1120262|NCT01227655|2712443|P1|COMPLETED|Overall Study||118
1120263|NCT01227655|2712441|P3|Full Analysis Set|Overall Study||135
1120264|NCT01227655|2712442|P2|Full Analysis Set|Overall Study||147
1120265|NCT01227655|2712443|P1|Full Analysis Set|Overall Study||125
1120266|NCT01227655|2712441|P3|Safety Set|Overall Study||136
1120267|NCT01227655|2712442|P2|Safety Set|Overall Study||150
1120268|NCT01227655|2712443|P1|Safety Set|Overall Study||125
1120269|NCT01227655|2712441|P3|STARTED|Overall Study||144
1120270|NCT01227655|2712442|P2|STARTED|Overall Study||154
1120271|NCT01227655|2712443|P1|STARTED|Overall Study||129
1120272|NCT01227668|2712462|P2|NOT COMPLETED|Phase 2 (Randomization Phase)||25
1120273|NCT01227668|2712463|P1|NOT COMPLETED|Phase 2 (Randomization Phase)||19
1120274|NCT01227668|2712462|P2|COMPLETED|Phase 2 (Randomization Phase)||19
1120275|NCT01227668|2712463|P1|COMPLETED|Phase 2 (Randomization Phase)||22
1120276|NCT01227668|2712462|P2|Received Treatment|Phase 2 (Randomization Phase)||43
1120277|NCT01227668|2712463|P1|Received Treatment|Phase 2 (Randomization Phase)||39
1120278|NCT01227668|2712462|P2|STARTED|Phase 2 (Randomization Phase)|Randomized|44
1120279|NCT01227668|2712463|P1|STARTED|Phase 2 (Randomization Phase)|Randomized|41
1120280|NCT01227668|2712462|P2|NOT COMPLETED|Phase 1 (Stabilization Phase)||0
1120281|NCT01227668|2712463|P1|NOT COMPLETED|Phase 1 (Stabilization Phase)||72
1120282|NCT01227668|2712462|P2|COMPLETED|Phase 1 (Stabilization Phase)||0
1120283|NCT01227668|2712463|P1|COMPLETED|Phase 1 (Stabilization Phase)||85
1120284|NCT01227668|2712462|P2|Received Treatment|Phase 1 (Stabilization Phase)||0
1120285|NCT01227668|2712463|P1|Received Treatment|Phase 1 (Stabilization Phase)||155
1120286|NCT01227668|2712462|P2|STARTED|Phase 1 (Stabilization Phase)||0
1120287|NCT01227668|2712463|P1|STARTED|Phase 1 (Stabilization Phase)|Randomized|157
1120288|NCT01227681|2712480|P3|NOT COMPLETED|Overall Study||0
1120289|NCT01227681|2712481|P2|NOT COMPLETED|Overall Study||0
1120290|NCT01227681|2712482|P1|NOT COMPLETED|Overall Study||0
1120291|NCT01227681|2712480|P3|COMPLETED|Overall Study||0
1120292|NCT01227681|2712481|P2|COMPLETED|Overall Study||0
1120293|NCT01227681|2712482|P1|COMPLETED|Overall Study||4
1120294|NCT01227681|2712480|P3|STARTED|Overall Study||0
1120295|NCT01227681|2712481|P2|STARTED|Overall Study||0
1120296|NCT01227681|2712482|P1|STARTED|Overall Study||4
1120297|NCT01227707|2712486|P1|NOT COMPLETED|Overall Study||24
1120298|NCT01227707|2712486|P1|COMPLETED|Overall Study||19
1120299|NCT01227707|2712486|P1|STARTED|Overall Study||43
1120300|NCT01227785|2712502|P1|NOT COMPLETED|Overall Study||12
1120301|NCT01227785|2712502|P1|COMPLETED|Overall Study||108
1120302|NCT01227785|2712502|P1|STARTED|Overall Study||120
1120303|NCT01227824|2712570|P2|NOT COMPLETED|Open-label Phase||0
1120304|NCT01227824|2712571|P1|NOT COMPLETED|Open-label Phase||338
1120305|NCT01227824|2712570|P2|COMPLETED|Open-label Phase||0
1120306|NCT01227824|2712571|P1|COMPLETED|Open-label Phase||0
1120307|NCT01227824|2712570|P2|Ongoing|Open-label Phase||0
1120308|NCT01227824|2712571|P1|Ongoing|Open-label Phase||337
1120309|NCT01227824|2712570|P2|STARTED|Open-label Phase||0
1120310|NCT01227824|2712571|P1|STARTED|Open-label Phase|Eleven participant completing the Double-blind Phase did not continue into the Open-label Phase.|338
1120311|NCT01227824|2712570|P2|NOT COMPLETED|Double-blind Phase||79
1120312|NCT01227824|2712571|P1|NOT COMPLETED|Double-blind Phase||62
1120313|NCT01227824|2712570|P2|COMPLETED|Double-blind Phase||332
1120314|NCT01227824|2712571|P1|COMPLETED|Double-blind Phase||349
1120315|NCT01227824|2712570|P2|STARTED|Double-blind Phase||411
1120316|NCT01227824|2712571|P1|STARTED|Double-blind Phase||411
1120317|NCT01227889|2712601|P2|NOT COMPLETED|Crossover Phase||37
1120318|NCT01227889|2712602|P1|NOT COMPLETED|Crossover Phase||0
1120319|NCT01227889|2712601|P2|COMPLETED|Crossover Phase||0
1120320|NCT01227889|2712602|P1|COMPLETED|Crossover Phase||0
1120321|NCT01227889|2712601|P2|STARTED|Crossover Phase|As of the data cut on December 18, 2012, 36 of 63 participants crossed over from DTIC to GSK2118436.|37
1120322|NCT01227889|2712602|P1|STARTED|Crossover Phase||0
1120323|NCT01227889|2712601|P2|NOT COMPLETED|Randomized Phase (RP)||63
1120324|NCT01227889|2712602|P1|NOT COMPLETED|Randomized Phase (RP)||187
1120325|NCT01227889|2712601|P2|COMPLETED|Randomized Phase (RP)||0
1120326|NCT01227889|2712602|P1|COMPLETED|Randomized Phase (RP)||0
1120327|NCT01227889|2712601|P2|STARTED|Randomized Phase (RP)||63
1120328|NCT01227889|2712602|P1|STARTED|Randomized Phase (RP)||187
1120329|NCT01227902|2712631|P4|NOT COMPLETED|Overall Study||10
1120330|NCT01227902|2712632|P3|NOT COMPLETED|Overall Study||19
1120331|NCT01227902|2712633|P2|NOT COMPLETED|Overall Study||13
1120332|NCT01227902|2712634|P1|NOT COMPLETED|Overall Study||18
1120333|NCT01227902|2712631|P4|COMPLETED|Overall Study||42
1120334|NCT01227902|2712632|P3|COMPLETED|Overall Study||25
1120335|NCT01227902|2712633|P2|COMPLETED|Overall Study||38
1120336|NCT01227902|2712634|P1|COMPLETED|Overall Study||38
1120337|NCT01227902|2712631|P4|STARTED|Overall Study||52
1120338|NCT01227902|2712632|P3|STARTED|Overall Study||44
1120339|NCT01227902|2712633|P2|STARTED|Overall Study||51
1120340|NCT01227902|2712634|P1|STARTED|Overall Study||56
1120341|NCT01227928|2712727|P2|NOT COMPLETED|Overall Study||17
1120342|NCT01227928|2712728|P1|NOT COMPLETED|Overall Study||22
1120343|NCT01227928|2712727|P2|COMPLETED|Overall Study||56
1120344|NCT01227928|2712728|P1|COMPLETED|Overall Study||50
1120345|NCT01227928|2712727|P2|STARTED|Overall Study||73
1120346|NCT01227928|2712728|P1|STARTED|Overall Study||72
1120347|NCT01227954|2712762|P1|NOT COMPLETED|Overall Study||13
1120348|NCT01227954|2712762|P1|COMPLETED|Overall Study|Eligible subjects available for analysis|100
1120349|NCT01227954|2712762|P1|STARTED|Overall Study||113
1120350|NCT01227967|2712776|P2|NOT COMPLETED|Overall Study||13
1120351|NCT01227967|2712777|P1|NOT COMPLETED|Overall Study||16
1120352|NCT01227967|2712776|P2|COMPLETED|Overall Study||303
1120353|NCT01227967|2712777|P1|COMPLETED|Overall Study||298
1120354|NCT01227967|2712776|P2|STARTED|Overall Study||316
1120355|NCT01227967|2712777|P1|STARTED|Overall Study||314
1120356|NCT01227980|2712813|P2|NOT COMPLETED|Overall Study||5
1120357|NCT01227980|2712814|P1|NOT COMPLETED|Overall Study||2
1120358|NCT01227980|2712813|P2|COMPLETED|Overall Study||25
1120359|NCT01227980|2712814|P1|COMPLETED|Overall Study|Two subjects did not complete the scripts sessions but completed the remainder of the protocol|38
1120360|NCT01227980|2712813|P2|Measure Drug Level Concentration|Overall Study|No placebo subjects completed this milestone which measured active drug levels|0
1120361|NCT01227980|2712814|P1|Measure Drug Level Concentration|Overall Study||10
1120362|NCT01227980|2712813|P2|Scripts Challenge Sessions|Overall Study||25
1120363|NCT01227980|2712814|P1|Scripts Challenge Sessions|Overall Study||26
1120364|NCT01227980|2712813|P2|STARTED|Overall Study||30
1120365|NCT01227980|2712814|P1|STARTED|Overall Study||40
1120366|NCT01227993|2712850|P1|NOT COMPLETED|Overall Study||0
1120367|NCT01227993|2712850|P1|COMPLETED|Overall Study||3
1120368|NCT01227993|2712850|P1|STARTED|Overall Study||3
1120369|NCT01228019|2712860|P1|NOT COMPLETED|Overall Study||304
1120370|NCT01228019|2712860|P1|COMPLETED|Overall Study||862
1120371|NCT01228019|2712860|P1|STARTED|Overall Study||1166
1120372|NCT01228071|2712875|P1|NOT COMPLETED|Overall Study||2
1120373|NCT01228071|2712875|P1|COMPLETED|Overall Study||32
1120374|NCT01228071|2712875|P1|STARTED|Overall Study||34
1120375|NCT01228084|2712881|P1|NOT COMPLETED|Overall Study||4
1120376|NCT01228084|2712881|P1|COMPLETED|Overall Study||16
1120377|NCT01228084|2712881|P1|STARTED|Overall Study||20
1120378|NCT01228149|2712894|P2|NOT COMPLETED|Overall Study||4
1120379|NCT01228149|2712895|P1|NOT COMPLETED|Overall Study||5
1120380|NCT01228149|2712894|P2|COMPLETED|Overall Study||26
1120381|NCT01228149|2712895|P1|COMPLETED|Overall Study||27
1120382|NCT01228149|2712894|P2|STARTED|Overall Study||30
1120383|NCT01228149|2712895|P1|STARTED|Overall Study||32
1120384|NCT01228175|2712919|P2|NOT COMPLETED|Overall Study||53
1120385|NCT01228175|2712920|P1|NOT COMPLETED|Overall Study||63
1120386|NCT01228175|2712919|P2|COMPLETED|Overall Study||46
1120387|NCT01228175|2712920|P1|COMPLETED|Overall Study||56
1120388|NCT01228175|2712919|P2|STARTED|Overall Study||99
1120389|NCT01228175|2712920|P1|STARTED|Overall Study||119
1120390|NCT01228435|2712928|P2|NOT COMPLETED|Overall Study||0
1120391|NCT01228435|2712929|P1|NOT COMPLETED|Overall Study||0
1120392|NCT01228435|2712928|P2|COMPLETED|Overall Study||2
1120393|NCT01228435|2712929|P1|COMPLETED|Overall Study||1
1120394|NCT01228435|2712928|P2|STARTED|Overall Study||2
1120395|NCT01228435|2712929|P1|STARTED|Overall Study||1
1120396|NCT01235715|2712937|P2|NOT COMPLETED|Overall Study||2
1120397|NCT01235715|2712938|P1|NOT COMPLETED|Overall Study||0
1120398|NCT01235715|2712937|P2|COMPLETED|Overall Study||100
1120399|NCT01235715|2712938|P1|COMPLETED|Overall Study||98
1120400|NCT01235715|2712937|P2|STARTED|Overall Study||102
1120401|NCT01235715|2712938|P1|STARTED|Overall Study||98
1120402|NCT01235728|2712976|P8|NOT COMPLETED|Overall Study||0
1120403|NCT01235728|2712977|P7|NOT COMPLETED|Overall Study||0
1120404|NCT01235728|2712978|P6|NOT COMPLETED|Overall Study||0
1120405|NCT01235728|2712979|P5|NOT COMPLETED|Overall Study||0
1120406|NCT01235728|2712980|P4|NOT COMPLETED|Overall Study||1
1120407|NCT01235728|2712981|P3|NOT COMPLETED|Overall Study||0
1120408|NCT01235728|2712982|P2|NOT COMPLETED|Overall Study||0
1120409|NCT01235728|2712983|P1|NOT COMPLETED|Overall Study||0
1120410|NCT01235728|2712976|P8|COMPLETED|Overall Study||3
1120411|NCT01235728|2712977|P7|COMPLETED|Overall Study||3
1120412|NCT01235728|2712978|P6|COMPLETED|Overall Study||3
1120413|NCT01235728|2712979|P5|COMPLETED|Overall Study||3
1120414|NCT01235728|2712980|P4|COMPLETED|Overall Study||2
1120415|NCT01235728|2712981|P3|COMPLETED|Overall Study||3
1120416|NCT01235728|2712982|P2|COMPLETED|Overall Study||3
1120417|NCT01235728|2712983|P1|COMPLETED|Overall Study||3
1120418|NCT01235728|2712976|P8|STARTED|Overall Study||3
1120419|NCT01235728|2712977|P7|STARTED|Overall Study||3
1120420|NCT01235728|2712978|P6|STARTED|Overall Study||3
1120421|NCT01235728|2712979|P5|STARTED|Overall Study||3
1120422|NCT01235728|2712980|P4|STARTED|Overall Study||3
1120423|NCT01235728|2712981|P3|STARTED|Overall Study||3
1120424|NCT01235728|2712982|P2|STARTED|Overall Study||3
1120425|NCT01235728|2712983|P1|STARTED|Overall Study||3
1120426|NCT01235741|2712994|P3|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||7
1120427|NCT01235741|2712995|P2|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||9
1120428|NCT01235741|2712996|P1|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||0
1120429|NCT01235741|2712994|P3|COMPLETED|Follow-Up Post Treatment up to Month 6|7 participants did not complete the 6 month follow up period|29
1120430|NCT01235741|2712995|P2|COMPLETED|Follow-Up Post Treatment up to Month 6|9 participants did not complete the 6 month follow up period|27
1120431|NCT01235741|2712996|P1|COMPLETED|Follow-Up Post Treatment up to Month 6||0
1120432|NCT01235741|2712994|P3|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with drug (36) were followed up 6 months post treatment.|36
1120433|NCT01235741|2712995|P2|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with placebo (36) were followed up 6 Months post treatment.|36
1120434|NCT01235741|2712996|P1|STARTED|Follow-Up Post Treatment up to Month 6||0
1120435|NCT01235741|2712994|P3|NOT COMPLETED|Randomized to Treatment||36
1120436|NCT01235741|2712995|P2|NOT COMPLETED|Randomized to Treatment||36
1120437|NCT01235741|2712996|P1|NOT COMPLETED|Randomized to Treatment||0
1120438|NCT01235741|2712994|P3|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
1120439|NCT01235741|2712995|P2|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
1120440|NCT01235741|2712996|P1|COMPLETED|Randomized to Treatment||0
1120441|NCT01235741|2712994|P3|STARTED|Randomized to Treatment||36
1120442|NCT01235741|2712995|P2|STARTED|Randomized to Treatment||36
1120443|NCT01235741|2712996|P1|STARTED|Randomized to Treatment||0
1120444|NCT01235741|2712994|P3|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
1120445|NCT01235741|2712995|P2|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
1120446|NCT01235741|2712996|P1|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||141
1120447|NCT01235741|2712994|P3|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
1120448|NCT01235741|2712995|P2|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
1120449|NCT01235741|2712996|P1|COMPLETED|Non-Randomized Low Calorie Diet Lead-In|Study terminated by Sponsor. 72 randomized to treatment at time study halted.|72
1120450|NCT01235741|2712994|P3|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
1120451|NCT01235741|2712995|P2|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
1120452|NCT01235741|2712996|P1|STARTED|Non-Randomized Low Calorie Diet Lead-In|6 Week LCD period. Those who lost >=2% of body weight were randomized to treatment.|213
1120453|NCT01235897|2713023|P1|NOT COMPLETED|Overall Study||0
1120454|NCT01235897|2713023|P1|COMPLETED|Overall Study||16
1120455|NCT01235897|2713023|P1|STARTED|Overall Study||16
1120456|NCT01235910|2713028|P1|NOT COMPLETED|Overall Study||0
1120457|NCT01235910|2713028|P1|COMPLETED|Overall Study||1
1120458|NCT01235910|2713028|P1|STARTED|Overall Study||1
1120459|NCT01235923|2713034|P2|NOT COMPLETED|Overall Study||0
1120460|NCT01235923|2713035|P1|NOT COMPLETED|Overall Study||0
1120461|NCT01235923|2713034|P2|COMPLETED|Overall Study||10
1120462|NCT01235923|2713035|P1|COMPLETED|Overall Study||10
1120463|NCT01235923|2713034|P2|STARTED|Overall Study||10
1120464|NCT01235923|2713035|P1|STARTED|Overall Study||10
1120465|NCT01235975|2713045|P2|NOT COMPLETED|Overall Study||7
1120466|NCT01235975|2713046|P1|NOT COMPLETED|Overall Study||17
1120467|NCT01235975|2713045|P2|COMPLETED|Overall Study||88
1120468|NCT01235975|2713046|P1|COMPLETED|Overall Study||257
1120469|NCT01235975|2713045|P2|STARTED|Overall Study||95
1120470|NCT01235975|2713046|P1|STARTED|Overall Study||274
1120471|NCT01236001|2713080|P2|NOT COMPLETED|Overall Study||22
1120472|NCT01236001|2713081|P1|NOT COMPLETED|Overall Study||18
1120473|NCT01236001|2713080|P2|COMPLETED|Overall Study||65
1120474|NCT01236001|2713081|P1|COMPLETED|Overall Study||87
1120475|NCT01236001|2713080|P2|STARTED|Overall Study||87
1120476|NCT01236001|2713081|P1|STARTED|Overall Study||105
1120477|NCT01236300|2713111|P1|NOT COMPLETED|Overall Study||0
1120478|NCT01236300|2713111|P1|COMPLETED|Overall Study||66
1120479|NCT01236300|2713111|P1|STARTED|Overall Study||66
1120480|NCT01236326|2713121|P2|NOT COMPLETED|Overall Study||4
1120481|NCT01236326|2713122|P1|NOT COMPLETED|Overall Study||1
1120482|NCT01236326|2713121|P2|COMPLETED|Overall Study||51
1120483|NCT01236326|2713122|P1|COMPLETED|Overall Study||49
1120484|NCT01236326|2713121|P2|STARTED|Overall Study||55
1120485|NCT01236326|2713122|P1|STARTED|Overall Study||50
1120486|NCT01236339|2713138|P2|NOT COMPLETED|Overall Study||13
1120487|NCT01236339|2713139|P1|NOT COMPLETED|Overall Study||11
1120488|NCT01236339|2713138|P2|COMPLETED|Overall Study||0
1120489|NCT01236339|2713139|P1|COMPLETED|Overall Study||2
1120490|NCT01236339|2713138|P2|LVP Crossover to TIPS|Overall Study|ONLY patients failing LVP and meeting crossover according to protocol definition|4
1120491|NCT01236339|2713139|P1|LVP Crossover to TIPS|Overall Study||0
1120492|NCT01236339|2713138|P2|STARTED|Overall Study||13
1120493|NCT01236339|2713139|P1|STARTED|Overall Study||13
1120494|NCT01236365|2713159|P2|NOT COMPLETED|Overall Study||2
1120495|NCT01236365|2713160|P1|NOT COMPLETED|Overall Study||2
1120496|NCT01236365|2713159|P2|COMPLETED|Overall Study||19
1120497|NCT01236365|2713160|P1|COMPLETED|Overall Study||19
1120498|NCT01236365|2713159|P2|STARTED|Overall Study||21
1120499|NCT01236365|2713160|P1|STARTED|Overall Study||21
1120500|NCT01236378|2713172|P1|NOT COMPLETED|Overall Study||0
1120501|NCT01236378|2713172|P1|COMPLETED|Overall Study||24
1120502|NCT01236378|2713172|P1|STARTED|Overall Study||24
1120503|NCT01236391|2713184|P1|NOT COMPLETED|Overall Study||16
1120504|NCT01236391|2713184|P1|COMPLETED|Overall Study|Participants who were on treatment or discontinued treatment due to disease progression or death|95
1120505|NCT01236391|2713184|P1|STARTED|Overall Study|Participants who received study treatment|111
1120506|NCT01236534|2713194|P2|NOT COMPLETED|Overall Study||0
1120507|NCT01236534|2713195|P1|NOT COMPLETED|Overall Study||3
1120508|NCT01236534|2713194|P2|COMPLETED|Overall Study||10
1120509|NCT01236534|2713195|P1|COMPLETED|Overall Study|2 subjects stopped treatment due to diarrhea, and 1 stopped treatment due to constipation.|8
1120510|NCT01236534|2713194|P2|STARTED|Overall Study||10
1120511|NCT01236534|2713195|P1|STARTED|Overall Study||11
1120512|NCT01236573|2713214|P11|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||1
1120513|NCT01236573|2713215|P10|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1120514|NCT01236573|2713216|P9|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1120515|NCT01236573|2713217|P8|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1120516|NCT01236573|2713218|P7|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1120517|NCT01236573|2713219|P6|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1120518|NCT01236573|2713220|P5|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1120519|NCT01236573|2713221|P4|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1120520|NCT01236573|2713222|P3|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1120521|NCT01236573|2713223|P2|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1120522|NCT01236573|2713224|P1|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1120523|NCT01236573|2713214|P11|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||5
1120524|NCT01236573|2713215|P10|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1120525|NCT01236573|2713216|P9|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1120526|NCT01236573|2713217|P8|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1120527|NCT01236573|2713218|P7|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1120528|NCT01236573|2713219|P6|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1120529|NCT01236573|2713220|P5|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1120530|NCT01236573|2713221|P4|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1120531|NCT01236573|2713222|P3|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1120532|NCT01236573|2713223|P2|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1120533|NCT01236573|2713224|P1|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1120534|NCT01236573|2713214|P11|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||6
1120535|NCT01236573|2713215|P10|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1120536|NCT01236573|2713216|P9|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1120537|NCT01236573|2713217|P8|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1120538|NCT01236573|2713218|P7|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1120539|NCT01236573|2713219|P6|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1120540|NCT01236573|2713220|P5|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1120541|NCT01236573|2713221|P4|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1120542|NCT01236573|2713222|P3|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1120543|NCT01236573|2713223|P2|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1120544|NCT01236573|2713224|P1|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
1120545|NCT01236573|2713214|P11|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1120546|NCT01236573|2713215|P10|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
1120547|NCT01236573|2713216|P9|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
1120548|NCT01236573|2713217|P8|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1120549|NCT01236573|2713218|P7|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
1120550|NCT01236573|2713219|P6|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1120551|NCT01236573|2713220|P5|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1120552|NCT01236573|2713221|P4|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1120553|NCT01236573|2713222|P3|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1120554|NCT01236573|2713223|P2|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1120555|NCT01236573|2713224|P1|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1120556|NCT01236573|2713214|P11|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1120557|NCT01236573|2713215|P10|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
1120558|NCT01236573|2713216|P9|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
1120559|NCT01236573|2713217|P8|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
1120560|NCT01236573|2713218|P7|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
1120561|NCT01236573|2713219|P6|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||4
1120562|NCT01236573|2713220|P5|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
1120563|NCT01236573|2713221|P4|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1120564|NCT01236573|2713222|P3|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1120565|NCT01236573|2713223|P2|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1120566|NCT01236573|2713224|P1|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
1120567|NCT01236573|2713214|P11|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
1120568|NCT01236573|2713215|P10|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
1120569|NCT01236573|2713216|P9|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
1120570|NCT01236573|2713217|P8|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
1120571|NCT01236573|2713218|P7|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
1120572|NCT01236573|2713219|P6|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
1120573|NCT01236573|2713220|P5|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||1
1120574|NCT01236573|2713221|P4|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
1120575|NCT01236573|2713222|P3|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
1120576|NCT01236573|2713223|P2|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
1120577|NCT01236573|2713224|P1|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
1120578|NCT01236573|2713214|P11|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1120579|NCT01236573|2713215|P10|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1120580|NCT01236573|2713216|P9|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1120581|NCT01236573|2713217|P8|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1120582|NCT01236573|2713218|P7|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1120583|NCT01236573|2713219|P6|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1120584|NCT01236573|2713220|P5|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1120585|NCT01236573|2713221|P4|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1120586|NCT01236573|2713222|P3|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1120587|NCT01236573|2713223|P2|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1120588|NCT01236573|2713224|P1|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1120589|NCT01236573|2713214|P11|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1120590|NCT01236573|2713215|P10|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1120591|NCT01236573|2713216|P9|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1120592|NCT01236573|2713217|P8|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1120593|NCT01236573|2713218|P7|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1120594|NCT01236573|2713219|P6|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1120595|NCT01236573|2713220|P5|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
1120596|NCT01236573|2713221|P4|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
1120597|NCT01236573|2713222|P3|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||6
1120598|NCT01236573|2713223|P2|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
1120599|NCT01236573|2713224|P1|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
1120600|NCT01236573|2713214|P11|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
1120601|NCT01236573|2713215|P10|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
1120602|NCT01236573|2713216|P9|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
1120603|NCT01236573|2713217|P8|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
1120604|NCT01236573|2713218|P7|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
1120605|NCT01236573|2713219|P6|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
1120606|NCT01236573|2713220|P5|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
1120607|NCT01236573|2713221|P4|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
1120608|NCT01236573|2713222|P3|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||6
1120609|NCT01236573|2713223|P2|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
1120610|NCT01236573|2713224|P1|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
1120611|NCT01236768|2713262|P2|NOT COMPLETED|Overall Study||61
1120612|NCT01236768|2713263|P1|NOT COMPLETED|Overall Study||89
1120613|NCT01236768|2713262|P2|COMPLETED|Overall Study||145
1120614|NCT01236768|2713263|P1|COMPLETED|Overall Study||112
1120615|NCT01236768|2713262|P2|STARTED|Overall Study||206
1120616|NCT01236768|2713263|P1|STARTED|Overall Study||201
1120617|NCT01237054|2713277|P1|NOT COMPLETED|Overall Study||1
1120618|NCT01237054|2713277|P1|COMPLETED|Overall Study||30
1120619|NCT01237054|2713277|P1|STARTED|Overall Study||31
1120620|NCT01237080|2713300|P2|NOT COMPLETED|Overall Study||0
1120621|NCT01237080|2713301|P1|NOT COMPLETED|Overall Study||0
1120622|NCT01237080|2713300|P2|COMPLETED|Overall Study||50
1120623|NCT01237080|2713301|P1|COMPLETED|Overall Study||50
1120624|NCT01237080|2713300|P2|STARTED|Overall Study||50
1120625|NCT01237080|2713301|P1|STARTED|Overall Study||50
1120626|NCT01237197|2713311|P2|NOT COMPLETED|Open Label Period||0
1120627|NCT01237197|2713312|P1|NOT COMPLETED|Open Label Period||0
1120628|NCT01237197|2713311|P2|COMPLETED|Open Label Period||10
1120629|NCT01237197|2713312|P1|COMPLETED|Open Label Period||12
1120630|NCT01237197|2713311|P2|STARTED|Open Label Period||10
1120631|NCT01237197|2713312|P1|STARTED|Open Label Period||12
1120632|NCT01237197|2713311|P2|NOT COMPLETED|Randomization Period||3
1120633|NCT01237197|2713312|P1|NOT COMPLETED|Randomization Period||1
1120634|NCT01237197|2713311|P2|COMPLETED|Randomization Period||10
1120635|NCT01237197|2713312|P1|COMPLETED|Randomization Period||12
1120636|NCT01237197|2713311|P2|STARTED|Randomization Period||13
1120637|NCT01237197|2713312|P1|STARTED|Randomization Period||13
1120638|NCT01237223|2713324|P6|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
1120639|NCT01237223|2713325|P5|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||4
1120640|NCT01237223|2713326|P4|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
1120641|NCT01237223|2713327|P3|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
1120642|NCT01237223|2713328|P2|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
1120643|NCT01237223|2713329|P1|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||33
1120644|NCT01237223|2713324|P6|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||154
1120645|NCT01237223|2713325|P5|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||155
1120646|NCT01237223|2713326|P4|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||153
1120647|NCT01237223|2713327|P3|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||143
1120648|NCT01237223|2713328|P2|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||142
1120649|NCT01237223|2713329|P1|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||120
1120650|NCT01237223|2713324|P6|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
1120651|NCT01237223|2713325|P5|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
1120652|NCT01237223|2713326|P4|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
1120653|NCT01237223|2713327|P3|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
1120654|NCT01237223|2713328|P2|STARTED|Double Blind (Treatment Period, 8 Weeks)||157
1120655|NCT01237223|2713329|P1|STARTED|Double Blind (Treatment Period, 8 Weeks)||153
1120656|NCT01237223|2713324|P6|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
1120657|NCT01237223|2713325|P5|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
1120658|NCT01237223|2713326|P4|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
1120659|NCT01237223|2713327|P3|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
1120660|NCT01237223|2713328|P2|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
1120661|NCT01237223|2713329|P1|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||398
1120662|NCT01237223|2713324|P6|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
1120663|NCT01237223|2713325|P5|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
1120664|NCT01237223|2713326|P4|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
1120665|NCT01237223|2713327|P3|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
1120666|NCT01237223|2713328|P2|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
1120667|NCT01237223|2713329|P1|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||944
1120668|NCT01237223|2713324|P6|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
1120669|NCT01237223|2713325|P5|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
1120670|NCT01237223|2713326|P4|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
1120671|NCT01237223|2713327|P3|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
1120672|NCT01237223|2713328|P2|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
1120673|NCT01237223|2713329|P1|STARTED|Single Blind(Run-in Period, 4 Weeks)|All the patients enrolled to single blind period received only placebo treatment.|1342
1120674|NCT01237301|2713370|P2|NOT COMPLETED|Overall Study||4
1120675|NCT01237301|2713371|P1|NOT COMPLETED|Overall Study||5
1120676|NCT01237301|2713370|P2|COMPLETED|Overall Study||55
1120677|NCT01237301|2713371|P1|COMPLETED|Overall Study||60
1120678|NCT01237301|2713370|P2|STARTED|Overall Study||59
1120679|NCT01237301|2713371|P1|STARTED|Overall Study||65
1120680|NCT01237327|2713379|P2|NOT COMPLETED|Overall Study||40
1120681|NCT01237327|2713380|P1|NOT COMPLETED|Overall Study||42
1120682|NCT01237327|2713379|P2|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
1120683|NCT01237327|2713380|P1|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
1120684|NCT01237327|2713379|P2|Continued Treatment in Extension Study|Overall Study||17
1120685|NCT01237327|2713380|P1|Continued Treatment in Extension Study|Overall Study||21
1120686|NCT01237327|2713379|P2|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|2
1120687|NCT01237327|2713380|P1|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|3
1120688|NCT01237327|2713379|P2|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|24
1120689|NCT01237327|2713380|P1|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|22
1120690|NCT01237327|2713379|P2|STARTED|Overall Study||41
1120691|NCT01237327|2713380|P1|STARTED|Overall Study||43
1120692|NCT01237340|2713394|P1|NOT COMPLETED|Overall Study||40
1120693|NCT01237340|2713394|P1|COMPLETED|Overall Study||19
1120694|NCT01237340|2713394|P1|STARTED|Overall Study||59
1120695|NCT01237353|2713406|P1|NOT COMPLETED|Overall Study||0
1120696|NCT01237353|2713406|P1|COMPLETED|Overall Study||6
1120697|NCT01237353|2713406|P1|STARTED|Overall Study||6
1120698|NCT01237613|2713411|P1|NOT COMPLETED|Overall Study||0
1120699|NCT01237613|2713411|P1|COMPLETED|Overall Study||4
1120700|NCT01237613|2713411|P1|STARTED|Overall Study||4
1120701|NCT01238211|2713435|P1|NOT COMPLETED|Overall Study||58
1120702|NCT01238211|2713435|P1|COMPLETED|Overall Study||3
1120703|NCT01238211|2713435|P1|STARTED|Overall Study||61
1120704|NCT01238341|2713439|P1|NOT COMPLETED|Overall Study||0
1120705|NCT01238341|2713439|P1|COMPLETED|Overall Study||7
1120706|NCT01238341|2713439|P1|STARTED|Overall Study||7
1120707|NCT01238471|2713448|P2|NOT COMPLETED|Overall Study||0
1120708|NCT01238471|2713449|P1|NOT COMPLETED|Overall Study||0
1120709|NCT01238471|2713448|P2|COMPLETED|Overall Study||10
1120710|NCT01238471|2713449|P1|COMPLETED|Overall Study||10
1120711|NCT01238471|2713448|P2|STARTED|Overall Study||10
1120712|NCT01238471|2713449|P1|STARTED|Overall Study||10
1120713|NCT01238575|2713457|P2|NOT COMPLETED|Overall Study||4
1120714|NCT01238575|2713458|P1|NOT COMPLETED|Overall Study||4
1120715|NCT01238575|2713457|P2|COMPLETED|Overall Study||28
1120716|NCT01238575|2713458|P1|COMPLETED|Overall Study||26
1120717|NCT01238575|2713457|P2|STARTED|Overall Study||32
1120718|NCT01238575|2713458|P1|STARTED|Overall Study||30
1120719|NCT01238588|2713494|P1|NOT COMPLETED|Overall Study||3
1120720|NCT01238588|2713494|P1|COMPLETED|Overall Study||9
1120721|NCT01238588|2713494|P1|STARTED|Overall Study||12
1120722|NCT01238640|2713505|P1|NOT COMPLETED|Overall Study||0
1120723|NCT01238640|2713505|P1|COMPLETED|Overall Study||84
1120724|NCT01238640|2713505|P1|STARTED|Overall Study||84
1120725|NCT01231373|2713526|P4|NOT COMPLETED|Overall Study||1
1120726|NCT01231373|2713527|P3|NOT COMPLETED|Overall Study||0
1120727|NCT01231373|2713528|P2|NOT COMPLETED|Overall Study||1
1120728|NCT01231373|2713529|P1|NOT COMPLETED|Overall Study||3
1120729|NCT01231373|2713526|P4|COMPLETED|Overall Study||57
1120730|NCT01231373|2713527|P3|COMPLETED|Overall Study||60
1120731|NCT01231373|2713528|P2|COMPLETED|Overall Study||57
1120732|NCT01231373|2713529|P1|COMPLETED|Overall Study||56
1120733|NCT01231373|2713526|P4|Patients Receiving Blinded Treatment|Overall Study||58
1120734|NCT01231373|2713527|P3|Patients Receiving Blinded Treatment|Overall Study||60
1120735|NCT01231373|2713528|P2|Patients Receiving Blinded Treatment|Overall Study||57
1120736|NCT01231373|2713529|P1|Patients Receiving Blinded Treatment|Overall Study||57
1120737|NCT01231373|2713526|P4|STARTED|Overall Study||58
1120738|NCT01231373|2713527|P3|STARTED|Overall Study||60
1120739|NCT01231373|2713528|P2|STARTED|Overall Study||58
1120740|NCT01231373|2713529|P1|STARTED|Overall Study||59
1120741|NCT01231399|2713547|P1|NOT COMPLETED|Overall Study||0
1120742|NCT01231399|2713547|P1|COMPLETED|Overall Study||6
1120743|NCT01231399|2713547|P1|STARTED|Overall Study||6
1120744|NCT01231464|2713556|P2|NOT COMPLETED|Overall Study||7
1120745|NCT01231464|2713557|P1|NOT COMPLETED|Overall Study||5
1120746|NCT01231464|2713556|P2|COMPLETED|Overall Study||176
1120747|NCT01231464|2713557|P1|COMPLETED|Overall Study||177
1120748|NCT01231464|2713556|P2|STARTED|Overall Study||183
1120749|NCT01231464|2713557|P1|STARTED|Overall Study||182
1120750|NCT01231503|2713575|P8|NOT COMPLETED|Overall Study||8
1120751|NCT01231503|2713576|P7|NOT COMPLETED|Overall Study||7
1120752|NCT01231503|2713577|P6|NOT COMPLETED|Overall Study||16
1120753|NCT01231503|2713578|P5|NOT COMPLETED|Overall Study||10
1120754|NCT01231503|2713579|P4|NOT COMPLETED|Overall Study||8
1120755|NCT01231503|2713580|P3|NOT COMPLETED|Overall Study||12
1120756|NCT01231503|2713581|P2|NOT COMPLETED|Overall Study||13
1120757|NCT01231503|2713582|P1|NOT COMPLETED|Overall Study||14
1120758|NCT01231503|2713575|P8|COMPLETED|Overall Study||52
1120759|NCT01231503|2713576|P7|COMPLETED|Overall Study||53
1120760|NCT01231503|2713577|P6|COMPLETED|Overall Study||44
1120761|NCT01231503|2713578|P5|COMPLETED|Overall Study||50
1120762|NCT01231503|2713579|P4|COMPLETED|Overall Study||52
1120763|NCT01231503|2713580|P3|COMPLETED|Overall Study||48
1120764|NCT01231503|2713581|P2|COMPLETED|Overall Study||46
1120765|NCT01231503|2713582|P1|COMPLETED|Overall Study||46
1120766|NCT01231503|2713575|P8|STARTED|Overall Study||60
1120767|NCT01231503|2713576|P7|STARTED|Overall Study||60
1120768|NCT01231503|2713577|P6|STARTED|Overall Study||60
1120769|NCT01231503|2713578|P5|STARTED|Overall Study||60
1120770|NCT01231503|2713579|P4|STARTED|Overall Study||60
1120771|NCT01231503|2713580|P3|STARTED|Overall Study||60
1120772|NCT01231503|2713581|P2|STARTED|Overall Study||59
1120773|NCT01231503|2713582|P1|STARTED|Overall Study||60
1120774|NCT01231516|2713798|P2|NOT COMPLETED|Open-label Phase||26
1120775|NCT01231516|2713799|P1|NOT COMPLETED|Open-label Phase||295
1120776|NCT01231516|2713798|P2|COMPLETED|Open-label Phase||1
1120777|NCT01231516|2713799|P1|COMPLETED|Open-label Phase||0
1120778|NCT01231516|2713798|P2|Ongoing at the Time of Analysis|Open-label Phase||23
1120779|NCT01231516|2713799|P1|Ongoing at the Time of Analysis|Open-label Phase||282
1120780|NCT01231516|2713798|P2|STARTED|Open-label Phase|256 participants completed the Double-blind Phase but did not enter the Open-label Phase.|27
1120781|NCT01231516|2713799|P1|STARTED|Open-label Phase|4 participants completed the Double-blind Phase but did not enter the Open-label Phase.|295
1120782|NCT01231516|2713798|P2|NOT COMPLETED|48 Week Double-blind Phase||79
1120783|NCT01231516|2713799|P1|NOT COMPLETED|48 Week Double-blind Phase||58
1120784|NCT01231516|2713798|P2|COMPLETED|48 Week Double-blind Phase||283
1120785|NCT01231516|2713799|P1|COMPLETED|48 Week Double-blind Phase||299
1120786|NCT01231516|2713798|P2|STARTED|48 Week Double-blind Phase||362
1120787|NCT01231516|2713799|P1|STARTED|48 Week Double-blind Phase||357
1120788|NCT01231581|2713823|P2|NOT COMPLETED|Overall Study||80
1120789|NCT01231581|2713824|P1|NOT COMPLETED|Overall Study||80
1120790|NCT01231581|2713823|P2|COMPLETED|Overall Study||0
1120791|NCT01231581|2713824|P1|COMPLETED|Overall Study||0
1120792|NCT01231581|2713823|P2|Ongoing|Overall Study||0
1120793|NCT01231581|2713824|P1|Ongoing|Overall Study|Participant is continuing treatment with trametinib and gemcitabine under roll over study MEK114375.|1
1120794|NCT01231581|2713823|P2|STARTED|Overall Study||80
1120795|NCT01231581|2713824|P1|STARTED|Overall Study||80
1120796|NCT01231607|2713847|P5|NOT COMPLETED|Overall Study||24
1120797|NCT01231607|2713848|P4|NOT COMPLETED|Overall Study||38
1120798|NCT01231607|2713849|P3|NOT COMPLETED|Overall Study||31
1120799|NCT01231607|2713850|P2|NOT COMPLETED|Overall Study||34
1120800|NCT01231607|2713851|P1|NOT COMPLETED|Overall Study||29
1120801|NCT01231607|2713847|P5|COMPLETED|Overall Study||157
1120802|NCT01231607|2713848|P4|COMPLETED|Overall Study||141
1120803|NCT01231607|2713849|P3|COMPLETED|Overall Study||153
1120804|NCT01231607|2713850|P2|COMPLETED|Overall Study||154
1120805|NCT01231607|2713851|P1|COMPLETED|Overall Study||156
1120806|NCT01231607|2713847|P5|STARTED|Overall Study||181
1120807|NCT01231607|2713848|P4|STARTED|Overall Study||179
1120808|NCT01231607|2713849|P3|STARTED|Overall Study||184
1120809|NCT01231607|2713850|P2|STARTED|Overall Study||188
1120810|NCT01231607|2713851|P1|STARTED|Overall Study||185
1120811|NCT01231646|2713943|P2|NOT COMPLETED|Overall Study||0
1120812|NCT01231646|2713944|P1|NOT COMPLETED|Overall Study||0
1120813|NCT01231646|2713943|P2|COMPLETED|Overall Study||10
1120814|NCT01231646|2713944|P1|COMPLETED|Overall Study||28
1120815|NCT01231646|2713943|P2|STARTED|Overall Study||10
1120816|NCT01231646|2713944|P1|STARTED|Overall Study||28
1120817|NCT01231750|2713952|P2|NOT COMPLETED|Overall Study||0
1120818|NCT01231750|2713953|P1|NOT COMPLETED|Overall Study||0
1120819|NCT01231750|2713952|P2|COMPLETED|Overall Study||4
1120820|NCT01231750|2713953|P1|COMPLETED|Overall Study||3
1120821|NCT01231750|2713952|P2|STARTED|Overall Study||4
1120822|NCT01231750|2713953|P1|STARTED|Overall Study||3
1120823|NCT01231841|2713969|P1|NOT COMPLETED|Overall Study||0
1120824|NCT01231841|2713969|P1|COMPLETED|Overall Study||20
1120825|NCT01231841|2713969|P1|STARTED|Overall Study||20
1120826|NCT01231984|2713975|P4|NOT COMPLETED|Study Period 2||4
1120827|NCT01231984|2713976|P3|NOT COMPLETED|Study Period 2||0
1120828|NCT01231984|2713977|P2|NOT COMPLETED|Study Period 2||2
1120829|NCT01231984|2713978|P1|NOT COMPLETED|Study Period 2||3
1120830|NCT01231984|2713975|P4|COMPLETED|Study Period 2||56
1120831|NCT01231984|2713976|P3|COMPLETED|Study Period 2||59
1120832|NCT01231984|2713977|P2|COMPLETED|Study Period 2||61
1120833|NCT01231984|2713978|P1|COMPLETED|Study Period 2||54
1120834|NCT01231984|2713975|P4|STARTED|Study Period 2||60
1120835|NCT01231984|2713976|P3|STARTED|Study Period 2||59
1120836|NCT01231984|2713977|P2|STARTED|Study Period 2||63
1120837|NCT01231984|2713978|P1|STARTED|Study Period 2||57
1120838|NCT01231984|2713975|P4|NOT COMPLETED|Study Period 1||9
1120839|NCT01231984|2713976|P3|NOT COMPLETED|Study Period 1||7
1120840|NCT01231984|2713977|P2|NOT COMPLETED|Study Period 1||7
1120841|NCT01231984|2713978|P1|NOT COMPLETED|Study Period 1||12
1120842|NCT01231984|2713975|P4|COMPLETED|Study Period 1||60
1120843|NCT01231984|2713976|P3|COMPLETED|Study Period 1||59
1120844|NCT01231984|2713977|P2|COMPLETED|Study Period 1||63
1120845|NCT01231984|2713978|P1|COMPLETED|Study Period 1||57
1120846|NCT01231984|2713975|P4|STARTED|Study Period 1||69
1120847|NCT01231984|2713976|P3|STARTED|Study Period 1||66
1120848|NCT01231984|2713977|P2|STARTED|Study Period 1||70
1120849|NCT01231984|2713978|P1|STARTED|Study Period 1||69
1120850|NCT01232127|2713999|P3|NOT COMPLETED|Period 3: Days 18-24||0
1120851|NCT01232127|2714000|P2|NOT COMPLETED|Period 3: Days 18-24||0
1120852|NCT01232127|2714001|P1|NOT COMPLETED|Period 3: Days 18-24||0
1120853|NCT01232127|2713999|P3|COMPLETED|Period 3: Days 18-24||24
1120854|NCT01232127|2714000|P2|COMPLETED|Period 3: Days 18-24||0
1120855|NCT01232127|2714001|P1|COMPLETED|Period 3: Days 18-24||0
1120856|NCT01232127|2713999|P3|STARTED|Period 3: Days 18-24|Participants who received treatment.|24
1120857|NCT01232127|2714000|P2|STARTED|Period 3: Days 18-24||0
1120858|NCT01232127|2714001|P1|STARTED|Period 3: Days 18-24||0
1120859|NCT01232127|2713999|P3|NOT COMPLETED|Period 2: Days 11-17||0
1120860|NCT01232127|2714000|P2|NOT COMPLETED|Period 2: Days 11-17||0
1120861|NCT01232127|2714001|P1|NOT COMPLETED|Period 2: Days 11-17||0
1120862|NCT01232127|2713999|P3|COMPLETED|Period 2: Days 11-17||0
1120863|NCT01232127|2714000|P2|COMPLETED|Period 2: Days 11-17||24
1120864|NCT01232127|2714001|P1|COMPLETED|Period 2: Days 11-17||0
1120865|NCT01232127|2713999|P3|STARTED|Period 2: Days 11-17||0
1120866|NCT01232127|2714000|P2|STARTED|Period 2: Days 11-17|Participants who received treatment.|24
1120867|NCT01232127|2714001|P1|STARTED|Period 2: Days 11-17||0
1120868|NCT01232127|2713999|P3|NOT COMPLETED|Period 1: Days 1-10||0
1120869|NCT01232127|2714000|P2|NOT COMPLETED|Period 1: Days 1-10||0
1120870|NCT01232127|2714001|P1|NOT COMPLETED|Period 1: Days 1-10||1
1120871|NCT01232127|2713999|P3|COMPLETED|Period 1: Days 1-10||0
1120872|NCT01232127|2714000|P2|COMPLETED|Period 1: Days 1-10||0
1120873|NCT01232127|2714001|P1|COMPLETED|Period 1: Days 1-10||24
1120874|NCT01232127|2713999|P3|STARTED|Period 1: Days 1-10||0
1120875|NCT01232127|2714000|P2|STARTED|Period 1: Days 1-10||0
1120876|NCT01232127|2714001|P1|STARTED|Period 1: Days 1-10|Participants who received treatment.|25
1120877|NCT01232205|2714025|P2|NOT COMPLETED|Overall Study||3
1120878|NCT01232205|2714026|P1|NOT COMPLETED|Overall Study||3
1120879|NCT01232205|2714025|P2|COMPLETED|Overall Study||55
1120880|NCT01232205|2714026|P1|COMPLETED|Overall Study||49
1120881|NCT01232205|2714025|P2|STARTED|Overall Study||58
1120882|NCT01232205|2714026|P1|STARTED|Overall Study||52
1120883|NCT01232283|2714034|P8|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
1120884|NCT01232283|2714035|P7|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||17
1120885|NCT01232283|2714036|P6|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||5
1120886|NCT01232283|2714037|P5|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
1120887|NCT01232283|2714038|P4|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1120888|NCT01232283|2714039|P3|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1120889|NCT01232283|2714040|P2|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1120890|NCT01232283|2714041|P1|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1120891|NCT01232283|2714034|P8|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||84
1120892|NCT01232283|2714035|P7|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||41
1120893|NCT01232283|2714036|P6|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||56
1120894|NCT01232283|2714037|P5|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||50
1120895|NCT01232283|2714038|P4|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1120896|NCT01232283|2714039|P3|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1120897|NCT01232283|2714040|P2|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1120898|NCT01232283|2714041|P1|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
1120899|NCT01232283|2714034|P8|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||17
1120900|NCT01232283|2714035|P7|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||28
1120901|NCT01232283|2714036|P6|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
1120902|NCT01232283|2714037|P5|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
1120903|NCT01232283|2714038|P4|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
1120904|NCT01232283|2714039|P3|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
1120905|NCT01232283|2714040|P2|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
1120906|NCT01232283|2714041|P1|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
1120907|NCT01232283|2714034|P8|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||96
1120908|NCT01232283|2714035|P7|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||58
1120909|NCT01232283|2714036|P6|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|13 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|61
1120910|NCT01232283|2714037|P5|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|4 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|62
1120911|NCT01232283|2714038|P4|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
1120912|NCT01232283|2714039|P3|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
1120913|NCT01232283|2714040|P2|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
1120914|NCT01232283|2714041|P1|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
1120915|NCT01232283|2714034|P8|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
1120916|NCT01232283|2714035|P7|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
1120917|NCT01232283|2714036|P6|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
1120918|NCT01232283|2714037|P5|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
1120919|NCT01232283|2714038|P4|NOT COMPLETED|Maintenance Phase (Weeks16-32)||8
1120920|NCT01232283|2714039|P3|NOT COMPLETED|Maintenance Phase (Weeks16-32)||40
1120921|NCT01232283|2714040|P2|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
1120922|NCT01232283|2714041|P1|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
1120923|NCT01232283|2714034|P8|COMPLETED|Maintenance Phase (Weeks16-32)||0
1120924|NCT01232283|2714035|P7|COMPLETED|Maintenance Phase (Weeks16-32)||0
1120925|NCT01232283|2714036|P6|COMPLETED|Maintenance Phase (Weeks16-32)||0
1120926|NCT01232283|2714037|P5|COMPLETED|Maintenance Phase (Weeks16-32)||0
1120927|NCT01232283|2714038|P4|COMPLETED|Maintenance Phase (Weeks16-32)||100
1120928|NCT01232283|2714039|P3|COMPLETED|Maintenance Phase (Weeks16-32)||194
1120929|NCT01232283|2714040|P2|COMPLETED|Maintenance Phase (Weeks16-32)||0
1120930|NCT01232283|2714041|P1|COMPLETED|Maintenance Phase (Weeks16-32)||0
1120931|NCT01232283|2714034|P8|STARTED|Maintenance Phase (Weeks16-32)||0
1120932|NCT01232283|2714035|P7|STARTED|Maintenance Phase (Weeks16-32)||0
1120933|NCT01232283|2714036|P6|STARTED|Maintenance Phase (Weeks16-32)||0
1120934|NCT01232283|2714037|P5|STARTED|Maintenance Phase (Weeks16-32)||0
1120935|NCT01232283|2714038|P4|STARTED|Maintenance Phase (Weeks16-32)|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|108
1120936|NCT01232283|2714039|P3|STARTED|Maintenance Phase (Weeks16-32)|5 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|234
1120937|NCT01232283|2714040|P2|STARTED|Maintenance Phase (Weeks16-32)||0
1120938|NCT01232283|2714041|P1|STARTED|Maintenance Phase (Weeks16-32)||0
1120939|NCT01232283|2714034|P8|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1120940|NCT01232283|2714035|P7|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1120941|NCT01232283|2714036|P6|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1120942|NCT01232283|2714037|P5|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1120943|NCT01232283|2714038|P4|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1120944|NCT01232283|2714039|P3|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1120945|NCT01232283|2714040|P2|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||26
1120946|NCT01232283|2714041|P1|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||36
1120947|NCT01232283|2714034|P8|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1120948|NCT01232283|2714035|P7|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1120949|NCT01232283|2714036|P6|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1120950|NCT01232283|2714037|P5|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1120951|NCT01232283|2714038|P4|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1120952|NCT01232283|2714039|P3|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
1120953|NCT01232283|2714040|P2|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||112
1120954|NCT01232283|2714041|P1|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||239
1120955|NCT01232283|2714034|P8|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
1120956|NCT01232283|2714035|P7|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
1120957|NCT01232283|2714036|P6|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
1120958|NCT01232283|2714037|P5|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
1120959|NCT01232283|2714038|P4|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
1120960|NCT01232283|2714039|P3|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
1120961|NCT01232283|2714040|P2|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|136
1121042|NCT01232790|2714202|P2|COMPLETED|Initial Assessment||11
1120962|NCT01232283|2714041|P1|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|272
1120963|NCT01232283|2714034|P8|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
1120964|NCT01232283|2714035|P7|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
1120965|NCT01232283|2714036|P6|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
1120966|NCT01232283|2714037|P5|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
1120967|NCT01232283|2714038|P4|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
1120968|NCT01232283|2714039|P3|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
1120969|NCT01232283|2714040|P2|STARTED|Placebo Controlled Phase (Weeks 0-16)||138
1120970|NCT01232283|2714041|P1|STARTED|Placebo Controlled Phase (Weeks 0-16)||275
1120971|NCT01232296|2714073|P2|NOT COMPLETED|Overall Study||83
1120972|NCT01232296|2714074|P1|NOT COMPLETED|Overall Study||82
1120973|NCT01232296|2714073|P2|COMPLETED|Overall Study||0
1120974|NCT01232296|2714074|P1|COMPLETED|Overall Study||0
1120975|NCT01232296|2714073|P2|Safety Set|Overall Study||83
1120976|NCT01232296|2714074|P1|Safety Set|Overall Study|The Safety Set includes all patients who received at least one dose of study medication|79
1120977|NCT01232296|2714073|P2|Full Analysis Set|Overall Study||83
1120978|NCT01232296|2714074|P1|Full Analysis Set|Overall Study||82
1120979|NCT01232296|2714073|P2|STARTED|Overall Study||83
1120980|NCT01232296|2714074|P1|STARTED|Overall Study||82
1120981|NCT01232465|2714091|P2|NOT COMPLETED|Overall Study||0
1120982|NCT01232465|2714092|P1|NOT COMPLETED|Overall Study||0
1120983|NCT01232465|2714091|P2|COMPLETED|Overall Study||402
1120984|NCT01232465|2714092|P1|COMPLETED|Overall Study||337
1120985|NCT01232465|2714091|P2|STARTED|Overall Study||402
1120986|NCT01232465|2714092|P1|STARTED|Overall Study||337
1120987|NCT01232491|2714100|P2|NOT COMPLETED|Overall Study||63
1120988|NCT01232491|2714101|P1|NOT COMPLETED|Overall Study||60
1120989|NCT01232491|2714100|P2|COMPLETED|Overall Study||242
1120990|NCT01232491|2714101|P1|COMPLETED|Overall Study||246
1120991|NCT01232491|2714100|P2|Exposed (Safety Analysis Set)|Overall Study|Four subjects withdrew prior to exposure to trial drug.|301
1120992|NCT01232491|2714101|P1|Exposed (Safety Analysis Set)|Overall Study|One subject withdrew prior to exposure to trial drug.|305
1120993|NCT01232491|2714100|P2|STARTED|Overall Study||305
1120994|NCT01232491|2714101|P1|STARTED|Overall Study||306
1120995|NCT01232504|2714122|P3|NOT COMPLETED|Overall Study||8
1120996|NCT01232504|2714123|P2|NOT COMPLETED|Overall Study||2
1120997|NCT01232504|2714124|P1|NOT COMPLETED|Overall Study||9
1120998|NCT01232504|2714122|P3|COMPLETED|Overall Study||61
1120999|NCT01232504|2714123|P2|COMPLETED|Overall Study||67
1121000|NCT01232504|2714124|P1|COMPLETED|Overall Study||59
1121001|NCT01232504|2714122|P3|STARTED|Overall Study||69
1121002|NCT01232504|2714123|P2|STARTED|Overall Study||69
1121003|NCT01232504|2714124|P1|STARTED|Overall Study||68
1121004|NCT01232569|2714158|P4|NOT COMPLETED|Open-label Extension Period||27
1121005|NCT01232569|2714159|P3|NOT COMPLETED|Open-label Extension Period||27
1121006|NCT01232569|2714160|P2|NOT COMPLETED|Open-label Extension Period||0
1121007|NCT01232569|2714161|P1|NOT COMPLETED|Open-label Extension Period||0
1121008|NCT01232569|2714158|P4|COMPLETED|Open-label Extension Period||200
1121009|NCT01232569|2714159|P3|COMPLETED|Open-label Extension Period||203
1121010|NCT01232569|2714160|P2|COMPLETED|Open-label Extension Period||0
1121011|NCT01232569|2714161|P1|COMPLETED|Open-label Extension Period||0
1121012|NCT01232569|2714158|P4|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|227
1121013|NCT01232569|2714159|P3|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|230
1121014|NCT01232569|2714160|P2|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
1121015|NCT01232569|2714161|P1|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
1121016|NCT01232569|2714158|P4|NOT COMPLETED|Double-blind Treatment Period||0
1121017|NCT01232569|2714159|P3|NOT COMPLETED|Double-blind Treatment Period||0
1121018|NCT01232569|2714160|P2|NOT COMPLETED|Double-blind Treatment Period||9
1121019|NCT01232569|2714161|P1|NOT COMPLETED|Double-blind Treatment Period||28
1121020|NCT01232569|2714158|P4|COMPLETED|Double-blind Treatment Period||0
1121021|NCT01232569|2714159|P3|COMPLETED|Double-blind Treatment Period||0
1121022|NCT01232569|2714160|P2|COMPLETED|Double-blind Treatment Period||209
1121023|NCT01232569|2714161|P1|COMPLETED|Double-blind Treatment Period||410
1121024|NCT01232569|2714158|P4|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
1121025|NCT01232569|2714159|P3|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
1121026|NCT01232569|2714160|P2|STARTED|Double-blind Treatment Period||218
1121027|NCT01232569|2714161|P1|STARTED|Double-blind Treatment Period||438
1121028|NCT01232790|2714202|P2|NOT COMPLETED|Second Crossover||2
1121029|NCT01232790|2714203|P1|NOT COMPLETED|Second Crossover||1
1121030|NCT01232790|2714202|P2|COMPLETED|Second Crossover||9
1121031|NCT01232790|2714203|P1|COMPLETED|Second Crossover||10
1121032|NCT01232790|2714202|P2|STARTED|Second Crossover||11
1121033|NCT01232790|2714203|P1|STARTED|Second Crossover||11
1121034|NCT01232790|2714202|P2|NOT COMPLETED|First Crossover||0
1121035|NCT01232790|2714203|P1|NOT COMPLETED|First Crossover||1
1121036|NCT01232790|2714202|P2|COMPLETED|First Crossover||11
1121037|NCT01232790|2714203|P1|COMPLETED|First Crossover||11
1121038|NCT01232790|2714202|P2|STARTED|First Crossover||11
1121039|NCT01232790|2714203|P1|STARTED|First Crossover||12
1121040|NCT01232790|2714202|P2|NOT COMPLETED|Initial Assessment||1
1121041|NCT01232790|2714203|P1|NOT COMPLETED|Initial Assessment||0
1121043|NCT01232790|2714203|P1|COMPLETED|Initial Assessment||12
1121044|NCT01232790|2714202|P2|STARTED|Initial Assessment||12
1121045|NCT01232790|2714203|P1|STARTED|Initial Assessment||12
1121046|NCT01232790|2714202|P2|NOT COMPLETED|Randomization||2
1121047|NCT01232790|2714203|P1|NOT COMPLETED|Randomization||2
1121048|NCT01232790|2714202|P2|COMPLETED|Randomization||12
1121049|NCT01232790|2714203|P1|COMPLETED|Randomization||12
1121050|NCT01232790|2714202|P2|STARTED|Randomization||14
1121051|NCT01232790|2714203|P1|STARTED|Randomization||14
1121052|NCT01232829|2714257|P1|NOT COMPLETED|Overall Study||0
1121053|NCT01232829|2714257|P1|COMPLETED|Overall Study||18
1121054|NCT01232829|2714257|P1|STARTED|Overall Study||18
1121061|NCT01232894|2714276|P2|NOT COMPLETED|Overall Study||8
1121062|NCT01232894|2714277|P1|NOT COMPLETED|Overall Study||12
1121063|NCT01232894|2714276|P2|COMPLETED|Overall Study||22
1121064|NCT01232894|2714277|P1|COMPLETED|Overall Study||48
1121065|NCT01232894|2714276|P2|Received Study Drug|Overall Study||28
1121066|NCT01232894|2714277|P1|Received Study Drug|Overall Study||59
1121067|NCT01232894|2714276|P2|STARTED|Overall Study||30
1121068|NCT01232894|2714277|P1|STARTED|Overall Study||60
1121069|NCT01232920|2714285|P2|NOT COMPLETED|Overall Study||7
1121070|NCT01232920|2714286|P1|NOT COMPLETED|Overall Study||6
1121071|NCT01232920|2714285|P2|COMPLETED|Overall Study||32
1121072|NCT01232920|2714286|P1|COMPLETED|Overall Study||35
1121073|NCT01232920|2714285|P2|STARTED|Overall Study||39
1121074|NCT01232920|2714286|P1|STARTED|Overall Study||41
1121075|NCT01233050|2714300|P2|NOT COMPLETED|Overall Study||6
1121076|NCT01233050|2714301|P1|NOT COMPLETED|Overall Study||8
1121077|NCT01233050|2714300|P2|COMPLETED|Overall Study|6 participants were excluded after treatment administered due to inclusion/exclusion criteria|396
1121078|NCT01233050|2714301|P1|COMPLETED|Overall Study|8 participants were excluded after treatment administered due to inclusion/exclusion criteria|392
1121079|NCT01233050|2714300|P2|STARTED|Overall Study||402
1121080|NCT01233050|2714301|P1|STARTED|Overall Study||400
1121081|NCT01233076|2714317|P2|NOT COMPLETED|Period 2, One Week||0
1121082|NCT01233076|2714318|P1|NOT COMPLETED|Period 2, One Week||1
1121083|NCT01233076|2714317|P2|COMPLETED|Period 2, One Week||30
1121084|NCT01233076|2714318|P1|COMPLETED|Period 2, One Week||29
1121085|NCT01233076|2714317|P2|STARTED|Period 2, One Week||30
1121086|NCT01233076|2714318|P1|STARTED|Period 2, One Week||30
1121087|NCT01233076|2714317|P2|NOT COMPLETED|Period 1, One Week||0
1121088|NCT01233076|2714318|P1|NOT COMPLETED|Period 1, One Week||0
1121089|NCT01233076|2714317|P2|COMPLETED|Period 1, One Week||30
1121090|NCT01233076|2714318|P1|COMPLETED|Period 1, One Week||30
1121091|NCT01233076|2714317|P2|STARTED|Period 1, One Week||30
1121092|NCT01233076|2714318|P1|STARTED|Period 1, One Week||30
1121093|NCT01238822|2714324|P1|NOT COMPLETED|Overall Study||3
1121094|NCT01238822|2714324|P1|COMPLETED|Overall Study||93
1121095|NCT01238822|2714324|P1|Received High Dosage|Overall Study||93
1121096|NCT01238822|2714324|P1|Received Medium Dosage|Overall Study||93
1121097|NCT01238822|2714324|P1|Received Low Dosage|Overall Study||93
1121098|NCT01238822|2714324|P1|Received Placebo|Overall Study||93
1121099|NCT01238822|2714324|P1|STARTED|Overall Study||96
1121100|NCT01238848|2714336|P2|NOT COMPLETED|Overall Study||5
1121101|NCT01238848|2714337|P1|NOT COMPLETED|Overall Study||13
1121102|NCT01238848|2714336|P2|COMPLETED|Overall Study||45
1121103|NCT01238848|2714337|P1|COMPLETED|Overall Study||37
1121104|NCT01238848|2714336|P2|STARTED|Overall Study||50
1121105|NCT01238848|2714337|P1|STARTED|Overall Study||50
1121106|NCT01238861|2714351|P6|NOT COMPLETED|Overall Study||15
1121107|NCT01238861|2714352|P5|NOT COMPLETED|Overall Study||13
1121108|NCT01238861|2714353|P4|NOT COMPLETED|Overall Study||13
1121109|NCT01238861|2714354|P3|NOT COMPLETED|Overall Study||11
1121110|NCT01238861|2714355|P2|NOT COMPLETED|Overall Study||8
1121111|NCT01238861|2714356|P1|NOT COMPLETED|Overall Study||11
1121112|NCT01238861|2714351|P6|COMPLETED|Overall Study||125
1121113|NCT01238861|2714352|P5|COMPLETED|Overall Study||129
1121114|NCT01238861|2714353|P4|COMPLETED|Overall Study||69
1121115|NCT01238861|2714354|P3|COMPLETED|Overall Study||70
1121116|NCT01238861|2714355|P2|COMPLETED|Overall Study||73
1121117|NCT01238861|2714356|P1|COMPLETED|Overall Study||69
1121118|NCT01238861|2714351|P6|STARTED|Overall Study||140
1121119|NCT01238861|2714352|P5|STARTED|Overall Study||142
1121120|NCT01238861|2714353|P4|STARTED|Overall Study||82
1121121|NCT01238861|2714354|P3|STARTED|Overall Study||81
1121122|NCT01238861|2714355|P2|STARTED|Overall Study||81
1121123|NCT01238861|2714356|P1|STARTED|Overall Study||80
1121124|NCT01238900|2714434|P1|NOT COMPLETED|<12 Months Post Stent Removal||5
1121125|NCT01238900|2714434|P1|COMPLETED|<12 Months Post Stent Removal||18
1121126|NCT01238900|2714434|P1|STARTED|<12 Months Post Stent Removal||23
1121127|NCT01238900|2714434|P1|NOT COMPLETED|6 Months Post Stent Placement||0
1121128|NCT01238900|2714434|P1|COMPLETED|6 Months Post Stent Placement||23
1121129|NCT01238900|2714434|P1|STARTED|6 Months Post Stent Placement||23
1121130|NCT01238991|2714452|P10|NOT COMPLETED|Overall Study||2
1121131|NCT01238991|2714453|P9|NOT COMPLETED|Overall Study||4
1121132|NCT01238991|2714454|P8|NOT COMPLETED|Overall Study||5
1121133|NCT01238991|2714455|P7|NOT COMPLETED|Overall Study||8
1121134|NCT01238991|2714456|P6|NOT COMPLETED|Overall Study||0
1121135|NCT01238991|2714457|P5|NOT COMPLETED|Overall Study||2
1121136|NCT01238991|2714458|P4|NOT COMPLETED|Overall Study||2
1121137|NCT01238991|2714459|P3|NOT COMPLETED|Overall Study||6
1121138|NCT01238991|2714460|P2|NOT COMPLETED|Overall Study||0
1121139|NCT01238991|2714461|P1|NOT COMPLETED|Overall Study||2
1121140|NCT01238991|2714452|P10|COMPLETED|Overall Study||0
1121141|NCT01238991|2714453|P9|COMPLETED|Overall Study||0
1121142|NCT01238991|2714454|P8|COMPLETED|Overall Study||0
1121143|NCT01238991|2714455|P7|COMPLETED|Overall Study||0
1121144|NCT01238991|2714456|P6|COMPLETED|Overall Study||2
1121145|NCT01238991|2714457|P5|COMPLETED|Overall Study||3
1121146|NCT01238991|2714458|P4|COMPLETED|Overall Study||4
1121147|NCT01238991|2714459|P3|COMPLETED|Overall Study||5
1121148|NCT01238991|2714460|P2|COMPLETED|Overall Study||3
1121149|NCT01238991|2714461|P1|COMPLETED|Overall Study||5
1121150|NCT01238991|2714452|P10|Received Treatment|Overall Study||2
1121151|NCT01238991|2714453|P9|Received Treatment|Overall Study||4
1121152|NCT01238991|2714454|P8|Received Treatment|Overall Study||5
1121153|NCT01238991|2714455|P7|Received Treatment|Overall Study||8
1121154|NCT01238991|2714456|P6|Received Treatment|Overall Study||2
1121155|NCT01238991|2714457|P5|Received Treatment|Overall Study||5
1121156|NCT01238991|2714458|P4|Received Treatment|Overall Study||6
1121157|NCT01238991|2714459|P3|Received Treatment|Overall Study||11
1121158|NCT01238991|2714460|P2|Received Treatment|Overall Study||3
1121159|NCT01238991|2714461|P1|Received Treatment|Overall Study||7
1121160|NCT01238991|2714452|P10|STARTED|Overall Study||2
1121161|NCT01238991|2714453|P9|STARTED|Overall Study||4
1121162|NCT01238991|2714454|P8|STARTED|Overall Study||5
1121163|NCT01238991|2714455|P7|STARTED|Overall Study||8
1121164|NCT01238991|2714456|P6|STARTED|Overall Study||2
1121165|NCT01238991|2714457|P5|STARTED|Overall Study||5
1121166|NCT01238991|2714458|P4|STARTED|Overall Study||6
1121167|NCT01238991|2714459|P3|STARTED|Overall Study||11
1121168|NCT01238991|2714460|P2|STARTED|Overall Study||3
1121169|NCT01238991|2714461|P1|STARTED|Overall Study||7
1121170|NCT01239680|2714550|P2|NOT COMPLETED|Overall Study||0
1121171|NCT01239680|2714551|P1|NOT COMPLETED|Overall Study||2
1121172|NCT01239680|2714550|P2|COMPLETED|Overall Study||2
1121173|NCT01239680|2714551|P1|COMPLETED|Overall Study||1
1121174|NCT01239680|2714550|P2|STARTED|Overall Study||2
1121175|NCT01239680|2714551|P1|STARTED|Overall Study||3
1121176|NCT01239732|2714557|P1|NOT COMPLETED|Overall Study||1021
1121177|NCT01239732|2714557|P1|COMPLETED|Overall Study||0
1121178|NCT01239732|2714557|P1|STARTED|Overall Study||1021
1121179|NCT01239745|2714568|P1|NOT COMPLETED|Overall Study||46
1121180|NCT01239745|2714568|P1|COMPLETED|Overall Study||0
1121181|NCT01239745|2714568|P1|STARTED|Overall Study||46
1121182|NCT01239797|2714581|P2|NOT COMPLETED|Treated Participants||274
1121183|NCT01239797|2714582|P1|NOT COMPLETED|Treated Participants||235
1121184|NCT01239797|2714581|P2|COMPLETED|Treated Participants|Completed = Still on Treatment|43
1121185|NCT01239797|2714582|P1|COMPLETED|Treated Participants|Completed = Still on Treatment|83
1121186|NCT01239797|2714581|P2|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|317
1121187|NCT01239797|2714582|P1|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|318
1121188|NCT01239797|2714581|P2|NOT COMPLETED|Randomized Participants||9
1121189|NCT01239797|2714582|P1|NOT COMPLETED|Randomized Participants||2
1121190|NCT01239797|2714581|P2|COMPLETED|Randomized Participants||316
1121191|NCT01239797|2714582|P1|COMPLETED|Randomized Participants||319
1121192|NCT01239797|2714581|P2|STARTED|Randomized Participants||325
1121193|NCT01239797|2714582|P1|STARTED|Randomized Participants||321
1121194|NCT01239992|2714590|P1|NOT COMPLETED|Overall Study||2
1121195|NCT01239992|2714590|P1|COMPLETED|Overall Study||10
1121196|NCT01239992|2714590|P1|STARTED|Overall Study||12
1121197|NCT01240122|2714597|P1|NOT COMPLETED|Overall Study||0
1121198|NCT01240122|2714597|P1|COMPLETED|Overall Study||29
1121199|NCT01240122|2714597|P1|STARTED|Overall Study||29
1121200|NCT01240135|2714606|P2|NOT COMPLETED|Period Two, 14 Days of Wear||2
1121201|NCT01240135|2714607|P1|NOT COMPLETED|Period Two, 14 Days of Wear||1
1121202|NCT01240135|2714606|P2|COMPLETED|Period Two, 14 Days of Wear||43
1121203|NCT01240135|2714607|P1|COMPLETED|Period Two, 14 Days of Wear||43
1121204|NCT01240135|2714606|P2|STARTED|Period Two, 14 Days of Wear||45
1121205|NCT01240135|2714607|P1|STARTED|Period Two, 14 Days of Wear||44
1121206|NCT01240135|2714606|P2|NOT COMPLETED|Period One, 14 Days of Wear||0
1121207|NCT01240135|2714607|P1|NOT COMPLETED|Period One, 14 Days of Wear||0
1121208|NCT01240135|2714606|P2|COMPLETED|Period One, 14 Days of Wear||45
1121209|NCT01240135|2714607|P1|COMPLETED|Period One, 14 Days of Wear||44
1121210|NCT01240135|2714606|P2|STARTED|Period One, 14 Days of Wear||45
1121211|NCT01240135|2714607|P1|STARTED|Period One, 14 Days of Wear||44
1121212|NCT01240200|2714617|P2|NOT COMPLETED|12-week Crossover Phase - Period 2||0
1121213|NCT01240200|2714618|P1|NOT COMPLETED|12-week Crossover Phase - Period 2||0
1121214|NCT01240200|2714617|P2|COMPLETED|12-week Crossover Phase - Period 2||23
1121215|NCT01240200|2714618|P1|COMPLETED|12-week Crossover Phase - Period 2||23
1121216|NCT01240200|2714617|P2|STARTED|12-week Crossover Phase - Period 2||23
1121217|NCT01240200|2714618|P1|STARTED|12-week Crossover Phase - Period 2||23
1121218|NCT01240200|2714617|P2|NOT COMPLETED|12-week Crossover Phase - Period 1||1
1121219|NCT01240200|2714618|P1|NOT COMPLETED|12-week Crossover Phase - Period 1||2
1121220|NCT01240200|2714617|P2|COMPLETED|12-week Crossover Phase - Period 1||23
1121221|NCT01240200|2714618|P1|COMPLETED|12-week Crossover Phase - Period 1||23
1121222|NCT01240200|2714617|P2|STARTED|12-week Crossover Phase - Period 1||24
1121223|NCT01240200|2714618|P1|STARTED|12-week Crossover Phase - Period 1||25
1121224|NCT01240330|2714624|P1|NOT COMPLETED|Overall Study||0
1121225|NCT01240330|2714624|P1|COMPLETED|Overall Study||33
1121226|NCT01240330|2714624|P1|STARTED|Overall Study||33
1121227|NCT01240356|2714632|P2|NOT COMPLETED|Overall Study||0
1121228|NCT01240356|2714633|P1|NOT COMPLETED|Overall Study||3
1121229|NCT01240356|2714632|P2|COMPLETED|Overall Study||20
1121230|NCT01240356|2714633|P1|COMPLETED|Overall Study||15
1121231|NCT01240356|2714632|P2|STARTED|Overall Study||20
1121232|NCT01240356|2714633|P1|STARTED|Overall Study||18
1121233|NCT01240382|2714646|P2|NOT COMPLETED|Overall Study||4
1121234|NCT01240382|2714647|P1|NOT COMPLETED|Overall Study||2
1121235|NCT01240382|2714646|P2|COMPLETED|Overall Study||139
1121236|NCT01240382|2714647|P1|COMPLETED|Overall Study||142
1121237|NCT01240382|2714646|P2|STARTED|Overall Study||143
1121238|NCT01240382|2714647|P1|STARTED|Overall Study||144
1121239|NCT01240551|2714657|P2|NOT COMPLETED|Overall Study||3
1121240|NCT01240551|2714658|P1|NOT COMPLETED|Overall Study||4
1121241|NCT01240551|2714657|P2|COMPLETED|Overall Study||27
1121242|NCT01240551|2714658|P1|COMPLETED|Overall Study||26
1121243|NCT01240551|2714657|P2|STARTED|Overall Study||30
1121244|NCT01240551|2714658|P1|STARTED|Overall Study||30
1121245|NCT01240590|2714671|P5|NOT COMPLETED|Phase II||1
1121246|NCT01240590|2714672|P4|NOT COMPLETED|Phase II||2
1121247|NCT01240590|2714673|P3|NOT COMPLETED|Phase II||0
1121248|NCT01240590|2714674|P2|NOT COMPLETED|Phase II||0
1121249|NCT01240590|2714675|P1|NOT COMPLETED|Phase II||0
1121250|NCT01240590|2714671|P5|COMPLETED|Phase II||0
1121251|NCT01240590|2714672|P4|COMPLETED|Phase II||15
1121252|NCT01240590|2714673|P3|COMPLETED|Phase II||0
1121253|NCT01240590|2714674|P2|COMPLETED|Phase II||0
1121254|NCT01240590|2714675|P1|COMPLETED|Phase II||0
1121255|NCT01240590|2714671|P5|STARTED|Phase II||1
1121256|NCT01240590|2714672|P4|STARTED|Phase II||17
1121257|NCT01240590|2714673|P3|STARTED|Phase II||0
1121258|NCT01240590|2714674|P2|STARTED|Phase II||0
1121259|NCT01240590|2714675|P1|STARTED|Phase II||0
1121260|NCT01240590|2714671|P5|NOT COMPLETED|Phase I||0
1121261|NCT01240590|2714672|P4|NOT COMPLETED|Phase I||0
1121262|NCT01240590|2714673|P3|NOT COMPLETED|Phase I||3
1121263|NCT01240590|2714674|P2|NOT COMPLETED|Phase I||0
1121264|NCT01240590|2714675|P1|NOT COMPLETED|Phase I||0
1121265|NCT01240590|2714671|P5|COMPLETED|Phase I||0
1121266|NCT01240590|2714672|P4|COMPLETED|Phase I||0
1121267|NCT01240590|2714673|P3|COMPLETED|Phase I||0
1121268|NCT01240590|2714674|P2|COMPLETED|Phase I||6
1121269|NCT01240590|2714675|P1|COMPLETED|Phase I||0
1121270|NCT01240590|2714671|P5|STARTED|Phase I||0
1121271|NCT01240590|2714672|P4|STARTED|Phase I||0
1121272|NCT01240590|2714673|P3|STARTED|Phase I||3
1121273|NCT01240590|2714674|P2|STARTED|Phase I||6
1121274|NCT01240590|2714675|P1|STARTED|Phase I||0
1121275|NCT01240746|2714704|P3|NOT COMPLETED|Overall Study||243
1121276|NCT01240746|2714705|P2|NOT COMPLETED|Overall Study||48
1121277|NCT01240746|2714706|P1|NOT COMPLETED|Overall Study||59
1121278|NCT01240746|2714704|P3|COMPLETED|Overall Study||2659
1121279|NCT01240746|2714705|P2|COMPLETED|Overall Study||677
1121280|NCT01240746|2714706|P1|COMPLETED|Overall Study||677
1121281|NCT01240746|2714704|P3|STARTED|Overall Study||2902
1121282|NCT01240746|2714705|P2|STARTED|Overall Study||725
1121283|NCT01240746|2714706|P1|STARTED|Overall Study||736
1121284|NCT01240785|2714758|P2|NOT COMPLETED|Overall Study||3
1121285|NCT01240785|2714759|P1|NOT COMPLETED|Overall Study||1
1121286|NCT01240785|2714758|P2|COMPLETED|Overall Study||107
1121287|NCT01240785|2714759|P1|COMPLETED|Overall Study|110 women completed in the metformin arm and 107 women completed in the insulin arm.|110
1121288|NCT01240785|2714758|P2|STARTED|Overall Study||110
1121289|NCT01240785|2714759|P1|STARTED|Overall Study||111
1121290|NCT01240811|2714790|P3|NOT COMPLETED|Overall Study||1
1121291|NCT01240811|2714791|P2|NOT COMPLETED|Overall Study||1
1121292|NCT01240811|2714792|P1|NOT COMPLETED|Overall Study||0
1121293|NCT01240811|2714790|P3|COMPLETED|Overall Study||16
1121294|NCT01240811|2714791|P2|COMPLETED|Overall Study||16
1121295|NCT01240811|2714792|P1|COMPLETED|Overall Study||8
1121296|NCT01240811|2714790|P3|STARTED|Overall Study||17
1121297|NCT01240811|2714791|P2|STARTED|Overall Study||17
1121298|NCT01240811|2714792|P1|STARTED|Overall Study||8
1121299|NCT01240863|2714802|P3|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||52
1121300|NCT01240863|2714803|P2|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||46
1121301|NCT01240863|2714804|P1|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
1121302|NCT01240863|2714802|P3|COMPLETED|Double-blind Treatment Period (12 Weeks)||94
1121303|NCT01240863|2714803|P2|COMPLETED|Double-blind Treatment Period (12 Weeks)||102
1121304|NCT01240863|2714804|P1|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
1121305|NCT01240863|2714802|P3|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||146
1121306|NCT01240863|2714803|P2|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||147
1121307|NCT01240863|2714804|P1|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||0
1121308|NCT01240863|2714802|P3|STARTED|Double-blind Treatment Period (12 Weeks)||146
1121309|NCT01240863|2714803|P2|STARTED|Double-blind Treatment Period (12 Weeks)||148
1121310|NCT01240863|2714804|P1|STARTED|Double-blind Treatment Period (12 Weeks)||0
1121311|NCT01240863|2714802|P3|NOT COMPLETED|Open-label Titration Period||0
1121312|NCT01240863|2714803|P2|NOT COMPLETED|Open-label Titration Period||0
1121313|NCT01240863|2714804|P1|NOT COMPLETED|Open-label Titration Period||97
1121314|NCT01240863|2714802|P3|COMPLETED|Open-label Titration Period||0
1121315|NCT01240863|2714803|P2|COMPLETED|Open-label Titration Period||0
1121316|NCT01240863|2714804|P1|COMPLETED|Open-label Titration Period||294
1121317|NCT01240863|2714802|P3|Safety Analysis Set|Open-label Titration Period||0
1121318|NCT01240863|2714803|P2|Safety Analysis Set|Open-label Titration Period||0
1121319|NCT01240863|2714804|P1|Safety Analysis Set|Open-label Titration Period||389
1121320|NCT01240863|2714802|P3|STARTED|Open-label Titration Period||0
1121321|NCT01240863|2714803|P2|STARTED|Open-label Titration Period||0
1121322|NCT01240863|2714804|P1|STARTED|Open-label Titration Period||391
1121335|NCT01240915|2714964|P9|NOT COMPLETED|Overall Study||8
1121336|NCT01240915|2714965|P8|NOT COMPLETED|Overall Study||4
1121337|NCT01240915|2714966|P7|NOT COMPLETED|Overall Study||8
1121338|NCT01240915|2714967|P6|NOT COMPLETED|Overall Study||10
1121339|NCT01240915|2714968|P5|NOT COMPLETED|Overall Study||4
1121340|NCT01240915|2714969|P4|NOT COMPLETED|Overall Study||3
1121341|NCT01240915|2714970|P3|NOT COMPLETED|Overall Study||0
1121342|NCT01240915|2714971|P2|NOT COMPLETED|Overall Study||1
1121343|NCT01240915|2714972|P1|NOT COMPLETED|Overall Study||2
1121344|NCT01240915|2714964|P9|COMPLETED|Overall Study||13
1121345|NCT01240915|2714965|P8|COMPLETED|Overall Study||15
1121346|NCT01240915|2714966|P7|COMPLETED|Overall Study||17
1121347|NCT01240915|2714967|P6|COMPLETED|Overall Study||13
1121348|NCT01240915|2714968|P5|COMPLETED|Overall Study||2
1121349|NCT01240915|2714969|P4|COMPLETED|Overall Study||1
1121350|NCT01240915|2714970|P3|COMPLETED|Overall Study||2
1121351|NCT01240915|2714971|P2|COMPLETED|Overall Study||2
1121352|NCT01240915|2714972|P1|COMPLETED|Overall Study||0
1121353|NCT01240915|2714964|P9|STARTED|Overall Study||21
1121354|NCT01240915|2714965|P8|STARTED|Overall Study||19
1121355|NCT01240915|2714966|P7|STARTED|Overall Study||25
1121356|NCT01240915|2714967|P6|STARTED|Overall Study||23
1121357|NCT01240915|2714968|P5|STARTED|Overall Study||6
1121358|NCT01240915|2714969|P4|STARTED|Overall Study||4
1121359|NCT01240915|2714970|P3|STARTED|Overall Study||2
1121360|NCT01240915|2714971|P2|STARTED|Overall Study||3
1121361|NCT01240915|2714972|P1|STARTED|Overall Study||2
1121362|NCT01241240|2715153|P2|NOT COMPLETED|Overall Study||9
1121363|NCT01241240|2715154|P1|NOT COMPLETED|Overall Study||8
1121364|NCT01241240|2715153|P2|COMPLETED|Overall Study||89
1121365|NCT01241240|2715154|P1|COMPLETED|Overall Study||86
1121366|NCT01241240|2715153|P2|STARTED|Overall Study||98
1121367|NCT01241240|2715154|P1|STARTED|Overall Study||94
1121368|NCT01241279|2715166|P2|NOT COMPLETED|Overall Study||1
1121369|NCT01241279|2715167|P1|NOT COMPLETED|Overall Study||0
1121370|NCT01241279|2715166|P2|COMPLETED|Overall Study||1
1121371|NCT01241279|2715167|P1|COMPLETED|Overall Study||4
1121372|NCT01241279|2715166|P2|STARTED|Overall Study||2
1121373|NCT01241279|2715167|P1|STARTED|Overall Study||4
1121374|NCT01241292|2715177|P2|NOT COMPLETED|Overall Study||2
1121375|NCT01241292|2715178|P1|NOT COMPLETED|Overall Study||1
1121376|NCT01241292|2715177|P2|COMPLETED|Overall Study|completed=treatment on-going|1
1121377|NCT01241292|2715178|P1|COMPLETED|Overall Study|completed=treatment on-going|2
1121378|NCT01241292|2715177|P2|STARTED|Overall Study||3
1121379|NCT01241292|2715178|P1|STARTED|Overall Study||3
1121380|NCT01241513|2715202|P2|NOT COMPLETED|Overall Study||0
1121381|NCT01241513|2715203|P1|NOT COMPLETED|Overall Study||0
1121382|NCT01241513|2715202|P2|COMPLETED|Overall Study||9
1121383|NCT01241513|2715203|P1|COMPLETED|Overall Study|Study has been completed|10
1121384|NCT01241513|2715202|P2|STARTED|Overall Study||9
1121385|NCT01241513|2715203|P1|STARTED|Overall Study||10
1121386|NCT01241539|2715208|P1|NOT COMPLETED|Period 2||0
1121387|NCT01241539|2715208|P1|COMPLETED|Period 2||7
1121388|NCT01241539|2715208|P1|STARTED|Period 2|After a wash-out phase of at least 6 weeks.|7
1121389|NCT01241539|2715208|P1|NOT COMPLETED|Period 1||0
1121390|NCT01241539|2715208|P1|COMPLETED|Period 1||7
1121391|NCT01241539|2715208|P1|STARTED|Period 1||7
1121392|NCT01241552|2715231|P4|NOT COMPLETED|Overall Study||64
1121393|NCT01241552|2715232|P3|NOT COMPLETED|Overall Study||60
1121394|NCT01241552|2715233|P2|NOT COMPLETED|Overall Study||63
1121395|NCT01241552|2715234|P1|NOT COMPLETED|Overall Study||41
1121396|NCT01241552|2715231|P4|COMPLETED|Overall Study||340
1121397|NCT01241552|2715232|P3|COMPLETED|Overall Study||343
1121398|NCT01241552|2715233|P2|COMPLETED|Overall Study||340
1121399|NCT01241552|2715234|P1|COMPLETED|Overall Study||201
1121400|NCT01241552|2715231|P4|Treated|Overall Study||397
1121401|NCT01241552|2715232|P3|Treated|Overall Study||388
1121402|NCT01241552|2715233|P2|Treated|Overall Study||392
1121403|NCT01241552|2715234|P1|Treated|Overall Study||235
1121404|NCT01241552|2715231|P4|STARTED|Overall Study||404
1121405|NCT01241552|2715232|P3|STARTED|Overall Study||403
1121406|NCT01241552|2715233|P2|STARTED|Overall Study||403
1121407|NCT01241552|2715234|P1|STARTED|Overall Study||242
1121408|NCT01241565|2715300|P1|NOT COMPLETED|Overall Study||0
1121409|NCT01241565|2715300|P1|COMPLETED|Overall Study||50
1121410|NCT01241565|2715300|P1|STARTED|Overall Study||50
1121411|NCT01241591|2715313|P4|NOT COMPLETED|Overall Study||12
1121412|NCT01241591|2715314|P3|NOT COMPLETED|Overall Study||22
1121413|NCT01241591|2715315|P2|NOT COMPLETED|Overall Study||24
1121414|NCT01241591|2715316|P1|NOT COMPLETED|Overall Study||23
1121415|NCT01241591|2715313|P4|COMPLETED|Overall Study||95
1121416|NCT01241591|2715314|P3|COMPLETED|Overall Study||313
1121417|NCT01241591|2715315|P2|COMPLETED|Overall Study||306
1121418|NCT01241591|2715316|P1|COMPLETED|Overall Study||306
1121419|NCT01241591|2715313|P4|STARTED|Overall Study||107
1121420|NCT01241591|2715314|P3|STARTED|Overall Study||335
1121421|NCT01241591|2715315|P2|STARTED|Overall Study||330
1121422|NCT01241591|2715316|P1|STARTED|Overall Study||329
1121423|NCT01241760|2715508|P2|NOT COMPLETED|Overall Study||40
1121424|NCT01241760|2715509|P1|NOT COMPLETED|Overall Study||34
1121425|NCT01241760|2715508|P2|COMPLETED|Overall Study||329
1121426|NCT01241760|2715509|P1|COMPLETED|Overall Study||337
1121427|NCT01241760|2715508|P2|STARTED|Overall Study||369
1121428|NCT01241760|2715509|P1|STARTED|Overall Study||371
1121429|NCT01241903|2715530|P2|NOT COMPLETED|Overall Study||0
1121430|NCT01241903|2715531|P1|NOT COMPLETED|Overall Study||1
1121431|NCT01241903|2715530|P2|COMPLETED|Overall Study||27
1121432|NCT01241903|2715531|P1|COMPLETED|Overall Study||26
1121433|NCT01241903|2715530|P2|STARTED|Overall Study||27
1121434|NCT01241903|2715531|P1|STARTED|Overall Study||27
1121435|NCT01241916|2715539|P2|NOT COMPLETED|Overall Study||10
1121436|NCT01241916|2715540|P1|NOT COMPLETED|Overall Study||7
1121437|NCT01241916|2715539|P2|COMPLETED|Overall Study||21
1121438|NCT01241916|2715540|P1|COMPLETED|Overall Study||28
1121439|NCT01241916|2715539|P2|STARTED|Overall Study||31
1121440|NCT01241916|2715540|P1|STARTED|Overall Study||35
1121441|NCT01242020|2715550|P2|NOT COMPLETED|Overall Study||0
1121442|NCT01242020|2715551|P1|NOT COMPLETED|Overall Study||3
1121443|NCT01242020|2715550|P2|COMPLETED|Overall Study||0
1121444|NCT01242020|2715551|P1|COMPLETED|Overall Study||3
1121445|NCT01242020|2715550|P2|STARTED|Overall Study||0
1121446|NCT01242020|2715551|P1|STARTED|Overall Study||6
1121447|NCT01236053|2715581|P22|NOT COMPLETED|Overall Study||0
1121448|NCT01236053|2715582|P21|NOT COMPLETED|Overall Study||0
1121449|NCT01236053|2715583|P20|NOT COMPLETED|Overall Study||0
1121450|NCT01236053|2715584|P19|NOT COMPLETED|Overall Study||0
1121451|NCT01236053|2715585|P18|NOT COMPLETED|Overall Study||0
1121452|NCT01236053|2715586|P17|NOT COMPLETED|Overall Study||0
1121453|NCT01236053|2715587|P16|NOT COMPLETED|Overall Study||0
1121454|NCT01236053|2715588|P15|NOT COMPLETED|Overall Study||0
1121455|NCT01236053|2715589|P14|NOT COMPLETED|Overall Study||0
1121456|NCT01236053|2715590|P13|NOT COMPLETED|Overall Study||0
1121457|NCT01236053|2715591|P12|NOT COMPLETED|Overall Study||0
1121458|NCT01236053|2715592|P11|NOT COMPLETED|Overall Study||0
1121459|NCT01236053|2715593|P10|NOT COMPLETED|Overall Study||0
1121460|NCT01236053|2715594|P9|NOT COMPLETED|Overall Study||0
1121461|NCT01236053|2715595|P8|NOT COMPLETED|Overall Study||0
1121462|NCT01236053|2715596|P7|NOT COMPLETED|Overall Study||0
1121463|NCT01236053|2715597|P6|NOT COMPLETED|Overall Study||0
1121464|NCT01236053|2715598|P5|NOT COMPLETED|Overall Study||0
1121465|NCT01236053|2715599|P4|NOT COMPLETED|Overall Study||0
1121466|NCT01236053|2715600|P3|NOT COMPLETED|Overall Study||0
1121467|NCT01236053|2715601|P2|NOT COMPLETED|Overall Study||0
1121468|NCT01236053|2715602|P1|NOT COMPLETED|Overall Study||0
1121469|NCT01236053|2715581|P22|COMPLETED|Overall Study||12167
1121470|NCT01236053|2715582|P21|COMPLETED|Overall Study||1272
1121471|NCT01236053|2715583|P20|COMPLETED|Overall Study||20382
1121472|NCT01236053|2715584|P19|COMPLETED|Overall Study||2155
1121473|NCT01236053|2715585|P18|COMPLETED|Overall Study||380
1121474|NCT01236053|2715586|P17|COMPLETED|Overall Study||38
1121475|NCT01236053|2715587|P16|COMPLETED|Overall Study||43559
1121476|NCT01236053|2715588|P15|COMPLETED|Overall Study||4600
1121477|NCT01236053|2715589|P14|COMPLETED|Overall Study||1396
1121478|NCT01236053|2715590|P13|COMPLETED|Overall Study||148
1121479|NCT01236053|2715591|P12|COMPLETED|Overall Study||188924
1121480|NCT01236053|2715592|P11|COMPLETED|Overall Study||19564
1121481|NCT01236053|2715593|P10|COMPLETED|Overall Study||2935
1121482|NCT01236053|2715594|P9|COMPLETED|Overall Study||300
1121483|NCT01236053|2715595|P8|COMPLETED|Overall Study||102836
1121484|NCT01236053|2715596|P7|COMPLETED|Overall Study||10855
1121485|NCT01236053|2715597|P6|COMPLETED|Overall Study||2067
1121486|NCT01236053|2715598|P5|COMPLETED|Overall Study||212
1121487|NCT01236053|2715599|P4|COMPLETED|Overall Study||17853
1121488|NCT01236053|2715600|P3|COMPLETED|Overall Study||1877
1121489|NCT01236053|2715601|P2|COMPLETED|Overall Study||1710950
1121490|NCT01236053|2715602|P1|COMPLETED|Overall Study||179138
1121491|NCT01236053|2715581|P22|STARTED|Overall Study||12167
1121492|NCT01236053|2715582|P21|STARTED|Overall Study||1272
1121493|NCT01236053|2715583|P20|STARTED|Overall Study||20382
1121494|NCT01236053|2715584|P19|STARTED|Overall Study||2155
1121495|NCT01236053|2715585|P18|STARTED|Overall Study||380
1121496|NCT01236053|2715586|P17|STARTED|Overall Study||38
1121497|NCT01236053|2715587|P16|STARTED|Overall Study||43559
1121498|NCT01236053|2715588|P15|STARTED|Overall Study||4600
1121499|NCT01236053|2715589|P14|STARTED|Overall Study||1396
1121500|NCT01236053|2715590|P13|STARTED|Overall Study||148
1121501|NCT01236053|2715591|P12|STARTED|Overall Study||188924
1121502|NCT01236053|2715592|P11|STARTED|Overall Study||19564
1121503|NCT01236053|2715593|P10|STARTED|Overall Study||2935
1121504|NCT01236053|2715594|P9|STARTED|Overall Study||300
1121505|NCT01236053|2715595|P8|STARTED|Overall Study||102836
1121506|NCT01236053|2715596|P7|STARTED|Overall Study||10855
1121507|NCT01236053|2715597|P6|STARTED|Overall Study||2067
1121508|NCT01236053|2715598|P5|STARTED|Overall Study||212
1121509|NCT01236053|2715599|P4|STARTED|Overall Study||17853
1121510|NCT01236053|2715600|P3|STARTED|Overall Study||1877
1121511|NCT01236053|2715601|P2|STARTED|Overall Study||1710950
1121512|NCT01236053|2715602|P1|STARTED|Overall Study||179138
1121513|NCT01236105|2715736|P1|NOT COMPLETED|Overall Study||0
1121514|NCT01236105|2715736|P1|COMPLETED|Overall Study||21
1121515|NCT01236105|2715736|P1|STARTED|Overall Study||21
1121516|NCT01236118|2715753|P3|NOT COMPLETED|Overall Study||3
1121517|NCT01236118|2715754|P2|NOT COMPLETED|Overall Study||1
1121518|NCT01236118|2715755|P1|NOT COMPLETED|Overall Study||2
1121519|NCT01236118|2715753|P3|COMPLETED|Overall Study||14
1121520|NCT01236118|2715754|P2|COMPLETED|Overall Study||4
1121521|NCT01236118|2715755|P1|COMPLETED|Overall Study||4
1121522|NCT01236118|2715753|P3|STARTED|Overall Study||17
1121523|NCT01236118|2715754|P2|STARTED|Overall Study||5
1121524|NCT01236118|2715755|P1|STARTED|Overall Study||6
1121525|NCT01236170|2715763|P1|NOT COMPLETED|Overall Study||15
1121526|NCT01236170|2715763|P1|COMPLETED|Overall Study||482
1121527|NCT01236170|2715763|P1|STARTED|Overall Study||497
1121528|NCT01236196|2715772|P2|NOT COMPLETED|Overall Study||8
1121529|NCT01236196|2715773|P1|NOT COMPLETED|Overall Study||1
1121530|NCT01236196|2715772|P2|COMPLETED|Overall Study||13
1121531|NCT01236196|2715773|P1|COMPLETED|Overall Study||17
1121532|NCT01236196|2715772|P2|STARTED|Overall Study||21
1121533|NCT01236196|2715773|P1|STARTED|Overall Study||18
1121534|NCT01242085|2715788|P3|NOT COMPLETED|Overall Study||0
1121535|NCT01242085|2715789|P2|NOT COMPLETED|Overall Study||7
1121536|NCT01242085|2715790|P1|NOT COMPLETED|Overall Study||8
1121537|NCT01242085|2715788|P3|COMPLETED|Overall Study||1
1121538|NCT01242085|2715789|P2|COMPLETED|Overall Study|7 patients did not receive allocated intervention since 5 had medical problems and 2 withdrew|26
1121539|NCT01242085|2715790|P1|COMPLETED|Overall Study|8 patients did not undergo intervention since 4 had medical problems and 4 withdrew|22
1121540|NCT01242085|2715788|P3|STARTED|Overall Study||1
1121541|NCT01242085|2715789|P2|STARTED|Overall Study||33
1121542|NCT01242085|2715790|P1|STARTED|Overall Study||30
1121543|NCT01242111|2715798|P1|NOT COMPLETED|Overall Study||3
1121544|NCT01242111|2715798|P1|COMPLETED|Overall Study||17
1121545|NCT01242111|2715798|P1|STARTED|Overall Study||20
1121546|NCT01242176|2715807|P2|NOT COMPLETED|Second Intervention||0
1121547|NCT01242176|2715808|P1|NOT COMPLETED|Second Intervention||0
1121548|NCT01242176|2715807|P2|COMPLETED|Second Intervention||10
1121549|NCT01242176|2715808|P1|COMPLETED|Second Intervention||11
1121550|NCT01242176|2715807|P2|STARTED|Second Intervention||10
1121551|NCT01242176|2715808|P1|STARTED|Second Intervention||11
1121552|NCT01242176|2715807|P2|NOT COMPLETED|Washout Period of 7 Days||2
1121553|NCT01242176|2715808|P1|NOT COMPLETED|Washout Period of 7 Days||1
1121554|NCT01242176|2715807|P2|COMPLETED|Washout Period of 7 Days||10
1121555|NCT01242176|2715808|P1|COMPLETED|Washout Period of 7 Days||11
1121556|NCT01242176|2715807|P2|STARTED|Washout Period of 7 Days||12
1121557|NCT01242176|2715808|P1|STARTED|Washout Period of 7 Days||12
1121558|NCT01242176|2715807|P2|NOT COMPLETED|First Intervention||0
1121559|NCT01242176|2715808|P1|NOT COMPLETED|First Intervention||0
1121560|NCT01242176|2715807|P2|COMPLETED|First Intervention||12
1121561|NCT01242176|2715808|P1|COMPLETED|First Intervention||12
1121562|NCT01242176|2715807|P2|STARTED|First Intervention||12
1121563|NCT01242176|2715808|P1|STARTED|First Intervention||12
1121564|NCT01242371|2715820|P2|NOT COMPLETED|Overall Study||5
1121565|NCT01242371|2715821|P1|NOT COMPLETED|Overall Study||2
1121566|NCT01242371|2715820|P2|COMPLETED|Overall Study||27
1121567|NCT01242371|2715821|P1|COMPLETED|Overall Study||31
1121568|NCT01242371|2715820|P2|STARTED|Overall Study||32
1121569|NCT01242371|2715821|P1|STARTED|Overall Study||33
1121570|NCT01243892|2715829|P2|NOT COMPLETED|Overall Study||0
1121571|NCT01243892|2715830|P1|NOT COMPLETED|Overall Study||2
1121572|NCT01243892|2715829|P2|COMPLETED|Overall Study||3
1121573|NCT01243892|2715830|P1|COMPLETED|Overall Study||13
1121574|NCT01243892|2715829|P2|STARTED|Overall Study||3
1121575|NCT01243892|2715830|P1|STARTED|Overall Study||15
1121576|NCT01243944|2715842|P2|NOT COMPLETED|Overall Study||108
1121577|NCT01243944|2715843|P1|NOT COMPLETED|Overall Study||17
1121578|NCT01243944|2715842|P2|COMPLETED|Overall Study|These are the numbers of subjects who completed 48 weeks of treatment.|3
1121579|NCT01243944|2715843|P1|COMPLETED|Overall Study|These are the numbers of subjects who completed 48 weeks of treatment.|93
1121580|NCT01243944|2715842|P2|STARTED|Overall Study|One subject withdrew consent 5 days after randomization to BAT arm and wasn't treated while on study|111
1121581|NCT01243944|2715843|P1|STARTED|Overall Study||110
1121582|NCT01244061|2715867|P2|NOT COMPLETED|Overall Study||103
1121583|NCT01244061|2715868|P1|NOT COMPLETED|Overall Study||82
1121584|NCT01244061|2715867|P2|COMPLETED|Overall Study||144
1121585|NCT01244061|2715868|P1|COMPLETED|Overall Study||169
1121586|NCT01244061|2715867|P2|STARTED|Overall Study||247
1121587|NCT01244061|2715868|P1|STARTED|Overall Study||251
1121588|NCT01244126|2715883|P3|NOT COMPLETED|Overall Study||9
1121589|NCT01244126|2715884|P2|NOT COMPLETED|Overall Study||3
1121590|NCT01244126|2715885|P1|NOT COMPLETED|Overall Study||3
1121591|NCT01244126|2715883|P3|COMPLETED|Overall Study||48
1121592|NCT01244126|2715884|P2|COMPLETED|Overall Study||52
1121593|NCT01244126|2715885|P1|COMPLETED|Overall Study||56
1121594|NCT01244126|2715883|P3|STARTED|Overall Study||57
1121595|NCT01244126|2715884|P2|STARTED|Overall Study||55
1121596|NCT01244126|2715885|P1|STARTED|Overall Study||59
1121597|NCT01244243|2715896|P1|NOT COMPLETED|Overall Study||0
1121598|NCT01244243|2715896|P1|COMPLETED|Overall Study||41
1121599|NCT01244243|2715896|P1|STARTED|Overall Study||41
1121600|NCT01244412|2715901|P1|NOT COMPLETED|Overall Study||0
1121601|NCT01244412|2715901|P1|COMPLETED|Overall Study||1
1121602|NCT01244412|2715901|P1|STARTED|Overall Study||1
1121603|NCT01244425|2715907|P2|NOT COMPLETED|Overall Study||3
1121604|NCT01244425|2715908|P1|NOT COMPLETED|Overall Study||3
1121605|NCT01244425|2715907|P2|COMPLETED|Overall Study|Adverse Event: septic shock with multi-organ failure due to liver abscess (death)|32
1121606|NCT01244425|2715908|P1|COMPLETED|Overall Study|Adverse Event: multi-organ failure (death)|32
1121607|NCT01244425|2715907|P2|STARTED|Overall Study||35
1121608|NCT01244425|2715908|P1|STARTED|Overall Study||35
1121615|NCT01244490|2715944|P3|NOT COMPLETED|Overall Study||23
1121616|NCT01244490|2715945|P2|NOT COMPLETED|Overall Study||24
1121617|NCT01244490|2715946|P1|NOT COMPLETED|Overall Study||19
1121618|NCT01244490|2715944|P3|COMPLETED|Overall Study||89
1121619|NCT01244490|2715945|P2|COMPLETED|Overall Study||91
1121620|NCT01244490|2715946|P1|COMPLETED|Overall Study||92
1121621|NCT01244490|2715944|P3|STARTED|Overall Study||112
1121622|NCT01244490|2715945|P2|STARTED|Overall Study||115
1121623|NCT01244490|2715946|P1|STARTED|Overall Study||111
1121624|NCT01244503|2715999|P1|NOT COMPLETED|Overall Study||0
1121625|NCT01244503|2715999|P1|COMPLETED|Overall Study||61
1121626|NCT01244503|2715999|P1|STARTED|Overall Study||61
1121627|NCT01244516|2716007|P3|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||2
1121628|NCT01244516|2716008|P2|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||1
1121629|NCT01244516|2716009|P1|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||3
1121630|NCT01244516|2716007|P3|COMPLETED|Period 2 (1-week to 2-week Visit)||168
1121631|NCT01244516|2716008|P2|COMPLETED|Period 2 (1-week to 2-week Visit)||170
1121632|NCT01244516|2716009|P1|COMPLETED|Period 2 (1-week to 2-week Visit)||163
1121633|NCT01244516|2716007|P3|STARTED|Period 2 (1-week to 2-week Visit)||170
1121634|NCT01244516|2716008|P2|STARTED|Period 2 (1-week to 2-week Visit)||171
1121635|NCT01244516|2716009|P1|STARTED|Period 2 (1-week to 2-week Visit)||166
1121636|NCT01244516|2716007|P3|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||3
1121637|NCT01244516|2716008|P2|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||6
1121638|NCT01244516|2716009|P1|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||4
1121639|NCT01244516|2716007|P3|COMPLETED|Period 1 (Baseline to 1-week Visit)||170
1121640|NCT01244516|2716008|P2|COMPLETED|Period 1 (Baseline to 1-week Visit)||171
1121641|NCT01244516|2716009|P1|COMPLETED|Period 1 (Baseline to 1-week Visit)||166
1121642|NCT01244516|2716007|P3|STARTED|Period 1 (Baseline to 1-week Visit)||173
1121643|NCT01244516|2716008|P2|STARTED|Period 1 (Baseline to 1-week Visit)||177
1121644|NCT01244516|2716009|P1|STARTED|Period 1 (Baseline to 1-week Visit)||170
1121645|NCT01244529|2716022|P1|NOT COMPLETED|Overall Study||0
1121646|NCT01244529|2716022|P1|COMPLETED|Overall Study||41
1121647|NCT01244529|2716022|P1|STARTED|Overall Study||41
1121648|NCT01244620|2716044|P4|NOT COMPLETED|Overall Study||4
1121649|NCT01244620|2716045|P3|NOT COMPLETED|Overall Study||4
1121650|NCT01244620|2716046|P2|NOT COMPLETED|Overall Study||4
1121651|NCT01244620|2716047|P1|NOT COMPLETED|Overall Study||4
1121652|NCT01244620|2716044|P4|COMPLETED|Overall Study||0
1121653|NCT01244620|2716045|P3|COMPLETED|Overall Study||0
1121654|NCT01244620|2716046|P2|COMPLETED|Overall Study||0
1121655|NCT01244620|2716047|P1|COMPLETED|Overall Study||0
1121656|NCT01244620|2716044|P4|STARTED|Overall Study||4
1121657|NCT01244620|2716045|P3|STARTED|Overall Study||4
1121658|NCT01244620|2716046|P2|STARTED|Overall Study||4
1121659|NCT01244620|2716047|P1|STARTED|Overall Study||4
1121660|NCT01244633|2716081|P1|NOT COMPLETED|Overall Study||3
1121661|NCT01244633|2716081|P1|COMPLETED|Overall Study||15
1121662|NCT01244633|2716081|P1|STARTED|Overall Study||18
1121663|NCT01244711|2716085|P1|NOT COMPLETED|Overall Study||0
1121664|NCT01244711|2716085|P1|COMPLETED|Overall Study||1
1121665|NCT01244711|2716085|P1|STARTED|Overall Study||1
1121666|NCT01244724|2716089|P1|NOT COMPLETED|Overall Study||8
1121667|NCT01244724|2716089|P1|COMPLETED|Overall Study||9
1121668|NCT01244724|2716089|P1|Week 2 Visit|Overall Study||15
1121669|NCT01244724|2716089|P1|STARTED|Overall Study|Of these 15 returned for a week 2 visit and are included in the efficacy analysis.|17
1121670|NCT01244815|2716097|P4|NOT COMPLETED|Overall Study||12
1121671|NCT01244815|2716098|P3|NOT COMPLETED|Overall Study||11
1121672|NCT01244815|2716099|P2|NOT COMPLETED|Overall Study||17
1121673|NCT01244815|2716100|P1|NOT COMPLETED|Overall Study||14
1121674|NCT01244815|2716097|P4|COMPLETED|Overall Study||87
1121675|NCT01244815|2716098|P3|COMPLETED|Overall Study||88
1121676|NCT01244815|2716099|P2|COMPLETED|Overall Study||88
1121677|NCT01244815|2716100|P1|COMPLETED|Overall Study||87
1121678|NCT01244815|2716097|P4|Treated|Overall Study||99
1121679|NCT01244815|2716098|P3|Treated|Overall Study||99
1121680|NCT01244815|2716099|P2|Treated|Overall Study||104
1121681|NCT01244815|2716100|P1|Treated|Overall Study||101
1121682|NCT01244815|2716097|P4|STARTED|Overall Study|Randomized|99
1121683|NCT01244815|2716098|P3|STARTED|Overall Study|Randomized|99
1121684|NCT01244815|2716099|P2|STARTED|Overall Study|Randomized|105
1121685|NCT01244815|2716100|P1|STARTED|Overall Study|Randomized|101
1121686|NCT01244828|2716174|P1|NOT COMPLETED|Overall Study||78
1121687|NCT01244828|2716174|P1|COMPLETED|Overall Study||79
1121688|NCT01244828|2716174|P1|STARTED|Overall Study|Received study drug|157
1121689|NCT01244893|2716186|P2|NOT COMPLETED|Final Visit||0
1121690|NCT01244893|2716187|P1|NOT COMPLETED|Final Visit||0
1121691|NCT01244893|2716186|P2|COMPLETED|Final Visit||21
1121692|NCT01244893|2716187|P1|COMPLETED|Final Visit||21
1121693|NCT01244893|2716186|P2|STARTED|Final Visit||21
1121694|NCT01244893|2716187|P1|STARTED|Final Visit||21
1121695|NCT01244893|2716186|P2|NOT COMPLETED|1-Week Follow Up||0
1121696|NCT01244893|2716187|P1|NOT COMPLETED|1-Week Follow Up||1
1121697|NCT01244893|2716186|P2|COMPLETED|1-Week Follow Up||21
1121698|NCT01244893|2716187|P1|COMPLETED|1-Week Follow Up||21
1121699|NCT01244893|2716186|P2|STARTED|1-Week Follow Up||21
1121700|NCT01244893|2716187|P1|STARTED|1-Week Follow Up||22
1121701|NCT01244893|2716186|P2|NOT COMPLETED|Baseline||1
1121702|NCT01244893|2716187|P1|NOT COMPLETED|Baseline||0
1121703|NCT01244893|2716186|P2|COMPLETED|Baseline||21
1121704|NCT01244893|2716187|P1|COMPLETED|Baseline||22
1121705|NCT01244893|2716186|P2|STARTED|Baseline||22
1121706|NCT01244893|2716187|P1|STARTED|Baseline||22
1121707|NCT01244906|2716199|P1|NOT COMPLETED|Overall Study||8
1121708|NCT01244906|2716199|P1|COMPLETED|Overall Study||18
1121709|NCT01244906|2716199|P1|STARTED|Overall Study||26
1121710|NCT01244984|2716211|P3|NOT COMPLETED|Overall Study||4
1121711|NCT01244984|2716212|P2|NOT COMPLETED|Overall Study||14
1121712|NCT01244984|2716213|P1|NOT COMPLETED|Overall Study||5
1121713|NCT01244984|2716211|P3|COMPLETED|Overall Study||86
1121714|NCT01244984|2716212|P2|COMPLETED|Overall Study||79
1121715|NCT01244984|2716213|P1|COMPLETED|Overall Study||55
1121716|NCT01244984|2716211|P3|STARTED|Overall Study||90
1121717|NCT01244984|2716212|P2|STARTED|Overall Study||93
1121718|NCT01244984|2716213|P1|STARTED|Overall Study||60
1121719|NCT01245049|2716289|P2|NOT COMPLETED|Overall Study||4
1121720|NCT01245049|2716290|P1|NOT COMPLETED|Overall Study||1
1121721|NCT01245049|2716289|P2|COMPLETED|Overall Study||126
1121722|NCT01245049|2716290|P1|COMPLETED|Overall Study||254
1121723|NCT01245049|2716289|P2|STARTED|Overall Study||130
1121724|NCT01245049|2716290|P1|STARTED|Overall Study||255
1121749|NCT01245101|2716378|P2|NOT COMPLETED|Period 3 (Treatment)||0
1121750|NCT01245101|2716379|P1|NOT COMPLETED|Period 3 (Treatment)||1
1121751|NCT01245101|2716378|P2|COMPLETED|Period 3 (Treatment)||0
1121752|NCT01245101|2716379|P1|COMPLETED|Period 3 (Treatment)||11
1121753|NCT01245101|2716378|P2|STARTED|Period 3 (Treatment)||0
1121754|NCT01245101|2716379|P1|STARTED|Period 3 (Treatment)||12
1121755|NCT01245101|2716378|P2|NOT COMPLETED|Period 2 (Washout)||0
1121756|NCT01245101|2716379|P1|NOT COMPLETED|Period 2 (Washout)||1
1121757|NCT01245101|2716378|P2|COMPLETED|Period 2 (Washout)||0
1121758|NCT01245101|2716379|P1|COMPLETED|Period 2 (Washout)||12
1121759|NCT01245101|2716378|P2|STARTED|Period 2 (Washout)||0
1121760|NCT01245101|2716379|P1|STARTED|Period 2 (Washout)||13
1121761|NCT01245101|2716378|P2|NOT COMPLETED|Period 1 (Treatment)||0
1121762|NCT01245101|2716379|P1|NOT COMPLETED|Period 1 (Treatment)||2
1121763|NCT01245101|2716378|P2|COMPLETED|Period 1 (Treatment)||0
1121764|NCT01245101|2716379|P1|COMPLETED|Period 1 (Treatment)||13
1121765|NCT01245101|2716378|P2|STARTED|Period 1 (Treatment)||0
1121766|NCT01245101|2716379|P1|STARTED|Period 1 (Treatment)||15
1121767|NCT01245140|2716389|P2|NOT COMPLETED|Overall Study||10
1121768|NCT01245140|2716390|P1|NOT COMPLETED|Overall Study||3
1121769|NCT01245140|2716389|P2|COMPLETED|Overall Study||14
1121770|NCT01245140|2716390|P1|COMPLETED|Overall Study||6
1121771|NCT01245140|2716389|P2|STARTED|Overall Study||24
1121772|NCT01245140|2716390|P1|STARTED|Overall Study||9
1121773|NCT01245270|2716446|P2|NOT COMPLETED|Overall Study||0
1121774|NCT01245270|2716447|P1|NOT COMPLETED|Overall Study||0
1121775|NCT01245270|2716446|P2|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
1121776|NCT01245270|2716447|P1|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
1121777|NCT01245270|2716446|P2|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
1121778|NCT01245270|2716447|P1|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
1121779|NCT01245283|2716458|P3|NOT COMPLETED|Overall Study||11
1121780|NCT01245283|2716459|P2|NOT COMPLETED|Overall Study||11
1121781|NCT01245283|2716460|P1|NOT COMPLETED|Overall Study||14
1121782|NCT01245283|2716458|P3|COMPLETED|Overall Study||19
1121783|NCT01245283|2716459|P2|COMPLETED|Overall Study||17
1121784|NCT01245283|2716460|P1|COMPLETED|Overall Study||18
1121785|NCT01245283|2716458|P3|STARTED|Overall Study||30
1121786|NCT01245283|2716459|P2|STARTED|Overall Study||28
1121787|NCT01245283|2716460|P1|STARTED|Overall Study||32
1121788|NCT01245374|2716492|P1|NOT COMPLETED|Overall Study||4
1121789|NCT01245374|2716492|P1|COMPLETED|Overall Study||99
1121790|NCT01245374|2716492|P1|STARTED|Overall Study||103
1121791|NCT01245387|2716512|P1|NOT COMPLETED|Overall Study||813
1121792|NCT01245387|2716512|P1|COMPLETED|Overall Study||188
1121793|NCT01245387|2716512|P1|STARTED|Overall Study||1001
1121794|NCT01245413|2716561|P2|NOT COMPLETED|Athena First,||0
1121795|NCT01245413|2716562|P1|NOT COMPLETED|Athena First,||0
1121796|NCT01245413|2716561|P2|COMPLETED|Athena First,||16
1121797|NCT01245413|2716562|P1|COMPLETED|Athena First,||16
1121798|NCT01245413|2716561|P2|STARTED|Athena First,||16
1121799|NCT01245413|2716562|P1|STARTED|Athena First,||16
1121800|NCT01245413|2716561|P2|NOT COMPLETED|Sensura First,||0
1121801|NCT01245413|2716562|P1|NOT COMPLETED|Sensura First,||0
1121802|NCT01245413|2716561|P2|COMPLETED|Sensura First,||16
1121803|NCT01245413|2716562|P1|COMPLETED|Sensura First,||16
1121804|NCT01245413|2716561|P2|STARTED|Sensura First,||16
1121805|NCT01245413|2716562|P1|STARTED|Sensura First,||16
1121806|NCT01245439|2716568|P1|NOT COMPLETED|Overall Study||0
1121807|NCT01245439|2716568|P1|COMPLETED|Overall Study||65
1121808|NCT01245439|2716568|P1|STARTED|Overall Study||65
1121809|NCT01245595|2716601|P2|NOT COMPLETED|Overall Study||0
1121810|NCT01245595|2716602|P1|NOT COMPLETED|Overall Study||0
1121811|NCT01245595|2716601|P2|COMPLETED|Overall Study||72
1121812|NCT01245595|2716602|P1|COMPLETED|Overall Study||72
1121813|NCT01245595|2716601|P2|Completed Full Course of Study Drug|Overall Study||61
1121814|NCT01245595|2716602|P1|Completed Full Course of Study Drug|Overall Study||57
1121815|NCT01245595|2716601|P2|STARTED|Overall Study||72
1121816|NCT01245595|2716602|P1|STARTED|Overall Study||72
1121817|NCT01245647|2716610|P2|NOT COMPLETED|Overall Study||4
1121818|NCT01245647|2716611|P1|NOT COMPLETED|Overall Study||0
1121819|NCT01245647|2716610|P2|COMPLETED|Overall Study||8
1121820|NCT01245647|2716611|P1|COMPLETED|Overall Study||7
1121821|NCT01245647|2716610|P2|STARTED|Overall Study||12
1121822|NCT01245647|2716611|P1|STARTED|Overall Study||7
1121823|NCT01245738|2716625|P1|NOT COMPLETED|Overall Study||40
1121824|NCT01245738|2716625|P1|COMPLETED|Overall Study||474
1121825|NCT01245738|2716625|P1|STARTED|Overall Study||514
1121826|NCT01245751|2716646|P4|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
1121827|NCT01245751|2716647|P3|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
1121828|NCT01245751|2716648|P2|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
1121829|NCT01245751|2716649|P1|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
1121830|NCT01245751|2716646|P4|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
1121831|NCT01245751|2716647|P3|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
1121832|NCT01245751|2716648|P2|COMPLETED|Part 2: Week 156 (3 Year) Visit||139
1121833|NCT01245751|2716649|P1|COMPLETED|Part 2: Week 156 (3 Year) Visit||161
1121834|NCT01245751|2716646|P4|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
1121835|NCT01245751|2716647|P3|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
1121836|NCT01245751|2716648|P2|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|139
1121837|NCT01245751|2716649|P1|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|161
1121838|NCT01245751|2716646|P4|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
1121839|NCT01245751|2716647|P3|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||0
1121840|NCT01245751|2716648|P2|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||5
1121841|NCT01245751|2716649|P1|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
1121842|NCT01245751|2716646|P4|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||98
1121843|NCT01245751|2716647|P3|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||100
1121844|NCT01245751|2716648|P2|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||194
1121845|NCT01245751|2716649|P1|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||199
1121846|NCT01245751|2716646|P4|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
1121847|NCT01245751|2716647|P3|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
1121848|NCT01245751|2716648|P2|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||199
1121849|NCT01245751|2716649|P1|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||201
1121850|NCT01245751|2716646|P4|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
1121851|NCT01245751|2716647|P3|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
1121852|NCT01245751|2716648|P2|STARTED|Part 1: Day 1 to Week 52 (1 Year)||199
1121853|NCT01245751|2716649|P1|STARTED|Part 1: Day 1 to Week 52 (1 Year)||201
1121854|NCT01245764|2716666|P4|NOT COMPLETED|Study Phase B||0
1121855|NCT01245764|2716667|P3|NOT COMPLETED|Study Phase B||0
1121856|NCT01245764|2716668|P2|NOT COMPLETED|Study Phase B||0
1121857|NCT01245764|2716669|P1|NOT COMPLETED|Study Phase B||0
1121858|NCT01245764|2716666|P4|COMPLETED|Study Phase B||17
1121859|NCT01245764|2716667|P3|COMPLETED|Study Phase B||0
1121860|NCT01245764|2716668|P2|COMPLETED|Study Phase B||0
1121861|NCT01245764|2716669|P1|COMPLETED|Study Phase B||0
1121862|NCT01245764|2716666|P4|Completed Vaccinations in Study Phase B|Study Phase B||17
1121863|NCT01245764|2716667|P3|Completed Vaccinations in Study Phase B|Study Phase B||0
1121864|NCT01245764|2716668|P2|Completed Vaccinations in Study Phase B|Study Phase B||0
1121865|NCT01245764|2716669|P1|Completed Vaccinations in Study Phase B|Study Phase B||0
1121866|NCT01245764|2716666|P4|STARTED|Study Phase B||17
1121867|NCT01245764|2716667|P3|STARTED|Study Phase B||0
1121868|NCT01245764|2716668|P2|STARTED|Study Phase B||0
1121869|NCT01245764|2716669|P1|STARTED|Study Phase B||0
1121870|NCT01245764|2716666|P4|NOT COMPLETED|Study Phase A||3
1121871|NCT01245764|2716667|P3|NOT COMPLETED|Study Phase A||10
1121872|NCT01245764|2716668|P2|NOT COMPLETED|Study Phase A||5
1121873|NCT01245764|2716669|P1|NOT COMPLETED|Study Phase A||9
1121874|NCT01245764|2716666|P4|COMPLETED|Study Phase A||17
1121875|NCT01245764|2716667|P3|COMPLETED|Study Phase A||110
1121876|NCT01245764|2716668|P2|COMPLETED|Study Phase A||25
1121877|NCT01245764|2716669|P1|COMPLETED|Study Phase A||71
1121878|NCT01245764|2716666|P4|Completed Vaccinations in Study Phase A|Study Phase A||19
1121879|NCT01245764|2716667|P3|Completed Vaccinations in Study Phase A|Study Phase A||117
1121880|NCT01245764|2716668|P2|Completed Vaccinations in Study Phase A|Study Phase A||28
1121881|NCT01245764|2716669|P1|Completed Vaccinations in Study Phase A|Study Phase A||77
1121882|NCT01245764|2716666|P4|STARTED|Study Phase A||20
1121883|NCT01245764|2716667|P3|STARTED|Study Phase A||120
1121884|NCT01245764|2716668|P2|STARTED|Study Phase A||30
1121885|NCT01245764|2716669|P1|STARTED|Study Phase A||80
1121886|NCT01246011|2716706|P3|NOT COMPLETED|Overall Study||4
1121887|NCT01246011|2716707|P2|NOT COMPLETED|Overall Study||0
1121888|NCT01246011|2716708|P1|NOT COMPLETED|Overall Study||0
1121889|NCT01246011|2716706|P3|COMPLETED|Overall Study||5
1121890|NCT01246011|2716707|P2|COMPLETED|Overall Study||0
1121891|NCT01246011|2716708|P1|COMPLETED|Overall Study||0
1121892|NCT01246011|2716706|P3|STARTED|Overall Study||9
1121893|NCT01246011|2716707|P2|STARTED|Overall Study||0
1121894|NCT01246011|2716708|P1|STARTED|Overall Study||0
1121895|NCT01246076|2716716|P1|NOT COMPLETED|Overall Study||0
1121896|NCT01246076|2716716|P1|COMPLETED|Overall Study||24
1121897|NCT01246076|2716716|P1|STARTED|Overall Study||24
1121898|NCT01246206|2716725|P1|NOT COMPLETED|Overall Study||1
1121899|NCT01246206|2716725|P1|COMPLETED|Overall Study||20
1121900|NCT01246206|2716725|P1|STARTED|Overall Study||21
1121901|NCT01246258|2716736|P1|NOT COMPLETED|Overall Study||0
1121902|NCT01246258|2716736|P1|COMPLETED|Overall Study||5
1121903|NCT01246258|2716736|P1|STARTED|Overall Study||5
1121904|NCT01246349|2716743|P2|NOT COMPLETED|Overall Study||0
1121905|NCT01246349|2716744|P1|NOT COMPLETED|Overall Study||0
1121906|NCT01246349|2716743|P2|COMPLETED|Overall Study||20
1121907|NCT01246349|2716744|P1|COMPLETED|Overall Study||20
1121908|NCT01246349|2716743|P2|STARTED|Overall Study||20
1121909|NCT01246349|2716744|P1|STARTED|Overall Study||20
1121910|NCT01239043|2716758|P2|NOT COMPLETED|Overall Study||1
1121911|NCT01239043|2716759|P1|NOT COMPLETED|Overall Study||2
1121912|NCT01239043|2716758|P2|COMPLETED|Overall Study||102
1121913|NCT01239043|2716759|P1|COMPLETED|Overall Study||34
1121914|NCT01239043|2716758|P2|STARTED|Overall Study||103
1121915|NCT01239043|2716759|P1|STARTED|Overall Study|For safety analysis number includes 1 participant randomized to Menactra who received Menomune.|36
1121916|NCT01239056|2716777|P1|NOT COMPLETED|Overall Study||0
1121917|NCT01239056|2716777|P1|COMPLETED|Overall Study||20
1121918|NCT01239056|2716777|P1|STARTED|Overall Study||20
1121919|NCT01239121|2716786|P3|NOT COMPLETED|Overall Study||0
1121920|NCT01239121|2716787|P2|NOT COMPLETED|Overall Study||4
1121921|NCT01239121|2716788|P1|NOT COMPLETED|Overall Study||2
1121922|NCT01239121|2716786|P3|COMPLETED|Overall Study||15
1121923|NCT01239121|2716787|P2|COMPLETED|Overall Study||195
1121924|NCT01239121|2716788|P1|COMPLETED|Overall Study||186
1121925|NCT01239121|2716786|P3|STARTED|Overall Study||15
1121926|NCT01239121|2716787|P2|STARTED|Overall Study||199
1121927|NCT01239121|2716788|P1|STARTED|Overall Study||188
1121928|NCT01239212|2716802|P1|NOT COMPLETED|Overall Study||0
1121929|NCT01239212|2716802|P1|COMPLETED|Overall Study||7
1121930|NCT01239212|2716802|P1|STARTED|Overall Study||7
1121931|NCT01239316|2716806|P1|NOT COMPLETED|Overall Study||12
1121932|NCT01239316|2716806|P1|COMPLETED|Overall Study||0
1121933|NCT01239316|2716806|P1|STARTED|Overall Study||12
1121934|NCT01239342|2716816|P2|NOT COMPLETED|Overall Study||6
1121935|NCT01239342|2716817|P1|NOT COMPLETED|Overall Study||3
1121936|NCT01239342|2716816|P2|COMPLETED|Overall Study||8
1121937|NCT01239342|2716817|P1|COMPLETED|Overall Study||26
1121938|NCT01239342|2716816|P2|STARTED|Overall Study||14
1121939|NCT01239342|2716817|P1|STARTED|Overall Study||29
1121940|NCT01239355|2716833|P1|NOT COMPLETED|Overall Study||0
1121941|NCT01239355|2716833|P1|COMPLETED|Overall Study||15
1121942|NCT01239355|2716833|P1|STARTED|Overall Study||15
1121943|NCT01239381|2716839|P1|NOT COMPLETED|Overall Study||2
1121944|NCT01239381|2716839|P1|COMPLETED|Overall Study||90
1121945|NCT01239381|2716839|P1|STARTED|Overall Study||92
1121949|NCT01239511|2716860|P4|NOT COMPLETED|Overall Study||9
1121950|NCT01239511|2716861|P3|NOT COMPLETED|Overall Study||4
1121951|NCT01239511|2716862|P2|NOT COMPLETED|Overall Study||5
1121952|NCT01239511|2716863|P1|NOT COMPLETED|Overall Study||1
1121953|NCT01239511|2716860|P4|COMPLETED|Overall Study||38
1121954|NCT01239511|2716861|P3|COMPLETED|Overall Study||43
1121955|NCT01239511|2716862|P2|COMPLETED|Overall Study||40
1121956|NCT01239511|2716863|P1|COMPLETED|Overall Study||46
1121957|NCT01239511|2716860|P4|STARTED|Overall Study||47
1121958|NCT01239511|2716861|P3|STARTED|Overall Study||47
1121959|NCT01239511|2716862|P2|STARTED|Overall Study||45
1121960|NCT01239511|2716863|P1|STARTED|Overall Study||47
1121961|NCT01246401|2716875|P2|NOT COMPLETED|Overall Study||0
1121962|NCT01246401|2716876|P1|NOT COMPLETED|Overall Study||0
1121963|NCT01246401|2716875|P2|COMPLETED|Overall Study||27
1121964|NCT01246401|2716876|P1|COMPLETED|Overall Study||66
1121965|NCT01246401|2716875|P2|STARTED|Overall Study||27
1121966|NCT01246401|2716876|P1|STARTED|Overall Study||66
1121967|NCT01246479|2716900|P1|NOT COMPLETED|Overall Study||5
1121968|NCT01246479|2716900|P1|COMPLETED|Overall Study|primary endpoint at Month 12|18
1121969|NCT01246479|2716900|P1|STARTED|Overall Study||23
1121970|NCT01246713|2716904|P2|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
1121971|NCT01246713|2716905|P1|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
1121972|NCT01246713|2716904|P2|COMPLETED|Second Acetaminophen Dosing (1 Day)||9
1121973|NCT01246713|2716905|P1|COMPLETED|Second Acetaminophen Dosing (1 Day)||6
1121974|NCT01246713|2716904|P2|STARTED|Second Acetaminophen Dosing (1 Day)||9
1121975|NCT01246713|2716905|P1|STARTED|Second Acetaminophen Dosing (1 Day)||6
1121976|NCT01246713|2716904|P2|NOT COMPLETED|Washout (at Least 14 Days)||0
1121977|NCT01246713|2716905|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
1121978|NCT01246713|2716904|P2|COMPLETED|Washout (at Least 14 Days)||9
1121979|NCT01246713|2716905|P1|COMPLETED|Washout (at Least 14 Days)||6
1121980|NCT01246713|2716904|P2|STARTED|Washout (at Least 14 Days)||9
1121981|NCT01246713|2716905|P1|STARTED|Washout (at Least 14 Days)||6
1121982|NCT01246713|2716904|P2|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
1121983|NCT01246713|2716905|P1|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
1121984|NCT01246713|2716904|P2|COMPLETED|First Acetaminophen Dosing (1 Day)||9
1121985|NCT01246713|2716905|P1|COMPLETED|First Acetaminophen Dosing (1 Day)||6
1121986|NCT01246713|2716904|P2|STARTED|First Acetaminophen Dosing (1 Day)||9
1121987|NCT01246713|2716905|P1|STARTED|First Acetaminophen Dosing (1 Day)||6
1121988|NCT01247220|2716913|P2|NOT COMPLETED|Overall Study||0
1121989|NCT01247220|2716914|P1|NOT COMPLETED|Overall Study||0
1121990|NCT01247220|2716913|P2|COMPLETED|Overall Study||6
1121991|NCT01247220|2716914|P1|COMPLETED|Overall Study||6
1121992|NCT01247220|2716913|P2|STARTED|Overall Study||6
1121993|NCT01247220|2716914|P1|STARTED|Overall Study||6
1121994|NCT01247272|2716926|P2|NOT COMPLETED|Second Intervention||0
1121995|NCT01247272|2716927|P1|NOT COMPLETED|Second Intervention||0
1121996|NCT01247272|2716926|P2|COMPLETED|Second Intervention||13
1121997|NCT01247272|2716927|P1|COMPLETED|Second Intervention||13
1121998|NCT01247272|2716926|P2|STARTED|Second Intervention||13
1121999|NCT01247272|2716927|P1|STARTED|Second Intervention||13
1122000|NCT01247272|2716926|P2|NOT COMPLETED|Washout of 28 Days||0
1122001|NCT01247272|2716927|P1|NOT COMPLETED|Washout of 28 Days||0
1122002|NCT01247272|2716926|P2|COMPLETED|Washout of 28 Days||13
1122003|NCT01247272|2716927|P1|COMPLETED|Washout of 28 Days||13
1122004|NCT01247272|2716926|P2|STARTED|Washout of 28 Days||13
1122005|NCT01247272|2716927|P1|STARTED|Washout of 28 Days||13
1122006|NCT01247272|2716926|P2|NOT COMPLETED|First Intervention||0
1122007|NCT01247272|2716927|P1|NOT COMPLETED|First Intervention||0
1122008|NCT01247272|2716926|P2|COMPLETED|First Intervention||13
1122009|NCT01247272|2716927|P1|COMPLETED|First Intervention||13
1122010|NCT01247272|2716926|P2|STARTED|First Intervention||13
1122011|NCT01247272|2716927|P1|STARTED|First Intervention||13
1122012|NCT01247285|2716945|P2|NOT COMPLETED|Second Intervention||0
1122013|NCT01247285|2716946|P1|NOT COMPLETED|Second Intervention||0
1122014|NCT01247285|2716945|P2|COMPLETED|Second Intervention||13
1122015|NCT01247285|2716946|P1|COMPLETED|Second Intervention||13
1122016|NCT01247285|2716945|P2|STARTED|Second Intervention||13
1122017|NCT01247285|2716946|P1|STARTED|Second Intervention||13
1122018|NCT01247285|2716945|P2|NOT COMPLETED|Washout of 28 Days||0
1122019|NCT01247285|2716946|P1|NOT COMPLETED|Washout of 28 Days||0
1122020|NCT01247285|2716945|P2|COMPLETED|Washout of 28 Days||13
1122021|NCT01247285|2716946|P1|COMPLETED|Washout of 28 Days||13
1122022|NCT01247285|2716945|P2|STARTED|Washout of 28 Days||13
1122023|NCT01247285|2716946|P1|STARTED|Washout of 28 Days||13
1122024|NCT01247285|2716945|P2|NOT COMPLETED|First Intervention||0
1122025|NCT01247285|2716946|P1|NOT COMPLETED|First Intervention||0
1122026|NCT01247285|2716945|P2|COMPLETED|First Intervention||13
1122027|NCT01247285|2716946|P1|COMPLETED|First Intervention||13
1122028|NCT01247285|2716945|P2|STARTED|First Intervention||13
1122029|NCT01247285|2716946|P1|STARTED|First Intervention||13
1122030|NCT01247298|2716962|P1|NOT COMPLETED|Overall Study||0
1122031|NCT01247298|2716962|P1|COMPLETED|Overall Study||17
1122032|NCT01247298|2716962|P1|STARTED|Overall Study||17
1122039|NCT01247428|2717004|P1|NOT COMPLETED|Overall Study||0
1122040|NCT01247428|2717004|P1|COMPLETED|Overall Study||30
1122041|NCT01247428|2717004|P1|STARTED|Overall Study||30
1122042|NCT01247571|2717025|P1|NOT COMPLETED|Overall Study||3
1122043|NCT01247571|2717025|P1|COMPLETED|Overall Study||19
1122044|NCT01247571|2717025|P1|STARTED|Overall Study||22
1122045|NCT01247675|2717037|P4|NOT COMPLETED|Overall Study||0
1122046|NCT01247675|2717038|P3|NOT COMPLETED|Overall Study||0
1122047|NCT01247675|2717039|P2|NOT COMPLETED|Overall Study||2
1122048|NCT01247675|2717040|P1|NOT COMPLETED|Overall Study||2
1122049|NCT01247675|2717037|P4|COMPLETED|Overall Study||8
1122050|NCT01247675|2717038|P3|COMPLETED|Overall Study||9
1122051|NCT01247675|2717039|P2|COMPLETED|Overall Study||8
1122052|NCT01247675|2717040|P1|COMPLETED|Overall Study||8
1122053|NCT01247675|2717037|P4|STARTED|Overall Study||8
1122054|NCT01247675|2717038|P3|STARTED|Overall Study||9
1122055|NCT01247675|2717039|P2|STARTED|Overall Study||10
1122056|NCT01247675|2717040|P1|STARTED|Overall Study||10
1122057|NCT01247922|2717062|P1|NOT COMPLETED|Overall Study||4
1122058|NCT01247922|2717062|P1|COMPLETED|Overall Study||0
1122059|NCT01247922|2717062|P1|Treated|Overall Study||4
1122060|NCT01247922|2717062|P1|STARTED|Overall Study||4
1122061|NCT01247974|2717070|P2|NOT COMPLETED|Overall Study||19
1122062|NCT01247974|2717071|P1|NOT COMPLETED|Overall Study||26
1122063|NCT01247974|2717070|P2|COMPLETED|Overall Study||203
1122064|NCT01247974|2717071|P1|COMPLETED|Overall Study||191
1122065|NCT01247974|2717070|P2|STARTED|Overall Study||222
1122066|NCT01247974|2717071|P1|STARTED|Overall Study||217
1122067|NCT01248013|2717079|P1|NOT COMPLETED|Overall Study||14
1122068|NCT01248013|2717079|P1|COMPLETED|Overall Study||75
1122069|NCT01248013|2717079|P1|Irritable Bowel Syndrome Hypnotherapy|Overall Study||75
1122070|NCT01248013|2717079|P1|STARTED|Overall Study||89
1122071|NCT01248065|2717085|P2|NOT COMPLETED|Overall Study||22
1122072|NCT01248065|2717086|P1|NOT COMPLETED|Overall Study||26
1122073|NCT01248065|2717085|P2|COMPLETED|Overall Study|All 201 participants were included in the primary time-to-event analysis.|179
1122074|NCT01248065|2717086|P1|COMPLETED|Overall Study|All 207 participants were included in the primary time-to-event analysis.|181
1122075|NCT01248065|2717085|P2|STARTED|Overall Study||201
1122076|NCT01248065|2717086|P1|STARTED|Overall Study||207
1122077|NCT01248130|2717098|P2|NOT COMPLETED|Overall Study||0
1122078|NCT01248130|2717099|P1|NOT COMPLETED|Overall Study||2
1122079|NCT01248130|2717098|P2|COMPLETED|Overall Study||4
1122080|NCT01248130|2717099|P1|COMPLETED|Overall Study||1
1122081|NCT01248130|2717098|P2|STARTED|Overall Study||4
1122082|NCT01248130|2717099|P1|STARTED|Overall Study||3
1122083|NCT01248221|2717107|P2|NOT COMPLETED|Overall Study||0
1122084|NCT01248221|2717108|P1|NOT COMPLETED|Overall Study||0
1122085|NCT01248221|2717107|P2|COMPLETED|Overall Study||15
1122086|NCT01248221|2717108|P1|COMPLETED|Overall Study||15
1122087|NCT01248221|2717107|P2|STARTED|Overall Study||15
1122088|NCT01248221|2717108|P1|STARTED|Overall Study||15
1122089|NCT01248364|2717124|P4|NOT COMPLETED|Overall Study||0
1122090|NCT01248364|2717125|P3|NOT COMPLETED|Overall Study||0
1122091|NCT01248364|2717126|P2|NOT COMPLETED|Overall Study||1
1122092|NCT01248364|2717127|P1|NOT COMPLETED|Overall Study||0
1122093|NCT01248364|2717124|P4|COMPLETED|Overall Study||12
1122094|NCT01248364|2717125|P3|COMPLETED|Overall Study||13
1122095|NCT01248364|2717126|P2|COMPLETED|Overall Study||33
1122096|NCT01248364|2717127|P1|COMPLETED|Overall Study||32
1122097|NCT01248364|2717124|P4|Completed Chronic Phase:28-day Treatment|Overall Study||0
1122098|NCT01248364|2717125|P3|Completed Chronic Phase:28-day Treatment|Overall Study||13
1122099|NCT01248364|2717126|P2|Completed Chronic Phase:28-day Treatment|Overall Study||33
1122100|NCT01248364|2717127|P1|Completed Chronic Phase:28-day Treatment|Overall Study||32
1122101|NCT01248364|2717124|P4|Completed Acute Phase:Single Dose, Day 1|Overall Study||12
1122102|NCT01248364|2717125|P3|Completed Acute Phase:Single Dose, Day 1|Overall Study||13
1122103|NCT01248364|2717126|P2|Completed Acute Phase:Single Dose, Day 1|Overall Study||34
1122104|NCT01248364|2717127|P1|Completed Acute Phase:Single Dose, Day 1|Overall Study||32
1122105|NCT01248364|2717124|P4|STARTED|Overall Study||12
1122106|NCT01248364|2717125|P3|STARTED|Overall Study||13
1122107|NCT01248364|2717126|P2|STARTED|Overall Study||34
1122108|NCT01248364|2717127|P1|STARTED|Overall Study||32
1122109|NCT01248455|2717173|P1|NOT COMPLETED|Overall Study||1
1122110|NCT01248455|2717173|P1|COMPLETED|Overall Study||8
1122111|NCT01248455|2717173|P1|STARTED|Overall Study||9
1122112|NCT01248468|2717181|P3|NOT COMPLETED|Overall Study||4
1122113|NCT01248468|2717182|P2|NOT COMPLETED|Overall Study||14
1122114|NCT01248468|2717183|P1|NOT COMPLETED|Overall Study||15
1122115|NCT01248468|2717181|P3|COMPLETED|Overall Study||145
1122116|NCT01248468|2717182|P2|COMPLETED|Overall Study||290
1122117|NCT01248468|2717183|P1|COMPLETED|Overall Study||284
1122118|NCT01248468|2717181|P3|ITT Population|Overall Study||125
1122119|NCT01248468|2717182|P2|ITT Population|Overall Study||261
1122120|NCT01248468|2717183|P1|ITT Population|Overall Study||256
1122121|NCT01248468|2717181|P3|Safety Population|Overall Study||133
1122122|NCT01248468|2717182|P2|Safety Population|Overall Study||271
1122123|NCT01248468|2717183|P1|Safety Population|Overall Study||266
1122124|NCT01248468|2717181|P3|STARTED|Overall Study||149
1122125|NCT01248468|2717182|P2|STARTED|Overall Study||304
1122126|NCT01248468|2717183|P1|STARTED|Overall Study||299
1122127|NCT01248715|2717202|P2|NOT COMPLETED|Overall Study||510
1122128|NCT01248715|2717203|P1|NOT COMPLETED|Overall Study||501
1122129|NCT01248715|2717202|P2|COMPLETED|Overall Study||41
1122130|NCT01248715|2717203|P1|COMPLETED|Overall Study||55
1122131|NCT01248715|2717202|P2|STARTED|Overall Study||551
1122132|NCT01248715|2717203|P1|STARTED|Overall Study||556
1122133|NCT01248728|2717223|P2|NOT COMPLETED|Overall Study||2
1122134|NCT01248728|2717224|P1|NOT COMPLETED|Overall Study||4
1122135|NCT01248728|2717223|P2|COMPLETED|Overall Study||17
1122136|NCT01248728|2717224|P1|COMPLETED|Overall Study||15
1122137|NCT01248728|2717223|P2|STARTED|Overall Study||19
1122138|NCT01248728|2717224|P1|STARTED|Overall Study||19
1122139|NCT01248780|2717240|P2|NOT COMPLETED|Overall Study||15
1122140|NCT01248780|2717241|P1|NOT COMPLETED|Overall Study||9
1122141|NCT01248780|2717240|P2|COMPLETED|Overall Study||117
1122142|NCT01248780|2717241|P1|COMPLETED|Overall Study||123
1122143|NCT01248780|2717240|P2|STARTED|Overall Study||132
1122144|NCT01248780|2717241|P1|STARTED|Overall Study||132
1122145|NCT01248793|2717255|P2|NOT COMPLETED|Overall Study||6
1122146|NCT01248793|2717256|P1|NOT COMPLETED|Overall Study||4
1122147|NCT01248793|2717255|P2|COMPLETED|Overall Study||102
1122148|NCT01248793|2717256|P1|COMPLETED|Overall Study||101
1122149|NCT01248793|2717255|P2|STARTED|Overall Study||108
1122150|NCT01248793|2717256|P1|STARTED|Overall Study||105
1122151|NCT01248884|2717271|P3|NOT COMPLETED|Overall Study||1
1122152|NCT01248884|2717272|P2|NOT COMPLETED|Overall Study||3
1122153|NCT01248884|2717273|P1|NOT COMPLETED|Overall Study||2
1122154|NCT01248884|2717271|P3|COMPLETED|Overall Study||238
1122155|NCT01248884|2717272|P2|COMPLETED|Overall Study||239
1122156|NCT01248884|2717273|P1|COMPLETED|Overall Study||238
1122157|NCT01248884|2717271|P3|STARTED|Overall Study||239
1122158|NCT01248884|2717272|P2|STARTED|Overall Study||242
1122159|NCT01248884|2717273|P1|STARTED|Overall Study||240
1122160|NCT01248936|2717323|P1|NOT COMPLETED|Overall Study||374
1122161|NCT01248936|2717323|P1|COMPLETED|Overall Study||0
1122162|NCT01248936|2717323|P1|STARTED|Overall Study||374
1122163|NCT01248949|2717338|P5|NOT COMPLETED|Overall Study||4
1122164|NCT01248949|2717339|P4|NOT COMPLETED|Overall Study||10
1122165|NCT01248949|2717340|P3|NOT COMPLETED|Overall Study||37
1122166|NCT01248949|2717341|P2|NOT COMPLETED|Overall Study||13
1122167|NCT01248949|2717342|P1|NOT COMPLETED|Overall Study||33
1122168|NCT01248949|2717338|P5|COMPLETED|Overall Study||3
1122169|NCT01248949|2717339|P4|COMPLETED|Overall Study||3
1122170|NCT01248949|2717340|P3|COMPLETED|Overall Study||1
1122171|NCT01248949|2717341|P2|COMPLETED|Overall Study||3
1122172|NCT01248949|2717342|P1|COMPLETED|Overall Study||9
1122173|NCT01248949|2717338|P5|STARTED|Overall Study||7
1122174|NCT01248949|2717339|P4|STARTED|Overall Study||13
1122175|NCT01248949|2717340|P3|STARTED|Overall Study||38
1122176|NCT01248949|2717341|P2|STARTED|Overall Study||16
1122177|NCT01248949|2717342|P1|STARTED|Overall Study||42
1122178|NCT01249092|2717454|P1|NOT COMPLETED|Overall Study||2
1122179|NCT01249092|2717454|P1|COMPLETED|Overall Study||18
1122180|NCT01249092|2717454|P1|STARTED|Overall Study||20
1122181|NCT01249118|2717460|P3|NOT COMPLETED|Second Washout Period||0
1122182|NCT01249118|2717461|P2|NOT COMPLETED|Second Washout Period||0
1122183|NCT01249118|2717462|P1|NOT COMPLETED|Second Washout Period||0
1122184|NCT01249118|2717460|P3|COMPLETED|Second Washout Period||5
1122185|NCT01249118|2717461|P2|COMPLETED|Second Washout Period||5
1122186|NCT01249118|2717462|P1|COMPLETED|Second Washout Period||2
1122187|NCT01249118|2717460|P3|STARTED|Second Washout Period||5
1122188|NCT01249118|2717461|P2|STARTED|Second Washout Period||5
1122189|NCT01249118|2717462|P1|STARTED|Second Washout Period||2
1122190|NCT01249118|2717460|P3|NOT COMPLETED|Second Intervention Period||0
1122191|NCT01249118|2717461|P2|NOT COMPLETED|Second Intervention Period||0
1122192|NCT01249118|2717462|P1|NOT COMPLETED|Second Intervention Period||0
1122193|NCT01249118|2717460|P3|COMPLETED|Second Intervention Period||5
1122194|NCT01249118|2717461|P2|COMPLETED|Second Intervention Period||5
1122195|NCT01249118|2717462|P1|COMPLETED|Second Intervention Period||2
1122196|NCT01249118|2717460|P3|STARTED|Second Intervention Period||5
1122197|NCT01249118|2717461|P2|STARTED|Second Intervention Period||5
1122198|NCT01249118|2717462|P1|STARTED|Second Intervention Period||2
1122199|NCT01249118|2717460|P3|NOT COMPLETED|First Washout Period||0
1122200|NCT01249118|2717461|P2|NOT COMPLETED|First Washout Period||1
1122201|NCT01249118|2717462|P1|NOT COMPLETED|First Washout Period||0
1122202|NCT01249118|2717460|P3|COMPLETED|First Washout Period||5
1122203|NCT01249118|2717461|P2|COMPLETED|First Washout Period||5
1122204|NCT01249118|2717462|P1|COMPLETED|First Washout Period||2
1122205|NCT01249118|2717460|P3|STARTED|First Washout Period||5
1122206|NCT01249118|2717461|P2|STARTED|First Washout Period||6
1122207|NCT01249118|2717462|P1|STARTED|First Washout Period||2
1122208|NCT01249118|2717460|P3|NOT COMPLETED|First Intervention Period||0
1122209|NCT01249118|2717461|P2|NOT COMPLETED|First Intervention Period||0
1122210|NCT01249118|2717462|P1|NOT COMPLETED|First Intervention Period||0
1122211|NCT01249118|2717460|P3|COMPLETED|First Intervention Period||5
1122212|NCT01249118|2717461|P2|COMPLETED|First Intervention Period||6
1122213|NCT01249118|2717462|P1|COMPLETED|First Intervention Period||2
1122214|NCT01249118|2717460|P3|STARTED|First Intervention Period||5
1122215|NCT01249118|2717461|P2|STARTED|First Intervention Period||6
1122216|NCT01249118|2717462|P1|STARTED|First Intervention Period||2
1122217|NCT01249131|2717496|P6|NOT COMPLETED|Third Intervention||0
1122218|NCT01249131|2717497|P5|NOT COMPLETED|Third Intervention||0
1122219|NCT01249131|2717498|P4|NOT COMPLETED|Third Intervention||0
1122220|NCT01249131|2717499|P3|NOT COMPLETED|Third Intervention||0
1122221|NCT01249131|2717500|P2|NOT COMPLETED|Third Intervention||0
1122222|NCT01249131|2717501|P1|NOT COMPLETED|Third Intervention||0
1122223|NCT01249131|2717496|P6|COMPLETED|Third Intervention||4
1122224|NCT01249131|2717497|P5|COMPLETED|Third Intervention||2
1122225|NCT01249131|2717498|P4|COMPLETED|Third Intervention||3
1122226|NCT01249131|2717499|P3|COMPLETED|Third Intervention||4
1122227|NCT01249131|2717500|P2|COMPLETED|Third Intervention||3
1122228|NCT01249131|2717501|P1|COMPLETED|Third Intervention||3
1122229|NCT01249131|2717496|P6|STARTED|Third Intervention||4
1122230|NCT01249131|2717497|P5|STARTED|Third Intervention||2
1122231|NCT01249131|2717498|P4|STARTED|Third Intervention||3
1122232|NCT01249131|2717499|P3|STARTED|Third Intervention||4
1122233|NCT01249131|2717500|P2|STARTED|Third Intervention||3
1122234|NCT01249131|2717501|P1|STARTED|Third Intervention||3
1122235|NCT01249131|2717496|P6|NOT COMPLETED|Washout Period of 10 Days||0
1122236|NCT01249131|2717497|P5|NOT COMPLETED|Washout Period of 10 Days||0
1122237|NCT01249131|2717498|P4|NOT COMPLETED|Washout Period of 10 Days||0
1122238|NCT01249131|2717499|P3|NOT COMPLETED|Washout Period of 10 Days||0
1122239|NCT01249131|2717500|P2|NOT COMPLETED|Washout Period of 10 Days||0
1122240|NCT01249131|2717501|P1|NOT COMPLETED|Washout Period of 10 Days||0
1122241|NCT01249131|2717496|P6|COMPLETED|Washout Period of 10 Days||4
1122242|NCT01249131|2717497|P5|COMPLETED|Washout Period of 10 Days||2
1122243|NCT01249131|2717498|P4|COMPLETED|Washout Period of 10 Days||3
1122244|NCT01249131|2717499|P3|COMPLETED|Washout Period of 10 Days||4
1122245|NCT01249131|2717500|P2|COMPLETED|Washout Period of 10 Days||3
1122246|NCT01249131|2717501|P1|COMPLETED|Washout Period of 10 Days||3
1122247|NCT01249131|2717496|P6|STARTED|Washout Period of 10 Days||4
1122248|NCT01249131|2717497|P5|STARTED|Washout Period of 10 Days||2
1122249|NCT01249131|2717498|P4|STARTED|Washout Period of 10 Days||3
1122250|NCT01249131|2717499|P3|STARTED|Washout Period of 10 Days||4
1122251|NCT01249131|2717500|P2|STARTED|Washout Period of 10 Days||3
1122252|NCT01249131|2717501|P1|STARTED|Washout Period of 10 Days||3
1122253|NCT01249131|2717496|P6|NOT COMPLETED|Second Intervention||0
1122254|NCT01249131|2717497|P5|NOT COMPLETED|Second Intervention||0
1122255|NCT01249131|2717498|P4|NOT COMPLETED|Second Intervention||0
1122256|NCT01249131|2717499|P3|NOT COMPLETED|Second Intervention||0
1122257|NCT01249131|2717500|P2|NOT COMPLETED|Second Intervention||0
1122258|NCT01249131|2717501|P1|NOT COMPLETED|Second Intervention||0
1122259|NCT01249131|2717496|P6|COMPLETED|Second Intervention||4
1122260|NCT01249131|2717497|P5|COMPLETED|Second Intervention||2
1122261|NCT01249131|2717498|P4|COMPLETED|Second Intervention||3
1122262|NCT01249131|2717499|P3|COMPLETED|Second Intervention||4
1122263|NCT01249131|2717500|P2|COMPLETED|Second Intervention||3
1122264|NCT01249131|2717501|P1|COMPLETED|Second Intervention||3
1122265|NCT01249131|2717496|P6|STARTED|Second Intervention||4
1122266|NCT01249131|2717497|P5|STARTED|Second Intervention||2
1122267|NCT01249131|2717498|P4|STARTED|Second Intervention||3
1122268|NCT01249131|2717499|P3|STARTED|Second Intervention||4
1122269|NCT01249131|2717500|P2|STARTED|Second Intervention||3
1122270|NCT01249131|2717501|P1|STARTED|Second Intervention||3
1122271|NCT01249131|2717496|P6|NOT COMPLETED|Washout Period of 10 Days||0
1122272|NCT01249131|2717497|P5|NOT COMPLETED|Washout Period of 10 Days||1
1122273|NCT01249131|2717498|P4|NOT COMPLETED|Washout Period of 10 Days||0
1122274|NCT01249131|2717499|P3|NOT COMPLETED|Washout Period of 10 Days||0
1122275|NCT01249131|2717500|P2|NOT COMPLETED|Washout Period of 10 Days||0
1122276|NCT01249131|2717501|P1|NOT COMPLETED|Washout Period of 10 Days||0
1122277|NCT01249131|2717496|P6|COMPLETED|Washout Period of 10 Days||4
1122278|NCT01249131|2717497|P5|COMPLETED|Washout Period of 10 Days||2
1122279|NCT01249131|2717498|P4|COMPLETED|Washout Period of 10 Days||3
1122280|NCT01249131|2717499|P3|COMPLETED|Washout Period of 10 Days||4
1122281|NCT01249131|2717500|P2|COMPLETED|Washout Period of 10 Days||3
1122282|NCT01249131|2717501|P1|COMPLETED|Washout Period of 10 Days||3
1122283|NCT01249131|2717496|P6|STARTED|Washout Period of 10 Days||4
1122284|NCT01249131|2717497|P5|STARTED|Washout Period of 10 Days||3
1122285|NCT01249131|2717498|P4|STARTED|Washout Period of 10 Days||3
1122286|NCT01249131|2717499|P3|STARTED|Washout Period of 10 Days||4
1122287|NCT01249131|2717500|P2|STARTED|Washout Period of 10 Days||3
1122288|NCT01249131|2717501|P1|STARTED|Washout Period of 10 Days||3
1122289|NCT01249131|2717496|P6|NOT COMPLETED|First Intervention||0
1122290|NCT01249131|2717497|P5|NOT COMPLETED|First Intervention||0
1122291|NCT01249131|2717498|P4|NOT COMPLETED|First Intervention||0
1122292|NCT01249131|2717499|P3|NOT COMPLETED|First Intervention||0
1122293|NCT01249131|2717500|P2|NOT COMPLETED|First Intervention||0
1122294|NCT01249131|2717501|P1|NOT COMPLETED|First Intervention||0
1122295|NCT01249131|2717496|P6|COMPLETED|First Intervention||4
1122296|NCT01249131|2717497|P5|COMPLETED|First Intervention||3
1122297|NCT01249131|2717498|P4|COMPLETED|First Intervention||3
1122298|NCT01249131|2717499|P3|COMPLETED|First Intervention||4
1122299|NCT01249131|2717500|P2|COMPLETED|First Intervention||3
1122300|NCT01249131|2717501|P1|COMPLETED|First Intervention||3
1122301|NCT01249131|2717496|P6|STARTED|First Intervention||4
1122302|NCT01249131|2717497|P5|STARTED|First Intervention||3
1122303|NCT01249131|2717498|P4|STARTED|First Intervention||3
1122304|NCT01249131|2717499|P3|STARTED|First Intervention||4
1122305|NCT01249131|2717500|P2|STARTED|First Intervention||3
1122306|NCT01249131|2717501|P1|STARTED|First Intervention||3
1122307|NCT01249157|2717521|P1|NOT COMPLETED|Overall Study||1
1122308|NCT01249157|2717521|P1|COMPLETED|Overall Study|No data displayed because Outcome Measure has zero total participants analyzed.|0
1122309|NCT01249157|2717521|P1|STARTED|Overall Study||1
1122310|NCT01249261|2717527|P2|NOT COMPLETED|Overall Study||0
1122311|NCT01249261|2717528|P1|NOT COMPLETED|Overall Study||1
1122312|NCT01249261|2717527|P2|COMPLETED|Overall Study||31
1122313|NCT01249261|2717528|P1|COMPLETED|Overall Study||29
1122314|NCT01249261|2717527|P2|STARTED|Overall Study||31
1122315|NCT01249261|2717528|P1|STARTED|Overall Study||30
1122316|NCT01249274|2717558|P2|NOT COMPLETED|Overall Study||6
1122317|NCT01249274|2717559|P1|NOT COMPLETED|Overall Study||4
1122318|NCT01249274|2717558|P2|COMPLETED|Overall Study||19
1122319|NCT01249274|2717559|P1|COMPLETED|Overall Study||21
1122320|NCT01249274|2717558|P2|Completed Post Trial Visit But Not tx|Overall Study||2
1122321|NCT01249274|2717559|P1|Completed Post Trial Visit But Not tx|Overall Study||1
1122322|NCT01249274|2717558|P2|Completed Treatment & Post Trial Visit|Overall Study||17
1122323|NCT01249274|2717559|P1|Completed Treatment & Post Trial Visit|Overall Study||20
1122324|NCT01249274|2717558|P2|Completed Treatment|Overall Study||19
1122325|NCT01249274|2717559|P1|Completed Treatment|Overall Study||21
1122326|NCT01249274|2717558|P2|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
1122327|NCT01249274|2717559|P1|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
1122328|NCT01249417|2717586|P3|NOT COMPLETED|Treatment Phase - ITT Population||4
1122329|NCT01249417|2717587|P2|NOT COMPLETED|Treatment Phase - ITT Population||4
1122330|NCT01249417|2717588|P1|NOT COMPLETED|Treatment Phase - ITT Population||1
1122331|NCT01249417|2717586|P3|COMPLETED|Treatment Phase - ITT Population||73
1122332|NCT01249417|2717587|P2|COMPLETED|Treatment Phase - ITT Population||75
1122333|NCT01249417|2717588|P1|COMPLETED|Treatment Phase - ITT Population||78
1122334|NCT01249417|2717586|P3|STARTED|Treatment Phase - ITT Population||77
1122335|NCT01249417|2717587|P2|STARTED|Treatment Phase - ITT Population||79
1122336|NCT01249417|2717588|P1|STARTED|Treatment Phase - ITT Population||79
1122337|NCT01249417|2717586|P3|NOT COMPLETED|Randomised Population||4
1122338|NCT01249417|2717587|P2|NOT COMPLETED|Randomised Population||1
1122339|NCT01249417|2717588|P1|NOT COMPLETED|Randomised Population||1
1122340|NCT01249417|2717586|P3|COMPLETED|Randomised Population||77
1122341|NCT01249417|2717587|P2|COMPLETED|Randomised Population||79
1122342|NCT01249417|2717588|P1|COMPLETED|Randomised Population||79
1122343|NCT01249417|2717586|P3|Treated|Randomised Population||79
1122344|NCT01249417|2717587|P2|Treated|Randomised Population||80
1122345|NCT01249417|2717588|P1|Treated|Randomised Population||80
1122346|NCT01249417|2717586|P3|STARTED|Randomised Population||81
1122347|NCT01249417|2717587|P2|STARTED|Randomised Population||80
1122348|NCT01249417|2717588|P1|STARTED|Randomised Population||80
1122349|NCT01249651|2717602|P1|NOT COMPLETED|Overall Study||7
1122350|NCT01249651|2717602|P1|COMPLETED|Overall Study|Completed the 8-week treatment period|94
1122351|NCT01249651|2717602|P1|STARTED|Overall Study|Enrolled|101
1122352|NCT01242514|2717612|P3|NOT COMPLETED|Overall Study||212
1122353|NCT01242514|2717613|P2|NOT COMPLETED|Overall Study||357
1122354|NCT01242514|2717614|P1|NOT COMPLETED|Overall Study||1343
1122355|NCT01242514|2717612|P3|COMPLETED|Overall Study|Due to project closure.|0
1122356|NCT01242514|2717613|P2|COMPLETED|Overall Study|Due to project closure.|0
1122357|NCT01242514|2717614|P1|COMPLETED|Overall Study|Due to project closure.|0
1122358|NCT01242514|2717612|P3|Enrolled But Did Not Receive Treatment|Overall Study|Adverse event/other|2
1122359|NCT01242514|2717613|P2|Enrolled But Did Not Receive Treatment|Overall Study||0
1122360|NCT01242514|2717614|P1|Enrolled But Did Not Receive Treatment|Overall Study|Other|3
1122361|NCT01242514|2717612|P3|STARTED|Overall Study|Patients who received treatment|212
1122362|NCT01242514|2717613|P2|STARTED|Overall Study|Patients who received treatment|357
1122363|NCT01242514|2717614|P1|STARTED|Overall Study|Patients who received treatment|1343
1122364|NCT01242527|2717635|P4|NOT COMPLETED|Overall Study||9
1122365|NCT01242527|2717636|P3|NOT COMPLETED|Overall Study||14
1122366|NCT01242527|2717637|P2|NOT COMPLETED|Overall Study||7
1122367|NCT01242527|2717638|P1|NOT COMPLETED|Overall Study||5
1122368|NCT01242527|2717635|P4|COMPLETED|Overall Study||90
1122369|NCT01242527|2717636|P3|COMPLETED|Overall Study||87
1122370|NCT01242527|2717637|P2|COMPLETED|Overall Study||93
1122371|NCT01242527|2717638|P1|COMPLETED|Overall Study||94
1122372|NCT01242527|2717635|P4|STARTED|Overall Study||99
1122373|NCT01242527|2717636|P3|STARTED|Overall Study||101
1122374|NCT01242527|2717637|P2|STARTED|Overall Study||100
1122375|NCT01242527|2717638|P1|STARTED|Overall Study||99
1122376|NCT01242748|2717650|P2|NOT COMPLETED|Overall Study||14
1122377|NCT01242748|2717651|P1|NOT COMPLETED|Overall Study||38
1122378|NCT01242748|2717650|P2|COMPLETED|Overall Study||80
1122379|NCT01242748|2717651|P1|COMPLETED|Overall Study|These participants were ongoing when the trial was closed by the Sponsor.|156
1122380|NCT01242748|2717650|P2|CS35/CS35A Full Analysis Set (FAS)|Overall Study||282
1122381|NCT01242748|2717651|P1|CS35/CS35A Full Analysis Set (FAS)|Overall Study|Received at least 1 dose of trial drug during CS35+had at least 1 efficacy assessment after dosing.|565
1122382|NCT01242748|2717650|P2|CS35/CS35A Safety Analysis Set|Overall Study||283
1122383|NCT01242748|2717651|P1|CS35/CS35A Safety Analysis Set|Overall Study|Received at least 1 dose of trial drug during the main CS35 trial.|565
1122384|NCT01242748|2717650|P2|STARTED|Overall Study||94
1122385|NCT01242748|2717651|P1|STARTED|Overall Study|Enrolled in CS35A, CS35A Full Analysis Set.|194
1122386|NCT01242813|2717671|P1|NOT COMPLETED|Overall Study||2
1122387|NCT01242813|2717671|P1|COMPLETED|Overall Study||18
1122388|NCT01242813|2717671|P1|STARTED|Overall Study||20
1122389|NCT01243112|2717691|P1|NOT COMPLETED|Overall Study||0
1122390|NCT01243112|2717691|P1|COMPLETED|Overall Study||25
1122391|NCT01243112|2717691|P1|STARTED|Overall Study||25
1122398|NCT01243242|2717717|P2|NOT COMPLETED|Overall Study||4
1122399|NCT01243242|2717718|P1|NOT COMPLETED|Overall Study||3
1122400|NCT01243242|2717717|P2|COMPLETED|Overall Study||56
1122401|NCT01243242|2717718|P1|COMPLETED|Overall Study||57
1122402|NCT01243242|2717717|P2|STARTED|Overall Study||60
1122403|NCT01243242|2717718|P1|STARTED|Overall Study||60
1122404|NCT01243294|2717730|P2|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
1122405|NCT01243294|2717731|P1|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
1122406|NCT01243294|2717730|P2|COMPLETED|Second Intervention (10 Days +/- 2 Days)||26
1122407|NCT01243294|2717731|P1|COMPLETED|Second Intervention (10 Days +/- 2 Days)||28
1122408|NCT01243294|2717730|P2|STARTED|Second Intervention (10 Days +/- 2 Days)||26
1122409|NCT01243294|2717731|P1|STARTED|Second Intervention (10 Days +/- 2 Days)||28
1122410|NCT01243294|2717730|P2|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
1122411|NCT01243294|2717731|P1|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
1122412|NCT01243294|2717730|P2|COMPLETED|First Intervention (10 Days +/- 2 Days)||26
1122413|NCT01243294|2717731|P1|COMPLETED|First Intervention (10 Days +/- 2 Days)||28
1122414|NCT01243294|2717730|P2|STARTED|First Intervention (10 Days +/- 2 Days)||26
1122415|NCT01243294|2717731|P1|STARTED|First Intervention (10 Days +/- 2 Days)||28
1122416|NCT01243320|2717747|P1|NOT COMPLETED|32ppm Oral Silver (14 Days)||0
1122417|NCT01243320|2717747|P1|COMPLETED|32ppm Oral Silver (14 Days)||24
1122418|NCT01243320|2717747|P1|STARTED|32ppm Oral Silver (14 Days)||24
1122419|NCT01243320|2717747|P1|NOT COMPLETED|Washout (3 Days)||0
1122420|NCT01243320|2717747|P1|COMPLETED|Washout (3 Days)||36
1122421|NCT01243320|2717747|P1|STARTED|Washout (3 Days)||36
1122422|NCT01243320|2717747|P1|NOT COMPLETED|10ppm Oral Silver (14 Days)||0
1122423|NCT01243320|2717747|P1|COMPLETED|10ppm Oral Silver (14 Days)||36
1122424|NCT01243320|2717747|P1|STARTED|10ppm Oral Silver (14 Days)||36
1122425|NCT01243320|2717747|P1|NOT COMPLETED|10ppm Oral Silver (7 Days)||0
1122426|NCT01243320|2717747|P1|COMPLETED|10ppm Oral Silver (7 Days)||36
1122427|NCT01243320|2717747|P1|STARTED|10ppm Oral Silver (7 Days)||36
1122428|NCT01243320|2717747|P1|NOT COMPLETED|10ppm Oral Silver (3 Days)||0
1122429|NCT01243320|2717747|P1|COMPLETED|10ppm Oral Silver (3 Days)||36
1122430|NCT01243320|2717747|P1|STARTED|10ppm Oral Silver (3 Days)||36
1122431|NCT01243411|2717823|P1|NOT COMPLETED|Overall Study||41
1122432|NCT01243411|2717823|P1|COMPLETED|Overall Study||306
1122433|NCT01243411|2717823|P1|STARTED|Overall Study||347
1122434|NCT01243450|2717838|P3|NOT COMPLETED|Overall Study||67
1122435|NCT01243450|2717839|P2|NOT COMPLETED|Overall Study||25
1122436|NCT01243450|2717840|P1|NOT COMPLETED|Overall Study||83
1122437|NCT01243450|2717838|P3|COMPLETED|Overall Study||337
1122438|NCT01243450|2717839|P2|COMPLETED|Overall Study||110
1122439|NCT01243450|2717840|P1|COMPLETED|Overall Study||318
1122440|NCT01243450|2717838|P3|STARTED|Overall Study||404
1122441|NCT01243450|2717839|P2|STARTED|Overall Study||135
1122442|NCT01243450|2717840|P1|STARTED|Overall Study||401
1122443|NCT01243567|2717850|P2|NOT COMPLETED|Overall Study||0
1122444|NCT01243567|2717851|P1|NOT COMPLETED|Overall Study||1
1122445|NCT01243567|2717850|P2|COMPLETED|Overall Study||38
1122446|NCT01243567|2717851|P1|COMPLETED|Overall Study||42
1122447|NCT01243567|2717850|P2|STARTED|Overall Study||38
1122448|NCT01243567|2717851|P1|STARTED|Overall Study||43
1122449|NCT01243619|2717865|P1|NOT COMPLETED|Overall Study||0
1122450|NCT01243619|2717865|P1|COMPLETED|Overall Study|Patient enrollment is complete, data analysis is ongoing|5
1122451|NCT01243619|2717865|P1|STARTED|Overall Study||5
1122452|NCT01243671|2717869|P1|NOT COMPLETED|Overall Study||5
1122453|NCT01243671|2717869|P1|COMPLETED|Overall Study|Completed 136 weeks of treatment.|15
1122454|NCT01243671|2717869|P1|Completed 52 Weeks of Treatment|Overall Study||17
1122455|NCT01243671|2717869|P1|Completed 24 Weeks of Treatment|Overall Study||18
1122456|NCT01243671|2717869|P1|STARTED|Overall Study||20
1122457|NCT01243775|2717882|P1|NOT COMPLETED|Overall Study||2
1122458|NCT01243775|2717882|P1|COMPLETED|Overall Study||31
1122459|NCT01243775|2717882|P1|STARTED|Overall Study||33
1122460|NCT01249664|2717891|P2|NOT COMPLETED|Overall Study||0
1122461|NCT01249664|2717892|P1|NOT COMPLETED|Overall Study||6
1122462|NCT01249664|2717891|P2|COMPLETED|Overall Study|Completers of study visits up to week 48|31
1122463|NCT01249664|2717892|P1|COMPLETED|Overall Study|Completers of study visits up to week 48|85
1122464|NCT01249664|2717891|P2|Completed 48 Weeks Treatment|Overall Study||24
1122465|NCT01249664|2717892|P1|Completed 48 Weeks Treatment|Overall Study||78
1122466|NCT01249664|2717891|P2|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|25
1122467|NCT01249664|2717892|P1|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|83
1122468|NCT01249664|2717891|P2|Fulfilled Requirements of FAS Population|Overall Study|FAS population: Basis of efficacy evaluation|31
1122469|NCT01249664|2717892|P1|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) population: Basis of efficacy evaluation|90
1122470|NCT01249664|2717891|P2|Participants Received Treatment|Overall Study|Safety population|31
1122471|NCT01249664|2717892|P1|Participants Received Treatment|Overall Study|Safety population|91
1122472|NCT01249664|2717891|P2|STARTED|Overall Study||31
1122473|NCT01249664|2717892|P1|STARTED|Overall Study||91
1122474|NCT01249833|2717944|P2|NOT COMPLETED|Overall Study||1
1122475|NCT01249833|2717945|P1|NOT COMPLETED|Overall Study||0
1122476|NCT01249833|2717944|P2|COMPLETED|Overall Study||62
1122477|NCT01249833|2717945|P1|COMPLETED|Overall Study||59
1122478|NCT01249833|2717944|P2|STARTED|Overall Study||63
1122479|NCT01249833|2717945|P1|STARTED|Overall Study||59
1122480|NCT01249872|2717963|P6|NOT COMPLETED|Overall Study||0
1122481|NCT01249872|2717964|P5|NOT COMPLETED|Overall Study||0
1122482|NCT01249872|2717965|P4|NOT COMPLETED|Overall Study||0
1122483|NCT01249872|2717966|P3|NOT COMPLETED|Overall Study||0
1122484|NCT01249872|2717967|P2|NOT COMPLETED|Overall Study||0
1122485|NCT01249872|2717968|P1|NOT COMPLETED|Overall Study||0
1122486|NCT01249872|2717963|P6|COMPLETED|Overall Study||16
1122487|NCT01249872|2717964|P5|COMPLETED|Overall Study||16
1122488|NCT01249872|2717965|P4|COMPLETED|Overall Study||16
1122489|NCT01249872|2717966|P3|COMPLETED|Overall Study||16
1122490|NCT01249872|2717967|P2|COMPLETED|Overall Study||16
1122491|NCT01249872|2717968|P1|COMPLETED|Overall Study||16
1122492|NCT01249872|2717963|P6|STARTED|Overall Study||16
1122493|NCT01249872|2717964|P5|STARTED|Overall Study||16
1122494|NCT01249872|2717965|P4|STARTED|Overall Study||16
1122495|NCT01249872|2717966|P3|STARTED|Overall Study||16
1122496|NCT01249872|2717967|P2|STARTED|Overall Study||16
1122497|NCT01249872|2717968|P1|STARTED|Overall Study||16
1122498|NCT01251120|2718014|P2|NOT COMPLETED|Overall Study||1
1122499|NCT01251120|2718015|P1|NOT COMPLETED|Overall Study||0
1122500|NCT01251120|2718014|P2|COMPLETED|Overall Study||0
1122501|NCT01251120|2718015|P1|COMPLETED|Overall Study||1
1122502|NCT01251120|2718014|P2|STARTED|Overall Study||1
1122503|NCT01251120|2718015|P1|STARTED|Overall Study||1
1122504|NCT01251146|2718037|P2|NOT COMPLETED|Overall Study||10
1122505|NCT01251146|2718038|P1|NOT COMPLETED|Overall Study||3
1122506|NCT01251146|2718037|P2|COMPLETED|Overall Study||81
1122507|NCT01251146|2718038|P1|COMPLETED|Overall Study||83
1122508|NCT01251146|2718037|P2|STARTED|Overall Study||91
1122509|NCT01251146|2718038|P1|STARTED|Overall Study||86
1122510|NCT01251276|2718060|P2|NOT COMPLETED|Overall Study||1
1122511|NCT01251276|2718061|P1|NOT COMPLETED|Overall Study||1
1122512|NCT01251276|2718060|P2|COMPLETED|Overall Study||107
1122513|NCT01251276|2718061|P1|COMPLETED|Overall Study||95
1122514|NCT01251276|2718060|P2|Vaccinated|Overall Study||108
1122515|NCT01251276|2718061|P1|Vaccinated|Overall Study||96
1122516|NCT01251276|2718060|P2|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|108
1122517|NCT01251276|2718061|P1|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|96
1122518|NCT01251315|2718083|P6|NOT COMPLETED|Overall Study||0
1122519|NCT01251315|2718084|P5|NOT COMPLETED|Overall Study||0
1122520|NCT01251315|2718085|P4|NOT COMPLETED|Overall Study||0
1122521|NCT01251315|2718086|P3|NOT COMPLETED|Overall Study||0
1122522|NCT01251315|2718087|P2|NOT COMPLETED|Overall Study||0
1122523|NCT01251315|2718088|P1|NOT COMPLETED|Overall Study||0
1122524|NCT01251315|2718083|P6|COMPLETED|Overall Study||4
1122525|NCT01251315|2718084|P5|COMPLETED|Overall Study||4
1122526|NCT01251315|2718085|P4|COMPLETED|Overall Study||4
1122527|NCT01251315|2718086|P3|COMPLETED|Overall Study||4
1122528|NCT01251315|2718087|P2|COMPLETED|Overall Study||4
1122529|NCT01251315|2718088|P1|COMPLETED|Overall Study||4
1122530|NCT01251315|2718083|P6|STARTED|Overall Study||4
1122531|NCT01251315|2718084|P5|STARTED|Overall Study||4
1122532|NCT01251315|2718085|P4|STARTED|Overall Study||4
1122533|NCT01251315|2718086|P3|STARTED|Overall Study||4
1122534|NCT01251315|2718087|P2|STARTED|Overall Study||4
1122535|NCT01251315|2718088|P1|STARTED|Overall Study||4
1122536|NCT01251354|2718108|P1|NOT COMPLETED|Overall Study||6
1122537|NCT01251354|2718108|P1|COMPLETED|Overall Study||0
1122538|NCT01251354|2718108|P1|STARTED|Overall Study||6
1122539|NCT01251380|2718118|P1|NOT COMPLETED|Overall Study||22
1122540|NCT01251380|2718118|P1|COMPLETED|Overall Study||194
1122541|NCT01251380|2718118|P1|Cycle 4|Overall Study||11
1122542|NCT01251380|2718118|P1|Cycle 3|Overall Study||86
1122543|NCT01251380|2718118|P1|Cycle 2|Overall Study||175
1122544|NCT01251380|2718118|P1|Cycle 1|Overall Study||207
1122545|NCT01251380|2718118|P1|STARTED|Overall Study|Safety population.|216
1122546|NCT01251588|2718144|P2|NOT COMPLETED|Overall Study||4
1122547|NCT01251588|2718145|P1|NOT COMPLETED|Overall Study||0
1122548|NCT01251588|2718144|P2|COMPLETED|Overall Study||59
1122549|NCT01251588|2718145|P1|COMPLETED|Overall Study||65
1122550|NCT01251588|2718144|P2|STARTED|Overall Study||63
1122551|NCT01251588|2718145|P1|STARTED|Overall Study||65
1122552|NCT01251614|2718180|P3|NOT COMPLETED|Overall Study||8
1122553|NCT01251614|2718181|P2|NOT COMPLETED|Overall Study||13
1122554|NCT01251614|2718182|P1|NOT COMPLETED|Overall Study||3
1122555|NCT01251614|2718180|P3|COMPLETED|Overall Study||30
1122556|NCT01251614|2718181|P2|COMPLETED|Overall Study||26
1122557|NCT01251614|2718182|P1|COMPLETED|Overall Study||34
1122558|NCT01251614|2718180|P3|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
1122559|NCT01251614|2718181|P2|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
1122560|NCT01251614|2718182|P1|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
1122561|NCT01251614|2718180|P3|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|19
1122562|NCT01251614|2718181|P2|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|11
1122563|NCT01251614|2718182|P1|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|8
1122564|NCT01251614|2718180|P3|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|23
1122565|NCT01251614|2718181|P2|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|18
1122566|NCT01251614|2718182|P1|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|13
1122567|NCT01251614|2718180|P3|STARTED|Overall Study||38
1122568|NCT01251614|2718181|P2|STARTED|Overall Study||39
1122569|NCT01251614|2718182|P1|STARTED|Overall Study||37
1122570|NCT01251653|2718263|P9|NOT COMPLETED|Overall Study||6
1122571|NCT01251653|2718264|P8|NOT COMPLETED|Overall Study||12
1122572|NCT01251653|2718265|P7|NOT COMPLETED|Overall Study||18
1122573|NCT01251653|2718266|P6|NOT COMPLETED|Overall Study||18
1122574|NCT01251653|2718267|P5|NOT COMPLETED|Overall Study||2
1122575|NCT01251653|2718268|P4|NOT COMPLETED|Overall Study||6
1122576|NCT01251653|2718269|P3|NOT COMPLETED|Overall Study||20
1122577|NCT01251653|2718270|P2|NOT COMPLETED|Overall Study||8
1122578|NCT01251653|2718271|P1|NOT COMPLETED|Overall Study||3
1122579|NCT01251653|2718263|P9|COMPLETED|Overall Study||0
1122580|NCT01251653|2718264|P8|COMPLETED|Overall Study||0
1122581|NCT01251653|2718265|P7|COMPLETED|Overall Study||0
1122582|NCT01251653|2718266|P6|COMPLETED|Overall Study||0
1122583|NCT01251653|2718267|P5|COMPLETED|Overall Study||0
1122584|NCT01251653|2718268|P4|COMPLETED|Overall Study||0
1122585|NCT01251653|2718269|P3|COMPLETED|Overall Study||0
1122586|NCT01251653|2718270|P2|COMPLETED|Overall Study||0
1122587|NCT01251653|2718271|P1|COMPLETED|Overall Study||0
1122588|NCT01251653|2718263|P9|STARTED|Overall Study||6
1122589|NCT01251653|2718264|P8|STARTED|Overall Study||12
1122590|NCT01251653|2718265|P7|STARTED|Overall Study||18
1122591|NCT01251653|2718266|P6|STARTED|Overall Study||18
1122592|NCT01251653|2718267|P5|STARTED|Overall Study||2
1122593|NCT01251653|2718268|P4|STARTED|Overall Study||6
1122594|NCT01251653|2718269|P3|STARTED|Overall Study||20
1122595|NCT01251653|2718270|P2|STARTED|Overall Study||8
1122596|NCT01251653|2718271|P1|STARTED|Overall Study||3
1122597|NCT01251757|2718399|P3|NOT COMPLETED|Overall Study||0
1122598|NCT01251757|2718400|P2|NOT COMPLETED|Overall Study||0
1122599|NCT01251757|2718401|P1|NOT COMPLETED|Overall Study||0
1122600|NCT01251757|2718399|P3|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.5) mos, but we computed an adherence score for everyone.|7250
1122601|NCT01251757|2718400|P2|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.4) mos, but we computed an adherence score for everyone.|7247
1122602|NCT01251757|2718401|P1|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.7 (2.3) mos, but we computed an adherence score for everyone.|7255
1122603|NCT01251757|2718399|P3|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7250
1122604|NCT01251757|2718400|P2|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7247
1122605|NCT01251757|2718401|P1|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7255
1122606|NCT01251770|2718432|P2|NOT COMPLETED|Overall Study||7
1122607|NCT01251770|2718433|P1|NOT COMPLETED|Overall Study||13
1122608|NCT01251770|2718432|P2|COMPLETED|Overall Study||29
1122609|NCT01251770|2718433|P1|COMPLETED|Overall Study||29
1122610|NCT01251770|2718432|P2|STARTED|Overall Study||36
1122611|NCT01251770|2718433|P1|STARTED|Overall Study||42
1122612|NCT01251952|2718441|P1|NOT COMPLETED|Overall Study||1
1122613|NCT01251952|2718441|P1|COMPLETED|Overall Study||1
1122614|NCT01251952|2718441|P1|STARTED|Overall Study||2
1122615|NCT01251978|2718447|P2|NOT COMPLETED|Overall Study||0
1122616|NCT01251978|2718448|P1|NOT COMPLETED|Overall Study||0
1122617|NCT01251978|2718447|P2|COMPLETED|Overall Study||3
1122618|NCT01251978|2718448|P1|COMPLETED|Overall Study||5
1122619|NCT01251978|2718447|P2|STARTED|Overall Study||3
1122620|NCT01251978|2718448|P1|STARTED|Overall Study||5
1122627|NCT01252134|2718466|P6|NOT COMPLETED|Period 3, 8 Hours||0
1122628|NCT01252134|2718467|P5|NOT COMPLETED|Period 3, 8 Hours||0
1122629|NCT01252134|2718468|P4|NOT COMPLETED|Period 3, 8 Hours||0
1122630|NCT01252134|2718469|P3|NOT COMPLETED|Period 3, 8 Hours||0
1122631|NCT01252134|2718470|P2|NOT COMPLETED|Period 3, 8 Hours||0
1122632|NCT01252134|2718471|P1|NOT COMPLETED|Period 3, 8 Hours||0
1122633|NCT01252134|2718466|P6|COMPLETED|Period 3, 8 Hours||4
1122634|NCT01252134|2718467|P5|COMPLETED|Period 3, 8 Hours||3
1122635|NCT01252134|2718468|P4|COMPLETED|Period 3, 8 Hours||5
1122636|NCT01252134|2718469|P3|COMPLETED|Period 3, 8 Hours||2
1122637|NCT01252134|2718470|P2|COMPLETED|Period 3, 8 Hours||3
1122638|NCT01252134|2718471|P1|COMPLETED|Period 3, 8 Hours||3
1122639|NCT01252134|2718466|P6|STARTED|Period 3, 8 Hours||4
1122640|NCT01252134|2718467|P5|STARTED|Period 3, 8 Hours||3
1122641|NCT01252134|2718468|P4|STARTED|Period 3, 8 Hours||5
1122642|NCT01252134|2718469|P3|STARTED|Period 3, 8 Hours||2
1122643|NCT01252134|2718470|P2|STARTED|Period 3, 8 Hours||3
1122644|NCT01252134|2718471|P1|STARTED|Period 3, 8 Hours||3
1122645|NCT01252134|2718466|P6|NOT COMPLETED|Period 2, 8 Hours||0
1122646|NCT01252134|2718467|P5|NOT COMPLETED|Period 2, 8 Hours||0
1122647|NCT01252134|2718468|P4|NOT COMPLETED|Period 2, 8 Hours||0
1122648|NCT01252134|2718469|P3|NOT COMPLETED|Period 2, 8 Hours||0
1122649|NCT01252134|2718470|P2|NOT COMPLETED|Period 2, 8 Hours||0
1122650|NCT01252134|2718471|P1|NOT COMPLETED|Period 2, 8 Hours||0
1122651|NCT01252134|2718466|P6|COMPLETED|Period 2, 8 Hours||4
1122652|NCT01252134|2718467|P5|COMPLETED|Period 2, 8 Hours||3
1122653|NCT01252134|2718468|P4|COMPLETED|Period 2, 8 Hours||5
1122654|NCT01252134|2718469|P3|COMPLETED|Period 2, 8 Hours||2
1122655|NCT01252134|2718470|P2|COMPLETED|Period 2, 8 Hours||3
1122656|NCT01252134|2718471|P1|COMPLETED|Period 2, 8 Hours||3
1122657|NCT01252134|2718466|P6|STARTED|Period 2, 8 Hours||4
1122658|NCT01252134|2718467|P5|STARTED|Period 2, 8 Hours||3
1122659|NCT01252134|2718468|P4|STARTED|Period 2, 8 Hours||5
1122660|NCT01252134|2718469|P3|STARTED|Period 2, 8 Hours||2
1122661|NCT01252134|2718470|P2|STARTED|Period 2, 8 Hours||3
1122662|NCT01252134|2718471|P1|STARTED|Period 2, 8 Hours||3
1122663|NCT01252134|2718466|P6|NOT COMPLETED|Period 1, 8 Hours||0
1122664|NCT01252134|2718467|P5|NOT COMPLETED|Period 1, 8 Hours||0
1122665|NCT01252134|2718468|P4|NOT COMPLETED|Period 1, 8 Hours||0
1122666|NCT01252134|2718469|P3|NOT COMPLETED|Period 1, 8 Hours||1
1122667|NCT01252134|2718470|P2|NOT COMPLETED|Period 1, 8 Hours||1
1122668|NCT01252134|2718471|P1|NOT COMPLETED|Period 1, 8 Hours||0
1122669|NCT01252134|2718466|P6|COMPLETED|Period 1, 8 Hours||4
1122670|NCT01252134|2718467|P5|COMPLETED|Period 1, 8 Hours||3
1122671|NCT01252134|2718468|P4|COMPLETED|Period 1, 8 Hours||5
1122672|NCT01252134|2718469|P3|COMPLETED|Period 1, 8 Hours||2
1122673|NCT01252134|2718470|P2|COMPLETED|Period 1, 8 Hours||3
1122674|NCT01252134|2718471|P1|COMPLETED|Period 1, 8 Hours||3
1122675|NCT01252134|2718466|P6|STARTED|Period 1, 8 Hours||4
1122676|NCT01252134|2718467|P5|STARTED|Period 1, 8 Hours||3
1122677|NCT01252134|2718468|P4|STARTED|Period 1, 8 Hours||5
1122678|NCT01252134|2718469|P3|STARTED|Period 1, 8 Hours||3
1122679|NCT01252134|2718470|P2|STARTED|Period 1, 8 Hours||4
1122680|NCT01252134|2718471|P1|STARTED|Period 1, 8 Hours||3
1122681|NCT01252147|2718488|P1|NOT COMPLETED|Overall Study||0
1122682|NCT01252147|2718488|P1|COMPLETED|Overall Study||68
1122683|NCT01252147|2718488|P1|STARTED|Overall Study||68
1122684|NCT01252186|2718496|P3|NOT COMPLETED|Overall Study||34
1122685|NCT01252186|2718497|P2|NOT COMPLETED|Overall Study||32
1122686|NCT01252186|2718498|P1|NOT COMPLETED|Overall Study||30
1122687|NCT01252186|2718496|P3|COMPLETED|Overall Study||53
1122688|NCT01252186|2718497|P2|COMPLETED|Overall Study||59
1122689|NCT01252186|2718498|P1|COMPLETED|Overall Study||57
1122690|NCT01252186|2718496|P3|Received Study Drug|Overall Study||80
1122691|NCT01252186|2718497|P2|Received Study Drug|Overall Study||89
1122692|NCT01252186|2718498|P1|Received Study Drug|Overall Study||83
1122693|NCT01252186|2718496|P3|STARTED|Overall Study||87
1122694|NCT01252186|2718497|P2|STARTED|Overall Study||91
1122695|NCT01252186|2718498|P1|STARTED|Overall Study||87
1122696|NCT01252238|2718569|P3|NOT COMPLETED|Overall Study||4
1122697|NCT01252238|2718570|P2|NOT COMPLETED|Overall Study||4
1122698|NCT01252238|2718571|P1|NOT COMPLETED|Overall Study||4
1122699|NCT01252238|2718569|P3|COMPLETED|Overall Study|sponsor terminated study|4
1122700|NCT01252238|2718570|P2|COMPLETED|Overall Study|sponsor terminated study|4
1122701|NCT01252238|2718571|P1|COMPLETED|Overall Study|sponsor terminated study|4
1122702|NCT01252238|2718569|P3|STARTED|Overall Study||8
1122703|NCT01252238|2718570|P2|STARTED|Overall Study||8
1122704|NCT01252238|2718571|P1|STARTED|Overall Study||8
1122705|NCT01252251|2718579|P1|NOT COMPLETED|Overall Study||1
1122706|NCT01252251|2718579|P1|COMPLETED|Overall Study||13
1122707|NCT01252251|2718579|P1|STARTED|Overall Study||14
1122708|NCT01252277|2718588|P1|NOT COMPLETED|Overall Study||2
1122709|NCT01252277|2718588|P1|COMPLETED|Overall Study||34
1122710|NCT01252277|2718588|P1|STARTED|Overall Study||36
1122711|NCT01252290|2718596|P1|NOT COMPLETED|Overall Study||1
1122712|NCT01252290|2718596|P1|COMPLETED|Overall Study||34
1122713|NCT01252290|2718596|P1|STARTED|Overall Study||35
1122714|NCT01252355|2718607|P3|NOT COMPLETED|Overall Study||179
1122715|NCT01252355|2718608|P2|NOT COMPLETED|Overall Study||178
1122716|NCT01252355|2718609|P1|NOT COMPLETED|Overall Study||177
1122717|NCT01252355|2718607|P3|COMPLETED|Overall Study||0
1122718|NCT01252355|2718608|P2|COMPLETED|Overall Study||0
1122719|NCT01252355|2718609|P1|COMPLETED|Overall Study||0
1122720|NCT01252355|2718607|P3|Treated|Overall Study|One participant received teriflunomide 7 mg.|179
1122721|NCT01252355|2718608|P2|Treated|Overall Study||178
1122722|NCT01252355|2718609|P1|Treated|Overall Study||175
1122723|NCT01252355|2718607|P3|STARTED|Overall Study|Randomized.|179
1122724|NCT01252355|2718608|P2|STARTED|Overall Study|Randomized.|178
1122725|NCT01252355|2718609|P1|STARTED|Overall Study|Randomized.|177
1122726|NCT01252810|2718649|P2|NOT COMPLETED|Overall Study||3
1122727|NCT01252810|2718650|P1|NOT COMPLETED|Overall Study||14
1122728|NCT01252810|2718649|P2|COMPLETED|Overall Study||139
1122729|NCT01252810|2718650|P1|COMPLETED|Overall Study||128
1122730|NCT01252810|2718649|P2|STARTED|Overall Study||142
1122731|NCT01252810|2718650|P1|STARTED|Overall Study||142
1122732|NCT01252940|2718662|P2|NOT COMPLETED|Extension Phase||3
1122733|NCT01252940|2718663|P1|NOT COMPLETED|Extension Phase||10
1122734|NCT01252940|2718662|P2|COMPLETED|Extension Phase||46
1122735|NCT01252940|2718663|P1|COMPLETED|Extension Phase||100
1122736|NCT01252940|2718662|P2|STARTED|Extension Phase|SBR/Delayed Switch Group: 49 participants completing the main study continued in extension phase.|49
1122737|NCT01252940|2718663|P1|STARTED|Extension Phase|FTC/RPV/TDF group: 110 participants completing the main study continued in extension phase.|110
1122738|NCT01252940|2718662|P2|NOT COMPLETED|Main Study Phase||12
1122739|NCT01252940|2718663|P1|NOT COMPLETED|Main Study Phase||26
1122740|NCT01252940|2718662|P2|COMPLETED|Main Study Phase|Discontinuations after switch: withdrawal by subject, 2; adverse event, 1; protocol violation, 1.|149
1122741|NCT01252940|2718663|P1|COMPLETED|Main Study Phase||295
1122742|NCT01252940|2718662|P2|Completed 24 Weeks|Main Study Phase|152 participants switched regimens at Week 24.|153
1122743|NCT01252940|2718663|P1|Completed 24 Weeks|Main Study Phase||0
1122744|NCT01252940|2718662|P2|STARTED|Main Study Phase||161
1122745|NCT01252940|2718663|P1|STARTED|Main Study Phase||321
1122746|NCT01252966|2718694|P2|NOT COMPLETED|Overall Study||13
1122747|NCT01252966|2718695|P1|NOT COMPLETED|Overall Study||23
1122748|NCT01252966|2718694|P2|COMPLETED|Overall Study||92
1122749|NCT01252966|2718695|P1|COMPLETED|Overall Study||85
1122750|NCT01252966|2718694|P2|STARTED|Overall Study||105
1122751|NCT01252966|2718695|P1|STARTED|Overall Study||108
1122752|NCT01253018|2718711|P2|NOT COMPLETED|Overall Study||2
1122753|NCT01253018|2718712|P1|NOT COMPLETED|Overall Study||4
1122754|NCT01253018|2718711|P2|COMPLETED|Overall Study||21
1122755|NCT01253018|2718712|P1|COMPLETED|Overall Study||18
1122756|NCT01253018|2718711|P2|STARTED|Overall Study||23
1122757|NCT01253018|2718712|P1|STARTED|Overall Study||22
1122758|NCT01253044|2718726|P2|NOT COMPLETED|Overall Study||29
1122759|NCT01253044|2718727|P1|NOT COMPLETED|Overall Study||38
1122760|NCT01253044|2718726|P2|COMPLETED|Overall Study||51
1122761|NCT01253044|2718727|P1|COMPLETED|Overall Study||42
1122762|NCT01253044|2718726|P2|STARTED|Overall Study||80
1122763|NCT01253044|2718727|P1|STARTED|Overall Study||80
1122764|NCT01253070|2718735|P1|NOT COMPLETED|Overall Study||0
1122765|NCT01253070|2718735|P1|COMPLETED|Overall Study||54
1122766|NCT01253070|2718735|P1|STARTED|Overall Study||54
1122767|NCT01253135|2718744|P1|NOT COMPLETED|Amended Protocol||1
1122768|NCT01253135|2718744|P1|COMPLETED|Amended Protocol||24
1122769|NCT01253135|2718744|P1|STARTED|Amended Protocol||25
1122770|NCT01253135|2718744|P1|NOT COMPLETED|Original Protocol||15
1122771|NCT01253135|2718744|P1|COMPLETED|Original Protocol||0
1122772|NCT01253135|2718744|P1|STARTED|Original Protocol||15
1122773|NCT01253148|2718752|P1|NOT COMPLETED|Overall Study||0
1122774|NCT01253148|2718752|P1|COMPLETED|Overall Study||25
1122775|NCT01253148|2718752|P1|STARTED|Overall Study||25
1122776|NCT01253174|2718758|P6|NOT COMPLETED|Period 3||0
1122777|NCT01253174|2718759|P5|NOT COMPLETED|Period 3||1
1122778|NCT01253174|2718760|P4|NOT COMPLETED|Period 3||0
1122779|NCT01253174|2718761|P3|NOT COMPLETED|Period 3||1
1122780|NCT01253174|2718762|P2|NOT COMPLETED|Period 3||1
1122781|NCT01253174|2718763|P1|NOT COMPLETED|Period 3||0
1122782|NCT01253174|2718758|P6|COMPLETED|Period 3||7
1122783|NCT01253174|2718759|P5|COMPLETED|Period 3||7
1122784|NCT01253174|2718760|P4|COMPLETED|Period 3||7
1122785|NCT01253174|2718761|P3|COMPLETED|Period 3||6
1122786|NCT01253174|2718762|P2|COMPLETED|Period 3||8
1122787|NCT01253174|2718763|P1|COMPLETED|Period 3||6
1122788|NCT01253174|2718758|P6|STARTED|Period 3||7
1122789|NCT01253174|2718759|P5|STARTED|Period 3||8
1122790|NCT01253174|2718760|P4|STARTED|Period 3||7
1122791|NCT01253174|2718761|P3|STARTED|Period 3||7
1122792|NCT01253174|2718762|P2|STARTED|Period 3||9
1122793|NCT01253174|2718763|P1|STARTED|Period 3||6
1122794|NCT01253174|2718758|P6|NOT COMPLETED|Period 2||0
1122795|NCT01253174|2718759|P5|NOT COMPLETED|Period 2||0
1122796|NCT01253174|2718760|P4|NOT COMPLETED|Period 2||0
1122797|NCT01253174|2718761|P3|NOT COMPLETED|Period 2||1
1122798|NCT01253174|2718762|P2|NOT COMPLETED|Period 2||0
1122799|NCT01253174|2718763|P1|NOT COMPLETED|Period 2||0
1122800|NCT01253174|2718758|P6|COMPLETED|Period 2||7
1122801|NCT01253174|2718759|P5|COMPLETED|Period 2||8
1122802|NCT01253174|2718760|P4|COMPLETED|Period 2||7
1122803|NCT01253174|2718761|P3|COMPLETED|Period 2||7
1122804|NCT01253174|2718762|P2|COMPLETED|Period 2||9
1122805|NCT01253174|2718763|P1|COMPLETED|Period 2||6
1122806|NCT01253174|2718758|P6|STARTED|Period 2||7
1122807|NCT01253174|2718759|P5|STARTED|Period 2||8
1122808|NCT01253174|2718760|P4|STARTED|Period 2||7
1122809|NCT01253174|2718761|P3|STARTED|Period 2||8
1122810|NCT01253174|2718762|P2|STARTED|Period 2||9
1122811|NCT01253174|2718763|P1|STARTED|Period 2||6
1122812|NCT01253174|2718758|P6|NOT COMPLETED|Period 1||0
1122813|NCT01253174|2718759|P5|NOT COMPLETED|Period 1||1
1122814|NCT01253174|2718760|P4|NOT COMPLETED|Period 1||0
1122815|NCT01253174|2718761|P3|NOT COMPLETED|Period 1||1
1122816|NCT01253174|2718762|P2|NOT COMPLETED|Period 1||1
1122817|NCT01253174|2718763|P1|NOT COMPLETED|Period 1||0
1122818|NCT01253174|2718758|P6|COMPLETED|Period 1||7
1122819|NCT01253174|2718759|P5|COMPLETED|Period 1||8
1122820|NCT01253174|2718760|P4|COMPLETED|Period 1||7
1122821|NCT01253174|2718761|P3|COMPLETED|Period 1||8
1122822|NCT01253174|2718762|P2|COMPLETED|Period 1||9
1122823|NCT01253174|2718763|P1|COMPLETED|Period 1||6
1122824|NCT01253174|2718758|P6|STARTED|Period 1||7
1122825|NCT01253174|2718759|P5|STARTED|Period 1||9
1122826|NCT01253174|2718760|P4|STARTED|Period 1||7
1122827|NCT01253174|2718761|P3|STARTED|Period 1||9
1122828|NCT01253174|2718762|P2|STARTED|Period 1||10
1122829|NCT01253174|2718763|P1|STARTED|Period 1||6
1122830|NCT01253187|2718792|P6|NOT COMPLETED|Period 3||0
1122831|NCT01253187|2718793|P5|NOT COMPLETED|Period 3||1
1122832|NCT01253187|2718794|P4|NOT COMPLETED|Period 3||0
1122833|NCT01253187|2718795|P3|NOT COMPLETED|Period 3||0
1122834|NCT01253187|2718796|P2|NOT COMPLETED|Period 3||1
1122835|NCT01253187|2718797|P1|NOT COMPLETED|Period 3||1
1122836|NCT01253187|2718792|P6|COMPLETED|Period 3||6
1122837|NCT01253187|2718793|P5|COMPLETED|Period 3||7
1122838|NCT01253187|2718794|P4|COMPLETED|Period 3||7
1122839|NCT01253187|2718795|P3|COMPLETED|Period 3||7
1122840|NCT01253187|2718796|P2|COMPLETED|Period 3||7
1122841|NCT01253187|2718797|P1|COMPLETED|Period 3||6
1122842|NCT01253187|2718792|P6|STARTED|Period 3||6
1122843|NCT01253187|2718793|P5|STARTED|Period 3||8
1122844|NCT01253187|2718794|P4|STARTED|Period 3||7
1122845|NCT01253187|2718795|P3|STARTED|Period 3||7
1122846|NCT01253187|2718796|P2|STARTED|Period 3||8
1122847|NCT01253187|2718797|P1|STARTED|Period 3||7
1122848|NCT01253187|2718792|P6|NOT COMPLETED|Period 2||0
1122849|NCT01253187|2718793|P5|NOT COMPLETED|Period 2||1
1122850|NCT01253187|2718794|P4|NOT COMPLETED|Period 2||0
1122851|NCT01253187|2718795|P3|NOT COMPLETED|Period 2||0
1122852|NCT01253187|2718796|P2|NOT COMPLETED|Period 2||0
1122853|NCT01253187|2718797|P1|NOT COMPLETED|Period 2||0
1122854|NCT01253187|2718792|P6|COMPLETED|Period 2||6
1122855|NCT01253187|2718793|P5|COMPLETED|Period 2||8
1122856|NCT01253187|2718794|P4|COMPLETED|Period 2||7
1122857|NCT01253187|2718795|P3|COMPLETED|Period 2||7
1122858|NCT01253187|2718796|P2|COMPLETED|Period 2||8
1122859|NCT01253187|2718797|P1|COMPLETED|Period 2||7
1122860|NCT01253187|2718792|P6|STARTED|Period 2||6
1122861|NCT01253187|2718793|P5|STARTED|Period 2||9
1122862|NCT01253187|2718794|P4|STARTED|Period 2||7
1122863|NCT01253187|2718795|P3|STARTED|Period 2||7
1122864|NCT01253187|2718796|P2|STARTED|Period 2||8
1122865|NCT01253187|2718797|P1|STARTED|Period 2||7
1122866|NCT01253187|2718792|P6|NOT COMPLETED|Period 1||0
1122867|NCT01253187|2718793|P5|NOT COMPLETED|Period 1||0
1122868|NCT01253187|2718794|P4|NOT COMPLETED|Period 1||0
1122869|NCT01253187|2718795|P3|NOT COMPLETED|Period 1||0
1122870|NCT01253187|2718796|P2|NOT COMPLETED|Period 1||0
1122871|NCT01253187|2718797|P1|NOT COMPLETED|Period 1||0
1122872|NCT01253187|2718792|P6|COMPLETED|Period 1||6
1122873|NCT01253187|2718793|P5|COMPLETED|Period 1||9
1122874|NCT01253187|2718794|P4|COMPLETED|Period 1||7
1122875|NCT01253187|2718795|P3|COMPLETED|Period 1||7
1122876|NCT01253187|2718796|P2|COMPLETED|Period 1||8
1122877|NCT01253187|2718797|P1|COMPLETED|Period 1||7
1122878|NCT01253187|2718792|P6|STARTED|Period 1||6
1122879|NCT01253187|2718793|P5|STARTED|Period 1||9
1122880|NCT01253187|2718794|P4|STARTED|Period 1||7
1122881|NCT01253187|2718795|P3|STARTED|Period 1||7
1122882|NCT01253187|2718796|P2|STARTED|Period 1||8
1122883|NCT01253187|2718797|P1|STARTED|Period 1||7
1122884|NCT01253265|2718831|P5|NOT COMPLETED|Overall Study||1
1122885|NCT01253265|2718832|P4|NOT COMPLETED|Overall Study||0
1122886|NCT01253265|2718833|P3|NOT COMPLETED|Overall Study||0
1122887|NCT01253265|2718834|P2|NOT COMPLETED|Overall Study||0
1122888|NCT01253265|2718835|P1|NOT COMPLETED|Overall Study||1
1122889|NCT01253265|2718831|P5|COMPLETED|Overall Study||7
1122890|NCT01253265|2718832|P4|COMPLETED|Overall Study||6
1122891|NCT01253265|2718833|P3|COMPLETED|Overall Study||6
1122892|NCT01253265|2718834|P2|COMPLETED|Overall Study||6
1122893|NCT01253265|2718835|P1|COMPLETED|Overall Study||5
1122894|NCT01253265|2718831|P5|STARTED|Overall Study||8
1122895|NCT01253265|2718832|P4|STARTED|Overall Study||6
1122896|NCT01253265|2718833|P3|STARTED|Overall Study||6
1122897|NCT01253265|2718834|P2|STARTED|Overall Study||6
1122898|NCT01253265|2718835|P1|STARTED|Overall Study||6
1122899|NCT01253304|2718883|P4|NOT COMPLETED|Overall Study||1
1122900|NCT01253304|2718884|P3|NOT COMPLETED|Overall Study||0
1122901|NCT01253304|2718885|P2|NOT COMPLETED|Overall Study||0
1122902|NCT01253304|2718886|P1|NOT COMPLETED|Overall Study||0
1122903|NCT01253304|2718883|P4|COMPLETED|Overall Study||2
1122904|NCT01253304|2718884|P3|COMPLETED|Overall Study||6
1122905|NCT01253304|2718885|P2|COMPLETED|Overall Study||6
1122906|NCT01253304|2718886|P1|COMPLETED|Overall Study||11
1122907|NCT01253304|2718883|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
1122908|NCT01253304|2718884|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
1122909|NCT01253304|2718885|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
1122910|NCT01253304|2718886|P1|Received at Least 1 Dose of Study Drug|Overall Study||11
1122911|NCT01253304|2718883|P4|STARTED|Overall Study||3
1122912|NCT01253304|2718884|P3|STARTED|Overall Study||6
1122913|NCT01253304|2718885|P2|STARTED|Overall Study||6
1122914|NCT01253304|2718886|P1|STARTED|Overall Study||11
1122915|NCT01253317|2718920|P1|NOT COMPLETED|Overall Study||2
1122916|NCT01253317|2718920|P1|COMPLETED|Overall Study||10
1122917|NCT01253317|2718920|P1|STARTED|Overall Study||12
1122918|NCT01253343|2718930|P2|NOT COMPLETED|Overall Study||0
1122919|NCT01253343|2718931|P1|NOT COMPLETED|Overall Study||0
1122920|NCT01253343|2718930|P2|COMPLETED|Overall Study||8
1122921|NCT01253343|2718931|P1|COMPLETED|Overall Study||9
1122922|NCT01253343|2718930|P2|STARTED|Overall Study||8
1122923|NCT01253343|2718931|P1|STARTED|Overall Study||9
1122924|NCT01253369|2718953|P1|NOT COMPLETED|Overall Study||33
1122925|NCT01253369|2718953|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
1122926|NCT01253369|2718953|P1|Evaluable|Overall Study|Evaluable pts were w/ measurable disease, min 1 cycle of trt rcvd and 1 on-trt disease assessment.|30
1122927|NCT01253369|2718953|P1|STARTED|Overall Study||33
1122928|NCT01253408|2718961|P3|NOT COMPLETED|Overall Study||0
1122929|NCT01253408|2718962|P2|NOT COMPLETED|Overall Study||1
1122930|NCT01253408|2718963|P1|NOT COMPLETED|Overall Study||0
1122931|NCT01253408|2718961|P3|COMPLETED|Overall Study||13
1122932|NCT01253408|2718962|P2|COMPLETED|Overall Study||12
1122933|NCT01253408|2718963|P1|COMPLETED|Overall Study||10
1122934|NCT01253408|2718961|P3|STARTED|Overall Study||13
1122935|NCT01253408|2718962|P2|STARTED|Overall Study||13
1122936|NCT01253408|2718963|P1|STARTED|Overall Study||10
1122937|NCT01253447|2718986|P1|NOT COMPLETED|Overall Study||2
1122938|NCT01253447|2718986|P1|COMPLETED|Overall Study||17
1122939|NCT01253447|2718986|P1|STARTED|Overall Study||19
1122940|NCT01253525|2718990|P1|NOT COMPLETED|Overall Study||0
1122941|NCT01253525|2718990|P1|COMPLETED|Overall Study||6
1122942|NCT01253525|2718990|P1|Received Any Quantity of Study Drug|Overall Study||6
1122943|NCT01253525|2718990|P1|STARTED|Overall Study||6
1122944|NCT01253564|2719017|P1|NOT COMPLETED|Overall Study||24
1122945|NCT01253564|2719017|P1|COMPLETED|Overall Study||0
1122946|NCT01253564|2719017|P1|STARTED|Overall Study||24
1122947|NCT01253577|2719034|P1|NOT COMPLETED|Overall Study||3
1122948|NCT01253577|2719034|P1|COMPLETED|Overall Study||102
1122949|NCT01253577|2719034|P1|STARTED|Overall Study||105
1122950|NCT01246791|2719042|P1|NOT COMPLETED|Overall Study||0
1122951|NCT01246791|2719042|P1|COMPLETED|Overall Study||12
1122952|NCT01246791|2719042|P1|STARTED|Overall Study||12
1122953|NCT01246960|2719059|P2|NOT COMPLETED|Overall Study||4
1122954|NCT01246960|2719060|P1|NOT COMPLETED|Overall Study||6
1122955|NCT01246960|2719059|P2|COMPLETED|Overall Study||80
1122956|NCT01246960|2719060|P1|COMPLETED|Overall Study||78
1122957|NCT01246960|2719059|P2|Received Any Quantity of Study Drug|Overall Study||80
1122958|NCT01246960|2719060|P1|Received Any Quantity of Study Drug|Overall Study||82
1122959|NCT01246960|2719059|P2|STARTED|Overall Study||84
1122960|NCT01246960|2719060|P1|STARTED|Overall Study||84
1122961|NCT01246973|2719080|P2|NOT COMPLETED|Overall Study||47
1122962|NCT01246973|2719081|P1|NOT COMPLETED|Overall Study||61
1122963|NCT01246973|2719080|P2|COMPLETED|Overall Study||295
1122964|NCT01246973|2719081|P1|COMPLETED|Overall Study||283
1122965|NCT01246973|2719080|P2|STARTED|Overall Study||342
1122966|NCT01246973|2719081|P1|STARTED|Overall Study||344
1122967|NCT01246999|2719093|P4|NOT COMPLETED|Overall Study||2
1122968|NCT01246999|2719094|P3|NOT COMPLETED|Overall Study||0
1122969|NCT01246999|2719095|P2|NOT COMPLETED|Overall Study||1
1122970|NCT01246999|2719096|P1|NOT COMPLETED|Overall Study||0
1122971|NCT01246999|2719093|P4|COMPLETED|Overall Study||15
1122972|NCT01246999|2719094|P3|COMPLETED|Overall Study||2
1122973|NCT01246999|2719095|P2|COMPLETED|Overall Study||3
1122974|NCT01246999|2719096|P1|COMPLETED|Overall Study||11
1122975|NCT01246999|2719093|P4|STARTED|Overall Study||17
1122976|NCT01246999|2719094|P3|STARTED|Overall Study||2
1122977|NCT01246999|2719095|P2|STARTED|Overall Study||4
1122978|NCT01246999|2719096|P1|STARTED|Overall Study||11
1122979|NCT01247064|2719131|P2|NOT COMPLETED|Overall Study||0
1122980|NCT01247064|2719132|P1|NOT COMPLETED|Overall Study||0
1122981|NCT01247064|2719131|P2|COMPLETED|Overall Study||31
1122982|NCT01247064|2719132|P1|COMPLETED|Overall Study||31
1122983|NCT01247064|2719131|P2|STARTED|Overall Study||31
1122984|NCT01247064|2719132|P1|STARTED|Overall Study||31
1122985|NCT01247090|2719149|P3|NOT COMPLETED|Overall Study||0
1122986|NCT01247090|2719150|P2|NOT COMPLETED|Overall Study||1
1122987|NCT01247090|2719151|P1|NOT COMPLETED|Overall Study||1
1122988|NCT01247090|2719149|P3|COMPLETED|Overall Study||4
1122989|NCT01247090|2719150|P2|COMPLETED|Overall Study||3
1122990|NCT01247090|2719151|P1|COMPLETED|Overall Study||3
1122991|NCT01247090|2719149|P3|STARTED|Overall Study||4
1122992|NCT01247090|2719150|P2|STARTED|Overall Study||4
1122993|NCT01247090|2719151|P1|STARTED|Overall Study||4
1122994|NCT01253811|2719159|P1|NOT COMPLETED|Overall Study||1
1122995|NCT01253811|2719159|P1|COMPLETED|Overall Study||5
1122996|NCT01253811|2719159|P1|Exposed|Overall Study||6
1122997|NCT01253811|2719159|P1|STARTED|Overall Study||6
1122998|NCT01253824|2719180|P2|NOT COMPLETED|Overall Study||0
1122999|NCT01253824|2719181|P1|NOT COMPLETED|Overall Study||0
1123000|NCT01253824|2719180|P2|COMPLETED|Overall Study||7
1123001|NCT01253824|2719181|P1|COMPLETED|Overall Study||7
1123002|NCT01253824|2719180|P2|STARTED|Overall Study||7
1123003|NCT01253824|2719181|P1|STARTED|Overall Study||7
1123004|NCT01253902|2719196|P3|NOT COMPLETED|Overall Study||4
1123005|NCT01253902|2719197|P2|NOT COMPLETED|Overall Study||2
1123006|NCT01253902|2719198|P1|NOT COMPLETED|Overall Study||5
1123007|NCT01253902|2719196|P3|COMPLETED|Overall Study||51
1123008|NCT01253902|2719197|P2|COMPLETED|Overall Study||51
1123009|NCT01253902|2719198|P1|COMPLETED|Overall Study||51
1123010|NCT01253902|2719196|P3|STARTED|Overall Study||55
1123011|NCT01253902|2719197|P2|STARTED|Overall Study||53
1123012|NCT01253902|2719198|P1|STARTED|Overall Study||56
1123013|NCT01254292|2719214|P2|NOT COMPLETED|LCS12 Extension Phase||0
1123014|NCT01254292|2719215|P1|NOT COMPLETED|LCS12 Extension Phase||37
1123015|NCT01254292|2719214|P2|COMPLETED|LCS12 Extension Phase||0
1123016|NCT01254292|2719215|P1|COMPLETED|LCS12 Extension Phase||163
1123017|NCT01254292|2719214|P2|STARTED|LCS12 Extension Phase|Optional Extension Phase was for LCS12 group only.|0
1123018|NCT01254292|2719215|P1|STARTED|LCS12 Extension Phase|A total of 200 participants elected to enter this optional Extension Phase.|200
1123019|NCT01254292|2719214|P2|NOT COMPLETED|Comparative Phase||81
1123020|NCT01254292|2719215|P1|NOT COMPLETED|Comparative Phase||55
1123021|NCT01254292|2719214|P2|COMPLETED|Comparative Phase||204
1123022|NCT01254292|2719215|P1|COMPLETED|Comparative Phase||227
1123023|NCT01254292|2719214|P2|Participants Received Treatment|Comparative Phase|safety population|281
1123024|NCT01254292|2719215|P1|Participants Received Treatment|Comparative Phase|safety population|279
1123025|NCT01254292|2719214|P2|STARTED|Comparative Phase||285
1123026|NCT01254292|2719215|P1|STARTED|Comparative Phase||282
1123027|NCT01254305|2719278|P3|NOT COMPLETED|Overall Study||17
1123028|NCT01254305|2719279|P2|NOT COMPLETED|Overall Study||18
1123029|NCT01254305|2719280|P1|NOT COMPLETED|Overall Study||22
1123030|NCT01254305|2719278|P3|COMPLETED|Overall Study||62
1123031|NCT01254305|2719279|P2|COMPLETED|Overall Study||72
1123032|NCT01254305|2719280|P1|COMPLETED|Overall Study||71
1123033|NCT01254305|2719278|P3|Safety Population|Overall Study||77
1123034|NCT01254305|2719279|P2|Safety Population|Overall Study||85
1123035|NCT01254305|2719280|P1|Safety Population|Overall Study||89
1123036|NCT01254305|2719278|P3|STARTED|Overall Study||79
1123037|NCT01254305|2719279|P2|STARTED|Overall Study||90
1123038|NCT01254305|2719280|P1|STARTED|Overall Study||93
1123039|NCT01254318|2719294|P1|NOT COMPLETED|Overall Study||52
1123040|NCT01254318|2719294|P1|COMPLETED|Overall Study|Alive at end of study|78
1123041|NCT01254318|2719294|P1|STARTED|Overall Study|Alive at start of study|130
1123042|NCT01254331|2719300|P1|NOT COMPLETED|Extension Phase||4
1123043|NCT01254331|2719300|P1|COMPLETED|Extension Phase||41
1123044|NCT01254331|2719300|P1|STARTED|Extension Phase|1 participant withdrew consent after completing initial phase and did not enter the extension phase|45
1123045|NCT01254331|2719300|P1|NOT COMPLETED|Initial Phase||5
1123046|NCT01254331|2719300|P1|COMPLETED|Initial Phase||46
1123047|NCT01254331|2719300|P1|STARTED|Initial Phase||51
1123048|NCT01254344|2719320|P2|NOT COMPLETED|Overall Study||19
1123049|NCT01254344|2719321|P1|NOT COMPLETED|Overall Study||13
1123050|NCT01254344|2719320|P2|COMPLETED|Overall Study||281
1123051|NCT01254344|2719321|P1|COMPLETED|Overall Study||286
1123052|NCT01254344|2719320|P2|Treated|Overall Study||297
1123053|NCT01254344|2719321|P1|Treated|Overall Study||290
1123054|NCT01254344|2719320|P2|STARTED|Overall Study||300
1123055|NCT01254344|2719321|P1|STARTED|Overall Study||299
1123056|NCT01254396|2719329|P2|NOT COMPLETED|Second Intervention Period||0
1123057|NCT01254396|2719330|P1|NOT COMPLETED|Second Intervention Period||0
1123058|NCT01254396|2719329|P2|COMPLETED|Second Intervention Period||6
1123059|NCT01254396|2719330|P1|COMPLETED|Second Intervention Period||6
1123060|NCT01254396|2719329|P2|STARTED|Second Intervention Period||6
1123061|NCT01254396|2719330|P1|STARTED|Second Intervention Period||6
1123062|NCT01254396|2719329|P2|NOT COMPLETED|Washout Period (at Least 1 Day)||0
1123063|NCT01254396|2719330|P1|NOT COMPLETED|Washout Period (at Least 1 Day)||0
1123064|NCT01254396|2719329|P2|COMPLETED|Washout Period (at Least 1 Day)||6
1123065|NCT01254396|2719330|P1|COMPLETED|Washout Period (at Least 1 Day)||6
1123066|NCT01254396|2719329|P2|STARTED|Washout Period (at Least 1 Day)||6
1123067|NCT01254396|2719330|P1|STARTED|Washout Period (at Least 1 Day)||6
1123068|NCT01254396|2719329|P2|NOT COMPLETED|First Intervention Period||0
1123069|NCT01254396|2719330|P1|NOT COMPLETED|First Intervention Period||0
1123070|NCT01254396|2719329|P2|COMPLETED|First Intervention Period||6
1123071|NCT01254396|2719330|P1|COMPLETED|First Intervention Period||6
1123072|NCT01254396|2719329|P2|STARTED|First Intervention Period||6
1123073|NCT01254396|2719330|P1|STARTED|First Intervention Period||6
1123074|NCT01254409|2719348|P4|NOT COMPLETED|Overall Study||0
1123075|NCT01254409|2719349|P3|NOT COMPLETED|Overall Study||0
1123076|NCT01254409|2719350|P2|NOT COMPLETED|Overall Study||1
1123077|NCT01254409|2719351|P1|NOT COMPLETED|Overall Study||0
1123078|NCT01254409|2719348|P4|COMPLETED|Overall Study||4
1123079|NCT01254409|2719349|P3|COMPLETED|Overall Study||5
1123080|NCT01254409|2719350|P2|COMPLETED|Overall Study||5
1123081|NCT01254409|2719351|P1|COMPLETED|Overall Study||6
1123082|NCT01254409|2719348|P4|STARTED|Overall Study||4
1123083|NCT01254409|2719349|P3|STARTED|Overall Study||5
1123084|NCT01254409|2719350|P2|STARTED|Overall Study||6
1123085|NCT01254409|2719351|P1|STARTED|Overall Study||6
1123086|NCT01254565|2719409|P6|NOT COMPLETED|Overall Study||4
1123087|NCT01254565|2719410|P5|NOT COMPLETED|Overall Study||4
1123088|NCT01254565|2719411|P4|NOT COMPLETED|Overall Study||1
1123089|NCT01254565|2719412|P3|NOT COMPLETED|Overall Study||0
1123090|NCT01254565|2719413|P2|NOT COMPLETED|Overall Study||1
1123091|NCT01254565|2719414|P1|NOT COMPLETED|Overall Study||1
1123092|NCT01254565|2719409|P6|COMPLETED|Overall Study||13
1123093|NCT01254565|2719410|P5|COMPLETED|Overall Study||12
1123094|NCT01254565|2719411|P4|COMPLETED|Overall Study||20
1123095|NCT01254565|2719412|P3|COMPLETED|Overall Study||21
1123096|NCT01254565|2719413|P2|COMPLETED|Overall Study||6
1123097|NCT01254565|2719414|P1|COMPLETED|Overall Study||4
1123098|NCT01254565|2719409|P6|Received Treatment|Overall Study||13
1123099|NCT01254565|2719410|P5|Received Treatment|Overall Study||13
1123100|NCT01254565|2719411|P4|Received Treatment|Overall Study||21
1123101|NCT01254565|2719412|P3|Received Treatment|Overall Study||21
1123102|NCT01254565|2719413|P2|Received Treatment|Overall Study||6
1123103|NCT01254565|2719414|P1|Received Treatment|Overall Study||4
1123104|NCT01254565|2719409|P6|STARTED|Overall Study||17
1123105|NCT01254565|2719410|P5|STARTED|Overall Study||16
1123106|NCT01254565|2719411|P4|STARTED|Overall Study||21
1123107|NCT01254565|2719412|P3|STARTED|Overall Study||21
1123108|NCT01254565|2719413|P2|STARTED|Overall Study||7
1123109|NCT01254565|2719414|P1|STARTED|Overall Study||5
1123110|NCT01254604|2719466|P2|NOT COMPLETED|Overall Study||9
1123111|NCT01254604|2719467|P1|NOT COMPLETED|Overall Study||8
1123112|NCT01254604|2719466|P2|COMPLETED|Overall Study||86
1123113|NCT01254604|2719467|P1|COMPLETED|Overall Study||87
1123114|NCT01254604|2719466|P2|Treated|Overall Study|"The 1 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|94
1123115|NCT01254604|2719467|P1|Treated|Overall Study|"The 2 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|93
1123116|NCT01254604|2719466|P2|STARTED|Overall Study||95
1123117|NCT01254604|2719467|P1|STARTED|Overall Study||95
1123118|NCT01254643|2719479|P1|NOT COMPLETED|Overall Study||1
1123119|NCT01254643|2719479|P1|COMPLETED|Overall Study||99
1123120|NCT01254643|2719479|P1|Vaccination 3|Overall Study||99
1123121|NCT01254643|2719479|P1|Vaccination 2|Overall Study||99
1123122|NCT01254643|2719479|P1|Vaccination 1|Overall Study||100
1123123|NCT01254643|2719479|P1|STARTED|Overall Study||100
1123124|NCT01254656|2719490|P3|NOT COMPLETED|Overall Study||18
1123125|NCT01254656|2719491|P2|NOT COMPLETED|Overall Study||43
1123126|NCT01254656|2719492|P1|NOT COMPLETED|Overall Study||47
1123127|NCT01254656|2719490|P3|COMPLETED|Overall Study||0
1123128|NCT01254656|2719491|P2|COMPLETED|Overall Study||0
1123129|NCT01254656|2719492|P1|COMPLETED|Overall Study||0
1123130|NCT01254656|2719490|P3|Treated|Overall Study||18
1123131|NCT01254656|2719491|P2|Treated|Overall Study||43
1123132|NCT01254656|2719492|P1|Treated|Overall Study||47
1123133|NCT01254656|2719490|P3|STARTED|Overall Study||18
1123134|NCT01254656|2719491|P2|STARTED|Overall Study||43
1123135|NCT01254656|2719492|P1|STARTED|Overall Study||47
1123136|NCT01254669|2719520|P2|NOT COMPLETED|Overall Study||4
1123137|NCT01254669|2719521|P1|NOT COMPLETED|Overall Study||3
1123138|NCT01254669|2719520|P2|COMPLETED|Overall Study||96
1123139|NCT01254669|2719521|P1|COMPLETED|Overall Study||97
1123140|NCT01254669|2719520|P2|STARTED|Overall Study||100
1123141|NCT01254669|2719521|P1|STARTED|Overall Study||100
1123142|NCT01254721|2719531|P2|NOT COMPLETED|Overall Study||22
1123143|NCT01254721|2719532|P1|NOT COMPLETED|Overall Study||15
1123144|NCT01254721|2719531|P2|COMPLETED|Overall Study||42
1123145|NCT01254721|2719532|P1|COMPLETED|Overall Study||52
1123146|NCT01254721|2719531|P2|STARTED|Overall Study|Seroquel XR: 300mg Lithium: 900mg|64
1123147|NCT01254721|2719532|P1|STARTED|Overall Study|Seroquel XR: 300mg|67
1123148|NCT01254747|2719544|P4|NOT COMPLETED|Overall Study||2
1123149|NCT01254747|2719545|P3|NOT COMPLETED|Overall Study||4
1123150|NCT01254747|2719546|P2|NOT COMPLETED|Overall Study||6
1123151|NCT01254747|2719547|P1|NOT COMPLETED|Overall Study||0
1123152|NCT01254747|2719544|P4|COMPLETED|Overall Study||28
1123153|NCT01254747|2719545|P3|COMPLETED|Overall Study||26
1123154|NCT01254747|2719546|P2|COMPLETED|Overall Study||23
1123155|NCT01254747|2719547|P1|COMPLETED|Overall Study||40
1123156|NCT01254747|2719544|P4|STARTED|Overall Study||30
1123157|NCT01254747|2719545|P3|STARTED|Overall Study||30
1123158|NCT01254747|2719546|P2|STARTED|Overall Study||29
1123159|NCT01254747|2719547|P1|STARTED|Overall Study||40
1123160|NCT01254760|2719585|P2|NOT COMPLETED|Second Period, 5 Days of Wear||0
1123161|NCT01254760|2719586|P1|NOT COMPLETED|Second Period, 5 Days of Wear||0
1123162|NCT01254760|2719585|P2|COMPLETED|Second Period, 5 Days of Wear||38
1123163|NCT01254760|2719586|P1|COMPLETED|Second Period, 5 Days of Wear||34
1123164|NCT01254760|2719585|P2|STARTED|Second Period, 5 Days of Wear||38
1123165|NCT01254760|2719586|P1|STARTED|Second Period, 5 Days of Wear||34
1123166|NCT01254760|2719585|P2|NOT COMPLETED|First Period, 5 Days of Wear||0
1123167|NCT01254760|2719586|P1|NOT COMPLETED|First Period, 5 Days of Wear||0
1123168|NCT01254760|2719585|P2|COMPLETED|First Period, 5 Days of Wear||38
1123169|NCT01254760|2719586|P1|COMPLETED|First Period, 5 Days of Wear||34
1123170|NCT01254760|2719585|P2|STARTED|First Period, 5 Days of Wear||38
1123171|NCT01254760|2719586|P1|STARTED|First Period, 5 Days of Wear||34
1123172|NCT01254851|2719602|P2|NOT COMPLETED|Overall Study||9
1123173|NCT01254851|2719603|P1|NOT COMPLETED|Overall Study||8
1123174|NCT01254851|2719602|P2|COMPLETED|Overall Study||68
1123175|NCT01254851|2719603|P1|COMPLETED|Overall Study||61
1123176|NCT01254851|2719602|P2|STARTED|Overall Study||77
1123177|NCT01254851|2719603|P1|STARTED|Overall Study||69
1123178|NCT01254890|2719611|P2|NOT COMPLETED|Overall Study||10
1123179|NCT01254890|2719612|P1|NOT COMPLETED|Overall Study||1
1123180|NCT01254890|2719611|P2|COMPLETED|Overall Study||47
1123181|NCT01254890|2719612|P1|COMPLETED|Overall Study||2
1123182|NCT01254890|2719611|P2|STARTED|Overall Study||57
1123183|NCT01254890|2719612|P1|STARTED|Overall Study||3
1123184|NCT01255137|2719618|P1|NOT COMPLETED|Overall Study||0
1123185|NCT01255137|2719618|P1|COMPLETED|Overall Study||13
1123186|NCT01255137|2719618|P1|STARTED|Overall Study||13
1123187|NCT01255306|2719625|P2|NOT COMPLETED|Overall Study||1
1123188|NCT01255306|2719626|P1|NOT COMPLETED|Overall Study||1
1123189|NCT01255306|2719625|P2|COMPLETED|Overall Study||32
1123190|NCT01255306|2719626|P1|COMPLETED|Overall Study||25
1123191|NCT01255306|2719625|P2|STARTED|Overall Study||33
1123192|NCT01255306|2719626|P1|STARTED|Overall Study||26
1123193|NCT01255423|2719637|P2|NOT COMPLETED|Overall Study||3
1123194|NCT01255423|2719638|P1|NOT COMPLETED|Overall Study||3
1123195|NCT01255423|2719637|P2|COMPLETED|Overall Study||99
1123196|NCT01255423|2719638|P1|COMPLETED|Overall Study||101
1123197|NCT01255423|2719637|P2|STARTED|Overall Study||102
1123198|NCT01255423|2719638|P1|STARTED|Overall Study||104
1123199|NCT01255436|2719654|P2|NOT COMPLETED|Overall Study||194
1123200|NCT01255436|2719655|P1|NOT COMPLETED|Overall Study||182
1123201|NCT01255436|2719654|P2|COMPLETED|Overall Study||135
1123202|NCT01255436|2719655|P1|COMPLETED|Overall Study||151
1123203|NCT01255436|2719654|P2|STARTED|Overall Study|350 patients enrolled but 21 excluded because of missing baseline data|329
1123204|NCT01255436|2719655|P1|STARTED|Overall Study|350 patients enrolled but 17 excluded because of missing baseline data.|333
1123205|NCT01255449|2719667|P1|NOT COMPLETED|Overall Study||0
1123206|NCT01255449|2719667|P1|COMPLETED|Overall Study||26
1123207|NCT01255449|2719667|P1|STARTED|Overall Study||26
1123208|NCT01255592|2719674|P2|NOT COMPLETED|Overall Study||1
1123209|NCT01255592|2719675|P1|NOT COMPLETED|Overall Study||6
1123210|NCT01255592|2719674|P2|COMPLETED|Overall Study||25
1123211|NCT01255592|2719675|P1|COMPLETED|Overall Study||20
1123212|NCT01255592|2719674|P2|STARTED|Overall Study||26
1123213|NCT01255592|2719675|P1|STARTED|Overall Study||26
1123214|NCT01255631|2719733|P2|NOT COMPLETED|Overall Study||6
1123215|NCT01255631|2719734|P1|NOT COMPLETED|Overall Study||9
1123216|NCT01255631|2719733|P2|COMPLETED|Overall Study|study terminated due to poor enrollment|3
1123217|NCT01255631|2719734|P1|COMPLETED|Overall Study|study terminated due to poor enrollment|4
1123218|NCT01255631|2719733|P2|STARTED|Overall Study||9
1123219|NCT01255631|2719734|P1|STARTED|Overall Study||13
1123220|NCT01255722|2719753|P3|NOT COMPLETED|Overall Study||1
1123221|NCT01255722|2719754|P2|NOT COMPLETED|Overall Study||1
1123222|NCT01255722|2719755|P1|NOT COMPLETED|Overall Study||3
1123223|NCT01255722|2719753|P3|COMPLETED|Overall Study||152
1123224|NCT01255722|2719754|P2|COMPLETED|Overall Study||159
1123225|NCT01255722|2719755|P1|COMPLETED|Overall Study||152
1123226|NCT01255722|2719753|P3|STARTED|Overall Study||153
1123227|NCT01255722|2719754|P2|STARTED|Overall Study||160
1123228|NCT01255722|2719755|P1|STARTED|Overall Study||155
1123229|NCT01255761|2719780|P2|NOT COMPLETED|Overall Study||175
1123230|NCT01255761|2719781|P1|NOT COMPLETED|Overall Study||182
1123231|NCT01255761|2719780|P2|COMPLETED|Overall Study||192
1123232|NCT01255761|2719781|P1|COMPLETED|Overall Study||187
1123233|NCT01255761|2719780|P2|STARTED|Overall Study||367
1123234|NCT01255761|2719781|P1|STARTED|Overall Study||369
1123235|NCT01255787|2719867|P4|NOT COMPLETED|Overall Study||22
1123236|NCT01255787|2719868|P3|NOT COMPLETED|Overall Study||18
1123237|NCT01255787|2719869|P2|NOT COMPLETED|Overall Study||17
1123238|NCT01255787|2719870|P1|NOT COMPLETED|Overall Study||16
1123239|NCT01255787|2719867|P4|COMPLETED|Overall Study||132
1123240|NCT01255787|2719868|P3|COMPLETED|Overall Study||132
1123241|NCT01255787|2719869|P2|COMPLETED|Overall Study||127
1123242|NCT01255787|2719870|P1|COMPLETED|Overall Study||136
1123243|NCT01255787|2719867|P4|Treated|Overall Study||150
1123244|NCT01255787|2719868|P3|Treated|Overall Study||148
1123245|NCT01255787|2719869|P2|Treated|Overall Study||144
1123246|NCT01255787|2719870|P1|Treated|Overall Study||152
1123247|NCT01255787|2719867|P4|STARTED|Overall Study||154
1123248|NCT01255787|2719868|P3|STARTED|Overall Study||150
1123249|NCT01255787|2719869|P2|STARTED|Overall Study||144
1123250|NCT01255787|2719870|P1|STARTED|Overall Study||152
1123251|NCT01255904|2719898|P2|NOT COMPLETED|Overall Study||4
1123252|NCT01255904|2719899|P1|NOT COMPLETED|Overall Study||1
1123253|NCT01255904|2719898|P2|COMPLETED|Overall Study||41
1123254|NCT01255904|2719899|P1|COMPLETED|Overall Study||44
1123255|NCT01255904|2719898|P2|STARTED|Overall Study||45
1123256|NCT01255904|2719899|P1|STARTED|Overall Study||45
1123257|NCT01256008|2719908|P3|NOT COMPLETED|Overall Study||21
1123258|NCT01256008|2719909|P2|NOT COMPLETED|Overall Study||7
1123259|NCT01256008|2719910|P1|NOT COMPLETED|Overall Study||8
1123260|NCT01256008|2719908|P3|COMPLETED|Overall Study||175
1123261|NCT01256008|2719909|P2|COMPLETED|Overall Study||91
1123262|NCT01256008|2719910|P1|COMPLETED|Overall Study||90
1123263|NCT01256008|2719908|P3|STARTED|Overall Study||196
1123264|NCT01256008|2719909|P2|STARTED|Overall Study||98
1123265|NCT01256008|2719910|P1|STARTED|Overall Study||98
1123266|NCT01256034|2719932|P2|NOT COMPLETED|Overall Study||25
1123267|NCT01256034|2719933|P1|NOT COMPLETED|Overall Study||25
1123268|NCT01256034|2719932|P2|COMPLETED|Overall Study||0
1123269|NCT01256034|2719933|P1|COMPLETED|Overall Study||0
1123270|NCT01256034|2719932|P2|STARTED|Overall Study||25
1123271|NCT01256034|2719933|P1|STARTED|Overall Study||25
1123272|NCT01256060|2719939|P4|NOT COMPLETED|Overall Study||0
1123273|NCT01256060|2719940|P3|NOT COMPLETED|Overall Study||0
1123274|NCT01256060|2719941|P2|NOT COMPLETED|Overall Study||1
1123275|NCT01256060|2719942|P1|NOT COMPLETED|Overall Study||0
1123276|NCT01256060|2719939|P4|COMPLETED|Overall Study||6
1123277|NCT01256060|2719940|P3|COMPLETED|Overall Study||3
1123278|NCT01256060|2719941|P2|COMPLETED|Overall Study||2
1123279|NCT01256060|2719942|P1|COMPLETED|Overall Study||3
1123280|NCT01256060|2719939|P4|STARTED|Overall Study||6
1123281|NCT01256060|2719940|P3|STARTED|Overall Study||3
1123282|NCT01256060|2719941|P2|STARTED|Overall Study||3
1123283|NCT01256060|2719942|P1|STARTED|Overall Study||3
1123284|NCT01256086|2719953|P4|NOT COMPLETED|Treatment Day 4||0
1123285|NCT01256086|2719954|P3|NOT COMPLETED|Treatment Day 4||0
1123286|NCT01256086|2719955|P2|NOT COMPLETED|Treatment Day 4||0
1123287|NCT01256086|2719956|P1|NOT COMPLETED|Treatment Day 4||0
1123288|NCT01256086|2719953|P4|COMPLETED|Treatment Day 4||11
1123289|NCT01256086|2719954|P3|COMPLETED|Treatment Day 4||9
1123290|NCT01256086|2719955|P2|COMPLETED|Treatment Day 4||10
1123291|NCT01256086|2719956|P1|COMPLETED|Treatment Day 4||11
1123292|NCT01256086|2719953|P4|STARTED|Treatment Day 4||11
1123293|NCT01256086|2719954|P3|STARTED|Treatment Day 4||9
1123294|NCT01256086|2719955|P2|STARTED|Treatment Day 4||10
1123295|NCT01256086|2719956|P1|STARTED|Treatment Day 4||11
1123296|NCT01256086|2719953|P4|NOT COMPLETED|Treatment Day 3||0
1123297|NCT01256086|2719954|P3|NOT COMPLETED|Treatment Day 3||0
1123298|NCT01256086|2719955|P2|NOT COMPLETED|Treatment Day 3||0
1123299|NCT01256086|2719956|P1|NOT COMPLETED|Treatment Day 3||0
1123300|NCT01256086|2719953|P4|COMPLETED|Treatment Day 3||11
1123301|NCT01256086|2719954|P3|COMPLETED|Treatment Day 3||9
1123302|NCT01256086|2719955|P2|COMPLETED|Treatment Day 3||10
1123303|NCT01256086|2719956|P1|COMPLETED|Treatment Day 3||11
1123304|NCT01256086|2719953|P4|STARTED|Treatment Day 3||11
1123305|NCT01256086|2719954|P3|STARTED|Treatment Day 3||9
1123306|NCT01256086|2719955|P2|STARTED|Treatment Day 3||10
1123307|NCT01256086|2719956|P1|STARTED|Treatment Day 3||11
1123308|NCT01256086|2719953|P4|NOT COMPLETED|Treatment Day 2||0
1123309|NCT01256086|2719954|P3|NOT COMPLETED|Treatment Day 2||0
1123310|NCT01256086|2719955|P2|NOT COMPLETED|Treatment Day 2||0
1123311|NCT01256086|2719956|P1|NOT COMPLETED|Treatment Day 2||0
1123312|NCT01256086|2719953|P4|COMPLETED|Treatment Day 2||11
1123313|NCT01256086|2719954|P3|COMPLETED|Treatment Day 2||9
1123314|NCT01256086|2719955|P2|COMPLETED|Treatment Day 2||10
1123315|NCT01256086|2719956|P1|COMPLETED|Treatment Day 2||11
1123316|NCT01256086|2719953|P4|STARTED|Treatment Day 2||11
1123317|NCT01256086|2719954|P3|STARTED|Treatment Day 2||9
1123318|NCT01256086|2719955|P2|STARTED|Treatment Day 2||10
1123319|NCT01256086|2719956|P1|STARTED|Treatment Day 2||11
1123320|NCT01256086|2719953|P4|NOT COMPLETED|Treatment Day 1||0
1123321|NCT01256086|2719954|P3|NOT COMPLETED|Treatment Day 1||0
1123322|NCT01256086|2719955|P2|NOT COMPLETED|Treatment Day 1||0
1123323|NCT01256086|2719956|P1|NOT COMPLETED|Treatment Day 1||0
1123324|NCT01256086|2719953|P4|COMPLETED|Treatment Day 1||11
1123325|NCT01256086|2719954|P3|COMPLETED|Treatment Day 1||11
1123326|NCT01256086|2719955|P2|COMPLETED|Treatment Day 1||11
1123327|NCT01256086|2719956|P1|COMPLETED|Treatment Day 1||11
1123328|NCT01256086|2719953|P4|STARTED|Treatment Day 1||11
1123329|NCT01256086|2719954|P3|STARTED|Treatment Day 1||11
1123330|NCT01256086|2719955|P2|STARTED|Treatment Day 1||11
1123331|NCT01256086|2719956|P1|STARTED|Treatment Day 1||11
1123332|NCT01256164|2719968|P2|NOT COMPLETED|Overall Study||0
1123333|NCT01256164|2719969|P1|NOT COMPLETED|Overall Study||0
1123334|NCT01256164|2719968|P2|COMPLETED|Overall Study||23
1123335|NCT01256164|2719969|P1|COMPLETED|Overall Study||47
1123336|NCT01256164|2719968|P2|STARTED|Overall Study||23
1123337|NCT01256164|2719969|P1|STARTED|Overall Study||47
1123338|NCT01256177|2719985|P2|NOT COMPLETED|Overall Study||37
1123339|NCT01256177|2719986|P1|NOT COMPLETED|Overall Study||50
1123340|NCT01256177|2719985|P2|COMPLETED|Overall Study||111
1123341|NCT01256177|2719986|P1|COMPLETED|Overall Study||98
1123342|NCT01256177|2719985|P2|STARTED|Overall Study||148
1123343|NCT01256177|2719986|P1|STARTED|Overall Study||148
1123344|NCT01256190|2720010|P2|NOT COMPLETED|Overall Study||0
1123345|NCT01256190|2720011|P1|NOT COMPLETED|Overall Study||2
1123346|NCT01256190|2720010|P2|COMPLETED|Overall Study||17
1123347|NCT01256190|2720011|P1|COMPLETED|Overall Study||37
1123348|NCT01256190|2720010|P2|STARTED|Overall Study||17
1123349|NCT01256190|2720011|P1|STARTED|Overall Study||39
1123350|NCT01256281|2720025|P1|NOT COMPLETED|Overall Study||0
1123351|NCT01256281|2720025|P1|COMPLETED|Overall Study||2
1123352|NCT01256281|2720025|P1|STARTED|Overall Study||2
1123353|NCT01256294|2720029|P2|NOT COMPLETED|Overall Study||2
1123354|NCT01256294|2720030|P1|NOT COMPLETED|Overall Study||4
1123355|NCT01256294|2720029|P2|COMPLETED|Overall Study||33
1123356|NCT01256294|2720030|P1|COMPLETED|Overall Study||32
1123357|NCT01256294|2720029|P2|STARTED|Overall Study||35
1123358|NCT01256294|2720030|P1|STARTED|Overall Study||36
1123359|NCT01256385|2720048|P2|NOT COMPLETED|Overall Study||3
1123360|NCT01256385|2720049|P1|NOT COMPLETED|Overall Study||3
1123361|NCT01256385|2720048|P2|COMPLETED|Overall Study||40
1123362|NCT01256385|2720049|P1|COMPLETED|Overall Study||40
1123363|NCT01256385|2720048|P2|Crossover From Arm B to Arm A|Overall Study||15
1123364|NCT01256385|2720049|P1|Crossover From Arm B to Arm A|Overall Study||0
1123365|NCT01256385|2720048|P2|STARTED|Overall Study||43
1123366|NCT01256385|2720049|P1|STARTED|Overall Study||43
1123367|NCT01256411|2720073|P6|NOT COMPLETED|Extension by Mono or Combination Therapy||4
1123368|NCT01256411|2720074|P5|NOT COMPLETED|Extension by Mono or Combination Therapy||17
1123369|NCT01256411|2720075|P4|NOT COMPLETED|Extension by Mono or Combination Therapy||0
1123370|NCT01256411|2720076|P3|NOT COMPLETED|Extension by Mono or Combination Therapy||0
1123371|NCT01256411|2720077|P2|NOT COMPLETED|Extension by Mono or Combination Therapy||0
1123372|NCT01256411|2720078|P1|NOT COMPLETED|Extension by Mono or Combination Therapy||0
1123373|NCT01256411|2720073|P6|COMPLETED|Extension by Mono or Combination Therapy||109
1123374|NCT01256411|2720074|P5|COMPLETED|Extension by Mono or Combination Therapy||211
1123375|NCT01256411|2720075|P4|COMPLETED|Extension by Mono or Combination Therapy||0
1123376|NCT01256411|2720076|P3|COMPLETED|Extension by Mono or Combination Therapy||0
1123377|NCT01256411|2720077|P2|COMPLETED|Extension by Mono or Combination Therapy||0
1123378|NCT01256411|2720078|P1|COMPLETED|Extension by Mono or Combination Therapy||0
1123379|NCT01256411|2720073|P6|STARTED|Extension by Mono or Combination Therapy||113
1123380|NCT01256411|2720074|P5|STARTED|Extension by Mono or Combination Therapy||228
1123381|NCT01256411|2720075|P4|STARTED|Extension by Mono or Combination Therapy||0
1123382|NCT01256411|2720076|P3|STARTED|Extension by Mono or Combination Therapy||0
1123383|NCT01256411|2720077|P2|STARTED|Extension by Mono or Combination Therapy||0
1123384|NCT01256411|2720078|P1|STARTED|Extension by Mono or Combination Therapy||0
1123385|NCT01256411|2720073|P6|NOT COMPLETED|Extension by Maximum Treatment||0
1123386|NCT01256411|2720074|P5|NOT COMPLETED|Extension by Maximum Treatment||0
1123387|NCT01256411|2720075|P4|NOT COMPLETED|Extension by Maximum Treatment||0
1123388|NCT01256411|2720076|P3|NOT COMPLETED|Extension by Maximum Treatment||4
1123389|NCT01256411|2720077|P2|NOT COMPLETED|Extension by Maximum Treatment||10
1123390|NCT01256411|2720078|P1|NOT COMPLETED|Extension by Maximum Treatment||7
1123391|NCT01256411|2720073|P6|COMPLETED|Extension by Maximum Treatment||0
1123392|NCT01256411|2720074|P5|COMPLETED|Extension by Maximum Treatment||0
1123393|NCT01256411|2720075|P4|COMPLETED|Extension by Maximum Treatment||4
1123394|NCT01256411|2720076|P3|COMPLETED|Extension by Maximum Treatment||105
1123395|NCT01256411|2720077|P2|COMPLETED|Extension by Maximum Treatment||79
1123396|NCT01256411|2720078|P1|COMPLETED|Extension by Maximum Treatment||132
1123397|NCT01256411|2720073|P6|Down Titrated to 100 mg|Extension by Maximum Treatment||0
1123398|NCT01256411|2720074|P5|Down Titrated to 100 mg|Extension by Maximum Treatment||0
1123399|NCT01256411|2720075|P4|Down Titrated to 100 mg|Extension by Maximum Treatment||0
1123400|NCT01256411|2720076|P3|Down Titrated to 100 mg|Extension by Maximum Treatment||0
1123401|NCT01256411|2720077|P2|Down Titrated to 100 mg|Extension by Maximum Treatment||0
1123402|NCT01256411|2720078|P1|Down Titrated to 100 mg|Extension by Maximum Treatment||12
1123403|NCT01256411|2720073|P6|STARTED|Extension by Maximum Treatment||0
1123404|NCT01256411|2720074|P5|STARTED|Extension by Maximum Treatment||0
1123405|NCT01256411|2720075|P4|STARTED|Extension by Maximum Treatment||4
1123406|NCT01256411|2720076|P3|STARTED|Extension by Maximum Treatment||109
1123407|NCT01256411|2720077|P2|STARTED|Extension by Maximum Treatment||89
1123408|NCT01256411|2720078|P1|STARTED|Extension by Maximum Treatment||139
1123409|NCT01256424|2720106|P4|NOT COMPLETED|Overall Study||7
1123410|NCT01256424|2720107|P3|NOT COMPLETED|Overall Study||7
1123411|NCT01256424|2720108|P2|NOT COMPLETED|Overall Study||8
1123412|NCT01256424|2720109|P1|NOT COMPLETED|Overall Study||9
1123413|NCT01256424|2720106|P4|COMPLETED|Overall Study||61
1123414|NCT01256424|2720107|P3|COMPLETED|Overall Study||55
1123415|NCT01256424|2720108|P2|COMPLETED|Overall Study||59
1123416|NCT01256424|2720109|P1|COMPLETED|Overall Study||56
1123417|NCT01256424|2720106|P4|STARTED|Overall Study||68
1123418|NCT01256424|2720107|P3|STARTED|Overall Study||62
1123419|NCT01256424|2720108|P2|STARTED|Overall Study||67
1123420|NCT01256424|2720109|P1|STARTED|Overall Study||65
1123421|NCT01256450|2720133|P3|NOT COMPLETED|Double-blind Treatment||37
1123422|NCT01256450|2720134|P2|NOT COMPLETED|Double-blind Treatment||28
1123423|NCT01256450|2720135|P1|NOT COMPLETED|Double-blind Treatment||0
1123424|NCT01256450|2720133|P3|COMPLETED|Double-blind Treatment||81
1123425|NCT01256450|2720134|P2|COMPLETED|Double-blind Treatment||89
1123426|NCT01256450|2720135|P1|COMPLETED|Double-blind Treatment||0
1123427|NCT01256450|2720133|P3|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|118
1123428|NCT01256450|2720134|P2|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|117
1123429|NCT01256450|2720135|P1|STARTED|Double-blind Treatment|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
1123430|NCT01256450|2720133|P3|NOT COMPLETED|Open-label Titration||0
1123431|NCT01256450|2720134|P2|NOT COMPLETED|Open-label Titration||0
1123432|NCT01256450|2720135|P1|NOT COMPLETED|Open-label Titration||99
1123433|NCT01256450|2720133|P3|COMPLETED|Open-label Titration||0
1123434|NCT01256450|2720134|P2|COMPLETED|Open-label Titration||0
1123435|NCT01256450|2720135|P1|COMPLETED|Open-label Titration||235
1123436|NCT01256450|2720133|P3|STARTED|Open-label Titration||0
1123437|NCT01256450|2720134|P2|STARTED|Open-label Titration||0
1123438|NCT01256450|2720135|P1|STARTED|Open-label Titration||334
1123439|NCT01256476|2720162|P2|NOT COMPLETED|Overall Study||7
1123440|NCT01256476|2720163|P1|NOT COMPLETED|Overall Study||6
1123441|NCT01256476|2720162|P2|COMPLETED|Overall Study||157
1123442|NCT01256476|2720163|P1|COMPLETED|Overall Study||158
1123443|NCT01256476|2720162|P2|STARTED|Overall Study||164
1123444|NCT01256476|2720163|P1|STARTED|Overall Study||164
1123445|NCT01256502|2720169|P1|NOT COMPLETED|Overall Study||10
1123446|NCT01256502|2720169|P1|COMPLETED|Overall Study||129
1123447|NCT01256502|2720169|P1|STARTED|Overall Study|Implanted with SERI during Stage I breast reconstruction surgery|139
1123448|NCT01256567|2720179|P1|NOT COMPLETED|Overall Study||1
1123449|NCT01256567|2720179|P1|COMPLETED|Overall Study||6
1123450|NCT01256567|2720179|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
1123451|NCT01256567|2720179|P1|STARTED|Overall Study||7
1123452|NCT01256658|2720191|P2|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||6372
1123453|NCT01256658|2720192|P1|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||5854
1123454|NCT01256658|2720191|P2|COMPLETED|Period 2 - Follow up Only - No Treatment||0
1123455|NCT01256658|2720192|P1|COMPLETED|Period 2 - Follow up Only - No Treatment||0
1123456|NCT01256658|2720191|P2|Study Termination|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6287
1123457|NCT01256658|2720192|P1|Study Termination|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5777
1123458|NCT01256658|2720191|P2|Death|Period 2 - Follow up Only - No Treatment||8
1123459|NCT01256658|2720192|P1|Death|Period 2 - Follow up Only - No Treatment||6
1123460|NCT01256658|2720191|P2|Lost to Follow up|Period 2 - Follow up Only - No Treatment||77
1123461|NCT01256658|2720192|P1|Lost to Follow up|Period 2 - Follow up Only - No Treatment||71
1123462|NCT01256658|2720191|P2|STARTED|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6372
1123463|NCT01256658|2720192|P1|STARTED|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5854
1123464|NCT01256658|2720191|P2|NOT COMPLETED|Period 1||748
1123465|NCT01256658|2720192|P1|NOT COMPLETED|Period 1||920
1123466|NCT01256658|2720191|P2|COMPLETED|Period 1||6510
1123467|NCT01256658|2720192|P1|COMPLETED|Period 1||5897
1123468|NCT01256658|2720191|P2|STARTED|Period 1||7258
1123469|NCT01256658|2720192|P1|STARTED|Period 1||6817
1123470|NCT01256684|2720245|P3|NOT COMPLETED|Overall Study||11
1123471|NCT01256684|2720246|P2|NOT COMPLETED|Overall Study||13
1123472|NCT01256684|2720247|P1|NOT COMPLETED|Overall Study||9
1123473|NCT01256684|2720245|P3|COMPLETED|Overall Study||76
1123474|NCT01256684|2720246|P2|COMPLETED|Overall Study||74
1123475|NCT01256684|2720247|P1|COMPLETED|Overall Study||72
1123476|NCT01256684|2720245|P3|ITT Population|Overall Study||81
1123477|NCT01256684|2720246|P2|ITT Population|Overall Study||79
1123478|NCT01256684|2720247|P1|ITT Population|Overall Study||77
1123479|NCT01256684|2720245|P3|Safety Population|Overall Study||87
1123480|NCT01256684|2720246|P2|Safety Population|Overall Study||86
1123481|NCT01256684|2720247|P1|Safety Population|Overall Study||80
1123482|NCT01256684|2720245|P3|STARTED|Overall Study||87
1123483|NCT01256684|2720246|P2|STARTED|Overall Study||87
1123484|NCT01256684|2720247|P1|STARTED|Overall Study||81
1123485|NCT01250002|2720281|P2|NOT COMPLETED|Overall Study||3
1123486|NCT01250002|2720282|P1|NOT COMPLETED|Overall Study||4
1123487|NCT01250002|2720281|P2|COMPLETED|Overall Study||32
1123488|NCT01250002|2720282|P1|COMPLETED|Overall Study||31
1123489|NCT01250002|2720281|P2|STARTED|Overall Study||35
1123490|NCT01250002|2720282|P1|STARTED|Overall Study||35
1123491|NCT01250054|2720290|P2|NOT COMPLETED|Period 2, One Week of Wear||0
1123492|NCT01250054|2720291|P1|NOT COMPLETED|Period 2, One Week of Wear||1
1123493|NCT01250054|2720290|P2|COMPLETED|Period 2, One Week of Wear||8
1123494|NCT01250054|2720291|P1|COMPLETED|Period 2, One Week of Wear||6
1123495|NCT01250054|2720290|P2|STARTED|Period 2, One Week of Wear||8
1123496|NCT01250054|2720291|P1|STARTED|Period 2, One Week of Wear||7
1123497|NCT01250054|2720290|P2|NOT COMPLETED|Period 1, One Week of Wear||0
1123498|NCT01250054|2720291|P1|NOT COMPLETED|Period 1, One Week of Wear||0
1123499|NCT01250054|2720290|P2|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to noncompliance.|8
1123500|NCT01250054|2720291|P1|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to power availability.|8
1123501|NCT01250054|2720290|P2|STARTED|Period 1, One Week of Wear|One subject did not wear Period 1 lenses due to power availability and proceeded to Period 2 lenses.|8
1123502|NCT01250054|2720291|P1|STARTED|Period 1, One Week of Wear||8
1123503|NCT01250119|2720297|P2|NOT COMPLETED|Treatment Phase||41
1123504|NCT01250119|2720298|P1|NOT COMPLETED|Treatment Phase||0
1123505|NCT01250119|2720297|P2|COMPLETED|Treatment Phase||0
1123506|NCT01250119|2720298|P1|COMPLETED|Treatment Phase||0
1123507|NCT01250119|2720297|P2|STARTED|Treatment Phase|Out of 52 participants with positive EGFR mutation test result, only 41 participants were treated.|41
1123508|NCT01250119|2720298|P1|STARTED|Treatment Phase||0
1123509|NCT01250119|2720297|P2|NOT COMPLETED|Diagnostic Phase||0
1123510|NCT01250119|2720298|P1|NOT COMPLETED|Diagnostic Phase||113
1123511|NCT01250119|2720297|P2|COMPLETED|Diagnostic Phase||0
1123512|NCT01250119|2720298|P1|COMPLETED|Diagnostic Phase|Completed refers to participants with both positive and negative EGFR mutation test result.|575
1123513|NCT01250119|2720297|P2|STARTED|Diagnostic Phase||0
1123514|NCT01250119|2720298|P1|STARTED|Diagnostic Phase||688
1123515|NCT01250145|2720315|P2|NOT COMPLETED|Overall Study||5
1123516|NCT01250145|2720316|P1|NOT COMPLETED|Overall Study||2
1123517|NCT01250145|2720315|P2|COMPLETED|Overall Study||205
1123518|NCT01250145|2720316|P1|COMPLETED|Overall Study||39
1123519|NCT01250145|2720315|P2|STARTED|Overall Study||210
1123520|NCT01250145|2720316|P1|STARTED|Overall Study||41
1123521|NCT01250171|2720339|P3|NOT COMPLETED|Overall Study||0
1123522|NCT01250171|2720340|P2|NOT COMPLETED|Overall Study||0
1123523|NCT01250171|2720341|P1|NOT COMPLETED|Overall Study||1
1123524|NCT01250171|2720339|P3|COMPLETED|Overall Study||24
1123525|NCT01250171|2720340|P2|COMPLETED|Overall Study||22
1123526|NCT01250171|2720341|P1|COMPLETED|Overall Study||25
1123527|NCT01250171|2720339|P3|STARTED|Overall Study||24
1123528|NCT01250171|2720340|P2|STARTED|Overall Study||22
1123529|NCT01250171|2720341|P1|STARTED|Overall Study||26
1123530|NCT01250184|2720373|P3|NOT COMPLETED|Overall Study||0
1123531|NCT01250184|2720374|P2|NOT COMPLETED|Overall Study||0
1123532|NCT01250184|2720375|P1|NOT COMPLETED|Overall Study||0
1123533|NCT01250184|2720373|P3|COMPLETED|Overall Study||43
1123534|NCT01250184|2720374|P2|COMPLETED|Overall Study||41
1123535|NCT01250184|2720375|P1|COMPLETED|Overall Study||43
1123536|NCT01250184|2720373|P3|STARTED|Overall Study||43
1123537|NCT01250184|2720374|P2|STARTED|Overall Study||41
1123538|NCT01250184|2720375|P1|STARTED|Overall Study||43
1123539|NCT01250379|2720400|P2|NOT COMPLETED|Overall Study||193
1123540|NCT01250379|2720401|P1|NOT COMPLETED|Overall Study||202
1123541|NCT01250379|2720400|P2|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|54
1123542|NCT01250379|2720401|P1|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|45
1123543|NCT01250379|2720400|P2|STARTED|Overall Study||247
1123544|NCT01250379|2720401|P1|STARTED|Overall Study||247
1123545|NCT01250418|2720461|P2|NOT COMPLETED|Overall Study||1
1123546|NCT01250418|2720462|P1|NOT COMPLETED|Overall Study||1
1123547|NCT01250418|2720461|P2|COMPLETED|Overall Study||15
1123548|NCT01250418|2720462|P1|COMPLETED|Overall Study||8
1123549|NCT01250418|2720461|P2|STARTED|Overall Study||16
1123550|NCT01250418|2720462|P1|STARTED|Overall Study||9
1123551|NCT01250509|2720470|P2|NOT COMPLETED|Overall Study||2
1123552|NCT01250509|2720471|P1|NOT COMPLETED|Overall Study||5
1123553|NCT01250509|2720470|P2|COMPLETED|Overall Study||21
1123554|NCT01250509|2720471|P1|COMPLETED|Overall Study||19
1123555|NCT01250509|2720470|P2|STARTED|Overall Study||23
1123556|NCT01250509|2720471|P1|STARTED|Overall Study||24
1123557|NCT01250717|2720483|P1|NOT COMPLETED|Overall Study||0
1123558|NCT01250717|2720483|P1|COMPLETED|Overall Study||28
1123559|NCT01250717|2720483|P1|STARTED|Overall Study||28
1123560|NCT01250730|2720490|P3|NOT COMPLETED|Overall Study||0
1123561|NCT01250730|2720491|P2|NOT COMPLETED|Overall Study||0
1123562|NCT01250730|2720492|P1|NOT COMPLETED|Overall Study||0
1123563|NCT01250730|2720490|P3|COMPLETED|Overall Study||6
1123564|NCT01250730|2720491|P2|COMPLETED|Overall Study||6
1123565|NCT01250730|2720492|P1|COMPLETED|Overall Study||6
1123566|NCT01250730|2720490|P3|STARTED|Overall Study||6
1123567|NCT01250730|2720491|P2|STARTED|Overall Study||6
1123568|NCT01250730|2720492|P1|STARTED|Overall Study||6
1123569|NCT01250756|2720550|P2|NOT COMPLETED|After Toddler Dose||1
1123570|NCT01250756|2720551|P1|NOT COMPLETED|After Toddler Dose||0
1123571|NCT01250756|2720550|P2|COMPLETED|After Toddler Dose||147
1123572|NCT01250756|2720551|P1|COMPLETED|After Toddler Dose||0
1123573|NCT01250756|2720550|P2|STARTED|After Toddler Dose||148
1123574|NCT01250756|2720551|P1|STARTED|After Toddler Dose||0
1123575|NCT01250756|2720550|P2|NOT COMPLETED|Toddler Dose||1
1123576|NCT01250756|2720551|P1|NOT COMPLETED|Toddler Dose||0
1123577|NCT01250756|2720550|P2|COMPLETED|Toddler Dose||148
1123578|NCT01250756|2720551|P1|COMPLETED|Toddler Dose||122
1123579|NCT01250756|2720550|P2|STARTED|Toddler Dose||149
1123580|NCT01250756|2720551|P1|STARTED|Toddler Dose||122
1123581|NCT01250756|2720550|P2|NOT COMPLETED|After Infant Series||4
1123582|NCT01250756|2720551|P1|NOT COMPLETED|After Infant Series||11
1123583|NCT01250756|2720550|P2|COMPLETED|After Infant Series||149
1123584|NCT01250756|2720551|P1|COMPLETED|After Infant Series||122
1123585|NCT01250756|2720550|P2|STARTED|After Infant Series||153
1123586|NCT01250756|2720551|P1|STARTED|After Infant Series||133
1123587|NCT01250756|2720550|P2|NOT COMPLETED|Infant Series||7
1123588|NCT01250756|2720551|P1|NOT COMPLETED|Infant Series||28
1123589|NCT01250756|2720550|P2|COMPLETED|Infant Series||153
1123590|NCT01250756|2720551|P1|COMPLETED|Infant Series||133
1123591|NCT01250756|2720550|P2|Vaccinated Dose 3|Infant Series||155
1123592|NCT01250756|2720551|P1|Vaccinated Dose 3|Infant Series||133
1123593|NCT01250756|2720550|P2|Vaccinated Dose 2|Infant Series||157
1123594|NCT01250756|2720551|P1|Vaccinated Dose 2|Infant Series||147
1123595|NCT01250756|2720550|P2|Vaccinated Dose 1|Infant Series||158
1123596|NCT01250756|2720551|P1|Vaccinated Dose 1|Infant Series||159
1123597|NCT01250756|2720550|P2|STARTED|Infant Series||160
1123598|NCT01250756|2720551|P1|STARTED|Infant Series||161
1123599|NCT01250769|2720605|P4|NOT COMPLETED|Overall Study||0
1123600|NCT01250769|2720606|P3|NOT COMPLETED|Overall Study||2
1123601|NCT01250769|2720607|P2|NOT COMPLETED|Overall Study||1
1123602|NCT01250769|2720608|P1|NOT COMPLETED|Overall Study||0
1123603|NCT01250769|2720605|P4|COMPLETED|Overall Study||11
1123604|NCT01250769|2720606|P3|COMPLETED|Overall Study||73
1123605|NCT01250769|2720607|P2|COMPLETED|Overall Study||72
1123606|NCT01250769|2720608|P1|COMPLETED|Overall Study||11
1123607|NCT01250769|2720605|P4|Day 14|Overall Study||11
1123608|NCT01250769|2720606|P3|Day 14|Overall Study||74
1123609|NCT01250769|2720607|P2|Day 14|Overall Study||72
1123610|NCT01250769|2720608|P1|Day 14|Overall Study||11
1123611|NCT01250769|2720605|P4|STARTED|Overall Study||11
1123612|NCT01250769|2720606|P3|STARTED|Overall Study||75
1123613|NCT01250769|2720607|P2|STARTED|Overall Study||73
1123614|NCT01250769|2720608|P1|STARTED|Overall Study||11
1123615|NCT01250834|2720638|P1|NOT COMPLETED|Overall Study||0
1123616|NCT01250834|2720638|P1|COMPLETED|Overall Study||27
1123617|NCT01250834|2720638|P1|STARTED|Overall Study||27
1123618|NCT01250899|2720657|P2|NOT COMPLETED|Overall Study||0
1123619|NCT01250899|2720658|P1|NOT COMPLETED|Overall Study||0
1123620|NCT01250899|2720657|P2|COMPLETED|Overall Study||82
1123621|NCT01250899|2720658|P1|COMPLETED|Overall Study||40
1123622|NCT01250899|2720657|P2|STARTED|Overall Study||82
1123623|NCT01250899|2720658|P1|STARTED|Overall Study||40
1123624|NCT01250925|2720665|P3|NOT COMPLETED|Overall Study||2
1123625|NCT01250925|2720666|P2|NOT COMPLETED|Overall Study||3
1123626|NCT01250925|2720667|P1|NOT COMPLETED|Overall Study||5
1123627|NCT01250925|2720665|P3|COMPLETED|Overall Study||30
1123628|NCT01250925|2720666|P2|COMPLETED|Overall Study||28
1123629|NCT01250925|2720667|P1|COMPLETED|Overall Study||26
1123630|NCT01250925|2720665|P3|STARTED|Overall Study||32
1123631|NCT01250925|2720666|P2|STARTED|Overall Study||31
1123632|NCT01250925|2720667|P1|STARTED|Overall Study||31
1123633|NCT01250990|2720707|P2|NOT COMPLETED|Overall Study||2
1123634|NCT01250990|2720708|P1|NOT COMPLETED|Overall Study||4
1123635|NCT01250990|2720707|P2|COMPLETED|Overall Study||9
1123636|NCT01250990|2720708|P1|COMPLETED|Overall Study||7
1123637|NCT01250990|2720707|P2|STARTED|Overall Study||11
1123638|NCT01250990|2720708|P1|STARTED|Overall Study||11
1123639|NCT01251042|2720716|P2|NOT COMPLETED|Overall Study||0
1123640|NCT01251042|2720717|P1|NOT COMPLETED|Overall Study||0
1123641|NCT01251042|2720716|P2|COMPLETED|Overall Study||23
1123642|NCT01251042|2720717|P1|COMPLETED|Overall Study||26
1123643|NCT01251042|2720716|P2|STARTED|Overall Study||23
1123644|NCT01251042|2720717|P1|STARTED|Overall Study||26
1123645|NCT01256918|2720747|P1|NOT COMPLETED|Overall Study||0
1123646|NCT01256918|2720747|P1|COMPLETED|Overall Study||200
1123647|NCT01256918|2720747|P1|Full Thickness Nuclear Crack Achieved|Overall Study||200
1123648|NCT01256918|2720747|P1|STARTED|Overall Study||200
1123649|NCT01256944|2720760|P2|NOT COMPLETED|Overall Study||0
1123650|NCT01256944|2720761|P1|NOT COMPLETED|Overall Study||0
1123651|NCT01256944|2720760|P2|COMPLETED|Overall Study||220
1123652|NCT01256944|2720761|P1|COMPLETED|Overall Study||70
1123653|NCT01256944|2720760|P2|STARTED|Overall Study||220
1123654|NCT01256944|2720761|P1|STARTED|Overall Study||70
1123655|NCT01256983|2720791|P2|NOT COMPLETED|Overall Study||3
1123656|NCT01256983|2720792|P1|NOT COMPLETED|Overall Study||1
1123657|NCT01256983|2720791|P2|COMPLETED|Overall Study||12
1123658|NCT01256983|2720792|P1|COMPLETED|Overall Study||14
1123659|NCT01256983|2720791|P2|STARTED|Overall Study||15
1123660|NCT01256983|2720792|P1|STARTED|Overall Study||15
1123661|NCT01258790|2720800|P2|NOT COMPLETED|Overall Study||0
1123662|NCT01258790|2720801|P1|NOT COMPLETED|Overall Study||0
1123663|NCT01258790|2720800|P2|COMPLETED|Overall Study||6
1123664|NCT01258790|2720801|P1|COMPLETED|Overall Study||6
1123665|NCT01258790|2720800|P2|STARTED|Overall Study||6
1123666|NCT01258790|2720801|P1|STARTED|Overall Study||6
1123667|NCT01258803|2720807|P6|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
1123668|NCT01258803|2720808|P5|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
1123669|NCT01258803|2720809|P4|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
1123670|NCT01258803|2720810|P3|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
1123671|NCT01258803|2720811|P2|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
1123672|NCT01258803|2720812|P1|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
1123673|NCT01258803|2720807|P6|COMPLETED|Treatment Period 4 (1 Dose)||15
1123674|NCT01258803|2720808|P5|COMPLETED|Treatment Period 4 (1 Dose)||15
1123675|NCT01258803|2720809|P4|COMPLETED|Treatment Period 4 (1 Dose)||15
1123676|NCT01258803|2720810|P3|COMPLETED|Treatment Period 4 (1 Dose)||14
1123677|NCT01258803|2720811|P2|COMPLETED|Treatment Period 4 (1 Dose)||14
1123678|NCT01258803|2720812|P1|COMPLETED|Treatment Period 4 (1 Dose)||14
1123679|NCT01258803|2720807|P6|STARTED|Treatment Period 4 (1 Dose)||15
1123680|NCT01258803|2720808|P5|STARTED|Treatment Period 4 (1 Dose)||15
1123681|NCT01258803|2720809|P4|STARTED|Treatment Period 4 (1 Dose)||15
1123682|NCT01258803|2720810|P3|STARTED|Treatment Period 4 (1 Dose)||14
1123683|NCT01258803|2720811|P2|STARTED|Treatment Period 4 (1 Dose)||14
1123684|NCT01258803|2720812|P1|STARTED|Treatment Period 4 (1 Dose)||14
1123685|NCT01258803|2720807|P6|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
1123686|NCT01258803|2720808|P5|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
1123687|NCT01258803|2720809|P4|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
1123688|NCT01258803|2720810|P3|NOT COMPLETED|Treatment Period 3 (1 Dose)||1
1123689|NCT01258803|2720811|P2|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
1123690|NCT01258803|2720812|P1|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
1123691|NCT01258803|2720807|P6|COMPLETED|Treatment Period 3 (1 Dose)||15
1123692|NCT01258803|2720808|P5|COMPLETED|Treatment Period 3 (1 Dose)||15
1123693|NCT01258803|2720809|P4|COMPLETED|Treatment Period 3 (1 Dose)||15
1123694|NCT01258803|2720810|P3|COMPLETED|Treatment Period 3 (1 Dose)||14
1123695|NCT01258803|2720811|P2|COMPLETED|Treatment Period 3 (1 Dose)||14
1123696|NCT01258803|2720812|P1|COMPLETED|Treatment Period 3 (1 Dose)||14
1123697|NCT01258803|2720807|P6|STARTED|Treatment Period 3 (1 Dose)||15
1123698|NCT01258803|2720808|P5|STARTED|Treatment Period 3 (1 Dose)||15
1123699|NCT01258803|2720809|P4|STARTED|Treatment Period 3 (1 Dose)||15
1123700|NCT01258803|2720810|P3|STARTED|Treatment Period 3 (1 Dose)||15
1123701|NCT01258803|2720811|P2|STARTED|Treatment Period 3 (1 Dose)||14
1123702|NCT01258803|2720812|P1|STARTED|Treatment Period 3 (1 Dose)||14
1123703|NCT01258803|2720807|P6|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
1123704|NCT01258803|2720808|P5|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
1123705|NCT01258803|2720809|P4|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
1123706|NCT01258803|2720810|P3|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
1123707|NCT01258803|2720811|P2|NOT COMPLETED|Treatment Period 2 (1 Dose)||2
1123708|NCT01258803|2720812|P1|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
1123709|NCT01258803|2720807|P6|COMPLETED|Treatment Period 2 (1 Dose)||15
1123710|NCT01258803|2720808|P5|COMPLETED|Treatment Period 2 (1 Dose)||15
1123711|NCT01258803|2720809|P4|COMPLETED|Treatment Period 2 (1 Dose)||15
1123712|NCT01258803|2720810|P3|COMPLETED|Treatment Period 2 (1 Dose)||15
1123713|NCT01258803|2720811|P2|COMPLETED|Treatment Period 2 (1 Dose)||14
1123714|NCT01258803|2720812|P1|COMPLETED|Treatment Period 2 (1 Dose)||14
1123715|NCT01258803|2720807|P6|STARTED|Treatment Period 2 (1 Dose)||16
1123716|NCT01258803|2720808|P5|STARTED|Treatment Period 2 (1 Dose)||15
1123717|NCT01258803|2720809|P4|STARTED|Treatment Period 2 (1 Dose)||15
1123718|NCT01258803|2720810|P3|STARTED|Treatment Period 2 (1 Dose)||15
1123719|NCT01258803|2720811|P2|STARTED|Treatment Period 2 (1 Dose)||16
1123720|NCT01258803|2720812|P1|STARTED|Treatment Period 2 (1 Dose)||15
1123721|NCT01258803|2720807|P6|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
1123722|NCT01258803|2720808|P5|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
1123723|NCT01258803|2720809|P4|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
1123724|NCT01258803|2720810|P3|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
1123725|NCT01258803|2720811|P2|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
1123726|NCT01258803|2720812|P1|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
1123727|NCT01258803|2720807|P6|COMPLETED|Treatment Period 1 (1 Dose)||16
1123728|NCT01258803|2720808|P5|COMPLETED|Treatment Period 1 (1 Dose)||15
1123729|NCT01258803|2720809|P4|COMPLETED|Treatment Period 1 (1 Dose)||15
1123730|NCT01258803|2720810|P3|COMPLETED|Treatment Period 1 (1 Dose)||15
1123731|NCT01258803|2720811|P2|COMPLETED|Treatment Period 1 (1 Dose)||16
1123732|NCT01258803|2720812|P1|COMPLETED|Treatment Period 1 (1 Dose)||15
1123733|NCT01258803|2720807|P6|STARTED|Treatment Period 1 (1 Dose)||16
1123734|NCT01258803|2720808|P5|STARTED|Treatment Period 1 (1 Dose)||15
1123735|NCT01258803|2720809|P4|STARTED|Treatment Period 1 (1 Dose)||15
1123736|NCT01258803|2720810|P3|STARTED|Treatment Period 1 (1 Dose)||15
1123737|NCT01258803|2720811|P2|STARTED|Treatment Period 1 (1 Dose)||16
1123738|NCT01258803|2720812|P1|STARTED|Treatment Period 1 (1 Dose)||15
1123739|NCT01258985|2720840|P2|NOT COMPLETED|Overall Study||0
1123740|NCT01258985|2720841|P1|NOT COMPLETED|Overall Study||0
1123741|NCT01258985|2720840|P2|COMPLETED|Overall Study||98
1123742|NCT01258985|2720841|P1|COMPLETED|Overall Study||106
1123743|NCT01258985|2720840|P2|STARTED|Overall Study||98
1123744|NCT01258985|2720841|P1|STARTED|Overall Study||106
1123745|NCT01258998|2720867|P1|NOT COMPLETED|Overall Study||1
1123746|NCT01258998|2720867|P1|COMPLETED|Overall Study||59
1123747|NCT01258998|2720867|P1|STARTED|Overall Study||60
1123748|NCT01259011|2720873|P2|NOT COMPLETED|After Patient Death||0
1123749|NCT01259011|2720874|P1|NOT COMPLETED|After Patient Death||0
1123750|NCT01259011|2720873|P2|COMPLETED|After Patient Death||28
1123751|NCT01259011|2720874|P1|COMPLETED|After Patient Death||17
1123752|NCT01259011|2720873|P2|STARTED|After Patient Death|of 109 patient-surrogate dyads/pairs randomized, 28 surrogates of patients who died|28
1123753|NCT01259011|2720874|P1|STARTED|After Patient Death|of 101 patient-surrogate dyads/pairs randomized, 17 surrogates of patients who died|17
1123754|NCT01259011|2720873|P2|NOT COMPLETED|Main Study Period||0
1123755|NCT01259011|2720874|P1|NOT COMPLETED|Main Study Period||0
1123756|NCT01259011|2720873|P2|COMPLETED|Main Study Period||109
1123757|NCT01259011|2720874|P1|COMPLETED|Main Study Period||101
1123758|NCT01259011|2720873|P2|STARTED|Main Study Period|109 dyads (=218 individuals)|109
1123759|NCT01259011|2720874|P1|STARTED|Main Study Period|101 dyads (=202 individuals)|101
1123760|NCT01259024|2720884|P1|NOT COMPLETED|Overall Study||1
1123761|NCT01259024|2720884|P1|COMPLETED|Overall Study||0
1123762|NCT01259024|2720884|P1|STARTED|Overall Study||1
1123763|NCT01259102|2720893|P5|NOT COMPLETED|Overall Study||1
1123764|NCT01259102|2720894|P4|NOT COMPLETED|Overall Study||2
1123765|NCT01259102|2720895|P3|NOT COMPLETED|Overall Study||2
1123766|NCT01259102|2720896|P2|NOT COMPLETED|Overall Study||0
1123767|NCT01259102|2720897|P1|NOT COMPLETED|Overall Study||1
1123768|NCT01259102|2720893|P5|COMPLETED|Overall Study||13
1123769|NCT01259102|2720894|P4|COMPLETED|Overall Study||12
1123770|NCT01259102|2720895|P3|COMPLETED|Overall Study||13
1123771|NCT01259102|2720896|P2|COMPLETED|Overall Study||14
1123772|NCT01259102|2720897|P1|COMPLETED|Overall Study||12
1123773|NCT01259102|2720893|P5|STARTED|Overall Study||14
1123774|NCT01259102|2720894|P4|STARTED|Overall Study||14
1123775|NCT01259102|2720895|P3|STARTED|Overall Study||15
1123776|NCT01259102|2720896|P2|STARTED|Overall Study||14
1123777|NCT01259102|2720897|P1|STARTED|Overall Study||13
1123778|NCT01259115|2720954|P2|NOT COMPLETED|Period 2||0
1123779|NCT01259115|2720955|P1|NOT COMPLETED|Period 2||1
1123780|NCT01259115|2720954|P2|COMPLETED|Period 2||9
1123781|NCT01259115|2720955|P1|COMPLETED|Period 2||6
1123782|NCT01259115|2720954|P2|STARTED|Period 2||9
1123783|NCT01259115|2720955|P1|STARTED|Period 2||7
1123784|NCT01259115|2720954|P2|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
1123785|NCT01259115|2720955|P1|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
1123786|NCT01259115|2720954|P2|COMPLETED|Period: Washout Period of 4 to 18 Days||9
1123787|NCT01259115|2720955|P1|COMPLETED|Period: Washout Period of 4 to 18 Days||7
1123788|NCT01259115|2720954|P2|STARTED|Period: Washout Period of 4 to 18 Days||9
1123789|NCT01259115|2720955|P1|STARTED|Period: Washout Period of 4 to 18 Days||7
1123790|NCT01259115|2720954|P2|NOT COMPLETED|Period 1||1
1123791|NCT01259115|2720955|P1|NOT COMPLETED|Period 1||3
1123792|NCT01259115|2720954|P2|COMPLETED|Period 1||9
1123793|NCT01259115|2720955|P1|COMPLETED|Period 1||7
1123794|NCT01259115|2720954|P2|STARTED|Period 1||10
1123795|NCT01259115|2720955|P1|STARTED|Period 1||10
1123796|NCT01259245|2720988|P2|NOT COMPLETED|Overall Study||26
1123797|NCT01259245|2720989|P1|NOT COMPLETED|Overall Study||28
1123798|NCT01259245|2720988|P2|COMPLETED|Overall Study|24 discontinued intervention and 2 deceased|68
1123799|NCT01259245|2720989|P1|COMPLETED|Overall Study|27 were lost to follow-up and 1 deceased|70
1123800|NCT01259245|2720988|P2|STARTED|Overall Study||94
1123801|NCT01259245|2720989|P1|STARTED|Overall Study||98
1123802|NCT01259284|2721016|P3|NOT COMPLETED|Overall Study||0
1123803|NCT01259284|2721017|P2|NOT COMPLETED|Overall Study||0
1123804|NCT01259284|2721018|P1|NOT COMPLETED|Overall Study||2
1123805|NCT01259284|2721016|P3|COMPLETED|Overall Study||0
1123806|NCT01259284|2721017|P2|COMPLETED|Overall Study||0
1123807|NCT01259284|2721018|P1|COMPLETED|Overall Study||0
1123808|NCT01259284|2721016|P3|STARTED|Overall Study||0
1123809|NCT01259284|2721017|P2|STARTED|Overall Study||0
1123810|NCT01259284|2721018|P1|STARTED|Overall Study||2
1123811|NCT01259297|2721034|P8|NOT COMPLETED|Double Blind Randomized Period||3
1123812|NCT01259297|2721035|P7|NOT COMPLETED|Double Blind Randomized Period||6
1123813|NCT01259297|2721036|P6|NOT COMPLETED|Double Blind Randomized Period||8
1123814|NCT01259297|2721037|P5|NOT COMPLETED|Double Blind Randomized Period||4
1123815|NCT01259297|2721038|P4|NOT COMPLETED|Double Blind Randomized Period||4
1123816|NCT01259297|2721039|P3|NOT COMPLETED|Double Blind Randomized Period||1
1123817|NCT01259297|2721040|P2|NOT COMPLETED|Double Blind Randomized Period||3
1123818|NCT01259297|2721041|P1|NOT COMPLETED|Double Blind Randomized Period||2
1123819|NCT01259297|2721034|P8|COMPLETED|Double Blind Randomized Period||196
1123820|NCT01259297|2721035|P7|COMPLETED|Double Blind Randomized Period||190
1123821|NCT01259297|2721036|P6|COMPLETED|Double Blind Randomized Period||245
1123822|NCT01259297|2721037|P5|COMPLETED|Double Blind Randomized Period||247
1123823|NCT01259297|2721038|P4|COMPLETED|Double Blind Randomized Period||191
1123824|NCT01259297|2721039|P3|COMPLETED|Double Blind Randomized Period||188
1123825|NCT01259297|2721040|P2|COMPLETED|Double Blind Randomized Period||229
1123826|NCT01259297|2721041|P1|COMPLETED|Double Blind Randomized Period||242
1123827|NCT01259297|2721034|P8|STARTED|Double Blind Randomized Period||199
1123828|NCT01259297|2721035|P7|STARTED|Double Blind Randomized Period||196
1123829|NCT01259297|2721036|P6|STARTED|Double Blind Randomized Period||253
1123830|NCT01259297|2721037|P5|STARTED|Double Blind Randomized Period||251
1123831|NCT01259297|2721038|P4|STARTED|Double Blind Randomized Period||195
1123832|NCT01259297|2721039|P3|STARTED|Double Blind Randomized Period||189
1123833|NCT01259297|2721040|P2|STARTED|Double Blind Randomized Period||232
1123834|NCT01259297|2721041|P1|STARTED|Double Blind Randomized Period||244
1123835|NCT01259297|2721034|P8|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
1123836|NCT01259297|2721035|P7|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
1123837|NCT01259297|2721036|P6|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
1123838|NCT01259297|2721037|P5|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
1123839|NCT01259297|2721038|P4|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
1123840|NCT01259297|2721039|P3|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||222
1123841|NCT01259297|2721040|P2|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
1123842|NCT01259297|2721041|P1|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||355
1123843|NCT01259297|2721034|P8|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
1123844|NCT01259297|2721035|P7|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
1123845|NCT01259297|2721036|P6|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
1123846|NCT01259297|2721037|P5|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
1123847|NCT01259297|2721038|P4|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
1123848|NCT01259297|2721039|P3|COMPLETED|Run-in Open Label Period (4-5 Weeks)||779
1123849|NCT01259297|2721040|P2|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
1123850|NCT01259297|2721041|P1|COMPLETED|Run-in Open Label Period (4-5 Weeks)||980
1123851|NCT01259297|2721034|P8|STARTED|Run-in Open Label Period (4-5 Weeks)||0
1123852|NCT01259297|2721035|P7|STARTED|Run-in Open Label Period (4-5 Weeks)||0
1123853|NCT01259297|2721036|P6|STARTED|Run-in Open Label Period (4-5 Weeks)||0
1123854|NCT01259297|2721037|P5|STARTED|Run-in Open Label Period (4-5 Weeks)||0
1123855|NCT01259297|2721038|P4|STARTED|Run-in Open Label Period (4-5 Weeks)||0
1123856|NCT01259297|2721039|P3|STARTED|Run-in Open Label Period (4-5 Weeks)||1001
1123857|NCT01259297|2721040|P2|STARTED|Run-in Open Label Period (4-5 Weeks)||0
1123858|NCT01259297|2721041|P1|STARTED|Run-in Open Label Period (4-5 Weeks)||1335
1123859|NCT01259375|2721069|P1|NOT COMPLETED|Overall Study||1
1123860|NCT01259375|2721069|P1|COMPLETED|Overall Study||23
1123861|NCT01259375|2721069|P1|STARTED|Overall Study||24
1123862|NCT01259401|2721080|P2|NOT COMPLETED|4-month Follow-up||2
1123863|NCT01259401|2721081|P1|NOT COMPLETED|4-month Follow-up||0
1123864|NCT01259401|2721080|P2|COMPLETED|4-month Follow-up||19
1123865|NCT01259401|2721081|P1|COMPLETED|4-month Follow-up||21
1123866|NCT01259401|2721080|P2|STARTED|4-month Follow-up||21
1123867|NCT01259401|2721081|P1|STARTED|4-month Follow-up||21
1123868|NCT01259401|2721080|P2|NOT COMPLETED|End of 4-week Intervention||0
1123869|NCT01259401|2721081|P1|NOT COMPLETED|End of 4-week Intervention||0
1123870|NCT01259401|2721080|P2|COMPLETED|End of 4-week Intervention||21
1123871|NCT01259401|2721081|P1|COMPLETED|End of 4-week Intervention||21
1123872|NCT01259401|2721080|P2|STARTED|End of 4-week Intervention||21
1123873|NCT01259401|2721081|P1|STARTED|End of 4-week Intervention||21
1123874|NCT01259427|2721091|P2|NOT COMPLETED|Overall Study||14
1123875|NCT01259427|2721092|P1|NOT COMPLETED|Overall Study||18
1123876|NCT01259427|2721091|P2|COMPLETED|Overall Study||110
1123877|NCT01259427|2721092|P1|COMPLETED|Overall Study||106
1123878|NCT01259427|2721091|P2|STARTED|Overall Study||124
1123879|NCT01259427|2721092|P1|STARTED|Overall Study||124
1123880|NCT01259440|2721110|P2|NOT COMPLETED|Overall Study||0
1123881|NCT01259440|2721111|P1|NOT COMPLETED|Overall Study||0
1123882|NCT01259440|2721110|P2|COMPLETED|Overall Study||10
1123883|NCT01259440|2721111|P1|COMPLETED|Overall Study||13
1123884|NCT01259440|2721110|P2|STARTED|Overall Study||10
1123885|NCT01259440|2721111|P1|STARTED|Overall Study||13
1123886|NCT01259466|2721119|P2|NOT COMPLETED|Overall Study||9
1123887|NCT01259466|2721120|P1|NOT COMPLETED|Overall Study||1
1123888|NCT01259466|2721119|P2|COMPLETED|Overall Study||18
1123889|NCT01259466|2721120|P1|COMPLETED|Overall Study||26
1123890|NCT01259466|2721119|P2|STARTED|Overall Study||27
1123891|NCT01259466|2721120|P1|STARTED|Overall Study||27
1123892|NCT01259492|2721132|P4|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||81
1123893|NCT01259492|2721133|P3|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||50
1123894|NCT01259492|2721134|P2|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||69
1123895|NCT01259492|2721135|P1|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||54
1123896|NCT01259492|2721132|P4|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|42
1123897|NCT01259492|2721133|P3|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|70
1123898|NCT01259492|2721134|P2|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|63
1123899|NCT01259492|2721135|P1|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|60
1123900|NCT01259492|2721132|P4|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||115
1123901|NCT01259492|2721133|P3|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||114
1123902|NCT01259492|2721134|P2|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||128
1123903|NCT01259492|2721135|P1|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||110
1123904|NCT01259492|2721132|P4|STARTED|Period 3 (Week 15 to End of Week 40)||123
1123905|NCT01259492|2721133|P3|STARTED|Period 3 (Week 15 to End of Week 40)||120
1123906|NCT01259492|2721134|P2|STARTED|Period 3 (Week 15 to End of Week 40)||132
1123907|NCT01259492|2721135|P1|STARTED|Period 3 (Week 15 to End of Week 40)|In period 3, all 489 patients who completed period 2 were re-randomized to 4 arms.|114
1123908|NCT01259492|2721132|P4|NOT COMPLETED|Period 2 (Week 10 to Week 14)||28
1123909|NCT01259492|2721133|P3|NOT COMPLETED|Period 2 (Week 10 to Week 14)||24
1123910|NCT01259492|2721134|P2|NOT COMPLETED|Period 2 (Week 10 to Week 14)||18
1123911|NCT01259492|2721135|P1|NOT COMPLETED|Period 2 (Week 10 to Week 14)||25
1123912|NCT01259492|2721132|P4|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|125
1123913|NCT01259492|2721133|P3|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|114
1123914|NCT01259492|2721134|P2|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|123
1123915|NCT01259492|2721135|P1|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|127
1123916|NCT01259492|2721132|P4|STARTED|Period 2 (Week 10 to Week 14)||153
1123917|NCT01259492|2721133|P3|STARTED|Period 2 (Week 10 to Week 14)||138
1123918|NCT01259492|2721134|P2|STARTED|Period 2 (Week 10 to Week 14)||141
1123919|NCT01259492|2721135|P1|STARTED|Period 2 (Week 10 to Week 14)|Treatment arms including Placebo indicate patients belong to respective treatment arms in Period 1|152
1123920|NCT01259492|2721132|P4|NOT COMPLETED|Period 1 (9 Weeks)||28
1123921|NCT01259492|2721133|P3|NOT COMPLETED|Period 1 (9 Weeks)||43
1123922|NCT01259492|2721134|P2|NOT COMPLETED|Period 1 (9 Weeks)||41
1123923|NCT01259492|2721135|P1|NOT COMPLETED|Period 1 (9 Weeks)||29
1123924|NCT01259492|2721132|P4|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|153
1123925|NCT01259492|2721133|P3|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|138
1123926|NCT01259492|2721134|P2|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|141
1123927|NCT01259492|2721135|P1|COMPLETED|Period 1 (9 Weeks)|"Completed indicates patients entered Period 2."|152
1123928|NCT01259492|2721132|P4|Full Analysis Set|Period 1 (9 Weeks)||172
1123929|NCT01259492|2721133|P3|Full Analysis Set|Period 1 (9 Weeks)||179
1123930|NCT01259492|2721134|P2|Full Analysis Set|Period 1 (9 Weeks)||175
1123931|NCT01259492|2721135|P1|Full Analysis Set|Period 1 (9 Weeks)||174
1123932|NCT01259492|2721132|P4|STARTED|Period 1 (9 Weeks)||181
1123933|NCT01259492|2721133|P3|STARTED|Period 1 (9 Weeks)||181
1123934|NCT01259492|2721134|P2|STARTED|Period 1 (9 Weeks)||182
1123935|NCT01259492|2721135|P1|STARTED|Period 1 (9 Weeks)||181
1123936|NCT01259596|2721184|P2|NOT COMPLETED|Overall Study||6
1123937|NCT01259596|2721185|P1|NOT COMPLETED|Overall Study||4
1123938|NCT01259596|2721184|P2|COMPLETED|Overall Study||65
1123939|NCT01259596|2721185|P1|COMPLETED|Overall Study||66
1123940|NCT01259596|2721184|P2|STARTED|Overall Study||71
1123941|NCT01259596|2721185|P1|STARTED|Overall Study||70
1123942|NCT01259713|2721199|P2|NOT COMPLETED|Overall Study||41
1123943|NCT01259713|2721200|P1|NOT COMPLETED|Overall Study||95
1123944|NCT01259713|2721199|P2|COMPLETED|Overall Study||77
1123945|NCT01259713|2721200|P1|COMPLETED|Overall Study||142
1123946|NCT01259713|2721199|P2|STARTED|Overall Study||118
1123947|NCT01259713|2721200|P1|STARTED|Overall Study||237
1123948|NCT01259726|2721226|P4|NOT COMPLETED|Overall Study||5
1123949|NCT01259726|2721227|P3|NOT COMPLETED|Overall Study||4
1123950|NCT01259726|2721228|P2|NOT COMPLETED|Overall Study||4
1123951|NCT01259726|2721229|P1|NOT COMPLETED|Overall Study||5
1123952|NCT01259726|2721226|P4|COMPLETED|Overall Study||36
1123953|NCT01259726|2721227|P3|COMPLETED|Overall Study||39
1123954|NCT01259726|2721228|P2|COMPLETED|Overall Study||37
1123955|NCT01259726|2721229|P1|COMPLETED|Overall Study||38
1123956|NCT01259726|2721226|P4|Treated|Overall Study||39
1123957|NCT01259726|2721227|P3|Treated|Overall Study||41
1123958|NCT01259726|2721228|P2|Treated|Overall Study||37
1123959|NCT01259726|2721229|P1|Treated|Overall Study||40
1123960|NCT01259726|2721226|P4|STARTED|Overall Study||41
1123961|NCT01259726|2721227|P3|STARTED|Overall Study||43
1123962|NCT01259726|2721228|P2|STARTED|Overall Study||41
1123963|NCT01259726|2721229|P1|STARTED|Overall Study||43
1123964|NCT01260142|2721265|P6|NOT COMPLETED|Treatment Period 2||0
1123965|NCT01260142|2721266|P5|NOT COMPLETED|Treatment Period 2||0
1123966|NCT01260142|2721267|P4|NOT COMPLETED|Treatment Period 2||0
1123967|NCT01260142|2721268|P3|NOT COMPLETED|Treatment Period 2||0
1123968|NCT01260142|2721269|P2|NOT COMPLETED|Treatment Period 2||0
1123969|NCT01260142|2721270|P1|NOT COMPLETED|Treatment Period 2||0
1123970|NCT01260142|2721265|P6|COMPLETED|Treatment Period 2||3
1123971|NCT01260142|2721266|P5|COMPLETED|Treatment Period 2||4
1123972|NCT01260142|2721267|P4|COMPLETED|Treatment Period 2||6
1123973|NCT01260142|2721268|P3|COMPLETED|Treatment Period 2||6
1123974|NCT01260142|2721269|P2|COMPLETED|Treatment Period 2||5
1123975|NCT01260142|2721270|P1|COMPLETED|Treatment Period 2||5
1123976|NCT01260142|2721265|P6|STARTED|Treatment Period 2||3
1123977|NCT01260142|2721266|P5|STARTED|Treatment Period 2||4
1123978|NCT01260142|2721267|P4|STARTED|Treatment Period 2||6
1123979|NCT01260142|2721268|P3|STARTED|Treatment Period 2||6
1123980|NCT01260142|2721269|P2|STARTED|Treatment Period 2||5
1123981|NCT01260142|2721270|P1|STARTED|Treatment Period 2||5
1123982|NCT01260142|2721265|P6|NOT COMPLETED|Treatment Period 1||3
1123983|NCT01260142|2721266|P5|NOT COMPLETED|Treatment Period 1||2
1123984|NCT01260142|2721267|P4|NOT COMPLETED|Treatment Period 1||0
1123985|NCT01260142|2721268|P3|NOT COMPLETED|Treatment Period 1||0
1123986|NCT01260142|2721269|P2|NOT COMPLETED|Treatment Period 1||1
1123987|NCT01260142|2721270|P1|NOT COMPLETED|Treatment Period 1||1
1123988|NCT01260142|2721265|P6|COMPLETED|Treatment Period 1||3
1123989|NCT01260142|2721266|P5|COMPLETED|Treatment Period 1||4
1123990|NCT01260142|2721267|P4|COMPLETED|Treatment Period 1||6
1123991|NCT01260142|2721268|P3|COMPLETED|Treatment Period 1||6
1123992|NCT01260142|2721269|P2|COMPLETED|Treatment Period 1||5
1123993|NCT01260142|2721270|P1|COMPLETED|Treatment Period 1||5
1123994|NCT01260142|2721265|P6|STARTED|Treatment Period 1||6
1123995|NCT01260142|2721266|P5|STARTED|Treatment Period 1||6
1123996|NCT01260142|2721267|P4|STARTED|Treatment Period 1||6
1123997|NCT01260142|2721268|P3|STARTED|Treatment Period 1||6
1123998|NCT01260142|2721269|P2|STARTED|Treatment Period 1||6
1123999|NCT01260142|2721270|P1|STARTED|Treatment Period 1||6
1124000|NCT01260194|2721320|P1|NOT COMPLETED|Overall Study||1
1124001|NCT01260194|2721320|P1|COMPLETED|Overall Study||3
1124002|NCT01260194|2721320|P1|STARTED|Overall Study||4
1124003|NCT01260272|2721334|P2|NOT COMPLETED|Overall Study||2
1124004|NCT01260272|2721335|P1|NOT COMPLETED|Overall Study||2
1124005|NCT01260272|2721334|P2|COMPLETED|Overall Study||30
1124006|NCT01260272|2721335|P1|COMPLETED|Overall Study||15
1124007|NCT01260272|2721334|P2|STARTED|Overall Study||32
1124008|NCT01260272|2721335|P1|STARTED|Overall Study||17
1124009|NCT01260311|2721355|P1|NOT COMPLETED|Overall Study||127
1124010|NCT01260311|2721355|P1|COMPLETED|Overall Study||381
1124011|NCT01260311|2721355|P1|STARTED|Overall Study||508
1124012|NCT01260324|2721365|P2|NOT COMPLETED|Overall Study||0
1124013|NCT01260324|2721366|P1|NOT COMPLETED|Overall Study||0
1124014|NCT01260324|2721365|P2|COMPLETED|Overall Study||20000
1124015|NCT01260324|2721366|P1|COMPLETED|Overall Study||1283
1124016|NCT01260324|2721365|P2|STARTED|Overall Study||20000
1124017|NCT01260324|2721366|P1|STARTED|Overall Study||1283
1124018|NCT01260350|2721400|P22|NOT COMPLETED|Overall Study||0
1124019|NCT01260350|2721401|P21|NOT COMPLETED|Overall Study||3
1124020|NCT01260350|2721402|P20|NOT COMPLETED|Overall Study||0
1124021|NCT01260350|2721403|P19|NOT COMPLETED|Overall Study||0
1124022|NCT01260350|2721404|P18|NOT COMPLETED|Overall Study||1
1124023|NCT01260350|2721405|P17|NOT COMPLETED|Overall Study||0
1124024|NCT01260350|2721406|P16|NOT COMPLETED|Overall Study||0
1124025|NCT01260350|2721407|P15|NOT COMPLETED|Overall Study||0
1124026|NCT01260350|2721408|P14|NOT COMPLETED|Overall Study||0
1124027|NCT01260350|2721409|P13|NOT COMPLETED|Overall Study||0
1124028|NCT01260350|2721410|P12|NOT COMPLETED|Overall Study||0
1124029|NCT01260350|2721411|P11|NOT COMPLETED|Overall Study||0
1124030|NCT01260350|2721412|P10|NOT COMPLETED|Overall Study||0
1124031|NCT01260350|2721413|P9|NOT COMPLETED|Overall Study||1
1124032|NCT01260350|2721414|P8|NOT COMPLETED|Overall Study||0
1124033|NCT01260350|2721415|P7|NOT COMPLETED|Overall Study||0
1124034|NCT01260350|2721416|P6|NOT COMPLETED|Overall Study||0
1124035|NCT01260350|2721417|P5|NOT COMPLETED|Overall Study||0
1124036|NCT01260350|2721418|P4|NOT COMPLETED|Overall Study||0
1124037|NCT01260350|2721419|P3|NOT COMPLETED|Overall Study||0
1124038|NCT01260350|2721420|P2|NOT COMPLETED|Overall Study||0
1124039|NCT01260350|2721421|P1|NOT COMPLETED|Overall Study||0
1124040|NCT01260350|2721400|P22|COMPLETED|Overall Study||0
1124041|NCT01260350|2721401|P21|COMPLETED|Overall Study||22
1124042|NCT01260350|2721402|P20|COMPLETED|Overall Study||14
1124043|NCT01260350|2721403|P19|COMPLETED|Overall Study||0
1124044|NCT01260350|2721404|P18|COMPLETED|Overall Study||9
1124045|NCT01260350|2721405|P17|COMPLETED|Overall Study||9
1124046|NCT01260350|2721406|P16|COMPLETED|Overall Study||10
1124047|NCT01260350|2721407|P15|COMPLETED|Overall Study||25
1124048|NCT01260350|2721408|P14|COMPLETED|Overall Study||10
1124049|NCT01260350|2721409|P13|COMPLETED|Overall Study||25
1124050|NCT01260350|2721410|P12|COMPLETED|Overall Study||9
1124051|NCT01260350|2721411|P11|COMPLETED|Overall Study||10
1124052|NCT01260350|2721412|P10|COMPLETED|Overall Study||25
1124053|NCT01260350|2721413|P9|COMPLETED|Overall Study||24
1124054|NCT01260350|2721414|P8|COMPLETED|Overall Study||25
1124055|NCT01260350|2721415|P7|COMPLETED|Overall Study||10
1124056|NCT01260350|2721416|P6|COMPLETED|Overall Study||10
1124057|NCT01260350|2721417|P5|COMPLETED|Overall Study||10
1124058|NCT01260350|2721418|P4|COMPLETED|Overall Study||11
1124059|NCT01260350|2721419|P3|COMPLETED|Overall Study||10
1124060|NCT01260350|2721420|P2|COMPLETED|Overall Study||9
1124061|NCT01260350|2721421|P1|COMPLETED|Overall Study||10
1124062|NCT01260350|2721400|P22|STARTED|Overall Study||0
1124063|NCT01260350|2721401|P21|STARTED|Overall Study||25
1124064|NCT01260350|2721402|P20|STARTED|Overall Study||14
1124065|NCT01260350|2721403|P19|STARTED|Overall Study||0
1124066|NCT01260350|2721404|P18|STARTED|Overall Study||10
1124067|NCT01260350|2721405|P17|STARTED|Overall Study||9
1124068|NCT01260350|2721406|P16|STARTED|Overall Study||10
1124069|NCT01260350|2721407|P15|STARTED|Overall Study||25
1124070|NCT01260350|2721408|P14|STARTED|Overall Study||10
1124071|NCT01260350|2721409|P13|STARTED|Overall Study||25
1124072|NCT01260350|2721410|P12|STARTED|Overall Study||9
1124073|NCT01260350|2721411|P11|STARTED|Overall Study||10
1124074|NCT01260350|2721412|P10|STARTED|Overall Study||25
1124075|NCT01260350|2721413|P9|STARTED|Overall Study||25
1124076|NCT01260350|2721414|P8|STARTED|Overall Study||25
1124077|NCT01260350|2721415|P7|STARTED|Overall Study||10
1124078|NCT01260350|2721416|P6|STARTED|Overall Study||10
1124079|NCT01260350|2721417|P5|STARTED|Overall Study||10
1124080|NCT01260350|2721418|P4|STARTED|Overall Study||11
1124081|NCT01260350|2721419|P3|STARTED|Overall Study||10
1124082|NCT01260350|2721420|P2|STARTED|Overall Study||9
1124083|NCT01260350|2721421|P1|STARTED|Overall Study||10
1124084|NCT01260454|2721611|P1|NOT COMPLETED|Overall Study||0
1124085|NCT01260454|2721611|P1|COMPLETED|Overall Study||6
1124086|NCT01260454|2721611|P1|STARTED|Overall Study||6
1124087|NCT01260467|2721617|P1|NOT COMPLETED|Overall Study||2
1124088|NCT01260467|2721617|P1|COMPLETED|Overall Study||2
1124089|NCT01260467|2721617|P1|STARTED|Overall Study||4
1124090|NCT01260493|2721625|P2|NOT COMPLETED|Overall Study||4
1124091|NCT01260493|2721626|P1|NOT COMPLETED|Overall Study||16
1124092|NCT01260493|2721625|P2|COMPLETED|Overall Study||85
1124093|NCT01260493|2721626|P1|COMPLETED|Overall Study||76
1124094|NCT01260493|2721625|P2|STARTED|Overall Study||89
1124095|NCT01260493|2721626|P1|STARTED|Overall Study||92
1124096|NCT01260584|2721636|P4|NOT COMPLETED|Period 2||1
1124097|NCT01260584|2721637|P3|NOT COMPLETED|Period 2||5
1124098|NCT01260584|2721638|P2|NOT COMPLETED|Period 2||3
1124099|NCT01260584|2721639|P1|NOT COMPLETED|Period 2||1
1124100|NCT01260584|2721636|P4|COMPLETED|Period 2||26
1124101|NCT01260584|2721637|P3|COMPLETED|Period 2||20
1124102|NCT01260584|2721638|P2|COMPLETED|Period 2||25
1124103|NCT01260584|2721639|P1|COMPLETED|Period 2||26
1124104|NCT01260584|2721636|P4|STARTED|Period 2||27
1124105|NCT01260584|2721637|P3|STARTED|Period 2||25
1124106|NCT01260584|2721638|P2|STARTED|Period 2||28
1124107|NCT01260584|2721639|P1|STARTED|Period 2||27
1124108|NCT01260584|2721636|P4|NOT COMPLETED|Period 1||1
1124109|NCT01260584|2721637|P3|NOT COMPLETED|Period 1||2
1124110|NCT01260584|2721638|P2|NOT COMPLETED|Period 1||0
1124111|NCT01260584|2721639|P1|NOT COMPLETED|Period 1||0
1124112|NCT01260584|2721636|P4|COMPLETED|Period 1||27
1124113|NCT01260584|2721637|P3|COMPLETED|Period 1||25
1124114|NCT01260584|2721638|P2|COMPLETED|Period 1||28
1124115|NCT01260584|2721639|P1|COMPLETED|Period 1||27
1124116|NCT01260584|2721636|P4|STARTED|Period 1||28
1124117|NCT01260584|2721637|P3|STARTED|Period 1||27
1124118|NCT01260584|2721638|P2|STARTED|Period 1||28
1124119|NCT01260584|2721639|P1|STARTED|Period 1||27
1124120|NCT01260649|2721675|P2|NOT COMPLETED|Overall Study||1
1124121|NCT01260649|2721676|P1|NOT COMPLETED|Overall Study||2
1124122|NCT01260649|2721675|P2|COMPLETED|Overall Study||8
1124123|NCT01260649|2721676|P1|COMPLETED|Overall Study||6
1124124|NCT01260649|2721675|P2|STARTED|Overall Study||9
1124125|NCT01260649|2721676|P1|STARTED|Overall Study||8
1124126|NCT01260662|2721687|P3|NOT COMPLETED|Overall Study||0
1124127|NCT01260662|2721688|P2|NOT COMPLETED|Overall Study||0
1124128|NCT01260662|2721689|P1|NOT COMPLETED|Overall Study||0
1124129|NCT01260662|2721687|P3|COMPLETED|Overall Study||96
1124130|NCT01260662|2721688|P2|COMPLETED|Overall Study||85
1124131|NCT01260662|2721689|P1|COMPLETED|Overall Study||90
1124132|NCT01260662|2721687|P3|STARTED|Overall Study||96
1124133|NCT01260662|2721688|P2|STARTED|Overall Study||85
1124134|NCT01260662|2721689|P1|STARTED|Overall Study||90
1124135|NCT01260688|2721708|P2|NOT COMPLETED|Overall Study||0
1124136|NCT01260688|2721709|P1|NOT COMPLETED|Overall Study||0
1124137|NCT01260688|2721708|P2|COMPLETED|Overall Study||11
1124138|NCT01260688|2721709|P1|COMPLETED|Overall Study||11
1124139|NCT01260688|2721708|P2|STARTED|Overall Study||11
1124140|NCT01260688|2721709|P1|STARTED|Overall Study||11
1124141|NCT01260701|2721715|P1|NOT COMPLETED|Overall Study||75
1124142|NCT01260701|2721715|P1|COMPLETED|Overall Study||0
1124143|NCT01260701|2721715|P1|Eligible and Began Protocol Therapy|Overall Study||70
1124144|NCT01260701|2721715|P1|Eligible|Overall Study||71
1124145|NCT01260701|2721715|P1|STARTED|Overall Study||75
1124146|NCT01260883|2721725|P3|NOT COMPLETED|Overall Study||0
1124147|NCT01260883|2721726|P2|NOT COMPLETED|Overall Study||0
1124148|NCT01260883|2721727|P1|NOT COMPLETED|Overall Study||0
1124149|NCT01260883|2721725|P3|COMPLETED|Overall Study||18
1124150|NCT01260883|2721726|P2|COMPLETED|Overall Study||11
1124151|NCT01260883|2721727|P1|COMPLETED|Overall Study||22
1124152|NCT01260883|2721725|P3|STARTED|Overall Study||18
1124153|NCT01260883|2721726|P2|STARTED|Overall Study||11
1124154|NCT01260883|2721727|P1|STARTED|Overall Study||22
1124155|NCT01260896|2721766|P2|NOT COMPLETED|Second Intervention||0
1124156|NCT01260896|2721767|P1|NOT COMPLETED|Second Intervention||0
1124157|NCT01260896|2721766|P2|COMPLETED|Second Intervention||12
1124158|NCT01260896|2721767|P1|COMPLETED|Second Intervention||10
1124159|NCT01260896|2721766|P2|STARTED|Second Intervention||12
1124160|NCT01260896|2721767|P1|STARTED|Second Intervention||10
1124161|NCT01260896|2721766|P2|NOT COMPLETED|Washout of 7 Days||0
1124162|NCT01260896|2721767|P1|NOT COMPLETED|Washout of 7 Days||0
1124163|NCT01260896|2721766|P2|COMPLETED|Washout of 7 Days||12
1124164|NCT01260896|2721767|P1|COMPLETED|Washout of 7 Days||10
1124165|NCT01260896|2721766|P2|STARTED|Washout of 7 Days||12
1124166|NCT01260896|2721767|P1|STARTED|Washout of 7 Days||10
1124167|NCT01260896|2721766|P2|NOT COMPLETED|First Intervention||0
1124168|NCT01260896|2721767|P1|NOT COMPLETED|First Intervention||2
1124169|NCT01260896|2721766|P2|COMPLETED|First Intervention||12
1124170|NCT01260896|2721767|P1|COMPLETED|First Intervention||10
1124171|NCT01260896|2721766|P2|STARTED|First Intervention||12
1124172|NCT01260896|2721767|P1|STARTED|First Intervention||12
1124173|NCT01260922|2721785|P2|NOT COMPLETED|Second Intervention||2
1124174|NCT01260922|2721786|P1|NOT COMPLETED|Second Intervention||0
1124175|NCT01260922|2721785|P2|COMPLETED|Second Intervention||8
1124176|NCT01260922|2721786|P1|COMPLETED|Second Intervention||9
1124177|NCT01260922|2721785|P2|STARTED|Second Intervention||10
1124178|NCT01260922|2721786|P1|STARTED|Second Intervention||9
1124179|NCT01260922|2721785|P2|NOT COMPLETED|Washout of 28 Days||2
1124180|NCT01260922|2721786|P1|NOT COMPLETED|Washout of 28 Days||4
1124181|NCT01260922|2721785|P2|COMPLETED|Washout of 28 Days||10
1124182|NCT01260922|2721786|P1|COMPLETED|Washout of 28 Days||9
1124183|NCT01260922|2721785|P2|STARTED|Washout of 28 Days||12
1124184|NCT01260922|2721786|P1|STARTED|Washout of 28 Days||13
1124185|NCT01260922|2721785|P2|NOT COMPLETED|First Intervention||1
1124186|NCT01260922|2721786|P1|NOT COMPLETED|First Intervention||0
1124187|NCT01260922|2721785|P2|COMPLETED|First Intervention||12
1124188|NCT01260922|2721786|P1|COMPLETED|First Intervention||13
1124189|NCT01260922|2721785|P2|STARTED|First Intervention||13
1124190|NCT01260922|2721786|P1|STARTED|First Intervention||13
1124191|NCT01260948|2721796|P2|NOT COMPLETED|Second Intervention||1
1124192|NCT01260948|2721797|P1|NOT COMPLETED|Second Intervention||0
1124193|NCT01260948|2721796|P2|COMPLETED|Second Intervention||9
1124194|NCT01260948|2721797|P1|COMPLETED|Second Intervention||12
1124195|NCT01260948|2721796|P2|STARTED|Second Intervention||10
1124196|NCT01260948|2721797|P1|STARTED|Second Intervention||12
1124197|NCT01260948|2721796|P2|NOT COMPLETED|Washout of 28 Days||3
1124198|NCT01260948|2721797|P1|NOT COMPLETED|Washout of 28 Days||1
1124199|NCT01260948|2721796|P2|COMPLETED|Washout of 28 Days||10
1124200|NCT01260948|2721797|P1|COMPLETED|Washout of 28 Days||12
1124201|NCT01260948|2721796|P2|STARTED|Washout of 28 Days||13
1124202|NCT01260948|2721797|P1|STARTED|Washout of 28 Days||13
1124203|NCT01260948|2721796|P2|NOT COMPLETED|First Intervention||0
1124204|NCT01260948|2721797|P1|NOT COMPLETED|First Intervention||0
1124205|NCT01260948|2721796|P2|COMPLETED|First Intervention||13
1124206|NCT01260948|2721797|P1|COMPLETED|First Intervention||13
1124207|NCT01260948|2721796|P2|STARTED|First Intervention||13
1124208|NCT01260948|2721797|P1|STARTED|First Intervention||13
1124209|NCT01261000|2721805|P1|NOT COMPLETED|Overall Study||1
1124210|NCT01261000|2721805|P1|COMPLETED|Overall Study||7
1124211|NCT01261000|2721805|P1|STARTED|Overall Study||8
1124212|NCT01261052|2721809|P1|NOT COMPLETED|APD Only Intervention (33 Hours)||0
1124213|NCT01261052|2721809|P1|COMPLETED|APD Only Intervention (33 Hours)||14
1124214|NCT01261052|2721809|P1|STARTED|APD Only Intervention (33 Hours)||14
1124215|NCT01261052|2721809|P1|NOT COMPLETED|FMPD/APD Intervention (33 Hours)||0
1124216|NCT01261052|2721809|P1|COMPLETED|FMPD/APD Intervention (33 Hours)||14
1124217|NCT01261052|2721809|P1|STARTED|FMPD/APD Intervention (33 Hours)||14
1124218|NCT01253980|2721817|P2|NOT COMPLETED|Overall Study||0
1124219|NCT01253980|2721818|P1|NOT COMPLETED|Overall Study||0
1124220|NCT01253980|2721817|P2|COMPLETED|Overall Study||39
1124221|NCT01253980|2721818|P1|COMPLETED|Overall Study||35
1124222|NCT01253980|2721817|P2|STARTED|Overall Study||39
1124223|NCT01253980|2721818|P1|STARTED|Overall Study||35
1124224|NCT01254045|2721824|P6|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
1124225|NCT01254045|2721825|P5|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
1124226|NCT01254045|2721826|P4|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
1124227|NCT01254045|2721827|P3|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
1124228|NCT01254045|2721828|P2|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
1124229|NCT01254045|2721829|P1|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
1124230|NCT01254045|2721824|P6|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
1124231|NCT01254045|2721825|P5|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
1124232|NCT01254045|2721826|P4|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
1124233|NCT01254045|2721827|P3|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
1124234|NCT01254045|2721828|P2|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
1124235|NCT01254045|2721829|P1|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
1124236|NCT01254045|2721824|P6|STARTED|Third/Time 3 (1 Day at Week 3)||1
1124237|NCT01254045|2721825|P5|STARTED|Third/Time 3 (1 Day at Week 3)||1
1124238|NCT01254045|2721826|P4|STARTED|Third/Time 3 (1 Day at Week 3)||1
1124239|NCT01254045|2721827|P3|STARTED|Third/Time 3 (1 Day at Week 3)||2
1124240|NCT01254045|2721828|P2|STARTED|Third/Time 3 (1 Day at Week 3)||2
1124241|NCT01254045|2721829|P1|STARTED|Third/Time 3 (1 Day at Week 3)||1
1124242|NCT01254045|2721824|P6|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
1124243|NCT01254045|2721825|P5|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
1124244|NCT01254045|2721826|P4|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
1124245|NCT01254045|2721827|P3|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
1124246|NCT01254045|2721828|P2|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
1124247|NCT01254045|2721829|P1|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
1124248|NCT01254045|2721824|P6|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
1124249|NCT01254045|2721825|P5|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
1124250|NCT01254045|2721826|P4|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
1124251|NCT01254045|2721827|P3|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
1124252|NCT01254045|2721828|P2|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
1124253|NCT01254045|2721829|P1|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
1124254|NCT01254045|2721824|P6|STARTED|Second/Time 2 (1 Day at Week 2)||1
1124255|NCT01254045|2721825|P5|STARTED|Second/Time 2 (1 Day at Week 2)||1
1124256|NCT01254045|2721826|P4|STARTED|Second/Time 2 (1 Day at Week 2)||1
1124257|NCT01254045|2721827|P3|STARTED|Second/Time 2 (1 Day at Week 2)||2
1124258|NCT01254045|2721828|P2|STARTED|Second/Time 2 (1 Day at Week 2)||2
1124259|NCT01254045|2721829|P1|STARTED|Second/Time 2 (1 Day at Week 2)||1
1124260|NCT01254045|2721824|P6|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
1124261|NCT01254045|2721825|P5|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
1124262|NCT01254045|2721826|P4|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
1124263|NCT01254045|2721827|P3|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
1124264|NCT01254045|2721828|P2|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
1124265|NCT01254045|2721829|P1|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||1
1124266|NCT01254045|2721824|P6|COMPLETED|First/Baseline (1 Day at Week 1 )||1
1124267|NCT01254045|2721825|P5|COMPLETED|First/Baseline (1 Day at Week 1 )||1
1124268|NCT01254045|2721826|P4|COMPLETED|First/Baseline (1 Day at Week 1 )||1
1124269|NCT01254045|2721827|P3|COMPLETED|First/Baseline (1 Day at Week 1 )||2
1124270|NCT01254045|2721828|P2|COMPLETED|First/Baseline (1 Day at Week 1 )||2
1124271|NCT01254045|2721829|P1|COMPLETED|First/Baseline (1 Day at Week 1 )||1
1124272|NCT01254045|2721824|P6|STARTED|First/Baseline (1 Day at Week 1 )||1
1124273|NCT01254045|2721825|P5|STARTED|First/Baseline (1 Day at Week 1 )||1
1124274|NCT01254045|2721826|P4|STARTED|First/Baseline (1 Day at Week 1 )||1
1124275|NCT01254045|2721827|P3|STARTED|First/Baseline (1 Day at Week 1 )||2
1124276|NCT01254045|2721828|P2|STARTED|First/Baseline (1 Day at Week 1 )||2
1124277|NCT01254045|2721829|P1|STARTED|First/Baseline (1 Day at Week 1 )|One completed all baseline measures including administration of placebo, but then lost to follow-up.|2
1124278|NCT01254188|2721840|P1|NOT COMPLETED|Overall Study||93
1124279|NCT01254188|2721840|P1|COMPLETED|Overall Study||328
1124280|NCT01254188|2721840|P1|STARTED|Overall Study||421
1124281|NCT01254214|2721853|P2|NOT COMPLETED|Overall Study||1
1124282|NCT01254214|2721854|P1|NOT COMPLETED|Overall Study||3
1124283|NCT01254214|2721853|P2|COMPLETED|Overall Study||27
1124284|NCT01254214|2721854|P1|COMPLETED|Overall Study||24
1124285|NCT01254214|2721853|P2|STARTED|Overall Study||28
1124286|NCT01254214|2721854|P1|STARTED|Overall Study||27
1124287|NCT01261325|2721871|P3|NOT COMPLETED|Overall Study||26
1124288|NCT01261325|2721872|P2|NOT COMPLETED|Overall Study||29
1124289|NCT01261325|2721873|P1|NOT COMPLETED|Overall Study||17
1124290|NCT01261325|2721871|P3|COMPLETED|Overall Study||225
1124291|NCT01261325|2721872|P2|COMPLETED|Overall Study||225
1124292|NCT01261325|2721873|P1|COMPLETED|Overall Study||246
1124293|NCT01261325|2721871|P3|STARTED|Overall Study||251
1124294|NCT01261325|2721872|P2|STARTED|Overall Study||254
1124295|NCT01261325|2721873|P1|STARTED|Overall Study||263
1124296|NCT01261390|2721909|P4|NOT COMPLETED|Overall Study||8
1124297|NCT01261390|2721910|P3|NOT COMPLETED|Overall Study||7
1124298|NCT01261390|2721911|P2|NOT COMPLETED|Overall Study||9
1124299|NCT01261390|2721912|P1|NOT COMPLETED|Overall Study||7
1124300|NCT01261390|2721909|P4|COMPLETED|Overall Study|14 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
1124301|NCT01261390|2721910|P3|COMPLETED|Overall Study|16 of the 35 participants that completed the study in this arm were under the 6-Month protocol.|35
1124302|NCT01261390|2721911|P2|COMPLETED|Overall Study|12 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
1124303|NCT01261390|2721912|P1|COMPLETED|Overall Study|14 of the 37 participants that completed the study in this arm were under the 6-Month protocol.|37
1124304|NCT01261390|2721909|P4|12-Month Visit|Overall Study||19
1124305|NCT01261390|2721910|P3|12-Month Visit|Overall Study||19
1124306|NCT01261390|2721911|P2|12-Month Visit|Overall Study||21
1124307|NCT01261390|2721912|P1|12-Month Visit|Overall Study||23
1124308|NCT01261390|2721909|P4|6-Month Visit|Overall Study|For 14 of the 32 participants in this arm, this was their final visit.|32
1124309|NCT01261390|2721910|P3|6-Month Visit|Overall Study|For 16 of the 34 participants in this arm, this was their final visit.|34
1124310|NCT01261390|2721911|P2|6-Month Visit|Overall Study|For 12 of the 34 participants in this arm, this was their final visit.|34
1124311|NCT01261390|2721912|P1|6-Month Visit|Overall Study|For 14 of the 30 participants in this arm, this was their final visit.|37
1124312|NCT01261390|2721909|P4|STARTED|Overall Study|15 of the 41 participants only had to complete a 6-month follow-up assessment.|41
1124313|NCT01261390|2721910|P3|STARTED|Overall Study|16 of the 42 participants only had to complete a 6-month follow-up assessment.|42
1124314|NCT01261390|2721911|P2|STARTED|Overall Study|15 of the 42 participants only had to complete a 6-month follow-up assessment.|42
1124315|NCT01261390|2721912|P1|STARTED|Overall Study|15 of the 44 participants only had to complete a 6-month follow-up assessment.|44
1124316|NCT01261507|2722074|P1|NOT COMPLETED|Overall Study||0
1124317|NCT01261507|2722074|P1|COMPLETED|Overall Study||15
1124318|NCT01261507|2722074|P1|STARTED|Overall Study||15
1124319|NCT01261559|2722085|P2|NOT COMPLETED|Overall Study||0
1124320|NCT01261559|2722086|P1|NOT COMPLETED|Overall Study||0
1124321|NCT01261559|2722085|P2|COMPLETED|Overall Study||36
1124322|NCT01261559|2722086|P1|COMPLETED|Overall Study||36
1124323|NCT01261559|2722085|P2|STARTED|Overall Study||36
1124324|NCT01261559|2722086|P1|STARTED|Overall Study||36
1124325|NCT01264380|2722094|P3|NOT COMPLETED|Period C||14
1124326|NCT01264380|2722095|P2|NOT COMPLETED|Period C||0
1124327|NCT01264380|2722096|P1|NOT COMPLETED|Period C||0
1124328|NCT01264380|2722094|P3|COMPLETED|Period C||2
1124329|NCT01264380|2722095|P2|COMPLETED|Period C||0
1124330|NCT01264380|2722096|P1|COMPLETED|Period C||0
1124331|NCT01264380|2722094|P3|STARTED|Period C||16
1124332|NCT01264380|2722095|P2|STARTED|Period C||0
1124333|NCT01264380|2722096|P1|STARTED|Period C||0
1124334|NCT01264380|2722094|P3|NOT COMPLETED|Period B||0
1124335|NCT01264380|2722095|P2|NOT COMPLETED|Period B||0
1124336|NCT01264380|2722096|P1|NOT COMPLETED|Period B||0
1124337|NCT01264380|2722094|P3|COMPLETED|Period B||0
1124338|NCT01264380|2722095|P2|COMPLETED|Period B||8
1124339|NCT01264380|2722096|P1|COMPLETED|Period B||8
1124340|NCT01264380|2722094|P3|STARTED|Period B||0
1124341|NCT01264380|2722095|P2|STARTED|Period B||8
1124342|NCT01264380|2722096|P1|STARTED|Period B||8
1124343|NCT01264380|2722094|P3|NOT COMPLETED|Period A||0
1124344|NCT01264380|2722095|P2|NOT COMPLETED|Period A||0
1124345|NCT01264380|2722096|P1|NOT COMPLETED|Period A||0
1124346|NCT01264380|2722094|P3|COMPLETED|Period A||0
1124347|NCT01264380|2722095|P2|COMPLETED|Period A||8
1124348|NCT01264380|2722096|P1|COMPLETED|Period A||8
1124349|NCT01264380|2722094|P3|STARTED|Period A||0
1124350|NCT01264380|2722095|P2|STARTED|Period A||8
1124351|NCT01264380|2722096|P1|STARTED|Period A||8
1124352|NCT01264614|2722119|P2|NOT COMPLETED|Overall Study||2
1124353|NCT01264614|2722120|P1|NOT COMPLETED|Overall Study||1
1124354|NCT01264614|2722119|P2|COMPLETED|Overall Study||7
1124355|NCT01264614|2722120|P1|COMPLETED|Overall Study||12
1124356|NCT01264614|2722119|P2|STARTED|Overall Study||9
1124357|NCT01264614|2722120|P1|STARTED|Overall Study||13
1124358|NCT01264770|2722140|P6|NOT COMPLETED|Overall Study||6
1124359|NCT01264770|2722141|P5|NOT COMPLETED|Overall Study||8
1124360|NCT01264770|2722142|P4|NOT COMPLETED|Overall Study||6
1124361|NCT01264770|2722143|P3|NOT COMPLETED|Overall Study||16
1124362|NCT01264770|2722144|P2|NOT COMPLETED|Overall Study||10
1124363|NCT01264770|2722145|P1|NOT COMPLETED|Overall Study||18
1124364|NCT01264770|2722140|P6|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
1124365|NCT01264770|2722141|P5|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
1124366|NCT01264770|2722142|P4|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|48
1124367|NCT01264770|2722143|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|41
1124368|NCT01264770|2722144|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|38
1124369|NCT01264770|2722145|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|36
1124370|NCT01264770|2722140|P6|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|0
1124371|NCT01264770|2722141|P5|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
1124372|NCT01264770|2722142|P4|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|3
1124373|NCT01264770|2722143|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
1124374|NCT01264770|2722144|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|5
1124375|NCT01264770|2722145|P1|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
1124376|NCT01264770|2722140|P6|STARTED|Overall Study|Patients who received treatment|25
1124377|NCT01264770|2722141|P5|STARTED|Overall Study|Patients who received treatment|27
1124378|NCT01264770|2722142|P4|STARTED|Overall Study|Patients who received treatment|54
1124379|NCT01264770|2722143|P3|STARTED|Overall Study|Patients who received treatment|57
1124380|NCT01264770|2722144|P2|STARTED|Overall Study|Patients who received treatment|48
1124381|NCT01264770|2722145|P1|STARTED|Overall Study|Patients who received treatment|54
1124382|NCT01264835|2722229|P1|NOT COMPLETED|Overall Study||1
1124383|NCT01264835|2722229|P1|COMPLETED|Overall Study||1
1124384|NCT01264835|2722229|P1|STARTED|Overall Study||2
1124385|NCT01264887|2722233|P1|NOT COMPLETED|Overall Study||31
1124386|NCT01264887|2722233|P1|COMPLETED|Overall Study||0
1124387|NCT01264887|2722233|P1|STARTED|Overall Study||31
1124388|NCT01264939|2722246|P2|NOT COMPLETED|Overall Study||28
1124389|NCT01264939|2722247|P1|NOT COMPLETED|Overall Study||18
1124390|NCT01264939|2722246|P2|COMPLETED|Overall Study||224
1124391|NCT01264939|2722247|P1|COMPLETED|Overall Study||66
1124392|NCT01264939|2722246|P2|STARTED|Overall Study||252
1124393|NCT01264939|2722247|P1|STARTED|Overall Study||84
1124394|NCT01264952|2722276|P3|NOT COMPLETED|Overall Study||0
1124395|NCT01264952|2722277|P2|NOT COMPLETED|Overall Study||0
1124396|NCT01264952|2722278|P1|NOT COMPLETED|Overall Study||0
1124397|NCT01264952|2722276|P3|COMPLETED|Overall Study||8
1124398|NCT01264952|2722277|P2|COMPLETED|Overall Study||2
1124399|NCT01264952|2722278|P1|COMPLETED|Overall Study||6
1124400|NCT01264952|2722276|P3|STARTED|Overall Study||8
1124401|NCT01264952|2722277|P2|STARTED|Overall Study||2
1124402|NCT01264952|2722278|P1|STARTED|Overall Study||6
1124403|NCT01265056|2722294|P2|NOT COMPLETED|Overall Study||2
1124404|NCT01265056|2722295|P1|NOT COMPLETED|Overall Study||2
1124405|NCT01265056|2722294|P2|COMPLETED|Overall Study||25
1124406|NCT01265056|2722295|P1|COMPLETED|Overall Study||24
1124407|NCT01265056|2722294|P2|STARTED|Overall Study||27
1124408|NCT01265056|2722295|P1|STARTED|Overall Study||26
1124409|NCT01265394|2722301|P1|NOT COMPLETED|Overall Study||37
1124410|NCT01265394|2722301|P1|COMPLETED|Overall Study||181
1124411|NCT01265394|2722301|P1|STARTED|Overall Study||218
1124412|NCT01265420|2722306|P1|NOT COMPLETED|Overall Study||1
1124413|NCT01265420|2722306|P1|COMPLETED|Overall Study|One patient was seen at Day 10 but did not return for Day 30 evaluation|6
1124414|NCT01265420|2722306|P1|STARTED|Overall Study||7
1124415|NCT01265446|2722312|P2|NOT COMPLETED|Overall Study||0
1124416|NCT01265446|2722313|P1|NOT COMPLETED|Overall Study||1
1124417|NCT01265446|2722312|P2|COMPLETED|Overall Study||125
1124418|NCT01265446|2722313|P1|COMPLETED|Overall Study||124
1124419|NCT01265446|2722312|P2|STARTED|Overall Study||125
1124420|NCT01265446|2722313|P1|STARTED|Overall Study||125
1124421|NCT01265459|2722324|P3|NOT COMPLETED|Overall Study||2
1124422|NCT01265459|2722325|P2|NOT COMPLETED|Overall Study||0
1124423|NCT01265459|2722326|P1|NOT COMPLETED|Overall Study||0
1124424|NCT01265459|2722324|P3|COMPLETED|Overall Study||20
1124425|NCT01265459|2722325|P2|COMPLETED|Overall Study||23
1124426|NCT01265459|2722326|P1|COMPLETED|Overall Study||23
1124427|NCT01265459|2722324|P3|STARTED|Overall Study||22
1124428|NCT01265459|2722325|P2|STARTED|Overall Study||23
1124429|NCT01265459|2722326|P1|STARTED|Overall Study||23
1124430|NCT01265498|2722348|P2|NOT COMPLETED|Overall Study||33
1124431|NCT01265498|2722349|P1|NOT COMPLETED|Overall Study||31
1124432|NCT01265498|2722348|P2|COMPLETED|Overall Study||109
1124433|NCT01265498|2722349|P1|COMPLETED|Overall Study||110
1124434|NCT01265498|2722348|P2|Both Baseline and Week 72 Biopsy|Overall Study||98
1124435|NCT01265498|2722349|P1|Both Baseline and Week 72 Biopsy|Overall Study||102
1124436|NCT01265498|2722348|P2|STARTED|Overall Study||142
1124437|NCT01265498|2722349|P1|STARTED|Overall Study||141
1124438|NCT01265511|2722451|P2|NOT COMPLETED|Overall Study||3
1124439|NCT01265511|2722452|P1|NOT COMPLETED|Overall Study||2
1124440|NCT01265511|2722451|P2|COMPLETED|Overall Study||5
1124441|NCT01265511|2722452|P1|COMPLETED|Overall Study||0
1124442|NCT01265511|2722451|P2|STARTED|Overall Study||8
1124443|NCT01265511|2722452|P1|STARTED|Overall Study||2
1124444|NCT01265524|2722466|P2|NOT COMPLETED|Overall Study||6
1124445|NCT01265524|2722467|P1|NOT COMPLETED|Overall Study||18
1124446|NCT01265524|2722466|P2|COMPLETED|Overall Study||46
1124447|NCT01265524|2722467|P1|COMPLETED|Overall Study||41
1124448|NCT01265524|2722466|P2|STARTED|Overall Study||52
1124449|NCT01265524|2722467|P1|STARTED|Overall Study||59
1124450|NCT01265563|2722490|P5|NOT COMPLETED|Overall Study||2
1124451|NCT01265563|2722491|P4|NOT COMPLETED|Overall Study||0
1124452|NCT01265563|2722492|P3|NOT COMPLETED|Overall Study||1
1124453|NCT01265563|2722493|P2|NOT COMPLETED|Overall Study||1
1124454|NCT01265563|2722494|P1|NOT COMPLETED|Overall Study||0
1124455|NCT01265563|2722490|P5|COMPLETED|Overall Study||14
1124456|NCT01265563|2722491|P4|COMPLETED|Overall Study||16
1124457|NCT01265563|2722492|P3|COMPLETED|Overall Study||16
1124458|NCT01265563|2722493|P2|COMPLETED|Overall Study||12
1124459|NCT01265563|2722494|P1|COMPLETED|Overall Study||16
1124460|NCT01265563|2722490|P5|STARTED|Overall Study||16
1124461|NCT01265563|2722491|P4|STARTED|Overall Study||16
1124462|NCT01265563|2722492|P3|STARTED|Overall Study||17
1124463|NCT01265563|2722493|P2|STARTED|Overall Study||13
1124464|NCT01265563|2722494|P1|STARTED|Overall Study||16
1124465|NCT01265615|2722515|P4|NOT COMPLETED|Overall Study||3
1124466|NCT01265615|2722516|P3|NOT COMPLETED|Overall Study||4
1124467|NCT01265615|2722517|P2|NOT COMPLETED|Overall Study||2
1124468|NCT01265615|2722518|P1|NOT COMPLETED|Overall Study||2
1124469|NCT01265615|2722515|P4|COMPLETED|Overall Study||27
1124470|NCT01265615|2722516|P3|COMPLETED|Overall Study||26
1124471|NCT01265615|2722517|P2|COMPLETED|Overall Study||28
1124472|NCT01265615|2722518|P1|COMPLETED|Overall Study||28
1124473|NCT01265615|2722515|P4|STARTED|Overall Study||30
1124474|NCT01265615|2722516|P3|STARTED|Overall Study||30
1124475|NCT01265615|2722517|P2|STARTED|Overall Study||30
1124476|NCT01265615|2722518|P1|STARTED|Overall Study||30
1124477|NCT01265667|2722566|P2|NOT COMPLETED|Overall Study||13
1124478|NCT01265667|2722567|P1|NOT COMPLETED|Overall Study||20
1124479|NCT01265667|2722566|P2|COMPLETED|Overall Study||135
1124480|NCT01265667|2722567|P1|COMPLETED|Overall Study||125
1124481|NCT01265667|2722566|P2|STARTED|Overall Study||148
1124482|NCT01265667|2722567|P1|STARTED|Overall Study||145
1124483|NCT01265784|2722582|P3|NOT COMPLETED|Overall Study||4
1124484|NCT01265784|2722583|P2|NOT COMPLETED|Overall Study||8
1124485|NCT01265784|2722584|P1|NOT COMPLETED|Overall Study||12
1124486|NCT01265784|2722582|P3|COMPLETED|Overall Study||26
1124487|NCT01265784|2722583|P2|COMPLETED|Overall Study||49
1124488|NCT01265784|2722584|P1|COMPLETED|Overall Study||44
1124489|NCT01265784|2722582|P3|Received at Least 1 Dose of Study Drug|Overall Study||29
1124490|NCT01265784|2722583|P2|Received at Least 1 Dose of Study Drug|Overall Study||56
1124491|NCT01265784|2722584|P1|Received at Least 1 Dose of Study Drug|Overall Study|1 participant randomized to TP-434 1.5 mg/kg took ertapenem. Results are included in ertapenem arm.|54
1124492|NCT01265784|2722582|P3|STARTED|Overall Study||30
1124493|NCT01265784|2722583|P2|STARTED|Overall Study||57
1124494|NCT01265784|2722584|P1|STARTED|Overall Study||56
1124495|NCT01265797|2722652|P2|NOT COMPLETED|Open Label Month||1
1124496|NCT01265797|2722653|P1|NOT COMPLETED|Open Label Month||0
1124497|NCT01265797|2722652|P2|COMPLETED|Open Label Month||26
1124498|NCT01265797|2722653|P1|COMPLETED|Open Label Month||24
1124499|NCT01265797|2722652|P2|STARTED|Open Label Month||27
1124500|NCT01265797|2722653|P1|STARTED|Open Label Month||24
1124501|NCT01265797|2722652|P2|NOT COMPLETED|Blinded Month||2
1124502|NCT01265797|2722653|P1|NOT COMPLETED|Blinded Month||10
1124503|NCT01265797|2722652|P2|COMPLETED|Blinded Month||27
1124504|NCT01265797|2722653|P1|COMPLETED|Blinded Month||24
1124505|NCT01265797|2722652|P2|STARTED|Blinded Month||29
1124506|NCT01265797|2722653|P1|STARTED|Blinded Month||34
1124507|NCT01265797|2722652|P2|NOT COMPLETED|Run-in Month||5
1124508|NCT01265797|2722653|P1|NOT COMPLETED|Run-in Month||0
1124509|NCT01265797|2722652|P2|COMPLETED|Run-in Month||29
1124510|NCT01265797|2722653|P1|COMPLETED|Run-in Month||34
1124511|NCT01265797|2722652|P2|STARTED|Run-in Month||34
1124512|NCT01265797|2722653|P1|STARTED|Run-in Month||34
1124513|NCT01265823|2722681|P1|NOT COMPLETED|Overall Study||7
1124514|NCT01265823|2722681|P1|COMPLETED|Overall Study||143
1124515|NCT01265823|2722681|P1|STARTED|Overall Study||150
1124516|NCT01265875|2722708|P1|NOT COMPLETED|Overall Study||1
1124517|NCT01265875|2722708|P1|COMPLETED|Overall Study||11
1124518|NCT01265875|2722708|P1|STARTED|Overall Study||12
1124519|NCT01265953|2722718|P2|NOT COMPLETED|Overall Study||3
1124520|NCT01265953|2722719|P1|NOT COMPLETED|Overall Study||5
1124521|NCT01265953|2722718|P2|COMPLETED|Overall Study||45
1124522|NCT01265953|2722719|P1|COMPLETED|Overall Study||45
1124523|NCT01265953|2722718|P2|STARTED|Overall Study||48
1124524|NCT01265953|2722719|P1|STARTED|Overall Study||50
1124525|NCT01265966|2722734|P3|NOT COMPLETED|Overall Study||2
1124526|NCT01265966|2722735|P2|NOT COMPLETED|Overall Study||2
1124527|NCT01265966|2722736|P1|NOT COMPLETED|Overall Study||3
1124528|NCT01265966|2722734|P3|COMPLETED|Overall Study||27
1124529|NCT01265966|2722735|P2|COMPLETED|Overall Study||39
1124530|NCT01265966|2722736|P1|COMPLETED|Overall Study||44
1124531|NCT01265966|2722734|P3|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
1124532|NCT01265966|2722735|P2|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
1124533|NCT01265966|2722736|P1|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|3
1124534|NCT01265966|2722734|P3|STARTED|Overall Study||29
1124535|NCT01265966|2722735|P2|STARTED|Overall Study||41
1124536|NCT01265966|2722736|P1|STARTED|Overall Study||47
1124537|NCT01265992|2722744|P1|NOT COMPLETED|Overall Study||9
1124538|NCT01265992|2722744|P1|COMPLETED|Overall Study||41
1124539|NCT01265992|2722744|P1|Received Treatment|Overall Study||49
1124540|NCT01265992|2722744|P1|STARTED|Overall Study||50
1124541|NCT01266018|2722757|P2|NOT COMPLETED|Overall Study||1
1124542|NCT01266018|2722758|P1|NOT COMPLETED|Overall Study||1
1124543|NCT01266018|2722757|P2|COMPLETED|Overall Study||12
1124544|NCT01266018|2722758|P1|COMPLETED|Overall Study|Defined as evaluable for the primary endpoint|8
1124545|NCT01266018|2722757|P2|STARTED|Overall Study||13
1124546|NCT01266018|2722758|P1|STARTED|Overall Study||9
1124547|NCT01266031|2722772|P3|NOT COMPLETED|Overall Study||3
1124548|NCT01266031|2722773|P2|NOT COMPLETED|Overall Study||3
1124549|NCT01266031|2722774|P1|NOT COMPLETED|Overall Study||0
1124550|NCT01266031|2722772|P3|COMPLETED|Overall Study||46
1124551|NCT01266031|2722773|P2|COMPLETED|Overall Study||38
1124552|NCT01266031|2722774|P1|COMPLETED|Overall Study||6
1124553|NCT01266031|2722772|P3|STARTED|Overall Study||49
1124554|NCT01266031|2722773|P2|STARTED|Overall Study||41
1124555|NCT01266031|2722774|P1|STARTED|Overall Study||6
1124556|NCT01266070|2722782|P1|NOT COMPLETED|Overall Study||4
1124557|NCT01266070|2722782|P1|COMPLETED|Overall Study||2
1124558|NCT01266070|2722782|P1|STARTED|Overall Study||6
1124559|NCT01266122|2722789|P2|NOT COMPLETED|Overall Study||6
1124560|NCT01266122|2722790|P1|NOT COMPLETED|Overall Study||6
1124561|NCT01266122|2722789|P2|COMPLETED|Overall Study||42
1124562|NCT01266122|2722790|P1|COMPLETED|Overall Study||42
1124563|NCT01266122|2722789|P2|STARTED|Overall Study||48
1124564|NCT01266122|2722790|P1|STARTED|Overall Study||48
1124565|NCT01266148|2722800|P2|NOT COMPLETED|Overall Study||3
1124566|NCT01266148|2722801|P1|NOT COMPLETED|Overall Study||7
1124567|NCT01266148|2722800|P2|COMPLETED|Overall Study||56
1124568|NCT01266148|2722801|P1|COMPLETED|Overall Study||49
1124569|NCT01266148|2722800|P2|STARTED|Overall Study||59
1124570|NCT01266148|2722801|P1|STARTED|Overall Study||56
1124571|NCT01266265|2722829|P2|NOT COMPLETED|Overall Study||190
1124572|NCT01266265|2722830|P1|NOT COMPLETED|Overall Study||205
1124573|NCT01266265|2722829|P2|COMPLETED|Overall Study||477
1124574|NCT01266265|2722830|P1|COMPLETED|Overall Study||461
1124575|NCT01266265|2722829|P2|STARTED|Overall Study||667
1124576|NCT01266265|2722830|P1|STARTED|Overall Study||666
1124577|NCT01266291|2722836|P1|NOT COMPLETED|Overall Study||1
1124578|NCT01266291|2722836|P1|COMPLETED|Overall Study||0
1124579|NCT01266291|2722836|P1|STARTED|Overall Study||1
1124580|NCT01266447|2722841|P1|NOT COMPLETED|Overall Study||0
1124581|NCT01266447|2722841|P1|COMPLETED|Overall Study|Eligible and treated patients|27
1124582|NCT01266447|2722841|P1|STARTED|Overall Study||27
1124583|NCT01257204|2722853|P3|NOT COMPLETED|Follow-up Period (up to Week 48)||10
1124584|NCT01257204|2722854|P2|NOT COMPLETED|Follow-up Period (up to Week 48)||6
1124585|NCT01257204|2722855|P1|NOT COMPLETED|Follow-up Period (up to Week 48)||1
1124586|NCT01257204|2722853|P3|COMPLETED|Follow-up Period (up to Week 48)||39
1124587|NCT01257204|2722854|P2|COMPLETED|Follow-up Period (up to Week 48)||41
1124588|NCT01257204|2722855|P1|COMPLETED|Follow-up Period (up to Week 48)||48
1124589|NCT01257204|2722853|P3|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
1124590|NCT01257204|2722854|P2|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|47
1124591|NCT01257204|2722855|P1|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
1124592|NCT01257204|2722853|P3|NOT COMPLETED|Treatment Period (up to Week 24)||9
1124593|NCT01257204|2722854|P2|NOT COMPLETED|Treatment Period (up to Week 24)||6
1124594|NCT01257204|2722855|P1|NOT COMPLETED|Treatment Period (up to Week 24)||5
1124595|NCT01257204|2722853|P3|COMPLETED|Treatment Period (up to Week 24)||42
1124596|NCT01257204|2722854|P2|COMPLETED|Treatment Period (up to Week 24)||44
1124597|NCT01257204|2722855|P1|COMPLETED|Treatment Period (up to Week 24)||45
1124598|NCT01257204|2722853|P3|STARTED|Treatment Period (up to Week 24)||51
1124599|NCT01257204|2722854|P2|STARTED|Treatment Period (up to Week 24)||50
1124600|NCT01257204|2722855|P1|STARTED|Treatment Period (up to Week 24)||50
1124601|NCT01257217|2722901|P2|NOT COMPLETED|Overall Study||0
1124602|NCT01257217|2722902|P1|NOT COMPLETED|Overall Study||2
1124603|NCT01257217|2722901|P2|COMPLETED|Overall Study||10
1124604|NCT01257217|2722902|P1|COMPLETED|Overall Study||13
1124605|NCT01257217|2722901|P2|STARTED|Overall Study||10
1124606|NCT01257217|2722902|P1|STARTED|Overall Study||15
1124607|NCT01257230|2722923|P3|NOT COMPLETED|Overall Study||6
1124608|NCT01257230|2722924|P2|NOT COMPLETED|Overall Study||10
1124609|NCT01257230|2722925|P1|NOT COMPLETED|Overall Study||6
1124610|NCT01257230|2722923|P3|COMPLETED|Overall Study||129
1124611|NCT01257230|2722924|P2|COMPLETED|Overall Study||115
1124612|NCT01257230|2722925|P1|COMPLETED|Overall Study||132
1124613|NCT01257230|2722923|P3|STARTED|Overall Study||135
1124614|NCT01257230|2722924|P2|STARTED|Overall Study||125
1124615|NCT01257230|2722925|P1|STARTED|Overall Study||138
1124616|NCT01257347|2722982|P4|NOT COMPLETED|Overall Study||0
1124617|NCT01257347|2722983|P3|NOT COMPLETED|Overall Study||0
1124618|NCT01257347|2722984|P2|NOT COMPLETED|Overall Study||0
1124619|NCT01257347|2722985|P1|NOT COMPLETED|Overall Study||0
1124620|NCT01257347|2722982|P4|COMPLETED|Overall Study||65
1124621|NCT01257347|2722983|P3|COMPLETED|Overall Study||35
1124622|NCT01257347|2722984|P2|COMPLETED|Overall Study||12
1124623|NCT01257347|2722985|P1|COMPLETED|Overall Study||12
1124624|NCT01257347|2722982|P4|STARTED|Overall Study||65
1124625|NCT01257347|2722983|P3|STARTED|Overall Study||35
1124626|NCT01257347|2722984|P2|STARTED|Overall Study|Median patients per provider = 4; range 1-13 (65 patients)|12
1124627|NCT01257347|2722985|P1|STARTED|Overall Study|Median patients per provider = 3; range 1-10 (35 patients)|12
1124628|NCT01257425|2723001|P2|NOT COMPLETED|Overall Study||6
1124629|NCT01257425|2723002|P1|NOT COMPLETED|Overall Study||6
1124630|NCT01257425|2723001|P2|COMPLETED|Overall Study||45
1124631|NCT01257425|2723002|P1|COMPLETED|Overall Study||46
1124632|NCT01257425|2723001|P2|STARTED|Overall Study||51
1124633|NCT01257425|2723002|P1|STARTED|Overall Study||52
1124634|NCT01257438|2723022|P2|NOT COMPLETED|Overall Study||46
1124635|NCT01257438|2723023|P1|NOT COMPLETED|Overall Study||30
1124636|NCT01257438|2723022|P2|COMPLETED|Overall Study||97
1124637|NCT01257438|2723023|P1|COMPLETED|Overall Study||102
1124638|NCT01257438|2723022|P2|STARTED|Overall Study||143
1124639|NCT01257438|2723023|P1|STARTED|Overall Study||132
1124640|NCT01257503|2723035|P2|NOT COMPLETED|Overall Study||11
1124641|NCT01257503|2723036|P1|NOT COMPLETED|Overall Study||8
1124642|NCT01257503|2723035|P2|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|119
1124643|NCT01257503|2723036|P1|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|125
1124644|NCT01257503|2723035|P2|Returned Dosage Logbooks|Overall Study||80
1124645|NCT01257503|2723036|P1|Returned Dosage Logbooks|Overall Study||75
1124646|NCT01257503|2723035|P2|Returned Symptom Diaries|Overall Study||83
1124647|NCT01257503|2723036|P1|Returned Symptom Diaries|Overall Study||80
1124648|NCT01257503|2723035|P2|STARTED|Overall Study||130
1124649|NCT01257503|2723036|P1|STARTED|Overall Study||133
1124656|NCT01257581|2723074|P3|NOT COMPLETED|Overall Study||6
1124657|NCT01257581|2723075|P2|NOT COMPLETED|Overall Study||3
1124658|NCT01257581|2723076|P1|NOT COMPLETED|Overall Study||5
1124659|NCT01257581|2723074|P3|COMPLETED|Overall Study||11
1124660|NCT01257581|2723075|P2|COMPLETED|Overall Study||18
1124661|NCT01257581|2723076|P1|COMPLETED|Overall Study||17
1124662|NCT01257581|2723074|P3|STARTED|Overall Study||17
1124663|NCT01257581|2723075|P2|STARTED|Overall Study||21
1124664|NCT01257581|2723076|P1|STARTED|Overall Study||22
1124668|NCT01257802|2723121|P2|NOT COMPLETED|Overall Study||6
1124669|NCT01257802|2723122|P1|NOT COMPLETED|Overall Study||1
1124670|NCT01257802|2723121|P2|COMPLETED|Overall Study||2
1124671|NCT01257802|2723122|P1|COMPLETED|Overall Study||5
1124672|NCT01257802|2723121|P2|6 Month / 24 Week Visit|Overall Study||2
1124673|NCT01257802|2723122|P1|6 Month / 24 Week Visit|Overall Study||5
1124674|NCT01257802|2723121|P2|STARTED|Overall Study||8
1124675|NCT01257802|2723122|P1|STARTED|Overall Study||6
1124676|NCT01257880|2723138|P2|NOT COMPLETED|Overall Study||0
1124677|NCT01257880|2723139|P1|NOT COMPLETED|Overall Study||0
1124678|NCT01257880|2723138|P2|COMPLETED|Overall Study||19
1124679|NCT01257880|2723139|P1|COMPLETED|Overall Study||12
1124680|NCT01257880|2723138|P2|STARTED|Overall Study||19
1124681|NCT01257880|2723139|P1|STARTED|Overall Study||12
1124682|NCT01258049|2723149|P2|NOT COMPLETED|Overall Study||2
1124683|NCT01258049|2723150|P1|NOT COMPLETED|Overall Study||2
1124684|NCT01258049|2723149|P2|COMPLETED|Overall Study||72
1124685|NCT01258049|2723150|P1|COMPLETED|Overall Study||75
1124686|NCT01258049|2723149|P2|STARTED|Overall Study||74
1124687|NCT01258049|2723150|P1|STARTED|Overall Study||77
1124688|NCT01258101|2723190|P4|NOT COMPLETED|Overall Study||25
1124689|NCT01258101|2723191|P3|NOT COMPLETED|Overall Study||11
1124690|NCT01258101|2723192|P2|NOT COMPLETED|Overall Study||34
1124691|NCT01258101|2723193|P1|NOT COMPLETED|Overall Study||33
1124692|NCT01258101|2723190|P4|COMPLETED|Overall Study||27
1124693|NCT01258101|2723191|P3|COMPLETED|Overall Study||22
1124694|NCT01258101|2723192|P2|COMPLETED|Overall Study||110
1124695|NCT01258101|2723193|P1|COMPLETED|Overall Study||118
1124696|NCT01258101|2723190|P4|Standard Analysis Population|Overall Study||26
1124697|NCT01258101|2723191|P3|Standard Analysis Population|Overall Study||21
1124698|NCT01258101|2723192|P2|Standard Analysis Population|Overall Study||110
1124699|NCT01258101|2723193|P1|Standard Analysis Population|Overall Study||115
1124700|NCT01258101|2723190|P4|Safety Analysis Population|Overall Study||48
1124701|NCT01258101|2723191|P3|Safety Analysis Population|Overall Study||30
1124702|NCT01258101|2723192|P2|Safety Analysis Population|Overall Study||141
1124703|NCT01258101|2723193|P1|Safety Analysis Population|Overall Study||144
1124704|NCT01258101|2723190|P4|STARTED|Overall Study||52
1124705|NCT01258101|2723191|P3|STARTED|Overall Study||33
1124706|NCT01258101|2723192|P2|STARTED|Overall Study||144
1124707|NCT01258101|2723193|P1|STARTED|Overall Study||151
1124708|NCT01258153|2723246|P3|NOT COMPLETED|Overall Study||1
1124709|NCT01258153|2723247|P2|NOT COMPLETED|Overall Study||1
1124710|NCT01258153|2723248|P1|NOT COMPLETED|Overall Study||1
1124711|NCT01258153|2723246|P3|COMPLETED|Overall Study||36
1124712|NCT01258153|2723247|P2|COMPLETED|Overall Study||37
1124713|NCT01258153|2723248|P1|COMPLETED|Overall Study||39
1124714|NCT01258153|2723246|P3|STARTED|Overall Study||37
1124715|NCT01258153|2723247|P2|STARTED|Overall Study||38
1124716|NCT01258153|2723248|P1|STARTED|Overall Study||40
1124717|NCT01258387|2723279|P7|NOT COMPLETED|Overall Study||0
1124718|NCT01258387|2723280|P6|NOT COMPLETED|Overall Study||0
1124719|NCT01258387|2723281|P5|NOT COMPLETED|Overall Study||0
1124720|NCT01258387|2723282|P4|NOT COMPLETED|Overall Study||0
1124721|NCT01258387|2723283|P3|NOT COMPLETED|Overall Study||0
1124722|NCT01258387|2723284|P2|NOT COMPLETED|Overall Study||0
1124723|NCT01258387|2723285|P1|NOT COMPLETED|Overall Study||0
1124724|NCT01258387|2723279|P7|COMPLETED|Overall Study||4
1124725|NCT01258387|2723280|P6|COMPLETED|Overall Study||6
1124726|NCT01258387|2723281|P5|COMPLETED|Overall Study||6
1124727|NCT01258387|2723282|P4|COMPLETED|Overall Study||6
1124728|NCT01258387|2723283|P3|COMPLETED|Overall Study||6
1124729|NCT01258387|2723284|P2|COMPLETED|Overall Study||6
1124730|NCT01258387|2723285|P1|COMPLETED|Overall Study||6
1124731|NCT01258387|2723279|P7|Patients Randomized to Placebo|Overall Study||1
1124732|NCT01258387|2723280|P6|Patients Randomized to Placebo|Overall Study||2
1124733|NCT01258387|2723281|P5|Patients Randomized to Placebo|Overall Study||2
1124734|NCT01258387|2723282|P4|Patients Randomized to Placebo|Overall Study||2
1124735|NCT01258387|2723283|P3|Patients Randomized to Placebo|Overall Study||2
1124736|NCT01258387|2723284|P2|Patients Randomized to Placebo|Overall Study||2
1124737|NCT01258387|2723285|P1|Patients Randomized to Placebo|Overall Study||2
1124738|NCT01258387|2723279|P7|Patients Randomized to GGF2|Overall Study||3
1124739|NCT01258387|2723280|P6|Patients Randomized to GGF2|Overall Study||4
1124740|NCT01258387|2723281|P5|Patients Randomized to GGF2|Overall Study||4
1124741|NCT01258387|2723282|P4|Patients Randomized to GGF2|Overall Study||4
1124742|NCT01258387|2723283|P3|Patients Randomized to GGF2|Overall Study||4
1124743|NCT01258387|2723284|P2|Patients Randomized to GGF2|Overall Study||4
1124744|NCT01258387|2723285|P1|Patients Randomized to GGF2|Overall Study||4
1124745|NCT01258387|2723279|P7|STARTED|Overall Study||4
1124746|NCT01258387|2723280|P6|STARTED|Overall Study||6
1124747|NCT01258387|2723281|P5|STARTED|Overall Study||6
1124748|NCT01258387|2723282|P4|STARTED|Overall Study||6
1124749|NCT01258387|2723283|P3|STARTED|Overall Study||6
1124750|NCT01258387|2723284|P2|STARTED|Overall Study||6
1124751|NCT01258387|2723285|P1|STARTED|Overall Study||6
1124752|NCT01258504|2723327|P1|NOT COMPLETED|Bosentan and SJW||0
1124753|NCT01258504|2723327|P1|COMPLETED|Bosentan and SJW||13
1124754|NCT01258504|2723327|P1|STARTED|Bosentan and SJW||13
1124755|NCT01258504|2723327|P1|NOT COMPLETED|Bosentan Steady-state||0
1124756|NCT01258504|2723327|P1|COMPLETED|Bosentan Steady-state||13
1124757|NCT01258504|2723327|P1|STARTED|Bosentan Steady-state||13
1124758|NCT01258504|2723327|P1|NOT COMPLETED|Bosentan Single Dose||0
1124759|NCT01258504|2723327|P1|COMPLETED|Bosentan Single Dose||13
1124760|NCT01258504|2723327|P1|STARTED|Bosentan Single Dose||13
1124761|NCT01258582|2723340|P2|NOT COMPLETED|Overall Study||258
1124762|NCT01258582|2723341|P1|NOT COMPLETED|Overall Study||282
1124763|NCT01258582|2723340|P2|COMPLETED|Overall Study||563
1124764|NCT01258582|2723341|P1|COMPLETED|Overall Study||548
1124765|NCT01258582|2723340|P2|STARTED|Overall Study||821
1124766|NCT01258582|2723341|P1|STARTED|Overall Study||830
1124767|NCT01258595|2723349|P2|NOT COMPLETED|Overall Study||1
1124768|NCT01258595|2723350|P1|NOT COMPLETED|Overall Study||1
1124769|NCT01258595|2723349|P2|COMPLETED|Overall Study||151
1124770|NCT01258595|2723350|P1|COMPLETED|Overall Study||147
1124771|NCT01258595|2723349|P2|STARTED|Overall Study||152
1124772|NCT01258595|2723350|P1|STARTED|Overall Study||148
1124773|NCT01258660|2723366|P2|NOT COMPLETED|Overall Study||11
1124774|NCT01258660|2723367|P1|NOT COMPLETED|Overall Study||11
1124775|NCT01258660|2723366|P2|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
1124776|NCT01258660|2723367|P1|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
1124777|NCT01258660|2723366|P2|Completed Treatment|Overall Study||81
1124778|NCT01258660|2723367|P1|Completed Treatment|Overall Study||79
1124779|NCT01258660|2723366|P2|Received Treatment|Overall Study||82
1124780|NCT01258660|2723367|P1|Received Treatment|Overall Study||79
1124781|NCT01258660|2723366|P2|STARTED|Overall Study|randomized and received at least one dose of treatment|86
1124782|NCT01258660|2723367|P1|STARTED|Overall Study|randomized and received at least one dose of treatment|86
1124783|NCT01258738|2723386|P2|NOT COMPLETED|Open-label Period||21
1124784|NCT01258738|2723387|P1|NOT COMPLETED|Open-label Period||17
1124785|NCT01258738|2723386|P2|COMPLETED|Open-label Period||85
1124786|NCT01258738|2723387|P1|COMPLETED|Open-label Period||85
1124787|NCT01258738|2723386|P2|STARTED|Open-label Period||106
1124788|NCT01258738|2723387|P1|STARTED|Open-label Period||102
1124789|NCT01258738|2723386|P2|NOT COMPLETED|Double-blind Period||7
1124790|NCT01258738|2723387|P1|NOT COMPLETED|Double-blind Period||9
1124791|NCT01258738|2723386|P2|COMPLETED|Double-blind Period|Only 106 participants entered the open label period.|107
1124792|NCT01258738|2723387|P1|COMPLETED|Double-blind Period||102
1124793|NCT01258738|2723386|P2|Treated|Double-blind Period||113
1124794|NCT01258738|2723387|P1|Treated|Double-blind Period||111
1124795|NCT01258738|2723386|P2|STARTED|Double-blind Period||114
1124796|NCT01258738|2723387|P1|STARTED|Double-blind Period||111
1124797|NCT01266824|2723525|P2|NOT COMPLETED|Overall Study||3
1124798|NCT01266824|2723526|P1|NOT COMPLETED|Overall Study||2
1124799|NCT01266824|2723525|P2|COMPLETED|Overall Study||0
1124800|NCT01266824|2723526|P1|COMPLETED|Overall Study||0
1124801|NCT01266824|2723525|P2|STARTED|Overall Study||3
1124802|NCT01266824|2723526|P1|STARTED|Overall Study||2
1124803|NCT01266850|2723543|P5|NOT COMPLETED|Overall Study||30
1124804|NCT01266850|2723544|P4|NOT COMPLETED|Overall Study||28
1124805|NCT01266850|2723545|P3|NOT COMPLETED|Overall Study||24
1124806|NCT01266850|2723546|P2|NOT COMPLETED|Overall Study||36
1124807|NCT01266850|2723547|P1|NOT COMPLETED|Overall Study||30
1124808|NCT01266850|2723543|P5|COMPLETED|Overall Study||297
1124809|NCT01266850|2723544|P4|COMPLETED|Overall Study||301
1124810|NCT01266850|2723545|P3|COMPLETED|Overall Study||214
1124811|NCT01266850|2723546|P2|COMPLETED|Overall Study||212
1124812|NCT01266850|2723547|P1|COMPLETED|Overall Study||212
1124813|NCT01266850|2723543|P5|Received Third Vaccine|Overall Study||299
1124814|NCT01266850|2723544|P4|Received Third Vaccine|Overall Study||0
1124815|NCT01266850|2723545|P3|Received Third Vaccine|Overall Study||217
1124816|NCT01266850|2723546|P2|Received Third Vaccine|Overall Study||221
1124817|NCT01266850|2723547|P1|Received Third Vaccine|Overall Study||221
1124818|NCT01266850|2723543|P5|Received Second Vaccine|Overall Study||307
1124819|NCT01266850|2723544|P4|Received Second Vaccine|Overall Study||311
1124820|NCT01266850|2723545|P3|Received Second Vaccine|Overall Study||227
1124821|NCT01266850|2723546|P2|Received Second Vaccine|Overall Study||233
1124822|NCT01266850|2723547|P1|Received Second Vaccine|Overall Study||231
1124823|NCT01266850|2723543|P5|STARTED|Overall Study||327
1124824|NCT01266850|2723544|P4|STARTED|Overall Study||329
1124825|NCT01266850|2723545|P3|STARTED|Overall Study||238
1124826|NCT01266850|2723546|P2|STARTED|Overall Study||248
1124827|NCT01266850|2723547|P1|STARTED|Overall Study||242
1124828|NCT01266876|2723604|P5|NOT COMPLETED|Overall Study||0
1124829|NCT01266876|2723605|P4|NOT COMPLETED|Overall Study||1
1124830|NCT01266876|2723606|P3|NOT COMPLETED|Overall Study||0
1124831|NCT01266876|2723607|P2|NOT COMPLETED|Overall Study||0
1124832|NCT01266876|2723608|P1|NOT COMPLETED|Overall Study||0
1124833|NCT01266876|2723604|P5|COMPLETED|Overall Study||16
1124834|NCT01266876|2723605|P4|COMPLETED|Overall Study||14
1124835|NCT01266876|2723606|P3|COMPLETED|Overall Study||16
1124836|NCT01266876|2723607|P2|COMPLETED|Overall Study||15
1124837|NCT01266876|2723608|P1|COMPLETED|Overall Study||15
1124838|NCT01266876|2723604|P5|STARTED|Overall Study||16
1124839|NCT01266876|2723605|P4|STARTED|Overall Study||15
1124840|NCT01266876|2723606|P3|STARTED|Overall Study||16
1124841|NCT01266876|2723607|P2|STARTED|Overall Study||15
1124842|NCT01266876|2723608|P1|STARTED|Overall Study||15
1124843|NCT01266967|2723712|P2|NOT COMPLETED|Overall Study||83
1124844|NCT01266967|2723713|P1|NOT COMPLETED|Overall Study||89
1124845|NCT01266967|2723712|P2|COMPLETED|Overall Study||0
1124846|NCT01266967|2723713|P1|COMPLETED|Overall Study||0
1124847|NCT01266967|2723712|P2|STARTED|Overall Study||83
1124848|NCT01266967|2723713|P1|STARTED|Overall Study||89
1124849|NCT01267019|2723763|P3|NOT COMPLETED|Overall Study||6
1124850|NCT01267019|2723764|P2|NOT COMPLETED|Overall Study||6
1124851|NCT01267019|2723765|P1|NOT COMPLETED|Overall Study||6
1124852|NCT01267019|2723763|P3|COMPLETED|Overall Study||47
1124853|NCT01267019|2723764|P2|COMPLETED|Overall Study||47
1124854|NCT01267019|2723765|P1|COMPLETED|Overall Study||41
1124855|NCT01267019|2723763|P3|STARTED|Overall Study||53
1124856|NCT01267019|2723764|P2|STARTED|Overall Study||53
1124857|NCT01267019|2723765|P1|STARTED|Overall Study||47
1124858|NCT01267045|2723781|P2|NOT COMPLETED|6-month Outcome||3
1124859|NCT01267045|2723782|P1|NOT COMPLETED|6-month Outcome||0
1124860|NCT01267045|2723781|P2|COMPLETED|6-month Outcome||23
1124861|NCT01267045|2723782|P1|COMPLETED|6-month Outcome||22
1124862|NCT01267045|2723781|P2|STARTED|6-month Outcome||26
1124863|NCT01267045|2723782|P1|STARTED|6-month Outcome||22
1124864|NCT01267045|2723781|P2|NOT COMPLETED|2-month Outcomes||3
1124865|NCT01267045|2723782|P1|NOT COMPLETED|2-month Outcomes||4
1124866|NCT01267045|2723781|P2|COMPLETED|2-month Outcomes||26
1124867|NCT01267045|2723782|P1|COMPLETED|2-month Outcomes||22
1124868|NCT01267045|2723781|P2|STARTED|2-month Outcomes||29
1124869|NCT01267045|2723782|P1|STARTED|2-month Outcomes||26
1124870|NCT01267266|2723814|P2|NOT COMPLETED|Randomized Phase||0
1124871|NCT01267266|2723815|P1|NOT COMPLETED|Randomized Phase||0
1124872|NCT01267266|2723814|P2|COMPLETED|Randomized Phase||5
1124873|NCT01267266|2723815|P1|COMPLETED|Randomized Phase||3
1124874|NCT01267266|2723814|P2|STARTED|Randomized Phase|5 of 8 patients randomized to placebo.|5
1124875|NCT01267266|2723815|P1|STARTED|Randomized Phase|3 of 8 patients randomized to saracatinib.|3
1124876|NCT01267266|2723814|P2|NOT COMPLETED|Lead-in Phase||0
1124877|NCT01267266|2723815|P1|NOT COMPLETED|Lead-in Phase||23
1124878|NCT01267266|2723814|P2|COMPLETED|Lead-in Phase||0
1124879|NCT01267266|2723815|P1|COMPLETED|Lead-in Phase|12 patients had radiographic progression, 8 clinical progression, 2 toxicity, 1 withdrawal.|8
1124880|NCT01267266|2723814|P2|STARTED|Lead-in Phase||0
1124881|NCT01267266|2723815|P1|STARTED|Lead-in Phase||31
1124882|NCT01267266|2723814|P2|NOT COMPLETED|Enrollment Phase||0
1124883|NCT01267266|2723815|P1|NOT COMPLETED|Enrollment Phase||2
1124884|NCT01267266|2723814|P2|COMPLETED|Enrollment Phase||0
1124885|NCT01267266|2723815|P1|COMPLETED|Enrollment Phase|Two patients signed consent but did not proceed to treatment.|31
1124886|NCT01267266|2723814|P2|STARTED|Enrollment Phase||0
1124887|NCT01267266|2723815|P1|STARTED|Enrollment Phase||33
1124888|NCT01267292|2723830|P2|NOT COMPLETED|Overall Study||6
1124889|NCT01267292|2723831|P1|NOT COMPLETED|Overall Study||4
1124890|NCT01267292|2723830|P2|COMPLETED|Overall Study||20
1124891|NCT01267292|2723831|P1|COMPLETED|Overall Study||20
1124892|NCT01267292|2723830|P2|STARTED|Overall Study||26
1124893|NCT01267292|2723831|P1|STARTED|Overall Study||24
1124894|NCT01267422|2723865|P2|NOT COMPLETED|Safety and Efficacy Study||0
1124895|NCT01267422|2723866|P1|NOT COMPLETED|Safety and Efficacy Study||0
1124896|NCT01267422|2723865|P2|COMPLETED|Safety and Efficacy Study||4
1124897|NCT01267422|2723866|P1|COMPLETED|Safety and Efficacy Study||5
1124898|NCT01267422|2723865|P2|STARTED|Safety and Efficacy Study||4
1124899|NCT01267422|2723866|P1|STARTED|Safety and Efficacy Study||5
1124900|NCT01267422|2723865|P2|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
1124901|NCT01267422|2723866|P1|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
1124902|NCT01267422|2723865|P2|COMPLETED|Intravitreal rAAV2-ND4 Injection||4
1124903|NCT01267422|2723866|P1|COMPLETED|Intravitreal rAAV2-ND4 Injection||5
1124904|NCT01267422|2723865|P2|STARTED|Intravitreal rAAV2-ND4 Injection||4
1124905|NCT01267422|2723866|P1|STARTED|Intravitreal rAAV2-ND4 Injection||5
1124906|NCT01267929|2723886|P2|NOT COMPLETED|Overall Study||0
1124907|NCT01267929|2723887|P1|NOT COMPLETED|Overall Study||0
1124908|NCT01267929|2723886|P2|COMPLETED|Overall Study||15
1124909|NCT01267929|2723887|P1|COMPLETED|Overall Study||15
1124910|NCT01267929|2723886|P2|STARTED|Overall Study||15
1124911|NCT01267929|2723887|P1|STARTED|Overall Study||15
1124912|NCT01267994|2723893|P1|NOT COMPLETED|Overall Study||2
1124913|NCT01267994|2723893|P1|COMPLETED|Overall Study|Excluded from analysis, could not reach first milestone (day 28) for efficacy assessment, n=2|10
1124914|NCT01267994|2723893|P1|STARTED|Overall Study|Declined to participate. n=1 Did not receive intervention due to infeciton, n=1|12
1124915|NCT01268098|2723899|P2|NOT COMPLETED|Overall Study||0
1124916|NCT01268098|2723900|P1|NOT COMPLETED|Overall Study||1
1124917|NCT01268098|2723899|P2|COMPLETED|Overall Study||23
1124918|NCT01268098|2723900|P1|COMPLETED|Overall Study||18
1124919|NCT01268098|2723899|P2|STARTED|Overall Study||23
1124920|NCT01268098|2723900|P1|STARTED|Overall Study||19
1124921|NCT01268111|2723910|P2|NOT COMPLETED|Overall Study||0
1124922|NCT01268111|2723911|P1|NOT COMPLETED|Overall Study||0
1124923|NCT01268111|2723910|P2|COMPLETED|Overall Study||6
1124924|NCT01268111|2723911|P1|COMPLETED|Overall Study||6
1124925|NCT01268111|2723910|P2|STARTED|Overall Study||6
1124926|NCT01268111|2723911|P1|STARTED|Overall Study||6
1124927|NCT01268150|2723917|P1|NOT COMPLETED|Extension Phase||27
1124928|NCT01268150|2723917|P1|COMPLETED|Extension Phase||1
1124929|NCT01268150|2723917|P1|Treatment Ongoing at Data Cutoff Date|Extension Phase||1
1124930|NCT01268150|2723917|P1|STARTED|Extension Phase|28 participants discontinued study drug in Treatment Phase so did not enter the Extension Phase|28
1124931|NCT01268150|2723917|P1|NOT COMPLETED|Treatment Phase||28
1124932|NCT01268150|2723917|P1|COMPLETED|Treatment Phase||28
1124933|NCT01268150|2723917|P1|STARTED|Treatment Phase||56
1124934|NCT01268189|2723925|P1|NOT COMPLETED|Overall Study||3
1124935|NCT01268189|2723925|P1|COMPLETED|Overall Study||17
1124936|NCT01268189|2723925|P1|STARTED|Overall Study||20
1124937|NCT01268267|2723939|P1|NOT COMPLETED|Overall Study||1
1124938|NCT01268267|2723939|P1|COMPLETED|Overall Study||93
1124939|NCT01268267|2723939|P1|STARTED|Overall Study||94
1124940|NCT01268293|2723946|P1|NOT COMPLETED|Overall Study||9
1124941|NCT01268293|2723946|P1|COMPLETED|Overall Study||0
1124942|NCT01268293|2723946|P1|Completed Cycle 1|Overall Study||9
1124943|NCT01268293|2723946|P1|STARTED|Overall Study||9
1124944|NCT01268306|2723951|P1|NOT COMPLETED|Overall Study||1
1124945|NCT01268306|2723951|P1|COMPLETED|Overall Study||7
1124946|NCT01268306|2723951|P1|STARTED|Overall Study||8
1124947|NCT01268488|2723955|P1|NOT COMPLETED|Overall Study||5
1124948|NCT01268488|2723955|P1|COMPLETED|Overall Study||93
1124949|NCT01268488|2723955|P1|STARTED|Overall Study||98
1124950|NCT01268501|2723962|P1|NOT COMPLETED|Overall Study||9
1124951|NCT01268501|2723962|P1|COMPLETED|Overall Study||87
1124952|NCT01268501|2723962|P1|STARTED|Overall Study||96
1124953|NCT01268553|2723966|P1|NOT COMPLETED|Overall Study||0
1124954|NCT01268553|2723966|P1|COMPLETED|Overall Study||6
1124955|NCT01268553|2723966|P1|STARTED|Overall Study||6
1124956|NCT01268566|2723975|P1|NOT COMPLETED|Overall Study||43
1124957|NCT01268566|2723975|P1|COMPLETED|Overall Study||13
1124958|NCT01268566|2723975|P1|STARTED|Overall Study||56
1124959|NCT01268683|2723993|P1|NOT COMPLETED|Overall Study||0
1124960|NCT01268683|2723993|P1|COMPLETED|Overall Study||10
1124961|NCT01268683|2723993|P1|STARTED|Overall Study||10
1124962|NCT01268891|2724002|P2|NOT COMPLETED|Overall Study||8
1124963|NCT01268891|2724003|P1|NOT COMPLETED|Overall Study||8
1124964|NCT01268891|2724002|P2|COMPLETED|Overall Study||58
1124965|NCT01268891|2724003|P1|COMPLETED|Overall Study||58
1124966|NCT01268891|2724002|P2|STARTED|Overall Study||66
1124967|NCT01268891|2724003|P1|STARTED|Overall Study||66
1124968|NCT01268943|2724019|P4|NOT COMPLETED|Overall Study||0
1124969|NCT01268943|2724020|P3|NOT COMPLETED|Overall Study||0
1124970|NCT01268943|2724021|P2|NOT COMPLETED|Overall Study||0
1124971|NCT01268943|2724022|P1|NOT COMPLETED|Overall Study||0
1124972|NCT01268943|2724019|P4|COMPLETED|Overall Study||6
1124973|NCT01268943|2724020|P3|COMPLETED|Overall Study||3
1124974|NCT01268943|2724021|P2|COMPLETED|Overall Study||3
1124975|NCT01268943|2724022|P1|COMPLETED|Overall Study||6
1124976|NCT01268943|2724019|P4|STARTED|Overall Study||6
1124977|NCT01268943|2724020|P3|STARTED|Overall Study||3
1124978|NCT01268943|2724021|P2|STARTED|Overall Study||3
1124979|NCT01268943|2724022|P1|STARTED|Overall Study||6
1124980|NCT01269125|2724035|P3|NOT COMPLETED|Overall Study||0
1124981|NCT01269125|2724036|P2|NOT COMPLETED|Overall Study||5
1124982|NCT01269125|2724037|P1|NOT COMPLETED|Overall Study||7
1124983|NCT01269125|2724035|P3|COMPLETED|Overall Study||60
1124984|NCT01269125|2724036|P2|COMPLETED|Overall Study|OHSS:4; premature luteinization: 1|55
1124985|NCT01269125|2724037|P1|COMPLETED|Overall Study|lost to follow up:4; OHSS: 2; premature luteinization: 1|53
1124986|NCT01269125|2724035|P3|STARTED|Overall Study||60
1124987|NCT01269125|2724036|P2|STARTED|Overall Study||60
1124988|NCT01269125|2724037|P1|STARTED|Overall Study||60
1124989|NCT01269346|2724057|P1|NOT COMPLETED|Extension Phase||43
1124990|NCT01269346|2724057|P1|COMPLETED|Extension Phase||0
1124991|NCT01269346|2724057|P1|STARTED|Extension Phase|Out of 52 participants randomized, only 43 continued into the Extension Phase of the study.|43
1124992|NCT01269346|2724057|P1|NOT COMPLETED|Treatment Phase||9
1124993|NCT01269346|2724057|P1|COMPLETED|Treatment Phase||43
1124994|NCT01269346|2724057|P1|Completed 6 Cycles|Treatment Phase||45
1124995|NCT01269346|2724057|P1|STARTED|Treatment Phase||52
1124996|NCT01269710|2724065|P1|NOT COMPLETED|Overall Study||3
1124997|NCT01269710|2724065|P1|COMPLETED|Overall Study|This refers to Week 52.|1
1124998|NCT01269710|2724065|P1|Week 36|Overall Study||2
1124999|NCT01269710|2724065|P1|Week 12|Overall Study||3
1125000|NCT01269710|2724065|P1|STARTED|Overall Study||4
1125001|NCT01261975|2724073|P1|NOT COMPLETED|Overall Study||1
1125002|NCT01261975|2724073|P1|COMPLETED|Overall Study|35 Participants 70 eyes completed|35
1125003|NCT01261975|2724073|P1|STARTED|Overall Study|36 Participants 72 eyes started|36
1125004|NCT01262027|2724092|P1|NOT COMPLETED|Overall Study||5
1125005|NCT01262027|2724092|P1|COMPLETED|Overall Study||17
1125006|NCT01262027|2724092|P1|STARTED|Overall Study||22
1125007|NCT01262092|2724099|P2|NOT COMPLETED|Gabapentin Taper||0
1125008|NCT01262092|2724100|P1|NOT COMPLETED|Gabapentin Taper||1
1125009|NCT01262092|2724099|P2|COMPLETED|Gabapentin Taper||11
1125010|NCT01262092|2724100|P1|COMPLETED|Gabapentin Taper||9
1125011|NCT01262092|2724099|P2|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|11
1125012|NCT01262092|2724100|P1|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|10
1125013|NCT01262092|2724099|P2|NOT COMPLETED|Buprenorphine Taper||1
1125014|NCT01262092|2724100|P1|NOT COMPLETED|Buprenorphine Taper||1
1125015|NCT01262092|2724099|P2|COMPLETED|Buprenorphine Taper||12
1125016|NCT01262092|2724100|P1|COMPLETED|Buprenorphine Taper||11
1125017|NCT01262092|2724099|P2|STARTED|Buprenorphine Taper||13
1125018|NCT01262092|2724100|P1|STARTED|Buprenorphine Taper|One left the study prior to starting the taper due to pharmacy error (started taper in wk 2)|12
1125019|NCT01262092|2724099|P2|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||1
1125020|NCT01262092|2724100|P1|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||3
1125021|NCT01262092|2724099|P2|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
1125022|NCT01262092|2724100|P1|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
1125023|NCT01262092|2724099|P2|STARTED|Buprenorphine+Gabapentin/Plac Induction||14
1125024|NCT01262092|2724100|P1|STARTED|Buprenorphine+Gabapentin/Plac Induction||16
1125025|NCT01262105|2724108|P2|NOT COMPLETED|Overall Study||0
1125026|NCT01262105|2724109|P1|NOT COMPLETED|Overall Study||0
1125027|NCT01262105|2724108|P2|COMPLETED|Overall Study||10
1125028|NCT01262105|2724109|P1|COMPLETED|Overall Study||13
1125029|NCT01262105|2724108|P2|STARTED|Overall Study||10
1125030|NCT01262105|2724109|P1|STARTED|Overall Study||13
1125031|NCT01262118|2724117|P2|NOT COMPLETED|Treatment Period (6 Weeks)||0
1125032|NCT01262118|2724118|P1|NOT COMPLETED|Treatment Period (6 Weeks)||0
1125033|NCT01262118|2724117|P2|COMPLETED|Treatment Period (6 Weeks)||0
1125034|NCT01262118|2724118|P1|COMPLETED|Treatment Period (6 Weeks)||36
1125035|NCT01262118|2724117|P2|STARTED|Treatment Period (6 Weeks)||0
1125036|NCT01262118|2724118|P1|STARTED|Treatment Period (6 Weeks)||36
1125037|NCT01262118|2724117|P2|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
1125038|NCT01262118|2724118|P1|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
1125039|NCT01262118|2724117|P2|COMPLETED|Baseline Assessment Period (3 Days)||33
1125040|NCT01262118|2724118|P1|COMPLETED|Baseline Assessment Period (3 Days)||36
1125041|NCT01262118|2724117|P2|STARTED|Baseline Assessment Period (3 Days)||33
1125042|NCT01262118|2724118|P1|STARTED|Baseline Assessment Period (3 Days)||36
1125043|NCT01262131|2724145|P3|NOT COMPLETED|Overall Study||0
1125044|NCT01262131|2724146|P2|NOT COMPLETED|Overall Study||0
1125045|NCT01262131|2724147|P1|NOT COMPLETED|Overall Study||0
1125046|NCT01262131|2724145|P3|COMPLETED|Overall Study||4
1125047|NCT01262131|2724146|P2|COMPLETED|Overall Study||4
1125048|NCT01262131|2724147|P1|COMPLETED|Overall Study||5
1125049|NCT01262131|2724145|P3|STARTED|Overall Study||4
1125050|NCT01262131|2724146|P2|STARTED|Overall Study||4
1125051|NCT01262131|2724147|P1|STARTED|Overall Study||5
1125052|NCT01262287|2724157|P2|NOT COMPLETED|Overall Study||1
1125053|NCT01262287|2724158|P1|NOT COMPLETED|Overall Study||2
1125054|NCT01262287|2724157|P2|COMPLETED|Overall Study||18
1125055|NCT01262287|2724158|P1|COMPLETED|Overall Study||18
1125056|NCT01262287|2724157|P2|STARTED|Overall Study||19
1125057|NCT01262287|2724158|P1|STARTED|Overall Study||20
1125058|NCT01262339|2724168|P1|NOT COMPLETED|Overall Study||0
1125059|NCT01262339|2724168|P1|COMPLETED|Overall Study||2
1125060|NCT01262339|2724168|P1|STARTED|Overall Study||2
1125061|NCT01262352|2724174|P2|NOT COMPLETED|Period 2||0
1125062|NCT01262352|2724175|P1|NOT COMPLETED|Period 2||0
1125063|NCT01262352|2724174|P2|COMPLETED|Period 2||8
1125064|NCT01262352|2724175|P1|COMPLETED|Period 2||9
1125065|NCT01262352|2724174|P2|Dosed|Period 2||8
1125066|NCT01262352|2724175|P1|Dosed|Period 2||9
1125067|NCT01262352|2724174|P2|STARTED|Period 2||8
1125068|NCT01262352|2724175|P1|STARTED|Period 2||9
1125069|NCT01262352|2724174|P2|NOT COMPLETED|Washout||2
1125070|NCT01262352|2724175|P1|NOT COMPLETED|Washout||1
1125071|NCT01262352|2724174|P2|COMPLETED|Washout||8
1125072|NCT01262352|2724175|P1|COMPLETED|Washout||9
1125073|NCT01262352|2724174|P2|STARTED|Washout||10
1125074|NCT01262352|2724175|P1|STARTED|Washout||10
1125075|NCT01262352|2724174|P2|NOT COMPLETED|Period 1||0
1125076|NCT01262352|2724175|P1|NOT COMPLETED|Period 1||1
1125077|NCT01262352|2724174|P2|COMPLETED|Period 1||10
1125078|NCT01262352|2724175|P1|COMPLETED|Period 1||10
1125079|NCT01262352|2724174|P2|Dosed|Period 1||10
1125080|NCT01262352|2724175|P1|Dosed|Period 1||10
1125081|NCT01262352|2724174|P2|STARTED|Period 1||10
1125082|NCT01262352|2724175|P1|STARTED|Period 1||11
1125083|NCT01262456|2724190|P3|NOT COMPLETED|1-Month Open-Label Extension Period||5
1125084|NCT01262456|2724191|P2|NOT COMPLETED|1-Month Open-Label Extension Period||3
1125085|NCT01262456|2724192|P1|NOT COMPLETED|1-Month Open-Label Extension Period||4
1125086|NCT01262456|2724190|P3|COMPLETED|1-Month Open-Label Extension Period||98
1125087|NCT01262456|2724191|P2|COMPLETED|1-Month Open-Label Extension Period||97
1125088|NCT01262456|2724192|P1|COMPLETED|1-Month Open-Label Extension Period||120
1125089|NCT01262456|2724190|P3|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period|1 subject was randomized to Desmopressin 75 μg but received 50 μg. Also true in Double-Blind Period|102
1125090|NCT01262456|2724191|P2|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||101
1125091|NCT01262456|2724192|P1|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||124
1125092|NCT01262456|2724190|P3|STARTED|1-Month Open-Label Extension Period||103
1125093|NCT01262456|2724191|P2|STARTED|1-Month Open-Label Extension Period||100
1125094|NCT01262456|2724192|P1|STARTED|1-Month Open-Label Extension Period||124
1125095|NCT01262456|2724190|P3|NOT COMPLETED|3-Month Double-Blind Period||26
1125096|NCT01262456|2724191|P2|NOT COMPLETED|3-Month Double-Blind Period||23
1125097|NCT01262456|2724192|P1|NOT COMPLETED|3-Month Double-Blind Period||19
1125098|NCT01262456|2724190|P3|COMPLETED|3-Month Double-Blind Period||103
1125099|NCT01262456|2724191|P2|COMPLETED|3-Month Double-Blind Period||100
1125100|NCT01262456|2724192|P1|COMPLETED|3-Month Double-Blind Period||124
1125101|NCT01262456|2724190|P3|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|122
1125102|NCT01262456|2724191|P2|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|119
1125103|NCT01262456|2724192|P1|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|143
1125104|NCT01262456|2724190|P3|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|124
1125105|NCT01262456|2724191|P2|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|119
1125106|NCT01262456|2724192|P1|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|142
1125107|NCT01262456|2724190|P3|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|129
1125108|NCT01262456|2724191|P2|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|123
1125109|NCT01262456|2724192|P1|STARTED|3-Month Double-Blind Period|Intent-to-Treat (ITT) population: randomized participants regardless of exposure to treatment|143
1125110|NCT01262547|2724233|P1|NOT COMPLETED|Overall Study||0
1125111|NCT01262547|2724233|P1|COMPLETED|Overall Study||3
1125112|NCT01262547|2724233|P1|STARTED|Overall Study||3
1125113|NCT01262560|2724247|P3|NOT COMPLETED|Overall Study||2
1125114|NCT01262560|2724248|P2|NOT COMPLETED|Overall Study||1
1125115|NCT01262560|2724249|P1|NOT COMPLETED|Overall Study||0
1125116|NCT01262560|2724247|P3|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|54
1125117|NCT01262560|2724248|P2|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
1125118|NCT01262560|2724249|P1|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
1125119|NCT01262560|2724247|P3|STARTED|Overall Study||56
1125120|NCT01262560|2724248|P2|STARTED|Overall Study||54
1125121|NCT01262560|2724249|P1|STARTED|Overall Study||53
1125122|NCT01262573|2724286|P2|NOT COMPLETED|Overall Study||1
1125123|NCT01262573|2724287|P1|NOT COMPLETED|Overall Study||0
1125124|NCT01262573|2724286|P2|COMPLETED|Overall Study||31
1125125|NCT01262573|2724287|P1|COMPLETED|Overall Study||32
1125126|NCT01262573|2724286|P2|STARTED|Overall Study||32
1125127|NCT01262573|2724287|P1|STARTED|Overall Study||32
1125128|NCT01262599|2724297|P2|NOT COMPLETED|Overall Study||0
1125129|NCT01262599|2724298|P1|NOT COMPLETED|Overall Study||0
1125130|NCT01262599|2724297|P2|COMPLETED|Overall Study||16
1125131|NCT01262599|2724298|P1|COMPLETED|Overall Study||16
1125132|NCT01262599|2724297|P2|STARTED|Overall Study||16
1125133|NCT01262599|2724298|P1|STARTED|Overall Study||16
1125134|NCT01262755|2724304|P1|NOT COMPLETED|Overall Study||0
1125135|NCT01262755|2724304|P1|COMPLETED|Overall Study||450
1125136|NCT01262755|2724304|P1|STARTED|Overall Study||450
1125137|NCT01262820|2724308|P1|NOT COMPLETED|Overall Study||15
1125138|NCT01262820|2724308|P1|COMPLETED|Overall Study||0
1125139|NCT01262820|2724308|P1|STARTED|Overall Study||15
1125140|NCT01262846|2724317|P2|NOT COMPLETED|Overall Study||3
1125141|NCT01262846|2724318|P1|NOT COMPLETED|Overall Study||2
1125142|NCT01262846|2724317|P2|COMPLETED|Overall Study||97
1125143|NCT01262846|2724318|P1|COMPLETED|Overall Study||93
1125144|NCT01262846|2724317|P2|STARTED|Overall Study||100
1125145|NCT01262846|2724318|P1|STARTED|Overall Study||95
1125146|NCT01262872|2724332|P8|NOT COMPLETED|Step 2||6
1125147|NCT01262872|2724333|P7|NOT COMPLETED|Step 2||9
1125148|NCT01262872|2724334|P6|NOT COMPLETED|Step 2||9
1125149|NCT01262872|2724335|P5|NOT COMPLETED|Step 2||5
1125150|NCT01262872|2724336|P4|NOT COMPLETED|Step 2||10
1125151|NCT01262872|2724337|P3|NOT COMPLETED|Step 2||9
1125152|NCT01262872|2724338|P2|NOT COMPLETED|Step 2||0
1125153|NCT01262872|2724339|P1|NOT COMPLETED|Step 2||0
1125154|NCT01262872|2724332|P8|COMPLETED|Step 2||194
1125155|NCT01262872|2724333|P7|COMPLETED|Step 2||191
1125156|NCT01262872|2724334|P6|COMPLETED|Step 2||191
1125157|NCT01262872|2724335|P5|COMPLETED|Step 2||195
1125158|NCT01262872|2724336|P4|COMPLETED|Step 2||190
1125159|NCT01262872|2724337|P3|COMPLETED|Step 2||191
1125160|NCT01262872|2724338|P2|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1125161|NCT01262872|2724339|P1|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1125162|NCT01262872|2724332|P8|STARTED|Step 2||200
1125163|NCT01262872|2724333|P7|STARTED|Step 2||200
1125164|NCT01262872|2724334|P6|STARTED|Step 2||200
1125165|NCT01262872|2724335|P5|STARTED|Step 2||200
1125166|NCT01262872|2724336|P4|STARTED|Step 2||200
1125167|NCT01262872|2724337|P3|STARTED|Step 2||200
1125168|NCT01262872|2724338|P2|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1125169|NCT01262872|2724339|P1|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1125170|NCT01262872|2724332|P8|NOT COMPLETED|Step 1||0
1125171|NCT01262872|2724333|P7|NOT COMPLETED|Step 1||0
1125172|NCT01262872|2724334|P6|NOT COMPLETED|Step 1||0
1125173|NCT01262872|2724335|P5|NOT COMPLETED|Step 1||0
1125174|NCT01262872|2724336|P4|NOT COMPLETED|Step 1||0
1125175|NCT01262872|2724337|P3|NOT COMPLETED|Step 1||0
1125176|NCT01262872|2724338|P2|NOT COMPLETED|Step 1||0
1125177|NCT01262872|2724339|P1|NOT COMPLETED|Step 1||0
1125178|NCT01262872|2724332|P8|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1125179|NCT01262872|2724333|P7|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1125180|NCT01262872|2724334|P6|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1125181|NCT01262872|2724335|P5|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1125182|NCT01262872|2724336|P4|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone|0
1125183|NCT01262872|2724337|P3|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1125184|NCT01262872|2724338|P2|COMPLETED|Step 1||60
1125185|NCT01262872|2724339|P1|COMPLETED|Step 1||60
1125186|NCT01262872|2724332|P8|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1125187|NCT01262872|2724333|P7|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1125188|NCT01262872|2724334|P6|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1125189|NCT01262872|2724335|P5|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1125190|NCT01262872|2724336|P4|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1125191|NCT01262872|2724337|P3|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
1125192|NCT01262872|2724338|P2|STARTED|Step 1||60
1125193|NCT01262872|2724339|P1|STARTED|Step 1||60
1125194|NCT01262989|2724592|P2|NOT COMPLETED|Period 2||1
1125195|NCT01262989|2724593|P1|NOT COMPLETED|Period 2||0
1125196|NCT01262989|2724592|P2|COMPLETED|Period 2||16
1125197|NCT01262989|2724593|P1|COMPLETED|Period 2||19
1125198|NCT01262989|2724592|P2|STARTED|Period 2||17
1125199|NCT01262989|2724593|P1|STARTED|Period 2||19
1125200|NCT01262989|2724592|P2|NOT COMPLETED|7-Day Washout Period||0
1125201|NCT01262989|2724593|P1|NOT COMPLETED|7-Day Washout Period||0
1125202|NCT01262989|2724592|P2|COMPLETED|7-Day Washout Period||17
1125203|NCT01262989|2724593|P1|COMPLETED|7-Day Washout Period||19
1125204|NCT01262989|2724592|P2|STARTED|7-Day Washout Period||17
1125205|NCT01262989|2724593|P1|STARTED|7-Day Washout Period||19
1125206|NCT01262989|2724592|P2|NOT COMPLETED|Period 1||3
1125207|NCT01262989|2724593|P1|NOT COMPLETED|Period 1||1
1125208|NCT01262989|2724592|P2|COMPLETED|Period 1||17
1125209|NCT01262989|2724593|P1|COMPLETED|Period 1||19
1125210|NCT01262989|2724592|P2|STARTED|Period 1||20
1125211|NCT01262989|2724593|P1|STARTED|Period 1||20
1125212|NCT01263015|2724605|P2|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||31
1125213|NCT01263015|2724606|P1|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||24
1125214|NCT01263015|2724605|P2|COMPLETED|Open-label Phase: 48 Weeks Duration||278
1125215|NCT01263015|2724606|P1|COMPLETED|Open-label Phase: 48 Weeks Duration||317
1125216|NCT01263015|2724605|P2|STARTED|Open-label Phase: 48 Weeks Duration||309
1125217|NCT01263015|2724606|P1|STARTED|Open-label Phase: 48 Weeks Duration||341
1125218|NCT01263015|2724605|P2|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||109
1125219|NCT01263015|2724606|P1|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||72
1125220|NCT01263015|2724605|P2|COMPLETED|Double-blind Phase: 96 Weeks Duration||310
1125221|NCT01263015|2724606|P1|COMPLETED|Double-blind Phase: 96 Weeks Duration||342
1125222|NCT01263015|2724605|P2|STARTED|Double-blind Phase: 96 Weeks Duration||419
1125223|NCT01263015|2724606|P1|STARTED|Double-blind Phase: 96 Weeks Duration||414
1125224|NCT01263028|2724632|P1|NOT COMPLETED|Overall Study||6
1125225|NCT01263028|2724632|P1|COMPLETED|Overall Study||0
1125226|NCT01263028|2724632|P1|STARTED|Overall Study||6
1125227|NCT01263054|2724642|P2|NOT COMPLETED|Overall Study||6
1125228|NCT01263054|2724643|P1|NOT COMPLETED|Overall Study||5
1125229|NCT01263054|2724642|P2|COMPLETED|Overall Study||28
1125230|NCT01263054|2724643|P1|COMPLETED|Overall Study||24
1125231|NCT01263054|2724642|P2|STARTED|Overall Study||34
1125232|NCT01263054|2724643|P1|STARTED|Overall Study||29
1125233|NCT01263132|2724663|P2|NOT COMPLETED|Overall Study||0
1125234|NCT01263132|2724664|P1|NOT COMPLETED|Overall Study||0
1125235|NCT01263132|2724663|P2|COMPLETED|Overall Study||37
1125236|NCT01263132|2724664|P1|COMPLETED|Overall Study||38
1125237|NCT01263132|2724663|P2|STARTED|Overall Study||37
1125238|NCT01263132|2724664|P1|STARTED|Overall Study||38
1125239|NCT01263301|2724680|P2|NOT COMPLETED|Overall Study||0
1125240|NCT01263301|2724681|P1|NOT COMPLETED|Overall Study||0
1125241|NCT01263301|2724680|P2|COMPLETED|Overall Study||11
1125242|NCT01263301|2724681|P1|COMPLETED|Overall Study||5
1125243|NCT01263301|2724680|P2|STARTED|Overall Study||11
1125244|NCT01263301|2724681|P1|STARTED|Overall Study||5
1125245|NCT01263444|2724693|P1|NOT COMPLETED|Overall Study||10
1125246|NCT01263444|2724693|P1|COMPLETED|Overall Study||37
1125247|NCT01263444|2724693|P1|STARTED|Overall Study||47
1125248|NCT01263470|2724706|P6|NOT COMPLETED|Overall Study||5
1125249|NCT01263470|2724707|P5|NOT COMPLETED|Overall Study||3
1125250|NCT01263470|2724708|P4|NOT COMPLETED|Overall Study||3
1125251|NCT01263470|2724709|P3|NOT COMPLETED|Overall Study||4
1125252|NCT01263470|2724710|P2|NOT COMPLETED|Overall Study||5
1125253|NCT01263470|2724711|P1|NOT COMPLETED|Overall Study||2
1125254|NCT01263470|2724706|P6|COMPLETED|Overall Study||78
1125255|NCT01263470|2724707|P5|COMPLETED|Overall Study||76
1125256|NCT01263470|2724708|P4|COMPLETED|Overall Study||77
1125257|NCT01263470|2724709|P3|COMPLETED|Overall Study||80
1125258|NCT01263470|2724710|P2|COMPLETED|Overall Study||74
1125259|NCT01263470|2724711|P1|COMPLETED|Overall Study||73
1125260|NCT01263470|2724706|P6|STARTED|Overall Study||83
1125261|NCT01263470|2724707|P5|STARTED|Overall Study||79
1125262|NCT01263470|2724708|P4|STARTED|Overall Study||80
1125263|NCT01263470|2724709|P3|STARTED|Overall Study||84
1125264|NCT01263470|2724710|P2|STARTED|Overall Study||79
1125265|NCT01263470|2724711|P1|STARTED|Overall Study||75
1125266|NCT01263483|2724824|P3|NOT COMPLETED|Overall Study||5
1125267|NCT01263483|2724825|P2|NOT COMPLETED|Overall Study||2
1125268|NCT01263483|2724826|P1|NOT COMPLETED|Overall Study||7
1125269|NCT01263483|2724824|P3|COMPLETED|Overall Study||74
1125270|NCT01263483|2724825|P2|COMPLETED|Overall Study||74
1125271|NCT01263483|2724826|P1|COMPLETED|Overall Study||68
1125272|NCT01263483|2724824|P3|STARTED|Overall Study||79
1125273|NCT01263483|2724825|P2|STARTED|Overall Study||76
1125274|NCT01263483|2724826|P1|STARTED|Overall Study||75
1125275|NCT01263496|2724887|P9|NOT COMPLETED|Entered - Long-Term Extension Study||3
1125276|NCT01263496|2724888|P8|NOT COMPLETED|Entered - Long-Term Extension Study||1
1125277|NCT01263496|2724889|P7|NOT COMPLETED|Entered - Long-Term Extension Study||1
1125278|NCT01263496|2724890|P6|NOT COMPLETED|Entered - Long-Term Extension Study||1
1125279|NCT01263496|2724891|P5|NOT COMPLETED|Entered - Long-Term Extension Study||10
1125280|NCT01263496|2724892|P4|NOT COMPLETED|Entered - Long-Term Extension Study||6
1125281|NCT01263496|2724893|P3|NOT COMPLETED|Entered - Long-Term Extension Study||10
1125282|NCT01263496|2724894|P2|NOT COMPLETED|Entered - Long-Term Extension Study||13
1125283|NCT01263496|2724895|P1|NOT COMPLETED|Entered - Long-Term Extension Study||9
1125284|NCT01263496|2724887|P9|COMPLETED|Entered - Long-Term Extension Study||15
1125285|NCT01263496|2724888|P8|COMPLETED|Entered - Long-Term Extension Study||16
1125286|NCT01263496|2724889|P7|COMPLETED|Entered - Long-Term Extension Study||16
1125287|NCT01263496|2724890|P6|COMPLETED|Entered - Long-Term Extension Study||16
1125288|NCT01263496|2724891|P5|COMPLETED|Entered - Long-Term Extension Study||61
1125289|NCT01263496|2724892|P4|COMPLETED|Entered - Long-Term Extension Study||68
1125290|NCT01263496|2724893|P3|COMPLETED|Entered - Long-Term Extension Study||62
1125291|NCT01263496|2724894|P2|COMPLETED|Entered - Long-Term Extension Study||59
1125292|NCT01263496|2724895|P1|COMPLETED|Entered - Long-Term Extension Study||62
1125293|NCT01263496|2724887|P9|STARTED|Entered - Long-Term Extension Study||18
1125294|NCT01263496|2724888|P8|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|17
1125295|NCT01263496|2724889|P7|STARTED|Entered - Long-Term Extension Study||17
1125296|NCT01263496|2724890|P6|STARTED|Entered - Long-Term Extension Study||17
1125297|NCT01263496|2724891|P5|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|71
1125298|NCT01263496|2724892|P4|STARTED|Entered - Long-Term Extension Study||74
1125299|NCT01263496|2724893|P3|STARTED|Entered - Long-Term Extension Study||72
1125300|NCT01263496|2724894|P2|STARTED|Entered - Long-Term Extension Study|3 participants did not enter from previous period (1 voluntary withdraw; 2 did not meet criteria).|72
1125301|NCT01263496|2724895|P1|STARTED|Entered - Long-Term Extension Study||71
1125302|NCT01263496|2724887|P9|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1125303|NCT01263496|2724888|P8|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1125304|NCT01263496|2724889|P7|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1125305|NCT01263496|2724890|P6|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1125306|NCT01263496|2724891|P5|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
1125307|NCT01263496|2724892|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
1125308|NCT01263496|2724893|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1125309|NCT01263496|2724894|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1125310|NCT01263496|2724895|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
1125311|NCT01263496|2724887|P9|COMPLETED|Enrolled - Long-Term Extension Study||18
1125312|NCT01263496|2724888|P8|COMPLETED|Enrolled - Long-Term Extension Study||18
1125313|NCT01263496|2724889|P7|COMPLETED|Enrolled - Long-Term Extension Study||17
1125314|NCT01263496|2724890|P6|COMPLETED|Enrolled - Long-Term Extension Study||17
1125315|NCT01263496|2724891|P5|COMPLETED|Enrolled - Long-Term Extension Study||72
1125316|NCT01263496|2724892|P4|COMPLETED|Enrolled - Long-Term Extension Study||74
1125317|NCT01263496|2724893|P3|COMPLETED|Enrolled - Long-Term Extension Study||72
1125318|NCT01263496|2724894|P2|COMPLETED|Enrolled - Long-Term Extension Study||75
1125319|NCT01263496|2724895|P1|COMPLETED|Enrolled - Long-Term Extension Study||71
1125320|NCT01263496|2724887|P9|STARTED|Enrolled - Long-Term Extension Study||18
1125321|NCT01263496|2724888|P8|STARTED|Enrolled - Long-Term Extension Study||18
1125322|NCT01263496|2724889|P7|STARTED|Enrolled - Long-Term Extension Study||17
1125323|NCT01263496|2724890|P6|STARTED|Enrolled - Long-Term Extension Study||17
1125324|NCT01263496|2724891|P5|STARTED|Enrolled - Long-Term Extension Study||74
1125325|NCT01263496|2724892|P4|STARTED|Enrolled - Long-Term Extension Study||75
1125326|NCT01263496|2724893|P3|STARTED|Enrolled - Long-Term Extension Study||72
1125327|NCT01263496|2724894|P2|STARTED|Enrolled - Long-Term Extension Study||75
1125328|NCT01263496|2724895|P1|STARTED|Enrolled - Long-Term Extension Study||72
1125329|NCT01263509|2725189|P4|NOT COMPLETED|Entered - Long-Term Extension Study||2
1125330|NCT01263509|2725190|P3|NOT COMPLETED|Entered - Long-Term Extension Study||5
1125331|NCT01263509|2725191|P2|NOT COMPLETED|Entered - Long-Term Extension Study||12
1125332|NCT01263509|2725192|P1|NOT COMPLETED|Entered - Long-Term Extension Study||8
1125333|NCT01263509|2725189|P4|COMPLETED|Entered - Long-Term Extension Study||24
1125334|NCT01263509|2725190|P3|COMPLETED|Entered - Long-Term Extension Study||27
1125335|NCT01263509|2725191|P2|COMPLETED|Entered - Long-Term Extension Study||48
1125336|NCT01263509|2725192|P1|COMPLETED|Entered - Long-Term Extension Study||53
1125337|NCT01263509|2725189|P4|STARTED|Entered - Long-Term Extension Study||26
1125338|NCT01263509|2725190|P3|STARTED|Entered - Long-Term Extension Study||32
1125339|NCT01263509|2725191|P2|STARTED|Entered - Long-Term Extension Study||60
1125340|NCT01263509|2725192|P1|STARTED|Entered - Long-Term Extension Study||61
1125341|NCT01263509|2725189|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1125342|NCT01263509|2725190|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1125343|NCT01263509|2725191|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1125344|NCT01263509|2725192|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1125345|NCT01263509|2725189|P4|COMPLETED|Enrolled - Long-Term Extension Study||26
1125346|NCT01263509|2725190|P3|COMPLETED|Enrolled - Long-Term Extension Study||32
1125347|NCT01263509|2725191|P2|COMPLETED|Enrolled - Long-Term Extension Study||60
1125348|NCT01263509|2725192|P1|COMPLETED|Enrolled - Long-Term Extension Study||61
1125349|NCT01263509|2725189|P4|STARTED|Enrolled - Long-Term Extension Study||26
1125350|NCT01263509|2725190|P3|STARTED|Enrolled - Long-Term Extension Study||32
1125351|NCT01263509|2725191|P2|STARTED|Enrolled - Long-Term Extension Study||60
1125352|NCT01263509|2725192|P1|STARTED|Enrolled - Long-Term Extension Study||61
1125353|NCT01263561|2725318|P2|NOT COMPLETED|Overall Study||2
1125354|NCT01263561|2725319|P1|NOT COMPLETED|Overall Study||1
1125355|NCT01263561|2725318|P2|COMPLETED|Overall Study||31
1125356|NCT01263561|2725319|P1|COMPLETED|Overall Study||30
1125357|NCT01263561|2725318|P2|STARTED|Overall Study||33
1125358|NCT01263561|2725319|P1|STARTED|Overall Study||31
1125359|NCT01263639|2725331|P2|NOT COMPLETED|Overall Study||79
1125360|NCT01263639|2725332|P1|NOT COMPLETED|Overall Study||73
1125361|NCT01263639|2725331|P2|COMPLETED|Overall Study||42
1125362|NCT01263639|2725332|P1|COMPLETED|Overall Study||34
1125363|NCT01263639|2725331|P2|STARTED|Overall Study||121
1125364|NCT01263639|2725332|P1|STARTED|Overall Study||107
1125365|NCT01263665|2725338|P1|NOT COMPLETED|Overall Study||9
1125366|NCT01263665|2725338|P1|COMPLETED|Overall Study||62
1125367|NCT01263665|2725338|P1|STARTED|Overall Study||71
1125368|NCT01263691|2725349|P6|NOT COMPLETED|Overall Study||0
1125369|NCT01263691|2725350|P5|NOT COMPLETED|Overall Study||0
1125370|NCT01263691|2725351|P4|NOT COMPLETED|Overall Study||1
1125371|NCT01263691|2725352|P3|NOT COMPLETED|Overall Study||1
1125372|NCT01263691|2725353|P2|NOT COMPLETED|Overall Study||0
1125373|NCT01263691|2725354|P1|NOT COMPLETED|Overall Study||3
1125374|NCT01263691|2725349|P6|COMPLETED|Overall Study||15
1125375|NCT01263691|2725350|P5|COMPLETED|Overall Study||18
1125376|NCT01263691|2725351|P4|COMPLETED|Overall Study||18
1125377|NCT01263691|2725352|P3|COMPLETED|Overall Study||16
1125378|NCT01263691|2725353|P2|COMPLETED|Overall Study||18
1125379|NCT01263691|2725354|P1|COMPLETED|Overall Study||15
1125380|NCT01263691|2725349|P6|STARTED|Overall Study||15
1125381|NCT01263691|2725350|P5|STARTED|Overall Study||18
1125382|NCT01263691|2725351|P4|STARTED|Overall Study||19
1125383|NCT01263691|2725352|P3|STARTED|Overall Study||17
1125384|NCT01263691|2725353|P2|STARTED|Overall Study||18
1125385|NCT01263691|2725354|P1|STARTED|Overall Study||18
1125394|NCT01263873|2725495|P2|NOT COMPLETED|Overall Study||1
1125395|NCT01263873|2725496|P1|NOT COMPLETED|Overall Study||1
1125396|NCT01263873|2725495|P2|COMPLETED|Overall Study||29
1125397|NCT01263873|2725496|P1|COMPLETED|Overall Study||29
1125398|NCT01263873|2725495|P2|STARTED|Overall Study||30
1125399|NCT01263873|2725496|P1|STARTED|Overall Study||30
1125400|NCT01263925|2725508|P2|NOT COMPLETED|Overall Study||52
1125401|NCT01263925|2725509|P1|NOT COMPLETED|Overall Study||51
1125402|NCT01263925|2725508|P2|COMPLETED|Overall Study||233
1125403|NCT01263925|2725509|P1|COMPLETED|Overall Study||225
1125404|NCT01263925|2725508|P2|Full Analysis Set|Overall Study||272
1125405|NCT01263925|2725509|P1|Full Analysis Set|Overall Study||269
1125406|NCT01263925|2725508|P2|STARTED|Overall Study||285
1125407|NCT01263925|2725509|P1|STARTED|Overall Study||276
1125408|NCT01264016|2725541|P1|NOT COMPLETED|Overall Study||2
1125409|NCT01264016|2725541|P1|COMPLETED|Overall Study||94
1125410|NCT01264016|2725541|P1|STARTED|Overall Study||96
1125411|NCT01264081|2725547|P1|NOT COMPLETED|Analysis||0
1125412|NCT01264081|2725547|P1|COMPLETED|Analysis||2
1125413|NCT01264081|2725547|P1|STARTED|Analysis||2
1125414|NCT01264081|2725547|P1|NOT COMPLETED|Started Treatment||2
1125415|NCT01264081|2725547|P1|COMPLETED|Started Treatment||2
1125416|NCT01264081|2725547|P1|STARTED|Started Treatment||4
1125417|NCT01264081|2725547|P1|NOT COMPLETED|Participants Screened||30
1125418|NCT01264081|2725547|P1|COMPLETED|Participants Screened||4
1125419|NCT01264081|2725547|P1|STARTED|Participants Screened||34
1125420|NCT01269736|2725554|P2|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
1125421|NCT01269736|2725555|P1|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
1125422|NCT01269736|2725554|P2|COMPLETED|Patient Outcomes (Hospital Admissions)|43799 unique patients assessed overall (at any time point) by end of study.|43799
1125423|NCT01269736|2725555|P1|COMPLETED|Patient Outcomes (Hospital Admissions)|52085 unique patients assessed overall (at any time point) by end of study.|52085
1125424|NCT01269736|2725554|P2|30 Months Assessment|Patient Outcomes (Hospital Admissions)|13265 unique patients, assessed at 6 hospitals.|13265
1125425|NCT01269736|2725555|P1|30 Months Assessment|Patient Outcomes (Hospital Admissions)|16702 unique patients, assessed at 7 hospitals.|16702
1125426|NCT01269736|2725554|P2|15 Months Assessment|Patient Outcomes (Hospital Admissions)|14075 unique patients, assessed at 6 hospitals.|14075
1125427|NCT01269736|2725555|P1|15 Months Assessment|Patient Outcomes (Hospital Admissions)|18031 unique patients, assessed at 7 hospitals.|18031
1125428|NCT01269736|2725554|P2|Baseline Assessment|Patient Outcomes (Hospital Admissions)|16549 unique patients, assessed at 6 hospitals.|16549
1125429|NCT01269736|2725555|P1|Baseline Assessment|Patient Outcomes (Hospital Admissions)|17352 unique patients, assessed at 7 hospitals.|17352
1125430|NCT01269736|2725554|P2|STARTED|Patient Outcomes (Hospital Admissions)|16459 unique patients were assessed at 6 hospitals at the initiation of the study.|43799
1125431|NCT01269736|2725555|P1|STARTED|Patient Outcomes (Hospital Admissions)|17352 unique patients were assessed at 7 hospitals at the initiation of the study.|52085
1125432|NCT01269736|2725554|P2|NOT COMPLETED|Patient Quality of Care Assessments||0
1125433|NCT01269736|2725555|P1|NOT COMPLETED|Patient Quality of Care Assessments||0
1125434|NCT01269736|2725554|P2|COMPLETED|Patient Quality of Care Assessments|2288 unique patients assessed overall (at any time point) by end of study.|2288
1125435|NCT01269736|2725555|P1|COMPLETED|Patient Quality of Care Assessments|2299 unique patients assessed overall (at any time point) by end of study.|2299
1125436|NCT01269736|2725554|P2|30 Months Assessment|Patient Quality of Care Assessments|626 unique patients, assessed at 7 hospitals.|626
1125437|NCT01269736|2725555|P1|30 Months Assessment|Patient Quality of Care Assessments|697 unique patients, assessed at 8 hospitals.|697
1125438|NCT01269736|2725554|P2|15 Months Assessment|Patient Quality of Care Assessments|773 unique patients, assessed at 8 hospitals.|773
1125439|NCT01269736|2725555|P1|15 Months Assessment|Patient Quality of Care Assessments|687 unique patients, assessed at 8 hospitals.|687
1125440|NCT01269736|2725554|P2|Baseline Assessment|Patient Quality of Care Assessments|889 unique patients, assessed at 8 hospitals.|889
1125441|NCT01269736|2725555|P1|Baseline Assessment|Patient Quality of Care Assessments|915 unique patients, assessed at 9 hospitals.|915
1125442|NCT01269736|2725554|P2|STARTED|Patient Quality of Care Assessments|889 unique patients were assessed at 8 hospitals at the initiation of the study.|2288
1125443|NCT01269736|2725555|P1|STARTED|Patient Quality of Care Assessments|915 unique patients were assessed at 9 hospitals at the initiation of the study.|2299
1125444|NCT01269736|2725554|P2|NOT COMPLETED|Nurses' Knowledge Assessments||0
1125445|NCT01269736|2725555|P1|NOT COMPLETED|Nurses' Knowledge Assessments||0
1125446|NCT01269736|2725554|P2|COMPLETED|Nurses' Knowledge Assessments|1428 unique nurses assessed overall (at any time point) by end of study.|1428
1125447|NCT01269736|2725555|P1|COMPLETED|Nurses' Knowledge Assessments|1585 unique nurses assessed overall (at any time point) by end of study.|1585
1125448|NCT01269736|2725554|P2|30 Months Assessment|Nurses' Knowledge Assessments|926 unique nurses, assessed at 8 hospitals.|926
1125449|NCT01269736|2725555|P1|30 Months Assessment|Nurses' Knowledge Assessments|741 unique nurses, assessed at 8 hospitals.|741
1125450|NCT01269736|2725554|P2|15 Months Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|782
1125451|NCT01269736|2725555|P1|15 Months Assessment|Nurses' Knowledge Assessments|1108 unique nurses, assessed at 9 hospitals.|1108
1125452|NCT01269736|2725554|P2|Baseline Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|866
1125544|NCT01275131|2725766|P1|COMPLETED|5- to 14-Day Washout Period||9
1125453|NCT01269736|2725555|P1|Baseline Assessment|Nurses' Knowledge Assessments|873 unique nurses, assessed at 9 hospitals.|873
1125454|NCT01269736|2725554|P2|STARTED|Nurses' Knowledge Assessments|866 unique nurses were assessed at 8 hospitals at the initiation of the study.|1428
1125455|NCT01269736|2725555|P1|STARTED|Nurses' Knowledge Assessments|873 unique nurses were assessed at 9 hospitals at the initiation of the study.|1585
1125456|NCT01269801|2725569|P2|NOT COMPLETED|Overall Study||3
1125457|NCT01269801|2725570|P1|NOT COMPLETED|Overall Study||0
1125458|NCT01269801|2725569|P2|COMPLETED|Overall Study||77
1125459|NCT01269801|2725570|P1|COMPLETED|Overall Study||74
1125460|NCT01269801|2725569|P2|STARTED|Overall Study||80
1125461|NCT01269801|2725570|P1|STARTED|Overall Study||74
1125462|NCT01269918|2725578|P2|NOT COMPLETED|Overall Study||3
1125463|NCT01269918|2725579|P1|NOT COMPLETED|Overall Study||0
1125464|NCT01269918|2725578|P2|COMPLETED|Overall Study||68
1125465|NCT01269918|2725579|P1|COMPLETED|Overall Study||71
1125466|NCT01269918|2725578|P2|STARTED|Overall Study||71
1125467|NCT01269918|2725579|P1|STARTED|Overall Study||71
1125468|NCT01274429|2725611|P1|NOT COMPLETED|Overall Study||5
1125469|NCT01274429|2725611|P1|COMPLETED|Overall Study||0
1125470|NCT01274429|2725611|P1|STARTED|Overall Study||5
1125471|NCT01274533|2725616|P1|NOT COMPLETED|Overall Study||4
1125472|NCT01274533|2725616|P1|COMPLETED|Overall Study||0
1125473|NCT01274533|2725616|P1|STARTED|Overall Study||4
1125474|NCT01274559|2725623|P2|NOT COMPLETED|Overall Study||145
1125475|NCT01274559|2725624|P1|NOT COMPLETED|Overall Study||197
1125476|NCT01274559|2725623|P2|COMPLETED|Overall Study||441
1125477|NCT01274559|2725624|P1|COMPLETED|Overall Study||390
1125478|NCT01274559|2725623|P2|Treated|Overall Study||572
1125479|NCT01274559|2725624|P1|Treated|Overall Study||572
1125480|NCT01274559|2725623|P2|STARTED|Overall Study||586
1125481|NCT01274559|2725624|P1|STARTED|Overall Study||587
1125482|NCT01274585|2725676|P2|NOT COMPLETED|Overall Study||0
1125483|NCT01274585|2725677|P1|NOT COMPLETED|Overall Study||0
1125484|NCT01274585|2725676|P2|COMPLETED|Overall Study||3
1125485|NCT01274585|2725677|P1|COMPLETED|Overall Study||2
1125486|NCT01274585|2725676|P2|STARTED|Overall Study||3
1125487|NCT01274585|2725677|P1|STARTED|Overall Study||2
1125488|NCT01274611|2725683|P1|NOT COMPLETED|Overall Study||0
1125489|NCT01274611|2725683|P1|COMPLETED|Overall Study||20
1125490|NCT01274611|2725683|P1|STARTED|Overall Study||20
1125491|NCT01274637|2725693|P2|NOT COMPLETED|Overall Study||2
1125492|NCT01274637|2725694|P1|NOT COMPLETED|Overall Study||0
1125493|NCT01274637|2725693|P2|COMPLETED|Overall Study||30
1125494|NCT01274637|2725694|P1|COMPLETED|Overall Study||30
1125495|NCT01274637|2725693|P2|STARTED|Overall Study||32
1125496|NCT01274637|2725694|P1|STARTED|Overall Study||30
1125497|NCT01274715|2725710|P1|NOT COMPLETED|Overall Study||4
1125498|NCT01274715|2725710|P1|COMPLETED|Overall Study||8
1125499|NCT01274715|2725710|P1|Screened Out at Baseline|Overall Study||3
1125500|NCT01274715|2725710|P1|STARTED|Overall Study||12
1125501|NCT01274897|2725717|P2|NOT COMPLETED|Overall Study||0
1125502|NCT01274897|2725718|P1|NOT COMPLETED|Overall Study||0
1125503|NCT01274897|2725717|P2|COMPLETED|Overall Study||153
1125504|NCT01274897|2725718|P1|COMPLETED|Overall Study||297
1125505|NCT01274897|2725717|P2|STARTED|Overall Study||153
1125506|NCT01274897|2725718|P1|STARTED|Overall Study||297
1125510|NCT01275066|2725737|P3|NOT COMPLETED|Overall Study||1
1125511|NCT01275066|2725738|P2|NOT COMPLETED|Overall Study||0
1125512|NCT01275066|2725739|P1|NOT COMPLETED|Overall Study||1
1125513|NCT01275066|2725737|P3|COMPLETED|Overall Study||57
1125514|NCT01275066|2725738|P2|COMPLETED|Overall Study||59
1125515|NCT01275066|2725739|P1|COMPLETED|Overall Study||59
1125516|NCT01275066|2725737|P3|Treated|Overall Study||58
1125517|NCT01275066|2725738|P2|Treated|Overall Study||59
1125518|NCT01275066|2725739|P1|Treated|Overall Study||59
1125519|NCT01275066|2725737|P3|STARTED|Overall Study||58
1125520|NCT01275066|2725738|P2|STARTED|Overall Study||59
1125521|NCT01275066|2725739|P1|STARTED|Overall Study||60
1125522|NCT01275092|2725753|P1|NOT COMPLETED|Overall Study||0
1125523|NCT01275092|2725753|P1|COMPLETED|Overall Study||164
1125524|NCT01275092|2725753|P1|STARTED|Overall Study||164
1125525|NCT01275131|2725763|P4|NOT COMPLETED|Period 2 (Crossover)||2
1125526|NCT01275131|2725764|P3|NOT COMPLETED|Period 2 (Crossover)||1
1125527|NCT01275131|2725765|P2|NOT COMPLETED|Period 2 (Crossover)||1
1125528|NCT01275131|2725766|P1|NOT COMPLETED|Period 2 (Crossover)||1
1125529|NCT01275131|2725763|P4|COMPLETED|Period 2 (Crossover)||8
1125530|NCT01275131|2725764|P3|COMPLETED|Period 2 (Crossover)||9
1125531|NCT01275131|2725765|P2|COMPLETED|Period 2 (Crossover)||8
1125532|NCT01275131|2725766|P1|COMPLETED|Period 2 (Crossover)||8
1125533|NCT01275131|2725763|P4|STARTED|Period 2 (Crossover)||10
1125534|NCT01275131|2725764|P3|STARTED|Period 2 (Crossover)||10
1125535|NCT01275131|2725765|P2|STARTED|Period 2 (Crossover)||9
1125536|NCT01275131|2725766|P1|STARTED|Period 2 (Crossover)||9
1125537|NCT01275131|2725763|P4|NOT COMPLETED|5- to 14-Day Washout Period||0
1125538|NCT01275131|2725764|P3|NOT COMPLETED|5- to 14-Day Washout Period||0
1125539|NCT01275131|2725765|P2|NOT COMPLETED|5- to 14-Day Washout Period||0
1125540|NCT01275131|2725766|P1|NOT COMPLETED|5- to 14-Day Washout Period||0
1125541|NCT01275131|2725763|P4|COMPLETED|5- to 14-Day Washout Period||10
1125542|NCT01275131|2725764|P3|COMPLETED|5- to 14-Day Washout Period||10
1125543|NCT01275131|2725765|P2|COMPLETED|5- to 14-Day Washout Period||9
1125545|NCT01275131|2725763|P4|STARTED|5- to 14-Day Washout Period||10
1125546|NCT01275131|2725764|P3|STARTED|5- to 14-Day Washout Period||10
1125547|NCT01275131|2725765|P2|STARTED|5- to 14-Day Washout Period||9
1125548|NCT01275131|2725766|P1|STARTED|5- to 14-Day Washout Period||9
1125549|NCT01275131|2725763|P4|NOT COMPLETED|Period 1||2
1125550|NCT01275131|2725764|P3|NOT COMPLETED|Period 1||3
1125551|NCT01275131|2725765|P2|NOT COMPLETED|Period 1||0
1125552|NCT01275131|2725766|P1|NOT COMPLETED|Period 1||2
1125553|NCT01275131|2725763|P4|COMPLETED|Period 1||10
1125554|NCT01275131|2725764|P3|COMPLETED|Period 1||10
1125555|NCT01275131|2725765|P2|COMPLETED|Period 1||9
1125556|NCT01275131|2725766|P1|COMPLETED|Period 1||9
1125557|NCT01275131|2725763|P4|Received at Least One Dose of Study Drug|Period 1||12
1125558|NCT01275131|2725764|P3|Received at Least One Dose of Study Drug|Period 1||13
1125559|NCT01275131|2725765|P2|Received at Least One Dose of Study Drug|Period 1||9
1125560|NCT01275131|2725766|P1|Received at Least One Dose of Study Drug|Period 1||11
1125561|NCT01275131|2725763|P4|STARTED|Period 1||12
1125562|NCT01275131|2725764|P3|STARTED|Period 1||13
1125563|NCT01275131|2725765|P2|STARTED|Period 1||9
1125564|NCT01275131|2725766|P1|STARTED|Period 1||11
1125565|NCT01275196|2725802|P2|NOT COMPLETED|Overall Study||21
1125566|NCT01275196|2725803|P1|NOT COMPLETED|Overall Study||20
1125567|NCT01275196|2725802|P2|COMPLETED|Overall Study||113
1125568|NCT01275196|2725803|P1|COMPLETED|Overall Study||113
1125569|NCT01275196|2725802|P2|Intended to Continue Into Extension|Overall Study||113
1125570|NCT01275196|2725803|P1|Intended to Continue Into Extension|Overall Study||112
1125571|NCT01275196|2725802|P2|STARTED|Overall Study||134
1125572|NCT01275196|2725803|P1|STARTED|Overall Study||133
1125573|NCT01275313|2725844|P2|NOT COMPLETED|Overall Study||52
1125574|NCT01275313|2725845|P1|NOT COMPLETED|Overall Study||25
1125575|NCT01275313|2725844|P2|COMPLETED|Overall Study||79
1125576|NCT01275313|2725845|P1|COMPLETED|Overall Study||102
1125577|NCT01275313|2725844|P2|STARTED|Overall Study||131
1125578|NCT01275313|2725845|P1|STARTED|Overall Study||127
1125579|NCT01275430|2725851|P1|NOT COMPLETED|Overall Study||9
1125580|NCT01275430|2725851|P1|COMPLETED|Overall Study||18
1125581|NCT01275430|2725851|P1|STARTED|Overall Study||27
1125582|NCT01275586|2725859|P1|NOT COMPLETED|Overall Study||3
1125583|NCT01275586|2725859|P1|COMPLETED|Overall Study||3
1125584|NCT01275586|2725859|P1|STARTED|Overall Study||6
1125585|NCT01275625|2725863|P1|NOT COMPLETED|Overall Study||13
1125586|NCT01275625|2725863|P1|COMPLETED|Overall Study||64
1125587|NCT01275625|2725863|P1|Treated|Overall Study||77
1125588|NCT01275625|2725863|P1|STARTED|Overall Study||77
1125589|NCT01275755|2725879|P2|NOT COMPLETED|Run-out Placebo Period||0
1125590|NCT01275755|2725880|P1|NOT COMPLETED|Run-out Placebo Period||1
1125591|NCT01275755|2725879|P2|COMPLETED|Run-out Placebo Period||37
1125592|NCT01275755|2725880|P1|COMPLETED|Run-out Placebo Period||38
1125593|NCT01275755|2725879|P2|STARTED|Run-out Placebo Period||37
1125594|NCT01275755|2725880|P1|STARTED|Run-out Placebo Period||39
1125595|NCT01275755|2725879|P2|NOT COMPLETED|Double-blind Treatment Period||3
1125596|NCT01275755|2725880|P1|NOT COMPLETED|Double-blind Treatment Period||2
1125597|NCT01275755|2725879|P2|COMPLETED|Double-blind Treatment Period||37
1125598|NCT01275755|2725880|P1|COMPLETED|Double-blind Treatment Period||39
1125599|NCT01275755|2725879|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||40
1125600|NCT01275755|2725880|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||41
1125601|NCT01275755|2725879|P2|STARTED|Double-blind Treatment Period||40
1125602|NCT01275755|2725880|P1|STARTED|Double-blind Treatment Period||41
1125603|NCT01275755|2725879|P2|NOT COMPLETED|Run-in Placebo Period||0
1125604|NCT01275755|2725880|P1|NOT COMPLETED|Run-in Placebo Period||0
1125605|NCT01275755|2725879|P2|COMPLETED|Run-in Placebo Period||40
1125606|NCT01275755|2725880|P1|COMPLETED|Run-in Placebo Period||41
1125607|NCT01275755|2725879|P2|STARTED|Run-in Placebo Period||40
1125608|NCT01275755|2725880|P1|STARTED|Run-in Placebo Period||41
1125609|NCT01275833|2725888|P2|NOT COMPLETED|Overall Study||1
1125610|NCT01275833|2725889|P1|NOT COMPLETED|Overall Study||1
1125611|NCT01275833|2725888|P2|COMPLETED|Overall Study||0
1125612|NCT01275833|2725889|P1|COMPLETED|Overall Study||0
1125613|NCT01275833|2725888|P2|STARTED|Overall Study||1
1125614|NCT01275833|2725889|P1|STARTED|Overall Study||1
1125615|NCT01276054|2725897|P2|NOT COMPLETED|Overall Study||2
1125616|NCT01276054|2725898|P1|NOT COMPLETED|Overall Study||2
1125617|NCT01276054|2725897|P2|COMPLETED|Overall Study||0
1125618|NCT01276054|2725898|P1|COMPLETED|Overall Study||0
1125619|NCT01276054|2725897|P2|STARTED|Overall Study||2
1125620|NCT01276054|2725898|P1|STARTED|Overall Study||2
1125621|NCT01276106|2725908|P4|NOT COMPLETED|Overall Study||13
1125622|NCT01276106|2725909|P3|NOT COMPLETED|Overall Study||16
1125623|NCT01276106|2725910|P2|NOT COMPLETED|Overall Study||9
1125624|NCT01276106|2725911|P1|NOT COMPLETED|Overall Study||12
1125625|NCT01276106|2725908|P4|COMPLETED|Overall Study||52
1125626|NCT01276106|2725909|P3|COMPLETED|Overall Study||49
1125627|NCT01276106|2725910|P2|COMPLETED|Overall Study||55
1125628|NCT01276106|2725911|P1|COMPLETED|Overall Study||53
1125629|NCT01276106|2725908|P4|STARTED|Overall Study||65
1125630|NCT01276106|2725909|P3|STARTED|Overall Study||65
1125631|NCT01276106|2725910|P2|STARTED|Overall Study||64
1125632|NCT01276106|2725911|P1|STARTED|Overall Study||65
1125633|NCT01276171|2725924|P3|NOT COMPLETED|Overall Study||0
1125634|NCT01276171|2725925|P2|NOT COMPLETED|Overall Study||0
1125635|NCT01276171|2725926|P1|NOT COMPLETED|Overall Study||0
1125636|NCT01276171|2725924|P3|COMPLETED|Overall Study||256
1125637|NCT01276171|2725925|P2|COMPLETED|Overall Study||244
1125638|NCT01276171|2725926|P1|COMPLETED|Overall Study||249
1125639|NCT01276171|2725924|P3|STARTED|Overall Study||256
1125640|NCT01276171|2725925|P2|STARTED|Overall Study||244
1125641|NCT01276171|2725926|P1|STARTED|Overall Study||249
1125642|NCT01276197|2725942|P2|NOT COMPLETED|Overall Study||110
1125643|NCT01276197|2725943|P1|NOT COMPLETED|Overall Study||108
1125644|NCT01276197|2725942|P2|COMPLETED|Overall Study||200
1125645|NCT01276197|2725943|P1|COMPLETED|Overall Study||200
1125646|NCT01276197|2725942|P2|STARTED|Overall Study||310
1125647|NCT01276197|2725943|P1|STARTED|Overall Study||308
1125648|NCT01276223|2725954|P3|NOT COMPLETED|Overall Study||3
1125649|NCT01276223|2725955|P2|NOT COMPLETED|Overall Study||4
1125650|NCT01276223|2725956|P1|NOT COMPLETED|Overall Study||11
1125651|NCT01276223|2725954|P3|COMPLETED|Overall Study||101
1125652|NCT01276223|2725955|P2|COMPLETED|Overall Study||103
1125653|NCT01276223|2725956|P1|COMPLETED|Overall Study||67
1125654|NCT01276223|2725954|P3|STARTED|Overall Study||104
1125655|NCT01276223|2725955|P2|STARTED|Overall Study||107
1125656|NCT01276223|2725956|P1|STARTED|Overall Study||78
1125657|NCT01276288|2725963|P4|NOT COMPLETED|Overall Study||0
1125658|NCT01276288|2725964|P3|NOT COMPLETED|Overall Study||0
1125659|NCT01276288|2725965|P2|NOT COMPLETED|Overall Study||1
1125660|NCT01276288|2725966|P1|NOT COMPLETED|Overall Study||2
1125661|NCT01276288|2725963|P4|COMPLETED|Overall Study||5
1125662|NCT01276288|2725964|P3|COMPLETED|Overall Study||5
1125663|NCT01276288|2725965|P2|COMPLETED|Overall Study||5
1125664|NCT01276288|2725966|P1|COMPLETED|Overall Study||5
1125665|NCT01276288|2725963|P4|Received EMPA+TOR|Overall Study||5
1125666|NCT01276288|2725964|P3|Received EMPA+TOR|Overall Study||5
1125667|NCT01276288|2725965|P2|Received EMPA+TOR|Overall Study||0
1125668|NCT01276288|2725966|P1|Received EMPA+TOR|Overall Study||0
1125669|NCT01276288|2725963|P4|Received EMPA+HCT|Overall Study||0
1125670|NCT01276288|2725964|P3|Received EMPA+HCT|Overall Study||0
1125671|NCT01276288|2725965|P2|Received EMPA+HCT|Overall Study||5
1125672|NCT01276288|2725966|P1|Received EMPA+HCT|Overall Study||5
1125673|NCT01276288|2725963|P4|Received EMPA|Overall Study||5
1125674|NCT01276288|2725964|P3|Received EMPA|Overall Study||5
1125675|NCT01276288|2725965|P2|Received EMPA|Overall Study||5
1125676|NCT01276288|2725966|P1|Received EMPA|Overall Study||6
1125677|NCT01276288|2725963|P4|STARTED|Overall Study||5
1125678|NCT01276288|2725964|P3|STARTED|Overall Study||5
1125679|NCT01276288|2725965|P2|STARTED|Overall Study||6
1125680|NCT01276288|2725966|P1|STARTED|Overall Study||7
1125681|NCT01276301|2726090|P2|NOT COMPLETED|Second Intervention||0
1125682|NCT01276301|2726091|P1|NOT COMPLETED|Second Intervention||0
1125683|NCT01276301|2726090|P2|COMPLETED|Second Intervention||8
1125684|NCT01276301|2726091|P1|COMPLETED|Second Intervention||8
1125685|NCT01276301|2726090|P2|STARTED|Second Intervention||8
1125686|NCT01276301|2726091|P1|STARTED|Second Intervention||8
1125687|NCT01276301|2726090|P2|NOT COMPLETED|Washout Period of 7 Days||0
1125688|NCT01276301|2726091|P1|NOT COMPLETED|Washout Period of 7 Days||0
1125689|NCT01276301|2726090|P2|COMPLETED|Washout Period of 7 Days||8
1125690|NCT01276301|2726091|P1|COMPLETED|Washout Period of 7 Days||8
1125691|NCT01276301|2726090|P2|STARTED|Washout Period of 7 Days||8
1125692|NCT01276301|2726091|P1|STARTED|Washout Period of 7 Days||8
1125693|NCT01276301|2726090|P2|NOT COMPLETED|First Intervention||0
1125694|NCT01276301|2726091|P1|NOT COMPLETED|First Intervention||0
1125695|NCT01276301|2726090|P2|COMPLETED|First Intervention||8
1125696|NCT01276301|2726091|P1|COMPLETED|First Intervention||8
1125697|NCT01276301|2726090|P2|STARTED|First Intervention||8
1125698|NCT01276301|2726091|P1|STARTED|First Intervention||8
1125699|NCT01276327|2726120|P2|NOT COMPLETED|Overall Study||3
1125700|NCT01276327|2726121|P1|NOT COMPLETED|Overall Study||2
1125701|NCT01276327|2726120|P2|COMPLETED|Overall Study||29
1125702|NCT01276327|2726121|P1|COMPLETED|Overall Study||30
1125703|NCT01276327|2726120|P2|STARTED|Overall Study||32
1125704|NCT01276327|2726121|P1|STARTED|Overall Study||32
1125705|NCT01276353|2726145|P2|NOT COMPLETED|Extension||9
1125706|NCT01276353|2726146|P1|NOT COMPLETED|Extension||7
1125707|NCT01276353|2726145|P2|COMPLETED|Extension||14
1125708|NCT01276353|2726146|P1|COMPLETED|Extension||12
1125709|NCT01276353|2726145|P2|STARTED|Extension||23
1125710|NCT01276353|2726146|P1|STARTED|Extension||19
1125711|NCT01276353|2726145|P2|NOT COMPLETED|Double-blind||0
1125712|NCT01276353|2726146|P1|NOT COMPLETED|Double-blind||3
1125713|NCT01276353|2726145|P2|COMPLETED|Double-blind||23
1125714|NCT01276353|2726146|P1|COMPLETED|Double-blind||19
1125715|NCT01276353|2726145|P2|STARTED|Double-blind||23
1125716|NCT01276353|2726146|P1|STARTED|Double-blind||22
1125717|NCT01276457|2726158|P2|NOT COMPLETED|Extension Study||2
1125718|NCT01276457|2726159|P1|NOT COMPLETED|Extension Study||6
1125719|NCT01276457|2726158|P2|COMPLETED|Extension Study||110
1125720|NCT01276457|2726159|P1|COMPLETED|Extension Study||105
1125721|NCT01276457|2726158|P2|STARTED|Extension Study||112
1125722|NCT01276457|2726159|P1|STARTED|Extension Study||111
1125723|NCT01276457|2726158|P2|NOT COMPLETED|Core Study||20
1125724|NCT01276457|2726159|P1|NOT COMPLETED|Core Study||13
1125725|NCT01276457|2726158|P2|COMPLETED|Core Study||123
1125726|NCT01276457|2726159|P1|COMPLETED|Core Study||129
1125727|NCT01276457|2726158|P2|STARTED|Core Study||143
1125728|NCT01276457|2726159|P1|STARTED|Core Study||142
1125741|NCT01276535|2726229|P1|NOT COMPLETED|Overall Study||0
1125742|NCT01276535|2726229|P1|COMPLETED|Overall Study||12
1125743|NCT01276535|2726229|P1|STARTED|Overall Study||12
1125779|NCT01261624|2726439|P2|NOT COMPLETED|Week 13 to Week 24||1
1125780|NCT01261624|2726440|P1|NOT COMPLETED|Week 13 to Week 24||0
1125781|NCT01261624|2726439|P2|COMPLETED|Week 13 to Week 24||10
1125782|NCT01261624|2726440|P1|COMPLETED|Week 13 to Week 24||1
1125783|NCT01261624|2726439|P2|STARTED|Week 13 to Week 24|Of 6 pts of HDTC: 3 non-responders went out of study, 3 continued. 8 swithched from LDTC to HDTC|11
1125784|NCT01261624|2726440|P1|STARTED|Week 13 to Week 24|Of 9 pts from LDTC: 5 non-responders switched to HDTC; 4 pts responded, but 3 switched to HDTC|1
1125785|NCT01261624|2726439|P2|NOT COMPLETED|Week 0 to Week 12||3
1125786|NCT01261624|2726440|P1|NOT COMPLETED|Week 0 to Week 12||1
1125787|NCT01261624|2726439|P2|COMPLETED|Week 0 to Week 12||3
1125788|NCT01261624|2726440|P1|COMPLETED|Week 0 to Week 12||9
1125789|NCT01261624|2726439|P2|STARTED|Week 0 to Week 12||6
1125790|NCT01261624|2726440|P1|STARTED|Week 0 to Week 12||10
1125791|NCT01267136|2726459|P2|NOT COMPLETED|Overall Study||6
1125792|NCT01267136|2726460|P1|NOT COMPLETED|Overall Study||4
1125793|NCT01267136|2726459|P2|COMPLETED|Overall Study||36
1125794|NCT01267136|2726460|P1|COMPLETED|Overall Study||38
1125795|NCT01267136|2726459|P2|STARTED|Overall Study||42
1125796|NCT01267136|2726460|P1|STARTED|Overall Study||42
1125797|NCT01267175|2726468|P1|NOT COMPLETED|Overall Study||2
1125798|NCT01267175|2726468|P1|COMPLETED|Overall Study||29
1125799|NCT01267175|2726468|P1|STARTED|Overall Study||31
1125800|NCT01267201|2726473|P6|NOT COMPLETED|Third Intervention Period||0
1125801|NCT01267201|2726474|P5|NOT COMPLETED|Third Intervention Period||0
1125802|NCT01267201|2726475|P4|NOT COMPLETED|Third Intervention Period||0
1125803|NCT01267201|2726476|P3|NOT COMPLETED|Third Intervention Period||0
1125804|NCT01267201|2726477|P2|NOT COMPLETED|Third Intervention Period||0
1125805|NCT01267201|2726478|P1|NOT COMPLETED|Third Intervention Period||0
1125806|NCT01267201|2726473|P6|COMPLETED|Third Intervention Period||4
1125807|NCT01267201|2726474|P5|COMPLETED|Third Intervention Period||4
1125808|NCT01267201|2726475|P4|COMPLETED|Third Intervention Period||4
1125809|NCT01267201|2726476|P3|COMPLETED|Third Intervention Period||4
1125810|NCT01267201|2726477|P2|COMPLETED|Third Intervention Period||3
1125811|NCT01267201|2726478|P1|COMPLETED|Third Intervention Period||3
1125812|NCT01267201|2726473|P6|STARTED|Third Intervention Period||4
1125813|NCT01267201|2726474|P5|STARTED|Third Intervention Period||4
1125814|NCT01267201|2726475|P4|STARTED|Third Intervention Period||4
1125815|NCT01267201|2726476|P3|STARTED|Third Intervention Period||4
1125816|NCT01267201|2726477|P2|STARTED|Third Intervention Period||3
1125817|NCT01267201|2726478|P1|STARTED|Third Intervention Period||3
1125818|NCT01267201|2726473|P6|NOT COMPLETED|Washout Period (At Least 2 Days)||0
1125819|NCT01267201|2726474|P5|NOT COMPLETED|Washout Period (At Least 2 Days)||0
1125820|NCT01267201|2726475|P4|NOT COMPLETED|Washout Period (At Least 2 Days)||0
1125821|NCT01267201|2726476|P3|NOT COMPLETED|Washout Period (At Least 2 Days)||0
1125822|NCT01267201|2726477|P2|NOT COMPLETED|Washout Period (At Least 2 Days)||0
1125823|NCT01267201|2726478|P1|NOT COMPLETED|Washout Period (At Least 2 Days)||0
1125824|NCT01267201|2726473|P6|COMPLETED|Washout Period (At Least 2 Days)||4
1125825|NCT01267201|2726474|P5|COMPLETED|Washout Period (At Least 2 Days)||4
1125826|NCT01267201|2726475|P4|COMPLETED|Washout Period (At Least 2 Days)||4
1125827|NCT01267201|2726476|P3|COMPLETED|Washout Period (At Least 2 Days)||4
1125828|NCT01267201|2726477|P2|COMPLETED|Washout Period (At Least 2 Days)||3
1125829|NCT01267201|2726478|P1|COMPLETED|Washout Period (At Least 2 Days)||3
1125830|NCT01267201|2726473|P6|STARTED|Washout Period (At Least 2 Days)||4
1125831|NCT01267201|2726474|P5|STARTED|Washout Period (At Least 2 Days)||4
1125832|NCT01267201|2726475|P4|STARTED|Washout Period (At Least 2 Days)||4
1125833|NCT01267201|2726476|P3|STARTED|Washout Period (At Least 2 Days)||4
1125834|NCT01267201|2726477|P2|STARTED|Washout Period (At Least 2 Days)||3
1125835|NCT01267201|2726478|P1|STARTED|Washout Period (At Least 2 Days)||3
1125836|NCT01267201|2726473|P6|NOT COMPLETED|Second Intervention Period||0
1125837|NCT01267201|2726474|P5|NOT COMPLETED|Second Intervention Period||0
1125838|NCT01267201|2726475|P4|NOT COMPLETED|Second Intervention Period||0
1125839|NCT01267201|2726476|P3|NOT COMPLETED|Second Intervention Period||0
1125840|NCT01267201|2726477|P2|NOT COMPLETED|Second Intervention Period||1
1125841|NCT01267201|2726478|P1|NOT COMPLETED|Second Intervention Period||0
1125842|NCT01267201|2726473|P6|COMPLETED|Second Intervention Period||4
1125843|NCT01267201|2726474|P5|COMPLETED|Second Intervention Period||4
1125844|NCT01267201|2726475|P4|COMPLETED|Second Intervention Period||4
1125845|NCT01267201|2726476|P3|COMPLETED|Second Intervention Period||4
1125846|NCT01267201|2726477|P2|COMPLETED|Second Intervention Period||3
1125847|NCT01267201|2726478|P1|COMPLETED|Second Intervention Period||3
1125848|NCT01267201|2726473|P6|STARTED|Second Intervention Period||4
1125849|NCT01267201|2726474|P5|STARTED|Second Intervention Period||4
1125850|NCT01267201|2726475|P4|STARTED|Second Intervention Period||4
1125851|NCT01267201|2726476|P3|STARTED|Second Intervention Period||4
1125852|NCT01267201|2726477|P2|STARTED|Second Intervention Period||4
1125853|NCT01267201|2726478|P1|STARTED|Second Intervention Period||3
1125854|NCT01267201|2726473|P6|NOT COMPLETED|Washout Period (At Least 2 Days)||0
1125855|NCT01267201|2726474|P5|NOT COMPLETED|Washout Period (At Least 2 Days)||0
1125856|NCT01267201|2726475|P4|NOT COMPLETED|Washout Period (At Least 2 Days)||0
1125857|NCT01267201|2726476|P3|NOT COMPLETED|Washout Period (At Least 2 Days)||0
1125858|NCT01267201|2726477|P2|NOT COMPLETED|Washout Period (At Least 2 Days)||0
1125859|NCT01267201|2726478|P1|NOT COMPLETED|Washout Period (At Least 2 Days)||0
1125860|NCT01267201|2726473|P6|COMPLETED|Washout Period (At Least 2 Days)||4
1125861|NCT01267201|2726474|P5|COMPLETED|Washout Period (At Least 2 Days)||4
1125862|NCT01267201|2726475|P4|COMPLETED|Washout Period (At Least 2 Days)||4
1125863|NCT01267201|2726476|P3|COMPLETED|Washout Period (At Least 2 Days)||4
1125864|NCT01267201|2726477|P2|COMPLETED|Washout Period (At Least 2 Days)||4
1125865|NCT01267201|2726478|P1|COMPLETED|Washout Period (At Least 2 Days)||3
1125866|NCT01267201|2726473|P6|STARTED|Washout Period (At Least 2 Days)||4
1125867|NCT01267201|2726474|P5|STARTED|Washout Period (At Least 2 Days)||4
1125868|NCT01267201|2726475|P4|STARTED|Washout Period (At Least 2 Days)||4
1125869|NCT01267201|2726476|P3|STARTED|Washout Period (At Least 2 Days)||4
1125870|NCT01267201|2726477|P2|STARTED|Washout Period (At Least 2 Days)||4
1125871|NCT01267201|2726478|P1|STARTED|Washout Period (At Least 2 Days)||3
1125872|NCT01267201|2726473|P6|NOT COMPLETED|First Intervention Period||0
1125873|NCT01267201|2726474|P5|NOT COMPLETED|First Intervention Period||0
1125874|NCT01267201|2726475|P4|NOT COMPLETED|First Intervention Period||0
1125875|NCT01267201|2726476|P3|NOT COMPLETED|First Intervention Period||0
1125876|NCT01267201|2726477|P2|NOT COMPLETED|First Intervention Period||0
1125877|NCT01267201|2726478|P1|NOT COMPLETED|First Intervention Period||1
1125878|NCT01267201|2726473|P6|COMPLETED|First Intervention Period||4
1125879|NCT01267201|2726474|P5|COMPLETED|First Intervention Period||4
1125880|NCT01267201|2726475|P4|COMPLETED|First Intervention Period||4
1125881|NCT01267201|2726476|P3|COMPLETED|First Intervention Period||4
1125882|NCT01267201|2726477|P2|COMPLETED|First Intervention Period||4
1125883|NCT01267201|2726478|P1|COMPLETED|First Intervention Period||3
1125884|NCT01267201|2726473|P6|STARTED|First Intervention Period||4
1125885|NCT01267201|2726474|P5|STARTED|First Intervention Period||4
1125886|NCT01267201|2726475|P4|STARTED|First Intervention Period||4
1125887|NCT01267201|2726476|P3|STARTED|First Intervention Period||4
1125888|NCT01267201|2726477|P2|STARTED|First Intervention Period||4
1125889|NCT01267201|2726478|P1|STARTED|First Intervention Period||4
1125890|NCT01267227|2726499|P4|NOT COMPLETED|Overall Study||3
1125891|NCT01267227|2726500|P3|NOT COMPLETED|Overall Study||2
1125892|NCT01267227|2726501|P2|NOT COMPLETED|Overall Study||1
1125893|NCT01267227|2726502|P1|NOT COMPLETED|Overall Study||1
1125894|NCT01267227|2726499|P4|COMPLETED|Overall Study||17
1125895|NCT01267227|2726500|P3|COMPLETED|Overall Study||18
1125896|NCT01267227|2726501|P2|COMPLETED|Overall Study||19
1125897|NCT01267227|2726502|P1|COMPLETED|Overall Study||19
1125898|NCT01267227|2726499|P4|STARTED|Overall Study||20
1125899|NCT01267227|2726500|P3|STARTED|Overall Study||20
1125900|NCT01267227|2726501|P2|STARTED|Overall Study||20
1125901|NCT01267227|2726502|P1|STARTED|Overall Study||20
1125902|NCT01267240|2726516|P1|NOT COMPLETED|Overall Study||0
1125903|NCT01267240|2726516|P1|COMPLETED|Overall Study||25
1125904|NCT01267240|2726516|P1|STARTED|Overall Study||25
1125905|NCT01267253|2726522|P1|NOT COMPLETED|Overall Study||3
1125998|NCT01278407|2726718|P1|COMPLETED|Extension Phase||0
1125906|NCT01267253|2726522|P1|COMPLETED|Overall Study|Eligible and treated patients|28
1125907|NCT01267253|2726522|P1|STARTED|Overall Study||31
1125908|NCT01276652|2726533|P3|NOT COMPLETED|Period 2: Observational||0
1125909|NCT01276652|2726534|P2|NOT COMPLETED|Period 2: Observational||0
1125910|NCT01276652|2726535|P1|NOT COMPLETED|Period 2: Observational||0
1125911|NCT01276652|2726533|P3|COMPLETED|Period 2: Observational||5
1125912|NCT01276652|2726534|P2|COMPLETED|Period 2: Observational||8
1125913|NCT01276652|2726535|P1|COMPLETED|Period 2: Observational||9
1125914|NCT01276652|2726533|P3|STARTED|Period 2: Observational|Subjects were only enrolled in the Observational arm during Period 2.|5
1125915|NCT01276652|2726534|P2|STARTED|Period 2: Observational||8
1125916|NCT01276652|2726535|P1|STARTED|Period 2: Observational||9
1125917|NCT01276652|2726533|P3|NOT COMPLETED|Period 1: Randomization||0
1125918|NCT01276652|2726534|P2|NOT COMPLETED|Period 1: Randomization||0
1125919|NCT01276652|2726535|P1|NOT COMPLETED|Period 1: Randomization||0
1125920|NCT01276652|2726533|P3|COMPLETED|Period 1: Randomization||0
1125921|NCT01276652|2726534|P2|COMPLETED|Period 1: Randomization||8
1125922|NCT01276652|2726535|P1|COMPLETED|Period 1: Randomization||9
1125923|NCT01276652|2726533|P3|STARTED|Period 1: Randomization|No subjects were enrolled in this arm during Period 1.|0
1125924|NCT01276652|2726534|P2|STARTED|Period 1: Randomization||8
1125925|NCT01276652|2726535|P1|STARTED|Period 1: Randomization||9
1125926|NCT01276756|2726560|P2|NOT COMPLETED|Overall Study||2
1125927|NCT01276756|2726561|P1|NOT COMPLETED|Overall Study||5
1125928|NCT01276756|2726560|P2|COMPLETED|Overall Study||48
1125929|NCT01276756|2726561|P1|COMPLETED|Overall Study||45
1125930|NCT01276756|2726560|P2|STARTED|Overall Study||50
1125931|NCT01276756|2726561|P1|STARTED|Overall Study||50
1125932|NCT01276821|2726577|P2|NOT COMPLETED|Overall Study||1
1125933|NCT01276821|2726578|P1|NOT COMPLETED|Overall Study||0
1125934|NCT01276821|2726577|P2|COMPLETED|Overall Study||49
1125935|NCT01276821|2726578|P1|COMPLETED|Overall Study||50
1125936|NCT01276821|2726577|P2|STARTED|Overall Study||50
1125937|NCT01276821|2726578|P1|STARTED|Overall Study||50
1125938|NCT01276847|2726599|P3|NOT COMPLETED|Overall Study||0
1125939|NCT01276847|2726600|P2|NOT COMPLETED|Overall Study||0
1125940|NCT01276847|2726601|P1|NOT COMPLETED|Overall Study||1
1125941|NCT01276847|2726599|P3|COMPLETED|Overall Study||20
1125942|NCT01276847|2726600|P2|COMPLETED|Overall Study||10
1125943|NCT01276847|2726601|P1|COMPLETED|Overall Study||9
1125944|NCT01276847|2726599|P3|STARTED|Overall Study||20
1125945|NCT01276847|2726600|P2|STARTED|Overall Study||10
1125946|NCT01276847|2726601|P1|STARTED|Overall Study||10
1125947|NCT01277822|2726611|P2|NOT COMPLETED|Overall Study||11
1125948|NCT01277822|2726612|P1|NOT COMPLETED|Overall Study||15
1125949|NCT01277822|2726611|P2|COMPLETED|Overall Study||155
1125950|NCT01277822|2726612|P1|COMPLETED|Overall Study||153
1125951|NCT01277822|2726611|P2|STARTED|Overall Study||166
1125952|NCT01277822|2726612|P1|STARTED|Overall Study||168
1125953|NCT01277861|2726634|P2|NOT COMPLETED|Overall Study||2
1125954|NCT01277861|2726635|P1|NOT COMPLETED|Overall Study||2
1125955|NCT01277861|2726634|P2|COMPLETED|Overall Study||47
1125956|NCT01277861|2726635|P1|COMPLETED|Overall Study||49
1125957|NCT01277861|2726634|P2|STARTED|Overall Study||49
1125958|NCT01277861|2726635|P1|STARTED|Overall Study||51
1125959|NCT01278030|2726647|P2|NOT COMPLETED|Overall Study||4
1125960|NCT01278030|2726648|P1|NOT COMPLETED|Overall Study||8
1125961|NCT01278030|2726647|P2|COMPLETED|Overall Study||31
1125962|NCT01278030|2726648|P1|COMPLETED|Overall Study||35
1125963|NCT01278030|2726647|P2|STARTED|Overall Study||35
1125964|NCT01278030|2726648|P1|STARTED|Overall Study||43
1125965|NCT01278160|2726656|P2|NOT COMPLETED|Overall Study||6
1125966|NCT01278160|2726657|P1|NOT COMPLETED|Overall Study||5
1125967|NCT01278160|2726656|P2|COMPLETED|Overall Study||84
1125968|NCT01278160|2726657|P1|COMPLETED|Overall Study||84
1125969|NCT01278160|2726656|P2|STARTED|Overall Study||90
1125970|NCT01278160|2726657|P1|STARTED|Overall Study||89
1125971|NCT01278173|2726671|P1|NOT COMPLETED|Overall Study||27
1125972|NCT01278173|2726671|P1|COMPLETED|Overall Study||38
1125973|NCT01278173|2726671|P1|STARTED|Overall Study||65
1125974|NCT01278303|2726676|P1|NOT COMPLETED|Overall Study||0
1125975|NCT01278303|2726676|P1|COMPLETED|Overall Study||82
1125976|NCT01278303|2726676|P1|STARTED|Overall Study||82
1125977|NCT01278342|2726685|P3|NOT COMPLETED|Overall Study||0
1125978|NCT01278342|2726686|P2|NOT COMPLETED|Overall Study||1
1125979|NCT01278342|2726687|P1|NOT COMPLETED|Overall Study||4
1125980|NCT01278342|2726685|P3|COMPLETED|Overall Study||32
1125981|NCT01278342|2726686|P2|COMPLETED|Overall Study||30
1125982|NCT01278342|2726687|P1|COMPLETED|Overall Study||3
1125983|NCT01278342|2726685|P3|STARTED|Overall Study||32
1125984|NCT01278342|2726686|P2|STARTED|Overall Study||31
1125985|NCT01278342|2726687|P1|STARTED|Overall Study||7
1125989|NCT01278407|2726714|P5|NOT COMPLETED|Extension Phase||30
1125990|NCT01278407|2726715|P4|NOT COMPLETED|Extension Phase||12
1125991|NCT01278407|2726716|P3|NOT COMPLETED|Extension Phase||0
1125992|NCT01278407|2726717|P2|NOT COMPLETED|Extension Phase||0
1125993|NCT01278407|2726718|P1|NOT COMPLETED|Extension Phase||0
1125994|NCT01278407|2726714|P5|COMPLETED|Extension Phase||66
1125995|NCT01278407|2726715|P4|COMPLETED|Extension Phase||34
1125996|NCT01278407|2726716|P3|COMPLETED|Extension Phase||0
1125997|NCT01278407|2726717|P2|COMPLETED|Extension Phase||0
1125999|NCT01278407|2726714|P5|STARTED|Extension Phase||96
1126000|NCT01278407|2726715|P4|STARTED|Extension Phase||46
1126001|NCT01278407|2726716|P3|STARTED|Extension Phase||0
1126002|NCT01278407|2726717|P2|STARTED|Extension Phase||0
1126003|NCT01278407|2726718|P1|STARTED|Extension Phase||0
1126004|NCT01278407|2726714|P5|NOT COMPLETED|Confirmatory Phase||0
1126005|NCT01278407|2726715|P4|NOT COMPLETED|Confirmatory Phase||0
1126006|NCT01278407|2726716|P3|NOT COMPLETED|Confirmatory Phase||6
1126007|NCT01278407|2726717|P2|NOT COMPLETED|Confirmatory Phase||16
1126008|NCT01278407|2726718|P1|NOT COMPLETED|Confirmatory Phase||9
1126009|NCT01278407|2726714|P5|COMPLETED|Confirmatory Phase||0
1126010|NCT01278407|2726715|P4|COMPLETED|Confirmatory Phase||0
1126011|NCT01278407|2726716|P3|COMPLETED|Confirmatory Phase||43
1126012|NCT01278407|2726717|P2|COMPLETED|Confirmatory Phase||31
1126013|NCT01278407|2726718|P1|COMPLETED|Confirmatory Phase||37
1126014|NCT01278407|2726714|P5|STARTED|Confirmatory Phase||0
1126015|NCT01278407|2726715|P4|STARTED|Confirmatory Phase||0
1126016|NCT01278407|2726716|P3|STARTED|Confirmatory Phase||49
1126017|NCT01278407|2726717|P2|STARTED|Confirmatory Phase||47
1126018|NCT01278407|2726718|P1|STARTED|Confirmatory Phase||46
1126019|NCT01278485|2726731|P1|NOT COMPLETED|Overall Study||0
1126020|NCT01278485|2726731|P1|COMPLETED|Overall Study||719
1126021|NCT01278485|2726731|P1|STARTED|Overall Study||719
1126022|NCT01278615|2726744|P1|NOT COMPLETED|Overall Study||2
1126023|NCT01278615|2726744|P1|COMPLETED|Overall Study||14
1126024|NCT01278615|2726744|P1|STARTED|Overall Study||16
1126025|NCT01278745|2726756|P4|NOT COMPLETED|Overall Study||78
1126026|NCT01278745|2726757|P3|NOT COMPLETED|Overall Study||121
1126027|NCT01278745|2726758|P2|NOT COMPLETED|Overall Study||6
1126028|NCT01278745|2726759|P1|NOT COMPLETED|Overall Study||5
1126029|NCT01278745|2726756|P4|COMPLETED|Overall Study||0
1126030|NCT01278745|2726757|P3|COMPLETED|Overall Study||0
1126031|NCT01278745|2726758|P2|COMPLETED|Overall Study||68
1126032|NCT01278745|2726759|P1|COMPLETED|Overall Study||84
1126033|NCT01278745|2726756|P4|STARTED|Overall Study||78
1126034|NCT01278745|2726757|P3|STARTED|Overall Study||121
1126035|NCT01278745|2726758|P2|STARTED|Overall Study||74
1126036|NCT01278745|2726759|P1|STARTED|Overall Study||89
1126037|NCT01278797|2726791|P2|NOT COMPLETED|Period 2||0
1126038|NCT01278797|2726792|P1|NOT COMPLETED|Period 2||0
1126039|NCT01278797|2726791|P2|COMPLETED|Period 2||13
1126040|NCT01278797|2726792|P1|COMPLETED|Period 2||13
1126041|NCT01278797|2726791|P2|STARTED|Period 2||13
1126042|NCT01278797|2726792|P1|STARTED|Period 2||13
1126043|NCT01278797|2726791|P2|NOT COMPLETED|Washout Period of 21 Days||0
1126044|NCT01278797|2726792|P1|NOT COMPLETED|Washout Period of 21 Days||0
1126045|NCT01278797|2726791|P2|COMPLETED|Washout Period of 21 Days||13
1126046|NCT01278797|2726792|P1|COMPLETED|Washout Period of 21 Days||13
1126047|NCT01278797|2726791|P2|STARTED|Washout Period of 21 Days||13
1126048|NCT01278797|2726792|P1|STARTED|Washout Period of 21 Days||13
1126049|NCT01278797|2726791|P2|NOT COMPLETED|Period 1||1
1126050|NCT01278797|2726792|P1|NOT COMPLETED|Period 1||1
1126051|NCT01278797|2726791|P2|COMPLETED|Period 1||13
1126052|NCT01278797|2726792|P1|COMPLETED|Period 1||13
1126053|NCT01278797|2726791|P2|STARTED|Period 1||14
1126054|NCT01278797|2726792|P1|STARTED|Period 1||14
1126055|NCT01278927|2726806|P4|NOT COMPLETED|Overall Study||0
1126056|NCT01278927|2726807|P3|NOT COMPLETED|Overall Study||0
1126057|NCT01278927|2726808|P2|NOT COMPLETED|Overall Study||0
1126058|NCT01278927|2726809|P1|NOT COMPLETED|Overall Study||0
1126059|NCT01278927|2726806|P4|COMPLETED|Overall Study||175
1126060|NCT01278927|2726807|P3|COMPLETED|Overall Study||178
1126061|NCT01278927|2726808|P2|COMPLETED|Overall Study||178
1126062|NCT01278927|2726809|P1|COMPLETED|Overall Study||180
1126063|NCT01278927|2726806|P4|STARTED|Overall Study||175
1126064|NCT01278927|2726807|P3|STARTED|Overall Study||178
1126065|NCT01278927|2726808|P2|STARTED|Overall Study||178
1126066|NCT01278927|2726809|P1|STARTED|Overall Study||180
1126067|NCT01278953|2726849|P2|NOT COMPLETED|Overall Study||11
1126068|NCT01278953|2726850|P1|NOT COMPLETED|Overall Study||9
1126069|NCT01278953|2726849|P2|COMPLETED|Overall Study||134
1126070|NCT01278953|2726850|P1|COMPLETED|Overall Study||146
1126071|NCT01278953|2726849|P2|STARTED|Overall Study||145
1126072|NCT01278953|2726850|P1|STARTED|Overall Study||155
1126073|NCT01279044|2726861|P3|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||3
1126074|NCT01279044|2726862|P2|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||11
1126075|NCT01279044|2726863|P1|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||0
1126076|NCT01279044|2726861|P3|COMPLETED|PHASE 2 - Randmonized Controlled Trial||161
1126077|NCT01279044|2726862|P2|COMPLETED|PHASE 2 - Randmonized Controlled Trial||151
1126078|NCT01279044|2726863|P1|COMPLETED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
1126079|NCT01279044|2726861|P3|STARTED|PHASE 2 - Randmonized Controlled Trial||164
1126080|NCT01279044|2726862|P2|STARTED|PHASE 2 - Randmonized Controlled Trial||162
1126081|NCT01279044|2726863|P1|STARTED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
1126082|NCT01279044|2726861|P3|NOT COMPLETED|PHASE 1 - Formative||0
1126083|NCT01279044|2726862|P2|NOT COMPLETED|PHASE 1 - Formative||0
1126084|NCT01279044|2726863|P1|NOT COMPLETED|PHASE 1 - Formative||0
1126085|NCT01279044|2726861|P3|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
1126086|NCT01279044|2726862|P2|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
1126087|NCT01279044|2726863|P1|COMPLETED|PHASE 1 - Formative||59
1126088|NCT01279044|2726861|P3|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
1126089|NCT01279044|2726862|P2|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
1126090|NCT01279044|2726863|P1|STARTED|PHASE 1 - Formative||59
1126091|NCT01279070|2726883|P2|NOT COMPLETED|Overall Study||4
1126092|NCT01279070|2726884|P1|NOT COMPLETED|Overall Study||5
1126093|NCT01279070|2726883|P2|COMPLETED|Overall Study|4 outpatients left the leisure group up to 2 months after starting Leisure group.|24
1126094|NCT01279070|2726884|P1|COMPLETED|Overall Study|5 outpatients left the treatment up to 2 months after starting REPYFLEC.|29
1126095|NCT01279070|2726883|P2|STARTED|Overall Study|28 outpatients were randomly assigned to 32 sessions of leisure group.|28
1126096|NCT01279070|2726884|P1|STARTED|Overall Study|34 outpatients were randomly assigned to 32 sessions of REPYFLEC.|34
1126097|NCT01279109|2726902|P2|NOT COMPLETED|Overall Study||12
1126098|NCT01279109|2726903|P1|NOT COMPLETED|Overall Study||13
1126099|NCT01279109|2726902|P2|COMPLETED|Overall Study||55
1126100|NCT01279109|2726903|P1|COMPLETED|Overall Study||55
1126101|NCT01279109|2726902|P2|STARTED|Overall Study||67
1126102|NCT01279109|2726903|P1|STARTED|Overall Study||68
1126103|NCT01279200|2726913|P2|NOT COMPLETED|Overall Study||7
1126104|NCT01279200|2726914|P1|NOT COMPLETED|Overall Study||2
1126105|NCT01279200|2726913|P2|COMPLETED|Overall Study||4
1126106|NCT01279200|2726914|P1|COMPLETED|Overall Study||8
1126107|NCT01279200|2726913|P2|STARTED|Overall Study||11
1126108|NCT01279200|2726914|P1|STARTED|Overall Study||10
1126109|NCT01279265|2726924|P2|NOT COMPLETED|Overall Study||6
1126110|NCT01279265|2726925|P1|NOT COMPLETED|Overall Study||4
1126111|NCT01279265|2726924|P2|COMPLETED|Overall Study||11
1126112|NCT01279265|2726925|P1|COMPLETED|Overall Study||9
1126113|NCT01279265|2726924|P2|STARTED|Overall Study||17
1126114|NCT01279265|2726925|P1|STARTED|Overall Study||13
1126115|NCT01279317|2726935|P2|NOT COMPLETED|Period 2||0
1126116|NCT01279317|2726936|P1|NOT COMPLETED|Period 2||0
1126117|NCT01279317|2726935|P2|COMPLETED|Period 2||6
1126118|NCT01279317|2726936|P1|COMPLETED|Period 2||6
1126119|NCT01279317|2726935|P2|STARTED|Period 2||6
1126120|NCT01279317|2726936|P1|STARTED|Period 2||6
1126121|NCT01279317|2726935|P2|NOT COMPLETED|Washout||0
1126122|NCT01279317|2726936|P1|NOT COMPLETED|Washout||0
1126123|NCT01279317|2726935|P2|COMPLETED|Washout||6
1126124|NCT01279317|2726936|P1|COMPLETED|Washout||6
1126125|NCT01279317|2726935|P2|STARTED|Washout||6
1126126|NCT01279317|2726936|P1|STARTED|Washout||6
1126127|NCT01279317|2726935|P2|NOT COMPLETED|Period 1||0
1126128|NCT01279317|2726936|P1|NOT COMPLETED|Period 1||0
1126129|NCT01279317|2726935|P2|COMPLETED|Period 1||6
1126130|NCT01279317|2726936|P1|COMPLETED|Period 1||6
1126131|NCT01279317|2726935|P2|STARTED|Period 1||6
1126132|NCT01279317|2726936|P1|STARTED|Period 1||6
1126133|NCT01279447|2726943|P2|NOT COMPLETED|Overall Study||1
1126134|NCT01279447|2726944|P1|NOT COMPLETED|Overall Study||3
1126135|NCT01279447|2726943|P2|COMPLETED|Overall Study||33
1126136|NCT01279447|2726944|P1|COMPLETED|Overall Study||31
1126137|NCT01279447|2726943|P2|STARTED|Overall Study||34
1126138|NCT01279447|2726944|P1|STARTED|Overall Study||34
1126139|NCT01279564|2726952|P2|NOT COMPLETED|Overall Study||0
1126140|NCT01279564|2726953|P1|NOT COMPLETED|Overall Study||0
1126141|NCT01279564|2726952|P2|COMPLETED|Overall Study||32
1126142|NCT01279564|2726953|P1|COMPLETED|Overall Study||40
1126143|NCT01279564|2726952|P2|STARTED|Overall Study||32
1126144|NCT01279564|2726953|P1|STARTED|Overall Study||40
1126145|NCT01280110|2726961|P2|NOT COMPLETED|Overall Study||0
1126146|NCT01280110|2726962|P1|NOT COMPLETED|Overall Study||0
1126147|NCT01280110|2726961|P2|COMPLETED|Overall Study||22
1126148|NCT01280110|2726962|P1|COMPLETED|Overall Study||22
1126149|NCT01280110|2726961|P2|STARTED|Overall Study||22
1126150|NCT01280110|2726962|P1|STARTED|Overall Study||22
1126151|NCT01280123|2726973|P3|NOT COMPLETED|Overall Study||1
1126152|NCT01280123|2726974|P2|NOT COMPLETED|Overall Study||4
1126153|NCT01280123|2726975|P1|NOT COMPLETED|Overall Study||1
1126154|NCT01280123|2726973|P3|COMPLETED|Overall Study||70
1126155|NCT01280123|2726974|P2|COMPLETED|Overall Study||63
1126156|NCT01280123|2726975|P1|COMPLETED|Overall Study||71
1126157|NCT01280123|2726973|P3|STARTED|Overall Study||71
1126158|NCT01280123|2726974|P2|STARTED|Overall Study||67
1126159|NCT01280123|2726975|P1|STARTED|Overall Study||72
1126160|NCT01280266|2727000|P2|NOT COMPLETED|Second Intervention (Week 5-9)||0
1126161|NCT01280266|2727001|P1|NOT COMPLETED|Second Intervention (Week 5-9)||0
1126162|NCT01280266|2727000|P2|COMPLETED|Second Intervention (Week 5-9)||12
1126163|NCT01280266|2727001|P1|COMPLETED|Second Intervention (Week 5-9)||14
1126164|NCT01280266|2727000|P2|STARTED|Second Intervention (Week 5-9)||12
1126165|NCT01280266|2727001|P1|STARTED|Second Intervention (Week 5-9)||14
1126166|NCT01280266|2727000|P2|NOT COMPLETED|Washout Period (Week 4-5)||0
1126167|NCT01280266|2727001|P1|NOT COMPLETED|Washout Period (Week 4-5)||0
1126168|NCT01280266|2727000|P2|COMPLETED|Washout Period (Week 4-5)||12
1126169|NCT01280266|2727001|P1|COMPLETED|Washout Period (Week 4-5)||14
1126170|NCT01280266|2727000|P2|STARTED|Washout Period (Week 4-5)||12
1126171|NCT01280266|2727001|P1|STARTED|Washout Period (Week 4-5)||14
1126172|NCT01280266|2727000|P2|NOT COMPLETED|First Intervention (Week 1-4)||2
1126173|NCT01280266|2727001|P1|NOT COMPLETED|First Intervention (Week 1-4)||1
1126174|NCT01280266|2727000|P2|COMPLETED|First Intervention (Week 1-4)||12
1126175|NCT01280266|2727001|P1|COMPLETED|First Intervention (Week 1-4)||14
1126176|NCT01280266|2727000|P2|STARTED|First Intervention (Week 1-4)||14
1126177|NCT01280266|2727001|P1|STARTED|First Intervention (Week 1-4)||15
1126178|NCT01270126|2727025|P2|NOT COMPLETED|Overall Study||0
1126179|NCT01270126|2727026|P1|NOT COMPLETED|Overall Study||0
1126180|NCT01270126|2727025|P2|COMPLETED|Overall Study||10
1126181|NCT01270126|2727026|P1|COMPLETED|Overall Study||12
1126182|NCT01270126|2727025|P2|STARTED|Overall Study||10
1126183|NCT01270126|2727026|P1|STARTED|Overall Study||12
1126184|NCT01270139|2727035|P3|NOT COMPLETED|Overall Study||20
1126185|NCT01270139|2727036|P2|NOT COMPLETED|Overall Study||26
1126186|NCT01270139|2727037|P1|NOT COMPLETED|Overall Study||18
1126187|NCT01270139|2727035|P3|COMPLETED|Overall Study|Pre-treatment evaluable population|40
1126188|NCT01270139|2727036|P2|COMPLETED|Overall Study|Pre-treatment evaluable population|34
1126189|NCT01270139|2727037|P1|COMPLETED|Overall Study|Pre-treatment evaluable population|42
1126190|NCT01270139|2727035|P3|STARTED|Overall Study|Intention-to-treat population|60
1126191|NCT01270139|2727036|P2|STARTED|Overall Study|Intention-to-treat population|60
1126192|NCT01270139|2727037|P1|STARTED|Overall Study|Intention-to-treat population|60
1126193|NCT01270256|2727097|P2|NOT COMPLETED|Overall Study||0
1126194|NCT01270256|2727098|P1|NOT COMPLETED|Overall Study||1
1126195|NCT01270256|2727097|P2|COMPLETED|Overall Study||20
1126196|NCT01270256|2727098|P1|COMPLETED|Overall Study||20
1126197|NCT01270256|2727097|P2|STARTED|Overall Study||20
1126198|NCT01270256|2727098|P1|STARTED|Overall Study||21
1126199|NCT01270464|2727107|P3|NOT COMPLETED|Overall Study||18
1126200|NCT01270464|2727108|P2|NOT COMPLETED|Overall Study||12
1126201|NCT01270464|2727109|P1|NOT COMPLETED|Overall Study||20
1126202|NCT01270464|2727107|P3|COMPLETED|Overall Study||88
1126203|NCT01270464|2727108|P2|COMPLETED|Overall Study||92
1126204|NCT01270464|2727109|P1|COMPLETED|Overall Study||85
1126205|NCT01270464|2727107|P3|Pharmacokinetic Analysis Set|Overall Study||103
1126206|NCT01270464|2727108|P2|Pharmacokinetic Analysis Set|Overall Study||103
1126207|NCT01270464|2727109|P1|Pharmacokinetic Analysis Set|Overall Study||105
1126208|NCT01270464|2727107|P3|Full Analysis Set|Overall Study||103
1126209|NCT01270464|2727108|P2|Full Analysis Set|Overall Study||103
1126210|NCT01270464|2727109|P1|Full Analysis Set|Overall Study||105
1126211|NCT01270464|2727107|P3|Safety Analysis Set|Overall Study||103
1126212|NCT01270464|2727108|P2|Safety Analysis Set|Overall Study||103
1126213|NCT01270464|2727109|P1|Safety Analysis Set|Overall Study||105
1126214|NCT01270464|2727107|P3|STARTED|Overall Study||106
1126215|NCT01270464|2727108|P2|STARTED|Overall Study||104
1126216|NCT01270464|2727109|P1|STARTED|Overall Study||105
1126217|NCT01270503|2727156|P1|NOT COMPLETED|Overall Study||1
1126218|NCT01270503|2727156|P1|COMPLETED|Overall Study||537
1126219|NCT01270503|2727156|P1|STARTED|Overall Study||538
1126220|NCT01270529|2727164|P3|NOT COMPLETED|Overall Study||0
1126221|NCT01270529|2727165|P2|NOT COMPLETED|Overall Study||0
1126222|NCT01270529|2727166|P1|NOT COMPLETED|Overall Study||0
1126223|NCT01270529|2727164|P3|COMPLETED|Overall Study||25
1126224|NCT01270529|2727165|P2|COMPLETED|Overall Study||7
1126225|NCT01270529|2727166|P1|COMPLETED|Overall Study||12
1126226|NCT01270529|2727164|P3|STARTED|Overall Study||25
1126227|NCT01270529|2727165|P2|STARTED|Overall Study||7
1126228|NCT01270529|2727166|P1|STARTED|Overall Study||12
1126229|NCT01270542|2727176|P2|NOT COMPLETED|Overall Study||1
1126230|NCT01270542|2727177|P1|NOT COMPLETED|Overall Study||1
1126231|NCT01270542|2727176|P2|COMPLETED|Overall Study||8
1126232|NCT01270542|2727177|P1|COMPLETED|Overall Study||9
1126233|NCT01270542|2727176|P2|STARTED|Overall Study||9
1126234|NCT01270542|2727177|P1|STARTED|Overall Study||10
1126235|NCT01270555|2727187|P1|NOT COMPLETED|Overall Study||13
1126236|NCT01270555|2727187|P1|COMPLETED|Overall Study||19
1126237|NCT01270555|2727187|P1|STARTED|Overall Study||32
1126238|NCT01270581|2727199|P2|NOT COMPLETED|Overall Study||0
1126239|NCT01270581|2727200|P1|NOT COMPLETED|Overall Study||1
1126240|NCT01270581|2727199|P2|COMPLETED|Overall Study||3
1126241|NCT01270581|2727200|P1|COMPLETED|Overall Study||3
1126242|NCT01270581|2727199|P2|STARTED|Overall Study||3
1126243|NCT01270581|2727200|P1|STARTED|Overall Study||4
1126244|NCT01270620|2727208|P2|NOT COMPLETED|Overall Study||3
1126245|NCT01270620|2727209|P1|NOT COMPLETED|Overall Study||1
1126246|NCT01270620|2727208|P2|COMPLETED|Overall Study||47
1126247|NCT01270620|2727209|P1|COMPLETED|Overall Study||49
1126248|NCT01270620|2727208|P2|STARTED|Overall Study||50
1126249|NCT01270620|2727209|P1|STARTED|Overall Study||50
1126250|NCT01271712|2727261|P2|NOT COMPLETED|Survival Follow-up||6
1126251|NCT01271712|2727262|P1|NOT COMPLETED|Survival Follow-up||15
1126252|NCT01271712|2727261|P2|COMPLETED|Survival Follow-up|33 participants died and completed survival follow-up.|33
1126253|NCT01271712|2727262|P1|COMPLETED|Survival Follow-up|85 participants died and completed survival follow-up.|85
1126254|NCT01271712|2727261|P2|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|39
1126255|NCT01271712|2727262|P1|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|100
1126256|NCT01271712|2727261|P2|NOT COMPLETED|Safety Follow-up||15
1126257|NCT01271712|2727262|P1|NOT COMPLETED|Safety Follow-up||21
1126258|NCT01271712|2727261|P2|COMPLETED|Safety Follow-up||37
1126259|NCT01271712|2727262|P1|COMPLETED|Safety Follow-up||97
1126260|NCT01271712|2727261|P2|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|52
1126261|NCT01271712|2727262|P1|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|118
1126262|NCT01271712|2727261|P2|NOT COMPLETED|Open Label Treatment||58
1126263|NCT01271712|2727262|P1|NOT COMPLETED|Open Label Treatment||91
1126264|NCT01271712|2727261|P2|COMPLETED|Open Label Treatment||0
1126265|NCT01271712|2727262|P1|COMPLETED|Open Label Treatment||0
1126266|NCT01271712|2727261|P2|STARTED|Open Label Treatment||58
1126267|NCT01271712|2727262|P1|STARTED|Open Label Treatment||91
1126268|NCT01271712|2727261|P2|NOT COMPLETED|Double Blind Treatment||8
1126269|NCT01271712|2727262|P1|NOT COMPLETED|Double Blind Treatment||42
1126270|NCT01271712|2727261|P2|COMPLETED|Double Blind Treatment|58 participants started open-label treatment with regorafenib|58
1126271|NCT01271712|2727262|P1|COMPLETED|Double Blind Treatment|91 participants started open-label treatment with regorafenib|91
1126272|NCT01271712|2727261|P2|Participants Received Treatment|Double Blind Treatment||66
1126273|NCT01271712|2727262|P1|Participants Received Treatment|Double Blind Treatment||132
1126274|NCT01271712|2727261|P2|STARTED|Double Blind Treatment||66
1126275|NCT01271712|2727262|P1|STARTED|Double Blind Treatment||133
1126276|NCT01271803|2727295|P12|NOT COMPLETED|Stage 2||39
1126277|NCT01271803|2727296|P11|NOT COMPLETED|Stage 2||27
1126278|NCT01271803|2727297|P10|NOT COMPLETED|Stage 2||0
1126279|NCT01271803|2727298|P9|NOT COMPLETED|Stage 2||0
1126280|NCT01271803|2727299|P8|NOT COMPLETED|Stage 2||0
1126281|NCT01271803|2727300|P7|NOT COMPLETED|Stage 2||0
1126282|NCT01271803|2727301|P6|NOT COMPLETED|Stage 2||0
1126283|NCT01271803|2727302|P5|NOT COMPLETED|Stage 2||0
1126284|NCT01271803|2727303|P4|NOT COMPLETED|Stage 2||0
1126285|NCT01271803|2727304|P3|NOT COMPLETED|Stage 2||0
1126286|NCT01271803|2727305|P2|NOT COMPLETED|Stage 2||0
1126287|NCT01271803|2727306|P1|NOT COMPLETED|Stage 2||0
1126288|NCT01271803|2727295|P12|COMPLETED|Stage 2||0
1126289|NCT01271803|2727296|P11|COMPLETED|Stage 2||0
1126290|NCT01271803|2727297|P10|COMPLETED|Stage 2||0
1126291|NCT01271803|2727298|P9|COMPLETED|Stage 2||0
1126292|NCT01271803|2727299|P8|COMPLETED|Stage 2||0
1126293|NCT01271803|2727300|P7|COMPLETED|Stage 2||0
1126294|NCT01271803|2727301|P6|COMPLETED|Stage 2||0
1126295|NCT01271803|2727302|P5|COMPLETED|Stage 2||0
1126296|NCT01271803|2727303|P4|COMPLETED|Stage 2||0
1126297|NCT01271803|2727304|P3|COMPLETED|Stage 2||0
1126298|NCT01271803|2727305|P2|COMPLETED|Stage 2||0
1126299|NCT01271803|2727306|P1|COMPLETED|Stage 2||0
1126300|NCT01271803|2727295|P12|STARTED|Stage 2||39
1126301|NCT01271803|2727296|P11|STARTED|Stage 2||27
1126302|NCT01271803|2727297|P10|STARTED|Stage 2||0
1126303|NCT01271803|2727298|P9|STARTED|Stage 2||0
1126304|NCT01271803|2727299|P8|STARTED|Stage 2||0
1126305|NCT01271803|2727300|P7|STARTED|Stage 2||0
1126306|NCT01271803|2727301|P6|STARTED|Stage 2||0
1126307|NCT01271803|2727302|P5|STARTED|Stage 2||0
1126308|NCT01271803|2727303|P4|STARTED|Stage 2||0
1126309|NCT01271803|2727304|P3|STARTED|Stage 2||0
1126310|NCT01271803|2727305|P2|STARTED|Stage 2||0
1126311|NCT01271803|2727306|P1|STARTED|Stage 2||0
1126312|NCT01271803|2727295|P12|NOT COMPLETED|Stage 1||0
1126313|NCT01271803|2727296|P11|NOT COMPLETED|Stage 1||0
1126314|NCT01271803|2727297|P10|NOT COMPLETED|Stage 1||2
1126315|NCT01271803|2727298|P9|NOT COMPLETED|Stage 1||5
1126316|NCT01271803|2727299|P8|NOT COMPLETED|Stage 1||3
1126317|NCT01271803|2727300|P7|NOT COMPLETED|Stage 1||4
1126318|NCT01271803|2727301|P6|NOT COMPLETED|Stage 1||4
1126319|NCT01271803|2727302|P5|NOT COMPLETED|Stage 1||4
1126320|NCT01271803|2727303|P4|NOT COMPLETED|Stage 1||3
1126321|NCT01271803|2727304|P3|NOT COMPLETED|Stage 1||27
1126322|NCT01271803|2727305|P2|NOT COMPLETED|Stage 1||8
1126323|NCT01271803|2727306|P1|NOT COMPLETED|Stage 1||5
1126324|NCT01271803|2727295|P12|COMPLETED|Stage 1||0
1126325|NCT01271803|2727296|P11|COMPLETED|Stage 1||0
1126326|NCT01271803|2727297|P10|COMPLETED|Stage 1||0
1126327|NCT01271803|2727298|P9|COMPLETED|Stage 1||0
1126328|NCT01271803|2727299|P8|COMPLETED|Stage 1||0
1126329|NCT01271803|2727300|P7|COMPLETED|Stage 1||0
1126330|NCT01271803|2727301|P6|COMPLETED|Stage 1||0
1126331|NCT01271803|2727302|P5|COMPLETED|Stage 1||0
1126332|NCT01271803|2727303|P4|COMPLETED|Stage 1||0
1126333|NCT01271803|2727304|P3|COMPLETED|Stage 1||0
1126334|NCT01271803|2727305|P2|COMPLETED|Stage 1||0
1126335|NCT01271803|2727306|P1|COMPLETED|Stage 1||0
1126336|NCT01271803|2727295|P12|STARTED|Stage 1||0
1126337|NCT01271803|2727296|P11|STARTED|Stage 1||0
1126338|NCT01271803|2727297|P10|STARTED|Stage 1||2
1126339|NCT01271803|2727298|P9|STARTED|Stage 1||5
1126340|NCT01271803|2727299|P8|STARTED|Stage 1||3
1126341|NCT01271803|2727300|P7|STARTED|Stage 1||4
1126342|NCT01271803|2727301|P6|STARTED|Stage 1||4
1126343|NCT01271803|2727302|P5|STARTED|Stage 1||4
1126344|NCT01271803|2727303|P4|STARTED|Stage 1||3
1126345|NCT01271803|2727304|P3|STARTED|Stage 1||27
1126346|NCT01271803|2727305|P2|STARTED|Stage 1||8
1126347|NCT01271803|2727306|P1|STARTED|Stage 1||5
1126348|NCT01271907|2727480|P3|NOT COMPLETED|Overall Study||0
1126349|NCT01271907|2727481|P2|NOT COMPLETED|Overall Study||0
1126350|NCT01271907|2727482|P1|NOT COMPLETED|Overall Study||0
1126351|NCT01271907|2727480|P3|COMPLETED|Overall Study||0
1126352|NCT01271907|2727481|P2|COMPLETED|Overall Study||0
1126353|NCT01271907|2727482|P1|COMPLETED|Overall Study||3
1126354|NCT01271907|2727480|P3|STARTED|Overall Study||0
1126355|NCT01271907|2727481|P2|STARTED|Overall Study||0
1126356|NCT01271907|2727482|P1|STARTED|Overall Study||3
1126357|NCT01271946|2727498|P2|NOT COMPLETED|Overall Study||0
1126358|NCT01271946|2727499|P1|NOT COMPLETED|Overall Study||0
1126359|NCT01271946|2727498|P2|COMPLETED|Overall Study||5
1126360|NCT01271946|2727499|P1|COMPLETED|Overall Study||346
1126361|NCT01271946|2727498|P2|STARTED|Overall Study||5
1126362|NCT01271946|2727499|P1|STARTED|Overall Study||346
1126363|NCT01272011|2727524|P3|NOT COMPLETED|Overall Study||0
1126364|NCT01272011|2727525|P2|NOT COMPLETED|Overall Study||2
1126365|NCT01272011|2727526|P1|NOT COMPLETED|Overall Study||0
1126366|NCT01272011|2727524|P3|COMPLETED|Overall Study||3
1126367|NCT01272011|2727525|P2|COMPLETED|Overall Study||8
1126368|NCT01272011|2727526|P1|COMPLETED|Overall Study||3
1126369|NCT01272011|2727524|P3|STARTED|Overall Study||3
1126370|NCT01272011|2727525|P2|STARTED|Overall Study||10
1126371|NCT01272011|2727526|P1|STARTED|Overall Study||3
1126372|NCT01272076|2727537|P1|NOT COMPLETED|Overall Study||0
1126373|NCT01272076|2727537|P1|COMPLETED|Overall Study||52
1126374|NCT01272076|2727537|P1|STARTED|Overall Study||52
1126375|NCT01272141|2727541|P1|NOT COMPLETED|Overall Study||0
1126376|NCT01272141|2727541|P1|COMPLETED|Overall Study||5
1126377|NCT01272141|2727541|P1|STARTED|Overall Study||5
1126378|NCT01272180|2727550|P4|NOT COMPLETED|Overall Study||14
1126379|NCT01272180|2727551|P3|NOT COMPLETED|Overall Study||13
1126380|NCT01272180|2727552|P2|NOT COMPLETED|Overall Study||21
1126381|NCT01272180|2727553|P1|NOT COMPLETED|Overall Study||17
1126382|NCT01272180|2727550|P4|COMPLETED|Overall Study||107
1126383|NCT01272180|2727551|P3|COMPLETED|Overall Study||109
1126384|NCT01272180|2727552|P2|COMPLETED|Overall Study||100
1126385|NCT01272180|2727553|P1|COMPLETED|Overall Study||103
1126386|NCT01272180|2727550|P4|STARTED|Overall Study||121
1126387|NCT01272180|2727551|P3|STARTED|Overall Study||122
1126388|NCT01272180|2727552|P2|STARTED|Overall Study||121
1126389|NCT01272180|2727553|P1|STARTED|Overall Study||120
1126390|NCT01272193|2727592|P2|NOT COMPLETED|Overall Study||12
1126391|NCT01272193|2727593|P1|NOT COMPLETED|Overall Study||10
1126392|NCT01272193|2727592|P2|COMPLETED|Overall Study||137
1126393|NCT01272193|2727593|P1|COMPLETED|Overall Study||137
1126394|NCT01272193|2727592|P2|STARTED|Overall Study||149
1126395|NCT01272193|2727593|P1|STARTED|Overall Study||147
1126483|NCT01272284|2727696|P1|NOT COMPLETED|12-month Follow-up Visit||4
1126484|NCT01272284|2727696|P1|COMPLETED|12-month Follow-up Visit||105
1126485|NCT01272284|2727696|P1|STARTED|12-month Follow-up Visit||109
1126486|NCT01272284|2727696|P1|NOT COMPLETED|6-month Follow-up Visit||3
1126487|NCT01272284|2727696|P1|COMPLETED|6-month Follow-up Visit||109
1126488|NCT01272284|2727696|P1|STARTED|6-month Follow-up Visit||112
1126489|NCT01272284|2727696|P1|NOT COMPLETED|3-month Follow-up Visit||1
1126490|NCT01272284|2727696|P1|COMPLETED|3-month Follow-up Visit||112
1126491|NCT01272284|2727696|P1|STARTED|3-month Follow-up Visit||113
1126492|NCT01272583|2727712|P2|NOT COMPLETED|Overall Study||0
1126493|NCT01272583|2727713|P1|NOT COMPLETED|Overall Study||0
1126494|NCT01272583|2727712|P2|COMPLETED|Overall Study||8
1126495|NCT01272583|2727713|P1|COMPLETED|Overall Study||8
1126496|NCT01272583|2727712|P2|STARTED|Overall Study||8
1126497|NCT01272583|2727713|P1|STARTED|Overall Study||8
1126498|NCT01272635|2727744|P4|NOT COMPLETED|Overall Study||23
1126499|NCT01272635|2727745|P3|NOT COMPLETED|Overall Study||31
1126500|NCT01272635|2727746|P2|NOT COMPLETED|Overall Study||20
1126501|NCT01272635|2727747|P1|NOT COMPLETED|Overall Study||31
1126502|NCT01272635|2727744|P4|COMPLETED|Overall Study||129
1126503|NCT01272635|2727745|P3|COMPLETED|Overall Study||117
1126504|NCT01272635|2727746|P2|COMPLETED|Overall Study||134
1126505|NCT01272635|2727747|P1|COMPLETED|Overall Study||122
1126506|NCT01272635|2727744|P4|STARTED|Overall Study||152
1126507|NCT01272635|2727745|P3|STARTED|Overall Study||148
1126508|NCT01272635|2727746|P2|STARTED|Overall Study||154
1126509|NCT01272635|2727747|P1|STARTED|Overall Study||153
1126510|NCT01272661|2727766|P3|NOT COMPLETED|Overall Study||72
1126511|NCT01272661|2727767|P2|NOT COMPLETED|Overall Study||209
1126512|NCT01272661|2727768|P1|NOT COMPLETED|Overall Study||126
1126513|NCT01272661|2727766|P3|COMPLETED|Overall Study||314
1126514|NCT01272661|2727767|P2|COMPLETED|Overall Study||288
1126515|NCT01272661|2727768|P1|COMPLETED|Overall Study||287
1126516|NCT01272661|2727766|P3|STARTED|Overall Study||386
1126517|NCT01272661|2727767|P2|STARTED|Overall Study||497
1126518|NCT01272661|2727768|P1|STARTED|Overall Study||413
1126519|NCT01272804|2727797|P6|NOT COMPLETED|Overall Study||1
1126520|NCT01272804|2727798|P5|NOT COMPLETED|Overall Study||2
1126521|NCT01272804|2727799|P4|NOT COMPLETED|Overall Study||0
1126522|NCT01272804|2727800|P3|NOT COMPLETED|Overall Study||0
1126523|NCT01272804|2727801|P2|NOT COMPLETED|Overall Study||0
1126524|NCT01272804|2727802|P1|NOT COMPLETED|Overall Study||1
1126525|NCT01272804|2727797|P6|COMPLETED|Overall Study||15
1126526|NCT01272804|2727798|P5|COMPLETED|Overall Study||7
1126527|NCT01272804|2727799|P4|COMPLETED|Overall Study||9
1126528|NCT01272804|2727800|P3|COMPLETED|Overall Study||9
1126529|NCT01272804|2727801|P2|COMPLETED|Overall Study||9
1126530|NCT01272804|2727802|P1|COMPLETED|Overall Study||8
1126531|NCT01272804|2727797|P6|STARTED|Overall Study||16
1126532|NCT01272804|2727798|P5|STARTED|Overall Study||9
1126533|NCT01272804|2727799|P4|STARTED|Overall Study||9
1126534|NCT01272804|2727800|P3|STARTED|Overall Study||9
1126535|NCT01272804|2727801|P2|STARTED|Overall Study||9
1126536|NCT01272804|2727802|P1|STARTED|Overall Study||9
1126537|NCT01272869|2727959|P2|NOT COMPLETED|Period 2 (14 Days)||0
1126538|NCT01272869|2727960|P1|NOT COMPLETED|Period 2 (14 Days)||1
1126539|NCT01272869|2727959|P2|COMPLETED|Period 2 (14 Days)||10
1126540|NCT01272869|2727960|P1|COMPLETED|Period 2 (14 Days)||9
1126541|NCT01272869|2727959|P2|STARTED|Period 2 (14 Days)||10
1126542|NCT01272869|2727960|P1|STARTED|Period 2 (14 Days)||10
1126543|NCT01272869|2727959|P2|NOT COMPLETED|Period 1 (14 Days)||0
1126544|NCT01272869|2727960|P1|NOT COMPLETED|Period 1 (14 Days)||0
1126545|NCT01272869|2727959|P2|COMPLETED|Period 1 (14 Days)||10
1126546|NCT01272869|2727960|P1|COMPLETED|Period 1 (14 Days)||10
1126547|NCT01272869|2727959|P2|STARTED|Period 1 (14 Days)||10
1126548|NCT01272869|2727960|P1|STARTED|Period 1 (14 Days)||10
1126549|NCT01272882|2727966|P1|NOT COMPLETED|Overall Study||0
1126550|NCT01272882|2727966|P1|COMPLETED|Overall Study||13
1126551|NCT01272882|2727966|P1|STARTED|Overall Study||13
1126552|NCT01272908|2727970|P1|NOT COMPLETED|Re-Treatment Period||6
1126553|NCT01272908|2727970|P1|COMPLETED|Re-Treatment Period||71
1126554|NCT01272908|2727970|P1|STARTED|Re-Treatment Period|Only participants with active disease as characterized by DAS-28 score ≥2.6 were included.|77
1126555|NCT01272908|2727970|P1|NOT COMPLETED|Initial Treatment Period||8
1126556|NCT01272908|2727970|P1|COMPLETED|Initial Treatment Period||112
1126557|NCT01272908|2727970|P1|STARTED|Initial Treatment Period||120
1126558|NCT01272921|2728006|P2|NOT COMPLETED|Overall Study||1
1126559|NCT01272921|2728007|P1|NOT COMPLETED|Overall Study||2
1126560|NCT01272921|2728006|P2|COMPLETED|Overall Study||70
1126561|NCT01272921|2728007|P1|COMPLETED|Overall Study||69
1126562|NCT01272921|2728006|P2|STARTED|Overall Study||71
1126563|NCT01272921|2728007|P1|STARTED|Overall Study||71
1126564|NCT01272934|2728017|P2|NOT COMPLETED|Overall Study||2
1126565|NCT01272934|2728018|P1|NOT COMPLETED|Overall Study||0
1126566|NCT01272934|2728017|P2|COMPLETED|Overall Study||101
1126567|NCT01272934|2728018|P1|COMPLETED|Overall Study||102
1126568|NCT01272934|2728017|P2|STARTED|Overall Study||103
1126569|NCT01272934|2728018|P1|STARTED|Overall Study||102
1126570|NCT01272947|2728028|P2|NOT COMPLETED|Overall Study||2
1126571|NCT01272947|2728029|P1|NOT COMPLETED|Overall Study||2
1126572|NCT01272947|2728028|P2|COMPLETED|Overall Study||98
1126573|NCT01272947|2728029|P1|COMPLETED|Overall Study||102
1126574|NCT01272947|2728028|P2|STARTED|Overall Study||100
1126575|NCT01272947|2728029|P1|STARTED|Overall Study||104
1126576|NCT01273038|2728039|P2|NOT COMPLETED|Second Intervention (14 Days)||2
1126577|NCT01273038|2728040|P1|NOT COMPLETED|Second Intervention (14 Days)||0
1126578|NCT01273038|2728039|P2|COMPLETED|Second Intervention (14 Days)||8
1126579|NCT01273038|2728040|P1|COMPLETED|Second Intervention (14 Days)||10
1126580|NCT01273038|2728039|P2|STARTED|Second Intervention (14 Days)||10
1126581|NCT01273038|2728040|P1|STARTED|Second Intervention (14 Days)||10
1126582|NCT01273038|2728039|P2|NOT COMPLETED|First Intervention (14 Days)||0
1126583|NCT01273038|2728040|P1|NOT COMPLETED|First Intervention (14 Days)||0
1126584|NCT01273038|2728039|P2|COMPLETED|First Intervention (14 Days)||10
1126585|NCT01273038|2728040|P1|COMPLETED|First Intervention (14 Days)||10
1126586|NCT01273038|2728039|P2|STARTED|First Intervention (14 Days)||10
1126587|NCT01273038|2728040|P1|STARTED|First Intervention (14 Days)||10
1126588|NCT01273064|2728051|P5|NOT COMPLETED|Overall Study||10
1126589|NCT01273064|2728052|P4|NOT COMPLETED|Overall Study||20
1126590|NCT01273064|2728053|P3|NOT COMPLETED|Overall Study||31
1126591|NCT01273064|2728054|P2|NOT COMPLETED|Overall Study||30
1126592|NCT01273064|2728055|P1|NOT COMPLETED|Overall Study||23
1126593|NCT01273064|2728051|P5|COMPLETED|Overall Study||0
1126594|NCT01273064|2728052|P4|COMPLETED|Overall Study||0
1126595|NCT01273064|2728053|P3|COMPLETED|Overall Study||0
1126596|NCT01273064|2728054|P2|COMPLETED|Overall Study||0
1126597|NCT01273064|2728055|P1|COMPLETED|Overall Study||0
1126598|NCT01273064|2728051|P5|STARTED|Overall Study|Began study on the placebo arm, and crossed over to CTS-1027 15 mg at Wk 12 due to lack of response|10
1126599|NCT01273064|2728052|P4|STARTED|Overall Study||20
1126600|NCT01273064|2728053|P3|STARTED|Overall Study||31
1126601|NCT01273064|2728054|P2|STARTED|Overall Study||30
1126602|NCT01273064|2728055|P1|STARTED|Overall Study||23
1126603|NCT01273181|2728076|P4|NOT COMPLETED|Phase 2, Dose 2||1
1126604|NCT01273181|2728077|P3|NOT COMPLETED|Phase 2, Dose 2||0
1126605|NCT01273181|2728078|P2|NOT COMPLETED|Phase 2, Dose 2||0
1126606|NCT01273181|2728079|P1|NOT COMPLETED|Phase 2, Dose 2||0
1126607|NCT01273181|2728076|P4|COMPLETED|Phase 2, Dose 2||0
1126608|NCT01273181|2728077|P3|COMPLETED|Phase 2, Dose 2||0
1126609|NCT01273181|2728078|P2|COMPLETED|Phase 2, Dose 2||0
1126610|NCT01273181|2728079|P1|COMPLETED|Phase 2, Dose 2||0
1126611|NCT01273181|2728076|P4|STARTED|Phase 2, Dose 2||1
1126612|NCT01273181|2728077|P3|STARTED|Phase 2, Dose 2||0
1126613|NCT01273181|2728078|P2|STARTED|Phase 2, Dose 2||0
1126614|NCT01273181|2728079|P1|STARTED|Phase 2, Dose 2||0
1126615|NCT01273181|2728076|P4|NOT COMPLETED|Phase 2, Dose 1||0
1126616|NCT01273181|2728077|P3|NOT COMPLETED|Phase 2, Dose 1||1
1126617|NCT01273181|2728078|P2|NOT COMPLETED|Phase 2, Dose 1||0
1126618|NCT01273181|2728079|P1|NOT COMPLETED|Phase 2, Dose 1||0
1126619|NCT01273181|2728076|P4|COMPLETED|Phase 2, Dose 1||0
1126620|NCT01273181|2728077|P3|COMPLETED|Phase 2, Dose 1||1
1126621|NCT01273181|2728078|P2|COMPLETED|Phase 2, Dose 1||0
1126622|NCT01273181|2728079|P1|COMPLETED|Phase 2, Dose 1||0
1126623|NCT01273181|2728076|P4|STARTED|Phase 2, Dose 1||0
1126624|NCT01273181|2728077|P3|STARTED|Phase 2, Dose 1||2
1126625|NCT01273181|2728078|P2|STARTED|Phase 2, Dose 1||0
1126626|NCT01273181|2728079|P1|STARTED|Phase 2, Dose 1||0
1126627|NCT01273181|2728076|P4|NOT COMPLETED|Phase I, Dose 2||0
1126628|NCT01273181|2728077|P3|NOT COMPLETED|Phase I, Dose 2||0
1126629|NCT01273181|2728078|P2|NOT COMPLETED|Phase I, Dose 2||1
1126630|NCT01273181|2728079|P1|NOT COMPLETED|Phase I, Dose 2||0
1126631|NCT01273181|2728076|P4|COMPLETED|Phase I, Dose 2||0
1126632|NCT01273181|2728077|P3|COMPLETED|Phase I, Dose 2||0
1126633|NCT01273181|2728078|P2|COMPLETED|Phase I, Dose 2||2
1126634|NCT01273181|2728079|P1|COMPLETED|Phase I, Dose 2||0
1126635|NCT01273181|2728076|P4|STARTED|Phase I, Dose 2||0
1126636|NCT01273181|2728077|P3|STARTED|Phase I, Dose 2||0
1126637|NCT01273181|2728078|P2|STARTED|Phase I, Dose 2||3
1126638|NCT01273181|2728079|P1|STARTED|Phase I, Dose 2||0
1126639|NCT01273181|2728076|P4|NOT COMPLETED|Phase I, Dose 1||0
1126640|NCT01273181|2728077|P3|NOT COMPLETED|Phase I, Dose 1||0
1126641|NCT01273181|2728078|P2|NOT COMPLETED|Phase I, Dose 1||0
1126642|NCT01273181|2728079|P1|NOT COMPLETED|Phase I, Dose 1||1
1126643|NCT01273181|2728076|P4|COMPLETED|Phase I, Dose 1||0
1126644|NCT01273181|2728077|P3|COMPLETED|Phase I, Dose 1||0
1126645|NCT01273181|2728078|P2|COMPLETED|Phase I, Dose 1||0
1126646|NCT01273181|2728079|P1|COMPLETED|Phase I, Dose 1||2
1126647|NCT01273181|2728076|P4|STARTED|Phase I, Dose 1||0
1126648|NCT01273181|2728077|P3|STARTED|Phase I, Dose 1||0
1126649|NCT01273181|2728078|P2|STARTED|Phase I, Dose 1||0
1126650|NCT01273181|2728079|P1|STARTED|Phase I, Dose 1||3
1126651|NCT01273519|2728096|P3|NOT COMPLETED|Overall Study||8
1126652|NCT01273519|2728097|P2|NOT COMPLETED|Overall Study||5
1126653|NCT01273519|2728098|P1|NOT COMPLETED|Overall Study||19
1126654|NCT01273519|2728096|P3|COMPLETED|Overall Study||39
1126655|NCT01273519|2728097|P2|COMPLETED|Overall Study||25
1126656|NCT01273519|2728098|P1|COMPLETED|Overall Study||59
1126657|NCT01273519|2728096|P3|STARTED|Overall Study||47
1126658|NCT01273519|2728097|P2|STARTED|Overall Study||30
1126659|NCT01273519|2728098|P1|STARTED|Overall Study||78
1126660|NCT01273597|2728131|P1|NOT COMPLETED|Overall Study||8
1126661|NCT01273597|2728131|P1|COMPLETED|Overall Study||52
1126662|NCT01273597|2728131|P1|STARTED|Overall Study||60
1126663|NCT01273623|2728143|P1|NOT COMPLETED|Overall Study||29
1126664|NCT01273623|2728143|P1|COMPLETED|Overall Study|met IVUS criteria|26
1126665|NCT01273623|2728143|P1|STARTED|Overall Study|met angiographic criteria|55
1126666|NCT01273766|2728153|P3|NOT COMPLETED|Overall Study||0
1126667|NCT01273766|2728154|P2|NOT COMPLETED|Overall Study||0
1126668|NCT01273766|2728155|P1|NOT COMPLETED|Overall Study||0
1126669|NCT01273766|2728153|P3|COMPLETED|Overall Study||5
1126670|NCT01273766|2728154|P2|COMPLETED|Overall Study||7
1126671|NCT01273766|2728155|P1|COMPLETED|Overall Study||4
1126672|NCT01273766|2728153|P3|STARTED|Overall Study||5
1126673|NCT01273766|2728154|P2|STARTED|Overall Study||7
1126674|NCT01273766|2728155|P1|STARTED|Overall Study||4
1126675|NCT01273805|2728163|P2|NOT COMPLETED|Overall Study||10
1126676|NCT01273805|2728164|P1|NOT COMPLETED|Overall Study||10
1126677|NCT01273805|2728163|P2|COMPLETED|Overall Study||0
1126678|NCT01273805|2728164|P1|COMPLETED|Overall Study||0
1126679|NCT01273805|2728163|P2|STARTED|Overall Study||10
1126680|NCT01273805|2728164|P1|STARTED|Overall Study||10
1126681|NCT01273818|2728183|P3|NOT COMPLETED|Overall Study||9
1126682|NCT01273818|2728184|P2|NOT COMPLETED|Overall Study||2
1126683|NCT01273818|2728185|P1|NOT COMPLETED|Overall Study||13
1126684|NCT01273818|2728183|P3|COMPLETED|Overall Study||91
1126685|NCT01273818|2728184|P2|COMPLETED|Overall Study||98
1126686|NCT01273818|2728185|P1|COMPLETED|Overall Study||87
1126687|NCT01273818|2728183|P3|STARTED|Overall Study||100
1126688|NCT01273818|2728184|P2|STARTED|Overall Study||100
1126689|NCT01273818|2728185|P1|STARTED|Overall Study||100
1126690|NCT01273857|2728195|P2|NOT COMPLETED|Overall Study||0
1126691|NCT01273857|2728196|P1|NOT COMPLETED|Overall Study||0
1126692|NCT01273857|2728195|P2|COMPLETED|Overall Study||7
1126693|NCT01273857|2728196|P1|COMPLETED|Overall Study||7
1126694|NCT01273857|2728195|P2|STARTED|Overall Study||7
1126695|NCT01273857|2728196|P1|STARTED|Overall Study||7
1126696|NCT01273883|2728204|P2|NOT COMPLETED|Second Intervention||1
1126697|NCT01273883|2728205|P1|NOT COMPLETED|Second Intervention||2
1126698|NCT01273883|2728204|P2|COMPLETED|Second Intervention||17
1126699|NCT01273883|2728205|P1|COMPLETED|Second Intervention||15
1126700|NCT01273883|2728204|P2|STARTED|Second Intervention||18
1126701|NCT01273883|2728205|P1|STARTED|Second Intervention||17
1126702|NCT01273883|2728204|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
1126703|NCT01273883|2728205|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
1126704|NCT01273883|2728204|P2|COMPLETED|Washout Period of 2 Weeks||18
1126705|NCT01273883|2728205|P1|COMPLETED|Washout Period of 2 Weeks||17
1126706|NCT01273883|2728204|P2|STARTED|Washout Period of 2 Weeks||18
1126707|NCT01273883|2728205|P1|STARTED|Washout Period of 2 Weeks||17
1126708|NCT01273883|2728204|P2|NOT COMPLETED|First Intervention||1
1126709|NCT01273883|2728205|P1|NOT COMPLETED|First Intervention||2
1126710|NCT01273883|2728204|P2|COMPLETED|First Intervention||18
1126711|NCT01273883|2728205|P1|COMPLETED|First Intervention||17
1126712|NCT01273883|2728204|P2|STARTED|First Intervention|Received at least 1 dose of study drug.|19
1126713|NCT01273883|2728205|P1|STARTED|First Intervention|Received at least 1 dose of study drug.|19
1126714|NCT01273896|2728217|P1|NOT COMPLETED|Overall Study||0
1126715|NCT01273896|2728217|P1|COMPLETED|Overall Study||22
1126716|NCT01273896|2728217|P1|STARTED|Overall Study||22
1126717|NCT01280357|2728221|P1|NOT COMPLETED|Overall Study||26
1126718|NCT01280357|2728221|P1|COMPLETED|Overall Study||34
1126719|NCT01280357|2728221|P1|STARTED|Overall Study||60
1126720|NCT01280552|2728230|P2|NOT COMPLETED|Overall Study||1
1126721|NCT01280552|2728231|P1|NOT COMPLETED|Overall Study||6
1126722|NCT01280552|2728230|P2|COMPLETED|Overall Study||42
1126723|NCT01280552|2728231|P1|COMPLETED|Overall Study|Survival is still being assessed|75
1126724|NCT01280552|2728230|P2|STARTED|Overall Study||43
1126725|NCT01280552|2728231|P1|STARTED|Overall Study||81
1126726|NCT01280591|2728247|P4|NOT COMPLETED|Overall Study||3
1126727|NCT01280591|2728248|P3|NOT COMPLETED|Overall Study||0
1126728|NCT01280591|2728249|P2|NOT COMPLETED|Overall Study||0
1126729|NCT01280591|2728250|P1|NOT COMPLETED|Overall Study||0
1126730|NCT01280591|2728247|P4|COMPLETED|Overall Study||99
1126731|NCT01280591|2728248|P3|COMPLETED|Overall Study||203
1126732|NCT01280591|2728249|P2|COMPLETED|Overall Study||204
1126733|NCT01280591|2728250|P1|COMPLETED|Overall Study||203
1126734|NCT01280591|2728247|P4|STARTED|Overall Study||102
1126735|NCT01280591|2728248|P3|STARTED|Overall Study||203
1126736|NCT01280591|2728249|P2|STARTED|Overall Study||204
1126737|NCT01280591|2728250|P1|STARTED|Overall Study||203
1126738|NCT01280604|2728342|P2|NOT COMPLETED|Overall Study||5
1126739|NCT01280604|2728343|P1|NOT COMPLETED|Overall Study||9
1126740|NCT01280604|2728342|P2|COMPLETED|Overall Study||28
1126741|NCT01280604|2728343|P1|COMPLETED|Overall Study||24
1126742|NCT01280604|2728342|P2|Subjects Meeting All Inclusion Criteria|Overall Study||29
1126743|NCT01280604|2728343|P1|Subjects Meeting All Inclusion Criteria|Overall Study||25
1126744|NCT01280604|2728342|P2|STARTED|Overall Study||33
1126745|NCT01280604|2728343|P1|STARTED|Overall Study||33
1126746|NCT01280955|2728359|P1|NOT COMPLETED|Overall Study||3
1126747|NCT01280955|2728359|P1|COMPLETED|Overall Study||27
1126748|NCT01280955|2728359|P1|STARTED|Overall Study||30
1126749|NCT01280968|2728392|P2|NOT COMPLETED|Overall Study||3
1126750|NCT01280968|2728393|P1|NOT COMPLETED|Overall Study||18
1126751|NCT01280968|2728392|P2|COMPLETED|Overall Study||4
1126752|NCT01280968|2728393|P1|COMPLETED|Overall Study||27
1126753|NCT01280968|2728392|P2|STARTED|Overall Study||7
1126754|NCT01280968|2728393|P1|STARTED|Overall Study||45
1126755|NCT01280981|2728409|P1|NOT COMPLETED|Overall Study||92
1126756|NCT01280981|2728409|P1|COMPLETED|Overall Study||196
1126757|NCT01280981|2728409|P1|Intent to Treat (ITT) Population|Overall Study|Participants who took drug during at least one menstrual cycle|260
1126758|NCT01280981|2728409|P1|STARTED|Overall Study||288
1126759|NCT01281007|2728420|P2|NOT COMPLETED|Overall Study||8
1126760|NCT01281007|2728421|P1|NOT COMPLETED|Overall Study||4
1126761|NCT01281007|2728420|P2|COMPLETED|Overall Study||67
1126762|NCT01281007|2728421|P1|COMPLETED|Overall Study||71
1126763|NCT01281007|2728420|P2|STARTED|Overall Study||75
1126764|NCT01281007|2728421|P1|STARTED|Overall Study||75
1126765|NCT01281124|2728427|P1|NOT COMPLETED|Overall Study||1
1126766|NCT01281124|2728427|P1|COMPLETED|Overall Study||0
1126767|NCT01281124|2728427|P1|STARTED|Overall Study||1
1126768|NCT01281202|2728435|P2|NOT COMPLETED|Overall Study||36
1126769|NCT01281202|2728436|P1|NOT COMPLETED|Overall Study||28
1126770|NCT01281202|2728435|P2|COMPLETED|Overall Study||68
1126771|NCT01281202|2728436|P1|COMPLETED|Overall Study||75
1126772|NCT01281202|2728435|P2|STARTED|Overall Study||104
1126773|NCT01281202|2728436|P1|STARTED|Overall Study||103
1126774|NCT01281306|2728451|P7|NOT COMPLETED|Overall Study||7
1126775|NCT01281306|2728452|P6|NOT COMPLETED|Overall Study||7
1126776|NCT01281306|2728453|P5|NOT COMPLETED|Overall Study||9
1126777|NCT01281306|2728454|P4|NOT COMPLETED|Overall Study||11
1126778|NCT01281306|2728455|P3|NOT COMPLETED|Overall Study||8
1126779|NCT01281306|2728456|P2|NOT COMPLETED|Overall Study||4
1126780|NCT01281306|2728457|P1|NOT COMPLETED|Overall Study||8
1126781|NCT01281306|2728451|P7|COMPLETED|Overall Study||51
1126782|NCT01281306|2728452|P6|COMPLETED|Overall Study||135
1126783|NCT01281306|2728453|P5|COMPLETED|Overall Study||134
1126784|NCT01281306|2728454|P4|COMPLETED|Overall Study||123
1126785|NCT01281306|2728455|P3|COMPLETED|Overall Study||133
1126786|NCT01281306|2728456|P2|COMPLETED|Overall Study||141
1126787|NCT01281306|2728457|P1|COMPLETED|Overall Study||136
1126788|NCT01281306|2728451|P7|Ambulatory Blood Pressure Monitoring Set|Overall Study||35
1126789|NCT01281306|2728452|P6|Ambulatory Blood Pressure Monitoring Set|Overall Study||91
1126790|NCT01281306|2728453|P5|Ambulatory Blood Pressure Monitoring Set|Overall Study||93
1126791|NCT01281306|2728454|P4|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
1126792|NCT01281306|2728455|P3|Ambulatory Blood Pressure Monitoring Set|Overall Study||92
1126793|NCT01281306|2728456|P2|Ambulatory Blood Pressure Monitoring Set|Overall Study||99
1126794|NCT01281306|2728457|P1|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
1126795|NCT01281306|2728451|P7|Safety Set|Overall Study||58
1126796|NCT01281306|2728452|P6|Safety Set|Overall Study||142
1126797|NCT01281306|2728453|P5|Safety Set|Overall Study||143
1126798|NCT01281306|2728454|P4|Safety Set|Overall Study||133
1126799|NCT01281306|2728455|P3|Safety Set|Overall Study||141
1126800|NCT01281306|2728456|P2|Safety Set|Overall Study||145
1126801|NCT01281306|2728457|P1|Safety Set|Overall Study||143
1126802|NCT01281306|2728451|P7|Full Analysis Set|Overall Study||58
1126803|NCT01281306|2728452|P6|Full Analysis Set|Overall Study||142
1126804|NCT01281306|2728453|P5|Full Analysis Set|Overall Study||143
1126805|NCT01281306|2728454|P4|Full Analysis Set|Overall Study||133
1126806|NCT01281306|2728455|P3|Full Analysis Set|Overall Study||141
1126807|NCT01281306|2728456|P2|Full Analysis Set|Overall Study||145
1126808|NCT01281306|2728457|P1|Full Analysis Set|Overall Study||143
1126809|NCT01281306|2728451|P7|STARTED|Overall Study||58
1126810|NCT01281306|2728452|P6|STARTED|Overall Study||142
1126811|NCT01281306|2728453|P5|STARTED|Overall Study||143
1126812|NCT01281306|2728454|P4|STARTED|Overall Study||134
1126813|NCT01281306|2728455|P3|STARTED|Overall Study||141
1126814|NCT01281306|2728456|P2|STARTED|Overall Study||145
1126815|NCT01281306|2728457|P1|STARTED|Overall Study||144
1126816|NCT01281475|2728573|P2|NOT COMPLETED|Overall Study||8
1126817|NCT01281475|2728574|P1|NOT COMPLETED|Overall Study||4
1126818|NCT01281475|2728573|P2|COMPLETED|Overall Study||26
1126819|NCT01281475|2728574|P1|COMPLETED|Overall Study||29
1126820|NCT01281475|2728573|P2|STARTED|Overall Study||34
1126821|NCT01281475|2728574|P1|STARTED|Overall Study||33
1126822|NCT01281501|2728584|P2|NOT COMPLETED|Overall Study||0
1126823|NCT01281501|2728585|P1|NOT COMPLETED|Overall Study||0
1126824|NCT01281501|2728584|P2|COMPLETED|Overall Study||43
1126825|NCT01281501|2728585|P1|COMPLETED|Overall Study||44
1126826|NCT01281501|2728584|P2|STARTED|Overall Study||43
1126827|NCT01281501|2728585|P1|STARTED|Overall Study||44
1126828|NCT01281644|2728597|P1|NOT COMPLETED|Overall Study||5
1126829|NCT01281644|2728597|P1|COMPLETED|Overall Study||18
1126830|NCT01281644|2728597|P1|STARTED|Overall Study||23
1126831|NCT01281839|2728607|P2|NOT COMPLETED|Overall Study||14
1126832|NCT01281839|2728608|P1|NOT COMPLETED|Overall Study||10
1126833|NCT01281839|2728607|P2|COMPLETED|Overall Study||119
1126834|NCT01281839|2728608|P1|COMPLETED|Overall Study||250
1126835|NCT01281839|2728607|P2|STARTED|Overall Study||133
1126836|NCT01281839|2728608|P1|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|260
1126837|NCT01281865|2728671|P2|NOT COMPLETED|Overall Study||1
1126838|NCT01281865|2728672|P1|NOT COMPLETED|Overall Study||3
1126839|NCT01281865|2728671|P2|COMPLETED|Overall Study||1
1126840|NCT01281865|2728672|P1|COMPLETED|Overall Study||9
1126841|NCT01281865|2728671|P2|STARTED|Overall Study||2
1126842|NCT01281865|2728672|P1|STARTED|Overall Study||12
1126843|NCT01281917|2728678|P1|NOT COMPLETED|Overall Study||1
1126844|NCT01281917|2728678|P1|COMPLETED|Overall Study||39
1126845|NCT01281917|2728678|P1|STARTED|Overall Study||40
1126846|NCT01282086|2728688|P1|NOT COMPLETED|Overall Study||0
1126847|NCT01282086|2728688|P1|COMPLETED|Overall Study||1365
1126848|NCT01282086|2728688|P1|STARTED|Overall Study||1365
1126849|NCT01282138|2728707|P2|NOT COMPLETED|CAPT||0
1126850|NCT01282138|2728708|P1|NOT COMPLETED|CAPT||0
1126851|NCT01282138|2728707|P2|COMPLETED|CAPT||7
1126852|NCT01282138|2728708|P1|COMPLETED|CAPT||6
1126853|NCT01282138|2728707|P2|STARTED|CAPT||7
1126854|NCT01282138|2728708|P1|STARTED|CAPT||6
1126855|NCT01282138|2728707|P2|NOT COMPLETED|EEC||0
1126856|NCT01282138|2728708|P1|NOT COMPLETED|EEC||0
1126857|NCT01282138|2728707|P2|COMPLETED|EEC||7
1126858|NCT01282138|2728708|P1|COMPLETED|EEC||6
1126859|NCT01282138|2728707|P2|STARTED|EEC||7
1126860|NCT01282138|2728708|P1|STARTED|EEC||6
1126861|NCT01282164|2728718|P2|NOT COMPLETED|Overall Study||0
1126862|NCT01282164|2728719|P1|NOT COMPLETED|Overall Study||1
1126863|NCT01282164|2728718|P2|COMPLETED|Overall Study||14
1126864|NCT01282164|2728719|P1|COMPLETED|Overall Study||28
1126865|NCT01282164|2728718|P2|STARTED|Overall Study||14
1126866|NCT01282164|2728719|P1|STARTED|Overall Study||29
1126867|NCT01282203|2728742|P1|NOT COMPLETED|Overall Study||1
1126868|NCT01282203|2728742|P1|COMPLETED|Overall Study||1121
1126869|NCT01282203|2728742|P1|STARTED|Overall Study||1122
1126870|NCT01282229|2728762|P1|NOT COMPLETED|Overall Study||2
1126871|NCT01282229|2728762|P1|COMPLETED|Overall Study|57 Participants contributed 228 quadrants (57*4)|57
1126872|NCT01282229|2728762|P1|STARTED|Overall Study|59 Participants contributed 236 quadrants (59*4)|59
1126873|NCT01282242|2728794|P2|NOT COMPLETED|Overall Study||0
1126874|NCT01282242|2728795|P1|NOT COMPLETED|Overall Study||0
1126875|NCT01282242|2728794|P2|COMPLETED|Overall Study||8
1126876|NCT01282242|2728795|P1|COMPLETED|Overall Study||80
1126877|NCT01282242|2728794|P2|STARTED|Overall Study||8
1126878|NCT01282242|2728795|P1|STARTED|Overall Study||80
1126879|NCT01282294|2728803|P1|NOT COMPLETED|Overall Study||19
1126880|NCT01282294|2728803|P1|COMPLETED|Overall Study||81
1126881|NCT01282294|2728803|P1|12 Months|Overall Study||86
1126882|NCT01282294|2728803|P1|6 Months|Overall Study||94
1126883|NCT01282294|2728803|P1|3 Months|Overall Study||95
1126884|NCT01282294|2728803|P1|6 Weeks|Overall Study||95
1126885|NCT01282294|2728803|P1|Post-operative|Overall Study||99
1126886|NCT01282294|2728803|P1|Intra-operative|Overall Study||99
1126887|NCT01282294|2728803|P1|STARTED|Overall Study||100
1126888|NCT01282372|2728821|P1|NOT COMPLETED|Overall Study||79
1126889|NCT01282372|2728821|P1|COMPLETED|Overall Study||421
1126890|NCT01282372|2728821|P1|STARTED|Overall Study||500
1126891|NCT01282424|2728849|P1|NOT COMPLETED|Overall Study||76
1126892|NCT01282424|2728849|P1|COMPLETED|Overall Study||49
1126893|NCT01282424|2728849|P1|Completed: Death|Overall Study||8
1126894|NCT01282424|2728849|P1|Completed: Disease Progression|Overall Study||41
1126895|NCT01282424|2728849|P1|STARTED|Overall Study||125
1126896|NCT01282476|2728866|P1|NOT COMPLETED|Overall Study||11
1126897|NCT01282476|2728866|P1|COMPLETED|Overall Study||7
1126898|NCT01282476|2728866|P1|STARTED|Overall Study||18
1126899|NCT01282710|2728872|P1|NOT COMPLETED|Overall Study||0
1126900|NCT01282710|2728872|P1|COMPLETED|Overall Study||20
1126901|NCT01282710|2728872|P1|STARTED|Overall Study||20
1126902|NCT01282723|2728876|P1|NOT COMPLETED|Overall Study||0
1126903|NCT01282723|2728876|P1|COMPLETED|Overall Study||20
1126904|NCT01282723|2728876|P1|STARTED|Overall Study||20
1126905|NCT01282801|2728882|P2|NOT COMPLETED|Second Intervention||1
1126906|NCT01282801|2728883|P1|NOT COMPLETED|Second Intervention||0
1126907|NCT01282801|2728882|P2|COMPLETED|Second Intervention||8
1126908|NCT01282801|2728883|P1|COMPLETED|Second Intervention||9
1126909|NCT01282801|2728882|P2|STARTED|Second Intervention||9
1126910|NCT01282801|2728883|P1|STARTED|Second Intervention||9
1126911|NCT01282801|2728882|P2|NOT COMPLETED|Washout of 7 Days||0
1126912|NCT01282801|2728883|P1|NOT COMPLETED|Washout of 7 Days||0
1126913|NCT01282801|2728882|P2|COMPLETED|Washout of 7 Days||9
1126914|NCT01282801|2728883|P1|COMPLETED|Washout of 7 Days||9
1126915|NCT01282801|2728882|P2|STARTED|Washout of 7 Days||9
1126916|NCT01282801|2728883|P1|STARTED|Washout of 7 Days||9
1126917|NCT01282801|2728882|P2|NOT COMPLETED|First Intervention||0
1126918|NCT01282801|2728883|P1|NOT COMPLETED|First Intervention||0
1126919|NCT01282801|2728882|P2|COMPLETED|First Intervention||9
1126920|NCT01282801|2728883|P1|COMPLETED|First Intervention||9
1126921|NCT01282801|2728882|P2|STARTED|First Intervention||9
1126922|NCT01282801|2728883|P1|STARTED|First Intervention||9
1126923|NCT01282814|2728901|P2|NOT COMPLETED|Second Intervention||0
1126924|NCT01282814|2728902|P1|NOT COMPLETED|Second Intervention||0
1126925|NCT01282814|2728901|P2|COMPLETED|Second Intervention||9
1126926|NCT01282814|2728902|P1|COMPLETED|Second Intervention||10
1126927|NCT01282814|2728901|P2|STARTED|Second Intervention||9
1126928|NCT01282814|2728902|P1|STARTED|Second Intervention||10
1126929|NCT01282814|2728901|P2|NOT COMPLETED|Washout of 7 Days||0
1126930|NCT01282814|2728902|P1|NOT COMPLETED|Washout of 7 Days||2
1126931|NCT01282814|2728901|P2|COMPLETED|Washout of 7 Days||9
1126932|NCT01282814|2728902|P1|COMPLETED|Washout of 7 Days||10
1126933|NCT01282814|2728901|P2|STARTED|Washout of 7 Days||9
1126934|NCT01282814|2728902|P1|STARTED|Washout of 7 Days||12
1126935|NCT01282814|2728901|P2|NOT COMPLETED|First Intervention||3
1126936|NCT01282814|2728902|P1|NOT COMPLETED|First Intervention||0
1126937|NCT01282814|2728901|P2|COMPLETED|First Intervention||9
1126938|NCT01282814|2728902|P1|COMPLETED|First Intervention||12
1126939|NCT01282814|2728901|P2|STARTED|First Intervention||12
1126940|NCT01282814|2728902|P1|STARTED|First Intervention||12
1126941|NCT01282866|2728912|P1|NOT COMPLETED|Overall Study||1
1126942|NCT01282866|2728912|P1|COMPLETED|Overall Study||34
1126943|NCT01282866|2728912|P1|STARTED|Overall Study||35
1126944|NCT01283022|2728918|P1|NOT COMPLETED|Overall Study||0
1126945|NCT01283022|2728918|P1|COMPLETED|Overall Study||24
1126946|NCT01283022|2728918|P1|STARTED|Overall Study||24
1126947|NCT01283035|2728924|P1|NOT COMPLETED|Overall Study||1
1126948|NCT01283035|2728924|P1|COMPLETED|Overall Study||5
1126949|NCT01283035|2728924|P1|STARTED|Overall Study||6
1126950|NCT01283139|2728937|P4|NOT COMPLETED|Overall Study||15
1126951|NCT01283139|2728938|P3|NOT COMPLETED|Overall Study||18
1126952|NCT01283139|2728939|P2|NOT COMPLETED|Overall Study||18
1126953|NCT01283139|2728940|P1|NOT COMPLETED|Overall Study||17
1126954|NCT01283139|2728937|P4|COMPLETED|Overall Study||92
1126955|NCT01283139|2728938|P3|COMPLETED|Overall Study||91
1126956|NCT01283139|2728939|P2|COMPLETED|Overall Study||90
1126957|NCT01283139|2728940|P1|COMPLETED|Overall Study||91
1126958|NCT01283139|2728937|P4|STARTED|Overall Study||107
1126959|NCT01283139|2728938|P3|STARTED|Overall Study||109
1126960|NCT01283139|2728939|P2|STARTED|Overall Study||108
1126961|NCT01283139|2728940|P1|STARTED|Overall Study||108
1126962|NCT01283152|2728984|P2|NOT COMPLETED|Overall Study||0
1126963|NCT01283152|2728985|P1|NOT COMPLETED|Overall Study||2
1126964|NCT01283152|2728984|P2|COMPLETED|Overall Study||25
1126965|NCT01283152|2728985|P1|COMPLETED|Overall Study||23
1126966|NCT01283152|2728984|P2|24-hr HESA Attempted|Overall Study||25
1126967|NCT01283152|2728985|P1|24-hr HESA Attempted|Overall Study||25
1126968|NCT01283152|2728984|P2|Study Treatment Received|Overall Study||25
1126969|NCT01283152|2728985|P1|Study Treatment Received|Overall Study||25
1126970|NCT01283152|2728984|P2|ITT Population|Overall Study||25
1126971|NCT01283152|2728985|P1|ITT Population|Overall Study||25
1126972|NCT01283152|2728984|P2|STARTED|Overall Study||25
1126973|NCT01283152|2728985|P1|STARTED|Overall Study||25
1126974|NCT01283282|2728995|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
1126975|NCT01283282|2728996|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
1126976|NCT01283282|2728995|P2|COMPLETED|Second Intervention (6 Weeks)||19
1126977|NCT01283282|2728996|P1|COMPLETED|Second Intervention (6 Weeks)||22
1126978|NCT01283282|2728995|P2|STARTED|Second Intervention (6 Weeks)||19
1126979|NCT01283282|2728996|P1|STARTED|Second Intervention (6 Weeks)||22
1126980|NCT01283282|2728995|P2|NOT COMPLETED|First Intervention (6 Weeks)||4
1126981|NCT01283282|2728996|P1|NOT COMPLETED|First Intervention (6 Weeks)||3
1126982|NCT01283282|2728995|P2|COMPLETED|First Intervention (6 Weeks)||19
1126983|NCT01283282|2728996|P1|COMPLETED|First Intervention (6 Weeks)||22
1126984|NCT01283282|2728995|P2|STARTED|First Intervention (6 Weeks)||23
1126985|NCT01283282|2728996|P1|STARTED|First Intervention (6 Weeks)||25
1126986|NCT01283321|2729016|P2|NOT COMPLETED|Overall Study||0
1126987|NCT01283321|2729017|P1|NOT COMPLETED|Overall Study||0
1126988|NCT01283321|2729016|P2|COMPLETED|Overall Study||10
1126989|NCT01283321|2729017|P1|COMPLETED|Overall Study||10
1126990|NCT01283321|2729016|P2|STARTED|Overall Study||10
1126991|NCT01283321|2729017|P1|STARTED|Overall Study||10
1126992|NCT01283334|2729023|P1|NOT COMPLETED|Overall Study||7
1126993|NCT01283334|2729023|P1|COMPLETED|Overall Study||13
1126994|NCT01283334|2729023|P1|STARTED|Overall Study||20
1126995|NCT01270659|2729033|P4|NOT COMPLETED|Overall Study||0
1126996|NCT01270659|2729034|P3|NOT COMPLETED|Overall Study||0
1126997|NCT01270659|2729035|P2|NOT COMPLETED|Overall Study||0
1126998|NCT01270659|2729036|P1|NOT COMPLETED|Overall Study||0
1126999|NCT01270659|2729033|P4|COMPLETED|Overall Study||25
1127000|NCT01270659|2729034|P3|COMPLETED|Overall Study||4
1127001|NCT01270659|2729035|P2|COMPLETED|Overall Study||25
1127002|NCT01270659|2729036|P1|COMPLETED|Overall Study||6
1127003|NCT01270659|2729033|P4|STARTED|Overall Study||25
1127004|NCT01270659|2729034|P3|STARTED|Overall Study||4
1127005|NCT01270659|2729035|P2|STARTED|Overall Study||25
1127006|NCT01270659|2729036|P1|STARTED|Overall Study||6
1127007|NCT01270711|2729062|P8|NOT COMPLETED|Part 2: Effectiveness||0
1127008|NCT01270711|2729063|P7|NOT COMPLETED|Part 2: Effectiveness||0
1127009|NCT01270711|2729064|P6|NOT COMPLETED|Part 2: Effectiveness||0
1127010|NCT01270711|2729065|P5|NOT COMPLETED|Part 2: Effectiveness||0
1127011|NCT01270711|2729066|P4|NOT COMPLETED|Part 2: Effectiveness||0
1127012|NCT01270711|2729067|P3|NOT COMPLETED|Part 2: Effectiveness||0
1127013|NCT01270711|2729068|P2|NOT COMPLETED|Part 2: Effectiveness||0
1127014|NCT01270711|2729069|P1|NOT COMPLETED|Part 2: Effectiveness||0
1127015|NCT01270711|2729062|P8|COMPLETED|Part 2: Effectiveness||48
1127016|NCT01270711|2729063|P7|COMPLETED|Part 2: Effectiveness||2
1127017|NCT01270711|2729064|P6|COMPLETED|Part 2: Effectiveness||11
1127018|NCT01270711|2729065|P5|COMPLETED|Part 2: Effectiveness||0
1127019|NCT01270711|2729066|P4|COMPLETED|Part 2: Effectiveness||0
1127020|NCT01270711|2729067|P3|COMPLETED|Part 2: Effectiveness||0
1127021|NCT01270711|2729068|P2|COMPLETED|Part 2: Effectiveness||0
1127022|NCT01270711|2729069|P1|COMPLETED|Part 2: Effectiveness||0
1127023|NCT01270711|2729062|P8|STARTED|Part 2: Effectiveness||48
1127024|NCT01270711|2729063|P7|STARTED|Part 2: Effectiveness||2
1127025|NCT01270711|2729064|P6|STARTED|Part 2: Effectiveness||11
1127026|NCT01270711|2729065|P5|STARTED|Part 2: Effectiveness||0
1127027|NCT01270711|2729066|P4|STARTED|Part 2: Effectiveness||0
1127028|NCT01270711|2729067|P3|STARTED|Part 2: Effectiveness||0
1127029|NCT01270711|2729068|P2|STARTED|Part 2: Effectiveness||0
1127030|NCT01270711|2729069|P1|STARTED|Part 2: Effectiveness||0
1127031|NCT01270711|2729062|P8|NOT COMPLETED|Part 1: Compliance||0
1127032|NCT01270711|2729063|P7|NOT COMPLETED|Part 1: Compliance||0
1127033|NCT01270711|2729064|P6|NOT COMPLETED|Part 1: Compliance||0
1127034|NCT01270711|2729065|P5|NOT COMPLETED|Part 1: Compliance||0
1127035|NCT01270711|2729066|P4|NOT COMPLETED|Part 1: Compliance||0
1127036|NCT01270711|2729067|P3|NOT COMPLETED|Part 1: Compliance||0
1127037|NCT01270711|2729068|P2|NOT COMPLETED|Part 1: Compliance||0
1127038|NCT01270711|2729069|P1|NOT COMPLETED|Part 1: Compliance||0
1127039|NCT01270711|2729062|P8|COMPLETED|Part 1: Compliance||0
1127040|NCT01270711|2729063|P7|COMPLETED|Part 1: Compliance||0
1127041|NCT01270711|2729064|P6|COMPLETED|Part 1: Compliance||0
1127042|NCT01270711|2729065|P5|COMPLETED|Part 1: Compliance||2024
1127043|NCT01270711|2729066|P4|COMPLETED|Part 1: Compliance||5486
1127044|NCT01270711|2729067|P3|COMPLETED|Part 1: Compliance||326
1127045|NCT01270711|2729068|P2|COMPLETED|Part 1: Compliance||6580
1127046|NCT01270711|2729069|P1|COMPLETED|Part 1: Compliance||7537
1127047|NCT01270711|2729062|P8|STARTED|Part 1: Compliance||0
1127048|NCT01270711|2729063|P7|STARTED|Part 1: Compliance||0
1127049|NCT01270711|2729064|P6|STARTED|Part 1: Compliance||0
1127050|NCT01270711|2729065|P5|STARTED|Part 1: Compliance||2024
1127051|NCT01270711|2729066|P4|STARTED|Part 1: Compliance||5486
1127052|NCT01270711|2729067|P3|STARTED|Part 1: Compliance||326
1127053|NCT01270711|2729068|P2|STARTED|Part 1: Compliance||6580
1127054|NCT01270711|2729069|P1|STARTED|Part 1: Compliance||7537
1127055|NCT01270802|2729168|P2|NOT COMPLETED|Overall Study||1
1127056|NCT01270802|2729169|P1|NOT COMPLETED|Overall Study||2
1127057|NCT01270802|2729168|P2|COMPLETED|Overall Study||14
1127058|NCT01270802|2729169|P1|COMPLETED|Overall Study||13
1127059|NCT01270802|2729168|P2|STARTED|Overall Study||15
1127060|NCT01270802|2729169|P1|STARTED|Overall Study||15
1127061|NCT01270828|2729179|P3|NOT COMPLETED|Double Blind Phase||0
1127062|NCT01270828|2729180|P2|NOT COMPLETED|Double Blind Phase||45
1127063|NCT01270828|2729181|P1|NOT COMPLETED|Double Blind Phase||26
1127064|NCT01270828|2729179|P3|COMPLETED|Double Blind Phase||0
1127065|NCT01270828|2729180|P2|COMPLETED|Double Blind Phase||160
1127066|NCT01270828|2729181|P1|COMPLETED|Double Blind Phase||182
1127067|NCT01270828|2729179|P3|STARTED|Double Blind Phase||0
1127068|NCT01270828|2729180|P2|STARTED|Double Blind Phase||205
1127069|NCT01270828|2729181|P1|STARTED|Double Blind Phase||208
1127070|NCT01270828|2729179|P3|NOT COMPLETED|Pregabalin CR SB||146
1127071|NCT01270828|2729180|P2|NOT COMPLETED|Pregabalin CR SB||0
1127072|NCT01270828|2729181|P1|NOT COMPLETED|Pregabalin CR SB||0
1127073|NCT01270828|2729179|P3|COMPLETED|Pregabalin CR SB||660
1127074|NCT01270828|2729180|P2|COMPLETED|Pregabalin CR SB||0
1127075|NCT01270828|2729181|P1|COMPLETED|Pregabalin CR SB||0
1127076|NCT01270828|2729179|P3|STARTED|Pregabalin CR SB||806
1127077|NCT01270828|2729180|P2|STARTED|Pregabalin CR SB||0
1127078|NCT01270828|2729181|P1|STARTED|Pregabalin CR SB||0
1127079|NCT01270841|2729225|P4|NOT COMPLETED|Overall Study||13
1127080|NCT01270841|2729226|P3|NOT COMPLETED|Overall Study||11
1127081|NCT01270841|2729227|P2|NOT COMPLETED|Overall Study||14
1127082|NCT01270841|2729228|P1|NOT COMPLETED|Overall Study||13
1127083|NCT01270841|2729225|P4|COMPLETED|Overall Study||20
1127084|NCT01270841|2729226|P3|COMPLETED|Overall Study||18
1127085|NCT01270841|2729227|P2|COMPLETED|Overall Study||19
1127086|NCT01270841|2729228|P1|COMPLETED|Overall Study||16
1127087|NCT01270841|2729225|P4|STARTED|Overall Study||33
1127088|NCT01270841|2729226|P3|STARTED|Overall Study||29
1127089|NCT01270841|2729227|P2|STARTED|Overall Study||33
1127090|NCT01270841|2729228|P1|STARTED|Overall Study||29
1127091|NCT01270867|2729252|P2|NOT COMPLETED|Overall Study||0
1127092|NCT01270867|2729253|P1|NOT COMPLETED|Overall Study||1
1127093|NCT01270867|2729252|P2|COMPLETED|Overall Study||88
1127094|NCT01270867|2729253|P1|COMPLETED|Overall Study||89
1127095|NCT01270867|2729252|P2|STARTED|Overall Study||88
1127096|NCT01270867|2729253|P1|STARTED|Overall Study||90
1127097|NCT01270880|2729267|P1|NOT COMPLETED|Overall Study||1
1127098|NCT01270880|2729267|P1|COMPLETED|Overall Study||17
1127099|NCT01270880|2729267|P1|STARTED|Overall Study||18
1127100|NCT01270919|2729271|P1|NOT COMPLETED|Overall Study||0
1127101|NCT01270919|2729271|P1|COMPLETED|Overall Study||0
1127102|NCT01270919|2729271|P1|STARTED|Overall Study|One participant was enrolled but was censored.|0
1127103|NCT01270958|2729276|P1|NOT COMPLETED|Overall Study||4
1127104|NCT01270958|2729276|P1|COMPLETED|Overall Study||56
1127105|NCT01270958|2729276|P1|STARTED|Overall Study||60
1127106|NCT01270971|2729302|P2|NOT COMPLETED|Overall Study||23
1127107|NCT01270971|2729303|P1|NOT COMPLETED|Overall Study||52
1127108|NCT01270971|2729302|P2|COMPLETED|Overall Study||171
1127109|NCT01270971|2729303|P1|COMPLETED|Overall Study||348
1127110|NCT01270971|2729302|P2|STARTED|Overall Study||194
1127111|NCT01270971|2729303|P1|STARTED|Overall Study||400
1127112|NCT01271036|2729317|P2|NOT COMPLETED|Overall Study||0
1127113|NCT01271036|2729318|P1|NOT COMPLETED|Overall Study||0
1127114|NCT01271036|2729317|P2|COMPLETED|Overall Study||62
1127115|NCT01271036|2729318|P1|COMPLETED|Overall Study||62
1127116|NCT01271036|2729317|P2|STARTED|Overall Study||62
1127117|NCT01271036|2729318|P1|STARTED|Overall Study||62
1127118|NCT01271244|2729334|P2|NOT COMPLETED|Overall Study||3
1127119|NCT01271244|2729335|P1|NOT COMPLETED|Overall Study||7
1127120|NCT01271244|2729334|P2|COMPLETED|Overall Study||5
1127121|NCT01271244|2729335|P1|COMPLETED|Overall Study||11
1127122|NCT01271244|2729334|P2|STARTED|Overall Study||8
1127123|NCT01271244|2729335|P1|STARTED|Overall Study||18
1127124|NCT01271413|2729343|P2|NOT COMPLETED|Overall Study||8
1127125|NCT01271413|2729344|P1|NOT COMPLETED|Overall Study||9
1127126|NCT01271413|2729343|P2|COMPLETED|Overall Study||28
1127127|NCT01271413|2729344|P1|COMPLETED|Overall Study||28
1127128|NCT01271413|2729343|P2|STARTED|Overall Study||36
1127129|NCT01271413|2729344|P1|STARTED|Overall Study||37
1127130|NCT01271452|2729352|P2|NOT COMPLETED|Overall Study||8
1127131|NCT01271452|2729353|P1|NOT COMPLETED|Overall Study||7
1127132|NCT01271452|2729352|P2|COMPLETED|Overall Study||104
1127133|NCT01271452|2729353|P1|COMPLETED|Overall Study||105
1127134|NCT01271452|2729352|P2|STARTED|Overall Study||112
1127135|NCT01271452|2729353|P1|STARTED|Overall Study||112
1127136|NCT01271543|2729375|P2|NOT COMPLETED|Overall Study||1
1127137|NCT01271543|2729376|P1|NOT COMPLETED|Overall Study||1
1127138|NCT01271543|2729375|P2|COMPLETED|Overall Study||29
1127139|NCT01271543|2729376|P1|COMPLETED|Overall Study||29
1127140|NCT01271543|2729375|P2|STARTED|Overall Study||30
1127141|NCT01271543|2729376|P1|STARTED|Overall Study||30
1127142|NCT01271686|2729384|P1|NOT COMPLETED|Overall Study||0
1127143|NCT01271686|2729384|P1|COMPLETED|Overall Study||16
1127144|NCT01271686|2729384|P1|STARTED|Overall Study||16
1127145|NCT01277042|2729390|P2|NOT COMPLETED|Overall Study||5
1127146|NCT01277042|2729391|P1|NOT COMPLETED|Overall Study||8
1127147|NCT01277042|2729390|P2|COMPLETED|Overall Study||601
1127148|NCT01277042|2729391|P1|COMPLETED|Overall Study||598
1127149|NCT01277042|2729390|P2|STARTED|Overall Study||606
1127150|NCT01277042|2729391|P1|STARTED|Overall Study||606
1127151|NCT01277081|2729415|P2|NOT COMPLETED|Overall Study||0
1127152|NCT01277081|2729416|P1|NOT COMPLETED|Overall Study||0
1127153|NCT01277081|2729415|P2|COMPLETED|Overall Study||100
1127154|NCT01277081|2729416|P1|COMPLETED|Overall Study||100
1127155|NCT01277081|2729415|P2|STARTED|Overall Study||100
1127156|NCT01277081|2729416|P1|STARTED|Overall Study||100
1127157|NCT01277159|2729437|P5|NOT COMPLETED|Overall Study||5
1127158|NCT01277159|2729438|P4|NOT COMPLETED|Overall Study||3
1127159|NCT01277159|2729439|P3|NOT COMPLETED|Overall Study||3
1127160|NCT01277159|2729440|P2|NOT COMPLETED|Overall Study||1
1127161|NCT01277159|2729441|P1|NOT COMPLETED|Overall Study||4
1127162|NCT01277159|2729437|P5|COMPLETED|Overall Study||16
1127163|NCT01277159|2729438|P4|COMPLETED|Overall Study||19
1127164|NCT01277159|2729439|P3|COMPLETED|Overall Study||19
1127165|NCT01277159|2729440|P2|COMPLETED|Overall Study||21
1127166|NCT01277159|2729441|P1|COMPLETED|Overall Study||17
1127167|NCT01277159|2729437|P5|STARTED|Overall Study||21
1127168|NCT01277159|2729438|P4|STARTED|Overall Study||22
1127169|NCT01277159|2729439|P3|STARTED|Overall Study||22
1127170|NCT01277159|2729440|P2|STARTED|Overall Study||22
1127171|NCT01277159|2729441|P1|STARTED|Overall Study||21
1127172|NCT01277211|2729455|P2|NOT COMPLETED|Overall Study||63
1127173|NCT01277211|2729456|P1|NOT COMPLETED|Overall Study||150
1127174|NCT01277211|2729455|P2|COMPLETED|Overall Study||182
1127175|NCT01277211|2729456|P1|COMPLETED|Overall Study||588
1127176|NCT01277211|2729455|P2|Treated|Overall Study||232
1127177|NCT01277211|2729456|P1|Treated|Overall Study||714
1127178|NCT01277211|2729455|P2|STARTED|Overall Study||245
1127179|NCT01277211|2729456|P1|STARTED|Overall Study||738
1127180|NCT01277302|2729469|P3|NOT COMPLETED|8-Month Alternate Dose Regimen Period||6
1127181|NCT01277302|2729470|P2|NOT COMPLETED|8-Month Alternate Dose Regimen Period||4
1127182|NCT01277302|2729471|P1|NOT COMPLETED|8-Month Alternate Dose Regimen Period||5
1127183|NCT01277302|2729469|P3|COMPLETED|8-Month Alternate Dose Regimen Period||13
1127184|NCT01277302|2729470|P2|COMPLETED|8-Month Alternate Dose Regimen Period||82
1127185|NCT01277302|2729471|P1|COMPLETED|8-Month Alternate Dose Regimen Period||80
1127186|NCT01277302|2729469|P3|STARTED|8-Month Alternate Dose Regimen Period||19
1127187|NCT01277302|2729470|P2|STARTED|8-Month Alternate Dose Regimen Period||86
1127188|NCT01277302|2729471|P1|STARTED|8-Month Alternate Dose Regimen Period||85
1127189|NCT01277302|2729469|P3|NOT COMPLETED|7-Month Fixed Treatment Period||12
1127190|NCT01277302|2729470|P2|NOT COMPLETED|7-Month Fixed Treatment Period||0
1127191|NCT01277302|2729471|P1|NOT COMPLETED|7-Month Fixed Treatment Period||0
1127192|NCT01277302|2729469|P3|COMPLETED|7-Month Fixed Treatment Period||19
1127193|NCT01277302|2729470|P2|COMPLETED|7-Month Fixed Treatment Period||86
1127194|NCT01277302|2729471|P1|COMPLETED|7-Month Fixed Treatment Period||85
1127195|NCT01277302|2729469|P3|STARTED|7-Month Fixed Treatment Period||31
1127196|NCT01277302|2729470|P2|STARTED|7-Month Fixed Treatment Period||86
1127197|NCT01277302|2729471|P1|STARTED|7-Month Fixed Treatment Period||85
1127198|NCT01277354|2729503|P2|NOT COMPLETED|Overall Study||0
1127199|NCT01277354|2729504|P1|NOT COMPLETED|Overall Study||0
1127200|NCT01277354|2729503|P2|COMPLETED|Overall Study||1
1127201|NCT01277354|2729504|P1|COMPLETED|Overall Study||1
1127202|NCT01277354|2729503|P2|STARTED|Overall Study||1
1127203|NCT01277354|2729504|P1|STARTED|Overall Study||1
1127204|NCT01277510|2729512|P2|NOT COMPLETED|Open-label Phase||3
1127205|NCT01277510|2729513|P1|NOT COMPLETED|Open-label Phase||7
1127206|NCT01277510|2729512|P2|COMPLETED|Open-label Phase|Completed investigational product|1
1127207|NCT01277510|2729513|P1|COMPLETED|Open-label Phase|Completed investigational product|1
1127208|NCT01277510|2729512|P2|Received Investigational Product|Open-label Phase||4
1127209|NCT01277510|2729513|P1|Received Investigational Product|Open-label Phase||6
1127210|NCT01277510|2729512|P2|STARTED|Open-label Phase||4
1127211|NCT01277510|2729513|P1|STARTED|Open-label Phase||8
1127212|NCT01277510|2729512|P2|NOT COMPLETED|Double-blind Phase||18
1127213|NCT01277510|2729513|P1|NOT COMPLETED|Double-blind Phase||13
1127214|NCT01277510|2729512|P2|COMPLETED|Double-blind Phase|Completed investigational product|4
1127215|NCT01277510|2729513|P1|COMPLETED|Double-blind Phase|Completed investigational product|8
1127216|NCT01277510|2729512|P2|Received Investigational Product|Double-blind Phase||22
1127217|NCT01277510|2729513|P1|Received Investigational Product|Double-blind Phase||21
1127218|NCT01277510|2729512|P2|STARTED|Double-blind Phase||22
1127219|NCT01277510|2729513|P1|STARTED|Double-blind Phase||21
1127220|NCT01277523|2729538|P3|NOT COMPLETED|Overall Study||0
1127221|NCT01277523|2729539|P2|NOT COMPLETED|Overall Study||1
1127222|NCT01277523|2729540|P1|NOT COMPLETED|Overall Study||3
1127223|NCT01277523|2729538|P3|COMPLETED|Overall Study||130
1127224|NCT01277523|2729539|P2|COMPLETED|Overall Study||126
1127225|NCT01277523|2729540|P1|COMPLETED|Overall Study||132
1127226|NCT01277523|2729538|P3|STARTED|Overall Study||130
1127227|NCT01277523|2729539|P2|STARTED|Overall Study||127
1127228|NCT01277523|2729540|P1|STARTED|Overall Study||135
1127229|NCT01277549|2729592|P2|NOT COMPLETED|Overall Study||14
1127230|NCT01277549|2729593|P1|NOT COMPLETED|Overall Study||26
1127231|NCT01277549|2729592|P2|COMPLETED|Overall Study||15
1127232|NCT01277549|2729593|P1|COMPLETED|Overall Study||15
1127233|NCT01277549|2729592|P2|STARTED|Overall Study||29
1127234|NCT01277549|2729593|P1|STARTED|Overall Study||41
1127235|NCT01277601|2729611|P4|NOT COMPLETED|Overall Study||36
1127236|NCT01277601|2729612|P3|NOT COMPLETED|Overall Study||27
1127237|NCT01277601|2729613|P2|NOT COMPLETED|Overall Study||48
1127238|NCT01277601|2729614|P1|NOT COMPLETED|Overall Study||37
1127239|NCT01277601|2729611|P4|COMPLETED|Overall Study||150
1127240|NCT01277601|2729612|P3|COMPLETED|Overall Study||163
1127241|NCT01277601|2729613|P2|COMPLETED|Overall Study||139
1127242|NCT01277601|2729614|P1|COMPLETED|Overall Study||151
1127243|NCT01277601|2729611|P4|STARTED|Overall Study||186
1127244|NCT01277601|2729612|P3|STARTED|Overall Study||190
1127245|NCT01277601|2729613|P2|STARTED|Overall Study||187
1127246|NCT01277601|2729614|P1|STARTED|Overall Study||188
1127247|NCT01277666|2729706|P3|NOT COMPLETED|Overall Study||49
1127248|NCT01277666|2729707|P2|NOT COMPLETED|Overall Study||59
1127249|NCT01277666|2729708|P1|NOT COMPLETED|Overall Study||45
1127250|NCT01277666|2729706|P3|COMPLETED|Overall Study||153
1127251|NCT01277666|2729707|P2|COMPLETED|Overall Study||144
1127252|NCT01277666|2729708|P1|COMPLETED|Overall Study||158
1127253|NCT01277666|2729706|P3|STARTED|Overall Study||202
1127254|NCT01277666|2729707|P2|STARTED|Overall Study||203
1127255|NCT01277666|2729708|P1|STARTED|Overall Study||203
1127256|NCT01277718|2729737|P2|NOT COMPLETED|Period 3 - Third Intervention||0
1127257|NCT01277718|2729738|P1|NOT COMPLETED|Period 3 - Third Intervention||0
1127258|NCT01277718|2729737|P2|COMPLETED|Period 3 - Third Intervention||7
1127259|NCT01277718|2729738|P1|COMPLETED|Period 3 - Third Intervention||10
1127260|NCT01277718|2729737|P2|STARTED|Period 3 - Third Intervention||7
1127261|NCT01277718|2729738|P1|STARTED|Period 3 - Third Intervention||10
1127262|NCT01277718|2729737|P2|NOT COMPLETED|Washout Period of 13 Days||0
1127263|NCT01277718|2729738|P1|NOT COMPLETED|Washout Period of 13 Days||0
1127264|NCT01277718|2729737|P2|COMPLETED|Washout Period of 13 Days||7
1127265|NCT01277718|2729738|P1|COMPLETED|Washout Period of 13 Days||10
1127266|NCT01277718|2729737|P2|STARTED|Washout Period of 13 Days||7
1127267|NCT01277718|2729738|P1|STARTED|Washout Period of 13 Days||10
1127268|NCT01277718|2729737|P2|NOT COMPLETED|Period 2 - Second Intervention||3
1127269|NCT01277718|2729738|P1|NOT COMPLETED|Period 2 - Second Intervention||0
1127270|NCT01277718|2729737|P2|COMPLETED|Period 2 - Second Intervention||7
1127271|NCT01277718|2729738|P1|COMPLETED|Period 2 - Second Intervention||10
1127272|NCT01277718|2729737|P2|STARTED|Period 2 - Second Intervention||10
1127273|NCT01277718|2729738|P1|STARTED|Period 2 - Second Intervention||10
1127274|NCT01277718|2729737|P2|NOT COMPLETED|Washout Period of 13 Days||0
1127275|NCT01277718|2729738|P1|NOT COMPLETED|Washout Period of 13 Days||0
1127276|NCT01277718|2729737|P2|COMPLETED|Washout Period of 13 Days||10
1127277|NCT01277718|2729738|P1|COMPLETED|Washout Period of 13 Days||10
1127278|NCT01277718|2729737|P2|STARTED|Washout Period of 13 Days||10
1127279|NCT01277718|2729738|P1|STARTED|Washout Period of 13 Days||10
1127280|NCT01277718|2729737|P2|NOT COMPLETED|Period 1 - First Intervention||0
1127281|NCT01277718|2729738|P1|NOT COMPLETED|Period 1 - First Intervention||0
1127282|NCT01277718|2729737|P2|COMPLETED|Period 1 - First Intervention||10
1127283|NCT01277718|2729738|P1|COMPLETED|Period 1 - First Intervention||10
1127284|NCT01277718|2729737|P2|STARTED|Period 1 - First Intervention||10
1127285|NCT01277718|2729738|P1|STARTED|Period 1 - First Intervention||10
1127286|NCT01277757|2729749|P1|NOT COMPLETED|Overall Study||2
1127287|NCT01277757|2729749|P1|COMPLETED|Overall Study||28
1127288|NCT01277757|2729749|P1|STARTED|Overall Study||30
1127289|NCT01283464|2729758|P2|NOT COMPLETED|Overall Study||1
1127290|NCT01283464|2729759|P1|NOT COMPLETED|Overall Study||2
1127291|NCT01283464|2729758|P2|COMPLETED|Overall Study||11
1127292|NCT01283464|2729759|P1|COMPLETED|Overall Study||10
1127293|NCT01283464|2729758|P2|STARTED|Overall Study||12
1127294|NCT01283464|2729759|P1|STARTED|Overall Study||12
1127295|NCT01283516|2729774|P9|NOT COMPLETED|Overall Study||122
1127296|NCT01283516|2729775|P8|NOT COMPLETED|Overall Study||3
1127297|NCT01283516|2729776|P7|NOT COMPLETED|Overall Study||8
1127298|NCT01283516|2729777|P6|NOT COMPLETED|Overall Study||8
1127299|NCT01283516|2729778|P5|NOT COMPLETED|Overall Study||13
1127300|NCT01283516|2729779|P4|NOT COMPLETED|Overall Study||3
1127301|NCT01283516|2729780|P3|NOT COMPLETED|Overall Study||2
1127302|NCT01283516|2729781|P2|NOT COMPLETED|Overall Study||2
1127303|NCT01283516|2729782|P1|NOT COMPLETED|Overall Study||2
1127304|NCT01283516|2729774|P9|COMPLETED|Overall Study||133
1127305|NCT01283516|2729775|P8|COMPLETED|Overall Study||2
1127306|NCT01283516|2729776|P7|COMPLETED|Overall Study||2
1127307|NCT01283516|2729777|P6|COMPLETED|Overall Study||2
1127308|NCT01283516|2729778|P5|COMPLETED|Overall Study||1
1127309|NCT01283516|2729779|P4|COMPLETED|Overall Study||0
1127310|NCT01283516|2729780|P3|COMPLETED|Overall Study||1
1127311|NCT01283516|2729781|P2|COMPLETED|Overall Study||0
1127312|NCT01283516|2729782|P1|COMPLETED|Overall Study|Completed = Treatment Ongoing|0
1127313|NCT01283516|2729774|P9|Dose-Determining Set (DDS)|Overall Study||8
1127314|NCT01283516|2729775|P8|Dose-Determining Set (DDS)|Overall Study||5
1127315|NCT01283516|2729776|P7|Dose-Determining Set (DDS)|Overall Study||10
1127316|NCT01283516|2729777|P6|Dose-Determining Set (DDS)|Overall Study||8
1127317|NCT01283516|2729778|P5|Dose-Determining Set (DDS)|Overall Study||14
1127318|NCT01283516|2729779|P4|Dose-Determining Set (DDS)|Overall Study||3
1127319|NCT01283516|2729780|P3|Dose-Determining Set (DDS)|Overall Study||3
1127320|NCT01283516|2729781|P2|Dose-Determining Set (DDS)|Overall Study||1
1127321|NCT01283516|2729782|P1|Dose-Determining Set (DDS)|Overall Study||2
1127322|NCT01283516|2729774|P9|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||246
1127323|NCT01283516|2729775|P8|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||5
1127324|NCT01283516|2729776|P7|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||9
1127325|NCT01283516|2729777|P6|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||10
1127326|NCT01283516|2729778|P5|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||12
1127327|NCT01283516|2729779|P4|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||3
1127328|NCT01283516|2729780|P3|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
1127329|NCT01283516|2729781|P2|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||1
1127330|NCT01283516|2729782|P1|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
1127331|NCT01283516|2729774|P9|STARTED|Overall Study||255
1127332|NCT01283516|2729775|P8|STARTED|Overall Study||5
1127333|NCT01283516|2729776|P7|STARTED|Overall Study||10
1127334|NCT01283516|2729777|P6|STARTED|Overall Study||10
1127335|NCT01283516|2729778|P5|STARTED|Overall Study||14
1127336|NCT01283516|2729779|P4|STARTED|Overall Study||3
1127337|NCT01283516|2729780|P3|STARTED|Overall Study||3
1127338|NCT01283516|2729781|P2|STARTED|Overall Study||2
1127339|NCT01283516|2729782|P1|STARTED|Overall Study|Started = Full Analysis Set and Safety Set|2
1127340|NCT01283555|2729804|P2|NOT COMPLETED|Second Intervention||0
1127341|NCT01283555|2729805|P1|NOT COMPLETED|Second Intervention||0
1127342|NCT01283555|2729804|P2|COMPLETED|Second Intervention||12
1127343|NCT01283555|2729805|P1|COMPLETED|Second Intervention||13
1127344|NCT01283555|2729804|P2|STARTED|Second Intervention||12
1127345|NCT01283555|2729805|P1|STARTED|Second Intervention||13
1127346|NCT01283555|2729804|P2|NOT COMPLETED|Washout Period of at Least 21 Days||0
1127347|NCT01283555|2729805|P1|NOT COMPLETED|Washout Period of at Least 21 Days||0
1127348|NCT01283555|2729804|P2|COMPLETED|Washout Period of at Least 21 Days||12
1127349|NCT01283555|2729805|P1|COMPLETED|Washout Period of at Least 21 Days||13
1127350|NCT01283555|2729804|P2|STARTED|Washout Period of at Least 21 Days||12
1127351|NCT01283555|2729805|P1|STARTED|Washout Period of at Least 21 Days||13
1127352|NCT01283555|2729804|P2|NOT COMPLETED|First Intervention||0
1127353|NCT01283555|2729805|P1|NOT COMPLETED|First Intervention||0
1127354|NCT01283555|2729804|P2|COMPLETED|First Intervention||12
1127355|NCT01283555|2729805|P1|COMPLETED|First Intervention||13
1127356|NCT01283555|2729804|P2|STARTED|First Intervention||12
1127357|NCT01283555|2729805|P1|STARTED|First Intervention||13
1127358|NCT01283581|2729851|P3|NOT COMPLETED|Overall Study||20
1127359|NCT01283581|2729852|P2|NOT COMPLETED|Overall Study||14
1127360|NCT01283581|2729853|P1|NOT COMPLETED|Overall Study||12
1127361|NCT01283581|2729851|P3|COMPLETED|Overall Study||78
1127362|NCT01283581|2729852|P2|COMPLETED|Overall Study||63
1127363|NCT01283581|2729853|P1|COMPLETED|Overall Study||69
1127364|NCT01283581|2729851|P3|STARTED|Overall Study||98
1127365|NCT01283581|2729852|P2|STARTED|Overall Study||77
1127366|NCT01283581|2729853|P1|STARTED|Overall Study||81
1127367|NCT01286805|2729866|P2|NOT COMPLETED|Overall Study||1
1127368|NCT01286805|2729867|P1|NOT COMPLETED|Overall Study||0
1127369|NCT01286805|2729866|P2|COMPLETED|Overall Study||41
1127370|NCT01286805|2729867|P1|COMPLETED|Overall Study||41
1127371|NCT01286805|2729866|P2|STARTED|Overall Study||42
1127372|NCT01286805|2729867|P1|STARTED|Overall Study||41
1127373|NCT01286818|2729887|P1|NOT COMPLETED|Overall Study||0
1127374|NCT01286818|2729887|P1|COMPLETED|Overall Study||6
1127375|NCT01286818|2729887|P1|Completed DLT Assessment Period|Overall Study||5
1127376|NCT01286818|2729887|P1|STARTED|Overall Study||6
1127377|NCT01287039|2729901|P2|NOT COMPLETED|Overall Study||27
1127378|NCT01287039|2729902|P1|NOT COMPLETED|Overall Study||29
1127379|NCT01287039|2729901|P2|COMPLETED|Overall Study||218
1127380|NCT01287039|2729902|P1|COMPLETED|Overall Study||215
1127381|NCT01287039|2729901|P2|STARTED|Overall Study||245
1127382|NCT01287039|2729902|P1|STARTED|Overall Study||244
1127383|NCT01287065|2729932|P6|NOT COMPLETED|Treatment Period 3||0
1127384|NCT01287065|2729933|P5|NOT COMPLETED|Treatment Period 3||0
1127385|NCT01287065|2729934|P4|NOT COMPLETED|Treatment Period 3||0
1127386|NCT01287065|2729935|P3|NOT COMPLETED|Treatment Period 3||0
1127387|NCT01287065|2729936|P2|NOT COMPLETED|Treatment Period 3||0
1127388|NCT01287065|2729937|P1|NOT COMPLETED|Treatment Period 3||0
1127389|NCT01287065|2729932|P6|COMPLETED|Treatment Period 3||4
1127390|NCT01287065|2729933|P5|COMPLETED|Treatment Period 3||4
1127391|NCT01287065|2729934|P4|COMPLETED|Treatment Period 3||4
1127392|NCT01287065|2729935|P3|COMPLETED|Treatment Period 3||4
1127393|NCT01287065|2729936|P2|COMPLETED|Treatment Period 3||4
1127394|NCT01287065|2729937|P1|COMPLETED|Treatment Period 3||4
1127395|NCT01287065|2729932|P6|STARTED|Treatment Period 3||4
1127396|NCT01287065|2729933|P5|STARTED|Treatment Period 3||4
1127397|NCT01287065|2729934|P4|STARTED|Treatment Period 3||4
1127398|NCT01287065|2729935|P3|STARTED|Treatment Period 3||4
1127399|NCT01287065|2729936|P2|STARTED|Treatment Period 3||4
1127400|NCT01287065|2729937|P1|STARTED|Treatment Period 3||4
1127401|NCT01287065|2729932|P6|NOT COMPLETED|Washout Period 2||0
1127402|NCT01287065|2729933|P5|NOT COMPLETED|Washout Period 2||0
1127403|NCT01287065|2729934|P4|NOT COMPLETED|Washout Period 2||0
1127404|NCT01287065|2729935|P3|NOT COMPLETED|Washout Period 2||0
1127405|NCT01287065|2729936|P2|NOT COMPLETED|Washout Period 2||0
1127406|NCT01287065|2729937|P1|NOT COMPLETED|Washout Period 2||0
1127407|NCT01287065|2729932|P6|COMPLETED|Washout Period 2||4
1127408|NCT01287065|2729933|P5|COMPLETED|Washout Period 2||4
1127409|NCT01287065|2729934|P4|COMPLETED|Washout Period 2||4
1127410|NCT01287065|2729935|P3|COMPLETED|Washout Period 2||4
1127411|NCT01287065|2729936|P2|COMPLETED|Washout Period 2||4
1127412|NCT01287065|2729937|P1|COMPLETED|Washout Period 2||4
1127413|NCT01287065|2729932|P6|STARTED|Washout Period 2||4
1127414|NCT01287065|2729933|P5|STARTED|Washout Period 2||4
1127415|NCT01287065|2729934|P4|STARTED|Washout Period 2||4
1127416|NCT01287065|2729935|P3|STARTED|Washout Period 2||4
1127417|NCT01287065|2729936|P2|STARTED|Washout Period 2||4
1127418|NCT01287065|2729937|P1|STARTED|Washout Period 2||4
1127419|NCT01287065|2729932|P6|NOT COMPLETED|Treatment Period 2||0
1127420|NCT01287065|2729933|P5|NOT COMPLETED|Treatment Period 2||0
1127421|NCT01287065|2729934|P4|NOT COMPLETED|Treatment Period 2||0
1127422|NCT01287065|2729935|P3|NOT COMPLETED|Treatment Period 2||0
1127423|NCT01287065|2729936|P2|NOT COMPLETED|Treatment Period 2||0
1127424|NCT01287065|2729937|P1|NOT COMPLETED|Treatment Period 2||0
1127425|NCT01287065|2729932|P6|COMPLETED|Treatment Period 2||4
1127426|NCT01287065|2729933|P5|COMPLETED|Treatment Period 2||4
1127427|NCT01287065|2729934|P4|COMPLETED|Treatment Period 2||4
1127428|NCT01287065|2729935|P3|COMPLETED|Treatment Period 2||4
1127429|NCT01287065|2729936|P2|COMPLETED|Treatment Period 2||4
1127430|NCT01287065|2729937|P1|COMPLETED|Treatment Period 2||4
1127431|NCT01287065|2729932|P6|STARTED|Treatment Period 2||4
1127432|NCT01287065|2729933|P5|STARTED|Treatment Period 2||4
1127433|NCT01287065|2729934|P4|STARTED|Treatment Period 2||4
1127434|NCT01287065|2729935|P3|STARTED|Treatment Period 2||4
1127435|NCT01287065|2729936|P2|STARTED|Treatment Period 2||4
1127436|NCT01287065|2729937|P1|STARTED|Treatment Period 2||4
1127437|NCT01287065|2729932|P6|NOT COMPLETED|Washout Period 1||0
1127438|NCT01287065|2729933|P5|NOT COMPLETED|Washout Period 1||0
1127439|NCT01287065|2729934|P4|NOT COMPLETED|Washout Period 1||0
1127440|NCT01287065|2729935|P3|NOT COMPLETED|Washout Period 1||0
1127441|NCT01287065|2729936|P2|NOT COMPLETED|Washout Period 1||0
1127442|NCT01287065|2729937|P1|NOT COMPLETED|Washout Period 1||0
1127443|NCT01287065|2729932|P6|COMPLETED|Washout Period 1||4
1127444|NCT01287065|2729933|P5|COMPLETED|Washout Period 1||4
1127445|NCT01287065|2729934|P4|COMPLETED|Washout Period 1||4
1127446|NCT01287065|2729935|P3|COMPLETED|Washout Period 1||4
1127447|NCT01287065|2729936|P2|COMPLETED|Washout Period 1||4
1127448|NCT01287065|2729937|P1|COMPLETED|Washout Period 1||4
1127449|NCT01287065|2729932|P6|STARTED|Washout Period 1||4
1127450|NCT01287065|2729933|P5|STARTED|Washout Period 1||4
1127451|NCT01287065|2729934|P4|STARTED|Washout Period 1||4
1127452|NCT01287065|2729935|P3|STARTED|Washout Period 1||4
1127453|NCT01287065|2729936|P2|STARTED|Washout Period 1||4
1127454|NCT01287065|2729937|P1|STARTED|Washout Period 1||4
1127455|NCT01287065|2729932|P6|NOT COMPLETED|Treatment Period 1||1
1127456|NCT01287065|2729933|P5|NOT COMPLETED|Treatment Period 1||1
1127457|NCT01287065|2729934|P4|NOT COMPLETED|Treatment Period 1||0
1127458|NCT01287065|2729935|P3|NOT COMPLETED|Treatment Period 1||0
1127459|NCT01287065|2729936|P2|NOT COMPLETED|Treatment Period 1||0
1127460|NCT01287065|2729937|P1|NOT COMPLETED|Treatment Period 1||0
1127461|NCT01287065|2729932|P6|COMPLETED|Treatment Period 1||4
1127462|NCT01287065|2729933|P5|COMPLETED|Treatment Period 1||4
1127463|NCT01287065|2729934|P4|COMPLETED|Treatment Period 1||4
1127464|NCT01287065|2729935|P3|COMPLETED|Treatment Period 1||4
1127465|NCT01287065|2729936|P2|COMPLETED|Treatment Period 1||4
1127466|NCT01287065|2729937|P1|COMPLETED|Treatment Period 1||4
1127467|NCT01287065|2729932|P6|STARTED|Treatment Period 1||5
1127468|NCT01287065|2729933|P5|STARTED|Treatment Period 1||5
1127469|NCT01287065|2729934|P4|STARTED|Treatment Period 1||4
1127470|NCT01287065|2729935|P3|STARTED|Treatment Period 1||4
1127471|NCT01287065|2729936|P2|STARTED|Treatment Period 1||4
1127472|NCT01287065|2729937|P1|STARTED|Treatment Period 1||4
1127473|NCT01287117|2729958|P4|NOT COMPLETED|Overall Study||12
1127474|NCT01287117|2729959|P3|NOT COMPLETED|Overall Study||16
1127475|NCT01287117|2729960|P2|NOT COMPLETED|Overall Study||14
1127476|NCT01287117|2729961|P1|NOT COMPLETED|Overall Study||15
1127477|NCT01287117|2729958|P4|COMPLETED|Overall Study||69
1127478|NCT01287117|2729959|P3|COMPLETED|Overall Study||64
1127479|NCT01287117|2729960|P2|COMPLETED|Overall Study||64
1127480|NCT01287117|2729961|P1|COMPLETED|Overall Study||65
1127481|NCT01287117|2729958|P4|Received Treatment|Overall Study||81
1127482|NCT01287117|2729959|P3|Received Treatment|Overall Study||80
1127483|NCT01287117|2729960|P2|Received Treatment|Overall Study||77
1127484|NCT01287117|2729961|P1|Received Treatment|Overall Study||80
1127485|NCT01287117|2729958|P4|STARTED|Overall Study||81
1127486|NCT01287117|2729959|P3|STARTED|Overall Study||80
1127487|NCT01287117|2729960|P2|STARTED|Overall Study||78
1127488|NCT01287117|2729961|P1|STARTED|Overall Study||80
1127489|NCT01287195|2730007|P1|NOT COMPLETED|Overall Study||2
1127490|NCT01287195|2730007|P1|COMPLETED|Overall Study||4
1127491|NCT01287195|2730007|P1|STARTED|Overall Study||6
1127492|NCT01287208|2730020|P2|NOT COMPLETED|Phase 2: Team Competition||0
1127493|NCT01287208|2730021|P1|NOT COMPLETED|Phase 2: Team Competition||0
1127494|NCT01287208|2730020|P2|COMPLETED|Phase 2: Team Competition||49
1127495|NCT01287208|2730021|P1|COMPLETED|Phase 2: Team Competition||50
1127496|NCT01287208|2730020|P2|STARTED|Phase 2: Team Competition||49
1127497|NCT01287208|2730021|P1|STARTED|Phase 2: Team Competition||50
1127498|NCT01287208|2730020|P2|NOT COMPLETED|Phase 1: Randomized Phase||3
1127499|NCT01287208|2730021|P1|NOT COMPLETED|Phase 1: Randomized Phase||2
1127500|NCT01287208|2730020|P2|COMPLETED|Phase 1: Randomized Phase||49
1127501|NCT01287208|2730021|P1|COMPLETED|Phase 1: Randomized Phase||50
1127502|NCT01287208|2730020|P2|STARTED|Phase 1: Randomized Phase||52
1127503|NCT01287208|2730021|P1|STARTED|Phase 1: Randomized Phase||52
1127504|NCT01287221|2730029|P2|NOT COMPLETED|Overall Study||5
1127505|NCT01287221|2730030|P1|NOT COMPLETED|Overall Study||4
1127506|NCT01287221|2730029|P2|COMPLETED|Overall Study||45
1127507|NCT01287221|2730030|P1|COMPLETED|Overall Study||46
1127508|NCT01287221|2730029|P2|Completed 12 Months Follow-up|Overall Study||39
1127509|NCT01287221|2730030|P1|Completed 12 Months Follow-up|Overall Study||40
1127510|NCT01287221|2730029|P2|Completed 9 Months Follow-up|Overall Study||40
1127511|NCT01287221|2730030|P1|Completed 9 Months Follow-up|Overall Study||42
1127512|NCT01287221|2730029|P2|Completed 6 Months Follow-up|Overall Study||43
1127513|NCT01287221|2730030|P1|Completed 6 Months Follow-up|Overall Study||47
1127514|NCT01287221|2730029|P2|Completed 3 Months Follow-up|Overall Study||50
1127515|NCT01287221|2730030|P1|Completed 3 Months Follow-up|Overall Study||49
1127516|NCT01287221|2730029|P2|STARTED|Overall Study||50
1127517|NCT01287221|2730030|P1|STARTED|Overall Study||50
1127518|NCT01287364|2730050|P2|NOT COMPLETED|Overall Study||10
1127519|NCT01287364|2730051|P1|NOT COMPLETED|Overall Study||9
1127520|NCT01287364|2730050|P2|COMPLETED|Overall Study||81
1127521|NCT01287364|2730051|P1|COMPLETED|Overall Study||85
1127522|NCT01287364|2730050|P2|STARTED|Overall Study||91
1127523|NCT01287364|2730051|P1|STARTED|Overall Study||94
1127524|NCT01287403|2730071|P1|NOT COMPLETED|6th and Last Intervention (1 Day)||0
1127525|NCT01287403|2730071|P1|COMPLETED|6th and Last Intervention (1 Day)||13
1127526|NCT01287403|2730071|P1|STARTED|6th and Last Intervention (1 Day)||13
1127527|NCT01287403|2730071|P1|NOT COMPLETED|Washout (7 Days)||0
1127528|NCT01287403|2730071|P1|COMPLETED|Washout (7 Days)||13
1127529|NCT01287403|2730071|P1|STARTED|Washout (7 Days)||13
1127530|NCT01287403|2730071|P1|NOT COMPLETED|5th Intervention (1 Day)||0
1127531|NCT01287403|2730071|P1|COMPLETED|5th Intervention (1 Day)||13
1127532|NCT01287403|2730071|P1|STARTED|5th Intervention (1 Day)||13
1127533|NCT01287403|2730071|P1|NOT COMPLETED|Washout (7 Days)||0
1127534|NCT01287403|2730071|P1|COMPLETED|Washout (7 Days)||13
1127535|NCT01287403|2730071|P1|STARTED|Washout (7 Days)||13
1127536|NCT01287403|2730071|P1|NOT COMPLETED|4th Intervention (1 Day)||0
1127537|NCT01287403|2730071|P1|COMPLETED|4th Intervention (1 Day)||13
1127538|NCT01287403|2730071|P1|STARTED|4th Intervention (1 Day)||13
1127539|NCT01287403|2730071|P1|NOT COMPLETED|Washout (7 Days)||0
1127540|NCT01287403|2730071|P1|COMPLETED|Washout (7 Days)||13
1127541|NCT01287403|2730071|P1|STARTED|Washout (7 Days)||13
1127542|NCT01287403|2730071|P1|NOT COMPLETED|3rd Intervention (1 Day)||0
1127543|NCT01287403|2730071|P1|COMPLETED|3rd Intervention (1 Day)||13
1127544|NCT01287403|2730071|P1|STARTED|3rd Intervention (1 Day)||13
1127545|NCT01287403|2730071|P1|NOT COMPLETED|Washout (7 Days)||0
1127546|NCT01287403|2730071|P1|COMPLETED|Washout (7 Days)||13
1127547|NCT01287403|2730071|P1|STARTED|Washout (7 Days)||13
1127548|NCT01287403|2730071|P1|NOT COMPLETED|2nd Intervention (1 Day)||0
1127549|NCT01287403|2730071|P1|COMPLETED|2nd Intervention (1 Day)||13
1127550|NCT01287403|2730071|P1|STARTED|2nd Intervention (1 Day)||13
1127551|NCT01287403|2730071|P1|NOT COMPLETED|Washout 7 Days||0
1127552|NCT01287403|2730071|P1|COMPLETED|Washout 7 Days||13
1127553|NCT01287403|2730071|P1|STARTED|Washout 7 Days||13
1127554|NCT01287403|2730071|P1|NOT COMPLETED|1st Intervention (1 Day)||1
1127555|NCT01287403|2730071|P1|COMPLETED|1st Intervention (1 Day)|"The adverse event was linked to the intake of refined wheat flour"|13
1127556|NCT01287403|2730071|P1|STARTED|1st Intervention (1 Day)||14
1127557|NCT01287403|2730071|P1|NOT COMPLETED|Diet Restriction (7 Days)||0
1127558|NCT01287403|2730071|P1|COMPLETED|Diet Restriction (7 Days)||14
1127559|NCT01287403|2730071|P1|STARTED|Diet Restriction (7 Days)||14
1127560|NCT01287416|2730087|P2|NOT COMPLETED|6 Month Follow-up||2
1127561|NCT01287416|2730088|P1|NOT COMPLETED|6 Month Follow-up||3
1127562|NCT01287416|2730087|P2|COMPLETED|6 Month Follow-up||22
1127563|NCT01287416|2730088|P1|COMPLETED|6 Month Follow-up||28
1127564|NCT01287416|2730087|P2|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|24
1127565|NCT01287416|2730088|P1|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|31
1127566|NCT01287416|2730087|P2|NOT COMPLETED|Pre-post Training||25
1127567|NCT01287416|2730088|P1|NOT COMPLETED|Pre-post Training||22
1127568|NCT01287416|2730087|P2|COMPLETED|Pre-post Training||23
1127569|NCT01287416|2730088|P1|COMPLETED|Pre-post Training||26
1127570|NCT01287416|2730087|P2|Post Training Questionnaire|Pre-post Training||23
1127571|NCT01287416|2730088|P1|Post Training Questionnaire|Pre-post Training||26
1127572|NCT01287416|2730087|P2|Training Workshop|Pre-post Training|number of people that showed up for the training session|24
1127573|NCT01287416|2730088|P1|Training Workshop|Pre-post Training|number of people that showed up for the training session|31
1127574|NCT01287416|2730087|P2|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
1127575|NCT01287416|2730088|P1|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
1127576|NCT01287611|2730126|P2|NOT COMPLETED|Overall Study||19
1127577|NCT01287611|2730127|P1|NOT COMPLETED|Overall Study||33
1127578|NCT01287611|2730126|P2|COMPLETED|Overall Study||65
1127579|NCT01287611|2730127|P1|COMPLETED|Overall Study||51
1127580|NCT01287611|2730126|P2|The Number of Patients Who Underwent C/S|Overall Study||84
1127581|NCT01287611|2730127|P1|The Number of Patients Who Underwent C/S|Overall Study||84
1127582|NCT01287611|2730126|P2|STARTED|Overall Study||84
1127583|NCT01287611|2730127|P1|STARTED|Overall Study||84
1127584|NCT01287741|2730137|P2|NOT COMPLETED|Overall Study||706
1127585|NCT01287741|2730138|P1|NOT COMPLETED|Overall Study||712
1127586|NCT01287741|2730137|P2|COMPLETED|Overall Study||0
1127587|NCT01287741|2730138|P1|COMPLETED|Overall Study||0
1127588|NCT01287741|2730137|P2|STARTED|Overall Study||706
1127589|NCT01287741|2730138|P1|STARTED|Overall Study||712
1127590|NCT01287754|2730174|P2|NOT COMPLETED|Overall Study||21
1127591|NCT01287754|2730175|P1|NOT COMPLETED|Overall Study||3
1127592|NCT01287754|2730174|P2|COMPLETED|Overall Study||0
1127593|NCT01287754|2730175|P1|COMPLETED|Overall Study||0
1127594|NCT01287754|2730174|P2|STARTED|Overall Study||21
1127595|NCT01287754|2730175|P1|STARTED|Overall Study||3
1127596|NCT01287832|2730187|P2|NOT COMPLETED|Overall Study||1
1127597|NCT01287832|2730188|P1|NOT COMPLETED|Overall Study||1
1127598|NCT01287832|2730187|P2|COMPLETED|Overall Study||4
1127599|NCT01287832|2730188|P1|COMPLETED|Overall Study||5
1127600|NCT01287832|2730187|P2|STARTED|Overall Study||5
1127601|NCT01287832|2730188|P1|STARTED|Overall Study||6
1127602|NCT01287897|2730198|P4|NOT COMPLETED|Overall Study||7
1127603|NCT01287897|2730199|P3|NOT COMPLETED|Overall Study||12
1127604|NCT01287897|2730200|P2|NOT COMPLETED|Overall Study||11
1127605|NCT01287897|2730201|P1|NOT COMPLETED|Overall Study||11
1127606|NCT01287897|2730198|P4|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|33
1127607|NCT01287897|2730199|P3|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
1127608|NCT01287897|2730200|P2|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|58
1127609|NCT01287897|2730201|P1|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
1127610|NCT01287897|2730198|P4|Enrolled in NCT01345318|Overall Study||29
1127611|NCT01287897|2730199|P3|Enrolled in NCT01345318|Overall Study||56
1127612|NCT01287897|2730200|P2|Enrolled in NCT01345318|Overall Study||50
1127613|NCT01287897|2730201|P1|Enrolled in NCT01345318|Overall Study||56
1127614|NCT01287897|2730198|P4|Completed Follow-up Period|Overall Study||4
1127615|NCT01287897|2730199|P3|Completed Follow-up Period|Overall Study||3
1127616|NCT01287897|2730200|P2|Completed Follow-up Period|Overall Study||8
1127617|NCT01287897|2730201|P1|Completed Follow-up Period|Overall Study||3
1127618|NCT01287897|2730198|P4|Completed Treatment Period|Overall Study||29
1127619|NCT01287897|2730199|P3|Completed Treatment Period|Overall Study||58
1127620|NCT01287897|2730200|P2|Completed Treatment Period|Overall Study||52
1127621|NCT01287897|2730201|P1|Completed Treatment Period|Overall Study||58
1127622|NCT01287897|2730198|P4|Treated|Overall Study||40
1127623|NCT01287897|2730199|P3|Treated|Overall Study||71
1127624|NCT01287897|2730200|P2|Treated|Overall Study||67
1127625|NCT01287897|2730201|P1|Treated|Overall Study||69
1127626|NCT01287897|2730198|P4|STARTED|Overall Study|Enrollment was halted before reaching the planned sample size due to safety findings in NCT01405196.|40
1127627|NCT01287897|2730199|P3|STARTED|Overall Study||71
1127628|NCT01287897|2730200|P2|STARTED|Overall Study||69
1127629|NCT01287897|2730201|P1|STARTED|Overall Study||70
1127630|NCT01288027|2730250|P1|NOT COMPLETED|Overall Study||0
1127631|NCT01288027|2730250|P1|COMPLETED|Overall Study||16
1127632|NCT01288027|2730250|P1|Full Analysis Set (FAS)|Overall Study|All participants who received at least 1 complete infusion of alglucosidase alfa.|16
1127633|NCT01288027|2730250|P1|STARTED|Overall Study||16
1127634|NCT01288079|2730264|P4|NOT COMPLETED|Overall Study||17
1127635|NCT01288079|2730265|P3|NOT COMPLETED|Overall Study||19
1127636|NCT01288079|2730266|P2|NOT COMPLETED|Overall Study||27
1127637|NCT01288079|2730267|P1|NOT COMPLETED|Overall Study||20
1127638|NCT01288079|2730264|P4|COMPLETED|Overall Study||18
1127639|NCT01288079|2730265|P3|COMPLETED|Overall Study||18
1127640|NCT01288079|2730266|P2|COMPLETED|Overall Study||9
1127641|NCT01288079|2730267|P1|COMPLETED|Overall Study||17
1127642|NCT01288079|2730264|P4|STARTED|Overall Study||35
1127643|NCT01288079|2730265|P3|STARTED|Overall Study||37
1127644|NCT01288079|2730266|P2|STARTED|Overall Study||36
1127645|NCT01288079|2730267|P1|STARTED|Overall Study||37
1127646|NCT01288209|2730279|P2|NOT COMPLETED|Overall Study||3
1127647|NCT01288209|2730280|P1|NOT COMPLETED|Overall Study||2
1127648|NCT01288209|2730279|P2|COMPLETED|Overall Study||50
1127649|NCT01288209|2730280|P1|COMPLETED|Overall Study||51
1127650|NCT01288209|2730279|P2|STARTED|Overall Study||53
1127651|NCT01288209|2730280|P1|STARTED|Overall Study||53
1127652|NCT01288287|2730306|P1|NOT COMPLETED|Overall Study||46
1127653|NCT01288287|2730306|P1|COMPLETED|Overall Study||103
1127654|NCT01288287|2730306|P1|Full Analysis Set|Overall Study||111
1127655|NCT01288287|2730306|P1|Safety Set|Overall Study||147
1127656|NCT01288287|2730306|P1|STARTED|Overall Study||149
1127657|NCT01288443|2730325|P6|NOT COMPLETED|Overall Study||5
1127658|NCT01288443|2730326|P5|NOT COMPLETED|Overall Study||7
1127659|NCT01288443|2730327|P4|NOT COMPLETED|Overall Study||4
1127660|NCT01288443|2730328|P3|NOT COMPLETED|Overall Study||1
1127661|NCT01288443|2730329|P2|NOT COMPLETED|Overall Study||1
1127662|NCT01288443|2730330|P1|NOT COMPLETED|Overall Study||0
1127663|NCT01288443|2730325|P6|COMPLETED|Overall Study||25
1127664|NCT01288443|2730326|P5|COMPLETED|Overall Study||23
1127665|NCT01288443|2730327|P4|COMPLETED|Overall Study||27
1127666|NCT01288443|2730328|P3|COMPLETED|Overall Study||30
1127667|NCT01288443|2730329|P2|COMPLETED|Overall Study||29
1127668|NCT01288443|2730330|P1|COMPLETED|Overall Study||31
1127669|NCT01288443|2730325|P6|Treated|Overall Study||30
1127670|NCT01288443|2730326|P5|Treated|Overall Study||29
1127671|NCT01288443|2730327|P4|Treated|Overall Study||31
1127672|NCT01288443|2730328|P3|Treated|Overall Study||31
1127673|NCT01288443|2730329|P2|Treated|Overall Study||30
1127674|NCT01288443|2730330|P1|Treated|Overall Study||31
1127675|NCT01288443|2730325|P6|STARTED|Overall Study|Randomized|30
1127676|NCT01288443|2730326|P5|STARTED|Overall Study|Randomized|30
1127677|NCT01288443|2730327|P4|STARTED|Overall Study|Randomized|31
1127678|NCT01288443|2730328|P3|STARTED|Overall Study|Randomized|31
1127679|NCT01288443|2730329|P2|STARTED|Overall Study|Randomized|30
1127680|NCT01288443|2730330|P1|STARTED|Overall Study|Randomized|31
1127681|NCT01288469|2730383|P3|NOT COMPLETED|Overall Study||2
1127682|NCT01288469|2730384|P2|NOT COMPLETED|Overall Study||3
1127683|NCT01288469|2730385|P1|NOT COMPLETED|Overall Study||7
1127684|NCT01288469|2730383|P3|COMPLETED|Overall Study||28
1127685|NCT01288469|2730384|P2|COMPLETED|Overall Study||28
1127686|NCT01288469|2730385|P1|COMPLETED|Overall Study||24
1127687|NCT01288469|2730383|P3|Treated|Overall Study||30
1127688|NCT01288469|2730384|P2|Treated|Overall Study||31
1127689|NCT01288469|2730385|P1|Treated|Overall Study||31
1127690|NCT01288469|2730383|P3|STARTED|Overall Study|Randomized|30
1127691|NCT01288469|2730384|P2|STARTED|Overall Study|Randomized|31
1127692|NCT01288469|2730385|P1|STARTED|Overall Study|Randomized|31
1127696|NCT01288612|2730418|P3|NOT COMPLETED|Overall Study||82
1127697|NCT01288612|2730419|P2|NOT COMPLETED|Overall Study||82
1127698|NCT01288612|2730420|P1|NOT COMPLETED|Overall Study||89
1127699|NCT01288612|2730418|P3|COMPLETED|Overall Study||76
1127700|NCT01288612|2730419|P2|COMPLETED|Overall Study||69
1127701|NCT01288612|2730420|P1|COMPLETED|Overall Study||61
1127702|NCT01288612|2730418|P3|Agreed to Take Part|Overall Study||76
1127703|NCT01288612|2730419|P2|Agreed to Take Part|Overall Study||72
1127704|NCT01288612|2730420|P1|Agreed to Take Part|Overall Study||61
1127705|NCT01288612|2730418|P3|Contacted|Overall Study||138
1127706|NCT01288612|2730419|P2|Contacted|Overall Study||135
1127707|NCT01288612|2730420|P1|Contacted|Overall Study||139
1127708|NCT01288612|2730418|P3|STARTED|Overall Study||158
1127709|NCT01288612|2730419|P2|STARTED|Overall Study||151
1127710|NCT01288612|2730420|P1|STARTED|Overall Study||150
1127711|NCT01288729|2730451|P2|NOT COMPLETED|Overall Study||0
1127712|NCT01288729|2730452|P1|NOT COMPLETED|Overall Study||1
1127713|NCT01288729|2730451|P2|COMPLETED|Overall Study||10
1127714|NCT01288729|2730452|P1|COMPLETED|Overall Study||9
1127715|NCT01288729|2730451|P2|STARTED|Overall Study||10
1127716|NCT01288729|2730452|P1|STARTED|Overall Study||10
1127717|NCT01288781|2730460|P2|NOT COMPLETED|Overall Study||0
1127718|NCT01288781|2730461|P1|NOT COMPLETED|Overall Study||0
1127719|NCT01288781|2730460|P2|COMPLETED|Overall Study||12
1127720|NCT01288781|2730461|P1|COMPLETED|Overall Study||11
1127721|NCT01288781|2730460|P2|STARTED|Overall Study||12
1127722|NCT01288781|2730461|P1|STARTED|Overall Study||11
1127723|NCT01288859|2730479|P6|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
1127724|NCT01288859|2730480|P5|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
1127725|NCT01288859|2730481|P4|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
1127726|NCT01288859|2730482|P3|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
1127727|NCT01288859|2730483|P2|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
1127728|NCT01288859|2730484|P1|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
1127729|NCT01288859|2730479|P6|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
1127730|NCT01288859|2730480|P5|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
1127731|NCT01288859|2730481|P4|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
1127732|NCT01288859|2730482|P3|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
1127733|NCT01288859|2730483|P2|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
1127734|NCT01288859|2730484|P1|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
1127735|NCT01288859|2730479|P6|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
1127736|NCT01288859|2730480|P5|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
1127737|NCT01288859|2730481|P4|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
1127738|NCT01288859|2730482|P3|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
1127739|NCT01288859|2730483|P2|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
1127740|NCT01288859|2730484|P1|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
1127741|NCT01288859|2730479|P6|NOT COMPLETED|Washout Period of 1 Week||0
1127742|NCT01288859|2730480|P5|NOT COMPLETED|Washout Period of 1 Week||0
1127743|NCT01288859|2730481|P4|NOT COMPLETED|Washout Period of 1 Week||0
1127744|NCT01288859|2730482|P3|NOT COMPLETED|Washout Period of 1 Week||0
1127745|NCT01288859|2730483|P2|NOT COMPLETED|Washout Period of 1 Week||0
1127746|NCT01288859|2730484|P1|NOT COMPLETED|Washout Period of 1 Week||0
1127747|NCT01288859|2730479|P6|COMPLETED|Washout Period of 1 Week||0
1127748|NCT01288859|2730480|P5|COMPLETED|Washout Period of 1 Week||5
1127749|NCT01288859|2730481|P4|COMPLETED|Washout Period of 1 Week||5
1127750|NCT01288859|2730482|P3|COMPLETED|Washout Period of 1 Week||0
1127751|NCT01288859|2730483|P2|COMPLETED|Washout Period of 1 Week||0
1127752|NCT01288859|2730484|P1|COMPLETED|Washout Period of 1 Week||0
1127753|NCT01288859|2730479|P6|STARTED|Washout Period of 1 Week||0
1127754|NCT01288859|2730480|P5|STARTED|Washout Period of 1 Week||5
1127755|NCT01288859|2730481|P4|STARTED|Washout Period of 1 Week||5
1127756|NCT01288859|2730482|P3|STARTED|Washout Period of 1 Week||0
1127757|NCT01288859|2730483|P2|STARTED|Washout Period of 1 Week||0
1127758|NCT01288859|2730484|P1|STARTED|Washout Period of 1 Week||0
1127759|NCT01288859|2730479|P6|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
1127760|NCT01288859|2730480|P5|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
1127761|NCT01288859|2730481|P4|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
1127762|NCT01288859|2730482|P3|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
1127763|NCT01288859|2730483|P2|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
1127764|NCT01288859|2730484|P1|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
1127765|NCT01288859|2730479|P6|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
1127766|NCT01288859|2730480|P5|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
1127767|NCT01288859|2730481|P4|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
1127768|NCT01288859|2730482|P3|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
1127769|NCT01288859|2730483|P2|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
1127770|NCT01288859|2730484|P1|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
1127771|NCT01288859|2730479|P6|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
1127772|NCT01288859|2730480|P5|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
1127773|NCT01288859|2730481|P4|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
1127774|NCT01288859|2730482|P3|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
1127775|NCT01288859|2730483|P2|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
1127776|NCT01288859|2730484|P1|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
1127777|NCT01288859|2730479|P6|NOT COMPLETED|Washout Period of 1 Week||0
1127778|NCT01288859|2730480|P5|NOT COMPLETED|Washout Period of 1 Week||0
1127779|NCT01288859|2730481|P4|NOT COMPLETED|Washout Period of 1 Week||0
1127780|NCT01288859|2730482|P3|NOT COMPLETED|Washout Period of 1 Week||0
1127781|NCT01288859|2730483|P2|NOT COMPLETED|Washout Period of 1 Week||0
1127782|NCT01288859|2730484|P1|NOT COMPLETED|Washout Period of 1 Week||0
1127783|NCT01288859|2730479|P6|COMPLETED|Washout Period of 1 Week||0
1127784|NCT01288859|2730480|P5|COMPLETED|Washout Period of 1 Week||5
1127785|NCT01288859|2730481|P4|COMPLETED|Washout Period of 1 Week||5
1127786|NCT01288859|2730482|P3|COMPLETED|Washout Period of 1 Week||0
1127787|NCT01288859|2730483|P2|COMPLETED|Washout Period of 1 Week||0
1127788|NCT01288859|2730484|P1|COMPLETED|Washout Period of 1 Week||0
1127789|NCT01288859|2730479|P6|STARTED|Washout Period of 1 Week||0
1127790|NCT01288859|2730480|P5|STARTED|Washout Period of 1 Week||5
1127791|NCT01288859|2730481|P4|STARTED|Washout Period of 1 Week||5
1127792|NCT01288859|2730482|P3|STARTED|Washout Period of 1 Week||0
1127793|NCT01288859|2730483|P2|STARTED|Washout Period of 1 Week||0
1127794|NCT01288859|2730484|P1|STARTED|Washout Period of 1 Week||0
1127795|NCT01288859|2730479|P6|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1127796|NCT01288859|2730480|P5|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1127797|NCT01288859|2730481|P4|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1127798|NCT01288859|2730482|P3|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1127799|NCT01288859|2730483|P2|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1127800|NCT01288859|2730484|P1|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1127801|NCT01288859|2730479|P6|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1127802|NCT01288859|2730480|P5|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1127803|NCT01288859|2730481|P4|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1127804|NCT01288859|2730482|P3|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
1127805|NCT01288859|2730483|P2|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
1127806|NCT01288859|2730484|P1|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1127807|NCT01288859|2730479|P6|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1127808|NCT01288859|2730480|P5|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1127809|NCT01288859|2730481|P4|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1127810|NCT01288859|2730482|P3|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
1127811|NCT01288859|2730483|P2|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
1127812|NCT01288859|2730484|P1|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
1127813|NCT01288859|2730479|P6|NOT COMPLETED|Washout Period of 1 Week||0
1127814|NCT01288859|2730480|P5|NOT COMPLETED|Washout Period of 1 Week||0
1127815|NCT01288859|2730481|P4|NOT COMPLETED|Washout Period of 1 Week||0
1127816|NCT01288859|2730482|P3|NOT COMPLETED|Washout Period of 1 Week||0
1127817|NCT01288859|2730483|P2|NOT COMPLETED|Washout Period of 1 Week||0
1127818|NCT01288859|2730484|P1|NOT COMPLETED|Washout Period of 1 Week||0
1127819|NCT01288859|2730479|P6|COMPLETED|Washout Period of 1 Week||0
1127820|NCT01288859|2730480|P5|COMPLETED|Washout Period of 1 Week||0
1127821|NCT01288859|2730481|P4|COMPLETED|Washout Period of 1 Week||0
1127822|NCT01288859|2730482|P3|COMPLETED|Washout Period of 1 Week||5
1127823|NCT01288859|2730483|P2|COMPLETED|Washout Period of 1 Week||5
1127824|NCT01288859|2730484|P1|COMPLETED|Washout Period of 1 Week||0
1127825|NCT01288859|2730479|P6|STARTED|Washout Period of 1 Week||0
1127826|NCT01288859|2730480|P5|STARTED|Washout Period of 1 Week||0
1127827|NCT01288859|2730481|P4|STARTED|Washout Period of 1 Week||0
1127828|NCT01288859|2730482|P3|STARTED|Washout Period of 1 Week||5
1127829|NCT01288859|2730483|P2|STARTED|Washout Period of 1 Week||5
1127830|NCT01288859|2730484|P1|STARTED|Washout Period of 1 Week||0
1127831|NCT01288859|2730479|P6|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1127832|NCT01288859|2730480|P5|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1127833|NCT01288859|2730481|P4|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1127834|NCT01288859|2730482|P3|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1127835|NCT01288859|2730483|P2|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1127836|NCT01288859|2730484|P1|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1127837|NCT01288859|2730479|P6|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1127838|NCT01288859|2730480|P5|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1127839|NCT01288859|2730481|P4|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1127840|NCT01288859|2730482|P3|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
1127841|NCT01288859|2730483|P2|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
1127842|NCT01288859|2730484|P1|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1127843|NCT01288859|2730479|P6|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1127844|NCT01288859|2730480|P5|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1127845|NCT01288859|2730481|P4|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1127846|NCT01288859|2730482|P3|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
1127847|NCT01288859|2730483|P2|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
1127848|NCT01288859|2730484|P1|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
1127849|NCT01288859|2730479|P6|NOT COMPLETED|Washout Period of 1 Week||0
1127850|NCT01288859|2730480|P5|NOT COMPLETED|Washout Period of 1 Week||0
1127851|NCT01288859|2730481|P4|NOT COMPLETED|Washout Period of 1 Week||0
1127852|NCT01288859|2730482|P3|NOT COMPLETED|Washout Period of 1 Week||0
1127853|NCT01288859|2730483|P2|NOT COMPLETED|Washout Period of 1 Week||0
1127854|NCT01288859|2730484|P1|NOT COMPLETED|Washout Period of 1 Week||0
1127855|NCT01288859|2730479|P6|COMPLETED|Washout Period of 1 Week||5
1127856|NCT01288859|2730480|P5|COMPLETED|Washout Period of 1 Week||0
1127857|NCT01288859|2730481|P4|COMPLETED|Washout Period of 1 Week||0
1127858|NCT01288859|2730482|P3|COMPLETED|Washout Period of 1 Week||0
1127859|NCT01288859|2730483|P2|COMPLETED|Washout Period of 1 Week||0
1127860|NCT01288859|2730484|P1|COMPLETED|Washout Period of 1 Week||5
1127861|NCT01288859|2730479|P6|STARTED|Washout Period of 1 Week||5
1127862|NCT01288859|2730480|P5|STARTED|Washout Period of 1 Week||0
1127863|NCT01288859|2730481|P4|STARTED|Washout Period of 1 Week||0
1127864|NCT01288859|2730482|P3|STARTED|Washout Period of 1 Week||0
1127865|NCT01288859|2730483|P2|STARTED|Washout Period of 1 Week||0
1127866|NCT01288859|2730484|P1|STARTED|Washout Period of 1 Week||5
1127867|NCT01288859|2730479|P6|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
1127868|NCT01288859|2730480|P5|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
1127869|NCT01288859|2730481|P4|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
1127870|NCT01288859|2730482|P3|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
1127871|NCT01288859|2730483|P2|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
1127872|NCT01288859|2730484|P1|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
1127873|NCT01288859|2730479|P6|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
1127874|NCT01288859|2730480|P5|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
1127875|NCT01288859|2730481|P4|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
1127876|NCT01288859|2730482|P3|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
1127877|NCT01288859|2730483|P2|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
1127878|NCT01288859|2730484|P1|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
1127879|NCT01288859|2730479|P6|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
1127880|NCT01288859|2730480|P5|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
1127881|NCT01288859|2730481|P4|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
1127882|NCT01288859|2730482|P3|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
1127883|NCT01288859|2730483|P2|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
1127884|NCT01288859|2730484|P1|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
1127885|NCT01288859|2730479|P6|NOT COMPLETED|Washout Period of 1 Week||0
1127886|NCT01288859|2730480|P5|NOT COMPLETED|Washout Period of 1 Week||0
1127887|NCT01288859|2730481|P4|NOT COMPLETED|Washout Period of 1 Week||0
1127888|NCT01288859|2730482|P3|NOT COMPLETED|Washout Period of 1 Week||0
1127889|NCT01288859|2730483|P2|NOT COMPLETED|Washout Period of 1 Week||0
1127890|NCT01288859|2730484|P1|NOT COMPLETED|Washout Period of 1 Week||0
1127891|NCT01288859|2730479|P6|COMPLETED|Washout Period of 1 Week||5
1127892|NCT01288859|2730480|P5|COMPLETED|Washout Period of 1 Week||0
1127893|NCT01288859|2730481|P4|COMPLETED|Washout Period of 1 Week||0
1127894|NCT01288859|2730482|P3|COMPLETED|Washout Period of 1 Week||0
1127895|NCT01288859|2730483|P2|COMPLETED|Washout Period of 1 Week||0
1127896|NCT01288859|2730484|P1|COMPLETED|Washout Period of 1 Week||5
1127897|NCT01288859|2730479|P6|STARTED|Washout Period of 1 Week||5
1127898|NCT01288859|2730480|P5|STARTED|Washout Period of 1 Week||0
1127899|NCT01288859|2730481|P4|STARTED|Washout Period of 1 Week||0
1127900|NCT01288859|2730482|P3|STARTED|Washout Period of 1 Week||0
1127901|NCT01288859|2730483|P2|STARTED|Washout Period of 1 Week||0
1127902|NCT01288859|2730484|P1|STARTED|Washout Period of 1 Week||5
1127903|NCT01288859|2730479|P6|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
1127904|NCT01288859|2730480|P5|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
1127905|NCT01288859|2730481|P4|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
1127906|NCT01288859|2730482|P3|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
1127907|NCT01288859|2730483|P2|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
1127908|NCT01288859|2730484|P1|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
1127909|NCT01288859|2730479|P6|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
1127910|NCT01288859|2730480|P5|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
1127911|NCT01288859|2730481|P4|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
1127912|NCT01288859|2730482|P3|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
1127913|NCT01288859|2730483|P2|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
1127914|NCT01288859|2730484|P1|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
1127915|NCT01288859|2730479|P6|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
1127916|NCT01288859|2730480|P5|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
1127917|NCT01288859|2730481|P4|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
1127918|NCT01288859|2730482|P3|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
1127919|NCT01288859|2730483|P2|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
1127920|NCT01288859|2730484|P1|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
1127921|NCT01288911|2730512|P2|NOT COMPLETED|Overall Study||170
1127922|NCT01288911|2730513|P1|NOT COMPLETED|Overall Study||125
1127923|NCT01288911|2730512|P2|COMPLETED|Overall Study|Indicates participants still receiving treatment as of 19 October 2014|21
1127924|NCT01288911|2730513|P1|COMPLETED|Overall Study|Indicates participants still receiving treatment as of 19 October 2014|59
1127925|NCT01288911|2730512|P2|Received Treatment|Overall Study||189
1127926|NCT01288911|2730513|P1|Received Treatment|Overall Study||183
1127927|NCT01288911|2730512|P2|STARTED|Overall Study||191
1127928|NCT01288911|2730513|P1|STARTED|Overall Study||184
1127929|NCT01289015|2730543|P2|NOT COMPLETED|Overall Study||54
1127930|NCT01289015|2730544|P1|NOT COMPLETED|Overall Study||99
1127931|NCT01289015|2730543|P2|COMPLETED|Overall Study||230
1127932|NCT01289015|2730544|P1|COMPLETED|Overall Study||472
1127933|NCT01289015|2730543|P2|STARTED|Overall Study||284
1127934|NCT01289015|2730544|P1|STARTED|Overall Study||571
1127935|NCT01289028|2730552|P1|NOT COMPLETED|Overall Study||83
1127936|NCT01289028|2730552|P1|COMPLETED|Overall Study||42
1127937|NCT01289028|2730552|P1|STARTED|Overall Study||125
1127938|NCT01289041|2730564|P1|NOT COMPLETED|Overall Study||70
1127939|NCT01289041|2730564|P1|COMPLETED|Overall Study||0
1127940|NCT01289041|2730564|P1|STARTED|Overall Study||70
1127941|NCT01289080|2730578|P2|NOT COMPLETED|Overall Study||0
1127942|NCT01289080|2730579|P1|NOT COMPLETED|Overall Study||0
1127943|NCT01289080|2730578|P2|COMPLETED|Overall Study||10
1127944|NCT01289080|2730579|P1|COMPLETED|Overall Study||9
1127945|NCT01289080|2730578|P2|STARTED|Overall Study||10
1127946|NCT01289080|2730579|P1|STARTED|Overall Study||9
1127947|NCT01289119|2730616|P6|NOT COMPLETED|Overall Study||4
1127948|NCT01289119|2730617|P5|NOT COMPLETED|Overall Study||5
1127949|NCT01289119|2730618|P4|NOT COMPLETED|Overall Study||6
1127950|NCT01289119|2730619|P3|NOT COMPLETED|Overall Study||9
1127951|NCT01289119|2730620|P2|NOT COMPLETED|Overall Study||9
1127952|NCT01289119|2730621|P1|NOT COMPLETED|Overall Study||9
1127953|NCT01289119|2730616|P6|COMPLETED|Overall Study||57
1127954|NCT01289119|2730617|P5|COMPLETED|Overall Study||58
1127955|NCT01289119|2730618|P4|COMPLETED|Overall Study||93
1127956|NCT01289119|2730619|P3|COMPLETED|Overall Study||89
1127957|NCT01289119|2730620|P2|COMPLETED|Overall Study||83
1127958|NCT01289119|2730621|P1|COMPLETED|Overall Study||84
1127959|NCT01289119|2730616|P6|Treated|Overall Study||61
1127960|NCT01289119|2730617|P5|Treated|Overall Study||63
1127961|NCT01289119|2730618|P4|Treated|Overall Study||99
1127962|NCT01289119|2730619|P3|Treated|Overall Study||98
1127963|NCT01289119|2730620|P2|Treated|Overall Study||92
1127964|NCT01289119|2730621|P1|Treated|Overall Study|Patients who took at least one dose of double-blind study drug.|92
1127965|NCT01289119|2730616|P6|STARTED|Overall Study||61
1127966|NCT01289119|2730617|P5|STARTED|Overall Study||63
1127967|NCT01289119|2730618|P4|STARTED|Overall Study||99
1127968|NCT01289119|2730619|P3|STARTED|Overall Study||98
1127969|NCT01289119|2730620|P2|STARTED|Overall Study||92
1127970|NCT01289119|2730621|P1|STARTED|Overall Study||93
1127971|NCT01289210|2730701|P1|NOT COMPLETED|Overall Study||1
1127972|NCT01289210|2730701|P1|COMPLETED|Overall Study||1
1127973|NCT01289210|2730701|P1|STARTED|Overall Study||2
1127974|NCT01280656|2730708|P3|NOT COMPLETED|Overall Study||63
1127975|NCT01280656|2730709|P2|NOT COMPLETED|Overall Study||47
1127976|NCT01280656|2730710|P1|NOT COMPLETED|Overall Study||3
1127977|NCT01280656|2730708|P3|COMPLETED|Overall Study||223
1127978|NCT01280656|2730709|P2|COMPLETED|Overall Study||265
1127979|NCT01280656|2730710|P1|COMPLETED|Overall Study||59
1127980|NCT01280656|2730708|P3|STARTED|Overall Study||286
1127981|NCT01280656|2730709|P2|STARTED|Overall Study||312
1127982|NCT01280656|2730710|P1|STARTED|Overall Study||62
1127983|NCT01280695|2730759|P5|NOT COMPLETED|Overall Study||2
1127984|NCT01280695|2730760|P4|NOT COMPLETED|Overall Study||4
1127985|NCT01280695|2730761|P3|NOT COMPLETED|Overall Study||5
1127986|NCT01280695|2730762|P2|NOT COMPLETED|Overall Study||1
1127987|NCT01280695|2730763|P1|NOT COMPLETED|Overall Study||0
1127988|NCT01280695|2730759|P5|COMPLETED|Overall Study||24
1127989|NCT01280695|2730760|P4|COMPLETED|Overall Study||22
1127990|NCT01280695|2730761|P3|COMPLETED|Overall Study||21
1127991|NCT01280695|2730762|P2|COMPLETED|Overall Study||24
1127992|NCT01280695|2730763|P1|COMPLETED|Overall Study||26
1127993|NCT01280695|2730759|P5|STARTED|Overall Study||26
1127994|NCT01280695|2730760|P4|STARTED|Overall Study||26
1127995|NCT01280695|2730761|P3|STARTED|Overall Study||26
1127996|NCT01280695|2730762|P2|STARTED|Overall Study||25
1127997|NCT01280695|2730763|P1|STARTED|Overall Study||26
1127998|NCT01289392|2730803|P3|NOT COMPLETED|Overall Study||0
1127999|NCT01289392|2730804|P2|NOT COMPLETED|Overall Study||0
1128000|NCT01289392|2730805|P1|NOT COMPLETED|Overall Study||0
1128001|NCT01289392|2730803|P3|COMPLETED|Overall Study||7
1128002|NCT01289392|2730804|P2|COMPLETED|Overall Study||9
1128003|NCT01289392|2730805|P1|COMPLETED|Overall Study||9
1128004|NCT01289392|2730803|P3|STARTED|Overall Study||7
1128005|NCT01289392|2730804|P2|STARTED|Overall Study||9
1128006|NCT01289392|2730805|P1|STARTED|Overall Study||9
1128007|NCT01289418|2730816|P1|NOT COMPLETED|Day 29 Survey||2468
1128008|NCT01289418|2730816|P1|COMPLETED|Day 29 Survey||4057
1128009|NCT01289418|2730816|P1|STARTED|Day 29 Survey||6525
1128010|NCT01289418|2730816|P1|NOT COMPLETED|Day 8 Survey||2218
1128011|NCT01289418|2730816|P1|COMPLETED|Day 8 Survey||4307
1128012|NCT01289418|2730816|P1|STARTED|Day 8 Survey||6525
1128013|NCT01289522|2730822|P1|NOT COMPLETED|Overall Study||11
1128014|NCT01289522|2730822|P1|COMPLETED|Overall Study||43
1128015|NCT01289522|2730822|P1|STARTED|Overall Study||54
1128016|NCT01289548|2730831|P3|NOT COMPLETED|Overall Study||0
1128017|NCT01289548|2730832|P2|NOT COMPLETED|Overall Study||0
1128018|NCT01289548|2730833|P1|NOT COMPLETED|Overall Study||0
1128019|NCT01289548|2730831|P3|COMPLETED|Overall Study||40
1128020|NCT01289548|2730832|P2|COMPLETED|Overall Study||40
1128021|NCT01289548|2730833|P1|COMPLETED|Overall Study||40
1128022|NCT01289548|2730831|P3|Recipients|Overall Study||20
1128023|NCT01289548|2730832|P2|Recipients|Overall Study||20
1128024|NCT01289548|2730833|P1|Recipients|Overall Study||20
1128025|NCT01289548|2730831|P3|Donors|Overall Study||20
1128026|NCT01289548|2730832|P2|Donors|Overall Study||20
1128027|NCT01289548|2730833|P1|Donors|Overall Study||20
1128028|NCT01289548|2730831|P3|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
1128029|NCT01289548|2730832|P2|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
1128030|NCT01289548|2730833|P1|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
1128031|NCT01289574|2730880|P3|NOT COMPLETED|Overall Study||3
1128032|NCT01289574|2730881|P2|NOT COMPLETED|Overall Study||3
1128033|NCT01289574|2730882|P1|NOT COMPLETED|Overall Study||7
1128034|NCT01289574|2730880|P3|COMPLETED|Overall Study||60
1128035|NCT01289574|2730881|P2|COMPLETED|Overall Study||57
1128036|NCT01289574|2730882|P1|COMPLETED|Overall Study||51
1128037|NCT01289574|2730880|P3|STARTED|Overall Study||63
1128038|NCT01289574|2730881|P2|STARTED|Overall Study||60
1128039|NCT01289574|2730882|P1|STARTED|Overall Study||58
1128040|NCT01290224|2730896|P1|NOT COMPLETED|Overall Study||5
1128041|NCT01290224|2730896|P1|COMPLETED|Overall Study||5
1128042|NCT01290224|2730896|P1|STARTED|Overall Study||10
1128043|NCT01290263|2730909|P5|NOT COMPLETED|Overall Study||37
1128044|NCT01290263|2730910|P4|NOT COMPLETED|Overall Study||27
1128045|NCT01290263|2730911|P3|NOT COMPLETED|Overall Study||7
1128046|NCT01290263|2730912|P2|NOT COMPLETED|Overall Study||3
1128047|NCT01290263|2730913|P1|NOT COMPLETED|Overall Study||11
1128048|NCT01290263|2730909|P5|COMPLETED|Overall Study||0
1128049|NCT01290263|2730910|P4|COMPLETED|Overall Study||0
1128050|NCT01290263|2730911|P3|COMPLETED|Overall Study||0
1128051|NCT01290263|2730912|P2|COMPLETED|Overall Study||0
1128052|NCT01290263|2730913|P1|COMPLETED|Overall Study||0
1128053|NCT01290263|2730909|P5|STARTED|Overall Study||37
1128054|NCT01290263|2730910|P4|STARTED|Overall Study||27
1128055|NCT01290263|2730911|P3|STARTED|Overall Study||7
1128056|NCT01290263|2730912|P2|STARTED|Overall Study||3
1128057|NCT01290263|2730913|P1|STARTED|Overall Study||11
1128058|NCT01290341|2730931|P2|NOT COMPLETED|Overall Study||29
1128059|NCT01290341|2730932|P1|NOT COMPLETED|Overall Study||92
1128060|NCT01290341|2730931|P2|COMPLETED|Overall Study||258
1128061|NCT01290341|2730932|P1|COMPLETED|Overall Study||481
1128062|NCT01290341|2730931|P2|STARTED|Overall Study||287
1128063|NCT01290341|2730932|P1|STARTED|Overall Study||573
1128064|NCT01290484|2730940|P1|NOT COMPLETED|Overall Study||0
1128065|NCT01290484|2730940|P1|COMPLETED|Overall Study||7
1128066|NCT01290484|2730940|P1|STARTED|Overall Study||7
1128067|NCT01290523|2730944|P1|NOT COMPLETED|Overall Study||0
1128068|NCT01290523|2730944|P1|COMPLETED|Overall Study||14
1128069|NCT01290523|2730944|P1|STARTED|Overall Study||14
1128070|NCT01290536|2730949|P1|NOT COMPLETED|Overall Study||0
1128071|NCT01290536|2730949|P1|COMPLETED|Overall Study||42
1128072|NCT01290536|2730949|P1|STARTED|Overall Study||42
1128073|NCT01290614|2730958|P2|NOT COMPLETED|Overall Study||0
1128074|NCT01290614|2730959|P1|NOT COMPLETED|Overall Study||552
1128075|NCT01290614|2730958|P2|COMPLETED|Overall Study||1129
1128076|NCT01290614|2730959|P1|COMPLETED|Overall Study||518
1128077|NCT01290614|2730958|P2|STARTED|Overall Study||1129
1128078|NCT01290614|2730959|P1|STARTED|Overall Study||1070
1128079|NCT01290627|2730970|P3|NOT COMPLETED|Overall Study||0
1128080|NCT01290627|2730971|P2|NOT COMPLETED|Overall Study||0
1128081|NCT01290627|2730972|P1|NOT COMPLETED|Overall Study||0
1128082|NCT01290627|2730970|P3|COMPLETED|Overall Study||10
1128083|NCT01290627|2730971|P2|COMPLETED|Overall Study||10
1128084|NCT01290627|2730972|P1|COMPLETED|Overall Study||10
1128085|NCT01290627|2730970|P3|STARTED|Overall Study||10
1128086|NCT01290627|2730971|P2|STARTED|Overall Study||10
1128087|NCT01290627|2730972|P1|STARTED|Overall Study||10
1128088|NCT01290640|2730994|P2|NOT COMPLETED|Overall Study||0
1128089|NCT01290640|2730995|P1|NOT COMPLETED|Overall Study||0
1128090|NCT01290640|2730994|P2|COMPLETED|Overall Study||10
1128091|NCT01290640|2730995|P1|COMPLETED|Overall Study||12
1128092|NCT01290640|2730994|P2|STARTED|Overall Study||10
1128093|NCT01290640|2730995|P1|STARTED|Overall Study||12
1128094|NCT01290666|2731003|P1|NOT COMPLETED|Overall Study||38
1128095|NCT01290666|2731003|P1|COMPLETED|Overall Study||55
1128096|NCT01290666|2731003|P1|STARTED|Overall Study||93
1128097|NCT01290679|2731009|P2|NOT COMPLETED|Overall Study||21
1128098|NCT01290679|2731010|P1|NOT COMPLETED|Overall Study||16
1128099|NCT01290679|2731009|P2|COMPLETED|Overall Study||113
1128100|NCT01290679|2731010|P1|COMPLETED|Overall Study||241
1128101|NCT01290679|2731009|P2|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|134
1128102|NCT01290679|2731010|P1|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|257
1128103|NCT01290718|2731079|P1|NOT COMPLETED|Overall Study||4
1128104|NCT01290718|2731079|P1|COMPLETED|Overall Study||0
1128105|NCT01290718|2731079|P1|STARTED|Overall Study||4
1128106|NCT01290731|2731086|P1|NOT COMPLETED|Overall Study||1
1128107|NCT01290731|2731086|P1|COMPLETED|Overall Study||48
1128108|NCT01290731|2731086|P1|STARTED|Overall Study||49
1128109|NCT01290757|2731100|P2|NOT COMPLETED|Overall Study||2
1128110|NCT01290757|2731101|P1|NOT COMPLETED|Overall Study||2
1128111|NCT01290757|2731100|P2|COMPLETED|Overall Study||88
1128112|NCT01290757|2731101|P1|COMPLETED|Overall Study||88
1128113|NCT01290757|2731100|P2|STARTED|Overall Study||90
1128114|NCT01290757|2731101|P1|STARTED|Overall Study||90
1128115|NCT01290796|2731117|P1|NOT COMPLETED|Overall Study||30
1128116|NCT01290796|2731117|P1|COMPLETED|Overall Study||123
1128117|NCT01290796|2731117|P1|STARTED|Overall Study||153
1128118|NCT01290822|2731131|P1|NOT COMPLETED|Overall Study||11
1128119|NCT01290822|2731131|P1|COMPLETED|Overall Study||1
1128120|NCT01290822|2731131|P1|STARTED|Overall Study||12
1128121|NCT01290887|2731142|P2|NOT COMPLETED|Overall Study||536
1128122|NCT01290887|2731143|P1|NOT COMPLETED|Overall Study||466
1128123|NCT01290887|2731142|P2|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|35
1128124|NCT01290887|2731143|P1|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|15
1128125|NCT01290887|2731142|P2|Safety Analysis Set|Overall Study||571
1128126|NCT01290887|2731143|P1|Safety Analysis Set|Overall Study|One patient was enrolled but not treated.|480
1128127|NCT01290887|2731142|P2|STARTED|Overall Study||571
1128128|NCT01290887|2731143|P1|STARTED|Overall Study||481
1128129|NCT01290913|2731181|P1|NOT COMPLETED|Overall Study||1
1128130|NCT01290913|2731181|P1|COMPLETED|Overall Study||12
1128131|NCT01290913|2731181|P1|STARTED|Overall Study||13
1128132|NCT01290952|2731188|P2|NOT COMPLETED|Overall Study||14
1128133|NCT01290952|2731189|P1|NOT COMPLETED|Overall Study||12
1128134|NCT01290952|2731188|P2|COMPLETED|Overall Study||193
1128135|NCT01290952|2731189|P1|COMPLETED|Overall Study||192
1128136|NCT01290952|2731188|P2|STARTED|Overall Study||207
1128137|NCT01290952|2731189|P1|STARTED|Overall Study||204
1128138|NCT01290978|2731197|P1|NOT COMPLETED|Overall Study||0
1128139|NCT01290978|2731197|P1|COMPLETED|Overall Study||22
1128140|NCT01290978|2731197|P1|STARTED|Overall Study||22
1128141|NCT01291017|2731204|P1|NOT COMPLETED|Overall Study||5
1128142|NCT01291017|2731204|P1|COMPLETED|Overall Study||14
1128143|NCT01291017|2731204|P1|STARTED|Overall Study||19
1128144|NCT01291056|2731214|P2|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
1128145|NCT01291056|2731215|P1|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
1128146|NCT01291056|2731214|P2|COMPLETED|Intervention Two (Menstration Days 3-7)||10
1128147|NCT01291056|2731215|P1|COMPLETED|Intervention Two (Menstration Days 3-7)||10
1128148|NCT01291056|2731214|P2|STARTED|Intervention Two (Menstration Days 3-7)||10
1128149|NCT01291056|2731215|P1|STARTED|Intervention Two (Menstration Days 3-7)||10
1128150|NCT01291056|2731214|P2|NOT COMPLETED|Washout||0
1128151|NCT01291056|2731215|P1|NOT COMPLETED|Washout||0
1128152|NCT01291056|2731214|P2|COMPLETED|Washout||10
1128153|NCT01291056|2731215|P1|COMPLETED|Washout||10
1128154|NCT01291056|2731214|P2|STARTED|Washout||10
1128155|NCT01291056|2731215|P1|STARTED|Washout||10
1128156|NCT01291056|2731214|P2|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
1128157|NCT01291056|2731215|P1|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
1128158|NCT01291056|2731214|P2|COMPLETED|Intervention One (Menstraution Day 3-7)||10
1128159|NCT01291056|2731215|P1|COMPLETED|Intervention One (Menstraution Day 3-7)||10
1128160|NCT01291056|2731214|P2|STARTED|Intervention One (Menstraution Day 3-7)||10
1128161|NCT01291056|2731215|P1|STARTED|Intervention One (Menstraution Day 3-7)||10
1128162|NCT01291108|2731231|P6|NOT COMPLETED|Month 2 (Adjunctive Therapy)||1
1128163|NCT01291108|2731232|P5|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
1128164|NCT01291108|2731233|P4|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
1128165|NCT01291108|2731234|P3|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
1128166|NCT01291108|2731235|P2|NOT COMPLETED|Month 2 (Adjunctive Therapy)||2
1128167|NCT01291108|2731236|P1|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
1128168|NCT01291108|2731231|P6|COMPLETED|Month 2 (Adjunctive Therapy)||25
1128169|NCT01291108|2731232|P5|COMPLETED|Month 2 (Adjunctive Therapy)||34
1128170|NCT01291108|2731233|P4|COMPLETED|Month 2 (Adjunctive Therapy)||0
1128171|NCT01291108|2731234|P3|COMPLETED|Month 2 (Adjunctive Therapy)||24
1128172|NCT01291108|2731235|P2|COMPLETED|Month 2 (Adjunctive Therapy)||38
1128173|NCT01291108|2731236|P1|COMPLETED|Month 2 (Adjunctive Therapy)||0
1128174|NCT01291108|2731231|P6|STARTED|Month 2 (Adjunctive Therapy)||26
1128175|NCT01291108|2731232|P5|STARTED|Month 2 (Adjunctive Therapy)||34
1128176|NCT01291108|2731233|P4|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
1128177|NCT01291108|2731234|P3|STARTED|Month 2 (Adjunctive Therapy)||24
1128178|NCT01291108|2731235|P2|STARTED|Month 2 (Adjunctive Therapy)||40
1128179|NCT01291108|2731236|P1|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
1128180|NCT01291108|2731231|P6|NOT COMPLETED|Month 1 (Monotherapy)||0
1128181|NCT01291108|2731232|P5|NOT COMPLETED|Month 1 (Monotherapy)||0
1128182|NCT01291108|2731233|P4|NOT COMPLETED|Month 1 (Monotherapy)||0
1128183|NCT01291108|2731234|P3|NOT COMPLETED|Month 1 (Monotherapy)||0
1128184|NCT01291108|2731235|P2|NOT COMPLETED|Month 1 (Monotherapy)||0
1128185|NCT01291108|2731236|P1|NOT COMPLETED|Month 1 (Monotherapy)||1
1128186|NCT01291108|2731231|P6|COMPLETED|Month 1 (Monotherapy)||0
1128187|NCT01291108|2731232|P5|COMPLETED|Month 1 (Monotherapy)||0
1128188|NCT01291108|2731233|P4|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|60
1128189|NCT01291108|2731234|P3|COMPLETED|Month 1 (Monotherapy)||0
1128190|NCT01291108|2731235|P2|COMPLETED|Month 1 (Monotherapy)||0
1128191|NCT01291108|2731236|P1|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|64
1128192|NCT01291108|2731231|P6|STARTED|Month 1 (Monotherapy)||0
1128193|NCT01291108|2731232|P5|STARTED|Month 1 (Monotherapy)||0
1128194|NCT01291108|2731233|P4|STARTED|Month 1 (Monotherapy)||60
1128195|NCT01291108|2731234|P3|STARTED|Month 1 (Monotherapy)||0
1128196|NCT01291108|2731235|P2|STARTED|Month 1 (Monotherapy)||0
1128197|NCT01291108|2731236|P1|STARTED|Month 1 (Monotherapy)||65
1128198|NCT01291160|2731252|P2|NOT COMPLETED|Overall Study||16
1128199|NCT01291160|2731253|P1|NOT COMPLETED|Overall Study||18
1128200|NCT01291160|2731252|P2|COMPLETED|Overall Study||48
1128201|NCT01291160|2731253|P1|COMPLETED|Overall Study||48
1128202|NCT01291160|2731252|P2|STARTED|Overall Study||64
1128203|NCT01291160|2731253|P1|STARTED|Overall Study||66
1128204|NCT01291173|2731263|P4|NOT COMPLETED|Overall Study||13
1128205|NCT01291173|2731264|P3|NOT COMPLETED|Overall Study||13
1128206|NCT01291173|2731265|P2|NOT COMPLETED|Overall Study||15
1128207|NCT01291173|2731266|P1|NOT COMPLETED|Overall Study||17
1128208|NCT01291173|2731263|P4|COMPLETED|Overall Study||52
1128209|NCT01291173|2731264|P3|COMPLETED|Overall Study||52
1128210|NCT01291173|2731265|P2|COMPLETED|Overall Study||51
1128211|NCT01291173|2731266|P1|COMPLETED|Overall Study||47
1128212|NCT01291173|2731263|P4|STARTED|Overall Study||65
1128213|NCT01291173|2731264|P3|STARTED|Overall Study||65
1128214|NCT01291173|2731265|P2|STARTED|Overall Study||66
1128215|NCT01291173|2731266|P1|STARTED|Overall Study||64
1128216|NCT01291225|2731330|P2|NOT COMPLETED|Overall Study||39
1128217|NCT01291225|2731331|P1|NOT COMPLETED|Overall Study||85
1128218|NCT01291225|2731330|P2|COMPLETED|Overall Study||121
1128219|NCT01291225|2731331|P1|COMPLETED|Overall Study||66
1128220|NCT01291225|2731330|P2|STARTED|Overall Study||160
1128221|NCT01291225|2731331|P1|STARTED|Overall Study||151
1128222|NCT01291264|2731341|P1|NOT COMPLETED|Overall Study||0
1128223|NCT01291264|2731341|P1|COMPLETED|Overall Study||260
1128224|NCT01291264|2731341|P1|STARTED|Overall Study||260
1128225|NCT01291277|2731347|P2|NOT COMPLETED|Overall Study||3
1128226|NCT01291277|2731348|P1|NOT COMPLETED|Overall Study||5
1128227|NCT01291277|2731347|P2|COMPLETED|Overall Study||42
1128228|NCT01291277|2731348|P1|COMPLETED|Overall Study||40
1128229|NCT01291277|2731347|P2|STARTED|Overall Study||45
1128230|NCT01291277|2731348|P1|STARTED|Overall Study||45
1128231|NCT01291498|2731354|P1|NOT COMPLETED|Overall Study||1
1128232|NCT01291498|2731354|P1|COMPLETED|Overall Study||0
1128233|NCT01291498|2731354|P1|STARTED|Overall Study||1
1128234|NCT01291784|2731360|P3|NOT COMPLETED|Overall Study||0
1128235|NCT01291784|2731361|P2|NOT COMPLETED|Overall Study||1
1128236|NCT01291784|2731362|P1|NOT COMPLETED|Overall Study||0
1128237|NCT01291784|2731360|P3|COMPLETED|Overall Study||1
1128238|NCT01291784|2731361|P2|COMPLETED|Overall Study||0
1128239|NCT01291784|2731362|P1|COMPLETED|Overall Study||1
1128240|NCT01291784|2731360|P3|STARTED|Overall Study||1
1128241|NCT01291784|2731361|P2|STARTED|Overall Study||1
1128242|NCT01291784|2731362|P1|STARTED|Overall Study||1
1128243|NCT01292005|2731384|P2|NOT COMPLETED|Overall Study||0
1128244|NCT01292005|2731385|P1|NOT COMPLETED|Overall Study||0
1128245|NCT01292005|2731384|P2|COMPLETED|Overall Study||14
1128246|NCT01292005|2731385|P1|COMPLETED|Overall Study||14
1128247|NCT01292005|2731384|P2|STARTED|Overall Study||14
1128248|NCT01292005|2731385|P1|STARTED|Overall Study||14
1128249|NCT01292057|2731411|P2|NOT COMPLETED|Overall Study||2
1128250|NCT01292057|2731412|P1|NOT COMPLETED|Overall Study||2
1128251|NCT01292057|2731411|P2|COMPLETED|Overall Study||48
1128252|NCT01292057|2731412|P1|COMPLETED|Overall Study||47
1128253|NCT01292057|2731411|P2|STARTED|Overall Study||50
1128254|NCT01292057|2731412|P1|STARTED|Overall Study||49
1128255|NCT01292070|2731420|P1|NOT COMPLETED|Overall Study||0
1128256|NCT01292070|2731420|P1|COMPLETED|Overall Study||4
1128257|NCT01292070|2731420|P1|STARTED|Overall Study||4
1128258|NCT01292135|2731426|P2|NOT COMPLETED|Overall Study||9
1128259|NCT01292135|2731427|P1|NOT COMPLETED|Overall Study||0
1128260|NCT01292135|2731426|P2|COMPLETED|Overall Study||21
1128261|NCT01292135|2731427|P1|COMPLETED|Overall Study||3
1128262|NCT01292135|2731426|P2|STARTED|Overall Study||30
1128263|NCT01292135|2731427|P1|STARTED|Overall Study||3
1128264|NCT01292187|2731447|P2|NOT COMPLETED|Overall Study||13
1128265|NCT01292187|2731448|P1|NOT COMPLETED|Overall Study||17
1128266|NCT01292187|2731447|P2|COMPLETED|Overall Study||30
1128267|NCT01292187|2731448|P1|COMPLETED|Overall Study||69
1128268|NCT01292187|2731447|P2|STARTED|Overall Study||43
1128269|NCT01292187|2731448|P1|STARTED|Overall Study||86
1128270|NCT01292226|2731456|P1|NOT COMPLETED|Overall Study||13
1128271|NCT01292226|2731456|P1|COMPLETED|Overall Study||32
1128272|NCT01292226|2731456|P1|STARTED|Overall Study||45
1128273|NCT01292239|2731489|P2|NOT COMPLETED|Overall Study||7
1128274|NCT01292239|2731490|P1|NOT COMPLETED|Overall Study||4
1128275|NCT01292239|2731489|P2|COMPLETED|Overall Study||53
1128276|NCT01292239|2731490|P1|COMPLETED|Overall Study||119
1128277|NCT01292239|2731489|P2|STARTED|Overall Study||60
1128278|NCT01292239|2731490|P1|STARTED|Overall Study||123
1128279|NCT01292265|2731511|P1|NOT COMPLETED|Overall Study||0
1128280|NCT01292265|2731511|P1|COMPLETED|Overall Study||3
1128281|NCT01292265|2731511|P1|STARTED|Overall Study||3
1128282|NCT01292304|2731518|P1|NOT COMPLETED|Overall Study||0
1128283|NCT01292304|2731518|P1|COMPLETED|Overall Study||10
1128284|NCT01292304|2731518|P1|STARTED|Overall Study||10
1128285|NCT01292473|2731530|P4|NOT COMPLETED|Overall Study||12
1128286|NCT01292473|2731531|P3|NOT COMPLETED|Overall Study||9
1128287|NCT01292473|2731532|P2|NOT COMPLETED|Overall Study||7
1128288|NCT01292473|2731533|P1|NOT COMPLETED|Overall Study||5
1128289|NCT01292473|2731530|P4|COMPLETED|Overall Study||67
1128290|NCT01292473|2731531|P3|COMPLETED|Overall Study||74
1128291|NCT01292473|2731532|P2|COMPLETED|Overall Study||75
1128292|NCT01292473|2731533|P1|COMPLETED|Overall Study||74
1128293|NCT01292473|2731530|P4|STARTED|Overall Study||79
1128294|NCT01292473|2731531|P3|STARTED|Overall Study||83
1128295|NCT01292473|2731532|P2|STARTED|Overall Study||82
1128296|NCT01292473|2731533|P1|STARTED|Overall Study||79
1128297|NCT01292486|2731575|P1|NOT COMPLETED|Overall Study||6
1128298|NCT01292486|2731575|P1|COMPLETED|Overall Study||26
1128299|NCT01292486|2731575|P1|STARTED|Overall Study||32
1128300|NCT01292538|2731587|P2|NOT COMPLETED|Overall Study||0
1128301|NCT01292538|2731588|P1|NOT COMPLETED|Overall Study||0
1128302|NCT01292538|2731587|P2|COMPLETED|Overall Study||32
1128303|NCT01292538|2731588|P1|COMPLETED|Overall Study||35
1128304|NCT01292538|2731587|P2|STARTED|Overall Study||32
1128305|NCT01292538|2731588|P1|STARTED|Overall Study||35
1128306|NCT01292603|2731599|P6|NOT COMPLETED|Part 2: Survival Follow-UP||13
1128307|NCT01292603|2731600|P5|NOT COMPLETED|Part 2: Survival Follow-UP||11
1128308|NCT01292603|2731601|P4|NOT COMPLETED|Part 2: Survival Follow-UP||0
1128309|NCT01292603|2731602|P3|NOT COMPLETED|Part 2: Survival Follow-UP||0
1128310|NCT01292603|2731603|P2|NOT COMPLETED|Part 2: Survival Follow-UP||0
1128311|NCT01292603|2731604|P1|NOT COMPLETED|Part 2: Survival Follow-UP||0
1128312|NCT01292603|2731599|P6|COMPLETED|Part 2: Survival Follow-UP||0
1128313|NCT01292603|2731600|P5|COMPLETED|Part 2: Survival Follow-UP||0
1128314|NCT01292603|2731601|P4|COMPLETED|Part 2: Survival Follow-UP||0
1128315|NCT01292603|2731602|P3|COMPLETED|Part 2: Survival Follow-UP||0
1128316|NCT01292603|2731603|P2|COMPLETED|Part 2: Survival Follow-UP||0
1128317|NCT01292603|2731604|P1|COMPLETED|Part 2: Survival Follow-UP||0
1128318|NCT01292603|2731599|P6|STARTED|Part 2: Survival Follow-UP||13
1128319|NCT01292603|2731600|P5|STARTED|Part 2: Survival Follow-UP||11
1128320|NCT01292603|2731601|P4|STARTED|Part 2: Survival Follow-UP||0
1128321|NCT01292603|2731602|P3|STARTED|Part 2: Survival Follow-UP||0
1128322|NCT01292603|2731603|P2|STARTED|Part 2: Survival Follow-UP||0
1128323|NCT01292603|2731604|P1|STARTED|Part 2: Survival Follow-UP||0
1128324|NCT01292603|2731599|P6|NOT COMPLETED|Part 2: Regular Follow-Up||78
1128325|NCT01292603|2731600|P5|NOT COMPLETED|Part 2: Regular Follow-Up||78
1128326|NCT01292603|2731601|P4|NOT COMPLETED|Part 2: Regular Follow-Up||0
1128327|NCT01292603|2731602|P3|NOT COMPLETED|Part 2: Regular Follow-Up||0
1128328|NCT01292603|2731603|P2|NOT COMPLETED|Part 2: Regular Follow-Up||0
1128329|NCT01292603|2731604|P1|NOT COMPLETED|Part 2: Regular Follow-Up||0
1128330|NCT01292603|2731599|P6|COMPLETED|Part 2: Regular Follow-Up||0
1128331|NCT01292603|2731600|P5|COMPLETED|Part 2: Regular Follow-Up||0
1128332|NCT01292603|2731601|P4|COMPLETED|Part 2: Regular Follow-Up||0
1128333|NCT01292603|2731602|P3|COMPLETED|Part 2: Regular Follow-Up||0
1128334|NCT01292603|2731603|P2|COMPLETED|Part 2: Regular Follow-Up||0
1128335|NCT01292603|2731604|P1|COMPLETED|Part 2: Regular Follow-Up||0
1128336|NCT01292603|2731599|P6|STARTED|Part 2: Regular Follow-Up||78
1128337|NCT01292603|2731600|P5|STARTED|Part 2: Regular Follow-Up||78
1128338|NCT01292603|2731601|P4|STARTED|Part 2: Regular Follow-Up||0
1128339|NCT01292603|2731602|P3|STARTED|Part 2: Regular Follow-Up||0
1128340|NCT01292603|2731603|P2|STARTED|Part 2: Regular Follow-Up||0
1128341|NCT01292603|2731604|P1|STARTED|Part 2: Regular Follow-Up||0
1128342|NCT01292603|2731599|P6|NOT COMPLETED|Part 2: Dose Confirmation Period||15
1128343|NCT01292603|2731600|P5|NOT COMPLETED|Part 2: Dose Confirmation Period||16
1128344|NCT01292603|2731601|P4|NOT COMPLETED|Part 2: Dose Confirmation Period||0
1128345|NCT01292603|2731602|P3|NOT COMPLETED|Part 2: Dose Confirmation Period||0
1128346|NCT01292603|2731603|P2|NOT COMPLETED|Part 2: Dose Confirmation Period||0
1128347|NCT01292603|2731604|P1|NOT COMPLETED|Part 2: Dose Confirmation Period||0
1128348|NCT01292603|2731599|P6|COMPLETED|Part 2: Dose Confirmation Period||73
1128349|NCT01292603|2731600|P5|COMPLETED|Part 2: Dose Confirmation Period||72
1128350|NCT01292603|2731601|P4|COMPLETED|Part 2: Dose Confirmation Period||0
1128351|NCT01292603|2731602|P3|COMPLETED|Part 2: Dose Confirmation Period||0
1128352|NCT01292603|2731603|P2|COMPLETED|Part 2: Dose Confirmation Period||0
1128353|NCT01292603|2731604|P1|COMPLETED|Part 2: Dose Confirmation Period||0
1128354|NCT01292603|2731599|P6|STARTED|Part 2: Dose Confirmation Period||88
1128355|NCT01292603|2731600|P5|STARTED|Part 2: Dose Confirmation Period||88
1128356|NCT01292603|2731601|P4|STARTED|Part 2: Dose Confirmation Period||0
1128357|NCT01292603|2731602|P3|STARTED|Part 2: Dose Confirmation Period||0
1128358|NCT01292603|2731603|P2|STARTED|Part 2: Dose Confirmation Period||0
1128359|NCT01292603|2731604|P1|STARTED|Part 2: Dose Confirmation Period||0
1128360|NCT01292603|2731599|P6|NOT COMPLETED|Part 1: Survival Follow-Up||0
1128361|NCT01292603|2731600|P5|NOT COMPLETED|Part 1: Survival Follow-Up||0
1128362|NCT01292603|2731601|P4|NOT COMPLETED|Part 1: Survival Follow-Up||0
1128363|NCT01292603|2731602|P3|NOT COMPLETED|Part 1: Survival Follow-Up||2
1128364|NCT01292603|2731603|P2|NOT COMPLETED|Part 1: Survival Follow-Up||2
1128365|NCT01292603|2731604|P1|NOT COMPLETED|Part 1: Survival Follow-Up||4
1128366|NCT01292603|2731599|P6|COMPLETED|Part 1: Survival Follow-Up||0
1128367|NCT01292603|2731600|P5|COMPLETED|Part 1: Survival Follow-Up||0
1128368|NCT01292603|2731601|P4|COMPLETED|Part 1: Survival Follow-Up||0
1128369|NCT01292603|2731602|P3|COMPLETED|Part 1: Survival Follow-Up||0
1128370|NCT01292603|2731603|P2|COMPLETED|Part 1: Survival Follow-Up||0
1128371|NCT01292603|2731604|P1|COMPLETED|Part 1: Survival Follow-Up||0
1128372|NCT01292603|2731599|P6|STARTED|Part 1: Survival Follow-Up||0
1128373|NCT01292603|2731600|P5|STARTED|Part 1: Survival Follow-Up||0
1128374|NCT01292603|2731601|P4|STARTED|Part 1: Survival Follow-Up||0
1128375|NCT01292603|2731602|P3|STARTED|Part 1: Survival Follow-Up||2
1128376|NCT01292603|2731603|P2|STARTED|Part 1: Survival Follow-Up||2
1128377|NCT01292603|2731604|P1|STARTED|Part 1: Survival Follow-Up||4
1128378|NCT01292603|2731599|P6|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
1128379|NCT01292603|2731600|P5|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
1128380|NCT01292603|2731601|P4|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
1128381|NCT01292603|2731602|P3|NOT COMPLETED|Part 1: Regular Follow-Up Period||23
1128382|NCT01292603|2731603|P2|NOT COMPLETED|Part 1: Regular Follow-Up Period||17
1128383|NCT01292603|2731604|P1|NOT COMPLETED|Part 1: Regular Follow-Up Period||16
1128384|NCT01292603|2731599|P6|COMPLETED|Part 1: Regular Follow-Up Period||0
1128385|NCT01292603|2731600|P5|COMPLETED|Part 1: Regular Follow-Up Period||0
1128386|NCT01292603|2731601|P4|COMPLETED|Part 1: Regular Follow-Up Period||0
1128468|NCT01284621|2731705|P6|COMPLETED|Washout Period 2 (7 Days)||4
1128387|NCT01292603|2731602|P3|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|0
1128388|NCT01292603|2731603|P2|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|0
1128389|NCT01292603|2731604|P1|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|0
1128390|NCT01292603|2731599|P6|STARTED|Part 1: Regular Follow-Up Period||0
1128391|NCT01292603|2731600|P5|STARTED|Part 1: Regular Follow-Up Period||0
1128392|NCT01292603|2731601|P4|STARTED|Part 1: Regular Follow-Up Period||0
1128393|NCT01292603|2731602|P3|STARTED|Part 1: Regular Follow-Up Period||23
1128394|NCT01292603|2731603|P2|STARTED|Part 1: Regular Follow-Up Period||17
1128395|NCT01292603|2731604|P1|STARTED|Part 1: Regular Follow-Up Period||16
1128396|NCT01292603|2731599|P6|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
1128397|NCT01292603|2731600|P5|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
1128398|NCT01292603|2731601|P4|NOT COMPLETED|Part 1: Pilot Dose Selection Period||8
1128399|NCT01292603|2731602|P3|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
1128400|NCT01292603|2731603|P2|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
1128401|NCT01292603|2731604|P1|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
1128402|NCT01292603|2731599|P6|COMPLETED|Part 1: Pilot Dose Selection Period||0
1128403|NCT01292603|2731600|P5|COMPLETED|Part 1: Pilot Dose Selection Period||0
1128404|NCT01292603|2731601|P4|COMPLETED|Part 1: Pilot Dose Selection Period||0
1128405|NCT01292603|2731602|P3|COMPLETED|Part 1: Pilot Dose Selection Period||23
1128406|NCT01292603|2731603|P2|COMPLETED|Part 1: Pilot Dose Selection Period||17
1128407|NCT01292603|2731604|P1|COMPLETED|Part 1: Pilot Dose Selection Period||16
1128408|NCT01292603|2731599|P6|STARTED|Part 1: Pilot Dose Selection Period||0
1128409|NCT01292603|2731600|P5|STARTED|Part 1: Pilot Dose Selection Period||0
1128410|NCT01292603|2731601|P4|STARTED|Part 1: Pilot Dose Selection Period|These participants were withdrawn prior to SC treatment.|8
1128411|NCT01292603|2731602|P3|STARTED|Part 1: Pilot Dose Selection Period|1 participant received a dose of 1000mg of rituximab by oversight.|23
1128412|NCT01292603|2731603|P2|STARTED|Part 1: Pilot Dose Selection Period||17
1128413|NCT01292603|2731604|P1|STARTED|Part 1: Pilot Dose Selection Period||16
1128414|NCT01292629|2731648|P1|NOT COMPLETED|Overall Study||0
1128415|NCT01292629|2731648|P1|COMPLETED|Overall Study||125
1128416|NCT01292629|2731648|P1|STARTED|Overall Study||125
1128417|NCT01292642|2731653|P1|NOT COMPLETED|Overall Study||5
1128418|NCT01292642|2731653|P1|COMPLETED|Overall Study||7
1128419|NCT01292642|2731653|P1|STARTED|Overall Study||12
1128420|NCT01284296|2731661|P1|NOT COMPLETED|Overall Study||0
1128421|NCT01284296|2731661|P1|COMPLETED|Overall Study||20
1128422|NCT01284296|2731661|P1|STARTED|Overall Study||20
1128423|NCT01284361|2731666|P1|NOT COMPLETED|Overall Study||9
1128424|NCT01284361|2731666|P1|COMPLETED|Overall Study||82
1128425|NCT01284361|2731666|P1|STARTED|Overall Study||91
1128426|NCT01284426|2731673|P1|NOT COMPLETED|Overall Study||2
1128427|NCT01284426|2731673|P1|COMPLETED|Overall Study||92
1128428|NCT01284426|2731673|P1|STARTED|Overall Study||94
1128429|NCT01284491|2731677|P1|NOT COMPLETED|Overall Study||13
1128430|NCT01284491|2731677|P1|COMPLETED|Overall Study||0
1128431|NCT01284491|2731677|P1|STARTED|Overall Study||13
1128438|NCT01284517|2731694|P2|NOT COMPLETED|Overall Study||36
1128439|NCT01284517|2731695|P1|NOT COMPLETED|Overall Study||32
1128440|NCT01284517|2731694|P2|COMPLETED|Overall Study||140
1128441|NCT01284517|2731695|P1|COMPLETED|Overall Study||148
1128442|NCT01284517|2731694|P2|STARTED|Overall Study||176
1128443|NCT01284517|2731695|P1|STARTED|Overall Study||180
1128444|NCT01284621|2731705|P6|NOT COMPLETED|Third Intervention (8 Days)||0
1128445|NCT01284621|2731706|P5|NOT COMPLETED|Third Intervention (8 Days)||0
1128446|NCT01284621|2731707|P4|NOT COMPLETED|Third Intervention (8 Days)||0
1128447|NCT01284621|2731708|P3|NOT COMPLETED|Third Intervention (8 Days)||0
1128448|NCT01284621|2731709|P2|NOT COMPLETED|Third Intervention (8 Days)||0
1128449|NCT01284621|2731710|P1|NOT COMPLETED|Third Intervention (8 Days)||0
1128450|NCT01284621|2731705|P6|COMPLETED|Third Intervention (8 Days)||4
1128451|NCT01284621|2731706|P5|COMPLETED|Third Intervention (8 Days)||3
1128452|NCT01284621|2731707|P4|COMPLETED|Third Intervention (8 Days)||4
1128453|NCT01284621|2731708|P3|COMPLETED|Third Intervention (8 Days)||4
1128454|NCT01284621|2731709|P2|COMPLETED|Third Intervention (8 Days)||4
1128455|NCT01284621|2731710|P1|COMPLETED|Third Intervention (8 Days)||3
1128456|NCT01284621|2731705|P6|STARTED|Third Intervention (8 Days)||4
1128457|NCT01284621|2731706|P5|STARTED|Third Intervention (8 Days)||3
1128458|NCT01284621|2731707|P4|STARTED|Third Intervention (8 Days)||4
1128459|NCT01284621|2731708|P3|STARTED|Third Intervention (8 Days)||4
1128460|NCT01284621|2731709|P2|STARTED|Third Intervention (8 Days)||4
1128461|NCT01284621|2731710|P1|STARTED|Third Intervention (8 Days)||3
1128462|NCT01284621|2731705|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
1128463|NCT01284621|2731706|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
1128464|NCT01284621|2731707|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
1128465|NCT01284621|2731708|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
1128466|NCT01284621|2731709|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
1128467|NCT01284621|2731710|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
1128469|NCT01284621|2731706|P5|COMPLETED|Washout Period 2 (7 Days)||3
1128470|NCT01284621|2731707|P4|COMPLETED|Washout Period 2 (7 Days)||4
1128471|NCT01284621|2731708|P3|COMPLETED|Washout Period 2 (7 Days)||4
1128472|NCT01284621|2731709|P2|COMPLETED|Washout Period 2 (7 Days)||4
1128473|NCT01284621|2731710|P1|COMPLETED|Washout Period 2 (7 Days)||3
1128474|NCT01284621|2731705|P6|STARTED|Washout Period 2 (7 Days)||4
1128475|NCT01284621|2731706|P5|STARTED|Washout Period 2 (7 Days)||3
1128476|NCT01284621|2731707|P4|STARTED|Washout Period 2 (7 Days)||4
1128477|NCT01284621|2731708|P3|STARTED|Washout Period 2 (7 Days)||4
1128478|NCT01284621|2731709|P2|STARTED|Washout Period 2 (7 Days)||4
1128479|NCT01284621|2731710|P1|STARTED|Washout Period 2 (7 Days)||3
1128480|NCT01284621|2731705|P6|NOT COMPLETED|Second Intervention (8 Days)||0
1128481|NCT01284621|2731706|P5|NOT COMPLETED|Second Intervention (8 Days)||0
1128482|NCT01284621|2731707|P4|NOT COMPLETED|Second Intervention (8 Days)||0
1128483|NCT01284621|2731708|P3|NOT COMPLETED|Second Intervention (8 Days)||0
1128484|NCT01284621|2731709|P2|NOT COMPLETED|Second Intervention (8 Days)||0
1128485|NCT01284621|2731710|P1|NOT COMPLETED|Second Intervention (8 Days)||0
1128486|NCT01284621|2731705|P6|COMPLETED|Second Intervention (8 Days)||4
1128487|NCT01284621|2731706|P5|COMPLETED|Second Intervention (8 Days)||3
1128488|NCT01284621|2731707|P4|COMPLETED|Second Intervention (8 Days)||4
1128489|NCT01284621|2731708|P3|COMPLETED|Second Intervention (8 Days)||4
1128490|NCT01284621|2731709|P2|COMPLETED|Second Intervention (8 Days)||4
1128491|NCT01284621|2731710|P1|COMPLETED|Second Intervention (8 Days)||3
1128492|NCT01284621|2731705|P6|STARTED|Second Intervention (8 Days)||4
1128493|NCT01284621|2731706|P5|STARTED|Second Intervention (8 Days)||3
1128494|NCT01284621|2731707|P4|STARTED|Second Intervention (8 Days)||4
1128495|NCT01284621|2731708|P3|STARTED|Second Intervention (8 Days)||4
1128496|NCT01284621|2731709|P2|STARTED|Second Intervention (8 Days)||4
1128497|NCT01284621|2731710|P1|STARTED|Second Intervention (8 Days)||3
1128498|NCT01284621|2731705|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
1128499|NCT01284621|2731706|P5|NOT COMPLETED|Washout Period 1 (7 Days)||1
1128500|NCT01284621|2731707|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
1128501|NCT01284621|2731708|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
1128502|NCT01284621|2731709|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
1128503|NCT01284621|2731710|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
1128504|NCT01284621|2731705|P6|COMPLETED|Washout Period 1 (7 Days)||4
1128505|NCT01284621|2731706|P5|COMPLETED|Washout Period 1 (7 Days)||3
1128506|NCT01284621|2731707|P4|COMPLETED|Washout Period 1 (7 Days)||4
1128507|NCT01284621|2731708|P3|COMPLETED|Washout Period 1 (7 Days)||4
1128508|NCT01284621|2731709|P2|COMPLETED|Washout Period 1 (7 Days)||4
1128509|NCT01284621|2731710|P1|COMPLETED|Washout Period 1 (7 Days)||3
1128510|NCT01284621|2731705|P6|STARTED|Washout Period 1 (7 Days)||4
1128511|NCT01284621|2731706|P5|STARTED|Washout Period 1 (7 Days)||4
1128512|NCT01284621|2731707|P4|STARTED|Washout Period 1 (7 Days)||4
1128513|NCT01284621|2731708|P3|STARTED|Washout Period 1 (7 Days)||4
1128514|NCT01284621|2731709|P2|STARTED|Washout Period 1 (7 Days)||4
1128515|NCT01284621|2731710|P1|STARTED|Washout Period 1 (7 Days)||3
1128516|NCT01284621|2731705|P6|NOT COMPLETED|First Intervention (8 Days)||0
1128517|NCT01284621|2731706|P5|NOT COMPLETED|First Intervention (8 Days)||0
1128518|NCT01284621|2731707|P4|NOT COMPLETED|First Intervention (8 Days)||0
1128519|NCT01284621|2731708|P3|NOT COMPLETED|First Intervention (8 Days)||0
1128520|NCT01284621|2731709|P2|NOT COMPLETED|First Intervention (8 Days)||0
1128521|NCT01284621|2731710|P1|NOT COMPLETED|First Intervention (8 Days)||0
1128522|NCT01284621|2731705|P6|COMPLETED|First Intervention (8 Days)||4
1128523|NCT01284621|2731706|P5|COMPLETED|First Intervention (8 Days)||4
1128524|NCT01284621|2731707|P4|COMPLETED|First Intervention (8 Days)||4
1128525|NCT01284621|2731708|P3|COMPLETED|First Intervention (8 Days)||4
1128526|NCT01284621|2731709|P2|COMPLETED|First Intervention (8 Days)||4
1128527|NCT01284621|2731710|P1|COMPLETED|First Intervention (8 Days)||3
1128528|NCT01284621|2731705|P6|STARTED|First Intervention (8 Days)||4
1128529|NCT01284621|2731706|P5|STARTED|First Intervention (8 Days)||4
1128530|NCT01284621|2731707|P4|STARTED|First Intervention (8 Days)||4
1128531|NCT01284621|2731708|P3|STARTED|First Intervention (8 Days)||4
1128532|NCT01284621|2731709|P2|STARTED|First Intervention (8 Days)||4
1128533|NCT01284621|2731710|P1|STARTED|First Intervention (8 Days)||3
1128534|NCT01284634|2731756|P4|NOT COMPLETED|Overall Study||1
1128535|NCT01284634|2731757|P3|NOT COMPLETED|Overall Study||2
1128536|NCT01284634|2731758|P2|NOT COMPLETED|Overall Study||0
1128537|NCT01284634|2731759|P1|NOT COMPLETED|Overall Study||1
1128538|NCT01284634|2731756|P4|COMPLETED|Overall Study||4
1128539|NCT01284634|2731757|P3|COMPLETED|Overall Study||5
1128540|NCT01284634|2731758|P2|COMPLETED|Overall Study||6
1128541|NCT01284634|2731759|P1|COMPLETED|Overall Study||6
1128542|NCT01284634|2731756|P4|STARTED|Overall Study||5
1128543|NCT01284634|2731757|P3|STARTED|Overall Study||7
1128544|NCT01284634|2731758|P2|STARTED|Overall Study||6
1128545|NCT01284634|2731759|P1|STARTED|Overall Study||7
1128546|NCT01284959|2731904|P3|NOT COMPLETED|Overall Study||1
1128547|NCT01284959|2731905|P2|NOT COMPLETED|Overall Study||0
1128548|NCT01284959|2731906|P1|NOT COMPLETED|Overall Study||1
1128549|NCT01284959|2731904|P3|COMPLETED|Overall Study||10
1128550|NCT01284959|2731905|P2|COMPLETED|Overall Study||12
1128551|NCT01284959|2731906|P1|COMPLETED|Overall Study||10
1128552|NCT01284959|2731904|P3|STARTED|Overall Study||11
1128553|NCT01284959|2731905|P2|STARTED|Overall Study||12
1128554|NCT01284959|2731906|P1|STARTED|Overall Study||11
1128555|NCT01285024|2731934|P2|NOT COMPLETED|Overall Study||0
1128556|NCT01285024|2731935|P1|NOT COMPLETED|Overall Study||0
1128557|NCT01285024|2731934|P2|COMPLETED|Overall Study||60
1128558|NCT01285024|2731935|P1|COMPLETED|Overall Study||49
1128559|NCT01285024|2731934|P2|STARTED|Overall Study||60
1128560|NCT01285024|2731935|P1|STARTED|Overall Study||49
1128561|NCT01285050|2731943|P1|NOT COMPLETED|Overall Study||1
1128562|NCT01285050|2731943|P1|COMPLETED|Overall Study||19
1128563|NCT01285050|2731943|P1|STARTED|Overall Study||20
1128564|NCT01285076|2731948|P1|NOT COMPLETED|Overall Study||0
1128565|NCT01285076|2731948|P1|COMPLETED|Overall Study||834
1128566|NCT01285076|2731948|P1|STARTED|Overall Study||834
1128597|NCT01285323|2732203|P2|NOT COMPLETED|Overall Study||30
1128598|NCT01285323|2732204|P1|NOT COMPLETED|Overall Study||33
1128599|NCT01285323|2732203|P2|COMPLETED|Overall Study||202
1128600|NCT01285323|2732204|P1|COMPLETED|Overall Study||199
1128601|NCT01285323|2732203|P2|Safety Analysis Set|Overall Study||232
1128602|NCT01285323|2732204|P1|Safety Analysis Set|Overall Study|Participants who received at least 1 dose of study drug|232
1128603|NCT01285323|2732203|P2|Full Analysis Set|Overall Study||232
1128604|NCT01285323|2732204|P1|Full Analysis Set|Overall Study|Randomized participants who received at least 1 dose of study drug|232
1128605|NCT01285323|2732203|P2|STARTED|Overall Study||232
1128606|NCT01285323|2732204|P1|STARTED|Overall Study||232
1128607|NCT01285401|2732238|P2|NOT COMPLETED|Overall Study||29
1128608|NCT01285401|2732239|P1|NOT COMPLETED|Overall Study||17
1128609|NCT01285401|2732238|P2|COMPLETED|Overall Study||88
1128610|NCT01285401|2732239|P1|COMPLETED|Overall Study||98
1128611|NCT01285401|2732238|P2|Treated|Overall Study||116
1128612|NCT01285401|2732239|P1|Treated|Overall Study||113
1128613|NCT01285401|2732238|P2|STARTED|Overall Study||117
1128614|NCT01285401|2732239|P1|STARTED|Overall Study||115
1128615|NCT01285427|2732277|P1|NOT COMPLETED|Overall Study||1
1128616|NCT01285427|2732277|P1|COMPLETED|Overall Study|One sample be discarded per FDA, sample drawn with heparin tube, not specified in protocol.|299
1128617|NCT01285427|2732277|P1|STARTED|Overall Study||300
1128618|NCT01285492|2732291|P2|NOT COMPLETED|Overall Study||1
1128619|NCT01285492|2732292|P1|NOT COMPLETED|Overall Study||17
1128620|NCT01285492|2732291|P2|COMPLETED|Overall Study||38
1128621|NCT01285492|2732292|P1|COMPLETED|Overall Study||104
1128622|NCT01285492|2732291|P2|Safety Set (for Demographics)|Overall Study|All patients who took study drug|39
1128623|NCT01285492|2732292|P1|Safety Set (for Demographics)|Overall Study|All patients who took study drug; 2 patients did not|119
1128624|NCT01285492|2732291|P2|STARTED|Overall Study|All patients randomized to this group|39
1128625|NCT01285492|2732292|P1|STARTED|Overall Study|All patients randomized to this group|121
1128626|NCT01285518|2732318|P8|NOT COMPLETED|Overall Study||0
1128627|NCT01285518|2732319|P7|NOT COMPLETED|Overall Study||0
1128628|NCT01285518|2732320|P6|NOT COMPLETED|Overall Study||1
1128629|NCT01285518|2732321|P5|NOT COMPLETED|Overall Study||0
1128630|NCT01285518|2732322|P4|NOT COMPLETED|Overall Study||0
1128631|NCT01285518|2732323|P3|NOT COMPLETED|Overall Study||0
1128632|NCT01285518|2732324|P2|NOT COMPLETED|Overall Study||0
1128633|NCT01285518|2732325|P1|NOT COMPLETED|Overall Study||0
1128634|NCT01285518|2732318|P8|COMPLETED|Overall Study||14
1128635|NCT01285518|2732319|P7|COMPLETED|Overall Study||10
1128636|NCT01285518|2732320|P6|COMPLETED|Overall Study||9
1128637|NCT01285518|2732321|P5|COMPLETED|Overall Study||10
1128638|NCT01285518|2732322|P4|COMPLETED|Overall Study||10
1128639|NCT01285518|2732323|P3|COMPLETED|Overall Study||10
1128640|NCT01285518|2732324|P2|COMPLETED|Overall Study||10
1128641|NCT01285518|2732325|P1|COMPLETED|Overall Study||10
1128642|NCT01285518|2732318|P8|STARTED|Overall Study||14
1128643|NCT01285518|2732319|P7|STARTED|Overall Study||10
1128644|NCT01285518|2732320|P6|STARTED|Overall Study||10
1128645|NCT01285518|2732321|P5|STARTED|Overall Study||10
1128646|NCT01285518|2732322|P4|STARTED|Overall Study||10
1128647|NCT01285518|2732323|P3|STARTED|Overall Study||10
1128648|NCT01285518|2732324|P2|STARTED|Overall Study||10
1128649|NCT01285518|2732325|P1|STARTED|Overall Study||10
1128650|NCT01285609|2732585|P2|NOT COMPLETED|Treated With Blinded Therapy||353
1128651|NCT01285609|2732586|P1|NOT COMPLETED|Treated With Blinded Therapy||379
1128652|NCT01285609|2732585|P2|COMPLETED|Treated With Blinded Therapy|Completed = Still on Treatment|8
1128653|NCT01285609|2732586|P1|COMPLETED|Treated With Blinded Therapy|Completed = Still on Treatment|9
1128654|NCT01285609|2732585|P2|STARTED|Treated With Blinded Therapy||361
1128655|NCT01285609|2732586|P1|STARTED|Treated With Blinded Therapy||388
1128656|NCT01285609|2732585|P2|NOT COMPLETED|Randomized||116
1128657|NCT01285609|2732586|P1|NOT COMPLETED|Randomized||91
1128658|NCT01285609|2732585|P2|COMPLETED|Randomized||361
1128659|NCT01285609|2732586|P1|COMPLETED|Randomized||388
1128660|NCT01285609|2732585|P2|Treated With Chemotherapy (1st Dose)|Randomized||473
1128661|NCT01285609|2732586|P1|Treated With Chemotherapy (1st Dose)|Randomized||475
1128662|NCT01285609|2732585|P2|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|477
1128663|NCT01285609|2732586|P1|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|479
1128664|NCT01285635|2732599|P3|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
1128665|NCT01285635|2732600|P2|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
1128666|NCT01285635|2732601|P1|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
1128667|NCT01285635|2732599|P3|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
1128668|NCT01285635|2732600|P2|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
1128669|NCT01285635|2732601|P1|COMPLETED|Second Intervention (10, 3 Week Cycles)||13
1128670|NCT01285635|2732599|P3|STARTED|Second Intervention (10, 3 Week Cycles)||11
1128671|NCT01285635|2732600|P2|STARTED|Second Intervention (10, 3 Week Cycles)||11
1128672|NCT01285635|2732601|P1|STARTED|Second Intervention (10, 3 Week Cycles)||13
1128673|NCT01285635|2732599|P3|NOT COMPLETED|First Intervention (2 Weeks)||0
1128674|NCT01285635|2732600|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
1128675|NCT01285635|2732601|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
1128676|NCT01285635|2732599|P3|COMPLETED|First Intervention (2 Weeks)||11
1128677|NCT01285635|2732600|P2|COMPLETED|First Intervention (2 Weeks)||11
1128678|NCT01285635|2732601|P1|COMPLETED|First Intervention (2 Weeks)||13
1128679|NCT01285635|2732599|P3|STARTED|First Intervention (2 Weeks)||11
1128680|NCT01285635|2732600|P2|STARTED|First Intervention (2 Weeks)||11
1128681|NCT01285635|2732601|P1|STARTED|First Intervention (2 Weeks)||13
1128682|NCT01285713|2732621|P2|NOT COMPLETED|Overall Study||0
1128683|NCT01285713|2732622|P1|NOT COMPLETED|Overall Study||0
1128684|NCT01285713|2732621|P2|COMPLETED|Overall Study||41
1128685|NCT01285713|2732622|P1|COMPLETED|Overall Study||42
1128686|NCT01285713|2732621|P2|STARTED|Overall Study||41
1128687|NCT01285713|2732622|P1|STARTED|Overall Study||42
1128688|NCT01285791|2732631|P3|NOT COMPLETED|Overall Study||0
1128689|NCT01285791|2732632|P2|NOT COMPLETED|Overall Study||0
1128690|NCT01285791|2732633|P1|NOT COMPLETED|Overall Study||0
1128691|NCT01285791|2732631|P3|COMPLETED|Overall Study||13
1128692|NCT01285791|2732632|P2|COMPLETED|Overall Study||15
1128693|NCT01285791|2732633|P1|COMPLETED|Overall Study||11
1128694|NCT01285791|2732631|P3|STARTED|Overall Study||13
1128695|NCT01285791|2732632|P2|STARTED|Overall Study||15
1128696|NCT01285791|2732633|P1|STARTED|Overall Study||11
1128697|NCT01285843|2732643|P2|NOT COMPLETED|Overall Study||2
1128698|NCT01285843|2732644|P1|NOT COMPLETED|Overall Study||2
1128699|NCT01285843|2732643|P2|COMPLETED|Overall Study||18
1128700|NCT01285843|2732644|P1|COMPLETED|Overall Study||18
1128701|NCT01285843|2732643|P2|STARTED|Overall Study||20
1128702|NCT01285843|2732644|P1|STARTED|Overall Study||20
1128703|NCT01285908|2732656|P3|NOT COMPLETED|Treatment Crossover||0
1128704|NCT01285908|2732657|P2|NOT COMPLETED|Treatment Crossover||0
1128705|NCT01285908|2732658|P1|NOT COMPLETED|Treatment Crossover||0
1128706|NCT01285908|2732656|P3|COMPLETED|Treatment Crossover||2
1128707|NCT01285908|2732657|P2|COMPLETED|Treatment Crossover||2
1128708|NCT01285908|2732658|P1|COMPLETED|Treatment Crossover||0
1128709|NCT01285908|2732656|P3|STARTED|Treatment Crossover||2
1128710|NCT01285908|2732657|P2|STARTED|Treatment Crossover|One subject in treatment crossover did not complete baseline testing as unable to complete tasks|2
1128711|NCT01285908|2732658|P1|STARTED|Treatment Crossover||0
1128712|NCT01285908|2732656|P3|NOT COMPLETED|Baseline Measurement||0
1128713|NCT01285908|2732657|P2|NOT COMPLETED|Baseline Measurement||0
1128714|NCT01285908|2732658|P1|NOT COMPLETED|Baseline Measurement||3
1128715|NCT01285908|2732656|P3|COMPLETED|Baseline Measurement||0
1128716|NCT01285908|2732657|P2|COMPLETED|Baseline Measurement||0
1128717|NCT01285908|2732658|P1|COMPLETED|Baseline Measurement||3
1128718|NCT01285908|2732656|P3|STARTED|Baseline Measurement||0
1128719|NCT01285908|2732657|P2|STARTED|Baseline Measurement||0
1128720|NCT01285908|2732658|P1|STARTED|Baseline Measurement||6
1128721|NCT01285947|2732692|P2|NOT COMPLETED|Overall Study||0
1128722|NCT01285947|2732693|P1|NOT COMPLETED|Overall Study||0
1128723|NCT01285947|2732692|P2|COMPLETED|Overall Study||10
1128724|NCT01285947|2732693|P1|COMPLETED|Overall Study||10
1128725|NCT01285947|2732692|P2|STARTED|Overall Study||10
1128726|NCT01285947|2732693|P1|STARTED|Overall Study||10
1128733|NCT01286077|2732712|P2|NOT COMPLETED|Overall Study||7
1128734|NCT01286077|2732713|P1|NOT COMPLETED|Overall Study||10
1128735|NCT01286077|2732712|P2|COMPLETED|Overall Study||46
1128736|NCT01286077|2732713|P1|COMPLETED|Overall Study||41
1128737|NCT01286077|2732712|P2|STARTED|Overall Study|One patient did not have any post-baseline assessment and was excluded from the ITT population.|53
1128738|NCT01286077|2732713|P1|STARTED|Overall Study|One patient did not start treatment and was excluded from the Intent to Treat (ITT) population.|51
1128739|NCT01286129|2732749|P2|NOT COMPLETED|Overall Study||5
1128740|NCT01286129|2732750|P1|NOT COMPLETED|Overall Study||8
1128741|NCT01286129|2732749|P2|COMPLETED|Overall Study||13
1128742|NCT01286129|2732750|P1|COMPLETED|Overall Study||19
1128743|NCT01286129|2732749|P2|STARTED|Overall Study||18
1128744|NCT01286129|2732750|P1|STARTED|Overall Study||27
1128745|NCT01286168|2732758|P1|NOT COMPLETED|Overall Study||3
1128746|NCT01286168|2732758|P1|COMPLETED|Overall Study||101
1128747|NCT01286168|2732758|P1|STARTED|Overall Study||104
1128748|NCT01286207|2732773|P3|NOT COMPLETED|Overall Study||90
1128749|NCT01286207|2732774|P2|NOT COMPLETED|Overall Study||248
1128750|NCT01286207|2732775|P1|NOT COMPLETED|Overall Study||298
1128751|NCT01286207|2732773|P3|COMPLETED|Overall Study||261
1128752|NCT01286207|2732774|P2|COMPLETED|Overall Study||609
1128753|NCT01286207|2732775|P1|COMPLETED|Overall Study||453
1128754|NCT01286207|2732773|P3|STARTED|Overall Study||351
1128755|NCT01286207|2732774|P2|STARTED|Overall Study||857
1128756|NCT01286207|2732775|P1|STARTED|Overall Study||751
1128757|NCT01286311|2732797|P2|NOT COMPLETED|Overall Study||0
1128758|NCT01286311|2732798|P1|NOT COMPLETED|Overall Study||14
1128759|NCT01286311|2732797|P2|COMPLETED|Overall Study|217 patients (of the 15 physician randomized to the intervention) completed the study.|232
1128760|NCT01286311|2732798|P1|COMPLETED|Overall Study|204 patients (of the 14 physician randomized to the intervention) completed the study.|218
1128761|NCT01286311|2732797|P2|STARTED|Overall Study|217 patients (of the 15 physician randomized to the intervention) started the study.|232
1128762|NCT01286311|2732798|P1|STARTED|Overall Study|218 patients (of the 14 physician randomized to the intervention) started the study.|232
1128763|NCT01286324|2732814|P2|NOT COMPLETED|Overall Study||0
1128764|NCT01286324|2732815|P1|NOT COMPLETED|Overall Study||0
1128765|NCT01286324|2732814|P2|COMPLETED|Overall Study||17
1128766|NCT01286324|2732815|P1|COMPLETED|Overall Study||17
1128767|NCT01286324|2732814|P2|STARTED|Overall Study||17
1128768|NCT01286324|2732815|P1|STARTED|Overall Study||17
1128769|NCT01286402|2732823|P2|NOT COMPLETED|Overall Study||0
1128770|NCT01286402|2732824|P1|NOT COMPLETED|Overall Study||0
1128771|NCT01286402|2732823|P2|COMPLETED|Overall Study||6
1128772|NCT01286402|2732824|P1|COMPLETED|Overall Study||5
1128773|NCT01286402|2732823|P2|STARTED|Overall Study||6
1128774|NCT01286402|2732824|P1|STARTED|Overall Study||5
1128775|NCT01286454|2732830|P11|NOT COMPLETED|Part II- Sixth Intervention Period||0
1128776|NCT01286454|2732831|P10|NOT COMPLETED|Part II- Sixth Intervention Period||0
1128777|NCT01286454|2732832|P9|NOT COMPLETED|Part II- Sixth Intervention Period||0
1128778|NCT01286454|2732833|P8|NOT COMPLETED|Part II- Sixth Intervention Period||0
1128779|NCT01286454|2732834|P7|NOT COMPLETED|Part II- Sixth Intervention Period||0
1128780|NCT01286454|2732835|P6|NOT COMPLETED|Part II- Sixth Intervention Period||0
1128781|NCT01286454|2732836|P5|NOT COMPLETED|Part II- Sixth Intervention Period||0
1128782|NCT01286454|2732837|P4|NOT COMPLETED|Part II- Sixth Intervention Period||0
1128783|NCT01286454|2732838|P3|NOT COMPLETED|Part II- Sixth Intervention Period||0
1128784|NCT01286454|2732839|P2|NOT COMPLETED|Part II- Sixth Intervention Period||0
1128785|NCT01286454|2732840|P1|NOT COMPLETED|Part II- Sixth Intervention Period||0
1128786|NCT01286454|2732830|P11|COMPLETED|Part II- Sixth Intervention Period||20
1128787|NCT01286454|2732831|P10|COMPLETED|Part II- Sixth Intervention Period||0
1128788|NCT01286454|2732832|P9|COMPLETED|Part II- Sixth Intervention Period||0
1128789|NCT01286454|2732833|P8|COMPLETED|Part II- Sixth Intervention Period||0
1128790|NCT01286454|2732834|P7|COMPLETED|Part II- Sixth Intervention Period||0
1128791|NCT01286454|2732835|P6|COMPLETED|Part II- Sixth Intervention Period||0
1128792|NCT01286454|2732836|P5|COMPLETED|Part II- Sixth Intervention Period||0
1128793|NCT01286454|2732837|P4|COMPLETED|Part II- Sixth Intervention Period||0
1128794|NCT01286454|2732838|P3|COMPLETED|Part II- Sixth Intervention Period||0
1128795|NCT01286454|2732839|P2|COMPLETED|Part II- Sixth Intervention Period||0
1128796|NCT01286454|2732840|P1|COMPLETED|Part II- Sixth Intervention Period||0
1128797|NCT01286454|2732830|P11|STARTED|Part II- Sixth Intervention Period||20
1128798|NCT01286454|2732831|P10|STARTED|Part II- Sixth Intervention Period||0
1128799|NCT01286454|2732832|P9|STARTED|Part II- Sixth Intervention Period||0
1128800|NCT01286454|2732833|P8|STARTED|Part II- Sixth Intervention Period||0
1128801|NCT01286454|2732834|P7|STARTED|Part II- Sixth Intervention Period||0
1128802|NCT01286454|2732835|P6|STARTED|Part II- Sixth Intervention Period||0
1128803|NCT01286454|2732836|P5|STARTED|Part II- Sixth Intervention Period||0
1128804|NCT01286454|2732837|P4|STARTED|Part II- Sixth Intervention Period||0
1128805|NCT01286454|2732838|P3|STARTED|Part II- Sixth Intervention Period||0
1128806|NCT01286454|2732839|P2|STARTED|Part II- Sixth Intervention Period||0
1128807|NCT01286454|2732840|P1|STARTED|Part II- Sixth Intervention Period||0
1128808|NCT01286454|2732830|P11|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
1128809|NCT01286454|2732831|P10|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
1128810|NCT01286454|2732832|P9|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
1128811|NCT01286454|2732833|P8|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
1128812|NCT01286454|2732834|P7|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
1128813|NCT01286454|2732835|P6|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
1128814|NCT01286454|2732836|P5|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
1128815|NCT01286454|2732837|P4|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
1128816|NCT01286454|2732838|P3|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
1128817|NCT01286454|2732839|P2|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
1128818|NCT01286454|2732840|P1|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
1128819|NCT01286454|2732830|P11|COMPLETED|Washout Period (Approximately 2 Weeks)||0
1128820|NCT01286454|2732831|P10|COMPLETED|Washout Period (Approximately 2 Weeks)||2
1128821|NCT01286454|2732832|P9|COMPLETED|Washout Period (Approximately 2 Weeks)||2
1128822|NCT01286454|2732833|P8|COMPLETED|Washout Period (Approximately 2 Weeks)||2
1128823|NCT01286454|2732834|P7|COMPLETED|Washout Period (Approximately 2 Weeks)||2
1128824|NCT01286454|2732835|P6|COMPLETED|Washout Period (Approximately 2 Weeks)||2
1128825|NCT01286454|2732836|P5|COMPLETED|Washout Period (Approximately 2 Weeks)||2
1128826|NCT01286454|2732837|P4|COMPLETED|Washout Period (Approximately 2 Weeks)||2
1128827|NCT01286454|2732838|P3|COMPLETED|Washout Period (Approximately 2 Weeks)||2
1128828|NCT01286454|2732839|P2|COMPLETED|Washout Period (Approximately 2 Weeks)||2
1128829|NCT01286454|2732840|P1|COMPLETED|Washout Period (Approximately 2 Weeks)||2
1128830|NCT01286454|2732830|P11|STARTED|Washout Period (Approximately 2 Weeks)||0
1128831|NCT01286454|2732831|P10|STARTED|Washout Period (Approximately 2 Weeks)||2
1128832|NCT01286454|2732832|P9|STARTED|Washout Period (Approximately 2 Weeks)||2
1128833|NCT01286454|2732833|P8|STARTED|Washout Period (Approximately 2 Weeks)||2
1128834|NCT01286454|2732834|P7|STARTED|Washout Period (Approximately 2 Weeks)||2
1128835|NCT01286454|2732835|P6|STARTED|Washout Period (Approximately 2 Weeks)||2
1128836|NCT01286454|2732836|P5|STARTED|Washout Period (Approximately 2 Weeks)||2
1128837|NCT01286454|2732837|P4|STARTED|Washout Period (Approximately 2 Weeks)||2
1128838|NCT01286454|2732838|P3|STARTED|Washout Period (Approximately 2 Weeks)||2
1128839|NCT01286454|2732839|P2|STARTED|Washout Period (Approximately 2 Weeks)||2
1128840|NCT01286454|2732840|P1|STARTED|Washout Period (Approximately 2 Weeks)||2
1128841|NCT01286454|2732830|P11|NOT COMPLETED|Fifth Intervention Period||0
1128842|NCT01286454|2732831|P10|NOT COMPLETED|Fifth Intervention Period||0
1128843|NCT01286454|2732832|P9|NOT COMPLETED|Fifth Intervention Period||0
1128844|NCT01286454|2732833|P8|NOT COMPLETED|Fifth Intervention Period||0
1128845|NCT01286454|2732834|P7|NOT COMPLETED|Fifth Intervention Period||0
1128846|NCT01286454|2732835|P6|NOT COMPLETED|Fifth Intervention Period||0
1128847|NCT01286454|2732836|P5|NOT COMPLETED|Fifth Intervention Period||0
1128848|NCT01286454|2732837|P4|NOT COMPLETED|Fifth Intervention Period||0
1128849|NCT01286454|2732838|P3|NOT COMPLETED|Fifth Intervention Period||0
1128850|NCT01286454|2732839|P2|NOT COMPLETED|Fifth Intervention Period||0
1128851|NCT01286454|2732840|P1|NOT COMPLETED|Fifth Intervention Period||0
1128852|NCT01286454|2732830|P11|COMPLETED|Fifth Intervention Period||0
1128853|NCT01286454|2732831|P10|COMPLETED|Fifth Intervention Period||2
1128854|NCT01286454|2732832|P9|COMPLETED|Fifth Intervention Period||2
1128855|NCT01286454|2732833|P8|COMPLETED|Fifth Intervention Period||2
1128856|NCT01286454|2732834|P7|COMPLETED|Fifth Intervention Period||2
1128857|NCT01286454|2732835|P6|COMPLETED|Fifth Intervention Period||2
1128858|NCT01286454|2732836|P5|COMPLETED|Fifth Intervention Period||2
1128859|NCT01286454|2732837|P4|COMPLETED|Fifth Intervention Period||2
1128860|NCT01286454|2732838|P3|COMPLETED|Fifth Intervention Period||2
1128861|NCT01286454|2732839|P2|COMPLETED|Fifth Intervention Period||2
1128862|NCT01286454|2732840|P1|COMPLETED|Fifth Intervention Period||2
1128863|NCT01286454|2732830|P11|STARTED|Fifth Intervention Period||0
1128864|NCT01286454|2732831|P10|STARTED|Fifth Intervention Period||2
1128865|NCT01286454|2732832|P9|STARTED|Fifth Intervention Period||2
1128866|NCT01286454|2732833|P8|STARTED|Fifth Intervention Period||2
1128867|NCT01286454|2732834|P7|STARTED|Fifth Intervention Period||2
1128868|NCT01286454|2732835|P6|STARTED|Fifth Intervention Period||2
1128869|NCT01286454|2732836|P5|STARTED|Fifth Intervention Period||2
1128870|NCT01286454|2732837|P4|STARTED|Fifth Intervention Period||2
1128871|NCT01286454|2732838|P3|STARTED|Fifth Intervention Period||2
1128872|NCT01286454|2732839|P2|STARTED|Fifth Intervention Period||2
1128873|NCT01286454|2732840|P1|STARTED|Fifth Intervention Period||2
1128874|NCT01286454|2732830|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1128875|NCT01286454|2732831|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1128876|NCT01286454|2732832|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1128877|NCT01286454|2732833|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1128878|NCT01286454|2732834|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1128879|NCT01286454|2732835|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1128880|NCT01286454|2732836|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1128881|NCT01286454|2732837|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1128882|NCT01286454|2732838|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1128883|NCT01286454|2732839|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1128884|NCT01286454|2732840|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1128885|NCT01286454|2732830|P11|COMPLETED|Washout Period (At Least 3 Days)||0
1128886|NCT01286454|2732831|P10|COMPLETED|Washout Period (At Least 3 Days)||2
1128887|NCT01286454|2732832|P9|COMPLETED|Washout Period (At Least 3 Days)||2
1128888|NCT01286454|2732833|P8|COMPLETED|Washout Period (At Least 3 Days)||2
1128889|NCT01286454|2732834|P7|COMPLETED|Washout Period (At Least 3 Days)||2
1128890|NCT01286454|2732835|P6|COMPLETED|Washout Period (At Least 3 Days)||2
1128891|NCT01286454|2732836|P5|COMPLETED|Washout Period (At Least 3 Days)||2
1128892|NCT01286454|2732837|P4|COMPLETED|Washout Period (At Least 3 Days)||2
1128893|NCT01286454|2732838|P3|COMPLETED|Washout Period (At Least 3 Days)||2
1128894|NCT01286454|2732839|P2|COMPLETED|Washout Period (At Least 3 Days)||2
1128895|NCT01286454|2732840|P1|COMPLETED|Washout Period (At Least 3 Days)||2
1128896|NCT01286454|2732830|P11|STARTED|Washout Period (At Least 3 Days)||0
1128897|NCT01286454|2732831|P10|STARTED|Washout Period (At Least 3 Days)||2
1128898|NCT01286454|2732832|P9|STARTED|Washout Period (At Least 3 Days)||2
1128899|NCT01286454|2732833|P8|STARTED|Washout Period (At Least 3 Days)||2
1128900|NCT01286454|2732834|P7|STARTED|Washout Period (At Least 3 Days)||2
1128901|NCT01286454|2732835|P6|STARTED|Washout Period (At Least 3 Days)||2
1128902|NCT01286454|2732836|P5|STARTED|Washout Period (At Least 3 Days)||2
1128903|NCT01286454|2732837|P4|STARTED|Washout Period (At Least 3 Days)||2
1128904|NCT01286454|2732838|P3|STARTED|Washout Period (At Least 3 Days)||2
1128905|NCT01286454|2732839|P2|STARTED|Washout Period (At Least 3 Days)||2
1128906|NCT01286454|2732840|P1|STARTED|Washout Period (At Least 3 Days)||2
1128907|NCT01286454|2732830|P11|NOT COMPLETED|Fourth Intervention Period||0
1128908|NCT01286454|2732831|P10|NOT COMPLETED|Fourth Intervention Period||0
1128909|NCT01286454|2732832|P9|NOT COMPLETED|Fourth Intervention Period||0
1128910|NCT01286454|2732833|P8|NOT COMPLETED|Fourth Intervention Period||0
1128911|NCT01286454|2732834|P7|NOT COMPLETED|Fourth Intervention Period||0
1128912|NCT01286454|2732835|P6|NOT COMPLETED|Fourth Intervention Period||0
1128913|NCT01286454|2732836|P5|NOT COMPLETED|Fourth Intervention Period||0
1128914|NCT01286454|2732837|P4|NOT COMPLETED|Fourth Intervention Period||0
1128915|NCT01286454|2732838|P3|NOT COMPLETED|Fourth Intervention Period||0
1128916|NCT01286454|2732839|P2|NOT COMPLETED|Fourth Intervention Period||0
1128917|NCT01286454|2732840|P1|NOT COMPLETED|Fourth Intervention Period||0
1128918|NCT01286454|2732830|P11|COMPLETED|Fourth Intervention Period||0
1128919|NCT01286454|2732831|P10|COMPLETED|Fourth Intervention Period||2
1128920|NCT01286454|2732832|P9|COMPLETED|Fourth Intervention Period||2
1128921|NCT01286454|2732833|P8|COMPLETED|Fourth Intervention Period||2
1128922|NCT01286454|2732834|P7|COMPLETED|Fourth Intervention Period||2
1128923|NCT01286454|2732835|P6|COMPLETED|Fourth Intervention Period||2
1128924|NCT01286454|2732836|P5|COMPLETED|Fourth Intervention Period||2
1128925|NCT01286454|2732837|P4|COMPLETED|Fourth Intervention Period||2
1128926|NCT01286454|2732838|P3|COMPLETED|Fourth Intervention Period||2
1128927|NCT01286454|2732839|P2|COMPLETED|Fourth Intervention Period||2
1128928|NCT01286454|2732840|P1|COMPLETED|Fourth Intervention Period||2
1128929|NCT01286454|2732830|P11|STARTED|Fourth Intervention Period||0
1128930|NCT01286454|2732831|P10|STARTED|Fourth Intervention Period||2
1128931|NCT01286454|2732832|P9|STARTED|Fourth Intervention Period||2
1128932|NCT01286454|2732833|P8|STARTED|Fourth Intervention Period||2
1128933|NCT01286454|2732834|P7|STARTED|Fourth Intervention Period||2
1128934|NCT01286454|2732835|P6|STARTED|Fourth Intervention Period||2
1128935|NCT01286454|2732836|P5|STARTED|Fourth Intervention Period||2
1128936|NCT01286454|2732837|P4|STARTED|Fourth Intervention Period||2
1128937|NCT01286454|2732838|P3|STARTED|Fourth Intervention Period||2
1128938|NCT01286454|2732839|P2|STARTED|Fourth Intervention Period||2
1128939|NCT01286454|2732840|P1|STARTED|Fourth Intervention Period||2
1128940|NCT01286454|2732830|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1128941|NCT01286454|2732831|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1128942|NCT01286454|2732832|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1128943|NCT01286454|2732833|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1128944|NCT01286454|2732834|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1128945|NCT01286454|2732835|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1128946|NCT01286454|2732836|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1128947|NCT01286454|2732837|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1128948|NCT01286454|2732838|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1128949|NCT01286454|2732839|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1128950|NCT01286454|2732840|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1128951|NCT01286454|2732830|P11|COMPLETED|Washout Period (At Least 3 Days)||0
1128952|NCT01286454|2732831|P10|COMPLETED|Washout Period (At Least 3 Days)||2
1128953|NCT01286454|2732832|P9|COMPLETED|Washout Period (At Least 3 Days)||2
1128954|NCT01286454|2732833|P8|COMPLETED|Washout Period (At Least 3 Days)||2
1128955|NCT01286454|2732834|P7|COMPLETED|Washout Period (At Least 3 Days)||2
1128956|NCT01286454|2732835|P6|COMPLETED|Washout Period (At Least 3 Days)||2
1128957|NCT01286454|2732836|P5|COMPLETED|Washout Period (At Least 3 Days)||2
1128958|NCT01286454|2732837|P4|COMPLETED|Washout Period (At Least 3 Days)||2
1128959|NCT01286454|2732838|P3|COMPLETED|Washout Period (At Least 3 Days)||2
1128960|NCT01286454|2732839|P2|COMPLETED|Washout Period (At Least 3 Days)||2
1128961|NCT01286454|2732840|P1|COMPLETED|Washout Period (At Least 3 Days)||2
1128962|NCT01286454|2732830|P11|STARTED|Washout Period (At Least 3 Days)||0
1128963|NCT01286454|2732831|P10|STARTED|Washout Period (At Least 3 Days)||2
1128964|NCT01286454|2732832|P9|STARTED|Washout Period (At Least 3 Days)||2
1128965|NCT01286454|2732833|P8|STARTED|Washout Period (At Least 3 Days)||2
1128966|NCT01286454|2732834|P7|STARTED|Washout Period (At Least 3 Days)||2
1128967|NCT01286454|2732835|P6|STARTED|Washout Period (At Least 3 Days)||2
1128968|NCT01286454|2732836|P5|STARTED|Washout Period (At Least 3 Days)||2
1128969|NCT01286454|2732837|P4|STARTED|Washout Period (At Least 3 Days)||2
1128970|NCT01286454|2732838|P3|STARTED|Washout Period (At Least 3 Days)||2
1128971|NCT01286454|2732839|P2|STARTED|Washout Period (At Least 3 Days)||2
1128972|NCT01286454|2732840|P1|STARTED|Washout Period (At Least 3 Days)||2
1128973|NCT01286454|2732830|P11|NOT COMPLETED|Third Intervention Period||0
1128974|NCT01286454|2732831|P10|NOT COMPLETED|Third Intervention Period||0
1128975|NCT01286454|2732832|P9|NOT COMPLETED|Third Intervention Period||0
1128976|NCT01286454|2732833|P8|NOT COMPLETED|Third Intervention Period||0
1128977|NCT01286454|2732834|P7|NOT COMPLETED|Third Intervention Period||0
1128978|NCT01286454|2732835|P6|NOT COMPLETED|Third Intervention Period||0
1128979|NCT01286454|2732836|P5|NOT COMPLETED|Third Intervention Period||0
1128980|NCT01286454|2732837|P4|NOT COMPLETED|Third Intervention Period||0
1128981|NCT01286454|2732838|P3|NOT COMPLETED|Third Intervention Period||0
1128982|NCT01286454|2732839|P2|NOT COMPLETED|Third Intervention Period||0
1128983|NCT01286454|2732840|P1|NOT COMPLETED|Third Intervention Period||0
1128984|NCT01286454|2732830|P11|COMPLETED|Third Intervention Period||0
1128985|NCT01286454|2732831|P10|COMPLETED|Third Intervention Period||2
1128986|NCT01286454|2732832|P9|COMPLETED|Third Intervention Period||2
1128987|NCT01286454|2732833|P8|COMPLETED|Third Intervention Period||2
1128988|NCT01286454|2732834|P7|COMPLETED|Third Intervention Period||2
1128989|NCT01286454|2732835|P6|COMPLETED|Third Intervention Period||2
1128990|NCT01286454|2732836|P5|COMPLETED|Third Intervention Period||2
1128991|NCT01286454|2732837|P4|COMPLETED|Third Intervention Period||2
1128992|NCT01286454|2732838|P3|COMPLETED|Third Intervention Period||2
1128993|NCT01286454|2732839|P2|COMPLETED|Third Intervention Period||2
1128994|NCT01286454|2732840|P1|COMPLETED|Third Intervention Period||2
1128995|NCT01286454|2732830|P11|STARTED|Third Intervention Period||0
1128996|NCT01286454|2732831|P10|STARTED|Third Intervention Period||2
1128997|NCT01286454|2732832|P9|STARTED|Third Intervention Period||2
1128998|NCT01286454|2732833|P8|STARTED|Third Intervention Period||2
1128999|NCT01286454|2732834|P7|STARTED|Third Intervention Period||2
1129000|NCT01286454|2732835|P6|STARTED|Third Intervention Period||2
1129001|NCT01286454|2732836|P5|STARTED|Third Intervention Period||2
1129002|NCT01286454|2732837|P4|STARTED|Third Intervention Period||2
1129003|NCT01286454|2732838|P3|STARTED|Third Intervention Period||2
1129004|NCT01286454|2732839|P2|STARTED|Third Intervention Period||2
1129005|NCT01286454|2732840|P1|STARTED|Third Intervention Period||2
1129006|NCT01286454|2732830|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1129007|NCT01286454|2732831|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1129008|NCT01286454|2732832|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1129009|NCT01286454|2732833|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1129010|NCT01286454|2732834|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1129011|NCT01286454|2732835|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1129012|NCT01286454|2732836|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1129013|NCT01286454|2732837|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1129014|NCT01286454|2732838|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1129015|NCT01286454|2732839|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1129016|NCT01286454|2732840|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1129017|NCT01286454|2732830|P11|COMPLETED|Washout Period (At Least 3 Days)||0
1129018|NCT01286454|2732831|P10|COMPLETED|Washout Period (At Least 3 Days)||2
1129019|NCT01286454|2732832|P9|COMPLETED|Washout Period (At Least 3 Days)||2
1129020|NCT01286454|2732833|P8|COMPLETED|Washout Period (At Least 3 Days)||2
1129021|NCT01286454|2732834|P7|COMPLETED|Washout Period (At Least 3 Days)||2
1129022|NCT01286454|2732835|P6|COMPLETED|Washout Period (At Least 3 Days)||2
1129023|NCT01286454|2732836|P5|COMPLETED|Washout Period (At Least 3 Days)||2
1129024|NCT01286454|2732837|P4|COMPLETED|Washout Period (At Least 3 Days)||2
1129025|NCT01286454|2732838|P3|COMPLETED|Washout Period (At Least 3 Days)||2
1129026|NCT01286454|2732839|P2|COMPLETED|Washout Period (At Least 3 Days)||2
1129027|NCT01286454|2732840|P1|COMPLETED|Washout Period (At Least 3 Days)||2
1129028|NCT01286454|2732830|P11|STARTED|Washout Period (At Least 3 Days)||0
1129029|NCT01286454|2732831|P10|STARTED|Washout Period (At Least 3 Days)||2
1129030|NCT01286454|2732832|P9|STARTED|Washout Period (At Least 3 Days)||2
1129031|NCT01286454|2732833|P8|STARTED|Washout Period (At Least 3 Days)||2
1129032|NCT01286454|2732834|P7|STARTED|Washout Period (At Least 3 Days)||2
1129033|NCT01286454|2732835|P6|STARTED|Washout Period (At Least 3 Days)||2
1129034|NCT01286454|2732836|P5|STARTED|Washout Period (At Least 3 Days)||2
1129035|NCT01286454|2732837|P4|STARTED|Washout Period (At Least 3 Days)||2
1129036|NCT01286454|2732838|P3|STARTED|Washout Period (At Least 3 Days)||2
1129037|NCT01286454|2732839|P2|STARTED|Washout Period (At Least 3 Days)||2
1129038|NCT01286454|2732840|P1|STARTED|Washout Period (At Least 3 Days)||2
1129039|NCT01286454|2732830|P11|NOT COMPLETED|Second Intervention Period||0
1129040|NCT01286454|2732831|P10|NOT COMPLETED|Second Intervention Period||0
1129041|NCT01286454|2732832|P9|NOT COMPLETED|Second Intervention Period||0
1129042|NCT01286454|2732833|P8|NOT COMPLETED|Second Intervention Period||0
1129043|NCT01286454|2732834|P7|NOT COMPLETED|Second Intervention Period||0
1129044|NCT01286454|2732835|P6|NOT COMPLETED|Second Intervention Period||0
1129045|NCT01286454|2732836|P5|NOT COMPLETED|Second Intervention Period||0
1129046|NCT01286454|2732837|P4|NOT COMPLETED|Second Intervention Period||0
1129047|NCT01286454|2732838|P3|NOT COMPLETED|Second Intervention Period||0
1129048|NCT01286454|2732839|P2|NOT COMPLETED|Second Intervention Period||0
1129049|NCT01286454|2732840|P1|NOT COMPLETED|Second Intervention Period||0
1129050|NCT01286454|2732830|P11|COMPLETED|Second Intervention Period||0
1129051|NCT01286454|2732831|P10|COMPLETED|Second Intervention Period||2
1129052|NCT01286454|2732832|P9|COMPLETED|Second Intervention Period||2
1129053|NCT01286454|2732833|P8|COMPLETED|Second Intervention Period||2
1129054|NCT01286454|2732834|P7|COMPLETED|Second Intervention Period||2
1129055|NCT01286454|2732835|P6|COMPLETED|Second Intervention Period||2
1129056|NCT01286454|2732836|P5|COMPLETED|Second Intervention Period||2
1129057|NCT01286454|2732837|P4|COMPLETED|Second Intervention Period||2
1129058|NCT01286454|2732838|P3|COMPLETED|Second Intervention Period||2
1129059|NCT01286454|2732839|P2|COMPLETED|Second Intervention Period||2
1129060|NCT01286454|2732840|P1|COMPLETED|Second Intervention Period||2
1129061|NCT01286454|2732830|P11|STARTED|Second Intervention Period||0
1129062|NCT01286454|2732831|P10|STARTED|Second Intervention Period||2
1129063|NCT01286454|2732832|P9|STARTED|Second Intervention Period||2
1129064|NCT01286454|2732833|P8|STARTED|Second Intervention Period||2
1129065|NCT01286454|2732834|P7|STARTED|Second Intervention Period||2
1129066|NCT01286454|2732835|P6|STARTED|Second Intervention Period||2
1129067|NCT01286454|2732836|P5|STARTED|Second Intervention Period||2
1129068|NCT01286454|2732837|P4|STARTED|Second Intervention Period||2
1129069|NCT01286454|2732838|P3|STARTED|Second Intervention Period||2
1129070|NCT01286454|2732839|P2|STARTED|Second Intervention Period||2
1129071|NCT01286454|2732840|P1|STARTED|Second Intervention Period||2
1129072|NCT01286454|2732830|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1129073|NCT01286454|2732831|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1129074|NCT01286454|2732832|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1129075|NCT01286454|2732833|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1129076|NCT01286454|2732834|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1129077|NCT01286454|2732835|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1129078|NCT01286454|2732836|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1129079|NCT01286454|2732837|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1129080|NCT01286454|2732838|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1129081|NCT01286454|2732839|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1129082|NCT01286454|2732840|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
1129083|NCT01286454|2732830|P11|COMPLETED|Washout Period (At Least 3 Days)||0
1129084|NCT01286454|2732831|P10|COMPLETED|Washout Period (At Least 3 Days)||2
1129085|NCT01286454|2732832|P9|COMPLETED|Washout Period (At Least 3 Days)||2
1129086|NCT01286454|2732833|P8|COMPLETED|Washout Period (At Least 3 Days)||2
1129087|NCT01286454|2732834|P7|COMPLETED|Washout Period (At Least 3 Days)||2
1129088|NCT01286454|2732835|P6|COMPLETED|Washout Period (At Least 3 Days)||2
1129089|NCT01286454|2732836|P5|COMPLETED|Washout Period (At Least 3 Days)||2
1129090|NCT01286454|2732837|P4|COMPLETED|Washout Period (At Least 3 Days)||2
1129091|NCT01286454|2732838|P3|COMPLETED|Washout Period (At Least 3 Days)||2
1129092|NCT01286454|2732839|P2|COMPLETED|Washout Period (At Least 3 Days)||2
1129093|NCT01286454|2732840|P1|COMPLETED|Washout Period (At Least 3 Days)||2
1129094|NCT01286454|2732830|P11|STARTED|Washout Period (At Least 3 Days)||0
1129095|NCT01286454|2732831|P10|STARTED|Washout Period (At Least 3 Days)||2
1129096|NCT01286454|2732832|P9|STARTED|Washout Period (At Least 3 Days)||2
1129097|NCT01286454|2732833|P8|STARTED|Washout Period (At Least 3 Days)||2
1129098|NCT01286454|2732834|P7|STARTED|Washout Period (At Least 3 Days)||2
1129099|NCT01286454|2732835|P6|STARTED|Washout Period (At Least 3 Days)||2
1129100|NCT01286454|2732836|P5|STARTED|Washout Period (At Least 3 Days)||2
1129101|NCT01286454|2732837|P4|STARTED|Washout Period (At Least 3 Days)||2
1129102|NCT01286454|2732838|P3|STARTED|Washout Period (At Least 3 Days)||2
1129103|NCT01286454|2732839|P2|STARTED|Washout Period (At Least 3 Days)||2
1129104|NCT01286454|2732840|P1|STARTED|Washout Period (At Least 3 Days)||2
1129105|NCT01286454|2732830|P11|NOT COMPLETED|Part I- First Intervention Period||0
1129106|NCT01286454|2732831|P10|NOT COMPLETED|Part I- First Intervention Period||0
1129107|NCT01286454|2732832|P9|NOT COMPLETED|Part I- First Intervention Period||0
1129108|NCT01286454|2732833|P8|NOT COMPLETED|Part I- First Intervention Period||0
1129109|NCT01286454|2732834|P7|NOT COMPLETED|Part I- First Intervention Period||0
1129110|NCT01286454|2732835|P6|NOT COMPLETED|Part I- First Intervention Period||0
1129111|NCT01286454|2732836|P5|NOT COMPLETED|Part I- First Intervention Period||0
1129112|NCT01286454|2732837|P4|NOT COMPLETED|Part I- First Intervention Period||0
1129113|NCT01286454|2732838|P3|NOT COMPLETED|Part I- First Intervention Period||0
1129114|NCT01286454|2732839|P2|NOT COMPLETED|Part I- First Intervention Period||0
1129115|NCT01286454|2732840|P1|NOT COMPLETED|Part I- First Intervention Period||0
1129116|NCT01286454|2732830|P11|COMPLETED|Part I- First Intervention Period||0
1129117|NCT01286454|2732831|P10|COMPLETED|Part I- First Intervention Period||2
1129118|NCT01286454|2732832|P9|COMPLETED|Part I- First Intervention Period||2
1129119|NCT01286454|2732833|P8|COMPLETED|Part I- First Intervention Period||2
1129120|NCT01286454|2732834|P7|COMPLETED|Part I- First Intervention Period||2
1129121|NCT01286454|2732835|P6|COMPLETED|Part I- First Intervention Period||2
1129122|NCT01286454|2732836|P5|COMPLETED|Part I- First Intervention Period||2
1129123|NCT01286454|2732837|P4|COMPLETED|Part I- First Intervention Period||2
1129124|NCT01286454|2732838|P3|COMPLETED|Part I- First Intervention Period||2
1129125|NCT01286454|2732839|P2|COMPLETED|Part I- First Intervention Period||2
1129126|NCT01286454|2732840|P1|COMPLETED|Part I- First Intervention Period||2
1129127|NCT01286454|2732830|P11|STARTED|Part I- First Intervention Period||0
1129128|NCT01286454|2732831|P10|STARTED|Part I- First Intervention Period||2
1129129|NCT01286454|2732832|P9|STARTED|Part I- First Intervention Period||2
1129130|NCT01286454|2732833|P8|STARTED|Part I- First Intervention Period||2
1129131|NCT01286454|2732834|P7|STARTED|Part I- First Intervention Period||2
1129132|NCT01286454|2732835|P6|STARTED|Part I- First Intervention Period||2
1129133|NCT01286454|2732836|P5|STARTED|Part I- First Intervention Period||2
1129134|NCT01286454|2732837|P4|STARTED|Part I- First Intervention Period||2
1129135|NCT01286454|2732838|P3|STARTED|Part I- First Intervention Period||2
1129136|NCT01286454|2732839|P2|STARTED|Part I- First Intervention Period||2
1129137|NCT01286454|2732840|P1|STARTED|Part I- First Intervention Period||2
1129138|NCT01286480|2732880|P2|NOT COMPLETED|Overall Study||3
1129139|NCT01286480|2732881|P1|NOT COMPLETED|Overall Study||5
1129140|NCT01286480|2732880|P2|COMPLETED|Overall Study||31
1129141|NCT01286480|2732881|P1|COMPLETED|Overall Study||27
1129142|NCT01286480|2732880|P2|STARTED|Overall Study||34
1129143|NCT01286480|2732881|P1|STARTED|Overall Study||32
1129144|NCT01286493|2732889|P1|NOT COMPLETED|Overall Study||3
1129145|NCT01286493|2732889|P1|COMPLETED|Overall Study||30
1129146|NCT01286493|2732889|P1|STARTED|Overall Study||33
1129147|NCT01286558|2732895|P2|NOT COMPLETED|Overall Study||2
1129148|NCT01286558|2732896|P1|NOT COMPLETED|Overall Study||1
1129149|NCT01286558|2732895|P2|COMPLETED|Overall Study||111
1129150|NCT01286558|2732896|P1|COMPLETED|Overall Study||111
1129151|NCT01286558|2732895|P2|STARTED|Overall Study||113
1129152|NCT01286558|2732896|P1|STARTED|Overall Study||112
1129153|NCT01286740|2732926|P1|NOT COMPLETED|Overall Study||2
1129154|NCT01286740|2732926|P1|COMPLETED|Overall Study||48
1129155|NCT01286740|2732926|P1|Week 12 (Primary Endpoint)|Overall Study||49
1129156|NCT01286740|2732926|P1|Enrolled and Treated|Overall Study||49
1129157|NCT01286740|2732926|P1|STARTED|Overall Study||50
1129158|NCT01286753|2732944|P2|NOT COMPLETED|Overall Study||25
1129159|NCT01286753|2732945|P1|NOT COMPLETED|Overall Study||26
1129160|NCT01286753|2732944|P2|COMPLETED|Overall Study||0
1129161|NCT01286753|2732945|P1|COMPLETED|Overall Study||0
1129162|NCT01286753|2732944|P2|STARTED|Overall Study||25
1129163|NCT01286753|2732945|P1|STARTED|Overall Study||26
1129164|NCT01292746|2732963|P1|NOT COMPLETED|Overall Study||0
1129165|NCT01292746|2732963|P1|COMPLETED|Overall Study||14
1129166|NCT01292746|2732963|P1|STARTED|Overall Study||14
1129167|NCT01292798|2732967|P1|NOT COMPLETED|Overall Study||0
1129168|NCT01292798|2732967|P1|COMPLETED|Overall Study||43
1129169|NCT01292798|2732967|P1|Persistent DME After 3 Months|Overall Study|Subjects with persistent DME after 3 monthly injections of 0.5 mg of ranibizumab|29
1129170|NCT01292798|2732967|P1|STARTED|Overall Study||43
1129171|NCT01292837|2732973|P1|NOT COMPLETED|Overall Study||2
1129172|NCT01292837|2732973|P1|COMPLETED|Overall Study||11
1129173|NCT01292837|2732973|P1|STARTED|Overall Study||13
1129174|NCT01292876|2732982|P1|NOT COMPLETED|Overall Study||4
1129175|NCT01292876|2732982|P1|COMPLETED|Overall Study||13
1129176|NCT01292876|2732982|P1|STARTED|Overall Study||17
1129177|NCT01292928|2732988|P1|NOT COMPLETED|Overall Study||24
1129178|NCT01292928|2732988|P1|COMPLETED|Overall Study||275
1129179|NCT01292928|2732988|P1|Completed 12-Month Clinical Follow-up|Overall Study||266
1129180|NCT01292928|2732988|P1|STARTED|Overall Study||299
1129181|NCT01293825|2733005|P1|NOT COMPLETED|Overall Study||10
1129182|NCT01293825|2733005|P1|COMPLETED|Overall Study||20
1129183|NCT01293825|2733005|P1|STARTED|Overall Study||30
1129184|NCT01293968|2733019|P2|NOT COMPLETED|Overall Study||3
1129185|NCT01293968|2733020|P1|NOT COMPLETED|Overall Study||3
1129186|NCT01293968|2733019|P2|COMPLETED|Overall Study||14
1129187|NCT01293968|2733020|P1|COMPLETED|Overall Study||17
1129188|NCT01293968|2733019|P2|STARTED|Overall Study||17
1129189|NCT01293968|2733020|P1|STARTED|Overall Study||20
1129190|NCT01294046|2733026|P1|NOT COMPLETED|Overall Study||3
1129191|NCT01294046|2733026|P1|COMPLETED|Overall Study||0
1129192|NCT01294046|2733026|P1|STARTED|Overall Study||3
1129193|NCT01294150|2733041|P2|NOT COMPLETED|Overall Study||2
1129194|NCT01294150|2733042|P1|NOT COMPLETED|Overall Study||2
1129195|NCT01294150|2733041|P2|COMPLETED|Overall Study||64
1129196|NCT01294150|2733042|P1|COMPLETED|Overall Study||138
1129197|NCT01294150|2733041|P2|STARTED|Overall Study||66
1129198|NCT01294150|2733042|P1|STARTED|Overall Study||140
1129199|NCT01294163|2733054|P3|NOT COMPLETED|Overall Study||3
1129200|NCT01294163|2733055|P2|NOT COMPLETED|Overall Study||0
1129201|NCT01294163|2733056|P1|NOT COMPLETED|Overall Study||1
1129202|NCT01294163|2733054|P3|COMPLETED|Overall Study||163
1129203|NCT01294163|2733055|P2|COMPLETED|Overall Study||165
1129204|NCT01294163|2733056|P1|COMPLETED|Overall Study||177
1129205|NCT01294163|2733054|P3|STARTED|Overall Study||166
1129206|NCT01294163|2733055|P2|STARTED|Overall Study||165
1129207|NCT01294163|2733056|P1|STARTED|Overall Study||178
1129208|NCT01294228|2733065|P1|NOT COMPLETED|Overall Study||0
1129209|NCT01294228|2733065|P1|COMPLETED|Overall Study||1001
1129210|NCT01294228|2733065|P1|STARTED|Overall Study||1001
1129211|NCT01294306|2733071|P2|NOT COMPLETED|Overall Study||0
1129212|NCT01294306|2733072|P1|NOT COMPLETED|Overall Study||0
1129213|NCT01294306|2733071|P2|COMPLETED|Overall Study||35
1129214|NCT01294306|2733072|P1|COMPLETED|Overall Study||45
1129215|NCT01294306|2733071|P2|STARTED|Overall Study||35
1129216|NCT01294306|2733072|P1|STARTED|Overall Study||45
1129217|NCT01294371|2733086|P1|NOT COMPLETED|Overall Study||34
1129218|NCT01294371|2733086|P1|COMPLETED|Overall Study||357
1129219|NCT01294371|2733086|P1|Treated|Overall Study||390
1129220|NCT01294371|2733086|P1|STARTED|Overall Study||391
1129221|NCT01294384|2733097|P3|NOT COMPLETED|Overall Study||9
1129222|NCT01294384|2733098|P2|NOT COMPLETED|Overall Study||6
1129223|NCT01294384|2733099|P1|NOT COMPLETED|Overall Study||4
1129224|NCT01294384|2733097|P3|COMPLETED|Overall Study||95
1129225|NCT01294384|2733098|P2|COMPLETED|Overall Study||94
1129226|NCT01294384|2733099|P1|COMPLETED|Overall Study||97
1129227|NCT01294384|2733097|P3|STARTED|Overall Study||104
1129228|NCT01294384|2733098|P2|STARTED|Overall Study||100
1129229|NCT01294384|2733099|P1|STARTED|Overall Study||101
1129230|NCT01294397|2733128|P1|NOT COMPLETED|Overall Study||2
1129231|NCT01294397|2733128|P1|COMPLETED|Overall Study||17
1129232|NCT01294397|2733128|P1|STARTED|Overall Study||19
1129233|NCT01294423|2733141|P3|NOT COMPLETED|Overall Study||8
1129234|NCT01294423|2733142|P2|NOT COMPLETED|Overall Study||9
1129235|NCT01294423|2733143|P1|NOT COMPLETED|Overall Study||5
1129236|NCT01294423|2733141|P3|COMPLETED|Overall Study||79
1129237|NCT01294423|2733142|P2|COMPLETED|Overall Study||79
1129238|NCT01294423|2733143|P1|COMPLETED|Overall Study||81
1129239|NCT01294423|2733141|P3|STARTED|Overall Study||87
1129240|NCT01294423|2733142|P2|STARTED|Overall Study||88
1129241|NCT01294423|2733143|P1|STARTED|Overall Study||86
1129242|NCT01294436|2733159|P2|NOT COMPLETED|Overall Study||70
1129243|NCT01294436|2733160|P1|NOT COMPLETED|Overall Study||28
1129244|NCT01294436|2733159|P2|COMPLETED|Overall Study||409
1129245|NCT01294436|2733160|P1|COMPLETED|Overall Study||221
1129246|NCT01294436|2733159|P2|STARTED|Overall Study||479
1129247|NCT01294436|2733160|P1|STARTED|Overall Study||249
1129248|NCT01294449|2733194|P2|NOT COMPLETED|Overall Study||15
1129249|NCT01294449|2733195|P1|NOT COMPLETED|Overall Study||12
1129250|NCT01294449|2733194|P2|COMPLETED|Overall Study||237
1129251|NCT01294449|2733195|P1|COMPLETED|Overall Study||144
1129252|NCT01294449|2733194|P2|Consent to Registry|Overall Study||245
1129253|NCT01294449|2733195|P1|Consent to Registry|Overall Study||149
1129254|NCT01294449|2733194|P2|STARTED|Overall Study||252
1129255|NCT01294449|2733195|P1|STARTED|Overall Study||156
1129256|NCT01294462|2733203|P2|NOT COMPLETED|Overall Study||63
1129257|NCT01294462|2733204|P1|NOT COMPLETED|Overall Study||66
1129258|NCT01294462|2733203|P2|COMPLETED|Overall Study||337
1129259|NCT01294462|2733204|P1|COMPLETED|Overall Study||335
1129260|NCT01294462|2733203|P2|Received Randomized Treatment|Overall Study||380
1129261|NCT01294462|2733204|P1|Received Randomized Treatment|Overall Study||387
1129262|NCT01294462|2733203|P2|STARTED|Overall Study||400
1129263|NCT01294462|2733204|P1|STARTED|Overall Study||401
1129264|NCT01294514|2733216|P1|NOT COMPLETED|Overall Study||1
1129265|NCT01294514|2733216|P1|COMPLETED|Overall Study||26
1129266|NCT01294514|2733216|P1|STARTED|Overall Study||27
1129267|NCT01294553|2733224|P1|NOT COMPLETED|Overall Study||269
1129268|NCT01294553|2733224|P1|COMPLETED|Overall Study||713
1129269|NCT01294553|2733224|P1|STARTED|Overall Study||982
1129270|NCT01294592|2733232|P2|NOT COMPLETED|Overall Study||73
1129271|NCT01294592|2733233|P1|NOT COMPLETED|Overall Study||77
1129272|NCT01294592|2733232|P2|COMPLETED|Overall Study||300
1129273|NCT01294592|2733233|P1|COMPLETED|Overall Study||292
1129274|NCT01294592|2733232|P2|STARTED|Overall Study||373
1129275|NCT01294592|2733233|P1|STARTED|Overall Study||369
1129276|NCT01294644|2733264|P3|NOT COMPLETED|Overall Study||14
1129277|NCT01294644|2733265|P2|NOT COMPLETED|Overall Study||10
1129278|NCT01294644|2733266|P1|NOT COMPLETED|Overall Study||10
1129279|NCT01294644|2733264|P3|COMPLETED|Overall Study||103
1129280|NCT01294644|2733265|P2|COMPLETED|Overall Study||112
1129281|NCT01294644|2733266|P1|COMPLETED|Overall Study||111
1129282|NCT01294644|2733264|P3|Received Treatment|Overall Study||114
1129283|NCT01294644|2733265|P2|Received Treatment|Overall Study||122
1129284|NCT01294644|2733266|P1|Received Treatment|Overall Study||118
1129285|NCT01294644|2733264|P3|STARTED|Overall Study||117
1129286|NCT01294644|2733265|P2|STARTED|Overall Study||122
1129287|NCT01294644|2733266|P1|STARTED|Overall Study||121
1129288|NCT01294683|2733297|P2|NOT COMPLETED|Post Crossover (Period III)||32
1129289|NCT01294683|2733298|P1|NOT COMPLETED|Post Crossover (Period III)||33
1129290|NCT01294683|2733297|P2|COMPLETED|Post Crossover (Period III)||190
1129291|NCT01294683|2733298|P1|COMPLETED|Post Crossover (Period III)||199
1129292|NCT01294683|2733297|P2|STARTED|Post Crossover (Period III)||222
1129293|NCT01294683|2733298|P1|STARTED|Post Crossover (Period III)||232
1129294|NCT01294683|2733297|P2|NOT COMPLETED|Precrossover (Periods I/II)||266
1129295|NCT01294683|2733298|P1|NOT COMPLETED|Precrossover (Periods I/II)||257
1129296|NCT01294683|2733297|P2|COMPLETED|Precrossover (Periods I/II)||222
1129297|NCT01294683|2733298|P1|COMPLETED|Precrossover (Periods I/II)||232
1129298|NCT01294683|2733297|P2|Treated|Precrossover (Periods I/II)||486
1129299|NCT01294683|2733298|P1|Treated|Precrossover (Periods I/II)||486
1129300|NCT01294683|2733297|P2|STARTED|Precrossover (Periods I/II)||488
1129301|NCT01294683|2733298|P1|STARTED|Precrossover (Periods I/II)||489
1129302|NCT01294696|2733350|P1|NOT COMPLETED|Overall Study||74
1129303|NCT01294696|2733350|P1|COMPLETED|Overall Study||1187
1129304|NCT01294696|2733350|P1|STARTED|Overall Study||1261
1129305|NCT01294709|2733362|P2|NOT COMPLETED|Period 2||0
1129306|NCT01294709|2733363|P1|NOT COMPLETED|Period 2||1
1129307|NCT01294709|2733362|P2|COMPLETED|Period 2||31
1129308|NCT01294709|2733363|P1|COMPLETED|Period 2||28
1129309|NCT01294709|2733362|P2|STARTED|Period 2||31
1129310|NCT01294709|2733363|P1|STARTED|Period 2||29
1129311|NCT01294709|2733362|P2|NOT COMPLETED|Washout Period||1
1129312|NCT01294709|2733363|P1|NOT COMPLETED|Washout Period||1
1129313|NCT01294709|2733362|P2|COMPLETED|Washout Period||31
1129314|NCT01294709|2733363|P1|COMPLETED|Washout Period||29
1129315|NCT01294709|2733362|P2|STARTED|Washout Period||32
1129316|NCT01294709|2733363|P1|STARTED|Washout Period||30
1129317|NCT01294709|2733362|P2|NOT COMPLETED|Period 1||1
1129318|NCT01294709|2733363|P1|NOT COMPLETED|Period 1||1
1129319|NCT01294709|2733362|P2|COMPLETED|Period 1||32
1129320|NCT01294709|2733363|P1|COMPLETED|Period 1||30
1129321|NCT01294709|2733362|P2|STARTED|Period 1||33
1129322|NCT01294709|2733363|P1|STARTED|Period 1||31
1129323|NCT01294748|2733382|P2|NOT COMPLETED|Overall Study||2
1129324|NCT01294748|2733383|P1|NOT COMPLETED|Overall Study||5
1129325|NCT01294748|2733382|P2|COMPLETED|Overall Study|At 270 days|59
1129326|NCT01294748|2733383|P1|COMPLETED|Overall Study|At 270 days|118
1129327|NCT01294748|2733382|P2|STARTED|Overall Study||61
1129328|NCT01294748|2733383|P1|STARTED|Overall Study||123
1129329|NCT01294787|2733409|P6|NOT COMPLETED|Period 3||0
1129330|NCT01294787|2733410|P5|NOT COMPLETED|Period 3||1
1129331|NCT01294787|2733411|P4|NOT COMPLETED|Period 3||0
1129332|NCT01294787|2733412|P3|NOT COMPLETED|Period 3||0
1129333|NCT01294787|2733413|P2|NOT COMPLETED|Period 3||0
1129334|NCT01294787|2733414|P1|NOT COMPLETED|Period 3||0
1129335|NCT01294787|2733409|P6|COMPLETED|Period 3||13
1129336|NCT01294787|2733410|P5|COMPLETED|Period 3||13
1129337|NCT01294787|2733411|P4|COMPLETED|Period 3||9
1129338|NCT01294787|2733412|P3|COMPLETED|Period 3||13
1129339|NCT01294787|2733413|P2|COMPLETED|Period 3||13
1129340|NCT01294787|2733414|P1|COMPLETED|Period 3||12
1129341|NCT01294787|2733409|P6|STARTED|Period 3||13
1129342|NCT01294787|2733410|P5|STARTED|Period 3||14
1129343|NCT01294787|2733411|P4|STARTED|Period 3||9
1129344|NCT01294787|2733412|P3|STARTED|Period 3||13
1129345|NCT01294787|2733413|P2|STARTED|Period 3||13
1129346|NCT01294787|2733414|P1|STARTED|Period 3||12
1129347|NCT01294787|2733409|P6|NOT COMPLETED|Period 2||0
1129348|NCT01294787|2733410|P5|NOT COMPLETED|Period 2||0
1129349|NCT01294787|2733411|P4|NOT COMPLETED|Period 2||2
1129350|NCT01294787|2733412|P3|NOT COMPLETED|Period 2||0
1129351|NCT01294787|2733413|P2|NOT COMPLETED|Period 2||3
1129352|NCT01294787|2733414|P1|NOT COMPLETED|Period 2||0
1129353|NCT01294787|2733409|P6|COMPLETED|Period 2||13
1129354|NCT01294787|2733410|P5|COMPLETED|Period 2||14
1129355|NCT01294787|2733411|P4|COMPLETED|Period 2||9
1129356|NCT01294787|2733412|P3|COMPLETED|Period 2||13
1129357|NCT01294787|2733413|P2|COMPLETED|Period 2||13
1129358|NCT01294787|2733414|P1|COMPLETED|Period 2||12
1129359|NCT01294787|2733409|P6|STARTED|Period 2||13
1129360|NCT01294787|2733410|P5|STARTED|Period 2||14
1129361|NCT01294787|2733411|P4|STARTED|Period 2||11
1129362|NCT01294787|2733412|P3|STARTED|Period 2||13
1129363|NCT01294787|2733413|P2|STARTED|Period 2||16
1129364|NCT01294787|2733414|P1|STARTED|Period 2||12
1129365|NCT01294787|2733409|P6|NOT COMPLETED|Period 1||2
1129366|NCT01294787|2733410|P5|NOT COMPLETED|Period 1||2
1129367|NCT01294787|2733411|P4|NOT COMPLETED|Period 1||1
1129368|NCT01294787|2733412|P3|NOT COMPLETED|Period 1||1
1129369|NCT01294787|2733413|P2|NOT COMPLETED|Period 1||0
1129370|NCT01294787|2733414|P1|NOT COMPLETED|Period 1||0
1129371|NCT01294787|2733409|P6|COMPLETED|Period 1||13
1129372|NCT01294787|2733410|P5|COMPLETED|Period 1||14
1129373|NCT01294787|2733411|P4|COMPLETED|Period 1||11
1129374|NCT01294787|2733412|P3|COMPLETED|Period 1||13
1129375|NCT01294787|2733413|P2|COMPLETED|Period 1||16
1129376|NCT01294787|2733414|P1|COMPLETED|Period 1||12
1129377|NCT01294787|2733409|P6|STARTED|Period 1|One randomized participant did not receive study drug|15
1129378|NCT01294787|2733410|P5|STARTED|Period 1||16
1129379|NCT01294787|2733411|P4|STARTED|Period 1||12
1129380|NCT01294787|2733412|P3|STARTED|Period 1||14
1129381|NCT01294787|2733413|P2|STARTED|Period 1||16
1129382|NCT01294787|2733414|P1|STARTED|Period 1||12
1129383|NCT01294800|2733460|P4|NOT COMPLETED|Overall Study||16
1129384|NCT01294800|2733461|P3|NOT COMPLETED|Overall Study||17
1129385|NCT01294800|2733462|P2|NOT COMPLETED|Overall Study||10
1129386|NCT01294800|2733463|P1|NOT COMPLETED|Overall Study||11
1129387|NCT01294800|2733460|P4|COMPLETED|Overall Study||97
1129388|NCT01294800|2733461|P3|COMPLETED|Overall Study||96
1129389|NCT01294800|2733462|P2|COMPLETED|Overall Study||103
1129390|NCT01294800|2733463|P1|COMPLETED|Overall Study||100
1129391|NCT01294800|2733460|P4|STARTED|Overall Study||113
1129392|NCT01294800|2733461|P3|STARTED|Overall Study||113
1129393|NCT01294800|2733462|P2|STARTED|Overall Study||113
1129394|NCT01294800|2733463|P1|STARTED|Overall Study||111
1129395|NCT01294917|2733489|P1|NOT COMPLETED|Overall Study||6
1129396|NCT01294917|2733489|P1|COMPLETED|Overall Study||36
1129397|NCT01294917|2733489|P1|Received OptiFree RepleniSH MPS|Overall Study||36
1129398|NCT01294917|2733489|P1|Received Clear Care|Overall Study||36
1129399|NCT01294917|2733489|P1|Received Investigational MPS|Overall Study||36
1129400|NCT01294917|2733489|P1|STARTED|Overall Study||42
1129401|NCT01295034|2733497|P2|NOT COMPLETED|Overall Study||5
1129402|NCT01295034|2733498|P1|NOT COMPLETED|Overall Study||5
1129403|NCT01295034|2733497|P2|COMPLETED|Overall Study||25
1129404|NCT01295034|2733498|P1|COMPLETED|Overall Study||27
1129405|NCT01295034|2733497|P2|STARTED|Overall Study||30
1129406|NCT01295034|2733498|P1|STARTED|Overall Study||32
1129407|NCT01295216|2733508|P2|NOT COMPLETED|Overall Study||34
1129408|NCT01295216|2733509|P1|NOT COMPLETED|Overall Study||50
1129409|NCT01295216|2733508|P2|COMPLETED|Overall Study||287
1129410|NCT01295216|2733509|P1|COMPLETED|Overall Study||266
1129411|NCT01295216|2733508|P2|STARTED|Overall Study||321
1129412|NCT01295216|2733509|P1|STARTED|Overall Study||316
1129413|NCT01295281|2733527|P2|NOT COMPLETED|Second Intervention (7days)||0
1129414|NCT01295281|2733528|P1|NOT COMPLETED|Second Intervention (7days)||0
1129415|NCT01295281|2733527|P2|COMPLETED|Second Intervention (7days)||51
1129416|NCT01295281|2733528|P1|COMPLETED|Second Intervention (7days)||53
1129417|NCT01295281|2733527|P2|STARTED|Second Intervention (7days)||51
1129418|NCT01295281|2733528|P1|STARTED|Second Intervention (7days)||53
1129419|NCT01295281|2733527|P2|NOT COMPLETED|First Intervention (7 Days)||1
1129420|NCT01295281|2733528|P1|NOT COMPLETED|First Intervention (7 Days)||0
1129421|NCT01295281|2733527|P2|COMPLETED|First Intervention (7 Days)||51
1129422|NCT01295281|2733528|P1|COMPLETED|First Intervention (7 Days)||53
1129423|NCT01295281|2733527|P2|STARTED|First Intervention (7 Days)||52
1129424|NCT01295281|2733528|P1|STARTED|First Intervention (7 Days)||53
1129425|NCT01295320|2733534|P1|NOT COMPLETED|Overall Study||10
1129426|NCT01295320|2733534|P1|COMPLETED|Overall Study||119
1129427|NCT01295320|2733534|P1|STARTED|Overall Study||129
1129428|NCT01295814|2733551|P2|NOT COMPLETED|Overall Study||2
1129429|NCT01295814|2733552|P1|NOT COMPLETED|Overall Study||2
1129430|NCT01295814|2733551|P2|COMPLETED|Overall Study||19
1129431|NCT01295814|2733552|P1|COMPLETED|Overall Study||20
1129432|NCT01295814|2733551|P2|STARTED|Overall Study||21
1129433|NCT01295814|2733552|P1|STARTED|Overall Study||22
1129434|NCT01295840|2733566|P1|NOT COMPLETED|Overall Study||1
1129435|NCT01295840|2733566|P1|COMPLETED|Overall Study||50
1129436|NCT01295840|2733566|P1|STARTED|Overall Study||51
1129437|NCT01295879|2733580|P1|NOT COMPLETED|Overall Study||0
1129438|NCT01295879|2733580|P1|COMPLETED|Overall Study||29
1129439|NCT01295879|2733580|P1|STARTED|Overall Study||29
1129440|NCT01295905|2733588|P2|NOT COMPLETED|Overall Study||0
1129441|NCT01295905|2733589|P1|NOT COMPLETED|Overall Study||2
1129442|NCT01295905|2733588|P2|COMPLETED|Overall Study||30
1129443|NCT01295905|2733589|P1|COMPLETED|Overall Study||58
1129444|NCT01295905|2733588|P2|STARTED|Overall Study||30
1129445|NCT01295905|2733589|P1|STARTED|Overall Study||60
1129446|NCT01296035|2733601|P1|NOT COMPLETED|Overall Study||1
1129447|NCT01296035|2733601|P1|COMPLETED|Overall Study||7
1129448|NCT01296035|2733601|P1|STARTED|Overall Study||8
1129449|NCT01296152|2733606|P1|NOT COMPLETED|Overall Study||1
1129450|NCT01296152|2733606|P1|COMPLETED|Overall Study||24
1129451|NCT01296152|2733606|P1|STARTED|Overall Study||25
1129452|NCT01283971|2733635|P2|NOT COMPLETED|Overall Study||12
1129453|NCT01283971|2733636|P1|NOT COMPLETED|Overall Study||15
1129454|NCT01283971|2733635|P2|COMPLETED|Overall Study||36
1129455|NCT01283971|2733636|P1|COMPLETED|Overall Study||33
1129456|NCT01283971|2733635|P2|Intent to Treat Population|Overall Study||48
1129457|NCT01283971|2733636|P1|Intent to Treat Population|Overall Study||46
1129458|NCT01283971|2733635|P2|STARTED|Overall Study||48
1129459|NCT01283971|2733636|P1|STARTED|Overall Study||48
1129460|NCT01284062|2733684|P4|NOT COMPLETED|Overall Study||14
1129461|NCT01284062|2733685|P3|NOT COMPLETED|Overall Study||6
1129462|NCT01284062|2733686|P2|NOT COMPLETED|Overall Study||8
1129463|NCT01284062|2733687|P1|NOT COMPLETED|Overall Study||11
1129464|NCT01284062|2733684|P4|COMPLETED|Overall Study||7
1129465|NCT01284062|2733685|P3|COMPLETED|Overall Study||15
1129466|NCT01284062|2733686|P2|COMPLETED|Overall Study||13
1129467|NCT01284062|2733687|P1|COMPLETED|Overall Study||10
1129468|NCT01284062|2733684|P4|STARTED|Overall Study||21
1129469|NCT01284062|2733685|P3|STARTED|Overall Study||21
1129470|NCT01284062|2733686|P2|STARTED|Overall Study||21
1129471|NCT01284062|2733687|P1|STARTED|Overall Study||21
1129472|NCT01284114|2733759|P1|NOT COMPLETED|Overall Study||4
1129473|NCT01284114|2733759|P1|COMPLETED|Overall Study||19
1129474|NCT01284114|2733759|P1|STARTED|Overall Study||23
1129475|NCT01284244|2733769|P2|NOT COMPLETED|Overall Study||0
1129476|NCT01284244|2733770|P1|NOT COMPLETED|Overall Study||0
1129477|NCT01284244|2733769|P2|COMPLETED|Overall Study||18
1129478|NCT01284244|2733770|P1|COMPLETED|Overall Study||18
1129479|NCT01284244|2733769|P2|STARTED|Overall Study||18
1129480|NCT01284244|2733770|P1|STARTED|Overall Study||18
1129481|NCT01289639|2733779|P3|NOT COMPLETED|Overall Study||0
1129482|NCT01289639|2733780|P2|NOT COMPLETED|Overall Study||0
1129483|NCT01289639|2733781|P1|NOT COMPLETED|Overall Study||1
1129484|NCT01289639|2733779|P3|COMPLETED|Overall Study||0
1129485|NCT01289639|2733780|P2|COMPLETED|Overall Study||6
1129486|NCT01289639|2733781|P1|COMPLETED|Overall Study||4
1129487|NCT01289639|2733779|P3|STARTED|Overall Study||0
1129488|NCT01289639|2733780|P2|STARTED|Overall Study||6
1129489|NCT01289639|2733781|P1|STARTED|Overall Study||5
1129490|NCT01289782|2733806|P2|NOT COMPLETED|Overall Study||12
1129491|NCT01289782|2733807|P1|NOT COMPLETED|Overall Study||25
1129492|NCT01289782|2733806|P2|COMPLETED|Overall Study||118
1129493|NCT01289782|2733807|P1|COMPLETED|Overall Study||239
1129494|NCT01289782|2733806|P2|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|130
1129495|NCT01289782|2733807|P1|STARTED|Overall Study||264
1129496|NCT01289821|2733876|P1|NOT COMPLETED|Survival Follow-up Period||18
1129497|NCT01289821|2733876|P1|COMPLETED|Survival Follow-up Period|34 participants died and completed survival follow-up period.|34
1129498|NCT01289821|2733876|P1|STARTED|Survival Follow-up Period||52
1129499|NCT01289821|2733876|P1|NOT COMPLETED|Safety Follow-up Period||5
1129500|NCT01289821|2733876|P1|COMPLETED|Safety Follow-up Period||49
1129501|NCT01289821|2733876|P1|STARTED|Safety Follow-up Period||54
1129502|NCT01289821|2733876|P1|NOT COMPLETED|Treatment Period||54
1129503|NCT01289821|2733876|P1|COMPLETED|Treatment Period||0
1129504|NCT01289821|2733876|P1|Participants Received Regorafenib|Treatment Period||54
1129505|NCT01289821|2733876|P1|STARTED|Treatment Period||54
1129506|NCT01289847|2733885|P1|NOT COMPLETED|Overall Study||1
1129507|NCT01289847|2733885|P1|COMPLETED|Overall Study||24
1129508|NCT01289847|2733885|P1|STARTED|Overall Study||25
1129509|NCT01289990|2733907|P13|NOT COMPLETED|Overall Study||98
1129510|NCT01289990|2733908|P12|NOT COMPLETED|Overall Study||68
1129511|NCT01289990|2733909|P11|NOT COMPLETED|Overall Study||76
1129512|NCT01289990|2733910|P10|NOT COMPLETED|Overall Study||86
1129513|NCT01289990|2733911|P9|NOT COMPLETED|Overall Study||75
1129514|NCT01289990|2733912|P8|NOT COMPLETED|Overall Study||55
1129515|NCT01289990|2733913|P7|NOT COMPLETED|Overall Study||88
1129516|NCT01289990|2733914|P6|NOT COMPLETED|Overall Study||74
1129517|NCT01289990|2733915|P5|NOT COMPLETED|Overall Study||72
1129518|NCT01289990|2733916|P4|NOT COMPLETED|Overall Study||87
1129519|NCT01289990|2733917|P3|NOT COMPLETED|Overall Study||109
1129520|NCT01289990|2733918|P2|NOT COMPLETED|Overall Study||81
1129521|NCT01289990|2733919|P1|NOT COMPLETED|Overall Study||77
1129522|NCT01289990|2733907|P13|COMPLETED|Overall Study||127
1129523|NCT01289990|2733908|P12|COMPLETED|Overall Study||150
1129524|NCT01289990|2733909|P11|COMPLETED|Overall Study||150
1129525|NCT01289990|2733910|P10|COMPLETED|Overall Study||121
1129526|NCT01289990|2733911|P9|COMPLETED|Overall Study||139
1129527|NCT01289990|2733912|P8|COMPLETED|Overall Study||162
1129528|NCT01289990|2733913|P7|COMPLETED|Overall Study||78
1129529|NCT01289990|2733914|P6|COMPLETED|Overall Study||94
1129530|NCT01289990|2733915|P5|COMPLETED|Overall Study||93
1129531|NCT01289990|2733916|P4|COMPLETED|Overall Study||136
1129532|NCT01289990|2733917|P3|COMPLETED|Overall Study||119
1129533|NCT01289990|2733918|P2|COMPLETED|Overall Study||143
1129534|NCT01289990|2733919|P1|COMPLETED|Overall Study||147
1129535|NCT01289990|2733907|P13|STARTED|Overall Study||225
1129536|NCT01289990|2733908|P12|STARTED|Overall Study||218
1129537|NCT01289990|2733909|P11|STARTED|Overall Study||226
1129538|NCT01289990|2733910|P10|STARTED|Overall Study||207
1129539|NCT01289990|2733911|P9|STARTED|Overall Study||214
1129540|NCT01289990|2733912|P8|STARTED|Overall Study||217
1129541|NCT01289990|2733913|P7|STARTED|Overall Study||166
1129542|NCT01289990|2733914|P6|STARTED|Overall Study||168
1129543|NCT01289990|2733915|P5|STARTED|Overall Study||165
1129544|NCT01289990|2733916|P4|STARTED|Overall Study||223
1129545|NCT01289990|2733917|P3|STARTED|Overall Study||228
1129546|NCT01289990|2733918|P2|STARTED|Overall Study||224
1129547|NCT01289990|2733919|P1|STARTED|Overall Study||224
1129548|NCT01290029|2734103|P1|NOT COMPLETED|Overall Study||2
1129549|NCT01290029|2734103|P1|COMPLETED|Overall Study||12
1129550|NCT01290029|2734103|P1|Received Study Treatment|Overall Study||12
1129551|NCT01290029|2734103|P1|STARTED|Overall Study||14
1129552|NCT01290068|2734118|P2|NOT COMPLETED|Overall Study||6
1129553|NCT01290068|2734119|P1|NOT COMPLETED|Overall Study||7
1129554|NCT01290068|2734118|P2|COMPLETED|Overall Study||94
1129555|NCT01290068|2734119|P1|COMPLETED|Overall Study||101
1129556|NCT01290068|2734118|P2|Implanted|Overall Study||98
1129557|NCT01290068|2734119|P1|Implanted|Overall Study||108
1129558|NCT01290068|2734118|P2|STARTED|Overall Study||100
1129559|NCT01290068|2734119|P1|STARTED|Overall Study||108
1129560|NCT01290094|2734131|P1|NOT COMPLETED|Overall Study||6
1129561|NCT01290094|2734131|P1|COMPLETED|Overall Study||35
1129562|NCT01290094|2734131|P1|STARTED|Overall Study||41
1129563|NCT01296347|2734144|P2|NOT COMPLETED|Overall Study||5
1129564|NCT01296347|2734145|P1|NOT COMPLETED|Overall Study||0
1129565|NCT01296347|2734144|P2|COMPLETED|Overall Study||47
1129566|NCT01296347|2734145|P1|COMPLETED|Overall Study||52
1129567|NCT01296347|2734144|P2|6 Weeks Afer Surgery|Overall Study||47
1129568|NCT01296347|2734145|P1|6 Weeks Afer Surgery|Overall Study||52
1129569|NCT01296347|2734144|P2|STARTED|Overall Study||52
1129570|NCT01296347|2734145|P1|STARTED|Overall Study||52
1129571|NCT01296360|2734153|P2|NOT COMPLETED|Overall Study||8
1129572|NCT01296360|2734154|P1|NOT COMPLETED|Overall Study||6
1129573|NCT01296360|2734153|P2|COMPLETED|Overall Study||142
1129574|NCT01296360|2734154|P1|COMPLETED|Overall Study||144
1129575|NCT01296360|2734153|P2|Visit 2a (Month 13)|Overall Study||0
1129576|NCT01296360|2734154|P1|Visit 2a (Month 13)|Overall Study|visit in Booster Group only: ~13 months after immunization in IC51-323 (i.e., 1 month post booster)|148
1129577|NCT01296360|2734153|P2|Visit 2 (Month 12)|Overall Study||149
1129578|NCT01296360|2734154|P1|Visit 2 (Month 12)|Overall Study|booster was administered|148
1129579|NCT01296360|2734153|P2|STARTED|Overall Study||150
1129580|NCT01296360|2734154|P1|STARTED|Overall Study||150
1129581|NCT01296412|2734162|P2|NOT COMPLETED|Overall Study||70
1129582|NCT01296412|2734163|P1|NOT COMPLETED|Overall Study||51
1129583|NCT01296412|2734162|P2|COMPLETED|Overall Study||257
1129584|NCT01296412|2734163|P1|COMPLETED|Overall Study||275
1129585|NCT01296412|2734162|P2|STARTED|Overall Study||327
1129586|NCT01296412|2734163|P1|STARTED|Overall Study||326
1129587|NCT01299571|2734175|P1|NOT COMPLETED|Overall Study||107
1129588|NCT01299571|2734175|P1|COMPLETED|Overall Study||3870
1129589|NCT01299571|2734175|P1|STARTED|Overall Study||3977
1129590|NCT01299584|2734181|P1|NOT COMPLETED|Overall Study||9
1129591|NCT01299584|2734181|P1|COMPLETED|Overall Study||766
1129592|NCT01299584|2734181|P1|STARTED|Overall Study||775
1129593|NCT01299805|2734190|P2|NOT COMPLETED|Overall Study||0
1129594|NCT01299805|2734191|P1|NOT COMPLETED|Overall Study||2
1129595|NCT01299805|2734190|P2|COMPLETED|Overall Study||5
1129596|NCT01299805|2734191|P1|COMPLETED|Overall Study||10
1129597|NCT01299805|2734190|P2|STARTED|Overall Study||5
1129598|NCT01299805|2734191|P1|STARTED|Overall Study||12
1129599|NCT01299896|2734221|P2|NOT COMPLETED|Overall Study||18
1129600|NCT01299896|2734222|P1|NOT COMPLETED|Overall Study||1
1129601|NCT01299896|2734221|P2|COMPLETED|Overall Study||296
1129602|NCT01299896|2734222|P1|COMPLETED|Overall Study||318
1129603|NCT01299896|2734221|P2|STARTED|Overall Study||314
1129604|NCT01299896|2734222|P1|STARTED|Overall Study||319
1129605|NCT01299909|2734231|P3|NOT COMPLETED|Overall Study||17
1129606|NCT01299909|2734232|P2|NOT COMPLETED|Overall Study||18
1129607|NCT01299909|2734233|P1|NOT COMPLETED|Overall Study||22
1129608|NCT01299909|2734231|P3|COMPLETED|Overall Study||23
1129609|NCT01299909|2734232|P2|COMPLETED|Overall Study||49
1129610|NCT01299909|2734233|P1|COMPLETED|Overall Study||46
1129611|NCT01299909|2734231|P3|STARTED|Overall Study||40
1129612|NCT01299909|2734232|P2|STARTED|Overall Study||67
1129613|NCT01299909|2734233|P1|STARTED|Overall Study||68
1129614|NCT01299961|2734240|P1|NOT COMPLETED|Overall Study||6
1129615|NCT01299961|2734240|P1|COMPLETED|Overall Study||19
1129616|NCT01299961|2734240|P1|STARTED|Overall Study||25
1129617|NCT01300052|2734248|P2|NOT COMPLETED|Overall Study||3
1129618|NCT01300052|2734249|P1|NOT COMPLETED|Overall Study||6
1129619|NCT01300052|2734248|P2|COMPLETED|Overall Study||19
1129620|NCT01300052|2734249|P1|COMPLETED|Overall Study||40
1129621|NCT01300052|2734248|P2|STARTED|Overall Study||22
1129622|NCT01300052|2734249|P1|STARTED|Overall Study||46
1129623|NCT01300234|2734269|P2|NOT COMPLETED|Overall Study||10
1129624|NCT01300234|2734270|P1|NOT COMPLETED|Overall Study||4
1129625|NCT01300234|2734269|P2|COMPLETED|Overall Study||245
1129626|NCT01300234|2734270|P1|COMPLETED|Overall Study||253
1129627|NCT01300234|2734269|P2|STARTED|Overall Study||255
1129628|NCT01300234|2734270|P1|STARTED|Overall Study||257
1129629|NCT01300247|2734302|P2|NOT COMPLETED|Overall Study||2
1129630|NCT01300247|2734303|P1|NOT COMPLETED|Overall Study||4
1129631|NCT01300247|2734302|P2|COMPLETED|Overall Study||18
1129632|NCT01300247|2734303|P1|COMPLETED|Overall Study||17
1129633|NCT01300247|2734302|P2|STARTED|Overall Study||20
1129634|NCT01300247|2734303|P1|STARTED|Overall Study||21
1129635|NCT01300260|2734335|P2|NOT COMPLETED|Period 2 of Study: Second Intervention||1
1129636|NCT01300260|2734336|P1|NOT COMPLETED|Period 2 of Study: Second Intervention||0
1129637|NCT01300260|2734335|P2|COMPLETED|Period 2 of Study: Second Intervention||15
1129638|NCT01300260|2734336|P1|COMPLETED|Period 2 of Study: Second Intervention||14
1129639|NCT01300260|2734335|P2|STARTED|Period 2 of Study: Second Intervention||16
1129640|NCT01300260|2734336|P1|STARTED|Period 2 of Study: Second Intervention||14
1129641|NCT01300260|2734335|P2|NOT COMPLETED|Washout Period of at Least 28 Days||0
1129642|NCT01300260|2734336|P1|NOT COMPLETED|Washout Period of at Least 28 Days||0
1129643|NCT01300260|2734335|P2|COMPLETED|Washout Period of at Least 28 Days||16
1129644|NCT01300260|2734336|P1|COMPLETED|Washout Period of at Least 28 Days||14
1129645|NCT01300260|2734335|P2|STARTED|Washout Period of at Least 28 Days||16
1129646|NCT01300260|2734336|P1|STARTED|Washout Period of at Least 28 Days||14
1129647|NCT01300260|2734335|P2|NOT COMPLETED|Period 1 of Study: First Intervention||1
1129648|NCT01300260|2734336|P1|NOT COMPLETED|Period 1 of Study: First Intervention||1
1129649|NCT01300260|2734335|P2|COMPLETED|Period 1 of Study: First Intervention||16
1129650|NCT01300260|2734336|P1|COMPLETED|Period 1 of Study: First Intervention||14
1129651|NCT01300260|2734335|P2|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||17
1129652|NCT01300260|2734336|P1|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||15
1129653|NCT01300260|2734335|P2|STARTED|Period 1 of Study: First Intervention||17
1129654|NCT01300260|2734336|P1|STARTED|Period 1 of Study: First Intervention||15
1129655|NCT01300286|2734366|P1|NOT COMPLETED|Overall Study||1
1129656|NCT01300286|2734366|P1|COMPLETED|Overall Study||22
1129657|NCT01300286|2734366|P1|STARTED|Overall Study||23
1129658|NCT01300338|2734376|P2|NOT COMPLETED|Overall Study||0
1129659|NCT01300338|2734377|P1|NOT COMPLETED|Overall Study||5
1129660|NCT01300338|2734376|P2|COMPLETED|Overall Study||25
1129661|NCT01300338|2734377|P1|COMPLETED|Overall Study||20
1129662|NCT01300338|2734376|P2|STARTED|Overall Study||25
1129663|NCT01300338|2734377|P1|STARTED|Overall Study||25
1129664|NCT01300351|2734387|P2|NOT COMPLETED|Overall Study||38
1129665|NCT01300351|2734388|P1|NOT COMPLETED|Overall Study||36
1129666|NCT01300351|2734387|P2|COMPLETED|Overall Study||72
1129667|NCT01300351|2734388|P1|COMPLETED|Overall Study||75
1129668|NCT01300351|2734387|P2|Received Study Treatment|Overall Study||110
1129669|NCT01300351|2734388|P1|Received Study Treatment|Overall Study||109
1129670|NCT01300351|2734387|P2|STARTED|Overall Study||110
1129671|NCT01300351|2734388|P1|STARTED|Overall Study||111
1129672|NCT01300455|2734404|P2|NOT COMPLETED|Period 2||0
1129673|NCT01300455|2734405|P1|NOT COMPLETED|Period 2||0
1129674|NCT01300455|2734404|P2|COMPLETED|Period 2||13
1129675|NCT01300455|2734405|P1|COMPLETED|Period 2||12
1129676|NCT01300455|2734404|P2|STARTED|Period 2||13
1129677|NCT01300455|2734405|P1|STARTED|Period 2||12
1129678|NCT01300455|2734404|P2|NOT COMPLETED|Washout||0
1129679|NCT01300455|2734405|P1|NOT COMPLETED|Washout||1
1129680|NCT01300455|2734404|P2|COMPLETED|Washout||13
1129681|NCT01300455|2734405|P1|COMPLETED|Washout||12
1129682|NCT01300455|2734404|P2|STARTED|Washout||13
1129683|NCT01300455|2734405|P1|STARTED|Washout||13
1129684|NCT01300455|2734404|P2|NOT COMPLETED|Period 1||0
1129685|NCT01300455|2734405|P1|NOT COMPLETED|Period 1||0
1129686|NCT01300455|2734404|P2|COMPLETED|Period 1||13
1129687|NCT01300455|2734405|P1|COMPLETED|Period 1||13
1129688|NCT01300455|2734404|P2|STARTED|Period 1||13
1129689|NCT01300455|2734405|P1|STARTED|Period 1||13
1129690|NCT01300546|2734425|P2|NOT COMPLETED|Overall Study||6
1129691|NCT01300546|2734426|P1|NOT COMPLETED|Overall Study||1
1129692|NCT01300546|2734425|P2|COMPLETED|Overall Study||14
1129693|NCT01300546|2734426|P1|COMPLETED|Overall Study||18
1129694|NCT01300546|2734425|P2|STARTED|Overall Study||20
1129695|NCT01300546|2734426|P1|STARTED|Overall Study||19
1129696|NCT01300559|2734456|P2|NOT COMPLETED|Overall Study||0
1129697|NCT01300559|2734457|P1|NOT COMPLETED|Overall Study||0
1129698|NCT01300559|2734456|P2|COMPLETED|Overall Study||30
1129699|NCT01300559|2734457|P1|COMPLETED|Overall Study||30
1129700|NCT01300559|2734456|P2|STARTED|Overall Study||30
1129701|NCT01300559|2734457|P1|STARTED|Overall Study||30
1129702|NCT01300624|2734463|P1|NOT COMPLETED|Overall Study||0
1129703|NCT01300624|2734463|P1|COMPLETED|Overall Study||11
1129704|NCT01300624|2734463|P1|STARTED|Overall Study||11
1129705|NCT01300650|2734473|P1|NOT COMPLETED|Overall Study||1
1129706|NCT01300650|2734473|P1|COMPLETED|Overall Study||7
1129707|NCT01300650|2734473|P1|STARTED|Overall Study||8
1129708|NCT01300728|2734481|P2|NOT COMPLETED|Overall Study||1
1129709|NCT01300728|2734482|P1|NOT COMPLETED|Overall Study||2
1129710|NCT01300728|2734481|P2|COMPLETED|Overall Study||25
1129711|NCT01300728|2734482|P1|COMPLETED|Overall Study||24
1129712|NCT01300728|2734481|P2|STARTED|Overall Study||26
1129713|NCT01300728|2734482|P1|STARTED|Overall Study||26
1129714|NCT01300741|2734496|P1|NOT COMPLETED|Overall Study||3
1129715|NCT01300741|2734496|P1|COMPLETED|Overall Study||72
1129716|NCT01300741|2734496|P1|STARTED|Overall Study||75
1129717|NCT01300767|2734524|P1|NOT COMPLETED|Overall Study||4
1129718|NCT01300767|2734524|P1|COMPLETED|Overall Study||70
1129719|NCT01300767|2734524|P1|STARTED|Overall Study||74
1129720|NCT01300819|2734554|P2|NOT COMPLETED|Overall Study||44
1129721|NCT01300819|2734555|P1|NOT COMPLETED|Overall Study||22
1129722|NCT01300819|2734554|P2|COMPLETED|Overall Study||180
1129723|NCT01300819|2734555|P1|COMPLETED|Overall Study||103
1129724|NCT01300819|2734554|P2|STARTED|Overall Study||224
1129725|NCT01300819|2734555|P1|STARTED|Overall Study||125
1129726|NCT01300923|2734583|P2|NOT COMPLETED|Overall Study||2
1129727|NCT01300923|2734584|P1|NOT COMPLETED|Overall Study||0
1129728|NCT01300923|2734583|P2|COMPLETED|Overall Study||0
1129729|NCT01300923|2734584|P1|COMPLETED|Overall Study||12
1129730|NCT01300923|2734583|P2|STARTED|Overall Study||2
1129731|NCT01300923|2734584|P1|STARTED|Overall Study||12
1129732|NCT01301027|2734597|P2|NOT COMPLETED|Overall Study||10
1129733|NCT01301027|2734598|P1|NOT COMPLETED|Overall Study||8
1129734|NCT01301027|2734597|P2|COMPLETED|Overall Study||37
1129735|NCT01301027|2734598|P1|COMPLETED|Overall Study||40
1129736|NCT01301027|2734597|P2|STARTED|Overall Study||47
1129737|NCT01301027|2734598|P1|STARTED|Overall Study||48
1129738|NCT01301066|2734612|P2|NOT COMPLETED|Overall Study||35
1129739|NCT01301066|2734613|P1|NOT COMPLETED|Overall Study||27
1129740|NCT01301066|2734612|P2|COMPLETED|Overall Study||91
1129741|NCT01301066|2734613|P1|COMPLETED|Overall Study||99
1129742|NCT01301066|2734612|P2|STARTED|Overall Study||126
1129743|NCT01301066|2734613|P1|STARTED|Overall Study||126
1129744|NCT01301079|2734621|P2|NOT COMPLETED|Overall Study||2
1129745|NCT01301079|2734622|P1|NOT COMPLETED|Overall Study||2
1129746|NCT01301079|2734621|P2|COMPLETED|Overall Study||28
1129747|NCT01301079|2734622|P1|COMPLETED|Overall Study||28
1129748|NCT01301079|2734621|P2|STARTED|Overall Study||30
1129749|NCT01301079|2734622|P1|STARTED|Overall Study||30
1129750|NCT01301092|2734701|P3|NOT COMPLETED|Overall Study||1
1129751|NCT01301092|2734702|P2|NOT COMPLETED|Overall Study||0
1129752|NCT01301092|2734703|P1|NOT COMPLETED|Overall Study||0
1129753|NCT01301092|2734701|P3|COMPLETED|Overall Study||7
1129754|NCT01301092|2734702|P2|COMPLETED|Overall Study||16
1129755|NCT01301092|2734703|P1|COMPLETED|Overall Study||6
1129756|NCT01301092|2734701|P3|STARTED|Overall Study||8
1129757|NCT01301092|2734702|P2|STARTED|Overall Study||16
1129758|NCT01301092|2734703|P1|STARTED|Overall Study||6
1129759|NCT01301274|2734720|P2|NOT COMPLETED|Overall Study||1
1129760|NCT01301274|2734721|P1|NOT COMPLETED|Overall Study||2
1129761|NCT01301274|2734720|P2|COMPLETED|Overall Study||31
1129762|NCT01301274|2734721|P1|COMPLETED|Overall Study||32
1129763|NCT01301274|2734720|P2|STARTED|Overall Study||32
1129764|NCT01301274|2734721|P1|STARTED|Overall Study||34
1129765|NCT01301508|2734735|P2|NOT COMPLETED|Overall Study||3
1129766|NCT01301508|2734736|P1|NOT COMPLETED|Overall Study||1
1129767|NCT01301508|2734735|P2|COMPLETED|Overall Study||22
1129768|NCT01301508|2734736|P1|COMPLETED|Overall Study||20
1129769|NCT01301508|2734735|P2|STARTED|Overall Study||25
1129770|NCT01301508|2734736|P1|STARTED|Overall Study||21
1129771|NCT01301729|2734754|P1|NOT COMPLETED|Overall Study||4
1129772|NCT01301729|2734754|P1|COMPLETED|Overall Study||28
1129773|NCT01301729|2734754|P1|STARTED|Overall Study||32
1129774|NCT01301742|2734765|P2|NOT COMPLETED|Second Intervention||0
1129775|NCT01301742|2734766|P1|NOT COMPLETED|Second Intervention||0
1129776|NCT01301742|2734765|P2|COMPLETED|Second Intervention||9
1129777|NCT01301742|2734766|P1|COMPLETED|Second Intervention||9
1129778|NCT01301742|2734765|P2|STARTED|Second Intervention||9
1129779|NCT01301742|2734766|P1|STARTED|Second Intervention||9
1129780|NCT01301742|2734765|P2|NOT COMPLETED|Washout Period of at Least 7 Days||0
1129781|NCT01301742|2734766|P1|NOT COMPLETED|Washout Period of at Least 7 Days||0
1129782|NCT01301742|2734765|P2|COMPLETED|Washout Period of at Least 7 Days||9
1129783|NCT01301742|2734766|P1|COMPLETED|Washout Period of at Least 7 Days||9
1129784|NCT01301742|2734765|P2|STARTED|Washout Period of at Least 7 Days||9
1129785|NCT01301742|2734766|P1|STARTED|Washout Period of at Least 7 Days||9
1129786|NCT01301742|2734765|P2|NOT COMPLETED|First Intervention||0
1129787|NCT01301742|2734766|P1|NOT COMPLETED|First Intervention||0
1129788|NCT01301742|2734765|P2|COMPLETED|First Intervention||9
1129789|NCT01301742|2734766|P1|COMPLETED|First Intervention||9
1129790|NCT01301742|2734765|P2|STARTED|First Intervention||9
1129791|NCT01301742|2734766|P1|STARTED|First Intervention||9
1129792|NCT01301833|2734781|P4|NOT COMPLETED|Overall Study||7
1129793|NCT01301833|2734782|P3|NOT COMPLETED|Overall Study||7
1129794|NCT01301833|2734783|P2|NOT COMPLETED|Overall Study||8
1129795|NCT01301833|2734784|P1|NOT COMPLETED|Overall Study||15
1129796|NCT01301833|2734781|P4|COMPLETED|Overall Study||68
1129797|NCT01301833|2734782|P3|COMPLETED|Overall Study||88
1129798|NCT01301833|2734783|P2|COMPLETED|Overall Study||72
1129799|NCT01301833|2734784|P1|COMPLETED|Overall Study||197
1129800|NCT01301833|2734781|P4|STARTED|Overall Study||75
1129801|NCT01301833|2734782|P3|STARTED|Overall Study||95
1129802|NCT01301833|2734783|P2|STARTED|Overall Study||80
1129803|NCT01301833|2734784|P1|STARTED|Overall Study||212
1129804|NCT01301950|2734812|P2|NOT COMPLETED|Overall Study||1
1129805|NCT01301950|2734813|P1|NOT COMPLETED|Overall Study||0
1129806|NCT01301950|2734812|P2|COMPLETED|Overall Study||14
1129807|NCT01301950|2734813|P1|COMPLETED|Overall Study||15
1129808|NCT01301950|2734812|P2|STARTED|Overall Study||15
1129809|NCT01301950|2734813|P1|STARTED|Overall Study||15
1129810|NCT01301963|2734829|P2|NOT COMPLETED|Overall Study||0
1129811|NCT01301963|2734830|P1|NOT COMPLETED|Overall Study||0
1129812|NCT01301963|2734829|P2|COMPLETED|Overall Study||4
1129813|NCT01301963|2734830|P1|COMPLETED|Overall Study||5
1129814|NCT01301963|2734829|P2|STARTED|Overall Study||4
1129815|NCT01301963|2734830|P1|STARTED|Overall Study||5
1129816|NCT01302041|2734838|P1|NOT COMPLETED|Overall Study||50
1129817|NCT01302041|2734838|P1|COMPLETED|Overall Study|Participants who discontinued treatment and completed the 30-day follow-up visit|17
1129818|NCT01302041|2734838|P1|STARTED|Overall Study||67
1129819|NCT01293006|2734871|P4|NOT COMPLETED|Period 2||0
1129820|NCT01293006|2734872|P3|NOT COMPLETED|Period 2||0
1129821|NCT01293006|2734873|P2|NOT COMPLETED|Period 2||0
1129822|NCT01293006|2734874|P1|NOT COMPLETED|Period 2||1
1129823|NCT01293006|2734871|P4|COMPLETED|Period 2||3
1129824|NCT01293006|2734872|P3|COMPLETED|Period 2||9
1129825|NCT01293006|2734873|P2|COMPLETED|Period 2||2
1129826|NCT01293006|2734874|P1|COMPLETED|Period 2||10
1129827|NCT01293006|2734871|P4|STARTED|Period 2||3
1129828|NCT01293006|2734872|P3|STARTED|Period 2||9
1129829|NCT01293006|2734873|P2|STARTED|Period 2||2
1129830|NCT01293006|2734874|P1|STARTED|Period 2||11
1129831|NCT01293006|2734871|P4|NOT COMPLETED|Washout||0
1129832|NCT01293006|2734872|P3|NOT COMPLETED|Washout||0
1129833|NCT01293006|2734873|P2|NOT COMPLETED|Washout||0
1129834|NCT01293006|2734874|P1|NOT COMPLETED|Washout||0
1129835|NCT01293006|2734871|P4|COMPLETED|Washout||3
1129836|NCT01293006|2734872|P3|COMPLETED|Washout||9
1129837|NCT01293006|2734873|P2|COMPLETED|Washout||2
1129838|NCT01293006|2734874|P1|COMPLETED|Washout||11
1129839|NCT01293006|2734871|P4|STARTED|Washout||3
1129840|NCT01293006|2734872|P3|STARTED|Washout||9
1129841|NCT01293006|2734873|P2|STARTED|Washout||2
1129842|NCT01293006|2734874|P1|STARTED|Washout||11
1129843|NCT01293006|2734871|P4|NOT COMPLETED|Period 1||0
1129844|NCT01293006|2734872|P3|NOT COMPLETED|Period 1||0
1129845|NCT01293006|2734873|P2|NOT COMPLETED|Period 1||0
1129846|NCT01293006|2734874|P1|NOT COMPLETED|Period 1||0
1129847|NCT01293006|2734871|P4|COMPLETED|Period 1||3
1129848|NCT01293006|2734872|P3|COMPLETED|Period 1||9
1129849|NCT01293006|2734873|P2|COMPLETED|Period 1||2
1129850|NCT01293006|2734874|P1|COMPLETED|Period 1||11
1129851|NCT01293006|2734871|P4|STARTED|Period 1||3
1129852|NCT01293006|2734872|P3|STARTED|Period 1||9
1129853|NCT01293006|2734873|P2|STARTED|Period 1||2
1129854|NCT01293006|2734874|P1|STARTED|Period 1||11
1129855|NCT01293032|2734899|P4|NOT COMPLETED|Treatment||1
1129856|NCT01293032|2734900|P3|NOT COMPLETED|Treatment||1
1129857|NCT01293032|2734901|P2|NOT COMPLETED|Treatment||5
1129858|NCT01293032|2734902|P1|NOT COMPLETED|Treatment||2
1129859|NCT01293032|2734899|P4|COMPLETED|Treatment||13
1129860|NCT01293032|2734900|P3|COMPLETED|Treatment||10
1129861|NCT01293032|2734901|P2|COMPLETED|Treatment||14
1129862|NCT01293032|2734902|P1|COMPLETED|Treatment||10
1129863|NCT01293032|2734899|P4|STARTED|Treatment||14
1129864|NCT01293032|2734900|P3|STARTED|Treatment||11
1129865|NCT01293032|2734901|P2|STARTED|Treatment|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|19
1129866|NCT01293032|2734902|P1|STARTED|Treatment||12
1129867|NCT01293032|2734899|P4|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
1129868|NCT01293032|2734900|P3|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||5
1129869|NCT01293032|2734901|P2|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
1129870|NCT01293032|2734902|P1|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
1129871|NCT01293032|2734899|P4|COMPLETED|Recurrence Score(RS)Assigned/Randomized||14
1129872|NCT01293032|2734900|P3|COMPLETED|Recurrence Score(RS)Assigned/Randomized|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|11
1129873|NCT01293032|2734901|P2|COMPLETED|Recurrence Score(RS)Assigned/Randomized||17
1129874|NCT01293032|2734902|P1|COMPLETED|Recurrence Score(RS)Assigned/Randomized||12
1129875|NCT01293032|2734899|P4|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||14
1129876|NCT01293032|2734900|P3|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||16
1129877|NCT01293032|2734901|P2|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||17
1129878|NCT01293032|2734902|P1|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||12
1129879|NCT01293032|2734899|P4|STARTED|Recurrence Score(RS)Assigned/Randomized||14
1129880|NCT01293032|2734900|P3|STARTED|Recurrence Score(RS)Assigned/Randomized||16
1129881|NCT01293032|2734901|P2|STARTED|Recurrence Score(RS)Assigned/Randomized||17
1129882|NCT01293032|2734902|P1|STARTED|Recurrence Score(RS)Assigned/Randomized||12
1129883|NCT01293084|2734909|P1|NOT COMPLETED|Overall Study||5
1129884|NCT01293084|2734909|P1|COMPLETED|Overall Study||12
1129885|NCT01293084|2734909|P1|STARTED|Overall Study||17
1129886|NCT01293240|2734917|P1|NOT COMPLETED|Overall Study||2
1129887|NCT01293240|2734917|P1|COMPLETED|Overall Study||115
1129888|NCT01293240|2734917|P1|STARTED|Overall Study||117
1129889|NCT01293539|2734932|P1|NOT COMPLETED|Overall Study||1
1129890|NCT01293539|2734932|P1|COMPLETED|Overall Study||9
1129891|NCT01293539|2734932|P1|STARTED|Overall Study||10
1129892|NCT01293695|2734938|P2|NOT COMPLETED|Overall Study||7
1129893|NCT01293695|2734939|P1|NOT COMPLETED|Overall Study||15
1129894|NCT01293695|2734938|P2|COMPLETED|Overall Study||87
1129895|NCT01293695|2734939|P1|COMPLETED|Overall Study||78
1129896|NCT01293695|2734938|P2|STARTED|Overall Study||94
1129897|NCT01293695|2734939|P1|STARTED|Overall Study||93
1129898|NCT01302054|2734953|P3|NOT COMPLETED|Double-Blind Treatment Phase||46
1129899|NCT01302054|2734954|P2|NOT COMPLETED|Double-Blind Treatment Phase||27
1129900|NCT01302054|2734955|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
1129901|NCT01302054|2734953|P3|COMPLETED|Double-Blind Treatment Phase||255
1129902|NCT01302054|2734954|P2|COMPLETED|Double-Blind Treatment Phase||281
1129903|NCT01302054|2734955|P1|COMPLETED|Double-Blind Treatment Phase||0
1129904|NCT01302054|2734953|P3|STARTED|Double-Blind Treatment Phase||301
1129905|NCT01302054|2734954|P2|STARTED|Double-Blind Treatment Phase||308
1129906|NCT01302054|2734955|P1|STARTED|Double-Blind Treatment Phase||0
1129907|NCT01302054|2734953|P3|NOT COMPLETED|Between Open-Label and Double Blind||0
1129908|NCT01302054|2734954|P2|NOT COMPLETED|Between Open-Label and Double Blind||0
1129909|NCT01302054|2734955|P1|NOT COMPLETED|Between Open-Label and Double Blind||2
1129910|NCT01302054|2734953|P3|COMPLETED|Between Open-Label and Double Blind||0
1129911|NCT01302054|2734954|P2|COMPLETED|Between Open-Label and Double Blind||0
1129912|NCT01302054|2734955|P1|COMPLETED|Between Open-Label and Double Blind||609
1129913|NCT01302054|2734953|P3|STARTED|Between Open-Label and Double Blind||0
1129914|NCT01302054|2734954|P2|STARTED|Between Open-Label and Double Blind||0
1129915|NCT01302054|2734955|P1|STARTED|Between Open-Label and Double Blind||611
1129916|NCT01302054|2734953|P3|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
1129917|NCT01302054|2734954|P2|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
1129918|NCT01302054|2734955|P1|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||379
1129919|NCT01302054|2734953|P3|COMPLETED|Tolterodine Open-Label Run-In Phase||0
1129920|NCT01302054|2734954|P2|COMPLETED|Tolterodine Open-Label Run-In Phase||0
1129921|NCT01302054|2734955|P1|COMPLETED|Tolterodine Open-Label Run-In Phase||611
1129922|NCT01302054|2734953|P3|STARTED|Tolterodine Open-Label Run-In Phase||0
1129923|NCT01302054|2734954|P2|STARTED|Tolterodine Open-Label Run-In Phase||0
1129924|NCT01302054|2734955|P1|STARTED|Tolterodine Open-Label Run-In Phase||990
1129925|NCT01302067|2734985|P3|NOT COMPLETED|Overall Study||98
1129926|NCT01302067|2734986|P2|NOT COMPLETED|Overall Study||34
1129927|NCT01302067|2734987|P1|NOT COMPLETED|Overall Study||78
1129928|NCT01302067|2734985|P3|COMPLETED|Overall Study||681
1129929|NCT01302067|2734986|P2|COMPLETED|Overall Study||352
1129930|NCT01302067|2734987|P1|COMPLETED|Overall Study||712
1129931|NCT01302067|2734985|P3|STARTED|Overall Study||779
1129932|NCT01302067|2734986|P2|STARTED|Overall Study||386
1129933|NCT01302067|2734987|P1|STARTED|Overall Study||790
1129934|NCT01302119|2735060|P2|NOT COMPLETED|Overall Study||28
1129935|NCT01302119|2735061|P1|NOT COMPLETED|Overall Study||50
1129936|NCT01302119|2735060|P2|COMPLETED|Overall Study||177
1129937|NCT01302119|2735061|P1|COMPLETED|Overall Study||349
1129938|NCT01302119|2735060|P2|STARTED|Overall Study||205
1129939|NCT01302119|2735061|P1|STARTED|Overall Study||399
1129940|NCT01302366|2735073|P1|NOT COMPLETED|Overall Study||5
1129941|NCT01302366|2735073|P1|COMPLETED|Overall Study||15
1129942|NCT01302366|2735073|P1|STARTED|Overall Study||20
1129943|NCT01302691|2735081|P2|NOT COMPLETED|Overall Study||6
1129944|NCT01302691|2735082|P1|NOT COMPLETED|Overall Study||10
1129945|NCT01302691|2735081|P2|COMPLETED|Overall Study||157
1129946|NCT01302691|2735082|P1|COMPLETED|Overall Study||154
1129947|NCT01302691|2735081|P2|STARTED|Overall Study||163
1129948|NCT01302691|2735082|P1|STARTED|Overall Study||164
1129949|NCT01302743|2735103|P3|NOT COMPLETED|Overall Study||2
1129950|NCT01302743|2735104|P2|NOT COMPLETED|Overall Study||1
1129951|NCT01302743|2735105|P1|NOT COMPLETED|Overall Study||1
1129952|NCT01302743|2735103|P3|COMPLETED|Overall Study||8
1129953|NCT01302743|2735104|P2|COMPLETED|Overall Study||7
1129954|NCT01302743|2735105|P1|COMPLETED|Overall Study||6
1129955|NCT01302743|2735103|P3|STARTED|Overall Study||10
1129956|NCT01302743|2735104|P2|STARTED|Overall Study||8
1129957|NCT01302743|2735105|P1|STARTED|Overall Study||7
1129958|NCT01302860|2735116|P1|NOT COMPLETED|Overall Study||0
1129959|NCT01302860|2735116|P1|COMPLETED|Overall Study||17
1129960|NCT01302860|2735116|P1|STARTED|Overall Study||17
1129961|NCT01302899|2735130|P2|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
1129962|NCT01302899|2735131|P1|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
1129963|NCT01302899|2735130|P2|COMPLETED|Period 4 (Weeks 19 to 26)||3
1129964|NCT01302899|2735131|P1|COMPLETED|Period 4 (Weeks 19 to 26)||3
1129965|NCT01302899|2735130|P2|STARTED|Period 4 (Weeks 19 to 26)||3
1129966|NCT01302899|2735131|P1|STARTED|Period 4 (Weeks 19 to 26)||3
1129967|NCT01302899|2735130|P2|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
1129968|NCT01302899|2735131|P1|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
1129969|NCT01302899|2735130|P2|COMPLETED|Period 3 (Weeks 13 to 18)||3
1129970|NCT01302899|2735131|P1|COMPLETED|Period 3 (Weeks 13 to 18)||3
1129971|NCT01302899|2735130|P2|STARTED|Period 3 (Weeks 13 to 18)||3
1129972|NCT01302899|2735131|P1|STARTED|Period 3 (Weeks 13 to 18)||3
1129973|NCT01302899|2735130|P2|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
1129974|NCT01302899|2735131|P1|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
1129975|NCT01302899|2735130|P2|COMPLETED|Period 2 (Weeks 7 to 12)||3
1129976|NCT01302899|2735131|P1|COMPLETED|Period 2 (Weeks 7 to 12)||3
1129977|NCT01302899|2735130|P2|STARTED|Period 2 (Weeks 7 to 12)||4
1129978|NCT01302899|2735131|P1|STARTED|Period 2 (Weeks 7 to 12)||4
1129979|NCT01302899|2735130|P2|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
1129980|NCT01302899|2735131|P1|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
1129981|NCT01302899|2735130|P2|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
1129982|NCT01302899|2735131|P1|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
1129983|NCT01302899|2735130|P2|STARTED|Period 1 (Day 1 to End of Week 6)||4
1129984|NCT01302899|2735131|P1|STARTED|Period 1 (Day 1 to End of Week 6)||4
1129985|NCT01302938|2735183|P2|NOT COMPLETED|Overall Study||0
1129986|NCT01302938|2735184|P1|NOT COMPLETED|Overall Study||2
1129987|NCT01302938|2735183|P2|COMPLETED|Overall Study||6
1129988|NCT01302938|2735184|P1|COMPLETED|Overall Study||10
1129989|NCT01302938|2735183|P2|STARTED|Overall Study||6
1129990|NCT01302938|2735184|P1|STARTED|Overall Study||12
1129991|NCT01303159|2735227|P1|NOT COMPLETED|Overall Study||23
1129992|NCT01303159|2735227|P1|COMPLETED|Overall Study||6
1129993|NCT01303159|2735227|P1|STARTED|Overall Study||29
1129994|NCT01303224|2735236|P4|NOT COMPLETED|Overall Study||10
1129995|NCT01303224|2735237|P3|NOT COMPLETED|Overall Study||6
1129996|NCT01303224|2735238|P2|NOT COMPLETED|Overall Study||11
1129997|NCT01303224|2735239|P1|NOT COMPLETED|Overall Study||11
1129998|NCT01303224|2735236|P4|COMPLETED|Overall Study||133
1129999|NCT01303224|2735237|P3|COMPLETED|Overall Study||133
1130000|NCT01303224|2735238|P2|COMPLETED|Overall Study||131
1130001|NCT01303224|2735239|P1|COMPLETED|Overall Study||130
1130002|NCT01303224|2735236|P4|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|142
1130003|NCT01303224|2735237|P3|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|139
1130004|NCT01303224|2735238|P2|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|138
1130005|NCT01303224|2735239|P1|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|140
1130006|NCT01303224|2735236|P4|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|143
1130007|NCT01303224|2735237|P3|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|139
1130008|NCT01303224|2735238|P2|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|142
1130009|NCT01303224|2735239|P1|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|141
1130010|NCT01303380|2735265|P1|NOT COMPLETED|Overall Study||1
1130011|NCT01303380|2735265|P1|COMPLETED|Overall Study||8
1130012|NCT01303380|2735265|P1|STARTED|Overall Study||9
1130013|NCT01303406|2735293|P2|NOT COMPLETED|Overall Study||1
1130014|NCT01303406|2735294|P1|NOT COMPLETED|Overall Study||0
1130015|NCT01303406|2735293|P2|COMPLETED|Overall Study||15
1130016|NCT01303406|2735294|P1|COMPLETED|Overall Study||13
1130017|NCT01303406|2735293|P2|STARTED|Overall Study||16
1130018|NCT01303406|2735294|P1|STARTED|Overall Study||13
1130019|NCT01303445|2735302|P2|NOT COMPLETED|Follow-up Period (14 Days)||1
1130020|NCT01303445|2735303|P1|NOT COMPLETED|Follow-up Period (14 Days)||0
1130021|NCT01303445|2735302|P2|COMPLETED|Follow-up Period (14 Days)||25
1130022|NCT01303445|2735303|P1|COMPLETED|Follow-up Period (14 Days)||26
1130023|NCT01303445|2735302|P2|STARTED|Follow-up Period (14 Days)||26
1130024|NCT01303445|2735303|P1|STARTED|Follow-up Period (14 Days)||26
1130025|NCT01303445|2735302|P2|NOT COMPLETED|Fourth Intervention (7 Days)||0
1130026|NCT01303445|2735303|P1|NOT COMPLETED|Fourth Intervention (7 Days)||1
1130027|NCT01303445|2735302|P2|COMPLETED|Fourth Intervention (7 Days)||26
1130028|NCT01303445|2735303|P1|COMPLETED|Fourth Intervention (7 Days)||26
1130029|NCT01303445|2735302|P2|STARTED|Fourth Intervention (7 Days)||26
1130030|NCT01303445|2735303|P1|STARTED|Fourth Intervention (7 Days)||27
1130031|NCT01303445|2735302|P2|NOT COMPLETED|Third Intervention (7 Days)||0
1130032|NCT01303445|2735303|P1|NOT COMPLETED|Third Intervention (7 Days)||0
1130033|NCT01303445|2735302|P2|COMPLETED|Third Intervention (7 Days)||26
1130034|NCT01303445|2735303|P1|COMPLETED|Third Intervention (7 Days)||27
1130035|NCT01303445|2735302|P2|STARTED|Third Intervention (7 Days)||26
1130036|NCT01303445|2735303|P1|STARTED|Third Intervention (7 Days)||27
1130037|NCT01303445|2735302|P2|NOT COMPLETED|Washout (14 Days)||2
1130038|NCT01303445|2735303|P1|NOT COMPLETED|Washout (14 Days)||1
1130039|NCT01303445|2735302|P2|COMPLETED|Washout (14 Days)||26
1130040|NCT01303445|2735303|P1|COMPLETED|Washout (14 Days)||27
1130041|NCT01303445|2735302|P2|STARTED|Washout (14 Days)||28
1130042|NCT01303445|2735303|P1|STARTED|Washout (14 Days)||28
1130043|NCT01303445|2735302|P2|NOT COMPLETED|Second Intervention (7 Days)||2
1130044|NCT01303445|2735303|P1|NOT COMPLETED|Second Intervention (7 Days)||1
1130045|NCT01303445|2735302|P2|COMPLETED|Second Intervention (7 Days)||28
1130046|NCT01303445|2735303|P1|COMPLETED|Second Intervention (7 Days)||28
1130047|NCT01303445|2735302|P2|STARTED|Second Intervention (7 Days)||30
1130048|NCT01303445|2735303|P1|STARTED|Second Intervention (7 Days)||29
1130049|NCT01303445|2735302|P2|NOT COMPLETED|First Intervention (7 Days)||0
1130050|NCT01303445|2735303|P1|NOT COMPLETED|First Intervention (7 Days)||1
1130051|NCT01303445|2735302|P2|COMPLETED|First Intervention (7 Days)||30
1130052|NCT01303445|2735303|P1|COMPLETED|First Intervention (7 Days)||29
1130053|NCT01303445|2735302|P2|STARTED|First Intervention (7 Days)||30
1130054|NCT01303445|2735303|P1|STARTED|First Intervention (7 Days)||30
1130055|NCT01303510|2735335|P2|NOT COMPLETED|Overall Study||0
1130056|NCT01303510|2735336|P1|NOT COMPLETED|Overall Study||1
1130057|NCT01303510|2735335|P2|COMPLETED|Overall Study||56
1130058|NCT01303510|2735336|P1|COMPLETED|Overall Study||54
1130059|NCT01303510|2735335|P2|STARTED|Overall Study||56
1130060|NCT01303510|2735336|P1|STARTED|Overall Study||55
1130061|NCT01303627|2735352|P2|NOT COMPLETED|Overall Study||1
1130062|NCT01303627|2735353|P1|NOT COMPLETED|Overall Study||0
1130063|NCT01303627|2735352|P2|COMPLETED|Overall Study|One patient excluded from the study because of the failure while performing uretero-renoscopy|20
1130064|NCT01303627|2735353|P1|COMPLETED|Overall Study||21
1130065|NCT01303627|2735352|P2|STARTED|Overall Study||21
1130066|NCT01303627|2735353|P1|STARTED|Overall Study||21
1130067|NCT01303744|2735363|P4|NOT COMPLETED|Overall Study||0
1130068|NCT01303744|2735364|P3|NOT COMPLETED|Overall Study||0
1130069|NCT01303744|2735365|P2|NOT COMPLETED|Overall Study||0
1130070|NCT01303744|2735366|P1|NOT COMPLETED|Overall Study||0
1130071|NCT01303744|2735363|P4|COMPLETED|Overall Study||24
1130072|NCT01303744|2735364|P3|COMPLETED|Overall Study||24
1130073|NCT01303744|2735365|P2|COMPLETED|Overall Study||24
1130074|NCT01303744|2735366|P1|COMPLETED|Overall Study||24
1130075|NCT01303744|2735363|P4|STARTED|Overall Study||24
1130076|NCT01303744|2735364|P3|STARTED|Overall Study||24
1130077|NCT01303744|2735365|P2|STARTED|Overall Study||24
1130078|NCT01303744|2735366|P1|STARTED|Overall Study||24
1130079|NCT01303835|2735386|P2|NOT COMPLETED|Overall Study||25
1130080|NCT01303835|2735387|P1|NOT COMPLETED|Overall Study||19
1130081|NCT01303835|2735386|P2|COMPLETED|Overall Study||31
1130082|NCT01303835|2735387|P1|COMPLETED|Overall Study||35
1130083|NCT01303835|2735386|P2|STARTED|Overall Study||56
1130084|NCT01303835|2735387|P1|STARTED|Overall Study||54
1130085|NCT01303861|2735402|P4|NOT COMPLETED|Overall Study||59
1130086|NCT01303861|2735403|P3|NOT COMPLETED|Overall Study||36
1130087|NCT01303861|2735404|P2|NOT COMPLETED|Overall Study||25
1130088|NCT01303861|2735405|P1|NOT COMPLETED|Overall Study||58
1130089|NCT01303861|2735402|P4|COMPLETED|Overall Study||54
1130090|NCT01303861|2735403|P3|COMPLETED|Overall Study||19
1130091|NCT01303861|2735404|P2|COMPLETED|Overall Study||25
1130092|NCT01303861|2735405|P1|COMPLETED|Overall Study||51
1130093|NCT01303861|2735402|P4|Finished Treatment Phase|Overall Study||72
1130094|NCT01303861|2735403|P3|Finished Treatment Phase|Overall Study||39
1130095|NCT01303861|2735404|P2|Finished Treatment Phase|Overall Study||34
1130096|NCT01303861|2735405|P1|Finished Treatment Phase|Overall Study||71
1130097|NCT01303861|2735402|P4|STARTED|Overall Study||113
1130098|NCT01303861|2735403|P3|STARTED|Overall Study||55
1130099|NCT01303861|2735404|P2|STARTED|Overall Study||50
1130100|NCT01303861|2735405|P1|STARTED|Overall Study||109
1130101|NCT01304082|2735424|P5|NOT COMPLETED|Overall Study||0
1130102|NCT01304082|2735425|P4|NOT COMPLETED|Overall Study||0
1130103|NCT01304082|2735426|P3|NOT COMPLETED|Overall Study||0
1130104|NCT01304082|2735427|P2|NOT COMPLETED|Overall Study||0
1130105|NCT01304082|2735428|P1|NOT COMPLETED|Overall Study||0
1130106|NCT01304082|2735424|P5|COMPLETED|Overall Study||5
1130107|NCT01304082|2735425|P4|COMPLETED|Overall Study||8
1130108|NCT01304082|2735426|P3|COMPLETED|Overall Study||11
1130109|NCT01304082|2735427|P2|COMPLETED|Overall Study||2
1130110|NCT01304082|2735428|P1|COMPLETED|Overall Study||3
1130111|NCT01304082|2735424|P5|Third Intervention|Overall Study||5
1130112|NCT01304082|2735425|P4|Third Intervention|Overall Study||8
1130113|NCT01304082|2735426|P3|Third Intervention|Overall Study||11
1130114|NCT01304082|2735427|P2|Third Intervention|Overall Study||2
1130115|NCT01304082|2735428|P1|Third Intervention|Overall Study||3
1130116|NCT01304082|2735424|P5|Second Intervention|Overall Study||5
1130117|NCT01304082|2735425|P4|Second Intervention|Overall Study||8
1130118|NCT01304082|2735426|P3|Second Intervention|Overall Study||11
1130119|NCT01304082|2735427|P2|Second Intervention|Overall Study||2
1130120|NCT01304082|2735428|P1|Second Intervention|Overall Study||3
1130121|NCT01304082|2735424|P5|First Intervention|Overall Study||5
1130122|NCT01304082|2735425|P4|First Intervention|Overall Study||8
1130123|NCT01304082|2735426|P3|First Intervention|Overall Study||11
1130124|NCT01304082|2735427|P2|First Intervention|Overall Study||2
1130125|NCT01304082|2735428|P1|First Intervention|Overall Study||3
1130126|NCT01304082|2735424|P5|STARTED|Overall Study||5
1130127|NCT01304082|2735425|P4|STARTED|Overall Study||8
1130128|NCT01304082|2735426|P3|STARTED|Overall Study||11
1130129|NCT01304082|2735427|P2|STARTED|Overall Study||2
1130130|NCT01304082|2735428|P1|STARTED|Overall Study||3
1130131|NCT01304147|2735445|P2|NOT COMPLETED|Second Intervention (7days)||1
1130132|NCT01304147|2735446|P1|NOT COMPLETED|Second Intervention (7days)||1
1130133|NCT01304147|2735445|P2|COMPLETED|Second Intervention (7days)||9
1130134|NCT01304147|2735446|P1|COMPLETED|Second Intervention (7days)||9
1130135|NCT01304147|2735445|P2|STARTED|Second Intervention (7days)||10
1130136|NCT01304147|2735446|P1|STARTED|Second Intervention (7days)||10
1130137|NCT01304147|2735445|P2|NOT COMPLETED|Washout (1 Day)||0
1130138|NCT01304147|2735446|P1|NOT COMPLETED|Washout (1 Day)||0
1130139|NCT01304147|2735445|P2|COMPLETED|Washout (1 Day)||10
1130140|NCT01304147|2735446|P1|COMPLETED|Washout (1 Day)||10
1130141|NCT01304147|2735445|P2|STARTED|Washout (1 Day)||10
1130142|NCT01304147|2735446|P1|STARTED|Washout (1 Day)||10
1130143|NCT01304147|2735445|P2|NOT COMPLETED|First Intervention (7days)||0
1130144|NCT01304147|2735446|P1|NOT COMPLETED|First Intervention (7days)||0
1130145|NCT01304147|2735445|P2|COMPLETED|First Intervention (7days)||10
1130146|NCT01304147|2735446|P1|COMPLETED|First Intervention (7days)||10
1130147|NCT01304147|2735445|P2|STARTED|First Intervention (7days)||10
1130148|NCT01304147|2735446|P1|STARTED|First Intervention (7days)||10
1130149|NCT01304238|2735464|P10|NOT COMPLETED|Overall Study||0
1130150|NCT01304238|2735465|P9|NOT COMPLETED|Overall Study||0
1130151|NCT01304238|2735466|P8|NOT COMPLETED|Overall Study||0
1130152|NCT01304238|2735467|P7|NOT COMPLETED|Overall Study||0
1130153|NCT01304238|2735468|P6|NOT COMPLETED|Overall Study||0
1130154|NCT01304238|2735469|P5|NOT COMPLETED|Overall Study||0
1130155|NCT01304238|2735470|P4|NOT COMPLETED|Overall Study||0
1130156|NCT01304238|2735471|P3|NOT COMPLETED|Overall Study||0
1130157|NCT01304238|2735472|P2|NOT COMPLETED|Overall Study||0
1130158|NCT01304238|2735473|P1|NOT COMPLETED|Overall Study||0
1130159|NCT01304238|2735464|P10|COMPLETED|Overall Study||3
1130160|NCT01304238|2735465|P9|COMPLETED|Overall Study||1
1130161|NCT01304238|2735466|P8|COMPLETED|Overall Study||4
1130162|NCT01304238|2735467|P7|COMPLETED|Overall Study||5
1130163|NCT01304238|2735468|P6|COMPLETED|Overall Study||11
1130164|NCT01304238|2735469|P5|COMPLETED|Overall Study||11
1130165|NCT01304238|2735470|P4|COMPLETED|Overall Study||78
1130166|NCT01304238|2735471|P3|COMPLETED|Overall Study||46
1130167|NCT01304238|2735472|P2|COMPLETED|Overall Study||4
1130168|NCT01304238|2735473|P1|COMPLETED|Overall Study||32
1130169|NCT01304238|2735464|P10|STARTED|Overall Study||3
1130170|NCT01304238|2735465|P9|STARTED|Overall Study||1
1130171|NCT01304238|2735466|P8|STARTED|Overall Study||4
1130172|NCT01304238|2735467|P7|STARTED|Overall Study||5
1130173|NCT01304238|2735468|P6|STARTED|Overall Study||11
1130174|NCT01304238|2735469|P5|STARTED|Overall Study||11
1130175|NCT01304238|2735470|P4|STARTED|Overall Study||78
1130176|NCT01304238|2735471|P3|STARTED|Overall Study||46
1130177|NCT01304238|2735472|P2|STARTED|Overall Study||4
1130178|NCT01304238|2735473|P1|STARTED|Overall Study||32
1130179|NCT01304277|2735545|P1|NOT COMPLETED|Treatment (Replagal AF, Week 2- EOS)||0
1130180|NCT01304277|2735545|P1|COMPLETED|Treatment (Replagal AF, Week 2- EOS)||17
1130181|NCT01304277|2735545|P1|STARTED|Treatment (Replagal AF, Week 2- EOS)||17
1130182|NCT01304277|2735545|P1|NOT COMPLETED|Screening (Replagal RB, Week 0- Week 2)||0
1130183|NCT01304277|2735545|P1|COMPLETED|Screening (Replagal RB, Week 0- Week 2)||17
1130184|NCT01304277|2735545|P1|STARTED|Screening (Replagal RB, Week 0- Week 2)||17
1130185|NCT01304316|2735557|P1|NOT COMPLETED|Overall Study||0
1130186|NCT01304316|2735557|P1|COMPLETED|Overall Study||12
1130187|NCT01304316|2735557|P1|STARTED|Overall Study||12
1130188|NCT01304329|2735571|P6|NOT COMPLETED|Third Intervention (3 Days)||0
1130189|NCT01304329|2735572|P5|NOT COMPLETED|Third Intervention (3 Days)||0
1130190|NCT01304329|2735573|P4|NOT COMPLETED|Third Intervention (3 Days)||0
1130191|NCT01304329|2735574|P3|NOT COMPLETED|Third Intervention (3 Days)||0
1130192|NCT01304329|2735575|P2|NOT COMPLETED|Third Intervention (3 Days)||1
1130193|NCT01304329|2735576|P1|NOT COMPLETED|Third Intervention (3 Days)||0
1130194|NCT01304329|2735571|P6|COMPLETED|Third Intervention (3 Days)||3
1130195|NCT01304329|2735572|P5|COMPLETED|Third Intervention (3 Days)||3
1130196|NCT01304329|2735573|P4|COMPLETED|Third Intervention (3 Days)||3
1130197|NCT01304329|2735574|P3|COMPLETED|Third Intervention (3 Days)||3
1130198|NCT01304329|2735575|P2|COMPLETED|Third Intervention (3 Days)||2
1130199|NCT01304329|2735576|P1|COMPLETED|Third Intervention (3 Days)||3
1130200|NCT01304329|2735571|P6|STARTED|Third Intervention (3 Days)||3
1130201|NCT01304329|2735572|P5|STARTED|Third Intervention (3 Days)||3
1130202|NCT01304329|2735573|P4|STARTED|Third Intervention (3 Days)||3
1130203|NCT01304329|2735574|P3|STARTED|Third Intervention (3 Days)||3
1130204|NCT01304329|2735575|P2|STARTED|Third Intervention (3 Days)||3
1130205|NCT01304329|2735576|P1|STARTED|Third Intervention (3 Days)||3
1130206|NCT01304329|2735571|P6|NOT COMPLETED|Second Intervention (3 Days)||0
1130207|NCT01304329|2735572|P5|NOT COMPLETED|Second Intervention (3 Days)||0
1130208|NCT01304329|2735573|P4|NOT COMPLETED|Second Intervention (3 Days)||0
1130209|NCT01304329|2735574|P3|NOT COMPLETED|Second Intervention (3 Days)||0
1130210|NCT01304329|2735575|P2|NOT COMPLETED|Second Intervention (3 Days)||0
1130211|NCT01304329|2735576|P1|NOT COMPLETED|Second Intervention (3 Days)||0
1130212|NCT01304329|2735571|P6|COMPLETED|Second Intervention (3 Days)||3
1130213|NCT01304329|2735572|P5|COMPLETED|Second Intervention (3 Days)||3
1130214|NCT01304329|2735573|P4|COMPLETED|Second Intervention (3 Days)||3
1130215|NCT01304329|2735574|P3|COMPLETED|Second Intervention (3 Days)||3
1130216|NCT01304329|2735575|P2|COMPLETED|Second Intervention (3 Days)||3
1130217|NCT01304329|2735576|P1|COMPLETED|Second Intervention (3 Days)||3
1130218|NCT01304329|2735571|P6|STARTED|Second Intervention (3 Days)||3
1130219|NCT01304329|2735572|P5|STARTED|Second Intervention (3 Days)||3
1130220|NCT01304329|2735573|P4|STARTED|Second Intervention (3 Days)||3
1130221|NCT01304329|2735574|P3|STARTED|Second Intervention (3 Days)||3
1130222|NCT01304329|2735575|P2|STARTED|Second Intervention (3 Days)||3
1130223|NCT01304329|2735576|P1|STARTED|Second Intervention (3 Days)||3
1130224|NCT01304329|2735571|P6|NOT COMPLETED|First Intervention (3 Days)||0
1130225|NCT01304329|2735572|P5|NOT COMPLETED|First Intervention (3 Days)||0
1130226|NCT01304329|2735573|P4|NOT COMPLETED|First Intervention (3 Days)||0
1130227|NCT01304329|2735574|P3|NOT COMPLETED|First Intervention (3 Days)||0
1130228|NCT01304329|2735575|P2|NOT COMPLETED|First Intervention (3 Days)||0
1130229|NCT01304329|2735576|P1|NOT COMPLETED|First Intervention (3 Days)||0
1130230|NCT01304329|2735571|P6|COMPLETED|First Intervention (3 Days)||3
1130231|NCT01304329|2735572|P5|COMPLETED|First Intervention (3 Days)||3
1130232|NCT01304329|2735573|P4|COMPLETED|First Intervention (3 Days)||3
1130233|NCT01304329|2735574|P3|COMPLETED|First Intervention (3 Days)||3
1130234|NCT01304329|2735575|P2|COMPLETED|First Intervention (3 Days)||3
1130235|NCT01304329|2735576|P1|COMPLETED|First Intervention (3 Days)||3
1130236|NCT01304329|2735571|P6|STARTED|First Intervention (3 Days)||3
1130237|NCT01304329|2735572|P5|STARTED|First Intervention (3 Days)||3
1130238|NCT01304329|2735573|P4|STARTED|First Intervention (3 Days)||3
1130239|NCT01304329|2735574|P3|STARTED|First Intervention (3 Days)||3
1130240|NCT01304329|2735575|P2|STARTED|First Intervention (3 Days)||3
1130241|NCT01304329|2735576|P1|STARTED|First Intervention (3 Days)||3
1130242|NCT01304498|2735595|P2|NOT COMPLETED|Overall Study||5
1130243|NCT01304498|2735596|P1|NOT COMPLETED|Overall Study||6
1130244|NCT01304498|2735595|P2|COMPLETED|Overall Study||295
1130245|NCT01304498|2735596|P1|COMPLETED|Overall Study||294
1130246|NCT01304498|2735595|P2|Received ≥1 Dose|Overall Study||300
1130247|NCT01304498|2735596|P1|Received ≥1 Dose|Overall Study||300
1130248|NCT01304498|2735595|P2|STARTED|Overall Study||300
1130249|NCT01304498|2735596|P1|STARTED|Overall Study||300
1130250|NCT01304589|2735616|P1|NOT COMPLETED|Overall Study||13
1130251|NCT01304589|2735616|P1|COMPLETED|Overall Study||18
1130252|NCT01304589|2735616|P1|STARTED|Overall Study||31
1130253|NCT01304641|2735625|P2|NOT COMPLETED|Overall Study||0
1130254|NCT01304641|2735626|P1|NOT COMPLETED|Overall Study||0
1130255|NCT01304641|2735625|P2|COMPLETED|Overall Study||20132
1130256|NCT01304641|2735626|P1|COMPLETED|Overall Study||11470
1130257|NCT01304641|2735625|P2|STARTED|Overall Study||20132
1130258|NCT01304641|2735626|P1|STARTED|Overall Study||11470
1130259|NCT01304693|2735649|P5|NOT COMPLETED|Overall Study||1
1130260|NCT01304693|2735650|P4|NOT COMPLETED|Overall Study||1
1130261|NCT01304693|2735651|P3|NOT COMPLETED|Overall Study||1
1130262|NCT01304693|2735652|P2|NOT COMPLETED|Overall Study||0
1130263|NCT01304693|2735653|P1|NOT COMPLETED|Overall Study||0
1130264|NCT01304693|2735649|P5|COMPLETED|Overall Study||60
1130265|NCT01304693|2735650|P4|COMPLETED|Overall Study||39
1130266|NCT01304693|2735651|P3|COMPLETED|Overall Study||47
1130267|NCT01304693|2735652|P2|COMPLETED|Overall Study||35
1130268|NCT01304693|2735653|P1|COMPLETED|Overall Study||10
1130269|NCT01304693|2735649|P5|STARTED|Overall Study||61
1130270|NCT01304693|2735650|P4|STARTED|Overall Study||40
1130271|NCT01304693|2735651|P3|STARTED|Overall Study||48
1130272|NCT01304693|2735652|P2|STARTED|Overall Study||35
1130273|NCT01304693|2735653|P1|STARTED|Overall Study||10
1130274|NCT01304706|2735670|P1|NOT COMPLETED|Overall Study||17
1130275|NCT01304706|2735670|P1|COMPLETED|Overall Study||104
1130276|NCT01304706|2735670|P1|STARTED|Overall Study||121
1130277|NCT01304966|2735674|P1|NOT COMPLETED|Overall Study||0
1130278|NCT01304966|2735674|P1|COMPLETED|Overall Study||15
1130279|NCT01304966|2735674|P1|STARTED|Overall Study||15
1130280|NCT01305044|2735682|P2|NOT COMPLETED|Overall Study||6
1130281|NCT01305044|2735683|P1|NOT COMPLETED|Overall Study||3
1130282|NCT01305044|2735682|P2|COMPLETED|Overall Study||25
1130283|NCT01305044|2735683|P1|COMPLETED|Overall Study||29
1130284|NCT01305044|2735682|P2|STARTED|Overall Study||31
1130285|NCT01305044|2735683|P1|STARTED|Overall Study||32
1130286|NCT01296646|2735709|P2|NOT COMPLETED|Overall Study||11
1130287|NCT01296646|2735710|P1|NOT COMPLETED|Overall Study||11
1130288|NCT01296646|2735709|P2|COMPLETED|Overall Study||29
1130289|NCT01296646|2735710|P1|COMPLETED|Overall Study||29
1130290|NCT01296646|2735709|P2|STARTED|Overall Study||40
1130291|NCT01296646|2735710|P1|STARTED|Overall Study||40
1130292|NCT01296672|2735720|P2|NOT COMPLETED|Overall Study||18
1130293|NCT01296672|2735721|P1|NOT COMPLETED|Overall Study||73
1130294|NCT01296672|2735720|P2|COMPLETED|Overall Study||59
1130295|NCT01296672|2735721|P1|COMPLETED|Overall Study||233
1130296|NCT01296672|2735720|P2|STARTED|Overall Study||77
1130297|NCT01296672|2735721|P1|STARTED|Overall Study||306
1130298|NCT01296698|2735733|P2|NOT COMPLETED|Overall Study||13
1130299|NCT01296698|2735734|P1|NOT COMPLETED|Overall Study||244
1130300|NCT01296698|2735733|P2|COMPLETED|Overall Study||0
1130301|NCT01296698|2735734|P1|COMPLETED|Overall Study||0
1130302|NCT01296698|2735733|P2|STARTED|Overall Study||13
1130303|NCT01296698|2735734|P1|STARTED|Overall Study||244
1130304|NCT01297062|2735792|P7|NOT COMPLETED|Overall Study||8
1130305|NCT01297062|2735793|P6|NOT COMPLETED|Overall Study||1
1130306|NCT01297062|2735794|P5|NOT COMPLETED|Overall Study||2
1130307|NCT01297062|2735795|P4|NOT COMPLETED|Overall Study||1
1130308|NCT01297062|2735796|P3|NOT COMPLETED|Overall Study||2
1130309|NCT01297062|2735797|P2|NOT COMPLETED|Overall Study||1
1130310|NCT01297062|2735798|P1|NOT COMPLETED|Overall Study||4
1130311|NCT01297062|2735792|P7|COMPLETED|Overall Study||0
1130312|NCT01297062|2735793|P6|COMPLETED|Overall Study||13
1130313|NCT01297062|2735794|P5|COMPLETED|Overall Study||13
1130314|NCT01297062|2735795|P4|COMPLETED|Overall Study||13
1130315|NCT01297062|2735796|P3|COMPLETED|Overall Study||12
1130316|NCT01297062|2735797|P2|COMPLETED|Overall Study||13
1130317|NCT01297062|2735798|P1|COMPLETED|Overall Study||11
1130318|NCT01297062|2735792|P7|Evaluable Population|Overall Study||0
1130319|NCT01297062|2735793|P6|Evaluable Population|Overall Study||13
1130320|NCT01297062|2735794|P5|Evaluable Population|Overall Study||13
1130321|NCT01297062|2735795|P4|Evaluable Population|Overall Study||13
1130322|NCT01297062|2735796|P3|Evaluable Population|Overall Study||12
1130323|NCT01297062|2735797|P2|Evaluable Population|Overall Study||12
1130324|NCT01297062|2735798|P1|Evaluable Population|Overall Study||11
1130325|NCT01297062|2735792|P7|Intent to Treat (ITT)|Overall Study||0
1130326|NCT01297062|2735793|P6|Intent to Treat (ITT)|Overall Study||14
1130327|NCT01297062|2735794|P5|Intent to Treat (ITT)|Overall Study||15
1130328|NCT01297062|2735795|P4|Intent to Treat (ITT)|Overall Study||14
1130329|NCT01297062|2735796|P3|Intent to Treat (ITT)|Overall Study||14
1130330|NCT01297062|2735797|P2|Intent to Treat (ITT)|Overall Study||14
1130331|NCT01297062|2735798|P1|Intent to Treat (ITT)|Overall Study||15
1130332|NCT01297062|2735792|P7|STARTED|Overall Study||8
1130333|NCT01297062|2735793|P6|STARTED|Overall Study||14
1130334|NCT01297062|2735794|P5|STARTED|Overall Study||15
1130335|NCT01297062|2735795|P4|STARTED|Overall Study||14
1130336|NCT01297062|2735796|P3|STARTED|Overall Study||14
1130337|NCT01297062|2735797|P2|STARTED|Overall Study||14
1130338|NCT01297062|2735798|P1|STARTED|Overall Study||15
1130339|NCT01297257|2735820|P1|NOT COMPLETED|Overall Study||0
1130340|NCT01297257|2735820|P1|COMPLETED|Overall Study||7740
1130341|NCT01297257|2735820|P1|STARTED|Overall Study||7740
1130342|NCT01297270|2735828|P3|NOT COMPLETED|Overall Study||29
1130343|NCT01297270|2735829|P2|NOT COMPLETED|Overall Study||72
1130344|NCT01297270|2735830|P1|NOT COMPLETED|Overall Study||45
1130345|NCT01297270|2735828|P3|COMPLETED|Overall Study||103
1130346|NCT01297270|2735829|P2|COMPLETED|Overall Study||192
1130347|NCT01297270|2735830|P1|COMPLETED|Overall Study||217
1130348|NCT01297270|2735828|P3|STARTED|Overall Study||132
1130349|NCT01297270|2735829|P2|STARTED|Overall Study||264
1130350|NCT01297270|2735830|P1|STARTED|Overall Study||262
1130351|NCT01297283|2735868|P1|NOT COMPLETED|Overall Study||19
1130352|NCT01297283|2735868|P1|COMPLETED|Overall Study||176
1130353|NCT01297283|2735868|P1|STARTED|Overall Study||195
1130354|NCT01297322|2735875|P2|NOT COMPLETED|Overall Study||1
1130355|NCT01297322|2735876|P1|NOT COMPLETED|Overall Study||1
1130356|NCT01297322|2735875|P2|COMPLETED|Overall Study||274
1130357|NCT01297322|2735876|P1|COMPLETED|Overall Study||141
1130358|NCT01297322|2735875|P2|STARTED|Overall Study||275
1130359|NCT01297322|2735876|P1|STARTED|Overall Study||142
1130360|NCT01297335|2735896|P1|NOT COMPLETED|Overall Study||0
1130361|NCT01297335|2735896|P1|COMPLETED|Overall Study||10
1130362|NCT01297335|2735896|P1|STARTED|Overall Study||10
1130363|NCT01297348|2735904|P2|NOT COMPLETED|Overall Study||0
1130364|NCT01297348|2735905|P1|NOT COMPLETED|Overall Study||0
1130365|NCT01297348|2735904|P2|COMPLETED|Overall Study||586401
1130366|NCT01297348|2735905|P1|COMPLETED|Overall Study||12281
1130367|NCT01297348|2735904|P2|STARTED|Overall Study||586401
1130368|NCT01297348|2735905|P1|STARTED|Overall Study||12281
1130369|NCT01297465|2735917|P2|NOT COMPLETED|Overall Study||10
1130370|NCT01297465|2735918|P1|NOT COMPLETED|Overall Study||8
1130371|NCT01297465|2735917|P2|COMPLETED|Overall Study||93
1130372|NCT01297465|2735918|P1|COMPLETED|Overall Study||91
1130373|NCT01297465|2735917|P2|STARTED|Overall Study||103
1130374|NCT01297465|2735918|P1|STARTED|Overall Study||99
1130375|NCT01297491|2735952|P2|NOT COMPLETED|Overall Study||33
1130376|NCT01297491|2735953|P1|NOT COMPLETED|Overall Study||30
1130377|NCT01297491|2735952|P2|COMPLETED|Overall Study||0
1130378|NCT01297491|2735953|P1|COMPLETED|Overall Study||0
1130379|NCT01297491|2735952|P2|STARTED|Overall Study||33
1130380|NCT01297491|2735953|P1|STARTED|Overall Study||30
1130381|NCT01297504|2735969|P1|NOT COMPLETED|Overall Study||67
1130382|NCT01297504|2735969|P1|COMPLETED|Overall Study||397
1130383|NCT01297504|2735969|P1|Participants Studied|Overall Study|Six participants were eliminated due to invalid consent, previous palivizumab or no study visits|458
1130384|NCT01297504|2735969|P1|STARTED|Overall Study||464
1130385|NCT01297517|2735984|P3|NOT COMPLETED|Overall Study||27
1130386|NCT01297517|2735985|P2|NOT COMPLETED|Overall Study||12
1130387|NCT01297517|2735986|P1|NOT COMPLETED|Overall Study||27
1130388|NCT01297517|2735984|P3|COMPLETED|Overall Study||193
1130389|NCT01297517|2735985|P2|COMPLETED|Overall Study||214
1130390|NCT01297517|2735986|P1|COMPLETED|Overall Study||187
1130391|NCT01297517|2735984|P3|STARTED|Overall Study||220
1130392|NCT01297517|2735985|P2|STARTED|Overall Study||226
1130393|NCT01297517|2735986|P1|STARTED|Overall Study||214
1130394|NCT01297595|2735994|P2|NOT COMPLETED|Second Intervention Period||0
1130395|NCT01297595|2735995|P1|NOT COMPLETED|Second Intervention Period||0
1130396|NCT01297595|2735994|P2|COMPLETED|Second Intervention Period||11
1130397|NCT01297595|2735995|P1|COMPLETED|Second Intervention Period||11
1130398|NCT01297595|2735994|P2|STARTED|Second Intervention Period||11
1130399|NCT01297595|2735995|P1|STARTED|Second Intervention Period||11
1130400|NCT01297595|2735994|P2|NOT COMPLETED|Washout Period (At Least 14 Days)||0
1130401|NCT01297595|2735995|P1|NOT COMPLETED|Washout Period (At Least 14 Days)||0
1130402|NCT01297595|2735994|P2|COMPLETED|Washout Period (At Least 14 Days)||11
1130403|NCT01297595|2735995|P1|COMPLETED|Washout Period (At Least 14 Days)||11
1130404|NCT01297595|2735994|P2|STARTED|Washout Period (At Least 14 Days)||11
1130405|NCT01297595|2735995|P1|STARTED|Washout Period (At Least 14 Days)||11
1130406|NCT01297595|2735994|P2|NOT COMPLETED|First Intervention Period||0
1130407|NCT01297595|2735995|P1|NOT COMPLETED|First Intervention Period||0
1130408|NCT01297595|2735994|P2|COMPLETED|First Intervention Period||11
1130409|NCT01297595|2735995|P1|COMPLETED|First Intervention Period||11
1130410|NCT01297595|2735994|P2|STARTED|First Intervention Period||11
1130411|NCT01297595|2735995|P1|STARTED|First Intervention Period||11
1130412|NCT01297920|2736030|P3|NOT COMPLETED|Overall Study||57
1130413|NCT01297920|2736031|P2|NOT COMPLETED|Overall Study||27
1130414|NCT01297920|2736032|P1|NOT COMPLETED|Overall Study||58
1130415|NCT01297920|2736030|P3|COMPLETED|Overall Study||178
1130416|NCT01297920|2736031|P2|COMPLETED|Overall Study||207
1130417|NCT01297920|2736032|P1|COMPLETED|Overall Study||163
1130418|NCT01297920|2736030|P3|STARTED|Overall Study||235
1130419|NCT01297920|2736031|P2|STARTED|Overall Study||234
1130420|NCT01297920|2736032|P1|STARTED|Overall Study||221
1130421|NCT01298063|2736045|P5|NOT COMPLETED|Overall Study||0
1130422|NCT01298063|2736046|P4|NOT COMPLETED|Overall Study||0
1130423|NCT01298063|2736047|P3|NOT COMPLETED|Overall Study||0
1130424|NCT01298063|2736048|P2|NOT COMPLETED|Overall Study||0
1130425|NCT01298063|2736049|P1|NOT COMPLETED|Overall Study||0
1130426|NCT01298063|2736045|P5|COMPLETED|Overall Study||8
1130427|NCT01298063|2736046|P4|COMPLETED|Overall Study||8
1130428|NCT01298063|2736047|P3|COMPLETED|Overall Study||8
1130429|NCT01298063|2736048|P2|COMPLETED|Overall Study||3
1130430|NCT01298063|2736049|P1|COMPLETED|Overall Study||8
1130431|NCT01298063|2736045|P5|STARTED|Overall Study||8
1130432|NCT01298063|2736046|P4|STARTED|Overall Study||8
1130433|NCT01298063|2736047|P3|STARTED|Overall Study||8
1130434|NCT01298063|2736048|P2|STARTED|Overall Study||3
1130435|NCT01298063|2736049|P1|STARTED|Overall Study||8
1130436|NCT01298128|2736078|P2|NOT COMPLETED|Overall Study||8
1130437|NCT01298128|2736079|P1|NOT COMPLETED|Overall Study||9
1130438|NCT01298128|2736078|P2|COMPLETED|Overall Study||27
1130439|NCT01298128|2736079|P1|COMPLETED|Overall Study||26
1130440|NCT01298128|2736078|P2|STARTED|Overall Study||35
1130441|NCT01298128|2736079|P1|STARTED|Overall Study||35
1130442|NCT01298167|2736087|P2|NOT COMPLETED|Overall Study||0
1130443|NCT01298167|2736088|P1|NOT COMPLETED|Overall Study||1
1130444|NCT01298167|2736087|P2|COMPLETED|Overall Study||8
1130445|NCT01298167|2736088|P1|COMPLETED|Overall Study||5
1130446|NCT01298167|2736087|P2|STARTED|Overall Study||8
1130447|NCT01298167|2736088|P1|STARTED|Overall Study||6
1130448|NCT01298323|2736096|P2|NOT COMPLETED|Overall Study||88
1130449|NCT01298323|2736097|P1|NOT COMPLETED|Overall Study||86
1130450|NCT01298323|2736096|P2|COMPLETED|Overall Study||15
1130451|NCT01298323|2736097|P1|COMPLETED|Overall Study||16
1130452|NCT01298323|2736096|P2|Ongoing|Overall Study||55
1130453|NCT01298323|2736097|P1|Ongoing|Overall Study||55
1130454|NCT01298323|2736096|P2|STARTED|Overall Study||103
1130455|NCT01298323|2736097|P1|STARTED|Overall Study||102
1130456|NCT01298362|2736105|P2|NOT COMPLETED|Overall Study||43
1130457|NCT01298362|2736106|P1|NOT COMPLETED|Overall Study||38
1130458|NCT01298362|2736105|P2|COMPLETED|Overall Study||123
1130459|NCT01298362|2736106|P1|COMPLETED|Overall Study||86
1130460|NCT01298362|2736105|P2|STARTED|Overall Study||166
1130461|NCT01298362|2736106|P1|STARTED|Overall Study||124
1130462|NCT01298492|2736124|P1|NOT COMPLETED|Overall Study||119
1130463|NCT01298492|2736124|P1|COMPLETED|Overall Study||149
1130464|NCT01298492|2736124|P1|STARTED|Overall Study||268
1130465|NCT01298518|2736133|P3|NOT COMPLETED|Overall Study||1
1130466|NCT01298518|2736134|P2|NOT COMPLETED|Overall Study||0
1130467|NCT01298518|2736135|P1|NOT COMPLETED|Overall Study||0
1130468|NCT01298518|2736133|P3|COMPLETED|Overall Study||15
1130469|NCT01298518|2736134|P2|COMPLETED|Overall Study||16
1130470|NCT01298518|2736135|P1|COMPLETED|Overall Study||16
1130471|NCT01298518|2736133|P3|STARTED|Overall Study||16
1130472|NCT01298518|2736134|P2|STARTED|Overall Study||16
1130473|NCT01298518|2736135|P1|STARTED|Overall Study||16
1130474|NCT01298531|2736189|P2|NOT COMPLETED|Overall Study||7
1130475|NCT01298531|2736190|P1|NOT COMPLETED|Overall Study||9
1130476|NCT01298531|2736189|P2|COMPLETED|Overall Study||41
1130477|NCT01298531|2736190|P1|COMPLETED|Overall Study||33
1130478|NCT01298531|2736189|P2|STARTED|Overall Study||48
1130479|NCT01298531|2736190|P1|STARTED|Overall Study||42
1130480|NCT01298544|2736316|P1|NOT COMPLETED|Overall Study||0
1130481|NCT01298544|2736316|P1|COMPLETED|Overall Study||335
1130482|NCT01298544|2736316|P1|STARTED|Overall Study||335
1130483|NCT01298648|2736325|P1|NOT COMPLETED|Overall Study||23
1130484|NCT01298648|2736325|P1|COMPLETED|Overall Study||1693
1130485|NCT01298648|2736325|P1|STARTED|Overall Study||1716
1130486|NCT01298661|2736337|P3|NOT COMPLETED|Overall Study||2
1130487|NCT01298661|2736338|P2|NOT COMPLETED|Overall Study||0
1130488|NCT01298661|2736339|P1|NOT COMPLETED|Overall Study||2
1130489|NCT01298661|2736337|P3|COMPLETED|Overall Study||32
1130490|NCT01298661|2736338|P2|COMPLETED|Overall Study||24
1130491|NCT01298661|2736339|P1|COMPLETED|Overall Study||31
1130492|NCT01298661|2736337|P3|STARTED|Overall Study||34
1130493|NCT01298661|2736338|P2|STARTED|Overall Study||24
1130494|NCT01298661|2736339|P1|STARTED|Overall Study||33
1130495|NCT01298778|2736419|P2|NOT COMPLETED|Overall Study||6
1130496|NCT01298778|2736420|P1|NOT COMPLETED|Overall Study||3
1130497|NCT01298778|2736419|P2|COMPLETED|Overall Study||30
1130498|NCT01298778|2736420|P1|COMPLETED|Overall Study||30
1130499|NCT01298778|2736419|P2|STARTED|Overall Study||36
1130500|NCT01298778|2736420|P1|STARTED|Overall Study||33
1130501|NCT01299025|2736442|P2|NOT COMPLETED|Overall Study||1
1130502|NCT01299025|2736443|P1|NOT COMPLETED|Overall Study||3
1130503|NCT01299025|2736442|P2|COMPLETED|Overall Study||41
1130504|NCT01299025|2736443|P1|COMPLETED|Overall Study||39
1130505|NCT01299025|2736442|P2|STARTED|Overall Study||42
1130506|NCT01299025|2736443|P1|STARTED|Overall Study||42
1130507|NCT01299077|2736455|P1|NOT COMPLETED|Overall Study||0
1130508|NCT01299077|2736455|P1|COMPLETED|Overall Study||478
1130509|NCT01299077|2736455|P1|STARTED|Overall Study||478
1130510|NCT01299090|2736463|P1|NOT COMPLETED|Overall Study||0
1130511|NCT01299090|2736463|P1|COMPLETED|Overall Study||49
1130512|NCT01299090|2736463|P1|STARTED|Overall Study||49
1130513|NCT01299103|2736471|P3|NOT COMPLETED|Overall Study||2
1130514|NCT01299103|2736472|P2|NOT COMPLETED|Overall Study||2
1130515|NCT01299103|2736473|P1|NOT COMPLETED|Overall Study||0
1130516|NCT01299103|2736471|P3|COMPLETED|Overall Study||8
1130517|NCT01299103|2736472|P2|COMPLETED|Overall Study||13
1130518|NCT01299103|2736473|P1|COMPLETED|Overall Study||15
1130519|NCT01299103|2736471|P3|STARTED|Overall Study||10
1130520|NCT01299103|2736472|P2|STARTED|Overall Study||15
1130521|NCT01299103|2736473|P1|STARTED|Overall Study||15
1130522|NCT01299285|2736484|P1|NOT COMPLETED|Overall Study||0
1130523|NCT01299285|2736484|P1|COMPLETED|Overall Study||6
1130524|NCT01299285|2736484|P1|STARTED|Overall Study||6
1130525|NCT01299376|2736499|P2|NOT COMPLETED|Extension (Weeks 9 to 52)||15
1130526|NCT01299376|2736500|P1|NOT COMPLETED|Extension (Weeks 9 to 52)||10
1130527|NCT01299376|2736499|P2|COMPLETED|Extension (Weeks 9 to 52)||118
1130528|NCT01299376|2736500|P1|COMPLETED|Extension (Weeks 9 to 52)||124
1130529|NCT01299376|2736499|P2|STARTED|Extension (Weeks 9 to 52)||133
1130530|NCT01299376|2736500|P1|STARTED|Extension (Weeks 9 to 52)||134
1130531|NCT01299376|2736499|P2|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||12
1130532|NCT01299376|2736500|P1|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||7
1130533|NCT01299376|2736499|P2|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||133
1130534|NCT01299376|2736500|P1|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||134
1130535|NCT01299376|2736499|P2|STARTED|Double-blind Treatment (Weeks 1 to 8)||145
1130536|NCT01299376|2736500|P1|STARTED|Double-blind Treatment (Weeks 1 to 8)||141
1130537|NCT01299389|2736532|P4|NOT COMPLETED|Post-observational||6
1130538|NCT01299389|2736533|P3|NOT COMPLETED|Post-observational||12
1130539|NCT01299389|2736534|P2|NOT COMPLETED|Post-observational||0
1130540|NCT01299389|2736535|P1|NOT COMPLETED|Post-observational||0
1130541|NCT01299389|2736532|P4|COMPLETED|Post-observational||149
1130542|NCT01299389|2736533|P3|COMPLETED|Post-observational||144
1130543|NCT01299389|2736534|P2|COMPLETED|Post-observational||0
1130544|NCT01299389|2736535|P1|COMPLETED|Post-observational||0
1130545|NCT01299389|2736532|P4|STARTED|Post-observational||155
1130546|NCT01299389|2736533|P3|STARTED|Post-observational||156
1130547|NCT01299389|2736534|P2|STARTED|Post-observational||0
1130548|NCT01299389|2736535|P1|STARTED|Post-observational||0
1130549|NCT01299389|2736532|P4|NOT COMPLETED|Double-blind||0
1130550|NCT01299389|2736533|P3|NOT COMPLETED|Double-blind||0
1130551|NCT01299389|2736534|P2|NOT COMPLETED|Double-blind||64
1130552|NCT01299389|2736535|P1|NOT COMPLETED|Double-blind||109
1130553|NCT01299389|2736532|P4|COMPLETED|Double-blind||0
1130554|NCT01299389|2736533|P3|COMPLETED|Double-blind||0
1130555|NCT01299389|2736534|P2|COMPLETED|Double-blind||95
1130556|NCT01299389|2736535|P1|COMPLETED|Double-blind||55
1130557|NCT01299389|2736532|P4|STARTED|Double-blind||0
1130558|NCT01299389|2736533|P3|STARTED|Double-blind||0
1130559|NCT01299389|2736534|P2|STARTED|Double-blind||159
1130560|NCT01299389|2736535|P1|STARTED|Double-blind||164
1130561|NCT01299454|2736559|P4|NOT COMPLETED|Overall Study||0
1130562|NCT01299454|2736560|P3|NOT COMPLETED|Overall Study||0
1130563|NCT01299454|2736561|P2|NOT COMPLETED|Overall Study||0
1130564|NCT01299454|2736562|P1|NOT COMPLETED|Overall Study||0
1130565|NCT01299454|2736559|P4|COMPLETED|Overall Study||23
1130566|NCT01299454|2736560|P3|COMPLETED|Overall Study||6
1130567|NCT01299454|2736561|P2|COMPLETED|Overall Study||8
1130568|NCT01299454|2736562|P1|COMPLETED|Overall Study||8
1130569|NCT01299454|2736559|P4|STARTED|Overall Study||23
1130570|NCT01299454|2736560|P3|STARTED|Overall Study||6
1130571|NCT01299454|2736561|P2|STARTED|Overall Study||8
1130572|NCT01299454|2736562|P1|STARTED|Overall Study||8
1130573|NCT01299480|2736725|P5|NOT COMPLETED|Overall Study||20
1130574|NCT01299480|2736726|P4|NOT COMPLETED|Overall Study||25
1130575|NCT01299480|2736727|P3|NOT COMPLETED|Overall Study||41
1130576|NCT01299480|2736728|P2|NOT COMPLETED|Overall Study||35
1130577|NCT01299480|2736729|P1|NOT COMPLETED|Overall Study||42
1130578|NCT01299480|2736725|P5|COMPLETED|Overall Study||123
1130579|NCT01299480|2736726|P4|COMPLETED|Overall Study||261
1130580|NCT01299480|2736727|P3|COMPLETED|Overall Study||386
1130581|NCT01299480|2736728|P2|COMPLETED|Overall Study||395
1130582|NCT01299480|2736729|P1|COMPLETED|Overall Study||385
1130583|NCT01299480|2736725|P5|STARTED|Overall Study||143
1130584|NCT01299480|2736726|P4|STARTED|Overall Study||286
1130585|NCT01299480|2736727|P3|STARTED|Overall Study||427
1130586|NCT01299480|2736728|P2|STARTED|Overall Study||430
1130587|NCT01299480|2736729|P1|STARTED|Overall Study||427
1130588|NCT01305200|2736767|P3|NOT COMPLETED|Overall Study||3
1130589|NCT01305200|2736768|P2|NOT COMPLETED|Overall Study||31
1130590|NCT01305200|2736769|P1|NOT COMPLETED|Overall Study||29
1130591|NCT01305200|2736767|P3|COMPLETED|Overall Study||0
1130592|NCT01305200|2736768|P2|COMPLETED|Overall Study||81
1130593|NCT01305200|2736769|P1|COMPLETED|Overall Study||82
1130594|NCT01305200|2736767|P3|STARTED|Overall Study||3
1130595|NCT01305200|2736768|P2|STARTED|Overall Study||112
1130596|NCT01305200|2736769|P1|STARTED|Overall Study||111
1130603|NCT01305239|2736808|P1|NOT COMPLETED|Overall Study||23
1130604|NCT01305239|2736808|P1|COMPLETED|Overall Study||375
1130605|NCT01305239|2736808|P1|Intent to Treat Population|Overall Study||287
1130606|NCT01305239|2736808|P1|Safety Set|Overall Study||397
1130607|NCT01305239|2736808|P1|STARTED|Overall Study||398
1130608|NCT01305252|2736818|P2|NOT COMPLETED|Overall Study||0
1130609|NCT01305252|2736819|P1|NOT COMPLETED|Overall Study||1
1130610|NCT01305252|2736818|P2|COMPLETED|Overall Study||11
1130611|NCT01305252|2736819|P1|COMPLETED|Overall Study||9
1130612|NCT01305252|2736818|P2|STARTED|Overall Study||11
1130613|NCT01305252|2736819|P1|STARTED|Overall Study||10
1130614|NCT01305265|2736835|P2|NOT COMPLETED|Overall Study||6
1130615|NCT01305265|2736836|P1|NOT COMPLETED|Overall Study||2
1130616|NCT01305265|2736835|P2|COMPLETED|Overall Study||64
1130617|NCT01305265|2736836|P1|COMPLETED|Overall Study||69
1130618|NCT01305265|2736835|P2|STARTED|Overall Study||70
1130619|NCT01305265|2736836|P1|STARTED|Overall Study||71
1130620|NCT01305408|2736844|P2|NOT COMPLETED|Overall Study||31
1130621|NCT01305408|2736845|P1|NOT COMPLETED|Overall Study||32
1130622|NCT01305408|2736844|P2|COMPLETED|Overall Study||169
1130623|NCT01305408|2736845|P1|COMPLETED|Overall Study||167
1130624|NCT01305408|2736844|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
1130625|NCT01305408|2736845|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
1130626|NCT01305408|2736844|P2|Safety Population|Overall Study|Treated participants.|200
1130627|NCT01305408|2736845|P1|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|198
1130628|NCT01305408|2736844|P2|STARTED|Overall Study||200
1130629|NCT01305408|2736845|P1|STARTED|Overall Study||199
1130630|NCT01305473|2736895|P1|NOT COMPLETED|Overall Study||0
1130631|NCT01305473|2736895|P1|COMPLETED|Overall Study||90
1130632|NCT01305473|2736895|P1|STARTED|Overall Study||90
1130633|NCT01306214|2736908|P3|NOT COMPLETED|Overall Study||22
1130634|NCT01306214|2736909|P2|NOT COMPLETED|Overall Study||28
1130635|NCT01306214|2736910|P1|NOT COMPLETED|Overall Study||28
1130636|NCT01306214|2736908|P3|COMPLETED|Overall Study||168
1130637|NCT01306214|2736909|P2|COMPLETED|Overall Study||159
1130638|NCT01306214|2736910|P1|COMPLETED|Overall Study||161
1130639|NCT01306214|2736908|P3|STARTED|Overall Study||190
1130640|NCT01306214|2736909|P2|STARTED|Overall Study||187
1130641|NCT01306214|2736910|P1|STARTED|Overall Study||189
1130642|NCT01306253|2736929|P2|NOT COMPLETED|Overall Study||1
1130643|NCT01306253|2736930|P1|NOT COMPLETED|Overall Study||1
1130644|NCT01306253|2736929|P2|COMPLETED|Overall Study||56
1130645|NCT01306253|2736930|P1|COMPLETED|Overall Study||56
1130646|NCT01306253|2736929|P2|STARTED|Overall Study||57
1130647|NCT01306253|2736930|P1|STARTED|Overall Study||57
1130648|NCT01306292|2736946|P4|NOT COMPLETED|Second Injection||0
1130649|NCT01306292|2736947|P3|NOT COMPLETED|Second Injection||1
1130650|NCT01306292|2736948|P2|NOT COMPLETED|Second Injection||0
1130651|NCT01306292|2736949|P1|NOT COMPLETED|Second Injection||0
1130652|NCT01306292|2736946|P4|COMPLETED|Second Injection||10
1130653|NCT01306292|2736947|P3|COMPLETED|Second Injection|1 subject completed both injections but not 24-hour follow-up; all other values were recorded.|7
1130654|NCT01306292|2736948|P2|COMPLETED|Second Injection||8
1130655|NCT01306292|2736949|P1|COMPLETED|Second Injection||10
1130656|NCT01306292|2736946|P4|STARTED|Second Injection||10
1130657|NCT01306292|2736947|P3|STARTED|Second Injection||8
1130658|NCT01306292|2736948|P2|STARTED|Second Injection||8
1130659|NCT01306292|2736949|P1|STARTED|Second Injection||10
1130660|NCT01306292|2736946|P4|NOT COMPLETED|Washout (at Least 10 Minutes)||0
1130661|NCT01306292|2736947|P3|NOT COMPLETED|Washout (at Least 10 Minutes)||0
1130662|NCT01306292|2736948|P2|NOT COMPLETED|Washout (at Least 10 Minutes)||0
1130663|NCT01306292|2736949|P1|NOT COMPLETED|Washout (at Least 10 Minutes)||0
1130664|NCT01306292|2736946|P4|COMPLETED|Washout (at Least 10 Minutes)||10
1130665|NCT01306292|2736947|P3|COMPLETED|Washout (at Least 10 Minutes)||8
1130666|NCT01306292|2736948|P2|COMPLETED|Washout (at Least 10 Minutes)||8
1130667|NCT01306292|2736949|P1|COMPLETED|Washout (at Least 10 Minutes)||10
1130668|NCT01306292|2736946|P4|STARTED|Washout (at Least 10 Minutes)||10
1130669|NCT01306292|2736947|P3|STARTED|Washout (at Least 10 Minutes)||8
1130670|NCT01306292|2736948|P2|STARTED|Washout (at Least 10 Minutes)||8
1130671|NCT01306292|2736949|P1|STARTED|Washout (at Least 10 Minutes)||10
1130672|NCT01306292|2736946|P4|NOT COMPLETED|First Injection||0
1130673|NCT01306292|2736947|P3|NOT COMPLETED|First Injection||0
1130674|NCT01306292|2736948|P2|NOT COMPLETED|First Injection||0
1130675|NCT01306292|2736949|P1|NOT COMPLETED|First Injection||0
1130676|NCT01306292|2736946|P4|COMPLETED|First Injection||10
1130677|NCT01306292|2736947|P3|COMPLETED|First Injection||8
1130678|NCT01306292|2736948|P2|COMPLETED|First Injection||8
1130679|NCT01306292|2736949|P1|COMPLETED|First Injection||10
1130680|NCT01306292|2736946|P4|STARTED|First Injection||10
1130681|NCT01306292|2736947|P3|STARTED|First Injection||8
1130682|NCT01306292|2736948|P2|STARTED|First Injection||8
1130683|NCT01306292|2736949|P1|STARTED|First Injection||10
1130684|NCT01306305|2736967|P2|NOT COMPLETED|Overall Study||0
1130685|NCT01306305|2736968|P1|NOT COMPLETED|Overall Study||2
1130686|NCT01306305|2736967|P2|COMPLETED|Overall Study||55
1130687|NCT01306305|2736968|P1|COMPLETED|Overall Study||53
1130688|NCT01306305|2736967|P2|STARTED|Overall Study||55
1130689|NCT01306305|2736968|P1|STARTED|Overall Study||55
1130690|NCT01306617|2736985|P3|NOT COMPLETED|Overall Study||5
1130691|NCT01306617|2736986|P2|NOT COMPLETED|Overall Study||1
1130692|NCT01306617|2736987|P1|NOT COMPLETED|Overall Study||1
1130693|NCT01306617|2736985|P3|COMPLETED|Overall Study|The number of participants who completed study drug|12
1130694|NCT01306617|2736986|P2|COMPLETED|Overall Study|The number of participants who completed study drug|13
1130695|NCT01306617|2736987|P1|COMPLETED|Overall Study|The number of participants who completed study drug|18
1130696|NCT01306617|2736985|P3|STARTED|Overall Study||17
1130697|NCT01306617|2736986|P2|STARTED|Overall Study||14
1130698|NCT01306617|2736987|P1|STARTED|Overall Study||19
1130699|NCT01306643|2737028|P1|NOT COMPLETED|Overall Study||13
1130700|NCT01306643|2737028|P1|COMPLETED|Overall Study|Completed Study was defined as participants who completed through Cycle 12 (Week 48) per protocol.|5
1130701|NCT01306643|2737028|P1|STARTED|Overall Study||18
1130702|NCT01306877|2737039|P2|NOT COMPLETED|Overall Study||4
1130703|NCT01306877|2737040|P1|NOT COMPLETED|Overall Study||3
1130704|NCT01306877|2737039|P2|COMPLETED|Overall Study||67
1130705|NCT01306877|2737040|P1|COMPLETED|Overall Study||75
1130706|NCT01306877|2737039|P2|STARTED|Overall Study||71
1130707|NCT01306877|2737040|P1|STARTED|Overall Study||78
1130708|NCT01306968|2737062|P4|NOT COMPLETED|Overall Study||4
1130709|NCT01306968|2737063|P3|NOT COMPLETED|Overall Study||1
1130710|NCT01306968|2737064|P2|NOT COMPLETED|Overall Study||3
1130711|NCT01306968|2737065|P1|NOT COMPLETED|Overall Study||1
1130712|NCT01306968|2737062|P4|COMPLETED|Overall Study||21
1130713|NCT01306968|2737063|P3|COMPLETED|Overall Study||23
1130714|NCT01306968|2737064|P2|COMPLETED|Overall Study||20
1130715|NCT01306968|2737065|P1|COMPLETED|Overall Study||6
1130716|NCT01306968|2737062|P4|STARTED|Overall Study|2 participants withdrew before chamber sessions were initiated|25
1130717|NCT01306968|2737063|P3|STARTED|Overall Study||24
1130718|NCT01306968|2737064|P2|STARTED|Overall Study||23
1130719|NCT01306968|2737065|P1|STARTED|Overall Study||7
1130720|NCT01307007|2737089|P2|NOT COMPLETED|Overall Study||0
1130721|NCT01307007|2737090|P1|NOT COMPLETED|Overall Study||0
1130722|NCT01307007|2737089|P2|COMPLETED|Overall Study||30
1130723|NCT01307007|2737090|P1|COMPLETED|Overall Study||25
1130724|NCT01307007|2737089|P2|STARTED|Overall Study||30
1130725|NCT01307007|2737090|P1|STARTED|Overall Study||25
1130726|NCT01307020|2737106|P10|NOT COMPLETED|Overall Study||0
1130727|NCT01307020|2737107|P9|NOT COMPLETED|Overall Study||0
1130728|NCT01307020|2737108|P8|NOT COMPLETED|Overall Study||0
1130729|NCT01307020|2737109|P7|NOT COMPLETED|Overall Study||1
1130730|NCT01307020|2737110|P6|NOT COMPLETED|Overall Study||0
1130731|NCT01307020|2737111|P5|NOT COMPLETED|Overall Study||0
1130732|NCT01307020|2737112|P4|NOT COMPLETED|Overall Study||1
1130733|NCT01307020|2737113|P3|NOT COMPLETED|Overall Study||1
1130734|NCT01307020|2737114|P2|NOT COMPLETED|Overall Study||1
1130735|NCT01307020|2737115|P1|NOT COMPLETED|Overall Study||0
1130736|NCT01307020|2737106|P10|COMPLETED|Overall Study||62
1130737|NCT01307020|2737107|P9|COMPLETED|Overall Study||61
1130738|NCT01307020|2737108|P8|COMPLETED|Overall Study||60
1130739|NCT01307020|2737109|P7|COMPLETED|Overall Study||58
1130740|NCT01307020|2737110|P6|COMPLETED|Overall Study||61
1130741|NCT01307020|2737111|P5|COMPLETED|Overall Study||60
1130742|NCT01307020|2737112|P4|COMPLETED|Overall Study||60
1130743|NCT01307020|2737113|P3|COMPLETED|Overall Study||62
1130744|NCT01307020|2737114|P2|COMPLETED|Overall Study||62
1130745|NCT01307020|2737115|P1|COMPLETED|Overall Study||61
1130746|NCT01307020|2737106|P10|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
1130747|NCT01307020|2737107|P9|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
1130748|NCT01307020|2737108|P8|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
1130749|NCT01307020|2737109|P7|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
1130750|NCT01307020|2737110|P6|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
1130751|NCT01307020|2737111|P5|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
1130752|NCT01307020|2737112|P4|ITT (>= 1 Assessment Post Randomization)|Overall Study||61
1130753|NCT01307020|2737113|P3|ITT (>= 1 Assessment Post Randomization)|Overall Study||63
1130754|NCT01307020|2737114|P2|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
1130755|NCT01307020|2737115|P1|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
1130756|NCT01307020|2737106|P10|Safety Population|Overall Study||62
1130757|NCT01307020|2737107|P9|Safety Population|Overall Study||61
1130758|NCT01307020|2737108|P8|Safety Population|Overall Study||60
1130759|NCT01307020|2737109|P7|Safety Population|Overall Study||59
1130760|NCT01307020|2737110|P6|Safety Population|Overall Study||61
1130761|NCT01307020|2737111|P5|Safety Population|Overall Study||60
1130762|NCT01307020|2737112|P4|Safety Population|Overall Study||61
1130763|NCT01307020|2737113|P3|Safety Population|Overall Study||63
1130764|NCT01307020|2737114|P2|Safety Population|Overall Study||63
1130765|NCT01307020|2737115|P1|Safety Population|Overall Study||61
1130766|NCT01307020|2737106|P10|STARTED|Overall Study||62
1130767|NCT01307020|2737107|P9|STARTED|Overall Study||61
1130768|NCT01307020|2737108|P8|STARTED|Overall Study||60
1130769|NCT01307020|2737109|P7|STARTED|Overall Study||59
1130770|NCT01307020|2737110|P6|STARTED|Overall Study||61
1130771|NCT01307020|2737111|P5|STARTED|Overall Study||60
1130772|NCT01307020|2737112|P4|STARTED|Overall Study||61
1130773|NCT01307020|2737113|P3|STARTED|Overall Study||63
1130774|NCT01307020|2737114|P2|STARTED|Overall Study||63
1130775|NCT01307020|2737115|P1|STARTED|Overall Study||61
1130776|NCT01307033|2737159|P4|NOT COMPLETED|44-week Open-label Extension||12
1130777|NCT01307033|2737160|P3|NOT COMPLETED|44-week Open-label Extension||11
1130778|NCT01307033|2737161|P2|NOT COMPLETED|44-week Open-label Extension||0
1130779|NCT01307033|2737162|P1|NOT COMPLETED|44-week Open-label Extension||0
1130780|NCT01307033|2737159|P4|COMPLETED|44-week Open-label Extension||115
1130781|NCT01307033|2737160|P3|COMPLETED|44-week Open-label Extension||120
1130782|NCT01307033|2737161|P2|COMPLETED|44-week Open-label Extension||0
1130783|NCT01307033|2737162|P1|COMPLETED|44-week Open-label Extension||0
1130784|NCT01307033|2737159|P4|STARTED|44-week Open-label Extension||127
1130785|NCT01307033|2737160|P3|STARTED|44-week Open-label Extension||131
1130786|NCT01307033|2737161|P2|STARTED|44-week Open-label Extension||0
1130787|NCT01307033|2737162|P1|STARTED|44-week Open-label Extension||0
1130788|NCT01307033|2737159|P4|NOT COMPLETED|8-week Double-blind Period||0
1130789|NCT01307033|2737160|P3|NOT COMPLETED|8-week Double-blind Period||0
1130790|NCT01307033|2737161|P2|NOT COMPLETED|8-week Double-blind Period||7
1130791|NCT01307033|2737162|P1|NOT COMPLETED|8-week Double-blind Period||13
1130792|NCT01307033|2737159|P4|COMPLETED|8-week Double-blind Period||0
1130793|NCT01307033|2737160|P3|COMPLETED|8-week Double-blind Period||0
1130794|NCT01307033|2737161|P2|COMPLETED|8-week Double-blind Period||127
1130795|NCT01307033|2737162|P1|COMPLETED|8-week Double-blind Period||131
1130796|NCT01307033|2737159|P4|STARTED|8-week Double-blind Period||0
1130797|NCT01307033|2737160|P3|STARTED|8-week Double-blind Period||0
1130798|NCT01307033|2737161|P2|STARTED|8-week Double-blind Period||134
1130799|NCT01307033|2737162|P1|STARTED|8-week Double-blind Period||144
1130800|NCT01307046|2737176|P2|NOT COMPLETED|Overall Study||11
1130801|NCT01307046|2737177|P1|NOT COMPLETED|Overall Study||12
1130802|NCT01307046|2737176|P2|COMPLETED|Overall Study||159
1130803|NCT01307046|2737177|P1|COMPLETED|Overall Study||154
1130804|NCT01307046|2737176|P2|STARTED|Overall Study||170
1130805|NCT01307046|2737177|P1|STARTED|Overall Study||166
1130806|NCT01307111|2737190|P2|NOT COMPLETED|1-2 Week IUD Check up||2
1130807|NCT01307111|2737191|P1|NOT COMPLETED|1-2 Week IUD Check up||2
1130808|NCT01307111|2737190|P2|COMPLETED|1-2 Week IUD Check up||38
1130809|NCT01307111|2737191|P1|COMPLETED|1-2 Week IUD Check up||38
1130810|NCT01307111|2737190|P2|STARTED|1-2 Week IUD Check up||40
1130811|NCT01307111|2737191|P1|STARTED|1-2 Week IUD Check up||40
1130812|NCT01307111|2737190|P2|NOT COMPLETED|IUD Insertion||0
1130813|NCT01307111|2737191|P1|NOT COMPLETED|IUD Insertion||2
1130814|NCT01307111|2737190|P2|COMPLETED|IUD Insertion||40
1130815|NCT01307111|2737191|P1|COMPLETED|IUD Insertion||40
1130816|NCT01307111|2737190|P2|STARTED|IUD Insertion||40
1130817|NCT01307111|2737191|P1|STARTED|IUD Insertion||42
1130818|NCT01307319|2737202|P3|NOT COMPLETED|Overall Study||7
1130819|NCT01307319|2737203|P2|NOT COMPLETED|Overall Study||8
1130820|NCT01307319|2737204|P1|NOT COMPLETED|Overall Study||4
1130821|NCT01307319|2737202|P3|COMPLETED|Overall Study||227
1130822|NCT01307319|2737203|P2|COMPLETED|Overall Study||234
1130823|NCT01307319|2737204|P1|COMPLETED|Overall Study||235
1130824|NCT01307319|2737202|P3|ITT Population|Overall Study||234
1130825|NCT01307319|2737203|P2|ITT Population|Overall Study||241
1130826|NCT01307319|2737204|P1|ITT Population|Overall Study|One participant provided no post-baseline assessment.|238
1130827|NCT01307319|2737202|P3|Safety Population|Overall Study||234
1130828|NCT01307319|2737203|P2|Safety Population|Overall Study|One participant was randomized in error and did not receive study medication.|241
1130829|NCT01307319|2737204|P1|Safety Population|Overall Study||239
1130830|NCT01307319|2737202|P3|STARTED|Overall Study|Randomized|234
1130831|NCT01307319|2737203|P2|STARTED|Overall Study|Randomized|242
1130832|NCT01307319|2737204|P1|STARTED|Overall Study|Randomized|239
1130833|NCT01307423|2737218|P7|NOT COMPLETED|Active Treatment Phase (Week 25-52)||1
1130834|NCT01307423|2737219|P6|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
1130835|NCT01307423|2737220|P5|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
1130836|NCT01307423|2737221|P4|NOT COMPLETED|Active Treatment Phase (Week 25-52)||8
1130837|NCT01307423|2737222|P3|NOT COMPLETED|Active Treatment Phase (Week 25-52)||9
1130838|NCT01307423|2737223|P2|NOT COMPLETED|Active Treatment Phase (Week 25-52)||19
1130839|NCT01307423|2737224|P1|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
1130840|NCT01307423|2737218|P7|COMPLETED|Active Treatment Phase (Week 25-52)||25
1130841|NCT01307423|2737219|P6|COMPLETED|Active Treatment Phase (Week 25-52)||43
1130842|NCT01307423|2737220|P5|COMPLETED|Active Treatment Phase (Week 25-52)||23
1130843|NCT01307423|2737221|P4|COMPLETED|Active Treatment Phase (Week 25-52)||38
1130844|NCT01307423|2737222|P3|COMPLETED|Active Treatment Phase (Week 25-52)||141
1130845|NCT01307423|2737223|P2|COMPLETED|Active Treatment Phase (Week 25-52)||132
1130846|NCT01307423|2737224|P1|COMPLETED|Active Treatment Phase (Week 25-52)||0
1130847|NCT01307423|2737218|P7|STARTED|Active Treatment Phase (Week 25-52)||26
1130848|NCT01307423|2737219|P6|STARTED|Active Treatment Phase (Week 25-52)|Six participants who escaped early and completed Week 24 did not enter the active treatment phase|46
1130849|NCT01307423|2737220|P5|STARTED|Active Treatment Phase (Week 25-52)||26
1130850|NCT01307423|2737221|P4|STARTED|Active Treatment Phase (Week 25-52)|Four participants who escaped early and completed Week 24 did not enter the active treatment phase.|46
1130851|NCT01307423|2737222|P3|STARTED|Active Treatment Phase (Week 25-52)|Five participants who completed Week 24 did not enter active treatment phase|150
1130852|NCT01307423|2737223|P2|STARTED|Active Treatment Phase (Week 25-52)|Nine participants who completed Week 24 did not enter active treatment phase|151
1130853|NCT01307423|2737224|P1|STARTED|Active Treatment Phase (Week 25-52)||0
1130854|NCT01307423|2737218|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1130855|NCT01307423|2737219|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1130856|NCT01307423|2737220|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1130857|NCT01307423|2737221|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1130858|NCT01307423|2737222|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
1130859|NCT01307423|2737223|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||15
1130860|NCT01307423|2737224|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
1130861|NCT01307423|2737218|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1130862|NCT01307423|2737219|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1130863|NCT01307423|2737220|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1130864|NCT01307423|2737221|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1130865|NCT01307423|2737222|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||155
1130866|NCT01307423|2737223|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||160
1130867|NCT01307423|2737224|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants did not escape early and finished Week 24 did not enter the active treatment phase|156
1130868|NCT01307423|2737218|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1130869|NCT01307423|2737219|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1130870|NCT01307423|2737220|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1130871|NCT01307423|2737221|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1130872|NCT01307423|2737222|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||79
1130873|NCT01307423|2737223|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||73
1130874|NCT01307423|2737224|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|One participant who escaped early did not complete Week 24|103
1130875|NCT01307423|2737218|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1130876|NCT01307423|2737219|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1130877|NCT01307423|2737220|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1130878|NCT01307423|2737221|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1130879|NCT01307423|2737222|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
1130880|NCT01307423|2737223|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||168
1130881|NCT01307423|2737224|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
1130882|NCT01307423|2737218|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1130883|NCT01307423|2737219|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1130884|NCT01307423|2737220|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1130885|NCT01307423|2737221|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1130886|NCT01307423|2737222|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
1130887|NCT01307423|2737223|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
1130888|NCT01307423|2737224|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||176
1130889|NCT01307423|2737218|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1130890|NCT01307423|2737219|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1130891|NCT01307423|2737220|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1130892|NCT01307423|2737221|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1130893|NCT01307423|2737222|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||177
1130894|NCT01307423|2737223|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||175
1130895|NCT01307423|2737224|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||176
1130896|NCT01307462|2737333|P1|NOT COMPLETED|Overall Study||1
1130897|NCT01307462|2737333|P1|COMPLETED|Overall Study||35
1130898|NCT01307462|2737333|P1|STARTED|Overall Study||36
1130899|NCT01307618|2737348|P2|NOT COMPLETED|Overall Study||0
1130900|NCT01307618|2737349|P1|NOT COMPLETED|Overall Study||0
1130901|NCT01307618|2737348|P2|COMPLETED|Overall Study||5
1130902|NCT01307618|2737349|P1|COMPLETED|Overall Study||5
1130903|NCT01307618|2737348|P2|STARTED|Overall Study||5
1130904|NCT01307618|2737349|P1|STARTED|Overall Study||5
1130905|NCT01307631|2737365|P2|NOT COMPLETED|Overall Study||0
1130906|NCT01307631|2737366|P1|NOT COMPLETED|Overall Study||0
1130907|NCT01307631|2737365|P2|COMPLETED|Overall Study||28
1130908|NCT01307631|2737366|P1|COMPLETED|Overall Study||9
1130909|NCT01307631|2737365|P2|STARTED|Overall Study||28
1130910|NCT01307631|2737366|P1|STARTED|Overall Study||9
1130911|NCT01307787|2737376|P2|NOT COMPLETED|Overall Study||0
1130912|NCT01307787|2737377|P1|NOT COMPLETED|Overall Study||2
1130913|NCT01307787|2737376|P2|COMPLETED|Overall Study||15
1130914|NCT01307787|2737377|P1|COMPLETED|Overall Study||17
1130915|NCT01307787|2737376|P2|T2= After 22 Weeks at Follow-up|Overall Study||15
1130916|NCT01307787|2737377|P1|T2= After 22 Weeks at Follow-up|Overall Study||17
1130917|NCT01307787|2737376|P2|T1= After 9 Weeks Post Intervention|Overall Study||15
1130918|NCT01307787|2737377|P1|T1= After 9 Weeks Post Intervention|Overall Study||18
1130919|NCT01307787|2737376|P2|STARTED|Overall Study||15
1130920|NCT01307787|2737377|P1|STARTED|Overall Study||19
1130927|NCT01308424|2737412|P3|NOT COMPLETED|Randomization||2
1130928|NCT01308424|2737413|P2|NOT COMPLETED|Randomization||3
1130929|NCT01308424|2737414|P1|NOT COMPLETED|Randomization||0
1130930|NCT01308424|2737412|P3|COMPLETED|Randomization||82
1130931|NCT01308424|2737413|P2|COMPLETED|Randomization||84
1130932|NCT01308424|2737414|P1|COMPLETED|Randomization||0
1130933|NCT01308424|2737412|P3|STARTED|Randomization||84
1130934|NCT01308424|2737413|P2|STARTED|Randomization||87
1130935|NCT01308424|2737414|P1|STARTED|Randomization||0
1130936|NCT01308424|2737412|P3|NOT COMPLETED|Baseline Eligibility||0
1130937|NCT01308424|2737413|P2|NOT COMPLETED|Baseline Eligibility||0
1130938|NCT01308424|2737414|P1|NOT COMPLETED|Baseline Eligibility||71
1130939|NCT01308424|2737412|P3|COMPLETED|Baseline Eligibility||0
1130940|NCT01308424|2737413|P2|COMPLETED|Baseline Eligibility||0
1130941|NCT01308424|2737414|P1|COMPLETED|Baseline Eligibility|Completed baseline run in and were eligible for randomization|171
1130942|NCT01308424|2737412|P3|STARTED|Baseline Eligibility||0
1130943|NCT01308424|2737413|P2|STARTED|Baseline Eligibility||0
1130944|NCT01308424|2737414|P1|STARTED|Baseline Eligibility||242
1130945|NCT01308450|2737421|P1|NOT COMPLETED|Overall Study||2
1130946|NCT01308450|2737421|P1|COMPLETED|Overall Study|Last subject was enrolled 06/28/2011|300
1130947|NCT01308450|2737421|P1|STARTED|Overall Study|302 subjects were screen. 300 subjects were enrolled in this one site, one visit study.|302
1130948|NCT01308463|2737425|P1|NOT COMPLETED|Overall Study||29
1130949|NCT01308463|2737425|P1|COMPLETED|Overall Study||0
1130950|NCT01308463|2737425|P1|12 Years|Overall Study||2
1130951|NCT01308463|2737425|P1|11 Years|Overall Study||8
1130952|NCT01308463|2737425|P1|10 Years|Overall Study||8
1130953|NCT01308463|2737425|P1|9 Years|Overall Study||11
1130954|NCT01308463|2737425|P1|8 Years|Overall Study||14
1130955|NCT01308463|2737425|P1|7 Years|Overall Study||12
1130956|NCT01308463|2737425|P1|6 Years|Overall Study||11
1130957|NCT01308463|2737425|P1|5 Years|Overall Study||20
1130958|NCT01308463|2737425|P1|4 Years|Overall Study||20
1130959|NCT01308463|2737425|P1|3 Years|Overall Study||17
1130960|NCT01308463|2737425|P1|2 Years|Overall Study||18
1130961|NCT01308463|2737425|P1|1 Year|Overall Study||21
1130962|NCT01308463|2737425|P1|6 Months|Overall Study||23
1130963|NCT01308463|2737425|P1|STARTED|Overall Study||29
1130964|NCT01308476|2737434|P2|NOT COMPLETED|Overall Study||2
1130965|NCT01308476|2737435|P1|NOT COMPLETED|Overall Study||3
1130966|NCT01308476|2737434|P2|COMPLETED|Overall Study||45
1130967|NCT01308476|2737435|P1|COMPLETED|Overall Study||45
1130968|NCT01308476|2737434|P2|STARTED|Overall Study|Entered and treated.|47
1130969|NCT01308476|2737435|P1|STARTED|Overall Study|Entered and treated.|48
1130985|NCT01308580|2737500|P2|NOT COMPLETED|Overall Study||7
1130986|NCT01308580|2737501|P1|NOT COMPLETED|Overall Study||12
1130987|NCT01308580|2737500|P2|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|595
1130988|NCT01308580|2737501|P1|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|586
1130989|NCT01308580|2737500|P2|Treated|Overall Study|Random assignment, was not actual treatment in some cases|588
1130990|NCT01308580|2737501|P1|Treated|Overall Study|Random assignment, was not actual treatment in some cases|587
1130991|NCT01308580|2737500|P2|STARTED|Overall Study||602
1130992|NCT01308580|2737501|P1|STARTED|Overall Study||598
1130993|NCT01308619|2737543|P2|NOT COMPLETED|Overall Study||3
1130994|NCT01308619|2737544|P1|NOT COMPLETED|Overall Study||7
1130995|NCT01308619|2737543|P2|COMPLETED|Overall Study||83
1130996|NCT01308619|2737544|P1|COMPLETED|Overall Study||77
1130997|NCT01308619|2737543|P2|STARTED|Overall Study||86
1130998|NCT01308619|2737544|P1|STARTED|Overall Study||84
1130999|NCT01296763|2737559|P3|NOT COMPLETED|Overall Study||0
1131000|NCT01296763|2737560|P2|NOT COMPLETED|Overall Study||0
1131001|NCT01296763|2737561|P1|NOT COMPLETED|Overall Study||0
1131002|NCT01296763|2737559|P3|COMPLETED|Overall Study||6
1131003|NCT01296763|2737560|P2|COMPLETED|Overall Study||5
1131004|NCT01296763|2737561|P1|COMPLETED|Overall Study||7
1131005|NCT01296763|2737559|P3|STARTED|Overall Study||6
1131006|NCT01296763|2737560|P2|STARTED|Overall Study||5
1131007|NCT01296763|2737561|P1|STARTED|Overall Study||7
1131008|NCT01296815|2737574|P2|NOT COMPLETED|Overall Study||0
1131009|NCT01296815|2737575|P1|NOT COMPLETED|Overall Study||0
1131010|NCT01296815|2737574|P2|COMPLETED|Overall Study||7
1131011|NCT01296815|2737575|P1|COMPLETED|Overall Study||7
1131012|NCT01296815|2737574|P2|STARTED|Overall Study||7
1131013|NCT01296815|2737575|P1|STARTED|Overall Study||7
1131014|NCT01296841|2737583|P2|NOT COMPLETED|Overall Study||0
1131015|NCT01296841|2737584|P1|NOT COMPLETED|Overall Study||0
1131016|NCT01296841|2737583|P2|COMPLETED|Overall Study||15
1131017|NCT01296841|2737584|P1|COMPLETED|Overall Study||19
1131018|NCT01296841|2737583|P2|STARTED|Overall Study||15
1131019|NCT01296841|2737584|P1|STARTED|Overall Study||19
1131020|NCT01302392|2737596|P2|NOT COMPLETED|Overall Study||1
1131021|NCT01302392|2737597|P1|NOT COMPLETED|Overall Study||7
1131022|NCT01302392|2737596|P2|COMPLETED|Overall Study||156
1131023|NCT01302392|2737597|P1|COMPLETED|Overall Study||151
1131024|NCT01302392|2737596|P2|Treated|Overall Study||157
1131025|NCT01302392|2737597|P1|Treated|Overall Study||153
1131026|NCT01302392|2737596|P2|STARTED|Overall Study||157
1131027|NCT01302392|2737597|P1|STARTED|Overall Study||158
1131028|NCT01302418|2737617|P1|NOT COMPLETED|Overall Study||18
1131029|NCT01302418|2737617|P1|COMPLETED|Overall Study||254
1131030|NCT01302418|2737617|P1|STARTED|Overall Study||272
1131031|NCT01302444|2737623|P2|NOT COMPLETED|Overall Study||0
1131032|NCT01302444|2737624|P1|NOT COMPLETED|Overall Study||0
1131033|NCT01302444|2737623|P2|COMPLETED|Overall Study||0
1131034|NCT01302444|2737624|P1|COMPLETED|Overall Study||1
1131035|NCT01302444|2737623|P2|STARTED|Overall Study||0
1131036|NCT01302444|2737624|P1|STARTED|Overall Study||1
1131037|NCT01302483|2737646|P2|NOT COMPLETED|Overall Study||0
1131038|NCT01302483|2737647|P1|NOT COMPLETED|Overall Study||0
1131039|NCT01302483|2737646|P2|COMPLETED|Overall Study||15
1131040|NCT01302483|2737647|P1|COMPLETED|Overall Study||30
1131041|NCT01302483|2737646|P2|STARTED|Overall Study||15
1131042|NCT01302483|2737647|P1|STARTED|Overall Study||30
1131043|NCT01302548|2737663|P2|NOT COMPLETED|Overall Study||1
1131044|NCT01302548|2737664|P1|NOT COMPLETED|Overall Study||2
1131045|NCT01302548|2737663|P2|COMPLETED|Overall Study||18
1131046|NCT01302548|2737664|P1|COMPLETED|Overall Study||12
1131047|NCT01302548|2737663|P2|STARTED|Overall Study||19
1131048|NCT01302548|2737664|P1|STARTED|Overall Study||14
1131049|NCT01308736|2737676|P2|NOT COMPLETED|Overall Study||5
1131050|NCT01308736|2737677|P1|NOT COMPLETED|Overall Study||6
1131051|NCT01308736|2737676|P2|COMPLETED|Overall Study||27
1131052|NCT01308736|2737677|P1|COMPLETED|Overall Study||25
1131053|NCT01308736|2737676|P2|STARTED|Overall Study||32
1131054|NCT01308736|2737677|P1|STARTED|Overall Study||31
1131055|NCT01308749|2737685|P2|NOT COMPLETED|Period 2: Open Label Treatment||2
1131056|NCT01308749|2737686|P1|NOT COMPLETED|Period 2: Open Label Treatment||0
1131057|NCT01308749|2737685|P2|COMPLETED|Period 2: Open Label Treatment||11
1131058|NCT01308749|2737686|P1|COMPLETED|Period 2: Open Label Treatment||11
1131059|NCT01308749|2737685|P2|STARTED|Period 2: Open Label Treatment||13
1131060|NCT01308749|2737686|P1|STARTED|Period 2: Open Label Treatment||11
1131061|NCT01308749|2737685|P2|NOT COMPLETED|Period 1: Double Blind Treatment||0
1131062|NCT01308749|2737686|P1|NOT COMPLETED|Period 1: Double Blind Treatment||1
1131063|NCT01308749|2737685|P2|COMPLETED|Period 1: Double Blind Treatment||13
1131064|NCT01308749|2737686|P1|COMPLETED|Period 1: Double Blind Treatment||11
1131065|NCT01308749|2737685|P2|STARTED|Period 1: Double Blind Treatment||13
1131066|NCT01308749|2737686|P1|STARTED|Period 1: Double Blind Treatment||12
1131067|NCT01308762|2737717|P3|NOT COMPLETED|Overall Study||0
1131068|NCT01308762|2737718|P2|NOT COMPLETED|Overall Study||1
1131069|NCT01308762|2737719|P1|NOT COMPLETED|Overall Study||0
1131070|NCT01308762|2737717|P3|COMPLETED|Overall Study||6
1131071|NCT01308762|2737718|P2|COMPLETED|Overall Study|One patient was withdrawn as they were retrospecively found to have been ineligible at study entry|6
1131072|NCT01308762|2737719|P1|COMPLETED|Overall Study||6
1131073|NCT01308762|2737717|P3|STARTED|Overall Study||6
1131074|NCT01308762|2737718|P2|STARTED|Overall Study||7
1131075|NCT01308762|2737719|P1|STARTED|Overall Study||6
1131076|NCT01308788|2737732|P2|NOT COMPLETED|2-year Treatment||11
1131077|NCT01308788|2737733|P1|NOT COMPLETED|2-year Treatment||4
1131078|NCT01308788|2737732|P2|COMPLETED|2-year Treatment||10
1131079|NCT01308788|2737733|P1|COMPLETED|2-year Treatment||10
1131080|NCT01308788|2737732|P2|STARTED|2-year Treatment||21
1131081|NCT01308788|2737733|P1|STARTED|2-year Treatment||14
1131082|NCT01308788|2737732|P2|NOT COMPLETED|6-month Treatment||0
1131083|NCT01308788|2737733|P1|NOT COMPLETED|6-month Treatment||0
1131084|NCT01308788|2737732|P2|COMPLETED|6-month Treatment||21
1131085|NCT01308788|2737733|P1|COMPLETED|6-month Treatment||14
1131086|NCT01308788|2737732|P2|STARTED|6-month Treatment||21
1131087|NCT01308788|2737733|P1|STARTED|6-month Treatment||14
1131088|NCT01308814|2737767|P2|NOT COMPLETED|Overall Study||23
1131089|NCT01308814|2737768|P1|NOT COMPLETED|Overall Study||17
1131090|NCT01308814|2737767|P2|COMPLETED|Overall Study||63
1131091|NCT01308814|2737768|P1|COMPLETED|Overall Study||69
1131092|NCT01308814|2737767|P2|STARTED|Overall Study||86
1131093|NCT01308814|2737768|P1|STARTED|Overall Study||86
1131094|NCT01308840|2737786|P1|NOT COMPLETED|Overall Study||0
1131095|NCT01308840|2737786|P1|COMPLETED|Overall Study||31
1131096|NCT01308840|2737786|P1|STARTED|Overall Study||31
1131097|NCT01308918|2737793|P1|NOT COMPLETED|Overall Study||0
1131098|NCT01308918|2737793|P1|COMPLETED|Overall Study||50
1131099|NCT01308918|2737793|P1|STARTED|Overall Study||50
1131100|NCT01309581|2737802|P2|NOT COMPLETED|Overall Study||0
1131101|NCT01309581|2737803|P1|NOT COMPLETED|Overall Study||0
1131102|NCT01309581|2737802|P2|COMPLETED|Overall Study||1
1131103|NCT01309581|2737803|P1|COMPLETED|Overall Study||2
1131104|NCT01309581|2737802|P2|STARTED|Overall Study||1
1131105|NCT01309581|2737803|P1|STARTED|Overall Study||2
1131106|NCT01309646|2737813|P2|NOT COMPLETED|Overall Study||0
1131107|NCT01309646|2737814|P1|NOT COMPLETED|Overall Study||0
1131108|NCT01309646|2737813|P2|COMPLETED|Overall Study||227
1131109|NCT01309646|2737814|P1|COMPLETED|Overall Study||224
1131110|NCT01309646|2737813|P2|STARTED|Overall Study||227
1131111|NCT01309646|2737814|P1|STARTED|Overall Study||224
1131112|NCT01309659|2737854|P2|NOT COMPLETED|Overall Study||1
1131113|NCT01309659|2737855|P1|NOT COMPLETED|Overall Study||0
1131114|NCT01309659|2737854|P2|COMPLETED|Overall Study||9
1131115|NCT01309659|2737855|P1|COMPLETED|Overall Study||9
1131116|NCT01309659|2737854|P2|STARTED|Overall Study||10
1131117|NCT01309659|2737855|P1|STARTED|Overall Study||9
1131118|NCT01309672|2737895|P1|NOT COMPLETED|Overall Study||37
1131119|NCT01309672|2737895|P1|COMPLETED|Overall Study||4
1131120|NCT01309672|2737895|P1|Received Protocol Treatment|Overall Study||40
1131121|NCT01309672|2737895|P1|STARTED|Overall Study||41
1131157|NCT01309802|2738107|P2|NOT COMPLETED|Overall Study||9
1131158|NCT01309802|2738108|P1|NOT COMPLETED|Overall Study||12
1131159|NCT01309802|2738107|P2|COMPLETED|Overall Study||14
1131160|NCT01309802|2738108|P1|COMPLETED|Overall Study||13
1131161|NCT01309802|2738107|P2|STARTED|Overall Study||23
1131162|NCT01309802|2738108|P1|STARTED|Overall Study||25
1131163|NCT01309828|2738126|P2|NOT COMPLETED|Overall Study||16
1131164|NCT01309828|2738127|P1|NOT COMPLETED|Overall Study||16
1131165|NCT01309828|2738126|P2|COMPLETED|Overall Study||60
1131166|NCT01309828|2738127|P1|COMPLETED|Overall Study||61
1131167|NCT01309828|2738126|P2|STARTED|Overall Study||76
1131168|NCT01309828|2738127|P1|STARTED|Overall Study||77
1131169|NCT01309841|2738142|P3|NOT COMPLETED|Overall Study||37
1131170|NCT01309841|2738143|P2|NOT COMPLETED|Overall Study||41
1131171|NCT01309841|2738144|P1|NOT COMPLETED|Overall Study||39
1131172|NCT01309841|2738142|P3|COMPLETED|Overall Study||180
1131173|NCT01309841|2738143|P2|COMPLETED|Overall Study||177
1131174|NCT01309841|2738144|P1|COMPLETED|Overall Study||178
1131175|NCT01309841|2738142|P3|STARTED|Overall Study||217
1131176|NCT01309841|2738143|P2|STARTED|Overall Study||218
1131177|NCT01309841|2738144|P1|STARTED|Overall Study||217
1131178|NCT01309880|2738182|P2|NOT COMPLETED|Overall Study||0
1131179|NCT01309880|2738183|P1|NOT COMPLETED|Overall Study||0
1131180|NCT01309880|2738182|P2|COMPLETED|Overall Study||33
1131181|NCT01309880|2738183|P1|COMPLETED|Overall Study||33
1131182|NCT01309880|2738182|P2|STARTED|Overall Study||33
1131183|NCT01309880|2738183|P1|STARTED|Overall Study||33
1131184|NCT01309893|2738193|P2|NOT COMPLETED|Week 2 - Crossover Intervention||1
1131185|NCT01309893|2738194|P1|NOT COMPLETED|Week 2 - Crossover Intervention||1
1131186|NCT01309893|2738193|P2|COMPLETED|Week 2 - Crossover Intervention||32
1131187|NCT01309893|2738194|P1|COMPLETED|Week 2 - Crossover Intervention||32
1131188|NCT01309893|2738193|P2|STARTED|Week 2 - Crossover Intervention||33
1131189|NCT01309893|2738194|P1|STARTED|Week 2 - Crossover Intervention||33
1131190|NCT01309893|2738193|P2|NOT COMPLETED|Week 1 - First Intervention||0
1131191|NCT01309893|2738194|P1|NOT COMPLETED|Week 1 - First Intervention||0
1131192|NCT01309893|2738193|P2|COMPLETED|Week 1 - First Intervention||33
1131193|NCT01309893|2738194|P1|COMPLETED|Week 1 - First Intervention||33
1131194|NCT01309893|2738193|P2|STARTED|Week 1 - First Intervention||33
1131195|NCT01309893|2738194|P1|STARTED|Week 1 - First Intervention||33
1131196|NCT01309919|2738206|P2|NOT COMPLETED|Overall Study||48
1131197|NCT01309919|2738207|P1|NOT COMPLETED|Overall Study||17
1131198|NCT01309919|2738206|P2|COMPLETED|Overall Study||27
1131199|NCT01309919|2738207|P1|COMPLETED|Overall Study||58
1131200|NCT01309919|2738206|P2|STARTED|Overall Study||75
1131201|NCT01309919|2738207|P1|STARTED|Overall Study||75
1131202|NCT01309997|2738221|P2|NOT COMPLETED|Overall Study||6
1131203|NCT01309997|2738222|P1|NOT COMPLETED|Overall Study||5
1131204|NCT01309997|2738221|P2|COMPLETED|Overall Study||31
1131205|NCT01309997|2738222|P1|COMPLETED|Overall Study||30
1131206|NCT01309997|2738221|P2|Crossed Over to Second Arm|Overall Study||23
1131207|NCT01309997|2738222|P1|Crossed Over to Second Arm|Overall Study||19
1131208|NCT01309997|2738221|P2|Remained on First Arm Only|Overall Study||14
1131209|NCT01309997|2738222|P1|Remained on First Arm Only|Overall Study||16
1131210|NCT01309997|2738221|P2|STARTED|Overall Study||37
1131211|NCT01309997|2738222|P1|STARTED|Overall Study||35
1131212|NCT01310127|2738246|P2|NOT COMPLETED|Overall Study||1
1131213|NCT01310127|2738247|P1|NOT COMPLETED|Overall Study||2
1131214|NCT01310127|2738246|P2|COMPLETED|Overall Study||10
1131215|NCT01310127|2738247|P1|COMPLETED|Overall Study||10
1131216|NCT01310127|2738246|P2|STARTED|Overall Study||11
1131217|NCT01310127|2738247|P1|STARTED|Overall Study||12
1131218|NCT01310179|2738259|P1|NOT COMPLETED|Overall Study||0
1131219|NCT01310179|2738259|P1|COMPLETED|Overall Study||12
1131220|NCT01310179|2738259|P1|STARTED|Overall Study||12
1131221|NCT01310400|2738267|P3|NOT COMPLETED|Overall Study||30
1131222|NCT01310400|2738268|P2|NOT COMPLETED|Overall Study||32
1131223|NCT01310400|2738269|P1|NOT COMPLETED|Overall Study||28
1131224|NCT01310400|2738267|P3|COMPLETED|Overall Study||422
1131225|NCT01310400|2738268|P2|COMPLETED|Overall Study||420
1131226|NCT01310400|2738269|P1|COMPLETED|Overall Study||424
1131227|NCT01310400|2738267|P3|STARTED|Overall Study||452
1131228|NCT01310400|2738268|P2|STARTED|Overall Study||452
1131229|NCT01310400|2738269|P1|STARTED|Overall Study||452
1131230|NCT01310413|2738292|P7|NOT COMPLETED|From Day U0 to Day U385||3
1131231|NCT01310413|2738293|P6|NOT COMPLETED|From Day U0 to Day U385||0
1131232|NCT01310413|2738294|P5|NOT COMPLETED|From Day U0 to Day U385||0
1131233|NCT01310413|2738295|P4|NOT COMPLETED|From Day U0 to Day U385||0
1131234|NCT01310413|2738296|P3|NOT COMPLETED|From Day U0 to Day U385||0
1131235|NCT01310413|2738297|P2|NOT COMPLETED|From Day U0 to Day U385||0
1131236|NCT01310413|2738298|P1|NOT COMPLETED|From Day U0 to Day U385||0
1131237|NCT01310413|2738292|P7|COMPLETED|From Day U0 to Day U385|Upto Day U42|152
1131238|NCT01310413|2738293|P6|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
1131239|NCT01310413|2738294|P5|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
1131240|NCT01310413|2738295|P4|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
1131241|NCT01310413|2738296|P3|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
1131242|NCT01310413|2738297|P2|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
1131243|NCT01310413|2738298|P1|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
1131244|NCT01310413|2738292|P7|STARTED|From Day U0 to Day U385|Upto Day U42|155
1131245|NCT01310413|2738293|P6|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
1131246|NCT01310413|2738294|P5|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
1131247|NCT01310413|2738295|P4|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
1131248|NCT01310413|2738296|P3|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
1131249|NCT01310413|2738297|P2|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
1131250|NCT01310413|2738298|P1|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
1131251|NCT01310413|2738292|P7|NOT COMPLETED|Day 0 to Day 385||0
1131252|NCT01310413|2738293|P6|NOT COMPLETED|Day 0 to Day 385||3
1131253|NCT01310413|2738294|P5|NOT COMPLETED|Day 0 to Day 385||3
1131254|NCT01310413|2738295|P4|NOT COMPLETED|Day 0 to Day 385||8
1131255|NCT01310413|2738296|P3|NOT COMPLETED|Day 0 to Day 385||7
1131256|NCT01310413|2738297|P2|NOT COMPLETED|Day 0 to Day 385||8
1131257|NCT01310413|2738298|P1|NOT COMPLETED|Day 0 to Day 385||27
1131258|NCT01310413|2738292|P7|COMPLETED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
1131259|NCT01310413|2738293|P6|COMPLETED|Day 0 to Day 385||77
1131260|NCT01310413|2738294|P5|COMPLETED|Day 0 to Day 385||73
1131261|NCT01310413|2738295|P4|COMPLETED|Day 0 to Day 385||67
1131262|NCT01310413|2738296|P3|COMPLETED|Day 0 to Day 385||203
1131263|NCT01310413|2738297|P2|COMPLETED|Day 0 to Day 385||190
1131264|NCT01310413|2738298|P1|COMPLETED|Day 0 to Day 385||172
1131265|NCT01310413|2738292|P7|STARTED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
1131266|NCT01310413|2738293|P6|STARTED|Day 0 to Day 385||80
1131267|NCT01310413|2738294|P5|STARTED|Day 0 to Day 385||76
1131268|NCT01310413|2738295|P4|STARTED|Day 0 to Day 385||75
1131269|NCT01310413|2738296|P3|STARTED|Day 0 to Day 385||210
1131270|NCT01310413|2738297|P2|STARTED|Day 0 to Day 385||198
1131271|NCT01310413|2738298|P1|STARTED|Day 0 to Day 385||199
1131272|NCT01310582|2738453|P2|NOT COMPLETED|Overall Study||0
1131273|NCT01310582|2738454|P1|NOT COMPLETED|Overall Study||0
1131274|NCT01310582|2738453|P2|COMPLETED|Overall Study||26
1131275|NCT01310582|2738454|P1|COMPLETED|Overall Study||31
1131276|NCT01310582|2738453|P2|STARTED|Overall Study||26
1131277|NCT01310582|2738454|P1|STARTED|Overall Study||31
1131278|NCT01310699|2738464|P2|NOT COMPLETED|Overall Study||6
1131279|NCT01310699|2738465|P1|NOT COMPLETED|Overall Study||4
1131280|NCT01310699|2738464|P2|COMPLETED|Overall Study||143
1131281|NCT01310699|2738465|P1|COMPLETED|Overall Study||128
1131282|NCT01310699|2738464|P2|STARTED|Overall Study||149
1131283|NCT01310699|2738465|P1|STARTED|Overall Study||132
1131284|NCT01310777|2738478|P3|NOT COMPLETED|Overall Study||30
1131285|NCT01310777|2738479|P2|NOT COMPLETED|Overall Study||14
1131286|NCT01310777|2738480|P1|NOT COMPLETED|Overall Study||33
1131287|NCT01310777|2738478|P3|COMPLETED|Overall Study||145
1131288|NCT01310777|2738479|P2|COMPLETED|Overall Study||178
1131289|NCT01310777|2738480|P1|COMPLETED|Overall Study||160
1131290|NCT01310777|2738478|P3|STARTED|Overall Study||175
1131291|NCT01310777|2738479|P2|STARTED|Overall Study||192
1131292|NCT01310777|2738480|P1|STARTED|Overall Study||193
1131293|NCT01310803|2738490|P2|NOT COMPLETED|Overall Study||0
1131294|NCT01310803|2738491|P1|NOT COMPLETED|Overall Study||1
1131295|NCT01310803|2738490|P2|COMPLETED|Overall Study||0
1131296|NCT01310803|2738491|P1|COMPLETED|Overall Study||0
1131297|NCT01310803|2738490|P2|STARTED|Overall Study||0
1131298|NCT01310803|2738491|P1|STARTED|Overall Study||1
1131299|NCT01310855|2738501|P2|NOT COMPLETED|Overall Study||0
1131300|NCT01310855|2738502|P1|NOT COMPLETED|Overall Study||0
1131301|NCT01310855|2738501|P2|COMPLETED|Overall Study||19
1131302|NCT01310855|2738502|P1|COMPLETED|Overall Study||19
1131303|NCT01310855|2738501|P2|STARTED|Overall Study||19
1131304|NCT01310855|2738502|P1|STARTED|Overall Study||19
1131305|NCT01310868|2738508|P1|NOT COMPLETED|Overall Study||13
1131306|NCT01310868|2738508|P1|COMPLETED|Overall Study||59
1131307|NCT01310868|2738508|P1|STARTED|Overall Study||72
1131314|NCT01311102|2738525|P2|NOT COMPLETED|Overall Study||0
1131315|NCT01311102|2738526|P1|NOT COMPLETED|Overall Study||0
1131316|NCT01311102|2738525|P2|COMPLETED|Overall Study||20
1131317|NCT01311102|2738526|P1|COMPLETED|Overall Study||20
1131318|NCT01311102|2738525|P2|STARTED|Overall Study||20
1131319|NCT01311102|2738526|P1|STARTED|Overall Study||20
1131320|NCT01311362|2738538|P1|NOT COMPLETED|Ambrisentan and SJW||0
1131321|NCT01311362|2738538|P1|COMPLETED|Ambrisentan and SJW||20
1131322|NCT01311362|2738538|P1|STARTED|Ambrisentan and SJW||20
1131323|NCT01311362|2738538|P1|NOT COMPLETED|Ambrisentan Steady-state||0
1131324|NCT01311362|2738538|P1|COMPLETED|Ambrisentan Steady-state||20
1131325|NCT01311362|2738538|P1|STARTED|Ambrisentan Steady-state||20
1131326|NCT01311362|2738538|P1|NOT COMPLETED|Ambrisentan Single Dose||0
1131327|NCT01311362|2738538|P1|COMPLETED|Ambrisentan Single Dose||20
1131328|NCT01311362|2738538|P1|STARTED|Ambrisentan Single Dose|All 20 study participants completed each study period. Total number of study participants: 20|20
1131329|NCT01311505|2738549|P2|NOT COMPLETED|Second Intervention Period||0
1131330|NCT01311505|2738550|P1|NOT COMPLETED|Second Intervention Period||0
1131331|NCT01311505|2738549|P2|COMPLETED|Second Intervention Period||10
1131332|NCT01311505|2738550|P1|COMPLETED|Second Intervention Period||10
1131333|NCT01311505|2738549|P2|STARTED|Second Intervention Period||10
1131334|NCT01311505|2738550|P1|STARTED|Second Intervention Period||10
1131335|NCT01311505|2738549|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1131336|NCT01311505|2738550|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
1131337|NCT01311505|2738549|P2|COMPLETED|Washout Period (at Least 7 Days)||10
1131338|NCT01311505|2738550|P1|COMPLETED|Washout Period (at Least 7 Days)||10
1131339|NCT01311505|2738549|P2|STARTED|Washout Period (at Least 7 Days)||10
1131340|NCT01311505|2738550|P1|STARTED|Washout Period (at Least 7 Days)||10
1131341|NCT01311505|2738549|P2|NOT COMPLETED|First Intervention Period||1
1131342|NCT01311505|2738550|P1|NOT COMPLETED|First Intervention Period||0
1131343|NCT01311505|2738549|P2|COMPLETED|First Intervention Period||10
1131344|NCT01311505|2738550|P1|COMPLETED|First Intervention Period||10
1131345|NCT01311505|2738549|P2|STARTED|First Intervention Period||11
1131346|NCT01311505|2738550|P1|STARTED|First Intervention Period||10
1131347|NCT01311557|2738580|P2|NOT COMPLETED|Overall Study||6
1131348|NCT01311557|2738581|P1|NOT COMPLETED|Overall Study||5
1131349|NCT01311557|2738580|P2|COMPLETED|Overall Study||645
1131350|NCT01311557|2738581|P1|COMPLETED|Overall Study||646
1131351|NCT01311557|2738580|P2|STARTED|Overall Study||651
1131352|NCT01311557|2738581|P1|STARTED|Overall Study||651
1131353|NCT01311661|2738597|P1|NOT COMPLETED|Overall Study||7
1131354|NCT01311661|2738597|P1|COMPLETED|Overall Study||199
1131355|NCT01311661|2738597|P1|Received Olo 10 mcg qd|Overall Study||102
1131356|NCT01311661|2738597|P1|Received Olo 5 mcg Bid|Overall Study||101
1131357|NCT01311661|2738597|P1|Received Olo 5 mcg qd|Overall Study||101
1131358|NCT01311661|2738597|P1|Received Olo 2.5 mcg Bid|Overall Study||101
1131359|NCT01311661|2738597|P1|Received Placebo|Overall Study||201
1131360|NCT01311661|2738597|P1|STARTED|Overall Study|Entered and treated|206
1131544|NCT01312129|2738994|P1|NOT COMPLETED|Second Intervention (24 Hours)||0
1131375|NCT01312038|2738794|P2|NOT COMPLETED|Overall Study||0
1131376|NCT01312038|2738795|P1|NOT COMPLETED|Overall Study||0
1131377|NCT01312038|2738794|P2|COMPLETED|Overall Study||12
1131378|NCT01312038|2738795|P1|COMPLETED|Overall Study||13
1131379|NCT01312038|2738794|P2|STARTED|Overall Study||12
1131380|NCT01312038|2738795|P1|STARTED|Overall Study||13
1131381|NCT01305564|2738801|P1|NOT COMPLETED|Overall Study||37
1131382|NCT01305564|2738801|P1|COMPLETED|Overall Study||163
1131383|NCT01305564|2738801|P1|STARTED|Overall Study||200
1131384|NCT01305577|2738819|P3|NOT COMPLETED|Overall Study||10
1131385|NCT01305577|2738820|P2|NOT COMPLETED|Overall Study||11
1131386|NCT01305577|2738821|P1|NOT COMPLETED|Overall Study||13
1131387|NCT01305577|2738819|P3|COMPLETED|Overall Study||112
1131388|NCT01305577|2738820|P2|COMPLETED|Overall Study||110
1131389|NCT01305577|2738821|P1|COMPLETED|Overall Study||107
1131390|NCT01305577|2738819|P3|Received Treatment|Overall Study||122
1131391|NCT01305577|2738820|P2|Received Treatment|Overall Study||121
1131392|NCT01305577|2738821|P1|Received Treatment|Overall Study||119
1131393|NCT01305577|2738819|P3|STARTED|Overall Study||122
1131394|NCT01305577|2738820|P2|STARTED|Overall Study||121
1131395|NCT01305577|2738821|P1|STARTED|Overall Study||120
1131396|NCT01305655|2738850|P1|NOT COMPLETED|Overall Study||0
1131397|NCT01305655|2738850|P1|COMPLETED|Overall Study|December 31, 2014|47
1131398|NCT01305655|2738850|P1|STARTED|Overall Study|July 2008|47
1131399|NCT01305772|2738856|P2|NOT COMPLETED|Overall Study||0
1131400|NCT01305772|2738857|P1|NOT COMPLETED|Overall Study||0
1131401|NCT01305772|2738856|P2|COMPLETED|Overall Study||1
1131402|NCT01305772|2738857|P1|COMPLETED|Overall Study||5
1131403|NCT01305772|2738856|P2|RT + Panitumumab Dose #2 / #3|Overall Study||1
1131404|NCT01305772|2738857|P1|RT + Panitumumab Dose #2 / #3|Overall Study|RT and doses #2 and #3 of panitumumab administered to patients regardless of 2nd biopsy status.|5
1131405|NCT01305772|2738856|P2|Surgery/Biopsy #2|Overall Study||1
1131406|NCT01305772|2738857|P1|Surgery/Biopsy #2|Overall Study|2nd research tissue sample not collected for 4 patients due to safety risk to subject.|1
1131407|NCT01305772|2738856|P2|Research PET/CT #2|Overall Study||1
1131408|NCT01305772|2738857|P1|Research PET/CT #2|Overall Study||5
1131409|NCT01305772|2738856|P2|Panitumumab Dose #1|Overall Study||1
1131410|NCT01305772|2738857|P1|Panitumumab Dose #1|Overall Study||5
1131411|NCT01305772|2738856|P2|Research PET/CT #1|Overall Study||1
1131412|NCT01305772|2738857|P1|Research PET/CT #1|Overall Study||5
1131413|NCT01305772|2738856|P2|Genomic Screening + Biopsy #1|Overall Study||1
1131414|NCT01305772|2738857|P1|Genomic Screening + Biopsy #1|Overall Study||5
1131415|NCT01305772|2738856|P2|STARTED|Overall Study||1
1131416|NCT01305772|2738857|P1|STARTED|Overall Study||5
1131417|NCT01305811|2738866|P2|NOT COMPLETED|Overall Study||11
1131418|NCT01305811|2738867|P1|NOT COMPLETED|Overall Study||8
1131419|NCT01305811|2738866|P2|COMPLETED|Overall Study||41
1131420|NCT01305811|2738867|P1|COMPLETED|Overall Study||44
1131421|NCT01305811|2738866|P2|STARTED|Overall Study||52
1131422|NCT01305811|2738867|P1|STARTED|Overall Study||52
1131423|NCT01306032|2738881|P6|NOT COMPLETED|Disease Progression/Crossover||0
1131424|NCT01306032|2738882|P5|NOT COMPLETED|Disease Progression/Crossover||0
1131425|NCT01306032|2738883|P4|NOT COMPLETED|Disease Progression/Crossover||3
1131426|NCT01306032|2738884|P3|NOT COMPLETED|Disease Progression/Crossover||0
1131427|NCT01306032|2738885|P2|NOT COMPLETED|Disease Progression/Crossover||2
1131428|NCT01306032|2738886|P1|NOT COMPLETED|Disease Progression/Crossover||0
1131429|NCT01306032|2738881|P6|COMPLETED|Disease Progression/Crossover||0
1131430|NCT01306032|2738882|P5|COMPLETED|Disease Progression/Crossover||0
1131431|NCT01306032|2738883|P4|COMPLETED|Disease Progression/Crossover||26
1131432|NCT01306032|2738884|P3|COMPLETED|Disease Progression/Crossover||0
1131433|NCT01306032|2738885|P2|COMPLETED|Disease Progression/Crossover||14
1131434|NCT01306032|2738886|P1|COMPLETED|Disease Progression/Crossover||0
1131435|NCT01306032|2738881|P6|STARTED|Disease Progression/Crossover||0
1131436|NCT01306032|2738882|P5|STARTED|Disease Progression/Crossover||0
1131437|NCT01306032|2738883|P4|STARTED|Disease Progression/Crossover||29
1131438|NCT01306032|2738884|P3|STARTED|Disease Progression/Crossover||0
1131439|NCT01306032|2738885|P2|STARTED|Disease Progression/Crossover||16
1131440|NCT01306032|2738886|P1|STARTED|Disease Progression/Crossover||0
1131441|NCT01306032|2738881|P6|NOT COMPLETED|First Intervention||2
1131442|NCT01306032|2738882|P5|NOT COMPLETED|First Intervention||2
1131443|NCT01306032|2738883|P4|NOT COMPLETED|First Intervention||1
1131444|NCT01306032|2738884|P3|NOT COMPLETED|First Intervention||2
1131445|NCT01306032|2738885|P2|NOT COMPLETED|First Intervention||2
1131446|NCT01306032|2738886|P1|NOT COMPLETED|First Intervention||1
1131447|NCT01306032|2738881|P6|COMPLETED|First Intervention||0
1131448|NCT01306032|2738882|P5|COMPLETED|First Intervention||0
1131449|NCT01306032|2738883|P4|COMPLETED|First Intervention||37
1131450|NCT01306032|2738884|P3|COMPLETED|First Intervention||35
1131451|NCT01306032|2738885|P2|COMPLETED|First Intervention||18
1131452|NCT01306032|2738886|P1|COMPLETED|First Intervention||21
1131453|NCT01306032|2738881|P6|STARTED|First Intervention||2
1131454|NCT01306032|2738882|P5|STARTED|First Intervention||2
1131455|NCT01306032|2738883|P4|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|38
1131456|NCT01306032|2738884|P3|STARTED|First Intervention||37
1131457|NCT01306032|2738885|P2|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|20
1131458|NCT01306032|2738886|P1|STARTED|First Intervention||22
1131459|NCT01306162|2738942|P4|NOT COMPLETED|Period 4||0
1131460|NCT01306162|2738943|P3|NOT COMPLETED|Period 4||0
1131461|NCT01306162|2738944|P2|NOT COMPLETED|Period 4||0
1131462|NCT01306162|2738945|P1|NOT COMPLETED|Period 4||0
1131463|NCT01306162|2738942|P4|COMPLETED|Period 4||8
1131464|NCT01306162|2738943|P3|COMPLETED|Period 4||9
1131465|NCT01306162|2738944|P2|COMPLETED|Period 4||8
1131466|NCT01306162|2738945|P1|COMPLETED|Period 4||9
1131467|NCT01306162|2738942|P4|STARTED|Period 4||8
1131468|NCT01306162|2738943|P3|STARTED|Period 4||9
1131469|NCT01306162|2738944|P2|STARTED|Period 4||8
1131470|NCT01306162|2738945|P1|STARTED|Period 4||9
1131471|NCT01306162|2738942|P4|NOT COMPLETED|Washout 2||0
1131472|NCT01306162|2738943|P3|NOT COMPLETED|Washout 2||0
1131473|NCT01306162|2738944|P2|NOT COMPLETED|Washout 2||0
1131474|NCT01306162|2738945|P1|NOT COMPLETED|Washout 2||0
1131475|NCT01306162|2738942|P4|COMPLETED|Washout 2||8
1131476|NCT01306162|2738943|P3|COMPLETED|Washout 2||9
1131477|NCT01306162|2738944|P2|COMPLETED|Washout 2||8
1131478|NCT01306162|2738945|P1|COMPLETED|Washout 2||9
1131479|NCT01306162|2738942|P4|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|8
1131480|NCT01306162|2738943|P3|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|9
1131481|NCT01306162|2738944|P2|STARTED|Washout 2|No washout period. Treatment D followed directly after treatment E.|8
1131482|NCT01306162|2738945|P1|STARTED|Washout 2|No washout period. Treatment E followed directly after treatment D.|9
1131483|NCT01306162|2738942|P4|NOT COMPLETED|Period 3||0
1131484|NCT01306162|2738943|P3|NOT COMPLETED|Period 3||0
1131485|NCT01306162|2738944|P2|NOT COMPLETED|Period 3||0
1131486|NCT01306162|2738945|P1|NOT COMPLETED|Period 3||0
1131487|NCT01306162|2738942|P4|COMPLETED|Period 3||8
1131488|NCT01306162|2738943|P3|COMPLETED|Period 3||9
1131489|NCT01306162|2738944|P2|COMPLETED|Period 3||8
1131490|NCT01306162|2738945|P1|COMPLETED|Period 3||9
1131491|NCT01306162|2738942|P4|STARTED|Period 3||8
1131492|NCT01306162|2738943|P3|STARTED|Period 3||9
1131493|NCT01306162|2738944|P2|STARTED|Period 3||8
1131494|NCT01306162|2738945|P1|STARTED|Period 3||9
1131495|NCT01306162|2738942|P4|NOT COMPLETED|Period 2||0
1131496|NCT01306162|2738943|P3|NOT COMPLETED|Period 2||0
1131497|NCT01306162|2738944|P2|NOT COMPLETED|Period 2||0
1131498|NCT01306162|2738945|P1|NOT COMPLETED|Period 2||0
1131499|NCT01306162|2738942|P4|COMPLETED|Period 2||8
1131500|NCT01306162|2738943|P3|COMPLETED|Period 2||9
1131501|NCT01306162|2738944|P2|COMPLETED|Period 2||8
1131502|NCT01306162|2738945|P1|COMPLETED|Period 2||9
1131503|NCT01306162|2738942|P4|STARTED|Period 2|No washout phase after Period 2.|8
1131504|NCT01306162|2738943|P3|STARTED|Period 2|No washout phase after Period 2.|9
1131505|NCT01306162|2738944|P2|STARTED|Period 2|No washout phase after Period 2.|8
1131506|NCT01306162|2738945|P1|STARTED|Period 2|No washout phase after Period 2.|9
1131507|NCT01306162|2738942|P4|NOT COMPLETED|Washout 1||0
1131508|NCT01306162|2738943|P3|NOT COMPLETED|Washout 1||0
1131509|NCT01306162|2738944|P2|NOT COMPLETED|Washout 1||1
1131510|NCT01306162|2738945|P1|NOT COMPLETED|Washout 1||0
1131511|NCT01306162|2738942|P4|COMPLETED|Washout 1||8
1131512|NCT01306162|2738943|P3|COMPLETED|Washout 1||9
1131513|NCT01306162|2738944|P2|COMPLETED|Washout 1||8
1131514|NCT01306162|2738945|P1|COMPLETED|Washout 1||9
1131515|NCT01306162|2738942|P4|STARTED|Washout 1|No washout period.Treatment E followed directly after treatment C.|8
1131516|NCT01306162|2738943|P3|STARTED|Washout 1|No washout period. Treatment D followed directly after treatment B.|9
1131517|NCT01306162|2738944|P2|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
1131518|NCT01306162|2738945|P1|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
1131519|NCT01306162|2738942|P4|NOT COMPLETED|Period 1||1
1131520|NCT01306162|2738943|P3|NOT COMPLETED|Period 1||0
1131521|NCT01306162|2738944|P2|NOT COMPLETED|Period 1||0
1131522|NCT01306162|2738945|P1|NOT COMPLETED|Period 1||0
1131523|NCT01306162|2738942|P4|COMPLETED|Period 1||8
1131524|NCT01306162|2738943|P3|COMPLETED|Period 1||9
1131525|NCT01306162|2738944|P2|COMPLETED|Period 1||9
1131526|NCT01306162|2738945|P1|COMPLETED|Period 1||9
1131527|NCT01306162|2738942|P4|STARTED|Period 1||9
1131528|NCT01306162|2738943|P3|STARTED|Period 1||9
1131529|NCT01306162|2738944|P2|STARTED|Period 1||9
1131530|NCT01306162|2738945|P1|STARTED|Period 1||9
1131531|NCT01306175|2738973|P1|NOT COMPLETED|Second Intervention||0
1131532|NCT01306175|2738973|P1|COMPLETED|Second Intervention||20
1131533|NCT01306175|2738973|P1|STARTED|Second Intervention||20
1131534|NCT01306175|2738973|P1|NOT COMPLETED|Washout Period of at Least 14 Days||0
1131535|NCT01306175|2738973|P1|COMPLETED|Washout Period of at Least 14 Days||20
1131536|NCT01306175|2738973|P1|STARTED|Washout Period of at Least 14 Days||20
1131537|NCT01306175|2738973|P1|NOT COMPLETED|First Intervention||0
1131538|NCT01306175|2738973|P1|COMPLETED|First Intervention||20
1131539|NCT01306175|2738973|P1|STARTED|First Intervention||20
1131540|NCT01306201|2738983|P1|NOT COMPLETED|Overall Study||10
1131541|NCT01306201|2738983|P1|COMPLETED|Overall Study|Total of 10 subjects were excluded from analysis|53
1131542|NCT01306201|2738983|P1|STARTED|Overall Study||63
1131543|NCT01312129|2738993|P2|NOT COMPLETED|Second Intervention (24 Hours)||1
1131545|NCT01312129|2738993|P2|COMPLETED|Second Intervention (24 Hours)||6
1131546|NCT01312129|2738994|P1|COMPLETED|Second Intervention (24 Hours)||6
1131547|NCT01312129|2738993|P2|Alcohol Cue|Second Intervention (24 Hours)||6
1131548|NCT01312129|2738994|P1|Alcohol Cue|Second Intervention (24 Hours)||6
1131549|NCT01312129|2738993|P2|Control Cue|Second Intervention (24 Hours)||6
1131550|NCT01312129|2738994|P1|Control Cue|Second Intervention (24 Hours)||6
1131551|NCT01312129|2738993|P2|STARTED|Second Intervention (24 Hours)||7
1131552|NCT01312129|2738994|P1|STARTED|Second Intervention (24 Hours)||6
1131553|NCT01312129|2738993|P2|NOT COMPLETED|Washout (1 Week)||0
1131554|NCT01312129|2738994|P1|NOT COMPLETED|Washout (1 Week)||0
1131555|NCT01312129|2738993|P2|COMPLETED|Washout (1 Week)||7
1131556|NCT01312129|2738994|P1|COMPLETED|Washout (1 Week)||6
1131557|NCT01312129|2738993|P2|STARTED|Washout (1 Week)||7
1131558|NCT01312129|2738994|P1|STARTED|Washout (1 Week)||6
1131559|NCT01312129|2738993|P2|NOT COMPLETED|First Intervention (24 Hours)||0
1131560|NCT01312129|2738994|P1|NOT COMPLETED|First Intervention (24 Hours)||0
1131561|NCT01312129|2738993|P2|COMPLETED|First Intervention (24 Hours)||7
1131562|NCT01312129|2738994|P1|COMPLETED|First Intervention (24 Hours)||6
1131563|NCT01312129|2738993|P2|Alcohol Cue|First Intervention (24 Hours)||7
1131564|NCT01312129|2738994|P1|Alcohol Cue|First Intervention (24 Hours)||6
1131565|NCT01312129|2738993|P2|Control Cue|First Intervention (24 Hours)||7
1131566|NCT01312129|2738994|P1|Control Cue|First Intervention (24 Hours)||6
1131567|NCT01312129|2738993|P2|STARTED|First Intervention (24 Hours)||7
1131568|NCT01312129|2738994|P1|STARTED|First Intervention (24 Hours)||6
1131569|NCT01312272|2739002|P2|NOT COMPLETED|Overall Study||1
1131570|NCT01312272|2739003|P1|NOT COMPLETED|Overall Study||0
1131571|NCT01312272|2739002|P2|COMPLETED|Overall Study||11
1131572|NCT01312272|2739003|P1|COMPLETED|Overall Study||12
1131573|NCT01312272|2739002|P2|STARTED|Overall Study||12
1131574|NCT01312272|2739003|P1|STARTED|Overall Study||12
1131575|NCT01313624|2739021|P2|NOT COMPLETED|Open-Label Phase||13
1131576|NCT01313624|2739022|P1|NOT COMPLETED|Open-Label Phase||4
1131577|NCT01313624|2739021|P2|COMPLETED|Open-Label Phase||109
1131578|NCT01313624|2739022|P1|COMPLETED|Open-Label Phase||92
1131579|NCT01313624|2739021|P2|STARTED|Open-Label Phase||122
1131580|NCT01313624|2739022|P1|STARTED|Open-Label Phase||96
1131581|NCT01313624|2739021|P2|NOT COMPLETED|Double-Blind Phase||10
1131582|NCT01313624|2739022|P1|NOT COMPLETED|Double-Blind Phase||38
1131583|NCT01313624|2739021|P2|COMPLETED|Double-Blind Phase||122
1131584|NCT01313624|2739022|P1|COMPLETED|Double-Blind Phase||96
1131585|NCT01313624|2739021|P2|STARTED|Double-Blind Phase||132
1131586|NCT01313624|2739022|P1|STARTED|Double-Blind Phase||134
1131599|NCT01313650|2739067|P4|NOT COMPLETED|Overall Study||81
1131600|NCT01313650|2739068|P3|NOT COMPLETED|Overall Study||103
1131601|NCT01313650|2739069|P2|NOT COMPLETED|Overall Study||94
1131602|NCT01313650|2739070|P1|NOT COMPLETED|Overall Study||76
1131603|NCT01313650|2739067|P4|COMPLETED|Overall Study||332
1131604|NCT01313650|2739068|P3|COMPLETED|Overall Study||318
1131605|NCT01313650|2739069|P2|COMPLETED|Overall Study||324
1131606|NCT01313650|2739070|P1|COMPLETED|Overall Study||204
1131607|NCT01313650|2739067|P4|STARTED|Overall Study||413
1131608|NCT01313650|2739068|P3|STARTED|Overall Study||421
1131609|NCT01313650|2739069|P2|STARTED|Overall Study||418
1131610|NCT01313650|2739070|P1|STARTED|Overall Study||280
1131611|NCT01313663|2739094|P2|NOT COMPLETED|Overall Study||8
1131612|NCT01313663|2739095|P1|NOT COMPLETED|Overall Study||4
1131613|NCT01313663|2739094|P2|COMPLETED|Overall Study||3
1131614|NCT01313663|2739095|P1|COMPLETED|Overall Study||5
1131615|NCT01313663|2739094|P2|STARTED|Overall Study||11
1131616|NCT01313663|2739095|P1|STARTED|Overall Study||9
1131629|NCT01313689|2739156|P4|NOT COMPLETED|24-Week Randomization 2||1
1131630|NCT01313689|2739157|P3|NOT COMPLETED|24-Week Randomization 2||3
1131631|NCT01313689|2739158|P2|NOT COMPLETED|24-Week Randomization 2||0
1131632|NCT01313689|2739159|P1|NOT COMPLETED|24-Week Randomization 2||0
1131633|NCT01313689|2739156|P4|COMPLETED|24-Week Randomization 2||12
1131634|NCT01313689|2739157|P3|COMPLETED|24-Week Randomization 2||21
1131635|NCT01313689|2739158|P2|COMPLETED|24-Week Randomization 2||0
1131636|NCT01313689|2739159|P1|COMPLETED|24-Week Randomization 2||0
1131637|NCT01313689|2739156|P4|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|13
1131638|NCT01313689|2739157|P3|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|24
1131639|NCT01313689|2739158|P2|STARTED|24-Week Randomization 2||0
1131640|NCT01313689|2739159|P1|STARTED|24-Week Randomization 2||0
1131641|NCT01313689|2739156|P4|NOT COMPLETED|24-Week Randomization 1||0
1131642|NCT01313689|2739157|P3|NOT COMPLETED|24-Week Randomization 1||0
1131643|NCT01313689|2739158|P2|NOT COMPLETED|24-Week Randomization 1||10
1131644|NCT01313689|2739159|P1|NOT COMPLETED|24-Week Randomization 1||19
1131645|NCT01313689|2739156|P4|COMPLETED|24-Week Randomization 1||0
1131646|NCT01313689|2739157|P3|COMPLETED|24-Week Randomization 1||0
1131647|NCT01313689|2739158|P2|COMPLETED|24-Week Randomization 1|Par. that did not receive OFA salvage continued visits for Follow-up and overall survival assessment|33
1131648|NCT01313689|2739159|P1|COMPLETED|24-Week Randomization 1|Par. not entering Randomization 2 continued visits for Follow-up and overall survival assessment|60
1131649|NCT01313689|2739156|P4|STARTED|24-Week Randomization 1||0
1131650|NCT01313689|2739157|P3|STARTED|24-Week Randomization 1||0
1131651|NCT01313689|2739158|P2|STARTED|24-Week Randomization 1||43
1131652|NCT01313689|2739159|P1|STARTED|24-Week Randomization 1||79
1131653|NCT01313728|2739222|P1|NOT COMPLETED|Baseline to Completion||0
1131654|NCT01313728|2739222|P1|COMPLETED|Baseline to Completion||25
1131655|NCT01313728|2739222|P1|STARTED|Baseline to Completion||25
1131656|NCT01313728|2739222|P1|NOT COMPLETED|Informed Consent to Baseline||1
1131657|NCT01313728|2739222|P1|COMPLETED|Informed Consent to Baseline|One subject withdrew after signing informed consent, but prior to Baseline measurements being taken.|25
1131658|NCT01313728|2739222|P1|STARTED|Informed Consent to Baseline||26
1131659|NCT01313780|2739239|P2|NOT COMPLETED|Overall Study||28
1131660|NCT01313780|2739240|P1|NOT COMPLETED|Overall Study||25
1131661|NCT01313780|2739239|P2|COMPLETED|Overall Study|PPS|31
1131662|NCT01313780|2739240|P1|COMPLETED|Overall Study|PPS|33
1131663|NCT01313780|2739239|P2|STARTED|Overall Study|FAS|59
1131664|NCT01313780|2739240|P1|STARTED|Overall Study|FAS|58
1131665|NCT01313858|2739251|P3|NOT COMPLETED|Overall Study||238
1131666|NCT01313858|2739252|P2|NOT COMPLETED|Overall Study||270
1131667|NCT01313858|2739253|P1|NOT COMPLETED|Overall Study||286
1131668|NCT01313858|2739251|P3|COMPLETED|Overall Study||305
1131669|NCT01313858|2739252|P2|COMPLETED|Overall Study||276
1131670|NCT01313858|2739253|P1|COMPLETED|Overall Study||238
1131671|NCT01313858|2739251|P3|STARTED|Overall Study||543
1131672|NCT01313858|2739252|P2|STARTED|Overall Study||546
1131673|NCT01313858|2739253|P1|STARTED|Overall Study||524
1131674|NCT01313884|2739274|P1|NOT COMPLETED|Overall Study||1
1131675|NCT01313884|2739274|P1|COMPLETED|Overall Study||2
1131676|NCT01313884|2739274|P1|STARTED|Overall Study||3
1131677|NCT01313897|2739278|P1|NOT COMPLETED|Overall Study||2
1131678|NCT01313897|2739278|P1|COMPLETED|Overall Study||8
1131679|NCT01313897|2739278|P1|STARTED|Overall Study||10
1131680|NCT01313910|2739282|P1|NOT COMPLETED|Overall Study||0
1131681|NCT01313910|2739282|P1|COMPLETED|Overall Study||8
1131682|NCT01313910|2739282|P1|STARTED|Overall Study||8
1131683|NCT01313923|2739290|P1|NOT COMPLETED|Overall Study||3
1131684|NCT01313923|2739290|P1|COMPLETED|Overall Study||0
1131685|NCT01313923|2739290|P1|STARTED|Overall Study||3
1131686|NCT01313936|2739296|P2|NOT COMPLETED|Overall Study||0
1131687|NCT01313936|2739297|P1|NOT COMPLETED|Overall Study||0
1131688|NCT01313936|2739296|P2|COMPLETED|Overall Study||26
1131689|NCT01313936|2739297|P1|COMPLETED|Overall Study||6
1131690|NCT01313936|2739296|P2|STARTED|Overall Study||26
1131691|NCT01313936|2739297|P1|STARTED|Overall Study||6
1131692|NCT01314001|2739311|P6|NOT COMPLETED|Overall Study||71
1131693|NCT01314001|2739312|P5|NOT COMPLETED|Overall Study||72
1131694|NCT01314001|2739313|P4|NOT COMPLETED|Overall Study||69
1131695|NCT01314001|2739314|P3|NOT COMPLETED|Overall Study||69
1131696|NCT01314001|2739315|P2|NOT COMPLETED|Overall Study||69
1131697|NCT01314001|2739316|P1|NOT COMPLETED|Overall Study||75
1131698|NCT01314001|2739311|P6|COMPLETED|Overall Study||129
1131699|NCT01314001|2739312|P5|COMPLETED|Overall Study||148
1131700|NCT01314001|2739313|P4|COMPLETED|Overall Study||122
1131701|NCT01314001|2739314|P3|COMPLETED|Overall Study||158
1131702|NCT01314001|2739315|P2|COMPLETED|Overall Study||124
1131703|NCT01314001|2739316|P1|COMPLETED|Overall Study||140
1131704|NCT01314001|2739311|P6|6-Month Follow Up Survey|Overall Study||139
1131705|NCT01314001|2739312|P5|6-Month Follow Up Survey|Overall Study||157
1131706|NCT01314001|2739313|P4|6-Month Follow Up Survey|Overall Study||135
1131707|NCT01314001|2739314|P3|6-Month Follow Up Survey|Overall Study||165
1131708|NCT01314001|2739315|P2|6-Month Follow Up Survey|Overall Study||137
1131709|NCT01314001|2739316|P1|6-Month Follow Up Survey|Overall Study||146
1131710|NCT01314001|2739311|P6|End-of-Treatment Visit|Overall Study||160
1131711|NCT01314001|2739312|P5|End-of-Treatment Visit|Overall Study||174
1131712|NCT01314001|2739313|P4|End-of-Treatment Visit|Overall Study||146
1131713|NCT01314001|2739314|P3|End-of-Treatment Visit|Overall Study||179
1131714|NCT01314001|2739315|P2|End-of-Treatment Visit|Overall Study||141
1131715|NCT01314001|2739316|P1|End-of-Treatment Visit|Overall Study||156
1131716|NCT01314001|2739311|P6|STARTED|Overall Study||200
1131717|NCT01314001|2739312|P5|STARTED|Overall Study||220
1131718|NCT01314001|2739313|P4|STARTED|Overall Study||191
1131719|NCT01314001|2739314|P3|STARTED|Overall Study||227
1131720|NCT01314001|2739315|P2|STARTED|Overall Study||193
1131721|NCT01314001|2739316|P1|STARTED|Overall Study||215
1131722|NCT01314014|2739360|P1|NOT COMPLETED|Overall Study||0
1131723|NCT01314014|2739360|P1|COMPLETED|Overall Study|Treatment continued for as long as the subject derived benefit.|22
1131724|NCT01314014|2739360|P1|STARTED|Overall Study||22
1131725|NCT01314105|2739367|P2|NOT COMPLETED|Overall Study||4
1131726|NCT01314105|2739368|P1|NOT COMPLETED|Overall Study||6
1131727|NCT01314105|2739367|P2|COMPLETED|Overall Study|On treatment at analysis cut off date of 15 April 2014|2
1131728|NCT01314105|2739368|P1|COMPLETED|Overall Study|On treatment at analysis cut off date of 15 April 2014|1
1131729|NCT01314105|2739367|P2|STARTED|Overall Study||6
1131730|NCT01314105|2739368|P1|STARTED|Overall Study||7
1131734|NCT01314261|2739401|P4|NOT COMPLETED|Overall Study||3
1131735|NCT01314261|2739402|P3|NOT COMPLETED|Overall Study||3
1131736|NCT01314261|2739403|P2|NOT COMPLETED|Overall Study||4
1131737|NCT01314261|2739404|P1|NOT COMPLETED|Overall Study||2
1131738|NCT01314261|2739401|P4|COMPLETED|Overall Study||6
1131739|NCT01314261|2739402|P3|COMPLETED|Overall Study||7
1131740|NCT01314261|2739403|P2|COMPLETED|Overall Study||5
1131741|NCT01314261|2739404|P1|COMPLETED|Overall Study||7
1131742|NCT01314261|2739401|P4|Discontinued pegIFN/RBV|Overall Study||1
1131743|NCT01314261|2739402|P3|Discontinued pegIFN/RBV|Overall Study||5
1131744|NCT01314261|2739403|P2|Discontinued pegIFN/RBV|Overall Study||4
1131745|NCT01314261|2739404|P1|Discontinued pegIFN/RBV|Overall Study||1
1131746|NCT01314261|2739401|P4|Discontinued ABT-267 or Placebo|Overall Study||0
1131747|NCT01314261|2739402|P3|Discontinued ABT-267 or Placebo|Overall Study||1
1131748|NCT01314261|2739403|P2|Discontinued ABT-267 or Placebo|Overall Study||0
1131749|NCT01314261|2739404|P1|Discontinued ABT-267 or Placebo|Overall Study||1
1131750|NCT01314261|2739401|P4|STARTED|Overall Study||9
1131751|NCT01314261|2739402|P3|STARTED|Overall Study||10
1131752|NCT01314261|2739403|P2|STARTED|Overall Study||9
1131753|NCT01314261|2739404|P1|STARTED|Overall Study||9
1131754|NCT01314417|2739455|P1|NOT COMPLETED|Overall Study||0
1131755|NCT01314417|2739455|P1|COMPLETED|Overall Study||2
1131756|NCT01314417|2739455|P1|STARTED|Overall Study||2
1131757|NCT01314443|2739486|P4|NOT COMPLETED|Overall Study||2
1131758|NCT01314443|2739487|P3|NOT COMPLETED|Overall Study||2
1131759|NCT01314443|2739488|P2|NOT COMPLETED|Overall Study||3
1131760|NCT01314443|2739489|P1|NOT COMPLETED|Overall Study||4
1131761|NCT01314443|2739486|P4|COMPLETED|Overall Study||13
1131762|NCT01314443|2739487|P3|COMPLETED|Overall Study||13
1131763|NCT01314443|2739488|P2|COMPLETED|Overall Study||16
1131764|NCT01314443|2739489|P1|COMPLETED|Overall Study||14
1131765|NCT01314443|2739486|P4|STARTED|Overall Study||15
1131766|NCT01314443|2739487|P3|STARTED|Overall Study||15
1131767|NCT01314443|2739488|P2|STARTED|Overall Study||19
1131768|NCT01314443|2739489|P1|STARTED|Overall Study||18
1131769|NCT01314703|2739507|P1|NOT COMPLETED|Overall Study||8
1131770|NCT01314703|2739507|P1|COMPLETED|Overall Study||27
1131771|NCT01314703|2739507|P1|Discontinued When Enrollment Completed|Overall Study||3
1131772|NCT01314703|2739507|P1|Non Qualified Bacterial Screening Counts|Overall Study||3
1131773|NCT01314703|2739507|P1|Excluded Prior to Screening Baseline|Overall Study||2
1131774|NCT01314703|2739507|P1|Completed Study|Overall Study||27
1131775|NCT01314703|2739507|P1|Completed Treatment Visit|Overall Study||27
1131776|NCT01314703|2739507|P1|Completed Screen Visit|Overall Study||33
1131777|NCT01314703|2739507|P1|Signed Informed Consent|Overall Study||35
1131778|NCT01314703|2739507|P1|STARTED|Overall Study||35
1131779|NCT01314716|2739514|P2|NOT COMPLETED|Open-Label Phase||12
1131780|NCT01314716|2739515|P1|NOT COMPLETED|Open-Label Phase||10
1131781|NCT01314716|2739514|P2|COMPLETED|Open-Label Phase||98
1131782|NCT01314716|2739515|P1|COMPLETED|Open-Label Phase||102
1131783|NCT01314716|2739514|P2|STARTED|Open-Label Phase|13 participants in this group did not continue from the randomized to the open-label phase.|110
1131784|NCT01314716|2739515|P1|STARTED|Open-Label Phase|7 participants in this group did not continue from the randomized to the open-label phase.|112
1131785|NCT01314716|2739514|P2|NOT COMPLETED|Double-Blind Phase||15
1131786|NCT01314716|2739515|P1|NOT COMPLETED|Double-Blind Phase||17
1131787|NCT01314716|2739514|P2|COMPLETED|Double-Blind Phase||123
1131788|NCT01314716|2739515|P1|COMPLETED|Double-Blind Phase||119
1131789|NCT01314716|2739514|P2|Randomized and Treated|Double-Blind Phase||137
1131790|NCT01314716|2739515|P1|Randomized and Treated|Double-Blind Phase||135
1131791|NCT01314716|2739514|P2|STARTED|Double-Blind Phase||138
1131792|NCT01314716|2739515|P1|STARTED|Double-Blind Phase||136
1131793|NCT01314742|2739529|P2|NOT COMPLETED|Overall Study||0
1131794|NCT01314742|2739530|P1|NOT COMPLETED|Overall Study||0
1131795|NCT01314742|2739529|P2|COMPLETED|Overall Study||21
1131796|NCT01314742|2739530|P1|COMPLETED|Overall Study||20
1131797|NCT01314742|2739529|P2|STARTED|Overall Study||21
1131798|NCT01314742|2739530|P1|STARTED|Overall Study||20
1131799|NCT01314872|2739549|P15|NOT COMPLETED|Period 2||24
1131800|NCT01314872|2739550|P14|NOT COMPLETED|Period 2||53
1131801|NCT01314872|2739551|P13|NOT COMPLETED|Period 2||60
1131802|NCT01314872|2739552|P12|NOT COMPLETED|Period 2||48
1131803|NCT01314872|2739553|P11|NOT COMPLETED|Period 2||0
1131804|NCT01314872|2739554|P10|NOT COMPLETED|Period 2||0
1131805|NCT01314872|2739555|P9|NOT COMPLETED|Period 2||0
1131806|NCT01314872|2739556|P8|NOT COMPLETED|Period 2||0
1131807|NCT01314872|2739557|P7|NOT COMPLETED|Period 2||0
1131808|NCT01314872|2739558|P6|NOT COMPLETED|Period 2||0
1131809|NCT01314872|2739559|P5|NOT COMPLETED|Period 2||0
1131810|NCT01314872|2739560|P4|NOT COMPLETED|Period 2||0
1131811|NCT01314872|2739561|P3|NOT COMPLETED|Period 2||0
1131812|NCT01314872|2739562|P2|NOT COMPLETED|Period 2||0
1131813|NCT01314872|2739563|P1|NOT COMPLETED|Period 2||0
1131814|NCT01314872|2739549|P15|COMPLETED|Period 2||110
1131815|NCT01314872|2739550|P14|COMPLETED|Period 2||187
1131816|NCT01314872|2739551|P13|COMPLETED|Period 2||188
1131817|NCT01314872|2739552|P12|COMPLETED|Period 2||175
1131818|NCT01314872|2739553|P11|COMPLETED|Period 2||0
1131819|NCT01314872|2739554|P10|COMPLETED|Period 2||0
1131820|NCT01314872|2739555|P9|COMPLETED|Period 2||0
1131821|NCT01314872|2739556|P8|COMPLETED|Period 2||0
1131822|NCT01314872|2739557|P7|COMPLETED|Period 2||0
1131823|NCT01314872|2739558|P6|COMPLETED|Period 2||0
1131824|NCT01314872|2739559|P5|COMPLETED|Period 2||0
1131825|NCT01314872|2739560|P4|COMPLETED|Period 2||0
1131826|NCT01314872|2739561|P3|COMPLETED|Period 2||0
1131827|NCT01314872|2739562|P2|COMPLETED|Period 2||0
1131828|NCT01314872|2739563|P1|COMPLETED|Period 2||0
1131829|NCT01314872|2739549|P15|STARTED|Period 2||134
1131830|NCT01314872|2739550|P14|STARTED|Period 2||240
1131831|NCT01314872|2739551|P13|STARTED|Period 2||248
1131832|NCT01314872|2739552|P12|STARTED|Period 2||223
1131833|NCT01314872|2739553|P11|STARTED|Period 2||0
1131834|NCT01314872|2739554|P10|STARTED|Period 2||0
1131835|NCT01314872|2739555|P9|STARTED|Period 2||0
1131836|NCT01314872|2739556|P8|STARTED|Period 2||0
1131837|NCT01314872|2739557|P7|STARTED|Period 2||0
1131838|NCT01314872|2739558|P6|STARTED|Period 2||0
1131839|NCT01314872|2739559|P5|STARTED|Period 2||0
1131840|NCT01314872|2739560|P4|STARTED|Period 2||0
1131841|NCT01314872|2739561|P3|STARTED|Period 2||0
1131842|NCT01314872|2739562|P2|STARTED|Period 2||0
1131843|NCT01314872|2739563|P1|STARTED|Period 2||0
1131844|NCT01314872|2739549|P15|NOT COMPLETED|Treatment Period 1||0
1131845|NCT01314872|2739550|P14|NOT COMPLETED|Treatment Period 1||0
1131846|NCT01314872|2739551|P13|NOT COMPLETED|Treatment Period 1||0
1131847|NCT01314872|2739552|P12|NOT COMPLETED|Treatment Period 1||0
1131848|NCT01314872|2739553|P11|NOT COMPLETED|Treatment Period 1||3
1131849|NCT01314872|2739554|P10|NOT COMPLETED|Treatment Period 1||4
1131850|NCT01314872|2739555|P9|NOT COMPLETED|Treatment Period 1||6
1131851|NCT01314872|2739556|P8|NOT COMPLETED|Treatment Period 1||7
1131852|NCT01314872|2739557|P7|NOT COMPLETED|Treatment Period 1||8
1131853|NCT01314872|2739558|P6|NOT COMPLETED|Treatment Period 1||7
1131854|NCT01314872|2739559|P5|NOT COMPLETED|Treatment Period 1||7
1131855|NCT01314872|2739560|P4|NOT COMPLETED|Treatment Period 1||7
1131856|NCT01314872|2739561|P3|NOT COMPLETED|Treatment Period 1||6
1131857|NCT01314872|2739562|P2|NOT COMPLETED|Treatment Period 1||6
1131858|NCT01314872|2739563|P1|NOT COMPLETED|Treatment Period 1||10
1131859|NCT01314872|2739549|P15|COMPLETED|Treatment Period 1||0
1131860|NCT01314872|2739550|P14|COMPLETED|Treatment Period 1||0
1131861|NCT01314872|2739551|P13|COMPLETED|Treatment Period 1||0
1131862|NCT01314872|2739552|P12|COMPLETED|Treatment Period 1||0
1131863|NCT01314872|2739553|P11|COMPLETED|Treatment Period 1||107
1131864|NCT01314872|2739554|P10|COMPLETED|Treatment Period 1||118
1131865|NCT01314872|2739555|P9|COMPLETED|Treatment Period 1||106
1131866|NCT01314872|2739556|P8|COMPLETED|Treatment Period 1||57
1131867|NCT01314872|2739557|P7|COMPLETED|Treatment Period 1||126
1131868|NCT01314872|2739558|P6|COMPLETED|Treatment Period 1||128
1131869|NCT01314872|2739559|P5|COMPLETED|Treatment Period 1||142
1131870|NCT01314872|2739560|P4|COMPLETED|Treatment Period 1||143
1131871|NCT01314872|2739561|P3|COMPLETED|Treatment Period 1||128
1131872|NCT01314872|2739562|P2|COMPLETED|Treatment Period 1||138
1131873|NCT01314872|2739563|P1|COMPLETED|Treatment Period 1||131
1131874|NCT01314872|2739549|P15|STARTED|Treatment Period 1||0
1131875|NCT01314872|2739550|P14|STARTED|Treatment Period 1||0
1131876|NCT01314872|2739551|P13|STARTED|Treatment Period 1||0
1131877|NCT01314872|2739552|P12|STARTED|Treatment Period 1||0
1131878|NCT01314872|2739553|P11|STARTED|Treatment Period 1||110
1131879|NCT01314872|2739554|P10|STARTED|Treatment Period 1||122
1131880|NCT01314872|2739555|P9|STARTED|Treatment Period 1||112
1131881|NCT01314872|2739556|P8|STARTED|Treatment Period 1||64
1131882|NCT01314872|2739557|P7|STARTED|Treatment Period 1||134
1131883|NCT01314872|2739558|P6|STARTED|Treatment Period 1||135
1131884|NCT01314872|2739559|P5|STARTED|Treatment Period 1||149
1131885|NCT01314872|2739560|P4|STARTED|Treatment Period 1||150
1131886|NCT01314872|2739561|P3|STARTED|Treatment Period 1||134
1131887|NCT01314872|2739562|P2|STARTED|Treatment Period 1||144
1131888|NCT01314872|2739563|P1|STARTED|Treatment Period 1||141
1131889|NCT01315002|2739654|P2|NOT COMPLETED|Overall Study||5
1131890|NCT01315002|2739655|P1|NOT COMPLETED|Overall Study||5
1131891|NCT01315002|2739654|P2|COMPLETED|Overall Study||55
1131892|NCT01315002|2739655|P1|COMPLETED|Overall Study||56
1131893|NCT01315002|2739654|P2|STARTED|Overall Study||60
1131894|NCT01315002|2739655|P1|STARTED|Overall Study||61
1131895|NCT01315028|2739663|P2|NOT COMPLETED|Overall Study||1
1131896|NCT01315028|2739664|P1|NOT COMPLETED|Overall Study||1
1131897|NCT01315028|2739663|P2|COMPLETED|Overall Study||9
1131898|NCT01315028|2739664|P1|COMPLETED|Overall Study||9
1131899|NCT01315028|2739663|P2|STARTED|Overall Study||10
1131900|NCT01315028|2739664|P1|STARTED|Overall Study||10
1131901|NCT01315145|2739678|P2|NOT COMPLETED|Overall Study||5
1131902|NCT01315145|2739679|P1|NOT COMPLETED|Overall Study||17
1131903|NCT01315145|2739678|P2|COMPLETED|Overall Study||11
1131904|NCT01315145|2739679|P1|COMPLETED|Overall Study||105
1131905|NCT01315145|2739678|P2|STARTED|Overall Study||16
1131906|NCT01315145|2739679|P1|STARTED|Overall Study||122
1131907|NCT01315158|2739687|P2|NOT COMPLETED|Overall Study||0
1131908|NCT01315158|2739688|P1|NOT COMPLETED|Overall Study||0
1131909|NCT01315158|2739687|P2|COMPLETED|Overall Study||19
1131910|NCT01315158|2739688|P1|COMPLETED|Overall Study||17
1131911|NCT01315158|2739687|P2|STARTED|Overall Study||19
1131912|NCT01315158|2739688|P1|STARTED|Overall Study||17
1131913|NCT01315249|2739712|P2|NOT COMPLETED|Overall Study||47
1131914|NCT01315249|2739713|P1|NOT COMPLETED|Overall Study||44
1131915|NCT01315249|2739712|P2|COMPLETED|Overall Study||217
1131916|NCT01315249|2739713|P1|COMPLETED|Overall Study||215
1131917|NCT01315249|2739712|P2|STARTED|Overall Study||264
1131918|NCT01315249|2739713|P1|STARTED|Overall Study||259
1131919|NCT01315574|2739741|P2|NOT COMPLETED|Overall Study||0
1131920|NCT01315574|2739742|P1|NOT COMPLETED|Overall Study||0
1131921|NCT01315574|2739741|P2|COMPLETED|Overall Study||7
1131922|NCT01315574|2739742|P1|COMPLETED|Overall Study||7
1131923|NCT01315574|2739741|P2|STARTED|Overall Study||7
1131924|NCT01315574|2739742|P1|STARTED|Overall Study||7
1131925|NCT01315665|2739754|P2|NOT COMPLETED|Overall Study||0
1131926|NCT01315665|2739755|P1|NOT COMPLETED|Overall Study||0
1131927|NCT01315665|2739754|P2|COMPLETED|Overall Study||5
1131928|NCT01315665|2739755|P1|COMPLETED|Overall Study||10
1131929|NCT01315665|2739754|P2|STARTED|Overall Study||5
1131930|NCT01315665|2739755|P1|STARTED|Overall Study||10
1131931|NCT01315847|2739771|P2|NOT COMPLETED|Part III, Period 2||0
1131932|NCT01315847|2739772|P1|NOT COMPLETED|Part III, Period 2||0
1131933|NCT01315847|2739771|P2|COMPLETED|Part III, Period 2||3
1131934|NCT01315847|2739772|P1|COMPLETED|Part III, Period 2||0
1131935|NCT01315847|2739771|P2|Received [11C]MK-4232|Part III, Period 2||3
1131936|NCT01315847|2739772|P1|Received [11C]MK-4232|Part III, Period 2||0
1131937|NCT01315847|2739771|P2|Received Telcagepant|Part III, Period 2||3
1131938|NCT01315847|2739772|P1|Received Telcagepant|Part III, Period 2||0
1131939|NCT01315847|2739771|P2|STARTED|Part III, Period 2||3
1131940|NCT01315847|2739772|P1|STARTED|Part III, Period 2||0
1131941|NCT01315847|2739771|P2|NOT COMPLETED|Part III, Period 1||1
1131942|NCT01315847|2739772|P1|NOT COMPLETED|Part III, Period 1||0
1131943|NCT01315847|2739771|P2|COMPLETED|Part III, Period 1||3
1131944|NCT01315847|2739772|P1|COMPLETED|Part III, Period 1||0
1131945|NCT01315847|2739771|P2|Received [11C]MK-4232|Part III, Period 1|One of these participants received [11C]MK-4232 only at baseline.|4
1131946|NCT01315847|2739772|P1|Received [11C]MK-4232|Part III, Period 1||0
1131947|NCT01315847|2739771|P2|Received Telcagepant|Part III, Period 1||4
1131948|NCT01315847|2739772|P1|Received Telcagepant|Part III, Period 1||0
1131949|NCT01315847|2739771|P2|STARTED|Part III, Period 1|Subjects who participated in Part III did not participate in Part I.|4
1131950|NCT01315847|2739772|P1|STARTED|Part III, Period 1||0
1131951|NCT01315847|2739771|P2|NOT COMPLETED|Part I, Period 2||0
1131952|NCT01315847|2739772|P1|NOT COMPLETED|Part I, Period 2||0
1131953|NCT01315847|2739771|P2|COMPLETED|Part I, Period 2||0
1131954|NCT01315847|2739772|P1|COMPLETED|Part I, Period 2||3
1131955|NCT01315847|2739771|P2|Received [11C]MK-4232|Part I, Period 2||0
1131956|NCT01315847|2739772|P1|Received [11C]MK-4232|Part I, Period 2||3
1131957|NCT01315847|2739771|P2|Received Telcagepant|Part I, Period 2||0
1131958|NCT01315847|2739772|P1|Received Telcagepant|Part I, Period 2||3
1131959|NCT01315847|2739771|P2|STARTED|Part I, Period 2||0
1131960|NCT01315847|2739772|P1|STARTED|Part I, Period 2|One of these subjects did not participate in Part I, Period 1.|3
1131961|NCT01315847|2739771|P2|NOT COMPLETED|Part I, Period 1||0
1131962|NCT01315847|2739772|P1|NOT COMPLETED|Part I, Period 1||3
1131963|NCT01315847|2739771|P2|COMPLETED|Part I, Period 1||0
1131964|NCT01315847|2739772|P1|COMPLETED|Part I, Period 1||2
1131965|NCT01315847|2739771|P2|Received [11C]MK-4232|Part I, Period 1||0
1131966|NCT01315847|2739772|P1|Received [11C]MK-4232|Part I, Period 1|One of these participants received [11C]MK-4232 only at baseline.|5
1131967|NCT01315847|2739771|P2|Received Telcagepant|Part I, Period 1||0
1131968|NCT01315847|2739772|P1|Received Telcagepant|Part I, Period 1||5
1131969|NCT01315847|2739771|P2|STARTED|Part I, Period 1||0
1131970|NCT01315847|2739772|P1|STARTED|Part I, Period 1|Subjects who participated in Part I did not participate in Part III.|5
1131971|NCT01316042|2739786|P2|NOT COMPLETED|Overall Study||1
1131972|NCT01316042|2739787|P1|NOT COMPLETED|Overall Study||0
1131973|NCT01316042|2739786|P2|COMPLETED|Overall Study||1
1131974|NCT01316042|2739787|P1|COMPLETED|Overall Study||2
1131975|NCT01316042|2739786|P2|STARTED|Overall Study||2
1131976|NCT01316042|2739787|P1|STARTED|Overall Study||2
1131977|NCT01316055|2739796|P3|NOT COMPLETED|Overall Study||0
1131978|NCT01316055|2739797|P2|NOT COMPLETED|Overall Study||0
1131979|NCT01316055|2739798|P1|NOT COMPLETED|Overall Study||1
1131980|NCT01316055|2739796|P3|COMPLETED|Overall Study||12
1131981|NCT01316055|2739797|P2|COMPLETED|Overall Study||17
1131982|NCT01316055|2739798|P1|COMPLETED|Overall Study||12
1131983|NCT01316055|2739796|P3|STARTED|Overall Study||12
1131984|NCT01316055|2739797|P2|STARTED|Overall Study||17
1131985|NCT01316055|2739798|P1|STARTED|Overall Study||13
1131986|NCT01309100|2739812|P1|NOT COMPLETED|Overall Study||2
1131987|NCT01309100|2739812|P1|COMPLETED|Overall Study||142
1131988|NCT01309100|2739812|P1|STARTED|Overall Study||144
1131989|NCT01309204|2739825|P2|NOT COMPLETED|Overall Study||75
1131990|NCT01309204|2739826|P1|NOT COMPLETED|Overall Study||67
1131991|NCT01309204|2739825|P2|COMPLETED|Overall Study||361
1131992|NCT01309204|2739826|P1|COMPLETED|Overall Study||385
1131993|NCT01309204|2739825|P2|STARTED|Overall Study||436
1131994|NCT01309204|2739826|P1|STARTED|Overall Study||452
1131995|NCT01309243|2739834|P2|NOT COMPLETED|Extension Phase||0
1131996|NCT01309243|2739835|P1|NOT COMPLETED|Extension Phase||6
1131997|NCT01309243|2739834|P2|COMPLETED|Extension Phase||117
1131998|NCT01309243|2739835|P1|COMPLETED|Extension Phase||34
1131999|NCT01309243|2739834|P2|STARTED|Extension Phase|117 participants from the Randomized Phase continued the study in the Extension Phase.|117
1132000|NCT01309243|2739835|P1|STARTED|Extension Phase|40 participants from the Randomized Phase continued the study in the Extension Phase.|40
1132001|NCT01309243|2739834|P2|NOT COMPLETED|Randomized Phase Through Week 96||109
1132002|NCT01309243|2739835|P1|NOT COMPLETED|Randomized Phase Through Week 96||84
1132003|NCT01309243|2739834|P2|COMPLETED|Randomized Phase Through Week 96||290
1132004|NCT01309243|2739835|P1|COMPLETED|Randomized Phase Through Week 96||316
1132005|NCT01309243|2739834|P2|Randomized and Treated|Randomized Phase Through Week 96||392
1132006|NCT01309243|2739835|P1|Randomized and Treated|Randomized Phase Through Week 96||394
1132007|NCT01309243|2739834|P2|STARTED|Randomized Phase Through Week 96||399
1132008|NCT01309243|2739835|P1|STARTED|Randomized Phase Through Week 96||400
1132009|NCT01309269|2739859|P1|NOT COMPLETED|Overall Study||840
1132010|NCT01309269|2739859|P1|COMPLETED|Overall Study||245
1132011|NCT01309269|2739859|P1|Treated|Overall Study||978
1132012|NCT01309269|2739859|P1|STARTED|Overall Study||1085
1132013|NCT01309282|2739865|P1|NOT COMPLETED|Overall Study||1
1132014|NCT01309282|2739865|P1|COMPLETED|Overall Study||8
1132015|NCT01309282|2739865|P1|STARTED|Overall Study||9
1132016|NCT01309308|2739884|P2|NOT COMPLETED|Overall Study||4
1132017|NCT01309308|2739885|P1|NOT COMPLETED|Overall Study||6
1132018|NCT01309308|2739884|P2|COMPLETED|Overall Study||71
1132019|NCT01309308|2739885|P1|COMPLETED|Overall Study||69
1132020|NCT01309308|2739884|P2|STARTED|Overall Study||75
1132021|NCT01309308|2739885|P1|STARTED|Overall Study||75
1132022|NCT01309360|2739896|P3|NOT COMPLETED|Overall Study||0
1132023|NCT01309360|2739897|P2|NOT COMPLETED|Overall Study||0
1132024|NCT01309360|2739898|P1|NOT COMPLETED|Overall Study||0
1132025|NCT01309360|2739896|P3|COMPLETED|Overall Study||40
1132026|NCT01309360|2739897|P2|COMPLETED|Overall Study||40
1132027|NCT01309360|2739898|P1|COMPLETED|Overall Study||40
1132028|NCT01309360|2739896|P3|STARTED|Overall Study||40
1132029|NCT01309360|2739897|P2|STARTED|Overall Study||40
1132030|NCT01309360|2739898|P1|STARTED|Overall Study||40
1132031|NCT01309386|2739923|P2|NOT COMPLETED|Overall Study||21
1132032|NCT01309386|2739924|P1|NOT COMPLETED|Overall Study||22
1132033|NCT01309386|2739923|P2|COMPLETED|Overall Study||29
1132034|NCT01309386|2739924|P1|COMPLETED|Overall Study||28
1132035|NCT01309386|2739923|P2|STARTED|Overall Study||50
1132036|NCT01309386|2739924|P1|STARTED|Overall Study||50
1132037|NCT01309451|2739944|P2|NOT COMPLETED|Overall Study||3
1132038|NCT01309451|2739945|P1|NOT COMPLETED|Overall Study||2
1132039|NCT01309451|2739944|P2|COMPLETED|Overall Study|unit of measure is number of eyes|18
1132040|NCT01309451|2739945|P1|COMPLETED|Overall Study|unit of measure is number of eyes|17
1132041|NCT01309451|2739944|P2|STARTED|Overall Study|unit of measure is number of eyes|21
1132042|NCT01309451|2739945|P1|STARTED|Overall Study|unit of measure is number of eyes|19
1132043|NCT01316224|2739953|P1|NOT COMPLETED|Overall Study||10
1132044|NCT01316224|2739953|P1|COMPLETED|Overall Study||42
1132045|NCT01316224|2739953|P1|Completed Visit 4 to Rheumatologist|Overall Study||28
1132046|NCT01316224|2739953|P1|Completed Visit 4 to Dermatologist|Overall Study||42
1132047|NCT01316224|2739953|P1|Completed Visit 3 to Rheumatologist|Overall Study||39
1132048|NCT01316224|2739953|P1|Completed Visit 3 to Dermatologist|Overall Study||48
1132049|NCT01316224|2739953|P1|Completed Visit 2 to Dermatologist|Overall Study||51
1132050|NCT01316224|2739953|P1|Completed Visit 1 to Rheumatologist|Overall Study||49
1132051|NCT01316224|2739953|P1|Completed Visit 1 to Dermatologist|Overall Study||52
1132052|NCT01316224|2739953|P1|STARTED|Overall Study||52
1132053|NCT01316263|2739969|P2|NOT COMPLETED|Overall Study||0
1132054|NCT01316263|2739970|P1|NOT COMPLETED|Overall Study||0
1132055|NCT01316263|2739969|P2|COMPLETED|Overall Study||14
1132056|NCT01316263|2739970|P1|COMPLETED|Overall Study||7
1132057|NCT01316263|2739969|P2|Received Any Study Drug|Overall Study||14
1132058|NCT01316263|2739970|P1|Received Any Study Drug|Overall Study||7
1132059|NCT01316263|2739969|P2|STARTED|Overall Study||14
1132060|NCT01316263|2739970|P1|STARTED|Overall Study||7
1132061|NCT01316302|2739998|P2|NOT COMPLETED|Overall Study||11
1132062|NCT01316302|2739999|P1|NOT COMPLETED|Overall Study||10
1132063|NCT01316302|2739998|P2|COMPLETED|Overall Study||22
1132064|NCT01316302|2739999|P1|COMPLETED|Overall Study||20
1132065|NCT01316302|2739998|P2|STARTED|Overall Study||33
1132066|NCT01316302|2739999|P1|STARTED|Overall Study||30
1132067|NCT01316315|2740011|P2|NOT COMPLETED|Sequence 2||0
1132068|NCT01316315|2740012|P1|NOT COMPLETED|Sequence 2||0
1132069|NCT01316315|2740011|P2|COMPLETED|Sequence 2||7
1132070|NCT01316315|2740012|P1|COMPLETED|Sequence 2||7
1132071|NCT01316315|2740011|P2|STARTED|Sequence 2||7
1132072|NCT01316315|2740012|P1|STARTED|Sequence 2||7
1132073|NCT01316315|2740011|P2|NOT COMPLETED|Sequence 1||0
1132074|NCT01316315|2740012|P1|NOT COMPLETED|Sequence 1||0
1132075|NCT01316315|2740011|P2|COMPLETED|Sequence 1||7
1132076|NCT01316315|2740012|P1|COMPLETED|Sequence 1||7
1132077|NCT01316315|2740011|P2|STARTED|Sequence 1||7
1132078|NCT01316315|2740012|P1|STARTED|Sequence 1||7
1132079|NCT01316341|2740027|P3|NOT COMPLETED|Overall Study||0
1132080|NCT01316341|2740028|P2|NOT COMPLETED|Overall Study||0
1132081|NCT01316341|2740029|P1|NOT COMPLETED|Overall Study||0
1132082|NCT01316341|2740027|P3|COMPLETED|Overall Study||9
1132083|NCT01316341|2740028|P2|COMPLETED|Overall Study||9
1132084|NCT01316341|2740029|P1|COMPLETED|Overall Study||6
1132085|NCT01316341|2740027|P3|STARTED|Overall Study||9
1132086|NCT01316341|2740028|P2|STARTED|Overall Study||9
1132087|NCT01316341|2740029|P1|STARTED|Overall Study||6
1132088|NCT01316380|2740098|P3|NOT COMPLETED|Overall Study||3
1132089|NCT01316380|2740099|P2|NOT COMPLETED|Overall Study||5
1132090|NCT01316380|2740100|P1|NOT COMPLETED|Overall Study||2
1132091|NCT01316380|2740098|P3|COMPLETED|Overall Study||152
1132092|NCT01316380|2740099|P2|COMPLETED|Overall Study||149
1132093|NCT01316380|2740100|P1|COMPLETED|Overall Study||154
1132094|NCT01316380|2740098|P3|STARTED|Overall Study||155
1132095|NCT01316380|2740099|P2|STARTED|Overall Study||154
1132096|NCT01316380|2740100|P1|STARTED|Overall Study||156
1132097|NCT01316419|2740138|P1|NOT COMPLETED|Overall Study||265
1132098|NCT01316419|2740138|P1|COMPLETED|Overall Study||1824
1132099|NCT01316419|2740138|P1|STARTED|Overall Study||2089
1132100|NCT01318499|2740164|P3|NOT COMPLETED|Overall Study||147
1132101|NCT01318499|2740165|P2|NOT COMPLETED|Overall Study||76
1132102|NCT01318499|2740166|P1|NOT COMPLETED|Overall Study||65
1132103|NCT01318499|2740164|P3|COMPLETED|Overall Study||121
1132104|NCT01318499|2740165|P2|COMPLETED|Overall Study||458
1132105|NCT01318499|2740166|P1|COMPLETED|Overall Study||475
1132106|NCT01318499|2740164|P3|STARTED|Overall Study||268
1132107|NCT01318499|2740165|P2|STARTED|Overall Study||534
1132108|NCT01318499|2740166|P1|STARTED|Overall Study||540
1132109|NCT01318512|2740184|P1|NOT COMPLETED|Maintenance Period (6 Months)||11
1132110|NCT01318512|2740184|P1|COMPLETED|Maintenance Period (6 Months)||329
1132111|NCT01318512|2740184|P1|STARTED|Maintenance Period (6 Months)||340
1132112|NCT01318512|2740184|P1|NOT COMPLETED|Titration Period (4 Months)||0
1132113|NCT01318512|2740184|P1|COMPLETED|Titration Period (4 Months)||340
1132114|NCT01318512|2740184|P1|STARTED|Titration Period (4 Months)||340
1132115|NCT01318538|2740202|P3|NOT COMPLETED|Overall Study||0
1132116|NCT01318538|2740203|P2|NOT COMPLETED|Overall Study||0
1132117|NCT01318538|2740204|P1|NOT COMPLETED|Overall Study||0
1132118|NCT01318538|2740202|P3|COMPLETED|Overall Study||8
1132119|NCT01318538|2740203|P2|COMPLETED|Overall Study||106
1132120|NCT01318538|2740204|P1|COMPLETED|Overall Study||52
1132121|NCT01318538|2740202|P3|STARTED|Overall Study||8
1132122|NCT01318538|2740203|P2|STARTED|Overall Study||106
1132123|NCT01318538|2740204|P1|STARTED|Overall Study||52
1132124|NCT01318694|2740232|P4|NOT COMPLETED|Overall Study||68
1132125|NCT01318694|2740233|P3|NOT COMPLETED|Overall Study||43
1132126|NCT01318694|2740234|P2|NOT COMPLETED|Overall Study||58
1132127|NCT01318694|2740235|P1|NOT COMPLETED|Overall Study||52
1132128|NCT01318694|2740232|P4|COMPLETED|Overall Study||200
1132129|NCT01318694|2740233|P3|COMPLETED|Overall Study||225
1132130|NCT01318694|2740234|P2|COMPLETED|Overall Study||212
1132131|NCT01318694|2740235|P1|COMPLETED|Overall Study||223
1132132|NCT01318694|2740232|P4|Safety Set|Overall Study||265
1132133|NCT01318694|2740233|P3|Safety Set|Overall Study||265
1132134|NCT01318694|2740234|P2|Safety Set|Overall Study||268
1132135|NCT01318694|2740235|P1|Safety Set|Overall Study||273
1132136|NCT01318694|2740232|P4|Full Analysis Set|Overall Study||268
1132137|NCT01318694|2740233|P3|Full Analysis Set|Overall Study||265
1132138|NCT01318694|2740234|P2|Full Analysis Set|Overall Study||270
1132139|NCT01318694|2740235|P1|Full Analysis Set|Overall Study||274
1132140|NCT01318694|2740232|P4|STARTED|Overall Study||268
1132141|NCT01318694|2740233|P3|STARTED|Overall Study||268
1132142|NCT01318694|2740234|P2|STARTED|Overall Study||270
1132143|NCT01318694|2740235|P1|STARTED|Overall Study||275
1132144|NCT01318733|2740289|P1|NOT COMPLETED|Overall Study||170
1132145|NCT01318733|2740289|P1|COMPLETED|Overall Study||279
1132146|NCT01318733|2740289|P1|STARTED|Overall Study||449
1132147|NCT01318876|2740293|P1|NOT COMPLETED|Day 29 Survey||1825
1132148|NCT01318876|2740293|P1|COMPLETED|Day 29 Survey||5724
1132149|NCT01318876|2740293|P1|STARTED|Day 29 Survey|All participants with a valid e-mail, have received the second survey|7549
1132150|NCT01318876|2740293|P1|NOT COMPLETED|Day 8 Survey||1820
1132151|NCT01318876|2740293|P1|COMPLETED|Day 8 Survey||5825
1132152|NCT01318876|2740293|P1|STARTED|Day 8 Survey||7645
1132153|NCT01318915|2740298|P1|NOT COMPLETED|Overall Study||8
1132154|NCT01318915|2740298|P1|COMPLETED|Overall Study||2
1132155|NCT01318915|2740298|P1|STARTED|Overall Study||10
1132156|NCT01318967|2740302|P1|NOT COMPLETED|Overall Study||0
1132157|NCT01318967|2740302|P1|COMPLETED|Overall Study||10
1132158|NCT01318967|2740302|P1|STARTED|Overall Study||10
1132159|NCT01318993|2740307|P1|NOT COMPLETED|Overall Study||398
1132160|NCT01318993|2740307|P1|COMPLETED|Overall Study||0
1132161|NCT01318993|2740307|P1|STARTED|Overall Study||398
1132162|NCT01319045|2740323|P1|NOT COMPLETED|Overall Study||2
1132163|NCT01319045|2740323|P1|COMPLETED|Overall Study|Study was discontinued due to low enrollment|3
1132164|NCT01319045|2740323|P1|STARTED|Overall Study||5
1132165|NCT01319110|2740332|P2|NOT COMPLETED|Overall Study||0
1132166|NCT01319110|2740333|P1|NOT COMPLETED|Overall Study||0
1132167|NCT01319110|2740332|P2|COMPLETED|Overall Study||5
1132168|NCT01319110|2740333|P1|COMPLETED|Overall Study||5
1132169|NCT01319110|2740332|P2|STARTED|Overall Study||5
1132170|NCT01319110|2740333|P1|STARTED|Overall Study||5
1132171|NCT01319318|2740341|P1|NOT COMPLETED|Overall Study||0
1132172|NCT01319318|2740341|P1|COMPLETED|Overall Study||25
1132173|NCT01319318|2740341|P1|STARTED|Overall Study||25
1132174|NCT01319383|2740345|P2|NOT COMPLETED|Overall Study||10
1132175|NCT01319383|2740346|P1|NOT COMPLETED|Overall Study||12
1132176|NCT01319383|2740345|P2|COMPLETED|Overall Study||3
1132177|NCT01319383|2740346|P1|COMPLETED|Overall Study||0
1132178|NCT01319383|2740345|P2|Step 4|Overall Study|Only 3/6 completed the study.|3
1132179|NCT01319383|2740346|P1|Step 4|Overall Study|Arm 1 did not have a Step 4|0
1132180|NCT01319383|2740345|P2|Step 3|Overall Study|3 Arm 1 participants enrolled here; 6/7 had in vivo response to 2 VOR doses given 72 hours apart.|6
1132181|NCT01319383|2740346|P1|Step 3|Overall Study|None who qualified for the 2 series of 11 doses of VOR (taken M-T-W & off for 4 days for 4 wks).|0
1132182|NCT01319383|2740345|P2|Step 2|Overall Study||0
1132183|NCT01319383|2740346|P1|Step 2|Overall Study|The 4 without ex vivo response (Step 1) took a single dose to see if in vivo response would occur|4
1132184|NCT01319383|2740345|P2|Step 2|Overall Study|The 7 participants without an in vivo response to single dose of VOR 400 mg PO were terminated.|4
1132185|NCT01319383|2740346|P1|Step 2|Overall Study|These participants demonstrated an ex vivo response in Step 1|8
1132186|NCT01319383|2740345|P2|Step 1|Overall Study|The 2 participants without an ex vivo response were terminated from the study.|11
1132187|NCT01319383|2740346|P1|Step 1|Overall Study||8
1132188|NCT01319383|2740345|P2|STARTED|Overall Study||13
1132189|NCT01319383|2740346|P1|STARTED|Overall Study||12
1132190|NCT01319396|2740363|P1|NOT COMPLETED|Overall Study||0
1132191|NCT01319396|2740363|P1|COMPLETED|Overall Study||24
1132192|NCT01319396|2740363|P1|STARTED|Overall Study||24
1132193|NCT01319422|2740369|P2|NOT COMPLETED|Overall Study||0
1132194|NCT01319422|2740370|P1|NOT COMPLETED|Overall Study||1
1132195|NCT01319422|2740369|P2|COMPLETED|Overall Study||20
1132196|NCT01319422|2740370|P1|COMPLETED|Overall Study||19
1132197|NCT01319422|2740369|P2|STARTED|Overall Study||20
1132198|NCT01319422|2740370|P1|STARTED|Overall Study||20
1132199|NCT01319500|2740386|P2|NOT COMPLETED|Overall Study||0
1132200|NCT01319500|2740387|P1|NOT COMPLETED|Overall Study||0
1132201|NCT01319500|2740386|P2|COMPLETED|Overall Study||2589
1132202|NCT01319500|2740387|P1|COMPLETED|Overall Study||1187
1132203|NCT01319500|2740386|P2|STARTED|Overall Study||2589
1132204|NCT01319500|2740387|P1|STARTED|Overall Study||1187
1132205|NCT01319539|2740404|P1|NOT COMPLETED|Overall Study||0
1132206|NCT01319539|2740404|P1|COMPLETED|Overall Study||12
1132207|NCT01319539|2740404|P1|STARTED|Overall Study||12
1132208|NCT01319552|2740412|P1|NOT COMPLETED|Overall Study||0
1132209|NCT01319552|2740412|P1|COMPLETED|Overall Study||14
1132210|NCT01319552|2740412|P1|STARTED|Overall Study||14
1132211|NCT01319617|2740417|P1|NOT COMPLETED|Overall Study||1
1132212|NCT01319617|2740417|P1|COMPLETED|Overall Study||40
1132213|NCT01319617|2740417|P1|STARTED|Overall Study||41
1132214|NCT01319721|2740423|P2|NOT COMPLETED|Overall Study||6
1132215|NCT01319721|2740424|P1|NOT COMPLETED|Overall Study||1
1132216|NCT01319721|2740423|P2|COMPLETED|Overall Study|The unit of measure is eyes.|42
1132217|NCT01319721|2740424|P1|COMPLETED|Overall Study|The unit of measure is eyes.|47
1132218|NCT01319721|2740423|P2|STARTED|Overall Study|The unit of measure is eyes.|48
1132219|NCT01319721|2740424|P1|STARTED|Overall Study|The unit of measure is eyes.|48
1132220|NCT01319773|2740443|P5|NOT COMPLETED|Overall Study||0
1132221|NCT01319773|2740444|P4|NOT COMPLETED|Overall Study||0
1132222|NCT01319773|2740445|P3|NOT COMPLETED|Overall Study||0
1132223|NCT01319773|2740446|P2|NOT COMPLETED|Overall Study||0
1132224|NCT01319773|2740447|P1|NOT COMPLETED|Overall Study||0
1132225|NCT01319773|2740443|P5|COMPLETED|Overall Study||8
1132226|NCT01319773|2740444|P4|COMPLETED|Overall Study||8
1132227|NCT01319773|2740445|P3|COMPLETED|Overall Study||8
1132228|NCT01319773|2740446|P2|COMPLETED|Overall Study||10
1132229|NCT01319773|2740447|P1|COMPLETED|Overall Study||10
1132230|NCT01319773|2740443|P5|STARTED|Overall Study||8
1132231|NCT01319773|2740444|P4|STARTED|Overall Study||8
1132232|NCT01319773|2740445|P3|STARTED|Overall Study||8
1132233|NCT01319773|2740446|P2|STARTED|Overall Study||10
1132234|NCT01319773|2740447|P1|STARTED|Overall Study||10
1132235|NCT01319799|2740461|P1|NOT COMPLETED|Overall Study||0
1132236|NCT01319799|2740461|P1|COMPLETED|Overall Study||10
1132237|NCT01319799|2740461|P1|STARTED|Overall Study||10
1132238|NCT01319812|2740468|P2|NOT COMPLETED|Overall Study||22
1132239|NCT01319812|2740469|P1|NOT COMPLETED|Overall Study||16
1132240|NCT01319812|2740468|P2|COMPLETED|Overall Study||280
1132241|NCT01319812|2740469|P1|COMPLETED|Overall Study||145
1132242|NCT01319812|2740468|P2|STARTED|Overall Study||302
1132243|NCT01319812|2740469|P1|STARTED|Overall Study||161
1132244|NCT01319851|2740541|P1|NOT COMPLETED|Overall Study||0
1132245|NCT01319851|2740541|P1|COMPLETED|Overall Study||3
1132246|NCT01319851|2740541|P1|STARTED|Overall Study||3
1132247|NCT01319877|2740553|P2|NOT COMPLETED|Overall Study||45
1132248|NCT01319877|2740554|P1|NOT COMPLETED|Overall Study||108
1132249|NCT01319877|2740553|P2|COMPLETED|Overall Study||108
1132250|NCT01319877|2740554|P1|COMPLETED|Overall Study||345
1132251|NCT01319877|2740553|P2|STARTED|Overall Study||153
1132252|NCT01319877|2740554|P1|STARTED|Overall Study||453
1132259|NCT01320137|2740603|P2|NOT COMPLETED|Overall Study||0
1132260|NCT01320137|2740604|P1|NOT COMPLETED|Overall Study||0
1132261|NCT01320137|2740603|P2|COMPLETED|Overall Study||40
1132262|NCT01320137|2740604|P1|COMPLETED|Overall Study||40
1132263|NCT01320137|2740603|P2|STARTED|Overall Study||40
1132264|NCT01320137|2740604|P1|STARTED|Overall Study||40
1132265|NCT01320202|2740618|P2|NOT COMPLETED|Overall Study||44
1132266|NCT01320202|2740619|P1|NOT COMPLETED|Overall Study||56
1132267|NCT01320202|2740618|P2|COMPLETED|Overall Study||109
1132268|NCT01320202|2740619|P1|COMPLETED|Overall Study||96
1132269|NCT01320202|2740618|P2|Completed St 3|Overall Study||82
1132270|NCT01320202|2740619|P1|Completed St 3|Overall Study||79
1132271|NCT01320202|2740618|P2|Enrolled in St 3|Overall Study||109
1132272|NCT01320202|2740619|P1|Enrolled in St 3|Overall Study||98
1132273|NCT01320202|2740618|P2|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||82
1132274|NCT01320202|2740619|P1|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||69
1132275|NCT01320202|2740618|P2|Comp 48 Wks in St 2|Overall Study||27
1132276|NCT01320202|2740619|P1|Comp 48 Wks in St 2|Overall Study||27
1132277|NCT01320202|2740618|P2|STARTED|Overall Study||153
1132278|NCT01320202|2740619|P1|STARTED|Overall Study||152
1132279|NCT01320293|2740654|P1|NOT COMPLETED|Overall Study||2
1132280|NCT01320293|2740654|P1|COMPLETED|Overall Study||16
1132281|NCT01320293|2740654|P1|STARTED|Overall Study||18
1132282|NCT01320553|2740664|P4|NOT COMPLETED|Overall Study||1
1132283|NCT01320553|2740665|P3|NOT COMPLETED|Overall Study||2
1132284|NCT01320553|2740666|P2|NOT COMPLETED|Overall Study||4
1132285|NCT01320553|2740667|P1|NOT COMPLETED|Overall Study||1
1132286|NCT01320553|2740664|P4|COMPLETED|Overall Study||29
1132287|NCT01320553|2740665|P3|COMPLETED|Overall Study||29
1132288|NCT01320553|2740666|P2|COMPLETED|Overall Study||26
1132289|NCT01320553|2740667|P1|COMPLETED|Overall Study||30
1132290|NCT01320553|2740664|P4|STARTED|Overall Study||30
1132291|NCT01320553|2740665|P3|STARTED|Overall Study||31
1132292|NCT01320553|2740666|P2|STARTED|Overall Study||30
1132293|NCT01320553|2740667|P1|STARTED|Overall Study||31
1132294|NCT01320683|2740681|P1|NOT COMPLETED|Overall Study||1
1132295|NCT01320683|2740681|P1|COMPLETED|Overall Study||0
1132296|NCT01320683|2740681|P1|STARTED|Overall Study||1
1132297|NCT01320722|2740691|P5|NOT COMPLETED|Overall Study||8
1132298|NCT01320722|2740692|P4|NOT COMPLETED|Overall Study||14
1132299|NCT01320722|2740693|P3|NOT COMPLETED|Overall Study||7
1132300|NCT01320722|2740694|P2|NOT COMPLETED|Overall Study||6
1132301|NCT01320722|2740695|P1|NOT COMPLETED|Overall Study||3
1132302|NCT01320722|2740691|P5|COMPLETED|Overall Study||45
1132303|NCT01320722|2740692|P4|COMPLETED|Overall Study||35
1132304|NCT01320722|2740693|P3|COMPLETED|Overall Study||40
1132305|NCT01320722|2740694|P2|COMPLETED|Overall Study||41
1132306|NCT01320722|2740695|P1|COMPLETED|Overall Study||43
1132307|NCT01320722|2740691|P5|Received Intervention|Overall Study||51
1132308|NCT01320722|2740692|P4|Received Intervention|Overall Study||48
1132309|NCT01320722|2740693|P3|Received Intervention|Overall Study||46
1132310|NCT01320722|2740694|P2|Received Intervention|Overall Study||45
1132311|NCT01320722|2740695|P1|Received Intervention|Overall Study||43
1132312|NCT01320722|2740691|P5|STARTED|Overall Study||53
1132313|NCT01320722|2740692|P4|STARTED|Overall Study||49
1132314|NCT01320722|2740693|P3|STARTED|Overall Study||47
1132315|NCT01320722|2740694|P2|STARTED|Overall Study||47
1132316|NCT01320722|2740695|P1|STARTED|Overall Study||46
1132317|NCT01320735|2740732|P1|NOT COMPLETED|Overall Study||106
1132318|NCT01320735|2740732|P1|COMPLETED|Overall Study||194
1132319|NCT01320735|2740732|P1|STARTED|Overall Study||300
1132320|NCT01320826|2740749|P1|NOT COMPLETED|Overall Study||0
1132321|NCT01320826|2740749|P1|COMPLETED|Overall Study||577
1132322|NCT01320826|2740749|P1|STARTED|Overall Study||577
1132323|NCT01312428|2740766|P2|NOT COMPLETED|Overall Study||4
1132324|NCT01312428|2740767|P1|NOT COMPLETED|Overall Study||3
1132325|NCT01312428|2740766|P2|COMPLETED|Overall Study||0
1132326|NCT01312428|2740767|P1|COMPLETED|Overall Study||0
1132327|NCT01312428|2740766|P2|STARTED|Overall Study||4
1132328|NCT01312428|2740767|P1|STARTED|Overall Study||3
1132329|NCT01312467|2740773|P1|NOT COMPLETED|Overall Study||13
1132330|NCT01312467|2740773|P1|COMPLETED|Overall Study||32
1132331|NCT01312467|2740773|P1|STARTED|Overall Study||45
1132332|NCT01312519|2740779|P2|NOT COMPLETED|Overall Study||0
1132333|NCT01312519|2740780|P1|NOT COMPLETED|Overall Study||0
1132334|NCT01312519|2740779|P2|COMPLETED|Overall Study||24
1132335|NCT01312519|2740780|P1|COMPLETED|Overall Study||26
1132336|NCT01312519|2740779|P2|STARTED|Overall Study||24
1132337|NCT01312519|2740780|P1|STARTED|Overall Study||26
1132338|NCT01312766|2740790|P2|NOT COMPLETED|Overall Study||5
1132339|NCT01312766|2740791|P1|NOT COMPLETED|Overall Study||6
1132340|NCT01312766|2740790|P2|COMPLETED|Overall Study||130
1132341|NCT01312766|2740791|P1|COMPLETED|Overall Study||129
1132342|NCT01312766|2740790|P2|STARTED|Overall Study||135
1132343|NCT01312766|2740791|P1|STARTED|Overall Study||135
1132344|NCT01312805|2740823|P2|NOT COMPLETED|Overall Study||0
1132345|NCT01312805|2740824|P1|NOT COMPLETED|Overall Study||0
1132346|NCT01312805|2740823|P2|COMPLETED|Overall Study||1082
1132347|NCT01312805|2740824|P1|COMPLETED|Overall Study||1016
1132348|NCT01312805|2740823|P2|STARTED|Overall Study||1082
1132349|NCT01312805|2740824|P1|STARTED|Overall Study||1016
1132350|NCT01312818|2740830|P1|NOT COMPLETED|Overall Study||0
1132351|NCT01312818|2740830|P1|COMPLETED|Overall Study||2
1132352|NCT01312818|2740830|P1|STARTED|Overall Study||2
1132353|NCT01312844|2740838|P2|NOT COMPLETED|Overall Study||0
1132354|NCT01312844|2740839|P1|NOT COMPLETED|Overall Study||0
1132355|NCT01312844|2740838|P2|COMPLETED|Overall Study||3
1132356|NCT01312844|2740839|P1|COMPLETED|Overall Study||4
1132357|NCT01312844|2740838|P2|STARTED|Overall Study||3
1132358|NCT01312844|2740839|P1|STARTED|Overall Study||4
1132359|NCT01312948|2740861|P1|NOT COMPLETED|Overall Study||0
1132360|NCT01312948|2740861|P1|COMPLETED|Overall Study||6
1132361|NCT01312948|2740861|P1|STARTED|Overall Study||6
1132362|NCT01312961|2740870|P2|NOT COMPLETED|Overall Study||7
1132363|NCT01312961|2740871|P1|NOT COMPLETED|Overall Study||17
1132364|NCT01312961|2740870|P2|COMPLETED|Overall Study||45
1132365|NCT01312961|2740871|P1|COMPLETED|Overall Study||35
1132366|NCT01312961|2740870|P2|Treated|Overall Study||52
1132367|NCT01312961|2740871|P1|Treated|Overall Study||52
1132368|NCT01312961|2740870|P2|STARTED|Overall Study||52
1132369|NCT01312961|2740871|P1|STARTED|Overall Study||52
1132370|NCT01313039|2740897|P1|NOT COMPLETED|Overall Study||2
1132371|NCT01313039|2740897|P1|COMPLETED|Overall Study||2
1132372|NCT01313039|2740897|P1|STARTED|Overall Study||4
1132373|NCT01313078|2740901|P1|NOT COMPLETED|Overall Study||3
1132374|NCT01313078|2740901|P1|COMPLETED|Overall Study||1
1132375|NCT01313078|2740901|P1|STARTED|Overall Study||4
1132376|NCT01313117|2740906|P1|NOT COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
1132377|NCT01313117|2740906|P1|COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||0
1132378|NCT01313117|2740906|P1|STARTED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
1132379|NCT01313117|2740906|P1|NOT COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||0
1132380|NCT01313117|2740906|P1|COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
1132381|NCT01313117|2740906|P1|STARTED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
1132382|NCT01313117|2740906|P1|NOT COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||0
1132383|NCT01313117|2740906|P1|COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
1132384|NCT01313117|2740906|P1|STARTED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
1132385|NCT01313117|2740906|P1|NOT COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
1132386|NCT01313117|2740906|P1|COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
1132387|NCT01313117|2740906|P1|STARTED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||2
1132388|NCT01313117|2740906|P1|NOT COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||0
1132389|NCT01313117|2740906|P1|COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
1132390|NCT01313117|2740906|P1|STARTED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
1132391|NCT01313182|2740915|P2|NOT COMPLETED|Overall Study||92
1132392|NCT01313182|2740916|P1|NOT COMPLETED|Overall Study||66
1132393|NCT01313182|2740915|P2|COMPLETED|Overall Study||763
1132394|NCT01313182|2740916|P1|COMPLETED|Overall Study||776
1132395|NCT01313182|2740915|P2|STARTED|Overall Study||855
1132396|NCT01313182|2740916|P1|STARTED|Overall Study||842
1132397|NCT01313208|2740924|P2|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||3
1132398|NCT01313208|2740925|P1|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||6
1132399|NCT01313208|2740924|P2|COMPLETED|Open-label Phase (Weeks 13 - 24)||98
1132400|NCT01313208|2740925|P1|COMPLETED|Open-label Phase (Weeks 13 - 24)||92
1132401|NCT01313208|2740924|P2|STARTED|Open-label Phase (Weeks 13 - 24)||101
1132402|NCT01313208|2740925|P1|STARTED|Open-label Phase (Weeks 13 - 24)||98
1132403|NCT01313208|2740924|P2|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||5
1132404|NCT01313208|2740925|P1|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||6
1132405|NCT01313208|2740924|P2|COMPLETED|Double-blind Phase (Weeks 1 - 12)||101
1132406|NCT01313208|2740925|P1|COMPLETED|Double-blind Phase (Weeks 1 - 12)||98
1132407|NCT01313208|2740924|P2|STARTED|Double-blind Phase (Weeks 1 - 12)||106
1132408|NCT01313208|2740925|P1|STARTED|Double-blind Phase (Weeks 1 - 12)||104
1132409|NCT01313221|2741016|P3|NOT COMPLETED|Overall Study||23
1132410|NCT01313221|2741017|P2|NOT COMPLETED|Overall Study||8
1132411|NCT01313221|2741018|P1|NOT COMPLETED|Overall Study||12
1132412|NCT01313221|2741016|P3|COMPLETED|Overall Study||0
1132413|NCT01313221|2741017|P2|COMPLETED|Overall Study||135
1132414|NCT01313221|2741018|P1|COMPLETED|Overall Study||132
1132415|NCT01313221|2741016|P3|Randomized|Overall Study||0
1132416|NCT01313221|2741017|P2|Randomized|Overall Study||143
1132417|NCT01313221|2741018|P1|Randomized|Overall Study||144
1132418|NCT01313221|2741016|P3|STARTED|Overall Study||23
1132419|NCT01313221|2741017|P2|STARTED|Overall Study||143
1132420|NCT01313221|2741018|P1|STARTED|Overall Study||144
1132421|NCT01313273|2741070|P2|NOT COMPLETED|Overall Study||1
1132422|NCT01313273|2741071|P1|NOT COMPLETED|Overall Study||2
1132423|NCT01313273|2741070|P2|COMPLETED|Overall Study||0
1132424|NCT01313273|2741071|P1|COMPLETED|Overall Study||0
1132425|NCT01313273|2741070|P2|STARTED|Overall Study||1
1132426|NCT01313273|2741071|P1|STARTED|Overall Study||2
1132427|NCT01313299|2741086|P3|NOT COMPLETED|Overall Study||4
1132428|NCT01313299|2741087|P2|NOT COMPLETED|Overall Study||3
1132429|NCT01313299|2741088|P1|NOT COMPLETED|Overall Study||7
1132430|NCT01313299|2741086|P3|COMPLETED|Overall Study||77
1132431|NCT01313299|2741087|P2|COMPLETED|Overall Study||78
1132432|NCT01313299|2741088|P1|COMPLETED|Overall Study||74
1132433|NCT01313299|2741086|P3|STARTED|Overall Study||81
1132434|NCT01313299|2741087|P2|STARTED|Overall Study||81
1132435|NCT01313299|2741088|P1|STARTED|Overall Study||81
1132436|NCT01313312|2741102|P1|NOT COMPLETED|Overall Study||36
1132437|NCT01313312|2741102|P1|COMPLETED|Overall Study||222
1132438|NCT01313312|2741102|P1|Cycle 5|Overall Study||11
1132439|NCT01313312|2741102|P1|Cycle 4|Overall Study||81
1132440|NCT01313312|2741102|P1|Cycle 3|Overall Study||175
1132441|NCT01313312|2741102|P1|Cycle 2|Overall Study||229
1132442|NCT01313312|2741102|P1|Cycle 1|Overall Study||254
1132443|NCT01313312|2741102|P1|STARTED|Overall Study||258
1132444|NCT01313494|2741148|P2|NOT COMPLETED|Overall Study||50
1132445|NCT01313494|2741149|P1|NOT COMPLETED|Overall Study||67
1132446|NCT01313494|2741148|P2|COMPLETED|Overall Study||263
1132447|NCT01313494|2741149|P1|COMPLETED|Overall Study||246
1132448|NCT01313494|2741148|P2|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|311
1132543|NCT01323270|2741498|P2|STARTED|Overall Study||376
1132449|NCT01313494|2741149|P1|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|315
1132450|NCT01313494|2741148|P2|STARTED|Overall Study||313
1132451|NCT01313494|2741149|P1|STARTED|Overall Study||313
1132452|NCT01313507|2741201|P1|NOT COMPLETED|Overall Study||0
1132453|NCT01313507|2741201|P1|COMPLETED|Overall Study||21
1132454|NCT01313507|2741201|P1|STARTED|Overall Study||21
1132455|NCT01313520|2741209|P2|NOT COMPLETED|Overall Study||0
1132456|NCT01313520|2741210|P1|NOT COMPLETED|Overall Study||0
1132457|NCT01313520|2741209|P2|COMPLETED|Overall Study||31
1132458|NCT01313520|2741210|P1|COMPLETED|Overall Study||30
1132459|NCT01313520|2741209|P2|STARTED|Overall Study||31
1132460|NCT01313520|2741210|P1|STARTED|Overall Study||30
1132461|NCT01320943|2741232|P2|NOT COMPLETED|Overall Study||2
1132462|NCT01320943|2741233|P1|NOT COMPLETED|Overall Study||1
1132463|NCT01320943|2741232|P2|COMPLETED|Overall Study||20
1132464|NCT01320943|2741233|P1|COMPLETED|Overall Study||20
1132465|NCT01320943|2741232|P2|STARTED|Overall Study||22
1132466|NCT01320943|2741233|P1|STARTED|Overall Study|13 participants did not restart TDF; 8 participants restarted TDF during the study.|21
1132467|NCT01321008|2741252|P1|NOT COMPLETED|Overall Study||1
1132468|NCT01321008|2741252|P1|COMPLETED|Overall Study||0
1132469|NCT01321008|2741252|P1|STARTED|Overall Study||1
1132470|NCT01322594|2741262|P6|NOT COMPLETED|Overall Study||0
1132471|NCT01322594|2741263|P5|NOT COMPLETED|Overall Study||0
1132472|NCT01322594|2741264|P4|NOT COMPLETED|Overall Study||0
1132473|NCT01322594|2741265|P3|NOT COMPLETED|Overall Study||0
1132474|NCT01322594|2741266|P2|NOT COMPLETED|Overall Study||0
1132475|NCT01322594|2741267|P1|NOT COMPLETED|Overall Study||0
1132476|NCT01322594|2741262|P6|COMPLETED|Overall Study||6
1132477|NCT01322594|2741263|P5|COMPLETED|Overall Study||7
1132478|NCT01322594|2741264|P4|COMPLETED|Overall Study||6
1132479|NCT01322594|2741265|P3|COMPLETED|Overall Study||3
1132480|NCT01322594|2741266|P2|COMPLETED|Overall Study||3
1132481|NCT01322594|2741267|P1|COMPLETED|Overall Study||6
1132482|NCT01322594|2741262|P6|STARTED|Overall Study||6
1132483|NCT01322594|2741263|P5|STARTED|Overall Study||7
1132484|NCT01322594|2741264|P4|STARTED|Overall Study||6
1132485|NCT01322594|2741265|P3|STARTED|Overall Study||3
1132486|NCT01322594|2741266|P2|STARTED|Overall Study||3
1132487|NCT01322594|2741267|P1|STARTED|Overall Study|RANDOMIZED SUBJECTS THROUGH STUDY DAY 240-300|6
1132488|NCT01322607|2741349|P2|NOT COMPLETED|Overall Study||0
1132489|NCT01322607|2741350|P1|NOT COMPLETED|Overall Study||1
1132490|NCT01322607|2741349|P2|COMPLETED|Overall Study||9
1132491|NCT01322607|2741350|P1|COMPLETED|Overall Study||10
1132492|NCT01322607|2741349|P2|STARTED|Overall Study||9
1132493|NCT01322607|2741350|P1|STARTED|Overall Study||11
1132494|NCT01322633|2741364|P2|NOT COMPLETED|Overall Study||0
1132495|NCT01322633|2741365|P1|NOT COMPLETED|Overall Study||0
1132496|NCT01322633|2741364|P2|COMPLETED|Overall Study||27686
1132497|NCT01322633|2741365|P1|COMPLETED|Overall Study||34178
1132498|NCT01322633|2741364|P2|STARTED|Overall Study||27686
1132499|NCT01322633|2741365|P1|STARTED|Overall Study||34178
1132500|NCT01322815|2741377|P2|NOT COMPLETED|Overall Study||0
1132501|NCT01322815|2741378|P1|NOT COMPLETED|Overall Study||0
1132502|NCT01322815|2741377|P2|COMPLETED|Overall Study||4
1132503|NCT01322815|2741378|P1|COMPLETED|Overall Study||7
1132504|NCT01322815|2741377|P2|STARTED|Overall Study||4
1132505|NCT01322815|2741378|P1|STARTED|Overall Study||7
1132506|NCT01322841|2741386|P2|NOT COMPLETED|Overall Study||0
1132507|NCT01322841|2741387|P1|NOT COMPLETED|Overall Study||0
1132508|NCT01322841|2741386|P2|COMPLETED|Overall Study||1123
1132509|NCT01322841|2741387|P1|COMPLETED|Overall Study||1116
1132510|NCT01322841|2741386|P2|STARTED|Overall Study||1123
1132511|NCT01322841|2741387|P1|STARTED|Overall Study||1116
1132512|NCT01322945|2741397|P2|NOT COMPLETED|Overall Study||0
1132513|NCT01322945|2741398|P1|NOT COMPLETED|Overall Study||0
1132514|NCT01322945|2741397|P2|COMPLETED|Overall Study||42
1132515|NCT01322945|2741398|P1|COMPLETED|Overall Study||52
1132516|NCT01322945|2741397|P2|STARTED|Overall Study||42
1132517|NCT01322945|2741398|P1|STARTED|Overall Study||52
1132518|NCT01322971|2741408|P2|NOT COMPLETED|Overall Study||1
1132519|NCT01322971|2741409|P1|NOT COMPLETED|Overall Study||1
1132520|NCT01322971|2741408|P2|COMPLETED|Overall Study||0
1132521|NCT01322971|2741409|P1|COMPLETED|Overall Study||0
1132522|NCT01322971|2741408|P2|STARTED|Overall Study||1
1132523|NCT01322971|2741409|P1|STARTED|Overall Study||1
1132524|NCT01323010|2741423|P2|NOT COMPLETED|Overall Study||0
1132525|NCT01323010|2741424|P1|NOT COMPLETED|Overall Study||0
1132526|NCT01323010|2741423|P2|COMPLETED|Overall Study||59
1132527|NCT01323010|2741424|P1|COMPLETED|Overall Study||60
1132528|NCT01323010|2741423|P2|STARTED|Overall Study||59
1132529|NCT01323010|2741424|P1|STARTED|Overall Study||60
1132530|NCT01323140|2741473|P1|NOT COMPLETED|Overall Study||2
1132531|NCT01323140|2741473|P1|COMPLETED|Overall Study||38
1132532|NCT01323140|2741473|P1|STARTED|Overall Study||40
1132533|NCT01323192|2741479|P2|NOT COMPLETED|Overall Study||6
1132534|NCT01323192|2741480|P1|NOT COMPLETED|Overall Study||9
1132535|NCT01323192|2741479|P2|COMPLETED|Overall Study||135
1132536|NCT01323192|2741480|P1|COMPLETED|Overall Study||134
1132537|NCT01323192|2741479|P2|STARTED|Overall Study||141
1132538|NCT01323192|2741480|P1|STARTED|Overall Study||143
1132539|NCT01323270|2741498|P2|NOT COMPLETED|Overall Study||29
1132540|NCT01323270|2741499|P1|NOT COMPLETED|Overall Study||43
1132541|NCT01323270|2741498|P2|COMPLETED|Overall Study||347
1132542|NCT01323270|2741499|P1|COMPLETED|Overall Study||330
1132544|NCT01323270|2741499|P1|STARTED|Overall Study||373
1132548|NCT01323478|2741530|P1|NOT COMPLETED|Overall Study||24
1132549|NCT01323478|2741530|P1|COMPLETED|Overall Study||47
1132550|NCT01323478|2741530|P1|STARTED|Overall Study||71
1132551|NCT01323582|2741545|P2|NOT COMPLETED|Weeks 8-11 (Period 2)||1
1132552|NCT01323582|2741546|P1|NOT COMPLETED|Weeks 8-11 (Period 2)||0
1132553|NCT01323582|2741545|P2|COMPLETED|Weeks 8-11 (Period 2)||10
1132554|NCT01323582|2741546|P1|COMPLETED|Weeks 8-11 (Period 2)||10
1132555|NCT01323582|2741545|P2|STARTED|Weeks 8-11 (Period 2)||11
1132556|NCT01323582|2741546|P1|STARTED|Weeks 8-11 (Period 2)||10
1132557|NCT01323582|2741545|P2|NOT COMPLETED|Weeks 5-7 (Washout)||1
1132558|NCT01323582|2741546|P1|NOT COMPLETED|Weeks 5-7 (Washout)||0
1132559|NCT01323582|2741545|P2|COMPLETED|Weeks 5-7 (Washout)||11
1132560|NCT01323582|2741546|P1|COMPLETED|Weeks 5-7 (Washout)||10
1132561|NCT01323582|2741545|P2|STARTED|Weeks 5-7 (Washout)||12
1132562|NCT01323582|2741546|P1|STARTED|Weeks 5-7 (Washout)||10
1132563|NCT01323582|2741545|P2|NOT COMPLETED|Weeks 1-4 (First Period)||2
1132564|NCT01323582|2741546|P1|NOT COMPLETED|Weeks 1-4 (First Period)||2
1132565|NCT01323582|2741545|P2|COMPLETED|Weeks 1-4 (First Period)||12
1132566|NCT01323582|2741546|P1|COMPLETED|Weeks 1-4 (First Period)||10
1132567|NCT01323582|2741545|P2|STARTED|Weeks 1-4 (First Period)||14
1132568|NCT01323582|2741546|P1|STARTED|Weeks 1-4 (First Period)||12
1132569|NCT01323595|2741564|P2|NOT COMPLETED|Overall Study||21
1132570|NCT01323595|2741565|P1|NOT COMPLETED|Overall Study||23
1132571|NCT01323595|2741564|P2|COMPLETED|Overall Study|Remaining subjects did not return questionaire|18
1132572|NCT01323595|2741565|P1|COMPLETED|Overall Study|Remaining subjects did not return questionnaire|16
1132573|NCT01323595|2741564|P2|STARTED|Overall Study||39
1132574|NCT01323595|2741565|P1|STARTED|Overall Study||39
1132575|NCT01323621|2741573|P3|NOT COMPLETED|12-week, Double-blind Treatment Period||20
1132576|NCT01323621|2741574|P2|NOT COMPLETED|12-week, Double-blind Treatment Period||15
1132577|NCT01323621|2741575|P1|NOT COMPLETED|12-week, Double-blind Treatment Period||0
1132578|NCT01323621|2741573|P3|COMPLETED|12-week, Double-blind Treatment Period||239
1132579|NCT01323621|2741574|P2|COMPLETED|12-week, Double-blind Treatment Period||237
1132580|NCT01323621|2741575|P1|COMPLETED|12-week, Double-blind Treatment Period||0
1132581|NCT01323621|2741573|P3|STARTED|12-week, Double-blind Treatment Period||259
1132582|NCT01323621|2741574|P2|STARTED|12-week, Double-blind Treatment Period||252
1132583|NCT01323621|2741575|P1|STARTED|12-week, Double-blind Treatment Period||0
1132584|NCT01323621|2741573|P3|NOT COMPLETED|2-week, Single-blind Run In Period||0
1132585|NCT01323621|2741574|P2|NOT COMPLETED|2-week, Single-blind Run In Period||0
1132586|NCT01323621|2741575|P1|NOT COMPLETED|2-week, Single-blind Run In Period||228
1132587|NCT01323621|2741573|P3|COMPLETED|2-week, Single-blind Run In Period||0
1132588|NCT01323621|2741574|P2|COMPLETED|2-week, Single-blind Run In Period||0
1132589|NCT01323621|2741575|P1|COMPLETED|2-week, Single-blind Run In Period||511
1132590|NCT01323621|2741573|P3|STARTED|2-week, Single-blind Run In Period||0
1132591|NCT01323621|2741574|P2|STARTED|2-week, Single-blind Run In Period||0
1132592|NCT01323621|2741575|P1|STARTED|2-week, Single-blind Run In Period||739
1132593|NCT01323634|2741585|P3|NOT COMPLETED|Double-Blind (DB) Treatment Period||22
1132594|NCT01323634|2741586|P2|NOT COMPLETED|Double-Blind (DB) Treatment Period||25
1132595|NCT01323634|2741587|P1|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
1132596|NCT01323634|2741585|P3|COMPLETED|Double-Blind (DB) Treatment Period||239
1132597|NCT01323634|2741586|P2|COMPLETED|Double-Blind (DB) Treatment Period||235
1132598|NCT01323634|2741587|P1|COMPLETED|Double-Blind (DB) Treatment Period||0
1132599|NCT01323634|2741585|P3|STARTED|Double-Blind (DB) Treatment Period||261
1132600|NCT01323634|2741586|P2|STARTED|Double-Blind (DB) Treatment Period||260
1132601|NCT01323634|2741587|P1|STARTED|Double-Blind (DB) Treatment Period||0
1132602|NCT01323634|2741585|P3|NOT COMPLETED|2-week Run-in Period||0
1132603|NCT01323634|2741586|P2|NOT COMPLETED|2-week Run-in Period||0
1132604|NCT01323634|2741587|P1|NOT COMPLETED|2-week Run-in Period||212
1132605|NCT01323634|2741585|P3|COMPLETED|2-week Run-in Period||0
1132606|NCT01323634|2741586|P2|COMPLETED|2-week Run-in Period||0
1132607|NCT01323634|2741587|P1|COMPLETED|2-week Run-in Period||521
1132608|NCT01323634|2741585|P3|STARTED|2-week Run-in Period||0
1132609|NCT01323634|2741586|P2|STARTED|2-week Run-in Period||0
1132610|NCT01323634|2741587|P1|STARTED|2-week Run-in Period||733
1132611|NCT01323647|2741597|P2|NOT COMPLETED|Overall Study||0
1132612|NCT01323647|2741598|P1|NOT COMPLETED|Overall Study||9
1132613|NCT01323647|2741597|P2|COMPLETED|Overall Study||487
1132614|NCT01323647|2741598|P1|COMPLETED|Overall Study||461
1132615|NCT01323647|2741597|P2|STARTED|Overall Study||487
1132616|NCT01323647|2741598|P1|STARTED|Overall Study||470
1132617|NCT01323660|2741613|P6|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
1132618|NCT01323660|2741614|P5|NOT COMPLETED|Treatment Period 2 (12 Weeks)||4
1132619|NCT01323660|2741615|P4|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
1132620|NCT01323660|2741616|P3|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
1132621|NCT01323660|2741617|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
1132622|NCT01323660|2741618|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||12
1132623|NCT01323660|2741613|P6|COMPLETED|Treatment Period 2 (12 Weeks)||51
1132624|NCT01323660|2741614|P5|COMPLETED|Treatment Period 2 (12 Weeks)||55
1132625|NCT01323660|2741615|P4|COMPLETED|Treatment Period 2 (12 Weeks)||25
1132626|NCT01323660|2741616|P3|COMPLETED|Treatment Period 2 (12 Weeks)||14
1132627|NCT01323660|2741617|P2|COMPLETED|Treatment Period 2 (12 Weeks)||17
1132628|NCT01323660|2741618|P1|COMPLETED|Treatment Period 2 (12 Weeks)||55
1132629|NCT01323660|2741613|P6|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|58
1132630|NCT01323660|2741614|P5|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|59
1132631|NCT01323660|2741615|P4|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|28
1132632|NCT01323660|2741616|P3|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|17
1132633|NCT01323660|2741617|P2|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|18
1132634|NCT01323660|2741618|P1|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|67
1132635|NCT01323660|2741613|P6|NOT COMPLETED|Washout Period (14 Days)||2
1132636|NCT01323660|2741614|P5|NOT COMPLETED|Washout Period (14 Days)||3
1132637|NCT01323660|2741615|P4|NOT COMPLETED|Washout Period (14 Days)||3
1132638|NCT01323660|2741616|P3|NOT COMPLETED|Washout Period (14 Days)||1
1132639|NCT01323660|2741617|P2|NOT COMPLETED|Washout Period (14 Days)||0
1132640|NCT01323660|2741618|P1|NOT COMPLETED|Washout Period (14 Days)||0
1132641|NCT01323660|2741613|P6|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|59
1132642|NCT01323660|2741614|P5|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|58
1132643|NCT01323660|2741615|P4|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|28
1132644|NCT01323660|2741616|P3|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
1132645|NCT01323660|2741617|P2|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
1132646|NCT01323660|2741618|P1|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|65
1132647|NCT01323660|2741613|P6|STARTED|Washout Period (14 Days)||61
1132648|NCT01323660|2741614|P5|STARTED|Washout Period (14 Days)||61
1132649|NCT01323660|2741615|P4|STARTED|Washout Period (14 Days)||31
1132650|NCT01323660|2741616|P3|STARTED|Washout Period (14 Days)||19
1132651|NCT01323660|2741617|P2|STARTED|Washout Period (14 Days)||21
1132652|NCT01323660|2741618|P1|STARTED|Washout Period (14 Days)||65
1132653|NCT01323660|2741613|P6|NOT COMPLETED|Treatment Period 1 (12 Weeks)||9
1132654|NCT01323660|2741614|P5|NOT COMPLETED|Treatment Period 1 (12 Weeks)||10
1132655|NCT01323660|2741615|P4|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
1132656|NCT01323660|2741616|P3|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
1132657|NCT01323660|2741617|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||1
1132658|NCT01323660|2741618|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||19
1132659|NCT01323660|2741613|P6|COMPLETED|Treatment Period 1 (12 Weeks)||61
1132660|NCT01323660|2741614|P5|COMPLETED|Treatment Period 1 (12 Weeks)||61
1132661|NCT01323660|2741615|P4|COMPLETED|Treatment Period 1 (12 Weeks)||31
1132662|NCT01323660|2741616|P3|COMPLETED|Treatment Period 1 (12 Weeks)||19
1132663|NCT01323660|2741617|P2|COMPLETED|Treatment Period 1 (12 Weeks)||21
1132664|NCT01323660|2741618|P1|COMPLETED|Treatment Period 1 (12 Weeks)||65
1132665|NCT01323660|2741613|P6|STARTED|Treatment Period 1 (12 Weeks)||70
1132666|NCT01323660|2741614|P5|STARTED|Treatment Period 1 (12 Weeks)||71
1132667|NCT01323660|2741615|P4|STARTED|Treatment Period 1 (12 Weeks)||36
1132668|NCT01323660|2741616|P3|STARTED|Treatment Period 1 (12 Weeks)||24
1132669|NCT01323660|2741617|P2|STARTED|Treatment Period 1 (12 Weeks)||22
1132670|NCT01323660|2741618|P1|STARTED|Treatment Period 1 (12 Weeks)||84
1132671|NCT01323673|2741664|P2|NOT COMPLETED|Overall Study||5
1132672|NCT01323673|2741665|P1|NOT COMPLETED|Overall Study||3
1132673|NCT01323673|2741664|P2|COMPLETED|Overall Study||58
1132674|NCT01323673|2741665|P1|COMPLETED|Overall Study||59
1132675|NCT01323673|2741664|P2|STARTED|Overall Study||63
1132676|NCT01323673|2741665|P1|STARTED|Overall Study||62
1132677|NCT01323777|2741685|P1|NOT COMPLETED|Overall Study||0
1132678|NCT01323777|2741685|P1|COMPLETED|Overall Study||65
1132679|NCT01323777|2741685|P1|STARTED|Overall Study||65
1132680|NCT01323790|2741699|P3|NOT COMPLETED|Overall Study||45
1132681|NCT01323790|2741700|P2|NOT COMPLETED|Overall Study||60
1132682|NCT01323790|2741701|P1|NOT COMPLETED|Overall Study||55
1132683|NCT01323790|2741699|P3|COMPLETED|Overall Study||188
1132684|NCT01323790|2741700|P2|COMPLETED|Overall Study||174
1132685|NCT01323790|2741701|P1|COMPLETED|Overall Study||178
1132686|NCT01323790|2741699|P3|STARTED|Overall Study||233
1132687|NCT01323790|2741700|P2|STARTED|Overall Study||234
1132688|NCT01323790|2741701|P1|STARTED|Overall Study||233
1132689|NCT01323855|2741744|P5|NOT COMPLETED|Overall Study||0
1132690|NCT01323855|2741745|P4|NOT COMPLETED|Overall Study||0
1132691|NCT01323855|2741746|P3|NOT COMPLETED|Overall Study||0
1132692|NCT01323855|2741747|P2|NOT COMPLETED|Overall Study||0
1132693|NCT01323855|2741748|P1|NOT COMPLETED|Overall Study||0
1132694|NCT01323855|2741744|P5|COMPLETED|Overall Study||11
1132695|NCT01323855|2741745|P4|COMPLETED|Overall Study||9
1132696|NCT01323855|2741746|P3|COMPLETED|Overall Study||8
1132697|NCT01323855|2741747|P2|COMPLETED|Overall Study||9
1132698|NCT01323855|2741748|P1|COMPLETED|Overall Study||9
1132699|NCT01323855|2741744|P5|STARTED|Overall Study||11
1132700|NCT01323855|2741745|P4|STARTED|Overall Study||9
1132701|NCT01323855|2741746|P3|STARTED|Overall Study||8
1132702|NCT01323855|2741747|P2|STARTED|Overall Study||9
1132703|NCT01323855|2741748|P1|STARTED|Overall Study||9
1132704|NCT01323920|2741770|P1|NOT COMPLETED|Overall Study||6
1132705|NCT01323920|2741770|P1|COMPLETED|Overall Study||29
1132706|NCT01323920|2741770|P1|STARTED|Overall Study||35
1132707|NCT01323959|2741780|P3|NOT COMPLETED|Overall Study||0
1132708|NCT01323959|2741781|P2|NOT COMPLETED|Overall Study||0
1132709|NCT01323959|2741782|P1|NOT COMPLETED|Overall Study||0
1132710|NCT01323959|2741780|P3|COMPLETED|Overall Study||72
1132711|NCT01323959|2741781|P2|COMPLETED|Overall Study||72
1132712|NCT01323959|2741782|P1|COMPLETED|Overall Study||67
1132713|NCT01323959|2741780|P3|STARTED|Overall Study||72
1132714|NCT01323959|2741781|P2|STARTED|Overall Study||72
1132715|NCT01323959|2741782|P1|STARTED|Overall Study||67
1132716|NCT01323972|2741842|P4|NOT COMPLETED|Overall Study||1
1132717|NCT01323972|2741843|P3|NOT COMPLETED|Overall Study||2
1132718|NCT01323972|2741844|P2|NOT COMPLETED|Overall Study||3
1132719|NCT01323972|2741845|P1|NOT COMPLETED|Overall Study||2
1132720|NCT01323972|2741842|P4|COMPLETED|Overall Study||79
1132721|NCT01323972|2741843|P3|COMPLETED|Overall Study||78
1132722|NCT01323972|2741844|P2|COMPLETED|Overall Study||76
1132723|NCT01323972|2741845|P1|COMPLETED|Overall Study||79
1132724|NCT01323972|2741842|P4|STARTED|Overall Study||80
1132725|NCT01323972|2741843|P3|STARTED|Overall Study||80
1132726|NCT01323972|2741844|P2|STARTED|Overall Study||79
1132727|NCT01323972|2741845|P1|STARTED|Overall Study||81
1132728|NCT01323998|2741882|P5|NOT COMPLETED|Overall Study||0
1132729|NCT01323998|2741883|P4|NOT COMPLETED|Overall Study||0
1132730|NCT01323998|2741884|P3|NOT COMPLETED|Overall Study||0
1132731|NCT01323998|2741885|P2|NOT COMPLETED|Overall Study||0
1132732|NCT01323998|2741886|P1|NOT COMPLETED|Overall Study||0
1132733|NCT01323998|2741882|P5|COMPLETED|Overall Study||6735
1132734|NCT01323998|2741883|P4|COMPLETED|Overall Study||12052
1132735|NCT01323998|2741884|P3|COMPLETED|Overall Study||10294
1132736|NCT01323998|2741885|P2|COMPLETED|Overall Study||18681
1132737|NCT01323998|2741886|P1|COMPLETED|Overall Study||200631
1132738|NCT01323998|2741882|P5|STARTED|Overall Study||6735
1132739|NCT01323998|2741883|P4|STARTED|Overall Study||12052
1132740|NCT01323998|2741884|P3|STARTED|Overall Study||10294
1132741|NCT01323998|2741885|P2|STARTED|Overall Study||18681
1132742|NCT01323998|2741886|P1|STARTED|Overall Study||200631
1132743|NCT01324024|2741898|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
1132744|NCT01324024|2741899|P1|NOT COMPLETED|Second Intervention (4 Weeks)||2
1132745|NCT01324024|2741898|P2|COMPLETED|Second Intervention (4 Weeks)||16
1132746|NCT01324024|2741899|P1|COMPLETED|Second Intervention (4 Weeks)||16
1132747|NCT01324024|2741898|P2|STARTED|Second Intervention (4 Weeks)||17
1132748|NCT01324024|2741899|P1|STARTED|Second Intervention (4 Weeks)||18
1132749|NCT01324024|2741898|P2|NOT COMPLETED|Washout (2 Weeks)||0
1132750|NCT01324024|2741899|P1|NOT COMPLETED|Washout (2 Weeks)||0
1132751|NCT01324024|2741898|P2|COMPLETED|Washout (2 Weeks)||17
1132752|NCT01324024|2741899|P1|COMPLETED|Washout (2 Weeks)||18
1132753|NCT01324024|2741898|P2|STARTED|Washout (2 Weeks)||17
1132754|NCT01324024|2741899|P1|STARTED|Washout (2 Weeks)||18
1132755|NCT01324024|2741898|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
1132756|NCT01324024|2741899|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
1132757|NCT01324024|2741898|P2|COMPLETED|First Intervention (4 Weeks)||17
1132758|NCT01324024|2741899|P1|COMPLETED|First Intervention (4 Weeks)||18
1132759|NCT01324024|2741898|P2|STARTED|First Intervention (4 Weeks)||17
1132760|NCT01324024|2741899|P1|STARTED|First Intervention (4 Weeks)||18
1132761|NCT01324102|2741914|P2|NOT COMPLETED|Overall Study||6
1132762|NCT01324102|2741915|P1|NOT COMPLETED|Overall Study||1
1132763|NCT01324102|2741914|P2|COMPLETED|Overall Study||6
1132764|NCT01324102|2741915|P1|COMPLETED|Overall Study||10
1132765|NCT01324102|2741914|P2|STARTED|Overall Study|Yoga group 4 and 6|12
1132766|NCT01324102|2741915|P1|STARTED|Overall Study|Yoga groups 3 and 5 (not including pre-randomization group)|11
1132767|NCT01324128|2741924|P4|NOT COMPLETED|Stage 2||3
1132768|NCT01324128|2741925|P3|NOT COMPLETED|Stage 2||8
1132769|NCT01324128|2741926|P2|NOT COMPLETED|Stage 2||0
1132770|NCT01324128|2741927|P1|NOT COMPLETED|Stage 2||0
1132771|NCT01324128|2741924|P4|COMPLETED|Stage 2||46
1132772|NCT01324128|2741925|P3|COMPLETED|Stage 2||42
1132773|NCT01324128|2741926|P2|COMPLETED|Stage 2||0
1132774|NCT01324128|2741927|P1|COMPLETED|Stage 2||0
1132775|NCT01324128|2741924|P4|STARTED|Stage 2||49
1132776|NCT01324128|2741925|P3|STARTED|Stage 2||50
1132777|NCT01324128|2741926|P2|STARTED|Stage 2||0
1132778|NCT01324128|2741927|P1|STARTED|Stage 2||0
1132779|NCT01324128|2741924|P4|NOT COMPLETED|Stage 1||0
1132780|NCT01324128|2741925|P3|NOT COMPLETED|Stage 1||0
1132781|NCT01324128|2741926|P2|NOT COMPLETED|Stage 1||56
1132782|NCT01324128|2741927|P1|NOT COMPLETED|Stage 1||195
1132783|NCT01324128|2741924|P4|COMPLETED|Stage 1||0
1132784|NCT01324128|2741925|P3|COMPLETED|Stage 1||0
1132785|NCT01324128|2741926|P2|COMPLETED|Stage 1||293
1132786|NCT01324128|2741927|P1|COMPLETED|Stage 1||515
1132787|NCT01324128|2741924|P4|STARTED|Stage 1||0
1132788|NCT01324128|2741925|P3|STARTED|Stage 1||0
1132789|NCT01324128|2741926|P2|STARTED|Stage 1||349
1132790|NCT01324128|2741927|P1|STARTED|Stage 1||710
1132791|NCT01324271|2741937|P2|NOT COMPLETED|Overall Study||0
1132792|NCT01324271|2741938|P1|NOT COMPLETED|Overall Study||4
1132793|NCT01324271|2741937|P2|COMPLETED|Overall Study||28
1132794|NCT01324271|2741938|P1|COMPLETED|Overall Study||53
1132795|NCT01324271|2741937|P2|STARTED|Overall Study||28
1132796|NCT01324271|2741938|P1|STARTED|Overall Study||57
1132797|NCT01324310|2741944|P1|NOT COMPLETED|Overall Study||2
1132798|NCT01324310|2741944|P1|COMPLETED|Overall Study||13
1132799|NCT01324310|2741944|P1|STARTED|Overall Study||15
1132800|NCT01324323|2741964|P1|NOT COMPLETED|Overall Study||1
1132801|NCT01324323|2741964|P1|COMPLETED|Overall Study||13
1132802|NCT01324323|2741964|P1|STARTED|Overall Study||14
1132803|NCT01324349|2741986|P2|NOT COMPLETED|Overall Study||2
1132804|NCT01324349|2741987|P1|NOT COMPLETED|Overall Study||1
1132805|NCT01324349|2741986|P2|COMPLETED|Overall Study||16
1132806|NCT01324349|2741987|P1|COMPLETED|Overall Study||31
1132807|NCT01324349|2741986|P2|STARTED|Overall Study||18
1132808|NCT01324349|2741987|P1|STARTED|Overall Study||32
1132809|NCT01324388|2742000|P4|NOT COMPLETED|Part 2 of Study: Second Intervention||0
1132810|NCT01324388|2742001|P3|NOT COMPLETED|Part 2 of Study: Second Intervention||1
1132811|NCT01324388|2742002|P2|NOT COMPLETED|Part 2 of Study: Second Intervention||0
1132812|NCT01324388|2742003|P1|NOT COMPLETED|Part 2 of Study: Second Intervention||0
1132813|NCT01324388|2742000|P4|COMPLETED|Part 2 of Study: Second Intervention||9
1132814|NCT01324388|2742001|P3|COMPLETED|Part 2 of Study: Second Intervention||9
1132815|NCT01324388|2742002|P2|COMPLETED|Part 2 of Study: Second Intervention||0
1132816|NCT01324388|2742003|P1|COMPLETED|Part 2 of Study: Second Intervention||0
1132817|NCT01324388|2742000|P4|STARTED|Part 2 of Study: Second Intervention||9
1132818|NCT01324388|2742001|P3|STARTED|Part 2 of Study: Second Intervention||10
1132819|NCT01324388|2742002|P2|STARTED|Part 2 of Study: Second Intervention||0
1132820|NCT01324388|2742003|P1|STARTED|Part 2 of Study: Second Intervention||0
1132821|NCT01324388|2742000|P4|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
1132822|NCT01324388|2742001|P3|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
1132823|NCT01324388|2742002|P2|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
1132824|NCT01324388|2742003|P1|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
1132825|NCT01324388|2742000|P4|COMPLETED|Part 2: Washout of at Least 21 Days||9
1132826|NCT01324388|2742001|P3|COMPLETED|Part 2: Washout of at Least 21 Days||10
1132827|NCT01324388|2742002|P2|COMPLETED|Part 2: Washout of at Least 21 Days||0
1132828|NCT01324388|2742003|P1|COMPLETED|Part 2: Washout of at Least 21 Days||0
1132829|NCT01324388|2742000|P4|STARTED|Part 2: Washout of at Least 21 Days||9
1132830|NCT01324388|2742001|P3|STARTED|Part 2: Washout of at Least 21 Days||10
1132831|NCT01324388|2742002|P2|STARTED|Part 2: Washout of at Least 21 Days||0
1132832|NCT01324388|2742003|P1|STARTED|Part 2: Washout of at Least 21 Days||0
1132833|NCT01324388|2742000|P4|NOT COMPLETED|Part 2 of Study: First Intervention||1
1132834|NCT01324388|2742001|P3|NOT COMPLETED|Part 2 of Study: First Intervention||0
1132835|NCT01324388|2742002|P2|NOT COMPLETED|Part 2 of Study: First Intervention||0
1132836|NCT01324388|2742003|P1|NOT COMPLETED|Part 2 of Study: First Intervention||0
1132837|NCT01324388|2742000|P4|COMPLETED|Part 2 of Study: First Intervention||9
1132838|NCT01324388|2742001|P3|COMPLETED|Part 2 of Study: First Intervention||10
1132839|NCT01324388|2742002|P2|COMPLETED|Part 2 of Study: First Intervention||0
1132840|NCT01324388|2742003|P1|COMPLETED|Part 2 of Study: First Intervention||0
1132841|NCT01324388|2742000|P4|STARTED|Part 2 of Study: First Intervention||10
1132842|NCT01324388|2742001|P3|STARTED|Part 2 of Study: First Intervention||10
1132843|NCT01324388|2742002|P2|STARTED|Part 2 of Study: First Intervention||0
1132844|NCT01324388|2742003|P1|STARTED|Part 2 of Study: First Intervention||0
1132845|NCT01324388|2742000|P4|NOT COMPLETED|Part 1 of Study||0
1132846|NCT01324388|2742001|P3|NOT COMPLETED|Part 1 of Study||0
1132847|NCT01324388|2742002|P2|NOT COMPLETED|Part 1 of Study||2
1132848|NCT01324388|2742003|P1|NOT COMPLETED|Part 1 of Study||4
1132849|NCT01324388|2742000|P4|COMPLETED|Part 1 of Study||0
1132850|NCT01324388|2742001|P3|COMPLETED|Part 1 of Study||0
1132851|NCT01324388|2742002|P2|COMPLETED|Part 1 of Study||6
1132852|NCT01324388|2742003|P1|COMPLETED|Part 1 of Study||19
1132853|NCT01324388|2742000|P4|Received at Least 1 Dose|Part 1 of Study||0
1132854|NCT01324388|2742001|P3|Received at Least 1 Dose|Part 1 of Study||0
1132855|NCT01324388|2742002|P2|Received at Least 1 Dose|Part 1 of Study||8
1132856|NCT01324388|2742003|P1|Received at Least 1 Dose|Part 1 of Study||23
1132857|NCT01324388|2742000|P4|STARTED|Part 1 of Study||0
1132858|NCT01324388|2742001|P3|STARTED|Part 1 of Study||0
1132859|NCT01324388|2742002|P2|STARTED|Part 1 of Study||8
1132860|NCT01324388|2742003|P1|STARTED|Part 1 of Study||23
1132861|NCT01324401|2742024|P2|NOT COMPLETED|Overall Study||6
1132862|NCT01324401|2742025|P1|NOT COMPLETED|Overall Study||1
1132863|NCT01324401|2742024|P2|COMPLETED|Overall Study|three (3) unable to complete due to adverse events|20
1132864|NCT01324401|2742025|P1|COMPLETED|Overall Study|one (1) could not tolerate minimum starting dose|3
1132865|NCT01324401|2742024|P2|STARTED|Overall Study|3 excluded from ITT analysis: 1 screen fail, 2 voluntary withdrawal pre-treatment|26
1132866|NCT01324401|2742025|P1|STARTED|Overall Study||4
1132867|NCT01324440|2742035|P2|NOT COMPLETED|Overall Study||1
1132868|NCT01324440|2742036|P1|NOT COMPLETED|Overall Study||0
1132869|NCT01324440|2742035|P2|COMPLETED|Overall Study||31
1132870|NCT01324440|2742036|P1|COMPLETED|Overall Study||32
1132871|NCT01324440|2742035|P2|STARTED|Overall Study||32
1132872|NCT01324440|2742036|P1|STARTED|Overall Study||32
1132873|NCT01324570|2742050|P2|NOT COMPLETED|Overall Study||14
1132874|NCT01324570|2742051|P1|NOT COMPLETED|Overall Study||4
1132875|NCT01324570|2742050|P2|COMPLETED|Overall Study||21
1132876|NCT01324570|2742051|P1|COMPLETED|Overall Study||2
1132877|NCT01324570|2742050|P2|STARTED|Overall Study||35
1132878|NCT01324570|2742051|P1|STARTED|Overall Study||6
1132879|NCT01324622|2742065|P2|NOT COMPLETED|Overall Study||7
1132880|NCT01324622|2742066|P1|NOT COMPLETED|Overall Study||9
1132881|NCT01324622|2742065|P2|COMPLETED|Overall Study||4
1132882|NCT01324622|2742066|P1|COMPLETED|Overall Study||4
1132883|NCT01324622|2742065|P2|STARTED|Overall Study||11
1132884|NCT01324622|2742066|P1|STARTED|Overall Study||13
1132885|NCT01324687|2742096|P2|NOT COMPLETED|Overall Study||15
1132886|NCT01324687|2742097|P1|NOT COMPLETED|Overall Study||0
1132887|NCT01324687|2742096|P2|COMPLETED|Overall Study||479
1132888|NCT01324687|2742097|P1|COMPLETED|Overall Study||1058
1132889|NCT01324687|2742096|P2|STARTED|Overall Study||494
1132890|NCT01324687|2742097|P1|STARTED|Overall Study||1058
1132891|NCT01324882|2742107|P2|NOT COMPLETED|Overall Study||0
1132892|NCT01324882|2742108|P1|NOT COMPLETED|Overall Study||0
1132893|NCT01324882|2742107|P2|COMPLETED|Overall Study|30 patients had the colonoscopy|30
1132894|NCT01324882|2742108|P1|COMPLETED|Overall Study|27 patients had the colonoscopy|27
1132895|NCT01324882|2742107|P2|STARTED|Overall Study|30 patients were randomized to this arm|30
1132896|NCT01324882|2742108|P1|STARTED|Overall Study|27 patients were randomized to this arm.|27
1132897|NCT01324947|2742114|P1|NOT COMPLETED|Overall Study||74
1132898|NCT01324947|2742114|P1|COMPLETED|Overall Study||0
1132899|NCT01324947|2742114|P1|Efficacy Evaluable Population (EEP)|Overall Study|Participants who received ≥ 1 dose of study drug and had at least 1 postbaseline efficacy assessment|64
1132900|NCT01324947|2742114|P1|Safety Population|Overall Study|Safety Population includes those who were enrolled and received at least one dose of study drug|73
1132901|NCT01324947|2742114|P1|STARTED|Overall Study||74
1132902|NCT01324999|2742125|P1|NOT COMPLETED|Overall Study||5
1132903|NCT01324999|2742125|P1|COMPLETED|Overall Study||7
1132904|NCT01324999|2742125|P1|STARTED|Overall Study||12
1132905|NCT01316575|2742138|P2|NOT COMPLETED|Overall Study||1
1132906|NCT01316575|2742139|P1|NOT COMPLETED|Overall Study||2
1132907|NCT01316575|2742138|P2|COMPLETED|Overall Study||19
1132908|NCT01316575|2742139|P1|COMPLETED|Overall Study||18
1132909|NCT01316575|2742138|P2|STARTED|Overall Study||20
1132910|NCT01316575|2742139|P1|STARTED|Overall Study||20
1132911|NCT01316614|2742151|P1|NOT COMPLETED|Overall Study||37
1132912|NCT01316614|2742151|P1|COMPLETED|Overall Study||100
1132913|NCT01316614|2742151|P1|STARTED|Overall Study||137
1132914|NCT01316692|2742166|P1|NOT COMPLETED|Overall Study||12
1132915|NCT01316692|2742166|P1|COMPLETED|Overall Study||0
1132916|NCT01316692|2742166|P1|STARTED|Overall Study||12
1132917|NCT01316887|2742178|P3|NOT COMPLETED|Overall Study||83
1132918|NCT01316887|2742179|P2|NOT COMPLETED|Overall Study||94
1132919|NCT01316887|2742180|P1|NOT COMPLETED|Overall Study||43
1132920|NCT01316887|2742178|P3|COMPLETED|Overall Study||143
1132921|NCT01316887|2742179|P2|COMPLETED|Overall Study||133
1132922|NCT01316887|2742180|P1|COMPLETED|Overall Study||66
1132923|NCT01316887|2742178|P3|STARTED|Overall Study||226
1132924|NCT01316887|2742179|P2|STARTED|Overall Study||227
1132925|NCT01316887|2742180|P1|STARTED|Overall Study||109
1132926|NCT01316900|2742246|P4|NOT COMPLETED|Overall Study||31
1132927|NCT01316900|2742247|P3|NOT COMPLETED|Overall Study||41
1132928|NCT01316900|2742248|P2|NOT COMPLETED|Overall Study||31
1132929|NCT01316900|2742249|P1|NOT COMPLETED|Overall Study||44
1132930|NCT01316900|2742246|P4|COMPLETED|Overall Study||177
1132931|NCT01316900|2742247|P3|COMPLETED|Overall Study||173
1132932|NCT01316900|2742248|P2|COMPLETED|Overall Study||181
1132933|NCT01316900|2742249|P1|COMPLETED|Overall Study||165
1132934|NCT01316900|2742246|P4|STARTED|Overall Study||208
1132935|NCT01316900|2742247|P3|STARTED|Overall Study||214
1132936|NCT01316900|2742248|P2|STARTED|Overall Study||212
1132937|NCT01316900|2742249|P1|STARTED|Overall Study||209
1132938|NCT01316913|2742271|P4|NOT COMPLETED|Overall Study||39
1132939|NCT01316913|2742272|P3|NOT COMPLETED|Overall Study||49
1132940|NCT01316913|2742273|P2|NOT COMPLETED|Overall Study||54
1132941|NCT01316913|2742274|P1|NOT COMPLETED|Overall Study||57
1132942|NCT01316913|2742271|P4|COMPLETED|Overall Study||176
1132943|NCT01316913|2742272|P3|COMPLETED|Overall Study||166
1132944|NCT01316913|2742273|P2|COMPLETED|Overall Study||163
1132945|NCT01316913|2742274|P1|COMPLETED|Overall Study||165
1132946|NCT01316913|2742271|P4|STARTED|Overall Study||215
1132947|NCT01316913|2742272|P3|STARTED|Overall Study||215
1132948|NCT01316913|2742273|P2|STARTED|Overall Study||217
1132949|NCT01316913|2742274|P1|STARTED|Overall Study||222
1132950|NCT01316926|2742292|P2|NOT COMPLETED|Period 2||0
1132951|NCT01316926|2742293|P1|NOT COMPLETED|Period 2||0
1132952|NCT01316926|2742292|P2|COMPLETED|Period 2||30
1132953|NCT01316926|2742293|P1|COMPLETED|Period 2||29
1132954|NCT01316926|2742292|P2|STARTED|Period 2||30
1132955|NCT01316926|2742293|P1|STARTED|Period 2|One participant completed Period 1, but did not appear in Period 2|29
1132956|NCT01316926|2742292|P2|NOT COMPLETED|Period 1||0
1132957|NCT01316926|2742293|P1|NOT COMPLETED|Period 1||0
1132958|NCT01316926|2742292|P2|COMPLETED|Period 1||30
1132959|NCT01316926|2742293|P1|COMPLETED|Period 1||30
1132960|NCT01316926|2742292|P2|STARTED|Period 1||30
1132961|NCT01316926|2742293|P1|STARTED|Period 1||30
1132962|NCT01316939|2742306|P3|NOT COMPLETED|Overall Study||69
1132963|NCT01316939|2742307|P2|NOT COMPLETED|Overall Study||68
1132964|NCT01316939|2742308|P1|NOT COMPLETED|Overall Study||63
1132965|NCT01316939|2742306|P3|COMPLETED|Overall Study||7
1132966|NCT01316939|2742307|P2|COMPLETED|Overall Study||9
1132967|NCT01316939|2742308|P1|COMPLETED|Overall Study||13
1132968|NCT01316939|2742306|P3|STARTED|Overall Study||76
1132969|NCT01316939|2742307|P2|STARTED|Overall Study||77
1132970|NCT01316939|2742308|P1|STARTED|Overall Study||76
1132971|NCT01317004|2742390|P2|NOT COMPLETED|Overall Study||9
1132972|NCT01317004|2742391|P1|NOT COMPLETED|Overall Study||4
1132973|NCT01317004|2742390|P2|COMPLETED|Overall Study||5
1132974|NCT01317004|2742391|P1|COMPLETED|Overall Study||47
1132975|NCT01317004|2742390|P2|Safety Set|Overall Study||11
1132976|NCT01317004|2742391|P1|Safety Set|Overall Study||50
1132977|NCT01317004|2742390|P2|STARTED|Overall Study||14
1132978|NCT01317004|2742391|P1|STARTED|Overall Study||51
1132979|NCT01317160|2742411|P2|NOT COMPLETED|Overall Study||6
1132980|NCT01317160|2742412|P1|NOT COMPLETED|Overall Study||4
1132981|NCT01317160|2742411|P2|COMPLETED|Overall Study||69
1132982|NCT01317160|2742412|P1|COMPLETED|Overall Study||71
1132983|NCT01317160|2742411|P2|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
1132984|NCT01317160|2742412|P1|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
1132985|NCT01317160|2742411|P2|STARTED|Overall Study||75
1132986|NCT01317160|2742412|P1|STARTED|Overall Study||75
1132987|NCT01317615|2742420|P1|NOT COMPLETED|Overall Study||49
1132988|NCT01317615|2742420|P1|COMPLETED|Overall Study||0
1132989|NCT01317615|2742420|P1|STARTED|Overall Study||49
1132990|NCT01317641|2742438|P9|NOT COMPLETED|Overall Study||5
1132991|NCT01317641|2742439|P8|NOT COMPLETED|Overall Study||5
1132992|NCT01317641|2742440|P7|NOT COMPLETED|Overall Study||3
1132993|NCT01317641|2742441|P6|NOT COMPLETED|Overall Study||0
1132994|NCT01317641|2742442|P5|NOT COMPLETED|Overall Study||0
1132995|NCT01317641|2742443|P4|NOT COMPLETED|Overall Study||1
1132996|NCT01317641|2742444|P3|NOT COMPLETED|Overall Study||0
1132997|NCT01317641|2742445|P2|NOT COMPLETED|Overall Study||1
1132998|NCT01317641|2742446|P1|NOT COMPLETED|Overall Study||1
1132999|NCT01317641|2742438|P9|COMPLETED|Overall Study||31
1133000|NCT01317641|2742439|P8|COMPLETED|Overall Study||33
1133001|NCT01317641|2742440|P7|COMPLETED|Overall Study||35
1133002|NCT01317641|2742441|P6|COMPLETED|Overall Study||3
1133003|NCT01317641|2742442|P5|COMPLETED|Overall Study||3
1133004|NCT01317641|2742443|P4|COMPLETED|Overall Study||3
1133005|NCT01317641|2742444|P3|COMPLETED|Overall Study||3
1133006|NCT01317641|2742445|P2|COMPLETED|Overall Study||6
1133007|NCT01317641|2742446|P1|COMPLETED|Overall Study||3
1133008|NCT01317641|2742438|P9|STARTED|Overall Study||36
1133009|NCT01317641|2742439|P8|STARTED|Overall Study||38
1133010|NCT01317641|2742440|P7|STARTED|Overall Study||38
1133011|NCT01317641|2742441|P6|STARTED|Overall Study||3
1133012|NCT01317641|2742442|P5|STARTED|Overall Study||3
1133013|NCT01317641|2742443|P4|STARTED|Overall Study||4
1133014|NCT01317641|2742444|P3|STARTED|Overall Study||3
1133015|NCT01317641|2742445|P2|STARTED|Overall Study||7
1133016|NCT01317641|2742446|P1|STARTED|Overall Study||4
1133017|NCT01317667|2742551|P3|NOT COMPLETED|Overall Study||0
1133018|NCT01317667|2742552|P2|NOT COMPLETED|Overall Study||0
1133019|NCT01317667|2742553|P1|NOT COMPLETED|Overall Study||0
1133020|NCT01317667|2742551|P3|COMPLETED|Overall Study|The original trial design was modified to limit the number of vaccinations in Group 3 to 1 dose.|10
1133021|NCT01317667|2742552|P2|COMPLETED|Overall Study||10
1133022|NCT01317667|2742553|P1|COMPLETED|Overall Study||10
1133023|NCT01317667|2742551|P3|STARTED|Overall Study||10
1133024|NCT01317667|2742552|P2|STARTED|Overall Study||10
1133025|NCT01317667|2742553|P1|STARTED|Overall Study||10
1133026|NCT01317797|2742567|P3|NOT COMPLETED|Overall Study||1
1133027|NCT01317797|2742568|P2|NOT COMPLETED|Overall Study||1
1133028|NCT01317797|2742569|P1|NOT COMPLETED|Overall Study||0
1133029|NCT01317797|2742567|P3|COMPLETED|Overall Study||8
1133030|NCT01317797|2742568|P2|COMPLETED|Overall Study||6
1133031|NCT01317797|2742569|P1|COMPLETED|Overall Study||8
1133032|NCT01317797|2742567|P3|STARTED|Overall Study||9
1133033|NCT01317797|2742568|P2|STARTED|Overall Study||7
1133034|NCT01317797|2742569|P1|STARTED|Overall Study||8
1133035|NCT01317901|2742623|P2|NOT COMPLETED|Overall Study||0
1133036|NCT01317901|2742624|P1|NOT COMPLETED|Overall Study||0
1133037|NCT01317901|2742623|P2|COMPLETED|Overall Study||6
1133038|NCT01317901|2742624|P1|COMPLETED|Overall Study||6
1133039|NCT01317901|2742623|P2|STARTED|Overall Study||6
1133040|NCT01317901|2742624|P1|STARTED|Overall Study||6
1133041|NCT01318070|2742633|P3|NOT COMPLETED|Overall Study||7
1133042|NCT01318070|2742634|P2|NOT COMPLETED|Overall Study||2
1133043|NCT01318070|2742635|P1|NOT COMPLETED|Overall Study||2
1133044|NCT01318070|2742633|P3|COMPLETED|Overall Study||108
1133045|NCT01318070|2742634|P2|COMPLETED|Overall Study||111
1133046|NCT01318070|2742635|P1|COMPLETED|Overall Study||109
1133047|NCT01318070|2742633|P3|STARTED|Overall Study||115
1133048|NCT01318070|2742634|P2|STARTED|Overall Study||113
1133049|NCT01318070|2742635|P1|STARTED|Overall Study||111
1133050|NCT01318083|2742670|P3|NOT COMPLETED|Overall Study||5
1133051|NCT01318083|2742671|P2|NOT COMPLETED|Overall Study||2
1133052|NCT01318083|2742672|P1|NOT COMPLETED|Overall Study||6
1133053|NCT01318083|2742670|P3|COMPLETED|Overall Study||98
1133054|NCT01318083|2742671|P2|COMPLETED|Overall Study||102
1133055|NCT01318083|2742672|P1|COMPLETED|Overall Study||99
1133056|NCT01318083|2742670|P3|STARTED|Overall Study||103
1133057|NCT01318083|2742671|P2|STARTED|Overall Study||104
1133058|NCT01318083|2742672|P1|STARTED|Overall Study||105
1133059|NCT01318109|2742707|P3|NOT COMPLETED|Overall Study||0
1133060|NCT01318109|2742708|P2|NOT COMPLETED|Overall Study||3
1133061|NCT01318109|2742709|P1|NOT COMPLETED|Overall Study||1
1133062|NCT01318109|2742707|P3|COMPLETED|Overall Study||100
1133063|NCT01318109|2742708|P2|COMPLETED|Overall Study||93
1133064|NCT01318109|2742709|P1|COMPLETED|Overall Study||91
1133065|NCT01318109|2742707|P3|STARTED|Overall Study||100
1133066|NCT01318109|2742708|P2|STARTED|Overall Study||96
1133067|NCT01318109|2742709|P1|STARTED|Overall Study||92
1133068|NCT01318122|2742743|P4|NOT COMPLETED|Entered - Long-Term Extension Study||4
1133069|NCT01318122|2742744|P3|NOT COMPLETED|Entered - Long-Term Extension Study||6
1133070|NCT01318122|2742745|P2|NOT COMPLETED|Entered - Long-Term Extension Study||11
1133071|NCT01318122|2742746|P1|NOT COMPLETED|Entered - Long-Term Extension Study||9
1133072|NCT01318122|2742743|P4|COMPLETED|Entered - Long-Term Extension Study||48
1133073|NCT01318122|2742744|P3|COMPLETED|Entered - Long-Term Extension Study||49
1133074|NCT01318122|2742745|P2|COMPLETED|Entered - Long-Term Extension Study||99
1133075|NCT01318122|2742746|P1|COMPLETED|Entered - Long-Term Extension Study||96
1133076|NCT01318122|2742743|P4|STARTED|Entered - Long-Term Extension Study||52
1133077|NCT01318122|2742744|P3|STARTED|Entered - Long-Term Extension Study||55
1133078|NCT01318122|2742745|P2|STARTED|Entered - Long-Term Extension Study||110
1133079|NCT01318122|2742746|P1|STARTED|Entered - Long-Term Extension Study||105
1133080|NCT01318122|2742743|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
1133081|NCT01318122|2742744|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
1133082|NCT01318122|2742745|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1133083|NCT01318122|2742746|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
1133084|NCT01318122|2742743|P4|COMPLETED|Enrolled - Long-Term Extension Study||52
1133085|NCT01318122|2742744|P3|COMPLETED|Enrolled - Long-Term Extension Study||55
1133086|NCT01318122|2742745|P2|COMPLETED|Enrolled - Long-Term Extension Study||110
1133087|NCT01318122|2742746|P1|COMPLETED|Enrolled - Long-Term Extension Study||105
1133088|NCT01318122|2742743|P4|STARTED|Enrolled - Long-Term Extension Study||53
1133089|NCT01318122|2742744|P3|STARTED|Enrolled - Long-Term Extension Study||57
1133090|NCT01318122|2742745|P2|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|110
1133091|NCT01318122|2742746|P1|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|106
1133092|NCT01318135|2742816|P8|NOT COMPLETED|Entered - Long-Term Extension Study||3
1133093|NCT01318135|2742817|P7|NOT COMPLETED|Entered - Long-Term Extension Study||1
1133094|NCT01318135|2742818|P6|NOT COMPLETED|Entered - Long-Term Extension Study||4
1133095|NCT01318135|2742819|P5|NOT COMPLETED|Entered - Long-Term Extension Study||9
1133096|NCT01318135|2742820|P4|NOT COMPLETED|Entered - Long-Term Extension Study||7
1133097|NCT01318135|2742821|P3|NOT COMPLETED|Entered - Long-Term Extension Study||8
1133098|NCT01318135|2742822|P2|NOT COMPLETED|Entered - Long-Term Extension Study||13
1133099|NCT01318135|2742823|P1|NOT COMPLETED|Entered - Long-Term Extension Study||17
1133100|NCT01318135|2742816|P8|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|46
1133101|NCT01318135|2742817|P7|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|49
1133102|NCT01318135|2742818|P6|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|83
1133103|NCT01318135|2742819|P5|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|81
1133104|NCT01318135|2742820|P4|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|42
1133105|NCT01318135|2742821|P3|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|38
1133106|NCT01318135|2742822|P2|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|89
1133107|NCT01318135|2742823|P1|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|80
1133108|NCT01318135|2742816|P8|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|49
1133109|NCT01318135|2742817|P7|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|50
1133110|NCT01318135|2742818|P6|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|87
1133111|NCT01318135|2742819|P5|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|90
1133112|NCT01318135|2742820|P4|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|49
1133113|NCT01318135|2742821|P3|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|46
1133114|NCT01318135|2742822|P2|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|102
1133115|NCT01318135|2742823|P1|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|97
1133116|NCT01318135|2742816|P8|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1133117|NCT01318135|2742817|P7|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1133118|NCT01318135|2742818|P6|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1133119|NCT01318135|2742819|P5|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1133120|NCT01318135|2742820|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1133121|NCT01318135|2742821|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1133122|NCT01318135|2742822|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
1133123|NCT01318135|2742823|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
1133124|NCT01318135|2742816|P8|COMPLETED|Enrolled - Long-Term Extension Study||49
1133125|NCT01318135|2742817|P7|COMPLETED|Enrolled - Long-Term Extension Study||50
1133126|NCT01318135|2742818|P6|COMPLETED|Enrolled - Long-Term Extension Study||90
1133127|NCT01318135|2742819|P5|COMPLETED|Enrolled - Long-Term Extension Study||91
1133128|NCT01318135|2742820|P4|COMPLETED|Enrolled - Long-Term Extension Study||49
1133129|NCT01318135|2742821|P3|COMPLETED|Enrolled - Long-Term Extension Study||46
1133130|NCT01318135|2742822|P2|COMPLETED|Enrolled - Long-Term Extension Study||102
1133131|NCT01318135|2742823|P1|COMPLETED|Enrolled - Long-Term Extension Study||97
1133132|NCT01318135|2742816|P8|STARTED|Enrolled - Long-Term Extension Study||49
1133133|NCT01318135|2742817|P7|STARTED|Enrolled - Long-Term Extension Study||50
1133134|NCT01318135|2742818|P6|STARTED|Enrolled - Long-Term Extension Study||90
1133135|NCT01318135|2742819|P5|STARTED|Enrolled - Long-Term Extension Study||91
1133136|NCT01318135|2742820|P4|STARTED|Enrolled - Long-Term Extension Study||49
1133137|NCT01318135|2742821|P3|STARTED|Enrolled - Long-Term Extension Study||46
1133138|NCT01318135|2742822|P2|STARTED|Enrolled - Long-Term Extension Study||102
1133139|NCT01318135|2742823|P1|STARTED|Enrolled - Long-Term Extension Study||99
1133140|NCT01318278|2742956|P3|NOT COMPLETED|Overall Study||0
1133141|NCT01318278|2742957|P2|NOT COMPLETED|Overall Study||0
1133142|NCT01318278|2742958|P1|NOT COMPLETED|Overall Study||0
1133143|NCT01318278|2742956|P3|COMPLETED|Overall Study||50
1133144|NCT01318278|2742957|P2|COMPLETED|Overall Study||10
1133145|NCT01318278|2742958|P1|COMPLETED|Overall Study||10
1133146|NCT01318278|2742956|P3|STARTED|Overall Study||50
1133147|NCT01318278|2742957|P2|STARTED|Overall Study||10
1133148|NCT01318278|2742958|P1|STARTED|Overall Study||10
1133149|NCT01318382|2743000|P1|NOT COMPLETED|Overall Study||13
1133150|NCT01318382|2743000|P1|COMPLETED|Overall Study||289
1133151|NCT01318382|2743000|P1|STARTED|Overall Study||302
1133152|NCT01318408|2743007|P1|NOT COMPLETED|Overall Study||8
1133153|NCT01318408|2743007|P1|COMPLETED|Overall Study||16
1133154|NCT01318408|2743007|P1|STARTED|Overall Study||24
1133155|NCT01325181|2743014|P2|NOT COMPLETED|Overall Study||2
1133156|NCT01325181|2743015|P1|NOT COMPLETED|Overall Study||0
1133157|NCT01325181|2743014|P2|COMPLETED|Overall Study||14
1133158|NCT01325181|2743015|P1|COMPLETED|Overall Study||18
1133159|NCT01325181|2743014|P2|STARTED|Overall Study||16
1133160|NCT01325181|2743015|P1|STARTED|Overall Study||18
1133161|NCT01325311|2743023|P2|NOT COMPLETED|Overall Study||0
1133162|NCT01325311|2743024|P1|NOT COMPLETED|Overall Study||0
1133163|NCT01325311|2743023|P2|COMPLETED|Overall Study||7
1133164|NCT01325311|2743024|P1|COMPLETED|Overall Study||8
1133165|NCT01325311|2743023|P2|STARTED|Overall Study||7
1133166|NCT01325311|2743024|P1|STARTED|Overall Study||8
1133167|NCT01325337|2743063|P5|NOT COMPLETED|Overall Study||8
1133168|NCT01325337|2743064|P4|NOT COMPLETED|Overall Study||10
1133169|NCT01325337|2743065|P3|NOT COMPLETED|Overall Study||9
1133170|NCT01325337|2743066|P2|NOT COMPLETED|Overall Study||9
1133171|NCT01325337|2743067|P1|NOT COMPLETED|Overall Study||5
1133172|NCT01325337|2743063|P5|COMPLETED|Overall Study||53
1133173|NCT01325337|2743064|P4|COMPLETED|Overall Study||52
1133174|NCT01325337|2743065|P3|COMPLETED|Overall Study||53
1133175|NCT01325337|2743066|P2|COMPLETED|Overall Study||52
1133176|NCT01325337|2743067|P1|COMPLETED|Overall Study||56
1133177|NCT01325337|2743063|P5|STARTED|Overall Study||61
1133178|NCT01325337|2743064|P4|STARTED|Overall Study||62
1133179|NCT01325337|2743065|P3|STARTED|Overall Study||62
1133180|NCT01325337|2743066|P2|STARTED|Overall Study||61
1133181|NCT01325337|2743067|P1|STARTED|Overall Study||61
1133182|NCT01325350|2743109|P5|NOT COMPLETED|Overall Study||12
1133183|NCT01325350|2743110|P4|NOT COMPLETED|Overall Study||9
1133184|NCT01325350|2743111|P3|NOT COMPLETED|Overall Study||17
1133185|NCT01325350|2743112|P2|NOT COMPLETED|Overall Study||5
1133186|NCT01325350|2743113|P1|NOT COMPLETED|Overall Study||6
1133187|NCT01325350|2743109|P5|COMPLETED|Overall Study||50
1133188|NCT01325350|2743110|P4|COMPLETED|Overall Study||52
1133189|NCT01325350|2743111|P3|COMPLETED|Overall Study||44
1133190|NCT01325350|2743112|P2|COMPLETED|Overall Study||56
1133191|NCT01325350|2743113|P1|COMPLETED|Overall Study||55
1133192|NCT01325350|2743109|P5|STARTED|Overall Study||62
1133193|NCT01325350|2743110|P4|STARTED|Overall Study||61
1133194|NCT01325350|2743111|P3|STARTED|Overall Study||61
1133195|NCT01325350|2743112|P2|STARTED|Overall Study||61
1133196|NCT01325350|2743113|P1|STARTED|Overall Study||61
1133197|NCT01325714|2743152|P2|NOT COMPLETED|Overall Study||31
1133198|NCT01325714|2743153|P1|NOT COMPLETED|Overall Study||34
1133199|NCT01325714|2743152|P2|COMPLETED|Overall Study||71
1133200|NCT01325714|2743153|P1|COMPLETED|Overall Study||67
1133201|NCT01325714|2743152|P2|12 Month Assessment|Overall Study||71
1133202|NCT01325714|2743153|P1|12 Month Assessment|Overall Study||67
1133203|NCT01325714|2743152|P2|6 Month Asessment|Overall Study||82
1133204|NCT01325714|2743153|P1|6 Month Asessment|Overall Study||75
1133205|NCT01325714|2743152|P2|3 Month Assessment|Overall Study||86
1133206|NCT01325714|2743153|P1|3 Month Assessment|Overall Study||82
1133207|NCT01325714|2743152|P2|STARTED|Overall Study||102
1133208|NCT01325714|2743153|P1|STARTED|Overall Study||101
1133209|NCT01325792|2743175|P1|NOT COMPLETED|Overall Study||17
1133210|NCT01325792|2743175|P1|COMPLETED|Overall Study||87
1133211|NCT01325792|2743175|P1|STARTED|Overall Study||104
1133212|NCT01325870|2743183|P3|NOT COMPLETED|Overall Study||8
1133213|NCT01325870|2743184|P2|NOT COMPLETED|Overall Study||13
1133214|NCT01325870|2743185|P1|NOT COMPLETED|Overall Study||11
1133215|NCT01325870|2743183|P3|COMPLETED|Overall Study||6
1133216|NCT01325870|2743184|P2|COMPLETED|Overall Study||3
1133217|NCT01325870|2743185|P1|COMPLETED|Overall Study||7
1133218|NCT01325870|2743183|P3|STARTED|Overall Study||14
1133219|NCT01325870|2743184|P2|STARTED|Overall Study||16
1133220|NCT01325870|2743185|P1|STARTED|Overall Study||18
1133221|NCT01326026|2743201|P2|NOT COMPLETED|Overall Study||13
1133222|NCT01326026|2743202|P1|NOT COMPLETED|Overall Study||12
1133223|NCT01326026|2743201|P2|COMPLETED|Overall Study||98
1133224|NCT01326026|2743202|P1|COMPLETED|Overall Study||99
1133225|NCT01326026|2743201|P2|Exposed|Overall Study||111
1133226|NCT01326026|2743202|P1|Exposed|Overall Study|One subject withdrew before exposure to trial drug|110
1133227|NCT01326026|2743201|P2|STARTED|Overall Study||111
1133228|NCT01326026|2743202|P1|STARTED|Overall Study||111
1133229|NCT01326533|2743218|P2|NOT COMPLETED|Overall Study||0
1133230|NCT01326533|2743219|P1|NOT COMPLETED|Overall Study||4
1133231|NCT01326533|2743218|P2|COMPLETED|Overall Study||15
1133232|NCT01326533|2743219|P1|COMPLETED|Overall Study||13
1133233|NCT01326533|2743218|P2|STARTED|Overall Study||15
1133234|NCT01326533|2743219|P1|STARTED|Overall Study||17
1133235|NCT01326845|2743229|P2|NOT COMPLETED|Overall Study||5
1133236|NCT01326845|2743230|P1|NOT COMPLETED|Overall Study||7
1133237|NCT01326845|2743229|P2|COMPLETED|Overall Study|Study terminated early|0
1133238|NCT01326845|2743230|P1|COMPLETED|Overall Study|Study terminated early|0
1133239|NCT01326845|2743229|P2|STARTED|Overall Study||5
1133240|NCT01326845|2743230|P1|STARTED|Overall Study||7
1133241|NCT01326910|2743254|P2|NOT COMPLETED|Overall Study||3
1133242|NCT01326910|2743255|P1|NOT COMPLETED|Overall Study||4
1133243|NCT01326910|2743254|P2|COMPLETED|Overall Study||42
1133244|NCT01326910|2743255|P1|COMPLETED|Overall Study||41
1133245|NCT01326910|2743254|P2|STARTED|Overall Study||45
1133246|NCT01326910|2743255|P1|STARTED|Overall Study||45
1133247|NCT01326962|2743267|P1|NOT COMPLETED|Overall Study||7
1133248|NCT01326962|2743267|P1|COMPLETED|Overall Study||21
1133249|NCT01326962|2743267|P1|STARTED|Overall Study||28
1133250|NCT01327053|2743285|P2|NOT COMPLETED|Overall Study||105
1133251|NCT01327053|2743286|P1|NOT COMPLETED|Overall Study||40
1133252|NCT01327053|2743285|P2|COMPLETED|Overall Study|Completed = patients ongoing at time of cut-off date (28-Jun-2013)|46
1133253|NCT01327053|2743286|P1|COMPLETED|Overall Study|Completed = patients ongoing at time of cut-off date (28-Jun-2013)|39
1133254|NCT01327053|2743285|P2|STARTED|Overall Study||151
1133255|NCT01327053|2743286|P1|STARTED|Overall Study||79
1133256|NCT01327300|2743314|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
1133257|NCT01327300|2743315|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
1133258|NCT01327300|2743314|P2|COMPLETED|Second Intervention (12 Weeks)||2
1133259|NCT01327300|2743315|P1|COMPLETED|Second Intervention (12 Weeks)||4
1133260|NCT01327300|2743314|P2|STARTED|Second Intervention (12 Weeks)||2
1133261|NCT01327300|2743315|P1|STARTED|Second Intervention (12 Weeks)||4
1133262|NCT01327300|2743314|P2|NOT COMPLETED|Washout (3 Weeks)||0
1133263|NCT01327300|2743315|P1|NOT COMPLETED|Washout (3 Weeks)||1
1133264|NCT01327300|2743314|P2|COMPLETED|Washout (3 Weeks)||2
1133265|NCT01327300|2743315|P1|COMPLETED|Washout (3 Weeks)||4
1133266|NCT01327300|2743314|P2|STARTED|Washout (3 Weeks)||2
1133267|NCT01327300|2743315|P1|STARTED|Washout (3 Weeks)||5
1133268|NCT01327300|2743314|P2|NOT COMPLETED|First Intervention (12 Weeks)||0
1133269|NCT01327300|2743315|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
1133270|NCT01327300|2743314|P2|COMPLETED|First Intervention (12 Weeks)||2
1133271|NCT01327300|2743315|P1|COMPLETED|First Intervention (12 Weeks)||5
1133272|NCT01327300|2743314|P2|STARTED|First Intervention (12 Weeks)||2
1133273|NCT01327300|2743315|P1|STARTED|First Intervention (12 Weeks)||5
1133274|NCT01327313|2743335|P4|NOT COMPLETED|Overall Study||0
1133275|NCT01327313|2743336|P3|NOT COMPLETED|Overall Study||0
1133276|NCT01327313|2743337|P2|NOT COMPLETED|Overall Study||0
1133277|NCT01327313|2743338|P1|NOT COMPLETED|Overall Study||0
1133278|NCT01327313|2743335|P4|COMPLETED|Overall Study||7
1133279|NCT01327313|2743336|P3|COMPLETED|Overall Study||6
1133280|NCT01327313|2743337|P2|COMPLETED|Overall Study||6
1133281|NCT01327313|2743338|P1|COMPLETED|Overall Study||8
1133282|NCT01327313|2743335|P4|STARTED|Overall Study||7
1133283|NCT01327313|2743336|P3|STARTED|Overall Study||6
1133284|NCT01327313|2743337|P2|STARTED|Overall Study||6
1133285|NCT01327313|2743338|P1|STARTED|Overall Study||8
1133286|NCT01327339|2743460|P1|NOT COMPLETED|Overall Study||8
1133287|NCT01327339|2743460|P1|COMPLETED|Overall Study||747
1133288|NCT01327339|2743460|P1|STARTED|Overall Study||755
1133289|NCT01327482|2743466|P1|NOT COMPLETED|Overall Study||1
1133290|NCT01327482|2743466|P1|COMPLETED|Overall Study|The 10th participant completed 2/3 visits|9
1133291|NCT01327482|2743466|P1|STARTED|Overall Study||10
1133292|NCT01327495|2743477|P6|NOT COMPLETED|Overall Study||2
1133293|NCT01327495|2743478|P5|NOT COMPLETED|Overall Study||3
1133294|NCT01327495|2743479|P4|NOT COMPLETED|Overall Study||0
1133295|NCT01327495|2743480|P3|NOT COMPLETED|Overall Study||2
1133296|NCT01327495|2743481|P2|NOT COMPLETED|Overall Study||2
1133297|NCT01327495|2743482|P1|NOT COMPLETED|Overall Study||2
1133298|NCT01327495|2743477|P6|COMPLETED|Overall Study|1 subject withdrawn d/t elevated LFTs, 1 dropped out d/t ski accident|9
1133299|NCT01327495|2743478|P5|COMPLETED|Overall Study|1 dropped out pre drug finish, 2 non-compliant subjects dropped|8
1133300|NCT01327495|2743479|P4|COMPLETED|Overall Study||9
1133301|NCT01327495|2743480|P3|COMPLETED|Overall Study|1 withdrawn due to injection AE. 1 drop-out (declined prostate biopsy and final visit).|8
1133302|NCT01327495|2743481|P2|COMPLETED|Overall Study|1 subject declined prostate biopsy & no-showed to final visit, 1 subject dropped d/t elevated LFTs.|9
1133303|NCT01327495|2743482|P1|COMPLETED|Overall Study|1 dropped due to decreased libido & energy, 1 dropped due to too much pain with acyline injections|8
1133304|NCT01327495|2743477|P6|STARTED|Overall Study||11
1133305|NCT01327495|2743478|P5|STARTED|Overall Study||11
1133306|NCT01327495|2743479|P4|STARTED|Overall Study||9
1133307|NCT01327495|2743480|P3|STARTED|Overall Study||10
1133308|NCT01327495|2743481|P2|STARTED|Overall Study||11
1133309|NCT01327495|2743482|P1|STARTED|Overall Study||10
1133310|NCT01327508|2743576|P2|NOT COMPLETED|Overall Study||0
1133311|NCT01327508|2743577|P1|NOT COMPLETED|Overall Study||0
1133312|NCT01327508|2743576|P2|COMPLETED|Overall Study||30
1133313|NCT01327508|2743577|P1|COMPLETED|Overall Study||30
1133314|NCT01327508|2743576|P2|STARTED|Overall Study||30
1133315|NCT01327508|2743577|P1|STARTED|Overall Study||30
1133316|NCT01327547|2743587|P2|NOT COMPLETED|Overall Study||67
1133317|NCT01327547|2743588|P1|NOT COMPLETED|Overall Study||70
1133318|NCT01327547|2743587|P2|COMPLETED|Overall Study||0
1133319|NCT01327547|2743588|P1|COMPLETED|Overall Study||0
1133320|NCT01327547|2743587|P2|In Study, Off Drug|Overall Study||2
1133321|NCT01327547|2743588|P1|In Study, Off Drug|Overall Study||2
1133322|NCT01327547|2743587|P2|STARTED|Overall Study||67
1133323|NCT01327547|2743588|P1|STARTED|Overall Study||70
1133324|NCT01327599|2743622|P1|NOT COMPLETED|Overall Study||3
1133325|NCT01327599|2743622|P1|COMPLETED|Overall Study||57
1133326|NCT01327599|2743622|P1|STARTED|Overall Study||60
1133327|NCT01327651|2743639|P9|NOT COMPLETED|Post Study Follow-up||2
1133328|NCT01327651|2743640|P8|NOT COMPLETED|Post Study Follow-up||1
1133329|NCT01327651|2743641|P7|NOT COMPLETED|Post Study Follow-up||4
1133330|NCT01327651|2743642|P6|NOT COMPLETED|Post Study Follow-up||0
1133331|NCT01327651|2743643|P5|NOT COMPLETED|Post Study Follow-up||0
1133332|NCT01327651|2743644|P4|NOT COMPLETED|Post Study Follow-up||0
1133333|NCT01327651|2743645|P3|NOT COMPLETED|Post Study Follow-up||1
1133334|NCT01327651|2743646|P2|NOT COMPLETED|Post Study Follow-up||1
1133335|NCT01327651|2743647|P1|NOT COMPLETED|Post Study Follow-up||0
1133336|NCT01327651|2743639|P9|COMPLETED|Post Study Follow-up||47
1133337|NCT01327651|2743640|P8|COMPLETED|Post Study Follow-up||49
1133338|NCT01327651|2743641|P7|COMPLETED|Post Study Follow-up||45
1133339|NCT01327651|2743642|P6|COMPLETED|Post Study Follow-up||59
1133340|NCT01327651|2743643|P5|COMPLETED|Post Study Follow-up||56
1133341|NCT01327651|2743644|P4|COMPLETED|Post Study Follow-up||57
1133342|NCT01327651|2743645|P3|COMPLETED|Post Study Follow-up||55
1133343|NCT01327651|2743646|P2|COMPLETED|Post Study Follow-up||55
1133344|NCT01327651|2743647|P1|COMPLETED|Post Study Follow-up||56
1133345|NCT01327651|2743639|P9|STARTED|Post Study Follow-up||49
1133346|NCT01327651|2743640|P8|STARTED|Post Study Follow-up||50
1133347|NCT01327651|2743641|P7|STARTED|Post Study Follow-up||49
1133348|NCT01327651|2743642|P6|STARTED|Post Study Follow-up||59
1133349|NCT01327651|2743643|P5|STARTED|Post Study Follow-up||56
1133350|NCT01327651|2743644|P4|STARTED|Post Study Follow-up||57
1133351|NCT01327651|2743645|P3|STARTED|Post Study Follow-up||56
1133352|NCT01327651|2743646|P2|STARTED|Post Study Follow-up||56
1133353|NCT01327651|2743647|P1|STARTED|Post Study Follow-up||56
1133354|NCT01327651|2743639|P9|NOT COMPLETED|Self-administered Dosing Period||11
1133355|NCT01327651|2743640|P8|NOT COMPLETED|Self-administered Dosing Period||10
1133356|NCT01327651|2743641|P7|NOT COMPLETED|Self-administered Dosing Period||10
1133357|NCT01327651|2743642|P6|NOT COMPLETED|Self-administered Dosing Period||0
1133358|NCT01327651|2743643|P5|NOT COMPLETED|Self-administered Dosing Period||3
1133359|NCT01327651|2743644|P4|NOT COMPLETED|Self-administered Dosing Period||3
1133360|NCT01327651|2743645|P3|NOT COMPLETED|Self-administered Dosing Period||4
1133361|NCT01327651|2743646|P2|NOT COMPLETED|Self-administered Dosing Period||3
1133362|NCT01327651|2743647|P1|NOT COMPLETED|Self-administered Dosing Period||4
1133363|NCT01327651|2743639|P9|COMPLETED|Self-administered Dosing Period||49
1133364|NCT01327651|2743640|P8|COMPLETED|Self-administered Dosing Period||50
1133365|NCT01327651|2743641|P7|COMPLETED|Self-administered Dosing Period||49
1133366|NCT01327651|2743642|P6|COMPLETED|Self-administered Dosing Period||59
1133367|NCT01327651|2743643|P5|COMPLETED|Self-administered Dosing Period||56
1133368|NCT01327651|2743644|P4|COMPLETED|Self-administered Dosing Period||57
1133369|NCT01327651|2743645|P3|COMPLETED|Self-administered Dosing Period||56
1133370|NCT01327651|2743646|P2|COMPLETED|Self-administered Dosing Period||56
1133371|NCT01327651|2743647|P1|COMPLETED|Self-administered Dosing Period||56
1133372|NCT01327651|2743639|P9|Week 26|Self-administered Dosing Period||49
1133373|NCT01327651|2743640|P8|Week 26|Self-administered Dosing Period||51
1133374|NCT01327651|2743641|P7|Week 26|Self-administered Dosing Period||50
1133375|NCT01327651|2743642|P6|Week 26|Self-administered Dosing Period||58
1133376|NCT01327651|2743643|P5|Week 26|Self-administered Dosing Period||56
1133377|NCT01327651|2743644|P4|Week 26|Self-administered Dosing Period||57
1133378|NCT01327651|2743645|P3|Week 26|Self-administered Dosing Period||53
1133379|NCT01327651|2743646|P2|Week 26|Self-administered Dosing Period||56
1133380|NCT01327651|2743647|P1|Week 26|Self-administered Dosing Period||58
1133381|NCT01327651|2743639|P9|Week 22|Self-administered Dosing Period||51
1133382|NCT01327651|2743640|P8|Week 22|Self-administered Dosing Period||50
1133383|NCT01327651|2743641|P7|Week 22|Self-administered Dosing Period||50
1133384|NCT01327651|2743642|P6|Week 22|Self-administered Dosing Period||59
1133385|NCT01327651|2743643|P5|Week 22|Self-administered Dosing Period||56
1133386|NCT01327651|2743644|P4|Week 22|Self-administered Dosing Period||58
1133387|NCT01327651|2743645|P3|Week 22|Self-administered Dosing Period||55
1133388|NCT01327651|2743646|P2|Week 22|Self-administered Dosing Period||56
1133389|NCT01327651|2743647|P1|Week 22|Self-administered Dosing Period||59
1133390|NCT01327651|2743639|P9|Week 18|Self-administered Dosing Period||53
1133391|NCT01327651|2743640|P8|Week 18|Self-administered Dosing Period||49
1133392|NCT01327651|2743641|P7|Week 18|Self-administered Dosing Period||53
1133393|NCT01327651|2743642|P6|Week 18|Self-administered Dosing Period||59
1133394|NCT01327651|2743643|P5|Week 18|Self-administered Dosing Period||57
1133395|NCT01327651|2743644|P4|Week 18|Self-administered Dosing Period||60
1133396|NCT01327651|2743645|P3|Week 18|Self-administered Dosing Period||56
1133397|NCT01327651|2743646|P2|Week 18|Self-administered Dosing Period||56
1133398|NCT01327651|2743647|P1|Week 18|Self-administered Dosing Period||57
1133399|NCT01327651|2743639|P9|Week 14|Self-administered Dosing Period||54
1133400|NCT01327651|2743640|P8|Week 14|Self-administered Dosing Period||51
1133401|NCT01327651|2743641|P7|Week 14|Self-administered Dosing Period||54
1133402|NCT01327651|2743642|P6|Week 14|Self-administered Dosing Period||59
1133403|NCT01327651|2743643|P5|Week 14|Self-administered Dosing Period||58
1133404|NCT01327651|2743644|P4|Week 14|Self-administered Dosing Period||60
1133405|NCT01327651|2743645|P3|Week 14|Self-administered Dosing Period||57
1133406|NCT01327651|2743646|P2|Week 14|Self-administered Dosing Period||55
1133407|NCT01327651|2743647|P1|Week 14|Self-administered Dosing Period||59
1133408|NCT01327651|2743639|P9|Week 10|Self-administered Dosing Period||56
1133409|NCT01327651|2743640|P8|Week 10|Self-administered Dosing Period||57
1133410|NCT01327651|2743641|P7|Week 10|Self-administered Dosing Period||57
1133411|NCT01327651|2743642|P6|Week 10|Self-administered Dosing Period||59
1133412|NCT01327651|2743643|P5|Week 10|Self-administered Dosing Period||59
1133413|NCT01327651|2743644|P4|Week 10|Self-administered Dosing Period||60
1133414|NCT01327651|2743645|P3|Week 10|Self-administered Dosing Period||60
1133415|NCT01327651|2743646|P2|Week 10|Self-administered Dosing Period||58
1133416|NCT01327651|2743647|P1|Week 10|Self-administered Dosing Period||59
1133417|NCT01327651|2743639|P9|STARTED|Self-administered Dosing Period||60
1133418|NCT01327651|2743640|P8|STARTED|Self-administered Dosing Period||60
1133419|NCT01327651|2743641|P7|STARTED|Self-administered Dosing Period||59
1133420|NCT01327651|2743642|P6|STARTED|Self-administered Dosing Period||59
1133421|NCT01327651|2743643|P5|STARTED|Self-administered Dosing Period||59
1133422|NCT01327651|2743644|P4|STARTED|Self-administered Dosing Period||60
1133423|NCT01327651|2743645|P3|STARTED|Self-administered Dosing Period||60
1133424|NCT01327651|2743646|P2|STARTED|Self-administered Dosing Period||59
1133425|NCT01327651|2743647|P1|STARTED|Self-administered Dosing Period||60
1133426|NCT01327677|2743768|P2|NOT COMPLETED|Overall Study||13
1133427|NCT01327677|2743769|P1|NOT COMPLETED|Overall Study||20
1133428|NCT01327677|2743768|P2|COMPLETED|Overall Study||56
1133429|NCT01327677|2743769|P1|COMPLETED|Overall Study||48
1133430|NCT01327677|2743768|P2|STARTED|Overall Study||69
1133431|NCT01327677|2743769|P1|STARTED|Overall Study||68
1133432|NCT01327703|2743781|P2|NOT COMPLETED|Second Treatment Period||2
1133433|NCT01327703|2743782|P1|NOT COMPLETED|Second Treatment Period||1
1133434|NCT01327703|2743781|P2|COMPLETED|Second Treatment Period||42
1133435|NCT01327703|2743782|P1|COMPLETED|Second Treatment Period||39
1133436|NCT01327703|2743781|P2|STARTED|Second Treatment Period|One participant discontinued between first and second treatment periods due to adverse event.|44
1133437|NCT01327703|2743782|P1|STARTED|Second Treatment Period|Two participants discontinued between first and second treatment periods due to adverse event.|40
1133438|NCT01327703|2743781|P2|NOT COMPLETED|First Treatment Period||0
1133439|NCT01327703|2743782|P1|NOT COMPLETED|First Treatment Period||0
1133440|NCT01327703|2743781|P2|COMPLETED|First Treatment Period||45
1133441|NCT01327703|2743782|P1|COMPLETED|First Treatment Period||42
1133442|NCT01327703|2743781|P2|STARTED|First Treatment Period||45
1133443|NCT01327703|2743782|P1|STARTED|First Treatment Period||42
1133444|NCT01327885|2743816|P2|NOT COMPLETED|Overall Study||224
1133445|NCT01327885|2743817|P1|NOT COMPLETED|Overall Study||228
1133446|NCT01327885|2743816|P2|COMPLETED|Overall Study||0
1133447|NCT01327885|2743817|P1|COMPLETED|Overall Study||0
1133448|NCT01327885|2743816|P2|STARTED|Overall Study||224
1133449|NCT01327885|2743817|P1|STARTED|Overall Study||228
1133450|NCT01327976|2743831|P2|NOT COMPLETED|Overall Study||7
1133451|NCT01327976|2743832|P1|NOT COMPLETED|Overall Study||8
1133452|NCT01327976|2743831|P2|COMPLETED|Overall Study||70
1133453|NCT01327976|2743832|P1|COMPLETED|Overall Study||154
1133454|NCT01327976|2743831|P2|STARTED|Overall Study||77
1133455|NCT01327976|2743832|P1|STARTED|Overall Study||162
1133456|NCT01327989|2743842|P1|NOT COMPLETED|Overall Study||14
1133457|NCT01327989|2743842|P1|COMPLETED|Overall Study||188
1133458|NCT01327989|2743842|P1|STARTED|Overall Study||202
1133459|NCT01328041|2743854|P1|NOT COMPLETED|Overall Study||57
1133460|NCT01328041|2743854|P1|COMPLETED|Overall Study||126
1133461|NCT01328041|2743854|P1|STARTED|Overall Study||183
1133462|NCT01328054|2743876|P2|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||5
1133463|NCT01328054|2743877|P1|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
1133464|NCT01328054|2743876|P2|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||53
1133465|NCT01328054|2743877|P1|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
1133466|NCT01328054|2743876|P2|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)|One par. was double dosed with lapatinib due to a dosing error - reason for difference in # Started.|58
1133467|NCT01328054|2743877|P1|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)||0
1133468|NCT01328054|2743876|P2|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
1133469|NCT01328054|2743877|P1|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
1133470|NCT01328054|2743876|P2|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
1133471|NCT01328054|2743877|P1|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||57
1133472|NCT01328054|2743876|P2|STARTED|Placebo on Day 1 and Day 2 (2 Days)||0
1133473|NCT01328054|2743877|P1|STARTED|Placebo on Day 1 and Day 2 (2 Days)||57
1133474|NCT01328080|2743902|P1|NOT COMPLETED|Overall Study||5
1133475|NCT01328080|2743902|P1|COMPLETED|Overall Study||6
1133476|NCT01328080|2743902|P1|STARTED|Overall Study|11 subjects consented; 1 withdrew consent before first UVB treatment|11
1133477|NCT01328158|2743906|P1|NOT COMPLETED|Overall Study||0
1133478|NCT01328158|2743906|P1|COMPLETED|Overall Study||220
1133479|NCT01328158|2743906|P1|STARTED|Overall Study||220
1133480|NCT01328184|2743944|P1|NOT COMPLETED|Overall Study||0
1133481|NCT01328184|2743944|P1|COMPLETED|Overall Study||18
1133482|NCT01328184|2743944|P1|STARTED|Overall Study||18
1133483|NCT01321554|2743986|P4|NOT COMPLETED|OOL Lenvatinib Treatment Period||2
1133484|NCT01321554|2743987|P3|NOT COMPLETED|OOL Lenvatinib Treatment Period||28
1133485|NCT01321554|2743988|P2|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
1133486|NCT01321554|2743989|P1|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
1133487|NCT01321554|2743986|P4|COMPLETED|OOL Lenvatinib Treatment Period|Discontinued due to disease progression or treatment ongoing at data cut off (15 Nov 2013)|25
1133488|NCT01321554|2743987|P3|COMPLETED|OOL Lenvatinib Treatment Period|Discontinued due to disease progression or treatment ongoing at data cut off (15 Nov 2013)|54
1133489|NCT01321554|2743988|P2|COMPLETED|OOL Lenvatinib Treatment Period||0
1133490|NCT01321554|2743989|P1|COMPLETED|OOL Lenvatinib Treatment Period||0
1133491|NCT01321554|2743986|P4|Discontinued Due to Disease Progression|OOL Lenvatinib Treatment Period||3
1133492|NCT01321554|2743987|P3|Discontinued Due to Disease Progression|OOL Lenvatinib Treatment Period||18
1133493|NCT01321554|2743988|P2|Discontinued Due to Disease Progression|OOL Lenvatinib Treatment Period||0
1133494|NCT01321554|2743989|P1|Discontinued Due to Disease Progression|OOL Lenvatinib Treatment Period||0
1133495|NCT01321554|2743986|P4|Treatment Ongoing at Data Cutoff|OOL Lenvatinib Treatment Period||22
1133496|NCT01321554|2743987|P3|Treatment Ongoing at Data Cutoff|OOL Lenvatinib Treatment Period||36
1133497|NCT01321554|2743988|P2|Treatment Ongoing at Data Cutoff|OOL Lenvatinib Treatment Period||0
1133498|NCT01321554|2743989|P1|Treatment Ongoing at Data Cutoff|OOL Lenvatinib Treatment Period||0
1133499|NCT01321554|2743986|P4|STARTED|OOL Lenvatinib Treatment Period||27
1133500|NCT01321554|2743987|P3|STARTED|OOL Lenvatinib Treatment Period||82
1133501|NCT01321554|2743988|P2|STARTED|OOL Lenvatinib Treatment Period||0
1133502|NCT01321554|2743989|P1|STARTED|OOL Lenvatinib Treatment Period||0
1133503|NCT01321554|2743986|P4|NOT COMPLETED|Randomization Phase||0
1133504|NCT01321554|2743987|P3|NOT COMPLETED|Randomization Phase||0
1133505|NCT01321554|2743988|P2|NOT COMPLETED|Randomization Phase||4
1133506|NCT01321554|2743989|P1|NOT COMPLETED|Randomization Phase||45
1133507|NCT01321554|2743986|P4|COMPLETED|Randomization Phase||0
1133508|NCT01321554|2743987|P3|COMPLETED|Randomization Phase||0
1133509|NCT01321554|2743988|P2|COMPLETED|Randomization Phase|Discontinued due to disease progression or treatment ongoing at data cut off (15 Nov 2013)|127
1133510|NCT01321554|2743989|P1|COMPLETED|Randomization Phase|Discontinued due to disease progression or treatment ongoing at data cut off (15 Nov 2013)|216
1133511|NCT01321554|2743986|P4|Discontinued Due to Disease Progression|Randomization Phase||0
1133512|NCT01321554|2743987|P3|Discontinued Due to Disease Progression|Randomization Phase||0
1133513|NCT01321554|2743988|P2|Discontinued Due to Disease Progression|Randomization Phase||119
1133514|NCT01321554|2743989|P1|Discontinued Due to Disease Progression|Randomization Phase||94
1133515|NCT01321554|2743986|P4|Treatment Ongoing at Data Cutoff|Randomization Phase||0
1133516|NCT01321554|2743987|P3|Treatment Ongoing at Data Cutoff|Randomization Phase||0
1133517|NCT01321554|2743988|P2|Treatment Ongoing at Data Cutoff|Randomization Phase||8
1133518|NCT01321554|2743989|P1|Treatment Ongoing at Data Cutoff|Randomization Phase||122
1133519|NCT01321554|2743986|P4|STARTED|Randomization Phase||0
1133520|NCT01321554|2743987|P3|STARTED|Randomization Phase||0
1133521|NCT01321554|2743988|P2|STARTED|Randomization Phase||131
1133522|NCT01321554|2743989|P1|STARTED|Randomization Phase||261
1133523|NCT01321697|2744002|P1|NOT COMPLETED|Overall Study||7
1133524|NCT01321697|2744002|P1|COMPLETED|Overall Study||0
1133525|NCT01321697|2744002|P1|STARTED|Overall Study||7
1133526|NCT01321710|2744009|P3|NOT COMPLETED|Overall Study||0
1133527|NCT01321710|2744010|P2|NOT COMPLETED|Overall Study||5
1133528|NCT01321710|2744011|P1|NOT COMPLETED|Overall Study||4
1133529|NCT01321710|2744009|P3|COMPLETED|Overall Study||44
1133530|NCT01321710|2744010|P2|COMPLETED|Overall Study||53
1133531|NCT01321710|2744011|P1|COMPLETED|Overall Study||46
1133532|NCT01321710|2744009|P3|STARTED|Overall Study||44
1133533|NCT01321710|2744010|P2|STARTED|Overall Study||58
1133534|NCT01321710|2744011|P1|STARTED|Overall Study||50
1133535|NCT01321723|2744029|P3|NOT COMPLETED|Overall Study||4
1133536|NCT01321723|2744030|P2|NOT COMPLETED|Overall Study||5
1133537|NCT01321723|2744031|P1|NOT COMPLETED|Overall Study||5
1133538|NCT01321723|2744029|P3|COMPLETED|Overall Study||28
1133539|NCT01321723|2744030|P2|COMPLETED|Overall Study||28
1133540|NCT01321723|2744031|P1|COMPLETED|Overall Study||27
1133541|NCT01321723|2744029|P3|STARTED|Overall Study||32
1133542|NCT01321723|2744030|P2|STARTED|Overall Study||33
1133543|NCT01321723|2744031|P1|STARTED|Overall Study||32
1133544|NCT01321749|2744052|P2|NOT COMPLETED|Overall Study||22
1133545|NCT01321749|2744053|P1|NOT COMPLETED|Overall Study||13
1133546|NCT01321749|2744052|P2|COMPLETED|Overall Study||30
1133547|NCT01321749|2744053|P1|COMPLETED|Overall Study||38
1133548|NCT01321749|2744052|P2|STARTED|Overall Study||52
1133549|NCT01321749|2744053|P1|STARTED|Overall Study||51
1133550|NCT01322009|2744061|P2|NOT COMPLETED|Overall Study||3
1133551|NCT01322009|2744062|P1|NOT COMPLETED|Overall Study||0
1133552|NCT01322009|2744061|P2|COMPLETED|Overall Study||4
1133553|NCT01322009|2744062|P1|COMPLETED|Overall Study||7
1133554|NCT01322009|2744061|P2|STARTED|Overall Study||7
1133555|NCT01322009|2744062|P1|STARTED|Overall Study||7
1133556|NCT01322022|2744072|P2|NOT COMPLETED|Overall Study||2
1133557|NCT01322022|2744073|P1|NOT COMPLETED|Overall Study||5
1133558|NCT01322022|2744072|P2|COMPLETED|Overall Study||18
1133559|NCT01322022|2744073|P1|COMPLETED|Overall Study||15
1133560|NCT01322022|2744072|P2|Week 4|Overall Study||18
1133561|NCT01322022|2744073|P1|Week 4|Overall Study||15
1133562|NCT01322022|2744072|P2|STARTED|Overall Study||20
1133563|NCT01322022|2744073|P1|STARTED|Overall Study||20
1133564|NCT01322048|2744087|P2|NOT COMPLETED|Overall Study||0
1133565|NCT01322048|2744088|P1|NOT COMPLETED|Overall Study||0
1133566|NCT01322048|2744087|P2|COMPLETED|Overall Study||26
1133567|NCT01322048|2744088|P1|COMPLETED|Overall Study||21
1133568|NCT01322048|2744087|P2|STARTED|Overall Study||26
1133569|NCT01322048|2744088|P1|STARTED|Overall Study||21
1133570|NCT01322347|2744098|P2|NOT COMPLETED|Overall Study||35
1133571|NCT01322347|2744099|P1|NOT COMPLETED|Overall Study||51
1133572|NCT01322347|2744098|P2|COMPLETED|Overall Study||112
1133573|NCT01322347|2744099|P1|COMPLETED|Overall Study||96
1133574|NCT01322347|2744098|P2|Completed St 3|Overall Study||86
1133575|NCT01322347|2744099|P1|Completed St 3|Overall Study||82
1133576|NCT01322347|2744098|P2|Enrolled in St 3|Overall Study||113
1133577|NCT01322347|2744099|P1|Enrolled in St 3|Overall Study||101
1133578|NCT01322347|2744098|P2|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||90
1133579|NCT01322347|2744099|P1|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||68
1133580|NCT01322347|2744098|P2|Completed 48 Wks in St 2|Overall Study||22
1133581|NCT01322347|2744099|P1|Completed 48 Wks in St 2|Overall Study||28
1133582|NCT01322347|2744098|P2|STARTED|Overall Study||147
1133583|NCT01322347|2744099|P1|STARTED|Overall Study||147
1133584|NCT01322360|2744134|P1|NOT COMPLETED|Overall Study||0
1133585|NCT01322360|2744134|P1|COMPLETED|Overall Study||50
1133586|NCT01322360|2744134|P1|STARTED|Overall Study||50
1133587|NCT01322386|2744141|P2|NOT COMPLETED|Overall Study||2
1133588|NCT01322386|2744142|P1|NOT COMPLETED|Overall Study||0
1133589|NCT01322386|2744141|P2|COMPLETED|Overall Study||9
1133590|NCT01322386|2744142|P1|COMPLETED|Overall Study||10
1133591|NCT01322386|2744141|P2|STARTED|Overall Study||11
1133592|NCT01322386|2744142|P1|STARTED|Overall Study||10
1133593|NCT01328366|2744150|P1|NOT COMPLETED|Overall Study||10
1133594|NCT01328366|2744150|P1|COMPLETED|Overall Study||143
1133595|NCT01328366|2744150|P1|STARTED|Overall Study||153
1133596|NCT01328379|2744171|P3|NOT COMPLETED|Overall Study||0
1133597|NCT01328379|2744172|P2|NOT COMPLETED|Overall Study||0
1133598|NCT01328379|2744173|P1|NOT COMPLETED|Overall Study||1
1133599|NCT01328379|2744171|P3|COMPLETED|Overall Study||143
1133600|NCT01328379|2744172|P2|COMPLETED|Overall Study||144
1133601|NCT01328379|2744173|P1|COMPLETED|Overall Study||142
1133602|NCT01328379|2744171|P3|STARTED|Overall Study||143
1133603|NCT01328379|2744172|P2|STARTED|Overall Study||144
1133604|NCT01328379|2744173|P1|STARTED|Overall Study||143
1133605|NCT01328405|2744201|P2|NOT COMPLETED|Overall Study||0
1133606|NCT01328405|2744202|P1|NOT COMPLETED|Overall Study||0
1133607|NCT01328405|2744201|P2|COMPLETED|Overall Study||48
1133608|NCT01328405|2744202|P1|COMPLETED|Overall Study||52
1133609|NCT01328405|2744201|P2|STARTED|Overall Study||48
1133610|NCT01328405|2744202|P1|STARTED|Overall Study||52
1133611|NCT01328431|2744218|P2|NOT COMPLETED|12 Month (12M)||97
1133612|NCT01328431|2744219|P1|NOT COMPLETED|12 Month (12M)||84
1133613|NCT01328431|2744218|P2|COMPLETED|12 Month (12M)||289
1133614|NCT01328431|2744219|P1|COMPLETED|12 Month (12M)||304
1133615|NCT01328431|2744218|P2|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|386
1133616|NCT01328431|2744219|P1|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|388
1133617|NCT01328431|2744218|P2|NOT COMPLETED|3 Month (3M)||72
1133618|NCT01328431|2744219|P1|NOT COMPLETED|3 Month (3M)||77
1133619|NCT01328431|2744218|P2|COMPLETED|3 Month (3M)||316
1133620|NCT01328431|2744219|P1|COMPLETED|3 Month (3M)||313
1133621|NCT01328431|2744218|P2|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|388
1133622|NCT01328431|2744219|P1|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|390
1133623|NCT01328431|2744218|P2|NOT COMPLETED|1 Month (1M)||58
1133624|NCT01328431|2744219|P1|NOT COMPLETED|1 Month (1M)||55
1133625|NCT01328431|2744218|P2|COMPLETED|1 Month (1M)||330
1133626|NCT01328431|2744219|P1|COMPLETED|1 Month (1M)||335
1133627|NCT01328431|2744218|P2|STARTED|1 Month (1M)||388
1133628|NCT01328431|2744219|P1|STARTED|1 Month (1M)||390
1133629|NCT01328431|2744218|P2|NOT COMPLETED|Baseline||2
1133630|NCT01328431|2744219|P1|NOT COMPLETED|Baseline||0
1133631|NCT01328431|2744218|P2|COMPLETED|Baseline|Two subjects enrolled in study twice. Protocol violation.|388
1133632|NCT01328431|2744219|P1|COMPLETED|Baseline||390
1133633|NCT01328431|2744218|P2|STARTED|Baseline||390
1133634|NCT01328431|2744219|P1|STARTED|Baseline||390
1133689|NCT01328496|2744278|P2|NOT COMPLETED|Overall Study||0
1133690|NCT01328496|2744279|P1|NOT COMPLETED|Overall Study||1
1133691|NCT01328496|2744278|P2|COMPLETED|Overall Study||4
1133692|NCT01328496|2744279|P1|COMPLETED|Overall Study||9
1133693|NCT01328496|2744278|P2|STARTED|Overall Study||4
1133694|NCT01328496|2744279|P1|STARTED|Overall Study||10
1133695|NCT01328548|2744299|P2|NOT COMPLETED|Overall Study||0
1133696|NCT01328548|2744300|P1|NOT COMPLETED|Overall Study||4
1133697|NCT01328548|2744299|P2|COMPLETED|Overall Study||50
1133698|NCT01328548|2744300|P1|COMPLETED|Overall Study||187
1133699|NCT01328548|2744299|P2|STARTED|Overall Study||50
1133700|NCT01328548|2744300|P1|STARTED|Overall Study||191
1133701|NCT01328574|2744318|P1|NOT COMPLETED|Overall Study||1
1133702|NCT01328574|2744318|P1|COMPLETED|Overall Study||12
1133703|NCT01328574|2744318|P1|STARTED|Overall Study||13
1133704|NCT01329185|2744332|P2|NOT COMPLETED|Overall Study||0
1133705|NCT01329185|2744333|P1|NOT COMPLETED|Overall Study||0
1133706|NCT01329185|2744332|P2|COMPLETED|Overall Study||7
1133707|NCT01329185|2744333|P1|COMPLETED|Overall Study||10
1133708|NCT01329185|2744332|P2|PTLD|Overall Study||0
1133709|NCT01329185|2744333|P1|PTLD|Overall Study||1
1133710|NCT01329185|2744332|P2|CMV Disease|Overall Study||0
1133711|NCT01329185|2744333|P1|CMV Disease|Overall Study||1
1133712|NCT01329185|2744332|P2|STARTED|Overall Study||7
1133713|NCT01329185|2744333|P1|STARTED|Overall Study||10
1133714|NCT01329198|2744341|P2|NOT COMPLETED|Overall Study||0
1133715|NCT01329198|2744342|P1|NOT COMPLETED|Overall Study||0
1133716|NCT01329198|2744341|P2|COMPLETED|Overall Study||2
1133717|NCT01329198|2744342|P1|COMPLETED|Overall Study||3
1133718|NCT01329198|2744341|P2|STARTED|Overall Study||2
1133719|NCT01329198|2744342|P1|STARTED|Overall Study||3
1133720|NCT01329263|2744355|P2|NOT COMPLETED|Overall Study||23
1133721|NCT01329263|2744356|P1|NOT COMPLETED|Overall Study||5
1133722|NCT01329263|2744355|P2|COMPLETED|Overall Study||22
1133723|NCT01329263|2744356|P1|COMPLETED|Overall Study||10
1133724|NCT01329263|2744355|P2|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||22
1133725|NCT01329263|2744356|P1|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||10
1133726|NCT01329263|2744355|P2|Completed Period 2 Own or CCrush Menthol|Overall Study||30
1133727|NCT01329263|2744356|P1|Completed Period 2 Own or CCrush Menthol|Overall Study||10
1133728|NCT01329263|2744355|P2|Completed Period 1 Own Menthol|Overall Study||45
1133729|NCT01329263|2744356|P1|Completed Period 1 Own Menthol|Overall Study||15
1133730|NCT01329263|2744355|P2|STARTED|Overall Study||45
1133731|NCT01329263|2744356|P1|STARTED|Overall Study||15
1133732|NCT01329419|2744368|P1|NOT COMPLETED|Overall Study||235
1133733|NCT01329419|2744368|P1|COMPLETED|Overall Study||4158
1133734|NCT01329419|2744368|P1|STARTED|Overall Study||4393
1133735|NCT01329549|2744374|P1|NOT COMPLETED|Overall Study||2
1133736|NCT01329549|2744374|P1|COMPLETED|Overall Study||0
1133737|NCT01329549|2744374|P1|STARTED|Overall Study||2
1133738|NCT01329562|2744387|P2|NOT COMPLETED|Overall Study||7
1133739|NCT01329562|2744388|P1|NOT COMPLETED|Overall Study||9
1133740|NCT01329562|2744387|P2|COMPLETED|Overall Study||14
1133741|NCT01329562|2744388|P1|COMPLETED|Overall Study||11
1133742|NCT01329562|2744387|P2|STARTED|Overall Study||21
1133743|NCT01329562|2744388|P1|STARTED|Overall Study||20
1133744|NCT01329679|2744437|P2|NOT COMPLETED|Overall Study||0
1133745|NCT01329679|2744438|P1|NOT COMPLETED|Overall Study||0
1133746|NCT01329679|2744437|P2|COMPLETED|Overall Study||13
1133747|NCT01329679|2744438|P1|COMPLETED|Overall Study||13
1133748|NCT01329679|2744437|P2|STARTED|Overall Study||13
1133749|NCT01329679|2744438|P1|STARTED|Overall Study||13
1133750|NCT01329848|2744456|P1|NOT COMPLETED|Overall Study||29
1133751|NCT01329848|2744456|P1|COMPLETED|Overall Study||54
1133752|NCT01329848|2744456|P1|STARTED|Overall Study||83
1133753|NCT01329939|2744465|P4|NOT COMPLETED|Overall Study||5
1133754|NCT01329939|2744466|P3|NOT COMPLETED|Overall Study||1
1133755|NCT01329939|2744467|P2|NOT COMPLETED|Overall Study||1
1133756|NCT01329939|2744468|P1|NOT COMPLETED|Overall Study||3
1133757|NCT01329939|2744465|P4|COMPLETED|Overall Study||4
1133758|NCT01329939|2744466|P3|COMPLETED|Overall Study||4
1133759|NCT01329939|2744467|P2|COMPLETED|Overall Study||4
1133760|NCT01329939|2744468|P1|COMPLETED|Overall Study||4
1133761|NCT01329939|2744465|P4|STARTED|Overall Study||9
1133762|NCT01329939|2744466|P3|STARTED|Overall Study||5
1133763|NCT01329939|2744467|P2|STARTED|Overall Study||5
1133764|NCT01329939|2744468|P1|STARTED|Overall Study||7
1133765|NCT01329978|2744509|P5|NOT COMPLETED|Rerandomization Treatment Period||4
1133766|NCT01329978|2744510|P4|NOT COMPLETED|Rerandomization Treatment Period||5
1133767|NCT01329978|2744511|P3|NOT COMPLETED|Rerandomization Treatment Period||0
1133768|NCT01329978|2744512|P2|NOT COMPLETED|Rerandomization Treatment Period||0
1133769|NCT01329978|2744513|P1|NOT COMPLETED|Rerandomization Treatment Period||0
1133770|NCT01329978|2744509|P5|COMPLETED|Rerandomization Treatment Period||71
1133771|NCT01329978|2744510|P4|COMPLETED|Rerandomization Treatment Period||70
1133772|NCT01329978|2744511|P3|COMPLETED|Rerandomization Treatment Period||0
1133773|NCT01329978|2744512|P2|COMPLETED|Rerandomization Treatment Period||0
1133774|NCT01329978|2744513|P1|COMPLETED|Rerandomization Treatment Period||0
1133775|NCT01329978|2744509|P5|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
1133776|NCT01329978|2744510|P4|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
1133777|NCT01329978|2744511|P3|STARTED|Rerandomization Treatment Period||0
1133778|NCT01329978|2744512|P2|STARTED|Rerandomization Treatment Period||0
1133779|NCT01329978|2744513|P1|STARTED|Rerandomization Treatment Period||0
1133780|NCT01329978|2744509|P5|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
1133781|NCT01329978|2744510|P4|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
1133782|NCT01329978|2744511|P3|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||5
1133783|NCT01329978|2744512|P2|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||13
1133784|NCT01329978|2744513|P1|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||4
1133785|NCT01329978|2744509|P5|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
1133786|NCT01329978|2744510|P4|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
1133787|NCT01329978|2744511|P3|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|150 participants were re-randomized after 12 weeks of treatment.|150
1133788|NCT01329978|2744512|P2|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|112
1133789|NCT01329978|2744513|P1|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|48
1133790|NCT01329978|2744509|P5|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
1133791|NCT01329978|2744510|P4|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
1133792|NCT01329978|2744511|P3|STARTED|Sofosbuvir+PEG+RBV Treatment Period||155
1133793|NCT01329978|2744512|P2|STARTED|Sofosbuvir+PEG+RBV Treatment Period||125
1133794|NCT01329978|2744513|P1|STARTED|Sofosbuvir+PEG+RBV Treatment Period||52
1133795|NCT01330017|2744588|P5|NOT COMPLETED|Overall Study||3
1133796|NCT01330017|2744589|P4|NOT COMPLETED|Overall Study||12
1133797|NCT01330017|2744590|P3|NOT COMPLETED|Overall Study||8
1133798|NCT01330017|2744591|P2|NOT COMPLETED|Overall Study||4
1133799|NCT01330017|2744592|P1|NOT COMPLETED|Overall Study||5
1133800|NCT01330017|2744588|P5|COMPLETED|Overall Study||100
1133801|NCT01330017|2744589|P4|COMPLETED|Overall Study||100
1133802|NCT01330017|2744590|P3|COMPLETED|Overall Study||99
1133803|NCT01330017|2744591|P2|COMPLETED|Overall Study||104
1133804|NCT01330017|2744592|P1|COMPLETED|Overall Study||104
1133805|NCT01330017|2744588|P5|STARTED|Overall Study||103
1133806|NCT01330017|2744589|P4|STARTED|Overall Study||112
1133807|NCT01330017|2744590|P3|STARTED|Overall Study||107
1133808|NCT01330017|2744591|P2|STARTED|Overall Study||108
1133809|NCT01330017|2744592|P1|STARTED|Overall Study||109
1133810|NCT01330030|2744640|P2|NOT COMPLETED|Overall Study||17
1133811|NCT01330030|2744641|P1|NOT COMPLETED|Overall Study||16
1133812|NCT01330030|2744640|P2|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
1133813|NCT01330030|2744641|P1|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
1133814|NCT01330030|2744640|P2|STARTED|Overall Study||122
1133815|NCT01330030|2744641|P1|STARTED|Overall Study||121
1133816|NCT01330043|2744649|P2|NOT COMPLETED|Overall Study||4
1133817|NCT01330043|2744650|P1|NOT COMPLETED|Overall Study||0
1133818|NCT01330043|2744649|P2|COMPLETED|Overall Study||108
1133819|NCT01330043|2744650|P1|COMPLETED|Overall Study||111
1133820|NCT01330043|2744649|P2|STARTED|Overall Study||112
1133821|NCT01330043|2744650|P1|STARTED|Overall Study||111
1133822|NCT01330108|2744658|P1|NOT COMPLETED|Overall Study||4
1133823|NCT01330108|2744658|P1|COMPLETED|Overall Study||28
1133824|NCT01330108|2744658|P1|STARTED|Overall Study||32
1133825|NCT01330290|2744663|P1|NOT COMPLETED|Overall Study||0
1133826|NCT01330290|2744663|P1|COMPLETED|Overall Study|As this is a cross-sectional study, the terms completed/not completed are not applicable.|148
1133827|NCT01330290|2744663|P1|STARTED|Overall Study||148
1133828|NCT01330303|2744687|P2|NOT COMPLETED|Period 2||0
1133829|NCT01330303|2744688|P1|NOT COMPLETED|Period 2||0
1133830|NCT01330303|2744687|P2|COMPLETED|Period 2||18
1133831|NCT01330303|2744688|P1|COMPLETED|Period 2||19
1133832|NCT01330303|2744687|P2|STARTED|Period 2||18
1133833|NCT01330303|2744688|P1|STARTED|Period 2||19
1133834|NCT01330303|2744687|P2|NOT COMPLETED|7-Day Washout Period||0
1133835|NCT01330303|2744688|P1|NOT COMPLETED|7-Day Washout Period||0
1133836|NCT01330303|2744687|P2|COMPLETED|7-Day Washout Period||18
1133837|NCT01330303|2744688|P1|COMPLETED|7-Day Washout Period||19
1133838|NCT01330303|2744687|P2|STARTED|7-Day Washout Period||18
1133839|NCT01330303|2744688|P1|STARTED|7-Day Washout Period||19
1133840|NCT01330303|2744687|P2|NOT COMPLETED|Period 1||2
1133841|NCT01330303|2744688|P1|NOT COMPLETED|Period 1||1
1133842|NCT01330303|2744687|P2|COMPLETED|Period 1||18
1133843|NCT01330303|2744688|P1|COMPLETED|Period 1||19
1133844|NCT01330303|2744687|P2|STARTED|Period 1||20
1133845|NCT01330303|2744688|P1|STARTED|Period 1||20
1133846|NCT01330316|2744700|P2|NOT COMPLETED|Overall Study||15
1133847|NCT01330316|2744701|P1|NOT COMPLETED|Overall Study||2
1133848|NCT01330316|2744700|P2|COMPLETED|Overall Study||60
1133849|NCT01330316|2744701|P1|COMPLETED|Overall Study||41
1133850|NCT01330316|2744700|P2|STARTED|Overall Study||75
1133851|NCT01330316|2744701|P1|STARTED|Overall Study||43
1133852|NCT01330355|2744739|P2|NOT COMPLETED|Overall Study||0
1133853|NCT01330355|2744740|P1|NOT COMPLETED|Overall Study||0
1133854|NCT01330355|2744739|P2|COMPLETED|Overall Study||17
1133855|NCT01330355|2744740|P1|COMPLETED|Overall Study||16
1133856|NCT01330355|2744739|P2|STARTED|Overall Study||17
1133857|NCT01330355|2744740|P1|STARTED|Overall Study||16
1133858|NCT01330381|2744754|P3|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||18
1133859|NCT01330381|2744755|P2|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||0
1133860|NCT01330381|2744756|P1|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||10
1133861|NCT01330381|2744754|P3|COMPLETED|Open-label Treatment Period (16 Weeks)||81
1133862|NCT01330381|2744755|P2|COMPLETED|Open-label Treatment Period (16 Weeks)||0
1133863|NCT01330381|2744756|P1|COMPLETED|Open-label Treatment Period (16 Weeks)||88
1133864|NCT01330381|2744754|P3|STARTED|Open-label Treatment Period (16 Weeks)||99
1133865|NCT01330381|2744755|P2|STARTED|Open-label Treatment Period (16 Weeks)||0
1133866|NCT01330381|2744756|P1|STARTED|Open-label Treatment Period (16 Weeks)||98
1133867|NCT01330381|2744754|P3|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||0
1133868|NCT01330381|2744755|P2|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||7
1133869|NCT01330381|2744756|P1|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||11
1133870|NCT01330381|2744754|P3|COMPLETED|Double-blind Treatment Period (8 Weeks)||0
1133871|NCT01330381|2744755|P2|COMPLETED|Double-blind Treatment Period (8 Weeks)||101
1133872|NCT01330381|2744756|P1|COMPLETED|Double-blind Treatment Period (8 Weeks)||96
1133873|NCT01330381|2744754|P3|Received Treatment|Double-blind Treatment Period (8 Weeks)||0
1133874|NCT01330381|2744755|P2|Received Treatment|Double-blind Treatment Period (8 Weeks)||107
1133875|NCT01330381|2744756|P1|Received Treatment|Double-blind Treatment Period (8 Weeks)||106
1133876|NCT01330381|2744754|P3|STARTED|Double-blind Treatment Period (8 Weeks)||0
1133877|NCT01330381|2744755|P2|STARTED|Double-blind Treatment Period (8 Weeks)||108
1133878|NCT01330381|2744756|P1|STARTED|Double-blind Treatment Period (8 Weeks)||107
1133879|NCT01330394|2744802|P2|NOT COMPLETED|Overall Study||0
1133880|NCT01330394|2744803|P1|NOT COMPLETED|Overall Study||0
1133881|NCT01330394|2744802|P2|COMPLETED|Overall Study||16
1133882|NCT01330394|2744803|P1|COMPLETED|Overall Study||17
1133883|NCT01330394|2744802|P2|STARTED|Overall Study||16
1133884|NCT01330394|2744803|P1|STARTED|Overall Study||17
1133885|NCT01330420|2744809|P1|NOT COMPLETED|Overall Study||4
1133886|NCT01330420|2744809|P1|COMPLETED|Overall Study||24
1133887|NCT01330420|2744809|P1|STARTED|Overall Study||28
1133888|NCT01330433|2744819|P2|NOT COMPLETED|Overall Study||3
1133889|NCT01330433|2744820|P1|NOT COMPLETED|Overall Study||2
1133890|NCT01330433|2744819|P2|COMPLETED|Overall Study||16
1133891|NCT01330433|2744820|P1|COMPLETED|Overall Study||14
1133892|NCT01330433|2744819|P2|STARTED|Overall Study||19
1133893|NCT01330433|2744820|P1|STARTED|Overall Study||16
1133894|NCT01330628|2744842|P2|NOT COMPLETED|Overall Study||40
1133895|NCT01330628|2744843|P1|NOT COMPLETED|Overall Study||70
1133896|NCT01330628|2744842|P2|COMPLETED|Overall Study||42
1133897|NCT01330628|2744843|P1|COMPLETED|Overall Study||100
1133898|NCT01330628|2744842|P2|6 Month Follow-up|Overall Study||60
1133899|NCT01330628|2744843|P1|6 Month Follow-up|Overall Study||135
1133900|NCT01330628|2744842|P2|30 Day Follow-up|Overall Study||73
1133901|NCT01330628|2744843|P1|30 Day Follow-up|Overall Study||165
1133902|NCT01330628|2744842|P2|STARTED|Overall Study||82
1133903|NCT01330628|2744843|P1|STARTED|Overall Study||170
1133904|NCT01330914|2744851|P1|NOT COMPLETED|Overall Study||7
1133905|NCT01330914|2744851|P1|COMPLETED|Overall Study||48
1133906|NCT01330914|2744851|P1|STARTED|Overall Study||55
1133907|NCT01331005|2744857|P2|NOT COMPLETED|Overall Study||4
1133908|NCT01331005|2744858|P1|NOT COMPLETED|Overall Study||4
1133909|NCT01331005|2744857|P2|COMPLETED|Overall Study||57
1133910|NCT01331005|2744858|P1|COMPLETED|Overall Study||60
1133911|NCT01331005|2744857|P2|STARTED|Overall Study||61
1133912|NCT01331005|2744858|P1|STARTED|Overall Study||64
1133913|NCT01331109|2744864|P1|NOT COMPLETED|Overall Study||57
1133914|NCT01331109|2744864|P1|COMPLETED|Overall Study||0
1133915|NCT01331109|2744864|P1|STARTED|Overall Study||57
1133922|NCT01331213|2744887|P2|NOT COMPLETED|Overall Study||0
1133923|NCT01331213|2744888|P1|NOT COMPLETED|Overall Study||0
1133924|NCT01331213|2744887|P2|COMPLETED|Overall Study||10
1133925|NCT01331213|2744888|P1|COMPLETED|Overall Study||8
1133926|NCT01331213|2744887|P2|STARTED|Overall Study||10
1133927|NCT01331213|2744888|P1|STARTED|Overall Study||8
1133928|NCT01331291|2744908|P2|NOT COMPLETED|Overall Study||9
1133929|NCT01331291|2744909|P1|NOT COMPLETED|Overall Study||2
1133930|NCT01331291|2744908|P2|COMPLETED|Overall Study||0
1133931|NCT01331291|2744909|P1|COMPLETED|Overall Study||0
1133932|NCT01331291|2744908|P2|STARTED|Overall Study||9
1133933|NCT01331291|2744909|P1|STARTED|Overall Study||2
1133934|NCT01331304|2744922|P2|NOT COMPLETED|Overall Study||60
1133935|NCT01331304|2744923|P1|NOT COMPLETED|Overall Study||58
1133936|NCT01331304|2744922|P2|COMPLETED|Overall Study||182
1133937|NCT01331304|2744923|P1|COMPLETED|Overall Study||182
1133938|NCT01331304|2744922|P2|STARTED|Overall Study||242
1133939|NCT01331304|2744923|P1|STARTED|Overall Study||240
1133940|NCT01331681|2744934|P3|NOT COMPLETED|Overall Study||35
1133941|NCT01331681|2744935|P2|NOT COMPLETED|Overall Study||34
1133942|NCT01331681|2744936|P1|NOT COMPLETED|Overall Study||35
1133943|NCT01331681|2744934|P3|COMPLETED|Overall Study|Completed Week 148|100
1133944|NCT01331681|2744935|P2|COMPLETED|Overall Study|Completed Week 148|101
1133945|NCT01331681|2744936|P1|COMPLETED|Overall Study|Completed Week 148|101
1133946|NCT01331681|2744934|P3|Completed Week 148|Overall Study||100
1133947|NCT01331681|2744935|P2|Completed Week 148|Overall Study||101
1133948|NCT01331681|2744936|P1|Completed Week 148|Overall Study||101
1133949|NCT01331681|2744934|P3|Completed Week 100|Overall Study||105
1133950|NCT01331681|2744935|P2|Completed Week 100|Overall Study||110
1133951|NCT01331681|2744936|P1|Completed Week 100|Overall Study||115
1133952|NCT01331681|2744934|P3|Completed Week 52|Overall Study||115
1133953|NCT01331681|2744935|P2|Completed Week 52|Overall Study||121
1133954|NCT01331681|2744936|P1|Completed Week 52|Overall Study||125
1133955|NCT01331681|2744934|P3|Participants Received Treatment|Overall Study|safety population|133
1133956|NCT01331681|2744935|P2|Participants Received Treatment|Overall Study|safety population|135
1133957|NCT01331681|2744936|P1|Participants Received Treatment|Overall Study|safety population|136
1133958|NCT01331681|2744934|P3|STARTED|Overall Study|randomized|135
1133959|NCT01331681|2744935|P2|STARTED|Overall Study|randomized|135
1133960|NCT01331681|2744936|P1|STARTED|Overall Study|randomized|136
1133961|NCT01331694|2744968|P6|NOT COMPLETED|Overall Study||0
1133962|NCT01331694|2744969|P5|NOT COMPLETED|Overall Study||0
1133963|NCT01331694|2744970|P4|NOT COMPLETED|Overall Study||0
1133964|NCT01331694|2744971|P3|NOT COMPLETED|Overall Study||0
1133965|NCT01331694|2744972|P2|NOT COMPLETED|Overall Study||0
1133966|NCT01331694|2744973|P1|NOT COMPLETED|Overall Study||0
1133967|NCT01331694|2744968|P6|COMPLETED|Overall Study||9126
1133968|NCT01331694|2744969|P5|COMPLETED|Overall Study||10617
1133969|NCT01331694|2744970|P4|COMPLETED|Overall Study||12595
1133970|NCT01331694|2744971|P3|COMPLETED|Overall Study||12659
1133971|NCT01331694|2744972|P2|COMPLETED|Overall Study||14449
1133972|NCT01331694|2744973|P1|COMPLETED|Overall Study||16684
1133973|NCT01331694|2744968|P6|STARTED|Overall Study||9126
1133974|NCT01331694|2744969|P5|STARTED|Overall Study||10617
1133975|NCT01331694|2744970|P4|STARTED|Overall Study||12595
1133976|NCT01331694|2744971|P3|STARTED|Overall Study||12659
1133977|NCT01331694|2744972|P2|STARTED|Overall Study||14449
1133978|NCT01331694|2744973|P1|STARTED|Overall Study||16684
1133979|NCT01325428|2744987|P1|NOT COMPLETED|Part B||3
1133980|NCT01325428|2744987|P1|COMPLETED|Part B||7
1133981|NCT01325428|2744987|P1|STARTED|Part B||10
1133982|NCT01325428|2744987|P1|NOT COMPLETED|Part A||16
1133983|NCT01325428|2744987|P1|COMPLETED|Part A||10
1133984|NCT01325428|2744987|P1|STARTED|Part A||26
1133985|NCT01325493|2745004|P2|NOT COMPLETED|Overall Study||3
1133986|NCT01325493|2745005|P1|NOT COMPLETED|Overall Study||1
1133987|NCT01325493|2745004|P2|COMPLETED|Overall Study||21
1133988|NCT01325493|2745005|P1|COMPLETED|Overall Study||29
1133989|NCT01325493|2745004|P2|STARTED|Overall Study||24
1133990|NCT01325493|2745005|P1|STARTED|Overall Study||30
1133991|NCT01325532|2745019|P2|NOT COMPLETED|Overall Study||0
1133992|NCT01325532|2745020|P1|NOT COMPLETED|Overall Study||2
1133993|NCT01325532|2745019|P2|COMPLETED|Overall Study||13
1133994|NCT01325532|2745020|P1|COMPLETED|Overall Study||15
1133995|NCT01325532|2745019|P2|STARTED|Overall Study||13
1133996|NCT01325532|2745020|P1|STARTED|Overall Study||17
1133997|NCT01325623|2745030|P1|NOT COMPLETED|Overall Study||3
1133998|NCT01325623|2745030|P1|COMPLETED|Overall Study||28
1133999|NCT01325623|2745030|P1|STARTED|Overall Study||31
1134000|NCT01325701|2745074|P2|NOT COMPLETED|Overall Study||3
1134001|NCT01325701|2745075|P1|NOT COMPLETED|Overall Study||21
1134002|NCT01325701|2745074|P2|COMPLETED|Overall Study||5
1134003|NCT01325701|2745075|P1|COMPLETED|Overall Study||49
1134004|NCT01325701|2745074|P2|STARTED|Overall Study||8
1134005|NCT01325701|2745075|P1|STARTED|Overall Study||70
1134006|NCT01331824|2745085|P1|NOT COMPLETED|Overall Study||13
1134007|NCT01331824|2745085|P1|COMPLETED|Overall Study||9
1134008|NCT01331824|2745085|P1|STARTED|Overall Study||22
1134009|NCT01331837|2745093|P2|NOT COMPLETED|Overall Study||67
1134010|NCT01331837|2745094|P1|NOT COMPLETED|Overall Study||56
1134011|NCT01331837|2745093|P2|COMPLETED|Overall Study||1475
1134012|NCT01331837|2745094|P1|COMPLETED|Overall Study||1482
1134013|NCT01331837|2745093|P2|STARTED|Overall Study||1542
1134014|NCT01331837|2745094|P1|STARTED|Overall Study||1538
1134015|NCT01332019|2745136|P2|NOT COMPLETED|Overall Study||122
1134016|NCT01332019|2745137|P1|NOT COMPLETED|Overall Study||113
1134017|NCT01332019|2745136|P2|COMPLETED|Overall Study||425
1134018|NCT01332019|2745137|P1|COMPLETED|Overall Study||417
1134019|NCT01332019|2745136|P2|STARTED|Overall Study||547
1134020|NCT01332019|2745137|P1|STARTED|Overall Study||530
1134021|NCT01333111|2745222|P3|NOT COMPLETED|Overall Study||2
1134022|NCT01333111|2745223|P2|NOT COMPLETED|Overall Study||3
1134023|NCT01333111|2745224|P1|NOT COMPLETED|Overall Study||2
1134024|NCT01333111|2745222|P3|COMPLETED|Overall Study||13
1134025|NCT01333111|2745223|P2|COMPLETED|Overall Study||26
1134026|NCT01333111|2745224|P1|COMPLETED|Overall Study||28
1134027|NCT01333111|2745222|P3|STARTED|Overall Study||15
1134028|NCT01333111|2745223|P2|STARTED|Overall Study||29
1134029|NCT01333111|2745224|P1|STARTED|Overall Study||30
1134030|NCT01333189|2745250|P2|NOT COMPLETED|Overall Study||2
1134031|NCT01333189|2745251|P1|NOT COMPLETED|Overall Study||2
1134032|NCT01333189|2745250|P2|COMPLETED|Overall Study||11
1134033|NCT01333189|2745251|P1|COMPLETED|Overall Study||11
1134034|NCT01333189|2745250|P2|STARTED|Overall Study||13
1134035|NCT01333189|2745251|P1|STARTED|Overall Study||13
1134036|NCT01333397|2745284|P5|NOT COMPLETED|Overall Study||0
1134037|NCT01333397|2745285|P4|NOT COMPLETED|Overall Study||1
1134038|NCT01333397|2745286|P3|NOT COMPLETED|Overall Study||0
1134039|NCT01333397|2745287|P2|NOT COMPLETED|Overall Study||0
1134040|NCT01333397|2745288|P1|NOT COMPLETED|Overall Study||1
1134041|NCT01333397|2745284|P5|COMPLETED|Overall Study||35
1134042|NCT01333397|2745285|P4|COMPLETED|Overall Study||34
1134043|NCT01333397|2745286|P3|COMPLETED|Overall Study||35
1134044|NCT01333397|2745287|P2|COMPLETED|Overall Study||36
1134045|NCT01333397|2745288|P1|COMPLETED|Overall Study||34
1134046|NCT01333397|2745284|P5|STARTED|Overall Study||35
1134047|NCT01333397|2745285|P4|STARTED|Overall Study||35
1134048|NCT01333397|2745286|P3|STARTED|Overall Study||35
1134049|NCT01333397|2745287|P2|STARTED|Overall Study||36
1134050|NCT01333397|2745288|P1|STARTED|Overall Study||35
1134051|NCT01333436|2745362|P2|NOT COMPLETED|Overall Study||0
1134052|NCT01333436|2745363|P1|NOT COMPLETED|Overall Study||0
1134053|NCT01333436|2745362|P2|COMPLETED|Overall Study||50
1134054|NCT01333436|2745363|P1|COMPLETED|Overall Study||43
1134055|NCT01333436|2745362|P2|STARTED|Overall Study||50
1134056|NCT01333436|2745363|P1|STARTED|Overall Study||43
1134057|NCT01333475|2745375|P2|NOT COMPLETED|Overall Study||3
1134058|NCT01333475|2745376|P1|NOT COMPLETED|Overall Study||2
1134059|NCT01333475|2745375|P2|COMPLETED|Overall Study||6
1134060|NCT01333475|2745376|P1|COMPLETED|Overall Study||10
1134061|NCT01333475|2745375|P2|STARTED|Overall Study||9
1134062|NCT01333475|2745376|P1|STARTED|Overall Study||12
1134063|NCT01333488|2745387|P3|NOT COMPLETED|Overall Study||0
1134064|NCT01333488|2745388|P2|NOT COMPLETED|Overall Study||0
1134065|NCT01333488|2745389|P1|NOT COMPLETED|Overall Study||0
1134066|NCT01333488|2745387|P3|COMPLETED|Overall Study||3
1134067|NCT01333488|2745388|P2|COMPLETED|Overall Study||1
1134068|NCT01333488|2745389|P1|COMPLETED|Overall Study||2
1134069|NCT01333488|2745387|P3|STARTED|Overall Study||3
1134070|NCT01333488|2745388|P2|STARTED|Overall Study||1
1134071|NCT01333488|2745389|P1|STARTED|Overall Study||2
1134072|NCT01333501|2745405|P2|NOT COMPLETED|Overall Study||21
1134073|NCT01333501|2745406|P1|NOT COMPLETED|Overall Study||9
1134074|NCT01333501|2745405|P2|COMPLETED|Overall Study||30
1134075|NCT01333501|2745406|P1|COMPLETED|Overall Study||97
1134076|NCT01333501|2745405|P2|Safety Population|Overall Study||47
1134077|NCT01333501|2745406|P1|Safety Population|Overall Study||104
1134078|NCT01333501|2745405|P2|Full Analysis Set (FAS)|Overall Study||28
1134079|NCT01333501|2745406|P1|Full Analysis Set (FAS)|Overall Study||80
1134080|NCT01333501|2745405|P2|STARTED|Overall Study||51
1134081|NCT01333501|2745406|P1|STARTED|Overall Study||106
1134082|NCT01333592|2745454|P2|NOT COMPLETED|Overall Study||17
1134083|NCT01333592|2745455|P1|NOT COMPLETED|Overall Study||9
1134084|NCT01333592|2745454|P2|COMPLETED|Overall Study||52
1134085|NCT01333592|2745455|P1|COMPLETED|Overall Study||58
1134086|NCT01333592|2745454|P2|STARTED|Overall Study||69
1134087|NCT01333592|2745455|P1|STARTED|Overall Study||67
1134088|NCT01333722|2745465|P2|NOT COMPLETED|Overall Study||3
1134089|NCT01333722|2745466|P1|NOT COMPLETED|Overall Study||0
1134090|NCT01333722|2745465|P2|COMPLETED|Overall Study||46
1134091|NCT01333722|2745466|P1|COMPLETED|Overall Study||51
1134092|NCT01333722|2745465|P2|STARTED|Overall Study||49
1134093|NCT01333722|2745466|P1|STARTED|Overall Study||51
1134094|NCT01333813|2745478|P1|NOT COMPLETED|Overall Study||0
1134095|NCT01333813|2745478|P1|COMPLETED|Overall Study||297
1134096|NCT01333813|2745478|P1|STARTED|Overall Study||297
1134097|NCT01333865|2745491|P1|NOT COMPLETED|Overall Study||2
1134098|NCT01333865|2745491|P1|COMPLETED|Overall Study|2 participants were withdrawn. One was still analyzed, but one was withdrawn too early for analysis|17
1134099|NCT01333865|2745491|P1|STARTED|Overall Study|25 participants signed consent, but only 19 completed screening and were analyzed at baseline.|19
1134100|NCT01333956|2745500|P4|NOT COMPLETED|Overall Study||2
1134101|NCT01333956|2745501|P3|NOT COMPLETED|Overall Study||1
1134102|NCT01333956|2745502|P2|NOT COMPLETED|Overall Study||4
1134103|NCT01333956|2745503|P1|NOT COMPLETED|Overall Study||2
1134104|NCT01333956|2745500|P4|COMPLETED|Overall Study||28
1134105|NCT01333956|2745501|P3|COMPLETED|Overall Study||29
1134106|NCT01333956|2745502|P2|COMPLETED|Overall Study||26
1134107|NCT01333956|2745503|P1|COMPLETED|Overall Study||28
1134108|NCT01333956|2745500|P4|STARTED|Overall Study||30
1134109|NCT01333956|2745501|P3|STARTED|Overall Study||30
1134110|NCT01333956|2745502|P2|STARTED|Overall Study||30
1134111|NCT01333956|2745503|P1|STARTED|Overall Study||30
1134112|NCT01334125|2745539|P2|NOT COMPLETED|Overall Study||3
1134113|NCT01334125|2745540|P1|NOT COMPLETED|Overall Study||3
1134114|NCT01334125|2745539|P2|COMPLETED|Overall Study|3 subjects left for college and moved out of the area|10
1134115|NCT01334125|2745540|P1|COMPLETED|Overall Study|3 subjects move to another city|12
1134116|NCT01334125|2745539|P2|STARTED|Overall Study||13
1134117|NCT01334125|2745540|P1|STARTED|Overall Study||15
1134118|NCT01334216|2745554|P2|NOT COMPLETED|Overall Study||0
1134119|NCT01334216|2745555|P1|NOT COMPLETED|Overall Study||0
1134120|NCT01334216|2745554|P2|COMPLETED|Overall Study||194
1134121|NCT01334216|2745555|P1|COMPLETED|Overall Study||168
1134122|NCT01334216|2745554|P2|STARTED|Overall Study||194
1134123|NCT01334216|2745555|P1|STARTED|Overall Study||168
1134124|NCT01334229|2745563|P2|NOT COMPLETED|Overall Study||0
1134125|NCT01334229|2745564|P1|NOT COMPLETED|Overall Study||0
1134126|NCT01334229|2745563|P2|COMPLETED|Overall Study||11
1134127|NCT01334229|2745564|P1|COMPLETED|Overall Study||11
1134128|NCT01334229|2745563|P2|STARTED|Overall Study||11
1134129|NCT01334229|2745564|P1|STARTED|Overall Study||11
1134130|NCT01334515|2745582|P2|NOT COMPLETED|Overall Study||29
1134131|NCT01334515|2745583|P1|NOT COMPLETED|Overall Study||12
1134132|NCT01334515|2745582|P2|COMPLETED|Overall Study||7
1134133|NCT01334515|2745583|P1|COMPLETED|Overall Study||4
1134134|NCT01334515|2745582|P2|STARTED|Overall Study||36
1134135|NCT01334515|2745583|P1|STARTED|Overall Study||16
1134136|NCT01334554|2745593|P2|NOT COMPLETED|Overall Study||2
1134137|NCT01334554|2745594|P1|NOT COMPLETED|Overall Study||4
1134138|NCT01334554|2745593|P2|COMPLETED|Overall Study||21
1134139|NCT01334554|2745594|P1|COMPLETED|Overall Study||19
1134140|NCT01334554|2745593|P2|STARTED|Overall Study||23
1134141|NCT01334554|2745594|P1|STARTED|Overall Study||23
1134142|NCT01334606|2745602|P1|NOT COMPLETED|Overall Study||18
1134143|NCT01334606|2745602|P1|COMPLETED|Overall Study||3
1134144|NCT01334606|2745602|P1|STARTED|Overall Study||21
1134145|NCT01334710|2745608|P1|NOT COMPLETED|Overall Study||3
1134146|NCT01334710|2745608|P1|COMPLETED|Overall Study|Due to safety signals in a parallel trial ON OSI906 in Hepatocellular cancer the trial was stopped.|0
1134147|NCT01334710|2745608|P1|STARTED|Overall Study||3
1134148|NCT01334723|2745614|P2|NOT COMPLETED|Overall Study||0
1134149|NCT01334723|2745615|P1|NOT COMPLETED|Overall Study||0
1134150|NCT01334723|2745614|P2|COMPLETED|Overall Study||17739
1134151|NCT01334723|2745615|P1|COMPLETED|Overall Study||17293
1134152|NCT01334723|2745614|P2|STARTED|Overall Study||17739
1134153|NCT01334723|2745615|P1|STARTED|Overall Study||17293
1134154|NCT01334866|2745641|P1|NOT COMPLETED|Overall Study||19
1134155|NCT01334866|2745641|P1|COMPLETED|Overall Study||72
1134156|NCT01334866|2745641|P1|STARTED|Overall Study|91 subjects were enrolled in the study; with 89 subjects receiving the study treatment.|91
1134157|NCT01334918|2745651|P2|NOT COMPLETED|Overall Study||1
1134158|NCT01334918|2745652|P1|NOT COMPLETED|Overall Study||8
1134159|NCT01334918|2745651|P2|COMPLETED|Overall Study||60
1134160|NCT01334918|2745652|P1|COMPLETED|Overall Study||55
1134161|NCT01334918|2745651|P2|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|61
1134162|NCT01334918|2745652|P1|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|57
1134163|NCT01334918|2745651|P2|STARTED|Overall Study||61
1134164|NCT01334918|2745652|P1|STARTED|Overall Study||63
1134165|NCT01334944|2745678|P2|NOT COMPLETED|Overall Study||0
1134166|NCT01334944|2745679|P1|NOT COMPLETED|Overall Study||0
1134167|NCT01334944|2745678|P2|COMPLETED|Overall Study||139
1134168|NCT01334944|2745679|P1|COMPLETED|Overall Study||11
1134169|NCT01334944|2745678|P2|Received Multiple Doses|Overall Study||43
1134170|NCT01334944|2745679|P1|Received Multiple Doses|Overall Study||10
1134171|NCT01334944|2745678|P2|Received Singel Dose|Overall Study||96
1134172|NCT01334944|2745679|P1|Received Singel Dose|Overall Study||1
1134173|NCT01334944|2745678|P2|STARTED|Overall Study||139
1134174|NCT01334944|2745679|P1|STARTED|Overall Study||11
1134175|NCT01334957|2745703|P1|NOT COMPLETED|Overall Study||0
1134176|NCT01334957|2745703|P1|COMPLETED|Overall Study||300
1134177|NCT01334957|2745703|P1|Received Multiple Doses|Overall Study||48
1134178|NCT01334957|2745703|P1|Received Single Dose|Overall Study||252
1134179|NCT01334957|2745703|P1|STARTED|Overall Study||300
1134180|NCT01335061|2745711|P1|NOT COMPLETED|Overall Study||0
1134181|NCT01335061|2745711|P1|COMPLETED|Overall Study||25
1134182|NCT01335061|2745711|P1|STARTED|Overall Study||25
1134183|NCT01335191|2745728|P2|NOT COMPLETED|Overall Study||0
1134184|NCT01335191|2745729|P1|NOT COMPLETED|Overall Study||0
1134185|NCT01335191|2745728|P2|COMPLETED|Overall Study||11
1134186|NCT01335191|2745729|P1|COMPLETED|Overall Study||16
1134187|NCT01335191|2745728|P2|STARTED|Overall Study||11
1134188|NCT01335191|2745729|P1|STARTED|Overall Study||16
1134189|NCT01335230|2745739|P4|NOT COMPLETED|Overall Study||0
1134190|NCT01335230|2745740|P3|NOT COMPLETED|Overall Study||0
1134191|NCT01335230|2745741|P2|NOT COMPLETED|Overall Study||0
1134192|NCT01335230|2745742|P1|NOT COMPLETED|Overall Study||0
1134193|NCT01335230|2745739|P4|COMPLETED|Overall Study|subjects|10
1134194|NCT01335230|2745740|P3|COMPLETED|Overall Study|subjects|10
1134195|NCT01335230|2745741|P2|COMPLETED|Overall Study|subjects|10
1134196|NCT01335230|2745742|P1|COMPLETED|Overall Study|subjects|10
1134197|NCT01335230|2745739|P4|STARTED|Overall Study|subjects|10
1134198|NCT01335230|2745740|P3|STARTED|Overall Study|subjects|10
1134199|NCT01335230|2745741|P2|STARTED|Overall Study|subjects|10
1134200|NCT01335230|2745742|P1|STARTED|Overall Study|subjects|10
1134201|NCT01335308|2745755|P3|NOT COMPLETED|Overall Study||81
1134202|NCT01335308|2745756|P2|NOT COMPLETED|Overall Study||67
1134203|NCT01335308|2745757|P1|NOT COMPLETED|Overall Study||40
1134204|NCT01335308|2745755|P3|COMPLETED|Overall Study||154
1134205|NCT01335308|2745756|P2|COMPLETED|Overall Study||145
1134206|NCT01335308|2745757|P1|COMPLETED|Overall Study||158
1134207|NCT01335308|2745755|P3|STARTED|Overall Study||235
1134208|NCT01335308|2745756|P2|STARTED|Overall Study||212
1134209|NCT01335308|2745757|P1|STARTED|Overall Study||198
1134210|NCT01335464|2745776|P2|NOT COMPLETED|Overall Study||49
1134211|NCT01335464|2745777|P1|NOT COMPLETED|Overall Study||32
1134212|NCT01335464|2745776|P2|COMPLETED|Overall Study||260
1134213|NCT01335464|2745777|P1|COMPLETED|Overall Study||174
1134214|NCT01335464|2745776|P2|STARTED|Overall Study||309
1134215|NCT01335464|2745777|P1|STARTED|Overall Study||206
1134216|NCT01335477|2745841|P2|NOT COMPLETED|Overall Study||59
1134217|NCT01335477|2745842|P1|NOT COMPLETED|Overall Study||41
1134218|NCT01335477|2745841|P2|COMPLETED|Overall Study||272
1134219|NCT01335477|2745842|P1|COMPLETED|Overall Study||179
1134220|NCT01335477|2745841|P2|STARTED|Overall Study||331
1134221|NCT01335477|2745842|P1|STARTED|Overall Study||220
1134222|NCT01328717|2745904|P1|NOT COMPLETED|Overall Study||1
1134223|NCT01328717|2745904|P1|COMPLETED|Overall Study||77
1134224|NCT01328717|2745904|P1|STARTED|Overall Study||78
1134225|NCT01328756|2745909|P1|NOT COMPLETED|Overall Study||123
1134226|NCT01328756|2745909|P1|COMPLETED|Overall Study||191
1134227|NCT01328756|2745909|P1|STARTED|Overall Study||314
1134228|NCT01328769|2745928|P2|NOT COMPLETED|Overall Study||1
1134229|NCT01328769|2745929|P1|NOT COMPLETED|Overall Study||0
1134230|NCT01328769|2745928|P2|COMPLETED|Overall Study||23
1134231|NCT01328769|2745929|P1|COMPLETED|Overall Study||25
1134232|NCT01328769|2745928|P2|STARTED|Overall Study||24
1134233|NCT01328769|2745929|P1|STARTED|Overall Study||25
1134234|NCT01328782|2745940|P3|NOT COMPLETED|Overall Study||0
1134235|NCT01328782|2745941|P2|NOT COMPLETED|Overall Study||0
1134236|NCT01328782|2745942|P1|NOT COMPLETED|Overall Study||0
1134237|NCT01328782|2745940|P3|COMPLETED|Overall Study||39
1134238|NCT01328782|2745941|P2|COMPLETED|Overall Study||42
1134239|NCT01328782|2745942|P1|COMPLETED|Overall Study||43
1134240|NCT01328782|2745940|P3|STARTED|Overall Study||39
1134241|NCT01328782|2745941|P2|STARTED|Overall Study||42
1134242|NCT01328782|2745942|P1|STARTED|Overall Study||43
1134243|NCT01328873|2745962|P1|NOT COMPLETED|Overall Study||0
1134244|NCT01328873|2745962|P1|COMPLETED|Overall Study||49
1134245|NCT01328873|2745962|P1|STARTED|Overall Study||49
1134246|NCT01328951|2745973|P2|NOT COMPLETED|Overall Study||322
1134247|NCT01328951|2745974|P1|NOT COMPLETED|Overall Study||321
1134248|NCT01328951|2745973|P2|COMPLETED|Overall Study||0
1134249|NCT01328951|2745974|P1|COMPLETED|Overall Study||0
1134250|NCT01328951|2745973|P2|STARTED|Overall Study||322
1134251|NCT01328951|2745974|P1|STARTED|Overall Study||321
1134252|NCT01328964|2746001|P3|NOT COMPLETED|Overall Study||0
1134253|NCT01328964|2746002|P2|NOT COMPLETED|Overall Study||0
1134254|NCT01328964|2746003|P1|NOT COMPLETED|Overall Study||0
1134255|NCT01328964|2746001|P3|COMPLETED|Overall Study||4424
1134256|NCT01328964|2746002|P2|COMPLETED|Overall Study||3270
1134257|NCT01328964|2746003|P1|COMPLETED|Overall Study||2212
1134258|NCT01328964|2746001|P3|STARTED|Overall Study||4424
1134259|NCT01328964|2746002|P2|STARTED|Overall Study||3270
1134260|NCT01328964|2746003|P1|STARTED|Overall Study||2212
1134261|NCT01329029|2746018|P2|NOT COMPLETED|Overall Study||192
1134262|NCT01329029|2746019|P1|NOT COMPLETED|Overall Study||269
1134263|NCT01329029|2746018|P2|COMPLETED|Overall Study||780
1134264|NCT01329029|2746019|P1|COMPLETED|Overall Study||704
1134265|NCT01329029|2746018|P2|Safety Population|Overall Study||967
1134266|NCT01329029|2746019|P1|Safety Population|Overall Study||968
1134267|NCT01329029|2746018|P2|Full Analysis Set (FAS)|Overall Study||966
1134268|NCT01329029|2746019|P1|Full Analysis Set (FAS)|Overall Study||969
1134269|NCT01329029|2746018|P2|STARTED|Overall Study||972
1134270|NCT01329029|2746019|P1|STARTED|Overall Study||973
1134271|NCT01335542|2746091|P2|NOT COMPLETED|Overall Study||0
1134272|NCT01335542|2746092|P1|NOT COMPLETED|Overall Study||0
1134273|NCT01335542|2746091|P2|COMPLETED|Overall Study||45
1134274|NCT01335542|2746092|P1|COMPLETED|Overall Study||45
1134275|NCT01335542|2746091|P2|STARTED|Overall Study||45
1134276|NCT01335542|2746092|P1|STARTED|Overall Study||45
1134277|NCT01335698|2746103|P5|NOT COMPLETED|Treatment Stage 2||6
1134278|NCT01335698|2746104|P4|NOT COMPLETED|Treatment Stage 2||24
1134279|NCT01335698|2746105|P3|NOT COMPLETED|Treatment Stage 2||16
1134280|NCT01335698|2746106|P2|NOT COMPLETED|Treatment Stage 2||4
1134281|NCT01335698|2746107|P1|NOT COMPLETED|Treatment Stage 2||15
1134282|NCT01335698|2746103|P5|COMPLETED|Treatment Stage 2||0
1134283|NCT01335698|2746104|P4|COMPLETED|Treatment Stage 2||2
1134284|NCT01335698|2746105|P3|COMPLETED|Treatment Stage 2||0
1134285|NCT01335698|2746106|P2|COMPLETED|Treatment Stage 2||0
1134286|NCT01335698|2746107|P1|COMPLETED|Treatment Stage 2||0
1134287|NCT01335698|2746103|P5|STARTED|Treatment Stage 2||6
1134288|NCT01335698|2746104|P4|STARTED|Treatment Stage 2||26
1134289|NCT01335698|2746105|P3|STARTED|Treatment Stage 2||16
1134290|NCT01335698|2746106|P2|STARTED|Treatment Stage 2||4
1134291|NCT01335698|2746107|P1|STARTED|Treatment Stage 2||15
1134292|NCT01335698|2746103|P5|NOT COMPLETED|Treatment Stage 1||2
1134293|NCT01335698|2746104|P4|NOT COMPLETED|Treatment Stage 1||9
1134294|NCT01335698|2746105|P3|NOT COMPLETED|Treatment Stage 1||5
1134295|NCT01335698|2746106|P2|NOT COMPLETED|Treatment Stage 1||8
1134296|NCT01335698|2746107|P1|NOT COMPLETED|Treatment Stage 1||8
1134297|NCT01335698|2746103|P5|COMPLETED|Treatment Stage 1||6
1134298|NCT01335698|2746104|P4|COMPLETED|Treatment Stage 1||26
1134299|NCT01335698|2746105|P3|COMPLETED|Treatment Stage 1||16
1134300|NCT01335698|2746106|P2|COMPLETED|Treatment Stage 1||4
1134301|NCT01335698|2746107|P1|COMPLETED|Treatment Stage 1||15
1134302|NCT01335698|2746103|P5|STARTED|Treatment Stage 1||8
1134303|NCT01335698|2746104|P4|STARTED|Treatment Stage 1||35
1134304|NCT01335698|2746105|P3|STARTED|Treatment Stage 1||21
1134305|NCT01335698|2746106|P2|STARTED|Treatment Stage 1||12
1134306|NCT01335698|2746107|P1|STARTED|Treatment Stage 1||23
1134307|NCT01335724|2746156|P2|NOT COMPLETED|Overall Study||0
1134308|NCT01335724|2746157|P1|NOT COMPLETED|Overall Study||0
1134309|NCT01335724|2746156|P2|COMPLETED|Overall Study||36
1134310|NCT01335724|2746157|P1|COMPLETED|Overall Study||36
1134311|NCT01335724|2746156|P2|STARTED|Overall Study||36
1134312|NCT01335724|2746157|P1|STARTED|Overall Study||36
1134313|NCT01335750|2746167|P1|NOT COMPLETED|Overall Study||0
1134314|NCT01335750|2746167|P1|COMPLETED|Overall Study||32
1134315|NCT01335750|2746167|P1|STARTED|Overall Study||32
1134316|NCT01335789|2746188|P2|NOT COMPLETED|Overall Study||0
1134317|NCT01335789|2746189|P1|NOT COMPLETED|Overall Study||0
1134318|NCT01335789|2746188|P2|COMPLETED|Overall Study||8
1134319|NCT01335789|2746189|P1|COMPLETED|Overall Study||8
1134320|NCT01335789|2746188|P2|STARTED|Overall Study||8
1134321|NCT01335789|2746189|P1|STARTED|Overall Study||8
1134322|NCT01335932|2746201|P2|NOT COMPLETED|Overall Study||4
1134323|NCT01335932|2746202|P1|NOT COMPLETED|Overall Study||0
1134324|NCT01335932|2746201|P2|COMPLETED|Overall Study||72
1134325|NCT01335932|2746202|P1|COMPLETED|Overall Study||84
1134326|NCT01335932|2746201|P2|STARTED|Overall Study||76
1134327|NCT01335932|2746202|P1|STARTED|Overall Study||84
1134328|NCT01335971|2746211|P3|NOT COMPLETED|Overall Study||1
1134329|NCT01335971|2746212|P2|NOT COMPLETED|Overall Study||1
1134330|NCT01335971|2746213|P1|NOT COMPLETED|Overall Study||2
1134331|NCT01335971|2746211|P3|COMPLETED|Overall Study||28
1134332|NCT01335971|2746212|P2|COMPLETED|Overall Study||28
1134333|NCT01335971|2746213|P1|COMPLETED|Overall Study||29
1134334|NCT01335971|2746211|P3|STARTED|Overall Study||29
1134335|NCT01335971|2746212|P2|STARTED|Overall Study||29
1134336|NCT01335971|2746213|P1|STARTED|Overall Study||31
1134337|NCT01335997|2746250|P2|NOT COMPLETED|Period III||79
1134338|NCT01335997|2746251|P1|NOT COMPLETED|Period III||78
1134339|NCT01335997|2746250|P2|COMPLETED|Period III||4
1134340|NCT01335997|2746251|P1|COMPLETED|Period III||6
1134341|NCT01335997|2746250|P2|STARTED|Period III||83
1134342|NCT01335997|2746251|P1|STARTED|Period III||84
1134343|NCT01335997|2746250|P2|NOT COMPLETED|Period I and II||479
1134344|NCT01335997|2746251|P1|NOT COMPLETED|Period I and II||493
1134345|NCT01335997|2746250|P2|COMPLETED|Period I and II||83
1134346|NCT01335997|2746251|P1|COMPLETED|Period I and II||84
1134347|NCT01335997|2746250|P2|STARTED|Period I and II||562
1134348|NCT01335997|2746251|P1|STARTED|Period I and II||577
1134349|NCT01336023|2746264|P3|NOT COMPLETED|Week 27 to 52||28
1134350|NCT01336023|2746265|P2|NOT COMPLETED|Week 27 to 52||44
1134351|NCT01336023|2746266|P1|NOT COMPLETED|Week 27 to 52||28
1134352|NCT01336023|2746264|P3|COMPLETED|Week 27 to 52||285
1134353|NCT01336023|2746265|P2|COMPLETED|Week 27 to 52||621
1134354|NCT01336023|2746266|P1|COMPLETED|Week 27 to 52||305
1134355|NCT01336023|2746264|P3|STARTED|Week 27 to 52|From the main trial, 29 subjects were not enrolled in the extension (week 27-52).|313
1134356|NCT01336023|2746265|P2|STARTED|Week 27 to 52|From the main trial, 71 subjects were not enrolled in the extension (week 27-52).|665
1134357|NCT01336023|2746266|P1|STARTED|Week 27 to 52|From the main trial, 33 subjects were not enrolled in the extension (week 27-52).|333
1134358|NCT01336023|2746264|P3|NOT COMPLETED|Week 0 to Week 26||73
1134359|NCT01336023|2746265|P2|NOT COMPLETED|Week 0 to Week 26||98
1134360|NCT01336023|2746266|P1|NOT COMPLETED|Week 0 to Week 26||48
1134361|NCT01336023|2746264|P3|COMPLETED|Week 0 to Week 26||342
1134362|NCT01336023|2746265|P2|COMPLETED|Week 0 to Week 26||736
1134363|NCT01336023|2746266|P1|COMPLETED|Week 0 to Week 26||366
1134364|NCT01336023|2746264|P3|Exposed|Week 0 to Week 26|2 subjects withdrew before exposure to trial drug and were not included in the analysis|413
1134365|NCT01336023|2746265|P2|Exposed|Week 0 to Week 26|8 subjects withdrew before exposure to trial drug and were not included in the analysis|826
1134366|NCT01336023|2746266|P1|Exposed|Week 0 to Week 26|1 subject withdrew before exposure to trial drug and was not included in the analysis|413
1134367|NCT01336023|2746264|P3|STARTED|Week 0 to Week 26||415
1134368|NCT01336023|2746265|P2|STARTED|Week 0 to Week 26||834
1134369|NCT01336023|2746266|P1|STARTED|Week 0 to Week 26||414
1134370|NCT01336140|2746287|P2|NOT COMPLETED|Overall Study||0
1134371|NCT01336140|2746288|P1|NOT COMPLETED|Overall Study||0
1134372|NCT01336140|2746287|P2|COMPLETED|Overall Study||150
1134373|NCT01336140|2746288|P1|COMPLETED|Overall Study||150
1134374|NCT01336140|2746287|P2|STARTED|Overall Study||150
1134375|NCT01336140|2746288|P1|STARTED|Overall Study||150
1134376|NCT01336205|2746302|P2|NOT COMPLETED|Overall Study||89
1134377|NCT01336205|2746303|P1|NOT COMPLETED|Overall Study||233
1134378|NCT01336205|2746302|P2|COMPLETED|Overall Study||192
1134379|NCT01336205|2746303|P1|COMPLETED|Overall Study||330
1134380|NCT01336205|2746302|P2|STARTED|Overall Study||281
1134381|NCT01336205|2746303|P1|STARTED|Overall Study||563
1134382|NCT01336296|2746315|P2|NOT COMPLETED|Overall Study||4
1134383|NCT01336296|2746316|P1|NOT COMPLETED|Overall Study||5
1134384|NCT01336296|2746315|P2|COMPLETED|Overall Study||17
1134385|NCT01336296|2746316|P1|COMPLETED|Overall Study||35
1134386|NCT01336296|2746315|P2|STARTED|Overall Study||21
1134387|NCT01336296|2746316|P1|STARTED|Overall Study||40
1134388|NCT01336569|2746330|P1|NOT COMPLETED|Overall Study||4
1134389|NCT01336569|2746330|P1|COMPLETED|Overall Study||45
1134390|NCT01336569|2746330|P1|STARTED|Overall Study||49
1134391|NCT01336608|2746337|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||24
1134392|NCT01336608|2746338|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||30
1134393|NCT01336608|2746339|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||44
1134394|NCT01336608|2746340|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
1134395|NCT01336608|2746337|P4|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|111
1134396|NCT01336608|2746338|P3|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|124
1134397|NCT01336608|2746339|P2|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|97
1134398|NCT01336608|2746340|P1|COMPLETED|24-week, Double-blind Treatment Period||0
1134399|NCT01336608|2746337|P4|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|110
1134400|NCT01336608|2746338|P3|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|124
1134401|NCT01336608|2746339|P2|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|96
1134402|NCT01336608|2746340|P1|Completed the Treatment Period|24-week, Double-blind Treatment Period||0
1134403|NCT01336608|2746337|P4|STARTED|24-week, Double-blind Treatment Period||135
1134404|NCT01336608|2746338|P3|STARTED|24-week, Double-blind Treatment Period||154
1134405|NCT01336608|2746339|P2|STARTED|24-week, Double-blind Treatment Period||141
1134406|NCT01336608|2746340|P1|STARTED|24-week, Double-blind Treatment Period||0
1134407|NCT01336608|2746337|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1134408|NCT01336608|2746338|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1134409|NCT01336608|2746339|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
1134410|NCT01336608|2746340|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||115
1134411|NCT01336608|2746337|P4|COMPLETED|2-week, Single-blind Run-In Period||0
1134412|NCT01336608|2746338|P3|COMPLETED|2-week, Single-blind Run-In Period||0
1134413|NCT01336608|2746339|P2|COMPLETED|2-week, Single-blind Run-In Period||0
1134414|NCT01336608|2746340|P1|COMPLETED|2-week, Single-blind Run-In Period||444
1134415|NCT01336608|2746337|P4|STARTED|2-week, Single-blind Run-In Period||0
1134416|NCT01336608|2746338|P3|STARTED|2-week, Single-blind Run-In Period||0
1134417|NCT01336608|2746339|P2|STARTED|2-week, Single-blind Run-In Period||0
1134418|NCT01336608|2746340|P1|STARTED|2-week, Single-blind Run-In Period||559
1134419|NCT01336647|2746357|P3|NOT COMPLETED|Overall Study||3
1134420|NCT01336647|2746358|P2|NOT COMPLETED|Overall Study||1
1134421|NCT01336647|2746359|P1|NOT COMPLETED|Overall Study||4
1134422|NCT01336647|2746357|P3|COMPLETED|Overall Study||44
1134423|NCT01336647|2746358|P2|COMPLETED|Overall Study||48
1134424|NCT01336647|2746359|P1|COMPLETED|Overall Study||42
1134425|NCT01336647|2746357|P3|STARTED|Overall Study||47
1134426|NCT01336647|2746358|P2|STARTED|Overall Study||49
1134427|NCT01336647|2746359|P1|STARTED|Overall Study||46
1134428|NCT01336712|2746370|P1|NOT COMPLETED|Overall Study||3
1134429|NCT01336712|2746370|P1|COMPLETED|Overall Study||27
1134430|NCT01336712|2746370|P1|STARTED|Overall Study||30
1134431|NCT01336738|2746385|P5|NOT COMPLETED|Overall Study||10
1134432|NCT01336738|2746386|P4|NOT COMPLETED|Overall Study||7
1134433|NCT01336738|2746387|P3|NOT COMPLETED|Overall Study||8
1134434|NCT01336738|2746388|P2|NOT COMPLETED|Overall Study||9
1134435|NCT01336738|2746389|P1|NOT COMPLETED|Overall Study||7
1134436|NCT01336738|2746385|P5|COMPLETED|Overall Study||43
1134437|NCT01336738|2746386|P4|COMPLETED|Overall Study||47
1134438|NCT01336738|2746387|P3|COMPLETED|Overall Study||45
1134439|NCT01336738|2746388|P2|COMPLETED|Overall Study||45
1134440|NCT01336738|2746389|P1|COMPLETED|Overall Study||45
1134441|NCT01336738|2746385|P5|STARTED|Overall Study||53
1134442|NCT01336738|2746386|P4|STARTED|Overall Study||54
1134443|NCT01336738|2746387|P3|STARTED|Overall Study||53
1134444|NCT01336738|2746388|P2|STARTED|Overall Study||54
1134445|NCT01336738|2746389|P1|STARTED|Overall Study||52
1134446|NCT01336764|2746433|P2|NOT COMPLETED|Overall Study||5
1134447|NCT01336764|2746434|P1|NOT COMPLETED|Overall Study||5
1134448|NCT01336764|2746433|P2|COMPLETED|Overall Study||5
1134449|NCT01336764|2746434|P1|COMPLETED|Overall Study||7
1134450|NCT01336764|2746433|P2|STARTED|Overall Study||10
1134451|NCT01336764|2746434|P1|STARTED|Overall Study||12
1134452|NCT01336894|2746442|P2|NOT COMPLETED|Follow-up||7
1134453|NCT01336894|2746443|P1|NOT COMPLETED|Follow-up||2
1134454|NCT01336894|2746442|P2|COMPLETED|Follow-up||0
1134455|NCT01336894|2746443|P1|COMPLETED|Follow-up||2
1134456|NCT01336894|2746442|P2|STARTED|Follow-up||7
1134457|NCT01336894|2746443|P1|STARTED|Follow-up||4
1134458|NCT01336894|2746442|P2|NOT COMPLETED|Protocol Interventions||0
1134459|NCT01336894|2746443|P1|NOT COMPLETED|Protocol Interventions||0
1134460|NCT01336894|2746442|P2|COMPLETED|Protocol Interventions||7
1134461|NCT01336894|2746443|P1|COMPLETED|Protocol Interventions||4
1134462|NCT01336894|2746442|P2|STARTED|Protocol Interventions||7
1134463|NCT01336894|2746443|P1|STARTED|Protocol Interventions||4
1134464|NCT01336972|2746464|P3|NOT COMPLETED|Overall Study||0
1134465|NCT01336972|2746465|P2|NOT COMPLETED|Overall Study||1
1134466|NCT01336972|2746466|P1|NOT COMPLETED|Overall Study||1
1134467|NCT01336972|2746464|P3|COMPLETED|Overall Study||9
1134468|NCT01336972|2746465|P2|COMPLETED|Overall Study||9
1134469|NCT01336972|2746466|P1|COMPLETED|Overall Study||9
1134470|NCT01336972|2746464|P3|STARTED|Overall Study||9
1134471|NCT01336972|2746465|P2|STARTED|Overall Study||10
1134472|NCT01336972|2746466|P1|STARTED|Overall Study||10
1134473|NCT01337050|2746504|P3|NOT COMPLETED|Overall Study||19
1134474|NCT01337050|2746505|P2|NOT COMPLETED|Overall Study||13
1134475|NCT01337050|2746506|P1|NOT COMPLETED|Overall Study||4
1134476|NCT01337050|2746504|P3|COMPLETED|Overall Study||0
1134477|NCT01337050|2746505|P2|COMPLETED|Overall Study||0
1134478|NCT01337050|2746506|P1|COMPLETED|Overall Study||0
1134479|NCT01337050|2746504|P3|STARTED|Overall Study||19
1134480|NCT01337050|2746505|P2|STARTED|Overall Study||13
1134481|NCT01337050|2746506|P1|STARTED|Overall Study||4
1134482|NCT01337076|2746564|P1|NOT COMPLETED|Overall Study||2
1134483|NCT01337076|2746564|P1|COMPLETED|Overall Study|subjects met the primary endpoint of 6 months postimplant activation|19
1134484|NCT01337076|2746564|P1|STARTED|Overall Study|subjects implanted|21
1134485|NCT01337115|2746570|P2|NOT COMPLETED|Overall Study||0
1134486|NCT01337115|2746571|P1|NOT COMPLETED|Overall Study||2
1134487|NCT01337115|2746570|P2|COMPLETED|Overall Study||25
1134488|NCT01337115|2746571|P1|COMPLETED|Overall Study|2 patients could not be assessed after 12h because of catheter dislocation|23
1134489|NCT01337115|2746570|P2|STARTED|Overall Study||25
1134490|NCT01337115|2746571|P1|STARTED|Overall Study||25
1134491|NCT01337167|2746585|P2|NOT COMPLETED|Toddler Vaccinations||13
1134492|NCT01337167|2746586|P1|NOT COMPLETED|Toddler Vaccinations||14
1134493|NCT01337167|2746585|P2|COMPLETED|Toddler Vaccinations||407
1134494|NCT01337167|2746586|P1|COMPLETED|Toddler Vaccinations||829
1134495|NCT01337167|2746585|P2|STARTED|Toddler Vaccinations||420
1134496|NCT01337167|2746586|P1|STARTED|Toddler Vaccinations||843
1134497|NCT01337167|2746585|P2|NOT COMPLETED|Interim Period||40
1134498|NCT01337167|2746586|P1|NOT COMPLETED|Interim Period||81
1134499|NCT01337167|2746585|P2|COMPLETED|Interim Period||420
1134500|NCT01337167|2746586|P1|COMPLETED|Interim Period||843
1134501|NCT01337167|2746585|P2|STARTED|Interim Period||460
1134502|NCT01337167|2746586|P1|STARTED|Interim Period||924
1134503|NCT01337167|2746585|P2|NOT COMPLETED|Infant Series||27
1134504|NCT01337167|2746586|P1|NOT COMPLETED|Infant Series||62
1134505|NCT01337167|2746585|P2|COMPLETED|Infant Series||460
1134506|NCT01337167|2746586|P1|COMPLETED|Infant Series||924
1134507|NCT01337167|2746585|P2|STARTED|Infant Series||487
1134508|NCT01337167|2746586|P1|STARTED|Infant Series||986
1134509|NCT01337297|2746654|P2|NOT COMPLETED|Overall Study||6
1134510|NCT01337297|2746655|P1|NOT COMPLETED|Overall Study||5
1134511|NCT01337297|2746654|P2|COMPLETED|Overall Study||3
1134512|NCT01337297|2746655|P1|COMPLETED|Overall Study||6
1134513|NCT01337297|2746654|P2|STARTED|Overall Study||9
1134514|NCT01337297|2746655|P1|STARTED|Overall Study||11
1134515|NCT01337336|2746663|P2|NOT COMPLETED|Overall Study||0
1134516|NCT01337336|2746664|P1|NOT COMPLETED|Overall Study||0
1134517|NCT01337336|2746663|P2|COMPLETED|Overall Study||2923
1134518|NCT01337336|2746664|P1|COMPLETED|Overall Study||1078
1134519|NCT01337336|2746663|P2|STARTED|Overall Study||2923
1134520|NCT01337336|2746664|P1|STARTED|Overall Study||1078
1134521|NCT01337609|2746679|P3|NOT COMPLETED|Overall Study||0
1134522|NCT01337609|2746680|P2|NOT COMPLETED|Overall Study||0
1134523|NCT01337609|2746681|P1|NOT COMPLETED|Overall Study||1
1134524|NCT01337609|2746679|P3|COMPLETED|Overall Study||2
1134525|NCT01337609|2746680|P2|COMPLETED|Overall Study||2
1134526|NCT01337609|2746681|P1|COMPLETED|Overall Study||0
1134527|NCT01337609|2746679|P3|STARTED|Overall Study||2
1134528|NCT01337609|2746680|P2|STARTED|Overall Study||2
1134529|NCT01337609|2746681|P1|STARTED|Overall Study||1
1134530|NCT01337635|2746703|P2|NOT COMPLETED|Overall Study||1
1134531|NCT01337635|2746704|P1|NOT COMPLETED|Overall Study||0
1134532|NCT01337635|2746703|P2|COMPLETED|Overall Study||2
1134533|NCT01337635|2746704|P1|COMPLETED|Overall Study||4
1134534|NCT01337635|2746703|P2|STARTED|Overall Study||3
1134535|NCT01337635|2746704|P1|STARTED|Overall Study||4
1134536|NCT01337674|2746712|P4|NOT COMPLETED|Treatment Period 2||0
1134537|NCT01337674|2746713|P3|NOT COMPLETED|Treatment Period 2||1
1134538|NCT01337674|2746714|P2|NOT COMPLETED|Treatment Period 2||0
1134539|NCT01337674|2746715|P1|NOT COMPLETED|Treatment Period 2||0
1134540|NCT01337674|2746712|P4|COMPLETED|Treatment Period 2||6
1134541|NCT01337674|2746713|P3|COMPLETED|Treatment Period 2||5
1134542|NCT01337674|2746714|P2|COMPLETED|Treatment Period 2||6
1134543|NCT01337674|2746715|P1|COMPLETED|Treatment Period 2||6
1134544|NCT01337674|2746712|P4|STARTED|Treatment Period 2||6
1134545|NCT01337674|2746713|P3|STARTED|Treatment Period 2||6
1134546|NCT01337674|2746714|P2|STARTED|Treatment Period 2||6
1134547|NCT01337674|2746715|P1|STARTED|Treatment Period 2||6
1134548|NCT01337674|2746712|P4|NOT COMPLETED|Two-week Washout Period||0
1134549|NCT01337674|2746713|P3|NOT COMPLETED|Two-week Washout Period||0
1134550|NCT01337674|2746714|P2|NOT COMPLETED|Two-week Washout Period||0
1134551|NCT01337674|2746715|P1|NOT COMPLETED|Two-week Washout Period||0
1134552|NCT01337674|2746712|P4|COMPLETED|Two-week Washout Period||6
1134553|NCT01337674|2746713|P3|COMPLETED|Two-week Washout Period||6
1134554|NCT01337674|2746714|P2|COMPLETED|Two-week Washout Period||6
1134555|NCT01337674|2746715|P1|COMPLETED|Two-week Washout Period||6
1134556|NCT01337674|2746712|P4|STARTED|Two-week Washout Period||6
1134557|NCT01337674|2746713|P3|STARTED|Two-week Washout Period||6
1134558|NCT01337674|2746714|P2|STARTED|Two-week Washout Period||6
1134559|NCT01337674|2746715|P1|STARTED|Two-week Washout Period||6
1134560|NCT01337674|2746712|P4|NOT COMPLETED|Treatment Period 1||1
1134561|NCT01337674|2746713|P3|NOT COMPLETED|Treatment Period 1||0
1134562|NCT01337674|2746714|P2|NOT COMPLETED|Treatment Period 1||1
1134563|NCT01337674|2746715|P1|NOT COMPLETED|Treatment Period 1||0
1134564|NCT01337674|2746712|P4|COMPLETED|Treatment Period 1||6
1134565|NCT01337674|2746713|P3|COMPLETED|Treatment Period 1||6
1134566|NCT01337674|2746714|P2|COMPLETED|Treatment Period 1||6
1134567|NCT01337674|2746715|P1|COMPLETED|Treatment Period 1||6
1134568|NCT01337674|2746712|P4|STARTED|Treatment Period 1|The discontinued participant was replaced|7
1134569|NCT01337674|2746713|P3|STARTED|Treatment Period 1||6
1134570|NCT01337674|2746714|P2|STARTED|Treatment Period 1|The discontinued participant was replaced|7
1134571|NCT01337674|2746715|P1|STARTED|Treatment Period 1||6
1134572|NCT01337739|2746733|P2|NOT COMPLETED|Overall Study||0
1134573|NCT01337739|2746734|P1|NOT COMPLETED|Overall Study||0
1134574|NCT01337739|2746733|P2|COMPLETED|Overall Study||4
1134575|NCT01337739|2746734|P1|COMPLETED|Overall Study||6
1134576|NCT01337739|2746733|P2|STARTED|Overall Study||4
1134577|NCT01337739|2746734|P1|STARTED|Overall Study||6
1134578|NCT01337960|2746745|P3|NOT COMPLETED|Overall Study||0
1134579|NCT01337960|2746746|P2|NOT COMPLETED|Overall Study||0
1134580|NCT01337960|2746747|P1|NOT COMPLETED|Overall Study||2
1134581|NCT01337960|2746745|P3|COMPLETED|Overall Study||6
1134582|NCT01337960|2746746|P2|COMPLETED|Overall Study||14
1134583|NCT01337960|2746747|P1|COMPLETED|Overall Study||12
1134584|NCT01337960|2746745|P3|STARTED|Overall Study||6
1134585|NCT01337960|2746746|P2|STARTED|Overall Study||14
1134586|NCT01337960|2746747|P1|STARTED|Overall Study||14
1134587|NCT01338012|2746767|P1|NOT COMPLETED|Overall Study||8
1134588|NCT01338012|2746767|P1|COMPLETED|Overall Study||0
1134589|NCT01338012|2746767|P1|STARTED|Overall Study||8
1134590|NCT01338025|2746773|P2|NOT COMPLETED|Overall Study||11
1134591|NCT01338025|2746774|P1|NOT COMPLETED|Overall Study||11
1134592|NCT01338025|2746773|P2|COMPLETED|Overall Study||6
1134593|NCT01338025|2746774|P1|COMPLETED|Overall Study||5
1134594|NCT01338025|2746773|P2|STARTED|Overall Study||17
1134595|NCT01338025|2746774|P1|STARTED|Overall Study||16
1134596|NCT01338493|2746786|P1|NOT COMPLETED|24 Months Follow up||0
1134597|NCT01338493|2746786|P1|COMPLETED|24 Months Follow up||104
1134598|NCT01338493|2746786|P1|STARTED|24 Months Follow up||104
1134599|NCT01338493|2746786|P1|NOT COMPLETED|12 Months Follow up||9
1134600|NCT01338493|2746786|P1|COMPLETED|12 Months Follow up||104
1134601|NCT01338493|2746786|P1|STARTED|12 Months Follow up||113
1134602|NCT01338493|2746786|P1|NOT COMPLETED|6 Months Follow up||19
1134603|NCT01338493|2746786|P1|COMPLETED|6 Months Follow up||113
1134604|NCT01338493|2746786|P1|STARTED|6 Months Follow up||132
1134605|NCT01338493|2746786|P1|NOT COMPLETED|Discharge||2
1134606|NCT01338493|2746786|P1|COMPLETED|Discharge||132
1134607|NCT01338493|2746786|P1|STARTED|Discharge||134
1134608|NCT01338493|2746786|P1|NOT COMPLETED|Implant||0
1134609|NCT01338493|2746786|P1|COMPLETED|Implant||134
1134610|NCT01338493|2746786|P1|STARTED|Implant||134
1134611|NCT01338493|2746786|P1|NOT COMPLETED|Enrolled||5
1134612|NCT01338493|2746786|P1|COMPLETED|Enrolled||134
1134613|NCT01338493|2746786|P1|STARTED|Enrolled||139
1134614|NCT01332071|2746791|P2|NOT COMPLETED|Period 2||0
1134615|NCT01332071|2746792|P1|NOT COMPLETED|Period 2||0
1134616|NCT01332071|2746791|P2|COMPLETED|Period 2||13
1134617|NCT01332071|2746792|P1|COMPLETED|Period 2||13
1134618|NCT01332071|2746791|P2|STARTED|Period 2||13
1134619|NCT01332071|2746792|P1|STARTED|Period 2||13
1134620|NCT01332071|2746791|P2|NOT COMPLETED|7-Day Washout Period||0
1134621|NCT01332071|2746792|P1|NOT COMPLETED|7-Day Washout Period||0
1134622|NCT01332071|2746791|P2|COMPLETED|7-Day Washout Period||13
1134623|NCT01332071|2746792|P1|COMPLETED|7-Day Washout Period||13
1134624|NCT01332071|2746791|P2|STARTED|7-Day Washout Period||13
1134625|NCT01332071|2746792|P1|STARTED|7-Day Washout Period||13
1134626|NCT01332071|2746791|P2|NOT COMPLETED|Period 1||0
1134627|NCT01332071|2746792|P1|NOT COMPLETED|Period 1||0
1134628|NCT01332071|2746791|P2|COMPLETED|Period 1||13
1134629|NCT01332071|2746792|P1|COMPLETED|Period 1||13
1134630|NCT01332071|2746791|P2|STARTED|Period 1||13
1134631|NCT01332071|2746792|P1|STARTED|Period 1||13
1134632|NCT01332123|2746808|P1|NOT COMPLETED|Overall Study||0
1134633|NCT01332123|2746808|P1|COMPLETED|Overall Study||10
1134634|NCT01332123|2746808|P1|STARTED|Overall Study||10
1134635|NCT01332149|2746815|P2|NOT COMPLETED|Overall Study||38
1134636|NCT01332149|2746816|P1|NOT COMPLETED|Overall Study||30
1134637|NCT01332149|2746815|P2|COMPLETED|Overall Study||271
1134638|NCT01332149|2746816|P1|COMPLETED|Overall Study||284
1134639|NCT01332149|2746815|P2|Treated|Overall Study||307
1134640|NCT01332149|2746816|P1|Treated|Overall Study||313
1134641|NCT01332149|2746815|P2|STARTED|Overall Study|Assigned to study treatment.|309
1134642|NCT01332149|2746816|P1|STARTED|Overall Study|Assigned to study treatment.|314
1134643|NCT01332188|2746874|P4|NOT COMPLETED|Overall Study||0
1134644|NCT01332188|2746875|P3|NOT COMPLETED|Overall Study||4
1134645|NCT01332188|2746876|P2|NOT COMPLETED|Overall Study||1
1134646|NCT01332188|2746877|P1|NOT COMPLETED|Overall Study||2
1134647|NCT01332188|2746874|P4|COMPLETED|Overall Study||25
1134648|NCT01332188|2746875|P3|COMPLETED|Overall Study||21
1134649|NCT01332188|2746876|P2|COMPLETED|Overall Study||25
1134650|NCT01332188|2746877|P1|COMPLETED|Overall Study||23
1134651|NCT01332188|2746874|P4|STARTED|Overall Study||25
1134652|NCT01332188|2746875|P3|STARTED|Overall Study||25
1134653|NCT01332188|2746876|P2|STARTED|Overall Study||26
1134654|NCT01332188|2746877|P1|STARTED|Overall Study||25
1134655|NCT01332227|2747033|P2|NOT COMPLETED|Overall Study||5
1134656|NCT01332227|2747034|P1|NOT COMPLETED|Overall Study||16
1134657|NCT01332227|2747033|P2|COMPLETED|Overall Study||32
1134658|NCT01332227|2747034|P1|COMPLETED|Overall Study||56
1134659|NCT01332227|2747033|P2|STARTED|Overall Study|Participants who received treatment|37
1134660|NCT01332227|2747034|P1|STARTED|Overall Study|Participants who received treatment|72
1134661|NCT01332253|2747054|P2|NOT COMPLETED|Overall Study||0
1134662|NCT01332253|2747055|P1|NOT COMPLETED|Overall Study||0
1134663|NCT01332253|2747054|P2|COMPLETED|Overall Study||79
1134664|NCT01332253|2747055|P1|COMPLETED|Overall Study||82
1134665|NCT01332253|2747054|P2|STARTED|Overall Study||79
1134666|NCT01332253|2747055|P1|STARTED|Overall Study||82
1134667|NCT01332292|2747081|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
1134668|NCT01332292|2747082|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||1
1134669|NCT01332292|2747081|P2|COMPLETED|Treatment Period 2 (14 Days)||11
1134670|NCT01332292|2747082|P1|COMPLETED|Treatment Period 2 (14 Days)||11
1134671|NCT01332292|2747081|P2|STARTED|Treatment Period 2 (14 Days)||12
1134672|NCT01332292|2747082|P1|STARTED|Treatment Period 2 (14 Days)||12
1134673|NCT01332292|2747081|P2|NOT COMPLETED|Washout Period (>=7 Days)||0
1134674|NCT01332292|2747082|P1|NOT COMPLETED|Washout Period (>=7 Days)||0
1134675|NCT01332292|2747081|P2|COMPLETED|Washout Period (>=7 Days)||12
1134676|NCT01332292|2747082|P1|COMPLETED|Washout Period (>=7 Days)||12
1134677|NCT01332292|2747081|P2|STARTED|Washout Period (>=7 Days)||12
1134678|NCT01332292|2747082|P1|STARTED|Washout Period (>=7 Days)||12
1134679|NCT01332292|2747081|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
1134680|NCT01332292|2747082|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
1134681|NCT01332292|2747081|P2|COMPLETED|Treatment Period 1 (14 Days)||12
1134682|NCT01332292|2747082|P1|COMPLETED|Treatment Period 1 (14 Days)||12
1134683|NCT01332292|2747081|P2|STARTED|Treatment Period 1 (14 Days)||13
1134684|NCT01332292|2747082|P1|STARTED|Treatment Period 1 (14 Days)||14
1134685|NCT01332305|2747147|P5|NOT COMPLETED|Overall Study||12
1134686|NCT01332305|2747148|P4|NOT COMPLETED|Overall Study||8
1134687|NCT01332305|2747149|P3|NOT COMPLETED|Overall Study||14
1134688|NCT01332305|2747150|P2|NOT COMPLETED|Overall Study||14
1134689|NCT01332305|2747151|P1|NOT COMPLETED|Overall Study||10
1134690|NCT01332305|2747147|P5|COMPLETED|Overall Study||33
1134691|NCT01332305|2747148|P4|COMPLETED|Overall Study||30
1134692|NCT01332305|2747149|P3|COMPLETED|Overall Study||31
1134693|NCT01332305|2747150|P2|COMPLETED|Overall Study||34
1134694|NCT01332305|2747151|P1|COMPLETED|Overall Study||31
1134695|NCT01332305|2747147|P5|STARTED|Overall Study||45
1134696|NCT01332305|2747148|P4|STARTED|Overall Study||38
1134697|NCT01332305|2747149|P3|STARTED|Overall Study||45
1134698|NCT01332305|2747150|P2|STARTED|Overall Study||48
1134699|NCT01332305|2747151|P1|STARTED|Overall Study||41
1134700|NCT01332318|2747177|P4|NOT COMPLETED|Overall Study||2
1134701|NCT01332318|2747178|P3|NOT COMPLETED|Overall Study||1
1134702|NCT01332318|2747179|P2|NOT COMPLETED|Overall Study||4
1134703|NCT01332318|2747180|P1|NOT COMPLETED|Overall Study||2
1134704|NCT01332318|2747177|P4|COMPLETED|Overall Study||28
1134705|NCT01332318|2747178|P3|COMPLETED|Overall Study||33
1134706|NCT01332318|2747179|P2|COMPLETED|Overall Study||28
1134707|NCT01332318|2747180|P1|COMPLETED|Overall Study||32
1134708|NCT01332318|2747177|P4|STARTED|Overall Study||30
1134709|NCT01332318|2747178|P3|STARTED|Overall Study||34
1134710|NCT01332318|2747179|P2|STARTED|Overall Study||32
1134711|NCT01332318|2747180|P1|STARTED|Overall Study||34
1134712|NCT01332357|2747286|P1|NOT COMPLETED|Overall Study||0
1134713|NCT01332357|2747286|P1|COMPLETED|Overall Study||6139
1134714|NCT01332357|2747286|P1|STARTED|Overall Study||6139
1134715|NCT01332435|2747294|P4|NOT COMPLETED|Overall Study||0
1134716|NCT01332435|2747295|P3|NOT COMPLETED|Overall Study||0
1134717|NCT01332435|2747296|P2|NOT COMPLETED|Overall Study||0
1134718|NCT01332435|2747297|P1|NOT COMPLETED|Overall Study||0
1134719|NCT01332435|2747294|P4|COMPLETED|Overall Study||1656
1134720|NCT01332435|2747295|P3|COMPLETED|Overall Study||2604
1134721|NCT01332435|2747296|P2|COMPLETED|Overall Study||1064
1134722|NCT01332435|2747297|P1|COMPLETED|Overall Study||1572
1134723|NCT01332435|2747294|P4|STARTED|Overall Study||1656
1134724|NCT01332435|2747295|P3|STARTED|Overall Study||2604
1134725|NCT01332435|2747296|P2|STARTED|Overall Study||1064
1134726|NCT01332435|2747297|P1|STARTED|Overall Study||1572
1134727|NCT01332461|2747329|P2|NOT COMPLETED|Overall Study||0
1134728|NCT01332461|2747330|P1|NOT COMPLETED|Overall Study||0
1134729|NCT01332461|2747329|P2|COMPLETED|Overall Study||4386
1134730|NCT01332461|2747330|P1|COMPLETED|Overall Study||1291
1134731|NCT01332461|2747329|P2|STARTED|Overall Study||4386
1134732|NCT01332461|2747330|P1|STARTED|Overall Study||1291
1134733|NCT01332487|2747342|P2|NOT COMPLETED|Overall Study||0
1134734|NCT01332487|2747343|P1|NOT COMPLETED|Overall Study||0
1134735|NCT01332487|2747342|P2|COMPLETED|Overall Study||3063
1134736|NCT01332487|2747343|P1|COMPLETED|Overall Study||5554
1134737|NCT01332487|2747342|P2|STARTED|Overall Study||3063
1134738|NCT01332487|2747343|P1|STARTED|Overall Study||5554
1134739|NCT01332500|2747355|P4|NOT COMPLETED|Overall Study||0
1134740|NCT01332500|2747356|P3|NOT COMPLETED|Overall Study||0
1134741|NCT01332500|2747357|P2|NOT COMPLETED|Overall Study||0
1134742|NCT01332500|2747358|P1|NOT COMPLETED|Overall Study||0
1134743|NCT01332500|2747355|P4|COMPLETED|Overall Study||5806
1134744|NCT01332500|2747356|P3|COMPLETED|Overall Study||2903
1134745|NCT01332500|2747357|P2|COMPLETED|Overall Study||39771
1134746|NCT01332500|2747358|P1|COMPLETED|Overall Study||13257
1134747|NCT01332500|2747355|P4|STARTED|Overall Study||5806
1134748|NCT01332500|2747356|P3|STARTED|Overall Study||2903
1134749|NCT01332500|2747357|P2|STARTED|Overall Study||39771
1134750|NCT01332500|2747358|P1|STARTED|Overall Study||13257
1134751|NCT01332578|2747376|P2|NOT COMPLETED|Period II||0
1134752|NCT01332578|2747377|P1|NOT COMPLETED|Period II||0
1134753|NCT01332578|2747376|P2|COMPLETED|Period II||13
1134754|NCT01332578|2747377|P1|COMPLETED|Period II||12
1134755|NCT01332578|2747376|P2|STARTED|Period II||13
1134756|NCT01332578|2747377|P1|STARTED|Period II||12
1134757|NCT01332578|2747376|P2|NOT COMPLETED|Washout Period||0
1134758|NCT01332578|2747377|P1|NOT COMPLETED|Washout Period||0
1134759|NCT01332578|2747376|P2|COMPLETED|Washout Period||13
1134760|NCT01332578|2747377|P1|COMPLETED|Washout Period||12
1134761|NCT01332578|2747376|P2|STARTED|Washout Period||13
1134762|NCT01332578|2747377|P1|STARTED|Washout Period||12
1134763|NCT01332578|2747376|P2|NOT COMPLETED|Period I||0
1134764|NCT01332578|2747377|P1|NOT COMPLETED|Period I||0
1134765|NCT01332578|2747376|P2|COMPLETED|Period I||13
1134766|NCT01332578|2747377|P1|COMPLETED|Period I||12
1134767|NCT01332578|2747376|P2|STARTED|Period I||13
1134768|NCT01332578|2747377|P1|STARTED|Period I||12
1134769|NCT01332721|2747396|P1|NOT COMPLETED|Overall Study||0
1134770|NCT01332721|2747396|P1|COMPLETED|Overall Study||38
1134771|NCT01332721|2747396|P1|STARTED|Overall Study||38
1134772|NCT01332968|2747404|P8|NOT COMPLETED|Follow-Up Period||531
1134773|NCT01332968|2747405|P7|NOT COMPLETED|Follow-Up Period||542
1134774|NCT01332968|2747406|P6|NOT COMPLETED|Follow-Up Period||0
1134775|NCT01332968|2747407|P5|NOT COMPLETED|Follow-Up Period||0
1134776|NCT01332968|2747408|P4|NOT COMPLETED|Follow-Up Period||0
1134777|NCT01332968|2747409|P3|NOT COMPLETED|Follow-Up Period||0
1134778|NCT01332968|2747410|P2|NOT COMPLETED|Follow-Up Period||0
1134779|NCT01332968|2747411|P1|NOT COMPLETED|Follow-Up Period||0
1134780|NCT01332968|2747404|P8|COMPLETED|Follow-Up Period||0
1134781|NCT01332968|2747405|P7|COMPLETED|Follow-Up Period||0
1134782|NCT01332968|2747406|P6|COMPLETED|Follow-Up Period||0
1134783|NCT01332968|2747407|P5|COMPLETED|Follow-Up Period||0
1134784|NCT01332968|2747408|P4|COMPLETED|Follow-Up Period||0
1134785|NCT01332968|2747409|P3|COMPLETED|Follow-Up Period||0
1134786|NCT01332968|2747410|P2|COMPLETED|Follow-Up Period||0
1134787|NCT01332968|2747411|P1|COMPLETED|Follow-Up Period||0
1134788|NCT01332968|2747404|P8|STARTED|Follow-Up Period||531
1134789|NCT01332968|2747405|P7|STARTED|Follow-Up Period||542
1134790|NCT01332968|2747406|P6|STARTED|Follow-Up Period||0
1134791|NCT01332968|2747407|P5|STARTED|Follow-Up Period||0
1134792|NCT01332968|2747408|P4|STARTED|Follow-Up Period||0
1134793|NCT01332968|2747409|P3|STARTED|Follow-Up Period||0
1134794|NCT01332968|2747410|P2|STARTED|Follow-Up Period||0
1134795|NCT01332968|2747411|P1|STARTED|Follow-Up Period||0
1134796|NCT01332968|2747404|P8|NOT COMPLETED|Maintenance/Observation Period||0
1134797|NCT01332968|2747405|P7|NOT COMPLETED|Maintenance/Observation Period||0
1134798|NCT01332968|2747406|P6|NOT COMPLETED|Maintenance/Observation Period||9
1134799|NCT01332968|2747407|P5|NOT COMPLETED|Maintenance/Observation Period||10
1134800|NCT01332968|2747408|P4|NOT COMPLETED|Maintenance/Observation Period||207
1134801|NCT01332968|2747409|P3|NOT COMPLETED|Maintenance/Observation Period||213
1134802|NCT01332968|2747410|P2|NOT COMPLETED|Maintenance/Observation Period||0
1134803|NCT01332968|2747411|P1|NOT COMPLETED|Maintenance/Observation Period||0
1134804|NCT01332968|2747404|P8|COMPLETED|Maintenance/Observation Period||0
1134805|NCT01332968|2747405|P7|COMPLETED|Maintenance/Observation Period||0
1134806|NCT01332968|2747406|P6|COMPLETED|Maintenance/Observation Period||2
1134807|NCT01332968|2747407|P5|COMPLETED|Maintenance/Observation Period||2
1134808|NCT01332968|2747408|P4|COMPLETED|Maintenance/Observation Period||417
1134809|NCT01332968|2747409|P3|COMPLETED|Maintenance/Observation Period||399
1134810|NCT01332968|2747410|P2|COMPLETED|Maintenance/Observation Period||0
1134811|NCT01332968|2747411|P1|COMPLETED|Maintenance/Observation Period||0
1134812|NCT01332968|2747404|P8|STARTED|Maintenance/Observation Period||0
1134813|NCT01332968|2747405|P7|STARTED|Maintenance/Observation Period||0
1134814|NCT01332968|2747406|P6|STARTED|Maintenance/Observation Period||11
1134815|NCT01332968|2747407|P5|STARTED|Maintenance/Observation Period||12
1134816|NCT01332968|2747408|P4|STARTED|Maintenance/Observation Period||624
1134817|NCT01332968|2747409|P3|STARTED|Maintenance/Observation Period||612
1134818|NCT01332968|2747410|P2|STARTED|Maintenance/Observation Period||0
1134819|NCT01332968|2747411|P1|STARTED|Maintenance/Observation Period||0
1134820|NCT01332968|2747404|P8|NOT COMPLETED|Induction Period||0
1134821|NCT01332968|2747405|P7|NOT COMPLETED|Induction Period||0
1134822|NCT01332968|2747406|P6|NOT COMPLETED|Induction Period||0
1134823|NCT01332968|2747407|P5|NOT COMPLETED|Induction Period||0
1134824|NCT01332968|2747408|P4|NOT COMPLETED|Induction Period||0
1134825|NCT01332968|2747409|P3|NOT COMPLETED|Induction Period||0
1134826|NCT01332968|2747410|P2|NOT COMPLETED|Induction Period||56
1134827|NCT01332968|2747411|P1|NOT COMPLETED|Induction Period||58
1134828|NCT01332968|2747404|P8|COMPLETED|Induction Period||0
1134829|NCT01332968|2747405|P7|COMPLETED|Induction Period||0
1134830|NCT01332968|2747406|P6|COMPLETED|Induction Period||0
1134831|NCT01332968|2747407|P5|COMPLETED|Induction Period||0
1134832|NCT01332968|2747408|P4|COMPLETED|Induction Period||0
1134833|NCT01332968|2747409|P3|COMPLETED|Induction Period||0
1134834|NCT01332968|2747410|P2|COMPLETED|Induction Period||646
1134835|NCT01332968|2747411|P1|COMPLETED|Induction Period||641
1134836|NCT01332968|2747404|P8|STARTED|Induction Period||0
1134837|NCT01332968|2747405|P7|STARTED|Induction Period||0
1134838|NCT01332968|2747406|P6|STARTED|Induction Period||0
1134839|NCT01332968|2747407|P5|STARTED|Induction Period||0
1134840|NCT01332968|2747408|P4|STARTED|Induction Period||0
1134841|NCT01332968|2747409|P3|STARTED|Induction Period||0
1134842|NCT01332968|2747410|P2|STARTED|Induction Period||702
1134843|NCT01332968|2747411|P1|STARTED|Induction Period||699
1134844|NCT01332981|2747475|P1|NOT COMPLETED|Overall Study||0
1134845|NCT01332981|2747475|P1|COMPLETED|Overall Study||220
1134846|NCT01332981|2747475|P1|STARTED|Overall Study||220
1134847|NCT01332994|2747486|P1|NOT COMPLETED|Overall Study||71
1134848|NCT01332994|2747486|P1|COMPLETED|Overall Study||448
1134849|NCT01332994|2747486|P1|Completed Week 66 (TCZ/RTX)|Overall Study||25
1134850|NCT01332994|2747486|P1|Completed Week 32 (TCZ/RTX)|Overall Study||26
1134851|NCT01332994|2747486|P1|Completed Week 32 (TCZ/TCZ)|Overall Study||200
1134852|NCT01332994|2747486|P1|Completed Week 16|Overall Study||463
1134853|NCT01332994|2747486|P1|STARTED|Overall Study||519
1134854|NCT01338610|2747545|P3|NOT COMPLETED|Overall Study||1
1134855|NCT01338610|2747546|P2|NOT COMPLETED|Overall Study||1
1134856|NCT01338610|2747547|P1|NOT COMPLETED|Overall Study||5
1134857|NCT01338610|2747545|P3|COMPLETED|Overall Study||28
1134858|NCT01338610|2747546|P2|COMPLETED|Overall Study||55
1134859|NCT01338610|2747547|P1|COMPLETED|Overall Study||34
1134860|NCT01338610|2747545|P3|STARTED|Overall Study||29
1134861|NCT01338610|2747546|P2|STARTED|Overall Study||56
1134862|NCT01338610|2747547|P1|STARTED|Overall Study||39
1134863|NCT01338636|2747554|P1|NOT COMPLETED|Overall Study||8
1134864|NCT01338636|2747554|P1|COMPLETED|Overall Study||22
1134865|NCT01338636|2747554|P1|STARTED|Overall Study||30
1134866|NCT01338649|2747567|P2|NOT COMPLETED|Overall Study||0
1134867|NCT01338649|2747568|P1|NOT COMPLETED|Overall Study||0
1134868|NCT01338649|2747567|P2|COMPLETED|Overall Study||14
1134869|NCT01338649|2747568|P1|COMPLETED|Overall Study||13
1134870|NCT01338649|2747567|P2|STARTED|Overall Study||14
1134871|NCT01338649|2747568|P1|STARTED|Overall Study||13
1134872|NCT01338792|2747574|P1|NOT COMPLETED|Overall Study||4
1134873|NCT01338792|2747574|P1|COMPLETED|Overall Study||43
1134874|NCT01338792|2747574|P1|STARTED|Overall Study||47
1134875|NCT01338818|2747580|P1|NOT COMPLETED|Overall Study||36
1134876|NCT01338818|2747580|P1|COMPLETED|Overall Study||262
1134877|NCT01338818|2747580|P1|STARTED|Overall Study||298
1134878|NCT01338857|2747586|P1|NOT COMPLETED|Overall Study||11
1134879|NCT01338857|2747586|P1|COMPLETED|Overall Study||1
1134880|NCT01338857|2747586|P1|STARTED|Overall Study||12
1134881|NCT01338870|2747597|P6|NOT COMPLETED|Overall Study||6
1134882|NCT01338870|2747598|P5|NOT COMPLETED|Overall Study||6
1134883|NCT01338870|2747599|P4|NOT COMPLETED|Overall Study||9
1134884|NCT01338870|2747600|P3|NOT COMPLETED|Overall Study||11
1134885|NCT01338870|2747601|P2|NOT COMPLETED|Overall Study||12
1134886|NCT01338870|2747602|P1|NOT COMPLETED|Overall Study||9
1134887|NCT01338870|2747597|P6|COMPLETED|Overall Study||44
1134888|NCT01338870|2747598|P5|COMPLETED|Overall Study||46
1134889|NCT01338870|2747599|P4|COMPLETED|Overall Study||41
1134890|NCT01338870|2747600|P3|COMPLETED|Overall Study||39
1134891|NCT01338870|2747601|P2|COMPLETED|Overall Study||37
1134892|NCT01338870|2747602|P1|COMPLETED|Overall Study||41
1134893|NCT01338870|2747597|P6|STARTED|Overall Study||50
1134894|NCT01338870|2747598|P5|STARTED|Overall Study||52
1134895|NCT01338870|2747599|P4|STARTED|Overall Study||50
1134896|NCT01338870|2747600|P3|STARTED|Overall Study||50
1134897|NCT01338870|2747601|P2|STARTED|Overall Study||49
1134898|NCT01338870|2747602|P1|STARTED|Overall Study||50
1134899|NCT01339247|2747652|P2|NOT COMPLETED|Period 2||0
1134900|NCT01339247|2747653|P1|NOT COMPLETED|Period 2||0
1134901|NCT01339247|2747652|P2|COMPLETED|Period 2||30
1134902|NCT01339247|2747653|P1|COMPLETED|Period 2||30
1134903|NCT01339247|2747652|P2|STARTED|Period 2||30
1134904|NCT01339247|2747653|P1|STARTED|Period 2||30
1134905|NCT01339247|2747652|P2|NOT COMPLETED|Period 1||0
1134906|NCT01339247|2747653|P1|NOT COMPLETED|Period 1||0
1134907|NCT01339247|2747652|P2|COMPLETED|Period 1||30
1134908|NCT01339247|2747653|P1|COMPLETED|Period 1||30
1134909|NCT01339247|2747652|P2|STARTED|Period 1||30
1134910|NCT01339247|2747653|P1|STARTED|Period 1||30
1134911|NCT01339260|2747665|P2|NOT COMPLETED|Multi-cycle Extension||193
1134912|NCT01339260|2747666|P1|NOT COMPLETED|Multi-cycle Extension||186
1134913|NCT01339260|2747665|P2|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|458
1134914|NCT01339260|2747666|P1|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|449
1134915|NCT01339260|2747665|P2|Safety Population|Multi-cycle Extension|Patients receiving palonosetron|651
1134916|NCT01339260|2747666|P1|Safety Population|Multi-cycle Extension|Patients receiving netupitant/palonosetron combination|635
1134917|NCT01339260|2747665|P2|STARTED|Multi-cycle Extension|Patients scheduled to palonosetron|651
1134918|NCT01339260|2747666|P1|STARTED|Multi-cycle Extension|Patients scheduled to netupitant/palonosetron combination|635
1134919|NCT01339260|2747665|P2|NOT COMPLETED|Cycle 1||10
1134920|NCT01339260|2747666|P1|NOT COMPLETED|Cycle 1||7
1134921|NCT01339260|2747665|P2|COMPLETED|Cycle 1||719
1134922|NCT01339260|2747666|P1|COMPLETED|Cycle 1||719
1134923|NCT01339260|2747665|P2|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to palonosetron|725
1134924|NCT01339260|2747666|P1|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to netupitant/palonosetron combination|724
1134925|NCT01339260|2747665|P2|Safety Population|Cycle 1|Patients receiving palonosetron|725
1134926|NCT01339260|2747666|P1|Safety Population|Cycle 1|Patients receiving netupitant/palonosetron combination|725
1134927|NCT01339260|2747665|P2|STARTED|Cycle 1|Intent-To-Treat: randomized patients|729
1134928|NCT01339260|2747666|P1|STARTED|Cycle 1|Intent-To-Treat: randomized patients|726
1134929|NCT01339299|2747680|P2|NOT COMPLETED|Overall Study||0
1134930|NCT01339299|2747681|P1|NOT COMPLETED|Overall Study||0
1134931|NCT01339299|2747680|P2|COMPLETED|Overall Study||50
1134932|NCT01339299|2747681|P1|COMPLETED|Overall Study||50
1134933|NCT01339299|2747680|P2|STARTED|Overall Study||50
1134934|NCT01339299|2747681|P1|STARTED|Overall Study||50
1134935|NCT01339390|2747689|P2|NOT COMPLETED|Overall Study||156
1134936|NCT01339390|2747690|P1|NOT COMPLETED|Overall Study||157
1134937|NCT01339390|2747689|P2|COMPLETED|Overall Study||1442
1134938|NCT01339390|2747690|P1|COMPLETED|Overall Study||1414
1134939|NCT01339390|2747689|P2|STARTED|Overall Study||1598
1134940|NCT01339390|2747690|P1|STARTED|Overall Study||1571
1134941|NCT01339403|2747698|P2|NOT COMPLETED|Overall Study||0
1134942|NCT01339403|2747699|P1|NOT COMPLETED|Overall Study||0
1134943|NCT01339403|2747698|P2|COMPLETED|Overall Study||257600
1134944|NCT01339403|2747699|P1|COMPLETED|Overall Study||24768
1134945|NCT01339403|2747698|P2|STARTED|Overall Study||257600
1134946|NCT01339403|2747699|P1|STARTED|Overall Study||24768
1134947|NCT01339416|2747719|P1|NOT COMPLETED|Overall Study||0
1134948|NCT01339416|2747719|P1|COMPLETED|Overall Study||8202
1134949|NCT01339416|2747719|P1|STARTED|Overall Study||8202
1134950|NCT01339429|2747729|P1|NOT COMPLETED|Overall Study||4
1134951|NCT01339429|2747729|P1|COMPLETED|Overall Study||37
1134952|NCT01339429|2747729|P1|STARTED|Overall Study||41
1134953|NCT01339832|2747734|P1|NOT COMPLETED|Overall Study||14
1134954|NCT01339832|2747734|P1|COMPLETED|Overall Study||37
1134955|NCT01339832|2747734|P1|STARTED|Overall Study||51
1134956|NCT01339897|2747749|P4|NOT COMPLETED|Overall Study||1
1134957|NCT01339897|2747750|P3|NOT COMPLETED|Overall Study||0
1134958|NCT01339897|2747751|P2|NOT COMPLETED|Overall Study||0
1134959|NCT01339897|2747752|P1|NOT COMPLETED|Overall Study||1
1134960|NCT01339897|2747749|P4|COMPLETED|Overall Study||5
1134961|NCT01339897|2747750|P3|COMPLETED|Overall Study||6
1134962|NCT01339897|2747751|P2|COMPLETED|Overall Study||6
1134963|NCT01339897|2747752|P1|COMPLETED|Overall Study||6
1134964|NCT01339897|2747749|P4|STARTED|Overall Study||6
1134965|NCT01339897|2747750|P3|STARTED|Overall Study||6
1134966|NCT01339897|2747751|P2|STARTED|Overall Study||6
1134967|NCT01339897|2747752|P1|STARTED|Overall Study||7
1134968|NCT01339923|2747785|P7|NOT COMPLETED|Overall Study||14
1134969|NCT01339923|2747786|P6|NOT COMPLETED|Overall Study||9
1134970|NCT01339923|2747787|P5|NOT COMPLETED|Overall Study||5
1134971|NCT01339923|2747788|P4|NOT COMPLETED|Overall Study||4
1134972|NCT01339923|2747789|P3|NOT COMPLETED|Overall Study||8
1134973|NCT01339923|2747790|P2|NOT COMPLETED|Overall Study||16
1134974|NCT01339923|2747791|P1|NOT COMPLETED|Overall Study||14
1134975|NCT01339923|2747785|P7|COMPLETED|Overall Study||111
1134976|NCT01339923|2747786|P6|COMPLETED|Overall Study||117
1134977|NCT01339923|2747787|P5|COMPLETED|Overall Study||295
1134978|NCT01339923|2747788|P4|COMPLETED|Overall Study||100
1134979|NCT01339923|2747789|P3|COMPLETED|Overall Study||243
1134980|NCT01339923|2747790|P2|COMPLETED|Overall Study||234
1134981|NCT01339923|2747791|P1|COMPLETED|Overall Study||239
1134982|NCT01339923|2747785|P7|STARTED|Overall Study||125
1134983|NCT01339923|2747786|P6|STARTED|Overall Study||126
1134984|NCT01339923|2747787|P5|STARTED|Overall Study||300
1134985|NCT01339923|2747788|P4|STARTED|Overall Study||104
1134986|NCT01339923|2747789|P3|STARTED|Overall Study||251
1134987|NCT01339923|2747790|P2|STARTED|Overall Study||250
1134988|NCT01339923|2747791|P1|STARTED|Overall Study||253
1134989|NCT01339936|2747860|P1|NOT COMPLETED|Overall Study||2
1134990|NCT01339936|2747860|P1|COMPLETED|Overall Study|plus 1 excluded from analysis set|36
1134991|NCT01339936|2747860|P1|STARTED|Overall Study|plus 2 screen failures|38
1134992|NCT01340014|2747868|P2|NOT COMPLETED|Period 2, Second 7 Days||1
1134993|NCT01340014|2747869|P1|NOT COMPLETED|Period 2, Second 7 Days||0
1134994|NCT01340014|2747868|P2|COMPLETED|Period 2, Second 7 Days||56
1134995|NCT01340014|2747869|P1|COMPLETED|Period 2, Second 7 Days||53
1134996|NCT01340014|2747868|P2|STARTED|Period 2, Second 7 Days||57
1134997|NCT01340014|2747869|P1|STARTED|Period 2, Second 7 Days||53
1134998|NCT01340014|2747868|P2|NOT COMPLETED|Period 1, First 7 Days||0
1134999|NCT01340014|2747869|P1|NOT COMPLETED|Period 1, First 7 Days||2
1135000|NCT01340014|2747868|P2|COMPLETED|Period 1, First 7 Days||57
1135001|NCT01340014|2747869|P1|COMPLETED|Period 1, First 7 Days||53
1135002|NCT01340014|2747868|P2|STARTED|Period 1, First 7 Days||57
1135003|NCT01340014|2747869|P1|STARTED|Period 1, First 7 Days||55
1135004|NCT01340027|2747889|P12|NOT COMPLETED|Overall Study||4
1135005|NCT01340027|2747890|P11|NOT COMPLETED|Overall Study||2
1135006|NCT01340027|2747891|P10|NOT COMPLETED|Overall Study||6
1135007|NCT01340027|2747892|P9|NOT COMPLETED|Overall Study||8
1135008|NCT01340027|2747893|P8|NOT COMPLETED|Overall Study||7
1135009|NCT01340027|2747894|P7|NOT COMPLETED|Overall Study||7
1135010|NCT01340027|2747895|P6|NOT COMPLETED|Overall Study||4
1135011|NCT01340027|2747896|P5|NOT COMPLETED|Overall Study||10
1135012|NCT01340027|2747897|P4|NOT COMPLETED|Overall Study||4
1135013|NCT01340027|2747898|P3|NOT COMPLETED|Overall Study||4
1135014|NCT01340027|2747899|P2|NOT COMPLETED|Overall Study||7
1135015|NCT01340027|2747900|P1|NOT COMPLETED|Overall Study||5
1135016|NCT01340027|2747889|P12|COMPLETED|Overall Study||77
1135017|NCT01340027|2747890|P11|COMPLETED|Overall Study||79
1135018|NCT01340027|2747891|P10|COMPLETED|Overall Study||146
1135019|NCT01340027|2747892|P9|COMPLETED|Overall Study||136
1135020|NCT01340027|2747893|P8|COMPLETED|Overall Study||142
1135021|NCT01340027|2747894|P7|COMPLETED|Overall Study||142
1135022|NCT01340027|2747895|P6|COMPLETED|Overall Study||74
1135023|NCT01340027|2747896|P5|COMPLETED|Overall Study||146
1135024|NCT01340027|2747897|P4|COMPLETED|Overall Study||75
1135025|NCT01340027|2747898|P3|COMPLETED|Overall Study||75
1135026|NCT01340027|2747899|P2|COMPLETED|Overall Study||71
1135027|NCT01340027|2747900|P1|COMPLETED|Overall Study||76
1135028|NCT01340027|2747889|P12|Received Treatment|Overall Study||81
1135029|NCT01340027|2747890|P11|Received Treatment|Overall Study||81
1135030|NCT01340027|2747891|P10|Received Treatment|Overall Study||152
1135031|NCT01340027|2747892|P9|Received Treatment|Overall Study||144
1135032|NCT01340027|2747893|P8|Received Treatment|Overall Study||149
1135033|NCT01340027|2747894|P7|Received Treatment|Overall Study||149
1135034|NCT01340027|2747895|P6|Received Treatment|Overall Study||78
1135035|NCT01340027|2747896|P5|Received Treatment|Overall Study||156
1135036|NCT01340027|2747897|P4|Received Treatment|Overall Study||79
1135037|NCT01340027|2747898|P3|Received Treatment|Overall Study||78
1135038|NCT01340027|2747899|P2|Received Treatment|Overall Study||78
1135039|NCT01340027|2747900|P1|Received Treatment|Overall Study||81
1135040|NCT01340027|2747889|P12|STARTED|Overall Study||81
1135041|NCT01340027|2747890|P11|STARTED|Overall Study||81
1135042|NCT01340027|2747891|P10|STARTED|Overall Study||152
1135043|NCT01340027|2747892|P9|STARTED|Overall Study||144
1135044|NCT01340027|2747893|P8|STARTED|Overall Study||149
1135045|NCT01340027|2747894|P7|STARTED|Overall Study||149
1135046|NCT01340027|2747895|P6|STARTED|Overall Study||78
1135047|NCT01340027|2747896|P5|STARTED|Overall Study||156
1135048|NCT01340027|2747897|P4|STARTED|Overall Study||79
1135049|NCT01340027|2747898|P3|STARTED|Overall Study||79
1135050|NCT01340027|2747899|P2|STARTED|Overall Study||78
1135051|NCT01340027|2747900|P1|STARTED|Overall Study||81
1135052|NCT01340066|2748276|P3|NOT COMPLETED|5 Week Double Blind Randomization Period||3
1135053|NCT01340066|2748277|P2|NOT COMPLETED|5 Week Double Blind Randomization Period||5
1135054|NCT01340066|2748278|P1|NOT COMPLETED|5 Week Double Blind Randomization Period||0
1135055|NCT01340066|2748276|P3|COMPLETED|5 Week Double Blind Randomization Period||31
1135056|NCT01340066|2748277|P2|COMPLETED|5 Week Double Blind Randomization Period||28
1135057|NCT01340066|2748278|P1|COMPLETED|5 Week Double Blind Randomization Period||0
1135058|NCT01340066|2748276|P3|STARTED|5 Week Double Blind Randomization Period||34
1135059|NCT01340066|2748277|P2|STARTED|5 Week Double Blind Randomization Period||33
1135060|NCT01340066|2748278|P1|STARTED|5 Week Double Blind Randomization Period||0
1135061|NCT01340066|2748276|P3|NOT COMPLETED|Placebo Run in Period||0
1135062|NCT01340066|2748277|P2|NOT COMPLETED|Placebo Run in Period||0
1135063|NCT01340066|2748278|P1|NOT COMPLETED|Placebo Run in Period||27
1135064|NCT01340066|2748276|P3|COMPLETED|Placebo Run in Period||0
1135065|NCT01340066|2748277|P2|COMPLETED|Placebo Run in Period||0
1135066|NCT01340066|2748278|P1|COMPLETED|Placebo Run in Period|Completed run in period and were eligible for randomization|67
1135067|NCT01340066|2748276|P3|STARTED|Placebo Run in Period||0
1135068|NCT01340066|2748277|P2|STARTED|Placebo Run in Period||0
1135069|NCT01340066|2748278|P1|STARTED|Placebo Run in Period||94
1135070|NCT01340144|2748287|P2|NOT COMPLETED|Overall Study||58
1135071|NCT01340144|2748288|P1|NOT COMPLETED|Overall Study||72
1135072|NCT01340144|2748287|P2|COMPLETED|Overall Study||567
1135073|NCT01340144|2748288|P1|COMPLETED|Overall Study||553
1135074|NCT01340144|2748287|P2|STARTED|Overall Study||625
1135075|NCT01340144|2748288|P1|STARTED|Overall Study||625
1135076|NCT01340196|2748294|P1|NOT COMPLETED|Treat. Period 3 (Faldaprevir)||2
1135077|NCT01340196|2748294|P1|COMPLETED|Treat. Period 3 (Faldaprevir)||14
1135078|NCT01340196|2748294|P1|STARTED|Treat. Period 3 (Faldaprevir)||16
1135079|NCT01340196|2748294|P1|NOT COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||0
1135080|NCT01340196|2748294|P1|COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
1135081|NCT01340196|2748294|P1|STARTED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
1135082|NCT01340196|2748294|P1|NOT COMPLETED|Treat. Period 1 (Tenofovir)||0
1135083|NCT01340196|2748294|P1|COMPLETED|Treat. Period 1 (Tenofovir)||16
1135084|NCT01340196|2748294|P1|STARTED|Treat. Period 1 (Tenofovir)||16
1135085|NCT01340209|2748326|P3|NOT COMPLETED|Overall Study||8
1135086|NCT01340209|2748327|P2|NOT COMPLETED|Overall Study||8
1135087|NCT01340209|2748328|P1|NOT COMPLETED|Overall Study||5
1135088|NCT01340209|2748326|P3|COMPLETED|Overall Study||106
1135089|NCT01340209|2748327|P2|COMPLETED|Overall Study||106
1135090|NCT01340209|2748328|P1|COMPLETED|Overall Study||52
1135091|NCT01340209|2748326|P3|STARTED|Overall Study||114
1135092|NCT01340209|2748327|P2|STARTED|Overall Study||114
1135093|NCT01340209|2748328|P1|STARTED|Overall Study||57
1135118|NCT01340573|2748400|P1|NOT COMPLETED|Overall Study||3
1135119|NCT01340573|2748400|P1|COMPLETED|Overall Study||0
1135120|NCT01340573|2748400|P1|STARTED|Overall Study||3
1135121|NCT01340586|2748423|P2|NOT COMPLETED|Overall Study||0
1135122|NCT01340586|2748424|P1|NOT COMPLETED|Overall Study||0
1135123|NCT01340586|2748423|P2|COMPLETED|Overall Study||8
1135124|NCT01340586|2748424|P1|COMPLETED|Overall Study||8
1135125|NCT01340586|2748423|P2|STARTED|Overall Study||8
1135126|NCT01340586|2748424|P1|STARTED|Overall Study||8
1135127|NCT01340625|2748491|P2|NOT COMPLETED|Second Intervention||0
1135128|NCT01340625|2748492|P1|NOT COMPLETED|Second Intervention||0
1135129|NCT01340625|2748491|P2|COMPLETED|Second Intervention||18
1135130|NCT01340625|2748492|P1|COMPLETED|Second Intervention||16
1135131|NCT01340625|2748491|P2|STARTED|Second Intervention||18
1135132|NCT01340625|2748492|P1|STARTED|Second Intervention||16
1135133|NCT01340625|2748491|P2|NOT COMPLETED|Washout Period of 28 Days||0
1135134|NCT01340625|2748492|P1|NOT COMPLETED|Washout Period of 28 Days||1
1135135|NCT01340625|2748491|P2|COMPLETED|Washout Period of 28 Days||18
1135136|NCT01340625|2748492|P1|COMPLETED|Washout Period of 28 Days||16
1135137|NCT01340625|2748491|P2|STARTED|Washout Period of 28 Days||18
1135138|NCT01340625|2748492|P1|STARTED|Washout Period of 28 Days||17
1135139|NCT01340625|2748491|P2|NOT COMPLETED|First Intervention||0
1135140|NCT01340625|2748492|P1|NOT COMPLETED|First Intervention||1
1135141|NCT01340625|2748491|P2|COMPLETED|First Intervention||18
1135142|NCT01340625|2748492|P1|COMPLETED|First Intervention||17
1135143|NCT01340625|2748491|P2|STARTED|First Intervention||18
1135144|NCT01340625|2748492|P1|STARTED|First Intervention||18
1135145|NCT01340651|2748508|P1|NOT COMPLETED|Overall Study||17
1135146|NCT01340651|2748508|P1|COMPLETED|Overall Study||24
1135147|NCT01340651|2748508|P1|STARTED|Overall Study||41
1135148|NCT01340664|2748525|P3|NOT COMPLETED|Overall Study||13
1135149|NCT01340664|2748526|P2|NOT COMPLETED|Overall Study||8
1135150|NCT01340664|2748527|P1|NOT COMPLETED|Overall Study||7
1135151|NCT01340664|2748525|P3|COMPLETED|Overall Study||80
1135152|NCT01340664|2748526|P2|COMPLETED|Overall Study||85
1135153|NCT01340664|2748527|P1|COMPLETED|Overall Study||86
1135154|NCT01340664|2748525|P3|STARTED|Overall Study||93
1135155|NCT01340664|2748526|P2|STARTED|Overall Study||93
1135156|NCT01340664|2748527|P1|STARTED|Overall Study||93
1135157|NCT01340768|2748546|P2|NOT COMPLETED|Overall Study||5
1135158|NCT01340768|2748547|P1|NOT COMPLETED|Overall Study||17
1135159|NCT01340768|2748546|P2|COMPLETED|Overall Study||429
1135160|NCT01340768|2748547|P1|COMPLETED|Overall Study||419
1135161|NCT01340768|2748546|P2|STARTED|Overall Study||434
1135162|NCT01340768|2748547|P1|STARTED|Overall Study||436
1135163|NCT01340794|2748557|P2|NOT COMPLETED|Overall Study||1
1135164|NCT01340794|2748558|P1|NOT COMPLETED|Overall Study||0
1135165|NCT01340794|2748557|P2|COMPLETED|Overall Study||4
1135166|NCT01340794|2748558|P1|COMPLETED|Overall Study||2
1135167|NCT01340794|2748557|P2|STARTED|Overall Study||5
1135168|NCT01340794|2748558|P1|STARTED|Overall Study||2
1135169|NCT01340937|2748576|P4|NOT COMPLETED|Period 3: Toddler Vaccinations||10
1135170|NCT01340937|2748577|P3|NOT COMPLETED|Period 3: Toddler Vaccinations||9
1135171|NCT01340937|2748578|P2|NOT COMPLETED|Period 3: Toddler Vaccinations||17
1135172|NCT01340937|2748579|P1|NOT COMPLETED|Period 3: Toddler Vaccinations||9
1135173|NCT01340937|2748576|P4|COMPLETED|Period 3: Toddler Vaccinations||319
1135174|NCT01340937|2748577|P3|COMPLETED|Period 3: Toddler Vaccinations||660
1135175|NCT01340937|2748578|P2|COMPLETED|Period 3: Toddler Vaccinations||641
1135176|NCT01340937|2748579|P1|COMPLETED|Period 3: Toddler Vaccinations||666
1135177|NCT01340937|2748576|P4|STARTED|Period 3: Toddler Vaccinations||329
1135178|NCT01340937|2748577|P3|STARTED|Period 3: Toddler Vaccinations||669
1135179|NCT01340937|2748578|P2|STARTED|Period 3: Toddler Vaccinations||658
1135180|NCT01340937|2748579|P1|STARTED|Period 3: Toddler Vaccinations||675
1135181|NCT01340937|2748576|P4|NOT COMPLETED|Period 2: Interim Period||41
1135182|NCT01340937|2748577|P3|NOT COMPLETED|Period 2: Interim Period||84
1135183|NCT01340937|2748578|P2|NOT COMPLETED|Period 2: Interim Period||79
1135184|NCT01340937|2748579|P1|NOT COMPLETED|Period 2: Interim Period||67
1135185|NCT01340937|2748576|P4|COMPLETED|Period 2: Interim Period||329
1135186|NCT01340937|2748577|P3|COMPLETED|Period 2: Interim Period||669
1135187|NCT01340937|2748578|P2|COMPLETED|Period 2: Interim Period||658
1135188|NCT01340937|2748579|P1|COMPLETED|Period 2: Interim Period||675
1135189|NCT01340937|2748576|P4|STARTED|Period 2: Interim Period||370
1135190|NCT01340937|2748577|P3|STARTED|Period 2: Interim Period||753
1135191|NCT01340937|2748578|P2|STARTED|Period 2: Interim Period||737
1135192|NCT01340937|2748579|P1|STARTED|Period 2: Interim Period||742
1135193|NCT01340937|2748576|P4|NOT COMPLETED|Period 1: Infant Series||32
1135194|NCT01340937|2748577|P3|NOT COMPLETED|Period 1: Infant Series||56
1135195|NCT01340937|2748578|P2|NOT COMPLETED|Period 1: Infant Series||60
1135196|NCT01340937|2748579|P1|NOT COMPLETED|Period 1: Infant Series||58
1135197|NCT01340937|2748576|P4|COMPLETED|Period 1: Infant Series||370
1135198|NCT01340937|2748577|P3|COMPLETED|Period 1: Infant Series||753
1135199|NCT01340937|2748578|P2|COMPLETED|Period 1: Infant Series||737
1135200|NCT01340937|2748579|P1|COMPLETED|Period 1: Infant Series||742
1135201|NCT01340937|2748576|P4|STARTED|Period 1: Infant Series||402
1135202|NCT01340937|2748577|P3|STARTED|Period 1: Infant Series||809
1135203|NCT01340937|2748578|P2|STARTED|Period 1: Infant Series||797
1135204|NCT01340937|2748579|P1|STARTED|Period 1: Infant Series||800
1135205|NCT01341067|2748736|P1|NOT COMPLETED|Overall Study||4
1135206|NCT01341067|2748736|P1|COMPLETED|Overall Study||26
1135207|NCT01341067|2748736|P1|STARTED|Overall Study||30
1135208|NCT01341444|2748745|P2|NOT COMPLETED|Overall Study||3
1135209|NCT01341444|2748746|P1|NOT COMPLETED|Overall Study||5
1135210|NCT01341444|2748745|P2|COMPLETED|Overall Study||29
1135211|NCT01341444|2748746|P1|COMPLETED|Overall Study||26
1135212|NCT01341444|2748745|P2|STARTED|Overall Study||32
1135213|NCT01341444|2748746|P1|STARTED|Overall Study||31
1135214|NCT01341600|2748755|P3|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
1135215|NCT01341600|2748756|P2|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
1135216|NCT01341600|2748757|P1|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
1135217|NCT01341600|2748755|P3|COMPLETED|Clopidogrel Plus Omeprazole||4
1135218|NCT01341600|2748756|P2|COMPLETED|Clopidogrel Plus Omeprazole||5
1135219|NCT01341600|2748757|P1|COMPLETED|Clopidogrel Plus Omeprazole||5
1135220|NCT01341600|2748755|P3|STARTED|Clopidogrel Plus Omeprazole||4
1135221|NCT01341600|2748756|P2|STARTED|Clopidogrel Plus Omeprazole||5
1135222|NCT01341600|2748757|P1|STARTED|Clopidogrel Plus Omeprazole||5
1135223|NCT01341600|2748755|P3|NOT COMPLETED|Clopidogrel 225 mg||0
1135224|NCT01341600|2748756|P2|NOT COMPLETED|Clopidogrel 225 mg||0
1135225|NCT01341600|2748757|P1|NOT COMPLETED|Clopidogrel 225 mg||0
1135226|NCT01341600|2748755|P3|COMPLETED|Clopidogrel 225 mg||6
1135227|NCT01341600|2748756|P2|COMPLETED|Clopidogrel 225 mg||6
1135228|NCT01341600|2748757|P1|COMPLETED|Clopidogrel 225 mg||6
1135229|NCT01341600|2748755|P3|STARTED|Clopidogrel 225 mg||6
1135230|NCT01341600|2748756|P2|STARTED|Clopidogrel 225 mg||6
1135231|NCT01341600|2748757|P1|STARTED|Clopidogrel 225 mg||6
1135232|NCT01341600|2748755|P3|NOT COMPLETED|Clopidogrel 150 mg||0
1135233|NCT01341600|2748756|P2|NOT COMPLETED|Clopidogrel 150 mg||0
1135234|NCT01341600|2748757|P1|NOT COMPLETED|Clopidogrel 150 mg||0
1135235|NCT01341600|2748755|P3|COMPLETED|Clopidogrel 150 mg||6
1135236|NCT01341600|2748756|P2|COMPLETED|Clopidogrel 150 mg||6
1135237|NCT01341600|2748757|P1|COMPLETED|Clopidogrel 150 mg||6
1135238|NCT01341600|2748755|P3|STARTED|Clopidogrel 150 mg||6
1135239|NCT01341600|2748756|P2|STARTED|Clopidogrel 150 mg||6
1135240|NCT01341600|2748757|P1|STARTED|Clopidogrel 150 mg||6
1135241|NCT01341600|2748755|P3|NOT COMPLETED|Clopidogrel 75 mg||0
1135242|NCT01341600|2748756|P2|NOT COMPLETED|Clopidogrel 75 mg||0
1135243|NCT01341600|2748757|P1|NOT COMPLETED|Clopidogrel 75 mg||0
1135244|NCT01341600|2748755|P3|COMPLETED|Clopidogrel 75 mg||6
1135245|NCT01341600|2748756|P2|COMPLETED|Clopidogrel 75 mg||6
1135246|NCT01341600|2748757|P1|COMPLETED|Clopidogrel 75 mg||6
1135247|NCT01341600|2748755|P3|STARTED|Clopidogrel 75 mg||6
1135248|NCT01341600|2748756|P2|STARTED|Clopidogrel 75 mg||6
1135249|NCT01341600|2748757|P1|STARTED|Clopidogrel 75 mg||6
1135250|NCT01335867|2748776|P2|NOT COMPLETED|Overall Study||4
1135251|NCT01335867|2748777|P1|NOT COMPLETED|Overall Study||7
1135252|NCT01335867|2748776|P2|COMPLETED|Overall Study||12
1135253|NCT01335867|2748777|P1|COMPLETED|Overall Study||9
1135254|NCT01335867|2748776|P2|STARTED|Overall Study||16
1135255|NCT01335867|2748777|P1|STARTED|Overall Study||16
1135256|NCT01341782|2748787|P2|NOT COMPLETED|Overall Study||14
1135257|NCT01341782|2748788|P1|NOT COMPLETED|Overall Study||15
1135258|NCT01341782|2748787|P2|COMPLETED|Overall Study||114
1135259|NCT01341782|2748788|P1|COMPLETED|Overall Study||112
1135260|NCT01341782|2748787|P2|STARTED|Overall Study||128
1135261|NCT01341782|2748788|P1|STARTED|Overall Study||127
1135262|NCT01341912|2748804|P1|NOT COMPLETED|Overall Study||0
1135263|NCT01341912|2748804|P1|COMPLETED|Overall Study||3
1135264|NCT01341912|2748804|P1|STARTED|Overall Study||3
1135265|NCT01341977|2748811|P2|NOT COMPLETED|Overall Study||15
1135266|NCT01341977|2748812|P1|NOT COMPLETED|Overall Study||14
1135267|NCT01341977|2748811|P2|COMPLETED|Overall Study||270
1135268|NCT01341977|2748812|P1|COMPLETED|Overall Study||274
1135269|NCT01341977|2748811|P2|STARTED|Overall Study||285
1135270|NCT01341977|2748812|P1|STARTED|Overall Study||288
1135271|NCT01342094|2748820|P2|NOT COMPLETED|Overall Study||3
1135272|NCT01342094|2748821|P1|NOT COMPLETED|Overall Study||5
1135273|NCT01342094|2748820|P2|COMPLETED|Overall Study||81
1135274|NCT01342094|2748821|P1|COMPLETED|Overall Study||77
1135275|NCT01342094|2748820|P2|STARTED|Overall Study||84
1135276|NCT01342094|2748821|P1|STARTED|Overall Study||82
1135277|NCT01342107|2748829|P2|NOT COMPLETED|Overall Study||0
1135278|NCT01342107|2748830|P1|NOT COMPLETED|Overall Study||0
1135279|NCT01342107|2748829|P2|COMPLETED|Overall Study||32
1135280|NCT01342107|2748830|P1|COMPLETED|Overall Study||34
1135281|NCT01342107|2748829|P2|STARTED|Overall Study||32
1135282|NCT01342107|2748830|P1|STARTED|Overall Study||34
1135283|NCT01342172|2748836|P1|NOT COMPLETED|Overall Study||0
1135284|NCT01342172|2748836|P1|COMPLETED|Overall Study||9
1135285|NCT01342172|2748836|P1|STARTED|Overall Study||9
1135286|NCT01342341|2748842|P2|NOT COMPLETED|Overall Study||4
1135287|NCT01342341|2748843|P1|NOT COMPLETED|Overall Study||4
1135288|NCT01342341|2748842|P2|COMPLETED|Overall Study||20
1135289|NCT01342341|2748843|P1|COMPLETED|Overall Study||20
1135290|NCT01342341|2748842|P2|STARTED|Overall Study||24
1135291|NCT01342341|2748843|P1|STARTED|Overall Study||24
1135292|NCT01342445|2748851|P2|NOT COMPLETED|Overall Study||2
1135293|NCT01342445|2748852|P1|NOT COMPLETED|Overall Study||0
1135294|NCT01342445|2748851|P2|COMPLETED|Overall Study||22
1135295|NCT01342445|2748852|P1|COMPLETED|Overall Study||26
1135296|NCT01342445|2748851|P2|STARTED|Overall Study||24
1135297|NCT01342445|2748852|P1|STARTED|Overall Study||26
1135298|NCT01342458|2748868|P2|NOT COMPLETED|Overall Study||4
1135299|NCT01342458|2748869|P1|NOT COMPLETED|Overall Study||2
1135300|NCT01342458|2748868|P2|COMPLETED|Overall Study||24
1135301|NCT01342458|2748869|P1|COMPLETED|Overall Study||26
1135302|NCT01342458|2748868|P2|STARTED|Overall Study||28
1135303|NCT01342458|2748869|P1|STARTED|Overall Study||28
1135304|NCT01342471|2748891|P2|NOT COMPLETED|Overall Study||6
1135305|NCT01342471|2748892|P1|NOT COMPLETED|Overall Study||5
1135306|NCT01342471|2748891|P2|COMPLETED|Overall Study||23
1135307|NCT01342471|2748892|P1|COMPLETED|Overall Study||24
1135308|NCT01342471|2748891|P2|STARTED|Overall Study||29
1135309|NCT01342471|2748892|P1|STARTED|Overall Study||29
1135310|NCT01342484|2748909|P3|NOT COMPLETED|Overall Study||1
1135311|NCT01342484|2748910|P2|NOT COMPLETED|Overall Study||0
1135312|NCT01342484|2748911|P1|NOT COMPLETED|Overall Study||2
1135313|NCT01342484|2748909|P3|COMPLETED|Overall Study||13
1135314|NCT01342484|2748910|P2|COMPLETED|Overall Study||10
1135315|NCT01342484|2748911|P1|COMPLETED|Overall Study||13
1135316|NCT01342484|2748909|P3|STARTED|Overall Study||14
1135317|NCT01342484|2748910|P2|STARTED|Overall Study||10
1135318|NCT01342484|2748911|P1|STARTED|Overall Study||15
1135319|NCT01342510|2748929|P4|NOT COMPLETED|Overall Study||11
1135320|NCT01342510|2748930|P3|NOT COMPLETED|Overall Study||13
1135321|NCT01342510|2748931|P2|NOT COMPLETED|Overall Study||6
1135322|NCT01342510|2748932|P1|NOT COMPLETED|Overall Study||12
1135323|NCT01342510|2748929|P4|COMPLETED|Overall Study||39
1135324|NCT01342510|2748930|P3|COMPLETED|Overall Study||37
1135325|NCT01342510|2748931|P2|COMPLETED|Overall Study||44
1135326|NCT01342510|2748932|P1|COMPLETED|Overall Study||38
1135327|NCT01342510|2748929|P4|STARTED|Overall Study||50
1135328|NCT01342510|2748930|P3|STARTED|Overall Study||50
1135329|NCT01342510|2748931|P2|STARTED|Overall Study||50
1135330|NCT01342510|2748932|P1|STARTED|Overall Study||50
1135331|NCT01342523|2748974|P32|NOT COMPLETED|Overall Study||1
1135332|NCT01342523|2748975|P31|NOT COMPLETED|Overall Study||1
1135333|NCT01342523|2748976|P30|NOT COMPLETED|Overall Study||1
1135334|NCT01342523|2748977|P29|NOT COMPLETED|Overall Study||1
1135335|NCT01342523|2748978|P28|NOT COMPLETED|Overall Study||1
1135336|NCT01342523|2748979|P27|NOT COMPLETED|Overall Study||1
1135337|NCT01342523|2748980|P26|NOT COMPLETED|Overall Study||2
1135338|NCT01342523|2748981|P25|NOT COMPLETED|Overall Study||1
1135339|NCT01342523|2748982|P24|NOT COMPLETED|Overall Study||1
1135340|NCT01342523|2748983|P23|NOT COMPLETED|Overall Study||0
1135341|NCT01342523|2748984|P22|NOT COMPLETED|Overall Study||0
1135342|NCT01342523|2748985|P21|NOT COMPLETED|Overall Study||0
1135343|NCT01342523|2748986|P20|NOT COMPLETED|Overall Study||0
1135344|NCT01342523|2748987|P19|NOT COMPLETED|Overall Study||0
1135345|NCT01342523|2748988|P18|NOT COMPLETED|Overall Study||0
1135346|NCT01342523|2748989|P17|NOT COMPLETED|Overall Study||1
1135347|NCT01342523|2748990|P16|NOT COMPLETED|Overall Study||0
1135348|NCT01342523|2748991|P15|NOT COMPLETED|Overall Study||1
1135349|NCT01342523|2748992|P14|NOT COMPLETED|Overall Study||2
1135350|NCT01342523|2748993|P13|NOT COMPLETED|Overall Study||0
1135351|NCT01342523|2748994|P12|NOT COMPLETED|Overall Study||2
1135352|NCT01342523|2748995|P11|NOT COMPLETED|Overall Study||0
1135353|NCT01342523|2748996|P10|NOT COMPLETED|Overall Study||0
1135354|NCT01342523|2748997|P9|NOT COMPLETED|Overall Study||0
1135355|NCT01342523|2748998|P8|NOT COMPLETED|Overall Study||0
1135356|NCT01342523|2748999|P7|NOT COMPLETED|Overall Study||0
1135357|NCT01342523|2749000|P6|NOT COMPLETED|Overall Study||0
1135358|NCT01342523|2749001|P5|NOT COMPLETED|Overall Study||0
1135359|NCT01342523|2749002|P4|NOT COMPLETED|Overall Study||1
1135360|NCT01342523|2749003|P3|NOT COMPLETED|Overall Study||0
1135361|NCT01342523|2749004|P2|NOT COMPLETED|Overall Study||0
1135362|NCT01342523|2749005|P1|NOT COMPLETED|Overall Study||1
1135363|NCT01342523|2748974|P32|COMPLETED|Overall Study||27
1135364|NCT01342523|2748975|P31|COMPLETED|Overall Study||30
1135365|NCT01342523|2748976|P30|COMPLETED|Overall Study||28
1135366|NCT01342523|2748977|P29|COMPLETED|Overall Study||34
1135367|NCT01342523|2748978|P28|COMPLETED|Overall Study||30
1135368|NCT01342523|2748979|P27|COMPLETED|Overall Study||33
1135369|NCT01342523|2748980|P26|COMPLETED|Overall Study||36
1135370|NCT01342523|2748981|P25|COMPLETED|Overall Study||36
1135371|NCT01342523|2748982|P24|COMPLETED|Overall Study||35
1135372|NCT01342523|2748983|P23|COMPLETED|Overall Study||36
1135373|NCT01342523|2748984|P22|COMPLETED|Overall Study||30
1135374|NCT01342523|2748985|P21|COMPLETED|Overall Study||29
1135375|NCT01342523|2748986|P20|COMPLETED|Overall Study||27
1135376|NCT01342523|2748987|P19|COMPLETED|Overall Study||21
1135377|NCT01342523|2748988|P18|COMPLETED|Overall Study||27
1135378|NCT01342523|2748989|P17|COMPLETED|Overall Study||28
1135379|NCT01342523|2748990|P16|COMPLETED|Overall Study||32
1135380|NCT01342523|2748991|P15|COMPLETED|Overall Study||37
1135381|NCT01342523|2748992|P14|COMPLETED|Overall Study||36
1135382|NCT01342523|2748993|P13|COMPLETED|Overall Study||39
1135383|NCT01342523|2748994|P12|COMPLETED|Overall Study||36
1135384|NCT01342523|2748995|P11|COMPLETED|Overall Study||38
1135385|NCT01342523|2748996|P10|COMPLETED|Overall Study||28
1135386|NCT01342523|2748997|P9|COMPLETED|Overall Study||28
1135387|NCT01342523|2748998|P8|COMPLETED|Overall Study||27
1135388|NCT01342523|2748999|P7|COMPLETED|Overall Study||22
1135389|NCT01342523|2749000|P6|COMPLETED|Overall Study||36
1135390|NCT01342523|2749001|P5|COMPLETED|Overall Study||36
1135391|NCT01342523|2749002|P4|COMPLETED|Overall Study||32
1135392|NCT01342523|2749003|P3|COMPLETED|Overall Study||36
1135393|NCT01342523|2749004|P2|COMPLETED|Overall Study||32
1135394|NCT01342523|2749005|P1|COMPLETED|Overall Study||34
1135395|NCT01342523|2748974|P32|STARTED|Overall Study||28
1135396|NCT01342523|2748975|P31|STARTED|Overall Study||31
1135397|NCT01342523|2748976|P30|STARTED|Overall Study||29
1135398|NCT01342523|2748977|P29|STARTED|Overall Study||35
1135399|NCT01342523|2748978|P28|STARTED|Overall Study||31
1135400|NCT01342523|2748979|P27|STARTED|Overall Study||34
1135401|NCT01342523|2748980|P26|STARTED|Overall Study||38
1135402|NCT01342523|2748981|P25|STARTED|Overall Study||37
1135403|NCT01342523|2748982|P24|STARTED|Overall Study||36
1135404|NCT01342523|2748983|P23|STARTED|Overall Study||36
1135405|NCT01342523|2748984|P22|STARTED|Overall Study||30
1135406|NCT01342523|2748985|P21|STARTED|Overall Study||29
1135407|NCT01342523|2748986|P20|STARTED|Overall Study||27
1135408|NCT01342523|2748987|P19|STARTED|Overall Study||21
1135409|NCT01342523|2748988|P18|STARTED|Overall Study||27
1135410|NCT01342523|2748989|P17|STARTED|Overall Study||29
1135411|NCT01342523|2748990|P16|STARTED|Overall Study||32
1135412|NCT01342523|2748991|P15|STARTED|Overall Study||38
1135413|NCT01342523|2748992|P14|STARTED|Overall Study||38
1135414|NCT01342523|2748993|P13|STARTED|Overall Study||39
1135415|NCT01342523|2748994|P12|STARTED|Overall Study||38
1135416|NCT01342523|2748995|P11|STARTED|Overall Study||38
1135417|NCT01342523|2748996|P10|STARTED|Overall Study||28
1135418|NCT01342523|2748997|P9|STARTED|Overall Study||28
1135419|NCT01342523|2748998|P8|STARTED|Overall Study||27
1135420|NCT01342523|2748999|P7|STARTED|Overall Study||22
1135421|NCT01342523|2749000|P6|STARTED|Overall Study||36
1135422|NCT01342523|2749001|P5|STARTED|Overall Study||36
1135423|NCT01342523|2749002|P4|STARTED|Overall Study||33
1135424|NCT01342523|2749003|P3|STARTED|Overall Study||36
1135425|NCT01342523|2749004|P2|STARTED|Overall Study||32
1135426|NCT01342523|2749005|P1|STARTED|Overall Study||35
1135427|NCT01342549|2749020|P2|NOT COMPLETED|Overall Study||0
1135428|NCT01342549|2749021|P1|NOT COMPLETED|Overall Study||0
1135429|NCT01342549|2749020|P2|COMPLETED|Overall Study||31
1135430|NCT01342549|2749021|P1|COMPLETED|Overall Study||31
1135431|NCT01342549|2749020|P2|STARTED|Overall Study||31
1135432|NCT01342549|2749021|P1|STARTED|Overall Study||31
1135433|NCT01342640|2749027|P1|NOT COMPLETED|Overall Study||41
1135434|NCT01342640|2749027|P1|COMPLETED|Overall Study||29
1135435|NCT01342640|2749027|P1|STARTED|Overall Study||70
1135436|NCT01342666|2749035|P2|NOT COMPLETED|Overall Study||0
1135437|NCT01342666|2749036|P1|NOT COMPLETED|Overall Study||0
1135438|NCT01342666|2749035|P2|COMPLETED|Overall Study||24
1135439|NCT01342666|2749036|P1|COMPLETED|Overall Study||26
1135440|NCT01342666|2749035|P2|STARTED|Overall Study||24
1135441|NCT01342666|2749036|P1|STARTED|Overall Study||26
1135442|NCT01342757|2749042|P1|NOT COMPLETED|Overall Study||0
1135443|NCT01342757|2749042|P1|COMPLETED|Overall Study||12
1135444|NCT01342757|2749042|P1|STARTED|Overall Study||12
1135445|NCT01342770|2749047|P1|NOT COMPLETED|Overall Study||0
1135446|NCT01342770|2749047|P1|COMPLETED|Overall Study||6
1135447|NCT01342770|2749047|P1|STARTED|Overall Study||6
1135448|NCT01342887|2749060|P1|NOT COMPLETED|Overall Study||2
1135449|NCT01342887|2749060|P1|COMPLETED|Overall Study||4
1135450|NCT01342887|2749060|P1|STARTED|Overall Study||6
1135451|NCT01342913|2749069|P3|NOT COMPLETED|Double-Blind Treatment Period||23
1135452|NCT01342913|2749070|P2|NOT COMPLETED|Double-Blind Treatment Period||16
1135453|NCT01342913|2749071|P1|NOT COMPLETED|Double-Blind Treatment Period||0
1135454|NCT01342913|2749069|P3|COMPLETED|Double-Blind Treatment Period||243
1135455|NCT01342913|2749070|P2|COMPLETED|Double-Blind Treatment Period||246
1135456|NCT01342913|2749071|P1|COMPLETED|Double-Blind Treatment Period||0
1135457|NCT01342913|2749069|P3|STARTED|Double-Blind Treatment Period||266
1135458|NCT01342913|2749070|P2|STARTED|Double-Blind Treatment Period||262
1135459|NCT01342913|2749071|P1|STARTED|Double-Blind Treatment Period||0
1135460|NCT01342913|2749069|P3|NOT COMPLETED|2-week Run-in Period||0
1135461|NCT01342913|2749070|P2|NOT COMPLETED|2-week Run-in Period||0
1135462|NCT01342913|2749071|P1|NOT COMPLETED|2-week Run-in Period||174
1135463|NCT01342913|2749069|P3|COMPLETED|2-week Run-in Period||0
1135464|NCT01342913|2749070|P2|COMPLETED|2-week Run-in Period||0
1135465|NCT01342913|2749071|P1|COMPLETED|2-week Run-in Period||528
1135466|NCT01342913|2749069|P3|STARTED|2-week Run-in Period||0
1135467|NCT01342913|2749070|P2|STARTED|2-week Run-in Period||0
1135468|NCT01342913|2749071|P1|STARTED|2-week Run-in Period||702
1135469|NCT01342926|2749085|P4|NOT COMPLETED|Overall Study||12
1135470|NCT01342926|2749086|P3|NOT COMPLETED|Overall Study||14
1135471|NCT01342926|2749087|P2|NOT COMPLETED|Overall Study||15
1135472|NCT01342926|2749088|P1|NOT COMPLETED|Overall Study||9
1135473|NCT01342926|2749085|P4|COMPLETED|Overall Study||39
1135474|NCT01342926|2749086|P3|COMPLETED|Overall Study||34
1135475|NCT01342926|2749087|P2|COMPLETED|Overall Study||31
1135476|NCT01342926|2749088|P1|COMPLETED|Overall Study||37
1135477|NCT01342926|2749085|P4|STARTED|Overall Study||51
1135478|NCT01342926|2749086|P3|STARTED|Overall Study||48
1135479|NCT01342926|2749087|P2|STARTED|Overall Study||46
1135480|NCT01342926|2749088|P1|STARTED|Overall Study||46
1135481|NCT01342965|2749168|P2|NOT COMPLETED|Overall Study||107
1135482|NCT01342965|2749169|P1|NOT COMPLETED|Overall Study||109
1135483|NCT01342965|2749168|P2|COMPLETED|Overall Study||0
1135484|NCT01342965|2749169|P1|COMPLETED|Overall Study||1
1135485|NCT01342965|2749168|P2|Received Treatment|Overall Study||104
1135486|NCT01342965|2749169|P1|Received Treatment|Overall Study||110
1135487|NCT01342965|2749168|P2|STARTED|Overall Study||107
1135488|NCT01342965|2749169|P1|STARTED|Overall Study||110
1135489|NCT01343004|2749186|P3|NOT COMPLETED|Overall Study||160
1135490|NCT01343004|2749187|P2|NOT COMPLETED|Overall Study||218
1135491|NCT01343004|2749188|P1|NOT COMPLETED|Overall Study||184
1135492|NCT01343004|2749186|P3|COMPLETED|Overall Study||658
1135493|NCT01343004|2749187|P2|COMPLETED|Overall Study||606
1135494|NCT01343004|2749188|P1|COMPLETED|Overall Study||637
1135495|NCT01343004|2749186|P3|STARTED|Overall Study||818
1135496|NCT01343004|2749187|P2|STARTED|Overall Study||824
1135497|NCT01343004|2749188|P1|STARTED|Overall Study||821
1135498|NCT01343056|2749215|P4|NOT COMPLETED|Overall Study||9
1135499|NCT01343056|2749216|P3|NOT COMPLETED|Overall Study||3
1135500|NCT01343056|2749217|P2|NOT COMPLETED|Overall Study||5
1135501|NCT01343056|2749218|P1|NOT COMPLETED|Overall Study||7
1135502|NCT01343056|2749215|P4|COMPLETED|Overall Study||29
1135503|NCT01343056|2749216|P3|COMPLETED|Overall Study||29
1135504|NCT01343056|2749217|P2|COMPLETED|Overall Study||31
1135505|NCT01343056|2749218|P1|COMPLETED|Overall Study||28
1135506|NCT01343056|2749215|P4|STARTED|Overall Study||38
1135507|NCT01343056|2749216|P3|STARTED|Overall Study||32
1135508|NCT01343056|2749217|P2|STARTED|Overall Study||36
1135509|NCT01343056|2749218|P1|STARTED|Overall Study||35
1135510|NCT01343082|2749256|P3|NOT COMPLETED|Treatment Period , Switched to DE-111||12
1135511|NCT01343082|2749257|P2|NOT COMPLETED|Treatment Period , Switched to DE-111||9
1135512|NCT01343082|2749258|P1|NOT COMPLETED|Treatment Period , Switched to DE-111||5
1135513|NCT01343082|2749256|P3|COMPLETED|Treatment Period , Switched to DE-111||31
1135514|NCT01343082|2749257|P2|COMPLETED|Treatment Period , Switched to DE-111||36
1135515|NCT01343082|2749258|P1|COMPLETED|Treatment Period , Switched to DE-111||43
1135516|NCT01343082|2749256|P3|STARTED|Treatment Period , Switched to DE-111||43
1135517|NCT01343082|2749257|P2|STARTED|Treatment Period , Switched to DE-111||45
1135518|NCT01343082|2749258|P1|STARTED|Treatment Period , Switched to DE-111||48
1135519|NCT01343082|2749256|P3|NOT COMPLETED|The run-in Period||5
1135520|NCT01343082|2749257|P2|NOT COMPLETED|The run-in Period||4
1135521|NCT01343082|2749258|P1|NOT COMPLETED|The run-in Period||3
1135522|NCT01343082|2749256|P3|COMPLETED|The run-in Period||43
1135523|NCT01343082|2749257|P2|COMPLETED|The run-in Period||45
1135524|NCT01343082|2749258|P1|COMPLETED|The run-in Period||48
1135525|NCT01343082|2749256|P3|STARTED|The run-in Period||48
1135526|NCT01343082|2749257|P2|STARTED|The run-in Period||49
1135527|NCT01343082|2749258|P1|STARTED|The run-in Period||51
1135528|NCT01343251|2749264|P2|NOT COMPLETED|Overall Study||0
1135529|NCT01343251|2749265|P1|NOT COMPLETED|Overall Study||0
1135530|NCT01343251|2749264|P2|COMPLETED|Overall Study||17
1135531|NCT01343251|2749265|P1|COMPLETED|Overall Study||16
1135532|NCT01343251|2749264|P2|STARTED|Overall Study||17
1135533|NCT01343251|2749265|P1|STARTED|Overall Study||16
1135534|NCT01343277|2749281|P2|NOT COMPLETED|Overall Study||193
1135535|NCT01343277|2749282|P1|NOT COMPLETED|Overall Study||384
1135536|NCT01343277|2749281|P2|COMPLETED|Overall Study||0
1135537|NCT01343277|2749282|P1|COMPLETED|Overall Study||0
1135538|NCT01343277|2749281|P2|Treated|Overall Study||172
1135539|NCT01343277|2749282|P1|Treated|Overall Study||378
1135540|NCT01343277|2749281|P2|STARTED|Overall Study||193
1135541|NCT01343277|2749282|P1|STARTED|Overall Study||384
1135542|NCT01343368|2749300|P2|NOT COMPLETED|Overall Study||0
1135543|NCT01343368|2749301|P1|NOT COMPLETED|Overall Study||2
1135544|NCT01343368|2749300|P2|COMPLETED|Overall Study||10
1135545|NCT01343368|2749301|P1|COMPLETED|Overall Study||7
1135546|NCT01343368|2749300|P2|STARTED|Overall Study||10
1135547|NCT01343368|2749301|P1|STARTED|Overall Study||9
1135548|NCT01343485|2749337|P2|NOT COMPLETED|Overall Study||134
1135549|NCT01343485|2749338|P1|NOT COMPLETED|Overall Study||149
1135550|NCT01343485|2749337|P2|COMPLETED|Overall Study||46
1135551|NCT01343485|2749338|P1|COMPLETED|Overall Study||36
1135552|NCT01343485|2749337|P2|STARTED|Overall Study||180
1135553|NCT01343485|2749338|P1|STARTED|Overall Study||185
1135554|NCT01343667|2749346|P2|NOT COMPLETED|Overall Study||56
1135555|NCT01343667|2749347|P1|NOT COMPLETED|Overall Study||12
1135556|NCT01343667|2749346|P2|COMPLETED|Overall Study||916
1135557|NCT01343667|2749347|P1|COMPLETED|Overall Study||413
1135558|NCT01343667|2749346|P2|STARTED|Overall Study||972
1135559|NCT01343667|2749347|P1|STARTED|Overall Study||425
1135560|NCT01343823|2749357|P4|NOT COMPLETED|Overall Study||1
1135561|NCT01343823|2749358|P3|NOT COMPLETED|Overall Study||0
1135562|NCT01343823|2749359|P2|NOT COMPLETED|Overall Study||0
1135563|NCT01343823|2749360|P1|NOT COMPLETED|Overall Study||2
1135564|NCT01343823|2749357|P4|COMPLETED|Overall Study||19
1135565|NCT01343823|2749358|P3|COMPLETED|Overall Study||19
1135566|NCT01343823|2749359|P2|COMPLETED|Overall Study||20
1135567|NCT01343823|2749360|P1|COMPLETED|Overall Study||18
1135568|NCT01343823|2749357|P4|STARTED|Overall Study||20
1135569|NCT01343823|2749358|P3|STARTED|Overall Study||19
1135570|NCT01343823|2749359|P2|STARTED|Overall Study||20
1135571|NCT01343823|2749360|P1|STARTED|Overall Study||20
1135572|NCT01343888|2749377|P3|NOT COMPLETED|Overall Study||22
1135573|NCT01343888|2749378|P2|NOT COMPLETED|Overall Study||39
1135574|NCT01343888|2749379|P1|NOT COMPLETED|Overall Study||25
1135575|NCT01343888|2749377|P3|COMPLETED|Overall Study||110
1135576|NCT01343888|2749378|P2|COMPLETED|Overall Study||222
1135577|NCT01343888|2749379|P1|COMPLETED|Overall Study||234
1135578|NCT01343888|2749377|P3|STARTED|Overall Study|133 subject randomized; 132 subjects treated with at least one dose; 1 subject was not treated|132
1135579|NCT01343888|2749378|P2|STARTED|Overall Study|262 subject randomized; 261 subjects treated with at least one dose; 1 subject was not treated|261
1135580|NCT01343888|2749379|P1|STARTED|Overall Study|261 subject randomized; 259 subjects treated with at least one dose; 2 subjects were not treated|259
1135581|NCT01343901|2749417|P1|NOT COMPLETED|Overall Study||113
1135582|NCT01343901|2749417|P1|COMPLETED|Overall Study||97
1135583|NCT01343901|2749417|P1|Efficacy Population|Overall Study||205
1135584|NCT01343901|2749417|P1|STARTED|Overall Study||210
1135585|NCT01344057|2749438|P1|NOT COMPLETED|Overall Study||1
1135586|NCT01344057|2749438|P1|COMPLETED|Overall Study||62
1135587|NCT01344057|2749438|P1|STARTED|Overall Study||63
1135588|NCT01344161|2749447|P2|NOT COMPLETED|Overall Study||3
1135589|NCT01344161|2749448|P1|NOT COMPLETED|Overall Study||5
1135590|NCT01344161|2749447|P2|COMPLETED|Overall Study||39
1135591|NCT01344161|2749448|P1|COMPLETED|Overall Study||38
1135592|NCT01344161|2749447|P2|STARTED|Overall Study||42
1135593|NCT01344161|2749448|P1|STARTED|Overall Study||43
1135594|NCT01344369|2749462|P2|NOT COMPLETED|Second Intervention||1
1135595|NCT01344369|2749463|P1|NOT COMPLETED|Second Intervention||0
1135596|NCT01344369|2749462|P2|COMPLETED|Second Intervention||16
1135597|NCT01344369|2749463|P1|COMPLETED|Second Intervention||17
1135598|NCT01344369|2749462|P2|STARTED|Second Intervention||17
1135599|NCT01344369|2749463|P1|STARTED|Second Intervention||17
1135600|NCT01344369|2749462|P2|NOT COMPLETED|Washout of 28 Days||1
1135601|NCT01344369|2749463|P1|NOT COMPLETED|Washout of 28 Days||1
1135602|NCT01344369|2749462|P2|COMPLETED|Washout of 28 Days||17
1135603|NCT01344369|2749463|P1|COMPLETED|Washout of 28 Days||17
1135604|NCT01344369|2749462|P2|STARTED|Washout of 28 Days||18
1135605|NCT01344369|2749463|P1|STARTED|Washout of 28 Days||18
1135606|NCT01344369|2749462|P2|NOT COMPLETED|First Intervention||0
1135607|NCT01344369|2749463|P1|NOT COMPLETED|First Intervention||0
1135608|NCT01344369|2749462|P2|COMPLETED|First Intervention||18
1135609|NCT01344369|2749463|P1|COMPLETED|First Intervention||18
1135610|NCT01344369|2749462|P2|STARTED|First Intervention||18
1135611|NCT01344369|2749463|P1|STARTED|First Intervention||18
1135612|NCT01344447|2749479|P1|NOT COMPLETED|Overall Study||8
1135613|NCT01344447|2749479|P1|COMPLETED|Overall Study||471
1135614|NCT01344447|2749479|P1|Fulfilled Requirement of FAS Population|Overall Study|Full Analysis Set (FAS)|457
1135615|NCT01344447|2749479|P1|STARTED|Overall Study|Participant received study drug; Safety analysis set|479
1135616|NCT01344460|2749521|P1|NOT COMPLETED|Overall Study||3
1135617|NCT01344460|2749521|P1|COMPLETED|Overall Study||312
1135618|NCT01344460|2749521|P1|Fulfilled Requirements of FAS Population|Overall Study|Full analysis set (FAS)|292
1135619|NCT01344460|2749521|P1|STARTED|Overall Study|Participants received study drug; Safety analysis set|315
1135620|NCT01344538|2749568|P2|NOT COMPLETED|Overall Study||1
1135621|NCT01344538|2749569|P1|NOT COMPLETED|Overall Study||2
1135622|NCT01344538|2749568|P2|COMPLETED|Overall Study||16
1135623|NCT01344538|2749569|P1|COMPLETED|Overall Study||14
1135624|NCT01344538|2749568|P2|STARTED|Overall Study||17
1135625|NCT01344538|2749569|P1|STARTED|Overall Study||16
1135626|NCT01339000|2749577|P2|NOT COMPLETED|Overall Study||0
1135627|NCT01339000|2749578|P1|NOT COMPLETED|Overall Study||1
1135628|NCT01339000|2749577|P2|COMPLETED|Overall Study||0
1135629|NCT01339000|2749578|P1|COMPLETED|Overall Study||0
1135630|NCT01339000|2749577|P2|STARTED|Overall Study||0
1135631|NCT01339000|2749578|P1|STARTED|Overall Study|The patient received day 1, 29, 36, 43, 50, and 57 vaccines but did not receive interleukin-7 (IL-7)|1
1135632|NCT01339013|2749592|P1|NOT COMPLETED|Overall Study||0
1135633|NCT01339013|2749592|P1|COMPLETED|Overall Study||6
1135634|NCT01339013|2749592|P1|STARTED|Overall Study||6
1135635|NCT01339052|2749598|P2|NOT COMPLETED|Overall Study||50
1135636|NCT01339052|2749599|P1|NOT COMPLETED|Overall Study||15
1135637|NCT01339052|2749598|P2|COMPLETED|Overall Study||0
1135638|NCT01339052|2749599|P1|COMPLETED|Overall Study||0
1135639|NCT01339052|2749598|P2|Evaluable Plasma Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
1135640|NCT01339052|2749599|P1|Evaluable Plasma Sample at Surgery|Overall Study||13
1135641|NCT01339052|2749598|P2|Evaluable Tumor Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
1135642|NCT01339052|2749599|P1|Evaluable Tumor Sample at Surgery|Overall Study||14
1135643|NCT01339052|2749598|P2|Measurable Disease|Overall Study|Radiographic response evaluated on participants with measurable disease only.|40
1135644|NCT01339052|2749599|P1|Measurable Disease|Overall Study||11
1135645|NCT01339052|2749598|P2|STARTED|Overall Study||50
1135646|NCT01339052|2749599|P1|STARTED|Overall Study||15
1135647|NCT01339091|2749621|P2|NOT COMPLETED|Overall Study||28
1135648|NCT01339091|2749622|P1|NOT COMPLETED|Overall Study||27
1135649|NCT01339091|2749621|P2|COMPLETED|Overall Study||257
1135650|NCT01339091|2749622|P1|COMPLETED|Overall Study||261
1135651|NCT01339091|2749621|P2|Safety Population|Overall Study||284
1135652|NCT01339091|2749622|P1|Safety Population|Overall Study||284
1135653|NCT01339091|2749621|P2|STARTED|Overall Study||285
1135654|NCT01339091|2749622|P1|STARTED|Overall Study||288
1135655|NCT01344616|2749636|P2|NOT COMPLETED|Overall Study||44
1135656|NCT01344616|2749637|P1|NOT COMPLETED|Overall Study||35
1135657|NCT01344616|2749636|P2|COMPLETED|Overall Study||194
1135658|NCT01344616|2749637|P1|COMPLETED|Overall Study||209
1135659|NCT01344616|2749636|P2|STARTED|Overall Study||238
1135660|NCT01344616|2749637|P1|STARTED|Overall Study||244
1135661|NCT01344629|2749645|P2|NOT COMPLETED|Crossover Period 4||0
1135662|NCT01344629|2749646|P1|NOT COMPLETED|Crossover Period 4||0
1135663|NCT01344629|2749645|P2|COMPLETED|Crossover Period 4||31
1135664|NCT01344629|2749646|P1|COMPLETED|Crossover Period 4||32
1135665|NCT01344629|2749645|P2|STARTED|Crossover Period 4||31
1135666|NCT01344629|2749646|P1|STARTED|Crossover Period 4||32
1135667|NCT01344629|2749645|P2|NOT COMPLETED|Crossover Period 3||0
1135668|NCT01344629|2749646|P1|NOT COMPLETED|Crossover Period 3||0
1135669|NCT01344629|2749645|P2|COMPLETED|Crossover Period 3||31
1135670|NCT01344629|2749646|P1|COMPLETED|Crossover Period 3||32
1135671|NCT01344629|2749645|P2|STARTED|Crossover Period 3||31
1135672|NCT01344629|2749646|P1|STARTED|Crossover Period 3||32
1135673|NCT01344629|2749645|P2|NOT COMPLETED|Crossover Period 2||1
1135674|NCT01344629|2749646|P1|NOT COMPLETED|Crossover Period 2||0
1135675|NCT01344629|2749645|P2|COMPLETED|Crossover Period 2||31
1135676|NCT01344629|2749646|P1|COMPLETED|Crossover Period 2||32
1135677|NCT01344629|2749645|P2|STARTED|Crossover Period 2||32
1135678|NCT01344629|2749646|P1|STARTED|Crossover Period 2||32
1135679|NCT01344629|2749645|P2|NOT COMPLETED|Crossover Period 1||0
1135680|NCT01344629|2749646|P1|NOT COMPLETED|Crossover Period 1||0
1135681|NCT01344629|2749645|P2|COMPLETED|Crossover Period 1||32
1135682|NCT01344629|2749646|P1|COMPLETED|Crossover Period 1||32
1135683|NCT01344629|2749645|P2|STARTED|Crossover Period 1||32
1135684|NCT01344629|2749646|P1|STARTED|Crossover Period 1||32
1135685|NCT01344759|2749666|P2|NOT COMPLETED|Overall Study||2
1135686|NCT01344759|2749667|P1|NOT COMPLETED|Overall Study||0
1135687|NCT01344759|2749666|P2|COMPLETED|Overall Study|Two of the original DEX group subjects were removed, due to receiving dexmedetomidine and propofol.|28
1135688|NCT01344759|2749667|P1|COMPLETED|Overall Study||30
1135689|NCT01344759|2749666|P2|STARTED|Overall Study||30
1135690|NCT01344759|2749667|P1|STARTED|Overall Study||30
1135694|NCT01344876|2749703|P5|NOT COMPLETED|Overall Study||1
1135695|NCT01344876|2749704|P4|NOT COMPLETED|Overall Study||3
1135696|NCT01344876|2749705|P3|NOT COMPLETED|Overall Study||1
1135697|NCT01344876|2749706|P2|NOT COMPLETED|Overall Study||0
1135698|NCT01344876|2749707|P1|NOT COMPLETED|Overall Study||1
1135699|NCT01344876|2749703|P5|COMPLETED|Overall Study||2
1135700|NCT01344876|2749704|P4|COMPLETED|Overall Study||3
1135701|NCT01344876|2749705|P3|COMPLETED|Overall Study||3
1135702|NCT01344876|2749706|P2|COMPLETED|Overall Study||3
1135703|NCT01344876|2749707|P1|COMPLETED|Overall Study||3
1135704|NCT01344876|2749703|P5|STARTED|Overall Study||3
1135705|NCT01344876|2749704|P4|STARTED|Overall Study||6
1135706|NCT01344876|2749705|P3|STARTED|Overall Study||4
1135707|NCT01344876|2749706|P2|STARTED|Overall Study||3
1135708|NCT01344876|2749707|P1|STARTED|Overall Study||4
1135709|NCT01345240|2749726|P5|NOT COMPLETED|Overall Study||7
1135710|NCT01345240|2749727|P4|NOT COMPLETED|Overall Study||10
1135711|NCT01345240|2749728|P3|NOT COMPLETED|Overall Study||10
1135712|NCT01345240|2749729|P2|NOT COMPLETED|Overall Study||14
1135713|NCT01345240|2749730|P1|NOT COMPLETED|Overall Study||2
1135714|NCT01345240|2749726|P5|COMPLETED|Overall Study||132
1135715|NCT01345240|2749727|P4|COMPLETED|Overall Study||131
1135716|NCT01345240|2749728|P3|COMPLETED|Overall Study||131
1135717|NCT01345240|2749729|P2|COMPLETED|Overall Study||128
1135718|NCT01345240|2749730|P1|COMPLETED|Overall Study||140
1135719|NCT01345240|2749726|P5|STARTED|Overall Study||139
1135720|NCT01345240|2749727|P4|STARTED|Overall Study||141
1135721|NCT01345240|2749728|P3|STARTED|Overall Study||141
1135722|NCT01345240|2749729|P2|STARTED|Overall Study||142
1135723|NCT01345240|2749730|P1|STARTED|Overall Study||142
1135730|NCT01345292|2749843|P3|NOT COMPLETED|Overall Study||1
1135731|NCT01345292|2749844|P2|NOT COMPLETED|Overall Study||0
1135732|NCT01345292|2749845|P1|NOT COMPLETED|Overall Study||2
1135733|NCT01345292|2749843|P3|COMPLETED|Overall Study||74
1135734|NCT01345292|2749844|P2|COMPLETED|Overall Study||76
1135735|NCT01345292|2749845|P1|COMPLETED|Overall Study||73
1135736|NCT01345292|2749843|P3|STARTED|Overall Study||75
1135737|NCT01345292|2749844|P2|STARTED|Overall Study||76
1135738|NCT01345292|2749845|P1|STARTED|Overall Study||75
1135739|NCT01345318|2749874|P1|NOT COMPLETED|Overall Study||80
1135740|NCT01345318|2749874|P1|COMPLETED|Overall Study||111
1135741|NCT01345318|2749874|P1|STARTED|Overall Study||191
1135742|NCT01345591|2749879|P1|NOT COMPLETED|Overall Study||1
1135743|NCT01345591|2749879|P1|COMPLETED|Overall Study||19
1135744|NCT01345591|2749879|P1|STARTED|Overall Study||20
1135745|NCT01345630|2749890|P2|NOT COMPLETED|Overall Study||359
1135746|NCT01345630|2749891|P1|NOT COMPLETED|Overall Study||361
1135747|NCT01345630|2749890|P2|COMPLETED|Overall Study||42
1135748|NCT01345630|2749891|P1|COMPLETED|Overall Study||35
1135749|NCT01345630|2749890|P2|STARTED|Overall Study||401
1135750|NCT01345630|2749891|P1|STARTED|Overall Study||396
1135751|NCT01345682|2749949|P2|NOT COMPLETED|Overall Study||157
1135752|NCT01345682|2749950|P1|NOT COMPLETED|Overall Study||306
1135753|NCT01345682|2749949|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date (07May2014)|4
1135754|NCT01345682|2749950|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (07May2014)|16
1135755|NCT01345682|2749949|P2|STARTED|Overall Study|Randomised|161
1135756|NCT01345682|2749950|P1|STARTED|Overall Study|Randomised|322
1135757|NCT01345721|2749985|P3|NOT COMPLETED|Overall Study||0
1135758|NCT01345721|2749986|P2|NOT COMPLETED|Overall Study||0
1135759|NCT01345721|2749987|P1|NOT COMPLETED|Overall Study||0
1135760|NCT01345721|2749985|P3|COMPLETED|Overall Study||65
1135761|NCT01345721|2749986|P2|COMPLETED|Overall Study||66
1135762|NCT01345721|2749987|P1|COMPLETED|Overall Study||74
1135763|NCT01345721|2749985|P3|STARTED|Overall Study||65
1135764|NCT01345721|2749986|P2|STARTED|Overall Study||66
1135765|NCT01345721|2749987|P1|STARTED|Overall Study||74
1135766|NCT01345786|2750018|P4|NOT COMPLETED|Overall Study||3
1135767|NCT01345786|2750019|P3|NOT COMPLETED|Overall Study||5
1135768|NCT01345786|2750020|P2|NOT COMPLETED|Overall Study||8
1135769|NCT01345786|2750021|P1|NOT COMPLETED|Overall Study||6
1135770|NCT01345786|2750018|P4|COMPLETED|Overall Study||35
1135771|NCT01345786|2750019|P3|COMPLETED|Overall Study||33
1135772|NCT01345786|2750020|P2|COMPLETED|Overall Study||33
1135773|NCT01345786|2750021|P1|COMPLETED|Overall Study||35
1135774|NCT01345786|2750018|P4|Treated|Overall Study||37
1135775|NCT01345786|2750019|P3|Treated|Overall Study||37
1135776|NCT01345786|2750020|P2|Treated|Overall Study||41
1135777|NCT01345786|2750021|P1|Treated|Overall Study||41
1135778|NCT01345786|2750018|P4|STARTED|Overall Study|Number randomized|38
1135779|NCT01345786|2750019|P3|STARTED|Overall Study|Number randomized|38
1135780|NCT01345786|2750020|P2|STARTED|Overall Study|Number randomized|41
1135781|NCT01345786|2750021|P1|STARTED|Overall Study|Number randomized|41
1135782|NCT01345929|2750069|P2|NOT COMPLETED|Overall Study||19
1135783|NCT01345929|2750070|P1|NOT COMPLETED|Overall Study||21
1135784|NCT01345929|2750069|P2|COMPLETED|Overall Study||516
1135785|NCT01345929|2750070|P1|COMPLETED|Overall Study||512
1135786|NCT01345929|2750069|P2|STARTED|Overall Study||535
1135787|NCT01345929|2750070|P1|STARTED|Overall Study||533
1135788|NCT01346059|2750080|P2|NOT COMPLETED|Overall Study||0
1135789|NCT01346059|2750081|P1|NOT COMPLETED|Overall Study||1
1135790|NCT01346059|2750080|P2|COMPLETED|Overall Study||1
1135791|NCT01346059|2750081|P1|COMPLETED|Overall Study||0
1135792|NCT01346059|2750080|P2|STARTED|Overall Study||1
1135793|NCT01346059|2750081|P1|STARTED|Overall Study||1
1135794|NCT01346072|2750093|P2|NOT COMPLETED|Overall Study||0
1135795|NCT01346072|2750094|P1|NOT COMPLETED|Overall Study||0
1135796|NCT01346072|2750093|P2|COMPLETED|Overall Study||10
1135797|NCT01346072|2750094|P1|COMPLETED|Overall Study||11
1135798|NCT01346072|2750093|P2|STARTED|Overall Study||10
1135799|NCT01346072|2750094|P1|STARTED|Overall Study||11
1135800|NCT01346085|2750102|P1|NOT COMPLETED|Overall Study||0
1135801|NCT01346085|2750102|P1|COMPLETED|Overall Study||10
1135802|NCT01346085|2750102|P1|STARTED|Overall Study||10
1135803|NCT01346176|2750110|P3|NOT COMPLETED|Completed Satisfaction Survey||6
1135804|NCT01346176|2750111|P2|NOT COMPLETED|Completed Satisfaction Survey||4
1135805|NCT01346176|2750112|P1|NOT COMPLETED|Completed Satisfaction Survey||6
1135806|NCT01346176|2750110|P3|COMPLETED|Completed Satisfaction Survey||27
1135807|NCT01346176|2750111|P2|COMPLETED|Completed Satisfaction Survey||22
1135808|NCT01346176|2750112|P1|COMPLETED|Completed Satisfaction Survey||29
1135809|NCT01346176|2750110|P3|STARTED|Completed Satisfaction Survey||33
1135810|NCT01346176|2750111|P2|STARTED|Completed Satisfaction Survey||26
1135811|NCT01346176|2750112|P1|STARTED|Completed Satisfaction Survey||35
1135812|NCT01346176|2750110|P3|NOT COMPLETED|Completed Advance Directive||10
1135813|NCT01346176|2750111|P2|NOT COMPLETED|Completed Advance Directive||14
1135814|NCT01346176|2750112|P1|NOT COMPLETED|Completed Advance Directive||13
1135815|NCT01346176|2750110|P3|COMPLETED|Completed Advance Directive||33
1135816|NCT01346176|2750111|P2|COMPLETED|Completed Advance Directive||26
1135817|NCT01346176|2750112|P1|COMPLETED|Completed Advance Directive||35
1135818|NCT01346176|2750110|P3|STARTED|Completed Advance Directive||43
1135819|NCT01346176|2750111|P2|STARTED|Completed Advance Directive||40
1135820|NCT01346176|2750112|P1|STARTED|Completed Advance Directive||48
1135821|NCT01346176|2750110|P3|NOT COMPLETED|Recruited||0
1135822|NCT01346176|2750111|P2|NOT COMPLETED|Recruited||0
1135823|NCT01346176|2750112|P1|NOT COMPLETED|Recruited||1
1135824|NCT01346176|2750110|P3|COMPLETED|Recruited||43
1135825|NCT01346176|2750111|P2|COMPLETED|Recruited||40
1135826|NCT01346176|2750112|P1|COMPLETED|Recruited||48
1135827|NCT01346176|2750110|P3|STARTED|Recruited||43
1135828|NCT01346176|2750111|P2|STARTED|Recruited||40
1135829|NCT01346176|2750112|P1|STARTED|Recruited||49
1135830|NCT01346293|2750125|P2|NOT COMPLETED|Overall Study||21
1135831|NCT01346293|2750126|P1|NOT COMPLETED|Overall Study||67
1135832|NCT01346293|2750125|P2|COMPLETED|Overall Study||608
1135833|NCT01346293|2750126|P1|COMPLETED|Overall Study||2676
1135834|NCT01346293|2750125|P2|STARTED|Overall Study||629
1135835|NCT01346293|2750126|P1|STARTED|Overall Study||2743
1135836|NCT01346397|2750154|P2|NOT COMPLETED|Overall Study||0
1135837|NCT01346397|2750155|P1|NOT COMPLETED|Overall Study||0
1135838|NCT01346397|2750154|P2|COMPLETED|Overall Study||85
1135839|NCT01346397|2750155|P1|COMPLETED|Overall Study||85
1135840|NCT01346397|2750154|P2|STARTED|Overall Study||85
1135841|NCT01346397|2750155|P1|STARTED|Overall Study||85
1135842|NCT01346475|2750165|P2|NOT COMPLETED|Second Intervention||0
1135843|NCT01346475|2750166|P1|NOT COMPLETED|Second Intervention||0
1135844|NCT01346475|2750165|P2|COMPLETED|Second Intervention||25
1135845|NCT01346475|2750166|P1|COMPLETED|Second Intervention||18
1135846|NCT01346475|2750165|P2|STARTED|Second Intervention||25
1135847|NCT01346475|2750166|P1|STARTED|Second Intervention||18
1135848|NCT01346475|2750165|P2|NOT COMPLETED|First Intervention||3
1135849|NCT01346475|2750166|P1|NOT COMPLETED|First Intervention||4
1135850|NCT01346475|2750165|P2|COMPLETED|First Intervention||25
1135851|NCT01346475|2750166|P1|COMPLETED|First Intervention||18
1135852|NCT01346475|2750165|P2|STARTED|First Intervention||28
1135853|NCT01346475|2750166|P1|STARTED|First Intervention||22
1135854|NCT01346488|2750178|P1|NOT COMPLETED|Overall Study||706
1135855|NCT01346488|2750178|P1|COMPLETED|Overall Study||1262
1135856|NCT01346488|2750178|P1|STARTED|Overall Study||1968
1135857|NCT01346501|2750198|P2|NOT COMPLETED|Overall Study||13
1135858|NCT01346501|2750199|P1|NOT COMPLETED|Overall Study||11
1135859|NCT01346501|2750198|P2|COMPLETED|Overall Study||80
1135860|NCT01346501|2750199|P1|COMPLETED|Overall Study||68
1135861|NCT01346501|2750198|P2|STARTED|Overall Study||93
1135862|NCT01346501|2750199|P1|STARTED|Overall Study||79
1135863|NCT01346514|2750214|P2|NOT COMPLETED|Overall Study||37
1135864|NCT01346514|2750215|P1|NOT COMPLETED|Overall Study||29
1135865|NCT01346514|2750214|P2|COMPLETED|Overall Study|Number of patients completing BL-12 months.|53
1135866|NCT01346514|2750215|P1|COMPLETED|Overall Study|Number of patients completing BL-12 months|62
1135867|NCT01346514|2750214|P2|12 Month Assessment|Overall Study||53
1135868|NCT01346514|2750215|P1|12 Month Assessment|Overall Study||62
1135869|NCT01346514|2750214|P2|9 Month Assessment|Overall Study||59
1135870|NCT01346514|2750215|P1|9 Month Assessment|Overall Study||67
1135871|NCT01346514|2750214|P2|6 Month Assessment|Overall Study||61
1135872|NCT01346514|2750215|P1|6 Month Assessment|Overall Study||74
1135873|NCT01346514|2750214|P2|3 Month Assessment|Overall Study||68
1135874|NCT01346514|2750215|P1|3 Month Assessment|Overall Study||83
1135875|NCT01346514|2750214|P2|STARTED|Overall Study||90
1135876|NCT01346514|2750215|P1|STARTED|Overall Study||91
1135877|NCT01346592|2750236|P3|NOT COMPLETED|Overall Study||78
1135878|NCT01346592|2750237|P2|NOT COMPLETED|Overall Study||89
1135879|NCT01346592|2750238|P1|NOT COMPLETED|Overall Study||153
1135880|NCT01346592|2750236|P3|COMPLETED|Overall Study||1408
1135881|NCT01346592|2750237|P2|COMPLETED|Overall Study||1389
1135882|NCT01346592|2750238|P1|COMPLETED|Overall Study||2983
1135883|NCT01346592|2750236|P3|STARTED|Overall Study||1486
1135884|NCT01346592|2750237|P2|STARTED|Overall Study||1478
1135885|NCT01346592|2750238|P1|STARTED|Overall Study||3136
1135886|NCT01346774|2750330|P2|NOT COMPLETED|Overall Study||17
1135887|NCT01346774|2750331|P1|NOT COMPLETED|Overall Study||13
1135888|NCT01346774|2750330|P2|COMPLETED|Overall Study||63
1135889|NCT01346774|2750331|P1|COMPLETED|Overall Study||67
1135890|NCT01346774|2750330|P2|STARTED|Overall Study||80
1135891|NCT01346774|2750331|P1|STARTED|Overall Study||80
1135892|NCT01346839|2750339|P2|NOT COMPLETED|Overall Study||209
1135893|NCT01346839|2750340|P1|NOT COMPLETED|Overall Study||314
1135894|NCT01346839|2750339|P2|COMPLETED|Overall Study|All triggers were applied retrospectively on 7/19/2012.|364
1135895|NCT01346839|2750340|P1|COMPLETED|Overall Study||369
1135896|NCT01346839|2750339|P2|STARTED|Overall Study||573
1135897|NCT01346839|2750340|P1|STARTED|Overall Study||683
1135898|NCT01346852|2750356|P2|NOT COMPLETED|Overall Study||0
1135899|NCT01346852|2750357|P1|NOT COMPLETED|Overall Study||0
1135900|NCT01346852|2750356|P2|COMPLETED|Overall Study||59684
1135901|NCT01346852|2750357|P1|COMPLETED|Overall Study||41753
1135902|NCT01346852|2750356|P2|STARTED|Overall Study||59684
1135903|NCT01346852|2750357|P1|STARTED|Overall Study||41753
1135904|NCT01347008|2750367|P2|NOT COMPLETED|Overall Study||0
1135905|NCT01347008|2750368|P1|NOT COMPLETED|Overall Study||0
1135906|NCT01347008|2750367|P2|COMPLETED|Overall Study||20
1135907|NCT01347008|2750368|P1|COMPLETED|Overall Study||21
1135908|NCT01347008|2750367|P2|STARTED|Overall Study||20
1135909|NCT01347008|2750368|P1|STARTED|Overall Study||21
1135910|NCT01347034|2750380|P2|NOT COMPLETED|Overall Study||0
1135911|NCT01347034|2750381|P1|NOT COMPLETED|Overall Study||0
1135912|NCT01347034|2750380|P2|COMPLETED|Overall Study||14
1135913|NCT01347034|2750381|P1|COMPLETED|Overall Study||6
1135914|NCT01347034|2750380|P2|STARTED|Overall Study||14
1135915|NCT01347034|2750381|P1|STARTED|Overall Study||6
1135916|NCT01347060|2750391|P2|NOT COMPLETED|Overall Study||0
1135917|NCT01347060|2750392|P1|NOT COMPLETED|Overall Study||0
1135918|NCT01347060|2750391|P2|COMPLETED|Overall Study||7580
1135919|NCT01347060|2750392|P1|COMPLETED|Overall Study||9868
1135920|NCT01347060|2750391|P2|STARTED|Overall Study||7580
1135921|NCT01347060|2750392|P1|STARTED|Overall Study||9868
1135922|NCT01347073|2750402|P1|NOT COMPLETED|Overall Study||2
1135923|NCT01347073|2750402|P1|COMPLETED|Overall Study||21
1135924|NCT01347073|2750402|P1|STARTED|Overall Study||23
1135925|NCT01347086|2750424|P10|NOT COMPLETED|Overall Study||1
1135926|NCT01347086|2750425|P9|NOT COMPLETED|Overall Study||0
1135927|NCT01347086|2750426|P8|NOT COMPLETED|Overall Study||1
1135928|NCT01347086|2750427|P7|NOT COMPLETED|Overall Study||1
1135929|NCT01347086|2750428|P6|NOT COMPLETED|Overall Study||0
1135930|NCT01347086|2750429|P5|NOT COMPLETED|Overall Study||0
1135931|NCT01347086|2750430|P4|NOT COMPLETED|Overall Study||0
1135932|NCT01347086|2750431|P3|NOT COMPLETED|Overall Study||1
1135933|NCT01347086|2750432|P2|NOT COMPLETED|Overall Study||0
1135934|NCT01347086|2750433|P1|NOT COMPLETED|Overall Study||0
1135935|NCT01347086|2750424|P10|COMPLETED|Overall Study||6
1135936|NCT01347086|2750425|P9|COMPLETED|Overall Study||6
1135937|NCT01347086|2750426|P8|COMPLETED|Overall Study||6
1135938|NCT01347086|2750427|P7|COMPLETED|Overall Study||6
1135939|NCT01347086|2750428|P6|COMPLETED|Overall Study||6
1135940|NCT01347086|2750429|P5|COMPLETED|Overall Study||6
1135941|NCT01347086|2750430|P4|COMPLETED|Overall Study||6
1135942|NCT01347086|2750431|P3|COMPLETED|Overall Study||6
1135943|NCT01347086|2750432|P2|COMPLETED|Overall Study||6
1135944|NCT01347086|2750433|P1|COMPLETED|Overall Study||2
1135945|NCT01347086|2750424|P10|STARTED|Overall Study|One subject was not treated.|7
1135946|NCT01347086|2750425|P9|STARTED|Overall Study||6
1135947|NCT01347086|2750426|P8|STARTED|Overall Study|One subject was not treated.|7
1135948|NCT01347086|2750427|P7|STARTED|Overall Study|"2 participants treated together with each dose level of Deleobuvir.
1 subject was not treated."|7
1135949|NCT01347086|2750428|P6|STARTED|Overall Study||6
1135950|NCT01347086|2750429|P5|STARTED|Overall Study||6
1135951|NCT01347086|2750430|P4|STARTED|Overall Study||6
1135952|NCT01347086|2750431|P3|STARTED|Overall Study|"2 participants were treated together with each dose level of Deleobuvir.
1 subject was not treated."|7
1135953|NCT01347086|2750432|P2|STARTED|Overall Study||6
1135954|NCT01347086|2750433|P1|STARTED|Overall Study||2
1135955|NCT01347112|2750534|P2|NOT COMPLETED|Overall Study||12
1135956|NCT01347112|2750535|P1|NOT COMPLETED|Overall Study||4
1135957|NCT01347112|2750534|P2|COMPLETED|Overall Study||5
1135958|NCT01347112|2750535|P1|COMPLETED|Overall Study||12
1135959|NCT01347112|2750534|P2|STARTED|Overall Study||17
1135960|NCT01347112|2750535|P1|STARTED|Overall Study||16
1135961|NCT01347255|2750545|P1|NOT COMPLETED|Overall Study||0
1135962|NCT01347255|2750545|P1|COMPLETED|Overall Study||24
1135963|NCT01347255|2750545|P1|STARTED|Overall Study||24
1135964|NCT01347554|2750570|P2|NOT COMPLETED|Overall Study||11
1135965|NCT01347554|2750571|P1|NOT COMPLETED|Overall Study||7
1135966|NCT01347554|2750570|P2|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=11) were excluded.|231
1135967|NCT01347554|2750571|P1|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=7) were excluded.|230
1135968|NCT01347554|2750570|P2|STARTED|Overall Study||242
1135969|NCT01347554|2750571|P1|STARTED|Overall Study||237
1135970|NCT01347580|2750585|P2|NOT COMPLETED|Overall Study||56
1135971|NCT01347580|2750586|P1|NOT COMPLETED|Overall Study||65
1135972|NCT01347580|2750585|P2|COMPLETED|Overall Study|based on randomized treatment|897
1135973|NCT01347580|2750586|P1|COMPLETED|Overall Study|based on randomized treatment|844
1135974|NCT01347580|2750585|P2|Safety Population|Overall Study|based on actual treatment|950
1135975|NCT01347580|2750586|P1|Safety Population|Overall Study|based on actual treatment|908
1135976|NCT01347580|2750585|P2|Modified Intent to Treat Population|Overall Study|based on randomized treatment|952
1135977|NCT01347580|2750586|P1|Modified Intent to Treat Population|Overall Study|based on randomized treatment|906
1135978|NCT01347580|2750585|P2|STARTED|Overall Study|based on randomized treatment|953
1135979|NCT01347580|2750586|P1|STARTED|Overall Study|based on randomized treatment|909
1135980|NCT01347632|2750614|P1|NOT COMPLETED|Overall Study||2
1135981|NCT01347632|2750614|P1|COMPLETED|Overall Study||33
1135982|NCT01347632|2750614|P1|STARTED|Overall Study||35
1135983|NCT01341990|2750620|P2|NOT COMPLETED|Overall Study||1
1135984|NCT01341990|2750621|P1|NOT COMPLETED|Overall Study||3
1135985|NCT01341990|2750620|P2|COMPLETED|Overall Study||32
1135986|NCT01341990|2750621|P1|COMPLETED|Overall Study||32
1135987|NCT01341990|2750620|P2|STARTED|Overall Study||33
1135988|NCT01341990|2750621|P1|STARTED|Overall Study||35
1135989|NCT01342081|2750632|P3|NOT COMPLETED|Overall Study||1
1135990|NCT01342081|2750633|P2|NOT COMPLETED|Overall Study||2
1135991|NCT01342081|2750634|P1|NOT COMPLETED|Overall Study||2
1135992|NCT01342081|2750632|P3|COMPLETED|Overall Study||163
1135993|NCT01342081|2750633|P2|COMPLETED|Overall Study||162
1135994|NCT01342081|2750634|P1|COMPLETED|Overall Study||159
1135995|NCT01342081|2750632|P3|STARTED|Overall Study||164
1135996|NCT01342081|2750633|P2|STARTED|Overall Study||164
1135997|NCT01342081|2750634|P1|STARTED|Overall Study||161
1135998|NCT01347710|2750642|P1|NOT COMPLETED|Overall Study||31
1135999|NCT01347710|2750642|P1|COMPLETED|Overall Study||764
1136000|NCT01347710|2750642|P1|STARTED|Overall Study||795
1136001|NCT01347788|2750657|P3|NOT COMPLETED|Overall Study||0
1136002|NCT01347788|2750658|P2|NOT COMPLETED|Overall Study||0
1136003|NCT01347788|2750659|P1|NOT COMPLETED|Overall Study||0
1136004|NCT01347788|2750657|P3|COMPLETED|Overall Study||13
1136005|NCT01347788|2750658|P2|COMPLETED|Overall Study||10
1136006|NCT01347788|2750659|P1|COMPLETED|Overall Study||11
1136007|NCT01347788|2750657|P3|STARTED|Overall Study||13
1136008|NCT01347788|2750658|P2|STARTED|Overall Study||10
1136009|NCT01347788|2750659|P1|STARTED|Overall Study||11
1136010|NCT01345058|2750669|P2|NOT COMPLETED|Overall Study||0
1136011|NCT01345058|2750670|P1|NOT COMPLETED|Overall Study||5
1136012|NCT01345058|2750669|P2|COMPLETED|Overall Study||36
1136013|NCT01345058|2750670|P1|COMPLETED|Overall Study||15
1136014|NCT01345058|2750669|P2|Received Lacosamide|Overall Study||0
1136015|NCT01345058|2750670|P1|Received Lacosamide|Overall Study||19
1136016|NCT01345058|2750669|P2|STARTED|Overall Study||36
1136017|NCT01345058|2750670|P1|STARTED|Overall Study||20
1136018|NCT01345123|2750687|P3|NOT COMPLETED|Overall Study||88
1136019|NCT01345123|2750688|P2|NOT COMPLETED|Overall Study||85
1136020|NCT01345123|2750689|P1|NOT COMPLETED|Overall Study||79
1136021|NCT01345123|2750687|P3|COMPLETED|Overall Study|3291 - 88 study participants who were no longer health plan eligible members (zero eligible months)|3203
1136022|NCT01345123|2750688|P2|COMPLETED|Overall Study|3311 - 85 study participants who were no longer health plan eligible members (zero eligible months)|3226
1136023|NCT01345123|2750689|P1|COMPLETED|Overall Study|3323 - 79 study participants who were no longer health plan eligible members (zero eligible months)|3244
1136024|NCT01345123|2750687|P3|STARTED|Overall Study||3291
1136025|NCT01345123|2750688|P2|STARTED|Overall Study||3311
1136026|NCT01345123|2750689|P1|STARTED|Overall Study||3323
1136027|NCT01345162|2750711|P2|NOT COMPLETED|Overall Study||4
1136028|NCT01345162|2750712|P1|NOT COMPLETED|Overall Study||2
1136029|NCT01345162|2750711|P2|COMPLETED|Overall Study||96
1136030|NCT01345162|2750712|P1|COMPLETED|Overall Study||98
1136031|NCT01345162|2750711|P2|STARTED|Overall Study||100
1136032|NCT01345162|2750712|P1|STARTED|Overall Study||100
1136039|NCT02800213|2750729|P2|NOT COMPLETED|Second Intervention||0
1136040|NCT02800213|2750730|P1|NOT COMPLETED|Second Intervention||0
1136041|NCT02800213|2750729|P2|COMPLETED|Second Intervention||35
1136042|NCT02800213|2750730|P1|COMPLETED|Second Intervention||35
1136043|NCT02800213|2750729|P2|STARTED|Second Intervention||35
1136044|NCT02800213|2750730|P1|STARTED|Second Intervention||35
1136045|NCT02800213|2750729|P2|NOT COMPLETED|First Intervention||0
1136046|NCT02800213|2750730|P1|NOT COMPLETED|First Intervention||0
1136047|NCT02800213|2750729|P2|COMPLETED|First Intervention||35
1136048|NCT02800213|2750730|P1|COMPLETED|First Intervention||35
1136049|NCT02800213|2750729|P2|STARTED|First Intervention||35
1136050|NCT02800213|2750730|P1|STARTED|First Intervention||35
1136072|NCT02600767|2750778|P1|NOT COMPLETED|Overall Study||5
1136073|NCT02600767|2750778|P1|COMPLETED|Overall Study||74
1136074|NCT02600767|2750778|P1|STARTED|Overall Study||79
1136084|NCT02551224|2750815|P2|NOT COMPLETED|Second Intervention (5 Min After First )||0
1136085|NCT02551224|2750816|P1|NOT COMPLETED|Second Intervention (5 Min After First )||0
1136086|NCT02551224|2750815|P2|COMPLETED|Second Intervention (5 Min After First )||50
1136087|NCT02551224|2750816|P1|COMPLETED|Second Intervention (5 Min After First )||50
1136088|NCT02551224|2750815|P2|STARTED|Second Intervention (5 Min After First )||50
1136089|NCT02551224|2750816|P1|STARTED|Second Intervention (5 Min After First )||50
1136090|NCT02551224|2750815|P2|NOT COMPLETED|First Intervention||0
1136091|NCT02551224|2750816|P1|NOT COMPLETED|First Intervention||0
1136092|NCT02551224|2750815|P2|COMPLETED|First Intervention||50
1136093|NCT02551224|2750816|P1|COMPLETED|First Intervention||50
1136094|NCT02551224|2750815|P2|STARTED|First Intervention||50
1136095|NCT02551224|2750816|P1|STARTED|First Intervention||50
1136096|NCT02524158|2750826|P2|NOT COMPLETED|6-month Assessment||21
1136097|NCT02524158|2750827|P1|NOT COMPLETED|6-month Assessment||22
1136098|NCT02524158|2750826|P2|COMPLETED|6-month Assessment||55
1136099|NCT02524158|2750827|P1|COMPLETED|6-month Assessment||54
1136100|NCT02524158|2750826|P2|STARTED|6-month Assessment||76
1136101|NCT02524158|2750827|P1|STARTED|6-month Assessment||76
1136102|NCT02524158|2750826|P2|NOT COMPLETED|12-weeks Assessment||13
1136103|NCT02524158|2750827|P1|NOT COMPLETED|12-weeks Assessment||19
1136104|NCT02524158|2750826|P2|COMPLETED|12-weeks Assessment||63
1136105|NCT02524158|2750827|P1|COMPLETED|12-weeks Assessment||57
1136106|NCT02524158|2750826|P2|STARTED|12-weeks Assessment||76
1136107|NCT02524158|2750827|P1|STARTED|12-weeks Assessment||76
1136121|NCT02374593|2750867|P2|NOT COMPLETED|Overall Study||0
1136122|NCT02374593|2750868|P1|NOT COMPLETED|Overall Study||2
1136123|NCT02374593|2750867|P2|COMPLETED|Overall Study||44
1136124|NCT02374593|2750868|P1|COMPLETED|Overall Study||22
1136125|NCT02374593|2750867|P2|STARTED|Overall Study||44
1136126|NCT02374593|2750868|P1|STARTED|Overall Study||24
1136127|NCT02369341|2750880|P2|NOT COMPLETED|Overall Study||0
1136128|NCT02369341|2750881|P1|NOT COMPLETED|Overall Study||1
1136129|NCT02369341|2750880|P2|COMPLETED|Overall Study||57
1136130|NCT02369341|2750881|P1|COMPLETED|Overall Study||62
1136131|NCT02369341|2750880|P2|STARTED|Overall Study||57
1136132|NCT02369341|2750881|P1|STARTED|Overall Study||63
1136133|NCT02343003|2750937|P2|NOT COMPLETED|Overall Study||7
1136134|NCT02343003|2750938|P1|NOT COMPLETED|Overall Study||18
1136135|NCT02343003|2750937|P2|COMPLETED|Overall Study||68
1136136|NCT02343003|2750938|P1|COMPLETED|Overall Study||58
1136137|NCT02343003|2750937|P2|STARTED|Overall Study||75
1136138|NCT02343003|2750938|P1|STARTED|Overall Study||76
1136175|NCT02256436|2750971|P2|NOT COMPLETED|Overall Study||272
1136176|NCT02256436|2750972|P1|NOT COMPLETED|Overall Study||270
1136177|NCT02256436|2750971|P2|COMPLETED|Overall Study||0
1136178|NCT02256436|2750972|P1|COMPLETED|Overall Study||0
1136179|NCT02256436|2750971|P2|Treated|Overall Study||255
1136180|NCT02256436|2750972|P1|Treated|Overall Study||266
1136181|NCT02256436|2750971|P2|STARTED|Overall Study||272
1136182|NCT02256436|2750972|P1|STARTED|Overall Study||270
1136279|NCT01908829|2751134|P3|NOT COMPLETED|Overall Study||39
1136280|NCT01908829|2751135|P2|NOT COMPLETED|Overall Study||49
1136281|NCT01908829|2751136|P1|NOT COMPLETED|Overall Study||49
1136282|NCT01908829|2751134|P3|COMPLETED|Overall Study||680
1136283|NCT01908829|2751135|P2|COMPLETED|Overall Study||679
1136284|NCT01908829|2751136|P1|COMPLETED|Overall Study||678
1136285|NCT01908829|2751134|P3|Treated With Double-blind Drug|Overall Study||719
1136286|NCT01908829|2751135|P2|Treated With Double-blind Drug|Overall Study||728
1136287|NCT01908829|2751136|P1|Treated With Double-blind Drug|Overall Study||725
1136288|NCT01908829|2751134|P3|STARTED|Overall Study||719
1136289|NCT01908829|2751135|P2|STARTED|Overall Study||728
1136290|NCT01908829|2751136|P1|STARTED|Overall Study||727
1136291|NCT01884597|2751252|P3|NOT COMPLETED|Overall Study||1
1136292|NCT01884597|2751253|P2|NOT COMPLETED|Overall Study||1
1136293|NCT01884597|2751254|P1|NOT COMPLETED|Overall Study||1
1136294|NCT01884597|2751252|P3|COMPLETED|Overall Study||15
1136295|NCT01884597|2751253|P2|COMPLETED|Overall Study||2
1136296|NCT01884597|2751254|P1|COMPLETED|Overall Study||4
1136297|NCT01884597|2751252|P3|STARTED|Overall Study||16
1136298|NCT01884597|2751253|P2|STARTED|Overall Study||3
1136299|NCT01884597|2751254|P1|STARTED|Overall Study||5
1136300|NCT01811316|2751286|P3|NOT COMPLETED|Overall Study||0
1136301|NCT01811316|2751287|P2|NOT COMPLETED|Overall Study||0
1136302|NCT01811316|2751288|P1|NOT COMPLETED|Overall Study||3
1136303|NCT01811316|2751286|P3|COMPLETED|Overall Study||19
1136304|NCT01811316|2751287|P2|COMPLETED|Overall Study||22
1136305|NCT01811316|2751288|P1|COMPLETED|Overall Study||18
1136306|NCT01811316|2751286|P3|Visit 12 Weeks|Overall Study||19
1136307|NCT01811316|2751287|P2|Visit 12 Weeks|Overall Study||22
1136308|NCT01811316|2751288|P1|Visit 12 Weeks|Overall Study||18
1136309|NCT01811316|2751286|P3|Visit 4 Weeks|Overall Study||19
1136310|NCT01811316|2751287|P2|Visit 4 Weeks|Overall Study||22
1136311|NCT01811316|2751288|P1|Visit 4 Weeks|Overall Study||19
1136312|NCT01811316|2751286|P3|STARTED|Overall Study||19
1136313|NCT01811316|2751287|P2|STARTED|Overall Study||22
1136314|NCT01811316|2751288|P1|STARTED|Overall Study||21
1136324|NCT01767506|2751329|P2|NOT COMPLETED|Overall Study||0
1136325|NCT01767506|2751330|P1|NOT COMPLETED|Overall Study||0
1136326|NCT01767506|2751329|P2|COMPLETED|Overall Study|The study was conducted at the community level.|0
1136327|NCT01767506|2751330|P1|COMPLETED|Overall Study|The study was conducted at the community level.|0
1136328|NCT01767506|2751329|P2|STARTED|Overall Study|"26 communities were randomized to control group
The study was conducted at the community level."|0
1136329|NCT01767506|2751330|P1|STARTED|Overall Study|"26 communities were randomized to intervention group
The study was conducted at the community level."|0
1136330|NCT01740297|2751343|P3|NOT COMPLETED|Overall Study||98
1136331|NCT01740297|2751344|P2|NOT COMPLETED|Overall Study||100
1136332|NCT01740297|2751345|P1|NOT COMPLETED|Overall Study||19
1136333|NCT01740297|2751343|P3|COMPLETED|Overall Study||0
1136334|NCT01740297|2751344|P2|COMPLETED|Overall Study||0
1136335|NCT01740297|2751345|P1|COMPLETED|Overall Study||0
1136336|NCT01740297|2751343|P3|Received Ipilimumab|Overall Study||92
1136337|NCT01740297|2751344|P2|Received Ipilimumab|Overall Study||95
1136338|NCT01740297|2751345|P1|Received Ipilimumab|Overall Study||18
1136339|NCT01740297|2751343|P3|Received Talimogene Laherparepvec|Overall Study||95
1136340|NCT01740297|2751344|P2|Received Talimogene Laherparepvec|Overall Study||0
1136341|NCT01740297|2751345|P1|Received Talimogene Laherparepvec|Overall Study||19
1136342|NCT01740297|2751343|P3|STARTED|Overall Study||98
1136343|NCT01740297|2751344|P2|STARTED|Overall Study||100
1136344|NCT01740297|2751345|P1|STARTED|Overall Study||19
1136345|NCT01717209|2751375|P1|NOT COMPLETED|Overall Study||0
1136346|NCT01717209|2751375|P1|COMPLETED|Overall Study||14
1136347|NCT01717209|2751375|P1|STARTED|Overall Study||14
1136354|NCT01693653|2751397|P2|NOT COMPLETED|Overall Study||0
1136355|NCT01693653|2751398|P1|NOT COMPLETED|Overall Study||0
1136356|NCT01693653|2751397|P2|COMPLETED|Overall Study||0
1136357|NCT01693653|2751398|P1|COMPLETED|Overall Study||1
1136358|NCT01693653|2751397|P2|STARTED|Overall Study||0
1136359|NCT01693653|2751398|P1|STARTED|Overall Study||1
1136360|NCT01688102|2751406|P2|NOT COMPLETED|Overall Study||18
1136361|NCT01688102|2751407|P1|NOT COMPLETED|Overall Study||16
1136362|NCT01688102|2751406|P2|COMPLETED|Overall Study||40
1136363|NCT01688102|2751407|P1|COMPLETED|Overall Study||44
1136364|NCT01688102|2751406|P2|STARTED|Overall Study||58
1136365|NCT01688102|2751407|P1|STARTED|Overall Study||60
1136372|NCT01682044|2751492|P1|NOT COMPLETED|Overall Study||4
1136373|NCT01682044|2751492|P1|COMPLETED|Overall Study||16
1136374|NCT01682044|2751492|P1|STARTED|Overall Study||20
1136381|NCT01646177|2751541|P4|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
1136382|NCT01646177|2751542|P3|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
1136383|NCT01646177|2751543|P2|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
1136384|NCT01646177|2751544|P1|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
1136385|NCT01646177|2751541|P4|COMPLETED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
1136386|NCT01646177|2751542|P3|COMPLETED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
1136387|NCT01646177|2751543|P2|COMPLETED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
1136388|NCT01646177|2751544|P1|COMPLETED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
1136389|NCT01646177|2751541|P4|STARTED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
1136390|NCT01646177|2751542|P3|STARTED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
1136391|NCT01646177|2751543|P2|STARTED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
1136392|NCT01646177|2751544|P1|STARTED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
1136393|NCT01646177|2751541|P4|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||22
1136394|NCT01646177|2751542|P3|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||26
1136395|NCT01646177|2751543|P2|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||13
1136396|NCT01646177|2751544|P1|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||10
1136397|NCT01646177|2751541|P4|COMPLETED|Blinded Induction Dosing (Week 0-12)||363
1136398|NCT01646177|2751542|P3|COMPLETED|Blinded Induction Dosing (Week 0-12)||360
1136399|NCT01646177|2751543|P2|COMPLETED|Blinded Induction Dosing (Week 0-12)||369
1136400|NCT01646177|2751544|P1|COMPLETED|Blinded Induction Dosing (Week 0-12)||183
1136401|NCT01646177|2751541|P4|STARTED|Blinded Induction Dosing (Week 0-12)||385
1136402|NCT01646177|2751542|P3|STARTED|Blinded Induction Dosing (Week 0-12)||386
1136403|NCT01646177|2751543|P2|STARTED|Blinded Induction Dosing (Week 0-12)||382
1136404|NCT01646177|2751544|P1|STARTED|Blinded Induction Dosing (Week 0-12)||193
1136422|NCT01576055|2751707|P2|NOT COMPLETED|Overall Study||6
1136423|NCT01576055|2751708|P1|NOT COMPLETED|Overall Study||19
1136424|NCT01576055|2751707|P2|COMPLETED|Overall Study||64
1136425|NCT01576055|2751708|P1|COMPLETED|Overall Study||178
1136426|NCT01576055|2751707|P2|STARTED|Overall Study||70
1136427|NCT01576055|2751708|P1|STARTED|Overall Study||197
1136449|NCT01465997|2751757|P2|NOT COMPLETED|Overall Study||89
1136450|NCT01465997|2751758|P1|NOT COMPLETED|Overall Study||68
1136451|NCT01465997|2751757|P2|COMPLETED|Overall Study||180
1136452|NCT01465997|2751758|P1|COMPLETED|Overall Study||211
1136453|NCT01465997|2751757|P2|STARTED|Overall Study||269
1136454|NCT01465997|2751758|P1|STARTED|Overall Study||279
1136455|NCT01463527|2751770|P2|NOT COMPLETED|Overall Study||7
1136456|NCT01463527|2751771|P1|NOT COMPLETED|Overall Study||6
1136457|NCT01463527|2751770|P2|COMPLETED|Overall Study||77
1136458|NCT01463527|2751771|P1|COMPLETED|Overall Study||77
1136459|NCT01463527|2751770|P2|STARTED|Overall Study||84
1136460|NCT01463527|2751771|P1|STARTED|Overall Study||83
1136461|NCT01439165|2751779|P2|NOT COMPLETED|Overall Study||2
1136462|NCT01439165|2751780|P1|NOT COMPLETED|Overall Study||21
1136463|NCT01439165|2751779|P2|COMPLETED|Overall Study||326
1136464|NCT01439165|2751780|P1|COMPLETED|Overall Study||981
1136465|NCT01439165|2751779|P2|STARTED|Overall Study||328
1136466|NCT01439165|2751780|P1|STARTED|Overall Study||1002
1136467|NCT01390948|2751795|P3|NOT COMPLETED|Overall Study||3
1136468|NCT01390948|2751796|P2|NOT COMPLETED|Overall Study||62
1136469|NCT01390948|2751797|P1|NOT COMPLETED|Overall Study||59
1136470|NCT01390948|2751795|P3|COMPLETED|Overall Study||0
1136471|NCT01390948|2751796|P2|COMPLETED|Overall Study||0
1136472|NCT01390948|2751797|P1|COMPLETED|Overall Study||0
1136473|NCT01390948|2751795|P3|Treated|Overall Study||3
1136474|NCT01390948|2751796|P2|Treated|Overall Study||60
1136475|NCT01390948|2751797|P1|Treated|Overall Study||56
1136476|NCT01390948|2751795|P3|STARTED|Overall Study||3
1136477|NCT01390948|2751796|P2|STARTED|Overall Study||62
1136478|NCT01390948|2751797|P1|STARTED|Overall Study||59
1136479|NCT01383928|2751833|P3|NOT COMPLETED|Phase 2||40
1136480|NCT01383928|2751834|P2|NOT COMPLETED|Phase 2||0
1136481|NCT01383928|2751835|P1|NOT COMPLETED|Phase 2||0
1136482|NCT01383928|2751833|P3|COMPLETED|Phase 2||10
1136483|NCT01383928|2751834|P2|COMPLETED|Phase 2||0
1136484|NCT01383928|2751835|P1|COMPLETED|Phase 2||0
1136485|NCT01383928|2751833|P3|STARTED|Phase 2||50
1136486|NCT01383928|2751834|P2|STARTED|Phase 2||0
1136487|NCT01383928|2751835|P1|STARTED|Phase 2||0
1136488|NCT01383928|2751833|P3|NOT COMPLETED|Phase 1||0
1136489|NCT01383928|2751834|P2|NOT COMPLETED|Phase 1||7
1136490|NCT01383928|2751835|P1|NOT COMPLETED|Phase 1||5
1136491|NCT01383928|2751833|P3|COMPLETED|Phase 1||0
1136492|NCT01383928|2751834|P2|COMPLETED|Phase 1||0
1136493|NCT01383928|2751835|P1|COMPLETED|Phase 1||2
1136494|NCT01383928|2751833|P3|STARTED|Phase 1||0
1136495|NCT01383928|2751834|P2|STARTED|Phase 1||7
1136496|NCT01383928|2751835|P1|STARTED|Phase 1||7
1136607|NCT01252095|2752145|P2|NOT COMPLETED|Overall Study||0
1136608|NCT01252095|2752146|P1|NOT COMPLETED|Overall Study||1
1136609|NCT01252095|2752145|P2|COMPLETED|Overall Study||1
1136610|NCT01252095|2752146|P1|COMPLETED|Overall Study||2
1136611|NCT01252095|2752145|P2|STARTED|Overall Study||1
1136612|NCT01252095|2752146|P1|STARTED|Overall Study||3
1136613|NCT01244477|2752154|P2|NOT COMPLETED|Overall Study||3
1136614|NCT01244477|2752155|P1|NOT COMPLETED|Overall Study||20
1136615|NCT01244477|2752154|P2|COMPLETED|Overall Study||20
1136616|NCT01244477|2752155|P1|COMPLETED|Overall Study||18
1136617|NCT01244477|2752154|P2|STARTED|Overall Study||23
1136618|NCT01244477|2752155|P1|STARTED|Overall Study||38
1136619|NCT01225887|2752165|P1|NOT COMPLETED|Overall Study||5
1136620|NCT01225887|2752165|P1|COMPLETED|Overall Study||32
1136621|NCT01225887|2752165|P1|STARTED|Overall Study||37
1136622|NCT01180049|2752175|P2|NOT COMPLETED|Overall Study||43
1136623|NCT01180049|2752176|P1|NOT COMPLETED|Overall Study||47
1136624|NCT01180049|2752175|P2|COMPLETED|Overall Study|This is an ongoing study. Date for data cut-off is 12 November 2015.|0
1136625|NCT01180049|2752176|P1|COMPLETED|Overall Study|This is an ongoing study. Date for data cut-off is 12 November 2015.|0
1136626|NCT01180049|2752175|P2|Treated|Overall Study||42
1136627|NCT01180049|2752176|P1|Treated|Overall Study||47
1136628|NCT01180049|2752175|P2|STARTED|Overall Study||43
1136629|NCT01180049|2752176|P1|STARTED|Overall Study||47
1136660|NCT00966446|2752253|P3|NOT COMPLETED|Overall Study||21
1136661|NCT00966446|2752254|P2|NOT COMPLETED|Overall Study||25
1136662|NCT00966446|2752255|P1|NOT COMPLETED|Overall Study||28
1136663|NCT00966446|2752253|P3|COMPLETED|Overall Study||52
1136664|NCT00966446|2752254|P2|COMPLETED|Overall Study||49
1136665|NCT00966446|2752255|P1|COMPLETED|Overall Study||48
1136666|NCT00966446|2752253|P3|STARTED|Overall Study||73
1136667|NCT00966446|2752254|P2|STARTED|Overall Study||74
1136668|NCT00966446|2752255|P1|STARTED|Overall Study||76
1136669|NCT00953225|2752271|P2|NOT COMPLETED|Overall Study||0
1136670|NCT00953225|2752272|P1|NOT COMPLETED|Overall Study||2
1136671|NCT00953225|2752271|P2|COMPLETED|Overall Study||37
1136672|NCT00953225|2752272|P1|COMPLETED|Overall Study||44
1136673|NCT00953225|2752271|P2|STARTED|Overall Study||37
1136674|NCT00953225|2752272|P1|STARTED|Overall Study||46
1136678|NCT00903409|2752289|P2|NOT COMPLETED|Overall Study||27
1136679|NCT00903409|2752290|P1|NOT COMPLETED|Overall Study||26
1136680|NCT00903409|2752289|P2|COMPLETED|Overall Study||73
1136681|NCT00903409|2752290|P1|COMPLETED|Overall Study||62
1136682|NCT00903409|2752289|P2|STARTED|Overall Study||100
1136683|NCT00903409|2752290|P1|STARTED|Overall Study||88
1136684|NCT00892775|2752306|P2|NOT COMPLETED|Overall Study||1
1136685|NCT00892775|2752307|P1|NOT COMPLETED|Overall Study||5
1136686|NCT00892775|2752306|P2|COMPLETED|Overall Study||165
1136687|NCT00892775|2752307|P1|COMPLETED|Overall Study||327
1136688|NCT00892775|2752306|P2|STARTED|Overall Study||166
1136689|NCT00892775|2752307|P1|STARTED|Overall Study||332
1136690|NCT00878709|2752333|P2|NOT COMPLETED|Overall Study||237
1136691|NCT00878709|2752334|P1|NOT COMPLETED|Overall Study||325
1136692|NCT00878709|2752333|P2|COMPLETED|Overall Study||1183
1136693|NCT00878709|2752334|P1|COMPLETED|Overall Study||1095
1136694|NCT00878709|2752333|P2|STARTED|Overall Study||1420
1136695|NCT00878709|2752334|P1|STARTED|Overall Study||1420
1136702|NCT00848744|2752369|P1|NOT COMPLETED|Overall Study||0
1136703|NCT00848744|2752369|P1|COMPLETED|Overall Study||10
1136704|NCT00848744|2752369|P1|STARTED|Overall Study||10
1136705|NCT00842153|2752376|P2|NOT COMPLETED|Overall Study||3
1136706|NCT00842153|2752377|P1|NOT COMPLETED|Overall Study||1
1136707|NCT00842153|2752376|P2|COMPLETED|Overall Study||27
1136708|NCT00842153|2752377|P1|COMPLETED|Overall Study||27
1136709|NCT00842153|2752376|P2|STARTED|Overall Study||30
1136710|NCT00842153|2752377|P1|STARTED|Overall Study||28
1136711|NCT00833859|2752415|P1|NOT COMPLETED|Overall Study||0
1136712|NCT00833859|2752415|P1|COMPLETED|Overall Study||2
1136713|NCT00833859|2752415|P1|STARTED|Overall Study||2
1136714|NCT00793611|2752424|P2|NOT COMPLETED|Overall Study||0
1136715|NCT00793611|2752425|P1|NOT COMPLETED|Overall Study||0
1136716|NCT00793611|2752424|P2|COMPLETED|Overall Study||10
1136717|NCT00793611|2752425|P1|COMPLETED|Overall Study||10
1136718|NCT00793611|2752424|P2|STARTED|Overall Study||10
1136719|NCT00793611|2752425|P1|STARTED|Overall Study||10
1136720|NCT00720096|2752437|P2|NOT COMPLETED|Overall Study||2
1136721|NCT00720096|2752438|P1|NOT COMPLETED|Overall Study||0
1136722|NCT00720096|2752437|P2|COMPLETED|Overall Study||0
1136723|NCT00720096|2752438|P1|COMPLETED|Overall Study||2
1136724|NCT00720096|2752437|P2|STARTED|Overall Study||2
1136725|NCT00720096|2752438|P1|STARTED|Overall Study||2
1136726|NCT00718328|2752450|P2|NOT COMPLETED|Overall Study||0
1136727|NCT00718328|2752451|P1|NOT COMPLETED|Overall Study||1
1136728|NCT00718328|2752450|P2|COMPLETED|Overall Study|Terminated due to poor enrollment|0
1136729|NCT00718328|2752451|P1|COMPLETED|Overall Study|Prematurely terminated due to poor enrollment|0
1136730|NCT00718328|2752450|P2|STARTED|Overall Study||0
1136731|NCT00718328|2752451|P1|STARTED|Overall Study||1
1136732|NCT00703092|2752457|P1|NOT COMPLETED|Overall Study||2
1136733|NCT00703092|2752457|P1|COMPLETED|Overall Study||0
1136734|NCT00703092|2752457|P1|STARTED|Overall Study||2
1136747|NCT00676052|2752485|P6|NOT COMPLETED|Overall Study||6
1136748|NCT00676052|2752486|P5|NOT COMPLETED|Overall Study||6
1136749|NCT00676052|2752487|P4|NOT COMPLETED|Overall Study||5
1136750|NCT00676052|2752488|P3|NOT COMPLETED|Overall Study||6
1136751|NCT00676052|2752489|P2|NOT COMPLETED|Overall Study||7
1136752|NCT00676052|2752490|P1|NOT COMPLETED|Overall Study||9
1136753|NCT00676052|2752485|P6|COMPLETED|Overall Study||91
1136754|NCT00676052|2752486|P5|COMPLETED|Overall Study||89
1136755|NCT00676052|2752487|P4|COMPLETED|Overall Study||92
1136756|NCT00676052|2752488|P3|COMPLETED|Overall Study||90
1136757|NCT00676052|2752489|P2|COMPLETED|Overall Study||88
1136758|NCT00676052|2752490|P1|COMPLETED|Overall Study||87
1136759|NCT00676052|2752485|P6|STARTED|Overall Study||97
1136760|NCT00676052|2752486|P5|STARTED|Overall Study||95
1136761|NCT00676052|2752487|P4|STARTED|Overall Study||97
1136762|NCT00676052|2752488|P3|STARTED|Overall Study||96
1136763|NCT00676052|2752489|P2|STARTED|Overall Study||95
1136764|NCT00676052|2752490|P1|STARTED|Overall Study||96
1136780|NCT00619983|2752576|P4|NOT COMPLETED|Gabapentin Alone||0
1136781|NCT00619983|2752577|P3|NOT COMPLETED|Gabapentin Alone||0
1136782|NCT00619983|2752578|P2|NOT COMPLETED|Gabapentin Alone||0
1136783|NCT00619983|2752579|P1|NOT COMPLETED|Gabapentin Alone||0
1136784|NCT00619983|2752576|P4|COMPLETED|Gabapentin Alone||3
1136785|NCT00619983|2752577|P3|COMPLETED|Gabapentin Alone||4
1136786|NCT00619983|2752578|P2|COMPLETED|Gabapentin Alone||4
1136787|NCT00619983|2752579|P1|COMPLETED|Gabapentin Alone||3
1136788|NCT00619983|2752576|P4|STARTED|Gabapentin Alone||3
1136789|NCT00619983|2752577|P3|STARTED|Gabapentin Alone||4
1136790|NCT00619983|2752578|P2|STARTED|Gabapentin Alone||4
1136791|NCT00619983|2752579|P1|STARTED|Gabapentin Alone||3
1136792|NCT00619983|2752576|P4|NOT COMPLETED|Test Drug Plus Gabapentin||0
1136793|NCT00619983|2752577|P3|NOT COMPLETED|Test Drug Plus Gabapentin||0
1136794|NCT00619983|2752578|P2|NOT COMPLETED|Test Drug Plus Gabapentin||0
1136795|NCT00619983|2752579|P1|NOT COMPLETED|Test Drug Plus Gabapentin||0
1136796|NCT00619983|2752576|P4|COMPLETED|Test Drug Plus Gabapentin||3
1136797|NCT00619983|2752577|P3|COMPLETED|Test Drug Plus Gabapentin||4
1136798|NCT00619983|2752578|P2|COMPLETED|Test Drug Plus Gabapentin||4
1136799|NCT00619983|2752579|P1|COMPLETED|Test Drug Plus Gabapentin||3
1136800|NCT00619983|2752576|P4|STARTED|Test Drug Plus Gabapentin||3
1136801|NCT00619983|2752577|P3|STARTED|Test Drug Plus Gabapentin||4
1136802|NCT00619983|2752578|P2|STARTED|Test Drug Plus Gabapentin||4
1136803|NCT00619983|2752579|P1|STARTED|Test Drug Plus Gabapentin||3
1136804|NCT00619983|2752576|P4|NOT COMPLETED|Test Drug Alone||3
1136805|NCT00619983|2752577|P3|NOT COMPLETED|Test Drug Alone||2
1136806|NCT00619983|2752578|P2|NOT COMPLETED|Test Drug Alone||1
1136807|NCT00619983|2752579|P1|NOT COMPLETED|Test Drug Alone||2
1136808|NCT00619983|2752576|P4|COMPLETED|Test Drug Alone||3
1136809|NCT00619983|2752577|P3|COMPLETED|Test Drug Alone||4
1136810|NCT00619983|2752578|P2|COMPLETED|Test Drug Alone||4
1136811|NCT00619983|2752579|P1|COMPLETED|Test Drug Alone||3
1136812|NCT00619983|2752576|P4|STARTED|Test Drug Alone||6
1136813|NCT00619983|2752577|P3|STARTED|Test Drug Alone||6
1136814|NCT00619983|2752578|P2|STARTED|Test Drug Alone||5
1136815|NCT00619983|2752579|P1|STARTED|Test Drug Alone||5
1136825|NCT00598806|2752604|P2|NOT COMPLETED|Overall Study||64
1136826|NCT00598806|2752605|P1|NOT COMPLETED|Overall Study||73
1136827|NCT00598806|2752604|P2|COMPLETED|Overall Study||346
1136828|NCT00598806|2752605|P1|COMPLETED|Overall Study||329
1136829|NCT00598806|2752604|P2|STARTED|Overall Study||410
1136830|NCT00598806|2752605|P1|STARTED|Overall Study||402
1136831|NCT00575159|2752625|P1|NOT COMPLETED|Overall Study||0
1136832|NCT00575159|2752625|P1|COMPLETED|Overall Study||10
1136833|NCT00575159|2752625|P1|STARTED|Overall Study||10
1136834|NCT00461591|2752735|P2|NOT COMPLETED|Overall Study||85
1136835|NCT00461591|2752736|P1|NOT COMPLETED|Overall Study||89
1136836|NCT00461591|2752735|P2|COMPLETED|Overall Study||311
1136837|NCT00461591|2752736|P1|COMPLETED|Overall Study||317
1136838|NCT00461591|2752735|P2|STARTED|Overall Study||396
1136839|NCT00461591|2752736|P1|STARTED|Overall Study||406
1136884|NCT03054077|2752859|P2|NOT COMPLETED|Overall Study||0
1136885|NCT03054077|2752860|P1|NOT COMPLETED|Overall Study||0
1136886|NCT03054077|2752859|P2|COMPLETED|Overall Study||12
1136887|NCT03054077|2752860|P1|COMPLETED|Overall Study||12
1136888|NCT03054077|2752859|P2|STARTED|Overall Study||12
1136889|NCT03054077|2752860|P1|STARTED|Overall Study||12
1136890|NCT02786927|2752866|P1|NOT COMPLETED|Overall Study||5
1136891|NCT02786927|2752866|P1|COMPLETED|Overall Study||207
1136892|NCT02786927|2752866|P1|STARTED|Overall Study||212
1136893|NCT02736175|2752875|P2|NOT COMPLETED|Overall Study||1
1136894|NCT02736175|2752876|P1|NOT COMPLETED|Overall Study||2
1136895|NCT02736175|2752875|P2|COMPLETED|Overall Study||221
1136896|NCT02736175|2752876|P1|COMPLETED|Overall Study||214
1136897|NCT02736175|2752875|P2|STARTED|Overall Study||222
1136898|NCT02736175|2752876|P1|STARTED|Overall Study||216
1136899|NCT02686437|2752886|P2|NOT COMPLETED|Overall Study||8
1136900|NCT02686437|2752887|P1|NOT COMPLETED|Overall Study||3
1136901|NCT02686437|2752886|P2|COMPLETED|Overall Study||12
1136902|NCT02686437|2752887|P1|COMPLETED|Overall Study||13
1136903|NCT02686437|2752886|P2|STARTED|Overall Study||20
1136904|NCT02686437|2752887|P1|STARTED|Overall Study||16
1136905|NCT02681510|2752895|P1|NOT COMPLETED|Overall Study||10
1136906|NCT02681510|2752895|P1|COMPLETED|Overall Study||26
1136907|NCT02681510|2752895|P1|STARTED|Overall Study||36
1136908|NCT02667821|2752902|P1|NOT COMPLETED|Overall Study||0
1136909|NCT02667821|2752902|P1|COMPLETED|Overall Study||20
1136910|NCT02667821|2752902|P1|STARTED|Overall Study||20
1136911|NCT02586506|2752908|P1|NOT COMPLETED|Overall Study||9
1136912|NCT02586506|2752908|P1|COMPLETED|Overall Study||250
1136913|NCT02586506|2752908|P1|STARTED|Overall Study||259
1136914|NCT02570126|2752916|P2|NOT COMPLETED|Overall Study||9
1136915|NCT02570126|2752917|P1|NOT COMPLETED|Overall Study||6
1136916|NCT02570126|2752916|P2|COMPLETED|Overall Study||607
1136917|NCT02570126|2752917|P1|COMPLETED|Overall Study||609
1136918|NCT02570126|2752916|P2|STARTED|Overall Study||616
1136919|NCT02570126|2752917|P1|STARTED|Overall Study||615
1136920|NCT02401256|2752941|P1|NOT COMPLETED|Overall Study||17
1136921|NCT02401256|2752941|P1|COMPLETED|Overall Study||53
1136922|NCT02401256|2752941|P1|Analysed|Overall Study|Volunteers that completed at least until Phase 2 inpatient visit (Volunteers with Efavirenz PK data)|61
1136923|NCT02401256|2752941|P1|Finished Phase 3|Overall Study||53
1136924|NCT02401256|2752941|P1|Finished Phase 2|Overall Study||58
1136925|NCT02401256|2752941|P1|Finished Phase 1|Overall Study||64
1136926|NCT02401256|2752941|P1|STARTED|Overall Study||70
1136927|NCT02387996|2752947|P1|NOT COMPLETED|Overall Study||204
1136928|NCT02387996|2752947|P1|COMPLETED|Overall Study|Completed equals continuing in the Treatment Period|66
1136929|NCT02387996|2752947|P1|STARTED|Overall Study||270
1136930|NCT02387749|2752958|P1|NOT COMPLETED|Overall Study||0
1136931|NCT02387749|2752958|P1|COMPLETED|Overall Study||10
1136932|NCT02387749|2752958|P1|STARTED|Overall Study||10
1136941|NCT02275052|2753022|P4|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||14
1136942|NCT02275052|2753023|P3|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||5
1136943|NCT02275052|2753024|P2|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
1136944|NCT02275052|2753025|P1|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
1136945|NCT02275052|2753022|P4|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||72
1136946|NCT02275052|2753023|P3|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||88
1136947|NCT02275052|2753024|P2|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
1136948|NCT02275052|2753025|P1|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
1136949|NCT02275052|2753022|P4|STARTED|Period 2: Treatment Period 2 (12 Weeks)||86
1136950|NCT02275052|2753023|P3|STARTED|Period 2: Treatment Period 2 (12 Weeks)||93
1136951|NCT02275052|2753024|P2|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
1136952|NCT02275052|2753025|P1|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
1136953|NCT02275052|2753022|P4|NOT COMPLETED|Washout Period (12-17 Days)||0
1136954|NCT02275052|2753023|P3|NOT COMPLETED|Washout Period (12-17 Days)||0
1136955|NCT02275052|2753024|P2|NOT COMPLETED|Washout Period (12-17 Days)||0
1136956|NCT02275052|2753025|P1|NOT COMPLETED|Washout Period (12-17 Days)||4
1136957|NCT02275052|2753022|P4|COMPLETED|Washout Period (12-17 Days)||0
1136958|NCT02275052|2753023|P3|COMPLETED|Washout Period (12-17 Days)||0
1136959|NCT02275052|2753024|P2|COMPLETED|Washout Period (12-17 Days)||93
1136960|NCT02275052|2753025|P1|COMPLETED|Washout Period (12-17 Days)||86
1136961|NCT02275052|2753022|P4|STARTED|Washout Period (12-17 Days)||0
1136962|NCT02275052|2753023|P3|STARTED|Washout Period (12-17 Days)||0
1136963|NCT02275052|2753024|P2|STARTED|Washout Period (12-17 Days)||93
1136964|NCT02275052|2753025|P1|STARTED|Washout Period (12-17 Days)||90
1136965|NCT02275052|2753022|P4|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
1136966|NCT02275052|2753023|P3|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
1136967|NCT02275052|2753024|P2|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||6
1136968|NCT02275052|2753025|P1|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||9
1136969|NCT02275052|2753022|P4|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
1136970|NCT02275052|2753023|P3|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
1136971|NCT02275052|2753024|P2|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||93
1136972|NCT02275052|2753025|P1|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||90
1136973|NCT02275052|2753022|P4|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
1136974|NCT02275052|2753023|P3|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
1136975|NCT02275052|2753024|P2|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
1136976|NCT02275052|2753025|P1|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
1136977|NCT02236611|2753039|P2|NOT COMPLETED|Overall Study||34
1136978|NCT02236611|2753040|P1|NOT COMPLETED|Overall Study||26
1136979|NCT02236611|2753039|P2|COMPLETED|Overall Study||484
1136980|NCT02236611|2753040|P1|COMPLETED|Overall Study||490
1136981|NCT02236611|2753039|P2|STARTED|Overall Study||518
1136982|NCT02236611|2753040|P1|STARTED|Overall Study||516
1136983|NCT02229487|2753048|P2|NOT COMPLETED|Overall Study||0
1136984|NCT02229487|2753049|P1|NOT COMPLETED|Overall Study||0
1136985|NCT02229487|2753048|P2|COMPLETED|Overall Study||27
1136986|NCT02229487|2753049|P1|COMPLETED|Overall Study||24
1136987|NCT02229487|2753048|P2|STARTED|Overall Study||27
1136988|NCT02229487|2753049|P1|STARTED|Overall Study||24
1137029|NCT02164539|2753199|P7|NOT COMPLETED|Treatment Phase C (1 Week)||2
1137030|NCT02164539|2753200|P6|NOT COMPLETED|Treatment Phase C (1 Week)||0
1137031|NCT02164539|2753201|P5|NOT COMPLETED|Treatment Phase C (1 Week)||0
1137032|NCT02164539|2753202|P4|NOT COMPLETED|Treatment Phase C (1 Week)||0
1137033|NCT02164539|2753203|P3|NOT COMPLETED|Treatment Phase C (1 Week)||0
1137034|NCT02164539|2753204|P2|NOT COMPLETED|Treatment Phase C (1 Week)||0
1137035|NCT02164539|2753205|P1|NOT COMPLETED|Treatment Phase C (1 Week)||1
1137036|NCT02164539|2753199|P7|COMPLETED|Treatment Phase C (1 Week)||78
1137037|NCT02164539|2753200|P6|COMPLETED|Treatment Phase C (1 Week)||82
1137038|NCT02164539|2753201|P5|COMPLETED|Treatment Phase C (1 Week)||84
1137039|NCT02164539|2753202|P4|COMPLETED|Treatment Phase C (1 Week)||0
1137040|NCT02164539|2753203|P3|COMPLETED|Treatment Phase C (1 Week)||0
1137041|NCT02164539|2753204|P2|COMPLETED|Treatment Phase C (1 Week)||0
1137042|NCT02164539|2753205|P1|COMPLETED|Treatment Phase C (1 Week)||78
1137043|NCT02164539|2753199|P7|STARTED|Treatment Phase C (1 Week)||80
1137044|NCT02164539|2753200|P6|STARTED|Treatment Phase C (1 Week)||82
1137045|NCT02164539|2753201|P5|STARTED|Treatment Phase C (1 Week)||84
1137046|NCT02164539|2753202|P4|STARTED|Treatment Phase C (1 Week)||0
1137047|NCT02164539|2753203|P3|STARTED|Treatment Phase C (1 Week)||0
1137048|NCT02164539|2753204|P2|STARTED|Treatment Phase C (1 Week)||0
1137049|NCT02164539|2753205|P1|STARTED|Treatment Phase C (1 Week)||79
1137050|NCT02164539|2753199|P7|NOT COMPLETED|Treatment Phase B (1 Week)||1
1137051|NCT02164539|2753200|P6|NOT COMPLETED|Treatment Phase B (1 Week)||0
1137052|NCT02164539|2753201|P5|NOT COMPLETED|Treatment Phase B (1 Week)||3
1137053|NCT02164539|2753202|P4|NOT COMPLETED|Treatment Phase B (1 Week)||0
1137054|NCT02164539|2753203|P3|NOT COMPLETED|Treatment Phase B (1 Week)||0
1137055|NCT02164539|2753204|P2|NOT COMPLETED|Treatment Phase B (1 Week)||0
1137056|NCT02164539|2753205|P1|NOT COMPLETED|Treatment Phase B (1 Week)||0
1137057|NCT02164539|2753199|P7|COMPLETED|Treatment Phase B (1 Week)||162
1137058|NCT02164539|2753200|P6|COMPLETED|Treatment Phase B (1 Week)||0
1137059|NCT02164539|2753201|P5|COMPLETED|Treatment Phase B (1 Week)||163
1137060|NCT02164539|2753202|P4|COMPLETED|Treatment Phase B (1 Week)||0
1137061|NCT02164539|2753203|P3|COMPLETED|Treatment Phase B (1 Week)||0
1137062|NCT02164539|2753204|P2|COMPLETED|Treatment Phase B (1 Week)||0
1137063|NCT02164539|2753205|P1|COMPLETED|Treatment Phase B (1 Week)||0
1137064|NCT02164539|2753199|P7|STARTED|Treatment Phase B (1 Week)||163
1137065|NCT02164539|2753200|P6|STARTED|Treatment Phase B (1 Week)||0
1137066|NCT02164539|2753201|P5|STARTED|Treatment Phase B (1 Week)||166
1137067|NCT02164539|2753202|P4|STARTED|Treatment Phase B (1 Week)||0
1137068|NCT02164539|2753203|P3|STARTED|Treatment Phase B (1 Week)||0
1137069|NCT02164539|2753204|P2|STARTED|Treatment Phase B (1 Week)||0
1137070|NCT02164539|2753205|P1|STARTED|Treatment Phase B (1 Week)||0
1137071|NCT02164539|2753199|P7|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
1137072|NCT02164539|2753200|P6|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
1137073|NCT02164539|2753201|P5|NOT COMPLETED|Treatment Phase A (4 Weeks)||3
1137074|NCT02164539|2753202|P4|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
1137075|NCT02164539|2753203|P3|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
1137076|NCT02164539|2753204|P2|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
1137077|NCT02164539|2753205|P1|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
1137078|NCT02164539|2753199|P7|COMPLETED|Treatment Phase A (4 Weeks)||0
1137079|NCT02164539|2753200|P6|COMPLETED|Treatment Phase A (4 Weeks)||83
1137080|NCT02164539|2753201|P5|COMPLETED|Treatment Phase A (4 Weeks)||82
1137081|NCT02164539|2753202|P4|COMPLETED|Treatment Phase A (4 Weeks)||44
1137082|NCT02164539|2753203|P3|COMPLETED|Treatment Phase A (4 Weeks)||39
1137083|NCT02164539|2753204|P2|COMPLETED|Treatment Phase A (4 Weeks)||42
1137084|NCT02164539|2753205|P1|COMPLETED|Treatment Phase A (4 Weeks)||39
1137085|NCT02164539|2753199|P7|STARTED|Treatment Phase A (4 Weeks)||0
1137086|NCT02164539|2753200|P6|STARTED|Treatment Phase A (4 Weeks)||84
1137087|NCT02164539|2753201|P5|STARTED|Treatment Phase A (4 Weeks)||85
1137088|NCT02164539|2753202|P4|STARTED|Treatment Phase A (4 Weeks)||46
1137089|NCT02164539|2753203|P3|STARTED|Treatment Phase A (4 Weeks)||40
1137090|NCT02164539|2753204|P2|STARTED|Treatment Phase A (4 Weeks)||42
1137091|NCT02164539|2753205|P1|STARTED|Treatment Phase A (4 Weeks)||41
1137104|NCT02162979|2753277|P2|NOT COMPLETED|Overall Study||0
1137105|NCT02162979|2753278|P1|NOT COMPLETED|Overall Study||0
1137106|NCT02162979|2753277|P2|COMPLETED|Overall Study||0
1137107|NCT02162979|2753278|P1|COMPLETED|Overall Study||0
1137108|NCT02162979|2753277|P2|STARTED|Overall Study||0
1137109|NCT02162979|2753278|P1|STARTED|Overall Study||0
1137110|NCT02091869|2753286|P2|NOT COMPLETED|Overall Study||3
1137111|NCT02091869|2753287|P1|NOT COMPLETED|Overall Study||0
1137112|NCT02091869|2753286|P2|COMPLETED|Overall Study||14
1137113|NCT02091869|2753287|P1|COMPLETED|Overall Study||17
1137114|NCT02091869|2753286|P2|STARTED|Overall Study||17
1137115|NCT02091869|2753287|P1|STARTED|Overall Study||17
1137116|NCT02068157|2753299|P1|NOT COMPLETED|Overall Study||0
1137117|NCT02068157|2753299|P1|COMPLETED|Overall Study||3
1137118|NCT02068157|2753299|P1|STARTED|Overall Study||3
1137131|NCT01980888|2753380|P2|NOT COMPLETED|Overall Study||133
1137132|NCT01980888|2753381|P1|NOT COMPLETED|Overall Study||144
1137133|NCT01980888|2753380|P2|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|21
1137134|NCT01980888|2753381|P1|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|13
1137135|NCT01980888|2753380|P2|STARTED|Overall Study||154
1137136|NCT01980888|2753381|P1|STARTED|Overall Study||157
1137197|NCT01797458|2753562|P3|NOT COMPLETED|Overall Study||7
1137198|NCT01797458|2753563|P2|NOT COMPLETED|Overall Study||9
1137199|NCT01797458|2753564|P1|NOT COMPLETED|Overall Study||12
1137200|NCT01797458|2753562|P3|COMPLETED|Overall Study||58
1137201|NCT01797458|2753563|P2|COMPLETED|Overall Study||43
1137202|NCT01797458|2753564|P1|COMPLETED|Overall Study||40
1137203|NCT01797458|2753562|P3|STARTED|Overall Study||65
1137204|NCT01797458|2753563|P2|STARTED|Overall Study||52
1137205|NCT01797458|2753564|P1|STARTED|Overall Study||52
1137242|NCT01696942|2753670|P2|NOT COMPLETED|Overall Study||3
1137243|NCT01696942|2753671|P1|NOT COMPLETED|Overall Study||2
1137244|NCT01696942|2753670|P2|COMPLETED|Overall Study||2
1137245|NCT01696942|2753671|P1|COMPLETED|Overall Study||3
1137246|NCT01696942|2753670|P2|STARTED|Overall Study||5
1137247|NCT01696942|2753671|P1|STARTED|Overall Study||5
1137248|NCT01685242|2753681|P2|NOT COMPLETED|Overall Study||3
1137249|NCT01685242|2753682|P1|NOT COMPLETED|Overall Study||1
1137250|NCT01685242|2753681|P2|COMPLETED|Overall Study||47
1137251|NCT01685242|2753682|P1|COMPLETED|Overall Study||49
1137252|NCT01685242|2753681|P2|STARTED|Overall Study||50
1137253|NCT01685242|2753682|P1|STARTED|Overall Study||50
1137272|NCT01649856|2753802|P2|NOT COMPLETED|Overall Study||78
1137273|NCT01649856|2753803|P1|NOT COMPLETED|Overall Study||139
1137274|NCT01649856|2753802|P2|COMPLETED|Overall Study||125
1137275|NCT01649856|2753803|P1|COMPLETED|Overall Study||230
1137276|NCT01649856|2753802|P2|STARTED|Overall Study||203
1137277|NCT01649856|2753803|P1|STARTED|Overall Study||369
1137278|NCT01639001|2753837|P2|NOT COMPLETED|Overall Study||103
1137279|NCT01639001|2753838|P1|NOT COMPLETED|Overall Study||104
1137280|NCT01639001|2753837|P2|COMPLETED|Overall Study||0
1137281|NCT01639001|2753838|P1|COMPLETED|Overall Study||0
1137282|NCT01639001|2753837|P2|Treated|Overall Study||101
1137283|NCT01639001|2753838|P1|Treated|Overall Study||104
1137284|NCT01639001|2753837|P2|STARTED|Overall Study||103
1137285|NCT01639001|2753838|P1|STARTED|Overall Study||104
1137304|NCT01612767|2753997|P1|NOT COMPLETED|Overall Study||9
1137305|NCT01612767|2753997|P1|COMPLETED|Overall Study||320
1137306|NCT01612767|2753997|P1|STARTED|Overall Study||329
1137313|NCT01597791|2754045|P2|NOT COMPLETED|Overall Study||10
1137314|NCT01597791|2754046|P1|NOT COMPLETED|Overall Study||8
1137315|NCT01597791|2754045|P2|COMPLETED|Overall Study||18
1137316|NCT01597791|2754046|P1|COMPLETED|Overall Study||20
1137317|NCT01597791|2754045|P2|STARTED|Overall Study||28
1137318|NCT01597791|2754046|P1|STARTED|Overall Study||28
1137325|NCT01550757|2754097|P4|NOT COMPLETED|Overall Study||54
1137326|NCT01550757|2754098|P3|NOT COMPLETED|Overall Study||45
1137327|NCT01550757|2754099|P2|NOT COMPLETED|Overall Study||14
1137328|NCT01550757|2754100|P1|NOT COMPLETED|Overall Study||23
1137329|NCT01550757|2754097|P4|COMPLETED|Overall Study||90
1137330|NCT01550757|2754098|P3|COMPLETED|Overall Study||85
1137331|NCT01550757|2754099|P2|COMPLETED|Overall Study||38
1137332|NCT01550757|2754100|P1|COMPLETED|Overall Study||33
1137333|NCT01550757|2754097|P4|STARTED|Overall Study||144
1137334|NCT01550757|2754098|P3|STARTED|Overall Study||130
1137335|NCT01550757|2754099|P2|STARTED|Overall Study||52
1137336|NCT01550757|2754100|P1|STARTED|Overall Study||56
1137343|NCT01542541|2754175|P2|NOT COMPLETED|Overall Study||0
1137344|NCT01542541|2754176|P1|NOT COMPLETED|Overall Study||8
1137345|NCT01542541|2754175|P2|COMPLETED|Overall Study||30
1137346|NCT01542541|2754176|P1|COMPLETED|Overall Study||30
1137347|NCT01542541|2754175|P2|STARTED|Overall Study||30
1137348|NCT01542541|2754176|P1|STARTED|Overall Study||38
1137349|NCT01514760|2754184|P1|NOT COMPLETED|Overall Study||2
1137350|NCT01514760|2754184|P1|COMPLETED|Overall Study||20
1137351|NCT01514760|2754184|P1|STARTED|Overall Study||22
1137421|NCT01376323|2754439|P5|NOT COMPLETED|Overall Study||1
1137422|NCT01376323|2754440|P4|NOT COMPLETED|Overall Study||5
1137423|NCT01376323|2754441|P3|NOT COMPLETED|Overall Study||3
1137424|NCT01376323|2754442|P2|NOT COMPLETED|Overall Study||1
1137425|NCT01376323|2754443|P1|NOT COMPLETED|Overall Study||2
1137426|NCT01376323|2754439|P5|COMPLETED|Overall Study||17
1137427|NCT01376323|2754440|P4|COMPLETED|Overall Study||14
1137428|NCT01376323|2754441|P3|COMPLETED|Overall Study||16
1137429|NCT01376323|2754442|P2|COMPLETED|Overall Study||17
1137430|NCT01376323|2754443|P1|COMPLETED|Overall Study||18
1137431|NCT01376323|2754439|P5|STARTED|Overall Study||18
1137432|NCT01376323|2754440|P4|STARTED|Overall Study||19
1137433|NCT01376323|2754441|P3|STARTED|Overall Study||19
1137434|NCT01376323|2754442|P2|STARTED|Overall Study||18
1137435|NCT01376323|2754443|P1|STARTED|Overall Study||20
1137501|NCT01345253|2754664|P2|NOT COMPLETED|Overall Study||79
1137502|NCT01345253|2754665|P1|NOT COMPLETED|Overall Study||56
1137503|NCT01345253|2754664|P2|COMPLETED|Overall Study||372
1137504|NCT01345253|2754665|P1|COMPLETED|Overall Study||170
1137505|NCT01345253|2754664|P2|STARTED|Overall Study||451
1137506|NCT01345253|2754665|P1|STARTED|Overall Study||226
1137507|NCT01342211|2754684|P5|NOT COMPLETED|Overall Study||2
1137508|NCT01342211|2754685|P4|NOT COMPLETED|Overall Study||2
1137509|NCT01342211|2754686|P3|NOT COMPLETED|Overall Study||0
1137510|NCT01342211|2754687|P2|NOT COMPLETED|Overall Study||2
1137511|NCT01342211|2754688|P1|NOT COMPLETED|Overall Study||0
1137512|NCT01342211|2754684|P5|COMPLETED|Overall Study||16
1137513|NCT01342211|2754685|P4|COMPLETED|Overall Study||17
1137514|NCT01342211|2754686|P3|COMPLETED|Overall Study||18
1137515|NCT01342211|2754687|P2|COMPLETED|Overall Study||17
1137516|NCT01342211|2754688|P1|COMPLETED|Overall Study||19
1137517|NCT01342211|2754684|P5|Treated|Overall Study||17
1137518|NCT01342211|2754685|P4|Treated|Overall Study||19
1137519|NCT01342211|2754686|P3|Treated|Overall Study||18
1137520|NCT01342211|2754687|P2|Treated|Overall Study||17
1137521|NCT01342211|2754688|P1|Treated|Overall Study||19
1137522|NCT01342211|2754684|P5|STARTED|Overall Study||18
1137523|NCT01342211|2754685|P4|STARTED|Overall Study||19
1137524|NCT01342211|2754686|P3|STARTED|Overall Study||18
1137525|NCT01342211|2754687|P2|STARTED|Overall Study||19
1137526|NCT01342211|2754688|P1|STARTED|Overall Study||19
1137557|NCT01328444|2754802|P6|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
1137558|NCT01328444|2754803|P5|NOT COMPLETED|Treatment Period 2 (12 Weeks)||8
1137559|NCT01328444|2754804|P4|NOT COMPLETED|Treatment Period 2 (12 Weeks)||5
1137560|NCT01328444|2754805|P3|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
1137561|NCT01328444|2754806|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
1137562|NCT01328444|2754807|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||11
1137563|NCT01328444|2754802|P6|COMPLETED|Treatment Period 2 (12 Weeks)||59
1137564|NCT01328444|2754803|P5|COMPLETED|Treatment Period 2 (12 Weeks)||63
1137565|NCT01328444|2754804|P4|COMPLETED|Treatment Period 2 (12 Weeks)||30
1137566|NCT01328444|2754805|P3|COMPLETED|Treatment Period 2 (12 Weeks)||19
1137567|NCT01328444|2754806|P2|COMPLETED|Treatment Period 2 (12 Weeks)||22
1137568|NCT01328444|2754807|P1|COMPLETED|Treatment Period 2 (12 Weeks)||65
1137569|NCT01328444|2754802|P6|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|66
1137570|NCT01328444|2754803|P5|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|71
1137571|NCT01328444|2754804|P4|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|35
1137572|NCT01328444|2754805|P3|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|22
1137573|NCT01328444|2754806|P2|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|23
1137574|NCT01328444|2754807|P1|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|76
1137575|NCT01328444|2754802|P6|NOT COMPLETED|Washout Period (14 Days)||4
1137576|NCT01328444|2754803|P5|NOT COMPLETED|Washout Period (14 Days)||1
1137577|NCT01328444|2754804|P4|NOT COMPLETED|Washout Period (14 Days)||1
1137578|NCT01328444|2754805|P3|NOT COMPLETED|Washout Period (14 Days)||0
1137579|NCT01328444|2754806|P2|NOT COMPLETED|Washout Period (14 Days)||1
1137580|NCT01328444|2754807|P1|NOT COMPLETED|Washout Period (14 Days)||1
1137581|NCT01328444|2754802|P6|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|68
1137582|NCT01328444|2754803|P5|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|66
1137583|NCT01328444|2754804|P4|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|32
1137584|NCT01328444|2754805|P3|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|25
1137585|NCT01328444|2754806|P2|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
1137586|NCT01328444|2754807|P1|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|82
1137587|NCT01328444|2754802|P6|STARTED|Washout Period (14 Days)||72
1137588|NCT01328444|2754803|P5|STARTED|Washout Period (14 Days)||67
1137589|NCT01328444|2754804|P4|STARTED|Washout Period (14 Days)||33
1137590|NCT01328444|2754805|P3|STARTED|Washout Period (14 Days)||25
1137591|NCT01328444|2754806|P2|STARTED|Washout Period (14 Days)||21
1137592|NCT01328444|2754807|P1|STARTED|Washout Period (14 Days)||83
1137593|NCT01328444|2754802|P6|NOT COMPLETED|Treatment Period 1 (12 Weeks)||6
1137594|NCT01328444|2754803|P5|NOT COMPLETED|Treatment Period 1 (12 Weeks)||14
1137595|NCT01328444|2754804|P4|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8
1137596|NCT01328444|2754805|P3|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
1137597|NCT01328444|2754806|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
1137598|NCT01328444|2754807|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11
1137599|NCT01328444|2754802|P6|COMPLETED|Treatment Period 1 (12 Weeks)||72
1137600|NCT01328444|2754803|P5|COMPLETED|Treatment Period 1 (12 Weeks)||67
1137601|NCT01328444|2754804|P4|COMPLETED|Treatment Period 1 (12 Weeks)||33
1137602|NCT01328444|2754805|P3|COMPLETED|Treatment Period 1 (12 Weeks)||25
1137603|NCT01328444|2754806|P2|COMPLETED|Treatment Period 1 (12 Weeks)||21
1137604|NCT01328444|2754807|P1|COMPLETED|Treatment Period 1 (12 Weeks)||83
1137605|NCT01328444|2754802|P6|STARTED|Treatment Period 1 (12 Weeks)||78
1137606|NCT01328444|2754803|P5|STARTED|Treatment Period 1 (12 Weeks)||81
1137607|NCT01328444|2754804|P4|STARTED|Treatment Period 1 (12 Weeks)||41
1137608|NCT01328444|2754805|P3|STARTED|Treatment Period 1 (12 Weeks)||28
1137609|NCT01328444|2754806|P2|STARTED|Treatment Period 1 (12 Weeks)||26
1137610|NCT01328444|2754807|P1|STARTED|Treatment Period 1 (12 Weeks)||94
1137611|NCT01313637|2754855|P4|NOT COMPLETED|Overall Study||78
1137612|NCT01313637|2754856|P3|NOT COMPLETED|Overall Study||106
1137613|NCT01313637|2754857|P2|NOT COMPLETED|Overall Study||95
1137614|NCT01313637|2754858|P1|NOT COMPLETED|Overall Study||92
1137615|NCT01313637|2754855|P4|COMPLETED|Overall Study||325
1137616|NCT01313637|2754856|P3|COMPLETED|Overall Study||298
1137617|NCT01313637|2754857|P2|COMPLETED|Overall Study||312
1137618|NCT01313637|2754858|P1|COMPLETED|Overall Study||183
1137619|NCT01313637|2754855|P4|STARTED|Overall Study||403
1137620|NCT01313637|2754856|P3|STARTED|Overall Study||404
1137621|NCT01313637|2754857|P2|STARTED|Overall Study||407
1137622|NCT01313637|2754858|P1|STARTED|Overall Study||275
1137881|NCT01086384|2755856|P3|NOT COMPLETED|Treatment Period||124
1137882|NCT01086384|2755857|P2|NOT COMPLETED|Treatment Period||148
1137883|NCT01086384|2755858|P1|NOT COMPLETED|Treatment Period||0
1137884|NCT01086384|2755856|P3|COMPLETED|Treatment Period||885
1137885|NCT01086384|2755857|P2|COMPLETED|Treatment Period||863
1137886|NCT01086384|2755858|P1|COMPLETED|Treatment Period||0
1137887|NCT01086384|2755856|P3|STARTED|Treatment Period||1009
1137888|NCT01086384|2755857|P2|STARTED|Treatment Period||1011
1137889|NCT01086384|2755858|P1|STARTED|Treatment Period||0
1137890|NCT01086384|2755856|P3|NOT COMPLETED|2-week Run-in Period||0
1137891|NCT01086384|2755857|P2|NOT COMPLETED|2-week Run-in Period||0
1137892|NCT01086384|2755858|P1|NOT COMPLETED|2-week Run-in Period||163
1137893|NCT01086384|2755856|P3|COMPLETED|2-week Run-in Period||0
1137894|NCT01086384|2755857|P2|COMPLETED|2-week Run-in Period||0
1137895|NCT01086384|2755858|P1|COMPLETED|2-week Run-in Period||2020
1137896|NCT01086384|2755856|P3|STARTED|2-week Run-in Period||0
1137897|NCT01086384|2755857|P2|STARTED|2-week Run-in Period||0
1137898|NCT01086384|2755858|P1|STARTED|2-week Run-in Period||2183
1137926|NCT01061671|2755977|P2|NOT COMPLETED|Overall Study||55
1137927|NCT01061671|2755978|P1|NOT COMPLETED|Overall Study||47
1137928|NCT01061671|2755977|P2|COMPLETED|Overall Study||397
1137929|NCT01061671|2755978|P1|COMPLETED|Overall Study||386
1137930|NCT01061671|2755977|P2|STARTED|Overall Study||452
1137931|NCT01061671|2755978|P1|STARTED|Overall Study||433
1137947|NCT01015118|2756053|P2|NOT COMPLETED|Overall Study||327
1137948|NCT01015118|2756054|P1|NOT COMPLETED|Overall Study||669
1137949|NCT01015118|2756053|P2|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|128
1137950|NCT01015118|2756054|P1|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|242
1137951|NCT01015118|2756053|P2|STARTED|Overall Study||455
1137952|NCT01015118|2756054|P1|STARTED|Overall Study||911
1138181|NCT00936910|2756314|P1|NOT COMPLETED|Overall Study||3
1138182|NCT00936910|2756314|P1|COMPLETED|Overall Study|The primary endpt. of 2 (-) cultures within 5 d of lock therapy was met for 10 patients|10
1138183|NCT00936910|2756314|P1|STARTED|Overall Study||13
1138248|NCT00858702|2756446|P2|NOT COMPLETED|Overall Study||2
1138249|NCT00858702|2756447|P1|NOT COMPLETED|Overall Study||5
1138250|NCT00858702|2756446|P2|COMPLETED|Overall Study||50
1138251|NCT00858702|2756447|P1|COMPLETED|Overall Study||48
1138252|NCT00858702|2756446|P2|STARTED|Overall Study||52
1138253|NCT00858702|2756447|P1|STARTED|Overall Study||53
1138845|NCT00681109|2757413|P3|NOT COMPLETED|Overall Study||0
1138846|NCT00681109|2757414|P2|NOT COMPLETED|Overall Study||6
1138847|NCT00681109|2757415|P1|NOT COMPLETED|Overall Study||2
1138848|NCT00681109|2757413|P3|COMPLETED|Overall Study||15
1138849|NCT00681109|2757414|P2|COMPLETED|Overall Study||24
1138850|NCT00681109|2757415|P1|COMPLETED|Overall Study||28
1138851|NCT00681109|2757413|P3|STARTED|Overall Study||15
1138852|NCT00681109|2757414|P2|STARTED|Overall Study||30
1138853|NCT00681109|2757415|P1|STARTED|Overall Study||30
1138866|NCT00657709|2757496|P5|NOT COMPLETED|Overall Study||33
1138867|NCT00657709|2757497|P4|NOT COMPLETED|Overall Study||14
1138868|NCT00657709|2757498|P3|NOT COMPLETED|Overall Study||28
1138869|NCT00657709|2757499|P2|NOT COMPLETED|Overall Study||33
1138870|NCT00657709|2757500|P1|NOT COMPLETED|Overall Study||23
1138871|NCT00657709|2757496|P5|COMPLETED|Overall Study||457
1138872|NCT00657709|2757497|P4|COMPLETED|Overall Study||645
1138873|NCT00657709|2757498|P3|COMPLETED|Overall Study||792
1138874|NCT00657709|2757499|P2|COMPLETED|Overall Study||795
1138875|NCT00657709|2757500|P1|COMPLETED|Overall Study||810
1138876|NCT00657709|2757496|P5|STARTED|Overall Study||490
1138877|NCT00657709|2757497|P4|STARTED|Overall Study||659
1138878|NCT00657709|2757498|P3|STARTED|Overall Study||820
1138879|NCT00657709|2757499|P2|STARTED|Overall Study||828
1138880|NCT00657709|2757500|P1|STARTED|Overall Study||833
1138949|NCT00605839|2757674|P3|NOT COMPLETED|Overall Study||0
1138950|NCT00605839|2757675|P2|NOT COMPLETED|Overall Study||0
1138951|NCT00605839|2757676|P1|NOT COMPLETED|Overall Study||1
1138952|NCT00605839|2757674|P3|COMPLETED|Overall Study||28
1138953|NCT00605839|2757675|P2|COMPLETED|Overall Study||37
1138954|NCT00605839|2757676|P1|COMPLETED|Overall Study|One patient would not keep to the text messaging constraints and had to be removed.|39
1138955|NCT00605839|2757674|P3|STARTED|Overall Study||28
1138956|NCT00605839|2757675|P2|STARTED|Overall Study||37
1138957|NCT00605839|2757676|P1|STARTED|Overall Study||40
1139558|NCT00320424|2759863|P1|NOT COMPLETED|Overall Study||6
1139559|NCT00320424|2759863|P1|COMPLETED|Overall Study||42
1139560|NCT00320424|2759863|P1|STARTED|Overall Study||48
1139639|NCT00250484|2760068|P2|NOT COMPLETED|Overall Study||0
1139640|NCT00250484|2760069|P1|NOT COMPLETED|Overall Study||0
1139641|NCT00250484|2760068|P2|COMPLETED|Overall Study||8
1139642|NCT00250484|2760069|P1|COMPLETED|Overall Study||9
1139643|NCT00250484|2760068|P2|STARTED|Overall Study||8
1139644|NCT00250484|2760069|P1|STARTED|Overall Study||9
1139915|NCT00083174|2760906|P2|NOT COMPLETED|Overall Study||0
1139916|NCT00083174|2760907|P1|NOT COMPLETED|Overall Study||0
1139917|NCT00083174|2760906|P2|COMPLETED|Overall Study|All women randomized were included in the analysis based on intent-to-treat principle.|2275
1139918|NCT00083174|2760907|P1|COMPLETED|Overall Study|All women randomized were included in the analysis based on intent-to-treat principle.|2285
1139919|NCT00083174|2760906|P2|STARTED|Overall Study||2275
1139920|NCT00083174|2760907|P1|STARTED|Overall Study||2285
1139944|NCT00066573|2760971|P2|NOT COMPLETED|Overall Study||28
1139945|NCT00066573|2760972|P1|NOT COMPLETED|Overall Study||28
1139946|NCT00066573|2760971|P2|COMPLETED|Overall Study||3759
1139947|NCT00066573|2760972|P1|COMPLETED|Overall Study||3761
1139948|NCT00066573|2760971|P2|STARTED|Overall Study||3787
1139949|NCT00066573|2760972|P1|STARTED|Overall Study||3789
1141182|NCT03073798|2764663|P1|NOT COMPLETED|Overall Study||2
1141183|NCT03073798|2764663|P1|COMPLETED|Overall Study||10
1141184|NCT03073798|2764663|P1|STARTED|Overall Study||12
1141260|NCT02294461|2764871|P2|NOT COMPLETED|Overall Study||137
1141261|NCT02294461|2764872|P1|NOT COMPLETED|Overall Study||65
1141262|NCT02294461|2764871|P2|COMPLETED|Overall Study||63
1141263|NCT02294461|2764872|P1|COMPLETED|Overall Study|Participants still receiving treatment as of 20 Sept 2016. Data cutoff date: 20 Sep 2015/20 Jan 2016|144
1141264|NCT02294461|2764871|P2|Treated/Received Study Drug|Overall Study||200
1141265|NCT02294461|2764872|P1|Treated/Received Study Drug|Overall Study||209
1141266|NCT02294461|2764871|P2|STARTED|Overall Study||200
1141267|NCT02294461|2764872|P1|STARTED|Overall Study||209
1141268|NCT02218697|2764926|P2|NOT COMPLETED|Overall Study||6
1141269|NCT02218697|2764927|P1|NOT COMPLETED|Overall Study||2
1141270|NCT02218697|2764926|P2|COMPLETED|Overall Study||171
1141271|NCT02218697|2764927|P1|COMPLETED|Overall Study||177
1141272|NCT02218697|2764926|P2|STARTED|Overall Study||177
1141273|NCT02218697|2764927|P1|STARTED|Overall Study||179
1141280|NCT02189837|2764997|P4|NOT COMPLETED|Overall Study||2
1141281|NCT02189837|2764998|P3|NOT COMPLETED|Overall Study||3
1141282|NCT02189837|2764999|P2|NOT COMPLETED|Overall Study||1
1141283|NCT02189837|2765000|P1|NOT COMPLETED|Overall Study||2
1141284|NCT02189837|2764997|P4|COMPLETED|Overall Study||19
1141285|NCT02189837|2764998|P3|COMPLETED|Overall Study||20
1141286|NCT02189837|2764999|P2|COMPLETED|Overall Study||22
1141287|NCT02189837|2765000|P1|COMPLETED|Overall Study||20
1141288|NCT02189837|2764997|P4|Received Treatment|Overall Study||20
1141289|NCT02189837|2764998|P3|Received Treatment|Overall Study||22
1141290|NCT02189837|2764999|P2|Received Treatment|Overall Study||22
1141291|NCT02189837|2765000|P1|Received Treatment|Overall Study||21
1141292|NCT02189837|2764997|P4|STARTED|Overall Study||21
1141293|NCT02189837|2764998|P3|STARTED|Overall Study||23
1141294|NCT02189837|2764999|P2|STARTED|Overall Study||23
1141295|NCT02189837|2765000|P1|STARTED|Overall Study||22
1141312|NCT02179892|2765131|P2|NOT COMPLETED|Overall Study||0
1141313|NCT02179892|2765132|P1|NOT COMPLETED|Overall Study||0
1141314|NCT02179892|2765131|P2|COMPLETED|Overall Study||4
1141315|NCT02179892|2765132|P1|COMPLETED|Overall Study||5
1141316|NCT02179892|2765131|P2|STARTED|Overall Study||4
1141317|NCT02179892|2765132|P1|STARTED|Overall Study||5
1141318|NCT02164929|2765148|P4|NOT COMPLETED|Overall Study||2
1141319|NCT02164929|2765149|P3|NOT COMPLETED|Overall Study||1
1141320|NCT02164929|2765150|P2|NOT COMPLETED|Overall Study||0
1141321|NCT02164929|2765151|P1|NOT COMPLETED|Overall Study||1
1141322|NCT02164929|2765148|P4|COMPLETED|Overall Study||2
1141323|NCT02164929|2765149|P3|COMPLETED|Overall Study||4
1141324|NCT02164929|2765150|P2|COMPLETED|Overall Study||3
1141325|NCT02164929|2765151|P1|COMPLETED|Overall Study||3
1141326|NCT02164929|2765148|P4|STARTED|Overall Study||4
1141327|NCT02164929|2765149|P3|STARTED|Overall Study||5
1141328|NCT02164929|2765150|P2|STARTED|Overall Study||3
1141329|NCT02164929|2765151|P1|STARTED|Overall Study||4
1141330|NCT02164318|2765197|P4|NOT COMPLETED|Overall Study||1
1141331|NCT02164318|2765198|P3|NOT COMPLETED|Overall Study||0
1141332|NCT02164318|2765199|P2|NOT COMPLETED|Overall Study||1
1141333|NCT02164318|2765200|P1|NOT COMPLETED|Overall Study||0
1141334|NCT02164318|2765197|P4|COMPLETED|Overall Study||2
1141335|NCT02164318|2765198|P3|COMPLETED|Overall Study||1
1141336|NCT02164318|2765199|P2|COMPLETED|Overall Study||2
1141337|NCT02164318|2765200|P1|COMPLETED|Overall Study||4
1141338|NCT02164318|2765197|P4|STARTED|Overall Study||3
1141339|NCT02164318|2765198|P3|STARTED|Overall Study||1
1141340|NCT02164318|2765199|P2|STARTED|Overall Study||3
1141341|NCT02164318|2765200|P1|STARTED|Overall Study||4
1141381|NCT02046148|2765342|P2|NOT COMPLETED|Overall Study||3
1141382|NCT02046148|2765343|P1|NOT COMPLETED|Overall Study||1
1141383|NCT02046148|2765342|P2|COMPLETED|Overall Study||23
1141384|NCT02046148|2765343|P1|COMPLETED|Overall Study||48
1141385|NCT02046148|2765342|P2|STARTED|Overall Study||26
1141386|NCT02046148|2765343|P1|STARTED|Overall Study||49
1141399|NCT01994629|2765450|P2|NOT COMPLETED|Overall Study||3
1141400|NCT01994629|2765451|P1|NOT COMPLETED|Overall Study||1
1141401|NCT01994629|2765450|P2|COMPLETED|Overall Study||99
1141402|NCT01994629|2765451|P1|COMPLETED|Overall Study||99
1141403|NCT01994629|2765450|P2|STARTED|Overall Study||102
1141404|NCT01994629|2765451|P1|STARTED|Overall Study||100
1141405|NCT01954251|2765477|P2|NOT COMPLETED|Overall Study||19
1141406|NCT01954251|2765478|P1|NOT COMPLETED|Overall Study||13
1141407|NCT01954251|2765477|P2|COMPLETED|Overall Study||396
1141408|NCT01954251|2765478|P1|COMPLETED|Overall Study||400
1141409|NCT01954251|2765477|P2|STARTED|Overall Study||415
1141410|NCT01954251|2765478|P1|STARTED|Overall Study||413
1141411|NCT01903720|2765512|P1|NOT COMPLETED|Overall Study||12
1141412|NCT01903720|2765512|P1|COMPLETED|Overall Study||59
1141413|NCT01903720|2765512|P1|STARTED|Overall Study||71
1141414|NCT01867307|2765529|P2|NOT COMPLETED|Overall Study||3
1141415|NCT01867307|2765530|P1|NOT COMPLETED|Overall Study||3
1141416|NCT01867307|2765529|P2|COMPLETED|Overall Study||16
1141417|NCT01867307|2765530|P1|COMPLETED|Overall Study||15
1141418|NCT01867307|2765529|P2|STARTED|Overall Study|Started are the treated patients|19
1141419|NCT01867307|2765530|P1|STARTED|Overall Study|Started are the treated patients|18
1141420|NCT01867047|2765538|P2|NOT COMPLETED|Overall Study||5
1141421|NCT01867047|2765539|P1|NOT COMPLETED|Overall Study||8
1141422|NCT01867047|2765538|P2|COMPLETED|Overall Study||23
1141423|NCT01867047|2765539|P1|COMPLETED|Overall Study||23
1141424|NCT01867047|2765538|P2|STARTED|Overall Study||28
1141425|NCT01867047|2765539|P1|STARTED|Overall Study||31
1141426|NCT01816048|2765557|P1|NOT COMPLETED|Overall Study||6
1141427|NCT01816048|2765557|P1|COMPLETED|Overall Study||2
1141428|NCT01816048|2765557|P1|STARTED|Overall Study||8
1141435|NCT01804842|2765586|P3|NOT COMPLETED|Overall Study||1
1141436|NCT01804842|2765587|P2|NOT COMPLETED|Overall Study||2
1141437|NCT01804842|2765588|P1|NOT COMPLETED|Overall Study||3
1141438|NCT01804842|2765586|P3|COMPLETED|Overall Study||8
1141439|NCT01804842|2765587|P2|COMPLETED|Overall Study||6
1141440|NCT01804842|2765588|P1|COMPLETED|Overall Study||6
1141441|NCT01804842|2765586|P3|Completed Treatment C|Overall Study||9
1141442|NCT01804842|2765587|P2|Completed Treatment C|Overall Study||7
1141443|NCT01804842|2765588|P1|Completed Treatment C|Overall Study||7
1141444|NCT01804842|2765586|P3|Completed Treatment B|Overall Study||8
1141445|NCT01804842|2765587|P2|Completed Treatment B|Overall Study||8
1141446|NCT01804842|2765588|P1|Completed Treatment B|Overall Study||8
1141447|NCT01804842|2765586|P3|Completed Treatment A|Overall Study||8
1141448|NCT01804842|2765587|P2|Completed Treatment A|Overall Study||6
1141449|NCT01804842|2765588|P1|Completed Treatment A|Overall Study||9
1141450|NCT01804842|2765586|P3|STARTED|Overall Study||9
1141451|NCT01804842|2765587|P2|STARTED|Overall Study||8
1141452|NCT01804842|2765588|P1|STARTED|Overall Study||9
1141453|NCT01797094|2765607|P2|NOT COMPLETED|Overall Study||2
1141454|NCT01797094|2765608|P1|NOT COMPLETED|Overall Study||6
1141455|NCT01797094|2765607|P2|COMPLETED|Overall Study||51
1141456|NCT01797094|2765608|P1|COMPLETED|Overall Study||42
1141457|NCT01797094|2765607|P2|STARTED|Overall Study||53
1141458|NCT01797094|2765608|P1|STARTED|Overall Study||48
1141459|NCT01797081|2765630|P4|NOT COMPLETED|Overall Study||9
1141460|NCT01797081|2765631|P3|NOT COMPLETED|Overall Study||5
1141461|NCT01797081|2765632|P2|NOT COMPLETED|Overall Study||4
1141462|NCT01797081|2765633|P1|NOT COMPLETED|Overall Study||14
1141463|NCT01797081|2765630|P4|COMPLETED|Overall Study||40
1141464|NCT01797081|2765631|P3|COMPLETED|Overall Study||43
1141465|NCT01797081|2765632|P2|COMPLETED|Overall Study||95
1141466|NCT01797081|2765633|P1|COMPLETED|Overall Study||90
1141467|NCT01797081|2765630|P4|STARTED|Overall Study||49
1141468|NCT01797081|2765631|P3|STARTED|Overall Study||48
1141469|NCT01797081|2765632|P2|STARTED|Overall Study||99
1141470|NCT01797081|2765633|P1|STARTED|Overall Study||104
1141471|NCT01721746|2765652|P3|NOT COMPLETED|Follow-Up Period||0
1141472|NCT01721746|2765653|P2|NOT COMPLETED|Follow-Up Period||0
1141473|NCT01721746|2765654|P1|NOT COMPLETED|Follow-Up Period||0
1141474|NCT01721746|2765652|P3|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|19
1141475|NCT01721746|2765653|P2|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|11
1141476|NCT01721746|2765654|P1|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|92
1141477|NCT01721746|2765652|P3|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|19
1141478|NCT01721746|2765653|P2|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|11
1141479|NCT01721746|2765654|P1|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|92
1141480|NCT01721746|2765652|P3|NOT COMPLETED|Treatment Period||57
1141481|NCT01721746|2765653|P2|NOT COMPLETED|Treatment Period||45
1141482|NCT01721746|2765654|P1|NOT COMPLETED|Treatment Period||233
1141483|NCT01721746|2765652|P3|COMPLETED|Treatment Period||0
1141484|NCT01721746|2765653|P2|COMPLETED|Treatment Period||0
1141485|NCT01721746|2765654|P1|COMPLETED|Treatment Period|Completed=Continuing in Treatment Period|35
1141486|NCT01721746|2765652|P3|STARTED|Treatment Period||57
1141487|NCT01721746|2765653|P2|STARTED|Treatment Period||45
1141488|NCT01721746|2765654|P1|STARTED|Treatment Period||268
1141489|NCT01721759|2765670|P1|NOT COMPLETED|Overall Study||102
1141490|NCT01721759|2765670|P1|COMPLETED|Overall Study|Completed=continuing to receive treatment|15
1141491|NCT01721759|2765670|P1|STARTED|Overall Study||117
1141492|NCT01714024|2765679|P3|NOT COMPLETED|Overall Study||3
1141493|NCT01714024|2765680|P2|NOT COMPLETED|Overall Study||6
1141494|NCT01714024|2765681|P1|NOT COMPLETED|Overall Study||1
1141495|NCT01714024|2765679|P3|COMPLETED|Overall Study||8
1141496|NCT01714024|2765680|P2|COMPLETED|Overall Study||12
1141497|NCT01714024|2765681|P1|COMPLETED|Overall Study||12
1141498|NCT01714024|2765679|P3|STARTED|Overall Study||11
1141499|NCT01714024|2765680|P2|STARTED|Overall Study||18
1141500|NCT01714024|2765681|P1|STARTED|Overall Study||13
1141501|NCT01710046|2765700|P2|NOT COMPLETED|Overall Study||0
1141502|NCT01710046|2765701|P1|NOT COMPLETED|Overall Study||1
1141503|NCT01710046|2765700|P2|COMPLETED|Overall Study||3
1141504|NCT01710046|2765701|P1|COMPLETED|Overall Study||8
1141505|NCT01710046|2765700|P2|STARTED|Overall Study||3
1141506|NCT01710046|2765701|P1|STARTED|Overall Study||9
1141516|NCT01680783|2765752|P2|NOT COMPLETED|Overall Study||0
1141517|NCT01680783|2765753|P1|NOT COMPLETED|Overall Study||0
1141518|NCT01680783|2765752|P2|COMPLETED|Overall Study||44
1141519|NCT01680783|2765753|P1|COMPLETED|Overall Study||39
1141520|NCT01680783|2765752|P2|STARTED|Overall Study||44
1141521|NCT01680783|2765753|P1|STARTED|Overall Study||39
1141522|NCT01662440|2765763|P4|NOT COMPLETED|Overall Study||4
1141523|NCT01662440|2765764|P3|NOT COMPLETED|Overall Study||6
1141524|NCT01662440|2765765|P2|NOT COMPLETED|Overall Study||6
1141525|NCT01662440|2765766|P1|NOT COMPLETED|Overall Study||9
1141526|NCT01662440|2765763|P4|COMPLETED|Overall Study||52
1141527|NCT01662440|2765764|P3|COMPLETED|Overall Study||215
1141528|NCT01662440|2765765|P2|COMPLETED|Overall Study||211
1141529|NCT01662440|2765766|P1|COMPLETED|Overall Study||158
1141530|NCT01662440|2765763|P4|STARTED|Overall Study||56
1141531|NCT01662440|2765764|P3|STARTED|Overall Study||221
1141532|NCT01662440|2765765|P2|STARTED|Overall Study||217
1141533|NCT01662440|2765766|P1|STARTED|Overall Study||167
1141540|NCT01621802|2765839|P6|NOT COMPLETED|Overall Study||12
1141541|NCT01621802|2765840|P5|NOT COMPLETED|Overall Study||35
1141542|NCT01621802|2765841|P4|NOT COMPLETED|Overall Study||11
1141543|NCT01621802|2765842|P3|NOT COMPLETED|Overall Study||33
1141544|NCT01621802|2765843|P2|NOT COMPLETED|Overall Study||23
1141545|NCT01621802|2765844|P1|NOT COMPLETED|Overall Study||47
1141546|NCT01621802|2765839|P6|COMPLETED|Overall Study||477
1141547|NCT01621802|2765840|P5|COMPLETED|Overall Study||1284
1141548|NCT01621802|2765841|P4|COMPLETED|Overall Study||292
1141549|NCT01621802|2765842|P3|COMPLETED|Overall Study||763
1141550|NCT01621802|2765843|P2|COMPLETED|Overall Study||275
1141551|NCT01621802|2765844|P1|COMPLETED|Overall Study||755
1141552|NCT01621802|2765839|P6|STARTED|Overall Study||489
1141553|NCT01621802|2765840|P5|STARTED|Overall Study||1319
1141554|NCT01621802|2765841|P4|STARTED|Overall Study||303
1141555|NCT01621802|2765842|P3|STARTED|Overall Study||796
1141556|NCT01621802|2765843|P2|STARTED|Overall Study||298
1141557|NCT01621802|2765844|P1|STARTED|Overall Study||802
1141564|NCT01600716|2765998|P2|NOT COMPLETED|Overall Study||7
1141565|NCT01600716|2765999|P1|NOT COMPLETED|Overall Study||7
1141566|NCT01600716|2765998|P2|COMPLETED|Overall Study||71
1141567|NCT01600716|2765999|P1|COMPLETED|Overall Study||59
1141568|NCT01600716|2765998|P2|STARTED|Overall Study||78
1141569|NCT01600716|2765999|P1|STARTED|Overall Study||66
1141573|NCT01570192|2766023|P2|NOT COMPLETED|Overall Study||13
1141574|NCT01570192|2766024|P1|NOT COMPLETED|Overall Study||7
1141575|NCT01570192|2766023|P2|COMPLETED|Overall Study||17
1141576|NCT01570192|2766024|P1|COMPLETED|Overall Study||6
1141577|NCT01570192|2766023|P2|STARTED|Overall Study||30
1141578|NCT01570192|2766024|P1|STARTED|Overall Study||13
1141579|NCT01547299|2766064|P2|NOT COMPLETED|Overall Study||2
1141580|NCT01547299|2766065|P1|NOT COMPLETED|Overall Study||2
1141581|NCT01547299|2766064|P2|COMPLETED|Overall Study||25
1141582|NCT01547299|2766065|P1|COMPLETED|Overall Study||23
1141583|NCT01547299|2766064|P2|STARTED|Overall Study||27
1141584|NCT01547299|2766065|P1|STARTED|Overall Study||25
1141608|NCT01466387|2766161|P6|NOT COMPLETED|Overall Study||1
1141609|NCT01466387|2766162|P5|NOT COMPLETED|Overall Study||0
1141610|NCT01466387|2766163|P4|NOT COMPLETED|Overall Study||2
1141611|NCT01466387|2766164|P3|NOT COMPLETED|Overall Study||1
1141612|NCT01466387|2766165|P2|NOT COMPLETED|Overall Study||0
1141613|NCT01466387|2766166|P1|NOT COMPLETED|Overall Study||1
1141614|NCT01466387|2766161|P6|COMPLETED|Overall Study||99
1141615|NCT01466387|2766162|P5|COMPLETED|Overall Study||51
1141616|NCT01466387|2766163|P4|COMPLETED|Overall Study||99
1141617|NCT01466387|2766164|P3|COMPLETED|Overall Study||98
1141618|NCT01466387|2766165|P2|COMPLETED|Overall Study||100
1141619|NCT01466387|2766166|P1|COMPLETED|Overall Study||100
1141620|NCT01466387|2766161|P6|STARTED|Overall Study||100
1141621|NCT01466387|2766162|P5|STARTED|Overall Study||51
1141622|NCT01466387|2766163|P4|STARTED|Overall Study||101
1141623|NCT01466387|2766164|P3|STARTED|Overall Study||99
1141624|NCT01466387|2766165|P2|STARTED|Overall Study||100
1141625|NCT01466387|2766166|P1|STARTED|Overall Study||101
1141626|NCT01453348|2766207|P3|NOT COMPLETED|Overall Study||1
1141627|NCT01453348|2766208|P2|NOT COMPLETED|Overall Study||1
1141628|NCT01453348|2766209|P1|NOT COMPLETED|Overall Study||1
1141629|NCT01453348|2766207|P3|COMPLETED|Overall Study||83
1141630|NCT01453348|2766208|P2|COMPLETED|Overall Study||83
1141631|NCT01453348|2766209|P1|COMPLETED|Overall Study||83
1141632|NCT01453348|2766207|P3|STARTED|Overall Study||84
1141633|NCT01453348|2766208|P2|STARTED|Overall Study||84
1141634|NCT01453348|2766209|P1|STARTED|Overall Study||84
1141635|NCT01439360|2766227|P2|NOT COMPLETED|Overall Study||208
1141636|NCT01439360|2766228|P1|NOT COMPLETED|Overall Study||198
1141637|NCT01439360|2766227|P2|COMPLETED|Overall Study||5804
1141638|NCT01439360|2766228|P1|COMPLETED|Overall Study||5808
1141639|NCT01439360|2766227|P2|STARTED|Overall Study||6012
1141640|NCT01439360|2766228|P1|STARTED|Overall Study||6006
1141641|NCT01423253|2766276|P1|NOT COMPLETED|Overall Study||9
1141642|NCT01423253|2766276|P1|COMPLETED|Overall Study||39
1141643|NCT01423253|2766276|P1|STARTED|Overall Study||48
1141644|NCT01422408|2766287|P1|NOT COMPLETED|Overall Study||4
1141645|NCT01422408|2766287|P1|COMPLETED|Overall Study||30
1141646|NCT01422408|2766287|P1|STARTED|Overall Study||34
1141647|NCT01411852|2766318|P2|NOT COMPLETED|Hospital Intervention Phase||18
1141648|NCT01411852|2766319|P1|NOT COMPLETED|Hospital Intervention Phase||24
1141649|NCT01411852|2766318|P2|COMPLETED|Hospital Intervention Phase|18 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|71
1141650|NCT01411852|2766319|P1|COMPLETED|Hospital Intervention Phase|24 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|59
1141651|NCT01411852|2766318|P2|STARTED|Hospital Intervention Phase||89
1141652|NCT01411852|2766319|P1|STARTED|Hospital Intervention Phase||83
1141653|NCT01411852|2766318|P2|NOT COMPLETED|Prehospital Intervention Phase||7
1141654|NCT01411852|2766319|P1|NOT COMPLETED|Prehospital Intervention Phase||12
1141655|NCT01411852|2766318|P2|COMPLETED|Prehospital Intervention Phase|7 patients had intervention stopped prior to hospital arrival|89
1141656|NCT01411852|2766319|P1|COMPLETED|Prehospital Intervention Phase|12 patients had the intervention stopped prior to hospital arrival|83
1141657|NCT01411852|2766318|P2|STARTED|Prehospital Intervention Phase|One patient was in police custody at the time of enrollment. Patient's data omitted from analyses.|96
1141658|NCT01411852|2766319|P1|STARTED|Prehospital Intervention Phase|1 patient randomized to 2000 mL bolus arm but received 250 mL bolus. Analyzed in 2000 mL arm.|95
1141659|NCT01409096|2766364|P2|NOT COMPLETED|Overall Study||5
1141660|NCT01409096|2766365|P1|NOT COMPLETED|Overall Study||2
1141661|NCT01409096|2766364|P2|COMPLETED|Overall Study||35
1141662|NCT01409096|2766365|P1|COMPLETED|Overall Study||38
1141663|NCT01409096|2766364|P2|STARTED|Overall Study||40
1141664|NCT01409096|2766365|P1|STARTED|Overall Study||40
1141665|NCT01406223|2766381|P4|NOT COMPLETED|Overall Study||16
1141666|NCT01406223|2766382|P3|NOT COMPLETED|Overall Study||18
1141667|NCT01406223|2766383|P2|NOT COMPLETED|Overall Study||12
1141668|NCT01406223|2766384|P1|NOT COMPLETED|Overall Study||12
1141669|NCT01406223|2766381|P4|COMPLETED|Overall Study||3
1141670|NCT01406223|2766382|P3|COMPLETED|Overall Study||2
1141671|NCT01406223|2766383|P2|COMPLETED|Overall Study||7
1141672|NCT01406223|2766384|P1|COMPLETED|Overall Study||6
1141673|NCT01406223|2766381|P4|STARTED|Overall Study||19
1141674|NCT01406223|2766382|P3|STARTED|Overall Study||20
1141675|NCT01406223|2766383|P2|STARTED|Overall Study||19
1141676|NCT01406223|2766384|P1|STARTED|Overall Study||18
1141677|NCT01375374|2766398|P1|NOT COMPLETED|Overall Study||1
1141678|NCT01375374|2766398|P1|COMPLETED|Overall Study||10
1141679|NCT01375374|2766398|P1|STARTED|Overall Study||11
1141680|NCT01369342|2766408|P3|NOT COMPLETED|Overall Study||3
1141681|NCT01369342|2766409|P2|NOT COMPLETED|Overall Study||9
1141682|NCT01369342|2766410|P1|NOT COMPLETED|Overall Study||13
1141683|NCT01369342|2766408|P3|COMPLETED|Overall Study||210
1141684|NCT01369342|2766409|P2|COMPLETED|Overall Study||204
1141685|NCT01369342|2766410|P1|COMPLETED|Overall Study||201
1141686|NCT01369342|2766408|P3|STARTED|Overall Study||213
1141687|NCT01369342|2766409|P2|STARTED|Overall Study||213
1141688|NCT01369342|2766410|P1|STARTED|Overall Study||214
1141689|NCT01369329|2766433|P3|NOT COMPLETED|Overall Study||14
1141690|NCT01369329|2766434|P2|NOT COMPLETED|Overall Study||11
1141691|NCT01369329|2766435|P1|NOT COMPLETED|Overall Study||12
1141692|NCT01369329|2766433|P3|COMPLETED|Overall Study||245
1141693|NCT01369329|2766434|P2|COMPLETED|Overall Study||243
1141694|NCT01369329|2766435|P1|COMPLETED|Overall Study||244
1141695|NCT01369329|2766433|P3|STARTED|Overall Study||259
1141696|NCT01369329|2766434|P2|STARTED|Overall Study||254
1141697|NCT01369329|2766435|P1|STARTED|Overall Study||256
1141698|NCT01363479|2766457|P2|NOT COMPLETED|Overall Study||21
1141699|NCT01363479|2766458|P1|NOT COMPLETED|Overall Study||12
1141700|NCT01363479|2766457|P2|COMPLETED|Overall Study||351
1141701|NCT01363479|2766458|P1|COMPLETED|Overall Study||359
1141702|NCT01363479|2766457|P2|STARTED|Overall Study|number of randomised patients|372
1141703|NCT01363479|2766458|P1|STARTED|Overall Study|number of randomised patients|371
1141704|NCT01362140|2766466|P2|NOT COMPLETED|Overall Study||11
1141705|NCT01362140|2766467|P1|NOT COMPLETED|Overall Study||10
1141706|NCT01362140|2766466|P2|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|87
1141707|NCT01362140|2766467|P1|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|39
1141708|NCT01362140|2766466|P2|Received Treatment|Overall Study||97
1141709|NCT01362140|2766467|P1|Received Treatment|Overall Study||49
1141710|NCT01362140|2766466|P2|STARTED|Overall Study||98
1141711|NCT01362140|2766467|P1|STARTED|Overall Study||49
1141712|NCT01354431|2766492|P3|NOT COMPLETED|Participants Treated||54
1141713|NCT01354431|2766493|P2|NOT COMPLETED|Participants Treated||54
1141714|NCT01354431|2766494|P1|NOT COMPLETED|Participants Treated||59
1141715|NCT01354431|2766492|P3|COMPLETED|Participants Treated||0
1141716|NCT01354431|2766493|P2|COMPLETED|Participants Treated||0
1141717|NCT01354431|2766494|P1|COMPLETED|Participants Treated||0
1141718|NCT01354431|2766492|P3|STARTED|Participants Treated||54
1141719|NCT01354431|2766493|P2|STARTED|Participants Treated||54
1141720|NCT01354431|2766494|P1|STARTED|Participants Treated||59
1141721|NCT01354431|2766492|P3|NOT COMPLETED|Randomized to Enter Treatment Period||0
1141722|NCT01354431|2766493|P2|NOT COMPLETED|Randomized to Enter Treatment Period||0
1141723|NCT01354431|2766494|P1|NOT COMPLETED|Randomized to Enter Treatment Period||1
1141724|NCT01354431|2766492|P3|COMPLETED|Randomized to Enter Treatment Period||54
1141725|NCT01354431|2766493|P2|COMPLETED|Randomized to Enter Treatment Period||54
1141726|NCT01354431|2766494|P1|COMPLETED|Randomized to Enter Treatment Period||59
1141727|NCT01354431|2766492|P3|STARTED|Randomized to Enter Treatment Period||54
1141728|NCT01354431|2766493|P2|STARTED|Randomized to Enter Treatment Period||54
1141729|NCT01354431|2766494|P1|STARTED|Randomized to Enter Treatment Period||60
1141730|NCT01350934|2766516|P2|NOT COMPLETED|Extension Study||4
1141731|NCT01350934|2766517|P1|NOT COMPLETED|Extension Study||5
1141732|NCT01350934|2766516|P2|COMPLETED|Extension Study||101
1141733|NCT01350934|2766517|P1|COMPLETED|Extension Study||95
1141734|NCT01350934|2766516|P2|STARTED|Extension Study||105
1141735|NCT01350934|2766517|P1|STARTED|Extension Study||100
1141736|NCT01350934|2766516|P2|NOT COMPLETED|Base Study||3
1141737|NCT01350934|2766517|P1|NOT COMPLETED|Base Study||11
1141738|NCT01350934|2766516|P2|COMPLETED|Base Study||105
1141739|NCT01350934|2766517|P1|COMPLETED|Base Study||100
1141740|NCT01350934|2766516|P2|STARTED|Base Study||108
1141741|NCT01350934|2766517|P1|STARTED|Base Study||111
1141742|NCT01340300|2766539|P4|NOT COMPLETED|Overall Study||21
1141743|NCT01340300|2766540|P3|NOT COMPLETED|Overall Study||21
1141744|NCT01340300|2766541|P2|NOT COMPLETED|Overall Study||14
1141745|NCT01340300|2766542|P1|NOT COMPLETED|Overall Study||15
1141746|NCT01340300|2766539|P4|COMPLETED|Overall Study||13
1141747|NCT01340300|2766540|P3|COMPLETED|Overall Study||14
1141748|NCT01340300|2766541|P2|COMPLETED|Overall Study||21
1141749|NCT01340300|2766542|P1|COMPLETED|Overall Study||20
1141750|NCT01340300|2766539|P4|Completed Treatment|Overall Study||17
1141751|NCT01340300|2766540|P3|Completed Treatment|Overall Study||18
1141752|NCT01340300|2766541|P2|Completed Treatment|Overall Study||24
1141753|NCT01340300|2766542|P1|Completed Treatment|Overall Study||23
1141754|NCT01340300|2766539|P4|Follow-up Blood Sample|Overall Study||17
1141755|NCT01340300|2766540|P3|Follow-up Blood Sample|Overall Study||19
1141756|NCT01340300|2766541|P2|Follow-up Blood Sample|Overall Study||26
1141757|NCT01340300|2766542|P1|Follow-up Blood Sample|Overall Study||25
1141758|NCT01340300|2766539|P4|Baseline Blood Sample|Overall Study||29
1141759|NCT01340300|2766540|P3|Baseline Blood Sample|Overall Study||32
1141760|NCT01340300|2766541|P2|Baseline Blood Sample|Overall Study||34
1141761|NCT01340300|2766542|P1|Baseline Blood Sample|Overall Study||33
1141762|NCT01340300|2766539|P4|STARTED|Overall Study||34
1141763|NCT01340300|2766540|P3|STARTED|Overall Study||35
1141764|NCT01340300|2766541|P2|STARTED|Overall Study||35
1141765|NCT01340300|2766542|P1|STARTED|Overall Study||35
1141766|NCT01331161|2766574|P2|NOT COMPLETED|Overall Study||2
1141767|NCT01331161|2766575|P1|NOT COMPLETED|Overall Study||1
1141768|NCT01331161|2766574|P2|COMPLETED|Overall Study||31
1141769|NCT01331161|2766575|P1|COMPLETED|Overall Study||43
1141770|NCT01331161|2766574|P2|STARTED|Overall Study||33
1141771|NCT01331161|2766575|P1|STARTED|Overall Study||44
1141772|NCT01309737|2766586|P5|NOT COMPLETED|Week 16 to 52||33
1141773|NCT01309737|2766587|P4|NOT COMPLETED|Week 16 to 52||34
1141774|NCT01309737|2766588|P3|NOT COMPLETED|Week 16 to 52||0
1141775|NCT01309737|2766589|P2|NOT COMPLETED|Week 16 to 52||103
1141776|NCT01309737|2766590|P1|NOT COMPLETED|Week 16 to 52||133
1141777|NCT01309737|2766586|P5|COMPLETED|Week 16 to 52||44
1141778|NCT01309737|2766587|P4|COMPLETED|Week 16 to 52||41
1141779|NCT01309737|2766588|P3|COMPLETED|Week 16 to 52||0
1141780|NCT01309737|2766589|P2|COMPLETED|Week 16 to 52||238
1141781|NCT01309737|2766590|P1|COMPLETED|Week 16 to 52||198
1141782|NCT01309737|2766586|P5|STARTED|Week 16 to 52||77
1141783|NCT01309737|2766587|P4|STARTED|Week 16 to 52||75
1141784|NCT01309737|2766588|P3|STARTED|Week 16 to 52||0
1141785|NCT01309737|2766589|P2|STARTED|Week 16 to 52||341
1141786|NCT01309737|2766590|P1|STARTED|Week 16 to 52||331
1141787|NCT01309737|2766586|P5|NOT COMPLETED|Week 0 to 16||0
1141788|NCT01309737|2766587|P4|NOT COMPLETED|Week 0 to 16||0
1141789|NCT01309737|2766588|P3|NOT COMPLETED|Week 0 to 16||44
1141790|NCT01309737|2766589|P2|NOT COMPLETED|Week 0 to 16||40
1141791|NCT01309737|2766590|P1|NOT COMPLETED|Week 0 to 16||52
1141792|NCT01309737|2766586|P5|COMPLETED|Week 0 to 16||0
1141793|NCT01309737|2766587|P4|COMPLETED|Week 0 to 16||0
1141794|NCT01309737|2766588|P3|COMPLETED|Week 0 to 16||152
1141795|NCT01309737|2766589|P2|COMPLETED|Week 0 to 16||341
1141796|NCT01309737|2766590|P1|COMPLETED|Week 0 to 16||331
1141797|NCT01309737|2766586|P5|Treated|Week 0 to 16||0
1141798|NCT01309737|2766587|P4|Treated|Week 0 to 16||0
1141799|NCT01309737|2766588|P3|Treated|Week 0 to 16||196
1141800|NCT01309737|2766589|P2|Treated|Week 0 to 16||381
1141801|NCT01309737|2766590|P1|Treated|Week 0 to 16||382
1141802|NCT01309737|2766586|P5|STARTED|Week 0 to 16||0
1141803|NCT01309737|2766587|P4|STARTED|Week 0 to 16||0
1141804|NCT01309737|2766588|P3|STARTED|Week 0 to 16||196
1141805|NCT01309737|2766589|P2|STARTED|Week 0 to 16||381
1141806|NCT01309737|2766590|P1|STARTED|Week 0 to 16||383
1141807|NCT01276509|2766789|P4|NOT COMPLETED|Overall Study||5
1141808|NCT01276509|2766790|P3|NOT COMPLETED|Overall Study||5
1141809|NCT01276509|2766791|P2|NOT COMPLETED|Overall Study||12
1141810|NCT01276509|2766792|P1|NOT COMPLETED|Overall Study||13
1141811|NCT01276509|2766789|P4|COMPLETED|Overall Study||58
1141812|NCT01276509|2766790|P3|COMPLETED|Overall Study||63
1141813|NCT01276509|2766791|P2|COMPLETED|Overall Study||53
1141814|NCT01276509|2766792|P1|COMPLETED|Overall Study||53
1141815|NCT01276509|2766789|P4|STARTED|Overall Study||63
1141816|NCT01276509|2766790|P3|STARTED|Overall Study||68
1141817|NCT01276509|2766791|P2|STARTED|Overall Study||65
1141818|NCT01276509|2766792|P1|STARTED|Overall Study||66
1141819|NCT01276639|2766846|P5|NOT COMPLETED|Week 16 to 52||21
1141820|NCT01276639|2766847|P4|NOT COMPLETED|Week 16 to 52||16
1141821|NCT01276639|2766848|P3|NOT COMPLETED|Week 16 to 52||0
1141822|NCT01276639|2766849|P2|NOT COMPLETED|Week 16 to 52||101
1141823|NCT01276639|2766850|P1|NOT COMPLETED|Week 16 to 52||127
1141824|NCT01276639|2766846|P5|COMPLETED|Week 16 to 52||45
1141825|NCT01276639|2766847|P4|COMPLETED|Week 16 to 52||50
1141826|NCT01276639|2766848|P3|COMPLETED|Week 16 to 52||0
1141827|NCT01276639|2766849|P2|COMPLETED|Week 16 to 52||219
1141828|NCT01276639|2766850|P1|COMPLETED|Week 16 to 52||186
1141829|NCT01276639|2766846|P5|STARTED|Week 16 to 52||66
1141830|NCT01276639|2766847|P4|STARTED|Week 16 to 52||66
1141831|NCT01276639|2766848|P3|STARTED|Week 16 to 52||0
1141832|NCT01276639|2766849|P2|STARTED|Week 16 to 52||320
1141833|NCT01276639|2766850|P1|STARTED|Week 16 to 52||313
1141834|NCT01276639|2766846|P5|NOT COMPLETED|Week 0 to 16||0
1141835|NCT01276639|2766847|P4|NOT COMPLETED|Week 0 to 16||0
1141836|NCT01276639|2766848|P3|NOT COMPLETED|Week 0 to 16||45
1141837|NCT01276639|2766849|P2|NOT COMPLETED|Week 0 to 16||41
1141838|NCT01276639|2766850|P1|NOT COMPLETED|Week 0 to 16||50
1141839|NCT01276639|2766846|P5|COMPLETED|Week 0 to 16||0
1141840|NCT01276639|2766847|P4|COMPLETED|Week 0 to 16||0
1141841|NCT01276639|2766848|P3|COMPLETED|Week 0 to 16||132
1141842|NCT01276639|2766849|P2|COMPLETED|Week 0 to 16||320
1141843|NCT01276639|2766850|P1|COMPLETED|Week 0 to 16||313
1141844|NCT01276639|2766846|P5|Treated|Week 0 to 16||0
1141845|NCT01276639|2766847|P4|Treated|Week 0 to 16||0
1141846|NCT01276639|2766848|P3|Treated|Week 0 to 16||177
1141847|NCT01276639|2766849|P2|Treated|Week 0 to 16||360
1141848|NCT01276639|2766850|P1|Treated|Week 0 to 16||363
1141849|NCT01276639|2766846|P5|STARTED|Week 0 to 16||0
1141850|NCT01276639|2766847|P4|STARTED|Week 0 to 16||0
1141851|NCT01276639|2766848|P3|STARTED|Week 0 to 16||177
1141852|NCT01276639|2766849|P2|STARTED|Week 0 to 16||361
1141853|NCT01276639|2766850|P1|STARTED|Week 0 to 16||363
1141878|NCT01257542|2767192|P2|NOT COMPLETED|Overall Study||7
1141879|NCT01257542|2767193|P1|NOT COMPLETED|Overall Study||3
1141880|NCT01257542|2767192|P2|COMPLETED|Overall Study||45
1141881|NCT01257542|2767193|P1|COMPLETED|Overall Study||52
1141882|NCT01257542|2767192|P2|STARTED|Overall Study||52
1141883|NCT01257542|2767193|P1|STARTED|Overall Study||55
1141884|NCT01232868|2767213|P2|NOT COMPLETED|Overall Study||4
1141885|NCT01232868|2767214|P1|NOT COMPLETED|Overall Study||2
1141886|NCT01232868|2767213|P2|COMPLETED|Overall Study||40
1141887|NCT01232868|2767214|P1|COMPLETED|Overall Study||20
1141888|NCT01232868|2767213|P2|STARTED|Overall Study||44
1141889|NCT01232868|2767214|P1|STARTED|Overall Study||22
1141890|NCT01228734|2767224|P2|NOT COMPLETED|Overall Study||8
1141891|NCT01228734|2767225|P1|NOT COMPLETED|Overall Study||16
1141892|NCT01228734|2767224|P2|COMPLETED|Overall Study||196
1141893|NCT01228734|2767225|P1|COMPLETED|Overall Study||177
1141894|NCT01228734|2767224|P2|Modified Safety Population|Overall Study||199
1141895|NCT01228734|2767225|P1|Modified Safety Population|Overall Study|One subject was randomized to FOLFOX-4 group but received cetuximab + FOLFOX-4 treatment instead|194
1141896|NCT01228734|2767224|P2|Modified Intent-to-treat (MITT) Populati|Overall Study||200
1141897|NCT01228734|2767225|P1|Modified Intent-to-treat (MITT) Populati|Overall Study||193
1141898|NCT01228734|2767224|P2|STARTED|Overall Study||204
1141899|NCT01228734|2767225|P1|STARTED|Overall Study||193
1141900|NCT01214850|2767242|P3|NOT COMPLETED|Overall Study||161
1141901|NCT01214850|2767243|P2|NOT COMPLETED|Overall Study||144
1141902|NCT01214850|2767244|P1|NOT COMPLETED|Overall Study||183
1141903|NCT01214850|2767242|P3|COMPLETED|Overall Study||826
1141904|NCT01214850|2767243|P2|COMPLETED|Overall Study||844
1141905|NCT01214850|2767244|P1|COMPLETED|Overall Study||796
1141906|NCT01214850|2767242|P3|STARTED|Overall Study||987
1141907|NCT01214850|2767243|P2|STARTED|Overall Study||988
1141908|NCT01214850|2767244|P1|STARTED|Overall Study||979
1141909|NCT01214837|2767328|P3|NOT COMPLETED|Overall Study||62
1141910|NCT01214837|2767329|P2|NOT COMPLETED|Overall Study||64
1141911|NCT01214837|2767330|P1|NOT COMPLETED|Overall Study||54
1141912|NCT01214837|2767328|P3|COMPLETED|Overall Study||184
1141913|NCT01214837|2767329|P2|COMPLETED|Overall Study||192
1141914|NCT01214837|2767330|P1|COMPLETED|Overall Study||195
1141915|NCT01214837|2767328|P3|STARTED|Overall Study||246
1141916|NCT01214837|2767329|P2|STARTED|Overall Study||256
1141917|NCT01214837|2767330|P1|STARTED|Overall Study||249
1141930|NCT01179191|2767376|P1|NOT COMPLETED|Maintenance Phase (8 Weeks)||117
1141931|NCT01179191|2767376|P1|COMPLETED|Maintenance Phase (8 Weeks)||234
1141932|NCT01179191|2767376|P1|STARTED|Maintenance Phase (8 Weeks)||351
1141933|NCT01179191|2767376|P1|NOT COMPLETED|Titration Phase (up to 6 Weeks)||333
1141934|NCT01179191|2767376|P1|COMPLETED|Titration Phase (up to 6 Weeks)||351
1141935|NCT01179191|2767376|P1|STARTED|Titration Phase (up to 6 Weeks)||684
1141936|NCT01167452|2767393|P1|NOT COMPLETED|Overall Study||0
1141937|NCT01167452|2767393|P1|COMPLETED|Overall Study||36
1141938|NCT01167452|2767393|P1|STARTED|Overall Study||36
1141939|NCT01165840|2767398|P1|NOT COMPLETED|Overall Study||0
1141940|NCT01165840|2767398|P1|COMPLETED|Overall Study||36
1141941|NCT01165840|2767398|P1|STARTED|Overall Study||36
1141957|NCT01152996|2767463|P1|NOT COMPLETED|Overall Study||537
1141958|NCT01152996|2767463|P1|COMPLETED|Overall Study||538
1141959|NCT01152996|2767463|P1|Treated|Overall Study||1073
1141960|NCT01152996|2767463|P1|STARTED|Overall Study||1075
1141961|NCT01144416|2767478|P2|NOT COMPLETED|Pregnancy Follow-up Period||10
1141962|NCT01144416|2767479|P1|NOT COMPLETED|Pregnancy Follow-up Period||8
1141963|NCT01144416|2767478|P2|COMPLETED|Pregnancy Follow-up Period||157
1141964|NCT01144416|2767479|P1|COMPLETED|Pregnancy Follow-up Period||146
1142119|NCT01090427|2767762|P3|COMPLETED|Controlled Period||36
1141965|NCT01144416|2767478|P2|STARTED|Pregnancy Follow-up Period|Participants received daily injections of 300 IU recFSH in Intervention Period and became pregnant.|167
1141966|NCT01144416|2767479|P1|STARTED|Pregnancy Follow-up Period|Participants received 150 ug SCH 900962 in Intervention Period and became pregnant.|154
1141967|NCT01144416|2767478|P2|NOT COMPLETED|Intervention Period||49
1141968|NCT01144416|2767479|P1|NOT COMPLETED|Intervention Period||62
1141969|NCT01144416|2767478|P2|COMPLETED|Intervention Period||647
1141970|NCT01144416|2767479|P1|COMPLETED|Intervention Period||632
1141971|NCT01144416|2767478|P2|STARTED|Intervention Period||696
1141972|NCT01144416|2767479|P1|STARTED|Intervention Period||694
1142018|NCT01131182|2767516|P2|NOT COMPLETED|Overall Study||16
1142019|NCT01131182|2767517|P1|NOT COMPLETED|Overall Study||16
1142020|NCT01131182|2767516|P2|COMPLETED|Overall Study||521
1142021|NCT01131182|2767517|P1|COMPLETED|Overall Study||513
1142022|NCT01131182|2767516|P2|STARTED|Overall Study||537
1142023|NCT01131182|2767517|P1|STARTED|Overall Study||529
1142024|NCT01126424|2767531|P6|NOT COMPLETED|Overall Study||0
1142025|NCT01126424|2767532|P5|NOT COMPLETED|Overall Study||2
1142026|NCT01126424|2767533|P4|NOT COMPLETED|Overall Study||3
1142027|NCT01126424|2767534|P3|NOT COMPLETED|Overall Study||1
1142028|NCT01126424|2767535|P2|NOT COMPLETED|Overall Study||0
1142029|NCT01126424|2767536|P1|NOT COMPLETED|Overall Study||0
1142030|NCT01126424|2767531|P6|COMPLETED|Overall Study||4
1142031|NCT01126424|2767532|P5|COMPLETED|Overall Study||2
1142032|NCT01126424|2767533|P4|COMPLETED|Overall Study||3
1142033|NCT01126424|2767534|P3|COMPLETED|Overall Study||4
1142034|NCT01126424|2767535|P2|COMPLETED|Overall Study||4
1142035|NCT01126424|2767536|P1|COMPLETED|Overall Study||3
1142036|NCT01126424|2767531|P6|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
1142037|NCT01126424|2767532|P5|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
1142038|NCT01126424|2767533|P4|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
1142120|NCT01090427|2767763|P2|COMPLETED|Controlled Period||37
1142039|NCT01126424|2767534|P3|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
1142040|NCT01126424|2767535|P2|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
1142041|NCT01126424|2767536|P1|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|3
1142042|NCT01126424|2767531|P6|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
1142043|NCT01126424|2767532|P5|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
1142044|NCT01126424|2767533|P4|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|6
1142045|NCT01126424|2767534|P3|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|5
1142046|NCT01126424|2767535|P2|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
1142047|NCT01126424|2767536|P1|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|3
1142054|NCT01116427|2767572|P2|NOT COMPLETED|Extension Phase||2
1142055|NCT01116427|2767573|P1|NOT COMPLETED|Extension Phase||9
1142056|NCT01116427|2767572|P2|COMPLETED|Extension Phase||18
1142057|NCT01116427|2767573|P1|COMPLETED|Extension Phase||29
1142058|NCT01116427|2767572|P2|STARTED|Extension Phase||20
1142059|NCT01116427|2767573|P1|STARTED|Extension Phase|One participant that completed core phase did not meet eligibility for Extension Phase|38
1142060|NCT01116427|2767572|P2|NOT COMPLETED|Core Phase||1
1142061|NCT01116427|2767573|P1|NOT COMPLETED|Core Phase||5
1142062|NCT01116427|2767572|P2|COMPLETED|Core Phase||20
1142063|NCT01116427|2767573|P1|COMPLETED|Core Phase||39
1142064|NCT01116427|2767572|P2|STARTED|Core Phase||21
1142065|NCT01116427|2767573|P1|STARTED|Core Phase||44
1142066|NCT01112059|2767611|P2|NOT COMPLETED|Overall Study||0
1142067|NCT01112059|2767612|P1|NOT COMPLETED|Overall Study||1
1142068|NCT01112059|2767611|P2|COMPLETED|Overall Study||20
1142069|NCT01112059|2767612|P1|COMPLETED|Overall Study||19
1142070|NCT01112059|2767611|P2|STARTED|Overall Study||20
1142071|NCT01112059|2767612|P1|STARTED|Overall Study||20
1142072|NCT01106534|2767624|P1|NOT COMPLETED|Overall Study||37
1142073|NCT01106534|2767624|P1|COMPLETED|Overall Study||2960
1142074|NCT01106534|2767624|P1|STARTED|Overall Study||2997
1142075|NCT01093534|2767648|P3|NOT COMPLETED|Overall Study||9
1142076|NCT01093534|2767649|P2|NOT COMPLETED|Overall Study||16
1142077|NCT01093534|2767650|P1|NOT COMPLETED|Overall Study||10
1142078|NCT01093534|2767648|P3|COMPLETED|Overall Study||169
1142079|NCT01093534|2767649|P2|COMPLETED|Overall Study||167
1142080|NCT01093534|2767650|P1|COMPLETED|Overall Study||176
1142081|NCT01093534|2767648|P3|Received Study Treatment|Overall Study||175
1142082|NCT01093534|2767649|P2|Received Study Treatment|Overall Study||182
1142083|NCT01093534|2767650|P1|Received Study Treatment|Overall Study||186
1142084|NCT01093534|2767648|P3|STARTED|Overall Study||178
1142085|NCT01093534|2767649|P2|STARTED|Overall Study||183
1142086|NCT01093534|2767650|P1|STARTED|Overall Study||186
1142087|NCT01090427|2767758|P7|NOT COMPLETED|After Controlled Period||2
1142088|NCT01090427|2767759|P6|NOT COMPLETED|After Controlled Period||5
1142089|NCT01090427|2767760|P5|NOT COMPLETED|After Controlled Period||0
1142090|NCT01090427|2767761|P4|NOT COMPLETED|After Controlled Period||2
1142091|NCT01090427|2767762|P3|NOT COMPLETED|After Controlled Period||0
1142092|NCT01090427|2767763|P2|NOT COMPLETED|After Controlled Period||0
1142093|NCT01090427|2767764|P1|NOT COMPLETED|After Controlled Period||0
1142094|NCT01090427|2767758|P7|COMPLETED|After Controlled Period||34
1142095|NCT01090427|2767759|P6|COMPLETED|After Controlled Period||32
1142096|NCT01090427|2767760|P5|COMPLETED|After Controlled Period||18
1142097|NCT01090427|2767761|P4|COMPLETED|After Controlled Period||17
1142098|NCT01090427|2767762|P3|COMPLETED|After Controlled Period||0
1142099|NCT01090427|2767763|P2|COMPLETED|After Controlled Period||0
1142100|NCT01090427|2767764|P1|COMPLETED|After Controlled Period||0
1142101|NCT01090427|2767758|P7|STARTED|After Controlled Period||36
1142102|NCT01090427|2767759|P6|STARTED|After Controlled Period||37
1142103|NCT01090427|2767760|P5|STARTED|After Controlled Period||18
1142104|NCT01090427|2767761|P4|STARTED|After Controlled Period||19
1142105|NCT01090427|2767762|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
1142106|NCT01090427|2767763|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
1142107|NCT01090427|2767764|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
1142108|NCT01090427|2767758|P7|NOT COMPLETED|Controlled Period||0
1142109|NCT01090427|2767759|P6|NOT COMPLETED|Controlled Period||0
1142110|NCT01090427|2767760|P5|NOT COMPLETED|Controlled Period||0
1142111|NCT01090427|2767761|P4|NOT COMPLETED|Controlled Period||0
1142112|NCT01090427|2767762|P3|NOT COMPLETED|Controlled Period||0
1142113|NCT01090427|2767763|P2|NOT COMPLETED|Controlled Period||0
1142114|NCT01090427|2767764|P1|NOT COMPLETED|Controlled Period||0
1142115|NCT01090427|2767758|P7|COMPLETED|Controlled Period||0
1142116|NCT01090427|2767759|P6|COMPLETED|Controlled Period||0
1142117|NCT01090427|2767760|P5|COMPLETED|Controlled Period||0
1142118|NCT01090427|2767761|P4|COMPLETED|Controlled Period||0
1142121|NCT01090427|2767764|P1|COMPLETED|Controlled Period||37
1142122|NCT01090427|2767758|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
1142123|NCT01090427|2767759|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
1142124|NCT01090427|2767760|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
1142125|NCT01090427|2767761|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
1142126|NCT01090427|2767762|P3|STARTED|Controlled Period||36
1142127|NCT01090427|2767763|P2|STARTED|Controlled Period||37
1142128|NCT01090427|2767764|P1|STARTED|Controlled Period||37
1142129|NCT01084278|2767802|P5|NOT COMPLETED|Overall Study||0
1142130|NCT01084278|2767803|P4|NOT COMPLETED|Overall Study||0
1142131|NCT01084278|2767804|P3|NOT COMPLETED|Overall Study||0
1142132|NCT01084278|2767805|P2|NOT COMPLETED|Overall Study||0
1142133|NCT01084278|2767806|P1|NOT COMPLETED|Overall Study||0
1142134|NCT01084278|2767802|P5|COMPLETED|Overall Study||8
1142135|NCT01084278|2767803|P4|COMPLETED|Overall Study||8
1142136|NCT01084278|2767804|P3|COMPLETED|Overall Study||8
1142137|NCT01084278|2767805|P2|COMPLETED|Overall Study||8
1142138|NCT01084278|2767806|P1|COMPLETED|Overall Study||8
1142139|NCT01084278|2767802|P5|STARTED|Overall Study||8
1142140|NCT01084278|2767803|P4|STARTED|Overall Study||8
1142141|NCT01084278|2767804|P3|STARTED|Overall Study||8
1142142|NCT01084278|2767805|P2|STARTED|Overall Study||8
1142143|NCT01084278|2767806|P1|STARTED|Overall Study||8
1142144|NCT01076686|2767891|P4|NOT COMPLETED|Overall Study||0
1142145|NCT01076686|2767892|P3|NOT COMPLETED|Overall Study||0
1142146|NCT01076686|2767893|P2|NOT COMPLETED|Overall Study||0
1142147|NCT01076686|2767894|P1|NOT COMPLETED|Overall Study||0
1142148|NCT01076686|2767891|P4|COMPLETED|Overall Study||31
1142149|NCT01076686|2767892|P3|COMPLETED|Overall Study||32
1142150|NCT01076686|2767893|P2|COMPLETED|Overall Study||14
1142151|NCT01076686|2767894|P1|COMPLETED|Overall Study||17
1142152|NCT01076686|2767891|P4|STARTED|Overall Study||31
1142153|NCT01076686|2767892|P3|STARTED|Overall Study||32
1142154|NCT01076686|2767893|P2|STARTED|Overall Study||14
1142155|NCT01076686|2767894|P1|STARTED|Overall Study||17
1142162|NCT01025336|2767920|P5|NOT COMPLETED|Overall Study||0
1142163|NCT01025336|2767921|P4|NOT COMPLETED|Overall Study||2
1142164|NCT01025336|2767922|P3|NOT COMPLETED|Overall Study||0
1142165|NCT01025336|2767923|P2|NOT COMPLETED|Overall Study||0
1142166|NCT01025336|2767924|P1|NOT COMPLETED|Overall Study||0
1142167|NCT01025336|2767920|P5|COMPLETED|Overall Study||222
1142168|NCT01025336|2767921|P4|COMPLETED|Overall Study||219
1142169|NCT01025336|2767922|P3|COMPLETED|Overall Study||179
1142170|NCT01025336|2767923|P2|COMPLETED|Overall Study||210
1142171|NCT01025336|2767924|P1|COMPLETED|Overall Study||130
1142172|NCT01025336|2767920|P5|STARTED|Overall Study||222
1142173|NCT01025336|2767921|P4|STARTED|Overall Study||221
1142174|NCT01025336|2767922|P3|STARTED|Overall Study||179
1142175|NCT01025336|2767923|P2|STARTED|Overall Study||210
1142176|NCT01025336|2767924|P1|STARTED|Overall Study||130
1142177|NCT01005966|2767976|P5|NOT COMPLETED|Treatment Period 5 (14 Days)||0
1142178|NCT01005966|2767977|P4|NOT COMPLETED|Treatment Period 5 (14 Days)||0
1142179|NCT01005966|2767978|P3|NOT COMPLETED|Treatment Period 5 (14 Days)||0
1142180|NCT01005966|2767979|P2|NOT COMPLETED|Treatment Period 5 (14 Days)||0
1142181|NCT01005966|2767980|P1|NOT COMPLETED|Treatment Period 5 (14 Days)||0
1142182|NCT01005966|2767976|P5|COMPLETED|Treatment Period 5 (14 Days)||10
1142183|NCT01005966|2767977|P4|COMPLETED|Treatment Period 5 (14 Days)||11
1142184|NCT01005966|2767978|P3|COMPLETED|Treatment Period 5 (14 Days)||11
1142185|NCT01005966|2767979|P2|COMPLETED|Treatment Period 5 (14 Days)||12
1142186|NCT01005966|2767980|P1|COMPLETED|Treatment Period 5 (14 Days)||9
1142187|NCT01005966|2767976|P5|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|10
1142188|NCT01005966|2767977|P4|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
1142189|NCT01005966|2767978|P3|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
1142190|NCT01005966|2767979|P2|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|12
1142191|NCT01005966|2767980|P1|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|9
1142192|NCT01005966|2767976|P5|NOT COMPLETED|Washout Period 4 (4 Days)||0
1142193|NCT01005966|2767977|P4|NOT COMPLETED|Washout Period 4 (4 Days)||0
1142194|NCT01005966|2767978|P3|NOT COMPLETED|Washout Period 4 (4 Days)||0
1142195|NCT01005966|2767979|P2|NOT COMPLETED|Washout Period 4 (4 Days)||0
1142196|NCT01005966|2767980|P1|NOT COMPLETED|Washout Period 4 (4 Days)||0
1142197|NCT01005966|2767976|P5|COMPLETED|Washout Period 4 (4 Days)||12
1142198|NCT01005966|2767977|P4|COMPLETED|Washout Period 4 (4 Days)||10
1142199|NCT01005966|2767978|P3|COMPLETED|Washout Period 4 (4 Days)||11
1142200|NCT01005966|2767979|P2|COMPLETED|Washout Period 4 (4 Days)||10
1142201|NCT01005966|2767980|P1|COMPLETED|Washout Period 4 (4 Days)||10
1142202|NCT01005966|2767976|P5|STARTED|Washout Period 4 (4 Days)||12
1142203|NCT01005966|2767977|P4|STARTED|Washout Period 4 (4 Days)||10
1142204|NCT01005966|2767978|P3|STARTED|Washout Period 4 (4 Days)||11
1142205|NCT01005966|2767979|P2|STARTED|Washout Period 4 (4 Days)||10
1142206|NCT01005966|2767980|P1|STARTED|Washout Period 4 (4 Days)||10
1142207|NCT01005966|2767976|P5|NOT COMPLETED|Treatment Period 4 (14 Days)||1
1142208|NCT01005966|2767977|P4|NOT COMPLETED|Treatment Period 4 (14 Days)||0
1142209|NCT01005966|2767978|P3|NOT COMPLETED|Treatment Period 4 (14 Days)||0
1142210|NCT01005966|2767979|P2|NOT COMPLETED|Treatment Period 4 (14 Days)||1
1142211|NCT01005966|2767980|P1|NOT COMPLETED|Treatment Period 4 (14 Days)||0
1142212|NCT01005966|2767976|P5|COMPLETED|Treatment Period 4 (14 Days)||12
1142213|NCT01005966|2767977|P4|COMPLETED|Treatment Period 4 (14 Days)||10
1142214|NCT01005966|2767978|P3|COMPLETED|Treatment Period 4 (14 Days)||11
1142215|NCT01005966|2767979|P2|COMPLETED|Treatment Period 4 (14 Days)||10
1142216|NCT01005966|2767980|P1|COMPLETED|Treatment Period 4 (14 Days)||10
1142217|NCT01005966|2767976|P5|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|13
1142218|NCT01005966|2767977|P4|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
1142219|NCT01005966|2767978|P3|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
1142220|NCT01005966|2767979|P2|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
1142221|NCT01005966|2767980|P1|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
1142222|NCT01005966|2767976|P5|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
1142223|NCT01005966|2767977|P4|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
1142224|NCT01005966|2767978|P3|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
1142225|NCT01005966|2767979|P2|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
1142226|NCT01005966|2767980|P1|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
1142227|NCT01005966|2767976|P5|COMPLETED|Washout Period 3 ( 4 Days)||11
1142228|NCT01005966|2767977|P4|COMPLETED|Washout Period 3 ( 4 Days)||13
1142229|NCT01005966|2767978|P3|COMPLETED|Washout Period 3 ( 4 Days)||12
1142230|NCT01005966|2767979|P2|COMPLETED|Washout Period 3 ( 4 Days)||7
1142231|NCT01005966|2767980|P1|COMPLETED|Washout Period 3 ( 4 Days)||12
1142232|NCT01005966|2767976|P5|STARTED|Washout Period 3 ( 4 Days)||11
1142233|NCT01005966|2767977|P4|STARTED|Washout Period 3 ( 4 Days)||13
1142234|NCT01005966|2767978|P3|STARTED|Washout Period 3 ( 4 Days)||12
1142235|NCT01005966|2767979|P2|STARTED|Washout Period 3 ( 4 Days)||7
1142236|NCT01005966|2767980|P1|STARTED|Washout Period 3 ( 4 Days)||12
1142237|NCT01005966|2767976|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||1
1142238|NCT01005966|2767977|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
1142239|NCT01005966|2767978|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||0
1142240|NCT01005966|2767979|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||1
1142241|NCT01005966|2767980|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
1142242|NCT01005966|2767976|P5|COMPLETED|Treatment Period 3 (14 Days)||11
1142243|NCT01005966|2767977|P4|COMPLETED|Treatment Period 3 (14 Days)||13
1142244|NCT01005966|2767978|P3|COMPLETED|Treatment Period 3 (14 Days)||12
1142245|NCT01005966|2767979|P2|COMPLETED|Treatment Period 3 (14 Days)||7
1142246|NCT01005966|2767980|P1|COMPLETED|Treatment Period 3 (14 Days)||12
1142247|NCT01005966|2767976|P5|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
1142248|NCT01005966|2767977|P4|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|13
1142249|NCT01005966|2767978|P3|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
1142250|NCT01005966|2767979|P2|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|8
1142251|NCT01005966|2767980|P1|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
1142252|NCT01005966|2767976|P5|NOT COMPLETED|Washout Period 2 (4 Days)||0
1142253|NCT01005966|2767977|P4|NOT COMPLETED|Washout Period 2 (4 Days)||0
1142254|NCT01005966|2767978|P3|NOT COMPLETED|Washout Period 2 (4 Days)||0
1142255|NCT01005966|2767979|P2|NOT COMPLETED|Washout Period 2 (4 Days)||0
1142256|NCT01005966|2767980|P1|NOT COMPLETED|Washout Period 2 (4 Days)||0
1142257|NCT01005966|2767976|P5|COMPLETED|Washout Period 2 (4 Days)||11
1142258|NCT01005966|2767977|P4|COMPLETED|Washout Period 2 (4 Days)||11
1142259|NCT01005966|2767978|P3|COMPLETED|Washout Period 2 (4 Days)||10
1142260|NCT01005966|2767979|P2|COMPLETED|Washout Period 2 (4 Days)||12
1142261|NCT01005966|2767980|P1|COMPLETED|Washout Period 2 (4 Days)||13
1142262|NCT01005966|2767976|P5|STARTED|Washout Period 2 (4 Days)||11
1142263|NCT01005966|2767977|P4|STARTED|Washout Period 2 (4 Days)||11
1142264|NCT01005966|2767978|P3|STARTED|Washout Period 2 (4 Days)||10
1142265|NCT01005966|2767979|P2|STARTED|Washout Period 2 (4 Days)||12
1142266|NCT01005966|2767980|P1|STARTED|Washout Period 2 (4 Days)||13
1142267|NCT01005966|2767976|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
1142268|NCT01005966|2767977|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
1142269|NCT01005966|2767978|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||2
1142270|NCT01005966|2767979|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
1142271|NCT01005966|2767980|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
1142272|NCT01005966|2767976|P5|COMPLETED|Treatment Period 2 (14 Days)||11
1142273|NCT01005966|2767977|P4|COMPLETED|Treatment Period 2 (14 Days)||11
1142274|NCT01005966|2767978|P3|COMPLETED|Treatment Period 2 (14 Days)||10
1142275|NCT01005966|2767979|P2|COMPLETED|Treatment Period 2 (14 Days)||12
1142276|NCT01005966|2767980|P1|COMPLETED|Treatment Period 2 (14 Days)||13
1142277|NCT01005966|2767976|P5|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
1142278|NCT01005966|2767977|P4|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
1142279|NCT01005966|2767978|P3|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
1142280|NCT01005966|2767979|P2|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
1142281|NCT01005966|2767980|P1|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
1142282|NCT01005966|2767976|P5|NOT COMPLETED|Washout Period 1 (4 Days)||0
1142283|NCT01005966|2767977|P4|NOT COMPLETED|Washout Period 1 (4 Days)||1
1142284|NCT01005966|2767978|P3|NOT COMPLETED|Washout Period 1 (4 Days)||0
1142285|NCT01005966|2767979|P2|NOT COMPLETED|Washout Period 1 (4 Days)||0
1142286|NCT01005966|2767980|P1|NOT COMPLETED|Washout Period 1 (4 Days)||0
1142287|NCT01005966|2767976|P5|COMPLETED|Washout Period 1 (4 Days)||13
1142288|NCT01005966|2767977|P4|COMPLETED|Washout Period 1 (4 Days)||12
1142289|NCT01005966|2767978|P3|COMPLETED|Washout Period 1 (4 Days)||12
1142290|NCT01005966|2767979|P2|COMPLETED|Washout Period 1 (4 Days)||13
1142291|NCT01005966|2767980|P1|COMPLETED|Washout Period 1 (4 Days)||11
1142292|NCT01005966|2767976|P5|STARTED|Washout Period 1 (4 Days)||13
1142293|NCT01005966|2767977|P4|STARTED|Washout Period 1 (4 Days)||13
1142294|NCT01005966|2767978|P3|STARTED|Washout Period 1 (4 Days)||12
1142295|NCT01005966|2767979|P2|STARTED|Washout Period 1 (4 Days)||13
1142296|NCT01005966|2767980|P1|STARTED|Washout Period 1 (4 Days)||11
1142297|NCT01005966|2767976|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||0
1142298|NCT01005966|2767977|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||0
1142299|NCT01005966|2767978|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||1
1142300|NCT01005966|2767979|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||0
1142301|NCT01005966|2767980|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
1142302|NCT01005966|2767976|P5|COMPLETED|Treatment Period 1 (14 Days)||13
1142303|NCT01005966|2767977|P4|COMPLETED|Treatment Period 1 (14 Days)||13
1142304|NCT01005966|2767978|P3|COMPLETED|Treatment Period 1 (14 Days)||12
1142305|NCT01005966|2767979|P2|COMPLETED|Treatment Period 1 (14 Days)||13
1142306|NCT01005966|2767980|P1|COMPLETED|Treatment Period 1 (14 Days)||11
1142307|NCT01005966|2767976|P5|STARTED|Treatment Period 1 (14 Days)||13
1142308|NCT01005966|2767977|P4|STARTED|Treatment Period 1 (14 Days)||13
1142309|NCT01005966|2767978|P3|STARTED|Treatment Period 1 (14 Days)||13
1142310|NCT01005966|2767979|P2|STARTED|Treatment Period 1 (14 Days)||13
1142311|NCT01005966|2767980|P1|STARTED|Treatment Period 1 (14 Days)||13
1142312|NCT01001975|2768002|P2|NOT COMPLETED|Overall Study||0
1142313|NCT01001975|2768003|P1|NOT COMPLETED|Overall Study||0
1142314|NCT01001975|2768002|P2|COMPLETED|Overall Study||5
1142315|NCT01001975|2768003|P1|COMPLETED|Overall Study||5
1142316|NCT01001975|2768002|P2|STARTED|Overall Study||5
1142317|NCT01001975|2768003|P1|STARTED|Overall Study||5
1142318|NCT00996307|2768015|P4|NOT COMPLETED|Overall Study||21
1142319|NCT00996307|2768016|P3|NOT COMPLETED|Overall Study||14
1142320|NCT00996307|2768017|P2|NOT COMPLETED|Overall Study||17
1142321|NCT00996307|2768018|P1|NOT COMPLETED|Overall Study||20
1142322|NCT00996307|2768015|P4|COMPLETED|Overall Study||144
1142323|NCT00996307|2768016|P3|COMPLETED|Overall Study||146
1142324|NCT00996307|2768017|P2|COMPLETED|Overall Study||148
1142325|NCT00996307|2768018|P1|COMPLETED|Overall Study||144
1142326|NCT00996307|2768015|P4|STARTED|Overall Study||165
1142327|NCT00996307|2768016|P3|STARTED|Overall Study||160
1142328|NCT00996307|2768017|P2|STARTED|Overall Study||165
1142329|NCT00996307|2768018|P1|STARTED|Overall Study||164
1142330|NCT00996281|2768078|P2|NOT COMPLETED|Overall Study||89
1142331|NCT00996281|2768079|P1|NOT COMPLETED|Overall Study||131
1142332|NCT00996281|2768078|P2|COMPLETED|Overall Study||330
1142333|NCT00996281|2768079|P1|COMPLETED|Overall Study||287
1142334|NCT00996281|2768078|P2|STARTED|Overall Study||419
1142335|NCT00996281|2768079|P1|STARTED|Overall Study||418
1142336|NCT00995722|2768089|P2|NOT COMPLETED|Overall Study: 36 Weeks||2
1142337|NCT00995722|2768090|P1|NOT COMPLETED|Overall Study: 36 Weeks||2
1142338|NCT00995722|2768089|P2|COMPLETED|Overall Study: 36 Weeks||2
1142339|NCT00995722|2768090|P1|COMPLETED|Overall Study: 36 Weeks||3
1142340|NCT00995722|2768089|P2|STARTED|Overall Study: 36 Weeks||4
1142341|NCT00995722|2768090|P1|STARTED|Overall Study: 36 Weeks||5
1142342|NCT00995722|2768089|P2|NOT COMPLETED|Double Blinded: 16 Weeks||1
1142343|NCT00995722|2768090|P1|NOT COMPLETED|Double Blinded: 16 Weeks||1
1142344|NCT00995722|2768089|P2|COMPLETED|Double Blinded: 16 Weeks||4
1142345|NCT00995722|2768090|P1|COMPLETED|Double Blinded: 16 Weeks||5
1142346|NCT00995722|2768089|P2|STARTED|Double Blinded: 16 Weeks||5
1142347|NCT00995722|2768090|P1|STARTED|Double Blinded: 16 Weeks||6
1142396|NCT00984659|2768153|P4|NOT COMPLETED|6-week Double-blind Treatment Period||13
1142397|NCT00984659|2768154|P3|NOT COMPLETED|6-week Double-blind Treatment Period||11
1142398|NCT00984659|2768155|P2|NOT COMPLETED|6-week Double-blind Treatment Period||6
1142399|NCT00984659|2768156|P1|NOT COMPLETED|6-week Double-blind Treatment Period||0
1142400|NCT00984659|2768153|P4|COMPLETED|6-week Double-blind Treatment Period||126
1142401|NCT00984659|2768154|P3|COMPLETED|6-week Double-blind Treatment Period||141
1142402|NCT00984659|2768155|P2|COMPLETED|6-week Double-blind Treatment Period||69
1142403|NCT00984659|2768156|P1|COMPLETED|6-week Double-blind Treatment Period||0
1142404|NCT00984659|2768153|P4|STARTED|6-week Double-blind Treatment Period||139
1142405|NCT00984659|2768154|P3|STARTED|6-week Double-blind Treatment Period||152
1142406|NCT00984659|2768155|P2|STARTED|6-week Double-blind Treatment Period||75
1142407|NCT00984659|2768156|P1|STARTED|6-week Double-blind Treatment Period||0
1142408|NCT00984659|2768153|P4|NOT COMPLETED|2-week Run-in Period||0
1142409|NCT00984659|2768154|P3|NOT COMPLETED|2-week Run-in Period||0
1142410|NCT00984659|2768155|P2|NOT COMPLETED|2-week Run-in Period||0
1142411|NCT00984659|2768156|P1|NOT COMPLETED|2-week Run-in Period||52
1142412|NCT00984659|2768153|P4|COMPLETED|2-week Run-in Period||0
1142413|NCT00984659|2768154|P3|COMPLETED|2-week Run-in Period||0
1142414|NCT00984659|2768155|P2|COMPLETED|2-week Run-in Period||0
1142415|NCT00984659|2768156|P1|COMPLETED|2-week Run-in Period||366
1142416|NCT00984659|2768153|P4|STARTED|2-week Run-in Period||0
1142417|NCT00984659|2768154|P3|STARTED|2-week Run-in Period||0
1142418|NCT00984659|2768155|P2|STARTED|2-week Run-in Period||0
1142419|NCT00984659|2768156|P1|STARTED|2-week Run-in Period||418
1142420|NCT00976248|2768181|P1|NOT COMPLETED|Overall Study||0
1142421|NCT00976248|2768181|P1|COMPLETED|Overall Study||33
1142422|NCT00976248|2768181|P1|STARTED|Overall Study||33
1142423|NCT00973479|2768189|P2|NOT COMPLETED|Overall Study||69
1142424|NCT00973479|2768190|P1|NOT COMPLETED|Overall Study||37
1142425|NCT00973479|2768189|P2|COMPLETED|Overall Study||326
1142426|NCT00973479|2768190|P1|COMPLETED|Overall Study||160
1142427|NCT00973479|2768189|P2|STARTED|Overall Study||395
1142428|NCT00973479|2768190|P1|STARTED|Overall Study||197
1142437|NCT00965458|2768221|P2|NOT COMPLETED|Overall Study||4
1142438|NCT00965458|2768222|P1|NOT COMPLETED|Overall Study||2
1142439|NCT00965458|2768221|P2|COMPLETED|Overall Study||12
1142440|NCT00965458|2768222|P1|COMPLETED|Overall Study||31
1142441|NCT00965458|2768221|P2|STARTED|Overall Study||16
1142442|NCT00965458|2768222|P1|STARTED|Overall Study||33
1142443|NCT00952341|2768240|P2|NOT COMPLETED|Cycle 2||12
1142444|NCT00952341|2768241|P1|NOT COMPLETED|Cycle 2||9
1142445|NCT00952341|2768240|P2|COMPLETED|Cycle 2||118
1142446|NCT00952341|2768241|P1|COMPLETED|Cycle 2||101
1142447|NCT00952341|2768240|P2|STARTED|Cycle 2||130
1142448|NCT00952341|2768241|P1|STARTED|Cycle 2||110
1142449|NCT00952341|2768240|P2|NOT COMPLETED|Cycle 1||13
1142450|NCT00952341|2768241|P1|NOT COMPLETED|Cycle 1||20
1142451|NCT00952341|2768240|P2|COMPLETED|Cycle 1||199
1142452|NCT00952341|2768241|P1|COMPLETED|Cycle 1||189
1142453|NCT00952341|2768240|P2|STARTED|Cycle 1||212
1142454|NCT00952341|2768241|P1|STARTED|Cycle 1||209
1142455|NCT00941330|2768263|P2|NOT COMPLETED|Overall Study||2
1142456|NCT00941330|2768264|P1|NOT COMPLETED|Overall Study||1
1142457|NCT00941330|2768263|P2|COMPLETED|Overall Study||9
1142458|NCT00941330|2768264|P1|COMPLETED|Overall Study||14
1142459|NCT00941330|2768263|P2|STARTED|Overall Study||11
1142460|NCT00941330|2768264|P1|STARTED|Overall Study||15
1142464|NCT00909870|2768281|P2|NOT COMPLETED|Overall Study||27
1142465|NCT00909870|2768282|P1|NOT COMPLETED|Overall Study||23
1142466|NCT00909870|2768281|P2|COMPLETED|Overall Study||236
1142467|NCT00909870|2768282|P1|COMPLETED|Overall Study||251
1142468|NCT00909870|2768281|P2|STARTED|Overall Study||263
1142469|NCT00909870|2768282|P1|STARTED|Overall Study||274
1142479|NCT00891839|2768310|P1|NOT COMPLETED|Overall Study||7
1142480|NCT00891839|2768310|P1|COMPLETED|Overall Study|completed treatment|38
1142481|NCT00891839|2768310|P1|STARTED|Overall Study||45
1142482|NCT00887510|2768321|P2|NOT COMPLETED|Overall Study||0
1142483|NCT00887510|2768322|P1|NOT COMPLETED|Overall Study||0
1142484|NCT00887510|2768321|P2|COMPLETED|Overall Study||12
1142485|NCT00887510|2768322|P1|COMPLETED|Overall Study||12
1142486|NCT00887510|2768321|P2|STARTED|Overall Study||12
1142487|NCT00887510|2768322|P1|STARTED|Overall Study||12
1142488|NCT00882557|2768332|P2|NOT COMPLETED|Overall Study||1
1142489|NCT00882557|2768333|P1|NOT COMPLETED|Overall Study||2
1142490|NCT00882557|2768332|P2|COMPLETED|Overall Study||7
1142491|NCT00882557|2768333|P1|COMPLETED|Overall Study||6
1142492|NCT00882557|2768332|P2|Completed Dose 2|Overall Study||7
1142493|NCT00882557|2768333|P1|Completed Dose 2|Overall Study||6
1142494|NCT00882557|2768332|P2|Completed Dose 1|Overall Study||7
1142495|NCT00882557|2768333|P1|Completed Dose 1|Overall Study||8
1142496|NCT00882557|2768332|P2|STARTED|Overall Study||8
1142497|NCT00882557|2768333|P1|STARTED|Overall Study||8
1142498|NCT00880698|2768355|P4|NOT COMPLETED|Overall Study||3
1142499|NCT00880698|2768356|P3|NOT COMPLETED|Overall Study||1
1142500|NCT00880698|2768357|P2|NOT COMPLETED|Overall Study||3
1142501|NCT00880698|2768358|P1|NOT COMPLETED|Overall Study||1
1142502|NCT00880698|2768355|P4|COMPLETED|Overall Study||36
1142503|NCT00880698|2768356|P3|COMPLETED|Overall Study||36
1142504|NCT00880698|2768357|P2|COMPLETED|Overall Study||61
1142505|NCT00880698|2768358|P1|COMPLETED|Overall Study||61
1142506|NCT00880698|2768355|P4|STARTED|Overall Study||39
1142507|NCT00880698|2768356|P3|STARTED|Overall Study||37
1142508|NCT00880698|2768357|P2|STARTED|Overall Study||64
1142509|NCT00880698|2768358|P1|STARTED|Overall Study||62
1142519|NCT00874120|2768447|P2|NOT COMPLETED|Second Intervention||0
1142520|NCT00874120|2768448|P1|NOT COMPLETED|Second Intervention||2
1142521|NCT00874120|2768447|P2|COMPLETED|Second Intervention||56
1142522|NCT00874120|2768448|P1|COMPLETED|Second Intervention||50
1142523|NCT00874120|2768447|P2|STARTED|Second Intervention||56
1142524|NCT00874120|2768448|P1|STARTED|Second Intervention||52
1142525|NCT00874120|2768447|P2|NOT COMPLETED|Wash-out Period||0
1142526|NCT00874120|2768448|P1|NOT COMPLETED|Wash-out Period||0
1142527|NCT00874120|2768447|P2|COMPLETED|Wash-out Period||56
1142528|NCT00874120|2768448|P1|COMPLETED|Wash-out Period||52
1142529|NCT00874120|2768447|P2|STARTED|Wash-out Period||56
1142530|NCT00874120|2768448|P1|STARTED|Wash-out Period||52
1142531|NCT00874120|2768447|P2|NOT COMPLETED|First Intervention||2
1142532|NCT00874120|2768448|P1|NOT COMPLETED|First Intervention||6
1142533|NCT00874120|2768447|P2|COMPLETED|First Intervention||56
1142534|NCT00874120|2768448|P1|COMPLETED|First Intervention||52
1142535|NCT00874120|2768447|P2|STARTED|First Intervention||58
1142536|NCT00874120|2768448|P1|STARTED|First Intervention||58
1142537|NCT00868140|2768456|P2|NOT COMPLETED|Overall Study||0
1142538|NCT00868140|2768457|P1|NOT COMPLETED|Overall Study||0
1142539|NCT00868140|2768456|P2|COMPLETED|Overall Study||25
1142540|NCT00868140|2768457|P1|COMPLETED|Overall Study||26
1142541|NCT00868140|2768456|P2|STARTED|Overall Study||25
1142542|NCT00868140|2768457|P1|STARTED|Overall Study||26
1142543|NCT00856284|2768476|P3|NOT COMPLETED|Overall Study||447
1142544|NCT00856284|2768477|P2|NOT COMPLETED|Overall Study||392
1142545|NCT00856284|2768478|P1|NOT COMPLETED|Overall Study||408
1142546|NCT00856284|2768476|P3|COMPLETED|Overall Study||427
1142547|NCT00856284|2768477|P2|COMPLETED|Overall Study||493
1142548|NCT00856284|2768478|P1|COMPLETED|Overall Study||472
1142549|NCT00856284|2768476|P3|Received Study Drug|Overall Study||869
1142550|NCT00856284|2768477|P2|Received Study Drug|Overall Study||878
1142551|NCT00856284|2768478|P1|Received Study Drug|Overall Study||873
1142552|NCT00856284|2768476|P3|STARTED|Overall Study||874
1142553|NCT00856284|2768477|P2|STARTED|Overall Study||885
1142554|NCT00856284|2768478|P1|STARTED|Overall Study||880
1142555|NCT00847912|2768506|P2|NOT COMPLETED|Overall Study||13
1142556|NCT00847912|2768507|P1|NOT COMPLETED|Overall Study||9
1142557|NCT00847912|2768506|P2|COMPLETED|Overall Study||464
1142558|NCT00847912|2768507|P1|COMPLETED|Overall Study||468
1142559|NCT00847912|2768506|P2|STARTED|Overall Study||477
1142560|NCT00847912|2768507|P1|STARTED|Overall Study||477
1142561|NCT00837434|2768517|P2|NOT COMPLETED|Overall Study||1
1142562|NCT00837434|2768518|P1|NOT COMPLETED|Overall Study||9
1142563|NCT00837434|2768517|P2|COMPLETED|Overall Study||19
1142564|NCT00837434|2768518|P1|COMPLETED|Overall Study||34
1142565|NCT00837434|2768517|P2|STARTED|Overall Study||20
1142566|NCT00837434|2768518|P1|STARTED|Overall Study||43
1142567|NCT00819390|2768540|P4|NOT COMPLETED|Overall Study||0
1142568|NCT00819390|2768541|P3|NOT COMPLETED|Overall Study||1
1142569|NCT00819390|2768542|P2|NOT COMPLETED|Overall Study||1
1142570|NCT00819390|2768543|P1|NOT COMPLETED|Overall Study||3
1142571|NCT00819390|2768540|P4|COMPLETED|Overall Study||19
1142572|NCT00819390|2768541|P3|COMPLETED|Overall Study||17
1142573|NCT00819390|2768542|P2|COMPLETED|Overall Study||16
1142574|NCT00819390|2768543|P1|COMPLETED|Overall Study||13
1142575|NCT00819390|2768540|P4|STARTED|Overall Study||19
1142576|NCT00819390|2768541|P3|STARTED|Overall Study||18
1142577|NCT00819390|2768542|P2|STARTED|Overall Study||17
1142578|NCT00819390|2768543|P1|STARTED|Overall Study||16
1142579|NCT00811928|2768655|P2|NOT COMPLETED|Overall Study||33
1142580|NCT00811928|2768656|P1|NOT COMPLETED|Overall Study||39
1142581|NCT00811928|2768655|P2|COMPLETED|Overall Study||90
1142582|NCT00811928|2768656|P1|COMPLETED|Overall Study||90
1142583|NCT00811928|2768655|P2|STARTED|Overall Study||123
1142584|NCT00811928|2768656|P1|STARTED|Overall Study||129
1142585|NCT00808405|2768676|P2|NOT COMPLETED|Overall Study||0
1142586|NCT00808405|2768677|P1|NOT COMPLETED|Overall Study||0
1142587|NCT00808405|2768676|P2|COMPLETED|Overall Study||27
1142588|NCT00808405|2768677|P1|COMPLETED|Overall Study||61
1142589|NCT00808405|2768676|P2|STARTED|Overall Study||27
1142590|NCT00808405|2768677|P1|STARTED|Overall Study||61
1142591|NCT00806351|2768687|P2|NOT COMPLETED|Overall Study||4
1142592|NCT00806351|2768688|P1|NOT COMPLETED|Overall Study||5
1142593|NCT00806351|2768687|P2|COMPLETED|Overall Study||2
1142594|NCT00806351|2768688|P1|COMPLETED|Overall Study||10
1142595|NCT00806351|2768687|P2|STARTED|Overall Study||6
1142596|NCT00806351|2768688|P1|STARTED|Overall Study||15
1142597|NCT00804843|2768721|P2|NOT COMPLETED|Overall Study||7
1142598|NCT00804843|2768722|P1|NOT COMPLETED|Overall Study||10
1142599|NCT00804843|2768721|P2|COMPLETED|Overall Study||43
1142600|NCT00804843|2768722|P1|COMPLETED|Overall Study||40
1142601|NCT00804843|2768721|P2|STARTED|Overall Study||50
1142602|NCT00804843|2768722|P1|STARTED|Overall Study||50
1142603|NCT00804609|2768734|P2|NOT COMPLETED|Overall Study||1
1142604|NCT00804609|2768735|P1|NOT COMPLETED|Overall Study||0
1142605|NCT00804609|2768734|P2|COMPLETED|Overall Study||14
1142606|NCT00804609|2768735|P1|COMPLETED|Overall Study||15
1142607|NCT00804609|2768734|P2|STARTED|Overall Study||15
1142608|NCT00804609|2768735|P1|STARTED|Overall Study||15
1142609|NCT00799617|2768743|P2|NOT COMPLETED|Anemia Trial||3
1142610|NCT00799617|2768744|P1|NOT COMPLETED|Anemia Trial||3
1142611|NCT00799617|2768743|P2|COMPLETED|Anemia Trial||32
1142612|NCT00799617|2768744|P1|COMPLETED|Anemia Trial||24
1142613|NCT00799617|2768743|P2|STARTED|Anemia Trial||35
1142614|NCT00799617|2768744|P1|STARTED|Anemia Trial||27
1142615|NCT00799617|2768743|P2|NOT COMPLETED|Cognitive Function Trial||1
1142616|NCT00799617|2768744|P1|NOT COMPLETED|Cognitive Function Trial||0
1142617|NCT00799617|2768743|P2|COMPLETED|Cognitive Function Trial||245
1142618|NCT00799617|2768744|P1|COMPLETED|Cognitive Function Trial||247
1142619|NCT00799617|2768743|P2|STARTED|Cognitive Function Trial||246
1142620|NCT00799617|2768744|P1|STARTED|Cognitive Function Trial||247
1142621|NCT00799617|2768743|P2|NOT COMPLETED|Bone Trial||16
1142622|NCT00799617|2768744|P1|NOT COMPLETED|Bone Trial||6
1142623|NCT00799617|2768743|P2|COMPLETED|Bone Trial||85
1142624|NCT00799617|2768744|P1|COMPLETED|Bone Trial||104
1142625|NCT00799617|2768743|P2|STARTED|Bone Trial||101
1142626|NCT00799617|2768744|P1|STARTED|Bone Trial||110
1142627|NCT00799617|2768743|P2|NOT COMPLETED|Cardiovascular Trial||17
1142628|NCT00799617|2768744|P1|NOT COMPLETED|Cardiovascular Trial||15
1142629|NCT00799617|2768743|P2|COMPLETED|Cardiovascular Trial||65
1142630|NCT00799617|2768744|P1|COMPLETED|Cardiovascular Trial||73
1142631|NCT00799617|2768743|P2|STARTED|Cardiovascular Trial||82
1142632|NCT00799617|2768744|P1|STARTED|Cardiovascular Trial||88
1142633|NCT00799617|2768743|P2|NOT COMPLETED|Vitality Trial||22
1142634|NCT00799617|2768744|P1|NOT COMPLETED|Vitality Trial||7
1142635|NCT00799617|2768743|P2|COMPLETED|Vitality Trial||216
1142636|NCT00799617|2768744|P1|COMPLETED|Vitality Trial||229
1142637|NCT00799617|2768743|P2|STARTED|Vitality Trial||238
1142638|NCT00799617|2768744|P1|STARTED|Vitality Trial||236
1142639|NCT00799617|2768743|P2|NOT COMPLETED|Physical Function Trial||11
1142640|NCT00799617|2768744|P1|NOT COMPLETED|Physical Function Trial||6
1142641|NCT00799617|2768743|P2|COMPLETED|Physical Function Trial||185
1142642|NCT00799617|2768744|P1|COMPLETED|Physical Function Trial||185
1142643|NCT00799617|2768743|P2|STARTED|Physical Function Trial||196
1142644|NCT00799617|2768744|P1|STARTED|Physical Function Trial||191
1142645|NCT00799617|2768743|P2|NOT COMPLETED|Sexual Funtion Trial||21
1142646|NCT00799617|2768744|P1|NOT COMPLETED|Sexual Funtion Trial||16
1142647|NCT00799617|2768743|P2|COMPLETED|Sexual Funtion Trial||215
1142648|NCT00799617|2768744|P1|COMPLETED|Sexual Funtion Trial||218
1142649|NCT00799617|2768743|P2|STARTED|Sexual Funtion Trial||236
1142650|NCT00799617|2768744|P1|STARTED|Sexual Funtion Trial||234
1142651|NCT00799617|2768743|P2|NOT COMPLETED|Main Testosterone Trial||21
1142652|NCT00799617|2768744|P1|NOT COMPLETED|Main Testosterone Trial||19
1142653|NCT00799617|2768743|P2|COMPLETED|Main Testosterone Trial||374
1142654|NCT00799617|2768744|P1|COMPLETED|Main Testosterone Trial|Participants qualified for 1 of the 3 main trials (sexual function, physical function, vitality).|376
1142655|NCT00799617|2768743|P2|STARTED|Main Testosterone Trial||395
1142656|NCT00799617|2768744|P1|STARTED|Main Testosterone Trial||395
1142657|NCT00793780|2768824|P2|NOT COMPLETED|Overall Study||1
1142658|NCT00793780|2768825|P1|NOT COMPLETED|Overall Study||2
1142659|NCT00793780|2768824|P2|COMPLETED|Overall Study||11
1142660|NCT00793780|2768825|P1|COMPLETED|Overall Study||10
1142661|NCT00793780|2768824|P2|Collected Baseline Data|Overall Study||12
1142662|NCT00793780|2768825|P1|Collected Baseline Data|Overall Study||11
1142663|NCT00793780|2768824|P2|Randomization|Overall Study||12
1142664|NCT00793780|2768825|P1|Randomization|Overall Study||12
1142665|NCT00793780|2768824|P2|STARTED|Overall Study||12
1142666|NCT00793780|2768825|P1|STARTED|Overall Study||12
1142667|NCT00783263|2768845|P4|NOT COMPLETED|Overall Study||3
1142668|NCT00783263|2768846|P3|NOT COMPLETED|Overall Study||3
1142669|NCT00783263|2768847|P2|NOT COMPLETED|Overall Study||2
1142670|NCT00783263|2768848|P1|NOT COMPLETED|Overall Study||4
1142671|NCT00783263|2768845|P4|COMPLETED|Overall Study||118
1142672|NCT00783263|2768846|P3|COMPLETED|Overall Study||119
1142673|NCT00783263|2768847|P2|COMPLETED|Overall Study||96
1142674|NCT00783263|2768848|P1|COMPLETED|Overall Study||95
1142675|NCT00783263|2768845|P4|STARTED|Overall Study||121
1142676|NCT00783263|2768846|P3|STARTED|Overall Study||122
1142677|NCT00783263|2768847|P2|STARTED|Overall Study||98
1142678|NCT00783263|2768848|P1|STARTED|Overall Study||99
1142679|NCT00771667|2768878|P10|NOT COMPLETED|Maintenance Phase||17
1142680|NCT00771667|2768879|P9|NOT COMPLETED|Maintenance Phase||22
1142681|NCT00771667|2768880|P8|NOT COMPLETED|Maintenance Phase||5
1142682|NCT00771667|2768881|P7|NOT COMPLETED|Maintenance Phase||10
1142683|NCT00771667|2768882|P6|NOT COMPLETED|Maintenance Phase||7
1142684|NCT00771667|2768883|P5|NOT COMPLETED|Maintenance Phase||2
1142685|NCT00771667|2768884|P4|NOT COMPLETED|Maintenance Phase||0
1142686|NCT00771667|2768885|P3|NOT COMPLETED|Maintenance Phase||0
1142687|NCT00771667|2768886|P2|NOT COMPLETED|Maintenance Phase||0
1142688|NCT00771667|2768887|P1|NOT COMPLETED|Maintenance Phase||0
1142689|NCT00771667|2768878|P10|COMPLETED|Maintenance Phase||92
1142690|NCT00771667|2768879|P9|COMPLETED|Maintenance Phase||88
1142691|NCT00771667|2768880|P8|COMPLETED|Maintenance Phase||67
1142692|NCT00771667|2768881|P7|COMPLETED|Maintenance Phase||63
1142693|NCT00771667|2768882|P6|COMPLETED|Maintenance Phase||78
1142694|NCT00771667|2768883|P5|COMPLETED|Maintenance Phase||26
1142695|NCT00771667|2768884|P4|COMPLETED|Maintenance Phase||0
1142696|NCT00771667|2768885|P3|COMPLETED|Maintenance Phase||0
1142697|NCT00771667|2768886|P2|COMPLETED|Maintenance Phase||0
1142698|NCT00771667|2768887|P1|COMPLETED|Maintenance Phase||0
1142699|NCT00771667|2768878|P10|STARTED|Maintenance Phase||109
1142700|NCT00771667|2768879|P9|STARTED|Maintenance Phase||110
1142701|NCT00771667|2768880|P8|STARTED|Maintenance Phase||72
1142702|NCT00771667|2768881|P7|STARTED|Maintenance Phase||73
1142703|NCT00771667|2768882|P6|STARTED|Maintenance Phase||85
1142704|NCT00771667|2768883|P5|STARTED|Maintenance Phase||28
1142705|NCT00771667|2768884|P4|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
1142706|NCT00771667|2768885|P3|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
1142707|NCT00771667|2768886|P2|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
1142708|NCT00771667|2768887|P1|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
1142709|NCT00771667|2768878|P10|NOT COMPLETED|Induction Phase||0
1142710|NCT00771667|2768879|P9|NOT COMPLETED|Induction Phase||0
1142711|NCT00771667|2768880|P8|NOT COMPLETED|Induction Phase||0
1142712|NCT00771667|2768881|P7|NOT COMPLETED|Induction Phase||0
1142713|NCT00771667|2768882|P6|NOT COMPLETED|Induction Phase||0
1142714|NCT00771667|2768883|P5|NOT COMPLETED|Induction Phase||0
1142715|NCT00771667|2768884|P4|NOT COMPLETED|Induction Phase||8
1142716|NCT00771667|2768885|P3|NOT COMPLETED|Induction Phase||12
1142717|NCT00771667|2768886|P2|NOT COMPLETED|Induction Phase||10
1142718|NCT00771667|2768887|P1|NOT COMPLETED|Induction Phase||19
1142719|NCT00771667|2768878|P10|COMPLETED|Induction Phase||0
1142720|NCT00771667|2768879|P9|COMPLETED|Induction Phase||0
1142721|NCT00771667|2768880|P8|COMPLETED|Induction Phase||0
1142722|NCT00771667|2768881|P7|COMPLETED|Induction Phase||0
1142723|NCT00771667|2768882|P6|COMPLETED|Induction Phase||0
1142724|NCT00771667|2768883|P5|COMPLETED|Induction Phase||0
1142725|NCT00771667|2768884|P4|COMPLETED|Induction Phase||123
1142726|NCT00771667|2768885|P3|COMPLETED|Induction Phase||120
1142727|NCT00771667|2768886|P2|COMPLETED|Induction Phase||121
1142728|NCT00771667|2768887|P1|COMPLETED|Induction Phase||113
1142729|NCT00771667|2768878|P10|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
1142730|NCT00771667|2768879|P9|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
1142731|NCT00771667|2768880|P8|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
1142732|NCT00771667|2768881|P7|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
1142733|NCT00771667|2768882|P6|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
1142734|NCT00771667|2768883|P5|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
1142735|NCT00771667|2768884|P4|STARTED|Induction Phase||131
1142736|NCT00771667|2768885|P3|STARTED|Induction Phase||132
1142737|NCT00771667|2768886|P2|STARTED|Induction Phase||131
1142738|NCT00771667|2768887|P1|STARTED|Induction Phase||132
1142739|NCT00770341|2768926|P3|NOT COMPLETED|Overall Study||3
1142740|NCT00770341|2768927|P2|NOT COMPLETED|Overall Study||5
1142741|NCT00770341|2768928|P1|NOT COMPLETED|Overall Study||12
1142742|NCT00770341|2768926|P3|COMPLETED|Overall Study||8
1142743|NCT00770341|2768927|P2|COMPLETED|Overall Study||17
1142744|NCT00770341|2768928|P1|COMPLETED|Overall Study||77
1142745|NCT00770341|2768926|P3|STARTED|Overall Study|Number randomized|11
1142746|NCT00770341|2768927|P2|STARTED|Overall Study|Number randomized|22
1142747|NCT00770341|2768928|P1|STARTED|Overall Study|Number randomized|89
1142748|NCT00761280|2768954|P2|NOT COMPLETED|First Dose to End of Study||11
1142749|NCT00761280|2768955|P1|NOT COMPLETED|First Dose to End of Study||12
1142750|NCT00761280|2768954|P2|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
1142751|NCT00761280|2768955|P1|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
1142752|NCT00761280|2768954|P2|STARTED|First Dose to End of Study||11
1142753|NCT00761280|2768955|P1|STARTED|First Dose to End of Study||12
1142754|NCT00761280|2768954|P2|NOT COMPLETED|Randomization to First Dose||2
1142755|NCT00761280|2768955|P1|NOT COMPLETED|Randomization to First Dose||2
1142756|NCT00761280|2768954|P2|COMPLETED|Randomization to First Dose||11
1142757|NCT00761280|2768955|P1|COMPLETED|Randomization to First Dose||12
1142758|NCT00761280|2768954|P2|First Dose of Study Drug / Chemotherapy|Randomization to First Dose|Safety population|11
1142759|NCT00761280|2768955|P1|First Dose of Study Drug / Chemotherapy|Randomization to First Dose||12
1142760|NCT00761280|2768954|P2|Catheter Surgery|Randomization to First Dose|Not applicable to control group|0
1142761|NCT00761280|2768955|P1|Catheter Surgery|Randomization to First Dose|Safety population|13
1142762|NCT00761280|2768954|P2|STARTED|Randomization to First Dose||13
1142763|NCT00761280|2768955|P1|STARTED|Randomization to First Dose||14
1142764|NCT00759109|2768985|P2|NOT COMPLETED|Overall Study||35
1142765|NCT00759109|2768986|P1|NOT COMPLETED|Overall Study||39
1142766|NCT00759109|2768985|P2|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|41
1142767|NCT00759109|2768986|P1|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|35
1142768|NCT00759109|2768985|P2|STARTED|Overall Study||76
1142769|NCT00759109|2768986|P1|STARTED|Overall Study||74
1142770|NCT00756938|2769005|P4|NOT COMPLETED|Optional Extension||37
1142771|NCT00756938|2769006|P3|NOT COMPLETED|Optional Extension||0
1142772|NCT00756938|2769007|P2|NOT COMPLETED|Optional Extension||0
1142773|NCT00756938|2769008|P1|NOT COMPLETED|Optional Extension||0
1142774|NCT00756938|2769005|P4|COMPLETED|Optional Extension||53
1142775|NCT00756938|2769006|P3|COMPLETED|Optional Extension||0
1142776|NCT00756938|2769007|P2|COMPLETED|Optional Extension||0
1142777|NCT00756938|2769008|P1|COMPLETED|Optional Extension||0
1142778|NCT00756938|2769005|P4|STARTED|Optional Extension|7 participants who completed base study opted not to enter extension|90
1142779|NCT00756938|2769006|P3|STARTED|Optional Extension||0
1142780|NCT00756938|2769007|P2|STARTED|Optional Extension||0
1142781|NCT00756938|2769008|P1|STARTED|Optional Extension||0
1142782|NCT00756938|2769005|P4|NOT COMPLETED|12-week Base Study||0
1142783|NCT00756938|2769006|P3|NOT COMPLETED|12-week Base Study||2
1142784|NCT00756938|2769007|P2|NOT COMPLETED|12-week Base Study||0
1142785|NCT00756938|2769008|P1|NOT COMPLETED|12-week Base Study||2
1142786|NCT00756938|2769005|P4|COMPLETED|12-week Base Study||0
1142787|NCT00756938|2769006|P3|COMPLETED|12-week Base Study||32
1142788|NCT00756938|2769007|P2|COMPLETED|12-week Base Study||34
1142789|NCT00756938|2769008|P1|COMPLETED|12-week Base Study||31
1142790|NCT00756938|2769005|P4|STARTED|12-week Base Study||0
1142791|NCT00756938|2769006|P3|STARTED|12-week Base Study||34
1142792|NCT00756938|2769007|P2|STARTED|12-week Base Study||34
1142793|NCT00756938|2769008|P1|STARTED|12-week Base Study||33
1142794|NCT00755716|2769037|P3|NOT COMPLETED|Overall Study||3
1142795|NCT00755716|2769038|P2|NOT COMPLETED|Overall Study||8
1142796|NCT00755716|2769039|P1|NOT COMPLETED|Overall Study||8
1142797|NCT00755716|2769037|P3|COMPLETED|Overall Study||16
1142798|NCT00755716|2769038|P2|COMPLETED|Overall Study||11
1142799|NCT00755716|2769039|P1|COMPLETED|Overall Study||11
1142800|NCT00755716|2769037|P3|STARTED|Overall Study||19
1142801|NCT00755716|2769038|P2|STARTED|Overall Study||19
1142802|NCT00755716|2769039|P1|STARTED|Overall Study||19
1142803|NCT00752089|2769050|P1|NOT COMPLETED|Overall Study||6
1142804|NCT00752089|2769050|P1|COMPLETED|Overall Study||14
1142805|NCT00752089|2769050|P1|Received Placebo|Overall Study||18
1142806|NCT00752089|2769050|P1|Received NaF|Overall Study||18
1142807|NCT00752089|2769050|P1|Received NaF/KNO3/ 0% Isopentane|Overall Study||17
1142808|NCT00752089|2769050|P1|Received NaF/ KNO3/ 2% Isopentane|Overall Study||19
1142809|NCT00752089|2769050|P1|STARTED|Overall Study||20
1142810|NCT00745823|2769066|P2|NOT COMPLETED|Overall Study||386
1142811|NCT00745823|2769067|P1|NOT COMPLETED|Overall Study||385
1142812|NCT00745823|2769066|P2|COMPLETED|Overall Study||3
1142813|NCT00745823|2769067|P1|COMPLETED|Overall Study||1
1142814|NCT00745823|2769066|P2|TREATED Week 0 - 96|Overall Study||388
1142815|NCT00745823|2769067|P1|TREATED Week 0 - 96|Overall Study||382
1142816|NCT00745823|2769066|P2|STARTED|Overall Study||389
1142817|NCT00745823|2769067|P1|STARTED|Overall Study||386
1142818|NCT00738972|2769095|P4|NOT COMPLETED|Overall Study||1
1142819|NCT00738972|2769096|P3|NOT COMPLETED|Overall Study||0
1142820|NCT00738972|2769097|P2|NOT COMPLETED|Overall Study||0
1142821|NCT00738972|2769098|P1|NOT COMPLETED|Overall Study||0
1142822|NCT00738972|2769095|P4|COMPLETED|Overall Study||2
1142823|NCT00738972|2769096|P3|COMPLETED|Overall Study||3
1142824|NCT00738972|2769097|P2|COMPLETED|Overall Study||3
1142825|NCT00738972|2769098|P1|COMPLETED|Overall Study||3
1142826|NCT00738972|2769095|P4|STARTED|Overall Study||3
1142827|NCT00738972|2769096|P3|STARTED|Overall Study||3
1142828|NCT00738972|2769097|P2|STARTED|Overall Study||3
1142829|NCT00738972|2769098|P1|STARTED|Overall Study||3
1142830|NCT00737672|2769110|P2|NOT COMPLETED|Overall Study||83
1142831|NCT00737672|2769111|P1|NOT COMPLETED|Overall Study||80
1142832|NCT00737672|2769110|P2|COMPLETED|Overall Study||65
1142833|NCT00737672|2769111|P1|COMPLETED|Overall Study||65
1142834|NCT00737672|2769110|P2|Per Protocol Population|Overall Study||138
1142835|NCT00737672|2769111|P1|Per Protocol Population|Overall Study||131
1142836|NCT00737672|2769110|P2|Exclusions Due to Protocol Deviations|Overall Study||10
1142837|NCT00737672|2769111|P1|Exclusions Due to Protocol Deviations|Overall Study||14
1142838|NCT00737672|2769110|P2|STARTED|Overall Study||148
1142839|NCT00737672|2769111|P1|STARTED|Overall Study||145
1142840|NCT00734539|2769149|P2|NOT COMPLETED|Long Term Follow up||31
1142841|NCT00734539|2769150|P1|NOT COMPLETED|Long Term Follow up||34
1142842|NCT00734539|2769149|P2|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|107
1142843|NCT00734539|2769150|P1|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|118
1142844|NCT00734539|2769149|P2|STARTED|Long Term Follow up||138
1142845|NCT00734539|2769150|P1|STARTED|Long Term Follow up||152
1142846|NCT00734539|2769149|P2|NOT COMPLETED|Main Study||35
1142847|NCT00734539|2769150|P1|NOT COMPLETED|Main Study||37
1142848|NCT00734539|2769149|P2|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|138
1142849|NCT00734539|2769150|P1|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|152
1142850|NCT00734539|2769149|P2|STARTED|Main Study||173
1142851|NCT00734539|2769150|P1|STARTED|Main Study||189
1142852|NCT00716976|2769180|P2|NOT COMPLETED|Overall Study||9
1142853|NCT00716976|2769181|P1|NOT COMPLETED|Overall Study||20
1142854|NCT00716976|2769180|P2|COMPLETED|Overall Study||57
1142855|NCT00716976|2769181|P1|COMPLETED|Overall Study||45
1142856|NCT00716976|2769180|P2|STARTED|Overall Study||66
1142857|NCT00716976|2769181|P1|STARTED|Overall Study||65
1142858|NCT00708123|2769201|P5|NOT COMPLETED|Period 5||0
1142859|NCT00708123|2769202|P4|NOT COMPLETED|Period 5||0
1142860|NCT00708123|2769203|P3|NOT COMPLETED|Period 5||0
1142861|NCT00708123|2769204|P2|NOT COMPLETED|Period 5||0
1142862|NCT00708123|2769205|P1|NOT COMPLETED|Period 5||0
1142863|NCT00708123|2769201|P5|COMPLETED|Period 5||10
1142864|NCT00708123|2769202|P4|COMPLETED|Period 5||11
1142865|NCT00708123|2769203|P3|COMPLETED|Period 5||11
1142866|NCT00708123|2769204|P2|COMPLETED|Period 5||10
1142867|NCT00708123|2769205|P1|COMPLETED|Period 5||10
1142868|NCT00708123|2769201|P5|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
1142869|NCT00708123|2769202|P4|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
1142870|NCT00708123|2769203|P3|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
1142871|NCT00708123|2769204|P2|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
1142872|NCT00708123|2769205|P1|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
1142873|NCT00708123|2769201|P5|NOT COMPLETED|Period 4||0
1142874|NCT00708123|2769202|P4|NOT COMPLETED|Period 4||0
1142875|NCT00708123|2769203|P3|NOT COMPLETED|Period 4||0
1142876|NCT00708123|2769204|P2|NOT COMPLETED|Period 4||1
1142877|NCT00708123|2769205|P1|NOT COMPLETED|Period 4||0
1142878|NCT00708123|2769201|P5|COMPLETED|Period 4||11
1142879|NCT00708123|2769202|P4|COMPLETED|Period 4||10
1142880|NCT00708123|2769203|P3|COMPLETED|Period 4||10
1142881|NCT00708123|2769204|P2|COMPLETED|Period 4||11
1142882|NCT00708123|2769205|P1|COMPLETED|Period 4||10
1142883|NCT00708123|2769201|P5|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|11
1142884|NCT00708123|2769202|P4|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
1142885|NCT00708123|2769203|P3|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
1142886|NCT00708123|2769204|P2|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
1142887|NCT00708123|2769205|P1|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
1142888|NCT00708123|2769201|P5|NOT COMPLETED|Period 3||0
1142889|NCT00708123|2769202|P4|NOT COMPLETED|Period 3||1
1142890|NCT00708123|2769203|P3|NOT COMPLETED|Period 3||1
1142891|NCT00708123|2769204|P2|NOT COMPLETED|Period 3||0
1142892|NCT00708123|2769205|P1|NOT COMPLETED|Period 3||0
1142893|NCT00708123|2769201|P5|COMPLETED|Period 3||10
1142894|NCT00708123|2769202|P4|COMPLETED|Period 3||11
1142895|NCT00708123|2769203|P3|COMPLETED|Period 3||10
1142896|NCT00708123|2769204|P2|COMPLETED|Period 3||10
1142897|NCT00708123|2769205|P1|COMPLETED|Period 3||12
1142898|NCT00708123|2769201|P5|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
1142899|NCT00708123|2769202|P4|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
1142900|NCT00708123|2769203|P3|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|11
1142901|NCT00708123|2769204|P2|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
1142902|NCT00708123|2769205|P1|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
1142903|NCT00708123|2769201|P5|NOT COMPLETED|Period 2||0
1142904|NCT00708123|2769202|P4|NOT COMPLETED|Period 2||1
1142905|NCT00708123|2769203|P3|NOT COMPLETED|Period 2||0
1142906|NCT00708123|2769204|P2|NOT COMPLETED|Period 2||0
1142907|NCT00708123|2769205|P1|NOT COMPLETED|Period 2||1
1142908|NCT00708123|2769201|P5|COMPLETED|Period 2||11
1142909|NCT00708123|2769202|P4|COMPLETED|Period 2||10
1142910|NCT00708123|2769203|P3|COMPLETED|Period 2||12
1142911|NCT00708123|2769204|P2|COMPLETED|Period 2||12
1142912|NCT00708123|2769205|P1|COMPLETED|Period 2||10
1142913|NCT00708123|2769201|P5|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
1142914|NCT00708123|2769202|P4|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
1142915|NCT00708123|2769203|P3|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
1142916|NCT00708123|2769204|P2|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
1142917|NCT00708123|2769205|P1|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
1142918|NCT00708123|2769201|P5|NOT COMPLETED|Period 1||0
1142919|NCT00708123|2769202|P4|NOT COMPLETED|Period 1||1
1142920|NCT00708123|2769203|P3|NOT COMPLETED|Period 1||1
1142921|NCT00708123|2769204|P2|NOT COMPLETED|Period 1||1
1142922|NCT00708123|2769205|P1|NOT COMPLETED|Period 1||0
1142923|NCT00708123|2769201|P5|COMPLETED|Period 1||12
1142924|NCT00708123|2769202|P4|COMPLETED|Period 1||11
1142925|NCT00708123|2769203|P3|COMPLETED|Period 1||11
1142926|NCT00708123|2769204|P2|COMPLETED|Period 1||11
1142927|NCT00708123|2769205|P1|COMPLETED|Period 1||12
1142928|NCT00708123|2769201|P5|STARTED|Period 1||12
1142929|NCT00708123|2769202|P4|STARTED|Period 1||12
1142930|NCT00708123|2769203|P3|STARTED|Period 1||12
1142931|NCT00708123|2769204|P2|STARTED|Period 1||12
1142932|NCT00708123|2769205|P1|STARTED|Period 1||12
1142933|NCT00708097|2769225|P5|NOT COMPLETED|Period 5||0
1142934|NCT00708097|2769226|P4|NOT COMPLETED|Period 5||0
1142935|NCT00708097|2769227|P3|NOT COMPLETED|Period 5||0
1142936|NCT00708097|2769228|P2|NOT COMPLETED|Period 5||0
1142937|NCT00708097|2769229|P1|NOT COMPLETED|Period 5||0
1142938|NCT00708097|2769225|P5|COMPLETED|Period 5||12
1142939|NCT00708097|2769226|P4|COMPLETED|Period 5||10
1142940|NCT00708097|2769227|P3|COMPLETED|Period 5||11
1142941|NCT00708097|2769228|P2|COMPLETED|Period 5||9
1142942|NCT00708097|2769229|P1|COMPLETED|Period 5||8
1142943|NCT00708097|2769225|P5|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|12
1142944|NCT00708097|2769226|P4|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|10
1142945|NCT00708097|2769227|P3|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|11
1142946|NCT00708097|2769228|P2|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|9
1142947|NCT00708097|2769229|P1|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|8
1142948|NCT00708097|2769225|P5|NOT COMPLETED|Period 4||0
1142949|NCT00708097|2769226|P4|NOT COMPLETED|Period 4||0
1142950|NCT00708097|2769227|P3|NOT COMPLETED|Period 4||0
1142951|NCT00708097|2769228|P2|NOT COMPLETED|Period 4||0
1142952|NCT00708097|2769229|P1|NOT COMPLETED|Period 4||0
1142953|NCT00708097|2769225|P5|COMPLETED|Period 4||8
1142954|NCT00708097|2769226|P4|COMPLETED|Period 4||11
1142955|NCT00708097|2769227|P3|COMPLETED|Period 4||10
1142956|NCT00708097|2769228|P2|COMPLETED|Period 4||9
1142957|NCT00708097|2769229|P1|COMPLETED|Period 4||12
1143033|NCT00708305|2769260|P3|NOT COMPLETED|Period 2||0
1142958|NCT00708097|2769225|P5|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|8
1142959|NCT00708097|2769226|P4|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|11
1142960|NCT00708097|2769227|P3|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|10
1142961|NCT00708097|2769228|P2|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|9
1142962|NCT00708097|2769229|P1|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|12
1142963|NCT00708097|2769225|P5|NOT COMPLETED|Period 3||0
1142964|NCT00708097|2769226|P4|NOT COMPLETED|Period 3||0
1142965|NCT00708097|2769227|P3|NOT COMPLETED|Period 3||0
1142966|NCT00708097|2769228|P2|NOT COMPLETED|Period 3||0
1142967|NCT00708097|2769229|P1|NOT COMPLETED|Period 3||0
1142968|NCT00708097|2769225|P5|COMPLETED|Period 3||10
1142969|NCT00708097|2769226|P4|COMPLETED|Period 3||10
1142970|NCT00708097|2769227|P3|COMPLETED|Period 3||10
1142971|NCT00708097|2769228|P2|COMPLETED|Period 3||11
1142972|NCT00708097|2769229|P1|COMPLETED|Period 3||9
1142973|NCT00708097|2769225|P5|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
1142974|NCT00708097|2769226|P4|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
1142975|NCT00708097|2769227|P3|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
1142976|NCT00708097|2769228|P2|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|11
1142977|NCT00708097|2769229|P1|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|9
1142978|NCT00708097|2769225|P5|NOT COMPLETED|Period 2||0
1142979|NCT00708097|2769226|P4|NOT COMPLETED|Period 2||1
1142980|NCT00708097|2769227|P3|NOT COMPLETED|Period 2||1
1142981|NCT00708097|2769228|P2|NOT COMPLETED|Period 2||1
1142982|NCT00708097|2769229|P1|NOT COMPLETED|Period 2||0
1142983|NCT00708097|2769225|P5|COMPLETED|Period 2||10
1142984|NCT00708097|2769226|P4|COMPLETED|Period 2||10
1142985|NCT00708097|2769227|P3|COMPLETED|Period 2||9
1142986|NCT00708097|2769228|P2|COMPLETED|Period 2||11
1142987|NCT00708097|2769229|P1|COMPLETED|Period 2||10
1142988|NCT00708097|2769225|P5|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
1142989|NCT00708097|2769226|P4|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|11
1142990|NCT00708097|2769227|P3|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
1142991|NCT00708097|2769228|P2|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|12
1142992|NCT00708097|2769229|P1|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
1142993|NCT00708097|2769225|P5|NOT COMPLETED|Period 1||1
1142994|NCT00708097|2769226|P4|NOT COMPLETED|Period 1||2
1142995|NCT00708097|2769227|P3|NOT COMPLETED|Period 1||0
1142996|NCT00708097|2769228|P2|NOT COMPLETED|Period 1||1
1142997|NCT00708097|2769229|P1|NOT COMPLETED|Period 1||0
1142998|NCT00708097|2769225|P5|COMPLETED|Period 1||10
1142999|NCT00708097|2769226|P4|COMPLETED|Period 1||9
1143000|NCT00708097|2769227|P3|COMPLETED|Period 1||12
1143001|NCT00708097|2769228|P2|COMPLETED|Period 1||11
1143002|NCT00708097|2769229|P1|COMPLETED|Period 1||11
1143003|NCT00708097|2769225|P5|STARTED|Period 1||11
1143004|NCT00708097|2769226|P4|STARTED|Period 1||11
1143005|NCT00708097|2769227|P3|STARTED|Period 1||12
1143006|NCT00708097|2769228|P2|STARTED|Period 1||12
1143007|NCT00708097|2769229|P1|STARTED|Period 1||11
1143008|NCT00708305|2769259|P4|NOT COMPLETED|Period 4||0
1143009|NCT00708305|2769260|P3|NOT COMPLETED|Period 4||0
1143010|NCT00708305|2769261|P2|NOT COMPLETED|Period 4||0
1143011|NCT00708305|2769262|P1|NOT COMPLETED|Period 4||0
1143012|NCT00708305|2769259|P4|COMPLETED|Period 4||14
1143013|NCT00708305|2769260|P3|COMPLETED|Period 4||14
1143014|NCT00708305|2769261|P2|COMPLETED|Period 4||14
1143015|NCT00708305|2769262|P1|COMPLETED|Period 4||12
1143016|NCT00708305|2769259|P4|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
1143017|NCT00708305|2769260|P3|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
1143018|NCT00708305|2769261|P2|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
1143019|NCT00708305|2769262|P1|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
1143020|NCT00708305|2769259|P4|NOT COMPLETED|Period 3||0
1143021|NCT00708305|2769260|P3|NOT COMPLETED|Period 3||0
1143022|NCT00708305|2769261|P2|NOT COMPLETED|Period 3||2
1143023|NCT00708305|2769262|P1|NOT COMPLETED|Period 3||1
1143024|NCT00708305|2769259|P4|COMPLETED|Period 3||14
1143025|NCT00708305|2769260|P3|COMPLETED|Period 3||14
1143026|NCT00708305|2769261|P2|COMPLETED|Period 3||12
1143027|NCT00708305|2769262|P1|COMPLETED|Period 3||14
1143028|NCT00708305|2769259|P4|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
1143029|NCT00708305|2769260|P3|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
1143030|NCT00708305|2769261|P2|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
1143031|NCT00708305|2769262|P1|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|15
1143032|NCT00708305|2769259|P4|NOT COMPLETED|Period 2||1
1143034|NCT00708305|2769261|P2|NOT COMPLETED|Period 2||2
1143035|NCT00708305|2769262|P1|NOT COMPLETED|Period 2||1
1143036|NCT00708305|2769259|P4|COMPLETED|Period 2||14
1143037|NCT00708305|2769260|P3|COMPLETED|Period 2||16
1143038|NCT00708305|2769261|P2|COMPLETED|Period 2||13
1143039|NCT00708305|2769262|P1|COMPLETED|Period 2||14
1143040|NCT00708305|2769259|P4|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
1143041|NCT00708305|2769260|P3|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|16
1143042|NCT00708305|2769261|P2|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
1143043|NCT00708305|2769262|P1|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
1143044|NCT00708305|2769259|P4|NOT COMPLETED|Period 1||2
1143045|NCT00708305|2769260|P3|NOT COMPLETED|Period 1||1
1143046|NCT00708305|2769261|P2|NOT COMPLETED|Period 1||0
1143047|NCT00708305|2769262|P1|NOT COMPLETED|Period 1||1
1143048|NCT00708305|2769259|P4|COMPLETED|Period 1||14
1143049|NCT00708305|2769260|P3|COMPLETED|Period 1||16
1143050|NCT00708305|2769261|P2|COMPLETED|Period 1||16
1143051|NCT00708305|2769262|P1|COMPLETED|Period 1||15
1143052|NCT00708305|2769259|P4|STARTED|Period 1||16
1143053|NCT00708305|2769260|P3|STARTED|Period 1||17
1143054|NCT00708305|2769261|P2|STARTED|Period 1||16
1143055|NCT00708305|2769262|P1|STARTED|Period 1||16
1143056|NCT00706446|2769300|P6|NOT COMPLETED|Overall Study||38
1143057|NCT00706446|2769301|P5|NOT COMPLETED|Overall Study||44
1143058|NCT00706446|2769302|P4|NOT COMPLETED|Overall Study||22
1143059|NCT00706446|2769303|P3|NOT COMPLETED|Overall Study||37
1143060|NCT00706446|2769304|P2|NOT COMPLETED|Overall Study||49
1143061|NCT00706446|2769305|P1|NOT COMPLETED|Overall Study||26
1143062|NCT00706446|2769300|P6|COMPLETED|Overall Study||7
1143063|NCT00706446|2769301|P5|COMPLETED|Overall Study||10
1143064|NCT00706446|2769302|P4|COMPLETED|Overall Study||4
1143065|NCT00706446|2769303|P3|COMPLETED|Overall Study||7
1143066|NCT00706446|2769304|P2|COMPLETED|Overall Study||8
1143067|NCT00706446|2769305|P1|COMPLETED|Overall Study||3
1143068|NCT00706446|2769300|P6|STARTED|Overall Study||45
1143069|NCT00706446|2769301|P5|STARTED|Overall Study||54
1143070|NCT00706446|2769302|P4|STARTED|Overall Study||26
1143071|NCT00706446|2769303|P3|STARTED|Overall Study||44
1143072|NCT00706446|2769304|P2|STARTED|Overall Study||57
1143073|NCT00706446|2769305|P1|STARTED|Overall Study||29
1143074|NCT00705783|2769345|P3|NOT COMPLETED|Depot Maintenance Phase||131
1143075|NCT00705783|2769346|P2|NOT COMPLETED|Depot Maintenance Phase||246
1143076|NCT00705783|2769347|P1|NOT COMPLETED|Depot Maintenance Phase||0
1143077|NCT00705783|2769345|P3|COMPLETED|Depot Maintenance Phase||3
1143078|NCT00705783|2769346|P2|COMPLETED|Depot Maintenance Phase||23
1143079|NCT00705783|2769347|P1|COMPLETED|Depot Maintenance Phase||0
1143080|NCT00705783|2769345|P3|STARTED|Depot Maintenance Phase||134
1143081|NCT00705783|2769346|P2|STARTED|Depot Maintenance Phase||269
1143082|NCT00705783|2769347|P1|STARTED|Depot Maintenance Phase|Patients were randomized into the aripiprazole and placebo depot groups in this phase of the study.|0
1143083|NCT00705783|2769345|P3|NOT COMPLETED|Depot Stabilization Phase||0
1143084|NCT00705783|2769346|P2|NOT COMPLETED|Depot Stabilization Phase||0
1143085|NCT00705783|2769347|P1|NOT COMPLETED|Depot Stabilization Phase||173
1143086|NCT00705783|2769345|P3|COMPLETED|Depot Stabilization Phase||0
1143087|NCT00705783|2769346|P2|COMPLETED|Depot Stabilization Phase||0
1143088|NCT00705783|2769347|P1|COMPLETED|Depot Stabilization Phase||403
1143089|NCT00705783|2769345|P3|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
1143090|NCT00705783|2769346|P2|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
1143091|NCT00705783|2769347|P1|STARTED|Depot Stabilization Phase||576
1143092|NCT00705783|2769345|P3|NOT COMPLETED|Oral Stabilization Phase||0
1143093|NCT00705783|2769346|P2|NOT COMPLETED|Oral Stabilization Phase||0
1143094|NCT00705783|2769347|P1|NOT COMPLETED|Oral Stabilization Phase||134
1143095|NCT00705783|2769345|P3|COMPLETED|Oral Stabilization Phase||0
1143096|NCT00705783|2769346|P2|COMPLETED|Oral Stabilization Phase||0
1143097|NCT00705783|2769347|P1|COMPLETED|Oral Stabilization Phase||576
1143098|NCT00705783|2769345|P3|Received Study Medication|Oral Stabilization Phase||0
1143099|NCT00705783|2769346|P2|Received Study Medication|Oral Stabilization Phase||0
1143100|NCT00705783|2769347|P1|Received Study Medication|Oral Stabilization Phase||709
1143101|NCT00705783|2769345|P3|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
1143102|NCT00705783|2769346|P2|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
1143103|NCT00705783|2769347|P1|STARTED|Oral Stabilization Phase|210 of the 710 patients who started this phase enrolled in this study directly into this phase.|710
1143104|NCT00705783|2769345|P3|NOT COMPLETED|Conversion Phase||0
1143105|NCT00705783|2769346|P2|NOT COMPLETED|Conversion Phase||0
1143106|NCT00705783|2769347|P1|NOT COMPLETED|Conversion Phase||133
1143107|NCT00705783|2769345|P3|COMPLETED|Conversion Phase||0
1143108|NCT00705783|2769346|P2|COMPLETED|Conversion Phase||0
1143109|NCT00705783|2769347|P1|COMPLETED|Conversion Phase||500
1143110|NCT00705783|2769345|P3|Received Study Medication|Conversion Phase||0
1143111|NCT00705783|2769346|P2|Received Study Medication|Conversion Phase||0
1143112|NCT00705783|2769347|P1|Received Study Medication|Conversion Phase||632
1143113|NCT00705783|2769345|P3|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
1143114|NCT00705783|2769346|P2|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
1143115|NCT00705783|2769347|P1|STARTED|Conversion Phase||633
1143116|NCT00700635|2769377|P3|NOT COMPLETED|Overall Study||1
1143117|NCT00700635|2769378|P2|NOT COMPLETED|Overall Study||8
1143118|NCT00700635|2769379|P1|NOT COMPLETED|Overall Study||11
1143119|NCT00700635|2769377|P3|COMPLETED|Overall Study||110
1143120|NCT00700635|2769378|P2|COMPLETED|Overall Study||103
1143121|NCT00700635|2769379|P1|COMPLETED|Overall Study||100
1143122|NCT00700635|2769377|P3|STARTED|Overall Study||111
1143123|NCT00700635|2769378|P2|STARTED|Overall Study||111
1143124|NCT00700635|2769379|P1|STARTED|Overall Study||111
1143125|NCT00686725|2769401|P2|NOT COMPLETED|Overall Study||42
1143126|NCT00686725|2769402|P1|NOT COMPLETED|Overall Study||46
1143127|NCT00686725|2769401|P2|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|10
1143128|NCT00686725|2769402|P1|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|1
1143129|NCT00686725|2769401|P2|STARTED|Overall Study||52
1143130|NCT00686725|2769402|P1|STARTED|Overall Study||47
1143140|NCT00674362|2769448|P2|NOT COMPLETED|Open Label||0
1143141|NCT00674362|2769449|P1|NOT COMPLETED|Open Label||2
1143142|NCT00674362|2769448|P2|COMPLETED|Open Label||7
1143143|NCT00674362|2769449|P1|COMPLETED|Open Label||18
1143144|NCT00674362|2769448|P2|STARTED|Open Label||7
1143145|NCT00674362|2769449|P1|STARTED|Open Label||20
1143146|NCT00674362|2769448|P2|NOT COMPLETED|Double Blind||18
1143147|NCT00674362|2769449|P1|NOT COMPLETED|Double Blind||12
1143148|NCT00674362|2769448|P2|COMPLETED|Double Blind||80
1143149|NCT00674362|2769449|P1|COMPLETED|Double Blind||84
1143150|NCT00674362|2769448|P2|STARTED|Double Blind||98
1143151|NCT00674362|2769449|P1|STARTED|Double Blind||96
1143184|NCT00646646|2769550|P4|NOT COMPLETED|Overall Study||0
1143185|NCT00646646|2769551|P3|NOT COMPLETED|Overall Study||0
1143186|NCT00646646|2769552|P2|NOT COMPLETED|Overall Study||0
1143187|NCT00646646|2769553|P1|NOT COMPLETED|Overall Study||0
1143188|NCT00646646|2769550|P4|COMPLETED|Overall Study||20
1143189|NCT00646646|2769551|P3|COMPLETED|Overall Study||15
1143190|NCT00646646|2769552|P2|COMPLETED|Overall Study||15
1143191|NCT00646646|2769553|P1|COMPLETED|Overall Study||15
1143192|NCT00646646|2769550|P4|STARTED|Overall Study||20
1143193|NCT00646646|2769551|P3|STARTED|Overall Study||15
1143194|NCT00646646|2769552|P2|STARTED|Overall Study||15
1143195|NCT00646646|2769553|P1|STARTED|Overall Study||15
1143196|NCT00645944|2769565|P2|NOT COMPLETED|Received Medication||3
1143197|NCT00645944|2769566|P1|NOT COMPLETED|Received Medication||6
1143198|NCT00645944|2769565|P2|COMPLETED|Received Medication||14
1143199|NCT00645944|2769566|P1|COMPLETED|Received Medication||13
1143200|NCT00645944|2769565|P2|STARTED|Received Medication||17
1143201|NCT00645944|2769566|P1|STARTED|Received Medication||19
1143202|NCT00645944|2769565|P2|NOT COMPLETED|Randomized||2
1143203|NCT00645944|2769566|P1|NOT COMPLETED|Randomized||1
1143204|NCT00645944|2769565|P2|COMPLETED|Randomized||17
1143205|NCT00645944|2769566|P1|COMPLETED|Randomized||19
1143206|NCT00645944|2769565|P2|STARTED|Randomized||19
1143207|NCT00645944|2769566|P1|STARTED|Randomized||20
1143216|NCT00643565|2769595|P2|NOT COMPLETED|Overall Study||74
1143217|NCT00643565|2769596|P1|NOT COMPLETED|Overall Study||80
1143218|NCT00643565|2769595|P2|COMPLETED|Overall Study||0
1143219|NCT00643565|2769596|P1|COMPLETED|Overall Study||0
1143220|NCT00643565|2769595|P2|STARTED|Overall Study||74
1143221|NCT00643565|2769596|P1|STARTED|Overall Study||80
1143222|NCT00623766|2769620|P2|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||2
1143223|NCT00623766|2769621|P1|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||10
1143224|NCT00623766|2769620|P2|COMPLETED|Maintenance Phase (Week 24 to Year 2)||0
1143225|NCT00623766|2769621|P1|COMPLETED|Maintenance Phase (Week 24 to Year 2)|Inadvertently not noted as discontinued (disease progression); data collection error at site closure|1
1143226|NCT00623766|2769620|P2|STARTED|Maintenance Phase (Week 24 to Year 2)||2
1143227|NCT00623766|2769621|P1|STARTED|Maintenance Phase (Week 24 to Year 2)||11
1143228|NCT00623766|2769620|P2|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||16
1143229|NCT00623766|2769621|P1|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||36
1143230|NCT00623766|2769620|P2|COMPLETED|Induction Phase (Day 1 to Week 24)|3 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|5
1143231|NCT00623766|2769621|P1|COMPLETED|Induction Phase (Day 1 to Week 24)|4 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|15
1143232|NCT00623766|2769620|P2|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|21
1143233|NCT00623766|2769621|P1|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|51
1143234|NCT00612560|2769647|P4|NOT COMPLETED|Overall Study||0
1143235|NCT00612560|2769648|P3|NOT COMPLETED|Overall Study||0
1143236|NCT00612560|2769649|P2|NOT COMPLETED|Overall Study||0
1143237|NCT00612560|2769650|P1|NOT COMPLETED|Overall Study||0
1143238|NCT00612560|2769647|P4|COMPLETED|Overall Study||6
1143239|NCT00612560|2769648|P3|COMPLETED|Overall Study||8
1143240|NCT00612560|2769649|P2|COMPLETED|Overall Study||7
1143241|NCT00612560|2769650|P1|COMPLETED|Overall Study||7
1143242|NCT00612560|2769647|P4|STARTED|Overall Study||6
1143243|NCT00612560|2769648|P3|STARTED|Overall Study||8
1143244|NCT00612560|2769649|P2|STARTED|Overall Study||7
1143245|NCT00612560|2769650|P1|STARTED|Overall Study||7
1143246|NCT00611130|2769674|P2|NOT COMPLETED|Overall Study||47
1143247|NCT00611130|2769675|P1|NOT COMPLETED|Overall Study||49
1143248|NCT00611130|2769674|P2|COMPLETED|Overall Study||47
1143249|NCT00611130|2769675|P1|COMPLETED|Overall Study||43
1143250|NCT00611130|2769674|P2|Completed 12 Week Treatment Phase|Overall Study||64
1143251|NCT00611130|2769675|P1|Completed 12 Week Treatment Phase|Overall Study||61
1143252|NCT00611130|2769674|P2|STARTED|Overall Study||94
1143253|NCT00611130|2769675|P1|STARTED|Overall Study||92
1143254|NCT00607126|2769684|P2|NOT COMPLETED|Overall Study||0
1143255|NCT00607126|2769685|P1|NOT COMPLETED|Overall Study||0
1143256|NCT00607126|2769684|P2|COMPLETED|Overall Study||19
1143257|NCT00607126|2769685|P1|COMPLETED|Overall Study||17
1143258|NCT00607126|2769684|P2|STARTED|Overall Study||19
1143259|NCT00607126|2769685|P1|STARTED|Overall Study||17
1143260|NCT00604175|2769700|P3|NOT COMPLETED|Week 29 Through Week 72||4
1143261|NCT00604175|2769701|P2|NOT COMPLETED|Week 29 Through Week 72||7
1143262|NCT00604175|2769702|P1|NOT COMPLETED|Week 29 Through Week 72||12
1143263|NCT00604175|2769700|P3|COMPLETED|Week 29 Through Week 72||89
1143264|NCT00604175|2769701|P2|COMPLETED|Week 29 Through Week 72||85
1143265|NCT00604175|2769702|P1|COMPLETED|Week 29 Through Week 72||108
1143266|NCT00604175|2769700|P3|STARTED|Week 29 Through Week 72||93
1143267|NCT00604175|2769701|P2|STARTED|Week 29 Through Week 72||92
1143268|NCT00604175|2769702|P1|STARTED|Week 29 Through Week 72||120
1143269|NCT00604175|2769700|P3|NOT COMPLETED|Entry Through Week 28||1
1143270|NCT00604175|2769701|P2|NOT COMPLETED|Entry Through Week 28||3
1143271|NCT00604175|2769702|P1|NOT COMPLETED|Entry Through Week 28||10
1143272|NCT00604175|2769700|P3|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|93
1143273|NCT00604175|2769701|P2|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|92
1143274|NCT00604175|2769702|P1|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|120
1143275|NCT00604175|2769700|P3|STARTED|Entry Through Week 28||94
1143276|NCT00604175|2769701|P2|STARTED|Entry Through Week 28||95
1143277|NCT00604175|2769702|P1|STARTED|Entry Through Week 28||130
1143278|NCT00603902|2769758|P3|NOT COMPLETED|Overall Study||769
1143279|NCT00603902|2769759|P2|NOT COMPLETED|Overall Study||686
1143280|NCT00603902|2769760|P1|NOT COMPLETED|Overall Study||329
1143281|NCT00603902|2769758|P3|COMPLETED|Overall Study||834
1143282|NCT00603902|2769759|P2|COMPLETED|Overall Study||917
1143283|NCT00603902|2769760|P1|COMPLETED|Overall Study||473
1143284|NCT00603902|2769758|P3|STARTED|Overall Study||1603
1143285|NCT00603902|2769759|P2|STARTED|Overall Study||1603
1143286|NCT00603902|2769760|P1|STARTED|Overall Study||802
1143287|NCT00603291|2769774|P3|NOT COMPLETED|Overall Study||96
1143288|NCT00603291|2769775|P2|NOT COMPLETED|Overall Study||87
1143289|NCT00603291|2769776|P1|NOT COMPLETED|Overall Study||20
1143290|NCT00603291|2769774|P3|COMPLETED|Overall Study||157
1143291|NCT00603291|2769775|P2|COMPLETED|Overall Study||169
1143292|NCT00603291|2769776|P1|COMPLETED|Overall Study||75
1143293|NCT00603291|2769774|P3|STARTED|Overall Study||253
1143294|NCT00603291|2769775|P2|STARTED|Overall Study||256
1143295|NCT00603291|2769776|P1|STARTED|Overall Study||95
1143299|NCT00582790|2769791|P1|NOT COMPLETED|Overall Study||1
1143300|NCT00582790|2769791|P1|COMPLETED|Overall Study||11
1143301|NCT00582790|2769791|P1|STARTED|Overall Study|only 11 of the 12 patients received study treatment.|12
1143302|NCT00582010|2769800|P2|NOT COMPLETED|Overall Study||1
1143303|NCT00582010|2769801|P1|NOT COMPLETED|Overall Study||0
1143304|NCT00582010|2769800|P2|COMPLETED|Overall Study||39
1143305|NCT00582010|2769801|P1|COMPLETED|Overall Study||40
1143306|NCT00582010|2769800|P2|STARTED|Overall Study||40
1143307|NCT00582010|2769801|P1|STARTED|Overall Study||40
1143308|NCT00580606|2769825|P2|NOT COMPLETED|Open Label (OL)||12
1143309|NCT00580606|2769826|P1|NOT COMPLETED|Open Label (OL)||9
1143310|NCT00580606|2769825|P2|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|5
1143311|NCT00580606|2769826|P1|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|9
1143312|NCT00580606|2769825|P2|Had Week 172 Oral Food Challenge|Open Label (OL)||2
1143313|NCT00580606|2769826|P1|Had Week 172 Oral Food Challenge|Open Label (OL)||2
1143314|NCT00580606|2769825|P2|Had Week 164 Oral Food Challenge|Open Label (OL)||5
1143315|NCT00580606|2769826|P1|Had Week 164 Oral Food Challenge|Open Label (OL)||9
1143316|NCT00580606|2769825|P2|Had Week 116 Oral Food Challenge|Open Label (OL)||6
1143317|NCT00580606|2769826|P1|Had Week 116 Oral Food Challenge|Open Label (OL)||13
1143318|NCT00580606|2769825|P2|Had Week 68 Oral Food Challenge|Open Label (OL)||12
1143319|NCT00580606|2769826|P1|Had Week 68 Oral Food Challenge|Open Label (OL)||15
1143320|NCT00580606|2769825|P2|Had Week 44 Oral Food Challenge|Open Label (OL)|After 44 weeks of OL high dose SLIT; 1 additional participant declined Week 44 OFC in OL period.|12
1143321|NCT00580606|2769826|P1|Had Week 44 Oral Food Challenge|Open Label (OL)|The Week 44 OFC for Low Dose Peanut SLIT was done at the end of the DB Period, not the OL period.|0
1143322|NCT00580606|2769825|P2|STARTED|Open Label (OL)|1 participant discontinued dosing before OL period; 2 passed Week 44 OFC & ineligible to crossover.|17
1143323|NCT00580606|2769826|P1|STARTED|Open Label (OL)|2 participants discontinued dosing before Open Label (OL) period.|18
1143324|NCT00580606|2769825|P2|NOT COMPLETED|Double Blind (DB)||0
1143325|NCT00580606|2769826|P1|NOT COMPLETED|Double Blind (DB)||0
1143326|NCT00580606|2769825|P2|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
1143327|NCT00580606|2769826|P1|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
1143328|NCT00580606|2769825|P2|Had Week 44 Oral Food Challenge|Double Blind (DB)||19
1143329|NCT00580606|2769826|P1|Had Week 44 Oral Food Challenge|Double Blind (DB)||18
1143330|NCT00580606|2769825|P2|STARTED|Double Blind (DB)||20
1143331|NCT00580606|2769826|P1|STARTED|Double Blind (DB)||20
1143332|NCT00578448|2769844|P1|NOT COMPLETED|1 Year Long Term Extension (LTE)||1
1143333|NCT00578448|2769844|P1|COMPLETED|1 Year Long Term Extension (LTE)||8
1143334|NCT00578448|2769844|P1|STARTED|1 Year Long Term Extension (LTE)||9
1143335|NCT00578448|2769844|P1|NOT COMPLETED|Day 1 up to 3 Years of Planned Study||3
1143336|NCT00578448|2769844|P1|COMPLETED|Day 1 up to 3 Years of Planned Study||9
1143337|NCT00578448|2769844|P1|STARTED|Day 1 up to 3 Years of Planned Study||12
1143338|NCT00556374|2769860|P2|NOT COMPLETED|Overall Study||220
1143339|NCT00556374|2769861|P1|NOT COMPLETED|Overall Study||247
1143340|NCT00556374|2769860|P2|COMPLETED|Overall Study|Indicates participants continuing study|1491
1143341|NCT00556374|2769861|P1|COMPLETED|Overall Study|Indicates participants continuing study|1462
1143342|NCT00556374|2769860|P2|Received Study Drug|Overall Study||1700
1143343|NCT00556374|2769861|P1|Received Study Drug|Overall Study||1699
1143344|NCT00556374|2769860|P2|STARTED|Overall Study||1711
1143345|NCT00556374|2769861|P1|STARTED|Overall Study||1709
1143346|NCT00555893|2769879|P2|NOT COMPLETED|Overall Study||0
1143347|NCT00555893|2769880|P1|NOT COMPLETED|Overall Study||0
1143348|NCT00555893|2769879|P2|COMPLETED|Overall Study||63
1143349|NCT00555893|2769880|P1|COMPLETED|Overall Study||130
1143350|NCT00555893|2769879|P2|Final Analysis|Overall Study|n=12 excluded from number started because >119 hrs|51
1143351|NCT00555893|2769880|P1|Final Analysis|Overall Study|n=16 excluded from number started because >119 hrs|114
1143352|NCT00555893|2769879|P2|STARTED|Overall Study||63
1143353|NCT00555893|2769880|P1|STARTED|Overall Study||130
1143354|NCT00555321|2769893|P5|NOT COMPLETED|Long-term Extension Phase||26
1143355|NCT00555321|2769894|P4|NOT COMPLETED|Long-term Extension Phase||38
1143356|NCT00555321|2769895|P3|NOT COMPLETED|Long-term Extension Phase||24
1143357|NCT00555321|2769896|P2|NOT COMPLETED|Long-term Extension Phase||27
1143358|NCT00555321|2769897|P1|NOT COMPLETED|Long-term Extension Phase||30
1143359|NCT00555321|2769893|P5|COMPLETED|Long-term Extension Phase||0
1143360|NCT00555321|2769894|P4|COMPLETED|Long-term Extension Phase||0
1143361|NCT00555321|2769895|P3|COMPLETED|Long-term Extension Phase||0
1143362|NCT00555321|2769896|P2|COMPLETED|Long-term Extension Phase||0
1143363|NCT00555321|2769897|P1|COMPLETED|Long-term Extension Phase||0
1143364|NCT00555321|2769893|P5|STARTED|Long-term Extension Phase|6 participants did not enter LTE|26
1143365|NCT00555321|2769894|P4|STARTED|Long-term Extension Phase|8 participants did not enter LTE|38
1143366|NCT00555321|2769895|P3|STARTED|Long-term Extension Phase|2 participants did not enter LTE|24
1143367|NCT00555321|2769896|P2|STARTED|Long-term Extension Phase|2 participants did not enter LTE|27
1143368|NCT00555321|2769897|P1|STARTED|Long-term Extension Phase|1 participant did not enter LTE|30
1143369|NCT00555321|2769893|P5|NOT COMPLETED|Treatment Phase up to 12-months||22
1143370|NCT00555321|2769894|P4|NOT COMPLETED|Treatment Phase up to 12-months||7
1143371|NCT00555321|2769895|P3|NOT COMPLETED|Treatment Phase up to 12-months||24
1143372|NCT00555321|2769896|P2|NOT COMPLETED|Treatment Phase up to 12-months||22
1143373|NCT00555321|2769897|P1|NOT COMPLETED|Treatment Phase up to 12-months||21
1143374|NCT00555321|2769893|P5|COMPLETED|Treatment Phase up to 12-months||32
1143375|NCT00555321|2769894|P4|COMPLETED|Treatment Phase up to 12-months||46
1143376|NCT00555321|2769895|P3|COMPLETED|Treatment Phase up to 12-months||26
1143377|NCT00555321|2769896|P2|COMPLETED|Treatment Phase up to 12-months||29
1143378|NCT00555321|2769897|P1|COMPLETED|Treatment Phase up to 12-months||31
1143379|NCT00555321|2769893|P5|Received Transplant and Treated|Treatment Phase up to 12-months||50
1143380|NCT00555321|2769894|P4|Received Transplant and Treated|Treatment Phase up to 12-months||53
1143381|NCT00555321|2769895|P3|Received Transplant and Treated|Treatment Phase up to 12-months||49
1143382|NCT00555321|2769896|P2|Received Transplant and Treated|Treatment Phase up to 12-months||48
1143383|NCT00555321|2769897|P1|Received Transplant and Treated|Treatment Phase up to 12-months||50
1143384|NCT00555321|2769893|P5|STARTED|Treatment Phase up to 12-months||54
1143385|NCT00555321|2769894|P4|STARTED|Treatment Phase up to 12-months||53
1143386|NCT00555321|2769895|P3|STARTED|Treatment Phase up to 12-months||50
1143387|NCT00555321|2769896|P2|STARTED|Treatment Phase up to 12-months||51
1143388|NCT00555321|2769897|P1|STARTED|Treatment Phase up to 12-months||52
1143389|NCT00552032|2770201|P2|NOT COMPLETED|Overall Study||19
1143390|NCT00552032|2770202|P1|NOT COMPLETED|Overall Study||17
1143391|NCT00552032|2770201|P2|COMPLETED|Overall Study||47
1143392|NCT00552032|2770202|P1|COMPLETED|Overall Study||49
1143393|NCT00552032|2770201|P2|STARTED|Overall Study||66
1143394|NCT00552032|2770202|P1|STARTED|Overall Study||66
1143395|NCT00550589|2770246|P1|NOT COMPLETED|Overall Study||0
1143396|NCT00550589|2770246|P1|COMPLETED|Overall Study||33
1143397|NCT00550589|2770246|P1|STARTED|Overall Study||33
1143398|NCT00550459|2770259|P2|NOT COMPLETED|Overall Study||3
1143399|NCT00550459|2770260|P1|NOT COMPLETED|Overall Study||1
1143400|NCT00550459|2770259|P2|COMPLETED|Overall Study||26
1143401|NCT00550459|2770260|P1|COMPLETED|Overall Study||27
1143402|NCT00550459|2770259|P2|STARTED|Overall Study||29
1143403|NCT00550459|2770260|P1|STARTED|Overall Study||28
1143404|NCT00545584|2770325|P3|NOT COMPLETED|Overall Study||56
1143405|NCT00545584|2770326|P2|NOT COMPLETED|Overall Study||80
1143406|NCT00545584|2770327|P1|NOT COMPLETED|Overall Study||79
1143407|NCT00545584|2770325|P3|COMPLETED|Overall Study||250
1143408|NCT00545584|2770326|P2|COMPLETED|Overall Study||334
1143409|NCT00545584|2770327|P1|COMPLETED|Overall Study||333
1143410|NCT00545584|2770325|P3|STARTED|Overall Study|306 subjects were randomized but only 305 were treated.|306
1143411|NCT00545584|2770326|P2|STARTED|Overall Study||414
1143412|NCT00545584|2770327|P1|STARTED|Overall Study||412
1143413|NCT00537316|2770344|P7|NOT COMPLETED|Part 2||2
1143414|NCT00537316|2770345|P6|NOT COMPLETED|Part 2||4
1143415|NCT00537316|2770346|P5|NOT COMPLETED|Part 2||1
1143416|NCT00537316|2770347|P4|NOT COMPLETED|Part 2||3
1143417|NCT00537316|2770348|P3|NOT COMPLETED|Part 2||32
1143418|NCT00537316|2770349|P2|NOT COMPLETED|Part 2||9
1143419|NCT00537316|2770350|P1|NOT COMPLETED|Part 2||26
1143420|NCT00537316|2770344|P7|COMPLETED|Part 2||0
1143421|NCT00537316|2770345|P6|COMPLETED|Part 2||0
1143422|NCT00537316|2770346|P5|COMPLETED|Part 2||1
1143423|NCT00537316|2770347|P4|COMPLETED|Part 2||2
1143424|NCT00537316|2770348|P3|COMPLETED|Part 2||16
1143425|NCT00537316|2770349|P2|COMPLETED|Part 2||1
1143426|NCT00537316|2770350|P1|COMPLETED|Part 2||11
1143427|NCT00537316|2770344|P7|STARTED|Part 2||2
1143428|NCT00537316|2770345|P6|STARTED|Part 2||4
1143429|NCT00537316|2770346|P5|STARTED|Part 2||2
1143430|NCT00537316|2770347|P4|STARTED|Part 2||5
1143431|NCT00537316|2770348|P3|STARTED|Part 2||48
1143432|NCT00537316|2770349|P2|STARTED|Part 2||10
1143433|NCT00537316|2770350|P1|STARTED|Part 2||37
1143434|NCT00537316|2770344|P7|NOT COMPLETED|Part 1||0
1143435|NCT00537316|2770345|P6|NOT COMPLETED|Part 1||0
1143436|NCT00537316|2770346|P5|NOT COMPLETED|Part 1||0
1143437|NCT00537316|2770347|P4|NOT COMPLETED|Part 1||0
1143438|NCT00537316|2770348|P3|NOT COMPLETED|Part 1||17
1143439|NCT00537316|2770349|P2|NOT COMPLETED|Part 1||27
1143440|NCT00537316|2770350|P1|NOT COMPLETED|Part 1||14
1143441|NCT00537316|2770344|P7|COMPLETED|Part 1||0
1143442|NCT00537316|2770345|P6|COMPLETED|Part 1||0
1143443|NCT00537316|2770346|P5|COMPLETED|Part 1||0
1143444|NCT00537316|2770347|P4|COMPLETED|Part 1||0
1143445|NCT00537316|2770348|P3|COMPLETED|Part 1||63
1143446|NCT00537316|2770349|P2|COMPLETED|Part 1||53
1143447|NCT00537316|2770350|P1|COMPLETED|Part 1||65
1143448|NCT00537316|2770344|P7|STARTED|Part 1||0
1143449|NCT00537316|2770345|P6|STARTED|Part 1||0
1143450|NCT00537316|2770346|P5|STARTED|Part 1||0
1143451|NCT00537316|2770347|P4|STARTED|Part 1||0
1143452|NCT00537316|2770348|P3|STARTED|Part 1||80
1143453|NCT00537316|2770349|P2|STARTED|Part 1||80
1143454|NCT00537316|2770350|P1|STARTED|Part 1||79
1143455|NCT00527735|2770378|P3|NOT COMPLETED|Overall Study||107
1143456|NCT00527735|2770379|P2|NOT COMPLETED|Overall Study||107
1143457|NCT00527735|2770380|P1|NOT COMPLETED|Overall Study||108
1143458|NCT00527735|2770378|P3|COMPLETED|Overall Study|Still on treatment|2
1143459|NCT00527735|2770379|P2|COMPLETED|Overall Study|Still on treatment|2
1143460|NCT00527735|2770380|P1|COMPLETED|Overall Study|Still on treatment|5
1143461|NCT00527735|2770378|P3|STARTED|Overall Study|Treated|109
1143462|NCT00527735|2770379|P2|STARTED|Overall Study|Treated|109
1143463|NCT00527735|2770380|P1|STARTED|Overall Study|Treated|113
1143464|NCT00527488|2770456|P4|NOT COMPLETED|Overall Study||0
1143465|NCT00527488|2770457|P3|NOT COMPLETED|Overall Study||1
1143466|NCT00527488|2770458|P2|NOT COMPLETED|Overall Study||1
1143467|NCT00527488|2770459|P1|NOT COMPLETED|Overall Study||0
1143468|NCT00527488|2770456|P4|COMPLETED|Overall Study||13
1143469|NCT00527488|2770457|P3|COMPLETED|Overall Study||12
1143470|NCT00527488|2770458|P2|COMPLETED|Overall Study||12
1143471|NCT00527488|2770459|P1|COMPLETED|Overall Study||13
1143472|NCT00527488|2770456|P4|STARTED|Overall Study||13
1143473|NCT00527488|2770457|P3|STARTED|Overall Study||13
1143474|NCT00527488|2770458|P2|STARTED|Overall Study||13
1143475|NCT00527488|2770459|P1|STARTED|Overall Study||13
1143476|NCT00526890|2770533|P1|NOT COMPLETED|Overall Study||2
1143477|NCT00526890|2770533|P1|COMPLETED|Overall Study||14
1143478|NCT00526890|2770533|P1|STARTED|Overall Study||16
1143479|NCT00524589|2770542|P1|NOT COMPLETED|Overall Study||18
1143480|NCT00524589|2770542|P1|COMPLETED|Overall Study||0
1143481|NCT00524589|2770542|P1|STARTED|Overall Study||18
1143482|NCT00500682|2770548|P2|NOT COMPLETED|Overall Study||287
1143483|NCT00500682|2770549|P1|NOT COMPLETED|Overall Study||306
1143484|NCT00500682|2770548|P2|COMPLETED|Overall Study||223
1143485|NCT00500682|2770549|P1|COMPLETED|Overall Study||204
1143486|NCT00500682|2770548|P2|STARTED|Overall Study||510
1143487|NCT00500682|2770549|P1|STARTED|Overall Study||510
1143488|NCT00501046|2770557|P2|NOT COMPLETED|Overall Study||294
1143489|NCT00501046|2770558|P1|NOT COMPLETED|Overall Study||270
1143490|NCT00501046|2770557|P2|COMPLETED|Overall Study||213
1143491|NCT00501046|2770558|P1|COMPLETED|Overall Study||238
1143492|NCT00501046|2770557|P2|STARTED|Overall Study||507
1143493|NCT00501046|2770558|P1|STARTED|Overall Study||508
1143494|NCT00498628|2770566|P2|NOT COMPLETED|Overall Study||21
1143495|NCT00498628|2770567|P1|NOT COMPLETED|Overall Study||15
1143496|NCT00498628|2770566|P2|COMPLETED|Overall Study||92
1143497|NCT00498628|2770567|P1|COMPLETED|Overall Study||90
1143498|NCT00498628|2770566|P2|STARTED|Overall Study||113
1143499|NCT00498628|2770567|P1|STARTED|Overall Study||105
1143500|NCT00496769|2770575|P2|NOT COMPLETED|Overall Study||649
1143501|NCT00496769|2770576|P1|NOT COMPLETED|Overall Study||558
1143502|NCT00496769|2770575|P2|COMPLETED|Overall Study||2142
1143503|NCT00496769|2770576|P1|COMPLETED|Overall Study||2249
1143504|NCT00496769|2770575|P2|Received Treatment|Overall Study||2708
1143505|NCT00496769|2770576|P1|Received Treatment|Overall Study||2798
1143506|NCT00496769|2770575|P2|STARTED|Overall Study|Randomized|2791
1143507|NCT00496769|2770576|P1|STARTED|Overall Study|Randomized|2807
1143508|NCT00488774|2770602|P4|NOT COMPLETED|Overall Study||3
1143509|NCT00488774|2770603|P3|NOT COMPLETED|Overall Study||5
1143510|NCT00488774|2770604|P2|NOT COMPLETED|Overall Study||5
1143511|NCT00488774|2770605|P1|NOT COMPLETED|Overall Study||8
1143512|NCT00488774|2770602|P4|COMPLETED|Overall Study||74
1143513|NCT00488774|2770603|P3|COMPLETED|Overall Study||70
1143514|NCT00488774|2770604|P2|COMPLETED|Overall Study||57
1143515|NCT00488774|2770605|P1|COMPLETED|Overall Study||69
1143516|NCT00488774|2770602|P4|STARTED|Overall Study||77
1143517|NCT00488774|2770603|P3|STARTED|Overall Study||75
1143518|NCT00488774|2770604|P2|STARTED|Overall Study||62
1143519|NCT00488774|2770605|P1|STARTED|Overall Study||77
1143520|NCT00488683|2770622|P3|NOT COMPLETED|Overall Study||2
1143521|NCT00488683|2770623|P2|NOT COMPLETED|Overall Study||6
1143522|NCT00488683|2770624|P1|NOT COMPLETED|Overall Study||12
1143523|NCT00488683|2770622|P3|COMPLETED|Overall Study||52
1143524|NCT00488683|2770623|P2|COMPLETED|Overall Study||48
1143525|NCT00488683|2770624|P1|COMPLETED|Overall Study||96
1143526|NCT00488683|2770622|P3|STARTED|Overall Study||54
1143527|NCT00488683|2770623|P2|STARTED|Overall Study||54
1143528|NCT00488683|2770624|P1|STARTED|Overall Study||108
1143529|NCT00487539|2770687|P4|NOT COMPLETED|Overall Study||4
1143530|NCT00487539|2770688|P3|NOT COMPLETED|Overall Study||3
1143531|NCT00487539|2770689|P2|NOT COMPLETED|Overall Study||3
1143532|NCT00487539|2770690|P1|NOT COMPLETED|Overall Study||7
1143533|NCT00487539|2770687|P4|COMPLETED|Overall Study||327
1143534|NCT00487539|2770688|P3|COMPLETED|Overall Study||328
1143535|NCT00487539|2770689|P2|COMPLETED|Overall Study||69
1143536|NCT00487539|2770690|P1|COMPLETED|Overall Study||324
1143537|NCT00487539|2770687|P4|STARTED|Overall Study||331
1143538|NCT00487539|2770688|P3|STARTED|Overall Study||331
1143539|NCT00487539|2770689|P2|STARTED|Overall Study||72
1143540|NCT00487539|2770690|P1|STARTED|Overall Study||331
1143547|NCT00474526|2770738|P17|NOT COMPLETED|Overall Study||9
1143548|NCT00474526|2770739|P16|NOT COMPLETED|Overall Study||18
1143549|NCT00474526|2770740|P15|NOT COMPLETED|Overall Study||77
1143550|NCT00474526|2770741|P14|NOT COMPLETED|Overall Study||156
1143551|NCT00474526|2770742|P13|NOT COMPLETED|Overall Study||15
1143552|NCT00474526|2770743|P12|NOT COMPLETED|Overall Study||11
1143553|NCT00474526|2770744|P11|NOT COMPLETED|Overall Study||10
1143554|NCT00474526|2770745|P10|NOT COMPLETED|Overall Study||27
1143555|NCT00474526|2770746|P9|NOT COMPLETED|Overall Study||6
1143556|NCT00474526|2770747|P8|NOT COMPLETED|Overall Study||6
1143557|NCT00474526|2770748|P7|NOT COMPLETED|Overall Study||25
1143558|NCT00474526|2770749|P6|NOT COMPLETED|Overall Study||16
1143559|NCT00474526|2770750|P5|NOT COMPLETED|Overall Study||68
1143560|NCT00474526|2770751|P4|NOT COMPLETED|Overall Study||119
1143561|NCT00474526|2770752|P3|NOT COMPLETED|Overall Study||49
1143562|NCT00474526|2770753|P2|NOT COMPLETED|Overall Study||46
1143563|NCT00474526|2770754|P1|NOT COMPLETED|Overall Study||33
1143564|NCT00474526|2770738|P17|COMPLETED|Overall Study||174
1143565|NCT00474526|2770739|P16|COMPLETED|Overall Study||152
1143566|NCT00474526|2770740|P15|COMPLETED|Overall Study||281
1143567|NCT00474526|2770741|P14|COMPLETED|Overall Study||1270
1143568|NCT00474526|2770742|P13|COMPLETED|Overall Study||135
1143569|NCT00474526|2770743|P12|COMPLETED|Overall Study||139
1143570|NCT00474526|2770744|P11|COMPLETED|Overall Study||141
1143571|NCT00474526|2770745|P10|COMPLETED|Overall Study||121
1143572|NCT00474526|2770746|P9|COMPLETED|Overall Study||144
1143573|NCT00474526|2770747|P8|COMPLETED|Overall Study||145
1143574|NCT00474526|2770748|P7|COMPLETED|Overall Study||178
1143575|NCT00474526|2770749|P6|COMPLETED|Overall Study||54
1143576|NCT00474526|2770750|P5|COMPLETED|Overall Study||8
1143577|NCT00474526|2770751|P4|COMPLETED|Overall Study||561
1143578|NCT00474526|2770752|P3|COMPLETED|Overall Study||110
1143579|NCT00474526|2770753|P2|COMPLETED|Overall Study||120
1143580|NCT00474526|2770754|P1|COMPLETED|Overall Study||121
1143581|NCT00474526|2770738|P17|STARTED|Overall Study||183
1143582|NCT00474526|2770739|P16|STARTED|Overall Study||170
1143583|NCT00474526|2770740|P15|STARTED|Overall Study||358
1143584|NCT00474526|2770741|P14|STARTED|Overall Study||1426
1143585|NCT00474526|2770742|P13|STARTED|Overall Study||150
1143586|NCT00474526|2770743|P12|STARTED|Overall Study||150
1143587|NCT00474526|2770744|P11|STARTED|Overall Study||151
1143588|NCT00474526|2770745|P10|STARTED|Overall Study||148
1143589|NCT00474526|2770746|P9|STARTED|Overall Study||150
1143590|NCT00474526|2770747|P8|STARTED|Overall Study||151
1143591|NCT00474526|2770748|P7|STARTED|Overall Study||203
1143592|NCT00474526|2770749|P6|STARTED|Overall Study||70
1143593|NCT00474526|2770750|P5|STARTED|Overall Study||76
1143594|NCT00474526|2770751|P4|STARTED|Overall Study||680
1143595|NCT00474526|2770752|P3|STARTED|Overall Study||159
1143596|NCT00474526|2770753|P2|STARTED|Overall Study||166
1143597|NCT00474526|2770754|P1|STARTED|Overall Study||154
1143598|NCT00466817|2770917|P2|NOT COMPLETED|Overall Study||4
1143599|NCT00466817|2770918|P1|NOT COMPLETED|Overall Study||5
1143600|NCT00466817|2770917|P2|COMPLETED|Overall Study||43
1143601|NCT00466817|2770918|P1|COMPLETED|Overall Study||44
1143602|NCT00466817|2770917|P2|STARTED|Overall Study||47
1143603|NCT00466817|2770918|P1|STARTED|Overall Study||49
1143604|NCT00465647|2770975|P4|NOT COMPLETED|Overall Study||13
1143605|NCT00465647|2770976|P3|NOT COMPLETED|Overall Study||11
1143606|NCT00465647|2770977|P2|NOT COMPLETED|Overall Study||8
1143607|NCT00465647|2770978|P1|NOT COMPLETED|Overall Study||13
1143608|NCT00465647|2770975|P4|COMPLETED|Overall Study||12
1143609|NCT00465647|2770976|P3|COMPLETED|Overall Study||18
1143610|NCT00465647|2770977|P2|COMPLETED|Overall Study||15
1143611|NCT00465647|2770978|P1|COMPLETED|Overall Study||26
1143612|NCT00465647|2770975|P4|STARTED|Overall Study||25
1143613|NCT00465647|2770976|P3|STARTED|Overall Study||29
1143614|NCT00465647|2770977|P2|STARTED|Overall Study||23
1143615|NCT00465647|2770978|P1|STARTED|Overall Study||39
1143616|NCT00462943|2771004|P3|NOT COMPLETED|Overall Study||23
1143617|NCT00462943|2771005|P2|NOT COMPLETED|Overall Study||30
1143618|NCT00462943|2771006|P1|NOT COMPLETED|Overall Study||45
1143619|NCT00462943|2771004|P3|COMPLETED|Overall Study||0
1143620|NCT00462943|2771005|P2|COMPLETED|Overall Study||1
1143621|NCT00462943|2771006|P1|COMPLETED|Overall Study||1
1143622|NCT00462943|2771004|P3|STARTED|Overall Study||23
1143623|NCT00462943|2771005|P2|STARTED|Overall Study||31
1143624|NCT00462943|2771006|P1|STARTED|Overall Study||46
1143625|NCT00457197|2771075|P2|NOT COMPLETED|Overall Study||1
1143626|NCT00457197|2771076|P1|NOT COMPLETED|Overall Study||1
1143627|NCT00457197|2771075|P2|COMPLETED|Overall Study||44
1143628|NCT00457197|2771076|P1|COMPLETED|Overall Study||44
1143629|NCT00457197|2771075|P2|STARTED|Overall Study||45
1143630|NCT00457197|2771076|P1|STARTED|Overall Study||45
1143631|NCT00455013|2771101|P3|NOT COMPLETED|Long Term Extension (LTE)||7
1143632|NCT00455013|2771102|P2|NOT COMPLETED|Long Term Extension (LTE)||3
1143633|NCT00455013|2771103|P1|NOT COMPLETED|Long Term Extension (LTE)||2
1143634|NCT00455013|2771101|P3|COMPLETED|Long Term Extension (LTE)||20
1143635|NCT00455013|2771102|P2|COMPLETED|Long Term Extension (LTE)||16
1143636|NCT00455013|2771103|P1|COMPLETED|Long Term Extension (LTE)||25
1143637|NCT00455013|2771101|P3|STARTED|Long Term Extension (LTE)|1 Participant chose not to enter the LTE.|27
1143638|NCT00455013|2771102|P2|STARTED|Long Term Extension (LTE)|2 Participants chose not to enter the LTE.|19
1143639|NCT00455013|2771103|P1|STARTED|Long Term Extension (LTE)||27
1143640|NCT00455013|2771101|P3|NOT COMPLETED|Short Term Period||2
1143641|NCT00455013|2771102|P2|NOT COMPLETED|Short Term Period||5
1143642|NCT00455013|2771103|P1|NOT COMPLETED|Short Term Period||6
1143643|NCT00455013|2771101|P3|COMPLETED|Short Term Period|1 discontinued tacrolimus by Month 6 and 2 discontinued by Month 12 (1 more by Month 12)|28
1143644|NCT00455013|2771102|P2|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6; 10 additional switched from sirolimus to MMF.|21
1143645|NCT00455013|2771103|P1|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6 (1 more by Month 12), 2 switched from MMF to sirolimus.|27
1143646|NCT00455013|2771101|P3|STARTED|Short Term Period|31 randomized, 30 transplanted and treated|30
1143647|NCT00455013|2771102|P2|STARTED|Short Term Period|27 randomized, 26 transplanted and treated.|26
1143648|NCT00455013|2771103|P1|STARTED|Short Term Period|35 randomized, 33 transplanted and treated.|33
1143649|NCT00453180|2771170|P2|NOT COMPLETED|Overall Study||3
1143650|NCT00453180|2771171|P1|NOT COMPLETED|Overall Study||3
1143651|NCT00453180|2771170|P2|COMPLETED|Overall Study||12
1143652|NCT00453180|2771171|P1|COMPLETED|Overall Study||13
1143653|NCT00453180|2771170|P2|STARTED|Overall Study||15
1143654|NCT00453180|2771171|P1|STARTED|Overall Study||16
1143655|NCT00452335|2771190|P3|NOT COMPLETED|Overall Study||9
1143656|NCT00452335|2771191|P2|NOT COMPLETED|Overall Study||4
1143657|NCT00452335|2771192|P1|NOT COMPLETED|Overall Study||2
1143658|NCT00452335|2771190|P3|COMPLETED|Overall Study||23
1143659|NCT00452335|2771191|P2|COMPLETED|Overall Study||61
1143660|NCT00452335|2771192|P1|COMPLETED|Overall Study||25
1143661|NCT00452335|2771190|P3|STARTED|Overall Study||32
1143662|NCT00452335|2771191|P2|STARTED|Overall Study||65
1143663|NCT00452335|2771192|P1|STARTED|Overall Study||27
1143664|NCT00445003|2771230|P3|NOT COMPLETED|Overall Study||4
1143665|NCT00445003|2771231|P2|NOT COMPLETED|Overall Study||10
1143666|NCT00445003|2771232|P1|NOT COMPLETED|Overall Study||5
1143667|NCT00445003|2771230|P3|COMPLETED|Overall Study||105
1143668|NCT00445003|2771231|P2|COMPLETED|Overall Study||103
1143669|NCT00445003|2771232|P1|COMPLETED|Overall Study||118
1143670|NCT00445003|2771230|P3|STARTED|Overall Study||109
1143671|NCT00445003|2771231|P2|STARTED|Overall Study||113
1143672|NCT00445003|2771232|P1|STARTED|Overall Study||123
1143673|NCT00443781|2771261|P1|NOT COMPLETED|Overall Study||25
1143674|NCT00443781|2771261|P1|COMPLETED|Overall Study||37
1143675|NCT00443781|2771261|P1|STARTED|Overall Study||62
1143676|NCT00436969|2771267|P2|NOT COMPLETED|Overall Study||52
1143677|NCT00436969|2771268|P1|NOT COMPLETED|Overall Study||22
1143678|NCT00436969|2771267|P2|COMPLETED|Overall Study||134
1143679|NCT00436969|2771268|P1|COMPLETED|Overall Study||66
1143680|NCT00436969|2771267|P2|Randomized But Not Treated|Overall Study||3
1143681|NCT00436969|2771268|P1|Randomized But Not Treated|Overall Study||1
1143682|NCT00436969|2771267|P2|STARTED|Overall Study||186
1143683|NCT00436969|2771268|P1|STARTED|Overall Study||88
1143684|NCT00430950|2771318|P2|NOT COMPLETED|Overall Study||13
1143685|NCT00430950|2771319|P1|NOT COMPLETED|Overall Study||13
1143686|NCT00430950|2771318|P2|COMPLETED|Overall Study||495
1143687|NCT00430950|2771319|P1|COMPLETED|Overall Study||489
1143688|NCT00430950|2771318|P2|STARTED|Overall Study||508
1143689|NCT00430950|2771319|P1|STARTED|Overall Study||502
1143690|NCT00424554|2771333|P2|NOT COMPLETED|Overall Study||0
1143691|NCT00424554|2771334|P1|NOT COMPLETED|Overall Study||0
1143692|NCT00424554|2771333|P2|COMPLETED|Overall Study||6
1143693|NCT00424554|2771334|P1|COMPLETED|Overall Study||34
1143694|NCT00424554|2771333|P2|STARTED|Overall Study||6
1143695|NCT00424554|2771334|P1|STARTED|Overall Study||34
1143696|NCT00409539|2771353|P5|NOT COMPLETED|Overall Study||25
1143697|NCT00409539|2771354|P4|NOT COMPLETED|Overall Study||12
1143698|NCT00409539|2771355|P3|NOT COMPLETED|Overall Study||14
1143699|NCT00409539|2771356|P2|NOT COMPLETED|Overall Study||11
1143700|NCT00409539|2771357|P1|NOT COMPLETED|Overall Study||11
1143701|NCT00409539|2771353|P5|COMPLETED|Overall Study||85
1143702|NCT00409539|2771354|P4|COMPLETED|Overall Study||97
1143703|NCT00409539|2771355|P3|COMPLETED|Overall Study||95
1143704|NCT00409539|2771356|P2|COMPLETED|Overall Study||100
1143705|NCT00409539|2771357|P1|COMPLETED|Overall Study||100
1143706|NCT00409539|2771353|P5|STARTED|Overall Study||110
1143707|NCT00409539|2771354|P4|STARTED|Overall Study||109
1143708|NCT00409539|2771355|P3|STARTED|Overall Study||109
1143709|NCT00409539|2771356|P2|STARTED|Overall Study||111
1143710|NCT00409539|2771357|P1|STARTED|Overall Study||111
1143711|NCT00404547|2771376|P2|NOT COMPLETED|Overall Study||25
1143712|NCT00404547|2771377|P1|NOT COMPLETED|Overall Study||90
1143713|NCT00404547|2771376|P2|COMPLETED|Overall Study||334
1143714|NCT00404547|2771377|P1|COMPLETED|Overall Study||672
1143715|NCT00404547|2771376|P2|STARTED|Overall Study||359
1143716|NCT00404547|2771377|P1|STARTED|Overall Study||762
1143717|NCT00402168|2771387|P2|NOT COMPLETED|Switched From CNI to Belatacept in LT||0
1143718|NCT00402168|2771388|P1|NOT COMPLETED|Switched From CNI to Belatacept in LT||6
1143719|NCT00402168|2771387|P2|COMPLETED|Switched From CNI to Belatacept in LT||0
1143720|NCT00402168|2771388|P1|COMPLETED|Switched From CNI to Belatacept in LT||32
1143721|NCT00402168|2771387|P2|STARTED|Switched From CNI to Belatacept in LT|Out of 81 starting LT period in CNI group, 38 switched from CNI to Belatacept during the LT period.|0
1143722|NCT00402168|2771388|P1|STARTED|Switched From CNI to Belatacept in LT|Participants switched from CNI to Belatacept during LT period.|38
1143723|NCT00402168|2771387|P2|NOT COMPLETED|Long Term (LT)||17
1143724|NCT00402168|2771388|P1|NOT COMPLETED|Long Term (LT)||11
1143725|NCT00402168|2771387|P2|COMPLETED|Long Term (LT)||64
1143726|NCT00402168|2771388|P1|COMPLETED|Long Term (LT)||70
1143727|NCT00402168|2771387|P2|STARTED|Long Term (LT)|5 completed 12 months, did not enter long term: 1 AE, 1 lack of efficacy, 3 other(non-specified).|81
1143728|NCT00402168|2771388|P1|STARTED|Long Term (LT)||81
1143729|NCT00402168|2771387|P2|NOT COMPLETED|Treatment (up to 12 Months)||2
1143730|NCT00402168|2771388|P1|NOT COMPLETED|Treatment (up to 12 Months)||2
1143731|NCT00402168|2771387|P2|COMPLETED|Treatment (up to 12 Months)||86
1143732|NCT00402168|2771388|P1|COMPLETED|Treatment (up to 12 Months)||81
1143733|NCT00402168|2771387|P2|STARTED|Treatment (up to 12 Months)||88
1143734|NCT00402168|2771388|P1|STARTED|Treatment (up to 12 Months)||83
1143735|NCT00402168|2771387|P2|NOT COMPLETED|Randomized||1
1143736|NCT00402168|2771388|P1|NOT COMPLETED|Randomized||1
1143737|NCT00402168|2771387|P2|COMPLETED|Randomized||88
1143738|NCT00402168|2771388|P1|COMPLETED|Randomized||83
1143739|NCT00402168|2771387|P2|STARTED|Randomized||89
1143740|NCT00402168|2771388|P1|STARTED|Randomized||84
1143741|NCT00396006|2771443|P1|NOT COMPLETED|Overall Study||0
1143742|NCT00396006|2771443|P1|COMPLETED|Overall Study||13
1143743|NCT00396006|2771443|P1|STARTED|Overall Study||13
1143744|NCT00395135|2771460|P5|NOT COMPLETED|Year 2||190
1143745|NCT00395135|2771461|P4|NOT COMPLETED|Year 2||88
1143746|NCT00395135|2771462|P3|NOT COMPLETED|Year 2||147
1143747|NCT00395135|2771463|P2|NOT COMPLETED|Year 2||0
1143748|NCT00395135|2771464|P1|NOT COMPLETED|Year 2||0
1143749|NCT00395135|2771460|P5|COMPLETED|Year 2||507
1143750|NCT00395135|2771461|P4|COMPLETED|Year 2||195
1143751|NCT00395135|2771462|P3|COMPLETED|Year 2||426
1143752|NCT00395135|2771463|P2|COMPLETED|Year 2||0
1143753|NCT00395135|2771464|P1|COMPLETED|Year 2||0
1143754|NCT00395135|2771460|P5|STARTED|Year 2||697
1143755|NCT00395135|2771461|P4|STARTED|Year 2||283
1143756|NCT00395135|2771462|P3|STARTED|Year 2||573
1143757|NCT00395135|2771463|P2|STARTED|Year 2||0
1143758|NCT00395135|2771464|P1|STARTED|Year 2||0
1143759|NCT00395135|2771460|P5|NOT COMPLETED|Year 1||0
1143760|NCT00395135|2771461|P4|NOT COMPLETED|Year 1||0
1143761|NCT00395135|2771462|P3|NOT COMPLETED|Year 1||0
1143762|NCT00395135|2771463|P2|NOT COMPLETED|Year 1||871
1143763|NCT00395135|2771464|P1|NOT COMPLETED|Year 1||712
1143764|NCT00395135|2771460|P5|COMPLETED|Year 1||0
1143765|NCT00395135|2771461|P4|COMPLETED|Year 1||0
1143766|NCT00395135|2771462|P3|COMPLETED|Year 1||0
1143767|NCT00395135|2771463|P2|COMPLETED|Year 1||716
1143768|NCT00395135|2771464|P1|COMPLETED|Year 1||883
1143769|NCT00395135|2771460|P5|STARTED|Year 1||0
1143770|NCT00395135|2771461|P4|STARTED|Year 1||0
1143771|NCT00395135|2771462|P3|STARTED|Year 1||0
1143772|NCT00395135|2771463|P2|STARTED|Year 1||1587
1143773|NCT00395135|2771464|P1|STARTED|Year 1||1595
1143774|NCT00379821|2771484|P4|NOT COMPLETED|Overall Study||79
1143775|NCT00379821|2771485|P3|NOT COMPLETED|Overall Study||67
1143776|NCT00379821|2771486|P2|NOT COMPLETED|Overall Study||89
1143777|NCT00379821|2771487|P1|NOT COMPLETED|Overall Study||73
1143778|NCT00379821|2771484|P4|COMPLETED|Overall Study||81
1143779|NCT00379821|2771485|P3|COMPLETED|Overall Study||93
1143780|NCT00379821|2771486|P2|COMPLETED|Overall Study||71
1143781|NCT00379821|2771487|P1|COMPLETED|Overall Study||87
1143782|NCT00379821|2771484|P4|STARTED|Overall Study||160
1143783|NCT00379821|2771485|P3|STARTED|Overall Study||160
1143784|NCT00379821|2771486|P2|STARTED|Overall Study||160
1143785|NCT00379821|2771487|P1|STARTED|Overall Study||160
1143786|NCT00375752|2771630|P2|NOT COMPLETED|Overall Study||15
1143787|NCT00375752|2771631|P1|NOT COMPLETED|Overall Study||12
1143788|NCT00375752|2771630|P2|COMPLETED|Overall Study||74
1143789|NCT00375752|2771631|P1|COMPLETED|Overall Study||67
1143790|NCT00375752|2771630|P2|STARTED|Overall Study||89
1143791|NCT00375752|2771631|P1|STARTED|Overall Study||79
1143792|NCT00375219|2771648|P3|NOT COMPLETED|Overall Study||21
1143793|NCT00375219|2771649|P2|NOT COMPLETED|Overall Study||20
1143794|NCT00375219|2771650|P1|NOT COMPLETED|Overall Study||59
1143795|NCT00375219|2771648|P3|COMPLETED|Overall Study||0
1143796|NCT00375219|2771649|P2|COMPLETED|Overall Study||0
1143797|NCT00375219|2771650|P1|COMPLETED|Overall Study||3
1143798|NCT00375219|2771648|P3|STARTED|Overall Study||21
1143799|NCT00375219|2771649|P2|STARTED|Overall Study||20
1143800|NCT00375219|2771650|P1|STARTED|Overall Study||62
1143801|NCT00374907|2771718|P2|NOT COMPLETED|116-Week Short-term + Long-term Period||14
1143802|NCT00374907|2771719|P1|NOT COMPLETED|116-Week Short-term + Long-term Period||13
1143803|NCT00374907|2771718|P2|COMPLETED|116-Week Short-term + Long-term Period||2
1143804|NCT00374907|2771719|P1|COMPLETED|116-Week Short-term + Long-term Period||7
1143805|NCT00374907|2771718|P2|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||15
1143806|NCT00374907|2771719|P1|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||17
1143807|NCT00374907|2771718|P2|STARTED|116-Week Short-term + Long-term Period||16
1143808|NCT00374907|2771719|P1|STARTED|116-Week Short-term + Long-term Period||20
1143809|NCT00374907|2771718|P2|NOT COMPLETED|12-Week Short-term Period||1
1143810|NCT00374907|2771719|P1|NOT COMPLETED|12-Week Short-term Period||3
1143811|NCT00374907|2771718|P2|COMPLETED|12-Week Short-term Period||15
1143812|NCT00374907|2771719|P1|COMPLETED|12-Week Short-term Period||17
1143813|NCT00374907|2771718|P2|STARTED|12-Week Short-term Period||16
1143814|NCT00374907|2771719|P1|STARTED|12-Week Short-term Period||20
1143815|NCT00355121|2771734|P3|NOT COMPLETED|Overall Study||5
1143816|NCT00355121|2771735|P2|NOT COMPLETED|Overall Study||29
1143817|NCT00355121|2771736|P1|NOT COMPLETED|Overall Study||21
1143818|NCT00355121|2771734|P3|COMPLETED|Overall Study||170
1143819|NCT00355121|2771735|P2|COMPLETED|Overall Study||324
1143820|NCT00355121|2771736|P1|COMPLETED|Overall Study||332
1143821|NCT00355121|2771734|P3|STARTED|Overall Study||175
1143822|NCT00355121|2771735|P2|STARTED|Overall Study||353
1143823|NCT00355121|2771736|P1|STARTED|Overall Study||353
1143824|NCT00354172|2771765|P1|NOT COMPLETED|Overall Study||1
1143825|NCT00354172|2771765|P1|COMPLETED|Overall Study|1 patient did not reach umbilical cord blood transplant|15
1143826|NCT00354172|2771765|P1|STARTED|Overall Study||16
1143833|NCT00324896|2771808|P2|NOT COMPLETED|Overall Study||8
1143834|NCT00324896|2771809|P1|NOT COMPLETED|Overall Study||3
1143835|NCT00324896|2771808|P2|COMPLETED|Overall Study||7
1143836|NCT00324896|2771809|P1|COMPLETED|Overall Study||12
1143837|NCT00324896|2771808|P2|STARTED|Overall Study||15
1143838|NCT00324896|2771809|P1|STARTED|Overall Study||15
1143839|NCT00324155|2771819|P2|NOT COMPLETED|Follow-up Phase||6
1143840|NCT00324155|2771820|P1|NOT COMPLETED|Follow-up Phase||11
1143841|NCT00324155|2771819|P2|COMPLETED|Follow-up Phase||245
1143842|NCT00324155|2771820|P1|COMPLETED|Follow-up Phase||236
1143843|NCT00324155|2771819|P2|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|251
1143844|NCT00324155|2771820|P1|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|247
1143845|NCT00324155|2771819|P2|NOT COMPLETED|Received Treatment in Maintenance Phase||47
1143846|NCT00324155|2771820|P1|NOT COMPLETED|Received Treatment in Maintenance Phase||32
1143847|NCT00324155|2771819|P2|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure. 6 participants in Maintenance Phase not yet summarized.|6
1143848|NCT00324155|2771820|P1|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure at this time. 11 in Maintenance Phase not yet summarized.|11
1143849|NCT00324155|2771819|P2|STARTED|Received Treatment in Maintenance Phase|1 completed Induction Phase but did not enter Maintenance Phase|53
1143850|NCT00324155|2771820|P1|STARTED|Received Treatment in Maintenance Phase|2 completed Induction Phase but did not enter Maintenance Phase|43
1143851|NCT00324155|2771819|P2|NOT COMPLETED|Received Treatment in Induction Phase||197
1143852|NCT00324155|2771820|P1|NOT COMPLETED|Received Treatment in Induction Phase||202
1143853|NCT00324155|2771819|P2|COMPLETED|Received Treatment in Induction Phase|54 participants on treatment at end of Induction Phase. Study undergoing closure.|54
1143854|NCT00324155|2771820|P1|COMPLETED|Received Treatment in Induction Phase|45 participants on treatment at end of Induction Phase. Study undergoing closure.|45
1143855|NCT00324155|2771819|P2|STARTED|Received Treatment in Induction Phase||251
1143856|NCT00324155|2771820|P1|STARTED|Received Treatment in Induction Phase||247
1143857|NCT00324155|2771819|P2|NOT COMPLETED|Enrolled and Randomized||1
1143858|NCT00324155|2771820|P1|NOT COMPLETED|Enrolled and Randomized||3
1143859|NCT00324155|2771819|P2|COMPLETED|Enrolled and Randomized|1 randomized but who did not receive treatment (lost to follow-up).|251
1143860|NCT00324155|2771820|P1|COMPLETED|Enrolled and Randomized|3 randomized but who did not receive treatment (no longer met study criteria).|247
1143861|NCT00324155|2771819|P2|STARTED|Enrolled and Randomized||252
1143862|NCT00324155|2771820|P1|STARTED|Enrolled and Randomized||250
1143863|NCT00322465|2771854|P4|NOT COMPLETED|Overall Study||26
1143864|NCT00322465|2771855|P3|NOT COMPLETED|Overall Study||26
1143865|NCT00322465|2771856|P2|NOT COMPLETED|Overall Study||24
1143866|NCT00322465|2771857|P1|NOT COMPLETED|Overall Study||20
1143867|NCT00322465|2771854|P4|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|53
1143868|NCT00322465|2771855|P3|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|51
1143869|NCT00322465|2771856|P2|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|49
1143870|NCT00322465|2771857|P1|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|56
1143871|NCT00322465|2771854|P4|STARTED|Overall Study|Randomized|79
1143872|NCT00322465|2771855|P3|STARTED|Overall Study|Randomized|77
1143873|NCT00322465|2771856|P2|STARTED|Overall Study|Randomized|73
1143874|NCT00322465|2771857|P1|STARTED|Overall Study|Randomized|76
1143875|NCT00306163|2771918|P2|NOT COMPLETED|Overall Study||0
1143876|NCT00306163|2771919|P1|NOT COMPLETED|Overall Study||0
1143877|NCT00306163|2771918|P2|COMPLETED|Overall Study||18
1143878|NCT00306163|2771919|P1|COMPLETED|Overall Study||19
1143879|NCT00306163|2771918|P2|STARTED|Overall Study||18
1143880|NCT00306163|2771919|P1|STARTED|Overall Study||19
1143881|NCT00289536|2771925|P3|NOT COMPLETED|Period 3||1
1143882|NCT00289536|2771926|P2|NOT COMPLETED|Period 3||0
1143883|NCT00289536|2771927|P1|NOT COMPLETED|Period 3||0
1143884|NCT00289536|2771925|P3|COMPLETED|Period 3||9
1143885|NCT00289536|2771926|P2|COMPLETED|Period 3||9
1143886|NCT00289536|2771927|P1|COMPLETED|Period 3||7
1143887|NCT00289536|2771925|P3|STARTED|Period 3|5 participants received Low Dose and 5 participants received Medium Dose in Period 2|10
1143888|NCT00289536|2771926|P2|STARTED|Period 3|5 participants received Low Dose and 4 participants received High Dose in Period 2|9
1143889|NCT00289536|2771927|P1|STARTED|Period 3|3 participants received Medium Dose and 4 participants received High Dose in Period 2|7
1143890|NCT00289536|2771925|P3|NOT COMPLETED|Period 2||0
1143891|NCT00289536|2771926|P2|NOT COMPLETED|Period 2||0
1143892|NCT00289536|2771927|P1|NOT COMPLETED|Period 2||0
1143893|NCT00289536|2771925|P3|COMPLETED|Period 2||7
1143894|NCT00289536|2771926|P2|COMPLETED|Period 2||9
1143895|NCT00289536|2771927|P1|COMPLETED|Period 2||10
1143896|NCT00289536|2771925|P3|STARTED|Period 2|4 participants received Low Dose and 3 participants received Medium Dose in Period 1|7
1143897|NCT00289536|2771926|P2|STARTED|Period 2|5 participants received Low Dose and 4 participants received High Dose in Period 1|9
1143898|NCT00289536|2771927|P1|STARTED|Period 2|5 participants received Medium Dose and 5 participants received High Dose in Period 1|10
1143899|NCT00289536|2771925|P3|NOT COMPLETED|Period 1||0
1143900|NCT00289536|2771926|P2|NOT COMPLETED|Period 1||0
1143901|NCT00289536|2771927|P1|NOT COMPLETED|Period 1||0
1143902|NCT00289536|2771925|P3|COMPLETED|Period 1||9
1143903|NCT00289536|2771926|P2|COMPLETED|Period 1||8
1143904|NCT00289536|2771927|P1|COMPLETED|Period 1||9
1143905|NCT00289536|2771925|P3|STARTED|Period 1||9
1143906|NCT00289536|2771926|P2|STARTED|Period 1||8
1143907|NCT00289536|2771927|P1|STARTED|Period 1||9
1143911|NCT00256750|2771978|P3|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||28
1143912|NCT00256750|2771979|P2|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||30
1143913|NCT00256750|2771980|P1|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||47
1143914|NCT00256750|2771978|P3|COMPLETED|Long Term Extension (LTE; 84 Months)||127
1143915|NCT00256750|2771979|P2|COMPLETED|Long Term Extension (LTE; 84 Months)||136
1143916|NCT00256750|2771980|P1|COMPLETED|Long Term Extension (LTE; 84 Months)||89
1143917|NCT00256750|2771978|P3|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 3 withdrew or refused.|155
1143918|NCT00256750|2771979|P2|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 4 withdrew or refused.|166
1143919|NCT00256750|2771980|P1|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 eligible to enroll in LTE; 2 ineligible, 5 withdrew or refused|136
1143920|NCT00256750|2771978|P3|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
1143921|NCT00256750|2771979|P2|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
1143922|NCT00256750|2771980|P1|NOT COMPLETED|Post-Transplant Treated (36 Months)||10
1143923|NCT00256750|2771978|P3|COMPLETED|Post-Transplant Treated (36 Months)||158
1143924|NCT00256750|2771979|P2|COMPLETED|Post-Transplant Treated (36 Months)||170
1143925|NCT00256750|2771980|P1|COMPLETED|Post-Transplant Treated (36 Months)||143
1143926|NCT00256750|2771978|P3|STARTED|Post-Transplant Treated (36 Months)||164
1143927|NCT00256750|2771979|P2|STARTED|Post-Transplant Treated (36 Months)||176
1143928|NCT00256750|2771980|P1|STARTED|Post-Transplant Treated (36 Months)||153
1143929|NCT00256750|2771978|P3|NOT COMPLETED|Post-Transplant Treated (24 Months)||9
1143930|NCT00256750|2771979|P2|NOT COMPLETED|Post-Transplant Treated (24 Months)||7
1143931|NCT00256750|2771980|P1|NOT COMPLETED|Post-Transplant Treated (24 Months)||21
1143932|NCT00256750|2771978|P3|COMPLETED|Post-Transplant Treated (24 Months)||164
1143933|NCT00256750|2771979|P2|COMPLETED|Post-Transplant Treated (24 Months)||176
1143934|NCT00256750|2771980|P1|COMPLETED|Post-Transplant Treated (24 Months)||153
1143935|NCT00256750|2771978|P3|STARTED|Post-Transplant Treated (24 Months)||173
1143936|NCT00256750|2771979|P2|STARTED|Post-Transplant Treated (24 Months)||183
1143937|NCT00256750|2771980|P1|STARTED|Post-Transplant Treated (24 Months)||174
1143938|NCT00256750|2771978|P3|NOT COMPLETED|Post-Transplant Treated (12 Months)||46
1143939|NCT00256750|2771979|P2|NOT COMPLETED|Post-Transplant Treated (12 Months)||43
1143940|NCT00256750|2771980|P1|NOT COMPLETED|Post-Transplant Treated (12 Months)||41
1143941|NCT00256750|2771978|P3|COMPLETED|Post-Transplant Treated (12 Months)||173
1143942|NCT00256750|2771979|P2|COMPLETED|Post-Transplant Treated (12 Months)||183
1143943|NCT00256750|2771980|P1|COMPLETED|Post-Transplant Treated (12 Months)||174
1143944|NCT00256750|2771978|P3|STARTED|Post-Transplant Treated (12 Months)||219
1143945|NCT00256750|2771979|P2|STARTED|Post-Transplant Treated (12 Months)||226
1143946|NCT00256750|2771980|P1|STARTED|Post-Transplant Treated (12 Months)||215
1143947|NCT00256750|2771978|P3|NOT COMPLETED|Transplanted Pre-Treatment||0
1143948|NCT00256750|2771979|P2|NOT COMPLETED|Transplanted Pre-Treatment||0
1143949|NCT00256750|2771980|P1|NOT COMPLETED|Transplanted Pre-Treatment||6
1143950|NCT00256750|2771978|P3|COMPLETED|Transplanted Pre-Treatment||219
1143951|NCT00256750|2771979|P2|COMPLETED|Transplanted Pre-Treatment||226
1143952|NCT00256750|2771980|P1|COMPLETED|Transplanted Pre-Treatment||215
1143953|NCT00256750|2771978|P3|STARTED|Transplanted Pre-Treatment||219
1143954|NCT00256750|2771979|P2|STARTED|Transplanted Pre-Treatment||226
1143955|NCT00256750|2771980|P1|STARTED|Transplanted Pre-Treatment||221
1143962|NCT00245037|2772187|P1|NOT COMPLETED|Overall Study||17
1143963|NCT00245037|2772187|P1|COMPLETED|Overall Study|17 participants died from infectious complications.|130
1143964|NCT00245037|2772187|P1|STARTED|Overall Study||147
1143965|NCT00241839|2772199|P2|NOT COMPLETED|Overall Study||18
1143966|NCT00241839|2772200|P1|NOT COMPLETED|Overall Study||19
1143967|NCT00241839|2772199|P2|COMPLETED|Overall Study|N=53 represents number with both baseline and 8-10 week data. N<53 implies missing data.|53
1143968|NCT00241839|2772200|P1|COMPLETED|Overall Study|N=52 represents number with both baseline and 8-10 week data. N<52 implies missing data.|52
1143969|NCT00241839|2772199|P2|STARTED|Overall Study||71
1143970|NCT00241839|2772200|P1|STARTED|Overall Study||71
1143971|NCT00238433|2772212|P1|NOT COMPLETED|Overall Study||3
1143972|NCT00238433|2772212|P1|COMPLETED|Overall Study||34
1143973|NCT00238433|2772212|P1|STARTED|Overall Study||37
1143974|NCT00219349|2772217|P1|NOT COMPLETED|Escitalopram Phase||11
1143975|NCT00219349|2772217|P1|COMPLETED|Escitalopram Phase||4
1143976|NCT00219349|2772217|P1|STARTED|Escitalopram Phase|7 responders to CBT were ineligible to start and 1 declined, leaving 7 who started escitalopram|15
1143977|NCT00219349|2772217|P1|NOT COMPLETED|Cognitive Behavioral Therapy Phase||10
1143978|NCT00219349|2772217|P1|COMPLETED|Cognitive Behavioral Therapy Phase||15
1143979|NCT00219349|2772217|P1|STARTED|Cognitive Behavioral Therapy Phase||25
1143980|NCT00211237|2772223|P3|NOT COMPLETED|12 Months||6
1143981|NCT00211237|2772224|P2|NOT COMPLETED|12 Months||2
1143982|NCT00211237|2772225|P1|NOT COMPLETED|12 Months||9
1143983|NCT00211237|2772223|P3|COMPLETED|12 Months||28
1143984|NCT00211237|2772224|P2|COMPLETED|12 Months||6
1143985|NCT00211237|2772225|P1|COMPLETED|12 Months||40
1143986|NCT00211237|2772223|P3|STARTED|12 Months||34
1143987|NCT00211237|2772224|P2|STARTED|12 Months|1 patient crossed over Balloon Kyphoplasty|8
1143988|NCT00211237|2772225|P1|STARTED|12 Months||49
1143989|NCT00211237|2772223|P3|NOT COMPLETED|6 Months||3
1143990|NCT00211237|2772224|P2|NOT COMPLETED|6 Months||2
1143991|NCT00211237|2772225|P1|NOT COMPLETED|6 Months||8
1143992|NCT00211237|2772223|P3|COMPLETED|6 Months||33
1143993|NCT00211237|2772224|P2|COMPLETED|6 Months||9
1143994|NCT00211237|2772225|P1|COMPLETED|6 Months||49
1143995|NCT00211237|2772223|P3|STARTED|6 Months||36
1143996|NCT00211237|2772224|P2|STARTED|6 Months|3 patients crossed over Balloon Kyphoplasty|11
1143997|NCT00211237|2772225|P1|STARTED|6 Months||57
1143998|NCT00211237|2772223|P3|NOT COMPLETED|3 Months||1
1143999|NCT00211237|2772224|P2|NOT COMPLETED|3 Months||4
1144000|NCT00211237|2772225|P1|NOT COMPLETED|3 Months||8
1144001|NCT00211237|2772223|P3|COMPLETED|3 Months||33
1144002|NCT00211237|2772224|P2|COMPLETED|3 Months||14
1144003|NCT00211237|2772225|P1|COMPLETED|3 Months||57
1144004|NCT00211237|2772223|P3|STARTED|3 Months||34
1144005|NCT00211237|2772224|P2|STARTED|3 Months|34 patients crossed over to Balloon Kyphoplasty.|18
1144006|NCT00211237|2772225|P1|STARTED|3 Months||65
1144007|NCT00211237|2772223|P3|NOT COMPLETED|1 Month||0
1144008|NCT00211237|2772224|P2|NOT COMPLETED|1 Month||9
1144009|NCT00211237|2772225|P1|NOT COMPLETED|1 Month||3
1144010|NCT00211237|2772223|P3|COMPLETED|1 Month||0
1144011|NCT00211237|2772224|P2|COMPLETED|1 Month||52
1144012|NCT00211237|2772225|P1|COMPLETED|1 Month||65
1144013|NCT00211237|2772223|P3|STARTED|1 Month||0
1144014|NCT00211237|2772224|P2|STARTED|1 Month||61
1144015|NCT00211237|2772225|P1|STARTED|1 Month||68
1144016|NCT00211237|2772223|P3|NOT COMPLETED|Baseline||0
1144017|NCT00211237|2772224|P2|NOT COMPLETED|Baseline||3
1144018|NCT00211237|2772225|P1|NOT COMPLETED|Baseline||2
1144019|NCT00211237|2772223|P3|COMPLETED|Baseline||0
1144020|NCT00211237|2772224|P2|COMPLETED|Baseline||61
1144021|NCT00211237|2772225|P1|COMPLETED|Baseline||68
1144022|NCT00211237|2772223|P3|STARTED|Baseline||0
1144023|NCT00211237|2772224|P2|STARTED|Baseline||64
1144024|NCT00211237|2772225|P1|STARTED|Baseline||70
1144025|NCT00205504|2772317|P2|NOT COMPLETED|Overall Study||0
1144026|NCT00205504|2772318|P1|NOT COMPLETED|Overall Study||7
1144027|NCT00205504|2772317|P2|COMPLETED|Overall Study||15
1144028|NCT00205504|2772318|P1|COMPLETED|Overall Study||14
1144029|NCT00205504|2772317|P2|STARTED|Overall Study||15
1144030|NCT00205504|2772318|P1|STARTED|Overall Study||21
1144031|NCT00187889|2772344|P2|NOT COMPLETED|Overall Study||4
1144032|NCT00187889|2772345|P1|NOT COMPLETED|Overall Study||6
1144033|NCT00187889|2772344|P2|COMPLETED|Overall Study||22
1144034|NCT00187889|2772345|P1|COMPLETED|Overall Study||19
1144035|NCT00187889|2772344|P2|STARTED|Overall Study||26
1144036|NCT00187889|2772345|P1|STARTED|Overall Study||25
1144037|NCT00163293|2772356|P3|NOT COMPLETED|Overall Study||19
1144038|NCT00163293|2772357|P2|NOT COMPLETED|Overall Study||7
1144039|NCT00163293|2772358|P1|NOT COMPLETED|Overall Study||13
1144040|NCT00163293|2772356|P3|COMPLETED|Overall Study||66
1144041|NCT00163293|2772357|P2|COMPLETED|Overall Study||69
1144042|NCT00163293|2772358|P1|COMPLETED|Overall Study||66
1144043|NCT00163293|2772356|P3|STARTED|Overall Study||85
1144044|NCT00163293|2772357|P2|STARTED|Overall Study||76
1144045|NCT00163293|2772358|P1|STARTED|Overall Study||79
1144046|NCT00162123|2772440|P8|NOT COMPLETED|Overall Study||58
1144047|NCT00162123|2772441|P7|NOT COMPLETED|Overall Study||4
1144048|NCT00162123|2772442|P6|NOT COMPLETED|Overall Study||9
1144049|NCT00162123|2772443|P5|NOT COMPLETED|Overall Study||31
1144050|NCT00162123|2772444|P4|NOT COMPLETED|Overall Study||8
1144051|NCT00162123|2772445|P3|NOT COMPLETED|Overall Study||21
1144052|NCT00162123|2772446|P2|NOT COMPLETED|Overall Study||29
1144053|NCT00162123|2772447|P1|NOT COMPLETED|Overall Study||44
1144054|NCT00162123|2772440|P8|COMPLETED|Overall Study|Still on treatment|0
1144055|NCT00162123|2772441|P7|COMPLETED|Overall Study|Still on treatment|0
1144056|NCT00162123|2772442|P6|COMPLETED|Overall Study|Still on treatment|4
1144057|NCT00162123|2772443|P5|COMPLETED|Overall Study|Still on treatment|14
1144058|NCT00162123|2772444|P4|COMPLETED|Overall Study|Still on treatment|3
1144059|NCT00162123|2772445|P3|COMPLETED|Overall Study|Still on treatment|3
1144060|NCT00162123|2772446|P2|COMPLETED|Overall Study|Still on treatment|5
1144061|NCT00162123|2772447|P1|COMPLETED|Overall Study|Still on treatment|9
1144062|NCT00162123|2772440|P8|Received Treatment|Overall Study||0
1144063|NCT00162123|2772441|P7|Received Treatment|Overall Study||4
1144064|NCT00162123|2772442|P6|Received Treatment|Overall Study||12
1144065|NCT00162123|2772443|P5|Received Treatment|Overall Study||33
1144066|NCT00162123|2772444|P4|Received Treatment|Overall Study||11
1144067|NCT00162123|2772445|P3|Received Treatment|Overall Study||24
1144068|NCT00162123|2772446|P2|Received Treatment|Overall Study||34
1144069|NCT00162123|2772447|P1|Received Treatment|Overall Study||53
1144070|NCT00162123|2772440|P8|STARTED|Overall Study|Enrolled|58
1144071|NCT00162123|2772441|P7|STARTED|Overall Study|Enrolled|4
1144072|NCT00162123|2772442|P6|STARTED|Overall Study|Enrolled|13
1144073|NCT00162123|2772443|P5|STARTED|Overall Study|Enrolled|45
1144074|NCT00162123|2772444|P4|STARTED|Overall Study|Enrolled|11
1144075|NCT00162123|2772445|P3|STARTED|Overall Study|Enrolled|24
1144076|NCT00162123|2772446|P2|STARTED|Overall Study|Enrolled|34
1144077|NCT00162123|2772447|P1|STARTED|Overall Study|Enrolled|53
1144078|NCT00157014|2772480|P4|NOT COMPLETED|Overall Study||1
1144079|NCT00157014|2772481|P3|NOT COMPLETED|Overall Study||1
1144080|NCT00157014|2772482|P2|NOT COMPLETED|Overall Study||5
1144081|NCT00157014|2772483|P1|NOT COMPLETED|Overall Study||7
1144082|NCT00157014|2772480|P4|COMPLETED|Overall Study||5
1144083|NCT00157014|2772481|P3|COMPLETED|Overall Study||4
1144084|NCT00157014|2772482|P2|COMPLETED|Overall Study||41
1144085|NCT00157014|2772483|P1|COMPLETED|Overall Study||45
1144086|NCT00157014|2772480|P4|STARTED|Overall Study||6
1144087|NCT00157014|2772481|P3|STARTED|Overall Study||5
1144088|NCT00157014|2772482|P2|STARTED|Overall Study||46
1144089|NCT00157014|2772483|P1|STARTED|Overall Study||52
1144090|NCT00153816|2772567|P6|NOT COMPLETED|Overall Study||27
1144091|NCT00153816|2772568|P5|NOT COMPLETED|Overall Study||17
1144092|NCT00153816|2772569|P4|NOT COMPLETED|Overall Study||31
1144093|NCT00153816|2772570|P3|NOT COMPLETED|Overall Study||32
1144094|NCT00153816|2772571|P2|NOT COMPLETED|Overall Study||32
1144095|NCT00153816|2772572|P1|NOT COMPLETED|Overall Study||32
1144096|NCT00153816|2772567|P6|COMPLETED|Overall Study||262
1144097|NCT00153816|2772568|P5|COMPLETED|Overall Study||278
1144098|NCT00153816|2772569|P4|COMPLETED|Overall Study||390
1144099|NCT00153816|2772570|P3|COMPLETED|Overall Study||388
1144100|NCT00153816|2772571|P2|COMPLETED|Overall Study||387
1144101|NCT00153816|2772572|P1|COMPLETED|Overall Study||383
1144102|NCT00153816|2772567|P6|STARTED|Overall Study||289
1144103|NCT00153816|2772568|P5|STARTED|Overall Study||295
1144104|NCT00153816|2772569|P4|STARTED|Overall Study||421
1144105|NCT00153816|2772570|P3|STARTED|Overall Study||420
1144106|NCT00153816|2772571|P2|STARTED|Overall Study||419
1144107|NCT00153816|2772572|P1|STARTED|Overall Study||415
1144108|NCT00138424|2772596|P4|NOT COMPLETED|Overall Study||0
1144109|NCT00138424|2772597|P3|NOT COMPLETED|Overall Study||0
1144110|NCT00138424|2772598|P2|NOT COMPLETED|Overall Study||1
1144111|NCT00138424|2772599|P1|NOT COMPLETED|Overall Study||0
1144112|NCT00138424|2772596|P4|COMPLETED|Overall Study||3
1144113|NCT00138424|2772597|P3|COMPLETED|Overall Study||5
1144114|NCT00138424|2772598|P2|COMPLETED|Overall Study||4
1144115|NCT00138424|2772599|P1|COMPLETED|Overall Study||9
1144116|NCT00138424|2772596|P4|STARTED|Overall Study||3
1144117|NCT00138424|2772597|P3|STARTED|Overall Study||5
1144118|NCT00138424|2772598|P2|STARTED|Overall Study||5
1144119|NCT00138424|2772599|P1|STARTED|Overall Study||9
1144120|NCT00121641|2772669|P5|NOT COMPLETED|48-month Short Term + Long Term Period||58
1144121|NCT00121641|2772670|P4|NOT COMPLETED|48-month Short Term + Long Term Period||71
1144122|NCT00121641|2772671|P3|NOT COMPLETED|48-month Short Term + Long Term Period||70
1144123|NCT00121641|2772672|P2|NOT COMPLETED|48-month Short Term + Long Term Period||82
1144124|NCT00121641|2772673|P1|NOT COMPLETED|48-month Short Term + Long Term Period||79
1144125|NCT00121641|2772669|P5|COMPLETED|48-month Short Term + Long Term Period||8
1144126|NCT00121641|2772670|P4|COMPLETED|48-month Short Term + Long Term Period||24
1144127|NCT00121641|2772671|P3|COMPLETED|48-month Short Term + Long Term Period||28
1144128|NCT00121641|2772672|P2|COMPLETED|48-month Short Term + Long Term Period||24
1144129|NCT00121641|2772673|P1|COMPLETED|48-month Short Term + Long Term Period||23
1144130|NCT00121641|2772669|P5|STARTED|48-month Short Term + Long Term Period||66
1144131|NCT00121641|2772670|P4|STARTED|48-month Short Term + Long Term Period||95
1144132|NCT00121641|2772671|P3|STARTED|48-month Short Term + Long Term Period||98
1144133|NCT00121641|2772672|P2|STARTED|48-month Short Term + Long Term Period||106
1144134|NCT00121641|2772673|P1|STARTED|48-month Short Term + Long Term Period||102
1144135|NCT00121641|2772669|P5|NOT COMPLETED|24-week Short-term Treatment Period||41
1144136|NCT00121641|2772670|P4|NOT COMPLETED|24-week Short-term Treatment Period||40
1144137|NCT00121641|2772671|P3|NOT COMPLETED|24-week Short-term Treatment Period||29
1144138|NCT00121641|2772672|P2|NOT COMPLETED|24-week Short-term Treatment Period||38
1144139|NCT00121641|2772673|P1|NOT COMPLETED|24-week Short-term Treatment Period||29
1144140|NCT00121641|2772669|P5|COMPLETED|24-week Short-term Treatment Period||25
1144141|NCT00121641|2772670|P4|COMPLETED|24-week Short-term Treatment Period||55
1144142|NCT00121641|2772671|P3|COMPLETED|24-week Short-term Treatment Period||69
1144143|NCT00121641|2772672|P2|COMPLETED|24-week Short-term Treatment Period||68
1144144|NCT00121641|2772673|P1|COMPLETED|24-week Short-term Treatment Period||73
1144145|NCT00121641|2772669|P5|STARTED|24-week Short-term Treatment Period||66
1144146|NCT00121641|2772670|P4|STARTED|24-week Short-term Treatment Period||95
1144147|NCT00121641|2772671|P3|STARTED|24-week Short-term Treatment Period||98
1144148|NCT00121641|2772672|P2|STARTED|24-week Short-term Treatment Period||106
1144149|NCT00121641|2772673|P1|STARTED|24-week Short-term Treatment Period||102
1144150|NCT00121667|2772788|P4|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||140
1144151|NCT00121667|2772789|P3|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||113
1144152|NCT00121667|2772790|P2|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||133
1144153|NCT00121667|2772791|P1|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||128
1144154|NCT00121667|2772788|P4|COMPLETED|Short Term (ST) + Long Term (LT) Period||39
1144155|NCT00121667|2772789|P3|COMPLETED|Short Term (ST) + Long Term (LT) Period||68
1144156|NCT00121667|2772790|P2|COMPLETED|Short Term (ST) + Long Term (LT) Period||58
1144157|NCT00121667|2772791|P1|COMPLETED|Short Term (ST) + Long Term (LT) Period||64
1144158|NCT00121667|2772788|P4|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||7
1144159|NCT00121667|2772789|P3|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||23
1144160|NCT00121667|2772790|P2|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||18
1144161|NCT00121667|2772791|P1|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||14
1144162|NCT00121667|2772788|P4|STARTED|Short Term (ST) + Long Term (LT) Period||179
1144163|NCT00121667|2772789|P3|STARTED|Short Term (ST) + Long Term (LT) Period||181
1144164|NCT00121667|2772790|P2|STARTED|Short Term (ST) + Long Term (LT) Period||191
1144165|NCT00121667|2772791|P1|STARTED|Short Term (ST) + Long Term (LT) Period||192
1144166|NCT00121667|2772788|P4|NOT COMPLETED|Short Term (ST) Period||67
1144167|NCT00121667|2772789|P3|NOT COMPLETED|Short Term (ST) Period||41
1144168|NCT00121667|2772790|P2|NOT COMPLETED|Short Term (ST) Period||48
1144169|NCT00121667|2772791|P1|NOT COMPLETED|Short Term (ST) Period||44
1144170|NCT00121667|2772788|P4|COMPLETED|Short Term (ST) Period||112
1144171|NCT00121667|2772789|P3|COMPLETED|Short Term (ST) Period||140
1144172|NCT00121667|2772790|P2|COMPLETED|Short Term (ST) Period||143
1144173|NCT00121667|2772791|P1|COMPLETED|Short Term (ST) Period||148
1144174|NCT00121667|2772788|P4|STARTED|Short Term (ST) Period||179
1144175|NCT00121667|2772789|P3|STARTED|Short Term (ST) Period||181
1144176|NCT00121667|2772790|P2|STARTED|Short Term (ST) Period||191
1144177|NCT00121667|2772791|P1|STARTED|Short Term (ST) Period||192
1144178|NCT00117598|2772888|P5|NOT COMPLETED|After Treament Cross Over||4
1144179|NCT00117598|2772889|P4|NOT COMPLETED|After Treament Cross Over||3
1144180|NCT00117598|2772890|P3|NOT COMPLETED|After Treament Cross Over||0
1144181|NCT00117598|2772891|P2|NOT COMPLETED|After Treament Cross Over||0
1144182|NCT00117598|2772892|P1|NOT COMPLETED|After Treament Cross Over||0
1144183|NCT00117598|2772888|P5|COMPLETED|After Treament Cross Over||0
1144184|NCT00117598|2772889|P4|COMPLETED|After Treament Cross Over||0
1144185|NCT00117598|2772890|P3|COMPLETED|After Treament Cross Over||0
1144186|NCT00117598|2772891|P2|COMPLETED|After Treament Cross Over||0
1144187|NCT00117598|2772892|P1|COMPLETED|After Treament Cross Over||0
1144188|NCT00117598|2772888|P5|STARTED|After Treament Cross Over||4
1144189|NCT00117598|2772889|P4|STARTED|After Treament Cross Over||3
1144190|NCT00117598|2772890|P3|STARTED|After Treament Cross Over||0
1144191|NCT00117598|2772891|P2|STARTED|After Treament Cross Over||0
1144192|NCT00117598|2772892|P1|STARTED|After Treament Cross Over||0
1144193|NCT00117598|2772888|P5|NOT COMPLETED|Prior to Treatment Cross Over||0
1144194|NCT00117598|2772889|P4|NOT COMPLETED|Prior to Treatment Cross Over||0
1144195|NCT00117598|2772890|P3|NOT COMPLETED|Prior to Treatment Cross Over||52
1144196|NCT00117598|2772891|P2|NOT COMPLETED|Prior to Treatment Cross Over||53
1144197|NCT00117598|2772892|P1|NOT COMPLETED|Prior to Treatment Cross Over||57
1144198|NCT00117598|2772888|P5|COMPLETED|Prior to Treatment Cross Over||0
1144199|NCT00117598|2772889|P4|COMPLETED|Prior to Treatment Cross Over||0
1144200|NCT00117598|2772890|P3|COMPLETED|Prior to Treatment Cross Over||4
1144201|NCT00117598|2772891|P2|COMPLETED|Prior to Treatment Cross Over||3
1144202|NCT00117598|2772892|P1|COMPLETED|Prior to Treatment Cross Over||0
1144203|NCT00117598|2772888|P5|STARTED|Prior to Treatment Cross Over||0
1144204|NCT00117598|2772889|P4|STARTED|Prior to Treatment Cross Over||0
1144205|NCT00117598|2772890|P3|STARTED|Prior to Treatment Cross Over||56
1144206|NCT00117598|2772891|P2|STARTED|Prior to Treatment Cross Over||56
1144207|NCT00117598|2772892|P1|STARTED|Prior to Treatment Cross Over||57
1144208|NCT00114777|2772923|P3|NOT COMPLETED|Long-Term Extension to Month 84||30
1144209|NCT00114777|2772924|P2|NOT COMPLETED|Long-Term Extension to Month 84||29
1144210|NCT00114777|2772925|P1|NOT COMPLETED|Long-Term Extension to Month 84||30
1144211|NCT00114777|2772923|P3|COMPLETED|Long-Term Extension to Month 84||57
1144212|NCT00114777|2772924|P2|COMPLETED|Long-Term Extension to Month 84||84
1144213|NCT00114777|2772925|P1|COMPLETED|Long-Term Extension to Month 84||74
1144214|NCT00114777|2772923|P3|STARTED|Long-Term Extension to Month 84||87
1144215|NCT00114777|2772924|P2|STARTED|Long-Term Extension to Month 84||113
1144216|NCT00114777|2772925|P1|STARTED|Long-Term Extension to Month 84||104
1144217|NCT00114777|2772923|P3|NOT COMPLETED|Randomization to Month 36||84
1144218|NCT00114777|2772924|P2|NOT COMPLETED|Randomization to Month 36||61
1144219|NCT00114777|2772925|P1|NOT COMPLETED|Randomization to Month 36||75
1144220|NCT00114777|2772923|P3|COMPLETED|Randomization to Month 36||100
1144221|NCT00114777|2772924|P2|COMPLETED|Randomization to Month 36||114
1144222|NCT00114777|2772925|P1|COMPLETED|Randomization to Month 36||109
1144223|NCT00114777|2772923|P3|STARTED|Randomization to Month 36||184
1144224|NCT00114777|2772924|P2|STARTED|Randomization to Month 36||175
1144225|NCT00114777|2772925|P1|STARTED|Randomization to Month 36||184
1144226|NCT00100230|2773001|P2|NOT COMPLETED|Overall Study||15
1144227|NCT00100230|2773002|P1|NOT COMPLETED|Overall Study||12
1144228|NCT00100230|2773001|P2|COMPLETED|Overall Study||22
1144229|NCT00100230|2773002|P1|COMPLETED|Overall Study||29
1144230|NCT00100230|2773001|P2|STARTED|Overall Study||37
1144231|NCT00100230|2773002|P1|STARTED|Overall Study||41
1144232|NCT00073073|2773012|P1|NOT COMPLETED|Overall Study||4
1144233|NCT00073073|2773012|P1|COMPLETED|Overall Study||42
1144234|NCT00073073|2773012|P1|STARTED|Overall Study||46
1144235|NCT00051363|2773025|P2|NOT COMPLETED|Overall Study||144
1144236|NCT00051363|2773026|P1|NOT COMPLETED|Overall Study||115
1144237|NCT00051363|2773025|P2|COMPLETED|Overall Study||403
1144238|NCT00051363|2773026|P1|COMPLETED|Overall Study||443
1144239|NCT00051363|2773025|P2|Completed 6M Vist On-Study|Overall Study||403
1144240|NCT00051363|2773026|P1|Completed 6M Vist On-Study|Overall Study||443
1144241|NCT00051363|2773025|P2|Completed 6M Visit On-Treatment|Overall Study||372
1144242|NCT00051363|2773026|P1|Completed 6M Visit On-Treatment|Overall Study||427
1144243|NCT00051363|2773025|P2|Completed 2M Visit On-Study|Overall Study||432
1144244|NCT00051363|2773026|P1|Completed 2M Visit On-Study|Overall Study||468
1144245|NCT00051363|2773025|P2|Completed 2M Visit On-Treatment|Overall Study||417
1144246|NCT00051363|2773026|P1|Completed 2M Visit On-Treatment|Overall Study||456
1144247|NCT00051363|2773025|P2|Randomized & Analyzed|Overall Study||542
1144248|NCT00051363|2773026|P1|Randomized & Analyzed|Overall Study||556
1144249|NCT00051363|2773025|P2|STARTED|Overall Study||547
1144250|NCT00051363|2773026|P1|STARTED|Overall Study||558
1144251|NCT00044213|2773064|P4|NOT COMPLETED|Overall Study||136
1144252|NCT00044213|2773065|P3|NOT COMPLETED|Overall Study||138
1144253|NCT00044213|2773066|P2|NOT COMPLETED|Overall Study||112
1144254|NCT00044213|2773067|P1|NOT COMPLETED|Overall Study||100
1144255|NCT00044213|2773064|P4|COMPLETED|Overall Study||301
1144256|NCT00044213|2773065|P3|COMPLETED|Overall Study||294
1144257|NCT00044213|2773066|P2|COMPLETED|Overall Study||306
1144258|NCT00044213|2773067|P1|COMPLETED|Overall Study||321
1144259|NCT00044213|2773064|P4|STARTED|Overall Study||437
1144260|NCT00044213|2773065|P3|STARTED|Overall Study||432
1144261|NCT00044213|2773066|P2|STARTED|Overall Study||418
1144262|NCT00044213|2773067|P1|STARTED|Overall Study||421
1144263|NCT00031486|2773083|P2|NOT COMPLETED|Overall Study||12
1144264|NCT00031486|2773084|P1|NOT COMPLETED|Overall Study||7
1144265|NCT00031486|2773083|P2|COMPLETED|Overall Study||35
1144266|NCT00031486|2773084|P1|COMPLETED|Overall Study||33
1144267|NCT00031486|2773083|P2|STARTED|Overall Study||47
1144268|NCT00031486|2773084|P1|STARTED|Overall Study||40
1144269|NCT02943213|2773108|P1|NOT COMPLETED|Treatment Period 2||0
1144270|NCT02943213|2773108|P1|COMPLETED|Treatment Period 2||20
1144271|NCT02943213|2773108|P1|STARTED|Treatment Period 2||20
1144272|NCT02943213|2773108|P1|NOT COMPLETED|Treatment Period 1||0
1144273|NCT02943213|2773108|P1|COMPLETED|Treatment Period 1||20
1144274|NCT02943213|2773108|P1|STARTED|Treatment Period 1||20
1144275|NCT02907268|2773138|P2|NOT COMPLETED|Overall Study||0
1144276|NCT02907268|2773139|P1|NOT COMPLETED|Overall Study||0
1144277|NCT02907268|2773138|P2|COMPLETED|Overall Study||5
1144278|NCT02907268|2773139|P1|COMPLETED|Overall Study||5
1144279|NCT02907268|2773138|P2|STARTED|Overall Study||5
1144280|NCT02907268|2773139|P1|STARTED|Overall Study||5
1144281|NCT02787564|2773148|P2|NOT COMPLETED|Overall Study||2
1144282|NCT02787564|2773149|P1|NOT COMPLETED|Overall Study||7
1144283|NCT02787564|2773148|P2|COMPLETED|Overall Study|n=12 food bank users; n=15 non-food bank users|27
1144284|NCT02787564|2773149|P1|COMPLETED|Overall Study|n=12 food bank users; n=13 non-food bank users|25
1144285|NCT02787564|2773148|P2|STARTED|Overall Study||29
1144286|NCT02787564|2773149|P1|STARTED|Overall Study||32
1144287|NCT02751320|2773165|P1|NOT COMPLETED|Overall Study||3
1144288|NCT02751320|2773165|P1|COMPLETED|Overall Study||42
1144289|NCT02751320|2773165|P1|Received Reference Product 3|Overall Study||28
1144290|NCT02751320|2773165|P1|Received Reference Product 2|Overall Study||28
1144291|NCT02751320|2773165|P1|Received Reference Product 1|Overall Study||29
1144292|NCT02751320|2773165|P1|Received Test Prodcut 3|Overall Study||28
1144293|NCT02751320|2773165|P1|Received Test Prodcut 2|Overall Study||28
1144294|NCT02751320|2773165|P1|Received Test Product 1|Overall Study||29
1144295|NCT02751320|2773165|P1|STARTED|Overall Study||45
1144296|NCT02730351|2773201|P2|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
1144297|NCT02730351|2773202|P1|NOT COMPLETED|Treatment Period 2 (2 Weeks)||2
1144298|NCT02730351|2773201|P2|COMPLETED|Treatment Period 2 (2 Weeks)||36
1144299|NCT02730351|2773202|P1|COMPLETED|Treatment Period 2 (2 Weeks)||33
1144300|NCT02730351|2773201|P2|STARTED|Treatment Period 2 (2 Weeks)||36
1144301|NCT02730351|2773202|P1|STARTED|Treatment Period 2 (2 Weeks)||35
1144302|NCT02730351|2773201|P2|NOT COMPLETED|Wash-out Period (2 Weeks)||1
1144303|NCT02730351|2773202|P1|NOT COMPLETED|Wash-out Period (2 Weeks)||1
1144304|NCT02730351|2773201|P2|COMPLETED|Wash-out Period (2 Weeks)||36
1144305|NCT02730351|2773202|P1|COMPLETED|Wash-out Period (2 Weeks)||35
1144306|NCT02730351|2773201|P2|STARTED|Wash-out Period (2 Weeks)||37
1144307|NCT02730351|2773202|P1|STARTED|Wash-out Period (2 Weeks)||36
1144308|NCT02730351|2773201|P2|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
1144309|NCT02730351|2773202|P1|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1
1144310|NCT02730351|2773201|P2|COMPLETED|Treatment Period 1 (2 Weeks)||37
1144311|NCT02730351|2773202|P1|COMPLETED|Treatment Period 1 (2 Weeks)||36
1144312|NCT02730351|2773201|P2|STARTED|Treatment Period 1 (2 Weeks)||37
1144313|NCT02730351|2773202|P1|STARTED|Treatment Period 1 (2 Weeks)||37
1144314|NCT02724111|2773216|P2|NOT COMPLETED|Overall Study||5
1144315|NCT02724111|2773217|P1|NOT COMPLETED|Overall Study||2
1144316|NCT02724111|2773216|P2|COMPLETED|Overall Study||40
1144317|NCT02724111|2773217|P1|COMPLETED|Overall Study||43
1144318|NCT02724111|2773216|P2|STARTED|Overall Study||45
1144319|NCT02724111|2773217|P1|STARTED|Overall Study||45
1144320|NCT02617901|2773237|P1|NOT COMPLETED|Overall Study||0
1144321|NCT02617901|2773237|P1|COMPLETED|Overall Study||20
1144322|NCT02617901|2773237|P1|STARTED|Overall Study||20
1144323|NCT02524054|2773243|P3|NOT COMPLETED|Overall Study||0
1144324|NCT02524054|2773244|P2|NOT COMPLETED|Overall Study||0
1144325|NCT02524054|2773245|P1|NOT COMPLETED|Overall Study||0
1144326|NCT02524054|2773243|P3|COMPLETED|Overall Study||8
1144327|NCT02524054|2773244|P2|COMPLETED|Overall Study||9
1144328|NCT02524054|2773245|P1|COMPLETED|Overall Study||7
1144329|NCT02524054|2773243|P3|STARTED|Overall Study||8
1144330|NCT02524054|2773244|P2|STARTED|Overall Study||9
1144331|NCT02524054|2773245|P1|STARTED|Overall Study||7
1144332|NCT02336594|2773260|P4|NOT COMPLETED|Overall Study||0
1144333|NCT02336594|2773261|P3|NOT COMPLETED|Overall Study||0
1144334|NCT02336594|2773262|P2|NOT COMPLETED|Overall Study||0
1144335|NCT02336594|2773263|P1|NOT COMPLETED|Overall Study||0
1144336|NCT02336594|2773260|P4|COMPLETED|Overall Study||4
1144337|NCT02336594|2773261|P3|COMPLETED|Overall Study||4
1144338|NCT02336594|2773262|P2|COMPLETED|Overall Study||4
1144339|NCT02336594|2773263|P1|COMPLETED|Overall Study||3
1144340|NCT02336594|2773260|P4|STARTED|Overall Study||4
1144341|NCT02336594|2773261|P3|STARTED|Overall Study||4
1144342|NCT02336594|2773262|P2|STARTED|Overall Study||4
1144343|NCT02336594|2773263|P1|STARTED|Overall Study||3
1144344|NCT02191137|2773303|P1|NOT COMPLETED|Follow-up||5
1144345|NCT02191137|2773303|P1|COMPLETED|Follow-up||60
1144346|NCT02191137|2773303|P1|STARTED|Follow-up||65
1144347|NCT02191137|2773303|P1|NOT COMPLETED|Treatment||10
1144348|NCT02191137|2773303|P1|COMPLETED|Treatment||65
1144349|NCT02191137|2773303|P1|STARTED|Treatment||75
1144350|NCT02187861|2773335|P4|NOT COMPLETED|Overall Study||51
1144351|NCT02187861|2773336|P3|NOT COMPLETED|Overall Study||51
1144352|NCT02187861|2773337|P2|NOT COMPLETED|Overall Study||53
1144353|NCT02187861|2773338|P1|NOT COMPLETED|Overall Study||9
1144354|NCT02187861|2773335|P4|COMPLETED|Overall Study||0
1144355|NCT02187861|2773336|P3|COMPLETED|Overall Study||0
1144356|NCT02187861|2773337|P2|COMPLETED|Overall Study||0
1144357|NCT02187861|2773338|P1|COMPLETED|Overall Study||0
1144358|NCT02187861|2773335|P4|Treated|Overall Study||50
1144359|NCT02187861|2773336|P3|Treated|Overall Study||49
1144360|NCT02187861|2773337|P2|Treated|Overall Study||52
1144361|NCT02187861|2773338|P1|Treated|Overall Study||9
1144362|NCT02187861|2773335|P4|STARTED|Overall Study||51
1144363|NCT02187861|2773336|P3|STARTED|Overall Study||51
1144364|NCT02187861|2773337|P2|STARTED|Overall Study||53
1144365|NCT02187861|2773338|P1|STARTED|Overall Study||9
1144366|NCT02128997|2773436|P2|NOT COMPLETED|Overall Study||11
1144367|NCT02128997|2773437|P1|NOT COMPLETED|Overall Study||6
1144368|NCT02128997|2773436|P2|COMPLETED|Overall Study||58
1144369|NCT02128997|2773437|P1|COMPLETED|Overall Study||61
1144370|NCT02128997|2773436|P2|STARTED|Overall Study||69
1144371|NCT02128997|2773437|P1|STARTED|Overall Study||67
1144372|NCT02092285|2773449|P1|NOT COMPLETED|Maintenance Phase & Follow-up||110
1144373|NCT02092285|2773449|P1|COMPLETED|Maintenance Phase & Follow-up||60
1144374|NCT02092285|2773449|P1|STARTED|Maintenance Phase & Follow-up||170
1144375|NCT02092285|2773449|P1|NOT COMPLETED|Induction Phase||35
1144376|NCT02092285|2773449|P1|COMPLETED|Induction Phase||170
1144377|NCT02092285|2773449|P1|STARTED|Induction Phase||205
1144378|NCT02077140|2773458|P5|NOT COMPLETED|Overall Study||5
1144379|NCT02077140|2773459|P4|NOT COMPLETED|Overall Study||4
1144380|NCT02077140|2773460|P3|NOT COMPLETED|Overall Study||2
1144381|NCT02077140|2773461|P2|NOT COMPLETED|Overall Study||2
1144382|NCT02077140|2773462|P1|NOT COMPLETED|Overall Study||4
1144383|NCT02077140|2773458|P5|COMPLETED|Overall Study||43
1144384|NCT02077140|2773459|P4|COMPLETED|Overall Study||32
1144385|NCT02077140|2773460|P3|COMPLETED|Overall Study||34
1144386|NCT02077140|2773461|P2|COMPLETED|Overall Study||34
1144387|NCT02077140|2773462|P1|COMPLETED|Overall Study||32
1144388|NCT02077140|2773458|P5|STARTED|Overall Study||48
1144389|NCT02077140|2773459|P4|STARTED|Overall Study||36
1144390|NCT02077140|2773460|P3|STARTED|Overall Study||36
1144391|NCT02077140|2773461|P2|STARTED|Overall Study||36
1144392|NCT02077140|2773462|P1|STARTED|Overall Study||36
1144393|NCT02049385|2773549|P2|NOT COMPLETED|Second Intervention||2
1144394|NCT02049385|2773550|P1|NOT COMPLETED|Second Intervention||0
1144395|NCT02049385|2773549|P2|COMPLETED|Second Intervention||0
1144396|NCT02049385|2773550|P1|COMPLETED|Second Intervention||1
1144397|NCT02049385|2773549|P2|STARTED|Second Intervention||2
1144398|NCT02049385|2773550|P1|STARTED|Second Intervention||1
1144399|NCT02049385|2773549|P2|NOT COMPLETED|First Intervention||0
1144400|NCT02049385|2773550|P1|NOT COMPLETED|First Intervention||3
1144401|NCT02049385|2773549|P2|COMPLETED|First Intervention||2
1144402|NCT02049385|2773550|P1|COMPLETED|First Intervention||1
1144403|NCT02049385|2773549|P2|STARTED|First Intervention||2
1144404|NCT02049385|2773550|P1|STARTED|First Intervention||4
1144405|NCT02035696|2773560|P4|NOT COMPLETED|Overall Study||3
1144406|NCT02035696|2773561|P3|NOT COMPLETED|Overall Study||3
1144407|NCT02035696|2773562|P2|NOT COMPLETED|Overall Study||3
1144408|NCT02035696|2773563|P1|NOT COMPLETED|Overall Study||3
1144409|NCT02035696|2773560|P4|COMPLETED|Overall Study||161
1144410|NCT02035696|2773561|P3|COMPLETED|Overall Study||164
1144411|NCT02035696|2773562|P2|COMPLETED|Overall Study||163
1144412|NCT02035696|2773563|P1|COMPLETED|Overall Study||171
1144413|NCT02035696|2773560|P4|STARTED|Overall Study||164
1144414|NCT02035696|2773561|P3|STARTED|Overall Study||167
1144415|NCT02035696|2773562|P2|STARTED|Overall Study||166
1144416|NCT02035696|2773563|P1|STARTED|Overall Study||174
1144417|NCT01807871|2773619|P2|NOT COMPLETED|Overall Study||218
1144418|NCT01807871|2773620|P1|NOT COMPLETED|Overall Study||178
1144419|NCT01807871|2773619|P2|COMPLETED|Overall Study||127
1144420|NCT01807871|2773620|P1|COMPLETED|Overall Study||178
1144421|NCT01807871|2773619|P2|STARTED|Overall Study||345
1144422|NCT01807871|2773620|P1|STARTED|Overall Study||356
1144423|NCT01683019|2773633|P3|NOT COMPLETED|Overall Study||4
1144424|NCT01683019|2773634|P2|NOT COMPLETED|Overall Study||1
1144425|NCT01683019|2773635|P1|NOT COMPLETED|Overall Study||2
1144426|NCT01683019|2773633|P3|COMPLETED|Overall Study||15
1144427|NCT01683019|2773634|P2|COMPLETED|Overall Study||14
1144428|NCT01683019|2773635|P1|COMPLETED|Overall Study||16
1144429|NCT01683019|2773633|P3|STARTED|Overall Study||19
1144430|NCT01683019|2773634|P2|STARTED|Overall Study||15
1144431|NCT01683019|2773635|P1|STARTED|Overall Study||18
1144432|NCT01639040|2773645|P2|NOT COMPLETED|Overall Study||0
1144433|NCT01639040|2773646|P1|NOT COMPLETED|Overall Study||1
1144434|NCT01639040|2773645|P2|COMPLETED|Overall Study||21
1144435|NCT01639040|2773646|P1|COMPLETED|Overall Study||9
1144436|NCT01639040|2773645|P2|STARTED|Overall Study||21
1144437|NCT01639040|2773646|P1|STARTED|Overall Study||10
1144438|NCT01612351|2773662|P1|NOT COMPLETED|Overall Study||0
1144439|NCT01612351|2773662|P1|COMPLETED|Overall Study||40
1144440|NCT01612351|2773662|P1|STARTED|Overall Study||40
1144441|NCT01610492|2773666|P1|NOT COMPLETED|Overall Study||6
1144442|NCT01610492|2773666|P1|COMPLETED|Overall Study||8
1144443|NCT01610492|2773666|P1|STARTED|Overall Study||14
1144444|NCT01575106|2773710|P1|NOT COMPLETED|Overall Study||14
1144445|NCT01575106|2773710|P1|COMPLETED|Overall Study||24
1144446|NCT01575106|2773710|P1|STARTED|Overall Study||38
1144447|NCT01539759|2773718|P2|NOT COMPLETED|Overall Study||8
1144448|NCT01539759|2773719|P1|NOT COMPLETED|Overall Study||6
1144449|NCT01539759|2773718|P2|COMPLETED|Overall Study||48
1144450|NCT01539759|2773719|P1|COMPLETED|Overall Study||50
1144451|NCT01539759|2773718|P2|IUD in Place at 6 Months Posptartum|Overall Study||40
1144452|NCT01539759|2773719|P1|IUD in Place at 6 Months Posptartum|Overall Study||32
1144453|NCT01539759|2773718|P2|IUD Removal|Overall Study||7
1144454|NCT01539759|2773719|P1|IUD Removal|Overall Study||2
1144455|NCT01539759|2773718|P2|IUD Expulsion|Overall Study||4
1144456|NCT01539759|2773719|P1|IUD Expulsion|Overall Study||1
1144457|NCT01539759|2773718|P2|Had Successful IUD Placement|Overall Study||53
1144458|NCT01539759|2773719|P1|Had Successful IUD Placement|Overall Study||34
1144459|NCT01539759|2773718|P2|STARTED|Overall Study||56
1144460|NCT01539759|2773719|P1|STARTED|Overall Study||56
1144461|NCT01506479|2773732|P3|NOT COMPLETED|Overall Study||3
1144462|NCT01506479|2773733|P2|NOT COMPLETED|Overall Study||5
1144463|NCT01506479|2773734|P1|NOT COMPLETED|Overall Study||3
1144464|NCT01506479|2773732|P3|COMPLETED|Overall Study||42
1144465|NCT01506479|2773733|P2|COMPLETED|Overall Study||38
1144466|NCT01506479|2773734|P1|COMPLETED|Overall Study||37
1144467|NCT01506479|2773732|P3|STARTED|Overall Study||45
1144468|NCT01506479|2773733|P2|STARTED|Overall Study||43
1144469|NCT01506479|2773734|P1|STARTED|Overall Study||40
1144470|NCT01262898|2773750|P4|NOT COMPLETED|Overall Study||0
1144471|NCT01262898|2773751|P3|NOT COMPLETED|Overall Study||0
1144472|NCT01262898|2773752|P2|NOT COMPLETED|Overall Study||2
1144473|NCT01262898|2773753|P1|NOT COMPLETED|Overall Study||3
1144474|NCT01262898|2773750|P4|COMPLETED|Overall Study||22
1144475|NCT01262898|2773751|P3|COMPLETED|Overall Study||18
1144476|NCT01262898|2773752|P2|COMPLETED|Overall Study||16
1144477|NCT01262898|2773753|P1|COMPLETED|Overall Study||18
1144478|NCT01262898|2773750|P4|STARTED|Overall Study||22
1144479|NCT01262898|2773751|P3|STARTED|Overall Study||18
1144480|NCT01262898|2773752|P2|STARTED|Overall Study||18
1144481|NCT01262898|2773753|P1|STARTED|Overall Study||21
1144482|NCT01257750|2773873|P1|NOT COMPLETED|Overall Study||0
1144483|NCT01257750|2773873|P1|COMPLETED|Overall Study||20
1144484|NCT01257750|2773873|P1|STARTED|Overall Study||20
1144485|NCT01256840|2773881|P3|NOT COMPLETED|Overall Study||0
1144486|NCT01256840|2773882|P2|NOT COMPLETED|Overall Study||0
1144487|NCT01256840|2773883|P1|NOT COMPLETED|Overall Study||0
1144488|NCT01256840|2773881|P3|COMPLETED|Overall Study||25
1144489|NCT01256840|2773882|P2|COMPLETED|Overall Study||16
1144490|NCT01256840|2773883|P1|COMPLETED|Overall Study||30
1144491|NCT01256840|2773881|P3|STARTED|Overall Study||25
1144492|NCT01256840|2773882|P2|STARTED|Overall Study||16
1144493|NCT01256840|2773883|P1|STARTED|Overall Study||30
1144494|NCT01213329|2773893|P2|NOT COMPLETED|Phase 2||0
1144495|NCT01213329|2773894|P1|NOT COMPLETED|Phase 2||0
1144496|NCT01213329|2773893|P2|COMPLETED|Phase 2||0
1144497|NCT01213329|2773894|P1|COMPLETED|Phase 2||0
1144498|NCT01213329|2773893|P2|STARTED|Phase 2||0
1144499|NCT01213329|2773894|P1|STARTED|Phase 2||0
1144500|NCT01213329|2773893|P2|NOT COMPLETED|Screening||0
1144501|NCT01213329|2773894|P1|NOT COMPLETED|Screening||0
1144502|NCT01213329|2773893|P2|COMPLETED|Screening||25
1144503|NCT01213329|2773894|P1|COMPLETED|Screening||25
1144504|NCT01213329|2773893|P2|STARTED|Screening||25
1144505|NCT01213329|2773894|P1|STARTED|Screening||25
1144506|NCT01154101|2773905|P5|NOT COMPLETED|Overall Study||1
1144507|NCT01154101|2773906|P4|NOT COMPLETED|Overall Study||2
1144508|NCT01154101|2773907|P3|NOT COMPLETED|Overall Study||3
1144509|NCT01154101|2773908|P2|NOT COMPLETED|Overall Study||4
1144510|NCT01154101|2773909|P1|NOT COMPLETED|Overall Study||0
1144511|NCT01154101|2773905|P5|COMPLETED|Overall Study||0
1144512|NCT01154101|2773906|P4|COMPLETED|Overall Study||9
1144513|NCT01154101|2773907|P3|COMPLETED|Overall Study||9
1144514|NCT01154101|2773908|P2|COMPLETED|Overall Study||5
1144515|NCT01154101|2773909|P1|COMPLETED|Overall Study||7
1144516|NCT01154101|2773905|P5|STARTED|Overall Study||1
1144517|NCT01154101|2773906|P4|STARTED|Overall Study||11
1144518|NCT01154101|2773907|P3|STARTED|Overall Study||12
1144519|NCT01154101|2773908|P2|STARTED|Overall Study||9
1144520|NCT01154101|2773909|P1|STARTED|Overall Study||7
1144521|NCT01130493|2773961|P3|NOT COMPLETED|Part 2: OLE||5
1144522|NCT01130493|2773962|P2|NOT COMPLETED|Part 2: OLE||3
1144523|NCT01130493|2773963|P1|NOT COMPLETED|Part 2: OLE||0
1144524|NCT01130493|2773961|P3|COMPLETED|Part 2: OLE||30
1144525|NCT01130493|2773962|P2|COMPLETED|Part 2: OLE||36
1144526|NCT01130493|2773963|P1|COMPLETED|Part 2: OLE||0
1144527|NCT01130493|2773961|P3|STARTED|Part 2: OLE|No subjects received CLE during OLE|35
1144528|NCT01130493|2773962|P2|STARTED|Part 2: OLE|All subjects received IPX066 during OLE|39
1144529|NCT01130493|2773963|P1|STARTED|Part 2: OLE||0
1144530|NCT01130493|2773961|P3|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||2
1144531|NCT01130493|2773962|P2|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0
1144532|NCT01130493|2773963|P1|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0
1144533|NCT01130493|2773961|P3|COMPLETED|Part 1: Double-blind Treatment Period 2||39
1144534|NCT01130493|2773962|P2|COMPLETED|Part 1: Double-blind Treatment Period 2||45
1144535|NCT01130493|2773963|P1|COMPLETED|Part 1: Double-blind Treatment Period 2||0
1144536|NCT01130493|2773961|P3|STARTED|Part 1: Double-blind Treatment Period 2||41
1144537|NCT01130493|2773962|P2|STARTED|Part 1: Double-blind Treatment Period 2||45
1144538|NCT01130493|2773963|P1|STARTED|Part 1: Double-blind Treatment Period 2||0
1144539|NCT01130493|2773961|P3|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||2
1144540|NCT01130493|2773962|P2|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||1
1144541|NCT01130493|2773963|P1|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||0
1144542|NCT01130493|2773961|P3|COMPLETED|Part 1: Open-Label IPX066 Washout||41
1144543|NCT01130493|2773962|P2|COMPLETED|Part 1: Open-Label IPX066 Washout||45
1144544|NCT01130493|2773963|P1|COMPLETED|Part 1: Open-Label IPX066 Washout||0
1144545|NCT01130493|2773961|P3|STARTED|Part 1: Open-Label IPX066 Washout||43
1144546|NCT01130493|2773962|P2|STARTED|Part 1: Open-Label IPX066 Washout||46
1144547|NCT01130493|2773963|P1|STARTED|Part 1: Open-Label IPX066 Washout||0
1144548|NCT01130493|2773961|P3|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0
1144549|NCT01130493|2773962|P2|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||2
1144550|NCT01130493|2773963|P1|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0
1144551|NCT01130493|2773961|P3|COMPLETED|Part 1: Double-blind Treatment Period 1||43
1144552|NCT01130493|2773962|P2|COMPLETED|Part 1: Double-blind Treatment Period 1||46
1144553|NCT01130493|2773963|P1|COMPLETED|Part 1: Double-blind Treatment Period 1||0
1144554|NCT01130493|2773961|P3|STARTED|Part 1: Double-blind Treatment Period 1|43 were randomized to CLE-IPX066 double-blind treatment sequence|43
1144555|NCT01130493|2773962|P2|STARTED|Part 1: Double-blind Treatment Period 1|48 were randomized to IPX066-CLE double-blind treatment sequence|48
1144556|NCT01130493|2773963|P1|STARTED|Part 1: Double-blind Treatment Period 1|91 subjects completed IPX066 dose conversion and were then randomized to the two treatment sequences|0
1144557|NCT01130493|2773961|P3|NOT COMPLETED|Open-label Dose Conversion to IPX066||0
1144558|NCT01130493|2773962|P2|NOT COMPLETED|Open-label Dose Conversion to IPX066||0
1144559|NCT01130493|2773963|P1|NOT COMPLETED|Open-label Dose Conversion to IPX066||19
1144560|NCT01130493|2773961|P3|COMPLETED|Open-label Dose Conversion to IPX066||0
1144561|NCT01130493|2773962|P2|COMPLETED|Open-label Dose Conversion to IPX066||0
1144562|NCT01130493|2773963|P1|COMPLETED|Open-label Dose Conversion to IPX066||91
1144563|NCT01130493|2773961|P3|STARTED|Open-label Dose Conversion to IPX066||0
1144564|NCT01130493|2773962|P2|STARTED|Open-label Dose Conversion to IPX066||0
1144565|NCT01130493|2773963|P1|STARTED|Open-label Dose Conversion to IPX066|During the open-label dose conversion to IPX066, all subjects received IPX066|110
1144566|NCT01118741|2773982|P2|NOT COMPLETED|Overall Study||0
1144567|NCT01118741|2773983|P1|NOT COMPLETED|Overall Study||0
1144568|NCT01118741|2773982|P2|COMPLETED|Overall Study||10
1144569|NCT01118741|2773983|P1|COMPLETED|Overall Study||9
1144570|NCT01118741|2773982|P2|STARTED|Overall Study||10
1144571|NCT01118741|2773983|P1|STARTED|Overall Study||9
1144572|NCT01057862|2773993|P2|NOT COMPLETED|Overall Study||2
1144573|NCT01057862|2773994|P1|NOT COMPLETED|Overall Study||1
1144574|NCT01057862|2773993|P2|COMPLETED|Overall Study||2
1144575|NCT01057862|2773994|P1|COMPLETED|Overall Study||4
1144576|NCT01057862|2773993|P2|STARTED|Overall Study||4
1144577|NCT01057862|2773994|P1|STARTED|Overall Study||5
1144578|NCT00992264|2774018|P16|NOT COMPLETED|Overall Study||0
1144579|NCT00992264|2774019|P15|NOT COMPLETED|Overall Study||0
1144580|NCT00992264|2774020|P14|NOT COMPLETED|Overall Study||0
1144581|NCT00992264|2774021|P13|NOT COMPLETED|Overall Study||0
1144582|NCT00992264|2774022|P12|NOT COMPLETED|Overall Study||0
1144583|NCT00992264|2774023|P11|NOT COMPLETED|Overall Study||0
1144584|NCT00992264|2774024|P10|NOT COMPLETED|Overall Study||0
1144585|NCT00992264|2774025|P9|NOT COMPLETED|Overall Study||0
1144586|NCT00992264|2774026|P8|NOT COMPLETED|Overall Study||0
1144587|NCT00992264|2774027|P7|NOT COMPLETED|Overall Study||0
1144588|NCT00992264|2774028|P6|NOT COMPLETED|Overall Study||0
1144589|NCT00992264|2774029|P5|NOT COMPLETED|Overall Study||0
1144590|NCT00992264|2774030|P4|NOT COMPLETED|Overall Study||0
1144591|NCT00992264|2774031|P3|NOT COMPLETED|Overall Study||0
1144592|NCT00992264|2774032|P2|NOT COMPLETED|Overall Study||0
1144593|NCT00992264|2774033|P1|NOT COMPLETED|Overall Study||0
1144594|NCT00992264|2774018|P16|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
1144595|NCT00992264|2774019|P15|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
1144596|NCT00992264|2774020|P14|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
1144597|NCT00992264|2774021|P13|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
1144598|NCT00992264|2774022|P12|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
1144599|NCT00992264|2774023|P11|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
1144600|NCT00992264|2774024|P10|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
1144601|NCT00992264|2774025|P9|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
1144602|NCT00992264|2774026|P8|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
1144603|NCT00992264|2774027|P7|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
1144604|NCT00992264|2774028|P6|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
1144605|NCT00992264|2774029|P5|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
1144606|NCT00992264|2774030|P4|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
1144607|NCT00992264|2774031|P3|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
1144608|NCT00992264|2774032|P2|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
1144609|NCT00992264|2774033|P1|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
1144610|NCT00992264|2774018|P16|STARTED|Overall Study||116
1144611|NCT00992264|2774019|P15|STARTED|Overall Study||117
1144612|NCT00992264|2774020|P14|STARTED|Overall Study||117
1144613|NCT00992264|2774021|P13|STARTED|Overall Study||116
1144614|NCT00992264|2774022|P12|STARTED|Overall Study||117
1144615|NCT00992264|2774023|P11|STARTED|Overall Study||117
1144616|NCT00992264|2774024|P10|STARTED|Overall Study||116
1144617|NCT00992264|2774025|P9|STARTED|Overall Study||116
1144618|NCT00992264|2774026|P8|STARTED|Overall Study||117
1144619|NCT00992264|2774027|P7|STARTED|Overall Study||116
1144620|NCT00992264|2774028|P6|STARTED|Overall Study||117
1144621|NCT00992264|2774029|P5|STARTED|Overall Study||117
1144622|NCT00992264|2774030|P4|STARTED|Overall Study||117
1144623|NCT00992264|2774031|P3|STARTED|Overall Study||117
1144624|NCT00992264|2774032|P2|STARTED|Overall Study||116
1144625|NCT00992264|2774033|P1|STARTED|Overall Study||116
1144626|NCT00972478|2774049|P2|NOT COMPLETED|Overall Study||38
1144627|NCT00972478|2774050|P1|NOT COMPLETED|Overall Study||7
1144628|NCT00972478|2774049|P2|COMPLETED|Overall Study||34
1144629|NCT00972478|2774050|P1|COMPLETED|Overall Study||4
1144630|NCT00972478|2774049|P2|Eligible and Began Protocol Therapy|Overall Study||63
1144631|NCT00972478|2774050|P1|Eligible and Began Protocol Therapy|Overall Study||9
1144632|NCT00972478|2774049|P2|STARTED|Overall Study||72
1144633|NCT00972478|2774050|P1|STARTED|Overall Study||11
1144637|NCT00896441|2774069|P2|NOT COMPLETED|Overall Study||0
1144638|NCT00896441|2774070|P1|NOT COMPLETED|Overall Study||2
1144639|NCT00896441|2774069|P2|COMPLETED|Overall Study||9
1144640|NCT00896441|2774070|P1|COMPLETED|Overall Study||15
1144641|NCT00896441|2774069|P2|STARTED|Overall Study||9
1144642|NCT00896441|2774070|P1|STARTED|Overall Study||17
1144643|NCT00880048|2774080|P3|NOT COMPLETED|Overall Study||35
1144644|NCT00880048|2774081|P2|NOT COMPLETED|Overall Study||33
1144645|NCT00880048|2774082|P1|NOT COMPLETED|Overall Study||28
1144646|NCT00880048|2774080|P3|COMPLETED|Overall Study||77
1144647|NCT00880048|2774081|P2|COMPLETED|Overall Study||82
1144648|NCT00880048|2774082|P1|COMPLETED|Overall Study||88
1144649|NCT00880048|2774080|P3|STARTED|Overall Study||112
1144650|NCT00880048|2774081|P2|STARTED|Overall Study||115
1144651|NCT00880048|2774082|P1|STARTED|Overall Study||116
1144652|NCT00685516|2774141|P3|NOT COMPLETED|Overall Study||7
1144653|NCT00685516|2774142|P2|NOT COMPLETED|Overall Study||5
1144654|NCT00685516|2774143|P1|NOT COMPLETED|Overall Study||8
1144655|NCT00685516|2774141|P3|COMPLETED|Overall Study||26
1144656|NCT00685516|2774142|P2|COMPLETED|Overall Study||33
1144657|NCT00685516|2774143|P1|COMPLETED|Overall Study||34
1144658|NCT00685516|2774141|P3|STARTED|Overall Study||33
1144659|NCT00685516|2774142|P2|STARTED|Overall Study||38
1144660|NCT00685516|2774143|P1|STARTED|Overall Study||42
1144661|NCT00659230|2774162|P2|NOT COMPLETED|Overall Study||12
1144662|NCT00659230|2774163|P1|NOT COMPLETED|Overall Study||9
1144663|NCT00659230|2774162|P2|COMPLETED|Overall Study||37
1144664|NCT00659230|2774163|P1|COMPLETED|Overall Study||42
1144665|NCT00659230|2774162|P2|STARTED|Overall Study|3 did not return post-randomization, 4 lost source documents, thus 7 excluded from results analysis|49
1144666|NCT00659230|2774163|P1|STARTED|Overall Study|2 did not return post-randomization, 5 lost source documents, thus 7 excluded from results analysis|51
1144693|NCT00644995|2774194|P2|NOT COMPLETED|Overall Study||4
1144694|NCT00644995|2774195|P1|NOT COMPLETED|Overall Study||2
1144695|NCT00644995|2774194|P2|COMPLETED|Overall Study||23
1144696|NCT00644995|2774195|P1|COMPLETED|Overall Study|Completed 6 month assessment|23
1144697|NCT00644995|2774194|P2|Completed 4 Month Assessment|Overall Study||24
1144698|NCT00644995|2774195|P1|Completed 4 Month Assessment|Overall Study||23
1144699|NCT00644995|2774194|P2|STARTED|Overall Study||27
1144700|NCT00644995|2774195|P1|STARTED|Overall Study||25
1144701|NCT00602836|2774213|P1|NOT COMPLETED|Overall Study||5
1144702|NCT00602836|2774213|P1|COMPLETED|Overall Study||39
1144703|NCT00602836|2774213|P1|STARTED|Overall Study||44
1144704|NCT00485953|2774219|P2|NOT COMPLETED|Overall Study||7
1144705|NCT00485953|2774220|P1|NOT COMPLETED|Overall Study||7
1144706|NCT00485953|2774219|P2|COMPLETED|Overall Study||47
1144707|NCT00485953|2774220|P1|COMPLETED|Overall Study||48
1144708|NCT00485953|2774219|P2|STARTED|Overall Study||54
1144709|NCT00485953|2774220|P1|STARTED|Overall Study||55
1144710|NCT00325819|2774232|P2|NOT COMPLETED|Overall Study||13
1144711|NCT00325819|2774233|P1|NOT COMPLETED|Overall Study||9
1144712|NCT00325819|2774232|P2|COMPLETED|Overall Study||176
1144713|NCT00325819|2774233|P1|COMPLETED|Overall Study||176
1144714|NCT00325819|2774232|P2|STARTED|Overall Study||189
1144715|NCT00325819|2774233|P1|STARTED|Overall Study||185
1144716|NCT00287365|2774253|P1|NOT COMPLETED|Overall Study||13
1144717|NCT00287365|2774253|P1|COMPLETED|Overall Study||12
1144718|NCT00287365|2774253|P1|STARTED|Overall Study||25
1144719|NCT00245518|2774264|P2|NOT COMPLETED|Overall Study||0
1144720|NCT00245518|2774265|P1|NOT COMPLETED|Overall Study||0
1144721|NCT00245518|2774264|P2|COMPLETED|Overall Study||16
1144722|NCT00245518|2774265|P1|COMPLETED|Overall Study||17
1144723|NCT00245518|2774264|P2|STARTED|Overall Study||16
1144724|NCT00245518|2774265|P1|STARTED|Overall Study||17
1146271|NCT02675634|2778098|P6|NOT COMPLETED|Test Period 3||0
1146272|NCT02675634|2778099|P5|NOT COMPLETED|Test Period 3||0
1146273|NCT02675634|2778100|P4|NOT COMPLETED|Test Period 3||0
1146274|NCT02675634|2778101|P3|NOT COMPLETED|Test Period 3||0
1146275|NCT02675634|2778102|P2|NOT COMPLETED|Test Period 3||0
1146276|NCT02675634|2778103|P1|NOT COMPLETED|Test Period 3||0
1146277|NCT02675634|2778098|P6|COMPLETED|Test Period 3||8
1146278|NCT02675634|2778099|P5|COMPLETED|Test Period 3||10
1146279|NCT02675634|2778100|P4|COMPLETED|Test Period 3||8
1146280|NCT02675634|2778101|P3|COMPLETED|Test Period 3||8
1146281|NCT02675634|2778102|P2|COMPLETED|Test Period 3||7
1146282|NCT02675634|2778103|P1|COMPLETED|Test Period 3||9
1146283|NCT02675634|2778098|P6|STARTED|Test Period 3||8
1146284|NCT02675634|2778099|P5|STARTED|Test Period 3||10
1146285|NCT02675634|2778100|P4|STARTED|Test Period 3||8
1146286|NCT02675634|2778101|P3|STARTED|Test Period 3||8
1146287|NCT02675634|2778102|P2|STARTED|Test Period 3||7
1146288|NCT02675634|2778103|P1|STARTED|Test Period 3||9
1146289|NCT02675634|2778098|P6|NOT COMPLETED|Test Period 2||1
1146290|NCT02675634|2778099|P5|NOT COMPLETED|Test Period 2||0
1146291|NCT02675634|2778100|P4|NOT COMPLETED|Test Period 2||0
1146292|NCT02675634|2778101|P3|NOT COMPLETED|Test Period 2||0
1146293|NCT02675634|2778102|P2|NOT COMPLETED|Test Period 2||0
1146294|NCT02675634|2778103|P1|NOT COMPLETED|Test Period 2||1
1146295|NCT02675634|2778098|P6|COMPLETED|Test Period 2||8
1146296|NCT02675634|2778099|P5|COMPLETED|Test Period 2||10
1146297|NCT02675634|2778100|P4|COMPLETED|Test Period 2||8
1146298|NCT02675634|2778101|P3|COMPLETED|Test Period 2||8
1146299|NCT02675634|2778102|P2|COMPLETED|Test Period 2||7
1146300|NCT02675634|2778103|P1|COMPLETED|Test Period 2||9
1146301|NCT02675634|2778098|P6|STARTED|Test Period 2||9
1146302|NCT02675634|2778099|P5|STARTED|Test Period 2||10
1146303|NCT02675634|2778100|P4|STARTED|Test Period 2||8
1146304|NCT02675634|2778101|P3|STARTED|Test Period 2||8
1146305|NCT02675634|2778102|P2|STARTED|Test Period 2||7
1146306|NCT02675634|2778103|P1|STARTED|Test Period 2||10
1146307|NCT02675634|2778098|P6|NOT COMPLETED|Test Period 1||0
1146308|NCT02675634|2778099|P5|NOT COMPLETED|Test Period 1||0
1146309|NCT02675634|2778100|P4|NOT COMPLETED|Test Period 1||1
1146310|NCT02675634|2778101|P3|NOT COMPLETED|Test Period 1||1
1146311|NCT02675634|2778102|P2|NOT COMPLETED|Test Period 1||1
1146312|NCT02675634|2778103|P1|NOT COMPLETED|Test Period 1||0
1146313|NCT02675634|2778098|P6|COMPLETED|Test Period 1||9
1146314|NCT02675634|2778099|P5|COMPLETED|Test Period 1||10
1146315|NCT02675634|2778100|P4|COMPLETED|Test Period 1||8
1146316|NCT02675634|2778101|P3|COMPLETED|Test Period 1||8
1146317|NCT02675634|2778102|P2|COMPLETED|Test Period 1||7
1146318|NCT02675634|2778103|P1|COMPLETED|Test Period 1||10
1146319|NCT02675634|2778098|P6|STARTED|Test Period 1||9
1146320|NCT02675634|2778099|P5|STARTED|Test Period 1||10
1146321|NCT02675634|2778100|P4|STARTED|Test Period 1||9
1146322|NCT02675634|2778101|P3|STARTED|Test Period 1||9
1146323|NCT02675634|2778102|P2|STARTED|Test Period 1||8
1146324|NCT02675634|2778103|P1|STARTED|Test Period 1||10
1146325|NCT02651194|2778111|P1|NOT COMPLETED|Overall Study||5
1146326|NCT02651194|2778111|P1|COMPLETED|Overall Study||99
1146327|NCT02651194|2778111|P1|STARTED|Overall Study||104
1146340|NCT02482805|2778141|P3|NOT COMPLETED|Overall Study||0
1146341|NCT02482805|2778142|P2|NOT COMPLETED|Overall Study||4
1146342|NCT02482805|2778143|P1|NOT COMPLETED|Overall Study||4
1146343|NCT02482805|2778141|P3|COMPLETED|Overall Study||20
1146344|NCT02482805|2778142|P2|COMPLETED|Overall Study||23
1146345|NCT02482805|2778143|P1|COMPLETED|Overall Study||22
1146346|NCT02482805|2778141|P3|STARTED|Overall Study||20
1146347|NCT02482805|2778142|P2|STARTED|Overall Study||27
1146348|NCT02482805|2778143|P1|STARTED|Overall Study||26
1146349|NCT02474901|2778159|P2|NOT COMPLETED|Overall Study||0
1146350|NCT02474901|2778160|P1|NOT COMPLETED|Overall Study||1
1146351|NCT02474901|2778159|P2|COMPLETED|Overall Study||56
1146352|NCT02474901|2778160|P1|COMPLETED|Overall Study||44
1146353|NCT02474901|2778159|P2|STARTED|Overall Study||56
1146354|NCT02474901|2778160|P1|STARTED|Overall Study||45
1146376|NCT02442284|2778215|P1|NOT COMPLETED|Overall Study||7
1146377|NCT02442284|2778215|P1|COMPLETED|Overall Study||92
1146378|NCT02442284|2778215|P1|STARTED|Overall Study||99
1146388|NCT02345642|2778242|P2|NOT COMPLETED|Overall Study||0
1146389|NCT02345642|2778243|P1|NOT COMPLETED|Overall Study||0
1146390|NCT02345642|2778242|P2|COMPLETED|Overall Study||10
1146391|NCT02345642|2778243|P1|COMPLETED|Overall Study||10
1146392|NCT02345642|2778242|P2|STARTED|Overall Study||10
1146393|NCT02345642|2778243|P1|STARTED|Overall Study||10
1146394|NCT02279082|2778249|P1|NOT COMPLETED|Overall Study||33
1146395|NCT02279082|2778249|P1|COMPLETED|Overall Study||134
1146396|NCT02279082|2778249|P1|STARTED|Overall Study|Intentions were to have 173 participants, but only 167 participants received study drug.|167
1146397|NCT02277769|2778256|P3|NOT COMPLETED|Overall Study||18
1146398|NCT02277769|2778257|P2|NOT COMPLETED|Overall Study||13
1146399|NCT02277769|2778258|P1|NOT COMPLETED|Overall Study||46
1146400|NCT02277769|2778256|P3|COMPLETED|Overall Study||221
1146401|NCT02277769|2778257|P2|COMPLETED|Overall Study||220
1146402|NCT02277769|2778258|P1|COMPLETED|Overall Study||190
1146403|NCT02277769|2778256|P3|Safety Population|Overall Study|2 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|237
1146404|NCT02277769|2778257|P2|Safety Population|Overall Study|3 participants (1 [placebo] + 2 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|236
1146405|NCT02277769|2778258|P1|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|234
1146406|NCT02277769|2778256|P3|Treated|Overall Study||239
1146407|NCT02277769|2778257|P2|Treated|Overall Study||233
1146408|NCT02277769|2778258|P1|Treated|Overall Study||235
1146409|NCT02277769|2778256|P3|STARTED|Overall Study||239
1146410|NCT02277769|2778257|P2|STARTED|Overall Study||233
1146411|NCT02277769|2778258|P1|STARTED|Overall Study||236
1146444|NCT02240654|2778470|P5|NOT COMPLETED|Overall Study||0
1146445|NCT02240654|2778471|P4|NOT COMPLETED|Overall Study||0
1146446|NCT02240654|2778472|P3|NOT COMPLETED|Overall Study||0
1146447|NCT02240654|2778473|P2|NOT COMPLETED|Overall Study||0
1146448|NCT02240654|2778474|P1|NOT COMPLETED|Overall Study||0
1146449|NCT02240654|2778470|P5|COMPLETED|Overall Study||1285
1146450|NCT02240654|2778471|P4|COMPLETED|Overall Study||2150
1146451|NCT02240654|2778472|P3|COMPLETED|Overall Study||28619
1146452|NCT02240654|2778473|P2|COMPLETED|Overall Study||2813
1146453|NCT02240654|2778474|P1|COMPLETED|Overall Study||1706
1146454|NCT02240654|2778470|P5|STARTED|Overall Study||1285
1146455|NCT02240654|2778471|P4|STARTED|Overall Study||2150
1146456|NCT02240654|2778472|P3|STARTED|Overall Study||28619
1146457|NCT02240654|2778473|P2|STARTED|Overall Study||2813
1146458|NCT02240654|2778474|P1|STARTED|Overall Study||1706
1146465|NCT02197247|2778497|P1|NOT COMPLETED|Part B: Day 78 to End Part B (AZD9291)||15
1146466|NCT02197247|2778497|P1|COMPLETED|Part B: Day 78 to End Part B (AZD9291)||19
1146467|NCT02197247|2778497|P1|STARTED|Part B: Day 78 to End Part B (AZD9291)|32 completed Part A + 2 entered Part B without completing Part A (both due to AE) =34 started Part B|34
1146468|NCT02197247|2778497|P1|NOT COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||5
1146469|NCT02197247|2778497|P1|COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||32
1146470|NCT02197247|2778497|P1|STARTED|Part A: Day 50-77 (AZD9291 Alone)||37
1146471|NCT02197247|2778497|P1|NOT COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||4
1146472|NCT02197247|2778497|P1|COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||37
1146473|NCT02197247|2778497|P1|STARTED|Part A: Day 29-49 (AZD9291+Rifampicin)||41
1146474|NCT02197247|2778497|P1|NOT COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||0
1146475|NCT02197247|2778497|P1|COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||41
1146476|NCT02197247|2778497|P1|STARTED|Part A: Day 1-28 (AZD9291 Alone)||41
1146483|NCT02105688|2778561|P2|NOT COMPLETED|Overall Study||99
1146484|NCT02105688|2778562|P1|NOT COMPLETED|Overall Study||26
1146485|NCT02105688|2778561|P2|COMPLETED|Overall Study|Completed means participant completed Follow-Up Week 24 visit|1
1146486|NCT02105688|2778562|P1|COMPLETED|Overall Study|Completed means participant completed Follow-Up Week 24 visit|175
1146487|NCT02105688|2778561|P2|Not Reached FU Week 12 Visit|Overall Study||15
1146488|NCT02105688|2778562|P1|Not Reached FU Week 12 Visit|Overall Study||2
1146489|NCT02105688|2778561|P2|Completed FU Week 12 Visit, Still in FU|Overall Study||75
1146490|NCT02105688|2778562|P1|Completed FU Week 12 Visit, Still in FU|Overall Study||10
1146491|NCT02105688|2778561|P2|STARTED|Overall Study||100
1146492|NCT02105688|2778562|P1|STARTED|Overall Study||201
1146523|NCT02004236|2778715|P3|NOT COMPLETED|Overall Study||16
1146524|NCT02004236|2778716|P2|NOT COMPLETED|Overall Study||0
1146525|NCT02004236|2778717|P1|NOT COMPLETED|Overall Study||0
1146526|NCT02004236|2778715|P3|COMPLETED|Overall Study|Leave the group because the parents does't find any clinical improvement.|59
1146527|NCT02004236|2778716|P2|COMPLETED|Overall Study||75
1146528|NCT02004236|2778717|P1|COMPLETED|Overall Study||75
1146529|NCT02004236|2778715|P3|STARTED|Overall Study||75
1146530|NCT02004236|2778716|P2|STARTED|Overall Study||75
1146531|NCT02004236|2778717|P1|STARTED|Overall Study||75
1146532|NCT01995071|2778773|P12|NOT COMPLETED|Overall Study||0
1146533|NCT01995071|2778774|P11|NOT COMPLETED|Overall Study||1
1146534|NCT01995071|2778775|P10|NOT COMPLETED|Overall Study||0
1146535|NCT01995071|2778776|P9|NOT COMPLETED|Overall Study||1
1146536|NCT01995071|2778777|P8|NOT COMPLETED|Overall Study||2
1146537|NCT01995071|2778778|P7|NOT COMPLETED|Overall Study||1
1146538|NCT01995071|2778779|P6|NOT COMPLETED|Overall Study||0
1146539|NCT01995071|2778780|P5|NOT COMPLETED|Overall Study||1
1146540|NCT01995071|2778781|P4|NOT COMPLETED|Overall Study||0
1146541|NCT01995071|2778782|P3|NOT COMPLETED|Overall Study||1
1146542|NCT01995071|2778783|P2|NOT COMPLETED|Overall Study||0
1146543|NCT01995071|2778784|P1|NOT COMPLETED|Overall Study||1
1146544|NCT01995071|2778773|P12|COMPLETED|Overall Study||0
1146545|NCT01995071|2778774|P11|COMPLETED|Overall Study||7
1146546|NCT01995071|2778775|P10|COMPLETED|Overall Study||8
1146547|NCT01995071|2778776|P9|COMPLETED|Overall Study||7
1146548|NCT01995071|2778777|P8|COMPLETED|Overall Study||6
1146549|NCT01995071|2778778|P7|COMPLETED|Overall Study||7
1146550|NCT01995071|2778779|P6|COMPLETED|Overall Study||8
1146551|NCT01995071|2778780|P5|COMPLETED|Overall Study||7
1146552|NCT01995071|2778781|P4|COMPLETED|Overall Study||8
1146553|NCT01995071|2778782|P3|COMPLETED|Overall Study||8
1146554|NCT01995071|2778783|P2|COMPLETED|Overall Study||8
1146555|NCT01995071|2778784|P1|COMPLETED|Overall Study||7
1146556|NCT01995071|2778773|P12|STARTED|Overall Study||0
1146557|NCT01995071|2778774|P11|STARTED|Overall Study||8
1146558|NCT01995071|2778775|P10|STARTED|Overall Study||8
1146559|NCT01995071|2778776|P9|STARTED|Overall Study||8
1146560|NCT01995071|2778777|P8|STARTED|Overall Study||8
1146561|NCT01995071|2778778|P7|STARTED|Overall Study||8
1146562|NCT01995071|2778779|P6|STARTED|Overall Study||8
1146563|NCT01995071|2778780|P5|STARTED|Overall Study||8
1146564|NCT01995071|2778781|P4|STARTED|Overall Study||8
1146565|NCT01995071|2778782|P3|STARTED|Overall Study||9
1146566|NCT01995071|2778783|P2|STARTED|Overall Study||8
1146567|NCT01995071|2778784|P1|STARTED|Overall Study||8
1146580|NCT01951963|2778862|P2|NOT COMPLETED|Overall Study||0
1146581|NCT01951963|2778863|P1|NOT COMPLETED|Overall Study||0
1146582|NCT01951963|2778862|P2|COMPLETED|Overall Study||32
1146583|NCT01951963|2778863|P1|COMPLETED|Overall Study||31
1146584|NCT01951963|2778862|P2|STARTED|Overall Study||32
1146585|NCT01951963|2778863|P1|STARTED|Overall Study||31
1146613|NCT01905423|2778965|P4|NOT COMPLETED|Overall Study||0
1146614|NCT01905423|2778966|P3|NOT COMPLETED|Overall Study||0
1146615|NCT01905423|2778967|P2|NOT COMPLETED|Overall Study||0
1146616|NCT01905423|2778968|P1|NOT COMPLETED|Overall Study||0
1146617|NCT01905423|2778965|P4|COMPLETED|Overall Study||3324
1146618|NCT01905423|2778966|P3|COMPLETED|Overall Study||4119
1146619|NCT01905423|2778967|P2|COMPLETED|Overall Study||4111
1146620|NCT01905423|2778968|P1|COMPLETED|Overall Study||7753
1146621|NCT01905423|2778965|P4|Year 3 Follow-up|Overall Study||0
1146622|NCT01905423|2778966|P3|Year 3 Follow-up|Overall Study||0
1146623|NCT01905423|2778967|P2|Year 3 Follow-up|Overall Study||1028
1146624|NCT01905423|2778968|P1|Year 3 Follow-up|Overall Study||1776
1146625|NCT01905423|2778965|P4|Year 2 Follow-up|Overall Study||0
1146626|NCT01905423|2778966|P3|Year 2 Follow-up|Overall Study||0
1146627|NCT01905423|2778967|P2|Year 2 Follow-up|Overall Study||1043
1146628|NCT01905423|2778968|P1|Year 2 Follow-up|Overall Study||1972
1146629|NCT01905423|2778965|P4|Year 1 Follow-up|Overall Study||1690
1146630|NCT01905423|2778966|P3|Year 1 Follow-up|Overall Study||2037
1146631|NCT01905423|2778967|P2|Year 1 Follow-up|Overall Study||1007
1146632|NCT01905423|2778968|P1|Year 1 Follow-up|Overall Study||1840
1146633|NCT01905423|2778965|P4|Baseline|Overall Study||1634
1146634|NCT01905423|2778966|P3|Baseline|Overall Study||2082
1146635|NCT01905423|2778967|P2|Baseline|Overall Study||1033
1146636|NCT01905423|2778968|P1|Baseline|Overall Study||2165
1146637|NCT01905423|2778965|P4|STARTED|Overall Study||3324
1146638|NCT01905423|2778966|P3|STARTED|Overall Study||4119
1146639|NCT01905423|2778967|P2|STARTED|Overall Study||4111
1146640|NCT01905423|2778968|P1|STARTED|Overall Study||7753
1146641|NCT01856686|2778978|P2|NOT COMPLETED|Overall Study||11
1146642|NCT01856686|2778979|P1|NOT COMPLETED|Overall Study||5
1146643|NCT01856686|2778978|P2|COMPLETED|Overall Study||22
1146644|NCT01856686|2778979|P1|COMPLETED|Overall Study||26
1146645|NCT01856686|2778978|P2|STARTED|Overall Study||33
1146646|NCT01856686|2778979|P1|STARTED|Overall Study||31
1146665|NCT01847885|2779042|P3|NOT COMPLETED|Randomization||2
1146666|NCT01847885|2779043|P2|NOT COMPLETED|Randomization||4
1146667|NCT01847885|2779044|P1|NOT COMPLETED|Randomization||0
1146668|NCT01847885|2779042|P3|COMPLETED|Randomization||13
1146669|NCT01847885|2779043|P2|COMPLETED|Randomization||27
1146670|NCT01847885|2779044|P1|COMPLETED|Randomization||0
1146671|NCT01847885|2779042|P3|Per Protocol Set|Randomization||13
1146672|NCT01847885|2779043|P2|Per Protocol Set|Randomization||27
1146673|NCT01847885|2779044|P1|Per Protocol Set|Randomization||0
1146674|NCT01847885|2779042|P3|Safety Set|Randomization||13
1146675|NCT01847885|2779043|P2|Safety Set|Randomization||28
1146676|NCT01847885|2779044|P1|Safety Set|Randomization||0
1146677|NCT01847885|2779042|P3|Full Analysis Set|Randomization||15
1146678|NCT01847885|2779043|P2|Full Analysis Set|Randomization||28
1146679|NCT01847885|2779044|P1|Full Analysis Set|Randomization||0
1146680|NCT01847885|2779042|P3|STARTED|Randomization||15
1146681|NCT01847885|2779043|P2|STARTED|Randomization||31
1146682|NCT01847885|2779044|P1|STARTED|Randomization||0
1146683|NCT01847885|2779042|P3|NOT COMPLETED|Initial Enrollment (Consented)||0
1146684|NCT01847885|2779043|P2|NOT COMPLETED|Initial Enrollment (Consented)||0
1146685|NCT01847885|2779044|P1|NOT COMPLETED|Initial Enrollment (Consented)||48
1146686|NCT01847885|2779042|P3|COMPLETED|Initial Enrollment (Consented)||0
1146687|NCT01847885|2779043|P2|COMPLETED|Initial Enrollment (Consented)||0
1146688|NCT01847885|2779044|P1|COMPLETED|Initial Enrollment (Consented)||40
1146689|NCT01847885|2779042|P3|Per Protocol Set|Initial Enrollment (Consented)||0
1146690|NCT01847885|2779043|P2|Per Protocol Set|Initial Enrollment (Consented)||0
1146691|NCT01847885|2779044|P1|Per Protocol Set|Initial Enrollment (Consented)||40
1146692|NCT01847885|2779042|P3|Safety Set|Initial Enrollment (Consented)||0
1146693|NCT01847885|2779043|P2|Safety Set|Initial Enrollment (Consented)||0
1146694|NCT01847885|2779044|P1|Safety Set|Initial Enrollment (Consented)||41
1146695|NCT01847885|2779042|P3|Full Analysis Set|Initial Enrollment (Consented)||0
1146696|NCT01847885|2779043|P2|Full Analysis Set|Initial Enrollment (Consented)||0
1146697|NCT01847885|2779044|P1|Full Analysis Set|Initial Enrollment (Consented)||43
1146698|NCT01847885|2779042|P3|Randomized|Initial Enrollment (Consented)||0
1146699|NCT01847885|2779043|P2|Randomized|Initial Enrollment (Consented)||0
1146700|NCT01847885|2779044|P1|Randomized|Initial Enrollment (Consented)||46
1146701|NCT01847885|2779042|P3|STARTED|Initial Enrollment (Consented)||0
1146702|NCT01847885|2779043|P2|STARTED|Initial Enrollment (Consented)||0
1146703|NCT01847885|2779044|P1|STARTED|Initial Enrollment (Consented)||88
1146716|NCT01801449|2779095|P1|NOT COMPLETED|Overall Study||0
1146717|NCT01801449|2779095|P1|COMPLETED|Overall Study||6
1146718|NCT01801449|2779095|P1|STARTED|Overall Study||6
1146803|NCT01646762|2779202|P1|NOT COMPLETED|Overall Study||0
1146804|NCT01646762|2779202|P1|COMPLETED|Overall Study||13
1146805|NCT01646762|2779202|P1|STARTED|Overall Study||13
1146851|NCT01561976|2779348|P6|NOT COMPLETED|Period 3||0
1146852|NCT01561976|2779349|P5|NOT COMPLETED|Period 3||0
1146853|NCT01561976|2779350|P4|NOT COMPLETED|Period 3||0
1146854|NCT01561976|2779351|P3|NOT COMPLETED|Period 3||0
1146855|NCT01561976|2779352|P2|NOT COMPLETED|Period 3||0
1146856|NCT01561976|2779353|P1|NOT COMPLETED|Period 3||0
1146857|NCT01561976|2779348|P6|COMPLETED|Period 3||4
1146858|NCT01561976|2779349|P5|COMPLETED|Period 3||5
1146859|NCT01561976|2779350|P4|COMPLETED|Period 3||4
1146860|NCT01561976|2779351|P3|COMPLETED|Period 3||3
1146861|NCT01561976|2779352|P2|COMPLETED|Period 3||5
1146862|NCT01561976|2779353|P1|COMPLETED|Period 3||4
1146863|NCT01561976|2779348|P6|STARTED|Period 3||4
1146864|NCT01561976|2779349|P5|STARTED|Period 3||5
1146865|NCT01561976|2779350|P4|STARTED|Period 3||4
1146866|NCT01561976|2779351|P3|STARTED|Period 3||3
1146867|NCT01561976|2779352|P2|STARTED|Period 3||5
1146868|NCT01561976|2779353|P1|STARTED|Period 3||4
1146869|NCT01561976|2779348|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
1146870|NCT01561976|2779349|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
1146871|NCT01561976|2779350|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
1146872|NCT01561976|2779351|P3|NOT COMPLETED|Washout Period 2 (7 Days)||1
1146873|NCT01561976|2779352|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
1146874|NCT01561976|2779353|P1|NOT COMPLETED|Washout Period 2 (7 Days)||1
1146875|NCT01561976|2779348|P6|COMPLETED|Washout Period 2 (7 Days)||4
1146876|NCT01561976|2779349|P5|COMPLETED|Washout Period 2 (7 Days)||5
1146877|NCT01561976|2779350|P4|COMPLETED|Washout Period 2 (7 Days)||4
1146878|NCT01561976|2779351|P3|COMPLETED|Washout Period 2 (7 Days)||3
1146879|NCT01561976|2779352|P2|COMPLETED|Washout Period 2 (7 Days)||5
1146880|NCT01561976|2779353|P1|COMPLETED|Washout Period 2 (7 Days)||4
1146881|NCT01561976|2779348|P6|STARTED|Washout Period 2 (7 Days)||4
1146882|NCT01561976|2779349|P5|STARTED|Washout Period 2 (7 Days)||5
1146883|NCT01561976|2779350|P4|STARTED|Washout Period 2 (7 Days)||4
1146884|NCT01561976|2779351|P3|STARTED|Washout Period 2 (7 Days)||4
1146885|NCT01561976|2779352|P2|STARTED|Washout Period 2 (7 Days)||5
1146886|NCT01561976|2779353|P1|STARTED|Washout Period 2 (7 Days)||5
1146887|NCT01561976|2779348|P6|NOT COMPLETED|Period 2||0
1146888|NCT01561976|2779349|P5|NOT COMPLETED|Period 2||0
1146889|NCT01561976|2779350|P4|NOT COMPLETED|Period 2||0
1146890|NCT01561976|2779351|P3|NOT COMPLETED|Period 2||0
1146891|NCT01561976|2779352|P2|NOT COMPLETED|Period 2||0
1146892|NCT01561976|2779353|P1|NOT COMPLETED|Period 2||0
1146893|NCT01561976|2779348|P6|COMPLETED|Period 2||4
1146894|NCT01561976|2779349|P5|COMPLETED|Period 2||5
1146895|NCT01561976|2779350|P4|COMPLETED|Period 2||4
1146896|NCT01561976|2779351|P3|COMPLETED|Period 2||4
1146897|NCT01561976|2779352|P2|COMPLETED|Period 2||5
1146898|NCT01561976|2779353|P1|COMPLETED|Period 2||5
1146899|NCT01561976|2779348|P6|STARTED|Period 2||4
1146900|NCT01561976|2779349|P5|STARTED|Period 2||5
1146901|NCT01561976|2779350|P4|STARTED|Period 2||4
1146902|NCT01561976|2779351|P3|STARTED|Period 2||4
1146903|NCT01561976|2779352|P2|STARTED|Period 2||5
1146904|NCT01561976|2779353|P1|STARTED|Period 2||5
1146905|NCT01561976|2779348|P6|NOT COMPLETED|Washout Period 1 (7 Days)||1
1146906|NCT01561976|2779349|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
1146907|NCT01561976|2779350|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
1146908|NCT01561976|2779351|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
1146909|NCT01561976|2779352|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
1146910|NCT01561976|2779353|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
1146911|NCT01561976|2779348|P6|COMPLETED|Washout Period 1 (7 Days)||4
1146912|NCT01561976|2779349|P5|COMPLETED|Washout Period 1 (7 Days)||5
1146913|NCT01561976|2779350|P4|COMPLETED|Washout Period 1 (7 Days)||4
1146914|NCT01561976|2779351|P3|COMPLETED|Washout Period 1 (7 Days)||4
1146915|NCT01561976|2779352|P2|COMPLETED|Washout Period 1 (7 Days)||5
1146916|NCT01561976|2779353|P1|COMPLETED|Washout Period 1 (7 Days)||5
1146917|NCT01561976|2779348|P6|STARTED|Washout Period 1 (7 Days)||5
1146918|NCT01561976|2779349|P5|STARTED|Washout Period 1 (7 Days)||5
1146919|NCT01561976|2779350|P4|STARTED|Washout Period 1 (7 Days)||5
1146920|NCT01561976|2779351|P3|STARTED|Washout Period 1 (7 Days)||4
1146921|NCT01561976|2779352|P2|STARTED|Washout Period 1 (7 Days)||5
1146922|NCT01561976|2779353|P1|STARTED|Washout Period 1 (7 Days)||5
1146923|NCT01561976|2779348|P6|NOT COMPLETED|Period 1||0
1146924|NCT01561976|2779349|P5|NOT COMPLETED|Period 1||0
1146925|NCT01561976|2779350|P4|NOT COMPLETED|Period 1||0
1146926|NCT01561976|2779351|P3|NOT COMPLETED|Period 1||1
1146927|NCT01561976|2779352|P2|NOT COMPLETED|Period 1||0
1146928|NCT01561976|2779353|P1|NOT COMPLETED|Period 1||0
1146929|NCT01561976|2779348|P6|COMPLETED|Period 1||5
1146930|NCT01561976|2779349|P5|COMPLETED|Period 1||5
1146931|NCT01561976|2779350|P4|COMPLETED|Period 1||5
1146932|NCT01561976|2779351|P3|COMPLETED|Period 1||4
1146933|NCT01561976|2779352|P2|COMPLETED|Period 1||5
1146934|NCT01561976|2779353|P1|COMPLETED|Period 1||5
1146935|NCT01561976|2779348|P6|STARTED|Period 1||5
1146936|NCT01561976|2779349|P5|STARTED|Period 1||5
1146937|NCT01561976|2779350|P4|STARTED|Period 1||5
1146938|NCT01561976|2779351|P3|STARTED|Period 1||5
1146939|NCT01561976|2779352|P2|STARTED|Period 1||5
1146940|NCT01561976|2779353|P1|STARTED|Period 1||5
1146941|NCT01535001|2779384|P2|NOT COMPLETED|Overall Study||6
1146942|NCT01535001|2779385|P1|NOT COMPLETED|Overall Study||3
1146943|NCT01535001|2779384|P2|COMPLETED|Overall Study||44
1146944|NCT01535001|2779385|P1|COMPLETED|Overall Study||47
1146945|NCT01535001|2779384|P2|STARTED|Overall Study||50
1146946|NCT01535001|2779385|P1|STARTED|Overall Study||50
1146947|NCT01528592|2779407|P1|NOT COMPLETED|Overall Study||0
1146948|NCT01528592|2779407|P1|COMPLETED|Overall Study||18
1146949|NCT01528592|2779407|P1|STARTED|Overall Study||18
1146950|NCT01470599|2779413|P2|NOT COMPLETED|Overall Study||43
1146951|NCT01470599|2779414|P1|NOT COMPLETED|Overall Study||19
1146952|NCT01470599|2779413|P2|COMPLETED|Overall Study||45
1146953|NCT01470599|2779414|P1|COMPLETED|Overall Study||43
1146954|NCT01470599|2779413|P2|STARTED|Overall Study||88
1146955|NCT01470599|2779414|P1|STARTED|Overall Study||62
1146956|NCT01462565|2779476|P1|NOT COMPLETED|Overall Study||0
1146957|NCT01462565|2779476|P1|COMPLETED|Overall Study||16
1146958|NCT01462565|2779476|P1|STARTED|Overall Study||16
1146959|NCT01462292|2779497|P3|NOT COMPLETED|Overall Study||0
1146960|NCT01462292|2779498|P2|NOT COMPLETED|Overall Study||0
1146961|NCT01462292|2779499|P1|NOT COMPLETED|Overall Study||0
1146962|NCT01462292|2779497|P3|COMPLETED|Overall Study||18
1146963|NCT01462292|2779498|P2|COMPLETED|Overall Study||17
1146964|NCT01462292|2779499|P1|COMPLETED|Overall Study||16
1146965|NCT01462292|2779497|P3|STARTED|Overall Study||18
1146966|NCT01462292|2779498|P2|STARTED|Overall Study||17
1146967|NCT01462292|2779499|P1|STARTED|Overall Study||16
1146968|NCT01435174|2779558|P1|NOT COMPLETED|Overall Study||9
1146969|NCT01435174|2779558|P1|COMPLETED|Overall Study||8
1146970|NCT01435174|2779558|P1|STARTED|Overall Study||17
1146971|NCT01410409|2779564|P2|NOT COMPLETED|Overall Study||4
1146972|NCT01410409|2779565|P1|NOT COMPLETED|Overall Study||1
1146973|NCT01410409|2779564|P2|COMPLETED|Overall Study||46
1146974|NCT01410409|2779565|P1|COMPLETED|Overall Study||49
1146975|NCT01410409|2779564|P2|STARTED|Overall Study||50
1146976|NCT01410409|2779565|P1|STARTED|Overall Study||50
1146992|NCT01314118|2779615|P1|NOT COMPLETED|Overall Study||131
1146993|NCT01314118|2779615|P1|COMPLETED|Overall Study||0
1146994|NCT01314118|2779615|P1|STARTED|Overall Study||131
1146995|NCT01311024|2779624|P2|NOT COMPLETED|Overall Study||22
1146996|NCT01311024|2779625|P1|NOT COMPLETED|Overall Study||35
1146997|NCT01311024|2779624|P2|COMPLETED|Overall Study||789
1146998|NCT01311024|2779625|P1|COMPLETED|Overall Study||1495
1146999|NCT01311024|2779624|P2|STARTED|Overall Study||811
1147000|NCT01311024|2779625|P1|STARTED|Overall Study||1530
1147004|NCT01299610|2779646|P3|NOT COMPLETED|Overall Study||0
1147005|NCT01299610|2779647|P2|NOT COMPLETED|Overall Study||0
1147006|NCT01299610|2779648|P1|NOT COMPLETED|Overall Study||0
1147007|NCT01299610|2779646|P3|COMPLETED|Overall Study||10
1147008|NCT01299610|2779647|P2|COMPLETED|Overall Study||5
1147009|NCT01299610|2779648|P1|COMPLETED|Overall Study||10
1147010|NCT01299610|2779646|P3|STARTED|Overall Study||10
1147011|NCT01299610|2779647|P2|STARTED|Overall Study||5
1147012|NCT01299610|2779648|P1|STARTED|Overall Study||10
1147019|NCT01278394|2779704|P1|NOT COMPLETED|Overall Study||1
1147020|NCT01278394|2779704|P1|COMPLETED|Overall Study||28
1147021|NCT01278394|2779704|P1|STARTED|Overall Study||29
1147104|NCT01204255|2780014|P1|NOT COMPLETED|Overall Study||1
1147105|NCT01204255|2780014|P1|COMPLETED|Overall Study||10
1147106|NCT01204255|2780014|P1|STARTED|Overall Study||11
1147116|NCT01177735|2780043|P1|NOT COMPLETED|Overall Study||71
1147117|NCT01177735|2780043|P1|COMPLETED|Overall Study||0
1147118|NCT01177735|2780043|P1|STARTED|Overall Study||71
1147122|NCT01128621|2780060|P2|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||2
1147123|NCT01128621|2780061|P1|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
1147124|NCT01128621|2780060|P2|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||65
1147125|NCT01128621|2780061|P1|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
1147126|NCT01128621|2780060|P2|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||67
1147127|NCT01128621|2780061|P1|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
1147128|NCT01128621|2780060|P2|NOT COMPLETED|Part A: GSK1292263 300 mg||0
1147129|NCT01128621|2780061|P1|NOT COMPLETED|Part A: GSK1292263 300 mg||0
1147130|NCT01128621|2780060|P2|COMPLETED|Part A: GSK1292263 300 mg||0
1147131|NCT01128621|2780061|P1|COMPLETED|Part A: GSK1292263 300 mg||6
1147132|NCT01128621|2780060|P2|STARTED|Part A: GSK1292263 300 mg||0
1147133|NCT01128621|2780061|P1|STARTED|Part A: GSK1292263 300 mg||6
1147149|NCT01029691|2780216|P3|NOT COMPLETED|Continued APAP to Delivery||1
1147150|NCT01029691|2780217|P2|NOT COMPLETED|Continued APAP to Delivery||0
1147151|NCT01029691|2780218|P1|NOT COMPLETED|Continued APAP to Delivery||0
1147152|NCT01029691|2780216|P3|COMPLETED|Continued APAP to Delivery||76
1147153|NCT01029691|2780217|P2|COMPLETED|Continued APAP to Delivery||16
1147154|NCT01029691|2780218|P1|COMPLETED|Continued APAP to Delivery||20
1147155|NCT01029691|2780216|P3|STARTED|Continued APAP to Delivery||77
1147156|NCT01029691|2780217|P2|STARTED|Continued APAP to Delivery||16
1147157|NCT01029691|2780218|P1|STARTED|Continued APAP to Delivery||20
1147158|NCT01029691|2780216|P3|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0
1147159|NCT01029691|2780217|P2|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||11
1147160|NCT01029691|2780218|P1|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0
1147161|NCT01029691|2780216|P3|COMPLETED|APAP Initiation to Week 1 or Delivery||77
1147162|NCT01029691|2780217|P2|COMPLETED|APAP Initiation to Week 1 or Delivery||16
1147163|NCT01029691|2780218|P1|COMPLETED|APAP Initiation to Week 1 or Delivery||20
1147164|NCT01029691|2780216|P3|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||77
1147165|NCT01029691|2780217|P2|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||16
1147166|NCT01029691|2780218|P1|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||20
1147167|NCT01029691|2780216|P3|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||77
1147168|NCT01029691|2780217|P2|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||23
1147169|NCT01029691|2780218|P1|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||20
1147170|NCT01029691|2780216|P3|STARTED|APAP Initiation to Week 1 or Delivery||77
1147171|NCT01029691|2780217|P2|STARTED|APAP Initiation to Week 1 or Delivery|4 delivered before APAP initiation 7 elected not to have APAP following baseline study|27
1147172|NCT01029691|2780218|P1|STARTED|APAP Initiation to Week 1 or Delivery||20
1147203|NCT00984165|2780424|P4|NOT COMPLETED|Overall Study||4
1147204|NCT00984165|2780425|P3|NOT COMPLETED|Overall Study||0
1147205|NCT00984165|2780426|P2|NOT COMPLETED|Overall Study||1
1147206|NCT00984165|2780427|P1|NOT COMPLETED|Overall Study||7
1147207|NCT00984165|2780424|P4|COMPLETED|Overall Study||0
1147208|NCT00984165|2780425|P3|COMPLETED|Overall Study||4
1147209|NCT00984165|2780426|P2|COMPLETED|Overall Study||0
1147210|NCT00984165|2780427|P1|COMPLETED|Overall Study||2
1147211|NCT00984165|2780424|P4|STARTED|Overall Study||4
1147212|NCT00984165|2780425|P3|STARTED|Overall Study||4
1147213|NCT00984165|2780426|P2|STARTED|Overall Study||1
1147214|NCT00984165|2780427|P1|STARTED|Overall Study||9
1147215|NCT00957723|2780440|P1|NOT COMPLETED|Overall Study||121
1147216|NCT00957723|2780440|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|298
1147217|NCT00957723|2780440|P1|STARTED|Overall Study||419
1147218|NCT00943722|2780456|P5|NOT COMPLETED|Overall Study||22
1147219|NCT00943722|2780457|P4|NOT COMPLETED|Overall Study||22
1147220|NCT00943722|2780458|P3|NOT COMPLETED|Overall Study||13
1147221|NCT00943722|2780459|P2|NOT COMPLETED|Overall Study||22
1147222|NCT00943722|2780460|P1|NOT COMPLETED|Overall Study||25
1147223|NCT00943722|2780456|P5|COMPLETED|Overall Study|Includes 4 participants for whom completion status is unknown|448
1147224|NCT00943722|2780457|P4|COMPLETED|Overall Study||647
1147225|NCT00943722|2780458|P3|COMPLETED|Overall Study||631
1147226|NCT00943722|2780459|P2|COMPLETED|Overall Study||621
1147227|NCT00943722|2780460|P1|COMPLETED|Overall Study||623
1147228|NCT00943722|2780456|P5|Vaccination 3|Overall Study||455
1147229|NCT00943722|2780457|P4|Vaccination 3|Overall Study||653
1147230|NCT00943722|2780458|P3|Vaccination 3|Overall Study||637
1147231|NCT00943722|2780459|P2|Vaccination 3|Overall Study||627
1147232|NCT00943722|2780460|P1|Vaccination 3|Overall Study||635
1147233|NCT00943722|2780456|P5|Vaccination 2|Overall Study||462
1147234|NCT00943722|2780457|P4|Vaccination 2|Overall Study||658
1147235|NCT00943722|2780458|P3|Vaccination 2|Overall Study||638
1147236|NCT00943722|2780459|P2|Vaccination 2|Overall Study||633
1147237|NCT00943722|2780460|P1|Vaccination 2|Overall Study||637
1147238|NCT00943722|2780456|P5|Vaccination 1|Overall Study||468
1147239|NCT00943722|2780457|P4|Vaccination 1|Overall Study||666
1147240|NCT00943722|2780458|P3|Vaccination 1|Overall Study||644
1147241|NCT00943722|2780459|P2|Vaccination 1|Overall Study||642
1147242|NCT00943722|2780460|P1|Vaccination 1|Overall Study||646
1147243|NCT00943722|2780456|P5|STARTED|Overall Study||470
1147244|NCT00943722|2780457|P4|STARTED|Overall Study||669
1147245|NCT00943722|2780458|P3|STARTED|Overall Study||644
1147246|NCT00943722|2780459|P2|STARTED|Overall Study||643
1147247|NCT00943722|2780460|P1|STARTED|Overall Study||648
1147248|NCT00887458|2780490|P2|NOT COMPLETED|Overall Study||4
1147249|NCT00887458|2780491|P1|NOT COMPLETED|Overall Study||0
1147250|NCT00887458|2780490|P2|COMPLETED|Overall Study||25
1147251|NCT00887458|2780491|P1|COMPLETED|Overall Study||17
1147252|NCT00887458|2780490|P2|STARTED|Overall Study||29
1147253|NCT00887458|2780491|P1|STARTED|Overall Study||17
1147299|NCT00846651|2780609|P2|NOT COMPLETED|Overall Study||4
1147300|NCT00846651|2780610|P1|NOT COMPLETED|Overall Study||4
1147301|NCT00846651|2780609|P2|COMPLETED|Overall Study||37
1147302|NCT00846651|2780610|P1|COMPLETED|Overall Study||37
1147303|NCT00846651|2780609|P2|STARTED|Overall Study||41
1147304|NCT00846651|2780610|P1|STARTED|Overall Study||41
1147305|NCT00833989|2780630|P4|NOT COMPLETED|Overall Study||2
1147306|NCT00833989|2780631|P3|NOT COMPLETED|Overall Study||1
1147307|NCT00833989|2780632|P2|NOT COMPLETED|Overall Study||0
1147308|NCT00833989|2780633|P1|NOT COMPLETED|Overall Study||3
1147309|NCT00833989|2780630|P4|COMPLETED|Overall Study||6
1147310|NCT00833989|2780631|P3|COMPLETED|Overall Study||8
1147311|NCT00833989|2780632|P2|COMPLETED|Overall Study||8
1147312|NCT00833989|2780633|P1|COMPLETED|Overall Study||14
1147313|NCT00833989|2780630|P4|STARTED|Overall Study||8
1147314|NCT00833989|2780631|P3|STARTED|Overall Study||9
1147315|NCT00833989|2780632|P2|STARTED|Overall Study||8
1147316|NCT00833989|2780633|P1|STARTED|Overall Study||17
1147329|NCT00739752|2780772|P6|NOT COMPLETED|Overall Study||0
1147330|NCT00739752|2780773|P5|NOT COMPLETED|Overall Study||0
1147331|NCT00739752|2780774|P4|NOT COMPLETED|Overall Study||0
1147332|NCT00739752|2780775|P3|NOT COMPLETED|Overall Study||0
1147333|NCT00739752|2780776|P2|NOT COMPLETED|Overall Study||0
1147334|NCT00739752|2780777|P1|NOT COMPLETED|Overall Study||0
1147335|NCT00739752|2780772|P6|COMPLETED|Overall Study||293
1147336|NCT00739752|2780773|P5|COMPLETED|Overall Study||291
1147337|NCT00739752|2780774|P4|COMPLETED|Overall Study||288
1147338|NCT00739752|2780775|P3|COMPLETED|Overall Study||292
1147339|NCT00739752|2780776|P2|COMPLETED|Overall Study||284
1147340|NCT00739752|2780777|P1|COMPLETED|Overall Study||299
1147341|NCT00739752|2780772|P6|STARTED|Overall Study||293
1147342|NCT00739752|2780773|P5|STARTED|Overall Study||291
1147343|NCT00739752|2780774|P4|STARTED|Overall Study||288
1147344|NCT00739752|2780775|P3|STARTED|Overall Study||292
1147345|NCT00739752|2780776|P2|STARTED|Overall Study||284
1147346|NCT00739752|2780777|P1|STARTED|Overall Study||299
1147347|NCT00725764|2780791|P1|NOT COMPLETED|Overall Study||14
1147348|NCT00725764|2780791|P1|COMPLETED|Overall Study||0
1147349|NCT00725764|2780791|P1|STARTED|Overall Study||14
1147353|NCT00715520|2780820|P3|NOT COMPLETED|Overall Study||2
1147354|NCT00715520|2780821|P2|NOT COMPLETED|Overall Study||1
1147355|NCT00715520|2780822|P1|NOT COMPLETED|Overall Study||10
1147356|NCT00715520|2780820|P3|COMPLETED|Overall Study||1
1147357|NCT00715520|2780821|P2|COMPLETED|Overall Study||9
1147358|NCT00715520|2780822|P1|COMPLETED|Overall Study||10
1147359|NCT00715520|2780820|P3|STARTED|Overall Study||3
1147360|NCT00715520|2780821|P2|STARTED|Overall Study||10
1147361|NCT00715520|2780822|P1|STARTED|Overall Study||20
1147368|NCT00692770|2780848|P2|NOT COMPLETED|Overall Study||558
1147369|NCT00692770|2780849|P1|NOT COMPLETED|Overall Study||556
1147370|NCT00692770|2780848|P2|COMPLETED|Overall Study||0
1147371|NCT00692770|2780849|P1|COMPLETED|Overall Study||0
1147372|NCT00692770|2780848|P2|Participants Received Treatment|Overall Study||554
1147373|NCT00692770|2780849|P1|Participants Received Treatment|Overall Study||553
1147374|NCT00692770|2780848|P2|STARTED|Overall Study||558
1147375|NCT00692770|2780849|P1|STARTED|Overall Study||556
1147376|NCT00657553|2780875|P2|NOT COMPLETED|Overall Study||5
1147377|NCT00657553|2780876|P1|NOT COMPLETED|Overall Study||5
1147378|NCT00657553|2780875|P2|COMPLETED|Overall Study||0
1147379|NCT00657553|2780876|P1|COMPLETED|Overall Study||0
1147380|NCT00657553|2780875|P2|STARTED|Overall Study||5
1147381|NCT00657553|2780876|P1|STARTED|Overall Study||5
1147385|NCT00616200|2780886|P1|NOT COMPLETED|Four Week Very Low Carbohydrate Diet||3
1147386|NCT00616200|2780886|P1|COMPLETED|Four Week Very Low Carbohydrate Diet||13
1147387|NCT00616200|2780886|P1|STARTED|Four Week Very Low Carbohydrate Diet||16
1147388|NCT00616200|2780886|P1|NOT COMPLETED|Two Week Standard Diet||1
1147389|NCT00616200|2780886|P1|COMPLETED|Two Week Standard Diet||16
1147390|NCT00616200|2780886|P1|STARTED|Two Week Standard Diet||17
1147391|NCT00612924|2780894|P2|NOT COMPLETED|Overall Study||9
1147392|NCT00612924|2780895|P1|NOT COMPLETED|Overall Study||7
1147393|NCT00612924|2780894|P2|COMPLETED|Overall Study||85
1147394|NCT00612924|2780895|P1|COMPLETED|Overall Study||94
1147395|NCT00612924|2780894|P2|STARTED|Overall Study||94
1147396|NCT00612924|2780895|P1|STARTED|Overall Study||101
1147449|NCT00545844|2780966|P1|NOT COMPLETED|Overall Study||12
1147450|NCT00545844|2780966|P1|COMPLETED|Overall Study||301
1147451|NCT00545844|2780966|P1|STARTED|Overall Study||313
1147452|NCT00534209|2780980|P1|NOT COMPLETED|Overall Study||0
1147453|NCT00534209|2780980|P1|COMPLETED|Overall Study||1
1147454|NCT00534209|2780980|P1|STARTED|Overall Study||1
1147464|NCT00494442|2781069|P2|NOT COMPLETED|Overall Study||16
1147465|NCT00494442|2781070|P1|NOT COMPLETED|Overall Study||17
1147466|NCT00494442|2781069|P2|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|17
1147467|NCT00494442|2781070|P1|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|7
1147468|NCT00494442|2781069|P2|STARTED|Overall Study|Patients received treatment|33
1147469|NCT00494442|2781070|P1|STARTED|Overall Study|Patients received treatment|24
1147470|NCT00218296|2781086|P2|NOT COMPLETED|Overall Study||121
1147471|NCT00218296|2781087|P1|NOT COMPLETED|Overall Study||111
1147472|NCT00218296|2781086|P2|COMPLETED|Overall Study||48
1147473|NCT00218296|2781087|P1|COMPLETED|Overall Study||52
1147474|NCT00218296|2781086|P2|Attended Visti|Overall Study||102
1147475|NCT00218296|2781087|P1|Attended Visti|Overall Study||97
1147476|NCT00218296|2781086|P2|STARTED|Overall Study||169
1147477|NCT00218296|2781087|P1|STARTED|Overall Study||163
1147481|NCT00189540|2781109|P2|NOT COMPLETED|Overall Study||1
1147482|NCT00189540|2781110|P1|NOT COMPLETED|Overall Study||7
1147483|NCT00189540|2781109|P2|COMPLETED|Overall Study||5
1147484|NCT00189540|2781110|P1|COMPLETED|Overall Study||14
1147485|NCT00189540|2781109|P2|STARTED|Overall Study||6
1147486|NCT00189540|2781110|P1|STARTED|Overall Study||21
1147493|NCT00151411|2781137|P2|NOT COMPLETED|Overall Study||43
1147494|NCT00151411|2781138|P1|NOT COMPLETED|Overall Study||33
1147495|NCT00151411|2781137|P2|COMPLETED|Overall Study||16
1147496|NCT00151411|2781138|P1|COMPLETED|Overall Study||22
1147497|NCT00151411|2781137|P2|STARTED|Overall Study||59
1147498|NCT00151411|2781138|P1|STARTED|Overall Study||55
1147499|NCT00130728|2781150|P2|NOT COMPLETED|Overall Study||213
1147500|NCT00130728|2781151|P1|NOT COMPLETED|Overall Study||211
1147501|NCT00130728|2781150|P2|COMPLETED|Overall Study||104
1147502|NCT00130728|2781151|P1|COMPLETED|Overall Study||108
1147503|NCT00130728|2781150|P2|Received Study Drug (Safety Population)|Overall Study||313
1147504|NCT00130728|2781151|P1|Received Study Drug (Safety Population)|Overall Study||313
1147505|NCT00130728|2781150|P2|STARTED|Overall Study||317
1147506|NCT00130728|2781151|P1|STARTED|Overall Study||319
1147507|NCT00113919|2781163|P1|NOT COMPLETED|Overall Study||14
1147508|NCT00113919|2781163|P1|COMPLETED|Overall Study||0
1147509|NCT00113919|2781163|P1|STARTED|Overall Study||14
1147510|NCT00105560|2781167|P1|NOT COMPLETED|Overall Study||1
1147511|NCT00105560|2781167|P1|COMPLETED|Overall Study||58
1147512|NCT00105560|2781167|P1|STARTED|Overall Study||59
1147513|NCT00083915|2781189|P2|NOT COMPLETED|Overall Study||37
1147514|NCT00083915|2781190|P1|NOT COMPLETED|Overall Study||50
1147515|NCT00083915|2781189|P2|COMPLETED|Overall Study||8
1147516|NCT00083915|2781190|P1|COMPLETED|Overall Study||2
1147517|NCT00083915|2781189|P2|STARTED|Overall Study||45
1147518|NCT00083915|2781190|P1|STARTED|Overall Study||52
1147558|NCT00054353|2781246|P2|NOT COMPLETED|Overall Study||0
1147559|NCT00054353|2781247|P1|NOT COMPLETED|Overall Study||0
1147560|NCT00054353|2781246|P2|COMPLETED|Overall Study||4
1147561|NCT00054353|2781247|P1|COMPLETED|Overall Study||12
1147562|NCT00054353|2781246|P2|STARTED|Overall Study||4
1147563|NCT00054353|2781247|P1|STARTED|Overall Study||12
1147591|NCT00001596|2781318|P2|NOT COMPLETED|Overall Study||10
1147592|NCT00001596|2781319|P1|NOT COMPLETED|Overall Study||17
1147593|NCT00001596|2781318|P2|COMPLETED|Overall Study||2
1147594|NCT00001596|2781319|P1|COMPLETED|Overall Study||6
1147595|NCT00001596|2781318|P2|STARTED|Overall Study||12
1147596|NCT00001596|2781319|P1|STARTED|Overall Study||23
1147597|NCT02847260|2781339|P1|NOT COMPLETED|Overall Study||7
1147598|NCT02847260|2781339|P1|COMPLETED|Overall Study||32
1147599|NCT02847260|2781339|P1|STARTED|Overall Study||39
1147600|NCT02829983|2781353|P2|NOT COMPLETED|Overall Study||0
1147601|NCT02829983|2781354|P1|NOT COMPLETED|Overall Study||0
1147602|NCT02829983|2781353|P2|COMPLETED|Overall Study||20
1147603|NCT02829983|2781354|P1|COMPLETED|Overall Study||20
1147604|NCT02829983|2781353|P2|STARTED|Overall Study||20
1147605|NCT02829983|2781354|P1|STARTED|Overall Study||20
1147615|NCT02596022|2781381|P2|NOT COMPLETED|Overall Study||0
1147616|NCT02596022|2781382|P1|NOT COMPLETED|Overall Study||0
1147617|NCT02596022|2781381|P2|COMPLETED|Overall Study||8
1147618|NCT02596022|2781382|P1|COMPLETED|Overall Study||10
1147619|NCT02596022|2781381|P2|STARTED|Overall Study||8
1147620|NCT02596022|2781382|P1|STARTED|Overall Study||10
1147621|NCT02556333|2781388|P1|NOT COMPLETED|Overall Study||0
1147622|NCT02556333|2781388|P1|COMPLETED|Overall Study||1
1147623|NCT02556333|2781388|P1|STARTED|Overall Study||1
1147636|NCT02461966|2781442|P3|NOT COMPLETED|Overall Study||0
1147637|NCT02461966|2781443|P2|NOT COMPLETED|Overall Study||0
1147638|NCT02461966|2781444|P1|NOT COMPLETED|Overall Study||0
1147639|NCT02461966|2781442|P3|COMPLETED|Overall Study||60
1147640|NCT02461966|2781443|P2|COMPLETED|Overall Study||80
1147641|NCT02461966|2781444|P1|COMPLETED|Overall Study||160
1147642|NCT02461966|2781442|P3|STARTED|Overall Study||60
1147643|NCT02461966|2781443|P2|STARTED|Overall Study||80
1147644|NCT02461966|2781444|P1|STARTED|Overall Study||160
1147657|NCT02359890|2781485|P1|NOT COMPLETED|Overall Study||10
1147658|NCT02359890|2781485|P1|COMPLETED|Overall Study||155
1147659|NCT02359890|2781485|P1|Per-Protocol (PP) Population|Overall Study|Subjects part of mITT population who had undergone RF ablation.|155
1147660|NCT02359890|2781485|P1|mITT Population|Overall Study|Enrolled subjects who met the inclusion/exclusion criteria and had the study catheter inserted|155
1147661|NCT02359890|2781485|P1|Safety Population|Overall Study|Enrolled subjects who had the study catheter inserted|159
1147662|NCT02359890|2781485|P1|STARTED|Overall Study|Patients who enrolled in the study are those who signed informed consent forms.|165
1147696|NCT02260986|2781659|P3|NOT COMPLETED|Overall Study||41
1147697|NCT02260986|2781660|P2|NOT COMPLETED|Overall Study||13
1147698|NCT02260986|2781661|P1|NOT COMPLETED|Overall Study||90
1147699|NCT02260986|2781659|P3|COMPLETED|Overall Study||278
1147700|NCT02260986|2781660|P2|COMPLETED|Overall Study||93
1147701|NCT02260986|2781661|P1|COMPLETED|Overall Study||225
1147702|NCT02260986|2781659|P3|Safety Population|Overall Study|4 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|315
1147703|NCT02260986|2781660|P2|Safety Population|Overall Study|4 participants from Dupilumab 300 mg qw arm analyzed in Dupilumab 300 mg q2w arm|110
1147704|NCT02260986|2781661|P1|Safety Population|Overall Study||315
1147705|NCT02260986|2781659|P3|STARTED|Overall Study||319
1147706|NCT02260986|2781660|P2|STARTED|Overall Study||106
1147707|NCT02260986|2781661|P1|STARTED|Overall Study||315
1147708|NCT02251990|2781779|P2|NOT COMPLETED|Period 3 (DTG Follow-up)||0
1147709|NCT02251990|2781780|P1|NOT COMPLETED|Period 3 (DTG Follow-up)||0
1147710|NCT02251990|2781779|P2|COMPLETED|Period 3 (DTG Follow-up)|Completed 24 weeks of follow-up|121
1147711|NCT02251990|2781780|P1|COMPLETED|Period 3 (DTG Follow-up)||0
1147712|NCT02251990|2781779|P2|STARTED|Period 3 (DTG Follow-up)|3 participants that discontinued treatment in Period 2 were included in Follow-up.|121
1147713|NCT02251990|2781780|P1|STARTED|Period 3 (DTG Follow-up)|The ITG completed the study with Period 2|0
1147714|NCT02251990|2781779|P2|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||3
1147715|NCT02251990|2781780|P1|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||0
1147716|NCT02251990|2781779|P2|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 12 weeks of Grazoprevir/Elbasvir|118
1147717|NCT02251990|2781780|P1|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 24 weeks of follow-up|360
1147798|NCT02075255|2782009|P3|NOT COMPLETED|Overall Study||3
1147718|NCT02251990|2781779|P2|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|1 participant completing Period 1 was not eligible for Period 2 and was not treated.|121
1147719|NCT02251990|2781780|P1|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|2 participants that did not complete Period 1 treatment were included in Follow-up.|360
1147720|NCT02251990|2781779|P2|NOT COMPLETED|Period 1 (Double-blind [DB])||1
1147721|NCT02251990|2781780|P1|NOT COMPLETED|Period 1 (Double-blind [DB])||8
1147722|NCT02251990|2781779|P2|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Placebo|122
1147723|NCT02251990|2781780|P1|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Grazoprevir/Elbasvir|358
1147724|NCT02251990|2781779|P2|Treated|Period 1 (Double-blind [DB])|Started Placebo|123
1147725|NCT02251990|2781780|P1|Treated|Period 1 (Double-blind [DB])|Started Grazoprevir/Elbasvir|365
1147726|NCT02251990|2781779|P2|STARTED|Period 1 (Double-blind [DB])||123
1147727|NCT02251990|2781780|P1|STARTED|Period 1 (Double-blind [DB])||366
1147768|NCT02119650|2781935|P2|NOT COMPLETED|Overall Study||26
1147769|NCT02119650|2781936|P1|NOT COMPLETED|Overall Study||25
1147770|NCT02119650|2781935|P2|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|11
1147771|NCT02119650|2781936|P1|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|14
1147772|NCT02119650|2781935|P2|STARTED|Overall Study||37
1147773|NCT02119650|2781936|P1|STARTED|Overall Study||39
1147799|NCT02075255|2782010|P2|NOT COMPLETED|Overall Study||4
1147800|NCT02075255|2782011|P1|NOT COMPLETED|Overall Study||4
1147801|NCT02075255|2782009|P3|COMPLETED|Overall Study||72
1147802|NCT02075255|2782010|P2|COMPLETED|Overall Study||69
1147803|NCT02075255|2782011|P1|COMPLETED|Overall Study||68
1147804|NCT02075255|2782009|P3|STARTED|Overall Study||75
1147805|NCT02075255|2782010|P2|STARTED|Overall Study||73
1147806|NCT02075255|2782011|P1|STARTED|Overall Study||72
1147813|NCT02015481|2782129|P1|NOT COMPLETED|Overall Study||1
1147814|NCT02015481|2782129|P1|COMPLETED|Overall Study||24
1147815|NCT02015481|2782129|P1|STARTED|Overall Study||25
1147908|NCT01916941|2782357|P2|NOT COMPLETED|Overall Study||4
1147909|NCT01916941|2782358|P1|NOT COMPLETED|Overall Study||5
1147910|NCT01916941|2782357|P2|COMPLETED|Overall Study||14
1147911|NCT01916941|2782358|P1|COMPLETED|Overall Study||13
1147912|NCT01916941|2782357|P2|STARTED|Overall Study||18
1147913|NCT01916941|2782358|P1|STARTED|Overall Study||18
1147962|NCT01762943|2782476|P2|NOT COMPLETED|Overall Study||2
1147963|NCT01762943|2782477|P1|NOT COMPLETED|Overall Study||4
1147964|NCT01762943|2782476|P2|COMPLETED|Overall Study||15
1147965|NCT01762943|2782477|P1|COMPLETED|Overall Study||15
1147966|NCT01762943|2782476|P2|Withdrawal|Overall Study||15
1147967|NCT01762943|2782477|P1|Withdrawal|Overall Study||15
1147968|NCT01762943|2782476|P2|Addback|Overall Study||15
1147969|NCT01762943|2782477|P1|Addback|Overall Study||16
1147970|NCT01762943|2782476|P2|Hypogonadism|Overall Study||15
1147971|NCT01762943|2782477|P1|Hypogonadism|Overall Study||18
1147972|NCT01762943|2782476|P2|STARTED|Overall Study||17
1147973|NCT01762943|2782477|P1|STARTED|Overall Study||19
1147974|NCT01751412|2782485|P1|NOT COMPLETED|Overall Study||1
1147975|NCT01751412|2782485|P1|COMPLETED|Overall Study||11
1147976|NCT01751412|2782485|P1|STARTED|Overall Study||12
1148059|NCT01658228|2782659|P2|NOT COMPLETED|Overall Study||8
1148060|NCT01658228|2782660|P1|NOT COMPLETED|Overall Study||7
1148061|NCT01658228|2782659|P2|COMPLETED|Overall Study||23
1148062|NCT01658228|2782660|P1|COMPLETED|Overall Study||23
1148063|NCT01658228|2782659|P2|STARTED|Overall Study||31
1148064|NCT01658228|2782660|P1|STARTED|Overall Study||30
1148092|NCT01602016|2782748|P1|NOT COMPLETED|Overall Study||0
1148093|NCT01602016|2782748|P1|COMPLETED|Overall Study||0
1148094|NCT01602016|2782748|P1|STARTED|Overall Study||0
1148107|NCT01590394|2782797|P1|NOT COMPLETED|Overall Study||0
1148108|NCT01590394|2782797|P1|COMPLETED|Overall Study||3
1148109|NCT01590394|2782797|P1|STARTED|Overall Study||3
1148191|NCT01305941|2783059|P1|NOT COMPLETED|Overall Study||10
1148192|NCT01305941|2783059|P1|COMPLETED|Overall Study||22
1148193|NCT01305941|2783059|P1|STARTED|Overall Study||32
1148230|NCT01275053|2783322|P1|NOT COMPLETED|Overall Study||0
1148231|NCT01275053|2783322|P1|COMPLETED|Overall Study||12
1148232|NCT01275053|2783322|P1|STARTED|Overall Study||12
1148237|NCT01249404|2783340|P3|NOT COMPLETED|Overall Study||7
1148238|NCT01249404|2783341|P2|NOT COMPLETED|Overall Study||8
1148239|NCT01249404|2783342|P1|NOT COMPLETED|Overall Study||7
1148240|NCT01249404|2783340|P3|COMPLETED|Overall Study||125
1148241|NCT01249404|2783341|P2|COMPLETED|Overall Study||121
1148242|NCT01249404|2783342|P1|COMPLETED|Overall Study||120
1148243|NCT01249404|2783340|P3|STARTED|Overall Study||132
1148244|NCT01249404|2783341|P2|STARTED|Overall Study||129
1148245|NCT01249404|2783342|P1|STARTED|Overall Study||127
1148348|NCT01147172|2783870|P1|NOT COMPLETED|Overall Study||4
1148349|NCT01147172|2783870|P1|COMPLETED|Overall Study||96
1148350|NCT01147172|2783870|P1|STARTED|Overall Study||100
1148360|NCT01098071|2783899|P1|NOT COMPLETED|Overall Study||15
1148361|NCT01098071|2783899|P1|COMPLETED|Overall Study||19
1148362|NCT01098071|2783899|P1|STARTED|Overall Study||34
1148385|NCT01033227|2783950|P2|NOT COMPLETED|Overall Study||0
1148386|NCT01033227|2783951|P1|NOT COMPLETED|Overall Study||0
1148387|NCT01033227|2783950|P2|COMPLETED|Overall Study||2
1148388|NCT01033227|2783951|P1|COMPLETED|Overall Study||3
1148389|NCT01033227|2783950|P2|STARTED|Overall Study||2
1148390|NCT01033227|2783951|P1|STARTED|Overall Study||3
1148409|NCT00989781|2784121|P2|NOT COMPLETED|Adrenal Response ot ACTH||3
1148410|NCT00989781|2784122|P1|NOT COMPLETED|Adrenal Response ot ACTH||5
1148411|NCT00989781|2784121|P2|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented and completed study|15
1148412|NCT00989781|2784122|P1|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented. 2 dropped out and 13 completed study|13
1148413|NCT00989781|2784121|P2|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18
1148414|NCT00989781|2784122|P1|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18
1148415|NCT00989781|2784121|P2|NOT COMPLETED|Ovarian Response to hCG||2
1148416|NCT00989781|2784122|P1|NOT COMPLETED|Ovarian Response to hCG||3
1148417|NCT00989781|2784121|P2|COMPLETED|Ovarian Response to hCG||18
1148418|NCT00989781|2784122|P1|COMPLETED|Ovarian Response to hCG||18
1148419|NCT00989781|2784121|P2|STARTED|Ovarian Response to hCG||20
1148420|NCT00989781|2784122|P1|STARTED|Ovarian Response to hCG||21
1148481|NCT00859573|2784241|P2|NOT COMPLETED|Overall Study||2
1148482|NCT00859573|2784242|P1|NOT COMPLETED|Overall Study||5
1148483|NCT00859573|2784241|P2|COMPLETED|Overall Study||1
1148484|NCT00859573|2784242|P1|COMPLETED|Overall Study||1
1148485|NCT00859573|2784241|P2|STARTED|Overall Study||3
1148486|NCT00859573|2784242|P1|STARTED|Overall Study||6
1148487|NCT00855413|2784248|P1|NOT COMPLETED|Overall Study||0
1148488|NCT00855413|2784248|P1|COMPLETED|Overall Study||15
1148489|NCT00855413|2784248|P1|STARTED|Overall Study||15
1148562|NCT00577512|2784538|P1|NOT COMPLETED|Overall Study||4
1148563|NCT00577512|2784538|P1|COMPLETED|Overall Study||0
1148564|NCT00577512|2784538|P1|STARTED|Overall Study||4
1148565|NCT00574080|2784544|P2|NOT COMPLETED|Overall Study||10
1148566|NCT00574080|2784545|P1|NOT COMPLETED|Overall Study||10
1148567|NCT00574080|2784544|P2|COMPLETED|Overall Study||0
1148568|NCT00574080|2784545|P1|COMPLETED|Overall Study||0
1148569|NCT00574080|2784544|P2|STARTED|Overall Study||10
1148570|NCT00574080|2784545|P1|STARTED|Overall Study||10
1148571|NCT00568178|2784553|P6|NOT COMPLETED|Open Label Extension||80
1148572|NCT00568178|2784554|P5|NOT COMPLETED|Open Label Extension||79
1148573|NCT00568178|2784555|P4|NOT COMPLETED|Open Label Extension||0
1148574|NCT00568178|2784556|P3|NOT COMPLETED|Open Label Extension||0
1148575|NCT00568178|2784557|P2|NOT COMPLETED|Open Label Extension||0
1148576|NCT00568178|2784558|P1|NOT COMPLETED|Open Label Extension||0
1148577|NCT00568178|2784553|P6|COMPLETED|Open Label Extension||54
1148578|NCT00568178|2784554|P5|COMPLETED|Open Label Extension||55
1148579|NCT00568178|2784555|P4|COMPLETED|Open Label Extension||0
1148580|NCT00568178|2784556|P3|COMPLETED|Open Label Extension||0
1148581|NCT00568178|2784557|P2|COMPLETED|Open Label Extension||0
1148582|NCT00568178|2784558|P1|COMPLETED|Open Label Extension||0
1148583|NCT00568178|2784553|P6|STARTED|Open Label Extension||134
1148584|NCT00568178|2784554|P5|STARTED|Open Label Extension||134
1148585|NCT00568178|2784555|P4|STARTED|Open Label Extension||0
1148586|NCT00568178|2784556|P3|STARTED|Open Label Extension||0
1148587|NCT00568178|2784557|P2|STARTED|Open Label Extension||0
1148588|NCT00568178|2784558|P1|STARTED|Open Label Extension||0
1148589|NCT00568178|2784553|P6|NOT COMPLETED|Double Blind Base Study||0
1148590|NCT00568178|2784554|P5|NOT COMPLETED|Double Blind Base Study||0
1148591|NCT00568178|2784555|P4|NOT COMPLETED|Double Blind Base Study||5
1148592|NCT00568178|2784556|P3|NOT COMPLETED|Double Blind Base Study||1
1148593|NCT00568178|2784557|P2|NOT COMPLETED|Double Blind Base Study||6
1148594|NCT00568178|2784558|P1|NOT COMPLETED|Double Blind Base Study||6
1148595|NCT00568178|2784553|P6|COMPLETED|Double Blind Base Study||0
1148596|NCT00568178|2784554|P5|COMPLETED|Double Blind Base Study||0
1148597|NCT00568178|2784555|P4|COMPLETED|Double Blind Base Study||25
1148598|NCT00568178|2784556|P3|COMPLETED|Double Blind Base Study||29
1148599|NCT00568178|2784557|P2|COMPLETED|Double Blind Base Study||118
1148600|NCT00568178|2784558|P1|COMPLETED|Double Blind Base Study||116
1148601|NCT00568178|2784553|P6|STARTED|Double Blind Base Study||0
1148602|NCT00568178|2784554|P5|STARTED|Double Blind Base Study||0
1148603|NCT00568178|2784555|P4|STARTED|Double Blind Base Study||30
1148604|NCT00568178|2784556|P3|STARTED|Double Blind Base Study||30
1148605|NCT00568178|2784557|P2|STARTED|Double Blind Base Study||124
1148606|NCT00568178|2784558|P1|STARTED|Double Blind Base Study||122
1148607|NCT00560755|2784574|P1|NOT COMPLETED|Overall Study||60
1148608|NCT00560755|2784574|P1|COMPLETED|Overall Study||3328
1148609|NCT00560755|2784574|P1|ProQuad® Dose 1 and Dose 2|Overall Study||3346
1148610|NCT00560755|2784574|P1|STARTED|Overall Study|Vaccinated (at least one ProQuad® dose)|3388
1148611|NCT00499746|2784593|P1|NOT COMPLETED|Phase 3 (9-14 One Day Sessions)||0
1148612|NCT00499746|2784593|P1|COMPLETED|Phase 3 (9-14 One Day Sessions)||8
1148613|NCT00499746|2784593|P1|STARTED|Phase 3 (9-14 One Day Sessions)||8
1148614|NCT00499746|2784593|P1|NOT COMPLETED|Phase 2 (6-9 One Day Sessions)||0
1148615|NCT00499746|2784593|P1|COMPLETED|Phase 2 (6-9 One Day Sessions)||8
1148616|NCT00499746|2784593|P1|STARTED|Phase 2 (6-9 One Day Sessions)||8
1148617|NCT00499746|2784593|P1|NOT COMPLETED|Phase 1(6-9 One Day Sessions)||12
1148618|NCT00499746|2784593|P1|COMPLETED|Phase 1(6-9 One Day Sessions)||8
1148619|NCT00499746|2784593|P1|STARTED|Phase 1(6-9 One Day Sessions)||20
1148666|NCT00081939|2784776|P1|NOT COMPLETED|Overall Study||0
1148667|NCT00081939|2784776|P1|COMPLETED|Overall Study||303
1148668|NCT00081939|2784776|P1|STARTED|Overall Study||303
1148696|NCT00068406|2784788|P1|NOT COMPLETED|Overall Study||3
1148697|NCT00068406|2784788|P1|COMPLETED|Overall Study||58
1148698|NCT00068406|2784788|P1|STARTED|Overall Study||61
1148741|NCT00016718|2784872|P3|NOT COMPLETED|Overall Study||0
1148742|NCT00016718|2784873|P2|NOT COMPLETED|Overall Study||0
1148743|NCT00016718|2784874|P1|NOT COMPLETED|Overall Study||0
1148744|NCT00016718|2784872|P3|COMPLETED|Overall Study||16
1148745|NCT00016718|2784873|P2|COMPLETED|Overall Study||21
1148746|NCT00016718|2784874|P1|COMPLETED|Overall Study||6
1148747|NCT00016718|2784872|P3|STARTED|Overall Study||16
1148748|NCT00016718|2784873|P2|STARTED|Overall Study||21
1148749|NCT00016718|2784874|P1|STARTED|Overall Study||6
1148765|NCT02609659|2784903|P1|NOT COMPLETED|Overall Study||8
1148766|NCT02609659|2784903|P1|COMPLETED|Overall Study||97
1148767|NCT02609659|2784903|P1|STARTED|Overall Study||105
1148795|NCT02475395|2784979|P2|NOT COMPLETED|Overall Study||3
1148796|NCT02475395|2784980|P1|NOT COMPLETED|Overall Study||30
1148797|NCT02475395|2784979|P2|COMPLETED|Overall Study||11
1148798|NCT02475395|2784980|P1|COMPLETED|Overall Study||228
1148799|NCT02475395|2784979|P2|STARTED|Overall Study||14
1148800|NCT02475395|2784980|P1|STARTED|Overall Study||258
1148801|NCT02450383|2784992|P2|NOT COMPLETED|Overall Study||0
1148802|NCT02450383|2784993|P1|NOT COMPLETED|Overall Study||0
1148803|NCT02450383|2784992|P2|COMPLETED|Overall Study||10
1148804|NCT02450383|2784993|P1|COMPLETED|Overall Study||10
1148805|NCT02450383|2784992|P2|STARTED|Overall Study||10
1148806|NCT02450383|2784993|P1|STARTED|Overall Study||10
1148810|NCT02419521|2785011|P1|NOT COMPLETED|Overall Study||1
1148811|NCT02419521|2785011|P1|COMPLETED|Overall Study||74
1148812|NCT02419521|2785011|P1|STARTED|Overall Study||75
1148901|NCT02207803|2785398|P2|NOT COMPLETED|Overall Study||17
1148902|NCT02207803|2785399|P1|NOT COMPLETED|Overall Study||15
1148903|NCT02207803|2785398|P2|COMPLETED|Overall Study||108
1148904|NCT02207803|2785399|P1|COMPLETED|Overall Study||110
1148905|NCT02207803|2785398|P2|STARTED|Overall Study||125
1148906|NCT02207803|2785399|P1|STARTED|Overall Study||125
1148934|NCT02102464|2785569|P3|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
1148935|NCT02102464|2785570|P2|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
1148936|NCT02102464|2785571|P1|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
1148937|NCT02102464|2785569|P3|COMPLETED|Crossover LipiFlow Treatment of Control||25
1148938|NCT02102464|2785570|P2|COMPLETED|Crossover LipiFlow Treatment of Control||0
1148939|NCT02102464|2785571|P1|COMPLETED|Crossover LipiFlow Treatment of Control||0
1148940|NCT02102464|2785569|P3|STARTED|Crossover LipiFlow Treatment of Control||25
1148941|NCT02102464|2785570|P2|STARTED|Crossover LipiFlow Treatment of Control||0
1148942|NCT02102464|2785571|P1|STARTED|Crossover LipiFlow Treatment of Control||0
1148943|NCT02102464|2785569|P3|NOT COMPLETED|Randomized Study||0
1148944|NCT02102464|2785570|P2|NOT COMPLETED|Randomized Study||1
1148945|NCT02102464|2785571|P1|NOT COMPLETED|Randomized Study||0
1148946|NCT02102464|2785569|P3|COMPLETED|Randomized Study||0
1148947|NCT02102464|2785570|P2|COMPLETED|Randomized Study||25
1148948|NCT02102464|2785571|P1|COMPLETED|Randomized Study||29
1148949|NCT02102464|2785569|P3|STARTED|Randomized Study||0
1148950|NCT02102464|2785570|P2|STARTED|Randomized Study||26
1148951|NCT02102464|2785571|P1|STARTED|Randomized Study||29
1149012|NCT01986686|2785791|P2|NOT COMPLETED|Overall Study||0
1149013|NCT01986686|2785792|P1|NOT COMPLETED|Overall Study||0
1149014|NCT01986686|2785791|P2|COMPLETED|Overall Study||26
1149015|NCT01986686|2785792|P1|COMPLETED|Overall Study||81
1149016|NCT01986686|2785791|P2|STARTED|Overall Study||26
1149017|NCT01986686|2785792|P1|STARTED|Overall Study||81
1149026|NCT01956435|2785817|P2|NOT COMPLETED|Overall Study||0
1149027|NCT01956435|2785818|P1|NOT COMPLETED|Overall Study||0
1149028|NCT01956435|2785817|P2|COMPLETED|Overall Study||3
1149029|NCT01956435|2785818|P1|COMPLETED|Overall Study||3
1149030|NCT01956435|2785817|P2|STARTED|Overall Study||3
1149031|NCT01956435|2785818|P1|STARTED|Overall Study||3
1149064|NCT01916967|2785858|P3|NOT COMPLETED|Overall Study||9
1149065|NCT01916967|2785859|P2|NOT COMPLETED|Overall Study||1
1149066|NCT01916967|2785860|P1|NOT COMPLETED|Overall Study||0
1149067|NCT01916967|2785858|P3|COMPLETED|Overall Study||71
1149068|NCT01916967|2785859|P2|COMPLETED|Overall Study||78
1149069|NCT01916967|2785860|P1|COMPLETED|Overall Study||80
1149070|NCT01916967|2785858|P3|STARTED|Overall Study||80
1149071|NCT01916967|2785859|P2|STARTED|Overall Study||79
1149072|NCT01916967|2785860|P1|STARTED|Overall Study||80
1149073|NCT01916980|2785903|P2|NOT COMPLETED|Overall Study||4
1149074|NCT01916980|2785904|P1|NOT COMPLETED|Overall Study||7
1149075|NCT01916980|2785903|P2|COMPLETED|Overall Study||25
1149076|NCT01916980|2785904|P1|COMPLETED|Overall Study||58
1149077|NCT01916980|2785903|P2|STARTED|Overall Study||29
1149078|NCT01916980|2785904|P1|STARTED|Overall Study||65
1149085|NCT01854710|2785929|P6|NOT COMPLETED|Overall Study||2
1149086|NCT01854710|2785930|P5|NOT COMPLETED|Overall Study||2
1149087|NCT01854710|2785931|P4|NOT COMPLETED|Overall Study||2
1149088|NCT01854710|2785932|P3|NOT COMPLETED|Overall Study||2
1149089|NCT01854710|2785933|P2|NOT COMPLETED|Overall Study||3
1149090|NCT01854710|2785934|P1|NOT COMPLETED|Overall Study||4
1149091|NCT01854710|2785929|P6|COMPLETED|Overall Study||8
1149092|NCT01854710|2785930|P5|COMPLETED|Overall Study||8
1149093|NCT01854710|2785931|P4|COMPLETED|Overall Study||8
1149094|NCT01854710|2785932|P3|COMPLETED|Overall Study||8
1149095|NCT01854710|2785933|P2|COMPLETED|Overall Study||7
1149096|NCT01854710|2785934|P1|COMPLETED|Overall Study||6
1149097|NCT01854710|2785929|P6|STARTED|Overall Study||10
1149098|NCT01854710|2785930|P5|STARTED|Overall Study||10
1149099|NCT01854710|2785931|P4|STARTED|Overall Study||10
1149100|NCT01854710|2785932|P3|STARTED|Overall Study||10
1149101|NCT01854710|2785933|P2|STARTED|Overall Study||10
1149102|NCT01854710|2785934|P1|STARTED|Overall Study||10
1149109|NCT01819311|2785998|P2|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
1149110|NCT01819311|2785999|P1|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
1149111|NCT01819311|2785998|P2|COMPLETED|Follow-up Phase (8 Weeks)||23
1149112|NCT01819311|2785999|P1|COMPLETED|Follow-up Phase (8 Weeks)||24
1149113|NCT01819311|2785998|P2|STARTED|Follow-up Phase (8 Weeks)||30
1149114|NCT01819311|2785999|P1|STARTED|Follow-up Phase (8 Weeks)||31
1149115|NCT01819311|2785998|P2|NOT COMPLETED|Treatment Phase (4 Weeks)||1
1149116|NCT01819311|2785999|P1|NOT COMPLETED|Treatment Phase (4 Weeks)||2
1149117|NCT01819311|2785998|P2|COMPLETED|Treatment Phase (4 Weeks)||30
1149118|NCT01819311|2785999|P1|COMPLETED|Treatment Phase (4 Weeks)||31
1149119|NCT01819311|2785998|P2|STARTED|Treatment Phase (4 Weeks)||31
1149120|NCT01819311|2785999|P1|STARTED|Treatment Phase (4 Weeks)||33
1149127|NCT01765530|2786030|P2|NOT COMPLETED|Overall Study||1
1149128|NCT01765530|2786031|P1|NOT COMPLETED|Overall Study||1
1149129|NCT01765530|2786030|P2|COMPLETED|Overall Study||36
1149130|NCT01765530|2786031|P1|COMPLETED|Overall Study||36
1149131|NCT01765530|2786030|P2|STARTED|Overall Study||37
1149132|NCT01765530|2786031|P1|STARTED|Overall Study||37
1149176|NCT01732445|2786202|P1|NOT COMPLETED|Overall Study||0
1149177|NCT01732445|2786202|P1|COMPLETED|Overall Study||14
1149178|NCT01732445|2786202|P1|STARTED|Overall Study||14
1149182|NCT01687712|2786219|P2|NOT COMPLETED|Cycle 3||24
1149183|NCT01687712|2786220|P1|NOT COMPLETED|Cycle 3||24
1149184|NCT01687712|2786219|P2|COMPLETED|Cycle 3||0
1149185|NCT01687712|2786220|P1|COMPLETED|Cycle 3||4
1149186|NCT01687712|2786219|P2|Clinical Pregnancy|Cycle 3||0
1149187|NCT01687712|2786220|P1|Clinical Pregnancy|Cycle 3||5
1149188|NCT01687712|2786219|P2|Biochemically Pregnant|Cycle 3||2
1149189|NCT01687712|2786220|P1|Biochemically Pregnant|Cycle 3||7
1149190|NCT01687712|2786219|P2|Embryo Transfer|Cycle 3||24
1149191|NCT01687712|2786220|P1|Embryo Transfer|Cycle 3||26
1149192|NCT01687712|2786219|P2|Fertilization Performed|Cycle 3||24
1149193|NCT01687712|2786220|P1|Fertilization Performed|Cycle 3||27
1149194|NCT01687712|2786219|P2|Ooctye/Ovum Pick-Up|Cycle 3||24
1149195|NCT01687712|2786220|P1|Ooctye/Ovum Pick-Up|Cycle 3||27
1149196|NCT01687712|2786219|P2|Received hCG|Cycle 3||24
1149197|NCT01687712|2786220|P1|Received hCG|Cycle 3||27
1149198|NCT01687712|2786219|P2|STARTED|Cycle 3||24
1149199|NCT01687712|2786220|P1|STARTED|Cycle 3||28
1149200|NCT01687712|2786219|P2|NOT COMPLETED|Cycle 2||95
1149201|NCT01687712|2786220|P1|NOT COMPLETED|Cycle 2||93
1149202|NCT01687712|2786219|P2|COMPLETED|Cycle 2||25
1149203|NCT01687712|2786220|P1|COMPLETED|Cycle 2||16
1149204|NCT01687712|2786219|P2|Clinical Pregnancy|Cycle 2||26
1149205|NCT01687712|2786220|P1|Clinical Pregnancy|Cycle 2||17
1149206|NCT01687712|2786219|P2|Biochemical Pregnancy|Cycle 2||43
1149207|NCT01687712|2786220|P1|Biochemical Pregnancy|Cycle 2||35
1149208|NCT01687712|2786219|P2|Embryo Transfer|Cycle 2||117
1149209|NCT01687712|2786220|P1|Embryo Transfer|Cycle 2||101
1149210|NCT01687712|2786219|P2|Fertilization Performed|Cycle 2||119
1149211|NCT01687712|2786220|P1|Fertilization Performed|Cycle 2||106
1149212|NCT01687712|2786219|P2|Oocyte/Ovum Pick Up|Cycle 2||119
1149213|NCT01687712|2786220|P1|Oocyte/Ovum Pick Up|Cycle 2||107
1149214|NCT01687712|2786219|P2|Received hCG|Cycle 2||119
1149215|NCT01687712|2786220|P1|Received hCG|Cycle 2||107
1149216|NCT01687712|2786219|P2|STARTED|Cycle 2||120
1149217|NCT01687712|2786220|P1|STARTED|Cycle 2||109
1149218|NCT01687712|2786219|P2|NOT COMPLETED|Cycle 1||429
1149219|NCT01687712|2786220|P1|NOT COMPLETED|Cycle 1||448
1149220|NCT01687712|2786219|P2|COMPLETED|Cycle 1||122
1149221|NCT01687712|2786220|P1|COMPLETED|Cycle 1||101
1149222|NCT01687712|2786219|P2|Clinical Pregnancy|Cycle 1||138
1149223|NCT01687712|2786220|P1|Clinical Pregnancy|Cycle 1||114
1149224|NCT01687712|2786219|P2|Biochemical Pregnancy|Cycle 1||203
1149225|NCT01687712|2786220|P1|Biochemical Pregnancy|Cycle 1||163
1149226|NCT01687712|2786219|P2|Embryo Transfer|Cycle 1||483
1149227|NCT01687712|2786220|P1|Embryo Transfer|Cycle 1||466
1149228|NCT01687712|2786219|P2|Fertilization Performed|Cycle 1||512
1149229|NCT01687712|2786220|P1|Fertilization Performed|Cycle 1||508
1149230|NCT01687712|2786219|P2|Oocyte/Ovum Pick Up|Cycle 1||517
1149231|NCT01687712|2786220|P1|Oocyte/Ovum Pick Up|Cycle 1||513
1149232|NCT01687712|2786219|P2|Received hCG|Cycle 1||520
1149233|NCT01687712|2786220|P1|Received hCG|Cycle 1||516
1149234|NCT01687712|2786219|P2|STARTED|Cycle 1||551
1149235|NCT01687712|2786220|P1|STARTED|Cycle 1||549
1149236|NCT01641042|2786260|P2|NOT COMPLETED|Overall Study||0
1149237|NCT01641042|2786261|P1|NOT COMPLETED|Overall Study||0
1149238|NCT01641042|2786260|P2|COMPLETED|Overall Study||43
1149239|NCT01641042|2786261|P1|COMPLETED|Overall Study||43
1149240|NCT01641042|2786260|P2|STARTED|Overall Study||43
1149241|NCT01641042|2786261|P1|STARTED|Overall Study||43
1149242|NCT01626352|2786307|P1|NOT COMPLETED|Overall Study||10
1149243|NCT01626352|2786307|P1|COMPLETED|Overall Study||12
1149244|NCT01626352|2786307|P1|STARTED|Overall Study||22
1149254|NCT01611792|2786332|P2|NOT COMPLETED|Followup: at 6 Months||13
1149255|NCT01611792|2786333|P1|NOT COMPLETED|Followup: at 6 Months||6
1149256|NCT01611792|2786332|P2|COMPLETED|Followup: at 6 Months||7
1149257|NCT01611792|2786333|P1|COMPLETED|Followup: at 6 Months||11
1149258|NCT01611792|2786332|P2|STARTED|Followup: at 6 Months||20
1149259|NCT01611792|2786333|P1|STARTED|Followup: at 6 Months||17
1149260|NCT01611792|2786332|P2|NOT COMPLETED|Follow-up: at 11 Weeks||0
1149261|NCT01611792|2786333|P1|NOT COMPLETED|Follow-up: at 11 Weeks||0
1149262|NCT01611792|2786332|P2|COMPLETED|Follow-up: at 11 Weeks||20
1149263|NCT01611792|2786333|P1|COMPLETED|Follow-up: at 11 Weeks||17
1149264|NCT01611792|2786332|P2|STARTED|Follow-up: at 11 Weeks||20
1149265|NCT01611792|2786333|P1|STARTED|Follow-up: at 11 Weeks||17
1149266|NCT01611792|2786332|P2|NOT COMPLETED|Initial Period: Time 0||9
1149267|NCT01611792|2786333|P1|NOT COMPLETED|Initial Period: Time 0||12
1149268|NCT01611792|2786332|P2|COMPLETED|Initial Period: Time 0||20
1149269|NCT01611792|2786333|P1|COMPLETED|Initial Period: Time 0||17
1149270|NCT01611792|2786332|P2|STARTED|Initial Period: Time 0||29
1149271|NCT01611792|2786333|P1|STARTED|Initial Period: Time 0||29
1149272|NCT01596283|2786351|P2|NOT COMPLETED|Overall Study||0
1149273|NCT01596283|2786352|P1|NOT COMPLETED|Overall Study||0
1149274|NCT01596283|2786351|P2|COMPLETED|Overall Study||66
1149275|NCT01596283|2786352|P1|COMPLETED|Overall Study||69
1149276|NCT01596283|2786351|P2|STARTED|Overall Study||66
1149277|NCT01596283|2786352|P1|STARTED|Overall Study||69
1149278|NCT01594385|2786368|P2|NOT COMPLETED|Overall Study||0
1149279|NCT01594385|2786369|P1|NOT COMPLETED|Overall Study||0
1149280|NCT01594385|2786368|P2|COMPLETED|Overall Study||13
1149281|NCT01594385|2786369|P1|COMPLETED|Overall Study||17
1149282|NCT01594385|2786368|P2|STARTED|Overall Study||13
1149283|NCT01594385|2786369|P1|STARTED|Overall Study||17
1149374|NCT01369641|2786667|P1|NOT COMPLETED|Overall Study||1
1149375|NCT01369641|2786667|P1|COMPLETED|Overall Study||0
1149376|NCT01369641|2786667|P1|STARTED|Overall Study||1
1149377|NCT01364090|2786674|P3|NOT COMPLETED|Overall Study||6
1149378|NCT01364090|2786675|P2|NOT COMPLETED|Overall Study||3
1149379|NCT01364090|2786676|P1|NOT COMPLETED|Overall Study||14
1149380|NCT01364090|2786674|P3|COMPLETED|Overall Study||0
1149381|NCT01364090|2786675|P2|COMPLETED|Overall Study||58
1149382|NCT01364090|2786676|P1|COMPLETED|Overall Study||12
1149383|NCT01364090|2786674|P3|STARTED|Overall Study||6
1149384|NCT01364090|2786675|P2|STARTED|Overall Study||61
1149385|NCT01364090|2786676|P1|STARTED|Overall Study||26
1149392|NCT01323387|2786703|P1|NOT COMPLETED|Overall Study||84
1149393|NCT01323387|2786703|P1|COMPLETED|Overall Study||94
1149394|NCT01323387|2786703|P1|STARTED|Overall Study||178
1149395|NCT01295112|2786716|P2|NOT COMPLETED|Overall Study||0
1149396|NCT01295112|2786717|P1|NOT COMPLETED|Overall Study||0
1149397|NCT01295112|2786716|P2|COMPLETED|Overall Study||33
1149398|NCT01295112|2786717|P1|COMPLETED|Overall Study||35
1149399|NCT01295112|2786716|P2|STARTED|Overall Study||33
1149400|NCT01295112|2786717|P1|STARTED|Overall Study||35
1149431|NCT01256671|2786965|P1|NOT COMPLETED|Overall Study||95
1149432|NCT01256671|2786965|P1|COMPLETED|Overall Study||435
1149433|NCT01256671|2786965|P1|Safety Population|Overall Study||521
1149434|NCT01256671|2786965|P1|STARTED|Overall Study||530
1149435|NCT01239394|2786976|P1|NOT COMPLETED|Overall Study||1
1149436|NCT01239394|2786976|P1|COMPLETED|Overall Study||41
1149437|NCT01239394|2786976|P1|STARTED|Overall Study||42
1149450|NCT01212770|2787139|P7|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
1149451|NCT01212770|2787140|P6|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||3
1149452|NCT01212770|2787141|P5|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
1149453|NCT01212770|2787142|P4|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||11
1149454|NCT01212770|2787143|P3|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||12
1149455|NCT01212770|2787144|P2|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||19
1149456|NCT01212770|2787145|P1|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
1149457|NCT01212770|2787139|P7|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
1149458|NCT01212770|2787140|P6|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||44
1149459|NCT01212770|2787141|P5|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
1149460|NCT01212770|2787142|P4|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||32
1149461|NCT01212770|2787143|P3|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||126
1149462|NCT01212770|2787144|P2|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||120
1149463|NCT01212770|2787145|P1|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
1149464|NCT01212770|2787139|P7|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
1149465|NCT01212770|2787140|P6|STARTED|Active Treatment Phase (Weeks 25 - 52)|Three participants who escaped early and completed Week 24 did not enter the active treatment phase|47
1149466|NCT01212770|2787141|P5|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
1149467|NCT01212770|2787142|P4|STARTED|Active Treatment Phase (Weeks 25 - 52)|Three participants who escaped early and completed Week 24 did not enter the active treatment phase|43
1149468|NCT01212770|2787143|P3|STARTED|Active Treatment Phase (Weeks 25 - 52)|Seven participants who completed the placebo-controlled phase did not enter this phase|138
1149469|NCT01212770|2787144|P2|STARTED|Active Treatment Phase (Weeks 25 - 52)|Eight participants who completed the placebo-controlled phase did not enter this phase|139
1149470|NCT01212770|2787145|P1|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
1149471|NCT01212770|2787139|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1149472|NCT01212770|2787140|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1149473|NCT01212770|2787141|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1149474|NCT01212770|2787142|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1149475|NCT01212770|2787143|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
1149476|NCT01212770|2787144|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
1149477|NCT01212770|2787145|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23
1149478|NCT01212770|2787139|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1149479|NCT01212770|2787140|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1149480|NCT01212770|2787141|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1149481|NCT01212770|2787142|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
1149482|NCT01212770|2787143|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||145
1149483|NCT01212770|2787144|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||147
1149484|NCT01212770|2787145|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||146
1149485|NCT01212770|2787139|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1149486|NCT01212770|2787140|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1149487|NCT01212770|2787141|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1149488|NCT01212770|2787142|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1149489|NCT01212770|2787143|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|One participant who escaped early did not complete Week 24|53
1149490|NCT01212770|2787144|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||76
1149491|NCT01212770|2787145|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|One participant who escaped early did not complete Week 24|97
1149492|NCT01212770|2787139|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1149493|NCT01212770|2787140|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1149494|NCT01212770|2787141|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1149495|NCT01212770|2787142|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
1149496|NCT01212770|2787143|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
1149497|NCT01212770|2787144|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||157
1149498|NCT01212770|2787145|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
1149499|NCT01212770|2787139|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1149500|NCT01212770|2787140|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1149501|NCT01212770|2787141|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1149502|NCT01212770|2787142|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
1149503|NCT01212770|2787143|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||167
1149504|NCT01212770|2787144|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
1149505|NCT01212770|2787145|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
1149506|NCT01212770|2787139|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1149507|NCT01212770|2787140|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1149508|NCT01212770|2787141|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1149509|NCT01212770|2787142|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
1149510|NCT01212770|2787143|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||167
1149511|NCT01212770|2787144|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
1149512|NCT01212770|2787145|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
1149513|NCT01196416|2787332|P1|NOT COMPLETED|Overall Study||2
1149514|NCT01196416|2787332|P1|COMPLETED|Overall Study||12
1149515|NCT01196416|2787332|P1|STARTED|Overall Study||14
1149516|NCT01192295|2787341|P2|NOT COMPLETED|Overall Study||23
1149517|NCT01192295|2787342|P1|NOT COMPLETED|Overall Study||10
1149518|NCT01192295|2787341|P2|COMPLETED|Overall Study||105
1149519|NCT01192295|2787342|P1|COMPLETED|Overall Study||17
1149520|NCT01192295|2787341|P2|STARTED|Overall Study||128
1149521|NCT01192295|2787342|P1|STARTED|Overall Study||27
1149549|NCT01108757|2787468|P2|NOT COMPLETED|Overall Study||0
1149550|NCT01108757|2787469|P1|NOT COMPLETED|Overall Study||0
1149551|NCT01108757|2787468|P2|COMPLETED|Overall Study||26
1149552|NCT01108757|2787469|P1|COMPLETED|Overall Study||26
1149553|NCT01108757|2787468|P2|STARTED|Overall Study||26
1149554|NCT01108757|2787469|P1|STARTED|Overall Study||26
1149595|NCT01009515|2787558|P1|NOT COMPLETED|Overall Study||3
1149596|NCT01009515|2787558|P1|COMPLETED|Overall Study||16
1149597|NCT01009515|2787558|P1|STARTED|Overall Study||19
1149601|NCT00996840|2787575|P5|NOT COMPLETED|Overall Study||2
1149602|NCT00996840|2787576|P4|NOT COMPLETED|Overall Study||1
1149603|NCT00996840|2787577|P3|NOT COMPLETED|Overall Study||1
1149604|NCT00996840|2787578|P2|NOT COMPLETED|Overall Study||2
1149605|NCT00996840|2787579|P1|NOT COMPLETED|Overall Study||1
1149606|NCT00996840|2787575|P5|COMPLETED|Overall Study||16
1149607|NCT00996840|2787576|P4|COMPLETED|Overall Study||17
1149608|NCT00996840|2787577|P3|COMPLETED|Overall Study||11
1149609|NCT00996840|2787578|P2|COMPLETED|Overall Study||7
1149610|NCT00996840|2787579|P1|COMPLETED|Overall Study||19
1149611|NCT00996840|2787575|P5|STARTED|Overall Study||18
1149612|NCT00996840|2787576|P4|STARTED|Overall Study||18
1149613|NCT00996840|2787577|P3|STARTED|Overall Study||12
1149614|NCT00996840|2787578|P2|STARTED|Overall Study||9
1149615|NCT00996840|2787579|P1|STARTED|Overall Study||20
1149653|NCT00866359|2787795|P4|NOT COMPLETED|Observational Follow-Up Phase||0
1149654|NCT00866359|2787796|P3|NOT COMPLETED|Observational Follow-Up Phase||0
1149655|NCT00866359|2787797|P2|NOT COMPLETED|Observational Follow-Up Phase||0
1149656|NCT00866359|2787798|P1|NOT COMPLETED|Observational Follow-Up Phase||0
1149657|NCT00866359|2787795|P4|COMPLETED|Observational Follow-Up Phase||54
1149658|NCT00866359|2787796|P3|COMPLETED|Observational Follow-Up Phase||54
1149659|NCT00866359|2787797|P2|COMPLETED|Observational Follow-Up Phase||0
1149660|NCT00866359|2787798|P1|COMPLETED|Observational Follow-Up Phase||0
1149661|NCT00866359|2787795|P4|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
1149662|NCT00866359|2787796|P3|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
1149663|NCT00866359|2787797|P2|STARTED|Observational Follow-Up Phase||0
1149664|NCT00866359|2787798|P1|STARTED|Observational Follow-Up Phase||0
1149665|NCT00866359|2787795|P4|NOT COMPLETED|Extension Phase (Day 86 to 169)||3
1149666|NCT00866359|2787796|P3|NOT COMPLETED|Extension Phase (Day 86 to 169)||1
1149667|NCT00866359|2787797|P2|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
1149668|NCT00866359|2787798|P1|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
1149669|NCT00866359|2787795|P4|COMPLETED|Extension Phase (Day 86 to 169)||47
1149670|NCT00866359|2787796|P3|COMPLETED|Extension Phase (Day 86 to 169)||44
1149671|NCT00866359|2787797|P2|COMPLETED|Extension Phase (Day 86 to 169)||0
1149672|NCT00866359|2787798|P1|COMPLETED|Extension Phase (Day 86 to 169)||0
1149673|NCT00866359|2787795|P4|STARTED|Extension Phase (Day 86 to 169)||50
1149674|NCT00866359|2787796|P3|STARTED|Extension Phase (Day 86 to 169)||45
1149675|NCT00866359|2787797|P2|STARTED|Extension Phase (Day 86 to 169)||0
1149676|NCT00866359|2787798|P1|STARTED|Extension Phase (Day 86 to 169)||0
1149677|NCT00866359|2787795|P4|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
1149678|NCT00866359|2787796|P3|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
1149679|NCT00866359|2787797|P2|NOT COMPLETED|Treatment Phase (Days 1 to 85)||5
1149680|NCT00866359|2787798|P1|NOT COMPLETED|Treatment Phase (Days 1 to 85)||11
1149681|NCT00866359|2787795|P4|COMPLETED|Treatment Phase (Days 1 to 85)||0
1149682|NCT00866359|2787796|P3|COMPLETED|Treatment Phase (Days 1 to 85)||0
1149683|NCT00866359|2787797|P2|COMPLETED|Treatment Phase (Days 1 to 85)||50
1149684|NCT00866359|2787798|P1|COMPLETED|Treatment Phase (Days 1 to 85)||45
1149685|NCT00866359|2787795|P4|STARTED|Treatment Phase (Days 1 to 85)||0
1149686|NCT00866359|2787796|P3|STARTED|Treatment Phase (Days 1 to 85)||0
1149687|NCT00866359|2787797|P2|STARTED|Treatment Phase (Days 1 to 85)||55
1149688|NCT00866359|2787798|P1|STARTED|Treatment Phase (Days 1 to 85)||56
1149689|NCT00832637|2787851|P1|NOT COMPLETED|Overall Study||0
1149690|NCT00832637|2787851|P1|COMPLETED|Overall Study||33
1149691|NCT00832637|2787851|P1|STARTED|Overall Study||33
1149692|NCT00832520|2787859|P1|NOT COMPLETED|Overall Study||0
1149693|NCT00832520|2787859|P1|COMPLETED|Overall Study||13
1149694|NCT00832520|2787859|P1|STARTED|Overall Study||13
1149695|NCT00818779|2787865|P2|NOT COMPLETED|Overall Study||1
1149696|NCT00818779|2787866|P1|NOT COMPLETED|Overall Study||6
1149697|NCT00818779|2787865|P2|COMPLETED|Overall Study||15
1149698|NCT00818779|2787866|P1|COMPLETED|Overall Study||16
1149699|NCT00818779|2787865|P2|STARTED|Overall Study||16
1149700|NCT00818779|2787866|P1|STARTED|Overall Study||22
1149725|NCT00722865|2787943|P1|NOT COMPLETED|Overall Study||2
1149726|NCT00722865|2787943|P1|COMPLETED|Overall Study||23
1149727|NCT00722865|2787943|P1|STARTED|Overall Study||25
1149728|NCT00704496|2787953|P2|NOT COMPLETED|Overall Study||0
1149729|NCT00704496|2787954|P1|NOT COMPLETED|Overall Study||0
1149730|NCT00704496|2787953|P2|COMPLETED|Overall Study||0
1149731|NCT00704496|2787954|P1|COMPLETED|Overall Study||0
1149732|NCT00704496|2787953|P2|STARTED|Overall Study||0
1149733|NCT00704496|2787954|P1|STARTED|Overall Study||0
1149788|NCT00619112|2788188|P1|NOT COMPLETED|Overall Study||0
1149789|NCT00619112|2788188|P1|COMPLETED|Overall Study|enrolled all patients from Nov 2007 to Jan 2012|60
1149790|NCT00619112|2788188|P1|STARTED|Overall Study||60
1149874|NCT00208026|2788482|P1|NOT COMPLETED|Overall Study||0
1149875|NCT00208026|2788482|P1|COMPLETED|Overall Study||3
1149876|NCT00208026|2788482|P1|STARTED|Overall Study||3
1149877|NCT00194129|2788488|P2|NOT COMPLETED|Overall Study||13
1149878|NCT00194129|2788489|P1|NOT COMPLETED|Overall Study||10
1149879|NCT00194129|2788488|P2|COMPLETED|Overall Study||3
1149880|NCT00194129|2788489|P1|COMPLETED|Overall Study||5
1149881|NCT00194129|2788488|P2|STARTED|Overall Study||16
1149882|NCT00194129|2788489|P1|STARTED|Overall Study||15
1149889|NCT00069238|2788504|P3|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||2
1149890|NCT00069238|2788505|P2|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
1149891|NCT00069238|2788506|P1|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
1149892|NCT00069238|2788504|P3|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||1
1149893|NCT00069238|2788505|P2|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
1149894|NCT00069238|2788506|P1|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
1149895|NCT00069238|2788504|P3|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||3
1149896|NCT00069238|2788505|P2|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
1149897|NCT00069238|2788506|P1|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
1149898|NCT00069238|2788504|P3|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
1149899|NCT00069238|2788505|P2|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||2
1149900|NCT00069238|2788506|P1|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
1149901|NCT00069238|2788504|P3|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
1149902|NCT00069238|2788505|P2|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||1
1149903|NCT00069238|2788506|P1|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
1149904|NCT00069238|2788504|P3|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
1149905|NCT00069238|2788505|P2|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||3
1149906|NCT00069238|2788506|P1|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
1149907|NCT00069238|2788504|P3|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
1149908|NCT00069238|2788505|P2|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
1149909|NCT00069238|2788506|P1|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||9
1149910|NCT00069238|2788504|P3|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
1149911|NCT00069238|2788505|P2|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
1149912|NCT00069238|2788506|P1|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||16
1149913|NCT00069238|2788504|P3|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
1149914|NCT00069238|2788505|P2|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
1149915|NCT00069238|2788506|P1|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||25
1149916|NCT00064753|2788514|P2|NOT COMPLETED|Overall Study||648
1149917|NCT00064753|2788515|P1|NOT COMPLETED|Overall Study||674
1149918|NCT00064753|2788514|P2|COMPLETED|Overall Study||1406
1149919|NCT00064753|2788515|P1|COMPLETED|Overall Study||1382
1149920|NCT00064753|2788514|P2|STARTED|Overall Study||2054
1149921|NCT00064753|2788515|P1|STARTED|Overall Study||2056
1149940|NCT00045708|2788561|P3|NOT COMPLETED|Phase 2||0
1149941|NCT00045708|2788562|P2|NOT COMPLETED|Phase 2||0
1149942|NCT00045708|2788563|P1|NOT COMPLETED|Phase 2||0
1149943|NCT00045708|2788561|P3|COMPLETED|Phase 2||19
1149944|NCT00045708|2788562|P2|COMPLETED|Phase 2||0
1149945|NCT00045708|2788563|P1|COMPLETED|Phase 2||0
1149946|NCT00045708|2788561|P3|STARTED|Phase 2||19
1149947|NCT00045708|2788562|P2|STARTED|Phase 2||0
1149948|NCT00045708|2788563|P1|STARTED|Phase 2||0
1149949|NCT00045708|2788561|P3|NOT COMPLETED|Phase 1||0
1149950|NCT00045708|2788562|P2|NOT COMPLETED|Phase 1||1
1149951|NCT00045708|2788563|P1|NOT COMPLETED|Phase 1||0
1149952|NCT00045708|2788561|P3|COMPLETED|Phase 1||0
1149953|NCT00045708|2788562|P2|COMPLETED|Phase 1||16
1149954|NCT00045708|2788563|P1|COMPLETED|Phase 1||21
1149955|NCT00045708|2788561|P3|STARTED|Phase 1||0
1149956|NCT00045708|2788562|P2|STARTED|Phase 1||17
1149957|NCT00045708|2788563|P1|STARTED|Phase 1||21
1149973|NCT02616250|2788606|P2|NOT COMPLETED|Overall Study||9
1149974|NCT02616250|2788607|P1|NOT COMPLETED|Overall Study||10
1149975|NCT02616250|2788606|P2|COMPLETED|Overall Study||86
1149976|NCT02616250|2788607|P1|COMPLETED|Overall Study||85
1149977|NCT02616250|2788606|P2|STARTED|Overall Study||95
1149978|NCT02616250|2788607|P1|STARTED|Overall Study||95
1150006|NCT02447848|2788679|P1|NOT COMPLETED|Overall Study||11
1150007|NCT02447848|2788679|P1|COMPLETED|Overall Study||65
1150008|NCT02447848|2788679|P1|STARTED|Overall Study||76
1150015|NCT02345226|2788710|P2|NOT COMPLETED|Overall Study||441
1150016|NCT02345226|2788711|P1|NOT COMPLETED|Overall Study||440
1150017|NCT02345226|2788710|P2|COMPLETED|Overall Study||0
1150018|NCT02345226|2788711|P1|COMPLETED|Overall Study||0
1150019|NCT02345226|2788710|P2|STARTED|Overall Study||441
1150020|NCT02345226|2788711|P1|STARTED|Overall Study||440
1150033|NCT02301364|2788753|P1|NOT COMPLETED|Overall Study||0
1150034|NCT02301364|2788753|P1|COMPLETED|Overall Study||4
1150035|NCT02301364|2788753|P1|STARTED|Overall Study||4
1150036|NCT02287025|2788762|P2|NOT COMPLETED|Overall Study||9
1150037|NCT02287025|2788763|P1|NOT COMPLETED|Overall Study||10
1150038|NCT02287025|2788762|P2|COMPLETED|Overall Study||2
1150039|NCT02287025|2788763|P1|COMPLETED|Overall Study||2
1150040|NCT02287025|2788762|P2|STARTED|Overall Study||11
1150041|NCT02287025|2788763|P1|STARTED|Overall Study||12
1150045|NCT02281773|2788838|P5|NOT COMPLETED|Overall Study||30
1150046|NCT02281773|2788839|P4|NOT COMPLETED|Overall Study||21
1150047|NCT02281773|2788840|P3|NOT COMPLETED|Overall Study||18
1150048|NCT02281773|2788841|P2|NOT COMPLETED|Overall Study||15
1150049|NCT02281773|2788842|P1|NOT COMPLETED|Overall Study||11
1150050|NCT02281773|2788838|P5|COMPLETED|Overall Study||143
1150051|NCT02281773|2788839|P4|COMPLETED|Overall Study||65
1150052|NCT02281773|2788840|P3|COMPLETED|Overall Study||67
1150053|NCT02281773|2788841|P2|COMPLETED|Overall Study||70
1150054|NCT02281773|2788842|P1|COMPLETED|Overall Study||76
1150055|NCT02281773|2788838|P5|STARTED|Overall Study|Started are the treated patients|173
1150056|NCT02281773|2788839|P4|STARTED|Overall Study||86
1150057|NCT02281773|2788840|P3|STARTED|Overall Study||85
1150058|NCT02281773|2788841|P2|STARTED|Overall Study|Started are the treated patients|85
1150059|NCT02281773|2788842|P1|STARTED|Overall Study||87
1150066|NCT02249065|2788938|P1|NOT COMPLETED|Overall Study||29
1150067|NCT02249065|2788938|P1|COMPLETED|Overall Study||176
1150068|NCT02249065|2788938|P1|Treated|Overall Study||181
1150069|NCT02249065|2788938|P1|STARTED|Overall Study||205
1150076|NCT02207231|2789024|P3|NOT COMPLETED|Active Controlled Period: Week 16 - 48||42
1150077|NCT02207231|2789025|P2|NOT COMPLETED|Active Controlled Period: Week 16 - 48||21
1150078|NCT02207231|2789026|P1|NOT COMPLETED|Active Controlled Period: Week 16 - 48||3
1150079|NCT02207231|2789024|P3|COMPLETED|Active Controlled Period: Week 16 - 48||282
1150080|NCT02207231|2789025|P2|COMPLETED|Active Controlled Period: Week 16 - 48||301
1150081|NCT02207231|2789026|P1|COMPLETED|Active Controlled Period: Week 16 - 48||162
1150082|NCT02207231|2789024|P3|STARTED|Active Controlled Period: Week 16 - 48||324
1150083|NCT02207231|2789025|P2|STARTED|Active Controlled Period: Week 16 - 48||322
1150084|NCT02207231|2789026|P1|STARTED|Active Controlled Period: Week 16 - 48|2 participants did not cross-over.|165
1150085|NCT02207231|2789024|P3|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||10
1150086|NCT02207231|2789025|P2|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7
1150087|NCT02207231|2789026|P1|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7
1150088|NCT02207231|2789024|P3|COMPLETED|Placebo Controlled Period: Week 0 - 16||324
1150089|NCT02207231|2789025|P2|COMPLETED|Placebo Controlled Period: Week 0 - 16||322
1150090|NCT02207231|2789026|P1|COMPLETED|Placebo Controlled Period: Week 0 - 16||167
1150091|NCT02207231|2789024|P3|Treated|Placebo Controlled Period: Week 0 - 16||333
1150092|NCT02207231|2789025|P2|Treated|Placebo Controlled Period: Week 0 - 16||329
1150093|NCT02207231|2789026|P1|Treated|Placebo Controlled Period: Week 0 - 16||174
1150094|NCT02207231|2789024|P3|STARTED|Placebo Controlled Period: Week 0 - 16||334
1150095|NCT02207231|2789025|P2|STARTED|Placebo Controlled Period: Week 0 - 16||329
1150096|NCT02207231|2789026|P1|STARTED|Placebo Controlled Period: Week 0 - 16||174
1150103|NCT02132468|2789119|P1|NOT COMPLETED|Overall Study||7
1150104|NCT02132468|2789119|P1|COMPLETED|Overall Study||11
1150105|NCT02132468|2789119|P1|STARTED|Overall Study||18
1150124|NCT02096081|2789220|P2|NOT COMPLETED|Overall Study||4
1150125|NCT02096081|2789221|P1|NOT COMPLETED|Overall Study||3
1150126|NCT02096081|2789220|P2|COMPLETED|Overall Study||124
1150127|NCT02096081|2789221|P1|COMPLETED|Overall Study||119
1150128|NCT02096081|2789220|P2|STARTED|Overall Study||128
1150129|NCT02096081|2789221|P1|STARTED|Overall Study||122
1150145|NCT02023983|2789318|P2|NOT COMPLETED|Overall Study||0
1150146|NCT02023983|2789319|P1|NOT COMPLETED|Overall Study||0
1150147|NCT02023983|2789318|P2|COMPLETED|Overall Study||75
1150148|NCT02023983|2789319|P1|COMPLETED|Overall Study||76
1150149|NCT02023983|2789318|P2|STARTED|Overall Study||75
1150150|NCT02023983|2789319|P1|STARTED|Overall Study||76
1150151|NCT02001714|2789329|P2|NOT COMPLETED|Overall Study||12
1150152|NCT02001714|2789330|P1|NOT COMPLETED|Overall Study||22
1150153|NCT02001714|2789329|P2|COMPLETED|Overall Study||219
1150154|NCT02001714|2789330|P1|COMPLETED|Overall Study||210
1150155|NCT02001714|2789329|P2|STARTED|Overall Study||231
1150156|NCT02001714|2789330|P1|STARTED|Overall Study||232
1150184|NCT01966003|2789421|P2|NOT COMPLETED|Overall Study||270
1150185|NCT01966003|2789422|P1|NOT COMPLETED|Overall Study||270
1150186|NCT01966003|2789421|P2|COMPLETED|Overall Study||44
1150187|NCT01966003|2789422|P1|COMPLETED|Overall Study||58
1150188|NCT01966003|2789421|P2|Received Study Drug|Overall Study||309
1150189|NCT01966003|2789422|P1|Received Study Drug|Overall Study||324
1150190|NCT01966003|2789421|P2|STARTED|Overall Study||314
1150191|NCT01966003|2789422|P1|STARTED|Overall Study||328
1150192|NCT01946529|2789441|P3|NOT COMPLETED|Completion of All Therapy||6
1150193|NCT01946529|2789442|P2|NOT COMPLETED|Completion of All Therapy||16
1150194|NCT01946529|2789443|P1|NOT COMPLETED|Completion of All Therapy||1
1150195|NCT01946529|2789441|P3|COMPLETED|Completion of All Therapy||0
1150196|NCT01946529|2789442|P2|COMPLETED|Completion of All Therapy||0
1150197|NCT01946529|2789443|P1|COMPLETED|Completion of All Therapy||0
1150198|NCT01946529|2789441|P3|STARTED|Completion of All Therapy||6
1150199|NCT01946529|2789442|P2|STARTED|Completion of All Therapy||16
1150200|NCT01946529|2789443|P1|STARTED|Completion of All Therapy||1
1150201|NCT01946529|2789441|P3|NOT COMPLETED|End of Window Therapy (2 Courses)||0
1150202|NCT01946529|2789442|P2|NOT COMPLETED|End of Window Therapy (2 Courses)||1
1150203|NCT01946529|2789443|P1|NOT COMPLETED|End of Window Therapy (2 Courses)||0
1150204|NCT01946529|2789441|P3|COMPLETED|End of Window Therapy (2 Courses)||6
1150205|NCT01946529|2789442|P2|COMPLETED|End of Window Therapy (2 Courses)||16
1150206|NCT01946529|2789443|P1|COMPLETED|End of Window Therapy (2 Courses)||1
1150207|NCT01946529|2789441|P3|STARTED|End of Window Therapy (2 Courses)||6
1150208|NCT01946529|2789442|P2|STARTED|End of Window Therapy (2 Courses)||17
1150209|NCT01946529|2789443|P1|STARTED|End of Window Therapy (2 Courses)||1
1150230|NCT01832090|2789479|P2|NOT COMPLETED|Overall Study||1
1150231|NCT01832090|2789480|P1|NOT COMPLETED|Overall Study||6
1150232|NCT01832090|2789479|P2|COMPLETED|Overall Study||28
1150233|NCT01832090|2789480|P1|COMPLETED|Overall Study||83
1150234|NCT01832090|2789479|P2|STARTED|Overall Study||29
1150235|NCT01832090|2789480|P1|STARTED|Overall Study||89
1150236|NCT01786902|2789525|P2|NOT COMPLETED|Overall Study||3
1150237|NCT01786902|2789526|P1|NOT COMPLETED|Overall Study||4
1150238|NCT01786902|2789525|P2|COMPLETED|Overall Study||31
1150239|NCT01786902|2789526|P1|COMPLETED|Overall Study||32
1150240|NCT01786902|2789525|P2|STARTED|Overall Study||34
1150241|NCT01786902|2789526|P1|STARTED|Overall Study||36
1150269|NCT01732458|2789634|P4|NOT COMPLETED|Overall Study||2
1150270|NCT01732458|2789635|P3|NOT COMPLETED|Overall Study||3
1150271|NCT01732458|2789636|P2|NOT COMPLETED|Overall Study||5
1150272|NCT01732458|2789637|P1|NOT COMPLETED|Overall Study||3
1150273|NCT01732458|2789634|P4|COMPLETED|Overall Study||50
1150274|NCT01732458|2789635|P3|COMPLETED|Overall Study||55
1150275|NCT01732458|2789636|P2|COMPLETED|Overall Study||53
1150276|NCT01732458|2789637|P1|COMPLETED|Overall Study||57
1150277|NCT01732458|2789634|P4|Treated|Overall Study||52
1150278|NCT01732458|2789635|P3|Treated|Overall Study||56
1150279|NCT01732458|2789636|P2|Treated|Overall Study||55
1150280|NCT01732458|2789637|P1|Treated|Overall Study||57
1150281|NCT01732458|2789634|P4|STARTED|Overall Study||52
1150282|NCT01732458|2789635|P3|STARTED|Overall Study||58
1150283|NCT01732458|2789636|P2|STARTED|Overall Study||58
1150284|NCT01732458|2789637|P1|STARTED|Overall Study||60
1150285|NCT01703169|2789699|P1|NOT COMPLETED|Overall Study||0
1150286|NCT01703169|2789699|P1|COMPLETED|Overall Study||13
1150287|NCT01703169|2789699|P1|STARTED|Overall Study||13
1150309|NCT01520207|2789742|P2|NOT COMPLETED|Overall Study||0
1150310|NCT01520207|2789743|P1|NOT COMPLETED|Overall Study||2
1150311|NCT01520207|2789742|P2|COMPLETED|Overall Study||25
1150312|NCT01520207|2789743|P1|COMPLETED|Overall Study||25
1150313|NCT01520207|2789742|P2|STARTED|Overall Study||25
1150314|NCT01520207|2789743|P1|STARTED|Overall Study||27
1150348|NCT01503164|2789829|P2|NOT COMPLETED|Overall Study||1
1150349|NCT01503164|2789830|P1|NOT COMPLETED|Overall Study||2
1150350|NCT01503164|2789829|P2|COMPLETED|Overall Study||55
1150351|NCT01503164|2789830|P1|COMPLETED|Overall Study||53
1150352|NCT01503164|2789829|P2|STARTED|Overall Study||56
1150353|NCT01503164|2789830|P1|STARTED|Overall Study||55
1150378|NCT01451463|2789970|P1|NOT COMPLETED|Overall Study||0
1150379|NCT01451463|2789970|P1|COMPLETED|Overall Study||11
1150380|NCT01451463|2789970|P1|STARTED|Overall Study||11
1150393|NCT01285310|2790018|P5|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||19
1150394|NCT01285310|2790019|P4|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||10
1150395|NCT01285310|2790020|P3|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||26
1150396|NCT01285310|2790021|P2|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||32
1150397|NCT01285310|2790022|P1|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||0
1150398|NCT01285310|2790018|P5|COMPLETED|Active Treatment Phase: Weeks 25-52||23
1150399|NCT01285310|2790019|P4|COMPLETED|Active Treatment Phase: Weeks 25-52||17
1150400|NCT01285310|2790020|P3|COMPLETED|Active Treatment Phase: Weeks 25-52||34
1150401|NCT01285310|2790021|P2|COMPLETED|Active Treatment Phase: Weeks 25-52||31
1150402|NCT01285310|2790022|P1|COMPLETED|Active Treatment Phase: Weeks 25-52||0
1150403|NCT01285310|2790018|P5|STARTED|Active Treatment Phase: Weeks 25-52||42
1150404|NCT01285310|2790019|P4|STARTED|Active Treatment Phase: Weeks 25-52||27
1150405|NCT01285310|2790020|P3|STARTED|Active Treatment Phase: Weeks 25-52||60
1150406|NCT01285310|2790021|P2|STARTED|Active Treatment Phase: Weeks 25-52||63
1150407|NCT01285310|2790022|P1|STARTED|Active Treatment Phase: Weeks 25-52||0
1150408|NCT01285310|2790018|P5|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
1150409|NCT01285310|2790019|P4|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
1150410|NCT01285310|2790020|P3|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
1150411|NCT01285310|2790021|P2|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
1150412|NCT01285310|2790022|P1|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||9
1150413|NCT01285310|2790018|P5|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
1150414|NCT01285310|2790019|P4|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
1150415|NCT01285310|2790020|P3|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter active treatment phase|61
1150416|NCT01285310|2790021|P2|COMPLETED|Placebo Controlled Phase: Weeks 0-24|Four participants chose not to enter the active treatment phase|67
1150417|NCT01285310|2790022|P1|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter the active treatment phase|70
1150418|NCT01285310|2790018|P5|STARTED|Placebo Controlled Phase: Weeks 0-24||0
1150419|NCT01285310|2790019|P4|STARTED|Placebo Controlled Phase: Weeks 0-24||0
1150420|NCT01285310|2790020|P3|STARTED|Placebo Controlled Phase: Weeks 0-24||76
1150421|NCT01285310|2790021|P2|STARTED|Placebo Controlled Phase: Weeks 0-24||82
1150422|NCT01285310|2790022|P1|STARTED|Placebo Controlled Phase: Weeks 0-24||79
1150462|NCT01101880|2790518|P1|NOT COMPLETED|Overall Study||0
1150463|NCT01101880|2790518|P1|COMPLETED|Overall Study||50
1150464|NCT01101880|2790518|P1|STARTED|Overall Study||50
1150471|NCT01079806|2790546|P2|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||2
1150472|NCT01079806|2790547|P1|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||0
1150473|NCT01079806|2790546|P2|COMPLETED|Long-term Follow-up: Day 1-End of Study||4
1150474|NCT01079806|2790547|P1|COMPLETED|Long-term Follow-up: Day 1-End of Study||14
1150475|NCT01079806|2790546|P2|STARTED|Long-term Follow-up: Day 1-End of Study||6
1150476|NCT01079806|2790547|P1|STARTED|Long-term Follow-up: Day 1-End of Study||14
1150477|NCT01079806|2790546|P2|NOT COMPLETED|Day 1 to Week 96||4
1150478|NCT01079806|2790547|P1|NOT COMPLETED|Day 1 to Week 96||4
1150479|NCT01079806|2790546|P2|COMPLETED|Day 1 to Week 96|Includes 53 continuing treatment|56
1150480|NCT01079806|2790547|P1|COMPLETED|Day 1 to Week 96|Includes 91 continuing treatment|116
1150481|NCT01079806|2790546|P2|Primary Endpoint Cohort|Day 1 to Week 96||41
1150482|NCT01079806|2790547|P1|Primary Endpoint Cohort|Day 1 to Week 96||82
1150483|NCT01079806|2790546|P2|Received Treatment|Day 1 to Week 96||60
1150484|NCT01079806|2790547|P1|Received Treatment|Day 1 to Week 96||120
1150485|NCT01079806|2790546|P2|STARTED|Day 1 to Week 96|Randomized|60
1150486|NCT01079806|2790547|P1|STARTED|Day 1 to Week 96|Randomized|120
1150487|NCT01062425|2790569|P2|NOT COMPLETED|Overall Study||6
1150488|NCT01062425|2790570|P1|NOT COMPLETED|Overall Study||3
1150489|NCT01062425|2790569|P2|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|97
1150490|NCT01062425|2790570|P1|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|52
1150491|NCT01062425|2790569|P2|STARTED|Overall Study||103
1150492|NCT01062425|2790570|P1|STARTED|Overall Study||55
1150505|NCT00932152|2790608|P2|NOT COMPLETED|Overall Study||2
1150506|NCT00932152|2790609|P1|NOT COMPLETED|Overall Study||1
1150507|NCT00932152|2790608|P2|COMPLETED|Overall Study||0
1150508|NCT00932152|2790609|P1|COMPLETED|Overall Study||0
1150509|NCT00932152|2790608|P2|STARTED|Overall Study||2
1150510|NCT00932152|2790609|P1|STARTED|Overall Study||1
1150511|NCT00923351|2790621|P3|NOT COMPLETED|Overall Study||12
1150512|NCT00923351|2790622|P2|NOT COMPLETED|Overall Study||0
1150513|NCT00923351|2790623|P1|NOT COMPLETED|Overall Study||0
1150514|NCT00923351|2790621|P3|COMPLETED|Overall Study||0
1150515|NCT00923351|2790622|P2|COMPLETED|Overall Study||26
1150516|NCT00923351|2790623|P1|COMPLETED|Overall Study||6
1150517|NCT00923351|2790621|P3|STARTED|Overall Study||12
1150518|NCT00923351|2790622|P2|STARTED|Overall Study||26
1150519|NCT00923351|2790623|P1|STARTED|Overall Study||6
1150520|NCT00920439|2790631|P1|NOT COMPLETED|Overall Study||0
1150521|NCT00920439|2790631|P1|COMPLETED|Overall Study||25
1150522|NCT00920439|2790631|P1|STARTED|Overall Study||25
1150523|NCT00912509|2790640|P2|NOT COMPLETED|Overall Study||3
1150524|NCT00912509|2790641|P1|NOT COMPLETED|Overall Study||5
1150525|NCT00912509|2790640|P2|COMPLETED|Overall Study||7
1150526|NCT00912509|2790641|P1|COMPLETED|Overall Study||15
1150527|NCT00912509|2790640|P2|STARTED|Overall Study||10
1150528|NCT00912509|2790641|P1|STARTED|Overall Study||20
1150566|NCT00689936|2790742|P3|NOT COMPLETED|Long-Term Follow Up Phase||144
1150567|NCT00689936|2790743|P2|NOT COMPLETED|Long-Term Follow Up Phase||188
1150568|NCT00689936|2790744|P1|NOT COMPLETED|Long-Term Follow Up Phase||127
1150569|NCT00689936|2790742|P3|COMPLETED|Long-Term Follow Up Phase||315
1150570|NCT00689936|2790743|P2|COMPLETED|Long-Term Follow Up Phase||275
1150571|NCT00689936|2790744|P1|COMPLETED|Long-Term Follow Up Phase||255
1150572|NCT00689936|2790742|P3|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|459
1150573|NCT00689936|2790743|P2|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|463
1150574|NCT00689936|2790744|P1|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|382
1150575|NCT00689936|2790742|P3|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
1150576|NCT00689936|2790743|P2|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
1150577|NCT00689936|2790744|P1|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
1150578|NCT00689936|2790742|P3|COMPLETED|Progression Free Survival-PFS-Follow-Up||273
1150579|NCT00689936|2790743|P2|COMPLETED|Progression Free Survival-PFS-Follow-Up||300
1150580|NCT00689936|2790744|P1|COMPLETED|Progression Free Survival-PFS-Follow-Up||87
1150581|NCT00689936|2790742|P3|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 12 cycles MPT and did not experience progressive disease.|273
1150582|NCT00689936|2790743|P2|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 18 cycles (Rd18) and did not experience progressive disease.|300
1150583|NCT00689936|2790744|P1|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who discontinued treatment for reasons other than progressive disease.|87
1150584|NCT00689936|2790742|P3|NOT COMPLETED|Active Treatment Phase||547
1150585|NCT00689936|2790743|P2|NOT COMPLETED|Active Treatment Phase||541
1150586|NCT00689936|2790744|P1|NOT COMPLETED|Active Treatment Phase||535
1150587|NCT00689936|2790742|P3|COMPLETED|Active Treatment Phase||0
1150588|NCT00689936|2790743|P2|COMPLETED|Active Treatment Phase||0
1150589|NCT00689936|2790744|P1|COMPLETED|Active Treatment Phase||0
1150590|NCT00689936|2790742|P3|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|6
1150591|NCT00689936|2790743|P2|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|1
1150592|NCT00689936|2790744|P1|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|3
1150593|NCT00689936|2790742|P3|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|541
1150594|NCT00689936|2790743|P2|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|540
1150595|NCT00689936|2790744|P1|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|532
1150596|NCT00689936|2790742|P3|STARTED|Active Treatment Phase||547
1150597|NCT00689936|2790743|P2|STARTED|Active Treatment Phase||541
1150598|NCT00689936|2790744|P1|STARTED|Active Treatment Phase||535
1150599|NCT00674583|2790886|P2|NOT COMPLETED|Overall Study||0
1150600|NCT00674583|2790887|P1|NOT COMPLETED|Overall Study||0
1150601|NCT00674583|2790886|P2|COMPLETED|Overall Study||103
1150602|NCT00674583|2790887|P1|COMPLETED|Overall Study||311
1150603|NCT00674583|2790886|P2|STARTED|Overall Study||103
1150604|NCT00674583|2790887|P1|STARTED|Overall Study||311
1150605|NCT00651794|2790914|P3|NOT COMPLETED|Overall Study||21
1150606|NCT00651794|2790915|P2|NOT COMPLETED|Overall Study||22
1150607|NCT00651794|2790916|P1|NOT COMPLETED|Overall Study||21
1150608|NCT00651794|2790914|P3|COMPLETED|Overall Study||10
1150609|NCT00651794|2790915|P2|COMPLETED|Overall Study||9
1150610|NCT00651794|2790916|P1|COMPLETED|Overall Study||15
1150611|NCT00651794|2790914|P3|STARTED|Overall Study||31
1150612|NCT00651794|2790915|P2|STARTED|Overall Study||31
1150613|NCT00651794|2790916|P1|STARTED|Overall Study||36
1150647|NCT00424047|2791110|P2|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||8
1150648|NCT00424047|2791111|P1|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||21
1150649|NCT00424047|2791110|P2|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
1150650|NCT00424047|2791111|P1|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
1150651|NCT00424047|2791110|P2|STARTED|Long Term Extension (Up to 25 Jun 2013)|2 participants opted to receive dex alone, 3 crossed over to Len/Dex and 3 added Len at a later date|8
1150652|NCT00424047|2791111|P1|STARTED|Long Term Extension (Up to 25 Jun 2013)||21
1150653|NCT00424047|2791110|P2|NOT COMPLETED|On Study at Time of Unblinding||167
1150654|NCT00424047|2791111|P1|NOT COMPLETED|On Study at Time of Unblinding||155
1150655|NCT00424047|2791110|P2|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term dexamethasone|8
1150656|NCT00424047|2791111|P1|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term Lenalidomide and dexamethasone|21
1150657|NCT00424047|2791110|P2|STARTED|On Study at Time of Unblinding||175
1150658|NCT00424047|2791111|P1|STARTED|On Study at Time of Unblinding|Refers to original treatment group assignment in the study.|176
1150659|NCT00424047|2791110|P2|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||156
1150660|NCT00424047|2791111|P1|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||122
1150661|NCT00424047|2791110|P2|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|Ongoing and includes 15 participants who crossed over to lenalidomide/dexamethasone after unblinding|19
1150662|NCT00424047|2791111|P1|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|54 participants ongoing and continuing on lenalidomide/dexamethasone treatment|54
1150663|NCT00424047|2791110|P2|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|4 participants excluded because they had no baseline M-protein assessment|171
1150664|NCT00424047|2791111|P1|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|1 participant excluded because they had no baseline M-protein assessment|175
1150665|NCT00424047|2791110|P2|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|175
1150666|NCT00424047|2791111|P1|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|176
1150667|NCT00424047|2791110|P2|STARTED|Blinded Treatment (Up to 03 Aug 2005)||175
1150668|NCT00424047|2791111|P1|STARTED|Blinded Treatment (Up to 03 Aug 2005)||176
1150685|NCT00374140|2791179|P1|NOT COMPLETED|Overall Study||2
1150686|NCT00374140|2791179|P1|COMPLETED|Overall Study||38
1150687|NCT00374140|2791179|P1|STARTED|Overall Study||40
1150694|NCT00304187|2791242|P2|NOT COMPLETED|Overall Study||1
1150695|NCT00304187|2791243|P1|NOT COMPLETED|Overall Study||2
1150696|NCT00304187|2791242|P2|COMPLETED|Overall Study||13
1150697|NCT00304187|2791243|P1|COMPLETED|Overall Study||13
1150698|NCT00304187|2791242|P2|STARTED|Overall Study||14
1150699|NCT00304187|2791243|P1|STARTED|Overall Study||15
1150709|NCT00056160|2791266|P2|NOT COMPLETED|Final Follow-up||0
1150710|NCT00056160|2791267|P1|NOT COMPLETED|Final Follow-up||6
1150711|NCT00056160|2791266|P2|COMPLETED|Final Follow-up||0
1150712|NCT00056160|2791267|P1|COMPLETED|Final Follow-up||0
1150713|NCT00056160|2791266|P2|STARTED|Final Follow-up||0
1150714|NCT00056160|2791267|P1|STARTED|Final Follow-up||6
1150715|NCT00056160|2791266|P2|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
1150716|NCT00056160|2791267|P1|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||171
1150717|NCT00056160|2791266|P2|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
1150718|NCT00056160|2791267|P1|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||6
1150719|NCT00056160|2791266|P2|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||0
1150720|NCT00056160|2791267|P1|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||177
1150721|NCT00056160|2791266|P2|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||163
1150722|NCT00056160|2791267|P1|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||113
1150723|NCT00056160|2791266|P2|COMPLETED|Up to Unblinding (07 Jun 2005)||13
1150724|NCT00056160|2791267|P1|COMPLETED|Up to Unblinding (07 Jun 2005)||64
1150725|NCT00056160|2791266|P2|STARTED|Up to Unblinding (07 Jun 2005)||176
1150726|NCT00056160|2791267|P1|STARTED|Up to Unblinding (07 Jun 2005)||177
1150733|NCT02730819|2791289|P1|NOT COMPLETED|Overall Study||9
1150734|NCT02730819|2791289|P1|COMPLETED|Overall Study||10
1150735|NCT02730819|2791289|P1|Follow-up Week 20|Overall Study||10
1150736|NCT02730819|2791289|P1|Follow-up Week 16|Overall Study||11
1150737|NCT02730819|2791289|P1|Follow-up Week 12|Overall Study||11
1150738|NCT02730819|2791289|P1|Follow-up Week 8|Overall Study||14
1150739|NCT02730819|2791289|P1|Follow-up Week 4|Overall Study||16
1150740|NCT02730819|2791289|P1|Follow-up Week 2|Overall Study||15
1150741|NCT02730819|2791289|P1|STARTED|Overall Study||19
1150742|NCT02584790|2791295|P1|NOT COMPLETED|Overall Study||15
1150743|NCT02584790|2791295|P1|COMPLETED|Overall Study||40
1150744|NCT02584790|2791295|P1|STARTED|Overall Study||55
1150745|NCT02480621|2791303|P2|NOT COMPLETED|Follow Up||2
1150746|NCT02480621|2791304|P1|NOT COMPLETED|Follow Up||4
1150747|NCT02480621|2791303|P2|COMPLETED|Follow Up||37
1150748|NCT02480621|2791304|P1|COMPLETED|Follow Up||39
1150749|NCT02480621|2791303|P2|STARTED|Follow Up||39
1150750|NCT02480621|2791304|P1|STARTED|Follow Up||43
1150751|NCT02480621|2791303|P2|NOT COMPLETED|Randomization||1
1150752|NCT02480621|2791304|P1|NOT COMPLETED|Randomization||1
1150753|NCT02480621|2791303|P2|COMPLETED|Randomization||39
1150754|NCT02480621|2791304|P1|COMPLETED|Randomization||43
1150755|NCT02480621|2791303|P2|STARTED|Randomization||40
1150756|NCT02480621|2791304|P1|STARTED|Randomization||44
1150757|NCT02478632|2791312|P2|NOT COMPLETED|Overall Study||5
1150758|NCT02478632|2791313|P1|NOT COMPLETED|Overall Study||4
1150759|NCT02478632|2791312|P2|COMPLETED|Overall Study||44
1150760|NCT02478632|2791313|P1|COMPLETED|Overall Study||49
1150761|NCT02478632|2791312|P2|STARTED|Overall Study||49
1150762|NCT02478632|2791313|P1|STARTED|Overall Study||53
1150763|NCT02404103|2791329|P2|NOT COMPLETED|Overall Study||3
1150764|NCT02404103|2791330|P1|NOT COMPLETED|Overall Study||4
1150765|NCT02404103|2791329|P2|COMPLETED|Overall Study||9
1150766|NCT02404103|2791330|P1|COMPLETED|Overall Study||10
1150767|NCT02404103|2791329|P2|STARTED|Overall Study||12
1150768|NCT02404103|2791330|P1|STARTED|Overall Study||14
1150769|NCT02317016|2791350|P1|NOT COMPLETED|Part B: Day 35 to End Part B (AZD9291)||31
1150770|NCT02317016|2791350|P1|COMPLETED|Part B: Day 35 to End Part B (AZD9291)||11
1150771|NCT02317016|2791350|P1|STARTED|Part B: Day 35 to End Part B (AZD9291)|41 completed Part A + 1 entered Part B without completing Part A (due to AE) = 42 started Part B|42
1150772|NCT02317016|2791350|P1|NOT COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||2
1150773|NCT02317016|2791350|P1|COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||41
1150774|NCT02317016|2791350|P1|STARTED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||43
1150775|NCT02317016|2791350|P1|NOT COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||1
1150776|NCT02317016|2791350|P1|COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||43
1150777|NCT02317016|2791350|P1|STARTED|Part A: Day 4-31 (AZD9291 Alone)||44
1150778|NCT02317016|2791350|P1|NOT COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||0
1150779|NCT02317016|2791350|P1|COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||44
1150780|NCT02317016|2791350|P1|STARTED|Part A: Day 1-3 (Rosuvastatin Alone)||44
1150781|NCT02260791|2791378|P2|NOT COMPLETED|Overall Study||34
1150782|NCT02260791|2791379|P1|NOT COMPLETED|Overall Study||33
1150783|NCT02260791|2791378|P2|COMPLETED|Overall Study||328
1150784|NCT02260791|2791379|P1|COMPLETED|Overall Study||333
1150785|NCT02260791|2791378|P2|STARTED|Overall Study||362
1150786|NCT02260791|2791379|P1|STARTED|Overall Study||366
1150787|NCT02135848|2791417|P2|NOT COMPLETED|Overall Study||1
1150788|NCT02135848|2791418|P1|NOT COMPLETED|Overall Study||3
1150789|NCT02135848|2791417|P2|COMPLETED|Overall Study||19
1150790|NCT02135848|2791418|P1|COMPLETED|Overall Study||23
1150791|NCT02135848|2791417|P2|STARTED|Overall Study||20
1150792|NCT02135848|2791418|P1|STARTED|Overall Study||26
1150793|NCT02108977|2791478|P2|NOT COMPLETED|Overall Study||1
1150794|NCT02108977|2791479|P1|NOT COMPLETED|Overall Study||10
1150795|NCT02108977|2791478|P2|COMPLETED|Overall Study||19
1150796|NCT02108977|2791479|P1|COMPLETED|Overall Study||8
1150797|NCT02108977|2791478|P2|STARTED|Overall Study||20
1150798|NCT02108977|2791479|P1|STARTED|Overall Study||18
1150799|NCT02105324|2791491|P2|NOT COMPLETED|Period 2||0
1150800|NCT02105324|2791492|P1|NOT COMPLETED|Period 2||0
1150801|NCT02105324|2791491|P2|COMPLETED|Period 2||10
1150802|NCT02105324|2791492|P1|COMPLETED|Period 2||9
1150803|NCT02105324|2791491|P2|STARTED|Period 2||10
1150804|NCT02105324|2791492|P1|STARTED|Period 2||9
1150805|NCT02105324|2791491|P2|NOT COMPLETED|Period 1||0
1150806|NCT02105324|2791492|P1|NOT COMPLETED|Period 1||0
1150807|NCT02105324|2791491|P2|COMPLETED|Period 1||10
1150808|NCT02105324|2791492|P1|COMPLETED|Period 1||9
1150809|NCT02105324|2791491|P2|STARTED|Period 1||10
1150810|NCT02105324|2791492|P1|STARTED|Period 1||9
1150811|NCT02092220|2791568|P2|NOT COMPLETED|Period 2||1
1150812|NCT02092220|2791569|P1|NOT COMPLETED|Period 2||1
1150813|NCT02092220|2791568|P2|COMPLETED|Period 2||19
1150814|NCT02092220|2791569|P1|COMPLETED|Period 2||20
1150815|NCT02092220|2791568|P2|STARTED|Period 2||20
1150816|NCT02092220|2791569|P1|STARTED|Period 2||21
1150817|NCT02092220|2791568|P2|NOT COMPLETED|Period 1||2
1150818|NCT02092220|2791569|P1|NOT COMPLETED|Period 1||0
1150819|NCT02092220|2791568|P2|COMPLETED|Period 1||20
1150820|NCT02092220|2791569|P1|COMPLETED|Period 1||21
1150821|NCT02092220|2791568|P2|STARTED|Period 1||22
1150822|NCT02092220|2791569|P1|STARTED|Period 1||21
1150823|NCT02037607|2791627|P1|NOT COMPLETED|Overall Study||9
1150824|NCT02037607|2791627|P1|COMPLETED|Overall Study||91
1150825|NCT02037607|2791627|P1|STARTED|Overall Study||100
1150826|NCT01939223|2791633|P2|NOT COMPLETED|Overall Study||11
1150827|NCT01939223|2791634|P1|NOT COMPLETED|Overall Study||13
1150828|NCT01939223|2791633|P2|COMPLETED|Overall Study||0
1150829|NCT01939223|2791634|P1|COMPLETED|Overall Study||1
1150830|NCT01939223|2791633|P2|Participants Received Treatment|Overall Study||11
1150831|NCT01939223|2791634|P1|Participants Received Treatment|Overall Study||14
1150832|NCT01939223|2791633|P2|STARTED|Overall Study||11
1150833|NCT01939223|2791634|P1|STARTED|Overall Study||14
1150834|NCT01938573|2791642|P2|NOT COMPLETED|Overall Study||0
1150835|NCT01938573|2791643|P1|NOT COMPLETED|Overall Study||2
1150836|NCT01938573|2791642|P2|COMPLETED|Overall Study||6
1150837|NCT01938573|2791643|P1|COMPLETED|Overall Study||13
1150838|NCT01938573|2791642|P2|STARTED|Overall Study||6
1150839|NCT01938573|2791643|P1|STARTED|Overall Study||15
1150840|NCT01916824|2791651|P2|NOT COMPLETED|Overall Study||9
1150841|NCT01916824|2791652|P1|NOT COMPLETED|Overall Study||7
1150842|NCT01916824|2791651|P2|COMPLETED|Overall Study||20
1150843|NCT01916824|2791652|P1|COMPLETED|Overall Study||17
1150844|NCT01916824|2791651|P2|STARTED|Overall Study||29
1150845|NCT01916824|2791652|P1|STARTED|Overall Study||24
1150852|NCT01748890|2791677|P1|NOT COMPLETED|Overall Study||4
1150853|NCT01748890|2791677|P1|COMPLETED|Overall Study|Insufficient recruitment for analysis|0
1150854|NCT01748890|2791677|P1|STARTED|Overall Study||4
1150855|NCT01748292|2791683|P2|NOT COMPLETED|Overall Study||12
1150856|NCT01748292|2791684|P1|NOT COMPLETED|Overall Study||2
1150857|NCT01748292|2791683|P2|COMPLETED|Overall Study||28
1150858|NCT01748292|2791684|P1|COMPLETED|Overall Study||18
1150859|NCT01748292|2791683|P2|STARTED|Overall Study||40
1150860|NCT01748292|2791684|P1|STARTED|Overall Study||20
1150861|NCT01736397|2791702|P2|NOT COMPLETED|Overall Study||24
1150862|NCT01736397|2791703|P1|NOT COMPLETED|Overall Study||14
1150863|NCT01736397|2791702|P2|COMPLETED|Overall Study||50
1150864|NCT01736397|2791703|P1|COMPLETED|Overall Study||61
1150865|NCT01736397|2791702|P2|STARTED|Overall Study||74
1150866|NCT01736397|2791703|P1|STARTED|Overall Study||75
1150867|NCT01623739|2791717|P2|NOT COMPLETED|Overall Study||4
1150868|NCT01623739|2791718|P1|NOT COMPLETED|Overall Study||2
1150869|NCT01623739|2791717|P2|COMPLETED|Overall Study||15
1150870|NCT01623739|2791718|P1|COMPLETED|Overall Study||17
1150871|NCT01623739|2791717|P2|STARTED|Overall Study||19
1150872|NCT01623739|2791718|P1|STARTED|Overall Study||19
1150873|NCT01617460|2791724|P1|NOT COMPLETED|Overall Study||40
1150874|NCT01617460|2791724|P1|COMPLETED|Overall Study||46
1150875|NCT01617460|2791724|P1|STARTED|Overall Study||86
1150876|NCT01572298|2791730|P2|NOT COMPLETED|Overall Study||1
1150877|NCT01572298|2791731|P1|NOT COMPLETED|Overall Study||2
1150878|NCT01572298|2791730|P2|COMPLETED|Overall Study||12
1150879|NCT01572298|2791731|P1|COMPLETED|Overall Study||12
1150880|NCT01572298|2791730|P2|STARTED|Overall Study||13
1150881|NCT01572298|2791731|P1|STARTED|Overall Study||14
1150882|NCT01536197|2791739|P2|NOT COMPLETED|Overall Study||0
1150883|NCT01536197|2791740|P1|NOT COMPLETED|Overall Study||0
1150884|NCT01536197|2791739|P2|COMPLETED|Overall Study||10
1150885|NCT01536197|2791740|P1|COMPLETED|Overall Study||17
1150886|NCT01536197|2791739|P2|STARTED|Overall Study||10
1150887|NCT01536197|2791740|P1|STARTED|Overall Study||17
1150888|NCT01514357|2791750|P2|NOT COMPLETED|Overall Study||0
1150889|NCT01514357|2791751|P1|NOT COMPLETED|Overall Study||4
1150890|NCT01514357|2791750|P2|COMPLETED|Overall Study||0
1150891|NCT01514357|2791751|P1|COMPLETED|Overall Study||8
1150892|NCT01514357|2791750|P2|STARTED|Overall Study||0
1150893|NCT01514357|2791751|P1|STARTED|Overall Study||12
1150894|NCT01420926|2791759|P2|NOT COMPLETED|Overall Study||65
1150895|NCT01420926|2791760|P1|NOT COMPLETED|Overall Study||60
1150896|NCT01420926|2791759|P2|COMPLETED|Overall Study||16
1150897|NCT01420926|2791760|P1|COMPLETED|Overall Study||22
1150898|NCT01420926|2791759|P2|STARTED|Overall Study||81
1150899|NCT01420926|2791760|P1|STARTED|Overall Study||82
1150900|NCT01336413|2791776|P2|NOT COMPLETED|Overall Study||8
1150901|NCT01336413|2791777|P1|NOT COMPLETED|Overall Study||1
1150902|NCT01336413|2791776|P2|COMPLETED|Overall Study||18
1150903|NCT01336413|2791777|P1|COMPLETED|Overall Study||26
1150904|NCT01336413|2791776|P2|STARTED|Overall Study||26
1150905|NCT01336413|2791777|P1|STARTED|Overall Study||27
1150906|NCT01187381|2791793|P1|NOT COMPLETED|Overall Study||0
1150907|NCT01187381|2791793|P1|COMPLETED|Overall Study|A participant completed study when the trastuzumab treatment was discontinued.|250
1150908|NCT01187381|2791793|P1|STARTED|Overall Study||250
1150909|NCT01126801|2791805|P2|NOT COMPLETED|Overall Study||0
1150910|NCT01126801|2791806|P1|NOT COMPLETED|Overall Study||0
1150911|NCT01126801|2791805|P2|COMPLETED|Overall Study||1
1150912|NCT01126801|2791806|P1|COMPLETED|Overall Study||1
1150913|NCT01126801|2791805|P2|STARTED|Overall Study||1
1150914|NCT01126801|2791806|P1|STARTED|Overall Study||1
1150915|NCT01114724|2791814|P1|NOT COMPLETED|Overall Study||10
1150916|NCT01114724|2791814|P1|COMPLETED|Overall Study||40
1150917|NCT01114724|2791814|P1|STARTED|Overall Study||50
1150918|NCT01094743|2791832|P1|NOT COMPLETED|Period 2||0
1150919|NCT01094743|2791832|P1|COMPLETED|Period 2||50
1150920|NCT01094743|2791832|P1|STARTED|Period 2||50
1150921|NCT01094743|2791832|P1|NOT COMPLETED|Period 1||2
1150922|NCT01094743|2791832|P1|COMPLETED|Period 1||50
1150923|NCT01094743|2791832|P1|STARTED|Period 1||52
1150924|NCT01035606|2791852|P3|NOT COMPLETED|Overall Study||4
1150925|NCT01035606|2791853|P2|NOT COMPLETED|Overall Study||3
1150926|NCT01035606|2791854|P1|NOT COMPLETED|Overall Study||3
1150927|NCT01035606|2791852|P3|COMPLETED|Overall Study||7
1150928|NCT01035606|2791853|P2|COMPLETED|Overall Study||16
1150929|NCT01035606|2791854|P1|COMPLETED|Overall Study||16
1150930|NCT01035606|2791852|P3|STARTED|Overall Study||11
1150931|NCT01035606|2791853|P2|STARTED|Overall Study||19
1150932|NCT01035606|2791854|P1|STARTED|Overall Study||19
1150933|NCT01005576|2791868|P1|NOT COMPLETED|Overall Study||0
1150934|NCT01005576|2791868|P1|COMPLETED|Overall Study|All participants completed the conditioning regimen and received their stem cell transplant|21
1150935|NCT01005576|2791868|P1|STARTED|Overall Study||21
1150936|NCT00907218|2791873|P1|NOT COMPLETED|Overall Study||0
1150937|NCT00907218|2791873|P1|COMPLETED|Overall Study||2
1150938|NCT00907218|2791873|P1|STARTED|Overall Study||2
1150939|NCT00899847|2791883|P1|NOT COMPLETED|Overall Study||2
1150940|NCT00899847|2791883|P1|COMPLETED|Overall Study||7
1150941|NCT00899847|2791883|P1|STARTED|Overall Study||9
1150942|NCT00888628|2791894|P1|NOT COMPLETED|Overall Study||3
1150943|NCT00888628|2791894|P1|COMPLETED|Overall Study||4
1150944|NCT00888628|2791894|P1|Transplanted|Overall Study||4
1150945|NCT00888628|2791894|P1|Withdrawn|Overall Study||1
1150946|NCT00888628|2791894|P1|Screen Failure|Overall Study||2
1150947|NCT00888628|2791894|P1|Enrolled|Overall Study||7
1150948|NCT00888628|2791894|P1|STARTED|Overall Study||7
1150949|NCT00805194|2791902|P2|NOT COMPLETED|Overall Study||654
1150950|NCT00805194|2791903|P1|NOT COMPLETED|Overall Study||649
1150951|NCT00805194|2791902|P2|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 February 2013).|5
1150952|NCT00805194|2791903|P1|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 February 2013)|6
1150953|NCT00805194|2791902|P2|STARTED|Overall Study|randomised patients|659
1150954|NCT00805194|2791903|P1|STARTED|Overall Study|randomised patients|655
1150955|NCT00790569|2791938|P3|NOT COMPLETED|End of Study (12 Month Interview)||50
1150956|NCT00790569|2791939|P2|NOT COMPLETED|End of Study (12 Month Interview)||19
1150957|NCT00790569|2791940|P1|NOT COMPLETED|End of Study (12 Month Interview)||66
1150958|NCT00790569|2791938|P3|COMPLETED|End of Study (12 Month Interview)||83
1150959|NCT00790569|2791939|P2|COMPLETED|End of Study (12 Month Interview)||26
1150960|NCT00790569|2791940|P1|COMPLETED|End of Study (12 Month Interview)||71
1150961|NCT00790569|2791938|P3|STARTED|End of Study (12 Month Interview)||133
1150962|NCT00790569|2791939|P2|STARTED|End of Study (12 Month Interview)||45
1150963|NCT00790569|2791940|P1|STARTED|End of Study (12 Month Interview)||137
1150964|NCT00790569|2791938|P3|NOT COMPLETED|End of Treatment (6 Month Interview)||26
1150965|NCT00790569|2791939|P2|NOT COMPLETED|End of Treatment (6 Month Interview)||10
1150966|NCT00790569|2791940|P1|NOT COMPLETED|End of Treatment (6 Month Interview)||22
1150967|NCT00790569|2791938|P3|COMPLETED|End of Treatment (6 Month Interview)||107
1150968|NCT00790569|2791939|P2|COMPLETED|End of Treatment (6 Month Interview)||35
1150969|NCT00790569|2791940|P1|COMPLETED|End of Treatment (6 Month Interview)||115
1150970|NCT00790569|2791938|P3|STARTED|End of Treatment (6 Month Interview)||133
1150971|NCT00790569|2791939|P2|STARTED|End of Treatment (6 Month Interview)||45
1150972|NCT00790569|2791940|P1|STARTED|End of Treatment (6 Month Interview)||137
1150973|NCT00625404|2791965|P2|NOT COMPLETED|Overall Study||173
1150974|NCT00625404|2791966|P1|NOT COMPLETED|Overall Study||207
1150975|NCT00625404|2791965|P2|COMPLETED|Overall Study||885
1150976|NCT00625404|2791966|P1|COMPLETED|Overall Study||855
1150977|NCT00625404|2791965|P2|STARTED|Overall Study||1058
1150978|NCT00625404|2791966|P1|STARTED|Overall Study||1062
1150979|NCT00601900|2791994|P2|NOT COMPLETED|Overall Study||3
1150980|NCT00601900|2791995|P1|NOT COMPLETED|Overall Study||0
1150981|NCT00601900|2791994|P2|COMPLETED|Overall Study||196
1150982|NCT00601900|2791995|P1|COMPLETED|Overall Study||195
1150983|NCT00601900|2791994|P2|STARTED|Overall Study||199
1150984|NCT00601900|2791995|P1|STARTED|Overall Study||195
1150985|NCT00573833|2792009|P1|NOT COMPLETED|Overall Study||2
1150986|NCT00573833|2792009|P1|COMPLETED|Overall Study||21
1150987|NCT00573833|2792009|P1|STARTED|Overall Study||23
1150988|NCT00573872|2792016|P1|NOT COMPLETED|Overall Study||11
1150989|NCT00573872|2792016|P1|COMPLETED|Overall Study|# of patients that completed treatment|32
1150990|NCT00573872|2792016|P1|STARTED|Overall Study|# of patients that signed consent|43
1150991|NCT00432159|2792027|P5|NOT COMPLETED|Overall Study||10
1150992|NCT00432159|2792028|P4|NOT COMPLETED|Overall Study||5
1150993|NCT00432159|2792029|P3|NOT COMPLETED|Overall Study||4
1150994|NCT00432159|2792030|P2|NOT COMPLETED|Overall Study||30
1150995|NCT00432159|2792031|P1|NOT COMPLETED|Overall Study||22
1150996|NCT00432159|2792027|P5|COMPLETED|Overall Study|Actual (Complete efficacy)|79
1150997|NCT00432159|2792028|P4|COMPLETED|Overall Study|Actual (Complete efficacy)|15
1150998|NCT00432159|2792029|P3|COMPLETED|Overall Study|Actual (Complete efficacy)|35
1150999|NCT00432159|2792030|P2|COMPLETED|Overall Study|Actual (Complete efficacy)|137
1151000|NCT00432159|2792031|P1|COMPLETED|Overall Study|Actual (Complete efficacy)|163
1151001|NCT00432159|2792027|P5|STARTED|Overall Study||89
1151002|NCT00432159|2792028|P4|STARTED|Overall Study||20
1151003|NCT00432159|2792029|P3|STARTED|Overall Study||39
1151004|NCT00432159|2792030|P2|STARTED|Overall Study||167
1151005|NCT00432159|2792031|P1|STARTED|Overall Study||185
1151006|NCT00414726|2792137|P2|NOT COMPLETED|Overall Study||1
1151007|NCT00414726|2792138|P1|NOT COMPLETED|Overall Study||0
1151008|NCT00414726|2792137|P2|COMPLETED|Overall Study||41
1151009|NCT00414726|2792138|P1|COMPLETED|Overall Study||43
1151010|NCT00414726|2792137|P2|STARTED|Overall Study||42
1151011|NCT00414726|2792138|P1|STARTED|Overall Study||43
1151012|NCT00409565|2792146|P1|NOT COMPLETED|Overall Study||1
1151013|NCT00409565|2792146|P1|COMPLETED|Overall Study||45
1151014|NCT00409565|2792146|P1|Overall Response Rate|Overall Study||7
1151015|NCT00409565|2792146|P1|STARTED|Overall Study||46
1151016|NCT00401817|2792154|P1|NOT COMPLETED|Overall Study||0
1151017|NCT00401817|2792154|P1|COMPLETED|Overall Study||11
1151018|NCT00401817|2792154|P1|STARTED|Overall Study||11
1151019|NCT00383760|2792161|P1|NOT COMPLETED|Overall Study||0
1151020|NCT00383760|2792161|P1|COMPLETED|Overall Study||15
1151021|NCT00383760|2792161|P1|STARTED|Overall Study||15
1151022|NCT00272844|2792175|P1|NOT COMPLETED|Overall Study||5
1151023|NCT00272844|2792175|P1|COMPLETED|Overall Study||18
1151024|NCT00272844|2792175|P1|STARTED|Overall Study||23
1151025|NCT00142506|2792183|P2|NOT COMPLETED|Overall Study||29
1151026|NCT00142506|2792184|P1|NOT COMPLETED|Overall Study||72
1151027|NCT00142506|2792183|P2|COMPLETED|Overall Study||77
1151028|NCT00142506|2792184|P1|COMPLETED|Overall Study||112
1151029|NCT00142506|2792183|P2|STARTED|Overall Study||106
1151030|NCT00142506|2792184|P1|STARTED|Overall Study||184
1151031|NCT00006184|2792192|P2|NOT COMPLETED|Overall Study||0
1151032|NCT00006184|2792193|P1|NOT COMPLETED|Overall Study||1
1151033|NCT00006184|2792192|P2|COMPLETED|Overall Study||10
1151034|NCT00006184|2792193|P1|COMPLETED|Overall Study||9
1151035|NCT00006184|2792192|P2|STARTED|Overall Study||10
1151036|NCT00006184|2792193|P1|STARTED|Overall Study||10
1151528|NCT02696317|2794076|P2|NOT COMPLETED|Period 2, 10 Days of Wear||0
1151529|NCT02696317|2794077|P1|NOT COMPLETED|Period 2, 10 Days of Wear||1
1151530|NCT02696317|2794076|P2|COMPLETED|Period 2, 10 Days of Wear||36
1151531|NCT02696317|2794077|P1|COMPLETED|Period 2, 10 Days of Wear||39
1151532|NCT02696317|2794076|P2|STARTED|Period 2, 10 Days of Wear||36
1151533|NCT02696317|2794077|P1|STARTED|Period 2, 10 Days of Wear||40
1151534|NCT02696317|2794076|P2|NOT COMPLETED|Period 1, 10 Days of Wear||0
1151535|NCT02696317|2794077|P1|NOT COMPLETED|Period 1, 10 Days of Wear||0
1151536|NCT02696317|2794076|P2|COMPLETED|Period 1, 10 Days of Wear||36
1151537|NCT02696317|2794077|P1|COMPLETED|Period 1, 10 Days of Wear||40
1151538|NCT02696317|2794076|P2|STARTED|Period 1, 10 Days of Wear||36
1151539|NCT02696317|2794077|P1|STARTED|Period 1, 10 Days of Wear||40
1151540|NCT02696317|2794076|P2|NOT COMPLETED|Habitual, 10 Days of Wear||4
1151541|NCT02696317|2794077|P1|NOT COMPLETED|Habitual, 10 Days of Wear||2
1151542|NCT02696317|2794076|P2|COMPLETED|Habitual, 10 Days of Wear||36
1151543|NCT02696317|2794077|P1|COMPLETED|Habitual, 10 Days of Wear||40
1151544|NCT02696317|2794076|P2|STARTED|Habitual, 10 Days of Wear||40
1151545|NCT02696317|2794077|P1|STARTED|Habitual, 10 Days of Wear||42
1151552|NCT02640482|2794104|P2|NOT COMPLETED|Overall Study||0
1151553|NCT02640482|2794105|P1|NOT COMPLETED|Overall Study||3
1151554|NCT02640482|2794104|P2|COMPLETED|Overall Study||100
1151555|NCT02640482|2794105|P1|COMPLETED|Overall Study||199
1151556|NCT02640482|2794104|P2|STARTED|Overall Study||100
1151557|NCT02640482|2794105|P1|STARTED|Overall Study||202
1151558|NCT02637804|2794117|P4|NOT COMPLETED|Second Intervention (1 Week)||0
1151559|NCT02637804|2794118|P3|NOT COMPLETED|Second Intervention (1 Week)||0
1151560|NCT02637804|2794119|P2|NOT COMPLETED|Second Intervention (1 Week)||0
1151561|NCT02637804|2794120|P1|NOT COMPLETED|Second Intervention (1 Week)||0
1151562|NCT02637804|2794117|P4|COMPLETED|Second Intervention (1 Week)||26
1151563|NCT02637804|2794118|P3|COMPLETED|Second Intervention (1 Week)||25
1151564|NCT02637804|2794119|P2|COMPLETED|Second Intervention (1 Week)||28
1151565|NCT02637804|2794120|P1|COMPLETED|Second Intervention (1 Week)||27
1151566|NCT02637804|2794117|P4|STARTED|Second Intervention (1 Week)||26
1151567|NCT02637804|2794118|P3|STARTED|Second Intervention (1 Week)||25
1151568|NCT02637804|2794119|P2|STARTED|Second Intervention (1 Week)||28
1151569|NCT02637804|2794120|P1|STARTED|Second Intervention (1 Week)||27
1151570|NCT02637804|2794117|P4|NOT COMPLETED|First Intervention (1 Week)||0
1151571|NCT02637804|2794118|P3|NOT COMPLETED|First Intervention (1 Week)||0
1151572|NCT02637804|2794119|P2|NOT COMPLETED|First Intervention (1 Week)||0
1151573|NCT02637804|2794120|P1|NOT COMPLETED|First Intervention (1 Week)||0
1151574|NCT02637804|2794117|P4|COMPLETED|First Intervention (1 Week)||26
1151575|NCT02637804|2794118|P3|COMPLETED|First Intervention (1 Week)||25
1151576|NCT02637804|2794119|P2|COMPLETED|First Intervention (1 Week)||28
1151577|NCT02637804|2794120|P1|COMPLETED|First Intervention (1 Week)||27
1151578|NCT02637804|2794117|P4|STARTED|First Intervention (1 Week)||26
1151579|NCT02637804|2794118|P3|STARTED|First Intervention (1 Week)||25
1151580|NCT02637804|2794119|P2|STARTED|First Intervention (1 Week)||28
1151581|NCT02637804|2794120|P1|STARTED|First Intervention (1 Week)||27
1151582|NCT02610634|2794226|P2|NOT COMPLETED|Overall Study||0
1151583|NCT02610634|2794227|P1|NOT COMPLETED|Overall Study||0
1151584|NCT02610634|2794226|P2|COMPLETED|Overall Study||40
1151585|NCT02610634|2794227|P1|COMPLETED|Overall Study||60
1151586|NCT02610634|2794226|P2|STARTED|Overall Study||40
1151587|NCT02610634|2794227|P1|STARTED|Overall Study||60
1151600|NCT02540356|2794338|P2|NOT COMPLETED|Overall Study||0
1151601|NCT02540356|2794339|P1|NOT COMPLETED|Overall Study||1
1151602|NCT02540356|2794338|P2|COMPLETED|Overall Study||0
1151603|NCT02540356|2794339|P1|COMPLETED|Overall Study||0
1151604|NCT02540356|2794338|P2|STARTED|Overall Study||0
1151605|NCT02540356|2794339|P1|STARTED|Overall Study||1
1151606|NCT02514473|2794372|P2|NOT COMPLETED|Overall Study||5
1151607|NCT02514473|2794373|P1|NOT COMPLETED|Overall Study||3
1151608|NCT02514473|2794372|P2|COMPLETED|Overall Study||98
1151609|NCT02514473|2794373|P1|COMPLETED|Overall Study||98
1151610|NCT02514473|2794372|P2|STARTED|Overall Study||103
1151611|NCT02514473|2794373|P1|STARTED|Overall Study||101
1151642|NCT02476032|2794490|P3|NOT COMPLETED|Overall Study||1
1151643|NCT02476032|2794491|P2|NOT COMPLETED|Overall Study||1
1151644|NCT02476032|2794492|P1|NOT COMPLETED|Overall Study||0
1151645|NCT02476032|2794490|P3|COMPLETED|Overall Study||19
1151646|NCT02476032|2794491|P2|COMPLETED|Overall Study||19
1151647|NCT02476032|2794492|P1|COMPLETED|Overall Study||20
1151648|NCT02476032|2794490|P3|STARTED|Overall Study||20
1151649|NCT02476032|2794491|P2|STARTED|Overall Study||20
1151650|NCT02476032|2794492|P1|STARTED|Overall Study||20
1151663|NCT02411578|2794599|P2|NOT COMPLETED|Extension Phase||0
1151664|NCT02411578|2794600|P1|NOT COMPLETED|Extension Phase||0
1151665|NCT02411578|2794599|P2|COMPLETED|Extension Phase||9
1151666|NCT02411578|2794600|P1|COMPLETED|Extension Phase||8
1151667|NCT02411578|2794599|P2|STARTED|Extension Phase|2 Crossover Trial participants could not continue due to study syringes expiration|9
1151668|NCT02411578|2794600|P1|STARTED|Extension Phase||8
1151669|NCT02411578|2794599|P2|NOT COMPLETED|Crossover Trial Phase||1
1151670|NCT02411578|2794600|P1|NOT COMPLETED|Crossover Trial Phase||0
1151671|NCT02411578|2794599|P2|COMPLETED|Crossover Trial Phase||11
1151672|NCT02411578|2794600|P1|COMPLETED|Crossover Trial Phase||8
1151673|NCT02411578|2794599|P2|STARTED|Crossover Trial Phase||12
1151674|NCT02411578|2794600|P1|STARTED|Crossover Trial Phase||8
1151675|NCT02410200|2794640|P1|NOT COMPLETED|Overall Study||2
1151676|NCT02410200|2794640|P1|COMPLETED|Overall Study||20
1151677|NCT02410200|2794640|P1|STARTED|Overall Study||22
1151690|NCT02317692|2794675|P2|NOT COMPLETED|Overall Study||0
1151691|NCT02317692|2794676|P1|NOT COMPLETED|Overall Study||6
1151692|NCT02317692|2794675|P2|COMPLETED|Overall Study||77
1151693|NCT02317692|2794676|P1|COMPLETED|Overall Study||63
1151694|NCT02317692|2794675|P2|STARTED|Overall Study||77
1151695|NCT02317692|2794676|P1|STARTED|Overall Study||69
1151704|NCT02283268|2794723|P1|NOT COMPLETED|Overall Study||1
1151705|NCT02283268|2794723|P1|COMPLETED|Overall Study||14
1151706|NCT02283268|2794723|P1|STARTED|Overall Study||15
1151729|NCT02210091|2794841|P2|NOT COMPLETED|Overall Study||2
1151730|NCT02210091|2794842|P1|NOT COMPLETED|Overall Study||0
1151731|NCT02210091|2794841|P2|COMPLETED|Overall Study||32
1151732|NCT02210091|2794842|P1|COMPLETED|Overall Study||32
1151733|NCT02210091|2794841|P2|STARTED|Overall Study||34
1151734|NCT02210091|2794842|P1|STARTED|Overall Study||32
1151747|NCT02071420|2794953|P2|NOT COMPLETED|Overall Study||3
1151748|NCT02071420|2794954|P1|NOT COMPLETED|Overall Study||3
1151749|NCT02071420|2794953|P2|COMPLETED|Overall Study||27
1151750|NCT02071420|2794954|P1|COMPLETED|Overall Study||27
1151751|NCT02071420|2794953|P2|STARTED|Overall Study||30
1151752|NCT02071420|2794954|P1|STARTED|Overall Study||30
1151759|NCT01989156|2794972|P3|NOT COMPLETED|End of Study (Population at Day 90)||3
1151760|NCT01989156|2794973|P2|NOT COMPLETED|End of Study (Population at Day 90)||5
1151761|NCT01989156|2794974|P1|NOT COMPLETED|End of Study (Population at Day 90)||7
1151762|NCT01989156|2794972|P3|COMPLETED|End of Study (Population at Day 90)||31
1151763|NCT01989156|2794973|P2|COMPLETED|End of Study (Population at Day 90)||35
1151764|NCT01989156|2794974|P1|COMPLETED|End of Study (Population at Day 90)||73
1151765|NCT01989156|2794972|P3|STARTED|End of Study (Population at Day 90)||34
1151766|NCT01989156|2794973|P2|STARTED|End of Study (Population at Day 90)||40
1151767|NCT01989156|2794974|P1|STARTED|End of Study (Population at Day 90)||80
1151768|NCT01989156|2794972|P3|NOT COMPLETED|Confinement Period (Population at Day 5)||5
1151769|NCT01989156|2794973|P2|NOT COMPLETED|Confinement Period (Population at Day 5)||1
1151770|NCT01989156|2794974|P1|NOT COMPLETED|Confinement Period (Population at Day 5)||0
1151771|NCT01989156|2794972|P3|COMPLETED|Confinement Period (Population at Day 5)||34
1151772|NCT01989156|2794973|P2|COMPLETED|Confinement Period (Population at Day 5)||40
1151773|NCT01989156|2794974|P1|COMPLETED|Confinement Period (Population at Day 5)||80
1151774|NCT01989156|2794972|P3|STARTED|Confinement Period (Population at Day 5)||39
1151775|NCT01989156|2794973|P2|STARTED|Confinement Period (Population at Day 5)||41
1151776|NCT01989156|2794974|P1|STARTED|Confinement Period (Population at Day 5)||80
1151777|NCT01987908|2794994|P3|NOT COMPLETED|Post-Treatment Observation Period||0
1151778|NCT01987908|2794995|P2|NOT COMPLETED|Post-Treatment Observation Period||3
1151779|NCT01987908|2794996|P1|NOT COMPLETED|Post-Treatment Observation Period||0
1151780|NCT01987908|2794994|P3|COMPLETED|Post-Treatment Observation Period||2
1151781|NCT01987908|2794995|P2|COMPLETED|Post-Treatment Observation Period||7
1151782|NCT01987908|2794996|P1|COMPLETED|Post-Treatment Observation Period||0
1151783|NCT01987908|2794994|P3|STARTED|Post-Treatment Observation Period||2
1151784|NCT01987908|2794995|P2|STARTED|Post-Treatment Observation Period||10
1151785|NCT01987908|2794996|P1|STARTED|Post-Treatment Observation Period||0
1151786|NCT01987908|2794994|P3|NOT COMPLETED|Treatment Period||1
1151787|NCT01987908|2794995|P2|NOT COMPLETED|Treatment Period||1
1151788|NCT01987908|2794996|P1|NOT COMPLETED|Treatment Period||0
1151789|NCT01987908|2794994|P3|COMPLETED|Treatment Period||2
1151790|NCT01987908|2794995|P2|COMPLETED|Treatment Period||10
1151791|NCT01987908|2794996|P1|COMPLETED|Treatment Period||0
1151792|NCT01987908|2794994|P3|STARTED|Treatment Period||3
1151793|NCT01987908|2794995|P2|STARTED|Treatment Period||11
1151794|NCT01987908|2794996|P1|STARTED|Treatment Period||0
1151795|NCT01987908|2794994|P3|NOT COMPLETED|Placebo Lead-in Period||0
1151796|NCT01987908|2794995|P2|NOT COMPLETED|Placebo Lead-in Period||0
1151797|NCT01987908|2794996|P1|NOT COMPLETED|Placebo Lead-in Period||9
1151798|NCT01987908|2794994|P3|COMPLETED|Placebo Lead-in Period||0
1151799|NCT01987908|2794995|P2|COMPLETED|Placebo Lead-in Period||0
1151800|NCT01987908|2794996|P1|COMPLETED|Placebo Lead-in Period||14
1151801|NCT01987908|2794994|P3|STARTED|Placebo Lead-in Period||0
1151802|NCT01987908|2794995|P2|STARTED|Placebo Lead-in Period||0
1151803|NCT01987908|2794996|P1|STARTED|Placebo Lead-in Period||23
1151804|NCT01942590|2795079|P2|NOT COMPLETED|Overall Study||1
1151805|NCT01942590|2795080|P1|NOT COMPLETED|Overall Study||1
1151806|NCT01942590|2795079|P2|COMPLETED|Overall Study||4
1151807|NCT01942590|2795080|P1|COMPLETED|Overall Study||7
1151808|NCT01942590|2795079|P2|STARTED|Overall Study||5
1151809|NCT01942590|2795080|P1|STARTED|Overall Study||8
1151864|NCT01828983|2795215|P2|NOT COMPLETED|Overall Study||0
1151865|NCT01828983|2795216|P1|NOT COMPLETED|Overall Study||0
1151866|NCT01828983|2795215|P2|COMPLETED|Overall Study||81
1151867|NCT01828983|2795216|P1|COMPLETED|Overall Study||80
1151868|NCT01828983|2795215|P2|STARTED|Overall Study||81
1151869|NCT01828983|2795216|P1|STARTED|Overall Study||80
1151870|NCT01800162|2795229|P3|NOT COMPLETED|Overall Study||0
1151871|NCT01800162|2795230|P2|NOT COMPLETED|Overall Study||0
1151872|NCT01800162|2795231|P1|NOT COMPLETED|Overall Study||0
1151873|NCT01800162|2795229|P3|COMPLETED|Overall Study||1
1151874|NCT01800162|2795230|P2|COMPLETED|Overall Study||0
1151875|NCT01800162|2795231|P1|COMPLETED|Overall Study||1
1151876|NCT01800162|2795229|P3|STARTED|Overall Study|1 subject randomized to expectant management on 11/1/2013.|1
1151877|NCT01800162|2795230|P2|STARTED|Overall Study||0
1151878|NCT01800162|2795231|P1|STARTED|Overall Study|1 subject was randomized to uterine evacuation on 6/26/2013.|1
1151879|NCT01790659|2795239|P2|NOT COMPLETED|Overall Study||6
1151880|NCT01790659|2795240|P1|NOT COMPLETED|Overall Study||6
1151881|NCT01790659|2795239|P2|COMPLETED|Overall Study||192
1151882|NCT01790659|2795240|P1|COMPLETED|Overall Study||195
1151883|NCT01790659|2795239|P2|STARTED|Overall Study||198
1151884|NCT01790659|2795240|P1|STARTED|Overall Study||201
1151892|NCT01757405|2795272|P2|NOT COMPLETED|Overall Study||2
1151893|NCT01757405|2795273|P1|NOT COMPLETED|Overall Study||1
1151894|NCT01757405|2795272|P2|COMPLETED|Overall Study||18
1151895|NCT01757405|2795273|P1|COMPLETED|Overall Study||17
1151896|NCT01757405|2795272|P2|STARTED|Overall Study||20
1151897|NCT01757405|2795273|P1|STARTED|Overall Study||18
1151898|NCT01749501|2795291|P2|NOT COMPLETED|Overall Study||0
1151899|NCT01749501|2795292|P1|NOT COMPLETED|Overall Study||0
1151900|NCT01749501|2795291|P2|COMPLETED|Overall Study||23
1151901|NCT01749501|2795292|P1|COMPLETED|Overall Study||22
1151902|NCT01749501|2795291|P2|STARTED|Overall Study||23
1151903|NCT01749501|2795292|P1|STARTED|Overall Study||22
1151910|NCT01736579|2795359|P2|NOT COMPLETED|Overall Study||2
1151911|NCT01736579|2795360|P1|NOT COMPLETED|Overall Study||2
1151912|NCT01736579|2795359|P2|COMPLETED|Overall Study||0
1151913|NCT01736579|2795360|P1|COMPLETED|Overall Study||0
1151914|NCT01736579|2795359|P2|STARTED|Overall Study||2
1151915|NCT01736579|2795360|P1|STARTED|Overall Study||2
1151916|NCT01725126|2795400|P6|NOT COMPLETED|Overall Study||0
1151917|NCT01725126|2795401|P5|NOT COMPLETED|Overall Study||0
1151918|NCT01725126|2795402|P4|NOT COMPLETED|Overall Study||1
1151919|NCT01725126|2795403|P3|NOT COMPLETED|Overall Study||0
1151920|NCT01725126|2795404|P2|NOT COMPLETED|Overall Study||1
1151921|NCT01725126|2795405|P1|NOT COMPLETED|Overall Study||0
1151922|NCT01725126|2795400|P6|COMPLETED|Overall Study||12
1151923|NCT01725126|2795401|P5|COMPLETED|Overall Study||6
1151924|NCT01725126|2795402|P4|COMPLETED|Overall Study||13
1151925|NCT01725126|2795403|P3|COMPLETED|Overall Study||6
1151926|NCT01725126|2795404|P2|COMPLETED|Overall Study||10
1151927|NCT01725126|2795405|P1|COMPLETED|Overall Study||4
1151928|NCT01725126|2795400|P6|STARTED|Overall Study||12
1151929|NCT01725126|2795401|P5|STARTED|Overall Study||6
1151930|NCT01725126|2795402|P4|STARTED|Overall Study||14
1151931|NCT01725126|2795403|P3|STARTED|Overall Study||6
1151932|NCT01725126|2795404|P2|STARTED|Overall Study||11
1151933|NCT01725126|2795405|P1|STARTED|Overall Study||4
1151954|NCT01614093|2795634|P1|NOT COMPLETED|Overall Study||1
1151955|NCT01614093|2795634|P1|COMPLETED|Overall Study||16
1151956|NCT01614093|2795634|P1|STARTED|Overall Study||17
1151978|NCT01508910|2795732|P4|NOT COMPLETED|Treatment||3
1151979|NCT01508910|2795733|P3|NOT COMPLETED|Treatment||10
1151980|NCT01508910|2795734|P2|NOT COMPLETED|Treatment||4
1151981|NCT01508910|2795735|P1|NOT COMPLETED|Treatment||2
1151982|NCT01508910|2795732|P4|COMPLETED|Treatment||3
1151983|NCT01508910|2795733|P3|COMPLETED|Treatment||18
1151984|NCT01508910|2795734|P2|COMPLETED|Treatment||24
1151985|NCT01508910|2795735|P1|COMPLETED|Treatment||48
1151986|NCT01508910|2795732|P4|STARTED|Treatment|3 moved from Treatment (Tx) to Active Control (AC) Arm; 6 in Not injected Arm(4 from Tx ; 2 from AC)|6
1151987|NCT01508910|2795733|P3|STARTED|Treatment||28
1151988|NCT01508910|2795734|P2|STARTED|Treatment||28
1151989|NCT01508910|2795735|P1|STARTED|Treatment||50
1151990|NCT01508910|2795732|P4|NOT COMPLETED|Randomization||0
1151991|NCT01508910|2795733|P3|NOT COMPLETED|Randomization||0
1151992|NCT01508910|2795734|P2|NOT COMPLETED|Randomization||0
1151993|NCT01508910|2795735|P1|NOT COMPLETED|Randomization||0
1151994|NCT01508910|2795732|P4|COMPLETED|Randomization||0
1151995|NCT01508910|2795733|P3|COMPLETED|Randomization||28
1151996|NCT01508910|2795734|P2|COMPLETED|Randomization||27
1151997|NCT01508910|2795735|P1|COMPLETED|Randomization||57
1151998|NCT01508910|2795732|P4|STARTED|Randomization|Participants not randomized into Not Injected arm, but some were re-assigned here during treatment.|0
1151999|NCT01508910|2795733|P3|STARTED|Randomization||28
1152000|NCT01508910|2795734|P2|STARTED|Randomization||27
1152001|NCT01508910|2795735|P1|STARTED|Randomization||57
1152002|NCT01507896|2795757|P1|NOT COMPLETED|Overall Study||2
1152003|NCT01507896|2795757|P1|COMPLETED|Overall Study|28 unique participants had 38 surgeries (participants could have multiple surgeries).|28
1152004|NCT01507896|2795757|P1|STARTED|Overall Study|30 unique participants had 40 surgeries planned (participants could have multiple surgeries).|30
1152029|NCT01488994|2795841|P2|NOT COMPLETED|Overall Study||1
1152030|NCT01488994|2795842|P1|NOT COMPLETED|Overall Study||0
1152031|NCT01488994|2795841|P2|COMPLETED|Overall Study||11
1152032|NCT01488994|2795842|P1|COMPLETED|Overall Study||11
1152033|NCT01488994|2795841|P2|STARTED|Overall Study||12
1152034|NCT01488994|2795842|P1|STARTED|Overall Study||11
1152035|NCT01485796|2795929|P1|NOT COMPLETED|Overall Trial (Incl. Safety Follow-up)||12
1152036|NCT01485796|2795929|P1|COMPLETED|Overall Trial (Incl. Safety Follow-up)|1 subject who completed Epoch 2 + 24 subjects who completed the safety follow-up|25
1152037|NCT01485796|2795929|P1|Completed Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||24
1152038|NCT01485796|2795929|P1|Switch to Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||26
1152039|NCT01485796|2795929|P1|Completed Epoch 2|Overall Trial (Incl. Safety Follow-up)||1
1152040|NCT01485796|2795929|P1|Treated in Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
1152041|NCT01485796|2795929|P1|Started Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
1152042|NCT01485796|2795929|P1|Completed Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||36
1152043|NCT01485796|2795929|P1|Treated in Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||37
1152044|NCT01485796|2795929|P1|STARTED|Overall Trial (Incl. Safety Follow-up)||37
1152045|NCT01485796|2795929|P1|NOT COMPLETED|Period 2: Epoch 2||35
1152046|NCT01485796|2795929|P1|COMPLETED|Period 2: Epoch 2||1
1152047|NCT01485796|2795929|P1|Treated in Epoch 2|Period 2: Epoch 2||36
1152048|NCT01485796|2795929|P1|STARTED|Period 2: Epoch 2||36
1152049|NCT01485796|2795929|P1|NOT COMPLETED|Period 1: Epoch 1 (Ramp-up)||1
1152050|NCT01485796|2795929|P1|COMPLETED|Period 1: Epoch 1 (Ramp-up)||36
1152051|NCT01485796|2795929|P1|Treated in Epoch 1|Period 1: Epoch 1 (Ramp-up)||37
1152052|NCT01485796|2795929|P1|STARTED|Period 1: Epoch 1 (Ramp-up)||37
1152091|NCT01390389|2796044|P2|NOT COMPLETED|Overall Study||1
1152092|NCT01390389|2796045|P1|NOT COMPLETED|Overall Study||4
1152093|NCT01390389|2796044|P2|COMPLETED|Overall Study||8
1152094|NCT01390389|2796045|P1|COMPLETED|Overall Study||6
1152095|NCT01390389|2796044|P2|STARTED|Overall Study||9
1152096|NCT01390389|2796045|P1|STARTED|Overall Study||10
1152097|NCT01345669|2796057|P2|NOT COMPLETED|Overall Study||119
1152098|NCT01345669|2796058|P1|NOT COMPLETED|Overall Study||287
1152099|NCT01345669|2796057|P2|COMPLETED|Overall Study||87
1152100|NCT01345669|2796058|P1|COMPLETED|Overall Study||124
1152101|NCT01345669|2796057|P2|STARTED|Overall Study||206
1152102|NCT01345669|2796058|P1|STARTED|Overall Study||411
1152103|NCT01308567|2796077|P3|NOT COMPLETED|Overall Study||4
1152104|NCT01308567|2796078|P2|NOT COMPLETED|Overall Study||4
1152105|NCT01308567|2796079|P1|NOT COMPLETED|Overall Study||2
1152106|NCT01308567|2796077|P3|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|384
1152107|NCT01308567|2796078|P2|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|385
1152108|NCT01308567|2796079|P1|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|389
1152109|NCT01308567|2796077|P3|Ongoing Treatment at Data Cut-off|Overall Study||3
1152110|NCT01308567|2796078|P2|Ongoing Treatment at Data Cut-off|Overall Study||6
1152111|NCT01308567|2796079|P1|Ongoing Treatment at Data Cut-off|Overall Study||4
1152112|NCT01308567|2796077|P3|Treated|Overall Study|For 2 participants, actual treatment received was Cabazitaxel 20 mg/m^2.|377
1152113|NCT01308567|2796078|P2|Treated|Overall Study|For 15 participants, actual treatment received was Cabazitaxel 25 mg/m^2.|382
1152114|NCT01308567|2796079|P1|Treated|Overall Study|For 1 participant, actual treatment received was Cabazitaxel 25 mg/m^2.|388
1152115|NCT01308567|2796077|P3|STARTED|Overall Study|Randomized|388
1152116|NCT01308567|2796078|P2|STARTED|Overall Study|Randomized|389
1152117|NCT01308567|2796079|P1|STARTED|Overall Study|Randomized|391
1152118|NCT01305213|2796119|P2|NOT COMPLETED|Overall Study||0
1152119|NCT01305213|2796120|P1|NOT COMPLETED|Overall Study||0
1152120|NCT01305213|2796119|P2|COMPLETED|Overall Study||54
1152121|NCT01305213|2796120|P1|COMPLETED|Overall Study||53
1152122|NCT01305213|2796119|P2|STARTED|Overall Study||54
1152123|NCT01305213|2796120|P1|STARTED|Overall Study||53
1152175|NCT01218438|2796330|P1|NOT COMPLETED|Epoch 4||3
1152176|NCT01218438|2796330|P1|COMPLETED|Epoch 4||67
1152177|NCT01218438|2796330|P1|STARTED|Epoch 4||70
1152178|NCT01218438|2796330|P1|NOT COMPLETED|Epoch 3||4
1152179|NCT01218438|2796330|P1|COMPLETED|Epoch 3||70
1152180|NCT01218438|2796330|P1|STARTED|Epoch 3||74
1152181|NCT01218438|2796330|P1|NOT COMPLETED|Epoch 2||0
1152182|NCT01218438|2796330|P1|COMPLETED|Epoch 2||45
1152183|NCT01218438|2796330|P1|STARTED|Epoch 2||45
1152184|NCT01218438|2796330|P1|NOT COMPLETED|Epoch 1||3
1152185|NCT01218438|2796330|P1|COMPLETED|Epoch 1||74
1152186|NCT01218438|2796330|P1|STARTED|Epoch 1||77
1152190|NCT01178294|2796491|P1|NOT COMPLETED|Overall Study||11
1152191|NCT01178294|2796491|P1|COMPLETED|Overall Study||18
1152192|NCT01178294|2796491|P1|STARTED|Overall Study|25 subjects enrolled under OBI-1-301 + 4 subjects enrolled under expanded access OBI-1-301a.|29
1152193|NCT01175213|2796516|P2|NOT COMPLETED|Safety Follow-up||0
1152194|NCT01175213|2796517|P1|NOT COMPLETED|Safety Follow-up||1
1152195|NCT01175213|2796516|P2|COMPLETED|Safety Follow-up||3
1152196|NCT01175213|2796517|P1|COMPLETED|Safety Follow-up||47
1152197|NCT01175213|2796516|P2|STARTED|Safety Follow-up||3
1152198|NCT01175213|2796517|P1|STARTED|Safety Follow-up||48
1152199|NCT01175213|2796516|P2|NOT COMPLETED|IGSC, 10%/rHuPH20||0
1152200|NCT01175213|2796517|P1|NOT COMPLETED|IGSC, 10%/rHuPH20||15
1152201|NCT01175213|2796516|P2|COMPLETED|IGSC, 10%/rHuPH20||3
1152202|NCT01175213|2796517|P1|COMPLETED|IGSC, 10%/rHuPH20||48
1152203|NCT01175213|2796516|P2|STARTED|IGSC, 10%/rHuPH20|3 participants treated IV with IGIV,10% without rHuPH20 throughout the study.|3
1152204|NCT01175213|2796517|P1|STARTED|IGSC, 10%/rHuPH20||63
1152205|NCT01162499|2796562|P2|NOT COMPLETED|Intervention 2 (4 Hours)||0
1152206|NCT01162499|2796563|P1|NOT COMPLETED|Intervention 2 (4 Hours)||0
1152207|NCT01162499|2796562|P2|COMPLETED|Intervention 2 (4 Hours)||3
1152208|NCT01162499|2796563|P1|COMPLETED|Intervention 2 (4 Hours)||3
1152209|NCT01162499|2796562|P2|STARTED|Intervention 2 (4 Hours)||3
1152210|NCT01162499|2796563|P1|STARTED|Intervention 2 (4 Hours)||3
1152211|NCT01162499|2796562|P2|NOT COMPLETED|Intervention 1 (4 Hours)||1
1152212|NCT01162499|2796563|P1|NOT COMPLETED|Intervention 1 (4 Hours)||0
1152213|NCT01162499|2796562|P2|COMPLETED|Intervention 1 (4 Hours)||3
1152214|NCT01162499|2796563|P1|COMPLETED|Intervention 1 (4 Hours)||3
1152215|NCT01162499|2796562|P2|Received Intervention|Intervention 1 (4 Hours)||3
1152216|NCT01162499|2796563|P1|Received Intervention|Intervention 1 (4 Hours)||3
1152217|NCT01162499|2796562|P2|STARTED|Intervention 1 (4 Hours)||4
1152218|NCT01162499|2796563|P1|STARTED|Intervention 1 (4 Hours)||3
1152219|NCT01154816|2796595|P12|NOT COMPLETED|Overall Study||4
1152220|NCT01154816|2796596|P11|NOT COMPLETED|Overall Study||11
1152221|NCT01154816|2796597|P10|NOT COMPLETED|Overall Study||10
1152222|NCT01154816|2796598|P9|NOT COMPLETED|Overall Study||9
1152223|NCT01154816|2796599|P8|NOT COMPLETED|Overall Study||7
1152224|NCT01154816|2796600|P7|NOT COMPLETED|Overall Study||6
1152225|NCT01154816|2796601|P6|NOT COMPLETED|Overall Study||8
1152226|NCT01154816|2796602|P5|NOT COMPLETED|Overall Study||10
1152227|NCT01154816|2796603|P4|NOT COMPLETED|Overall Study||10
1152228|NCT01154816|2796604|P3|NOT COMPLETED|Overall Study||10
1152229|NCT01154816|2796605|P2|NOT COMPLETED|Overall Study||10
1152230|NCT01154816|2796606|P1|NOT COMPLETED|Overall Study||20
1152231|NCT01154816|2796595|P12|COMPLETED|Overall Study||0
1152232|NCT01154816|2796596|P11|COMPLETED|Overall Study||0
1152233|NCT01154816|2796597|P10|COMPLETED|Overall Study||0
1152234|NCT01154816|2796598|P9|COMPLETED|Overall Study||1
1152235|NCT01154816|2796599|P8|COMPLETED|Overall Study||0
1152236|NCT01154816|2796600|P7|COMPLETED|Overall Study||0
1152237|NCT01154816|2796601|P6|COMPLETED|Overall Study||0
1152238|NCT01154816|2796602|P5|COMPLETED|Overall Study||0
1152239|NCT01154816|2796603|P4|COMPLETED|Overall Study||0
1152240|NCT01154816|2796604|P3|COMPLETED|Overall Study||0
1152241|NCT01154816|2796605|P2|COMPLETED|Overall Study||2
1152242|NCT01154816|2796606|P1|COMPLETED|Overall Study||0
1152243|NCT01154816|2796595|P12|STARTED|Overall Study||4
1152244|NCT01154816|2796596|P11|STARTED|Overall Study||11
1152245|NCT01154816|2796597|P10|STARTED|Overall Study||10
1152246|NCT01154816|2796598|P9|STARTED|Overall Study||10
1152247|NCT01154816|2796599|P8|STARTED|Overall Study||7
1152248|NCT01154816|2796600|P7|STARTED|Overall Study||6
1152249|NCT01154816|2796601|P6|STARTED|Overall Study||8
1152250|NCT01154816|2796602|P5|STARTED|Overall Study||10
1152251|NCT01154816|2796603|P4|STARTED|Overall Study||10
1152252|NCT01154816|2796604|P3|STARTED|Overall Study||10
1152253|NCT01154816|2796605|P2|STARTED|Overall Study||12
1152254|NCT01154816|2796606|P1|STARTED|Overall Study||20
1152282|NCT01104402|2796725|P2|NOT COMPLETED|Overall Study||33
1152283|NCT01104402|2796726|P1|NOT COMPLETED|Overall Study||21
1152284|NCT01104402|2796725|P2|COMPLETED|Overall Study||102
1152285|NCT01104402|2796726|P1|COMPLETED|Overall Study||111
1152286|NCT01104402|2796725|P2|STARTED|Overall Study||135
1152287|NCT01104402|2796726|P1|STARTED|Overall Study||132
1152288|NCT01101867|2796746|P2|NOT COMPLETED|Overall Study||4
1152289|NCT01101867|2796747|P1|NOT COMPLETED|Overall Study||1
1152290|NCT01101867|2796746|P2|COMPLETED|Overall Study||59
1152291|NCT01101867|2796747|P1|COMPLETED|Overall Study||62
1152292|NCT01101867|2796746|P2|STARTED|Overall Study||63
1152293|NCT01101867|2796747|P1|STARTED|Overall Study||63
1152297|NCT01015807|2796768|P3|NOT COMPLETED|Overall Study||0
1152298|NCT01015807|2796769|P2|NOT COMPLETED|Overall Study||0
1152299|NCT01015807|2796770|P1|NOT COMPLETED|Overall Study||0
1152300|NCT01015807|2796768|P3|COMPLETED|Overall Study||30
1152301|NCT01015807|2796769|P2|COMPLETED|Overall Study||30
1152302|NCT01015807|2796770|P1|COMPLETED|Overall Study||30
1152303|NCT01015807|2796768|P3|STARTED|Overall Study||30
1152304|NCT01015807|2796769|P2|STARTED|Overall Study||30
1152305|NCT01015807|2796770|P1|STARTED|Overall Study||30
1152309|NCT00939393|2796785|P2|NOT COMPLETED|Overall Study||0
1152310|NCT00939393|2796786|P1|NOT COMPLETED|Overall Study||4
1152311|NCT00939393|2796785|P2|COMPLETED|Overall Study||35
1152312|NCT00939393|2796786|P1|COMPLETED|Overall Study||33
1152313|NCT00939393|2796785|P2|STARTED|Overall Study||35
1152314|NCT00939393|2796786|P1|STARTED|Overall Study||37
1152352|NCT00835731|2796946|P2|NOT COMPLETED|Overall Study||1
1152353|NCT00835731|2796947|P1|NOT COMPLETED|Overall Study||2
1152354|NCT00835731|2796946|P2|COMPLETED|Overall Study||60
1152355|NCT00835731|2796947|P1|COMPLETED|Overall Study||62
1152356|NCT00835731|2796946|P2|STARTED|Overall Study||61
1152357|NCT00835731|2796947|P1|STARTED|Overall Study||64
1152364|NCT00781898|2797040|P2|NOT COMPLETED|Overall Study||29
1152365|NCT00781898|2797041|P1|NOT COMPLETED|Overall Study||34
1152366|NCT00781898|2797040|P2|COMPLETED|Overall Study||126
1152367|NCT00781898|2797041|P1|COMPLETED|Overall Study||119
1152368|NCT00781898|2797040|P2|STARTED|Overall Study||155
1152369|NCT00781898|2797041|P1|STARTED|Overall Study||153
1152415|NCT00661427|2797133|P2|NOT COMPLETED|Overall Study||7
1152416|NCT00661427|2797134|P1|NOT COMPLETED|Overall Study||5
1152417|NCT00661427|2797133|P2|COMPLETED|Overall Study||19
1152418|NCT00661427|2797134|P1|COMPLETED|Overall Study||30
1152419|NCT00661427|2797133|P2|STARTED|Overall Study||26
1152420|NCT00661427|2797134|P1|STARTED|Overall Study||35
1152462|NCT00571324|2797190|P2|NOT COMPLETED|Intervention 2 (7 Hours)||0
1152463|NCT00571324|2797191|P1|NOT COMPLETED|Intervention 2 (7 Hours)||0
1152464|NCT00571324|2797190|P2|COMPLETED|Intervention 2 (7 Hours)||4
1152465|NCT00571324|2797191|P1|COMPLETED|Intervention 2 (7 Hours)||5
1152466|NCT00571324|2797190|P2|STARTED|Intervention 2 (7 Hours)||4
1152467|NCT00571324|2797191|P1|STARTED|Intervention 2 (7 Hours)||5
1152468|NCT00571324|2797190|P2|NOT COMPLETED|Intervention 1 (7 Hours)||0
1152469|NCT00571324|2797191|P1|NOT COMPLETED|Intervention 1 (7 Hours)||0
1152470|NCT00571324|2797190|P2|COMPLETED|Intervention 1 (7 Hours)||4
1152471|NCT00571324|2797191|P1|COMPLETED|Intervention 1 (7 Hours)||5
1152472|NCT00571324|2797190|P2|STARTED|Intervention 1 (7 Hours)||4
1152473|NCT00571324|2797191|P1|STARTED|Intervention 1 (7 Hours)||5
1152474|NCT00570089|2797203|P2|NOT COMPLETED|Perod 2||0
1152475|NCT00570089|2797204|P1|NOT COMPLETED|Perod 2||0
1152476|NCT00570089|2797203|P2|COMPLETED|Perod 2||10
1152477|NCT00570089|2797204|P1|COMPLETED|Perod 2||10
1152478|NCT00570089|2797203|P2|STARTED|Perod 2||10
1152479|NCT00570089|2797204|P1|STARTED|Perod 2||10
1152480|NCT00570089|2797203|P2|NOT COMPLETED|Period 1||0
1152481|NCT00570089|2797204|P1|NOT COMPLETED|Period 1||0
1152482|NCT00570089|2797203|P2|COMPLETED|Period 1||10
1152483|NCT00570089|2797204|P1|COMPLETED|Period 1||10
1152484|NCT00570089|2797203|P2|STARTED|Period 1||10
1152485|NCT00570089|2797204|P1|STARTED|Period 1||10
1152486|NCT00496964|2797214|P2|NOT COMPLETED|Overall Study||1
1152487|NCT00496964|2797215|P1|NOT COMPLETED|Overall Study||0
1152488|NCT00496964|2797214|P2|COMPLETED|Overall Study||3
1152489|NCT00496964|2797215|P1|COMPLETED|Overall Study||1
1152490|NCT00496964|2797214|P2|STARTED|Overall Study||4
1152491|NCT00496964|2797215|P1|STARTED|Overall Study||1
1152495|NCT00464568|2797241|P1|NOT COMPLETED|Overall Study||2
1152496|NCT00464568|2797241|P1|COMPLETED|Overall Study||30
1152497|NCT00464568|2797241|P1|STARTED|Overall Study||32
1152504|NCT00381797|2797328|P5|NOT COMPLETED|Overall Study||2
1152505|NCT00381797|2797329|P4|NOT COMPLETED|Overall Study||1
1152506|NCT00381797|2797330|P3|NOT COMPLETED|Overall Study||0
1152507|NCT00381797|2797331|P2|NOT COMPLETED|Overall Study||1
1152508|NCT00381797|2797332|P1|NOT COMPLETED|Overall Study||1
1152509|NCT00381797|2797328|P5|COMPLETED|Overall Study||35
1152510|NCT00381797|2797329|P4|COMPLETED|Overall Study||14
1152511|NCT00381797|2797330|P3|COMPLETED|Overall Study||10
1152512|NCT00381797|2797331|P2|COMPLETED|Overall Study||16
1152513|NCT00381797|2797332|P1|COMPLETED|Overall Study||17
1152514|NCT00381797|2797328|P5|STARTED|Overall Study||37
1152515|NCT00381797|2797329|P4|STARTED|Overall Study||15
1152516|NCT00381797|2797330|P3|STARTED|Overall Study||10
1152517|NCT00381797|2797331|P2|STARTED|Overall Study||17
1152518|NCT00381797|2797332|P1|STARTED|Overall Study||18
1152519|NCT00376688|2797401|P1|NOT COMPLETED|Overall Study||4
1152520|NCT00376688|2797401|P1|COMPLETED|Overall Study||27
1152521|NCT00376688|2797401|P1|STARTED|Overall Study||31
1152522|NCT00357656|2797407|P2|NOT COMPLETED|Overall Study||3
1152523|NCT00357656|2797408|P1|NOT COMPLETED|Overall Study||0
1152524|NCT00357656|2797407|P2|COMPLETED|Overall Study||29
1152525|NCT00357656|2797408|P1|COMPLETED|Overall Study||31
1152526|NCT00357656|2797407|P2|STARTED|Overall Study||32
1152527|NCT00357656|2797408|P1|STARTED|Overall Study||31
1152695|NCT02542072|2797707|P2|NOT COMPLETED|Second Intervention (1 Month)||0
1152696|NCT02542072|2797708|P1|NOT COMPLETED|Second Intervention (1 Month)||2
1152697|NCT02542072|2797707|P2|COMPLETED|Second Intervention (1 Month)||43
1152698|NCT02542072|2797708|P1|COMPLETED|Second Intervention (1 Month)||37
1152699|NCT02542072|2797707|P2|STARTED|Second Intervention (1 Month)||43
1152700|NCT02542072|2797708|P1|STARTED|Second Intervention (1 Month)||39
1152701|NCT02542072|2797707|P2|NOT COMPLETED|First Intervention (1 Month)||3
1152702|NCT02542072|2797708|P1|NOT COMPLETED|First Intervention (1 Month)||5
1152703|NCT02542072|2797707|P2|COMPLETED|First Intervention (1 Month)||43
1152704|NCT02542072|2797708|P1|COMPLETED|First Intervention (1 Month)||39
1152705|NCT02542072|2797707|P2|STARTED|First Intervention (1 Month)||46
1152706|NCT02542072|2797708|P1|STARTED|First Intervention (1 Month)||44
1152755|NCT02454608|2797923|P2|NOT COMPLETED|Overall Study||2
1152756|NCT02454608|2797924|P1|NOT COMPLETED|Overall Study||0
1152757|NCT02454608|2797923|P2|COMPLETED|Overall Study||8
1152758|NCT02454608|2797924|P1|COMPLETED|Overall Study||10
1152759|NCT02454608|2797923|P2|STARTED|Overall Study||10
1152760|NCT02454608|2797924|P1|STARTED|Overall Study||10
1152764|NCT02422797|2797956|P2|NOT COMPLETED|Overall Study||16
1152765|NCT02422797|2797957|P1|NOT COMPLETED|Overall Study||16
1152766|NCT02422797|2797956|P2|COMPLETED|Overall Study||239
1152767|NCT02422797|2797957|P1|COMPLETED|Overall Study||245
1152768|NCT02422797|2797956|P2|STARTED|Overall Study||255
1152769|NCT02422797|2797957|P1|STARTED|Overall Study||261
1152786|NCT02302716|2798058|P2|NOT COMPLETED|Overall Study||19
1152787|NCT02302716|2798059|P1|NOT COMPLETED|Overall Study||19
1152788|NCT02302716|2798058|P2|COMPLETED|Overall Study||225
1152789|NCT02302716|2798059|P1|COMPLETED|Overall Study||230
1152790|NCT02302716|2798058|P2|Received at Least 1 Dose of Study Drug|Overall Study||244
1152791|NCT02302716|2798059|P1|Received at Least 1 Dose of Study Drug|Overall Study||249
1152792|NCT02302716|2798058|P2|STARTED|Overall Study||244
1152793|NCT02302716|2798059|P1|STARTED|Overall Study||249
1152794|NCT02255097|2798085|P1|NOT COMPLETED|Overall Study||172
1152795|NCT02255097|2798085|P1|COMPLETED|Overall Study||0
1152796|NCT02255097|2798085|P1|Treated|Overall Study||171
1152797|NCT02255097|2798085|P1|STARTED|Overall Study||172
1152801|NCT02229396|2798113|P3|NOT COMPLETED|Overall Study||38
1152802|NCT02229396|2798114|P2|NOT COMPLETED|Overall Study||29
1152803|NCT02229396|2798115|P1|NOT COMPLETED|Overall Study||25
1152804|NCT02229396|2798113|P3|COMPLETED|Overall Study||193
1152805|NCT02229396|2798114|P2|COMPLETED|Overall Study||202
1152806|NCT02229396|2798115|P1|COMPLETED|Overall Study||208
1152807|NCT02229396|2798113|P3|ITT Analysis Set|Overall Study||227
1152808|NCT02229396|2798114|P2|ITT Analysis Set|Overall Study||228
1152809|NCT02229396|2798115|P1|ITT Analysis Set|Overall Study||230
1152810|NCT02229396|2798113|P3|Safety Analysis Set|Overall Study||230
1152811|NCT02229396|2798114|P2|Safety Analysis Set|Overall Study||231
1152812|NCT02229396|2798115|P1|Safety Analysis Set|Overall Study||233
1152813|NCT02229396|2798113|P3|RANDOMIZATION CODE ALLOCATED|Overall Study||231
1152814|NCT02229396|2798114|P2|RANDOMIZATION CODE ALLOCATED|Overall Study||231
1152815|NCT02229396|2798115|P1|RANDOMIZATION CODE ALLOCATED|Overall Study||233
1152816|NCT02229396|2798113|P3|STARTED|Overall Study||231
1152817|NCT02229396|2798114|P2|STARTED|Overall Study||231
1152818|NCT02229396|2798115|P1|STARTED|Overall Study||233
1152830|NCT02147184|2798195|P2|NOT COMPLETED|Overall Study||27
1152831|NCT02147184|2798196|P1|NOT COMPLETED|Overall Study||49
1152832|NCT02147184|2798195|P2|COMPLETED|Overall Study||110
1152833|NCT02147184|2798196|P1|COMPLETED|Overall Study||78
1152834|NCT02147184|2798195|P2|STARTED|Overall Study||137
1152835|NCT02147184|2798196|P1|STARTED|Overall Study||127
1152836|NCT02133508|2798214|P1|NOT COMPLETED|Overall Study||15
1152837|NCT02133508|2798214|P1|COMPLETED|Overall Study||141
1152838|NCT02133508|2798214|P1|STARTED|Overall Study||156
1152932|NCT01788358|2798432|P1|NOT COMPLETED|Overall Study||98
1152933|NCT01788358|2798432|P1|COMPLETED|Overall Study|217 subjects completed the study at Week 28 while the remaining 193 subjects completed at Week 52|410
1152934|NCT01788358|2798432|P1|Completed Week 52|Overall Study||193
1152935|NCT01788358|2798432|P1|Entered Extension to Week 52|Overall Study|Only the first 200 subjects who completed Week 28 visit, continued treatment up to 52 weeks.|200
1152936|NCT01788358|2798432|P1|Completed Week 28|Overall Study||417
1152937|NCT01788358|2798432|P1|Treated|Overall Study||508
1152938|NCT01788358|2798432|P1|STARTED|Overall Study||508
1152960|NCT01692691|2798523|P1|NOT COMPLETED|Overall Study||0
1152961|NCT01692691|2798523|P1|COMPLETED|Overall Study||1
1152962|NCT01692691|2798523|P1|STARTED|Overall Study||1
1152966|NCT01658813|2798548|P1|NOT COMPLETED|Overall Study||3
1152967|NCT01658813|2798548|P1|COMPLETED|Overall Study||15
1152968|NCT01658813|2798548|P1|Treated|Overall Study||18
1152969|NCT01658813|2798548|P1|Eligible|Overall Study||18
1152970|NCT01658813|2798548|P1|STARTED|Overall Study||18
1153000|NCT01515189|2798659|P2|NOT COMPLETED|First Re-Induction Phase||15
1153001|NCT01515189|2798660|P1|NOT COMPLETED|First Re-Induction Phase||14
1153002|NCT01515189|2798659|P2|COMPLETED|First Re-Induction Phase||17
1153003|NCT01515189|2798660|P1|COMPLETED|First Re-Induction Phase||9
1153004|NCT01515189|2798659|P2|STARTED|First Re-Induction Phase||32
1153005|NCT01515189|2798660|P1|STARTED|First Re-Induction Phase||23
1153006|NCT01515189|2798659|P2|NOT COMPLETED|Induction||232
1153007|NCT01515189|2798660|P1|NOT COMPLETED|Induction||237
1153008|NCT01515189|2798659|P2|COMPLETED|Induction||130
1153009|NCT01515189|2798660|P1|COMPLETED|Induction||128
1153010|NCT01515189|2798659|P2|STARTED|Induction||362
1153011|NCT01515189|2798660|P1|STARTED|Induction|Includes 1 subject who was randomized but not treated due to an Adverse Event before treatment|365
1153012|NCT01495988|2798684|P4|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
1153013|NCT01495988|2798685|P3|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
1153014|NCT01495988|2798686|P2|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
1153015|NCT01495988|2798687|P1|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
1153016|NCT01495988|2798684|P4|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
1153017|NCT01495988|2798685|P3|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
1153018|NCT01495988|2798686|P2|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||2
1153019|NCT01495988|2798687|P1|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
1153020|NCT01495988|2798684|P4|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
1153021|NCT01495988|2798685|P3|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
1153022|NCT01495988|2798686|P2|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||2
1153023|NCT01495988|2798687|P1|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
1153024|NCT01495988|2798684|P4|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
1153025|NCT01495988|2798685|P3|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
1153026|NCT01495988|2798686|P2|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
1153027|NCT01495988|2798687|P1|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
1153028|NCT01495988|2798684|P4|COMPLETED|Vem +/- Bev (Protocol v2.0)||3
1153029|NCT01495988|2798685|P3|COMPLETED|Vem +/- Bev (Protocol v2.0)||5
1153030|NCT01495988|2798686|P2|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
1153031|NCT01495988|2798687|P1|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
1153032|NCT01495988|2798684|P4|STARTED|Vem +/- Bev (Protocol v2.0)||3
1153033|NCT01495988|2798685|P3|STARTED|Vem +/- Bev (Protocol v2.0)||5
1153034|NCT01495988|2798686|P2|STARTED|Vem +/- Bev (Protocol v2.0)||0
1153035|NCT01495988|2798687|P1|STARTED|Vem +/- Bev (Protocol v2.0)||0
1153036|NCT01455519|2798723|P2|NOT COMPLETED|Overall Study||5
1153037|NCT01455519|2798724|P1|NOT COMPLETED|Overall Study||4
1153038|NCT01455519|2798723|P2|COMPLETED|Overall Study||18
1153039|NCT01455519|2798724|P1|COMPLETED|Overall Study||8
1153040|NCT01455519|2798723|P2|STARTED|Overall Study||23
1153041|NCT01455519|2798724|P1|STARTED|Overall Study||12
1153042|NCT01452529|2798756|P3|NOT COMPLETED|Double-blind (DB) Period||82
1153043|NCT01452529|2798757|P2|NOT COMPLETED|Double-blind (DB) Period||67
1153044|NCT01452529|2798758|P1|NOT COMPLETED|Double-blind (DB) Period||0
1153045|NCT01452529|2798756|P3|COMPLETED|Double-blind (DB) Period||210
1153046|NCT01452529|2798757|P2|COMPLETED|Double-blind (DB) Period|4 subjects who did not receive DB medication were still counted as discontinued in the DB period|229
1153047|NCT01452529|2798758|P1|COMPLETED|Double-blind (DB) Period||0
1153048|NCT01452529|2798756|P3|STARTED|Double-blind (DB) Period||292
1153049|NCT01452529|2798757|P2|STARTED|Double-blind (DB) Period|Four subjects were randomized but did not receive DB medication|296
1153050|NCT01452529|2798758|P1|STARTED|Double-blind (DB) Period||0
1153051|NCT01452529|2798756|P3|NOT COMPLETED|Run-in Period||0
1153052|NCT01452529|2798757|P2|NOT COMPLETED|Run-in Period||0
1153053|NCT01452529|2798758|P1|NOT COMPLETED|Run-in Period||313
1153054|NCT01452529|2798756|P3|COMPLETED|Run-in Period||0
1153055|NCT01452529|2798757|P2|COMPLETED|Run-in Period||0
1153056|NCT01452529|2798758|P1|COMPLETED|Run-in Period||592
1153057|NCT01452529|2798756|P3|STARTED|Run-in Period||0
1153058|NCT01452529|2798757|P2|STARTED|Run-in Period||0
1153059|NCT01452529|2798758|P1|STARTED|Run-in Period||905
1153068|NCT01400139|2798804|P1|NOT COMPLETED|HYD Extension Period||23
1153069|NCT01400139|2798804|P1|COMPLETED|HYD Extension Period||83
1153070|NCT01400139|2798804|P1|STARTED|HYD Extension Period|Subjects completing the Core Study were offered an option to enter the 24-week open-label Extension|106
1153071|NCT01400139|2798804|P1|NOT COMPLETED|HYD Core Study||512
1153072|NCT01400139|2798804|P1|COMPLETED|HYD Core Study||410
1153073|NCT01400139|2798804|P1|STARTED|HYD Core Study||922
1153094|NCT01288534|2798878|P1|NOT COMPLETED|Overall Study||0
1153095|NCT01288534|2798878|P1|COMPLETED|Overall Study||68
1153096|NCT01288534|2798878|P1|STARTED|Overall Study||68
1153151|NCT01223352|2799081|P2|NOT COMPLETED|Overall Study||0
1153152|NCT01223352|2799082|P1|NOT COMPLETED|Overall Study||0
1153153|NCT01223352|2799081|P2|COMPLETED|Overall Study||33
1153154|NCT01223352|2799082|P1|COMPLETED|Overall Study||31
1153155|NCT01223352|2799081|P2|STARTED|Overall Study||33
1153156|NCT01223352|2799082|P1|STARTED|Overall Study||31
1153160|NCT01147653|2799112|P2|NOT COMPLETED|Year 2||3
1153161|NCT01147653|2799113|P1|NOT COMPLETED|Year 2||2
1153162|NCT01147653|2799112|P2|COMPLETED|Year 2||28
1153163|NCT01147653|2799113|P1|COMPLETED|Year 2||30
1153164|NCT01147653|2799112|P2|STARTED|Year 2||31
1153165|NCT01147653|2799113|P1|STARTED|Year 2||32
1153166|NCT01147653|2799112|P2|NOT COMPLETED|Year 1||0
1153167|NCT01147653|2799113|P1|NOT COMPLETED|Year 1||0
1153168|NCT01147653|2799112|P2|COMPLETED|Year 1||31
1153169|NCT01147653|2799113|P1|COMPLETED|Year 1||32
1153170|NCT01147653|2799112|P2|STARTED|Year 1||31
1153171|NCT01147653|2799113|P1|STARTED|Year 1||32
1153190|NCT01012492|2799202|P1|NOT COMPLETED|Overall Study||0
1153191|NCT01012492|2799202|P1|COMPLETED|Overall Study||10
1153192|NCT01012492|2799202|P1|STARTED|Overall Study||10
1153229|NCT00924729|2799284|P2|NOT COMPLETED|Overall Study||0
1153230|NCT00924729|2799285|P1|NOT COMPLETED|Overall Study||2
1153231|NCT00924729|2799284|P2|COMPLETED|Overall Study||25
1153232|NCT00924729|2799285|P1|COMPLETED|Overall Study||23
1153233|NCT00924729|2799284|P2|STARTED|Overall Study||25
1153234|NCT00924729|2799285|P1|STARTED|Overall Study||25
1153238|NCT00853112|2799317|P7|NOT COMPLETED|Overall Study||1
1153239|NCT00853112|2799318|P6|NOT COMPLETED|Overall Study||0
1153240|NCT00853112|2799319|P5|NOT COMPLETED|Overall Study||0
1153241|NCT00853112|2799320|P4|NOT COMPLETED|Overall Study||2
1153242|NCT00853112|2799321|P3|NOT COMPLETED|Overall Study||0
1153243|NCT00853112|2799322|P2|NOT COMPLETED|Overall Study||1
1153244|NCT00853112|2799323|P1|NOT COMPLETED|Overall Study||0
1153245|NCT00853112|2799317|P7|COMPLETED|Overall Study||6
1153246|NCT00853112|2799318|P6|COMPLETED|Overall Study||7
1153247|NCT00853112|2799319|P5|COMPLETED|Overall Study||6
1153248|NCT00853112|2799320|P4|COMPLETED|Overall Study||6
1153249|NCT00853112|2799321|P3|COMPLETED|Overall Study||7
1153250|NCT00853112|2799322|P2|COMPLETED|Overall Study||6
1153251|NCT00853112|2799323|P1|COMPLETED|Overall Study||6
1153252|NCT00853112|2799317|P7|Treated|Overall Study||6
1153253|NCT00853112|2799318|P6|Treated|Overall Study||7
1153254|NCT00853112|2799319|P5|Treated|Overall Study||6
1153255|NCT00853112|2799320|P4|Treated|Overall Study||6
1153256|NCT00853112|2799321|P3|Treated|Overall Study||7
1153257|NCT00853112|2799322|P2|Treated|Overall Study||6
1153258|NCT00853112|2799323|P1|Treated|Overall Study||6
1153259|NCT00853112|2799317|P7|STARTED|Overall Study||7
1153260|NCT00853112|2799318|P6|STARTED|Overall Study||7
1153261|NCT00853112|2799319|P5|STARTED|Overall Study||6
1153262|NCT00853112|2799320|P4|STARTED|Overall Study||8
1153263|NCT00853112|2799321|P3|STARTED|Overall Study||7
1153264|NCT00853112|2799322|P2|STARTED|Overall Study||7
1153265|NCT00853112|2799323|P1|STARTED|Overall Study||6
1153269|NCT00788697|2799456|P1|NOT COMPLETED|Overall Study||109
1153270|NCT00788697|2799456|P1|COMPLETED|Overall Study||240
1153271|NCT00788697|2799456|P1|STARTED|Overall Study||349
1153383|NCT00596011|2799676|P2|NOT COMPLETED|Overall Study||10
1153384|NCT00596011|2799677|P1|NOT COMPLETED|Overall Study||13
1153385|NCT00596011|2799676|P2|COMPLETED|Overall Study||38
1153386|NCT00596011|2799677|P1|COMPLETED|Overall Study||36
1153387|NCT00596011|2799676|P2|STARTED|Overall Study||48
1153388|NCT00596011|2799677|P1|STARTED|Overall Study||49
1153398|NCT00575042|2799796|P1|NOT COMPLETED|Overall Study||3
1153399|NCT00575042|2799796|P1|COMPLETED|Overall Study|2 with side effects and 1 lost to follow-up|17
1153400|NCT00575042|2799796|P1|STARTED|Overall Study||20
1153401|NCT00470366|2799801|P1|NOT COMPLETED|Overall Study||4
1153402|NCT00470366|2799801|P1|COMPLETED|Overall Study||56
1153403|NCT00470366|2799801|P1|STARTED|Overall Study||60
1153467|NCT00156013|2799905|P1|NOT COMPLETED|Overall Study||2
1153468|NCT00156013|2799905|P1|COMPLETED|Overall Study||31
1153469|NCT00156013|2799905|P1|STARTED|Overall Study||33
1153476|NCT00116428|2799936|P2|NOT COMPLETED|Overall Study||5
1153477|NCT00116428|2799937|P1|NOT COMPLETED|Overall Study||3
1153478|NCT00116428|2799936|P2|COMPLETED|Overall Study||56
1153479|NCT00116428|2799937|P1|COMPLETED|Overall Study||103
1153480|NCT00116428|2799936|P2|Underwent Study Ablation Procedure|Overall Study||36
1153481|NCT00116428|2799937|P1|Underwent Study Ablation Procedure|Overall Study||103
1153482|NCT00116428|2799936|P2|STARTED|Overall Study||61
1153483|NCT00116428|2799937|P1|STARTED|Overall Study||106
1153565|NCT00003659|2800058|P1|NOT COMPLETED|Overall Study||3
1153566|NCT00003659|2800058|P1|COMPLETED|Overall Study||36
1153567|NCT00003659|2800058|P1|STARTED|Overall Study||39
1153568|NCT00038727|2800067|P3|NOT COMPLETED|Overall Study||0
1153569|NCT00038727|2800068|P2|NOT COMPLETED|Overall Study||0
1153570|NCT00038727|2800069|P1|NOT COMPLETED|Overall Study||0
1153571|NCT00038727|2800067|P3|COMPLETED|Overall Study||936
1153572|NCT00038727|2800068|P2|COMPLETED|Overall Study||927
1153573|NCT00038727|2800069|P1|COMPLETED|Overall Study||916
1153574|NCT00038727|2800067|P3|DPPOS Phase 3 Enrolled|Overall Study||936
1153575|NCT00038727|2800068|P2|DPPOS Phase 3 Enrolled|Overall Study||927
1153576|NCT00038727|2800069|P1|DPPOS Phase 3 Enrolled|Overall Study||916
1153577|NCT00038727|2800067|P3|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|780
1153578|NCT00038727|2800068|P2|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|772
1153579|NCT00038727|2800069|P1|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|751
1153580|NCT00038727|2800067|P3|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|935
1153581|NCT00038727|2800068|P2|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|926
1153582|NCT00038727|2800069|P1|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|915
1153583|NCT00038727|2800067|P3|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|932
1153584|NCT00038727|2800068|P2|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|924
1153585|NCT00038727|2800069|P1|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|910
1153586|NCT00038727|2800067|P3|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|936
1153587|NCT00038727|2800068|P2|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|927
1153588|NCT00038727|2800069|P1|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|916
1153589|NCT03044431|2800080|P1|NOT COMPLETED|Overall Study||59
1153590|NCT03044431|2800080|P1|COMPLETED|Overall Study||148
1153591|NCT03044431|2800080|P1|STARTED|Overall Study||207
1153592|NCT02798289|2800090|P1|NOT COMPLETED|Overall Study||0
1153593|NCT02798289|2800090|P1|COMPLETED|Overall Study||55
1153594|NCT02798289|2800090|P1|STARTED|Overall Study||55
1153595|NCT02750943|2800096|P2|NOT COMPLETED|Overall Study||9
1153596|NCT02750943|2800097|P1|NOT COMPLETED|Overall Study||6
1153597|NCT02750943|2800096|P2|COMPLETED|Overall Study||119
1153598|NCT02750943|2800097|P1|COMPLETED|Overall Study||119
1153599|NCT02750943|2800096|P2|STARTED|Overall Study||128
1153600|NCT02750943|2800097|P1|STARTED|Overall Study||125
1153607|NCT02643862|2800140|P2|NOT COMPLETED|Overall Study||0
1153608|NCT02643862|2800141|P1|NOT COMPLETED|Overall Study||0
1153609|NCT02643862|2800140|P2|COMPLETED|Overall Study||12
1153610|NCT02643862|2800141|P1|COMPLETED|Overall Study||36
1153611|NCT02643862|2800140|P2|STARTED|Overall Study||12
1153612|NCT02643862|2800141|P1|STARTED|Overall Study||36
1153613|NCT02642432|2800149|P1|NOT COMPLETED|Overall Study||8
1153614|NCT02642432|2800149|P1|COMPLETED|Overall Study||138
1153615|NCT02642432|2800149|P1|STARTED|Overall Study||146
1153628|NCT02513160|2800214|P4|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||2
1153629|NCT02513160|2800215|P3|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||1
1153630|NCT02513160|2800216|P2|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||4
1153631|NCT02513160|2800217|P1|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||6
1153632|NCT02513160|2800214|P4|COMPLETED|Treatment Period (Day 0 to Week 6)||103
1153633|NCT02513160|2800215|P3|COMPLETED|Treatment Period (Day 0 to Week 6)||104
1153634|NCT02513160|2800216|P2|COMPLETED|Treatment Period (Day 0 to Week 6)||104
1153635|NCT02513160|2800217|P1|COMPLETED|Treatment Period (Day 0 to Week 6)||101
1153636|NCT02513160|2800214|P4|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105
1153637|NCT02513160|2800215|P3|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105
1153638|NCT02513160|2800216|P2|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|108
1153639|NCT02513160|2800217|P1|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|107
1153640|NCT02513160|2800214|P4|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
1153641|NCT02513160|2800215|P3|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
1153642|NCT02513160|2800216|P2|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
1153643|NCT02513160|2800217|P1|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||288
1153644|NCT02513160|2800214|P4|COMPLETED|Run-In Period (Days -14 to Day -1)||0
1153645|NCT02513160|2800215|P3|COMPLETED|Run-In Period (Days -14 to Day -1)||0
1153646|NCT02513160|2800216|P2|COMPLETED|Run-In Period (Days -14 to Day -1)||0
1153647|NCT02513160|2800217|P1|COMPLETED|Run-In Period (Days -14 to Day -1)||425
1153648|NCT02513160|2800214|P4|STARTED|Run-In Period (Days -14 to Day -1)||0
1153649|NCT02513160|2800215|P3|STARTED|Run-In Period (Days -14 to Day -1)||0
1153650|NCT02513160|2800216|P2|STARTED|Run-In Period (Days -14 to Day -1)||0
1153651|NCT02513160|2800217|P1|STARTED|Run-In Period (Days -14 to Day -1)|Enrolled|713
1153652|NCT02487771|2800254|P2|NOT COMPLETED|Overall Study||14
1153653|NCT02487771|2800255|P1|NOT COMPLETED|Overall Study||10
1153654|NCT02487771|2800254|P2|COMPLETED|Overall Study||85
1153655|NCT02487771|2800255|P1|COMPLETED|Overall Study||81
1153656|NCT02487771|2800254|P2|STARTED|Overall Study||99
1153657|NCT02487771|2800255|P1|STARTED|Overall Study||91
1153658|NCT02478580|2800285|P2|NOT COMPLETED|Overall Study||0
1153659|NCT02478580|2800286|P1|NOT COMPLETED|Overall Study||0
1153660|NCT02478580|2800285|P2|COMPLETED|Overall Study||33
1153661|NCT02478580|2800286|P1|COMPLETED|Overall Study||34
1153662|NCT02478580|2800285|P2|STARTED|Overall Study||33
1153663|NCT02478580|2800286|P1|STARTED|Overall Study||34
1153672|NCT02464163|2800335|P4|NOT COMPLETED|Overall Study||5
1153673|NCT02464163|2800336|P3|NOT COMPLETED|Overall Study||5
1153674|NCT02464163|2800337|P2|NOT COMPLETED|Overall Study||8
1153675|NCT02464163|2800338|P1|NOT COMPLETED|Overall Study||3
1153676|NCT02464163|2800335|P4|COMPLETED|Overall Study||96
1153677|NCT02464163|2800336|P3|COMPLETED|Overall Study||97
1153678|NCT02464163|2800337|P2|COMPLETED|Overall Study||94
1153679|NCT02464163|2800338|P1|COMPLETED|Overall Study||99
1153680|NCT02464163|2800335|P4|STARTED|Overall Study||101
1153681|NCT02464163|2800336|P3|STARTED|Overall Study||102
1153682|NCT02464163|2800337|P2|STARTED|Overall Study||102
1153683|NCT02464163|2800338|P1|STARTED|Overall Study||102
1153684|NCT02434146|2800360|P1|NOT COMPLETED|Overall Study||0
1153685|NCT02434146|2800360|P1|COMPLETED|Overall Study||3
1153686|NCT02434146|2800360|P1|STARTED|Overall Study||3
1153687|NCT02408692|2800375|P3|NOT COMPLETED|Overall Study||0
1153688|NCT02408692|2800376|P2|NOT COMPLETED|Overall Study||0
1153689|NCT02408692|2800377|P1|NOT COMPLETED|Overall Study||0
1153690|NCT02408692|2800375|P3|COMPLETED|Overall Study||5
1153691|NCT02408692|2800376|P2|COMPLETED|Overall Study||5
1153692|NCT02408692|2800377|P1|COMPLETED|Overall Study||5
1153693|NCT02408692|2800375|P3|STARTED|Overall Study||5
1153694|NCT02408692|2800376|P2|STARTED|Overall Study||5
1153695|NCT02408692|2800377|P1|STARTED|Overall Study||5
1153696|NCT02395653|2800388|P1|NOT COMPLETED|Overall Study||12
1153697|NCT02395653|2800388|P1|COMPLETED|Overall Study||59
1153698|NCT02395653|2800388|P1|Received at Least 1 Dose of Study Drug|Overall Study||61
1153699|NCT02395653|2800388|P1|STARTED|Overall Study||71
1153700|NCT02345772|2800395|P1|NOT COMPLETED|Overall Study||0
1153701|NCT02345772|2800395|P1|COMPLETED|Overall Study||0
1153702|NCT02345772|2800395|P1|STARTED|Overall Study||0
1153724|NCT02241720|2800506|P1|NOT COMPLETED|Overall Study||4
1153725|NCT02241720|2800506|P1|COMPLETED|Overall Study||1
1153726|NCT02241720|2800506|P1|STARTED|Overall Study||5
1153753|NCT02166476|2800555|P2|NOT COMPLETED|Overall Study||23
1153754|NCT02166476|2800556|P1|NOT COMPLETED|Overall Study||14
1153755|NCT02166476|2800555|P2|COMPLETED|Overall Study||250
1153756|NCT02166476|2800556|P1|COMPLETED|Overall Study||258
1153757|NCT02166476|2800555|P2|Received at Least 1 Dose of Study Drug|Overall Study||273
1153758|NCT02166476|2800556|P1|Received at Least 1 Dose of Study Drug|Overall Study||272
1153759|NCT02166476|2800555|P2|STARTED|Overall Study||273
1153760|NCT02166476|2800556|P1|STARTED|Overall Study||272
1153761|NCT02149264|2800589|P1|NOT COMPLETED|Overall Study||20
1153762|NCT02149264|2800589|P1|COMPLETED|Overall Study||139
1153763|NCT02149264|2800589|P1|STARTED|Overall Study|Of the 160 enrolled subjects, one discontinued before receiving treatment.|159
1153770|NCT02076243|2800632|P1|NOT COMPLETED|Overall Study||2
1153771|NCT02076243|2800632|P1|COMPLETED|Overall Study||0
1153772|NCT02076243|2800632|P1|STARTED|Overall Study||2
1153782|NCT02035553|2800670|P2|NOT COMPLETED|Overall Study||23
1153783|NCT02035553|2800671|P1|NOT COMPLETED|Overall Study||18
1153784|NCT02035553|2800670|P2|COMPLETED|Overall Study||67
1153785|NCT02035553|2800671|P1|COMPLETED|Overall Study||73
1153786|NCT02035553|2800670|P2|STARTED|Overall Study||90
1153787|NCT02035553|2800671|P1|STARTED|Overall Study||91
1153788|NCT02019472|2800680|P3|NOT COMPLETED|Overall Study||42
1153789|NCT02019472|2800681|P2|NOT COMPLETED|Overall Study||52
1153790|NCT02019472|2800682|P1|NOT COMPLETED|Overall Study||37
1153791|NCT02019472|2800680|P3|COMPLETED|Overall Study||145
1153792|NCT02019472|2800681|P2|COMPLETED|Overall Study||134
1153793|NCT02019472|2800682|P1|COMPLETED|Overall Study||149
1153794|NCT02019472|2800680|P3|STARTED|Overall Study||187
1153795|NCT02019472|2800681|P2|STARTED|Overall Study||186
1153796|NCT02019472|2800682|P1|STARTED|Overall Study||186
1153797|NCT01981057|2800705|P2|NOT COMPLETED|Overall Study||0
1153798|NCT01981057|2800706|P1|NOT COMPLETED|Overall Study||0
1153799|NCT01981057|2800705|P2|COMPLETED|Overall Study||50
1153800|NCT01981057|2800706|P1|COMPLETED|Overall Study||50
1153801|NCT01981057|2800705|P2|STARTED|Overall Study||50
1153802|NCT01981057|2800706|P1|STARTED|Overall Study||50
1153803|NCT01972568|2800715|P3|NOT COMPLETED|Overall Study||16
1153804|NCT01972568|2800716|P2|NOT COMPLETED|Overall Study||12
1153805|NCT01972568|2800717|P1|NOT COMPLETED|Overall Study||16
1153806|NCT01972568|2800715|P3|COMPLETED|Overall Study||84
1153807|NCT01972568|2800716|P2|COMPLETED|Overall Study||92
1153808|NCT01972568|2800717|P1|COMPLETED|Overall Study||86
1153809|NCT01972568|2800715|P3|STARTED|Overall Study||100
1153810|NCT01972568|2800716|P2|STARTED|Overall Study||104
1153811|NCT01972568|2800717|P1|STARTED|Overall Study||102
1153812|NCT01944098|2800754|P2|NOT COMPLETED|Overall Study||0
1153813|NCT01944098|2800755|P1|NOT COMPLETED|Overall Study||1
1153814|NCT01944098|2800754|P2|COMPLETED|Overall Study||10
1153815|NCT01944098|2800755|P1|COMPLETED|Overall Study||9
1153816|NCT01944098|2800754|P2|STARTED|Overall Study||10
1153817|NCT01944098|2800755|P1|STARTED|Overall Study||10
1153845|NCT01936974|2800788|P2|NOT COMPLETED|Overall Study||0
1153846|NCT01936974|2800789|P1|NOT COMPLETED|Overall Study||2
1153847|NCT01936974|2800788|P2|COMPLETED|Overall Study||0
1153848|NCT01936974|2800789|P1|COMPLETED|Overall Study||0
1153849|NCT01936974|2800788|P2|STARTED|Overall Study||0
1153850|NCT01936974|2800789|P1|STARTED|Overall Study||2
1153860|NCT01877564|2800821|P2|NOT COMPLETED|Overall Study||0
1153861|NCT01877564|2800822|P1|NOT COMPLETED|Overall Study||0
1153862|NCT01877564|2800821|P2|COMPLETED|Overall Study||4
1153863|NCT01877564|2800822|P1|COMPLETED|Overall Study||6
1153864|NCT01877564|2800821|P2|STARTED|Overall Study||4
1153865|NCT01877564|2800822|P1|STARTED|Overall Study||6
1153866|NCT01871805|2800834|P6|NOT COMPLETED|Phase II||87
1153867|NCT01871805|2800835|P5|NOT COMPLETED|Phase II||0
1153868|NCT01871805|2800836|P4|NOT COMPLETED|Phase II||0
1153869|NCT01871805|2800837|P3|NOT COMPLETED|Phase II||0
1153870|NCT01871805|2800838|P2|NOT COMPLETED|Phase II||0
1153871|NCT01871805|2800839|P1|NOT COMPLETED|Phase II||0
1153872|NCT01871805|2800834|P6|COMPLETED|Phase II||0
1153873|NCT01871805|2800835|P5|COMPLETED|Phase II||0
1153874|NCT01871805|2800836|P4|COMPLETED|Phase II||0
1153875|NCT01871805|2800837|P3|COMPLETED|Phase II||0
1153876|NCT01871805|2800838|P2|COMPLETED|Phase II||0
1153877|NCT01871805|2800839|P1|COMPLETED|Phase II||0
1153878|NCT01871805|2800834|P6|STARTED|Phase II||87
1153879|NCT01871805|2800835|P5|STARTED|Phase II||0
1153880|NCT01871805|2800836|P4|STARTED|Phase II||0
1153881|NCT01871805|2800837|P3|STARTED|Phase II||0
1153882|NCT01871805|2800838|P2|STARTED|Phase II||0
1153883|NCT01871805|2800839|P1|STARTED|Phase II||0
1153884|NCT01871805|2800834|P6|NOT COMPLETED|Phase I||0
1153885|NCT01871805|2800835|P5|NOT COMPLETED|Phase I||13
1153886|NCT01871805|2800836|P4|NOT COMPLETED|Phase I||7
1153887|NCT01871805|2800837|P3|NOT COMPLETED|Phase I||13
1153888|NCT01871805|2800838|P2|NOT COMPLETED|Phase I||7
1153889|NCT01871805|2800839|P1|NOT COMPLETED|Phase I||7
1153890|NCT01871805|2800834|P6|COMPLETED|Phase I||0
1153891|NCT01871805|2800835|P5|COMPLETED|Phase I||0
1153892|NCT01871805|2800836|P4|COMPLETED|Phase I||0
1153893|NCT01871805|2800837|P3|COMPLETED|Phase I||0
1153894|NCT01871805|2800838|P2|COMPLETED|Phase I||0
1153895|NCT01871805|2800839|P1|COMPLETED|Phase I||0
1153896|NCT01871805|2800834|P6|STARTED|Phase I||0
1153897|NCT01871805|2800835|P5|STARTED|Phase I||13
1153898|NCT01871805|2800836|P4|STARTED|Phase I||7
1153899|NCT01871805|2800837|P3|STARTED|Phase I||13
1153900|NCT01871805|2800838|P2|STARTED|Phase I||7
1153901|NCT01871805|2800839|P1|STARTED|Phase I||7
1153918|NCT01860040|2800928|P2|NOT COMPLETED|Overall Study||0
1153919|NCT01860040|2800929|P1|NOT COMPLETED|Overall Study||1
1153920|NCT01860040|2800928|P2|COMPLETED|Overall Study|did not meet recruitment goal|0
1153921|NCT01860040|2800929|P1|COMPLETED|Overall Study|did not meet recruitment goal|0
1153922|NCT01860040|2800928|P2|STARTED|Overall Study|did not meet recruitment goal|0
1153923|NCT01860040|2800929|P1|STARTED|Overall Study|did not meet recruitment goal|1
1153924|NCT01744483|2800937|P3|NOT COMPLETED|Overall Study||28
1153925|NCT01744483|2800938|P2|NOT COMPLETED|Overall Study||22
1153926|NCT01744483|2800939|P1|NOT COMPLETED|Overall Study||29
1153927|NCT01744483|2800937|P3|COMPLETED|Overall Study||10
1153928|NCT01744483|2800938|P2|COMPLETED|Overall Study||13
1153929|NCT01744483|2800939|P1|COMPLETED|Overall Study||15
1153930|NCT01744483|2800937|P3|STARTED|Overall Study||38
1153931|NCT01744483|2800938|P2|STARTED|Overall Study||35
1153932|NCT01744483|2800939|P1|STARTED|Overall Study||44
1153933|NCT01741259|2800949|P2|NOT COMPLETED|Overall Study||6
1153934|NCT01741259|2800950|P1|NOT COMPLETED|Overall Study||6
1153935|NCT01741259|2800949|P2|COMPLETED|Overall Study||129
1153936|NCT01741259|2800950|P1|COMPLETED|Overall Study||127
1153937|NCT01741259|2800949|P2|STARTED|Overall Study||135
1153938|NCT01741259|2800950|P1|STARTED|Overall Study||133
1153939|NCT01709409|2801006|P2|NOT COMPLETED|Overall Study||0
1153940|NCT01709409|2801007|P1|NOT COMPLETED|Overall Study||1
1153941|NCT01709409|2801006|P2|COMPLETED|Overall Study||45
1153942|NCT01709409|2801007|P1|COMPLETED|Overall Study||42
1153943|NCT01709409|2801006|P2|STARTED|Overall Study||45
1153944|NCT01709409|2801007|P1|STARTED|Overall Study||43
1153965|NCT01665599|2801109|P1|NOT COMPLETED|Overall Study||8
1153966|NCT01665599|2801109|P1|COMPLETED|Overall Study||172
1153967|NCT01665599|2801109|P1|STARTED|Overall Study||180
1153968|NCT01655719|2801129|P1|NOT COMPLETED|Overall Study||0
1153969|NCT01655719|2801129|P1|COMPLETED|Overall Study||1
1153970|NCT01655719|2801129|P1|STARTED|Overall Study||1
1153971|NCT01650545|2801137|P2|NOT COMPLETED|Overall Study||0
1153972|NCT01650545|2801138|P1|NOT COMPLETED|Overall Study||0
1153973|NCT01650545|2801137|P2|COMPLETED|Overall Study||10
1153974|NCT01650545|2801138|P1|COMPLETED|Overall Study||11
1153975|NCT01650545|2801137|P2|STARTED|Overall Study||10
1153976|NCT01650545|2801138|P1|STARTED|Overall Study||11
1153983|NCT01624233|2801165|P1|NOT COMPLETED|Period 3 - Maintenance||7
1153984|NCT01624233|2801165|P1|COMPLETED|Period 3 - Maintenance||83
1153985|NCT01624233|2801165|P1|Received at Least 1 Dose of Study Drug|Period 3 - Maintenance||90
1153986|NCT01624233|2801165|P1|STARTED|Period 3 - Maintenance||90
1153987|NCT01624233|2801165|P1|NOT COMPLETED|Period 2 - Induction||1
1153988|NCT01624233|2801165|P1|COMPLETED|Period 2 - Induction||90
1153989|NCT01624233|2801165|P1|Plaque Ps|Period 2 - Induction||78
1153990|NCT01624233|2801165|P1|Pustular Ps|Period 2 - Induction||5
1153991|NCT01624233|2801165|P1|Erythrodermic Psoriasis (Ps)|Period 2 - Induction||8
1153992|NCT01624233|2801165|P1|Received at Least 1 Dose of Study Drug|Period 2 - Induction||91
1153993|NCT01624233|2801165|P1|STARTED|Period 2 - Induction||91
1154018|NCT01531374|2801248|P3|NOT COMPLETED|Overall Study||283
1154019|NCT01531374|2801249|P2|NOT COMPLETED|Overall Study||142
1154020|NCT01531374|2801250|P1|NOT COMPLETED|Overall Study||364
1154021|NCT01531374|2801248|P3|COMPLETED|Overall Study||836
1154022|NCT01531374|2801249|P2|COMPLETED|Overall Study||231
1154023|NCT01531374|2801250|P1|COMPLETED|Overall Study||921
1154024|NCT01531374|2801248|P3|STARTED|Overall Study||1119
1154025|NCT01531374|2801249|P2|STARTED|Overall Study||373
1154026|NCT01531374|2801250|P1|STARTED|Overall Study||1285
1154039|NCT01449929|2801348|P2|NOT COMPLETED|Overall Study||242
1154040|NCT01449929|2801349|P1|NOT COMPLETED|Overall Study||242
1154041|NCT01449929|2801348|P2|COMPLETED|Overall Study||0
1154042|NCT01449929|2801349|P1|COMPLETED|Overall Study||0
1154043|NCT01449929|2801348|P2|Ongoing|Overall Study||213
1154044|NCT01449929|2801349|P1|Ongoing|Overall Study||224
1154045|NCT01449929|2801348|P2|STARTED|Overall Study||242
1154046|NCT01449929|2801349|P1|STARTED|Overall Study||242
1154117|NCT01311687|2801562|P2|NOT COMPLETED|PFS Follow-up Phase||1
1154118|NCT01311687|2801563|P1|NOT COMPLETED|PFS Follow-up Phase||3
1154119|NCT01311687|2801562|P2|COMPLETED|PFS Follow-up Phase||7
1154120|NCT01311687|2801563|P1|COMPLETED|PFS Follow-up Phase||5
1154121|NCT01311687|2801562|P2|STARTED|PFS Follow-up Phase||8
1154122|NCT01311687|2801563|P1|STARTED|PFS Follow-up Phase||8
1154123|NCT01311687|2801562|P2|NOT COMPLETED|Treatment Phase||11
1154124|NCT01311687|2801563|P1|NOT COMPLETED|Treatment Phase||60
1154125|NCT01311687|2801562|P2|COMPLETED|Treatment Phase|Completed represents participants who discontinued from study treatment|142
1154126|NCT01311687|2801563|P1|COMPLETED|Treatment Phase|Completed represents participants who discontinued from study treatment|242
1154127|NCT01311687|2801562|P2|Received Study Treatment|Treatment Phase||150
1154128|NCT01311687|2801563|P1|Received Study Treatment|Treatment Phase||300
1154129|NCT01311687|2801562|P2|STARTED|Treatment Phase||153
1154130|NCT01311687|2801563|P1|STARTED|Treatment Phase||302
1154131|NCT01307891|2801615|P2|NOT COMPLETED|Overall Study||1
1154132|NCT01307891|2801616|P1|NOT COMPLETED|Overall Study||3
1154133|NCT01307891|2801615|P2|COMPLETED|Overall Study||21
1154134|NCT01307891|2801616|P1|COMPLETED|Overall Study||39
1154135|NCT01307891|2801615|P2|STARTED|Overall Study||22
1154136|NCT01307891|2801616|P1|STARTED|Overall Study||42
1154143|NCT01264601|2801639|P2|NOT COMPLETED|Overall Study||0
1154144|NCT01264601|2801640|P1|NOT COMPLETED|Overall Study||0
1154145|NCT01264601|2801639|P2|COMPLETED|Overall Study||14
1154146|NCT01264601|2801640|P1|COMPLETED|Overall Study||17
1154147|NCT01264601|2801639|P2|STARTED|Overall Study||14
1154148|NCT01264601|2801640|P1|STARTED|Overall Study||17
1154149|NCT01247324|2801650|P2|NOT COMPLETED|Overall Study||44
1154150|NCT01247324|2801651|P1|NOT COMPLETED|Overall Study||71
1154151|NCT01247324|2801650|P2|COMPLETED|Overall Study||366
1154152|NCT01247324|2801651|P1|COMPLETED|Overall Study||340
1154153|NCT01247324|2801650|P2|STARTED|Overall Study||410
1154154|NCT01247324|2801651|P1|STARTED|Overall Study||411
1154155|NCT01245062|2801684|P3|NOT COMPLETED|Cross-over Phase||51
1154156|NCT01245062|2801685|P2|NOT COMPLETED|Cross-over Phase||0
1154157|NCT01245062|2801686|P1|NOT COMPLETED|Cross-over Phase||0
1154158|NCT01245062|2801684|P3|COMPLETED|Cross-over Phase||0
1154159|NCT01245062|2801685|P2|COMPLETED|Cross-over Phase||0
1154160|NCT01245062|2801686|P1|COMPLETED|Cross-over Phase||0
1154161|NCT01245062|2801684|P3|Ongoing|Cross-over Phase||34
1154162|NCT01245062|2801685|P2|Ongoing|Cross-over Phase||0
1154163|NCT01245062|2801686|P1|Ongoing|Cross-over Phase||0
1154164|NCT01245062|2801684|P3|STARTED|Cross-over Phase|51 of the 108 participants randomized to chemotherapy elected to cross-over to Trametinib.|51
1154165|NCT01245062|2801685|P2|STARTED|Cross-over Phase||0
1154166|NCT01245062|2801686|P1|STARTED|Cross-over Phase||0
1154167|NCT01245062|2801684|P3|NOT COMPLETED|Randomization Phase||0
1154168|NCT01245062|2801685|P2|NOT COMPLETED|Randomization Phase||108
1154169|NCT01245062|2801686|P1|NOT COMPLETED|Randomization Phase||214
1154170|NCT01245062|2801684|P3|COMPLETED|Randomization Phase||0
1154171|NCT01245062|2801685|P2|COMPLETED|Randomization Phase||0
1154172|NCT01245062|2801686|P1|COMPLETED|Randomization Phase||0
1154173|NCT01245062|2801684|P3|Ongoing|Randomization Phase||0
1154174|NCT01245062|2801685|P2|Ongoing|Randomization Phase||65
1154175|NCT01245062|2801686|P1|Ongoing|Randomization Phase||169
1154176|NCT01245062|2801684|P3|STARTED|Randomization Phase||0
1154177|NCT01245062|2801685|P2|STARTED|Randomization Phase||108
1154178|NCT01245062|2801686|P1|STARTED|Randomization Phase||214
1154179|NCT01243177|2801720|P2|NOT COMPLETED|Overall Study||178
1154180|NCT01243177|2801721|P1|NOT COMPLETED|Overall Study||178
1154181|NCT01243177|2801720|P2|COMPLETED|Overall Study||264
1154182|NCT01243177|2801721|P1|COMPLETED|Overall Study||266
1154183|NCT01243177|2801720|P2|STARTED|Overall Study||442
1154184|NCT01243177|2801721|P1|STARTED|Overall Study||444
1154185|NCT01240902|2801741|P4|NOT COMPLETED|Overall Study||165
1154186|NCT01240902|2801742|P3|NOT COMPLETED|Overall Study||100
1154187|NCT01240902|2801743|P2|NOT COMPLETED|Overall Study||79
1154188|NCT01240902|2801744|P1|NOT COMPLETED|Overall Study||211
1154189|NCT01240902|2801741|P4|COMPLETED|Overall Study||237
1154190|NCT01240902|2801742|P3|COMPLETED|Overall Study||295
1154191|NCT01240902|2801743|P2|COMPLETED|Overall Study||77
1154192|NCT01240902|2801744|P1|COMPLETED|Overall Study||289
1154193|NCT01240902|2801741|P4|STARTED|Overall Study||402
1154194|NCT01240902|2801742|P3|STARTED|Overall Study||395
1154195|NCT01240902|2801743|P2|STARTED|Overall Study||156
1154196|NCT01240902|2801744|P1|STARTED|Overall Study||500
1154197|NCT01186692|2801830|P1|NOT COMPLETED|Overall Study||32
1154198|NCT01186692|2801830|P1|COMPLETED|Overall Study||99
1154199|NCT01186692|2801830|P1|STARTED|Overall Study||131
1154200|NCT01144455|2801841|P3|NOT COMPLETED|Overall Study||36
1154201|NCT01144455|2801842|P2|NOT COMPLETED|Overall Study||42
1154202|NCT01144455|2801843|P1|NOT COMPLETED|Overall Study||50
1154203|NCT01144455|2801841|P3|COMPLETED|Overall Study||38
1154204|NCT01144455|2801842|P2|COMPLETED|Overall Study||29
1154205|NCT01144455|2801843|P1|COMPLETED|Overall Study||19
1154206|NCT01144455|2801841|P3|STARTED|Overall Study||74
1154207|NCT01144455|2801842|P2|STARTED|Overall Study||71
1154208|NCT01144455|2801843|P1|STARTED|Overall Study||69
1154212|NCT01129245|2801872|P2|NOT COMPLETED|Overall Study||0
1154213|NCT01129245|2801873|P1|NOT COMPLETED|Overall Study||0
1154214|NCT01129245|2801872|P2|COMPLETED|Overall Study||4
1154215|NCT01129245|2801873|P1|COMPLETED|Overall Study||7
1154216|NCT01129245|2801872|P2|STARTED|Overall Study||4
1154217|NCT01129245|2801873|P1|STARTED|Overall Study||7
1154227|NCT01071512|2801896|P1|NOT COMPLETED|Overall Study||5
1154228|NCT01071512|2801896|P1|COMPLETED|Overall Study||15
1154229|NCT01071512|2801896|P1|STARTED|Overall Study||20
1154233|NCT01004003|2801921|P9|NOT COMPLETED|Overall Study||30
1154234|NCT01004003|2801922|P8|NOT COMPLETED|Overall Study||60
1154235|NCT01004003|2801923|P7|NOT COMPLETED|Overall Study||8
1154236|NCT01004003|2801924|P6|NOT COMPLETED|Overall Study||4
1154237|NCT01004003|2801925|P5|NOT COMPLETED|Overall Study||4
1154238|NCT01004003|2801926|P4|NOT COMPLETED|Overall Study||3
1154239|NCT01004003|2801927|P3|NOT COMPLETED|Overall Study||4
1154240|NCT01004003|2801928|P2|NOT COMPLETED|Overall Study||3
1154241|NCT01004003|2801929|P1|NOT COMPLETED|Overall Study||6
1154242|NCT01004003|2801921|P9|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|1
1154243|NCT01004003|2801922|P8|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|2
1154244|NCT01004003|2801923|P7|COMPLETED|Overall Study||0
1154245|NCT01004003|2801924|P6|COMPLETED|Overall Study||0
1154246|NCT01004003|2801925|P5|COMPLETED|Overall Study||0
1154247|NCT01004003|2801926|P4|COMPLETED|Overall Study||0
1154248|NCT01004003|2801927|P3|COMPLETED|Overall Study||0
1154249|NCT01004003|2801928|P2|COMPLETED|Overall Study||0
1154250|NCT01004003|2801929|P1|COMPLETED|Overall Study||0
1154251|NCT01004003|2801921|P9|STARTED|Overall Study||31
1154252|NCT01004003|2801922|P8|STARTED|Overall Study||62
1154253|NCT01004003|2801923|P7|STARTED|Overall Study||8
1154254|NCT01004003|2801924|P6|STARTED|Overall Study||4
1154255|NCT01004003|2801925|P5|STARTED|Overall Study||4
1154256|NCT01004003|2801926|P4|STARTED|Overall Study||3
1154257|NCT01004003|2801927|P3|STARTED|Overall Study||4
1154258|NCT01004003|2801928|P2|STARTED|Overall Study||3
1154259|NCT01004003|2801929|P1|STARTED|Overall Study||6
1154266|NCT00937937|2801994|P1|NOT COMPLETED|Overall Study||72
1154267|NCT00937937|2801994|P1|COMPLETED|Overall Study||0
1154268|NCT00937937|2801994|P1|STARTED|Overall Study||72
1154269|NCT00931632|2802003|P2|NOT COMPLETED|Overall Study||18
1154270|NCT00931632|2802004|P1|NOT COMPLETED|Overall Study||21
1154271|NCT00931632|2802003|P2|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|204
1154272|NCT00931632|2802004|P1|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|208
1154273|NCT00931632|2802003|P2|STARTED|Overall Study|Randomized|222
1154274|NCT00931632|2802004|P1|STARTED|Overall Study|Randomized|229
1154299|NCT00857220|2802174|P1|NOT COMPLETED|Overall Study||183
1154300|NCT00857220|2802174|P1|COMPLETED|Overall Study||121
1154301|NCT00857220|2802174|P1|STARTED|Overall Study||304
1154302|NCT00811317|2802191|P1|NOT COMPLETED|Overall Study||0
1154303|NCT00811317|2802191|P1|COMPLETED|Overall Study||11
1154304|NCT00811317|2802191|P1|STARTED|Overall Study||11
1154305|NCT00780715|2802221|P4|NOT COMPLETED|Overall Study||0
1154306|NCT00780715|2802222|P3|NOT COMPLETED|Overall Study||0
1154307|NCT00780715|2802223|P2|NOT COMPLETED|Overall Study||0
1154308|NCT00780715|2802224|P1|NOT COMPLETED|Overall Study||0
1154309|NCT00780715|2802221|P4|COMPLETED|Overall Study||11
1154310|NCT00780715|2802222|P3|COMPLETED|Overall Study||6
1154311|NCT00780715|2802223|P2|COMPLETED|Overall Study||6
1154312|NCT00780715|2802224|P1|COMPLETED|Overall Study||6
1154313|NCT00780715|2802221|P4|STARTED|Overall Study||11
1154314|NCT00780715|2802222|P3|STARTED|Overall Study||6
1154315|NCT00780715|2802223|P2|STARTED|Overall Study||6
1154316|NCT00780715|2802224|P1|STARTED|Overall Study||6
1154317|NCT00742963|2802234|P1|NOT COMPLETED|Overall Study||33
1154318|NCT00742963|2802234|P1|COMPLETED|Overall Study||68
1154319|NCT00742963|2802234|P1|Completed All Treatment Cycles|Overall Study||68
1154320|NCT00742963|2802234|P1|STARTED|Overall Study||101
1154321|NCT00742859|2802242|P4|NOT COMPLETED|Overall Study||8
1154322|NCT00742859|2802243|P3|NOT COMPLETED|Overall Study||11
1154323|NCT00742859|2802244|P2|NOT COMPLETED|Overall Study||12
1154324|NCT00742859|2802245|P1|NOT COMPLETED|Overall Study||11
1154325|NCT00742859|2802242|P4|COMPLETED|Overall Study||119
1154326|NCT00742859|2802243|P3|COMPLETED|Overall Study||116
1154327|NCT00742859|2802244|P2|COMPLETED|Overall Study||115
1154328|NCT00742859|2802245|P1|COMPLETED|Overall Study||116
1154329|NCT00742859|2802242|P4|STARTED|Overall Study||127
1154330|NCT00742859|2802243|P3|STARTED|Overall Study||127
1154331|NCT00742859|2802244|P2|STARTED|Overall Study||127
1154332|NCT00742859|2802245|P1|STARTED|Overall Study||127
1154333|NCT00740870|2802259|P1|NOT COMPLETED|Overall Study||21
1154334|NCT00740870|2802259|P1|COMPLETED|Overall Study||150
1154335|NCT00740870|2802259|P1|STARTED|Overall Study||171
1154336|NCT00731731|2802274|P3|NOT COMPLETED|Overall Study||3
1154337|NCT00731731|2802275|P2|NOT COMPLETED|Overall Study||0
1154338|NCT00731731|2802276|P1|NOT COMPLETED|Overall Study||0
1154339|NCT00731731|2802274|P3|COMPLETED|Overall Study||107
1154340|NCT00731731|2802275|P2|COMPLETED|Overall Study||3
1154341|NCT00731731|2802276|P1|COMPLETED|Overall Study||12
1154342|NCT00731731|2802274|P3|STARTED|Overall Study||110
1154343|NCT00731731|2802275|P2|STARTED|Overall Study||3
1154344|NCT00731731|2802276|P1|STARTED|Overall Study||12
1154345|NCT00725322|2802293|P2|NOT COMPLETED|Second Injection Visit||0
1154346|NCT00725322|2802294|P1|NOT COMPLETED|Second Injection Visit||0
1154347|NCT00725322|2802293|P2|COMPLETED|Second Injection Visit||14
1154348|NCT00725322|2802294|P1|COMPLETED|Second Injection Visit||13
1154349|NCT00725322|2802293|P2|STARTED|Second Injection Visit||14
1154350|NCT00725322|2802294|P1|STARTED|Second Injection Visit||13
1154351|NCT00725322|2802293|P2|NOT COMPLETED|Washout (28 Days)||1
1154352|NCT00725322|2802294|P1|NOT COMPLETED|Washout (28 Days)||2
1154353|NCT00725322|2802293|P2|COMPLETED|Washout (28 Days)||14
1154354|NCT00725322|2802294|P1|COMPLETED|Washout (28 Days)||13
1154355|NCT00725322|2802293|P2|STARTED|Washout (28 Days)||15
1154356|NCT00725322|2802294|P1|STARTED|Washout (28 Days)||15
1154357|NCT00725322|2802293|P2|NOT COMPLETED|First Injection Visit||0
1154358|NCT00725322|2802294|P1|NOT COMPLETED|First Injection Visit||0
1154359|NCT00725322|2802293|P2|COMPLETED|First Injection Visit||15
1154360|NCT00725322|2802294|P1|COMPLETED|First Injection Visit||15
1154361|NCT00725322|2802293|P2|STARTED|First Injection Visit||15
1154362|NCT00725322|2802294|P1|STARTED|First Injection Visit||15
1154363|NCT00699816|2802304|P2|NOT COMPLETED|Overall Study||3
1154364|NCT00699816|2802305|P1|NOT COMPLETED|Overall Study||1
1154365|NCT00699816|2802304|P2|COMPLETED|Overall Study||112
1154366|NCT00699816|2802305|P1|COMPLETED|Overall Study||114
1154367|NCT00699816|2802304|P2|STARTED|Overall Study||115
1154368|NCT00699816|2802305|P1|STARTED|Overall Study||115
1154384|NCT00676715|2802403|P4|NOT COMPLETED|Overall Study||40
1154385|NCT00676715|2802404|P3|NOT COMPLETED|Overall Study||41
1154386|NCT00676715|2802405|P2|NOT COMPLETED|Overall Study||47
1154387|NCT00676715|2802406|P1|NOT COMPLETED|Overall Study||40
1154388|NCT00676715|2802403|P4|COMPLETED|Overall Study||14
1154389|NCT00676715|2802404|P3|COMPLETED|Overall Study||14
1154390|NCT00676715|2802405|P2|COMPLETED|Overall Study||8
1154391|NCT00676715|2802406|P1|COMPLETED|Overall Study||14
1154392|NCT00676715|2802403|P4|STARTED|Overall Study||54
1154393|NCT00676715|2802404|P3|STARTED|Overall Study||55
1154394|NCT00676715|2802405|P2|STARTED|Overall Study||55
1154395|NCT00676715|2802406|P1|STARTED|Overall Study||54
1154396|NCT00672204|2802436|P1|NOT COMPLETED|Overall Study||20
1154397|NCT00672204|2802436|P1|COMPLETED|Overall Study||3
1154398|NCT00672204|2802436|P1|STARTED|Overall Study||23
1154399|NCT00658814|2802442|P2|NOT COMPLETED|Maintenance Therapy||1
1154400|NCT00658814|2802443|P1|NOT COMPLETED|Maintenance Therapy||3
1154401|NCT00658814|2802442|P2|COMPLETED|Maintenance Therapy||7
1154402|NCT00658814|2802443|P1|COMPLETED|Maintenance Therapy||17
1154403|NCT00658814|2802442|P2|Eligible|Maintenance Therapy||8
1154404|NCT00658814|2802443|P1|Eligible|Maintenance Therapy||19
1154405|NCT00658814|2802442|P2|STARTED|Maintenance Therapy||8
1154406|NCT00658814|2802443|P1|STARTED|Maintenance Therapy||20
1154407|NCT00658814|2802442|P2|NOT COMPLETED|Consolidation Therapy||3
1154408|NCT00658814|2802443|P1|NOT COMPLETED|Consolidation Therapy||2
1154409|NCT00658814|2802442|P2|COMPLETED|Consolidation Therapy||10
1154410|NCT00658814|2802443|P1|COMPLETED|Consolidation Therapy||22
1154411|NCT00658814|2802442|P2|Eligible|Consolidation Therapy||11
1154412|NCT00658814|2802443|P1|Eligible|Consolidation Therapy||22
1154413|NCT00658814|2802442|P2|STARTED|Consolidation Therapy||13
1154414|NCT00658814|2802443|P1|STARTED|Consolidation Therapy||24
1154415|NCT00658814|2802442|P2|NOT COMPLETED|Remission Induction Chemotherapy||18
1154416|NCT00658814|2802443|P1|NOT COMPLETED|Remission Induction Chemotherapy||8
1154417|NCT00658814|2802442|P2|COMPLETED|Remission Induction Chemotherapy||41
1154418|NCT00658814|2802443|P1|COMPLETED|Remission Induction Chemotherapy||75
1154419|NCT00658814|2802442|P2|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||54
1154420|NCT00658814|2802443|P1|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||79
1154421|NCT00658814|2802442|P2|Eligible|Remission Induction Chemotherapy||57
1154422|NCT00658814|2802443|P1|Eligible|Remission Induction Chemotherapy||82
1154423|NCT00658814|2802442|P2|STARTED|Remission Induction Chemotherapy||59
1154424|NCT00658814|2802443|P1|STARTED|Remission Induction Chemotherapy||83
1154425|NCT00616759|2802459|P2|NOT COMPLETED|Overall Study||2
1154426|NCT00616759|2802460|P1|NOT COMPLETED|Overall Study||3
1154427|NCT00616759|2802459|P2|COMPLETED|Overall Study||8
1154428|NCT00616759|2802460|P1|COMPLETED|Overall Study||7
1154429|NCT00616759|2802459|P2|STARTED|Overall Study||10
1154430|NCT00616759|2802460|P1|STARTED|Overall Study||10
1154431|NCT00586339|2802469|P3|NOT COMPLETED|Overall Study||6
1154432|NCT00586339|2802470|P2|NOT COMPLETED|Overall Study||7
1154433|NCT00586339|2802471|P1|NOT COMPLETED|Overall Study||7
1154434|NCT00586339|2802469|P3|COMPLETED|Overall Study||24
1154435|NCT00586339|2802470|P2|COMPLETED|Overall Study||52
1154436|NCT00586339|2802471|P1|COMPLETED|Overall Study||54
1154437|NCT00586339|2802469|P3|STARTED|Overall Study||30
1154438|NCT00586339|2802470|P2|STARTED|Overall Study||59
1154439|NCT00586339|2802471|P1|STARTED|Overall Study||61
1154459|NCT00392236|2802620|P2|NOT COMPLETED|Overall Study||6
1154460|NCT00392236|2802621|P1|NOT COMPLETED|Overall Study||12
1154461|NCT00392236|2802620|P2|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|12
1154462|NCT00392236|2802621|P1|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|8
1154463|NCT00392236|2802620|P2|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|18
1154464|NCT00392236|2802621|P1|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|20
1154465|NCT00390429|2802630|P4|NOT COMPLETED|Overall Study||0
1154466|NCT00390429|2802631|P3|NOT COMPLETED|Overall Study||0
1154467|NCT00390429|2802632|P2|NOT COMPLETED|Overall Study||0
1154468|NCT00390429|2802633|P1|NOT COMPLETED|Overall Study||0
1154469|NCT00390429|2802630|P4|COMPLETED|Overall Study||39
1154470|NCT00390429|2802631|P3|COMPLETED|Overall Study||25
1154471|NCT00390429|2802632|P2|COMPLETED|Overall Study||12
1154472|NCT00390429|2802633|P1|COMPLETED|Overall Study||5
1154473|NCT00390429|2802630|P4|STARTED|Overall Study||39
1154474|NCT00390429|2802631|P3|STARTED|Overall Study||25
1154475|NCT00390429|2802632|P2|STARTED|Overall Study||12
1154476|NCT00390429|2802633|P1|STARTED|Overall Study||5
1154477|NCT00331409|2802649|P1|NOT COMPLETED|Overall Study||4
1154478|NCT00331409|2802649|P1|COMPLETED|Overall Study|15 patients accrued to the first stage;if>9 were progression-free at 3 months,enrollment continued.|15
1154479|NCT00331409|2802649|P1|STARTED|Overall Study|19 patients were enrolled in the first stage due to 4 patients who withdrew early.|19
1154500|NCT00321685|2802678|P1|NOT COMPLETED|Overall Study||39
1154501|NCT00321685|2802678|P1|COMPLETED|Overall Study||18
1154502|NCT00321685|2802678|P1|Eligible and Treated|Overall Study||53
1154503|NCT00321685|2802678|P1|Started Protocol Therapy|Overall Study||55
1154504|NCT00321685|2802678|P1|Eligible|Overall Study||55
1154505|NCT00321685|2802678|P1|STARTED|Overall Study||57
1154506|NCT00310401|2802688|P2|NOT COMPLETED|Overall Study||0
1154507|NCT00310401|2802689|P1|NOT COMPLETED|Overall Study||0
1154508|NCT00310401|2802688|P2|COMPLETED|Overall Study||246
1154509|NCT00310401|2802689|P1|COMPLETED|Overall Study||260
1154510|NCT00310401|2802688|P2|STARTED|Overall Study||246
1154511|NCT00310401|2802689|P1|STARTED|Overall Study||260
1154515|NCT00249444|2802713|P2|NOT COMPLETED|Overall Study||15
1154516|NCT00249444|2802714|P1|NOT COMPLETED|Overall Study||12
1154517|NCT00249444|2802713|P2|COMPLETED|Overall Study||29
1154518|NCT00249444|2802714|P1|COMPLETED|Overall Study||30
1154519|NCT00249444|2802713|P2|STARTED|Overall Study||44
1154520|NCT00249444|2802714|P1|STARTED|Overall Study||42
1154521|NCT00233324|2802726|P4|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||11
1154522|NCT00233324|2802727|P3|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||18
1154523|NCT00233324|2802728|P2|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||14
1154524|NCT00233324|2802729|P1|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||13
1154525|NCT00233324|2802726|P4|COMPLETED|Follow up at 18-22 Months Corrected Age||269
1154526|NCT00233324|2802727|P3|COMPLETED|Follow up at 18-22 Months Corrected Age||256
1154527|NCT00233324|2802728|P2|COMPLETED|Follow up at 18-22 Months Corrected Age||261
1154528|NCT00233324|2802729|P1|COMPLETED|Follow up at 18-22 Months Corrected Age||237
1154529|NCT00233324|2802726|P4|STARTED|Follow up at 18-22 Months Corrected Age||280
1154530|NCT00233324|2802727|P3|STARTED|Follow up at 18-22 Months Corrected Age||274
1154531|NCT00233324|2802728|P2|STARTED|Follow up at 18-22 Months Corrected Age||275
1154532|NCT00233324|2802729|P1|STARTED|Follow up at 18-22 Months Corrected Age||250
1154533|NCT00233324|2802726|P4|NOT COMPLETED|Main Study||47
1154534|NCT00233324|2802727|P3|NOT COMPLETED|Main Study||62
1154535|NCT00233324|2802728|P2|NOT COMPLETED|Main Study||60
1154536|NCT00233324|2802729|P1|NOT COMPLETED|Main Study||68
1154537|NCT00233324|2802726|P4|COMPLETED|Main Study||280
1154538|NCT00233324|2802727|P3|COMPLETED|Main Study||274
1154539|NCT00233324|2802728|P2|COMPLETED|Main Study||275
1154540|NCT00233324|2802729|P1|COMPLETED|Main Study||250
1154541|NCT00233324|2802726|P4|STARTED|Main Study||327
1154542|NCT00233324|2802727|P3|STARTED|Main Study||336
1154543|NCT00233324|2802728|P2|STARTED|Main Study||335
1154544|NCT00233324|2802729|P1|STARTED|Main Study||318
1154545|NCT00126581|2802745|P2|NOT COMPLETED|Overall Study||20
1154546|NCT00126581|2802746|P1|NOT COMPLETED|Overall Study||13
1154547|NCT00126581|2802745|P2|COMPLETED|Overall Study||80
1154548|NCT00126581|2802746|P1|COMPLETED|Overall Study||68
1154549|NCT00126581|2802745|P2|STARTED|Overall Study||100
1154550|NCT00126581|2802746|P1|STARTED|Overall Study||81
1154554|NCT00114101|2802773|P2|NOT COMPLETED|Overall Study||0
1154555|NCT00114101|2802774|P1|NOT COMPLETED|Overall Study||0
1154556|NCT00114101|2802773|P2|COMPLETED|Overall Study||229
1154557|NCT00114101|2802774|P1|COMPLETED|Overall Study||231
1154558|NCT00114101|2802773|P2|STARTED|Overall Study||229
1154559|NCT00114101|2802774|P1|STARTED|Overall Study||231
1154560|NCT00098475|2802788|P4|NOT COMPLETED|Step 2||0
1154561|NCT00098475|2802789|P3|NOT COMPLETED|Step 2||0
1154562|NCT00098475|2802790|P2|NOT COMPLETED|Step 2||10
1154563|NCT00098475|2802791|P1|NOT COMPLETED|Step 2||5
1154564|NCT00098475|2802788|P4|COMPLETED|Step 2||0
1154565|NCT00098475|2802789|P3|COMPLETED|Step 2||0
1154566|NCT00098475|2802790|P2|COMPLETED|Step 2||5
1154567|NCT00098475|2802791|P1|COMPLETED|Step 2||0
1154568|NCT00098475|2802788|P4|Eligible|Step 2||0
1154569|NCT00098475|2802789|P3|Eligible|Step 2||0
1154570|NCT00098475|2802790|P2|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|9
1154571|NCT00098475|2802791|P1|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|2
1154572|NCT00098475|2802788|P4|Treated|Step 2||0
1154573|NCT00098475|2802789|P3|Treated|Step 2||0
1154574|NCT00098475|2802790|P2|Treated|Step 2||14
1154575|NCT00098475|2802791|P1|Treated|Step 2||4
1154576|NCT00098475|2802788|P4|STARTED|Step 2||0
1154577|NCT00098475|2802789|P3|STARTED|Step 2||0
1154578|NCT00098475|2802790|P2|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|15
1154579|NCT00098475|2802791|P1|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|5
1154580|NCT00098475|2802788|P4|NOT COMPLETED|Step 1||3
1154581|NCT00098475|2802789|P3|NOT COMPLETED|Step 1||4
1154582|NCT00098475|2802790|P2|NOT COMPLETED|Step 1||173
1154583|NCT00098475|2802791|P1|NOT COMPLETED|Step 1||171
1154584|NCT00098475|2802788|P4|COMPLETED|Step 1||0
1154585|NCT00098475|2802789|P3|COMPLETED|Step 1||0
1154586|NCT00098475|2802790|P2|COMPLETED|Step 1||49
1154587|NCT00098475|2802791|P1|COMPLETED|Step 1||52
1154588|NCT00098475|2802788|P4|Eligible|Step 1||3
1154589|NCT00098475|2802789|P3|Eligible|Step 1||4
1154590|NCT00098475|2802790|P2|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|208
1154591|NCT00098475|2802791|P1|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|214
1154592|NCT00098475|2802788|P4|Treated|Step 1||3
1154593|NCT00098475|2802789|P3|Treated|Step 1||4
1154594|NCT00098475|2802790|P2|Treated|Step 1||220
1154595|NCT00098475|2802791|P1|Treated|Step 1||223
1154596|NCT00098475|2802788|P4|STARTED|Step 1||3
1154597|NCT00098475|2802789|P3|STARTED|Step 1||4
1154598|NCT00098475|2802790|P2|STARTED|Step 1||222
1154599|NCT00098475|2802791|P1|STARTED|Step 1||223
1154600|NCT00095784|2802803|P1|NOT COMPLETED|Overall Study||0
1154601|NCT00095784|2802803|P1|COMPLETED|Overall Study||21
1154602|NCT00095784|2802803|P1|STARTED|Overall Study||21
1154603|NCT00070499|2802830|P4|NOT COMPLETED|Overall Study||110
1154604|NCT00070499|2802831|P3|NOT COMPLETED|Overall Study||120
1154605|NCT00070499|2802832|P2|NOT COMPLETED|Overall Study||26
1154606|NCT00070499|2802833|P1|NOT COMPLETED|Overall Study||38
1154607|NCT00070499|2802830|P4|COMPLETED|Overall Study||17
1154608|NCT00070499|2802831|P3|COMPLETED|Overall Study||6
1154609|NCT00070499|2802832|P2|COMPLETED|Overall Study||52
1154610|NCT00070499|2802833|P1|COMPLETED|Overall Study||37
1154611|NCT00070499|2802830|P4|Eligible and Treated|Overall Study||123
1154612|NCT00070499|2802831|P3|Eligible and Treated|Overall Study||123
1154613|NCT00070499|2802832|P2|Eligible and Treated|Overall Study||73
1154614|NCT00070499|2802833|P1|Eligible and Treated|Overall Study||72
1154615|NCT00070499|2802830|P4|Eligible|Overall Study||125
1154616|NCT00070499|2802831|P3|Eligible|Overall Study||123
1154617|NCT00070499|2802832|P2|Eligible|Overall Study||73
1154618|NCT00070499|2802833|P1|Eligible|Overall Study||73
1154619|NCT00070499|2802830|P4|STARTED|Overall Study||127
1154620|NCT00070499|2802831|P3|STARTED|Overall Study||126
1154621|NCT00070499|2802832|P2|STARTED|Overall Study||78
1154622|NCT00070499|2802833|P1|STARTED|Overall Study||75
1154623|NCT00060528|2802859|P4|NOT COMPLETED|Overall Study||0
1154624|NCT00060528|2802860|P3|NOT COMPLETED|Overall Study||0
1154625|NCT00060528|2802861|P2|NOT COMPLETED|Overall Study||0
1154626|NCT00060528|2802862|P1|NOT COMPLETED|Overall Study||0
1154627|NCT00060528|2802859|P4|COMPLETED|Overall Study||8
1154628|NCT00060528|2802860|P3|COMPLETED|Overall Study||7
1154629|NCT00060528|2802861|P2|COMPLETED|Overall Study||9
1154630|NCT00060528|2802862|P1|COMPLETED|Overall Study||8
1154631|NCT00060528|2802859|P4|STARTED|Overall Study||8
1154632|NCT00060528|2802860|P3|STARTED|Overall Study||7
1154633|NCT00060528|2802861|P2|STARTED|Overall Study||9
1154634|NCT00060528|2802862|P1|STARTED|Overall Study|32 participants are reported for the phase II portion.|8
1154635|NCT02647944|2802878|P2|NOT COMPLETED|Overall Study||3
1154636|NCT02647944|2802879|P1|NOT COMPLETED|Overall Study||2
1154637|NCT02647944|2802878|P2|COMPLETED|Overall Study||18
1154638|NCT02647944|2802879|P1|COMPLETED|Overall Study||17
1154639|NCT02647944|2802878|P2|STARTED|Overall Study||21
1154640|NCT02647944|2802879|P1|STARTED|Overall Study||19
1154641|NCT02609672|2802905|P2|NOT COMPLETED|Overall Study||1
1154642|NCT02609672|2802906|P1|NOT COMPLETED|Overall Study||3
1154643|NCT02609672|2802905|P2|COMPLETED|Overall Study||11
1154644|NCT02609672|2802906|P1|COMPLETED|Overall Study||9
1154645|NCT02609672|2802905|P2|STARTED|Overall Study||12
1154646|NCT02609672|2802906|P1|STARTED|Overall Study||12
1154647|NCT02517515|2802942|P2|NOT COMPLETED|Overall Study||2
1154648|NCT02517515|2802943|P1|NOT COMPLETED|Overall Study||2
1154649|NCT02517515|2802942|P2|COMPLETED|Overall Study||323
1154650|NCT02517515|2802943|P1|COMPLETED|Overall Study||323
1154651|NCT02517515|2802942|P2|STARTED|Overall Study||325
1154652|NCT02517515|2802943|P1|STARTED|Overall Study||325
1154653|NCT02474082|2802960|P2|NOT COMPLETED|Overall Study||54
1154654|NCT02474082|2802961|P1|NOT COMPLETED|Overall Study||6
1154655|NCT02474082|2802960|P2|COMPLETED|Overall Study||43
1154656|NCT02474082|2802961|P1|COMPLETED|Overall Study||99
1154657|NCT02474082|2802960|P2|Full Analysis Set (FAS)|Overall Study||95
1154658|NCT02474082|2802961|P1|Full Analysis Set (FAS)|Overall Study||105
1154659|NCT02474082|2802960|P2|STARTED|Overall Study||97
1154660|NCT02474082|2802961|P1|STARTED|Overall Study||105
1154661|NCT02312713|2802998|P3|NOT COMPLETED|Overall Study||5
1154662|NCT02312713|2802999|P2|NOT COMPLETED|Overall Study||30
1154663|NCT02312713|2803000|P1|NOT COMPLETED|Overall Study||11
1154664|NCT02312713|2802998|P3|COMPLETED|Overall Study||63
1154665|NCT02312713|2802999|P2|COMPLETED|Overall Study||112
1154666|NCT02312713|2803000|P1|COMPLETED|Overall Study||129
1154667|NCT02312713|2802998|P3|STARTED|Overall Study||68
1154668|NCT02312713|2802999|P2|STARTED|Overall Study||142
1154669|NCT02312713|2803000|P1|STARTED|Overall Study||140
1154670|NCT02302092|2803046|P2|NOT COMPLETED|Overall Study||0
1154671|NCT02302092|2803047|P1|NOT COMPLETED|Overall Study||0
1154672|NCT02302092|2803046|P2|COMPLETED|Overall Study||7
1154673|NCT02302092|2803047|P1|COMPLETED|Overall Study||6
1154674|NCT02302092|2803046|P2|STARTED|Overall Study||7
1154675|NCT02302092|2803047|P1|STARTED|Overall Study||6
1154676|NCT02285998|2803075|P2|NOT COMPLETED|Overall Study||253
1154677|NCT02285998|2803076|P1|NOT COMPLETED|Overall Study||246
1154678|NCT02285998|2803075|P2|COMPLETED|Overall Study||4236
1154679|NCT02285998|2803076|P1|COMPLETED|Overall Study||4228
1154680|NCT02285998|2803075|P2|STARTED|Overall Study||4489
1154681|NCT02285998|2803076|P1|STARTED|Overall Study||4474
1154682|NCT02224846|2803102|P2|NOT COMPLETED|Period 2 (Month 12 to Month 24)||357
1154683|NCT02224846|2803103|P1|NOT COMPLETED|Period 2 (Month 12 to Month 24)||173
1154684|NCT02224846|2803102|P2|COMPLETED|Period 2 (Month 12 to Month 24)||0
1154685|NCT02224846|2803103|P1|COMPLETED|Period 2 (Month 12 to Month 24)||0
1154686|NCT02224846|2803102|P2|STARTED|Period 2 (Month 12 to Month 24)||357
1154687|NCT02224846|2803103|P1|STARTED|Period 2 (Month 12 to Month 24)||173
1154688|NCT02224846|2803102|P2|NOT COMPLETED|Period 2 (Month 3 to Month 12)||31
1154689|NCT02224846|2803103|P1|NOT COMPLETED|Period 2 (Month 3 to Month 12)||19
1154690|NCT02224846|2803102|P2|COMPLETED|Period 2 (Month 3 to Month 12)||357
1154691|NCT02224846|2803103|P1|COMPLETED|Period 2 (Month 3 to Month 12)||173
1154692|NCT02224846|2803102|P2|STARTED|Period 2 (Month 3 to Month 12)||388
1154693|NCT02224846|2803103|P1|STARTED|Period 2 (Month 3 to Month 12)||192
1154694|NCT02224846|2803102|P2|NOT COMPLETED|Period 1 (Month 3)||36
1154695|NCT02224846|2803103|P1|NOT COMPLETED|Period 1 (Month 3)||19
1154696|NCT02224846|2803102|P2|COMPLETED|Period 1 (Month 3)||388
1154697|NCT02224846|2803103|P1|COMPLETED|Period 1 (Month 3)||192
1154698|NCT02224846|2803102|P2|Received at Least One Dose of Study Drug|Period 1 (Month 3)||421
1154699|NCT02224846|2803103|P1|Received at Least One Dose of Study Drug|Period 1 (Month 3)||210
1154700|NCT02224846|2803102|P2|STARTED|Period 1 (Month 3)||424
1154701|NCT02224846|2803103|P1|STARTED|Period 1 (Month 3)||211
1154702|NCT02211534|2803122|P2|NOT COMPLETED|Overall Study||5
1154703|NCT02211534|2803123|P1|NOT COMPLETED|Overall Study||13
1154704|NCT02211534|2803122|P2|COMPLETED|Overall Study||6
1154705|NCT02211534|2803123|P1|COMPLETED|Overall Study||11
1154706|NCT02211534|2803122|P2|STARTED|Overall Study||11
1154707|NCT02211534|2803123|P1|STARTED|Overall Study||24
1154708|NCT02136004|2803145|P1|NOT COMPLETED|Overall Study||1
1154709|NCT02136004|2803145|P1|COMPLETED|Overall Study||219
1154710|NCT02136004|2803145|P1|STARTED|Overall Study|Enrollment commenced on May 20, 2014 and the last subject completed follow-up on February 28, 2015|220
1154711|NCT02108951|2803156|P1|NOT COMPLETED|Overall Study||16
1154712|NCT02108951|2803156|P1|COMPLETED|Overall Study||4
1154713|NCT02108951|2803156|P1|STARTED|Overall Study|Indicates patients in enrolled, full analysis and safety set|20
1154714|NCT02057952|2803176|P3|NOT COMPLETED|Overall Study||22
1154715|NCT02057952|2803177|P2|NOT COMPLETED|Overall Study||10
1154716|NCT02057952|2803178|P1|NOT COMPLETED|Overall Study||8
1154717|NCT02057952|2803176|P3|COMPLETED|Overall Study||28
1154718|NCT02057952|2803177|P2|COMPLETED|Overall Study||39
1154719|NCT02057952|2803178|P1|COMPLETED|Overall Study||43
1154720|NCT02057952|2803176|P3|STARTED|Overall Study||50
1154721|NCT02057952|2803177|P2|STARTED|Overall Study||49
1154722|NCT02057952|2803178|P1|STARTED|Overall Study||51
1154723|NCT01943435|2803204|P3|NOT COMPLETED|6 Month Follow up||15
1154724|NCT01943435|2803205|P2|NOT COMPLETED|6 Month Follow up||7
1154725|NCT01943435|2803206|P1|NOT COMPLETED|6 Month Follow up||12
1154726|NCT01943435|2803204|P3|COMPLETED|6 Month Follow up||65
1154727|NCT01943435|2803205|P2|COMPLETED|6 Month Follow up||59
1154728|NCT01943435|2803206|P1|COMPLETED|6 Month Follow up||67
1154729|NCT01943435|2803204|P3|STARTED|6 Month Follow up||80
1154730|NCT01943435|2803205|P2|STARTED|6 Month Follow up||66
1154731|NCT01943435|2803206|P1|STARTED|6 Month Follow up||79
1154732|NCT01943435|2803204|P3|NOT COMPLETED|2 Month Follow up||0
1154733|NCT01943435|2803205|P2|NOT COMPLETED|2 Month Follow up||3
1154734|NCT01943435|2803206|P1|NOT COMPLETED|2 Month Follow up||2
1154735|NCT01943435|2803204|P3|COMPLETED|2 Month Follow up||80
1154736|NCT01943435|2803205|P2|COMPLETED|2 Month Follow up||66
1154737|NCT01943435|2803206|P1|COMPLETED|2 Month Follow up||79
1154738|NCT01943435|2803204|P3|STARTED|2 Month Follow up||80
1154739|NCT01943435|2803205|P2|STARTED|2 Month Follow up||69
1154740|NCT01943435|2803206|P1|STARTED|2 Month Follow up||81
1154741|NCT01943435|2803204|P3|NOT COMPLETED|Intervention Period||4
1154742|NCT01943435|2803205|P2|NOT COMPLETED|Intervention Period||3
1154743|NCT01943435|2803206|P1|NOT COMPLETED|Intervention Period||3
1154744|NCT01943435|2803204|P3|COMPLETED|Intervention Period||80
1154745|NCT01943435|2803205|P2|COMPLETED|Intervention Period||69
1154746|NCT01943435|2803206|P1|COMPLETED|Intervention Period||81
1154747|NCT01943435|2803204|P3|STARTED|Intervention Period||84
1154748|NCT01943435|2803205|P2|STARTED|Intervention Period||72
1154749|NCT01943435|2803206|P1|STARTED|Intervention Period||84
1154750|NCT01911169|2803222|P2|NOT COMPLETED|Overall Study||0
1154751|NCT01911169|2803223|P1|NOT COMPLETED|Overall Study||0
1154752|NCT01911169|2803222|P2|COMPLETED|Overall Study||3
1154753|NCT01911169|2803223|P1|COMPLETED|Overall Study||6
1154754|NCT01911169|2803222|P2|STARTED|Overall Study||3
1154755|NCT01911169|2803223|P1|STARTED|Overall Study||6
1154756|NCT01905683|2803231|P1|NOT COMPLETED|Overall Study||51
1154757|NCT01905683|2803231|P1|COMPLETED|Overall Study||319
1154758|NCT01905683|2803231|P1|STARTED|Overall Study||370
1154759|NCT01867710|2803248|P4|NOT COMPLETED|Overall Study||7
1154760|NCT01867710|2803249|P3|NOT COMPLETED|Overall Study||9
1154761|NCT01867710|2803250|P2|NOT COMPLETED|Overall Study||7
1154762|NCT01867710|2803251|P1|NOT COMPLETED|Overall Study||8
1154763|NCT01867710|2803248|P4|COMPLETED|Overall Study||35
1154764|NCT01867710|2803249|P3|COMPLETED|Overall Study||31
1154765|NCT01867710|2803250|P2|COMPLETED|Overall Study||34
1154766|NCT01867710|2803251|P1|COMPLETED|Overall Study||33
1154767|NCT01867710|2803248|P4|Treated|Overall Study||42
1154768|NCT01867710|2803249|P3|Treated|Overall Study||39
1154769|NCT01867710|2803250|P2|Treated|Overall Study||41
1154770|NCT01867710|2803251|P1|Treated|Overall Study||41
1154771|NCT01867710|2803248|P4|STARTED|Overall Study||42
1154772|NCT01867710|2803249|P3|STARTED|Overall Study||40
1154773|NCT01867710|2803250|P2|STARTED|Overall Study||41
1154774|NCT01867710|2803251|P1|STARTED|Overall Study||41
1154775|NCT01695239|2803269|P4|NOT COMPLETED|Overall Study||6
1154776|NCT01695239|2803270|P3|NOT COMPLETED|Overall Study||10
1154777|NCT01695239|2803271|P2|NOT COMPLETED|Overall Study||4
1154778|NCT01695239|2803272|P1|NOT COMPLETED|Overall Study||15
1154779|NCT01695239|2803269|P4|COMPLETED|Overall Study||97
1154780|NCT01695239|2803270|P3|COMPLETED|Overall Study||97
1154781|NCT01695239|2803271|P2|COMPLETED|Overall Study||97
1154782|NCT01695239|2803272|P1|COMPLETED|Overall Study||91
1154783|NCT01695239|2803269|P4|Classified as Inadequate Responder (IR)|Overall Study||10
1154784|NCT01695239|2803270|P3|Classified as Inadequate Responder (IR)|Overall Study||11
1154785|NCT01695239|2803271|P2|Classified as Inadequate Responder (IR)|Overall Study||9
1154786|NCT01695239|2803272|P1|Classified as Inadequate Responder (IR)|Overall Study||27
1154787|NCT01695239|2803269|P4|Received at Least 1 Dose of Study Drug|Overall Study||102
1154788|NCT01695239|2803270|P3|Received at Least 1 Dose of Study Drug|Overall Study||107
1154789|NCT01695239|2803271|P2|Received at Least 1 Dose of Study Drug|Overall Study||101
1154790|NCT01695239|2803272|P1|Received at Least 1 Dose of Study Drug|Overall Study||106
1154791|NCT01695239|2803269|P4|STARTED|Overall Study||103
1154792|NCT01695239|2803270|P3|STARTED|Overall Study||107
1154793|NCT01695239|2803271|P2|STARTED|Overall Study||101
1154794|NCT01695239|2803272|P1|STARTED|Overall Study||106
1154795|NCT01639443|2803363|P2|NOT COMPLETED|Overall Study||0
1154796|NCT01639443|2803364|P1|NOT COMPLETED|Overall Study||0
1154797|NCT01639443|2803363|P2|COMPLETED|Overall Study|These individuals all booked appointments using typical booking.|4855
1154798|NCT01639443|2803364|P1|COMPLETED|Overall Study|Intervention is limited to appointment booking, and all completed.|180
1154799|NCT01639443|2803363|P2|STARTED|Overall Study|These individuals opted to not participate in Fast-tracked group, and were not consented.|4855
1154800|NCT01639443|2803364|P1|STARTED|Overall Study|These individuals opted into Fast-tracked group and were consented.|180
1154801|NCT01618162|2803382|P2|NOT COMPLETED|Overall Study||35
1154802|NCT01618162|2803383|P1|NOT COMPLETED|Overall Study||38
1154803|NCT01618162|2803382|P2|COMPLETED|Overall Study||111
1154804|NCT01618162|2803383|P1|COMPLETED|Overall Study||251
1154805|NCT01618162|2803382|P2|Exposed|Overall Study||146
1154806|NCT01618162|2803383|P1|Exposed|Overall Study||288
1154807|NCT01618162|2803382|P2|STARTED|Overall Study||146
1154808|NCT01618162|2803383|P1|STARTED|Overall Study||289
1154809|NCT01606124|2803403|P2|NOT COMPLETED|Overall Study||0
1154810|NCT01606124|2803404|P1|NOT COMPLETED|Overall Study||0
1154811|NCT01606124|2803403|P2|COMPLETED|Overall Study||20
1154812|NCT01606124|2803404|P1|COMPLETED|Overall Study||19
1154813|NCT01606124|2803403|P2|STARTED|Overall Study||20
1154814|NCT01606124|2803404|P1|STARTED|Overall Study||19
1154815|NCT01544179|2803414|P2|NOT COMPLETED|Overall Study||46
1154816|NCT01544179|2803415|P1|NOT COMPLETED|Overall Study||63
1154817|NCT01544179|2803414|P2|COMPLETED|Overall Study|Patients are ongoing in the study|86
1154818|NCT01544179|2803415|P1|COMPLETED|Overall Study|Patients are ongoing in the study|70
1154819|NCT01544179|2803414|P2|Did Not Receive Treatment|Overall Study||0
1154820|NCT01544179|2803415|P1|Did Not Receive Treatment|Overall Study||1
1154821|NCT01544179|2803414|P2|Received Treatment|Overall Study||132
1154822|NCT01544179|2803415|P1|Received Treatment|Overall Study||132
1154823|NCT01544179|2803414|P2|STARTED|Overall Study||132
1154824|NCT01544179|2803415|P1|STARTED|Overall Study||133
1154825|NCT01512693|2803445|P2|NOT COMPLETED|Overall Study||1
1154826|NCT01512693|2803446|P1|NOT COMPLETED|Overall Study||0
1154827|NCT01512693|2803445|P2|COMPLETED|Overall Study||8
1154828|NCT01512693|2803446|P1|COMPLETED|Overall Study||8
1154829|NCT01512693|2803445|P2|STARTED|Overall Study||9
1154830|NCT01512693|2803446|P1|STARTED|Overall Study||8
1154831|NCT01468896|2803460|P2|NOT COMPLETED|Overall Study||0
1154832|NCT01468896|2803461|P1|NOT COMPLETED|Overall Study||0
1154833|NCT01468896|2803460|P2|COMPLETED|Overall Study||17
1154834|NCT01468896|2803461|P1|COMPLETED|Overall Study||6
1154835|NCT01468896|2803460|P2|STARTED|Overall Study||17
1154836|NCT01468896|2803461|P1|STARTED|Overall Study||6
1154837|NCT01437098|2803477|P1|NOT COMPLETED|Overall Study||13
1154838|NCT01437098|2803477|P1|COMPLETED|Overall Study||42
1154839|NCT01437098|2803477|P1|36 Months|Overall Study||36
1154840|NCT01437098|2803477|P1|24 Months|Overall Study||42
1154841|NCT01437098|2803477|P1|12 Months|Overall Study||45
1154842|NCT01437098|2803477|P1|6 Months|Overall Study||47
1154843|NCT01437098|2803477|P1|30 Days|Overall Study||51
1154844|NCT01437098|2803477|P1|STARTED|Overall Study||55
1154845|NCT01392573|2803534|P2|NOT COMPLETED|Overall Study||35
1154846|NCT01392573|2803535|P1|NOT COMPLETED|Overall Study||32
1154847|NCT01392573|2803534|P2|COMPLETED|Overall Study||171
1154848|NCT01392573|2803535|P1|COMPLETED|Overall Study||175
1154849|NCT01392573|2803534|P2|Exposed|Overall Study||206
1154850|NCT01392573|2803535|P1|Exposed|Overall Study||207
1154851|NCT01392573|2803534|P2|STARTED|Overall Study||206
1154852|NCT01392573|2803535|P1|STARTED|Overall Study||207
1154853|NCT01387282|2803545|P2|NOT COMPLETED|Overall Study||47
1154854|NCT01387282|2803546|P1|NOT COMPLETED|Overall Study||97
1154855|NCT01387282|2803545|P2|COMPLETED|Overall Study||118
1154856|NCT01387282|2803546|P1|COMPLETED|Overall Study||233
1154857|NCT01387282|2803545|P2|Safety Population|Overall Study||161
1154858|NCT01387282|2803546|P1|Safety Population|Overall Study||330
1154859|NCT01387282|2803545|P2|MITT Population|Overall Study||136
1154860|NCT01387282|2803546|P1|MITT Population|Overall Study||268
1154861|NCT01387282|2803545|P2|ITT Population|Overall Study||165
1154862|NCT01387282|2803546|P1|ITT Population|Overall Study||330
1154863|NCT01387282|2803545|P2|STARTED|Overall Study||165
1154864|NCT01387282|2803546|P1|STARTED|Overall Study||330
1154865|NCT01387269|2803562|P2|NOT COMPLETED|Overall Study||40
1154866|NCT01387269|2803563|P1|NOT COMPLETED|Overall Study||92
1154867|NCT01387269|2803562|P2|COMPLETED|Overall Study||121
1154868|NCT01387269|2803563|P1|COMPLETED|Overall Study||231
1154869|NCT01387269|2803562|P2|Safety Population|Overall Study||161
1154870|NCT01387269|2803563|P1|Safety Population|Overall Study||320
1154871|NCT01387269|2803562|P2|MITT Population|Overall Study||141
1154872|NCT01387269|2803563|P1|MITT Population|Overall Study||284
1154873|NCT01387269|2803562|P2|ITT Population|Overall Study||161
1154874|NCT01387269|2803563|P1|ITT Population|Overall Study||323
1154875|NCT01387269|2803562|P2|STARTED|Overall Study||161
1154876|NCT01387269|2803563|P1|STARTED|Overall Study||323
1154877|NCT01352221|2803579|P4|NOT COMPLETED|Open-label Phase||11
1154878|NCT01352221|2803580|P3|NOT COMPLETED|Open-label Phase||13
1154879|NCT01352221|2803581|P2|NOT COMPLETED|Open-label Phase||0
1154880|NCT01352221|2803582|P1|NOT COMPLETED|Open-label Phase||0
1154881|NCT01352221|2803579|P4|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|36
1154882|NCT01352221|2803580|P3|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|37
1154883|NCT01352221|2803581|P2|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
1154884|NCT01352221|2803582|P1|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
1154885|NCT01352221|2803579|P4|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|47
1154886|NCT01352221|2803580|P3|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|50
1154887|NCT01352221|2803581|P2|STARTED|Open-label Phase|Not Applicable to open-label phase|0
1154888|NCT01352221|2803582|P1|STARTED|Open-label Phase|Not Applicable to open-label phase|0
1154889|NCT01352221|2803579|P4|NOT COMPLETED|Double-blind Phase||0
1154890|NCT01352221|2803580|P3|NOT COMPLETED|Double-blind Phase||0
1154891|NCT01352221|2803581|P2|NOT COMPLETED|Double-blind Phase||11
1154892|NCT01352221|2803582|P1|NOT COMPLETED|Double-blind Phase||9
1154893|NCT01352221|2803579|P4|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
1154894|NCT01352221|2803580|P3|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
1154895|NCT01352221|2803581|P2|COMPLETED|Double-blind Phase||53
1154896|NCT01352221|2803582|P1|COMPLETED|Double-blind Phase||55
1154897|NCT01352221|2803579|P4|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
1154898|NCT01352221|2803580|P3|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
1154899|NCT01352221|2803581|P2|STARTED|Double-blind Phase||64
1154900|NCT01352221|2803582|P1|STARTED|Double-blind Phase||64
1154901|NCT01320072|2803642|P2|NOT COMPLETED|Overall Study||0
1154902|NCT01320072|2803643|P1|NOT COMPLETED|Overall Study||0
1154903|NCT01320072|2803642|P2|COMPLETED|Overall Study||13
1154904|NCT01320072|2803643|P1|COMPLETED|Overall Study||16
1154905|NCT01320072|2803642|P2|STARTED|Overall Study||13
1154906|NCT01320072|2803643|P1|STARTED|Overall Study||16
1154907|NCT01286012|2803654|P2|NOT COMPLETED|Overall Study||14
1154908|NCT01286012|2803655|P1|NOT COMPLETED|Overall Study||13
1154909|NCT01286012|2803654|P2|COMPLETED|Overall Study||40
1154910|NCT01286012|2803655|P1|COMPLETED|Overall Study||41
1154911|NCT01286012|2803654|P2|STARTED|Overall Study|3 patients randomized to placebo did not receive study drug.|54
1154912|NCT01286012|2803655|P1|STARTED|Overall Study|2 patients randomized to SFP did not receive study drug.|54
1154913|NCT01141712|2803663|P1|NOT COMPLETED|Overall Study||3
1154914|NCT01141712|2803663|P1|COMPLETED|Overall Study||40
1154915|NCT01141712|2803663|P1|STARTED|Overall Study||43
1154916|NCT01120782|2803682|P1|NOT COMPLETED|Overall Study||11
1154917|NCT01120782|2803682|P1|COMPLETED|Overall Study||34
1154918|NCT01120782|2803682|P1|STARTED|Overall Study||45
1154919|NCT01111305|2803688|P2|NOT COMPLETED|Overall Study||0
1154920|NCT01111305|2803689|P1|NOT COMPLETED|Overall Study||0
1154921|NCT01111305|2803688|P2|COMPLETED|Overall Study||4
1154922|NCT01111305|2803689|P1|COMPLETED|Overall Study||4
1154923|NCT01111305|2803688|P2|STARTED|Overall Study||4
1154924|NCT01111305|2803689|P1|STARTED|Overall Study||4
1154925|NCT01042535|2803699|P1|NOT COMPLETED|Overall Study||8
1154926|NCT01042535|2803699|P1|COMPLETED|Overall Study||36
1154927|NCT01042535|2803699|P1|STARTED|Overall Study||44
1154928|NCT01002742|2803709|P2|NOT COMPLETED|Overall Study||1
1154929|NCT01002742|2803710|P1|NOT COMPLETED|Overall Study||0
1154930|NCT01002742|2803709|P2|COMPLETED|Overall Study||116
1154931|NCT01002742|2803710|P1|COMPLETED|Overall Study||119
1154932|NCT01002742|2803709|P2|STARTED|Overall Study||117
1154933|NCT01002742|2803710|P1|STARTED|Overall Study||119
1154934|NCT00912223|2803744|P1|NOT COMPLETED|Overall Study||3
1154935|NCT00912223|2803744|P1|COMPLETED|Overall Study||62
1154936|NCT00912223|2803744|P1|STARTED|Overall Study||65
1154937|NCT00910962|2803763|P3|NOT COMPLETED|Overall Study||76
1154938|NCT00910962|2803764|P2|NOT COMPLETED|Overall Study||78
1154939|NCT00910962|2803765|P1|NOT COMPLETED|Overall Study||43
1154940|NCT00910962|2803763|P3|COMPLETED|Overall Study||116
1154941|NCT00910962|2803764|P2|COMPLETED|Overall Study||121
1154942|NCT00910962|2803765|P1|COMPLETED|Overall Study||92
1154943|NCT00910962|2803763|P3|STARTED|Overall Study||192
1154944|NCT00910962|2803764|P2|STARTED|Overall Study||199
1154945|NCT00910962|2803765|P1|STARTED|Overall Study||135
1154946|NCT00908388|2803855|P1|NOT COMPLETED|Overall Study||10
1154947|NCT00908388|2803855|P1|COMPLETED|Overall Study||40
1154948|NCT00908388|2803855|P1|STARTED|Overall Study||50
1154949|NCT00864227|2803863|P1|NOT COMPLETED|Overall Study||4
1154950|NCT00864227|2803863|P1|COMPLETED|Overall Study||50
1154951|NCT00864227|2803863|P1|STARTED|Overall Study||54
1154952|NCT00859040|2803880|P2|NOT COMPLETED|Overall Study||0
1154953|NCT00859040|2803881|P1|NOT COMPLETED|Overall Study||0
1154954|NCT00859040|2803880|P2|COMPLETED|Overall Study||16
1154955|NCT00859040|2803881|P1|COMPLETED|Overall Study||18
1154956|NCT00859040|2803880|P2|STARTED|Overall Study||16
1154957|NCT00859040|2803881|P1|STARTED|Overall Study||18
1154958|NCT00694551|2803897|P3|NOT COMPLETED|Overall Study||1
1154959|NCT00694551|2803898|P2|NOT COMPLETED|Overall Study||0
1154960|NCT00694551|2803899|P1|NOT COMPLETED|Overall Study||1
1154961|NCT00694551|2803897|P3|COMPLETED|Overall Study||8
1154962|NCT00694551|2803898|P2|COMPLETED|Overall Study||10
1154963|NCT00694551|2803899|P1|COMPLETED|Overall Study||9
1154964|NCT00694551|2803897|P3|STARTED|Overall Study||9
1154965|NCT00694551|2803898|P2|STARTED|Overall Study||10
1154966|NCT00694551|2803899|P1|STARTED|Overall Study||10
1154967|NCT00678301|2803915|P2|NOT COMPLETED|Overall Study||2
1154968|NCT00678301|2803916|P1|NOT COMPLETED|Overall Study||8
1154969|NCT00678301|2803915|P2|COMPLETED|Overall Study||116
1154970|NCT00678301|2803916|P1|COMPLETED|Overall Study||231
1154971|NCT00678301|2803915|P2|STARTED|Overall Study||118
1154972|NCT00678301|2803916|P1|STARTED|Overall Study||239
1154973|NCT00581308|2803972|P1|NOT COMPLETED|Month 12||21
1154974|NCT00581308|2803972|P1|COMPLETED|Month 12||177
1154975|NCT00581308|2803972|P1|STARTED|Month 12||198
1154976|NCT00581308|2803972|P1|NOT COMPLETED|Month 6||5
1154977|NCT00581308|2803972|P1|COMPLETED|Month 6||198
1154978|NCT00581308|2803972|P1|STARTED|Month 6||203
1154979|NCT00581308|2803972|P1|NOT COMPLETED|Month 1||9
1154980|NCT00581308|2803972|P1|COMPLETED|Month 1||203
1154981|NCT00581308|2803972|P1|STARTED|Month 1||212
1154982|NCT00581308|2803972|P1|NOT COMPLETED|Pre Discharge||3
1154983|NCT00581308|2803972|P1|COMPLETED|Pre Discharge||212
1154984|NCT00581308|2803972|P1|STARTED|Pre Discharge||215
1154985|NCT00554515|2803980|P1|NOT COMPLETED|Overall Study||118
1154986|NCT00554515|2803980|P1|COMPLETED|Overall Study||5
1154987|NCT00554515|2803980|P1|Treated|Overall Study||120
1154988|NCT00554515|2803980|P1|STARTED|Overall Study||123
1154989|NCT00483496|2804009|P1|NOT COMPLETED|Overall Study||1
1154990|NCT00483496|2804009|P1|COMPLETED|Overall Study||15
1154991|NCT00483496|2804009|P1|STARTED|Overall Study||16
1154992|NCT00326417|2804023|P4|NOT COMPLETED|Overall Study||3
1154993|NCT00326417|2804024|P3|NOT COMPLETED|Overall Study||1
1154994|NCT00326417|2804025|P2|NOT COMPLETED|Overall Study||0
1154995|NCT00326417|2804026|P1|NOT COMPLETED|Overall Study||14
1154996|NCT00326417|2804023|P4|COMPLETED|Overall Study|Arm was closed to accrual after 3 patients experienced graft failure.|0
1154997|NCT00326417|2804024|P3|COMPLETED|Overall Study||38
1154998|NCT00326417|2804025|P2|COMPLETED|Overall Study||41
1154999|NCT00326417|2804026|P1|COMPLETED|Overall Study|Dose level was closed for excessive toxicity after 8 patients in Phase II accrued.|0
1155000|NCT00326417|2804023|P4|Phase II|Overall Study||0
1155001|NCT00326417|2804024|P3|Phase II|Overall Study||33
1155002|NCT00326417|2804025|P2|Phase II|Overall Study||35
1155003|NCT00326417|2804026|P1|Phase II|Overall Study||8
1155004|NCT00326417|2804023|P4|Phase I|Overall Study||3
1155005|NCT00326417|2804024|P3|Phase I|Overall Study||6
1155006|NCT00326417|2804025|P2|Phase I|Overall Study||6
1155007|NCT00326417|2804026|P1|Phase I|Overall Study||6
1155008|NCT00326417|2804023|P4|STARTED|Overall Study||3
1155009|NCT00326417|2804024|P3|STARTED|Overall Study||39
1155010|NCT00326417|2804025|P2|STARTED|Overall Study||41
1155011|NCT00326417|2804026|P1|STARTED|Overall Study||14
1155012|NCT00290693|2804042|P1|NOT COMPLETED|Overall Study||2
1155013|NCT00290693|2804042|P1|COMPLETED|Overall Study||43
1155014|NCT00290693|2804042|P1|STARTED|Overall Study||45
1155015|NCT00125762|2804050|P1|NOT COMPLETED|Overall Study||159
1155016|NCT00125762|2804050|P1|COMPLETED|Overall Study||748
1155017|NCT00125762|2804050|P1|STARTED|Overall Study||907
1155743|NCT03109769|2806167|P2|NOT COMPLETED|Overall Study||0
1155744|NCT03109769|2806168|P1|NOT COMPLETED|Overall Study||0
1155745|NCT03109769|2806167|P2|COMPLETED|Overall Study||22
1155746|NCT03109769|2806168|P1|COMPLETED|Overall Study||22
1155747|NCT03109769|2806167|P2|STARTED|Overall Study||22
1155748|NCT03109769|2806168|P1|STARTED|Overall Study||22
1155749|NCT02706327|2806179|P3|NOT COMPLETED|Overall Study||2
1155750|NCT02706327|2806180|P2|NOT COMPLETED|Overall Study||1
1155751|NCT02706327|2806181|P1|NOT COMPLETED|Overall Study||1
1155752|NCT02706327|2806179|P3|COMPLETED|Overall Study||21
1155753|NCT02706327|2806180|P2|COMPLETED|Overall Study||21
1155754|NCT02706327|2806181|P1|COMPLETED|Overall Study||21
1155755|NCT02706327|2806179|P3|STARTED|Overall Study||23
1155756|NCT02706327|2806180|P2|STARTED|Overall Study||22
1155757|NCT02706327|2806181|P1|STARTED|Overall Study||22
1155758|NCT02543398|2806203|P2|NOT COMPLETED|Overall Study||0
1155759|NCT02543398|2806204|P1|NOT COMPLETED|Overall Study||0
1155760|NCT02543398|2806203|P2|COMPLETED|Overall Study||20
1155761|NCT02543398|2806204|P1|COMPLETED|Overall Study||20
1155762|NCT02543398|2806203|P2|STARTED|Overall Study||20
1155763|NCT02543398|2806204|P1|STARTED|Overall Study||20
1155764|NCT02526290|2806210|P1|NOT COMPLETED|Overall Study||8
1155765|NCT02526290|2806210|P1|COMPLETED|Overall Study||89
1155766|NCT02526290|2806210|P1|STARTED|Overall Study||97
1155767|NCT02507388|2806219|P2|NOT COMPLETED|Overall Study||0
1155768|NCT02507388|2806220|P1|NOT COMPLETED|Overall Study||0
1155769|NCT02507388|2806219|P2|COMPLETED|Overall Study||25
1155770|NCT02507388|2806220|P1|COMPLETED|Overall Study||25
1155771|NCT02507388|2806219|P2|STARTED|Overall Study||25
1155772|NCT02507388|2806220|P1|STARTED|Overall Study||25
1155773|NCT02494076|2806243|P2|NOT COMPLETED|Overall Study||0
1155774|NCT02494076|2806244|P1|NOT COMPLETED|Overall Study||0
1155775|NCT02494076|2806243|P2|COMPLETED|Overall Study||26
1155776|NCT02494076|2806244|P1|COMPLETED|Overall Study||26
1155777|NCT02494076|2806243|P2|STARTED|Overall Study||26
1155778|NCT02494076|2806244|P1|STARTED|Overall Study||26
1155779|NCT02493855|2806257|P3|NOT COMPLETED|Overall Study||0
1155780|NCT02493855|2806258|P2|NOT COMPLETED|Overall Study||1
1155781|NCT02493855|2806259|P1|NOT COMPLETED|Overall Study||2
1155782|NCT02493855|2806257|P3|COMPLETED|Overall Study||6
1155783|NCT02493855|2806258|P2|COMPLETED|Overall Study||18
1155784|NCT02493855|2806259|P1|COMPLETED|Overall Study||19
1155785|NCT02493855|2806257|P3|STARTED|Overall Study||6
1155786|NCT02493855|2806258|P2|STARTED|Overall Study||19
1155787|NCT02493855|2806259|P1|STARTED|Overall Study||21
1155788|NCT02480153|2806269|P2|NOT COMPLETED|Overall Study||27
1155789|NCT02480153|2806270|P1|NOT COMPLETED|Overall Study||11
1155790|NCT02480153|2806269|P2|COMPLETED|Overall Study||273
1155791|NCT02480153|2806270|P1|COMPLETED|Overall Study||286
1155792|NCT02480153|2806269|P2|Received Treatment|Overall Study||299
1155793|NCT02480153|2806270|P1|Received Treatment|Overall Study||297
1155794|NCT02480153|2806269|P2|STARTED|Overall Study||300
1155795|NCT02480153|2806270|P1|STARTED|Overall Study||297
1155796|NCT02471326|2806276|P1|NOT COMPLETED|Overall Study||1
1155797|NCT02471326|2806276|P1|COMPLETED|Overall Study||9
1155798|NCT02471326|2806276|P1|STARTED|Overall Study||10
1155799|NCT02452528|2806283|P2|NOT COMPLETED|Overall Study||1
1155800|NCT02452528|2806284|P1|NOT COMPLETED|Overall Study||1
1155801|NCT02452528|2806283|P2|COMPLETED|Overall Study||1
1155802|NCT02452528|2806284|P1|COMPLETED|Overall Study||1
1155803|NCT02452528|2806283|P2|STARTED|Overall Study||2
1155804|NCT02452528|2806284|P1|STARTED|Overall Study||2
1155805|NCT02433483|2806316|P1|NOT COMPLETED|Overall Study||2
1155806|NCT02433483|2806316|P1|COMPLETED|Overall Study||0
1155807|NCT02433483|2806316|P1|STARTED|Overall Study||2
1155808|NCT02390219|2806328|P1|NOT COMPLETED|Overall Study||13
1155809|NCT02390219|2806328|P1|COMPLETED|Overall Study||33
1155810|NCT02390219|2806328|P1|STARTED|Overall Study||46
1155811|NCT02340715|2806338|P1|NOT COMPLETED|Overall Study||0
1155812|NCT02340715|2806338|P1|COMPLETED|Overall Study|158|158
1155813|NCT02340715|2806338|P1|STARTED|Overall Study|158|158
1155814|NCT02301975|2806345|P3|NOT COMPLETED|Overall Study||22
1155815|NCT02301975|2806346|P2|NOT COMPLETED|Overall Study||25
1155816|NCT02301975|2806347|P1|NOT COMPLETED|Overall Study||31
1155817|NCT02301975|2806345|P3|COMPLETED|Overall Study||477
1155818|NCT02301975|2806346|P2|COMPLETED|Overall Study||476
1155819|NCT02301975|2806347|P1|COMPLETED|Overall Study||473
1155820|NCT02301975|2806345|P3|STARTED|Overall Study||499
1155821|NCT02301975|2806346|P2|STARTED|Overall Study||501
1155822|NCT02301975|2806347|P1|STARTED|Overall Study||504
1155823|NCT02229383|2806375|P2|NOT COMPLETED|Overall Study||24
1155824|NCT02229383|2806376|P1|NOT COMPLETED|Overall Study||22
1155825|NCT02229383|2806375|P2|COMPLETED|Overall Study||207
1155826|NCT02229383|2806376|P1|COMPLETED|Overall Study||211
1155827|NCT02229383|2806375|P2|ITT Analysis Set|Overall Study||230
1155828|NCT02229383|2806376|P1|ITT Analysis Set|Overall Study||231
1155829|NCT02229383|2806375|P2|Safety Analysis Set|Overall Study||231
1155830|NCT02229383|2806376|P1|Safety Analysis Set|Overall Study||232
1155831|NCT02229383|2806375|P2|Received Treatment|Overall Study||231
1155832|NCT02229383|2806376|P1|Received Treatment|Overall Study||232
1155833|NCT02229383|2806375|P2|STARTED|Overall Study||231
1155834|NCT02229383|2806376|P1|STARTED|Overall Study||233
1155835|NCT02210000|2806396|P2|NOT COMPLETED|Overall Study||21
1155836|NCT02210000|2806397|P1|NOT COMPLETED|Overall Study||19
1155837|NCT02210000|2806396|P2|COMPLETED|Overall Study||36
1155838|NCT02210000|2806397|P1|COMPLETED|Overall Study||38
1155839|NCT02210000|2806396|P2|STARTED|Overall Study||57
1155840|NCT02210000|2806397|P1|STARTED|Overall Study||57
1155841|NCT02164916|2806421|P2|NOT COMPLETED|Overall Study||54
1155842|NCT02164916|2806422|P1|NOT COMPLETED|Overall Study||52
1155843|NCT02164916|2806421|P2|COMPLETED|Overall Study||0
1155844|NCT02164916|2806422|P1|COMPLETED|Overall Study||0
1155845|NCT02164916|2806421|P2|Cross-over to Arm II|Overall Study||0
1155846|NCT02164916|2806422|P1|Cross-over to Arm II|Overall Study|Following disease progression on Arm 1. Note: these patients are also counted in 'Not Completed'.|24
1155847|NCT02164916|2806421|P2|Eligible|Overall Study||49
1155848|NCT02164916|2806422|P1|Eligible|Overall Study||50
1155849|NCT02164916|2806421|P2|STARTED|Overall Study||54
1155850|NCT02164916|2806422|P1|STARTED|Overall Study||52
1155851|NCT02116309|2806441|P2|NOT COMPLETED|Overall Study||1
1155852|NCT02116309|2806442|P1|NOT COMPLETED|Overall Study||0
1155853|NCT02116309|2806441|P2|COMPLETED|Overall Study||477
1155854|NCT02116309|2806442|P1|COMPLETED|Overall Study||482
1155855|NCT02116309|2806441|P2|STARTED|Overall Study||478
1155856|NCT02116309|2806442|P1|STARTED|Overall Study||482
1155857|NCT02099110|2806455|P5|NOT COMPLETED|Overall Study||27
1155858|NCT02099110|2806456|P4|NOT COMPLETED|Overall Study||22
1155859|NCT02099110|2806457|P3|NOT COMPLETED|Overall Study||28
1155860|NCT02099110|2806458|P2|NOT COMPLETED|Overall Study||31
1155861|NCT02099110|2806459|P1|NOT COMPLETED|Overall Study||24
1155862|NCT02099110|2806455|P5|COMPLETED|Overall Study||218
1155863|NCT02099110|2806456|P4|COMPLETED|Overall Study||221
1155864|NCT02099110|2806457|P3|COMPLETED|Overall Study||219
1155865|NCT02099110|2806458|P2|COMPLETED|Overall Study||217
1155866|NCT02099110|2806459|P1|COMPLETED|Overall Study||226
1155867|NCT02099110|2806455|P5|Treated|Overall Study||244
1155868|NCT02099110|2806456|P4|Treated|Overall Study||243
1155869|NCT02099110|2806457|P3|Treated|Overall Study||247
1155870|NCT02099110|2806458|P2|Treated|Overall Study||248
1155871|NCT02099110|2806459|P1|Treated|Overall Study||250
1155872|NCT02099110|2806455|P5|STARTED|Overall Study||245
1155873|NCT02099110|2806456|P4|STARTED|Overall Study||243
1155874|NCT02099110|2806457|P3|STARTED|Overall Study||247
1155875|NCT02099110|2806458|P2|STARTED|Overall Study||248
1155876|NCT02099110|2806459|P1|STARTED|Overall Study||250
1155877|NCT01999920|2806508|P2|NOT COMPLETED|Overall Study||2
1155878|NCT01999920|2806509|P1|NOT COMPLETED|Overall Study||6
1155879|NCT01999920|2806508|P2|COMPLETED|Overall Study||9
1155880|NCT01999920|2806509|P1|COMPLETED|Overall Study||7
1155881|NCT01999920|2806508|P2|STARTED|Overall Study||11
1155882|NCT01999920|2806509|P1|STARTED|Overall Study||13
1155883|NCT01999322|2806527|P2|NOT COMPLETED|Overall Study||0
1155884|NCT01999322|2806528|P1|NOT COMPLETED|Overall Study||1
1155885|NCT01999322|2806527|P2|COMPLETED|Overall Study||12
1155886|NCT01999322|2806528|P1|COMPLETED|Overall Study||24
1155887|NCT01999322|2806527|P2|STARTED|Overall Study||12
1155888|NCT01999322|2806528|P1|STARTED|Overall Study||25
1155889|NCT01994395|2806542|P2|NOT COMPLETED|Overall Study||2
1155890|NCT01994395|2806543|P1|NOT COMPLETED|Overall Study||1
1155891|NCT01994395|2806542|P2|COMPLETED|Overall Study||25
1155892|NCT01994395|2806543|P1|COMPLETED|Overall Study||25
1155893|NCT01994395|2806542|P2|STARTED|Overall Study||27
1155894|NCT01994395|2806543|P1|STARTED|Overall Study||26
1155895|NCT01945021|2806565|P1|NOT COMPLETED|Overall Study||47
1155896|NCT01945021|2806565|P1|COMPLETED|Overall Study|Completed is defined as patients who continued crizotinib at the time of final analysis (ongoing)|80
1155897|NCT01945021|2806565|P1|Patient Reported Outcome -Evaluable|Overall Study|All patients from the safety population who completed a baseline and >/= 1 post-baseline assessment.|123
1155898|NCT01945021|2806565|P1|Response Evaluable Population|Overall Study|All patients in the safety population who had an adequate baseline tumor assessment|127
1155899|NCT01945021|2806565|P1|Safety Population|Overall Study|All enrolled patients who received at least 1 dose of study medication.|127
1155900|NCT01945021|2806565|P1|STARTED|Overall Study|127 pts with ROS1+ & ALK negative tumors were consented and started study (2 more were screen fails)|127
1155901|NCT01752712|2806581|P2|NOT COMPLETED|Overall Study||15
1155902|NCT01752712|2806582|P1|NOT COMPLETED|Overall Study||9
1155903|NCT01752712|2806581|P2|COMPLETED|Overall Study||16
1155904|NCT01752712|2806582|P1|COMPLETED|Overall Study||22
1155905|NCT01752712|2806581|P2|STARTED|Overall Study||31
1155906|NCT01752712|2806582|P1|STARTED|Overall Study||31
1155907|NCT01740427|2806600|P2|NOT COMPLETED|Overall Study||222
1155908|NCT01740427|2806601|P1|NOT COMPLETED|Overall Study||444
1155909|NCT01740427|2806600|P2|COMPLETED|Overall Study||0
1155910|NCT01740427|2806601|P1|COMPLETED|Overall Study||0
1155911|NCT01740427|2806600|P2|STARTED|Overall Study||222
1155912|NCT01740427|2806601|P1|STARTED|Overall Study||444
1155913|NCT01737268|2806628|P1|NOT COMPLETED|Overall Study||9
1155914|NCT01737268|2806628|P1|COMPLETED|Overall Study||11
1155915|NCT01737268|2806628|P1|Treated|Overall Study||20
1155916|NCT01737268|2806628|P1|STARTED|Overall Study||20
1155917|NCT01732822|2806642|P2|NOT COMPLETED|Overall Study||113
1155918|NCT01732822|2806643|P1|NOT COMPLETED|Overall Study||123
1155919|NCT01732822|2806642|P2|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6842
1155920|NCT01732822|2806643|P1|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6807
1155921|NCT01732822|2806642|P2|STARTED|Overall Study||6955
1155922|NCT01732822|2806643|P1|STARTED|Overall Study||6930
1155923|NCT01702909|2806713|P1|NOT COMPLETED|Overall Study||0
1155924|NCT01702909|2806713|P1|COMPLETED|Overall Study||7
1155925|NCT01702909|2806713|P1|STARTED|Overall Study||7
1155926|NCT01688921|2806721|P2|NOT COMPLETED|Overall Study||15
1155927|NCT01688921|2806722|P1|NOT COMPLETED|Overall Study||16
1155928|NCT01688921|2806721|P2|COMPLETED|Overall Study||608
1155929|NCT01688921|2806722|P1|COMPLETED|Overall Study||611
1155930|NCT01688921|2806721|P2|STARTED|Overall Study||623
1155931|NCT01688921|2806722|P1|STARTED|Overall Study||627
1155932|NCT01684215|2806749|P4|NOT COMPLETED|Overall Study||43
1155933|NCT01684215|2806750|P3|NOT COMPLETED|Overall Study||6
1155934|NCT01684215|2806751|P2|NOT COMPLETED|Overall Study||6
1155935|NCT01684215|2806752|P1|NOT COMPLETED|Overall Study||6
1155936|NCT01684215|2806749|P4|COMPLETED|Overall Study||0
1155937|NCT01684215|2806750|P3|COMPLETED|Overall Study||0
1155938|NCT01684215|2806751|P2|COMPLETED|Overall Study||0
1155939|NCT01684215|2806752|P1|COMPLETED|Overall Study||0
1155940|NCT01684215|2806749|P4|Treated|Overall Study||42
1155941|NCT01684215|2806750|P3|Treated|Overall Study||6
1155942|NCT01684215|2806751|P2|Treated|Overall Study||6
1155943|NCT01684215|2806752|P1|Treated|Overall Study||6
1155944|NCT01684215|2806749|P4|STARTED|Overall Study||43
1155945|NCT01684215|2806750|P3|STARTED|Overall Study||6
1155946|NCT01684215|2806751|P2|STARTED|Overall Study||6
1155947|NCT01684215|2806752|P1|STARTED|Overall Study||6
1155948|NCT01668784|2806828|P2|NOT COMPLETED|Treated (Overall)||369
1155949|NCT01668784|2806829|P1|NOT COMPLETED|Treated (Overall)||339
1155950|NCT01668784|2806828|P2|COMPLETED|Treated (Overall)||28
1155951|NCT01668784|2806829|P1|COMPLETED|Treated (Overall)||67
1155952|NCT01668784|2806828|P2|STARTED|Treated (Overall)||397
1155953|NCT01668784|2806829|P1|STARTED|Treated (Overall)||406
1155954|NCT01668784|2806828|P2|NOT COMPLETED|Randomized (Pre-treatment)||14
1155955|NCT01668784|2806829|P1|NOT COMPLETED|Randomized (Pre-treatment)||4
1155956|NCT01668784|2806828|P2|COMPLETED|Randomized (Pre-treatment)||397
1155957|NCT01668784|2806829|P1|COMPLETED|Randomized (Pre-treatment)||406
1155958|NCT01668784|2806828|P2|STARTED|Randomized (Pre-treatment)||411
1155959|NCT01668784|2806829|P1|STARTED|Randomized (Pre-treatment)||410
1155960|NCT01641471|2806855|P2|NOT COMPLETED|Overall Study||27
1155961|NCT01641471|2806856|P1|NOT COMPLETED|Overall Study||23
1155962|NCT01641471|2806855|P2|COMPLETED|Overall Study||31
1155963|NCT01641471|2806856|P1|COMPLETED|Overall Study||35
1155964|NCT01641471|2806855|P2|STARTED|Overall Study||58
1155965|NCT01641471|2806856|P1|STARTED|Overall Study||58
1155966|NCT01625182|2806864|P2|NOT COMPLETED|Overall Study||11
1155967|NCT01625182|2806865|P1|NOT COMPLETED|Overall Study||20
1155968|NCT01625182|2806864|P2|COMPLETED|Overall Study||41
1155969|NCT01625182|2806865|P1|COMPLETED|Overall Study||34
1155970|NCT01625182|2806864|P2|STARTED|Overall Study||52
1155971|NCT01625182|2806865|P1|STARTED|Overall Study||54
1155972|NCT01615731|2806880|P2|NOT COMPLETED|Overall Study||2
1155973|NCT01615731|2806881|P1|NOT COMPLETED|Overall Study||3
1155974|NCT01615731|2806880|P2|COMPLETED|Overall Study||24
1155975|NCT01615731|2806881|P1|COMPLETED|Overall Study||21
1155976|NCT01615731|2806880|P2|STARTED|Overall Study||26
1155977|NCT01615731|2806881|P1|STARTED|Overall Study||24
1155978|NCT01607346|2806899|P1|NOT COMPLETED|Overall Study||3
1155979|NCT01607346|2806899|P1|COMPLETED|Overall Study||7
1155980|NCT01607346|2806899|P1|STARTED|Overall Study||10
1155981|NCT01572389|2806917|P2|NOT COMPLETED|Overall Study||21
1155982|NCT01572389|2806918|P1|NOT COMPLETED|Overall Study||46
1155983|NCT01572389|2806917|P2|COMPLETED|Overall Study||68
1155984|NCT01572389|2806918|P1|COMPLETED|Overall Study||90
1155985|NCT01572389|2806917|P2|STARTED|Overall Study||89
1155986|NCT01572389|2806918|P1|STARTED|Overall Study||136
1155987|NCT01557166|2806928|P2|NOT COMPLETED|Overall Study||37
1155988|NCT01557166|2806929|P1|NOT COMPLETED|Overall Study||46
1155989|NCT01557166|2806928|P2|COMPLETED|Overall Study||142
1155990|NCT01557166|2806929|P1|COMPLETED|Overall Study||134
1155991|NCT01557166|2806928|P2|Exposed|Overall Study||179
1155992|NCT01557166|2806929|P1|Exposed|Overall Study||176
1155993|NCT01557166|2806928|P2|STARTED|Overall Study||179
1155994|NCT01557166|2806929|P1|STARTED|Overall Study||180
1155995|NCT01496846|2806947|P6|NOT COMPLETED|Supplemental Buccal Infiltration||0
1155996|NCT01496846|2806948|P5|NOT COMPLETED|Supplemental Buccal Infiltration||0
1155997|NCT01496846|2806949|P4|NOT COMPLETED|Supplemental Buccal Infiltration||0
1155998|NCT01496846|2806950|P3|NOT COMPLETED|Supplemental Buccal Infiltration||0
1155999|NCT01496846|2806951|P2|NOT COMPLETED|Supplemental Buccal Infiltration||0
1156000|NCT01496846|2806952|P1|NOT COMPLETED|Supplemental Buccal Infiltration||0
1156001|NCT01496846|2806947|P6|COMPLETED|Supplemental Buccal Infiltration||38
1156002|NCT01496846|2806948|P5|COMPLETED|Supplemental Buccal Infiltration||35
1156003|NCT01496846|2806949|P4|COMPLETED|Supplemental Buccal Infiltration||40
1156004|NCT01496846|2806950|P3|COMPLETED|Supplemental Buccal Infiltration||36
1156005|NCT01496846|2806951|P2|COMPLETED|Supplemental Buccal Infiltration||0
1156006|NCT01496846|2806952|P1|COMPLETED|Supplemental Buccal Infiltration||0
1156007|NCT01496846|2806947|P6|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|38
1156008|NCT01496846|2806948|P5|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|35
1156009|NCT01496846|2806949|P4|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|40
1156010|NCT01496846|2806950|P3|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|36
1156011|NCT01496846|2806951|P2|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0
1156012|NCT01496846|2806952|P1|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0
1156013|NCT01496846|2806947|P6|NOT COMPLETED|IANB Articaine (All Participants)||0
1156014|NCT01496846|2806948|P5|NOT COMPLETED|IANB Articaine (All Participants)||0
1156015|NCT01496846|2806949|P4|NOT COMPLETED|IANB Articaine (All Participants)||0
1156016|NCT01496846|2806950|P3|NOT COMPLETED|IANB Articaine (All Participants)||0
1156017|NCT01496846|2806951|P2|NOT COMPLETED|IANB Articaine (All Participants)||1
1156018|NCT01496846|2806952|P1|NOT COMPLETED|IANB Articaine (All Participants)||1
1156019|NCT01496846|2806947|P6|COMPLETED|IANB Articaine (All Participants)||38
1156020|NCT01496846|2806948|P5|COMPLETED|IANB Articaine (All Participants)||35
1156021|NCT01496846|2806949|P4|COMPLETED|IANB Articaine (All Participants)||40
1156022|NCT01496846|2806950|P3|COMPLETED|IANB Articaine (All Participants)||36
1156023|NCT01496846|2806951|P2|COMPLETED|IANB Articaine (All Participants)||23
1156024|NCT01496846|2806952|P1|COMPLETED|IANB Articaine (All Participants)||27
1156025|NCT01496846|2806947|P6|STARTED|IANB Articaine (All Participants)||38
1156026|NCT01496846|2806948|P5|STARTED|IANB Articaine (All Participants)||35
1156027|NCT01496846|2806949|P4|STARTED|IANB Articaine (All Participants)||40
1156028|NCT01496846|2806950|P3|STARTED|IANB Articaine (All Participants)||36
1156029|NCT01496846|2806951|P2|STARTED|IANB Articaine (All Participants)||24
1156030|NCT01496846|2806952|P1|STARTED|IANB Articaine (All Participants)||28
1156031|NCT01454076|2806968|P5|NOT COMPLETED|Overall Study||6
1156032|NCT01454076|2806969|P4|NOT COMPLETED|Overall Study||2
1156033|NCT01454076|2806970|P3|NOT COMPLETED|Overall Study||9
1156034|NCT01454076|2806971|P2|NOT COMPLETED|Overall Study||6
1156035|NCT01454076|2806972|P1|NOT COMPLETED|Overall Study||13
1156036|NCT01454076|2806968|P5|COMPLETED|Overall Study||15
1156037|NCT01454076|2806969|P4|COMPLETED|Overall Study||16
1156038|NCT01454076|2806970|P3|COMPLETED|Overall Study||15
1156039|NCT01454076|2806971|P2|COMPLETED|Overall Study||14
1156040|NCT01454076|2806972|P1|COMPLETED|Overall Study||16
1156041|NCT01454076|2806968|P5|STARTED|Overall Study||21
1156042|NCT01454076|2806969|P4|STARTED|Overall Study||18
1156043|NCT01454076|2806970|P3|STARTED|Overall Study||24
1156044|NCT01454076|2806971|P2|STARTED|Overall Study||20
1156045|NCT01454076|2806972|P1|STARTED|Overall Study||29
1156046|NCT01416584|2807026|P3|NOT COMPLETED|Overall Study||1
1156047|NCT01416584|2807027|P2|NOT COMPLETED|Overall Study||2
1156048|NCT01416584|2807028|P1|NOT COMPLETED|Overall Study||3
1156049|NCT01416584|2807026|P3|COMPLETED|Overall Study||32
1156050|NCT01416584|2807027|P2|COMPLETED|Overall Study||33
1156051|NCT01416584|2807028|P1|COMPLETED|Overall Study||27
1156052|NCT01416584|2807026|P3|STARTED|Overall Study||33
1156053|NCT01416584|2807027|P2|STARTED|Overall Study||35
1156054|NCT01416584|2807028|P1|STARTED|Overall Study||30
1156055|NCT01415232|2807063|P1|NOT COMPLETED|Overall Study||0
1156056|NCT01415232|2807063|P1|COMPLETED|Overall Study||160
1156057|NCT01415232|2807063|P1|STARTED|Overall Study||160
1156058|NCT01371110|2807069|P2|NOT COMPLETED|Overall Study||0
1156059|NCT01371110|2807070|P1|NOT COMPLETED|Overall Study||0
1156060|NCT01371110|2807069|P2|COMPLETED|Overall Study||2
1156061|NCT01371110|2807070|P1|COMPLETED|Overall Study||1
1156062|NCT01371110|2807069|P2|STARTED|Overall Study||2
1156063|NCT01371110|2807070|P1|STARTED|Overall Study||1
1156064|NCT01344824|2807078|P1|NOT COMPLETED|Overall Study||37
1156065|NCT01344824|2807078|P1|COMPLETED|Overall Study||1
1156066|NCT01344824|2807078|P1|STARTED|Overall Study||38
1156067|NCT01313676|2807088|P4|NOT COMPLETED|Overall Study||994
1156068|NCT01313676|2807089|P3|NOT COMPLETED|Overall Study||1088
1156069|NCT01313676|2807090|P2|NOT COMPLETED|Overall Study||1113
1156070|NCT01313676|2807091|P1|NOT COMPLETED|Overall Study||1250
1156071|NCT01313676|2807088|P4|COMPLETED|Overall Study||3146
1156072|NCT01313676|2807089|P3|COMPLETED|Overall Study||3052
1156073|NCT01313676|2807090|P2|COMPLETED|Overall Study||3044
1156074|NCT01313676|2807091|P1|COMPLETED|Overall Study||2881
1156075|NCT01313676|2807088|P4|STARTED|Overall Study||4140
1156076|NCT01313676|2807089|P3|STARTED|Overall Study||4140
1156077|NCT01313676|2807090|P2|STARTED|Overall Study||4157
1156078|NCT01313676|2807091|P1|STARTED|Overall Study||4131
1156079|NCT01284504|2807111|P2|NOT COMPLETED|Overall Study||0
1156080|NCT01284504|2807112|P1|NOT COMPLETED|Overall Study||1
1156081|NCT01284504|2807111|P2|COMPLETED|Overall Study||0
1156082|NCT01284504|2807112|P1|COMPLETED|Overall Study||0
1156083|NCT01284504|2807111|P2|STARTED|Overall Study||0
1156084|NCT01284504|2807112|P1|STARTED|Overall Study|Patient changed her mind before randomization to any of the treatment groups|1
1156085|NCT01272232|2807121|P3|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||5
1156086|NCT01272232|2807122|P2|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||10
1156087|NCT01272232|2807123|P1|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||14
1156088|NCT01272232|2807121|P3|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||135
1156089|NCT01272232|2807122|P2|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||154
1156090|NCT01272232|2807123|P1|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||310
1156091|NCT01272232|2807121|P3|STARTED|Off Drug Follow-up Period (Weeks 56-68)||140
1156092|NCT01272232|2807122|P2|STARTED|Off Drug Follow-up Period (Weeks 56-68)||164
1156093|NCT01272232|2807123|P1|STARTED|Off Drug Follow-up Period (Weeks 56-68)||324
1156094|NCT01272232|2807121|P3|NOT COMPLETED|Weeks 0-56||72
1156095|NCT01272232|2807122|P2|NOT COMPLETED|Weeks 0-56||47
1156096|NCT01272232|2807123|P1|NOT COMPLETED|Weeks 0-56||99
1156097|NCT01272232|2807121|P3|COMPLETED|Weeks 0-56||140
1156098|NCT01272232|2807122|P2|COMPLETED|Weeks 0-56||164
1156099|NCT01272232|2807123|P1|COMPLETED|Weeks 0-56||324
1156100|NCT01272232|2807121|P3|Exposed|Weeks 0-56||212
1156101|NCT01272232|2807122|P2|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|210
1156102|NCT01272232|2807123|P1|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|422
1156103|NCT01272232|2807121|P3|STARTED|Weeks 0-56||212
1156104|NCT01272232|2807122|P2|STARTED|Weeks 0-56||211
1156105|NCT01272232|2807123|P1|STARTED|Weeks 0-56||423
1156106|NCT01272219|2807168|P6|NOT COMPLETED|Main + Extension Period: Week 0-172||422
1156107|NCT01272219|2807169|P5|NOT COMPLETED|Main + Extension Period: Week 0-172||722
1156108|NCT01272219|2807170|P4|NOT COMPLETED|Main + Extension Period: Week 0-172||0
1156109|NCT01272219|2807171|P3|NOT COMPLETED|Main + Extension Period: Week 0-172||0
1156110|NCT01272219|2807172|P2|NOT COMPLETED|Main + Extension Period: Week 0-172||0
1156111|NCT01272219|2807173|P1|NOT COMPLETED|Main + Extension Period: Week 0-172||0
1156112|NCT01272219|2807168|P6|COMPLETED|Main + Extension Period: Week 0-172||327
1156113|NCT01272219|2807169|P5|COMPLETED|Main + Extension Period: Week 0-172||783
1156114|NCT01272219|2807170|P4|COMPLETED|Main + Extension Period: Week 0-172||0
1156115|NCT01272219|2807171|P3|COMPLETED|Main + Extension Period: Week 0-172||0
1156116|NCT01272219|2807172|P2|COMPLETED|Main + Extension Period: Week 0-172||0
1156117|NCT01272219|2807173|P1|COMPLETED|Main + Extension Period: Week 0-172||0
1156118|NCT01272219|2807168|P6|Exposed|Main + Extension Period: Week 0-172||747
1156119|NCT01272219|2807169|P5|Exposed|Main + Extension Period: Week 0-172||1501
1156120|NCT01272219|2807170|P4|Exposed|Main + Extension Period: Week 0-172||0
1156121|NCT01272219|2807171|P3|Exposed|Main + Extension Period: Week 0-172||0
1156122|NCT01272219|2807172|P2|Exposed|Main + Extension Period: Week 0-172||0
1156123|NCT01272219|2807173|P1|Exposed|Main + Extension Period: Week 0-172||0
1156124|NCT01272219|2807168|P6|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|749
1156125|NCT01272219|2807169|P5|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|1505
1156126|NCT01272219|2807170|P4|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main and re-randomised period|0
1156127|NCT01272219|2807171|P3|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
1156128|NCT01272219|2807172|P2|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
1156129|NCT01272219|2807173|P1|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main period|0
1156130|NCT01272219|2807168|P6|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
1156131|NCT01272219|2807169|P5|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
1156132|NCT01272219|2807170|P4|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||15
1156133|NCT01272219|2807171|P3|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||7
1156134|NCT01272219|2807172|P2|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||9
1156135|NCT01272219|2807173|P1|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
1156136|NCT01272219|2807168|P6|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
1156137|NCT01272219|2807169|P5|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
1156138|NCT01272219|2807170|P4|COMPLETED|Re-randomised Period: Week 56 to Week 68||289
1156139|NCT01272219|2807171|P3|COMPLETED|Re-randomised Period: Week 56 to Week 68||343
1156140|NCT01272219|2807172|P2|COMPLETED|Re-randomised Period: Week 56 to Week 68||342
1156141|NCT01272219|2807173|P1|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
1156142|NCT01272219|2807168|P6|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
1156143|NCT01272219|2807169|P5|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
1156144|NCT01272219|2807170|P4|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|304
1156145|NCT01272219|2807171|P3|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|350
1156146|NCT01272219|2807172|P2|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|351
1156147|NCT01272219|2807173|P1|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
1156148|NCT01272219|2807168|P6|NOT COMPLETED|Main Period: Week 0 to Week 56||252
1156149|NCT01272219|2807169|P5|NOT COMPLETED|Main Period: Week 0 to Week 56||418
1156150|NCT01272219|2807170|P4|NOT COMPLETED|Main Period: Week 0 to Week 56||191
1156151|NCT01272219|2807171|P3|NOT COMPLETED|Main Period: Week 0 to Week 56||0
1156152|NCT01272219|2807172|P2|NOT COMPLETED|Main Period: Week 0 to Week 56||0
1156153|NCT01272219|2807173|P1|NOT COMPLETED|Main Period: Week 0 to Week 56||280
1156154|NCT01272219|2807168|P6|COMPLETED|Main Period: Week 0 to Week 56||505
1156155|NCT01272219|2807169|P5|COMPLETED|Main Period: Week 0 to Week 56||1110
1156156|NCT01272219|2807170|P4|COMPLETED|Main Period: Week 0 to Week 56||296
1156157|NCT01272219|2807171|P3|COMPLETED|Main Period: Week 0 to Week 56||0
1156158|NCT01272219|2807172|P2|COMPLETED|Main Period: Week 0 to Week 56||0
1156159|NCT01272219|2807173|P1|COMPLETED|Main Period: Week 0 to Week 56||679
1156160|NCT01272219|2807168|P6|Exposed|Main Period: Week 0 to Week 56||755
1156161|NCT01272219|2807169|P5|Exposed|Main Period: Week 0 to Week 56||1524
1156162|NCT01272219|2807170|P4|Exposed|Main Period: Week 0 to Week 56||487
1156163|NCT01272219|2807171|P3|Exposed|Main Period: Week 0 to Week 56||0
1156164|NCT01272219|2807172|P2|Exposed|Main Period: Week 0 to Week 56||0
1156165|NCT01272219|2807173|P1|Exposed|Main Period: Week 0 to Week 56||957
1156166|NCT01272219|2807168|P6|STARTED|Main Period: Week 0 to Week 56||757
1156167|NCT01272219|2807169|P5|STARTED|Main Period: Week 0 to Week 56||1528
1156168|NCT01272219|2807170|P4|STARTED|Main Period: Week 0 to Week 56||487
1156169|NCT01272219|2807171|P3|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
1156170|NCT01272219|2807172|P2|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
1156171|NCT01272219|2807173|P1|STARTED|Main Period: Week 0 to Week 56||959
1156172|NCT01263717|2807207|P2|NOT COMPLETED|Overall Study||6
1156173|NCT01263717|2807208|P1|NOT COMPLETED|Overall Study||5
1156174|NCT01263717|2807207|P2|COMPLETED|Overall Study||20
1156175|NCT01263717|2807208|P1|COMPLETED|Overall Study||23
1156176|NCT01263717|2807207|P2|Baseline Visit|Overall Study||22
1156177|NCT01263717|2807208|P1|Baseline Visit|Overall Study||28
1156178|NCT01263717|2807207|P2|STARTED|Overall Study||26
1156179|NCT01263717|2807208|P1|STARTED|Overall Study||28
1156180|NCT01243762|2807243|P7|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||6
1156181|NCT01243762|2807244|P6|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
1156182|NCT01243762|2807245|P5|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||4
1156183|NCT01243762|2807246|P4|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||2
1156184|NCT01243762|2807247|P3|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
1156185|NCT01243762|2807248|P2|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||5
1156186|NCT01243762|2807249|P1|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||1
1156187|NCT01243762|2807243|P7|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
1156188|NCT01243762|2807244|P6|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
1156189|NCT01243762|2807245|P5|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
1156190|NCT01243762|2807246|P4|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
1156191|NCT01243762|2807247|P3|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
1156192|NCT01243762|2807248|P2|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
1156193|NCT01243762|2807249|P1|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
1156194|NCT01243762|2807243|P7|STARTED|Part 2 (Dose Confirmation/Efficacy)|New participants were enrolled in Part 2 of the study that did not participate in Part 1|6
1156195|NCT01243762|2807244|P6|STARTED|Part 2 (Dose Confirmation/Efficacy)||0
1156196|NCT01243762|2807245|P5|STARTED|Part 2 (Dose Confirmation/Efficacy)||4
1156197|NCT01243762|2807246|P4|STARTED|Part 2 (Dose Confirmation/Efficacy)||2
1156198|NCT01243762|2807247|P3|STARTED|Part 2 (Dose Confirmation/Efficacy)||0
1156199|NCT01243762|2807248|P2|STARTED|Part 2 (Dose Confirmation/Efficacy)||5
1156200|NCT01243762|2807249|P1|STARTED|Part 2 (Dose Confirmation/Efficacy)||1
1156201|NCT01243762|2807243|P7|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||0
1156202|NCT01243762|2807244|P6|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
1156203|NCT01243762|2807245|P5|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6
1156204|NCT01243762|2807246|P4|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6
1156205|NCT01243762|2807247|P3|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
1156206|NCT01243762|2807248|P2|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||8
1156207|NCT01243762|2807249|P1|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
1156208|NCT01243762|2807243|P7|COMPLETED|Part 1 (Dose Escalation/MTD)||0
1156209|NCT01243762|2807244|P6|COMPLETED|Part 1 (Dose Escalation/MTD)||0
1156210|NCT01243762|2807245|P5|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|4
1156211|NCT01243762|2807246|P4|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|2
1156212|NCT01243762|2807247|P3|COMPLETED|Part 1 (Dose Escalation/MTD)||0
1156213|NCT01243762|2807248|P2|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|5
1156214|NCT01243762|2807249|P1|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|1
1156215|NCT01243762|2807243|P7|STARTED|Part 1 (Dose Escalation/MTD)||0
1156216|NCT01243762|2807244|P6|STARTED|Part 1 (Dose Escalation/MTD)||3
1156217|NCT01243762|2807245|P5|STARTED|Part 1 (Dose Escalation/MTD)||10
1156218|NCT01243762|2807246|P4|STARTED|Part 1 (Dose Escalation/MTD)||8
1156219|NCT01243762|2807247|P3|STARTED|Part 1 (Dose Escalation/MTD)||3
1156220|NCT01243762|2807248|P2|STARTED|Part 1 (Dose Escalation/MTD)||13
1156221|NCT01243762|2807249|P1|STARTED|Part 1 (Dose Escalation/MTD)||4
1156222|NCT01234831|2807270|P2|NOT COMPLETED|Overall Study||4
1156223|NCT01234831|2807271|P1|NOT COMPLETED|Overall Study||2
1156224|NCT01234831|2807270|P2|COMPLETED|Overall Study||198
1156225|NCT01234831|2807271|P1|COMPLETED|Overall Study||259
1156226|NCT01234831|2807270|P2|STARTED|Overall Study||202
1156227|NCT01234831|2807271|P1|STARTED|Overall Study||261
1156228|NCT01200355|2807285|P2|NOT COMPLETED|Overall Study||2
1156229|NCT01200355|2807286|P1|NOT COMPLETED|Overall Study||7
1156230|NCT01200355|2807285|P2|COMPLETED|Overall Study||53
1156231|NCT01200355|2807286|P1|COMPLETED|Overall Study||51
1156232|NCT01200355|2807285|P2|STARTED|Overall Study||55
1156233|NCT01200355|2807286|P1|STARTED|Overall Study||58
1156234|NCT01142297|2807300|P1|NOT COMPLETED|Overall Study||6
1156235|NCT01142297|2807300|P1|COMPLETED|Overall Study||18
1156236|NCT01142297|2807300|P1|STARTED|Overall Study||24
1156237|NCT01108445|2807308|P2|NOT COMPLETED|Overall Study||49
1156238|NCT01108445|2807309|P1|NOT COMPLETED|Overall Study||56
1156239|NCT01108445|2807308|P2|COMPLETED|Overall Study||2
1156240|NCT01108445|2807309|P1|COMPLETED|Overall Study||1
1156241|NCT01108445|2807308|P2|STARTED|Overall Study||51
1156242|NCT01108445|2807309|P1|STARTED|Overall Study||57
1156243|NCT01078909|2807348|P5|NOT COMPLETED|Overall Study||2
1156244|NCT01078909|2807349|P4|NOT COMPLETED|Overall Study||1
1156245|NCT01078909|2807350|P3|NOT COMPLETED|Overall Study||1
1156246|NCT01078909|2807351|P2|NOT COMPLETED|Overall Study||4
1156247|NCT01078909|2807352|P1|NOT COMPLETED|Overall Study||2
1156248|NCT01078909|2807348|P5|COMPLETED|Overall Study||23
1156249|NCT01078909|2807349|P4|COMPLETED|Overall Study||24
1156250|NCT01078909|2807350|P3|COMPLETED|Overall Study||24
1156251|NCT01078909|2807351|P2|COMPLETED|Overall Study||21
1156252|NCT01078909|2807352|P1|COMPLETED|Overall Study||23
1156253|NCT01078909|2807348|P5|STARTED|Overall Study||25
1156254|NCT01078909|2807349|P4|STARTED|Overall Study||25
1156255|NCT01078909|2807350|P3|STARTED|Overall Study||25
1156256|NCT01078909|2807351|P2|STARTED|Overall Study||25
1156257|NCT01078909|2807352|P1|STARTED|Overall Study||25
1156258|NCT01036321|2807376|P2|NOT COMPLETED|Overall Study||4
1156259|NCT01036321|2807377|P1|NOT COMPLETED|Overall Study||5
1156260|NCT01036321|2807376|P2|COMPLETED|Overall Study||31
1156261|NCT01036321|2807377|P1|COMPLETED|Overall Study||31
1156262|NCT01036321|2807376|P2|STARTED|Overall Study||35
1156263|NCT01036321|2807377|P1|STARTED|Overall Study||36
1156264|NCT01014533|2807403|P2|NOT COMPLETED|Overall Study||5
1156265|NCT01014533|2807404|P1|NOT COMPLETED|Overall Study||5
1156266|NCT01014533|2807403|P2|COMPLETED|Overall Study||25
1156267|NCT01014533|2807404|P1|COMPLETED|Overall Study||24
1156268|NCT01014533|2807403|P2|STARTED|Overall Study||30
1156269|NCT01014533|2807404|P1|STARTED|Overall Study||29
1156270|NCT01000506|2807418|P4|NOT COMPLETED|Overall Study||23
1156271|NCT01000506|2807419|P3|NOT COMPLETED|Overall Study||21
1156272|NCT01000506|2807420|P2|NOT COMPLETED|Overall Study||24
1156273|NCT01000506|2807421|P1|NOT COMPLETED|Overall Study||28
1156274|NCT01000506|2807418|P4|COMPLETED|Overall Study||133
1156275|NCT01000506|2807419|P3|COMPLETED|Overall Study||131
1156276|NCT01000506|2807420|P2|COMPLETED|Overall Study||129
1156277|NCT01000506|2807421|P1|COMPLETED|Overall Study||127
1156278|NCT01000506|2807418|P4|STARTED|Overall Study||156
1156279|NCT01000506|2807419|P3|STARTED|Overall Study||152
1156280|NCT01000506|2807420|P2|STARTED|Overall Study||153
1156281|NCT01000506|2807421|P1|STARTED|Overall Study||155
1156282|NCT00981149|2807465|P2|NOT COMPLETED|Overall Study||3
1156283|NCT00981149|2807466|P1|NOT COMPLETED|Overall Study||2
1156284|NCT00981149|2807465|P2|COMPLETED|Overall Study||9
1156285|NCT00981149|2807466|P1|COMPLETED|Overall Study||10
1156286|NCT00981149|2807465|P2|STARTED|Overall Study||12
1156287|NCT00981149|2807466|P1|STARTED|Overall Study||12
1156288|NCT00950300|2807474|P2|NOT COMPLETED|SFU Period||54
1156289|NCT00950300|2807475|P1|NOT COMPLETED|SFU Period||53
1156290|NCT00950300|2807474|P2|COMPLETED|SFU Period|Participants who consented to 2 years of follow-up only.|22
1156291|NCT00950300|2807475|P1|COMPLETED|SFU Period|Participants who consented to 2 years of follow-up only.|22
1156292|NCT00950300|2807474|P2|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|76
1156293|NCT00950300|2807475|P1|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|75
1156294|NCT00950300|2807474|P2|NOT COMPLETED|TFFU Period||252
1156295|NCT00950300|2807475|P1|NOT COMPLETED|TFFU Period||254
1156296|NCT00950300|2807474|P2|COMPLETED|TFFU Period|Participants who consented to 2 years of follow-up only; includes 7 participants with missing data.|16
1156297|NCT00950300|2807475|P1|COMPLETED|TFFU Period|Participants who consented to 2 years of follow-up only; includes 3 participants with missing data.|11
1156298|NCT00950300|2807474|P2|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|268
1156299|NCT00950300|2807475|P1|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|265
1156300|NCT00950300|2807474|P2|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
1156301|NCT00950300|2807475|P1|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
1156302|NCT00950300|2807474|P2|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||255
1156303|NCT00950300|2807475|P1|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||257
1156304|NCT00950300|2807474|P2|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||274
1156305|NCT00950300|2807475|P1|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||277
1156306|NCT00950300|2807474|P2|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||273
1156307|NCT00950300|2807475|P1|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||278
1156308|NCT00950300|2807474|P2|STARTED|Neoadjuvant/Adjuvant Treatment Periods||297
1156309|NCT00950300|2807475|P1|STARTED|Neoadjuvant/Adjuvant Treatment Periods||299
1156310|NCT00868608|2807531|P3|NOT COMPLETED|Overall Study||5
1156311|NCT00868608|2807532|P2|NOT COMPLETED|Overall Study||3
1156312|NCT00868608|2807533|P1|NOT COMPLETED|Overall Study||23
1156313|NCT00868608|2807531|P3|COMPLETED|Overall Study||0
1156314|NCT00868608|2807532|P2|COMPLETED|Overall Study||1
1156315|NCT00868608|2807533|P1|COMPLETED|Overall Study||49
1156316|NCT00868608|2807531|P3|STARTED|Overall Study||5
1156317|NCT00868608|2807532|P2|STARTED|Overall Study||4
1156318|NCT00868608|2807533|P1|STARTED|Overall Study||72
1156319|NCT00860743|2807563|P2|NOT COMPLETED|Overall Study||0
1156320|NCT00860743|2807564|P1|NOT COMPLETED|Overall Study||3
1156321|NCT00860743|2807563|P2|COMPLETED|Overall Study||23
1156322|NCT00860743|2807564|P1|COMPLETED|Overall Study||37
1156323|NCT00860743|2807563|P2|STARTED|Overall Study||23
1156324|NCT00860743|2807564|P1|STARTED|Overall Study||40
1156325|NCT00858494|2807570|P1|NOT COMPLETED|Overall Study||4
1156326|NCT00858494|2807570|P1|COMPLETED|Overall Study|2 participants dropped out before giving study medication. Symptoms resolved without a dose in 2.|45
1156327|NCT00858494|2807570|P1|STARTED|Overall Study||49
1156328|NCT00845182|2807578|P3|NOT COMPLETED|Overall Study||6
1156329|NCT00845182|2807579|P2|NOT COMPLETED|Overall Study||4
1156330|NCT00845182|2807580|P1|NOT COMPLETED|Overall Study||3
1156331|NCT00845182|2807578|P3|COMPLETED|Overall Study||9
1156332|NCT00845182|2807579|P2|COMPLETED|Overall Study||11
1156333|NCT00845182|2807580|P1|COMPLETED|Overall Study||10
1156334|NCT00845182|2807578|P3|STARTED|Overall Study||15
1156335|NCT00845182|2807579|P2|STARTED|Overall Study||15
1156336|NCT00845182|2807580|P1|STARTED|Overall Study||13
1156337|NCT00781937|2807593|P2|NOT COMPLETED|Follow up Period (Week 56-68)||5
1156338|NCT00781937|2807594|P1|NOT COMPLETED|Follow up Period (Week 56-68)||6
1156339|NCT00781937|2807593|P2|COMPLETED|Follow up Period (Week 56-68)||141
1156340|NCT00781937|2807594|P1|COMPLETED|Follow up Period (Week 56-68)||153
1156341|NCT00781937|2807593|P2|STARTED|Follow up Period (Week 56-68)||146
1156342|NCT00781937|2807594|P1|STARTED|Follow up Period (Week 56-68)||159
1156343|NCT00781937|2807593|P2|NOT COMPLETED|Main Trial Period Through Week 56||64
1156344|NCT00781937|2807594|P1|NOT COMPLETED|Main Trial Period Through Week 56||53
1156345|NCT00781937|2807593|P2|COMPLETED|Main Trial Period Through Week 56||146
1156346|NCT00781937|2807594|P1|COMPLETED|Main Trial Period Through Week 56||159
1156347|NCT00781937|2807593|P2|STARTED|Main Trial Period Through Week 56||210
1156348|NCT00781937|2807594|P1|STARTED|Main Trial Period Through Week 56||212
1156349|NCT00721409|2807653|P3|NOT COMPLETED|Overall Study||81
1156350|NCT00721409|2807654|P2|NOT COMPLETED|Overall Study||84
1156351|NCT00721409|2807655|P1|NOT COMPLETED|Overall Study||12
1156352|NCT00721409|2807653|P3|COMPLETED|Overall Study||0
1156353|NCT00721409|2807654|P2|COMPLETED|Overall Study||0
1156354|NCT00721409|2807655|P1|COMPLETED|Overall Study||0
1156355|NCT00721409|2807653|P3|Treated|Overall Study||77
1156356|NCT00721409|2807654|P2|Treated|Overall Study||83
1156357|NCT00721409|2807655|P1|Treated|Overall Study||12
1156358|NCT00721409|2807653|P3|STARTED|Overall Study||81
1156359|NCT00721409|2807654|P2|STARTED|Overall Study||84
1156360|NCT00721409|2807655|P1|STARTED|Overall Study||12
1156361|NCT00719186|2807780|P2|NOT COMPLETED|Overall Study||0
1156362|NCT00719186|2807781|P1|NOT COMPLETED|Overall Study||0
1156363|NCT00719186|2807780|P2|COMPLETED|Overall Study||374
1156364|NCT00719186|2807781|P1|COMPLETED|Overall Study||376
1156365|NCT00719186|2807780|P2|STARTED|Overall Study||374
1156366|NCT00719186|2807781|P1|STARTED|Overall Study||376
1156367|NCT00690924|2807795|P1|NOT COMPLETED|Overall Study||0
1156368|NCT00690924|2807795|P1|COMPLETED|Overall Study||16
1156369|NCT00690924|2807795|P1|STARTED|Overall Study||16
1156370|NCT00581529|2807799|P1|NOT COMPLETED|Overall Study||0
1156371|NCT00581529|2807799|P1|COMPLETED|Overall Study||34
1156372|NCT00581529|2807799|P1|STARTED|Overall Study||34
1156373|NCT00581256|2807808|P2|NOT COMPLETED|Overall Study||0
1156374|NCT00581256|2807809|P1|NOT COMPLETED|Overall Study||0
1156375|NCT00581256|2807808|P2|COMPLETED|Overall Study||26
1156376|NCT00581256|2807809|P1|COMPLETED|Overall Study||28
1156377|NCT00581256|2807808|P2|STARTED|Overall Study||26
1156378|NCT00581256|2807809|P1|STARTED|Overall Study||28
1156379|NCT00578331|2807823|P2|NOT COMPLETED|Overall Study||125
1156380|NCT00578331|2807824|P1|NOT COMPLETED|Overall Study||116
1156381|NCT00578331|2807823|P2|COMPLETED|Overall Study||320
1156382|NCT00578331|2807824|P1|COMPLETED|Overall Study||329
1156383|NCT00578331|2807823|P2|STARTED|Overall Study||445
1156384|NCT00578331|2807824|P1|STARTED|Overall Study||445
1156385|NCT00542425|2807837|P5|NOT COMPLETED|Extended 24 Weeks of Treatment||1
1156386|NCT00542425|2807838|P4|NOT COMPLETED|Extended 24 Weeks of Treatment||1
1156387|NCT00542425|2807839|P3|NOT COMPLETED|Extended 24 Weeks of Treatment||2
1156388|NCT00542425|2807840|P2|NOT COMPLETED|Extended 24 Weeks of Treatment||2
1156389|NCT00542425|2807841|P1|NOT COMPLETED|Extended 24 Weeks of Treatment||1
1156390|NCT00542425|2807837|P5|COMPLETED|Extended 24 Weeks of Treatment||13
1156391|NCT00542425|2807838|P4|COMPLETED|Extended 24 Weeks of Treatment||6
1156392|NCT00542425|2807839|P3|COMPLETED|Extended 24 Weeks of Treatment||8
1156393|NCT00542425|2807840|P2|COMPLETED|Extended 24 Weeks of Treatment||11
1156394|NCT00542425|2807841|P1|COMPLETED|Extended 24 Weeks of Treatment||10
1156395|NCT00542425|2807837|P5|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|14
1156396|NCT00542425|2807838|P4|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|7
1156397|NCT00542425|2807839|P3|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|10
1156398|NCT00542425|2807840|P2|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|13
1156399|NCT00542425|2807841|P1|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|11
1156400|NCT00542425|2807837|P5|NOT COMPLETED|Initial 24 Weeks||6
1156401|NCT00542425|2807838|P4|NOT COMPLETED|Initial 24 Weeks||11
1156402|NCT00542425|2807839|P3|NOT COMPLETED|Initial 24 Weeks||7
1156403|NCT00542425|2807840|P2|NOT COMPLETED|Initial 24 Weeks||10
1156404|NCT00542425|2807841|P1|NOT COMPLETED|Initial 24 Weeks||4
1156405|NCT00542425|2807837|P5|COMPLETED|Initial 24 Weeks||39
1156406|NCT00542425|2807838|P4|COMPLETED|Initial 24 Weeks||34
1156407|NCT00542425|2807839|P3|COMPLETED|Initial 24 Weeks||36
1156408|NCT00542425|2807840|P2|COMPLETED|Initial 24 Weeks||33
1156409|NCT00542425|2807841|P1|COMPLETED|Initial 24 Weeks||42
1156410|NCT00542425|2807837|P5|STARTED|Initial 24 Weeks||45
1156411|NCT00542425|2807838|P4|STARTED|Initial 24 Weeks||45
1156412|NCT00542425|2807839|P3|STARTED|Initial 24 Weeks||43
1156413|NCT00542425|2807840|P2|STARTED|Initial 24 Weeks||43
1156414|NCT00542425|2807841|P1|STARTED|Initial 24 Weeks||46
1156415|NCT00537290|2807873|P1|NOT COMPLETED|Overall Study||0
1156416|NCT00537290|2807873|P1|COMPLETED|Overall Study||19
1156417|NCT00537290|2807873|P1|STARTED|Overall Study||19
1156418|NCT00521885|2807880|P2|NOT COMPLETED|Overall Study||0
1156419|NCT00521885|2807881|P1|NOT COMPLETED|Overall Study||0
1156420|NCT00521885|2807880|P2|COMPLETED|Overall Study||0
1156421|NCT00521885|2807881|P1|COMPLETED|Overall Study||0
1156422|NCT00521885|2807880|P2|STARTED|Overall Study||0
1156423|NCT00521885|2807881|P1|STARTED|Overall Study||0
1156424|NCT00495469|2807896|P7|NOT COMPLETED|Overall Study||5
1156425|NCT00495469|2807897|P6|NOT COMPLETED|Overall Study||5
1156426|NCT00495469|2807898|P5|NOT COMPLETED|Overall Study||5
1156427|NCT00495469|2807899|P4|NOT COMPLETED|Overall Study||4
1156428|NCT00495469|2807900|P3|NOT COMPLETED|Overall Study||7
1156429|NCT00495469|2807901|P2|NOT COMPLETED|Overall Study||7
1156430|NCT00495469|2807902|P1|NOT COMPLETED|Overall Study||6
1156431|NCT00495469|2807896|P7|COMPLETED|Overall Study||30
1156432|NCT00495469|2807897|P6|COMPLETED|Overall Study||31
1156433|NCT00495469|2807898|P5|COMPLETED|Overall Study||31
1156434|NCT00495469|2807899|P4|COMPLETED|Overall Study||32
1156435|NCT00495469|2807900|P3|COMPLETED|Overall Study||27
1156436|NCT00495469|2807901|P2|COMPLETED|Overall Study||30
1156437|NCT00495469|2807902|P1|COMPLETED|Overall Study||30
1156438|NCT00495469|2807896|P7|STARTED|Overall Study||35
1156439|NCT00495469|2807897|P6|STARTED|Overall Study||36
1156440|NCT00495469|2807898|P5|STARTED|Overall Study||36
1156441|NCT00495469|2807899|P4|STARTED|Overall Study||36
1156442|NCT00495469|2807900|P3|STARTED|Overall Study||34
1156443|NCT00495469|2807901|P2|STARTED|Overall Study||37
1156444|NCT00495469|2807902|P1|STARTED|Overall Study||36
1156445|NCT00442611|2808046|P2|NOT COMPLETED|Overall Study||0
1156446|NCT00442611|2808047|P1|NOT COMPLETED|Overall Study||1
1156447|NCT00442611|2808046|P2|COMPLETED|Overall Study||3
1156448|NCT00442611|2808047|P1|COMPLETED|Overall Study||6
1156449|NCT00442611|2808046|P2|STARTED|Overall Study||3
1156450|NCT00442611|2808047|P1|STARTED|Overall Study||7
1156451|NCT00425802|2808063|P1|NOT COMPLETED|Overall Study||0
1156452|NCT00425802|2808063|P1|COMPLETED|Overall Study||61
1156453|NCT00425802|2808063|P1|STARTED|Overall Study||61
1156454|NCT00422058|2808081|P6|NOT COMPLETED|Open-Label Extension, Week 20-104||34
1156455|NCT00422058|2808082|P5|NOT COMPLETED|Open-Label Extension, Week 20-104||35
1156456|NCT00422058|2808083|P4|NOT COMPLETED|Open-Label Extension, Week 20-104||28
1156457|NCT00422058|2808084|P3|NOT COMPLETED|Open-Label Extension, Week 20-104||36
1156458|NCT00422058|2808085|P2|NOT COMPLETED|Open-Label Extension, Week 20-104||39
1156459|NCT00422058|2808086|P1|NOT COMPLETED|Open-Label Extension, Week 20-104||32
1156460|NCT00422058|2808081|P6|COMPLETED|Open-Label Extension, Week 20-104||45
1156461|NCT00422058|2808082|P5|COMPLETED|Open-Label Extension, Week 20-104||47
1156462|NCT00422058|2808083|P4|COMPLETED|Open-Label Extension, Week 20-104||45
1156463|NCT00422058|2808084|P3|COMPLETED|Open-Label Extension, Week 20-104||38
1156464|NCT00422058|2808085|P2|COMPLETED|Open-Label Extension, Week 20-104||46
1156465|NCT00422058|2808086|P1|COMPLETED|Open-Label Extension, Week 20-104||47
1156466|NCT00422058|2808081|P6|Enrolled in Extension|Open-Label Extension, Week 20-104||67
1156467|NCT00422058|2808082|P5|Enrolled in Extension|Open-Label Extension, Week 20-104||72
1156468|NCT00422058|2808083|P4|Enrolled in Extension|Open-Label Extension, Week 20-104||65
1156469|NCT00422058|2808084|P3|Enrolled in Extension|Open-Label Extension, Week 20-104||59
1156470|NCT00422058|2808085|P2|Enrolled in Extension|Open-Label Extension, Week 20-104||68
1156471|NCT00422058|2808086|P1|Enrolled in Extension|Open-Label Extension, Week 20-104||67
1156472|NCT00422058|2808081|P6|STARTED|Open-Label Extension, Week 20-104||79
1156473|NCT00422058|2808082|P5|STARTED|Open-Label Extension, Week 20-104||82
1156474|NCT00422058|2808083|P4|STARTED|Open-Label Extension, Week 20-104||73
1156475|NCT00422058|2808084|P3|STARTED|Open-Label Extension, Week 20-104||74
1156476|NCT00422058|2808085|P2|STARTED|Open-Label Extension, Week 20-104||85
1156477|NCT00422058|2808086|P1|STARTED|Open-Label Extension, Week 20-104||79
1156478|NCT00422058|2808081|P6|NOT COMPLETED|Double-Blind, Week 0-20||16
1156479|NCT00422058|2808082|P5|NOT COMPLETED|Double-Blind, Week 0-20||11
1156480|NCT00422058|2808083|P4|NOT COMPLETED|Double-Blind, Week 0-20||20
1156481|NCT00422058|2808084|P3|NOT COMPLETED|Double-Blind, Week 0-20||16
1156482|NCT00422058|2808085|P2|NOT COMPLETED|Double-Blind, Week 0-20||10
1156483|NCT00422058|2808086|P1|NOT COMPLETED|Double-Blind, Week 0-20||19
1156484|NCT00422058|2808081|P6|COMPLETED|Double-Blind, Week 0-20||79
1156485|NCT00422058|2808082|P5|COMPLETED|Double-Blind, Week 0-20||82
1156486|NCT00422058|2808083|P4|COMPLETED|Double-Blind, Week 0-20||73
1156487|NCT00422058|2808084|P3|COMPLETED|Double-Blind, Week 0-20||74
1156488|NCT00422058|2808085|P2|COMPLETED|Double-Blind, Week 0-20||85
1156489|NCT00422058|2808086|P1|COMPLETED|Double-Blind, Week 0-20||79
1156490|NCT00422058|2808081|P6|STARTED|Double-Blind, Week 0-20||95
1156491|NCT00422058|2808082|P5|STARTED|Double-Blind, Week 0-20||93
1156492|NCT00422058|2808083|P4|STARTED|Double-Blind, Week 0-20||93
1156493|NCT00422058|2808084|P3|STARTED|Double-Blind, Week 0-20||90
1156494|NCT00422058|2808085|P2|STARTED|Double-Blind, Week 0-20||95
1156495|NCT00422058|2808086|P1|STARTED|Double-Blind, Week 0-20||98
1156496|NCT00359736|2808216|P2|NOT COMPLETED|Overall Study||0
1156497|NCT00359736|2808217|P1|NOT COMPLETED|Overall Study||0
1156498|NCT00359736|2808216|P2|COMPLETED|Overall Study||15
1156499|NCT00359736|2808217|P1|COMPLETED|Overall Study||14
1156500|NCT00359736|2808216|P2|STARTED|Overall Study||15
1156501|NCT00359736|2808217|P1|STARTED|Overall Study||14
1156502|NCT00331344|2808225|P9|NOT COMPLETED|Phase II||4
1156503|NCT00331344|2808226|P8|NOT COMPLETED|Phase II||0
1156504|NCT00331344|2808227|P7|NOT COMPLETED|Phase II||0
1156505|NCT00331344|2808228|P6|NOT COMPLETED|Phase II||0
1156506|NCT00331344|2808229|P5|NOT COMPLETED|Phase II||0
1156507|NCT00331344|2808230|P4|NOT COMPLETED|Phase II||0
1156508|NCT00331344|2808231|P3|NOT COMPLETED|Phase II||0
1156509|NCT00331344|2808232|P2|NOT COMPLETED|Phase II||0
1156510|NCT00331344|2808233|P1|NOT COMPLETED|Phase II||0
1156511|NCT00331344|2808225|P9|COMPLETED|Phase II||48
1156512|NCT00331344|2808226|P8|COMPLETED|Phase II||6
1156513|NCT00331344|2808227|P7|COMPLETED|Phase II||0
1156514|NCT00331344|2808228|P6|COMPLETED|Phase II||0
1156515|NCT00331344|2808229|P5|COMPLETED|Phase II||0
1156516|NCT00331344|2808230|P4|COMPLETED|Phase II||0
1156517|NCT00331344|2808231|P3|COMPLETED|Phase II||0
1156518|NCT00331344|2808232|P2|COMPLETED|Phase II||0
1156519|NCT00331344|2808233|P1|COMPLETED|Phase II||0
1156520|NCT00331344|2808225|P9|STARTED|Phase II|Protocol enrollment (63) minus 11 ineligible prior to receiving treatment.|52
1156521|NCT00331344|2808226|P8|STARTED|Phase II|6 patients in Phase I Group VIa continued to the Phase II period.|6
1156522|NCT00331344|2808227|P7|STARTED|Phase II||0
1156523|NCT00331344|2808228|P6|STARTED|Phase II||0
1156524|NCT00331344|2808229|P5|STARTED|Phase II||0
1156525|NCT00331344|2808230|P4|STARTED|Phase II||0
1156526|NCT00331344|2808231|P3|STARTED|Phase II||0
1156527|NCT00331344|2808232|P2|STARTED|Phase II||0
1156528|NCT00331344|2808233|P1|STARTED|Phase II||0
1156529|NCT00331344|2808225|P9|NOT COMPLETED|Phase I||0
1156530|NCT00331344|2808226|P8|NOT COMPLETED|Phase I||1
1156531|NCT00331344|2808227|P7|NOT COMPLETED|Phase I||0
1156532|NCT00331344|2808228|P6|NOT COMPLETED|Phase I||2
1156533|NCT00331344|2808229|P5|NOT COMPLETED|Phase I||2
1156534|NCT00331344|2808230|P4|NOT COMPLETED|Phase I||1
1156535|NCT00331344|2808231|P3|NOT COMPLETED|Phase I||0
1156536|NCT00331344|2808232|P2|NOT COMPLETED|Phase I||0
1156537|NCT00331344|2808233|P1|NOT COMPLETED|Phase I||0
1156538|NCT00331344|2808225|P9|COMPLETED|Phase I||0
1156539|NCT00331344|2808226|P8|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5
1156540|NCT00331344|2808227|P7|COMPLETED|Phase I||4
1156541|NCT00331344|2808228|P6|COMPLETED|Phase I|2 participants reached dose limiting toxicity|3
1156542|NCT00331344|2808229|P5|COMPLETED|Phase I|2 participants reached dose limiting toxicity|4
1156543|NCT00331344|2808230|P4|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5
1156544|NCT00331344|2808231|P3|COMPLETED|Phase I||3
1156545|NCT00331344|2808232|P2|COMPLETED|Phase I||3
1156546|NCT00331344|2808233|P1|COMPLETED|Phase I||3
1156547|NCT00331344|2808225|P9|STARTED|Phase I||0
1156548|NCT00331344|2808226|P8|STARTED|Phase I|1 participant who was enrolled died prior to initiating protocol therapy.|6
1156549|NCT00331344|2808227|P7|STARTED|Phase I||4
1156550|NCT00331344|2808228|P6|STARTED|Phase I||5
1156551|NCT00331344|2808229|P5|STARTED|Phase I||6
1156552|NCT00331344|2808230|P4|STARTED|Phase I||6
1156553|NCT00331344|2808231|P3|STARTED|Phase I||3
1156554|NCT00331344|2808232|P2|STARTED|Phase I||3
1156555|NCT00331344|2808233|P1|STARTED|Phase I||3
1156556|NCT00266864|2808249|P2|NOT COMPLETED|Overall Study||2
1156557|NCT00266864|2808250|P1|NOT COMPLETED|Overall Study||5
1156558|NCT00266864|2808249|P2|COMPLETED|Overall Study||11
1156559|NCT00266864|2808250|P1|COMPLETED|Overall Study||13
1156560|NCT00266864|2808249|P2|STARTED|Overall Study||13
1156561|NCT00266864|2808250|P1|STARTED|Overall Study||18
1156562|NCT00249470|2808259|P2|NOT COMPLETED|Overall Study||0
1156563|NCT00249470|2808260|P1|NOT COMPLETED|Overall Study||0
1156564|NCT00249470|2808259|P2|COMPLETED|Overall Study||28
1156565|NCT00249470|2808260|P1|COMPLETED|Overall Study||28
1156566|NCT00249470|2808259|P2|STARTED|Overall Study||28
1156567|NCT00249470|2808260|P1|STARTED|Overall Study||28
1156568|NCT00223795|2808270|P2|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
1156569|NCT00223795|2808271|P1|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
1156570|NCT00223795|2808270|P2|COMPLETED|Second Intervention - All Use Canes 4 mo||17
1156571|NCT00223795|2808271|P1|COMPLETED|Second Intervention - All Use Canes 4 mo||18
1156572|NCT00223795|2808270|P2|STARTED|Second Intervention - All Use Canes 4 mo||18
1156573|NCT00223795|2808271|P1|STARTED|Second Intervention - All Use Canes 4 mo||19
1156574|NCT00223795|2808270|P2|NOT COMPLETED|First Intervention - Eight Weeks||9
1156575|NCT00223795|2808271|P1|NOT COMPLETED|First Intervention - Eight Weeks||7
1156576|NCT00223795|2808270|P2|COMPLETED|First Intervention - Eight Weeks||18
1156577|NCT00223795|2808271|P1|COMPLETED|First Intervention - Eight Weeks||19
1156578|NCT00223795|2808270|P2|STARTED|First Intervention - Eight Weeks||27
1156579|NCT00223795|2808271|P1|STARTED|First Intervention - Eight Weeks||26
1156580|NCT00005044|2808280|P2|NOT COMPLETED|Overall Study||52
1156581|NCT00005044|2808281|P1|NOT COMPLETED|Overall Study||38
1156582|NCT00005044|2808280|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|737
1156583|NCT00005044|2808281|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|752
1156584|NCT00005044|2808280|P2|STARTED|Overall Study||789
1156585|NCT00005044|2808281|P1|STARTED|Overall Study||790
